Age_modified	ID	Flank3	UTR3	Flank5	UTR5	Frame_Shift_Del	Frame_Shift_Ins	In_Frame_Del	In_Frame_Ins	Intron	Missense_Mutation	Nonsense_Mutation	Nonstop_Mutation	RNA	Silent	Splice_Site	Translation_Start_Site	CNV_ID	CNV_nsegs	CNV_fracaltered	CNV_nextrama	ABS_ID	ABS_number	ABS_ASprime	ABS_LOH_nseg	ABS_LOH_frac_altered	HRD_ID	HRD_AI1	HRD_lst1	HRD-LOH	HRD	Sample_Status	CNum	bcr_patient_barcode	type	age_at_initial_pathologic_diagnosis	gender	race	ajcc_pathologic_tumor_stage	clinical_stage	histological_type	histological_grade	initial_pathologic_dx_year	menopause_status	birth_days_to	vital_status	tumor_status	last_contact_days_to	death_days_to	cause_of_death	new_tumor_event_type	new_tumor_event_site	new_tumor_event_site_other	new_tumor_event_dx_days_to	treatment_outcome_first_course	margin_status	residual_tumor	OS	OS.time	DSS	DSS.time	DFI	DFI.time	PFI	PFI.time	Redaction
60	TCGA-OR-A5J1	0	2	0	0	3	0	0	0	3	19	0	0	0	14	1	0	TCGA-OR-A5J1-01	692	0.07489330437929173	495	TCGA-OR-A5J1-01	2	3	114	0.03605866535351095	TCGA-OR-A5J1-01	3	2	2	7	PASS	1	TCGA-OR-A5J1	ACC	58	MALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2000	NA	-21496	Dead	WITH TUMOR	NA	1355	NA	Distant Metastasis	Peritoneal Surfaces	NA	754	Complete Remission/Response	NA	NA	1	1355	1	1355	1	754	1	754	
40	TCGA-OR-A5J2	0	4	0	3	2	0	0	0	1	22	4	0	1	8	0	0	TCGA-OR-A5J2-01	131	0.8873981321896378	72	TCGA-OR-A5J2-01	10	19	229	0.7366713819888221	TCGA-OR-A5J2-01	4	2	3	9	PASS	2	TCGA-OR-A5J2	ACC	44	FEMALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2004	NA	-16090	Dead	WITH TUMOR	NA	1677	NA	Distant Metastasis	Soft Tissue	NA	289	Progressive Disease	NA	NA	1	1677	1	1677	NA	NA	1	289	
30	TCGA-OR-A5J3	0	3	0	0	0	0	0	0	2	9	1	0	0	4	0	0	TCGA-OR-A5J3-01	123	0.9477115188436576	70	TCGA-OR-A5J3-01	12	15	206	0.7329490662336793	TCGA-OR-A5J3-01	0	0	0	0	PASS	3	TCGA-OR-A5J3	ACC	23	FEMALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2008	NA	-8624	Alive	WITH TUMOR	2091	NA	NA	Distant Metastasis	Lung	NA	53	Complete Remission/Response	NA	NA	0	2091	0	2091	1	53	1	53	
30	TCGA-OR-A5J4	0	9	1	7	3	1	4	0	3	97	7	0	3	30	4	0	TCGA-OR-A5J4-01	611	0.987138825332568	416	TCGA-OR-A5J4-01	17	33	221	0.2659856835491811	TCGA-OR-A5J4-01	18	24	5	47	PASS	4	TCGA-OR-A5J4	ACC	23	FEMALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2000	NA	-8451	Dead	WITH TUMOR	NA	423	NA	Locoregional Recurrence	Peritoneal Surfaces	NA	126	Progressive Disease	NA	NA	1	423	1	423	NA	NA	1	126	
30	TCGA-OR-A5J5	3	35	0	9	23	6	2	0	15	305	14	0	5	128	1	0	TCGA-OR-A5J5-01	130	0.9477442297372736	72	TCGA-OR-A5J5-01	33	18	104	0.5781837099027659	TCGA-OR-A5J5-01	2	2	4	8	PASS	5	TCGA-OR-A5J5	ACC	30	MALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2000	NA	-11171	Dead	WITH TUMOR	NA	365	NA	Locoregional Recurrence	"Other, specify"	vena cava thrombus	50	Progressive Disease	NA	NA	1	365	1	365	NA	NA	1	50	
30	TCGA-OR-A5J6	0	1	0	0	0	0	0	0	0	28	0	0	0	11	1	0	TCGA-OR-A5J6-01	79	0.5929021536386695	39	TCGA-OR-A5J6-01	22	16	39	0.09792749682313598	TCGA-OR-A5J6-01	3	1	1	5	PASS	6	TCGA-OR-A5J6	ACC	29	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2006	NA	-10839	Alive	TUMOR FREE	2703	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2703	0	2703	0	2703	0	2703	
30	TCGA-OR-A5J7	1	2	0	2	3	1	0	1	2	41	2	0	0	8	0	0	TCGA-OR-A5J7-01	467	0.9470142627985508	308	TCGA-OR-A5J7-01	24	35	169	0.2788113157702094	TCGA-OR-A5J7-01	10	8	3	21	PASS	7	TCGA-OR-A5J7	ACC	30	FEMALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2009	NA	-11279	Dead	WITH TUMOR	NA	490	NA	Locoregional Recurrence	Retroperitoneal lymph nodes	NA	162	Progressive Disease	NA	NA	1	490	1	490	NA	NA	1	162	
70	TCGA-OR-A5J8	0	8	1	1	0	0	1	0	2	71	13	0	2	25	2	0	TCGA-OR-A5J8-01	324	0.6117824290187592	202	TCGA-OR-A5J8-01	7	19	343	0.7816219541009444	TCGA-OR-A5J8-01	7	2	7	16	PASS	8	TCGA-OR-A5J8	ACC	66	MALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-24266	Dead	WITH TUMOR	NA	579	NA	Locoregional Recurrence	Peritoneal Surfaces	NA	530	Complete Remission/Response	NA	NA	1	579	1	579	1	530	1	530	
30	TCGA-OR-A5J9	0	4	1	0	1	0	0	0	1	29	0	0	1	6	0	0	TCGA-OR-A5J9-01	212	0.947049816065928	121	TCGA-OR-A5J9-01	27	26	134	0.4130879708913165	TCGA-OR-A5J9-01	9	4	5	18	PASS	9	TCGA-OR-A5J9	ACC	22	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2010	NA	-8175	Alive	WITH TUMOR	1352	NA	NA	Distant Metastasis	Lung	NA	414	Complete Remission/Response	NA	NA	0	1352	0	1352	1	414	1	414	
50	TCGA-OR-A5JA	0	40	8	16	2	1	0	0	26	373	81	2	8	97	12	2	TCGA-OR-A5JA-01	252	0.8194973922403447	144	TCGA-OR-A5JA-01	33	25	206	0.5319051658412531	TCGA-OR-A5JA-01	14	12	5	31	PASS	10	TCGA-OR-A5JA	ACC	53	FEMALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2004	NA	-19436	Dead	WITH TUMOR	NA	922	NA	NA	NA	NA	NA	NA	NA	NA	1	922	1	922	NA	NA	1	922	
50	TCGA-OR-A5JB	3	25	3	12	7	3	0	0	8	238	26	0	10	87	8	1	TCGA-OR-A5JB-01	143	0.8809434249017627	86	TCGA-OR-A5JB-01	13	18	108	0.4296344293234667	TCGA-OR-A5JB-01	9	9	6	24	PASS	11	TCGA-OR-A5JB	ACC	52	MALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2000	NA	-19172	Dead	NA	NA	551	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	551	NA	551	NA	NA	0	551	
40	TCGA-OR-A5JC	0	2	0	1	0	0	0	0	2	25	1	0	3	7	0	0	TCGA-OR-A5JC-01	247	0.9253917958148402	183	TCGA-OR-A5JC-01	28	24	139	0.4356070337404892	TCGA-OR-A5JC-01	0	0	8	8	PASS	12	TCGA-OR-A5JC	ACC	37	MALE	WHITE	NA	NA	Adrenocortical carcinoma- Usual Type	NA	2001	NA	-13862	Dead	NA	NA	1750	NA	NA	NA	NA	NA	NA	NA	NA	1	1750	NA	1750	NA	NA	0	1750	
60	TCGA-OR-A5JD	0	2	0	0	1	1	0	0	1	24	1	0	1	6	0	0	TCGA-OR-A5JD-01	67	0.9477284704738004	19	TCGA-OR-A5JD-01	39	12	49	0.4040384261162555	TCGA-OR-A5JD-01	0	0	0	0	PASS	13	TCGA-OR-A5JD	ACC	57	FEMALE	WHITE	Stage II	NA	Adrenocortical Carcinoma- Oncocytic Type	NA	2005	NA	-20989	Alive	TUMOR FREE	3038	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3038	0	3038	0	3038	0	3038	
20	TCGA-OR-A5JE	0	4	0	1	0	1	1	0	1	44	2	0	3	14	4	0	TCGA-OR-A5JE-01	149	0.6413752256548063	83	TCGA-OR-A5JE-01	21	19	23	0.0743739568005927	TCGA-OR-A5JE-01	5	6	1	12	PASS	14	TCGA-OR-A5JE	ACC	17	FEMALE	WHITE	Stage I	NA	Adrenocortical carcinoma- Usual Type	NA	2005	NA	-6455	Dead	WITH TUMOR	NA	2105	NA	Locoregional Recurrence	NA	NA	477	[Unknown]	NA	NA	1	2105	1	2105	NA	NA	1	477	
70	TCGA-OR-A5JF	1	6	0	2	0	1	0	0	2	60	2	0	0	17	4	0	TCGA-OR-A5JF-01	127	0.9477828166019362	65	TCGA-OR-A5JF-01	18	14	157	0.5953713415436545	TCGA-OR-A5JF-01	3	1	0	4	PASS	15	TCGA-OR-A5JF	ACC	69	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2007	NA	-25502	Alive	TUMOR FREE	2015	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2015	0	2015	0	2015	0	2015	
60	TCGA-OR-A5JG	1	1	0	0	1	1	0	0	1	24	0	0	1	9	1	0	TCGA-OR-A5JG-01	85	0.6884135671434629	36	TCGA-OR-A5JG-01	39	28	141	0.660537581138921	TCGA-OR-A5JG-01	3	3	2	8	PASS	16	TCGA-OR-A5JG	ACC	61	MALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2008	NA	-22390	Dead	WITH TUMOR	NA	541	NA	NA	NA	NA	NA	NA	NA	NA	1	541	1	541	NA	NA	1	541	
30	TCGA-OR-A5JH	0	0	0	1	0	0	0	0	0	4	1	0	0	4	1	0	TCGA-OR-A5JH-01	68	0.9476801215506971	23	TCGA-OR-A5JH-01	19	13	89	0.5066105540343296	TCGA-OR-A5JH-01	1	1	1	3	PASS	17	TCGA-OR-A5JH	ACC	32	FEMALE	WHITE	Stage II	NA	Adrenocortical Carcinoma- Oncocytic Type	NA	2008	NA	-11994	Alive	TUMOR FREE	2110	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2110	0	2110	0	2110	0	2110	
30	TCGA-OR-A5JI	0	0	0	0	1	1	0	0	2	10	0	0	0	1	0	0	TCGA-OR-A5JI-01	71	0.4828116767974207	26	TCGA-OR-A5JI-01	22	20	22	0.12560087072736212	TCGA-OR-A5JI-01	0	0	0	0	PASS	18	TCGA-OR-A5JI	ACC	22	MALE	WHITE	Stage I	NA	Adrenocortical carcinoma- Usual Type	NA	2008	NA	-8177	Alive	TUMOR FREE	2331	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2331	0	2331	0	2331	0	2331	
70	TCGA-OR-A5JJ	0	1	0	1	1	0	0	0	0	17	0	0	0	4	0	0	TCGA-OR-A5JJ-01	121	0.9476466408965274	55	TCGA-OR-A5JJ-01	17	16	146	0.6253760106216876	TCGA-OR-A5JJ-01	5	3	6	14	PASS	19	TCGA-OR-A5JJ	ACC	65	MALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2009	NA	-24082	Dead	WITH TUMOR	NA	490	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	490	1	490	NA	NA	1	490	
50	TCGA-OR-A5JK	0	2	0	2	0	0	0	0	1	21	3	0	1	6	0	0	TCGA-OR-A5JK-01	124	0.9033409893989524	64	TCGA-OR-A5JK-01	20	14	134	0.5696626309198238	TCGA-OR-A5JK-01	3	4	0	7	PASS	20	TCGA-OR-A5JK	ACC	49	MALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2009	NA	-18214	Alive	TUMOR FREE	1497	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1497	0	1497	NA	NA	0	1497	
40	TCGA-OR-A5JL	0	2	0	0	2	0	0	0	0	7	2	0	0	1	0	0	TCGA-OR-A5JL-01	77	0.9477280274639709	29	TCGA-OR-A5JL-01	14	13	130	0.5923592920928815	TCGA-OR-A5JL-01	1	1	0	2	PASS	21	TCGA-OR-A5JL	ACC	36	FEMALE	WHITE	Stage I	NA	Adrenocortical carcinoma- Usual Type	NA	2009	NA	-13155	Alive	TUMOR FREE	2056	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2056	0	2056	0	2056	0	2056	
30	TCGA-OR-A5JM	0	5	0	9	7	1	5	0	6	43	1	0	1	17	4	0	TCGA-OR-A5JM-01	326	0.466061685117146	212	TCGA-OR-A5JM-01	15	28	48	0.10122370415477122	TCGA-OR-A5JM-01	10	10	5	25	PASS	22	TCGA-OR-A5JM	ACC	25	FEMALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-9359	Dead	WITH TUMOR	NA	562	NA	Distant Metastasis	Liver	NA	72	Progressive Disease	NA	NA	1	562	1	562	NA	NA	1	72	
30	TCGA-OR-A5JO	0	2	0	1	0	0	0	0	0	11	1	0	0	2	1	0	TCGA-OR-A5JO-01	61	2.4648461377943993e-05	22	TCGA-OR-A5JO-01	0	0	7	0.021493797902836547	TCGA-OR-A5JO-01	0	0	1	1	PASS	23	TCGA-OR-A5JO	ACC	26	FEMALE	WHITE	Stage I	NA	Adrenocortical carcinoma- Usual Type	NA	2005	NA	-9547	Alive	TUMOR FREE	1194	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1194	0	1194	0	1194	0	1194	
40	TCGA-OR-A5JP	1	6	0	6	3	3	2	0	4	53	3	0	2	19	2	0	TCGA-OR-A5JP-01	164	0.5382205350083664	82	TCGA-OR-A5JP-01	18	24	41	0.16878173434696794	TCGA-OR-A5JP-01	8	11	3	22	PASS	24	TCGA-OR-A5JP	ACC	40	MALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2012	NA	-14667	Alive	TUMOR FREE	464	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	464	0	464	0	464	0	464	
30	TCGA-OR-A5JQ	0	0	0	0	0	0	0	0	0	5	0	0	0	3	1	0	TCGA-OR-A5JQ-01	70	0.9496616158487488	28	TCGA-OR-A5JQ-01	17	11	103	0.4833318029838675	TCGA-OR-A5JQ-01	0	0	0	0	PASS	25	TCGA-OR-A5JQ	ACC	26	FEMALE	WHITE	Stage II	NA	Adrenocortical Carcinoma- Myxoid Type	NA	2006	NA	-9667	Alive	TUMOR FREE	1103	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1103	0	1103	0	1103	0	1103	
50	TCGA-OR-A5JR	0	0	0	1	0	0	0	0	0	3	1	0	0	2	0	0	TCGA-OR-A5JR-01	104	0.9475282885781564	50	TCGA-OR-A5JR-01	17	15	119	0.585630882511197	TCGA-OR-A5JR-01	1	0	1	2	PASS	26	TCGA-OR-A5JR	ACC	45	MALE	WHITE	Stage I	NA	Adrenocortical carcinoma- Usual Type	NA	2002	NA	-16604	Alive	TUMOR FREE	3688	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3688	0	3688	0	3688	0	3688	
70	TCGA-OR-A5JS	0	3	0	2	2	0	0	0	2	23	2	0	0	16	2	0	TCGA-OR-A5JS-01	226	0.8389223126870314	134	TCGA-OR-A5JS-01	31	16	102	0.21683566314542432	TCGA-OR-A5JS-01	9	3	7	19	PASS	27	TCGA-OR-A5JS	ACC	65	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-24017	Alive	WITH TUMOR	383	NA	NA	Distant Metastasis	Lung	NA	166	NA	NA	NA	0	383	0	383	NA	NA	1	166	
70	TCGA-OR-A5JT	0	2	0	2	1	1	0	0	1	20	1	1	0	12	0	0	TCGA-OR-A5JT-01	151	0.947107908983122	77	TCGA-OR-A5JT-01	37	18	189	0.6552482831891551	TCGA-OR-A5JT-01	1	1	7	9	PASS	28	TCGA-OR-A5JT	ACC	65	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-23794	Alive	WITH TUMOR	907	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	907	0	907	NA	NA	0	907	
60	TCGA-OR-A5JU	0	0	0	0	0	0	1	0	3	19	1	1	0	5	2	0	TCGA-OR-A5JU-01	53	0.02649248205506921	16	TCGA-OR-A5JU-01	2	5	20	0.07142688577705611	TCGA-OR-A5JU-01	4	6	4	14	PASS	29	TCGA-OR-A5JU	ACC	58	FEMALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2010	NA	-21292	Dead	WITH TUMOR	NA	289	NA	Distant Metastasis	"Other, specify"	Ovarian	268	Progressive Disease	NA	NA	1	289	1	289	NA	NA	1	268	
60	TCGA-OR-A5JV	0	3	0	2	0	0	0	0	1	24	1	0	0	5	0	0	TCGA-OR-A5JV-01	151	0.8409504209265121	92	TCGA-OR-A5JV-01	31	19	142	0.5673656001774079	TCGA-OR-A5JV-01	7	3	1	11	PASS	30	TCGA-OR-A5JV	ACC	55	MALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2008	NA	-20319	Alive	TUMOR FREE	2023	NA	NA	New Primary Tumor	Lymph Node(s)	NA	953	Complete Remission/Response	NA	NA	0	2023	0	2023	0	2023	1	953	
50	TCGA-OR-A5JW	0	1	0	1	0	0	0	0	0	23	2	0	0	8	2	0	TCGA-OR-A5JW-01	98	0.9476439282657608	49	TCGA-OR-A5JW-01	17	14	104	0.544701097447982	TCGA-OR-A5JW-01	1	0	0	1	PASS	31	TCGA-OR-A5JW	ACC	47	MALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2008	NA	-17513	Alive	TUMOR FREE	2202	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2202	0	2202	0	2202	0	2202	
50	TCGA-OR-A5JX	0	0	0	2	0	0	1	0	1	27	3	0	0	8	1	0	TCGA-OR-A5JX-01	221	0.595655674707299	146	TCGA-OR-A5JX-01	25	21	72	0.2255657556241785	TCGA-OR-A5JX-01	4	3	2	9	PASS	32	TCGA-OR-A5JX	ACC	50	MALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2009	NA	-18402	Alive	TUMOR FREE	950	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	950	0	950	NA	NA	0	950	
70	TCGA-OR-A5JY	0	8	1	7	3	0	0	0	1	61	3	0	1	18	1	0	TCGA-OR-A5JY-01	758	0.7330206756569699	551	TCGA-OR-A5JY-01	14	22	238	0.1816130915181436	TCGA-OR-A5JY-01	26	19	8	53	PASS	33	TCGA-OR-A5JY	ACC	68	FEMALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-25190	Dead	WITH TUMOR	NA	552	NA	Distant Metastasis	Liver	NA	75	Progressive Disease	NA	NA	1	552	1	552	NA	NA	1	75	
60	TCGA-OR-A5JZ	0	1	0	1	0	0	1	0	1	14	0	0	0	4	0	0	TCGA-OR-A5JZ-01	156	0.9477084162541376	92	TCGA-OR-A5JZ-01	9	17	189	0.8012341729558836	TCGA-OR-A5JZ-01	1	1	1	3	PASS	34	TCGA-OR-A5JZ	ACC	60	MALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-22218	Alive	WITH TUMOR	822	NA	NA	Distant Metastasis	Liver	NA	247	Progressive Disease	NA	NA	0	822	0	822	NA	NA	1	247	
70	TCGA-OR-A5K0	1	5	0	2	7	0	3	0	2	35	3	0	0	24	0	1	TCGA-OR-A5K0-01	218	0.9899182941684151	140	TCGA-OR-A5K0-01	4	7	107	0.19894161245044825	TCGA-OR-A5K0-01	12	11	11	34	PASS	35	TCGA-OR-A5K0	ACC	69	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2009	NA	-25400	Alive	WITH TUMOR	1029	NA	NA	Distant Metastasis	Lung	NA	659	Progressive Disease	NA	NA	0	1029	0	1029	NA	NA	1	659	
50	TCGA-OR-A5K1	0	0	2	0	2	0	0	0	2	10	0	0	0	1	1	0	TCGA-OR-A5K1-01	48	0.9477281487510372	11	TCGA-OR-A5K1-01	12	16	159	0.7225123979965713	TCGA-OR-A5K1-01	0	0	2	2	PASS	36	TCGA-OR-A5K1	ACC	48	MALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2006	NA	-17596	Alive	TUMOR FREE	3289	NA	NA	Locoregional Recurrence	Peritoneal Surfaces	NA	826	Complete Remission/Response	NA	NA	0	3289	0	3289	1	826	1	826	
30	TCGA-OR-A5K2	1	4	0	3	2	0	0	0	2	39	0	0	0	23	3	0	TCGA-OR-A5K2-01	223	0.358181914151214	139	TCGA-OR-A5K2-01	16	28	27	0.04403993563753658	TCGA-OR-A5K2-01	7	4	0	11	PASS	37	TCGA-OR-A5K2	ACC	32	FEMALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2010	NA	-11970	Dead	WITH TUMOR	NA	994	NA	Distant Metastasis	Lung	NA	97	Progressive Disease	NA	NA	1	994	1	994	NA	NA	1	97	
50	TCGA-OR-A5K3	0	0	0	1	0	0	0	0	0	14	0	0	1	4	0	0	TCGA-OR-A5K3-01	71	0.9476417107908206	30	TCGA-OR-A5K3-01	13	16	127	0.7374011622286695	TCGA-OR-A5K3-01	1	0	2	3	PASS	38	TCGA-OR-A5K3	ACC	53	MALE	WHITE	Stage II	NA	Adrenocortical Carcinoma- Oncocytic Type	NA	2005	NA	-19375	Alive	TUMOR FREE	3465	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3465	0	3465	0	3465	0	3465	
60	TCGA-OR-A5K4	3	21	0	7	0	0	1	0	8	198	11	0	6	89	1	0	TCGA-OR-A5K4-01	102	0.9477263059768204	48	TCGA-OR-A5K4-01	12	16	156	0.7135300313505569	TCGA-OR-A5K4-01	1	0	2	3	PASS	39	TCGA-OR-A5K4	ACC	64	FEMALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-23481	Alive	TUMOR FREE	1082	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1082	0	1082	0	1082	0	1082	
60	TCGA-OR-A5K5	1	12	1	4	5	2	6	0	3	93	6	0	2	34	2	0	TCGA-OR-A5K5-01	578	0.5467817950656416	465	TCGA-OR-A5K5-01	19	24	54	0.07432062420037472	TCGA-OR-A5K5-01	10	9	2	21	PASS	40	TCGA-OR-A5K5	ACC	59	FEMALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2012	NA	-21907	Dead	WITH TUMOR	NA	498	NA	Distant Metastasis	Lung	NA	108	Progressive Disease	NA	NA	1	498	1	498	NA	NA	1	108	
60	TCGA-OR-A5K6	1	2	0	0	2	0	0	0	3	21	2	0	1	6	0	0	TCGA-OR-A5K6-01	147	0.6224650083835087	74	TCGA-OR-A5K6-01	3	4	53	0.12297154239576916	TCGA-OR-A5K6-01	5	4	3	12	PASS	41	TCGA-OR-A5K6	ACC	56	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2010	NA	-20657	Alive	WITH TUMOR	1493	NA	NA	Distant Metastasis	Liver	NA	391	Complete Remission/Response	NA	NA	0	1493	0	1493	1	391	1	391	
40	TCGA-OR-A5K8	0	5	0	0	1	0	0	0	3	22	1	0	1	3	1	0	TCGA-OR-A5K8-01	134	0.9476546304181086	81	TCGA-OR-A5K8-01	20	15	123	0.5763076267873691	TCGA-OR-A5K8-01	2	2	1	5	PASS	42	TCGA-OR-A5K8	ACC	39	MALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2012	NA	-14435	Alive	TUMOR FREE	749	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	749	0	749	0	749	0	749	
60	TCGA-OR-A5K9	1	4	1	10	2	0	1	0	3	105	6	0	1	37	0	1	TCGA-OR-A5K9-01	238	0.9273884836459996	144	TCGA-OR-A5K9-01	17	29	120	0.2367551169717057	TCGA-OR-A5K9-01	4	5	3	12	PASS	43	TCGA-OR-A5K9	ACC	61	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2002	NA	-22596	Dead	WITH TUMOR	NA	344	NA	Locoregional Recurrence	Peritoneal Surfaces	NA	236	NA	NA	NA	1	344	1	344	NA	NA	1	236	
60	TCGA-OR-A5KB	10	186	19	92	39	12	3	0	91	1588	140	3	55	582	54	2	TCGA-OR-A5KB-01	254	0.6335784049445911	145	TCGA-OR-A5KB-01	20	33	120	0.2247694071021098	TCGA-OR-A5KB-01	15	9	9	33	hypermutated sample	44	TCGA-OR-A5KB	ACC	61	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-22550	Alive	WITH TUMOR	741	NA	NA	Distant Metastasis	Soft Tissue	NA	214	Progressive Disease	NA	NA	0	741	0	741	NA	NA	1	214	
40	TCGA-OR-A5KO	0	3	0	3	1	0	0	0	0	27	1	0	0	9	0	0	TCGA-OR-A5KO-01	415	0.9516841948073008	318	TCGA-OR-A5KO-01	18	14	278	0.566938969041516	TCGA-OR-A5KO-01	5	5	4	14	PASS	45	TCGA-OR-A5KO	ACC	39	FEMALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2009	NA	-14606	Alive	WITH TUMOR	1414	NA	NA	Distant Metastasis	Lung	NA	541	Progressive Disease	NA	NA	0	1414	0	1414	NA	NA	1	541	
50	TCGA-OR-A5KP	1	4	0	2	9	0	3	0	6	45	3	0	1	15	1	0	TCGA-OR-A5KP-01	129	0.5239781423604696	59	TCGA-OR-A5KP-01	21	23	46	0.1658176338606795	TCGA-OR-A5KP-01	1	3	4	8	PASS	46	TCGA-OR-A5KP	ACC	45	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2006	NA	-16702	Alive	TUMOR FREE	2777	NA	NA	Distant Metastasis	Liver	NA	1250	Complete Remission/Response	NA	NA	0	2777	0	2777	1	1250	1	1250	
30	TCGA-OR-A5KQ	0	0	0	0	0	0	0	0	0	10	0	0	0	3	0	0	TCGA-OR-A5KQ-01	43	0.040484199188188935	9	TCGA-OR-A5KQ-01	1	1	22	0.03198383121730521	TCGA-OR-A5KQ-01	1	0	1	2	PASS	47	TCGA-OR-A5KQ	ACC	20	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2006	NA	-7459	Alive	TUMOR FREE	2677	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2677	0	2677	0	2677	0	2677	
70	TCGA-OR-A5KS	0	1	1	1	1	0	1	0	2	15	2	0	0	3	0	0	TCGA-OR-A5KS-01	282	0.9477571885765942	175	TCGA-OR-A5KS-01	31	23	493	0.5320181676098373	TCGA-OR-A5KS-01	22	12	9	43	PASS	48	TCGA-OR-A5KS	ACC	72	MALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2006	NA	-26404	Alive	TUMOR FREE	2549	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2549	0	2549	0	2549	0	2549	
40	TCGA-OR-A5KT	0	8	0	2	2	1	0	0	2	17	2	0	1	5	2	0	TCGA-OR-A5KT-01	229	0.0836642864333902	160	TCGA-OR-A5KT-01	1	2	70	0.0505694754787939	TCGA-OR-A5KT-01	5	3	4	12	PASS	49	TCGA-OR-A5KT	ACC	44	FEMALE	WHITE	Stage I	NA	Adrenocortical carcinoma- Usual Type	NA	2006	NA	-16217	Alive	TUMOR FREE	2895	NA	NA	Distant Metastasis	"Other, specify"	Pancreas	2099	Complete Remission/Response	NA	NA	0	2895	0	2895	1	2099	1	2099	
40	TCGA-OR-A5KU	0	3	0	0	0	1	0	0	0	16	1	0	0	10	0	0	TCGA-OR-A5KU-01	81	0.947727952847658	40	TCGA-OR-A5KU-01	32	22	103	0.517646919413114	TCGA-OR-A5KU-01	2	1	2	5	PASS	50	TCGA-OR-A5KU	ACC	37	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2000	NA	-13559	Alive	TUMOR FREE	4673	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4673	0	4673	0	4673	0	4673	
20	TCGA-OR-A5KV	0	2	0	3	1	0	0	0	2	16	1	0	0	3	0	0	TCGA-OR-A5KV-01	76	0.005285719153818993	38	TCGA-OR-A5KV-01	0	0	8	0.0018517075577149926	TCGA-OR-A5KV-01	1	0	0	1	PASS	51	TCGA-OR-A5KV	ACC	17	FEMALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2003	NA	-6250	Alive	TUMOR FREE	3878	NA	NA	Distant Metastasis	Lung	NA	1116	Complete Remission/Response	NA	NA	0	3878	0	3878	1	1116	1	1116	
60	TCGA-OR-A5KW	0	1	0	1	0	0	1	0	1	17	2	0	1	11	1	0	TCGA-OR-A5KW-01	160	1.0	97	TCGA-OR-A5KW-01	14	12	170	0.6092661288682706	TCGA-OR-A5KW-01	3	3	4	10	PASS	52	TCGA-OR-A5KW	ACC	55	FEMALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2009	NA	-20328	Alive	TUMOR FREE	2076	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2076	0	2076	0	2076	0	2076	
30	TCGA-OR-A5KX	0	2	0	4	4	0	0	0	6	29	2	0	0	13	0	0	TCGA-OR-A5KX-01	459	0.2887423942583112	302	TCGA-OR-A5KX-01	11	11	69	0.04063029381309738	TCGA-OR-A5KX-01	9	4	2	15	PASS	53	TCGA-OR-A5KX	ACC	25	FEMALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2010	NA	-9298	Alive	WITH TUMOR	1364	NA	NA	Distant Metastasis	Bone	NA	62	Progressive Disease	NA	NA	0	1364	0	1364	NA	NA	1	62	
30	TCGA-OR-A5KY	0	1	0	1	1	0	0	0	1	21	4	0	0	9	1	0	TCGA-OR-A5KY-01	204	0.9483099725931232	123	TCGA-OR-A5KY-01	16	23	239	0.6586064992915589	TCGA-OR-A5KY-01	5	1	4	10	PASS	54	TCGA-OR-A5KY	ACC	23	FEMALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2010	NA	-8745	Dead	WITH TUMOR	NA	391	NA	Locoregional Recurrence	Peritoneal Surfaces	NA	178	Progressive Disease	NA	NA	1	391	1	391	NA	NA	1	178	
40	TCGA-OR-A5KZ	1	4	0	0	2	1	1	0	1	19	2	0	1	4	2	0	TCGA-OR-A5KZ-01	164	0.9061881178353054	100	TCGA-OR-A5KZ-01	16	28	173	0.5673355146772614	TCGA-OR-A5KZ-01	3	2	0	5	PASS	55	TCGA-OR-A5KZ	ACC	42	MALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2012	NA	-15594	Dead	WITH TUMOR	NA	125	NA	Locoregional Recurrence	"Other, specify"	abdomen	36	Progressive Disease	NA	NA	1	125	1	125	NA	NA	1	36	
40	TCGA-OR-A5L1	0	3	0	0	0	0	1	0	2	12	0	0	0	9	0	1	TCGA-OR-A5L1-01	81	0.9477286259471456	30	TCGA-OR-A5L1-01	31	21	95	0.4223550793404594	TCGA-OR-A5L1-01	0	0	4	4	PASS	56	TCGA-OR-A5L1	ACC	37	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2000	NA	-13840	Alive	WITH TUMOR	1781	NA	NA	Distant Metastasis	Bone	NA	685	Complete Remission/Response	NA	NA	0	1781	0	1781	1	685	1	685	
80	TCGA-OR-A5L2	2	9	0	5	0	0	1	0	6	112	14	0	2	43	1	0	TCGA-OR-A5L2-01	302	0.7394501155092493	177	TCGA-OR-A5L2-01	21	54	166	0.4887758485238791	TCGA-OR-A5L2-01	30	20	10	60	PASS	57	TCGA-OR-A5L2	ACC	83	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2001	NA	-30535	Dead	TUMOR FREE	NA	1852	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1852	0	1852	0	1852	0	1852	
70	TCGA-OR-A5L3	0	3	0	2	1	0	0	0	0	18	1	0	0	7	1	0	TCGA-OR-A5L3-01	60	0.03637075821659694	23	TCGA-OR-A5L3-01	1	1	23	0.040370890593676094	TCGA-OR-A5L3-01	1	1	2	4	PASS	58	TCGA-OR-A5L3	ACC	67	FEMALE	WHITE	Stage I	NA	Adrenocortical carcinoma- Usual Type	NA	2000	NA	-24763	Alive	TUMOR FREE	4628	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4628	0	4628	0	4628	0	4628	
50	TCGA-OR-A5L4	0	0	0	0	1	0	1	0	0	20	1	0	0	8	1	0	TCGA-OR-A5L4-01	69	0.9477739555611522	24	TCGA-OR-A5L4-01	37	16	129	0.6613525874206961	TCGA-OR-A5L4-01	0	0	1	1	PASS	59	TCGA-OR-A5L4	ACC	48	FEMALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-17819	Alive	TUMOR FREE	967	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	967	0	967	0	967	0	967	
80	TCGA-OR-A5L5	0	0	1	0	0	0	1	0	0	9	0	0	1	1	0	0	TCGA-OR-A5L5-01	56	0.9481445579796898	12	TCGA-OR-A5L5-01	9	18	145	0.7858995104135991	TCGA-OR-A5L5-01	1	2	2	5	PASS	60	TCGA-OR-A5L5	ACC	77	FEMALE	WHITE	Stage I	NA	Adrenocortical carcinoma- Usual Type	NA	2010	NA	-28270	Alive	TUMOR FREE	1317	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1317	0	1317	0	1317	0	1317	
60	TCGA-OR-A5L6	0	1	0	3	2	1	0	0	4	34	0	0	0	11	0	0	TCGA-OR-A5L6-01	115	0.4931659558793482	67	TCGA-OR-A5L6-01	21	37	163	0.7797557180152381	TCGA-OR-A5L6-01	5	3	5	13	PASS	61	TCGA-OR-A5L6	ACC	60	MALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-22057	Alive	TUMOR FREE	861	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	861	0	861	0	861	0	861	
40	TCGA-OR-A5L8	1	0	0	0	0	0	0	0	0	14	0	0	1	7	0	0	TCGA-OR-A5L8-01	47	0.9477340150031668	8	TCGA-OR-A5L8-01	29	24	53	0.3703830420108722	TCGA-OR-A5L8-01	1	0	2	3	PASS	62	TCGA-OR-A5L8	ACC	36	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-13472	Alive	TUMOR FREE	885	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	885	0	885	0	885	0	885	
50	TCGA-OR-A5L9	0	4	0	0	0	0	0	1	0	6	0	0	0	1	0	0	TCGA-OR-A5L9-01	66	0.9479709091017696	18	TCGA-OR-A5L9-01	10	17	163	0.7812985730645129	TCGA-OR-A5L9-01	1	0	1	2	PASS	63	TCGA-OR-A5L9	ACC	53	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-19526	Alive	TUMOR FREE	871	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	871	0	871	0	871	0	871	
50	TCGA-OR-A5LA	1	2	0	0	0	0	0	0	0	7	0	0	1	3	0	0	TCGA-OR-A5LA-01	61	0.9477286840927456	19	TCGA-OR-A5LA-01	39	17	94	0.6541347547313121	TCGA-OR-A5LA-01	0	0	2	2	PASS	64	TCGA-OR-A5LA	ACC	52	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2012	NA	-19242	Alive	TUMOR FREE	719	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	719	0	719	0	719	0	719	
60	TCGA-OR-A5LB	4	31	4	11	39	16	15	0	7	141	9	0	6	62	2	0	TCGA-OR-A5LB-01	138	0.9468609603648084	69	TCGA-OR-A5LB-01	18	14	135	0.5935424640438777	TCGA-OR-A5LB-01	3	1	2	6	PASS	65	TCGA-OR-A5LB	ACC	59	MALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2006	NA	-21565	Dead	WITH TUMOR	NA	1204	NA	Distant Metastasis	Liver	NA	611	Progressive Disease	NA	NA	1	1204	1	1204	NA	NA	1	611	
70	TCGA-OR-A5LC	1	3	0	2	2	0	0	0	0	36	2	0	0	18	4	0	TCGA-OR-A5LC-01	139	0.7193560251510982	78	TCGA-OR-A5LC-01	26	13	69	0.2387822205289177	TCGA-OR-A5LC-01	3	3	3	9	PASS	66	TCGA-OR-A5LC	ACC	71	FEMALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-26084	Dead	WITH TUMOR	NA	159	NA	Distant Metastasis	Lung	NA	50	Progressive Disease	NA	NA	1	159	1	159	NA	NA	1	50	
50	TCGA-OR-A5LD	0	6	0	6	2	1	2	0	4	43	6	0	3	18	0	0	TCGA-OR-A5LD-01	179	0.4548261194546958	110	TCGA-OR-A5LD-01	16	22	13	0.023879388731548348	TCGA-OR-A5LD-01	5	5	1	11	PASS	67	TCGA-OR-A5LD	ACC	52	MALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	1998	NA	-19111	Dead	WITH TUMOR	NA	1197	NA	Distant Metastasis	Lung	NA	444	[Unknown]	NA	NA	1	1197	1	1197	NA	NA	1	444	
20	TCGA-OR-A5LE	1	2	0	0	3	0	0	0	0	19	0	0	0	4	0	0	TCGA-OR-A5LE-01	152	0.9162308205502926	81	TCGA-OR-A5LE-01	7	6	51	0.1577927970947324	TCGA-OR-A5LE-01	5	9	7	21	PASS	68	TCGA-OR-A5LE	ACC	14	MALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	1997	NA	-5383	Dead	WITH TUMOR	NA	662	NA	Locoregional Recurrence	Peritoneal Surfaces	NA	265	[Unknown]	NA	NA	1	662	1	662	NA	NA	1	265	
70	TCGA-OR-A5LF	0	0	0	1	3	0	0	0	1	16	2	0	0	6	0	0	TCGA-OR-A5LF-01	205	0.9438189128075686	129	TCGA-OR-A5LF-01	34	20	198	0.6578935338289879	TCGA-OR-A5LF-01	4	4	8	16	PASS	69	TCGA-OR-A5LF	ACC	74	FEMALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2002	NA	-27179	Dead	TUMOR FREE	NA	445	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	445	0	445	0	445	0	445	
50	TCGA-OR-A5LG	0	1	1	2	0	0	0	0	4	16	2	0	0	7	0	0	TCGA-OR-A5LG-01	147	0.9487470806706572	82	TCGA-OR-A5LG-01	4	10	84	0.2058275712627427	TCGA-OR-A5LG-01	11	7	13	31	PASS	70	TCGA-OR-A5LG	ACC	46	MALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2008	NA	-16875	Alive	WITH TUMOR	1589	NA	NA	Distant Metastasis	Lung	NA	1393	Complete Remission/Response	NA	NA	0	1589	0	1589	1	1393	1	1393	
40	TCGA-OR-A5LH	0	0	0	0	2	0	0	0	0	7	0	0	0	1	0	0	TCGA-OR-A5LH-01	105	0.9165516182738206	56	TCGA-OR-A5LH-01	8	18	165	0.7626356379643949	TCGA-OR-A5LH-01	0	0	2	2	PASS	71	TCGA-OR-A5LH	ACC	36	FEMALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2005	NA	-13182	Dead	WITH TUMOR	NA	2385	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	2385	1	2385	NA	NA	1	2385	
40	TCGA-OR-A5LI	0	9	0	7	1	0	2	0	4	45	3	0	3	14	0	0	TCGA-OR-A5LI-01	576	0.936797182615239	395	TCGA-OR-A5LI-01	18	17	34	0.028660644069573544	TCGA-OR-A5LI-01	12	7	1	20	PASS	72	TCGA-OR-A5LI	ACC	42	FEMALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	1998	NA	-15536	Dead	WITH TUMOR	NA	436	NA	Distant Metastasis	Bone	NA	61	Progressive Disease	NA	NA	1	436	1	436	NA	NA	1	61	
50	TCGA-OR-A5LJ	5	39	4	10	48	9	16	0	23	308	15	0	8	143	4	0	TCGA-OR-A5LJ-01	82	0.9476490331654264	35	TCGA-OR-A5LJ-01	15	14	140	0.6105739226678264	TCGA-OR-A5LJ-01	5	6	2	13	PASS	73	TCGA-OR-A5LJ	ACC	54	FEMALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2005	NA	-20069	Dead	WITH TUMOR	NA	1105	NA	Distant Metastasis	Lung	NA	98	Progressive Disease	NA	NA	1	1105	1	1105	NA	NA	1	98	
60	TCGA-OR-A5LK	0	4	1	2	0	0	0	1	4	36	2	0	2	14	1	1	TCGA-OR-A5LK-01	81	1.0	38	TCGA-OR-A5LK-01	39	17	88	0.545294446525791	TCGA-OR-A5LK-01	2	2	5	9	PASS	74	TCGA-OR-A5LK	ACC	62	MALE	[Not Evaluated]	Stage II	NA	Adrenocortical Carcinoma- Oncocytic Type	NA	2007	NA	-22919	Alive	TUMOR FREE	2740	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2740	0	2740	0	2740	0	2740	
80	TCGA-OR-A5LL	1	4	0	2	0	2	0	0	4	46	1	0	2	13	0	0	TCGA-OR-A5LL-01	303	0.8134793097786608	190	TCGA-OR-A5LL-01	10	13	110	0.09799778632132576	TCGA-OR-A5LL-01	8	6	5	19	PASS	75	TCGA-OR-A5LL	ACC	75	FEMALE	[Not Evaluated]	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2007	NA	-27607	Dead	WITH TUMOR	NA	1613	NA	Distant Metastasis	Liver	NA	213	Complete Remission/Response	NA	NA	1	1613	1	1613	1	213	1	213	
30	TCGA-OR-A5LM	0	3	0	1	0	0	0	0	0	21	1	0	0	6	1	0	TCGA-OR-A5LM-01	164	0.9091713807757448	98	TCGA-OR-A5LM-01	32	44	139	0.4646755001053804	TCGA-OR-A5LM-01	8	5	4	17	PASS	76	TCGA-OR-A5LM	ACC	23	MALE	[Not Evaluated]	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2008	NA	-8735	Alive	TUMOR FREE	1858	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1858	0	1858	0	1858	0	1858	
30	TCGA-OR-A5LN	0	1	0	3	0	0	0	0	0	11	0	0	0	3	0	0	TCGA-OR-A5LN-01	83	0.6519715322460758	37	TCGA-OR-A5LN-01	26	21	33	0.10856232530233023	TCGA-OR-A5LN-01	2	1	1	4	PASS	77	TCGA-OR-A5LN	ACC	31	FEMALE	[Not Evaluated]	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2008	NA	-11414	Alive	TUMOR FREE	2342	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2342	0	2342	0	2342	0	2342	
60	TCGA-OR-A5LO	0	10	2	1	2	0	1	0	6	53	2	1	0	21	1	0	TCGA-OR-A5LO-01	235	0.9476743982062632	139	TCGA-OR-A5LO-01	33	25	222	0.6217226956467844	TCGA-OR-A5LO-01	8	8	7	23	PASS	78	TCGA-OR-A5LO	ACC	61	FEMALE	[Not Evaluated]	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2008	NA	-22370	Dead	WITH TUMOR	NA	2405	NA	Distant Metastasis	Lung	NA	153	Complete Remission/Response	NA	NA	1	2405	1	2405	1	153	1	153	
40	TCGA-OR-A5LP	0	0	0	1	0	0	0	0	2	17	0	0	0	2	1	0	TCGA-OR-A5LP-01	53	0.9477178406910574	14	TCGA-OR-A5LP-01	12	16	163	0.7547405533419672	TCGA-OR-A5LP-01	0	0	0	0	PASS	79	TCGA-OR-A5LP	ACC	37	FEMALE	[Not Evaluated]	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2009	NA	-13574	Alive	TUMOR FREE	1857	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1857	0	1857	0	1857	0	1857	
30	TCGA-OR-A5LR	0	1	0	0	0	0	0	0	0	11	0	0	0	1	0	1	TCGA-OR-A5LR-01	51	0.9477288643800836	12	TCGA-OR-A5LR-01	10	17	142	0.7798296324945153	TCGA-OR-A5LR-01	0	0	0	0	PASS	80	TCGA-OR-A5LR	ACC	30	FEMALE	[Not Evaluated]	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-11261	Alive	TUMOR FREE	853	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	853	0	853	0	853	0	853	
30	TCGA-OR-A5LS	0	1	0	0	0	0	0	0	2	7	3	0	1	4	1	0	TCGA-OR-A5LS-01	105	0.9254867376174832	49	TCGA-OR-A5LS-01	36	16	156	0.5281213677169216	TCGA-OR-A5LS-01	5	2	3	10	PASS	81	TCGA-OR-A5LS	ACC	34	FEMALE	[Not Evaluated]	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-12663	Alive	TUMOR FREE	1096	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1096	0	1096	0	1096	0	1096	
60	TCGA-OR-A5LT	0	0	0	1	2	2	0	0	0	14	2	0	0	7	2	0	TCGA-OR-A5LT-01	172	0.9475930234618334	96	TCGA-OR-A5LT-01	31	20	158	0.592986973357372	TCGA-OR-A5LT-01	3	2	3	8	PASS	82	TCGA-OR-A5LT	ACC	57	MALE	[Not Evaluated]	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2012	NA	-21032	Alive	TUMOR FREE	549	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	549	0	549	0	549	0	549	
50	TCGA-OU-A5PI	0	1	0	0	2	0	1	0	1	24	0	0	0	9	1	0	TCGA-OU-A5PI-01	183	0.9475995616522186	92	TCGA-OU-A5PI-01	19	13	139	0.5119251418375179	TCGA-OU-A5PI-01	4	0	4	8	PASS	83	TCGA-OU-A5PI	ACC	53	FEMALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-19492	Alive	WITH TUMOR	1171	NA	NA	Distant Metastasis	Lung	NA	351	Stable Disease	NA	NA	0	1171	0	1171	NA	NA	1	351	
60	TCGA-P6-A5OF	0	2	1	1	2	0	1	0	1	21	3	0	0	10	1	0	TCGA-P6-A5OF	0	0	0	TCGA-P6-A5OF	0	0	0	0	TCGA-P6-A5OF	0	0	0	0	PASS	84	TCGA-P6-A5OF	ACC	55	FEMALE	WHITE	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2010	NA	-20106	Dead	WITH TUMOR	NA	207	NA	Distant Metastasis	Lung	NA	143	[Unknown]	NA	NA	1	207	1	207	NA	NA	1	143	
50	TCGA-P6-A5OG	1	17	1	6	4	2	0	0	10	182	15	1	3	70	9	0	TCGA-P6-A5OG	0	0	0	TCGA-P6-A5OG	0	0	0	0	TCGA-P6-A5OG-01	7	8	3	18	PASS	85	TCGA-P6-A5OG	ACC	45	FEMALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-16659	Dead	WITH TUMOR	NA	383	NA	Distant Metastasis	Lung	NA	11	Complete Remission/Response	NA	NA	1	383	1	383	NA	NA	1	11	
60	TCGA-P6-A5OH	0	9	0	6	7	1	7	0	5	100	6	0	1	33	2	0	TCGA-P6-A5OH-01	278	0.4975192004580035	167	TCGA-P6-A5OH-01	12	24	39	0.05220056268869183	TCGA-P6-A5OH-01	9	10	1	20	PASS	86	TCGA-P6-A5OH	ACC	59	FEMALE	WHITE	Stage IV	NA	Adrenocortical carcinoma- Usual Type	NA	2010	NA	-21627	Dead	WITH TUMOR	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	1	0	NA	NA	1	0	
50	TCGA-PA-A5YG	0	0	0	0	0	0	0	0	0	8	2	0	0	1	0	0	TCGA-PA-A5YG-01	56	0.9477267762260516	17	TCGA-PA-A5YG-01	12	17	109	0.7537307579706316	TCGA-PA-A5YG-01	1	1	1	3	PASS	87	TCGA-PA-A5YG	ACC	51	MALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2012	NA	-18926	Alive	TUMOR FREE	756	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	756	0	756	0	756	0	756	
40	TCGA-PK-A5H8	0	3	0	1	2	1	1	0	1	15	0	0	0	8	1	0	TCGA-PK-A5H8	0	0	0	TCGA-PK-A5H8	0	0	0	0	TCGA-PK-A5H8	0	0	0	0	PASS	88	TCGA-PK-A5H8	ACC	42	MALE	WHITE	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2004	NA	-15373	Alive	TUMOR FREE	3623	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3623	0	3623	0	3623	0	3623	
30	TCGA-PK-A5H9	0	1	0	1	0	0	0	0	1	12	3	0	0	4	0	0	TCGA-PK-A5H9-01	55	0.01069296328780485	11	TCGA-PK-A5H9-01	0	0	14	0.018881598825029527	TCGA-PK-A5H9-01	1	0	1	2	PASS	89	TCGA-PK-A5H9	ACC	27	FEMALE	ASIAN	Stage II	NA	Adrenocortical carcinoma- Usual Type	NA	2012	NA	-10173	Alive	TUMOR FREE	616	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	616	0	616	0	616	0	616	
60	TCGA-PK-A5HA	0	4	0	5	1	0	0	0	5	42	4	0	0	13	1	0	TCGA-PK-A5HA-01	112	0.9901504491069872	57	TCGA-PK-A5HA-01	11	12	69	0.3818988021158505	TCGA-PK-A5HA-01	5	5	4	14	PASS	90	TCGA-PK-A5HA	ACC	63	MALE	[Unknown]	Stage I	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-23345	Alive	TUMOR FREE	1201	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1201	0	1201	0	1201	0	1201	
60	TCGA-PK-A5HB	10	119	10	56	61	25	9	1	51	812	44	1	19	350	21	1	TCGA-PK-A5HB-01	128	0.9480049186213768	63	TCGA-PK-A5HB-01	13	8	64	0.3325304131370768	TCGA-PK-A5HB-01	3	4	5	12	hypermutated sample	91	TCGA-PK-A5HB	ACC	63	MALE	[Unknown]	NA	NA	Adrenocortical carcinoma- Usual Type	NA	2003	NA	-23293	Alive	WITH TUMOR	1293	NA	NA	Distant Metastasis	Lung	NA	213	NA	NA	NA	0	1293	0	1293	NA	NA	1	213	
40	TCGA-PK-A5HC	0	7	2	1	0	2	0	0	4	50	1	0	1	17	2	0	TCGA-PK-A5HC-01	256	0.9862120360923344	174	TCGA-PK-A5HC-01	21	32	168	0.3987680130369751	TCGA-PK-A5HC-01	20	13	11	44	PASS	92	TCGA-PK-A5HC	ACC	44	FEMALE	ASIAN	Stage III	NA	Adrenocortical carcinoma- Usual Type	NA	2011	NA	-16182	Alive	WITH TUMOR	679	NA	NA	Distant Metastasis	Lung	NA	131	Complete Remission/Response	NA	NA	0	679	0	679	1	131	1	131	
60	TCGA-2F-A9KO	1	28	4	26	3	3	0	0	26	427	41	2	6	166	7	0	TCGA-2F-A9KO-01	210	0.6850826302955565	139	TCGA-2F-A9KO-01	19	36	96	0.2661000954685431	TCGA-2F-A9KO-01	16	13	12	41	PASS	93	TCGA-2F-A9KO	BLCA	63	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-23323	Dead	WITH TUMOR	NA	734	NA	Distant Metastasis	Liver	NA	651	Progressive Disease	NA	NA	1	734	1	734	NA	NA	1	651	
70	TCGA-2F-A9KP	0	6	0	2	3	3	1	0	6	110	8	0	0	40	5	0	TCGA-2F-A9KP-01	341	0.3586644690984567	215	TCGA-2F-A9KP-01	10	18	70	0.08775859741374484	TCGA-2F-A9KP-01	12	10	6	28	PASS	94	TCGA-2F-A9KP	BLCA	66	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-24428	Dead	WITH TUMOR	NA	364	NA	Distant Metastasis	Liver	NA	343	Progressive Disease	NA	NA	1	364	1	364	NA	NA	1	343	
70	TCGA-2F-A9KQ	0	6	0	0	1	1	0	0	2	53	3	0	3	17	2	0	TCGA-2F-A9KQ-01	124	0.6099848400400227	69	TCGA-2F-A9KQ-01	6	7	33	0.14900750147064742	TCGA-2F-A9KQ-01	4	2	3	9	PASS	95	TCGA-2F-A9KQ	BLCA	69	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-25259	Alive	TUMOR FREE	2886	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2886	0	2886	0	2886	0	2886	
60	TCGA-2F-A9KR	2	12	0	8	1	1	0	0	9	176	20	1	6	76	7	0	TCGA-2F-A9KR-01	166	0.9314551285698563	103	TCGA-2F-A9KR-01	11	8	80	0.26607330167668675	TCGA-2F-A9KR-01	4	2	4	10	PASS	96	TCGA-2F-A9KR	BLCA	59	FEMALE	[Not Evaluated]	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2000	NA	-21848	Dead	WITH TUMOR	NA	3183	NA	Distant Metastasis	Lung	NA	3086	Complete Remission/Response	NA	NA	1	3183	1	3183	1	3086	1	3086	
80	TCGA-2F-A9KT	1	12	1	10	2	2	3	0	14	280	35	2	5	88	5	1	TCGA-2F-A9KT-01	247	0.7115435855582981	150	TCGA-2F-A9KT-01	11	15	70	0.18219938426413865	TCGA-2F-A9KT-01	12	9	5	26	PASS	97	TCGA-2F-A9KT	BLCA	83	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-30520	Alive	TUMOR FREE	3314	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3314	0	3314	0	3314	0	3314	
70	TCGA-2F-A9KW	1	12	0	2	2	2	0	0	3	81	4	0	2	39	4	0	TCGA-2F-A9KW-01	405	0.7672267574090411	249	TCGA-2F-A9KW-01	9	14	135	0.20122414333647687	TCGA-2F-A9KW-01	19	16	13	48	PASS	98	TCGA-2F-A9KW	BLCA	67	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-24703	Dead	WITH TUMOR	NA	254	NA	Distant Metastasis	Bone	NA	85	Stable Disease	NA	NA	1	254	1	254	NA	NA	1	85	
70	TCGA-4Z-AA7M	1	26	2	14	7	1	0	0	20	410	45	1	9	166	5	0	TCGA-4Z-AA7M-01	337	0.7344551232364431	212	TCGA-4Z-AA7M-01	18	30	89	0.16928582415686952	TCGA-4Z-AA7M-01	21	17	8	46	PASS	99	TCGA-4Z-AA7M	BLCA	65	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-23817	Alive	TUMOR FREE	495	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	495	0	495	0	495	0	495	
70	TCGA-4Z-AA7N	0	0	1	1	0	0	0	0	0	10	2	0	0	11	0	0	TCGA-4Z-AA7N-01	45	0.052016252216584034	8	TCGA-4Z-AA7N	0	0	0	0	TCGA-4Z-AA7N	0	0	0	0	PASS	100	TCGA-4Z-AA7N	BLCA	65	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-24090	Dead	TUMOR FREE	NA	1367	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1367	0	1367	0	1367	0	1367	
60	TCGA-4Z-AA7O	0	12	0	5	3	2	1	0	14	135	10	0	5	68	5	0	TCGA-4Z-AA7O-01	136	0.48697441237520894	67	TCGA-4Z-AA7O-01	4	3	52	0.1414093513352509	TCGA-4Z-AA7O-01	6	3	3	12	PASS	101	TCGA-4Z-AA7O	BLCA	64	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-23645	Alive	TUMOR FREE	512	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	512	0	512	0	512	0	512	
80	TCGA-4Z-AA7Q	1	14	1	5	2	1	1	1	8	195	18	1	1	78	3	0	TCGA-4Z-AA7Q-01	224	0.5479326453769816	119	TCGA-4Z-AA7Q-01	16	35	132	0.3657619652716981	TCGA-4Z-AA7Q-01	13	13	15	41	PASS	102	TCGA-4Z-AA7Q	BLCA	79	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-28981	Dead	TUMOR FREE	NA	510	NA	NA	NA	NA	NA	NA	NA	NA	1	510	0	510	NA	NA	0	510	
70	TCGA-4Z-AA7R	1	15	0	9	4	0	2	0	10	278	26	0	4	114	8	0	TCGA-4Z-AA7R-01	462	0.569281849763104	308	TCGA-4Z-AA7R-01	15	31	128	0.1983949461371513	TCGA-4Z-AA7R-01	19	22	10	51	PASS	103	TCGA-4Z-AA7R	BLCA	73	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-26781	Dead	WITH TUMOR	NA	522	NA	Locoregional (Urothelial tumor event)	Lymph Node Only	NA	353	Partial Remission/Response	NA	NA	1	522	1	522	NA	NA	1	353	
70	TCGA-4Z-AA7S	0	3	0	1	1	1	1	0	1	51	3	0	0	18	1	0	TCGA-4Z-AA7S-01	193	0.33796930914334805	129	TCGA-4Z-AA7S-01	13	15	19	0.049294073096781424	TCGA-4Z-AA7S-01	6	3	1	10	PASS	104	TCGA-4Z-AA7S	BLCA	66	MALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-24111	Dead	TUMOR FREE	NA	1064	NA	NA	NA	NA	NA	NA	NA	NA	1	1064	0	1064	NA	NA	0	1064	
60	TCGA-4Z-AA7W	2	23	0	13	5	2	1	0	26	440	44	1	6	141	7	1	TCGA-4Z-AA7W-01	172	0.5097403729773619	90	TCGA-4Z-AA7W-01	18	37	113	0.4084854006683126	TCGA-4Z-AA7W-01	18	22	15	55	PASS	105	TCGA-4Z-AA7W	BLCA	55	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-20424	Alive	WITH TUMOR	840	NA	NA	Locoregional (Urothelial tumor event)	"Other, specify"	Rectum	760	Complete Remission/Response	NA	NA	0	840	0	840	1	760	1	760	
60	TCGA-4Z-AA7Y	0	13	4	9	6	2	0	0	7	220	27	0	7	106	3	0	TCGA-4Z-AA7Y-01	149	0.06494005577840174	85	TCGA-4Z-AA7Y-01	2	1	35	0.05812540338394007	TCGA-4Z-AA7Y-01	3	3	1	7	PASS	106	TCGA-4Z-AA7Y	BLCA	60	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-22056	Alive	TUMOR FREE	1522	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1522	0	1522	0	1522	0	1522	
70	TCGA-4Z-AA80	1	20	2	7	4	1	2	0	9	323	33	1	4	134	7	0	TCGA-4Z-AA80-01	356	0.8135722990980714	220	TCGA-4Z-AA80-01	23	64	119	0.2477324248188294	TCGA-4Z-AA80-01	31	23	10	64	PASS	107	TCGA-4Z-AA80	BLCA	73	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-26873	Dead	TUMOR FREE	NA	19	NA	NA	NA	NA	NA	NA	NA	NA	1	19	0	19	NA	NA	0	19	
80	TCGA-4Z-AA81	0	8	1	6	5	1	0	0	6	162	19	0	2	67	4	0	TCGA-4Z-AA81-01	169	0.6258415695808556	90	TCGA-4Z-AA81-01	21	30	40	0.11828440510370235	TCGA-4Z-AA81-01	11	5	2	18	PASS	108	TCGA-4Z-AA81	BLCA	80	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-29457	Dead	TUMOR FREE	NA	1270	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1270	0	1270	0	1270	0	1270	
60	TCGA-4Z-AA82	2	7	0	4	4	1	0	0	1	83	6	0	2	32	1	0	TCGA-4Z-AA82-01	297	0.4685298814137321	174	TCGA-4Z-AA82-01	19	30	87	0.1443481379457428	TCGA-4Z-AA82-01	9	12	2	23	PASS	109	TCGA-4Z-AA82	BLCA	59	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-21893	Dead	WITH TUMOR	NA	1556	NA	Distant Metastasis	Bone	NA	1150	Complete Remission/Response	NA	NA	1	1556	1	1556	NA	NA	1	1150	
50	TCGA-4Z-AA83	0	10	0	2	2	1	0	0	2	61	8	0	0	29	2	0	TCGA-4Z-AA83-01	85	0.07450648947705202	36	TCGA-4Z-AA83-01	5	3	25	0.05675959000866464	TCGA-4Z-AA83-01	1	1	1	3	PASS	110	TCGA-4Z-AA83	BLCA	52	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-19280	Alive	TUMOR FREE	2024	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2024	0	2024	0	2024	0	2024	
60	TCGA-4Z-AA84	3	20	2	24	6	5	4	0	31	365	25	0	2	191	6	0	TCGA-4Z-AA84-01	441	0.7784769404025385	288	TCGA-4Z-AA84-01	21	67	147	0.2306330683394811	TCGA-4Z-AA84-01	26	27	15	68	PASS	111	TCGA-4Z-AA84	BLCA	61	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-22397	Alive	WITH TUMOR	460	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	460	0	460	NA	NA	0	460	
70	TCGA-4Z-AA86	1	8	0	6	2	0	1	0	9	170	19	0	2	68	2	1	TCGA-4Z-AA86-01	114	0.402867337233695	47	TCGA-4Z-AA86-01	18	40	58	0.21720254452078835	TCGA-4Z-AA86-01	18	13	13	44	PASS	112	TCGA-4Z-AA86	BLCA	66	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-24465	Dead	WITH TUMOR	NA	311	NA	Locoregional (Urothelial tumor event)	"Other, specify"	Pelvis	136	Complete Remission/Response	NA	NA	1	311	1	311	NA	NA	1	136	
70	TCGA-4Z-AA87	3	8	1	9	8	1	0	0	11	196	19	0	3	70	5	0	TCGA-4Z-AA87-01	692	0.8248612669073756	445	TCGA-4Z-AA87-01	18	30	195	0.12716548524387716	TCGA-4Z-AA87-01	22	24	8	54	PASS	113	TCGA-4Z-AA87	BLCA	72	MALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-26430	Alive	WITH TUMOR	1454	NA	NA	Distant Metastasis	Bone	NA	221	[Unknown]	NA	NA	0	1454	0	1454	NA	NA	1	221	
60	TCGA-4Z-AA89	1	2	0	2	2	1	0	0	8	95	20	1	2	43	5	1	TCGA-4Z-AA89-01	146	0.14405629240353754	92	TCGA-4Z-AA89-01	1	2	25	0.034980884849249105	TCGA-4Z-AA89-01	3	5	2	10	PASS	114	TCGA-4Z-AA89	BLCA	60	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-22271	Alive	WITH TUMOR	1029	NA	NA	New Primary Tumor	Lung	NA	648	Complete Remission/Response	NA	NA	0	1029	0	1029	NA	NA	1	648	
80	TCGA-5N-A9KI	0	8	1	5	4	2	0	0	7	130	11	0	0	53	0	0	TCGA-5N-A9KI-01	129	0.913448902100596	61	TCGA-5N-A9KI-01	19	20	34	0.12993995700221472	TCGA-5N-A9KI-01	14	11	6	31	PASS	115	TCGA-5N-A9KI	BLCA	76	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-27777	Dead	TUMOR FREE	NA	76	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	76	0	76	0	76	0	76	
70	TCGA-5N-A9KM	2	6	0	7	6	3	1	0	8	154	13	1	3	74	7	1	TCGA-5N-A9KM-01	182	0.3430998151557931	103	TCGA-5N-A9KM-01	6	10	93	0.16707425180023353	TCGA-5N-A9KM-01	13	9	12	34	PASS	116	TCGA-5N-A9KM	BLCA	73	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-26906	Dead	WITH TUMOR	NA	530	NA	NA	NA	NA	276	Complete Remission/Response	NA	NA	1	530	1	530	1	276	1	276	
70	TCGA-BL-A0C8	0	5	1	3	3	4	0	0	6	92	6	0	1	40	3	0	TCGA-BL-A0C8-01	489	0.7597517186309168	303	TCGA-BL-A0C8-01	25	24	67	0.0960425363350234	TCGA-BL-A0C8-01	12	18	7	37	PASS	117	TCGA-BL-A0C8	BLCA	73	MALE	WHITE	Stage I	NA	NA	High Grade	2009	NA	-26819	Alive	NA	1219	NA	NA	Locoregional (Urothelial tumor event)	Bladder	NA	630	Complete Remission/Response	NA	NA	0	1219	0	1219	1	630	1	630	
60	TCGA-BL-A13I	0	8	2	0	5	2	0	0	4	173	10	1	4	55	6	0	TCGA-BL-A13I-01	86	0.07060179548086785	33	TCGA-BL-A13I-01	2	3	11	0.13507282567905946	TCGA-BL-A13I-01	2	1	2	5	PASS	118	TCGA-BL-A13I	BLCA	57	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-20885	Dead	WITH TUMOR	NA	223	NA	Metastatic	NA	NA	216	Progressive Disease	NA	NA	1	223	1	223	NA	NA	1	216	
70	TCGA-BL-A13J	0	4	2	12	2	2	0	0	14	164	18	0	2	72	6	0	TCGA-BL-A13J-01	209	0.7360328849478416	112	TCGA-BL-A13J-01	20	64	119	0.3178510539260279	TCGA-BL-A13J-01	21	13	9	43	PASS	119	TCGA-BL-A13J	BLCA	65	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-23927	Dead	WITH TUMOR	NA	81	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	81	1	81	NA	NA	1	81	
60	TCGA-BL-A3JM	1	6	3	9	2	1	0	0	12	152	16	0	4	70	4	1	TCGA-BL-A3JM-01	110	0.9400404121144884	52	TCGA-BL-A3JM-01	18	29	47	0.4332117729531839	TCGA-BL-A3JM-01	4	2	1	7	PASS	120	TCGA-BL-A3JM	BLCA	62	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-23000	Dead	WITH TUMOR	NA	205	NA	Metastatic	Bone	NA	111	Progressive Disease	NA	NA	1	205	1	205	NA	NA	1	111	
80	TCGA-BL-A5ZZ	0	13	1	12	7	4	0	0	6	184	26	0	3	95	7	0	TCGA-BL-A5ZZ-01	60	0.23577236395775564	18	TCGA-BL-A5ZZ-01	10	11	19	0.028635644991679594	TCGA-BL-A5ZZ-01	4	5	4	13	PASS	121	TCGA-BL-A5ZZ	BLCA	80	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-29247	Alive	WITH TUMOR	377	NA	NA	Distant Metastasis	Lung	NA	242	Complete Remission/Response	NA	NA	0	377	0	377	1	242	1	242	
80	TCGA-BT-A0S7	0	3	0	2	3	1	0	0	1	28	4	0	1	13	1	0	TCGA-BT-A0S7-01	130	0.2871549338280942	66	TCGA-BT-A0S7-01	21	35	39	0.2076885868631164	TCGA-BT-A0S7-01	14	6	2	22	PASS	122	TCGA-BT-A0S7	BLCA	75	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-27533	Dead	WITH TUMOR	NA	200	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	200	1	200	NA	NA	1	200	
70	TCGA-BT-A0YX	0	50	2	30	4	0	1	0	32	520	42	4	21	192	8	0	TCGA-BT-A0YX-01	91	0.10102124769180132	35	TCGA-BT-A0YX-01	1	7	12	0.07666274710030066	TCGA-BT-A0YX-01	5	7	4	16	PASS	123	TCGA-BT-A0YX	BLCA	70	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-25570	Dead	WITH TUMOR	NA	400	NA	Metastatic	"Other, specify"	lower abdominal wall and right pelvis	326	Progressive Disease	NA	NA	1	400	1	400	NA	NA	1	326	
80	TCGA-BT-A20J	0	33	1	12	2	0	1	0	15	384	29	2	6	151	4	0	TCGA-BT-A20J-01	361	0.5662188846510601	223	TCGA-BT-A20J-01	16	34	77	0.3019833251842376	TCGA-BT-A20J-01	20	23	8	51	PASS	124	TCGA-BT-A20J	BLCA	75	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	1999	NA	-27646	Dead	WITH TUMOR	NA	579	NA	Distant Metastasis	"Other, specify"	Adrenal	254	Progressive Disease	NA	NA	1	579	1	579	NA	NA	1	254	
70	TCGA-BT-A20N	0	16	4	13	6	3	0	0	9	208	15	0	4	87	5	1	TCGA-BT-A20N-01	274	0.7609570242377761	156	TCGA-BT-A20N-01	15	21	81	0.5698887354998069	TCGA-BT-A20N-01	20	21	22	63	PASS	125	TCGA-BT-A20N	BLCA	72	MALE	NA	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2003	NA	-26456	Dead	WITH TUMOR	NA	795	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	795	1	795	NA	NA	1	795	
80	TCGA-BT-A20O	0	12	1	1	1	0	0	0	9	153	15	0	5	44	0	1	TCGA-BT-A20O-01	69	0.02359439029754286	31	TCGA-BT-A20O-01	1	6	3	0.0613961707511087	TCGA-BT-A20O-01	1	2	1	4	PASS	126	TCGA-BT-A20O	BLCA	75	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2003	NA	-27534	Dead	WITH TUMOR	NA	370	NA	Locoregional (Urothelial tumor event)	Lymph Node Only	NA	315	Progressive Disease	NA	NA	1	370	1	370	NA	NA	1	315	
80	TCGA-BT-A20P	3	3	1	2	2	1	0	0	3	72	9	2	1	26	0	0	TCGA-BT-A20P-01	249	0.23686478421142346	169	TCGA-BT-A20P-01	7	5	41	0.07300064352926378	TCGA-BT-A20P-01	3	4	4	11	PASS	127	TCGA-BT-A20P	BLCA	81	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2005	NA	-29634	Dead	NA	NA	544	NA	NA	NA	NA	NA	NA	NA	NA	1	544	NA	544	NA	NA	0	544	
70	TCGA-BT-A20Q	0	3	1	3	2	2	1	0	3	70	13	0	2	26	2	0	TCGA-BT-A20Q-01	185	0.15482456642076645	113	TCGA-BT-A20Q-01	6	5	35	0.07342741267576479	TCGA-BT-A20Q-01	5	2	4	11	PASS	128	TCGA-BT-A20Q	BLCA	73	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-26778	Dead	WITH TUMOR	NA	593	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	593	1	593	NA	NA	1	593	
80	TCGA-BT-A20R	2	19	0	14	3	0	0	1	10	215	25	0	3	83	4	0	TCGA-BT-A20R-01	122	0.4307564290757793	52	TCGA-BT-A20R-01	15	24	21	0.17654161326605985	TCGA-BT-A20R-01	14	8	5	27	PASS	129	TCGA-BT-A20R	BLCA	79	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-28987	Dead	NA	NA	154	NA	NA	NA	NA	NA	NA	NA	NA	1	154	NA	154	NA	NA	0	154	
60	TCGA-BT-A20T	1	15	0	10	3	0	1	0	13	198	25	0	5	82	4	1	TCGA-BT-A20T-01	222	0.7124285502224019	132	TCGA-BT-A20T-01	6	6	58	0.18660573836186306	TCGA-BT-A20T-01	3	11	11	25	PASS	130	TCGA-BT-A20T	BLCA	63	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-23220	Dead	WITH TUMOR	NA	453	NA	Distant Metastasis	Liver	NA	314	Progressive Disease	NA	NA	1	453	1	453	NA	NA	1	314	
70	TCGA-BT-A20U	1	3	1	2	0	0	1	0	8	73	8	0	3	20	0	1	TCGA-BT-A20U-01	73	0.04860733378841044	18	TCGA-BT-A20U-01	0	2	8	0.056401912819115975	TCGA-BT-A20U-01	3	3	3	9	PASS	131	TCGA-BT-A20U	BLCA	70	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-25761	Dead	TUMOR FREE	NA	455	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	455	0	455	0	455	0	455	
60	TCGA-BT-A20V	0	8	2	3	1	1	1	2	3	85	6	0	0	28	1	0	TCGA-BT-A20V-01	368	0.7719670020690653	225	TCGA-BT-A20V-01	22	40	41	0.3073379303352689	TCGA-BT-A20V-01	22	13	4	39	pathology review	132	TCGA-BT-A20V	BLCA	59	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-21551	Dead	NA	NA	154	NA	NA	NA	NA	NA	NA	NA	NA	1	154	NA	154	NA	NA	0	154	
70	TCGA-BT-A20W	0	1	0	1	1	1	0	0	1	76	4	0	2	23	2	0	TCGA-BT-A20W-01	330	0.4914989745112165	200	TCGA-BT-A20W-01	3	3	30	0.0454107147353387	TCGA-BT-A20W-01	9	6	3	18	PASS	133	TCGA-BT-A20W	BLCA	71	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-26078	Dead	TUMOR FREE	NA	254	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	254	0	254	0	254	0	254	
60	TCGA-BT-A20X	0	4	0	0	1	0	0	0	0	61	5	0	2	20	2	0	TCGA-BT-A20X-01	80	0.4135713478859516	29	TCGA-BT-A20X-01	24	19	17	0.1778911575075919	TCGA-BT-A20X-01	7	6	5	18	pathology review	134	TCGA-BT-A20X	BLCA	56	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-20519	Dead	WITH TUMOR	NA	251	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	251	1	251	NA	NA	1	251	
50	TCGA-BT-A2LA	2	4	1	8	0	2	0	0	15	149	15	0	3	63	5	0	TCGA-BT-A2LA-01	228	0.6417243894191199	127	TCGA-BT-A2LA-01	13	20	58	0.237388820782014	TCGA-BT-A2LA-01	13	11	13	37	pathology review	135	TCGA-BT-A2LA	BLCA	54	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-20032	Alive	TUMOR FREE	522	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	522	0	522	0	522	0	522	
70	TCGA-BT-A2LB	6	36	2	103	22	5	6	2	38	867	80	2	22	437	24	4	TCGA-BT-A2LB-01	170	0.7070564690333138	101	TCGA-BT-A2LB-01	25	27	32	0.23332711179576485	TCGA-BT-A2LB-01	10	7	6	23	PASS	136	TCGA-BT-A2LB	BLCA	73	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-26846	Dead	TUMOR FREE	NA	492	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	492	0	492	0	492	0	492	
80	TCGA-BT-A2LD	0	4	0	2	1	3	1	0	6	83	5	0	0	31	2	0	TCGA-BT-A2LD-01	261	0.6252822921478369	142	TCGA-BT-A2LD-01	7	18	61	0.287613026883264	TCGA-BT-A2LD-01	12	12	9	33	PASS	137	TCGA-BT-A2LD	BLCA	78	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-28673	Dead	WITH TUMOR	NA	623	NA	Distant Metastasis	"Other, specify"	brain and spinal cord	555	Progressive Disease	NA	NA	1	623	1	623	NA	NA	1	555	
80	TCGA-BT-A3PH	0	18	4	16	1	2	0	0	16	358	45	0	7	131	4	0	TCGA-BT-A3PH-01	138	0.7541878111861527	64	TCGA-BT-A3PH-01	14	12	19	0.12241857378807053	TCGA-BT-A3PH-01	9	5	5	19	PASS	138	TCGA-BT-A3PH	BLCA	76	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-28030	Dead	WITH TUMOR	NA	142	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	142	1	142	NA	NA	1	142	
80	TCGA-BT-A3PJ	0	21	3	32	4	2	5	0	21	379	34	2	10	170	10	0	TCGA-BT-A3PJ-01	271	0.902918763043829	152	TCGA-BT-A3PJ-01	23	31	51	0.1960035514775151	TCGA-BT-A3PJ-01	22	14	7	43	PASS	139	TCGA-BT-A3PJ	BLCA	76	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-27821	Alive	TUMOR FREE	789	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	789	0	789	0	789	0	789	
80	TCGA-BT-A3PK	0	12	2	10	7	0	1	0	15	304	20	1	5	105	5	1	TCGA-BT-A3PK-01	94	0.17066874818980596	38	TCGA-BT-A3PK-01	5	7	20	0.22631915921062595	TCGA-BT-A3PK-01	3	11	7	21	PASS	140	TCGA-BT-A3PK	BLCA	80	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-29314	Dead	WITH TUMOR	NA	303	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	303	1	303	NA	NA	1	303	
60	TCGA-BT-A42B	0	5	1	1	2	0	0	0	3	42	8	0	3	25	1	0	TCGA-BT-A42B-01	226	0.8668779393798841	150	TCGA-BT-A42B-01	9	7	132	0.2491094489451093	TCGA-BT-A42B-01	5	7	12	24	PASS	141	TCGA-BT-A42B	BLCA	59	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-21788	Dead	WITH TUMOR	NA	534	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	534	1	534	NA	NA	1	534	
60	TCGA-BT-A42C	1	26	0	20	5	2	4	0	20	297	22	0	8	100	7	1	TCGA-BT-A42C-01	164	0.7308665913787502	83	TCGA-BT-A42C-01	18	25	58	0.19272326374366272	TCGA-BT-A42C-01	23	20	10	53	PASS	142	TCGA-BT-A42C	BLCA	64	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-23584	Alive	TUMOR FREE	873	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	873	0	873	0	873	0	873	
70	TCGA-BT-A42E	0	9	2	6	1	1	1	0	12	141	12	0	2	45	1	1	TCGA-BT-A42E-01	146	0.6220971744257286	71	TCGA-BT-A42E-01	17	31	108	0.4086954497373565	TCGA-BT-A42E-01	22	14	20	56	PASS	143	TCGA-BT-A42E	BLCA	74	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-27045	Alive	TUMOR FREE	1108	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1108	0	1108	0	1108	0	1108	
60	TCGA-BT-A42F	2	4	0	3	1	0	0	0	4	145	14	0	0	53	0	0	TCGA-BT-A42F-01	63	0.20314511650592146	14	TCGA-BT-A42F-01	25	37	39	0.1912502141527635	TCGA-BT-A42F-01	19	15	8	42	PASS	144	TCGA-BT-A42F	BLCA	64	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-23713	Alive	TUMOR FREE	864	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	864	0	864	NA	NA	0	864	
70	TCGA-C4-A0EZ	0	8	1	9	3	0	0	0	8	141	19	0	3	64	6	0	TCGA-C4-A0EZ-01	998	0.5895475987909363	891	TCGA-C4-A0EZ-01	17	24	25	0.08117057967702432	TCGA-C4-A0EZ-01	9	5	3	17	pathology review	145	TCGA-C4-A0EZ	BLCA	69	FEMALE	NA	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-25202	Dead	WITH TUMOR	NA	273	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	273	1	273	NA	NA	1	273	Redacted
60	TCGA-C4-A0F0	2	8	1	6	8	0	3	0	3	66	5	0	2	31	5	0	TCGA-C4-A0F0-01	145	0.5250213646813146	77	TCGA-C4-A0F0-01	26	36	22	0.2244790170825368	TCGA-C4-A0F0-01	11	6	10	27	PASS	146	TCGA-C4-A0F0	BLCA	60	MALE	NA	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-22068	Alive	TUMOR FREE	59	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	59	0	59	NA	NA	0	59	
70	TCGA-C4-A0F1	0	15	0	7	1	0	0	0	12	133	14	0	1	61	1	0	TCGA-C4-A0F1	0	0	0	TCGA-C4-A0F1	0	0	0	0	TCGA-C4-A0F1	0	0	0	0	PASS	147	TCGA-C4-A0F1	BLCA	71	MALE	NA	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-26178	Alive	TUMOR FREE	89	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	89	0	89	NA	NA	0	89	Redacted
80	TCGA-C4-A0F6	0	11	0	7	1	1	1	0	12	164	13	0	3	55	4	0	TCGA-C4-A0F6-01	210	0.5218226370312498	127	TCGA-C4-A0F6-01	18	28	36	0.2523135008503898	TCGA-C4-A0F6-01	7	5	5	17	PASS	148	TCGA-C4-A0F6	BLCA	82	FEMALE	NA	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-29951	Alive	TUMOR FREE	700	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	700	0	700	NA	NA	0	700	
80	TCGA-C4-A0F7	1	3	2	9	4	0	0	0	2	54	4	0	1	30	1	0	TCGA-C4-A0F7	0	0	0	TCGA-C4-A0F7	0	0	0	0	TCGA-C4-A0F7	0	0	0	0	PASS	149	TCGA-C4-A0F7	BLCA	77	MALE	NA	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-28428	Dead	WITH TUMOR	NA	62	NA	NA	NA	NA	NA	NA	NA	NA	1	62	1	62	NA	NA	1	62	Redacted
60	TCGA-CF-A1HR	1	18	2	10	1	2	0	0	11	215	23	0	2	93	9	0	TCGA-CF-A1HR-01	137	0.4536360067365176	71	TCGA-CF-A1HR-01	18	17	14	0.06886786378723285	TCGA-CF-A1HR-01	8	4	2	14	PASS	150	TCGA-CF-A1HR	BLCA	62	MALE	ASIAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-22777	Alive	WITH TUMOR	389	NA	NA	Distant Metastasis	Liver	NA	294	Complete Remission/Response	NA	NA	0	389	0	389	1	294	1	294	
80	TCGA-CF-A1HS	0	13	2	9	4	2	0	0	7	209	13	0	5	82	10	0	TCGA-CF-A1HS-01	298	0.7410832463219658	192	TCGA-CF-A1HS-01	15	28	33	0.26863820951538864	TCGA-CF-A1HS-01	17	14	14	45	PASS	151	TCGA-CF-A1HS	BLCA	75	FEMALE	ASIAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-27565	Alive	WITH TUMOR	382	NA	NA	Distant Metastasis	"Other, specify"	Pelvis	133	Complete Remission/Response	NA	NA	0	382	0	382	1	133	1	133	
50	TCGA-CF-A27C	1	11	1	1	2	0	0	0	4	105	19	1	4	55	4	0	TCGA-CF-A27C-01	160	0.19036567381656225	90	TCGA-CF-A27C-01	3	3	21	0.09250988864915904	TCGA-CF-A27C-01	5	4	4	13	PASS	152	TCGA-CF-A27C	BLCA	52	MALE	ASIAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-19270	Alive	TUMOR FREE	425	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	425	0	425	0	425	0	425	
30	TCGA-CF-A3MF	0	0	0	0	0	0	0	0	0	19	4	0	0	8	0	0	TCGA-CF-A3MF-01	95	0.4539768763536425	38	TCGA-CF-A3MF-01	18	20	10	0.1504752340136826	TCGA-CF-A3MF-01	1	1	0	2	PASS	153	TCGA-CF-A3MF	BLCA	34	MALE	ASIAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2011	NA	-12557	Alive	TUMOR FREE	383	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	383	0	383	0	383	0	383	
50	TCGA-CF-A3MG	0	7	1	4	2	1	0	0	8	99	18	0	2	49	1	0	TCGA-CF-A3MG-01	114	0.7383821406498471	50	TCGA-CF-A3MG-01	20	24	24	0.2912116823457777	TCGA-CF-A3MG-01	7	4	5	16	PASS	154	TCGA-CF-A3MG	BLCA	48	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2011	NA	-17600	Alive	TUMOR FREE	369	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	369	0	369	0	369	0	369	
80	TCGA-CF-A3MH	0	3	0	2	1	2	1	0	3	36	1	0	1	10	2	0	TCGA-CF-A3MH-01	104	0.2586758606856783	47	TCGA-CF-A3MH-01	9	10	24	0.20755898499003805	TCGA-CF-A3MH-01	5	1	4	10	PASS	155	TCGA-CF-A3MH	BLCA	75	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2011	NA	-27458	Alive	TUMOR FREE	398	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	398	0	398	0	398	0	398	
60	TCGA-CF-A3MI	0	3	0	6	1	1	0	0	2	54	3	0	2	23	3	0	TCGA-CF-A3MI-01	195	0.6120007385204725	118	TCGA-CF-A3MI-01	17	20	25	0.05155555778400058	TCGA-CF-A3MI-01	9	6	3	18	PASS	156	TCGA-CF-A3MI	BLCA	62	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2011	NA	-22716	Alive	TUMOR FREE	370	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	370	0	370	0	370	0	370	
40	TCGA-CF-A47S	0	1	0	1	3	2	0	0	1	17	4	0	0	6	0	0	TCGA-CF-A47S-01	48	0.1579628186937116	8	TCGA-CF-A47S-01	5	4	18	0.09108709498971272	TCGA-CF-A47S-01	6	5	6	17	PASS	157	TCGA-CF-A47S	BLCA	41	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2011	NA	-15225	Alive	TUMOR FREE	333	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	333	0	333	0	333	0	333	
60	TCGA-CF-A47T	0	1	0	1	2	1	1	0	1	19	4	0	1	9	0	0	TCGA-CF-A47T-01	51	0.05084435182571735	12	TCGA-CF-A47T-01	3	4	20	0.06789688876400761	TCGA-CF-A47T-01	4	1	2	7	PASS	158	TCGA-CF-A47T	BLCA	58	FEMALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2011	NA	-21347	Dead	WITH TUMOR	NA	385	NA	Distant Metastasis	Bone	NA	139	Complete Remission/Response	NA	NA	1	385	1	385	1	139	1	139	
50	TCGA-CF-A47V	0	5	0	4	0	0	0	0	3	63	2	0	3	27	0	0	TCGA-CF-A47V-01	152	0.12656853844372198	89	TCGA-CF-A47V-01	3	5	23	0.03131339502968505	TCGA-CF-A47V-01	4	2	1	7	PASS	159	TCGA-CF-A47V	BLCA	52	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-19265	Alive	TUMOR FREE	379	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	379	0	379	0	379	0	379	
40	TCGA-CF-A47W	0	3	0	4	0	0	0	0	1	19	4	0	0	7	3	0	TCGA-CF-A47W-01	47	7.453217654915977e-05	11	TCGA-CF-A47W-01	0	0	5	0.0009076887786320396	TCGA-CF-A47W-01	0	0	0	0	PASS	160	TCGA-CF-A47W	BLCA	42	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2012	NA	-15497	Alive	TUMOR FREE	368	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	368	0	368	0	368	0	368	
60	TCGA-CF-A47X	4	20	2	19	4	3	0	0	10	248	26	0	3	98	7	0	TCGA-CF-A47X-01	122	0.8999127129931345	59	TCGA-CF-A47X-01	16	18	20	0.030699225007270462	TCGA-CF-A47X-01	6	3	2	11	PASS	161	TCGA-CF-A47X	BLCA	60	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2012	NA	-22200	Alive	TUMOR FREE	384	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	384	0	384	0	384	0	384	
60	TCGA-CF-A47Y	0	6	0	1	1	1	0	0	2	48	8	0	1	23	1	0	TCGA-CF-A47Y-01	49	0.0001643521346350818	4	TCGA-CF-A47Y-01	0	0	13	0.016624751725243258	TCGA-CF-A47Y-01	1	0	1	2	PASS	162	TCGA-CF-A47Y	BLCA	55	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2012	NA	-20432	Alive	TUMOR FREE	373	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	373	0	373	0	373	0	373	
60	TCGA-CF-A5U8	0	2	0	1	1	0	0	0	2	39	3	0	2	22	2	0	TCGA-CF-A5U8-01	53	0.17808970865681992	18	TCGA-CF-A5U8-01	2	1	12	0.050757802458417635	TCGA-CF-A5U8-01	0	0	0	0	PASS	163	TCGA-CF-A5U8	BLCA	59	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2012	NA	-21734	Alive	TUMOR FREE	399	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	399	0	399	0	399	0	399	
70	TCGA-CF-A5UA	1	1	0	1	0	0	0	0	6	58	3	1	1	26	4	0	TCGA-CF-A5UA-01	182	0.34300965973949554	102	TCGA-CF-A5UA-01	8	15	68	0.0732016186798773	TCGA-CF-A5UA-01	12	5	5	22	PASS	164	TCGA-CF-A5UA	BLCA	67	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2012	NA	-24625	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	365	0	365	0	365	0	365	
50	TCGA-CF-A7I0	0	4	0	2	0	1	0	0	3	31	3	0	1	24	1	0	TCGA-CF-A7I0-01	146	0.1820310869263792	85	TCGA-CF-A7I0-01	3	2	68	0.15015299796262693	TCGA-CF-A7I0-01	3	4	4	11	PASS	165	TCGA-CF-A7I0	BLCA	54	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2013	NA	-20059	Alive	TUMOR FREE	368	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	368	0	368	0	368	0	368	
60	TCGA-CF-A8HX	1	6	0	3	2	0	0	0	3	48	1	0	3	23	1	0	TCGA-CF-A8HX-01	176	0.2519158993928045	103	TCGA-CF-A8HX-01	5	5	63	0.0990943740353999	TCGA-CF-A8HX-01	5	7	6	18	PASS	166	TCGA-CF-A8HX	BLCA	55	FEMALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-20259	Alive	TUMOR FREE	345	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	345	0	345	0	345	0	345	
60	TCGA-CF-A8HY	0	4	1	1	2	3	1	0	3	68	10	0	2	32	2	0	TCGA-CF-A8HY-01	182	0.5659324512101304	103	TCGA-CF-A8HY-01	25	16	79	0.20955143080284647	TCGA-CF-A8HY-01	9	5	8	22	PASS	167	TCGA-CF-A8HY	BLCA	59	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-21636	Alive	TUMOR FREE	345	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	345	0	345	0	345	0	345	
50	TCGA-CF-A9FF	1	6	1	8	5	0	0	0	2	104	21	0	0	42	1	0	TCGA-CF-A9FF-01	104	0.2292333140916188	58	TCGA-CF-A9FF-01	5	5	33	0.08664458196626093	TCGA-CF-A9FF-01	5	2	2	9	PASS	168	TCGA-CF-A9FF	BLCA	52	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-19195	Alive	TUMOR FREE	361	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	361	0	361	0	361	0	361	
90	TCGA-CF-A9FH	0	0	0	1	0	2	0	0	0	33	3	0	1	7	0	0	TCGA-CF-A9FH-01	82	0.11321549969931735	38	TCGA-CF-A9FH-01	5	7	39	0.1444497552833508	TCGA-CF-A9FH-01	2	0	2	4	PASS	169	TCGA-CF-A9FH	BLCA	85	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2013	NA	-31236	Alive	TUMOR FREE	-64	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	0	0	0	0	0	0	0	
90	TCGA-CF-A9FL	0	0	1	3	8	1	1	0	2	41	4	0	1	16	2	0	TCGA-CF-A9FL-01	111	0.1501962873957322	49	TCGA-CF-A9FL-01	4	3	34	0.07118643854939781	TCGA-CF-A9FL-01	5	6	1	12	PASS	170	TCGA-CF-A9FL	BLCA	85	MALE	ASIAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-31099	Dead	WITH TUMOR	NA	565	NA	Locoregional (Urothelial tumor event)	NA	NA	322	Complete Remission/Response	NA	NA	1	565	1	565	1	322	1	322	
50	TCGA-CF-A9FM	1	0	0	0	1	2	1	0	1	16	0	0	2	8	0	0	TCGA-CF-A9FM-01	75	0.019799883550931662	30	TCGA-CF-A9FM-01	0	1	11	0.02014485417063181	TCGA-CF-A9FM-01	0	2	1	3	PASS	171	TCGA-CF-A9FM	BLCA	50	MALE	ASIAN	Stage I	NA	NA	High Grade	2013	NA	-18445	Alive	TUMOR FREE	398	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	398	0	398	0	398	0	398	
60	TCGA-CU-A0YN	1	7	0	5	5	1	0	0	1	122	11	0	7	47	6	0	TCGA-CU-A0YN-01	179	0.6216503215108345	94	TCGA-CU-A0YN-01	22	22	24	0.2600629869102269	TCGA-CU-A0YN-01	14	9	8	31	PASS	172	TCGA-CU-A0YN	BLCA	60	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2005	NA	-21927	Dead	NA	NA	393	NA	NA	NA	NA	NA	NA	NA	NA	1	393	NA	393	NA	NA	0	393	
80	TCGA-CU-A0YO	0	5	0	1	3	1	0	0	6	72	13	0	2	30	2	0	TCGA-CU-A0YO-01	63	0.3628354463829768	19	TCGA-CU-A0YO-01	15	11	14	0.3832590479645596	TCGA-CU-A0YO-01	1	8	3	12	PASS	173	TCGA-CU-A0YO	BLCA	84	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-30817	Dead	WITH TUMOR	NA	149	NA	Metastatic	"Other, specify"	peritoneum	118	Complete Remission/Response	NA	NA	1	149	1	149	NA	NA	1	118	
80	TCGA-CU-A0YR	0	29	0	7	12	6	4	0	10	226	14	0	2	91	12	0	TCGA-CU-A0YR-01	262	0.5987228229881023	153	TCGA-CU-A0YR-01	12	25	49	0.2187760234677595	TCGA-CU-A0YR-01	21	18	15	54	PASS	174	TCGA-CU-A0YR	BLCA	83	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-30674	Dead	WITH TUMOR	NA	460	NA	Metastatic	Lymph Node Only	NA	219	Complete Remission/Response	NA	NA	1	460	1	460	NA	NA	1	219	
80	TCGA-CU-A3KJ	2	9	0	5	1	0	1	0	15	178	16	0	4	73	3	0	TCGA-CU-A3KJ-01	317	0.6732910668871173	211	TCGA-CU-A3KJ-01	18	33	75	0.2244641302146505	TCGA-CU-A3KJ-01	20	16	8	44	PASS	175	TCGA-CU-A3KJ	BLCA	75	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-27692	Alive	WITH TUMOR	562	NA	NA	Distant Metastasis	Lung	NA	166	Progressive Disease	NA	NA	0	562	0	562	NA	NA	1	166	
60	TCGA-CU-A3QU	1	8	0	5	2	1	0	0	5	74	8	0	1	35	1	0	TCGA-CU-A3QU-01	179	0.8722649735555396	102	TCGA-CU-A3QU-01	14	21	95	0.2914024296350424	TCGA-CU-A3QU-01	14	10	14	38	PASS	176	TCGA-CU-A3QU	BLCA	58	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-21233	Alive	TUMOR FREE	158	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	158	0	158	NA	NA	0	158	
70	TCGA-CU-A3YL	3	7	0	5	5	4	0	0	7	185	13	0	5	58	3	0	TCGA-CU-A3YL-01	71	0.20522837599570534	24	TCGA-CU-A3YL-01	5	7	36	0.07553044452183205	TCGA-CU-A3YL-01	3	4	6	13	PASS	177	TCGA-CU-A3YL	BLCA	67	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-24524	Alive	TUMOR FREE	906	NA	NA	Distant Metastasis	Lung	NA	370	Complete Remission/Response	NA	NA	0	906	0	906	1	370	1	370	
70	TCGA-CU-A5W6	1	12	0	11	2	2	0	0	5	178	14	0	1	70	1	1	TCGA-CU-A5W6-01	176	0.5369670075130373	103	TCGA-CU-A5W6-01	18	18	62	0.150158145728677	TCGA-CU-A5W6-01	7	12	9	28	PASS	178	TCGA-CU-A5W6	BLCA	70	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-25706	Dead	TUMOR FREE	NA	56	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	56	0	56	0	56	0	56	
80	TCGA-CU-A72E	0	3	1	4	2	2	1	0	2	72	11	0	1	37	2	0	TCGA-CU-A72E-01	120	0.1870983216907064	64	TCGA-CU-A72E-01	6	7	61	0.16717131992805162	TCGA-CU-A72E-01	3	0	2	5	PASS	179	TCGA-CU-A72E	BLCA	76	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-27963	Dead	WITH TUMOR	NA	413	NA	New Primary Tumor	Lymph Node Only	NA	256	Partial Remission/Response	NA	NA	1	413	1	413	NA	NA	1	256	
60	TCGA-DK-A1A3	3	35	2	24	5	5	1	0	23	485	49	0	13	199	11	1	TCGA-DK-A1A3-01	261	0.6441813564615504	155	TCGA-DK-A1A3-01	21	34	27	0.1929691153265145	TCGA-DK-A1A3-01	13	7	6	26	PASS	180	TCGA-DK-A1A3	BLCA	60	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-22235	Dead	WITH TUMOR	NA	665	NA	NA	NA	NA	NA	NA	NA	NA	1	665	1	665	NA	NA	1	665	
80	TCGA-DK-A1A5	2	19	2	13	3	1	1	0	11	210	14	0	5	88	2	0	TCGA-DK-A1A5-01	260	0.6280560551790325	161	TCGA-DK-A1A5-01	17	24	34	0.22613424272071064	TCGA-DK-A1A5-01	20	12	5	37	PASS	181	TCGA-DK-A1A5	BLCA	79	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-29111	Dead	TUMOR FREE	NA	65	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	65	0	65	0	65	0	65	
50	TCGA-DK-A1A6	1	16	2	8	2	4	1	0	10	214	21	2	5	74	9	0	TCGA-DK-A1A6-01	341	0.8905600297438779	197	TCGA-DK-A1A6-06	18	29	66	0.10281812558289714	TCGA-DK-A1A6-06	17	8	4	29	PASS	182	TCGA-DK-A1A6	BLCA	53	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-19554	Alive	TUMOR FREE	2020	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2020	0	2020	NA	NA	0	2020	
70	TCGA-DK-A1A7	2	11	1	13	8	1	4	0	12	174	15	0	2	52	9	0	TCGA-DK-A1A7-01	484	0.6545591985300188	298	TCGA-DK-A1A7-01	13	35	79	0.21664319813300967	TCGA-DK-A1A7-01	23	16	10	49	PASS	183	TCGA-DK-A1A7	BLCA	67	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-24499	Alive	WITH TUMOR	560	NA	NA	Metastatic	Lung	NA	112	NA	NA	NA	0	560	0	560	NA	NA	1	112	
60	TCGA-DK-A1AA	1	11	1	2	1	4	0	0	2	65	6	0	1	15	0	0	TCGA-DK-A1AA-01	91	0.10572320601492206	36	TCGA-DK-A1AA-01	2	1	11	0.0578514256973258	TCGA-DK-A1AA-01	2	1	0	3	PASS	184	TCGA-DK-A1AA	BLCA	57	MALE	MALE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-21093	Alive	TUMOR FREE	578	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	578	0	578	0	578	0	578	
70	TCGA-DK-A1AB	1	7	2	10	0	0	0	0	10	150	22	0	6	65	1	0	TCGA-DK-A1AB-01	55	0.7241925768497384	14	TCGA-DK-A1AB-01	11	9	13	0.2440920383117064	TCGA-DK-A1AB-01	4	1	4	9	PASS	185	TCGA-DK-A1AB	BLCA	74	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-27126	Dead	NA	NA	508	NA	Metastatic	Lung	NA	364	Progressive Disease	NA	NA	1	508	NA	508	NA	NA	1	364	
70	TCGA-DK-A1AC	11	103	9	83	15	5	3	0	70	1108	101	2	18	563	25	5	TCGA-DK-A1AC-01	340	0.633065297771165	185	TCGA-DK-A1AC-01	12	33	32	0.15900071486735928	TCGA-DK-A1AC-01	16	19	9	44	hypermutated sample	186	TCGA-DK-A1AC	BLCA	72	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2000	NA	-26307	Alive	TUMOR FREE	3981	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3981	0	3981	0	3981	0	3981	
70	TCGA-DK-A1AD	2	11	1	10	5	0	3	0	8	194	12	0	5	76	4	0	TCGA-DK-A1AD-01	267	0.6900448162804081	155	TCGA-DK-A1AD-01	15	42	26	0.1125145923661064	TCGA-DK-A1AD-01	15	17	6	38	PASS	187	TCGA-DK-A1AD	BLCA	69	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2002	NA	-25317	Alive	TUMOR FREE	3420	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3420	0	3420	NA	NA	0	3420	
80	TCGA-DK-A1AE	3	3	1	5	1	3	0	0	5	94	7	0	1	32	2	0	TCGA-DK-A1AE-01	196	0.10174538751508497	122	TCGA-DK-A1AE-01	0	3	44	0.02295106818310993	TCGA-DK-A1AE-01	5	11	0	16	PASS	188	TCGA-DK-A1AE	BLCA	84	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-30707	Alive	WITH TUMOR	491	NA	NA	Metastatic	Bone	NA	211	Progressive Disease	NA	NA	0	491	0	491	NA	NA	1	211	
80	TCGA-DK-A1AF	0	4	1	1	0	0	0	0	4	92	7	0	1	29	2	1	TCGA-DK-A1AF-01	59	0.008515728103728963	16	TCGA-DK-A1AF-01	4	2	3	0.08701782475004452	TCGA-DK-A1AF-01	1	1	1	3	PASS	189	TCGA-DK-A1AF	BLCA	84	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-30914	Alive	TUMOR FREE	536	NA	NA	Metastatic	Lymph Node Only	NA	283	Progressive Disease	NA	NA	0	536	0	536	NA	NA	1	283	
70	TCGA-DK-A1AG	0	7	1	4	4	0	0	0	3	85	16	1	1	37	4	0	TCGA-DK-A1AG-01	121	0.06501002553039575	59	TCGA-DK-A1AG-01	2	1	12	0.05366555504715178	TCGA-DK-A1AG-01	0	0	0	0	PASS	190	TCGA-DK-A1AG	BLCA	65	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-24095	Alive	TUMOR FREE	475	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	475	0	475	0	475	0	475	
80	TCGA-DK-A2HX	3	5	1	4	2	1	0	0	3	77	10	1	2	29	3	1	TCGA-DK-A2HX-01	196	0.5986633159363585	108	TCGA-DK-A2HX-01	19	27	6	0.07326084069374468	TCGA-DK-A2HX-01	12	10	2	24	PASS	191	TCGA-DK-A2HX	BLCA	80	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-29332	Dead	TUMOR FREE	NA	1420	NA	NA	NA	NA	NA	NA	NA	NA	1	1420	0	1420	NA	NA	0	1420	
70	TCGA-DK-A2I1	3	63	1	37	3	3	0	1	48	591	84	1	8	198	20	0	TCGA-DK-A2I1-01	339	0.7177375368070629	212	TCGA-DK-A2I1-01	23	28	85	0.24954264187493405	TCGA-DK-A2I1-01	11	5	5	21	PASS	192	TCGA-DK-A2I1	BLCA	73	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-26726	Alive	TUMOR FREE	546	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	546	0	546	0	546	0	546	
60	TCGA-DK-A2I2	3	32	1	17	2	1	1	0	22	345	39	0	10	149	10	0	TCGA-DK-A2I2-01	156	0.6117429794959441	87	TCGA-DK-A2I2-01	19	32	53	0.32185623935890423	TCGA-DK-A2I2-01	12	12	8	32	PASS	193	TCGA-DK-A2I2	BLCA	63	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-23116	Dead	WITH TUMOR	NA	237	NA	Distant Metastasis	Liver	NA	163	Complete Remission/Response	NA	NA	1	237	1	237	NA	NA	1	163	
80	TCGA-DK-A2I4	8	36	4	35	0	3	0	0	47	682	84	0	10	353	15	2	TCGA-DK-A2I4-01	92	0.3844208534097139	40	TCGA-DK-A2I4-01	20	36	19	0.2287843970103106	TCGA-DK-A2I4-01	9	10	6	25	hypermutated sample	194	TCGA-DK-A2I4	BLCA	79	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2001	NA	-29037	Alive	TUMOR FREE	4343	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4343	0	4343	0	4343	0	4343	
80	TCGA-DK-A2I6	0	9	1	18	3	0	4	0	15	216	17	1	3	101	2	1	TCGA-DK-A2I6-01	369	0.7814107069898623	211	TCGA-DK-A2I6-01	21	62	50	0.2318298676326852	TCGA-DK-A2I6-01	22	22	10	54	PASS	195	TCGA-DK-A2I6	BLCA	81	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2005	NA	-29789	Alive	TUMOR FREE	2656	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2656	0	2656	NA	NA	0	2656	
90	TCGA-DK-A3IK	1	10	1	6	1	0	1	0	4	178	13	0	3	50	2	1	TCGA-DK-A3IK-01	276	0.5461835644153434	169	TCGA-DK-A3IK-01	14	39	89	0.3456995450670691	TCGA-DK-A3IK-01	22	16	9	47	PASS	196	TCGA-DK-A3IK	BLCA	87	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-32076	Dead	TUMOR FREE	NA	146	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	146	0	146	NA	NA	0	146	
80	TCGA-DK-A3IL	1	9	0	6	4	2	1	0	6	159	6	0	1	40	2	0	TCGA-DK-A3IL-01	144	0.5577812037829399	81	TCGA-DK-A3IL-01	18	23	23	0.14417695796141675	TCGA-DK-A3IL-01	8	7	7	22	PASS	197	TCGA-DK-A3IL	BLCA	79	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-29047	Dead	TUMOR FREE	NA	413	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	413	0	413	NA	NA	0	413	
80	TCGA-DK-A3IM	0	3	0	1	3	0	0	0	5	61	9	0	1	28	2	0	TCGA-DK-A3IM-01	352	0.7616527246689896	224	TCGA-DK-A3IM-01	14	30	107	0.4679063625931635	TCGA-DK-A3IM-01	28	15	17	60	PASS	198	TCGA-DK-A3IM	BLCA	76	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-28106	Dead	WITH TUMOR	NA	248	NA	Locoregional (Urothelial tumor event)	Lymph Node Only	NA	201	Complete Remission/Response	NA	NA	1	248	1	248	1	201	1	201	
70	TCGA-DK-A3IN	0	13	0	11	5	1	0	0	22	305	25	1	5	128	5	0	TCGA-DK-A3IN-01	151	0.5837173509008592	79	TCGA-DK-A3IN-01	23	24	14	0.1542100193217169	TCGA-DK-A3IN-01	12	6	7	25	PASS	199	TCGA-DK-A3IN	BLCA	72	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-26562	Dead	TUMOR FREE	NA	250	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	250	0	250	0	250	0	250	
70	TCGA-DK-A3IQ	0	11	1	5	1	1	0	0	9	141	14	0	1	59	5	0	TCGA-DK-A3IQ-01	290	0.35841717469608797	201	TCGA-DK-A3IQ-01	10	12	132	0.2648999570126141	TCGA-DK-A3IQ-01	5	10	11	26	PASS	200	TCGA-DK-A3IQ	BLCA	74	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-27194	Dead	WITH TUMOR	NA	539	NA	Locoregional (Urothelial tumor event)	Lymph Node Only	NA	250	Complete Remission/Response	NA	NA	1	539	1	539	1	250	1	250	
70	TCGA-DK-A3IS	2	9	2	12	3	1	0	0	15	260	29	1	3	121	7	1	TCGA-DK-A3IS-01	244	0.8555577376526833	154	TCGA-DK-A3IS-01	22	14	37	0.0875358803253353	TCGA-DK-A3IS-01	5	7	3	15	PASS	201	TCGA-DK-A3IS	BLCA	68	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-25098	Alive	TUMOR FREE	1529	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1529	0	1529	0	1529	0	1529	
60	TCGA-DK-A3IT	3	22	2	19	2	1	0	0	22	338	41	0	13	90	5	1	TCGA-DK-A3IT-01	229	0.8662532262608781	130	TCGA-DK-A3IT-01	18	16	52	0.1975995185016992	TCGA-DK-A3IT-01	13	5	5	23	PASS	202	TCGA-DK-A3IT	BLCA	62	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-22786	Alive	TUMOR FREE	648	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	648	0	648	0	648	0	648	
60	TCGA-DK-A3IU	3	14	3	11	2	0	0	0	17	307	33	1	4	155	4	0	TCGA-DK-A3IU-01	64	0.29665329481052616	16	TCGA-DK-A3IU-01	8	18	8	0.17005033342118298	TCGA-DK-A3IU-01	5	4	2	11	PASS	203	TCGA-DK-A3IU	BLCA	58	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-21369	Dead	WITH TUMOR	NA	706	NA	Distant Metastasis	Lung	NA	462	Complete Remission/Response	NA	NA	1	706	1	706	1	462	1	462	
60	TCGA-DK-A3IV	0	2	0	2	1	0	0	0	4	65	8	0	2	22	1	0	TCGA-DK-A3IV-01	201	0.28690008638872017	107	TCGA-DK-A3IV-01	9	15	52	0.2806404228519617	TCGA-DK-A3IV-01	13	8	8	29	PASS	204	TCGA-DK-A3IV	BLCA	60	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-22237	Dead	WITH TUMOR	NA	294	NA	Locoregional (Urothelial tumor event)	Lymph Node Only	NA	212	Stable Disease	NA	NA	1	294	1	294	NA	NA	1	212	
60	TCGA-DK-A3WW	5	72	9	44	5	0	0	0	61	926	103	3	19	368	20	2	TCGA-DK-A3WW-01	84	0.004677287376123548	35	TCGA-DK-A3WW-01	0	2	32	0.0404517251504545	TCGA-DK-A3WW-01	2	1	2	5	hypermutated sample	205	TCGA-DK-A3WW	BLCA	57	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-20909	Alive	TUMOR FREE	633	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	633	0	633	0	633	0	633	
70	TCGA-DK-A3WX	1	4	1	1	2	1	0	0	3	29	0	0	0	13	1	0	TCGA-DK-A3WX-01	62	0.27473876777532924	16	TCGA-DK-A3WX-01	12	8	34	0.2593663722764721	TCGA-DK-A3WX-01	6	2	6	14	PASS	206	TCGA-DK-A3WX	BLCA	67	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-24553	Dead	WITH TUMOR	NA	321	NA	Locoregional (Urothelial tumor event)	Bladder	NA	167	Progressive Disease	NA	NA	1	321	1	321	NA	NA	1	167	
70	TCGA-DK-A3WY	0	0	0	0	0	0	0	0	0	14	4	0	0	5	0	0	TCGA-DK-A3WY-01	43	3.558893372866434e-06	5	TCGA-DK-A3WY	0	0	0	0	TCGA-DK-A3WY	0	0	0	0	PASS	207	TCGA-DK-A3WY	BLCA	67	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2001	NA	-24536	Alive	TUMOR FREE	4967	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4967	0	4967	0	4967	0	4967	
80	TCGA-DK-A3X1	5	59	7	44	2	0	0	0	40	657	85	2	11	291	12	3	TCGA-DK-A3X1-01	287	0.5406079940848099	168	TCGA-DK-A3X1-01	17	27	77	0.16659423702058607	TCGA-DK-A3X1-01	19	11	10	40	hypermutated sample	208	TCGA-DK-A3X1	BLCA	78	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-28757	Alive	TUMOR FREE	2009	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2009	0	2009	0	2009	0	2009	
90	TCGA-DK-A3X2	0	7	0	1	5	4	1	0	2	104	5	0	3	30	2	0	TCGA-DK-A3X2-01	244	0.7029007903404171	134	TCGA-DK-A3X2-01	23	27	93	0.23236930638335315	TCGA-DK-A3X2-01	13	8	8	29	PASS	209	TCGA-DK-A3X2	BLCA	85	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-31160	Dead	WITH TUMOR	NA	547	NA	Distant Metastasis	Liver	NA	533	Complete Remission/Response	NA	NA	1	547	1	547	NA	NA	1	533	
80	TCGA-DK-A6AV	0	7	2	3	2	3	1	0	7	85	9	0	1	47	1	0	TCGA-DK-A6AV-01	292	0.7228882435679418	196	TCGA-DK-A6AV-01	27	25	115	0.3236210227245445	TCGA-DK-A6AV-01	16	8	11	35	PASS	210	TCGA-DK-A6AV	BLCA	82	FEMALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-30089	Alive	TUMOR FREE	1952	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1952	0	1952	0	1952	0	1952	
70	TCGA-DK-A6AW	18	273	20	84	3	12	0	1	139	3020	434	4	88	922	56	2	TCGA-DK-A6AW-01	62	0.021639129684011976	17	TCGA-DK-A6AW-01	0	0	17	0.020889883667909885	TCGA-DK-A6AW-01	1	0	2	3	hypermutated sample	211	TCGA-DK-A6AW	BLCA	70	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-25644	Alive	TUMOR FREE	1621	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1621	0	1621	0	1621	0	1621	
60	TCGA-DK-A6B0	0	2	0	1	1	1	0	1	0	20	1	0	1	5	0	0	TCGA-DK-A6B0-01	47	0.00034156854581243056	10	TCGA-DK-A6B0-01	0	0	14	0.003312768001723729	TCGA-DK-A6B0-01	1	0	0	1	PASS	212	TCGA-DK-A6B0	BLCA	61	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-22439	Alive	TUMOR FREE	2330	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2330	0	2330	0	2330	0	2330	
70	TCGA-DK-A6B1	0	14	2	7	6	1	1	0	7	101	9	0	2	41	6	0	TCGA-DK-A6B1-01	110	0.5812181176522677	45	TCGA-DK-A6B1-01	18	17	36	0.10904178448410266	TCGA-DK-A6B1-01	6	5	3	14	PASS	213	TCGA-DK-A6B1	BLCA	67	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-24607	Alive	TUMOR FREE	2049	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2049	0	2049	0	2049	0	2049	
70	TCGA-DK-A6B2	2	7	0	14	7	1	2	0	8	146	13	0	3	67	1	0	TCGA-DK-A6B2-01	235	0.535203472928813	139	TCGA-DK-A6B2-01	21	36	120	0.2695580123216443	TCGA-DK-A6B2-01	15	13	10	38	PASS	214	TCGA-DK-A6B2	BLCA	70	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-25625	Alive	WITH TUMOR	477	NA	NA	Distant Metastasis	Liver	NA	268	Complete Remission/Response	NA	NA	0	477	0	477	NA	NA	1	268	
50	TCGA-DK-A6B5	0	14	1	5	2	1	0	0	5	100	9	0	4	42	2	0	TCGA-DK-A6B5-01	376	0.9477887920258444	240	TCGA-DK-A6B5-01	14	14	218	0.4209624854960514	TCGA-DK-A6B5-01	13	10	22	45	PASS	215	TCGA-DK-A6B5	BLCA	45	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-16453	Alive	TUMOR FREE	1542	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1542	0	1542	NA	NA	0	1542	
60	TCGA-DK-A6B6	4	67	1	61	8	0	1	0	64	667	87	1	9	386	7	2	TCGA-DK-A6B6-01	168	0.7436789219281532	83	TCGA-DK-A6B6-01	18	21	74	0.2048577966390608	TCGA-DK-A6B6-01	10	6	12	28	hypermutated sample	216	TCGA-DK-A6B6	BLCA	57	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-21007	Alive	TUMOR FREE	1115	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1115	0	1115	0	1115	0	1115	
50	TCGA-DK-AA6L	2	27	1	11	10	1	10	0	16	320	26	0	4	116	6	0	TCGA-DK-AA6L-01	299	0.6405588979735996	187	TCGA-DK-AA6L-01	16	34	82	0.2005364132778244	TCGA-DK-AA6L-01	23	15	7	45	PASS	217	TCGA-DK-AA6L	BLCA	48	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-17635	Dead	WITH TUMOR	NA	1163	NA	Distant Metastasis	Bone	NA	920	Progressive Disease	NA	NA	1	1163	1	1163	NA	NA	1	920	
60	TCGA-DK-AA6M	0	2	0	2	2	0	1	0	1	51	6	0	2	27	0	0	TCGA-DK-AA6M-01	123	0.25479184489229084	60	TCGA-DK-AA6M-01	8	10	38	0.10298178117942328	TCGA-DK-AA6M-01	6	4	4	14	PASS	218	TCGA-DK-AA6M	BLCA	64	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-23574	Alive	TUMOR FREE	1582	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1582	0	1582	NA	NA	0	1582	
70	TCGA-DK-AA6P	0	10	1	9	3	0	0	1	11	141	21	1	0	57	2	1	TCGA-DK-AA6P-01	381	0.7655013066148568	235	TCGA-DK-AA6P-01	23	51	107	0.2295427033475693	TCGA-DK-AA6P-01	27	22	9	58	PASS	219	TCGA-DK-AA6P	BLCA	72	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-26560	Alive	TUMOR FREE	457	NA	NA	Distant Metastasis	Bone	NA	16	Partial Remission/Response	NA	NA	0	457	0	457	NA	NA	1	16	
60	TCGA-DK-AA6Q	1	5	0	1	3	0	2	0	8	94	6	0	2	32	3	0	TCGA-DK-AA6Q-01	169	0.94422618250115	95	TCGA-DK-AA6Q-01	9	9	68	0.2795242124062349	TCGA-DK-AA6Q-01	11	7	8	26	PASS	220	TCGA-DK-AA6Q	BLCA	61	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-22314	Dead	WITH TUMOR	NA	413	NA	Distant Metastasis	Liver	NA	285	Progressive Disease	NA	NA	1	413	1	413	NA	NA	1	285	
70	TCGA-DK-AA6R	0	19	1	4	7	0	1	1	11	284	23	1	1	90	10	1	TCGA-DK-AA6R-01	253	0.7205362988775305	147	TCGA-DK-AA6R-01	15	37	97	0.2932990176319485	TCGA-DK-AA6R-01	20	23	19	62	PASS	221	TCGA-DK-AA6R	BLCA	68	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2001	NA	-25196	Alive	WITH TUMOR	5041	NA	NA	New Primary Tumor	"Other, specify"	Colon	4907	Stable Disease	NA	NA	0	5041	0	5041	NA	NA	1	4907	
60	TCGA-DK-AA6S	4	35	4	24	6	2	0	0	29	442	48	2	5	186	7	4	TCGA-DK-AA6S-01	277	0.7712208166622248	164	TCGA-DK-AA6S-01	8	11	144	0.2809186082909281	TCGA-DK-AA6S-01	9	7	12	28	PASS	222	TCGA-DK-AA6S	BLCA	60	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2000	NA	-22027	Alive	TUMOR FREE	5050	NA	NA	Distant Metastasis	"Other, specify"	soft tissue pelvic mass	539	Complete Remission/Response	NA	NA	0	5050	0	5050	1	539	1	539	
60	TCGA-DK-AA6T	1	5	0	2	0	0	1	0	3	74	6	0	1	26	2	0	TCGA-DK-AA6T-01	82	0.24493745046253296	27	TCGA-DK-AA6T-01	4	8	27	0.08241259644058897	TCGA-DK-AA6T-01	7	4	3	14	PASS	223	TCGA-DK-AA6T	BLCA	63	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-23198	Alive	TUMOR FREE	572	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	572	0	572	0	572	0	572	
60	TCGA-DK-AA6U	0	16	4	11	7	1	2	0	15	364	31	0	4	123	8	1	TCGA-DK-AA6U-01	398	0.6436439395263109	245	TCGA-DK-AA6U-01	10	17	128	0.1963203935363484	TCGA-DK-AA6U-01	14	11	5	30	PASS	224	TCGA-DK-AA6U	BLCA	64	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	[Unknown]	2013	NA	-23611	Alive	TUMOR FREE	578	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	578	0	578	0	578	0	578	
80	TCGA-DK-AA6W	2	12	3	9	4	0	1	0	7	196	22	0	4	77	9	0	TCGA-DK-AA6W-01	307	0.8756520895987516	174	TCGA-DK-AA6W-01	13	38	113	0.22212151143354386	TCGA-DK-AA6W-01	17	23	11	51	PASS	225	TCGA-DK-AA6W	BLCA	78	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-28853	Dead	WITH TUMOR	NA	415	NA	Distant Metastasis	Lung	NA	379	Stable Disease	NA	NA	1	415	1	415	NA	NA	1	379	
60	TCGA-DK-AA6X	0	5	0	4	0	1	0	0	2	97	11	0	3	25	1	0	TCGA-DK-AA6X-01	78	0.28719593816816164	28	TCGA-DK-AA6X-01	8	8	45	0.15674113015278085	TCGA-DK-AA6X-01	5	3	9	17	PASS	226	TCGA-DK-AA6X	BLCA	63	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-23208	Alive	TUMOR FREE	467	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	467	0	467	NA	NA	0	467	
70	TCGA-DK-AA71	2	31	3	23	3	0	1	0	31	515	49	1	8	217	14	0	TCGA-DK-AA71-01	174	0.4136861978497056	98	TCGA-DK-AA71-01	12	22	30	0.08641622452201429	TCGA-DK-AA71-01	3	7	3	13	PASS	227	TCGA-DK-AA71	BLCA	71	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-25950	Alive	WITH TUMOR	415	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	415	0	415	NA	NA	0	415	
80	TCGA-DK-AA74	0	6	0	8	0	0	0	0	8	183	27	0	4	53	4	0	TCGA-DK-AA74-01	121	0.21794654779392045	68	TCGA-DK-AA74-01	10	18	63	0.2649065098437938	TCGA-DK-AA74-01	13	8	10	31	PASS	228	TCGA-DK-AA74	BLCA	75	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-27730	Alive	TUMOR FREE	1708	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1708	0	1708	0	1708	0	1708	
80	TCGA-DK-AA75	2	25	5	20	4	2	1	0	21	354	37	0	10	172	5	0	TCGA-DK-AA75-01	281	0.7490506832162311	181	TCGA-DK-AA75	0	0	0	0	TCGA-DK-AA75	0	0	0	0	PASS	229	TCGA-DK-AA75	BLCA	82	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-30090	Dead	WITH TUMOR	NA	340	NA	Distant Metastasis	Bone	NA	328	Stable Disease	NA	NA	1	340	1	340	NA	NA	1	328	
60	TCGA-DK-AA76	1	10	2	6	4	2	1	0	9	192	19	0	3	67	7	0	TCGA-DK-AA76-01	449	0.7807975471851385	315	TCGA-DK-AA76-01	6	8	181	0.17856968977987253	TCGA-DK-AA76-01	11	11	11	33	PASS	230	TCGA-DK-AA76	BLCA	64	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-23542	Alive	WITH TUMOR	366	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	366	0	366	0	366	0	366	
60	TCGA-DK-AA77	2	13	2	10	1	1	0	0	15	278	19	1	4	122	15	0	TCGA-DK-AA77-01	133	0.5727976580509351	55	TCGA-DK-AA77-01	7	6	52	0.18859961714955853	TCGA-DK-AA77-01	8	6	8	22	PASS	231	TCGA-DK-AA77	BLCA	61	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-22365	Alive	TUMOR FREE	618	NA	NA	Distant Metastasis	"Other, specify"	Pelvis	467	Stable Disease	NA	NA	0	618	0	618	NA	NA	1	467	
60	TCGA-E5-A2PC	1	19	2	17	5	1	0	0	8	179	9	1	7	75	5	2	TCGA-E5-A2PC-01	209	0.8487759891928964	129	TCGA-E5-A2PC-01	24	18	45	0.22211485712634688	TCGA-E5-A2PC-01	9	6	7	22	PASS	232	TCGA-E5-A2PC	BLCA	61	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-22308	Alive	TUMOR FREE	1326	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1326	0	1326	NA	NA	0	1326	
60	TCGA-E5-A4TZ	3	21	3	11	10	0	3	0	17	357	30	1	5	153	11	0	TCGA-E5-A4TZ-01	327	0.6805580875886348	204	TCGA-E5-A4TZ-01	25	47	148	0.2858523882692637	TCGA-E5-A4TZ-01	22	13	13	48	PASS	233	TCGA-E5-A4TZ	BLCA	64	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-23566	Dead	WITH TUMOR	NA	467	NA	Locoregional (Urothelial tumor event)	"Other, specify"	soft tissue pelvic mass	435	Progressive Disease	NA	NA	1	467	1	467	NA	NA	1	435	
70	TCGA-E5-A4U1	2	36	4	21	4	1	0	0	22	472	56	1	15	181	10	0	TCGA-E5-A4U1-01	406	0.5995396941690344	244	TCGA-E5-A4U1-01	16	24	85	0.16019931578328506	TCGA-E5-A4U1-01	15	10	5	30	PASS	234	TCGA-E5-A4U1	BLCA	72	MALE	[Unknown]	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-26305	Alive	WITH TUMOR	1181	NA	NA	Distant Metastasis	Bone	NA	705	Complete Remission/Response	NA	NA	0	1181	0	1181	1	705	1	705	
70	TCGA-E7-A3X6	0	6	1	2	2	2	0	0	1	96	8	0	1	33	0	0	TCGA-E7-A3X6-01	143	0.9214948531623496	74	TCGA-E7-A3X6-01	10	9	76	0.2553693978336337	TCGA-E7-A3X6-01	8	6	9	23	PASS	235	TCGA-E7-A3X6	BLCA	70	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2011	NA	-25584	Dead	WITH TUMOR	NA	904	NA	Distant Metastasis	Bone	NA	369	Complete Remission/Response	NA	NA	1	904	1	904	1	369	1	369	
60	TCGA-E7-A3Y1	0	11	1	8	14	1	1	0	3	116	12	0	2	54	6	0	TCGA-E7-A3Y1-01	38	0.10405397055569574	5	TCGA-E7-A3Y1-01	1	2	19	0.06315889135469685	TCGA-E7-A3Y1-01	4	2	3	9	PASS	236	TCGA-E7-A3Y1	BLCA	57	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2012	NA	-20917	Alive	TUMOR FREE	163	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	163	0	163	0	163	0	163	
60	TCGA-E7-A4IJ	1	20	0	14	4	1	0	1	17	264	21	0	4	121	6	2	TCGA-E7-A4IJ-01	304	0.7086124918062777	175	TCGA-E7-A4IJ-01	23	58	163	0.3567528456713172	TCGA-E7-A4IJ-01	24	18	13	55	PASS	237	TCGA-E7-A4IJ	BLCA	56	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-20723	Dead	WITH TUMOR	NA	674	NA	Distant Metastasis	Bone	NA	620	Complete Remission/Response	NA	NA	1	674	1	674	1	620	1	620	
70	TCGA-E7-A4XJ	1	3	1	0	1	2	1	0	1	31	3	0	1	16	0	0	TCGA-E7-A4XJ-01	63	0.016423199601517717	26	TCGA-E7-A4XJ-01	0	2	13	0.029463067622255118	TCGA-E7-A4XJ-01	0	2	1	3	PASS	238	TCGA-E7-A4XJ	BLCA	66	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-24279	Dead	TUMOR FREE	NA	68	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	68	0	68	0	68	0	68	
70	TCGA-E7-A519	0	5	0	0	8	2	0	0	1	53	2	0	1	19	2	0	TCGA-E7-A519-01	59	0.016397790426777387	19	TCGA-E7-A519-01	0	1	4	0.017284234758392004	TCGA-E7-A519-01	0	2	1	3	PASS	239	TCGA-E7-A519	BLCA	72	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-26427	Alive	TUMOR FREE	508	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	508	0	508	0	508	0	508	
70	TCGA-E7-A541	1	10	0	13	9	0	0	0	8	373	31	0	4	130	7	1	TCGA-E7-A541-01	211	0.7467075890294658	116	TCGA-E7-A541-01	26	64	13	0.021455641307013155	TCGA-E7-A541-01	20	12	1	33	PASS	240	TCGA-E7-A541	BLCA	66	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-24206	Dead	TUMOR FREE	NA	778	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	778	0	778	0	778	0	778	
80	TCGA-E7-A5KE	0	20	1	19	6	2	0	0	8	146	11	1	1	77	3	0	TCGA-E7-A5KE-01	308	0.5119116069146413	187	TCGA-E7-A5KE-01	15	36	94	0.22158742194018397	TCGA-E7-A5KE-01	12	11	8	31	PASS	241	TCGA-E7-A5KE	BLCA	78	FEMALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-28714	Alive	TUMOR FREE	17	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	17	0	17	NA	NA	0	17	
70	TCGA-E7-A5KF	0	8	1	9	3	2	0	0	9	153	14	0	6	70	0	0	TCGA-E7-A5KF-01	92	0.11947602360952428	50	TCGA-E7-A5KF-01	3	2	23	0.050441160836126375	TCGA-E7-A5KF-01	4	3	3	10	PASS	242	TCGA-E7-A5KF	BLCA	67	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2012	NA	-24528	Alive	TUMOR FREE	20	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	20	0	20	NA	NA	0	20	
80	TCGA-E7-A677	0	19	1	17	5	1	5	2	2	188	8	0	3	73	2	0	TCGA-E7-A677-01	84	0.10421417154567653	43	TCGA-E7-A677-01	3	5	25	0.04169986136009965	TCGA-E7-A677-01	4	3	4	11	PASS	243	TCGA-E7-A677	BLCA	81	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2012	NA	-29613	Alive	TUMOR FREE	820	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	820	0	820	0	820	0	820	
60	TCGA-E7-A678	0	1	0	0	1	0	0	0	2	38	3	0	1	16	4	0	TCGA-E7-A678-01	59	0.00028658537830476935	22	TCGA-E7-A678-01	0	0	11	0.00037600794913899714	TCGA-E7-A678-01	0	0	0	0	PASS	244	TCGA-E7-A678	BLCA	55	MALE	ASIAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2012	NA	-20169	Alive	TUMOR FREE	798	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	798	0	798	0	798	0	798	
70	TCGA-E7-A6MD	8	21	5	16	3	1	0	0	28	344	35	0	4	151	4	0	TCGA-E7-A6MD-01	166	0.5256983119335424	83	TCGA-E7-A6MD-01	20	29	90	0.2372411027126968	TCGA-E7-A6MD-01	12	8	9	29	PASS	245	TCGA-E7-A6MD	BLCA	66	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-24180	Alive	NA	129	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	129	0	129	NA	NA	0	129	
80	TCGA-E7-A6ME	1	5	0	2	5	2	2	0	6	101	5	0	2	45	2	0	TCGA-E7-A6ME-01	204	0.6209033983971445	107	TCGA-E7-A6ME-01	9	11	76	0.19379050913942653	TCGA-E7-A6ME-01	9	4	9	22	PASS	246	TCGA-E7-A6ME	BLCA	75	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-27670	Alive	TUMOR FREE	731	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	731	0	731	0	731	0	731	
40	TCGA-E7-A6MF	0	5	0	2	0	0	0	0	2	32	6	0	2	13	1	0	TCGA-E7-A6MF-01	49	0.00011396232644396804	10	TCGA-E7-A6MF-01	0	0	6	9.766350147228315e-05	TCGA-E7-A6MF-01	0	0	0	0	PASS	247	TCGA-E7-A6MF	BLCA	37	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2013	NA	-13867	Alive	TUMOR FREE	750	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	750	0	750	0	750	0	750	
70	TCGA-E7-A7DU	2	11	0	11	0	1	0	0	9	218	18	1	3	80	4	1	TCGA-E7-A7DU-01	62	0.7488525123463381	17	TCGA-E7-A7DU-01	17	15	13	0.058975565032038726	TCGA-E7-A7DU-01	4	2	1	7	PASS	248	TCGA-E7-A7DU	BLCA	73	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2013	NA	-27000	Alive	TUMOR FREE	28	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	28	0	28	0	28	0	28	
40	TCGA-E7-A7DV	2	16	1	10	2	1	0	0	15	392	89	0	5	156	6	0	TCGA-E7-A7DV-01	303	0.5179314105548315	180	TCGA-E7-A7DV-01	16	35	121	0.2953133114094882	TCGA-E7-A7DV-01	21	13	13	47	PASS	249	TCGA-E7-A7DV	BLCA	44	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-16145	Alive	WITH TUMOR	37	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	37	0	37	NA	NA	0	37	
60	TCGA-E7-A7PW	1	7	0	3	1	0	2	0	4	65	4	0	0	38	2	0	TCGA-E7-A7PW-01	305	0.7453535640704226	175	TCGA-E7-A7PW-01	15	25	93	0.16762901315949774	TCGA-E7-A7PW-01	13	16	9	38	PASS	250	TCGA-E7-A7PW	BLCA	63	MALE	ASIAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-23057	Alive	TUMOR FREE	416	NA	NA	Distant Metastasis	Bone	NA	174	Complete Remission/Response	NA	NA	0	416	0	416	1	174	1	174	
70	TCGA-E7-A7XN	2	47	13	34	4	0	0	0	42	747	74	0	11	266	16	1	TCGA-E7-A7XN-01	41	0.0005669345622607068	5	TCGA-E7-A7XN-01	0	4	29	0.07512710089596314	TCGA-E7-A7XN-01	2	2	4	8	hypermutated sample	251	TCGA-E7-A7XN	BLCA	66	MALE	ASIAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-24466	Alive	WITH TUMOR	428	NA	NA	Locoregional (Urothelial tumor event)	Bladder	NA	190	Progressive Disease	NA	NA	0	428	0	428	NA	NA	1	190	
60	TCGA-E7-A85H	0	23	4	21	12	7	5	1	10	334	8	0	8	122	12	0	TCGA-E7-A85H-01	745	0.6593725405773135	488	TCGA-E7-A85H-01	10	33	254	0.2373541273736328	TCGA-E7-A85H-01	25	35	14	74	PASS	252	TCGA-E7-A85H	BLCA	64	MALE	ASIAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-23497	Alive	TUMOR FREE	394	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	394	0	394	0	394	0	394	
50	TCGA-E7-A8O7	0	1	0	0	1	1	0	1	2	18	4	0	0	14	0	1	TCGA-E7-A8O7-01	80	0.03418374919279279	30	TCGA-E7-A8O7-01	0	2	23	0.04845241037069231	TCGA-E7-A8O7-01	3	3	3	9	PASS	253	TCGA-E7-A8O7	BLCA	52	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2013	NA	-19063	Alive	TUMOR FREE	466	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	466	0	466	0	466	0	466	
60	TCGA-E7-A8O8	1	6	0	4	5	1	1	0	6	91	13	0	1	30	2	0	TCGA-E7-A8O8	0	0	0	TCGA-E7-A8O8	0	0	0	0	TCGA-E7-A8O8	0	0	0	0	PASS	254	TCGA-E7-A8O8	BLCA	59	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-21629	Alive	TUMOR FREE	13	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	13	0	13	0	13	0	13	
70	TCGA-E7-A97P	0	14	0	4	7	3	3	0	7	161	14	1	4	55	3	0	TCGA-E7-A97P-01	108	0.1628814709252178	45	TCGA-E7-A97P-01	2	7	61	0.12026221683202293	TCGA-E7-A97P-01	5	3	4	12	PASS	255	TCGA-E7-A97P	BLCA	73	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-26956	Dead	TUMOR FREE	NA	437	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	437	0	437	0	437	0	437	
60	TCGA-E7-A97Q	0	5	0	6	6	2	0	0	1	49	6	0	0	14	0	0	TCGA-E7-A97Q-01	262	0.9704438135892977	156	TCGA-E7-A97Q-01	25	30	107	0.25992432505885965	TCGA-E7-A97Q-01	14	14	12	40	PASS	256	TCGA-E7-A97Q	BLCA	60	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-22249	Dead	WITH TUMOR	NA	246	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	246	1	246	NA	NA	1	246	
70	TCGA-FD-A3B3	0	10	1	6	2	1	0	0	2	136	16	1	2	53	3	0	TCGA-FD-A3B3-01	106	0.221769669957105	44	TCGA-FD-A3B3-01	11	18	9	0.1073741025729666	TCGA-FD-A3B3-01	5	5	1	11	PASS	257	TCGA-FD-A3B3	BLCA	74	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-27068	Dead	TUMOR FREE	NA	974	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	974	0	974	0	974	0	974	
60	TCGA-FD-A3B4	1	3	0	1	2	1	1	0	2	62	6	0	1	25	0	0	TCGA-FD-A3B4-01	181	0.2812015154839205	104	TCGA-FD-A3B4-01	7	16	25	0.16580079163253553	TCGA-FD-A3B4-01	14	11	6	31	pathology review	258	TCGA-FD-A3B4	BLCA	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-20379	Dead	WITH TUMOR	NA	510	NA	Locoregional (Urothelial tumor event)	"Other, specify"	Left posterior pelvic wall	359	Complete Remission/Response	NA	NA	1	510	1	510	1	359	1	359	
90	TCGA-FD-A3B5	0	6	0	5	2	1	1	0	8	120	13	0	0	36	2	1	TCGA-FD-A3B5-01	196	0.7543358541079831	126	TCGA-FD-A3B5-01	16	51	40	0.1751439493383329	TCGA-FD-A3B5-01	20	22	5	47	PASS	259	TCGA-FD-A3B5	BLCA	86	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-31442	Dead	WITH TUMOR	NA	272	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	272	1	272	NA	NA	1	272	
80	TCGA-FD-A3B6	0	9	2	6	4	1	0	0	9	215	29	1	2	74	5	0	TCGA-FD-A3B6-01	239	0.6315775466440949	135	TCGA-FD-A3B6-01	15	30	32	0.14489581476929586	TCGA-FD-A3B6-01	10	16	6	32	PASS	260	TCGA-FD-A3B6	BLCA	75	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-27541	Dead	TUMOR FREE	NA	1005	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1005	0	1005	0	1005	0	1005	
70	TCGA-FD-A3B7	0	0	2	2	1	1	0	0	2	56	6	1	3	16	1	0	TCGA-FD-A3B7-01	128	0.3827055719073216	63	TCGA-FD-A3B7-01	12	22	27	0.33582121806076354	TCGA-FD-A3B7-01	8	9	11	28	PASS	261	TCGA-FD-A3B7	BLCA	66	MALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-24245	Dead	WITH TUMOR	NA	122	NA	Distant Metastasis	Lymph Node Only	NA	110	Progressive Disease	NA	NA	1	122	1	122	NA	NA	1	110	
60	TCGA-FD-A3B8	0	1	0	0	0	0	0	0	2	35	3	0	0	11	0	0	TCGA-FD-A3B8-01	60	0.0015184729717384387	18	TCGA-FD-A3B8	0	0	0	0	TCGA-FD-A3B8	0	0	0	0	PASS	262	TCGA-FD-A3B8	BLCA	56	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-20555	Alive	TUMOR FREE	384	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	384	0	384	0	384	0	384	
70	TCGA-FD-A3N5	1	12	3	18	10	2	2	0	7	237	16	0	2	118	6	0	TCGA-FD-A3N5-01	247	0.40035556089269625	160	TCGA-FD-A3N5-01	9	23	27	0.13056690334841825	TCGA-FD-A3N5-01	13	14	6	33	PASS	263	TCGA-FD-A3N5	BLCA	69	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-25342	Dead	WITH TUMOR	NA	685	NA	Locoregional (Urothelial tumor event)	"Other, specify"	Pelvis	346	NA	NA	NA	1	685	1	685	NA	NA	1	346	
40	TCGA-FD-A3N6	0	4	0	3	1	1	3	0	5	98	7	0	1	34	1	0	TCGA-FD-A3N6-01	160	0.07533636103663363	94	TCGA-FD-A3N6-01	1	3	25	0.03164829747214889	TCGA-FD-A3N6-01	4	3	2	9	pathology review	264	TCGA-FD-A3N6	BLCA	43	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-15758	Alive	TUMOR FREE	851	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	851	0	851	0	851	0	851	
60	TCGA-FD-A3NA	0	8	1	6	1	1	0	0	10	145	12	0	0	45	3	1	TCGA-FD-A3NA-01	285	0.4659640284474501	172	TCGA-FD-A3NA-01	18	31	58	0.1817365456876274	TCGA-FD-A3NA-01	14	7	6	27	PASS	265	TCGA-FD-A3NA	BLCA	60	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-21936	Alive	TUMOR FREE	1845	NA	NA	New Primary Tumor	Lung	NA	1338	Complete Remission/Response	NA	NA	0	1845	0	1845	0	1845	1	1338	
60	TCGA-FD-A3SJ	1	10	1	5	6	3	0	0	9	191	12	1	3	77	5	2	TCGA-FD-A3SJ-01	376	0.6622934238749764	234	TCGA-FD-A3SJ-01	15	31	101	0.23356691368934604	TCGA-FD-A3SJ-01	20	23	12	55	PASS	266	TCGA-FD-A3SJ	BLCA	59	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-21615	Dead	WITH TUMOR	NA	739	NA	Distant Metastasis	Lymph Node Only	NA	281	NA	NA	NA	1	739	1	739	NA	NA	1	281	
60	TCGA-FD-A3SL	0	18	1	8	6	3	2	0	15	170	11	2	3	61	7	0	TCGA-FD-A3SL-01	117	0.4775111851059131	53	TCGA-FD-A3SL-01	14	26	55	0.2574671104962933	TCGA-FD-A3SL-01	16	15	13	44	PASS	267	TCGA-FD-A3SL	BLCA	60	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-22020	Dead	WITH TUMOR	NA	712	NA	Distant Metastasis	Lung	NA	260	Progressive Disease	NA	NA	1	712	1	712	NA	NA	1	260	
70	TCGA-FD-A3SM	0	15	2	5	6	2	1	0	8	150	17	0	3	53	3	2	TCGA-FD-A3SM-01	91	0.2010224737945588	31	TCGA-FD-A3SM-01	7	6	29	0.12805586052813164	TCGA-FD-A3SM-01	4	0	3	7	PASS	268	TCGA-FD-A3SM	BLCA	70	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-25852	Dead	WITH TUMOR	NA	547	NA	Distant Metastasis	Lymph Node Only	NA	144	[Unknown]	NA	NA	1	547	1	547	NA	NA	1	144	
80	TCGA-FD-A3SN	2	15	3	31	7	2	4	1	23	284	27	0	5	132	6	1	TCGA-FD-A3SN-01	102	0.947698192915366	48	TCGA-FD-A3SN-01	10	14	53	0.3626117071705762	TCGA-FD-A3SN-01	12	9	16	37	PASS	269	TCGA-FD-A3SN	BLCA	79	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-29169	Alive	TUMOR FREE	887	NA	NA	Distant Metastasis	Lung	NA	110	Progressive Disease	NA	NA	0	887	0	887	NA	NA	1	110	
70	TCGA-FD-A3SO	1	26	0	15	2	1	2	0	16	270	30	0	4	122	6	0	TCGA-FD-A3SO-01	88	0.26425008435467706	40	TCGA-FD-A3SO-01	12	13	69	0.2335169244542791	TCGA-FD-A3SO-01	7	2	9	18	PASS	270	TCGA-FD-A3SO	BLCA	68	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-25147	Dead	WITH TUMOR	NA	168	NA	Locoregional (Urothelial tumor event)	Renal Pelvis	NA	143	Progressive Disease	NA	NA	1	168	1	168	NA	NA	1	143	
60	TCGA-FD-A3SP	1	7	1	3	2	1	0	0	6	90	10	0	2	46	0	0	TCGA-FD-A3SP-01	96	0.25228893042113354	42	TCGA-FD-A3SP-01	9	15	45	0.2377264435996468	TCGA-FD-A3SP-01	7	7	5	19	PASS	271	TCGA-FD-A3SP	BLCA	60	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-22005	Alive	TUMOR FREE	783	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	783	0	783	0	783	0	783	
60	TCGA-FD-A3SQ	2	2	0	1	1	2	2	0	4	50	9	0	1	27	3	0	TCGA-FD-A3SQ-01	73	0.3644984223180254	30	TCGA-FD-A3SQ-01	9	8	36	0.1698504522201084	TCGA-FD-A3SQ-01	6	7	5	18	PASS	272	TCGA-FD-A3SQ	BLCA	62	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-22687	Dead	WITH TUMOR	NA	1423	NA	Locoregional (Urothelial tumor event)	"Other, specify"	sigmoid colon	991	Stable Disease	NA	NA	1	1423	1	1423	NA	NA	1	991	
70	TCGA-FD-A3SR	0	8	0	5	3	1	0	0	4	112	11	0	2	28	3	0	TCGA-FD-A3SR-01	255	0.6421140808543705	147	TCGA-FD-A3SR-01	14	42	76	0.1847457635845884	TCGA-FD-A3SR-01	19	17	9	45	PASS	273	TCGA-FD-A3SR	BLCA	68	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-24979	Dead	WITH TUMOR	NA	602	NA	Locoregional (Urothelial tumor event)	"Other, specify"	pelvis	372	[Unknown]	NA	NA	1	602	1	602	NA	NA	1	372	
70	TCGA-FD-A3SS	1	33	2	19	7	0	0	1	20	384	33	0	6	161	7	0	TCGA-FD-A3SS-01	146	0.7798875782013283	79	TCGA-FD-A3SS-01	8	9	54	0.2390321967291973	TCGA-FD-A3SS-01	10	11	13	34	PASS	274	TCGA-FD-A3SS	BLCA	66	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-24408	Dead	WITH TUMOR	NA	391	NA	Locoregional (Urothelial tumor event)	"Other, specify"	local & retroperitonium	220	[Unknown]	NA	NA	1	391	1	391	NA	NA	1	220	
80	TCGA-FD-A43N	0	11	1	6	8	1	1	0	6	143	8	0	3	59	2	0	TCGA-FD-A43N-01	173	0.5816817011471228	84	TCGA-FD-A43N-01	19	51	27	0.05321657461635921	TCGA-FD-A43N-01	17	19	3	39	PASS	275	TCGA-FD-A43N	BLCA	76	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-27833	Alive	TUMOR FREE	699	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	699	0	699	NA	NA	0	699	
70	TCGA-FD-A43P	2	24	1	9	3	1	0	0	14	323	35	0	6	141	5	0	TCGA-FD-A43P-01	213	0.574431769011772	111	TCGA-FD-A43P-01	13	26	49	0.1397976175451553	TCGA-FD-A43P-01	17	14	8	39	PASS	276	TCGA-FD-A43P	BLCA	74	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-27201	Alive	TUMOR FREE	832	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	832	0	832	0	832	0	832	
70	TCGA-FD-A43S	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-FD-A43S-01	43	2.8835346281630805e-05	8	TCGA-FD-A43S-01	0	0	7	0.0016773926357517288	TCGA-FD-A43S-01	0	0	0	0	PASS	277	TCGA-FD-A43S	BLCA	71	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-25993	Alive	TUMOR FREE	455	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	455	0	455	0	455	0	455	
70	TCGA-FD-A43U	1	4	0	1	1	1	0	0	4	57	1	0	0	28	0	0	TCGA-FD-A43U-01	80	0.3003163536563003	29	TCGA-FD-A43U-01	27	15	44	0.26214734812169804	TCGA-FD-A43U-01	13	13	8	34	PASS	278	TCGA-FD-A43U	BLCA	70	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-25841	Alive	WITH TUMOR	636	NA	NA	Distant Metastasis	Bone	NA	497	Complete Remission/Response	NA	NA	0	636	0	636	NA	NA	1	497	
80	TCGA-FD-A43X	2	8	3	16	4	2	0	0	20	235	34	0	5	103	7	1	TCGA-FD-A43X-01	98	0.3074912978216257	40	TCGA-FD-A43X-01	10	12	31	0.05462944961550102	TCGA-FD-A43X-01	7	3	3	13	PASS	279	TCGA-FD-A43X	BLCA	84	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-30764	Alive	TUMOR FREE	110	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	110	0	110	0	110	0	110	
70	TCGA-FD-A43Y	0	6	0	3	2	1	2	0	2	45	4	0	0	23	3	0	TCGA-FD-A43Y-01	184	0.3981726610531371	99	TCGA-FD-A43Y-01	8	17	102	0.33049144426918137	TCGA-FD-A43Y-01	12	8	18	38	PASS	280	TCGA-FD-A43Y	BLCA	65	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-23889	Dead	TUMOR FREE	NA	474	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	474	0	474	0	474	0	474	
60	TCGA-FD-A5BR	0	2	0	1	6	0	1	0	4	72	4	0	0	24	3	0	TCGA-FD-A5BR-01	96	0.4351662496858942	41	TCGA-FD-A5BR-01	8	12	33	0.12955553347388354	TCGA-FD-A5BR-01	9	11	7	27	PASS	281	TCGA-FD-A5BR	BLCA	57	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-20964	Alive	TUMOR FREE	813	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	813	0	813	0	813	0	813	
70	TCGA-FD-A5BS	0	2	0	0	0	0	0	0	1	22	0	0	0	9	0	0	TCGA-FD-A5BS-01	69	0.01978045589032644	27	TCGA-FD-A5BS-01	0	0	4	4.671823229298592e-05	TCGA-FD-A5BS-01	0	1	0	1	PASS	282	TCGA-FD-A5BS	BLCA	68	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-24963	Alive	TUMOR FREE	1639	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1639	0	1639	0	1639	0	1639	
80	TCGA-FD-A5BT	0	2	1	6	2	0	0	0	3	95	10	0	2	49	1	0	TCGA-FD-A5BT-01	104	0.18287327573119333	46	TCGA-FD-A5BT-01	27	27	42	0.19046271101223566	TCGA-FD-A5BT-01	8	7	4	19	PASS	283	TCGA-FD-A5BT	BLCA	84	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-30686	Dead	TUMOR FREE	NA	328	NA	NA	NA	NA	NA	NA	NA	NA	1	328	0	328	NA	NA	0	328	
80	TCGA-FD-A5BU	0	0	0	1	2	4	0	0	4	60	2	0	1	16	0	0	TCGA-FD-A5BU-01	110	0.22758292115936235	59	TCGA-FD-A5BU-01	5	14	52	0.2265589910570904	TCGA-FD-A5BU-01	10	5	8	23	PASS	284	TCGA-FD-A5BU	BLCA	76	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-27882	Alive	TUMOR FREE	588	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	588	0	588	0	588	0	588	
50	TCGA-FD-A5BV	0	9	0	1	2	3	1	0	4	94	5	0	3	39	3	0	TCGA-FD-A5BV-01	125	0.6512831024433163	60	TCGA-FD-A5BV-01	7	12	84	0.3016018983517613	TCGA-FD-A5BV-01	10	10	13	33	PASS	285	TCGA-FD-A5BV	BLCA	47	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-17501	Dead	WITH TUMOR	NA	163	NA	Locoregional (Urothelial tumor event)	"Other, specify"	Peritoneal carcinomatosis	134	Progressive Disease	NA	NA	1	163	1	163	NA	NA	1	134	
80	TCGA-FD-A5BX	2	18	2	13	0	0	2	0	14	277	28	1	5	107	4	0	TCGA-FD-A5BX-01	76	0.10498569192023888	26	TCGA-FD-A5BX-01	3	7	21	0.08396330355322143	TCGA-FD-A5BX-01	4	1	3	8	PASS	286	TCGA-FD-A5BX	BLCA	82	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-30276	Dead	WITH TUMOR	NA	173	NA	Locoregional (Urothelial tumor event)	Lymph Node Only	NA	99	Progressive Disease	NA	NA	1	173	1	173	NA	NA	1	99	
60	TCGA-FD-A5BY	0	4	0	4	0	0	0	0	4	39	3	0	0	9	2	0	TCGA-FD-A5BY-01	103	0.8172218222235184	47	TCGA-FD-A5BY-01	28	22	79	0.3514912745174096	TCGA-FD-A5BY-01	18	9	14	41	PASS	287	TCGA-FD-A5BY	BLCA	63	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-23080	Alive	TUMOR FREE	251	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	251	0	251	0	251	0	251	
80	TCGA-FD-A5BZ	3	8	1	3	0	0	0	0	7	99	5	0	1	45	4	0	TCGA-FD-A5BZ-01	258	0.6584336063784153	156	TCGA-FD-A5BZ-01	23	21	67	0.14873760565138633	TCGA-FD-A5BZ-01	12	8	4	24	PASS	288	TCGA-FD-A5BZ	BLCA	77	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-28451	Dead	WITH TUMOR	NA	835	NA	Locoregional (Urothelial tumor event)	Lymph Node Only	NA	533	NA	NA	NA	1	835	1	835	NA	NA	1	533	
60	TCGA-FD-A5C0	0	11	1	5	8	2	0	0	4	87	6	0	5	37	5	0	TCGA-FD-A5C0-01	155	0.6791218055969291	82	TCGA-FD-A5C0-01	22	39	78	0.2735954456081945	TCGA-FD-A5C0-01	16	7	9	32	PASS	289	TCGA-FD-A5C0	BLCA	61	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-22500	Dead	WITH TUMOR	NA	550	NA	New Primary Tumor	Lung	NA	27	Complete Remission/Response	NA	NA	1	550	1	550	NA	NA	1	27	
60	TCGA-FD-A5C1	0	7	2	4	0	0	1	0	6	116	11	0	5	37	3	0	TCGA-FD-A5C1-01	114	0.544664264575543	56	TCGA-FD-A5C1-01	16	16	88	0.4007601804774669	TCGA-FD-A5C1-01	10	10	10	30	PASS	290	TCGA-FD-A5C1	BLCA	61	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-22505	Alive	TUMOR FREE	1792	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1792	0	1792	0	1792	0	1792	
70	TCGA-FD-A62N	0	3	0	4	4	0	0	0	3	67	5	0	2	32	6	0	TCGA-FD-A62N-01	107	0.4526215935561575	51	TCGA-FD-A62N-01	13	15	102	0.4325244721810125	TCGA-FD-A62N-01	13	6	14	33	PASS	291	TCGA-FD-A62N	BLCA	69	MALE	ASIAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-25297	Alive	TUMOR FREE	82	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	82	0	82	0	82	0	82	
70	TCGA-FD-A62O	2	10	2	10	6	1	0	0	8	138	11	0	1	62	4	0	TCGA-FD-A62O-01	96	0.7357337902869908	44	TCGA-FD-A62O-01	23	27	44	0.13513700902131193	TCGA-FD-A62O-01	10	6	4	20	PASS	292	TCGA-FD-A62O	BLCA	74	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-27310	Dead	TUMOR FREE	NA	216	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	216	0	216	NA	NA	0	216	
80	TCGA-FD-A62P	4	23	1	12	3	1	0	0	20	310	33	0	2	115	8	0	TCGA-FD-A62P-01	142	0.5026946332991757	78	TCGA-FD-A62P-01	25	57	36	0.09244902632813458	TCGA-FD-A62P-01	20	20	6	46	PASS	293	TCGA-FD-A62P	BLCA	76	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-27843	Dead	WITH TUMOR	NA	191	NA	NA	NA	NA	NA	NA	NA	NA	1	191	1	191	NA	NA	1	191	
60	TCGA-FD-A62S	0	3	0	2	4	1	1	0	4	61	3	0	1	20	1	0	TCGA-FD-A62S-01	144	0.4218979947654642	79	TCGA-FD-A62S-01	21	28	78	0.2977351750574048	TCGA-FD-A62S-01	9	4	10	23	PASS	294	TCGA-FD-A62S	BLCA	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-22000	Dead	WITH TUMOR	NA	406	NA	Distant Metastasis	"Other, specify"	sigmoid colon	306	Progressive Disease	NA	NA	1	406	1	406	NA	NA	1	306	
60	TCGA-FD-A6TA	1	12	0	12	0	2	0	0	15	214	23	0	4	68	4	0	TCGA-FD-A6TA-01	365	0.8691232055989685	255	TCGA-FD-A6TA-01	10	9	212	0.2851942153589241	TCGA-FD-A6TA-01	9	3	9	21	PASS	295	TCGA-FD-A6TA	BLCA	58	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-21196	Alive	TUMOR FREE	1912	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1912	0	1912	NA	NA	0	1912	
80	TCGA-FD-A6TB	1	21	0	8	1	0	0	0	3	161	19	0	2	57	2	1	TCGA-FD-A6TB-01	80	0.18766597943184166	28	TCGA-FD-A6TB-01	9	11	47	0.207793784837564	TCGA-FD-A6TB-01	8	1	10	19	PASS	296	TCGA-FD-A6TB	BLCA	82	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-30185	Alive	TUMOR FREE	572	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	572	0	572	0	572	0	572	
80	TCGA-FD-A6TC	6	52	3	38	9	1	3	1	42	750	78	1	10	307	12	1	TCGA-FD-A6TC-01	315	0.5536226621280735	198	TCGA-FD-A6TC-01	14	29	139	0.2586483825471089	TCGA-FD-A6TC-01	20	14	11	45	hypermutated sample	297	TCGA-FD-A6TC	BLCA	79	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-28963	Alive	TUMOR FREE	187	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	187	0	187	0	187	0	187	
80	TCGA-FD-A6TD	1	6	1	7	3	2	0	0	6	101	11	1	3	45	2	0	TCGA-FD-A6TD-01	144	0.3995838283647264	70	TCGA-FD-A6TD-01	12	23	77	0.2603652692529237	TCGA-FD-A6TD-01	10	11	8	29	PASS	298	TCGA-FD-A6TD	BLCA	77	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-28328	Dead	TUMOR FREE	NA	386	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	386	0	386	0	386	0	386	
50	TCGA-FD-A6TE	2	25	2	10	1	0	1	0	10	205	36	0	4	79	4	0	TCGA-FD-A6TE-01	113	0.7614058940382031	52	TCGA-FD-A6TE-01	26	23	78	0.23705691542414306	TCGA-FD-A6TE-01	13	7	12	32	PASS	299	TCGA-FD-A6TE	BLCA	54	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-19874	Alive	TUMOR FREE	376	NA	NA	Distant Metastasis	"Other, specify"	sacrum	321	[Unknown]	NA	NA	0	376	0	376	NA	NA	1	321	
80	TCGA-FD-A6TF	0	8	1	1	4	1	0	0	7	103	11	0	7	44	7	1	TCGA-FD-A6TF-01	151	0.558374245787322	80	TCGA-FD-A6TF-01	19	30	99	0.3307527843342701	TCGA-FD-A6TF-01	19	14	8	41	PASS	300	TCGA-FD-A6TF	BLCA	80	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-29317	Dead	TUMOR FREE	NA	69	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	69	0	69	NA	NA	0	69	
70	TCGA-FD-A6TG	0	24	0	14	4	0	0	1	18	318	26	0	7	116	8	0	TCGA-FD-A6TG-01	219	0.6567125587445461	116	TCGA-FD-A6TG-01	23	39	21	0.024680539122392226	TCGA-FD-A6TG-01	13	17	2	32	PASS	301	TCGA-FD-A6TG	BLCA	73	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-26893	Dead	TUMOR FREE	NA	93	NA	NA	NA	NA	NA	NA	NA	NA	1	93	0	93	NA	NA	0	93	
60	TCGA-FD-A6TH	0	11	0	1	1	3	0	1	5	131	7	0	4	44	3	0	TCGA-FD-A6TH-01	155	0.7402792772246357	85	TCGA-FD-A6TH-01	17	37	88	0.2420716473896213	TCGA-FD-A6TH-01	16	12	9	37	PASS	302	TCGA-FD-A6TH	BLCA	63	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-23236	Dead	WITH TUMOR	NA	131	NA	Distant Metastasis	Lung	NA	126	Complete Remission/Response	NA	NA	1	131	1	131	NA	NA	1	126	
70	TCGA-FD-A6TI	1	8	0	4	3	0	2	0	6	97	2	0	3	27	10	0	TCGA-FD-A6TI-01	50	0.2371869587298767	12	TCGA-FD-A6TI-01	27	45	7	0.051634662701381374	TCGA-FD-A6TI-01	4	3	0	7	PASS	303	TCGA-FD-A6TI	BLCA	73	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-26874	Dead	TUMOR FREE	NA	294	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	294	0	294	NA	NA	0	294	
60	TCGA-FD-A6TK	0	4	2	3	2	1	0	0	1	98	10	0	2	40	0	0	TCGA-FD-A6TK-01	144	0.30502377827569865	84	TCGA-FD-A6TK-01	16	32	114	0.3983643283950552	TCGA-FD-A6TK-01	16	15	11	42	PASS	304	TCGA-FD-A6TK	BLCA	60	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-21942	Alive	TUMOR FREE	330	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	330	0	330	0	330	0	330	
80	TCGA-FJ-A3Z7	2	23	3	8	1	2	1	0	10	255	26	2	7	91	6	0	TCGA-FJ-A3Z7-01	203	0.5087756074455687	118	TCGA-FJ-A3Z7-01	14	35	91	0.2580027915154721	TCGA-FJ-A3Z7-01	23	17	8	48	PASS	305	TCGA-FJ-A3Z7	BLCA	76	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-28052	Alive	TUMOR FREE	945	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	945	0	945	NA	NA	0	945	
70	TCGA-FJ-A3Z9	0	5	0	4	3	2	1	0	1	55	4	0	1	22	1	0	TCGA-FJ-A3Z9-01	73	0.039193879811524	29	TCGA-FJ-A3Z9-01	1	1	15	0.010651700309853566	TCGA-FJ-A3Z9-01	1	2	1	4	PASS	306	TCGA-FJ-A3Z9	BLCA	72	MALE	WHITE	NA	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-26515	Dead	TUMOR FREE	NA	385	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	385	0	385	0	385	0	385	
70	TCGA-FJ-A3ZE	0	26	2	10	13	3	0	1	15	326	13	0	10	120	13	0	TCGA-FJ-A3ZE-01	168	0.7328294739596359	90	TCGA-FJ-A3ZE-01	10	11	91	0.2515836134357377	TCGA-FJ-A3ZE-01	13	10	9	32	PASS	307	TCGA-FJ-A3ZE	BLCA	65	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-23866	Dead	WITH TUMOR	NA	324	NA	Distant Metastasis	Bone	NA	152	Progressive Disease	NA	NA	1	324	1	324	NA	NA	1	152	
70	TCGA-FJ-A3ZF	0	12	0	11	1	1	1	0	12	190	20	0	21	74	7	0	TCGA-FJ-A3ZF-01	105	0.6653875643242694	43	TCGA-FJ-A3ZF-01	14	35	33	0.10009503643155987	TCGA-FJ-A3ZF-01	13	15	5	33	PASS	308	TCGA-FJ-A3ZF	BLCA	73	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-26825	Alive	TUMOR FREE	524	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	524	0	524	0	524	0	524	
50	TCGA-FJ-A871	1	3	1	0	2	0	1	0	1	36	3	0	0	15	2	0	TCGA-FJ-A871-01	96	0.0093683341909734	44	TCGA-FJ-A871-01	0	0	33	0.029834488258534183	TCGA-FJ-A871-01	2	3	3	8	PASS	309	TCGA-FJ-A871	BLCA	49	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-18051	Dead	WITH TUMOR	NA	272	NA	Locoregional (Urothelial tumor event)	"Other, specify"	Pelvic	106	Progressive Disease	NA	NA	1	272	1	272	NA	NA	1	106	
80	TCGA-FT-A3EE	0	10	1	2	2	3	0	1	5	100	6	0	1	32	3	1	TCGA-FT-A3EE-01	128	0.9999981695347354	66	TCGA-FT-A3EE-01	23	28	23	0.41317143564386216	TCGA-FT-A3EE-01	9	6	8	23	PASS	310	TCGA-FT-A3EE	BLCA	80	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-29293	Dead	TUMOR FREE	NA	99	NA	NA	NA	NA	NA	NA	NA	NA	1	99	0	99	NA	NA	0	99	
80	TCGA-FT-A61P	0	10	0	8	3	1	0	0	5	130	9	0	2	56	2	0	TCGA-FT-A61P-01	121	0.663704489315546	58	TCGA-FT-A61P-01	21	77	33	0.11733834229092553	TCGA-FT-A61P-01	8	10	4	22	PASS	311	TCGA-FT-A61P	BLCA	76	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-28082	Alive	TUMOR FREE	337	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	337	0	337	NA	NA	0	337	
60	TCGA-G2-A2EC	0	11	2	13	4	1	2	0	8	141	14	0	1	49	2	0	TCGA-G2-A2EC	0	0	0	TCGA-G2-A2EC	0	0	0	0	TCGA-G2-A2EC	0	0	0	0	PASS	312	TCGA-G2-A2EC	BLCA	58	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-21215	Dead	WITH TUMOR	NA	696	NA	Distant Metastasis	"Other, specify"	small bowel	679	Partial Remission/Response	NA	NA	1	696	1	696	NA	NA	1	679	
50	TCGA-G2-A2EF	1	22	2	11	7	1	1	0	14	204	16	0	3	76	3	2	TCGA-G2-A2EF-01	398	0.5412451608790471	261	TCGA-G2-A2EF-01	14	39	62	0.21002542516293604	TCGA-G2-A2EF-01	18	15	7	40	PASS	313	TCGA-G2-A2EF	BLCA	50	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-18467	Alive	TUMOR FREE	1884	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1884	0	1884	NA	NA	0	1884	
60	TCGA-G2-A2EJ	0	34	4	20	4	2	0	0	29	446	58	1	20	193	9	1	TCGA-G2-A2EJ-01	234	0.20115209295142936	158	TCGA-G2-A2EJ-01	8	7	60	0.13653769769072754	TCGA-G2-A2EJ-01	7	4	9	20	PASS	314	TCGA-G2-A2EJ	BLCA	56	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-20649	Alive	TUMOR FREE	1460	NA	NA	Distant Metastasis	Lung	NA	910	Complete Remission/Response	NA	NA	0	1460	0	1460	1	910	1	910	
60	TCGA-G2-A2EK	0	3	0	1	0	2	0	0	3	56	5	0	2	16	0	0	TCGA-G2-A2EK-01	152	0.22885976119112025	96	TCGA-G2-A2EK-01	6	7	37	0.10640262624412246	TCGA-G2-A2EK-01	6	8	7	21	PASS	315	TCGA-G2-A2EK	BLCA	57	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-20995	Alive	WITH TUMOR	485	NA	NA	Distant Metastasis	Renal Pelvis	NA	485	Stable Disease	NA	NA	0	485	0	485	NA	NA	1	485	
80	TCGA-G2-A2EL	1	12	2	5	1	1	0	0	17	170	25	0	4	75	7	0	TCGA-G2-A2EL-01	146	0.9271621735514772	79	TCGA-G2-A2EL-01	6	8	45	0.2610885259635815	TCGA-G2-A2EL-01	6	6	7	19	pathology review	316	TCGA-G2-A2EL	BLCA	77	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-28370	Dead	WITH TUMOR	NA	819	NA	Distant Metastasis	Bone	NA	105	Stable Disease	NA	NA	1	819	1	819	NA	NA	1	105	
70	TCGA-G2-A2EO	5	50	1	42	5	2	0	0	41	699	73	1	18	273	17	1	TCGA-G2-A2EO-01	191	0.4890896677048844	104	TCGA-G2-A2EO-01	22	16	27	0.10692412245256036	TCGA-G2-A2EO-01	7	3	1	11	hypermutated sample	317	TCGA-G2-A2EO	BLCA	69	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-25440	Dead	TUMOR FREE	NA	1804	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1804	0	1804	0	1804	0	1804	
90	TCGA-G2-A2ES	1	22	4	29	7	5	6	0	25	343	26	1	3	149	17	3	TCGA-G2-A2ES-01	230	0.237357608174908	134	TCGA-G2-A2ES-01	6	12	44	0.2858195065586545	TCGA-G2-A2ES-01	10	2	4	16	PASS	318	TCGA-G2-A2ES	BLCA	85	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-31293	Dead	WITH TUMOR	NA	1004	NA	New Primary Tumor	"Other, specify"	NA	897	Progressive Disease	NA	NA	1	1004	1	1004	NA	NA	1	897	
70	TCGA-G2-A3IB	2	5	1	3	1	2	0	0	3	74	6	0	2	24	0	0	TCGA-G2-A3IB-01	140	0.8549453391177526	66	TCGA-G2-A3IB-01	6	5	24	0.2079438427795144	TCGA-G2-A3IB-01	7	2	7	16	PASS	319	TCGA-G2-A3IB	BLCA	66	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-24149	Dead	WITH TUMOR	NA	220	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	220	1	220	NA	NA	1	220	
50	TCGA-G2-A3IE	1	10	3	15	6	1	3	0	21	279	30	2	8	110	10	0	TCGA-G2-A3IE-01	160	0.44968990436693945	78	TCGA-G2-A3IE-01	4	8	36	0.19015758428691654	TCGA-G2-A3IE-01	14	16	11	41	PASS	320	TCGA-G2-A3IE	BLCA	51	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-18983	Dead	WITH TUMOR	NA	612	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	612	1	612	NA	NA	1	612	
70	TCGA-G2-A3VY	7	51	5	28	9	0	4	0	29	570	56	3	10	200	17	0	TCGA-G2-A3VY-01	494	0.7804502142937477	306	TCGA-G2-A3VY-01	18	25	118	0.2961356280500898	TCGA-G2-A3VY-01	24	23	12	59	PASS	321	TCGA-G2-A3VY	BLCA	66	MALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-24112	Alive	WITH TUMOR	536	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	536	0	536	NA	NA	0	536	
80	TCGA-G2-AA3B	1	37	4	17	5	1	1	1	25	573	54	2	8	212	14	0	TCGA-G2-AA3B-01	460	0.7925816173471035	279	TCGA-G2-AA3B-01	8	22	339	0.4545204902257364	TCGA-G2-AA3B-01	19	22	24	65	PASS	322	TCGA-G2-AA3B	BLCA	75	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-27646	Alive	TUMOR FREE	2008	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2008	0	2008	0	2008	0	2008	
70	TCGA-G2-AA3C	0	18	1	10	3	3	0	0	3	188	17	1	3	79	5	0	TCGA-G2-AA3C-01	144	0.03378884707709258	71	TCGA-G2-AA3C-01	2	6	69	0.1453641034903105	TCGA-G2-AA3C-01	4	3	3	10	PASS	323	TCGA-G2-AA3C	BLCA	66	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-24267	Dead	WITH TUMOR	NA	211	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	211	1	211	NA	NA	1	211	
60	TCGA-G2-AA3D	1	7	1	7	1	3	0	0	9	211	18	0	0	63	3	1	TCGA-G2-AA3D-01	324	0.5039765380163576	201	TCGA-G2-AA3D-01	6	7	135	0.16293562541478682	TCGA-G2-AA3D-01	11	7	11	29	PASS	324	TCGA-G2-AA3D	BLCA	60	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-22205	Alive	TUMOR FREE	2139	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2139	0	2139	NA	NA	0	2139	
80	TCGA-G2-AA3F	0	7	1	4	6	4	2	0	2	110	5	1	2	39	3	0	TCGA-G2-AA3F-01	276	0.793044999292728	161	TCGA-G2-AA3F-01	13	29	47	0.06743344323419885	TCGA-G2-AA3F-01	12	8	4	24	PASS	325	TCGA-G2-AA3F	BLCA	77	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-28457	Alive	TUMOR FREE	893	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	893	0	893	NA	NA	0	893	
70	TCGA-GC-A3BM	0	10	0	8	12	2	0	0	7	175	5	0	2	80	2	0	TCGA-GC-A3BM-01	130	0.7233505395915657	65	TCGA-GC-A3BM-01	29	21	49	0.14645283719149926	TCGA-GC-A3BM-01	10	4	7	21	PASS	326	TCGA-GC-A3BM	BLCA	70	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-25609	Dead	WITH TUMOR	NA	651	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	651	1	651	NA	NA	1	651	
50	TCGA-GC-A3I6	2	9	2	6	2	1	0	0	7	146	15	0	6	61	3	0	TCGA-GC-A3I6-01	83	0.9211478646152976	33	TCGA-GC-A3I6-01	18	34	12	0.1059396637010277	TCGA-GC-A3I6-01	4	0	4	8	PASS	327	TCGA-GC-A3I6	BLCA	45	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-16504	Dead	WITH TUMOR	NA	630	NA	Locoregional (Urothelial tumor event)	Bladder	NA	546	Progressive Disease	NA	NA	1	630	1	630	NA	NA	1	546	
80	TCGA-GC-A3OO	1	10	0	7	0	0	0	0	3	104	8	0	1	49	2	1	TCGA-GC-A3OO-01	59	0.3688951776658595	27	TCGA-GC-A3OO-01	13	17	29	0.16691650894114005	TCGA-GC-A3OO-01	3	3	1	7	PASS	328	TCGA-GC-A3OO	BLCA	79	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-29065	Alive	TUMOR FREE	481	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	481	0	481	0	481	0	481	
50	TCGA-GC-A3RB	1	6	1	7	3	3	1	0	7	130	5	0	3	61	5	0	TCGA-GC-A3RB-01	572	0.5443619624271329	380	TCGA-GC-A3RB-01	8	30	65	0.16537998680763416	TCGA-GC-A3RB-01	25	22	9	56	PASS	329	TCGA-GC-A3RB	BLCA	54	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-20021	Alive	TUMOR FREE	582	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	582	0	582	0	582	0	582	
60	TCGA-GC-A3RC	4	22	1	17	8	4	5	1	19	257	17	0	5	138	13	1	TCGA-GC-A3RC-01	149	0.5154408538422641	76	TCGA-GC-A3RC-01	18	28	54	0.14511761331318845	TCGA-GC-A3RC-01	17	15	9	41	PASS	330	TCGA-GC-A3RC	BLCA	59	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-21668	Alive	TUMOR FREE	484	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	484	0	484	0	484	0	484	
80	TCGA-GC-A3RD	1	6	0	2	3	2	0	0	4	61	7	0	0	35	0	0	TCGA-GC-A3RD-01	170	0.6847532016272267	93	TCGA-GC-A3RD-01	20	39	88	0.4685848639044685	TCGA-GC-A3RD-01	17	15	12	44	PASS	331	TCGA-GC-A3RD	BLCA	83	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-30529	Alive	TUMOR FREE	428	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	428	0	428	0	428	0	428	
80	TCGA-GC-A3WC	4	18	0	13	2	2	2	0	20	229	34	0	5	88	2	0	TCGA-GC-A3WC-01	62	0.2748002947461594	16	TCGA-GC-A3WC-01	7	9	41	0.17883197490250374	TCGA-GC-A3WC-01	9	6	6	21	PASS	332	TCGA-GC-A3WC	BLCA	80	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-29295	Alive	TUMOR FREE	540	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	540	0	540	0	540	0	540	
60	TCGA-GC-A3YS	0	19	2	7	3	0	1	0	20	189	12	0	5	79	4	0	TCGA-GC-A3YS-01	261	0.6669968260131426	151	TCGA-GC-A3YS-01	22	61	186	0.5842438677654167	TCGA-GC-A3YS-01	23	14	22	59	PASS	333	TCGA-GC-A3YS	BLCA	61	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-22515	Alive	TUMOR FREE	758	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	758	0	758	NA	NA	0	758	
70	TCGA-GC-A4ZW	2	22	5	23	3	2	1	0	26	554	45	1	9	204	3	2	TCGA-GC-A4ZW-01	352	0.7181089329636351	210	TCGA-GC-A4ZW-01	17	55	126	0.2029532925720343	TCGA-GC-A4ZW-01	26	24	11	61	PASS	334	TCGA-GC-A4ZW	BLCA	71	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-25964	Alive	TUMOR FREE	15	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	15	0	15	NA	NA	0	15	
90	TCGA-GC-A6I1	2	13	3	13	3	2	2	0	13	169	22	0	2	84	5	0	TCGA-GC-A6I1-01	134	0.4594678439057509	65	TCGA-GC-A6I1-01	13	34	116	0.4500052060280245	TCGA-GC-A6I1-01	17	13	14	44	PASS	335	TCGA-GC-A6I1	BLCA	90	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-32873	Dead	TUMOR FREE	NA	272	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	272	0	272	0	272	0	272	
90	TCGA-GC-A6I3	8	31	4	16	0	0	4	0	15	310	25	0	7	132	2	0	TCGA-GC-A6I3-01	199	0.5850912358158924	112	TCGA-GC-A6I3-01	18	29	89	0.1418373828404107	TCGA-GC-A6I3-01	18	19	3	40	PASS	336	TCGA-GC-A6I3	BLCA	90	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-32873	Alive	TUMOR FREE	423	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	423	0	423	NA	NA	0	423	
50	TCGA-GD-A2C5	0	20	0	21	4	2	0	2	25	337	40	1	7	140	6	0	TCGA-GD-A2C5-01	262	0.5574628106461159	144	TCGA-GD-A2C5-01	17	59	32	0.18714183008754365	TCGA-GD-A2C5-01	18	21	8	47	PASS	337	TCGA-GD-A2C5	BLCA	53	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-19498	Alive	WITH TUMOR	812	NA	NA	Metastatic	Lung	NA	214	Progressive Disease	NA	NA	0	812	0	812	NA	NA	1	214	
80	TCGA-GD-A3OP	0	20	2	27	7	0	4	0	18	564	63	0	10	235	12	0	TCGA-GD-A3OP-01	59	0.3903256107132376	19	TCGA-GD-A3OP-01	16	21	7	0.07391096078394938	TCGA-GD-A3OP-01	6	3	2	11	PASS	338	TCGA-GD-A3OP	BLCA	84	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-30956	Alive	NA	64	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	64	0	64	NA	NA	0	64	
50	TCGA-GD-A3OQ	0	10	0	2	2	8	0	0	8	184	12	0	0	40	4	0	TCGA-GD-A3OQ-01	78	0.08597452767854183	28	TCGA-GD-A3OQ-01	0	2	8	0.056896385941334685	TCGA-GD-A3OQ-01	4	4	0	8	PASS	339	TCGA-GD-A3OQ	BLCA	48	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-17682	Alive	NA	95	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	95	0	95	NA	NA	0	95	
50	TCGA-GD-A3OS	0	3	1	1	3	1	0	0	2	76	4	0	0	27	1	0	TCGA-GD-A3OS-01	361	0.9685184965596071	237	TCGA-GD-A3OS-01	22	42	75	0.3942563429695905	TCGA-GD-A3OS-01	16	14	11	41	PASS	340	TCGA-GD-A3OS	BLCA	54	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-19776	Alive	WITH TUMOR	638	NA	NA	Locoregional (Urothelial tumor event)	Bladder	NA	223	Progressive Disease	NA	NA	0	638	0	638	NA	NA	1	223	
60	TCGA-GD-A6C6	3	19	1	9	3	1	2	0	10	199	21	0	5	94	5	1	TCGA-GD-A6C6-01	273	0.9682287519434356	169	TCGA-GD-A6C6-01	16	35	196	0.4223996840383407	TCGA-GD-A6C6-01	19	17	11	47	PASS	341	TCGA-GD-A6C6	BLCA	64	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-23631	Alive	TUMOR FREE	67	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	67	0	67	0	67	0	67	
90	TCGA-GD-A76B	0	4	2	5	1	2	0	0	10	156	13	0	2	54	4	1	TCGA-GD-A76B-01	58	0.3911928920436539	16	TCGA-GD-A76B-01	8	10	45	0.1893489576133489	TCGA-GD-A76B-01	8	5	7	20	PASS	342	TCGA-GD-A76B	BLCA	86	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-31571	Alive	TUMOR FREE	224	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	224	0	224	0	224	0	224	
70	TCGA-GU-A42P	1	14	0	6	3	2	0	0	7	186	22	0	4	114	2	0	TCGA-GU-A42P-01	100	0.7250811456050487	31	TCGA-GU-A42P-01	24	59	53	0.21061473518788326	TCGA-GU-A42P-01	18	5	6	29	PASS	343	TCGA-GU-A42P	BLCA	72	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-26546	Dead	TUMOR FREE	NA	332	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	332	0	332	NA	NA	0	332	
70	TCGA-GU-A42Q	0	11	1	4	0	1	1	2	6	138	16	0	5	58	4	0	TCGA-GU-A42Q-01	138	0.3757098721245114	67	TCGA-GU-A42Q-01	8	26	89	0.2275602426441096	TCGA-GU-A42Q-01	13	10	11	34	PASS	344	TCGA-GU-A42Q	BLCA	67	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-24534	Dead	TUMOR FREE	NA	344	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	344	0	344	0	344	0	344	
70	TCGA-GU-A42R	0	10	0	9	3	1	0	0	13	110	11	0	2	67	4	0	TCGA-GU-A42R-01	208	0.23475415404695185	118	TCGA-GU-A42R-01	6	12	102	0.2464471660094554	TCGA-GU-A42R-01	9	9	8	26	PASS	345	TCGA-GU-A42R	BLCA	68	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-25134	Dead	WITH TUMOR	NA	577	NA	Distant Metastasis	Lung	NA	91	Progressive Disease	NA	NA	1	577	1	577	NA	NA	1	91	
90	TCGA-GU-A762	0	5	2	2	4	0	0	0	1	88	15	0	0	33	0	0	TCGA-GU-A762-01	303	0.4757223894289162	198	TCGA-GU-A762-01	18	18	158	0.3313791246815232	TCGA-GU-A762-01	16	12	16	44	PASS	346	TCGA-GU-A762	BLCA	87	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-31812	Dead	WITH TUMOR	NA	232	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	232	1	232	NA	NA	1	232	
70	TCGA-GU-A763	0	1	0	1	1	1	0	0	3	48	7	0	0	22	1	0	TCGA-GU-A763-01	73	0.03737051262907902	26	TCGA-GU-A763-01	1	1	24	0.03127434994020432	TCGA-GU-A763-01	2	1	1	4	PASS	347	TCGA-GU-A763	BLCA	72	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-26527	Alive	WITH TUMOR	997	NA	NA	Distant Metastasis	Lung	NA	303	Stable Disease	NA	NA	0	997	0	997	NA	NA	1	303	
70	TCGA-GU-A764	0	10	0	4	2	0	2	0	2	100	11	0	3	39	0	0	TCGA-GU-A764-01	112	0.21038242402058	45	TCGA-GU-A764-01	18	42	57	0.16422844427253616	TCGA-GU-A764-01	22	17	10	49	PASS	348	TCGA-GU-A764	BLCA	66	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-24343	Alive	TUMOR FREE	610	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	610	0	610	0	610	0	610	
60	TCGA-GU-A766	2	14	0	4	2	0	0	0	13	146	16	0	1	56	1	1	TCGA-GU-A766-01	114	0.23527245951975545	51	TCGA-GU-A766-01	8	18	105	0.3751118159254415	TCGA-GU-A766-01	11	6	7	24	PASS	349	TCGA-GU-A766	BLCA	62	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-22774	Alive	WITH TUMOR	480	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	480	0	480	NA	NA	0	480	
80	TCGA-GU-A767	4	22	1	6	7	2	1	0	17	319	27	1	6	112	4	1	TCGA-GU-A767-01	259	0.4526251258152281	166	TCGA-GU-A767-01	13	68	68	0.1803696757372284	TCGA-GU-A767-01	24	26	8	58	PASS	350	TCGA-GU-A767	BLCA	81	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-29739	Dead	WITH TUMOR	NA	144	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	144	1	144	NA	NA	1	144	
80	TCGA-GU-AATO	0	11	2	10	2	1	0	0	17	253	21	3	4	95	5	0	TCGA-GU-AATO-01	187	0.7056161658036042	106	TCGA-GU-AATO-01	24	70	75	0.1684857598262828	TCGA-GU-AATO-01	11	8	6	25	PASS	351	TCGA-GU-AATO	BLCA	75	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-27684	Dead	WITH TUMOR	NA	324	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	324	1	324	NA	NA	1	324	
70	TCGA-GU-AATP	1	20	0	9	5	2	2	0	15	243	28	1	5	93	9	1	TCGA-GU-AATP-01	242	0.784301932641071	144	TCGA-GU-AATP-01	19	27	71	0.15999418243254007	TCGA-GU-AATP-01	11	3	4	18	PASS	352	TCGA-GU-AATP	BLCA	74	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-27049	Alive	WITH TUMOR	1003	NA	NA	New Primary Tumor	Urethra	NA	596	Progressive Disease	NA	NA	0	1003	0	1003	NA	NA	1	596	
70	TCGA-GU-AATQ	0	12	1	4	0	1	1	0	6	124	15	0	5	54	3	0	TCGA-GU-AATQ-01	195	0.6585615752855986	114	TCGA-GU-AATQ-01	17	24	91	0.22333139251302395	TCGA-GU-AATQ-01	14	13	10	37	PASS	353	TCGA-GU-AATQ	BLCA	68	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-25185	Dead	WITH TUMOR	NA	213	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	213	1	213	NA	NA	1	213	
70	TCGA-GV-A3JV	0	7	1	2	1	2	1	1	5	91	7	0	2	39	3	0	TCGA-GV-A3JV-01	247	0.5527206228428677	158	TCGA-GV-A3JV-01	17	22	26	0.14120170388594044	TCGA-GV-A3JV-01	6	3	2	11	PASS	354	TCGA-GV-A3JV	BLCA	66	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-24243	Dead	WITH TUMOR	NA	434	NA	Locoregional (Urothelial tumor event)	Bladder	NA	134	Partial Remission/Response	NA	NA	1	434	1	434	NA	NA	1	134	
70	TCGA-GV-A3JW	0	3	0	4	1	0	0	0	3	62	4	0	0	22	4	1	TCGA-GV-A3JW-01	380	0.8392515285975578	235	TCGA-GV-A3JW-01	13	36	114	0.3713046386070555	TCGA-GV-A3JW-01	21	28	18	67	PASS	355	TCGA-GV-A3JW	BLCA	74	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-27091	Alive	WITH TUMOR	649	NA	NA	Distant Metastasis	Bone	NA	271	Stable Disease	NA	NA	0	649	0	649	NA	NA	1	271	
60	TCGA-GV-A3JX	1	4	1	4	3	3	0	0	12	241	16	0	6	76	5	0	TCGA-GV-A3JX-01	133	0.7658577592869384	67	TCGA-GV-A3JX-01	14	18	41	0.3625781388434636	TCGA-GV-A3JX-01	10	2	7	19	PASS	356	TCGA-GV-A3JX	BLCA	59	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-21888	Alive	TUMOR FREE	581	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	581	0	581	0	581	0	581	
60	TCGA-GV-A3JZ	2	20	4	21	1	0	2	0	11	368	36	0	5	129	10	0	TCGA-GV-A3JZ-01	486	0.6273161200497489	300	TCGA-GV-A3JZ-01	16	37	122	0.19388098124458109	TCGA-GV-A3JZ-01	20	26	11	57	PASS	357	TCGA-GV-A3JZ	BLCA	55	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-20420	Alive	WITH TUMOR	603	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	603	0	603	NA	NA	0	603	
80	TCGA-GV-A3QF	1	6	0	3	6	4	1	1	5	102	7	0	1	42	5	1	TCGA-GV-A3QF-01	190	0.6500293189898391	107	TCGA-GV-A3QF-01	21	26	93	0.2885447343976008	TCGA-GV-A3QF-01	15	6	9	30	PASS	358	TCGA-GV-A3QF	BLCA	79	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-28890	Dead	TUMOR FREE	NA	617	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	617	0	617	NA	NA	0	617	
70	TCGA-GV-A3QG	0	7	0	4	0	4	2	0	3	76	5	0	1	23	2	0	TCGA-GV-A3QG-01	86	0.2761530129151867	33	TCGA-GV-A3QG-01	2	6	7	0.08298302519995147	TCGA-GV-A3QG-01	9	11	4	24	PASS	359	TCGA-GV-A3QG	BLCA	65	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-23847	Dead	WITH TUMOR	NA	NA	NA	Distant Metastasis	"Other, specify"	Brain	84	NA	NA	NA	1	NA	1	NA	NA	NA	1	84	
70	TCGA-GV-A3QH	0	4	0	6	0	1	0	0	8	134	10	0	2	49	7	0	TCGA-GV-A3QH-01	283	0.7661671167192562	173	TCGA-GV-A3QH-01	26	45	70	0.19321917510236367	TCGA-GV-A3QH-01	17	11	8	36	PASS	360	TCGA-GV-A3QH	BLCA	67	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-24681	Dead	TUMOR FREE	NA	258	NA	Locoregional (Urothelial tumor event)	Bladder	NA	125	Stable Disease	NA	NA	1	258	0	258	NA	NA	1	125	
50	TCGA-GV-A3QI	5	19	1	10	11	3	2	0	23	357	24	0	7	152	18	0	TCGA-GV-A3QI-01	534	0.6242063908218765	345	TCGA-GV-A3QI-01	15	24	111	0.2254458279319039	TCGA-GV-A3QI-01	21	24	12	57	PASS	361	TCGA-GV-A3QI	BLCA	47	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-17383	Alive	WITH TUMOR	1110	NA	NA	Distant Metastasis	"Other, specify"	Abdominal wall	768	Complete Remission/Response	NA	NA	0	1110	0	1110	1	768	1	768	
60	TCGA-GV-A3QK	0	9	0	5	4	2	1	0	4	106	7	0	4	50	3	0	TCGA-GV-A3QK-01	122	0.38744786957804017	59	TCGA-GV-A3QK-01	11	10	43	0.12029052788220194	TCGA-GV-A3QK-01	7	4	6	17	PASS	362	TCGA-GV-A3QK	BLCA	56	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-20802	Alive	WITH TUMOR	832	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	832	0	832	NA	NA	0	832	
80	TCGA-GV-A40E	0	10	0	2	4	2	1	0	1	119	13	1	0	49	2	0	TCGA-GV-A40E-01	289	0.6207569566438048	169	TCGA-GV-A40E-01	24	51	106	0.27265066839925284	TCGA-GV-A40E-01	28	25	13	66	PASS	363	TCGA-GV-A40E	BLCA	75	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-27569	Dead	WITH TUMOR	NA	261	NA	Distant Metastasis	Lung	NA	219	Stable Disease	NA	NA	1	261	1	261	NA	NA	1	219	
80	TCGA-GV-A40G	1	8	0	6	4	1	0	0	3	129	8	0	4	52	4	0	TCGA-GV-A40G-01	267	0.6844082399881023	160	TCGA-GV-A40G-01	19	30	104	0.286979994578899	TCGA-GV-A40G-01	18	17	14	49	PASS	364	TCGA-GV-A40G	BLCA	77	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-28204	Alive	TUMOR FREE	580	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	580	0	580	0	580	0	580	
50	TCGA-GV-A6ZA	1	18	0	7	3	1	0	0	12	255	24	2	3	84	4	1	TCGA-GV-A6ZA-01	156	0.6577225226904532	77	TCGA-GV-A6ZA-01	16	22	49	0.1279183528219074	TCGA-GV-A6ZA-01	14	13	5	32	PASS	365	TCGA-GV-A6ZA	BLCA	54	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-19871	Alive	TUMOR FREE	691	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	691	0	691	0	691	0	691	
50	TCGA-H4-A2HO	1	24	4	13	6	1	0	0	23	279	42	0	1	121	6	1	TCGA-H4-A2HO-01	395	0.03382393060683093	257	TCGA-H4-A2HO-01	0	0	2	0.00014109394557766406	TCGA-H4-A2HO-01	0	0	0	0	PASS	366	TCGA-H4-A2HO	BLCA	53	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-19630	Alive	TUMOR FREE	46	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	46	0	46	0	46	0	46	
60	TCGA-H4-A2HQ	2	25	1	20	6	1	0	0	19	364	35	0	8	149	12	1	TCGA-H4-A2HQ-01	282	0.8527836790782831	178	TCGA-H4-A2HQ-01	26	61	38	0.2032860150101584	TCGA-H4-A2HQ-01	20	9	7	36	PASS	367	TCGA-H4-A2HQ	BLCA	64	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-23538	Alive	WITH TUMOR	590	NA	NA	Distant Metastasis	Lung	NA	318	Complete Remission/Response	NA	NA	0	590	0	590	NA	NA	1	318	
70	TCGA-HQ-A2OE	0	6	1	4	1	2	0	0	4	115	15	0	2	44	4	0	TCGA-HQ-A2OE-01	366	0.8864228769831135	233	TCGA-HQ-A2OE-01	27	28	50	0.2386421430542157	TCGA-HQ-A2OE-01	19	19	9	47	PASS	368	TCGA-HQ-A2OE	BLCA	69	MALE	[Not Evaluated]	NA	NA	Muscle invasive urothelial carcinoma (pT2 or above)	[Unknown]	2007	NA	NA	Alive	NA	1174	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1174	0	1174	NA	NA	0	1174	
50	TCGA-HQ-A2OF	1	6	0	3	4	0	1	0	4	84	6	0	1	47	1	0	TCGA-HQ-A2OF-01	146	0.8017463960698148	80	TCGA-HQ-A2OF-01	20	34	69	0.34326313704590405	TCGA-HQ-A2OF-01	12	5	11	28	PASS	369	TCGA-HQ-A2OF	BLCA	52	FEMALE	[Not Evaluated]	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-19016	Alive	TUMOR FREE	1947	NA	NA	Locoregional (Urothelial tumor event)	Lymph Node Only	NA	907	Complete Remission/Response	NA	NA	0	1947	0	1947	1	907	1	907	
80	TCGA-HQ-A5ND	1	4	0	4	2	2	1	0	2	61	8	0	2	33	1	1	TCGA-HQ-A5ND-01	171	0.6155334680998369	93	TCGA-HQ-A5ND-01	19	33	53	0.13295134984376245	TCGA-HQ-A5ND-01	10	7	5	22	PASS	370	TCGA-HQ-A5ND	BLCA	78	MALE	[Not Evaluated]	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-28555	Dead	WITH TUMOR	NA	274	NA	Distant Metastasis	Lymph Node Only	NA	84	Progressive Disease	NA	NA	1	274	1	274	NA	NA	1	84	
60	TCGA-HQ-A5NE	0	21	1	12	4	2	0	0	11	297	30	0	8	120	2	1	TCGA-HQ-A5NE-01	147	0.4266260435279921	65	TCGA-HQ-A5NE-01	30	68	45	0.23677279583473976	TCGA-HQ-A5NE-01	22	12	8	42	PASS	371	TCGA-HQ-A5NE	BLCA	57	MALE	[Not Evaluated]	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-20647	Dead	WITH TUMOR	NA	370	NA	Distant Metastasis	Renal Pelvis	NA	211	Complete Remission/Response	NA	NA	1	370	1	370	1	211	1	211	
70	TCGA-K4-A3WS	1	14	3	6	4	1	2	0	15	223	22	1	2	74	5	0	TCGA-K4-A3WS-01	135	0.4688209938277055	62	TCGA-K4-A3WS-01	15	59	4	0.0003734049149089558	TCGA-K4-A3WS-01	23	29	0	52	PASS	372	TCGA-K4-A3WS	BLCA	66	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-24124	Alive	TUMOR FREE	761	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	761	0	761	0	761	0	761	
90	TCGA-K4-A3WU	0	10	1	10	1	3	1	0	10	159	8	0	2	58	3	1	TCGA-K4-A3WU-01	112	0.3787867735091655	55	TCGA-K4-A3WU-01	1	1	7	0.005054338104796675	TCGA-K4-A3WU-01	3	4	0	7	PASS	373	TCGA-K4-A3WU	BLCA	87	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-32134	Alive	TUMOR FREE	105	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	105	0	105	NA	NA	0	105	
80	TCGA-K4-A3WV	2	5	0	4	2	1	0	0	4	104	4	0	8	44	4	0	TCGA-K4-A3WV-01	566	0.6609842107169424	376	TCGA-K4-A3WV-01	15	28	261	0.38157776983264224	TCGA-K4-A3WV-01	19	22	18	59	PASS	374	TCGA-K4-A3WV	BLCA	77	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-28444	Alive	TUMOR FREE	646	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	646	0	646	NA	NA	0	646	
80	TCGA-K4-A4AB	1	9	2	4	2	1	0	0	3	71	9	0	3	33	2	0	TCGA-K4-A4AB-01	85	0.3401577525681687	35	TCGA-K4-A4AB-01	12	17	39	0.24260434247667825	TCGA-K4-A4AB-01	7	5	4	16	PASS	375	TCGA-K4-A4AB	BLCA	76	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-27922	Alive	NA	84	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	84	0	84	NA	NA	0	84	
80	TCGA-K4-A4AC	0	6	0	1	2	3	1	0	7	115	12	0	2	49	2	0	TCGA-K4-A4AC-01	179	0.5481750773825235	104	TCGA-K4-A4AC-01	18	40	85	0.2642136116575873	TCGA-K4-A4AC-01	19	15	11	45	PASS	376	TCGA-K4-A4AC	BLCA	83	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-30655	Dead	WITH TUMOR	NA	278	NA	Distant Metastasis	"Other, specify"	psoas	170	Partial Remission/Response	NA	NA	1	278	1	278	NA	NA	1	170	
60	TCGA-K4-A54R	5	88	12	57	11	4	0	0	111	1412	168	0	30	573	26	4	TCGA-K4-A54R-01	129	0.8261556776313081	63	TCGA-K4-A54R-01	5	7	67	0.21672300929829136	TCGA-K4-A54R-01	13	14	12	39	hypermutated sample	377	TCGA-K4-A54R	BLCA	59	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-21601	Alive	TUMOR FREE	842	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	842	0	842	0	842	0	842	
70	TCGA-K4-A5RH	6	26	2	4	5	2	2	0	18	297	28	2	5	100	2	2	TCGA-K4-A5RH-01	230	0.6348345121281944	139	TCGA-K4-A5RH-01	13	42	178	0.3913549173247162	TCGA-K4-A5RH-01	17	13	10	40	PASS	378	TCGA-K4-A5RH	BLCA	69	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-25305	Alive	WITH TUMOR	276	NA	NA	Distant Metastasis	Lung	NA	196	Progressive Disease	NA	NA	0	276	0	276	NA	NA	1	196	
70	TCGA-K4-A5RI	2	6	0	13	6	8	0	0	10	196	20	2	0	96	6	0	TCGA-K4-A5RI-01	116	0.8829351324142509	57	TCGA-K4-A5RI-01	16	35	101	0.34206445495904914	TCGA-K4-A5RI-01	9	4	6	19	PASS	379	TCGA-K4-A5RI	BLCA	67	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-24614	Dead	WITH TUMOR	NA	356	NA	Locoregional (Urothelial tumor event)	"Other, specify"	ileum	236	Progressive Disease	NA	NA	1	356	1	356	NA	NA	1	236	
80	TCGA-K4-A5RJ	2	17	2	17	1	0	1	0	18	278	30	0	12	114	4	0	TCGA-K4-A5RJ-01	119	0.6354187753250384	53	TCGA-K4-A5RJ-01	16	18	63	0.21727429509836746	TCGA-K4-A5RJ-01	13	10	11	34	PASS	380	TCGA-K4-A5RJ	BLCA	75	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-27518	Alive	TUMOR FREE	539	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	539	0	539	0	539	0	539	
80	TCGA-K4-A6FZ	4	48	2	45	9	8	2	0	33	614	48	2	8	211	12	0	TCGA-K4-A6FZ-01	122	0.6598918283318648	63	TCGA-K4-A6FZ-01	23	24	80	0.3249842757899133	TCGA-K4-A6FZ-01	13	12	10	35	PASS	381	TCGA-K4-A6FZ	BLCA	75	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-27686	Alive	TUMOR FREE	55	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	55	0	55	0	55	0	55	
60	TCGA-K4-A6MB	1	28	6	11	3	1	2	0	12	255	27	3	8	111	5	0	TCGA-K4-A6MB-01	439	0.4627685108108562	282	TCGA-K4-A6MB-01	12	32	134	0.2703522024533488	TCGA-K4-A6MB-01	14	12	9	35	PASS	382	TCGA-K4-A6MB	BLCA	64	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-23664	Alive	TUMOR FREE	469	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	469	0	469	NA	NA	0	469	
80	TCGA-K4-A83P	8	21	6	8	6	1	1	0	18	410	28	2	6	150	6	0	TCGA-K4-A83P-01	92	0.0987291967523917	41	TCGA-K4-A83P-01	29	35	54	0.19557541986495605	TCGA-K4-A83P-01	19	23	6	48	PASS	383	TCGA-K4-A83P	BLCA	77	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	[Unknown]	2013	NA	-28463	Alive	WITH TUMOR	495	NA	NA	Distant Metastasis	Liver	NA	70	Partial Remission/Response	NA	NA	0	495	0	495	NA	NA	1	70	
60	TCGA-K4-AAQO	3	15	1	8	3	0	0	0	10	206	13	0	3	70	6	0	TCGA-K4-AAQO-01	174	0.4703096640208553	84	TCGA-K4-AAQO-01	14	36	62	0.1666311432865312	TCGA-K4-AAQO-01	14	14	8	36	PASS	384	TCGA-K4-AAQO	BLCA	56	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-20683	Alive	NA	359	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	359	0	359	NA	NA	0	359	
70	TCGA-KQ-A41N	9	82	4	43	9	5	4	0	58	1745	702	8	18	867	25	4	TCGA-KQ-A41N-01	242	0.27407093264777793	147	TCGA-KQ-A41N-01	4	8	98	0.1640626241439247	TCGA-KQ-A41N-01	12	12	10	34	PASS	385	TCGA-KQ-A41N	BLCA	73	MALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-26837	Alive	TUMOR FREE	1604	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1604	0	1604	0	1604	0	1604	
80	TCGA-KQ-A41O	2	9	1	5	3	1	0	0	15	179	21	0	3	81	4	1	TCGA-KQ-A41O-01	206	0.9396010372918916	121	TCGA-KQ-A41O-01	20	24	50	0.1260916504332961	TCGA-KQ-A41O-01	11	8	4	23	PASS	386	TCGA-KQ-A41O	BLCA	84	MALE	[Unknown]	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-30774	Alive	TUMOR FREE	1538	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1538	0	1538	NA	NA	0	1538	
80	TCGA-KQ-A41P	1	13	2	8	1	2	1	0	14	230	33	0	3	100	7	2	TCGA-KQ-A41P-01	341	0.8427326102330945	217	TCGA-KQ-A41P-01	20	36	150	0.32537600122166743	TCGA-KQ-A41P-01	15	11	9	35	PASS	387	TCGA-KQ-A41P	BLCA	76	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-27816	Alive	WITH TUMOR	1094	NA	NA	Locoregional (Urothelial tumor event)	Lymph Node Only	NA	178	Stable Disease	NA	NA	0	1094	0	1094	NA	NA	1	178	
90	TCGA-KQ-A41Q	2	9	1	7	4	3	1	0	9	176	38	0	4	93	3	0	TCGA-KQ-A41Q-01	311	0.6224499147322641	184	TCGA-KQ-A41Q-01	16	37	76	0.12774227312560382	TCGA-KQ-A41Q-01	15	15	7	37	PASS	388	TCGA-KQ-A41Q	BLCA	89	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-32511	Alive	NA	1429	NA	NA	Locoregional (Urothelial tumor event)	Lymph Node Only	NA	1314	[Unknown]	NA	NA	0	1429	0	1429	NA	NA	1	1314	
80	TCGA-KQ-A41R	6	39	2	48	14	2	7	1	42	562	61	0	12	266	17	1	TCGA-KQ-A41R-01	209	0.6157328113450482	127	TCGA-KQ-A41R-01	16	23	19	0.032044813504992865	TCGA-KQ-A41R-01	12	13	1	26	hypermutated sample	389	TCGA-KQ-A41R	BLCA	80	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-29351	Alive	TUMOR FREE	1350	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1350	0	1350	0	1350	0	1350	
90	TCGA-KQ-A41S	0	15	0	8	3	0	1	0	8	203	18	1	3	83	4	1	TCGA-KQ-A41S-01	111	0.7888157167877962	54	TCGA-KQ-A41S-01	34	55	35	0.1087647492129917	TCGA-KQ-A41S-01	13	7	3	23	PASS	390	TCGA-KQ-A41S	BLCA	87	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-32041	Alive	TUMOR FREE	35	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	35	0	35	0	35	0	35	
80	TCGA-LC-A66R	1	17	1	4	2	2	0	0	5	104	11	1	1	40	1	0	TCGA-LC-A66R-01	244	0.5315957258000271	149	TCGA-LC-A66R-01	18	23	77	0.14553859421117846	TCGA-LC-A66R-01	17	10	8	35	PASS	391	TCGA-LC-A66R	BLCA	78	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-28793	Alive	TUMOR FREE	466	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	466	0	466	NA	NA	0	466	
60	TCGA-LT-A5Z6	2	33	5	24	0	1	0	0	27	396	51	0	10	189	3	0	TCGA-LT-A5Z6-01	227	0.8157818276270934	138	TCGA-LT-A5Z6-01	9	10	123	0.2724904396902682	TCGA-LT-A5Z6-01	9	5	6	20	PASS	392	TCGA-LT-A5Z6	BLCA	56	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-20746	Alive	TUMOR FREE	474	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	474	0	474	0	474	0	474	
70	TCGA-LT-A8JT	1	5	0	2	0	0	2	0	5	56	7	0	0	25	2	0	TCGA-LT-A8JT-01	71	0.1094892228817158	31	TCGA-LT-A8JT-01	5	3	27	0.08030467563647964	TCGA-LT-A8JT-01	3	1	2	6	PASS	393	TCGA-LT-A8JT	BLCA	69	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-25498	Alive	TUMOR FREE	641	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	641	0	641	0	641	0	641	
80	TCGA-MV-A51V	11	68	6	40	4	1	0	0	52	1240	124	7	18	399	20	1	TCGA-MV-A51V-01	193	0.8151252448028001	101	TCGA-MV-A51V-01	24	62	20	0.06456105574708314	TCGA-MV-A51V-01	23	12	3	38	hypermutated sample	394	TCGA-MV-A51V	BLCA	75	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-27430	Alive	TUMOR FREE	410	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	410	0	410	0	410	0	410	
70	TCGA-PQ-A6FI	3	12	1	6	1	4	0	1	8	121	8	1	2	38	3	0	TCGA-PQ-A6FI-01	263	0.7674128889681967	153	TCGA-PQ-A6FI-01	17	32	147	0.34856493671096705	TCGA-PQ-A6FI-01	15	16	8	39	PASS	395	TCGA-PQ-A6FI	BLCA	70	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-25672	Alive	TUMOR FREE	372	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	372	0	372	0	372	0	372	
80	TCGA-PQ-A6FN	0	4	0	3	4	1	1	0	2	59	5	0	2	23	6	0	TCGA-PQ-A6FN-01	121	0.3877445338439389	61	TCGA-PQ-A6FN-01	20	19	99	0.2555095055081847	TCGA-PQ-A6FN-01	16	9	11	36	PASS	396	TCGA-PQ-A6FN	BLCA	78	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-28546	Alive	NA	507	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	507	0	507	NA	NA	0	507	
70	TCGA-R3-A69X	1	10	1	7	2	2	0	0	8	174	15	0	2	65	3	0	TCGA-R3-A69X-01	69	0.6177291374957744	20	TCGA-R3-A69X-01	32	25	40	0.1676822543469018	TCGA-R3-A69X-01	12	4	6	22	PASS	397	TCGA-R3-A69X	BLCA	70	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-25576	Alive	TUMOR FREE	433	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	433	0	433	0	433	0	433	
80	TCGA-S5-A6DX	3	32	6	31	4	0	1	0	35	514	54	1	8	207	13	2	TCGA-S5-A6DX-01	322	0.6105950594028131	227	TCGA-S5-A6DX-01	22	19	151	0.15858862971382542	TCGA-S5-A6DX-01	7	7	8	22	PASS	398	TCGA-S5-A6DX	BLCA	83	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-30594	Dead	WITH TUMOR	NA	56	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	56	1	56	NA	NA	1	56	
50	TCGA-S5-AA26	1	19	0	8	1	2	0	0	10	193	14	0	1	59	1	0	TCGA-S5-AA26-01	147	0.8439353708762058	87	TCGA-S5-AA26-01	6	8	70	0.2031158602578753	TCGA-S5-AA26-01	5	6	4	15	PASS	399	TCGA-S5-AA26	BLCA	46	MALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-16972	Alive	TUMOR FREE	503	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	503	0	503	0	503	0	503	
80	TCGA-SY-A9G0	1	4	0	1	0	0	0	0	1	37	7	0	2	14	1	0	TCGA-SY-A9G0-01	74	0.22183284401509631	23	TCGA-SY-A9G0-01	31	35	25	0.09864591841417404	TCGA-SY-A9G0-01	10	8	5	23	PASS	400	TCGA-SY-A9G0	BLCA	82	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-30205	Dead	TUMOR FREE	NA	1008	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1008	0	1008	NA	NA	0	1008	
70	TCGA-SY-A9G5	2	60	7	44	5	2	1	1	45	808	81	2	12	288	9	0	TCGA-SY-A9G5-01	220	0.5752179756164116	130	TCGA-SY-A9G5-01	19	22	89	0.2070935545927269	TCGA-SY-A9G5-01	12	11	11	34	hypermutated sample	401	TCGA-SY-A9G5	BLCA	66	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-24260	Alive	TUMOR FREE	1186	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1186	0	1186	0	1186	0	1186	
60	TCGA-UY-A78K	0	39	1	19	21	5	2	0	27	647	58	1	11	221	25	0	TCGA-UY-A78K-01	207	0.5766282500556736	108	TCGA-UY-A78K-01	27	66	75	0.1908540308829053	TCGA-UY-A78K-01	27	16	8	51	hypermutated sample	402	TCGA-UY-A78K	BLCA	60	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-22020	Dead	NA	NA	536	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	536	NA	536	NA	NA	0	536	
60	TCGA-UY-A78L	1	18	2	5	4	1	0	0	8	159	18	0	1	71	3	0	TCGA-UY-A78L-01	138	0.4122904565382816	70	TCGA-UY-A78L-01	9	71	87	0.32284889460463223	TCGA-UY-A78L-01	17	18	7	42	PASS	403	TCGA-UY-A78L	BLCA	62	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-22717	Alive	WITH TUMOR	1127	NA	NA	NA	NA	NA	355	Progressive Disease	NA	NA	0	1127	0	1127	NA	NA	1	355	
80	TCGA-UY-A78M	0	3	4	3	1	2	0	1	4	120	17	0	1	47	2	0	TCGA-UY-A78M-01	195	0.7805441042376065	110	TCGA-UY-A78M-01	6	16	106	0.3322222900453525	TCGA-UY-A78M-01	13	9	12	34	PASS	404	TCGA-UY-A78M	BLCA	81	FEMALE	ASIAN	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-29706	Dead	WITH TUMOR	NA	690	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	690	1	690	NA	NA	1	690	
80	TCGA-UY-A78N	2	11	0	9	4	3	3	0	11	218	26	0	3	89	7	0	TCGA-UY-A78N-01	356	0.5951055457900365	244	TCGA-UY-A78N-01	21	17	71	0.11688181134503065	TCGA-UY-A78N-01	8	3	4	15	PASS	405	TCGA-UY-A78N	BLCA	80	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-29132	Dead	WITH TUMOR	NA	2641	NA	Distant Metastasis	Renal Pelvis	NA	2472	Complete Remission/Response	NA	NA	1	2641	1	2641	NA	NA	1	2472	
80	TCGA-UY-A78O	1	6	1	5	3	2	1	0	8	163	3	0	1	53	2	0	TCGA-UY-A78O-01	402	0.7147335634184235	302	TCGA-UY-A78O-01	15	26	71	0.08776257410253058	TCGA-UY-A78O-01	18	8	2	28	PASS	406	TCGA-UY-A78O	BLCA	75	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-27234	Alive	TUMOR FREE	2312	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2312	0	2312	0	2312	0	2312	
80	TCGA-UY-A78P	1	14	2	3	0	0	0	0	12	220	24	0	7	97	5	0	TCGA-UY-A78P-01	138	0.14633797615200633	70	TCGA-UY-A78P-01	6	11	88	0.1772826435735227	TCGA-UY-A78P-01	9	5	7	21	PASS	407	TCGA-UY-A78P	BLCA	78	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-28719	Alive	TUMOR FREE	2380	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2380	0	2380	0	2380	0	2380	
60	TCGA-UY-A8OB	0	14	0	5	8	1	1	1	10	273	18	1	7	73	5	0	TCGA-UY-A8OB-01	334	0.9118440739928506	211	TCGA-UY-A8OB-01	21	39	157	0.3757962417114772	TCGA-UY-A8OB-01	15	15	12	42	PASS	408	TCGA-UY-A8OB	BLCA	63	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-23360	Alive	TUMOR FREE	2109	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2109	0	2109	NA	NA	0	2109	
90	TCGA-UY-A8OC	0	10	1	2	0	1	0	0	3	77	7	0	0	28	1	0	TCGA-UY-A8OC-01	224	0.4340059706841277	139	TCGA-UY-A8OC-01	15	24	92	0.1681700738540375	TCGA-UY-A8OC-01	7	10	5	22	PASS	409	TCGA-UY-A8OC	BLCA	90	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-32918	Dead	WITH TUMOR	NA	92	NA	Distant Metastasis	Lymph Node Only	NA	32	Partial Remission/Response	NA	NA	1	92	1	92	NA	NA	1	32	
70	TCGA-UY-A8OD	0	5	0	3	6	0	0	0	2	73	7	0	3	33	0	1	TCGA-UY-A8OD-01	224	0.8703085491214636	132	TCGA-UY-A8OD-01	19	22	112	0.2994893595213409	TCGA-UY-A8OD-01	18	8	13	39	PASS	410	TCGA-UY-A8OD	BLCA	68	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-24588	Alive	TUMOR FREE	3432	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3432	0	3432	0	3432	0	3432	
50	TCGA-UY-A9PA	2	8	0	3	3	1	0	0	6	139	8	0	2	56	6	1	TCGA-UY-A9PA-01	75	0.08111524041077531	28	TCGA-UY-A9PA-01	9	15	55	0.27470090597608593	TCGA-UY-A9PA-01	10	8	7	25	PASS	411	TCGA-UY-A9PA	BLCA	48	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-17520	Alive	TUMOR FREE	1072	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1072	0	1072	0	1072	0	1072	
50	TCGA-UY-A9PB	3	29	3	14	12	3	0	0	24	428	35	0	8	203	11	0	TCGA-UY-A9PB-01	184	0.6328085912061207	102	TCGA-UY-A9PB-01	15	41	107	0.295453776736374	TCGA-UY-A9PB-01	17	15	12	44	PASS	412	TCGA-UY-A9PB	BLCA	49	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-17885	Alive	TUMOR FREE	899	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	899	0	899	0	899	0	899	
80	TCGA-UY-A9PD	1	17	2	8	6	3	1	0	12	226	19	0	4	90	4	0	TCGA-UY-A9PD-01	475	0.999835265604618	315	TCGA-UY-A9PD-01	17	29	92	0.1258805000065152	TCGA-UY-A9PD-01	18	16	5	39	PASS	413	TCGA-UY-A9PD	BLCA	80	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-29565	Alive	TUMOR FREE	542	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	542	0	542	0	542	0	542	
90	TCGA-UY-A9PE	0	16	5	14	2	0	1	0	11	166	23	1	3	60	4	0	TCGA-UY-A9PE-01	328	0.6510830819422087	183	TCGA-UY-A9PE-01	16	29	57	0.13676161670422265	TCGA-UY-A9PE-01	15	18	6	39	PASS	414	TCGA-UY-A9PE	BLCA	86	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-31755	Alive	WITH TUMOR	189	NA	NA	Distant Metastasis	Lung	NA	473	Complete Remission/Response	NA	NA	0	189	0	189	NA	NA	1	473	
80	TCGA-UY-A9PF	4	29	3	35	7	0	2	0	33	365	28	0	6	161	4	1	TCGA-UY-A9PF-01	125	0.6325732160331086	58	TCGA-UY-A9PF-01	17	22	15	0.05920826528177805	TCGA-UY-A9PF-01	11	13	3	27	PASS	415	TCGA-UY-A9PF	BLCA	77	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-28470	Alive	TUMOR FREE	117	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	117	0	117	NA	NA	0	117	
70	TCGA-UY-A9PH	0	22	2	20	1	0	0	0	14	279	32	0	5	134	7	2	TCGA-UY-A9PH-01	225	0.6318235964243603	134	TCGA-UY-A9PH-01	23	20	89	0.2551928197987616	TCGA-UY-A9PH-01	9	4	6	19	PASS	416	TCGA-UY-A9PH	BLCA	73	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	NA	NA	-26654	Alive	TUMOR FREE	1561	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1561	0	1561	0	1561	0	1561	
50	TCGA-XF-A8HB	1	7	0	3	0	0	0	0	1	67	1	0	0	16	2	0	TCGA-XF-A8HB-01	217	0.22952000401413014	138	TCGA-XF-A8HB-01	6	9	51	0.10720254366202812	TCGA-XF-A8HB-01	10	7	6	23	PASS	417	TCGA-XF-A8HB	BLCA	50	FEMALE	[Unknown]	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-18544	Alive	TUMOR FREE	1370	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1370	0	1370	0	1370	0	1370	
80	TCGA-XF-A8HC	1	15	1	4	2	1	1	0	13	96	11	0	3	57	3	0	TCGA-XF-A8HC-01	237	0.8138048485656969	141	TCGA-XF-A8HC-01	15	30	63	0.11124427929730947	TCGA-XF-A8HC-01	11	5	6	22	PASS	418	TCGA-XF-A8HC	BLCA	79	MALE	ASIAN	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2005	NA	-28996	Dead	NA	NA	200	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	200	NA	200	NA	NA	0	200	
80	TCGA-XF-A8HD	0	27	3	11	1	1	3	0	24	383	32	0	4	150	6	0	TCGA-XF-A8HD-01	103	0.5118927379287166	43	TCGA-XF-A8HD-01	18	33	78	0.29352486177637344	TCGA-XF-A8HD-01	7	10	6	23	PASS	419	TCGA-XF-A8HD	BLCA	77	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-28305	Alive	TUMOR FREE	2964	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2964	0	2964	0	2964	0	2964	
50	TCGA-XF-A8HE	0	30	1	10	2	2	1	0	25	328	30	1	8	126	6	0	TCGA-XF-A8HE-01	80	0.0844055551353775	29	TCGA-XF-A8HE-01	5	9	33	0.14130905128754656	TCGA-XF-A8HE-01	4	0	3	7	PASS	420	TCGA-XF-A8HE	BLCA	47	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2004	NA	-17212	Alive	TUMOR FREE	3817	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3817	0	3817	0	3817	0	3817	
80	TCGA-XF-A8HF	0	5	0	6	3	0	0	0	3	127	8	0	0	44	6	0	TCGA-XF-A8HF-01	185	0.871214744307701	119	TCGA-XF-A8HF-01	25	58	75	0.18214577252251946	TCGA-XF-A8HF-01	14	7	9	30	PASS	421	TCGA-XF-A8HF	BLCA	80	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2004	NA	-29288	Dead	TUMOR FREE	NA	2954	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2954	0	2954	0	2954	0	2954	
70	TCGA-XF-A8HG	2	19	1	10	10	2	1	0	10	237	17	0	1	109	3	0	TCGA-XF-A8HG-01	161	0.947212476119307	104	TCGA-XF-A8HG-01	28	26	71	0.12141567623495494	TCGA-XF-A8HG-01	8	5	5	18	PASS	422	TCGA-XF-A8HG	BLCA	69	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2005	NA	-25421	Dead	WITH TUMOR	NA	467	NA	Distant Metastasis	Liver	NA	398	Complete Remission/Response	NA	NA	1	467	1	467	1	398	1	398	
60	TCGA-XF-A8HH	0	10	0	6	2	0	0	0	4	71	9	0	2	51	2	0	TCGA-XF-A8HH-01	104	0.3695488639772617	43	TCGA-XF-A8HH-01	16	14	33	0.08210422283083936	TCGA-XF-A8HH-01	6	3	4	13	PASS	423	TCGA-XF-A8HH	BLCA	61	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2004	NA	-22393	Dead	WITH TUMOR	NA	57	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	57	1	57	NA	NA	1	57	
60	TCGA-XF-A8HI	0	5	0	1	0	2	1	0	3	53	7	0	1	35	0	0	TCGA-XF-A8HI-01	80	0.2148255240436432	27	TCGA-XF-A8HI-01	3	2	15	0.0505693090963333	TCGA-XF-A8HI-01	3	0	0	3	PASS	424	TCGA-XF-A8HI	BLCA	57	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2005	NA	-21059	Dead	WITH TUMOR	NA	544	NA	Distant Metastasis	Lung	NA	468	Progressive Disease	NA	NA	1	544	1	544	NA	NA	1	468	
80	TCGA-XF-A9SG	0	10	2	5	0	3	0	0	10	155	15	0	1	63	1	0	TCGA-XF-A9SG-01	216	0.6731163791680056	121	TCGA-XF-A9SG-01	22	30	71	0.14612325994545236	TCGA-XF-A9SG-01	10	8	4	22	PASS	425	TCGA-XF-A9SG	BLCA	81	MALE	[Unknown]	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-29825	Alive	TUMOR FREE	1479	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1479	0	1479	0	1479	0	1479	
70	TCGA-XF-A9SH	0	1	0	3	0	0	1	0	2	35	1	0	0	16	1	0	TCGA-XF-A9SH-01	166	0.13749407277676942	88	TCGA-XF-A9SH-01	4	4	45	0.0504799361245248	TCGA-XF-A9SH-01	6	5	2	13	PASS	426	TCGA-XF-A9SH	BLCA	65	FEMALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2005	NA	-24060	Dead	WITH TUMOR	NA	1971	NA	Locoregional (Urothelial tumor event)	Lymph Node Only	NA	547	Stable Disease	NA	NA	1	1971	1	1971	NA	NA	1	547	
70	TCGA-XF-A9SI	1	13	1	10	0	1	0	0	17	285	29	1	3	104	6	0	TCGA-XF-A9SI-01	100	0.1897262154395576	44	TCGA-XF-A9SI-01	20	19	175	0.5273125482656992	TCGA-XF-A9SI-01	15	7	10	32	PASS	427	TCGA-XF-A9SI	BLCA	73	FEMALE	ASIAN	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-26719	Alive	TUMOR FREE	2423	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2423	0	2423	0	2423	0	2423	
80	TCGA-XF-A9SJ	0	13	3	7	2	1	0	0	8	225	21	1	3	106	4	1	TCGA-XF-A9SJ-01	165	0.6682212900862299	84	TCGA-XF-A9SJ-01	13	24	95	0.4076786381687799	TCGA-XF-A9SJ-01	19	15	17	51	PASS	428	TCGA-XF-A9SJ	BLCA	83	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2004	NA	-30362	Dead	WITH TUMOR	NA	98	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	98	1	98	NA	NA	1	98	
70	TCGA-XF-A9SK	0	14	1	7	2	0	1	0	8	118	11	0	2	38	1	0	TCGA-XF-A9SK-01	305	0.6644855922874126	190	TCGA-XF-A9SK-01	21	28	126	0.2686459857199142	TCGA-XF-A9SK-01	19	8	8	35	PASS	429	TCGA-XF-A9SK	BLCA	65	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2004	NA	-24019	Dead	WITH TUMOR	NA	486	NA	Distant Metastasis	Bone	NA	382	Stable Disease	NA	NA	1	486	1	486	NA	NA	1	382	
70	TCGA-XF-A9SL	0	3	0	1	0	0	0	0	8	76	8	0	3	21	1	0	TCGA-XF-A9SL-01	51	0.000335755785854672	13	TCGA-XF-A9SL	0	0	0	0	TCGA-XF-A9SL	0	0	0	0	PASS	430	TCGA-XF-A9SL	BLCA	69	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2004	NA	-25460	Dead	TUMOR FREE	NA	2020	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2020	0	2020	NA	NA	0	2020	
80	TCGA-XF-A9SM	1	13	0	9	2	0	0	0	15	190	17	0	0	75	2	0	TCGA-XF-A9SM-01	120	0.35670586256470466	58	TCGA-XF-A9SM-01	15	34	86	0.2825524096852107	TCGA-XF-A9SM-01	15	15	13	43	PASS	431	TCGA-XF-A9SM	BLCA	76	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2004	NA	-27826	Alive	TUMOR FREE	1048	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1048	0	1048	0	1048	0	1048	
60	TCGA-XF-A9SP	1	9	1	10	2	0	1	0	14	238	26	0	2	111	7	0	TCGA-XF-A9SP-01	183	0.5906286861248391	90	TCGA-XF-A9SP-01	25	61	30	0.10734657605841352	TCGA-XF-A9SP-01	21	17	5	43	PASS	432	TCGA-XF-A9SP	BLCA	59	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2004	NA	-21776	Dead	WITH TUMOR	NA	454	NA	Locoregional (Urothelial tumor event)	Renal Pelvis	NA	310	Stable Disease	NA	NA	1	454	1	454	NA	NA	1	310	
70	TCGA-XF-A9ST	0	29	0	21	16	2	5	1	32	428	31	0	9	152	26	1	TCGA-XF-A9ST-01	291	0.5654053666244863	169	TCGA-XF-A9ST-01	10	72	126	0.2645153339125065	TCGA-XF-A9ST-01	27	26	8	61	PASS	433	TCGA-XF-A9ST	BLCA	68	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2005	NA	-25080	Dead	NA	NA	128	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	128	NA	128	NA	NA	0	128	
70	TCGA-XF-A9SU	0	1	0	0	0	2	0	0	2	52	0	0	1	11	2	0	TCGA-XF-A9SU-01	166	0.30394476050184216	90	TCGA-XF-A9SU-01	16	60	63	0.16192046218649256	TCGA-XF-A9SU-01	12	16	2	30	PASS	434	TCGA-XF-A9SU	BLCA	74	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-27068	Dead	WITH TUMOR	NA	182	NA	Distant Metastasis	Liver	NA	103	Progressive Disease	NA	NA	1	182	1	182	NA	NA	1	103	
80	TCGA-XF-A9SV	0	4	0	2	1	1	0	0	5	48	4	0	1	27	5	1	TCGA-XF-A9SV-01	197	0.510337391378085	113	TCGA-XF-A9SV-01	16	55	62	0.20392587225376585	TCGA-XF-A9SV-01	10	12	3	25	PASS	435	TCGA-XF-A9SV	BLCA	82	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-30265	Dead	WITH TUMOR	NA	388	NA	Distant Metastasis	Lung	NA	237	Progressive Disease	NA	NA	1	388	1	388	NA	NA	1	237	
90	TCGA-XF-A9SW	1	7	0	2	1	0	0	0	3	41	1	0	1	25	2	0	TCGA-XF-A9SW-01	106	0.3986018381570273	42	TCGA-XF-A9SW-01	11	13	99	0.3760558334684342	TCGA-XF-A9SW-01	15	11	17	43	PASS	436	TCGA-XF-A9SW	BLCA	85	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-31049	Dead	WITH TUMOR	NA	362	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	362	1	362	NA	NA	1	362	
60	TCGA-XF-A9SX	1	6	0	4	3	1	0	0	5	81	12	0	3	28	1	1	TCGA-XF-A9SX-01	154	0.2280749753279503	81	TCGA-XF-A9SX-01	5	7	55	0.10194327873984277	TCGA-XF-A9SX-01	8	6	6	20	PASS	437	TCGA-XF-A9SX	BLCA	63	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-23349	Dead	WITH TUMOR	NA	719	NA	Distant Metastasis	Lung	NA	475	Progressive Disease	NA	NA	1	719	1	719	NA	NA	1	475	
60	TCGA-XF-A9SY	2	18	1	7	1	1	0	0	16	357	33	0	2	135	4	0	TCGA-XF-A9SY-01	123	0.2786094039854011	63	TCGA-XF-A9SY-01	21	42	109	0.4536049247100109	TCGA-XF-A9SY-01	18	13	13	44	PASS	438	TCGA-XF-A9SY	BLCA	60	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-22212	Alive	WITH TUMOR	640	NA	NA	Distant Metastasis	"Other, specify"	Groin	168	Progressive Disease	NA	NA	0	640	0	640	NA	NA	1	168	
80	TCGA-XF-A9SZ	1	12	1	4	8	0	1	0	5	177	11	0	1	58	2	0	TCGA-XF-A9SZ-01	203	0.3076602807074681	117	TCGA-XF-A9SZ-01	5	14	111	0.2337409285839703	TCGA-XF-A9SZ-01	15	14	12	41	PASS	439	TCGA-XF-A9SZ	BLCA	79	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-29100	Dead	WITH TUMOR	NA	859	NA	Distant Metastasis	Lung	NA	854	Complete Remission/Response	NA	NA	1	859	1	859	NA	NA	1	854	
70	TCGA-XF-A9T0	6	41	4	42	12	1	7	1	42	577	55	0	10	277	15	0	TCGA-XF-A9T0-01	385	0.5030382791437896	244	TCGA-XF-A9T0-01	12	16	157	0.19609325446878145	TCGA-XF-A9T0-01	14	14	6	34	hypermutated sample	440	TCGA-XF-A9T0	BLCA	68	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-25190	Alive	TUMOR FREE	799	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	799	0	799	0	799	0	799	
50	TCGA-XF-A9T2	1	9	0	5	1	2	0	0	4	64	8	0	1	28	2	0	TCGA-XF-A9T2-01	63	3.243938689106157e-05	23	TCGA-XF-A9T2-01	0	0	7	0.01094158117576213	TCGA-XF-A9T2-01	1	1	1	3	PASS	441	TCGA-XF-A9T2	BLCA	54	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-19945	Dead	NA	NA	575	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	575	NA	575	NA	NA	0	575	
70	TCGA-XF-A9T3	1	21	1	18	7	0	1	0	21	309	21	1	2	144	13	1	TCGA-XF-A9T3-01	114	0.4286830590938837	54	TCGA-XF-A9T3-01	14	28	66	0.21542333762366547	TCGA-XF-A9T3-01	16	12	9	37	PASS	442	TCGA-XF-A9T3	BLCA	69	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-25532	Alive	TUMOR FREE	68	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	68	0	68	NA	NA	0	68	
50	TCGA-XF-A9T4	1	3	0	1	0	0	0	0	2	31	2	0	1	10	1	0	TCGA-XF-A9T4-01	197	0.03392128146269725	143	TCGA-XF-A9T4-01	2	4	91	0.06567334577661016	TCGA-XF-A9T4-01	2	1	3	6	PASS	443	TCGA-XF-A9T4	BLCA	48	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-17728	Dead	WITH TUMOR	NA	495	NA	Distant Metastasis	Lung	NA	182	Partial Remission/Response	NA	NA	1	495	1	495	NA	NA	1	182	
80	TCGA-XF-A9T5	2	37	7	26	3	1	0	0	37	543	55	1	14	202	13	1	TCGA-XF-A9T5-01	229	0.6301112038730996	143	TCGA-XF-A9T5-01	24	35	138	0.22878354158696154	TCGA-XF-A9T5-01	11	5	11	27	PASS	444	TCGA-XF-A9T5	BLCA	78	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-28578	Alive	TUMOR FREE	2027	NA	NA	Locoregional (Urothelial tumor event)	"Other, specify"	Vagina	664	Complete Remission/Response	NA	NA	0	2027	0	2027	NA	NA	1	664	
90	TCGA-XF-A9T6	1	16	1	14	8	2	3	1	11	246	14	0	5	88	11	4	TCGA-XF-A9T6-01	268	0.25003957992181525	142	TCGA-XF-A9T6-01	2	7	97	0.18021626651755024	TCGA-XF-A9T6-01	16	21	8	45	PASS	445	TCGA-XF-A9T6	BLCA	88	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-32207	Alive	NA	64	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	64	0	64	NA	NA	0	64	
60	TCGA-XF-A9T8	5	32	1	18	3	0	1	0	31	561	66	0	8	223	1	1	TCGA-XF-A9T8-01	195	0.16226192338956413	110	TCGA-XF-A9T8-01	3	9	84	0.1163275088527572	TCGA-XF-A9T8-01	9	4	7	20	PASS	446	TCGA-XF-A9T8	BLCA	64	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-23403	Dead	NA	NA	418	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	418	NA	418	NA	NA	0	418	
60	TCGA-XF-AAME	0	0	0	0	0	1	0	0	0	20	0	0	0	3	1	0	TCGA-XF-AAME-01	49	0.04756582144709269	14	TCGA-XF-AAME-01	6	11	7	0.035307397547538574	TCGA-XF-AAME-01	7	7	2	16	PASS	447	TCGA-XF-AAME	BLCA	64	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-23448	Dead	WITH TUMOR	NA	2828	NA	Locoregional (Urothelial tumor event)	"Other, specify"	Vagina	1651	Progressive Disease	NA	NA	1	2828	1	2828	NA	NA	1	1651	
70	TCGA-XF-AAMF	0	5	0	2	3	1	0	0	3	63	2	0	0	20	1	0	TCGA-XF-AAMF-01	162	0.39566647455310255	90	TCGA-XF-AAMF-01	10	15	114	0.3130304472358011	TCGA-XF-AAMF-01	14	13	8	35	PASS	448	TCGA-XF-AAMF	BLCA	68	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2004	NA	-25023	Dead	WITH TUMOR	NA	329	NA	Distant Metastasis	Lung	NA	157	Stable Disease	NA	NA	1	329	1	329	NA	NA	1	157	
50	TCGA-XF-AAMG	2	61	2	34	4	2	1	0	34	777	75	2	7	285	21	1	TCGA-XF-AAMG-01	403	0.8082252844890043	246	TCGA-XF-AAMG-01	14	78	136	0.21451339554615986	TCGA-XF-AAMG-01	29	35	7	71	hypermutated sample	449	TCGA-XF-AAMG	BLCA	49	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2004	NA	-18021	Alive	TUMOR FREE	3364	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3364	0	3364	0	3364	0	3364	
80	TCGA-XF-AAMH	0	1	0	2	5	1	0	0	4	43	7	0	0	23	0	0	TCGA-XF-AAMH-01	74	0.2757338466190245	25	TCGA-XF-AAMH-01	6	10	25	0.05464298612507304	TCGA-XF-AAMH-01	2	0	2	4	PASS	450	TCGA-XF-AAMH	BLCA	80	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2005	NA	-29547	Dead	WITH TUMOR	NA	344	NA	Distant Metastasis	"Other, specify"	lumbar spine and right hemipelvis	313	Progressive Disease	NA	NA	1	344	1	344	NA	NA	1	313	
70	TCGA-XF-AAMJ	0	3	0	1	2	1	0	0	0	35	1	0	0	14	1	0	TCGA-XF-AAMJ-01	113	0.2999530385677932	59	TCGA-XF-AAMJ-01	17	17	46	0.17378799462303027	TCGA-XF-AAMJ-01	10	4	7	21	PASS	451	TCGA-XF-AAMJ	BLCA	70	MALE	ASIAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-25838	Dead	TUMOR FREE	NA	1670	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1670	0	1670	0	1670	0	1670	
80	TCGA-XF-AAML	0	25	2	17	4	2	1	0	24	378	43	0	7	163	12	0	TCGA-XF-AAML-01	159	0.770543535020599	87	TCGA-XF-AAML-01	21	24	40	0.09549944738663134	TCGA-XF-AAML-01	15	10	5	30	PASS	452	TCGA-XF-AAML	BLCA	75	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-27422	Dead	TUMOR FREE	NA	232	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	232	0	232	0	232	0	232	
60	TCGA-XF-AAMQ	3	11	0	9	2	1	0	0	12	144	18	0	4	74	2	0	TCGA-XF-AAMQ-01	242	0.5559281830301711	153	TCGA-XF-AAMQ-01	20	25	150	0.3987260477654948	TCGA-XF-AAMQ-01	10	3	8	21	PASS	453	TCGA-XF-AAMQ	BLCA	59	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-21660	Alive	TUMOR FREE	2177	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2177	0	2177	0	2177	0	2177	
50	TCGA-XF-AAMR	1	5	1	7	0	1	2	0	2	80	2	0	0	30	5	0	TCGA-XF-AAMR-01	161	0.2985567383039649	90	TCGA-XF-AAMR-01	15	13	94	0.1903557563754497	TCGA-XF-AAMR-01	4	4	4	12	PASS	454	TCGA-XF-AAMR	BLCA	48	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-17670	Alive	TUMOR FREE	2790	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2790	0	2790	0	2790	0	2790	
80	TCGA-XF-AAMT	1	5	2	2	8	0	1	0	5	80	2	0	0	30	5	0	TCGA-XF-AAMT-01	118	0.7124448289178054	51	TCGA-XF-AAMT-01	11	12	94	0.3460994406293927	TCGA-XF-AAMT-01	8	6	13	27	PASS	455	TCGA-XF-AAMT	BLCA	75	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-27397	Dead	WITH TUMOR	NA	90	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	90	1	90	NA	NA	1	90	
80	TCGA-XF-AAMW	0	2	1	3	1	0	0	0	1	20	2	0	0	11	1	0	TCGA-XF-AAMW-01	533	0.6658070678188382	465	TCGA-XF-AAMW-01	16	14	166	0.07381860413816141	TCGA-XF-AAMW-01	15	2	4	21	PASS	456	TCGA-XF-AAMW	BLCA	79	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-28903	Dead	WITH TUMOR	NA	253	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	253	1	253	NA	NA	1	253	
90	TCGA-XF-AAMX	0	19	3	10	5	2	1	0	12	258	19	0	5	98	9	1	TCGA-XF-AAMX-01	673	0.9319121321054824	455	TCGA-XF-AAMX-01	10	36	405	0.5242610159295135	TCGA-XF-AAMX-01	32	38	31	101	PASS	457	TCGA-XF-AAMX	BLCA	87	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-31884	Dead	TUMOR FREE	NA	206	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	206	0	206	0	206	0	206	
80	TCGA-XF-AAMY	0	2	0	3	3	1	1	0	1	92	6	0	2	37	2	0	TCGA-XF-AAMY-01	267	0.8667824116257499	147	TCGA-XF-AAMY-01	25	34	82	0.10728972844895557	TCGA-XF-AAMY-01	11	7	4	22	PASS	458	TCGA-XF-AAMY	BLCA	78	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-28509	Alive	TUMOR FREE	3011	NA	NA	Distant Metastasis	Lung	NA	637	Complete Remission/Response	NA	NA	0	3011	0	3011	1	637	1	637	
80	TCGA-XF-AAMZ	2	11	2	6	1	0	0	0	8	236	21	1	2	64	2	0	TCGA-XF-AAMZ-01	304	0.69294641415603	191	TCGA-XF-AAMZ-01	24	54	29	0.03280226012989771	TCGA-XF-AAMZ-01	24	15	3	42	PASS	459	TCGA-XF-AAMZ	BLCA	81	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-29667	Dead	WITH TUMOR	NA	1348	NA	Locoregional (Urothelial tumor event)	Lymph Node Only	NA	1344	Partial Remission/Response	NA	NA	1	1348	1	1348	NA	NA	1	1344	
70	TCGA-XF-AAN0	1	27	2	10	3	1	0	0	17	337	32	4	7	119	3	0	TCGA-XF-AAN0-01	114	0.7367034567338634	54	TCGA-XF-AAN0-01	18	14	49	0.1779411468252181	TCGA-XF-AAN0-01	2	0	4	6	PASS	460	TCGA-XF-AAN0	BLCA	68	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-24877	Dead	WITH TUMOR	NA	1718	NA	Locoregional (Urothelial tumor event)	"Other, specify"	Scrotum and Perineum	603	Complete Remission/Response	NA	NA	1	1718	1	1718	NA	NA	1	603	
80	TCGA-XF-AAN1	0	2	1	1	0	1	0	0	3	64	2	0	1	35	1	1	TCGA-XF-AAN1-01	157	0.12814220566021936	92	TCGA-XF-AAN1-01	5	9	83	0.17860156415506592	TCGA-XF-AAN1-01	5	4	6	15	PASS	461	TCGA-XF-AAN1	BLCA	75	FEMALE	[Unknown]	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2006	NA	-27687	Dead	WITH TUMOR	NA	941	NA	Locoregional (Urothelial tumor event)	"Other, specify"	Pelvis and vagina	650	Partial Remission/Response	NA	NA	1	941	1	941	NA	NA	1	650	
70	TCGA-XF-AAN2	3	31	3	17	4	2	1	0	24	350	30	1	12	144	10	0	TCGA-XF-AAN2-01	117	0.6737404246676244	49	TCGA-XF-AAN2-01	12	16	37	0.10430147323946236	TCGA-XF-AAN2-01	10	9	8	27	PASS	462	TCGA-XF-AAN2	BLCA	73	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-26720	Dead	TUMOR FREE	NA	1869	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1869	0	1869	0	1869	0	1869	
80	TCGA-XF-AAN3	1	6	0	9	0	0	0	0	5	120	6	2	5	59	0	0	TCGA-XF-AAN3-01	55	0.471434160806772	16	TCGA-XF-AAN3-01	18	16	78	0.3337708427357602	TCGA-XF-AAN3-01	5	1	5	11	PASS	463	TCGA-XF-AAN3	BLCA	76	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-27909	Alive	TUMOR FREE	2625	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2625	0	2625	NA	NA	0	2625	
80	TCGA-XF-AAN4	0	0	0	1	0	0	0	0	1	40	2	0	2	10	0	0	TCGA-XF-AAN4-01	108	0.011850097986232684	34	TCGA-XF-AAN4-01	1	1	12	0.005287747906687467	TCGA-XF-AAN4-01	1	0	0	1	PASS	464	TCGA-XF-AAN4	BLCA	77	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-28302	Dead	TUMOR FREE	NA	823	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	823	0	823	0	823	0	823	
60	TCGA-XF-AAN5	3	11	3	5	4	3	1	0	17	239	32	0	9	84	7	0	TCGA-XF-AAN5-01	110	0.2604582747738577	43	TCGA-XF-AAN5-01	6	10	51	0.1298634448528412	TCGA-XF-AAN5-01	7	5	3	15	PASS	465	TCGA-XF-AAN5	BLCA	61	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-22411	Alive	TUMOR FREE	2293	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2293	0	2293	0	2293	0	2293	
60	TCGA-XF-AAN7	0	4	1	4	6	1	0	0	3	112	10	0	4	44	1	0	TCGA-XF-AAN7-01	327	0.6017171421414146	222	TCGA-XF-AAN7-01	14	32	76	0.1069276533104152	TCGA-XF-AAN7-01	10	11	2	23	PASS	466	TCGA-XF-AAN7	BLCA	60	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-21951	Dead	WITH TUMOR	NA	565	NA	Locoregional (Urothelial tumor event)	Bladder	NA	321	Complete Remission/Response	NA	NA	1	565	1	565	NA	NA	1	321	
70	TCGA-XF-AAN8	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	TCGA-XF-AAN8-01	86	0.0010436204183572775	38	TCGA-XF-AAN8-01	0	0	4	0.0001527776803443606	TCGA-XF-AAN8-01	0	0	0	0	PASS	467	TCGA-XF-AAN8	BLCA	74	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-27309	Dead	NA	NA	118	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	118	NA	118	NA	NA	0	118	
80	TCGA-YC-A89H	12	80	12	107	16	5	5	1	89	1160	120	0	15	647	30	6	TCGA-YC-A89H-01	134	0.07802600561430073	66	TCGA-YC-A89H-01	4	4	26	0.026546030354376682	TCGA-YC-A89H-01	4	2	2	8	hypermutated sample	468	TCGA-YC-A89H	BLCA	78	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-28741	Alive	TUMOR FREE	573	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	573	0	573	0	573	0	573	
70	TCGA-YC-A8S6	1	0	1	1	3	0	0	0	3	80	9	0	1	23	4	0	TCGA-YC-A8S6-01	49	0.0202143609150727	13	TCGA-YC-A8S6-01	2	1	10	0.01053687255420139	TCGA-YC-A8S6-01	0	2	1	3	PASS	469	TCGA-YC-A8S6	BLCA	71	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-26130	Alive	TUMOR FREE	293	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	293	0	293	0	293	0	293	
70	TCGA-YC-A9TC	1	8	1	0	2	2	0	0	3	101	5	0	2	29	1	0	TCGA-YC-A9TC-01	105	0.036913455572425966	51	TCGA-YC-A9TC-01	1	1	37	0.027950362561313783	TCGA-YC-A9TC-01	2	2	1	5	PASS	470	TCGA-YC-A9TC	BLCA	71	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-26283	Dead	WITH TUMOR	NA	20	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	20	1	20	NA	NA	1	20	
50	TCGA-YF-AA3L	2	21	0	16	16	1	0	0	16	237	17	0	8	84	7	0	TCGA-YF-AA3L-01	328	0.9963146679552448	236	TCGA-YF-AA3L-01	19	23	47	0.122528024536187	TCGA-YF-AA3L-01	11	9	3	23	PASS	471	TCGA-YF-AA3L	BLCA	47	FEMALE	[Unknown]	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-17268	Alive	TUMOR FREE	364	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	364	0	364	0	364	0	364	
60	TCGA-YF-AA3M	1	8	2	7	6	1	1	0	5	114	12	1	5	74	0	0	TCGA-YF-AA3M-01	249	0.8372675269634302	159	TCGA-YF-AA3M-01	23	67	69	0.13386981227450853	TCGA-YF-AA3M-01	21	9	6	36	PASS	472	TCGA-YF-AA3M	BLCA	57	MALE	[Unknown]	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-21097	Alive	WITH TUMOR	415	NA	NA	Locoregional (Urothelial tumor event)	"Other, specify"	Pelvis	381	Complete Remission/Response	NA	NA	0	415	0	415	1	381	1	381	
80	TCGA-ZF-A9R0	1	14	1	5	2	0	1	1	7	155	16	0	2	65	1	0	TCGA-ZF-A9R0-01	195	0.7977165204826758	129	TCGA-ZF-A9R0-01	23	27	147	0.34137017418679466	TCGA-ZF-A9R0-01	15	8	7	30	PASS	473	TCGA-ZF-A9R0	BLCA	82	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-30222	Dead	WITH TUMOR	NA	680	NA	Locoregional (Urothelial tumor event)	"Other, specify"	right hemipelvis	559	Progressive Disease	NA	NA	1	680	1	680	NA	NA	1	559	
80	TCGA-ZF-A9R1	1	5	0	3	2	2	1	0	4	75	4	0	5	28	0	0	TCGA-ZF-A9R1-01	181	0.5063986720604157	97	TCGA-ZF-A9R1-01	11	9	82	0.2401061776532186	TCGA-ZF-A9R1-01	8	12	8	28	PASS	474	TCGA-ZF-A9R1	BLCA	81	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-29610	Alive	WITH TUMOR	773	NA	NA	Distant Metastasis	Bone	NA	758	Complete Remission/Response	NA	NA	0	773	0	773	NA	NA	1	758	
80	TCGA-ZF-A9R2	0	9	0	2	0	0	0	0	5	117	10	0	2	47	4	0	TCGA-ZF-A9R2-01	99	0.6433746275488726	48	TCGA-ZF-A9R2-01	21	22	79	0.3000604831376265	TCGA-ZF-A9R2-01	7	9	4	20	PASS	475	TCGA-ZF-A9R2	BLCA	75	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-27537	Alive	TUMOR FREE	642	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	642	0	642	0	642	0	642	
50	TCGA-ZF-A9R3	1	2	0	3	2	2	0	0	4	68	6	0	3	25	2	0	TCGA-ZF-A9R3-01	92	0.4598670610704238	40	TCGA-ZF-A9R3-01	12	15	51	0.11598910814069704	TCGA-ZF-A9R3-01	6	4	3	13	PASS	476	TCGA-ZF-A9R3	BLCA	53	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-19384	Dead	WITH TUMOR	NA	949	NA	Distant Metastasis	Bone	NA	917	Complete Remission/Response	NA	NA	1	949	1	949	1	917	1	917	
80	TCGA-ZF-A9R4	3	12	4	7	2	2	0	0	8	199	22	0	3	69	1	0	TCGA-ZF-A9R4-01	230	0.7548451431415459	132	TCGA-ZF-A9R4-01	21	20	43	0.11592157588757247	TCGA-ZF-A9R4-01	9	8	5	22	PASS	477	TCGA-ZF-A9R4	BLCA	83	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-30398	Alive	TUMOR FREE	921	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	921	0	921	0	921	0	921	
60	TCGA-ZF-A9R5	0	2	0	2	5	2	0	0	2	79	5	0	1	25	5	2	TCGA-ZF-A9R5-01	65	0.00017692630693663718	24	TCGA-ZF-A9R5-01	0	0	8	0.006892123176556299	TCGA-ZF-A9R5-01	1	1	1	3	PASS	478	TCGA-ZF-A9R5	BLCA	59	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-21811	Alive	TUMOR FREE	1090	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1090	0	1090	0	1090	0	1090	
80	TCGA-ZF-A9R7	1	51	6	27	1	0	0	0	40	549	62	0	6	202	8	2	TCGA-ZF-A9R7-01	215	0.33128930496902737	125	TCGA-ZF-A9R7-01	13	19	82	0.17062444326683088	TCGA-ZF-A9R7-01	9	5	4	18	PASS	479	TCGA-ZF-A9R7	BLCA	76	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011	NA	-28063	Alive	TUMOR FREE	665	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	665	0	665	0	665	0	665	
60	TCGA-ZF-A9R9	4	4	1	2	2	1	0	1	11	152	17	0	2	62	2	0	TCGA-ZF-A9R9-01	198	0.8747924064776046	116	TCGA-ZF-A9R9-01	17	23	19	0.08678415255978728	TCGA-ZF-A9R9-01	11	7	2	20	PASS	480	TCGA-ZF-A9R9	BLCA	58	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-21491	Dead	WITH TUMOR	NA	864	NA	Distant Metastasis	"Other, specify"	penis	629	Complete Remission/Response	NA	NA	1	864	1	864	NA	NA	1	629	
80	TCGA-ZF-A9RC	3	44	10	44	9	6	1	0	38	752	50	0	10	354	18	2	TCGA-ZF-A9RC-01	195	0.675598193592879	106	TCGA-ZF-A9RC-01	25	47	45	0.1332589396314718	TCGA-ZF-A9RC-01	28	14	5	47	hypermutated sample	481	TCGA-ZF-A9RC	BLCA	77	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-28275	Alive	TUMOR FREE	2868	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2868	0	2868	0	2868	0	2868	
80	TCGA-ZF-A9RD	0	11	0	7	0	0	0	0	5	137	13	0	1	64	5	0	TCGA-ZF-A9RD-01	168	0.4857263850839264	84	TCGA-ZF-A9RD-01	18	27	128	0.3690181660042002	TCGA-ZF-A9RD-01	16	6	13	35	PASS	482	TCGA-ZF-A9RD	BLCA	75	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-27496	Dead	NA	NA	408	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	408	NA	408	NA	NA	0	408	
80	TCGA-ZF-A9RE	1	2	1	3	1	1	1	0	3	53	4	1	0	17	1	0	TCGA-ZF-A9RE-01	126	0.4308491422949749	58	TCGA-ZF-A9RE-01	10	9	84	0.2678758520714099	TCGA-ZF-A9RE-01	7	2	6	15	PASS	483	TCGA-ZF-A9RE	BLCA	78	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-28622	Dead	WITH TUMOR	NA	106	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	106	1	106	NA	NA	1	106	
70	TCGA-ZF-A9RF	1	12	1	7	5	2	2	0	7	196	17	1	7	61	4	2	TCGA-ZF-A9RF-01	385	0.6031834382647595	236	TCGA-ZF-A9RF-01	9	33	201	0.3158123623346564	TCGA-ZF-A9RF-01	23	29	18	70	PASS	484	TCGA-ZF-A9RF	BLCA	74	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-27281	Alive	TUMOR FREE	1949	NA	NA	Locoregional (Urothelial tumor event)	Bladder	NA	1565	Complete Remission/Response	NA	NA	0	1949	0	1949	1	1565	1	1565	
70	TCGA-ZF-A9RG	1	10	1	8	1	0	1	0	5	193	16	0	2	82	6	0	TCGA-ZF-A9RG-01	81	0.4948415224366001	29	TCGA-ZF-A9RG-01	19	32	59	0.1813698223419307	TCGA-ZF-A9RG-01	13	13	7	33	PASS	485	TCGA-ZF-A9RG	BLCA	70	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-25656	Alive	WITH TUMOR	1786	NA	NA	Distant Metastasis	"Other, specify"	neck lymph node	440	Complete Remission/Response	NA	NA	0	1786	0	1786	1	440	1	440	
60	TCGA-ZF-A9RL	3	14	2	13	1	1	1	0	17	267	26	2	10	82	8	0	TCGA-ZF-A9RL-01	117	0.8319525914055382	53	TCGA-ZF-A9RL-01	18	18	25	0.0758742297549307	TCGA-ZF-A9RL-01	9	5	2	16	PASS	486	TCGA-ZF-A9RL	BLCA	61	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007	NA	-22480	Alive	TUMOR FREE	2703	NA	NA	Locoregional (Urothelial tumor event)	Bladder	NA	1064	Complete Remission/Response	NA	NA	0	2703	0	2703	1	1064	1	1064	
70	TCGA-ZF-A9RM	0	8	0	0	3	0	0	0	4	72	4	0	2	21	2	0	TCGA-ZF-A9RM-01	279	0.8731896912798653	175	TCGA-ZF-A9RM-01	14	18	69	0.07500391182659563	TCGA-ZF-A9RM-01	15	13	5	33	PASS	487	TCGA-ZF-A9RM	BLCA	70	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-25642	Alive	TUMOR FREE	1455	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1455	0	1455	0	1455	0	1455	
70	TCGA-ZF-A9RN	1	12	1	7	1	2	0	0	3	144	12	0	5	66	5	0	TCGA-ZF-A9RN-01	440	0.917444431307236	320	TCGA-ZF-A9RN-01	20	38	285	0.4086468292558599	TCGA-ZF-A9RN-01	17	12	14	43	PASS	488	TCGA-ZF-A9RN	BLCA	67	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-24795	Dead	WITH TUMOR	NA	615	NA	Distant Metastasis	Lung	NA	516	Partial Remission/Response	NA	NA	1	615	1	615	NA	NA	1	516	
70	TCGA-ZF-AA4N	1	8	3	4	2	1	0	0	9	123	16	0	4	42	5	0	TCGA-ZF-AA4N-01	160	0.4336846151224936	96	TCGA-ZF-AA4N-01	9	7	82	0.25367230450712464	TCGA-ZF-AA4N-01	3	2	1	6	PASS	489	TCGA-ZF-AA4N	BLCA	74	MALE	WHITE	Stage II	NA	NA	High Grade	2011	NA	-27056	Dead	WITH TUMOR	NA	88	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	88	1	88	NA	NA	1	88	
70	TCGA-ZF-AA4R	0	3	0	0	3	1	1	0	3	52	4	0	0	18	0	0	TCGA-ZF-AA4R-01	186	0.3897299095212887	107	TCGA-ZF-AA4R-01	8	14	78	0.22669419581443265	TCGA-ZF-AA4R-01	13	11	9	33	PASS	490	TCGA-ZF-AA4R	BLCA	67	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-24537	Dead	WITH TUMOR	NA	1036	NA	Locoregional (Urothelial tumor event)	Lymph Node Only	NA	750	[Unknown]	NA	NA	1	1036	1	1036	NA	NA	1	750	
70	TCGA-ZF-AA4T	0	7	0	1	1	3	0	0	5	83	2	0	0	28	0	0	TCGA-ZF-AA4T-01	384	0.7532430116677649	217	TCGA-ZF-AA4T-01	20	47	132	0.30908662715658064	TCGA-ZF-AA4T-01	29	18	14	61	PASS	491	TCGA-ZF-AA4T	BLCA	65	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-23974	Dead	WITH TUMOR	NA	599	NA	Distant Metastasis	Lung	NA	511	[Unknown]	NA	NA	1	599	1	599	NA	NA	1	511	
70	TCGA-ZF-AA4U	0	5	0	2	1	0	0	0	3	45	5	0	1	22	2	0	TCGA-ZF-AA4U-01	205	0.9983372618000209	113	TCGA-ZF-AA4U-01	16	14	49	0.057757362712591735	TCGA-ZF-AA4U-01	7	4	3	14	PASS	492	TCGA-ZF-AA4U	BLCA	70	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-25682	Dead	WITH TUMOR	NA	262	NA	Distant Metastasis	Bone	NA	199	Progressive Disease	NA	NA	1	262	1	262	NA	NA	1	199	
70	TCGA-ZF-AA4V	2	41	5	26	10	1	0	0	36	513	34	1	13	237	12	2	TCGA-ZF-AA4V-01	250	0.9078471248985338	146	TCGA-ZF-AA4V-01	22	40	91	0.21257278807392369	TCGA-ZF-AA4V-01	15	11	11	37	PASS	493	TCGA-ZF-AA4V	BLCA	66	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008	NA	-24448	Alive	TUMOR FREE	1806	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1806	0	1806	0	1806	0	1806	
60	TCGA-ZF-AA4W	2	19	1	15	43	25	3	0	10	393	25	0	5	148	10	0	TCGA-ZF-AA4W-01	124	0.327050204171841	61	TCGA-ZF-AA4W-01	12	11	77	0.2194216203454712	TCGA-ZF-AA4W-01	13	6	9	28	PASS	494	TCGA-ZF-AA4W	BLCA	56	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-20611	Alive	NA	1830	NA	NA	Locoregional (Urothelial tumor event)	"Other, specify"	penile urethra	1679	Complete Remission/Response	NA	NA	0	1830	0	1830	1	1679	1	1679	
60	TCGA-ZF-AA4X	2	35	2	20	1	1	0	1	30	505	53	0	7	201	10	2	TCGA-ZF-AA4X-01	79	0.7383459950576177	24	TCGA-ZF-AA4X-01	14	21	6	0.01089529652112262	TCGA-ZF-AA4X-01	6	10	1	17	PASS	495	TCGA-ZF-AA4X	BLCA	56	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-20579	Alive	WITH TUMOR	2044	NA	NA	Locoregional (Urothelial tumor event)	Bladder	NA	1665	Complete Remission/Response	NA	NA	0	2044	0	2044	1	1665	1	1665	
70	TCGA-ZF-AA51	3	38	5	22	7	2	2	0	27	530	60	2	13	204	9	1	TCGA-ZF-AA51-01	371	0.6868848684070371	250	TCGA-ZF-AA51-01	23	32	108	0.2275388171595792	TCGA-ZF-AA51-01	21	21	9	51	PASS	496	TCGA-ZF-AA51	BLCA	69	FEMALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-25484	Alive	TUMOR FREE	1714	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1714	0	1714	0	1714	0	1714	
70	TCGA-ZF-AA52	1	8	0	2	0	3	0	0	4	95	4	0	3	39	1	0	TCGA-ZF-AA52-01	73	0.5758810466256383	30	TCGA-ZF-AA52-01	24	60	25	0.09596272184526496	TCGA-ZF-AA52-01	8	4	3	15	PASS	497	TCGA-ZF-AA52	BLCA	70	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-25579	Dead	NA	NA	1077	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	1077	NA	1077	NA	NA	0	1077	
60	TCGA-ZF-AA53	1	12	0	4	3	1	0	0	7	141	14	0	0	60	3	0	TCGA-ZF-AA53-01	183	0.32673679987008103	99	TCGA-ZF-AA53-01	20	32	39	0.07260869098513638	TCGA-ZF-AA53-01	15	18	6	39	PASS	498	TCGA-ZF-AA53	BLCA	60	MALE	WHITE	Stage II	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-22035	Alive	TUMOR FREE	1761	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1761	0	1761	0	1761	0	1761	
70	TCGA-ZF-AA54	1	9	1	5	4	0	1	0	13	142	17	1	1	51	7	0	TCGA-ZF-AA54-01	156	0.5779743858622511	81	TCGA-ZF-AA54-01	21	32	83	0.3349463807643128	TCGA-ZF-AA54-01	17	5	12	34	PASS	499	TCGA-ZF-AA54	BLCA	71	MALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009	NA	-26128	Dead	NA	NA	590	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	590	NA	590	NA	NA	0	590	
80	TCGA-ZF-AA56	0	2	0	1	0	3	0	0	3	91	4	0	1	23	3	0	TCGA-ZF-AA56-01	154	0.393781785515967	86	TCGA-ZF-AA56-01	12	28	91	0.2774866215180105	TCGA-ZF-AA56-01	15	12	10	37	PASS	500	TCGA-ZF-AA56	BLCA	79	FEMALE	WHITE	Stage III	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-28937	Dead	WITH TUMOR	NA	259	NA	Distant Metastasis	Liver	NA	248	Progressive Disease	NA	NA	1	259	1	259	NA	NA	1	248	
60	TCGA-ZF-AA58	1	8	2	7	2	0	0	0	9	179	14	1	0	64	5	0	TCGA-ZF-AA58-01	196	0.4945178287666874	115	TCGA-ZF-AA58-01	10	44	109	0.37421503457629296	TCGA-ZF-AA58-01	24	19	19	62	PASS	501	TCGA-ZF-AA58	BLCA	61	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010	NA	-22549	Alive	TUMOR FREE	1649	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1649	0	1649	NA	NA	0	1649	
60	TCGA-ZF-AA5H	2	3	1	1	0	1	0	0	2	49	3	0	1	20	2	0	TCGA-ZF-AA5H-01	251	0.7657773596808977	141	TCGA-ZF-AA5H-01	20	38	98	0.25362790481657993	TCGA-ZF-AA5H-01	18	12	13	43	PASS	502	TCGA-ZF-AA5H	BLCA	60	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012	NA	-22122	Alive	WITH TUMOR	897	NA	NA	Locoregional (Urothelial tumor event)	"Other, specify"	peritoneum	177	Stable Disease	NA	NA	0	897	0	897	NA	NA	1	177	
60	TCGA-ZF-AA5N	0	2	0	1	5	1	0	0	3	41	1	1	1	13	0	0	TCGA-ZF-AA5N-01	58	0.05664451370999851	19	TCGA-ZF-AA5N-01	3	3	10	0.012615073566103523	TCGA-ZF-AA5N-01	2	1	1	4	PASS	503	TCGA-ZF-AA5N	BLCA	62	FEMALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-22741	Dead	WITH TUMOR	NA	168	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	168	1	168	NA	NA	1	168	
70	TCGA-ZF-AA5P	0	1	0	0	2	0	0	0	0	46	2	0	0	19	1	0	TCGA-ZF-AA5P-01	131	0.0798523772920181	63	TCGA-ZF-AA5P	0	0	0	0	TCGA-ZF-AA5P	0	0	0	0	PASS	504	TCGA-ZF-AA5P	BLCA	65	MALE	WHITE	Stage IV	NA	Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013	NA	-23971	Alive	TUMOR FREE	372	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	372	0	372	NA	NA	0	372	
60	TCGA-3C-AAAU	1	8	2	2	0	2	0	0	1	17	1	0	3	11	2	0	TCGA-3C-AAAU-01	313	0.9998649382904372	193	TCGA-3C-AAAU-01	19	32	51	0.157576402746089	TCGA-3C-AAAU-01	6	5	4	15	PASS	505	TCGA-3C-AAAU	BRCA	55	FEMALE	WHITE	Stage X	NA	Infiltrating Lobular Carcinoma	NA	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-20211	Alive	WITH TUMOR	4047	NA	NA	Distant Metastasis	Lung	NA	1808	NA	Negative	NA	0	4047	0	4047	1	1808	1	1808	
50	TCGA-3C-AALI	14	109	5	38	2	2	0	0	50	399	35	0	19	143	7	1	TCGA-3C-AALI-01	298	0.7296934253023086	173	TCGA-3C-AALI-01	22	31	89	0.18594037200618507	TCGA-3C-AALI-01	12	12	8	32	PASS	506	TCGA-3C-AALI	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18538	Alive	TUMOR FREE	4005	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	4005	0	4005	0	4005	0	4005	
60	TCGA-3C-AALJ	2	19	2	4	2	1	2	0	10	22	0	0	1	6	1	0	TCGA-3C-AALJ-01	483	0.5852082988324235	311	TCGA-3C-AALJ-01	13	23	133	0.1359763490286086	TCGA-3C-AALJ-01	14	11	6	31	PASS	507	TCGA-3C-AALJ	BRCA	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22848	Alive	TUMOR FREE	1474	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1474	0	1474	0	1474	0	1474	
50	TCGA-3C-AALK	0	8	2	2	2	1	0	0	3	39	2	0	2	7	1	0	TCGA-3C-AALK-01	104	0.095868136463929	49	TCGA-3C-AALK-01	4	4	18	0.030413949007338726	TCGA-3C-AALK-01	3	1	3	7	PASS	508	TCGA-3C-AALK	BRCA	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2011	[Unknown]	-19074	Alive	TUMOR FREE	1448	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	1448	0	1448	NA	NA	0	1448	
50	TCGA-4H-AAAK	0	7	0	2	0	0	0	0	2	18	1	0	1	5	1	0	TCGA-4H-AAAK-01	109	0.23680294965282506	56	TCGA-4H-AAAK-01	7	9	39	0.06039923799614584	TCGA-4H-AAAK-01	6	6	4	16	PASS	509	TCGA-4H-AAAK	BRCA	50	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18371	Alive	TUMOR FREE	348	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	348	0	348	0	348	0	348	
40	TCGA-5L-AAT0	2	44	2	19	0	1	1	0	15	120	11	1	3	63	0	0	TCGA-5L-AAT0-01	101	0.07022695216972101	50	TCGA-5L-AAT0-01	3	3	44	0.04412667577147755	TCGA-5L-AAT0-01	3	3	3	9	PASS	510	TCGA-5L-AAT0	BRCA	42	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-15393	Alive	TUMOR FREE	1477	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	1477	0	1477	NA	NA	0	1477	
60	TCGA-5L-AAT1	17	310	21	113	0	3	0	0	97	884	125	3	45	360	17	3	TCGA-5L-AAT1	0	0	0	TCGA-5L-AAT1	0	0	0	0	TCGA-5L-AAT1	0	0	0	0	hypermutated sample	511	TCGA-5L-AAT1	BRCA	63	FEMALE	WHITE	Stage IV	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23225	Alive	WITH TUMOR	1471	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1471	0	1471	NA	NA	0	1471	
50	TCGA-5T-A9QA	2	8	2	3	1	0	0	0	2	49	2	0	1	20	3	0	TCGA-5T-A9QA-01	216	0.41386592140718975	140	TCGA-5T-A9QA-01	14	21	64	0.1501605830871488	TCGA-5T-A9QA-01	7	2	6	15	PASS	512	TCGA-5T-A9QA	BRCA	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	"Other, specify"	NA	2013	[Unknown]	-19031	Alive	NA	303	NA	NA	NA	NA	NA	NA	NA	[Unknown]	NA	0	303	0	303	NA	NA	0	303	
70	TCGA-A1-A0SB	0	0	0	0	0	2	0	0	1	13	0	0	0	3	0	0	TCGA-A1-A0SB-01	65	0.00080166510216155	24	TCGA-A1-A0SB-01	0	0	2	0.000806390863909578	TCGA-A1-A0SB-01	0	0	0	0	PASS	513	TCGA-A1-A0SB	BRCA	70	FEMALE	WHITE	Stage I	NA	"Other, specify"	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25833	Alive	TUMOR FREE	259	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	259	0	259	0	259	0	259	
60	TCGA-A1-A0SD	0	2	0	1	0	2	2	0	1	28	1	0	0	7	0	0	TCGA-A1-A0SD-01	119	0.2914986670344897	63	TCGA-A1-A0SD-01	11	14	26	0.22175024519023773	TCGA-A1-A0SD-01	9	7	9	25	PASS	514	TCGA-A1-A0SD	BRCA	59	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2005	NA	-21793	Alive	NA	437	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	437	0	437	0	437	0	437	
60	TCGA-A1-A0SE	0	1	0	0	0	1	1	0	0	23	3	0	0	10	0	0	TCGA-A1-A0SE-01	111	0.2465764737310181	52	TCGA-A1-A0SE-01	10	11	12	0.16681852184649354	TCGA-A1-A0SE-01	8	1	6	15	PASS	515	TCGA-A1-A0SE	BRCA	56	FEMALE	WHITE	Stage I	NA	Mixed Histology (please specify)	NA	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-20717	Alive	TUMOR FREE	1321	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1321	0	1321	0	1321	0	1321	
50	TCGA-A1-A0SF	1	2	0	1	1	0	0	0	1	43	3	0	0	14	1	0	TCGA-A1-A0SF-01	121	0.3947512758840627	77	TCGA-A1-A0SF-01	14	20	21	0.1103783806754913	TCGA-A1-A0SF-01	8	8	7	23	PASS	516	TCGA-A1-A0SF	BRCA	54	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19731	Alive	TUMOR FREE	1463	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1463	0	1463	0	1463	0	1463	
60	TCGA-A1-A0SG	0	1	0	0	0	1	0	0	1	25	1	0	1	7	0	0	TCGA-A1-A0SG-01	89	0.12925576427223098	40	TCGA-A1-A0SG-01	4	4	16	0.0447987935818295	TCGA-A1-A0SG-01	4	5	3	12	PASS	517	TCGA-A1-A0SG	BRCA	61	FEMALE	WHITE	Stage IIB	NA	"Other, specify"	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22380	Alive	NA	434	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	434	0	434	0	434	0	434	
40	TCGA-A1-A0SH	0	10	0	4	2	0	1	0	9	79	8	0	1	28	1	0	TCGA-A1-A0SH-01	135	0.1824998418922528	64	TCGA-A1-A0SH-01	2	6	11	0.08417822837348674	TCGA-A1-A0SH-01	11	13	8	32	PASS	518	TCGA-A1-A0SH	BRCA	39	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14595	Alive	TUMOR FREE	1437	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1437	0	1437	0	1437	0	1437	
50	TCGA-A1-A0SI	0	11	2	11	0	0	1	0	11	149	18	0	3	66	6	1	TCGA-A1-A0SI-01	57	0.3858656999520598	13	TCGA-A1-A0SI-01	15	14	13	0.2450303593214955	TCGA-A1-A0SI-01	6	3	4	13	PASS	519	TCGA-A1-A0SI	BRCA	52	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	NA	-19250	Alive	TUMOR FREE	635	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	635	0	635	0	635	0	635	
40	TCGA-A1-A0SJ	0	2	0	0	2	0	0	0	1	27	2	0	0	8	0	0	TCGA-A1-A0SJ-01	417	0.787482186184291	280	TCGA-A1-A0SJ-01	24	23	76	0.17180905771579771	TCGA-A1-A0SJ-01	12	3	7	22	PASS	520	TCGA-A1-A0SJ	BRCA	39	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2006	NA	-14383	Alive	TUMOR FREE	416	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	416	0	416	0	416	0	416	
50	TCGA-A1-A0SK	1	4	0	2	2	0	1	0	3	53	2	0	2	17	1	0	TCGA-A1-A0SK-01	314	0.8400316386102663	208	TCGA-A1-A0SK-01	16	25	34	0.21106972274277955	TCGA-A1-A0SK-01	13	14	6	33	PASS	521	TCGA-A1-A0SK	BRCA	54	FEMALE	ASIAN	Stage IIA	NA	"Other, specify"	NA	2007	Indeterminate (neither Pre or Postmenopausal)	-20048	Dead	WITH TUMOR	NA	967	NA	NA	NA	NA	NA	NA	Negative	NA	1	967	1	967	NA	NA	1	967	
80	TCGA-A1-A0SM	0	1	1	0	1	0	0	0	1	16	2	0	1	11	0	0	TCGA-A1-A0SM-01	117	0.18079124234719496	60	TCGA-A1-A0SM-01	3	7	13	0.08457575742498367	TCGA-A1-A0SM-01	6	3	5	14	PASS	522	TCGA-A1-A0SM	BRCA	77	MALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	NA	-28198	Alive	TUMOR FREE	242	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	242	0	242	0	242	0	242	
50	TCGA-A1-A0SN	1	5	1	2	2	0	0	0	2	45	3	0	1	17	1	0	TCGA-A1-A0SN-01	216	0.6574112223176801	124	TCGA-A1-A0SN-01	18	30	30	0.18255533922721587	TCGA-A1-A0SN-01	7	2	1	10	PASS	523	TCGA-A1-A0SN	BRCA	50	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18401	Alive	TUMOR FREE	1196	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1196	0	1196	0	1196	0	1196	
70	TCGA-A1-A0SO	1	17	4	9	14	0	4	0	7	229	14	0	4	76	7	0	TCGA-A1-A0SO-01	555	0.9170255366727076	355	TCGA-A1-A0SO	0	0	0	0	TCGA-A1-A0SO-01	27	29	26	82	PASS	524	TCGA-A1-A0SO	BRCA	67	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24826	Alive	TUMOR FREE	852	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	852	0	852	0	852	0	852	
40	TCGA-A1-A0SP	0	4	1	2	3	0	0	0	1	42	5	0	2	14	1	0	TCGA-A1-A0SP-01	327	0.5967311764425733	196	TCGA-A1-A0SP-01	13	14	41	0.300100352877374	TCGA-A1-A0SP-01	10	3	6	19	PASS	525	TCGA-A1-A0SP	BRCA	40	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	NA	-14954	Alive	TUMOR FREE	584	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	584	0	584	0	584	0	584	
50	TCGA-A1-A0SQ	0	3	0	4	0	2	0	0	0	19	2	0	1	9	0	0	TCGA-A1-A0SQ-01	144	0.10944553181030868	82	TCGA-A1-A0SQ-01	3	4	21	0.06403080802375953	TCGA-A1-A0SQ-01	5	1	2	8	mutation call filter	526	TCGA-A1-A0SQ	BRCA	45	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16458	Alive	TUMOR FREE	554	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	554	0	554	0	554	0	554	
70	TCGA-A2-A04N	0	1	0	2	3	0	1	0	1	33	2	0	0	12	2	0	TCGA-A2-A04N-01	63	0.08617808829673873	25	TCGA-A2-A04N-01	3	5	3	0.0267984227931948	TCGA-A2-A04N-01	4	1	2	7	PASS	527	TCGA-A2-A04N	BRCA	66	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24155	Alive	TUMOR FREE	4354	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	4354	0	4354	0	4354	0	4354	
40	TCGA-A2-A04P	0	6	2	7	6	0	3	0	7	105	4	0	5	29	6	0	TCGA-A2-A04P-01	467	0.7482038995353704	308	TCGA-A2-A04P-01	9	30	111	0.4103730552563393	TCGA-A2-A04P-01	28	33	22	83	mutation call filter	528	TCGA-A2-A04P	BRCA	36	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13238	Dead	WITH TUMOR	NA	548	NA	Distant Metastasis	Bone	NA	102	NA	Positive	NA	1	548	1	548	NA	NA	1	102	
50	TCGA-A2-A04Q	0	4	0	1	0	1	0	1	2	38	2	0	0	19	3	0	TCGA-A2-A04Q-01	97	0.21283554182610198	38	TCGA-A2-A04Q-01	11	21	16	0.41652218860336815	TCGA-A2-A04Q-01	7	5	4	16	mutation call filter	529	TCGA-A2-A04Q	BRCA	48	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17660	Alive	TUMOR FREE	2385	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2385	0	2385	0	2385	0	2385	
40	TCGA-A2-A04R	0	6	1	3	3	0	0	0	2	64	4	0	0	21	5	0	TCGA-A2-A04R-01	185	0.5295740931551484	103	TCGA-A2-A04R-01	5	13	22	0.2074912881488446	TCGA-A2-A04R-01	13	12	11	36	PASS	530	TCGA-A2-A04R	BRCA	36	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13483	Alive	TUMOR FREE	3709	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3709	0	3709	0	3709	0	3709	
60	TCGA-A2-A04T	1	5	0	7	3	2	3	0	1	67	5	0	2	25	6	0	TCGA-A2-A04T-01	414	0.8638740520486273	267	TCGA-A2-A04T-01	14	36	103	0.5478801092806679	TCGA-A2-A04T-01	30	24	23	77	mutation call filter	531	TCGA-A2-A04T	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22707	Alive	TUMOR FREE	2246	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2246	0	2246	0	2246	0	2246	
50	TCGA-A2-A04U	0	3	1	2	3	0	0	0	0	46	0	0	1	15	0	0	TCGA-A2-A04U-01	1602	0.8101520657483712	1095	TCGA-A2-A04U-01	21	45	559	0.5174715763421572	TCGA-A2-A04U-01	28	17	14	59	PASS	532	TCGA-A2-A04U	BRCA	47	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2004	Peri (6-12 months since last menstrual period)	-17474	Alive	TUMOR FREE	2654	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2654	0	2654	0	2654	0	2654	
40	TCGA-A2-A04V	0	4	0	2	1	2	1	0	4	19	2	0	0	9	0	0	TCGA-A2-A04V-01	198	0.11340540107912918	122	TCGA-A2-A04V-01	6	5	18	0.07092973226969157	TCGA-A2-A04V-01	5	1	4	10	mutation call filter	533	TCGA-A2-A04V	BRCA	39	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14250	Dead	WITH TUMOR	NA	1920	NA	NA	NA	NA	1470	NA	Negative	NA	1	1920	1	1920	1	1470	1	1470	
50	TCGA-A2-A04W	1	8	1	6	1	0	0	0	2	105	15	0	4	43	4	0	TCGA-A2-A04W-01	394	0.4661552452196828	248	TCGA-A2-A04W-01	17	27	43	0.21683857373467494	TCGA-A2-A04W-01	8	8	6	22	PASS	534	TCGA-A2-A04W	BRCA	50	FEMALE	WHITE	Stage IIB	NA	"Other, specify"	NA	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18345	Alive	TUMOR FREE	3102	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3102	0	3102	0	3102	0	3102	
30	TCGA-A2-A04X	1	6	1	3	1	0	1	0	1	21	2	0	2	14	1	0	TCGA-A2-A04X-01	247	0.256104393968067	167	TCGA-A2-A04X-01	8	7	50	0.17829766050950366	TCGA-A2-A04X-01	6	8	4	18	mutation call filter	535	TCGA-A2-A04X	BRCA	34	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12642	Alive	TUMOR FREE	1686	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1686	0	1686	0	1686	0	1686	
50	TCGA-A2-A04Y	0	3	0	4	2	1	1	0	0	41	1	0	1	10	2	0	TCGA-A2-A04Y-01	287	0.16666325450112854	184	TCGA-A2-A04Y-01	4	6	25	0.0569700824137408	TCGA-A2-A04Y-01	9	6	5	20	mutation call filter	536	TCGA-A2-A04Y	BRCA	53	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19533	Alive	TUMOR FREE	1099	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1099	0	1099	0	1099	0	1099	
60	TCGA-A2-A0CK	0	7	0	0	0	2	0	0	1	9	1	0	1	12	0	0	TCGA-A2-A0CK-01	81	0.1005204481037682	39	TCGA-A2-A0CK-01	4	4	7	0.053198917343901635	TCGA-A2-A0CK-01	4	0	3	7	PASS	537	TCGA-A2-A0CK	BRCA	60	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2001	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22094	Alive	TUMOR FREE	4159	NA	NA	New Primary Tumor	"Other, specify"	LEFT BREAST	1364	NA	Negative	NA	0	4159	0	4159	1	1364	1	1364	
40	TCGA-A2-A0CL	1	9	1	6	0	0	0	0	6	107	21	0	3	50	1	0	TCGA-A2-A0CL-01	287	0.2953317697401655	163	TCGA-A2-A0CL-01	25	31	70	0.3966320576379245	TCGA-A2-A0CL-01	13	15	10	38	PASS	538	TCGA-A2-A0CL	BRCA	37	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13556	Alive	TUMOR FREE	3015	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	3015	0	3015	NA	NA	0	3015	
40	TCGA-A2-A0CM	0	2	0	2	4	1	0	0	2	41	5	0	2	16	1	0	TCGA-A2-A0CM-01	386	0.7202012779607874	280	TCGA-A2-A0CM-01	24	50	48	0.29098638165061	TCGA-A2-A0CM-01	19	14	7	40	mutation call filter	539	TCGA-A2-A0CM	BRCA	40	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14969	Dead	WITH TUMOR	NA	754	NA	NA	NA	NA	382	NA	Negative	NA	1	754	1	754	1	382	1	382	
90	TCGA-A2-A0CO	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A2-A0CO-01	62	0.1808548706397106	19	TCGA-A2-A0CO-01	8	6	8	0.14206892779732844	TCGA-A2-A0CO-01	6	2	5	13	PASS	540	TCGA-A2-A0CO	BRCA	85	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31404	Dead	TUMOR FREE	NA	3492	NA	NA	NA	NA	NA	NA	Positive	NA	1	3492	0	3492	NA	NA	0	3492	
60	TCGA-A2-A0CP	0	4	0	2	0	1	0	0	2	31	2	0	0	7	3	0	TCGA-A2-A0CP-01	109	0.08700564702637417	59	TCGA-A2-A0CP-01	5	5	4	0.04080327497619824	TCGA-A2-A0CP-01	3	0	2	5	mutation call filter	541	TCGA-A2-A0CP	BRCA	60	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22133	Alive	TUMOR FREE	2813	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2813	0	2813	0	2813	0	2813	
60	TCGA-A2-A0CQ	0	4	1	3	0	0	0	0	0	27	2	0	0	13	1	0	TCGA-A2-A0CQ-01	47	0.11975934265071662	12	TCGA-A2-A0CQ-01	5	4	4	0.07875226100022609	TCGA-A2-A0CQ-01	3	0	1	4	mutation call filter	542	TCGA-A2-A0CQ	BRCA	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22810	Alive	TUMOR FREE	2695	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2695	0	2695	0	2695	0	2695	
50	TCGA-A2-A0CR	2	30	2	10	0	0	1	0	8	117	8	0	3	38	2	0	TCGA-A2-A0CR-01	57	0.08904092352900872	19	TCGA-A2-A0CR-01	6	4	4	0.12616845287329226	TCGA-A2-A0CR-01	0	1	1	2	PASS	543	TCGA-A2-A0CR	BRCA	54	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20075	Alive	TUMOR FREE	3283	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	3283	0	3283	NA	NA	0	3283	
70	TCGA-A2-A0CS	0	4	1	3	4	3	0	0	4	20	2	0	1	13	2	0	TCGA-A2-A0CS-01	67	0.8528352659285905	21	TCGA-A2-A0CS-01	17	21	4	0.13351724330190584	TCGA-A2-A0CS-01	2	0	1	3	PASS	544	TCGA-A2-A0CS	BRCA	73	FEMALE	WHITE	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26817	Dead	TUMOR FREE	NA	2348	NA	NA	NA	NA	NA	NA	Positive	NA	1	2348	0	2348	NA	NA	0	2348	
70	TCGA-A2-A0CT	0	6	1	4	0	0	1	1	3	72	4	0	3	30	1	0	TCGA-A2-A0CT-01	168	0.9144743697777676	90	TCGA-A2-A0CT-01	25	56	33	0.2821521235956116	TCGA-A2-A0CT-01	12	10	8	30	mutation call filter	545	TCGA-A2-A0CT	BRCA	71	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25959	Alive	TUMOR FREE	2289	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2289	0	2289	0	2289	0	2289	
70	TCGA-A2-A0CU	2	2	0	1	2	2	0	0	2	33	1	0	0	16	3	0	TCGA-A2-A0CU-01	171	0.5461074361189663	104	TCGA-A2-A0CU-01	20	25	32	0.18095557518525693	TCGA-A2-A0CU-01	8	9	4	21	mutation call filter	546	TCGA-A2-A0CU	BRCA	73	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26823	Dead	TUMOR FREE	NA	158	NA	NA	NA	NA	NA	NA	Close	NA	1	158	0	158	NA	NA	0	158	
40	TCGA-A2-A0CV	0	0	0	0	0	0	0	0	1	19	2	0	0	4	1	0	TCGA-A2-A0CV-01	73	0.6144774764093518	20	TCGA-A2-A0CV-01	24	20	6	0.2041255645138499	TCGA-A2-A0CV-01	2	0	1	3	PASS	547	TCGA-A2-A0CV	BRCA	41	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-15289	Alive	TUMOR FREE	3011	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3011	0	3011	0	3011	0	3011	
70	TCGA-A2-A0CW	2	4	0	1	3	1	0	0	4	54	2	0	2	19	1	0	TCGA-A2-A0CW-01	419	0.9174145959032326	272	TCGA-A2-A0CW-01	15	23	92	0.21123863835536394	TCGA-A2-A0CW-01	19	13	12	44	PASS	548	TCGA-A2-A0CW	BRCA	67	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24541	Alive	TUMOR FREE	3283	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3283	0	3283	0	3283	0	3283	
50	TCGA-A2-A0CX	4	23	0	4	1	0	0	0	17	219	20	0	4	76	3	0	TCGA-A2-A0CX-01	216	0.5479899394590235	147	TCGA-A2-A0CX-01	19	28	55	0.1462339976073988	TCGA-A2-A0CX-01	11	5	5	21	mutation call filter	549	TCGA-A2-A0CX	BRCA	52	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19152	Alive	TUMOR FREE	1728	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1728	0	1728	0	1728	0	1728	
60	TCGA-A2-A0CY	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A2-A0CY	0	0	0	TCGA-A2-A0CY	0	0	0	0	TCGA-A2-A0CY	0	0	0	0	PASS	550	TCGA-A2-A0CY	BRCA	63	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23229	Alive	TUMOR FREE	1673	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1673	0	1673	0	1673	0	1673	
50	TCGA-A2-A0CZ	1	1	1	0	3	1	0	0	2	19	1	0	0	3	0	0	TCGA-A2-A0CZ	0	0	0	TCGA-A2-A0CZ	0	0	0	0	TCGA-A2-A0CZ	0	0	0	0	mutation call filter	551	TCGA-A2-A0CZ	BRCA	46	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Peri (6-12 months since last menstrual period)	-17026	Alive	TUMOR FREE	1616	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	1616	0	1616	NA	NA	0	1616	
60	TCGA-A2-A0D0	1	8	1	3	4	0	1	0	3	61	4	0	1	23	4	0	TCGA-A2-A0D0-01	565	0.870993255135885	349	TCGA-A2-A0D0-01	17	29	167	0.4879175428331475	TCGA-A2-A0D0-01	24	28	10	62	mutation call filter	552	TCGA-A2-A0D0	BRCA	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22115	Alive	TUMOR FREE	2048	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2048	0	2048	0	2048	0	2048	
80	TCGA-A2-A0D1	0	6	1	1	3	1	0	0	6	35	5	0	0	21	0	0	TCGA-A2-A0D1-01	356	0.9184553200200992	245	TCGA-A2-A0D1-01	10	14	64	0.22272982133638114	TCGA-A2-A0D1-01	12	6	12	30	mutation call filter	553	TCGA-A2-A0D1	BRCA	76	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28084	Alive	TUMOR FREE	1051	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1051	0	1051	0	1051	0	1051	
50	TCGA-A2-A0D2	0	8	0	2	5	0	1	0	2	68	2	0	0	25	3	0	TCGA-A2-A0D2-01	455	0.9710601739635352	299	TCGA-A2-A0D2-01	13	22	182	0.6937758074783251	TCGA-A2-A0D2-01	26	32	15	73	mutation call filter	554	TCGA-A2-A0D2	BRCA	45	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16623	Alive	TUMOR FREE	1027	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1027	0	1027	0	1027	0	1027	
40	TCGA-A2-A0D3	0	3	0	0	2	2	0	0	0	17	4	0	1	10	0	0	TCGA-A2-A0D3-01	59	0.1107517471603397	17	TCGA-A2-A0D3-01	5	6	19	0.015826308469610518	TCGA-A2-A0D3-01	3	0	1	4	PASS	555	TCGA-A2-A0D3	BRCA	42	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-15524	Alive	TUMOR FREE	1873	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1873	0	1873	0	1873	0	1873	
40	TCGA-A2-A0D4	0	1	0	0	1	2	0	0	3	31	1	0	0	9	0	0	TCGA-A2-A0D4-01	290	0.9313258222089988	194	TCGA-A2-A0D4-01	19	20	49	0.22829623437410884	TCGA-A2-A0D4-01	15	4	12	31	mutation call filter	556	TCGA-A2-A0D4	BRCA	37	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13805	Alive	TUMOR FREE	767	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	767	0	767	0	767	0	767	
70	TCGA-A2-A0EM	1	2	0	1	1	1	0	0	1	25	3	0	0	4	0	0	TCGA-A2-A0EM-01	51	0.10246934911835816	12	TCGA-A2-A0EM-01	5	4	2	0.03291130490023608	TCGA-A2-A0EM-01	4	2	2	8	mutation call filter	557	TCGA-A2-A0EM	BRCA	73	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26845	Alive	TUMOR FREE	3094	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3094	0	3094	0	3094	0	3094	
70	TCGA-A2-A0EN	0	2	0	0	3	1	0	0	2	25	1	0	0	8	1	0	TCGA-A2-A0EN-01	67	0.22109574847275354	29	TCGA-A2-A0EN-01	9	7	10	0.1304254925563849	TCGA-A2-A0EN-01	4	1	2	7	PASS	558	TCGA-A2-A0EN	BRCA	70	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25771	Alive	TUMOR FREE	4088	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	4088	0	4088	0	4088	0	4088	
50	TCGA-A2-A0EO	0	5	0	0	1	0	0	0	2	25	2	0	0	10	0	0	TCGA-A2-A0EO-01	77	0.5687311151002701	28	TCGA-A2-A0EO-01	22	17	7	0.08742365828744522	TCGA-A2-A0EO-01	5	0	2	7	mutation call filter	559	TCGA-A2-A0EO	BRCA	54	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2003	Peri (6-12 months since last menstrual period)	-19880	Alive	TUMOR FREE	2442	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	2442	0	2442	NA	NA	0	2442	
60	TCGA-A2-A0EP	0	7	1	0	0	0	0	0	1	7	2	0	2	2	0	0	TCGA-A2-A0EP-01	41	1.216724602364218e-05	4	TCGA-A2-A0EP	0	0	0	0	TCGA-A2-A0EP	0	0	0	0	PASS	560	TCGA-A2-A0EP	BRCA	56	FEMALE	WHITE	Stage I	NA	Infiltrating Lobular Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20585	Alive	TUMOR FREE	3603	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3603	0	3603	0	3603	0	3603	
60	TCGA-A2-A0EQ	0	13	0	7	1	2	1	0	8	190	10	1	1	84	5	0	TCGA-A2-A0EQ-01	217	0.5775382169217157	128	TCGA-A2-A0EQ-01	21	34	26	0.3203978129670101	TCGA-A2-A0EQ-01	15	13	10	38	mutation call filter	561	TCGA-A2-A0EQ	BRCA	64	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23543	Alive	TUMOR FREE	2426	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2426	0	2426	0	2426	0	2426	
60	TCGA-A2-A0ER	0	1	0	0	0	1	0	0	3	22	0	0	1	7	2	0	TCGA-A2-A0ER-01	135	0.07560213188424891	74	TCGA-A2-A0ER-01	4	3	12	0.04597721901914691	TCGA-A2-A0ER-01	4	1	2	7	mutation call filter	562	TCGA-A2-A0ER	BRCA	63	FEMALE	WHITE	Stage IB	NA	Infiltrating Ductal Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23021	Alive	TUMOR FREE	2263	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2263	0	2263	0	2263	0	2263	
50	TCGA-A2-A0ES	0	0	0	0	1	0	0	0	0	11	1	0	1	8	0	0	TCGA-A2-A0ES-01	75	0.005626082756839597	29	TCGA-A2-A0ES-01	0	0	0	0.0	TCGA-A2-A0ES-01	0	1	0	1	PASS	563	TCGA-A2-A0ES	BRCA	52	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19160	Alive	TUMOR FREE	2190	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2190	0	2190	0	2190	0	2190	
60	TCGA-A2-A0ET	1	6	1	3	0	2	0	0	1	36	5	0	1	17	0	0	TCGA-A2-A0ET-01	130	0.6784422010780322	74	TCGA-A2-A0ET-01	22	23	7	0.13768190557073706	TCGA-A2-A0ET-01	4	2	1	7	mutation call filter	564	TCGA-A2-A0ET	BRCA	58	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21464	Alive	TUMOR FREE	1066	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1066	0	1066	0	1066	0	1066	
80	TCGA-A2-A0EU	0	1	0	1	1	1	0	0	0	39	1	0	0	12	1	0	TCGA-A2-A0EU-01	99	0.5453345397006396	53	TCGA-A2-A0EU-01	26	57	5	0.06692250549327823	TCGA-A2-A0EU-01	1	0	2	3	mutation call filter	565	TCGA-A2-A0EU	BRCA	79	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29144	Alive	TUMOR FREE	1043	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1043	0	1043	0	1043	0	1043	
80	TCGA-A2-A0EV	0	5	0	2	0	1	0	0	2	50	5	0	0	14	4	0	TCGA-A2-A0EV-01	170	0.4430860486144976	97	TCGA-A2-A0EV-01	15	24	15	0.17300062796053106	TCGA-A2-A0EV-01	11	8	6	25	mutation call filter	566	TCGA-A2-A0EV	BRCA	80	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29285	Alive	TUMOR FREE	968	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	968	0	968	0	968	0	968	
50	TCGA-A2-A0EW	0	2	0	0	0	0	0	0	1	14	0	0	0	3	1	0	TCGA-A2-A0EW-01	115	0.07236328476516443	53	TCGA-A2-A0EW-01	2	4	16	0.06866419976546548	TCGA-A2-A0EW-01	3	2	3	8	PASS	567	TCGA-A2-A0EW	BRCA	53	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19413	Dead	WITH TUMOR	NA	1884	NA	Distant Metastasis	Bone	NA	1353	NA	Positive	NA	1	1884	1	1884	NA	NA	1	1353	
50	TCGA-A2-A0EX	0	3	0	0	0	0	0	0	0	23	3	0	0	5	1	0	TCGA-A2-A0EX-01	196	0.10030320337610288	124	TCGA-A2-A0EX-01	5	6	17	0.04110058402339516	TCGA-A2-A0EX-01	5	1	4	10	mutation call filter	568	TCGA-A2-A0EX	BRCA	46	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16858	Alive	TUMOR FREE	752	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	752	0	752	0	752	0	752	
60	TCGA-A2-A0EY	0	14	4	9	4	2	0	0	18	151	14	0	0	79	4	0	TCGA-A2-A0EY-01	370	0.6945128197232467	246	TCGA-A2-A0EY-01	23	28	48	0.30889200392015703	TCGA-A2-A0EY-01	21	15	13	49	mutation call filter	569	TCGA-A2-A0EY	BRCA	62	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22872	Alive	TUMOR FREE	1925	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1925	0	1925	0	1925	0	1925	
60	TCGA-A2-A0ST	0	0	0	0	0	0	0	0	1	12	3	0	0	12	0	0	TCGA-A2-A0ST-01	110	0.033272033846364374	52	TCGA-A2-A0ST	0	0	0	0	TCGA-A2-A0ST	0	0	0	0	PASS	570	TCGA-A2-A0ST	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22922	Alive	WITH TUMOR	3017	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3017	0	3017	0	3017	0	3017	
70	TCGA-A2-A0SU	0	2	0	1	3	1	2	0	2	21	2	0	0	6	3	0	TCGA-A2-A0SU-01	87	0.11783932823213925	42	TCGA-A2-A0SU-01	4	9	18	0.10248433375400016	TCGA-A2-A0SU-01	8	5	5	18	PASS	571	TCGA-A2-A0SU	BRCA	66	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24219	Alive	TUMOR FREE	1662	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1662	0	1662	0	1662	0	1662	
60	TCGA-A2-A0SV	0	2	0	0	0	1	3	0	2	27	1	0	0	14	1	0	TCGA-A2-A0SV-01	173	0.7354812212364871	98	TCGA-A2-A0SV-01	13	24	44	0.4536286948718879	TCGA-A2-A0SV-01	14	6	15	35	mutation call filter	572	TCGA-A2-A0SV	BRCA	63	FEMALE	WHITE	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23126	Dead	WITH TUMOR	NA	825	NA	NA	NA	NA	NA	NA	Positive	NA	1	825	1	825	NA	NA	1	825	
80	TCGA-A2-A0SW	0	3	0	1	1	2	0	1	2	45	0	0	0	14	2	0	TCGA-A2-A0SW-01	212	0.4790265730714996	140	TCGA-A2-A0SW-01	13	39	37	0.4030250629893081	TCGA-A2-A0SW-01	12	14	6	32	mutation call filter	573	TCGA-A2-A0SW	BRCA	82	FEMALE	WHITE	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30085	Dead	WITH TUMOR	NA	1365	NA	NA	NA	NA	653	NA	Negative	NA	1	1365	1	1365	NA	NA	1	653	
50	TCGA-A2-A0SX	2	4	0	1	0	0	0	0	2	19	2	0	0	11	1	0	TCGA-A2-A0SX-01	218	0.6610017558898342	129	TCGA-A2-A0SX-01	11	20	61	0.4621362583176698	TCGA-A2-A0SX-01	14	10	12	36	PASS	574	TCGA-A2-A0SX	BRCA	48	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17774	Alive	WITH TUMOR	1534	NA	NA	NA	NA	NA	1239	NA	Negative	NA	0	1534	0	1534	1	1239	1	1239	
60	TCGA-A2-A0SY	0	10	0	3	2	2	0	0	8	100	9	0	2	44	1	0	TCGA-A2-A0SY-01	148	0.10425230266391926	81	TCGA-A2-A0SY-01	2	4	13	0.04348205955617997	TCGA-A2-A0SY-01	5	2	3	10	PASS	575	TCGA-A2-A0SY	BRCA	62	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22928	Alive	TUMOR FREE	1347	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1347	0	1347	0	1347	0	1347	
60	TCGA-A2-A0T0	1	12	2	5	9	3	3	0	8	130	11	0	2	45	8	0	TCGA-A2-A0T0-01	263	0.463488382564219	163	TCGA-A2-A0T0-01	4	16	56	0.27277421713715483	TCGA-A2-A0T0-01	19	35	16	70	PASS	576	TCGA-A2-A0T0	BRCA	59	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21575	Alive	TUMOR FREE	533	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	533	0	533	0	533	0	533	
60	TCGA-A2-A0T1	0	3	0	0	1	1	0	0	0	21	0	0	0	9	0	0	TCGA-A2-A0T1-01	289	0.3842060316412662	185	TCGA-A2-A0T1-01	17	32	26	0.10017227866531846	TCGA-A2-A0T1-01	12	11	8	31	PASS	577	TCGA-A2-A0T1	BRCA	55	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20227	Alive	TUMOR FREE	521	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	521	0	521	0	521	0	521	
70	TCGA-A2-A0T2	1	5	1	1	2	5	0	0	0	17	0	0	0	9	2	0	TCGA-A2-A0T2-01	220	0.9462791668790412	143	TCGA-A2-A0T2-01	34	21	54	0.5916805405826844	TCGA-A2-A0T2-01	7	8	11	26	mutation call filter	578	TCGA-A2-A0T2	BRCA	66	FEMALE	WHITE	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24235	Dead	WITH TUMOR	NA	255	NA	NA	NA	NA	NA	NA	Close	NA	1	255	1	255	NA	NA	1	255	
40	TCGA-A2-A0T3	1	2	0	1	1	2	0	0	2	23	3	0	0	13	0	0	TCGA-A2-A0T3-01	241	0.9066092672438342	160	TCGA-A2-A0T3-01	31	50	52	0.2718125099927393	TCGA-A2-A0T3-01	21	6	12	39	PASS	579	TCGA-A2-A0T3	BRCA	37	FEMALE	WHITE	Stage IB	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13680	Alive	TUMOR FREE	1516	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1516	0	1516	0	1516	0	1516	
60	TCGA-A2-A0T4	0	0	0	0	1	1	2	0	3	24	1	0	0	11	2	0	TCGA-A2-A0T4-01	119	0.2602763006218829	54	TCGA-A2-A0T4-01	7	7	19	0.18823147038352112	TCGA-A2-A0T4-01	7	1	7	15	PASS	580	TCGA-A2-A0T4	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22849	Alive	TUMOR FREE	624	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	624	0	624	0	624	0	624	
40	TCGA-A2-A0T5	0	0	0	0	2	2	0	0	0	11	0	0	0	2	0	0	TCGA-A2-A0T5-01	75	0.11530473365421975	31	TCGA-A2-A0T5-01	5	6	19	0.021137938555171504	TCGA-A2-A0T5-01	2	0	1	3	PASS	581	TCGA-A2-A0T5	BRCA	39	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14503	Alive	TUMOR FREE	531	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	531	0	531	0	531	0	531	
50	TCGA-A2-A0T6	0	0	2	2	0	1	0	0	0	15	1	0	0	8	0	0	TCGA-A2-A0T6-01	61	0.22889103610488715	17	TCGA-A2-A0T6-01	6	5	5	0.06431216718962343	TCGA-A2-A0T6-01	1	1	2	4	PASS	582	TCGA-A2-A0T6	BRCA	50	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18334	Alive	TUMOR FREE	575	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	575	0	575	0	575	0	575	
50	TCGA-A2-A0T7	0	2	0	0	2	1	0	0	1	16	2	0	0	7	2	0	TCGA-A2-A0T7-01	167	0.5734775996577758	84	TCGA-A2-A0T7-01	12	13	27	0.2300852631536851	TCGA-A2-A0T7-01	8	6	9	23	PASS	583	TCGA-A2-A0T7	BRCA	51	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18756	Alive	TUMOR FREE	631	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	631	0	631	0	631	0	631	
60	TCGA-A2-A0YC	0	2	1	1	1	1	1	0	4	19	0	0	1	4	0	0	TCGA-A2-A0YC-01	101	0.11101733981099124	51	TCGA-A2-A0YC-01	4	5	15	0.06915080290722464	TCGA-A2-A0YC-01	4	1	1	6	PASS	584	TCGA-A2-A0YC	BRCA	59	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21685	Alive	WITH TUMOR	990	NA	NA	Locoregional Disease	NA	NA	756	NA	Close	NA	0	990	0	990	NA	NA	1	756	
60	TCGA-A2-A0YD	0	5	0	5	2	1	0	0	4	47	2	0	1	27	1	0	TCGA-A2-A0YD-01	56	0.09347486737084584	16	TCGA-A2-A0YD-01	6	9	8	0.06784410734891459	TCGA-A2-A0YD-01	4	2	2	8	PASS	585	TCGA-A2-A0YD	BRCA	63	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23021	Alive	TUMOR FREE	769	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	769	0	769	0	769	0	769	
50	TCGA-A2-A0YE	0	6	1	2	2	1	0	0	0	20	4	0	1	12	1	0	TCGA-A2-A0YE-01	248	0.8363920314575976	149	TCGA-A2-A0YE-01	24	32	63	0.5427144756098924	TCGA-A2-A0YE-01	20	10	10	40	PASS	586	TCGA-A2-A0YE	BRCA	48	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17727	Alive	TUMOR FREE	554	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	554	0	554	0	554	0	554	
70	TCGA-A2-A0YF	0	2	1	2	2	1	1	0	3	18	1	1	2	15	0	0	TCGA-A2-A0YF-01	116	0.1292707271689545	55	TCGA-A2-A0YF-01	4	5	13	0.09362987215242577	TCGA-A2-A0YF-01	6	3	5	14	PASS	587	TCGA-A2-A0YF	BRCA	67	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24660	Alive	TUMOR FREE	1535	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1535	0	1535	0	1535	0	1535	
60	TCGA-A2-A0YG	0	3	0	1	0	0	1	0	2	43	4	0	1	22	2	0	TCGA-A2-A0YG-01	319	0.8923847506531609	222	TCGA-A2-A0YG-01	29	24	14	0.08849731625386036	TCGA-A2-A0YG-01	14	11	4	29	PASS	588	TCGA-A2-A0YG	BRCA	63	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23058	Alive	TUMOR FREE	666	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	666	0	666	0	666	0	666	
50	TCGA-A2-A0YH	0	5	0	0	0	0	0	0	7	58	6	1	3	23	1	0	TCGA-A2-A0YH-01	122	0.4896688756188257	64	TCGA-A2-A0YH-01	17	32	22	0.18495224400667892	TCGA-A2-A0YH-01	10	4	7	21	PASS	589	TCGA-A2-A0YH	BRCA	53	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19596	Alive	TUMOR FREE	659	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	659	0	659	0	659	0	659	
60	TCGA-A2-A0YI	0	1	0	0	0	0	0	0	0	10	1	0	0	6	1	0	TCGA-A2-A0YI-01	84	0.18910245056467528	35	TCGA-A2-A0YI-01	4	5	5	0.09648616657690592	TCGA-A2-A0YI-01	3	2	2	7	PASS	590	TCGA-A2-A0YI	BRCA	62	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22961	Alive	TUMOR FREE	1505	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1505	0	1505	0	1505	0	1505	
40	TCGA-A2-A0YJ	0	3	1	1	0	1	0	0	2	68	4	0	0	18	2	1	TCGA-A2-A0YJ-01	221	0.7376683292448558	117	TCGA-A2-A0YJ-01	25	60	34	0.2366310492612768	TCGA-A2-A0YJ-01	16	6	3	25	PASS	591	TCGA-A2-A0YJ	BRCA	39	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14448	Alive	WITH TUMOR	566	NA	NA	Distant Metastasis	"Other, specify"	Left Cervical Lymph Node	559	NA	Negative	NA	0	566	0	566	1	559	1	559	
60	TCGA-A2-A0YK	1	20	1	13	1	0	0	0	23	270	31	2	3	119	4	1	TCGA-A2-A0YK-01	59	0.18978465586979928	20	TCGA-A2-A0YK-01	6	5	5	0.10759693936024388	TCGA-A2-A0YK-01	3	0	3	6	PASS	592	TCGA-A2-A0YK	BRCA	61	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22625	Alive	TUMOR FREE	588	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	588	0	588	NA	NA	0	588	
50	TCGA-A2-A0YL	0	3	0	2	1	1	0	0	3	21	5	0	0	14	0	0	TCGA-A2-A0YL-01	84	0.13008470857484122	39	TCGA-A2-A0YL-01	4	6	8	0.11516733032274032	TCGA-A2-A0YL-01	3	2	3	8	PASS	593	TCGA-A2-A0YL	BRCA	48	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17702	Alive	TUMOR FREE	1474	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1474	0	1474	0	1474	0	1474	
70	TCGA-A2-A0YM	0	10	0	1	2	0	0	1	5	67	6	0	0	22	1	0	TCGA-A2-A0YM-01	361	0.6519394400203582	213	TCGA-A2-A0YM-01	27	76	91	0.3834710058164944	TCGA-A2-A0YM-01	20	13	3	36	PASS	594	TCGA-A2-A0YM	BRCA	67	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24831	Alive	TUMOR FREE	965	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	965	0	965	0	965	0	965	
60	TCGA-A2-A0YT	0	5	0	3	1	1	0	0	4	47	5	0	1	18	2	0	TCGA-A2-A0YT-01	293	0.7354607880498067	190	TCGA-A2-A0YT-01	25	65	49	0.2945921336103223	TCGA-A2-A0YT-01	20	11	13	44	PASS	595	TCGA-A2-A0YT	BRCA	56	FEMALE	WHITE	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20482	Dead	TUMOR FREE	NA	723	NA	NA	NA	NA	NA	NA	Negative	NA	1	723	0	723	0	723	0	723	
70	TCGA-A2-A1FV	0	1	1	1	2	3	0	0	3	31	3	0	2	10	0	0	TCGA-A2-A1FV-01	206	0.3999059479766698	120	TCGA-A2-A1FV-01	12	15	42	0.1792024396162639	TCGA-A2-A1FV-01	11	12	11	34	PASS	596	TCGA-A2-A1FV	BRCA	74	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27287	Alive	TUMOR FREE	714	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	714	0	714	0	714	0	714	
60	TCGA-A2-A1FW	0	3	0	3	1	1	0	0	1	53	4	0	1	30	2	0	TCGA-A2-A1FW-01	574	0.8541677484713291	377	TCGA-A2-A1FW-01	21	30	44	0.15829557951709214	TCGA-A2-A1FW-01	12	18	3	33	PASS	597	TCGA-A2-A1FW	BRCA	62	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22779	Alive	TUMOR FREE	528	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	528	0	528	0	528	0	528	
60	TCGA-A2-A1FX	0	0	0	2	0	0	0	0	1	21	2	0	0	5	1	0	TCGA-A2-A1FX-01	135	0.5822714547602863	76	TCGA-A2-A1FX-01	14	10	28	0.2173329924734864	TCGA-A2-A1FX-01	8	3	6	17	PASS	598	TCGA-A2-A1FX	BRCA	61	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22344	Alive	TUMOR FREE	1847	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1847	0	1847	0	1847	0	1847	
60	TCGA-A2-A1FZ	0	0	0	1	1	1	0	0	2	20	2	0	0	7	2	0	TCGA-A2-A1FZ-01	72	0.10090281091378167	28	TCGA-A2-A1FZ-01	2	4	4	0.021505069248425282	TCGA-A2-A1FZ-01	2	1	1	4	PASS	599	TCGA-A2-A1FZ	BRCA	63	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23055	Alive	TUMOR FREE	683	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	683	0	683	0	683	0	683	
50	TCGA-A2-A1G0	0	2	1	0	3	0	0	0	0	14	2	0	0	3	1	0	TCGA-A2-A1G0-01	101	0.9429968101048182	48	TCGA-A2-A1G0-01	16	11	14	0.030727834571093283	TCGA-A2-A1G0-01	6	2	2	10	PASS	600	TCGA-A2-A1G0	BRCA	49	FEMALE	WHITE	Stage IIB	NA	"Other, specify"	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18002	Alive	TUMOR FREE	616	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	616	0	616	0	616	0	616	
90	TCGA-A2-A1G1	0	2	1	3	2	0	0	1	1	22	0	0	1	11	2	0	TCGA-A2-A1G1-01	195	0.6744219804077634	106	TCGA-A2-A1G1-01	20	34	29	0.36357703624128535	TCGA-A2-A1G1-01	12	2	3	17	PASS	601	TCGA-A2-A1G1	BRCA	85	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31223	Alive	TUMOR FREE	584	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	584	0	584	0	584	0	584	
70	TCGA-A2-A1G4	0	4	0	0	2	1	1	0	1	23	1	0	0	12	0	0	TCGA-A2-A1G4-01	135	0.15313058675347352	75	TCGA-A2-A1G4-01	4	4	18	0.04023854561322157	TCGA-A2-A1G4-01	4	4	3	11	mutation call filter	602	TCGA-A2-A1G4	BRCA	71	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25966	Alive	TUMOR FREE	595	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	595	0	595	0	595	0	595	
50	TCGA-A2-A1G6	0	0	0	0	0	0	0	0	0	7	0	0	1	2	1	0	TCGA-A2-A1G6-01	55	0.00010965643007211572	15	TCGA-A2-A1G6	0	0	0	0	TCGA-A2-A1G6	0	0	0	0	PASS	603	TCGA-A2-A1G6	BRCA	50	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18514	Alive	TUMOR FREE	501	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	501	0	501	0	501	0	501	
70	TCGA-A2-A259	0	2	0	0	1	0	1	0	0	16	2	1	2	6	0	0	TCGA-A2-A259-01	74	0.12594643026937255	29	TCGA-A2-A259-01	4	6	9	0.04432568458191825	TCGA-A2-A259-01	3	2	3	8	PASS	604	TCGA-A2-A259	BRCA	70	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25666	Alive	TUMOR FREE	1596	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	1596	0	1596	NA	NA	0	1596	
40	TCGA-A2-A25A	1	13	0	4	1	0	0	0	11	271	22	0	2	82	5	0	TCGA-A2-A25A-01	65	0.1189101352591797	24	TCGA-A2-A25A-01	5	5	5	0.0958415324047283	TCGA-A2-A25A-01	3	1	2	6	PASS	605	TCGA-A2-A25A	BRCA	44	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16084	Alive	TUMOR FREE	3276	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3276	0	3276	0	3276	0	3276	
40	TCGA-A2-A25B	3	4	1	4	4	1	1	0	2	83	5	0	3	30	3	0	TCGA-A2-A25B-01	298	0.7464527406417234	175	TCGA-A2-A25B	0	0	0	0	TCGA-A2-A25B	0	0	0	0	PASS	606	TCGA-A2-A25B	BRCA	39	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14454	Alive	WITH TUMOR	1291	NA	NA	Distant Metastasis	Bone	NA	1290	NA	Close	NA	0	1291	0	1291	NA	NA	1	1290	
50	TCGA-A2-A25C	0	1	0	2	0	0	0	0	2	29	2	0	0	7	3	0	TCGA-A2-A25C-01	150	0.3264100361496535	91	TCGA-A2-A25C-01	10	8	37	0.2136283049502765	TCGA-A2-A25C-01	6	3	5	14	PASS	607	TCGA-A2-A25C	BRCA	50	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18508	Alive	TUMOR FREE	523	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	523	0	523	0	523	0	523	
90	TCGA-A2-A25D	0	3	0	2	3	2	1	0	1	36	3	0	0	17	4	0	TCGA-A2-A25D-01	202	0.23626520304147255	106	TCGA-A2-A25D-01	7	11	31	0.12831242168776955	TCGA-A2-A25D-01	12	14	7	33	PASS	608	TCGA-A2-A25D	BRCA	90	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32872	Alive	TUMOR FREE	552	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	552	0	552	NA	NA	0	552	
30	TCGA-A2-A25E	0	2	1	2	1	0	1	1	1	43	4	0	3	9	1	0	TCGA-A2-A25E-01	154	0.3777401047397949	81	TCGA-A2-A25E-01	5	19	30	0.20625173422929527	TCGA-A2-A25E-01	16	24	13	53	PASS	609	TCGA-A2-A25E	BRCA	34	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12601	Alive	TUMOR FREE	3204	NA	NA	Locoregional Recurrence	"Other, specify"	Left Chest Wall	2989	NA	Negative	NA	0	3204	0	3204	1	2989	1	2989	
70	TCGA-A2-A25F	0	0	0	2	0	0	0	0	1	4	1	0	0	1	0	0	TCGA-A2-A25F-01	58	0.0031575344098294478	16	TCGA-A2-A25F	0	0	0	0	TCGA-A2-A25F	0	0	0	0	PASS	610	TCGA-A2-A25F	BRCA	66	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24319	Alive	TUMOR FREE	322	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	322	0	322	0	322	0	322	
60	TCGA-A2-A3KC	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A2-A3KC-01	73	0.14038770802684386	30	TCGA-A2-A3KC-01	6	5	11	0.08289876369711491	TCGA-A2-A3KC-01	4	2	3	9	PASS	611	TCGA-A2-A3KC	BRCA	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-20401	Alive	TUMOR FREE	1102	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1102	0	1102	0	1102	0	1102	
50	TCGA-A2-A3KD	0	4	0	0	0	0	0	0	0	6	0	0	1	5	1	1	TCGA-A2-A3KD-01	86	0.20214380163906448	35	TCGA-A2-A3KD-01	5	10	16	0.14077651719954015	TCGA-A2-A3KD-01	5	4	4	13	PASS	612	TCGA-A2-A3KD	BRCA	47	FEMALE	WHITE	Stage IIIA	NA	Mucinous Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17372	Alive	TUMOR FREE	1206	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	1206	0	1206	NA	NA	0	1206	
60	TCGA-A2-A3XS	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A2-A3XS-01	223	0.7895616262743149	132	TCGA-A2-A3XS-01	22	53	89	0.3086385272425707	TCGA-A2-A3XS-01	22	18	12	52	PASS	613	TCGA-A2-A3XS	BRCA	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23000	Dead	WITH TUMOR	NA	1032	NA	Distant Metastasis	Lung	NA	682	NA	Negative	NA	1	1032	1	1032	1	682	1	682	
50	TCGA-A2-A3XT	0	28	0	9	2	0	0	0	5	58	3	0	5	16	4	1	TCGA-A2-A3XT-01	158	0.6874353089853819	89	TCGA-A2-A3XT-01	14	29	88	0.3605218264708032	TCGA-A2-A3XT-01	24	29	13	66	PASS	614	TCGA-A2-A3XT	BRCA	45	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16649	Alive	TUMOR FREE	2770	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2770	0	2770	0	2770	0	2770	
40	TCGA-A2-A3XU	0	8	1	2	1	2	0	0	1	15	1	0	1	6	0	0	TCGA-A2-A3XU-01	171	0.3358770003885205	106	TCGA-A2-A3XU-01	10	12	86	0.20220411012744324	TCGA-A2-A3XU-01	4	3	3	10	PASS	615	TCGA-A2-A3XU	BRCA	35	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-13046	Dead	WITH TUMOR	NA	912	NA	Distant Metastasis	Bone	NA	574	NA	Negative	NA	1	912	1	912	1	574	1	574	
50	TCGA-A2-A3XV	1	7	0	1	3	0	1	0	2	28	4	0	2	4	3	0	TCGA-A2-A3XV-01	107	0.1244432858390491	44	TCGA-A2-A3XV-01	6	3	26	0.05932450132294141	TCGA-A2-A3XV-01	3	2	3	8	PASS	616	TCGA-A2-A3XV	BRCA	46	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16971	Alive	TUMOR FREE	996	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	996	0	996	0	996	0	996	
40	TCGA-A2-A3XW	0	8	0	0	0	0	0	0	2	5	1	0	0	3	0	0	TCGA-A2-A3XW-01	92	0.0179412404141306	44	TCGA-A2-A3XW	0	0	0	0	TCGA-A2-A3XW	0	0	0	0	PASS	617	TCGA-A2-A3XW	BRCA	42	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15670	Alive	TUMOR FREE	1712	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1712	0	1712	0	1712	0	1712	
50	TCGA-A2-A3XX	2	7	0	2	0	1	1	0	3	26	1	0	1	8	3	0	TCGA-A2-A3XX-01	185	0.6515052078384831	115	TCGA-A2-A3XX-01	23	37	100	0.2817003603998457	TCGA-A2-A3XX-01	9	1	3	13	PASS	618	TCGA-A2-A3XX	BRCA	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17981	Dead	TUMOR FREE	NA	1439	NA	NA	NA	NA	NA	NA	Negative	NA	1	1439	0	1439	0	1439	0	1439	
50	TCGA-A2-A3XY	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A2-A3XY-01	114	0.3751551224747394	51	TCGA-A2-A3XY-01	8	13	15	0.04645749179507022	TCGA-A2-A3XY-01	4	5	0	9	PASS	619	TCGA-A2-A3XY	BRCA	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18059	Dead	WITH TUMOR	NA	1093	NA	Distant Metastasis	Lung	NA	802	NA	Negative	NA	1	1093	1	1093	1	802	1	802	
50	TCGA-A2-A3XZ	1	9	0	1	0	1	0	0	2	29	1	0	2	12	1	0	TCGA-A2-A3XZ-01	131	0.3486100231829477	67	TCGA-A2-A3XZ-01	9	9	61	0.08867880293781419	TCGA-A2-A3XZ-01	9	6	6	21	PASS	620	TCGA-A2-A3XZ	BRCA	46	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16978	Alive	TUMOR FREE	1532	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1532	0	1532	0	1532	0	1532	
60	TCGA-A2-A3Y0	1	32	4	15	1	0	0	0	10	132	9	0	4	40	4	0	TCGA-A2-A3Y0-01	282	0.5915050401579567	177	TCGA-A2-A3Y0-01	6	13	187	0.3591897736424098	TCGA-A2-A3Y0-01	17	17	21	55	PASS	621	TCGA-A2-A3Y0	BRCA	57	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21024	Alive	TUMOR FREE	1546	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	1546	0	1546	NA	NA	0	1546	
50	TCGA-A2-A4RW	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A2-A4RW-01	218	0.3425620960306445	126	TCGA-A2-A4RW-01	5	15	132	0.3375676416751189	TCGA-A2-A4RW-01	23	21	14	58	PASS	622	TCGA-A2-A4RW	BRCA	49	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18060	Alive	TUMOR FREE	222	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	222	0	222	0	222	0	222	
70	TCGA-A2-A4RX	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A2-A4RX-01	91	0.6012667699279324	45	TCGA-A2-A4RX-01	20	17	82	0.3730592317586688	TCGA-A2-A4RX-01	0	0	0	0	PASS	623	TCGA-A2-A4RX	BRCA	67	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Metaplastic Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24779	Alive	TUMOR FREE	742	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	742	0	742	0	742	0	742	
50	TCGA-A2-A4RY	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A2-A4RY-01	43	0.02428696883473722	11	TCGA-A2-A4RY-01	0	0	17	0.01220620003132657	TCGA-A2-A4RY-01	2	0	0	2	PASS	624	TCGA-A2-A4RY	BRCA	46	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17157	Alive	TUMOR FREE	648	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	648	0	648	0	648	0	648	
80	TCGA-A2-A4S0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A2-A4S0-01	55	5.442494178248866e-05	17	TCGA-A2-A4S0-01	0	0	6	0.00022008150943392734	TCGA-A2-A4S0-01	0	0	0	0	PASS	625	TCGA-A2-A4S0	BRCA	77	FEMALE	WHITE	Stage IIA	NA	Mucinous Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28416	Alive	TUMOR FREE	706	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	706	0	706	0	706	0	706	
70	TCGA-A2-A4S1	1	13	0	5	4	1	0	0	4	61	4	0	3	9	1	0	TCGA-A2-A4S1-01	240	0.7147779989252998	136	TCGA-A2-A4S1-01	26	19	90	0.2638477056874648	TCGA-A2-A4S1-01	11	10	8	29	PASS	626	TCGA-A2-A4S1	BRCA	66	FEMALE	WHITE	Stage IIA	NA	Metaplastic Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24353	Alive	TUMOR FREE	820	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	820	0	820	0	820	0	820	
60	TCGA-A2-A4S2	0	9	0	3	0	1	0	0	0	22	4	0	1	7	0	0	TCGA-A2-A4S2-01	111	0.4611223252504912	63	TCGA-A2-A4S2-01	13	15	36	0.11823692287031425	TCGA-A2-A4S2-01	3	4	4	11	PASS	627	TCGA-A2-A4S2	BRCA	62	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22936	Alive	TUMOR FREE	643	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	643	0	643	0	643	0	643	
60	TCGA-A2-A4S3	3	19	2	8	1	0	1	0	4	47	3	0	1	23	2	1	TCGA-A2-A4S3-01	228	0.913028844761718	136	TCGA-A2-A4S3-01	11	20	146	0.4511762023347717	TCGA-A2-A4S3-01	21	22	22	65	PASS	628	TCGA-A2-A4S3	BRCA	59	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21762	Alive	TUMOR FREE	666	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	666	0	666	0	666	0	666	
70	TCGA-A7-A0CD	0	2	0	1	0	0	1	0	2	21	0	0	0	11	0	0	TCGA-A7-A0CD-01	75	0.9015527969433288	34	TCGA-A7-A0CD-01	27	17	8	0.15259456296044782	TCGA-A7-A0CD-01	5	2	3	10	mutation call filter	629	TCGA-A7-A0CD	BRCA	66	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Indeterminate (neither Pre or Postmenopausal)	-24242	Alive	TUMOR FREE	1165	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1165	0	1165	0	1165	0	1165	
60	TCGA-A7-A0CE	2	27	2	2	2	4	0	0	5	157	13	0	7	62	2	0	TCGA-A7-A0CE-01	225	0.7324750611508919	119	TCGA-A7-A0CE-01	10	35	65	0.2966126993394805	TCGA-A7-A0CE-01	20	21	9	50	PASS	630	TCGA-A7-A0CE	BRCA	57	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Indeterminate (neither Pre or Postmenopausal)	-20863	Alive	TUMOR FREE	1074	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1074	0	1074	0	1074	0	1074	
80	TCGA-A7-A0CG	0	4	0	1	0	1	0	0	1	40	5	0	2	24	0	0	TCGA-A7-A0CG-01	158	0.12210141939713365	90	TCGA-A7-A0CG-01	7	8	14	0.11445150446650212	TCGA-A7-A0CG-01	3	5	3	11	mutation call filter	631	TCGA-A7-A0CG	BRCA	78	FEMALE	WHITE	Stage IIA	NA	Mixed Histology (please specify)	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28596	Alive	TUMOR FREE	1043	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	1043	0	1043	NA	NA	0	1043	
80	TCGA-A7-A0CH	0	2	0	2	2	1	1	0	2	47	2	0	6	15	0	0	TCGA-A7-A0CH-01	83	0.06272337573926268	37	TCGA-A7-A0CH-01	3	3	6	0.017947658123421632	TCGA-A7-A0CH-01	3	0	1	4	PASS	632	TCGA-A7-A0CH	BRCA	79	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29104	Alive	TUMOR FREE	1079	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1079	0	1079	0	1079	0	1079	
60	TCGA-A7-A0CJ	0	2	0	2	1	1	0	0	6	48	1	1	1	12	1	1	TCGA-A7-A0CJ-01	436	0.9254833351987608	282	TCGA-A7-A0CJ-01	22	34	104	0.25402362827391595	TCGA-A7-A0CJ-01	27	15	12	54	mutation call filter	633	TCGA-A7-A0CJ	BRCA	57	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21014	Alive	TUMOR FREE	931	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	931	0	931	NA	NA	0	931	
40	TCGA-A7-A0D9	0	4	0	2	0	0	0	0	0	34	4	0	0	17	2	0	TCGA-A7-A0D9-01	251	0.1879917220606479	146	TCGA-A7-A0D9-01	7	5	20	0.07722411596778772	TCGA-A7-A0D9-01	8	4	4	16	PASS	634	TCGA-A7-A0D9	BRCA	37	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13836	Alive	TUMOR FREE	1139	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1139	0	1139	0	1139	0	1139	
60	TCGA-A7-A0DA	1	12	3	7	8	0	7	0	9	119	6	0	4	25	9	0	TCGA-A7-A0DA-01	365	0.9186364219384602	234	TCGA-A7-A0DA-01	16	38	85	0.5002009658723473	TCGA-A7-A0DA-01	31	34	9	74	PASS	635	TCGA-A7-A0DA	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22708	Alive	TUMOR FREE	1085	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1085	0	1085	0	1085	0	1085	
60	TCGA-A7-A0DB	0	7	1	5	0	2	0	0	1	25	2	0	0	17	0	0	TCGA-A7-A0DB-01	69	0.8979048722627879	26	TCGA-A7-A0DB-01	17	11	2	0.02761274404681353	TCGA-A7-A0DB-01	3	0	1	4	PASS	636	TCGA-A7-A0DB	BRCA	56	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20570	Alive	TUMOR FREE	1007	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	1007	0	1007	NA	NA	0	1007	
60	TCGA-A7-A0DC	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A7-A0DC-01	112	0.711675174098553	47	TCGA-A7-A0DC	0	0	0	0	TCGA-A7-A0DC	0	0	0	0	PASS	637	TCGA-A7-A0DC	BRCA	63	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23294	Alive	TUMOR FREE	906	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	906	0	906	0	906	0	906	Redacted
50	TCGA-A7-A13D	1	27	2	6	5	0	3	0	8	69	9	0	3	23	2	0	TCGA-A7-A13D-01	684	0.8558332634440019	467	TCGA-A7-A13D-01	28	25	223	0.6175682332934282	TCGA-A7-A13D-01	24	11	11	46	PASS	638	TCGA-A7-A13D	BRCA	46	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17070	Alive	TUMOR FREE	965	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	965	0	965	0	965	0	965	
60	TCGA-A7-A13E	4	12	0	3	6	0	3	2	3	82	0	0	4	37	0	0	TCGA-A7-A13E-01	168	0.6514990435694022	89	TCGA-A7-A13E-01	22	36	29	0.30064043070444824	TCGA-A7-A13E-01	13	8	10	31	PASS	639	TCGA-A7-A13E	BRCA	62	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22690	Dead	WITH TUMOR	NA	614	NA	Distant Metastasis	"Other, specify"	"Lung, Bone, Liver, Brain and Skin Nodules"	556	NA	Negative	NA	1	614	1	614	1	556	1	556	
40	TCGA-A7-A13F	0	6	0	5	2	2	2	0	4	63	2	0	0	9	2	0	TCGA-A7-A13F-01	207	0.924575450468162	117	TCGA-A7-A13F-01	25	17	12	0.1245226328018386	TCGA-A7-A13F-01	5	1	3	9	PASS	640	TCGA-A7-A13F	BRCA	44	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16363	Alive	TUMOR FREE	765	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	765	0	765	0	765	0	765	
80	TCGA-A7-A13G	0	1	0	2	2	0	0	0	1	18	0	0	0	12	0	0	TCGA-A7-A13G-01	109	0.11498029298803344	56	TCGA-A7-A13G-01	4	4	4	0.05190437877581027	TCGA-A7-A13G-01	5	2	2	9	PASS	641	TCGA-A7-A13G	BRCA	79	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28969	Alive	TUMOR FREE	718	NA	NA	New Primary Tumor	"Other, specify"	"Skin, right leg"	586	NA	Negative	NA	0	718	0	718	0	718	1	586	
60	TCGA-A7-A13H	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A7-A13H-01	115	0.12147700362437458	57	TCGA-A7-A13H-01	5	6	22	0.0767432648858286	TCGA-A7-A13H-01	5	5	4	14	PASS	642	TCGA-A7-A13H	BRCA	61	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22643	Alive	TUMOR FREE	899	NA	NA	New Primary Tumor	"Other, specify"	Skin lesion-Basal Cell Left Lower Lateral Back	795	NA	Negative	NA	0	899	0	899	0	899	1	795	
70	TCGA-A7-A26E	0	12	0	2	1	1	0	0	1	36	1	0	3	14	0	0	TCGA-A7-A26E-01	48	0.3102860757541654	10	TCGA-A7-A26E-01	5	4	18	0.08171554271984383	TCGA-A7-A26E-01	1	1	2	4	PASS	643	TCGA-A7-A26E	BRCA	71	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26274	Alive	TUMOR FREE	954	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	954	0	954	0	954	0	954	
60	TCGA-A7-A26F	0	6	0	0	2	1	0	1	0	31	1	0	1	13	1	0	TCGA-A7-A26F-01	80	0.4288843036663818	34	TCGA-A7-A26F-01	9	12	20	0.2500827283422833	TCGA-A7-A26F-01	9	9	7	25	PASS	644	TCGA-A7-A26F	BRCA	55	FEMALE	WHITE	Stage IA	NA	"Other, specify"	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20210	Alive	TUMOR FREE	738	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	738	0	738	0	738	0	738	
50	TCGA-A7-A26G	0	4	0	1	0	0	0	0	1	41	1	0	0	21	3	0	TCGA-A7-A26G-01	130	0.4753436562760925	61	TCGA-A7-A26G-01	10	12	32	0.346041877416085	TCGA-A7-A26G-01	10	11	10	31	PASS	645	TCGA-A7-A26G	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	"Other, specify"	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18362	Alive	TUMOR FREE	722	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	722	0	722	0	722	0	722	
70	TCGA-A7-A26H	0	5	0	2	3	1	0	0	5	87	15	0	1	36	1	0	TCGA-A7-A26H-01	79	0.2274909587590273	35	TCGA-A7-A26H-01	8	12	13	0.09920168925036472	TCGA-A7-A26H-01	7	5	6	18	PASS	646	TCGA-A7-A26H	BRCA	72	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26423	Alive	WITH TUMOR	724	NA	NA	Distant Metastasis	Liver	NA	291	NA	Negative	NA	0	724	0	724	1	291	1	291	
70	TCGA-A7-A26I	0	1	0	2	0	0	0	0	2	33	1	0	2	6	0	0	TCGA-A7-A26I-01	260	0.6793305629884687	150	TCGA-A7-A26I-01	26	31	72	0.5585719713148368	TCGA-A7-A26I-01	19	9	10	38	PASS	647	TCGA-A7-A26I	BRCA	65	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23948	Alive	TUMOR FREE	661	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	661	0	661	0	661	0	661	
50	TCGA-A7-A26J	1	11	2	2	1	0	0	0	3	19	3	0	2	8	0	0	TCGA-A7-A26J-01	91	0.4667968374497438	44	TCGA-A7-A26J-01	18	12	40	0.14419806304378474	TCGA-A7-A26J-01	8	1	6	15	PASS	648	TCGA-A7-A26J	BRCA	49	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17930	Alive	TUMOR FREE	627	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	627	0	627	0	627	0	627	
50	TCGA-A7-A2KD	0	13	0	1	1	1	0	0	2	25	3	0	2	15	0	0	TCGA-A7-A2KD-01	343	0.7321957295058796	219	TCGA-A7-A2KD-01	17	33	67	0.13648529126558376	TCGA-A7-A2KD-01	20	11	8	39	PASS	649	TCGA-A7-A2KD	BRCA	53	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19563	Alive	TUMOR FREE	679	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	679	0	679	0	679	0	679	
70	TCGA-A7-A3IY	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A7-A3IY-01	47	0.07998817853637903	10	TCGA-A7-A3IY-01	1	1	2	0.008318855576469789	TCGA-A7-A3IY-01	0	2	1	3	PASS	650	TCGA-A7-A3IY	BRCA	71	FEMALE	WHITE	Stage I	NA	Mucinous Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26042	Alive	TUMOR FREE	345	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	345	0	345	0	345	0	345	
60	TCGA-A7-A3IZ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A7-A3IZ-01	143	0.29806805436569705	78	TCGA-A7-A3IZ-01	5	6	26	0.12670116644863216	TCGA-A7-A3IZ-01	6	5	7	18	PASS	651	TCGA-A7-A3IZ	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22997	Alive	TUMOR FREE	322	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	322	0	322	0	322	0	322	
60	TCGA-A7-A3J0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A7-A3J0-01	52	0.9138737936747048	12	TCGA-A7-A3J0-01	11	6	0	0.0	TCGA-A7-A3J0-01	0	0	0	0	PASS	652	TCGA-A7-A3J0	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Mucinous Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22672	Alive	TUMOR FREE	313	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	313	0	313	0	313	0	313	
60	TCGA-A7-A3J1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A7-A3J1-01	62	0.33476507715390297	19	TCGA-A7-A3J1-01	6	7	17	0.1902947303069986	TCGA-A7-A3J1-01	5	5	7	17	PASS	653	TCGA-A7-A3J1	BRCA	63	FEMALE	WHITE	Stage IA	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23209	Alive	TUMOR FREE	343	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	343	0	343	0	343	0	343	
80	TCGA-A7-A3RF	1	8	1	2	2	1	0	0	2	26	1	0	0	19	2	0	TCGA-A7-A3RF-01	55	0.0022501660224735977	15	TCGA-A7-A3RF-01	0	0	6	0.002308645641522757	TCGA-A7-A3RF-01	0	0	0	0	PASS	654	TCGA-A7-A3RF	BRCA	79	FEMALE	WHITE	Stage IIA	NA	Mucinous Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29184	Alive	WITH TUMOR	408	NA	NA	Distant Metastasis	Bone	NA	174	NA	Negative	NA	0	408	0	408	1	174	1	174	
70	TCGA-A7-A425	0	5	0	1	2	0	0	0	0	26	0	0	0	8	0	0	TCGA-A7-A425-01	109	0.9999933139331731	53	TCGA-A7-A425-01	25	18	24	0.06798101275969316	TCGA-A7-A425-01	5	2	3	10	PASS	655	TCGA-A7-A425	BRCA	70	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25678	Alive	WITH TUMOR	447	NA	NA	Locoregional Recurrence	"Other, specify"	Left Breast	419	NA	Negative	NA	0	447	0	447	1	419	1	419	
50	TCGA-A7-A426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A7-A426-01	59	0.17078043790765216	15	TCGA-A7-A426-01	7	5	29	0.09081579108048576	TCGA-A7-A426-01	5	1	4	10	PASS	656	TCGA-A7-A426	BRCA	50	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18296	Alive	TUMOR FREE	364	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	364	0	364	0	364	0	364	
40	TCGA-A7-A4SA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A7-A4SA-01	136	0.45660178851091704	73	TCGA-A7-A4SA-01	10	17	105	0.3607914184636945	TCGA-A7-A4SA-01	19	26	14	59	PASS	657	TCGA-A7-A4SA	BRCA	40	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14906	Alive	TUMOR FREE	454	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	454	0	454	0	454	0	454	
60	TCGA-A7-A4SB	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A7-A4SB-01	143	0.5146198509472485	75	TCGA-A7-A4SB-01	18	24	50	0.12861415951766986	TCGA-A7-A4SB-01	10	2	10	22	PASS	658	TCGA-A7-A4SB	BRCA	56	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20539	Alive	TUMOR FREE	418	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	418	0	418	0	418	0	418	
60	TCGA-A7-A4SC	0	9	0	6	6	0	0	0	4	40	2	0	2	12	2	0	TCGA-A7-A4SC	0	0	0	TCGA-A7-A4SC	0	0	0	0	TCGA-A7-A4SC	0	0	0	0	PASS	659	TCGA-A7-A4SC	BRCA	62	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23008	Alive	TUMOR FREE	446	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	446	0	446	0	446	0	446	
50	TCGA-A7-A4SD	0	24	0	8	6	0	2	0	7	73	4	0	4	16	2	0	TCGA-A7-A4SD-01	434	0.8906946022076535	291	TCGA-A7-A4SD-01	20	33	220	0.4521533544734988	TCGA-A7-A4SD-01	18	15	13	46	PASS	660	TCGA-A7-A4SD	BRCA	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19131	Alive	TUMOR FREE	441	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	441	0	441	0	441	0	441	
50	TCGA-A7-A4SE	6	54	2	15	13	0	2	0	15	152	6	0	7	43	6	0	TCGA-A7-A4SE-01	348	0.8117182692467589	214	TCGA-A7-A4SE-01	15	23	254	0.5566810621789731	TCGA-A7-A4SE-01	26	16	18	60	PASS	661	TCGA-A7-A4SE	BRCA	54	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20080	Alive	TUMOR FREE	644	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	644	0	644	0	644	0	644	
50	TCGA-A7-A4SF	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A7-A4SF-01	259	0.9289033423413648	158	TCGA-A7-A4SF-01	22	35	116	0.2919373553875203	TCGA-A7-A4SF-01	15	10	8	33	PASS	662	TCGA-A7-A4SF	BRCA	54	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19985	Alive	TUMOR FREE	545	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	545	0	545	NA	NA	0	545	
80	TCGA-A7-A56D	7	55	2	24	2	4	2	0	15	203	27	0	21	108	2	0	TCGA-A7-A56D-01	323	0.6727290699428125	199	TCGA-A7-A56D-01	14	15	148	0.33871295881668784	TCGA-A7-A56D-01	10	10	14	34	PASS	663	TCGA-A7-A56D	BRCA	84	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30783	Alive	TUMOR FREE	448	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	448	0	448	0	448	0	448	
60	TCGA-A7-A5ZV	3	38	3	18	8	1	0	0	8	139	7	0	3	47	5	0	TCGA-A7-A5ZV-01	635	0.9614672050388452	412	TCGA-A7-A5ZV-01	19	39	325	0.5014984840458796	TCGA-A7-A5ZV-01	26	16	13	55	PASS	664	TCGA-A7-A5ZV	BRCA	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Carcinoma NOS	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22966	Alive	TUMOR FREE	368	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	368	0	368	0	368	0	368	
50	TCGA-A7-A5ZW	1	2	0	1	1	1	0	0	0	26	1	0	3	6	0	0	TCGA-A7-A5ZW-01	75	0.05971147402655131	33	TCGA-A7-A5ZW-01	2	2	9	0.015947181717927774	TCGA-A7-A5ZW-01	2	0	2	4	PASS	665	TCGA-A7-A5ZW	BRCA	47	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2012	Peri (6-12 months since last menstrual period)	-17529	Alive	TUMOR FREE	326	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	326	0	326	0	326	0	326	
50	TCGA-A7-A5ZX	2	10	0	2	6	0	0	0	0	50	2	0	4	16	4	0	TCGA-A7-A5ZX-01	62	0.0683594969545694	22	TCGA-A7-A5ZX-01	3	4	10	0.034489567549615574	TCGA-A7-A5ZX-01	1	3	2	6	PASS	666	TCGA-A7-A5ZX	BRCA	48	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17683	Alive	TUMOR FREE	336	NA	NA	NA	NA	NA	NA	NA	[Unknown]	NA	0	336	0	336	NA	NA	0	336	
50	TCGA-A7-A6VV	0	8	0	4	2	0	0	0	1	37	2	0	2	12	2	0	TCGA-A7-A6VV-01	543	0.7168461904319867	381	TCGA-A7-A6VV-01	23	35	296	0.4858862811342452	TCGA-A7-A6VV-01	29	8	22	59	PASS	667	TCGA-A7-A6VV	BRCA	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2013	Peri (6-12 months since last menstrual period)	-18695	Alive	TUMOR FREE	313	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	313	0	313	0	313	0	313	
50	TCGA-A7-A6VW	2	21	0	0	1	0	1	0	4	48	4	0	1	16	1	1	TCGA-A7-A6VW-01	296	0.921775802542822	193	TCGA-A7-A6VW-01	13	14	174	0.3955322823205744	TCGA-A7-A6VW-01	16	20	12	48	PASS	668	TCGA-A7-A6VW	BRCA	48	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17539	Alive	TUMOR FREE	285	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	285	0	285	NA	NA	0	285	
70	TCGA-A7-A6VX	4	26	1	12	4	1	3	0	7	95	10	0	2	31	4	0	TCGA-A7-A6VX-01	291	0.7495180308732367	197	TCGA-A7-A6VX-01	17	35	126	0.2711858836782348	TCGA-A7-A6VX-01	26	28	14	68	PASS	669	TCGA-A7-A6VX	BRCA	68	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25066	Alive	TUMOR FREE	317	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	317	0	317	0	317	0	317	
50	TCGA-A7-A6VY	0	26	0	5	2	1	0	0	5	87	4	0	1	23	0	0	TCGA-A7-A6VY-01	387	0.9479016077824616	231	TCGA-A7-A6VY-01	7	12	211	0.4450987337116589	TCGA-A7-A6VY-01	19	29	28	76	PASS	670	TCGA-A7-A6VY	BRCA	48	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17640	Alive	TUMOR FREE	266	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	266	0	266	0	266	0	266	
70	TCGA-A8-A06N	0	7	0	1	0	1	0	0	2	31	1	0	0	10	0	0	TCGA-A8-A06N-01	117	0.6250126504547349	66	TCGA-A8-A06N-01	21	25	17	0.1631757546436221	TCGA-A8-A06N-01	9	5	6	20	mutation call filter	671	TCGA-A8-A06N	BRCA	66	FEMALE	NA	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24288	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	0	0	0	0	0	0	0	
60	TCGA-A8-A06O	1	3	0	2	6	0	2	0	2	56	4	0	3	10	1	0	TCGA-A8-A06O-01	162	0.7877814524171315	96	TCGA-A8-A06O-01	22	19	43	0.310114544597592	TCGA-A8-A06O-01	13	5	12	30	mutation call filter	672	TCGA-A8-A06O	BRCA	60	FEMALE	NA	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22157	Alive	TUMOR FREE	396	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	396	0	396	0	396	0	396	
60	TCGA-A8-A06P	1	2	0	3	1	0	0	0	0	28	2	0	1	10	0	0	TCGA-A8-A06P-01	51	0.09445907780766602	12	TCGA-A8-A06P-01	5	5	5	0.04852929540711032	TCGA-A8-A06P-01	3	2	3	8	mutation call filter	673	TCGA-A8-A06P	BRCA	63	FEMALE	NA	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23011	Alive	TUMOR FREE	396	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	396	0	396	0	396	0	396	
60	TCGA-A8-A06Q	3	16	2	9	1	2	1	0	11	184	20	0	2	69	2	0	TCGA-A8-A06Q-01	591	0.7103534818494883	397	TCGA-A8-A06Q-01	20	28	84	0.2016840558817845	TCGA-A8-A06Q-01	14	15	9	38	mutation call filter	674	TCGA-A8-A06Q	BRCA	63	FEMALE	NA	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23164	Alive	TUMOR FREE	31	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	31	0	31	0	31	0	31	
70	TCGA-A8-A06R	1	6	1	2	4	1	2	0	4	43	5	0	4	13	3	0	TCGA-A8-A06R-01	968	0.7991768380612285	632	TCGA-A8-A06R-01	20	67	117	0.22720700823691825	TCGA-A8-A06R-01	30	23	10	63	mutation call filter	675	TCGA-A8-A06R	BRCA	69	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25477	Alive	TUMOR FREE	547	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	547	0	547	0	547	0	547	
80	TCGA-A8-A06T	1	3	0	1	2	1	0	0	2	22	0	0	4	4	1	0	TCGA-A8-A06T-01	142	0.7920666411333829	82	TCGA-A8-A06T-01	27	18	35	0.23438413034146705	TCGA-A8-A06T-01	11	9	11	31	mutation call filter	676	TCGA-A8-A06T	BRCA	75	FEMALE	NA	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27393	Alive	TUMOR FREE	1614	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1614	0	1614	0	1614	0	1614	
80	TCGA-A8-A06U	0	12	0	1	1	0	1	0	3	50	7	0	0	21	2	0	TCGA-A8-A06U-01	886	0.7830484654341042	614	TCGA-A8-A06U-01	19	57	243	0.3866417163585378	TCGA-A8-A06U-01	27	19	21	67	mutation call filter	677	TCGA-A8-A06U	BRCA	80	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29525	Dead	TUMOR FREE	NA	883	NA	NA	NA	NA	NA	NA	Negative	NA	1	883	0	883	0	883	0	883	
80	TCGA-A8-A06X	0	16	0	9	1	3	3	0	10	163	6	0	3	55	6	0	TCGA-A8-A06X-01	402	0.6119961486652701	255	TCGA-A8-A06X-01	11	29	103	0.3259587337003675	TCGA-A8-A06X-01	26	21	12	59	mutation call filter	678	TCGA-A8-A06X	BRCA	77	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28338	Dead	TUMOR FREE	NA	943	NA	NA	NA	NA	NA	NA	Negative	NA	1	943	0	943	0	943	0	943	
70	TCGA-A8-A06Y	0	4	1	3	1	1	1	0	0	21	1	0	1	8	3	0	TCGA-A8-A06Y-01	84	0.8520921814082356	39	TCGA-A8-A06Y-01	12	8	16	0.21466400975684072	TCGA-A8-A06Y-01	2	0	2	4	mutation call filter	679	TCGA-A8-A06Y	BRCA	66	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24442	Alive	TUMOR FREE	791	NA	NA	NA	NA	NA	791	NA	Negative	NA	0	791	0	791	1	791	1	791	
80	TCGA-A8-A06Z	0	8	0	0	3	0	0	0	6	64	1	0	2	22	2	0	TCGA-A8-A06Z-01	310	0.9145414716720668	201	TCGA-A8-A06Z-01	24	30	100	0.3576444473846053	TCGA-A8-A06Z-01	13	8	10	31	mutation call filter	680	TCGA-A8-A06Z	BRCA	84	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30984	Alive	NA	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
40	TCGA-A8-A075	0	5	2	2	4	1	1	0	6	61	4	0	1	21	2	1	TCGA-A8-A075-01	258	0.7830282000946456	156	TCGA-A8-A075-01	19	30	47	0.3735349712836489	TCGA-A8-A075-01	20	22	13	55	PASS	681	TCGA-A8-A075	BRCA	42	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15369	Alive	TUMOR FREE	518	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	518	0	518	0	518	0	518	
70	TCGA-A8-A076	0	10	0	3	0	2	0	0	3	61	5	0	1	14	0	0	TCGA-A8-A076-01	208	0.5910859770587629	133	TCGA-A8-A076-01	20	22	29	0.12398024496558185	TCGA-A8-A076-01	7	10	4	21	mutation call filter	682	TCGA-A8-A076	BRCA	66	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24230	Alive	TUMOR FREE	1642	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1642	0	1642	0	1642	0	1642	
70	TCGA-A8-A079	1	4	0	4	1	0	0	0	2	60	2	0	2	22	1	0	TCGA-A8-A079-01	202	0.6693003392826815	121	TCGA-A8-A079-01	14	63	40	0.17709875509534145	TCGA-A8-A079-01	16	9	6	31	mutation call filter	683	TCGA-A8-A079	BRCA	69	FEMALE	NA	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25294	Alive	TUMOR FREE	274	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	274	0	274	0	274	0	274	
70	TCGA-A8-A07B	0	3	0	1	4	1	0	0	4	53	5	0	1	20	1	0	TCGA-A8-A07B-01	274	0.6720642640379395	182	TCGA-A8-A07B-01	16	19	41	0.15766408230303358	TCGA-A8-A07B-01	14	10	5	29	mutation call filter	684	TCGA-A8-A07B	BRCA	69	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25475	Alive	TUMOR FREE	1308	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1308	0	1308	0	1308	0	1308	
60	TCGA-A8-A07C	0	15	0	6	5	1	7	1	5	108	12	0	1	32	2	0	TCGA-A8-A07C	0	0	0	TCGA-A8-A07C	0	0	0	0	TCGA-A8-A07C	0	0	0	0	mutation call filter	685	TCGA-A8-A07C	BRCA	57	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20820	Alive	TUMOR FREE	1034	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1034	0	1034	0	1034	0	1034	
80	TCGA-A8-A07E	2	1	0	4	1	0	2	0	3	49	4	0	2	11	1	0	TCGA-A8-A07E-01	155	0.21379085019535105	84	TCGA-A8-A07E-01	6	7	47	0.15790241195253266	TCGA-A8-A07E-01	8	6	6	20	mutation call filter	686	TCGA-A8-A07E	BRCA	81	FEMALE	NA	Stage X	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29800	Alive	TUMOR FREE	608	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	608	0	608	0	608	0	608	
70	TCGA-A8-A07F	0	3	0	0	3	1	0	0	0	20	3	0	0	10	1	0	TCGA-A8-A07F-01	71	0.610400100185786	29	TCGA-A8-A07F-01	22	28	4	0.023026694109094636	TCGA-A8-A07F-01	2	1	2	5	mutation call filter	687	TCGA-A8-A07F	BRCA	65	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23742	Alive	TUMOR FREE	577	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	577	0	577	0	577	0	577	
70	TCGA-A8-A07G	0	4	0	0	2	2	0	0	3	44	10	0	0	18	1	0	TCGA-A8-A07G-01	184	0.4029300952730776	100	TCGA-A8-A07G-01	5	13	30	0.19620011733895293	TCGA-A8-A07G-01	12	17	9	38	mutation call filter	688	TCGA-A8-A07G	BRCA	65	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23926	Alive	TUMOR FREE	577	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	577	0	577	0	577	0	577	
70	TCGA-A8-A07I	0	4	0	3	0	1	1	0	1	36	2	0	2	10	0	0	TCGA-A8-A07I-01	359	0.2447628902058676	227	TCGA-A8-A07I-01	5	12	106	0.18637415115960235	TCGA-A8-A07I-01	9	7	9	25	mutation call filter	689	TCGA-A8-A07I	BRCA	69	FEMALE	NA	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25263	Alive	TUMOR FREE	426	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	426	0	426	0	426	0	426	
40	TCGA-A8-A07J	0	5	0	0	1	0	2	0	1	31	1	0	0	11	2	0	TCGA-A8-A07J-01	95	0.16123584287776385	43	TCGA-A8-A07J-01	6	6	9	0.10716688747946992	TCGA-A8-A07J-01	5	4	4	13	mutation call filter	690	TCGA-A8-A07J	BRCA	35	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12965	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	365	0	365	0	365	0	365	
60	TCGA-A8-A07L	0	4	2	0	2	1	1	0	1	69	4	0	1	18	2	1	TCGA-A8-A07L-01	404	0.6486797941606923	260	TCGA-A8-A07L-01	5	20	111	0.35413232726384564	TCGA-A8-A07L-01	24	27	20	71	mutation call filter	691	TCGA-A8-A07L	BRCA	58	FEMALE	NA	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21428	Alive	TUMOR FREE	975	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	975	0	975	0	975	0	975	
50	TCGA-A8-A07O	0	3	1	2	0	0	2	0	0	33	0	0	1	13	3	0	TCGA-A8-A07O-01	358	0.313638974470122	234	TCGA-A8-A07O-01	11	9	50	0.1799849091119881	TCGA-A8-A07O-01	10	6	7	23	mutation call filter	692	TCGA-A8-A07O	BRCA	51	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18870	Alive	TUMOR FREE	304	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	304	0	304	0	304	0	304	
70	TCGA-A8-A07P	1	3	0	0	3	0	1	0	3	35	5	0	0	16	2	0	TCGA-A8-A07P-01	147	0.4429587084344139	82	TCGA-A8-A07P-01	5	10	22	0.1661017054588078	TCGA-A8-A07P-01	9	7	7	23	mutation call filter	693	TCGA-A8-A07P	BRCA	68	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24929	Alive	TUMOR FREE	334	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	334	0	334	0	334	0	334	
80	TCGA-A8-A07R	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A8-A07R-01	387	0.9222029096289646	240	TCGA-A8-A07R-01	13	38	148	0.7028774963919638	TCGA-A8-A07R-01	31	35	21	87	PASS	694	TCGA-A8-A07R	BRCA	80	FEMALE	NA	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2009	NA	-29251	Alive	NA	273	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	273	0	273	NA	NA	0	273	
70	TCGA-A8-A07S	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A8-A07S-01	131	0.10645108230233227	68	TCGA-A8-A07S-01	5	5	12	0.0650698307266719	TCGA-A8-A07S-01	5	1	4	10	PASS	695	TCGA-A8-A07S	BRCA	73	FEMALE	NA	Stage IIA	NA	Mixed Histology (please specify)	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26998	Alive	WITH TUMOR	243	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	243	0	243	NA	NA	0	243	
70	TCGA-A8-A07U	2	0	0	2	2	1	1	0	1	54	4	0	1	23	0	0	TCGA-A8-A07U-01	154	0.4292310307589363	84	TCGA-A8-A07U-01	26	36	39	0.4762663342876384	TCGA-A8-A07U-01	16	8	9	33	mutation call filter	696	TCGA-A8-A07U	BRCA	66	FEMALE	NA	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24411	Alive	TUMOR FREE	760	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	760	0	760	0	760	0	760	
80	TCGA-A8-A07W	0	14	1	4	1	0	4	0	6	113	2	0	3	30	8	0	TCGA-A8-A07W-01	256	0.7478988056229936	155	TCGA-A8-A07W-01	26	76	36	0.17496139950168624	TCGA-A8-A07W-01	12	7	5	24	mutation call filter	697	TCGA-A8-A07W	BRCA	76	FEMALE	NA	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27942	Alive	WITH TUMOR	304	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	304	0	304	NA	NA	0	304	
90	TCGA-A8-A07Z	0	2	0	2	2	0	0	0	0	11	2	0	0	7	0	0	TCGA-A8-A07Z-01	124	0.93595631238072	66	TCGA-A8-A07Z-01	11	18	31	0.7495985881309458	TCGA-A8-A07Z-01	6	1	4	11	mutation call filter	698	TCGA-A8-A07Z	BRCA	85	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31351	Alive	TUMOR FREE	1371	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1371	0	1371	0	1371	0	1371	
80	TCGA-A8-A081	0	15	0	5	2	3	1	0	5	93	2	0	5	24	6	0	TCGA-A8-A081-01	291	0.9203796596943341	194	TCGA-A8-A081-01	22	34	69	0.2878888562822526	TCGA-A8-A081-01	10	11	12	33	mutation call filter	699	TCGA-A8-A081	BRCA	80	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29555	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	0	0	0	0	0	0	0	
60	TCGA-A8-A082	0	1	0	0	1	1	1	0	1	12	1	0	0	9	1	0	TCGA-A8-A082-01	95	0.12370524291088733	40	TCGA-A8-A082-01	5	4	15	0.07180935568544608	TCGA-A8-A082-01	5	3	4	12	mutation call filter	700	TCGA-A8-A082	BRCA	58	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21338	Alive	TUMOR FREE	549	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	549	0	549	0	549	0	549	
70	TCGA-A8-A083	0	1	0	0	0	2	0	0	0	26	0	0	0	2	1	0	TCGA-A8-A083-01	63	0.18185893068404665	21	TCGA-A8-A083-01	8	5	7	0.05319727978227912	TCGA-A8-A083-01	4	2	2	8	mutation call filter	701	TCGA-A8-A083	BRCA	67	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24746	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	0	0	0	0	0	0	0	
80	TCGA-A8-A084	2	8	0	1	1	3	0	0	3	50	5	0	1	13	3	0	TCGA-A8-A084	0	0	0	TCGA-A8-A084	0	0	0	0	TCGA-A8-A084-01	8	5	3	16	mutation call filter	702	TCGA-A8-A084	BRCA	81	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29858	Alive	WITH TUMOR	458	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	458	0	458	NA	NA	0	458	
40	TCGA-A8-A085	0	6	0	2	4	0	0	0	2	51	3	0	0	18	1	1	TCGA-A8-A085-01	187	0.2973669851641911	103	TCGA-A8-A085-01	4	9	29	0.15573007957120125	TCGA-A8-A085-01	13	19	9	41	mutation call filter	703	TCGA-A8-A085	BRCA	44	MALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	NA	-16377	Alive	TUMOR FREE	1124	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1124	0	1124	0	1124	0	1124	
60	TCGA-A8-A086	0	0	0	0	3	0	0	0	2	13	1	0	0	6	1	0	TCGA-A8-A086-01	98	0.27741624141822313	48	TCGA-A8-A086-01	13	12	11	0.08897341587156231	TCGA-A8-A086-01	6	4	4	14	mutation call filter	704	TCGA-A8-A086	BRCA	59	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21731	Alive	TUMOR FREE	396	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	396	0	396	0	396	0	396	
90	TCGA-A8-A08A	0	2	0	1	0	2	2	0	1	19	1	0	0	6	0	0	TCGA-A8-A08A-01	70	0.08636933784035121	30	TCGA-A8-A08A-01	3	4	6	0.04203560941998278	TCGA-A8-A08A-01	5	4	2	11	mutation call filter	705	TCGA-A8-A08A	BRCA	89	FEMALE	NA	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32750	Alive	TUMOR FREE	30	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	30	0	30	0	30	0	30	
50	TCGA-A8-A08B	1	7	0	1	0	1	1	0	2	38	5	0	0	17	1	0	TCGA-A8-A08B-01	292	0.829912279516003	168	TCGA-A8-A08B-01	19	16	28	0.234499790792959	TCGA-A8-A08B-01	12	6	8	26	mutation call filter	706	TCGA-A8-A08B	BRCA	52	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19114	Alive	TUMOR FREE	1156	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1156	0	1156	0	1156	0	1156	
70	TCGA-A8-A08C	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A8-A08C-01	99	0.946921030127037	49	TCGA-A8-A08C-01	15	11	19	0.015826778502529764	TCGA-A8-A08C-01	3	0	1	4	PASS	707	TCGA-A8-A08C	BRCA	65	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24017	Alive	TUMOR FREE	881	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	881	0	881	0	881	0	881	
60	TCGA-A8-A08F	0	17	2	2	8	1	2	0	4	106	6	1	3	33	3	0	TCGA-A8-A08F	0	0	0	TCGA-A8-A08F	0	0	0	0	TCGA-A8-A08F-01	26	37	13	76	mutation call filter	708	TCGA-A8-A08F	BRCA	59	FEMALE	NA	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21641	Alive	TUMOR FREE	1004	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1004	0	1004	0	1004	0	1004	
40	TCGA-A8-A08G	0	3	0	1	0	1	0	0	4	37	4	0	1	10	1	0	TCGA-A8-A08G-01	364	0.9275539782019911	203	TCGA-A8-A08G-01	24	29	56	0.0931117379163509	TCGA-A8-A08G-01	11	7	6	24	mutation call filter	709	TCGA-A8-A08G	BRCA	41	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14976	Alive	TUMOR FREE	607	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	607	0	607	0	607	0	607	
70	TCGA-A8-A08H	0	7	0	7	2	1	0	0	4	88	11	0	0	56	2	0	TCGA-A8-A08H-01	71	0.03675714571625846	25	TCGA-A8-A08H-01	0	0	0	0.0	TCGA-A8-A08H-01	0	0	0	0	mutation call filter	710	TCGA-A8-A08H	BRCA	66	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24137	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	0	0	0	0	0	0	0	
50	TCGA-A8-A08I	0	2	0	2	1	0	1	0	1	32	0	0	1	11	0	0	TCGA-A8-A08I-01	369	0.8094136757494049	261	TCGA-A8-A08I-01	19	34	94	0.35232602320017303	TCGA-A8-A08I-01	14	10	9	33	mutation call filter	711	TCGA-A8-A08I	BRCA	53	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19389	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	365	0	365	0	365	0	365	
50	TCGA-A8-A08J	0	6	0	1	1	2	0	1	1	31	0	0	0	6	1	0	TCGA-A8-A08J-01	449	0.5593638224654249	281	TCGA-A8-A08J-01	16	36	64	0.20227850631440794	TCGA-A8-A08J-01	17	16	6	39	mutation call filter	712	TCGA-A8-A08J	BRCA	52	FEMALE	NA	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19266	Dead	WITH TUMOR	NA	1127	NA	NA	NA	NA	NA	NA	Positive	NA	1	1127	1	1127	NA	NA	1	1127	
90	TCGA-A8-A08L	2	19	1	4	4	2	2	0	8	164	13	1	7	52	5	0	TCGA-A8-A08L-01	250	0.9411316807637786	147	TCGA-A8-A08L-01	9	21	90	0.4952667363702766	TCGA-A8-A08L-01	28	28	23	79	mutation call filter	713	TCGA-A8-A08L	BRCA	89	FEMALE	NA	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32842	Dead	TUMOR FREE	NA	304	NA	NA	NA	NA	NA	NA	Negative	NA	1	304	0	304	0	304	0	304	
50	TCGA-A8-A08O	0	1	0	1	1	0	1	0	1	17	0	0	1	9	1	0	TCGA-A8-A08O-01	412	0.752056924607148	317	TCGA-A8-A08O-01	7	10	94	0.2160414457080423	TCGA-A8-A08O-01	10	6	9	25	mutation call filter	714	TCGA-A8-A08O	BRCA	45	FEMALE	NA	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16681	Alive	WITH TUMOR	943	NA	NA	NA	NA	NA	762	NA	Positive	NA	0	943	0	943	NA	NA	1	762	
70	TCGA-A8-A08P	0	4	0	2	1	0	1	0	0	56	5	0	0	18	3	0	TCGA-A8-A08P-01	472	0.8198130045718659	303	TCGA-A8-A08P	0	0	0	0	TCGA-A8-A08P	0	0	0	0	mutation call filter	715	TCGA-A8-A08P	BRCA	70	FEMALE	NA	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25598	Alive	TUMOR FREE	943	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	943	0	943	0	943	0	943	
50	TCGA-A8-A08R	1	23	3	11	8	1	2	0	7	193	15	0	2	76	5	0	TCGA-A8-A08R-01	290	0.7585219071836934	178	TCGA-A8-A08R-01	17	43	87	0.5207062845291529	TCGA-A8-A08R-01	29	35	21	85	mutation call filter	716	TCGA-A8-A08R	BRCA	52	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19298	Alive	TUMOR FREE	30	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	30	0	30	0	30	0	30	
70	TCGA-A8-A08S	0	5	0	2	2	0	1	1	3	37	0	0	1	19	1	0	TCGA-A8-A08S	0	0	0	TCGA-A8-A08S	0	0	0	0	TCGA-A8-A08S	0	0	0	0	mutation call filter	717	TCGA-A8-A08S	BRCA	71	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25994	Alive	TUMOR FREE	1004	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1004	0	1004	0	1004	0	1004	
60	TCGA-A8-A08T	1	4	0	1	1	0	1	0	4	30	7	0	2	10	0	0	TCGA-A8-A08T-01	195	0.3755588734988081	121	TCGA-A8-A08T-01	8	8	14	0.0843943171721296	TCGA-A8-A08T-01	6	3	3	12	mutation call filter	718	TCGA-A8-A08T	BRCA	64	FEMALE	NA	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23560	Dead	WITH TUMOR	NA	3409	NA	NA	NA	NA	2557	NA	Positive	NA	1	3409	1	3409	NA	NA	1	2557	
40	TCGA-A8-A08X	1	2	0	1	0	0	0	0	0	29	2	0	0	10	2	0	TCGA-A8-A08X-01	202	0.6465166449271655	112	TCGA-A8-A08X-01	23	34	30	0.4020517176370748	TCGA-A8-A08X-01	16	10	9	35	mutation call filter	719	TCGA-A8-A08X	BRCA	43	FEMALE	NA	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15705	Alive	TUMOR FREE	1308	NA	NA	NA	NA	NA	366	NA	Negative	NA	0	1308	0	1308	1	366	1	366	
80	TCGA-A8-A08Z	0	6	0	0	1	1	1	0	2	21	2	0	0	11	2	0	TCGA-A8-A08Z-01	82	0.10543580535296596	36	TCGA-A8-A08Z-01	6	6	16	0.06787037073312187	TCGA-A8-A08Z-01	6	3	4	13	mutation call filter	720	TCGA-A8-A08Z	BRCA	76	FEMALE	NA	[Discrepancy]	NA	Infiltrating Ductal Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28003	Alive	TUMOR FREE	1217	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1217	0	1217	0	1217	0	1217	
70	TCGA-A8-A090	0	4	0	0	0	2	1	0	0	27	2	0	1	12	1	0	TCGA-A8-A090-01	157	0.9163712415639046	97	TCGA-A8-A090-01	17	17	27	0.1937944237259003	TCGA-A8-A090-01	7	2	4	13	mutation call filter	721	TCGA-A8-A090	BRCA	74	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27121	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	0	0	0	0	0	0	0	
60	TCGA-A8-A091	0	3	0	1	0	1	1	0	0	16	1	0	0	6	0	0	TCGA-A8-A091-01	169	0.8794361258388923	85	TCGA-A8-A091-01	17	16	13	0.0648444438605677	TCGA-A8-A091-01	7	0	4	11	mutation call filter	722	TCGA-A8-A091	BRCA	61	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22554	Alive	TUMOR FREE	1004	NA	NA	NA	NA	NA	243	NA	Negative	NA	0	1004	0	1004	1	243	1	243	
50	TCGA-A8-A092	0	1	1	2	0	1	1	0	3	56	7	0	2	19	3	0	TCGA-A8-A092-01	92	0.6933779837342746	37	TCGA-A8-A092-01	24	33	16	0.30422673014561363	TCGA-A8-A092-01	8	1	4	13	mutation call filter	723	TCGA-A8-A092	BRCA	48	FEMALE	NA	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17807	Alive	TUMOR FREE	942	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	942	0	942	0	942	0	942	
60	TCGA-A8-A093	1	10	0	5	1	0	2	0	7	71	13	0	0	33	1	0	TCGA-A8-A093-01	135	0.9468976155769608	67	TCGA-A8-A093-01	22	17	12	0.07872283006479294	TCGA-A8-A093-01	5	0	2	7	mutation call filter	724	TCGA-A8-A093	BRCA	61	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22373	Alive	TUMOR FREE	546	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	546	0	546	0	546	0	546	
80	TCGA-A8-A094	2	16	2	6	10	0	2	0	9	143	9	1	2	45	6	1	TCGA-A8-A094-01	297	0.8493397356703316	196	TCGA-A8-A094-01	11	14	85	0.41072924310535536	TCGA-A8-A094-01	7	15	17	39	mutation call filter	725	TCGA-A8-A094	BRCA	75	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27729	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	0	0	0	0	0	0	0	
50	TCGA-A8-A095	0	23	0	6	1	0	0	0	15	108	13	0	3	41	4	0	TCGA-A8-A095-01	47	0.26300320036790475	8	TCGA-A8-A095-01	9	10	3	0.030580339923894057	TCGA-A8-A095-01	2	2	2	6	mutation call filter	726	TCGA-A8-A095	BRCA	45	FEMALE	NA	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16742	Alive	TUMOR FREE	1277	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1277	0	1277	0	1277	0	1277	
70	TCGA-A8-A096	0	4	0	1	1	2	0	0	0	24	0	0	0	6	2	0	TCGA-A8-A096-01	39	0.06829153695800119	7	TCGA-A8-A096-01	2	3	2	0.03660473601601843	TCGA-A8-A096-01	2	2	2	6	mutation call filter	727	TCGA-A8-A096	BRCA	73	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26723	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	0	0	0	0	0	0	0	
70	TCGA-A8-A097	0	7	1	3	3	1	0	0	5	79	4	0	2	30	1	0	TCGA-A8-A097-01	290	0.7500556088563544	174	TCGA-A8-A097-01	17	28	38	0.16991820105785035	TCGA-A8-A097-01	17	23	11	51	mutation call filter	728	TCGA-A8-A097	BRCA	65	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23741	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	365	0	365	0	365	0	365	
80	TCGA-A8-A099	0	2	0	0	0	0	0	0	2	24	1	0	1	6	0	0	TCGA-A8-A099-01	86	0.3964320840068984	41	TCGA-A8-A099-01	5	7	24	0.20669383841501987	TCGA-A8-A099-01	4	3	5	12	mutation call filter	729	TCGA-A8-A099	BRCA	76	FEMALE	NA	Stage X	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28063	Alive	NA	304	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	304	0	304	NA	NA	0	304	
40	TCGA-A8-A09A	0	20	1	8	7	1	4	0	8	169	16	0	4	54	9	0	TCGA-A8-A09A-01	197	0.5837528470412089	116	TCGA-A8-A09A-01	13	29	44	0.27316851450522645	TCGA-A8-A09A-01	26	33	11	70	mutation call filter	730	TCGA-A8-A09A	BRCA	40	FEMALE	NA	Stage X	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14883	Alive	WITH TUMOR	304	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	304	0	304	NA	NA	0	304	
60	TCGA-A8-A09B	0	5	0	1	0	0	1	0	3	34	2	0	0	13	1	0	TCGA-A8-A09B-01	104	0.7592476236367207	60	TCGA-A8-A09B-01	26	23	7	0.07314859047846327	TCGA-A8-A09B-01	6	6	1	13	mutation call filter	731	TCGA-A8-A09B	BRCA	58	FEMALE	NA	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21520	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	365	0	365	0	365	0	365	
70	TCGA-A8-A09C	1	4	0	1	0	0	0	0	2	23	1	0	1	14	0	0	TCGA-A8-A09C-01	251	0.5320177092456845	157	TCGA-A8-A09C-01	19	25	37	0.19502143216973453	TCGA-A8-A09C-01	10	5	9	24	mutation call filter	732	TCGA-A8-A09C	BRCA	69	FEMALE	NA	Stage X	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25355	Alive	NA	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
50	TCGA-A8-A09D	0	4	0	0	2	0	1	0	2	34	0	0	1	18	2	0	TCGA-A8-A09D-01	394	0.2359895776201037	256	TCGA-A8-A09D-01	4	8	71	0.1570718505162398	TCGA-A8-A09D-01	10	7	7	24	mutation call filter	733	TCGA-A8-A09D	BRCA	47	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17440	Alive	TUMOR FREE	1522	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1522	0	1522	0	1522	0	1522	
70	TCGA-A8-A09E	0	12	0	1	1	2	0	0	2	43	2	0	4	14	1	0	TCGA-A8-A09E	0	0	0	TCGA-A8-A09E	0	0	0	0	TCGA-A8-A09E-01	5	1	3	9	mutation call filter	734	TCGA-A8-A09E	BRCA	73	FEMALE	NA	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26724	Alive	WITH TUMOR	1492	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	1492	0	1492	NA	NA	0	1492	
80	TCGA-A8-A09G	1	37	0	5	4	1	0	0	19	207	19	3	3	64	0	0	TCGA-A8-A09G-01	149	0.24243417393741004	88	TCGA-A8-A09G-01	9	7	33	0.1872708810254973	TCGA-A8-A09G-01	3	3	4	10	mutation call filter	735	TCGA-A8-A09G	BRCA	79	FEMALE	NA	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29006	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	0	0	0	0	0	0	0	
80	TCGA-A8-A09I	2	9	0	2	2	1	2	0	10	110	10	0	2	44	1	0	TCGA-A8-A09I-01	382	0.5480463848717977	256	TCGA-A8-A09I-01	16	18	37	0.14309184793100754	TCGA-A8-A09I-01	14	12	8	34	mutation call filter	736	TCGA-A8-A09I	BRCA	84	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30711	Alive	TUMOR FREE	1371	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1371	0	1371	0	1371	0	1371	
70	TCGA-A8-A09K	0	3	0	0	3	0	0	0	0	29	2	0	0	12	1	0	TCGA-A8-A09K	0	0	0	TCGA-A8-A09K	0	0	0	0	TCGA-A8-A09K	0	0	0	0	mutation call filter	737	TCGA-A8-A09K	BRCA	68	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24960	Alive	TUMOR FREE	912	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	912	0	912	0	912	0	912	
80	TCGA-A8-A09M	0	11	0	3	6	1	2	0	3	116	2	0	2	45	3	0	TCGA-A8-A09M-01	184	0.7825405472192878	100	TCGA-A8-A09M-01	2	13	34	0.19372768483130995	TCGA-A8-A09M-01	18	21	12	51	mutation call filter	738	TCGA-A8-A09M	BRCA	75	FEMALE	NA	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27455	Alive	TUMOR FREE	1006	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1006	0	1006	0	1006	0	1006	
60	TCGA-A8-A09N	2	8	0	2	1	2	1	0	4	52	1	0	1	31	1	0	TCGA-A8-A09N-01	458	0.8450832104459013	321	TCGA-A8-A09N-01	14	11	84	0.31243055976621154	TCGA-A8-A09N-01	10	3	9	22	mutation call filter	739	TCGA-A8-A09N	BRCA	57	FEMALE	NA	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21002	Alive	TUMOR FREE	31	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	31	0	31	0	31	0	31	
80	TCGA-A8-A09Q	2	13	0	3	0	0	1	0	10	116	9	0	2	44	2	0	TCGA-A8-A09Q-01	667	0.7251995085183683	481	TCGA-A8-A09Q-01	24	46	176	0.31207317540129403	TCGA-A8-A09Q-01	16	18	12	46	mutation call filter	740	TCGA-A8-A09Q	BRCA	83	FEMALE	NA	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30528	Alive	WITH TUMOR	761	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	761	0	761	NA	NA	0	761	
80	TCGA-A8-A09R	0	6	0	1	2	1	5	0	1	50	2	0	1	14	5	0	TCGA-A8-A09R-01	157	0.6133499039706427	88	TCGA-A8-A09R-01	20	32	11	0.2497551171814523	TCGA-A8-A09R-01	8	3	5	16	mutation call filter	741	TCGA-A8-A09R	BRCA	82	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30196	Alive	TUMOR FREE	273	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	273	0	273	0	273	0	273	
70	TCGA-A8-A09T	1	1	1	0	0	1	0	0	0	18	2	0	0	2	1	0	TCGA-A8-A09T-01	94	0.3946246336212016	35	TCGA-A8-A09T-01	13	11	15	0.05081934789024446	TCGA-A8-A09T-01	6	2	2	10	mutation call filter	742	TCGA-A8-A09T	BRCA	68	FEMALE	NA	[Discrepancy]	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25110	Alive	TUMOR FREE	579	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	579	0	579	0	579	0	579	
50	TCGA-A8-A09V	0	2	1	3	4	2	2	0	1	21	1	0	1	11	0	0	TCGA-A8-A09V-01	77	0.07025055421060215	33	TCGA-A8-A09V-01	3	3	13	0.026425724244401986	TCGA-A8-A09V-01	3	0	1	4	mutation call filter	743	TCGA-A8-A09V	BRCA	51	FEMALE	NA	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18628	Alive	TUMOR FREE	457	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	457	0	457	0	457	0	457	
70	TCGA-A8-A09W	1	11	0	4	3	0	0	0	4	67	5	0	1	19	4	0	TCGA-A8-A09W-01	193	0.4215616902213197	97	TCGA-A8-A09W-01	7	17	28	0.2395084466490525	TCGA-A8-A09W-01	18	26	12	56	mutation call filter	744	TCGA-A8-A09W	BRCA	70	FEMALE	NA	Stage IIIB	NA	Infiltrating Lobular Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25659	Alive	NA	30	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	30	0	30	NA	NA	0	30	
60	TCGA-A8-A09X	0	6	0	1	2	0	0	0	2	41	2	0	1	18	1	0	TCGA-A8-A09X-01	138	0.5725006240939168	89	TCGA-A8-A09X-01	21	20	27	0.07916273715457765	TCGA-A8-A09X-01	12	10	4	26	mutation call filter	745	TCGA-A8-A09X	BRCA	62	FEMALE	NA	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22858	Dead	NA	NA	426	NA	NA	NA	NA	NA	NA	NA	NA	1	426	NA	426	NA	NA	0	426	
80	TCGA-A8-A09Z	7	163	6	29	109	45	22	1	66	828	40	3	23	342	34	2	TCGA-A8-A09Z-01	70	0.12047816726544565	26	TCGA-A8-A09Z-01	4	4	8	0.07486273027746539	TCGA-A8-A09Z-01	2	5	3	10	mutation call filter	746	TCGA-A8-A09Z	BRCA	83	FEMALE	NA	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30590	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	0	0	0	NA	NA	0	0	
80	TCGA-A8-A0A1	0	3	0	1	3	0	0	0	0	36	4	0	1	12	2	0	TCGA-A8-A0A1-01	99	0.30992603840205424	42	TCGA-A8-A0A1-01	3	4	12	0.1027144293084492	TCGA-A8-A0A1-01	5	7	6	18	mutation call filter	747	TCGA-A8-A0A1	BRCA	84	FEMALE	NA	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30742	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	365	0	365	0	365	0	365	
70	TCGA-A8-A0A2	0	8	0	0	1	1	1	0	2	20	3	0	1	18	2	0	TCGA-A8-A0A2-01	108	0.6014733499822074	49	TCGA-A8-A0A2-01	17	19	11	0.03835451193701443	TCGA-A8-A0A2-01	7	4	3	14	mutation call filter	748	TCGA-A8-A0A2	BRCA	66	FEMALE	NA	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24380	Alive	TUMOR FREE	579	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	579	0	579	0	579	0	579	
70	TCGA-A8-A0A4	0	2	0	3	0	1	0	0	2	19	3	0	1	10	0	0	TCGA-A8-A0A4-01	147	0.3309899072784913	87	TCGA-A8-A0A4-01	7	9	39	0.2111048803149272	TCGA-A8-A0A4-01	7	10	11	28	mutation call filter	749	TCGA-A8-A0A4	BRCA	73	FEMALE	NA	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26693	Alive	TUMOR FREE	396	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	396	0	396	0	396	0	396	
60	TCGA-A8-A0A6	1	3	1	1	1	0	0	0	1	20	4	0	0	10	1	0	TCGA-A8-A0A6-01	144	0.3886597788328901	71	TCGA-A8-A0A6-01	17	15	17	0.1776169044849189	TCGA-A8-A0A6-01	7	2	5	14	mutation call filter	750	TCGA-A8-A0A6	BRCA	64	FEMALE	NA	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23404	Alive	TUMOR FREE	640	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	640	0	640	0	640	0	640	
60	TCGA-A8-A0A7	2	18	2	6	0	1	0	0	12	172	13	0	5	69	4	0	TCGA-A8-A0A7-01	133	0.2184129028287548	71	TCGA-A8-A0A7-01	15	15	23	0.35396057137136266	TCGA-A8-A0A7-01	6	6	9	21	mutation call filter	751	TCGA-A8-A0A7	BRCA	57	FEMALE	NA	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20940	Alive	TUMOR FREE	30	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	30	0	30	0	30	0	30	
80	TCGA-A8-A0A9	0	2	0	1	0	0	0	0	0	49	3	0	1	10	0	0	TCGA-A8-A0A9-01	119	0.7249808026202801	68	TCGA-A8-A0A9-01	33	51	11	0.05544115997852126	TCGA-A8-A0A9-01	6	2	3	11	mutation call filter	752	TCGA-A8-A0A9	BRCA	80	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29370	Alive	TUMOR FREE	822	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	822	0	822	0	822	0	822	
50	TCGA-A8-A0AB	0	2	0	1	2	1	1	0	1	24	1	0	1	9	0	0	TCGA-A8-A0AB-01	139	0.8111883287636363	84	TCGA-A8-A0AB-01	17	14	24	0.10206763885588982	TCGA-A8-A0AB-01	6	6	6	18	mutation call filter	753	TCGA-A8-A0AB	BRCA	54	FEMALE	NA	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19814	Alive	TUMOR FREE	518	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	518	0	518	0	518	0	518	
80	TCGA-A8-A0AD	0	4	0	2	1	1	0	0	2	18	1	0	0	11	3	0	TCGA-A8-A0AD-01	423	0.4654524326461667	339	TCGA-A8-A0AD-01	8	5	103	0.1603908221613315	TCGA-A8-A0AD-01	3	1	4	8	mutation call filter	754	TCGA-A8-A0AD	BRCA	83	FEMALE	NA	Stage I	NA	Mixed Histology (please specify)	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30407	Alive	TUMOR FREE	1157	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1157	0	1157	0	1157	0	1157	
60	TCGA-AC-A23C	0	6	0	4	6	0	1	0	1	92	7	1	2	30	3	0	TCGA-AC-A23C-01	299	0.2471943994239426	198	TCGA-AC-A23C-01	4	10	44	0.14072339865170153	TCGA-AC-A23C-01	11	7	8	26	PASS	755	TCGA-AC-A23C	BRCA	62	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22751	Alive	TUMOR FREE	585	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	585	0	585	0	585	0	585	
50	TCGA-AC-A23E	0	2	0	1	1	0	0	0	0	14	2	0	0	7	1	0	TCGA-AC-A23E-01	91	0.7745771835764642	42	TCGA-AC-A23E-01	19	17	5	0.033919626792534005	TCGA-AC-A23E-01	4	1	3	8	PASS	756	TCGA-AC-A23E	BRCA	50	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	NA	-18500	Alive	TUMOR FREE	698	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	698	0	698	0	698	0	698	
80	TCGA-AC-A23G	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AC-A23G-01	77	0.2877035451598605	32	TCGA-AC-A23G-01	18	19	9	0.06877602313598033	TCGA-AC-A23G-01	3	0	3	6	PASS	757	TCGA-AC-A23G	BRCA	76	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27934	Alive	TUMOR FREE	2248	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2248	0	2248	0	2248	0	2248	
90	TCGA-AC-A23H	32	363	22	185	16	3	1	0	263	3647	404	7	59	1334	73	10	TCGA-AC-A23H-01	285	0.875266156802492	176	TCGA-AC-A23H-01	16	29	40	0.11528152230075504	TCGA-AC-A23H-01	11	6	4	21	hypermutated sample	758	TCGA-AC-A23H	BRCA	90	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32873	Dead	WITH TUMOR	NA	174	NA	NA	NA	NA	NA	NA	Negative	NA	1	174	1	174	NA	NA	1	174	
80	TCGA-AC-A2B8	1	7	0	7	1	0	2	0	2	74	4	0	2	32	1	0	TCGA-AC-A2B8-01	74	0.1088007094325498	26	TCGA-AC-A2B8-01	3	9	14	0.12138587452759167	TCGA-AC-A2B8-01	8	7	4	19	PASS	759	TCGA-AC-A2B8	BRCA	84	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31003	Alive	TUMOR FREE	677	NA	NA	New Primary Tumor	"Other, specify"	Rectum	654	NA	Negative	NA	0	677	0	677	0	677	1	654	
80	TCGA-AC-A2BK	3	23	0	3	7	0	1	0	3	61	5	0	3	17	4	0	TCGA-AC-A2BK-01	276	0.9222521143758918	158	TCGA-AC-A2BK-01	14	37	98	0.4801647227972227	TCGA-AC-A2BK-01	22	12	15	49	PASS	760	TCGA-AC-A2BK	BRCA	78	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28625	Alive	TUMOR FREE	2222	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2222	0	2222	0	2222	0	2222	
40	TCGA-AC-A2BM	0	4	1	2	0	0	0	0	2	18	1	0	1	3	0	0	TCGA-AC-A2BM-01	316	0.7890149070179396	189	TCGA-AC-A2BM-01	18	19	134	0.3113608505736725	TCGA-AC-A2BM-01	11	9	5	25	PASS	761	TCGA-AC-A2BM	BRCA	41	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2005	NA	-15212	Alive	TUMOR FREE	3022	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3022	0	3022	0	3022	0	3022	
70	TCGA-AC-A2FB	0	1	0	0	0	0	0	0	0	7	3	0	0	6	0	0	TCGA-AC-A2FB-01	115	0.09738696688808604	57	TCGA-AC-A2FB-01	4	4	14	0.06541069194337107	TCGA-AC-A2FB-01	2	3	3	8	PASS	762	TCGA-AC-A2FB	BRCA	65	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2009	NA	-23851	Alive	TUMOR FREE	1234	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1234	0	1234	0	1234	0	1234	
60	TCGA-AC-A2FE	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AC-A2FE-01	153	0.186205041011808	94	TCGA-AC-A2FE-01	5	5	23	0.07658395634893052	TCGA-AC-A2FE-01	6	5	3	14	PASS	763	TCGA-AC-A2FE	BRCA	62	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22746	Dead	WITH TUMOR	NA	2636	NA	Distant Metastasis	Bone	NA	766	NA	Negative	NA	1	2636	1	2636	1	766	1	766	
40	TCGA-AC-A2FF	0	1	0	0	2	1	0	0	0	12	1	0	0	2	0	0	TCGA-AC-A2FF-01	95	0.07450535409264561	44	TCGA-AC-A2FF-01	0	0	0	0.0	TCGA-AC-A2FF-01	0	0	0	0	PASS	764	TCGA-AC-A2FF	BRCA	40	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2006	NA	NA	Alive	TUMOR FREE	2759	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2759	0	2759	0	2759	0	2759	
80	TCGA-AC-A2FG	0	3	0	1	2	1	0	0	0	24	0	0	0	11	0	0	TCGA-AC-A2FG-01	74	0.07883871740596217	23	TCGA-AC-A2FG-01	3	3	6	0.035052920184037134	TCGA-AC-A2FG-01	5	2	3	10	PASS	765	TCGA-AC-A2FG	BRCA	79	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29211	Alive	TUMOR FREE	1853	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1853	0	1853	0	1853	0	1853	
50	TCGA-AC-A2FK	0	1	0	0	0	0	0	0	0	0	0	0	0	1	1	0	TCGA-AC-A2FK-01	45	1.5984199471907787e-05	6	TCGA-AC-A2FK-01	0	0	0	0.0	TCGA-AC-A2FK-01	0	0	0	0	PASS	766	TCGA-AC-A2FK	BRCA	45	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2006	NA	-16627	Alive	TUMOR FREE	2650	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2650	0	2650	0	2650	0	2650	
90	TCGA-AC-A2FM	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AC-A2FM-01	203	0.7719466925182176	124	TCGA-AC-A2FM-01	11	11	31	0.1573799418702387	TCGA-AC-A2FM-01	5	0	5	10	PASS	767	TCGA-AC-A2FM	BRCA	87	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31805	Dead	WITH TUMOR	NA	792	NA	Distant Metastasis	"Other, specify"	Bone Marrow	780	NA	Negative	NA	1	792	1	792	1	780	1	780	
70	TCGA-AC-A2FO	0	0	0	1	0	2	0	0	1	15	3	0	1	5	4	0	TCGA-AC-A2FO-01	126	0.13455607659530658	58	TCGA-AC-A2FO-01	2	3	19	0.07729638937319172	TCGA-AC-A2FO-01	10	6	6	22	PASS	768	TCGA-AC-A2FO	BRCA	65	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23928	Alive	TUMOR FREE	2255	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2255	0	2255	0	2255	0	2255	
60	TCGA-AC-A2QH	0	1	0	0	3	0	3	0	1	17	2	0	0	9	1	0	TCGA-AC-A2QH-01	404	0.5677877751298066	242	TCGA-AC-A2QH-01	18	59	71	0.262316458129998	TCGA-AC-A2QH-01	20	11	9	40	PASS	769	TCGA-AC-A2QH	BRCA	58	FEMALE	WHITE	Stage IIB	NA	Metaplastic Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21488	Alive	TUMOR FREE	1005	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1005	0	1005	0	1005	0	1005	
80	TCGA-AC-A2QI	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AC-A2QI-01	69	0.2558012760942726	21	TCGA-AC-A2QI-01	5	5	5	0.04971946564887191	TCGA-AC-A2QI-01	5	2	4	11	PASS	770	TCGA-AC-A2QI	BRCA	76	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27865	Alive	TUMOR FREE	588	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	588	0	588	0	588	0	588	
50	TCGA-AC-A2QJ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AC-A2QJ-01	116	0.6246190067426527	60	TCGA-AC-A2QJ-01	23	27	14	0.07339276590083625	TCGA-AC-A2QJ-01	6	1	2	9	PASS	771	TCGA-AC-A2QJ	BRCA	48	FEMALE	WHITE	Stage IIIB	NA	Metaplastic Carcinoma	NA	2011	Peri (6-12 months since last menstrual period)	-17569	Dead	WITH TUMOR	NA	446	NA	Distant Metastasis	Bone	NA	237	NA	Negative	NA	1	446	1	446	1	237	1	237	
50	TCGA-AC-A3BB	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AC-A3BB-01	73	0.2670307071630339	29	TCGA-AC-A3BB-01	13	13	6	0.059409062450134976	TCGA-AC-A3BB-01	3	2	2	7	PASS	772	TCGA-AC-A3BB	BRCA	46	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2011	NA	-16983	Alive	TUMOR FREE	987	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	987	0	987	0	987	0	987	
80	TCGA-AC-A3EH	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AC-A3EH-01	131	0.3664185283986913	73	TCGA-AC-A3EH-01	13	15	32	0.1512975539441664	TCGA-AC-A3EH-01	5	3	3	11	PASS	773	TCGA-AC-A3EH	BRCA	79	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29014	Dead	TUMOR FREE	NA	197	NA	NA	NA	NA	NA	NA	Negative	NA	1	197	0	197	0	197	0	197	
90	TCGA-AC-A3HN	0	2	0	2	0	0	0	1	1	11	0	0	0	6	0	0	TCGA-AC-A3HN-01	82	0.1526572409772787	38	TCGA-AC-A3HN-01	5	5	9	0.055539425594936284	TCGA-AC-A3HN-01	4	3	3	10	PASS	774	TCGA-AC-A3HN	BRCA	87	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32061	Alive	TUMOR FREE	496	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	496	0	496	0	496	0	496	
70	TCGA-AC-A3OD	1	5	0	3	1	0	0	0	1	21	6	0	2	6	0	0	TCGA-AC-A3OD-01	192	0.3187214823412696	129	TCGA-AC-A3OD-01	6	10	49	0.16329419704464385	TCGA-AC-A3OD-01	10	7	8	25	PASS	775	TCGA-AC-A3OD	BRCA	68	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25186	Alive	TUMOR FREE	451	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	451	0	451	0	451	0	451	
80	TCGA-AC-A3QP	1	5	1	0	0	1	1	0	1	17	2	0	1	7	1	0	TCGA-AC-A3QP-01	66	0.0716322023527689	26	TCGA-AC-A3QP-01	2	5	23	0.0389913476680486	TCGA-AC-A3QP-01	5	2	3	10	PASS	776	TCGA-AC-A3QP	BRCA	79	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29113	Alive	TUMOR FREE	675	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	675	0	675	0	675	0	675	
50	TCGA-AC-A3QQ	1	3	0	2	1	0	0	0	0	22	2	0	1	5	0	0	TCGA-AC-A3QQ-01	117	0.13442477593496258	63	TCGA-AC-A3QQ-01	6	7	5	0.05581233314058357	TCGA-AC-A3QQ-01	6	4	4	14	PASS	777	TCGA-AC-A3QQ	BRCA	54	FEMALE	WHITE	Stage IA	NA	Infiltrating Lobular Carcinoma	NA	2011	Peri (6-12 months since last menstrual period)	-19723	Alive	TUMOR FREE	734	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	734	0	734	NA	NA	0	734	
50	TCGA-AC-A3TM	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AC-A3TM-01	135	0.1223000699228264	73	TCGA-AC-A3TM-01	5	5	17	0.07578493937458343	TCGA-AC-A3TM-01	5	1	2	8	PASS	778	TCGA-AC-A3TM	BRCA	50	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2011	Peri (6-12 months since last menstrual period)	-18535	Alive	TUMOR FREE	762	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	762	0	762	0	762	0	762	
80	TCGA-AC-A3TN	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AC-A3TN-01	45	0.07100240606535227	8	TCGA-AC-A3TN-01	4	4	3	0.03902370798758216	TCGA-AC-A3TN-01	4	0	3	7	PASS	779	TCGA-AC-A3TN	BRCA	75	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27421	Alive	TUMOR FREE	456	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	456	0	456	0	456	0	456	
70	TCGA-AC-A3W5	7	40	2	13	4	0	2	0	12	101	7	0	4	35	4	0	TCGA-AC-A3W5-01	227	0.6259864847786005	136	TCGA-AC-A3W5-01	23	24	51	0.2345271558002757	TCGA-AC-A3W5-01	16	13	7	36	PASS	780	TCGA-AC-A3W5	BRCA	65	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2011	[Not Evaluated]	-24029	Alive	TUMOR FREE	504	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	504	0	504	NA	NA	0	504	
90	TCGA-AC-A3W6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AC-A3W6-01	62	0.1897654480078815	21	TCGA-AC-A3W6-01	6	4	8	0.11089909588773234	TCGA-AC-A3W6-01	1	0	1	2	PASS	781	TCGA-AC-A3W6	BRCA	90	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32872	Alive	TUMOR FREE	602	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	602	0	602	0	602	0	602	
70	TCGA-AC-A3W7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AC-A3W7-01	71	0.14536091855133898	25	TCGA-AC-A3W7-01	8	6	7	0.1168013340613719	TCGA-AC-A3W7-01	4	1	3	8	PASS	782	TCGA-AC-A3W7	BRCA	66	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24327	Alive	TUMOR FREE	471	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	471	0	471	0	471	0	471	
70	TCGA-AC-A3YI	1	1	0	0	0	1	0	0	2	13	0	0	0	3	0	0	TCGA-AC-A3YI-01	79	0.05713548208018381	31	TCGA-AC-A3YI-01	0	0	9	0.0005524663825891068	TCGA-AC-A3YI-01	0	3	0	3	PASS	783	TCGA-AC-A3YI	BRCA	74	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27143	Alive	TUMOR FREE	707	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	707	0	707	0	707	0	707	
70	TCGA-AC-A3YJ	0	7	0	3	1	0	2	0	3	14	0	0	3	10	0	0	TCGA-AC-A3YJ-01	63	0.04430274325649861	20	TCGA-AC-A3YJ-01	1	1	12	0.0017485327381929535	TCGA-AC-A3YJ-01	1	2	0	3	PASS	784	TCGA-AC-A3YJ	BRCA	66	FEMALE	WHITE	Stage IIA	NA	"Other, specify"	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24439	Alive	TUMOR FREE	754	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	754	0	754	0	754	0	754	
60	TCGA-AC-A4ZE	1	15	2	1	1	1	0	0	6	40	1	0	3	7	2	0	TCGA-AC-A4ZE-01	147	0.34544434676310765	81	TCGA-AC-A4ZE-01	7	9	46	0.10869724364153692	TCGA-AC-A4ZE-01	5	1	7	13	PASS	785	TCGA-AC-A4ZE	BRCA	63	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23284	Alive	TUMOR FREE	890	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	890	0	890	0	890	0	890	
80	TCGA-AC-A5EH	2	24	2	6	1	4	1	0	5	104	9	1	4	44	6	1	TCGA-AC-A5EH-01	250	0.7496281440565303	176	TCGA-AC-A5EH-01	25	19	107	0.19366961463731872	TCGA-AC-A5EH-01	10	15	12	37	PASS	786	TCGA-AC-A5EH	BRCA	76	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2012	NA	-27964	Alive	TUMOR FREE	511	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	511	0	511	0	511	0	511	
90	TCGA-AC-A5EI	2	10	0	2	2	1	1	0	0	23	0	0	1	7	2	0	TCGA-AC-A5EI-01	94	0.8712703576264179	37	TCGA-AC-A5EI-01	8	22	187	0.6916153270090701	TCGA-AC-A5EI-01	5	10	10	25	PASS	787	TCGA-AC-A5EI	BRCA	88	FEMALE	WHITE	Stage IB	NA	"Other, specify"	NA	2012	NA	-32375	Alive	TUMOR FREE	442	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	442	0	442	0	442	0	442	
70	TCGA-AC-A5XS	14	214	20	50	10	0	0	0	68	712	54	0	16	284	12	0	TCGA-AC-A5XS-01	77	0.26025141098626514	29	TCGA-AC-A5XS-01	9	9	36	0.1713809476522146	TCGA-AC-A5XS-01	7	11	7	25	PASS	788	TCGA-AC-A5XS	BRCA	74	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2012	NA	-27160	Alive	TUMOR FREE	588	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	588	0	588	0	588	0	588	
70	TCGA-AC-A5XU	3	19	1	7	0	1	0	1	8	47	4	0	2	25	1	0	TCGA-AC-A5XU-01	515	0.713736421213087	325	TCGA-AC-A5XU-01	4	9	141	0.13356574498884774	TCGA-AC-A5XU-01	10	7	6	23	PASS	789	TCGA-AC-A5XU	BRCA	74	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2013	NA	-27191	Alive	TUMOR FREE	455	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	455	0	455	0	455	0	455	
60	TCGA-AC-A62V	4	12	2	3	3	0	0	0	6	63	1	0	1	19	0	0	TCGA-AC-A62V-01	441	0.5005087221158215	283	TCGA-AC-A62V-01	18	30	92	0.13598853416360565	TCGA-AC-A62V-01	14	9	5	28	PASS	790	TCGA-AC-A62V	BRCA	58	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	2013	[Not Evaluated]	-21389	Dead	WITH TUMOR	NA	348	NA	NA	NA	NA	NA	NA	Negative	NA	1	348	1	348	NA	NA	1	348	
70	TCGA-AC-A62X	0	15	3	3	1	1	0	1	5	49	1	0	1	12	0	0	TCGA-AC-A62X-01	173	0.8644750995826455	98	TCGA-AC-A62X-01	29	74	81	0.2638891324546362	TCGA-AC-A62X-01	13	8	3	24	PASS	791	TCGA-AC-A62X	BRCA	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26627	Alive	TUMOR FREE	417	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	417	0	417	0	417	0	417	
80	TCGA-AC-A62Y	0	16	1	4	1	2	1	0	1	48	4	0	1	15	1	0	TCGA-AC-A62Y-01	75	0.5691644794342627	34	TCGA-AC-A62Y-01	22	23	12	0.05703142303323181	TCGA-AC-A62Y-01	5	8	2	15	PASS	792	TCGA-AC-A62Y	BRCA	79	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28876	Alive	TUMOR FREE	530	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	530	0	530	NA	NA	0	530	
50	TCGA-AC-A6IV	0	5	0	2	1	0	0	0	1	15	1	0	1	6	1	0	TCGA-AC-A6IV-01	59	0.12379887739267145	20	TCGA-AC-A6IV-01	6	6	21	0.06837541404199232	TCGA-AC-A6IV-01	6	3	3	12	PASS	793	TCGA-AC-A6IV	BRCA	47	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2012	NA	-17521	Alive	TUMOR FREE	568	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	568	0	568	0	568	0	568	
70	TCGA-AC-A6IW	2	46	0	7	2	1	0	0	12	116	3	0	7	51	4	0	TCGA-AC-A6IW-01	302	0.6726489212006636	191	TCGA-AC-A6IW-01	13	26	331	0.7994056290840029	TCGA-AC-A6IW-01	15	12	4	31	PASS	794	TCGA-AC-A6IW	BRCA	73	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26896	Alive	TUMOR FREE	413	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	413	0	413	0	413	0	413	
50	TCGA-AC-A6IX	4	15	2	4	6	0	0	0	1	77	3	1	2	27	0	0	TCGA-AC-A6IX-01	178	0.19115784675220407	97	TCGA-AC-A6IX-06	4	8	60	0.12910082469405434	TCGA-AC-A6IX-06	5	4	11	20	mutation call filter	795	TCGA-AC-A6IX	BRCA	49	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2013	Peri (6-12 months since last menstrual period)	-17969	Alive	TUMOR FREE	373	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	373	0	373	0	373	0	373	
40	TCGA-AC-A6NO	1	6	0	3	1	1	0	0	1	22	2	0	1	13	0	0	TCGA-AC-A6NO-01	77	0.17494730238400208	31	TCGA-AC-A6NO-01	8	6	9	0.033188574108651184	TCGA-AC-A6NO-01	2	2	2	6	PASS	796	TCGA-AC-A6NO	BRCA	43	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2011	[Unknown]	-15996	Alive	TUMOR FREE	51	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	51	0	51	0	51	0	51	
50	TCGA-AC-A7VB	2	4	0	4	2	0	0	0	2	17	2	0	0	8	1	0	TCGA-AC-A7VB-01	422	0.35145642770105395	285	TCGA-AC-A7VB-01	8	8	144	0.18334042255135452	TCGA-AC-A7VB-01	8	9	7	24	PASS	797	TCGA-AC-A7VB	BRCA	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2013	[Unknown]	-18806	Alive	TUMOR FREE	250	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	250	0	250	0	250	0	250	
60	TCGA-AC-A7VC	1	3	0	1	0	0	1	0	3	12	2	0	1	5	0	0	TCGA-AC-A7VC-01	84	0.6246430975069145	29	TCGA-AC-A7VC-01	1	6	28	0.10056135374354876	TCGA-AC-A7VC-01	3	2	3	8	PASS	798	TCGA-AC-A7VC	BRCA	56	FEMALE	WHITE	Stage IIB	NA	Metaplastic Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20479	Alive	TUMOR FREE	1	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1	0	1	0	1	0	1	
70	TCGA-AC-A8OP	5	40	3	7	3	3	0	0	9	114	10	0	10	52	5	1	TCGA-AC-A8OP-01	245	0.4280923288350226	154	TCGA-AC-A8OP-01	20	27	74	0.08294986326085765	TCGA-AC-A8OP-01	16	14	6	36	PASS	799	TCGA-AC-A8OP	BRCA	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26550	Alive	TUMOR FREE	614	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	614	0	614	0	614	0	614	
70	TCGA-AC-A8OQ	3	25	2	6	0	0	1	0	10	67	5	0	5	22	3	0	TCGA-AC-A8OQ-01	460	0.6619322464461049	292	TCGA-AC-A8OQ-01	23	68	284	0.4873956642212395	TCGA-AC-A8OQ-01	25	29	17	71	PASS	800	TCGA-AC-A8OQ	BRCA	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26535	Alive	TUMOR FREE	34	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	34	0	34	0	34	0	34	
80	TCGA-AC-A8OR	0	9	5	3	1	0	0	0	2	53	1	0	2	15	3	0	TCGA-AC-A8OR-01	80	0.032836641783942445	34	TCGA-AC-A8OR-01	1	1	15	0.03383461529060857	TCGA-AC-A8OR-01	1	0	3	4	PASS	801	TCGA-AC-A8OR	BRCA	75	FEMALE	WHITE	Stage IA	NA	Mucinous Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27605	Alive	TUMOR FREE	40	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	40	0	40	0	40	0	40	
70	TCGA-AC-A8OS	0	12	1	1	3	1	0	0	5	31	4	0	3	22	2	0	TCGA-AC-A8OS-01	67	0.1344491615046184	25	TCGA-AC-A8OS-01	8	7	27	0.14593771103154715	TCGA-AC-A8OS-01	3	1	3	7	PASS	802	TCGA-AC-A8OS	BRCA	71	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26248	Alive	TUMOR FREE	70	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	70	0	70	0	70	0	70	
70	TCGA-AN-A03X	0	4	0	1	1	1	1	0	5	29	2	0	2	8	0	0	TCGA-AN-A03X-01	116	0.3072201984654973	58	TCGA-AN-A03X-01	14	10	20	0.20659459581984888	TCGA-AN-A03X-01	7	1	4	12	mutation call filter	803	TCGA-AN-A03X	BRCA	74	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27163	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	10	0	10	0	10	0	10	
70	TCGA-AN-A03Y	0	1	0	0	1	1	0	0	1	22	2	0	0	14	1	0	TCGA-AN-A03Y-01	156	0.9469274398207372	87	TCGA-AN-A03Y-01	24	20	11	0.1990906612656484	TCGA-AN-A03Y-01	6	1	3	10	mutation call filter	804	TCGA-AN-A03Y	BRCA	66	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24232	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	10	0	10	0	10	0	10	
30	TCGA-AN-A041	0	1	1	2	2	0	0	0	1	26	0	0	1	9	0	0	TCGA-AN-A041-01	203	0.6081391855261223	121	TCGA-AN-A041-01	14	18	27	0.10906269484655426	TCGA-AN-A041-01	10	3	4	17	mutation call filter	805	TCGA-AN-A041	BRCA	29	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-10812	Alive	TUMOR FREE	7	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	7	0	7	0	7	0	7	
70	TCGA-AN-A046	20	451	19	123	3	12	0	0	218	4497	757	6	89	1300	91	0	TCGA-AN-A046-01	80	0.141588642671182	34	TCGA-AN-A046-01	7	5	4	0.023199207270890386	TCGA-AN-A046-01	4	2	2	8	mutation call filter	806	TCGA-AN-A046	BRCA	68	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25158	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	10	0	10	0	10	0	10	
60	TCGA-AN-A049	0	2	0	1	3	1	0	0	1	25	0	0	0	8	0	0	TCGA-AN-A049-01	210	0.37964294152262396	117	TCGA-AN-A049-01	10	16	57	0.21786772630395326	TCGA-AN-A049-01	17	13	10	40	mutation call filter	807	TCGA-AN-A049	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22710	Alive	TUMOR FREE	19	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	19	0	19	NA	NA	0	19	
40	TCGA-AN-A04A	0	2	0	1	0	0	1	0	4	34	5	0	2	13	0	0	TCGA-AN-A04A-01	231	0.5433002329864017	141	TCGA-AN-A04A-01	14	28	40	0.27577020969528365	TCGA-AN-A04A-01	13	16	14	43	mutation call filter	808	TCGA-AN-A04A	BRCA	36	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Peri (6-12 months since last menstrual period)	-13445	Alive	TUMOR FREE	90	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	90	0	90	NA	NA	0	90	
50	TCGA-AN-A04C	1	4	0	2	3	0	0	0	3	57	4	0	3	23	2	0	TCGA-AN-A04C-01	344	0.7671672433626023	225	TCGA-AN-A04C-01	19	28	70	0.17710252518055328	TCGA-AN-A04C-01	16	11	8	35	mutation call filter	809	TCGA-AN-A04C	BRCA	51	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18851	Alive	TUMOR FREE	54	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	54	0	54	NA	NA	0	54	
60	TCGA-AN-A04D	0	11	0	0	3	1	3	1	2	70	3	0	0	30	2	0	TCGA-AN-A04D-01	171	0.3693971801734935	85	TCGA-AN-A04D-01	4	11	40	0.20050753611943287	TCGA-AN-A04D-01	20	29	12	61	mutation call filter	810	TCGA-AN-A04D	BRCA	58	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21426	Alive	TUMOR FREE	52	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	52	0	52	NA	NA	0	52	
80	TCGA-AN-A0AJ	1	9	1	3	4	0	2	0	3	63	6	0	3	21	2	1	TCGA-AN-A0AJ-01	468	0.7287418793491337	275	TCGA-AN-A0AJ-01	16	40	75	0.20585460238641576	TCGA-AN-A0AJ-01	20	13	7	40	mutation call filter	811	TCGA-AN-A0AJ	BRCA	79	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29131	Alive	TUMOR FREE	303	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	303	0	303	0	303	0	303	
80	TCGA-AN-A0AK	7	139	6	33	131	48	33	2	67	812	47	0	23	366	33	1	TCGA-AN-A0AK-01	113	0.6471960088055111	50	TCGA-AN-A0AK-01	12	17	6	0.047199514632887365	TCGA-AN-A0AK-01	7	6	3	16	mutation call filter	812	TCGA-AN-A0AK	BRCA	76	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27977	Alive	TUMOR FREE	224	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	224	0	224	0	224	0	224	
40	TCGA-AN-A0AL	0	8	3	4	8	0	2	0	3	61	5	0	3	16	3	0	TCGA-AN-A0AL-01	176	0.8802615787145017	102	TCGA-AN-A0AL-01	6	17	75	0.3392461726590701	TCGA-AN-A0AL-01	20	29	17	66	mutation call filter	813	TCGA-AN-A0AL	BRCA	41	FEMALE	WHITE	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15286	Alive	TUMOR FREE	227	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	227	0	227	0	227	0	227	
60	TCGA-AN-A0AM	0	3	1	1	1	1	0	0	4	75	5	0	1	33	3	0	TCGA-AN-A0AM-01	783	0.5915427246207976	494	TCGA-AN-A0AM-01	21	29	52	0.16046806195510901	TCGA-AN-A0AM-01	21	13	10	44	mutation call filter	814	TCGA-AN-A0AM	BRCA	56	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20713	Alive	TUMOR FREE	5	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	5	0	5	0	5	0	5	
60	TCGA-AN-A0AR	2	11	1	7	8	0	4	0	2	88	5	0	4	24	5	1	TCGA-AN-A0AR-01	611	0.9457442432324644	407	TCGA-AN-A0AR-01	10	21	161	0.4655163792365542	TCGA-AN-A0AR-01	25	30	20	75	mutation call filter	815	TCGA-AN-A0AR	BRCA	55	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-20152	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	10	0	10	0	10	0	10	
70	TCGA-AN-A0AS	0	2	0	0	0	1	1	0	0	33	3	0	1	7	4	0	TCGA-AN-A0AS-01	245	0.6399531402898855	154	TCGA-AN-A0AS-01	24	25	39	0.14511631876202608	TCGA-AN-A0AS-01	12	4	5	21	mutation call filter	816	TCGA-AN-A0AS	BRCA	70	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25658	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	10	0	10	0	10	0	10	
60	TCGA-AN-A0AT	1	5	0	2	8	1	0	0	2	104	4	0	2	23	1	0	TCGA-AN-A0AT-01	481	0.9326167141828771	293	TCGA-AN-A0AT-01	8	18	127	0.4730908143426667	TCGA-AN-A0AT-01	23	24	20	67	mutation call filter	817	TCGA-AN-A0AT	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22798	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	10	0	10	0	10	0	10	
70	TCGA-AN-A0FD	0	1	0	2	2	1	0	0	0	26	2	0	0	13	0	0	TCGA-AN-A0FD-01	304	0.4271827093331434	183	TCGA-AN-A0FD-01	6	8	52	0.17697394602273048	TCGA-AN-A0FD-01	6	6	8	20	mutation call filter	818	TCGA-AN-A0FD	BRCA	71	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26007	Alive	TUMOR FREE	196	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	196	0	196	0	196	0	196	
30	TCGA-AN-A0FF	0	2	0	1	0	1	1	0	1	16	2	0	1	4	0	0	TCGA-AN-A0FF-01	88	0.15089235691263925	38	TCGA-AN-A0FF-01	4	6	12	0.06326041773149774	TCGA-AN-A0FF-01	4	5	2	11	mutation call filter	819	TCGA-AN-A0FF	BRCA	32	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11929	Alive	TUMOR FREE	172	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	172	0	172	0	172	0	172	
60	TCGA-AN-A0FJ	0	13	0	7	3	1	0	0	8	67	5	0	1	23	1	0	TCGA-AN-A0FJ-01	709	0.8719864177551411	498	TCGA-AN-A0FJ-01	12	16	156	0.4090769971496334	TCGA-AN-A0FJ-01	11	9	7	27	mutation call filter	820	TCGA-AN-A0FJ	BRCA	59	FEMALE	WHITE	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	2010	Peri (6-12 months since last menstrual period)	-21910	Alive	TUMOR FREE	242	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	242	0	242	NA	NA	0	242	
90	TCGA-AN-A0FK	0	2	0	1	1	0	1	0	1	29	2	0	0	22	1	0	TCGA-AN-A0FK-01	67	0.6215741721394711	27	TCGA-AN-A0FK-01	23	25	12	0.07202118823393584	TCGA-AN-A0FK-01	4	2	3	9	mutation call filter	821	TCGA-AN-A0FK	BRCA	88	FEMALE	WHITE	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32462	Alive	TUMOR FREE	213	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	213	0	213	0	213	0	213	
60	TCGA-AN-A0FL	2	4	0	9	5	2	2	0	9	121	13	0	2	44	5	0	TCGA-AN-A0FL-01	536	0.5440490272422033	381	TCGA-AN-A0FL-01	7	15	75	0.2941495199870055	TCGA-AN-A0FL-01	18	25	14	57	mutation call filter	822	TCGA-AN-A0FL	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22805	Alive	TUMOR FREE	231	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	231	0	231	0	231	0	231	
60	TCGA-AN-A0FN	0	3	0	1	1	3	0	0	4	33	1	0	2	11	0	0	TCGA-AN-A0FN-01	57	0.11277102109138387	17	TCGA-AN-A0FN-01	3	2	2	0.07232726864373641	TCGA-AN-A0FN-01	1	0	2	3	mutation call filter	823	TCGA-AN-A0FN	BRCA	61	FEMALE	WHITE	Stage IA	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22629	Alive	TUMOR FREE	218	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	218	0	218	0	218	0	218	
60	TCGA-AN-A0FS	0	3	1	3	1	1	0	0	1	51	7	0	1	26	1	0	TCGA-AN-A0FS-01	187	0.13844412505595222	103	TCGA-AN-A0FS-01	3	6	21	0.0709898474789706	TCGA-AN-A0FS-01	4	3	5	12	mutation call filter	824	TCGA-AN-A0FS	BRCA	55	FEMALE	WHITE	Stage IA	NA	Infiltrating Lobular Carcinoma	NA	2010	Peri (6-12 months since last menstrual period)	-20352	Alive	TUMOR FREE	210	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	210	0	210	0	210	0	210	
60	TCGA-AN-A0FT	0	6	0	7	2	2	0	0	3	67	9	0	2	35	3	0	TCGA-AN-A0FT-01	537	0.7254425426076978	365	TCGA-AN-A0FT-01	19	44	62	0.1875503032740473	TCGA-AN-A0FT-01	25	22	10	57	mutation call filter	825	TCGA-AN-A0FT	BRCA	63	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23300	Alive	TUMOR FREE	214	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	214	0	214	0	214	0	214	
60	TCGA-AN-A0FV	0	7	2	2	3	0	0	0	4	71	5	0	1	25	0	1	TCGA-AN-A0FV-01	286	0.943003781392686	186	TCGA-AN-A0FV-01	19	35	65	0.2667483232961418	TCGA-AN-A0FV-01	15	11	9	35	mutation call filter	826	TCGA-AN-A0FV	BRCA	58	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21479	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	10	0	10	0	10	0	10	
70	TCGA-AN-A0FW	0	10	1	5	2	2	1	0	3	85	11	1	4	32	3	0	TCGA-AN-A0FW-01	252	0.875087766651352	166	TCGA-AN-A0FW-01	20	25	37	0.1279626201523432	TCGA-AN-A0FW-01	11	7	5	23	mutation call filter	827	TCGA-AN-A0FW	BRCA	67	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24692	Alive	TUMOR FREE	11	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	11	0	11	0	11	0	11	
50	TCGA-AN-A0FX	1	11	0	0	8	2	3	0	4	97	5	0	5	28	0	0	TCGA-AN-A0FX-01	313	0.6805351775212615	197	TCGA-AN-A0FX-01	14	29	78	0.4832334560271373	TCGA-AN-A0FX-01	19	28	12	59	mutation call filter	828	TCGA-AN-A0FX	BRCA	52	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19309	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	10	0	10	0	10	0	10	
60	TCGA-AN-A0FY	0	5	0	0	1	0	1	0	2	44	2	0	0	10	0	0	TCGA-AN-A0FY-01	309	0.9030860681370786	186	TCGA-AN-A0FY-01	19	31	50	0.2518442426923211	TCGA-AN-A0FY-01	18	12	12	42	mutation call filter	829	TCGA-AN-A0FY	BRCA	55	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20347	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	10	0	10	0	10	0	10	
50	TCGA-AN-A0FZ	1	8	0	2	1	1	0	0	1	62	2	0	1	18	0	0	TCGA-AN-A0FZ-01	440	0.6358759628873895	295	TCGA-AN-A0FZ-01	16	17	73	0.23178800053405	TCGA-AN-A0FZ-01	13	5	10	28	mutation call filter	830	TCGA-AN-A0FZ	BRCA	45	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16533	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	10	0	10	0	10	0	10	
60	TCGA-AN-A0G0	0	4	0	2	0	2	0	0	4	26	4	0	2	7	0	0	TCGA-AN-A0G0	0	0	0	TCGA-AN-A0G0	0	0	0	0	TCGA-AN-A0G0	0	0	0	0	mutation call filter	831	TCGA-AN-A0G0	BRCA	56	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20504	Alive	TUMOR FREE	16	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	16	0	16	0	16	0	16	
60	TCGA-AN-A0XL	0	2	0	3	1	2	1	0	2	23	5	0	0	10	1	0	TCGA-AN-A0XL-01	81	0.3436886708697324	37	TCGA-AN-A0XL-01	13	16	13	0.16213607057504645	TCGA-AN-A0XL-01	10	5	5	20	PASS	832	TCGA-AN-A0XL	BRCA	61	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22341	Alive	TUMOR FREE	163	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	163	0	163	0	163	0	163	
70	TCGA-AN-A0XN	2	9	0	4	5	2	2	0	3	121	9	0	1	29	6	0	TCGA-AN-A0XN-01	541	0.5851787375298683	406	TCGA-AN-A0XN-01	12	39	58	0.194183145824752	TCGA-AN-A0XN-01	29	35	7	71	PASS	833	TCGA-AN-A0XN	BRCA	68	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25029	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	10	0	10	0	10	0	10	
60	TCGA-AN-A0XO	0	1	0	2	1	0	1	0	3	27	2	0	0	7	1	1	TCGA-AN-A0XO-01	110	0.33699774464841153	55	TCGA-AN-A0XO-01	4	7	19	0.08931224246378744	TCGA-AN-A0XO-01	8	10	5	23	PASS	834	TCGA-AN-A0XO	BRCA	59	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21640	Alive	TUMOR FREE	375	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	375	0	375	0	375	0	375	
70	TCGA-AN-A0XP	0	2	0	2	3	0	0	0	2	18	2	0	2	5	3	0	TCGA-AN-A0XP-01	82	0.35137498231151804	36	TCGA-AN-A0XP-01	14	11	5	0.05158025989400476	TCGA-AN-A0XP-01	3	0	2	5	PASS	835	TCGA-AN-A0XP	BRCA	69	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25305	Alive	TUMOR FREE	9	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	9	0	9	0	9	0	9	
60	TCGA-AN-A0XR	0	2	0	2	0	3	0	0	3	25	0	0	0	6	1	0	TCGA-AN-A0XR-01	140	0.12008656135737812	63	TCGA-AN-A0XR-01	6	7	12	0.07646305101715041	TCGA-AN-A0XR-01	4	2	4	10	PASS	836	TCGA-AN-A0XR	BRCA	55	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20381	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	10	0	10	0	10	0	10	
60	TCGA-AN-A0XS	0	2	0	2	2	0	0	0	2	21	1	0	0	4	1	0	TCGA-AN-A0XS-01	66	0.4682723490580072	25	TCGA-AN-A0XS-01	19	16	5	0.055824307985236785	TCGA-AN-A0XS-01	4	2	3	9	PASS	837	TCGA-AN-A0XS	BRCA	63	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23358	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	10	0	10	0	10	0	10	
50	TCGA-AN-A0XT	0	0	0	2	0	0	0	0	1	10	0	0	1	7	1	0	TCGA-AN-A0XT-01	227	0.9505143392844876	147	TCGA-AN-A0XT-01	9	9	60	0.3337532559222618	TCGA-AN-A0XT-01	12	9	14	35	PASS	838	TCGA-AN-A0XT	BRCA	54	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19794	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	10	0	10	0	10	0	10	
50	TCGA-AN-A0XU	1	8	1	1	6	1	4	0	4	90	5	0	3	23	6	0	TCGA-AN-A0XU-01	487	0.7979517000677585	323	TCGA-AN-A0XU-01	10	67	99	0.4310880026588354	TCGA-AN-A0XU-01	31	31	22	84	PASS	839	TCGA-AN-A0XU	BRCA	54	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20052	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	10	0	10	0	10	0	10	
70	TCGA-AN-A0XV	1	5	1	0	3	0	0	0	1	25	3	0	1	8	1	0	TCGA-AN-A0XV-01	208	0.0908348581125152	121	TCGA-AN-A0XV-01	2	7	29	0.12298359356420435	TCGA-AN-A0XV-01	3	1	3	7	PASS	840	TCGA-AN-A0XV	BRCA	67	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24779	Alive	TUMOR FREE	162	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	162	0	162	0	162	0	162	
40	TCGA-AN-A0XW	0	22	3	8	0	2	0	0	16	251	27	0	7	91	2	0	TCGA-AN-A0XW-01	301	0.24949321520040355	204	TCGA-AN-A0XW-01	6	10	49	0.2058992320058542	TCGA-AN-A0XW-01	10	5	11	26	PASS	841	TCGA-AN-A0XW	BRCA	36	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13208	Alive	TUMOR FREE	170	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	170	0	170	0	170	0	170	
30	TCGA-AO-A03L	0	2	0	1	1	0	0	0	1	24	2	0	0	7	1	0	TCGA-AO-A03L-01	334	0.6667257437259415	229	TCGA-AO-A03L-01	23	22	57	0.2581666618987083	TCGA-AO-A03L-01	13	9	10	32	mutation call filter	842	TCGA-AO-A03L	BRCA	34	FEMALE	ASIAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12443	Alive	TUMOR FREE	2442	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2442	0	2442	0	2442	0	2442	
30	TCGA-AO-A03M	3	52	6	30	0	0	0	0	42	668	51	1	13	266	17	2	TCGA-AO-A03M-01	179	0.4058542640040246	93	TCGA-AO-A03M-01	14	14	21	0.12432074564365367	TCGA-AO-A03M-01	12	5	5	22	hypermutated sample	843	TCGA-AO-A03M	BRCA	29	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-10616	Alive	TUMOR FREE	1866	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1866	0	1866	0	1866	0	1866	
60	TCGA-AO-A03N	2	4	0	2	0	0	0	0	7	77	8	0	1	33	1	0	TCGA-AO-A03N-01	239	0.6379678383478424	136	TCGA-AO-A03N-01	23	24	33	0.12377964422517312	TCGA-AO-A03N-01	9	6	4	19	PASS	844	TCGA-AO-A03N	BRCA	59	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21816	Alive	WITH TUMOR	2031	NA	NA	Locoregional Disease	NA	NA	1645	NA	Negative	NA	0	2031	0	2031	1	1645	1	1645	
70	TCGA-AO-A03O	0	6	0	2	1	0	3	0	2	58	7	0	2	19	3	0	TCGA-AO-A03O-01	661	0.7548657596551201	431	TCGA-AO-A03O-01	24	37	86	0.2457057028032213	TCGA-AO-A03O-01	23	10	13	46	mutation call filter	845	TCGA-AO-A03O	BRCA	69	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25362	Dead	TUMOR FREE	NA	2483	NA	NA	NA	NA	NA	NA	Negative	NA	1	2483	0	2483	0	2483	0	2483	
50	TCGA-AO-A03P	0	5	0	2	2	2	1	0	4	31	2	0	2	18	2	0	TCGA-AO-A03P-01	447	0.5214198109834981	286	TCGA-AO-A03P-01	11	21	39	0.0992493502993629	TCGA-AO-A03P-01	12	9	4	25	mutation call filter	846	TCGA-AO-A03P	BRCA	54	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19724	Dead	WITH TUMOR	NA	2911	NA	Distant Metastasis	Liver	NA	1922	NA	Close	NA	1	2911	1	2911	NA	NA	1	1922	
60	TCGA-AO-A03R	0	5	0	2	1	0	0	0	1	33	2	0	0	14	1	0	TCGA-AO-A03R-01	94	0.2804910989651677	41	TCGA-AO-A03R-01	8	10	16	0.15134212782009993	TCGA-AO-A03R-01	6	2	5	13	mutation call filter	847	TCGA-AO-A03R	BRCA	57	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20930	Alive	TUMOR FREE	2091	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2091	0	2091	0	2091	0	2091	
40	TCGA-AO-A03T	0	6	2	3	5	3	1	0	9	73	5	1	0	22	1	0	TCGA-AO-A03T-01	125	0.3201270150400197	55	TCGA-AO-A03T-01	6	11	18	0.19939121276386806	TCGA-AO-A03T-01	17	15	11	43	mutation call filter	848	TCGA-AO-A03T	BRCA	42	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15540	Alive	TUMOR FREE	2124	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2124	0	2124	0	2124	0	2124	
30	TCGA-AO-A03U	0	0	0	0	1	0	0	1	0	3	0	0	0	2	0	0	TCGA-AO-A03U-01	47	0.03389498787888493	12	TCGA-AO-A03U-01	1	1	2	0.0010057342337894118	TCGA-AO-A03U-01	0	0	0	0	PASS	849	TCGA-AO-A03U	BRCA	31	FEMALE	WHITE	Stage I	NA	"Other, specify"	NA	2001	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11354	Dead	TUMOR FREE	NA	1793	NA	New Primary Tumor	Lung	NA	1614	NA	Negative	NA	1	1793	0	1793	0	1793	1	1614	
40	TCGA-AO-A03V	0	6	0	3	1	0	0	0	3	46	2	1	2	9	1	0	TCGA-AO-A03V-01	446	0.33694144293954964	300	TCGA-AO-A03V-01	7	11	107	0.17162383967952746	TCGA-AO-A03V-01	22	12	7	41	PASS	850	TCGA-AO-A03V	BRCA	41	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2008	Peri (6-12 months since last menstrual period)	-15284	Alive	TUMOR FREE	1351	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1351	0	1351	0	1351	0	1351	
40	TCGA-AO-A0J2	0	3	1	2	2	1	2	0	5	40	4	0	4	23	4	0	TCGA-AO-A0J2-01	528	0.8290010750986183	346	TCGA-AO-A0J2-01	9	29	101	0.3805130166577145	TCGA-AO-A0J2-01	31	30	22	83	mutation call filter	851	TCGA-AO-A0J2	BRCA	41	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15324	Alive	TUMOR FREE	997	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	997	0	997	0	997	0	997	
70	TCGA-AO-A0J3	1	7	0	1	3	2	1	0	1	63	5	0	1	21	2	0	TCGA-AO-A0J3-01	320	0.7947700586121189	217	TCGA-AO-A0J3-01	12	34	49	0.17547892541697088	TCGA-AO-A0J3-01	13	16	10	39	mutation call filter	852	TCGA-AO-A0J3	BRCA	67	FEMALE	WHITE	Stage IIB	NA	"Other, specify"	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24519	Alive	TUMOR FREE	651	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	651	0	651	0	651	0	651	
40	TCGA-AO-A0J4	0	8	0	6	2	1	1	0	3	92	7	0	1	29	1	0	TCGA-AO-A0J4-01	293	0.6967582621058565	194	TCGA-AO-A0J4-01	19	25	42	0.280029914778448	TCGA-AO-A0J4-01	20	22	10	52	mutation call filter	853	TCGA-AO-A0J4	BRCA	41	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15052	Alive	TUMOR FREE	1587	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1587	0	1587	0	1587	0	1587	
50	TCGA-AO-A0J5	1	9	0	2	0	2	0	0	1	43	6	0	1	19	1	0	TCGA-AO-A0J5-01	159	0.24502810854215146	86	TCGA-AO-A0J5-01	3	7	20	0.14015506385345228	TCGA-AO-A0J5-01	7	6	5	18	mutation call filter	854	TCGA-AO-A0J5	BRCA	48	FEMALE	WHITE	Stage IV	NA	"Other, specify"	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17815	Dead	WITH TUMOR	NA	792	NA	NA	NA	NA	NA	NA	Close	NA	1	792	1	792	NA	NA	1	792	
60	TCGA-AO-A0J6	4	9	0	10	8	1	2	0	5	79	6	0	0	20	3	0	TCGA-AO-A0J6-01	368	0.5734541096969401	229	TCGA-AO-A0J6-01	5	16	100	0.469147615735406	TCGA-AO-A0J6-01	22	31	20	73	mutation call filter	855	TCGA-AO-A0J6	BRCA	61	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22462	Alive	TUMOR FREE	1140	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1140	0	1140	0	1140	0	1140	
70	TCGA-AO-A0J7	0	1	0	2	1	2	0	0	0	12	2	0	0	7	1	0	TCGA-AO-A0J7-01	58	0.8151420106924732	14	TCGA-AO-A0J7-01	15	12	12	0.4286787062317135	TCGA-AO-A0J7-01	2	0	2	4	mutation call filter	856	TCGA-AO-A0J7	BRCA	71	FEMALE	WHITE	Stage IIB	NA	"Other, specify"	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26281	Alive	TUMOR FREE	618	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	618	0	618	0	618	0	618	
60	TCGA-AO-A0J8	0	2	0	0	2	1	0	0	4	17	2	0	2	7	0	0	TCGA-AO-A0J8-01	72	0.13078371354094054	23	TCGA-AO-A0J8-01	6	5	4	0.09038829079619874	TCGA-AO-A0J8-01	3	0	1	4	mutation call filter	857	TCGA-AO-A0J8	BRCA	61	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22284	Alive	TUMOR FREE	680	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	680	0	680	0	680	0	680	
60	TCGA-AO-A0J9	3	10	3	5	5	0	0	0	8	89	7	0	2	36	2	0	TCGA-AO-A0J9-01	86	0.433718309463825	39	TCGA-AO-A0J9-01	17	26	10	0.17943497403250014	TCGA-AO-A0J9-01	5	2	2	9	mutation call filter	858	TCGA-AO-A0J9	BRCA	61	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22642	Alive	WITH TUMOR	1613	NA	NA	Distant Metastasis	Bone	NA	1066	NA	Negative	NA	0	1613	0	1613	1	1066	1	1066	
40	TCGA-AO-A0JA	0	2	0	1	2	1	0	0	2	16	2	0	0	10	0	0	TCGA-AO-A0JA-01	143	0.947062873951192	82	TCGA-AO-A0JA-01	10	10	39	0.2664519820243169	TCGA-AO-A0JA-01	10	11	16	37	mutation call filter	859	TCGA-AO-A0JA	BRCA	36	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13307	Alive	WITH TUMOR	655	NA	NA	Distant Metastasis	Bone	NA	143	NA	Negative	NA	0	655	0	655	1	143	1	143	
50	TCGA-AO-A0JB	0	5	1	3	5	2	1	0	11	76	4	0	1	30	2	0	TCGA-AO-A0JB-01	317	0.4931308838069857	186	TCGA-AO-A0JB-01	7	21	82	0.3849702959171728	TCGA-AO-A0JB-01	22	27	19	68	mutation call filter	860	TCGA-AO-A0JB	BRCA	50	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18561	Alive	TUMOR FREE	1542	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1542	0	1542	0	1542	0	1542	
60	TCGA-AO-A0JC	1	11	1	1	0	0	0	0	6	125	9	0	7	47	2	0	TCGA-AO-A0JC-01	59	6.091082665518152e-05	23	TCGA-AO-A0JC	0	0	0	0	TCGA-AO-A0JC	0	0	0	0	mutation call filter	861	TCGA-AO-A0JC	BRCA	64	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23404	Alive	TUMOR FREE	1547	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1547	0	1547	0	1547	0	1547	
60	TCGA-AO-A0JD	0	10	0	2	1	0	0	1	4	86	10	0	1	24	3	0	TCGA-AO-A0JD-01	424	0.6618547628781511	280	TCGA-AO-A0JD-01	7	11	106	0.3670025987164835	TCGA-AO-A0JD-01	18	16	17	51	mutation call filter	862	TCGA-AO-A0JD	BRCA	59	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21831	Alive	TUMOR FREE	2190	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2190	0	2190	0	2190	0	2190	
50	TCGA-AO-A0JE	0	1	0	1	0	0	0	0	2	38	6	0	1	12	0	0	TCGA-AO-A0JE-01	361	0.4120594365177328	235	TCGA-AO-A0JE-01	12	17	41	0.2345301384831619	TCGA-AO-A0JE-01	13	9	12	34	mutation call filter	863	TCGA-AO-A0JE	BRCA	53	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19516	Alive	TUMOR FREE	2335	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	2335	0	2335	NA	NA	0	2335	
70	TCGA-AO-A0JF	0	0	0	0	2	1	0	1	2	18	1	0	0	11	1	0	TCGA-AO-A0JF-01	79	0.05361331575848252	34	TCGA-AO-A0JF-01	2	2	19	0.015656647567060908	TCGA-AO-A0JF-01	2	1	1	4	mutation call filter	864	TCGA-AO-A0JF	BRCA	68	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24923	Alive	TUMOR FREE	1980	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1980	0	1980	0	1980	0	1980	
50	TCGA-AO-A0JG	0	1	0	4	0	1	0	0	0	14	0	0	0	1	1	0	TCGA-AO-A0JG-01	148	0.2284104986708113	88	TCGA-AO-A0JG-01	6	8	43	0.18338588346015666	TCGA-AO-A0JG-01	5	4	7	16	PASS	865	TCGA-AO-A0JG	BRCA	49	FEMALE	WHITE	Stage IIIA	NA	"Other, specify"	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18021	Alive	TUMOR FREE	798	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	798	0	798	NA	NA	0	798	
60	TCGA-AO-A0JI	0	3	0	0	0	1	0	0	3	11	1	0	0	4	1	0	TCGA-AO-A0JI-01	140	0.5425145792642586	71	TCGA-AO-A0JI-01	7	8	18	0.18711066752254288	TCGA-AO-A0JI-01	5	1	8	14	mutation call filter	866	TCGA-AO-A0JI	BRCA	56	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20694	Alive	TUMOR FREE	1528	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1528	0	1528	0	1528	0	1528	
50	TCGA-AO-A0JJ	0	3	0	0	2	0	0	0	1	12	1	0	0	5	0	0	TCGA-AO-A0JJ-01	65	0.2089338112339288	20	TCGA-AO-A0JJ-01	4	5	8	0.1202518117553512	TCGA-AO-A0JJ-01	6	2	2	10	mutation call filter	867	TCGA-AO-A0JJ	BRCA	54	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19758	Alive	TUMOR FREE	1887	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1887	0	1887	0	1887	0	1887	
60	TCGA-AO-A0JL	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AO-A0JL-01	247	0.7072624627711317	134	TCGA-AO-A0JL-01	25	54	37	0.26199232916902004	TCGA-AO-A0JL-01	20	17	8	45	PASS	868	TCGA-AO-A0JL	BRCA	59	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21895	Alive	TUMOR FREE	1683	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1683	0	1683	0	1683	0	1683	
40	TCGA-AO-A0JM	1	3	0	0	1	1	0	0	2	27	4	0	3	12	0	0	TCGA-AO-A0JM-01	371	0.5645840427219091	234	TCGA-AO-A0JM-01	15	21	54	0.17807430956174122	TCGA-AO-A0JM-01	14	14	8	36	mutation call filter	869	TCGA-AO-A0JM	BRCA	40	FEMALE	NA	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14653	Alive	TUMOR FREE	2184	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2184	0	2184	0	2184	0	2184	
40	TCGA-AO-A124	1	14	0	7	4	4	2	0	5	110	5	0	5	30	7	0	TCGA-AO-A124-01	585	0.9346292958865146	395	TCGA-AO-A124-01	15	36	187	0.6329033223615921	TCGA-AO-A124-01	36	27	26	89	PASS	870	TCGA-AO-A124	BRCA	38	FEMALE	WHITE	Stage IIA	NA	"Other, specify"	NA	2002	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14174	Alive	TUMOR FREE	3506	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3506	0	3506	0	3506	0	3506	
70	TCGA-AO-A125	1	1	1	2	0	0	1	0	1	27	3	0	0	12	0	0	TCGA-AO-A125-01	65	0.11536222588164564	23	TCGA-AO-A125-01	5	4	2	0.015826502896615215	TCGA-AO-A125-01	3	0	1	4	PASS	871	TCGA-AO-A125	BRCA	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	"Other, specify"	NA	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26466	Alive	TUMOR FREE	3456	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3456	0	3456	0	3456	0	3456	
40	TCGA-AO-A126	0	1	0	1	1	0	0	0	2	17	0	0	1	4	1	1	TCGA-AO-A126-01	144	0.1535091442180508	92	TCGA-AO-A126-01	4	5	37	0.1255928522399942	TCGA-AO-A126-01	5	6	8	19	PASS	872	TCGA-AO-A126	BRCA	39	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2002	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14264	Alive	TUMOR FREE	3307	NA	NA	Locoregional Disease	NA	NA	267	NA	Negative	NA	0	3307	0	3307	1	267	1	267	
60	TCGA-AO-A128	2	38	3	23	30	3	2	0	33	738	26	2	9	330	23	1	TCGA-AO-A128-01	95	0.5305324978454756	44	TCGA-AO-A128-01	25	33	25	0.6028875729882106	TCGA-AO-A128-01	9	4	2	15	hypermutated sample	873	TCGA-AO-A128	BRCA	61	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22340	Alive	TUMOR FREE	3248	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3248	0	3248	0	3248	0	3248	
30	TCGA-AO-A129	0	9	0	3	4	0	3	0	4	93	5	0	1	33	2	0	TCGA-AO-A129-01	336	0.5675753210511487	194	TCGA-AO-A129-01	9	13	70	0.3901820762572595	TCGA-AO-A129-01	23	26	16	65	PASS	874	TCGA-AO-A129	BRCA	29	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2002	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-10898	Alive	TUMOR FREE	3286	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3286	0	3286	0	3286	0	3286	
50	TCGA-AO-A12A	0	3	0	0	0	0	0	0	1	12	1	0	0	3	1	0	TCGA-AO-A12A-01	65	0.5217201974925584	26	TCGA-AO-A12A-01	25	22	3	0.05921737270664256	TCGA-AO-A12A-01	4	1	2	7	PASS	875	TCGA-AO-A12A	BRCA	47	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17420	Alive	TUMOR FREE	3112	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	3112	0	3112	NA	NA	0	3112	
60	TCGA-AO-A12B	0	2	0	0	2	0	0	0	1	13	2	0	1	6	1	0	TCGA-AO-A12B-01	59	0.9469599369780526	19	TCGA-AO-A12B-01	19	13	3	0.025363201229192243	TCGA-AO-A12B-01	2	1	2	5	PASS	876	TCGA-AO-A12B	BRCA	63	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23150	Alive	TUMOR FREE	2989	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2989	0	2989	0	2989	0	2989	
40	TCGA-AO-A12C	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AO-A12C	0	0	0	TCGA-AO-A12C	0	0	0	0	TCGA-AO-A12C	0	0	0	0	PASS	877	TCGA-AO-A12C	BRCA	42	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15469	Alive	TUMOR FREE	2372	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2372	0	2372	0	2372	0	2372	
40	TCGA-AO-A12D	0	1	0	0	1	0	0	0	3	49	2	0	0	18	0	0	TCGA-AO-A12D-01	297	0.4905054873634489	193	TCGA-AO-A12D-01	16	28	25	0.12233413595105352	TCGA-AO-A12D-01	12	5	9	26	PASS	878	TCGA-AO-A12D	BRCA	43	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15774	Alive	TUMOR FREE	2515	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2515	0	2515	0	2515	0	2515	
50	TCGA-AO-A12E	0	0	0	1	3	0	0	0	0	22	0	0	0	9	1	0	TCGA-AO-A12E-01	128	0.40129440108499614	69	TCGA-AO-A12E-01	18	12	16	0.13386474773345114	TCGA-AO-A12E-01	4	2	4	10	PASS	879	TCGA-AO-A12E	BRCA	51	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18721	Alive	TUMOR FREE	2142	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2142	0	2142	0	2142	0	2142	
40	TCGA-AO-A12F	1	0	0	2	4	0	0	0	2	29	2	0	0	6	0	0	TCGA-AO-A12F-01	465	0.833217422729975	316	TCGA-AO-A12F-01	21	59	96	0.3938510443447296	TCGA-AO-A12F-01	27	19	10	56	PASS	880	TCGA-AO-A12F	BRCA	36	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13409	Alive	TUMOR FREE	1842	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1842	0	1842	0	1842	0	1842	
80	TCGA-AO-A12G	0	1	1	1	2	2	1	1	3	26	2	0	2	9	0	0	TCGA-AO-A12G-01	149	0.3167591968984953	75	TCGA-AO-A12G-01	6	12	25	0.15226257596584172	TCGA-AO-A12G-01	13	9	9	31	PASS	881	TCGA-AO-A12G	BRCA	75	FEMALE	WHITE	Stage IIA	NA	"Other, specify"	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27705	Alive	TUMOR FREE	1639	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1639	0	1639	0	1639	0	1639	
70	TCGA-AO-A12H	2	1	0	0	0	1	1	0	0	18	1	0	3	6	0	0	TCGA-AO-A12H-01	43	2.4480309196990107e-06	11	TCGA-AO-A12H-01	0	0	0	0.0	TCGA-AO-A12H-01	0	0	0	0	PASS	882	TCGA-AO-A12H	BRCA	69	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	"Other, specify"	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-25515	Alive	TUMOR FREE	1234	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1234	0	1234	0	1234	0	1234	
50	TCGA-AO-A1KO	0	0	0	0	0	0	0	0	0	4	1	0	0	5	0	0	TCGA-AO-A1KO-01	49	9.437197659465716e-06	14	TCGA-AO-A1KO	0	0	0	0	TCGA-AO-A1KO	0	0	0	0	PASS	883	TCGA-AO-A1KO	BRCA	46	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16817	Alive	TUMOR FREE	622	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	622	0	622	0	622	0	622	
80	TCGA-AO-A1KP	0	2	0	0	0	0	0	0	4	15	0	0	0	5	1	0	TCGA-AO-A1KP-01	123	0.2030726994089982	57	TCGA-AO-A1KP-01	7	5	11	0.0931936612204129	TCGA-AO-A1KP-01	7	6	3	16	mutation call filter	884	TCGA-AO-A1KP	BRCA	77	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28247	Alive	TUMOR FREE	2953	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2953	0	2953	0	2953	0	2953	
80	TCGA-AO-A1KQ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AO-A1KQ-01	187	0.6497011735056265	103	TCGA-AO-A1KQ	0	0	0	0	TCGA-AO-A1KQ	0	0	0	0	PASS	885	TCGA-AO-A1KQ	BRCA	84	MALE	WHITE	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	2006	NA	-30859	Alive	TUMOR FREE	1882	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1882	0	1882	0	1882	0	1882	
50	TCGA-AO-A1KR	0	5	0	0	1	1	2	0	0	54	3	0	1	24	3	0	TCGA-AO-A1KR-01	353	0.5960815305212146	217	TCGA-AO-A1KR-01	13	28	44	0.2321402553540957	TCGA-AO-A1KR-01	15	17	8	40	PASS	886	TCGA-AO-A1KR	BRCA	51	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18900	Alive	TUMOR FREE	2513	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2513	0	2513	0	2513	0	2513	
70	TCGA-AO-A1KS	0	4	1	4	1	0	0	0	1	26	3	0	2	15	2	0	TCGA-AO-A1KS-01	189	0.8076458957141619	119	TCGA-AO-A1KS-01	24	20	20	0.08524392854518226	TCGA-AO-A1KS-01	10	9	4	23	mutation call filter	887	TCGA-AO-A1KS	BRCA	69	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25230	Alive	TUMOR FREE	350	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	350	0	350	0	350	0	350	
80	TCGA-AO-A1KT	0	2	1	0	0	1	0	0	2	29	4	0	1	15	1	0	TCGA-AO-A1KT-01	121	0.3732060020141254	59	TCGA-AO-A1KT-01	11	13	20	0.2165853346247429	TCGA-AO-A1KT-01	15	5	9	29	PASS	888	TCGA-AO-A1KT	BRCA	78	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28660	Alive	TUMOR FREE	541	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	541	0	541	0	541	0	541	
60	TCGA-AQ-A04H	0	5	0	3	1	1	0	0	2	52	5	0	0	17	1	0	TCGA-AQ-A04H-01	303	0.42027338536186404	193	TCGA-AQ-A04H-01	15	29	56	0.12406095655570605	TCGA-AQ-A04H-01	12	9	4	25	PASS	889	TCGA-AQ-A04H	BRCA	61	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22539	Alive	TUMOR FREE	754	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	754	0	754	0	754	0	754	
50	TCGA-AQ-A04J	0	6	0	2	3	0	0	0	2	59	4	0	1	26	3	0	TCGA-AQ-A04J-01	194	0.4190842509278944	104	TCGA-AQ-A04J-01	5	17	51	0.3716847554051491	TCGA-AQ-A04J-01	19	23	17	59	mutation call filter	890	TCGA-AQ-A04J	BRCA	45	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16615	Alive	TUMOR FREE	819	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	819	0	819	0	819	0	819	
50	TCGA-AQ-A04L	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AQ-A04L-01	607	0.7546000908386841	400	TCGA-AQ-A04L-01	19	73	70	0.2112550404615545	TCGA-AQ-A04L-01	16	12	12	40	PASS	891	TCGA-AQ-A04L	BRCA	48	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2001	Peri (6-12 months since last menstrual period)	-17759	Alive	TUMOR FREE	3957	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3957	0	3957	0	3957	0	3957	
70	TCGA-AQ-A0Y5	0	3	0	0	1	0	2	0	2	46	4	0	0	14	1	1	TCGA-AQ-A0Y5-01	329	0.636090690190344	207	TCGA-AQ-A0Y5-01	20	23	53	0.2917678349756884	TCGA-AQ-A0Y5-01	9	5	3	17	PASS	892	TCGA-AQ-A0Y5	BRCA	70	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25793	Dead	TUMOR FREE	NA	172	NA	NA	NA	NA	NA	NA	Negative	NA	1	172	0	172	0	172	0	172	
80	TCGA-AQ-A1H2	0	2	0	3	1	1	1	0	1	17	3	0	2	8	0	0	TCGA-AQ-A1H2-01	172	0.9154683453609884	94	TCGA-AQ-A1H2-01	10	8	35	0.2189371735926748	TCGA-AQ-A1H2-01	8	10	9	27	PASS	893	TCGA-AQ-A1H2	BRCA	84	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30958	Alive	TUMOR FREE	475	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	475	0	475	0	475	0	475	
50	TCGA-AQ-A1H3	1	0	0	0	1	3	0	0	2	14	1	0	0	10	1	0	TCGA-AQ-A1H3-01	66	0.2037834431559344	16	TCGA-AQ-A1H3-01	9	6	3	0.03293533456943795	TCGA-AQ-A1H3-01	4	2	3	9	PASS	894	TCGA-AQ-A1H3	BRCA	49	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18177	Alive	TUMOR FREE	989	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	989	0	989	0	989	0	989	
50	TCGA-AQ-A54N	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AQ-A54N-01	697	0.9364938996060213	489	TCGA-AQ-A54N-01	23	25	314	0.40836383352882616	TCGA-AQ-A54N-01	14	4	17	35	PASS	895	TCGA-AQ-A54N	BRCA	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18741	Alive	TUMOR FREE	78	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	78	0	78	0	78	0	78	
50	TCGA-AQ-A54O	1	3	0	0	1	0	0	0	0	16	1	0	0	5	0	0	TCGA-AQ-A54O-01	172	0.8657013343846527	102	TCGA-AQ-A54O-01	20	37	75	0.1716887883384145	TCGA-AQ-A54O-01	8	4	4	16	PASS	896	TCGA-AQ-A54O	BRCA	51	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	NA	-18694	Alive	TUMOR FREE	1001	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1001	0	1001	0	1001	0	1001	
60	TCGA-AQ-A7U7	1	16	0	7	1	2	0	0	1	47	6	0	0	24	1	1	TCGA-AQ-A7U7-01	111	0.26624040222737944	51	TCGA-AQ-A7U7-01	10	10	76	0.2302407640604528	TCGA-AQ-A7U7-01	4	5	5	14	PASS	897	TCGA-AQ-A7U7	BRCA	55	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20239	Dead	TUMOR FREE	NA	584	NA	NA	NA	NA	NA	NA	Negative	NA	1	584	0	584	0	584	0	584	
40	TCGA-AR-A0TP	1	4	0	3	5	1	2	0	4	44	0	0	2	15	2	0	TCGA-AR-A0TP-01	343	0.9303988481799766	209	TCGA-AR-A0TP-01	5	21	67	0.402790115635516	TCGA-AR-A0TP-01	22	29	19	70	PASS	898	TCGA-AR-A0TP	BRCA	43	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15812	Alive	TUMOR FREE	4275	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	4275	0	4275	0	4275	0	4275	
30	TCGA-AR-A0TQ	0	4	0	2	0	1	1	0	0	29	0	0	1	13	1	0	TCGA-AR-A0TQ-01	116	0.2903608173367164	59	TCGA-AR-A0TQ-01	11	8	12	0.011649581666307076	TCGA-AR-A0TQ-01	5	5	0	10	PASS	899	TCGA-AR-A0TQ	BRCA	27	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-9873	Alive	TUMOR FREE	2991	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2991	0	2991	0	2991	0	2991	
70	TCGA-AR-A0TR	0	3	0	1	2	1	1	0	0	26	0	0	1	10	1	0	TCGA-AR-A0TR-01	96	0.6027062778669192	44	TCGA-AR-A0TR-01	19	20	16	0.10114193436721083	TCGA-AR-A0TR-01	7	3	6	16	PASS	900	TCGA-AR-A0TR	BRCA	68	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25190	Dead	NA	NA	160	NA	NA	NA	NA	NA	NA	Negative	NA	1	160	NA	160	0	160	0	160	
50	TCGA-AR-A0TS	0	7	0	0	3	0	1	1	2	57	3	0	1	23	2	0	TCGA-AR-A0TS-01	138	0.5338496632474525	57	TCGA-AR-A0TS-01	14	23	39	0.5702153795292039	TCGA-AR-A0TS-01	18	18	13	49	PASS	901	TCGA-AR-A0TS	BRCA	46	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17141	Alive	TUMOR FREE	2558	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2558	0	2558	0	2558	0	2558	
50	TCGA-AR-A0TT	0	4	0	1	2	0	1	0	3	46	2	0	1	17	3	0	TCGA-AR-A0TT-01	402	0.5937646417632071	263	TCGA-AR-A0TT-01	12	23	87	0.2986423729261082	TCGA-AR-A0TT-01	14	15	9	38	PASS	902	TCGA-AR-A0TT	BRCA	53	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19679	Alive	TUMOR FREE	3316	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3316	0	3316	0	3316	0	3316	
40	TCGA-AR-A0TU	0	8	0	1	3	0	2	0	7	48	5	0	1	21	2	0	TCGA-AR-A0TU	0	0	0	TCGA-AR-A0TU	0	0	0	0	TCGA-AR-A0TU	0	0	0	0	PASS	903	TCGA-AR-A0TU	BRCA	35	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13039	Alive	TUMOR FREE	709	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	709	0	709	0	709	0	709	
70	TCGA-AR-A0TV	1	3	0	3	2	1	1	0	4	49	3	0	3	13	0	0	TCGA-AR-A0TV-01	358	0.85790836502525	247	TCGA-AR-A0TV-01	15	23	73	0.2662668996629389	TCGA-AR-A0TV-01	13	12	11	36	PASS	904	TCGA-AR-A0TV	BRCA	66	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24279	Alive	TUMOR FREE	2288	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2288	0	2288	0	2288	0	2288	
50	TCGA-AR-A0TW	0	3	0	1	2	1	0	0	1	38	5	0	1	17	2	0	TCGA-AR-A0TW-01	411	0.5833986102469788	265	TCGA-AR-A0TW-01	16	28	77	0.2042835528099685	TCGA-AR-A0TW-01	21	25	12	58	PASS	905	TCGA-AR-A0TW	BRCA	50	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18263	Alive	TUMOR FREE	3009	NA	NA	NA	NA	NA	739	NA	Negative	NA	0	3009	0	3009	1	739	1	739	
60	TCGA-AR-A0TX	1	25	4	12	3	1	0	0	14	235	31	2	2	83	1	0	TCGA-AR-A0TX-01	259	0.22368126203328909	147	TCGA-AR-A0TX-01	7	14	40	0.16060451021397024	TCGA-AR-A0TX-01	11	6	5	22	PASS	906	TCGA-AR-A0TX	BRCA	64	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23653	Alive	TUMOR FREE	1972	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1972	0	1972	0	1972	0	1972	
50	TCGA-AR-A0TY	1	4	0	8	2	3	0	0	6	67	7	0	2	20	1	0	TCGA-AR-A0TY-01	342	0.9211981034340124	227	TCGA-AR-A0TY-01	8	9	98	0.3037707581379667	TCGA-AR-A0TY-01	11	13	11	35	mutation call filter	907	TCGA-AR-A0TY	BRCA	54	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19836	Dead	WITH TUMOR	NA	1699	NA	Distant Metastasis	Bone	NA	544	NA	Negative	NA	1	1699	1	1699	1	544	1	544	
40	TCGA-AR-A0TZ	0	1	0	0	1	0	1	0	2	47	4	0	0	12	2	0	TCGA-AR-A0TZ-01	200	0.947110704424866	111	TCGA-AR-A0TZ-01	9	11	43	0.2584778922888335	TCGA-AR-A0TZ-01	9	7	10	26	PASS	908	TCGA-AR-A0TZ	BRCA	43	FEMALE	WHITE	[Discrepancy]	NA	Infiltrating Ductal Carcinoma	NA	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15720	Dead	NA	NA	3262	NA	Distant Metastasis	Bone	NA	1313	NA	Negative	NA	1	3262	NA	3262	1	1313	1	1313	
70	TCGA-AR-A0U0	0	4	0	1	0	2	1	0	3	30	3	0	0	10	1	0	TCGA-AR-A0U0-01	117	0.588639615487689	60	TCGA-AR-A0U0-01	20	37	25	0.2888810826475292	TCGA-AR-A0U0-01	12	10	10	32	PASS	909	TCGA-AR-A0U0	BRCA	73	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26993	Alive	TUMOR FREE	1988	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1988	0	1988	0	1988	0	1988	
40	TCGA-AR-A0U1	1	6	0	3	1	0	0	0	3	66	5	0	1	21	5	0	TCGA-AR-A0U1-01	252	0.5614872680784331	131	TCGA-AR-A0U1-01	6	21	71	0.5076288172270631	TCGA-AR-A0U1-01	25	29	18	72	PASS	910	TCGA-AR-A0U1	BRCA	36	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13467	Alive	TUMOR FREE	4052	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	4052	0	4052	0	4052	0	4052	Redacted
50	TCGA-AR-A0U2	0	5	1	2	0	3	1	0	0	37	1	0	0	10	1	0	TCGA-AR-A0U2-01	187	0.8268550583789404	102	TCGA-AR-A0U2-01	22	40	40	0.2906132105313468	TCGA-AR-A0U2-01	18	11	11	40	PASS	911	TCGA-AR-A0U2	BRCA	47	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17390	Dead	WITH TUMOR	NA	2551	NA	Distant Metastasis	Bone	Liver	1609	NA	Negative	NA	1	2551	1	2551	1	1609	1	1609	
60	TCGA-AR-A0U3	0	2	0	1	2	1	0	0	2	22	5	0	0	8	1	0	TCGA-AR-A0U3-01	360	0.9223741039325584	258	TCGA-AR-A0U3-01	14	13	86	0.3517211790293191	TCGA-AR-A0U3-01	11	9	11	31	PASS	912	TCGA-AR-A0U3	BRCA	59	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21755	Alive	TUMOR FREE	4080	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	4080	0	4080	0	4080	0	4080	
50	TCGA-AR-A0U4	2	13	1	7	3	1	2	0	5	126	9	1	2	38	2	0	TCGA-AR-A0U4-01	320	0.5841580096473323	206	TCGA-AR-A0U4-01	11	25	103	0.510537500257491	TCGA-AR-A0U4-01	28	26	24	78	PASS	913	TCGA-AR-A0U4	BRCA	54	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19729	Alive	TUMOR FREE	3261	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3261	0	3261	0	3261	0	3261	
50	TCGA-AR-A1AH	0	10	0	5	4	2	1	0	4	64	2	0	0	35	4	0	TCGA-AR-A1AH-01	298	0.9415398987255852	195	TCGA-AR-A1AH-01	12	12	53	0.4575073636920625	TCGA-AR-A1AH-01	10	12	5	27	PASS	914	TCGA-AR-A1AH	BRCA	51	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18991	Alive	TUMOR FREE	3807	NA	NA	New Primary Tumor	"Other, specify"	Renal	1136	NA	Negative	NA	0	3807	0	3807	0	3807	1	1136	
50	TCGA-AR-A1AI	0	1	0	2	2	0	0	0	0	65	2	0	1	18	1	0	TCGA-AR-A1AI-01	323	0.7037390597935004	211	TCGA-AR-A1AI-01	22	40	64	0.4989164032102007	TCGA-AR-A1AI-01	18	15	14	47	PASS	915	TCGA-AR-A1AI	BRCA	47	FEMALE	WHITE	Stage IIA	NA	Medullary Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17229	Alive	TUMOR FREE	3296	NA	NA	New Primary Tumor	"Other, specify"	Contralateral Breast	588	NA	Negative	NA	0	3296	0	3296	1	588	1	588	
80	TCGA-AR-A1AJ	0	4	1	0	0	0	1	0	2	39	1	0	1	8	0	0	TCGA-AR-A1AJ-01	92	0.2974357131294168	30	TCGA-AR-A1AJ-01	33	26	18	0.2785947037280539	TCGA-AR-A1AJ-01	6	1	5	12	PASS	916	TCGA-AR-A1AJ	BRCA	83	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30489	Alive	TUMOR FREE	3072	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3072	0	3072	0	3072	0	3072	
70	TCGA-AR-A1AK	0	2	0	2	0	2	0	0	6	46	6	0	3	16	1	0	TCGA-AR-A1AK-01	107	0.3439641277685633	54	TCGA-AR-A1AK-01	14	15	13	0.1089791057402111	TCGA-AR-A1AK-01	11	2	5	18	PASS	917	TCGA-AR-A1AK	BRCA	70	FEMALE	WHITE	Stage I	NA	Infiltrating Lobular Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25825	Alive	TUMOR FREE	3159	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3159	0	3159	0	3159	0	3159	
60	TCGA-AR-A1AL	0	1	0	1	2	0	0	0	3	22	0	0	2	5	0	0	TCGA-AR-A1AL-01	69	0.08165601374184019	21	TCGA-AR-A1AL-01	3	4	5	0.03832557759872768	TCGA-AR-A1AL-01	4	3	3	10	PASS	918	TCGA-AR-A1AL	BRCA	60	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22023	Alive	TUMOR FREE	2971	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2971	0	2971	0	2971	0	2971	
50	TCGA-AR-A1AM	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AR-A1AM-01	73	0.12161285710742405	21	TCGA-AR-A1AM-01	3	7	8	0.09215268882611258	TCGA-AR-A1AM-01	7	9	5	21	PASS	919	TCGA-AR-A1AM	BRCA	52	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19123	Alive	TUMOR FREE	2991	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2991	0	2991	0	2991	0	2991	
50	TCGA-AR-A1AN	0	4	0	0	1	0	0	0	2	20	1	0	0	4	3	0	TCGA-AR-A1AN-01	280	0.33671933312261176	190	TCGA-AR-A1AN-01	9	14	63	0.2617148791808121	TCGA-AR-A1AN-01	14	8	8	30	PASS	920	TCGA-AR-A1AN	BRCA	46	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16974	Alive	TUMOR FREE	2920	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2920	0	2920	0	2920	0	2920	
50	TCGA-AR-A1AO	0	4	0	1	3	0	0	0	2	81	5	0	2	28	0	0	TCGA-AR-A1AO-01	63	0.016799571650968896	18	TCGA-AR-A1AO-01	0	0	19	5.000461587640317e-05	TCGA-AR-A1AO-01	0	0	0	0	PASS	921	TCGA-AR-A1AO	BRCA	47	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17332	Alive	TUMOR FREE	2618	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2618	0	2618	0	2618	0	2618	
80	TCGA-AR-A1AP	0	8	0	5	0	0	0	0	6	29	1	0	0	5	1	0	TCGA-AR-A1AP-01	240	0.3947869581296284	148	TCGA-AR-A1AP-01	12	16	46	0.2907089783428882	TCGA-AR-A1AP-01	8	4	7	19	PASS	922	TCGA-AR-A1AP	BRCA	80	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29406	Alive	TUMOR FREE	2856	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2856	0	2856	0	2856	0	2856	
50	TCGA-AR-A1AQ	0	4	0	0	4	2	0	0	2	26	4	0	0	9	0	1	TCGA-AR-A1AQ-01	191	0.7575633872715686	95	TCGA-AR-A1AQ-01	18	28	55	0.7409416560059658	TCGA-AR-A1AQ-01	12	11	8	31	PASS	923	TCGA-AR-A1AQ	BRCA	49	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18109	Alive	TUMOR FREE	3021	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3021	0	3021	0	3021	0	3021	
50	TCGA-AR-A1AR	1	3	0	2	2	1	0	0	4	38	5	0	3	11	1	0	TCGA-AR-A1AR-01	297	0.6083950947056067	209	TCGA-AR-A1AR-01	17	16	79	0.36537590687702587	TCGA-AR-A1AR-01	7	9	10	26	PASS	924	TCGA-AR-A1AR	BRCA	50	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18482	Dead	WITH TUMOR	NA	524	NA	New Primary Tumor	"Other, specify"	Breast	268	NA	Negative	NA	1	524	1	524	1	268	1	268	
50	TCGA-AR-A1AS	0	1	1	1	1	0	0	0	2	23	2	1	0	11	1	0	TCGA-AR-A1AS-01	98	0.22389152174021976	44	TCGA-AR-A1AS-01	6	10	9	0.0690795735859791	TCGA-AR-A1AS-01	5	0	4	9	PASS	925	TCGA-AR-A1AS	BRCA	54	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20028	Alive	TUMOR FREE	1150	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1150	0	1150	0	1150	0	1150	
60	TCGA-AR-A1AT	0	3	0	0	4	0	0	0	1	22	0	0	1	7	1	0	TCGA-AR-A1AT	0	0	0	TCGA-AR-A1AT	0	0	0	0	TCGA-AR-A1AT	0	0	0	0	PASS	926	TCGA-AR-A1AT	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22942	Dead	NA	NA	1272	NA	NA	NA	NA	NA	NA	Negative	NA	1	1272	NA	1272	0	1272	0	1272	
40	TCGA-AR-A1AU	0	0	0	0	0	1	0	0	2	15	2	0	1	6	0	0	TCGA-AR-A1AU-01	271	0.2155503347732426	156	TCGA-AR-A1AU-01	6	11	91	0.20589870421610626	TCGA-AR-A1AU-01	9	7	6	22	PASS	927	TCGA-AR-A1AU	BRCA	39	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14564	Alive	TUMOR FREE	2868	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2868	0	2868	0	2868	0	2868	
70	TCGA-AR-A1AV	1	4	0	2	4	0	1	0	0	34	3	0	1	6	0	0	TCGA-AR-A1AV-01	73	0.8778590562144912	26	TCGA-AR-A1AV-01	23	21	4	0.09547299971655084	TCGA-AR-A1AV-01	3	2	1	6	PASS	928	TCGA-AR-A1AV	BRCA	68	MALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	NA	-24875	Alive	TUMOR FREE	1864	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1864	0	1864	0	1864	0	1864	
70	TCGA-AR-A1AW	0	2	0	1	1	0	0	0	2	25	3	0	0	10	0	0	TCGA-AR-A1AW-01	94	0.38818176739917204	44	TCGA-AR-A1AW-01	12	17	22	0.2495843330099481	TCGA-AR-A1AW-01	8	2	6	16	PASS	929	TCGA-AR-A1AW	BRCA	65	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23855	Alive	TUMOR FREE	2632	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2632	0	2632	0	2632	0	2632	
60	TCGA-AR-A1AX	0	0	0	0	1	0	1	0	1	22	1	0	1	8	1	0	TCGA-AR-A1AX-01	61	0.1859917080933195	17	TCGA-AR-A1AX-01	7	7	5	0.06397273949882562	TCGA-AR-A1AX-01	4	0	2	6	PASS	930	TCGA-AR-A1AX	BRCA	64	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23507	Alive	TUMOR FREE	2629	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2629	0	2629	0	2629	0	2629	
70	TCGA-AR-A1AY	0	5	0	1	3	0	1	0	0	46	5	0	1	15	2	0	TCGA-AR-A1AY-01	211	0.9228288773493364	127	TCGA-AR-A1AY-01	13	18	43	0.4248752383968867	TCGA-AR-A1AY-01	10	12	11	33	PASS	931	TCGA-AR-A1AY	BRCA	65	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23927	Alive	TUMOR FREE	1026	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1026	0	1026	0	1026	0	1026	
70	TCGA-AR-A24H	0	5	2	3	7	1	3	0	3	101	6	0	2	32	4	0	TCGA-AR-A24H-01	308	0.8751843531012502	184	TCGA-AR-A24H-01	15	24	57	0.2632164194163909	TCGA-AR-A24H-01	21	33	11	65	PASS	932	TCGA-AR-A24H	BRCA	65	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2001	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24046	Alive	TUMOR FREE	4894	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	4894	0	4894	0	4894	0	4894	
50	TCGA-AR-A24K	0	2	0	0	0	1	0	0	2	25	0	0	1	6	1	0	TCGA-AR-A24K-01	207	0.938336853412478	139	TCGA-AR-A24K-01	18	22	47	0.2541752208854721	TCGA-AR-A24K-01	6	10	8	24	PASS	933	TCGA-AR-A24K	BRCA	46	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16961	Alive	TUMOR FREE	1548	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1548	0	1548	0	1548	0	1548	
30	TCGA-AR-A24L	0	2	0	1	1	1	0	0	3	33	1	1	1	14	3	0	TCGA-AR-A24L-01	152	0.4324203316136813	75	TCGA-AR-A24L-01	8	12	31	0.238474984167548	TCGA-AR-A24L-01	17	16	17	50	PASS	934	TCGA-AR-A24L	BRCA	26	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-9706	Dead	WITH TUMOR	NA	2866	NA	Locoregional Disease	NA	NA	1414	NA	Negative	NA	1	2866	1	2866	1	1414	1	1414	
40	TCGA-AR-A24M	0	1	0	0	1	0	0	0	3	12	0	0	0	10	1	0	TCGA-AR-A24M-01	63	0.15785942003623282	21	TCGA-AR-A24M-01	4	6	9	0.02964819467997329	TCGA-AR-A24M-01	3	6	2	11	PASS	935	TCGA-AR-A24M	BRCA	38	FEMALE	WHITE	Stage IIIA	NA	Mixed Histology (please specify)	NA	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14119	Alive	TUMOR FREE	3660	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3660	0	3660	0	3660	0	3660	
50	TCGA-AR-A24N	0	1	1	2	0	1	0	0	0	27	3	0	1	12	1	0	TCGA-AR-A24N-01	56	0.15967483645789246	22	TCGA-AR-A24N-01	3	9	2	0.04328780156690189	TCGA-AR-A24N-01	5	2	2	9	PASS	936	TCGA-AR-A24N	BRCA	54	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2005	Peri (6-12 months since last menstrual period)	-19989	Alive	TUMOR FREE	3035	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3035	0	3035	0	3035	0	3035	
40	TCGA-AR-A24O	1	0	0	0	1	0	0	0	1	17	1	0	0	5	1	0	TCGA-AR-A24O-01	57	0.11361102840343258	13	TCGA-AR-A24O-01	5	4	7	0.10318906049842028	TCGA-AR-A24O-01	2	0	2	4	PASS	937	TCGA-AR-A24O	BRCA	43	FEMALE	WHITE	Stage IIIA	NA	Mixed Histology (please specify)	NA	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15977	Alive	WITH TUMOR	3607	NA	NA	NA	NA	NA	2561	NA	Negative	NA	0	3607	0	3607	1	2561	1	2561	
50	TCGA-AR-A24P	0	1	0	0	1	1	0	0	0	17	1	0	0	4	1	0	TCGA-AR-A24P-01	44	0.15873437087524533	6	TCGA-AR-A24P-01	8	6	5	0.09791137679420273	TCGA-AR-A24P-01	4	0	2	6	PASS	938	TCGA-AR-A24P	BRCA	47	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17490	Alive	NA	84	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	84	0	84	0	84	0	84	
50	TCGA-AR-A24Q	3	13	0	5	7	0	1	0	5	138	6	0	3	54	9	0	TCGA-AR-A24Q-01	292	0.7882703190226096	168	TCGA-AR-A24Q-01	16	32	84	0.4027382141346886	TCGA-AR-A24Q-01	30	26	16	72	PASS	939	TCGA-AR-A24Q	BRCA	49	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18084	Alive	TUMOR FREE	3172	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3172	0	3172	0	3172	0	3172	
50	TCGA-AR-A24R	0	2	0	0	3	0	1	0	2	18	0	0	0	5	0	0	TCGA-AR-A24R-01	217	0.5284456649833611	116	TCGA-AR-A24R-01	17	18	27	0.1321843169996728	TCGA-AR-A24R-01	5	4	5	14	PASS	940	TCGA-AR-A24R	BRCA	45	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16642	Alive	TUMOR FREE	3430	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3430	0	3430	0	3430	0	3430	
60	TCGA-AR-A24S	0	2	0	1	1	1	0	0	2	38	2	0	0	14	1	0	TCGA-AR-A24S-01	196	0.8374371535376136	123	TCGA-AR-A24S-01	16	26	34	0.1383628274438837	TCGA-AR-A24S-01	9	12	7	28	PASS	941	TCGA-AR-A24S	BRCA	61	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22587	Alive	NA	2976	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2976	0	2976	0	2976	0	2976	
50	TCGA-AR-A24T	1	1	1	0	2	2	0	0	1	15	4	0	0	5	0	0	TCGA-AR-A24T-01	78	0.2169257934991322	28	TCGA-AR-A24T	0	0	0	0	TCGA-AR-A24T	0	0	0	0	PASS	942	TCGA-AR-A24T	BRCA	46	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17135	Alive	TUMOR FREE	3202	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3202	0	3202	0	3202	0	3202	
50	TCGA-AR-A24U	0	2	0	1	1	0	0	0	1	26	6	0	1	10	1	0	TCGA-AR-A24U-01	188	0.2700555137893468	101	TCGA-AR-A24U-01	8	9	28	0.1549167365995421	TCGA-AR-A24U-01	10	6	7	23	PASS	943	TCGA-AR-A24U	BRCA	47	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17523	Alive	TUMOR FREE	3128	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3128	0	3128	0	3128	0	3128	
50	TCGA-AR-A24V	0	0	0	0	0	0	0	0	0	20	0	0	0	8	0	0	TCGA-AR-A24V-01	119	0.6053303622781308	63	TCGA-AR-A24V-01	23	22	19	0.096842024637975	TCGA-AR-A24V-01	7	4	7	18	PASS	944	TCGA-AR-A24V	BRCA	52	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	Peri (6-12 months since last menstrual period)	-19027	Alive	TUMOR FREE	3203	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3203	0	3203	0	3203	0	3203	
60	TCGA-AR-A24W	0	0	0	0	1	0	0	0	1	13	0	0	0	4	0	0	TCGA-AR-A24W-01	46	0.4166594582343852	11	TCGA-AR-A24W-01	28	28	13	0.4899285623610493	TCGA-AR-A24W-01	3	2	3	8	PASS	945	TCGA-AR-A24W	BRCA	55	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20123	Alive	TUMOR FREE	1550	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1550	0	1550	0	1550	0	1550	
50	TCGA-AR-A24X	0	1	0	0	1	0	0	0	1	21	2	0	1	8	3	0	TCGA-AR-A24X-01	67	0.07133652626741077	25	TCGA-AR-A24X-01	4	4	4	0.027818021176681976	TCGA-AR-A24X-01	3	0	1	4	PASS	946	TCGA-AR-A24X	BRCA	52	FEMALE	WHITE	Stage IIA	NA	Mixed Histology (please specify)	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19030	Alive	TUMOR FREE	3004	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3004	0	3004	0	3004	0	3004	
60	TCGA-AR-A24Z	0	2	0	2	2	0	1	0	3	38	1	0	0	13	0	0	TCGA-AR-A24Z-01	518	0.5235864296169969	347	TCGA-AR-A24Z-01	18	23	96	0.1928398644605112	TCGA-AR-A24Z-01	13	12	8	33	PASS	947	TCGA-AR-A24Z	BRCA	57	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20900	Alive	TUMOR FREE	3001	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3001	0	3001	0	3001	0	3001	
60	TCGA-AR-A250	0	11	0	4	3	2	2	0	2	101	7	0	3	28	2	0	TCGA-AR-A250-01	221	0.6429285948924921	134	TCGA-AR-A250-01	19	30	27	0.13022669642347326	TCGA-AR-A250-01	16	7	7	30	PASS	948	TCGA-AR-A250	BRCA	58	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21309	Alive	TUMOR FREE	2707	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2707	0	2707	0	2707	0	2707	
50	TCGA-AR-A251	1	12	1	6	7	1	1	0	8	137	5	1	1	33	5	0	TCGA-AR-A251-01	546	0.9411576747427228	366	TCGA-AR-A251-01	13	33	153	0.5322569748880911	TCGA-AR-A251-01	32	29	18	79	PASS	949	TCGA-AR-A251	BRCA	51	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18771	Alive	TUMOR FREE	3030	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3030	0	3030	0	3030	0	3030	
50	TCGA-AR-A252	0	0	0	0	0	0	0	0	1	14	0	0	0	4	0	0	TCGA-AR-A252-01	105	0.1233630743667647	52	TCGA-AR-A252-01	16	22	6	0.05497175229234299	TCGA-AR-A252-01	2	0	1	3	PASS	950	TCGA-AR-A252	BRCA	50	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18611	Alive	TUMOR FREE	2838	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2838	0	2838	0	2838	0	2838	
50	TCGA-AR-A254	0	2	0	3	1	0	0	0	0	27	4	1	0	9	0	0	TCGA-AR-A254-01	292	0.44133429085579706	185	TCGA-AR-A254-01	11	26	40	0.13022072381563884	TCGA-AR-A254-01	8	6	7	21	PASS	951	TCGA-AR-A254	BRCA	50	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18270	Alive	TUMOR FREE	2605	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2605	0	2605	0	2605	0	2605	
60	TCGA-AR-A255	1	7	0	1	1	1	0	0	3	57	6	0	1	18	1	0	TCGA-AR-A255-01	213	0.7546295256895434	128	TCGA-AR-A255-01	25	31	31	0.3075278841274582	TCGA-AR-A255-01	16	13	12	41	PASS	952	TCGA-AR-A255	BRCA	62	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22809	Alive	TUMOR FREE	2161	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2161	0	2161	0	2161	0	2161	
50	TCGA-AR-A256	0	10	3	8	10	3	3	0	9	135	6	0	2	46	10	0	TCGA-AR-A256-01	674	0.7640844581186509	437	TCGA-AR-A256-01	17	29	179	0.4514179516920682	TCGA-AR-A256-01	24	19	20	63	PASS	953	TCGA-AR-A256	BRCA	45	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2001	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16642	Dead	NA	NA	2854	NA	Locoregional Disease	NA	NA	1640	NA	Negative	NA	1	2854	NA	2854	1	1640	1	1640	
70	TCGA-AR-A2LE	0	17	1	13	2	0	0	0	17	218	27	0	7	98	1	0	TCGA-AR-A2LE-01	62	0.07248980550868951	19	TCGA-AR-A2LE-01	4	4	7	0.0412540160334153	TCGA-AR-A2LE-01	4	0	3	7	PASS	954	TCGA-AR-A2LE	BRCA	69	FEMALE	WHITE	Stage I	NA	Infiltrating Lobular Carcinoma	NA	2001	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25499	Alive	TUMOR FREE	5062	NA	NA	New Primary Tumor	"Other, specify"	Endometrium	4203	NA	Negative	NA	0	5062	0	5062	0	5062	1	4203	
60	TCGA-AR-A2LH	0	1	0	1	2	0	0	0	1	49	8	0	0	12	1	0	TCGA-AR-A2LH-01	27	7.781155076172778e-07	2	TCGA-AR-A2LH-01	3	2	19	0.031066166486862307	TCGA-AR-A2LH-01	0	0	0	0	PASS	955	TCGA-AR-A2LH	BRCA	55	FEMALE	WHITE	Stage III	NA	Infiltrating Lobular Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20288	Dead	NA	NA	616	NA	Distant Metastasis	Bone	NA	434	NA	Negative	NA	1	616	NA	616	1	434	1	434	
40	TCGA-AR-A2LJ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AR-A2LJ-01	119	0.08738871636549356	67	TCGA-AR-A2LJ-01	3	4	12	0.04710433298961236	TCGA-AR-A2LJ-01	4	3	2	9	PASS	956	TCGA-AR-A2LJ	BRCA	40	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14723	Alive	TUMOR FREE	2632	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2632	0	2632	0	2632	0	2632	
60	TCGA-AR-A2LK	0	3	0	2	2	0	0	0	2	29	1	0	0	13	0	1	TCGA-AR-A2LK-01	52	0.6626098631505563	12	TCGA-AR-A2LK-01	26	37	11	0.30530669704787	TCGA-AR-A2LK-01	5	0	3	8	PASS	957	TCGA-AR-A2LK	BRCA	62	FEMALE	WHITE	Stage III	NA	Infiltrating Lobular Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22800	Dead	NA	NA	1649	NA	Distant Metastasis	Bone	NA	1304	NA	Negative	NA	1	1649	NA	1649	1	1304	1	1304	
70	TCGA-AR-A2LL	0	0	0	1	0	1	0	0	1	31	1	0	0	5	0	0	TCGA-AR-A2LL	0	0	0	TCGA-AR-A2LL	0	0	0	0	TCGA-AR-A2LL-01	9	6	6	21	PASS	958	TCGA-AR-A2LL	BRCA	70	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25747	Alive	TUMOR FREE	2012	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2012	0	2012	0	2012	0	2012	
50	TCGA-AR-A2LM	0	3	0	0	0	1	0	0	0	10	0	0	1	3	0	0	TCGA-AR-A2LM-01	80	0.10002038360517927	36	TCGA-AR-A2LM-01	4	4	17	0.047206277539121405	TCGA-AR-A2LM-01	5	2	3	10	PASS	959	TCGA-AR-A2LM	BRCA	49	FEMALE	WHITE	Stage II	NA	Infiltrating Lobular Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18053	Alive	TUMOR FREE	1935	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1935	0	1935	0	1935	0	1935	
70	TCGA-AR-A2LN	0	3	0	1	0	2	0	0	1	31	4	0	2	16	1	0	TCGA-AR-A2LN-01	82	0.0982799550130483	40	TCGA-AR-A2LN-01	2	2	16	0.042237584847029684	TCGA-AR-A2LN-01	4	2	2	8	PASS	960	TCGA-AR-A2LN	BRCA	65	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23992	Alive	TUMOR FREE	1161	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1161	0	1161	0	1161	0	1161	
50	TCGA-AR-A2LO	0	1	0	0	0	0	0	0	1	15	0	0	0	3	0	0	TCGA-AR-A2LO-01	59	0.3330829877849463	17	TCGA-AR-A2LO-01	11	13	16	0.2296673615128928	TCGA-AR-A2LO-01	7	5	8	20	PASS	961	TCGA-AR-A2LO	BRCA	46	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17080	Alive	TUMOR FREE	1198	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1198	0	1198	0	1198	0	1198	
60	TCGA-AR-A2LQ	0	0	0	1	0	0	0	0	0	10	0	0	0	5	0	0	TCGA-AR-A2LQ-01	45	0.004718725223158709	8	TCGA-AR-A2LQ-01	1	1	0	0.0	TCGA-AR-A2LQ-01	1	1	0	2	PASS	962	TCGA-AR-A2LQ	BRCA	59	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21865	Alive	TUMOR FREE	1233	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1233	0	1233	0	1233	0	1233	
50	TCGA-AR-A2LR	0	3	0	1	4	1	1	0	3	46	2	0	1	17	0	0	TCGA-AR-A2LR	0	0	0	TCGA-AR-A2LR	0	0	0	0	TCGA-AR-A2LR-01	26	19	14	59	PASS	963	TCGA-AR-A2LR	BRCA	49	FEMALE	WHITE	Stage I	NA	Metaplastic Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18214	Alive	TUMOR FREE	1742	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1742	0	1742	0	1742	0	1742	
60	TCGA-AR-A5QM	0	4	0	2	0	0	0	0	3	21	3	0	0	5	0	0	TCGA-AR-A5QM-01	68	0.9019590851020868	26	TCGA-AR-A5QM-01	19	27	141	0.5701593485009633	TCGA-AR-A5QM-01	4	1	8	13	PASS	964	TCGA-AR-A5QM	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22780	Alive	TUMOR FREE	2231	NA	NA	New Primary Tumor	"Other, specify"	Malignant melanoma	968	NA	NA	NA	0	2231	0	2231	NA	NA	1	968	
70	TCGA-AR-A5QN	0	9	0	5	3	1	0	0	3	23	3	0	2	9	0	1	TCGA-AR-A5QN-01	113	0.20118274310866108	49	TCGA-AR-A5QN-01	6	6	54	0.13651751370260984	TCGA-AR-A5QN-01	7	3	7	17	PASS	965	TCGA-AR-A5QN	BRCA	68	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25089	Alive	TUMOR FREE	1013	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1013	0	1013	NA	NA	0	1013	
50	TCGA-AR-A5QP	0	3	1	2	2	0	0	0	3	22	0	0	0	4	1	0	TCGA-AR-A5QP-01	88	0.22997886803024475	40	TCGA-AR-A5QP-01	8	9	15	0.0668845752910961	TCGA-AR-A5QP-01	5	6	4	15	PASS	966	TCGA-AR-A5QP	BRCA	54	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19805	Alive	TUMOR FREE	1185	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1185	0	1185	NA	NA	0	1185	
70	TCGA-AR-A5QQ	1	12	0	4	5	0	0	0	3	60	1	0	2	17	1	0	TCGA-AR-A5QQ-01	49	0.11867070747862025	10	TCGA-AR-A5QQ-01	7	6	32	0.14659951933359006	TCGA-AR-A5QQ-01	5	4	4	13	PASS	967	TCGA-AR-A5QQ	BRCA	68	FEMALE	WHITE	Stage IIIA	NA	"Other, specify"	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24841	Dead	WITH TUMOR	NA	322	NA	Distant Metastasis	Lung	"Liver, bone, chest wall, adrenal glands"	301	NA	NA	NA	1	322	1	322	NA	NA	1	301	
70	TCGA-B6-A0I1	0	16	5	3	1	0	0	0	5	46	2	0	2	11	1	0	TCGA-B6-A0I1-01	271	0.3768190953617788	161	TCGA-B6-A0I1-01	9	17	62	0.2847565338136365	TCGA-B6-A0I1-01	12	18	13	43	PASS	968	TCGA-B6-A0I1	BRCA	73	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	1998	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26902	Dead	TUMOR FREE	NA	2361	NA	Distant Metastasis	Lung	NA	1120	NA	Negative	NA	1	2361	0	2361	1	1120	1	1120	
50	TCGA-B6-A0I2	1	2	0	1	0	1	0	0	4	46	6	0	2	17	0	0	TCGA-B6-A0I2-01	170	0.8564045543668085	96	TCGA-B6-A0I2-01	23	23	37	0.5324704208060799	TCGA-B6-A0I2-01	20	11	9	40	mutation call filter	969	TCGA-B6-A0I2	BRCA	45	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	1995	Indeterminate (neither Pre or Postmenopausal)	-16702	Alive	TUMOR FREE	4361	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4361	0	4361	NA	NA	0	4361	
50	TCGA-B6-A0I5	0	1	1	0	0	0	1	0	1	21	0	0	2	8	0	0	TCGA-B6-A0I5-01	55	0.8924749845757879	16	TCGA-B6-A0I5-01	11	9	2	0.015882632651607498	TCGA-B6-A0I5-01	3	0	1	4	mutation call filter	970	TCGA-B6-A0I5	BRCA	49	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1988	Indeterminate (neither Pre or Postmenopausal)	-18038	Alive	TUMOR FREE	8556	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	8556	0	8556	0	8556	0	8556	
50	TCGA-B6-A0I6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B6-A0I6	0	0	0	TCGA-B6-A0I6	0	0	0	0	TCGA-B6-A0I6	0	0	0	0	PASS	971	TCGA-B6-A0I6	BRCA	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	1990	Indeterminate (neither Pre or Postmenopausal)	-18014	Dead	WITH TUMOR	NA	991	NA	Distant Metastasis	"Other, specify"	Skin and bone	859	NA	Negative	NA	1	991	1	991	1	859	1	859	
50	TCGA-B6-A0I8	0	11	1	5	10	0	2	0	5	90	6	0	1	40	3	0	TCGA-B6-A0I8	0	0	0	TCGA-B6-A0I8	0	0	0	0	TCGA-B6-A0I8	0	0	0	0	mutation call filter	972	TCGA-B6-A0I8	BRCA	46	FEMALE	WHITE	Stage X	NA	Infiltrating Ductal Carcinoma	NA	1992	Indeterminate (neither Pre or Postmenopausal)	-17073	Dead	WITH TUMOR	NA	749	NA	Locoregional Disease	"Other, specify"	Pectoral muscle	746	NA	NA	NA	1	749	1	749	NA	NA	1	746	
60	TCGA-B6-A0I9	0	7	1	10	4	1	0	0	2	59	5	0	3	23	3	0	TCGA-B6-A0I9-01	631	0.5241879766146444	458	TCGA-B6-A0I9-01	12	31	110	0.2549962727949341	TCGA-B6-A0I9-01	16	6	11	33	mutation call filter	973	TCGA-B6-A0I9	BRCA	62	FEMALE	WHITE	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	1992	Indeterminate (neither Pre or Postmenopausal)	-22798	Dead	WITH TUMOR	NA	362	NA	NA	NA	NA	NA	NA	NA	NA	1	362	1	362	NA	NA	1	362	
50	TCGA-B6-A0IA	0	1	0	1	1	1	0	1	3	20	2	0	0	14	1	0	TCGA-B6-A0IA-01	153	0.2386196539557011	87	TCGA-B6-A0IA-01	6	8	15	0.08842459740786636	TCGA-B6-A0IA-01	7	8	5	20	mutation call filter	974	TCGA-B6-A0IA	BRCA	51	FEMALE	WHITE	Stage IIA	NA	"Other, specify"	NA	1992	Indeterminate (neither Pre or Postmenopausal)	-18748	Alive	TUMOR FREE	8391	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	8391	0	8391	0	8391	0	8391	
60	TCGA-B6-A0IB	1	4	3	6	2	1	0	0	3	49	8	0	0	18	4	0	TCGA-B6-A0IB-01	85	0.6029667734729698	34	TCGA-B6-A0IB-01	21	25	7	0.12544311620833648	TCGA-B6-A0IB-01	6	10	6	22	mutation call filter	975	TCGA-B6-A0IB	BRCA	64	FEMALE	WHITE	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	1992	Indeterminate (neither Pre or Postmenopausal)	-23646	Dead	WITH TUMOR	NA	3941	NA	Distant Metastasis	"Other, specify"	"lung, bone, liver"	2717	NA	Negative	NA	1	3941	1	3941	NA	NA	1	2717	
90	TCGA-B6-A0IC	0	5	0	1	3	1	0	0	5	25	0	0	0	8	1	0	TCGA-B6-A0IC-01	94	0.07880203083490163	42	TCGA-B6-A0IC-01	4	2	7	0.04453300808902355	TCGA-B6-A0IC-01	3	0	2	5	mutation call filter	976	TCGA-B6-A0IC	BRCA	90	FEMALE	WHITE	Stage X	NA	"Other, specify"	NA	1992	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32872	Dead	TUMOR FREE	NA	1542	NA	NA	NA	NA	NA	NA	Negative	NA	1	1542	0	1542	0	1542	0	1542	
40	TCGA-B6-A0IE	0	9	0	1	0	0	0	0	1	23	3	0	0	5	2	0	TCGA-B6-A0IE-01	352	0.3801922521580705	276	TCGA-B6-A0IE-01	12	15	47	0.1765230130601443	TCGA-B6-A0IE-01	8	5	8	21	mutation call filter	977	TCGA-B6-A0IE	BRCA	38	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Mixed Histology (please specify)	NA	1995	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13982	Dead	WITH TUMOR	NA	1993	NA	Distant Metastasis	Bone	NA	834	NA	Negative	NA	1	1993	1	1993	1	834	1	834	
50	TCGA-B6-A0IG	0	2	0	2	2	1	0	0	0	31	1	0	0	8	1	0	TCGA-B6-A0IG-01	721	0.946192447396847	595	TCGA-B6-A0IG-01	11	11	60	0.304075349568322	TCGA-B6-A0IG-01	10	5	11	26	mutation call filter	978	TCGA-B6-A0IG	BRCA	50	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1994	Indeterminate (neither Pre or Postmenopausal)	-18433	Dead	WITH TUMOR	NA	4456	NA	NA	NA	NA	NA	NA	Negative	NA	1	4456	1	4456	NA	NA	1	4456	
80	TCGA-B6-A0IH	0	0	0	1	1	1	1	0	2	30	4	0	0	8	0	0	TCGA-B6-A0IH-01	96	0.6864651782122541	43	TCGA-B6-A0IH-01	27	58	11	0.1040703385140735	TCGA-B6-A0IH-01	7	8	1	16	PASS	979	TCGA-B6-A0IH	BRCA	81	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	1995	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29907	Dead	NA	NA	3418	NA	NA	NA	NA	NA	NA	Negative	NA	1	3418	NA	3418	0	3418	0	3418	
40	TCGA-B6-A0IJ	0	12	0	3	1	0	1	0	1	119	8	0	2	27	3	0	TCGA-B6-A0IJ-01	336	0.7847827646763824	196	TCGA-B6-A0IJ-01	14	36	101	0.4484377178682273	TCGA-B6-A0IJ-01	29	23	21	73	mutation call filter	980	TCGA-B6-A0IJ	BRCA	42	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1995	Indeterminate (neither Pre or Postmenopausal)	-15625	Alive	TUMOR FREE	7106	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	7106	0	7106	0	7106	0	7106	
60	TCGA-B6-A0IK	1	18	2	5	0	1	0	0	13	98	9	0	2	54	4	0	TCGA-B6-A0IK-01	199	0.4251788570332595	110	TCGA-B6-A0IK-01	13	12	33	0.3902612368348842	TCGA-B6-A0IK-01	8	2	10	20	mutation call filter	981	TCGA-B6-A0IK	BRCA	63	FEMALE	WHITE	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	1994	Indeterminate (neither Pre or Postmenopausal)	-23150	Dead	WITH TUMOR	NA	571	NA	Distant Metastasis	Brain	NA	489	NA	Negative	NA	1	571	1	571	1	489	1	489	
80	TCGA-B6-A0IM	0	4	0	1	2	1	0	0	2	20	1	0	0	11	4	0	TCGA-B6-A0IM-01	194	0.22148917599188675	114	TCGA-B6-A0IM-01	9	7	10	0.0846173058268704	TCGA-B6-A0IM-01	5	3	6	14	mutation call filter	982	TCGA-B6-A0IM	BRCA	75	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	"Other, specify"	NA	1997	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27557	Dead	TUMOR FREE	NA	3873	NA	NA	NA	NA	NA	NA	Negative	NA	1	3873	0	3873	0	3873	0	3873	
50	TCGA-B6-A0IN	0	4	0	3	1	2	0	0	4	21	4	0	2	10	1	0	TCGA-B6-A0IN-01	373	0.2492980167528643	232	TCGA-B6-A0IN-01	7	10	58	0.08798124620714863	TCGA-B6-A0IN-01	11	5	5	21	mutation call filter	983	TCGA-B6-A0IN	BRCA	45	FEMALE	WHITE	Stage X	NA	"Other, specify"	NA	1996	Indeterminate (neither Pre or Postmenopausal)	-16705	Dead	WITH TUMOR	NA	2573	NA	Distant Metastasis	"Other, specify"	"bone, brain"	1412	NA	Negative	NA	1	2573	1	2573	1	1412	1	1412	
70	TCGA-B6-A0IO	0	2	1	2	3	0	0	0	2	50	3	0	3	26	1	0	TCGA-B6-A0IO-01	275	0.6722190364920886	193	TCGA-B6-A0IO-01	21	18	69	0.1907214510246442	TCGA-B6-A0IO-01	10	12	4	26	mutation call filter	984	TCGA-B6-A0IO	BRCA	66	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2001	Indeterminate (neither Pre or Postmenopausal)	-24322	Alive	TUMOR FREE	5042	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	5042	0	5042	0	5042	0	5042	
70	TCGA-B6-A0IP	1	5	1	1	1	1	0	0	4	21	8	0	2	11	3	0	TCGA-B6-A0IP-01	61	0.07711354642591578	18	TCGA-B6-A0IP-01	2	3	2	0.032679049493980115	TCGA-B6-A0IP-01	2	1	2	5	mutation call filter	985	TCGA-B6-A0IP	BRCA	74	FEMALE	WHITE	Stage IA	NA	Infiltrating Lobular Carcinoma	NA	1997	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27047	Dead	TUMOR FREE	NA	3926	NA	NA	NA	NA	NA	NA	Negative	NA	1	3926	0	3926	0	3926	0	3926	
40	TCGA-B6-A0IQ	0	3	0	3	6	0	1	0	2	49	7	0	0	19	1	1	TCGA-B6-A0IQ-01	401	0.6513576037095401	260	TCGA-B6-A0IQ-01	14	28	82	0.3192251411960909	TCGA-B6-A0IQ-01	20	26	11	57	mutation call filter	986	TCGA-B6-A0IQ	BRCA	40	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	1996	Indeterminate (neither Pre or Postmenopausal)	-14669	Alive	TUMOR FREE	4285	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	4285	0	4285	0	4285	0	4285	
60	TCGA-B6-A0RE	0	16	0	4	3	2	2	0	6	117	11	1	3	45	1	0	TCGA-B6-A0RE-01	288	0.7091048328415654	180	TCGA-B6-A0RE-01	20	32	48	0.3889136919170539	TCGA-B6-A0RE-01	19	12	8	39	mutation call filter	987	TCGA-B6-A0RE	BRCA	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage X	NA	Infiltrating Ductal Carcinoma	NA	1989	Indeterminate (neither Pre or Postmenopausal)	-22449	Alive	TUMOR FREE	7777	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	7777	0	7777	0	7777	0	7777	
30	TCGA-B6-A0RG	0	10	0	2	5	0	0	0	3	58	3	0	1	12	0	0	TCGA-B6-A0RG-01	192	0.4847612992063218	112	TCGA-B6-A0RG-01	7	11	24	0.11969088626466755	TCGA-B6-A0RG-01	13	11	6	30	mutation call filter	988	TCGA-B6-A0RG	BRCA	26	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1991	Indeterminate (neither Pre or Postmenopausal)	-9840	Alive	TUMOR FREE	2082	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2082	0	2082	0	2082	0	2082	
50	TCGA-B6-A0RH	0	1	0	2	2	1	0	0	1	29	3	0	0	9	2	0	TCGA-B6-A0RH-01	210	0.2893960251324981	132	TCGA-B6-A0RH-01	10	8	47	0.17819970473090313	TCGA-B6-A0RH-01	11	6	7	24	PASS	989	TCGA-B6-A0RH	BRCA	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	1991	Indeterminate (neither Pre or Postmenopausal)	-18759	Dead	TUMOR FREE	NA	6456	NA	Locoregional Disease	"Other, specify"	Chest Wall	2165	NA	Negative	NA	1	6456	0	6456	1	2165	1	2165	
40	TCGA-B6-A0RI	1	3	0	2	1	1	0	1	2	11	3	0	0	5	2	0	TCGA-B6-A0RI-01	82	0.1043917294723126	34	TCGA-B6-A0RI-01	3	4	11	0.03758415556182235	TCGA-B6-A0RI-01	6	4	3	13	mutation call filter	990	TCGA-B6-A0RI	BRCA	44	FEMALE	WHITE	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	1992	Indeterminate (neither Pre or Postmenopausal)	-16138	Alive	WITH TUMOR	7126	NA	NA	Locoregional Disease	"Other, specify"	Chest Wall	1100	NA	Negative	NA	0	7126	0	7126	1	1100	1	1100	
60	TCGA-B6-A0RL	0	1	0	3	2	1	0	0	5	44	3	0	0	15	1	1	TCGA-B6-A0RL-01	230	0.8544314601599838	116	TCGA-B6-A0RL-01	9	9	32	0.20082255313069491	TCGA-B6-A0RL-01	9	4	7	20	PASS	991	TCGA-B6-A0RL	BRCA	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	1993	NA	-22238	Dead	TUMOR FREE	NA	2469	NA	NA	NA	NA	NA	NA	Negative	NA	1	2469	0	2469	0	2469	0	2469	
60	TCGA-B6-A0RM	1	1	0	1	4	0	0	0	1	21	2	0	0	9	0	0	TCGA-B6-A0RM-01	137	0.08048955009885972	75	TCGA-B6-A0RM-01	4	5	4	0.030540133360088317	TCGA-B6-A0RM-01	2	0	2	4	PASS	992	TCGA-B6-A0RM	BRCA	57	FEMALE	BLACK OR AFRICAN AMERICAN	Stage X	NA	Infiltrating Ductal Carcinoma	NA	1993	Indeterminate (neither Pre or Postmenopausal)	-21047	Dead	TUMOR FREE	NA	2373	NA	NA	NA	NA	NA	NA	NA	NA	1	2373	0	2373	NA	NA	0	2373	
60	TCGA-B6-A0RN	0	0	0	1	2	0	1	1	0	21	0	0	1	11	0	0	TCGA-B6-A0RN-01	85	0.07409682267210138	31	TCGA-B6-A0RN-01	4	4	3	0.0304918738760327	TCGA-B6-A0RN-01	3	0	1	4	PASS	993	TCGA-B6-A0RN	BRCA	60	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	1993	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22077	Alive	TUMOR FREE	8008	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	8008	0	8008	0	8008	0	8008	
70	TCGA-B6-A0RO	0	4	0	1	1	2	1	0	4	24	4	0	1	4	1	0	TCGA-B6-A0RO-01	129	0.4970109847672718	66	TCGA-B6-A0RO-01	19	22	15	0.12354894056229655	TCGA-B6-A0RO-01	6	5	7	18	PASS	994	TCGA-B6-A0RO	BRCA	71	FEMALE	WHITE	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	1993	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26269	Alive	TUMOR FREE	4929	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	4929	0	4929	0	4929	0	4929	
70	TCGA-B6-A0RP	1	3	1	1	0	0	0	0	1	17	1	0	0	5	1	0	TCGA-B6-A0RP-01	93	0.4882279634484208	44	TCGA-B6-A0RP-01	20	15	3	0.051128695898506805	TCGA-B6-A0RP-01	3	0	1	4	PASS	995	TCGA-B6-A0RP	BRCA	73	FEMALE	WHITE	[Discrepancy]	NA	Mixed Histology (please specify)	NA	1994	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26941	Dead	WITH TUMOR	NA	3126	NA	Distant Metastasis	Bone	NA	2787	NA	Negative	NA	1	3126	1	3126	1	2787	1	2787	
70	TCGA-B6-A0RQ	0	0	0	1	1	0	0	0	2	33	2	0	0	15	3	0	TCGA-B6-A0RQ-01	64	0.07682475698731732	25	TCGA-B6-A0RQ	0	0	0	0	TCGA-B6-A0RQ	0	0	0	0	PASS	996	TCGA-B6-A0RQ	BRCA	68	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	1994	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25010	Dead	TUMOR FREE	NA	4267	NA	NA	NA	NA	NA	NA	Negative	NA	1	4267	0	4267	0	4267	0	4267	
40	TCGA-B6-A0RS	2	12	1	4	3	0	2	0	8	124	5	0	3	37	4	0	TCGA-B6-A0RS-01	400	0.7850192824580716	247	TCGA-B6-A0RS-01	13	24	82	0.3360145400752257	TCGA-B6-A0RS-01	29	33	15	77	mutation call filter	997	TCGA-B6-A0RS	BRCA	38	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	1988	Indeterminate (neither Pre or Postmenopausal)	-14134	Dead	WITH TUMOR	NA	3063	NA	New Primary Tumor	"Other, specify"	Breast	2041	NA	Negative	NA	1	3063	1	3063	1	2041	1	2041	
40	TCGA-B6-A0RT	0	2	0	2	1	0	0	0	1	49	3	0	0	13	2	0	TCGA-B6-A0RT-01	105	0.04774145182579749	46	TCGA-B6-A0RT-01	2	3	6	0.05586001522203695	TCGA-B6-A0RT-01	7	4	2	13	PASS	998	TCGA-B6-A0RT	BRCA	39	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	1996	Indeterminate (neither Pre or Postmenopausal)	-14374	Alive	TUMOR FREE	2721	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	2721	0	2721	NA	NA	0	2721	
40	TCGA-B6-A0RU	1	3	0	1	3	0	1	0	4	35	6	0	0	11	0	0	TCGA-B6-A0RU-01	114	0.8761582894505101	55	TCGA-B6-A0RU-01	13	14	37	0.5470727896615251	TCGA-B6-A0RU-01	14	12	6	32	PASS	999	TCGA-B6-A0RU	BRCA	40	FEMALE	WHITE	Stage IA	NA	"Other, specify"	NA	1990	Indeterminate (neither Pre or Postmenopausal)	-14920	Alive	TUMOR FREE	8605	NA	NA	New Primary Tumor	"Other, specify"	Right Breast	3076	NA	Negative	NA	0	8605	0	8605	1	3076	1	3076	
40	TCGA-B6-A0RV	0	8	0	0	0	0	0	0	2	30	3	0	3	19	3	0	TCGA-B6-A0RV-01	227	0.1644088828185324	133	TCGA-B6-A0RV-01	7	6	24	0.11610430988517062	TCGA-B6-A0RV-01	8	5	5	18	PASS	1000	TCGA-B6-A0RV	BRCA	42	FEMALE	WHITE	Stage IIIA	NA	Mixed Histology (please specify)	NA	1996	Indeterminate (neither Pre or Postmenopausal)	-15507	Alive	TUMOR FREE	5156	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	5156	0	5156	0	5156	0	5156	
60	TCGA-B6-A0WS	0	1	0	0	0	0	0	0	0	11	1	0	0	6	1	0	TCGA-B6-A0WS-01	163	0.2277089455099442	85	TCGA-B6-A0WS-01	9	10	16	0.2265304051270515	TCGA-B6-A0WS-01	8	6	6	20	PASS	1001	TCGA-B6-A0WS	BRCA	58	FEMALE	BLACK OR AFRICAN AMERICAN	Stage X	NA	Infiltrating Ductal Carcinoma	NA	1996	Indeterminate (neither Pre or Postmenopausal)	-21230	Dead	TUMOR FREE	NA	2965	NA	NA	NA	NA	NA	NA	Positive	NA	1	2965	0	2965	NA	NA	0	2965	
60	TCGA-B6-A0WT	1	0	0	1	1	0	0	0	1	11	1	0	0	6	1	0	TCGA-B6-A0WT-01	88	0.1539730150380194	35	TCGA-B6-A0WT-01	3	8	18	0.0908116228786515	TCGA-B6-A0WT-01	12	10	6	28	PASS	1002	TCGA-B6-A0WT	BRCA	61	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1995	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22362	Alive	TUMOR FREE	5739	NA	NA	New Primary Tumor	"Other, specify"	right breast cancer contralateral	3862	NA	Negative	NA	0	5739	0	5739	1	3862	1	3862	
70	TCGA-B6-A0WV	1	3	0	2	3	3	2	0	2	20	0	0	0	10	0	0	TCGA-B6-A0WV-01	127	0.6451108756489033	66	TCGA-B6-A0WV-01	24	20	23	0.2032734948432998	TCGA-B6-A0WV-01	6	4	8	18	PASS	1003	TCGA-B6-A0WV	BRCA	67	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1995	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24803	Dead	TUMOR FREE	NA	2417	NA	NA	NA	NA	NA	NA	Negative	NA	1	2417	0	2417	0	2417	0	2417	
60	TCGA-B6-A0WW	0	4	2	2	3	1	0	0	0	24	3	0	0	12	1	0	TCGA-B6-A0WW-01	177	0.3928477056323331	83	TCGA-B6-A0WW-01	9	11	28	0.2381813274076401	TCGA-B6-A0WW-01	11	5	11	27	PASS	1004	TCGA-B6-A0WW	BRCA	58	FEMALE	BLACK OR AFRICAN AMERICAN	Stage X	NA	Infiltrating Ductal Carcinoma	NA	1997	Indeterminate (neither Pre or Postmenopausal)	-21479	Dead	WITH TUMOR	NA	558	NA	Distant Metastasis	Liver	NA	447	NA	Negative	NA	1	558	1	558	1	447	1	447	
40	TCGA-B6-A0WX	0	4	0	1	0	0	0	0	1	24	2	0	2	13	1	0	TCGA-B6-A0WX-01	201	0.4762482895221754	120	TCGA-B6-A0WX-01	16	22	47	0.39873239852516656	TCGA-B6-A0WX-01	14	5	14	33	PASS	1005	TCGA-B6-A0WX	BRCA	40	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	"Other, specify"	NA	1998	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14784	Dead	WITH TUMOR	NA	639	NA	Distant Metastasis	Bone	NA	563	NA	Negative	NA	1	639	1	639	1	563	1	563	
40	TCGA-B6-A0WY	0	4	0	1	0	1	3	0	0	23	4	0	0	3	0	0	TCGA-B6-A0WY-01	128	0.6848162343401809	63	TCGA-B6-A0WY-01	25	25	36	0.3172713977148099	TCGA-B6-A0WY-01	13	8	8	29	PASS	1006	TCGA-B6-A0WY	BRCA	40	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	1996	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14778	Dead	WITH TUMOR	NA	3461	NA	Distant Metastasis	Bone	NA	2011	NA	Negative	NA	1	3461	1	3461	1	2011	1	2011	
50	TCGA-B6-A0WZ	1	4	1	4	0	0	0	0	0	53	3	0	2	29	0	0	TCGA-B6-A0WZ-01	55	0.2979138169600035	13	TCGA-B6-A0WZ-01	11	8	4	0.023207252429538645	TCGA-B6-A0WZ-01	3	1	2	6	PASS	1007	TCGA-B6-A0WZ	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Infiltrating Ductal Carcinoma	NA	1996	Indeterminate (neither Pre or Postmenopausal)	-18584	Alive	TUMOR FREE	6292	NA	NA	New Primary Tumor	Bone	NA	5117	NA	Negative	NA	0	6292	0	6292	0	6292	1	5117	
50	TCGA-B6-A0X0	0	0	0	2	0	0	1	0	1	15	1	0	0	7	1	0	TCGA-B6-A0X0-01	51	0.1143408754517489	18	TCGA-B6-A0X0-01	5	4	4	0.023650039573619826	TCGA-B6-A0X0-01	3	1	2	6	PASS	1008	TCGA-B6-A0X0	BRCA	54	FEMALE	WHITE	Stage I	NA	"Other, specify"	NA	1996	Indeterminate (neither Pre or Postmenopausal)	-19802	Dead	NA	NA	3945	NA	NA	NA	NA	NA	NA	Negative	NA	1	3945	NA	3945	0	3945	0	3945	
50	TCGA-B6-A0X1	0	7	0	1	3	1	2	0	5	54	4	0	1	18	3	0	TCGA-B6-A0X1-01	574	0.948535234748736	400	TCGA-B6-A0X1-01	13	24	219	0.7065774524473072	TCGA-B6-A0X1-01	26	28	24	78	PASS	1009	TCGA-B6-A0X1	BRCA	48	FEMALE	WHITE	[Discrepancy]	NA	Infiltrating Ductal Carcinoma	NA	1994	Indeterminate (neither Pre or Postmenopausal)	-17624	Dead	TUMOR FREE	NA	7455	NA	Distant Metastasis	Brain	NA	490	NA	Negative	NA	1	7455	0	7455	1	490	1	490	
60	TCGA-B6-A0X4	0	1	0	0	1	1	0	0	0	12	4	0	0	5	0	0	TCGA-B6-A0X4-01	53	0.03051097847795722	15	TCGA-B6-A0X4-01	0	1	0	0.0	TCGA-B6-A0X4-01	0	1	0	1	PASS	1010	TCGA-B6-A0X4	BRCA	62	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1996	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22688	Dead	WITH TUMOR	NA	860	NA	Distant Metastasis	Bone	NA	716	NA	Negative	NA	1	860	1	860	1	716	1	716	
60	TCGA-B6-A0X5	0	4	0	0	2	2	0	0	2	27	1	0	1	13	2	0	TCGA-B6-A0X5-01	119	0.0827195396684799	63	TCGA-B6-A0X5-01	3	2	6	0.05213236457865368	TCGA-B6-A0X5-01	1	1	3	5	PASS	1011	TCGA-B6-A0X5	BRCA	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1995	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22380	Dead	WITH TUMOR	NA	2097	NA	Distant Metastasis	"Other, specify"	Liver and Pleura and Bone	1343	NA	Negative	NA	1	2097	1	2097	1	1343	1	1343	
60	TCGA-B6-A0X7	0	1	0	0	1	0	2	0	1	11	1	0	0	9	0	0	TCGA-B6-A0X7-01	76	0.17476680276905585	25	TCGA-B6-A0X7-01	5	7	10	0.08769062702544751	TCGA-B6-A0X7-01	6	5	6	17	PASS	1012	TCGA-B6-A0X7	BRCA	62	FEMALE	WHITE	Stage X	NA	Mixed Histology (please specify)	NA	1994	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22723	Dead	TUMOR FREE	NA	1781	NA	New Primary Tumor	"Other, specify"	colon	1104	NA	NA	NA	1	1781	0	1781	NA	NA	1	1104	
70	TCGA-B6-A1KC	0	1	0	0	1	1	1	0	3	22	0	0	0	10	1	0	TCGA-B6-A1KC-01	146	0.7552493331569754	83	TCGA-B6-A1KC-01	27	57	18	0.3050500786035504	TCGA-B6-A1KC-01	7	3	3	13	mutation call filter	1013	TCGA-B6-A1KC	BRCA	67	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24791	Alive	TUMOR FREE	1326	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1326	0	1326	0	1326	0	1326	
70	TCGA-B6-A1KF	1	6	1	4	1	1	0	0	4	42	1	0	1	20	1	0	TCGA-B6-A1KF-01	176	0.6073506670920286	91	TCGA-B6-A1KF-01	22	35	16	0.1788505994753801	TCGA-B6-A1KF-01	12	5	4	21	mutation call filter	1014	TCGA-B6-A1KF	BRCA	68	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1998	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24891	Alive	TUMOR FREE	3088	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3088	0	3088	0	3088	0	3088	
60	TCGA-B6-A1KI	0	2	0	0	2	0	1	0	2	17	1	0	0	8	0	0	TCGA-B6-A1KI-01	103	0.4340709257566734	50	TCGA-B6-A1KI-01	29	46	3	0.025396604042375964	TCGA-B6-A1KI-01	3	1	2	6	mutation call filter	1015	TCGA-B6-A1KI	BRCA	63	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23031	Alive	TUMOR FREE	2236	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2236	0	2236	0	2236	0	2236	
60	TCGA-B6-A1KN	1	6	0	0	2	1	1	0	2	49	3	0	0	12	2	0	TCGA-B6-A1KN-01	306	0.7919809505950072	202	TCGA-B6-A1KN-01	17	23	48	0.2139085863402924	TCGA-B6-A1KN-01	14	7	12	33	PASS	1016	TCGA-B6-A1KN	BRCA	57	FEMALE	WHITE	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	1998	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21183	Alive	TUMOR FREE	4233	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	4233	0	4233	0	4233	0	4233	
60	TCGA-B6-A2IU	0	3	1	3	1	0	0	0	1	29	6	0	2	10	0	0	TCGA-B6-A2IU-01	87	0.2248008942195349	33	TCGA-B6-A2IU-01	9	10	9	0.12227377497834625	TCGA-B6-A2IU-01	5	2	3	10	PASS	1017	TCGA-B6-A2IU	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	1998	Indeterminate (neither Pre or Postmenopausal)	-22905	Alive	WITH TUMOR	5176	NA	NA	New Primary Tumor	"Other, specify"	Lung	4224	NA	Negative	NA	0	5176	0	5176	0	5176	1	4224	
50	TCGA-B6-A3ZX	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B6-A3ZX-01	78	0.12859463360503687	30	TCGA-B6-A3ZX-01	19	40	79	0.4163826840879288	TCGA-B6-A3ZX-01	20	27	8	55	PASS	1018	TCGA-B6-A3ZX	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Mixed Histology (please specify)	NA	2007	[Unknown]	-18434	Dead	WITH TUMOR	NA	1152	NA	Distant Metastasis	Bone	NA	994	NA	Negative	NA	1	1152	1	1152	NA	NA	1	994	
40	TCGA-B6-A400	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B6-A400-01	261	0.4742922091410331	155	TCGA-B6-A400-01	6	37	219	0.6360367944348387	TCGA-B6-A400-01	27	23	19	69	PASS	1019	TCGA-B6-A400	BRCA	43	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2008	[Unknown]	-16022	Alive	TUMOR FREE	215	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	215	0	215	0	215	0	215	
50	TCGA-B6-A401	0	3	1	2	2	0	0	0	1	15	2	0	1	6	0	0	TCGA-B6-A401-01	85	0.4129490129194497	32	TCGA-B6-A401-01	24	52	95	0.5729519906141947	TCGA-B6-A401-01	9	9	9	27	PASS	1020	TCGA-B6-A401	BRCA	47	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	[Unknown]	-17438	Alive	TUMOR FREE	2596	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2596	0	2596	0	2596	0	2596	
50	TCGA-B6-A402	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B6-A402-01	297	0.6923563718574183	181	TCGA-B6-A402-01	17	41	161	0.2867732836889817	TCGA-B6-A402-01	22	10	10	42	PASS	1021	TCGA-B6-A402	BRCA	47	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2008	[Unknown]	-17314	Alive	WITH TUMOR	2281	NA	NA	Locoregional Recurrence	"Other, specify"	breast	1516	NA	Negative	NA	0	2281	0	2281	1	1516	1	1516	
60	TCGA-B6-A408	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B6-A408-01	174	0.6607396070205589	97	TCGA-B6-A408-01	21	23	77	0.15171138207901375	TCGA-B6-A408-01	9	5	6	20	PASS	1022	TCGA-B6-A408	BRCA	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Mixed Histology (please specify)	NA	2008	[Unknown]	-20102	Alive	TUMOR FREE	2072	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2072	0	2072	0	2072	0	2072	
40	TCGA-B6-A409	0	7	0	0	1	1	0	0	3	23	2	0	1	19	1	0	TCGA-B6-A409-01	194	0.8046142235443949	112	TCGA-B6-A409-01	30	34	130	0.4542055774049111	TCGA-B6-A409-01	22	16	13	51	PASS	1023	TCGA-B6-A409	BRCA	44	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16178	Dead	WITH TUMOR	NA	573	NA	Distant Metastasis	Lung	NA	456	NA	Negative	NA	1	573	1	573	1	456	1	456	
80	TCGA-B6-A40B	0	9	0	2	0	0	0	0	4	38	2	0	2	13	0	0	TCGA-B6-A40B-01	106	0.2557841724029289	55	TCGA-B6-A40B-01	7	5	31	0.10133818247733813	TCGA-B6-A40B-01	3	0	4	7	PASS	1024	TCGA-B6-A40B	BRCA	76	FEMALE	WHITE	Stage I	NA	Infiltrating Lobular Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27811	Alive	TUMOR FREE	3152	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3152	0	3152	0	3152	0	3152	
50	TCGA-B6-A40C	1	8	0	0	1	2	0	0	3	28	2	0	0	12	0	0	TCGA-B6-A40C-01	97	0.2042427386887543	43	TCGA-B6-A40C-01	8	7	34	0.10885546536933413	TCGA-B6-A40C-01	5	3	4	12	PASS	1025	TCGA-B6-A40C	BRCA	51	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2005	[Unknown]	-18852	Alive	TUMOR FREE	2164	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2164	0	2164	0	2164	0	2164	
50	TCGA-BH-A0AU	0	0	0	0	1	1	0	0	0	12	3	0	0	8	0	0	TCGA-BH-A0AU-01	202	0.8108225982849294	125	TCGA-BH-A0AU-01	25	17	43	0.33143449422936444	TCGA-BH-A0AU-01	11	13	8	32	PASS	1026	TCGA-BH-A0AU	BRCA	45	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16688	Alive	TUMOR FREE	1914	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1914	0	1914	0	1914	0	1914	
50	TCGA-BH-A0AV	2	7	1	0	2	1	1	0	8	46	1	0	2	18	3	0	TCGA-BH-A0AV-01	295	0.9298283698450008	175	TCGA-BH-A0AV-01	12	19	59	0.5151455690027583	TCGA-BH-A0AV-01	23	26	19	68	PASS	1027	TCGA-BH-A0AV	BRCA	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2008	NA	-19314	Alive	TUMOR FREE	1820	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1820	0	1820	0	1820	0	1820	
60	TCGA-BH-A0AW	1	22	0	2	6	1	2	0	6	113	11	0	4	49	2	0	TCGA-BH-A0AW-01	353	0.528525691225422	225	TCGA-BH-A0AW-01	16	28	46	0.13272882195292202	TCGA-BH-A0AW-01	20	13	8	41	mutation call filter	1028	TCGA-BH-A0AW	BRCA	56	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20468	Alive	TUMOR FREE	622	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	622	0	622	0	622	0	622	
60	TCGA-BH-A0AY	0	19	0	2	4	1	0	0	6	83	6	0	2	35	4	0	TCGA-BH-A0AY-01	136	0.7460521476073073	72	TCGA-BH-A0AY-01	25	21	24	0.13751580759099227	TCGA-BH-A0AY-01	10	3	4	17	PASS	1029	TCGA-BH-A0AY	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22703	Alive	TUMOR FREE	777	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	777	0	777	0	777	0	777	
50	TCGA-BH-A0AZ	0	6	0	2	4	1	1	0	0	44	2	0	2	15	3	0	TCGA-BH-A0AZ-01	145	0.28532998343300725	71	TCGA-BH-A0AZ-01	3	14	29	0.229887948618166	TCGA-BH-A0AZ-01	16	15	11	42	PASS	1030	TCGA-BH-A0AZ	BRCA	47	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17465	Alive	TUMOR FREE	1919	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1919	0	1919	0	1919	0	1919	
60	TCGA-BH-A0B0	0	6	0	1	0	0	0	0	2	59	5	1	0	27	0	0	TCGA-BH-A0B0-01	50	0.2342406327080385	10	TCGA-BH-A0B0-01	9	6	8	0.21159912009939816	TCGA-BH-A0B0-01	3	3	3	9	PASS	1031	TCGA-BH-A0B0	BRCA	56	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2006	Peri (6-12 months since last menstrual period)	-20776	Alive	TUMOR FREE	2477	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2477	0	2477	0	2477	0	2477	
70	TCGA-BH-A0B1	1	5	0	4	3	1	1	0	1	42	2	0	0	16	0	0	TCGA-BH-A0B1	0	0	0	TCGA-BH-A0B1	0	0	0	0	TCGA-BH-A0B1	0	0	0	0	mutation call filter	1032	TCGA-BH-A0B1	BRCA	66	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24315	Alive	TUMOR FREE	1148	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1148	0	1148	0	1148	0	1148	
50	TCGA-BH-A0B3	2	7	2	2	6	0	0	0	6	60	4	0	2	21	2	0	TCGA-BH-A0B3-01	313	0.6707454361832114	192	TCGA-BH-A0B3-01	8	20	97	0.7147557488679734	TCGA-BH-A0B3-01	11	14	12	37	PASS	1033	TCGA-BH-A0B3	BRCA	53	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19479	Alive	TUMOR FREE	1203	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1203	0	1203	0	1203	0	1203	
70	TCGA-BH-A0B4	1	3	1	2	4	0	0	0	3	56	3	0	0	9	2	0	TCGA-BH-A0B4-01	214	0.373904553966484	119	TCGA-BH-A0B4-01	4	21	36	0.22433614467969212	TCGA-BH-A0B4-01	20	33	18	71	mutation call filter	1034	TCGA-BH-A0B4	BRCA	65	MALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2007	NA	-23980	Alive	TUMOR FREE	1191	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1191	0	1191	0	1191	0	1191	
40	TCGA-BH-A0B5	0	11	0	4	2	0	1	0	3	51	5	0	1	14	1	0	TCGA-BH-A0B5-01	91	0.5392676306069749	38	TCGA-BH-A0B5-01	21	17	8	0.07274560288064301	TCGA-BH-A0B5-01	6	1	3	10	mutation call filter	1035	TCGA-BH-A0B5	BRCA	40	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14920	Alive	TUMOR FREE	2136	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	2136	0	2136	NA	NA	0	2136	
50	TCGA-BH-A0B6	11	199	10	61	1	2	0	0	68	573	73	0	23	267	8	1	TCGA-BH-A0B6	0	0	0	TCGA-BH-A0B6	0	0	0	0	TCGA-BH-A0B6-01	10	6	6	22	hypermutated sample	1036	TCGA-BH-A0B6	BRCA	47	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2006	NA	-17346	Alive	TUMOR FREE	2483	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2483	0	2483	0	2483	0	2483	
40	TCGA-BH-A0B7	0	4	0	2	2	0	0	0	4	57	8	0	2	14	4	0	TCGA-BH-A0B7-01	181	0.3041482951956596	94	TCGA-BH-A0B7-01	10	14	50	0.2495281102267243	TCGA-BH-A0B7-01	10	9	8	27	PASS	1037	TCGA-BH-A0B7	BRCA	42	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15593	Alive	TUMOR FREE	2559	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2559	0	2559	0	2559	0	2559	
60	TCGA-BH-A0B8	4	10	0	1	2	3	0	0	8	97	10	0	4	52	2	2	TCGA-BH-A0B8	0	0	0	TCGA-BH-A0B8	0	0	0	0	TCGA-BH-A0B8	0	0	0	0	PASS	1038	TCGA-BH-A0B8	BRCA	64	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23380	Alive	TUMOR FREE	1569	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1569	0	1569	0	1569	0	1569	
40	TCGA-BH-A0B9	2	2	0	3	1	0	1	0	0	27	1	0	0	9	0	0	TCGA-BH-A0B9-01	475	0.39402524272229933	322	TCGA-BH-A0B9-01	8	17	103	0.3198489571620573	TCGA-BH-A0B9-01	13	12	12	37	mutation call filter	1039	TCGA-BH-A0B9	BRCA	44	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16310	Alive	TUMOR FREE	1572	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1572	0	1572	0	1572	0	1572	
50	TCGA-BH-A0BA	0	4	0	2	2	0	0	0	0	64	4	0	2	30	2	0	TCGA-BH-A0BA-01	292	0.8664125778875332	201	TCGA-BH-A0BA-01	34	15	39	0.4970910479928287	TCGA-BH-A0BA-01	10	1	12	23	PASS	1040	TCGA-BH-A0BA	BRCA	51	FEMALE	WHITE	Stage IIIC	NA	Mixed Histology (please specify)	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18839	Alive	TUMOR FREE	1132	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1132	0	1132	0	1132	0	1132	
60	TCGA-BH-A0BC	0	4	0	0	2	0	0	0	2	48	8	0	2	26	0	0	TCGA-BH-A0BC-01	125	0.1966965720566699	63	TCGA-BH-A0BC-01	3	6	22	0.13531813890596622	TCGA-BH-A0BC-01	7	3	4	14	PASS	1041	TCGA-BH-A0BC	BRCA	60	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21949	Alive	TUMOR FREE	974	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	974	0	974	0	974	0	974	
50	TCGA-BH-A0BD	0	4	0	2	2	0	0	0	3	26	0	0	0	5	0	0	TCGA-BH-A0BD-01	106	0.17941647664313273	55	TCGA-BH-A0BD-01	5	8	10	0.07760414308354252	TCGA-BH-A0BD-01	2	3	3	8	mutation call filter	1042	TCGA-BH-A0BD	BRCA	47	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17275	Alive	TUMOR FREE	554	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	554	0	554	0	554	0	554	
60	TCGA-BH-A0BF	0	1	1	1	0	0	2	0	1	19	0	0	0	12	0	0	TCGA-BH-A0BF-01	171	0.3519993020840473	92	TCGA-BH-A0BF-01	12	12	42	0.29051736880121376	TCGA-BH-A0BF-01	9	10	7	26	PASS	1043	TCGA-BH-A0BF	BRCA	56	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20691	Dead	TUMOR FREE	NA	1324	NA	NA	NA	NA	NA	NA	Negative	NA	1	1324	0	1324	0	1324	0	1324	
70	TCGA-BH-A0BG	0	5	0	0	0	1	0	1	2	31	1	0	0	8	0	0	TCGA-BH-A0BG-01	126	0.7096146839690654	54	TCGA-BH-A0BG-01	19	29	37	0.4038375170079314	TCGA-BH-A0BG-01	24	19	19	62	PASS	1044	TCGA-BH-A0BG	BRCA	73	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26988	Alive	TUMOR FREE	1871	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1871	0	1871	0	1871	0	1871	
40	TCGA-BH-A0BJ	0	2	0	3	0	3	2	0	3	42	4	0	0	14	0	2	TCGA-BH-A0BJ-01	49	0.4886403183632027	14	TCGA-BH-A0BJ-01	16	26	7	0.11602431280146615	TCGA-BH-A0BJ-01	4	2	1	7	PASS	1045	TCGA-BH-A0BJ	BRCA	41	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15027	Alive	TUMOR FREE	660	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	660	0	660	0	660	0	660	
40	TCGA-BH-A0BL	0	8	0	0	4	0	3	0	8	81	16	0	3	18	2	0	TCGA-BH-A0BL-01	249	0.8147236635478317	154	TCGA-BH-A0BL-01	17	19	10	0.0230667953183442	TCGA-BH-A0BL-01	20	20	1	41	PASS	1046	TCGA-BH-A0BL	BRCA	35	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12841	Alive	TUMOR FREE	2278	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2278	0	2278	0	2278	0	2278	
50	TCGA-BH-A0BM	0	4	0	0	2	2	0	0	0	40	4	0	2	21	2	0	TCGA-BH-A0BM-01	53	0.09363184606738142	12	TCGA-BH-A0BM-01	4	4	5	0.06333659234748802	TCGA-BH-A0BM-01	4	1	3	8	PASS	1047	TCGA-BH-A0BM	BRCA	54	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20049	Alive	TUMOR FREE	1876	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1876	0	1876	0	1876	0	1876	
50	TCGA-BH-A0BO	0	0	0	0	0	4	0	0	2	40	4	0	2	10	4	0	TCGA-BH-A0BO-01	36	0.0812345183180953	7	TCGA-BH-A0BO-01	3	2	4	0.05119597203302002	TCGA-BH-A0BO-01	2	2	1	5	PASS	1048	TCGA-BH-A0BO	BRCA	54	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19767	Alive	TUMOR FREE	2197	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2197	0	2197	0	2197	0	2197	
80	TCGA-BH-A0BP	1	11	3	6	3	1	0	0	2	120	8	0	2	44	5	0	TCGA-BH-A0BP-01	577	0.7378874217644911	375	TCGA-BH-A0BP-01	15	34	134	0.4222803759867755	TCGA-BH-A0BP-01	27	13	22	62	PASS	1049	TCGA-BH-A0BP	BRCA	76	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27917	Dead	TUMOR FREE	NA	2296	NA	NA	NA	NA	NA	NA	Negative	NA	1	2296	0	2296	0	2296	0	2296	
40	TCGA-BH-A0BQ	0	6	0	0	0	0	0	0	0	33	8	0	2	12	2	0	TCGA-BH-A0BQ-01	68	0.10088674529211454	22	TCGA-BH-A0BQ-01	5	5	5	0.06049352037939833	TCGA-BH-A0BQ-01	4	1	3	8	PASS	1050	TCGA-BH-A0BQ	BRCA	39	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14494	Alive	TUMOR FREE	2255	NA	NA	Locoregional Recurrence	"Other, specify"	Dermis and epidermis	1709	NA	Negative	NA	0	2255	0	2255	1	1709	1	1709	
60	TCGA-BH-A0BR	0	7	0	4	1	0	0	0	7	45	1	0	2	10	1	0	TCGA-BH-A0BR-01	364	0.9874161520171316	225	TCGA-BH-A0BR-01	12	11	64	0.3775506144663904	TCGA-BH-A0BR-01	9	14	14	37	mutation call filter	1051	TCGA-BH-A0BR	BRCA	59	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21622	Alive	TUMOR FREE	2330	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2330	0	2330	0	2330	0	2330	
60	TCGA-BH-A0BS	1	4	0	2	1	0	0	0	2	10	0	0	0	5	1	0	TCGA-BH-A0BS-01	69	0.0493478542762721	24	TCGA-BH-A0BS-01	2	2	19	0.015826568287963368	TCGA-BH-A0BS-01	2	0	1	3	PASS	1052	TCGA-BH-A0BS	BRCA	55	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20374	Alive	TUMOR FREE	2612	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2612	0	2612	0	2612	0	2612	
60	TCGA-BH-A0BT	0	1	0	2	1	0	0	0	0	34	1	1	1	9	0	0	TCGA-BH-A0BT-01	129	0.7770478996506148	62	TCGA-BH-A0BT-01	21	19	24	0.2290100765664838	TCGA-BH-A0BT-01	8	3	5	16	PASS	1053	TCGA-BH-A0BT	BRCA	56	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	NA	-20625	Alive	TUMOR FREE	2365	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2365	0	2365	0	2365	0	2365	
80	TCGA-BH-A0BV	0	12	0	4	2	3	0	0	0	44	4	0	2	12	0	0	TCGA-BH-A0BV-01	96	0.8627142453947496	54	TCGA-BH-A0BV-01	14	14	14	0.0615090927377002	TCGA-BH-A0BV-01	2	1	2	5	PASS	1054	TCGA-BH-A0BV	BRCA	78	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28699	Alive	TUMOR FREE	1519	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1519	0	1519	0	1519	0	1519	
70	TCGA-BH-A0BW	0	20	1	5	13	4	3	1	7	103	13	0	2	44	2	0	TCGA-BH-A0BW-01	210	0.5372248010293258	122	TCGA-BH-A0BW-01	10	18	52	0.4339001491796163	TCGA-BH-A0BW-01	20	21	15	56	PASS	1055	TCGA-BH-A0BW	BRCA	71	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25974	Alive	TUMOR FREE	2371	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2371	0	2371	0	2371	0	2371	
60	TCGA-BH-A0BZ	0	18	2	6	17	3	5	1	9	187	15	0	3	52	13	0	TCGA-BH-A0BZ-01	62	0.3455954824961279	20	TCGA-BH-A0BZ-01	20	25	9	0.19081391546919813	TCGA-BH-A0BZ-01	9	8	5	22	PASS	1056	TCGA-BH-A0BZ	BRCA	59	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21856	Alive	TUMOR FREE	2255	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2255	0	2255	0	2255	0	2255	
60	TCGA-BH-A0C0	0	18	0	5	8	0	4	0	3	147	14	0	4	31	10	0	TCGA-BH-A0C0-01	276	0.6709207027811824	170	TCGA-BH-A0C0-01	16	30	61	0.3907899246913951	TCGA-BH-A0C0-01	29	28	17	74	PASS	1057	TCGA-BH-A0C0	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23006	Alive	TUMOR FREE	1270	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1270	0	1270	0	1270	0	1270	
60	TCGA-BH-A0C1	0	3	0	1	3	0	0	0	0	26	3	0	1	17	0	0	TCGA-BH-A0C1-01	128	0.7365714419902372	75	TCGA-BH-A0C1-01	19	19	17	0.1096789789743834	TCGA-BH-A0C1-01	5	3	3	11	PASS	1058	TCGA-BH-A0C1	BRCA	61	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22377	Dead	WITH TUMOR	NA	1411	NA	Distant Metastasis	Bone	NA	1123	NA	Negative	NA	1	1411	1	1411	1	1123	1	1123	
50	TCGA-BH-A0C3	0	2	0	0	1	0	0	0	2	8	1	0	1	5	0	0	TCGA-BH-A0C3-01	74	0.24006020522618446	32	TCGA-BH-A0C3-01	11	11	10	0.2449566931447245	TCGA-BH-A0C3-01	5	4	5	14	PASS	1059	TCGA-BH-A0C3	BRCA	47	FEMALE	WHITE	Stage I	NA	Mixed Histology (please specify)	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17221	Alive	WITH TUMOR	2709	NA	NA	Distant Metastasis	Bone	NA	2674	NA	Negative	NA	0	2709	0	2709	1	2674	1	2674	
50	TCGA-BH-A0C7	1	4	0	1	4	0	0	0	2	35	3	0	0	15	1	0	TCGA-BH-A0C7-01	191	0.8098267490707379	107	TCGA-BH-A0C7-01	19	19	40	0.20451194211305032	TCGA-BH-A0C7-01	17	11	11	39	PASS	1060	TCGA-BH-A0C7	BRCA	48	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	Peri (6-12 months since last menstrual period)	-17871	Alive	TUMOR FREE	2767	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2767	0	2767	0	2767	0	2767	
60	TCGA-BH-A0DD	1	3	1	0	0	0	0	0	0	18	1	0	0	12	1	1	TCGA-BH-A0DD-01	364	0.3575129763613347	230	TCGA-BH-A0DD-01	15	25	9	0.033756693684035416	TCGA-BH-A0DD-01	7	8	2	17	PASS	1061	TCGA-BH-A0DD	BRCA	58	MALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	NA	-21386	Alive	TUMOR FREE	2486	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2486	0	2486	0	2486	0	2486	
60	TCGA-BH-A0DE	0	6	1	2	2	2	2	0	1	47	2	0	0	15	2	0	TCGA-BH-A0DE-01	66	0.19756744570756785	21	TCGA-BH-A0DE-01	7	6	15	0.1647185537122536	TCGA-BH-A0DE-01	7	4	7	18	PASS	1062	TCGA-BH-A0DE	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22656	Alive	TUMOR FREE	2372	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2372	0	2372	0	2372	0	2372	
30	TCGA-BH-A0DG	1	3	0	3	0	1	0	0	2	31	0	0	0	6	1	0	TCGA-BH-A0DG-01	303	0.21132441777792746	186	TCGA-BH-A0DG-01	2	5	37	0.07988510479492944	TCGA-BH-A0DG-01	8	9	2	19	PASS	1063	TCGA-BH-A0DG	BRCA	30	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11204	Alive	TUMOR FREE	2041	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2041	0	2041	0	2041	0	2041	
60	TCGA-BH-A0DH	2	8	2	2	4	0	1	0	5	50	8	0	0	21	2	0	TCGA-BH-A0DH-01	87	0.9474605090005686	37	TCGA-BH-A0DH-01	9	7	17	0.18807813213301994	TCGA-BH-A0DH-01	8	9	9	26	PASS	1064	TCGA-BH-A0DH	BRCA	63	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23366	Alive	TUMOR FREE	1156	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1156	0	1156	0	1156	0	1156	
60	TCGA-BH-A0DI	1	8	0	2	0	0	2	0	3	33	3	0	0	11	1	0	TCGA-BH-A0DI-01	286	0.32989467195931976	178	TCGA-BH-A0DI-01	8	10	36	0.1973610422230012	TCGA-BH-A0DI-01	11	8	10	29	PASS	1065	TCGA-BH-A0DI	BRCA	63	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23327	Alive	TUMOR FREE	912	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	912	0	912	0	912	0	912	
50	TCGA-BH-A0DK	2	22	0	4	10	4	0	0	16	141	11	0	12	42	2	0	TCGA-BH-A0DK-01	180	0.22289701400487436	100	TCGA-BH-A0DK-01	7	7	30	0.16570732055017975	TCGA-BH-A0DK-01	5	6	5	16	PASS	1066	TCGA-BH-A0DK	BRCA	49	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18237	Alive	TUMOR FREE	423	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	423	0	423	0	423	0	423	
60	TCGA-BH-A0DL	0	6	0	4	0	0	0	0	4	95	0	0	4	20	2	0	TCGA-BH-A0DL-01	94	0.5836643853703221	36	TCGA-BH-A0DL-01	10	13	27	0.26551656270067303	TCGA-BH-A0DL-01	9	3	6	18	PASS	1067	TCGA-BH-A0DL	BRCA	64	FEMALE	WHITE	Stage IIA	NA	"Other, specify"	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23628	Alive	TUMOR FREE	2381	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2381	0	2381	0	2381	0	2381	
80	TCGA-BH-A0DO	0	3	0	0	3	0	0	0	1	15	1	0	2	9	1	0	TCGA-BH-A0DO-01	77	0.18677491980294791	24	TCGA-BH-A0DO-01	9	6	2	0.01584743271369491	TCGA-BH-A0DO-01	3	0	1	4	PASS	1068	TCGA-BH-A0DO	BRCA	78	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28529	Alive	TUMOR FREE	1644	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1644	0	1644	0	1644	0	1644	
60	TCGA-BH-A0DP	0	4	2	2	2	1	0	0	2	48	2	0	2	13	0	0	TCGA-BH-A0DP-01	55	0.4437522364663915	16	TCGA-BH-A0DP-01	19	26	3	0.0263887795167301	TCGA-BH-A0DP-01	5	1	2	8	PASS	1069	TCGA-BH-A0DP	BRCA	60	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22199	Alive	TUMOR FREE	476	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	476	0	476	0	476	0	476	
40	TCGA-BH-A0DQ	0	0	0	0	2	4	0	0	4	46	6	0	0	12	3	0	TCGA-BH-A0DQ-01	154	0.287488144849858	83	TCGA-BH-A0DQ-01	7	11	18	0.14110827329990305	TCGA-BH-A0DQ-01	11	7	8	26	PASS	1070	TCGA-BH-A0DQ	BRCA	42	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15533	Alive	TUMOR FREE	98	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	98	0	98	0	98	0	98	
70	TCGA-BH-A0DS	0	4	0	1	1	1	0	0	4	30	3	0	1	17	0	0	TCGA-BH-A0DS-01	105	0.8062857021485451	45	TCGA-BH-A0DS-01	26	16	3	0.045998021287346896	TCGA-BH-A0DS-01	5	4	3	12	mutation call filter	1071	TCGA-BH-A0DS	BRCA	71	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25944	Alive	TUMOR FREE	78	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	78	0	78	0	78	0	78	
40	TCGA-BH-A0DT	0	1	0	0	2	1	0	0	0	11	0	0	0	3	1	1	TCGA-BH-A0DT-01	55	0.25097850351011786	16	TCGA-BH-A0DT-01	11	9	3	0.08521818168692677	TCGA-BH-A0DT-01	3	0	1	4	PASS	1072	TCGA-BH-A0DT	BRCA	41	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15078	Alive	TUMOR FREE	2403	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2403	0	2403	0	2403	0	2403	
50	TCGA-BH-A0DV	0	1	0	1	2	1	0	0	0	13	0	0	0	2	1	0	TCGA-BH-A0DV-01	52	0.11488001609205956	17	TCGA-BH-A0DV-01	4	2	2	0.015694825315154946	TCGA-BH-A0DV-01	3	1	1	5	PASS	1073	TCGA-BH-A0DV	BRCA	54	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Peri (6-12 months since last menstrual period)	-19781	Alive	TUMOR FREE	2064	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2064	0	2064	0	2064	0	2064	
60	TCGA-BH-A0DX	0	4	0	2	0	0	1	0	2	53	4	0	0	13	0	0	TCGA-BH-A0DX-01	131	0.26431699860695906	51	TCGA-BH-A0DX-01	4	9	20	0.15568159578127233	TCGA-BH-A0DX-01	9	9	9	27	PASS	1074	TCGA-BH-A0DX	BRCA	62	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22833	Alive	TUMOR FREE	2156	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2156	0	2156	0	2156	0	2156	
40	TCGA-BH-A0DZ	2	71	3	25	0	0	0	0	35	384	36	2	10	199	12	0	TCGA-BH-A0DZ-01	207	0.21303901580099213	122	TCGA-BH-A0DZ-01	4	8	31	0.1610604802401848	TCGA-BH-A0DZ-01	9	4	9	22	PASS	1075	TCGA-BH-A0DZ	BRCA	43	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15980	Alive	TUMOR FREE	495	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	495	0	495	0	495	0	495	
40	TCGA-BH-A0E0	2	8	0	2	0	0	0	1	6	51	6	0	0	16	1	0	TCGA-BH-A0E0-01	160	0.681463321866709	86	TCGA-BH-A0E0-01	22	27	28	0.48632569758368	TCGA-BH-A0E0-01	10	10	7	27	PASS	1076	TCGA-BH-A0E0	BRCA	38	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14175	Alive	TUMOR FREE	134	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	134	0	134	0	134	0	134	
50	TCGA-BH-A0E1	2	2	0	2	0	2	0	0	1	40	2	0	0	21	0	0	TCGA-BH-A0E1-01	82	0.11011531769798392	34	TCGA-BH-A0E1-01	3	4	2	0.0265932616414637	TCGA-BH-A0E1-01	2	0	2	4	PASS	1077	TCGA-BH-A0E1	BRCA	52	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Peri (6-12 months since last menstrual period)	-19192	Alive	TUMOR FREE	477	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	477	0	477	0	477	0	477	
50	TCGA-BH-A0E2	0	3	1	1	0	3	0	0	0	33	4	0	1	17	1	0	TCGA-BH-A0E2-01	427	0.506364123867252	304	TCGA-BH-A0E2-01	6	8	50	0.1965319122216625	TCGA-BH-A0E2-01	12	7	9	28	mutation call filter	1078	TCGA-BH-A0E2	BRCA	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18152	Alive	TUMOR FREE	435	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	435	0	435	0	435	0	435	
70	TCGA-BH-A0E6	0	5	0	5	2	2	0	0	3	60	4	0	2	17	0	0	TCGA-BH-A0E6-01	224	0.7003340522776705	142	TCGA-BH-A0E6-01	20	39	28	0.3248389891013268	TCGA-BH-A0E6-01	17	11	4	32	mutation call filter	1079	TCGA-BH-A0E6	BRCA	69	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25408	Alive	TUMOR FREE	293	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	293	0	293	0	293	0	293	
80	TCGA-BH-A0E7	0	1	0	0	4	3	0	0	0	28	4	0	0	11	1	0	TCGA-BH-A0E7-01	71	0.07900042797560734	29	TCGA-BH-A0E7-01	4	4	3	0.029320278973727267	TCGA-BH-A0E7-01	2	0	2	4	mutation call filter	1080	TCGA-BH-A0E7	BRCA	79	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29115	Alive	TUMOR FREE	1363	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1363	0	1363	0	1363	0	1363	
50	TCGA-BH-A0E9	0	2	0	0	2	3	0	0	0	25	1	0	1	2	2	0	TCGA-BH-A0E9-01	53	0.3816374335296207	14	TCGA-BH-A0E9-01	24	17	6	0.11599477103319553	TCGA-BH-A0E9-01	3	3	4	10	PASS	1081	TCGA-BH-A0E9	BRCA	53	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19415	Alive	TUMOR FREE	2489	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2489	0	2489	0	2489	0	2489	
70	TCGA-BH-A0EA	1	1	0	0	0	0	0	0	0	22	2	0	0	6	1	0	TCGA-BH-A0EA-01	59	0.060252168837111014	22	TCGA-BH-A0EA-01	3	3	2	0.015903544743594813	TCGA-BH-A0EA-01	3	0	1	4	PASS	1082	TCGA-BH-A0EA	BRCA	72	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26548	Dead	TUMOR FREE	NA	991	NA	NA	NA	NA	NA	NA	Negative	NA	1	991	0	991	0	991	0	991	
70	TCGA-BH-A0EB	0	0	0	1	1	2	0	0	3	37	1	0	0	16	1	0	TCGA-BH-A0EB-01	96	0.7680389898140296	49	TCGA-BH-A0EB-01	19	11	4	0.05713952142636562	TCGA-BH-A0EB-01	4	2	2	8	mutation call filter	1083	TCGA-BH-A0EB	BRCA	69	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25259	Alive	TUMOR FREE	745	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	745	0	745	0	745	0	745	
70	TCGA-BH-A0EE	1	10	2	6	5	1	1	0	6	105	4	2	2	39	2	0	TCGA-BH-A0EE-01	199	0.6138428761335303	127	TCGA-BH-A0EE-01	22	59	34	0.12281529510356633	TCGA-BH-A0EE-01	12	3	6	21	mutation call filter	1084	TCGA-BH-A0EE	BRCA	68	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24850	Alive	TUMOR FREE	943	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	943	0	943	0	943	0	943	
50	TCGA-BH-A0EI	1	1	0	1	0	1	0	0	0	15	0	0	2	4	0	0	TCGA-BH-A0EI-01	102	0.16222600092402645	57	TCGA-BH-A0EI-01	6	6	12	0.07817485391405872	TCGA-BH-A0EI-01	5	2	4	11	PASS	1085	TCGA-BH-A0EI	BRCA	51	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Peri (6-12 months since last menstrual period)	-18741	Alive	TUMOR FREE	1926	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1926	0	1926	0	1926	0	1926	
70	TCGA-BH-A0GY	0	1	0	1	3	0	1	0	4	29	1	0	2	6	0	0	TCGA-BH-A0GY-01	195	0.8101528353001282	125	TCGA-BH-A0GY-01	29	27	17	0.12098792683724288	TCGA-BH-A0GY-01	9	11	2	22	mutation call filter	1086	TCGA-BH-A0GY	BRCA	67	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24493	Alive	TUMOR FREE	923	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	923	0	923	0	923	0	923	
60	TCGA-BH-A0GZ	1	3	0	0	1	0	0	0	0	29	2	0	1	8	2	0	TCGA-BH-A0GZ-01	150	0.2782030082523451	92	TCGA-BH-A0GZ-01	6	6	40	0.19446603035994012	TCGA-BH-A0GZ-01	7	5	5	17	mutation call filter	1087	TCGA-BH-A0GZ	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22714	Alive	TUMOR FREE	328	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	328	0	328	0	328	0	328	
70	TCGA-BH-A0H0	0	2	0	0	0	0	0	0	0	16	0	0	0	8	2	0	TCGA-BH-A0H0-01	105	0.2644897891596428	58	TCGA-BH-A0H0-01	10	12	25	0.2076563697201311	TCGA-BH-A0H0-01	7	1	9	17	mutation call filter	1088	TCGA-BH-A0H0	BRCA	69	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25223	Alive	TUMOR FREE	461	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	461	0	461	0	461	0	461	
50	TCGA-BH-A0H3	0	3	0	0	0	2	0	0	1	9	1	0	0	4	1	0	TCGA-BH-A0H3-01	54	0.06062764964662237	15	TCGA-BH-A0H3-01	3	3	2	0.015837024534512918	TCGA-BH-A0H3-01	3	0	1	4	PASS	1089	TCGA-BH-A0H3	BRCA	46	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17152	Alive	TUMOR FREE	1928	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1928	0	1928	0	1928	0	1928	
50	TCGA-BH-A0H5	0	10	0	8	0	0	0	0	3	203	22	0	2	84	2	0	TCGA-BH-A0H5-01	61	1.9920343790929165e-05	16	TCGA-BH-A0H5-01	0	0	19	8.101111337263098e-06	TCGA-BH-A0H5-01	0	0	0	0	PASS	1090	TCGA-BH-A0H5	BRCA	45	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16719	Alive	TUMOR FREE	1620	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1620	0	1620	0	1620	0	1620	
80	TCGA-BH-A0H6	0	5	0	1	3	0	0	0	1	12	1	0	0	6	1	0	TCGA-BH-A0H6-01	94	0.09818104554930986	50	TCGA-BH-A0H6-01	3	9	3	0.030185687949541868	TCGA-BH-A0H6-01	5	2	2	9	mutation call filter	1091	TCGA-BH-A0H6	BRCA	82	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30125	Alive	TUMOR FREE	747	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	747	0	747	0	747	0	747	
70	TCGA-BH-A0H7	0	5	0	0	0	0	1	0	5	66	9	0	5	25	3	0	TCGA-BH-A0H7-01	595	0.8268848617952029	432	TCGA-BH-A0H7-01	21	34	147	0.276500644847468	TCGA-BH-A0H7-01	20	10	9	39	PASS	1092	TCGA-BH-A0H7	BRCA	65	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23972	Alive	TUMOR FREE	702	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	702	0	702	0	702	0	702	
70	TCGA-BH-A0H9	0	10	0	6	4	2	0	0	8	56	4	0	0	18	0	0	TCGA-BH-A0H9-01	288	0.3068653727207632	183	TCGA-BH-A0H9-01	12	10	43	0.2343974884487692	TCGA-BH-A0H9-01	6	3	6	15	PASS	1093	TCGA-BH-A0H9	BRCA	69	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25289	Alive	TUMOR FREE	1247	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1247	0	1247	0	1247	0	1247	
30	TCGA-BH-A0HA	2	23	1	9	45	8	11	0	9	239	13	0	5	97	8	0	TCGA-BH-A0HA-01	74	0.08382361325376941	30	TCGA-BH-A0HA-01	4	4	12	0.08767154455204097	TCGA-BH-A0HA-01	2	1	4	7	PASS	1094	TCGA-BH-A0HA	BRCA	31	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11379	Alive	TUMOR FREE	1611	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1611	0	1611	0	1611	0	1611	
60	TCGA-BH-A0HB	1	2	0	0	2	0	0	0	1	26	2	0	0	10	1	0	TCGA-BH-A0HB-01	523	0.2999226468010271	373	TCGA-BH-A0HB-01	8	10	85	0.18649354687495054	TCGA-BH-A0HB-01	11	8	8	27	mutation call filter	1095	TCGA-BH-A0HB	BRCA	55	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20448	Alive	TUMOR FREE	806	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	806	0	806	0	806	0	806	
80	TCGA-BH-A0HF	7	85	4	37	1	1	0	0	35	750	51	0	13	444	27	0	TCGA-BH-A0HF	0	0	0	TCGA-BH-A0HF	0	0	0	0	TCGA-BH-A0HF	0	0	0	0	mutation call filter	1096	TCGA-BH-A0HF	BRCA	77	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28233	Alive	TUMOR FREE	727	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	727	0	727	0	727	0	727	
80	TCGA-BH-A0HI	0	2	0	2	2	0	1	0	0	27	0	0	0	4	1	0	TCGA-BH-A0HI-01	82	0.07963923963289896	40	TCGA-BH-A0HI-01	2	2	10	0.04102380400988874	TCGA-BH-A0HI-01	1	4	2	7	PASS	1097	TCGA-BH-A0HI	BRCA	78	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28644	Alive	TUMOR FREE	620	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	620	0	620	0	620	0	620	
80	TCGA-BH-A0HK	2	20	2	6	4	1	2	0	18	140	14	0	4	70	6	0	TCGA-BH-A0HK-01	121	0.09243198869444934	62	TCGA-BH-A0HK-01	5	7	12	0.05631167960762636	TCGA-BH-A0HK-01	5	1	4	10	PASS	1098	TCGA-BH-A0HK	BRCA	81	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29751	Alive	TUMOR FREE	178	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	178	0	178	0	178	0	178	
60	TCGA-BH-A0HL	0	1	0	0	1	2	0	0	0	27	1	0	0	11	1	0	TCGA-BH-A0HL	0	0	0	TCGA-BH-A0HL	0	0	0	0	TCGA-BH-A0HL	0	0	0	0	mutation call filter	1099	TCGA-BH-A0HL	BRCA	56	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20804	Alive	TUMOR FREE	72	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	72	0	72	0	72	0	72	Redacted
70	TCGA-BH-A0HN	0	2	0	0	2	0	1	0	2	21	1	0	0	8	0	0	TCGA-BH-A0HN	0	0	0	TCGA-BH-A0HN	0	0	0	0	TCGA-BH-A0HN	0	0	0	0	PASS	1100	TCGA-BH-A0HN	BRCA	67	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24731	Alive	TUMOR FREE	516	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	516	0	516	0	516	0	516	Redacted
50	TCGA-BH-A0HO	0	4	0	3	1	0	0	0	0	11	2	0	2	6	0	0	TCGA-BH-A0HO-01	81	0.04927991700780651	38	TCGA-BH-A0HO-01	2	2	2	0.015828386649565478	TCGA-BH-A0HO-01	2	0	1	3	mutation call filter	1101	TCGA-BH-A0HO	BRCA	48	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17710	Alive	TUMOR FREE	76	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	76	0	76	0	76	0	76	
70	TCGA-BH-A0HP	1	23	1	8	0	1	0	0	11	207	19	0	1	83	8	1	TCGA-BH-A0HP-01	92	0.17672888871142722	42	TCGA-BH-A0HP-01	6	7	15	0.10401562314117042	TCGA-BH-A0HP-01	6	4	2	12	PASS	1102	TCGA-BH-A0HP	BRCA	65	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23883	Alive	TUMOR FREE	414	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	414	0	414	0	414	0	414	
60	TCGA-BH-A0HQ	0	4	0	3	1	1	0	0	1	21	4	0	1	13	0	0	TCGA-BH-A0HQ-01	1678	0.8090972791661909	1561	TCGA-BH-A0HQ-01	23	21	19	0.02094312791987161	TCGA-BH-A0HQ-01	2	1	1	4	mutation call filter	1103	TCGA-BH-A0HQ	BRCA	56	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20719	Alive	TUMOR FREE	1121	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1121	0	1121	0	1121	0	1121	
50	TCGA-BH-A0HU	0	8	0	0	0	0	1	0	1	28	1	0	1	9	1	0	TCGA-BH-A0HU-01	141	0.8945625158605656	62	TCGA-BH-A0HU-01	9	11	27	0.2505570825586093	TCGA-BH-A0HU-01	11	11	11	33	mutation call filter	1104	TCGA-BH-A0HU	BRCA	52	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2009	Peri (6-12 months since last menstrual period)	-19216	Alive	TUMOR FREE	392	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	392	0	392	0	392	0	392	
60	TCGA-BH-A0HW	1	1	0	0	0	2	0	0	3	27	2	0	0	8	2	0	TCGA-BH-A0HW-01	147	0.9105745350735116	87	TCGA-BH-A0HW-01	10	9	23	0.10396907381819144	TCGA-BH-A0HW-01	9	5	7	21	mutation call filter	1105	TCGA-BH-A0HW	BRCA	62	FEMALE	ASIAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22962	Alive	TUMOR FREE	1561	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1561	0	1561	0	1561	0	1561	
50	TCGA-BH-A0HX	2	6	0	1	2	1	0	0	2	50	1	0	1	23	3	0	TCGA-BH-A0HX-01	278	0.6054049007174891	179	TCGA-BH-A0HX-01	18	25	45	0.3162700666099289	TCGA-BH-A0HX-01	16	15	13	44	mutation call filter	1106	TCGA-BH-A0HX	BRCA	54	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19900	Alive	TUMOR FREE	829	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	829	0	829	0	829	0	829	
60	TCGA-BH-A0HY	0	11	0	3	1	0	1	0	5	45	3	0	0	18	2	0	TCGA-BH-A0HY-01	348	0.7411438506541258	229	TCGA-BH-A0HY-01	18	32	65	0.2166129476981477	TCGA-BH-A0HY-01	19	19	11	49	mutation call filter	1107	TCGA-BH-A0HY	BRCA	60	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22179	Alive	TUMOR FREE	1545	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1545	0	1545	0	1545	0	1545	
60	TCGA-BH-A0RX	0	2	0	0	1	0	1	0	2	33	3	0	0	12	0	1	TCGA-BH-A0RX-01	97	0.20486509130771388	47	TCGA-BH-A0RX	0	0	0	0	TCGA-BH-A0RX	0	0	0	0	PASS	1108	TCGA-BH-A0RX	BRCA	59	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21857	Alive	TUMOR FREE	170	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	170	0	170	0	170	0	170	
60	TCGA-BH-A0W3	0	0	0	1	1	0	0	0	0	12	0	0	0	9	1	0	TCGA-BH-A0W3-01	154	0.8903642053300553	95	TCGA-BH-A0W3-01	17	13	12	0.09193946047452377	TCGA-BH-A0W3-01	3	0	3	6	PASS	1109	TCGA-BH-A0W3	BRCA	58	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Indeterminate (neither Pre or Postmenopausal)	-21369	Alive	TUMOR FREE	728	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	728	0	728	NA	NA	0	728	
50	TCGA-BH-A0W4	0	1	0	0	2	0	0	0	2	28	2	0	2	5	1	0	TCGA-BH-A0W4-01	56	0.020731785680133598	18	TCGA-BH-A0W4-01	2	4	6	0.053083325931579765	TCGA-BH-A0W4-01	2	0	2	4	PASS	1110	TCGA-BH-A0W4	BRCA	46	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	NA	-16911	Alive	TUMOR FREE	759	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	759	0	759	NA	NA	0	759	
80	TCGA-BH-A0W5	0	1	0	1	1	0	1	0	0	23	1	0	0	3	0	0	TCGA-BH-A0W5-01	47	0.10814992696480973	12	TCGA-BH-A0W5-01	6	7	3	0.04067434872286933	TCGA-BH-A0W5-01	3	0	2	5	PASS	1111	TCGA-BH-A0W5	BRCA	77	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	NA	-28304	Alive	TUMOR FREE	1288	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1288	0	1288	0	1288	0	1288	
50	TCGA-BH-A0W7	1	11	1	10	0	0	0	0	10	143	12	0	1	72	3	1	TCGA-BH-A0W7-01	129	0.33187465705427555	69	TCGA-BH-A0W7-01	12	9	24	0.10344431852479084	TCGA-BH-A0W7-01	6	6	6	18	PASS	1112	TCGA-BH-A0W7	BRCA	49	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2008	NA	-17996	Alive	TUMOR FREE	1363	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1363	0	1363	0	1363	0	1363	
80	TCGA-BH-A0WA	0	5	0	3	3	0	1	0	3	75	3	0	2	21	6	1	TCGA-BH-A0WA-01	234	0.7359558360941256	131	TCGA-BH-A0WA-01	13	32	48	0.4369923176966031	TCGA-BH-A0WA-01	23	26	14	63	PASS	1113	TCGA-BH-A0WA	BRCA	82	FEMALE	WHITE	Stage I	NA	NA	NA	2008	NA	-30025	Alive	TUMOR FREE	701	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	701	0	701	0	701	0	701	
50	TCGA-BH-A18F	0	3	0	3	2	1	0	0	2	41	2	0	0	17	0	1	TCGA-BH-A18F-01	84	0.44699234087972617	32	TCGA-BH-A18F-01	21	15	7	0.1414480536602825	TCGA-BH-A18F-01	4	0	3	7	PASS	1114	TCGA-BH-A18F	BRCA	50	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Peri (6-12 months since last menstrual period)	-18594	Alive	TUMOR FREE	1001	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1001	0	1001	0	1001	0	1001	
80	TCGA-BH-A18G	7	130	8	39	128	40	12	0	63	974	46	1	23	416	33	2	TCGA-BH-A18G-01	48	0.07098594438430451	9	TCGA-BH-A18G-01	1	6	5	0.01850713737558597	TCGA-BH-A18G-01	1	3	2	6	hypermutated sample	1115	TCGA-BH-A18G	BRCA	81	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29820	Alive	TUMOR FREE	149	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	149	0	149	0	149	0	149	
60	TCGA-BH-A18H	0	5	1	1	2	0	0	0	0	35	3	0	0	11	1	0	TCGA-BH-A18H-01	163	0.4955302121431114	92	TCGA-BH-A18H-01	20	26	23	0.16785304910705204	TCGA-BH-A18H-01	12	10	8	30	PASS	1116	TCGA-BH-A18H	BRCA	63	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23065	Alive	TUMOR FREE	652	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	652	0	652	0	652	0	652	
50	TCGA-BH-A18I	0	2	0	4	2	1	1	0	1	20	1	0	0	5	0	0	TCGA-BH-A18I-01	134	0.3237684753412789	70	TCGA-BH-A18I-01	5	7	14	0.09194690874693892	TCGA-BH-A18I-01	5	2	5	12	PASS	1117	TCGA-BH-A18I	BRCA	53	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19489	Alive	TUMOR FREE	1093	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1093	0	1093	0	1093	0	1093	
60	TCGA-BH-A18J	0	5	0	8	1	0	0	0	3	62	9	0	1	23	1	0	TCGA-BH-A18J-01	384	0.314990510949064	236	TCGA-BH-A18J-01	5	10	79	0.2041910445831324	TCGA-BH-A18J-01	10	6	9	25	PASS	1118	TCGA-BH-A18J	BRCA	56	FEMALE	WHITE	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	2000	NA	-20678	Dead	WITH TUMOR	NA	612	NA	NA	NA	NA	NA	NA	Negative	NA	1	612	1	612	NA	NA	1	612	
50	TCGA-BH-A18K	1	2	0	2	0	0	2	1	3	41	6	0	0	19	0	0	TCGA-BH-A18K-01	149	0.5294082533763864	75	TCGA-BH-A18K-01	18	23	17	0.21925015542389145	TCGA-BH-A18K-01	12	8	10	30	PASS	1119	TCGA-BH-A18K	BRCA	46	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	1999	NA	-16824	Dead	WITH TUMOR	NA	2763	NA	NA	NA	NA	NA	NA	Negative	NA	1	2763	1	2763	NA	NA	1	2763	
50	TCGA-BH-A18L	1	1	1	2	0	1	0	0	3	39	3	0	1	18	2	0	TCGA-BH-A18L-01	150	0.6976820394702526	75	TCGA-BH-A18L-01	27	26	24	0.19439218506467784	TCGA-BH-A18L-01	16	4	6	26	PASS	1120	TCGA-BH-A18L	BRCA	50	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2003	NA	-18519	Dead	NA	NA	811	NA	NA	NA	NA	NA	NA	Negative	NA	1	811	NA	811	0	811	0	811	
40	TCGA-BH-A18M	0	0	0	0	0	0	0	0	0	16	1	0	0	5	0	0	TCGA-BH-A18M-01	63	0.17705136681638628	19	TCGA-BH-A18M-01	4	7	5	0.0824930522886419	TCGA-BH-A18M-01	4	4	2	10	PASS	1121	TCGA-BH-A18M	BRCA	39	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2001	NA	-14532	Dead	NA	NA	2207	NA	NA	NA	NA	NA	NA	Negative	NA	1	2207	NA	2207	0	2207	0	2207	
90	TCGA-BH-A18N	0	0	0	1	2	1	0	0	0	26	2	0	0	15	0	0	TCGA-BH-A18N-01	141	0.9474557281835838	87	TCGA-BH-A18N-01	23	19	14	0.027624865575928977	TCGA-BH-A18N-01	2	1	1	4	PASS	1122	TCGA-BH-A18N	BRCA	88	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2001	NA	-32404	Dead	NA	NA	1148	NA	NA	NA	NA	NA	NA	Negative	NA	1	1148	NA	1148	0	1148	0	1148	
60	TCGA-BH-A18P	1	26	0	19	4	1	0	0	22	228	30	0	5	102	6	2	TCGA-BH-A18P-01	88	0.167331400198758	32	TCGA-BH-A18P-01	6	7	7	0.05658344590030895	TCGA-BH-A18P-01	3	1	4	8	PASS	1123	TCGA-BH-A18P	BRCA	60	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2003	NA	-22222	Dead	WITH TUMOR	NA	921	NA	NA	NA	NA	NA	NA	Negative	NA	1	921	1	921	NA	NA	1	921	
60	TCGA-BH-A18Q	0	10	1	3	6	3	0	0	4	60	4	0	0	28	2	0	TCGA-BH-A18Q-01	190	0.7665082554949499	102	TCGA-BH-A18Q-01	18	27	46	0.4102800199589797	TCGA-BH-A18Q-01	24	27	11	62	PASS	1124	TCGA-BH-A18Q	BRCA	56	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2001	NA	-20675	Dead	NA	NA	1692	NA	NA	NA	NA	NA	NA	Negative	NA	1	1692	NA	1692	0	1692	0	1692	
50	TCGA-BH-A18R	0	3	0	1	2	1	0	0	2	25	1	0	0	10	0	0	TCGA-BH-A18R-01	326	0.2871536416781165	209	TCGA-BH-A18R-01	4	9	61	0.11497146297168835	TCGA-BH-A18R-01	9	11	7	27	PASS	1125	TCGA-BH-A18R	BRCA	50	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2001	NA	-18524	Dead	TUMOR FREE	NA	1142	NA	NA	NA	NA	NA	NA	Negative	NA	1	1142	0	1142	0	1142	0	1142	
80	TCGA-BH-A18S	0	3	0	1	0	0	0	0	1	23	2	0	0	9	0	0	TCGA-BH-A18S-01	177	0.1760486765351421	108	TCGA-BH-A18S-01	4	5	16	0.07496282922618616	TCGA-BH-A18S-01	4	2	4	10	PASS	1126	TCGA-BH-A18S	BRCA	79	FEMALE	WHITE	Stage I	NA	Mucinous Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28974	Dead	TUMOR FREE	NA	2009	NA	NA	NA	NA	NA	NA	Negative	NA	1	2009	0	2009	0	2009	0	2009	
70	TCGA-BH-A18T	0	6	0	5	2	0	0	0	5	69	1	0	2	21	0	0	TCGA-BH-A18T-01	625	0.7745687585580473	426	TCGA-BH-A18T-01	22	31	151	0.4634757762322861	TCGA-BH-A18T-01	21	15	17	53	PASS	1127	TCGA-BH-A18T	BRCA	70	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25674	Dead	WITH TUMOR	NA	224	NA	NA	NA	NA	NA	NA	Negative	NA	1	224	1	224	NA	NA	1	224	
70	TCGA-BH-A18U	0	8	1	5	4	1	1	0	5	102	10	0	2	46	3	0	TCGA-BH-A18U-01	524	0.7117192097280575	367	TCGA-BH-A18U-01	24	55	62	0.19482516445812045	TCGA-BH-A18U-01	27	17	10	54	PASS	1128	TCGA-BH-A18U	BRCA	72	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26426	Dead	TUMOR FREE	NA	1563	NA	NA	NA	NA	NA	NA	Negative	NA	1	1563	0	1563	0	1563	0	1563	
50	TCGA-BH-A18V	3	30	1	15	9	0	5	0	24	325	20	0	11	105	15	2	TCGA-BH-A18V-01	607	0.8266296107255711	401	TCGA-BH-A18V-06	9	23	258	0.5471060074433532	TCGA-BH-A18V-06	28	27	29	84	mutation call filter	1129	TCGA-BH-A18V	BRCA	48	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2001	NA	-17682	Dead	NA	NA	1556	NA	NA	NA	NA	NA	NA	Negative	NA	1	1556	NA	1556	0	1556	0	1556	
80	TCGA-BH-A1EN	1	3	0	3	3	1	0	0	2	56	3	0	0	17	1	0	TCGA-BH-A1EN-01	226	0.6877107729566112	138	TCGA-BH-A1EN-01	24	21	41	0.15977131798293698	TCGA-BH-A1EN-01	11	8	8	27	mutation call filter	1130	TCGA-BH-A1EN	BRCA	78	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	1999	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28724	Dead	TUMOR FREE	NA	2127	NA	NA	NA	NA	NA	NA	Negative	NA	1	2127	0	2127	0	2127	0	2127	
70	TCGA-BH-A1EO	0	3	0	0	1	1	0	0	1	31	6	0	2	6	2	0	TCGA-BH-A1EO-01	186	0.5346630780627797	107	TCGA-BH-A1EO-01	22	21	21	0.16445196188566208	TCGA-BH-A1EO-01	9	3	9	21	PASS	1131	TCGA-BH-A1EO	BRCA	68	FEMALE	WHITE	Stage IIA	NA	Mixed Histology (please specify)	NA	1999	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25136	Dead	TUMOR FREE	NA	2798	NA	NA	NA	NA	NA	NA	NA	NA	1	2798	0	2798	NA	NA	0	2798	
40	TCGA-BH-A1ES	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BH-A1ES-01	203	0.40965623608389296	117	TCGA-BH-A1ES-06	22	30	76	0.1556602233021727	TCGA-BH-A1ES-06	11	5	5	21	PASS	1132	TCGA-BH-A1ES	BRCA	35	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1999	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13138	Dead	WITH TUMOR	NA	3462	NA	NA	NA	NA	NA	NA	NA	NA	1	3462	1	3462	NA	NA	1	3462	
60	TCGA-BH-A1ET	0	5	0	1	0	0	0	0	1	22	1	0	0	6	2	0	TCGA-BH-A1ET-01	78	0.08920290724365858	33	TCGA-BH-A1ET-01	3	2	4	0.025449982641134832	TCGA-BH-A1ET-01	2	0	1	3	PASS	1133	TCGA-BH-A1ET	BRCA	55	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	1999	NA	-20425	Dead	TUMOR FREE	NA	2520	NA	NA	NA	NA	NA	NA	NA	NA	1	2520	0	2520	NA	NA	0	2520	
80	TCGA-BH-A1EU	0	4	0	0	1	0	1	0	1	23	0	0	0	7	1	0	TCGA-BH-A1EU-01	150	0.6141190342248193	94	TCGA-BH-A1EU-01	23	25	41	0.1880351046883519	TCGA-BH-A1EU-01	5	7	5	17	PASS	1134	TCGA-BH-A1EU	BRCA	83	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	1999	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30339	Dead	TUMOR FREE	NA	1286	NA	NA	NA	NA	NA	NA	NA	NA	1	1286	0	1286	NA	NA	0	1286	
50	TCGA-BH-A1EV	0	7	0	8	0	0	0	0	7	83	1	0	0	24	0	1	TCGA-BH-A1EV-01	555	0.8848963607056816	378	TCGA-BH-A1EV-01	18	20	71	0.1653178557198232	TCGA-BH-A1EV-01	13	5	8	26	PASS	1135	TCGA-BH-A1EV	BRCA	45	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	1999	NA	-16504	Dead	WITH TUMOR	NA	365	NA	NA	NA	NA	NA	NA	NA	NA	1	365	1	365	NA	NA	1	365	
40	TCGA-BH-A1EW	1	2	0	0	0	0	0	0	2	12	1	0	1	2	1	0	TCGA-BH-A1EW-01	223	0.4595442822775954	136	TCGA-BH-A1EW-01	15	32	22	0.1720674845338923	TCGA-BH-A1EW-01	12	8	6	26	PASS	1136	TCGA-BH-A1EW	BRCA	38	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	1999	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14090	Dead	WITH TUMOR	NA	1694	NA	NA	NA	NA	NA	NA	NA	NA	1	1694	1	1694	NA	NA	1	1694	
70	TCGA-BH-A1EX	1	2	0	1	0	0	0	0	2	22	1	0	1	5	0	0	TCGA-BH-A1EX-01	59	0.8599502520468041	19	TCGA-BH-A1EX-01	12	14	3	0.040646490846315976	TCGA-BH-A1EX-01	1	1	0	2	PASS	1137	TCGA-BH-A1EX	BRCA	67	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2000	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24544	Dead	WITH TUMOR	NA	1508	NA	NA	NA	NA	NA	NA	NA	NA	1	1508	1	1508	NA	NA	1	1508	
80	TCGA-BH-A1EY	0	2	0	1	0	0	1	0	1	30	1	0	0	19	3	0	TCGA-BH-A1EY-01	371	0.9475397948173544	217	TCGA-BH-A1EY-01	11	14	67	0.332466759729872	TCGA-BH-A1EY-01	12	9	14	35	PASS	1138	TCGA-BH-A1EY	BRCA	79	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2000	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28940	Dead	WITH TUMOR	NA	538	NA	Distant Metastasis	Lung	Liver	396	NA	NA	NA	1	538	1	538	NA	NA	1	396	
80	TCGA-BH-A1F0	0	8	0	3	1	0	0	0	1	55	3	0	0	30	0	0	TCGA-BH-A1F0-01	143	0.17597028061982992	76	TCGA-BH-A1F0-01	7	39	26	0.4669631024932085	TCGA-BH-A1F0-01	16	15	11	42	PASS	1139	TCGA-BH-A1F0	BRCA	80	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2000	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29335	Dead	WITH TUMOR	NA	785	NA	NA	NA	NA	NA	NA	NA	NA	1	785	1	785	NA	NA	1	785	
50	TCGA-BH-A1F2	0	1	1	0	1	1	1	0	4	43	2	0	1	19	1	0	TCGA-BH-A1F2-01	187	0.6003635943380475	105	TCGA-BH-A1F2-01	18	26	33	0.26656982620917025	TCGA-BH-A1F2-01	16	12	11	39	PASS	1140	TCGA-BH-A1F2	BRCA	53	FEMALE	WHITE	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	1999	NA	-19701	Dead	TUMOR FREE	NA	959	NA	NA	NA	NA	NA	NA	NA	NA	1	959	0	959	NA	NA	0	959	
60	TCGA-BH-A1F5	0	0	1	1	1	0	0	0	2	27	3	0	0	10	0	0	TCGA-BH-A1F5-01	105	0.14567737414482831	56	TCGA-BH-A1F5	0	0	0	0	TCGA-BH-A1F5-01	3	0	2	5	PASS	1141	TCGA-BH-A1F5	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2002	NA	-22842	Dead	TUMOR FREE	NA	2712	NA	NA	NA	NA	NA	NA	NA	NA	1	2712	0	2712	NA	NA	0	2712	
50	TCGA-BH-A1F6	0	4	0	2	3	1	0	0	0	27	0	0	0	20	1	0	TCGA-BH-A1F6-01	423	0.6798940286258565	253	TCGA-BH-A1F6-01	21	24	60	0.29436917596391105	TCGA-BH-A1F6-01	10	16	6	32	PASS	1142	TCGA-BH-A1F6	BRCA	51	FEMALE	WHITE	NA	NA	Infiltrating Ductal Carcinoma	NA	1996	NA	-18691	Dead	NA	NA	2965	NA	NA	NA	NA	NA	NA	NA	NA	1	2965	NA	2965	NA	NA	0	2965	
90	TCGA-BH-A1F8	1	12	0	7	1	3	0	0	8	105	13	1	2	43	1	0	TCGA-BH-A1F8-01	218	1.0	142	TCGA-BH-A1F8-01	16	17	51	0.4330544368407821	TCGA-BH-A1F8-01	10	8	12	30	PASS	1143	TCGA-BH-A1F8	BRCA	90	FEMALE	WHITE	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	1999	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32871	Dead	WITH TUMOR	NA	763	NA	NA	NA	NA	NA	NA	NA	NA	1	763	1	763	NA	NA	1	763	
60	TCGA-BH-A1FB	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BH-A1FB-01	53	0.08042138029877148	15	TCGA-BH-A1FB	0	0	0	0	TCGA-BH-A1FB	0	0	0	0	PASS	1144	TCGA-BH-A1FB	BRCA	60	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2000	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21933	Dead	WITH TUMOR	NA	3669	NA	NA	NA	NA	NA	NA	NA	NA	1	3669	1	3669	NA	NA	1	3669	
80	TCGA-BH-A1FC	4	6	0	2	2	2	0	0	2	90	2	0	1	19	5	0	TCGA-BH-A1FC-01	363	0.7036970732425951	257	TCGA-BH-A1FC-01	25	37	37	0.19996405396189207	TCGA-BH-A1FC-01	21	13	6	40	PASS	1145	TCGA-BH-A1FC	BRCA	78	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Medullary Carcinoma	NA	1998	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28706	Dead	TUMOR FREE	NA	3472	NA	NA	NA	NA	NA	NA	NA	NA	1	3472	0	3472	NA	NA	0	3472	
70	TCGA-BH-A1FD	0	2	0	1	0	0	1	0	1	25	1	1	1	11	0	0	TCGA-BH-A1FD-01	463	0.9462645653013736	306	TCGA-BH-A1FD-01	9	12	109	0.3103197907354349	TCGA-BH-A1FD-01	16	11	12	39	mutation call filter	1146	TCGA-BH-A1FD	BRCA	68	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	1998	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24940	Dead	WITH TUMOR	NA	1009	NA	NA	NA	NA	NA	NA	NA	NA	1	1009	1	1009	NA	NA	1	1009	
30	TCGA-BH-A1FE	0	1	0	0	0	2	0	0	2	16	1	0	0	6	1	0	TCGA-BH-A1FE-01	325	0.2566561656593081	215	TCGA-BH-A1FE-06	0	0	3	9.683821950182966e-05	TCGA-BH-A1FE-06	0	0	0	0	mutation call filter	1147	TCGA-BH-A1FE	BRCA	31	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1998	NA	-11650	Dead	WITH TUMOR	NA	2273	NA	NA	NA	NA	NA	NA	NA	NA	1	2273	1	2273	NA	NA	1	2273	
90	TCGA-BH-A1FG	0	2	0	0	2	0	0	0	1	13	1	0	0	7	1	0	TCGA-BH-A1FG-01	91	0.11852231027557368	41	TCGA-BH-A1FG-01	5	6	9	0.04184152026517481	TCGA-BH-A1FG-01	3	1	4	8	PASS	1148	TCGA-BH-A1FG	BRCA	88	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	1998	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32295	Dead	NA	NA	3736	NA	NA	NA	NA	NA	NA	NA	NA	1	3736	NA	3736	NA	NA	0	3736	
50	TCGA-BH-A1FH	0	2	0	0	2	1	0	0	1	19	1	0	1	9	0	1	TCGA-BH-A1FH-01	169	0.14629102351840229	93	TCGA-BH-A1FH	0	0	0	0	TCGA-BH-A1FH	0	0	0	0	PASS	1149	TCGA-BH-A1FH	BRCA	47	FEMALE	WHITE	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	1998	NA	-17172	Dead	WITH TUMOR	NA	1034	NA	NA	NA	NA	NA	NA	NA	NA	1	1034	1	1034	NA	NA	1	1034	
70	TCGA-BH-A1FJ	0	2	0	2	0	1	1	0	1	19	1	0	0	18	3	0	TCGA-BH-A1FJ-01	139	0.1215876858628238	73	TCGA-BH-A1FJ-01	3	5	9	0.06288568745815974	TCGA-BH-A1FJ-01	1	2	1	4	PASS	1150	TCGA-BH-A1FJ	BRCA	66	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	1998	NA	-24262	Dead	NA	NA	1927	NA	NA	NA	NA	NA	NA	NA	NA	1	1927	NA	1927	NA	NA	0	1927	
70	TCGA-BH-A1FL	0	1	0	1	1	2	0	0	2	14	1	0	0	8	0	0	TCGA-BH-A1FL-01	111	0.09081672920121976	58	TCGA-BH-A1FL-01	4	4	14	0.04796343524307541	TCGA-BH-A1FL-01	3	4	3	10	PASS	1151	TCGA-BH-A1FL	BRCA	69	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1998	NA	-25558	Dead	WITH TUMOR	NA	1673	NA	NA	NA	NA	NA	NA	NA	NA	1	1673	1	1673	NA	NA	1	1673	
40	TCGA-BH-A1FM	0	1	0	0	0	1	1	0	2	41	3	0	0	17	2	0	TCGA-BH-A1FM-01	446	0.7599109695767816	286	TCGA-BH-A1FM-01	21	22	62	0.19740441542016354	TCGA-BH-A1FM-01	16	12	5	33	PASS	1152	TCGA-BH-A1FM	BRCA	44	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	1998	NA	-16289	Dead	NA	NA	1388	NA	NA	NA	NA	NA	NA	NA	NA	1	1388	NA	1388	NA	NA	0	1388	
30	TCGA-BH-A1FN	0	16	1	2	3	1	1	0	11	78	5	0	0	34	6	0	TCGA-BH-A1FN-01	432	0.6836625325701037	285	TCGA-BH-A1FN-01	12	23	58	0.18764800483934327	TCGA-BH-A1FN-01	25	26	13	64	PASS	1153	TCGA-BH-A1FN	BRCA	34	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	1997	NA	-12525	Dead	WITH TUMOR	NA	2192	NA	NA	NA	NA	NA	NA	NA	NA	1	2192	1	2192	NA	NA	1	2192	
70	TCGA-BH-A1FR	0	0	0	1	0	0	0	0	0	13	1	0	0	2	0	0	TCGA-BH-A1FR-01	81	0.0005493513197086377	35	TCGA-BH-A1FR	0	0	0	0	TCGA-BH-A1FR	0	0	0	0	PASS	1154	TCGA-BH-A1FR	BRCA	73	FEMALE	WHITE	Stage IIIB	NA	"Other, specify"	NA	1997	NA	-26684	Dead	WITH TUMOR	NA	1642	NA	NA	NA	NA	NA	NA	NA	NA	1	1642	1	1642	NA	NA	1	1642	
40	TCGA-BH-A1FU	0	3	1	6	0	0	0	0	5	72	7	0	1	23	1	0	TCGA-BH-A1FU-01	89	0.21939742850087424	39	TCGA-BH-A1FU-01	26	34	10	0.20868245521315976	TCGA-BH-A1FU-01	6	10	4	20	PASS	1155	TCGA-BH-A1FU	BRCA	44	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	1997	NA	-16174	Dead	WITH TUMOR	NA	1688	NA	NA	NA	NA	NA	NA	NA	NA	1	1688	1	1688	NA	NA	1	1688	
60	TCGA-BH-A201	0	1	0	1	0	0	1	0	1	19	0	0	1	3	1	0	TCGA-BH-A201-01	105	0.12675488022327058	50	TCGA-BH-A201-01	4	4	15	0.07061480834993328	TCGA-BH-A201-01	5	2	3	10	PASS	1156	TCGA-BH-A201	BRCA	64	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23423	Alive	TUMOR FREE	856	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	856	0	856	NA	NA	0	856	
60	TCGA-BH-A202	0	1	0	0	1	1	1	0	1	20	2	0	0	4	0	0	TCGA-BH-A202-01	124	0.5933148503184761	58	TCGA-BH-A202-01	21	20	16	0.20249086343163505	TCGA-BH-A202-01	8	1	4	13	PASS	1157	TCGA-BH-A202	BRCA	60	FEMALE	WHITE	Stage II	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22052	Alive	TUMOR FREE	795	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	795	0	795	NA	NA	0	795	
80	TCGA-BH-A203	0	8	1	2	2	0	0	0	1	54	4	0	0	33	1	0	TCGA-BH-A203-01	475	0.4879867375564149	330	TCGA-BH-A203-01	15	37	59	0.24734308839787186	TCGA-BH-A203-01	17	20	12	49	PASS	1158	TCGA-BH-A203	BRCA	78	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1996	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28609	Dead	WITH TUMOR	NA	1174	NA	NA	NA	NA	NA	NA	NA	NA	1	1174	1	1174	NA	NA	1	1174	
80	TCGA-BH-A204	0	6	0	4	1	1	0	0	3	32	2	0	0	7	0	0	TCGA-BH-A204-01	179	0.3381456778414153	103	TCGA-BH-A204-01	7	9	33	0.17104194140779955	TCGA-BH-A204-01	9	11	8	28	PASS	1159	TCGA-BH-A204	BRCA	80	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1996	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29529	Dead	NA	NA	2534	NA	NA	NA	NA	NA	NA	NA	NA	1	2534	NA	2534	NA	NA	0	2534	
50	TCGA-BH-A208	0	7	0	2	1	0	1	0	2	47	7	0	1	19	1	0	TCGA-BH-A208-01	142	0.6149847047028191	70	TCGA-BH-A208-01	19	25	30	0.2525186128663533	TCGA-BH-A208-01	13	6	7	26	PASS	1160	TCGA-BH-A208	BRCA	48	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1995	NA	-17715	Dead	TUMOR FREE	NA	1759	NA	NA	NA	NA	NA	NA	NA	NA	1	1759	0	1759	NA	NA	0	1759	
80	TCGA-BH-A209	0	5	0	4	2	1	0	0	6	73	5	0	0	35	2	0	TCGA-BH-A209-01	275	0.40118675207856985	174	TCGA-BH-A209-01	19	22	42	0.2201738938972201	TCGA-BH-A209-01	12	10	7	29	PASS	1161	TCGA-BH-A209	BRCA	77	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Medullary Carcinoma	NA	1996	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28403	Dead	TUMOR FREE	NA	3959	NA	NA	NA	NA	NA	NA	NA	NA	1	3959	0	3959	NA	NA	0	3959	
50	TCGA-BH-A28O	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BH-A28O-01	43	0.005191965107199475	12	TCGA-BH-A28O-01	2	1	2	0.04821713147274925	TCGA-BH-A28O-01	0	0	0	0	PASS	1162	TCGA-BH-A28O	BRCA	50	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2010	NA	-18501	Alive	TUMOR FREE	1120	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1120	0	1120	0	1120	0	1120	
50	TCGA-BH-A28Q	0	2	0	0	1	1	0	0	0	15	1	0	1	8	1	0	TCGA-BH-A28Q-01	92	0.16051115480017886	38	TCGA-BH-A28Q-01	7	7	8	0.09338900247727433	TCGA-BH-A28Q-01	5	2	4	11	PASS	1163	TCGA-BH-A28Q	BRCA	46	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16882	Alive	TUMOR FREE	1119	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1119	0	1119	NA	NA	0	1119	
50	TCGA-BH-A2L8	1	26	0	13	1	0	0	0	21	377	38	1	4	152	3	0	TCGA-BH-A2L8-01	36	0.12064898395399265	6	TCGA-BH-A2L8-01	4	7	6	0.09360219442321774	TCGA-BH-A2L8-01	2	0	1	3	PASS	1164	TCGA-BH-A2L8	BRCA	45	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16658	Alive	TUMOR FREE	612	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	612	0	612	0	612	0	612	
80	TCGA-BH-A42T	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BH-A42T-01	185	0.945007739774332	119	TCGA-BH-A42T-01	11	11	97	0.31769954568446857	TCGA-BH-A42T-01	8	11	14	33	PASS	1165	TCGA-BH-A42T	BRCA	75	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27731	Dead	TUMOR FREE	NA	320	NA	NA	NA	NA	NA	NA	Negative	NA	1	320	0	320	0	320	0	320	
80	TCGA-BH-A42U	1	2	2	1	1	0	0	0	2	16	1	0	1	9	1	0	TCGA-BH-A42U-01	77	4.957188886848886e-05	33	TCGA-BH-A42U	0	0	0	0	TCGA-BH-A42U	0	0	0	0	PASS	1166	TCGA-BH-A42U	BRCA	80	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29330	Alive	TUMOR FREE	3364	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3364	0	3364	0	3364	0	3364	
40	TCGA-BH-A42V	0	6	1	1	3	0	0	0	3	31	4	0	1	11	1	0	TCGA-BH-A42V-01	95	0.1389669775828681	49	TCGA-BH-A42V-01	2	3	36	0.05271225365774127	TCGA-BH-A42V-01	3	4	4	11	PASS	1167	TCGA-BH-A42V	BRCA	41	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Infiltrating Ductal Carcinoma	NA	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15158	Alive	TUMOR FREE	635	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	635	0	635	0	635	0	635	
50	TCGA-BH-A5IZ	0	30	4	7	6	0	1	0	10	92	10	0	6	39	2	0	TCGA-BH-A5IZ-01	157	0.9230468176331388	82	TCGA-BH-A5IZ-01	11	17	102	0.4518613762422192	TCGA-BH-A5IZ-01	19	18	18	55	PASS	1168	TCGA-BH-A5IZ	BRCA	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18927	Alive	TUMOR FREE	567	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	567	0	567	0	567	0	567	
60	TCGA-BH-A5J0	1	16	2	8	2	1	0	0	5	53	5	0	2	14	0	0	TCGA-BH-A5J0-01	306	0.6256298620643692	215	TCGA-BH-A5J0-01	21	27	126	0.18592258676657747	TCGA-BH-A5J0-01	18	17	12	47	PASS	1169	TCGA-BH-A5J0	BRCA	63	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23072	Alive	TUMOR FREE	715	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	715	0	715	0	715	0	715	
50	TCGA-BH-A6R8	0	4	0	0	1	0	0	0	2	27	2	0	1	7	0	0	TCGA-BH-A6R8-01	122	0.8528122415641692	68	TCGA-BH-A6R8-01	14	23	39	0.1402862507913691	TCGA-BH-A6R8-01	4	3	6	13	PASS	1170	TCGA-BH-A6R8	BRCA	46	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2012	[Unknown]	-16829	Alive	TUMOR FREE	293	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	293	0	293	0	293	0	293	
60	TCGA-BH-A6R9	0	10	0	0	0	0	0	0	2	12	1	0	0	6	1	0	TCGA-BH-A6R9-01	51	0.10597653839884437	11	TCGA-BH-A6R9-01	0	0	7	0.0002917897263852346	TCGA-BH-A6R9-01	0	0	0	0	PASS	1171	TCGA-BH-A6R9	BRCA	61	FEMALE	WHITE	Stage IIA	NA	Metaplastic Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22325	Alive	TUMOR FREE	160	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	160	0	160	0	160	0	160	
90	TCGA-BH-A8FY	1	8	0	0	1	0	0	0	1	36	2	0	5	10	0	0	TCGA-BH-A8FY-01	76	0.17984525885832356	35	TCGA-BH-A8FY-01	5	6	29	0.07788859801820976	TCGA-BH-A8FY-01	3	2	3	8	PASS	1172	TCGA-BH-A8FY	BRCA	87	FEMALE	WHITE	Stage IA	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31932	Dead	TUMOR FREE	NA	295	NA	NA	NA	NA	NA	NA	Negative	NA	1	295	0	295	0	295	0	295	
60	TCGA-BH-A8FZ	3	15	2	3	2	1	0	0	4	50	2	0	2	15	2	0	TCGA-BH-A8FZ-01	91	0.30240157058621703	36	TCGA-BH-A8FZ-01	9	8	48	0.2102120276917956	TCGA-BH-A8FZ-01	14	17	12	43	PASS	1173	TCGA-BH-A8FZ	BRCA	58	FEMALE	WHITE	Stage IA	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21343	Alive	TUMOR FREE	574	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	574	0	574	0	574	0	574	
50	TCGA-BH-A8G0	0	3	0	0	0	0	0	0	0	10	1	0	0	6	0	1	TCGA-BH-A8G0-01	47	0.059468698743971884	11	TCGA-BH-A8G0-01	2	2	10	0.0210588041077848	TCGA-BH-A8G0-01	1	1	1	3	PASS	1174	TCGA-BH-A8G0	BRCA	54	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2012	Peri (6-12 months since last menstrual period)	-19975	Alive	TUMOR FREE	662	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	662	0	662	0	662	0	662	
50	TCGA-BH-AB28	4	17	3	2	0	5	2	0	0	44	0	0	2	20	2	0	TCGA-BH-AB28-01	62	0.1392556016061259	16	TCGA-BH-AB28-01	4	6	32	0.10623505702758686	TCGA-BH-AB28-01	4	4	5	13	PASS	1175	TCGA-BH-AB28	BRCA	53	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2013	[Unknown]	-19570	Alive	TUMOR FREE	287	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	287	0	287	0	287	0	287	
80	TCGA-C8-A12K	2	13	0	3	5	0	1	0	5	105	6	0	3	35	6	0	TCGA-C8-A12K-01	289	0.7162465639097523	182	TCGA-C8-A12K-01	6	15	69	0.4488876904098654	TCGA-C8-A12K-01	19	24	15	58	PASS	1176	TCGA-C8-A12K	BRCA	80	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29463	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	0	0	0	0	0	0	0	
70	TCGA-C8-A12L	0	5	1	1	4	2	4	0	6	61	1	0	0	16	1	0	TCGA-C8-A12L-01	441	0.7582090625383213	282	TCGA-C8-A12L-01	16	27	126	0.5339417387633331	TCGA-C8-A12L-01	30	26	20	76	PASS	1177	TCGA-C8-A12L	BRCA	67	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24710	Alive	TUMOR FREE	363	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	363	0	363	0	363	0	363	
70	TCGA-C8-A12M	0	10	0	0	3	1	0	0	4	44	4	0	2	21	0	0	TCGA-C8-A12M-01	483	0.5342536913985771	311	TCGA-C8-A12M-01	17	25	62	0.11173367400971317	TCGA-C8-A12M-01	12	8	5	25	PASS	1178	TCGA-C8-A12M	BRCA	70	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25811	Alive	TUMOR FREE	358	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	358	0	358	0	358	0	358	
60	TCGA-C8-A12N	0	1	0	0	4	0	0	0	1	13	1	0	0	12	1	0	TCGA-C8-A12N-01	55	0.07572096412572836	17	TCGA-C8-A12N-01	4	4	4	0.03588767058097738	TCGA-C8-A12N-01	4	1	3	8	PASS	1179	TCGA-C8-A12N	BRCA	58	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21428	Alive	TUMOR FREE	358	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	358	0	358	0	358	0	358	
50	TCGA-C8-A12O	0	3	1	1	1	0	1	0	0	32	1	0	1	11	0	0	TCGA-C8-A12O-01	159	0.5684088608557157	83	TCGA-C8-A12O-01	27	30	74	0.2404086223697981	TCGA-C8-A12O-01	13	8	7	28	PASS	1180	TCGA-C8-A12O	BRCA	50	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18506	Alive	TUMOR FREE	385	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	385	0	385	0	385	0	385	
60	TCGA-C8-A12P	0	7	2	6	5	0	0	0	4	124	7	1	4	46	4	0	TCGA-C8-A12P-01	547	0.7530237206951962	372	TCGA-C8-A12P-01	17	39	102	0.2842331239643691	TCGA-C8-A12P-01	20	19	12	51	PASS	1181	TCGA-C8-A12P	BRCA	55	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20332	Alive	TUMOR FREE	358	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	358	0	358	0	358	0	358	
80	TCGA-C8-A12Q	0	6	0	2	2	1	1	0	4	81	9	1	2	36	1	0	TCGA-C8-A12Q-01	369	0.4796690977426332	245	TCGA-C8-A12Q-01	13	17	96	0.2875246249031194	TCGA-C8-A12Q-01	14	14	13	41	PASS	1182	TCGA-C8-A12Q	BRCA	78	FEMALE	ASIAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28733	Dead	WITH TUMOR	NA	385	NA	NA	NA	NA	NA	NA	Negative	NA	1	385	1	385	NA	NA	1	385	
40	TCGA-C8-A12T	1	8	0	9	0	0	0	0	7	130	17	0	4	36	2	0	TCGA-C8-A12T-01	195	0.3184483882585505	117	TCGA-C8-A12T-01	2	3	34	0.07603817960374287	TCGA-C8-A12T-01	6	9	4	19	PASS	1183	TCGA-C8-A12T	BRCA	43	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	NA	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	0	0	0	0	0	0	0	
50	TCGA-C8-A12U	0	3	0	1	0	2	0	0	2	35	5	0	1	14	2	0	TCGA-C8-A12U-01	571	0.5668213689953251	387	TCGA-C8-A12U-01	18	30	105	0.2874154218221367	TCGA-C8-A12U-01	16	18	10	44	PASS	1184	TCGA-C8-A12U	BRCA	46	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17045	Alive	TUMOR FREE	385	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	385	0	385	0	385	0	385	
60	TCGA-C8-A12V	0	2	0	2	0	0	1	0	0	36	3	0	1	8	2	0	TCGA-C8-A12V-01	69	0.07717757563569158	30	TCGA-C8-A12V	0	0	0	0	TCGA-C8-A12V	0	0	0	0	PASS	1185	TCGA-C8-A12V	BRCA	55	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20346	Alive	TUMOR FREE	385	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	385	0	385	NA	NA	0	385	
50	TCGA-C8-A12W	2	6	0	0	1	0	0	0	5	47	2	0	0	19	1	0	TCGA-C8-A12W-01	235	0.6492393050100075	145	TCGA-C8-A12W-01	27	66	38	0.28851096573291807	TCGA-C8-A12W-01	13	7	8	28	PASS	1186	TCGA-C8-A12W	BRCA	49	FEMALE	ASIAN	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18140	Alive	TUMOR FREE	385	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	385	0	385	0	385	0	385	
60	TCGA-C8-A12X	0	6	0	3	0	1	0	0	1	38	6	0	2	15	0	0	TCGA-C8-A12X-01	126	0.5891924100145013	58	TCGA-C8-A12X-01	10	9	11	0.10255157343259286	TCGA-C8-A12X-01	2	2	5	9	PASS	1187	TCGA-C8-A12X	BRCA	62	FEMALE	ASIAN	Stage IIB	NA	Mucinous Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22889	Alive	TUMOR FREE	385	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	385	0	385	0	385	0	385	
40	TCGA-C8-A12Y	0	2	0	1	1	0	0	0	3	27	1	0	0	15	2	0	TCGA-C8-A12Y-01	163	0.2368705468472125	92	TCGA-C8-A12Y-01	8	11	23	0.12879939974957744	TCGA-C8-A12Y-01	7	4	6	17	PASS	1188	TCGA-C8-A12Y	BRCA	44	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	NA	Alive	TUMOR FREE	1476	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1476	0	1476	0	1476	0	1476	
50	TCGA-C8-A12Z	0	5	1	1	0	0	1	0	0	40	2	0	0	12	1	0	TCGA-C8-A12Z-01	224	0.29540124910689103	133	TCGA-C8-A12Z-01	9	10	41	0.1823756360047465	TCGA-C8-A12Z-01	11	7	11	29	PASS	1189	TCGA-C8-A12Z	BRCA	45	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Peri (6-12 months since last menstrual period)	-16508	Alive	TUMOR FREE	382	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	382	0	382	0	382	0	382	
50	TCGA-C8-A130	0	2	1	2	1	0	1	0	1	29	2	0	0	17	2	0	TCGA-C8-A130-01	511	0.8111930616087577	317	TCGA-C8-A130-01	20	29	112	0.24714124039864666	TCGA-C8-A130-01	25	18	10	53	PASS	1190	TCGA-C8-A130	BRCA	52	FEMALE	ASIAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Peri (6-12 months since last menstrual period)	-19117	Alive	TUMOR FREE	370	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	370	0	370	0	370	0	370	
80	TCGA-C8-A131	0	4	0	3	4	2	0	0	5	50	1	0	0	15	0	0	TCGA-C8-A131-01	100	0.43524896696441856	40	TCGA-C8-A131-01	21	58	8	0.17114657017723706	TCGA-C8-A131-01	8	5	2	15	PASS	1191	TCGA-C8-A131	BRCA	82	FEMALE	ASIAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29966	Alive	TUMOR FREE	411	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	411	0	411	0	411	0	411	
60	TCGA-C8-A132	0	3	0	2	2	0	0	0	5	53	5	0	1	15	2	0	TCGA-C8-A132-01	220	0.3823627623745547	127	TCGA-C8-A132-01	14	15	53	0.21100306708923613	TCGA-C8-A132-01	15	6	15	36	PASS	1192	TCGA-C8-A132	BRCA	56	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20471	Alive	TUMOR FREE	383	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	383	0	383	0	383	0	383	
70	TCGA-C8-A133	0	4	0	0	2	0	0	0	1	20	2	0	0	7	0	0	TCGA-C8-A133-01	67	0.005322335256839551	20	TCGA-C8-A133-01	0	0	0	0.0	TCGA-C8-A133-01	0	0	0	0	PASS	1193	TCGA-C8-A133	BRCA	65	FEMALE	WHITE	Stage IIIA	NA	"Other, specify"	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23922	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	0	0	0	0	0	0	0	
50	TCGA-C8-A134	2	6	1	1	4	1	1	0	3	73	3	0	2	26	1	0	TCGA-C8-A134-01	265	0.5873517163041952	153	TCGA-C8-A134-01	8	20	65	0.4208856265069307	TCGA-C8-A134-01	24	32	20	76	PASS	1194	TCGA-C8-A134	BRCA	52	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Peri (6-12 months since last menstrual period)	-19010	Alive	TUMOR FREE	383	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	383	0	383	0	383	0	383	
60	TCGA-C8-A135	2	2	2	2	2	2	0	0	4	50	0	0	1	20	0	0	TCGA-C8-A135-01	205	0.4268337874252627	117	TCGA-C8-A135-01	20	27	46	0.3485431022079519	TCGA-C8-A135-01	11	6	12	29	PASS	1195	TCGA-C8-A135	BRCA	64	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23667	Alive	TUMOR FREE	393	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	393	0	393	0	393	0	393	
30	TCGA-C8-A137	0	5	0	3	1	0	0	0	4	33	2	1	1	11	3	0	TCGA-C8-A137-01	334	0.2701918382607387	212	TCGA-C8-A137-01	5	8	63	0.17908962902457076	TCGA-C8-A137-01	12	11	11	34	PASS	1196	TCGA-C8-A137	BRCA	34	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12729	Alive	WITH TUMOR	379	NA	NA	Locoregional Recurrence	NA	NA	136	NA	Negative	NA	0	379	0	379	1	136	1	136	
50	TCGA-C8-A138	0	0	0	2	2	0	0	1	0	36	3	0	0	15	0	0	TCGA-C8-A138-01	243	0.5666786548811817	136	TCGA-C8-A138-01	19	28	47	0.2646722865344461	TCGA-C8-A138-01	13	10	10	33	PASS	1197	TCGA-C8-A138	BRCA	54	FEMALE	ASIAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20053	Alive	TUMOR FREE	380	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	380	0	380	0	380	0	380	
60	TCGA-C8-A1HE	1	0	0	0	1	0	0	0	3	30	4	0	2	16	1	0	TCGA-C8-A1HE-01	91	0.12129836518959322	42	TCGA-C8-A1HE-01	4	4	19	0.09536922302524403	TCGA-C8-A1HE-01	5	6	5	16	PASS	1198	TCGA-C8-A1HE	BRCA	59	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	NA	Alive	TUMOR FREE	375	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	375	0	375	0	375	0	375	
50	TCGA-C8-A1HF	0	2	0	3	1	0	0	0	3	22	1	0	1	9	1	0	TCGA-C8-A1HF-01	186	0.7406125680040974	110	TCGA-C8-A1HF-01	24	18	43	0.23055530428101545	TCGA-C8-A1HF-01	9	8	9	26	PASS	1199	TCGA-C8-A1HF	BRCA	48	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	NA	Alive	TUMOR FREE	332	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	332	0	332	0	332	0	332	
50	TCGA-C8-A1HG	1	4	0	5	0	1	1	0	3	36	2	0	1	21	0	0	TCGA-C8-A1HG-01	332	0.6299141792643382	209	TCGA-C8-A1HG-01	16	30	75	0.2521637232231241	TCGA-C8-A1HG-01	16	8	15	39	PASS	1200	TCGA-C8-A1HG	BRCA	50	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	NA	Alive	TUMOR FREE	345	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	345	0	345	0	345	0	345	
40	TCGA-C8-A1HI	0	4	0	4	0	1	1	0	4	41	1	0	2	17	2	0	TCGA-C8-A1HI-01	211	0.4876588330248144	117	TCGA-C8-A1HI-01	25	23	19	0.1410333587152509	TCGA-C8-A1HI-01	8	4	4	16	PASS	1201	TCGA-C8-A1HI	BRCA	40	FEMALE	ASIAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	NA	Alive	TUMOR FREE	343	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	343	0	343	0	343	0	343	
50	TCGA-C8-A1HJ	0	6	2	2	5	0	3	0	2	79	5	0	0	28	3	0	TCGA-C8-A1HJ-01	361	0.9963806464469046	240	TCGA-C8-A1HJ-01	8	19	109	0.5225017425117271	TCGA-C8-A1HJ-01	24	25	23	72	PASS	1202	TCGA-C8-A1HJ	BRCA	53	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Peri (6-12 months since last menstrual period)	-19629	Alive	TUMOR FREE	5	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	5	0	5	0	5	0	5	
50	TCGA-C8-A1HK	0	6	1	0	2	1	0	0	1	47	1	0	2	14	1	0	TCGA-C8-A1HK-01	309	0.8417531905940555	185	TCGA-C8-A1HK-01	25	22	29	0.15097161925555574	TCGA-C8-A1HK-01	9	7	6	22	PASS	1203	TCGA-C8-A1HK	BRCA	53	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Peri (6-12 months since last menstrual period)	NA	Alive	TUMOR FREE	366	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	366	0	366	0	366	0	366	
40	TCGA-C8-A1HL	0	4	0	0	1	0	0	0	0	23	2	0	0	7	1	0	TCGA-C8-A1HL-01	223	0.3933752422460258	137	TCGA-C8-A1HL-01	12	11	23	0.10310067759546462	TCGA-C8-A1HL-01	8	5	4	17	PASS	1204	TCGA-C8-A1HL	BRCA	38	FEMALE	ASIAN	Stage IIIA	NA	"Other, specify"	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	NA	Alive	TUMOR FREE	317	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	317	0	317	0	317	0	317	
70	TCGA-C8-A1HM	3	26	3	13	0	1	1	0	21	272	19	0	7	87	8	1	TCGA-C8-A1HM-01	252	0.6936685969705176	156	TCGA-C8-A1HM-01	23	59	52	0.3793922961846505	TCGA-C8-A1HM-01	24	19	17	60	PASS	1205	TCGA-C8-A1HM	BRCA	74	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27063	Alive	TUMOR FREE	375	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	375	0	375	0	375	0	375	
60	TCGA-C8-A1HN	0	6	0	0	2	2	0	0	2	34	6	0	2	20	2	0	TCGA-C8-A1HN-01	699	0.5012956433030744	466	TCGA-C8-A1HN-01	20	33	69	0.12585397249681518	TCGA-C8-A1HN-01	21	11	5	37	PASS	1206	TCGA-C8-A1HN	BRCA	56	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20712	Alive	TUMOR FREE	394	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	394	0	394	0	394	0	394	
30	TCGA-C8-A1HO	1	2	1	2	0	1	0	0	0	23	4	0	3	14	0	0	TCGA-C8-A1HO-01	184	0.322239202786802	93	TCGA-C8-A1HO-01	5	6	22	0.14328598855196695	TCGA-C8-A1HO-01	7	2	6	15	PASS	1207	TCGA-C8-A1HO	BRCA	34	FEMALE	ASIAN	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12715	Alive	TUMOR FREE	375	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	375	0	375	0	375	0	375	
50	TCGA-C8-A26V	0	6	0	0	0	0	0	0	2	61	3	0	3	23	1	0	TCGA-C8-A26V-01	121	0.18549998396602596	63	TCGA-C8-A26V-01	4	9	19	0.15597200107413736	TCGA-C8-A26V-01	11	8	9	28	PASS	1208	TCGA-C8-A26V	BRCA	47	FEMALE	ASIAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Peri (6-12 months since last menstrual period)	-17468	Alive	TUMOR FREE	616	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	616	0	616	0	616	0	616	
60	TCGA-C8-A26W	0	4	1	0	1	0	0	0	3	43	2	0	1	18	0	0	TCGA-C8-A26W-01	236	0.4494146923930861	137	TCGA-C8-A26W-01	7	8	41	0.2414342920091956	TCGA-C8-A26W-01	13	6	13	32	PASS	1209	TCGA-C8-A26W	BRCA	58	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21391	Alive	TUMOR FREE	381	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	381	0	381	0	381	0	381	
60	TCGA-C8-A26X	0	4	0	1	5	3	1	0	0	56	2	0	1	15	2	0	TCGA-C8-A26X-01	196	0.4454976113113625	118	TCGA-C8-A26X-01	27	28	42	0.2888758521863473	TCGA-C8-A26X-01	11	12	8	31	PASS	1210	TCGA-C8-A26X	BRCA	58	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21463	Alive	TUMOR FREE	376	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	376	0	376	0	376	0	376	
90	TCGA-C8-A26Y	3	47	2	25	12	2	3	1	33	528	61	1	11	198	14	1	TCGA-C8-A26Y-01	275	0.6754788836400547	176	TCGA-C8-A26Y-01	20	38	74	0.35742235538013944	TCGA-C8-A26Y-01	19	14	9	42	PASS	1211	TCGA-C8-A26Y	BRCA	90	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32872	Alive	TUMOR FREE	394	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	394	0	394	0	394	0	394	
60	TCGA-C8-A26Z	0	4	0	2	3	0	0	0	6	36	3	0	0	8	0	0	TCGA-C8-A26Z-01	248	0.54093561051318	155	TCGA-C8-A26Z-01	20	26	52	0.16974952172916333	TCGA-C8-A26Z-01	13	3	6	22	PASS	1212	TCGA-C8-A26Z	BRCA	59	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	NA	Alive	TUMOR FREE	470	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	470	0	470	0	470	0	470	
30	TCGA-C8-A273	1	2	0	0	0	2	0	0	3	12	0	0	0	6	2	0	TCGA-C8-A273-01	249	0.2254281216044592	140	TCGA-C8-A273-01	7	6	23	0.09360607874082384	TCGA-C8-A273-01	6	6	5	17	PASS	1213	TCGA-C8-A273	BRCA	29	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	NA	Alive	TUMOR FREE	513	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	513	0	513	0	513	0	513	
60	TCGA-C8-A274	0	19	0	11	2	4	1	0	12	166	13	0	3	64	2	0	TCGA-C8-A274-01	99	0.4371003559398133	51	TCGA-C8-A274-01	16	29	6	0.103987155377681	TCGA-C8-A274-01	10	4	3	17	PASS	1214	TCGA-C8-A274	BRCA	63	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23337	Alive	TUMOR FREE	508	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	508	0	508	0	508	0	508	
60	TCGA-C8-A275	0	2	0	1	1	0	0	0	3	95	5	0	0	37	2	0	TCGA-C8-A275-01	204	0.22229699330536504	108	TCGA-C8-A275-01	5	15	26	0.12240427666905015	TCGA-C8-A275-01	6	6	5	17	PASS	1215	TCGA-C8-A275	BRCA	56	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20774	Alive	TUMOR FREE	1	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1	0	1	0	1	0	1	
60	TCGA-C8-A278	0	2	0	0	1	0	0	0	0	40	2	0	1	11	0	0	TCGA-C8-A278-01	175	0.4645556730431667	97	TCGA-C8-A278-01	17	23	10	0.05970909892641015	TCGA-C8-A278-01	13	10	6	29	PASS	1216	TCGA-C8-A278	BRCA	61	FEMALE	ASIAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22598	Alive	TUMOR FREE	297	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	297	0	297	0	297	0	297	
50	TCGA-C8-A27A	1	1	0	0	0	0	0	0	1	23	1	0	0	14	0	0	TCGA-C8-A27A-01	482	0.9176741350097956	337	TCGA-C8-A27A-01	16	18	64	0.21344295625532825	TCGA-C8-A27A-01	13	15	14	42	PASS	1217	TCGA-C8-A27A	BRCA	48	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Peri (6-12 months since last menstrual period)	-17779	Alive	TUMOR FREE	747	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	747	0	747	0	747	0	747	
50	TCGA-C8-A27B	1	6	1	1	3	0	2	0	6	114	4	0	0	30	0	1	TCGA-C8-A27B-01	268	0.8232753068084121	164	TCGA-C8-A27B-01	14	36	75	0.5339817216844731	TCGA-C8-A27B-01	28	22	17	67	PASS	1218	TCGA-C8-A27B	BRCA	48	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2011	Peri (6-12 months since last menstrual period)	-17763	Alive	TUMOR FREE	439	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	439	0	439	0	439	0	439	
60	TCGA-C8-A3M7	2	34	1	5	1	1	0	0	12	110	14	0	4	45	0	0	TCGA-C8-A3M7-01	92	0.18889285573652745	42	TCGA-C8-A3M7-01	8	6	22	0.08238120174534884	TCGA-C8-A3M7-01	2	3	1	6	PASS	1219	TCGA-C8-A3M7	BRCA	60	FEMALE	ASIAN	Stage IIIB	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22096	Dead	WITH TUMOR	NA	1034	NA	Locoregional Recurrence	NA	NA	1034	NA	Negative	NA	1	1034	1	1034	1	1034	1	1034	
70	TCGA-C8-A3M8	1	9	1	0	3	1	1	0	4	35	1	0	1	10	1	0	TCGA-C8-A3M8-01	156	0.2516504587225529	91	TCGA-C8-A3M8-01	9	12	47	0.18136638452124484	TCGA-C8-A3M8-01	9	7	6	22	PASS	1220	TCGA-C8-A3M8	BRCA	68	FEMALE	ASIAN	Stage IA	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24877	Alive	TUMOR FREE	394	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	394	0	394	0	394	0	394	
60	TCGA-C8-A8HP	6	44	6	5	0	0	1	0	15	122	17	1	5	53	1	0	TCGA-C8-A8HP-01	206	0.35375188361753673	114	TCGA-C8-A8HP-01	10	17	151	0.3671135217639992	TCGA-C8-A8HP-01	10	8	14	32	PASS	1221	TCGA-C8-A8HP	BRCA	59	FEMALE	ASIAN	Stage IIIA	NA	Metaplastic Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21613	Alive	TUMOR FREE	396	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	396	0	396	0	396	0	396	
50	TCGA-C8-A8HQ	6	54	3	18	3	1	0	0	13	186	20	0	5	68	2	0	TCGA-C8-A8HQ-01	184	0.4468188774693084	119	TCGA-C8-A8HQ-01	5	7	100	0.17171419104953484	TCGA-C8-A8HQ-01	8	6	9	23	PASS	1222	TCGA-C8-A8HQ	BRCA	53	FEMALE	ASIAN	Stage IIB	NA	Mucinous Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19432	Alive	TUMOR FREE	380	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	380	0	380	0	380	0	380	
50	TCGA-C8-A8HR	1	7	1	2	0	0	0	0	3	37	2	0	0	10	1	0	TCGA-C8-A8HR-01	75	0.2616720795879008	29	TCGA-C8-A8HR-01	10	11	71	0.3073210878484593	TCGA-C8-A8HR-01	12	11	12	35	PASS	1223	TCGA-C8-A8HR	BRCA	49	FEMALE	ASIAN	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2013	Peri (6-12 months since last menstrual period)	-17921	Alive	TUMOR FREE	408	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	408	0	408	0	408	0	408	
50	TCGA-C8-A9FZ	0	4	1	1	2	0	0	0	2	18	1	0	0	3	0	0	TCGA-C8-A9FZ-01	250	0.9698024057143134	167	TCGA-C8-A9FZ-01	7	7	125	0.2513436498971669	TCGA-C8-A9FZ-01	7	12	14	33	PASS	1224	TCGA-C8-A9FZ	BRCA	49	FEMALE	WHITE	Stage IIB	NA	Mixed Histology (please specify)	NA	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18038	Alive	TUMOR FREE	592	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	592	0	592	0	592	0	592	
50	TCGA-D8-A13Y	1	3	1	0	5	1	1	0	1	54	2	0	0	20	3	0	TCGA-D8-A13Y-01	253	0.9471050729361472	147	TCGA-D8-A13Y-01	13	17	69	0.4165209436730989	TCGA-D8-A13Y-01	20	24	14	58	PASS	1225	TCGA-D8-A13Y	BRCA	52	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19028	Alive	TUMOR FREE	1728	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1728	0	1728	0	1728	0	1728	
50	TCGA-D8-A13Z	2	7	0	0	0	1	1	1	4	72	3	0	1	18	2	0	TCGA-D8-A13Z-01	196	0.8040866799762328	116	TCGA-D8-A13Z-01	27	55	42	0.4018108195098683	TCGA-D8-A13Z-01	17	17	3	37	PASS	1226	TCGA-D8-A13Z	BRCA	51	FEMALE	WHITE	NA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18942	Alive	TUMOR FREE	635	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	635	0	635	0	635	0	635	
60	TCGA-D8-A140	1	9	2	4	2	6	0	0	8	76	9	0	3	28	1	0	TCGA-D8-A140-01	470	0.2369628512354082	316	TCGA-D8-A140-01	5	7	87	0.11462695893017345	TCGA-D8-A140-01	8	7	5	20	PASS	1227	TCGA-D8-A140	BRCA	62	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22900	Alive	TUMOR FREE	403	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	403	0	403	0	403	0	403	
40	TCGA-D8-A141	0	1	0	1	1	1	0	0	0	16	0	0	0	4	1	0	TCGA-D8-A141-01	35	0.2270321302606137	2	TCGA-D8-A141-01	9	11	3	0.0961377622783603	TCGA-D8-A141-01	3	0	1	4	PASS	1228	TCGA-D8-A141	BRCA	40	FEMALE	WHITE	NA	NA	Infiltrating Ductal Carcinoma	NA	2010	Indeterminate (neither Pre or Postmenopausal)	-14626	Alive	TUMOR FREE	626	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	626	0	626	0	626	0	626	
70	TCGA-D8-A142	0	3	0	3	4	0	1	0	4	100	7	0	1	47	3	0	TCGA-D8-A142-01	231	0.7284503466001053	133	TCGA-D8-A142	0	0	0	0	TCGA-D8-A142	0	0	0	0	PASS	1229	TCGA-D8-A142	BRCA	74	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27313	Alive	TUMOR FREE	425	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	425	0	425	0	425	0	425	
50	TCGA-D8-A143	0	4	0	4	2	1	4	0	4	37	3	0	0	10	1	0	TCGA-D8-A143-01	149	0.858516093553396	78	TCGA-D8-A143-01	20	40	50	0.5568157832047383	TCGA-D8-A143-01	17	10	7	34	PASS	1230	TCGA-D8-A143	BRCA	51	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18984	Alive	TUMOR FREE	431	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	431	0	431	0	431	0	431	
80	TCGA-D8-A145	0	3	0	0	2	1	0	0	2	38	0	0	1	7	0	0	TCGA-D8-A145-01	56	0.4172979535476044	19	TCGA-D8-A145-01	4	4	7	0.05519918086257986	TCGA-D8-A145-01	1	3	2	6	PASS	1231	TCGA-D8-A145	BRCA	80	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29280	Alive	TUMOR FREE	410	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	410	0	410	0	410	0	410	
60	TCGA-D8-A146	1	1	0	2	2	1	0	0	2	26	3	0	0	7	0	0	TCGA-D8-A146	0	0	0	TCGA-D8-A146	0	0	0	0	TCGA-D8-A146-01	4	3	4	11	PASS	1232	TCGA-D8-A146	BRCA	57	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20861	Alive	TUMOR FREE	643	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	643	0	643	0	643	0	643	
50	TCGA-D8-A147	1	13	2	8	6	0	2	1	5	129	7	0	3	36	2	0	TCGA-D8-A147-01	280	0.6495928432744055	170	TCGA-D8-A147-01	11	30	76	0.35703334383680524	TCGA-D8-A147-01	22	32	15	69	PASS	1233	TCGA-D8-A147	BRCA	45	FEMALE	WHITE	NA	NA	Infiltrating Ductal Carcinoma	NA	2010	Indeterminate (neither Pre or Postmenopausal)	-16736	Alive	TUMOR FREE	584	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	584	0	584	0	584	0	584	
80	TCGA-D8-A1J8	6	65	2	22	39	10	5	1	35	563	46	0	6	226	19	0	TCGA-D8-A1J8-01	73	0.947642032493375	28	TCGA-D8-A1J8-01	19	17	29	0.5794259464336654	TCGA-D8-A1J8-01	4	2	1	7	hypermutated sample	1234	TCGA-D8-A1J8	BRCA	77	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28444	Alive	TUMOR FREE	431	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	431	0	431	0	431	0	431	
50	TCGA-D8-A1J9	4	14	0	9	1	1	0	0	14	148	17	0	3	67	2	0	TCGA-D8-A1J9-01	301	0.5125394721149007	204	TCGA-D8-A1J9-01	10	14	64	0.23899761105786155	TCGA-D8-A1J9-01	13	8	10	31	PASS	1235	TCGA-D8-A1J9	BRCA	48	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17879	Alive	TUMOR FREE	532	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	532	0	532	0	532	0	532	
60	TCGA-D8-A1JA	6	65	5	41	5	1	3	1	30	694	70	0	18	249	11	2	TCGA-D8-A1JA-01	262	0.2728160390629479	165	TCGA-D8-A1JA-01	6	10	53	0.20418102982282224	TCGA-D8-A1JA-01	8	14	6	28	mutation call filter	1236	TCGA-D8-A1JA	BRCA	60	FEMALE	WHITE	NA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21918	Alive	WITH TUMOR	502	NA	NA	Locoregional Disease	NA	NA	431	NA	Negative	NA	0	502	0	502	1	431	1	431	
50	TCGA-D8-A1JB	0	6	0	0	3	0	0	0	5	35	1	0	1	18	0	0	TCGA-D8-A1JB-01	106	0.2045424292772064	48	TCGA-D8-A1JB-01	8	10	29	0.4026415350911568	TCGA-D8-A1JB-01	13	16	12	41	PASS	1237	TCGA-D8-A1JB	BRCA	54	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19822	Alive	TUMOR FREE	1688	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1688	0	1688	0	1688	0	1688	
60	TCGA-D8-A1JC	0	13	0	8	3	1	0	0	4	65	5	0	1	25	1	0	TCGA-D8-A1JC-01	209	0.6982477624636475	121	TCGA-D8-A1JC-01	14	12	47	0.2743593896753173	TCGA-D8-A1JC-01	14	6	13	33	PASS	1238	TCGA-D8-A1JC	BRCA	59	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21898	Alive	TUMOR FREE	480	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	480	0	480	0	480	0	480	
40	TCGA-D8-A1JD	0	8	0	3	6	0	1	0	6	82	5	1	0	21	4	0	TCGA-D8-A1JD-01	204	0.6003205984238783	122	TCGA-D8-A1JD-01	18	58	18	0.09075647124180848	TCGA-D8-A1JD-01	20	15	5	40	PASS	1239	TCGA-D8-A1JD	BRCA	41	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15166	Alive	TUMOR FREE	552	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	552	0	552	0	552	0	552	
60	TCGA-D8-A1JE	1	2	1	0	1	0	0	0	1	24	2	0	1	7	1	0	TCGA-D8-A1JE-01	79	0.6779394569114433	30	TCGA-D8-A1JE-01	24	27	8	0.1854123287736084	TCGA-D8-A1JE-01	7	2	3	12	PASS	1240	TCGA-D8-A1JE	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22683	Alive	TUMOR FREE	575	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	575	0	575	0	575	0	575	
80	TCGA-D8-A1JF	1	0	1	0	2	1	1	1	1	33	1	0	1	12	1	0	TCGA-D8-A1JF-01	166	0.7240633350273639	89	TCGA-D8-A1JF-01	24	71	12	0.15775423882390965	TCGA-D8-A1JF-01	11	8	4	23	PASS	1241	TCGA-D8-A1JF	BRCA	79	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29199	Alive	TUMOR FREE	366	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	366	0	366	0	366	0	366	
60	TCGA-D8-A1JG	0	9	0	5	2	2	2	0	5	102	21	0	2	33	2	0	TCGA-D8-A1JG-01	232	0.6798712276974666	138	TCGA-D8-A1JG-01	25	33	67	0.5109572359542413	TCGA-D8-A1JG-01	11	5	11	27	PASS	1242	TCGA-D8-A1JG	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22878	Alive	TUMOR FREE	1612	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1612	0	1612	0	1612	0	1612	
60	TCGA-D8-A1JH	0	0	1	0	1	2	0	0	2	17	0	0	0	4	0	0	TCGA-D8-A1JH-01	53	0.07165323070356364	15	TCGA-D8-A1JH-01	0	0	19	4.646512340123037e-05	TCGA-D8-A1JH-01	0	0	0	0	PASS	1243	TCGA-D8-A1JH	BRCA	56	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20497	Alive	TUMOR FREE	426	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	426	0	426	0	426	0	426	
50	TCGA-D8-A1JI	1	3	0	0	0	0	0	0	4	19	2	0	0	14	1	0	TCGA-D8-A1JI-01	165	0.8992810900362906	90	TCGA-D8-A1JI-01	9	9	22	0.2743899032923732	TCGA-D8-A1JI-01	5	4	8	17	PASS	1244	TCGA-D8-A1JI	BRCA	54	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20072	Alive	TUMOR FREE	577	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	577	0	577	0	577	0	577	
50	TCGA-D8-A1JJ	0	3	2	3	0	0	0	0	2	64	1	0	0	27	0	0	TCGA-D8-A1JJ-01	213	0.6139674108589677	126	TCGA-D8-A1JJ-01	22	25	27	0.15493019588345475	TCGA-D8-A1JJ-01	10	12	3	25	PASS	1245	TCGA-D8-A1JJ	BRCA	54	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19966	Alive	TUMOR FREE	611	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	611	0	611	0	611	0	611	
90	TCGA-D8-A1JK	0	15	2	3	18	3	5	0	10	148	12	0	3	59	5	0	TCGA-D8-A1JK-01	337	0.6650884105725656	206	TCGA-D8-A1JK-01	21	63	72	0.2669481280478743	TCGA-D8-A1JK-01	24	19	10	53	PASS	1246	TCGA-D8-A1JK	BRCA	90	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32872	Alive	TUMOR FREE	612	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	612	0	612	0	612	0	612	
70	TCGA-D8-A1JL	0	4	0	3	2	0	0	0	6	74	6	0	2	34	5	0	TCGA-D8-A1JL-01	166	0.6436418909728228	82	TCGA-D8-A1JL-01	23	34	76	0.6673480012225302	TCGA-D8-A1JL-01	24	19	8	51	PASS	1247	TCGA-D8-A1JL	BRCA	72	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26484	Alive	TUMOR FREE	611	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	611	0	611	0	611	0	611	
60	TCGA-D8-A1JM	0	2	0	1	0	1	1	0	0	31	4	0	0	18	0	0	TCGA-D8-A1JM-01	272	0.9455670198069449	167	TCGA-D8-A1JM-01	14	23	78	0.3830238780547189	TCGA-D8-A1JM-01	17	10	15	42	PASS	1248	TCGA-D8-A1JM	BRCA	59	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21602	Alive	TUMOR FREE	590	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	590	0	590	0	590	0	590	
80	TCGA-D8-A1JN	0	8	1	10	2	2	0	0	6	102	11	0	5	62	3	1	TCGA-D8-A1JN-01	91	0.1747418317373882	38	TCGA-D8-A1JN-01	7	7	9	0.11799668686615684	TCGA-D8-A1JN-01	2	2	2	6	PASS	1249	TCGA-D8-A1JN	BRCA	80	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29331	Alive	TUMOR FREE	620	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	620	0	620	0	620	0	620	
70	TCGA-D8-A1JP	1	5	1	4	3	0	3	0	5	88	4	0	0	33	1	0	TCGA-D8-A1JP-01	241	0.5384727438185171	128	TCGA-D8-A1JP-01	4	17	59	0.3299429418813139	TCGA-D8-A1JP-01	19	31	19	69	PASS	1250	TCGA-D8-A1JP	BRCA	73	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26862	Alive	TUMOR FREE	639	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	639	0	639	0	639	0	639	
80	TCGA-D8-A1JS	0	3	0	2	1	0	0	0	0	17	0	0	0	9	1	0	TCGA-D8-A1JS-01	45	0.061928626104638285	13	TCGA-D8-A1JS-01	2	2	3	0.02919697600870388	TCGA-D8-A1JS-01	2	2	2	6	PASS	1251	TCGA-D8-A1JS	BRCA	77	FEMALE	WHITE	Stage IA	NA	"Other, specify"	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28178	Alive	TUMOR FREE	371	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	371	0	371	0	371	0	371	
70	TCGA-D8-A1JT	1	4	1	1	2	0	1	0	1	24	0	0	0	12	0	0	TCGA-D8-A1JT-01	90	0.9265749989443136	47	TCGA-D8-A1JT-01	18	13	8	0.08868915686095284	TCGA-D8-A1JT-01	5	4	4	13	PASS	1252	TCGA-D8-A1JT	BRCA	70	FEMALE	WHITE	Stage IIA	NA	"Other, specify"	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25677	Alive	TUMOR FREE	405	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	405	0	405	0	405	0	405	
50	TCGA-D8-A1JU	0	0	0	0	1	0	0	0	0	11	0	0	1	7	1	0	TCGA-D8-A1JU-01	60	0.15334343398413766	17	TCGA-D8-A1JU-01	4	6	5	0.1159049024307421	TCGA-D8-A1JU-01	4	0	2	6	PASS	1253	TCGA-D8-A1JU	BRCA	51	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18733	Alive	TUMOR FREE	447	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	447	0	447	0	447	0	447	
80	TCGA-D8-A1X5	0	2	0	3	0	4	0	0	0	38	5	0	1	20	0	0	TCGA-D8-A1X5-01	288	0.7000451824131927	184	TCGA-D8-A1X5-01	20	29	71	0.33332164610412024	TCGA-D8-A1X5-01	19	8	10	37	PASS	1254	TCGA-D8-A1X5	BRCA	81	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29734	Alive	TUMOR FREE	565	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	565	0	565	0	565	0	565	
80	TCGA-D8-A1X6	0	3	0	1	1	4	0	0	2	29	1	0	0	6	2	0	TCGA-D8-A1X6-01	52	0.3624064745390524	12	TCGA-D8-A1X6-01	13	15	2	0.02410310313428541	TCGA-D8-A1X6-01	3	1	2	6	PASS	1255	TCGA-D8-A1X6	BRCA	80	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29256	Alive	TUMOR FREE	541	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	541	0	541	0	541	0	541	
40	TCGA-D8-A1X7	0	1	0	2	0	0	0	0	2	18	2	0	1	6	0	0	TCGA-D8-A1X7-01	66	0.08530750299781119	25	TCGA-D8-A1X7-01	4	5	2	0.0071594967023868375	TCGA-D8-A1X7-01	2	1	1	4	PASS	1256	TCGA-D8-A1X7	BRCA	40	FEMALE	WHITE	Stage IIA	NA	"Other, specify"	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14858	Alive	TUMOR FREE	509	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	509	0	509	0	509	0	509	
60	TCGA-D8-A1X8	0	2	0	0	1	1	0	0	0	18	1	0	1	11	1	0	TCGA-D8-A1X8-01	73	0.11527098501877918	34	TCGA-D8-A1X8-01	3	4	7	0.08047677159045495	TCGA-D8-A1X8-01	5	4	6	15	mutation call filter	1257	TCGA-D8-A1X8	BRCA	62	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22995	Alive	TUMOR FREE	783	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	783	0	783	0	783	0	783	
70	TCGA-D8-A1X9	0	4	0	0	1	0	0	0	2	72	6	0	1	18	4	0	TCGA-D8-A1X9-01	275	0.31747095968361144	156	TCGA-D8-A1X9-01	4	11	57	0.2411558739158209	TCGA-D8-A1X9-01	19	24	12	55	PASS	1258	TCGA-D8-A1X9	BRCA	66	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24417	Alive	TUMOR FREE	727	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	727	0	727	NA	NA	0	727	
60	TCGA-D8-A1XA	0	2	0	2	4	1	0	0	0	16	2	1	0	6	0	0	TCGA-D8-A1XA-01	105	0.8817609920035505	48	TCGA-D8-A1XA-01	17	13	23	0.4140504608980039	TCGA-D8-A1XA-01	6	1	5	12	PASS	1259	TCGA-D8-A1XA	BRCA	64	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23387	Alive	TUMOR FREE	839	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	839	0	839	0	839	0	839	
60	TCGA-D8-A1XB	0	7	1	0	1	0	2	0	0	30	1	1	0	11	0	0	TCGA-D8-A1XB-01	77	0.4613172443105394	34	TCGA-D8-A1XB-01	3	3	10	0.050660843582794914	TCGA-D8-A1XB-01	4	2	2	8	PASS	1260	TCGA-D8-A1XB	BRCA	62	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22976	Alive	TUMOR FREE	552	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	552	0	552	0	552	0	552	
90	TCGA-D8-A1XC	0	1	0	1	1	0	0	0	0	21	2	0	1	7	2	0	TCGA-D8-A1XC-01	42	0.056588847150741375	9	TCGA-D8-A1XC-01	2	2	19	0.0018074417190532496	TCGA-D8-A1XC-01	3	0	0	3	PASS	1261	TCGA-D8-A1XC	BRCA	85	FEMALE	WHITE	Stage IIIB	NA	Mucinous Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31220	Dead	WITH TUMOR	NA	377	NA	NA	NA	NA	NA	NA	Negative	NA	1	377	1	377	NA	NA	1	377	
40	TCGA-D8-A1XD	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-D8-A1XD-01	268	0.19421238667452612	181	TCGA-D8-A1XD-01	6	7	43	0.10850182466434298	TCGA-D8-A1XD-01	6	3	5	14	PASS	1262	TCGA-D8-A1XD	BRCA	36	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13510	Alive	TUMOR FREE	522	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	522	0	522	0	522	0	522	
50	TCGA-D8-A1XF	0	8	1	1	0	0	0	0	4	26	1	0	1	13	1	0	TCGA-D8-A1XF-01	148	0.6893759186347972	73	TCGA-D8-A1XF-01	25	25	28	0.3191979644686042	TCGA-D8-A1XF-01	12	3	12	27	PASS	1263	TCGA-D8-A1XF	BRCA	45	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16787	Alive	TUMOR FREE	463	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	463	0	463	NA	NA	0	463	
90	TCGA-D8-A1XG	0	2	0	1	3	0	1	0	6	13	0	0	0	10	0	0	TCGA-D8-A1XG-01	80	0.17853721674372816	32	TCGA-D8-A1XG-01	4	3	9	0.12010664926444918	TCGA-D8-A1XG-01	1	4	3	8	PASS	1264	TCGA-D8-A1XG	BRCA	86	FEMALE	WHITE	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31748	Alive	TUMOR FREE	448	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	448	0	448	0	448	0	448	
80	TCGA-D8-A1XJ	1	7	0	2	4	0	1	0	6	65	6	0	3	24	2	0	TCGA-D8-A1XJ-01	312	0.8058682473990698	181	TCGA-D8-A1XJ-01	14	20	62	0.18473048972781952	TCGA-D8-A1XJ-01	18	13	9	40	mutation call filter	1265	TCGA-D8-A1XJ	BRCA	76	FEMALE	WHITE	Stage IIIA	NA	"Other, specify"	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27967	Alive	TUMOR FREE	664	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	664	0	664	0	664	0	664	
60	TCGA-D8-A1XK	4	105	2	21	68	15	2	0	54	781	17	1	17	278	61	0	TCGA-D8-A1XK-01	319	0.7402819598389373	186	TCGA-D8-A1XK-01	15	27	88	0.4745315073100835	TCGA-D8-A1XK-01	26	28	18	72	hypermutated sample	1266	TCGA-D8-A1XK	BRCA	55	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20092	Alive	TUMOR FREE	441	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	441	0	441	0	441	0	441	
30	TCGA-D8-A1XL	0	2	0	6	3	2	2	0	5	78	1	0	1	14	4	0	TCGA-D8-A1XL-01	280	0.6393910883358839	176	TCGA-D8-A1XL-01	17	30	43	0.2340643441257288	TCGA-D8-A1XL-01	17	23	7	47	PASS	1267	TCGA-D8-A1XL	BRCA	34	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12668	Alive	TUMOR FREE	606	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	606	0	606	0	606	0	606	
60	TCGA-D8-A1XM	1	0	0	2	0	0	1	0	1	36	4	0	3	17	3	0	TCGA-D8-A1XM-01	56	0.16665826055643393	16	TCGA-D8-A1XM-01	5	7	12	0.1073516249225523	TCGA-D8-A1XM-01	6	4	6	16	PASS	1268	TCGA-D8-A1XM	BRCA	57	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21056	Alive	TUMOR FREE	538	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	538	0	538	0	538	0	538	
60	TCGA-D8-A1XO	1	5	0	2	0	0	0	0	2	9	4	0	0	8	0	0	TCGA-D8-A1XO-01	78	0.30811913220953074	31	TCGA-D8-A1XO-01	7	7	20	0.1986395869553681	TCGA-D8-A1XO-01	4	5	3	12	PASS	1269	TCGA-D8-A1XO	BRCA	56	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20606	Alive	TUMOR FREE	1682	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1682	0	1682	0	1682	0	1682	
70	TCGA-D8-A1XQ	4	59	3	26	85	11	15	1	36	607	33	0	11	255	33	1	TCGA-D8-A1XQ-01	303	0.6501998279199789	182	TCGA-D8-A1XQ-01	10	72	106	0.5197370435932085	TCGA-D8-A1XQ-01	29	28	15	72	hypermutated sample	1270	TCGA-D8-A1XQ	BRCA	69	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25345	Alive	TUMOR FREE	499	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	499	0	499	0	499	0	499	
60	TCGA-D8-A1XR	0	0	0	1	0	2	1	0	3	22	0	0	1	7	0	0	TCGA-D8-A1XR-01	72	0.503114247450329	23	TCGA-D8-A1XR-01	6	7	9	0.13975408809561538	TCGA-D8-A1XR-01	4	4	5	13	PASS	1271	TCGA-D8-A1XR	BRCA	56	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20488	Alive	TUMOR FREE	482	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	482	0	482	0	482	0	482	
50	TCGA-D8-A1XS	0	0	0	0	1	0	0	0	1	21	0	0	0	9	0	0	TCGA-D8-A1XS-01	131	0.3243102718594144	78	TCGA-D8-A1XS-01	8	9	11	0.05648543614264277	TCGA-D8-A1XS-01	5	1	4	10	PASS	1272	TCGA-D8-A1XS	BRCA	48	MALE	WHITE	Stage IIIC	NA	"Other, specify"	NA	2010	NA	-17708	Alive	TUMOR FREE	496	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	496	0	496	0	496	0	496	
60	TCGA-D8-A1XT	0	2	0	0	2	0	0	0	2	29	3	0	0	10	0	0	TCGA-D8-A1XT-01	329	0.4271789568569974	201	TCGA-D8-A1XT-01	12	19	93	0.35726636495163633	TCGA-D8-A1XT-01	16	8	12	36	PASS	1273	TCGA-D8-A1XT	BRCA	61	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22448	Alive	TUMOR FREE	506	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	506	0	506	0	506	0	506	
60	TCGA-D8-A1XU	0	4	0	3	1	0	1	0	0	18	3	0	0	9	1	0	TCGA-D8-A1XU-01	132	0.9473157924043784	61	TCGA-D8-A1XU-01	19	14	45	0.5062987945392106	TCGA-D8-A1XU-01	10	4	11	25	PASS	1274	TCGA-D8-A1XU	BRCA	56	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20715	Alive	TUMOR FREE	395	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	395	0	395	0	395	0	395	
80	TCGA-D8-A1XV	0	1	0	1	1	0	0	0	2	21	2	0	0	9	1	0	TCGA-D8-A1XV-01	35	0.2144877903943296	3	TCGA-D8-A1XV-01	1	2	19	0.0003584939596707146	TCGA-D8-A1XV-01	1	1	0	2	PASS	1275	TCGA-D8-A1XV	BRCA	84	FEMALE	WHITE	Stage IIA	NA	Mucinous Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30830	Alive	TUMOR FREE	461	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	461	0	461	0	461	0	461	
50	TCGA-D8-A1XW	0	7	1	4	4	0	0	0	4	71	5	0	2	27	5	0	TCGA-D8-A1XW-01	148	0.8760149481580828	70	TCGA-D8-A1XW-01	18	37	33	0.4536534126362669	TCGA-D8-A1XW-01	20	24	6	50	PASS	1276	TCGA-D8-A1XW	BRCA	53	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19478	Alive	TUMOR FREE	1309	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1309	0	1309	0	1309	0	1309	
70	TCGA-D8-A1XY	0	1	1	1	2	0	0	0	1	39	2	0	1	18	0	0	TCGA-D8-A1XY-01	149	0.5714978253433396	83	TCGA-D8-A1XY-01	25	24	30	0.188502700841038	TCGA-D8-A1XY-01	7	10	8	25	PASS	1277	TCGA-D8-A1XY	BRCA	74	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27106	Alive	TUMOR FREE	503	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	503	0	503	NA	NA	0	503	
80	TCGA-D8-A1XZ	1	1	0	4	1	0	2	0	1	62	5	0	1	25	2	0	TCGA-D8-A1XZ-01	421	0.774888602620192	268	TCGA-D8-A1XZ-01	18	21	31	0.1029309695197776	TCGA-D8-A1XZ-01	11	9	6	26	PASS	1278	TCGA-D8-A1XZ	BRCA	81	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29916	Alive	TUMOR FREE	466	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	466	0	466	0	466	0	466	
70	TCGA-D8-A1Y0	0	3	0	3	1	0	1	0	2	48	3	0	1	21	1	0	TCGA-D8-A1Y0-01	243	0.3935577078989	141	TCGA-D8-A1Y0-01	10	18	51	0.2389765592895501	TCGA-D8-A1Y0-01	18	17	9	44	PASS	1279	TCGA-D8-A1Y0	BRCA	65	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24083	Alive	TUMOR FREE	472	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	472	0	472	NA	NA	0	472	
80	TCGA-D8-A1Y1	0	14	1	3	35	4	5	0	4	143	12	1	2	65	3	0	TCGA-D8-A1Y1-01	85	0.5329280630362988	39	TCGA-D8-A1Y1-01	21	30	12	0.33849431933805	TCGA-D8-A1Y1-01	5	2	3	10	PASS	1280	TCGA-D8-A1Y1	BRCA	80	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29474	Dead	WITH TUMOR	NA	302	NA	NA	NA	NA	NA	NA	NA	NA	1	302	1	302	NA	NA	1	302	
70	TCGA-D8-A1Y2	0	0	0	1	0	0	0	0	0	18	0	0	1	4	0	0	TCGA-D8-A1Y2-01	82	0.31509189108842456	33	TCGA-D8-A1Y2-01	12	11	14	0.12545930667734406	TCGA-D8-A1Y2-01	5	2	5	12	PASS	1281	TCGA-D8-A1Y2	BRCA	71	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26021	Alive	TUMOR FREE	433	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	433	0	433	0	433	0	433	
60	TCGA-D8-A1Y3	0	3	0	0	0	0	2	0	3	43	2	0	1	17	0	0	TCGA-D8-A1Y3-01	188	0.8433411240396196	102	TCGA-D8-A1Y3-01	22	35	40	0.4047732369580167	TCGA-D8-A1Y3-01	17	8	10	35	PASS	1282	TCGA-D8-A1Y3	BRCA	61	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22317	Alive	TUMOR FREE	430	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	430	0	430	0	430	0	430	
70	TCGA-D8-A27E	0	1	0	0	1	0	0	1	1	8	0	0	1	1	0	0	TCGA-D8-A27E-01	41	0.0001407879976131711	6	TCGA-D8-A27E-01	0	0	0	0.0	TCGA-D8-A27E-01	0	0	0	0	PASS	1283	TCGA-D8-A27E	BRCA	66	FEMALE	WHITE	Stage IA	NA	"Other, specify"	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24315	Alive	TUMOR FREE	530	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	530	0	530	0	530	0	530	
40	TCGA-D8-A27F	0	2	0	1	5	0	3	0	4	48	3	0	1	15	2	0	TCGA-D8-A27F-01	165	0.9549669646213872	87	TCGA-D8-A27F-01	7	22	68	0.4593882442233649	TCGA-D8-A27F-01	25	23	29	77	PASS	1284	TCGA-D8-A27F	BRCA	40	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14731	Alive	TUMOR FREE	488	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	488	0	488	0	488	0	488	
80	TCGA-D8-A27G	5	60	7	31	2	3	0	0	35	709	74	2	9	237	10	4	TCGA-D8-A27G-01	172	0.10845239064735067	105	TCGA-D8-A27G-01	4	4	27	0.06722461347348926	TCGA-D8-A27G-01	4	2	4	10	hypermutated sample	1285	TCGA-D8-A27G	BRCA	75	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27521	Alive	TUMOR FREE	409	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	409	0	409	0	409	0	409	
70	TCGA-D8-A27H	1	9	4	4	4	0	0	0	0	116	2	0	3	28	1	0	TCGA-D8-A27H-01	375	0.4990989416820298	248	TCGA-D8-A27H-01	5	19	83	0.3597086408970233	TCGA-D8-A27H-01	25	31	19	75	PASS	1286	TCGA-D8-A27H	BRCA	72	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26588	Alive	TUMOR FREE	397	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	397	0	397	0	397	0	397	
60	TCGA-D8-A27I	0	2	0	0	2	0	0	0	0	26	1	0	0	8	0	0	TCGA-D8-A27I-01	65	0.3075103787341681	20	TCGA-D8-A27I-01	12	15	9	0.17033784966155002	TCGA-D8-A27I-01	3	1	2	6	PASS	1287	TCGA-D8-A27I	BRCA	58	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21327	Alive	TUMOR FREE	439	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	439	0	439	0	439	0	439	
50	TCGA-D8-A27K	0	0	0	0	0	2	1	0	0	14	3	0	0	6	1	0	TCGA-D8-A27K-01	43	0.1153248388783364	5	TCGA-D8-A27K-01	5	4	19	0.015826341248239457	TCGA-D8-A27K-01	3	0	1	4	PASS	1288	TCGA-D8-A27K	BRCA	47	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17426	Alive	TUMOR FREE	1461	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1461	0	1461	0	1461	0	1461	
50	TCGA-D8-A27L	0	3	1	0	0	2	1	0	1	31	4	0	0	14	1	0	TCGA-D8-A27L-01	41	0.1112774270549909	9	TCGA-D8-A27L-01	7	6	6	0.06143942937870785	TCGA-D8-A27L-01	4	2	3	9	PASS	1289	TCGA-D8-A27L	BRCA	49	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18025	Alive	TUMOR FREE	499	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	499	0	499	0	499	0	499	
60	TCGA-D8-A27M	1	4	1	1	1	0	1	0	2	61	6	0	3	18	2	0	TCGA-D8-A27M-01	190	0.5325010096933404	102	TCGA-D8-A27M-01	8	14	45	0.3127217643701332	TCGA-D8-A27M-01	17	16	15	48	PASS	1290	TCGA-D8-A27M	BRCA	59	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21910	Alive	TUMOR FREE	410	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	410	0	410	0	410	0	410	
40	TCGA-D8-A27N	0	4	1	1	2	0	1	0	0	33	2	0	1	17	2	0	TCGA-D8-A27N-01	320	0.2536064646932911	199	TCGA-D8-A27N-01	8	7	45	0.17018354814111214	TCGA-D8-A27N-01	11	5	6	22	PASS	1291	TCGA-D8-A27N	BRCA	36	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13243	Alive	TUMOR FREE	519	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	519	0	519	0	519	0	519	
60	TCGA-D8-A27P	0	0	0	1	0	0	0	0	2	17	3	0	0	10	1	0	TCGA-D8-A27P-01	41	0.04851712341245841	5	TCGA-D8-A27P-01	2	2	19	0.015637434369449858	TCGA-D8-A27P-01	2	1	1	4	PASS	1292	TCGA-D8-A27P	BRCA	64	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23576	Alive	TUMOR FREE	49	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	49	0	49	0	49	0	49	
40	TCGA-D8-A27R	0	2	0	1	1	0	0	0	0	29	2	0	1	6	2	0	TCGA-D8-A27R-01	223	0.6688076026734574	138	TCGA-D8-A27R-01	21	27	37	0.22306797014954885	TCGA-D8-A27R-01	15	9	13	37	PASS	1293	TCGA-D8-A27R	BRCA	41	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-15122	Alive	TUMOR FREE	307	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	307	0	307	0	307	0	307	
50	TCGA-D8-A27T	0	2	0	0	0	0	1	0	3	18	0	0	0	9	1	0	TCGA-D8-A27T-01	87	0.7532080363319641	38	TCGA-D8-A27T-01	29	12	16	0.16526139854868307	TCGA-D8-A27T-01	5	2	3	10	PASS	1294	TCGA-D8-A27T	BRCA	53	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19591	Alive	TUMOR FREE	398	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	398	0	398	0	398	0	398	
60	TCGA-D8-A27V	6	63	7	48	2875	0	1	0	61	140	16	0	18	52	45	1	TCGA-D8-A27V-01	180	0.4129773703471191	117	TCGA-D8-A27V-01	13	12	41	0.08784828064747255	TCGA-D8-A27V-01	7	6	5	18	hypermutated sample	1295	TCGA-D8-A27V	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22958	Alive	TUMOR FREE	381	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	381	0	381	0	381	0	381	
60	TCGA-D8-A27W	0	2	0	2	0	1	0	0	3	38	3	0	0	10	1	0	TCGA-D8-A27W-01	139	0.6616403537637635	78	TCGA-D8-A27W-01	34	52	28	0.1457478153988274	TCGA-D8-A27W-01	10	5	6	21	PASS	1296	TCGA-D8-A27W	BRCA	55	FEMALE	WHITE	Stage IIIB	NA	Mucinous Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20173	Alive	TUMOR FREE	373	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	373	0	373	0	373	0	373	
50	TCGA-D8-A3Z5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-D8-A3Z5-01	47	0.1264680047599606	11	TCGA-D8-A3Z5-01	6	5	12	0.028751904948519105	TCGA-D8-A3Z5-01	3	1	1	5	PASS	1297	TCGA-D8-A3Z5	BRCA	54	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19846	Alive	TUMOR FREE	1015	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1015	0	1015	0	1015	0	1015	
60	TCGA-D8-A3Z6	1	5	0	5	3	0	1	0	1	21	0	0	2	5	0	0	TCGA-D8-A3Z6-01	113	0.3379662626513664	58	TCGA-D8-A3Z6-01	10	8	39	0.04141478833173643	TCGA-D8-A3Z6-01	5	3	3	11	PASS	1298	TCGA-D8-A3Z6	BRCA	56	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20629	Alive	TUMOR FREE	563	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	563	0	563	0	563	0	563	
70	TCGA-D8-A4Z1	0	2	1	0	0	0	0	0	2	26	3	0	0	13	0	0	TCGA-D8-A4Z1-01	55	0.02606568559514514	19	TCGA-D8-A4Z1-01	1	3	12	0.033500950851644964	TCGA-D8-A4Z1-01	2	3	1	6	PASS	1299	TCGA-D8-A4Z1	BRCA	68	FEMALE	WHITE	Stage IA	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25097	Alive	TUMOR FREE	659	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	659	0	659	0	659	0	659	
90	TCGA-D8-A73U	1	32	1	6	2	1	0	0	5	103	11	0	6	44	4	0	TCGA-D8-A73U-01	53	0.2299475517162635	12	TCGA-D8-A73U-01	12	12	65	0.34927379538778713	TCGA-D8-A73U-01	4	4	5	13	PASS	1300	TCGA-D8-A73U	BRCA	88	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32208	Alive	WITH TUMOR	492	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	492	0	492	0	492	0	492	
80	TCGA-D8-A73W	0	7	0	3	2	0	0	0	1	30	5	0	1	9	0	0	TCGA-D8-A73W-01	63	0.12761094575744664	25	TCGA-D8-A73W-01	5	5	37	0.09950199217681437	TCGA-D8-A73W-01	6	4	5	15	PASS	1301	TCGA-D8-A73W	BRCA	79	FEMALE	WHITE	Stage IIIA	NA	Mucinous Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29125	Dead	WITH TUMOR	NA	385	NA	Distant Metastasis	Lung	NA	21	NA	Negative	NA	1	385	1	385	1	21	1	21	
50	TCGA-D8-A73X	1	5	0	4	1	0	1	0	3	25	2	0	2	14	0	0	TCGA-D8-A73X-01	57	0.2515388198987581	16	TCGA-D8-A73X-01	5	5	25	0.059026803443849876	TCGA-D8-A73X-01	3	0	1	4	PASS	1302	TCGA-D8-A73X	BRCA	53	FEMALE	WHITE	Stage IIA	NA	"Other, specify"	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19607	Alive	TUMOR FREE	767	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	767	0	767	0	767	0	767	
80	TCGA-E2-A105	0	3	0	0	2	2	1	0	6	44	2	0	1	14	1	0	TCGA-E2-A105-01	240	0.13697508851957846	151	TCGA-E2-A105-01	6	15	44	0.08808589578979821	TCGA-E2-A105-01	8	5	5	18	PASS	1303	TCGA-E2-A105	BRCA	79	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28855	Alive	TUMOR FREE	1308	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1308	0	1308	0	1308	0	1308	
30	TCGA-E2-A106	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-E2-A106	0	0	0	TCGA-E2-A106	0	0	0	0	TCGA-E2-A106	0	0	0	0	PASS	1304	TCGA-E2-A106	BRCA	34	FEMALE	ASIAN	Stage IB	NA	Infiltrating Ductal Carcinoma	NA	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12528	Alive	TUMOR FREE	2541	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2541	0	2541	0	2541	0	2541	
50	TCGA-E2-A107	0	1	0	0	2	2	0	0	4	21	0	0	0	14	0	0	TCGA-E2-A107-01	96	0.5567346382516457	45	TCGA-E2-A107-01	22	55	14	0.0699973678494623	TCGA-E2-A107-01	6	3	3	12	PASS	1305	TCGA-E2-A107	BRCA	54	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20065	Alive	TUMOR FREE	1047	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1047	0	1047	0	1047	0	1047	
60	TCGA-E2-A108	1	13	0	4	0	2	1	0	3	115	15	0	3	36	2	0	TCGA-E2-A108-01	76	0.05036711970684233	34	TCGA-E2-A108-01	9	8	9	0.2605415369582321	TCGA-E2-A108-01	6	4	4	14	PASS	1306	TCGA-E2-A108	BRCA	64	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23530	Alive	WITH TUMOR	837	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	837	0	837	0	837	0	837	
60	TCGA-E2-A109	0	3	3	3	3	1	1	0	2	55	1	0	0	22	0	0	TCGA-E2-A109-01	424	0.6471887339004799	280	TCGA-E2-A109-01	16	25	64	0.17785600652234335	TCGA-E2-A109-01	15	10	7	32	PASS	1307	TCGA-E2-A109	BRCA	64	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23521	Alive	TUMOR FREE	1417	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1417	0	1417	0	1417	0	1417	
40	TCGA-E2-A10A	0	4	1	1	2	2	1	0	0	15	1	0	0	8	1	0	TCGA-E2-A10A-01	276	0.21265105211899266	188	TCGA-E2-A10A-01	6	6	47	0.1175576387089998	TCGA-E2-A10A-01	8	4	6	18	PASS	1308	TCGA-E2-A10A	BRCA	41	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15085	Alive	WITH TUMOR	1229	NA	NA	Distant Metastasis	Bone	NA	75	NA	Negative	NA	0	1229	0	1229	1	75	1	75	
70	TCGA-E2-A10B	0	3	0	4	1	0	0	0	2	40	4	0	1	19	1	0	TCGA-E2-A10B-01	99	0.8234276154348491	40	TCGA-E2-A10B-01	35	28	22	0.6365424106172253	TCGA-E2-A10B-01	3	1	4	8	PASS	1309	TCGA-E2-A10B	BRCA	67	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24577	Alive	TUMOR FREE	1141	NA	NA	New Primary Tumor	Lung	NA	195	NA	Close	NA	0	1141	0	1141	NA	NA	1	195	
50	TCGA-E2-A10C	4	27	3	19	2	0	0	0	20	285	30	2	6	116	8	1	TCGA-E2-A10C-01	109	0.5853028528767309	56	TCGA-E2-A10C-01	21	31	11	0.20561043911765006	TCGA-E2-A10C-01	9	9	4	22	PASS	1310	TCGA-E2-A10C	BRCA	54	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19849	Alive	TUMOR FREE	1220	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1220	0	1220	0	1220	0	1220	
60	TCGA-E2-A10E	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-E2-A10E-01	104	0.17536833807729446	52	TCGA-E2-A10E-01	5	4	15	0.10589148546104704	TCGA-E2-A10E-01	3	0	4	7	PASS	1311	TCGA-E2-A10E	BRCA	64	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23684	Alive	TUMOR FREE	865	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	865	0	865	0	865	0	865	
50	TCGA-E2-A10F	0	4	0	1	0	1	1	0	0	17	2	0	0	6	0	0	TCGA-E2-A10F-01	54	0.1319365673102936	13	TCGA-E2-A10F-01	6	6	9	0.09074396503087236	TCGA-E2-A10F-01	4	4	4	12	PASS	1312	TCGA-E2-A10F	BRCA	47	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17257	Alive	TUMOR FREE	878	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	878	0	878	0	878	0	878	
40	TCGA-E2-A14N	0	7	0	5	1	0	1	0	7	65	5	0	1	19	4	0	TCGA-E2-A14N-01	163	0.4307538137874768	84	TCGA-E2-A14N-01	19	34	57	0.4962150874016173	TCGA-E2-A14N-01	24	26	19	69	PASS	1313	TCGA-E2-A14N	BRCA	37	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13743	Alive	TUMOR FREE	1434	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1434	0	1434	0	1434	0	1434	
80	TCGA-E2-A14O	0	2	0	1	1	0	1	0	1	27	2	0	0	5	0	0	TCGA-E2-A14O-01	85	0.8024563944741495	38	TCGA-E2-A14O-01	32	21	17	0.4691040232034345	TCGA-E2-A14O-01	6	0	4	10	PASS	1314	TCGA-E2-A14O	BRCA	76	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27837	Alive	TUMOR FREE	1359	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1359	0	1359	0	1359	0	1359	
80	TCGA-E2-A14P	0	9	0	4	2	1	1	0	7	55	3	0	4	31	1	0	TCGA-E2-A14P-01	788	0.9684596159794456	536	TCGA-E2-A14P-01	14	38	256	0.4951331945296605	TCGA-E2-A14P-01	29	15	21	65	PASS	1315	TCGA-E2-A14P	BRCA	79	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28923	Alive	TUMOR FREE	1246	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1246	0	1246	0	1246	0	1246	
50	TCGA-E2-A14Q	1	5	2	0	2	0	1	0	2	22	0	0	1	7	0	1	TCGA-E2-A14Q-01	117	0.1835377109142923	59	TCGA-E2-A14Q-01	8	7	17	0.13189302939798084	TCGA-E2-A14Q-01	8	4	6	18	PASS	1316	TCGA-E2-A14Q	BRCA	50	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18507	Alive	TUMOR FREE	1163	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1163	0	1163	0	1163	0	1163	
60	TCGA-E2-A14R	0	10	2	3	4	1	2	0	6	93	6	0	3	18	5	0	TCGA-E2-A14R-01	581	0.7243001619228301	367	TCGA-E2-A14R-01	11	40	130	0.39359341623556493	TCGA-E2-A14R-01	34	33	18	85	PASS	1317	TCGA-E2-A14R	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22686	Alive	TUMOR FREE	1174	NA	NA	New Primary Tumor	"Other, specify"	Endometrial	971	NA	Negative	NA	0	1174	0	1174	0	1174	1	971	
70	TCGA-E2-A14S	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-E2-A14S-01	207	0.25192963660332784	132	TCGA-E2-A14S-01	8	10	27	0.07132279997197234	TCGA-E2-A14S-01	5	4	5	14	PASS	1318	TCGA-E2-A14S	BRCA	65	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23878	Alive	TUMOR FREE	1009	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1009	0	1009	0	1009	0	1009	
50	TCGA-E2-A14T	0	5	0	1	2	1	1	0	2	29	1	0	0	7	1	0	TCGA-E2-A14T-01	327	0.5962682120749617	211	TCGA-E2-A14T-01	16	29	78	0.11678878973120302	TCGA-E2-A14T-01	12	11	7	30	PASS	1319	TCGA-E2-A14T	BRCA	52	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19237	Alive	TUMOR FREE	2311	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2311	0	2311	0	2311	0	2311	
70	TCGA-E2-A14U	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-E2-A14U-01	43	0.08038374054180203	11	TCGA-E2-A14U-01	3	2	19	0.013471994545513434	TCGA-E2-A14U-01	2	0	1	3	PASS	1320	TCGA-E2-A14U	BRCA	74	FEMALE	WHITE	Stage I	NA	Infiltrating Lobular Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27389	Alive	TUMOR FREE	1318	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1318	0	1318	0	1318	0	1318	
50	TCGA-E2-A14V	0	6	1	3	1	2	1	0	3	99	3	0	0	29	4	0	TCGA-E2-A14V-01	337	0.484260626620109	214	TCGA-E2-A14V-01	17	28	48	0.18084837845689847	TCGA-E2-A14V-01	10	6	8	24	PASS	1321	TCGA-E2-A14V	BRCA	53	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19643	Alive	TUMOR FREE	1042	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1042	0	1042	0	1042	0	1042	
80	TCGA-E2-A14W	2	3	0	1	13	0	7	0	5	69	2	0	3	19	4	0	TCGA-E2-A14W-01	231	0.3403304544677549	147	TCGA-E2-A14W-01	5	8	45	0.25340989197207603	TCGA-E2-A14W-01	17	29	15	61	PASS	1322	TCGA-E2-A14W	BRCA	78	MALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	NA	-28664	Alive	TUMOR FREE	974	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	974	0	974	0	974	0	974	
60	TCGA-E2-A14X	0	1	0	0	1	1	0	0	2	21	2	0	1	15	0	0	TCGA-E2-A14X-01	157	0.7567108979460847	84	TCGA-E2-A14X-01	27	28	14	0.10848431040357462	TCGA-E2-A14X-01	5	4	3	12	PASS	1323	TCGA-E2-A14X	BRCA	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20105	Alive	TUMOR FREE	972	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	972	0	972	0	972	0	972	
40	TCGA-E2-A14Y	0	6	0	2	3	2	0	0	2	65	4	0	0	28	2	0	TCGA-E2-A14Y-01	185	0.3279964002985146	89	TCGA-E2-A14Y-01	6	8	19	0.06425620535062268	TCGA-E2-A14Y-01	8	7	4	19	PASS	1324	TCGA-E2-A14Y	BRCA	35	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13004	Alive	TUMOR FREE	2109	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2109	0	2109	0	2109	0	2109	
60	TCGA-E2-A14Z	0	10	0	4	3	1	0	0	6	50	4	0	1	22	1	0	TCGA-E2-A14Z-01	292	0.6717114666871881	203	TCGA-E2-A14Z-01	22	28	93	0.3992069527807273	TCGA-E2-A14Z-01	20	12	12	44	PASS	1325	TCGA-E2-A14Z	BRCA	64	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23682	Dead	WITH TUMOR	NA	563	NA	Distant Metastasis	Bone	NA	188	NA	Negative	NA	1	563	1	563	1	188	1	188	
50	TCGA-E2-A150	0	4	0	2	2	0	0	0	1	61	5	0	2	18	1	0	TCGA-E2-A150-01	336	0.7149485258155476	208	TCGA-E2-A150-01	16	29	66	0.3777832051834047	TCGA-E2-A150-01	20	17	12	49	PASS	1326	TCGA-E2-A150	BRCA	48	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17580	Alive	TUMOR FREE	1935	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1935	0	1935	0	1935	0	1935	
60	TCGA-E2-A152	1	5	0	5	0	0	1	0	10	101	16	0	1	33	2	0	TCGA-E2-A152-01	140	0.6949158194450471	74	TCGA-E2-A152-01	25	19	22	0.20184015744321127	TCGA-E2-A152-01	8	4	6	18	PASS	1327	TCGA-E2-A152	BRCA	56	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20705	Alive	TUMOR FREE	2128	NA	NA	Distant Metastasis	Liver	NA	54	NA	Negative	NA	0	2128	0	2128	1	54	1	54	
50	TCGA-E2-A153	0	5	0	0	6	0	0	0	0	36	2	0	0	12	0	0	TCGA-E2-A153-01	49	0.21373478655489456	13	TCGA-E2-A153-01	28	53	5	0.03906984710774957	TCGA-E2-A153-01	6	0	2	8	PASS	1328	TCGA-E2-A153	BRCA	51	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18875	Alive	TUMOR FREE	707	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	707	0	707	0	707	0	707	
70	TCGA-E2-A154	0	2	0	1	2	0	1	0	3	37	2	0	3	10	0	0	TCGA-E2-A154-01	67	0.454300070325567	27	TCGA-E2-A154-01	29	53	3	0.015875096933819062	TCGA-E2-A154-01	6	1	1	8	PASS	1329	TCGA-E2-A154	BRCA	68	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24999	Alive	TUMOR FREE	591	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	591	0	591	0	591	0	591	
60	TCGA-E2-A155	0	4	0	0	3	1	0	0	3	46	7	0	3	18	1	0	TCGA-E2-A155-01	231	0.5451197009001235	143	TCGA-E2-A155-01	8	10	48	0.2147777272278447	TCGA-E2-A155-01	11	3	12	26	PASS	1330	TCGA-E2-A155	BRCA	58	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21348	Alive	TUMOR FREE	640	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	640	0	640	0	640	0	640	
60	TCGA-E2-A156	0	1	0	0	2	1	0	0	1	18	3	0	0	4	2	0	TCGA-E2-A156-01	78	0.048220563287180884	30	TCGA-E2-A156-01	2	2	14	0.036758176493848035	TCGA-E2-A156-01	3	1	2	6	PASS	1331	TCGA-E2-A156	BRCA	61	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22422	Alive	TUMOR FREE	726	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	726	0	726	0	726	0	726	
40	TCGA-E2-A158	0	6	0	9	3	0	4	0	3	80	2	0	1	20	5	0	TCGA-E2-A158-01	409	0.9978904894159852	242	TCGA-E2-A158-01	7	15	104	0.36281144693403694	TCGA-E2-A158-01	27	34	15	76	PASS	1332	TCGA-E2-A158	BRCA	43	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15903	Alive	TUMOR FREE	450	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	450	0	450	0	450	0	450	
50	TCGA-E2-A159	1	10	1	7	1	0	0	0	16	111	9	0	1	42	4	0	TCGA-E2-A159-01	155	0.9109145035370464	95	TCGA-E2-A159-01	18	15	47	0.4991152422451127	TCGA-E2-A159-01	9	8	9	26	PASS	1333	TCGA-E2-A159	BRCA	50	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18621	Alive	TUMOR FREE	762	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	762	0	762	0	762	0	762	
50	TCGA-E2-A15A	0	1	1	0	2	2	2	0	2	78	6	0	2	9	4	0	TCGA-E2-A15A-01	388	0.6722473887262981	246	TCGA-E2-A15A-06	17	28	87	0.4278044678049085	TCGA-E2-A15A-06	17	11	17	45	mutation call filter	1334	TCGA-E2-A15A	BRCA	45	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16750	Alive	TUMOR FREE	710	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	710	0	710	0	710	0	710	
60	TCGA-E2-A15C	1	4	1	0	1	2	0	0	2	31	0	0	0	11	1	0	TCGA-E2-A15C-01	53	0.13470704799447106	15	TCGA-E2-A15C-01	9	7	3	0.04004004330475178	TCGA-E2-A15C-01	3	0	2	5	PASS	1335	TCGA-E2-A15C	BRCA	61	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22583	Alive	TUMOR FREE	694	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	694	0	694	0	694	0	694	
50	TCGA-E2-A15D	0	2	0	0	2	1	0	0	0	27	2	0	0	5	1	0	TCGA-E2-A15D-01	62	0.2738846713469521	20	TCGA-E2-A15D-01	10	9	15	0.017534656611158668	TCGA-E2-A15D-01	3	1	2	6	PASS	1336	TCGA-E2-A15D	BRCA	47	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17224	Alive	TUMOR FREE	526	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	526	0	526	0	526	0	526	
40	TCGA-E2-A15E	0	1	0	1	2	0	0	0	2	62	0	0	0	14	2	0	TCGA-E2-A15E-01	333	0.4342037833572286	204	TCGA-E2-A15E-06	18	19	54	0.2283341538154325	TCGA-E2-A15E-06	16	7	7	30	mutation call filter	1337	TCGA-E2-A15E	BRCA	40	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14894	Alive	TUMOR FREE	630	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	630	0	630	0	630	0	630	
60	TCGA-E2-A15F	0	1	0	0	1	2	0	0	0	20	0	0	0	7	0	0	TCGA-E2-A15F-01	179	0.414906375684054	97	TCGA-E2-A15F-01	9	8	70	0.20047290177688987	TCGA-E2-A15F-01	7	3	6	16	PASS	1338	TCGA-E2-A15F	BRCA	64	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23660	Alive	TUMOR FREE	658	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	658	0	658	0	658	0	658	
80	TCGA-E2-A15G	0	2	0	0	2	2	0	0	2	39	5	0	0	23	3	0	TCGA-E2-A15G-01	80	0.7076298929803126	29	TCGA-E2-A15G-01	16	15	5	0.061780213089058136	TCGA-E2-A15G-01	2	2	1	5	PASS	1339	TCGA-E2-A15G	BRCA	76	FEMALE	WHITE	Stage IIA	NA	Mixed Histology (please specify)	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28013	Alive	TUMOR FREE	554	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	554	0	554	0	554	0	554	
40	TCGA-E2-A15H	0	0	0	0	2	2	0	0	1	23	1	0	1	8	0	0	TCGA-E2-A15H-01	342	0.7682363869024845	225	TCGA-E2-A15H-01	17	13	41	0.1355254921294195	TCGA-E2-A15H-01	6	4	5	15	PASS	1340	TCGA-E2-A15H	BRCA	38	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13985	Alive	TUMOR FREE	393	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	393	0	393	0	393	0	393	
40	TCGA-E2-A15I	0	4	0	2	4	0	0	0	6	45	6	0	2	24	2	0	TCGA-E2-A15I-01	81	0.14980843799387125	39	TCGA-E2-A15I-01	7	10	5	0.08524831998491351	TCGA-E2-A15I-01	4	1	2	7	PASS	1341	TCGA-E2-A15I	BRCA	44	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16163	Alive	TUMOR FREE	1692	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1692	0	1692	0	1692	0	1692	
50	TCGA-E2-A15J	0	2	0	0	0	0	0	0	0	15	3	0	0	5	2	0	TCGA-E2-A15J-01	64	0.10942294578265672	23	TCGA-E2-A15J-01	5	4	3	0.031548590615814116	TCGA-E2-A15J-01	4	0	2	6	PASS	1342	TCGA-E2-A15J	BRCA	51	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18771	Alive	TUMOR FREE	1640	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1640	0	1640	0	1640	0	1640	
60	TCGA-E2-A15K	1	16	0	8	2	2	4	0	14	127	4	0	0	36	0	0	TCGA-E2-A15K-01	147	0.2161071839421292	88	TCGA-E2-A15K-06	5	5	14	0.05565036226750632	TCGA-E2-A15K-06	5	1	2	8	mutation call filter	1343	TCGA-E2-A15K	BRCA	58	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21514	Alive	TUMOR FREE	275	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	275	0	275	0	275	0	275	
70	TCGA-E2-A15L	0	1	1	5	2	1	0	0	1	32	2	0	1	4	0	0	TCGA-E2-A15L-01	61	0.11446151512820014	19	TCGA-E2-A15L-01	3	4	2	0.016971924807138668	TCGA-E2-A15L-01	4	4	1	9	PASS	1344	TCGA-E2-A15L	BRCA	65	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23845	Alive	TUMOR FREE	626	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	626	0	626	0	626	0	626	
70	TCGA-E2-A15M	0	4	2	12	4	0	1	0	4	133	2	0	2	55	7	0	TCGA-E2-A15M-01	223	0.5584553144094663	130	TCGA-E2-A15M-01	16	30	47	0.34246307916917845	TCGA-E2-A15M-01	15	13	11	39	PASS	1345	TCGA-E2-A15M	BRCA	66	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24266	Dead	TUMOR FREE	NA	336	NA	NA	NA	NA	NA	NA	Negative	NA	1	336	0	336	0	336	0	336	
90	TCGA-E2-A15O	0	2	0	2	3	0	0	0	0	22	0	0	0	7	2	0	TCGA-E2-A15O-01	118	0.29352685003592577	60	TCGA-E2-A15O-01	11	14	18	0.13114469516541274	TCGA-E2-A15O-01	7	7	7	21	PASS	1346	TCGA-E2-A15O	BRCA	89	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32583	Alive	TUMOR FREE	1545	NA	NA	Locoregional Recurrence	NA	NA	1210	NA	Negative	NA	0	1545	0	1545	1	1210	1	1210	
60	TCGA-E2-A15P	0	3	0	1	9	0	14	0	1	18	0	0	1	7	0	0	TCGA-E2-A15P-01	173	0.9291806614369604	105	TCGA-E2-A15P-01	6	8	48	0.20193752717979446	TCGA-E2-A15P-01	6	5	6	17	PASS	1347	TCGA-E2-A15P	BRCA	61	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22524	Alive	TUMOR FREE	595	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	595	0	595	0	595	0	595	
60	TCGA-E2-A15R	1	2	1	0	1	1	0	0	0	30	2	0	1	12	0	0	TCGA-E2-A15R-01	129	0.3571373151178883	54	TCGA-E2-A15R-01	9	13	15	0.18334078937652792	TCGA-E2-A15R-01	14	5	8	27	PASS	1348	TCGA-E2-A15R	BRCA	64	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23570	Alive	TUMOR FREE	1732	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1732	0	1732	0	1732	0	1732	
30	TCGA-E2-A15S	1	4	0	0	4	0	0	1	2	44	4	0	0	15	0	0	TCGA-E2-A15S-01	149	0.5872058891220424	70	TCGA-E2-A15S-01	10	22	51	0.16684750044952135	TCGA-E2-A15S-01	27	21	14	62	PASS	1349	TCGA-E2-A15S	BRCA	34	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-12671	Alive	TUMOR FREE	428	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	428	0	428	0	428	0	428	
70	TCGA-E2-A15T	0	0	0	3	1	0	0	0	1	20	2	0	0	14	1	0	TCGA-E2-A15T-01	158	0.16395930880321954	84	TCGA-E2-A15T-01	5	6	50	0.08905701526628021	TCGA-E2-A15T-01	7	6	6	19	PASS	1350	TCGA-E2-A15T	BRCA	65	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24054	Alive	TUMOR FREE	1563	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1563	0	1563	0	1563	0	1563	
60	TCGA-E2-A1AZ	0	6	1	2	2	0	1	0	3	42	3	1	2	21	0	0	TCGA-E2-A1AZ-01	389	0.8827559152617772	254	TCGA-E2-A1AZ-01	22	34	86	0.3897975325547751	TCGA-E2-A1AZ-01	15	15	12	42	PASS	1351	TCGA-E2-A1AZ	BRCA	63	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23230	Alive	TUMOR FREE	2329	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2329	0	2329	0	2329	0	2329	
50	TCGA-E2-A1B0	0	3	0	0	0	1	0	0	3	37	2	0	0	16	1	0	TCGA-E2-A1B0-01	340	0.6263079875771863	215	TCGA-E2-A1B0-01	27	34	46	0.3083625313457235	TCGA-E2-A1B0-01	17	6	12	35	PASS	1352	TCGA-E2-A1B0	BRCA	50	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18346	Alive	TUMOR FREE	1631	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1631	0	1631	0	1631	0	1631	
50	TCGA-E2-A1B1	1	3	0	0	0	0	1	0	1	47	4	0	0	14	1	0	TCGA-E2-A1B1-01	78	0.044028688934249466	32	TCGA-E2-A1B1-01	2	3	9	0.03198325225672677	TCGA-E2-A1B1-01	1	1	1	3	PASS	1353	TCGA-E2-A1B1	BRCA	45	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16603	Alive	TUMOR FREE	2653	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2653	0	2653	0	2653	0	2653	
70	TCGA-E2-A1B4	0	3	0	0	0	1	0	0	5	26	4	0	1	4	0	0	TCGA-E2-A1B4-01	63	0.03020071010639638	23	TCGA-E2-A1B4-01	2	2	19	0.015656549126333286	TCGA-E2-A1B4-01	2	0	1	3	PASS	1354	TCGA-E2-A1B4	BRCA	74	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27241	Dead	TUMOR FREE	NA	1004	NA	NA	NA	NA	NA	NA	Negative	NA	1	1004	0	1004	0	1004	0	1004	
50	TCGA-E2-A1B5	0	5	0	2	0	2	2	0	4	56	2	0	0	28	0	0	TCGA-E2-A1B5-01	95	0.19835023153110426	40	TCGA-E2-A1B5-01	5	6	11	0.07231174625754977	TCGA-E2-A1B5-01	7	6	5	18	PASS	1355	TCGA-E2-A1B5	BRCA	46	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17039	Alive	TUMOR FREE	984	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	984	0	984	0	984	0	984	
40	TCGA-E2-A1B6	0	5	0	4	2	0	0	0	3	38	2	0	0	8	1	0	TCGA-E2-A1B6-01	61	0.05001094339599881	18	TCGA-E2-A1B6	0	0	0	0	TCGA-E2-A1B6	0	0	0	0	PASS	1356	TCGA-E2-A1B6	BRCA	44	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16370	Alive	TUMOR FREE	867	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	867	0	867	0	867	0	867	
60	TCGA-E2-A1BC	0	7	0	0	4	0	0	0	2	48	8	0	4	18	6	0	TCGA-E2-A1BC-01	79	0.13813478381842864	32	TCGA-E2-A1BC-01	7	6	18	0.1107048666660625	TCGA-E2-A1BC-01	6	1	4	11	PASS	1357	TCGA-E2-A1BC	BRCA	63	FEMALE	NA	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23168	Alive	TUMOR FREE	501	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	501	0	501	NA	NA	0	501	
50	TCGA-E2-A1BD	0	3	0	0	2	1	0	0	2	31	3	0	0	6	0	0	TCGA-E2-A1BD-01	79	0.6626028437662106	36	TCGA-E2-A1BD-01	20	59	8	0.029979287120361464	TCGA-E2-A1BD-01	4	2	1	7	PASS	1358	TCGA-E2-A1BD	BRCA	53	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19627	Alive	TUMOR FREE	1133	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1133	0	1133	0	1133	0	1133	
60	TCGA-E2-A1IE	1	3	0	1	0	0	0	0	1	18	0	0	2	5	0	0	TCGA-E2-A1IE-01	188	0.26913051626354245	100	TCGA-E2-A1IE-01	5	10	41	0.2176867749630122	TCGA-E2-A1IE-01	13	10	9	32	PASS	1359	TCGA-E2-A1IE	BRCA	61	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22510	Alive	WITH TUMOR	2362	NA	NA	Distant Metastasis	Liver	NA	1810	NA	Negative	NA	0	2362	0	2362	1	1810	1	1810	
70	TCGA-E2-A1IF	0	2	0	0	2	0	0	0	1	15	1	0	0	5	0	0	TCGA-E2-A1IF-01	38	0.11803667088675175	5	TCGA-E2-A1IF-01	6	8	4	0.07075544349980273	TCGA-E2-A1IF-01	3	1	2	6	PASS	1360	TCGA-E2-A1IF	BRCA	74	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27341	Alive	TUMOR FREE	1138	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1138	0	1138	0	1138	0	1138	
50	TCGA-E2-A1IG	0	2	0	1	1	2	2	0	4	32	2	0	1	16	2	0	TCGA-E2-A1IG-01	154	0.12636054688598836	86	TCGA-E2-A1IG-01	4	4	22	0.060976625656074375	TCGA-E2-A1IG-01	6	2	4	12	PASS	1361	TCGA-E2-A1IG	BRCA	45	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16757	Alive	TUMOR FREE	2140	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2140	0	2140	0	2140	0	2140	
80	TCGA-E2-A1IH	0	6	0	3	2	1	0	0	2	56	4	0	1	12	2	0	TCGA-E2-A1IH-01	221	0.6148313945024578	148	TCGA-E2-A1IH-01	22	24	41	0.13663687941812014	TCGA-E2-A1IH-01	13	8	7	28	PASS	1362	TCGA-E2-A1IH	BRCA	80	FEMALE	WHITE	Stage I	NA	Infiltrating Lobular Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29444	Alive	TUMOR FREE	1026	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1026	0	1026	0	1026	0	1026	
50	TCGA-E2-A1II	0	1	0	1	3	0	0	0	1	24	0	0	0	7	1	0	TCGA-E2-A1II-01	167	0.8221450901987682	100	TCGA-E2-A1II-01	18	15	48	0.43789458235371503	TCGA-E2-A1II-01	10	9	10	29	PASS	1363	TCGA-E2-A1II	BRCA	51	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18788	Alive	TUMOR FREE	1025	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1025	0	1025	0	1025	0	1025	
60	TCGA-E2-A1IJ	0	0	0	0	2	1	0	0	0	11	1	0	1	7	0	0	TCGA-E2-A1IJ-01	86	0.1355774307620282	37	TCGA-E2-A1IJ-01	6	7	17	0.039712237552477936	TCGA-E2-A1IJ-01	4	1	2	7	PASS	1364	TCGA-E2-A1IJ	BRCA	57	FEMALE	WHITE	Stage I	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20956	Alive	TUMOR FREE	865	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	865	0	865	0	865	0	865	
70	TCGA-E2-A1IK	0	1	0	0	1	1	0	0	1	12	0	0	0	5	1	0	TCGA-E2-A1IK-01	25	4.863649245057735e-07	0	TCGA-E2-A1IK-01	0	0	0	0.0	TCGA-E2-A1IK-01	0	0	0	0	PASS	1365	TCGA-E2-A1IK	BRCA	71	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26052	Alive	TUMOR FREE	1800	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1800	0	1800	0	1800	0	1800	
80	TCGA-E2-A1IL	0	3	0	0	3	0	0	0	2	19	1	0	0	10	0	0	TCGA-E2-A1IL-01	98	0.1685513961390235	44	TCGA-E2-A1IL-01	6	5	14	0.0837380774676211	TCGA-E2-A1IL-01	5	4	4	13	PASS	1366	TCGA-E2-A1IL	BRCA	78	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28495	Alive	TUMOR FREE	118	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	118	0	118	0	118	0	118	
60	TCGA-E2-A1IN	0	15	0	7	2	0	0	0	10	144	11	0	5	58	2	0	TCGA-E2-A1IN-01	142	0.5192755996135259	76	TCGA-E2-A1IN-01	20	24	28	0.09911987940204584	TCGA-E2-A1IN-01	10	3	3	16	PASS	1367	TCGA-E2-A1IN	BRCA	60	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22199	Alive	TUMOR FREE	675	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	675	0	675	0	675	0	675	
40	TCGA-E2-A1IO	0	1	0	1	0	1	0	0	1	11	0	0	0	1	1	0	TCGA-E2-A1IO-01	270	0.5237168148398748	182	TCGA-E2-A1IO-01	10	14	58	0.29748480226660595	TCGA-E2-A1IO-01	13	6	11	30	PASS	1368	TCGA-E2-A1IO	BRCA	37	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13671	Alive	TUMOR FREE	1855	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1855	0	1855	0	1855	0	1855	
60	TCGA-E2-A1IU	1	1	0	1	0	0	0	1	0	17	4	0	0	11	0	0	TCGA-E2-A1IU-01	89	0.15969903496319438	39	TCGA-E2-A1IU-01	3	3	10	0.03874591005916976	TCGA-E2-A1IU-01	3	0	2	5	PASS	1369	TCGA-E2-A1IU	BRCA	60	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22279	Alive	TUMOR FREE	337	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	337	0	337	0	337	0	337	
40	TCGA-E2-A1L6	0	2	0	1	0	0	2	0	0	15	1	0	1	7	2	0	TCGA-E2-A1L6-01	67	0.12877947944836826	24	TCGA-E2-A1L6-01	5	4	6	0.040036122247513316	TCGA-E2-A1L6-01	4	2	3	9	PASS	1370	TCGA-E2-A1L6	BRCA	44	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16403	Alive	TUMOR FREE	1648	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1648	0	1648	0	1648	0	1648	
40	TCGA-E2-A1L7	1	4	0	2	2	0	0	0	1	54	2	0	1	14	2	0	TCGA-E2-A1L7-01	322	0.8018267238138037	204	TCGA-E2-A1L7-01	6	14	81	0.31906797601681897	TCGA-E2-A1L7-01	18	29	15	62	PASS	1371	TCGA-E2-A1L7	BRCA	40	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14854	Alive	TUMOR FREE	1836	NA	NA	New Primary Tumor	"Other, specify"	left breast	1619	NA	Negative	NA	0	1836	0	1836	1	1619	1	1619	
50	TCGA-E2-A1L8	1	4	0	0	1	0	0	0	3	24	0	0	0	8	1	0	TCGA-E2-A1L8-01	110	0.92851425076271	54	TCGA-E2-A1L8-01	20	34	23	0.2274000446897059	TCGA-E2-A1L8-01	6	4	4	14	PASS	1372	TCGA-E2-A1L8	BRCA	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19187	Alive	TUMOR FREE	2240	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2240	0	2240	0	2240	0	2240	
40	TCGA-E2-A1L9	0	1	0	0	2	1	0	0	2	20	1	0	0	6	0	0	TCGA-E2-A1L9-01	55	0.0944445442723546	16	TCGA-E2-A1L9-01	4	8	4	0.03620033729691622	TCGA-E2-A1L9-01	3	1	2	6	PASS	1373	TCGA-E2-A1L9	BRCA	40	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14868	Alive	TUMOR FREE	598	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	598	0	598	0	598	0	598	
60	TCGA-E2-A1LA	1	3	1	2	5	0	0	0	3	67	2	0	2	29	0	0	TCGA-E2-A1LA-01	141	0.4750761614855914	69	TCGA-E2-A1LA-01	3	11	32	0.2448621689448344	TCGA-E2-A1LA-01	17	24	17	58	PASS	1374	TCGA-E2-A1LA	BRCA	59	FEMALE	NA	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21773	Alive	TUMOR FREE	748	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	748	0	748	0	748	0	748	
40	TCGA-E2-A1LB	0	4	0	1	1	0	1	0	1	32	7	0	0	13	1	0	TCGA-E2-A1LB-01	174	0.11095336822772743	94	TCGA-E2-A1LB-01	1	2	26	0.10483910016063136	TCGA-E2-A1LB-01	7	9	6	22	PASS	1375	TCGA-E2-A1LB	BRCA	41	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15283	Alive	TUMOR FREE	2306	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2306	0	2306	0	2306	0	2306	
70	TCGA-E2-A1LE	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-E2-A1LE-01	709	0.43056096585782094	515	TCGA-E2-A1LE-01	13	20	177	0.3325169665223301	TCGA-E2-A1LE-01	15	14	16	45	PASS	1376	TCGA-E2-A1LE	BRCA	71	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26239	Dead	WITH TUMOR	NA	879	NA	Distant Metastasis	Lung	NA	361	NA	Negative	NA	1	879	1	879	1	361	1	361	
50	TCGA-E2-A1LG	1	6	3	8	0	0	2	0	5	126	11	0	3	53	4	0	TCGA-E2-A1LG-01	239	0.5605412281770603	145	TCGA-E2-A1LG-01	19	29	31	0.18141734394979275	TCGA-E2-A1LG-01	10	1	4	15	PASS	1377	TCGA-E2-A1LG	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2010	Peri (6-12 months since last menstrual period)	-18492	Alive	TUMOR FREE	1523	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1523	0	1523	0	1523	0	1523	
60	TCGA-E2-A1LH	0	7	0	6	7	1	3	0	8	153	6	0	1	44	7	0	TCGA-E2-A1LH-01	248	0.6755517965096192	143	TCGA-E2-A1LH-01	18	38	57	0.4361605656297291	TCGA-E2-A1LH-01	28	29	17	74	PASS	1378	TCGA-E2-A1LH	BRCA	59	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21628	Alive	TUMOR FREE	3247	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3247	0	3247	0	3247	0	3247	
60	TCGA-E2-A1LI	0	4	0	2	0	0	0	0	0	25	0	1	1	5	1	0	TCGA-E2-A1LI-01	187	0.5597279088191708	104	TCGA-E2-A1LI-01	26	49	52	0.4856686897872823	TCGA-E2-A1LI-01	23	10	10	43	PASS	1379	TCGA-E2-A1LI	BRCA	57	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21064	Alive	TUMOR FREE	3121	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	3121	0	3121	NA	NA	0	3121	
80	TCGA-E2-A1LK	1	2	1	1	1	2	0	0	6	29	1	0	0	19	1	0	TCGA-E2-A1LK-01	127	0.5745442528310721	69	TCGA-E2-A1LK-01	16	23	28	0.1694989273573533	TCGA-E2-A1LK-01	9	7	8	24	PASS	1380	TCGA-E2-A1LK	BRCA	84	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30757	Dead	WITH TUMOR	NA	266	NA	Locoregional Disease	"Other, specify"	Left axilla	155	NA	Negative	NA	1	266	1	266	1	155	1	155	
70	TCGA-E2-A1LL	0	2	0	2	1	0	0	0	3	36	2	1	2	13	2	0	TCGA-E2-A1LL-01	641	0.6197680308458573	491	TCGA-E2-A1LL-01	13	34	125	0.3329705932933609	TCGA-E2-A1LL-01	16	25	11	52	PASS	1381	TCGA-E2-A1LL	BRCA	73	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27028	Alive	WITH TUMOR	1309	NA	NA	Distant Metastasis	Liver	NA	1303	NA	Negative	NA	0	1309	0	1309	1	1303	1	1303	
50	TCGA-E2-A1LS	2	2	1	3	5	1	0	0	3	55	2	0	1	15	0	0	TCGA-E2-A1LS	0	0	0	TCGA-E2-A1LS	0	0	0	0	TCGA-E2-A1LS	0	0	0	0	mutation call filter	1382	TCGA-E2-A1LS	BRCA	46	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16887	Alive	TUMOR FREE	1604	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1604	0	1604	0	1604	0	1604	
80	TCGA-E2-A2P5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-E2-A2P5-01	184	0.6638193216236983	103	TCGA-E2-A2P5-01	26	23	14	0.12375500026896764	TCGA-E2-A2P5-01	7	6	4	17	PASS	1383	TCGA-E2-A2P5	BRCA	78	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28621	Dead	WITH TUMOR	NA	821	NA	Distant Metastasis	Bone	NA	597	NA	Negative	NA	1	821	1	821	1	597	1	597	
80	TCGA-E2-A2P6	1	26	1	6	1	2	1	0	2	88	10	0	7	50	2	0	TCGA-E2-A2P6-01	147	0.14049595020923106	82	TCGA-E2-A2P6-01	6	6	26	0.0948265856720132	TCGA-E2-A2P6-01	5	4	5	14	PASS	1384	TCGA-E2-A2P6	BRCA	77	FEMALE	NA	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28411	Alive	TUMOR FREE	1051	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1051	0	1051	0	1051	0	1051	
40	TCGA-E2-A3DX	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-E2-A3DX-01	46	0.06562722753110761	11	TCGA-E2-A3DX-01	2	2	19	0.02092809758568857	TCGA-E2-A3DX-01	1	0	1	2	PASS	1385	TCGA-E2-A3DX	BRCA	43	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15969	Alive	TUMOR FREE	1325	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	1325	0	1325	NA	NA	0	1325	
70	TCGA-E2-A56Z	0	7	0	3	2	0	0	0	2	39	2	0	0	9	1	0	TCGA-E2-A56Z-01	192	0.7278768554891611	120	TCGA-E2-A56Z-01	17	25	31	0.09870921295413077	TCGA-E2-A56Z-01	13	13	5	31	PASS	1386	TCGA-E2-A56Z	BRCA	69	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25282	Alive	TUMOR FREE	252	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	252	0	252	0	252	0	252	
50	TCGA-E2-A570	0	7	1	2	1	2	0	0	1	11	4	0	1	8	1	0	TCGA-E2-A570-01	87	0.13707919547851974	41	TCGA-E2-A570-01	7	6	7	0.015996992434383538	TCGA-E2-A570-01	3	0	2	5	PASS	1387	TCGA-E2-A570	BRCA	47	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17456	Alive	TUMOR FREE	931	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	931	0	931	0	931	0	931	
70	TCGA-E2-A572	1	2	0	0	0	0	0	0	0	18	3	0	1	3	1	0	TCGA-E2-A572	0	0	0	TCGA-E2-A572	0	0	0	0	TCGA-E2-A572	0	0	0	0	PASS	1388	TCGA-E2-A572	BRCA	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26399	Alive	TUMOR FREE	1208	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1208	0	1208	0	1208	0	1208	
50	TCGA-E2-A573	1	14	0	4	2	0	2	0	1	38	2	0	3	12	2	0	TCGA-E2-A573-01	115	0.6211207969839735	46	TCGA-E2-A573-01	27	30	114	0.5217554930828391	TCGA-E2-A573-01	17	11	15	43	PASS	1389	TCGA-E2-A573	BRCA	48	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2011	Peri (6-12 months since last menstrual period)	-17689	Alive	TUMOR FREE	1062	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1062	0	1062	0	1062	0	1062	
40	TCGA-E2-A574	3	23	0	6	3	0	0	0	7	80	5	0	2	34	2	0	TCGA-E2-A574-01	294	0.7116508449010387	169	TCGA-E2-A574-01	27	54	128	0.3877106182591796	TCGA-E2-A574-01	18	16	10	44	PASS	1390	TCGA-E2-A574	BRCA	44	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16195	Alive	TUMOR FREE	1179	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1179	0	1179	0	1179	0	1179	
70	TCGA-E2-A576	2	14	1	1	3	1	0	0	1	39	0	0	1	15	1	0	TCGA-E2-A576-01	159	0.7968778410755066	90	TCGA-E2-A576-01	10	10	77	0.2544535679682388	TCGA-E2-A576-01	7	4	12	23	PASS	1391	TCGA-E2-A576	BRCA	69	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25350	Alive	TUMOR FREE	1043	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1043	0	1043	0	1043	0	1043	
90	TCGA-E2-A9RU	0	19	2	3	3	0	0	0	5	57	2	0	2	20	2	0	TCGA-E2-A9RU-01	594	0.6974995985386097	408	TCGA-E2-A9RU-01	27	53	130	0.19007378389866653	TCGA-E2-A9RU-01	21	25	8	54	PASS	1392	TCGA-E2-A9RU	BRCA	90	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32873	Alive	TUMOR FREE	538	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	538	0	538	0	538	0	538	
70	TCGA-E9-A1N3	0	1	0	0	0	1	0	0	2	19	2	0	2	4	0	1	TCGA-E9-A1N3-01	45	0.07788478187753141	8	TCGA-E9-A1N3-01	1	1	4	0.024483918376637884	TCGA-E9-A1N3-01	0	3	1	4	PASS	1393	TCGA-E9-A1N3	BRCA	70	FEMALE	WHITE	Stage IIIA	NA	Mixed Histology (please specify)	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25714	Alive	TUMOR FREE	1059	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1059	0	1059	0	1059	0	1059	
40	TCGA-E9-A1N4	1	2	0	2	0	0	0	0	1	17	3	0	0	9	0	0	TCGA-E9-A1N4-01	147	0.8454495722755957	92	TCGA-E9-A1N4-01	6	5	28	0.1993425222191868	TCGA-E9-A1N4-01	6	2	6	14	PASS	1394	TCGA-E9-A1N4	BRCA	41	FEMALE	WHITE	Stage IIIA	NA	Mixed Histology (please specify)	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15055	Alive	TUMOR FREE	1000	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1000	0	1000	0	1000	0	1000	
50	TCGA-E9-A1N5	0	2	0	0	1	1	1	0	2	24	3	0	0	9	0	0	TCGA-E9-A1N5-01	81	0.18462428341507184	28	TCGA-E9-A1N5-01	7	7	14	0.12355481848435095	TCGA-E9-A1N5-01	7	2	5	14	PASS	1395	TCGA-E9-A1N5	BRCA	45	FEMALE	WHITE	Stage IIB	NA	Mixed Histology (please specify)	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16736	Alive	TUMOR FREE	1120	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1120	0	1120	0	1120	0	1120	
50	TCGA-E9-A1N6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-E9-A1N6-01	243	0.5920646833485134	136	TCGA-E9-A1N6-01	15	17	37	0.11252810732766153	TCGA-E9-A1N6-01	8	7	3	18	PASS	1396	TCGA-E9-A1N6	BRCA	52	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19327	Dead	WITH TUMOR	NA	678	NA	Distant Metastasis	Bone	NA	443	NA	Negative	NA	1	678	1	678	1	443	1	443	
50	TCGA-E9-A1N8	0	2	0	2	2	1	0	0	1	25	1	0	0	7	2	0	TCGA-E9-A1N8-01	225	0.9347729939187092	140	TCGA-E9-A1N8-01	10	21	32	0.3816250229042948	TCGA-E9-A1N8-01	11	11	6	28	PASS	1397	TCGA-E9-A1N8	BRCA	48	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17652	Alive	TUMOR FREE	1039	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1039	0	1039	0	1039	0	1039	
60	TCGA-E9-A1N9	0	1	0	1	0	0	0	0	5	45	1	0	3	17	1	0	TCGA-E9-A1N9-01	386	0.7322242095192464	250	TCGA-E9-A1N9-01	17	73	85	0.20253051385145546	TCGA-E9-A1N9-01	23	18	9	50	PASS	1398	TCGA-E9-A1N9	BRCA	58	FEMALE	WHITE	Stage IIA	NA	Mixed Histology (please specify)	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21228	Alive	TUMOR FREE	1101	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1101	0	1101	0	1101	0	1101	
60	TCGA-E9-A1NA	0	8	0	4	2	3	1	0	2	74	6	0	1	21	2	0	TCGA-E9-A1NA-01	796	0.5773078210017197	595	TCGA-E9-A1NA-01	11	18	154	0.2296726149791249	TCGA-E9-A1NA-01	18	13	11	42	PASS	1399	TCGA-E9-A1NA	BRCA	58	FEMALE	WHITE	Stage IIA	NA	Mixed Histology (please specify)	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21397	Alive	TUMOR FREE	1112	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1112	0	1112	0	1112	0	1112	
60	TCGA-E9-A1NC	0	6	0	6	2	2	1	0	3	55	4	0	0	14	1	0	TCGA-E9-A1NC-01	209	0.4930208937983251	112	TCGA-E9-A1NC-01	5	16	74	0.4725938561447929	TCGA-E9-A1NC-01	25	30	20	75	mutation call filter	1400	TCGA-E9-A1NC	BRCA	61	FEMALE	WHITE	Stage IIB	NA	Mixed Histology (please specify)	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22355	Alive	TUMOR FREE	1203	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1203	0	1203	0	1203	0	1203	Redacted
80	TCGA-E9-A1ND	0	1	0	0	3	2	0	0	5	75	4	0	1	22	0	0	TCGA-E9-A1ND-01	205	0.6536518997225279	120	TCGA-E9-A1ND-01	16	32	78	0.5635794462689929	TCGA-E9-A1ND-01	18	21	3	42	mutation call filter	1401	TCGA-E9-A1ND	BRCA	75	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27400	Alive	TUMOR FREE	1266	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1266	0	1266	0	1266	0	1266	
30	TCGA-E9-A1NE	0	1	0	1	1	0	0	0	1	44	1	0	0	11	3	0	TCGA-E9-A1NE-01	65	0.1335890463942117	25	TCGA-E9-A1NE-01	4	2	19	0.002950312510169889	TCGA-E9-A1NE-01	3	3	0	6	PASS	1402	TCGA-E9-A1NE	BRCA	28	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-10564	Alive	TUMOR FREE	1088	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1088	0	1088	0	1088	0	1088	
60	TCGA-E9-A1NF	0	6	0	2	2	1	0	1	1	42	2	0	1	11	2	0	TCGA-E9-A1NF-01	313	0.7555095942937317	222	TCGA-E9-A1NF-01	21	42	76	0.20384623625243886	TCGA-E9-A1NF-01	22	13	11	46	PASS	1403	TCGA-E9-A1NF	BRCA	60	FEMALE	WHITE	Stage IIA	NA	Mixed Histology (please specify)	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21981	Dead	WITH TUMOR	NA	1072	NA	Distant Metastasis	Lung	NA	90	NA	Negative	NA	1	1072	1	1072	1	90	1	90	
60	TCGA-E9-A1NG	0	1	0	2	0	0	0	0	1	13	3	0	0	4	0	0	TCGA-E9-A1NG-01	103	0.08757463365138303	60	TCGA-E9-A1NG-01	5	4	26	0.06738673719520412	TCGA-E9-A1NG-01	6	5	3	14	PASS	1404	TCGA-E9-A1NG	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22896	Dead	TUMOR FREE	NA	786	NA	NA	NA	NA	NA	NA	Negative	NA	1	786	0	786	0	786	0	786	
70	TCGA-E9-A1NH	2	1	1	1	2	0	1	0	2	17	3	0	0	11	1	0	TCGA-E9-A1NH-01	58	0.45542525768346	15	TCGA-E9-A1NH-01	19	14	2	0.02339743525064705	TCGA-E9-A1NH-01	6	5	2	13	PASS	1405	TCGA-E9-A1NH	BRCA	71	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26221	Alive	TUMOR FREE	576	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	576	0	576	0	576	0	576	
50	TCGA-E9-A1NI	0	0	0	2	0	8	0	0	0	21	3	0	1	8	0	0	TCGA-E9-A1NI-01	131	0.5567933701941203	65	TCGA-E9-A1NI-01	22	19	8	0.1362864640321698	TCGA-E9-A1NI-01	8	10	5	23	mutation call filter	1406	TCGA-E9-A1NI	BRCA	51	FEMALE	WHITE	Stage IIA	NA	Mixed Histology (please specify)	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18985	Alive	TUMOR FREE	300	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	300	0	300	0	300	0	300	
60	TCGA-E9-A1QZ	0	0	0	1	2	0	0	0	0	18	1	0	0	5	0	0	TCGA-E9-A1QZ-01	80	0.27875955920228784	27	TCGA-E9-A1QZ-01	11	7	7	0.10764273947949758	TCGA-E9-A1QZ-01	5	1	3	9	PASS	1407	TCGA-E9-A1QZ	BRCA	61	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22397	Alive	TUMOR FREE	755	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	755	0	755	0	755	0	755	
60	TCGA-E9-A1R0	0	3	0	0	0	0	0	0	1	22	2	0	1	9	0	0	TCGA-E9-A1R0-01	63	0.09703440552504816	28	TCGA-E9-A1R0-01	5	4	11	0.08037002847208773	TCGA-E9-A1R0-01	4	1	2	7	PASS	1408	TCGA-E9-A1R0	BRCA	58	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21394	Alive	TUMOR FREE	860	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	860	0	860	NA	NA	0	860	
50	TCGA-E9-A1R2	0	3	0	2	6	0	1	0	3	40	7	0	0	12	1	0	TCGA-E9-A1R2-01	133	0.3226247435512454	54	TCGA-E9-A1R2-01	7	15	31	0.2613369950850337	TCGA-E9-A1R2-01	19	20	15	54	PASS	1409	TCGA-E9-A1R2	BRCA	51	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18936	Alive	TUMOR FREE	1063	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	1063	0	1063	NA	NA	0	1063	
70	TCGA-E9-A1R3	0	0	0	1	1	1	0	0	1	16	1	0	0	5	2	0	TCGA-E9-A1R3-01	72	0.523908761034658	31	TCGA-E9-A1R3-01	23	21	5	0.06042628116611502	TCGA-E9-A1R3-01	5	1	3	9	PASS	1410	TCGA-E9-A1R3	BRCA	70	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25693	Alive	TUMOR FREE	78	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	78	0	78	0	78	0	78	
70	TCGA-E9-A1R4	0	10	0	5	1	1	0	0	5	93	13	0	1	30	3	0	TCGA-E9-A1R4-01	161	0.6092183491911147	91	TCGA-E9-A1R4-01	17	27	30	0.2261857822059951	TCGA-E9-A1R4-01	15	16	9	40	PASS	1411	TCGA-E9-A1R4	BRCA	66	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24181	Alive	TUMOR FREE	186	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	186	0	186	0	186	0	186	
60	TCGA-E9-A1R5	0	2	0	0	3	1	0	1	1	29	5	0	3	11	2	0	TCGA-E9-A1R5-01	159	0.2876102368027648	96	TCGA-E9-A1R5-01	10	9	33	0.10010250196015502	TCGA-E9-A1R5-01	6	3	4	13	PASS	1412	TCGA-E9-A1R5	BRCA	63	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23116	Alive	TUMOR FREE	92	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	92	0	92	0	92	0	92	
60	TCGA-E9-A1R6	0	1	0	0	1	1	1	0	2	24	1	0	1	7	0	0	TCGA-E9-A1R6-01	174	0.5300552549025779	110	TCGA-E9-A1R6-01	21	29	35	0.2305645714347661	TCGA-E9-A1R6-01	6	5	2	13	PASS	1413	TCGA-E9-A1R6	BRCA	63	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23347	Alive	TUMOR FREE	339	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	339	0	339	0	339	0	339	
60	TCGA-E9-A1R7	0	2	0	1	0	1	0	0	3	39	4	0	0	15	0	0	TCGA-E9-A1R7-01	353	0.4405286322623074	233	TCGA-E9-A1R7-01	13	16	72	0.2954106119038236	TCGA-E9-A1R7-01	15	8	14	37	PASS	1414	TCGA-E9-A1R7	BRCA	64	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23397	Alive	TUMOR FREE	1467	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1467	0	1467	0	1467	0	1467	
50	TCGA-E9-A1RA	0	0	1	0	1	0	0	0	0	13	1	0	1	10	0	0	TCGA-E9-A1RA-01	47	0.5503752958126439	7	TCGA-E9-A1RA-01	25	24	4	0.1647355045877535	TCGA-E9-A1RA-01	2	1	1	4	PASS	1415	TCGA-E9-A1RA	BRCA	48	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17699	Alive	TUMOR FREE	1369	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1369	0	1369	0	1369	0	1369	
40	TCGA-E9-A1RB	0	0	0	3	1	0	1	0	1	23	0	0	2	11	1	0	TCGA-E9-A1RB-01	198	0.7956985785118349	100	TCGA-E9-A1RB-01	27	26	50	0.4120137447436273	TCGA-E9-A1RB-01	14	7	9	30	PASS	1416	TCGA-E9-A1RB	BRCA	40	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14755	Dead	TUMOR FREE	NA	976	NA	NA	NA	NA	NA	NA	Negative	NA	1	976	0	976	0	976	0	976	
60	TCGA-E9-A1RC	0	3	0	2	2	0	0	0	3	31	4	0	1	11	1	1	TCGA-E9-A1RC-01	205	0.911737186127052	126	TCGA-E9-A1RC-01	28	33	42	0.17554029506895213	TCGA-E9-A1RC-01	7	7	2	16	PASS	1417	TCGA-E9-A1RC	BRCA	56	FEMALE	WHITE	Stage IIIC	NA	Mixed Histology (please specify)	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20795	Alive	TUMOR FREE	1224	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1224	0	1224	0	1224	0	1224	
70	TCGA-E9-A1RD	0	0	0	0	0	2	0	0	1	17	1	0	0	5	1	0	TCGA-E9-A1RD-01	53	0.2261603335970377	11	TCGA-E9-A1RD-01	12	22	19	0.015826294749044068	TCGA-E9-A1RD-01	2	0	1	3	PASS	1418	TCGA-E9-A1RD	BRCA	67	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24719	Alive	TUMOR FREE	34	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	34	0	34	0	34	0	34	
70	TCGA-E9-A1RE	0	4	0	4	1	0	0	0	2	41	5	0	0	10	1	0	TCGA-E9-A1RE-01	322	0.5124750547504162	218	TCGA-E9-A1RE-01	18	32	80	0.20716584722039905	TCGA-E9-A1RE-01	16	14	12	42	PASS	1419	TCGA-E9-A1RE	BRCA	74	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27392	Alive	TUMOR FREE	1419	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1419	0	1419	0	1419	0	1419	
70	TCGA-E9-A1RF	2	7	0	4	3	1	0	0	4	118	4	0	1	35	2	0	TCGA-E9-A1RF-01	389	0.6652839001682185	246	TCGA-E9-A1RF-01	16	30	81	0.3013045147713771	TCGA-E9-A1RF-01	18	20	11	49	PASS	1420	TCGA-E9-A1RF	BRCA	68	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25119	Alive	TUMOR FREE	200	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	200	0	200	0	200	0	200	
60	TCGA-E9-A1RG	0	4	0	0	0	2	0	0	0	26	3	0	0	8	2	0	TCGA-E9-A1RG-01	366	0.8984495776252026	232	TCGA-E9-A1RG-01	20	40	85	0.30700345859055644	TCGA-E9-A1RG-01	20	15	12	47	PASS	1421	TCGA-E9-A1RG	BRCA	62	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22788	Alive	TUMOR FREE	647	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	647	0	647	0	647	0	647	
60	TCGA-E9-A1RH	0	3	0	1	4	0	3	0	8	68	7	1	0	25	2	0	TCGA-E9-A1RH-01	267	0.5779510511808844	154	TCGA-E9-A1RH-01	23	35	68	0.2714520937885698	TCGA-E9-A1RH-01	18	11	10	39	PASS	1422	TCGA-E9-A1RH	BRCA	63	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23224	Alive	TUMOR FREE	1417	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1417	0	1417	0	1417	0	1417	
40	TCGA-E9-A1RI	1	2	1	1	0	1	0	0	1	12	0	0	0	12	0	0	TCGA-E9-A1RI-01	79	0.2292888539410449	27	TCGA-E9-A1RI-01	6	5	11	0.07405739982420909	TCGA-E9-A1RI-01	6	3	4	13	PASS	1423	TCGA-E9-A1RI	BRCA	43	FEMALE	WHITE	Stage IIIA	NA	Mixed Histology (please specify)	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15942	Alive	TUMOR FREE	1449	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1449	0	1449	0	1449	0	1449	
50	TCGA-E9-A226	0	5	1	1	4	1	0	0	1	52	2	0	0	18	2	0	TCGA-E9-A226-01	217	0.3974873269189063	122	TCGA-E9-A226-01	7	10	25	0.16823941550254834	TCGA-E9-A226-01	8	6	8	22	PASS	1424	TCGA-E9-A226	BRCA	45	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16511	Dead	WITH TUMOR	NA	1048	NA	Distant Metastasis	Bone	NA	790	NA	Negative	NA	1	1048	1	1048	1	790	1	790	
40	TCGA-E9-A227	0	0	0	1	1	2	0	0	2	11	1	0	2	3	0	0	TCGA-E9-A227-01	67	0.050587394398279854	26	TCGA-E9-A227-01	2	2	3	0.017746045607653006	TCGA-E9-A227-01	2	0	1	3	PASS	1425	TCGA-E9-A227	BRCA	42	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15602	Alive	TUMOR FREE	975	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	975	0	975	0	975	0	975	
60	TCGA-E9-A228	0	1	0	2	0	1	0	0	0	36	2	0	0	14	0	0	TCGA-E9-A228-01	300	0.17061569774676946	171	TCGA-E9-A228-01	3	7	45	0.182152495349732	TCGA-E9-A228-01	8	6	12	26	PASS	1426	TCGA-E9-A228	BRCA	58	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21294	Alive	TUMOR FREE	1285	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1285	0	1285	0	1285	0	1285	
40	TCGA-E9-A229	0	4	0	1	2	0	1	0	0	15	2	0	0	10	0	0	TCGA-E9-A229-01	194	0.20449514917889008	130	TCGA-E9-A229-01	4	8	52	0.14419393131346386	TCGA-E9-A229-01	7	8	8	23	PASS	1427	TCGA-E9-A229	BRCA	37	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13817	Alive	TUMOR FREE	1148	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1148	0	1148	0	1148	0	1148	
70	TCGA-E9-A22A	0	2	0	2	1	0	1	0	1	22	2	0	0	7	1	0	TCGA-E9-A22A-01	207	0.31244223876545923	125	TCGA-E9-A22A-01	9	12	50	0.2157729436655336	TCGA-E9-A22A-01	12	5	9	26	PASS	1428	TCGA-E9-A22A	BRCA	74	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27288	Alive	TUMOR FREE	1189	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1189	0	1189	0	1189	0	1189	
70	TCGA-E9-A22B	0	5	0	2	1	0	0	0	1	49	3	0	1	16	0	0	TCGA-E9-A22B-01	166	0.4527582772786959	97	TCGA-E9-A22B-01	9	12	33	0.1847102311611337	TCGA-E9-A22B-01	7	7	8	22	PASS	1429	TCGA-E9-A22B	BRCA	71	FEMALE	WHITE	Stage IA	NA	Mixed Histology (please specify)	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26278	Alive	TUMOR FREE	1167	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1167	0	1167	0	1167	0	1167	
40	TCGA-E9-A22D	0	1	1	1	1	1	0	0	3	24	0	0	0	10	2	0	TCGA-E9-A22D-01	396	0.4602871973977296	248	TCGA-E9-A22D-01	16	34	41	0.11889270868022515	TCGA-E9-A22D-01	17	13	5	35	PASS	1430	TCGA-E9-A22D	BRCA	38	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14115	Alive	TUMOR FREE	1248	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1248	0	1248	0	1248	0	1248	
60	TCGA-E9-A22E	0	5	0	2	3	0	0	0	4	101	9	0	2	28	4	0	TCGA-E9-A22E-01	215	0.6070723113748785	118	TCGA-E9-A22E-01	16	31	63	0.4027870984080309	TCGA-E9-A22E-01	23	28	16	67	PASS	1431	TCGA-E9-A22E	BRCA	56	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20574	Alive	TUMOR FREE	1269	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1269	0	1269	0	1269	0	1269	
50	TCGA-E9-A22G	1	5	1	1	6	1	0	0	7	64	6	0	0	32	4	0	TCGA-E9-A22G-01	354	0.9327281962698584	213	TCGA-E9-A22G-01	11	19	112	0.5200276471794176	TCGA-E9-A22G-01	26	33	20	79	PASS	1432	TCGA-E9-A22G	BRCA	47	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17300	Alive	TUMOR FREE	1239	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1239	0	1239	0	1239	0	1239	
40	TCGA-E9-A22H	0	0	0	1	1	2	0	0	1	23	0	0	0	2	0	0	TCGA-E9-A22H-01	95	0.10394268547918167	41	TCGA-E9-A22H-01	4	8	9	0.1088652635615952	TCGA-E9-A22H-01	4	2	3	9	PASS	1433	TCGA-E9-A22H	BRCA	42	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15504	Alive	TUMOR FREE	1232	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1232	0	1232	0	1232	0	1232	
50	TCGA-E9-A243	0	2	0	3	2	0	1	0	1	59	5	0	1	21	0	0	TCGA-E9-A243-01	96	0.2701177085820932	33	TCGA-E9-A243-01	21	26	29	0.3849490490472975	TCGA-E9-A243-01	17	13	12	42	PASS	1434	TCGA-E9-A243	BRCA	52	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Peri (6-12 months since last menstrual period)	-19035	Alive	WITH TUMOR	612	NA	NA	Distant Metastasis	Bone	NA	305	NA	Negative	NA	0	612	0	612	1	305	1	305	
50	TCGA-E9-A244	1	10	0	6	2	2	1	0	5	69	4	0	3	29	2	0	TCGA-E9-A244-01	361	0.6248985826672285	223	TCGA-E9-A244-01	13	78	74	0.2337412603629473	TCGA-E9-A244-01	30	33	14	77	PASS	1435	TCGA-E9-A244	BRCA	54	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19778	Alive	TUMOR FREE	21	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	21	0	21	0	21	0	21	
50	TCGA-E9-A245	0	2	0	1	2	0	1	0	1	10	2	0	0	4	3	0	TCGA-E9-A245-01	58	0.034489601116040075	20	TCGA-E9-A245-01	1	2	2	0.0007200122212417048	TCGA-E9-A245-01	1	1	0	2	PASS	1436	TCGA-E9-A245	BRCA	47	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17363	Alive	TUMOR FREE	26	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	26	0	26	0	26	0	26	
60	TCGA-E9-A247	0	3	0	0	1	0	0	0	2	36	2	0	0	9	0	0	TCGA-E9-A247-01	213	0.7005625555964029	134	TCGA-E9-A247-01	22	64	28	0.19987837271321046	TCGA-E9-A247-01	18	15	11	44	PASS	1437	TCGA-E9-A247	BRCA	59	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21562	Alive	TUMOR FREE	1186	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1186	0	1186	0	1186	0	1186	
50	TCGA-E9-A248	0	0	1	0	4	0	1	0	3	21	1	0	0	3	2	0	TCGA-E9-A248-01	310	0.3681518630023286	180	TCGA-E9-A248-01	15	39	46	0.14764748647377068	TCGA-E9-A248-01	9	4	1	14	PASS	1438	TCGA-E9-A248	BRCA	51	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Peri (6-12 months since last menstrual period)	-18684	Alive	TUMOR FREE	59	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	59	0	59	0	59	0	59	
50	TCGA-E9-A249	0	3	0	1	1	0	0	0	0	15	0	0	1	9	2	0	TCGA-E9-A249-01	47	0.6164255088225865	15	TCGA-E9-A249-01	23	19	2	0.02761234943858173	TCGA-E9-A249-01	3	0	1	4	PASS	1439	TCGA-E9-A249	BRCA	45	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16689	Alive	TUMOR FREE	217	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	217	0	217	0	217	0	217	
70	TCGA-E9-A24A	0	0	0	1	1	1	0	0	0	19	1	0	0	2	0	0	TCGA-E9-A24A-01	50	0.12655638294665875	12	TCGA-E9-A24A-01	6	5	3	0.0627875237402461	TCGA-E9-A24A-01	4	0	2	6	PASS	1440	TCGA-E9-A24A	BRCA	69	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25370	Alive	TUMOR FREE	747	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	747	0	747	0	747	0	747	
70	TCGA-E9-A295	0	6	0	2	4	0	0	0	4	72	7	0	0	22	2	0	TCGA-E9-A295-01	98	0.5948893740870207	37	TCGA-E9-A295-01	23	31	18	0.2216048669411481	TCGA-E9-A295-01	9	7	5	21	PASS	1441	TCGA-E9-A295	BRCA	71	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25957	Alive	TUMOR FREE	375	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	375	0	375	0	375	0	375	
70	TCGA-E9-A2JS	1	7	0	3	2	2	1	0	4	46	3	0	1	26	2	0	TCGA-E9-A2JS-01	200	0.6622758852125601	110	TCGA-E9-A2JS-01	15	35	38	0.391224588030909	TCGA-E9-A2JS-01	26	21	14	61	PASS	1442	TCGA-E9-A2JS	BRCA	72	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26407	Dead	WITH TUMOR	NA	904	NA	Distant Metastasis	Bone	Liver	524	NA	Negative	NA	1	904	1	904	1	524	1	524	
60	TCGA-E9-A2JT	0	0	0	1	0	0	0	0	0	16	4	0	0	6	1	0	TCGA-E9-A2JT-01	48	0.0018570685239498329	8	TCGA-E9-A2JT-01	0	0	0	0.0	TCGA-E9-A2JT-01	0	0	0	0	PASS	1443	TCGA-E9-A2JT	BRCA	63	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23318	Alive	TUMOR FREE	288	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	288	0	288	0	288	0	288	
50	TCGA-E9-A3HO	0	12	1	5	6	2	0	0	3	45	0	0	2	9	1	0	TCGA-E9-A3HO-01	194	0.973727331933227	107	TCGA-E9-A3HO-01	11	23	33	0.17335526279699426	TCGA-E9-A3HO-01	15	28	11	54	PASS	1444	TCGA-E9-A3HO	BRCA	49	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18046	Alive	TUMOR FREE	1158	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1158	0	1158	0	1158	0	1158	
80	TCGA-E9-A3Q9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-E9-A3Q9-01	72	0.027465677329096518	27	TCGA-E9-A3Q9-01	0	2	2	6.407980720791227e-05	TCGA-E9-A3Q9-01	1	1	0	2	PASS	1445	TCGA-E9-A3Q9	BRCA	78	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28715	Alive	TUMOR FREE	1001	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1001	0	1001	0	1001	0	1001	
30	TCGA-E9-A3QA	0	6	1	3	0	0	0	0	2	35	2	0	0	15	2	0	TCGA-E9-A3QA-01	153	0.4593236607285383	76	TCGA-E9-A3QA-01	6	16	45	0.41668167747499096	TCGA-E9-A3QA-01	24	20	12	56	PASS	1446	TCGA-E9-A3QA	BRCA	33	FEMALE	WHITE	Stage IIA	NA	Medullary Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12142	Alive	TUMOR FREE	918	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	918	0	918	0	918	0	918	
50	TCGA-E9-A3X8	1	6	0	2	1	1	0	0	1	22	2	0	0	8	0	0	TCGA-E9-A3X8-01	57	0.5597823330536428	15	TCGA-E9-A3X8-01	22	24	28	0.08227352125613951	TCGA-E9-A3X8-01	3	0	2	5	PASS	1447	TCGA-E9-A3X8	BRCA	48	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17588	Alive	TUMOR FREE	926	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	926	0	926	0	926	0	926	
90	TCGA-E9-A54X	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-E9-A54X-01	100	0.2724742797590157	57	TCGA-E9-A54X-01	9	9	42	0.07055294871341625	TCGA-E9-A54X-01	2	2	1	5	PASS	1448	TCGA-E9-A54X	BRCA	85	FEMALE	WHITE	Stage IA	NA	Mucinous Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31173	Alive	TUMOR FREE	727	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	727	0	727	0	727	0	727	
60	TCGA-E9-A54Y	0	13	1	1	2	1	0	0	2	30	3	0	0	13	0	0	TCGA-E9-A54Y-01	140	0.6304663067954158	76	TCGA-E9-A54Y-01	9	19	92	0.2853802101700183	TCGA-E9-A54Y-01	12	13	9	34	PASS	1449	TCGA-E9-A54Y	BRCA	63	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23057	Alive	TUMOR FREE	725	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	725	0	725	0	725	0	725	
60	TCGA-E9-A5FK	0	10	2	0	1	1	1	0	1	17	1	0	2	7	1	0	TCGA-E9-A5FK-01	60	0.21240776263105396	16	TCGA-E9-A5FK	0	0	0	0	TCGA-E9-A5FK	0	0	0	0	PASS	1450	TCGA-E9-A5FK	BRCA	60	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22199	Alive	TUMOR FREE	812	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	812	0	812	0	812	0	812	
70	TCGA-E9-A5FL	0	26	1	8	2	1	0	0	8	66	8	0	2	20	3	0	TCGA-E9-A5FL-01	100	0.5541736547552994	44	TCGA-E9-A5FL-01	20	33	99	0.3857577008449722	TCGA-E9-A5FL-01	21	22	22	65	PASS	1451	TCGA-E9-A5FL	BRCA	65	FEMALE	WHITE	Stage IIB	NA	Metaplastic Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24053	Alive	TUMOR FREE	24	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	24	0	24	0	24	0	24	
40	TCGA-E9-A5UO	1	10	1	1	1	2	1	0	1	17	3	0	1	7	0	0	TCGA-E9-A5UO-01	324	0.8336156370254558	219	TCGA-E9-A5UO-01	9	7	106	0.17133062839893046	TCGA-E9-A5UO-01	7	5	8	20	PASS	1452	TCGA-E9-A5UO	BRCA	41	FEMALE	WHITE	Stage IIA	NA	Mucinous Carcinoma	NA	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15050	Alive	TUMOR FREE	785	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	785	0	785	0	785	0	785	
60	TCGA-E9-A5UP	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-E9-A5UP-01	93	0.9468491769037118	45	TCGA-E9-A5UP-01	23	20	34	0.1222632019439332	TCGA-E9-A5UP-01	7	0	5	12	PASS	1453	TCGA-E9-A5UP	BRCA	63	FEMALE	WHITE	Stage IIA	NA	"Other, specify"	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23371	Alive	TUMOR FREE	803	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	803	0	803	0	803	0	803	
50	TCGA-E9-A6HE	1	1	1	0	2	0	1	0	1	14	1	0	1	4	1	0	TCGA-E9-A6HE-01	95	0.16609074959715914	43	TCGA-E9-A6HE-01	8	8	36	0.09799686835044594	TCGA-E9-A6HE-01	5	2	5	12	PASS	1454	TCGA-E9-A6HE	BRCA	45	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16697	Alive	TUMOR FREE	847	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	847	0	847	0	847	0	847	
80	TCGA-EW-A1IW	1	6	0	3	2	0	0	0	10	62	9	0	1	32	5	0	TCGA-EW-A1IW-01	143	0.17557960514833895	88	TCGA-EW-A1IW-01	6	5	36	0.1459134093525478	TCGA-EW-A1IW-01	4	6	10	20	PASS	1455	TCGA-EW-A1IW	BRCA	80	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29529	Alive	TUMOR FREE	371	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	371	0	371	0	371	0	371	
50	TCGA-EW-A1IX	2	5	1	0	0	0	0	0	1	26	4	0	0	4	1	0	TCGA-EW-A1IX-01	102	0.06757569580095593	48	TCGA-EW-A1IX-01	3	4	14	0.06374566084110188	TCGA-EW-A1IX-01	4	4	6	14	PASS	1456	TCGA-EW-A1IX	BRCA	48	FEMALE	ASIAN	Stage IIA	NA	"Other, specify"	NA	2008	Peri (6-12 months since last menstrual period)	-17597	Alive	TUMOR FREE	1208	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1208	0	1208	0	1208	0	1208	
40	TCGA-EW-A1IY	0	2	0	0	1	1	0	0	2	21	4	0	1	10	0	0	TCGA-EW-A1IY-01	92	0.5777983349834064	45	TCGA-EW-A1IY-01	2	4	6	0.052182885003158735	TCGA-EW-A1IY-01	0	0	1	1	PASS	1457	TCGA-EW-A1IY	BRCA	38	FEMALE	ASIAN	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14122	Alive	TUMOR FREE	258	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	258	0	258	0	258	0	258	
50	TCGA-EW-A1IZ	1	16	0	6	69	11	3	0	15	248	20	0	9	123	13	0	TCGA-EW-A1IZ-01	71	0.07277525139819291	28	TCGA-EW-A1IZ-01	2	3	6	0.06956463561855579	TCGA-EW-A1IZ-01	2	2	2	6	PASS	1458	TCGA-EW-A1IZ	BRCA	53	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19706	Alive	TUMOR FREE	554	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	554	0	554	0	554	0	554	
40	TCGA-EW-A1J1	0	1	0	0	1	1	0	0	0	11	1	0	0	9	1	0	TCGA-EW-A1J1-01	133	0.9473501023389798	71	TCGA-EW-A1J1-01	13	15	27	0.09788013356809942	TCGA-EW-A1J1-01	7	6	6	19	PASS	1459	TCGA-EW-A1J1	BRCA	38	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14122	Alive	TUMOR FREE	575	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	575	0	575	0	575	0	575	
50	TCGA-EW-A1J2	0	1	0	1	0	0	0	0	2	29	3	0	0	7	0	0	TCGA-EW-A1J2-01	85	0.1556932877999068	36	TCGA-EW-A1J2-01	4	7	11	0.09870000516249301	TCGA-EW-A1J2-01	5	4	4	13	mutation call filter	1460	TCGA-EW-A1J2	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	[Discrepancy]	NA	Infiltrating Lobular Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18558	Alive	TUMOR FREE	403	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	403	0	403	0	403	0	403	
60	TCGA-EW-A1J3	0	4	0	0	0	0	0	0	1	19	0	0	0	6	2	0	TCGA-EW-A1J3-01	118	0.18229134364596453	64	TCGA-EW-A1J3-01	9	9	11	0.0627136954450817	TCGA-EW-A1J3-01	6	3	4	13	PASS	1461	TCGA-EW-A1J3	BRCA	61	FEMALE	WHITE	Stage IA	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22332	Alive	TUMOR FREE	504	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	504	0	504	0	504	0	504	
60	TCGA-EW-A1J5	2	20	0	15	1	1	0	0	19	324	27	2	3	126	5	0	TCGA-EW-A1J5-01	107	0.17767939958903334	48	TCGA-EW-A1J5-01	8	10	16	0.18391300533705668	TCGA-EW-A1J5-01	9	1	6	16	PASS	1462	TCGA-EW-A1J5	BRCA	59	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21559	Alive	TUMOR FREE	477	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	477	0	477	0	477	0	477	
70	TCGA-EW-A1J6	0	2	0	1	1	1	1	0	1	24	2	0	1	13	0	0	TCGA-EW-A1J6-01	275	0.9021721656866584	170	TCGA-EW-A1J6-01	16	16	81	0.4648823362961584	TCGA-EW-A1J6-01	16	8	13	37	PASS	1463	TCGA-EW-A1J6	BRCA	70	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25830	Alive	TUMOR FREE	875	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	875	0	875	0	875	0	875	
60	TCGA-EW-A1OV	0	8	0	1	2	0	0	0	4	78	14	0	2	32	3	0	TCGA-EW-A1OV-01	117	0.4032738387982078	57	TCGA-EW-A1OV-01	18	23	24	0.25294736025590603	TCGA-EW-A1OV-01	13	11	12	36	PASS	1464	TCGA-EW-A1OV	BRCA	56	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20764	Alive	TUMOR FREE	789	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	789	0	789	0	789	0	789	
60	TCGA-EW-A1OW	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-EW-A1OW-01	244	0.8042220269588871	152	TCGA-EW-A1OW-01	19	28	34	0.4073384431388116	TCGA-EW-A1OW-01	16	8	10	34	PASS	1465	TCGA-EW-A1OW	BRCA	58	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21465	Alive	TUMOR FREE	694	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	694	0	694	0	694	0	694	
40	TCGA-EW-A1OX	0	0	0	3	0	1	0	0	0	10	1	0	1	8	0	0	TCGA-EW-A1OX-01	184	0.09245245818702784	97	TCGA-EW-A1OX-01	1	3	13	0.044644384331362766	TCGA-EW-A1OX-01	3	3	4	10	PASS	1466	TCGA-EW-A1OX	BRCA	43	FEMALE	WHITE	Stage IIA	NA	Mucinous Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15837	Alive	TUMOR FREE	911	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	911	0	911	0	911	0	911	
60	TCGA-EW-A1OY	0	6	1	2	3	0	0	0	0	47	4	0	0	19	3	0	TCGA-EW-A1OY-01	245	0.6872479288104495	152	TCGA-EW-A1OY-01	18	42	53	0.2986810473632481	TCGA-EW-A1OY-01	17	14	9	40	mutation call filter	1467	TCGA-EW-A1OY	BRCA	63	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23266	Alive	TUMOR FREE	908	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	908	0	908	0	908	0	908	
60	TCGA-EW-A1OZ	0	6	0	0	2	0	0	0	3	48	3	0	2	15	0	0	TCGA-EW-A1OZ-01	532	0.6902181298752564	369	TCGA-EW-A1OZ-01	16	69	109	0.3075266353906536	TCGA-EW-A1OZ-01	19	20	12	51	PASS	1468	TCGA-EW-A1OZ	BRCA	56	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20664	Alive	TUMOR FREE	1229	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1229	0	1229	0	1229	0	1229	
60	TCGA-EW-A1P0	0	1	0	0	1	0	0	0	1	18	0	0	1	7	0	0	TCGA-EW-A1P0-01	158	0.2664775608977244	104	TCGA-EW-A1P0-01	5	11	33	0.1064119631012846	TCGA-EW-A1P0-01	8	8	5	21	PASS	1469	TCGA-EW-A1P0	BRCA	55	FEMALE	WHITE	Stage IIB	NA	"Other, specify"	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20107	Alive	TUMOR FREE	1251	NA	NA	Distant Metastasis	"Other, specify"	mediastinal lymph node	1094	NA	Negative	NA	0	1251	0	1251	1	1094	1	1094	
70	TCGA-EW-A1P1	0	0	0	0	0	0	0	0	0	2	0	0	0	1	0	0	TCGA-EW-A1P1-01	53	0.0008293915423543273	18	TCGA-EW-A1P1-01	0	0	19	1.2800613495454072e-05	TCGA-EW-A1P1-01	0	0	0	0	PASS	1470	TCGA-EW-A1P1	BRCA	68	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24923	Alive	TUMOR FREE	1210	NA	NA	Distant Metastasis	Lung	NA	1014	NA	Negative	NA	0	1210	0	1210	1	1014	1	1014	
50	TCGA-EW-A1P3	0	2	0	0	1	1	0	0	3	16	3	0	0	4	0	0	TCGA-EW-A1P3-01	94	0.2812176802231052	41	TCGA-EW-A1P3-01	11	7	8	0.0928239180777862	TCGA-EW-A1P3-01	4	2	3	9	PASS	1471	TCGA-EW-A1P3	BRCA	48	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17637	Alive	TUMOR FREE	1611	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1611	0	1611	0	1611	0	1611	
40	TCGA-EW-A1P4	0	4	0	3	2	0	1	0	3	48	3	0	0	16	3	0	TCGA-EW-A1P4-01	367	0.6279510302379291	215	TCGA-EW-A1P4-01	17	28	96	0.4164936341100804	TCGA-EW-A1P4-01	23	24	20	67	PASS	1472	TCGA-EW-A1P4	BRCA	43	FEMALE	WHITE	Stage IIA	NA	Medullary Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15989	Alive	TUMOR FREE	907	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	907	0	907	0	907	0	907	
80	TCGA-EW-A1P5	0	1	0	0	0	0	1	0	0	12	3	0	1	6	0	0	TCGA-EW-A1P5-01	93	0.9410647476401932	40	TCGA-EW-A1P5-01	19	16	10	0.09893847105525096	TCGA-EW-A1P5-01	8	5	3	16	PASS	1473	TCGA-EW-A1P5	BRCA	77	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28177	Alive	TUMOR FREE	703	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	703	0	703	0	703	0	703	
60	TCGA-EW-A1P6	0	2	0	2	1	1	0	0	1	18	0	0	0	4	0	0	TCGA-EW-A1P6-01	79	0.1505596921477032	36	TCGA-EW-A1P6-01	5	6	8	0.04141486741528688	TCGA-EW-A1P6-01	2	1	2	5	PASS	1474	TCGA-EW-A1P6	BRCA	64	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23485	Alive	TUMOR FREE	562	NA	NA	NA	NA	NA	NA	NA	Close	NA	0	562	0	562	NA	NA	0	562	
60	TCGA-EW-A1P7	1	2	0	0	3	1	0	0	0	15	1	0	1	5	0	0	TCGA-EW-A1P7-01	72	0.032977212207155084	32	TCGA-EW-A1P7-01	1	3	5	0.09687722983852223	TCGA-EW-A1P7-01	4	5	5	14	PASS	1475	TCGA-EW-A1P7	BRCA	59	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21750	Alive	WITH TUMOR	915	NA	NA	Distant Metastasis	"Other, specify"	mediastinal lymph nodes	729	NA	Negative	NA	0	915	0	915	1	729	1	729	
60	TCGA-EW-A1P8	0	0	0	1	1	2	0	0	0	19	5	0	1	12	1	0	TCGA-EW-A1P8-01	201	0.946488405028838	116	TCGA-EW-A1P8-01	18	24	52	0.5701177737261993	TCGA-EW-A1P8-01	19	8	12	39	PASS	1476	TCGA-EW-A1P8	BRCA	58	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21501	Dead	WITH TUMOR	NA	239	NA	Distant Metastasis	Lung	NA	207	NA	Negative	NA	1	239	1	239	1	207	1	207	
60	TCGA-EW-A1PA	0	3	0	1	1	1	0	0	1	24	2	0	3	10	0	0	TCGA-EW-A1PA-01	275	0.4306451670072928	179	TCGA-EW-A1PA-01	9	21	52	0.32992019061039096	TCGA-EW-A1PA-01	9	8	9	26	PASS	1477	TCGA-EW-A1PA	BRCA	59	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21837	Alive	TUMOR FREE	575	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	575	0	575	0	575	0	575	
70	TCGA-EW-A1PB	0	13	1	5	4	0	1	0	4	108	11	0	4	37	4	0	TCGA-EW-A1PB-01	318	0.92091938968057	189	TCGA-EW-A1PB-01	14	21	99	0.6514265425104153	TCGA-EW-A1PB-01	25	18	29	72	PASS	1478	TCGA-EW-A1PB	BRCA	70	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25770	Alive	TUMOR FREE	608	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	608	0	608	0	608	0	608	
70	TCGA-EW-A1PC	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-EW-A1PC-01	311	0.7242507037835836	215	TCGA-EW-A1PC-01	25	67	71	0.2897855522680347	TCGA-EW-A1PC-01	22	13	6	41	PASS	1479	TCGA-EW-A1PC	BRCA	66	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24434	Alive	TUMOR FREE	187	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	187	0	187	0	187	0	187	
60	TCGA-EW-A1PD	1	5	0	2	4	0	1	0	4	56	5	0	1	19	3	0	TCGA-EW-A1PD-01	122	0.3329257027879025	56	TCGA-EW-A1PD-01	9	16	30	0.22792348785909386	TCGA-EW-A1PD-01	15	25	14	54	PASS	1480	TCGA-EW-A1PD	BRCA	61	MALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	NA	-22536	Alive	TUMOR FREE	424	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	424	0	424	0	424	0	424	
60	TCGA-EW-A1PE	0	2	0	2	1	0	1	0	1	22	4	0	1	9	0	0	TCGA-EW-A1PE-01	71	0.2591171041235887	23	TCGA-EW-A1PE-01	6	5	7	0.1801711108972585	TCGA-EW-A1PE-01	4	0	2	6	PASS	1481	TCGA-EW-A1PE	BRCA	56	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20694	Alive	TUMOR FREE	320	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	320	0	320	0	320	0	320	
50	TCGA-EW-A1PF	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-EW-A1PF-01	101	0.2543726210663413	45	TCGA-EW-A1PF-01	8	8	17	0.23055346601076715	TCGA-EW-A1PF-01	9	8	4	21	PASS	1482	TCGA-EW-A1PF	BRCA	50	FEMALE	WHITE	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18384	Alive	TUMOR FREE	439	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	439	0	439	0	439	0	439	
50	TCGA-EW-A1PG	1	1	0	0	2	0	0	0	0	5	2	0	0	4	0	0	TCGA-EW-A1PG-01	38	0.06810773356747676	6	TCGA-EW-A1PG-01	0	0	19	1.1340324034811033e-05	TCGA-EW-A1PG-01	0	0	0	0	PASS	1483	TCGA-EW-A1PG	BRCA	53	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19464	Alive	TUMOR FREE	1051	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1051	0	1051	0	1051	0	1051	
50	TCGA-EW-A1PH	0	7	0	2	1	0	1	0	3	38	4	0	1	11	0	0	TCGA-EW-A1PH-01	286	0.5640108837619262	168	TCGA-EW-A1PH-01	11	35	33	0.20174610110396893	TCGA-EW-A1PH-01	16	13	9	38	PASS	1484	TCGA-EW-A1PH	BRCA	52	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19073	Alive	TUMOR FREE	607	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	607	0	607	0	607	0	607	
60	TCGA-EW-A2FR	0	6	1	1	0	0	0	0	2	38	0	0	0	9	0	0	TCGA-EW-A2FR-01	159	0.2574360195057379	84	TCGA-EW-A2FR-01	22	29	21	0.1524430499371082	TCGA-EW-A2FR-01	12	2	5	19	PASS	1485	TCGA-EW-A2FR	BRCA	59	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21628	Alive	TUMOR FREE	1673	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1673	0	1673	0	1673	0	1673	
40	TCGA-EW-A2FS	0	1	0	0	1	1	0	1	2	20	3	0	0	21	0	0	TCGA-EW-A2FS-01	178	0.4089270967642475	86	TCGA-EW-A2FS-01	4	9	27	0.181034743066121	TCGA-EW-A2FS-01	9	5	9	23	PASS	1486	TCGA-EW-A2FS	BRCA	41	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15302	Alive	TUMOR FREE	1604	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1604	0	1604	0	1604	0	1604	
40	TCGA-EW-A2FV	9	101	10	71	3846	0	0	0	99	19	0	0	38	5	34	0	TCGA-EW-A2FV-01	169	0.4938615295293463	89	TCGA-EW-A2FV-01	21	19	20	0.0670786277100281	TCGA-EW-A2FV-01	9	4	3	16	hypermutated sample	1487	TCGA-EW-A2FV	BRCA	39	FEMALE	WHITE	Stage IIIC	NA	"Other, specify"	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14316	Alive	TUMOR FREE	788	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	788	0	788	0	788	0	788	
50	TCGA-EW-A2FW	0	2	0	0	1	1	0	0	2	18	3	0	0	4	0	0	TCGA-EW-A2FW-01	298	0.2170157389430684	187	TCGA-EW-A2FW-01	5	7	38	0.17541766333650946	TCGA-EW-A2FW-01	5	2	4	11	PASS	1488	TCGA-EW-A2FW	BRCA	52	FEMALE	WHITE	Stage IIA	NA	"Other, specify"	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19085	Alive	TUMOR FREE	672	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	672	0	672	0	672	0	672	
60	TCGA-EW-A3E8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-EW-A3E8-01	121	0.11723436215140548	70	TCGA-EW-A3E8-01	4	7	50	0.10892293687749184	TCGA-EW-A3E8-01	6	6	5	17	PASS	1489	TCGA-EW-A3E8	BRCA	60	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2011	[Not Evaluated]	-21922	Alive	TUMOR FREE	1035	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1035	0	1035	0	1035	0	1035	
60	TCGA-EW-A3U0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-EW-A3U0-01	553	0.6057786201692793	368	TCGA-EW-A3U0-01	12	25	130	0.42931713935600974	TCGA-EW-A3U0-01	33	27	17	77	PASS	1490	TCGA-EW-A3U0	BRCA	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22520	Alive	TUMOR FREE	532	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	532	0	532	0	532	0	532	
80	TCGA-EW-A423	5	15	0	7	1	1	0	0	7	37	3	0	0	19	0	0	TCGA-EW-A423-01	172	0.7420969354090193	97	TCGA-EW-A423-01	28	16	73	0.2454088218917156	TCGA-EW-A423-01	8	6	8	22	PASS	1491	TCGA-EW-A423	BRCA	75	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27627	Alive	TUMOR FREE	533	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	533	0	533	0	533	0	533	
50	TCGA-EW-A424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-EW-A424-01	131	0.2919339525184164	77	TCGA-EW-A424-01	4	36	157	0.7778294701803168	TCGA-EW-A424-01	13	22	26	61	PASS	1492	TCGA-EW-A424	BRCA	51	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2012	[Not Evaluated]	-18850	Alive	TUMOR FREE	715	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	715	0	715	0	715	0	715	
30	TCGA-EW-A6S9	1	9	1	1	1	0	0	0	4	22	1	0	2	9	0	0	TCGA-EW-A6S9-01	253	0.3704169643649608	163	TCGA-EW-A6S9-01	4	4	86	0.12292402139431095	TCGA-EW-A6S9-01	1	4	5	10	PASS	1493	TCGA-EW-A6S9	BRCA	34	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2013	NA	-12755	Alive	TUMOR FREE	463	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	463	0	463	NA	NA	0	463	
60	TCGA-EW-A6SA	2	25	0	3	1	0	0	0	3	60	3	0	7	23	2	0	TCGA-EW-A6SA-01	266	0.7782743292108926	167	TCGA-EW-A6SA-01	16	16	77	0.17868089585536445	TCGA-EW-A6SA-01	16	14	9	39	PASS	1494	TCGA-EW-A6SA	BRCA	59	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Infiltrating Ductal Carcinoma	NA	2013	NA	-21623	Alive	TUMOR FREE	510	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	510	0	510	0	510	0	510	
60	TCGA-EW-A6SB	0	9	0	1	1	1	0	0	8	58	5	1	0	8	0	0	TCGA-EW-A6SB-01	112	0.5957638994572094	52	TCGA-EW-A6SB-01	23	36	110	0.4035168330860705	TCGA-EW-A6SB-01	15	9	8	32	PASS	1495	TCGA-EW-A6SB	BRCA	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Infiltrating Ductal Carcinoma	NA	2012	NA	-22844	Alive	TUMOR FREE	760	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	760	0	760	0	760	0	760	
60	TCGA-EW-A6SC	1	6	1	0	1	0	0	0	1	21	3	0	3	9	1	0	TCGA-EW-A6SC-01	158	0.1298403243951483	91	TCGA-EW-A6SC-01	5	5	49	0.09024870922207012	TCGA-EW-A6SC-01	7	5	5	17	PASS	1496	TCGA-EW-A6SC	BRCA	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2012	NA	-21918	Alive	TUMOR FREE	952	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	952	0	952	0	952	0	952	
30	TCGA-EW-A6SD	2	14	0	5	2	1	0	0	0	36	3	0	0	16	1	0	TCGA-EW-A6SD-01	379	0.8421661112116126	234	TCGA-EW-A6SD-01	24	21	143	0.3307208652889549	TCGA-EW-A6SD-01	17	11	17	45	PASS	1497	TCGA-EW-A6SD	BRCA	32	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2012	NA	-12006	Alive	TUMOR FREE	1010	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1010	0	1010	0	1010	0	1010	
60	TCGA-GI-A2C8	1	5	0	4	0	0	0	0	2	99	6	0	1	32	1	0	TCGA-GI-A2C8-01	350	0.5935212521862469	230	TCGA-GI-A2C8-01	13	32	56	0.22180854032361985	TCGA-GI-A2C8-01	19	14	10	43	PASS	1498	TCGA-GI-A2C8	BRCA	63	FEMALE	WHITE	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	2004	NA	-23103	Alive	NA	225	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	225	0	225	0	225	0	225	
60	TCGA-GI-A2C9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-GI-A2C9-01	309	0.8010597711805146	190	TCGA-GI-A2C9-01	8	19	106	0.4512619855590189	TCGA-GI-A2C9-01	20	22	18	60	PASS	1499	TCGA-GI-A2C9	BRCA	58	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21534	Alive	TUMOR FREE	3342	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3342	0	3342	0	3342	0	3342	
70	TCGA-GM-A2D9	1	29	2	22	1	0	0	0	24	378	37	1	8	146	8	1	TCGA-GM-A2D9-01	128	0.15445477669085966	69	TCGA-GM-A2D9-01	5	6	19	0.09850001466971588	TCGA-GM-A2D9-01	8	6	5	19	PASS	1500	TCGA-GM-A2D9	BRCA	69	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25490	Dead	WITH TUMOR	NA	1812	NA	Distant Metastasis	Bone	NA	536	NA	Negative	NA	1	1812	1	1812	1	536	1	536	
50	TCGA-GM-A2DA	0	2	0	2	1	1	0	0	1	28	1	0	0	12	1	0	TCGA-GM-A2DA-01	125	0.14340187853371011	62	TCGA-GM-A2DA-01	5	6	19	0.09728876338041967	TCGA-GM-A2DA-01	7	2	4	13	PASS	1501	TCGA-GM-A2DA	BRCA	46	FEMALE	WHITE	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	1993	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16854	Dead	WITH TUMOR	NA	6593	NA	Distant Metastasis	Bone	NA	3014	NA	Negative	NA	1	6593	1	6593	1	3014	1	3014	
60	TCGA-GM-A2DB	1	6	0	2	17	4	3	0	4	86	11	0	1	24	3	0	TCGA-GM-A2DB-01	223	0.4957531370083793	128	TCGA-GM-A2DB-01	20	29	27	0.159237768878593	TCGA-GM-A2DB-01	13	12	7	32	PASS	1502	TCGA-GM-A2DB	BRCA	62	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22883	Alive	TUMOR FREE	2406	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2406	0	2406	0	2406	0	2406	
60	TCGA-GM-A2DC	0	2	1	2	1	1	0	0	2	11	0	0	1	10	1	0	TCGA-GM-A2DC-01	184	0.41306124426764057	110	TCGA-GM-A2DC-01	18	24	27	0.3151472600405355	TCGA-GM-A2DC-01	9	4	8	21	PASS	1503	TCGA-GM-A2DC	BRCA	57	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21122	Alive	TUMOR FREE	2535	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2535	0	2535	0	2535	0	2535	
50	TCGA-GM-A2DD	1	6	0	0	1	0	0	1	3	46	1	0	3	14	1	0	TCGA-GM-A2DD-01	151	0.4437097516922849	73	TCGA-GM-A2DD-01	20	33	19	0.11400183056596536	TCGA-GM-A2DD-01	15	15	2	32	PASS	1504	TCGA-GM-A2DD	BRCA	53	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19415	Alive	TUMOR FREE	2282	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2282	0	2282	0	2282	0	2282	
50	TCGA-GM-A2DF	0	3	1	1	1	0	0	0	1	32	1	0	1	11	3	0	TCGA-GM-A2DF-01	257	0.5074842718515816	153	TCGA-GM-A2DF-01	12	20	82	0.4828013733127892	TCGA-GM-A2DF-01	18	17	13	48	PASS	1505	TCGA-GM-A2DF	BRCA	53	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19614	Alive	TUMOR FREE	2155	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2155	0	2155	0	2155	0	2155	
60	TCGA-GM-A2DH	1	11	0	5	4	1	2	0	9	144	12	2	2	42	6	1	TCGA-GM-A2DH-01	185	0.5777675648977919	102	TCGA-GM-A2DH-01	16	30	31	0.12948181509889944	TCGA-GM-A2DH-01	21	13	8	42	PASS	1506	TCGA-GM-A2DH	BRCA	58	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21344	Alive	TUMOR FREE	2193	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2193	0	2193	0	2193	0	2193	
50	TCGA-GM-A2DI	0	2	0	3	1	0	0	0	5	60	3	0	1	19	0	0	TCGA-GM-A2DI-01	65	0.18324555877836127	18	TCGA-GM-A2DI-01	9	7	7	0.16927815745563685	TCGA-GM-A2DI-01	5	0	3	8	PASS	1507	TCGA-GM-A2DI	BRCA	52	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19030	Alive	TUMOR FREE	2590	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2590	0	2590	0	2590	0	2590	
60	TCGA-GM-A2DK	0	5	0	2	1	0	0	0	1	18	1	0	1	9	0	0	TCGA-GM-A2DK-01	170	0.18706769999146464	87	TCGA-GM-A2DK-01	6	13	28	0.11258710557455462	TCGA-GM-A2DK-01	8	2	8	18	PASS	1508	TCGA-GM-A2DK	BRCA	58	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21198	Alive	TUMOR FREE	2645	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2645	0	2645	0	2645	0	2645	
50	TCGA-GM-A2DL	0	2	0	1	2	0	0	0	3	36	4	0	1	6	1	0	TCGA-GM-A2DL-01	232	0.18371915727023905	146	TCGA-GM-A2DL-01	8	8	54	0.13804793150486672	TCGA-GM-A2DL-01	6	6	6	18	PASS	1509	TCGA-GM-A2DL	BRCA	50	FEMALE	WHITE	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2003	Peri (6-12 months since last menstrual period)	-18475	Alive	TUMOR FREE	3519	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3519	0	3519	0	3519	0	3519	
60	TCGA-GM-A2DM	0	1	0	0	0	0	0	0	0	24	0	0	0	3	0	0	TCGA-GM-A2DM-01	53	0.0055440557162764	14	TCGA-GM-A2DM-01	0	0	19	0.0057784662002130895	TCGA-GM-A2DM-01	0	2	1	3	PASS	1510	TCGA-GM-A2DM	BRCA	57	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21160	Alive	TUMOR FREE	3226	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3226	0	3226	0	3226	0	3226	
60	TCGA-GM-A2DN	0	1	0	0	0	0	0	0	1	21	1	0	0	3	1	0	TCGA-GM-A2DN-01	39	0.06494887039431647	8	TCGA-GM-A2DN-01	3	5	2	0.05105289098780348	TCGA-GM-A2DN-01	3	0	1	4	PASS	1511	TCGA-GM-A2DN	BRCA	58	FEMALE	WHITE	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21288	Alive	TUMOR FREE	3091	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3091	0	3091	0	3091	0	3091	
50	TCGA-GM-A2DO	0	6	0	4	0	0	0	0	5	123	13	0	3	64	2	0	TCGA-GM-A2DO-01	72	0.10221733146802887	27	TCGA-GM-A2DO-01	1	1	3	0.0002033300167812015	TCGA-GM-A2DO-01	0	0	0	0	PASS	1512	TCGA-GM-A2DO	BRCA	54	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Infiltrating Lobular Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19842	Alive	TUMOR FREE	2596	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2596	0	2596	0	2596	0	2596	
60	TCGA-GM-A3NW	3	12	0	1	0	0	1	0	3	46	3	0	3	27	1	0	TCGA-GM-A3NW-01	132	0.2472458925680373	75	TCGA-GM-A3NW-01	7	8	15	0.058960773653918275	TCGA-GM-A3NW-01	5	6	3	14	PASS	1513	TCGA-GM-A3NW	BRCA	63	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23041	Alive	TUMOR FREE	3361	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3361	0	3361	0	3361	0	3361	
70	TCGA-GM-A3NY	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-GM-A3NY-01	81	0.11168340028090068	36	TCGA-GM-A3NY-01	4	4	19	0.06755026953859758	TCGA-GM-A3NY-01	3	6	3	12	PASS	1514	TCGA-GM-A3NY	BRCA	72	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26642	Alive	TUMOR FREE	1162	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1162	0	1162	0	1162	0	1162	
50	TCGA-GM-A3XG	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-GM-A3XG-01	39	1.884655861942946e-05	7	TCGA-GM-A3XG	0	0	0	0	TCGA-GM-A3XG	0	0	0	0	PASS	1515	TCGA-GM-A3XG	BRCA	46	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16948	Alive	TUMOR FREE	1330	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1330	0	1330	0	1330	0	1330	
50	TCGA-GM-A3XL	2	31	1	2	4	0	5	0	13	67	8	1	2	17	3	0	TCGA-GM-A3XL-01	335	0.7511981786166254	203	TCGA-GM-A3XL-01	4	12	140	0.3453723945412371	TCGA-GM-A3XL-01	22	27	23	72	PASS	1516	TCGA-GM-A3XL	BRCA	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18171	Alive	TUMOR FREE	2108	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2108	0	2108	0	2108	0	2108	
40	TCGA-GM-A3XN	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-GM-A3XN-01	40	0.22269092131925214	8	TCGA-GM-A3XN-01	9	7	11	0.0691895974562986	TCGA-GM-A3XN-01	2	0	2	4	PASS	1517	TCGA-GM-A3XN	BRCA	44	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16109	Alive	TUMOR FREE	2019	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2019	0	2019	0	2019	0	2019	
70	TCGA-GM-A4E0	0	3	0	1	2	0	0	0	5	18	0	0	2	12	0	0	TCGA-GM-A4E0-01	47	0.21530254312652547	9	TCGA-GM-A4E0-01	7	9	46	0.19976345355269173	TCGA-GM-A4E0-01	6	4	8	18	PASS	1518	TCGA-GM-A4E0	BRCA	67	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24788	Alive	TUMOR FREE	2191	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2191	0	2191	0	2191	0	2191	
60	TCGA-GM-A5PV	0	8	0	2	1	0	0	0	2	25	0	0	0	10	1	0	TCGA-GM-A5PV-01	43	0.10953370347664426	5	TCGA-GM-A5PV-01	2	2	16	0.035733038739287376	TCGA-GM-A5PV-01	1	0	2	3	PASS	1519	TCGA-GM-A5PV	BRCA	63	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23215	Alive	TUMOR FREE	412	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	412	0	412	0	412	0	412	
70	TCGA-GM-A5PX	1	7	0	4	1	1	0	0	1	18	4	0	0	7	0	0	TCGA-GM-A5PX-01	63	0.10045018894419304	19	TCGA-GM-A5PX-01	3	5	16	0.06693838829764374	TCGA-GM-A5PX-01	4	3	5	12	PASS	1520	TCGA-GM-A5PX	BRCA	65	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23753	Alive	TUMOR FREE	551	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	551	0	551	0	551	0	551	
60	TCGA-HN-A2NL	0	7	0	2	3	1	1	1	2	56	4	0	1	21	3	0	TCGA-HN-A2NL-01	178	0.9497690205272687	100	TCGA-HN-A2NL-01	11	18	61	0.6386788413069642	TCGA-HN-A2NL-01	27	20	21	68	PASS	1521	TCGA-HN-A2NL	BRCA	56	FEMALE	[Not Evaluated]	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	NA	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20483	Alive	TUMOR FREE	79	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	79	0	79	0	79	0	79	
50	TCGA-HN-A2OB	1	3	0	0	1	1	0	0	1	16	0	0	0	3	0	0	TCGA-HN-A2OB-01	65	0.1234015821482439	21	TCGA-HN-A2OB-01	2	2	22	0.031518887218070904	TCGA-HN-A2OB-01	3	3	1	7	PASS	1522	TCGA-HN-A2OB	BRCA	45	FEMALE	[Not Evaluated]	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	NA	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16672	Dead	WITH TUMOR	NA	1900	NA	Distant Metastasis	Bone	NA	1543	NA	Negative	NA	1	1900	1	1900	1	1543	1	1543	
50	TCGA-JL-A3YW	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-JL-A3YW-01	185	0.38275272543462696	95	TCGA-JL-A3YW-01	15	35	83	0.2601327442123099	TCGA-JL-A3YW-01	19	26	11	56	PASS	1523	TCGA-JL-A3YW	BRCA	49	FEMALE	ASIAN	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	NA	Alive	NA	360	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	360	0	360	0	360	0	360	
50	TCGA-JL-A3YX	1	7	1	5	2	0	2	0	4	19	3	0	1	10	1	0	TCGA-JL-A3YX-01	94	0.7102528194834142	41	TCGA-JL-A3YX-01	15	15	26	0.09380064205056184	TCGA-JL-A3YX-01	8	9	4	21	PASS	1524	TCGA-JL-A3YX	BRCA	46	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	NA	Alive	NA	352	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	352	0	352	0	352	0	352	
40	TCGA-LD-A66U	3	6	0	0	1	1	0	0	1	27	1	0	0	8	1	0	TCGA-LD-A66U-01	68	0.2863818837051104	22	TCGA-LD-A66U-01	10	13	26	0.12262296925278207	TCGA-LD-A66U-01	5	3	4	12	PASS	1525	TCGA-LD-A66U	BRCA	44	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2012	[Not Evaluated]	-16101	Alive	TUMOR FREE	646	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	646	0	646	0	646	0	646	
80	TCGA-LD-A74U	3	50	6	16	0	1	0	0	19	163	19	0	4	75	5	0	TCGA-LD-A74U-01	46	0.2209586104012105	10	TCGA-LD-A74U-01	7	5	24	0.1348084307270321	TCGA-LD-A74U-01	3	1	3	7	PASS	1526	TCGA-LD-A74U	BRCA	79	FEMALE	WHITE	Stage IIIC	NA	"Other, specify"	NA	2013	NA	-28981	Alive	WITH TUMOR	402	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	402	0	402	0	402	0	402	
50	TCGA-LD-A7W5	1	8	0	3	0	1	0	0	4	35	3	0	2	11	2	0	TCGA-LD-A7W5-01	316	0.3649553121287665	217	TCGA-LD-A7W5-01	23	21	122	0.19242858369577745	TCGA-LD-A7W5-01	17	11	13	41	PASS	1527	TCGA-LD-A7W5	BRCA	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19169	Alive	WITH TUMOR	216	NA	NA	NA	NA	NA	NA	NA	Positive	NA	0	216	0	216	NA	NA	0	216	
50	TCGA-LD-A7W6	0	9	0	2	0	0	0	0	3	22	3	1	1	7	3	0	TCGA-LD-A7W6-01	75	0.12698996421114386	29	TCGA-LD-A7W6-01	4	5	25	0.08782187651729252	TCGA-LD-A7W6-01	6	4	4	14	PASS	1528	TCGA-LD-A7W6	BRCA	54	FEMALE	WHITE	Stage IIB	NA	"Other, specify"	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20077	Alive	TUMOR FREE	404	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	404	0	404	0	404	0	404	
70	TCGA-LD-A9QF	1	6	2	1	1	0	0	0	2	17	1	0	0	10	0	0	TCGA-LD-A9QF-01	131	0.1132060343847282	59	TCGA-LD-A9QF	0	0	0	0	TCGA-LD-A9QF	0	0	0	0	PASS	1529	TCGA-LD-A9QF	BRCA	73	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26869	Alive	TUMOR FREE	323	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	323	0	323	0	323	0	323	
60	TCGA-LL-A440	0	2	0	1	0	0	0	0	0	3	0	0	0	3	0	0	TCGA-LL-A440-01	81	0.0076084255158183935	39	TCGA-LL-A440-01	0	0	19	8.179312888740548e-05	TCGA-LL-A440-01	1	0	0	1	PASS	1530	TCGA-LL-A440	BRCA	61	FEMALE	WHITE	Stage IA	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22497	Alive	TUMOR FREE	759	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	759	0	759	0	759	0	759	
60	TCGA-LL-A441	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-LL-A441-01	135	0.44076959343962907	73	TCGA-LL-A441-01	11	37	117	0.4032242722319225	TCGA-LL-A441-01	24	39	21	84	PASS	1531	TCGA-LL-A441	BRCA	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22772	Alive	TUMOR FREE	996	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	996	0	996	0	996	0	996	
60	TCGA-LL-A442	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-LL-A442-01	43	0.016200611768080412	9	TCGA-LL-A442-01	0	23	163	0.9805844836712349	TCGA-LL-A442-01	3	4	19	26	PASS	1532	TCGA-LL-A442	BRCA	56	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20495	Alive	TUMOR FREE	889	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	889	0	889	0	889	0	889	
80	TCGA-LL-A50Y	0	7	0	3	3	0	0	0	3	16	5	0	0	13	0	0	TCGA-LL-A50Y-01	75	0.08485847501474629	24	TCGA-LL-A50Y-01	4	4	20	0.042396154202759	TCGA-LL-A50Y-01	4	2	3	9	PASS	1533	TCGA-LL-A50Y	BRCA	84	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30934	Alive	TUMOR FREE	762	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	762	0	762	0	762	0	762	
60	TCGA-LL-A5YL	1	12	0	4	0	2	0	0	3	47	3	0	2	20	3	0	TCGA-LL-A5YL-01	72	0.1994259876985988	25	TCGA-LL-A5YL-01	5	8	38	0.1992567629633038	TCGA-LL-A5YL-01	5	11	11	27	PASS	1534	TCGA-LL-A5YL	BRCA	64	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23395	Alive	NA	519	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	519	0	519	0	519	0	519	
90	TCGA-LL-A5YM	0	9	0	2	3	1	0	0	3	17	1	0	1	8	1	0	TCGA-LL-A5YM-01	189	0.8027746970538701	106	TCGA-LL-A5YM-01	16	13	91	0.3518523012405643	TCGA-LL-A5YM-01	13	4	11	28	PASS	1535	TCGA-LL-A5YM	BRCA	88	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32478	Alive	WITH TUMOR	466	NA	NA	Locoregional Recurrence	"Other, specify"	Skin left chest wall	258	NA	Negative	NA	0	466	0	466	1	258	1	258	
50	TCGA-LL-A5YN	1	12	0	1	0	1	0	0	4	26	0	0	2	4	0	0	TCGA-LL-A5YN-01	185	0.39990418914433	109	TCGA-LL-A5YN-01	5	13	99	0.2356989855917944	TCGA-LL-A5YN-01	11	11	12	34	PASS	1536	TCGA-LL-A5YN	BRCA	46	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16884	Alive	TUMOR FREE	447	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	447	0	447	0	447	0	447	
50	TCGA-LL-A5YO	0	7	0	1	0	0	0	0	1	39	1	0	2	11	1	0	TCGA-LL-A5YO-01	73	0.1420914391788009	24	TCGA-LL-A5YO	0	0	0	0	TCGA-LL-A5YO	0	0	0	0	PASS	1537	TCGA-LL-A5YO	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18354	Alive	TUMOR FREE	440	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	440	0	440	0	440	0	440	
50	TCGA-LL-A5YP	3	14	0	6	0	0	0	0	5	56	6	0	2	16	2	0	TCGA-LL-A5YP-01	378	0.7831085856733018	233	TCGA-LL-A5YP-01	16	30	234	0.4278479488679349	TCGA-LL-A5YP-01	29	31	19	79	PASS	1538	TCGA-LL-A5YP	BRCA	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18041	Alive	NA	450	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	450	0	450	0	450	0	450	
90	TCGA-LL-A6FP	1	8	0	5	3	1	2	0	3	36	6	0	2	13	2	1	TCGA-LL-A6FP-01	100	0.4129121024864818	40	TCGA-LL-A6FP-01	17	34	61	0.22149288633542544	TCGA-LL-A6FP-01	7	8	6	21	PASS	1539	TCGA-LL-A6FP	BRCA	90	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32873	Alive	TUMOR FREE	677	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	677	0	677	0	677	0	677	
80	TCGA-LL-A6FQ	1	10	1	2	1	1	0	0	3	31	4	0	1	17	1	0	TCGA-LL-A6FQ-01	300	0.6253950967742682	182	TCGA-LL-A6FQ-01	21	15	72	0.07272752074907947	TCGA-LL-A6FQ-01	3	1	4	8	PASS	1540	TCGA-LL-A6FQ	BRCA	77	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28375	Alive	NA	80	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	80	0	80	0	80	0	80	
50	TCGA-LL-A6FR	5	10	2	0	3	0	2	0	4	27	3	0	5	11	1	0	TCGA-LL-A6FR-01	249	0.7126301729650024	151	TCGA-LL-A6FR-01	15	33	150	0.403816393113314	TCGA-LL-A6FR-01	21	14	15	50	PASS	1541	TCGA-LL-A6FR	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18520	Alive	TUMOR FREE	489	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	489	0	489	0	489	0	489	
70	TCGA-LL-A73Y	1	41	8	7	0	1	1	0	10	87	8	0	2	30	3	0	TCGA-LL-A73Y-01	200	0.8911025313388415	118	TCGA-LL-A73Y-01	24	30	167	0.6928790816386865	TCGA-LL-A73Y-01	15	6	8	29	PASS	1542	TCGA-LL-A73Y	BRCA	67	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24647	Alive	TUMOR FREE	477	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	477	0	477	0	477	0	477	
60	TCGA-LL-A73Z	1	8	0	2	1	2	2	0	2	34	1	0	2	7	0	0	TCGA-LL-A73Z-01	111	0.3321881891073581	57	TCGA-LL-A73Z-01	11	20	81	0.2047846584330363	TCGA-LL-A73Z-01	12	13	7	32	PASS	1543	TCGA-LL-A73Z	BRCA	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20118	Dead	WITH TUMOR	NA	227	NA	Distant Metastasis	Brain	NA	192	NA	Positive	NA	1	227	1	227	NA	NA	1	192	
60	TCGA-LL-A740	2	13	0	2	3	1	2	0	6	33	2	0	0	14	2	0	TCGA-LL-A740-01	223	0.1924425960539568	132	TCGA-LL-A740-01	6	5	49	0.056335319405309676	TCGA-LL-A740-01	3	1	3	7	PASS	1544	TCGA-LL-A740	BRCA	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22416	Alive	TUMOR FREE	441	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	441	0	441	0	441	0	441	
50	TCGA-LL-A7SZ	3	18	0	2	0	0	0	0	2	82	4	0	2	17	0	0	TCGA-LL-A7SZ-01	300	0.5205003431068742	190	TCGA-LL-A7SZ-01	15	36	171	0.3664272468284148	TCGA-LL-A7SZ-01	25	18	10	53	PASS	1545	TCGA-LL-A7SZ	BRCA	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18161	Alive	TUMOR FREE	594	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	594	0	594	0	594	0	594	
70	TCGA-LL-A7T0	2	18	1	3	1	0	0	0	3	35	4	0	1	13	0	0	TCGA-LL-A7T0-01	227	0.9265543622029658	136	TCGA-LL-A7T0-01	24	32	76	0.22373391918299212	TCGA-LL-A7T0-01	15	10	9	34	PASS	1546	TCGA-LL-A7T0	BRCA	70	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25867	Alive	TUMOR FREE	376	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	376	0	376	0	376	0	376	
60	TCGA-LL-A8F5	4	32	2	3	6	3	2	0	13	104	8	0	2	30	8	0	TCGA-LL-A8F5-01	446	0.770072076723175	299	TCGA-LL-A8F5-01	17	34	305	0.5172460996195272	TCGA-LL-A8F5-01	30	32	23	85	PASS	1547	TCGA-LL-A8F5	BRCA	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22544	Alive	TUMOR FREE	596	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	596	0	596	0	596	0	596	
70	TCGA-LL-A9Q3	0	12	0	0	2	2	0	0	1	37	6	0	0	15	0	0	TCGA-LL-A9Q3-01	126	0.338899130619408	59	TCGA-LL-A9Q3-01	13	13	36	0.0651081456548738	TCGA-LL-A9Q3-01	6	3	5	14	PASS	1548	TCGA-LL-A9Q3	BRCA	69	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25477	Alive	TUMOR FREE	532	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	532	0	532	0	532	0	532	
70	TCGA-LQ-A4E4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-LQ-A4E4-01	134	0.6066228485236901	65	TCGA-LQ-A4E4-01	7	7	65	0.17070392034952428	TCGA-LQ-A4E4-01	7	6	8	21	PASS	1549	TCGA-LQ-A4E4	BRCA	73	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26883	Alive	WITH TUMOR	849	NA	NA	Distant Metastasis	Bone	NA	681	NA	Positive	NA	0	849	0	849	NA	NA	1	681	
40	TCGA-MS-A51U	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-MS-A51U-01	118	0.2485362585555416	67	TCGA-MS-A51U-01	18	22	49	0.053308842075726434	TCGA-MS-A51U-01	7	0	2	9	PASS	1550	TCGA-MS-A51U	BRCA	44	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2012	NA	-16213	Alive	TUMOR FREE	681	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	681	0	681	0	681	0	681	
60	TCGA-OK-A5Q2	0	5	0	4	0	1	0	0	2	18	4	0	1	8	1	0	TCGA-OK-A5Q2-01	130	0.09977039324053533	73	TCGA-OK-A5Q2-01	3	4	21	0.053039052751387435	TCGA-OK-A5Q2-01	5	3	3	11	PASS	1551	TCGA-OK-A5Q2	BRCA	59	FEMALE	[Not Evaluated]	Stage II	NA	Infiltrating Lobular Carcinoma	NA	2012	[Unknown]	-21555	Alive	NA	64	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	64	0	64	0	64	0	64	
70	TCGA-OL-A5D6	0	10	0	3	1	0	1	1	3	29	0	0	0	14	0	0	TCGA-OL-A5D6-01	150	0.1847625995008448	83	TCGA-OL-A5D6-01	4	6	59	0.14520583866145895	TCGA-OL-A5D6-01	6	8	5	19	PASS	1552	TCGA-OL-A5D6	BRCA	71	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26052	Dead	TUMOR FREE	NA	1104	NA	NA	NA	NA	NA	NA	Negative	NA	1	1104	0	1104	0	1104	0	1104	
70	TCGA-OL-A5D7	1	9	0	4	1	2	1	0	2	46	0	0	1	16	3	0	TCGA-OL-A5D7-01	349	0.6098669016336289	213	TCGA-OL-A5D7-01	14	15	204	0.4260712017653988	TCGA-OL-A5D7-01	16	8	19	43	PASS	1553	TCGA-OL-A5D7	BRCA	70	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25643	Alive	TUMOR FREE	1780	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1780	0	1780	0	1780	0	1780	
40	TCGA-OL-A5D8	2	12	0	1	3	1	0	0	0	17	3	0	0	7	0	0	TCGA-OL-A5D8-01	249	0.17547149354801087	145	TCGA-OL-A5D8-01	5	5	47	0.07507536618334283	TCGA-OL-A5D8-01	6	8	6	20	PASS	1554	TCGA-OL-A5D8	BRCA	40	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14853	Alive	TUMOR FREE	973	NA	NA	NA	NA	NA	NA	NA	[Unknown]	NA	0	973	0	973	NA	NA	0	973	
60	TCGA-OL-A5DA	1	19	3	2	0	1	0	0	4	55	3	0	3	27	0	0	TCGA-OL-A5DA-01	132	0.2926979705182827	69	TCGA-OL-A5DA-01	6	7	53	0.08684312494874417	TCGA-OL-A5DA-01	7	5	6	18	PASS	1555	TCGA-OL-A5DA	BRCA	61	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22411	Alive	TUMOR FREE	1783	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1783	0	1783	0	1783	0	1783	
60	TCGA-OL-A5RU	2	6	0	2	3	0	0	0	2	29	1	0	0	4	1	0	TCGA-OL-A5RU-01	72	0.03985555520207097	28	TCGA-OL-A5RU-01	1	4	26	0.037412731136373605	TCGA-OL-A5RU-01	1	1	0	2	PASS	1556	TCGA-OL-A5RU	BRCA	63	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23108	Alive	TUMOR FREE	1219	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1219	0	1219	0	1219	0	1219	
40	TCGA-OL-A5RV	0	3	1	1	0	0	0	0	0	10	1	0	0	2	0	0	TCGA-OL-A5RV-01	83	0.07538484317630226	37	TCGA-OL-A5RV-01	2	2	9	0.020171254098563383	TCGA-OL-A5RV-01	1	1	2	4	PASS	1557	TCGA-OL-A5RV	BRCA	43	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15820	Alive	TUMOR FREE	1062	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1062	0	1062	0	1062	0	1062	
40	TCGA-OL-A5RW	7	46	0	10	3	0	1	0	17	130	9	0	6	32	0	0	TCGA-OL-A5RW-01	649	0.8542878722036593	433	TCGA-OL-A5RW-01	17	21	275	0.44544714029364135	TCGA-OL-A5RW-01	23	35	18	76	PASS	1558	TCGA-OL-A5RW	BRCA	40	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14638	Alive	TUMOR FREE	1106	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1106	0	1106	0	1106	0	1106	
50	TCGA-OL-A5RX	0	7	1	0	1	0	0	0	3	18	3	0	0	6	0	0	TCGA-OL-A5RX-01	83	0.12882249639799714	34	TCGA-OL-A5RX-01	5	4	14	0.016275507415936846	TCGA-OL-A5RX-01	3	1	2	6	PASS	1559	TCGA-OL-A5RX	BRCA	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18942	Alive	TUMOR FREE	878	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	878	0	878	0	878	0	878	
50	TCGA-OL-A5RY	1	3	0	2	0	0	0	0	0	10	0	0	0	1	0	0	TCGA-OL-A5RY-01	80	0.036530135843156786	31	TCGA-OL-A5RY-01	0	0	11	0.0006356539244026008	TCGA-OL-A5RY-01	0	2	0	2	PASS	1560	TCGA-OL-A5RY	BRCA	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19216	Alive	TUMOR FREE	752	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	752	0	752	0	752	0	752	
60	TCGA-OL-A5RZ	2	17	2	5	1	1	2	0	8	87	2	0	1	38	1	0	TCGA-OL-A5RZ-01	435	0.7534952366837927	285	TCGA-OL-A5RZ-01	13	26	76	0.08113450384788695	TCGA-OL-A5RZ-01	13	9	4	26	PASS	1561	TCGA-OL-A5RZ	BRCA	57	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21038	Alive	TUMOR FREE	679	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	679	0	679	0	679	0	679	
70	TCGA-OL-A5S0	0	8	0	4	2	2	1	0	3	25	0	0	0	8	0	0	TCGA-OL-A5S0-01	238	0.8201304980746685	143	TCGA-OL-A5S0-01	21	40	157	0.4131998753634791	TCGA-OL-A5S0-01	23	19	11	53	PASS	1562	TCGA-OL-A5S0	BRCA	66	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24139	Alive	TUMOR FREE	620	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	620	0	620	0	620	0	620	
NA	TCGA-OL-A66H	0	6	0	1	2	0	0	0	0	15	1	0	1	5	0	0	TCGA-OL-A66H-01	73	0.058682205555713136	30	TCGA-OL-A66H-01	2	1	13	0.0045430620251351314	TCGA-OL-A66H-01	0	0	0	0	PASS	1563	TCGA-OL-A66H	BRCA	NA	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Mucinous Carcinoma	NA	NA	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	NA	Alive	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	NA	0	NA	0	NA	0	NA	
40	TCGA-OL-A66I	1	6	0	1	0	1	0	0	2	32	4	0	0	11	2	0	TCGA-OL-A66I-01	328	0.5683354290619338	205	TCGA-OL-A66I-01	21	30	178	0.3063493740121145	TCGA-OL-A66I-01	21	19	11	51	PASS	1564	TCGA-OL-A66I	BRCA	36	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2008	[Not Evaluated]	-13458	Alive	TUMOR FREE	714	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	714	0	714	0	714	0	714	
80	TCGA-OL-A66J	0	9	1	4	1	0	0	0	0	40	3	0	2	10	2	0	TCGA-OL-A66J-01	77	0.12853689154891762	34	TCGA-OL-A66J-01	3	3	28	0.0685979106529295	TCGA-OL-A66J-01	4	1	4	9	PASS	1565	TCGA-OL-A66J	BRCA	80	FEMALE	WHITE	Stage I	NA	Infiltrating Lobular Carcinoma	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29345	Alive	TUMOR FREE	1996	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1996	0	1996	0	1996	0	1996	
70	TCGA-OL-A66K	2	10	0	2	1	1	0	0	2	24	1	0	0	10	1	0	TCGA-OL-A66K-01	63	0.5399221568105804	28	TCGA-OL-A66K-01	20	24	13	0.032037090434251236	TCGA-OL-A66K-01	3	2	3	8	PASS	1566	TCGA-OL-A66K	BRCA	72	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26299	Dead	TUMOR FREE	NA	1275	NA	NA	NA	NA	NA	NA	Negative	NA	1	1275	0	1275	0	1275	0	1275	
70	TCGA-OL-A66L	1	12	2	2	0	0	0	0	2	52	1	0	1	22	2	1	TCGA-OL-A66L-01	120	0.11102454639526392	67	TCGA-OL-A66L-01	5	4	45	0.0764156888223445	TCGA-OL-A66L-01	6	1	2	9	PASS	1567	TCGA-OL-A66L	BRCA	71	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26186	Alive	TUMOR FREE	1301	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1301	0	1301	0	1301	0	1301	
60	TCGA-OL-A66N	0	7	0	4	1	1	0	0	4	29	2	0	0	14	0	0	TCGA-OL-A66N-01	75	0.5186428516646204	38	TCGA-OL-A66N-01	21	59	23	0.07405309138486336	TCGA-OL-A66N-01	3	2	1	6	PASS	1568	TCGA-OL-A66N	BRCA	59	FEMALE	WHITE	Stage IIIC	NA	Infiltrating Lobular Carcinoma	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21608	Alive	TUMOR FREE	792	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	792	0	792	0	792	0	792	
40	TCGA-OL-A66O	0	4	1	3	1	2	0	0	2	20	4	0	0	7	1	0	TCGA-OL-A66O-01	141	0.16890103061908224	82	TCGA-OL-A66O-01	6	7	36	0.06239527505718361	TCGA-OL-A66O-01	4	2	4	10	PASS	1569	TCGA-OL-A66O	BRCA	39	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14272	Alive	TUMOR FREE	528	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	528	0	528	0	528	0	528	
80	TCGA-OL-A66P	1	18	0	2	10	5	1	0	4	71	4	0	1	25	1	0	TCGA-OL-A66P-01	231	0.2397039413285044	142	TCGA-OL-A66P-01	3	10	55	0.09978449929448586	TCGA-OL-A66P-01	8	15	5	28	PASS	1570	TCGA-OL-A66P	BRCA	75	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2013	NA	-27489	Alive	TUMOR FREE	428	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	428	0	428	0	428	0	428	
40	TCGA-OL-A6VO	0	10	1	4	0	0	0	0	1	28	1	0	2	13	2	0	TCGA-OL-A6VO-01	310	0.7386225834242414	201	TCGA-OL-A6VO-01	25	32	258	0.6076607993820875	TCGA-OL-A6VO-01	19	16	7	42	PASS	1571	TCGA-OL-A6VO	BRCA	43	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2012	[Unknown]	-15780	Alive	TUMOR FREE	858	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	858	0	858	0	858	0	858	
50	TCGA-OL-A6VQ	2	23	1	6	2	2	0	0	7	58	4	0	2	30	0	0	TCGA-OL-A6VQ-01	61	0.1431738005107582	22	TCGA-OL-A6VQ-01	8	11	11	0.016204053752141106	TCGA-OL-A6VQ-01	4	1	1	6	PASS	1572	TCGA-OL-A6VQ	BRCA	49	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18151	Alive	TUMOR FREE	600	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	600	0	600	0	600	0	600	
50	TCGA-OL-A6VR	0	7	0	0	0	0	1	0	1	21	0	0	1	8	0	1	TCGA-OL-A6VR-01	107	0.12376436486144897	56	TCGA-OL-A6VR-01	2	7	27	0.05785068241518247	TCGA-OL-A6VR-01	5	4	4	13	PASS	1573	TCGA-OL-A6VR	BRCA	48	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Infiltrating Ductal Carcinoma	NA	2011	[Unknown]	-17702	Alive	TUMOR FREE	1220	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1220	0	1220	0	1220	0	1220	
70	TCGA-OL-A97C	3	13	1	3	9	0	4	0	2	45	1	0	1	13	1	0	TCGA-OL-A97C-01	122	0.20874699632262647	58	TCGA-OL-A97C-01	8	8	42	0.08225031769042981	TCGA-OL-A97C-01	2	5	3	10	PASS	1574	TCGA-OL-A97C	BRCA	67	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	"Other, specify"	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24735	Alive	TUMOR FREE	271	NA	NA	Distant Metastasis	Lung	NA	275	NA	NA	NA	0	271	0	271	NA	NA	1	275	
70	TCGA-PE-A5DC	1	25	4	6	8	0	2	0	8	70	4	0	2	35	6	0	TCGA-PE-A5DC-01	231	0.921755157820394	134	TCGA-PE-A5DC	0	0	0	0	TCGA-PE-A5DC	0	0	0	0	PASS	1575	TCGA-PE-A5DC	BRCA	72	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26514	Dead	TUMOR FREE	NA	1430	NA	NA	NA	NA	NA	NA	NA	NA	1	1430	0	1430	NA	NA	0	1430	
60	TCGA-PE-A5DD	0	14	0	2	2	0	1	1	4	46	2	0	2	17	1	0	TCGA-PE-A5DD-01	114	0.7910760669378877	52	TCGA-PE-A5DD-01	8	7	49	0.20583204327933385	TCGA-PE-A5DD-01	5	9	7	21	PASS	1576	TCGA-PE-A5DD	BRCA	64	FEMALE	ASIAN	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23686	Alive	TUMOR FREE	1953	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1953	0	1953	0	1953	0	1953	
40	TCGA-PE-A5DE	5	99	1	16	0	0	1	0	31	352	25	2	8	157	5	2	TCGA-PE-A5DE-01	81	0.5283902194610871	30	TCGA-PE-A5DE-01	23	26	44	0.17613109277829678	TCGA-PE-A5DE-01	7	4	5	16	PASS	1577	TCGA-PE-A5DE	BRCA	41	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15216	Alive	TUMOR FREE	2645	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2645	0	2645	NA	NA	0	2645	
50	TCGA-PL-A8LV	6	21	2	6	3	1	0	0	8	82	3	0	1	29	5	0	TCGA-PL-A8LV-01	188	0.8589201935261559	98	TCGA-PL-A8LV-01	24	30	162	0.444564538467678	TCGA-PL-A8LV-01	22	17	16	55	PASS	1578	TCGA-PL-A8LV	BRCA	54	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Medullary Carcinoma	NA	2013	[Unknown]	-19746	Alive	WITH TUMOR	-7	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
40	TCGA-PL-A8LX	0	11	1	0	0	2	0	0	2	26	1	0	0	10	0	0	TCGA-PL-A8LX-01	155	0.8640202098147491	93	TCGA-PL-A8LX-01	19	17	48	0.05749911567851607	TCGA-PL-A8LX-01	5	4	3	12	PASS	1579	TCGA-PL-A8LX	BRCA	35	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12840	Alive	WITH TUMOR	5	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	5	0	5	NA	NA	0	5	
30	TCGA-PL-A8LY	0	2	0	1	0	0	0	0	0	4	0	0	0	1	0	0	TCGA-PL-A8LY-01	115	5.568111049308315e-05	65	TCGA-PL-A8LY-01	0	0	2	1.2431434740466847e-05	TCGA-PL-A8LY-01	0	0	0	0	PASS	1580	TCGA-PL-A8LY	BRCA	30	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11199	Alive	WITH TUMOR	8	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	8	0	8	NA	NA	0	8	
30	TCGA-PL-A8LZ	4	26	0	5	3	0	0	0	3	69	7	0	5	16	2	0	TCGA-PL-A8LZ-01	238	0.6265417760107991	148	TCGA-PL-A8LZ-01	21	28	238	0.6369589750232449	TCGA-PL-A8LZ-01	24	28	12	64	PASS	1581	TCGA-PL-A8LZ	BRCA	29	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Infiltrating Ductal Carcinoma	NA	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-10869	Alive	TUMOR FREE	302	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	302	0	302	NA	NA	0	302	
60	TCGA-S3-A6ZF	0	6	0	4	1	0	2	0	3	23	3	0	2	15	1	0	TCGA-S3-A6ZF-01	188	0.6185392731118108	107	TCGA-S3-A6ZF-01	19	28	65	0.19763021565530445	TCGA-S3-A6ZF-01	16	13	9	38	PASS	1582	TCGA-S3-A6ZF	BRCA	64	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23650	Alive	TUMOR FREE	572	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	572	0	572	0	572	0	572	
70	TCGA-S3-A6ZG	1	12	0	1	1	2	0	0	3	31	1	0	0	12	1	0	TCGA-S3-A6ZG-01	90	0.8619275226602771	42	TCGA-S3-A6ZG-01	17	16	28	0.06313180046150545	TCGA-S3-A6ZG-01	9	7	4	20	PASS	1583	TCGA-S3-A6ZG	BRCA	71	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Mixed Histology (please specify)	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26141	Alive	TUMOR FREE	562	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	562	0	562	0	562	0	562	
30	TCGA-S3-A6ZH	0	6	2	1	2	1	0	0	0	27	2	0	1	10	0	0	TCGA-S3-A6ZH-01	153	0.8421678584627047	92	TCGA-S3-A6ZH-01	20	22	78	0.18246926696776888	TCGA-S3-A6ZH-01	8	3	8	19	PASS	1584	TCGA-S3-A6ZH	BRCA	29	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Infiltrating Ductal Carcinoma	NA	2013	[Unknown]	-10832	Alive	TUMOR FREE	641	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	641	0	641	0	641	0	641	
60	TCGA-S3-AA0Z	2	11	0	5	1	1	0	0	6	37	6	0	1	10	0	0	TCGA-S3-AA0Z-01	271	0.6168468784775106	194	TCGA-S3-AA0Z-01	12	46	150	0.3858840676855084	TCGA-S3-AA0Z-01	15	8	12	35	PASS	1585	TCGA-S3-AA0Z	BRCA	63	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23314	Alive	TUMOR FREE	629	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	629	0	629	0	629	0	629	
70	TCGA-S3-AA10	1	43	2	4	5	3	3	0	12	115	4	0	3	33	2	1	TCGA-S3-AA10-01	247	0.7743921020963154	161	TCGA-S3-AA10-01	22	28	205	0.5618400807624994	TCGA-S3-AA10-01	22	26	16	64	PASS	1586	TCGA-S3-AA10	BRCA	65	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24075	Alive	TUMOR FREE	586	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	586	0	586	0	586	0	586	
70	TCGA-S3-AA11	2	28	0	2	1	2	1	0	4	48	6	0	1	15	0	0	TCGA-S3-AA11-01	97	0.05602971180205815	43	TCGA-S3-AA11-01	1	1	14	0.022672219435764016	TCGA-S3-AA11-01	1	3	1	5	PASS	1587	TCGA-S3-AA11	BRCA	67	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24813	Alive	TUMOR FREE	421	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	421	0	421	0	421	0	421	
80	TCGA-S3-AA12	1	14	0	0	0	2	2	0	7	28	1	0	3	13	1	0	TCGA-S3-AA12-01	136	0.145809799087344	70	TCGA-S3-AA12-01	4	7	43	0.08748408267542325	TCGA-S3-AA12-01	7	6	6	19	PASS	1588	TCGA-S3-AA12	BRCA	82	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30101	Alive	TUMOR FREE	574	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	574	0	574	0	574	0	574	
50	TCGA-S3-AA14	0	5	0	0	0	1	0	0	1	14	0	0	0	5	1	0	TCGA-S3-AA14-01	211	0.7371403255614225	140	TCGA-S3-AA14-01	2	6	86	0.17277045487106454	TCGA-S3-AA14-01	7	7	7	21	PASS	1589	TCGA-S3-AA14	BRCA	47	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17352	Alive	TUMOR FREE	529	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	529	0	529	0	529	0	529	
50	TCGA-S3-AA15	1	20	1	3	1	0	0	0	6	32	1	0	1	14	0	1	TCGA-S3-AA15-01	79	0.001361128454690551	33	TCGA-S3-AA15	0	0	0	0	TCGA-S3-AA15	0	0	0	0	PASS	1590	TCGA-S3-AA15	BRCA	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18659	Alive	TUMOR FREE	525	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	525	0	525	0	525	0	525	
60	TCGA-S3-AA17	6	22	2	4	8	0	2	0	13	68	6	0	5	21	4	0	TCGA-S3-AA17-01	118	0.3667681149650813	58	TCGA-S3-AA17-01	9	25	73	0.2078674189581107	TCGA-S3-AA17-01	23	33	16	72	PASS	1591	TCGA-S3-AA17	BRCA	64	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23642	Alive	TUMOR FREE	424	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	424	0	424	0	424	0	424	
70	TCGA-UL-AAZ6	3	23	2	9	1	2	0	0	8	66	3	0	5	25	3	0	TCGA-UL-AAZ6-01	580	0.6097251487177099	375	TCGA-UL-AAZ6-01	19	25	98	0.09356522134094616	TCGA-UL-AAZ6-01	15	15	6	36	PASS	1592	TCGA-UL-AAZ6	BRCA	73	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26999	Alive	TUMOR FREE	518	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	518	0	518	NA	NA	0	518	
60	TCGA-UU-A93S	2	43	0	6	3	1	1	0	7	120	8	1	4	41	4	0	TCGA-UU-A93S-01	570	0.5191798725868288	402	TCGA-UU-A93S-01	15	35	217	0.2908996203894272	TCGA-UU-A93S-01	21	14	13	48	PASS	1593	TCGA-UU-A93S	BRCA	63	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Infiltrating Ductal Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23278	Dead	WITH TUMOR	NA	116	NA	NA	NA	NA	NA	NA	Positive	NA	1	116	1	116	NA	NA	1	116	
80	TCGA-V7-A7HQ	2	4	0	1	1	1	0	0	1	17	3	0	0	5	0	0	TCGA-V7-A7HQ-01	117	0.16731061970145167	61	TCGA-V7-A7HQ-01	6	6	44	0.0720850243440199	TCGA-V7-A7HQ-01	3	2	4	9	PASS	1594	TCGA-V7-A7HQ	BRCA	75	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Infiltrating Ductal Carcinoma	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27684	Alive	TUMOR FREE	2033	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	2033	0	2033	0	2033	0	2033	
70	TCGA-W8-A86G	2	6	2	2	0	2	0	0	3	11	0	0	1	8	2	0	TCGA-W8-A86G-01	106	0.3112532248148902	58	TCGA-W8-A86G-01	14	11	33	0.0504695827831646	TCGA-W8-A86G-01	6	2	3	11	PASS	1595	TCGA-W8-A86G	BRCA	66	FEMALE	WHITE	Stage IIA	NA	Infiltrating Lobular Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24125	Alive	TUMOR FREE	347	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	347	0	347	0	347	0	347	
60	TCGA-WT-AB41	0	12	1	3	0	1	0	0	1	36	1	0	0	9	1	1	TCGA-WT-AB41-01	210	0.31264069411068257	122	TCGA-WT-AB41-01	8	11	85	0.24347875388289505	TCGA-WT-AB41-01	13	5	10	28	PASS	1596	TCGA-WT-AB41	BRCA	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Infiltrating Ductal Carcinoma	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	NA	Alive	TUMOR FREE	1611	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	1611	0	1611	0	1611	0	1611	
80	TCGA-WT-AB44	2	18	1	3	1	1	0	0	4	23	3	0	1	8	1	0	TCGA-WT-AB44-01	85	0.4207170048644355	33	TCGA-WT-AB44-01	18	16	77	0.16870414080166002	TCGA-WT-AB44-01	5	0	6	11	PASS	1597	TCGA-WT-AB44	BRCA	77	FEMALE	WHITE	Stage IA	NA	Infiltrating Lobular Carcinoma	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	NA	Alive	TUMOR FREE	883	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	883	0	883	0	883	0	883	
50	TCGA-XX-A899	0	17	2	4	2	0	0	0	2	66	6	0	0	31	0	0	TCGA-XX-A899-01	90	0.1600196330836827	47	TCGA-XX-A899-01	4	5	31	0.09708110245498801	TCGA-XX-A899-01	4	5	5	14	PASS	1598	TCGA-XX-A899	BRCA	46	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17022	Alive	TUMOR FREE	467	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	467	0	467	0	467	0	467	
70	TCGA-XX-A89A	1	40	4	13	0	0	0	0	14	139	8	1	5	46	0	0	TCGA-XX-A89A-01	119	0.7430914704233705	59	TCGA-XX-A89A-01	32	13	63	0.17951728106075704	TCGA-XX-A89A-01	5	0	7	12	PASS	1599	TCGA-XX-A89A	BRCA	68	FEMALE	WHITE	Stage IIB	NA	Infiltrating Lobular Carcinoma	NA	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25000	Alive	TUMOR FREE	488	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	488	0	488	0	488	0	488	
60	TCGA-Z7-A8R5	1	2	0	2	1	0	0	0	1	18	3	0	3	4	1	0	TCGA-Z7-A8R5-01	51	0.3224227716945253	19	TCGA-Z7-A8R5-01	21	28	89	0.08395554917500184	TCGA-Z7-A8R5-01	12	8	2	22	PASS	1600	TCGA-Z7-A8R5	BRCA	61	FEMALE	WHITE	Stage IIIA	NA	Infiltrating Lobular Carcinoma	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22280	Alive	WITH TUMOR	3287	NA	NA	Locoregional Recurrence	NA	NA	181	NA	Positive	NA	0	3287	0	3287	NA	NA	1	181	
50	TCGA-Z7-A8R6	0	19	1	3	3	1	2	0	7	47	8	0	2	22	2	0	TCGA-Z7-A8R6-01	163	0.5502837234299941	98	TCGA-Z7-A8R6-01	14	12	60	0.10117094737323724	TCGA-Z7-A8R6-01	9	4	5	18	PASS	1601	TCGA-Z7-A8R6	BRCA	46	FEMALE	WHITE	Stage I	NA	Infiltrating Lobular Carcinoma	NA	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16955	Alive	TUMOR FREE	3256	NA	NA	NA	NA	NA	NA	NA	Negative	NA	0	3256	0	3256	0	3256	0	3256	
50	TCGA-2W-A8YY	272	3010	139	422	130	76	4	0	708	10091	671	5	313	4271	234	7	TCGA-2W-A8YY-01	41	0.07431551012305522	6	TCGA-2W-A8YY-01	0	1	14	0.05032571530315592	TCGA-2W-A8YY-01	2	2	2	6	hypermutated sample	1602	TCGA-2W-A8YY	CESC	51	FEMALE	WHITE	NA	Stage IB2	Adenosquamous	G3	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18886	Alive	TUMOR FREE	533	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	533	0	533	0	533	0	533	
30	TCGA-4J-AA1J	1	43	3	9	1	0	1	0	10	116	9	0	3	57	2	0	TCGA-4J-AA1J-01	220	0.4499406623102976	121	TCGA-4J-AA1J-01	6	5	124	0.19581109071224886	TCGA-4J-AA1J-01	10	7	11	28	PASS	1603	TCGA-4J-AA1J	CESC	31	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11611	Alive	TUMOR FREE	542	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	542	0	542	0	542	0	542	
50	TCGA-BI-A0VR	2	6	0	2	0	1	3	0	6	97	4	0	2	53	0	0	TCGA-BI-A0VR-01	65	0.3944079894051294	20	TCGA-BI-A0VR-01	9	16	10	0.23516592650119544	TCGA-BI-A0VR-01	5	2	7	14	PASS	1604	TCGA-BI-A0VR	CESC	53	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19473	Alive	TUMOR FREE	1505	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1505	0	1505	NA	NA	0	1505	
50	TCGA-BI-A0VS	1	4	0	5	1	1	2	0	7	92	10	0	0	40	2	0	TCGA-BI-A0VS-01	127	0.5104175265861449	55	TCGA-BI-A0VS-01	24	32	21	0.2147110324110437	TCGA-BI-A0VS-01	14	11	7	32	PASS	1605	TCGA-BI-A0VS	CESC	48	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G3	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17839	Alive	TUMOR FREE	1735	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1735	0	1735	0	1735	0	1735	
50	TCGA-BI-A20A	0	4	0	4	1	1	0	0	1	42	4	0	0	17	1	0	TCGA-BI-A20A-01	91	0.520330952927986	33	TCGA-BI-A20A-01	18	16	12	0.1772230652141297	TCGA-BI-A20A-01	12	4	8	24	PASS	1606	TCGA-BI-A20A	CESC	49	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2010	NA	-18215	Alive	TUMOR FREE	720	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	720	0	720	0	720	0	720	
30	TCGA-C5-A0TN	1	2	0	2	0	0	0	0	3	20	0	0	1	2	1	0	TCGA-C5-A0TN-01	159	0.936824131994944	85	TCGA-C5-A0TN-01	11	12	18	0.3270175055342582	TCGA-C5-A0TN-01	8	4	6	18	PASS	1607	TCGA-C5-A0TN	CESC	21	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	1997	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-7760	Dead	WITH TUMOR	NA	348	Cervical Cancer	Distant Metastasis	"Other, specify"	Pelvis/Liver	62	Progressive Disease	NA	NA	1	348	1	348	NA	NA	1	62	
60	TCGA-C5-A1BE	0	4	0	2	3	1	2	0	4	54	4	0	0	21	2	0	TCGA-C5-A1BE-01	94	0.1582651527740942	37	TCGA-C5-A1BE-01	4	7	20	0.1770123349413357	TCGA-C5-A1BE-01	9	7	8	24	PASS	1608	TCGA-C5-A1BE	CESC	64	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G2	2000	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23727	Dead	WITH TUMOR	NA	2094	Cervical Cancer	NA	NA	NA	1674	Complete Remission/Response	NA	NA	1	2094	1	2094	1	1674	1	1674	
50	TCGA-C5-A1BF	0	8	0	1	1	3	0	0	5	50	6	0	1	22	3	0	TCGA-C5-A1BF-01	78	0.23139097967669436	29	TCGA-C5-A1BF-01	4	5	18	0.10882247369382048	TCGA-C5-A1BF-01	8	6	6	20	PASS	1609	TCGA-C5-A1BF	CESC	46	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G1	1997	NA	-16975	Dead	WITH TUMOR	NA	570	Cervical Cancer	Distant Metastasis	"Other, specify"	"Lung, Sternum"	93	Complete Remission/Response	NA	NA	1	570	1	570	1	93	1	93	
30	TCGA-C5-A1BI	0	6	1	2	1	0	0	0	11	92	4	1	5	43	3	0	TCGA-C5-A1BI-01	55	0.23476674313237705	10	TCGA-C5-A1BI-01	3	9	5	0.13087054895464578	TCGA-C5-A1BI-01	2	2	0	4	PASS	1610	TCGA-C5-A1BI	CESC	31	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2001	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11564	Alive	TUMOR FREE	1112	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1112	0	1112	0	1112	0	1112	
30	TCGA-C5-A1BJ	0	11	0	2	0	1	1	0	7	120	13	1	2	34	2	1	TCGA-C5-A1BJ-01	127	0.2841040380773115	56	TCGA-C5-A1BJ-01	7	8	19	0.2163758788273913	TCGA-C5-A1BJ-01	11	8	9	28	PASS	1611	TCGA-C5-A1BJ	CESC	34	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G2	1997	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12611	Alive	TUMOR FREE	4385	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4385	0	4385	0	4385	0	4385	
40	TCGA-C5-A1BK	3	19	0	7	2	0	0	0	5	132	15	0	0	47	4	0	TCGA-C5-A1BK-01	140	0.2412890761989389	75	TCGA-C5-A1BK-01	6	8	17	0.12316279130926087	TCGA-C5-A1BK-01	7	6	7	20	PASS	1612	TCGA-C5-A1BK	CESC	36	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	1994	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13297	Alive	TUMOR FREE	5385	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	5385	0	5385	0	5385	0	5385	
30	TCGA-C5-A1BL	3	9	0	5	1	1	2	0	5	178	21	0	0	74	3	0	TCGA-C5-A1BL-01	135	0.38059875354540335	57	TCGA-C5-A1BL-01	13	15	26	0.2651593036843219	TCGA-C5-A1BL-01	17	10	11	38	PASS	1613	TCGA-C5-A1BL	CESC	32	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	1994	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11723	Alive	TUMOR FREE	5271	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	5271	0	5271	0	5271	0	5271	
80	TCGA-C5-A1BM	1	7	2	3	0	2	0	0	6	106	12	0	1	38	2	0	TCGA-C5-A1BM-01	84	0.3411326236699132	39	TCGA-C5-A1BM-01	9	6	10	0.1441379646551912	TCGA-C5-A1BM-01	2	2	3	7	PASS	1614	TCGA-C5-A1BM	CESC	78	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	1997	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28815	Dead	TUMOR FREE	NA	2520	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2520	0	2520	0	2520	0	2520	
30	TCGA-C5-A1BN	0	2	2	4	0	1	0	0	1	52	6	0	1	20	1	0	TCGA-C5-A1BN-01	209	0.5033952986603772	122	TCGA-C5-A1BN-01	8	14	27	0.2803076414726333	TCGA-C5-A1BN-01	14	4	5	23	PASS	1615	TCGA-C5-A1BN	CESC	26	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-9783	Dead	WITH TUMOR	NA	166	Cervical Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	166	1	166	NA	NA	1	166	
70	TCGA-C5-A1BQ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-C5-A1BQ-01	84	0.20309731927912406	37	TCGA-C5-A1BQ-01	6	8	13	0.12582307586526242	TCGA-C5-A1BQ-01	8	2	5	15	PASS	1616	TCGA-C5-A1BQ	CESC	65	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24018	Dead	TUMOR FREE	NA	604	Cervical Cancer	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	604	1	604	NA	NA	0	604	
50	TCGA-C5-A1M5	0	4	0	1	0	2	0	0	3	49	4	0	0	31	3	0	TCGA-C5-A1M5-01	135	0.16055936339626872	63	TCGA-C5-A1M5-01	3	5	14	0.06533596441123808	TCGA-C5-A1M5-01	9	6	5	20	PASS	1617	TCGA-C5-A1M5	CESC	53	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	1996	Indeterminate (neither Pre or Postmenopausal)	-19672	Dead	WITH TUMOR	NA	2052	Cervical Cancer	Distant Metastasis	"Other, specify"	Regional recurrence NOS	693	Complete Remission/Response	NA	NA	1	2052	1	2052	1	693	1	693	
60	TCGA-C5-A1M6	1	9	0	5	1	2	1	1	6	108	14	0	4	48	0	0	TCGA-C5-A1M6-01	157	0.94251316426766	78	TCGA-C5-A1M6-01	23	37	19	0.25043669101654364	TCGA-C5-A1M6-01	12	4	3	19	PASS	1618	TCGA-C5-A1M6	CESC	55	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G3	1998	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20090	Dead	WITH TUMOR	NA	955	Cervical Cancer	Distant Metastasis	Lung	NA	316	Complete Remission/Response	NA	NA	1	955	1	955	1	316	1	316	
40	TCGA-C5-A1M7	0	2	1	3	1	1	0	0	4	88	8	0	0	44	2	0	TCGA-C5-A1M7-01	110	0.3399920142750576	55	TCGA-C5-A1M7-01	11	11	8	0.045550380811829744	TCGA-C5-A1M7-01	3	4	2	9	PASS	1619	TCGA-C5-A1M7	CESC	37	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	1999	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13808	Alive	TUMOR FREE	1409	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1409	0	1409	0	1409	0	1409	
40	TCGA-C5-A1M8	0	7	0	0	0	0	0	0	2	53	5	0	1	19	1	0	TCGA-C5-A1M8-01	162	0.9184864254316936	94	TCGA-C5-A1M8-01	8	7	38	0.2677529776386915	TCGA-C5-A1M8-01	6	4	11	21	PASS	1620	TCGA-C5-A1M8	CESC	43	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2001	Indeterminate (neither Pre or Postmenopausal)	-15848	Alive	TUMOR FREE	919	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	919	0	919	0	919	0	919	
50	TCGA-C5-A1M9	0	3	0	2	1	0	0	0	2	41	2	0	2	12	0	0	TCGA-C5-A1M9-01	121	0.7398025928611017	66	TCGA-C5-A1M9-01	14	15	12	0.04685938573710216	TCGA-C5-A1M9-01	4	6	4	14	PASS	1621	TCGA-C5-A1M9	CESC	46	FEMALE	WHITE	NA	Stage IB1	Endocervical Type of Adenocarcinoma	G3	2002	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17020	Dead	WITH TUMOR	NA	1065	Cervical Cancer	Distant Metastasis	Lung	NA	555	Complete Remission/Response	NA	NA	1	1065	1	1065	1	555	1	555	
40	TCGA-C5-A1ME	0	1	0	1	0	1	1	0	6	58	2	0	1	19	1	0	TCGA-C5-A1ME-01	183	0.4871672661618809	111	TCGA-C5-A1ME-01	14	34	14	0.07981208439685203	TCGA-C5-A1ME-01	12	7	4	23	PASS	1622	TCGA-C5-A1ME	CESC	40	FEMALE	WHITE	NA	Stage IB1	Endocervical Type of Adenocarcinoma	G1	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14970	Alive	TUMOR FREE	1756	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1756	0	1756	0	1756	0	1756	
50	TCGA-C5-A1MF	0	8	0	2	1	0	1	0	0	73	10	0	1	32	0	0	TCGA-C5-A1MF-01	165	0.3797855451443552	91	TCGA-C5-A1MF-01	9	13	25	0.17682097361758525	TCGA-C5-A1MF-01	8	10	8	26	PASS	1623	TCGA-C5-A1MF	CESC	49	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G2	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17911	Alive	TUMOR FREE	1617	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1617	0	1617	0	1617	0	1617	
70	TCGA-C5-A1MH	0	19	1	8	1	1	1	0	12	400	37	0	4	143	10	1	TCGA-C5-A1MH-01	58	0.4883076148711689	21	TCGA-C5-A1MH-01	24	33	6	0.23264246606515945	TCGA-C5-A1MH-01	1	1	1	3	PASS	1624	TCGA-C5-A1MH	CESC	71	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26234	Dead	WITH TUMOR	NA	1186	Cervical Cancer	Distant Metastasis	Lung	NA	178	Complete Remission/Response	NA	NA	1	1186	1	1186	1	178	1	178	
50	TCGA-C5-A1MI	0	5	1	1	1	0	0	0	2	41	1	1	2	23	0	0	TCGA-C5-A1MI-01	156	0.8634234535972183	93	TCGA-C5-A1MI-01	25	36	13	0.09800206826646336	TCGA-C5-A1MI-01	4	1	2	7	PASS	1625	TCGA-C5-A1MI	CESC	50	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2004	Peri (6-12 months since last menstrual period)	-18336	Dead	WITH TUMOR	NA	1083	Cervical Cancer	Distant Metastasis	"Other, specify"	distant recurrence multiple sites	805	Complete Remission/Response	NA	NA	1	1083	1	1083	1	805	1	805	
60	TCGA-C5-A1MJ	0	5	1	3	1	1	0	0	2	73	5	0	2	35	1	0	TCGA-C5-A1MJ-01	96	0.5005322982285374	38	TCGA-C5-A1MJ-01	21	56	19	0.010235524535577694	TCGA-C5-A1MJ-01	2	1	1	4	PASS	1626	TCGA-C5-A1MJ	CESC	61	FEMALE	WHITE	NA	Stage IB1	Endocervical Type of Adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22308	Dead	TUMOR FREE	NA	14	NA	NA	NA	NA	NA	NA	NA	NA	1	14	0	14	NA	NA	0	14	
80	TCGA-C5-A1MK	2	18	4	14	0	1	1	0	16	252	24	1	5	102	2	2	TCGA-C5-A1MK-01	67	0.3566153444544713	25	TCGA-C5-A1MK-01	9	11	8	0.12627767846630186	TCGA-C5-A1MK-01	7	4	3	14	PASS	1627	TCGA-C5-A1MK	CESC	79	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28939	Dead	WITH TUMOR	NA	74	Cervical Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	74	1	74	NA	NA	1	74	
50	TCGA-C5-A1ML	1	4	0	3	0	1	0	0	3	55	8	0	1	24	0	1	TCGA-C5-A1ML-01	75	0.7080533171838309	23	TCGA-C5-A1ML-01	22	15	6	0.1075594143207872	TCGA-C5-A1ML-01	2	1	1	4	PASS	1628	TCGA-C5-A1ML	CESC	49	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18067	Dead	WITH TUMOR	NA	636	Cervical Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	636	1	636	NA	NA	1	636	
40	TCGA-C5-A1MN	3	7	1	3	1	1	0	0	7	115	10	0	1	47	1	0	TCGA-C5-A1MN-01	164	0.7501662667423036	92	TCGA-C5-A1MN-01	16	17	28	0.24063340974878705	TCGA-C5-A1MN-01	13	8	10	31	PASS	1629	TCGA-C5-A1MN	CESC	42	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15499	Dead	TUMOR FREE	NA	1245	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1245	0	1245	0	1245	0	1245	
30	TCGA-C5-A1MP	0	2	0	1	0	0	0	0	1	41	2	0	0	19	2	0	TCGA-C5-A1MP-01	69	0.8291062513020863	26	TCGA-C5-A1MP-01	12	14	3	0.0963798070045534	TCGA-C5-A1MP-01	5	1	3	9	PASS	1630	TCGA-C5-A1MP	CESC	34	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12692	Alive	TUMOR FREE	109	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	109	0	109	0	109	0	109	
40	TCGA-C5-A1MQ	1	3	0	0	1	0	0	0	2	32	7	0	0	15	1	0	TCGA-C5-A1MQ	0	0	0	TCGA-C5-A1MQ	0	0	0	0	TCGA-C5-A1MQ	0	0	0	0	PASS	1631	TCGA-C5-A1MQ	CESC	35	FEMALE	WHITE	NA	Stage IIA	Cervical Squamous Cell Carcinoma	G2	2009	NA	-12836	Alive	TUMOR FREE	1031	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1031	0	1031	0	1031	0	1031	
40	TCGA-C5-A2LS	2	10	0	2	2	0	0	0	1	40	3	0	1	27	2	0	TCGA-C5-A2LS-01	46	0.09536794678370038	10	TCGA-C5-A2LS-01	4	4	6	0.02000638915911924	TCGA-C5-A2LS-01	3	2	2	7	PASS	1632	TCGA-C5-A2LS	CESC	37	FEMALE	WHITE	NA	Stage IB2	Endocervical Adenocarcinoma of the Usual Type	G1	2005	NA	-13857	Alive	TUMOR FREE	1345	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1345	0	1345	0	1345	0	1345	
40	TCGA-C5-A2LT	0	11	0	2	0	0	0	0	3	32	1	0	2	14	2	0	TCGA-C5-A2LT-01	94	0.7443689558981363	39	TCGA-C5-A2LT-01	27	24	17	0.2018973293260107	TCGA-C5-A2LT-01	7	3	4	14	PASS	1633	TCGA-C5-A2LT	CESC	38	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G3	2001	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13966	Alive	TUMOR FREE	2226	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2226	0	2226	0	2226	0	2226	
40	TCGA-C5-A2LV	2	21	0	7	1	0	0	1	6	51	5	0	2	20	0	0	TCGA-C5-A2LV-01	160	0.8790377665711508	85	TCGA-C5-A2LV-01	14	35	26	0.22610549580852485	TCGA-C5-A2LV-01	17	10	7	34	PASS	1634	TCGA-C5-A2LV	CESC	36	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Cervical Squamous Cell Carcinoma	G3	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13447	Alive	TUMOR FREE	2234	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2234	0	2234	0	2234	0	2234	
50	TCGA-C5-A2LX	3	46	1	9	2	1	0	0	19	152	11	0	9	59	5	0	TCGA-C5-A2LX-01	148	0.7895593236185078	71	TCGA-C5-A2LX-01	14	32	34	0.19820044441431275	TCGA-C5-A2LX-01	11	15	4	30	PASS	1635	TCGA-C5-A2LX	CESC	54	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20070	Alive	TUMOR FREE	2526	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2526	0	2526	0	2526	0	2526	
30	TCGA-C5-A2LY	3	31	1	11	0	0	0	0	7	75	7	0	3	30	0	0	TCGA-C5-A2LY-01	120	0.256403490978582	51	TCGA-C5-A2LY-01	7	12	16	0.05775798439887065	TCGA-C5-A2LY-01	11	4	4	19	PASS	1636	TCGA-C5-A2LY	CESC	30	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2002	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11018	Alive	TUMOR FREE	2383	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2383	0	2383	0	2383	0	2383	
70	TCGA-C5-A2LZ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-C5-A2LZ-01	77	0.3433382990542046	28	TCGA-C5-A2LZ-01	9	13	12	0.13710040320638034	TCGA-C5-A2LZ-01	5	3	3	11	PASS	1637	TCGA-C5-A2LZ	CESC	65	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	1998	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24059	Dead	WITH TUMOR	NA	3046	Cervical Cancer	Distant Metastasis	NA	NA	2893	Complete Remission/Response	NA	NA	1	3046	1	3046	1	2893	1	2893	
40	TCGA-C5-A2M1	1	15	2	6	2	1	2	0	2	73	6	0	7	32	0	0	TCGA-C5-A2M1-01	148	0.14032783382561614	76	TCGA-C5-A2M1-01	5	12	32	0.27258285799925397	TCGA-C5-A2M1-01	7	3	8	18	PASS	1638	TCGA-C5-A2M1	CESC	37	FEMALE	WHITE	NA	Stage IB1	Endocervical Type of Adenocarcinoma	G2	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13835	Alive	TUMOR FREE	1169	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1169	0	1169	0	1169	0	1169	
60	TCGA-C5-A2M2	0	12	0	3	2	0	0	0	1	49	5	0	0	19	0	0	TCGA-C5-A2M2-01	108	0.12359536632407665	49	TCGA-C5-A2M2-01	1	7	20	0.10447596199898894	TCGA-C5-A2M2-01	12	13	6	31	PASS	1639	TCGA-C5-A2M2	CESC	56	FEMALE	WHITE	NA	Stage IB2	Endocervical Type of Adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20480	Dead	NA	NA	1011	NA	NA	NA	NA	NA	NA	NA	NA	1	1011	NA	1011	NA	NA	0	1011	
50	TCGA-C5-A3HD	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-C5-A3HD-01	238	0.7074174285597123	139	TCGA-C5-A3HD-01	1	10	75	0.2940154433641745	TCGA-C5-A3HD-01	20	27	17	64	PASS	1640	TCGA-C5-A3HD	CESC	51	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G2	2004	NA	-18690	Alive	TUMOR FREE	1582	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1582	0	1582	0	1582	0	1582	
40	TCGA-C5-A3HE	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-C5-A3HE-01	97	0.4281187729640186	34	TCGA-C5-A3HE-01	13	19	49	0.15670310654580605	TCGA-C5-A3HE-01	6	4	3	13	PASS	1641	TCGA-C5-A3HE	CESC	44	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	2006	NA	-16139	Alive	NA	548	NA	NA	Locoregional Recurrence	Cervix	NA	252	NA	NA	NA	0	548	0	548	NA	NA	1	252	
30	TCGA-C5-A3HF	3	9	1	2	1	0	0	0	1	30	0	0	1	13	0	0	TCGA-C5-A3HF-01	61	0.1951786954305856	23	TCGA-C5-A3HF-01	3	3	7	0.02606362126510301	TCGA-C5-A3HF-01	2	4	2	8	PASS	1642	TCGA-C5-A3HF	CESC	24	FEMALE	WHITE	NA	Stage IB2	Mucinous Adenocarcinoma of Endocervical Type	G2	1996	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-9115	Dead	WITH TUMOR	NA	543	Cervical Cancer	Distant Metastasis	"Other, specify"	Pelvis	450	NA	NA	NA	1	543	1	543	NA	NA	1	450	
80	TCGA-C5-A3HL	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-C5-A3HL-01	41	0.04489182137894368	10	TCGA-C5-A3HL-01	0	4	4	0.0229530740697121	TCGA-C5-A3HL-01	1	4	2	7	PASS	1643	TCGA-C5-A3HL	CESC	76	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27963	Alive	TUMOR FREE	621	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	621	0	621	0	621	0	621	
60	TCGA-C5-A7CG	0	10	0	7	4	1	1	0	2	38	3	0	1	11	3	0	TCGA-C5-A7CG-01	53	0.4646687277024051	17	TCGA-C5-A7CG-01	16	22	8	0.015889743960005188	TCGA-C5-A7CG-01	10	8	2	20	PASS	1644	TCGA-C5-A7CG	CESC	55	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	1997	NA	-20242	Alive	TUMOR FREE	6408	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	6408	0	6408	NA	NA	0	6408	
40	TCGA-C5-A7CH	3	19	1	5	3	0	0	0	6	49	2	0	2	15	1	0	TCGA-C5-A7CH-01	173	0.7370637186873426	101	TCGA-C5-A7CH-01	21	66	54	0.16117030942979624	TCGA-C5-A7CH-01	11	10	6	27	PASS	1645	TCGA-C5-A7CH	CESC	43	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G2	2001	NA	-15777	Alive	TUMOR FREE	4694	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4694	0	4694	NA	NA	0	4694	
40	TCGA-C5-A7CJ	0	14	0	2	0	1	1	0	3	48	6	0	0	38	2	0	TCGA-C5-A7CJ-01	87	0.2255260840417729	32	TCGA-C5-A7CJ-01	4	4	27	0.0666495140485015	TCGA-C5-A7CJ-01	4	1	3	8	PASS	1646	TCGA-C5-A7CJ	CESC	42	FEMALE	WHITE	NA	Stage IIA	Cervical Squamous Cell Carcinoma	G2	2002	NA	-15652	Dead	TUMOR FREE	NA	3097	NA	NA	NA	NA	NA	NA	NA	NA	1	3097	0	3097	NA	NA	0	3097	
60	TCGA-C5-A7CK	0	32	2	11	3	0	1	0	13	95	12	0	5	34	6	0	TCGA-C5-A7CK-01	155	0.3095336402747396	84	TCGA-C5-A7CK-01	9	17	85	0.285922130245066	TCGA-C5-A7CK-01	12	10	5	27	PASS	1647	TCGA-C5-A7CK	CESC	58	FEMALE	WHITE	NA	Stage IVA	Cervical Squamous Cell Carcinoma	G2	2001	NA	-21520	Dead	TUMOR FREE	NA	4086	NA	NA	NA	NA	NA	NA	NA	NA	1	4086	0	4086	NA	NA	0	4086	
50	TCGA-C5-A7CL	3	21	2	7	2	1	1	0	13	90	8	0	0	38	1	0	TCGA-C5-A7CL-01	109	0.31451458216132355	43	TCGA-C5-A7CL-01	9	13	98	0.3098928611193316	TCGA-C5-A7CL-01	7	6	7	20	PASS	1648	TCGA-C5-A7CL	CESC	48	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2002	NA	-17869	Dead	WITH TUMOR	NA	471	Cervical Cancer	NA	NA	NA	NA	NA	NA	NA	1	471	1	471	NA	NA	1	471	
40	TCGA-C5-A7CM	0	8	0	1	0	1	0	0	0	15	0	0	0	7	0	0	TCGA-C5-A7CM-01	215	0.3170693041205575	143	TCGA-C5-A7CM-01	11	20	116	0.2980266057334381	TCGA-C5-A7CM-01	10	8	7	25	PASS	1649	TCGA-C5-A7CM	CESC	35	FEMALE	WHITE	NA	Stage IB2	Endocervical Adenocarcinoma of the Usual Type	G2	2012	NA	-12853	Alive	TUMOR FREE	619	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	619	0	619	0	619	0	619	
70	TCGA-C5-A7CO	2	21	3	5	3	0	0	0	5	88	11	0	3	28	1	0	TCGA-C5-A7CO-01	496	0.5371288509998893	433	TCGA-C5-A7CO-01	19	24	109	0.22771504016169186	TCGA-C5-A7CO-01	6	4	4	14	PASS	1650	TCGA-C5-A7CO	CESC	68	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G2	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25045	Alive	TUMOR FREE	4482	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4482	0	4482	0	4482	0	4482	
50	TCGA-C5-A7UC	1	11	1	5	2	0	1	0	5	51	4	0	3	18	0	0	TCGA-C5-A7UC-01	92	0.2684028171411458	34	TCGA-C5-A7UC-01	6	7	29	0.10313595544909196	TCGA-C5-A7UC-01	7	1	6	14	PASS	1651	TCGA-C5-A7UC	CESC	48	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G3	2002	NA	-17765	Dead	TUMOR FREE	NA	523	NA	NA	NA	NA	NA	NA	NA	NA	1	523	0	523	NA	NA	0	523	
50	TCGA-C5-A7UE	3	28	1	6	2	1	0	1	11	129	8	0	4	51	2	0	TCGA-C5-A7UE-01	86	0.2625277037646529	36	TCGA-C5-A7UE-01	7	6	38	0.0987529065934904	TCGA-C5-A7UE-01	4	4	2	10	PASS	1652	TCGA-C5-A7UE	CESC	45	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2001	NA	-16473	Alive	TUMOR FREE	4738	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4738	0	4738	0	4738	0	4738	
60	TCGA-C5-A7UH	5	47	2	13	6	1	0	0	14	171	17	0	5	54	2	0	TCGA-C5-A7UH-01	225	0.8011371068428237	135	TCGA-C5-A7UH-01	23	25	102	0.24509020051636835	TCGA-C5-A7UH-01	13	5	8	26	PASS	1653	TCGA-C5-A7UH	CESC	55	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2003	NA	-20189	Alive	TUMOR FREE	3988	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3988	0	3988	NA	NA	0	3988	
40	TCGA-C5-A7UI	2	24	3	4	2	1	0	0	11	95	6	0	4	36	0	0	TCGA-C5-A7UI-01	172	0.32628612541795804	106	TCGA-C5-A7UI-01	9	16	138	0.3105153949672195	TCGA-C5-A7UI-01	10	8	10	28	PASS	1654	TCGA-C5-A7UI	CESC	42	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2004	NA	-15349	Dead	TUMOR FREE	NA	2888	NA	NA	NA	NA	NA	NA	NA	NA	1	2888	0	2888	NA	NA	0	2888	
70	TCGA-C5-A7X3	4	15	1	3	2	0	2	1	0	53	5	0	4	14	2	0	TCGA-C5-A7X3-01	81	0.2765443064527893	31	TCGA-C5-A7X3-01	20	23	31	0.1319531517281225	TCGA-C5-A7X3-01	7	4	3	14	PASS	1655	TCGA-C5-A7X3	CESC	70	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	1997	NA	-25665	Dead	TUMOR FREE	NA	284	NA	NA	NA	NA	NA	NA	NA	NA	1	284	0	284	NA	NA	0	284	
70	TCGA-C5-A7X5	6	38	4	11	2	0	1	0	24	172	14	0	10	86	1	0	TCGA-C5-A7X5-01	439	0.6731602783586286	288	TCGA-C5-A7X5-01	16	40	57	0.08543476424521326	TCGA-C5-A7X5-01	18	10	6	34	PASS	1656	TCGA-C5-A7X5	CESC	72	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IVB	Cervical Squamous Cell Carcinoma	G3	2003	NA	-26542	Dead	WITH TUMOR	NA	414	Cervical Cancer	NA	NA	NA	NA	NA	NA	NA	1	414	1	414	NA	NA	1	414	
40	TCGA-C5-A7X8	1	18	0	1	1	1	1	0	4	50	2	0	1	32	3	0	TCGA-C5-A7X8-01	110	0.7569797334461283	53	TCGA-C5-A7X8-01	29	20	49	0.09816897207615376	TCGA-C5-A7X8-01	6	3	2	11	PASS	1657	TCGA-C5-A7X8	CESC	35	FEMALE	WHITE	NA	Stage IB1	Mucinous Adenocarcinoma of Endocervical Type	G2	2003	NA	-12977	Alive	TUMOR FREE	83	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	83	0	83	NA	NA	0	83	
30	TCGA-C5-A7XC	1	17	0	3	0	0	0	0	5	61	4	0	4	25	3	0	TCGA-C5-A7XC-01	234	0.35197953871657	135	TCGA-C5-A7XC-01	7	11	110	0.11808754950547742	TCGA-C5-A7XC-01	14	8	7	29	PASS	1658	TCGA-C5-A7XC	CESC	26	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2004	NA	-9776	Alive	TUMOR FREE	1551	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1551	0	1551	NA	NA	0	1551	
40	TCGA-C5-A8XH	4	57	4	15	10	1	6	0	24	196	19	1	7	77	5	0	TCGA-C5-A8XH-01	218	0.6598822798576522	121	TCGA-C5-A8XH-01	10	37	125	0.3437244348740971	TCGA-C5-A8XH-01	28	26	14	68	PASS	1659	TCGA-C5-A8XH	CESC	39	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	NA	2007	NA	-14444	Dead	TUMOR FREE	NA	1394	NA	NA	NA	NA	NA	NA	NA	NA	1	1394	0	1394	NA	NA	0	1394	
70	TCGA-C5-A8XI	1	11	0	0	0	0	1	0	2	49	1	0	2	17	0	0	TCGA-C5-A8XI-01	102	0.7372244334429618	46	TCGA-C5-A8XI-01	11	7	22	0.05301608052600375	TCGA-C5-A8XI-01	4	5	4	13	PASS	1660	TCGA-C5-A8XI	CESC	69	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25220	Alive	TUMOR FREE	254	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	254	0	254	NA	NA	0	254	
70	TCGA-C5-A8XJ	3	89	3	23	2	1	2	0	31	247	23	0	17	116	1	1	TCGA-C5-A8XJ-01	113	0.1813641301325626	49	TCGA-C5-A8XJ-01	7	7	60	0.17775721651644755	TCGA-C5-A8XJ-01	9	5	9	23	PASS	1661	TCGA-C5-A8XJ	CESC	74	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	NA	2002	NA	-27087	Alive	TUMOR FREE	4467	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4467	0	4467	NA	NA	0	4467	
30	TCGA-C5-A8XK	5	56	4	13	2	1	1	0	14	169	9	1	8	82	0	0	TCGA-C5-A8XK-01	142	0.7275286033571727	76	TCGA-C5-A8XK-01	5	13	83	0.24997093984334795	TCGA-C5-A8XK-01	14	10	8	32	PASS	1662	TCGA-C5-A8XK	CESC	30	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Cervical Squamous Cell Carcinoma	G3	2000	NA	-11268	Alive	TUMOR FREE	3039	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3039	0	3039	NA	NA	0	3039	
80	TCGA-C5-A8YQ	4	45	5	7	3	0	0	0	14	139	9	0	1	41	3	0	TCGA-C5-A8YQ-01	180	0.6717456589824009	105	TCGA-C5-A8YQ-01	20	36	58	0.2585359243108783	TCGA-C5-A8YQ-01	16	13	7	36	PASS	1663	TCGA-C5-A8YQ	CESC	79	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28873	Dead	WITH TUMOR	NA	715	Cervical Cancer	NA	NA	NA	NA	NA	NA	NA	1	715	1	715	NA	NA	1	715	
60	TCGA-C5-A8YR	2	35	1	4	0	1	0	0	9	95	8	0	4	49	2	0	TCGA-C5-A8YR-01	151	0.5490955072345242	77	TCGA-C5-A8YR-01	20	27	100	0.3749583500354656	TCGA-C5-A8YR-01	8	6	5	19	PASS	1664	TCGA-C5-A8YR	CESC	56	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G3	1994	NA	-20672	Dead	NA	NA	837	NA	Locoregional Recurrence	NA	regional recurrence NOS	272	NA	NA	NA	1	837	NA	837	NA	NA	1	272	
40	TCGA-C5-A8YT	0	2	0	0	0	0	0	0	0	5	0	0	0	1	0	0	TCGA-C5-A8YT-01	39	0.00017660564546697848	6	TCGA-C5-A8YT-01	0	0	15	0.013102456052388392	TCGA-C5-A8YT-01	0	2	1	3	PASS	1665	TCGA-C5-A8YT	CESC	36	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2008	NA	-13253	Dead	WITH TUMOR	NA	633	NA	NA	NA	NA	NA	NA	NA	NA	1	633	1	633	NA	NA	1	633	
40	TCGA-C5-A8ZZ	4	23	4	5	1	0	0	0	1	82	2	0	3	24	0	0	TCGA-C5-A8ZZ-01	116	0.2591675126883354	62	TCGA-C5-A8ZZ-01	7	6	45	0.1389445295782982	TCGA-C5-A8ZZ-01	3	5	5	13	PASS	1666	TCGA-C5-A8ZZ	CESC	41	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G2	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15262	Alive	TUMOR FREE	636	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	636	0	636	NA	NA	0	636	
40	TCGA-C5-A901	1	26	5	5	0	0	0	0	15	68	4	0	4	38	6	0	TCGA-C5-A901	0	0	0	TCGA-C5-A901	0	0	0	0	TCGA-C5-A901	0	0	0	0	PASS	1667	TCGA-C5-A901	CESC	44	FEMALE	WHITE	NA	NA	Cervical Squamous Cell Carcinoma	G2	2000	NA	-16186	Alive	TUMOR FREE	518	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	518	0	518	NA	NA	0	518	
40	TCGA-C5-A902	7	75	1	20	3	1	0	0	20	217	22	0	10	113	6	0	TCGA-C5-A902	0	0	0	TCGA-C5-A902	0	0	0	0	TCGA-C5-A902	0	0	0	0	PASS	1668	TCGA-C5-A902	CESC	35	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	2008	NA	-12959	Alive	TUMOR FREE	149	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	149	0	149	NA	NA	0	149	
40	TCGA-C5-A905	2	14	3	6	1	1	1	0	3	70	5	0	1	28	0	0	TCGA-C5-A905	0	0	0	TCGA-C5-A905	0	0	0	0	TCGA-C5-A905	0	0	0	0	PASS	1669	TCGA-C5-A905	CESC	37	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	1994	NA	-13584	Alive	TUMOR FREE	4879	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4879	0	4879	NA	NA	0	4879	
50	TCGA-C5-A907	0	13	0	2	2	0	0	0	4	43	5	0	0	10	1	1	TCGA-C5-A907-01	208	0.09666877179750356	131	TCGA-C5-A907-01	5	9	84	0.1851943538910797	TCGA-C5-A907-01	5	2	5	12	PASS	1670	TCGA-C5-A907	CESC	47	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G2	2013	NA	-17304	Alive	TUMOR FREE	448	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	448	0	448	NA	NA	0	448	
30	TCGA-DG-A2KH	0	13	1	3	0	1	1	0	4	58	1	0	3	15	1	0	TCGA-DG-A2KH-01	102	0.6745112664670891	51	TCGA-DG-A2KH-01	19	17	19	0.061730070682269725	TCGA-DG-A2KH-01	4	5	0	9	PASS	1671	TCGA-DG-A2KH	CESC	25	FEMALE	[Not Evaluated]	NA	Stage IB1	Adenosquamous	GX	NA	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-9209	Alive	NA	34	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	34	0	34	NA	NA	0	34	
50	TCGA-DG-A2KJ	1	18	0	7	2	0	0	0	4	70	3	0	2	30	2	0	TCGA-DG-A2KJ-01	258	0.8032299272048333	140	TCGA-DG-A2KJ-01	12	20	72	0.5480085926926248	TCGA-DG-A2KJ-01	15	11	12	38	PASS	1672	TCGA-DG-A2KJ	CESC	50	FEMALE	[Not Evaluated]	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2006	[Unknown]	-18453	Alive	TUMOR FREE	2893	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2893	0	2893	0	2893	0	2893	
50	TCGA-DG-A2KK	4	88	4	37	3	1	2	0	20	246	31	1	7	133	5	1	TCGA-DG-A2KK-01	102	0.11560710132809242	45	TCGA-DG-A2KK-01	5	5	16	0.0725961711371804	TCGA-DG-A2KK-01	4	2	2	8	PASS	1673	TCGA-DG-A2KK	CESC	51	FEMALE	[Not Evaluated]	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18834	Alive	TUMOR FREE	2496	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2496	0	2496	0	2496	0	2496	
50	TCGA-DG-A2KL	3	43	5	13	2	1	0	0	11	131	9	0	3	75	6	0	TCGA-DG-A2KL-01	77	0.5468040662237279	26	TCGA-DG-A2KL-01	18	22	6	0.08100241150063031	TCGA-DG-A2KL-01	3	2	1	6	PASS	1674	TCGA-DG-A2KL	CESC	53	FEMALE	[Not Evaluated]	NA	Stage IIA	Cervical Squamous Cell Carcinoma	G1	NA	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19539	Alive	TUMOR FREE	1367	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1367	0	1367	0	1367	0	1367	
50	TCGA-DG-A2KM	2	44	1	12	0	0	0	0	8	152	13	0	6	60	4	0	TCGA-DG-A2KM-01	62	0.25128842903086385	22	TCGA-DG-A2KM-01	12	9	9	0.23844537087514994	TCGA-DG-A2KM-01	4	1	3	8	PASS	1675	TCGA-DG-A2KM	CESC	46	FEMALE	[Not Evaluated]	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2008	[Unknown]	-16808	Alive	TUMOR FREE	1946	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1946	0	1946	0	1946	0	1946	
50	TCGA-DR-A0ZL	0	3	0	2	1	0	0	0	3	56	3	0	0	21	0	0	TCGA-DR-A0ZL-01	172	0.4552756161459662	98	TCGA-DR-A0ZL-01	11	12	29	0.3236940829765609	TCGA-DR-A0ZL-01	15	10	8	33	PASS	1676	TCGA-DR-A0ZL	CESC	53	FEMALE	ASIAN	NA	Stage IB	Cervical Squamous Cell Carcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19384	Alive	TUMOR FREE	2669	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2669	0	2669	0	2669	0	2669	
60	TCGA-DR-A0ZM	9	82	6	52	7	1	0	0	71	1000	104	3	18	393	18	3	TCGA-DR-A0ZM-01	52	0.034834031170666864	11	TCGA-DR-A0ZM-01	1	2	3	0.007929308488829423	TCGA-DR-A0ZM-01	2	1	1	4	hypermutated sample	1677	TCGA-DR-A0ZM	CESC	61	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22464	Alive	TUMOR FREE	1791	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1791	0	1791	0	1791	0	1791	
50	TCGA-DS-A0VK	1	9	0	2	2	0	0	0	3	102	8	0	0	54	1	0	TCGA-DS-A0VK-01	139	0.3057160566636471	68	TCGA-DS-A0VK-01	7	8	22	0.1883441002663024	TCGA-DS-A0VK-01	11	6	10	27	PASS	1678	TCGA-DS-A0VK	CESC	45	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G3	1996	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16792	Dead	WITH TUMOR	NA	1118	NA	Distant Metastasis	"Other, specify"	Vagina	209	Progressive Disease	NA	NA	1	1118	1	1118	NA	NA	1	209	
30	TCGA-DS-A0VL	0	2	1	4	0	0	0	0	2	55	7	0	3	25	0	0	TCGA-DS-A0VL-01	120	0.28064202067221616	49	TCGA-DS-A0VL-01	3	9	13	0.0626343554140256	TCGA-DS-A0VL-01	7	4	5	16	PASS	1679	TCGA-DS-A0VL	CESC	25	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	2001	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-9186	Alive	TUMOR FREE	81	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	81	0	81	0	81	0	81	
50	TCGA-DS-A0VM	1	17	1	10	1	1	2	1	13	219	27	0	8	106	4	1	TCGA-DS-A0VM-01	242	0.3038140679206022	146	TCGA-DS-A0VM-01	3	15	48	0.2398054608021921	TCGA-DS-A0VM-01	14	12	8	34	PASS	1680	TCGA-DS-A0VM	CESC	51	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G3	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18839	Alive	TUMOR FREE	3589	NA	NA	Distant Metastasis	Lung	NA	868	Complete Remission/Response	NA	NA	0	3589	0	3589	1	868	1	868	
50	TCGA-DS-A0VN	1	11	1	6	1	1	0	0	12	105	8	0	1	46	2	1	TCGA-DS-A0VN-01	105	0.9206240283393048	37	TCGA-DS-A0VN-01	18	16	6	0.059211924823571474	TCGA-DS-A0VN-01	5	5	3	13	PASS	1681	TCGA-DS-A0VN	CESC	47	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	2002	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17433	Alive	TUMOR FREE	3609	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3609	0	3609	0	3609	0	3609	
80	TCGA-DS-A1O9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DS-A1O9	0	0	0	TCGA-DS-A1O9	0	0	0	0	TCGA-DS-A1O9	0	0	0	0	PASS	1682	TCGA-DS-A1O9	CESC	75	FEMALE	WHITE	NA	Stage IVA	Cervical Squamous Cell Carcinoma	G3	1999	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27433	Dead	WITH TUMOR	266	266	Cervical Cancer	NA	NA	NA	NA	NA	NA	NA	1	266	1	266	NA	NA	1	266	
80	TCGA-DS-A1OA	2	9	0	3	0	0	0	0	5	44	0	0	7	30	0	0	TCGA-DS-A1OA	0	0	0	TCGA-DS-A1OA	0	0	0	0	TCGA-DS-A1OA	0	0	0	0	PASS	1683	TCGA-DS-A1OA	CESC	77	FEMALE	ASIAN	NA	Stage IB	Cervical Squamous Cell Carcinoma	G3	2001	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28160	Dead	WITH TUMOR	879	879	Cervical Cancer	Locoregional Recurrence	NA	NA	379	NA	NA	NA	1	879	1	879	NA	NA	1	379	
50	TCGA-DS-A1OB	9	35	1	20	5	0	3	2	25	451	39	1	12	282	5	2	TCGA-DS-A1OB	0	0	0	TCGA-DS-A1OB	0	0	0	0	TCGA-DS-A1OB	0	0	0	0	PASS	1684	TCGA-DS-A1OB	CESC	45	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16685	Dead	WITH TUMOR	NA	861	Cervical Cancer	Distant Metastasis	Head & Neck	NA	652	Complete Remission/Response	NA	NA	1	861	1	861	1	652	1	652	
50	TCGA-DS-A1OC	4	45	0	7	2	2	2	0	17	225	16	1	6	117	7	1	TCGA-DS-A1OC	0	0	0	TCGA-DS-A1OC	0	0	0	0	TCGA-DS-A1OC	0	0	0	0	PASS	1685	TCGA-DS-A1OC	CESC	47	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17357	Alive	TUMOR FREE	376	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	376	0	376	0	376	0	376	
50	TCGA-DS-A1OD	4	36	0	6	4	1	3	1	14	100	1	0	6	69	1	0	TCGA-DS-A1OD	0	0	0	TCGA-DS-A1OD	0	0	0	0	TCGA-DS-A1OD	0	0	0	0	PASS	1686	TCGA-DS-A1OD	CESC	49	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17954	Alive	TUMOR FREE	3874	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3874	0	3874	0	3874	0	3874	
50	TCGA-DS-A3LQ	1	14	0	0	1	1	1	0	4	28	2	0	5	12	3	0	TCGA-DS-A3LQ-01	221	0.9788218709265618	132	TCGA-DS-A3LQ-01	22	41	49	0.2877013512522222	TCGA-DS-A3LQ-01	18	14	5	37	PASS	1687	TCGA-DS-A3LQ	CESC	46	FEMALE	NA	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16861	Alive	TUMOR FREE	699	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	699	0	699	0	699	0	699	
80	TCGA-DS-A5RQ	1	29	1	8	0	0	1	0	6	72	9	0	6	38	0	0	TCGA-DS-A5RQ-01	97	0.1537675353817275	34	TCGA-DS-A5RQ-01	3	8	56	0.17663853093733006	TCGA-DS-A5RQ-01	9	7	7	23	PASS	1688	TCGA-DS-A5RQ	CESC	80	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29526	Alive	TUMOR FREE	512	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	512	0	512	0	512	0	512	
40	TCGA-DS-A7WF	2	7	0	2	2	0	0	0	0	35	3	0	0	12	1	0	TCGA-DS-A7WF-01	86	0.05399270587859795	39	TCGA-DS-A7WF-01	0	0	6	0.0017510405999748414	TCGA-DS-A7WF-01	0	0	0	0	PASS	1689	TCGA-DS-A7WF	CESC	41	FEMALE	[Unknown]	NA	Stage IB2	Adenosquamous	G3	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15319	Dead	WITH TUMOR	NA	492	Cervical Cancer	Distant Metastasis	Lung	NA	321	Partial Remission/Response	NA	NA	1	492	1	492	NA	NA	1	321	
30	TCGA-DS-A7WH	1	30	1	4	1	0	0	0	8	80	7	0	2	29	2	0	TCGA-DS-A7WH-01	117	0.31230080723640824	57	TCGA-DS-A7WH-01	5	7	27	0.04379580061369846	TCGA-DS-A7WH-01	7	8	2	17	PASS	1690	TCGA-DS-A7WH	CESC	34	FEMALE	WHITE	NA	Stage IB1	Mucinous Adenocarcinoma of Endocervical Type	G2	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12644	Alive	TUMOR FREE	533	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	533	0	533	0	533	0	533	
40	TCGA-DS-A7WI	0	12	0	2	0	1	0	0	2	21	3	0	2	9	0	0	TCGA-DS-A7WI-01	195	0.5431704473622548	113	TCGA-DS-A7WI-01	5	10	68	0.09039513514491583	TCGA-DS-A7WI-01	10	10	3	23	PASS	1691	TCGA-DS-A7WI	CESC	43	FEMALE	WHITE	NA	Stage IIA2	Cervical Squamous Cell Carcinoma	G2	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15970	Dead	WITH TUMOR	NA	252	Cervical Cancer	Locoregional Recurrence	"Other, specify"	Retroperitoneum	206	Complete Remission/Response	NA	NA	1	252	1	252	1	206	1	206	
50	TCGA-EA-A1QS	3	15	2	2	0	0	0	0	5	52	6	0	2	13	0	0	TCGA-EA-A1QS-01	66	0.34635050078992474	22	TCGA-EA-A1QS-01	9	18	65	0.2761388445375563	TCGA-EA-A1QS-01	12	14	11	37	PASS	1692	TCGA-EA-A1QS	CESC	46	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16923	Alive	TUMOR FREE	1203	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1203	0	1203	0	1203	0	1203	
50	TCGA-EA-A1QT	0	4	0	2	2	0	1	0	3	57	2	0	2	18	1	0	TCGA-EA-A1QT-01	345	0.8535856532003453	233	TCGA-EA-A1QT-01	8	14	65	0.34884564129448903	TCGA-EA-A1QT-01	19	11	11	41	PASS	1693	TCGA-EA-A1QT	CESC	47	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17475	Alive	TUMOR FREE	1243	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1243	0	1243	0	1243	0	1243	
60	TCGA-EA-A3HQ	2	17	3	9	3	1	2	0	4	69	8	0	2	31	1	0	TCGA-EA-A3HQ-01	122	0.9180130518031638	53	TCGA-EA-A3HQ-01	10	14	20	0.10085765731760606	TCGA-EA-A3HQ-01	6	4	3	13	PASS	1694	TCGA-EA-A3HQ	CESC	60	FEMALE	WHITE	NA	Stage II	Cervical Squamous Cell Carcinoma	G2	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21966	Alive	TUMOR FREE	1136	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1136	0	1136	0	1136	0	1136	
60	TCGA-EA-A3HR	4	13	2	5	2	0	0	0	6	51	8	0	2	33	0	0	TCGA-EA-A3HR-01	111	0.3591827580137891	43	TCGA-EA-A3HR-01	8	13	24	0.21995718344769127	TCGA-EA-A3HR-01	11	8	8	27	PASS	1695	TCGA-EA-A3HR	CESC	57	FEMALE	WHITE	NA	Stage II	Cervical Squamous Cell Carcinoma	G2	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20980	Alive	TUMOR FREE	940	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	940	0	940	0	940	0	940	
40	TCGA-EA-A3HS	11	182	13	29	25	13	0	0	44	619	31	0	10	228	13	0	TCGA-EA-A3HS-01	83	0.13941944123515934	31	TCGA-EA-A3HS-01	5	5	11	0.06491101555976969	TCGA-EA-A3HS-01	3	3	3	9	hypermutated sample	1696	TCGA-EA-A3HS	CESC	35	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G1	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13117	Alive	TUMOR FREE	959	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	959	0	959	0	959	0	959	
70	TCGA-EA-A3HT	2	22	1	8	1	0	0	1	7	80	8	0	4	37	2	0	TCGA-EA-A3HT-01	70	0.19338430977756735	28	TCGA-EA-A3HT-01	4	8	8	0.11032649898916436	TCGA-EA-A3HT-01	4	4	4	12	PASS	1697	TCGA-EA-A3HT	CESC	68	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G1	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25138	Alive	TUMOR FREE	954	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	954	0	954	0	954	0	954	
40	TCGA-EA-A3HU	11	294	17	57	50	14	10	1	72	814	54	1	40	340	13	1	TCGA-EA-A3HU	0	0	0	TCGA-EA-A3HU	0	0	0	0	TCGA-EA-A3HU	0	0	0	0	hypermutated sample	1698	TCGA-EA-A3HU	CESC	43	FEMALE	WHITE	NA	Stage II	Cervical Squamous Cell Carcinoma	G2	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15909	Alive	TUMOR FREE	1013	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1013	0	1013	0	1013	0	1013	
60	TCGA-EA-A3QD	1	27	1	5	0	0	0	0	4	74	8	0	6	36	2	0	TCGA-EA-A3QD-01	110	0.23469763306886796	42	TCGA-EA-A3QD-01	5	10	38	0.18678181757260007	TCGA-EA-A3QD-01	12	7	7	26	PASS	1699	TCGA-EA-A3QD	CESC	59	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21655	Alive	TUMOR FREE	397	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	397	0	397	0	397	0	397	
50	TCGA-EA-A3QE	3	12	1	7	0	0	0	1	5	51	6	0	2	22	0	0	TCGA-EA-A3QE-01	89	0.280390578156117	32	TCGA-EA-A3QE-01	4	4	20	0.18127370288250444	TCGA-EA-A3QE-01	4	6	5	15	PASS	1700	TCGA-EA-A3QE	CESC	45	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16460	Alive	TUMOR FREE	761	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	761	0	761	0	761	0	761	
40	TCGA-EA-A3Y4	1	43	3	9	0	1	0	0	7	101	7	1	6	43	2	1	TCGA-EA-A3Y4-01	94	0.1150451062553008	37	TCGA-EA-A3Y4-01	4	9	54	0.1305548559607798	TCGA-EA-A3Y4-01	6	2	4	12	PASS	1701	TCGA-EA-A3Y4	CESC	40	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14706	Alive	TUMOR FREE	1122	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1122	0	1122	0	1122	0	1122	
50	TCGA-EA-A410	35	504	16	59	277	36	14	0	106	1059	60	0	53	464	19	1	TCGA-EA-A410-01	59	0.00038100196900634083	20	TCGA-EA-A410-01	0	0	9	0.019580797848041443	TCGA-EA-A410-01	1	1	1	3	hypermutated sample	1702	TCGA-EA-A410	CESC	51	FEMALE	WHITE	NA	Stage IIA2	Cervical Squamous Cell Carcinoma	G2	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18720	Alive	TUMOR FREE	803	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	803	0	803	0	803	0	803	
50	TCGA-EA-A411	0	15	1	3	0	0	1	0	1	43	3	0	3	15	3	0	TCGA-EA-A411-01	118	0.6732468756921148	59	TCGA-EA-A411-01	21	20	63	0.1836476003303488	TCGA-EA-A411-01	11	5	10	26	PASS	1703	TCGA-EA-A411	CESC	50	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18561	Alive	TUMOR FREE	747	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	747	0	747	0	747	0	747	
50	TCGA-EA-A439	1	19	2	2	1	0	0	0	6	80	6	0	4	42	2	0	TCGA-EA-A439-01	214	0.8690784336721353	133	TCGA-EA-A439-01	23	32	84	0.15391622785970954	TCGA-EA-A439-01	7	4	2	13	PASS	1704	TCGA-EA-A439	CESC	50	FEMALE	ASIAN	NA	Stage IIA1	Cervical Squamous Cell Carcinoma	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18529	Alive	TUMOR FREE	965	NA	NA	Locoregional Recurrence	Cervix	NA	316	Complete Remission/Response	NA	NA	0	965	0	965	1	316	1	316	
40	TCGA-EA-A43B	6	38	5	8	2	1	0	0	14	173	8	0	4	65	3	0	TCGA-EA-A43B-01	66	0.5698492789493339	22	TCGA-EA-A43B-01	21	24	36	0.12163951079536695	TCGA-EA-A43B-01	11	9	5	25	PASS	1705	TCGA-EA-A43B	CESC	43	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15871	Alive	TUMOR FREE	791	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	791	0	791	0	791	0	791	
30	TCGA-EA-A44S	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-EA-A44S-01	148	0.8761120756128125	82	TCGA-EA-A44S-01	8	9	84	0.25976132047238315	TCGA-EA-A44S-01	10	4	10	24	PASS	1706	TCGA-EA-A44S	CESC	31	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11621	Alive	TUMOR FREE	369	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	369	0	369	NA	NA	0	369	
50	TCGA-EA-A4BA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-EA-A4BA-01	63	0.049935638158598715	23	TCGA-EA-A4BA-01	1	2	14	0.02288586086869329	TCGA-EA-A4BA-01	3	1	1	5	PASS	1707	TCGA-EA-A4BA	CESC	49	FEMALE	WHITE	NA	Stage IB2	Endocervical Type of Adenocarcinoma	G2	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17995	Alive	TUMOR FREE	755	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	755	0	755	0	755	0	755	
50	TCGA-EA-A50E	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-EA-A50E-01	106	0.22322571853497108	48	TCGA-EA-A50E-01	6	7	48	0.17862015580270374	TCGA-EA-A50E-01	9	7	10	26	PASS	1708	TCGA-EA-A50E	CESC	45	FEMALE	ASIAN	NA	Stage IVA	Cervical Squamous Cell Carcinoma	G2	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16609	Dead	WITH TUMOR	NA	227	Cervical Cancer	Locoregional Recurrence	Vulva	NA	208	Progressive Disease	NA	NA	1	227	1	227	NA	NA	1	208	
40	TCGA-EA-A556	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-EA-A556-01	223	0.5284407578112356	129	TCGA-EA-A556-01	8	14	47	0.07379047200186667	TCGA-EA-A556-01	17	14	4	35	PASS	1709	TCGA-EA-A556	CESC	38	FEMALE	WHITE	NA	Stage IB1	Endometrioid Adenocarcinoma of Endocervix	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13988	Alive	TUMOR FREE	453	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	453	0	453	0	453	0	453	
60	TCGA-EA-A5FO	0	15	3	7	0	1	2	0	4	56	4	0	2	31	3	0	TCGA-EA-A5FO-01	70	0.06271670903102597	25	TCGA-EA-A5FO-01	3	4	28	0.057061528104766564	TCGA-EA-A5FO-01	3	2	3	8	PASS	1710	TCGA-EA-A5FO	CESC	59	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21561	Alive	TUMOR FREE	815	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	815	0	815	0	815	0	815	
40	TCGA-EA-A5O9	2	15	1	1	1	1	1	0	4	40	4	0	2	14	1	0	TCGA-EA-A5O9-01	249	0.9477092568894188	150	TCGA-EA-A5O9-01	21	41	87	0.18438114409532447	TCGA-EA-A5O9-01	14	14	8	36	PASS	1711	TCGA-EA-A5O9	CESC	39	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G2	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14472	Alive	TUMOR FREE	788	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	788	0	788	0	788	0	788	
40	TCGA-EA-A5ZD	1	5	0	0	0	0	0	0	1	19	2	0	0	6	0	0	TCGA-EA-A5ZD-01	94	0.12340974378169997	46	TCGA-EA-A5ZD-01	3	5	23	0.01609134630905053	TCGA-EA-A5ZD-01	2	1	1	4	PASS	1712	TCGA-EA-A5ZD	CESC	40	FEMALE	ASIAN	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14629	Alive	TUMOR FREE	830	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	830	0	830	0	830	0	830	
50	TCGA-EA-A5ZE	0	18	1	7	1	3	1	0	5	37	0	0	3	22	0	0	TCGA-EA-A5ZE-01	90	0.29036569988992306	36	TCGA-EA-A5ZE-01	6	12	61	0.1654440894698805	TCGA-EA-A5ZE-01	8	4	8	20	PASS	1713	TCGA-EA-A5ZE	CESC	54	FEMALE	ASIAN	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2012	Peri (6-12 months since last menstrual period)	-19868	Alive	TUMOR FREE	829	NA	NA	Distant Metastasis	"Other, specify"	"Lymph node, inguinal"	425	Complete Remission/Response	NA	NA	0	829	0	829	1	425	1	425	
60	TCGA-EA-A5ZF	0	12	2	3	3	0	2	1	3	51	4	1	1	32	2	0	TCGA-EA-A5ZF-01	151	0.9223969332031366	87	TCGA-EA-A5ZF-01	29	38	88	0.33010191102941344	TCGA-EA-A5ZF-01	11	5	4	20	PASS	1714	TCGA-EA-A5ZF	CESC	56	FEMALE	ASIAN	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2012	Peri (6-12 months since last menstrual period)	-20506	Alive	WITH TUMOR	828	NA	NA	Locoregional Recurrence	Cervix	NA	440	Complete Remission/Response	NA	NA	0	828	0	828	1	440	1	440	
50	TCGA-EA-A6QX	1	19	1	1	0	1	0	0	7	45	6	0	4	28	2	0	TCGA-EA-A6QX-01	119	0.227747342657826	59	TCGA-EA-A6QX-01	7	8	63	0.2109497668743877	TCGA-EA-A6QX-01	8	7	3	18	PASS	1715	TCGA-EA-A6QX	CESC	49	FEMALE	ASIAN	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2013	Peri (6-12 months since last menstrual period)	-18035	Alive	TUMOR FREE	730	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	730	0	730	0	730	0	730	
50	TCGA-EA-A78R	1	19	1	2	2	0	1	0	1	44	4	0	1	24	0	0	TCGA-EA-A78R-01	90	0.2105027606400449	36	TCGA-EA-A78R-01	3	8	63	0.16479323873177404	TCGA-EA-A78R-01	13	15	12	40	PASS	1716	TCGA-EA-A78R	CESC	54	FEMALE	ASIAN	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2013	Peri (6-12 months since last menstrual period)	-19942	Alive	TUMOR FREE	410	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	410	0	410	0	410	0	410	
40	TCGA-EA-A97N	4	34	0	3	2	0	0	0	8	92	10	0	7	56	0	0	TCGA-EA-A97N-01	68	0.903473330221792	25	TCGA-EA-A97N-01	22	32	66	0.17436678521160506	TCGA-EA-A97N-01	5	2	2	9	PASS	1717	TCGA-EA-A97N	CESC	38	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G2	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13984	Alive	TUMOR FREE	11	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	11	0	11	0	11	0	11	
60	TCGA-EK-A2GZ	2	21	0	4	3	0	0	0	2	56	3	0	1	28	0	0	TCGA-EK-A2GZ-01	89	0.5843200100310301	35	TCGA-EK-A2GZ-01	10	13	9	0.17675368826341067	TCGA-EK-A2GZ-01	7	3	3	13	PASS	1718	TCGA-EK-A2GZ	CESC	64	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23599	Alive	WITH TUMOR	383	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	383	0	383	NA	NA	0	383	
30	TCGA-EK-A2H0	5	41	2	17	0	2	1	0	10	129	17	0	7	55	0	0	TCGA-EK-A2H0-01	207	0.34937052360008064	126	TCGA-EK-A2H0-01	5	10	35	0.2638076446835861	TCGA-EK-A2H0-01	17	11	13	41	PASS	1719	TCGA-EK-A2H0	CESC	24	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G3	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-8918	Alive	TUMOR FREE	1847	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1847	0	1847	0	1847	0	1847	
30	TCGA-EK-A2H1	2	17	0	1	0	0	0	0	2	25	4	0	2	5	0	0	TCGA-EK-A2H1-01	72	0.4104272454012205	25	TCGA-EK-A2H1-01	7	10	6	0.08582754601429925	TCGA-EK-A2H1-01	4	3	4	11	PASS	1720	TCGA-EK-A2H1	CESC	20	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-7649	Alive	TUMOR FREE	799	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	799	0	799	NA	NA	0	799	
30	TCGA-EK-A2IP	0	34	1	7	1	0	0	0	14	101	5	0	4	55	0	2	TCGA-EK-A2IP-01	86	0.3134655490630271	30	TCGA-EK-A2IP-01	2	7	10	0.13018972283081132	TCGA-EK-A2IP-01	6	4	5	15	PASS	1721	TCGA-EK-A2IP	CESC	28	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2006	NA	-10347	Alive	NA	202	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	202	0	202	NA	NA	0	202	
50	TCGA-EK-A2IR	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-EK-A2IR	0	0	0	TCGA-EK-A2IR	0	0	0	0	TCGA-EK-A2IR	0	0	0	0	PASS	1722	TCGA-EK-A2IR	CESC	48	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	1997	NA	-17581	Alive	TUMOR FREE	3442	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3442	0	3442	0	3442	0	3442	
90	TCGA-EK-A2PG	5	124	8	41	1	2	0	0	39	475	35	0	13	191	6	0	TCGA-EK-A2PG-01	210	0.9170564612537656	131	TCGA-EK-A2PG-01	24	59	43	0.4840441111454402	TCGA-EK-A2PG-01	14	18	4	36	PASS	1723	TCGA-EK-A2PG	CESC	88	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Cervical Squamous Cell Carcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32500	Alive	NA	46	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	46	0	46	NA	NA	0	46	
40	TCGA-EK-A2PI	1	17	2	5	0	0	0	0	7	65	5	1	1	28	0	0	TCGA-EK-A2PI-01	176	0.6612371720765231	99	TCGA-EK-A2PI-01	11	11	32	0.1968152921668005	TCGA-EK-A2PI-01	14	10	10	34	PASS	1724	TCGA-EK-A2PI	CESC	44	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2009	NA	-16324	Alive	WITH TUMOR	586	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	586	0	586	NA	NA	0	586	
40	TCGA-EK-A2PK	1	4	0	3	1	1	0	0	2	23	0	0	1	15	0	0	TCGA-EK-A2PK-01	88	0.3963155072697429	38	TCGA-EK-A2PK-01	16	31	13	0.2125788129232345	TCGA-EK-A2PK-01	7	2	2	11	PASS	1725	TCGA-EK-A2PK	CESC	43	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2006	Indeterminate (neither Pre or Postmenopausal)	-15939	Alive	TUMOR FREE	12	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	12	0	12	NA	NA	0	12	
40	TCGA-EK-A2PL	2	46	2	6	2	1	0	0	17	142	14	0	1	40	0	1	TCGA-EK-A2PL-01	114	0.3769564561943249	52	TCGA-EK-A2PL-01	8	12	24	0.17066029267903518	TCGA-EK-A2PL-01	9	6	11	26	PASS	1726	TCGA-EK-A2PL	CESC	36	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	NA	2008	NA	-13384	Alive	WITH TUMOR	13	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	13	0	13	NA	NA	0	13	
80	TCGA-EK-A2PM	5	75	5	14	4	0	2	0	22	229	18	0	9	91	8	0	TCGA-EK-A2PM-01	273	0.8663120766933574	169	TCGA-EK-A2PM-01	22	20	79	0.4087882261565231	TCGA-EK-A2PM-01	20	22	10	52	PASS	1727	TCGA-EK-A2PM	CESC	81	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29747	Alive	WITH TUMOR	18	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	18	0	18	NA	NA	0	18	
50	TCGA-EK-A2R7	4	32	2	3	1	0	1	0	12	106	11	1	2	34	2	0	TCGA-EK-A2R7-01	132	0.3428094885982197	72	TCGA-EK-A2R7-01	10	17	10	0.2595018876016319	TCGA-EK-A2R7-01	5	1	2	8	PASS	1728	TCGA-EK-A2R7	CESC	45	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G3	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16487	Alive	TUMOR FREE	27	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	27	0	27	NA	NA	0	27	
50	TCGA-EK-A2R8	2	79	4	12	1	0	1	0	24	223	22	0	6	101	3	1	TCGA-EK-A2R8-01	81	0.2737357085409833	28	TCGA-EK-A2R8-01	11	17	10	0.11007068324159944	TCGA-EK-A2R8-01	5	2	3	10	PASS	1729	TCGA-EK-A2R8	CESC	48	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17692	Alive	WITH TUMOR	44	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	44	0	44	NA	NA	0	44	
60	TCGA-EK-A2R9	0	13	2	1	2	1	0	0	4	40	5	0	5	18	0	0	TCGA-EK-A2R9-01	81	0.14253242929572446	37	TCGA-EK-A2R9-01	8	8	14	0.09470448773248992	TCGA-EK-A2R9-01	4	1	2	7	PASS	1730	TCGA-EK-A2R9	CESC	58	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2011	NA	-21242	Alive	WITH TUMOR	4	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4	0	4	NA	NA	0	4	
70	TCGA-EK-A2RA	4	63	1	13	2	2	1	0	10	165	16	0	9	78	3	1	TCGA-EK-A2RA-01	97	0.6426992536621311	47	TCGA-EK-A2RA-01	33	67	11	0.22125248580706167	TCGA-EK-A2RA-01	7	6	2	15	PASS	1731	TCGA-EK-A2RA	CESC	74	FEMALE	NA	NA	Stage IIA2	Cervical Squamous Cell Carcinoma	G3	2011	NA	-27209	Alive	WITH TUMOR	1246	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1246	0	1246	NA	NA	0	1246	
50	TCGA-EK-A2RB	1	20	0	5	2	1	2	0	2	87	5	0	2	38	2	0	TCGA-EK-A2RB-01	110	0.21183130823023552	57	TCGA-EK-A2RB-01	5	3	8	0.07058550797057278	TCGA-EK-A2RB-01	2	0	2	4	PASS	1732	TCGA-EK-A2RB	CESC	48	FEMALE	WHITE	NA	Stage IVB	Cervical Squamous Cell Carcinoma	G3	2011	NA	-17752	Alive	TUMOR FREE	9	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	9	0	9	NA	NA	0	9	
30	TCGA-EK-A2RC	1	40	4	7	1	0	0	0	12	135	12	1	7	57	0	0	TCGA-EK-A2RC-01	90	0.16138657273045254	38	TCGA-EK-A2RC-01	5	5	5	0.12870333000327427	TCGA-EK-A2RC-01	3	2	1	6	PASS	1733	TCGA-EK-A2RC	CESC	33	FEMALE	NA	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2009	NA	-12353	Alive	TUMOR FREE	129	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	129	0	129	NA	NA	0	129	
50	TCGA-EK-A2RD	3	44	4	11	0	0	0	0	19	140	11	0	3	64	2	1	TCGA-EK-A2RD-01	139	0.18887881700339829	67	TCGA-EK-A2RD-01	6	10	33	0.15868890566014668	TCGA-EK-A2RD-01	8	6	8	22	PASS	1734	TCGA-EK-A2RD	CESC	47	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17191	Alive	TUMOR FREE	2	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2	0	2	NA	NA	0	2	
30	TCGA-EK-A2RE	0	5	0	3	0	1	0	0	0	16	2	0	0	8	1	0	TCGA-EK-A2RE-01	87	0.2314332052567171	34	TCGA-EK-A2RE-01	5	5	8	0.10809569682730152	TCGA-EK-A2RE-01	4	2	6	12	PASS	1735	TCGA-EK-A2RE	CESC	26	FEMALE	WHITE	NA	Stage IIA	Cervical Squamous Cell Carcinoma	G2	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-9743	Alive	TUMOR FREE	57	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	57	0	57	NA	NA	0	57	
50	TCGA-EK-A2RJ	7	65	8	20	1	0	0	0	20	294	29	0	7	113	6	2	TCGA-EK-A2RJ-01	81	0.6883508409517134	32	TCGA-EK-A2RJ-01	28	45	16	0.24434318963950444	TCGA-EK-A2RJ-01	9	6	3	18	PASS	1736	TCGA-EK-A2RJ	CESC	51	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	2009	NA	-18664	Alive	TUMOR FREE	53	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	53	0	53	NA	NA	0	53	
70	TCGA-EK-A2RK	4	70	0	7	3	1	0	0	16	175	20	1	7	60	0	0	TCGA-EK-A2RK-01	61	0.9476428893312808	19	TCGA-EK-A2RK-01	17	10	11	0.3803393850587064	TCGA-EK-A2RK-01	4	2	3	9	PASS	1737	TCGA-EK-A2RK	CESC	67	FEMALE	WHITE	NA	Stage IA2	Cervical Squamous Cell Carcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24541	Alive	NA	13	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	13	0	13	NA	NA	0	13	
30	TCGA-EK-A2RL	0	10	1	2	0	1	0	0	4	19	1	0	0	14	0	0	TCGA-EK-A2RL-01	147	0.1337503684258286	80	TCGA-EK-A2RL-01	3	6	21	0.060064211052018875	TCGA-EK-A2RL-01	5	10	3	18	PASS	1738	TCGA-EK-A2RL	CESC	32	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endocervical Type of Adenocarcinoma	G2	2009	NA	-12047	Dead	WITH TUMOR	NA	1453	Cervical Cancer	Locoregional Recurrence	Cervix	NA	1143	Progressive Disease	NA	NA	1	1453	1	1453	NA	NA	1	1143	
40	TCGA-EK-A2RM	2	20	1	8	4	0	0	0	3	68	7	0	2	23	1	0	TCGA-EK-A2RM-01	215	0.8214795107779844	122	TCGA-EK-A2RM-01	20	26	62	0.3840390965621585	TCGA-EK-A2RM-01	18	13	14	45	PASS	1739	TCGA-EK-A2RM	CESC	40	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G3	2009	NA	-14842	Alive	WITH TUMOR	50	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	50	0	50	NA	NA	0	50	
50	TCGA-EK-A2RN	5	30	3	5	1	0	0	0	10	120	10	1	10	47	3	0	TCGA-EK-A2RN-01	110	0.6175066919083766	59	TCGA-EK-A2RN-01	20	32	34	0.3051291125216232	TCGA-EK-A2RN-01	3	0	0	3	PASS	1740	TCGA-EK-A2RN	CESC	45	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16487	Alive	WITH TUMOR	71	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	71	0	71	NA	NA	0	71	
60	TCGA-EK-A2RO	1	30	0	3	1	0	1	0	6	100	14	0	7	31	1	0	TCGA-EK-A2RO-01	129	0.1984825510359307	64	TCGA-EK-A2RO-01	7	13	9	0.16470954341835287	TCGA-EK-A2RO-01	4	2	4	10	PASS	1741	TCGA-EK-A2RO	CESC	59	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21844	Alive	WITH TUMOR	2	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2	0	2	NA	NA	0	2	
50	TCGA-EK-A3GJ	2	61	2	10	1	0	1	0	14	165	29	0	7	80	2	0	TCGA-EK-A3GJ-01	148	0.2529046886620713	77	TCGA-EK-A3GJ-01	6	12	20	0.08095822546288989	TCGA-EK-A3GJ-01	12	11	6	29	PASS	1742	TCGA-EK-A3GJ	CESC	51	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2010	NA	-18630	Alive	[Discrepancy]	3	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3	0	3	NA	NA	0	3	
30	TCGA-EK-A3GK	21	287	15	88	3	2	1	0	89	956	113	1	38	421	14	2	TCGA-EK-A3GK-01	105	0.2456239658424217	42	TCGA-EK-A3GK-01	6	7	18	0.12668501442895827	TCGA-EK-A3GK-01	8	4	5	17	hypermutated sample	1743	TCGA-EK-A3GK	CESC	33	FEMALE	WHITE	NA	Stage IB1	Endocervical Type of Adenocarcinoma	G3	2009	NA	-12207	Alive	TUMOR FREE	15	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	15	0	15	NA	NA	0	15	
70	TCGA-EK-A3GM	3	55	4	11	2	1	1	0	12	141	13	0	2	58	1	0	TCGA-EK-A3GM-01	139	0.607835283314376	69	TCGA-EK-A3GM-01	18	32	13	0.0840973212971001	TCGA-EK-A3GM-01	10	8	3	21	PASS	1744	TCGA-EK-A3GM	CESC	65	FEMALE	WHITE	NA	Stage IIA	Endocervical Type of Adenocarcinoma	G2	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23879	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
50	TCGA-EK-A3GN	1	17	2	2	1	0	0	0	2	38	6	0	3	35	0	0	TCGA-EK-A3GN-01	194	0.4339846918795048	109	TCGA-EK-A3GN-01	6	20	49	0.16667263955819406	TCGA-EK-A3GN-01	12	11	4	27	PASS	1745	TCGA-EK-A3GN	CESC	47	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2005	NA	-17425	Alive	WITH TUMOR	27	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	27	0	27	NA	NA	0	27	
60	TCGA-EX-A1H5	0	3	0	1	2	0	2	0	0	34	3	0	3	16	0	0	TCGA-EX-A1H5-01	82	0.947861042136796	32	TCGA-EX-A1H5-01	14	9	14	0.3471196832790128	TCGA-EX-A1H5-01	4	0	3	7	PASS	1746	TCGA-EX-A1H5	CESC	58	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21338	Alive	TUMOR FREE	619	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	619	0	619	0	619	0	619	
40	TCGA-EX-A1H6	1	23	2	9	0	1	1	0	11	78	6	0	3	32	2	0	TCGA-EX-A1H6-01	64	0.19582083156662794	21	TCGA-EX-A1H6-01	4	5	32	0.13213958832931294	TCGA-EX-A1H6-01	5	5	5	15	PASS	1747	TCGA-EX-A1H6	CESC	38	FEMALE	WHITE	NA	Stage IB1	Endocervical Type of Adenocarcinoma	G1	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14214	Alive	TUMOR FREE	241	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	241	0	241	0	241	0	241	
30	TCGA-EX-A3L1	0	10	0	1	1	0	0	0	3	33	4	0	0	12	0	0	TCGA-EX-A3L1-01	114	0.3541769772688261	49	TCGA-EX-A3L1-01	16	26	16	0.2444408896755593	TCGA-EX-A3L1-01	13	7	4	24	PASS	1748	TCGA-EX-A3L1	CESC	32	FEMALE	WHITE	NA	Stage IIA1	Cervical Squamous Cell Carcinoma	G3	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11943	Alive	TUMOR FREE	463	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	463	0	463	0	463	0	463	
40	TCGA-EX-A449	0	7	0	5	1	0	0	0	0	24	1	0	3	15	0	0	TCGA-EX-A449	0	0	0	TCGA-EX-A449	0	0	0	0	TCGA-EX-A449	0	0	0	0	PASS	1749	TCGA-EX-A449	CESC	42	FEMALE	WHITE	NA	Stage IVB	Endocervical Type of Adenocarcinoma	G1	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15559	Alive	TUMOR FREE	447	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	447	0	447	NA	NA	0	447	
40	TCGA-EX-A69L	2	16	0	2	0	0	0	0	5	46	0	0	0	24	5	0	TCGA-EX-A69L-01	98	0.30750875656897386	37	TCGA-EX-A69L-01	7	11	54	0.16606199202397842	TCGA-EX-A69L-01	8	6	7	21	PASS	1750	TCGA-EX-A69L	CESC	41	FEMALE	ASIAN	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15121	Alive	TUMOR FREE	602	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	602	0	602	0	602	0	602	
60	TCGA-EX-A69M	1	15	1	3	3	0	0	0	4	37	3	0	1	17	0	0	TCGA-EX-A69M-01	97	0.3115356180089492	44	TCGA-EX-A69M-01	8	9	47	0.10161188676174826	TCGA-EX-A69M-01	10	7	7	24	PASS	1751	TCGA-EX-A69M	CESC	62	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22917	Dead	TUMOR FREE	NA	253	NA	New Primary Tumor	Lung	NA	77	Complete Remission/Response	NA	NA	1	253	0	253	0	253	1	77	
40	TCGA-EX-A8YF	1	7	0	2	0	1	1	0	4	30	6	0	4	16	0	0	TCGA-EX-A8YF-01	104	0.3690630759631732	51	TCGA-EX-A8YF-01	13	12	48	0.17278131539878933	TCGA-EX-A8YF-01	7	5	6	18	PASS	1752	TCGA-EX-A8YF	CESC	44	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16258	Alive	WITH TUMOR	473	NA	NA	Locoregional Recurrence	"Other, specify"	Vagina	396	Complete Remission/Response	NA	NA	0	473	0	473	1	396	1	396	
30	TCGA-FU-A23K	0	10	0	1	0	0	0	0	6	82	9	0	1	38	2	0	TCGA-FU-A23K-01	98	0.09396995272941644	44	TCGA-FU-A23K-01	6	10	11	0.13295117314703422	TCGA-FU-A23K-01	6	4	2	12	PASS	1753	TCGA-FU-A23K	CESC	28	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-10551	Alive	TUMOR FREE	372	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	372	0	372	0	372	0	372	
60	TCGA-FU-A23L	1	9	1	2	4	0	0	0	6	131	11	0	2	43	4	0	TCGA-FU-A23L-01	129	0.6321363238381943	61	TCGA-FU-A23L-01	23	35	20	0.19000637079351554	TCGA-FU-A23L-01	12	6	6	24	PASS	1754	TCGA-FU-A23L	CESC	60	FEMALE	WHITE	NA	Stage IIA1	Cervical Squamous Cell Carcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21962	Alive	TUMOR FREE	725	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	725	0	725	0	725	0	725	
30	TCGA-FU-A2QG	1	28	0	7	1	0	0	0	9	63	7	0	0	35	1	0	TCGA-FU-A2QG-01	77	0.35911719277903104	36	TCGA-FU-A2QG-01	5	6	17	0.2257731188007945	TCGA-FU-A2QG-01	5	2	5	12	PASS	1755	TCGA-FU-A2QG	CESC	29	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2011	Peri (6-12 months since last menstrual period)	-10865	Alive	TUMOR FREE	579	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	579	0	579	0	579	0	579	
60	TCGA-FU-A3EO	2	14	0	4	1	1	1	0	2	44	0	0	1	16	0	0	TCGA-FU-A3EO-01	85	0.12759672944456646	32	TCGA-FU-A3EO-01	4	5	7	0.05574053239181787	TCGA-FU-A3EO-01	5	2	3	10	PASS	1756	TCGA-FU-A3EO	CESC	55	FEMALE	WHITE	NA	Stage IIB	Endocervical Type of Adenocarcinoma	G2	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20207	Alive	TUMOR FREE	490	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	490	0	490	0	490	0	490	
50	TCGA-FU-A3HY	2	57	4	14	0	0	1	0	10	147	10	0	3	61	1	0	TCGA-FU-A3HY-01	132	0.4789560873589536	70	TCGA-FU-A3HY-01	9	9	31	0.16755112729884972	TCGA-FU-A3HY-01	9	6	3	18	PASS	1757	TCGA-FU-A3HY	CESC	47	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G2	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17228	Alive	TUMOR FREE	954	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	954	0	954	0	954	0	954	
60	TCGA-FU-A3HZ	50	669	12	78	5	4	3	0	114	1633	199	6	60	409	29	2	TCGA-FU-A3HZ-01	81	0.0006980261151986523	35	TCGA-FU-A3HZ-01	0	0	5	0.00036513093110803797	TCGA-FU-A3HZ-01	0	0	0	0	pathology review	1758	TCGA-FU-A3HZ	CESC	64	FEMALE	WHITE	NA	Stage IIA2	Cervical Squamous Cell Carcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23565	Alive	TUMOR FREE	1103	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1103	0	1103	0	1103	0	1103	
50	TCGA-FU-A3NI	4	24	0	4	0	1	1	0	9	81	6	0	3	33	1	0	TCGA-FU-A3NI-01	188	0.7127271175180043	96	TCGA-FU-A3NI-01	22	25	37	0.28624474652719306	TCGA-FU-A3NI-01	20	12	10	42	PASS	1759	TCGA-FU-A3NI	CESC	45	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16533	Dead	TUMOR FREE	NA	638	NA	NA	NA	NA	NA	NA	NA	NA	1	638	0	638	NA	NA	0	638	
60	TCGA-FU-A3TQ	0	8	1	4	0	2	0	0	3	44	3	0	1	20	5	0	TCGA-FU-A3TQ-01	75	0.15683112447832853	28	TCGA-FU-A3TQ-01	5	6	38	0.12063304984320812	TCGA-FU-A3TQ-01	6	2	4	12	PASS	1760	TCGA-FU-A3TQ	CESC	55	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20302	Alive	TUMOR FREE	795	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	795	0	795	0	795	0	795	
80	TCGA-FU-A3TX	1	14	1	4	0	1	0	0	2	45	6	1	0	17	2	0	TCGA-FU-A3TX-01	110	0.3285414094254591	55	TCGA-FU-A3TX-01	10	20	48	0.08729412886614987	TCGA-FU-A3TX-01	8	11	5	24	PASS	1761	TCGA-FU-A3TX	CESC	78	FEMALE	[Not Evaluated]	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28825	Alive	NA	45	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	45	0	45	NA	NA	0	45	
40	TCGA-FU-A3WB	3	10	0	4	1	1	0	0	8	58	4	1	0	17	1	0	TCGA-FU-A3WB-01	63	0.12033731763573947	17	TCGA-FU-A3WB-01	3	4	20	0.07704554699919318	TCGA-FU-A3WB-01	5	3	4	12	PASS	1762	TCGA-FU-A3WB	CESC	43	FEMALE	WHITE	NA	Stage IIA2	Cervical Squamous Cell Carcinoma	G2	2012	[Unknown]	-15833	Alive	TUMOR FREE	491	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	491	0	491	0	491	0	491	
40	TCGA-FU-A3YQ	3	26	0	9	1	0	0	0	3	59	5	0	3	24	2	1	TCGA-FU-A3YQ-01	54	0.13532885729285066	13	TCGA-FU-A3YQ-01	4	4	21	0.1088170418959436	TCGA-FU-A3YQ-01	5	4	4	13	PASS	1763	TCGA-FU-A3YQ	CESC	35	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G1	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12816	Alive	TUMOR FREE	861	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	861	0	861	0	861	0	861	
40	TCGA-FU-A40J	8	44	3	22	4	1	0	0	15	168	13	0	4	59	1	0	TCGA-FU-A40J-01	92	0.4531329634071307	38	TCGA-FU-A40J-01	18	24	22	0.0442919573418553	TCGA-FU-A40J-01	14	10	2	26	PASS	1764	TCGA-FU-A40J	CESC	38	FEMALE	WHITE	NA	Stage IIIB	Endocervical Type of Adenocarcinoma	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14182	Alive	TUMOR FREE	426	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	426	0	426	0	426	0	426	
50	TCGA-FU-A57G	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-FU-A57G-01	49	0.10838009023770444	11	TCGA-FU-A57G-01	4	4	24	0.11557684142061354	TCGA-FU-A57G-01	3	3	4	10	PASS	1765	TCGA-FU-A57G	CESC	49	FEMALE	WHITE	NA	Stage IB2	Endocervical Type of Adenocarcinoma	G2	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17905	Alive	TUMOR FREE	1078	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1078	0	1078	0	1078	0	1078	
30	TCGA-FU-A5XV	3	27	4	5	2	2	0	0	4	68	7	1	0	31	4	0	TCGA-FU-A5XV-01	84	0.3000607781707852	31	TCGA-FU-A5XV-01	6	4	35	0.17757375329454647	TCGA-FU-A5XV-01	4	2	4	10	PASS	1766	TCGA-FU-A5XV	CESC	32	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11692	Alive	TUMOR FREE	321	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	321	0	321	0	321	0	321	
30	TCGA-FU-A770	0	18	1	1	0	2	0	0	3	33	4	0	2	18	1	0	TCGA-FU-A770-01	94	0.0948570473569537	35	TCGA-FU-A770-01	2	4	50	0.12145082571626672	TCGA-FU-A770-01	7	6	7	20	PASS	1767	TCGA-FU-A770	CESC	33	FEMALE	WHITE	NA	Stage IIIB	Endocervical Adenocarcinoma of the Usual Type	G2	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12248	Alive	TUMOR FREE	34	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	34	0	34	NA	NA	0	34	
30	TCGA-GH-A9DA	4	15	2	6	1	1	0	0	5	63	7	1	3	16	2	1	TCGA-GH-A9DA-01	102	0.3934629417457562	42	TCGA-GH-A9DA-01	12	14	50	0.16518641520096208	TCGA-GH-A9DA-01	5	2	3	10	PASS	1768	TCGA-GH-A9DA	CESC	27	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2013	[Not Evaluated]	-10160	Alive	TUMOR FREE	540	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	540	0	540	0	540	0	540	
40	TCGA-HG-A2PA	1	7	1	1	1	0	0	0	6	56	1	1	3	24	2	1	TCGA-HG-A2PA-01	94	0.2335954888430739	36	TCGA-HG-A2PA-01	7	7	21	0.15893692501373294	TCGA-HG-A2PA-01	7	1	4	12	PASS	1769	TCGA-HG-A2PA	CESC	38	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G2	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14025	Dead	WITH TUMOR	NA	773	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	773	1	773	NA	NA	1	773	
50	TCGA-HG-A9SC	4	18	1	3	0	3	2	0	4	66	8	0	3	23	0	0	TCGA-HG-A9SC-01	211	0.31097243112659906	118	TCGA-HG-A9SC-01	9	15	90	0.16132788193173545	TCGA-HG-A9SC-01	10	13	12	35	PASS	1770	TCGA-HG-A9SC	CESC	49	FEMALE	WHITE	NA	Stage IIB	Adenosquamous	G3	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17963	Alive	TUMOR FREE	504	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	504	0	504	0	504	0	504	
40	TCGA-HM-A3JJ	0	18	4	5	4	0	0	0	10	113	10	0	6	27	3	0	TCGA-HM-A3JJ-01	120	0.8529814872988634	59	TCGA-HM-A3JJ-01	17	37	32	0.2332790821563392	TCGA-HM-A3JJ-01	14	7	3	24	PASS	1771	TCGA-HM-A3JJ	CESC	40	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14736	Dead	WITH TUMOR	NA	659	Cervical Cancer	Distant Metastasis	NA	NA	385	Complete Remission/Response	NA	NA	1	659	1	659	1	385	1	385	
60	TCGA-HM-A3JK	2	13	0	3	1	0	0	0	0	41	4	0	0	24	0	0	TCGA-HM-A3JK-01	62	0.2984809855525805	15	TCGA-HM-A3JK-01	13	23	8	0.1144252137143033	TCGA-HM-A3JK-01	6	6	0	12	PASS	1772	TCGA-HM-A3JK	CESC	64	FEMALE	WHITE	NA	Stage IIA2	Cervical Squamous Cell Carcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23618	Alive	TUMOR FREE	632	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	632	0	632	0	632	0	632	
50	TCGA-HM-A4S6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-HM-A4S6-01	60	0.16638253012348564	18	TCGA-HM-A4S6-01	2	5	23	0.05119356361327288	TCGA-HM-A4S6-01	9	7	2	18	PASS	1773	TCGA-HM-A4S6	CESC	51	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18903	Alive	TUMOR FREE	454	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	454	0	454	0	454	0	454	
30	TCGA-HM-A6W2	2	22	1	6	3	0	2	0	3	60	8	0	3	43	3	0	TCGA-HM-A6W2-01	521	0.15238132954807124	335	TCGA-HM-A6W2-06	6	7	182	0.15122197141022165	TCGA-HM-A6W2-06	6	5	7	18	mutation call filter	1774	TCGA-HM-A6W2	CESC	34	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IVB	Adenosquamous	G3	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12775	Alive	TUMOR FREE	287	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	287	0	287	NA	NA	0	287	
40	TCGA-IR-A3L7	0	10	0	3	2	0	0	0	2	18	1	0	4	10	1	0	TCGA-IR-A3L7-01	74	0.18075624226753628	25	TCGA-IR-A3L7-01	1	7	6	0.10530093590541374	TCGA-IR-A3L7-01	4	4	2	10	PASS	1775	TCGA-IR-A3L7	CESC	37	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2000	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13559	Alive	TUMOR FREE	4483	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4483	0	4483	0	4483	0	4483	
60	TCGA-IR-A3LA	23	258	17	84	2	1	1	0	103	833	81	5	37	364	13	1	TCGA-IR-A3LA-01	197	0.3330502192715406	113	TCGA-IR-A3LA-01	3	11	66	0.12623464893167574	TCGA-IR-A3LA-01	16	17	7	40	hypermutated sample	1776	TCGA-IR-A3LA	CESC	60	FEMALE	WHITE	NA	Stage IB1	Endometrioid Adenocarcinoma of Endocervix	G3	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21949	Alive	TUMOR FREE	4172	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4172	0	4172	0	4172	0	4172	
50	TCGA-IR-A3LB	2	14	0	0	1	1	0	0	1	42	3	0	0	15	0	0	TCGA-IR-A3LB-01	227	0.9490200261669384	147	TCGA-IR-A3LB-01	6	7	125	0.22129784861040733	TCGA-IR-A3LB-01	6	9	8	23	PASS	1777	TCGA-IR-A3LB	CESC	53	FEMALE	WHITE	NA	Stage IB1	Endocervical Type of Adenocarcinoma	G3	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19374	Dead	WITH TUMOR	NA	2032	NA	Distant Metastasis	Lung	NA	317	Complete Remission/Response	NA	NA	1	2032	1	2032	1	317	1	317	
40	TCGA-IR-A3LC	0	15	1	5	1	1	3	0	2	29	2	0	3	8	1	0	TCGA-IR-A3LC-01	106	0.25938672734255674	52	TCGA-IR-A3LC-01	4	9	14	0.04853162851430034	TCGA-IR-A3LC-01	6	4	2	12	PASS	1778	TCGA-IR-A3LC	CESC	40	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14697	Alive	TUMOR FREE	3935	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3935	0	3935	0	3935	0	3935	
60	TCGA-IR-A3LF	2	29	4	10	1	1	0	0	10	94	9	0	3	46	1	0	TCGA-IR-A3LF-01	66	0.1432622635582989	26	TCGA-IR-A3LF-01	6	9	25	0.10135999803248852	TCGA-IR-A3LF-01	8	10	4	22	PASS	1779	TCGA-IR-A3LF	CESC	64	FEMALE	WHITE	NA	Stage IB1	Endocervical Adenocarcinoma of the Usual Type	G2	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23721	Alive	TUMOR FREE	2949	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2949	0	2949	0	2949	0	2949	
50	TCGA-IR-A3LH	9	196	10	58	6	1	0	0	68	655	72	0	20	277	11	1	TCGA-IR-A3LH-01	198	0.3752022146196579	112	TCGA-IR-A3LH-01	10	16	64	0.3177160528229487	TCGA-IR-A3LH-01	17	13	14	44	hypermutated sample	1780	TCGA-IR-A3LH	CESC	49	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIA1	Cervical Squamous Cell Carcinoma	G4	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18118	Alive	TUMOR FREE	2394	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2394	0	2394	0	2394	0	2394	
50	TCGA-IR-A3LI	12	76	5	29	0	0	1	1	21	266	29	0	6	134	3	0	TCGA-IR-A3LI-01	116	0.099706704637261	50	TCGA-IR-A3LI-01	1	5	17	0.02874433645242115	TCGA-IR-A3LI-01	3	4	2	9	PASS	1781	TCGA-IR-A3LI	CESC	48	FEMALE	WHITE	NA	Stage IVB	Endocervical Type of Adenocarcinoma	G2	2005	Peri (6-12 months since last menstrual period)	-17741	Alive	TUMOR FREE	2493	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2493	0	2493	NA	NA	0	2493	
70	TCGA-IR-A3LK	19	326	14	81	3	4	2	0	109	1025	105	5	36	393	19	0	TCGA-IR-A3LK-01	183	0.20857507043891807	101	TCGA-IR-A3LK-01	6	9	48	0.14769310683036158	TCGA-IR-A3LK-01	10	7	10	27	hypermutated sample	1782	TCGA-IR-A3LK	CESC	69	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25440	Dead	WITH TUMOR	NA	908	Cervical Cancer	Distant Metastasis	"Other, specify"	"thoracic lymph nodes, liver, abdominal wall"	574	Complete Remission/Response	NA	NA	1	908	1	908	1	574	1	574	
60	TCGA-IR-A3LL	9	76	1	21	0	0	0	0	25	294	29	1	14	129	6	1	TCGA-IR-A3LL-01	115	0.7997440503280109	55	TCGA-IR-A3LL-01	13	38	38	0.1524944281374131	TCGA-IR-A3LL-01	3	3	5	11	PASS	1783	TCGA-IR-A3LL	CESC	60	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22123	Alive	TUMOR FREE	1106	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1106	0	1106	0	1106	0	1106	
40	TCGA-JW-A5VG	0	1	1	2	0	0	1	0	1	26	2	0	1	4	1	0	TCGA-JW-A5VG-01	209	0.16175823616871282	139	TCGA-JW-A5VG-01	6	10	43	0.1059471275837932	TCGA-JW-A5VG-01	7	5	4	16	PASS	1784	TCGA-JW-A5VG	CESC	35	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IIA	Cervical Squamous Cell Carcinoma	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13109	Alive	TUMOR FREE	834	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	834	0	834	0	834	0	834	
50	TCGA-JW-A5VH	1	11	2	1	1	1	0	0	3	60	3	0	2	15	1	0	TCGA-JW-A5VH-01	63	0.00010828155064489336	18	TCGA-JW-A5VH-01	0	2	16	0.04204301088009752	TCGA-JW-A5VH-01	2	2	2	6	PASS	1785	TCGA-JW-A5VH	CESC	53	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IVB	Cervical Squamous Cell Carcinoma	G2	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19423	Dead	WITH TUMOR	NA	100	Cervical Cancer	Distant Metastasis	"Other, specify"	Brain	94	Progressive Disease	NA	NA	1	100	1	100	NA	NA	1	94	
50	TCGA-JW-A5VI	0	14	0	2	0	2	1	0	2	53	7	0	2	16	4	0	TCGA-JW-A5VI-01	110	0.2574179328105475	54	TCGA-JW-A5VI-01	7	11	50	0.2267310600118221	TCGA-JW-A5VI-01	10	1	8	19	PASS	1786	TCGA-JW-A5VI	CESC	45	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16444	Alive	WITH TUMOR	747	NA	NA	Distant Metastasis	Lung	NA	558	Complete Remission/Response	NA	NA	0	747	0	747	1	558	1	558	
60	TCGA-JW-A5VJ	5	52	3	17	0	0	0	0	14	164	20	2	2	64	0	1	TCGA-JW-A5VJ-01	188	0.3959241446770178	102	TCGA-JW-A5VJ-01	10	14	111	0.2697143838095867	TCGA-JW-A5VJ-01	8	3	4	15	PASS	1787	TCGA-JW-A5VJ	CESC	56	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20714	Alive	WITH TUMOR	652	NA	NA	Distant Metastasis	Head & Neck	NA	267	Progressive Disease	NA	NA	0	652	0	652	NA	NA	1	267	
40	TCGA-JW-A5VK	1	13	0	2	4	2	0	0	2	31	2	0	5	17	0	0	TCGA-JW-A5VK-01	171	0.41595753683606346	104	TCGA-JW-A5VK-01	10	10	71	0.21845492172196213	TCGA-JW-A5VK-01	6	3	5	14	PASS	1788	TCGA-JW-A5VK	CESC	43	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15965	Alive	TUMOR FREE	623	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	623	0	623	0	623	0	623	
40	TCGA-JW-A5VL	38	500	27	151	1	5	1	0	160	1646	163	2	51	611	23	3	TCGA-JW-A5VL-01	163	0.4223561381821857	83	TCGA-JW-A5VL-01	5	6	47	0.054082866218261784	TCGA-JW-A5VL-01	8	9	3	20	hypermutated sample	1789	TCGA-JW-A5VL	CESC	37	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	G1	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13604	Alive	TUMOR FREE	474	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	474	0	474	0	474	0	474	
40	TCGA-JW-A69B	0	12	0	2	1	0	0	0	3	34	1	0	3	18	1	0	TCGA-JW-A69B-01	202	0.2552086549045507	133	TCGA-JW-A69B-01	9	7	85	0.13781248960833595	TCGA-JW-A69B-01	6	5	9	20	PASS	1790	TCGA-JW-A69B	CESC	44	FEMALE	WHITE	NA	Stage IB2	Endocervical Type of Adenocarcinoma	GX	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16080	Alive	TUMOR FREE	863	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	863	0	863	0	863	0	863	
40	TCGA-JW-A852	1	20	0	4	0	1	0	0	4	73	6	0	0	36	0	0	TCGA-JW-A852-01	138	0.2402752519606041	60	TCGA-JW-A852-01	2	4	21	0.012562714981064971	TCGA-JW-A852-01	6	3	0	9	PASS	1791	TCGA-JW-A852	CESC	42	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G2	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15682	Dead	WITH TUMOR	NA	252	Cervical Cancer	New Primary Tumor	NA	Breast	153	Complete Remission/Response	NA	NA	1	252	1	252	0	252	1	153	
50	TCGA-JW-AAVH	2	18	2	11	3	1	0	0	9	88	8	0	1	32	0	0	TCGA-JW-AAVH-01	127	0.20583771125471648	75	TCGA-JW-AAVH-01	5	7	91	0.2019120808055306	TCGA-JW-AAVH-01	5	2	3	10	PASS	1792	TCGA-JW-AAVH	CESC	46	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16894	Alive	TUMOR FREE	552	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	552	0	552	0	552	0	552	
30	TCGA-JX-A3PZ	0	14	0	3	0	0	0	0	2	38	4	0	2	18	0	0	TCGA-JX-A3PZ-01	139	0.5250507629578234	66	TCGA-JX-A3PZ-01	10	11	33	0.10675692354724252	TCGA-JX-A3PZ-01	11	4	8	23	PASS	1793	TCGA-JX-A3PZ	CESC	25	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	1995	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-9303	Dead	WITH TUMOR	NA	642	Cervical Cancer	Locoregional Recurrence	"Other, specify"	Pelvis	491	Complete Remission/Response	NA	NA	1	642	1	642	1	491	1	491	
60	TCGA-JX-A3Q0	13	158	9	43	0	2	2	0	54	590	64	0	21	266	6	0	TCGA-JX-A3Q0-01	117	0.7439891929127209	65	TCGA-JX-A3Q0-01	10	8	18	0.045672686153291335	TCGA-JX-A3Q0-01	2	2	1	5	hypermutated sample	1794	TCGA-JX-A3Q0	CESC	63	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage III	Cervical Squamous Cell Carcinoma	G2	1997	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23313	Alive	TUMOR FREE	6375	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	6375	0	6375	0	6375	0	6375	
40	TCGA-JX-A3Q8	1	11	1	3	0	1	0	0	3	49	0	0	4	17	4	0	TCGA-JX-A3Q8-01	195	0.5992713346938022	117	TCGA-JX-A3Q8-01	18	19	26	0.16245519032600714	TCGA-JX-A3Q8-01	6	5	6	17	PASS	1795	TCGA-JX-A3Q8	CESC	40	FEMALE	ASIAN	NA	Stage IB1	Endocervical Type of Adenocarcinoma	G3	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14839	Alive	TUMOR FREE	1357	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1357	0	1357	0	1357	0	1357	
40	TCGA-JX-A5QV	1	12	0	1	1	0	0	0	2	41	1	0	1	19	0	0	TCGA-JX-A5QV-01	121	0.5850293502760007	59	TCGA-JX-A5QV-01	21	24	44	0.13738104238382598	TCGA-JX-A5QV-01	6	5	2	13	PASS	1796	TCGA-JX-A5QV	CESC	37	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13667	Alive	TUMOR FREE	636	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	636	0	636	0	636	0	636	
40	TCGA-LP-A4AU	2	8	2	3	1	0	0	0	5	35	4	0	1	22	1	0	TCGA-LP-A4AU-01	80	0.414002386045252	28	TCGA-LP-A4AU-01	18	28	38	0.11625406409015834	TCGA-LP-A4AU-01	9	4	5	18	PASS	1797	TCGA-LP-A4AU	CESC	35	FEMALE	ASIAN	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13074	Alive	TUMOR FREE	343	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	343	0	343	NA	NA	0	343	
60	TCGA-LP-A4AV	6	85	4	18	1	3	0	0	21	304	39	2	17	117	5	0	TCGA-LP-A4AV-01	86	0.28893048895977275	34	TCGA-LP-A4AV-01	5	7	36	0.06886559124054638	TCGA-LP-A4AV-01	10	5	6	21	PASS	1798	TCGA-LP-A4AV	CESC	63	FEMALE	ASIAN	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	2011	[Not Evaluated]	NA	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
50	TCGA-LP-A4AW	3	29	3	5	3	0	0	1	11	78	7	0	5	30	1	0	TCGA-LP-A4AW-01	133	0.29540557692068725	64	TCGA-LP-A4AW-01	5	10	93	0.2415077142256486	TCGA-LP-A4AW-01	17	15	12	44	PASS	1799	TCGA-LP-A4AW	CESC	52	FEMALE	ASIAN	NA	Stage IA	Cervical Squamous Cell Carcinoma	G1	2011	Peri (6-12 months since last menstrual period)	-19079	Alive	TUMOR FREE	27	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	27	0	27	NA	NA	0	27	
50	TCGA-LP-A4AX	0	11	0	2	0	0	1	0	6	32	4	0	1	17	0	0	TCGA-LP-A4AX-01	103	0.3705953301957151	39	TCGA-LP-A4AX-01	7	9	69	0.206251965432742	TCGA-LP-A4AX-01	10	4	10	24	PASS	1800	TCGA-LP-A4AX	CESC	45	FEMALE	ASIAN	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2011	Peri (6-12 months since last menstrual period)	-16544	Alive	TUMOR FREE	380	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	380	0	380	0	380	0	380	
30	TCGA-LP-A5U2	4	44	2	10	0	0	0	0	11	169	12	0	10	55	2	1	TCGA-LP-A5U2-01	151	0.464587971814902	80	TCGA-LP-A5U2-01	10	11	32	0.08591587279963765	TCGA-LP-A5U2-01	6	4	6	16	PASS	1801	TCGA-LP-A5U2	CESC	30	FEMALE	ASIAN	NA	Stage IIIB	Endocervical Adenocarcinoma of the Usual Type	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11049	Alive	TUMOR FREE	9	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	9	0	9	0	9	0	9	
40	TCGA-LP-A5U3	0	7	0	1	0	0	0	0	2	33	4	0	2	15	0	0	TCGA-LP-A5U3-01	169	0.2556819896873839	101	TCGA-LP-A5U3-01	3	7	54	0.11775338644531574	TCGA-LP-A5U3-01	13	10	5	28	PASS	1802	TCGA-LP-A5U3	CESC	40	FEMALE	ASIAN	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14698	Alive	TUMOR FREE	25	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	25	0	25	0	25	0	25	
50	TCGA-LP-A7HU	3	43	0	11	2	1	3	0	14	121	11	0	3	60	3	0	TCGA-LP-A7HU-01	122	0.5403088350970949	62	TCGA-LP-A7HU-01	21	20	152	0.5829864287224857	TCGA-LP-A7HU-01	2	4	6	12	PASS	1803	TCGA-LP-A7HU	CESC	53	FEMALE	ASIAN	NA	Stage II	Endocervical Type of Adenocarcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19595	Alive	TUMOR FREE	406	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	406	0	406	0	406	0	406	
50	TCGA-MA-AA3W	0	11	1	6	1	0	0	0	1	50	7	0	2	16	1	0	TCGA-MA-AA3W-01	104	0.26816937675495023	49	TCGA-MA-AA3W-01	5	10	61	0.1839804383075452	TCGA-MA-AA3W-01	12	15	10	37	PASS	1804	TCGA-MA-AA3W	CESC	54	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20066	Alive	TUMOR FREE	685	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	685	0	685	0	685	0	685	
50	TCGA-MA-AA3X	0	24	1	2	2	0	0	0	2	49	4	0	1	31	1	0	TCGA-MA-AA3X-01	113	0.522447286065678	55	TCGA-MA-AA3X-01	22	25	44	0.13743221409556938	TCGA-MA-AA3X-01	1	0	1	2	PASS	1805	TCGA-MA-AA3X	CESC	50	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18412	Alive	TUMOR FREE	617	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	617	0	617	0	617	0	617	
50	TCGA-MA-AA3Y	2	44	1	11	2	1	0	0	13	128	14	0	5	55	2	0	TCGA-MA-AA3Y-01	149	0.11184188191687534	78	TCGA-MA-AA3Y-01	5	6	43	0.06643520483251464	TCGA-MA-AA3Y-01	8	2	2	12	PASS	1806	TCGA-MA-AA3Y	CESC	48	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17795	Alive	TUMOR FREE	542	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	542	0	542	0	542	0	542	
40	TCGA-MA-AA3Z	3	44	3	12	1	0	1	0	15	140	12	0	8	64	2	0	TCGA-MA-AA3Z-01	154	0.14110372874200308	89	TCGA-MA-AA3Z-01	3	2	65	0.10250943428230999	TCGA-MA-AA3Z-01	9	6	4	19	PASS	1807	TCGA-MA-AA3Z	CESC	43	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	GX	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15762	Alive	TUMOR FREE	595	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	595	0	595	0	595	0	595	
30	TCGA-MA-AA41	17	140	4	26	1	0	1	0	29	369	43	0	14	164	6	0	TCGA-MA-AA41-01	191	0.7908300387970921	99	TCGA-MA-AA41-01	9	10	72	0.1263586760454102	TCGA-MA-AA41-01	11	6	5	22	PASS	1808	TCGA-MA-AA41	CESC	33	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G2	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12398	Alive	WITH TUMOR	279	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	279	0	279	NA	NA	0	279	
80	TCGA-MA-AA42	4	146	8	20	36	15	7	0	22	363	21	0	18	165	13	0	TCGA-MA-AA42-01	186	0.5114120482459611	122	TCGA-MA-AA42-01	12	10	426	0.2782761460193428	TCGA-MA-AA42-01	9	1	7	17	PASS	1809	TCGA-MA-AA42	CESC	75	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27460	Alive	TUMOR FREE	259	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	259	0	259	0	259	0	259	
50	TCGA-MA-AA43	1	17	2	3	2	1	0	0	5	49	6	0	3	15	1	0	TCGA-MA-AA43-01	86	0.7203525653706362	36	TCGA-MA-AA43-01	27	57	30	0.19857027686681186	TCGA-MA-AA43-01	7	6	1	14	PASS	1810	TCGA-MA-AA43	CESC	48	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2013	Peri (6-12 months since last menstrual period)	-17658	Alive	TUMOR FREE	346	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	346	0	346	0	346	0	346	
30	TCGA-MU-A51Y	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-MU-A51Y-01	74	0.10535163621301004	19	TCGA-MU-A51Y-01	2	5	17	0.04972719329024634	TCGA-MU-A51Y-01	5	3	2	10	PASS	1811	TCGA-MU-A51Y	CESC	27	FEMALE	WHITE	NA	Stage IIA1	Cervical Squamous Cell Carcinoma	G2	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-10199	Alive	TUMOR FREE	854	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	854	0	854	0	854	0	854	
60	TCGA-MU-A5YI	1	21	0	6	1	0	0	0	2	56	5	0	2	30	0	0	TCGA-MU-A5YI-01	157	0.23838435266318886	88	TCGA-MU-A5YI-01	9	9	57	0.19034330964766275	TCGA-MU-A5YI-01	8	0	9	17	PASS	1812	TCGA-MU-A5YI	CESC	60	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA1	Cervical Squamous Cell Carcinoma	G2	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21927	Alive	WITH TUMOR	1053	NA	NA	Distant Metastasis	"Other, specify"	Thoracic Spine	630	NA	NA	NA	0	1053	0	1053	NA	NA	1	630	
50	TCGA-MU-A8JM	2	30	1	11	1	2	0	0	13	72	9	0	4	42	2	0	TCGA-MU-A8JM-01	56	0.12405823619091408	17	TCGA-MU-A8JM-01	4	6	27	0.07456626265245363	TCGA-MU-A8JM-01	4	1	3	8	PASS	1813	TCGA-MU-A8JM	CESC	46	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2013	[Unknown]	-17156	Alive	TUMOR FREE	607	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	607	0	607	0	607	0	607	
60	TCGA-MY-A5BD	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-MY-A5BD-01	122	0.1851219582602147	59	TCGA-MY-A5BD-01	2	5	48	0.11866571990015025	TCGA-MY-A5BD-01	8	8	5	21	PASS	1814	TCGA-MY-A5BD	CESC	62	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22901	Alive	TUMOR FREE	1667	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1667	0	1667	NA	NA	0	1667	
40	TCGA-MY-A5BE	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-MY-A5BE-01	54	0.1495283078382989	14	TCGA-MY-A5BE-01	15	32	60	0.2576108822036848	TCGA-MY-A5BE-01	4	4	1	9	PASS	1815	TCGA-MY-A5BE	CESC	42	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-15466	Alive	TUMOR FREE	1066	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1066	0	1066	0	1066	0	1066	
70	TCGA-MY-A5BF	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-MY-A5BF-01	71	0.306033589754312	23	TCGA-MY-A5BF-01	7	11	42	0.18628029006070368	TCGA-MY-A5BF-01	8	4	8	20	PASS	1816	TCGA-MY-A5BF	CESC	68	FEMALE	WHITE	NA	Stage IIA2	Cervical Squamous Cell Carcinoma	G1	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25082	Alive	TUMOR FREE	634	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	634	0	634	NA	NA	0	634	
30	TCGA-MY-A913	3	36	4	15	1	0	0	0	10	139	16	0	6	51	0	0	TCGA-MY-A913-01	162	0.8280740165991732	89	TCGA-MY-A913-01	17	17	52	0.1317891196731243	TCGA-MY-A913-01	12	9	7	28	PASS	1817	TCGA-MY-A913	CESC	28	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIA	Cervical Squamous Cell Carcinoma	G3	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-10379	Alive	TUMOR FREE	524	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	524	0	524	0	524	0	524	
40	TCGA-PN-A8MA	8	35	2	7	1	1	1	0	6	123	10	0	3	44	2	0	TCGA-PN-A8MA-01	165	0.4919197830204835	97	TCGA-PN-A8MA-01	20	56	102	0.24844184437569736	TCGA-PN-A8MA-01	11	4	4	19	PASS	1818	TCGA-PN-A8MA	CESC	43	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G3	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15918	Alive	WITH TUMOR	90	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	90	0	90	NA	NA	0	90	
30	TCGA-Q1-A5R1	1	10	1	5	1	1	0	0	9	48	9	0	3	20	0	0	TCGA-Q1-A5R1-01	65	0.18441955124365975	22	TCGA-Q1-A5R1-01	1	1	8	0.05354906220819754	TCGA-Q1-A5R1-01	3	3	1	7	PASS	1819	TCGA-Q1-A5R1	CESC	32	FEMALE	WHITE	NA	Stage IB1	Mucinous Adenocarcinoma of Endocervical Type	G2	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11705	Alive	TUMOR FREE	474	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	474	0	474	0	474	0	474	
60	TCGA-Q1-A5R2	1	93	7	16	1	2	1	0	31	309	33	1	13	139	2	0	TCGA-Q1-A5R2-01	150	0.6793311167657884	75	TCGA-Q1-A5R2-01	14	36	39	0.13145885098622484	TCGA-Q1-A5R2-01	16	18	6	40	PASS	1820	TCGA-Q1-A5R2	CESC	64	FEMALE	WHITE	NA	NA	Cervical Squamous Cell Carcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23523	Alive	TUMOR FREE	499	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	499	0	499	NA	NA	0	499	
60	TCGA-Q1-A5R3	0	9	2	5	1	1	0	0	3	51	4	0	0	19	1	0	TCGA-Q1-A5R3-01	118	0.4420613296348749	61	TCGA-Q1-A5R3-01	12	18	75	0.1566392032671263	TCGA-Q1-A5R3-01	11	6	7	24	PASS	1821	TCGA-Q1-A5R3	CESC	56	FEMALE	WHITE	NA	NA	Cervical Squamous Cell Carcinoma	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20574	Alive	TUMOR FREE	485	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	485	0	485	0	485	0	485	
60	TCGA-Q1-A6DT	4	31	5	6	5	1	0	0	18	131	14	0	3	46	1	0	TCGA-Q1-A6DT-01	356	0.6441557685015814	211	TCGA-Q1-A6DT-01	20	44	84	0.1934743265074048	TCGA-Q1-A6DT-01	21	12	9	42	PASS	1822	TCGA-Q1-A6DT	CESC	55	FEMALE	WHITE	NA	Stage I	Cervical Squamous Cell Carcinoma	GX	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20286	Dead	WITH TUMOR	NA	275	Cervical Cancer	NA	NA	NA	NA	NA	NA	NA	1	275	1	275	NA	NA	1	275	
40	TCGA-Q1-A6DV	0	9	3	5	3	0	0	0	4	18	1	0	2	13	2	0	TCGA-Q1-A6DV-01	104	0.002617658014672685	51	TCGA-Q1-A6DV-01	0	0	19	0.0021189910580926494	TCGA-Q1-A6DV-01	0	0	0	0	PASS	1823	TCGA-Q1-A6DV	CESC	36	FEMALE	ASIAN	NA	Stage IB1	Mucinous Adenocarcinoma of Endocervical Type	G2	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13166	Alive	TUMOR FREE	491	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	491	0	491	0	491	0	491	
40	TCGA-Q1-A6DW	2	22	3	6	1	0	1	0	4	87	6	0	1	29	0	0	TCGA-Q1-A6DW-01	107	0.3072889521893992	51	TCGA-Q1-A6DW-01	6	10	44	0.10291849411732948	TCGA-Q1-A6DW-01	9	7	6	22	PASS	1824	TCGA-Q1-A6DW	CESC	44	FEMALE	WHITE	NA	Stage I	Cervical Squamous Cell Carcinoma	GX	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16200	Alive	NA	534	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	534	0	534	NA	NA	0	534	
40	TCGA-Q1-A73O	22	404	18	84	5	2	0	0	118	1125	111	2	26	473	34	4	TCGA-Q1-A73O-01	110	0.036469522184946576	48	TCGA-Q1-A73O-01	1	2	24	0.0038097561791779646	TCGA-Q1-A73O-01	2	0	0	2	hypermutated sample	1825	TCGA-Q1-A73O	CESC	37	FEMALE	[Not Evaluated]	NA	Stage IB2	Cervical Squamous Cell Carcinoma	GX	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13601	Alive	TUMOR FREE	428	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	428	0	428	0	428	0	428	
50	TCGA-Q1-A73P	4	65	7	28	5	1	1	0	24	180	24	1	6	71	5	0	TCGA-Q1-A73P-01	109	0.05683791936051001	55	TCGA-Q1-A73P-01	2	6	43	0.0716137443784452	TCGA-Q1-A73P-01	4	2	5	11	PASS	1826	TCGA-Q1-A73P	CESC	45	FEMALE	WHITE	NA	Stage IB1	Endocervical Type of Adenocarcinoma	G1	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16450	Alive	TUMOR FREE	483	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	483	0	483	0	483	0	483	
50	TCGA-Q1-A73Q	3	19	0	4	2	1	1	0	6	51	1	0	1	24	0	0	TCGA-Q1-A73Q-01	134	0.2439018894276736	72	TCGA-Q1-A73Q-01	5	6	36	0.11062435004000852	TCGA-Q1-A73Q-01	7	7	5	19	PASS	1827	TCGA-Q1-A73Q	CESC	46	FEMALE	WHITE	NA	Stage I	Cervical Squamous Cell Carcinoma	GX	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16851	Alive	WITH TUMOR	284	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	284	0	284	NA	NA	0	284	
50	TCGA-Q1-A73R	0	16	0	9	0	2	0	0	6	38	4	0	5	11	1	0	TCGA-Q1-A73R-01	106	0.12786973842703958	45	TCGA-Q1-A73R-01	1	2	11	0.033351793942161284	TCGA-Q1-A73R-01	2	2	2	6	PASS	1828	TCGA-Q1-A73R	CESC	45	FEMALE	WHITE	NA	Stage I	Endocervical Type of Adenocarcinoma	GX	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16701	Alive	TUMOR FREE	567	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	567	0	567	0	567	0	567	
30	TCGA-Q1-A73S	0	13	2	2	1	0	0	0	0	18	2	0	2	7	1	0	TCGA-Q1-A73S-01	120	0.380088011665738	58	TCGA-Q1-A73S-01	13	9	83	0.2182564643307939	TCGA-Q1-A73S-01	6	11	8	25	PASS	1829	TCGA-Q1-A73S	CESC	33	FEMALE	WHITE	NA	Stage IB1	Adenosquamous	G2	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12229	Alive	TUMOR FREE	688	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	688	0	688	0	688	0	688	
40	TCGA-R2-A69V	0	20	2	7	0	0	0	0	10	83	6	0	3	40	1	0	TCGA-R2-A69V-01	85	0.3467265436286288	32	TCGA-R2-A69V-01	8	21	86	0.2607549623569012	TCGA-R2-A69V-01	17	27	11	55	PASS	1830	TCGA-R2-A69V	CESC	42	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G3	2011	Peri (6-12 months since last menstrual period)	-15479	Alive	TUMOR FREE	596	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	596	0	596	0	596	0	596	
30	TCGA-RA-A741	0	18	1	2	2	0	0	0	6	45	2	0	4	11	1	0	TCGA-RA-A741-01	124	0.1971966606845479	51	TCGA-RA-A741-01	7	5	45	0.08473107271666527	TCGA-RA-A741-01	6	1	7	14	PASS	1831	TCGA-RA-A741	CESC	34	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	GX	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12607	Alive	TUMOR FREE	444	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	444	0	444	0	444	0	444	
30	TCGA-UC-A7PD	0	10	0	5	0	0	0	0	3	27	3	0	2	13	0	0	TCGA-UC-A7PD-01	154	0.3893753473972844	97	TCGA-UC-A7PD-01	1	3	32	0.0413141055694934	TCGA-UC-A7PD-01	5	3	2	10	PASS	1832	TCGA-UC-A7PD	CESC	21	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	1997	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-7855	Dead	WITH TUMOR	NA	355	Cervical Cancer	Locoregional Recurrence	NA	vaginal cuff	202	Complete Remission/Response	NA	NA	1	355	1	355	1	202	1	202	
40	TCGA-UC-A7PF	9	106	6	34	2	0	2	0	40	297	38	2	21	154	4	1	TCGA-UC-A7PF-01	102	0.25368334932472675	47	TCGA-UC-A7PF-01	7	9	34	0.11232599727110618	TCGA-UC-A7PF-01	13	6	6	25	PASS	1833	TCGA-UC-A7PF	CESC	44	FEMALE	[Not Evaluated]	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	1999	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16412	Dead	NA	NA	2859	NA	NA	NA	NA	NA	NA	NA	NA	1	2859	NA	2859	NA	NA	0	2859	
40	TCGA-UC-A7PG	15	129	2	27	2	0	0	0	38	398	35	0	18	163	7	1	TCGA-UC-A7PG-01	114	0.8584666905344128	56	TCGA-UC-A7PG-06	24	31	43	0.1451219992277267	TCGA-UC-A7PG-06	4	3	3	10	mutation call filter	1834	TCGA-UC-A7PG	CESC	44	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G1	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16231	Dead	WITH TUMOR	NA	370	Cervical Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	370	1	370	NA	NA	1	370	
40	TCGA-UC-A7PI	1	13	1	4	1	0	0	0	3	42	4	0	0	17	1	1	TCGA-UC-A7PI-01	85	0.14843488168704935	31	TCGA-UC-A7PI-01	6	4	21	0.0637231414818854	TCGA-UC-A7PI-01	3	1	3	7	PASS	1835	TCGA-UC-A7PI	CESC	44	FEMALE	WHITE	NA	Stage IB1	Endometrioid Adenocarcinoma of Endocervix	G1	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16427	Alive	TUMOR FREE	2114	NA	NA	Locoregional Recurrence	"Other, specify"	NA	778	Complete Remission/Response	NA	NA	0	2114	0	2114	1	778	1	778	
40	TCGA-VS-A8EB	2	16	1	8	1	0	0	0	7	57	3	1	1	23	0	0	TCGA-VS-A8EB-01	203	0.7592127273674208	97	TCGA-VS-A8EB-01	18	29	95	0.2488144474717337	TCGA-VS-A8EB-01	20	11	10	41	PASS	1836	TCGA-VS-A8EB	CESC	41	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	GX	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15215	Dead	WITH TUMOR	NA	305	Cervical Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	305	1	305	NA	NA	1	305	
60	TCGA-VS-A8EC	4	25	0	11	2	2	2	0	8	105	2	0	6	52	5	0	TCGA-VS-A8EC-01	597	0.48937931657891703	421	TCGA-VS-A8EC-01	16	31	201	0.2434836888889781	TCGA-VS-A8EC-01	16	13	5	34	PASS	1837	TCGA-VS-A8EC	CESC	55	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2011	Peri (6-12 months since last menstrual period)	-20286	Alive	TUMOR FREE	1415	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1415	0	1415	0	1415	0	1415	
40	TCGA-VS-A8EG	0	7	1	1	1	0	2	0	3	32	2	0	2	13	0	0	TCGA-VS-A8EG-01	142	0.14522114798508096	81	TCGA-VS-A8EG-01	2	5	38	0.08206841461993551	TCGA-VS-A8EG-01	7	8	6	21	PASS	1838	TCGA-VS-A8EG	CESC	36	FEMALE	[Unknown]	NA	Stage IB1	Cervical Squamous Cell Carcinoma	GX	2011	Peri (6-12 months since last menstrual period)	-13166	Alive	TUMOR FREE	1386	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1386	0	1386	0	1386	0	1386	
60	TCGA-VS-A8EH	0	21	1	3	0	0	1	0	4	52	5	0	2	25	0	0	TCGA-VS-A8EH-01	263	0.6412576849094144	158	TCGA-VS-A8EH-01	13	31	99	0.18124732183329206	TCGA-VS-A8EH-01	14	8	7	29	PASS	1839	TCGA-VS-A8EH	CESC	56	FEMALE	[Unknown]	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2012	Peri (6-12 months since last menstrual period)	-20728	Alive	TUMOR FREE	986	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	986	0	986	0	986	0	986	
40	TCGA-VS-A8EI	2	22	2	6	0	0	0	0	9	99	14	0	3	35	4	0	TCGA-VS-A8EI-01	145	0.5462689654687998	71	TCGA-VS-A8EI-01	9	17	106	0.4124234311625074	TCGA-VS-A8EI-01	19	12	16	47	PASS	1840	TCGA-VS-A8EI	CESC	38	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	GX	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14129	Alive	TUMOR FREE	729	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	729	0	729	0	729	0	729	
60	TCGA-VS-A8EJ	4	37	0	9	8	0	1	0	7	104	13	0	5	35	2	0	TCGA-VS-A8EJ-01	599	0.9934593588529506	418	TCGA-VS-A8EJ-01	16	36	251	0.3784282870611467	TCGA-VS-A8EJ-01	22	28	9	59	PASS	1841	TCGA-VS-A8EJ	CESC	60	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22000	Dead	WITH TUMOR	NA	607	Cervical Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	607	1	607	NA	NA	1	607	
70	TCGA-VS-A8EK	7	48	5	13	5	2	0	0	14	171	14	1	8	79	4	1	TCGA-VS-A8EK	0	0	0	TCGA-VS-A8EK	0	0	0	0	TCGA-VS-A8EK	0	0	0	0	PASS	1842	TCGA-VS-A8EK	CESC	65	FEMALE	WHITE	NA	Stage IVA	Cervical Squamous Cell Carcinoma	G2	2008	[Not Evaluated]	-23817	Dead	WITH TUMOR	NA	829	Cervical Cancer	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	829	1	829	NA	NA	1	829	
40	TCGA-VS-A8EL	8	61	2	21	3	0	0	0	22	279	17	0	3	106	2	1	TCGA-VS-A8EL-01	188	0.381117346493202	120	TCGA-VS-A8EL-01	4	9	49	0.14040305765394778	TCGA-VS-A8EL-01	7	6	6	19	PASS	1843	TCGA-VS-A8EL	CESC	38	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G3	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14162	Alive	TUMOR FREE	1992	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1992	0	1992	0	1992	0	1992	
30	TCGA-VS-A8Q8	4	23	1	4	0	2	0	0	9	63	4	0	0	31	2	0	TCGA-VS-A8Q8-01	86	0.3216642033726665	29	TCGA-VS-A8Q8-01	10	10	66	0.26247598224323354	TCGA-VS-A8Q8-01	9	5	6	20	PASS	1844	TCGA-VS-A8Q8	CESC	26	FEMALE	WHITE	NA	Stage IB	Cervical Squamous Cell Carcinoma	G2	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-9571	Dead	WITH TUMOR	NA	978	Cervical Cancer	Locoregional Recurrence	NA	Pelvis	488	Progressive Disease	NA	NA	1	978	1	978	NA	NA	1	488	
80	TCGA-VS-A8Q9	0	13	1	3	2	2	0	0	4	32	1	0	0	25	2	0	TCGA-VS-A8Q9-01	168	0.2914037700884701	89	TCGA-VS-A8Q9-01	10	13	66	0.15005326330974592	TCGA-VS-A8Q9-01	11	7	8	26	PASS	1845	TCGA-VS-A8Q9	CESC	79	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28881	Alive	TUMOR FREE	1630	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1630	0	1630	0	1630	0	1630	
40	TCGA-VS-A8QA	4	46	4	11	0	3	1	0	14	147	8	0	10	58	1	0	TCGA-VS-A8QA-01	157	0.2385706070175931	87	TCGA-VS-A8QA-01	8	10	30	0.10446759452524476	TCGA-VS-A8QA-01	5	2	3	10	PASS	1846	TCGA-VS-A8QA	CESC	44	FEMALE	[Unknown]	NA	Stage IB1	Cervical Squamous Cell Carcinoma	GX	2011	Peri (6-12 months since last menstrual period)	-16072	Alive	TUMOR FREE	1099	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1099	0	1099	0	1099	0	1099	
50	TCGA-VS-A8QC	3	32	2	6	5	1	0	0	9	113	12	0	1	49	2	1	TCGA-VS-A8QC-01	156	0.5301819279957442	80	TCGA-VS-A8QC-01	12	13	84	0.24114249783951805	TCGA-VS-A8QC-01	11	9	11	31	PASS	1847	TCGA-VS-A8QC	CESC	51	FEMALE	WHITE	NA	Stage IVA	Cervical Squamous Cell Carcinoma	G2	2009	Peri (6-12 months since last menstrual period)	-18743	Dead	WITH TUMOR	NA	350	Cervical Cancer	Distant Metastasis	NA	Liver	263	Progressive Disease	NA	NA	1	350	1	350	NA	NA	1	263	
40	TCGA-VS-A8QF	3	22	1	8	1	0	0	0	8	92	11	1	4	34	0	1	TCGA-VS-A8QF-01	366	0.6422616926969711	233	TCGA-VS-A8QF-01	7	13	234	0.3139594924455434	TCGA-VS-A8QF-01	15	8	15	38	PASS	1848	TCGA-VS-A8QF	CESC	42	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G2	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15374	Alive	TUMOR FREE	1800	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1800	0	1800	0	1800	0	1800	
80	TCGA-VS-A8QH	2	41	3	2	0	1	0	0	9	104	7	0	6	24	2	0	TCGA-VS-A8QH-01	179	0.4116440461426837	108	TCGA-VS-A8QH-01	8	11	102	0.1882325326076935	TCGA-VS-A8QH-01	7	3	3	13	PASS	1849	TCGA-VS-A8QH	CESC	76	FEMALE	WHITE	NA	Stage IB1	Mucinous Adenocarcinoma of Endocervical Type	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27909	Dead	WITH TUMOR	NA	1210	Cervical Cancer	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	1210	1	1210	NA	NA	1	1210	
50	TCGA-VS-A8QM	1	20	2	7	2	0	0	0	5	87	5	0	1	30	2	0	TCGA-VS-A8QM-01	56	0.08862622092424921	20	TCGA-VS-A8QM-01	5	38	60	0.4929182173335197	TCGA-VS-A8QM-01	2	0	2	4	PASS	1850	TCGA-VS-A8QM	CESC	47	FEMALE	[Unknown]	NA	Stage IVB	Cervical Squamous Cell Carcinoma	GX	2009	NA	-17168	Dead	WITH TUMOR	NA	951	Cervical Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	951	1	951	NA	NA	1	951	
40	TCGA-VS-A94W	0	24	3	4	0	0	0	0	4	54	8	0	3	19	0	0	TCGA-VS-A94W-01	110	0.18624905675268408	51	TCGA-VS-A94W-01	7	12	54	0.1912694070423252	TCGA-VS-A94W-01	6	4	5	15	PASS	1851	TCGA-VS-A94W	CESC	39	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G2	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14399	Alive	TUMOR FREE	1243	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1243	0	1243	0	1243	0	1243	
40	TCGA-VS-A94X	3	70	3	19	3	1	0	0	27	220	31	0	14	83	6	0	TCGA-VS-A94X-01	167	0.9834900934662528	98	TCGA-VS-A94X-01	13	35	175	0.5409260033583503	TCGA-VS-A94X-01	7	2	5	14	PASS	1852	TCGA-VS-A94X	CESC	40	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G2	2010	[Not Evaluated]	-14955	Dead	WITH TUMOR	NA	506	Cervical Cancer	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	506	1	506	NA	NA	1	506	
50	TCGA-VS-A94Y	1	7	1	2	1	0	1	0	3	38	2	0	1	19	1	0	TCGA-VS-A94Y-01	308	0.9375642602911618	188	TCGA-VS-A94Y-01	9	18	184	0.39752626852404455	TCGA-VS-A94Y-01	22	16	16	54	PASS	1853	TCGA-VS-A94Y	CESC	47	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	GX	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17465	Dead	WITH TUMOR	NA	144	Cervical Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	144	1	144	NA	NA	1	144	
40	TCGA-VS-A94Z	16	187	7	46	65	19	3	0	51	518	37	1	21	226	9	0	TCGA-VS-A94Z-01	92	0.23735716304012056	43	TCGA-VS-A94Z-01	7	8	52	0.15926288769129215	TCGA-VS-A94Z-01	6	3	9	18	hypermutated sample	1854	TCGA-VS-A94Z	CESC	38	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G2	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14046	Alive	TUMOR FREE	1015	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1015	0	1015	0	1015	0	1015	
40	TCGA-VS-A950	3	18	2	4	1	0	0	0	5	81	9	0	2	36	1	1	TCGA-VS-A950-01	99	0.6284987618317411	41	TCGA-VS-A950-01	24	60	81	0.3232253723881988	TCGA-VS-A950-01	15	10	11	36	PASS	1855	TCGA-VS-A950	CESC	42	FEMALE	[Unknown]	NA	Stage IIIA	Cervical Squamous Cell Carcinoma	G3	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15365	Alive	WITH TUMOR	1221	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1221	0	1221	NA	NA	0	1221	
70	TCGA-VS-A952	1	29	5	11	4	2	1	0	7	91	8	0	4	44	2	0	TCGA-VS-A952-01	193	0.1538770368043683	115	TCGA-VS-A952-01	5	6	59	0.08691744372088947	TCGA-VS-A952-01	8	4	7	19	PASS	1856	TCGA-VS-A952	CESC	66	FEMALE	WHITE	NA	Stage IB1	Mucinous Adenocarcinoma of Endocervical Type	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24345	Alive	TUMOR FREE	1778	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1778	0	1778	0	1778	0	1778	
60	TCGA-VS-A953	7	98	7	22	1	1	0	0	41	290	26	1	18	139	4	0	TCGA-VS-A953-01	295	0.7711085359827193	188	TCGA-VS-A953-01	29	53	57	0.09860937750328946	TCGA-VS-A953-01	9	7	2	18	PASS	1857	TCGA-VS-A953	CESC	63	FEMALE	[Unknown]	NA	Stage IVA	Cervical Squamous Cell Carcinoma	GX	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23277	Dead	WITH TUMOR	NA	477	Cervical Cancer	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	477	1	477	NA	NA	1	477	
70	TCGA-VS-A954	1	23	1	7	2	0	0	0	8	55	6	0	2	43	2	0	TCGA-VS-A954-01	111	0.4862893916691548	51	TCGA-VS-A954-01	9	8	47	0.06315554785130625	TCGA-VS-A954-01	3	4	5	12	PASS	1858	TCGA-VS-A954	CESC	67	FEMALE	[Unknown]	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24498	Alive	TUMOR FREE	1714	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1714	0	1714	0	1714	0	1714	
60	TCGA-VS-A957	1	17	1	5	2	0	0	1	0	49	4	0	5	21	4	0	TCGA-VS-A957-01	110	0.2705356807790145	53	TCGA-VS-A957-01	3	7	60	0.14248630400628168	TCGA-VS-A957-01	6	6	6	18	PASS	1859	TCGA-VS-A957	CESC	64	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23585	Alive	TUMOR FREE	1688	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1688	0	1688	0	1688	0	1688	
50	TCGA-VS-A958	16	230	9	54	1	0	0	0	61	659	58	2	20	249	14	1	TCGA-VS-A958-01	149	0.16151131651716796	81	TCGA-VS-A958-01	4	6	58	0.12691007087022885	TCGA-VS-A958-01	4	3	2	9	hypermutated sample	1860	TCGA-VS-A958	CESC	46	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G2	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16905	Alive	TUMOR FREE	1525	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1525	0	1525	0	1525	0	1525	
80	TCGA-VS-A959	4	71	2	14	2	0	0	0	12	204	19	0	5	94	2	0	TCGA-VS-A959-01	102	0.555250407897164	49	TCGA-VS-A959-01	14	34	87	0.2414029564925007	TCGA-VS-A959-01	16	20	5	41	PASS	1861	TCGA-VS-A959	CESC	76	FEMALE	[Unknown]	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27897	Alive	TUMOR FREE	1561	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1561	0	1561	0	1561	0	1561	
60	TCGA-VS-A9U5	2	27	1	4	2	0	0	0	6	64	4	0	2	36	2	0	TCGA-VS-A9U5-01	198	0.7567367081074583	106	TCGA-VS-A9U5-01	22	32	94	0.25704401331177273	TCGA-VS-A9U5-01	19	21	12	52	PASS	1862	TCGA-VS-A9U5	CESC	57	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G3	2010	Peri (6-12 months since last menstrual period)	-21149	Alive	TUMOR FREE	1535	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1535	0	1535	0	1535	0	1535	
50	TCGA-VS-A9U6	12	123	6	30	43	17	7	1	33	316	26	0	9	163	9	0	TCGA-VS-A9U6-01	171	0.4093981475145781	91	TCGA-VS-A9U6-01	9	15	91	0.1602477486231887	TCGA-VS-A9U6-01	13	3	7	23	PASS	1863	TCGA-VS-A9U6	CESC	52	FEMALE	WHITE	NA	Stage IVB	Cervical Squamous Cell Carcinoma	GX	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19109	Alive	WITH TUMOR	1320	NA	NA	Distant Metastasis	NA	Diaphragm	711	Stable Disease	NA	NA	0	1320	0	1320	NA	NA	1	711	
30	TCGA-VS-A9U7	3	47	4	13	2	0	0	0	13	128	15	1	6	51	1	1	TCGA-VS-A9U7-01	169	0.17915398782895375	92	TCGA-VS-A9U7-01	1	4	106	0.14003947417750584	TCGA-VS-A9U7-01	15	11	8	34	PASS	1864	TCGA-VS-A9U7	CESC	30	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G3	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11210	Alive	TUMOR FREE	1472	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1472	0	1472	0	1472	0	1472	
60	TCGA-VS-A9UA	6	46	0	13	0	0	1	0	17	132	17	1	5	62	3	0	TCGA-VS-A9UA-01	97	0.23442084522670625	49	TCGA-VS-A9UA-01	6	12	37	0.07497963103519978	TCGA-VS-A9UA-01	8	7	4	19	PASS	1865	TCGA-VS-A9UA	CESC	60	FEMALE	WHITE	NA	Stage IIIA	Cervical Squamous Cell Carcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22221	Alive	TUMOR FREE	867	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	867	0	867	0	867	0	867	
50	TCGA-VS-A9UB	4	26	2	6	2	0	0	0	9	85	4	0	4	29	3	0	TCGA-VS-A9UB-01	145	0.9508271640077072	77	TCGA-VS-A9UB-01	11	38	90	0.3136068765550307	TCGA-VS-A9UB-01	10	11	10	31	PASS	1866	TCGA-VS-A9UB	CESC	54	FEMALE	[Unknown]	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19737	Alive	TUMOR FREE	911	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	911	0	911	0	911	0	911	
30	TCGA-VS-A9UC	2	40	2	12	1	0	0	0	15	132	21	1	6	46	3	0	TCGA-VS-A9UC-01	143	0.35416825924921913	76	TCGA-VS-A9UC-01	4	9	61	0.14804284774608298	TCGA-VS-A9UC-01	9	12	6	27	PASS	1867	TCGA-VS-A9UC	CESC	32	FEMALE	[Unknown]	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G2	2012	Peri (6-12 months since last menstrual period)	-11790	Alive	WITH TUMOR	825	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	825	0	825	NA	NA	0	825	
70	TCGA-VS-A9UD	3	48	5	5	2	2	0	0	13	132	15	0	4	79	1	0	TCGA-VS-A9UD-01	143	0.8233663120338341	61	TCGA-VS-A9UD-01	28	26	83	0.2708733744591162	TCGA-VS-A9UD-01	15	11	9	35	PASS	1868	TCGA-VS-A9UD	CESC	73	FEMALE	WHITE	NA	Stage IIIA	Cervical Squamous Cell Carcinoma	G2	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26815	Alive	TUMOR FREE	739	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	739	0	739	0	739	0	739	
50	TCGA-VS-A9UH	6	59	3	12	0	0	1	0	13	168	19	1	6	58	3	1	TCGA-VS-A9UH-01	82	0.2806919509092175	30	TCGA-VS-A9UH-01	22	23	19	0.049658321247259066	TCGA-VS-A9UH-01	11	6	0	17	PASS	1869	TCGA-VS-A9UH	CESC	53	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IVA	Cervical Squamous Cell Carcinoma	GX	2010	NA	-19454	Alive	TUMOR FREE	1427	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1427	0	1427	NA	NA	0	1427	
80	TCGA-VS-A9UI	4	24	1	9	0	0	1	0	4	107	10	0	5	53	3	0	TCGA-VS-A9UI-01	165	0.7847759981656273	94	TCGA-VS-A9UI-01	15	38	118	0.35953143465008297	TCGA-VS-A9UI-01	9	6	5	20	PASS	1870	TCGA-VS-A9UI	CESC	76	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	GX	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27838	Dead	TUMOR FREE	NA	1372	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1372	0	1372	0	1372	0	1372	
60	TCGA-VS-A9UJ	5	116	3	17	59	18	4	1	19	222	18	0	8	99	13	0	TCGA-VS-A9UJ-01	79	0.0009745968650250262	31	TCGA-VS-A9UJ-01	0	0	11	0.0003857754383165078	TCGA-VS-A9UJ-01	0	0	0	0	PASS	1871	TCGA-VS-A9UJ	CESC	55	FEMALE	[Unknown]	NA	Stage IIB	Cervical Squamous Cell Carcinoma	GX	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-20264	Dead	WITH TUMOR	NA	52	Cervical Cancer	NA	NA	NA	NA	NA	NA	NA	1	52	1	52	NA	NA	1	52	
80	TCGA-VS-A9UL	1	30	5	6	0	1	0	0	15	103	7	0	5	45	1	1	TCGA-VS-A9UL-01	153	0.6471639852784269	81	TCGA-VS-A9UL-01	18	63	4	0.003743386323422776	TCGA-VS-A9UL-01	14	16	0	30	PASS	1872	TCGA-VS-A9UL	CESC	79	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29033	Dead	WITH TUMOR	NA	442	Cervical Cancer	Distant Metastasis	NA	Bone	336	Progressive Disease	NA	NA	1	442	1	442	NA	NA	1	336	
40	TCGA-VS-A9UM	3	21	2	3	4	0	0	0	6	44	6	0	3	26	3	0	TCGA-VS-A9UM-01	119	0.3292658999865289	57	TCGA-VS-A9UM-01	6	7	53	0.17230979405334798	TCGA-VS-A9UM-01	6	5	3	14	PASS	1873	TCGA-VS-A9UM	CESC	39	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IVB	Cervical Squamous Cell Carcinoma	G2	2011	Peri (6-12 months since last menstrual period)	-14255	Dead	TUMOR FREE	NA	829	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	829	0	829	NA	NA	0	829	
40	TCGA-VS-A9UO	2	8	0	2	3	0	0	0	2	38	3	0	0	16	4	0	TCGA-VS-A9UO-01	195	0.783040500258662	104	TCGA-VS-A9UO-01	5	9	112	0.2912919929431574	TCGA-VS-A9UO-01	17	17	9	43	PASS	1874	TCGA-VS-A9UO	CESC	43	FEMALE	WHITE	NA	Stage IIB	Mucinous Adenocarcinoma of Endocervical Type	G2	2011	Peri (6-12 months since last menstrual period)	-15813	Alive	TUMOR FREE	1456	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1456	0	1456	0	1456	0	1456	
40	TCGA-VS-A9UP	6	49	4	7	3	0	1	0	12	147	23	0	6	59	5	0	TCGA-VS-A9UP-01	235	0.6260508928883249	133	TCGA-VS-A9UP-01	28	52	139	0.3949356793481021	TCGA-VS-A9UP-01	23	13	12	48	PASS	1875	TCGA-VS-A9UP	CESC	43	FEMALE	[Unknown]	NA	Stage IIA	Mucinous Adenocarcinoma of Endocervical Type	G3	2011	Peri (6-12 months since last menstrual period)	-15849	Alive	WITH TUMOR	1444	NA	NA	Distant Metastasis	"Other, specify"	Paraortic lymph nodes	352	Complete Remission/Response	NA	NA	0	1444	0	1444	1	352	1	352	
30	TCGA-VS-A9UQ	1	14	0	1	1	0	0	0	3	22	1	0	0	6	0	0	TCGA-VS-A9UQ-01	122	0.15444444132266286	59	TCGA-VS-A9UQ-01	2	5	50	0.12408426571157274	TCGA-VS-A9UQ-01	7	9	6	22	PASS	1876	TCGA-VS-A9UQ	CESC	32	FEMALE	[Unknown]	NA	Stage IB	Mucinous Adenocarcinoma of Endocervical Type	G2	2011	Peri (6-12 months since last menstrual period)	-11853	Alive	TUMOR FREE	1263	NA	NA	Distant Metastasis	"Other, specify"	Ovary	561	Complete Remission/Response	NA	NA	0	1263	0	1263	1	561	1	561	
50	TCGA-VS-A9UR	1	33	0	13	2	0	0	0	5	87	10	0	5	36	3	1	TCGA-VS-A9UR-01	106	0.9473498547996076	50	TCGA-VS-A9UR-01	5	7	80	0.18753615405484095	TCGA-VS-A9UR-01	5	9	7	21	PASS	1877	TCGA-VS-A9UR	CESC	53	FEMALE	WHITE	NA	Stage IIA	Mucinous Adenocarcinoma of Endocervical Type	GX	2013	[Unknown]	-19688	Alive	WITH TUMOR	793	NA	NA	Distant Metastasis	"Other, specify"	Retroperitoneal	675	Complete Remission/Response	NA	NA	0	793	0	793	1	675	1	675	
70	TCGA-VS-A9UT	0	12	0	0	0	1	0	0	2	19	4	0	1	14	1	0	TCGA-VS-A9UT-01	258	0.8247888744715787	168	TCGA-VS-A9UT-01	13	14	165	0.3796645856922233	TCGA-VS-A9UT-01	12	9	14	35	PASS	1878	TCGA-VS-A9UT	CESC	72	FEMALE	ASIAN	NA	Stage IB	Mucinous Adenocarcinoma of Endocervical Type	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26603	Alive	TUMOR FREE	482	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	482	0	482	0	482	0	482	
40	TCGA-VS-A9UU	3	14	0	2	1	0	0	0	2	53	5	0	1	21	2	0	TCGA-VS-A9UU-01	104	0.5038148065867697	57	TCGA-VS-A9UU-01	23	53	13	0.04775671670519472	TCGA-VS-A9UU-01	4	2	1	7	PASS	1879	TCGA-VS-A9UU	CESC	42	FEMALE	[Unknown]	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G1	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15534	Alive	TUMOR FREE	442	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	442	0	442	0	442	0	442	
70	TCGA-VS-A9UV	4	18	1	6	2	0	2	0	7	68	7	0	6	31	1	0	TCGA-VS-A9UV-01	138	0.3111586784054424	72	TCGA-VS-A9UV-01	10	14	77	0.25346479479383816	TCGA-VS-A9UV-01	12	5	10	27	PASS	1880	TCGA-VS-A9UV	CESC	74	FEMALE	[Unknown]	NA	Stage IVA	Cervical Squamous Cell Carcinoma	GX	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27348	Dead	WITH TUMOR	NA	104	Cervical Cancer	NA	NA	NA	NA	[Unknown]	NA	NA	1	104	1	104	NA	NA	1	104	
30	TCGA-VS-A9UY	0	32	2	7	2	2	3	1	9	84	14	0	4	43	1	1	TCGA-VS-A9UY-01	174	0.2016088820874256	84	TCGA-VS-A9UY-01	5	11	80	0.13979534708864122	TCGA-VS-A9UY-01	11	7	9	27	PASS	1881	TCGA-VS-A9UY	CESC	29	FEMALE	[Unknown]	NA	Stage IVB	Cervical Squamous Cell Carcinoma	G2	2012	[Unknown]	-10707	Dead	WITH TUMOR	NA	555	Cervical Cancer	Distant Metastasis	Head & Neck	NA	412	Progressive Disease	NA	NA	1	555	1	555	NA	NA	1	412	
60	TCGA-VS-A9UZ	6	49	6	21	2	0	2	0	21	129	15	0	5	56	2	1	TCGA-VS-A9UZ-01	98	0.05481978253849381	45	TCGA-VS-A9UZ-01	1	3	31	0.04609381173266176	TCGA-VS-A9UZ-01	5	2	2	9	PASS	1882	TCGA-VS-A9UZ	CESC	61	FEMALE	WHITE	NA	Stage IB1	Mucinous Adenocarcinoma of Endocervical Type	G2	2009	Peri (6-12 months since last menstrual period)	-22344	Alive	TUMOR FREE	2044	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2044	0	2044	0	2044	0	2044	
60	TCGA-VS-A9V0	2	9	0	2	3	0	0	0	5	37	0	0	2	18	0	0	TCGA-VS-A9V0-01	405	0.4734635135235472	271	TCGA-VS-A9V0-01	10	8	141	0.23469677286871224	TCGA-VS-A9V0-01	12	14	13	39	PASS	1883	TCGA-VS-A9V0	CESC	58	FEMALE	[Unknown]	NA	Stage IB	Mucinous Adenocarcinoma of Endocervical Type	G3	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-21215	Alive	WITH TUMOR	573	NA	NA	Distant Metastasis	"Other, specify"	Retroperitoneal lymph node and pelvic lymph node and lung	475	Complete Remission/Response	NA	NA	0	573	0	573	1	475	1	475	
50	TCGA-VS-A9V1	3	51	3	9	1	1	0	0	10	124	10	0	3	56	7	0	TCGA-VS-A9V1-01	81	0.1525408889660765	28	TCGA-VS-A9V1-01	2	5	44	0.10639695315386508	TCGA-VS-A9V1-01	6	5	5	16	PASS	1884	TCGA-VS-A9V1	CESC	46	FEMALE	WHITE	NA	Stage IVB	Mucinous Adenocarcinoma of Endocervical Type	G2	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17001	Dead	WITH TUMOR	NA	157	Cervical Cancer	Distant Metastasis	NA	Retroperitoneo	58	Progressive Disease	NA	NA	1	157	1	157	NA	NA	1	58	
30	TCGA-VS-A9V2	0	9	0	2	2	1	0	0	2	35	0	0	2	15	0	0	TCGA-VS-A9V2-01	118	0.2822695902927321	52	TCGA-VS-A9V2-01	6	9	66	0.1933227766920284	TCGA-VS-A9V2-01	16	10	10	36	PASS	1885	TCGA-VS-A9V2	CESC	29	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2013	Peri (6-12 months since last menstrual period)	-10637	Alive	TUMOR FREE	555	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	555	0	555	0	555	0	555	
60	TCGA-VS-A9V3	6	38	3	12	6	0	0	0	21	127	12	0	7	51	4	0	TCGA-VS-A9V3-01	119	0.3806396519711982	59	TCGA-VS-A9V3-01	7	6	47	0.09907185498390324	TCGA-VS-A9V3-01	5	4	2	11	PASS	1886	TCGA-VS-A9V3	CESC	62	FEMALE	WHITE	NA	Stage IVB	Cervical Squamous Cell Carcinoma	G3	2013	[Not Evaluated]	-22990	Alive	WITH TUMOR	540	NA	NA	Distant Metastasis	"Other, specify"	Mediastinal lymph nodes	456	Complete Remission/Response	NA	NA	0	540	0	540	NA	NA	1	456	
60	TCGA-VS-A9V4	1	33	3	2	1	2	0	0	12	96	6	0	3	35	3	0	TCGA-VS-A9V4-01	82	0.4307795500765622	27	TCGA-VS-A9V4-01	17	34	73	0.3406216812196265	TCGA-VS-A9V4-01	12	5	5	22	PASS	1887	TCGA-VS-A9V4	CESC	63	FEMALE	WHITE	NA	Stage IVA	Mucinous Adenocarcinoma of Endocervical Type	G2	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23334	Dead	WITH TUMOR	NA	132	Cervical Cancer	New Primary Tumor	NA	Sigmoid colon	100	[Unknown]	NA	NA	1	132	1	132	NA	NA	1	100	
50	TCGA-VS-A9V5	2	36	4	17	2	1	0	0	10	101	10	1	2	42	2	0	TCGA-VS-A9V5-01	116	0.13297380111825402	62	TCGA-VS-A9V5-01	4	3	57	0.10634034844457166	TCGA-VS-A9V5-01	7	2	5	14	PASS	1888	TCGA-VS-A9V5	CESC	50	FEMALE	WHITE	NA	Stage IIB	Mucinous Adenocarcinoma of Endocervical Type	G2	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18577	Dead	WITH TUMOR	NA	494	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	494	1	494	NA	NA	1	494	
50	TCGA-VS-AA62	3	32	3	6	0	0	0	0	3	83	3	0	6	26	2	0	TCGA-VS-AA62-01	82	0.1039728592142451	29	TCGA-VS-AA62-01	3	6	6	0.003368819319058201	TCGA-VS-AA62-01	4	2	0	6	PASS	1889	TCGA-VS-AA62	CESC	51	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G2	2009	Peri (6-12 months since last menstrual period)	-18792	Dead	WITH TUMOR	NA	469	Cervical Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	469	1	469	NA	NA	1	469	
60	TCGA-WL-A834	2	14	2	5	1	0	0	0	4	81	3	0	2	31	2	0	TCGA-WL-A834-01	155	0.43654152932925466	78	TCGA-WL-A834-01	12	18	68	0.23116838378995705	TCGA-WL-A834-01	9	5	7	21	PASS	1890	TCGA-WL-A834	CESC	57	FEMALE	WHITE	NA	NA	Cervical Squamous Cell Carcinoma	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	NA	Alive	TUMOR FREE	791	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	791	0	791	NA	NA	0	791	
40	TCGA-XS-A8TJ	2	18	1	5	0	2	0	0	8	68	12	0	3	35	2	0	TCGA-XS-A8TJ-01	96	0.5665710567491016	43	TCGA-XS-A8TJ-01	20	60	77	0.3252234028499217	TCGA-XS-A8TJ-01	8	3	7	18	PASS	1891	TCGA-XS-A8TJ	CESC	41	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15298	Alive	TUMOR FREE	890	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	890	0	890	0	890	0	890	
70	TCGA-ZJ-A8QO	1	14	1	1	3	1	1	0	4	51	5	0	2	22	3	0	TCGA-ZJ-A8QO-01	151	0.4581548913363137	77	TCGA-ZJ-A8QO-01	17	10	69	0.19683727018728744	TCGA-ZJ-A8QO-01	5	2	5	12	PASS	1892	TCGA-ZJ-A8QO	CESC	73	FEMALE	[Unknown]	NA	NA	Cervical Squamous Cell Carcinoma	NA	2007	[Unknown]	-26723	Alive	NA	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
30	TCGA-ZJ-A8QQ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-ZJ-A8QQ-01	228	0.3436396043223805	131	TCGA-ZJ-A8QQ-01	5	10	114	0.2792576236942965	TCGA-ZJ-A8QQ-01	17	11	14	42	PASS	1893	TCGA-ZJ-A8QQ	CESC	24	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	GX	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-8918	Alive	TUMOR FREE	2056	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2056	0	2056	0	2056	0	2056	
40	TCGA-ZJ-A8QR	1	26	2	10	2	1	1	0	10	103	11	0	7	37	4	1	TCGA-ZJ-A8QR-01	219	0.4312267215122837	127	TCGA-ZJ-A8QR-01	5	12	59	0.10358407226562152	TCGA-ZJ-A8QR-01	13	12	8	33	PASS	1894	TCGA-ZJ-A8QR	CESC	38	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NA	Stage I	Cervical Squamous Cell Carcinoma	GX	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14225	Dead	NA	NA	582	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	582	NA	582	NA	NA	0	582	
90	TCGA-ZJ-AAX4	1	16	0	1	0	0	0	0	8	44	1	0	0	23	0	0	TCGA-ZJ-AAX4-01	125	0.8709521115800719	61	TCGA-ZJ-AAX4-01	16	20	95	0.25773939136031604	TCGA-ZJ-AAX4-01	8	5	9	22	PASS	1895	TCGA-ZJ-AAX4	CESC	85	FEMALE	WHITE	NA	Stage II	Cervical Squamous Cell Carcinoma	G3	2008	[Unknown]	-31258	Alive	NA	21	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	21	0	21	NA	NA	0	21	
60	TCGA-ZJ-AAX8	1	18	0	2	2	0	0	0	4	51	7	0	3	21	1	0	TCGA-ZJ-AAX8-01	133	0.10031924485559286	59	TCGA-ZJ-AAX8-01	1	7	55	0.10767968908786647	TCGA-ZJ-AAX8-01	9	5	2	16	PASS	1896	TCGA-ZJ-AAX8	CESC	58	FEMALE	[Unknown]	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2009	[Unknown]	-21481	Alive	NA	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
60	TCGA-ZJ-AAXA	4	16	0	5	1	0	0	0	2	47	7	0	4	29	1	0	TCGA-ZJ-AAXA-01	141	0.8982870705374871	75	TCGA-ZJ-AAXA-01	17	34	68	0.2339521605203139	TCGA-ZJ-AAXA-01	4	5	1	10	PASS	1897	TCGA-ZJ-AAXA	CESC	64	FEMALE	WHITE	NA	Stage IB1	Cervical Squamous Cell Carcinoma	G2	2009	[Unknown]	-23603	Alive	NA	43	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	43	0	43	NA	NA	0	43	
40	TCGA-ZJ-AAXB	5	39	2	9	6	3	2	0	9	112	5	0	9	47	4	0	TCGA-ZJ-AAXB-01	214	0.9169208274096504	126	TCGA-ZJ-AAXB-01	23	40	86	0.1735980526595758	TCGA-ZJ-AAXB-01	16	8	4	28	PASS	1898	TCGA-ZJ-AAXB	CESC	42	FEMALE	WHITE	NA	Stage IB2	Endocervical Adenocarcinoma of the Usual Type	G3	2009	[Unknown]	-15492	Alive	NA	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
40	TCGA-ZJ-AAXD	2	19	0	4	1	0	0	0	4	74	6	0	3	26	0	0	TCGA-ZJ-AAXD-01	54	0.6404786586557729	11	TCGA-ZJ-AAXD-01	23	24	28	0.09528140899940106	TCGA-ZJ-AAXD-01	2	0	1	3	PASS	1899	TCGA-ZJ-AAXD	CESC	35	FEMALE	[Unknown]	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2010	[Unknown]	-12968	Alive	NA	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
60	TCGA-ZJ-AAXF	0	10	0	4	0	1	1	0	4	42	3	0	0	19	0	0	TCGA-ZJ-AAXF-01	76	0.2934362490349398	29	TCGA-ZJ-AAXF-01	21	19	28	0.09179854392797704	TCGA-ZJ-AAXF-01	5	4	2	11	PASS	1900	TCGA-ZJ-AAXF	CESC	62	FEMALE	[Unknown]	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G3	2010	[Unknown]	-22709	Alive	NA	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-ZJ-AAXI	1	23	3	4	0	0	0	0	8	53	9	1	1	23	0	0	TCGA-ZJ-AAXI-01	91	0.2280279926936136	39	TCGA-ZJ-AAXI-01	6	9	32	0.10631305736377808	TCGA-ZJ-AAXI-01	7	4	5	16	PASS	1901	TCGA-ZJ-AAXI	CESC	67	FEMALE	[Unknown]	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G2	2010	[Unknown]	-24497	Alive	NA	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
40	TCGA-ZJ-AAXJ	2	22	2	4	3	2	1	0	7	70	12	0	5	37	0	0	TCGA-ZJ-AAXJ-01	204	0.3233954782278289	107	TCGA-ZJ-AAXJ-01	7	12	81	0.21198585172939705	TCGA-ZJ-AAXJ-01	10	8	8	26	PASS	1902	TCGA-ZJ-AAXJ	CESC	43	FEMALE	[Unknown]	NA	Stage IIB	Cervical Squamous Cell Carcinoma	NA	2010	[Unknown]	-16007	Alive	NA	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
30	TCGA-ZJ-AAXN	1	14	1	4	0	1	0	0	1	47	3	0	3	17	0	0	TCGA-ZJ-AAXN-01	150	0.34323633457198705	73	TCGA-ZJ-AAXN-01	3	7	63	0.16469750266651634	TCGA-ZJ-AAXN-01	8	7	4	19	PASS	1903	TCGA-ZJ-AAXN	CESC	34	FEMALE	WHITE	NA	Stage IB2	Cervical Squamous Cell Carcinoma	NA	2010	[Unknown]	-12701	Alive	NA	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
50	TCGA-ZJ-AAXT	4	52	2	9	0	0	0	0	16	118	23	0	5	54	2	0	TCGA-ZJ-AAXT-01	120	0.1972968449613369	64	TCGA-ZJ-AAXT-01	8	9	58	0.1787834798125989	TCGA-ZJ-AAXT-01	5	4	6	15	PASS	1904	TCGA-ZJ-AAXT	CESC	54	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2009	[Unknown]	-19847	Alive	NA	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
50	TCGA-ZJ-AAXU	3	107	1	12	1	0	1	0	21	306	42	1	12	140	7	0	TCGA-ZJ-AAXU-01	149	0.2022805120021577	77	TCGA-ZJ-AAXU-01	9	13	75	0.20623048295860769	TCGA-ZJ-AAXU-01	12	3	5	20	PASS	1905	TCGA-ZJ-AAXU	CESC	51	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	G2	2010	[Unknown]	-18773	Alive	NA	5	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	5	0	5	NA	NA	0	5	
50	TCGA-ZJ-AB0H	3	27	0	6	1	0	0	0	12	92	4	0	3	36	1	0	TCGA-ZJ-AB0H-01	148	0.8166921436511058	85	TCGA-ZJ-AB0H-01	28	68	57	0.16171117766108847	TCGA-ZJ-AB0H-01	15	9	5	29	PASS	1906	TCGA-ZJ-AB0H	CESC	48	FEMALE	[Unknown]	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	NA	2006	[Unknown]	-17869	Alive	NA	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
30	TCGA-ZJ-AB0I	2	27	2	8	2	0	0	1	4	83	4	0	4	24	1	0	TCGA-ZJ-AB0I-01	272	0.35600438532952844	163	TCGA-ZJ-AB0I-01	4	13	100	0.1583845231465375	TCGA-ZJ-AB0I-01	24	20	12	56	PASS	1907	TCGA-ZJ-AB0I	CESC	25	FEMALE	WHITE	NA	Stage IIB	Cervical Squamous Cell Carcinoma	NA	2006	[Unknown]	-9486	Alive	NA	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
60	TCGA-ZX-AA5X	2	10	0	2	0	1	1	0	6	55	3	0	1	21	1	0	TCGA-ZX-AA5X-01	73	0.14618982545499398	32	TCGA-ZX-AA5X-01	4	5	41	0.08387635157556991	TCGA-ZX-AA5X-01	4	6	7	17	PASS	1908	TCGA-ZX-AA5X	CESC	64	FEMALE	WHITE	NA	Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23440	Alive	WITH TUMOR	119	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	119	0	119	NA	NA	0	119	
70	TCGA-3X-AAV9	1	10	0	1	0	0	0	0	3	36	7	0	1	16	0	0	TCGA-3X-AAV9-01	89	0.2030227218581524	32	TCGA-3X-AAV9-01	10	12	89	0.3652252769884154	TCGA-3X-AAV9-01	10	8	12	30	PASS	1909	TCGA-3X-AAV9	CHOL	72	MALE	ASIAN	Stage I	NA	Cholangiocarcinoma; intrahepatic	G2	2010	NA	-26349	Dead	WITH TUMOR	NA	339	NA	Locoregional Recurrence	Liver	NA	216	NA	NA	R0	1	339	1	339	1	216	1	216	
50	TCGA-3X-AAVA	4	4	0	3	1	0	1	0	2	26	2	0	1	16	0	0	TCGA-3X-AAVA-01	100	0.4411463699425824	43	TCGA-3X-AAVA-01	5	5	55	0.15322075775840674	TCGA-3X-AAVA-01	3	1	4	8	PASS	1910	TCGA-3X-AAVA	CHOL	50	FEMALE	WHITE	Stage II	NA	Cholangiocarcinoma; intrahepatic	G2	2012	NA	-18303	Dead	WITH TUMOR	NA	445	NA	Extrahepatic Recurrence	Bone	NA	264	NA	NA	R0	1	445	1	445	1	264	1	264	
70	TCGA-3X-AAVB	1	8	1	2	2	0	0	0	2	25	2	0	0	4	1	0	TCGA-3X-AAVB-01	100	0.5749177921348462	41	TCGA-3X-AAVB-01	24	17	70	0.28674686487030565	TCGA-3X-AAVB-01	8	5	10	23	PASS	1911	TCGA-3X-AAVB	CHOL	70	FEMALE	WHITE	Stage IVB	NA	Cholangiocarcinoma; distal	G1	2012	NA	-25819	Alive	NA	402	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	402	0	402	NA	NA	0	402	
70	TCGA-3X-AAVC	1	8	1	2	2	0	2	0	8	43	2	0	0	15	0	0	TCGA-3X-AAVC-01	144	0.5573292824737627	78	TCGA-3X-AAVC-01	24	30	124	0.4145144533004316	TCGA-3X-AAVC-01	16	6	13	35	pathology review	1912	TCGA-3X-AAVC	CHOL	72	FEMALE	WHITE	Stage I	NA	Cholangiocarcinoma; hilar/perihilar	G3	2012	NA	-26493	Alive	TUMOR FREE	709	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	709	0	709	0	709	0	709	
60	TCGA-3X-AAVE	1	11	0	2	0	1	1	0	4	34	2	0	0	12	0	0	TCGA-3X-AAVE-01	95	0.5890682776155145	42	TCGA-3X-AAVE-01	9	8	70	0.2448443459306858	TCGA-3X-AAVE-01	5	2	7	14	PASS	1913	TCGA-3X-AAVE	CHOL	60	MALE	ASIAN	Stage II	NA	Cholangiocarcinoma; intrahepatic	G2	2013	NA	-21943	Alive	TUMOR FREE	650	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	650	0	650	0	650	0	650	
70	TCGA-4G-AAZF	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-4G-AAZF	0	0	0	TCGA-4G-AAZF	0	0	0	0	TCGA-4G-AAZF	0	0	0	0	PASS	1914	TCGA-4G-AAZF	CHOL	74	FEMALE	WHITE	Stage III	NA	Cholangiocarcinoma; intrahepatic	G2	2010	NA	-27109	Alive	TUMOR FREE	1777	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1777	0	1777	0	1777	0	1777	
80	TCGA-4G-AAZG	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-4G-AAZG	0	0	0	TCGA-4G-AAZG	0	0	0	0	TCGA-4G-AAZG	0	0	0	0	PASS	1915	TCGA-4G-AAZG	CHOL	75	MALE	WHITE	Stage III	NA	Cholangiocarcinoma; intrahepatic	G2	2011	NA	-27490	Alive	TUMOR FREE	1716	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1716	0	1716	0	1716	0	1716	
70	TCGA-4G-AAZO	2	8	0	2	3	1	0	0	2	31	2	0	1	17	0	0	TCGA-4G-AAZO-01	112	0.9464770232750208	50	TCGA-4G-AAZO-01	9	11	34	0.10335100207660164	TCGA-4G-AAZO-01	8	13	5	26	PASS	1916	TCGA-4G-AAZO	CHOL	71	FEMALE	WHITE	Stage II	NA	Cholangiocarcinoma; intrahepatic	G2	2012	NA	-25989	Alive	WITH TUMOR	1177	NA	NA	Intrahepatic Recurrence	Liver	NA	424	NA	NA	R1	0	1177	0	1177	NA	NA	1	424	
70	TCGA-4G-AAZR	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-4G-AAZR	0	0	0	TCGA-4G-AAZR	0	0	0	0	TCGA-4G-AAZR	0	0	0	0	PASS	1917	TCGA-4G-AAZR	CHOL	74	MALE	WHITE	Stage II	NA	Cholangiocarcinoma; hilar/perihilar	G2	2013	NA	-27151	Dead	NA	NA	28	NA	NA	NA	NA	NA	NA	NA	R1	1	28	NA	28	NA	NA	0	28	
60	TCGA-4G-AAZT	0	27	2	8	4	0	0	0	8	71	6	0	0	17	4	0	TCGA-4G-AAZT-01	64	0.5172705480601829	14	TCGA-4G-AAZT-01	5	5	38	0.12343117810987485	TCGA-4G-AAZT-01	5	1	5	11	PASS	1918	TCGA-4G-AAZT	CHOL	62	MALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G2	2013	NA	-22777	Alive	TUMOR FREE	420	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	420	0	420	0	420	0	420	
60	TCGA-W5-AA2G	2	18	1	1	1	2	0	0	5	28	5	0	1	16	0	0	TCGA-W5-AA2G-01	148	0.5718410314225811	84	TCGA-W5-AA2G-01	10	12	114	0.2695245673543834	TCGA-W5-AA2G-01	15	18	13	46	PASS	1919	TCGA-W5-AA2G	CHOL	62	FEMALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G3	2008	NA	-22933	Alive	TUMOR FREE	1976	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1976	0	1976	0	1976	0	1976	
70	TCGA-W5-AA2H	0	4	0	1	0	0	0	0	0	5	1	0	0	1	0	0	TCGA-W5-AA2H-01	43	0.00015105138757712442	10	TCGA-W5-AA2H-01	0	0	15	0.0015376210178262447	TCGA-W5-AA2H-01	0	0	0	0	PASS	1920	TCGA-W5-AA2H	CHOL	70	FEMALE	WHITE	Stage III	NA	Cholangiocarcinoma; distal	G3	2012	NA	-25775	Alive	TUMOR FREE	1077	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1077	0	1077	0	1077	0	1077	
70	TCGA-W5-AA2I	2	18	0	4	6	2	0	2	4	79	6	0	2	14	0	0	TCGA-W5-AA2I-01	85	0.8508358754506893	32	TCGA-W5-AA2I-01	6	6	74	0.2502120781241229	TCGA-W5-AA2I-01	9	7	8	24	PASS	1921	TCGA-W5-AA2I	CHOL	66	MALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G2	2005	NA	-24388	Dead	WITH TUMOR	NA	1939	NA	New Primary Tumor	"Other, specify"	bladder	217	NA	NA	R0	1	1939	1	1939	0	1939	1	217	
70	TCGA-W5-AA2J	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-W5-AA2J	0	0	0	TCGA-W5-AA2J	0	0	0	0	TCGA-W5-AA2J	0	0	0	0	PASS	1922	TCGA-W5-AA2J	CHOL	66	FEMALE	WHITE	Stage IVA	NA	Cholangiocarcinoma; hilar/perihilar	G2	2012	NA	-24140	Alive	TUMOR FREE	916	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	916	0	916	NA	NA	0	916	
80	TCGA-W5-AA2K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-W5-AA2K	0	0	0	TCGA-W5-AA2K	0	0	0	0	TCGA-W5-AA2K	0	0	0	0	PASS	1923	TCGA-W5-AA2K	CHOL	75	FEMALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G3	2008	NA	-27718	Dead	NA	NA	833	NA	NA	NA	NA	NA	NA	NA	R0	1	833	NA	833	0	833	0	833	
50	TCGA-W5-AA2M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-W5-AA2M	0	0	0	TCGA-W5-AA2M	0	0	0	0	TCGA-W5-AA2M	0	0	0	0	PASS	1924	TCGA-W5-AA2M	CHOL	49	MALE	[Unknown]	Stage IVB	NA	Cholangiocarcinoma; hilar/perihilar	G2	2006	NA	-17989	Dead	WITH TUMOR	NA	540	NA	Extrahepatic Recurrence	"Other, specify"	"peritoneum, lungs"	157	NA	NA	R0	1	540	1	540	NA	NA	1	157	
60	TCGA-W5-AA2O	0	14	4	2	2	1	0	2	5	35	7	0	0	16	4	0	TCGA-W5-AA2O-01	151	0.9233279414608712	75	TCGA-W5-AA2O-01	12	9	96	0.3217050002363854	TCGA-W5-AA2O-01	9	5	10	24	PASS	1925	TCGA-W5-AA2O	CHOL	57	MALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G3	2006	NA	-21118	Dead	WITH TUMOR	NA	640	NA	Intrahepatic Recurrence	Liver	NA	215	NA	NA	R0	1	640	1	640	1	215	1	215	
70	TCGA-W5-AA2Q	2	13	2	8	4	2	0	0	3	75	8	0	2	23	0	0	TCGA-W5-AA2Q-01	144	0.8223444004261066	76	TCGA-W5-AA2Q-01	6	10	32	0.036107579807476434	TCGA-W5-AA2Q-01	10	6	2	18	PASS	1926	TCGA-W5-AA2Q	CHOL	68	MALE	WHITE	Stage II	NA	Cholangiocarcinoma; intrahepatic	G2	2006	NA	-25069	Alive	TUMOR FREE	50	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	50	0	50	0	50	0	50	
80	TCGA-W5-AA2R	0	19	0	5	0	0	2	0	2	34	2	0	1	8	4	0	TCGA-W5-AA2R-01	104	0.27870082945636604	46	TCGA-W5-AA2R-01	4	9	83	0.20252999426400115	TCGA-W5-AA2R-01	10	11	7	28	PASS	1927	TCGA-W5-AA2R	CHOL	77	FEMALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G3	2006	NA	-28367	Alive	TUMOR FREE	1542	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1542	0	1542	0	1542	0	1542	
60	TCGA-W5-AA2T	0	30	2	4	0	2	0	0	0	56	4	0	4	30	0	0	TCGA-W5-AA2T-01	213	0.9495077776034369	124	TCGA-W5-AA2T-01	13	13	124	0.24780517623880216	TCGA-W5-AA2T-01	8	5	9	22	PASS	1928	TCGA-W5-AA2T	CHOL	64	FEMALE	WHITE	Stage II	NA	Cholangiocarcinoma; intrahepatic	G3	2008	NA	-23560	Dead	WITH TUMOR	NA	1220	NA	Extrahepatic Recurrence	Bone	NA	295	NA	NA	R0	1	1220	1	1220	1	295	1	295	
80	TCGA-W5-AA2U	2	57	0	6	2	0	4	0	12	115	16	0	3	31	2	0	TCGA-W5-AA2U-01	154	0.9480416133977858	88	TCGA-W5-AA2U-01	8	11	85	0.2941214636710897	TCGA-W5-AA2U-01	12	13	6	31	PASS	1929	TCGA-W5-AA2U	CHOL	78	FEMALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G3	2010	NA	-28552	Dead	WITH TUMOR	NA	627	NA	New Primary Tumor	Lung	NA	95	NA	NA	R0	1	627	1	627	0	627	1	95	
30	TCGA-W5-AA2W	1	7	0	1	1	1	1	0	1	21	2	0	2	3	3	0	TCGA-W5-AA2W-01	103	0.311545091290595	43	TCGA-W5-AA2W-01	6	9	57	0.18525326495095665	TCGA-W5-AA2W-01	9	6	7	22	PASS	1930	TCGA-W5-AA2W	CHOL	31	FEMALE	WHITE	Stage IVA	NA	Cholangiocarcinoma; intrahepatic	G3	2010	NA	-11438	Dead	WITH TUMOR	NA	924	NA	Intrahepatic Recurrence	Liver	NA	237	NA	NA	R0	1	924	1	924	NA	NA	1	237	
70	TCGA-W5-AA2X	0	16	5	4	6	0	2	0	8	84	12	0	0	20	6	0	TCGA-W5-AA2X-01	218	0.7241086046050761	125	TCGA-W5-AA2X-01	29	21	111	0.275602671496189	TCGA-W5-AA2X-01	11	3	9	23	PASS	1931	TCGA-W5-AA2X	CHOL	67	MALE	WHITE	Stage IVB	NA	Cholangiocarcinoma; hilar/perihilar	G4	2010	NA	-24797	Dead	NA	NA	271	NA	NA	NA	NA	NA	NA	NA	RX	1	271	NA	271	NA	NA	0	271	
30	TCGA-W5-AA2Z	1	7	1	3	1	1	0	0	2	18	3	0	0	4	2	0	TCGA-W5-AA2Z-01	70	0.4080806999911982	25	TCGA-W5-AA2Z-01	13	10	43	0.16299840274997301	TCGA-W5-AA2Z-01	6	4	6	16	PASS	1932	TCGA-W5-AA2Z	CHOL	29	FEMALE	WHITE	Stage II	NA	Cholangiocarcinoma; intrahepatic	G3	2010	NA	-10659	Alive	WITH TUMOR	1614	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	1614	0	1614	NA	NA	0	1614	
80	TCGA-W5-AA30	4	26	0	5	2	0	2	0	12	88	4	0	0	43	4	0	TCGA-W5-AA30-01	136	0.6406452784439829	73	TCGA-W5-AA30-01	10	11	107	0.34126144238933315	TCGA-W5-AA30-01	11	12	15	38	PASS	1933	TCGA-W5-AA30	CHOL	82	MALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G3	2010	NA	-30039	Alive	TUMOR FREE	1153	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1153	0	1153	0	1153	0	1153	
70	TCGA-W5-AA31	4	21	2	4	4	0	0	0	3	69	4	0	0	17	2	0	TCGA-W5-AA31-01	406	0.6549890468588908	332	TCGA-W5-AA31-01	23	22	169	0.2314676024017821	TCGA-W5-AA31-01	8	5	6	19	PASS	1934	TCGA-W5-AA31	CHOL	71	MALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G3	2010	NA	-26139	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	10	0	10	0	10	0	10	
60	TCGA-W5-AA33	4	15	2	2	0	0	0	0	8	39	9	0	0	13	2	0	TCGA-W5-AA33-01	98	0.2274218520017275	50	TCGA-W5-AA33-01	7	7	66	0.1894061077618091	TCGA-W5-AA33-01	4	11	8	23	PASS	1935	TCGA-W5-AA33	CHOL	60	MALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G3	2011	NA	-22090	Alive	TUMOR FREE	1449	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1449	0	1449	0	1449	0	1449	
80	TCGA-W5-AA34	0	20	4	10	0	0	2	0	4	64	0	0	0	17	0	0	TCGA-W5-AA34-01	73	0.5216361059492018	22	TCGA-W5-AA34-01	12	10	58	0.22325397989039894	TCGA-W5-AA34-01	9	7	10	26	PASS	1936	TCGA-W5-AA34	CHOL	75	FEMALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G2	2012	NA	-27535	Dead	WITH TUMOR	NA	555	NA	Intrahepatic Recurrence	Liver	NA	40	NA	NA	R0	1	555	1	555	1	40	1	40	
50	TCGA-W5-AA36	1	13	0	2	0	0	0	0	2	36	5	0	2	10	1	0	TCGA-W5-AA36-01	150	0.8365584510093188	97	TCGA-W5-AA36-01	4	5	89	0.19962742030807049	TCGA-W5-AA36-01	4	10	3	17	PASS	1937	TCGA-W5-AA36	CHOL	51	FEMALE	WHITE	Stage IV	NA	Cholangiocarcinoma; hilar/perihilar	G3	2008	NA	-18882	Dead	WITH TUMOR	NA	1402	NA	Intrahepatic Recurrence	Liver	NA	362	NA	NA	R0	1	1402	1	1402	NA	NA	1	362	
60	TCGA-W5-AA38	1	14	1	2	2	1	0	0	3	20	4	0	1	6	2	0	TCGA-W5-AA38-01	64	0.8376185119932227	16	TCGA-W5-AA38-01	8	8	85	0.3293549887145052	TCGA-W5-AA38-01	6	4	7	17	PASS	1938	TCGA-W5-AA38	CHOL	55	FEMALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G3	2011	NA	-20285	Alive	TUMOR FREE	1471	NA	NA	Locoregional Recurrence	Liver	NA	377	NA	NA	R0	0	1471	0	1471	1	377	1	377	
80	TCGA-W5-AA39	18	270	17	64	25	3	9	2	67	557	22	2	26	187	14	2	TCGA-W5-AA39-01	119	0.31594452266781226	61	TCGA-W5-AA39-01	10	7	54	0.11725109158879725	TCGA-W5-AA39-01	6	2	4	12	hypermutated sample	1939	TCGA-W5-AA39	CHOL	81	MALE	WHITE	Stage II	NA	Cholangiocarcinoma; intrahepatic	G4	2010	NA	-29594	Dead	WITH TUMOR	NA	170	NA	NA	NA	NA	NA	NA	NA	RX	1	170	1	170	NA	NA	1	170	
50	TCGA-W6-AA0S	0	6	1	4	2	3	1	0	2	27	2	0	1	9	1	0	TCGA-W6-AA0S-01	146	0.9471227976171732	77	TCGA-W6-AA0S-01	9	12	87	0.2721909795878519	TCGA-W6-AA0S-01	13	6	12	31	PASS	1940	TCGA-W6-AA0S	CHOL	46	FEMALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G2	2013	NA	-16951	Alive	TUMOR FREE	808	NA	NA	Extrahepatic Recurrence	Non-regional / Distant Lymph Nodes	NA	549	NA	NA	R0	0	808	0	808	1	549	1	549	
60	TCGA-W6-AA0T	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-W6-AA0T	0	0	0	TCGA-W6-AA0T	0	0	0	0	TCGA-W6-AA0T	0	0	0	0	PASS	1941	TCGA-W6-AA0T	CHOL	62	FEMALE	WHITE	Stage III	NA	Cholangiocarcinoma; intrahepatic	G2	2013	NA	-23004	Alive	TUMOR FREE	656	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	656	0	656	0	656	0	656	
70	TCGA-WD-A7RX	4	10	0	0	1	0	0	0	2	27	1	0	1	14	0	0	TCGA-WD-A7RX-01	173	0.8073731149132761	107	TCGA-WD-A7RX-01	9	9	81	0.3025541685411268	TCGA-WD-A7RX-01	9	7	11	27	PASS	1942	TCGA-WD-A7RX	CHOL	71	FEMALE	WHITE	Stage II	NA	Cholangiocarcinoma; intrahepatic	G2	2013	NA	-26006	Dead	TUMOR FREE	NA	21	NA	NA	NA	NA	NA	NA	NA	RX	1	21	0	21	NA	NA	0	21	
50	TCGA-YR-A95A	2	12	0	0	1	2	0	0	3	24	0	0	0	10	0	0	TCGA-YR-A95A-01	195	0.7840470334096362	123	TCGA-YR-A95A-01	3	4	80	0.1588148044368443	TCGA-YR-A95A-01	7	7	9	23	PASS	1943	TCGA-YR-A95A	CHOL	52	MALE	WHITE	Stage IV	NA	Cholangiocarcinoma; hilar/perihilar	G2	2009	NA	-19292	Dead	WITH TUMOR	NA	26	NA	New Primary Tumor	"Other, specify"	Adrenal gland	17	NA	NA	R1	1	26	1	26	NA	NA	1	17	
70	TCGA-ZD-A8I3	0	11	0	1	2	1	0	0	0	27	4	0	1	9	1	0	TCGA-ZD-A8I3-01	101	0.6508968963064047	48	TCGA-ZD-A8I3-01	5	4	53	0.1886639101204158	TCGA-ZD-A8I3-01	2	1	2	5	PASS	1944	TCGA-ZD-A8I3	CHOL	73	FEMALE	ASIAN	Stage II	NA	Cholangiocarcinoma; intrahepatic	G3	2013	NA	-26754	Dead	WITH TUMOR	NA	169	NA	Locoregional Recurrence	Liver	NA	59	NA	NA	R0	1	169	1	169	1	59	1	59	
70	TCGA-ZH-A8Y1	0	13	1	1	0	1	0	0	3	35	1	0	1	8	0	0	TCGA-ZH-A8Y1-01	118	0.27740927326423803	59	TCGA-ZH-A8Y1-01	6	7	49	0.12134274434699062	TCGA-ZH-A8Y1-01	8	7	7	22	PASS	1945	TCGA-ZH-A8Y1	CHOL	74	FEMALE	WHITE	Stage IVA	NA	Cholangiocarcinoma; intrahepatic	G2	2012	NA	-27279	Dead	WITH TUMOR	NA	385	NA	Locoregional Recurrence	NA	NA	49	NA	NA	R1	1	385	1	385	NA	NA	1	49	
60	TCGA-ZH-A8Y2	0	10	0	2	3	2	0	0	3	38	3	0	4	11	1	0	TCGA-ZH-A8Y2-01	184	0.7785617834945108	114	TCGA-ZH-A8Y2-01	28	22	134	0.39006355446058105	TCGA-ZH-A8Y2-01	8	3	11	22	PASS	1946	TCGA-ZH-A8Y2	CHOL	59	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Cholangiocarcinoma; intrahepatic	G2	2011	NA	-21743	Dead	WITH TUMOR	NA	701	NA	Locoregional Recurrence	NA	NA	198	NA	NA	R0	1	701	1	701	1	198	1	198	
60	TCGA-ZH-A8Y3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-ZH-A8Y3	0	0	0	TCGA-ZH-A8Y3	0	0	0	0	TCGA-ZH-A8Y3	0	0	0	0	PASS	1947	TCGA-ZH-A8Y3	CHOL	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Cholangiocarcinoma; intrahepatic	G2	2010	NA	-22436	Dead	WITH TUMOR	NA	561	NA	NA	NA	NA	NA	NA	NA	R1	1	561	1	561	NA	NA	1	561	
60	TCGA-ZH-A8Y4	2	16	0	4	3	3	2	0	5	45	5	0	2	13	1	0	TCGA-ZH-A8Y4-01	118	0.8949603977465852	49	TCGA-ZH-A8Y4-01	24	21	60	0.2481317319753265	TCGA-ZH-A8Y4-01	10	7	6	23	PASS	1948	TCGA-ZH-A8Y4	CHOL	58	MALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G3	2010	NA	-21503	Dead	WITH TUMOR	NA	741	NA	Locoregional Recurrence	NA	NA	281	NA	NA	R1	1	741	1	741	NA	NA	1	281	
70	TCGA-ZH-A8Y5	1	11	0	1	0	0	0	0	1	20	1	0	0	9	1	0	TCGA-ZH-A8Y5-01	150	0.3079750819196325	82	TCGA-ZH-A8Y5-01	7	16	84	0.19025745160650315	TCGA-ZH-A8Y5-01	12	15	10	37	PASS	1949	TCGA-ZH-A8Y5	CHOL	69	MALE	WHITE	Stage IVB	NA	Cholangiocarcinoma; intrahepatic	G3	2012	NA	-25268	Alive	WITH TUMOR	1229	NA	NA	Extrahepatic Recurrence	Lung	NA	242	NA	NA	R0	0	1229	0	1229	NA	NA	1	242	
40	TCGA-ZH-A8Y6	1	20	1	4	0	0	0	0	6	36	0	0	3	16	1	0	TCGA-ZH-A8Y6-01	70	0.0012011338110419234	26	TCGA-ZH-A8Y6-01	0	0	11	0.001879165188092009	TCGA-ZH-A8Y6-01	0	0	0	0	PASS	1950	TCGA-ZH-A8Y6	CHOL	41	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Cholangiocarcinoma; intrahepatic	G2	2013	NA	-14976	Alive	TUMOR FREE	519	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	519	0	519	0	519	0	519	
60	TCGA-ZH-A8Y7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-ZH-A8Y7	0	0	0	TCGA-ZH-A8Y7	0	0	0	0	TCGA-ZH-A8Y7	0	0	0	0	PASS	1951	TCGA-ZH-A8Y7	CHOL	59	MALE	WHITE	Stage IVB	NA	Cholangiocarcinoma; intrahepatic	G3	2013	NA	-21880	Alive	WITH TUMOR	755	NA	NA	Intrahepatic Recurrence	NA	NA	301	NA	NA	R1	0	755	0	755	NA	NA	1	301	
70	TCGA-ZH-A8Y8	0	10	0	2	3	1	0	0	1	25	2	0	1	9	0	0	TCGA-ZH-A8Y8-01	107	0.487169965730941	55	TCGA-ZH-A8Y8-01	14	10	89	0.3341985329754128	TCGA-ZH-A8Y8-01	7	6	7	20	PASS	1952	TCGA-ZH-A8Y8	CHOL	73	MALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G2	2013	NA	-26744	Alive	TUMOR FREE	602	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	602	0	602	0	602	0	602	
50	TCGA-ZU-A8S4	2	29	0	4	3	0	0	0	10	85	4	0	4	26	0	0	TCGA-ZU-A8S4-01	86	0.12123749270929805	35	TCGA-ZU-A8S4-01	3	6	62	0.15824202420644046	TCGA-ZU-A8S4-01	8	8	8	24	PASS	1953	TCGA-ZU-A8S4	CHOL	52	MALE	WHITE	Stage I	NA	Cholangiocarcinoma; intrahepatic	G3	2012	NA	-19264	Dead	WITH TUMOR	NA	98	NA	Intrahepatic Recurrence	Liver	NA	72	NA	NA	R0	1	98	1	98	1	72	1	72	
60	TCGA-3L-AA1B	3	7	0	1	1	0	1	0	3	110	7	0	2	49	1	0	TCGA-3L-AA1B-01	116	0.8437721219719834	67	TCGA-3L-AA1B-01	19	21	24	0.031202098948514938	TCGA-3L-AA1B-01	0	1	0	1	PASS	1954	TCGA-3L-AA1B	COAD	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Colon Adenocarcinoma	NA	2013	NA	-22379	Alive	TUMOR FREE	475	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	475	0	475	0	475	0	475	
70	TCGA-4N-A93T	1	8	0	8	4	1	0	0	6	75	5	0	0	42	1	0	TCGA-4N-A93T-01	134	0.947176358053806	79	TCGA-4N-A93T-01	13	11	108	0.2753547974853391	TCGA-4N-A93T-01	5	4	4	13	PASS	1955	TCGA-4N-A93T	COAD	67	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Colon Adenocarcinoma	NA	2013	NA	-24523	Alive	WITH TUMOR	146	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	146	0	146	NA	NA	0	146	
40	TCGA-4T-AA8H	1	9	0	9	2	1	1	0	10	103	10	0	0	38	2	1	TCGA-4T-AA8H-01	80	0.8804613489013247	36	TCGA-4T-AA8H-01	18	23	17	0.028485017644489408	TCGA-4T-AA8H-01	2	1	0	3	PASS	1956	TCGA-4T-AA8H	COAD	42	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2013	NA	-15494	Alive	TUMOR FREE	385	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	385	0	385	0	385	0	385	
70	TCGA-5M-AAT4	1	20	3	5	6	3	0	1	11	154	7	0	5	51	1	0	TCGA-5M-AAT4-01	352	0.65964424598174	261	TCGA-5M-AAT4-01	18	28	121	0.22396506729952426	TCGA-5M-AAT4-01	13	11	9	33	PASS	1957	TCGA-5M-AAT4	COAD	74	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Colon Adenocarcinoma	NA	2009	NA	-27095	Dead	WITH TUMOR	NA	49	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	49	1	49	NA	NA	1	49	
40	TCGA-5M-AAT6	20	221	17	78	259	37	11	0	99	1437	65	2	25	637	35	5	TCGA-5M-AAT6-01	52	0.08268154536905185	14	TCGA-5M-AAT6-01	3	3	14	0.05565553992616728	TCGA-5M-AAT6-01	1	1	2	4	hypermutated sample	1958	TCGA-5M-AAT6	COAD	40	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Colon Adenocarcinoma	NA	2009	NA	-14852	Dead	WITH TUMOR	NA	290	NA	NA	NA	NA	219	Progressive Disease	NA	NA	1	290	1	290	NA	NA	1	219	
80	TCGA-5M-AATE	0	10	1	7	0	2	2	0	5	102	7	0	5	51	1	0	TCGA-5M-AATE-01	159	0.7222567226539336	99	TCGA-5M-AATE-01	20	64	49	0.1177720434461341	TCGA-5M-AATE-01	12	14	3	29	PASS	1959	TCGA-5M-AATE	COAD	76	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-27870	Alive	WITH TUMOR	1200	NA	NA	NA	NA	NA	810	Progressive Disease	NA	NA	0	1200	0	1200	NA	NA	1	810	
50	TCGA-A6-2670	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A6-2670	0	0	0	TCGA-A6-2670	0	0	0	0	TCGA-A6-2670	0	0	0	0	PASS	1960	TCGA-A6-2670	COAD	45	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-16512	Alive	TUMOR FREE	775	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	775	0	775	NA	NA	0	775	Redacted
90	TCGA-A6-2671	2	2	3	4	10	2	5	0	4	97	4	0	0	70	0	0	TCGA-A6-2671-01	182	0.8608992429938525	107	TCGA-A6-2671-01	25	26	35	0.3067358921623751	TCGA-A6-2671-01	11	7	9	27	PASS	1961	TCGA-A6-2671	COAD	85	MALE	WHITE	Stage IV	NA	Colon Adenocarcinoma	NA	2009	NA	-31329	Dead	WITH TUMOR	NA	1331	NA	NA	NA	NA	535	NA	NA	NA	1	1331	1	1331	NA	NA	1	535	
80	TCGA-A6-2672	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A6-2672-01	146	0.0356705084001639	83	TCGA-A6-2672-01	1	2	5	0.0016328937848534555	TCGA-A6-2672-01	0	0	0	0	PASS	1962	TCGA-A6-2672	COAD	82	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2009	NA	-30237	Alive	TUMOR FREE	1419	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1419	0	1419	0	1419	0	1419	
70	TCGA-A6-2674	0	17	2	7	1	3	0	0	11	205	12	0	8	88	3	2	TCGA-A6-2674-01	155	0.4861475284027295	86	TCGA-A6-2674-01	24	27	15	0.22170823869820908	TCGA-A6-2674-01	8	7	4	19	PASS	1963	TCGA-A6-2674	COAD	71	MALE	WHITE	Stage IV	NA	Colon Mucinous Adenocarcinoma	NA	2009	NA	-26292	Alive	TUMOR FREE	1331	NA	NA	NA	NA	NA	735	Complete Remission/Response	NA	NA	0	1331	0	1331	NA	NA	1	735	
80	TCGA-A6-2675	2	16	0	10	4	2	0	0	8	156	11	0	4	87	0	0	TCGA-A6-2675-01	230	0.5231100104005917	141	TCGA-A6-2675-01	21	24	26	0.1498493960831558	TCGA-A6-2675-01	12	7	3	22	PASS	1964	TCGA-A6-2675	COAD	78	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-28813	Alive	TUMOR FREE	1321	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1321	0	1321	0	1321	0	1321	
80	TCGA-A6-2676	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A6-2676-01	181	0.04364106039834157	113	TCGA-A6-2676-01	1	3	16	0.031918251677253096	TCGA-A6-2676-01	2	2	1	5	PASS	1965	TCGA-A6-2676	COAD	75	FEMALE	WHITE	Stage IIB	NA	Colon Adenocarcinoma	NA	2009	NA	-27403	Dead	TUMOR FREE	NA	1305	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1305	0	1305	0	1305	0	1305	
70	TCGA-A6-2677	4	24	4	20	7	2	0	0	12	206	16	0	8	100	2	0	TCGA-A6-2677-01	182	0.2786162718192777	106	TCGA-A6-2677-01	8	9	77	0.12317028879273224	TCGA-A6-2677-01	7	5	5	17	PASS	1966	TCGA-A6-2677	COAD	68	FEMALE	WHITE	Stage IIIC	NA	Colon Adenocarcinoma	NA	2009	NA	-25143	Dead	TUMOR FREE	NA	740	NA	NA	NA	NA	NA	NA	NA	NA	1	740	0	740	NA	NA	0	740	
40	TCGA-A6-2678	0	1	2	0	0	0	0	0	2	50	2	0	0	7	0	0	TCGA-A6-2678-01	175	0.8896834124715125	99	TCGA-A6-2678-01	7	11	31	0.27441220470609384	TCGA-A6-2678-01	11	13	7	31	mutation call filter	1967	TCGA-A6-2678	COAD	43	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2009	NA	-16030	Alive	TUMOR FREE	1286	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1286	0	1286	0	1286	0	1286	
70	TCGA-A6-2679	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A6-2679-01	162	0.6229048885925573	93	TCGA-A6-2679-01	23	30	15	0.230847140599606	TCGA-A6-2679-01	7	12	3	22	PASS	1968	TCGA-A6-2679	COAD	73	FEMALE	WHITE	Stage IIB	NA	Colon Adenocarcinoma	NA	2009	NA	-26820	Alive	TUMOR FREE	1366	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1366	0	1366	0	1366	0	1366	
70	TCGA-A6-2680	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A6-2680-01	92	0.5103873339428584	48	TCGA-A6-2680-01	18	27	5	0.13414456078480488	TCGA-A6-2680-01	2	1	3	6	PASS	1969	TCGA-A6-2680	COAD	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Colon Adenocarcinoma	NA	2009	NA	-26533	Alive	TUMOR FREE	1068	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1068	0	1068	0	1068	0	1068	
70	TCGA-A6-2681	0	19	2	11	3	2	1	0	10	236	10	0	6	73	2	0	TCGA-A6-2681-01	147	0.4913245076742338	83	TCGA-A6-2681-01	13	16	34	0.2780064886373025	TCGA-A6-2681-01	6	7	8	21	PASS	1970	TCGA-A6-2681	COAD	73	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-26929	Alive	TUMOR FREE	1387	NA	NA	NA	NA	NA	1150	Complete Remission/Response	NA	NA	0	1387	0	1387	1	1150	1	1150	
70	TCGA-A6-2682	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A6-2682-01	69	0.38292295432528695	21	TCGA-A6-2682	0	0	0	0	TCGA-A6-2682	0	0	0	0	PASS	1971	TCGA-A6-2682	COAD	70	MALE	WHITE	Stage IV	NA	Colon Adenocarcinoma	NA	2009	NA	-25683	Dead	WITH TUMOR	NA	424	NA	NA	NA	NA	381	NA	NA	NA	1	424	1	424	NA	NA	1	381	
60	TCGA-A6-2683	0	2	0	2	0	0	0	0	2	56	4	0	4	19	4	0	TCGA-A6-2683-01	200	0.6207420539353626	123	TCGA-A6-2683-01	20	63	17	0.2301430076734214	TCGA-A6-2683-01	7	5	3	15	mutation call filter	1972	TCGA-A6-2683	COAD	57	FEMALE	WHITE	Stage IV	NA	Colon Adenocarcinoma	NA	2009	NA	-20871	Dead	WITH TUMOR	NA	504	NA	NA	NA	NA	300	NA	NA	NA	1	504	1	504	NA	NA	1	300	
80	TCGA-A6-2684	1	16	1	4	2	4	0	0	4	177	8	0	2	76	4	0	TCGA-A6-2684-01	69	0.13057725413624302	22	TCGA-A6-2684-01	7	6	46	0.18044650326124065	TCGA-A6-2684-01	3	1	3	7	PASS	1973	TCGA-A6-2684	COAD	75	FEMALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2009	NA	-27708	Alive	TUMOR FREE	1127	NA	NA	Locoregional Disease	NA	NA	976	NA	NA	NA	0	1127	0	1127	NA	NA	1	976	
50	TCGA-A6-2685	2	3	0	8	0	0	0	0	2	79	6	0	2	35	0	0	TCGA-A6-2685-01	143	0.27850056826413033	86	TCGA-A6-2685-01	11	17	27	0.3013188673849676	TCGA-A6-2685-01	7	5	4	16	PASS	1974	TCGA-A6-2685	COAD	48	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-17757	Alive	TUMOR FREE	1133	NA	NA	Locoregional Disease	NA	NA	948	NA	NA	NA	0	1133	0	1133	NA	NA	1	948	
80	TCGA-A6-2686	24	419	12	129	638	140	86	0	163	2907	186	0	61	1366	72	4	TCGA-A6-2686-01	210	0.6082492147200671	135	TCGA-A6-2686-01	19	24	23	0.1096109826270524	TCGA-A6-2686-01	14	19	5	38	hypermutated sample	1975	TCGA-A6-2686	COAD	81	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-29623	Dead	TUMOR FREE	NA	1126	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1126	0	1126	0	1126	0	1126	
50	TCGA-A6-3807	0	6	1	3	1	0	0	0	6	76	8	1	0	22	2	0	TCGA-A6-3807-01	221	0.4806388804016409	132	TCGA-A6-3807-01	16	34	34	0.11317047177175266	TCGA-A6-3807-01	12	4	4	20	mutation call filter	1976	TCGA-A6-3807	COAD	53	FEMALE	WHITE	Stage IIIC	NA	Colon Adenocarcinoma	NA	2009	NA	-19624	Alive	TUMOR FREE	1054	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1054	0	1054	NA	NA	0	1054	
70	TCGA-A6-3808	1	14	1	5	0	6	0	0	2	124	9	0	3	39	4	0	TCGA-A6-3808	0	0	0	TCGA-A6-3808	0	0	0	0	TCGA-A6-3808	0	0	0	0	mutation call filter	1977	TCGA-A6-3808	COAD	73	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-26666	Alive	TUMOR FREE	1014	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1014	0	1014	NA	NA	0	1014	
70	TCGA-A6-3809	4	147	12	47	200	37	16	0	71	840	37	1	18	375	23	3	TCGA-A6-3809-01	65	0.04617429103889679	27	TCGA-A6-3809-01	2	1	11	0.0016076677786933456	TCGA-A6-3809-01	0	0	0	0	hypermutated sample	1978	TCGA-A6-3809	COAD	71	FEMALE	WHITE	Stage IIB	NA	Colon Mucinous Adenocarcinoma	NA	2009	NA	-26274	Alive	TUMOR FREE	996	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	996	0	996	NA	NA	0	996	
60	TCGA-A6-3810	1	20	2	6	1	0	0	0	5	154	8	0	2	54	2	1	TCGA-A6-3810-01	97	0.7050439120240817	42	TCGA-A6-3810-01	22	41	55	0.12542966561620472	TCGA-A6-3810-01	6	6	3	15	PASS	1979	TCGA-A6-3810	COAD	62	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-22999	Alive	TUMOR FREE	1111	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1111	0	1111	0	1111	0	1111	
80	TCGA-A6-4105	1	13	1	10	1	3	0	0	5	133	5	0	4	44	3	0	TCGA-A6-4105-01	128	0.5339411153435285	62	TCGA-A6-4105-01	17	37	16	0.1483846348129198	TCGA-A6-4105-01	7	4	4	15	PASS	1980	TCGA-A6-4105	COAD	79	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-29097	Dead	TUMOR FREE	NA	442	NA	NA	NA	NA	364	NA	NA	NA	1	442	0	442	NA	NA	1	364	
60	TCGA-A6-4107	2	30	2	12	4	6	0	0	5	302	14	0	14	115	6	0	TCGA-A6-4107-01	96	0.6828231838306723	44	TCGA-A6-4107-01	27	33	8	0.04039125562554943	TCGA-A6-4107-01	4	2	1	7	PASS	1981	TCGA-A6-4107	COAD	57	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-21064	Alive	TUMOR FREE	987	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	987	0	987	0	987	0	987	
70	TCGA-A6-5656	0	10	1	12	2	2	2	1	5	91	5	0	2	41	1	0	TCGA-A6-5656-01	122	0.27573925558825163	74	TCGA-A6-5656-01	10	15	67	0.15536833486015553	TCGA-A6-5656-01	9	4	6	19	PASS	1982	TCGA-A6-5656	COAD	74	MALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2010	NA	-27184	Alive	TUMOR FREE	1001	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1001	0	1001	0	1001	0	1001	
70	TCGA-A6-5657	3	25	2	12	4	7	0	0	8	172	12	0	5	78	2	2	TCGA-A6-5657-01	80	0.16861120230442198	33	TCGA-A6-5657-01	8	8	12	0.0620449606382792	TCGA-A6-5657-01	6	2	5	13	PASS	1983	TCGA-A6-5657	COAD	65	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-23920	Alive	TUMOR FREE	962	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	962	0	962	0	962	0	962	
80	TCGA-A6-5659	0	37	2	25	6	2	5	0	35	343	33	0	4	127	4	0	TCGA-A6-5659-01	114	0.6583492130233768	60	TCGA-A6-5659-01	12	15	56	0.2304597807140421	TCGA-A6-5659-01	4	2	4	10	PASS	1984	TCGA-A6-5659	COAD	82	MALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2010	NA	-30028	Alive	TUMOR FREE	926	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	926	0	926	0	926	0	926	
70	TCGA-A6-5660	0	19	0	4	4	6	3	2	11	198	7	0	10	85	4	0	TCGA-A6-5660-01	176	0.4442580116733673	106	TCGA-A6-5660-01	16	34	11	0.17317053076488004	TCGA-A6-5660-01	7	2	2	11	PASS	1985	TCGA-A6-5660	COAD	73	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Colon Adenocarcinoma	NA	2010	NA	-26803	Alive	TUMOR FREE	888	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	888	0	888	0	888	0	888	
80	TCGA-A6-5661	21	282	22	95	304	119	32	0	143	1791	107	2	44	795	41	6	TCGA-A6-5661-01	77	0.03492924543739837	31	TCGA-A6-5661-01	0	1	12	0.021167188856447063	TCGA-A6-5661-01	2	1	1	4	hypermutated sample	1986	TCGA-A6-5661	COAD	80	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-29446	Alive	TUMOR FREE	1020	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1020	0	1020	0	1020	0	1020	
50	TCGA-A6-5662	0	13	0	4	5	1	1	2	4	109	8	0	7	41	0	0	TCGA-A6-5662-01	149	0.35653784364631297	81	TCGA-A6-5662-01	8	15	20	0.22739697338860865	TCGA-A6-5662-01	7	3	7	17	PASS	1987	TCGA-A6-5662	COAD	46	MALE	WHITE	Stage IVA	NA	Colon Adenocarcinoma	NA	2010	NA	-16873	Alive	WITH TUMOR	718	NA	NA	NA	NA	NA	495	NA	NA	NA	0	718	0	718	NA	NA	1	495	
80	TCGA-A6-5664	0	1	0	2	2	0	0	0	0	52	7	0	0	17	1	0	TCGA-A6-5664-01	82	0.06071190698536452	37	TCGA-A6-5664-01	2	2	5	0.019451100315448347	TCGA-A6-5664-01	2	2	1	5	PASS	1988	TCGA-A6-5664	COAD	80	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Colon Adenocarcinoma	NA	2010	NA	-29426	Alive	WITH TUMOR	672	NA	NA	NA	NA	NA	183	NA	NA	NA	0	672	0	672	NA	NA	1	183	
80	TCGA-A6-5665	40	517	16	139	520	251	39	9	171	2454	141	6	56	1062	77	8	TCGA-A6-5665-01	99	0.013255441785937057	45	TCGA-A6-5665-01	1	1	5	0.011966049551534514	TCGA-A6-5665-01	0	0	0	0	hypermutated sample	1989	TCGA-A6-5665	COAD	84	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-30915	Alive	TUMOR FREE	671	NA	NA	NA	NA	NA	529	NA	NA	NA	0	671	0	671	NA	NA	1	529	
80	TCGA-A6-5666	0	21	2	5	6	3	2	0	10	153	8	0	7	44	0	0	TCGA-A6-5666-01	107	0.3220325616509452	53	TCGA-A6-5666-01	11	11	13	0.14130779763110551	TCGA-A6-5666-01	5	3	2	10	PASS	1990	TCGA-A6-5666	COAD	78	MALE	WHITE	Stage IIC	NA	Colon Adenocarcinoma	NA	2010	NA	-28514	Alive	WITH TUMOR	995	NA	NA	NA	NA	NA	509	Complete Remission/Response	NA	NA	0	995	0	995	1	509	1	509	
40	TCGA-A6-5667	0	14	0	2	0	5	3	0	4	97	4	0	4	52	4	0	TCGA-A6-5667-01	125	0.6665561708339335	58	TCGA-A6-5667-01	22	27	21	0.2955228885804338	TCGA-A6-5667-01	8	7	4	19	PASS	1991	TCGA-A6-5667	COAD	40	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-14756	Alive	TUMOR FREE	887	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	887	0	887	0	887	0	887	
60	TCGA-A6-6137	0	13	2	5	1	3	2	0	4	96	8	0	2	34	2	2	TCGA-A6-6137-01	102	0.2602862204859965	46	TCGA-A6-6137-01	8	9	18	0.07468220216663846	TCGA-A6-6137-01	3	5	3	11	PASS	1992	TCGA-A6-6137	COAD	55	MALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-20095	Alive	TUMOR FREE	824	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	824	0	824	0	824	0	824	
60	TCGA-A6-6138	0	8	0	6	2	2	1	0	5	85	3	0	1	47	3	0	TCGA-A6-6138-01	124	0.3082833274568059	67	TCGA-A6-6138-01	9	12	25	0.1948578363543988	TCGA-A6-6138-01	8	6	5	19	PASS	1993	TCGA-A6-6138	COAD	61	MALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2010	NA	-22523	Alive	TUMOR FREE	685	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	685	0	685	NA	NA	0	685	
60	TCGA-A6-6140	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A6-6140-01	94	0.3182604147862331	44	TCGA-A6-6140-01	14	12	13	0.14495612941982186	TCGA-A6-6140-01	7	7	6	20	PASS	1994	TCGA-A6-6140	COAD	62	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-22835	Alive	TUMOR FREE	734	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	734	0	734	0	734	0	734	
30	TCGA-A6-6141	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A6-6141-01	69	0.00020983056026711253	27	TCGA-A6-6141-01	0	0	0	0.0	TCGA-A6-6141-01	0	0	0	0	PASS	1995	TCGA-A6-6141	COAD	31	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-11391	Alive	TUMOR FREE	255	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	255	0	255	NA	NA	0	255	
60	TCGA-A6-6142	1	13	0	5	5	0	1	0	5	64	6	0	1	22	2	0	TCGA-A6-6142-01	123	0.5672660926550372	61	TCGA-A6-6142-01	21	24	14	0.16621719777920405	TCGA-A6-6142-01	6	3	5	14	PASS	1996	TCGA-A6-6142	COAD	56	FEMALE	WHITE	Stage IVA	NA	Colon Adenocarcinoma	NA	2011	NA	-20485	Alive	WITH TUMOR	763	NA	NA	NA	NA	NA	654	Complete Remission/Response	NA	NA	0	763	0	763	NA	NA	1	654	
60	TCGA-A6-6648	0	5	1	2	3	0	2	0	3	72	6	0	1	24	3	0	TCGA-A6-6648-01	196	0.4718022150563016	118	TCGA-A6-6648-01	20	36	49	0.2794843643393713	TCGA-A6-6648-01	10	9	12	31	PASS	1997	TCGA-A6-6648	COAD	56	MALE	WHITE	Stage IVA	NA	Colon Adenocarcinoma	NA	2010	NA	-20641	Alive	WITH TUMOR	766	NA	NA	NA	NA	NA	686	NA	NA	NA	0	766	0	766	NA	NA	1	686	
70	TCGA-A6-6649	1	9	0	1	1	1	2	0	4	104	6	0	3	40	2	0	TCGA-A6-6649-01	100	0.5389492746546365	43	TCGA-A6-6649-01	19	22	7	0.15493381776525902	TCGA-A6-6649-01	6	5	0	11	PASS	1998	TCGA-A6-6649	COAD	66	MALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-24237	Alive	TUMOR FREE	735	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	735	0	735	0	735	0	735	
70	TCGA-A6-6650	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A6-6650-01	127	0.705619537157755	64	TCGA-A6-6650-01	19	24	51	0.16093733705238572	TCGA-A6-6650-01	10	8	6	24	PASS	1999	TCGA-A6-6650	COAD	69	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-25516	Alive	TUMOR FREE	627	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	627	0	627	NA	NA	0	627	
60	TCGA-A6-6651	0	5	0	2	3	1	0	0	3	78	2	0	2	31	0	0	TCGA-A6-6651-01	96	0.5480160305243483	44	TCGA-A6-6651-01	26	28	15	0.37182196168147547	TCGA-A6-6651-01	5	4	4	13	PASS	2000	TCGA-A6-6651	COAD	55	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-20110	Alive	TUMOR FREE	662	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	662	0	662	NA	NA	0	662	
60	TCGA-A6-6652	1	7	0	1	6	0	0	1	5	65	4	0	4	23	0	0	TCGA-A6-6652-01	146	0.8533041928967958	69	TCGA-A6-6652-01	13	11	16	0.06496619313466083	TCGA-A6-6652-01	4	2	3	9	PASS	2001	TCGA-A6-6652	COAD	59	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	NA	Colon Adenocarcinoma	NA	2011	NA	-21638	Alive	WITH TUMOR	751	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	751	0	751	NA	NA	0	751	
80	TCGA-A6-6653	10	127	9	44	149	42	12	0	59	798	33	0	14	368	21	0	TCGA-A6-6653-01	163	0.03968518250906137	98	TCGA-A6-6653-01	1	3	17	0.02948256336950782	TCGA-A6-6653-01	1	1	1	3	hypermutated sample	2002	TCGA-A6-6653	COAD	82	MALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2011	NA	-29996	Alive	TUMOR FREE	742	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	742	0	742	0	742	0	742	
70	TCGA-A6-6654	0	7	3	5	3	2	1	1	3	157	5	0	4	69	0	0	TCGA-A6-6654-01	127	0.6410198412436916	68	TCGA-A6-6654-01	26	32	13	0.16151273778310388	TCGA-A6-6654-01	5	9	5	19	PASS	2003	TCGA-A6-6654	COAD	65	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2011	NA	-23953	Alive	TUMOR FREE	726	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	726	0	726	0	726	0	726	
70	TCGA-A6-6780	10	181	11	58	189	56	16	1	68	825	42	2	19	360	33	2	TCGA-A6-6780-01	66	0.07718105044360593	22	TCGA-A6-6780-01	2	2	26	0.06548443265356872	TCGA-A6-6780-01	2	4	3	9	hypermutated sample	2004	TCGA-A6-6780	COAD	74	MALE	WHITE	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2011	NA	-27250	Alive	TUMOR FREE	612	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	612	0	612	0	612	0	612	
40	TCGA-A6-6781	12	207	16	66	264	65	17	1	91	1461	75	0	35	641	22	0	TCGA-A6-6781-01	39	0.00014752396728754454	5	TCGA-A6-6781-01	0	0	3	0.0002474115604106184	TCGA-A6-6781-01	0	0	0	0	hypermutated sample	2005	TCGA-A6-6781	COAD	43	MALE	WHITE	Stage IIIC	NA	Colon Mucinous Adenocarcinoma	NA	2011	NA	-15842	Alive	TUMOR FREE	598	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	598	0	598	0	598	0	598	
80	TCGA-A6-6782	1	11	0	4	2	0	0	0	4	102	17	0	3	52	1	1	TCGA-A6-6782-01	103	0.4081742490360501	50	TCGA-A6-6782-01	11	13	17	0.12623684277285982	TCGA-A6-6782-01	7	2	2	11	PASS	2006	TCGA-A6-6782	COAD	82	MALE	WHITE	Stage IIB	NA	Colon Adenocarcinoma	NA	2011	NA	-30012	Alive	TUMOR FREE	617	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	617	0	617	0	617	0	617	
30	TCGA-A6-A565	0	27	1	10	38	10	2	0	16	291	17	0	6	138	3	0	TCGA-A6-A565-01	55	0.008224893302278408	19	TCGA-A6-A565-01	0	1	27	0.04524570222988018	TCGA-A6-A565-01	4	2	3	9	PASS	2007	TCGA-A6-A565	COAD	34	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Colon Mucinous Adenocarcinoma	NA	2008	NA	-12526	Dead	WITH TUMOR	NA	494	NA	NA	NA	NA	301	Progressive Disease	NA	NA	1	494	1	494	NA	NA	1	301	
60	TCGA-A6-A566	3	9	0	4	7	3	0	0	5	126	10	0	0	61	3	0	TCGA-A6-A566-01	79	0.12085626187174485	31	TCGA-A6-A566-01	4	4	28	0.06293408700255329	TCGA-A6-A566-01	1	2	1	4	PASS	2008	TCGA-A6-A566	COAD	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Colon Mucinous Adenocarcinoma	NA	2007	NA	-20181	Dead	WITH TUMOR	NA	758	NA	NA	NA	NA	257	Progressive Disease	NA	NA	1	758	1	758	NA	NA	1	257	
60	TCGA-A6-A567	0	4	0	2	1	0	0	1	4	43	4	0	2	18	1	0	TCGA-A6-A567-01	153	0.833930640654539	81	TCGA-A6-A567-01	14	12	98	0.2473213061858386	TCGA-A6-A567-01	5	0	5	10	PASS	2009	TCGA-A6-A567	COAD	56	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Colon Adenocarcinoma	NA	2007	NA	-20493	Dead	WITH TUMOR	NA	1881	NA	Metastatic	NA	NA	612	[Unknown]	NA	NA	1	1881	1	1881	NA	NA	1	612	
60	TCGA-A6-A56B	0	15	1	2	3	1	0	0	1	73	6	0	3	31	1	0	TCGA-A6-A56B-01	289	0.4580340236714966	189	TCGA-A6-A56B-01	11	37	75	0.15836992477900574	TCGA-A6-A56B-01	13	19	4	36	PASS	2010	TCGA-A6-A56B	COAD	57	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Colon Adenocarcinoma	NA	2008	NA	-20903	Dead	TUMOR FREE	NA	1711	NA	NA	NA	NA	1678	Complete Remission/Response	NA	NA	1	1711	0	1711	1	1678	1	1678	
60	TCGA-A6-A5ZU	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A6-A5ZU-01	167	0.493535108363407	109	TCGA-A6-A5ZU	0	0	0	0	TCGA-A6-A5ZU	0	0	0	0	PASS	2011	TCGA-A6-A5ZU	COAD	59	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Colon Adenocarcinoma	NA	2013	NA	-21554	Alive	TUMOR FREE	293	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	293	0	293	0	293	0	293	
60	TCGA-AA-3488	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3488-01	274	0.5937221919791369	171	TCGA-AA-3488-01	22	31	24	0.18309699583407946	TCGA-AA-3488-01	10	5	5	20	PASS	2012	TCGA-AA-3488	COAD	58	MALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2002	NA	-21519	Dead	WITH TUMOR	NA	153	NA	NA	NA	NA	NA	NA	NA	NA	1	153	1	153	NA	NA	1	153	
80	TCGA-AA-3489	0	6	3	2	0	5	0	0	9	89	9	0	1	27	5	0	TCGA-AA-3489-01	59	0.21894438064555	18	TCGA-AA-3489-01	9	13	7	0.23150650995765285	TCGA-AA-3489-01	2	2	2	6	PASS	2013	TCGA-AA-3489	COAD	75	MALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2002	NA	-27606	Dead	WITH TUMOR	NA	214	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	214	1	214	NA	NA	1	214	
90	TCGA-AA-3492	20	230	13	81	281	58	24	0	117	1544	67	2	39	671	24	4	TCGA-AA-3492-01	137	0.004653154002852752	80	TCGA-AA-3492-01	0	0	11	0.02185784815154965	TCGA-AA-3492-01	1	2	1	4	hypermutated sample	2014	TCGA-AA-3492	COAD	90	FEMALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2002	NA	-32871	Dead	TUMOR FREE	NA	92	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	92	0	92	NA	NA	0	92	
60	TCGA-AA-3494	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3494-01	125	0.40353961619702294	66	TCGA-AA-3494-01	18	29	10	0.1040804422705845	TCGA-AA-3494-01	7	6	4	17	PASS	2015	TCGA-AA-3494	COAD	55	MALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2002	NA	-20089	Alive	WITH TUMOR	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
80	TCGA-AA-3495	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3495-01	105	0.21074634464037806	48	TCGA-AA-3495-01	11	11	13	0.06414832290941967	TCGA-AA-3495-01	5	3	4	12	PASS	2016	TCGA-AA-3495	COAD	79	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2002	NA	-28886	Alive	TUMOR FREE	1127	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1127	0	1127	0	1127	0	1127	
80	TCGA-AA-3496	0	14	1	3	3	6	1	0	8	123	8	0	5	59	0	0	TCGA-AA-3496-01	102	0.31538232529090754	51	TCGA-AA-3496-01	12	13	19	0.2387560515172792	TCGA-AA-3496-01	4	2	4	10	PASS	2017	TCGA-AA-3496	COAD	83	FEMALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2002	NA	-30438	Alive	WITH TUMOR	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
70	TCGA-AA-3502	0	17	1	2	4	2	0	0	12	151	8	0	2	56	2	1	TCGA-AA-3502-01	98	0.1300008119188003	44	TCGA-AA-3502-01	5	4	5	0.006846007814497336	TCGA-AA-3502-01	1	1	0	2	PASS	2018	TCGA-AA-3502	COAD	73	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2003	NA	-26724	Alive	WITH TUMOR	1065	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1065	0	1065	0	1065	0	1065	
80	TCGA-AA-3506	0	16	0	8	5	1	0	0	5	120	8	0	3	50	3	0	TCGA-AA-3506-01	156	0.2720377058471509	84	TCGA-AA-3506-01	9	8	17	0.0382205367293443	TCGA-AA-3506-01	1	1	1	3	PASS	2019	TCGA-AA-3506	COAD	77	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2004	NA	-28275	Alive	WITH TUMOR	1765	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1765	0	1765	NA	NA	0	1765	
50	TCGA-AA-3509	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3509	0	0	0	TCGA-AA-3509	0	0	0	0	TCGA-AA-3509	0	0	0	0	PASS	2020	TCGA-AA-3509	COAD	54	FEMALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2005	NA	-19786	Alive	TUMOR FREE	1915	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1915	0	1915	0	1915	0	1915	
70	TCGA-AA-3510	15	412	20	103	0	7	0	0	163	2584	411	3	65	783	44	4	TCGA-AA-3510-01	79	0.0001783764704758343	26	TCGA-AA-3510-01	0	0	3	0.00011430562736115972	TCGA-AA-3510-01	0	0	0	0	hypermutated sample	2021	TCGA-AA-3510	COAD	70	MALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2005	NA	-25902	Alive	TUMOR FREE	1946	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1946	0	1946	0	1946	0	1946	
60	TCGA-AA-3511	0	16	0	4	2	0	1	0	8	102	10	0	2	39	4	0	TCGA-AA-3511-01	99	0.6478708560370398	49	TCGA-AA-3511-01	19	20	16	0.1492504457998934	TCGA-AA-3511-01	8	8	4	20	PASS	2022	TCGA-AA-3511	COAD	64	MALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2005	NA	-23407	Alive	TUMOR FREE	212	NA	NA	NA	NA	NA	59	Complete Remission/Response	NA	NA	0	212	0	212	1	59	1	59	
80	TCGA-AA-3514	0	5	0	0	1	0	0	0	2	51	6	0	0	17	0	0	TCGA-AA-3514-01	67	0.07821912802800048	27	TCGA-AA-3514-01	4	4	5	0.029982757911952238	TCGA-AA-3514-01	0	2	1	3	mutation call filter	2023	TCGA-AA-3514	COAD	81	FEMALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2006	NA	-29738	Alive	TUMOR FREE	31	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	31	0	31	NA	NA	0	31	
70	TCGA-AA-3516	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3516-01	84	0.009686978094622278	31	TCGA-AA-3516	0	0	0	0	TCGA-AA-3516-01	1	1	1	3	PASS	2024	TCGA-AA-3516	COAD	74	FEMALE	NA	Stage III	NA	Colon Mucinous Adenocarcinoma	NA	2007	NA	-27303	Dead	WITH TUMOR	NA	396	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	396	1	396	NA	NA	1	396	
60	TCGA-AA-3517	0	3	1	2	0	0	0	0	1	18	4	0	0	13	0	0	TCGA-AA-3517-01	173	0.8827966177004463	107	TCGA-AA-3517-01	21	18	18	0.17679587322241805	TCGA-AA-3517-01	5	2	5	12	mutation call filter	2025	TCGA-AA-3517	COAD	60	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2007	NA	-22099	Alive	TUMOR FREE	1186	NA	NA	NA	NA	NA	821	Complete Remission/Response	NA	NA	0	1186	0	1186	1	821	1	821	
80	TCGA-AA-3518	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3518-01	126	0.002637618156552792	57	TCGA-AA-3518-01	0	0	10	0.0012482703334300695	TCGA-AA-3518-01	0	0	0	0	PASS	2026	TCGA-AA-3518	COAD	81	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2007	NA	-29769	Alive	WITH TUMOR	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
60	TCGA-AA-3519	0	4	0	0	0	0	0	0	2	40	0	0	1	17	0	0	TCGA-AA-3519-01	193	0.5820977434466637	116	TCGA-AA-3519-01	16	25	14	0.1473036662268498	TCGA-AA-3519-01	9	7	5	21	mutation call filter	2027	TCGA-AA-3519	COAD	63	MALE	NA	Stage III	NA	Colon Adenocarcinoma	NA	2007	NA	-23131	Alive	TUMOR FREE	276	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	276	0	276	0	276	0	276	
90	TCGA-AA-3520	0	1	0	1	0	0	0	0	0	17	0	0	0	12	2	0	TCGA-AA-3520-01	168	0.2030603952374618	93	TCGA-AA-3520-01	8	9	27	0.1779961887096614	TCGA-AA-3520-01	8	4	4	16	mutation call filter	2028	TCGA-AA-3520	COAD	86	FEMALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2007	NA	-31531	Alive	WITH TUMOR	731	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	731	0	731	NA	NA	0	731	
90	TCGA-AA-3521	0	1	0	2	1	0	0	0	1	14	1	0	0	4	1	0	TCGA-AA-3521-01	151	0.9394957974425336	84	TCGA-AA-3521-01	30	26	15	0.2133226980223522	TCGA-AA-3521-01	8	6	4	18	mutation call filter	2029	TCGA-AA-3521	COAD	87	MALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2007	NA	-31805	Alive	WITH TUMOR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
70	TCGA-AA-3522	0	5	2	0	0	0	0	0	0	29	2	0	0	18	0	0	TCGA-AA-3522-01	119	0.5174285888773656	57	TCGA-AA-3522-01	9	10	24	0.2944259046811022	TCGA-AA-3522-01	8	10	7	25	PASS	2030	TCGA-AA-3522	COAD	67	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2007	NA	-24653	Alive	TUMOR FREE	1127	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1127	0	1127	0	1127	0	1127	
90	TCGA-AA-3524	0	0	0	1	1	0	0	0	0	17	0	0	0	3	0	0	TCGA-AA-3524-01	135	0.18964997326367128	71	TCGA-AA-3524-01	7	14	33	0.11811955504750753	TCGA-AA-3524-01	7	3	5	15	mutation call filter	2031	TCGA-AA-3524	COAD	85	MALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2007	NA	-31197	Alive	TUMOR FREE	1096	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1096	0	1096	0	1096	0	1096	
90	TCGA-AA-3525	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3525-01	120	0.001762182636011438	61	TCGA-AA-3525-01	0	0	3	0.0015693707678237766	TCGA-AA-3525-01	0	0	0	0	PASS	2032	TCGA-AA-3525	COAD	90	MALE	NA	Stage IIIB	NA	Colon Adenocarcinoma	NA	2007	NA	-32871	Alive	TUMOR FREE	245	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	245	0	245	NA	NA	0	245	
60	TCGA-AA-3526	0	1	0	0	0	1	1	0	0	21	2	0	0	6	0	0	TCGA-AA-3526-01	53	0.12448915596377905	10	TCGA-AA-3526-01	5	7	9	0.13007179825135612	TCGA-AA-3526-01	2	5	3	10	mutation call filter	2033	TCGA-AA-3526	COAD	57	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2007	NA	-21123	Alive	TUMOR FREE	580	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	580	0	580	0	580	0	580	
90	TCGA-AA-3527	0	0	0	0	0	0	2	0	4	36	0	0	0	28	0	0	TCGA-AA-3527-01	75	0.0639437332241484	29	TCGA-AA-3527-01	3	2	6	0.0742760178546988	TCGA-AA-3527-01	4	3	3	10	mutation call filter	2034	TCGA-AA-3527	COAD	90	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2007	NA	-32871	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
80	TCGA-AA-3529	0	2	0	0	0	0	0	0	0	9	1	0	0	10	0	0	TCGA-AA-3529-01	203	0.1864631028594485	120	TCGA-AA-3529-01	7	10	36	0.07375606462169063	TCGA-AA-3529-01	3	2	2	7	mutation call filter	2035	TCGA-AA-3529	COAD	78	FEMALE	NA	Stage IIIC	NA	Colon Adenocarcinoma	NA	2007	NA	-28609	Dead	WITH TUMOR	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	1	0	NA	NA	1	0	
80	TCGA-AA-3530	0	5	1	2	2	0	0	0	0	75	6	0	0	26	2	0	TCGA-AA-3530-01	61	0.1065320923395786	21	TCGA-AA-3530-01	6	5	6	0.12309668128734692	TCGA-AA-3530-01	2	4	3	9	mutation call filter	2036	TCGA-AA-3530	COAD	80	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2007	NA	-29402	Alive	TUMOR FREE	580	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	580	0	580	0	580	0	580	
80	TCGA-AA-3531	0	0	2	0	0	1	0	0	2	24	8	0	2	16	0	0	TCGA-AA-3531-01	104	0.3433110329255293	50	TCGA-AA-3531-01	6	9	16	0.13456060671870254	TCGA-AA-3531-01	3	2	3	8	mutation call filter	2037	TCGA-AA-3531	COAD	75	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2007	NA	-27514	Alive	TUMOR FREE	1035	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1035	0	1035	0	1035	0	1035	
60	TCGA-AA-3532	0	1	0	1	0	1	0	0	0	17	2	0	0	5	0	0	TCGA-AA-3532-01	139	0.5097538381899916	80	TCGA-AA-3532-01	30	28	25	0.1455378053356902	TCGA-AA-3532-01	9	11	7	27	mutation call filter	2038	TCGA-AA-3532	COAD	63	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2007	NA	-23133	Alive	WITH TUMOR	882	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	882	0	882	NA	NA	0	882	
80	TCGA-AA-3534	0	2	0	0	0	1	0	0	0	17	0	0	1	12	2	0	TCGA-AA-3534-01	99	0.9477267356569756	44	TCGA-AA-3534-01	16	34	6	0.06869375945545993	TCGA-AA-3534-01	2	1	1	4	mutation call filter	2039	TCGA-AA-3534	COAD	78	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2007	NA	-28489	Alive	TUMOR FREE	882	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	882	0	882	0	882	0	882	
50	TCGA-AA-3538	0	0	0	1	2	0	1	0	0	12	0	0	0	8	0	0	TCGA-AA-3538-01	129	0.4514642142169463	69	TCGA-AA-3538-01	10	13	15	0.17453862077885496	TCGA-AA-3538-01	6	2	6	14	mutation call filter	2040	TCGA-AA-3538	COAD	54	FEMALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2008	NA	-19752	Alive	TUMOR FREE	791	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	791	0	791	0	791	0	791	
70	TCGA-AA-3542	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3542-01	333	0.6545175985518603	226	TCGA-AA-3542-01	22	21	29	0.14564452967206626	TCGA-AA-3542-01	6	3	5	14	PASS	2041	TCGA-AA-3542	COAD	69	MALE	NA	Stage IIIC	NA	Colon Adenocarcinoma	NA	2008	NA	-25324	Alive	TUMOR FREE	395	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	395	0	395	0	395	0	395	
80	TCGA-AA-3543	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3543-01	130	0.04760736710862259	81	TCGA-AA-3543-01	1	1	7	0.039600497124168216	TCGA-AA-3543-01	2	2	1	5	PASS	2042	TCGA-AA-3543	COAD	84	MALE	NA	Stage I	NA	Colon Mucinous Adenocarcinoma	NA	2008	NA	-30772	Alive	TUMOR FREE	30	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	30	0	30	NA	NA	0	30	
70	TCGA-AA-3544	0	1	0	2	1	1	0	0	1	17	0	0	1	12	0	0	TCGA-AA-3544-01	211	0.3123516381350184	139	TCGA-AA-3544-01	12	11	45	0.20496044012212947	TCGA-AA-3544-01	5	13	7	25	mutation call filter	2043	TCGA-AA-3544	COAD	68	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2008	NA	-24959	Alive	TUMOR FREE	426	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	426	0	426	0	426	0	426	
70	TCGA-AA-3548	0	0	0	2	0	0	0	0	1	15	1	0	0	8	1	0	TCGA-AA-3548-01	67	0.4354165882985068	23	TCGA-AA-3548-01	14	13	9	0.18577213174422166	TCGA-AA-3548-01	5	1	3	9	mutation call filter	2044	TCGA-AA-3548	COAD	71	FEMALE	NA	Stage IIIC	NA	Colon Adenocarcinoma	NA	2008	NA	-26175	Alive	TUMOR FREE	1034	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1034	0	1034	0	1034	0	1034	
70	TCGA-AA-3549	0	2	0	0	0	0	0	1	1	16	0	0	0	4	1	0	TCGA-AA-3549-01	199	0.29668020451597105	123	TCGA-AA-3549-01	8	12	58	0.2232555627138801	TCGA-AA-3549-01	6	6	4	16	mutation call filter	2045	TCGA-AA-3549	COAD	69	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2008	NA	-25415	Alive	TUMOR FREE	639	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	639	0	639	0	639	0	639	
90	TCGA-AA-3552	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3552-01	188	0.5836123166286316	115	TCGA-AA-3552-01	25	28	22	0.15871045661393193	TCGA-AA-3552-01	11	5	5	21	PASS	2046	TCGA-AA-3552	COAD	85	MALE	NA	Stage IIIC	NA	Colon Adenocarcinoma	NA	2008	NA	-31290	Dead	TUMOR FREE	NA	396	NA	NA	NA	NA	122	Complete Remission/Response	NA	NA	1	396	0	396	1	122	1	122	
60	TCGA-AA-3553	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3553-01	96	0.5290254637216047	49	TCGA-AA-3553-01	22	24	15	0.13729376625627027	TCGA-AA-3553-01	7	4	6	17	PASS	2047	TCGA-AA-3553	COAD	61	FEMALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2008	NA	-22524	Alive	TUMOR FREE	730	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	730	0	730	0	730	0	730	
60	TCGA-AA-3554	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3554	0	0	0	TCGA-AA-3554	0	0	0	0	TCGA-AA-3554-01	0	2	0	2	PASS	2048	TCGA-AA-3554	COAD	62	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2008	NA	-22799	Alive	TUMOR FREE	546	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	546	0	546	0	546	0	546	
80	TCGA-AA-3555	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3555-01	79	0.0003505365081470652	38	TCGA-AA-3555-01	0	0	19	0.0070572695629906815	TCGA-AA-3555-01	1	1	1	3	PASS	2049	TCGA-AA-3555	COAD	81	FEMALE	NA	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2008	NA	-29617	Alive	TUMOR FREE	911	NA	NA	NA	NA	NA	91	Complete Remission/Response	NA	NA	0	911	0	911	1	91	1	91	
80	TCGA-AA-3556	0	0	0	2	0	0	0	0	0	16	0	0	0	8	0	0	TCGA-AA-3556	0	0	0	TCGA-AA-3556	0	0	0	0	TCGA-AA-3556-01	3	3	3	9	PASS	2050	TCGA-AA-3556	COAD	78	MALE	NA	Stage I	NA	NA	NA	2008	NA	-28704	Alive	WITH TUMOR	700	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	700	0	700	NA	NA	0	700	
70	TCGA-AA-3558	0	3	0	1	0	0	0	0	2	14	1	0	0	7	0	0	TCGA-AA-3558-01	79	0.3035544207686569	32	TCGA-AA-3558-01	7	8	8	0.11250660586902478	TCGA-AA-3558-01	3	0	1	4	mutation call filter	2051	TCGA-AA-3558	COAD	70	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2008	NA	-25752	Alive	TUMOR FREE	638	NA	NA	NA	NA	NA	92	Complete Remission/Response	NA	NA	0	638	0	638	1	92	1	92	
70	TCGA-AA-3560	0	1	1	0	0	0	0	0	1	18	1	0	0	6	0	0	TCGA-AA-3560-01	211	0.5789847424509345	139	TCGA-AA-3560-01	12	13	28	0.2886727596113133	TCGA-AA-3560-01	3	3	5	11	mutation call filter	2052	TCGA-AA-3560	COAD	72	FEMALE	NA	Stage IIIC	NA	Colon Adenocarcinoma	NA	2009	NA	-26359	Alive	TUMOR FREE	608	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	608	0	608	0	608	0	608	
70	TCGA-AA-3561	0	2	0	0	0	0	0	0	0	16	1	0	0	2	0	0	TCGA-AA-3561-01	151	0.2300894580069781	75	TCGA-AA-3561-01	9	14	14	0.11575403075333338	TCGA-AA-3561-01	8	9	5	22	mutation call filter	2053	TCGA-AA-3561	COAD	72	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-26420	Alive	TUMOR FREE	424	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	424	0	424	0	424	0	424	
80	TCGA-AA-3562	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3562	0	0	0	TCGA-AA-3562	0	0	0	0	TCGA-AA-3562-01	6	1	2	9	PASS	2054	TCGA-AA-3562	COAD	82	MALE	NA	Stage IIIC	NA	Colon Adenocarcinoma	NA	2008	NA	-30254	Alive	WITH TUMOR	608	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	608	0	608	NA	NA	0	608	
70	TCGA-AA-3655	0	6	1	0	0	3	0	0	3	67	5	1	3	23	0	0	TCGA-AA-3655-01	135	0.17234209647613594	74	TCGA-AA-3655-01	5	8	16	0.14715521325521522	TCGA-AA-3655-01	4	3	6	13	PASS	2055	TCGA-AA-3655	COAD	68	MALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2005	NA	-24896	Alive	TUMOR FREE	1856	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1856	0	1856	0	1856	0	1856	
50	TCGA-AA-3660	0	8	3	4	3	1	3	1	5	106	12	0	5	34	2	0	TCGA-AA-3660-01	228	0.5751586907085665	147	TCGA-AA-3660-01	15	19	59	0.24542946574871946	TCGA-AA-3660-01	10	9	5	24	PASS	2056	TCGA-AA-3660	COAD	51	FEMALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2005	NA	-18932	Alive	TUMOR FREE	2375	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2375	0	2375	0	2375	0	2375	
80	TCGA-AA-3662	0	4	1	5	1	1	1	0	3	68	5	0	0	29	0	1	TCGA-AA-3662	0	0	0	TCGA-AA-3662	0	0	0	0	TCGA-AA-3662-01	5	6	3	14	PASS	2057	TCGA-AA-3662	COAD	80	FEMALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2005	NA	-29554	Alive	WITH TUMOR	184	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	184	0	184	NA	NA	0	184	
40	TCGA-AA-3663	20	212	16	55	327	65	17	0	90	1391	65	1	26	560	52	1	TCGA-AA-3663-01	88	0.09856150107029496	40	TCGA-AA-3663-01	4	2	4	0.012430292283198342	TCGA-AA-3663-01	1	1	1	3	hypermutated sample	2058	TCGA-AA-3663	COAD	42	MALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2005	NA	-15675	Alive	TUMOR FREE	212	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	212	0	212	0	212	0	212	
70	TCGA-AA-3664	0	20	2	5	3	2	2	0	5	126	10	0	3	43	1	0	TCGA-AA-3664-01	220	0.2558093672860973	133	TCGA-AA-3664-01	4	9	29	0.0820769274902895	TCGA-AA-3664-01	15	15	5	35	mutation call filter	2059	TCGA-AA-3664	COAD	74	FEMALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2005	NA	-27363	Alive	WITH TUMOR	1643	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1643	0	1643	NA	NA	0	1643	
70	TCGA-AA-3666	0	13	1	1	3	1	0	0	3	152	10	0	5	40	3	1	TCGA-AA-3666-01	292	0.8057629295049743	194	TCGA-AA-3666-01	24	33	33	0.1751557355442386	TCGA-AA-3666-01	9	6	2	17	mutation call filter	2060	TCGA-AA-3666	COAD	68	MALE	NA	Stage III	NA	Colon Adenocarcinoma	NA	2005	NA	-25020	Dead	WITH TUMOR	NA	61	NA	NA	NA	NA	NA	NA	NA	NA	1	61	1	61	NA	NA	1	61	
40	TCGA-AA-3667	2	11	0	2	5	1	0	0	4	57	5	0	3	16	2	0	TCGA-AA-3667-01	155	0.31953795480237945	86	TCGA-AA-3667-01	12	15	19	0.13215069879199418	TCGA-AA-3667-01	4	1	0	5	mutation call filter	2061	TCGA-AA-3667	COAD	36	FEMALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2005	NA	-13302	Alive	TUMOR FREE	426	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	426	0	426	0	426	0	426	
90	TCGA-AA-3672	12	265	13	42	267	42	11	0	121	1180	66	0	36	511	31	4	TCGA-AA-3672	0	0	0	TCGA-AA-3672	0	0	0	0	TCGA-AA-3672-01	0	0	0	0	mutation call filter	2062	TCGA-AA-3672	COAD	90	FEMALE	NA	Stage III	NA	Colon Adenocarcinoma	NA	2006	NA	-32873	Alive	TUMOR FREE	28	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	28	0	28	NA	NA	0	28	
50	TCGA-AA-3673	0	9	0	1	3	4	0	0	1	57	5	0	2	18	1	0	TCGA-AA-3673-01	65	0.5201786519350979	18	TCGA-AA-3673-01	11	8	6	0.10210455954328687	TCGA-AA-3673-01	1	0	2	3	mutation call filter	2063	TCGA-AA-3673	COAD	53	FEMALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2006	NA	-19509	Alive	TUMOR FREE	1522	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1522	0	1522	0	1522	0	1522	
80	TCGA-AA-3675	0	13	1	2	2	1	1	0	7	61	8	0	3	36	2	0	TCGA-AA-3675-01	74	0.05557590792508199	36	TCGA-AA-3675-01	3	5	19	0.06592533449962867	TCGA-AA-3675-01	1	0	0	1	mutation call filter	2064	TCGA-AA-3675	COAD	84	MALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2006	NA	-30801	Alive	TUMOR FREE	1431	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1431	0	1431	0	1431	0	1431	
60	TCGA-AA-3678	0	5	0	1	3	1	1	0	5	55	2	0	1	24	2	0	TCGA-AA-3678-01	103	0.2923524788774666	47	TCGA-AA-3678-01	9	16	17	0.27349415044795394	TCGA-AA-3678-01	5	5	5	15	mutation call filter	2065	TCGA-AA-3678	COAD	60	FEMALE	NA	Stage III	NA	Colon Adenocarcinoma	NA	2006	NA	-22219	Alive	TUMOR FREE	1430	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1430	0	1430	0	1430	0	1430	
60	TCGA-AA-3679	0	6	0	1	2	1	0	0	2	52	4	0	5	22	1	0	TCGA-AA-3679-01	244	0.99757491667114	155	TCGA-AA-3679-01	16	16	20	0.1254817524433572	TCGA-AA-3679-01	14	8	5	27	mutation call filter	2066	TCGA-AA-3679	COAD	59	MALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2006	NA	-21611	Alive	WITH TUMOR	457	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	457	0	457	NA	NA	0	457	
70	TCGA-AA-3680	2	14	0	5	8	1	0	0	2	84	10	0	3	27	2	0	TCGA-AA-3680-01	115	0.134464790101104	57	TCGA-AA-3680-01	2	5	19	0.04919568453350046	TCGA-AA-3680-01	2	11	4	17	mutation call filter	2067	TCGA-AA-3680	COAD	67	FEMALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2006	NA	-24655	Dead	WITH TUMOR	NA	335	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	335	1	335	NA	NA	1	335	
80	TCGA-AA-3681	1	7	1	0	1	2	1	0	2	90	4	0	5	31	1	0	TCGA-AA-3681-01	273	0.33481594565637995	199	TCGA-AA-3681-01	13	12	19	0.09861399437154793	TCGA-AA-3681-01	7	2	6	15	mutation call filter	2068	TCGA-AA-3681	COAD	77	FEMALE	NA	Stage III	NA	Colon Adenocarcinoma	NA	2006	NA	-28399	Alive	TUMOR FREE	182	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	182	0	182	0	182	0	182	
70	TCGA-AA-3684	1	8	5	5	3	2	0	0	6	103	13	0	2	37	4	0	TCGA-AA-3684-01	77	0.14784762044377076	30	TCGA-AA-3684-01	15	13	8	0.06274759258409746	TCGA-AA-3684-01	2	0	2	4	mutation call filter	2069	TCGA-AA-3684	COAD	65	FEMALE	NA	Stage IV	NA	Colon Mucinous Adenocarcinoma	NA	2007	NA	-23741	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-AA-3685	2	12	0	2	1	3	0	0	1	63	10	0	3	21	4	0	TCGA-AA-3685-01	256	0.8285352986390543	178	TCGA-AA-3685-01	26	37	48	0.20811016488636366	TCGA-AA-3685-01	9	4	4	17	mutation call filter	2070	TCGA-AA-3685	COAD	69	MALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2007	NA	-25506	Alive	TUMOR FREE	1127	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1127	0	1127	0	1127	0	1127	
80	TCGA-AA-3688	1	6	0	1	1	1	0	0	3	54	7	0	2	14	1	0	TCGA-AA-3688-01	139	0.3693535367454168	74	TCGA-AA-3688-01	16	25	20	0.2989152141444111	TCGA-AA-3688-01	4	1	2	7	mutation call filter	2071	TCGA-AA-3688	COAD	80	MALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2007	NA	-29220	Alive	WITH TUMOR	578	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	578	0	578	NA	NA	0	578	
50	TCGA-AA-3692	1	3	0	1	2	1	0	0	4	55	3	0	2	13	4	0	TCGA-AA-3692-01	87	0.6471909532891685	33	TCGA-AA-3692-01	8	7	10	0.11645672010984408	TCGA-AA-3692-01	4	1	5	10	mutation call filter	2072	TCGA-AA-3692	COAD	47	FEMALE	NA	Stage IV	NA	Colon Mucinous Adenocarcinoma	NA	2008	NA	-17167	Dead	WITH TUMOR	NA	1095	NA	NA	NA	NA	396	Progressive Disease	NA	NA	1	1095	1	1095	NA	NA	1	396	
80	TCGA-AA-3693	0	19	0	1	1	0	1	0	10	118	9	0	4	50	2	0	TCGA-AA-3693-01	127	0.3702711281895358	68	TCGA-AA-3693-01	13	15	28	0.2544008805888799	TCGA-AA-3693-01	8	4	4	16	mutation call filter	2073	TCGA-AA-3693	COAD	77	FEMALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2008	NA	-28459	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
60	TCGA-AA-3695	0	11	0	5	0	2	0	0	2	129	13	0	2	50	3	0	TCGA-AA-3695-01	113	0.4576232339080264	63	TCGA-AA-3695-01	19	29	5	0.04347812076927921	TCGA-AA-3695-01	1	2	2	5	mutation call filter	2074	TCGA-AA-3695	COAD	63	FEMALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2009	NA	-23164	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
80	TCGA-AA-3696	1	5	0	1	2	1	1	0	9	67	5	0	3	26	4	0	TCGA-AA-3696-01	121	0.920217617059328	64	TCGA-AA-3696-01	10	8	2	0.03891566902347296	TCGA-AA-3696-01	2	2	1	5	mutation call filter	2075	TCGA-AA-3696	COAD	75	FEMALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2009	NA	-27667	Dead	WITH TUMOR	NA	153	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	153	1	153	NA	NA	1	153	
80	TCGA-AA-3697	2	30	1	8	8	3	0	0	12	145	15	0	6	55	7	0	TCGA-AA-3697	0	0	0	TCGA-AA-3697	0	0	0	0	TCGA-AA-3697-01	7	3	3	13	PASS	2076	TCGA-AA-3697	COAD	77	MALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2003	NA	-28367	Alive	WITH TUMOR	2587	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	2587	0	2587	NA	NA	0	2587	
80	TCGA-AA-3710	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3710-01	109	0.05053304804630007	53	TCGA-AA-3710-01	2	3	9	0.030763956118035517	TCGA-AA-3710-01	0	0	0	0	PASS	2077	TCGA-AA-3710	COAD	80	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2008	NA	-29465	Alive	TUMOR FREE	821	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	821	0	821	0	821	0	821	
70	TCGA-AA-3712	2	17	2	2	0	1	0	0	8	101	4	0	4	56	7	0	TCGA-AA-3712-01	135	0.5704758597945329	71	TCGA-AA-3712-01	21	29	8	0.21713793084502192	TCGA-AA-3712-01	9	10	3	22	PASS	2078	TCGA-AA-3712	COAD	65	MALE	NA	Stage III	NA	Colon Adenocarcinoma	NA	2004	NA	-23831	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-AA-3713	3	130	12	36	181	64	12	1	48	701	29	0	17	302	21	2	TCGA-AA-3713-01	83	0.051749038484905766	37	TCGA-AA-3713-01	2	3	9	0.03153304202377963	TCGA-AA-3713-01	1	1	2	4	hypermutated sample	2079	TCGA-AA-3713	COAD	68	MALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2005	NA	-24927	Alive	TUMOR FREE	579	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	579	0	579	NA	NA	0	579	
80	TCGA-AA-3715	18	188	15	71	315	42	17	3	92	1591	81	3	23	622	49	3	TCGA-AA-3715-01	148	0.21730807248309286	82	TCGA-AA-3715-01	6	5	14	0.020534711567158186	TCGA-AA-3715-01	1	0	1	2	mutation call filter	2080	TCGA-AA-3715	COAD	77	MALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2006	NA	-28428	Dead	WITH TUMOR	NA	579	NA	NA	NA	NA	153	[Unknown]	NA	NA	1	579	1	579	NA	NA	1	153	
80	TCGA-AA-3811	12	192	9	49	201	39	21	0	89	1516	71	1	17	618	45	0	TCGA-AA-3811-01	363	0.5964815546254183	284	TCGA-AA-3811	0	0	0	0	TCGA-AA-3811	0	0	0	0	mutation call filter	2081	TCGA-AA-3811	COAD	84	FEMALE	NA	Stage III	NA	Colon Adenocarcinoma	NA	2007	NA	-30893	Dead	WITH TUMOR	NA	306	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	306	1	306	NA	NA	1	306	
80	TCGA-AA-3812	0	16	0	4	4	1	0	0	4	95	3	1	3	36	3	0	TCGA-AA-3812-01	130	0.6995296973236256	68	TCGA-AA-3812-01	13	32	17	0.3067592890701445	TCGA-AA-3812-01	2	1	1	4	mutation call filter	2082	TCGA-AA-3812	COAD	82	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2007	NA	-29980	Alive	TUMOR FREE	1066	NA	NA	NA	NA	NA	762	Complete Remission/Response	NA	NA	0	1066	0	1066	1	762	1	762	
90	TCGA-AA-3814	1	15	1	7	1	3	0	0	5	78	5	0	9	38	0	0	TCGA-AA-3814-01	68	0.8979476485257591	28	TCGA-AA-3814-01	26	22	9	0.08246443792626477	TCGA-AA-3814-01	3	1	1	5	mutation call filter	2083	TCGA-AA-3814	COAD	85	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2007	NA	-31380	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-AA-3815	6	113	4	43	109	30	10	0	54	651	37	1	11	271	30	0	TCGA-AA-3815	0	0	0	TCGA-AA-3815	0	0	0	0	TCGA-AA-3815	0	0	0	0	mutation call filter	2084	TCGA-AA-3815	COAD	65	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2007	NA	-23922	Alive	TUMOR FREE	1005	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1005	0	1005	0	1005	0	1005	
80	TCGA-AA-3818	1	16	0	3	1	4	0	0	4	116	11	0	4	45	4	0	TCGA-AA-3818-01	131	0.36647239811301263	68	TCGA-AA-3818-01	9	8	8	0.04528923186595271	TCGA-AA-3818-01	1	1	1	3	mutation call filter	2085	TCGA-AA-3818	COAD	78	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2007	NA	-28763	Dead	WITH TUMOR	NA	30	NA	NA	NA	NA	NA	NA	NA	NA	1	30	1	30	NA	NA	1	30	
40	TCGA-AA-3819	3	17	1	5	6	0	0	0	12	155	11	0	7	54	4	0	TCGA-AA-3819-01	142	0.12422230226336076	67	TCGA-AA-3819-01	6	6	10	0.10202578096512653	TCGA-AA-3819-01	7	4	5	16	mutation call filter	2086	TCGA-AA-3819	COAD	41	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2008	NA	-15280	Alive	TUMOR FREE	761	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	761	0	761	0	761	0	761	
80	TCGA-AA-3821	8	112	6	38	116	29	6	1	34	583	41	0	14	268	11	0	TCGA-AA-3821-01	101	0.002337506748117403	44	TCGA-AA-3821-01	0	0	5	0.0021170545877322697	TCGA-AA-3821-01	1	0	0	1	mutation call filter	2087	TCGA-AA-3821	COAD	81	FEMALE	NA	Stage I	NA	Colon Mucinous Adenocarcinoma	NA	2008	NA	-29706	Alive	TUMOR FREE	31	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	31	0	31	NA	NA	0	31	
70	TCGA-AA-3831	2	14	1	4	4	2	1	0	10	88	6	1	2	25	1	0	TCGA-AA-3831-01	99	0.0012014697442887519	39	TCGA-AA-3831-01	0	6	5	0.14442457027771016	TCGA-AA-3831-01	1	0	2	3	mutation call filter	2088	TCGA-AA-3831	COAD	66	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2008	NA	-24411	Alive	TUMOR FREE	547	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	547	0	547	0	547	0	547	
60	TCGA-AA-3833	4	62	5	12	80	19	3	0	39	434	23	0	18	200	8	1	TCGA-AA-3833-01	83	0.00029825829500546643	35	TCGA-AA-3833-01	0	1	3	0.015990855615383527	TCGA-AA-3833-01	1	1	1	3	mutation call filter	2089	TCGA-AA-3833	COAD	63	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2008	NA	-23011	Alive	TUMOR FREE	485	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	485	0	485	0	485	0	485	
70	TCGA-AA-3837	2	11	1	6	2	6	1	0	3	95	9	1	0	50	2	0	TCGA-AA-3837-01	140	0.5510188533148963	96	TCGA-AA-3837-01	16	31	6	0.17885612268278894	TCGA-AA-3837-01	1	0	0	1	mutation call filter	2090	TCGA-AA-3837	COAD	67	MALE	NA	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2008	NA	-24655	Alive	TUMOR FREE	1186	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1186	0	1186	0	1186	0	1186	
70	TCGA-AA-3841	0	8	2	4	1	3	1	0	5	57	3	0	1	26	1	0	TCGA-AA-3841-01	210	0.5586360162368342	132	TCGA-AA-3841-01	18	27	29	0.35260782477718483	TCGA-AA-3841-01	12	5	5	22	mutation call filter	2091	TCGA-AA-3841	COAD	66	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-24230	Alive	TUMOR FREE	1124	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1124	0	1124	0	1124	0	1124	
50	TCGA-AA-3842	2	5	0	1	1	1	1	0	2	79	4	0	1	39	2	0	TCGA-AA-3842-01	206	0.6107970657176075	132	TCGA-AA-3842-01	18	25	14	0.16679357143379167	TCGA-AA-3842-01	9	8	1	18	mutation call filter	2092	TCGA-AA-3842	COAD	51	MALE	NA	Stage IIIA	NA	Colon Adenocarcinoma	NA	2009	NA	-18842	Alive	TUMOR FREE	1126	NA	NA	NA	NA	NA	396	Complete Remission/Response	NA	NA	0	1126	0	1126	1	396	1	396	
80	TCGA-AA-3844	0	11	1	3	0	1	0	0	1	98	12	0	1	35	2	0	TCGA-AA-3844-01	264	0.903553658793293	202	TCGA-AA-3844-01	16	15	22	0.1682021759968093	TCGA-AA-3844-01	0	0	0	0	mutation call filter	2093	TCGA-AA-3844	COAD	78	FEMALE	NA	Stage IIIC	NA	Colon Adenocarcinoma	NA	2009	NA	-28521	Alive	WITH TUMOR	454	NA	NA	NA	NA	NA	365	Progressive Disease	NA	NA	0	454	0	454	NA	NA	1	365	
90	TCGA-AA-3845	3	112	3	27	126	21	18	0	57	673	40	1	10	293	17	0	TCGA-AA-3845-01	87	0.08918448758433192	41	TCGA-AA-3845-01	5	3	2	0.0005629100805907934	TCGA-AA-3845-01	2	1	0	3	mutation call filter	2094	TCGA-AA-3845	COAD	86	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-31593	Dead	WITH TUMOR	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	1	0	NA	NA	1	0	
70	TCGA-AA-3846	0	10	0	4	2	1	0	0	5	82	9	0	1	33	4	0	TCGA-AA-3846-01	121	0.4461607182923278	67	TCGA-AA-3846-01	19	22	6	0.1620381511137262	TCGA-AA-3846-01	1	0	0	1	mutation call filter	2095	TCGA-AA-3846	COAD	74	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-27057	Alive	WITH TUMOR	518	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	518	0	518	NA	NA	0	518	
80	TCGA-AA-3848	0	15	0	4	0	2	2	0	7	123	6	0	4	51	0	1	TCGA-AA-3848-01	216	0.5775794916466905	131	TCGA-AA-3848-01	4	6	26	0.11498465680658948	TCGA-AA-3848-01	2	3	6	11	mutation call filter	2096	TCGA-AA-3848	COAD	82	FEMALE	NA	Stage IIIC	NA	Colon Adenocarcinoma	NA	2009	NA	-30194	Dead	WITH TUMOR	NA	306	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	306	1	306	NA	NA	1	306	
70	TCGA-AA-3850	3	7	4	2	3	4	1	0	7	84	9	0	1	47	4	0	TCGA-AA-3850-01	780	0.0147756240755723	701	TCGA-AA-3850-01	20	39	87	0.1597883940419884	TCGA-AA-3850-01	16	33	1	50	mutation call filter	2097	TCGA-AA-3850	COAD	74	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2009	NA	-27090	Dead	WITH TUMOR	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	1	0	NA	NA	1	0	
70	TCGA-AA-3851	0	12	0	7	4	4	0	0	1	75	6	0	2	37	0	0	TCGA-AA-3851-01	121	0.5998515685251801	63	TCGA-AA-3851-01	19	22	12	0.13766452564041295	TCGA-AA-3851-01	4	5	3	12	mutation call filter	2098	TCGA-AA-3851	COAD	74	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-27090	Alive	WITH TUMOR	1006	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1006	0	1006	NA	NA	0	1006	
90	TCGA-AA-3852	1	11	0	6	5	4	1	0	7	120	7	1	4	44	3	0	TCGA-AA-3852-01	85	0.2331842351611393	33	TCGA-AA-3852-01	9	5	19	0.0007783455228323054	TCGA-AA-3852-01	0	0	0	0	mutation call filter	2099	TCGA-AA-3852	COAD	88	MALE	NA	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2009	NA	-32203	Dead	WITH TUMOR	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	1	0	NA	NA	1	0	
70	TCGA-AA-3854	0	15	1	1	1	0	1	0	6	127	6	1	2	48	1	0	TCGA-AA-3854-01	143	0.1704781034522601	77	TCGA-AA-3854-01	2	7	11	0.11467699634556013	TCGA-AA-3854-01	9	5	4	18	mutation call filter	2100	TCGA-AA-3854	COAD	71	FEMALE	NA	Stage I	NA	Colon Mucinous Adenocarcinoma	NA	2009	NA	-26022	Alive	TUMOR FREE	1096	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1096	0	1096	0	1096	0	1096	
70	TCGA-AA-3855	1	13	2	11	3	1	1	0	5	126	13	0	3	55	0	0	TCGA-AA-3855-01	109	0.3279021408047298	54	TCGA-AA-3855-01	8	7	9	0.03731890098720711	TCGA-AA-3855-01	6	3	3	12	mutation call filter	2101	TCGA-AA-3855	COAD	72	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2009	NA	-26541	Alive	WITH TUMOR	975	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	975	0	975	NA	NA	0	975	
60	TCGA-AA-3856	0	5	0	1	3	1	0	0	3	44	7	0	0	21	1	0	TCGA-AA-3856-01	121	0.5037937817738039	69	TCGA-AA-3856-01	21	20	8	0.18353095478086204	TCGA-AA-3856-01	3	2	3	8	mutation call filter	2102	TCGA-AA-3856	COAD	59	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-21670	Alive	WITH TUMOR	30	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	30	0	30	NA	NA	0	30	
70	TCGA-AA-3858	1	7	1	0	1	3	0	1	5	48	6	0	1	24	0	0	TCGA-AA-3858-01	186	0.39670706776603903	118	TCGA-AA-3858-01	13	20	21	0.11258674215050674	TCGA-AA-3858-01	9	3	4	16	mutation call filter	2103	TCGA-AA-3858	COAD	67	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2009	NA	-24806	Alive	TUMOR FREE	945	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	945	0	945	0	945	0	945	
50	TCGA-AA-3860	0	5	1	0	3	0	0	0	4	43	5	0	0	19	0	0	TCGA-AA-3860	0	0	0	TCGA-AA-3860	0	0	0	0	TCGA-AA-3860-01	11	9	11	31	mutation call filter	2104	TCGA-AA-3860	COAD	53	FEMALE	NA	Stage IIIB	NA	Colon Adenocarcinoma	NA	2009	NA	-19449	Alive	TUMOR FREE	945	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	945	0	945	0	945	0	945	
70	TCGA-AA-3861	0	10	0	3	2	3	0	0	3	109	6	0	4	49	2	0	TCGA-AA-3861	0	0	0	TCGA-AA-3861	0	0	0	0	TCGA-AA-3861	0	0	0	0	mutation call filter	2105	TCGA-AA-3861	COAD	72	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-26602	Alive	TUMOR FREE	914	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	914	0	914	0	914	0	914	
80	TCGA-AA-3862	1	8	1	5	0	1	0	0	3	73	4	0	3	27	1	0	TCGA-AA-3862	0	0	0	TCGA-AA-3862	0	0	0	0	TCGA-AA-3862	0	0	0	0	mutation call filter	2106	TCGA-AA-3862	COAD	82	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-30163	Alive	TUMOR FREE	914	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	914	0	914	0	914	0	914	
70	TCGA-AA-3864	14	210	12	52	91	24	5	0	94	2159	114	0	31	1000	32	2	TCGA-AA-3864-01	191	0.0007604795640711745	126	TCGA-AA-3864-01	0	0	8	0.02152539184822521	TCGA-AA-3864-01	1	1	1	3	mutation call filter	2107	TCGA-AA-3864	COAD	71	MALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2005	NA	-26237	Alive	TUMOR FREE	1612	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1612	0	1612	0	1612	0	1612	
80	TCGA-AA-3866	0	9	0	1	1	4	0	0	4	83	9	0	1	34	3	0	TCGA-AA-3866-01	125	0.630133058212083	68	TCGA-AA-3866-01	26	28	10	0.08394608735817352	TCGA-AA-3866-01	7	2	2	11	mutation call filter	2108	TCGA-AA-3866	COAD	78	FEMALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2006	NA	-28672	Alive	TUMOR FREE	518	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	518	0	518	0	518	0	518	
70	TCGA-AA-3867	2	2	0	5	6	2	2	0	1	76	5	0	1	25	1	0	TCGA-AA-3867-01	232	0.8811711538368976	155	TCGA-AA-3867-01	26	27	22	0.1836273083859821	TCGA-AA-3867-01	8	5	5	18	mutation call filter	2109	TCGA-AA-3867	COAD	74	MALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2007	NA	-27028	Alive	WITH TUMOR	731	NA	NA	NA	NA	NA	394	[Unknown]	NA	NA	0	731	0	731	NA	NA	1	394	
80	TCGA-AA-3869	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3869-01	187	0.7514124619978969	109	TCGA-AA-3869-01	18	19	15	0.08114671810255628	TCGA-AA-3869-01	5	3	4	12	PASS	2110	TCGA-AA-3869	COAD	76	MALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2009	NA	-28062	Dead	WITH TUMOR	NA	822	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	822	1	822	NA	NA	1	822	
70	TCGA-AA-3870	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3870-01	251	0.3139914970191444	167	TCGA-AA-3870-01	9	14	48	0.27180038616500185	TCGA-AA-3870-01	11	9	10	30	PASS	2111	TCGA-AA-3870	COAD	71	FEMALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2009	NA	-26086	Alive	TUMOR FREE	912	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	912	0	912	NA	NA	0	912	
50	TCGA-AA-3872	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3872-01	212	0.7457673877409019	143	TCGA-AA-3872-01	24	34	27	0.3398685017836407	TCGA-AA-3872-01	13	11	9	33	PASS	2112	TCGA-AA-3872	COAD	45	MALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2009	NA	-16651	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
80	TCGA-AA-3875	0	9	0	3	1	3	2	0	4	97	11	0	2	30	2	0	TCGA-AA-3875-01	174	0.35379251521248034	86	TCGA-AA-3875-01	17	15	19	0.08490605329636683	TCGA-AA-3875-01	4	1	2	7	mutation call filter	2113	TCGA-AA-3875	COAD	78	FEMALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2007	NA	-28640	Alive	WITH TUMOR	549	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	549	0	549	NA	NA	0	549	
80	TCGA-AA-3877	11	114	3	51	147	19	16	0	55	817	38	1	11	412	27	3	TCGA-AA-3877-01	93	0.055918195500805	31	TCGA-AA-3877-01	2	1	7	0.0015603420305190985	TCGA-AA-3877-01	0	0	0	0	mutation call filter	2114	TCGA-AA-3877	COAD	83	FEMALE	NA	Stage I	NA	Colon Mucinous Adenocarcinoma	NA	2007	NA	-30377	Alive	TUMOR FREE	943	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	943	0	943	0	943	0	943	
70	TCGA-AA-3930	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3930-01	128	0.3431689272576257	67	TCGA-AA-3930-01	9	11	22	0.2311356671725758	TCGA-AA-3930-01	6	4	6	16	PASS	2115	TCGA-AA-3930	COAD	66	MALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2008	NA	-24321	Dead	WITH TUMOR	NA	61	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	61	1	61	NA	NA	1	61	
80	TCGA-AA-3939	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3939-01	104	0.7141933569881145	50	TCGA-AA-3939	0	0	0	0	TCGA-AA-3939	0	0	0	0	PASS	2116	TCGA-AA-3939	COAD	83	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-30439	Alive	WITH TUMOR	395	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	395	0	395	NA	NA	0	395	
80	TCGA-AA-3941	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3941-01	620	0.5618285572643649	560	TCGA-AA-3941-01	18	30	55	0.20369278348150985	TCGA-AA-3941-01	13	17	6	36	PASS	2117	TCGA-AA-3941	COAD	84	FEMALE	NA	Stage IVA	NA	Colon Adenocarcinoma	NA	2010	NA	-31015	Alive	WITH TUMOR	730	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	730	0	730	NA	NA	0	730	
60	TCGA-AA-3947	20	273	18	99	316	69	16	3	100	1763	63	1	28	714	39	1	TCGA-AA-3947-01	136	0.02742048955397667	83	TCGA-AA-3947-01	0	0	3	0.0011456503783029018	TCGA-AA-3947-01	0	0	0	0	hypermutated sample	2118	TCGA-AA-3947	COAD	60	FEMALE	NA	Stage IIB	NA	Colon Mucinous Adenocarcinoma	NA	2009	NA	-22035	Alive	TUMOR FREE	1004	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1004	0	1004	0	1004	0	1004	
90	TCGA-AA-3949	5	145	6	30	101	27	2	0	54	947	55	0	10	399	23	1	TCGA-AA-3949-01	71	0.07882492784521472	27	TCGA-AA-3949-01	3	7	3	0.02910046212790807	TCGA-AA-3949-01	1	2	0	3	mutation call filter	2119	TCGA-AA-3949	COAD	87	FEMALE	NA	Stage IIIB	NA	Colon Mucinous Adenocarcinoma	NA	2009	NA	-32081	Alive	TUMOR FREE	791	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	791	0	791	0	791	0	791	
80	TCGA-AA-3950	0	19	1	3	16	0	1	0	14	100	7	0	3	56	1	0	TCGA-AA-3950-01	69	0.1007972675713388	24	TCGA-AA-3950-01	5	3	2	0.004379800486268836	TCGA-AA-3950-01	1	1	0	2	mutation call filter	2120	TCGA-AA-3950	COAD	79	FEMALE	NA	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2010	NA	-29130	Alive	TUMOR FREE	730	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	730	0	730	0	730	0	730	
70	TCGA-AA-3952	0	13	0	5	5	3	2	0	1	77	7	0	2	37	2	1	TCGA-AA-3952-01	231	0.9057558830552644	131	TCGA-AA-3952-01	11	16	52	0.3244445777136154	TCGA-AA-3952-01	15	12	15	42	mutation call filter	2121	TCGA-AA-3952	COAD	68	MALE	NA	Stage IIIC	NA	Colon Adenocarcinoma	NA	2008	NA	-24868	Dead	WITH TUMOR	NA	61	NA	NA	NA	NA	NA	NA	NA	NA	1	61	1	61	NA	NA	1	61	
40	TCGA-AA-3955	0	11	2	5	3	3	1	0	10	105	13	0	2	35	4	0	TCGA-AA-3955-01	210	0.4005250677517884	141	TCGA-AA-3955-01	15	22	10	0.09205479303219977	TCGA-AA-3955-01	7	3	2	12	mutation call filter	2122	TCGA-AA-3955	COAD	38	MALE	NA	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-14186	Alive	TUMOR FREE	638	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	638	0	638	0	638	0	638	
70	TCGA-AA-3956	1	14	0	12	2	4	0	0	3	122	6	0	4	34	2	0	TCGA-AA-3956-01	149	0.2326644440318019	92	TCGA-AA-3956-01	12	18	21	0.15303014213283772	TCGA-AA-3956-01	5	5	7	17	mutation call filter	2123	TCGA-AA-3956	COAD	65	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2007	NA	-24045	Alive	WITH TUMOR	1035	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1035	0	1035	NA	NA	0	1035	
90	TCGA-AA-3966	8	184	4	43	168	34	12	0	55	795	45	1	28	316	29	1	TCGA-AA-3966-01	142	0.8709884792701793	71	TCGA-AA-3966-01	18	16	16	0.040974749203306064	TCGA-AA-3966-01	8	5	3	16	mutation call filter	2124	TCGA-AA-3966	COAD	89	FEMALE	NA	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2009	NA	-32537	Alive	WITH TUMOR	61	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	61	0	61	NA	NA	0	61	
80	TCGA-AA-3967	1	12	0	8	0	3	1	0	7	140	9	0	3	57	6	1	TCGA-AA-3967	0	0	0	TCGA-AA-3967	0	0	0	0	TCGA-AA-3967	0	0	0	0	mutation call filter	2125	TCGA-AA-3967	COAD	77	MALE	NA	Stage IIIB	NA	Colon Adenocarcinoma	NA	2008	NA	-28216	Alive	TUMOR FREE	943	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	943	0	943	0	943	0	943	
60	TCGA-AA-3968	1	9	1	4	1	1	0	0	1	114	10	0	6	27	9	0	TCGA-AA-3968-01	185	0.8187453493104	110	TCGA-AA-3968-01	16	34	51	0.08049983772030066	TCGA-AA-3968-01	8	9	3	20	mutation call filter	2126	TCGA-AA-3968	COAD	55	FEMALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2008	NA	-20089	Alive	TUMOR FREE	669	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	669	0	669	0	669	0	669	
70	TCGA-AA-3970	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3970	0	0	0	TCGA-AA-3970	0	0	0	0	TCGA-AA-3970	0	0	0	0	PASS	2127	TCGA-AA-3970	COAD	65	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-23741	Alive	TUMOR FREE	1096	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1096	0	1096	0	1096	0	1096	
60	TCGA-AA-3971	0	12	0	2	1	2	0	0	2	67	6	0	2	29	2	0	TCGA-AA-3971-01	100	0.42201787797202794	50	TCGA-AA-3971-01	17	38	35	0.3081973875780426	TCGA-AA-3971-01	5	1	2	8	mutation call filter	2128	TCGA-AA-3971	COAD	58	MALE	NA	Stage III	NA	Colon Adenocarcinoma	NA	2007	NA	-21518	Alive	TUMOR FREE	489	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	489	0	489	0	489	0	489	
70	TCGA-AA-3972	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-3972	0	0	0	TCGA-AA-3972	0	0	0	0	TCGA-AA-3972-01	5	5	1	11	PASS	2129	TCGA-AA-3972	COAD	72	MALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2008	NA	-26360	Alive	WITH TUMOR	1551	NA	NA	NA	NA	NA	1216	Progressive Disease	NA	NA	0	1551	0	1551	NA	NA	1	1216	
70	TCGA-AA-3973	0	8	2	2	1	4	1	0	3	65	11	0	3	25	2	0	TCGA-AA-3973-01	161	0.19518034274234472	97	TCGA-AA-3973-01	9	10	14	0.16122596294218342	TCGA-AA-3973-01	2	0	1	3	mutation call filter	2130	TCGA-AA-3973	COAD	69	MALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2007	NA	-25536	Alive	WITH TUMOR	397	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	397	0	397	NA	NA	0	397	
80	TCGA-AA-3975	2	16	0	4	0	1	0	0	7	121	10	2	4	39	8	0	TCGA-AA-3975-01	189	0.26013290885839085	115	TCGA-AA-3975-01	11	16	16	0.1297326541213101	TCGA-AA-3975-01	5	3	2	10	mutation call filter	2131	TCGA-AA-3975	COAD	80	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2009	NA	-29310	Alive	TUMOR FREE	1036	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1036	0	1036	0	1036	0	1036	
70	TCGA-AA-3976	0	8	0	4	2	0	0	0	2	75	5	0	2	30	2	0	TCGA-AA-3976-01	100	0.6295092862622406	47	TCGA-AA-3976-01	22	26	7	0.16793287732823847	TCGA-AA-3976-01	5	5	2	12	mutation call filter	2132	TCGA-AA-3976	COAD	70	MALE	NA	Stage IIIA	NA	Colon Adenocarcinoma	NA	2009	NA	-25599	Alive	WITH TUMOR	791	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	791	0	791	0	791	0	791	
70	TCGA-AA-3977	18	324	10	100	8	5	0	0	134	2965	407	2	50	870	38	4	TCGA-AA-3977-01	176	0.0007730139525787496	122	TCGA-AA-3977-01	0	0	6	0.028975327317294707	TCGA-AA-3977-01	2	1	2	5	mutation call filter	2133	TCGA-AA-3977	COAD	65	MALE	NA	NA	NA	Colon Adenocarcinoma	NA	2009	NA	-23832	Alive	TUMOR FREE	761	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	761	0	761	0	761	0	761	
80	TCGA-AA-3979	1	9	0	7	4	4	0	0	5	108	10	0	0	43	2	0	TCGA-AA-3979-01	266	0.7216935429358223	169	TCGA-AA-3979-01	12	10	34	0.2182803399855366	TCGA-AA-3979-01	8	5	8	21	mutation call filter	2134	TCGA-AA-3979	COAD	84	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-30742	Alive	TUMOR FREE	730	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	730	0	730	0	730	0	730	
90	TCGA-AA-3980	1	4	0	3	1	1	0	1	4	82	7	0	0	24	1	0	TCGA-AA-3980	0	0	0	TCGA-AA-3980	0	0	0	0	TCGA-AA-3980	0	0	0	0	mutation call filter	2135	TCGA-AA-3980	COAD	89	FEMALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2009	NA	-32630	Alive	TUMOR FREE	822	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	822	0	822	0	822	0	822	
80	TCGA-AA-3982	1	7	1	1	3	2	1	0	7	99	12	0	0	31	5	0	TCGA-AA-3982-01	303	0.3955386986735469	239	TCGA-AA-3982-01	13	16	61	0.4061997781700861	TCGA-AA-3982-01	8	22	17	47	mutation call filter	2136	TCGA-AA-3982	COAD	75	MALE	NA	Stage IIIB	NA	Colon Adenocarcinoma	NA	2009	NA	-27608	Alive	WITH TUMOR	822	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	822	0	822	NA	NA	0	822	
60	TCGA-AA-3984	32	621	26	138	2	13	1	1	237	4453	537	5	94	1421	66	1	TCGA-AA-3984-01	150	0.16398329722062618	87	TCGA-AA-3984-01	7	4	6	0.0011463955374818866	TCGA-AA-3984-01	1	0	0	1	hypermutated sample	2137	TCGA-AA-3984	COAD	61	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-22585	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-AA-3986	0	8	0	4	1	0	0	0	5	74	6	0	3	34	3	0	TCGA-AA-3986-01	81	0.055085985171579074	33	TCGA-AA-3986-01	3	2	3	0.009986827968063028	TCGA-AA-3986-01	1	1	1	3	mutation call filter	2138	TCGA-AA-3986	COAD	73	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2007	NA	-26967	Alive	TUMOR FREE	580	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	580	0	580	0	580	0	580	
80	TCGA-AA-3989	0	5	2	5	3	4	0	0	2	101	5	0	2	33	2	1	TCGA-AA-3989-01	207	0.6704669816151178	146	TCGA-AA-3989-01	19	20	6	0.046625885314477235	TCGA-AA-3989-01	3	6	1	10	mutation call filter	2139	TCGA-AA-3989	COAD	84	MALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2009	NA	-30712	Dead	WITH TUMOR	NA	242	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	242	1	242	NA	NA	1	242	
70	TCGA-AA-3994	0	17	2	3	2	3	0	1	10	154	15	0	4	62	2	1	TCGA-AA-3994-01	100	0.21440938211639798	33	TCGA-AA-3994-01	7	11	11	0.15442529100559846	TCGA-AA-3994-01	3	3	3	9	mutation call filter	2140	TCGA-AA-3994	COAD	69	MALE	NA	Stage IIIB	NA	Colon Mucinous Adenocarcinoma	NA	2008	NA	-25323	Alive	TUMOR FREE	822	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	822	0	822	0	822	0	822	
80	TCGA-AA-A004	0	9	0	1	3	0	2	0	3	55	2	1	1	20	2	1	TCGA-AA-A004-01	148	0.3767601853669565	90	TCGA-AA-A004-01	10	18	33	0.3026287175476594	TCGA-AA-A004-01	11	1	3	15	mutation call filter	2141	TCGA-AA-A004	COAD	76	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-27943	Alive	TUMOR FREE	424	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	424	0	424	0	424	0	424	
80	TCGA-AA-A00A	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A00A-01	153	0.012156578773311544	91	TCGA-AA-A00A-01	0	0	6	0.016064647227288897	TCGA-AA-A00A-01	1	3	1	5	PASS	2142	TCGA-AA-A00A	COAD	80	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-29463	Alive	WITH TUMOR	1157	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1157	0	1157	NA	NA	0	1157	
70	TCGA-AA-A00D	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A00D-01	117	0.288653941379556	60	TCGA-AA-A00D-01	8	10	8	0.0723494387335622	TCGA-AA-A00D-01	3	0	3	6	PASS	2143	TCGA-AA-A00D	COAD	70	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2007	NA	-25689	Alive	TUMOR FREE	578	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	578	0	578	0	578	0	578	
70	TCGA-AA-A00E	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A00E-01	144	0.02162440917771755	69	TCGA-AA-A00E-01	0	4	21	0.03528891550047482	TCGA-AA-A00E-01	2	4	2	8	PASS	2144	TCGA-AA-A00E	COAD	65	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2007	NA	-23741	Alive	TUMOR FREE	913	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	913	0	913	0	913	0	913	
70	TCGA-AA-A00F	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A00F-01	163	0.6400697035211171	89	TCGA-AA-A00F-01	25	27	22	0.2198586933685457	TCGA-AA-A00F-01	11	9	6	26	PASS	2145	TCGA-AA-A00F	COAD	66	MALE	NA	Stage IIIC	NA	Colon Adenocarcinoma	NA	2007	NA	-24379	Alive	TUMOR FREE	1035	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1035	0	1035	NA	NA	0	1035	
80	TCGA-AA-A00J	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A00J-01	107	0.10822621806779067	54	TCGA-AA-A00J-01	1	3	14	0.07220186974956716	TCGA-AA-A00J-01	2	1	1	4	PASS	2146	TCGA-AA-A00J	COAD	80	MALE	NA	Stage IIIB	NA	Colon Mucinous Adenocarcinoma	NA	2009	NA	-29371	Alive	TUMOR FREE	549	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	549	0	549	NA	NA	0	549	
80	TCGA-AA-A00K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A00K-01	109	0.149098213960036	58	TCGA-AA-A00K-01	7	13	14	0.1606535981363102	TCGA-AA-A00K-01	2	1	1	4	PASS	2147	TCGA-AA-A00K	COAD	79	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-29189	Alive	WITH TUMOR	549	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	549	0	549	NA	NA	0	549	
70	TCGA-AA-A00L	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A00L-01	274	0.1823593011114825	176	TCGA-AA-A00L-01	9	13	50	0.1584391668258978	TCGA-AA-A00L-01	4	2	3	9	PASS	2148	TCGA-AA-A00L	COAD	66	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-24319	Alive	TUMOR FREE	1157	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1157	0	1157	0	1157	0	1157	
80	TCGA-AA-A00N	27	550	28	139	2	12	1	1	217	4259	493	5	125	1490	57	4	TCGA-AA-A00N-01	57	0.0007176777356528981	19	TCGA-AA-A00N-01	0	0	2	0.00015969617448492114	TCGA-AA-A00N-01	0	0	0	0	hypermutated sample	2149	TCGA-AA-A00N	COAD	75	MALE	NA	Stage IIB	NA	Colon Mucinous Adenocarcinoma	NA	2008	NA	-27667	Dead	WITH TUMOR	NA	122	NA	NA	NA	NA	NA	NA	NA	NA	1	122	1	122	NA	NA	1	122	
80	TCGA-AA-A00O	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A00O-01	205	0.2995182704950264	115	TCGA-AA-A00O-01	7	18	54	0.294958077268382	TCGA-AA-A00O-01	8	6	4	18	PASS	2150	TCGA-AA-A00O	COAD	83	FEMALE	NA	Stage IIIC	NA	Colon Adenocarcinoma	NA	2008	NA	-30316	Alive	[Discrepancy]	822	NA	NA	NA	NA	NA	NA	[Discrepancy]	NA	NA	0	822	0	822	NA	NA	0	822	
70	TCGA-AA-A00Q	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A00Q-01	65	0.8288944856929327	20	TCGA-AA-A00Q-01	22	21	8	0.14587104302918638	TCGA-AA-A00Q-01	2	0	2	4	PASS	2151	TCGA-AA-A00Q	COAD	66	FEMALE	NA	Stage IIIB	NA	Colon Adenocarcinoma	NA	2008	NA	-24199	Alive	TUMOR FREE	1278	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1278	0	1278	0	1278	0	1278	
60	TCGA-AA-A00R	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A00R-01	96	0.10386309635410038	39	TCGA-AA-A00R-01	2	1	8	0.0015407853115986193	TCGA-AA-A00R-01	0	0	0	0	PASS	2152	TCGA-AA-A00R	COAD	64	FEMALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2008	NA	-23528	Alive	WITH TUMOR	30	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	30	0	30	NA	NA	0	30	
50	TCGA-AA-A00U	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A00U-01	189	0.14820813024833307	115	TCGA-AA-A00U-01	7	7	27	0.08318267109434084	TCGA-AA-A00U-01	5	1	3	9	PASS	2153	TCGA-AA-A00U	COAD	50	MALE	NA	Stage IIIB	NA	Colon Adenocarcinoma	NA	2009	NA	-18263	Alive	TUMOR FREE	518	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	518	0	518	0	518	0	518	
80	TCGA-AA-A00W	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A00W-01	87	0.15395157575787224	36	TCGA-AA-A00W-01	7	7	7	0.08062091272476607	TCGA-AA-A00W-01	3	0	1	4	PASS	2154	TCGA-AA-A00W	COAD	80	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2008	NA	-29311	Alive	TUMOR FREE	456	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	456	0	456	NA	NA	0	456	
70	TCGA-AA-A00Z	0	1	0	1	1	0	0	0	0	13	0	0	0	2	0	0	TCGA-AA-A00Z-01	205	0.20065555078952305	131	TCGA-AA-A00Z-01	10	10	38	0.1855351976344424	TCGA-AA-A00Z-01	7	3	4	14	mutation call filter	2155	TCGA-AA-A00Z	COAD	70	MALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2008	NA	-25872	Alive	TUMOR FREE	669	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	669	0	669	0	669	0	669	
50	TCGA-AA-A010	50	921	50	252	20	20	2	0	406	6551	699	6	166	2049	131	3	TCGA-AA-A010-01	66	0.005584009144279574	27	TCGA-AA-A010-01	0	0	3	0.0001966483101115545	TCGA-AA-A010-01	0	2	0	2	hypermutated sample	2156	TCGA-AA-A010	COAD	46	FEMALE	NA	Stage IIB	NA	Colon Adenocarcinoma	NA	2008	NA	-16922	Alive	TUMOR FREE	1064	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1064	0	1064	0	1064	0	1064	
60	TCGA-AA-A017	1	3	0	3	1	0	1	0	1	47	5	0	5	16	0	0	TCGA-AA-A017-01	99	0.2310418483446617	51	TCGA-AA-A017-01	9	25	34	0.4927543350553679	TCGA-AA-A017-01	5	4	1	10	mutation call filter	2157	TCGA-AA-A017	COAD	57	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-21032	Alive	TUMOR FREE	457	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	457	0	457	0	457	0	457	
80	TCGA-AA-A01C	0	5	0	0	3	2	1	0	2	75	3	0	1	20	1	0	TCGA-AA-A01C-01	103	0.42868821565438425	42	TCGA-AA-A01C-01	17	27	9	0.0461587815796864	TCGA-AA-A01C-01	3	3	4	10	mutation call filter	2158	TCGA-AA-A01C	COAD	75	MALE	NA	Stage IIIA	NA	Colon Adenocarcinoma	NA	2009	NA	-27729	Alive	TUMOR FREE	457	NA	NA	NA	NA	NA	NA	[Discrepancy]	NA	NA	0	457	0	457	NA	NA	0	457	
50	TCGA-AA-A01D	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A01D-01	98	0.410368732145893	45	TCGA-AA-A01D-01	20	21	23	0.1504696001863683	TCGA-AA-A01D-01	5	3	4	12	PASS	2159	TCGA-AA-A01D	COAD	47	FEMALE	NA	Stage IIIC	NA	Colon Mucinous Adenocarcinoma	NA	2009	NA	-17318	Dead	WITH TUMOR	NA	334	NA	NA	NA	NA	183	Progressive Disease	NA	NA	1	334	1	334	NA	NA	1	183	
70	TCGA-AA-A01F	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A01F-01	101	0.94769439960419	42	TCGA-AA-A01F-01	20	32	9	0.09284340063871607	TCGA-AA-A01F-01	4	3	2	9	PASS	2160	TCGA-AA-A01F	COAD	72	MALE	NA	Stage IIIB	NA	Colon Adenocarcinoma	NA	2009	NA	-26298	Alive	WITH TUMOR	974	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	974	0	974	NA	NA	0	974	
60	TCGA-AA-A01G	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A01G-01	131	0.3677368299380003	61	TCGA-AA-A01G-01	12	15	9	0.034589614978564005	TCGA-AA-A01G-01	7	2	2	11	PASS	2161	TCGA-AA-A01G	COAD	63	MALE	NA	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2009	NA	-23133	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	365	0	365	0	365	0	365	
80	TCGA-AA-A01I	0	9	1	2	2	1	0	0	4	88	7	0	3	27	3	1	TCGA-AA-A01I-01	73	0.6325411824049892	26	TCGA-AA-A01I-01	9	5	0	0.0	TCGA-AA-A01I-01	0	0	0	0	mutation call filter	2162	TCGA-AA-A01I	COAD	76	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2009	NA	-27759	Alive	TUMOR FREE	943	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	943	0	943	0	943	0	943	
70	TCGA-AA-A01K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A01K-01	147	0.8594063559256193	85	TCGA-AA-A01K-01	12	15	47	0.4012011578882586	TCGA-AA-A01K-01	6	4	6	16	PASS	2163	TCGA-AA-A01K	COAD	74	FEMALE	NA	Stage IIIC	NA	Colon Adenocarcinoma	NA	2009	NA	-27029	Alive	TUMOR FREE	943	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	943	0	943	0	943	0	943	
80	TCGA-AA-A01P	1	86	4	31	127	21	12	1	51	634	27	0	15	280	20	0	TCGA-AA-A01P-01	57	0.0003291075127394102	22	TCGA-AA-A01P-01	0	0	5	0.008234243082068347	TCGA-AA-A01P-01	1	1	1	3	hypermutated sample	2164	TCGA-AA-A01P	COAD	80	FEMALE	NA	Stage III	NA	Colon Adenocarcinoma	NA	2003	NA	-29554	Dead	WITH TUMOR	NA	1158	NA	NA	NA	NA	762	[Unknown]	NA	NA	1	1158	1	1158	NA	NA	1	762	
50	TCGA-AA-A01Q	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A01Q-01	199	0.0462318330305687	130	TCGA-AA-A01Q-01	1	1	24	0.016275780887416928	TCGA-AA-A01Q-01	2	3	1	6	PASS	2165	TCGA-AA-A01Q	COAD	48	FEMALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2003	NA	-17715	Alive	WITH TUMOR	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
50	TCGA-AA-A01R	16	166	8	54	42	18	2	0	73	1430	93	1	25	681	21	0	TCGA-AA-A01R-01	150	0.0831869771812344	76	TCGA-AA-A01R-01	2	4	10	0.03524779454360507	TCGA-AA-A01R-01	5	5	1	11	hypermutated sample	2166	TCGA-AA-A01R	COAD	47	MALE	NA	Stage III	NA	Colon Mucinous Adenocarcinoma	NA	2004	NA	-17289	Alive	WITH TUMOR	1065	NA	NA	NA	NA	NA	608	Partial Remission/Response	NA	NA	0	1065	0	1065	NA	NA	1	608	
50	TCGA-AA-A01S	0	5	0	0	1	0	0	0	4	40	6	0	0	23	2	0	TCGA-AA-A01S-01	237	0.22491224205678134	162	TCGA-AA-A01S-01	7	9	49	0.13282523117664588	TCGA-AA-A01S-01	7	7	5	19	mutation call filter	2167	TCGA-AA-A01S	COAD	47	FEMALE	NA	Stage III	NA	Colon Adenocarcinoma	NA	2004	NA	-17257	Alive	WITH TUMOR	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
60	TCGA-AA-A01T	0	11	0	0	1	2	1	0	3	77	6	0	1	25	3	0	TCGA-AA-A01T-01	141	0.910212919427186	83	TCGA-AA-A01T-01	22	54	36	0.3561515516818248	TCGA-AA-A01T-01	11	4	1	16	mutation call filter	2168	TCGA-AA-A01T	COAD	63	FEMALE	NA	Stage III	NA	Colon Adenocarcinoma	NA	2004	NA	-23192	Alive	TUMOR FREE	1005	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1005	0	1005	0	1005	0	1005	
60	TCGA-AA-A01V	0	3	1	2	3	3	0	1	7	93	9	0	3	40	1	0	TCGA-AA-A01V-01	55	0.00014970396658159314	15	TCGA-AA-A01V-01	0	0	3	8.213565634372457e-05	TCGA-AA-A01V-01	0	0	0	0	mutation call filter	2169	TCGA-AA-A01V	COAD	59	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2004	NA	-21792	Alive	WITH TUMOR	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
80	TCGA-AA-A01X	0	5	0	1	2	0	2	0	3	51	6	0	2	32	3	0	TCGA-AA-A01X-01	50	0.5221354695150027	13	TCGA-AA-A01X-01	21	29	19	0.06241352394899781	TCGA-AA-A01X-01	1	0	0	1	mutation call filter	2170	TCGA-AA-A01X	COAD	80	FEMALE	NA	Stage III	NA	Colon Adenocarcinoma	NA	2004	NA	-29281	Alive	WITH TUMOR	791	NA	NA	NA	NA	NA	791	[Unknown]	NA	NA	0	791	0	791	NA	NA	1	791	
70	TCGA-AA-A01Z	0	3	0	2	0	4	2	1	3	79	5	0	1	25	2	0	TCGA-AA-A01Z-01	259	0.17980138145302535	170	TCGA-AA-A01Z-01	8	9	53	0.14007544570474847	TCGA-AA-A01Z-01	7	10	4	21	mutation call filter	2171	TCGA-AA-A01Z	COAD	68	MALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2004	NA	-24990	Alive	WITH TUMOR	1126	NA	NA	NA	NA	NA	1126	Progressive Disease	NA	NA	0	1126	0	1126	NA	NA	1	1126	
90	TCGA-AA-A022	10	179	7	68	236	51	21	3	77	1061	60	0	27	527	27	0	TCGA-AA-A022-01	147	0.15183337697577534	86	TCGA-AA-A022-01	7	5	14	0.047098080167588964	TCGA-AA-A022-01	0	1	2	3	hypermutated sample	2172	TCGA-AA-A022	COAD	88	FEMALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2005	NA	-32446	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
80	TCGA-AA-A024	2	7	0	4	2	0	1	1	7	62	9	0	2	24	2	0	TCGA-AA-A024-01	61	0.0005814427013429539	24	TCGA-AA-A024-01	0	4	6	0.09594699144141736	TCGA-AA-A024-01	1	1	1	3	mutation call filter	2173	TCGA-AA-A024	COAD	81	MALE	NA	Stage II	NA	Colon Mucinous Adenocarcinoma	NA	2005	NA	-29708	Dead	TUMOR FREE	NA	1188	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1188	0	1188	0	1188	0	1188	
70	TCGA-AA-A029	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A029-01	70	0.8643550561310009	29	TCGA-AA-A029-01	13	15	5	0.19743937577115112	TCGA-AA-A029-01	1	0	0	1	PASS	2174	TCGA-AA-A029	COAD	67	MALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2006	NA	-24686	Alive	TUMOR FREE	1581	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1581	0	1581	0	1581	0	1581	
80	TCGA-AA-A02E	1	23	0	8	4	2	3	0	3	128	5	1	1	42	5	0	TCGA-AA-A02E-01	166	0.7268910209147459	98	TCGA-AA-A02E-01	23	22	24	0.1226141464538223	TCGA-AA-A02E-01	12	4	5	21	mutation call filter	2175	TCGA-AA-A02E	COAD	82	FEMALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2007	NA	-30256	Dead	WITH TUMOR	NA	90	NA	NA	NA	NA	NA	NA	NA	NA	1	90	1	90	NA	NA	1	90	
70	TCGA-AA-A02F	0	10	2	0	1	3	1	0	3	40	3	0	3	24	4	0	TCGA-AA-A02F-01	178	0.947580272447368	115	TCGA-AA-A02F-01	13	11	48	0.2591586812448328	TCGA-AA-A02F-01	8	4	8	20	mutation call filter	2176	TCGA-AA-A02F	COAD	68	FEMALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2007	NA	-25051	Alive	WITH TUMOR	1216	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1216	0	1216	NA	NA	0	1216	
70	TCGA-AA-A02H	0	3	0	3	5	0	1	0	4	62	3	0	1	18	2	0	TCGA-AA-A02H-01	147	0.4270543533903083	72	TCGA-AA-A02H-01	11	31	30	0.3834378092548685	TCGA-AA-A02H-01	11	10	5	26	mutation call filter	2177	TCGA-AA-A02H	COAD	74	FEMALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2007	NA	-27362	Dead	WITH TUMOR	NA	61	NA	NA	NA	NA	NA	NA	NA	NA	1	61	1	61	NA	NA	1	61	
70	TCGA-AA-A02J	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AA-A02J-01	139	0.18546538029329607	70	TCGA-AA-A02J-01	9	7	15	0.05413326356753971	TCGA-AA-A02J-01	2	2	2	6	PASS	2178	TCGA-AA-A02J	COAD	70	FEMALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2008	NA	-25749	Dead	WITH TUMOR	NA	153	NA	NA	NA	NA	NA	NA	NA	NA	1	153	1	153	NA	NA	1	153	
50	TCGA-AA-A02K	0	6	0	3	5	2	1	0	1	109	7	0	4	41	4	0	TCGA-AA-A02K	0	0	0	TCGA-AA-A02K	0	0	0	0	TCGA-AA-A02K	0	0	0	0	mutation call filter	2179	TCGA-AA-A02K	COAD	50	MALE	NA	Stage IV	NA	Colon Adenocarcinoma	NA	2009	NA	-18506	Dead	WITH TUMOR	NA	426	NA	NA	NA	NA	306	Progressive Disease	NA	NA	1	426	1	426	NA	NA	1	306	
80	TCGA-AA-A02O	0	16	1	7	4	2	1	0	7	144	4	0	1	39	1	0	TCGA-AA-A02O-01	132	0.7627879812803264	59	TCGA-AA-A02O-01	12	11	18	0.06753773249109618	TCGA-AA-A02O-01	3	1	2	6	mutation call filter	2180	TCGA-AA-A02O	COAD	82	MALE	NA	Stage II	NA	Colon Adenocarcinoma	NA	2005	NA	-30288	Alive	WITH TUMOR	28	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	28	0	28	NA	NA	0	28	
80	TCGA-AA-A02R	15	166	2	27	197	36	9	2	67	757	52	0	22	353	20	1	TCGA-AA-A02R-01	93	0.04657197178790823	44	TCGA-AA-A02R-01	2	3	12	0.012265983944751223	TCGA-AA-A02R-01	0	0	0	0	mutation call filter	2181	TCGA-AA-A02R	COAD	84	FEMALE	NA	Stage IIA	NA	Colon Adenocarcinoma	NA	2006	NA	-30834	Dead	WITH TUMOR	NA	670	NA	NA	NA	NA	NA	NA	NA	NA	1	670	1	670	NA	NA	1	670	
70	TCGA-AA-A02W	0	6	1	0	1	0	1	1	1	75	8	0	1	34	5	0	TCGA-AA-A02W-01	154	0.7834440187893711	88	TCGA-AA-A02W-01	21	38	9	0.05154087509365457	TCGA-AA-A02W-01	5	1	3	9	mutation call filter	2182	TCGA-AA-A02W	COAD	73	FEMALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2006	NA	-26693	Alive	TUMOR FREE	1247	NA	NA	NA	NA	NA	1005	Complete Remission/Response	NA	NA	0	1247	0	1247	1	1005	1	1005	
70	TCGA-AA-A02Y	0	9	0	3	4	0	1	0	3	94	7	0	1	27	2	0	TCGA-AA-A02Y-01	74	0.5354762054730531	23	TCGA-AA-A02Y-01	8	7	7	0.0761057027663524	TCGA-AA-A02Y-01	3	1	2	6	mutation call filter	2183	TCGA-AA-A02Y	COAD	73	MALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2007	NA	-26724	Alive	TUMOR FREE	1216	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1216	0	1216	0	1216	0	1216	
90	TCGA-AA-A03F	1	9	1	5	1	1	0	0	4	113	10	0	2	37	1	0	TCGA-AA-A03F-01	73	3.598651281812574e-05	27	TCGA-AA-A03F-01	0	0	19	0.018586227047751903	TCGA-AA-A03F-01	1	1	1	3	mutation call filter	2184	TCGA-AA-A03F	COAD	90	FEMALE	NA	Stage III	NA	Colon Mucinous Adenocarcinoma	NA	2004	NA	-32873	Dead	WITH TUMOR	NA	549	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	549	1	549	NA	NA	1	549	
70	TCGA-AA-A03J	1	8	2	4	0	0	0	0	6	69	3	0	1	35	4	0	TCGA-AA-A03J-01	119	0.5072686478449333	64	TCGA-AA-A03J-01	21	28	14	0.2479274331538423	TCGA-AA-A03J-01	3	4	3	10	mutation call filter	2185	TCGA-AA-A03J	COAD	65	FEMALE	NA	Stage I	NA	Colon Adenocarcinoma	NA	2004	NA	-23986	Alive	TUMOR FREE	1246	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1246	0	1246	0	1246	0	1246	
70	TCGA-AD-5900	11	198	7	60	208	56	27	1	72	1078	61	0	14	501	31	4	TCGA-AD-5900-01	67	0.1197155484512459	27	TCGA-AD-5900-01	6	7	9	0.08726256047059934	TCGA-AD-5900-01	1	2	0	3	hypermutated sample	2186	TCGA-AD-5900	COAD	67	MALE	WHITE	Stage I	NA	Colon Mucinous Adenocarcinoma	NA	2010	NA	-24776	Alive	TUMOR FREE	370	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	370	0	370	0	370	0	370	
80	TCGA-AD-6548	0	6	0	2	4	1	0	1	2	104	10	0	3	48	0	0	TCGA-AD-6548-01	125	0.07526485653213935	65	TCGA-AD-6548-01	4	6	19	0.06417479547291763	TCGA-AD-6548-01	4	3	1	8	PASS	2187	TCGA-AD-6548	COAD	81	FEMALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2011	NA	-29758	Alive	TUMOR FREE	650	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	650	0	650	0	650	0	650	
70	TCGA-AD-6888	1	12	2	4	2	2	2	0	5	86	11	0	0	27	1	0	TCGA-AD-6888-01	137	0.9475617712624256	79	TCGA-AD-6888-01	30	27	17	0.13443772326633946	TCGA-AD-6888-01	8	4	2	14	PASS	2188	TCGA-AD-6888	COAD	73	MALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-26816	Dead	WITH TUMOR	NA	472	NA	NA	NA	NA	343	Complete Remission/Response	NA	NA	1	472	1	472	1	343	1	343	
80	TCGA-AD-6889	13	207	10	68	299	84	20	0	82	1178	75	0	30	535	37	0	TCGA-AD-6889-01	118	0.0008025511158347358	63	TCGA-AD-6889-01	0	0	5	0.0005102067489205323	TCGA-AD-6889-01	0	0	0	0	hypermutated sample	2189	TCGA-AD-6889	COAD	76	MALE	ASIAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2005	NA	NA	Dead	TUMOR FREE	NA	2532	NA	NA	NA	NA	1516	Complete Remission/Response	NA	NA	1	2532	0	2532	1	1516	1	1516	
70	TCGA-AD-6890	1	12	0	4	3	3	2	0	6	81	9	0	1	33	2	0	TCGA-AD-6890-01	89	0.25346575231430857	35	TCGA-AD-6890-01	9	25	14	0.0654642519792311	TCGA-AD-6890-01	4	3	4	11	PASS	2190	TCGA-AD-6890	COAD	65	MALE	WHITE	NA	NA	Colon Adenocarcinoma	NA	2010	NA	-23769	Alive	TUMOR FREE	746	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	746	0	746	0	746	0	746	
80	TCGA-AD-6895	5	169	17	74	132	40	21	0	67	1237	64	1	24	599	27	0	TCGA-AD-6895-01	100	0.023079674802705768	42	TCGA-AD-6895-01	0	0	7	0.0008740937607418918	TCGA-AD-6895-01	0	0	0	0	hypermutated sample	2191	TCGA-AD-6895	COAD	84	MALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2011	NA	-30879	Alive	TUMOR FREE	763	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	763	0	763	0	763	0	763	
80	TCGA-AD-6899	0	10	0	10	2	1	1	0	4	119	10	0	1	62	2	0	TCGA-AD-6899-01	96	0.5701805169524227	45	TCGA-AD-6899-01	20	39	18	0.2179710108596289	TCGA-AD-6899-01	8	5	3	16	PASS	2192	TCGA-AD-6899	COAD	84	MALE	WHITE	Stage IIIC	NA	Colon Mucinous Adenocarcinoma	NA	2011	NA	-30693	Dead	TUMOR FREE	NA	176	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	176	0	176	0	176	0	176	
80	TCGA-AD-6901	1	12	1	14	6	1	1	0	8	199	11	0	4	87	4	0	TCGA-AD-6901-01	124	0.9318470909457296	72	TCGA-AD-6901-01	25	32	24	0.2341600740620854	TCGA-AD-6901-01	8	6	2	16	PASS	2193	TCGA-AD-6901	COAD	78	MALE	WHITE	NA	NA	Colon Adenocarcinoma	NA	2011	NA	-28579	Dead	WITH TUMOR	NA	682	NA	Metastatic	NA	NA	468	Complete Remission/Response	NA	NA	1	682	1	682	1	468	1	468	
60	TCGA-AD-6963	0	11	0	4	1	1	0	0	6	67	3	0	2	23	1	0	TCGA-AD-6963-01	131	0.4156481133267725	71	TCGA-AD-6963-01	19	27	10	0.14623538683823886	TCGA-AD-6963-01	4	0	2	6	PASS	2194	TCGA-AD-6963	COAD	58	MALE	WHITE	NA	NA	Colon Adenocarcinoma	NA	2011	NA	-21294	Alive	TUMOR FREE	834	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	834	0	834	0	834	0	834	
60	TCGA-AD-6964	8	148	7	46	132	48	8	0	70	1144	41	1	20	479	30	0	TCGA-AD-6964-01	75	0.011102787740055292	22	TCGA-AD-6964-01	0	0	6	0.011311080973244007	TCGA-AD-6964-01	0	2	1	3	hypermutated sample	2195	TCGA-AD-6964	COAD	58	MALE	WHITE	NA	NA	Colon Adenocarcinoma	NA	2011	NA	-21457	Dead	WITH TUMOR	NA	331	NA	Metastatic	NA	NA	325	Progressive Disease	NA	NA	1	331	1	331	NA	NA	1	325	
60	TCGA-AD-6965	0	7	0	6	4	2	0	0	5	88	7	0	1	47	4	0	TCGA-AD-6965-01	130	0.7403156405987805	59	TCGA-AD-6965-01	18	18	28	0.13913003078415798	TCGA-AD-6965-01	11	1	6	18	PASS	2196	TCGA-AD-6965	COAD	62	MALE	WHITE	Stage IIIC	NA	Colon Adenocarcinoma	NA	2011	NA	-22853	Alive	WITH TUMOR	805	NA	NA	NA	NA	NA	648	Complete Remission/Response	NA	NA	0	805	0	805	1	648	1	648	
70	TCGA-AD-A5EJ	12	173	12	70	276	72	17	5	71	977	45	1	14	448	30	3	TCGA-AD-A5EJ-01	66	0.011378296492873512	20	TCGA-AD-A5EJ-01	1	1	13	0.015411713035505153	TCGA-AD-A5EJ-01	1	0	0	1	hypermutated sample	2197	TCGA-AD-A5EJ	COAD	74	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2012	NA	-27180	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
50	TCGA-AD-A5EK	2	12	3	2	0	0	1	0	1	67	5	0	0	35	0	0	TCGA-AD-A5EK-01	218	0.9475892323125652	152	TCGA-AD-A5EK-01	25	40	72	0.14383486702696066	TCGA-AD-A5EK-01	6	2	3	11	PASS	2198	TCGA-AD-A5EK	COAD	51	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Colon Adenocarcinoma	NA	2012	NA	-18731	Alive	TUMOR FREE	500	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	500	0	500	0	500	0	500	
60	TCGA-AM-5820	0	1	0	1	1	0	0	0	2	67	2	0	2	30	0	0	TCGA-AM-5820-01	580	0.2673292910672753	380	TCGA-AM-5820-01	6	11	63	0.2059322072218323	TCGA-AM-5820-01	11	10	12	33	PASS	2199	TCGA-AM-5820	COAD	59	FEMALE	WHITE	Stage IVA	NA	Colon Adenocarcinoma	NA	2010	NA	-21902	Alive	TUMOR FREE	14	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	14	0	14	NA	NA	0	14	
70	TCGA-AM-5821	6	150	7	43	158	34	9	0	62	945	37	0	23	402	22	0	TCGA-AM-5821-01	120	0.11854350205183267	58	TCGA-AM-5821-01	4	3	12	0.020799410180464745	TCGA-AM-5821-01	1	1	1	3	hypermutated sample	2200	TCGA-AM-5821	COAD	68	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-24903	Alive	TUMOR FREE	28	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	28	0	28	NA	NA	0	28	
80	TCGA-AU-3779	1	8	0	2	0	0	0	0	3	83	7	0	3	33	2	1	TCGA-AU-3779-01	138	0.8823926154283901	74	TCGA-AU-3779-01	20	35	29	0.31474038911076463	TCGA-AU-3779-01	11	5	5	21	PASS	2201	TCGA-AU-3779	COAD	80	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-29460	Alive	TUMOR FREE	441	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	441	0	441	NA	NA	0	441	
70	TCGA-AU-6004	7	117	11	32	174	43	18	2	46	661	33	0	17	298	19	0	TCGA-AU-6004-01	94	0.05050256469258824	43	TCGA-AU-6004-01	2	1	8	0.0042260208519518064	TCGA-AU-6004-01	1	1	0	2	hypermutated sample	2202	TCGA-AU-6004	COAD	69	FEMALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2010	NA	-25259	Alive	TUMOR FREE	824	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	824	0	824	NA	NA	0	824	
50	TCGA-AY-4070	2	14	1	6	1	2	1	1	5	136	2	1	3	47	7	0	TCGA-AY-4070-01	292	0.5919224756884338	195	TCGA-AY-4070-01	18	64	33	0.2621179337214922	TCGA-AY-4070-01	23	16	8	47	mutation call filter	2203	TCGA-AY-4070	COAD	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Colon Adenocarcinoma	NA	2007	NA	-18621	Dead	WITH TUMOR	NA	496	NA	NA	NA	NA	186	NA	NA	NA	1	496	1	496	NA	NA	1	186	
60	TCGA-AY-4071	0	9	0	6	5	1	0	0	5	98	8	0	1	35	2	1	TCGA-AY-4071-01	130	0.4207601333539336	71	TCGA-AY-4071-01	17	35	23	0.2319483469999352	TCGA-AY-4071-01	7	4	8	19	mutation call filter	2204	TCGA-AY-4071	COAD	63	FEMALE	WHITE	Stage I	NA	NA	NA	2009	NA	-23320	Dead	TUMOR FREE	NA	29	NA	NA	NA	NA	NA	NA	NA	NA	1	29	0	29	NA	NA	0	29	
70	TCGA-AY-5543	1	12	2	7	1	0	0	0	4	92	3	0	4	45	0	0	TCGA-AY-5543-01	134	0.360678157037944	77	TCGA-AY-5543-01	14	15	31	0.19561847931433746	TCGA-AY-5543-01	8	0	4	12	PASS	2205	TCGA-AY-5543	COAD	65	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVA	NA	Colon Adenocarcinoma	NA	2010	NA	-23870	Alive	TUMOR FREE	1004	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1004	0	1004	NA	NA	0	1004	
50	TCGA-AY-6196	1	22	2	7	5	2	1	0	16	175	15	0	9	61	12	0	TCGA-AY-6196-01	223	0.7390357510657497	126	TCGA-AY-6196-01	17	36	50	0.29022234329465524	TCGA-AY-6196-01	27	28	9	64	PASS	2206	TCGA-AY-6196	COAD	47	MALE	WHITE	Stage IIIC	NA	Colon Mucinous Adenocarcinoma	NA	2010	NA	-17311	Alive	TUMOR FREE	6	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	6	0	6	NA	NA	0	6	
60	TCGA-AY-6197	8	140	6	38	174	41	15	0	70	764	14	0	15	321	38	1	TCGA-AY-6197-01	157	0.08971091999506559	96	TCGA-AY-6197-01	3	4	6	0.07825198363343537	TCGA-AY-6197-01	0	2	1	3	hypermutated sample	2207	TCGA-AY-6197	COAD	60	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-21957	Alive	TUMOR FREE	652	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	652	0	652	0	652	0	652	
70	TCGA-AY-6386	3	3	0	2	3	4	0	0	11	73	13	0	3	39	5	0	TCGA-AY-6386-01	107	0.0544459192236536	57	TCGA-AY-6386-01	2	1	19	6.404991585613652e-05	TCGA-AY-6386-01	0	0	0	0	PASS	2208	TCGA-AY-6386	COAD	66	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-24453	Alive	TUMOR FREE	542	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	542	0	542	0	542	0	542	
70	TCGA-AY-A54L	1	18	0	1	6	3	1	0	10	116	9	0	4	41	4	0	TCGA-AY-A54L-01	70	0.6920716965945855	19	TCGA-AY-A54L-01	27	61	36	0.1462391000655338	TCGA-AY-A54L-01	8	10	6	24	PASS	2209	TCGA-AY-A54L	COAD	74	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Colon Adenocarcinoma	NA	2012	NA	-27074	Alive	WITH TUMOR	525	NA	NA	NA	NA	NA	396	Complete Remission/Response	NA	NA	0	525	0	525	1	396	1	396	
60	TCGA-AY-A69D	2	26	0	9	3	3	1	0	8	162	11	0	3	57	4	0	TCGA-AY-A69D-01	175	0.8685538864339974	112	TCGA-AY-A69D-01	23	18	32	0.01999517439429064	TCGA-AY-A69D-01	4	3	2	9	PASS	2210	TCGA-AY-A69D	COAD	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2012	NA	-20299	Alive	TUMOR FREE	543	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	543	0	543	0	543	0	543	
50	TCGA-AY-A71X	3	4	0	2	2	2	0	0	4	80	3	0	2	21	2	0	TCGA-AY-A71X-01	139	0.0814804876343951	81	TCGA-AY-A71X-01	0	0	44	0.05562068136264933	TCGA-AY-A71X-01	1	9	3	13	PASS	2211	TCGA-AY-A71X	COAD	54	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Colon Adenocarcinoma	NA	2013	NA	-19904	Alive	TUMOR FREE	588	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	588	0	588	0	588	0	588	
40	TCGA-AY-A8YK	1	9	0	5	0	0	0	0	2	54	5	0	0	21	1	0	TCGA-AY-A8YK-01	204	0.8999909997415181	133	TCGA-AY-A8YK-01	26	30	84	0.15964434239172015	TCGA-AY-A8YK-01	12	7	5	24	PASS	2212	TCGA-AY-A8YK	COAD	44	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	NA	Colon Adenocarcinoma	NA	2013	NA	-16140	Alive	TUMOR FREE	573	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	573	0	573	NA	NA	0	573	
50	TCGA-AZ-4308	0	2	0	1	0	0	0	0	3	65	7	0	1	17	2	0	TCGA-AZ-4308-01	229	0.1973898041517712	165	TCGA-AZ-4308-01	8	12	58	0.11700070701952466	TCGA-AZ-4308-01	6	4	4	14	PASS	2213	TCGA-AZ-4308	COAD	47	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2006	NA	-17321	Alive	TUMOR FREE	3324	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3324	0	3324	0	3324	0	3324	
50	TCGA-AZ-4313	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AZ-4313-01	61	0.13813386198727384	15	TCGA-AZ-4313-01	5	3	19	0.002640292680096217	TCGA-AZ-4313-01	0	0	0	0	PASS	2214	TCGA-AZ-4313	COAD	51	FEMALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2007	NA	-18765	Alive	TUMOR FREE	2310	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2310	0	2310	0	2310	0	2310	
60	TCGA-AZ-4315	50	968	42	229	10	23	0	0	345	5579	574	2	121	1824	84	2	TCGA-AZ-4315-01	125	0.0012725216722367625	72	TCGA-AZ-4315-01	0	0	12	0.003297689098907239	TCGA-AZ-4315-01	1	0	0	1	hypermutated sample	2215	TCGA-AZ-4315	COAD	61	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2006	NA	-22340	Alive	TUMOR FREE	1776	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1776	0	1776	NA	NA	0	1776	
40	TCGA-AZ-4323	1	3	0	4	0	0	0	0	1	47	4	0	3	18	0	0	TCGA-AZ-4323-01	97	0.09302113690774104	49	TCGA-AZ-4323-01	5	11	8	0.10784537696482632	TCGA-AZ-4323-01	2	0	2	4	PASS	2216	TCGA-AZ-4323	COAD	37	MALE	WHITE	Stage IV	NA	Colon Adenocarcinoma	NA	2002	NA	-13755	Dead	WITH TUMOR	NA	43	NA	NA	NA	NA	NA	NA	NA	NA	1	43	1	43	NA	NA	1	43	
70	TCGA-AZ-4614	0	20	1	10	4	4	2	0	10	152	8	0	6	64	5	1	TCGA-AZ-4614-01	293	0.5741367851384603	176	TCGA-AZ-4614-01	7	11	45	0.2442758826715023	TCGA-AZ-4614-01	13	4	6	23	PASS	2217	TCGA-AZ-4614	COAD	71	FEMALE	WHITE	Stage IVA	NA	Colon Adenocarcinoma	NA	2008	NA	-26267	Dead	WITH TUMOR	NA	172	NA	NA	NA	NA	NA	NA	NA	NA	1	172	1	172	NA	NA	1	172	
80	TCGA-AZ-4615	2	103	8	22	182	29	15	1	60	542	28	2	15	254	20	1	TCGA-AZ-4615-01	100	0.058709583260944775	53	TCGA-AZ-4615-01	2	1	12	0.010278214372218493	TCGA-AZ-4615-01	0	1	0	1	hypermutated sample	2218	TCGA-AZ-4615	COAD	84	MALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2009	NA	-30908	Alive	WITH TUMOR	1002	NA	NA	NA	NA	NA	688	NA	NA	NA	0	1002	0	1002	NA	NA	1	688	
80	TCGA-AZ-4616	0	6	1	0	1	3	0	0	5	76	5	0	2	32	4	0	TCGA-AZ-4616-01	88	0.4856166178582378	36	TCGA-AZ-4616-01	13	30	18	0.14122841294846428	TCGA-AZ-4616-01	8	9	5	22	PASS	2219	TCGA-AZ-4616	COAD	82	FEMALE	WHITE	Stage IV	NA	Colon Adenocarcinoma	NA	2009	NA	-30043	Dead	WITH TUMOR	NA	156	NA	NA	NA	NA	NA	NA	NA	NA	1	156	1	156	NA	NA	1	156	
80	TCGA-AZ-4681	0	6	0	4	0	5	1	1	2	67	4	0	2	22	2	0	TCGA-AZ-4681-01	143	0.24342488901549544	82	TCGA-AZ-4681-01	11	7	15	0.12631711601586407	TCGA-AZ-4681-01	3	3	5	11	PASS	2220	TCGA-AZ-4681	COAD	79	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2004	NA	-28906	Alive	TUMOR FREE	3247	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3247	0	3247	0	3247	0	3247	
60	TCGA-AZ-4682	0	5	0	1	1	0	1	0	4	63	6	0	5	25	0	0	TCGA-AZ-4682-01	126	0.4433230540889318	77	TCGA-AZ-4682-01	10	11	18	0.1471215299469947	TCGA-AZ-4682-01	1	3	3	7	PASS	2221	TCGA-AZ-4682	COAD	61	MALE	WHITE	Stage IVA	NA	Colon Adenocarcinoma	NA	2006	NA	-22409	Dead	WITH TUMOR	NA	680	NA	NA	NA	NA	NA	NA	NA	NA	1	680	1	680	NA	NA	1	680	
50	TCGA-AZ-4684	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AZ-4684-01	188	0.5581822141745296	112	TCGA-AZ-4684-01	21	19	21	0.2335104120003253	TCGA-AZ-4684-01	7	5	8	20	PASS	2222	TCGA-AZ-4684	COAD	49	MALE	WHITE	Stage IVA	NA	Colon Adenocarcinoma	NA	2006	NA	-18252	Alive	WITH TUMOR	1977	NA	NA	NA	NA	NA	411	NA	NA	NA	0	1977	0	1977	NA	NA	1	411	
40	TCGA-AZ-5403	0	6	1	1	1	0	0	0	7	64	6	0	1	18	4	0	TCGA-AZ-5403-01	144	0.4051420435793544	73	TCGA-AZ-5403-01	17	29	23	0.3331486977005773	TCGA-AZ-5403-01	4	3	5	12	PASS	2223	TCGA-AZ-5403	COAD	43	MALE	WHITE	Stage II	NA	Colon Adenocarcinoma	NA	2000	NA	-15983	Dead	WITH TUMOR	NA	1910	NA	NA	NA	NA	304	NA	NA	NA	1	1910	1	1910	NA	NA	1	304	
50	TCGA-AZ-5407	0	12	0	0	0	0	1	0	5	77	8	0	1	29	2	0	TCGA-AZ-5407-01	75	0.2142467809118508	33	TCGA-AZ-5407-01	7	4	2	2.3811327087214565e-05	TCGA-AZ-5407-01	0	1	0	1	PASS	2224	TCGA-AZ-5407	COAD	51	FEMALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2007	NA	-18820	Alive	TUMOR FREE	2683	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2683	0	2683	0	2683	0	2683	
80	TCGA-AZ-6598	14	318	13	77	480	92	28	2	119	1578	68	1	38	702	46	1	TCGA-AZ-6598-01	123	0.9476864429962432	70	TCGA-AZ-6598-01	11	6	5	0.0004104547097839321	TCGA-AZ-6598-01	0	0	0	0	hypermutated sample	2225	TCGA-AZ-6598	COAD	77	FEMALE	WHITE	Stage II	NA	Colon Adenocarcinoma	NA	2000	NA	-28182	Dead	TUMOR FREE	NA	1503	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1503	0	1503	0	1503	0	1503	
70	TCGA-AZ-6599	3	29	0	55	3	0	2	0	22	196	18	0	4	97	6	0	TCGA-AZ-6599-01	75	0.05152513834915848	31	TCGA-AZ-6599-01	0	0	3	0.006183667023125914	TCGA-AZ-6599-01	0	2	1	3	PASS	2226	TCGA-AZ-6599	COAD	72	MALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2001	NA	-26438	Dead	TUMOR FREE	NA	206	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	206	0	206	0	206	0	206	
60	TCGA-AZ-6600	1	12	0	5	0	3	1	0	8	102	15	0	1	39	3	0	TCGA-AZ-6600-01	165	0.5018790849047399	100	TCGA-AZ-6600-01	21	26	15	0.12779424779083398	TCGA-AZ-6600-01	3	5	4	12	PASS	2227	TCGA-AZ-6600	COAD	64	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Colon Adenocarcinoma	NA	2001	NA	-23581	Dead	WITH TUMOR	NA	368	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	368	1	368	NA	NA	1	368	
70	TCGA-AZ-6601	10	197	17	72	40	15	2	0	76	1659	85	0	30	718	32	3	TCGA-AZ-6601	0	0	0	TCGA-AZ-6601	0	0	0	0	TCGA-AZ-6601-01	1	1	1	3	hypermutated sample	2228	TCGA-AZ-6601	COAD	68	MALE	WHITE	Stage II	NA	Colon Adenocarcinoma	NA	2001	NA	-25082	Dead	WITH TUMOR	NA	3042	NA	Locoregional Disease	NA	NA	2270	Progressive Disease	NA	NA	1	3042	1	3042	NA	NA	1	2270	
80	TCGA-AZ-6603	1	8	1	1	4	1	1	0	3	65	1	0	0	24	1	0	TCGA-AZ-6603-01	110	0.7231720044917294	62	TCGA-AZ-6603-01	27	29	12	0.12786914321639245	TCGA-AZ-6603-01	6	2	3	11	PASS	2229	TCGA-AZ-6603	COAD	77	FEMALE	WHITE	NA	NA	Colon Adenocarcinoma	NA	2002	NA	-28424	Dead	TUMOR FREE	NA	899	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	899	0	899	0	899	0	899	
80	TCGA-AZ-6605	2	10	0	1	2	0	0	0	5	90	8	0	4	51	2	0	TCGA-AZ-6605-01	98	0.4909181908067486	41	TCGA-AZ-6605-01	21	25	9	0.08055701257605431	TCGA-AZ-6605-01	6	1	1	8	PASS	2230	TCGA-AZ-6605	COAD	77	MALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2008	NA	-28485	Dead	TUMOR FREE	NA	159	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	159	0	159	NA	NA	0	159	
80	TCGA-AZ-6606	1	10	2	5	4	2	0	0	10	112	10	0	2	53	2	0	TCGA-AZ-6606-01	107	0.71675956234623	44	TCGA-AZ-6606-01	8	14	21	0.09690117018589624	TCGA-AZ-6606-01	9	4	4	17	PASS	2231	TCGA-AZ-6606	COAD	81	MALE	WHITE	Stage IV	NA	Colon Adenocarcinoma	NA	2009	NA	-29704	Dead	WITH TUMOR	NA	357	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	357	1	357	NA	NA	1	357	
70	TCGA-AZ-6607	1	5	0	0	1	0	0	0	4	62	3	0	0	25	1	1	TCGA-AZ-6607-01	120	0.7968838255984492	55	TCGA-AZ-6607-01	22	24	13	0.059341967557461614	TCGA-AZ-6607-01	6	6	4	16	PASS	2232	TCGA-AZ-6607	COAD	69	MALE	WHITE	Stage IV	NA	Colon Adenocarcinoma	NA	2009	NA	-25448	Dead	WITH TUMOR	NA	97	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	97	1	97	NA	NA	1	97	
60	TCGA-AZ-6608	0	20	0	10	3	5	1	0	9	115	9	0	3	47	11	0	TCGA-AZ-6608	0	0	0	TCGA-AZ-6608	0	0	0	0	TCGA-AZ-6608-01	5	1	2	8	PASS	2233	TCGA-AZ-6608	COAD	55	FEMALE	WHITE	Stage IIIA	NA	Colon Adenocarcinoma	NA	2009	NA	-20094	Dead	[Discrepancy]	NA	59	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	59	NA	59	NA	NA	0	59	
40	TCGA-CA-5254	3	19	0	7	3	3	0	0	8	161	12	0	4	56	1	0	TCGA-CA-5254-01	402	0.5471512053125835	271	TCGA-CA-5254-01	17	20	56	0.1464582803383604	TCGA-CA-5254-01	13	11	4	28	PASS	2234	TCGA-CA-5254	COAD	42	FEMALE	ASIAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-15415	Alive	TUMOR FREE	386	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	386	0	386	0	386	0	386	
50	TCGA-CA-5255	0	3	0	6	1	1	0	0	4	45	2	0	1	16	1	0	TCGA-CA-5255-01	44	0.37437909658391216	10	TCGA-CA-5255-01	18	23	4	0.09067240918070343	TCGA-CA-5255-01	1	1	0	2	PASS	2235	TCGA-CA-5255	COAD	45	MALE	ASIAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-16743	Alive	TUMOR FREE	376	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	376	0	376	0	376	0	376	
50	TCGA-CA-5256	0	4	0	4	2	2	2	0	3	58	8	0	0	31	0	0	TCGA-CA-5256-01	97	0.8444377744508891	43	TCGA-CA-5256-01	22	17	8	0.060712310495781276	TCGA-CA-5256-01	4	0	2	6	PASS	2236	TCGA-CA-5256	COAD	54	FEMALE	ASIAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-19785	Alive	TUMOR FREE	379	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	379	0	379	0	379	0	379	
50	TCGA-CA-5796	0	7	2	3	1	1	1	0	6	47	6	0	0	24	2	0	TCGA-CA-5796-01	54	0.11352704618262854	13	TCGA-CA-5796-01	4	2	3	0.005324605558418597	TCGA-CA-5796-01	0	1	0	1	PASS	2237	TCGA-CA-5796	COAD	52	FEMALE	ASIAN	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2010	NA	-19353	Alive	TUMOR FREE	377	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	377	0	377	0	377	0	377	
60	TCGA-CA-5797	0	8	1	1	3	3	0	0	5	46	5	0	2	23	1	0	TCGA-CA-5797-01	181	0.4821001721745445	102	TCGA-CA-5797-01	17	33	31	0.29530373088980016	TCGA-CA-5797-01	12	5	6	23	PASS	2238	TCGA-CA-5797	COAD	56	MALE	ASIAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-20662	Alive	TUMOR FREE	383	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	383	0	383	0	383	0	383	
60	TCGA-CA-6715	0	10	0	3	3	0	2	0	3	81	5	0	0	25	4	0	TCGA-CA-6715-01	196	0.280923028343855	115	TCGA-CA-6715-01	11	8	25	0.12250712001627885	TCGA-CA-6715-01	5	8	3	16	PASS	2239	TCGA-CA-6715	COAD	63	MALE	ASIAN	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-23075	Alive	TUMOR FREE	383	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	383	0	383	0	383	0	383	
70	TCGA-CA-6716	1	11	1	2	0	6	0	0	7	117	11	0	3	64	2	0	TCGA-CA-6716-01	55	0.58477470797652	16	TCGA-CA-6716-01	21	25	4	0.0005194206197113143	TCGA-CA-6716-01	3	3	0	6	PASS	2240	TCGA-CA-6716	COAD	65	MALE	ASIAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-23943	Alive	TUMOR FREE	371	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	371	0	371	0	371	0	371	
60	TCGA-CA-6717	43	970	32	240	12	28	0	0	386	8299	981	12	122	2273	179	5	TCGA-CA-6717-01	37	9.537913497906169e-07	6	TCGA-CA-6717	0	0	0	0	TCGA-CA-6717	0	0	0	0	hypermutated sample	2241	TCGA-CA-6717	COAD	57	MALE	ASIAN	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2010	NA	-20984	Alive	TUMOR FREE	388	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	388	0	388	0	388	0	388	
50	TCGA-CA-6718	18	392	14	92	2	9	0	0	125	2682	457	2	59	630	38	3	TCGA-CA-6718-01	91	0.11410044240444135	41	TCGA-CA-6718-01	2	3	3	0.04191648739116066	TCGA-CA-6718-01	4	5	2	11	hypermutated sample	2242	TCGA-CA-6718	COAD	46	MALE	ASIAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-17109	Dead	WITH TUMOR	NA	306	NA	NA	NA	NA	207	Complete Remission/Response	NA	NA	1	306	1	306	1	207	1	207	
80	TCGA-CA-6719	1	4	0	0	1	4	0	0	8	99	7	0	3	37	3	0	TCGA-CA-6719-01	119	0.5577151519537585	54	TCGA-CA-6719-01	16	28	16	0.1600664981966825	TCGA-CA-6719-01	15	11	8	34	PASS	2243	TCGA-CA-6719	COAD	77	MALE	ASIAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-28343	Alive	WITH TUMOR	435	NA	NA	NA	NA	NA	354	Progressive Disease	NA	NA	0	435	0	435	NA	NA	1	354	
50	TCGA-CK-4947	0	7	0	4	2	2	1	0	6	78	2	0	1	33	3	0	TCGA-CK-4947-01	70	0.0877468782230818	26	TCGA-CK-4947-01	4	8	6	0.05058639052041624	TCGA-CK-4947-01	1	1	1	3	PASS	2244	TCGA-CK-4947	COAD	46	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2003	NA	-16980	Alive	WITH TUMOR	534	NA	NA	NA	NA	NA	21	Stable Disease	NA	NA	0	534	0	534	NA	NA	1	21	
50	TCGA-CK-4948	2	10	0	2	1	1	1	0	6	81	11	0	2	28	3	0	TCGA-CK-4948-01	115	0.33063061692283435	57	TCGA-CK-4948-01	20	22	16	0.09342239754074884	TCGA-CK-4948-01	9	4	5	18	PASS	2245	TCGA-CK-4948	COAD	45	FEMALE	WHITE	Stage III	NA	Colon Adenocarcinoma	NA	2002	NA	-16736	Alive	TUMOR FREE	4502	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4502	0	4502	0	4502	0	4502	
70	TCGA-CK-4950	1	12	0	6	5	2	0	0	5	132	13	0	3	58	0	1	TCGA-CK-4950-01	88	0.22964918156719435	41	TCGA-CK-4950-01	8	8	4	0.059931414885764075	TCGA-CK-4950-01	1	1	3	5	PASS	2246	TCGA-CK-4950	COAD	68	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Colon Mucinous Adenocarcinoma	NA	2008	NA	-24944	Alive	TUMOR FREE	2599	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2599	0	2599	0	2599	0	2599	
80	TCGA-CK-4951	22	426	37	204	193	33	17	0	229	3577	217	6	48	1709	78	6	TCGA-CK-4951-01	111	0.0026217208175579234	63	TCGA-CK-4951-01	0	2	12	0.03154274518879038	TCGA-CK-4951-01	0	0	0	0	hypermutated sample	2247	TCGA-CK-4951	COAD	79	FEMALE	WHITE	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2007	NA	-28982	Dead	TUMOR FREE	NA	2134	NA	Locoregional Disease	NA	NA	480	NA	NA	NA	1	2134	0	2134	NA	NA	1	480	
50	TCGA-CK-4952	2	9	0	7	3	4	2	0	3	120	6	0	4	59	1	0	TCGA-CK-4952-01	120	0.15468166295435382	55	TCGA-CK-4952-01	4	5	11	0.05859499397809454	TCGA-CK-4952-01	2	2	2	6	PASS	2248	TCGA-CK-4952	COAD	48	FEMALE	WHITE	Stage IIIC	NA	Colon Mucinous Adenocarcinoma	NA	2007	NA	-17826	Alive	TUMOR FREE	475	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	475	0	475	NA	NA	0	475	
80	TCGA-CK-5912	1	12	1	1	3	2	1	1	2	53	2	0	1	15	0	0	TCGA-CK-5912-01	97	0.7108064282835082	48	TCGA-CK-5912-01	22	21	14	0.3250617826319888	TCGA-CK-5912-01	6	2	3	11	PASS	2249	TCGA-CK-5912	COAD	81	MALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2006	NA	-29938	Dead	TUMOR FREE	NA	1493	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1493	0	1493	0	1493	0	1493	
60	TCGA-CK-5913	7	104	7	39	121	40	6	0	55	582	35	1	18	253	13	0	TCGA-CK-5913-01	79	0.05951690792718092	24	TCGA-CK-5913-01	2	3	9	0.029525660687531475	TCGA-CK-5913-01	2	2	0	4	hypermutated sample	2250	TCGA-CK-5913	COAD	58	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2008	NA	-21399	Alive	TUMOR FREE	1561	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1561	0	1561	0	1561	0	1561	
80	TCGA-CK-5914	1	14	2	5	2	0	2	0	9	117	7	0	2	37	1	0	TCGA-CK-5914-01	94	0.6582119177798471	35	TCGA-CK-5914-01	19	28	14	0.19077595528431854	TCGA-CK-5914-01	5	2	4	11	PASS	2251	TCGA-CK-5914	COAD	81	MALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2008	NA	-29586	Alive	TUMOR FREE	669	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	669	0	669	NA	NA	0	669	
60	TCGA-CK-5915	0	11	0	3	0	4	0	0	6	68	6	0	2	37	3	0	TCGA-CK-5915-01	97	0.8643776219533892	42	TCGA-CK-5915-01	21	14	5	0.07069494354761277	TCGA-CK-5915-01	0	2	0	2	PASS	2252	TCGA-CK-5915	COAD	63	MALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2007	NA	-23040	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-CK-5916	11	173	11	71	218	52	25	1	77	1025	47	0	22	475	18	0	TCGA-CK-5916-01	53	0.00017807571717450764	11	TCGA-CK-5916-01	0	2	4	0.011655215212087526	TCGA-CK-5916-01	0	0	0	0	hypermutated sample	2253	TCGA-CK-5916	COAD	71	FEMALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2003	NA	-26024	Dead	WITH TUMOR	NA	643	NA	NA	NA	NA	292	Progressive Disease	NA	NA	1	643	1	643	NA	NA	1	292	
80	TCGA-CK-6746	7	155	12	51	230	47	6	0	59	834	45	1	11	353	21	4	TCGA-CK-6746-01	166	0.0504290916443054	98	TCGA-CK-6746-01	2	3	15	0.08981094478299917	TCGA-CK-6746-01	2	2	3	7	hypermutated sample	2254	TCGA-CK-6746	COAD	84	FEMALE	WHITE	Stage IIB	NA	Colon Adenocarcinoma	NA	2009	NA	-30957	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
90	TCGA-CK-6747	1	10	1	6	29	2	35	0	3	92	9	0	8	45	3	0	TCGA-CK-6747-01	51	0.00043279305862997154	17	TCGA-CK-6747-01	0	2	2	0.04641472254705376	TCGA-CK-6747-01	1	0	1	2	PASS	2255	TCGA-CK-6747	COAD	87	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2008	NA	-32052	Alive	TUMOR FREE	2523	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2523	0	2523	0	2523	0	2523	
50	TCGA-CK-6748	1	8	0	0	2	1	0	0	4	45	4	1	2	29	2	0	TCGA-CK-6748-01	105	0.4577537482878006	50	TCGA-CK-6748-01	16	30	12	0.18256012740751365	TCGA-CK-6748-01	7	4	3	14	PASS	2256	TCGA-CK-6748	COAD	45	FEMALE	WHITE	Stage IV	NA	Colon Mucinous Adenocarcinoma	NA	2008	NA	-16529	Alive	WITH TUMOR	61	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	61	0	61	NA	NA	0	61	
90	TCGA-CK-6751	2	12	1	2	5	1	0	0	5	143	12	1	1	53	1	1	TCGA-CK-6751-01	53	0.004171484154917289	15	TCGA-CK-6751-01	0	0	19	0.003883249436366772	TCGA-CK-6751-01	0	2	0	2	PASS	2257	TCGA-CK-6751	COAD	88	FEMALE	WHITE	Stage I	NA	Colon Mucinous Adenocarcinoma	NA	2002	NA	-32354	Alive	TUMOR FREE	3780	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3780	0	3780	NA	NA	0	3780	
70	TCGA-CM-4743	8	122	7	54	175	35	15	2	58	821	20	3	17	360	25	2	TCGA-CM-4743-01	74	0.004703611843986075	32	TCGA-CM-4743-01	0	2	5	0.052873636161172265	TCGA-CM-4743-01	1	0	0	1	hypermutated sample	2258	TCGA-CM-4743	COAD	69	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-25291	Alive	TUMOR FREE	701	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	701	0	701	0	701	0	701	
70	TCGA-CM-4744	0	12	2	5	5	6	1	1	7	118	9	0	2	48	0	1	TCGA-CM-4744-01	109	0.21350877368644847	48	TCGA-CM-4744-01	11	20	2	0.04105305748299015	TCGA-CM-4744-01	2	1	1	4	PASS	2259	TCGA-CM-4744	COAD	69	MALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2010	NA	-25506	Alive	TUMOR FREE	609	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	609	0	609	0	609	0	609	
60	TCGA-CM-4746	6	102	3	31	92	26	7	1	29	535	37	0	5	245	13	0	TCGA-CM-4746-01	110	0.13588191010657552	57	TCGA-CM-4746-01	5	7	14	0.03610546289623929	TCGA-CM-4746-01	5	1	2	8	hypermutated sample	2260	TCGA-CM-4746	COAD	61	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Colon Adenocarcinoma	NA	2009	NA	-22403	Alive	TUMOR FREE	1126	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1126	0	1126	0	1126	0	1126	
50	TCGA-CM-4747	1	11	0	1	2	0	1	0	4	71	4	0	4	45	2	0	TCGA-CM-4747-01	115	0.4462031556629204	54	TCGA-CM-4747-01	16	21	11	0.09838805412148366	TCGA-CM-4747-01	6	10	5	21	PASS	2261	TCGA-CM-4747	COAD	47	MALE	WHITE	Stage IVA	NA	Colon Adenocarcinoma	NA	2010	NA	-17198	Alive	[Discrepancy]	761	NA	NA	NA	NA	NA	NA	[Discrepancy]	NA	NA	0	761	0	761	NA	NA	0	761	
50	TCGA-CM-4748	0	3	1	7	1	1	1	0	1	56	5	0	0	21	2	0	TCGA-CM-4748-01	51	0.011900034644885728	12	TCGA-CM-4748-01	0	2	5	0.0403995895826745	TCGA-CM-4748-01	0	2	1	3	PASS	2262	TCGA-CM-4748	COAD	53	MALE	WHITE	Stage IIIB	NA	Colon Mucinous Adenocarcinoma	NA	2010	NA	-19509	Alive	TUMOR FREE	792	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	792	0	792	0	792	0	792	
30	TCGA-CM-4750	0	6	0	1	2	0	1	0	8	68	8	0	2	24	3	0	TCGA-CM-4750-01	132	0.8795459268081703	67	TCGA-CM-4750-01	22	22	9	0.08222019817377581	TCGA-CM-4750-01	3	2	2	7	PASS	2263	TCGA-CM-4750	COAD	34	FEMALE	WHITE	Stage IIIA	NA	Colon Adenocarcinoma	NA	2010	NA	-12478	Alive	TUMOR FREE	244	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	244	0	244	0	244	0	244	
60	TCGA-CM-4751	0	5	0	2	0	2	0	0	4	80	5	0	1	33	1	0	TCGA-CM-4751-01	71	0.1867347846300217	24	TCGA-CM-4751-01	8	7	12	0.09355339216229104	TCGA-CM-4751-01	7	3	4	14	PASS	2264	TCGA-CM-4751	COAD	62	MALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2009	NA	-22891	Alive	TUMOR FREE	822	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	822	0	822	0	822	0	822	
60	TCGA-CM-4752	0	14	1	5	2	2	2	0	4	102	8	0	2	42	1	0	TCGA-CM-4752-01	226	0.5690746901208071	148	TCGA-CM-4752-01	28	35	9	0.07877487160231851	TCGA-CM-4752-01	10	7	5	22	PASS	2265	TCGA-CM-4752	COAD	58	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-21519	Alive	TUMOR FREE	396	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	396	0	396	0	396	0	396	
80	TCGA-CM-5341	1	17	0	5	3	0	1	0	6	128	11	0	3	39	3	0	TCGA-CM-5341-01	166	0.5439195600214014	86	TCGA-CM-5341-01	19	20	14	0.09166690301199704	TCGA-CM-5341-01	8	5	4	17	PASS	2266	TCGA-CM-5341	COAD	82	FEMALE	WHITE	Stage IIIA	NA	Colon Adenocarcinoma	NA	2010	NA	-30163	Alive	TUMOR FREE	884	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	884	0	884	0	884	0	884	
40	TCGA-CM-5344	0	11	0	5	3	1	2	0	6	49	3	0	1	27	0	0	TCGA-CM-5344-01	85	0.6089108976908769	38	TCGA-CM-5344-01	21	28	19	0.3780476945860863	TCGA-CM-5344-01	7	3	4	14	PASS	2267	TCGA-CM-5344	COAD	39	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-14426	Alive	TUMOR FREE	670	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	670	0	670	NA	NA	0	670	
70	TCGA-CM-5348	1	15	5	2	6	0	1	0	9	145	11	0	5	62	4	0	TCGA-CM-5348-01	140	0.891511884698261	73	TCGA-CM-5348-01	24	40	45	0.3708334983760857	TCGA-CM-5348-01	14	12	3	29	PASS	2268	TCGA-CM-5348	COAD	72	MALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-26543	Alive	TUMOR FREE	699	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	699	0	699	NA	NA	0	699	
70	TCGA-CM-5349	1	11	1	2	3	2	0	0	5	80	8	0	5	37	0	1	TCGA-CM-5349-01	105	0.27800208743285204	46	TCGA-CM-5349-01	9	9	17	0.12885690117304435	TCGA-CM-5349-01	10	9	6	25	PASS	2269	TCGA-CM-5349	COAD	68	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-24867	Alive	TUMOR FREE	915	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	915	0	915	NA	NA	0	915	
40	TCGA-CM-5860	0	9	0	6	4	0	1	0	5	86	6	0	0	45	4	0	TCGA-CM-5860-01	98	0.9477019195135704	45	TCGA-CM-5860-01	28	58	18	0.2541930590818	TCGA-CM-5860-01	4	3	5	12	PASS	2270	TCGA-CM-5860	COAD	44	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-16344	Alive	TUMOR FREE	974	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	974	0	974	NA	NA	0	974	
60	TCGA-CM-5861	8	202	15	61	182	44	8	0	84	1037	34	0	17	447	45	3	TCGA-CM-5861-01	66	0.08472278524063495	16	TCGA-CM-5861-01	3	3	6	0.00020065588650474642	TCGA-CM-5861-01	1	0	0	1	hypermutated sample	2271	TCGA-CM-5861	COAD	63	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-23253	Alive	TUMOR FREE	457	NA	NA	Locoregional Disease	NA	NA	335	NA	NA	NA	0	457	0	457	NA	NA	1	335	
80	TCGA-CM-5862	0	11	0	6	1	0	0	0	1	78	2	0	3	34	4	0	TCGA-CM-5862-01	183	0.8597969335505845	116	TCGA-CM-5862-01	26	37	29	0.3068701237372077	TCGA-CM-5862-01	7	4	6	17	PASS	2272	TCGA-CM-5862	COAD	80	MALE	WHITE	Stage IVA	NA	Colon Adenocarcinoma	NA	2010	NA	-29493	Dead	WITH TUMOR	NA	153	NA	NA	NA	NA	31	NA	NA	NA	1	153	1	153	NA	NA	1	31	
60	TCGA-CM-5863	0	6	0	1	2	1	0	0	3	52	5	0	4	21	0	0	TCGA-CM-5863-01	61	0.1944004127435672	21	TCGA-CM-5863	0	0	0	0	TCGA-CM-5863-01	1	1	0	2	PASS	2273	TCGA-CM-5863	COAD	60	FEMALE	WHITE	Stage IIIB	NA	Colon Mucinous Adenocarcinoma	NA	2010	NA	-22127	Alive	TUMOR FREE	457	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	457	0	457	NA	NA	0	457	
60	TCGA-CM-5864	0	10	4	5	4	0	1	0	9	153	11	0	7	67	3	0	TCGA-CM-5864-01	124	0.6532553171512019	60	TCGA-CM-5864-01	26	22	4	0.039345308672307434	TCGA-CM-5864-01	5	5	1	11	PASS	2274	TCGA-CM-5864	COAD	60	MALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2010	NA	-22219	Alive	TUMOR FREE	457	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	457	0	457	NA	NA	0	457	
60	TCGA-CM-5868	1	11	1	1	3	2	0	0	2	67	5	0	1	40	1	0	TCGA-CM-5868-01	81	0.44748315984211184	34	TCGA-CM-5868-01	11	18	24	0.3553482996684176	TCGA-CM-5868-01	3	4	1	8	PASS	2275	TCGA-CM-5868	COAD	59	FEMALE	WHITE	Stage IVA	NA	Colon Adenocarcinoma	NA	2010	NA	-21672	Alive	WITH TUMOR	518	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	518	0	518	NA	NA	0	518	
40	TCGA-CM-6161	1	12	3	6	1	1	0	0	4	70	4	0	3	38	1	0	TCGA-CM-6161-01	70	0.9477286205156396	30	TCGA-CM-6161-01	16	36	9	0.10475107729150952	TCGA-CM-6161-01	1	0	1	2	PASS	2276	TCGA-CM-6161	COAD	36	FEMALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2010	NA	-13363	Alive	TUMOR FREE	457	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	457	0	457	NA	NA	0	457	
50	TCGA-CM-6162	3	78	2	21	83	21	10	1	44	798	58	0	17	408	20	0	TCGA-CM-6162-01	51	0.000495124600978083	11	TCGA-CM-6162-01	0	0	19	2.705917304541403e-05	TCGA-CM-6162-01	0	0	0	0	mutation call filter	2277	TCGA-CM-6162	COAD	48	FEMALE	WHITE	Stage IIIB	NA	Colon Mucinous Adenocarcinoma	NA	2010	NA	-17624	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	365	0	365	NA	NA	0	365	
70	TCGA-CM-6163	1	8	0	5	0	0	0	0	2	79	11	1	1	32	4	0	TCGA-CM-6163-01	98	0.6957577335807911	43	TCGA-CM-6163-01	27	26	23	0.42043756826801176	TCGA-CM-6163-01	9	6	3	18	PASS	2278	TCGA-CM-6163	COAD	74	MALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2010	NA	-27150	Alive	TUMOR FREE	427	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	427	0	427	NA	NA	0	427	
50	TCGA-CM-6164	0	7	0	0	1	1	1	0	2	58	6	0	2	26	0	0	TCGA-CM-6164-01	95	0.3975498601459301	42	TCGA-CM-6164-01	19	22	10	0.19294913139401101	TCGA-CM-6164-01	4	0	5	9	PASS	2279	TCGA-CM-6164	COAD	46	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-16802	Alive	TUMOR FREE	883	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	883	0	883	NA	NA	0	883	
70	TCGA-CM-6165	2	10	0	9	3	1	0	1	6	91	6	0	4	28	3	0	TCGA-CM-6165-01	93	0.16414280615062446	48	TCGA-CM-6165-01	6	6	7	0.1215928357315546	TCGA-CM-6165-01	0	0	0	0	PASS	2280	TCGA-CM-6165	COAD	74	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-27302	Alive	TUMOR FREE	488	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	488	0	488	NA	NA	0	488	
50	TCGA-CM-6166	0	9	2	5	1	2	0	0	3	71	3	0	0	23	3	1	TCGA-CM-6166-01	71	0.6500376755778106	34	TCGA-CM-6166-01	16	13	5	0.10697425924207372	TCGA-CM-6166-01	2	1	2	5	PASS	2281	TCGA-CM-6166	COAD	48	FEMALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2010	NA	-17807	Alive	TUMOR FREE	669	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	669	0	669	NA	NA	0	669	
60	TCGA-CM-6167	0	3	1	3	1	3	0	1	4	61	8	0	0	24	3	0	TCGA-CM-6167-01	92	0.22083235689063788	42	TCGA-CM-6167-01	27	39	8	0.1425372710152037	TCGA-CM-6167-01	5	4	2	11	PASS	2282	TCGA-CM-6167	COAD	57	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Colon Adenocarcinoma	NA	2010	NA	-21031	Alive	TUMOR FREE	456	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	456	0	456	NA	NA	0	456	
80	TCGA-CM-6168	2	22	0	5	13	3	1	0	8	162	20	0	3	74	4	2	TCGA-CM-6168-01	72	0.16399412161919655	30	TCGA-CM-6168-01	7	5	4	0.016468107692243942	TCGA-CM-6168-01	1	2	1	4	PASS	2283	TCGA-CM-6168	COAD	84	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-30834	Alive	TUMOR FREE	395	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	395	0	395	NA	NA	0	395	
70	TCGA-CM-6169	0	6	0	3	4	0	0	1	4	89	5	0	2	27	1	1	TCGA-CM-6169-01	110	0.5308117638315006	63	TCGA-CM-6169-01	9	16	20	0.273965908312211	TCGA-CM-6169-01	6	2	4	12	PASS	2284	TCGA-CM-6169	COAD	67	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-24564	Alive	TUMOR FREE	396	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	396	0	396	NA	NA	0	396	
70	TCGA-CM-6170	0	11	1	2	1	1	1	0	3	69	6	0	0	39	2	0	TCGA-CM-6170-01	116	0.7268438220296359	62	TCGA-CM-6170-01	14	12	35	0.2363784150891605	TCGA-CM-6170-01	3	3	4	10	PASS	2285	TCGA-CM-6170	COAD	73	FEMALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2010	NA	-26663	Alive	TUMOR FREE	457	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	457	0	457	NA	NA	0	457	
80	TCGA-CM-6171	10	134	11	44	173	37	21	1	56	855	43	0	22	390	21	2	TCGA-CM-6171-01	59	0.09400422106429887	17	TCGA-CM-6171-01	1	3	5	0.02908693968461025	TCGA-CM-6171-01	1	2	1	4	hypermutated sample	2286	TCGA-CM-6171	COAD	77	FEMALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2010	NA	-28307	Alive	TUMOR FREE	427	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	427	0	427	NA	NA	0	427	
70	TCGA-CM-6172	0	11	1	3	1	1	0	0	2	74	7	0	3	45	0	0	TCGA-CM-6172-01	166	0.3887814022735837	87	TCGA-CM-6172-01	10	13	39	0.21588552402408906	TCGA-CM-6172-01	7	3	8	18	PASS	2287	TCGA-CM-6172	COAD	70	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-25902	Alive	TUMOR FREE	335	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	335	0	335	NA	NA	0	335	
40	TCGA-CM-6674	5	101	3	28	118	32	20	0	42	618	37	1	10	282	9	0	TCGA-CM-6674-01	53	0.00011577255824828064	12	TCGA-CM-6674-01	0	2	19	0.011742564252755064	TCGA-CM-6674-01	0	0	0	0	hypermutated sample	2288	TCGA-CM-6674	COAD	39	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-14368	Alive	TUMOR FREE	394	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	394	0	394	NA	NA	0	394	
40	TCGA-CM-6675	0	8	0	7	5	2	0	0	4	71	1	0	3	34	1	0	TCGA-CM-6675-01	245	0.9431043012127912	164	TCGA-CM-6675-01	4	9	36	0.20084134667220954	TCGA-CM-6675-01	8	18	13	39	PASS	2289	TCGA-CM-6675	COAD	35	MALE	BLACK OR AFRICAN AMERICAN	Stage IVB	NA	Colon Adenocarcinoma	NA	2011	NA	-12935	Alive	WITH TUMOR	397	NA	NA	NA	NA	NA	337	NA	NA	NA	0	397	0	397	NA	NA	1	337	
80	TCGA-CM-6676	0	7	1	3	0	2	1	0	4	84	7	0	0	39	2	0	TCGA-CM-6676-01	64	0.5836640995951471	22	TCGA-CM-6676-01	21	31	9	0.05209033477762708	TCGA-CM-6676-01	5	0	4	9	PASS	2290	TCGA-CM-6676	COAD	82	MALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2011	NA	-30223	Alive	TUMOR FREE	337	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	337	0	337	NA	NA	0	337	
80	TCGA-CM-6677	0	11	1	2	5	2	1	1	5	117	4	0	1	43	3	0	TCGA-CM-6677-01	145	0.5186496293141931	87	TCGA-CM-6677-01	19	57	35	0.3985443105023433	TCGA-CM-6677-01	6	6	2	14	PASS	2291	TCGA-CM-6677	COAD	75	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-27575	Alive	TUMOR FREE	337	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	337	0	337	NA	NA	0	337	
60	TCGA-CM-6678	0	12	0	3	2	4	0	1	2	107	9	0	1	49	1	0	TCGA-CM-6678-01	49	0.7100378882708207	6	TCGA-CM-6678-01	12	14	5	0.17261223622276325	TCGA-CM-6678-01	1	1	0	2	PASS	2292	TCGA-CM-6678	COAD	63	FEMALE	WHITE	Stage IVA	NA	Colon Adenocarcinoma	NA	2011	NA	-23070	Alive	WITH TUMOR	335	NA	NA	Metastatic	NA	NA	0	NA	NA	NA	0	335	0	335	NA	NA	1	0	
60	TCGA-CM-6679	0	4	1	2	1	1	0	0	5	65	2	0	1	28	2	0	TCGA-CM-6679-01	79	0.54239961062555	36	TCGA-CM-6679-01	25	49	21	0.222530024663052	TCGA-CM-6679-01	8	2	5	15	PASS	2293	TCGA-CM-6679	COAD	58	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-21519	Alive	TUMOR FREE	306	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	306	0	306	NA	NA	0	306	
80	TCGA-CM-6680	0	8	0	2	4	1	0	0	5	71	6	0	1	35	0	0	TCGA-CM-6680-01	65	0.035427354584573086	22	TCGA-CM-6680-01	2	1	4	0.045883097739422514	TCGA-CM-6680-01	1	2	2	5	PASS	2294	TCGA-CM-6680	COAD	78	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2011	NA	-28701	Alive	TUMOR FREE	366	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	366	0	366	NA	NA	0	366	
80	TCGA-D5-5537	1	7	0	5	3	3	0	0	1	78	9	0	3	39	2	0	TCGA-D5-5537-01	70	0.9425527391912074	28	TCGA-D5-5537-01	19	29	7	0.2265321629605585	TCGA-D5-5537-01	0	1	1	2	PASS	2295	TCGA-D5-5537	COAD	83	MALE	WHITE	[Discrepancy]	NA	Colon Adenocarcinoma	NA	2010	NA	-30505	Dead	WITH TUMOR	NA	1381	NA	NA	NA	NA	722	Complete Remission/Response	NA	NA	1	1381	1	1381	1	722	1	722	
60	TCGA-D5-5538	1	15	1	9	2	0	0	0	5	88	8	1	3	34	4	0	TCGA-D5-5538-01	144	0.19804314600298675	84	TCGA-D5-5538-01	7	7	39	0.1150911036304628	TCGA-D5-5538-01	3	3	3	9	PASS	2296	TCGA-D5-5538	COAD	60	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-21974	Dead	WITH TUMOR	NA	1661	NA	NA	NA	NA	1007	Progressive Disease	NA	NA	1	1661	1	1661	NA	NA	1	1007	
60	TCGA-D5-5539	1	7	3	5	0	2	1	0	3	77	9	0	2	41	2	0	TCGA-D5-5539-01	143	0.925679729878825	76	TCGA-D5-5539-01	21	19	28	0.09342540033368484	TCGA-D5-5539-01	7	5	5	17	PASS	2297	TCGA-D5-5539	COAD	60	MALE	WHITE	Stage IIIA	NA	Colon Mucinous Adenocarcinoma	NA	2010	NA	-22097	Alive	WITH TUMOR	596	NA	NA	NA	NA	NA	579	NA	NA	NA	0	596	0	596	NA	NA	1	579	
70	TCGA-D5-5540	0	12	0	4	1	1	0	0	5	101	2	1	0	52	3	0	TCGA-D5-5540-01	137	0.5298959432665609	76	TCGA-D5-5540-01	12	13	40	0.27258947322774635	TCGA-D5-5540-01	9	2	7	18	PASS	2298	TCGA-D5-5540	COAD	73	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-26972	Alive	TUMOR FREE	1706	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1706	0	1706	0	1706	0	1706	
60	TCGA-D5-5541	0	6	0	3	1	0	1	0	2	49	8	0	2	22	1	0	TCGA-D5-5541-01	91	0.926358334650996	42	TCGA-D5-5541-01	12	16	19	0.15399271064990633	TCGA-D5-5541-01	4	2	2	8	PASS	2299	TCGA-D5-5541	COAD	63	MALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-23109	Alive	TUMOR FREE	1701	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1701	0	1701	0	1701	0	1701	
70	TCGA-D5-6529	1	7	2	4	3	1	1	0	9	82	6	1	1	37	1	0	TCGA-D5-6529-01	66	0.534862560869634	22	TCGA-D5-6529-01	21	25	10	0.1802275356292901	TCGA-D5-6529-01	6	5	4	15	PASS	2300	TCGA-D5-6529	COAD	69	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-25394	Alive	WITH TUMOR	614	NA	NA	NA	NA	NA	386	NA	NA	NA	0	614	0	614	NA	NA	1	386	
50	TCGA-D5-6530	3	150	4	33	226	50	19	1	62	690	43	0	19	357	16	1	TCGA-D5-6530-01	87	0.0077965838097947375	40	TCGA-D5-6530-01	0	0	4	0.01793523112608302	TCGA-D5-6530-01	1	3	2	6	hypermutated sample	2301	TCGA-D5-6530	COAD	53	MALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2010	NA	-19591	Alive	TUMOR FREE	621	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	621	0	621	NA	NA	0	621	
80	TCGA-D5-6531	2	18	2	14	4	1	3	0	6	148	8	0	4	52	4	0	TCGA-D5-6531-01	143	0.6456301826613079	73	TCGA-D5-6531-01	25	52	19	0.12423343078847765	TCGA-D5-6531-01	10	9	4	23	PASS	2302	TCGA-D5-6531	COAD	75	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-27633	Alive	TUMOR FREE	540	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	540	0	540	NA	NA	0	540	
60	TCGA-D5-6532	1	10	1	8	4	0	0	0	6	82	7	0	1	51	1	0	TCGA-D5-6532-01	134	0.1540650822567544	74	TCGA-D5-6532-01	7	14	22	0.2565089406296797	TCGA-D5-6532-01	4	5	3	12	PASS	2303	TCGA-D5-6532	COAD	61	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-22344	Alive	TUMOR FREE	555	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	555	0	555	NA	NA	0	555	
70	TCGA-D5-6533	0	24	3	8	4	0	1	0	8	120	13	1	2	48	3	0	TCGA-D5-6533-01	216	0.7393590861687284	147	TCGA-D5-6533-01	21	20	47	0.2873837455079641	TCGA-D5-6533-01	8	5	5	18	PASS	2304	TCGA-D5-6533	COAD	68	FEMALE	WHITE	[Discrepancy]	NA	Colon Adenocarcinoma	NA	2010	NA	-24971	Alive	TUMOR FREE	775	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	775	0	775	0	775	0	775	
60	TCGA-D5-6534	0	12	0	5	2	2	0	1	7	129	8	0	3	44	6	0	TCGA-D5-6534-01	106	0.31959884148695283	46	TCGA-D5-6534-01	13	13	19	0.16592379922653333	TCGA-D5-6534-01	7	4	6	17	PASS	2305	TCGA-D5-6534	COAD	62	FEMALE	WHITE	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2010	NA	-22778	Alive	TUMOR FREE	1316	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1316	0	1316	0	1316	0	1316	
80	TCGA-D5-6535	0	16	0	9	0	1	1	0	7	138	10	0	3	50	3	1	TCGA-D5-6535-01	217	0.6037182423106158	133	TCGA-D5-6535-01	17	27	53	0.2658918299329572	TCGA-D5-6535-01	10	7	6	23	PASS	2306	TCGA-D5-6535	COAD	80	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-29278	Alive	TUMOR FREE	460	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	460	0	460	NA	NA	0	460	
70	TCGA-D5-6536	1	8	1	2	3	3	0	0	5	94	4	0	2	25	1	0	TCGA-D5-6536-01	133	0.3336918680391232	80	TCGA-D5-6536-01	9	11	29	0.1615282106017657	TCGA-D5-6536-01	6	8	9	23	PASS	2307	TCGA-D5-6536	COAD	73	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-26890	Alive	WITH TUMOR	543	NA	NA	Locoregional Disease	NA	NA	493	NA	NA	NA	0	543	0	543	NA	NA	1	493	
60	TCGA-D5-6537	0	11	1	1	1	0	1	0	2	88	6	0	2	31	4	1	TCGA-D5-6537-01	116	0.9474773578196104	64	TCGA-D5-6537-01	12	14	6	0.07545957277751238	TCGA-D5-6537-01	5	1	2	8	PASS	2308	TCGA-D5-6537	COAD	64	MALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-23381	Dead	WITH TUMOR	NA	146	NA	NA	NA	NA	123	NA	NA	NA	1	146	1	146	NA	NA	1	123	
80	TCGA-D5-6538	2	16	3	5	1	2	0	0	2	100	9	0	3	44	4	0	TCGA-D5-6538-01	147	0.9475273259846092	86	TCGA-D5-6538-01	31	28	15	0.07450688320469738	TCGA-D5-6538-01	6	3	4	13	PASS	2309	TCGA-D5-6538	COAD	79	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2010	NA	-29194	Alive	TUMOR FREE	521	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	521	0	521	NA	NA	0	521	
50	TCGA-D5-6539	0	5	0	3	1	1	1	0	3	86	4	0	3	23	1	1	TCGA-D5-6539-01	116	0.3745085588126214	58	TCGA-D5-6539-01	27	26	10	0.0376320075083284	TCGA-D5-6539-01	8	7	2	17	PASS	2310	TCGA-D5-6539	COAD	45	FEMALE	WHITE	[Discrepancy]	NA	Colon Adenocarcinoma	NA	2010	NA	-16703	Alive	TUMOR FREE	380	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	380	0	380	NA	NA	0	380	
70	TCGA-D5-6540	6	122	9	54	207	43	10	0	59	872	42	0	25	416	14	2	TCGA-D5-6540-01	55	0.07654708572674211	11	TCGA-D5-6540-01	4	4	2	0.011801695027596612	TCGA-D5-6540-01	0	0	0	0	hypermutated sample	2311	TCGA-D5-6540	COAD	66	MALE	WHITE	Stage I	NA	Colon Mucinous Adenocarcinoma	NA	2010	NA	-24282	Alive	TUMOR FREE	491	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	491	0	491	NA	NA	0	491	
50	TCGA-D5-6541	0	6	2	3	2	2	2	0	4	73	5	0	0	25	0	0	TCGA-D5-6541-01	84	0.08310020292476007	30	TCGA-D5-6541-01	4	4	9	0.04710659128986647	TCGA-D5-6541-01	6	0	3	9	PASS	2312	TCGA-D5-6541	COAD	49	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2010	NA	-18029	Alive	TUMOR FREE	474	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	474	0	474	NA	NA	0	474	
50	TCGA-D5-6898	0	3	0	5	0	3	0	1	1	57	6	1	1	23	3	0	TCGA-D5-6898-01	105	0.5003910986722351	53	TCGA-D5-6898-01	15	33	20	0.24531090493180802	TCGA-D5-6898-01	13	7	9	29	PASS	2313	TCGA-D5-6898	COAD	51	FEMALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2011	NA	-18874	Alive	TUMOR FREE	229	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	229	0	229	NA	NA	0	229	
80	TCGA-D5-6920	0	8	1	3	4	1	0	1	3	91	8	0	4	32	1	1	TCGA-D5-6920-01	53	0.021680501207809674	12	TCGA-D5-6920-01	2	5	5	0.057147110097060874	TCGA-D5-6920-01	0	0	0	0	PASS	2314	TCGA-D5-6920	COAD	77	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-28124	Alive	TUMOR FREE	377	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	377	0	377	NA	NA	0	377	
80	TCGA-D5-6922	2	8	0	3	2	2	0	0	8	82	8	0	2	38	2	0	TCGA-D5-6922-01	136	0.4476610920864751	70	TCGA-D5-6922-01	16	30	20	0.0989066369787144	TCGA-D5-6922-01	9	5	4	18	PASS	2315	TCGA-D5-6922	COAD	76	MALE	WHITE	Stage IIIA	NA	Colon Adenocarcinoma	NA	2011	NA	-27771	Alive	TUMOR FREE	308	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	308	0	308	NA	NA	0	308	
60	TCGA-D5-6923	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-D5-6923-01	184	0.3224903492845685	110	TCGA-D5-6923-01	9	12	26	0.17242854356065984	TCGA-D5-6923-01	4	5	7	16	PASS	2316	TCGA-D5-6923	COAD	57	MALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2011	NA	-21118	Alive	TUMOR FREE	378	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	378	0	378	NA	NA	0	378	
70	TCGA-D5-6924	0	12	0	5	3	1	2	0	4	126	10	0	0	46	1	0	TCGA-D5-6924-01	82	0.4111838001764794	35	TCGA-D5-6924-01	17	28	15	0.17995119505885024	TCGA-D5-6924-01	7	6	3	16	PASS	2317	TCGA-D5-6924	COAD	68	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-24964	Alive	TUMOR FREE	435	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	435	0	435	NA	NA	0	435	
70	TCGA-D5-6926	1	20	0	6	1	0	0	0	3	90	4	0	0	37	5	1	TCGA-D5-6926-01	78	0.4325718181459401	32	TCGA-D5-6926-01	16	24	7	0.048932299757801605	TCGA-D5-6926-01	7	3	2	12	PASS	2318	TCGA-D5-6926	COAD	65	MALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2011	NA	-23768	Alive	TUMOR FREE	275	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	275	0	275	NA	NA	0	275	
30	TCGA-D5-6927	4	73	7	22	122	29	9	0	33	446	26	1	13	205	22	1	TCGA-D5-6927-01	63	0.0004142033643164298	21	TCGA-D5-6927-01	0	0	3	0.00025211094642501344	TCGA-D5-6927-01	0	0	0	0	hypermutated sample	2319	TCGA-D5-6927	COAD	34	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-12737	Alive	TUMOR FREE	287	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	287	0	287	NA	NA	0	287	
80	TCGA-D5-6928	11	156	11	55	196	49	18	2	67	1242	68	1	30	500	24	1	TCGA-D5-6928-01	48	0.15275949375956466	6	TCGA-D5-6928-01	9	6	4	0.00048137199688565743	TCGA-D5-6928-01	1	0	0	1	hypermutated sample	2320	TCGA-D5-6928	COAD	80	MALE	WHITE	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2011	NA	-29411	Alive	TUMOR FREE	354	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	354	0	354	NA	NA	0	354	
50	TCGA-D5-6929	3	16	0	4	4	2	2	0	5	88	7	1	1	40	2	0	TCGA-D5-6929-01	245	0.8358258006883171	152	TCGA-D5-6929-01	18	31	29	0.3124037125526055	TCGA-D5-6929-01	7	8	3	18	PASS	2321	TCGA-D5-6929	COAD	49	FEMALE	WHITE	Stage IV	NA	Colon Adenocarcinoma	NA	2011	NA	-17919	Alive	TUMOR FREE	408	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	408	0	408	NA	NA	0	408	
70	TCGA-D5-6930	3	115	8	47	161	41	8	0	44	920	66	0	19	427	11	2	TCGA-D5-6930-01	73	0.0013328943254013461	22	TCGA-D5-6930-01	0	0	4	0.0008826513950353813	TCGA-D5-6930-01	0	0	0	0	hypermutated sample	2322	TCGA-D5-6930	COAD	67	MALE	WHITE	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2011	NA	-24764	Alive	TUMOR FREE	406	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	406	0	406	NA	NA	0	406	
80	TCGA-D5-6931	2	25	0	10	1	3	0	0	12	252	16	0	5	94	4	1	TCGA-D5-6931-01	108	0.17508822893684406	49	TCGA-D5-6931-01	4	12	19	0.19534011069630555	TCGA-D5-6931-01	5	5	4	14	PASS	2323	TCGA-D5-6931	COAD	77	MALE	WHITE	Stage IIIC	NA	Colon Adenocarcinoma	NA	2011	NA	-28292	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	365	0	365	NA	NA	0	365	
70	TCGA-D5-6932	0	13	2	4	5	0	0	0	8	105	7	2	4	33	1	0	TCGA-D5-6932-01	205	0.7256062706790719	126	TCGA-D5-6932-01	19	21	41	0.16832060342166155	TCGA-D5-6932-01	8	5	6	19	PASS	2324	TCGA-D5-6932	COAD	69	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-25466	Alive	TUMOR FREE	346	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	346	0	346	NA	NA	0	346	
80	TCGA-D5-7000	0	10	0	5	1	2	2	0	1	90	6	0	3	37	1	0	TCGA-D5-7000-01	113	0.21447912234306926	55	TCGA-D5-7000-01	9	13	14	0.2014803982537723	TCGA-D5-7000-01	1	0	1	2	PASS	2325	TCGA-D5-7000	COAD	79	FEMALE	WHITE	Stage I	NA	Colon Mucinous Adenocarcinoma	NA	2011	NA	-28913	Alive	TUMOR FREE	312	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	312	0	312	NA	NA	0	312	
70	TCGA-DM-A0X9	0	13	2	4	3	1	1	0	10	146	14	0	3	47	3	0	TCGA-DM-A0X9-01	109	0.6814018006522571	47	TCGA-DM-A0X9-01	9	8	12	0.0007111911463524247	TCGA-DM-A0X9-01	3	1	0	4	PASS	2326	TCGA-DM-A0X9	COAD	71	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2001	NA	-26217	Alive	NA	3641	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3641	0	3641	NA	NA	0	3641	
70	TCGA-DM-A0XD	2	21	0	5	6	2	0	0	7	131	5	0	2	53	7	1	TCGA-DM-A0XD-01	260	0.17901517897534333	152	TCGA-DM-A0XD-01	6	10	35	0.17096093018971753	TCGA-DM-A0XD-01	5	3	4	12	PASS	2327	TCGA-DM-A0XD	COAD	65	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2000	NA	-23966	Dead	NA	NA	743	NA	NA	NA	NA	484	NA	NA	NA	1	743	NA	743	NA	NA	1	484	
70	TCGA-DM-A0XF	0	18	0	2	2	1	0	0	6	100	7	0	3	41	1	0	TCGA-DM-A0XF-01	108	0.2803483734002134	43	TCGA-DM-A0XF-01	13	14	18	0.1865249526787673	TCGA-DM-A0XF-01	6	6	4	16	PASS	2328	TCGA-DM-A0XF	COAD	68	FEMALE	WHITE	Stage IIIC	NA	[Discrepancy]	NA	1999	NA	-25032	Dead	NA	NA	1162	NA	NA	NA	NA	NA	NA	NA	NA	1	1162	NA	1162	NA	NA	0	1162	
80	TCGA-DM-A1D0	2	14	0	3	3	1	1	0	8	83	3	0	1	39	3	0	TCGA-DM-A1D0-01	210	0.2478951730669245	128	TCGA-DM-A1D0-01	9	20	43	0.28552028014388203	TCGA-DM-A1D0-01	10	6	6	22	PASS	2329	TCGA-DM-A1D0	COAD	79	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2001	NA	-28875	Alive	NA	3974	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3974	0	3974	NA	NA	0	3974	
80	TCGA-DM-A1D4	2	18	2	1	2	2	0	0	5	147	8	0	3	54	2	1	TCGA-DM-A1D4-01	114	0.24550088729439615	57	TCGA-DM-A1D4-01	9	8	18	0.13553899318522222	TCGA-DM-A1D4-01	7	3	5	15	PASS	2330	TCGA-DM-A1D4	COAD	80	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	1999	NA	-29403	Dead	NA	2821	2821	NA	NA	NA	NA	1920	NA	NA	NA	1	2821	NA	2821	NA	NA	1	1920	
90	TCGA-DM-A1D6	3	14	1	4	1	1	1	0	5	82	4	0	1	42	1	1	TCGA-DM-A1D6-01	153	0.6283758671403074	80	TCGA-DM-A1D6-01	10	8	36	0.22299493822365807	TCGA-DM-A1D6-01	9	3	6	18	PASS	2331	TCGA-DM-A1D6	COAD	88	MALE	WHITE	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2000	NA	-32302	Dead	NA	1518	1518	NA	NA	NA	NA	NA	NA	NA	NA	1	1518	NA	1518	NA	NA	0	1518	
80	TCGA-DM-A1D7	0	11	0	6	1	2	0	0	4	111	5	0	3	53	5	0	TCGA-DM-A1D7-01	157	0.20566927978326147	89	TCGA-DM-A1D7-01	5	6	20	0.06079716822775338	TCGA-DM-A1D7-01	7	6	4	17	PASS	2332	TCGA-DM-A1D7	COAD	82	MALE	WHITE	Stage IIA	NA	[Discrepancy]	NA	2000	NA	-30142	Dead	NA	NA	405	NA	NA	NA	NA	80	NA	NA	NA	1	405	NA	405	NA	NA	1	80	
50	TCGA-DM-A1D8	2	20	0	13	0	3	0	0	9	131	4	0	3	45	4	0	TCGA-DM-A1D8-01	136	0.4187621147837824	71	TCGA-DM-A1D8-01	17	23	12	0.12084869695949367	TCGA-DM-A1D8-01	6	5	1	12	PASS	2333	TCGA-DM-A1D8	COAD	50	FEMALE	WHITE	NA	NA	Colon Adenocarcinoma	NA	2000	NA	-18311	Dead	NA	383	383	NA	NA	NA	NA	NA	NA	NA	NA	1	383	NA	383	NA	NA	0	383	
70	TCGA-DM-A1D9	2	17	4	7	3	5	5	0	6	98	4	0	3	40	3	1	TCGA-DM-A1D9-01	124	0.9324744639090096	63	TCGA-DM-A1D9-01	9	10	29	0.22746942820654764	TCGA-DM-A1D9-01	4	4	6	14	PASS	2334	TCGA-DM-A1D9	COAD	67	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2000	NA	-24514	Alive	NA	4270	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4270	0	4270	NA	NA	0	4270	
70	TCGA-DM-A1DA	2	24	0	16	4	0	0	1	9	223	14	0	12	68	10	0	TCGA-DM-A1DA-01	196	0.9296321904116732	122	TCGA-DM-A1DA-01	17	33	34	0.5171636267772761	TCGA-DM-A1DA-01	3	4	1	8	PASS	2335	TCGA-DM-A1DA	COAD	71	FEMALE	WHITE	Stage IIIC	NA	Colon Adenocarcinoma	NA	1999	NA	-26169	Dead	NA	228	228	NA	NA	NA	NA	NA	NA	NA	NA	1	228	NA	228	NA	NA	0	228	
70	TCGA-DM-A1DB	2	10	2	4	0	0	1	0	1	57	5	0	1	22	1	0	TCGA-DM-A1DB-01	201	0.33759024140929034	125	TCGA-DM-A1DB-01	12	13	45	0.21621086147681345	TCGA-DM-A1DB-01	9	7	8	24	PASS	2336	TCGA-DM-A1DB	COAD	68	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2000	NA	-24888	Dead	NA	1348	1348	NA	NA	NA	NA	NA	NA	NA	NA	1	1348	NA	1348	NA	NA	0	1348	
80	TCGA-DM-A1HA	0	15	1	5	3	1	0	0	3	114	12	0	2	40	3	0	TCGA-DM-A1HA-01	256	0.8957010313389203	174	TCGA-DM-A1HA-01	10	23	63	0.4736487113578858	TCGA-DM-A1HA-01	11	17	9	37	PASS	2337	TCGA-DM-A1HA	COAD	82	MALE	WHITE	Stage IIIC	NA	Colon Adenocarcinoma	NA	2000	NA	-30272	Alive	NA	4000	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4000	0	4000	NA	NA	0	4000	
80	TCGA-DM-A1HB	9	153	15	53	177	41	14	1	60	798	37	0	18	392	31	6	TCGA-DM-A1HB-01	81	0.0004082870347770768	30	TCGA-DM-A1HB-01	0	0	4	0.00024115189417754258	TCGA-DM-A1HB-01	0	0	0	0	hypermutated sample	2338	TCGA-DM-A1HB	COAD	75	MALE	WHITE	Stage IIIB	NA	[Discrepancy]	NA	2000	NA	-27708	Alive	NA	4126	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4126	0	4126	NA	NA	0	4126	
70	TCGA-DM-A280	0	12	0	4	2	2	0	0	6	111	5	0	0	46	1	0	TCGA-DM-A280-01	48	0.09421476207277243	9	TCGA-DM-A280-01	3	6	5	0.06476038779667652	TCGA-DM-A280-01	0	2	1	3	PASS	2339	TCGA-DM-A280	COAD	70	FEMALE	WHITE	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	1998	NA	-25649	Dead	NA	236	236	NA	NA	NA	NA	NA	NA	NA	NA	1	236	NA	236	NA	NA	0	236	
60	TCGA-DM-A282	0	11	3	4	3	2	0	0	2	83	3	0	0	37	1	0	TCGA-DM-A282-01	70	0.06252785122115231	27	TCGA-DM-A282-01	5	4	6	0.048422134700922534	TCGA-DM-A282-01	1	2	2	5	PASS	2340	TCGA-DM-A282	COAD	60	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2000	NA	-22265	Alive	NA	4233	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4233	0	4233	NA	NA	0	4233	
70	TCGA-DM-A285	1	16	0	8	5	1	0	0	3	148	11	0	1	54	4	0	TCGA-DM-A285-01	152	0.6435326193438056	84	TCGA-DM-A285-01	16	15	23	0.1837053435618736	TCGA-DM-A285-01	6	2	5	13	PASS	2341	TCGA-DM-A285	COAD	71	FEMALE	WHITE	Stage IV	NA	Colon Mucinous Adenocarcinoma	NA	2001	NA	-26021	Dead	NA	NA	179	NA	NA	NA	NA	NA	NA	NA	NA	1	179	NA	179	NA	NA	0	179	
70	TCGA-DM-A288	2	14	1	5	3	2	0	0	2	59	6	0	2	37	3	0	TCGA-DM-A288-01	190	0.4907178735788282	112	TCGA-DM-A288-01	16	31	35	0.20766558512739386	TCGA-DM-A288-01	8	9	9	26	PASS	2342	TCGA-DM-A288	COAD	68	MALE	WHITE	Stage IIIC	NA	Colon Mucinous Adenocarcinoma	NA	2001	NA	-25084	Dead	NA	427	427	NA	NA	NA	NA	320	NA	NA	NA	1	427	NA	427	NA	NA	1	320	
80	TCGA-DM-A28A	0	12	2	4	4	0	1	0	3	118	5	0	3	49	1	0	TCGA-DM-A28A-01	190	0.6436011801693773	117	TCGA-DM-A28A-01	8	12	35	0.18144245104522572	TCGA-DM-A28A-01	8	7	7	22	PASS	2343	TCGA-DM-A28A	COAD	78	MALE	WHITE	Stage IIIC	NA	Colon Adenocarcinoma	NA	2001	NA	-28833	Dead	NA	805	805	NA	NA	NA	NA	NA	NA	NA	NA	1	805	NA	805	NA	NA	0	805	
70	TCGA-DM-A28C	0	10	1	7	4	2	1	0	4	85	6	0	3	26	1	0	TCGA-DM-A28C-01	64	0.034188733489926106	28	TCGA-DM-A28C-01	1	2	2	0.00010878710775648628	TCGA-DM-A28C-01	1	0	0	1	PASS	2344	TCGA-DM-A28C	COAD	74	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2001	NA	-27073	Dead	NA	2475	2475	NA	NA	NA	NA	1929	NA	NA	NA	1	2475	NA	2475	NA	NA	1	1929	
70	TCGA-DM-A28E	3	8	0	4	7	1	0	0	2	71	6	0	0	30	2	0	TCGA-DM-A28E-01	115	0.11727388626640572	69	TCGA-DM-A28E-01	6	8	24	0.07170961474820317	TCGA-DM-A28E-01	2	0	2	4	PASS	2345	TCGA-DM-A28E	COAD	72	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2001	NA	-26602	Alive	NA	3648	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3648	0	3648	NA	NA	0	3648	
70	TCGA-DM-A28F	3	17	0	9	5	5	0	0	13	195	13	0	9	78	6	0	TCGA-DM-A28F-01	258	0.888301846299828	163	TCGA-DM-A28F-01	16	43	53	0.23096279222367275	TCGA-DM-A28F-01	16	6	4	26	PASS	2346	TCGA-DM-A28F	COAD	73	MALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2002	NA	-26856	Dead	NA	1094	1094	NA	NA	NA	NA	NA	NA	NA	NA	1	1094	NA	1094	NA	NA	0	1094	
80	TCGA-DM-A28G	1	7	1	2	0	3	1	0	6	94	7	0	1	50	3	0	TCGA-DM-A28G-01	51	0.05156997012057269	9	TCGA-DM-A28G-01	2	1	3	0.019223771328596814	TCGA-DM-A28G-01	1	2	1	4	PASS	2347	TCGA-DM-A28G	COAD	75	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2001	NA	-27641	Dead	NA	1849	1849	NA	NA	NA	NA	NA	NA	NA	NA	1	1849	NA	1849	NA	NA	0	1849	
50	TCGA-DM-A28H	0	8	3	5	4	6	1	0	6	100	7	0	1	38	2	0	TCGA-DM-A28H-01	293	0.21220823764614927	198	TCGA-DM-A28H-01	7	12	74	0.21183169038109154	TCGA-DM-A28H-01	9	9	5	23	PASS	2348	TCGA-DM-A28H	COAD	50	MALE	WHITE	Stage IIIC	NA	Colon Adenocarcinoma	NA	2002	NA	-18325	Alive	NA	3561	NA	NA	Locoregional Disease	NA	NA	484	NA	NA	NA	0	3561	0	3561	NA	NA	1	484	
80	TCGA-DM-A28K	0	11	1	3	2	4	1	0	0	85	5	0	2	40	3	0	TCGA-DM-A28K-01	94	0.2745726839694306	43	TCGA-DM-A28K-01	8	9	11	0.06085154304255421	TCGA-DM-A28K-01	4	4	4	12	PASS	2349	TCGA-DM-A28K	COAD	75	MALE	WHITE	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2003	NA	-27428	Alive	NA	2988	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2988	0	2988	NA	NA	0	2988	
60	TCGA-DM-A28M	0	4	0	5	4	1	1	0	0	83	5	0	0	39	4	0	TCGA-DM-A28M-01	59	0.8609895608728496	19	TCGA-DM-A28M-01	20	25	3	0.06533361542562988	TCGA-DM-A28M-01	0	1	1	2	PASS	2350	TCGA-DM-A28M	COAD	63	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2003	NA	-23043	Alive	NA	2895	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2895	0	2895	NA	NA	0	2895	
60	TCGA-F4-6459	1	15	0	5	6	4	0	0	8	102	6	0	3	35	4	0	TCGA-F4-6459-01	181	0.9167306247711454	88	TCGA-F4-6459-01	11	38	37	0.3686872803901676	TCGA-F4-6459-01	16	16	4	36	PASS	2351	TCGA-F4-6459	COAD	61	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2011	NA	-22574	Dead	TUMOR FREE	NA	262	NA	NA	NA	NA	NA	NA	NA	NA	1	262	0	262	NA	NA	0	262	
50	TCGA-F4-6460	1	20	0	5	0	1	0	0	4	114	9	0	5	51	1	0	TCGA-F4-6460-01	247	0.8656004718962875	166	TCGA-F4-6460-01	20	37	51	0.3072074040552635	TCGA-F4-6460-01	13	12	5	30	PASS	2352	TCGA-F4-6460	COAD	51	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2011	NA	-18637	Dead	WITH TUMOR	NA	972	NA	NA	NA	NA	313	Complete Remission/Response	NA	NA	1	972	1	972	1	313	1	313	
40	TCGA-F4-6461	1	14	1	3	1	1	0	0	5	120	8	0	3	40	5	0	TCGA-F4-6461-01	195	0.10435657913752977	131	TCGA-F4-6461-01	1	1	66	0.06226935599868614	TCGA-F4-6461-01	2	4	4	10	PASS	2353	TCGA-F4-6461	COAD	41	FEMALE	WHITE	Stage IIIC	NA	Colon Adenocarcinoma	NA	2011	NA	-15151	Dead	WITH TUMOR	NA	338	NA	NA	NA	NA	288	NA	NA	NA	1	338	1	338	NA	NA	1	288	
50	TCGA-F4-6463	0	4	0	1	2	2	1	1	1	59	3	0	0	29	1	0	TCGA-F4-6463-01	54	0.1206265059393834	15	TCGA-F4-6463-01	4	6	4	0.0511024276741689	TCGA-F4-6463-01	5	2	2	9	PASS	2354	TCGA-F4-6463	COAD	51	MALE	WHITE	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2011	NA	-18804	Alive	TUMOR FREE	1087	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1087	0	1087	0	1087	0	1087	
60	TCGA-F4-6569	0	2	1	1	4	1	2	0	6	98	10	0	5	34	2	0	TCGA-F4-6569-01	77	0.2142673034976187	29	TCGA-F4-6569-01	10	7	14	0.07730565232542032	TCGA-F4-6569-01	3	2	3	8	PASS	2355	TCGA-F4-6569	COAD	60	MALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2011	NA	-22203	Alive	TUMOR FREE	1087	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1087	0	1087	0	1087	0	1087	
80	TCGA-F4-6570	4	170	11	69	241	54	21	0	79	1214	62	0	22	494	34	1	TCGA-F4-6570-01	84	0.13036044695050975	31	TCGA-F4-6570-01	1	4	9	0.014357062154478822	TCGA-F4-6570-01	2	2	1	5	hypermutated sample	2356	TCGA-F4-6570	COAD	78	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-28772	Dead	TUMOR FREE	NA	188	NA	NA	NA	NA	NA	NA	NA	NA	1	188	0	188	NA	NA	0	188	
60	TCGA-F4-6703	4	21	1	14	62	15	5	0	19	410	18	0	7	167	20	0	TCGA-F4-6703-01	41	0.038093806208213975	8	TCGA-F4-6703-01	4	4	3	0.04018606876589626	TCGA-F4-6703-01	0	0	0	0	PASS	2357	TCGA-F4-6703	COAD	64	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-23644	Alive	TUMOR FREE	1456	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1456	0	1456	0	1456	0	1456	
60	TCGA-F4-6704	1	5	2	2	0	0	0	0	0	72	5	0	1	17	1	0	TCGA-F4-6704-01	118	0.658713316906788	49	TCGA-F4-6704-01	20	30	14	0.12881968951960748	TCGA-F4-6704-01	13	11	2	26	PASS	2358	TCGA-F4-6704	COAD	60	MALE	AMERICAN INDIAN OR ALASKA NATIVE	Stage IIIC	NA	Colon Mucinous Adenocarcinoma	NA	2011	NA	-21949	Alive	TUMOR FREE	47	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	47	0	47	NA	NA	0	47	
60	TCGA-F4-6805	2	3	0	3	2	1	1	0	2	57	5	0	1	25	1	1	TCGA-F4-6805-01	89	0.1049072281139076	41	TCGA-F4-6805-01	5	5	16	0.09309860810740576	TCGA-F4-6805-01	7	2	4	13	PASS	2359	TCGA-F4-6805	COAD	58	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-21241	Alive	TUMOR FREE	1047	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1047	0	1047	0	1047	0	1047	
60	TCGA-F4-6806	0	7	0	3	3	3	3	0	9	83	8	0	1	39	1	0	TCGA-F4-6806-01	45	0.13297161933035798	6	TCGA-F4-6806-01	1	1	19	0.0123045090985514	TCGA-F4-6806-01	1	1	1	3	PASS	2360	TCGA-F4-6806	COAD	59	FEMALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2011	NA	-21625	Alive	WITH TUMOR	1260	NA	NA	Metastatic	NA	NA	336	Complete Remission/Response	NA	NA	0	1260	0	1260	1	336	1	336	
50	TCGA-F4-6807	2	16	1	4	1	1	2	0	6	135	8	1	1	49	6	0	TCGA-F4-6807-01	80	0.2586969578315223	31	TCGA-F4-6807-01	9	9	20	0.1494784689796596	TCGA-F4-6807-01	4	9	5	18	PASS	2361	TCGA-F4-6807	COAD	51	FEMALE	WHITE	Stage IIIC	NA	Colon Adenocarcinoma	NA	2011	NA	-18690	Alive	TUMOR FREE	1309	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1309	0	1309	0	1309	0	1309	
50	TCGA-F4-6808	0	10	2	3	0	1	1	0	5	110	11	0	3	48	0	0	TCGA-F4-6808-01	155	0.7184382098600361	84	TCGA-F4-6808-01	14	20	36	0.201381157236428	TCGA-F4-6808-01	9	6	12	27	PASS	2362	TCGA-F4-6808	COAD	54	FEMALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2011	NA	-19803	Alive	TUMOR FREE	1024	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1024	0	1024	0	1024	0	1024	
50	TCGA-F4-6809	0	21	0	7	0	3	0	0	7	127	14	0	2	35	4	0	TCGA-F4-6809-01	106	0.16772904141196554	50	TCGA-F4-6809-01	8	7	20	0.1344731937929282	TCGA-F4-6809-01	8	5	5	18	PASS	2363	TCGA-F4-6809	COAD	52	FEMALE	WHITE	Stage IVA	NA	Colon Adenocarcinoma	NA	2011	NA	-19039	Dead	WITH TUMOR	NA	403	NA	NA	NA	NA	NA	NA	NA	NA	1	403	1	403	NA	NA	1	403	
80	TCGA-F4-6854	1	9	0	1	2	2	1	0	1	100	7	0	2	30	2	0	TCGA-F4-6854-01	131	0.23814262372121944	69	TCGA-F4-6854-01	10	12	24	0.25699709331221404	TCGA-F4-6854-01	4	3	2	9	PASS	2364	TCGA-F4-6854	COAD	77	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-28272	Alive	TUMOR FREE	16	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	16	0	16	0	16	0	16	
70	TCGA-F4-6855	1	10	1	4	1	1	0	0	8	74	11	0	3	38	7	0	TCGA-F4-6855-01	62	0.341911116908234	18	TCGA-F4-6855-01	15	26	4	0.0002747608252971353	TCGA-F4-6855-01	3	0	0	3	PASS	2365	TCGA-F4-6855	COAD	70	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-25890	Alive	TUMOR FREE	1442	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1442	0	1442	0	1442	0	1442	
50	TCGA-F4-6856	8	103	6	36	156	43	22	1	53	698	30	0	19	329	13	0	TCGA-F4-6856-01	71	0.014649762133960841	24	TCGA-F4-6856-01	0	0	5	0.029089103698895526	TCGA-F4-6856-01	1	2	2	5	hypermutated sample	2366	TCGA-F4-6856	COAD	45	MALE	WHITE	Stage I	NA	Colon Mucinous Adenocarcinoma	NA	2011	NA	-16519	Alive	TUMOR FREE	1074	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1074	0	1074	0	1074	0	1074	
50	TCGA-G4-6293	0	10	0	5	4	2	3	0	6	87	5	0	2	43	1	0	TCGA-G4-6293-01	65	0.11067123007402116	24	TCGA-G4-6293-01	5	6	4	0.04849635195882816	TCGA-G4-6293-01	0	0	0	0	PASS	2367	TCGA-G4-6293	COAD	49	FEMALE	WHITE	Stage III	NA	Colon Adenocarcinoma	NA	2002	NA	-18076	Alive	TUMOR FREE	4051	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4051	0	4051	0	4051	0	4051	
80	TCGA-G4-6294	0	11	2	3	3	0	0	0	11	125	14	0	3	38	4	0	TCGA-G4-6294-01	155	0.18969570090076274	82	TCGA-G4-6294-01	7	23	29	0.30589066899080464	TCGA-G4-6294-01	4	6	1	11	PASS	2368	TCGA-G4-6294	COAD	75	MALE	WHITE	Stage IV	NA	Colon Adenocarcinoma	NA	2004	NA	-27755	Dead	WITH TUMOR	NA	858	NA	NA	NA	NA	517	NA	NA	NA	1	858	1	858	NA	NA	1	517	
70	TCGA-G4-6295	1	25	0	19	4	2	2	0	11	163	12	0	1	63	8	0	TCGA-G4-6295-01	146	0.9380269441205096	65	TCGA-G4-6295-01	25	37	19	0.05187565231915228	TCGA-G4-6295-01	4	2	3	9	PASS	2369	TCGA-G4-6295	COAD	70	FEMALE	WHITE	Stage II	NA	Colon Adenocarcinoma	NA	2004	NA	-25758	Alive	TUMOR FREE	254	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	254	0	254	NA	NA	0	254	
60	TCGA-G4-6297	1	12	1	4	4	3	2	0	5	134	15	0	3	61	4	0	TCGA-G4-6297-01	66	0.498071318565796	18	TCGA-G4-6297-01	29	35	8	0.13353648457268755	TCGA-G4-6297-01	5	3	1	9	PASS	2370	TCGA-G4-6297	COAD	55	FEMALE	WHITE	Stage IV	NA	Colon Adenocarcinoma	NA	2005	NA	-20103	Alive	WITH TUMOR	2506	NA	NA	NA	NA	NA	439	NA	NA	NA	0	2506	0	2506	NA	NA	1	439	
90	TCGA-G4-6298	0	12	2	8	3	4	0	0	6	130	12	0	5	49	7	0	TCGA-G4-6298-01	72	0.3192984975329437	25	TCGA-G4-6298-01	13	13	14	0.29039058434278786	TCGA-G4-6298-01	4	2	5	11	PASS	2371	TCGA-G4-6298	COAD	90	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Colon Adenocarcinoma	NA	2005	NA	-32873	Dead	WITH TUMOR	NA	715	NA	NA	NA	NA	291	NA	NA	NA	1	715	1	715	NA	NA	1	291	
70	TCGA-G4-6299	0	15	0	3	7	2	4	0	6	133	9	0	2	48	3	0	TCGA-G4-6299-01	211	0.938495723282337	135	TCGA-G4-6299-01	17	37	78	0.4976728191987362	TCGA-G4-6299-01	20	14	17	51	PASS	2372	TCGA-G4-6299	COAD	69	MALE	WHITE	Stage IIIC	NA	Colon Adenocarcinoma	NA	2005	NA	-25318	Alive	TUMOR FREE	2268	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2268	0	2268	NA	NA	0	2268	
90	TCGA-G4-6302	11	137	16	55	206	52	24	2	47	1357	89	2	18	571	44	4	TCGA-G4-6302-01	31	3.86543457238254e-06	2	TCGA-G4-6302-01	2	1	0	0.0	TCGA-G4-6302-01	0	0	0	0	hypermutated sample	2373	TCGA-G4-6302	COAD	90	FEMALE	WHITE	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2006	NA	-32872	Dead	TUMOR FREE	NA	2047	NA	NA	NA	NA	NA	NA	NA	NA	1	2047	0	2047	NA	NA	0	2047	
50	TCGA-G4-6303	0	6	1	3	0	2	0	0	4	73	8	0	4	39	0	0	TCGA-G4-6303-01	162	0.4988562102096114	87	TCGA-G4-6303-01	17	38	19	0.2010357219493912	TCGA-G4-6303-01	15	7	4	26	PASS	2374	TCGA-G4-6303	COAD	54	FEMALE	WHITE	Stage IV	NA	Colon Adenocarcinoma	NA	2006	NA	-19800	Dead	WITH TUMOR	NA	2003	NA	NA	NA	NA	872	NA	NA	NA	1	2003	1	2003	NA	NA	1	872	
70	TCGA-G4-6304	8	84	1	34	123	27	6	1	37	716	27	0	14	308	17	0	TCGA-G4-6304-01	43	0.00017171601162155691	11	TCGA-G4-6304-01	0	2	19	0.05256007768302776	TCGA-G4-6304-01	0	0	0	0	hypermutated sample	2375	TCGA-G4-6304	COAD	66	FEMALE	WHITE	Stage IIB	NA	Colon Adenocarcinoma	NA	2006	NA	-24172	Alive	TUMOR FREE	1631	NA	NA	NA	NA	NA	859	NA	NA	NA	0	1631	0	1631	NA	NA	1	859	
70	TCGA-G4-6306	0	7	1	2	3	0	2	0	7	91	8	1	0	36	1	0	TCGA-G4-6306-01	63	0.8188107773966241	20	TCGA-G4-6306-01	12	12	3	0.03870050074189065	TCGA-G4-6306-01	4	1	3	8	PASS	2376	TCGA-G4-6306	COAD	71	MALE	WHITE	[Discrepancy]	NA	Colon Adenocarcinoma	NA	2007	NA	-26163	Alive	TUMOR FREE	1359	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1359	0	1359	NA	NA	0	1359	
40	TCGA-G4-6307	0	11	2	3	0	0	0	1	4	64	5	0	1	24	1	0	TCGA-G4-6307-01	89	0.4961018868666526	37	TCGA-G4-6307-01	19	27	10	0.11838751509081825	TCGA-G4-6307-01	5	2	3	10	PASS	2377	TCGA-G4-6307	COAD	37	FEMALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2007	NA	-13648	Alive	TUMOR FREE	1674	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1674	0	1674	NA	NA	0	1674	
40	TCGA-G4-6309	7	75	8	25	114	41	15	1	35	593	30	0	5	240	7	0	TCGA-G4-6309-01	161	0.0008492115456672192	101	TCGA-G4-6309-01	0	0	10	0.015507509308304784	TCGA-G4-6309-01	2	1	1	4	hypermutated sample	2378	TCGA-G4-6309	COAD	40	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Colon Adenocarcinoma	NA	2007	NA	-14729	Alive	TUMOR FREE	2600	NA	NA	NA	NA	NA	2176	Complete Remission/Response	NA	NA	0	2600	0	2600	1	2176	1	2176	
70	TCGA-G4-6310	0	9	0	4	2	1	1	0	7	83	8	0	4	44	4	0	TCGA-G4-6310	0	0	0	TCGA-G4-6310	0	0	0	0	TCGA-G4-6310-01	7	3	3	13	PASS	2379	TCGA-G4-6310	COAD	69	MALE	WHITE	Stage IIIB	NA	Colon Adenocarcinoma	NA	2008	NA	-25243	Alive	TUMOR FREE	1935	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1935	0	1935	0	1935	0	1935	
80	TCGA-G4-6311	5	32	0	13	4	4	0	0	7	218	8	0	7	97	6	0	TCGA-G4-6311-01	130	0.925374632586153	58	TCGA-G4-6311-01	26	36	41	0.39395337102721617	TCGA-G4-6311-01	9	2	2	13	PASS	2380	TCGA-G4-6311	COAD	80	MALE	WHITE	Stage III	NA	Colon Adenocarcinoma	NA	2008	NA	-29297	Alive	TUMOR FREE	1199	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1199	0	1199	NA	NA	0	1199	
80	TCGA-G4-6314	2	19	2	11	2	2	0	0	4	226	22	0	11	73	2	0	TCGA-G4-6314	0	0	0	TCGA-G4-6314	0	0	0	0	TCGA-G4-6314-01	11	7	5	23	PASS	2381	TCGA-G4-6314	COAD	76	FEMALE	WHITE	Stage IV	NA	Colon Adenocarcinoma	NA	2008	NA	-27958	Alive	WITH TUMOR	1093	NA	NA	NA	NA	NA	38	NA	NA	NA	0	1093	0	1093	NA	NA	1	38	
70	TCGA-G4-6315	0	9	2	6	4	3	1	0	10	112	10	0	4	45	1	0	TCGA-G4-6315-01	78	0.487715160966097	32	TCGA-G4-6315-01	21	20	8	0.13156492203162118	TCGA-G4-6315-01	3	3	3	9	PASS	2382	TCGA-G4-6315	COAD	66	MALE	WHITE	Stage IV	NA	Colon Adenocarcinoma	NA	2008	NA	-24174	Alive	TUMOR FREE	1883	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1883	0	1883	NA	NA	0	1883	
50	TCGA-G4-6317	1	23	5	14	6	3	2	0	12	175	12	1	5	82	6	0	TCGA-G4-6317-01	150	0.6483879348087601	81	TCGA-G4-6317-02	27	27	19	0.2656494217889312	TCGA-G4-6317-02	5	7	4	16	mutation call filter	2383	TCGA-G4-6317	COAD	51	FEMALE	WHITE	Stage IIIC	NA	Colon Adenocarcinoma	NA	2008	NA	-18822	Alive	TUMOR FREE	1095	NA	NA	Metastatic	NA	NA	592	NA	NA	NA	0	1095	0	1095	NA	NA	1	592	
70	TCGA-G4-6320	14	225	20	99	185	33	24	0	106	1591	76	0	40	709	40	2	TCGA-G4-6320-01	60	0.2551066402354379	14	TCGA-G4-6320-01	11	15	5	0.11407669915815982	TCGA-G4-6320-01	2	0	2	4	hypermutated sample	2384	TCGA-G4-6320	COAD	73	MALE	WHITE	Stage III	NA	Colon Adenocarcinoma	NA	2009	NA	-26840	Alive	TUMOR FREE	804	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	804	0	804	NA	NA	0	804	
60	TCGA-G4-6321	1	9	0	3	0	1	0	0	2	66	5	0	1	18	0	0	TCGA-G4-6321-01	39	0.000304748471157593	6	TCGA-G4-6321-01	0	0	19	0.002453267382704052	TCGA-G4-6321-01	1	0	0	1	PASS	2385	TCGA-G4-6321	COAD	60	FEMALE	WHITE	Stage III	NA	Colon Adenocarcinoma	NA	2009	NA	-21921	Alive	TUMOR FREE	672	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	672	0	672	NA	NA	0	672	
70	TCGA-G4-6322	2	19	0	20	3	0	0	6	2	135	14	0	6	55	2	0	TCGA-G4-6322-01	239	0.21115530037053784	164	TCGA-G4-6322-01	2	1	71	0.0982399547258669	TCGA-G4-6322-01	1	5	2	8	PASS	2386	TCGA-G4-6322	COAD	65	MALE	WHITE	Stage IIIB	NA	Colon Mucinous Adenocarcinoma	NA	2009	NA	-23825	Alive	WITH TUMOR	792	NA	NA	NA	NA	NA	789	NA	NA	NA	0	792	0	792	NA	NA	1	789	
50	TCGA-G4-6323	0	8	2	7	1	2	0	0	8	74	10	0	1	27	3	0	TCGA-G4-6323-01	67	0.07638565999055974	26	TCGA-G4-6323-01	2	1	5	0.010049221427170164	TCGA-G4-6323-01	0	2	1	3	PASS	2387	TCGA-G4-6323	COAD	50	MALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Colon Adenocarcinoma	NA	2010	NA	-18334	Alive	TUMOR FREE	419	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	419	0	419	NA	NA	0	419	
70	TCGA-G4-6586	9	128	6	55	199	33	12	0	52	795	39	0	19	342	20	2	TCGA-G4-6586-01	61	0.04504172567711372	17	TCGA-G4-6586-01	1	3	11	0.03802745514684352	TCGA-G4-6586-01	2	2	1	5	hypermutated sample	2388	TCGA-G4-6586	COAD	73	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2008	NA	-27020	Alive	TUMOR FREE	1089	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1089	0	1089	NA	NA	0	1089	
60	TCGA-G4-6588	12	246	26	97	307	65	23	0	130	1423	72	3	31	659	42	3	TCGA-G4-6588-01	97	0.003258217201433159	47	TCGA-G4-6588-01	0	0	5	0.003402746967541717	TCGA-G4-6588-01	0	0	0	0	hypermutated sample	2389	TCGA-G4-6588	COAD	58	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2009	NA	-21532	Alive	TUMOR FREE	796	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	796	0	796	NA	NA	0	796	
80	TCGA-G4-6625	0	13	1	2	1	3	0	0	4	94	9	0	0	41	2	0	TCGA-G4-6625	0	0	0	TCGA-G4-6625	0	0	0	0	TCGA-G4-6625-01	10	2	4	16	PASS	2390	TCGA-G4-6625	COAD	77	FEMALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2004	NA	-28163	Alive	TUMOR FREE	2792	NA	NA	NA	NA	NA	2564	NA	NA	NA	0	2792	0	2792	NA	NA	1	2564	
90	TCGA-G4-6626	3	15	0	4	1	0	4	0	5	103	10	0	4	51	0	0	TCGA-G4-6626-01	282	0.6277671941084053	179	TCGA-G4-6626-01	20	26	60	0.2471504195259776	TCGA-G4-6626-01	19	22	6	47	PASS	2391	TCGA-G4-6626	COAD	90	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2006	NA	-32871	Dead	TUMOR FREE	NA	1422	NA	NA	NA	NA	NA	NA	NA	NA	1	1422	0	1422	NA	NA	0	1422	
80	TCGA-G4-6627	1	4	0	2	0	2	0	0	1	86	7	0	1	31	2	0	TCGA-G4-6627-01	37	0.18476210184508995	6	TCGA-G4-6627-01	7	7	0	0.0	TCGA-G4-6627-01	0	0	0	0	PASS	2392	TCGA-G4-6627	COAD	84	MALE	WHITE	Stage IIA	NA	Colon Adenocarcinoma	NA	2007	NA	-30697	Alive	TUMOR FREE	2275	NA	NA	NA	NA	NA	1003	Complete Remission/Response	NA	NA	0	2275	0	2275	1	1003	1	1003	
80	TCGA-G4-6628	15	175	12	56	234	97	12	2	86	1392	81	1	29	651	37	1	TCGA-G4-6628-01	71	0.088476341951119	25	TCGA-G4-6628-01	2	1	6	0.005407763432926055	TCGA-G4-6628-01	0	2	0	2	hypermutated sample	2393	TCGA-G4-6628	COAD	78	MALE	WHITE	Stage I	NA	Colon Adenocarcinoma	NA	2006	NA	-28772	Alive	TUMOR FREE	2424	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2424	0	2424	0	2424	0	2424	
70	TCGA-NH-A50T	1	6	0	4	0	3	0	0	4	107	8	0	1	36	2	0	TCGA-NH-A50T-01	114	0.5653630293854243	62	TCGA-NH-A50T-01	19	58	31	0.06430013507481804	TCGA-NH-A50T-01	6	8	1	15	PASS	2394	TCGA-NH-A50T	COAD	68	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2012	NA	-25089	Alive	TUMOR FREE	553	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	553	0	553	0	553	0	553	
40	TCGA-NH-A50U	0	8	1	2	1	1	2	1	3	71	5	0	1	29	2	1	TCGA-NH-A50U-01	148	0.921959862948902	78	TCGA-NH-A50U-01	23	25	68	0.1536741937562752	TCGA-NH-A50U-01	1	2	6	9	PASS	2395	TCGA-NH-A50U	COAD	42	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	NA	Colon Mucinous Adenocarcinoma	NA	2012	NA	-15450	Dead	WITH TUMOR	NA	334	NA	NA	NA	NA	276	Partial Remission/Response	NA	NA	1	334	1	334	NA	NA	1	276	
70	TCGA-NH-A50V	1	13	2	8	3	2	1	0	7	124	14	0	3	54	1	0	TCGA-NH-A50V-01	166	0.20496194005004587	96	TCGA-NH-A50V-01	10	13	80	0.2363273484901713	TCGA-NH-A50V-01	6	4	7	17	PASS	2396	TCGA-NH-A50V	COAD	69	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Colon Adenocarcinoma	NA	2012	NA	-25467	Alive	TUMOR FREE	588	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	588	0	588	0	588	0	588	
90	TCGA-NH-A5IV	21	373	20	129	442	74	31	0	129	1711	67	0	44	768	39	2	TCGA-NH-A5IV-01	61	0.0007568598321219537	21	TCGA-NH-A5IV-01	0	0	16	0.008014515385253971	TCGA-NH-A5IV-01	1	2	1	4	hypermutated sample	2397	TCGA-NH-A5IV	COAD	90	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2012	NA	-32872	Alive	TUMOR FREE	588	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	588	0	588	0	588	0	588	
60	TCGA-NH-A6GA	0	9	0	5	1	1	0	0	6	71	10	0	0	33	0	1	TCGA-NH-A6GA-01	116	0.9005657366819585	57	TCGA-NH-A6GA-01	13	11	103	0.3324202171167901	TCGA-NH-A6GA-01	12	6	6	24	PASS	2398	TCGA-NH-A6GA	COAD	58	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Colon Adenocarcinoma	NA	2013	NA	-21313	Dead	WITH TUMOR	NA	302	NA	NA	NA	NA	6	Progressive Disease	NA	NA	1	302	1	302	NA	NA	1	6	
70	TCGA-NH-A6GB	2	24	2	10	5	2	2	1	9	124	8	1	4	54	3	0	TCGA-NH-A6GB-01	189	0.439943251878324	117	TCGA-NH-A6GB-01	7	10	34	0.05471366350730757	TCGA-NH-A6GB-01	7	2	2	11	PASS	2399	TCGA-NH-A6GB	COAD	71	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Colon Adenocarcinoma	NA	2013	NA	-26100	Alive	WITH TUMOR	476	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	476	0	476	NA	NA	0	476	
70	TCGA-NH-A6GC	0	13	0	5	4	2	1	0	7	97	8	0	4	28	2	1	TCGA-NH-A6GC-01	122	0.6420191789107089	68	TCGA-NH-A6GC-01	23	22	70	0.1727350310554422	TCGA-NH-A6GC-01	6	3	3	12	PASS	2400	TCGA-NH-A6GC	COAD	66	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVB	NA	Colon Mucinous Adenocarcinoma	NA	2013	NA	-24355	Alive	NA	389	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	389	0	389	NA	NA	0	389	
50	TCGA-NH-A8F7	2	25	1	10	10	3	5	0	10	174	15	0	5	81	5	0	TCGA-NH-A8F7-01	138	0.4101362482875285	79	TCGA-NH-A8F7-06	22	21	45	0.07764375422014615	TCGA-NH-A8F7-06	4	3	4	11	mutation call filter	2401	TCGA-NH-A8F7	COAD	53	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2013	NA	-19535	Alive	WITH TUMOR	543	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	543	0	543	NA	NA	0	543	
80	TCGA-NH-A8F8	0	17	1	9	3	1	0	0	5	84	10	0	2	33	4	0	TCGA-NH-A8F8-01	116	0.7068578121703003	57	TCGA-NH-A8F8-01	13	12	62	0.2382033022483533	TCGA-NH-A8F8-01	8	4	10	22	PASS	2402	TCGA-NH-A8F8	COAD	79	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Colon Adenocarcinoma	NA	2013	NA	-29185	Dead	WITH TUMOR	NA	511	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	511	1	511	NA	NA	1	511	
60	TCGA-QG-A5YV	1	14	0	3	6	3	0	0	3	144	6	0	3	54	3	0	TCGA-QG-A5YV-01	183	0.5365931874246826	113	TCGA-QG-A5YV-01	18	15	27	0.04710474219684891	TCGA-QG-A5YV-01	7	0	2	9	PASS	2403	TCGA-QG-A5YV	COAD	64	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Colon Adenocarcinoma	NA	2011	NA	-23499	Alive	TUMOR FREE	1301	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1301	0	1301	0	1301	0	1301	
60	TCGA-QG-A5YW	1	13	1	2	4	1	1	1	7	120	12	0	2	43	7	0	TCGA-QG-A5YW-01	115	0.5581979867119646	61	TCGA-QG-A5YW-01	21	20	56	0.11399960331366844	TCGA-QG-A5YW-01	4	1	1	6	PASS	2404	TCGA-QG-A5YW	COAD	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Colon Mucinous Adenocarcinoma	NA	2011	NA	-20391	Alive	TUMOR FREE	896	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	896	0	896	0	896	0	896	
60	TCGA-QG-A5YX	0	12	0	2	7	3	0	0	4	65	3	0	2	31	1	0	TCGA-QG-A5YX-01	148	0.26930605941156777	91	TCGA-QG-A5YX-01	10	6	42	0.04269098951000362	TCGA-QG-A5YX-01	2	3	3	8	PASS	2405	TCGA-QG-A5YX	COAD	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2011	NA	-22617	Alive	TUMOR FREE	1003	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1003	0	1003	0	1003	0	1003	
70	TCGA-QG-A5Z1	0	5	0	7	5	0	0	0	1	78	10	0	2	33	1	0	TCGA-QG-A5Z1-01	132	0.2736608440193414	63	TCGA-QG-A5Z1-01	9	9	45	0.14680803365143608	TCGA-QG-A5Z1-01	8	4	5	17	PASS	2406	TCGA-QG-A5Z1	COAD	71	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Colon Adenocarcinoma	NA	2011	NA	-26220	Dead	TUMOR FREE	NA	256	NA	NA	NA	NA	NA	NA	NA	NA	1	256	0	256	NA	NA	0	256	
60	TCGA-QG-A5Z2	9	96	2	38	161	27	12	0	47	757	44	1	11	348	20	0	TCGA-QG-A5Z2-01	67	0.00022790945020998877	29	TCGA-QG-A5Z2-01	0	0	13	0.0003997558345651911	TCGA-QG-A5Z2-01	0	0	0	0	hypermutated sample	2407	TCGA-QG-A5Z2	COAD	61	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Colon Adenocarcinoma	NA	2012	NA	-22367	Alive	TUMOR FREE	952	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	952	0	952	0	952	0	952	
80	TCGA-QL-A97D	0	29	4	11	5	1	0	0	18	192	11	0	6	66	1	0	TCGA-QL-A97D-01	227	0.706691609438657	151	TCGA-QL-A97D-01	21	21	106	0.2357795386934144	TCGA-QL-A97D-01	13	6	6	25	PASS	2408	TCGA-QL-A97D	COAD	84	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Colon Adenocarcinoma	NA	2012	NA	-30914	Alive	TUMOR FREE	666	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	666	0	666	0	666	0	666	
50	TCGA-RU-A8FL	1	14	1	8	2	2	2	0	14	110	6	0	6	50	2	0	TCGA-RU-A8FL-01	223	0.8924597033962658	145	TCGA-RU-A8FL-01	26	23	92	0.18352864391036616	TCGA-RU-A8FL-01	10	3	6	19	PASS	2409	TCGA-RU-A8FL	COAD	51	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Colon Adenocarcinoma	NA	2011	NA	-18975	Alive	WITH TUMOR	1177	NA	NA	Metastatic	NA	NA	256	Partial Remission/Response	NA	NA	0	1177	0	1177	NA	NA	1	256	
40	TCGA-SS-A7HO	2	15	1	6	3	1	0	0	5	126	12	0	3	53	3	0	TCGA-SS-A7HO-01	185	0.94698527828342	103	TCGA-SS-A7HO-01	18	18	77	0.18316990899246025	TCGA-SS-A7HO-01	6	3	5	14	PASS	2410	TCGA-SS-A7HO	COAD	44	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Colon Adenocarcinoma	NA	2010	NA	-16416	Alive	WITH TUMOR	1829	NA	NA	Locoregional Disease	NA	NA	506	Complete Remission/Response	NA	NA	0	1829	0	1829	1	506	1	506	
80	TCGA-T9-A92H	1	21	2	11	2	2	0	0	13	140	10	0	6	60	4	0	TCGA-T9-A92H-01	237	0.947693056054101	144	TCGA-T9-A92H-01	11	16	79	0.14617464469659056	TCGA-T9-A92H-01	6	4	4	14	PASS	2411	TCGA-T9-A92H	COAD	82	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Adenocarcinoma	NA	2013	NA	-30058	Alive	WITH TUMOR	362	NA	NA	NA	NA	NA	81	Complete Remission/Response	NA	NA	0	362	0	362	1	81	1	81	
50	TCGA-WS-AB45	14	234	10	113	345	77	23	0	121	1915	95	1	35	917	43	0	TCGA-WS-AB45-01	76	0.2013429520824503	28	TCGA-WS-AB45-01	7	7	23	0.08857253314673648	TCGA-WS-AB45-01	2	2	2	6	hypermutated sample	2412	TCGA-WS-AB45	COAD	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Colon Mucinous Adenocarcinoma	NA	2008	NA	NA	Alive	TUMOR FREE	2130	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2130	0	2130	0	2130	0	2130	
80	TCGA-FA-8693	1	5	1	14	7	3	1	0	4	139	7	0	2	49	7	6	TCGA-FA-8693-01	47	0.010503010737571991	9	TCGA-FA-8693-01	0	2	10	0.02374074664503846	TCGA-FA-8693-01	0	4	1	5	PASS	2413	TCGA-FA-8693	DLBC	75	MALE	WHITE	NA	Stage I	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2012	NA	-27468	Alive	TUMOR FREE	132	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	132	0	132	0	132	0	132	
70	TCGA-FA-A4BB	0	11	2	8	2	1	1	0	4	73	13	0	3	56	2	0	TCGA-FA-A4BB-01	64	0.02772344660034716	20	TCGA-FA-A4BB-01	1	4	25	0.09772529629891999	TCGA-FA-A4BB-01	3	8	4	15	PASS	2414	TCGA-FA-A4BB	DLBC	67	MALE	WHITE	NA	Stage IV	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2012	NA	-24590	Alive	TUMOR FREE	132	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	132	0	132	NA	NA	0	132	
40	TCGA-FA-A4XK	1	10	1	7	1	2	0	0	3	78	3	1	3	29	2	0	TCGA-FA-A4XK-01	119	0.8246249976327217	59	TCGA-FA-A4XK-01	7	6	40	0.042423798077082533	TCGA-FA-A4XK-01	4	6	2	12	PASS	2415	TCGA-FA-A4XK	DLBC	40	MALE	ASIAN	NA	Stage II	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2012	NA	-14723	Dead	TUMOR FREE	NA	708	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	708	0	708	0	708	0	708	
70	TCGA-FA-A6HN	0	17	4	22	9	2	2	0	5	138	9	0	2	80	2	0	TCGA-FA-A6HN-01	97	0.05445019584245811	44	TCGA-FA-A6HN-01	0	6	43	0.06919733563811295	TCGA-FA-A6HN-01	4	5	2	11	PASS	2416	TCGA-FA-A6HN	DLBC	73	MALE	ASIAN	NA	NA	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2013	NA	-27025	Dead	TUMOR FREE	NA	58	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	58	0	58	NA	NA	0	58	
60	TCGA-FA-A6HO	1	6	1	5	0	0	0	0	1	49	6	0	0	17	1	0	TCGA-FA-A6HO-01	105	0.6239869252127863	52	TCGA-FA-A6HO-01	24	54	31	0.06788192592200754	TCGA-FA-A6HO-01	6	14	6	26	PASS	2417	TCGA-FA-A6HO	DLBC	58	FEMALE	ASIAN	NA	NA	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2013	NA	-21330	Alive	WITH TUMOR	749	NA	NA	NA	Paraaortic lymph nodes	NA	739	Complete Remission/Response	NA	NA	0	749	0	749	1	739	1	739	
50	TCGA-FA-A7DS	1	7	1	9	3	2	1	0	3	93	5	0	1	44	4	0	TCGA-FA-A7DS-01	212	0.0839809039088811	135	TCGA-FA-A7DS-01	2	2	58	0.04929225877429861	TCGA-FA-A7DS-01	6	5	3	14	PASS	2418	TCGA-FA-A7DS	DLBC	54	FEMALE	ASIAN	NA	Stage II	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2013	NA	-20087	Alive	TUMOR FREE	719	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	719	0	719	0	719	0	719	
60	TCGA-FA-A7Q1	2	17	6	13	4	1	2	0	15	137	11	1	1	70	4	0	TCGA-FA-A7Q1-01	144	0.3068629268902123	79	TCGA-FA-A7Q1-01	9	12	80	0.14723908115607634	TCGA-FA-A7Q1-01	11	8	4	23	PASS	2419	TCGA-FA-A7Q1	DLBC	61	FEMALE	ASIAN	NA	Stage I	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2013	NA	-22454	Dead	TUMOR FREE	NA	248	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	248	0	248	0	248	0	248	
50	TCGA-FA-A82F	1	15	1	8	3	1	2	0	11	137	10	0	2	48	2	0	TCGA-FA-A82F-01	209	0.5536853934945801	118	TCGA-FA-A82F-01	23	54	37	0.04370237719031172	TCGA-FA-A82F-01	9	4	2	15	PASS	2420	TCGA-FA-A82F	DLBC	48	FEMALE	ASIAN	NA	Stage II	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2013	NA	-17819	Alive	TUMOR FREE	427	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	427	0	427	0	427	0	427	
60	TCGA-FA-A86F	1	5	0	11	3	3	1	0	4	90	6	1	2	35	1	1	TCGA-FA-A86F-01	73	0.0937777041129738	27	TCGA-FA-A86F-01	2	4	39	0.05307257942555841	TCGA-FA-A86F-01	4	5	3	12	PASS	2421	TCGA-FA-A86F	DLBC	64	FEMALE	WHITE	NA	Stage III	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2013	NA	-23641	Alive	WITH TUMOR	553	NA	NA	NA	"Other, specify"	"Inguinal, mediastinal, submandibular, hilar"	150	Partial Remission/Response	NA	NA	0	553	0	553	NA	NA	1	150	
30	TCGA-FF-8041	2	19	4	10	6	3	3	0	15	150	8	1	0	59	3	1	TCGA-FF-8041-01	95	0.9237154777143662	50	TCGA-FF-8041-01	15	18	8	0.03146502002973209	TCGA-FF-8041-01	2	2	0	4	PASS	2422	TCGA-FF-8041	DLBC	28	FEMALE	ASIAN	NA	Stage I	Primary mediastinal (thymic) DLBCL	NA	2010	NA	-10466	Alive	TUMOR FREE	1081	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1081	0	1081	0	1081	0	1081	
60	TCGA-FF-8042	2	20	1	10	5	2	0	0	10	211	11	0	3	68	4	1	TCGA-FF-8042-01	299	0.9751850151920748	188	TCGA-FF-8042-01	7	9	52	0.052676233834491284	TCGA-FF-8042-01	9	12	3	24	PASS	2423	TCGA-FF-8042	DLBC	57	FEMALE	ASIAN	NA	Stage II	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2010	NA	-21005	Alive	TUMOR FREE	946	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	946	0	946	0	946	0	946	
70	TCGA-FF-8043	1	4	2	4	3	1	0	0	1	88	4	0	2	38	1	0	TCGA-FF-8043-01	208	0.3734031095693393	123	TCGA-FF-8043-01	9	13	49	0.22116842800223688	TCGA-FF-8043-01	7	7	6	20	PASS	2424	TCGA-FF-8043	DLBC	70	FEMALE	ASIAN	NA	Stage II	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2010	NA	-25612	Alive	TUMOR FREE	965	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	965	0	965	0	965	0	965	
50	TCGA-FF-8046	1	3	0	2	1	1	1	0	2	58	4	0	3	25	3	0	TCGA-FF-8046-01	77	0.06727576646687311	35	TCGA-FF-8046-01	2	2	4	0.007745062144736023	TCGA-FF-8046-01	0	2	1	3	PASS	2425	TCGA-FF-8046	DLBC	51	MALE	ASIAN	NA	Stage II	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2011	NA	-18853	Alive	TUMOR FREE	751	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	751	0	751	0	751	0	751	
40	TCGA-FF-8047	0	14	1	3	2	2	0	0	5	94	10	0	1	35	3	2	TCGA-FF-8047-01	177	0.18428250951814076	112	TCGA-FF-8047-01	5	5	58	0.12757050198242467	TCGA-FF-8047-01	5	7	5	17	PASS	2426	TCGA-FF-8047	DLBC	38	FEMALE	ASIAN	NA	Stage II	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2011	NA	-13996	Alive	WITH TUMOR	126	NA	NA	NA	Leptomeninges	NA	24	Progressive Disease	NA	NA	0	126	0	126	NA	NA	1	24	
40	TCGA-FF-8061	0	10	3	5	4	1	1	0	7	119	7	0	2	35	0	0	TCGA-FF-8061-01	167	0.007114574117489845	93	TCGA-FF-8061-01	0	2	16	0.07092314910494653	TCGA-FF-8061-01	3	2	3	8	PASS	2427	TCGA-FF-8061	DLBC	42	MALE	ASIAN	NA	Stage II	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2010	NA	-15358	Alive	TUMOR FREE	832	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	832	0	832	0	832	0	832	
60	TCGA-FF-8062	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-FF-8062-01	137	5.832945119387283e-05	78	TCGA-FF-8062-01	0	0	9	0.08643615652980316	TCGA-FF-8062-01	1	2	3	6	PASS	2428	TCGA-FF-8062	DLBC	60	FEMALE	ASIAN	NA	Stage I	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2011	NA	-21959	Alive	TUMOR FREE	679	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	679	0	679	0	679	0	679	
70	TCGA-FF-A7CQ	0	9	1	11	4	4	1	1	4	114	11	0	1	51	6	0	TCGA-FF-A7CQ-01	203	0.11963879480310564	130	TCGA-FF-A7CQ-01	4	7	84	0.0913724402085192	TCGA-FF-A7CQ-01	5	3	1	9	PASS	2429	TCGA-FF-A7CQ	DLBC	74	MALE	ASIAN	NA	Stage IV	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2010	NA	-27255	Alive	NA	298	NA	NA	NA	Brain	NA	255	Stable Disease	NA	NA	0	298	0	298	NA	NA	1	255	
60	TCGA-FF-A7CR	2	19	9	25	3	1	2	0	6	168	6	0	3	72	7	2	TCGA-FF-A7CR-01	141	0.07196494054897094	83	TCGA-FF-A7CR-01	0	2	45	0.06790705777855796	TCGA-FF-A7CR-01	7	8	4	19	PASS	2430	TCGA-FF-A7CR	DLBC	61	MALE	ASIAN	NA	Stage IV	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2012	NA	-22471	Dead	WITH TUMOR	NA	313	NA	NA	"Other, specify"	Skin (Calf and Chest wall)	290	Progressive Disease	NA	NA	1	313	1	313	NA	NA	1	290	
70	TCGA-FF-A7CW	2	1	1	3	3	0	1	0	2	41	3	0	0	12	1	0	TCGA-FF-A7CW-01	101	0.2519905341525123	44	TCGA-FF-A7CW-01	8	9	43	0.14007391459528798	TCGA-FF-A7CW-01	2	2	6	10	PASS	2431	TCGA-FF-A7CW	DLBC	72	MALE	ASIAN	NA	Stage II	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2012	NA	-26520	Alive	TUMOR FREE	791	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	791	0	791	0	791	0	791	
50	TCGA-FF-A7CX	2	9	0	4	3	1	1	0	6	98	6	0	1	45	3	1	TCGA-FF-A7CX-01	115	0.07850292617497691	57	TCGA-FF-A7CX-01	2	5	66	0.17521842655885494	TCGA-FF-A7CX-01	5	3	6	14	PASS	2432	TCGA-FF-A7CX	DLBC	46	MALE	ASIAN	NA	Stage IV	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2011	NA	-16924	Alive	TUMOR FREE	385	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	385	0	385	NA	NA	0	385	
70	TCGA-FM-8000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-FM-8000-01	81	0.1125216316457044	30	TCGA-FM-8000-01	4	9	12	0.09372552034394332	TCGA-FM-8000-01	4	1	3	8	PASS	2433	TCGA-FM-8000	DLBC	70	FEMALE	WHITE	NA	Stage II	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2011	NA	-25724	Alive	TUMOR FREE	972	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	972	0	972	0	972	0	972	
40	TCGA-G8-6324	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-G8-6324-01	90	0.02880303919027598	34	TCGA-G8-6324	0	0	0	0	TCGA-G8-6324	0	0	0	0	PASS	2434	TCGA-G8-6324	DLBC	43	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IV	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2006	NA	-15750	Dead	WITH TUMOR	NA	1252	NA	NA	Supraclavicular lymph nodes	NA	338	Complete Remission/Response	NA	NA	1	1252	1	1252	NA	NA	1	338	
70	TCGA-G8-6325	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-G8-6325-01	77	0.18726501243583224	34	TCGA-G8-6325-01	3	4	21	0.1391234920246949	TCGA-G8-6325-01	7	9	5	21	PASS	2435	TCGA-G8-6325	DLBC	69	MALE	WHITE	NA	Stage IV	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2008	NA	-25256	Alive	TUMOR FREE	1581	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1581	0	1581	NA	NA	0	1581	
50	TCGA-G8-6326	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-G8-6326-01	43	3.130704710235622e-05	12	TCGA-G8-6326-01	0	0	19	2.452613450955034e-05	TCGA-G8-6326-01	0	0	0	0	PASS	2436	TCGA-G8-6326	DLBC	52	MALE	WHITE	NA	Stage IV	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2009	NA	-19238	Alive	TUMOR FREE	2131	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	2131	0	2131	NA	NA	0	2131	
60	TCGA-G8-6906	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-G8-6906-01	51	0.039862380678762056	11	TCGA-G8-6906-01	1	1	5	0.03953250307910098	TCGA-G8-6906-01	1	0	2	3	PASS	2437	TCGA-G8-6906	DLBC	58	MALE	WHITE	NA	NA	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	1987	NA	-21272	Dead	TUMOR FREE	NA	6425	NA	NA	NA	NA	6383	Complete Remission/Response	NA	NA	1	6425	0	6425	1	6383	1	6383	
60	TCGA-G8-6907	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-G8-6907-01	95	0.06357760565156223	45	TCGA-G8-6907-01	0	0	9	0.026908275853360985	TCGA-G8-6907-01	0	6	2	8	PASS	2438	TCGA-G8-6907	DLBC	57	FEMALE	WHITE	NA	Stage IV	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2000	NA	-21021	Dead	WITH TUMOR	NA	595	NA	NA	Ovary	NA	279	Stable Disease	NA	NA	1	595	1	595	NA	NA	1	279	
70	TCGA-G8-6909	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-G8-6909-01	199	0.14242873585467838	119	TCGA-G8-6909-01	3	8	49	0.14825695006115386	TCGA-G8-6909-01	11	9	3	23	PASS	2439	TCGA-G8-6909	DLBC	67	MALE	WHITE	NA	Stage III	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2002	NA	-24661	Dead	TUMOR FREE	NA	3553	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	3553	0	3553	0	3553	0	3553	
70	TCGA-G8-6914	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-G8-6914-01	102	0.14051034087435305	45	TCGA-G8-6914-01	5	5	3	5.555090799354229e-05	TCGA-G8-6914-01	0	1	0	1	PASS	2440	TCGA-G8-6914	DLBC	67	MALE	WHITE	NA	Stage III	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	1996	NA	-24569	Alive	TUMOR FREE	5980	NA	NA	NA	NA	NA	3669	Complete Remission/Response	NA	NA	0	5980	0	5980	1	3669	1	3669	
60	TCGA-GR-7351	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-GR-7351-01	117	0.1028259156383789	53	TCGA-GR-7351-01	1	6	16	0.09074384831980324	TCGA-GR-7351-01	5	5	6	16	PASS	2441	TCGA-GR-7351	DLBC	56	FEMALE	WHITE	NA	Stage I	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2001	NA	-20812	Alive	TUMOR FREE	4578	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4578	0	4578	0	4578	0	4578	
40	TCGA-GR-7353	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-GR-7353-01	150	0.3518701670085096	87	TCGA-GR-7353-01	10	10	32	0.1771497812499472	TCGA-GR-7353-01	5	8	8	21	PASS	2442	TCGA-GR-7353	DLBC	36	MALE	WHITE	NA	Stage II	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2005	NA	-13317	Alive	TUMOR FREE	2983	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2983	0	2983	0	2983	0	2983	
60	TCGA-GR-A4D4	0	13	1	7	1	0	0	1	4	80	3	0	0	24	6	0	TCGA-GR-A4D4-01	128	0.21400482080479105	63	TCGA-GR-A4D4-01	9	7	69	0.16000326831428685	TCGA-GR-A4D4-01	9	4	8	21	PASS	2443	TCGA-GR-A4D4	DLBC	57	FEMALE	WHITE	NA	Stage IV	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2010	NA	-20888	Alive	TUMOR FREE	1581	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1581	0	1581	NA	NA	0	1581	
50	TCGA-GR-A4D5	1	3	3	3	0	0	1	0	1	48	4	0	0	21	1	0	TCGA-GR-A4D5-01	33	0.0916127989612814	0	TCGA-GR-A4D5-01	5	4	20	0.051082054110060095	TCGA-GR-A4D5-01	1	3	2	6	PASS	2444	TCGA-GR-A4D5	DLBC	46	FEMALE	WHITE	NA	Stage IV	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2010	NA	-17023	Alive	TUMOR FREE	1299	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1299	0	1299	NA	NA	0	1299	
50	TCGA-GR-A4D6	0	3	0	3	0	0	0	0	5	44	2	0	1	24	1	0	TCGA-GR-A4D6-01	128	0.2499098792236666	70	TCGA-GR-A4D6-01	8	6	76	0.09160894541243944	TCGA-GR-A4D6-01	1	8	4	13	PASS	2445	TCGA-GR-A4D6	DLBC	54	FEMALE	ASIAN	NA	Stage I	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2010	NA	-19838	Alive	TUMOR FREE	1334	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1334	0	1334	0	1334	0	1334	
70	TCGA-GR-A4D9	0	6	1	2	3	0	0	0	3	65	3	0	3	22	2	0	TCGA-GR-A4D9-01	119	0.1150403392080488	66	TCGA-GR-A4D9-01	3	6	35	0.05991515281733609	TCGA-GR-A4D9-01	3	7	4	14	PASS	2446	TCGA-GR-A4D9	DLBC	66	FEMALE	WHITE	NA	Stage IV	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2009	NA	-24405	Alive	WITH TUMOR	1739	NA	NA	NA	Soft Tissue	NA	1218	Complete Remission/Response	NA	NA	0	1739	0	1739	NA	NA	1	1218	
70	TCGA-GS-A9TQ	0	14	1	15	3	3	0	1	14	141	13	0	2	58	8	0	TCGA-GS-A9TQ-01	201	0.6653344248448017	134	TCGA-GS-A9TQ-01	20	63	40	0.1205933719401532	TCGA-GS-A9TQ-01	10	7	2	19	PASS	2447	TCGA-GS-A9TQ	DLBC	69	FEMALE	WHITE	NA	Stage II	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2012	NA	-25292	Alive	TUMOR FREE	982	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	982	0	982	0	982	0	982	
70	TCGA-GS-A9TT	0	28	8	21	4	2	1	1	6	200	14	0	4	89	3	1	TCGA-GS-A9TT-01	225	0.12357719204047067	140	TCGA-GS-A9TT-01	4	8	68	0.06884343723844348	TCGA-GS-A9TT-01	6	9	4	19	PASS	2448	TCGA-GS-A9TT	DLBC	70	MALE	WHITE	NA	Stage IV	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2011	NA	-25794	Alive	TUMOR FREE	1163	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1163	0	1163	NA	NA	0	1163	
50	TCGA-GS-A9TU	1	7	0	4	2	3	0	0	2	50	3	0	0	24	0	0	TCGA-GS-A9TU-01	84	0.14318634364876906	34	TCGA-GS-A9TU-01	5	11	25	0.06737511408773374	TCGA-GS-A9TU-01	6	4	5	15	PASS	2449	TCGA-GS-A9TU	DLBC	45	MALE	WHITE	NA	Stage II	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2004	NA	-16720	Alive	TUMOR FREE	3897	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3897	0	3897	0	3897	0	3897	
40	TCGA-GS-A9TV	1	10	0	5	0	0	0	0	5	78	5	0	1	27	1	0	TCGA-GS-A9TV-01	59	0.011429187210295474	17	TCGA-GS-A9TV-01	0	0	9	0.00040149612127186857	TCGA-GS-A9TV-01	0	0	0	0	PASS	2450	TCGA-GS-A9TV	DLBC	40	FEMALE	WHITE	NA	Stage II	Primary mediastinal (thymic) DLBCL	NA	2013	NA	-14838	Alive	TUMOR FREE	730	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	730	0	730	0	730	0	730	
30	TCGA-GS-A9TW	2	46	3	20	9	4	4	0	10	244	16	0	2	111	7	0	TCGA-GS-A9TW-01	171	0.370147725625826	107	TCGA-GS-A9TW-01	16	20	61	0.11115520826097416	TCGA-GS-A9TW-01	9	9	4	22	PASS	2451	TCGA-GS-A9TW	DLBC	23	FEMALE	WHITE	NA	Stage II	Primary mediastinal (thymic) DLBCL	NA	2010	NA	-8493	Alive	TUMOR FREE	1617	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1617	0	1617	0	1617	0	1617	
40	TCGA-GS-A9TX	0	7	2	3	1	0	2	0	7	57	6	0	0	34	1	0	TCGA-GS-A9TX-01	77	0.2638382967603913	31	TCGA-GS-A9TX-01	6	8	54	0.11893351726168902	TCGA-GS-A9TX-01	10	13	5	28	PASS	2452	TCGA-GS-A9TX	DLBC	37	MALE	WHITE	NA	Stage I	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2011	NA	-13708	Alive	TUMOR FREE	1373	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1373	0	1373	0	1373	0	1373	
80	TCGA-GS-A9TY	1	18	0	13	6	2	1	0	9	136	7	0	3	41	0	1	TCGA-GS-A9TY-01	458	0.6331565648102837	307	TCGA-GS-A9TY-01	13	31	246	0.3335167408892312	TCGA-GS-A9TY-01	20	24	10	54	PASS	2453	TCGA-GS-A9TY	DLBC	82	FEMALE	WHITE	NA	Stage I	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2005	NA	-30256	Alive	WITH TUMOR	3333	NA	NA	NA	Pleura/Pleural effusion	NA	3255	Complete Remission/Response	NA	NA	0	3333	0	3333	1	3255	1	3255	
50	TCGA-GS-A9TZ	3	44	7	42	7	2	4	1	33	328	25	0	6	137	10	3	TCGA-GS-A9TZ-01	74	0.4481505817192715	24	TCGA-GS-A9TZ-01	15	51	33	0.09074012610249388	TCGA-GS-A9TZ-01	7	8	4	19	PASS	2454	TCGA-GS-A9TZ	DLBC	51	MALE	WHITE	NA	Stage II	Primary mediastinal (thymic) DLBCL	NA	2012	NA	-18691	Alive	TUMOR FREE	765	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	765	0	765	NA	NA	0	765	
80	TCGA-GS-A9U3	0	4	1	3	1	1	0	0	8	72	7	0	1	21	0	0	TCGA-GS-A9U3-01	73	0.1997026336257532	27	TCGA-GS-A9U3-01	6	8	27	0.06751442870432771	TCGA-GS-A9U3-01	3	3	3	9	PASS	2455	TCGA-GS-A9U3	DLBC	77	FEMALE	WHITE	NA	Stage III	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2005	NA	-28474	Alive	TUMOR FREE	3394	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3394	0	3394	0	3394	0	3394	
30	TCGA-GS-A9U4	0	3	0	1	0	0	0	0	0	30	1	0	1	14	0	0	TCGA-GS-A9U4-01	49	0.2732866302497842	11	TCGA-GS-A9U4-01	11	11	22	0.11588359975734025	TCGA-GS-A9U4-01	2	1	2	5	PASS	2456	TCGA-GS-A9U4	DLBC	27	FEMALE	WHITE	NA	Stage II	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2011	NA	-10075	Dead	WITH TUMOR	NA	391	NA	NA	Cervical Lymph Nodes	NA	106	Progressive Disease	NA	NA	1	391	1	391	NA	NA	1	106	
60	TCGA-RQ-A68N	2	21	2	17	3	0	0	0	7	167	14	0	5	65	4	1	TCGA-RQ-A68N-01	148	0.4822613990512268	81	TCGA-RQ-A68N-01	16	52	77	0.2539861924890593	TCGA-RQ-A68N-01	3	5	1	9	PASS	2457	TCGA-RQ-A68N	DLBC	63	MALE	WHITE	NA	NA	Primary DLBCL of the CNS	NA	2012	NA	-23127	Alive	TUMOR FREE	788	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	788	0	788	NA	NA	0	788	
60	TCGA-RQ-A6JB	1	7	0	5	0	0	2	1	2	92	2	1	3	30	1	0	TCGA-RQ-A6JB-01	104	0.02044413834785037	54	TCGA-RQ-A6JB-01	0	2	53	0.11751201629216508	TCGA-RQ-A6JB-01	4	6	6	16	PASS	2458	TCGA-RQ-A6JB	DLBC	62	FEMALE	WHITE	NA	NA	Primary DLBCL of the CNS	NA	2011	NA	-22859	Alive	NA	1	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1	0	1	NA	NA	0	1	
60	TCGA-RQ-AAAT	2	12	4	14	1	3	0	0	6	150	4	0	2	63	11	1	TCGA-RQ-AAAT-01	142	0.7000644814632558	67	TCGA-RQ-AAAT-01	13	18	51	0.12560091891972505	TCGA-RQ-AAAT-01	10	9	5	24	PASS	2459	TCGA-RQ-AAAT	DLBC	63	FEMALE	WHITE	NA	NA	Primary DLBCL of the CNS	NA	2013	NA	-23178	Alive	TUMOR FREE	17	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	17	0	17	0	17	0	17	
60	TCGA-VB-A8QN	0	16	3	7	0	0	3	0	14	114	17	0	2	65	6	0	TCGA-VB-A8QN-01	320	0.107549501445808	230	TCGA-VB-A8QN-01	1	1	112	0.08137142255537219	TCGA-VB-A8QN-01	2	15	6	23	PASS	2460	TCGA-VB-A8QN	DLBC	55	MALE	WHITE	NA	Stage III	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	NA	2013	NA	-20270	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-2H-A9GF	4	53	7	16	5	5	4	0	18	224	6	0	4	92	2	0	TCGA-2H-A9GF-01	524	0.8668381984780276	345	TCGA-2H-A9GF-01	18	34	220	0.2411085762364264	TCGA-2H-A9GF-01	17	20	12	49	PASS	2461	TCGA-2H-A9GF	ESCA	67	MALE	[Unknown]	Stage III	NA	"Esophagus Adenocarcinoma, NOS"	G3	2001	NA	-24487	Dead	WITH TUMOR	NA	784	NA	Distant Metastasis	Brain	NA	172	NA	NA	NA	1	784	1	784	NA	NA	1	172	
70	TCGA-2H-A9GG	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-2H-A9GG	0	0	0	TCGA-2H-A9GG	0	0	0	0	TCGA-2H-A9GG	0	0	0	0	PASS	2462	TCGA-2H-A9GG	ESCA	66	MALE	[Unknown]	Stage III	NA	"Esophagus Adenocarcinoma, NOS"	G2	1999	NA	-24328	Dead	WITH TUMOR	NA	610	NA	Distant Metastasis	Brain	NA	504	NA	NA	NA	1	610	1	610	NA	NA	1	504	
40	TCGA-2H-A9GH	1	27	0	2	1	0	1	0	10	95	5	0	3	38	0	0	TCGA-2H-A9GH-01	358	0.4787952585086184	217	TCGA-2H-A9GH	0	0	0	0	TCGA-2H-A9GH	0	0	0	0	PASS	2463	TCGA-2H-A9GH	ESCA	44	MALE	[Unknown]	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	G2	1998	NA	-16197	Dead	WITH TUMOR	NA	951	NA	Locoregional Recurrence	NA	NA	800	NA	NA	NA	1	951	1	951	NA	NA	1	800	
70	TCGA-2H-A9GI	3	54	0	8	1	6	1	0	12	150	12	0	12	60	1	0	TCGA-2H-A9GI-01	279	0.9156347020761214	154	TCGA-2H-A9GI-01	21	40	182	0.3294420112547001	TCGA-2H-A9GI-01	13	9	13	35	PASS	2464	TCGA-2H-A9GI	ESCA	68	MALE	[Unknown]	Stage III	NA	"Esophagus Adenocarcinoma, NOS"	G2	1999	NA	-25097	Dead	WITH TUMOR	NA	435	NA	Locoregional Recurrence	NA	NA	400	NA	NA	NA	1	435	1	435	NA	NA	1	400	
60	TCGA-2H-A9GJ	1	38	4	8	2	1	1	0	4	79	7	0	4	27	1	0	TCGA-2H-A9GJ-01	356	0.3655784762365343	232	TCGA-2H-A9GJ-01	7	21	174	0.38699539774057096	TCGA-2H-A9GJ-01	10	9	9	28	pathology review	2465	TCGA-2H-A9GJ	ESCA	57	MALE	[Unknown]	Stage I	NA	"Esophagus Adenocarcinoma, NOS"	G2	2000	NA	-21180	Dead	WITH TUMOR	NA	1781	NA	Locoregional Recurrence	NA	NA	1261	NA	NA	NA	1	1781	1	1781	NA	NA	1	1261	
40	TCGA-2H-A9GK	11	44	3	9	2	0	0	0	20	149	6	0	5	63	3	0	TCGA-2H-A9GK-01	143	0.3868602936409917	69	TCGA-2H-A9GK-01	6	14	104	0.2992553104612823	TCGA-2H-A9GK-01	14	13	12	39	PASS	2466	TCGA-2H-A9GK	ESCA	43	MALE	[Unknown]	Stage III	NA	"Esophagus Adenocarcinoma, NOS"	G3	2000	NA	-16067	Dead	WITH TUMOR	NA	232	NA	Distant Metastasis	"Other, specify"	Lymph node	113	NA	NA	NA	1	232	1	232	NA	NA	1	113	
70	TCGA-2H-A9GL	4	52	4	11	3	3	4	0	13	169	8	0	9	55	3	0	TCGA-2H-A9GL-01	219	0.6714420898069319	133	TCGA-2H-A9GL-01	16	39	139	0.3482822285189344	TCGA-2H-A9GL-01	22	14	8	44	PASS	2467	TCGA-2H-A9GL	ESCA	74	MALE	[Unknown]	Stage III	NA	"Esophagus Adenocarcinoma, NOS"	G3	2000	NA	-27115	Dead	WITH TUMOR	NA	180	NA	Distant Metastasis	NA	NA	109	NA	NA	NA	1	180	1	180	NA	NA	1	109	
50	TCGA-2H-A9GM	1	34	0	6	2	1	0	1	7	88	6	0	2	31	3	0	TCGA-2H-A9GM-01	373	0.6311043308804473	216	TCGA-2H-A9GM	0	0	0	0	TCGA-2H-A9GM	0	0	0	0	PASS	2468	TCGA-2H-A9GM	ESCA	53	MALE	[Unknown]	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	G2	2000	NA	-19484	Dead	WITH TUMOR	NA	424	NA	Distant Metastasis	"Other, specify"	peritoneum	367	NA	NA	NA	1	424	1	424	NA	NA	1	367	
70	TCGA-2H-A9GN	1	40	1	7	3	2	1	0	10	90	4	0	3	31	2	1	TCGA-2H-A9GN-01	509	0.7022171405687919	348	TCGA-2H-A9GN-01	25	26	276	0.4949933262181842	TCGA-2H-A9GN-01	11	15	8	34	PASS	2469	TCGA-2H-A9GN	ESCA	70	MALE	[Unknown]	Stage III	NA	"Esophagus Adenocarcinoma, NOS"	G3	2000	NA	-25664	Dead	WITH TUMOR	NA	272	NA	Distant Metastasis	Brain	NA	242	NA	NA	NA	1	272	1	272	NA	NA	1	242	
60	TCGA-2H-A9GO	2	29	1	4	1	2	1	0	10	110	7	0	5	48	2	0	TCGA-2H-A9GO-01	189	0.6254032947774163	99	TCGA-2H-A9GO-01	13	24	229	0.6455489005657328	TCGA-2H-A9GO-01	12	8	16	36	PASS	2470	TCGA-2H-A9GO	ESCA	58	MALE	[Unknown]	Stage IVA	NA	"Esophagus Adenocarcinoma, NOS"	G3	2000	NA	-21486	Dead	WITH TUMOR	NA	494	NA	Locoregional Recurrence	NA	NA	362	NA	NA	NA	1	494	1	494	NA	NA	1	362	
80	TCGA-2H-A9GQ	2	42	0	8	7	1	0	0	13	101	4	0	4	50	2	0	TCGA-2H-A9GQ-01	810	0.8637133531903073	579	TCGA-2H-A9GQ-01	17	35	344	0.19343531233245675	TCGA-2H-A9GQ-01	15	10	7	32	PASS	2471	TCGA-2H-A9GQ	ESCA	80	MALE	[Unknown]	Stage III	NA	"Esophagus Adenocarcinoma, NOS"	G3	2001	NA	-29497	Dead	WITH TUMOR	NA	128	NA	Locoregional Recurrence	NA	NA	112	NA	NA	NA	1	128	1	128	NA	NA	1	112	
80	TCGA-2H-A9GR	4	91	3	13	2	0	1	0	21	274	16	0	16	85	5	0	TCGA-2H-A9GR-01	259	0.5034726305771726	155	TCGA-2H-A9GR-01	8	12	152	0.2313023230398002	TCGA-2H-A9GR-01	18	11	15	44	PASS	2472	TCGA-2H-A9GR	ESCA	80	MALE	[Unknown]	Stage IIA	NA	"Esophagus Adenocarcinoma, NOS"	G2	1999	NA	-29451	Dead	WITH TUMOR	NA	987	NA	NA	NA	NA	NA	NA	NA	NA	1	987	1	987	NA	NA	1	987	
60	TCGA-IC-A6RE	30	249	16	34	18	0	4	0	53	787	36	0	40	240	4	4	TCGA-IC-A6RE-01	420	0.4121614633311039	259	TCGA-IC-A6RE-01	8	22	223	0.3246422686593528	TCGA-IC-A6RE-01	14	6	11	31	PASS	2473	TCGA-IC-A6RE	ESCA	59	MALE	WHITE	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	G2	2013	NA	-21640	Alive	WITH TUMOR	234	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	234	0	234	0	234	0	234	
70	TCGA-IC-A6RF	3	51	4	6	8	2	2	0	11	138	5	1	2	78	7	0	TCGA-IC-A6RF	0	0	0	TCGA-IC-A6RF	0	0	0	0	TCGA-IC-A6RF	0	0	0	0	PASS	2474	TCGA-IC-A6RF	ESCA	69	FEMALE	WHITE	Stage IA	Stage IIB	Esophagus Squamous Cell Carcinoma	GX	2013	NA	-25417	Alive	TUMOR FREE	477	NA	NA	Locoregional Recurrence	"Other, specify"	regional lymph nodes	293	Complete Remission/Response	NA	NA	0	477	0	477	1	293	1	293	
50	TCGA-IG-A3I8	4	37	0	6	4	0	2	1	14	167	12	0	4	69	4	0	TCGA-IG-A3I8-01	142	0.6389963117876706	71	TCGA-IG-A3I8-01	20	16	47	0.12388749544607686	TCGA-IG-A3I8-01	7	4	2	13	PASS	2475	TCGA-IG-A3I8	ESCA	51	FEMALE	WHITE	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G2	2011	NA	-18786	Alive	TUMOR FREE	1012	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1012	0	1012	0	1012	0	1012	
50	TCGA-IG-A3QL	2	27	0	6	3	1	1	0	4	70	5	1	4	40	1	0	TCGA-IG-A3QL-01	137	0.6946713293121011	72	TCGA-IG-A3QL	0	0	0	0	TCGA-IG-A3QL	0	0	0	0	PASS	2476	TCGA-IG-A3QL	ESCA	54	MALE	WHITE	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G2	2011	NA	-19755	Alive	TUMOR FREE	1071	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1071	0	1071	0	1071	0	1071	
70	TCGA-IG-A3Y9	5	55	3	10	0	1	1	0	15	178	14	0	7	71	0	0	TCGA-IG-A3Y9-01	113	0.4642479197865026	58	TCGA-IG-A3Y9-01	24	34	62	0.20238842598790288	TCGA-IG-A3Y9-01	11	4	6	21	PASS	2477	TCGA-IG-A3Y9	ESCA	72	MALE	WHITE	Stage IIIA	NA	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-26330	Dead	TUMOR FREE	NA	26	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	26	0	26	0	26	0	26	
50	TCGA-IG-A3YA	4	13	2	4	0	0	0	0	5	69	6	0	4	24	0	0	TCGA-IG-A3YA-01	93	0.35535191702988866	36	TCGA-IG-A3YA-01	11	34	100	0.3316381423656051	TCGA-IG-A3YA-01	12	5	6	23	PASS	2478	TCGA-IG-A3YA	ESCA	53	MALE	WHITE	Stage IIIA	NA	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-19567	Alive	TUMOR FREE	632	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	632	0	632	0	632	0	632	
60	TCGA-IG-A3YB	4	16	0	7	6	1	1	1	10	51	5	0	4	20	5	1	TCGA-IG-A3YB-01	242	0.5907158114444423	146	TCGA-IG-A3YB-01	17	31	133	0.4454202778516881	TCGA-IG-A3YB-01	18	20	16	54	PASS	2479	TCGA-IG-A3YB	ESCA	61	MALE	WHITE	Stage IIIA	NA	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-22316	Alive	TUMOR FREE	80	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	80	0	80	0	80	0	80	
60	TCGA-IG-A3YC	2	9	0	3	1	1	2	0	4	41	2	0	0	12	1	1	TCGA-IG-A3YC-01	127	0.554292022336928	59	TCGA-IG-A3YC-01	19	35	83	0.19789229199675915	TCGA-IG-A3YC-01	16	20	6	42	PASS	2480	TCGA-IG-A3YC	ESCA	62	MALE	WHITE	Stage IIIA	NA	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-22774	Alive	WITH TUMOR	612	NA	NA	New Primary Tumor	Lung	NA	542	Stable Disease	NA	NA	0	612	0	612	NA	NA	1	542	
50	TCGA-IG-A4P3	4	62	5	13	3	0	0	0	8	199	12	0	10	52	4	0	TCGA-IG-A4P3-01	229	0.5022369939261428	132	TCGA-IG-A4P3-01	11	18	136	0.2826342073109919	TCGA-IG-A4P3-01	19	20	13	52	PASS	2481	TCGA-IG-A4P3	ESCA	48	MALE	WHITE	Stage IIB	NA	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-17860	Dead	WITH TUMOR	NA	567	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	567	1	567	NA	NA	1	567	
70	TCGA-IG-A4QS	2	51	0	9	8	3	2	0	12	187	10	0	4	52	1	0	TCGA-IG-A4QS-01	284	0.7905710367179497	171	TCGA-IG-A4QS-01	21	45	106	0.21778125109272106	TCGA-IG-A4QS-01	24	13	7	44	PASS	2482	TCGA-IG-A4QS	ESCA	71	MALE	WHITE	Stage IIIB	NA	"Esophagus Adenocarcinoma, NOS"	G3	2012	NA	-26273	Dead	TUMOR FREE	NA	118	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	118	0	118	0	118	0	118	
60	TCGA-IG-A4QT	0	2	0	1	0	0	0	0	0	1	0	0	2	2	0	0	TCGA-IG-A4QT-01	53	2.412506067342851e-05	13	TCGA-IG-A4QT-01	0	0	10	0.001808907776256548	TCGA-IG-A4QT-01	0	0	0	0	pathology review	2483	TCGA-IG-A4QT	ESCA	56	MALE	WHITE	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-20506	Dead	TUMOR FREE	NA	283	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	283	0	283	0	283	0	283	
60	TCGA-IG-A50L	0	21	0	5	1	5	0	0	7	94	6	0	3	29	0	0	TCGA-IG-A50L-01	297	0.7117673959077453	176	TCGA-IG-A50L-01	15	22	266	0.5327733975589001	TCGA-IG-A50L-01	15	13	20	48	PASS	2484	TCGA-IG-A50L	ESCA	58	MALE	ASIAN	Stage IIIA	Stage IIIA	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-21214	Alive	TUMOR FREE	16	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	16	0	16	NA	NA	0	16	
60	TCGA-IG-A51D	2	31	4	3	4	1	1	0	7	109	5	0	5	46	3	1	TCGA-IG-A51D-01	173	0.4353821204789923	86	TCGA-IG-A51D-01	14	69	114	0.3165063047903444	TCGA-IG-A51D-01	10	5	3	18	PASS	2485	TCGA-IG-A51D	ESCA	63	MALE	WHITE	Stage IIB	Stage IV	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-23259	Alive	TUMOR FREE	518	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	518	0	518	NA	NA	0	518	
70	TCGA-IG-A5B8	9	60	5	21	1	2	1	0	17	204	18	0	5	103	4	0	TCGA-IG-A5B8-01	161	0.5642484879658715	90	TCGA-IG-A5B8-01	19	25	90	0.2430173455351063	TCGA-IG-A5B8-01	13	9	5	27	PASS	2486	TCGA-IG-A5B8	ESCA	72	MALE	WHITE	Stage IB	NA	Esophagus Squamous Cell Carcinoma	G1	2012	NA	-26574	Dead	TUMOR FREE	NA	24	NA	NA	NA	NA	NA	NA	NA	NA	1	24	0	24	NA	NA	0	24	
70	TCGA-IG-A5S3	1	22	1	2	3	0	0	0	7	54	2	0	3	25	2	0	TCGA-IG-A5S3-01	110	0.7899741845977848	52	TCGA-IG-A5S3-01	31	50	93	0.2736933357768657	TCGA-IG-A5S3-01	13	5	4	22	PASS	2487	TCGA-IG-A5S3	ESCA	69	FEMALE	WHITE	Stage IIB	NA	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-25414	Alive	TUMOR FREE	712	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	712	0	712	0	712	0	712	
60	TCGA-IG-A625	3	22	0	4	1	4	1	0	5	43	2	0	1	15	2	0	TCGA-IG-A625-01	217	0.35846552872323634	132	TCGA-IG-A625-01	10	19	119	0.2733117862931629	TCGA-IG-A625-01	7	3	9	19	PASS	2488	TCGA-IG-A625	ESCA	60	MALE	ASIAN	Stage IIIB	NA	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-22070	Dead	TUMOR FREE	NA	390	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	390	0	390	NA	NA	0	390	
50	TCGA-IG-A6QS	1	12	1	5	2	0	0	0	8	50	1	0	7	17	1	0	TCGA-IG-A6QS-01	178	0.3531124765777454	103	TCGA-IG-A6QS-01	10	18	135	0.32601791287013593	TCGA-IG-A6QS-01	10	5	9	24	PASS	2489	TCGA-IG-A6QS	ESCA	54	MALE	WHITE	Stage IIB	NA	Esophagus Squamous Cell Carcinoma	G1	2013	NA	-19900	Dead	TUMOR FREE	NA	303	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	303	0	303	0	303	0	303	
50	TCGA-IG-A7DP	0	1	0	1	0	0	0	0	0	10	0	0	0	4	0	0	TCGA-IG-A7DP-01	47	4.5217403457952476e-05	9	TCGA-IG-A7DP-01	0	0	8	0.0007402492708068973	TCGA-IG-A7DP-01	0	0	0	0	pathology review	2490	TCGA-IG-A7DP	ESCA	50	FEMALE	WHITE	Stage IIIA	NA	"Esophagus Adenocarcinoma, NOS"	G2	2013	NA	-18364	Alive	TUMOR FREE	452	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	452	0	452	0	452	0	452	
60	TCGA-IG-A8O2	3	46	4	7	5	1	1	0	13	102	7	0	2	42	2	0	TCGA-IG-A8O2-01	336	0.6650798504429509	212	TCGA-IG-A8O2-01	16	31	119	0.2364787024331253	TCGA-IG-A8O2-01	19	11	6	36	PASS	2491	TCGA-IG-A8O2	ESCA	62	MALE	ASIAN	Stage IIIB	NA	Esophagus Squamous Cell Carcinoma	G3	2013	NA	-22869	Dead	TUMOR FREE	NA	142	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	142	0	142	0	142	0	142	
40	TCGA-IG-A97H	1	27	1	5	3	2	1	0	13	75	3	0	5	23	3	0	TCGA-IG-A97H-01	288	0.7988486493286596	182	TCGA-IG-A97H	0	0	0	0	TCGA-IG-A97H	0	0	0	0	PASS	2492	TCGA-IG-A97H	ESCA	36	MALE	ASIAN	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G3	2013	NA	-13166	Alive	TUMOR FREE	441	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	441	0	441	0	441	0	441	
60	TCGA-IG-A97I	1	34	2	8	3	0	2	0	9	86	9	1	7	33	1	0	TCGA-IG-A97I-01	174	0.23735533742408396	91	TCGA-IG-A97I-01	8	9	83	0.1802190123902183	TCGA-IG-A97I-01	9	7	8	24	PASS	2493	TCGA-IG-A97I	ESCA	58	MALE	WHITE	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G2	2013	NA	-21271	Alive	TUMOR FREE	370	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	370	0	370	0	370	0	370	
60	TCGA-JY-A6F8	1	36	1	8	2	2	0	0	6	83	6	0	4	45	0	0	TCGA-JY-A6F8-01	280	0.8341906260353825	166	TCGA-JY-A6F8-01	23	32	73	0.1045922794436566	TCGA-JY-A6F8-01	13	17	4	34	PASS	2494	TCGA-JY-A6F8	ESCA	56	MALE	WHITE	Stage I	NA	"Esophagus Adenocarcinoma, NOS"	G1	2003	NA	-20550	Alive	TUMOR FREE	3714	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3714	0	3714	0	3714	0	3714	
50	TCGA-JY-A6FA	2	40	2	2	4	3	1	0	5	88	8	0	5	37	1	0	TCGA-JY-A6FA-01	506	0.4850873914399022	324	TCGA-JY-A6FA-01	7	22	261	0.4005274520749911	TCGA-JY-A6FA-01	22	10	17	49	pathology review	2495	TCGA-JY-A6FA	ESCA	51	MALE	ASIAN	Stage IIB	NA	Esophagus Squamous Cell Carcinoma	G2	2006	NA	-18978	Dead	WITH TUMOR	NA	1361	NA	Distant Metastasis	Lung	NA	477	NA	NA	NA	1	1361	1	1361	NA	NA	1	477	
80	TCGA-JY-A6FB	3	31	1	5	2	6	1	0	3	63	5	0	1	34	2	0	TCGA-JY-A6FB-01	209	0.606666157271353	120	TCGA-JY-A6FB-01	15	30	89	0.2108273463027712	TCGA-JY-A6FB-01	8	8	5	21	PASS	2496	TCGA-JY-A6FB	ESCA	77	MALE	WHITE	Stage I	NA	"Esophagus Adenocarcinoma, NOS"	G2	2007	NA	-28269	Alive	TUMOR FREE	1837	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1837	0	1837	0	1837	0	1837	
50	TCGA-JY-A6FD	4	29	0	5	4	1	0	1	9	100	12	0	5	43	2	0	TCGA-JY-A6FD-01	159	0.318191768406503	85	TCGA-JY-A6FD-01	9	16	83	0.2585461929778843	TCGA-JY-A6FD-01	10	3	7	20	PASS	2497	TCGA-JY-A6FD	ESCA	51	FEMALE	ASIAN	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G1	2008	NA	-18808	Alive	TUMOR FREE	2069	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2069	0	2069	0	2069	0	2069	
50	TCGA-JY-A6FE	3	28	1	6	4	2	1	0	6	42	3	0	3	12	5	0	TCGA-JY-A6FE-01	375	0.9554790611341676	243	TCGA-JY-A6FE-01	24	32	318	0.7045231631713914	TCGA-JY-A6FE-01	26	14	26	66	PASS	2498	TCGA-JY-A6FE	ESCA	49	MALE	WHITE	Stage III	NA	Esophagus Squamous Cell Carcinoma	G3	2009	NA	-18105	Dead	WITH TUMOR	NA	112	NA	Distant Metastasis	"Other, specify"	Pleural Mets	55	NA	NA	NA	1	112	1	112	NA	NA	1	55	
50	TCGA-JY-A6FG	8	50	3	8	6	6	2	0	16	175	7	0	1	72	7	0	TCGA-JY-A6FG-01	166	0.06804388947829246	71	TCGA-JY-A6FG-01	0	0	33	0.024186288697466245	TCGA-JY-A6FG-01	4	8	2	14	PASS	2499	TCGA-JY-A6FG	ESCA	50	MALE	WHITE	Stage III	NA	Esophagus Squamous Cell Carcinoma	G2	2009	NA	-18348	Dead	TUMOR FREE	NA	1263	NA	NA	NA	NA	NA	NA	NA	NA	1	1263	0	1263	NA	NA	0	1263	
50	TCGA-JY-A6FH	0	33	1	8	0	6	0	0	5	104	4	0	3	40	3	0	TCGA-JY-A6FH-01	555	0.9392329255773813	369	TCGA-JY-A6FH-01	17	18	295	0.4459933465495111	TCGA-JY-A6FH-01	16	3	14	33	PASS	2500	TCGA-JY-A6FH	ESCA	53	MALE	WHITE	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	G2	2010	NA	-19549	Alive	TUMOR FREE	1441	NA	NA	Distant Metastasis	Lung	NA	749	Progressive Disease	NA	NA	0	1441	0	1441	NA	NA	1	749	
80	TCGA-JY-A938	4	27	2	6	7	0	3	0	6	109	4	0	4	46	2	0	TCGA-JY-A938-01	185	0.3009527145527073	98	TCGA-JY-A938-01	12	11	117	0.2482381764485909	TCGA-JY-A938-01	16	8	14	38	PASS	2501	TCGA-JY-A938	ESCA	75	MALE	WHITE	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	G3	2012	NA	-27633	Alive	WITH TUMOR	1060	NA	NA	Distant Metastasis	"Other, specify"	Adrenal Gland	493	Complete Remission/Response	NA	NA	0	1060	0	1060	1	493	1	493	
80	TCGA-JY-A939	0	18	0	2	0	0	0	0	6	47	3	0	4	19	2	0	TCGA-JY-A939-01	105	0.012349180355329665	46	TCGA-JY-A939-01	4	6	22	0.018039982825812543	TCGA-JY-A939-01	8	8	0	16	pathology review	2502	TCGA-JY-A939	ESCA	77	MALE	WHITE	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	G3	2012	NA	-28181	Alive	WITH TUMOR	660	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	660	0	660	NA	NA	0	660	
50	TCGA-JY-A93C	3	25	2	4	3	1	2	0	2	68	9	0	4	41	1	0	TCGA-JY-A93C-01	145	0.5990268506568518	87	TCGA-JY-A93C-01	21	23	100	0.2057989955977819	TCGA-JY-A93C-01	11	6	4	21	PASS	2503	TCGA-JY-A93C	ESCA	47	MALE	ASIAN	Stage IIIB	NA	"Esophagus Adenocarcinoma, NOS"	G3	2011	NA	-17228	Alive	WITH TUMOR	705	NA	NA	Locoregional Recurrence	NA	NA	652	Complete Remission/Response	NA	NA	0	705	0	705	1	652	1	652	
50	TCGA-JY-A93D	1	19	1	3	2	0	2	0	4	82	6	0	4	33	0	0	TCGA-JY-A93D-01	123	0.3583028092924748	50	TCGA-JY-A93D-01	10	43	127	0.4155419900780972	TCGA-JY-A93D-01	11	10	9	30	PASS	2504	TCGA-JY-A93D	ESCA	51	MALE	WHITE	Stage IIIC	NA	"Esophagus Adenocarcinoma, NOS"	G3	2012	NA	-18813	Dead	WITH TUMOR	NA	960	NA	Locoregional Recurrence	"Other, specify"	Mediastinal lymph node	732	Complete Remission/Response	NA	NA	1	960	1	960	1	732	1	732	
60	TCGA-JY-A93E	2	44	0	9	2	3	0	0	11	151	7	0	5	59	5	0	TCGA-JY-A93E-01	216	0.7025505765720352	127	TCGA-JY-A93E-01	21	37	103	0.2593795151134107	TCGA-JY-A93E-01	11	2	7	20	PASS	2505	TCGA-JY-A93E	ESCA	61	MALE	WHITE	Stage IIIA	NA	"Esophagus Adenocarcinoma, NOS"	G3	2012	NA	-22427	Alive	WITH TUMOR	767	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	767	0	767	NA	NA	0	767	
60	TCGA-JY-A93F	2	37	1	8	4	2	1	0	4	68	6	0	3	25	3	1	TCGA-JY-A93F-01	111	0.10567079249140164	53	TCGA-JY-A93F-01	2	2	30	0.002802620481555901	TCGA-JY-A93F-01	1	2	0	3	PASS	2506	TCGA-JY-A93F	ESCA	58	FEMALE	WHITE	Stage IB	NA	Esophagus Squamous Cell Carcinoma	G1	2012	NA	-21257	Alive	TUMOR FREE	731	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	731	0	731	0	731	0	731	
80	TCGA-KH-A6WC	2	7	0	2	0	0	0	0	0	22	1	0	0	3	1	0	TCGA-KH-A6WC-01	72	0.0026971018604311997	24	TCGA-KH-A6WC-01	4	7	15	0.04128205489291488	TCGA-KH-A6WC-01	6	3	3	12	PASS	2507	TCGA-KH-A6WC	ESCA	82	MALE	WHITE	Stage IA	Stage IA	Esophagus Squamous Cell Carcinoma	GX	2013	NA	-30167	Alive	TUMOR FREE	191	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	191	0	191	0	191	0	191	
80	TCGA-L5-A43C	2	28	2	6	2	1	2	0	9	111	10	0	3	38	2	1	TCGA-L5-A43C-01	127	0.5278682029945649	66	TCGA-L5-A43C-01	26	21	100	0.3945966459313499	TCGA-L5-A43C-01	9	9	11	29	PASS	2508	TCGA-L5-A43C	ESCA	81	MALE	WHITE	NA	Stage III	"Esophagus Adenocarcinoma, NOS"	GX	2009	NA	-29753	Alive	TUMOR FREE	96	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	96	0	96	NA	NA	0	96	
70	TCGA-L5-A43E	6	53	4	14	2	4	0	0	8	249	11	0	14	92	4	0	TCGA-L5-A43E-01	138	0.4842631141433469	75	TCGA-L5-A43E-01	20	34	98	0.2909265919413975	TCGA-L5-A43E-01	9	4	0	13	pathology review	2509	TCGA-L5-A43E	ESCA	74	MALE	WHITE	Stage I	NA	"Esophagus Adenocarcinoma, NOS"	GX	2011	NA	-27143	Alive	TUMOR FREE	920	NA	NA	New Primary Tumor	"Other, specify"	Right diaphragm-HG spindle cell sarcoma	885	Complete Remission/Response	NA	NA	0	920	0	920	0	920	1	885	
80	TCGA-L5-A43H	1	13	0	2	0	4	0	0	2	70	8	0	1	23	1	0	TCGA-L5-A43H-01	112	0.5978971897434986	43	TCGA-L5-A43H-01	12	16	111	0.5108921843327306	TCGA-L5-A43H-01	16	9	15	40	PASS	2510	TCGA-L5-A43H	ESCA	75	MALE	WHITE	Stage III	NA	Esophagus Squamous Cell Carcinoma	GX	2011	NA	-27592	Dead	WITH TUMOR	NA	9	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	9	1	9	NA	NA	1	9	
80	TCGA-L5-A43I	6	46	1	11	3	2	3	0	19	149	9	1	5	67	6	0	TCGA-L5-A43I-01	333	0.5447695491822531	205	TCGA-L5-A43I-01	12	27	110	0.1896370242659323	TCGA-L5-A43I-01	19	18	13	50	PASS	2511	TCGA-L5-A43I	ESCA	77	MALE	WHITE	Stage IIIA	NA	"Esophagus Adenocarcinoma, NOS"	GX	2011	NA	-28367	Dead	TUMOR FREE	NA	556	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	556	0	556	0	556	0	556	
90	TCGA-L5-A43J	21	324	6	35	118	27	29	0	42	497	18	0	25	204	9	0	TCGA-L5-A43J-01	268	0.7514499479206882	165	TCGA-L5-A43J-01	22	28	120	0.2545084357957888	TCGA-L5-A43J-01	16	25	10	51	hypermutated sample	2512	TCGA-L5-A43J	ESCA	90	MALE	WHITE	Stage IIB	NA	Esophagus Squamous Cell Carcinoma	G3	2011	NA	-32872	Dead	WITH TUMOR	NA	131	NA	Distant Metastasis	Liver	NA	98	Progressive Disease	NA	NA	1	131	1	131	NA	NA	1	98	
80	TCGA-L5-A43M	0	7	0	3	0	2	0	0	2	39	2	0	2	15	1	1	TCGA-L5-A43M-01	271	0.724886226084808	161	TCGA-L5-A43M-01	27	22	118	0.2676100606146267	TCGA-L5-A43M-01	20	9	13	42	pathology review	2513	TCGA-L5-A43M	ESCA	84	FEMALE	[Not Evaluated]	[Unknown]	NA	"Esophagus Adenocarcinoma, NOS"	GX	2009	NA	-30783	Alive	NA	272	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	272	0	272	NA	NA	0	272	
80	TCGA-L5-A4OE	5	66	4	23	2	1	0	0	23	230	27	0	6	95	4	0	TCGA-L5-A4OE-01	118	0.8132620704384875	52	TCGA-L5-A4OE-01	21	19	51	0.13802847804693447	TCGA-L5-A4OE-01	10	6	8	24	PASS	2514	TCGA-L5-A4OE	ESCA	81	MALE	WHITE	Stage IIIB	NA	"Esophagus Adenocarcinoma, NOS"	G2	2011	NA	-29591	Dead	NA	NA	730	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	730	NA	730	0	730	0	730	
60	TCGA-L5-A4OF	1	6	1	7	3	1	1	0	5	59	5	0	2	22	2	1	TCGA-L5-A4OF-01	201	0.4942238937231371	113	TCGA-L5-A4OF-01	6	19	114	0.2924051868561058	TCGA-L5-A4OF-01	12	13	6	31	PASS	2515	TCGA-L5-A4OF	ESCA	63	MALE	WHITE	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	G3	2012	NA	-23194	Dead	NA	NA	801	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	801	NA	801	0	801	0	801	
80	TCGA-L5-A4OG	0	30	1	12	3	1	1	0	8	132	10	0	2	43	4	1	TCGA-L5-A4OG-01	159	0.576327004862374	93	TCGA-L5-A4OG-01	22	33	109	0.32649729098925745	TCGA-L5-A4OG-01	10	6	3	19	PASS	2516	TCGA-L5-A4OG	ESCA	79	FEMALE	WHITE	Stage I	NA	"Esophagus Adenocarcinoma, NOS"	G1	2012	NA	-29105	Alive	NA	143	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	143	0	143	NA	NA	0	143	
70	TCGA-L5-A4OH	3	33	1	4	4	1	0	0	8	137	9	0	4	40	7	0	TCGA-L5-A4OH-01	278	0.6774370569879992	175	TCGA-L5-A4OH-01	19	29	163	0.3790164520289769	TCGA-L5-A4OH-01	16	12	8	36	PASS	2517	TCGA-L5-A4OH	ESCA	71	MALE	WHITE	Stage I	NA	"Esophagus Adenocarcinoma, NOS"	GX	2012	NA	-26180	Alive	TUMOR FREE	992	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	992	0	992	0	992	0	992	
80	TCGA-L5-A4OI	47	725	22	95	349	70	26	0	135	1175	50	0	54	527	29	3	TCGA-L5-A4OI-01	158	0.20753299498888486	96	TCGA-L5-A4OI-01	6	7	34	0.014935176561490147	TCGA-L5-A4OI-01	4	3	1	8	hypermutated sample	2518	TCGA-L5-A4OI	ESCA	79	MALE	WHITE	Stage IIIC	NA	"Esophagus Adenocarcinoma, NOS"	G2	2012	NA	-29190	Alive	WITH TUMOR	608	NA	NA	Locoregional Recurrence	"Other, specify"	Lymph Node	267	Stable Disease	NA	NA	0	608	0	608	NA	NA	1	267	
70	TCGA-L5-A4OJ	3	45	3	10	4	6	0	1	14	199	15	2	10	76	2	0	TCGA-L5-A4OJ-01	230	0.8284652939869807	128	TCGA-L5-A4OJ-01	3	7	85	0.21029142335802986	TCGA-L5-A4OJ-01	6	7	14	27	PASS	2519	TCGA-L5-A4OJ	ESCA	70	FEMALE	WHITE	Stage I	NA	"Esophagus Adenocarcinoma, NOS"	G3	2012	NA	-25657	Alive	TUMOR FREE	639	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	639	0	639	0	639	0	639	
50	TCGA-L5-A4OM	1	20	0	1	0	0	1	0	7	56	1	0	1	17	1	0	TCGA-L5-A4OM-01	192	0.7020989644384745	107	TCGA-L5-A4OM-01	9	7	62	0.21057502557276864	TCGA-L5-A4OM-01	9	6	7	22	PASS	2520	TCGA-L5-A4OM	ESCA	54	FEMALE	WHITE	Stage IA	NA	Esophagus Squamous Cell Carcinoma	GX	2010	NA	-19845	Dead	TUMOR FREE	NA	1458	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1458	0	1458	0	1458	0	1458	
70	TCGA-L5-A4ON	3	36	3	9	1	2	0	1	8	123	5	0	5	51	1	0	TCGA-L5-A4ON-01	338	0.9497418092834276	199	TCGA-L5-A4ON	0	0	0	0	TCGA-L5-A4ON	0	0	0	0	PASS	2521	TCGA-L5-A4ON	ESCA	65	MALE	WHITE	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	GX	2010	NA	-23970	Dead	TUMOR FREE	NA	558	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	558	0	558	0	558	0	558	
80	TCGA-L5-A4OO	2	27	1	4	4	2	0	0	8	79	6	0	5	28	1	0	TCGA-L5-A4OO-01	201	0.6025621390309982	113	TCGA-L5-A4OO-01	9	12	154	0.3031812169115106	TCGA-L5-A4OO-01	16	12	19	47	PASS	2522	TCGA-L5-A4OO	ESCA	75	MALE	WHITE	Stage IIIC	NA	"Esophagus Adenocarcinoma, NOS"	G2	2010	NA	-27757	Alive	NA	101	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	101	0	101	NA	NA	0	101	
70	TCGA-L5-A4OP	2	25	0	3	1	0	2	0	6	90	5	0	2	25	1	0	TCGA-L5-A4OP-01	133	0.9302380359152908	60	TCGA-L5-A4OP-01	12	16	95	0.3440724066505785	TCGA-L5-A4OP-01	10	9	9	28	PASS	2523	TCGA-L5-A4OP	ESCA	67	FEMALE	WHITE	Stage IA	NA	"Esophagus Adenocarcinoma, NOS"	G2	2010	NA	-24829	Alive	TUMOR FREE	218	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	218	0	218	NA	NA	0	218	
80	TCGA-L5-A4OQ	2	17	2	3	3	1	1	0	3	45	3	0	1	18	1	0	TCGA-L5-A4OQ-01	1080	0.6287027327280234	731	TCGA-L5-A4OQ	0	0	0	0	TCGA-L5-A4OQ	0	0	0	0	PASS	2524	TCGA-L5-A4OQ	ESCA	75	MALE	WHITE	Stage IIIA	NA	"Esophagus Adenocarcinoma, NOS"	GX	2010	NA	-27565	Dead	WITH TUMOR	NA	42	NA	Distant Metastasis	Brain	NA	29	NA	NA	NA	1	42	1	42	NA	NA	1	29	
80	TCGA-L5-A4OR	3	22	2	5	5	3	0	1	5	127	8	0	4	57	6	0	TCGA-L5-A4OR-01	274	0.7330162783127602	166	TCGA-L5-A4OR-01	22	61	115	0.2067357942815631	TCGA-L5-A4OR-01	21	10	8	39	PASS	2525	TCGA-L5-A4OR	ESCA	83	MALE	WHITE	Stage IA	NA	"Esophagus Adenocarcinoma, NOS"	GX	2010	NA	-30417	Dead	TUMOR FREE	NA	96	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	96	0	96	0	96	0	96	
90	TCGA-L5-A4OS	2	25	0	5	0	1	0	0	10	70	3	0	1	33	1	0	TCGA-L5-A4OS-01	335	0.25061658579809404	222	TCGA-L5-A4OS-01	8	17	140	0.2316518289556229	TCGA-L5-A4OS-01	18	15	12	45	PASS	2526	TCGA-L5-A4OS	ESCA	86	FEMALE	WHITE	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	G3	2010	NA	-31601	Alive	TUMOR FREE	1782	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1782	0	1782	NA	NA	0	1782	
80	TCGA-L5-A4OT	8	52	3	8	2	1	0	0	15	198	10	0	13	55	3	0	TCGA-L5-A4OT-01	258	0.5303357319128247	155	TCGA-L5-A4OT-01	22	23	164	0.2947695301728889	TCGA-L5-A4OT-01	12	6	7	25	PASS	2527	TCGA-L5-A4OT	ESCA	77	MALE	WHITE	Stage IV	NA	"Esophagus Adenocarcinoma, NOS"	GX	2006	NA	-28162	Dead	WITH TUMOR	NA	149	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	149	1	149	NA	NA	1	149	
80	TCGA-L5-A4OU	3	52	2	6	2	2	1	1	13	137	6	0	7	63	1	0	TCGA-L5-A4OU-01	158	0.3621807016725466	80	TCGA-L5-A4OU-01	16	32	89	0.23586278882470424	TCGA-L5-A4OU-01	11	6	4	21	PASS	2528	TCGA-L5-A4OU	ESCA	81	MALE	WHITE	Stage IIA	NA	"Esophagus Adenocarcinoma, NOS"	GX	2009	NA	-29674	Alive	TUMOR FREE	882	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	882	0	882	NA	NA	0	882	
60	TCGA-L5-A4OW	4	51	0	5	3	1	1	0	8	216	7	0	8	70	3	1	TCGA-L5-A4OW-01	280	0.6066171402670277	157	TCGA-L5-A4OW-01	16	30	137	0.3450147493254688	TCGA-L5-A4OW-01	14	12	9	35	PASS	2529	TCGA-L5-A4OW	ESCA	56	FEMALE	[Not Evaluated]	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	GX	2006	NA	-20796	Dead	TUMOR FREE	NA	217	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	217	0	217	0	217	0	217	
60	TCGA-L5-A4OX	3	42	0	11	3	3	2	0	7	107	5	0	6	43	1	0	TCGA-L5-A4OX-01	173	0.4227080560291276	93	TCGA-L5-A4OX-01	7	6	86	0.19123663343944028	TCGA-L5-A4OX-01	4	4	9	17	PASS	2530	TCGA-L5-A4OX	ESCA	60	MALE	WHITE	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	GX	2006	NA	-22015	Dead	TUMOR FREE	NA	226	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	226	0	226	0	226	0	226	
80	TCGA-L5-A88S	1	20	1	3	2	1	0	0	2	70	2	0	4	22	1	0	TCGA-L5-A88S-01	182	0.4917905127196732	90	TCGA-L5-A88S-01	11	16	115	0.4150719196779649	TCGA-L5-A88S-01	9	8	12	29	PASS	2531	TCGA-L5-A88S	ESCA	84	MALE	WHITE	Stage IB	NA	Esophagus Squamous Cell Carcinoma	GX	2013	NA	-30954	Alive	TUMOR FREE	471	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	471	0	471	0	471	0	471	
90	TCGA-L5-A88T	1	16	2	1	0	1	0	0	1	51	4	0	3	16	1	0	TCGA-L5-A88T	0	0	0	TCGA-L5-A88T	0	0	0	0	TCGA-L5-A88T	0	0	0	0	PASS	2532	TCGA-L5-A88T	ESCA	86	MALE	WHITE	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	GX	2012	NA	-31480	Alive	TUMOR FREE	694	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	694	0	694	0	694	0	694	
60	TCGA-L5-A88V	4	51	5	8	3	2	2	0	12	125	15	0	5	46	2	0	TCGA-L5-A88V-01	444	0.7185296325574927	300	TCGA-L5-A88V-01	24	30	179	0.2901645558856989	TCGA-L5-A88V-01	14	11	14	39	PASS	2533	TCGA-L5-A88V	ESCA	60	MALE	WHITE	Stage III	NA	"Esophagus Adenocarcinoma, NOS"	GX	2007	NA	-22066	Alive	TUMOR FREE	79	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	79	0	79	NA	NA	0	79	
70	TCGA-L5-A88W	4	44	1	8	5	5	1	0	9	114	6	0	5	36	3	0	TCGA-L5-A88W-01	72	0.0007376263311108506	27	TCGA-L5-A88W-01	0	0	15	0.003228855587372649	TCGA-L5-A88W-01	0	0	0	0	PASS	2534	TCGA-L5-A88W	ESCA	67	MALE	WHITE	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	GX	2007	NA	-24716	Dead	WITH TUMOR	NA	764	NA	Distant Metastasis	Liver	NA	315	NA	NA	NA	1	764	1	764	NA	NA	1	315	
80	TCGA-L5-A88Y	2	48	4	7	4	1	2	0	17	185	8	1	10	52	1	0	TCGA-L5-A88Y-01	213	0.6177024603876915	122	TCGA-L5-A88Y	0	0	0	0	TCGA-L5-A88Y	0	0	0	0	PASS	2535	TCGA-L5-A88Y	ESCA	76	MALE	WHITE	[Unknown]	NA	"Esophagus Adenocarcinoma, NOS"	GX	2006	NA	-28061	Alive	NA	11	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	11	0	11	NA	NA	0	11	
70	TCGA-L5-A88Z	0	24	0	3	2	3	0	0	4	52	7	0	1	26	3	0	TCGA-L5-A88Z-01	87	0.340082173356449	33	TCGA-L5-A88Z-01	6	4	32	0.11871209355994447	TCGA-L5-A88Z-01	5	2	4	11	PASS	2536	TCGA-L5-A88Z	ESCA	70	FEMALE	WHITE	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	GX	2005	NA	-25890	Alive	TUMOR FREE	225	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	225	0	225	NA	NA	0	225	
50	TCGA-L5-A891	1	36	2	8	6	0	1	0	6	133	11	0	7	42	0	0	TCGA-L5-A891-01	996	0.8532763082647341	775	TCGA-L5-A891-01	14	14	426	0.3679193852253087	TCGA-L5-A891-01	8	8	3	19	PASS	2537	TCGA-L5-A891	ESCA	51	MALE	WHITE	[Unknown]	NA	"Esophagus Adenocarcinoma, NOS"	GX	2005	NA	-18925	Alive	TUMOR FREE	114	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	114	0	114	NA	NA	0	114	
70	TCGA-L5-A893	4	26	2	2	1	2	0	1	8	104	6	0	4	44	2	1	TCGA-L5-A893-01	110	0.4692781960523513	54	TCGA-L5-A893-01	18	27	51	0.10189170064642064	TCGA-L5-A893-01	6	3	3	12	pathology review	2538	TCGA-L5-A893	ESCA	71	FEMALE	WHITE	Stage I	NA	"Esophagus Adenocarcinoma, NOS"	GX	2005	NA	-26143	Alive	TUMOR FREE	92	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	92	0	92	NA	NA	0	92	
80	TCGA-L5-A8NE	5	60	4	9	2	1	1	0	11	199	9	0	10	56	5	0	TCGA-L5-A8NE-01	804	0.7781404617656031	562	TCGA-L5-A8NE-01	14	22	222	0.19043158797827395	TCGA-L5-A8NE-01	19	19	9	47	PASS	2539	TCGA-L5-A8NE	ESCA	77	MALE	WHITE	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	GX	2000	NA	-28243	Alive	TUMOR FREE	1688	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1688	0	1688	NA	NA	0	1688	
60	TCGA-L5-A8NF	2	39	1	8	3	2	0	0	8	91	12	0	4	41	1	0	TCGA-L5-A8NF-01	313	0.7462480827310894	182	TCGA-L5-A8NF-01	23	72	139	0.21533483419847915	TCGA-L5-A8NF-01	13	12	6	31	PASS	2540	TCGA-L5-A8NF	ESCA	57	MALE	WHITE	Stage IVA	NA	"Esophagus Adenocarcinoma, NOS"	GX	2001	NA	-21134	Dead	TUMOR FREE	NA	81	NA	NA	NA	NA	NA	NA	NA	NA	1	81	0	81	NA	NA	0	81	
80	TCGA-L5-A8NG	4	41	1	10	2	0	1	0	9	113	3	0	5	47	1	2	TCGA-L5-A8NG-01	188	0.4122001301404694	104	TCGA-L5-A8NG-01	9	9	124	0.2907420170445528	TCGA-L5-A8NG-01	7	6	8	21	PASS	2541	TCGA-L5-A8NG	ESCA	77	MALE	WHITE	Stage III	NA	"Esophagus Adenocarcinoma, NOS"	GX	2001	NA	-28219	Alive	TUMOR FREE	1094	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1094	0	1094	NA	NA	0	1094	
50	TCGA-L5-A8NH	2	28	0	5	1	3	1	0	9	111	6	0	4	30	1	0	TCGA-L5-A8NH-01	184	0.6114493010650744	102	TCGA-L5-A8NH-01	8	16	112	0.3342365344113906	TCGA-L5-A8NH-01	9	8	6	23	PASS	2542	TCGA-L5-A8NH	ESCA	54	MALE	WHITE	Stage IV	NA	"Esophagus Adenocarcinoma, NOS"	GX	2001	NA	-19991	Dead	TUMOR FREE	NA	393	NA	NA	NA	NA	NA	NA	NA	NA	1	393	0	393	NA	NA	0	393	
80	TCGA-L5-A8NI	3	45	5	13	9	0	4	0	15	162	7	0	9	55	6	0	TCGA-L5-A8NI-01	935	0.9527858604499776	656	TCGA-L5-A8NI-01	4	11	343	0.3249869969152938	TCGA-L5-A8NI-01	18	21	20	59	PASS	2543	TCGA-L5-A8NI	ESCA	79	MALE	WHITE	Stage III	NA	"Esophagus Adenocarcinoma, NOS"	G3	2004	NA	-29135	Dead	WITH TUMOR	NA	410	NA	Locoregional Recurrence	NA	NA	401	NA	NA	NA	1	410	1	410	NA	NA	1	401	
80	TCGA-L5-A8NJ	2	58	0	7	4	1	0	1	13	189	6	1	13	58	5	0	TCGA-L5-A8NJ-01	225	0.8723766033752738	122	TCGA-L5-A8NJ-01	20	33	93	0.15799857187934838	TCGA-L5-A8NJ-01	12	8	4	24	PASS	2544	TCGA-L5-A8NJ	ESCA	77	MALE	WHITE	Stage III	NA	"Esophagus Adenocarcinoma, NOS"	GX	2000	NA	-28200	Alive	WITH TUMOR	501	NA	NA	Distant Metastasis	Lung	NA	396	[Unknown]	NA	NA	0	501	0	501	NA	NA	1	396	
80	TCGA-L5-A8NK	4	45	4	11	5	0	1	0	11	153	12	0	6	58	1	0	TCGA-L5-A8NK-01	123	0.3289779106030675	53	TCGA-L5-A8NK-01	14	21	104	0.3628933808706575	TCGA-L5-A8NK-01	13	11	14	38	PASS	2545	TCGA-L5-A8NK	ESCA	84	FEMALE	WHITE	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G1	2004	NA	-30719	Alive	WITH TUMOR	412	NA	NA	Locoregional Recurrence	NA	NA	325	[Unknown]	NA	NA	0	412	0	412	NA	NA	1	325	
60	TCGA-L5-A8NL	1	29	2	6	1	2	0	0	3	81	6	0	2	27	3	0	TCGA-L5-A8NL-01	177	0.3917832249243197	103	TCGA-L5-A8NL-01	11	10	119	0.2850177932990677	TCGA-L5-A8NL-01	15	10	13	38	PASS	2546	TCGA-L5-A8NL	ESCA	56	MALE	WHITE	Stage III	NA	"Esophagus Adenocarcinoma, NOS"	GX	2004	NA	-20542	Alive	TUMOR FREE	402	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	402	0	402	NA	NA	0	402	
80	TCGA-L5-A8NM	37	469	23	84	227	76	19	3	94	1028	49	0	43	478	16	0	TCGA-L5-A8NM-01	61	0.05045166739505688	19	TCGA-L5-A8NM-01	2	5	19	0.013823584919667169	TCGA-L5-A8NM-01	1	1	1	3	hypermutated sample	2547	TCGA-L5-A8NM	ESCA	84	FEMALE	WHITE	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	GX	2004	NA	-30936	Dead	TUMOR FREE	NA	236	NA	NA	NA	NA	NA	NA	NA	NA	1	236	0	236	NA	NA	0	236	
80	TCGA-L5-A8NN	3	27	3	8	2	1	0	0	6	90	6	1	3	33	1	0	TCGA-L5-A8NN-01	180	0.8236560945480317	101	TCGA-L5-A8NN-01	22	35	139	0.4208531697201609	TCGA-L5-A8NN-01	16	14	12	42	PASS	2548	TCGA-L5-A8NN	ESCA	81	MALE	WHITE	Stage III	NA	"Esophagus Adenocarcinoma, NOS"	GX	2004	NA	-29891	Alive	NA	167	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	167	0	167	NA	NA	0	167	
70	TCGA-L5-A8NQ	6	52	4	20	0	1	0	0	8	185	13	0	3	64	7	2	TCGA-L5-A8NQ-01	96	0.19250270984468415	41	TCGA-L5-A8NQ-01	25	36	127	0.5216404001426181	TCGA-L5-A8NQ-01	14	14	19	47	PASS	2549	TCGA-L5-A8NQ	ESCA	71	MALE	WHITE	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G3	2001	NA	-26250	Dead	WITH TUMOR	NA	650	NA	Locoregional Recurrence	NA	NA	337	NA	NA	NA	1	650	1	650	NA	NA	1	337	
80	TCGA-L5-A8NR	4	66	2	11	8	1	2	0	7	159	14	0	7	86	3	0	TCGA-L5-A8NR-01	362	0.5004708921687112	219	TCGA-L5-A8NR-01	17	33	147	0.1833700295054828	TCGA-L5-A8NR-01	14	9	11	34	PASS	2550	TCGA-L5-A8NR	ESCA	81	FEMALE	[Not Evaluated]	Stage III	NA	"Esophagus Adenocarcinoma, NOS"	GX	2001	NA	-29730	Alive	WITH TUMOR	265	NA	NA	Distant Metastasis	Liver	NA	265	[Unknown]	NA	NA	0	265	0	265	NA	NA	1	265	
80	TCGA-L5-A8NS	14	109	4	24	10	0	3	0	19	314	21	0	17	89	11	0	TCGA-L5-A8NS-01	205	0.7569419475900308	111	TCGA-L5-A8NS-01	9	13	172	0.3739296818571842	TCGA-L5-A8NS-01	15	22	18	55	PASS	2551	TCGA-L5-A8NS	ESCA	76	MALE	WHITE	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	GX	2001	NA	-27800	Alive	WITH TUMOR	408	NA	NA	Distant Metastasis	Lung	NA	300	[Unknown]	NA	NA	0	408	0	408	NA	NA	1	300	
70	TCGA-L5-A8NT	2	15	1	4	3	5	0	1	7	75	4	1	5	28	1	0	TCGA-L5-A8NT-01	124	0.6911656448349422	52	TCGA-L5-A8NT-01	27	21	79	0.2526577429544805	TCGA-L5-A8NT-01	10	4	11	25	PASS	2552	TCGA-L5-A8NT	ESCA	69	MALE	WHITE	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	GX	2001	NA	-25259	Alive	WITH TUMOR	825	NA	NA	Distant Metastasis	Liver	NA	825	[Unknown]	NA	NA	0	825	0	825	NA	NA	1	825	
80	TCGA-L5-A8NU	1	11	1	1	0	0	1	0	5	43	3	0	4	22	1	0	TCGA-L5-A8NU-01	130	0.2370999732979527	68	TCGA-L5-A8NU-01	7	9	83	0.2551379939583444	TCGA-L5-A8NU-01	8	6	12	26	PASS	2553	TCGA-L5-A8NU	ESCA	84	MALE	WHITE	Stage IIA	NA	"Esophagus Adenocarcinoma, NOS"	G3	2001	NA	-30738	Dead	TUMOR FREE	NA	2532	NA	NA	NA	NA	NA	NA	NA	NA	1	2532	0	2532	NA	NA	0	2532	
80	TCGA-L5-A8NV	1	23	0	10	3	0	2	0	7	93	7	0	4	43	2	0	TCGA-L5-A8NV-01	189	0.529919159751919	103	TCGA-L5-A8NV-01	18	29	96	0.20091053973215234	TCGA-L5-A8NV-01	12	12	10	34	PASS	2554	TCGA-L5-A8NV	ESCA	75	MALE	WHITE	Stage IIA	NA	"Esophagus Adenocarcinoma, NOS"	G3	2001	NA	-27546	Dead	WITH TUMOR	NA	1599	NA	Locoregional Recurrence	NA	NA	1252	NA	NA	NA	1	1599	1	1599	NA	NA	1	1252	
60	TCGA-L5-A8NW	2	38	2	7	5	4	0	0	4	123	5	0	4	54	1	0	TCGA-L5-A8NW-01	380	0.4549729657110863	241	TCGA-L5-A8NW-01	9	42	287	0.570977686281875	TCGA-L5-A8NW-01	17	22	16	55	PASS	2555	TCGA-L5-A8NW	ESCA	55	MALE	WHITE	[Discrepancy]	NA	"Esophagus Adenocarcinoma, NOS"	GX	2001	NA	-20194	Dead	WITH TUMOR	NA	1402	NA	Locoregional Recurrence	NA	NA	1147	NA	NA	NA	1	1402	1	1402	NA	NA	1	1147	
70	TCGA-L7-A56G	0	21	0	5	3	1	0	0	7	59	4	0	7	21	3	0	TCGA-L7-A56G-01	184	0.6604890811209456	102	TCGA-L7-A56G-01	27	24	148	0.2920798317828352	TCGA-L7-A56G-01	16	6	12	34	PASS	2556	TCGA-L7-A56G	ESCA	65	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Esophagus Squamous Cell Carcinoma	G3	2012	NA	-24106	Dead	WITH TUMOR	NA	330	NA	Distant Metastasis	Lung	NA	270	Stable Disease	NA	NA	1	330	1	330	NA	NA	1	270	
60	TCGA-L7-A6VZ	3	33	2	5	0	2	2	0	3	105	6	0	6	46	1	0	TCGA-L7-A6VZ-01	231	0.7324095524043276	137	TCGA-L7-A6VZ	0	0	0	0	TCGA-L7-A6VZ	0	0	0	0	PASS	2557	TCGA-L7-A6VZ	ESCA	62	MALE	WHITE	Stage IIIC	NA	"Esophagus Adenocarcinoma, NOS"	G2	2013	NA	-22730	Alive	TUMOR FREE	315	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	315	0	315	0	315	0	315	
70	TCGA-LN-A49K	0	27	1	7	3	0	0	0	5	67	4	1	5	19	1	0	TCGA-LN-A49K-01	184	0.8375767917838904	109	TCGA-LN-A49K-01	13	14	147	0.4799089555469365	TCGA-LN-A49K-01	14	12	13	39	PASS	2558	TCGA-LN-A49K	ESCA	66	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G2	2010	NA	-24379	Dead	TUMOR FREE	NA	180	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	180	0	180	0	180	0	180	
40	TCGA-LN-A49L	4	38	2	7	5	1	1	1	11	125	13	0	4	33	5	0	TCGA-LN-A49L-01	457	0.9584182487697044	308	TCGA-LN-A49L-01	17	36	247	0.4434179015879704	TCGA-LN-A49L-01	24	24	19	67	PASS	2559	TCGA-LN-A49L	ESCA	44	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G2	2010	NA	-16164	Dead	TUMOR FREE	NA	318	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	318	0	318	0	318	0	318	
60	TCGA-LN-A49M	6	47	3	21	3	2	0	0	15	166	20	0	8	73	2	3	TCGA-LN-A49M-01	283	0.9618968109473762	162	TCGA-LN-A49M	0	0	0	0	TCGA-LN-A49M	0	0	0	0	PASS	2560	TCGA-LN-A49M	ESCA	62	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G1	2010	NA	-22933	Alive	TUMOR FREE	385	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	385	0	385	0	385	0	385	
50	TCGA-LN-A49N	1	8	1	3	3	3	1	0	2	38	3	0	1	16	0	0	TCGA-LN-A49N-01	119	0.3850763753013461	57	TCGA-LN-A49N-01	13	16	97	0.3324512627376796	TCGA-LN-A49N-01	13	4	14	31	PASS	2561	TCGA-LN-A49N	ESCA	50	MALE	ASIAN	Stage IIB	Stage IIB	Esophagus Squamous Cell Carcinoma	G2	2010	NA	-18503	Alive	TUMOR FREE	378	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	378	0	378	0	378	0	378	
50	TCGA-LN-A49O	4	19	0	2	1	4	0	0	8	50	3	0	3	19	1	0	TCGA-LN-A49O-01	270	0.5517951856844557	182	TCGA-LN-A49O-01	20	39	185	0.4547183235804325	TCGA-LN-A49O-01	17	14	8	39	PASS	2562	TCGA-LN-A49O	ESCA	47	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G3	2011	NA	-17237	Alive	WITH TUMOR	408	NA	NA	Locoregional Recurrence	NA	NA	193	Complete Remission/Response	NA	NA	0	408	0	408	1	193	1	193	
70	TCGA-LN-A49P	3	29	1	5	4	0	0	0	7	55	6	0	0	18	2	0	TCGA-LN-A49P-01	172	0.37620353372265575	87	TCGA-LN-A49P-01	9	37	165	0.5371860602867055	TCGA-LN-A49P-01	16	9	14	39	PASS	2563	TCGA-LN-A49P	ESCA	71	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G2	2011	NA	-26189	Alive	WITH TUMOR	375	NA	NA	Locoregional Recurrence	NA	NA	320	Complete Remission/Response	NA	NA	0	375	0	375	1	320	1	320	
50	TCGA-LN-A49R	1	35	0	5	2	6	1	0	8	92	5	0	2	23	3	0	TCGA-LN-A49R-01	278	0.7435086741381727	162	TCGA-LN-A49R-01	23	24	143	0.358775033651848	TCGA-LN-A49R-01	20	9	9	38	PASS	2564	TCGA-LN-A49R	ESCA	46	MALE	ASIAN	Stage III	Stage III	Esophagus Squamous Cell Carcinoma	G3	2011	NA	-17109	Alive	TUMOR FREE	407	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	407	0	407	0	407	0	407	
60	TCGA-LN-A49S	1	34	2	13	2	1	0	0	6	117	6	0	6	52	2	1	TCGA-LN-A49S-01	250	0.7506773347277931	143	TCGA-LN-A49S-01	18	43	169	0.3802482353419997	TCGA-LN-A49S-01	24	18	12	54	PASS	2565	TCGA-LN-A49S	ESCA	59	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G2	2011	NA	-21865	Alive	WITH TUMOR	400	NA	NA	Locoregional Recurrence	NA	NA	49	Complete Remission/Response	NA	NA	0	400	0	400	1	49	1	49	
60	TCGA-LN-A49U	4	49	1	10	2	1	0	0	10	104	7	0	9	44	3	0	TCGA-LN-A49U-01	245	0.4148780870216552	134	TCGA-LN-A49U-01	10	20	148	0.3166302797740342	TCGA-LN-A49U-01	12	9	5	26	PASS	2566	TCGA-LN-A49U	ESCA	62	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G1	2011	NA	-22969	Alive	TUMOR FREE	467	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	467	0	467	0	467	0	467	
50	TCGA-LN-A49V	2	18	0	10	3	1	2	0	8	80	8	0	2	45	4	0	TCGA-LN-A49V-01	272	0.8356790336501815	157	TCGA-LN-A49V-01	18	37	204	0.5957039224031146	TCGA-LN-A49V-01	22	15	10	47	PASS	2567	TCGA-LN-A49V	ESCA	49	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G3	2011	NA	-17922	Alive	TUMOR FREE	383	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	383	0	383	0	383	0	383	
70	TCGA-LN-A49W	4	17	0	3	0	4	0	0	5	63	2	0	3	27	5	0	TCGA-LN-A49W-01	405	0.6340822053814339	254	TCGA-LN-A49W	0	0	0	0	TCGA-LN-A49W	0	0	0	0	PASS	2568	TCGA-LN-A49W	ESCA	73	MALE	ASIAN	Stage III	Stage III	Esophagus Squamous Cell Carcinoma	G3	2011	NA	-26910	Alive	TUMOR FREE	403	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	403	0	403	0	403	0	403	
40	TCGA-LN-A49X	2	22	0	3	1	2	0	0	4	47	6	0	1	22	3	0	TCGA-LN-A49X-01	211	0.3873316763844932	125	TCGA-LN-A49X-01	10	18	99	0.21928899899031834	TCGA-LN-A49X-01	11	13	8	32	PASS	2569	TCGA-LN-A49X	ESCA	44	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G2	2011	NA	-16154	Alive	TUMOR FREE	384	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	384	0	384	0	384	0	384	
80	TCGA-LN-A49Y	3	44	2	14	0	1	2	0	14	190	18	1	8	82	3	0	TCGA-LN-A49Y-01	298	0.8851486318845123	188	TCGA-LN-A49Y-01	10	13	154	0.3399711550418407	TCGA-LN-A49Y-01	16	16	14	46	PASS	2570	TCGA-LN-A49Y	ESCA	77	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G2	2011	NA	-28125	Alive	WITH TUMOR	379	NA	NA	Locoregional Recurrence	NA	NA	90	Complete Remission/Response	NA	NA	0	379	0	379	1	90	1	90	
60	TCGA-LN-A4A1	0	28	0	4	3	2	1	0	9	98	5	0	3	32	0	0	TCGA-LN-A4A1-01	445	0.8167638050643526	309	TCGA-LN-A4A1	0	0	0	0	TCGA-LN-A4A1	0	0	0	0	PASS	2571	TCGA-LN-A4A1	ESCA	60	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G3	2011	NA	-21954	Alive	WITH TUMOR	383	NA	NA	Locoregional Recurrence	NA	NA	205	Complete Remission/Response	NA	NA	0	383	0	383	1	205	1	205	
60	TCGA-LN-A4A2	3	32	0	5	2	1	2	0	9	108	9	0	5	39	2	0	TCGA-LN-A4A2-01	233	0.6941468819512927	141	TCGA-LN-A4A2-01	19	30	67	0.1524859801360808	TCGA-LN-A4A2-01	17	7	5	29	PASS	2572	TCGA-LN-A4A2	ESCA	57	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G1	2011	NA	-21122	Alive	TUMOR FREE	380	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	380	0	380	0	380	0	380	
60	TCGA-LN-A4A3	2	12	0	2	0	2	0	0	8	53	3	0	3	16	1	0	TCGA-LN-A4A3-01	143	0.648806694424057	67	TCGA-LN-A4A3-01	20	16	151	0.5101360940607407	TCGA-LN-A4A3-01	12	6	9	27	PASS	2573	TCGA-LN-A4A3	ESCA	61	MALE	ASIAN	Stage III	Stage III	Esophagus Squamous Cell Carcinoma	G2	2011	NA	-22313	Alive	TUMOR FREE	388	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	388	0	388	0	388	0	388	
40	TCGA-LN-A4A4	3	22	1	3	1	0	2	0	5	76	9	1	5	24	3	0	TCGA-LN-A4A4-01	239	0.9471211936698593	142	TCGA-LN-A4A4-01	26	38	202	0.5147504490055163	TCGA-LN-A4A4-01	15	9	11	35	PASS	2574	TCGA-LN-A4A4	ESCA	36	MALE	ASIAN	Stage III	Stage III	Esophagus Squamous Cell Carcinoma	GX	2011	NA	-13419	Alive	TUMOR FREE	383	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	383	0	383	0	383	0	383	
50	TCGA-LN-A4A5	3	14	2	3	0	3	0	0	3	54	1	0	2	19	1	0	TCGA-LN-A4A5-01	212	0.3789674812528132	124	TCGA-LN-A4A5-01	11	18	128	0.3919251930640646	TCGA-LN-A4A5-01	17	6	15	38	PASS	2575	TCGA-LN-A4A5	ESCA	49	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G2	2011	NA	-18160	Dead	WITH TUMOR	NA	681	NA	Locoregional Recurrence	NA	NA	224	Complete Remission/Response	NA	NA	1	681	1	681	1	224	1	224	
70	TCGA-LN-A4A6	2	22	0	2	2	6	1	0	5	80	6	0	2	27	1	0	TCGA-LN-A4A6-01	258	0.6502532624856083	149	TCGA-LN-A4A6	0	0	0	0	TCGA-LN-A4A6	0	0	0	0	PASS	2576	TCGA-LN-A4A6	ESCA	65	MALE	ASIAN	Stage II	Stage II	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-24011	Alive	TUMOR FREE	391	NA	NA	Locoregional Recurrence	NA	NA	158	Complete Remission/Response	NA	NA	0	391	0	391	1	158	1	158	
50	TCGA-LN-A4A8	2	33	0	12	1	3	2	0	9	86	7	2	1	44	1	0	TCGA-LN-A4A8-01	187	0.3724562148059475	108	TCGA-LN-A4A8-01	9	9	85	0.21120351768973086	TCGA-LN-A4A8-01	9	4	7	20	PASS	2577	TCGA-LN-A4A8	ESCA	52	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-19046	Alive	TUMOR FREE	472	NA	NA	Locoregional Recurrence	NA	NA	250	Complete Remission/Response	NA	NA	0	472	0	472	1	250	1	250	
60	TCGA-LN-A4A9	5	67	2	11	1	2	1	0	13	165	11	1	7	63	1	0	TCGA-LN-A4A9-01	505	0.9028934900869716	346	TCGA-LN-A4A9-01	10	36	326	0.5761053592489949	TCGA-LN-A4A9-01	12	11	16	39	PASS	2578	TCGA-LN-A4A9	ESCA	58	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G1	2012	NA	-21217	Dead	WITH TUMOR	NA	351	NA	Locoregional Recurrence	NA	NA	274	Complete Remission/Response	NA	NA	1	351	1	351	1	274	1	274	
50	TCGA-LN-A4MQ	1	23	1	6	1	2	1	0	2	57	5	0	2	21	0	1	TCGA-LN-A4MQ-01	202	0.7224401844955801	107	TCGA-LN-A4MQ-01	13	21	160	0.4326023953460153	TCGA-LN-A4MQ-01	19	15	16	50	PASS	2579	TCGA-LN-A4MQ	ESCA	46	MALE	ASIAN	Stage III	Stage III	Esophagus Squamous Cell Carcinoma	G3	2010	NA	-16990	Alive	TUMOR FREE	375	NA	NA	Locoregional Recurrence	NA	NA	25	Complete Remission/Response	NA	NA	0	375	0	375	1	25	1	25	
60	TCGA-LN-A4MR	1	35	1	13	2	1	0	0	11	115	14	1	4	41	6	1	TCGA-LN-A4MR-01	190	0.6244917542298681	111	TCGA-LN-A4MR-01	21	32	156	0.5004913661444721	TCGA-LN-A4MR-01	19	10	13	42	PASS	2580	TCGA-LN-A4MR	ESCA	57	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-21142	Alive	TUMOR FREE	402	NA	NA	Locoregional Recurrence	NA	NA	226	Complete Remission/Response	NA	NA	0	402	0	402	1	226	1	226	
60	TCGA-LN-A5U5	2	11	0	4	3	0	1	1	3	39	3	0	2	21	0	0	TCGA-LN-A5U5-01	215	0.3816675739521451	121	TCGA-LN-A5U5	0	0	0	0	TCGA-LN-A5U5	0	0	0	0	PASS	2581	TCGA-LN-A5U5	ESCA	57	MALE	ASIAN	Stage IV	NA	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-20993	Dead	WITH TUMOR	NA	136	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	136	1	136	NA	NA	1	136	
50	TCGA-LN-A5U6	2	20	0	3	3	5	1	0	4	87	3	0	2	19	2	0	TCGA-LN-A5U6-01	528	0.9363981849076304	347	TCGA-LN-A5U6-01	17	42	273	0.39002171642885336	TCGA-LN-A5U6-01	21	20	16	57	PASS	2582	TCGA-LN-A5U6	ESCA	54	MALE	ASIAN	Stage IIB	NA	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-19840	Alive	TUMOR FREE	375	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	375	0	375	0	375	0	375	
50	TCGA-LN-A5U7	4	38	1	5	2	1	0	1	11	92	4	0	3	33	5	0	TCGA-LN-A5U7-01	527	0.6536321188471363	346	TCGA-LN-A5U7-01	17	36	264	0.31922004064621523	TCGA-LN-A5U7-01	21	17	12	50	PASS	2583	TCGA-LN-A5U7	ESCA	46	MALE	ASIAN	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G1	2012	NA	-16928	Alive	TUMOR FREE	768	NA	NA	Locoregional Recurrence	NA	NA	535	Complete Remission/Response	NA	NA	0	768	0	768	1	535	1	535	
60	TCGA-LN-A7HV	1	19	1	6	3	0	1	0	4	83	1	0	0	27	3	0	TCGA-LN-A7HV-01	281	0.8814074007290772	169	TCGA-LN-A7HV-01	7	13	164	0.3596091480456139	TCGA-LN-A7HV-01	13	9	11	33	PASS	2584	TCGA-LN-A7HV	ESCA	58	MALE	ASIAN	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G1	2012	NA	-21462	Alive	TUMOR FREE	320	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	320	0	320	0	320	0	320	
60	TCGA-LN-A7HW	0	32	2	2	0	0	1	0	7	75	2	1	2	28	2	0	TCGA-LN-A7HW-01	305	0.8757360541431273	190	TCGA-LN-A7HW-01	25	26	227	0.4928854054741957	TCGA-LN-A7HW-01	22	14	18	54	PASS	2585	TCGA-LN-A7HW	ESCA	59	MALE	ASIAN	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G2	2013	NA	-21840	Alive	TUMOR FREE	365	NA	NA	Locoregional Recurrence	NA	NA	97	Complete Remission/Response	NA	NA	0	365	0	365	1	97	1	97	
70	TCGA-LN-A7HX	2	35	4	4	3	0	1	0	18	89	6	0	5	37	0	0	TCGA-LN-A7HX-01	310	0.6266400522433391	192	TCGA-LN-A7HX-01	18	24	142	0.19809006208308752	TCGA-LN-A7HX-01	18	20	7	45	PASS	2586	TCGA-LN-A7HX	ESCA	72	MALE	ASIAN	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G2	2013	NA	-26517	Alive	TUMOR FREE	372	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	372	0	372	0	372	0	372	
50	TCGA-LN-A7HY	1	29	3	8	3	0	0	0	13	127	5	0	8	45	4	0	TCGA-LN-A7HY-01	591	0.6709239446344183	428	TCGA-LN-A7HY-01	16	31	323	0.4066840642075695	TCGA-LN-A7HY-01	28	22	23	73	PASS	2587	TCGA-LN-A7HY	ESCA	50	MALE	ASIAN	Stage III	NA	Esophagus Squamous Cell Carcinoma	G2	2013	NA	-18296	Alive	TUMOR FREE	366	NA	NA	Locoregional Recurrence	NA	NA	88	Complete Remission/Response	NA	NA	0	366	0	366	1	88	1	88	
50	TCGA-LN-A7HZ	1	30	0	2	3	0	1	0	7	45	2	0	1	25	0	0	TCGA-LN-A7HZ-01	223	0.6173184854725294	137	TCGA-LN-A7HZ-01	18	29	153	0.3355668756733867	TCGA-LN-A7HZ-01	15	8	9	32	PASS	2588	TCGA-LN-A7HZ	ESCA	49	MALE	ASIAN	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G2	2013	NA	-17931	Alive	TUMOR FREE	401	NA	NA	Locoregional Recurrence	NA	NA	117	Complete Remission/Response	NA	NA	0	401	0	401	1	117	1	117	
60	TCGA-LN-A8HZ	4	26	1	3	3	5	0	0	7	80	5	0	3	20	2	0	TCGA-LN-A8HZ-01	142	0.7849758357593615	74	TCGA-LN-A8HZ-01	12	12	86	0.347927077916509	TCGA-LN-A8HZ-01	14	10	12	36	PASS	2589	TCGA-LN-A8HZ	ESCA	56	MALE	ASIAN	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G3	2013	NA	-20510	Alive	TUMOR FREE	375	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	375	0	375	0	375	0	375	
50	TCGA-LN-A8I0	1	13	1	6	1	0	1	1	4	38	2	0	2	18	0	0	TCGA-LN-A8I0-01	193	0.5805572561191592	114	TCGA-LN-A8I0	0	0	0	0	TCGA-LN-A8I0	0	0	0	0	PASS	2590	TCGA-LN-A8I0	ESCA	52	MALE	ASIAN	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G2	2013	NA	-19328	Alive	TUMOR FREE	407	NA	NA	Locoregional Recurrence	NA	NA	57	Complete Remission/Response	NA	NA	0	407	0	407	1	57	1	57	
70	TCGA-LN-A8I1	1	29	1	5	2	3	4	0	5	72	3	0	5	20	3	0	TCGA-LN-A8I1-01	441	0.7492736909400273	292	TCGA-LN-A8I1-01	22	27	209	0.4002691156036973	TCGA-LN-A8I1-01	17	16	18	51	PASS	2591	TCGA-LN-A8I1	ESCA	67	FEMALE	ASIAN	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G3	2013	NA	-24551	Alive	TUMOR FREE	401	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	401	0	401	0	401	0	401	
40	TCGA-LN-A9FO	2	31	0	5	0	2	0	0	3	77	5	0	7	30	2	0	TCGA-LN-A9FO-01	251	0.6575345096095285	148	TCGA-LN-A9FO-01	20	24	169	0.32659119945663595	TCGA-LN-A9FO-01	13	10	11	34	PASS	2592	TCGA-LN-A9FO	ESCA	42	MALE	ASIAN	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G2	2013	NA	-15551	Alive	TUMOR FREE	4	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4	0	4	NA	NA	0	4	
60	TCGA-LN-A9FP	4	68	6	24	0	1	0	0	17	327	31	0	23	120	13	1	TCGA-LN-A9FP-01	102	0.05650593000415996	39	TCGA-LN-A9FP-01	0	11	50	0.12131918856003647	TCGA-LN-A9FP-01	11	15	3	29	PASS	2593	TCGA-LN-A9FP	ESCA	60	FEMALE	ASIAN	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G3	2013	NA	-22104	Alive	WITH TUMOR	366	NA	NA	Locoregional Recurrence	NA	NA	290	Complete Remission/Response	NA	NA	0	366	0	366	1	290	1	290	
60	TCGA-LN-A9FQ	0	22	0	5	0	0	0	0	5	78	4	0	0	34	2	0	TCGA-LN-A9FQ-01	236	0.8166078940331665	126	TCGA-LN-A9FQ-01	16	17	193	0.4804965496695612	TCGA-LN-A9FQ-01	14	10	18	42	PASS	2594	TCGA-LN-A9FQ	ESCA	62	MALE	ASIAN	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G3	2013	NA	-22717	Alive	TUMOR FREE	391	NA	NA	Locoregional Recurrence	NA	NA	82	Complete Remission/Response	NA	NA	0	391	0	391	1	82	1	82	
70	TCGA-LN-A9FR	1	17	4	3	0	1	0	0	6	58	2	0	4	14	2	0	TCGA-LN-A9FR-01	180	0.8259531579852767	98	TCGA-LN-A9FR-01	14	18	159	0.5274590972076943	TCGA-LN-A9FR-01	18	13	15	46	PASS	2595	TCGA-LN-A9FR	ESCA	70	MALE	ASIAN	Stage IIB	NA	Esophagus Squamous Cell Carcinoma	G2	2013	NA	-25657	Alive	TUMOR FREE	373	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	373	0	373	0	373	0	373	
60	TCGA-M9-A5M8	1	21	0	7	1	3	1	0	5	57	4	0	2	23	5	0	TCGA-M9-A5M8-01	198	0.8974837502676446	114	TCGA-M9-A5M8-01	10	14	131	0.321661624407154	TCGA-M9-A5M8-01	8	3	11	22	PASS	2596	TCGA-M9-A5M8	ESCA	58	MALE	[Not Evaluated]	Stage IIA	NA	"Esophagus Adenocarcinoma, NOS"	G2	NA	NA	-21433	Alive	TUMOR FREE	1007	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1007	0	1007	0	1007	0	1007	
60	TCGA-Q9-A6FU	0	31	1	6	1	1	0	0	10	123	10	0	12	44	6	0	TCGA-Q9-A6FU-01	200	0.7405426333215428	109	TCGA-Q9-A6FU-01	8	16	123	0.34217516565756456	TCGA-Q9-A6FU-01	13	9	13	35	PASS	2597	TCGA-Q9-A6FU	ESCA	57	FEMALE	WHITE	Stage IIIB	NA	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-21108	Dead	WITH TUMOR	NA	157	NA	Distant Metastasis	Liver	NA	99	NA	NA	NA	1	157	1	157	NA	NA	1	99	
60	TCGA-Q9-A6FW	4	37	3	5	3	2	3	1	6	169	10	0	8	54	3	0	TCGA-Q9-A6FW-01	148	0.38255788119901	90	TCGA-Q9-A6FW-01	5	11	89	0.1651951384750384	TCGA-Q9-A6FW-01	16	12	10	38	PASS	2598	TCGA-Q9-A6FW	ESCA	61	MALE	WHITE	Stage IIIB	NA	"Esophagus Adenocarcinoma, NOS"	G2	2013	NA	-22586	Alive	TUMOR FREE	238	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	238	0	238	0	238	0	238	
60	TCGA-R6-A6DN	4	17	3	5	1	2	0	1	1	75	6	1	2	29	2	0	TCGA-R6-A6DN-01	419	0.6584777708310684	269	TCGA-R6-A6DN-01	14	76	206	0.3222963530988357	TCGA-R6-A6DN-01	22	13	15	50	PASS	2599	TCGA-R6-A6DN	ESCA	58	MALE	WHITE	NA	Stage IV	"Esophagus Adenocarcinoma, NOS"	G3	2011	NA	-21259	Dead	WITH TUMOR	NA	243	NA	Distant Metastasis	"Other, specify"	Brain	199	Partial Remission/Response	NA	NA	1	243	1	243	NA	NA	1	199	
70	TCGA-R6-A6DQ	4	14	1	3	2	0	0	0	6	61	6	0	2	27	3	0	TCGA-R6-A6DQ-01	151	0.5924600980196144	81	TCGA-R6-A6DQ	0	0	0	0	TCGA-R6-A6DQ	0	0	0	0	PASS	2600	TCGA-R6-A6DQ	ESCA	74	FEMALE	WHITE	NA	Stage IIIA	"Esophagus Adenocarcinoma, NOS"	G3	2010	NA	-27098	Dead	WITH TUMOR	NA	231	NA	NA	NA	NA	NA	NA	NA	NA	1	231	1	231	NA	NA	1	231	
40	TCGA-R6-A6KZ	5	23	0	5	0	1	0	0	10	125	6	0	3	47	4	0	TCGA-R6-A6KZ-01	229	0.7855435910751078	133	TCGA-R6-A6KZ-01	22	33	167	0.3730114878559687	TCGA-R6-A6KZ-01	15	7	11	33	PASS	2601	TCGA-R6-A6KZ	ESCA	42	MALE	WHITE	NA	Stage IV	"Esophagus Adenocarcinoma, NOS"	G3	2010	NA	-15512	Dead	WITH TUMOR	NA	154	NA	NA	NA	NA	NA	NA	NA	NA	1	154	1	154	NA	NA	1	154	
30	TCGA-R6-A6L4	0	25	2	3	0	0	0	0	5	96	7	0	1	26	1	0	TCGA-R6-A6L4-01	194	0.9953749451213816	113	TCGA-R6-A6L4-01	11	20	222	0.6973406590372322	TCGA-R6-A6L4-01	7	8	12	27	PASS	2602	TCGA-R6-A6L4	ESCA	27	MALE	WHITE	NA	Stage IIIA	"Esophagus Adenocarcinoma, NOS"	G2	2012	NA	-10222	Dead	WITH TUMOR	NA	496	NA	Distant Metastasis	Liver	NA	160	Progressive Disease	NA	NA	1	496	1	496	NA	NA	1	160	
70	TCGA-R6-A6L6	2	31	2	4	2	4	0	0	6	90	7	0	3	34	5	0	TCGA-R6-A6L6-01	142	0.3356742796031256	79	TCGA-R6-A6L6-01	16	28	54	0.17705747263255575	TCGA-R6-A6L6-01	12	10	4	26	PASS	2603	TCGA-R6-A6L6	ESCA	68	MALE	WHITE	NA	Stage IV	"Esophagus Adenocarcinoma, NOS"	G3	2010	NA	-25092	Dead	WITH TUMOR	NA	214	NA	NA	NA	NA	NA	NA	NA	NA	1	214	1	214	NA	NA	1	214	
60	TCGA-R6-A6XG	4	48	3	8	3	1	2	1	13	150	8	0	9	64	3	0	TCGA-R6-A6XG-01	282	0.7621209619270286	163	TCGA-R6-A6XG-01	17	39	158	0.3136287818223168	TCGA-R6-A6XG-01	22	21	9	52	PASS	2604	TCGA-R6-A6XG	ESCA	64	MALE	WHITE	NA	Stage IIIA	"Esophagus Adenocarcinoma, NOS"	G2	2011	NA	-23484	Alive	WITH TUMOR	1168	NA	NA	Distant Metastasis	"Other, specify"	brain	572	Complete Remission/Response	NA	NA	0	1168	0	1168	1	572	1	572	
60	TCGA-R6-A6XQ	1	13	1	6	3	0	0	0	3	62	4	0	3	24	2	0	TCGA-R6-A6XQ-01	1157	0.7180554364529459	1014	TCGA-R6-A6XQ-01	25	47	471	0.3029405937363892	TCGA-R6-A6XQ-01	8	6	16	30	PASS	2605	TCGA-R6-A6XQ	ESCA	58	MALE	WHITE	NA	Stage IVB	"Esophagus Adenocarcinoma, NOS"	G3	2008	NA	-21410	Dead	WITH TUMOR	NA	193	NA	NA	NA	NA	NA	NA	NA	NA	1	193	1	193	NA	NA	1	193	
50	TCGA-R6-A6Y0	4	57	3	10	2	0	0	0	12	136	11	0	8	41	3	0	TCGA-R6-A6Y0-01	793	0.4807885188658483	528	TCGA-R6-A6Y0	0	0	0	0	TCGA-R6-A6Y0	0	0	0	0	pathology review	2606	TCGA-R6-A6Y0	ESCA	54	MALE	WHITE	NA	Stage IVA	"Esophagus Adenocarcinoma, NOS"	G2	2005	NA	-20045	Alive	WITH TUMOR	1641	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1641	0	1641	NA	NA	0	1641	
70	TCGA-R6-A6Y2	2	24	2	7	2	0	0	0	8	83	11	0	5	32	1	1	TCGA-R6-A6Y2-01	128	0.3457475844691201	63	TCGA-R6-A6Y2-01	11	27	123	0.41548483387008095	TCGA-R6-A6Y2-01	10	7	10	27	PASS	2607	TCGA-R6-A6Y2	ESCA	71	MALE	WHITE	NA	Stage IIB	"Esophagus Adenocarcinoma, NOS"	G3	2005	NA	-25940	Dead	WITH TUMOR	NA	283	NA	Distant Metastasis	Bone	NA	102	NA	NA	NA	1	283	1	283	NA	NA	1	102	
60	TCGA-R6-A8W5	2	26	2	5	2	2	0	1	7	76	8	0	3	34	3	0	TCGA-R6-A8W5-01	641	0.4578735565503789	419	TCGA-R6-A8W5-01	7	5	450	0.21996923762000548	TCGA-R6-A8W5-01	13	9	9	31	PASS	2608	TCGA-R6-A8W5	ESCA	60	MALE	WHITE	Stage IVA	NA	"Esophagus Adenocarcinoma, NOS"	G2	2004	NA	-21917	Dead	WITH TUMOR	NA	480	NA	Distant Metastasis	Liver	NA	336	NA	NA	NA	1	480	1	480	NA	NA	1	336	
70	TCGA-R6-A8W8	5	30	3	3	3	2	2	0	12	108	4	0	2	45	1	0	TCGA-R6-A8W8-01	349	0.9963423611049596	214	TCGA-R6-A8W8-01	12	36	215	0.3935247019324643	TCGA-R6-A8W8-01	23	24	10	57	PASS	2609	TCGA-R6-A8W8	ESCA	72	MALE	WHITE	NA	Stage IIIA	"Esophagus Adenocarcinoma, NOS"	G2	2012	NA	-26535	Dead	WITH TUMOR	NA	88	NA	NA	NA	NA	NA	NA	NA	NA	1	88	1	88	NA	NA	1	88	
60	TCGA-R6-A8WC	4	32	1	7	5	2	4	2	11	94	10	0	1	45	1	0	TCGA-R6-A8WC-01	197	0.9477752111929668	108	TCGA-R6-A8WC-01	18	32	93	0.2284794460975729	TCGA-R6-A8WC-01	9	8	4	21	PASS	2610	TCGA-R6-A8WC	ESCA	56	MALE	WHITE	NA	Stage IIA	"Esophagus Adenocarcinoma, NOS"	G2	2013	NA	-20812	Alive	WITH TUMOR	70	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	70	0	70	NA	NA	0	70	
60	TCGA-R6-A8WG	0	26	0	12	1	1	1	0	7	86	3	0	7	33	2	0	TCGA-R6-A8WG-01	166	0.885874473162022	91	TCGA-R6-A8WG-01	30	25	121	0.3413865239181132	TCGA-R6-A8WG-01	9	3	8	20	PASS	2611	TCGA-R6-A8WG	ESCA	60	MALE	WHITE	NA	Stage IIA	"Esophagus Adenocarcinoma, NOS"	G3	2013	NA	-22093	Dead	WITH TUMOR	NA	386	NA	Distant Metastasis	"Other, specify"	left supraclavicular nodal metastasis	107	NA	NA	NA	1	386	1	386	NA	NA	1	107	
70	TCGA-RE-A7BO	5	54	2	10	1	1	1	0	12	177	7	1	5	67	3	0	TCGA-RE-A7BO-01	173	0.4700837131674092	90	TCGA-RE-A7BO-01	16	34	141	0.3516753395818158	TCGA-RE-A7BO-01	12	6	7	25	PASS	2612	TCGA-RE-A7BO	ESCA	72	FEMALE	WHITE	Stage IIB	NA	"Esophagus Adenocarcinoma, NOS"	G3	2006	NA	-26348	Dead	TUMOR FREE	NA	213	NA	NA	NA	NA	NA	NA	NA	NA	1	213	0	213	NA	NA	0	213	
80	TCGA-S8-A6BV	0	29	5	7	2	0	1	0	6	99	6	1	6	40	1	0	TCGA-S8-A6BV-01	200	0.6469107143365564	109	TCGA-S8-A6BV-01	19	35	75	0.17776391857645218	TCGA-S8-A6BV-01	17	11	2	30	PASS	2613	TCGA-S8-A6BV	ESCA	76	MALE	WHITE	Stage IIIA	Stage IB	"Esophagus Adenocarcinoma, NOS"	G2	2012	NA	-28111	Alive	WITH TUMOR	609	NA	NA	Distant Metastasis	Liver	NA	267	Progressive Disease	NA	NA	0	609	0	609	NA	NA	1	267	
50	TCGA-S8-A6BW	2	25	1	5	1	1	0	0	4	70	8	0	5	36	1	0	TCGA-S8-A6BW-01	180	0.7590763290242651	96	TCGA-S8-A6BW-01	21	19	120	0.3194905416944879	TCGA-S8-A6BW-01	15	20	11	46	PASS	2614	TCGA-S8-A6BW	ESCA	51	MALE	WHITE	Stage IB	NA	Esophagus Squamous Cell Carcinoma	G1	2012	NA	-18944	Alive	TUMOR FREE	620	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	620	0	620	0	620	0	620	
60	TCGA-V5-A7RB	6	65	4	7	3	0	3	0	10	191	9	0	9	56	3	0	TCGA-V5-A7RB-01	312	0.2761797620057601	192	TCGA-V5-A7RB-01	10	17	162	0.2148198157642284	TCGA-V5-A7RB-01	10	10	10	30	PASS	2615	TCGA-V5-A7RB	ESCA	59	MALE	[Unknown]	[Unknown]	Stage IIB	"Esophagus Adenocarcinoma, NOS"	GX	NA	NA	-21654	Dead	TUMOR FREE	NA	161	NA	NA	NA	NA	NA	NA	NA	NA	1	161	0	161	NA	NA	0	161	
60	TCGA-V5-A7RC	8	56	4	10	9	6	2	2	22	150	5	0	9	58	7	0	TCGA-V5-A7RC-01	236	0.9081045205157828	135	TCGA-V5-A7RC-06	17	28	85	0.22981769089711104	TCGA-V5-A7RC-06	22	7	8	37	mutation call filter	2616	TCGA-V5-A7RC	ESCA	55	MALE	BLACK OR AFRICAN AMERICAN	NA	Stage IV	Esophagus Squamous Cell Carcinoma	GX	NA	NA	-20439	Dead	WITH TUMOR	NA	104	NA	Distant Metastasis	Liver	NA	88	Progressive Disease	NA	NA	1	104	1	104	NA	NA	1	88	
50	TCGA-V5-A7RE	5	43	1	6	4	4	1	0	10	168	5	3	13	67	2	0	TCGA-V5-A7RE-01	450	0.6348309721641117	318	TCGA-V5-A7RE-01	18	33	210	0.22055120362178052	TCGA-V5-A7RE-01	15	6	6	27	PASS	2617	TCGA-V5-A7RE	ESCA	45	MALE	WHITE	Stage IB	Stage IIIA	"Esophagus Adenocarcinoma, NOS"	G2	NA	NA	-16643	Alive	WITH TUMOR	500	NA	NA	Distant Metastasis	"Other, specify"	bone	294	Partial Remission/Response	NA	NA	0	500	0	500	NA	NA	1	294	
70	TCGA-V5-AASV	3	33	1	6	15	4	13	0	9	79	9	0	3	29	3	0	TCGA-V5-AASV-01	226	0.7688104509898919	145	TCGA-V5-AASV-01	11	8	78	0.09420961482880706	TCGA-V5-AASV-01	4	1	3	8	PASS	2618	TCGA-V5-AASV	ESCA	67	MALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Esophagus Squamous Cell Carcinoma	G3	NA	NA	-24559	Alive	WITH TUMOR	467	NA	NA	Distant Metastasis	Lung	NA	322	Partial Remission/Response	NA	NA	0	467	0	467	NA	NA	1	322	
70	TCGA-V5-AASW	3	33	2	7	0	3	0	0	8	105	3	0	3	51	3	0	TCGA-V5-AASW-01	239	0.8803030037953289	136	TCGA-V5-AASW-01	23	32	129	0.2704551197127355	TCGA-V5-AASW-01	11	4	7	22	PASS	2619	TCGA-V5-AASW	ESCA	72	MALE	WHITE	NA	Stage IIIA	"Esophagus Adenocarcinoma, NOS"	G3	NA	NA	-26571	Alive	WITH TUMOR	282	NA	NA	Distant Metastasis	Lung	NA	282	[Unknown]	NA	NA	0	282	0	282	NA	NA	1	282	
70	TCGA-V5-AASX	6	114	4	21	10	5	1	2	33	382	26	0	9	156	5	0	TCGA-V5-AASX-01	142	0.4100696381289912	68	TCGA-V5-AASX-01	4	7	50	0.1792835525014654	TCGA-V5-AASX-01	4	4	7	15	PASS	2620	TCGA-V5-AASX	ESCA	74	MALE	WHITE	NA	Stage IV	"Esophagus Adenocarcinoma, NOS"	G2	NA	NA	-27081	Alive	WITH TUMOR	273	NA	NA	Distant Metastasis	"Other, specify"	bone	273	[Unknown]	NA	NA	0	273	0	273	NA	NA	1	273	
50	TCGA-VR-A8EO	1	16	0	1	2	0	1	0	5	39	1	1	0	14	2	0	TCGA-VR-A8EO-01	159	0.6684704985187484	84	TCGA-VR-A8EO	0	0	0	0	TCGA-VR-A8EO	0	0	0	0	PASS	2621	TCGA-VR-A8EO	ESCA	49	MALE	WHITE	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G3	2013	NA	-18123	Alive	TUMOR FREE	785	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	785	0	785	0	785	0	785	
50	TCGA-VR-A8EP	1	29	4	4	5	0	1	1	14	81	3	0	3	22	2	0	TCGA-VR-A8EP-01	199	0.6726190722340247	99	TCGA-VR-A8EP-01	23	23	148	0.4564855609366658	TCGA-VR-A8EP-01	17	10	20	47	PASS	2622	TCGA-VR-A8EP	ESCA	51	MALE	WHITE	Stage IIIB	Stage IIB	Esophagus Squamous Cell Carcinoma	G3	2013	NA	-18942	Alive	TUMOR FREE	824	NA	NA	Locoregional Recurrence	NA	NA	242	Progressive Disease	NA	NA	0	824	0	824	NA	NA	1	242	
70	TCGA-VR-A8EQ	4	40	0	3	3	3	0	0	8	132	9	0	4	51	0	0	TCGA-VR-A8EQ-01	263	0.6308558239886235	157	TCGA-VR-A8EQ-01	21	32	199	0.5043988404592235	TCGA-VR-A8EQ-01	16	10	6	32	PASS	2623	TCGA-VR-A8EQ	ESCA	73	MALE	WHITE	Stage III	Stage III	"Esophagus Adenocarcinoma, NOS"	G2	2009	NA	-26912	Dead	WITH TUMOR	NA	694	NA	NA	NA	NA	NA	NA	NA	NA	1	694	1	694	NA	NA	1	694	
50	TCGA-VR-A8ER	2	21	0	5	0	0	0	0	5	48	3	1	4	14	0	0	TCGA-VR-A8ER-01	217	0.3784993525457279	126	TCGA-VR-A8ER-01	11	16	137	0.3359966544141162	TCGA-VR-A8ER-01	15	10	13	38	PASS	2624	TCGA-VR-A8ER	ESCA	54	MALE	[Unknown]	Stage III	Stage III	Esophagus Squamous Cell Carcinoma	GX	2009	NA	-19951	Dead	WITH TUMOR	NA	378	NA	NA	NA	NA	NA	NA	NA	NA	1	378	1	378	NA	NA	1	378	
60	TCGA-VR-A8ET	0	6	0	1	1	0	0	0	1	15	1	0	0	5	2	0	TCGA-VR-A8ET-01	97	0.060235357614155764	41	TCGA-VR-A8ET	0	0	0	0	TCGA-VR-A8ET	0	0	0	0	PASS	2625	TCGA-VR-A8ET	ESCA	64	MALE	WHITE	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G2	2010	NA	-23517	Dead	TUMOR FREE	NA	47	NA	NA	NA	NA	NA	NA	NA	NA	1	47	0	47	NA	NA	0	47	
50	TCGA-VR-A8EU	3	31	1	7	0	1	2	0	3	76	7	0	3	33	0	1	TCGA-VR-A8EU-01	471	0.5598126832069752	305	TCGA-VR-A8EU-01	15	33	168	0.24926061861907786	TCGA-VR-A8EU-01	22	17	10	49	PASS	2626	TCGA-VR-A8EU	ESCA	51	MALE	WHITE	Stage IV	Stage IV	Esophagus Squamous Cell Carcinoma	G2	2011	NA	-18711	Dead	WITH TUMOR	NA	557	NA	NA	NA	NA	NA	NA	NA	NA	1	557	1	557	NA	NA	1	557	
60	TCGA-VR-A8EW	1	27	1	5	2	1	2	0	6	90	6	0	3	31	3	0	TCGA-VR-A8EW-01	246	0.7653181195818052	150	TCGA-VR-A8EW-01	25	49	67	0.11709643498961632	TCGA-VR-A8EW-01	18	16	6	40	PASS	2627	TCGA-VR-A8EW	ESCA	57	MALE	ASIAN	Stage IIIB	Stage IIIB	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-20902	Dead	WITH TUMOR	NA	247	NA	NA	NA	NA	NA	NA	NA	NA	1	247	1	247	NA	NA	1	247	
60	TCGA-VR-A8EX	3	27	1	3	1	2	0	0	10	102	11	1	5	29	1	0	TCGA-VR-A8EX-01	237	0.5988889405211575	130	TCGA-VR-A8EX-01	6	10	121	0.33627937929949586	TCGA-VR-A8EX-01	9	9	12	30	PASS	2628	TCGA-VR-A8EX	ESCA	63	MALE	[Unknown]	Stage IVA	Stage IVA	Esophagus Squamous Cell Carcinoma	G2	2009	NA	-23226	Dead	WITH TUMOR	NA	855	NA	NA	NA	NA	NA	NA	NA	NA	1	855	1	855	NA	NA	1	855	
40	TCGA-VR-A8EY	3	26	0	10	5	1	0	0	5	75	4	1	4	24	3	0	TCGA-VR-A8EY-01	274	0.8053136931912881	171	TCGA-VR-A8EY-01	7	21	132	0.2308734302393023	TCGA-VR-A8EY-01	20	11	4	35	PASS	2629	TCGA-VR-A8EY	ESCA	44	FEMALE	WHITE	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G1	2012	NA	-16255	Alive	TUMOR FREE	1025	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1025	0	1025	0	1025	0	1025	
50	TCGA-VR-A8EZ	4	40	3	11	2	1	0	0	15	123	11	0	10	44	2	0	TCGA-VR-A8EZ-01	365	0.707248621250357	207	TCGA-VR-A8EZ-01	9	28	162	0.3233670120659904	TCGA-VR-A8EZ-01	25	33	15	73	PASS	2630	TCGA-VR-A8EZ	ESCA	47	MALE	WHITE	Stage IIIC	Stage IIA	Esophagus Squamous Cell Carcinoma	G2	2013	NA	-17449	Dead	WITH TUMOR	NA	553	NA	Distant Metastasis	Bone	NA	379	NA	NA	NA	1	553	1	553	NA	NA	1	379	
60	TCGA-VR-A8Q7	2	26	1	6	5	1	0	0	8	73	5	0	6	21	2	0	TCGA-VR-A8Q7-01	538	0.7010118622947493	369	TCGA-VR-A8Q7-01	23	52	324	0.48152999594020396	TCGA-VR-A8Q7-01	21	11	10	42	PASS	2631	TCGA-VR-A8Q7	ESCA	60	MALE	WHITE	Stage IIIA	Stage IIIA	Esophagus Squamous Cell Carcinoma	G3	2010	NA	-22149	Alive	TUMOR FREE	1590	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1590	0	1590	0	1590	0	1590	
50	TCGA-VR-AA4D	0	26	2	4	3	3	1	1	7	76	3	0	3	30	1	0	TCGA-VR-AA4D-01	178	0.7098820276808546	98	TCGA-VR-AA4D-01	19	27	39	0.09369943314887587	TCGA-VR-AA4D-01	10	14	4	28	PASS	2632	TCGA-VR-AA4D	ESCA	53	MALE	WHITE	Stage IIB	Stage IA	"Esophagus Adenocarcinoma, NOS"	G2	2010	NA	-19714	Dead	WITH TUMOR	NA	1405	NA	Distant Metastasis	Lung	NA	832	Progressive Disease	NA	NA	1	1405	1	1405	NA	NA	1	832	
50	TCGA-VR-AA4G	2	20	1	3	2	1	0	0	4	54	1	0	0	22	2	0	TCGA-VR-AA4G-01	159	0.28442314191955204	78	TCGA-VR-AA4G	0	0	0	0	TCGA-VR-AA4G	0	0	0	0	PASS	2633	TCGA-VR-AA4G	ESCA	51	FEMALE	WHITE	Stage IIIA	Stage IIIA	Esophagus Squamous Cell Carcinoma	G2	2013	NA	-18909	Alive	TUMOR FREE	549	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	549	0	549	0	549	0	549	
70	TCGA-VR-AA7B	3	45	3	6	4	1	1	0	8	136	15	0	5	41	3	0	TCGA-VR-AA7B-01	361	0.6805170690707385	213	TCGA-VR-AA7B-01	17	34	157	0.4095781640382045	TCGA-VR-AA7B-01	21	19	19	59	PASS	2634	TCGA-VR-AA7B	ESCA	65	FEMALE	WHITE	Stage IV	Stage IIB	Esophagus Squamous Cell Carcinoma	G2	2011	NA	-23915	Alive	WITH TUMOR	342	NA	NA	Distant Metastasis	Brain	NA	207	NA	NA	NA	0	342	0	342	NA	NA	1	207	
60	TCGA-VR-AA7D	0	40	2	3	3	1	0	0	10	69	6	0	3	32	2	1	TCGA-VR-AA7D-01	153	0.29797042406382696	75	TCGA-VR-AA7D-01	10	17	90	0.21893751552824545	TCGA-VR-AA7D-01	11	10	7	28	PASS	2635	TCGA-VR-AA7D	ESCA	58	MALE	[Unknown]	Stage IIIC	Stage IIIC	Esophagus Squamous Cell Carcinoma	G2	2012	NA	-21468	Dead	WITH TUMOR	NA	279	NA	Distant Metastasis	"Other, specify"	Head and neck lymph node	244	NA	NA	NA	1	279	1	279	NA	NA	1	244	
70	TCGA-VR-AA7I	2	43	1	6	3	4	1	0	5	87	4	0	3	31	2	0	TCGA-VR-AA7I-01	202	0.6153991846744508	117	TCGA-VR-AA7I	0	0	0	0	TCGA-VR-AA7I	0	0	0	0	PASS	2636	TCGA-VR-AA7I	ESCA	70	MALE	WHITE	Stage III	Stage III	Esophagus Squamous Cell Carcinoma	G1	2010	NA	-25855	Dead	WITH TUMOR	NA	484	NA	NA	NA	NA	NA	NA	NA	NA	1	484	1	484	NA	NA	1	484	
70	TCGA-X8-AAAR	5	39	1	1	1	3	0	0	6	87	2	0	6	32	2	0	TCGA-X8-AAAR-01	139	0.7009033368658663	61	TCGA-X8-AAAR-01	9	7	94	0.34807940243628804	TCGA-X8-AAAR-01	8	5	11	24	PASS	2637	TCGA-X8-AAAR	ESCA	69	MALE	WHITE	[Unknown]	NA	"Esophagus Adenocarcinoma, NOS"	G1	2013	NA	-25370	Alive	TUMOR FREE	554	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	554	0	554	0	554	0	554	
50	TCGA-XP-A8T6	2	18	1	6	2	1	0	0	2	68	4	1	4	28	1	0	TCGA-XP-A8T6-01	326	0.7451432541134464	207	TCGA-XP-A8T6-01	12	37	127	0.2584339323346073	TCGA-XP-A8T6-01	23	24	9	56	PASS	2638	TCGA-XP-A8T6	ESCA	54	MALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Esophagus Squamous Cell Carcinoma	G2	2009	NA	-19886	Dead	TUMOR FREE	NA	763	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	763	0	763	0	763	0	763	
60	TCGA-XP-A8T7	4	21	2	2	4	2	1	0	7	62	4	0	3	27	2	0	TCGA-XP-A8T7-01	146	0.22162473846318687	74	TCGA-XP-A8T7-01	9	14	114	0.3300593346554838	TCGA-XP-A8T7-01	7	2	5	14	PASS	2639	TCGA-XP-A8T7	ESCA	63	FEMALE	WHITE	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G2	2010	NA	-23375	Alive	TUMOR FREE	1254	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1254	0	1254	0	1254	0	1254	
50	TCGA-XP-A8T8	5	16	2	5	5	3	1	0	3	85	4	0	3	25	1	0	TCGA-XP-A8T8-01	273	0.7509658943270577	164	TCGA-XP-A8T8-01	23	34	132	0.3546248870495875	TCGA-XP-A8T8-01	19	7	14	40	PASS	2640	TCGA-XP-A8T8	ESCA	49	MALE	BLACK OR AFRICAN AMERICAN	Stage IIB	Stage IIB	Esophagus Squamous Cell Carcinoma	G1	2011	NA	-18048	Alive	TUMOR FREE	437	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	437	0	437	0	437	0	437	
50	TCGA-Z6-A8JD	0	44	1	11	4	0	1	0	20	150	16	1	4	60	4	0	TCGA-Z6-A8JD-01	196	0.4578971408002584	109	TCGA-Z6-A8JD-01	12	32	126	0.3995144024874961	TCGA-Z6-A8JD-01	18	16	17	51	PASS	2641	TCGA-Z6-A8JD	ESCA	53	MALE	WHITE	Stage IIB	NA	Esophagus Squamous Cell Carcinoma	G2	2013	NA	-19523	Alive	TUMOR FREE	104	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	104	0	104	0	104	0	104	
60	TCGA-Z6-A8JE	6	39	5	17	0	1	0	0	9	149	13	0	9	35	2	1	TCGA-Z6-A8JE-01	288	0.7508638768982815	176	TCGA-Z6-A8JE-01	14	37	277	0.6294546354959851	TCGA-Z6-A8JE-01	23	15	12	50	PASS	2642	TCGA-Z6-A8JE	ESCA	57	MALE	WHITE	Stage IIIA	Stage IIIA	Esophagus Squamous Cell Carcinoma	G3	2013	NA	-20855	Alive	TUMOR FREE	64	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	64	0	64	0	64	0	64	
50	TCGA-Z6-A9VB	1	21	3	4	3	1	0	0	5	72	3	0	2	32	0	0	TCGA-Z6-A9VB-01	252	0.4971314915233551	136	TCGA-Z6-A9VB-01	8	20	189	0.3752958055420931	TCGA-Z6-A9VB-01	20	10	14	44	PASS	2643	TCGA-Z6-A9VB	ESCA	53	MALE	WHITE	Stage IIIA	NA	Esophagus Squamous Cell Carcinoma	G2	2013	NA	-19470	Alive	TUMOR FREE	40	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	40	0	40	0	40	0	40	
60	TCGA-Z6-AAPN	9	99	7	17	1	0	1	0	18	289	30	1	7	84	3	0	TCGA-Z6-AAPN-01	245	0.641726658730507	138	TCGA-Z6-AAPN-01	18	34	174	0.4434314554288543	TCGA-Z6-AAPN-01	16	18	17	51	PASS	2644	TCGA-Z6-AAPN	ESCA	57	MALE	WHITE	Stage IIA	NA	Esophagus Squamous Cell Carcinoma	G1	2013	NA	-20926	Alive	TUMOR FREE	81	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	81	0	81	0	81	0	81	
70	TCGA-ZR-A9CJ	3	25	0	5	5	2	3	1	8	102	8	0	2	39	1	0	TCGA-ZR-A9CJ-01	232	0.6692482005914931	133	TCGA-ZR-A9CJ-01	18	32	92	0.2857334455961369	TCGA-ZR-A9CJ-01	22	16	12	50	PASS	2645	TCGA-ZR-A9CJ	ESCA	65	MALE	WHITE	Stage IIIC	NA	"Esophagus Adenocarcinoma, NOS"	G3	2012	NA	-23752	Dead	WITH TUMOR	NA	600	NA	Distant Metastasis	Liver	NA	163	[Unknown]	NA	NA	1	600	1	600	NA	NA	1	163	
40	TCGA-02-0001	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0001-01	117	0.7011208341623989	63	TCGA-02-0001-01	15	22	20	0.14895066675710586	TCGA-02-0001-01	5	8	5	18	PASS	2646	TCGA-02-0001	GBM	44	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-16179	Dead	WITH TUMOR	279	358	NA	Recurrence	NA	NA	137	NA	NA	NA	1	358	1	358	NA	NA	1	137	
50	TCGA-02-0003	0	3	1	0	0	0	0	0	0	44	0	0	1	12	0	0	TCGA-02-0003-01	99	0.14798835752670542	41	TCGA-02-0003-01	4	4	5	0.09746982131876528	TCGA-02-0003-01	2	4	1	7	PASS	2647	TCGA-02-0003	GBM	50	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-18341	Dead	WITH TUMOR	144	144	NA	Recurrence	NA	NA	40	NA	NA	NA	1	144	1	144	NA	NA	1	40	
60	TCGA-02-0004	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0004	0	0	0	TCGA-02-0004	0	0	0	0	TCGA-02-0004	0	0	0	0	PASS	2648	TCGA-02-0004	GBM	59	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-21617	Dead	WITH TUMOR	345	345	NA	Progression of Disease	NA	NA	314	NA	NA	NA	1	345	1	345	NA	NA	1	314	
60	TCGA-02-0006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0006-01	165	0.23905458354439835	119	TCGA-02-0006-01	11	7	37	0.15930136985329715	TCGA-02-0006-01	1	9	3	13	PASS	2649	TCGA-02-0006	GBM	56	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-20516	Dead	WITH TUMOR	558	558	NA	Recurrence	NA	NA	302	NA	NA	NA	1	558	1	558	NA	NA	1	302	
40	TCGA-02-0007	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0007-01	161	0.9036962817599556	84	TCGA-02-0007-01	5	11	18	0.1988941860858697	TCGA-02-0007-01	6	4	8	18	PASS	2650	TCGA-02-0007	GBM	40	FEMALE	WHITE	NA	NA	Treated primary GBM	NA	2002	NA	-14806	Dead	WITH TUMOR	705	705	NA	Progression of Disease	NA	NA	518	NA	NA	NA	1	705	1	705	NA	NA	1	518	
60	TCGA-02-0009	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0009-01	301	0.1600481916499984	228	TCGA-02-0009-01	6	5	46	0.08925849667094363	TCGA-02-0009-01	3	2	1	6	PASS	2651	TCGA-02-0009	GBM	61	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-22457	Dead	WITH TUMOR	322	322	NA	Progression of Disease	NA	NA	264	NA	NA	NA	1	322	1	322	NA	NA	1	264	
30	TCGA-02-0010	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0010-01	163	0.5631650046861435	87	TCGA-02-0010-01	1	4	29	0.14592959235231326	TCGA-02-0010-01	9	11	9	29	PASS	2652	TCGA-02-0010	GBM	20	FEMALE	WHITE	NA	NA	Treated primary GBM	NA	2002	NA	-7452	Dead	WITH TUMOR	1077	1077	NA	Progression of Disease	NA	NA	351	NA	NA	NA	1	1077	1	1077	NA	NA	1	351	
20	TCGA-02-0011	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0011-01	107	0.9385648613256536	52	TCGA-02-0011-01	9	9	14	0.18213884454197168	TCGA-02-0011-01	7	3	2	12	PASS	2653	TCGA-02-0011	GBM	18	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-6926	Dead	WITH TUMOR	630	630	NA	Progression of Disease	NA	NA	145	NA	NA	NA	1	630	1	630	NA	NA	1	145	
30	TCGA-02-0014	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0014-01	231	0.2365193085486193	140	TCGA-02-0014-01	2	4	30	0.12790094105522776	TCGA-02-0014-01	11	12	8	31	PASS	2654	TCGA-02-0014	GBM	25	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1997	NA	-9369	Dead	WITH TUMOR	2512	2512	NA	Progression of Disease	NA	NA	2243	NA	NA	NA	1	2512	1	2512	NA	NA	1	2243	
50	TCGA-02-0015	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0015-01	544	0.18003710660214747	443	TCGA-02-0015-01	7	7	34	0.10253145070844437	TCGA-02-0015-01	4	6	6	16	PASS	2655	TCGA-02-0015	GBM	50	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-18404	Dead	WITH TUMOR	627	627	NA	Recurrence	NA	NA	456	NA	NA	NA	1	627	1	627	NA	NA	1	456	
50	TCGA-02-0016	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0016-01	431	0.23370241313922566	325	TCGA-02-0016-01	9	6	18	0.1382791214403805	TCGA-02-0016-01	1	1	3	5	PASS	2656	TCGA-02-0016	GBM	50	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-18271	Dead	WITH TUMOR	NA	2648	NA	Recurrence	NA	NA	1699	NA	NA	NA	1	2648	1	2648	NA	NA	1	1699	
40	TCGA-02-0021	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0021-01	435	0.17464428121039635	367	TCGA-02-0021-01	8	4	62	0.07644825420391795	TCGA-02-0021-01	1	4	1	6	PASS	2657	TCGA-02-0021	GBM	43	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1999	NA	-16035	Dead	WITH TUMOR	2362	2362	NA	Progression of Disease	NA	NA	255	NA	NA	NA	1	2362	1	2362	NA	NA	1	255	
40	TCGA-02-0023	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0023-01	423	0.1883284646434072	346	TCGA-02-0023-01	8	4	16	0.116657202557624	TCGA-02-0023-01	3	1	2	6	PASS	2658	TCGA-02-0023	GBM	38	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-14003	Dead	WITH TUMOR	612	612	NA	Progression of Disease	NA	NA	435	NA	NA	NA	1	612	1	612	NA	NA	1	435	
40	TCGA-02-0024	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0024-01	174	0.637978024564782	97	TCGA-02-0024-01	6	11	22	0.09334977980574544	TCGA-02-0024-01	5	15	3	23	PASS	2659	TCGA-02-0024	GBM	35	MALE	WHITE	NA	NA	Treated primary GBM	NA	2000	NA	-13116	Dead	WITH TUMOR	1615	1615	NA	Recurrence	NA	NA	1401	NA	NA	NA	1	1615	1	1615	NA	NA	1	1401	
50	TCGA-02-0025	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0025-01	600	0.3629930091425119	525	TCGA-02-0025-01	13	46	21	0.2813565914445052	TCGA-02-0025-01	10	22	4	36	PASS	2660	TCGA-02-0025	GBM	47	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-17402	Dead	WITH TUMOR	1300	1300	NA	Progression of Disease	NA	NA	656	NA	NA	NA	1	1300	1	1300	NA	NA	1	656	
30	TCGA-02-0026	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0026-01	350	0.4691065823060396	266	TCGA-02-0026-01	1	5	21	0.14399008556937795	TCGA-02-0026-01	9	9	8	26	PASS	2661	TCGA-02-0026	GBM	27	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-10022	Dead	WITH TUMOR	748	748	NA	Progression of Disease	NA	NA	462	NA	NA	NA	1	748	1	748	NA	NA	1	462	
30	TCGA-02-0027	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0027-01	99	0.16179577887386162	44	TCGA-02-0027-01	6	4	9	0.1124978635356473	TCGA-02-0027-01	1	3	4	8	PASS	2662	TCGA-02-0027	GBM	33	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-12369	Dead	WITH TUMOR	315	370	NA	Progression of Disease	NA	NA	257	NA	NA	NA	1	370	1	370	NA	NA	1	257	
40	TCGA-02-0028	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0028-01	133	0.2080862154431749	74	TCGA-02-0028-01	4	4	13	0.11687049145348324	TCGA-02-0028-01	4	9	6	19	PASS	2663	TCGA-02-0028	GBM	39	MALE	WHITE	NA	NA	Treated primary GBM	NA	1998	NA	-14304	Dead	WITH TUMOR	2755	2755	NA	Progression of Disease	NA	NA	1921	NA	NA	NA	1	2755	1	2755	NA	NA	1	1921	
50	TCGA-02-0033	0	0	0	2	0	0	1	1	1	23	2	0	0	10	1	0	TCGA-02-0033-01	41	0.16427307175601893	7	TCGA-02-0033-01	7	4	4	0.11598688457885313	TCGA-02-0033-01	0	0	0	0	PASS	2664	TCGA-02-0033	GBM	54	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-20070	Dead	WITH TUMOR	86	86	NA	Progression of Disease	NA	NA	32	NA	NA	NA	1	86	1	86	NA	NA	1	32	
60	TCGA-02-0034	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0034-01	210	0.2664274586736778	145	TCGA-02-0034-01	8	7	26	0.1691315076110073	TCGA-02-0034-01	4	3	4	11	PASS	2665	TCGA-02-0034	GBM	60	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-22166	Dead	WITH TUMOR	430	430	NA	Progression of Disease	NA	NA	386	NA	NA	NA	1	430	1	430	NA	NA	1	386	
70	TCGA-02-0037	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0037-01	129	0.18853446676209615	72	TCGA-02-0037-01	9	5	12	0.0709683689294358	TCGA-02-0037-01	3	0	1	4	PASS	2666	TCGA-02-0037	GBM	74	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-27063	Dead	WITH TUMOR	110	110	NA	Progression of Disease	NA	NA	37	NA	NA	NA	1	110	1	110	NA	NA	1	37	
50	TCGA-02-0038	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0038-01	139	0.17952172229536226	82	TCGA-02-0038-01	7	5	16	0.09523164428419192	TCGA-02-0038-01	0	6	2	8	PASS	2667	TCGA-02-0038	GBM	48	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-17749	Dead	WITH TUMOR	326	326	NA	Progression of Disease	NA	NA	239	NA	NA	NA	1	326	1	326	NA	NA	1	239	
50	TCGA-02-0039	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0039-01	466	0.3735909461619813	385	TCGA-02-0039-01	7	5	11	0.1897781435346607	TCGA-02-0039-01	2	0	0	2	PASS	2668	TCGA-02-0039	GBM	54	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-20065	Dead	WITH TUMOR	320	320	NA	Progression of Disease	NA	NA	102	NA	NA	NA	1	320	1	320	NA	NA	1	102	
50	TCGA-02-0043	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0043-01	131	0.17468654657600197	73	TCGA-02-0043-01	7	4	16	0.07483728653344016	TCGA-02-0043-01	2	7	1	10	PASS	2669	TCGA-02-0043	GBM	54	FEMALE	WHITE	NA	NA	Treated primary GBM	NA	2004	NA	-19882	Dead	WITH TUMOR	557	557	NA	Progression of Disease	NA	NA	282	NA	NA	NA	1	557	1	557	NA	NA	1	282	
60	TCGA-02-0046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0046-01	109	0.10376299011549177	59	TCGA-02-0046-01	4	2	9	0.0516180007000393	TCGA-02-0046-01	0	0	0	0	PASS	2670	TCGA-02-0046	GBM	61	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-22417	Dead	WITH TUMOR	209	209	NA	Progression of Disease	NA	NA	195	NA	NA	NA	1	209	1	209	NA	NA	1	195	
80	TCGA-02-0047	0	4	0	1	2	0	1	0	2	56	2	1	2	15	1	0	TCGA-02-0047-01	68	0.09774461386854784	28	TCGA-02-0047-01	1	1	6	0.027295531472730297	TCGA-02-0047-01	3	2	2	7	PASS	2671	TCGA-02-0047	GBM	78	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-28759	Dead	WITH TUMOR	448	448	NA	Progression of Disease	NA	NA	57	NA	NA	NA	1	448	1	448	NA	NA	1	57	
80	TCGA-02-0048	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0048-01	646	0.6570940908811116	564	TCGA-02-0048-01	3	4	25	0.13616943366014744	TCGA-02-0048-01	2	1	3	6	PASS	2672	TCGA-02-0048	GBM	80	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-29299	Dead	NA	98	98	NA	Progression of Disease	NA	NA	23	NA	NA	NA	1	98	NA	98	NA	NA	1	23	
40	TCGA-02-0051	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0051-01	446	0.6013574154533156	381	TCGA-02-0051-01	15	32	26	0.4232816546525066	TCGA-02-0051-01	7	4	1	12	PASS	2673	TCGA-02-0051	GBM	43	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-15983	Dead	WITH TUMOR	459	459	NA	Progression of Disease	NA	NA	89	NA	NA	NA	1	459	1	459	NA	NA	1	89	
50	TCGA-02-0052	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0052-01	77	0.32285256606128376	33	TCGA-02-0052-01	4	4	8	0.08035960292343608	TCGA-02-0052-01	0	1	3	4	PASS	2674	TCGA-02-0052	GBM	49	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-18061	Dead	WITH TUMOR	383	383	NA	Progression of Disease	NA	NA	204	NA	NA	NA	1	383	1	383	NA	NA	1	204	
40	TCGA-02-0054	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0054-01	93	0.3692859510764215	41	TCGA-02-0054-01	11	12	6	0.08694885531493579	TCGA-02-0054-01	4	3	5	12	PASS	2675	TCGA-02-0054	GBM	44	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-16224	Dead	WITH TUMOR	199	199	NA	Progression of Disease	NA	NA	72	NA	NA	NA	1	199	1	199	NA	NA	1	72	
60	TCGA-02-0055	1	5	1	1	0	0	0	0	2	47	1	0	1	16	2	0	TCGA-02-0055-01	63	0.5588708688509828	22	TCGA-02-0055-01	22	17	13	0.20004536169053652	TCGA-02-0055-01	0	2	1	3	PASS	2676	TCGA-02-0055	GBM	62	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-22798	Dead	WITH TUMOR	76	76	NA	Progression of Disease	NA	NA	6	NA	NA	NA	1	76	1	76	NA	NA	1	6	
70	TCGA-02-0057	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0057-01	65	0.15857839341566835	25	TCGA-02-0057-01	8	4	3	0.05728641014123498	TCGA-02-0057-01	0	1	1	2	PASS	2677	TCGA-02-0057	GBM	66	FEMALE	WHITE	NA	NA	Treated primary GBM	NA	2004	NA	-24140	Dead	WITH TUMOR	604	604	NA	Progression of Disease	NA	NA	473	NA	NA	NA	1	604	1	604	NA	NA	1	473	
30	TCGA-02-0058	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0058-01	94	0.17414885861406307	43	TCGA-02-0058-01	0	2	17	0.05573173852379363	TCGA-02-0058-01	5	8	4	17	PASS	2678	TCGA-02-0058	GBM	28	FEMALE	WHITE	NA	NA	Treated primary GBM	NA	2005	NA	-10517	Dead	WITH TUMOR	254	254	NA	Progression of Disease	NA	NA	172	NA	NA	NA	1	254	1	254	NA	NA	1	172	
70	TCGA-02-0059	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0059-01	683	0.3264949237367754	619	TCGA-02-0059-01	8	7	13	0.15608453824801502	TCGA-02-0059-01	0	0	0	0	PASS	2679	TCGA-02-0059	GBM	68	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-25097	Dead	WITH TUMOR	291	291	NA	Recurrence	NA	NA	21	NA	NA	NA	1	291	1	291	NA	NA	1	21	
70	TCGA-02-0060	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0060-01	166	0.131434271794986	95	TCGA-02-0060-01	3	3	9	0.05944880928713605	TCGA-02-0060-01	3	2	4	9	PASS	2680	TCGA-02-0060	GBM	66	FEMALE	ASIAN	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-24151	Dead	WITH TUMOR	183	183	NA	Progression of Disease	NA	NA	183	NA	NA	NA	1	183	1	183	NA	NA	1	183	
50	TCGA-02-0064	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0064-01	152	0.17333810404803845	81	TCGA-02-0064-01	7	5	16	0.10132812349944266	TCGA-02-0064-01	4	2	3	9	PASS	2681	TCGA-02-0064	GBM	50	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-18280	Dead	WITH TUMOR	600	600	NA	Recurrence	NA	NA	496	NA	NA	NA	1	600	1	600	NA	NA	1	496	
60	TCGA-02-0068	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0068-01	218	0.15159778955219455	140	TCGA-02-0068-01	7	4	26	0.11272234681737656	TCGA-02-0068-01	1	4	2	7	PASS	2682	TCGA-02-0068	GBM	57	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-21160	Dead	WITH TUMOR	804	804	NA	Recurrence	NA	NA	175	NA	NA	NA	1	804	1	804	NA	NA	1	175	
30	TCGA-02-0069	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0069-01	283	0.5021099556943096	203	TCGA-02-0069-01	17	30	26	0.33368405980847804	TCGA-02-0069-01	13	8	5	26	PASS	2683	TCGA-02-0069	GBM	31	FEMALE	ASIAN	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-11668	Alive	WITH TUMOR	873	NA	NA	Progression of Disease	NA	NA	873	NA	NA	NA	0	873	0	873	NA	NA	1	873	
70	TCGA-02-0070	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0070-01	229	0.17215468095528833	167	TCGA-02-0070-01	8	4	10	0.05125946101781912	TCGA-02-0070-01	0	0	0	0	PASS	2684	TCGA-02-0070	GBM	70	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-25916	Alive	WITH TUMOR	762	NA	NA	Recurrence	NA	NA	762	NA	NA	NA	0	762	0	762	NA	NA	1	762	
50	TCGA-02-0071	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0071-01	204	0.14104933469730924	130	TCGA-02-0071-01	5	3	14	0.0689904321383231	TCGA-02-0071-01	0	2	1	3	PASS	2685	TCGA-02-0071	GBM	53	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-19425	Dead	WITH TUMOR	167	167	NA	Progression of Disease	NA	NA	8	NA	NA	NA	1	167	1	167	NA	NA	1	8	
70	TCGA-02-0074	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0074-01	151	0.7162665041960808	80	TCGA-02-0074-01	4	5	14	0.09866037692982713	TCGA-02-0074-01	0	0	1	1	PASS	2686	TCGA-02-0074	GBM	68	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-24906	Dead	WITH TUMOR	310	310	NA	Progression of Disease	NA	NA	154	NA	NA	NA	1	310	1	310	NA	NA	1	154	
60	TCGA-02-0075	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0075-01	73	0.5909984703096618	31	TCGA-02-0075-01	7	6	7	0.16188997454565354	TCGA-02-0075-01	0	0	0	0	PASS	2687	TCGA-02-0075	GBM	63	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-23205	Dead	WITH TUMOR	634	634	NA	Progression of Disease	NA	NA	336	NA	NA	NA	1	634	1	634	NA	NA	1	336	
60	TCGA-02-0079	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0079-01	168	0.3238298381864844	108	TCGA-02-0079-01	13	10	32	0.23814797101043644	TCGA-02-0079-01	5	2	6	13	PASS	2688	TCGA-02-0079	GBM	57	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-21173	Dead	WITH TUMOR	829	829	NA	Progression of Disease	NA	NA	798	NA	NA	NA	1	829	1	829	NA	NA	1	798	
30	TCGA-02-0080	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0080-01	198	0.08814842052880206	135	TCGA-02-0080-01	4	8	15	0.0179848101355137	TCGA-02-0080-01	7	3	1	11	PASS	2689	TCGA-02-0080	GBM	28	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1999	NA	-10310	Dead	WITH TUMOR	2729	2729	NA	Progression of Disease	NA	NA	2339	NA	NA	NA	1	2729	1	2729	NA	NA	1	2339	
60	TCGA-02-0083	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0083-01	258	0.13151951742783333	166	TCGA-02-0083-01	3	4	23	0.09472196284354854	TCGA-02-0083-01	3	4	4	11	PASS	2690	TCGA-02-0083	GBM	59	FEMALE	WHITE	NA	NA	Treated primary GBM	NA	2005	NA	-21626	Dead	WITH TUMOR	691	691	NA	Progression of Disease	NA	NA	463	NA	NA	NA	1	691	1	691	NA	NA	1	463	
40	TCGA-02-0084	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0084-01	97	0.4708099981892871	46	TCGA-02-0084-01	1	2	8	0.05988673177669712	TCGA-02-0084-01	3	2	3	8	PASS	2691	TCGA-02-0084	GBM	36	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-13263	Dead	NA	7	384	NA	NA	NA	NA	NA	NA	NA	NA	1	384	NA	384	NA	NA	0	384	
60	TCGA-02-0085	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0085-01	79	0.11805013653813498	33	TCGA-02-0085-01	4	3	8	0.06296002531324832	TCGA-02-0085-01	1	1	0	2	PASS	2692	TCGA-02-0085	GBM	63	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-23289	Dead	WITH TUMOR	1561	1561	NA	Progression of Disease	NA	NA	976	NA	NA	NA	1	1561	1	1561	NA	NA	1	976	
50	TCGA-02-0086	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0086-01	139	0.4112527314591289	81	TCGA-02-0086-01	18	27	10	0.18709439270148034	TCGA-02-0086-01	1	1	4	6	PASS	2693	TCGA-02-0086	GBM	45	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-16763	Dead	WITH TUMOR	268	268	NA	Progression of Disease	NA	NA	97	NA	NA	NA	1	268	1	268	NA	NA	1	97	
30	TCGA-02-0087	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0087-01	58	0.15903766350075452	17	TCGA-02-0087-01	4	6	2	0.02244027171794225	TCGA-02-0087-01	4	2	1	7	PASS	2694	TCGA-02-0087	GBM	27	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-10185	Alive	NA	1757	NA	NA	Recurrence	NA	NA	1757	NA	NA	NA	0	1757	0	1757	NA	NA	1	1757	
50	TCGA-02-0089	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0089-01	188	0.15813915320664462	134	TCGA-02-0089-01	7	4	38	0.08004262734075179	TCGA-02-0089-01	1	4	2	7	PASS	2695	TCGA-02-0089	GBM	52	MALE	WHITE	NA	NA	Treated primary GBM	NA	2005	NA	-19233	Dead	WITH TUMOR	516	516	NA	Progression of Disease	NA	NA	358	NA	NA	NA	1	516	1	516	NA	NA	1	358	
50	TCGA-02-0099	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0099-01	248	0.7032393960194359	167	TCGA-02-0099-01	8	8	37	0.2396027634558794	TCGA-02-0099-01	4	9	7	20	PASS	2696	TCGA-02-0099	GBM	46	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-17080	Dead	WITH TUMOR	106	106	NA	NA	NA	NA	NA	NA	NA	NA	1	106	1	106	NA	NA	1	106	
40	TCGA-02-0102	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0102-01	150	0.1622367158831884	90	TCGA-02-0102-01	6	3	9	0.06107502950648198	TCGA-02-0102-01	0	1	1	2	PASS	2697	TCGA-02-0102	GBM	42	MALE	WHITE	NA	NA	Treated primary GBM	NA	2004	NA	-15660	Dead	WITH TUMOR	822	822	NA	Progression of Disease	NA	NA	450	NA	NA	NA	1	822	1	822	NA	NA	1	450	
30	TCGA-02-0104	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0104-01	542	0.2673506777185572	453	TCGA-02-0104-01	1	6	28	0.11524736777558947	TCGA-02-0104-01	11	11	8	30	PASS	2698	TCGA-02-0104	GBM	29	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-10699	Dead	WITH TUMOR	1977	1977	NA	Recurrence	NA	NA	1457	NA	NA	NA	1	1977	1	1977	NA	NA	1	1457	
50	TCGA-02-0106	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0106-01	130	0.7453239376296946	60	TCGA-02-0106-01	27	21	20	0.18165173385676134	TCGA-02-0106-01	10	8	6	24	PASS	2699	TCGA-02-0106	GBM	54	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-19883	Dead	WITH TUMOR	355	355	NA	Recurrence	NA	NA	196	NA	NA	NA	1	355	1	355	NA	NA	1	196	
60	TCGA-02-0107	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0107-01	83	0.17868460922632898	45	TCGA-02-0107-01	7	5	5	0.1309943199253298	TCGA-02-0107-01	0	0	0	0	PASS	2700	TCGA-02-0107	GBM	56	MALE	WHITE	NA	NA	Treated primary GBM	NA	2004	NA	-20557	Dead	WITH TUMOR	537	537	NA	Recurrence	NA	NA	146	NA	NA	NA	1	537	1	537	NA	NA	1	146	
60	TCGA-02-0111	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0111-01	158	0.1963026683841518	91	TCGA-02-0111-01	9	6	16	0.10345539052288344	TCGA-02-0111-01	4	5	6	15	PASS	2701	TCGA-02-0111	GBM	56	MALE	ASIAN	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-20813	Dead	WITH TUMOR	705	705	NA	Progression of Disease	NA	NA	74	NA	NA	NA	1	705	1	705	NA	NA	1	74	
40	TCGA-02-0113	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0113-01	89	0.8496243146983349	42	TCGA-02-0113-01	20	12	15	0.4925031311221969	TCGA-02-0113-01	0	0	0	0	PASS	2702	TCGA-02-0113	GBM	43	FEMALE	WHITE	NA	NA	Treated primary GBM	NA	2001	NA	-15836	Alive	WITH TUMOR	2818	NA	NA	Recurrence	NA	NA	1560	NA	NA	NA	0	2818	0	2818	NA	NA	1	1560	
40	TCGA-02-0114	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0114-01	165	0.16085078670492214	91	TCGA-02-0114-01	5	7	17	0.10420936206708464	TCGA-02-0114-01	7	9	6	22	PASS	2703	TCGA-02-0114	GBM	37	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Treated primary GBM	NA	1998	NA	-13681	Dead	WITH TUMOR	3041	3041	NA	Recurrence	NA	NA	2296	NA	NA	NA	1	3041	1	3041	NA	NA	1	2296	
50	TCGA-02-0115	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0115-01	195	0.2751723716610677	128	TCGA-02-0115-01	6	6	31	0.0989073755542943	TCGA-02-0115-01	4	7	4	15	PASS	2704	TCGA-02-0115	GBM	52	MALE	ASIAN	NA	NA	Treated primary GBM	NA	2006	NA	-19257	Dead	WITH TUMOR	476	476	NA	Progression of Disease	NA	NA	91	NA	NA	NA	1	476	1	476	NA	NA	1	91	
50	TCGA-02-0116	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0116-01	137	0.1928847231159519	70	TCGA-02-0116-01	9	6	16	0.10004559006881217	TCGA-02-0116-01	1	3	3	7	PASS	2705	TCGA-02-0116	GBM	51	MALE	WHITE	NA	NA	Treated primary GBM	NA	2003	NA	-18657	Dead	WITH TUMOR	1489	1489	NA	Progression of Disease	NA	NA	1231	NA	NA	NA	1	1489	1	1489	NA	NA	1	1231	
40	TCGA-02-0258	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0258-01	156	0.3848840747933411	83	TCGA-02-0258-01	3	5	24	0.12990520284320894	TCGA-02-0258-01	8	12	9	29	PASS	2706	TCGA-02-0258	GBM	36	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1989	NA	-13269	Dead	WITH TUMOR	503	503	NA	Recurrence	NA	NA	503	NA	NA	NA	1	503	1	503	NA	NA	1	503	
50	TCGA-02-0260	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0260-01	160	0.12354678778429425	90	TCGA-02-0260-01	6	5	15	0.07954745704444703	TCGA-02-0260-01	3	0	4	7	PASS	2707	TCGA-02-0260	GBM	54	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1989	NA	-19956	Dead	WITH TUMOR	515	515	NA	NA	NA	NA	NA	NA	NA	NA	1	515	1	515	NA	NA	1	515	
20	TCGA-02-0266	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0266-01	339	0.9133505686973608	245	TCGA-02-0266-01	13	21	105	0.7427262969253221	TCGA-02-0266-01	5	6	0	11	PASS	2708	TCGA-02-0266	GBM	14	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	1990	NA	-5303	Dead	WITH TUMOR	539	539	NA	Progression of Disease	NA	NA	293	NA	NA	NA	1	539	1	539	NA	NA	1	293	
70	TCGA-02-0269	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0269-01	173	0.2759470809297642	110	TCGA-02-0269-01	10	5	17	0.053934906721881296	TCGA-02-0269-01	0	0	0	0	PASS	2709	TCGA-02-0269	GBM	68	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1990	NA	-25194	Dead	WITH TUMOR	327	327	NA	Progression of Disease	NA	NA	99	NA	NA	NA	1	327	1	327	NA	NA	1	99	
30	TCGA-02-0271	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0271-01	129	0.17369836515910278	67	TCGA-02-0271-01	39	45	40	0.8676100304927888	TCGA-02-0271-01	3	3	0	6	PASS	2710	TCGA-02-0271	GBM	26	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	1990	NA	-9578	Dead	NA	440	440	NA	NA	NA	NA	NA	NA	NA	NA	1	440	NA	440	NA	NA	0	440	
80	TCGA-02-0281	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0281-01	137	0.6161616560394942	73	TCGA-02-0281-01	27	40	12	0.090956901326517	TCGA-02-0281-01	3	3	2	8	PASS	2711	TCGA-02-0281	GBM	78	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1991	NA	-28696	Dead	WITH TUMOR	121	121	NA	NA	NA	NA	NA	NA	NA	NA	1	121	1	121	NA	NA	1	121	
50	TCGA-02-0285	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0285-01	171	0.18418755459389535	100	TCGA-02-0285-01	10	6	11	0.06503560282217248	TCGA-02-0285-01	2	0	2	4	PASS	2712	TCGA-02-0285	GBM	50	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1991	NA	-18353	Dead	WITH TUMOR	422	422	NA	NA	NA	NA	NA	NA	NA	NA	1	422	1	422	NA	NA	1	422	
60	TCGA-02-0289	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0289-01	681	0.1775220688479035	575	TCGA-02-0289	0	0	0	0	TCGA-02-0289	0	0	0	0	PASS	2713	TCGA-02-0289	GBM	57	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1992	NA	-21031	Dead	WITH TUMOR	432	432	NA	Progression of Disease	NA	NA	245	NA	NA	NA	1	432	1	432	NA	NA	1	245	
50	TCGA-02-0290	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0290-01	226	0.15866746851063004	155	TCGA-02-0290-01	8	5	14	0.06350303316864146	TCGA-02-0290-01	3	0	1	4	PASS	2714	TCGA-02-0290	GBM	49	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1992	NA	-18066	Dead	WITH TUMOR	485	485	NA	Progression of Disease	NA	NA	374	NA	NA	NA	1	485	1	485	NA	NA	1	374	
40	TCGA-02-0317	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0317-01	176	0.14034933824629514	116	TCGA-02-0317-01	4	4	19	0.08519452100152927	TCGA-02-0317-01	2	1	4	7	PASS	2715	TCGA-02-0317	GBM	40	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1994	NA	-14636	Dead	WITH TUMOR	372	372	NA	Progression of Disease	NA	NA	238	NA	NA	NA	1	372	1	372	NA	NA	1	238	
70	TCGA-02-0321	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0321-01	182	0.19068829387467587	125	TCGA-02-0321-01	4	8	46	0.16758501703651535	TCGA-02-0321-01	6	7	6	19	PASS	2716	TCGA-02-0321	GBM	74	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1995	NA	-27125	Dead	WITH TUMOR	301	301	NA	Progression of Disease	NA	NA	73	NA	NA	NA	1	301	1	301	NA	NA	1	73	
70	TCGA-02-0324	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0324-01	88	0.3746828255912312	35	TCGA-02-0324-01	6	4	8	0.11903627993796018	TCGA-02-0324-01	1	0	1	2	PASS	2717	TCGA-02-0324	GBM	69	FEMALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	1995	NA	-25352	Dead	WITH TUMOR	235	235	NA	Progression of Disease	NA	NA	164	NA	NA	NA	1	235	1	235	NA	NA	1	164	
60	TCGA-02-0325	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0325-01	119	0.4579982875019186	60	TCGA-02-0325-01	9	7	19	0.200826995787404	TCGA-02-0325-01	2	3	1	6	PASS	2718	TCGA-02-0325	GBM	61	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1996	NA	-22598	Dead	WITH TUMOR	323	323	NA	Progression of Disease	NA	NA	284	NA	NA	NA	1	323	1	323	NA	NA	1	284	
80	TCGA-02-0326	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0326-01	112	0.07087609282283906	57	TCGA-02-0326-01	3	4	8	0.04525019206415104	TCGA-02-0326-01	0	0	0	0	PASS	2719	TCGA-02-0326	GBM	82	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1995	NA	-30160	Dead	WITH TUMOR	5	223	NA	Progression of Disease	NA	NA	5	NA	NA	NA	1	223	1	223	NA	NA	1	5	
50	TCGA-02-0330	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0330-01	132	0.6572431359971079	77	TCGA-02-0330-01	10	7	15	0.26049220230649683	TCGA-02-0330-01	2	2	3	7	PASS	2720	TCGA-02-0330	GBM	51	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	1995	NA	-18654	Dead	WITH TUMOR	484	484	NA	Progression of Disease	NA	NA	120	NA	NA	NA	1	484	1	484	NA	NA	1	120	
50	TCGA-02-0332	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0332-01	68	0.3269923088195772	21	TCGA-02-0332-01	10	8	2	0.004707038648860527	TCGA-02-0332-01	2	3	0	5	PASS	2721	TCGA-02-0332	GBM	46	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1995	NA	-17021	Dead	WITH TUMOR	782	782	NA	Progression of Disease	NA	NA	438	NA	NA	NA	1	782	1	782	NA	NA	1	438	
80	TCGA-02-0333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0333-01	282	0.22208818722097606	183	TCGA-02-0333-01	7	9	50	0.148696013313541	TCGA-02-0333-01	3	3	4	10	PASS	2722	TCGA-02-0333	GBM	77	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1996	NA	-28449	Dead	WITH TUMOR	133	133	NA	Progression of Disease	NA	NA	4	NA	NA	NA	1	133	1	133	NA	NA	1	4	
50	TCGA-02-0337	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0337-01	241	0.13829469278536174	182	TCGA-02-0337-01	6	4	9	0.07701976836255534	TCGA-02-0337-01	0	1	1	2	PASS	2723	TCGA-02-0337	GBM	48	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1996	NA	-17643	Dead	WITH TUMOR	764	764	NA	Progression of Disease	NA	NA	691	NA	NA	NA	1	764	1	764	NA	NA	1	691	
40	TCGA-02-0338	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0338-01	235	0.021885615746620225	172	TCGA-02-0338-01	0	2	4	0.004840529981264912	TCGA-02-0338-01	1	1	0	2	PASS	2724	TCGA-02-0338	GBM	41	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1996	NA	-15231	Dead	WITH TUMOR	322	322	NA	Progression of Disease	NA	NA	168	NA	NA	NA	1	322	1	322	NA	NA	1	168	
70	TCGA-02-0339	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0339-01	103	0.61146610154668	48	TCGA-02-0339-01	5	5	10	0.1243418839040724	TCGA-02-0339-01	5	1	4	10	PASS	2725	TCGA-02-0339	GBM	67	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1995	NA	-24524	Dead	WITH TUMOR	377	377	NA	Progression of Disease	NA	NA	148	NA	NA	NA	1	377	1	377	NA	NA	1	148	
50	TCGA-02-0422	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0422-01	180	0.14443329018682335	113	TCGA-02-0422-01	4	5	31	0.12610064622020642	TCGA-02-0422-01	3	3	2	8	PASS	2726	TCGA-02-0422	GBM	50	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1996	NA	-18368	Dead	WITH TUMOR	441	441	NA	Progression of Disease	NA	NA	125	NA	NA	NA	1	441	1	441	NA	NA	1	125	
70	TCGA-02-0430	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0430-01	108	0.1884606794857155	41	TCGA-02-0430-01	7	5	14	0.11677439890715335	TCGA-02-0430-01	3	3	4	10	PASS	2727	TCGA-02-0430	GBM	67	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1997	NA	-24641	Dead	WITH TUMOR	321	321	NA	NA	NA	NA	NA	NA	NA	NA	1	321	1	321	NA	NA	1	321	
40	TCGA-02-0432	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0432-01	83	0.433129345640184	37	TCGA-02-0432-01	3	6	8	0.08479762897704933	TCGA-02-0432-01	9	4	5	18	PASS	2728	TCGA-02-0432	GBM	36	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1997	NA	-13260	Dead	WITH TUMOR	1433	1433	NA	Progression of Disease	NA	NA	1053	NA	NA	NA	1	1433	1	1433	NA	NA	1	1053	
70	TCGA-02-0439	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0439	0	0	0	TCGA-02-0439	0	0	0	0	TCGA-02-0439	0	0	0	0	PASS	2729	TCGA-02-0439	GBM	70	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1997	NA	-25624	Dead	WITH TUMOR	20	20	NA	Progression of Disease	NA	NA	13	NA	NA	NA	1	20	1	20	NA	NA	1	13	
60	TCGA-02-0440	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0440-01	185	0.1624318871862623	121	TCGA-02-0440-01	5	4	17	0.0990499650195921	TCGA-02-0440-01	0	1	1	2	PASS	2730	TCGA-02-0440	GBM	62	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1997	NA	-22955	Dead	WITH TUMOR	345	345	NA	Progression of Disease	NA	NA	212	NA	NA	NA	1	345	1	345	NA	NA	1	212	
60	TCGA-02-0446	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0446-01	203	0.20088346952513805	126	TCGA-02-0446-01	5	3	22	0.1079063921873426	TCGA-02-0446-01	1	5	1	7	PASS	2731	TCGA-02-0446	GBM	61	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1997	NA	-22541	Dead	WITH TUMOR	282	282	NA	Recurrence	NA	NA	15	NA	NA	NA	1	282	1	282	NA	NA	1	15	
60	TCGA-02-0451	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0451-01	298	0.21883345226603404	219	TCGA-02-0451-01	5	4	36	0.09480917592346604	TCGA-02-0451-01	2	5	2	9	PASS	2732	TCGA-02-0451	GBM	62	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-22662	Dead	WITH TUMOR	493	493	NA	Recurrence	NA	NA	428	NA	NA	NA	1	493	1	493	NA	NA	1	428	
70	TCGA-02-0456	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-02-0456-01	67	0.4590357931835942	26	TCGA-02-0456-01	10	6	7	0.17410282709009398	TCGA-02-0456-01	1	1	0	2	PASS	2733	TCGA-02-0456	GBM	67	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-24796	Dead	WITH TUMOR	102	102	NA	Recurrence	NA	NA	12	NA	NA	NA	1	102	1	102	NA	NA	1	12	
60	TCGA-02-2466	1	6	0	3	5	1	1	0	5	77	3	0	1	26	13	0	TCGA-02-2466-01	239	0.7864778904702362	168	TCGA-02-2466-01	11	8	42	0.18196246368885893	TCGA-02-2466-01	8	7	5	20	mutation call filter	2734	TCGA-02-2466	GBM	61	MALE	WHITE	NA	NA	Treated primary GBM	NA	2007	NA	-22457	Dead	WITH TUMOR	511	511	NA	Progression of Disease	NA	NA	128	NA	NA	NA	1	511	1	511	NA	NA	1	128	
60	TCGA-02-2470	0	4	2	2	1	0	1	0	3	44	3	0	0	15	1	0	TCGA-02-2470-01	104	0.11403546354028915	52	TCGA-02-2470-01	5	7	13	0.1344709449980406	TCGA-02-2470-01	4	5	3	12	PASS	2735	TCGA-02-2470	GBM	57	MALE	WHITE	NA	NA	Treated primary GBM	NA	2007	NA	-21021	Dead	WITH TUMOR	393	393	NA	Progression of Disease	NA	NA	183	NA	NA	NA	1	393	1	393	NA	NA	1	183	
40	TCGA-02-2483	0	4	0	2	1	0	0	0	2	43	0	0	1	16	1	0	TCGA-02-2483-01	213	0.32023162092586804	134	TCGA-02-2483-01	4	8	33	0.17522086570717835	TCGA-02-2483-01	9	6	7	22	PASS	2736	TCGA-02-2483	GBM	43	MALE	ASIAN	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-15964	Alive	WITH TUMOR	466	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	466	0	466	NA	NA	0	466	
50	TCGA-02-2485	0	5	0	0	3	0	2	0	1	46	2	0	2	17	1	0	TCGA-02-2485-01	215	0.188346360576873	138	TCGA-02-2485-01	8	5	7	0.05011737032134532	TCGA-02-2485-01	1	2	0	3	PASS	2737	TCGA-02-2485	GBM	53	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-19494	Alive	WITH TUMOR	470	NA	NA	Progression of Disease	NA	NA	186	NA	NA	NA	0	470	0	470	NA	NA	1	186	
60	TCGA-02-2486	1	0	0	1	1	1	0	0	1	51	3	0	0	14	1	0	TCGA-02-2486-01	192	0.23936442689902246	121	TCGA-02-2486-01	8	6	24	0.15724077214240553	TCGA-02-2486-01	1	5	3	9	PASS	2738	TCGA-02-2486	GBM	64	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-23394	Dead	WITH TUMOR	NA	618	NA	NA	NA	NA	NA	NA	NA	NA	1	618	1	618	NA	NA	1	618	
80	TCGA-06-0119	1	1	0	3	1	0	0	0	2	59	5	0	0	12	3	0	TCGA-06-0119-01	73	0.15676758973575086	37	TCGA-06-0119-01	8	8	3	0.06434432274282252	TCGA-06-0119-01	0	1	0	1	PASS	2739	TCGA-06-0119	GBM	81	FEMALE	WHITE	NA	NA	Glioblastoma Multiforme (GBM)	NA	2005	NA	-29606	Dead	WITH TUMOR	NA	82	NA	NA	NA	NA	NA	NA	NA	NA	1	82	1	82	NA	NA	1	82	
80	TCGA-06-0122	0	5	0	2	3	0	0	0	1	55	8	0	1	29	1	0	TCGA-06-0122-01	130	0.19922562825148	74	TCGA-06-0122-01	9	8	13	0.15870128741203748	TCGA-06-0122-01	4	9	4	17	PASS	2740	TCGA-06-0122	GBM	84	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-30968	Dead	NA	8	187	NA	NA	NA	NA	NA	NA	NA	NA	1	187	NA	187	NA	NA	0	187	
70	TCGA-06-0124	0	5	0	1	1	0	1	0	0	43	7	0	2	16	2	0	TCGA-06-0124-01	75	0.17450609424144606	25	TCGA-06-0124-01	6	6	12	0.11125086488361616	TCGA-06-0124-01	3	4	2	9	PASS	2741	TCGA-06-0124	GBM	67	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-24591	Dead	WITH TUMOR	123	620	NA	NA	NA	NA	NA	NA	NA	NA	1	620	1	620	NA	NA	1	620	
60	TCGA-06-0125	0	4	1	5	10	0	0	2	3	113	6	0	4	35	5	2	TCGA-06-0125-01	231	0.155485660745586	142	TCGA-06-0125-02	6	4	15	0.07141348155208255	TCGA-06-0125-02	3	3	3	9	mutation call filter	2742	TCGA-06-0125	GBM	63	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-23343	Dead	WITH TUMOR	1439	1448	NA	Progression of Disease	NA	NA	797	NA	NA	NA	1	1448	1	1448	NA	NA	1	797	
90	TCGA-06-0126	1	4	0	4	1	1	1	0	3	44	1	0	2	17	0	0	TCGA-06-0126-01	107	0.16608904863205934	59	TCGA-06-0126-01	8	5	13	0.07484495364370758	TCGA-06-0126-01	2	4	2	8	PASS	2743	TCGA-06-0126	GBM	86	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-31627	Dead	NA	3	211	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	211	NA	211	NA	NA	0	211	
70	TCGA-06-0127	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0127-01	163	0.10156614573022983	100	TCGA-06-0127-01	6	4	23	0.05826495927281264	TCGA-06-0127-01	2	4	2	8	PASS	2744	TCGA-06-0127	GBM	67	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-24502	Dead	WITH TUMOR	109	121	NA	Progression of Disease	NA	NA	91	NA	NA	NA	1	121	1	121	NA	NA	1	91	
70	TCGA-06-0128	0	2	2	1	4	2	0	0	2	42	4	0	0	15	2	0	TCGA-06-0128-01	63	0.6174896733324643	23	TCGA-06-0128-01	2	2	3	0.05064921642102983	TCGA-06-0128-01	3	1	1	5	PASS	2745	TCGA-06-0128	GBM	66	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-24217	Dead	WITH TUMOR	691	691	NA	Progression of Disease	NA	NA	190	NA	NA	NA	1	691	1	691	NA	NA	1	190	
30	TCGA-06-0129	0	0	0	2	5	0	3	0	0	27	5	0	0	7	0	0	TCGA-06-0129-01	860	0.20377191142554416	701	TCGA-06-0129-01	7	7	109	0.04640442043581065	TCGA-06-0129-01	5	5	1	11	PASS	2746	TCGA-06-0129	GBM	30	MALE	ASIAN	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-11284	Dead	WITH TUMOR	989	1024	NA	Progression of Disease	NA	NA	148	NA	NA	NA	1	1024	1	1024	NA	NA	1	148	
50	TCGA-06-0130	0	2	0	1	1	0	0	0	0	22	1	1	3	7	1	0	TCGA-06-0130-01	86	0.4116560014950044	37	TCGA-06-0130-01	30	15	22	0.28077729515050553	TCGA-06-0130-01	3	3	3	9	PASS	2747	TCGA-06-0130	GBM	54	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-19812	Dead	WITH TUMOR	320	394	NA	Progression of Disease	NA	NA	244	NA	NA	NA	1	394	1	394	NA	NA	1	244	
50	TCGA-06-0132	0	0	0	0	1	0	0	0	0	19	0	0	0	11	0	0	TCGA-06-0132-01	73	0.149048821689387	29	TCGA-06-0132-01	6	3	25	0.1366294881408541	TCGA-06-0132-01	0	1	2	3	PASS	2748	TCGA-06-0132	GBM	49	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-18125	Dead	WITH TUMOR	570	771	NA	Progression of Disease	NA	NA	482	NA	NA	NA	1	771	1	771	NA	NA	1	482	
60	TCGA-06-0133	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0133-01	161	0.2746527242027668	109	TCGA-06-0133-01	8	5	11	0.058760426083305575	TCGA-06-0133-01	1	1	2	4	PASS	2749	TCGA-06-0133	GBM	64	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-23402	Dead	WITH TUMOR	428	435	NA	Progression of Disease	NA	NA	78	NA	NA	NA	1	435	1	435	NA	NA	1	78	
60	TCGA-06-0137	1	2	0	2	2	1	0	0	5	57	4	0	4	30	0	0	TCGA-06-0137-01	166	0.15607115552914988	106	TCGA-06-0137-01	7	4	23	0.07366630452880367	TCGA-06-0137-01	1	1	0	2	PASS	2750	TCGA-06-0137	GBM	63	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-23273	Dead	WITH TUMOR	702	812	NA	Progression of Disease	NA	NA	487	NA	NA	NA	1	812	1	812	NA	NA	1	487	
40	TCGA-06-0138	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0138-01	121	0.5642695190489769	58	TCGA-06-0138	0	0	0	0	TCGA-06-0138	0	0	0	0	PASS	2751	TCGA-06-0138	GBM	43	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-15736	Dead	WITH TUMOR	674	737	NA	Progression of Disease	NA	NA	394	NA	NA	NA	1	737	1	737	NA	NA	1	394	
40	TCGA-06-0139	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	TCGA-06-0139-01	95	0.019551491510053136	47	TCGA-06-0139	0	0	0	0	TCGA-06-0139	0	0	0	0	PASS	2752	TCGA-06-0139	GBM	40	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-14729	Dead	WITH TUMOR	327	362	NA	Progression of Disease	NA	NA	152	NA	NA	NA	1	362	1	362	NA	NA	1	152	
90	TCGA-06-0140	0	4	1	0	1	0	0	0	2	41	3	0	0	12	0	0	TCGA-06-0140-01	131	0.1643362132483094	74	TCGA-06-0140-01	7	5	8	0.1033888874275436	TCGA-06-0140-01	0	1	1	2	PASS	2753	TCGA-06-0140	GBM	86	MALE	WHITE	NA	NA	Glioblastoma Multiforme (GBM)	NA	2003	NA	-31566	Dead	WITH TUMOR	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	1	6	1	6	NA	NA	1	6	
60	TCGA-06-0141	0	0	0	0	0	0	0	0	1	15	1	0	0	6	0	0	TCGA-06-0141-01	85	0.05433422511351597	41	TCGA-06-0141-01	1	3	0	0.0	TCGA-06-0141-01	1	1	0	2	PASS	2754	TCGA-06-0141	GBM	62	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-22926	Dead	WITH TUMOR	280	313	NA	Progression of Disease	NA	NA	145	NA	NA	NA	1	313	1	313	NA	NA	1	145	
80	TCGA-06-0142	0	0	0	1	0	0	0	0	0	24	1	0	1	7	1	0	TCGA-06-0142-01	101	0.001318204021057384	50	TCGA-06-0142	0	0	0	0	TCGA-06-0142	0	0	0	0	PASS	2755	TCGA-06-0142	GBM	81	MALE	WHITE	NA	NA	Glioblastoma Multiforme (GBM)	NA	2002	NA	-29642	Dead	WITH TUMOR	NA	67	NA	NA	NA	NA	NA	NA	NA	NA	1	67	1	67	NA	NA	1	67	
60	TCGA-06-0143	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0143-01	178	0.1454178403584821	116	TCGA-06-0143-01	4	3	9	0.07732923910515183	TCGA-06-0143-01	1	4	2	7	PASS	2756	TCGA-06-0143	GBM	58	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-21386	Dead	WITH TUMOR	357	357	NA	Recurrence	NA	NA	265	NA	NA	NA	1	357	1	357	NA	NA	1	265	
50	TCGA-06-0145	3	9	0	2	2	0	0	0	5	72	7	0	2	24	1	0	TCGA-06-0145-01	173	0.15102982217623095	90	TCGA-06-0145-01	6	5	15	0.07299049677574393	TCGA-06-0145-01	3	1	2	6	PASS	2757	TCGA-06-0145	GBM	53	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-19661	Dead	WITH TUMOR	71	71	NA	NA	NA	NA	NA	NA	NA	NA	1	71	1	71	NA	NA	1	71	
30	TCGA-06-0146	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0146-01	164	0.18337999686191475	91	TCGA-06-0146	0	0	0	0	TCGA-06-0146	0	0	0	0	PASS	2758	TCGA-06-0146	GBM	33	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1995	NA	-12253	Dead	WITH TUMOR	611	611	NA	Progression of Disease	NA	NA	530	NA	NA	NA	1	611	1	611	NA	NA	1	530	
50	TCGA-06-0147	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0147-01	41	0.21257602160366548	6	TCGA-06-0147	0	0	0	0	TCGA-06-0147	0	0	0	0	PASS	2759	TCGA-06-0147	GBM	51	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1999	NA	-18743	Dead	WITH TUMOR	508	541	NA	Progression of Disease	NA	NA	92	NA	NA	NA	1	541	1	541	NA	NA	1	92	
80	TCGA-06-0148	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0148-01	318	0.1575613333116167	221	TCGA-06-0148-01	6	7	36	0.10885094066398401	TCGA-06-0148-01	5	4	2	11	PASS	2760	TCGA-06-0148	GBM	76	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-27842	Dead	WITH TUMOR	298	307	NA	Progression of Disease	NA	NA	189	NA	NA	NA	1	307	1	307	NA	NA	1	189	
70	TCGA-06-0149	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0149-01	87	0.2512700738303498	35	TCGA-06-0149-01	8	6	11	0.0957248019238468	TCGA-06-0149-01	1	3	0	4	PASS	2761	TCGA-06-0149	GBM	74	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-27315	Dead	WITH TUMOR	239	262	NA	Progression of Disease	NA	NA	204	NA	NA	NA	1	262	1	262	NA	NA	1	204	
50	TCGA-06-0150	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0150-01	82	0.17433044198928546	43	TCGA-06-0150	0	0	0	0	TCGA-06-0150	0	0	0	0	PASS	2762	TCGA-06-0150	GBM	45	MALE	WHITE	NA	NA	Glioblastoma Multiforme (GBM)	NA	1995	NA	-16442	Dead	WITH TUMOR	NA	592	NA	NA	NA	NA	NA	NA	NA	NA	1	592	1	592	NA	NA	1	592	
30	TCGA-06-0151	0	2	0	0	1	0	0	0	0	17	2	0	1	1	0	0	TCGA-06-0151-01	105	0.9235167895927718	56	TCGA-06-0151-01	20	20	41	0.16279045308407333	TCGA-06-0151-01	3	3	2	8	PASS	2763	TCGA-06-0151	GBM	32	FEMALE	WHITE	NA	NA	Glioblastoma Multiforme (GBM)	NA	1995	NA	-11956	Dead	WITH TUMOR	NA	1417	NA	NA	NA	NA	NA	NA	NA	NA	1	1417	1	1417	NA	NA	1	1417	
70	TCGA-06-0152	0	6	0	7	7	1	0	0	3	99	5	0	2	40	0	0	TCGA-06-0152-01	162	0.6671356801056327	103	TCGA-06-0152-02	9	7	18	0.08097465560895156	TCGA-06-0152-02	3	0	1	4	mutation call filter	2764	TCGA-06-0152	GBM	68	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1995	NA	-24844	Dead	WITH TUMOR	359	375	NA	Progression of Disease	NA	NA	299	NA	NA	NA	1	375	1	375	NA	NA	1	299	
50	TCGA-06-0154	0	2	0	1	1	0	0	0	0	47	2	0	1	18	0	0	TCGA-06-0154-01	186	0.1467775939113653	129	TCGA-06-0154-01	7	6	64	0.0913689783498682	TCGA-06-0154-01	4	1	6	11	PASS	2765	TCGA-06-0154	GBM	54	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-20018	Dead	WITH TUMOR	389	424	NA	Progression of Disease	NA	NA	208	NA	NA	NA	1	424	1	424	NA	NA	1	208	
60	TCGA-06-0155	0	3	0	4	2	0	1	0	2	54	3	0	3	21	1	0	TCGA-06-0155-01	110	0.13033348137921122	49	TCGA-06-0155-01	6	3	11	0.06019032004817345	TCGA-06-0155-01	0	2	0	2	PASS	2766	TCGA-06-0155	GBM	61	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-22498	Dead	WITH TUMOR	263	318	NA	Progression of Disease	NA	NA	256	NA	NA	NA	1	318	1	318	NA	NA	1	256	
60	TCGA-06-0156	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0156	0	0	0	TCGA-06-0156	0	0	0	0	TCGA-06-0156	0	0	0	0	PASS	2767	TCGA-06-0156	GBM	57	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-20932	Dead	WITH TUMOR	164	178	NA	NA	NA	NA	NA	NA	NA	NA	1	178	1	178	NA	NA	1	178	
60	TCGA-06-0157	0	6	0	4	3	1	0	0	1	37	4	0	2	15	2	0	TCGA-06-0157-01	108	0.15009390260758898	50	TCGA-06-0157-01	5	3	20	0.05970123111170924	TCGA-06-0157-01	1	2	0	3	PASS	2768	TCGA-06-0157	GBM	63	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-23128	Dead	WITH TUMOR	97	97	NA	NA	NA	NA	NA	NA	NA	NA	1	97	1	97	NA	NA	1	97	
70	TCGA-06-0158	0	4	0	3	1	0	0	0	0	43	1	0	0	20	1	0	TCGA-06-0158-01	117	0.2107991008127066	65	TCGA-06-0158-01	8	6	42	0.10772628693667728	TCGA-06-0158-01	2	4	2	8	PASS	2769	TCGA-06-0158	GBM	73	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-26856	Dead	WITH TUMOR	166	329	NA	Progression of Disease	NA	NA	90	NA	NA	NA	1	329	1	329	NA	NA	1	90	
70	TCGA-06-0159	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0159-01	77	0.3656226016803629	33	TCGA-06-0159-01	12	7	8	0.2254149550970861	TCGA-06-0159-01	0	0	0	0	PASS	2770	TCGA-06-0159	GBM	74	MALE	WHITE	NA	NA	Glioblastoma Multiforme (GBM)	NA	1998	NA	-27368	Dead	WITH TUMOR	NA	287	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	287	1	287	NA	NA	1	287	
60	TCGA-06-0160	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0160-01	79	0.0008494903405594582	32	TCGA-06-0160	0	0	0	0	TCGA-06-0160	0	0	0	0	PASS	2771	TCGA-06-0160	GBM	56	FEMALE	WHITE	NA	NA	Glioblastoma Multiforme (GBM)	NA	1999	NA	-20684	Dead	WITH TUMOR	NA	359	NA	NA	NA	NA	NA	[Discrepancy]	NA	NA	1	359	1	359	NA	NA	1	359	
50	TCGA-06-0162	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0162-01	330	0.8849735862348136	229	TCGA-06-0162-01	11	7	49	0.2645570659625128	TCGA-06-0162-01	4	6	1	11	PASS	2772	TCGA-06-0162	GBM	47	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-17272	Dead	WITH TUMOR	78	104	NA	NA	NA	NA	NA	NA	NA	NA	1	104	1	104	NA	NA	1	104	
50	TCGA-06-0164	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0164-01	80	0.2944864672461701	29	TCGA-06-0164-01	10	7	15	0.14112266436007806	TCGA-06-0164-01	2	3	4	9	PASS	2773	TCGA-06-0164	GBM	47	MALE	ASIAN	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-17510	Dead	WITH TUMOR	1730	1731	NA	Progression of Disease	NA	NA	1428	NA	NA	NA	1	1731	1	1731	NA	NA	1	1428	
50	TCGA-06-0165	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	TCGA-06-0165-01	77	7.182716191385838e-05	32	TCGA-06-0165	0	0	0	0	TCGA-06-0165	0	0	0	0	PASS	2774	TCGA-06-0165	GBM	52	MALE	WHITE	NA	NA	Glioblastoma Multiforme (GBM)	NA	2001	NA	-19198	Dead	WITH TUMOR	NA	324	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	324	1	324	NA	NA	1	324	
50	TCGA-06-0166	0	5	0	0	0	2	1	0	1	32	5	0	0	3	0	0	TCGA-06-0166-01	124	0.6453399218558894	69	TCGA-06-0166-01	10	7	54	0.2786436391180377	TCGA-06-0166-01	4	5	3	12	PASS	2775	TCGA-06-0166	GBM	51	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-18902	Dead	WITH TUMOR	161	178	NA	Progression of Disease	NA	NA	66	NA	NA	NA	1	178	1	178	NA	NA	1	66	
40	TCGA-06-0167	0	1	0	0	0	0	0	0	1	0	0	0	0	2	0	0	TCGA-06-0167	0	0	0	TCGA-06-0167	0	0	0	0	TCGA-06-0167	0	0	0	0	PASS	2776	TCGA-06-0167	GBM	44	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2001	NA	-16170	Dead	WITH TUMOR	NA	347	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	347	1	347	NA	NA	1	347	
60	TCGA-06-0168	0	4	0	1	2	0	1	0	0	30	2	0	0	13	1	1	TCGA-06-0168-01	79	0.2600235329677631	32	TCGA-06-0168-01	10	7	53	0.14075428530247036	TCGA-06-0168-01	2	2	7	11	PASS	2777	TCGA-06-0168	GBM	59	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-21776	Dead	WITH TUMOR	579	598	NA	Progression of Disease	NA	NA	461	NA	NA	NA	1	598	1	598	NA	NA	1	461	
70	TCGA-06-0169	0	2	1	1	2	0	0	0	3	42	1	0	1	15	1	0	TCGA-06-0169-01	128	0.13062189145788353	74	TCGA-06-0169-01	6	5	20	0.08713670144296272	TCGA-06-0169-01	2	1	0	3	PASS	2778	TCGA-06-0169	GBM	68	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-25127	Dead	WITH TUMOR	95	100	NA	Progression of Disease	NA	NA	92	NA	NA	NA	1	100	1	100	NA	NA	1	92	
70	TCGA-06-0171	0	3	0	2	3	0	3	0	4	72	7	0	2	19	4	0	TCGA-06-0171-01	108	0.3210192154381843	61	TCGA-06-0171-02	8	5	3	0.056858167454302375	TCGA-06-0171-02	1	3	1	5	mutation call filter	2779	TCGA-06-0171	GBM	65	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-24085	Dead	WITH TUMOR	396	399	NA	Progression of Disease	NA	NA	117	NA	NA	NA	1	399	1	399	NA	NA	1	117	
70	TCGA-06-0173	0	1	1	3	1	0	0	0	2	64	1	0	2	21	2	0	TCGA-06-0173-01	166	0.19812486849986047	102	TCGA-06-0173-01	8	5	52	0.06167001282371505	TCGA-06-0173-01	0	2	1	3	PASS	2780	TCGA-06-0173	GBM	72	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-26549	Dead	WITH TUMOR	7	136	NA	NA	NA	NA	NA	NA	NA	NA	1	136	1	136	NA	NA	1	136	
50	TCGA-06-0174	1	3	0	1	2	0	0	0	1	59	3	0	0	22	0	0	TCGA-06-0174-01	120	0.26352072178234537	60	TCGA-06-0174-01	6	3	36	0.05875693667407366	TCGA-06-0174-01	0	2	0	2	PASS	2781	TCGA-06-0174	GBM	54	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-19824	Dead	WITH TUMOR	67	98	NA	Progression of Disease	NA	NA	47	NA	NA	NA	1	98	1	98	NA	NA	1	47	
70	TCGA-06-0175	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0175-01	175	0.2632495145889682	106	TCGA-06-0175-01	11	7	33	0.12366148757835745	TCGA-06-0175-01	6	7	5	18	PASS	2782	TCGA-06-0175	GBM	69	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-25559	Dead	WITH TUMOR	83	123	NA	Progression of Disease	NA	NA	39	NA	NA	NA	1	123	1	123	NA	NA	1	39	
30	TCGA-06-0176	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0176-01	67	0.08681148761717257	25	TCGA-06-0176	0	0	0	0	TCGA-06-0176	0	0	0	0	PASS	2783	TCGA-06-0176	GBM	34	MALE	ASIAN	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-12777	Alive	TUMOR FREE	2768	NA	NA	Progression of Disease	NA	NA	41	NA	NA	NA	0	2768	0	2768	NA	NA	1	41	
60	TCGA-06-0177	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0177-01	303	0.7002863157732574	228	TCGA-06-0177-01	20	13	49	0.06749918549233884	TCGA-06-0177-01	1	3	1	5	PASS	2784	TCGA-06-0177	GBM	64	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-23498	Dead	WITH TUMOR	61	127	NA	NA	NA	NA	NA	NA	NA	NA	1	127	1	127	NA	NA	1	127	
40	TCGA-06-0178	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0178-01	41	0.0002926092079073334	5	TCGA-06-0178	0	0	0	0	TCGA-06-0178	0	0	0	0	PASS	2785	TCGA-06-0178	GBM	38	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-14235	Dead	WITH TUMOR	NA	2681	NA	Progression of Disease	NA	NA	192	NA	NA	NA	1	2681	1	2681	NA	NA	1	192	
60	TCGA-06-0179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0179-01	80	0.1430543253860831	39	TCGA-06-0179-01	8	4	2	0.04986521960512538	TCGA-06-0179-01	0	0	0	0	PASS	2786	TCGA-06-0179	GBM	64	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-23450	Dead	WITH TUMOR	578	616	NA	Progression of Disease	NA	NA	250	NA	NA	NA	1	616	1	616	NA	NA	1	250	
80	TCGA-06-0182	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0182-01	168	0.3765615598666282	107	TCGA-06-0182-01	8	7	32	0.06284078489849723	TCGA-06-0182-01	4	8	3	15	PASS	2787	TCGA-06-0182	GBM	76	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-27964	Dead	WITH TUMOR	77	111	NA	NA	NA	NA	NA	NA	NA	NA	1	111	1	111	NA	NA	1	111	
60	TCGA-06-0184	0	3	0	1	2	0	1	0	2	38	5	0	1	17	2	0	TCGA-06-0184-01	167	0.6036059304794155	104	TCGA-06-0184-01	13	7	32	0.31017020077464946	TCGA-06-0184-01	3	3	1	7	PASS	2788	TCGA-06-0184	GBM	63	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-23317	Dead	WITH TUMOR	NA	2126	NA	NA	NA	NA	1276	NA	NA	NA	1	2126	1	2126	NA	NA	1	1276	
50	TCGA-06-0185	1	3	0	1	2	0	0	0	0	50	3	0	2	18	2	0	TCGA-06-0185-01	101	0.2283983255636409	48	TCGA-06-0185-01	11	9	35	0.10861576771505213	TCGA-06-0185-01	3	0	3	6	PASS	2789	TCGA-06-0185	GBM	54	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-19923	Alive	WITH TUMOR	2246	NA	NA	Progression of Disease	NA	NA	711	NA	NA	NA	0	2246	0	2246	NA	NA	1	711	
70	TCGA-06-0187	0	0	1	1	0	0	1	0	2	33	1	0	0	10	3	0	TCGA-06-0187-01	182	0.2239026280851546	116	TCGA-06-0187-01	6	6	41	0.11273492848149698	TCGA-06-0187-01	6	2	3	11	PASS	2790	TCGA-06-0187	GBM	69	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-25318	Dead	WITH TUMOR	801	828	NA	Recurrence	NA	NA	531	NA	NA	NA	1	828	1	828	NA	NA	1	531	
70	TCGA-06-0188	0	2	1	1	3	0	0	0	3	36	4	0	3	18	1	1	TCGA-06-0188-01	188	0.6109266255181569	136	TCGA-06-0188-01	7	7	82	0.14624218946834472	TCGA-06-0188-01	4	3	4	11	PASS	2791	TCGA-06-0188	GBM	71	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-26080	Dead	WITH TUMOR	NA	1356	NA	NA	NA	NA	310	NA	NA	NA	1	1356	1	1356	NA	NA	1	310	
60	TCGA-06-0189	0	0	0	2	0	0	0	0	0	21	1	0	0	6	0	0	TCGA-06-0189-01	81	0.1513566077310238	33	TCGA-06-0189	0	0	0	0	TCGA-06-0189	0	0	0	0	PASS	2792	TCGA-06-0189	GBM	55	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-20297	Dead	WITH TUMOR	454	469	NA	NA	NA	NA	NA	NA	NA	NA	1	469	1	469	NA	NA	1	469	
60	TCGA-06-0190	0	7	2	3	6	1	2	0	6	139	2	0	0	52	5	0	TCGA-06-0190-01	126	0.24458357791239665	76	TCGA-06-0190-02	6	9	18	0.2266528504671635	TCGA-06-0190-02	3	4	4	11	mutation call filter	2793	TCGA-06-0190	GBM	62	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-22835	Dead	WITH TUMOR	313	317	NA	Progression of Disease	NA	NA	88	NA	NA	NA	1	317	1	317	NA	NA	1	88	
60	TCGA-06-0192	0	2	0	2	1	2	0	0	1	47	7	0	1	26	2	0	TCGA-06-0192-01	125	0.3196604499052494	72	TCGA-06-0192-01	8	5	20	0.06332551802383557	TCGA-06-0192-01	0	0	1	1	PASS	2794	TCGA-06-0192	GBM	58	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-21243	Dead	WITH TUMOR	NA	1185	NA	Locoregional Disease	NA	NA	648	NA	NA	NA	1	1185	1	1185	NA	NA	1	648	
40	TCGA-06-0194	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0194-01	61	0.1414395475413278	20	TCGA-06-0194-01	6	4	4	0.09168526194192328	TCGA-06-0194-01	0	0	0	0	PASS	2795	TCGA-06-0194	GBM	37	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1994	NA	-13852	Dead	WITH TUMOR	142	142	NA	Progression of Disease	NA	NA	125	NA	NA	NA	1	142	1	142	NA	NA	1	125	
60	TCGA-06-0195	0	4	0	2	1	1	0	1	4	58	3	0	3	16	1	0	TCGA-06-0195-01	74	0.5409780741172608	25	TCGA-06-0195-01	21	22	52	0.19143925395918893	TCGA-06-0195-01	3	1	2	6	PASS	2796	TCGA-06-0195	GBM	63	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1994	NA	-23132	Dead	WITH TUMOR	214	225	NA	Progression of Disease	NA	NA	147	NA	NA	NA	1	225	1	225	NA	NA	1	147	
70	TCGA-06-0197	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0197-01	75	0.4110849730964154	25	TCGA-06-0197-01	10	6	34	0.16445747622704254	TCGA-06-0197-01	0	0	2	2	PASS	2797	TCGA-06-0197	GBM	65	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1994	NA	-24095	Dead	WITH TUMOR	79	169	NA	Progression of Disease	NA	NA	47	NA	NA	NA	1	169	1	169	NA	NA	1	47	
50	TCGA-06-0201	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0201-01	49	0.15512018867751576	10	TCGA-06-0201-01	6	4	11	0.0894213032769702	TCGA-06-0201-01	0	5	2	7	PASS	2798	TCGA-06-0201	GBM	51	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1995	NA	-18649	Dead	WITH TUMOR	12	12	NA	NA	NA	NA	NA	NA	NA	NA	1	12	1	12	NA	NA	1	12	
40	TCGA-06-0206	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0206-01	67	0.3037652883782188	30	TCGA-06-0206-01	10	7	23	0.1478199471832996	TCGA-06-0206-01	2	1	3	6	PASS	2799	TCGA-06-0206	GBM	40	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1996	NA	-14937	Dead	WITH TUMOR	197	233	NA	Recurrence	NA	NA	106	NA	NA	NA	1	233	1	233	NA	NA	1	106	
50	TCGA-06-0208	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0208-01	106	0.13870050446486612	58	TCGA-06-0208-01	6	4	38	0.07641130123246281	TCGA-06-0208-01	2	2	2	6	PASS	2800	TCGA-06-0208	GBM	52	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1997	NA	-19108	Dead	WITH TUMOR	167	256	NA	Progression of Disease	NA	NA	149	NA	NA	NA	1	256	1	256	NA	NA	1	149	
80	TCGA-06-0209	0	3	0	2	2	1	1	0	4	59	3	0	4	21	3	0	TCGA-06-0209	0	0	0	TCGA-06-0209	0	0	0	0	TCGA-06-0209-01	3	1	0	4	PASS	2801	TCGA-06-0209	GBM	76	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1997	NA	-27877	Dead	WITH TUMOR	119	232	NA	NA	NA	NA	NA	NA	NA	NA	1	232	1	232	NA	NA	1	232	
70	TCGA-06-0210	0	6	0	3	2	0	0	0	4	105	7	0	4	31	2	2	TCGA-06-0210-01	78	0.15496732943569036	34	TCGA-06-0210-02	22	15	20	0.10839727632258736	TCGA-06-0210-02	3	0	0	3	mutation call filter	2802	TCGA-06-0210	GBM	72	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1997	NA	-26600	Dead	WITH TUMOR	151	225	NA	Progression of Disease	NA	NA	67	NA	NA	NA	1	225	1	225	NA	NA	1	67	
50	TCGA-06-0211	2	2	0	5	2	0	2	0	5	89	10	0	2	39	1	0	TCGA-06-0211-01	116	0.2727630298192321	50	TCGA-06-0211-02	9	5	19	0.06401630668560451	TCGA-06-0211-02	2	0	1	3	mutation call filter	2803	TCGA-06-0211	GBM	47	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1997	NA	-17515	Dead	WITH TUMOR	360	360	NA	Progression of Disease	NA	NA	53	NA	NA	NA	1	360	1	360	NA	NA	1	53	
60	TCGA-06-0213	0	2	1	1	1	0	2	0	2	45	4	0	3	17	1	0	TCGA-06-0213-01	85	0.16261597012388548	39	TCGA-06-0213-01	3	4	29	0.057974605352756586	TCGA-06-0213-01	5	6	3	14	PASS	2804	TCGA-06-0213	GBM	55	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-20134	Dead	WITH TUMOR	6	16	NA	NA	NA	NA	NA	NA	NA	NA	1	16	1	16	NA	NA	1	16	
70	TCGA-06-0214	0	8	1	3	0	0	1	0	2	55	4	0	0	26	3	0	TCGA-06-0214-01	136	0.5252762162574076	77	TCGA-06-0214-01	8	7	58	0.1951917747394951	TCGA-06-0214-01	5	3	9	17	PASS	2805	TCGA-06-0214	GBM	66	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-24187	Dead	WITH TUMOR	378	457	NA	Progression of Disease	NA	NA	48	NA	NA	NA	1	457	1	457	NA	NA	1	48	
60	TCGA-06-0216	0	2	0	0	1	2	2	0	1	39	6	0	0	22	1	0	TCGA-06-0216-01	133	0.6224918419552071	70	TCGA-06-0216-01	8	5	20	0.16630295689266272	TCGA-06-0216-01	3	2	3	8	PASS	2806	TCGA-06-0216	GBM	61	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1999	NA	-22524	Dead	WITH TUMOR	684	735	NA	Progression of Disease	NA	NA	175	NA	NA	NA	1	735	1	735	NA	NA	1	175	
70	TCGA-06-0219	0	1	0	0	1	0	0	0	8	31	4	0	1	8	1	0	TCGA-06-0219-01	149	0.8103742700589395	83	TCGA-06-0219-01	5	5	49	0.17373641760940925	TCGA-06-0219-01	2	8	5	15	PASS	2807	TCGA-06-0219	GBM	67	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-24488	Dead	WITH TUMOR	11	22	NA	NA	NA	NA	NA	NA	NA	NA	1	22	1	22	NA	NA	1	22	
30	TCGA-06-0221	0	3	0	1	9	0	2	0	0	61	5	0	6	29	0	0	TCGA-06-0221-01	178	0.3732650754451357	109	TCGA-06-0221-02	1	4	27	0.0824374742166907	TCGA-06-0221-02	10	9	5	24	mutation call filter	2808	TCGA-06-0221	GBM	31	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-11333	Dead	WITH TUMOR	548	603	NA	Progression of Disease	NA	NA	260	NA	NA	NA	1	603	1	603	NA	NA	1	260	
80	TCGA-06-0237	0	5	0	2	1	1	0	0	1	31	0	0	1	16	2	0	TCGA-06-0237-01	132	0.5690173809054944	75	TCGA-06-0237-01	9	8	70	0.17150664037545096	TCGA-06-0237-01	0	2	3	5	PASS	2809	TCGA-06-0237	GBM	75	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-27735	Dead	WITH TUMOR	315	415	NA	NA	NA	NA	NA	NA	NA	NA	1	415	1	415	NA	NA	1	415	
50	TCGA-06-0238	0	1	0	3	1	1	1	0	2	37	1	0	1	6	0	0	TCGA-06-0238-01	91	0.1948267218063321	36	TCGA-06-0238-01	4	4	8	0.09728198935706524	TCGA-06-0238-01	1	3	1	5	PASS	2810	TCGA-06-0238	GBM	46	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-17037	Dead	WITH TUMOR	359	405	NA	Progression of Disease	NA	NA	311	NA	NA	NA	1	405	1	405	NA	NA	1	311	
60	TCGA-06-0240	0	0	0	0	0	0	0	0	0	7	0	0	0	0	0	0	TCGA-06-0240-01	49	0.0010509954996159208	13	TCGA-06-0240	0	0	0	0	TCGA-06-0240	0	0	0	0	PASS	2811	TCGA-06-0240	GBM	57	MALE	WHITE	NA	NA	Glioblastoma Multiforme (GBM)	NA	2007	NA	-20937	Dead	WITH TUMOR	NA	621	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	621	1	621	NA	NA	1	621	
70	TCGA-06-0241	0	4	1	1	2	1	0	0	4	39	3	0	1	21	0	0	TCGA-06-0241-01	138	0.26079121757017104	80	TCGA-06-0241-01	6	4	59	0.1287603479957926	TCGA-06-0241-01	4	5	1	10	PASS	2812	TCGA-06-0241	GBM	65	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-24101	Dead	WITH TUMOR	NA	1481	NA	Recurrence	NA	NA	196	NA	NA	NA	1	1481	1	1481	NA	NA	1	196	
50	TCGA-06-0394	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0394-01	92	0.14979319299607602	42	TCGA-06-0394-01	7	5	10	0.06722998669784387	TCGA-06-0394-01	2	1	1	4	PASS	2813	TCGA-06-0394	GBM	51	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	1992	NA	-18913	Dead	WITH TUMOR	314	329	NA	Progression of Disease	NA	NA	87	NA	NA	NA	1	329	1	329	NA	NA	1	87	
60	TCGA-06-0397	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0397-01	114	0.18039343989022236	61	TCGA-06-0397-01	7	6	20	0.04749632532300077	TCGA-06-0397-01	2	3	2	7	PASS	2814	TCGA-06-0397	GBM	57	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1993	NA	-20845	Dead	WITH TUMOR	168	274	NA	NA	NA	NA	NA	NA	NA	NA	1	274	1	274	NA	NA	1	274	
70	TCGA-06-0402	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0402-01	322	0.2372924765654477	209	TCGA-06-0402-01	8	8	63	0.11950708999666268	TCGA-06-0402-01	5	6	7	18	PASS	2815	TCGA-06-0402	GBM	71	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1993	NA	-26059	Dead	WITH TUMOR	8	8	NA	NA	NA	NA	NA	NA	NA	NA	1	8	1	8	NA	NA	1	8	
40	TCGA-06-0409	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0409-01	186	0.6584522142446403	121	TCGA-06-0409-01	16	15	16	0.20542325754561647	TCGA-06-0409-01	8	6	0	14	PASS	2816	TCGA-06-0409	GBM	43	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	1994	NA	-16023	Dead	WITH TUMOR	2145	2201	NA	Progression of Disease	NA	NA	334	NA	NA	NA	1	2201	1	2201	NA	NA	1	334	
80	TCGA-06-0410	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0410-01	176	0.7408248587435111	101	TCGA-06-0410-01	23	19	24	0.20709403802414306	TCGA-06-0410-01	6	2	5	13	PASS	2817	TCGA-06-0410	GBM	76	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1995	NA	-28084	Dead	WITH TUMOR	143	143	NA	NA	NA	NA	NA	NA	NA	NA	1	143	1	143	NA	NA	1	143	
60	TCGA-06-0412	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0412-01	122	0.16291575849148807	62	TCGA-06-0412-01	6	4	7	0.10991228045551353	TCGA-06-0412-01	2	1	2	5	PASS	2818	TCGA-06-0412	GBM	56	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1995	NA	-20619	Dead	WITH TUMOR	245	291	NA	Progression of Disease	NA	NA	130	NA	NA	NA	1	291	1	291	NA	NA	1	130	
80	TCGA-06-0413	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0413-01	212	0.17250845412618251	140	TCGA-06-0413-01	5	5	21	0.06888320100388601	TCGA-06-0413-01	1	3	2	6	PASS	2819	TCGA-06-0413	GBM	77	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1995	NA	-28433	Dead	WITH TUMOR	5	96	NA	NA	NA	NA	NA	NA	NA	NA	1	96	1	96	NA	NA	1	96	
60	TCGA-06-0414	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-0414-01	144	0.7005947710043999	81	TCGA-06-0414-01	26	15	14	0.13153924433596492	TCGA-06-0414-01	0	0	0	0	PASS	2820	TCGA-06-0414	GBM	63	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1996	NA	-23215	Dead	TUMOR FREE	1065	1068	NA	Recurrence	NA	NA	1013	NA	NA	NA	1	1068	0	1068	NA	NA	1	1013	
70	TCGA-06-0644	0	2	0	0	2	0	1	0	1	39	3	0	2	20	2	0	TCGA-06-0644-01	97	0.2975415808406056	42	TCGA-06-0644-01	9	7	14	0.10234627012879907	TCGA-06-0644-01	1	2	1	4	PASS	2821	TCGA-06-0644	GBM	71	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-26247	Dead	WITH TUMOR	NA	384	NA	Recurrence	NA	NA	85	NA	NA	NA	1	384	1	384	NA	NA	1	85	
60	TCGA-06-0645	0	3	0	2	0	0	0	0	1	50	2	0	0	20	0	0	TCGA-06-0645-01	106	0.3284858858400802	53	TCGA-06-0645-01	10	5	13	0.046780274641742635	TCGA-06-0645-01	1	3	3	7	PASS	2822	TCGA-06-0645	GBM	55	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-20449	Dead	WITH TUMOR	98	175	NA	NA	NA	NA	NA	NA	NA	NA	1	175	1	175	NA	NA	1	175	
60	TCGA-06-0646	0	1	1	0	3	0	0	0	2	28	0	0	0	13	0	0	TCGA-06-0646-01	151	0.20924367712734315	90	TCGA-06-0646-01	6	6	22	0.14515405656412614	TCGA-06-0646-01	0	1	1	2	PASS	2823	TCGA-06-0646	GBM	60	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-22273	Dead	WITH TUMOR	136	175	NA	Progression of Disease	NA	NA	90	NA	NA	NA	1	175	1	175	NA	NA	1	90	
80	TCGA-06-0648	1	0	0	3	2	0	0	1	5	48	4	0	0	23	0	0	TCGA-06-0648-01	199	0.23262068523012375	139	TCGA-06-0648-01	6	5	34	0.09432232214330236	TCGA-06-0648-01	2	1	1	4	PASS	2824	TCGA-06-0648	GBM	77	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-28477	Dead	WITH TUMOR	294	298	NA	Progression of Disease	NA	NA	202	NA	NA	NA	1	298	1	298	NA	NA	1	202	
70	TCGA-06-0649	2	9	2	2	2	0	1	0	3	97	10	1	4	57	2	0	TCGA-06-0649-01	192	0.4714214656907729	115	TCGA-06-0649-01	7	6	37	0.15753030802141224	TCGA-06-0649-01	1	4	3	8	PASS	2825	TCGA-06-0649	GBM	73	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-26796	Dead	WITH TUMOR	62	64	NA	NA	NA	NA	NA	NA	NA	NA	1	64	1	64	NA	NA	1	64	
40	TCGA-06-0650	0	0	0	1	1	0	0	0	1	31	2	0	0	9	0	0	TCGA-06-0650-01	51	0.1216804294742156	13	TCGA-06-0650-01	6	3	3	0.049775412805155926	TCGA-06-0650-01	0	0	0	0	PASS	2826	TCGA-06-0650	GBM	39	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-14560	Dead	WITH TUMOR	717	717	NA	Progression of Disease	NA	NA	351	NA	NA	NA	1	717	1	717	NA	NA	1	351	
50	TCGA-06-0686	0	7	0	3	1	0	0	0	3	46	4	0	2	17	3	0	TCGA-06-0686-01	162	0.38926693842937393	104	TCGA-06-0686-01	4	3	28	0.05918388930403627	TCGA-06-0686-01	0	4	0	4	PASS	2827	TCGA-06-0686	GBM	53	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-19503	Dead	WITH TUMOR	NA	432	NA	Progression of Disease	NA	NA	160	NA	NA	NA	1	432	1	432	NA	NA	1	160	
70	TCGA-06-0743	0	8	1	1	4	0	0	0	4	76	4	0	4	32	1	0	TCGA-06-0743-01	154	0.33817226665888817	83	TCGA-06-0743-01	8	5	28	0.06413554914962062	TCGA-06-0743-01	1	3	0	4	PASS	2828	TCGA-06-0743	GBM	69	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-25434	Dead	WITH TUMOR	NA	803	NA	Progression of Disease	NA	NA	176	NA	NA	NA	1	803	1	803	NA	NA	1	176	
70	TCGA-06-0744	0	5	0	2	1	1	0	0	1	57	3	0	1	20	2	0	TCGA-06-0744-01	201	0.2062489983172048	124	TCGA-06-0744-01	7	5	36	0.09514740309656107	TCGA-06-0744-01	5	3	3	11	PASS	2829	TCGA-06-0744	GBM	66	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-24471	Dead	WITH TUMOR	NA	1426	NA	NA	NA	NA	1277	NA	NA	NA	1	1426	1	1426	NA	NA	1	1277	
60	TCGA-06-0745	0	3	0	4	0	0	1	0	2	37	4	0	1	12	2	0	TCGA-06-0745-01	139	0.2944841922059863	80	TCGA-06-0745-01	7	9	27	0.1618841426782609	TCGA-06-0745-01	5	10	6	21	PASS	2830	TCGA-06-0745	GBM	59	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-21884	Dead	WITH TUMOR	164	239	NA	Progression of Disease	NA	NA	92	NA	NA	NA	1	239	1	239	NA	NA	1	92	
50	TCGA-06-0747	0	3	0	3	2	0	2	0	1	60	3	0	1	21	0	0	TCGA-06-0747-01	85	0.1673923374666181	34	TCGA-06-0747-01	7	10	13	0.1863051185238386	TCGA-06-0747-01	3	4	5	12	PASS	2831	TCGA-06-0747	GBM	53	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-19657	Dead	WITH TUMOR	82	82	NA	NA	NA	NA	NA	NA	NA	NA	1	82	1	82	NA	NA	1	82	
50	TCGA-06-0749	0	0	0	0	4	0	1	0	1	37	5	0	1	20	0	0	TCGA-06-0749-01	119	0.1562720367827304	73	TCGA-06-0749-01	6	4	17	0.1201685329867678	TCGA-06-0749-01	2	3	4	9	PASS	2832	TCGA-06-0749	GBM	50	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-18571	Dead	WITH TUMOR	66	82	NA	NA	NA	NA	NA	NA	NA	NA	1	82	1	82	NA	NA	1	82	
40	TCGA-06-0750	0	4	1	4	0	0	0	0	0	29	4	0	0	11	1	0	TCGA-06-0750-01	93	0.19251499617109996	48	TCGA-06-0750-01	7	5	14	0.14471948671933624	TCGA-06-0750-01	2	1	4	7	PASS	2833	TCGA-06-0750	GBM	43	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-16018	Dead	WITH TUMOR	28	28	NA	NA	NA	NA	NA	NA	NA	NA	1	28	1	28	NA	NA	1	28	
60	TCGA-06-0875	1	4	0	1	2	0	1	0	2	56	3	0	0	16	0	0	TCGA-06-0875-01	171	0.4733781889597397	95	TCGA-06-0875-01	11	11	11	0.08699475611819531	TCGA-06-0875-01	2	2	2	6	PASS	2834	TCGA-06-0875	GBM	61	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-22312	Alive	TUMOR FREE	1322	NA	NA	Progression of Disease	NA	NA	279	NA	NA	NA	0	1322	0	1322	NA	NA	1	279	
70	TCGA-06-0876	0	6	0	2	2	0	1	0	0	53	5	0	0	25	2	0	TCGA-06-0876-01	195	0.15657044484081492	125	TCGA-06-0876-01	6	4	16	0.08697879079477268	TCGA-06-0876-01	3	3	2	8	PASS	2835	TCGA-06-0876	GBM	72	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-26372	Alive	WITH TUMOR	1405	NA	NA	NA	NA	NA	424	NA	NA	NA	0	1405	0	1405	NA	NA	1	424	
80	TCGA-06-0877	1	3	1	2	1	0	0	0	2	51	5	0	0	24	2	0	TCGA-06-0877-01	234	0.27601099948234004	149	TCGA-06-0877-01	12	6	12	0.05391245517605277	TCGA-06-0877-01	0	0	0	0	PASS	2836	TCGA-06-0877	GBM	78	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-28760	Alive	WITH TUMOR	204	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	204	0	204	NA	NA	0	204	
70	TCGA-06-0878	1	5	1	0	1	1	0	0	1	35	1	0	1	18	1	0	TCGA-06-0878-01	130	0.21920747223748446	69	TCGA-06-0878-01	8	6	25	0.15758349166150185	TCGA-06-0878-01	3	2	3	8	PASS	2837	TCGA-06-0878	GBM	74	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-27319	Alive	WITH TUMOR	218	NA	NA	Recurrence	NA	NA	66	NA	NA	NA	0	218	0	218	NA	NA	1	66	
50	TCGA-06-0879	2	4	1	2	0	0	1	0	1	40	4	0	1	20	0	0	TCGA-06-0879-01	106	0.2196320773825305	50	TCGA-06-0879-01	9	6	13	0.06839574359711592	TCGA-06-0879-01	4	1	1	6	PASS	2838	TCGA-06-0879	GBM	52	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-19154	Dead	WITH TUMOR	NA	1229	NA	Recurrence	NA	NA	699	NA	NA	NA	1	1229	1	1229	NA	NA	1	699	
50	TCGA-06-0881	0	0	0	1	0	0	0	0	0	19	0	0	0	6	0	0	TCGA-06-0881-01	67	0.0011095025905091644	22	TCGA-06-0881	0	0	0	0	TCGA-06-0881	0	0	0	0	PASS	2839	TCGA-06-0881	GBM	50	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-18278	Dead	WITH TUMOR	NA	504	NA	Recurrence	NA	NA	141	NA	NA	NA	1	504	1	504	NA	NA	1	141	
30	TCGA-06-0882	0	1	1	1	1	0	0	0	1	29	2	0	0	13	0	0	TCGA-06-0882-01	148	0.16648365161877915	89	TCGA-06-0882-01	8	7	30	0.13149024207659554	TCGA-06-0882-01	2	3	2	7	PASS	2840	TCGA-06-0882	GBM	30	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-11112	Dead	WITH TUMOR	NA	632	NA	Recurrence	NA	NA	213	NA	NA	NA	1	632	1	632	NA	NA	1	213	
80	TCGA-06-0939	1	5	0	3	1	0	0	0	1	53	3	0	1	32	2	0	TCGA-06-0939-01	113	0.13519772052282727	72	TCGA-06-0939-01	5	4	17	0.08514913559837706	TCGA-06-0939-01	0	1	1	2	PASS	2841	TCGA-06-0939	GBM	79	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-28893	Dead	WITH TUMOR	NA	814	NA	Progression of Disease	NA	NA	329	NA	NA	NA	1	814	1	814	NA	NA	1	329	
50	TCGA-06-1084	0	6	0	3	2	4	0	0	2	79	3	1	1	20	1	0	TCGA-06-1084-01	257	0.2900896634017167	159	TCGA-06-1084-01	7	11	25	0.16613568471779533	TCGA-06-1084-01	5	5	5	15	mutation call filter	2842	TCGA-06-1084	GBM	54	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-19899	Dead	WITH TUMOR	NA	728	NA	Progression of Disease	NA	NA	208	NA	NA	NA	1	728	1	728	NA	NA	1	208	
40	TCGA-06-1086	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-06-1086-01	171	0.3801190812767489	100	TCGA-06-1086-01	18	19	5	0.06539225875680987	TCGA-06-1086-01	2	0	1	3	PASS	2843	TCGA-06-1086	GBM	42	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-15645	Dead	WITH TUMOR	193	208	NA	NA	NA	NA	NA	NA	NA	NA	1	208	1	208	NA	NA	1	208	
80	TCGA-06-1087	0	5	0	2	2	1	1	0	6	69	8	0	2	26	3	1	TCGA-06-1087-01	450	0.7124165132744946	335	TCGA-06-1087-01	27	15	60	0.2270378324895639	TCGA-06-1087-01	7	8	7	22	mutation call filter	2844	TCGA-06-1087	GBM	75	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-27658	Dead	WITH TUMOR	109	123	NA	Recurrence	NA	NA	109	NA	NA	NA	1	123	1	123	NA	NA	1	109	
60	TCGA-06-1800	0	7	1	0	0	0	0	0	2	64	2	0	1	21	3	0	TCGA-06-1800-01	101	0.5409800946322487	47	TCGA-06-1800-01	6	7	19	0.1601543239675997	TCGA-06-1800-01	1	2	4	7	mutation call filter	2845	TCGA-06-1800	GBM	61	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-22332	Dead	WITH TUMOR	815	815	NA	Recurrence	NA	NA	750	NA	NA	NA	1	815	1	815	NA	NA	1	750	
60	TCGA-06-1801	3	21	1	14	6	3	2	0	14	206	11	0	2	73	11	1	TCGA-06-1801-01	183	0.18388951078601856	120	TCGA-06-1801-01	4	6	63	0.11558755762387073	TCGA-06-1801-01	1	5	4	10	mutation call filter	2846	TCGA-06-1801	GBM	56	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-20538	Dead	WITH TUMOR	NA	360	NA	Recurrence	NA	NA	232	NA	NA	NA	1	360	1	360	NA	NA	1	232	
60	TCGA-06-1802	1	18	0	8	6	11	5	1	11	461	29	0	8	159	15	0	TCGA-06-1802-01	374	0.3036365459167601	291	TCGA-06-1802-01	5	4	88	0.1289146098738933	TCGA-06-1802-01	2	3	5	10	mutation call filter	2847	TCGA-06-1802	GBM	61	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-22537	Dead	WITH TUMOR	NA	466	NA	Recurrence	NA	NA	81	NA	NA	NA	1	466	1	466	NA	NA	1	81	
80	TCGA-06-1804	0	5	0	1	0	0	0	0	1	61	4	0	3	32	3	0	TCGA-06-1804-01	336	0.19530199091932998	243	TCGA-06-1804-01	6	6	42	0.2005592628009963	TCGA-06-1804-01	0	3	1	4	PASS	2848	TCGA-06-1804	GBM	81	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-29802	Dead	WITH TUMOR	414	414	NA	NA	NA	NA	NA	NA	NA	NA	1	414	1	414	NA	NA	1	414	
30	TCGA-06-1805	1	27	2	9	4	4	0	0	20	269	21	0	4	70	10	1	TCGA-06-1805-01	161	0.10199996070951577	101	TCGA-06-1805-01	4	4	31	0.0790806576852419	TCGA-06-1805-01	2	1	3	6	mutation call filter	2849	TCGA-06-1805	GBM	28	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-10542	Alive	TUMOR FREE	1031	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1031	0	1031	NA	NA	0	1031	
50	TCGA-06-1806	0	1	0	1	1	0	0	0	1	20	0	0	3	10	0	0	TCGA-06-1806-01	104	0.6224867791567054	54	TCGA-06-1806-01	8	5	19	0.00640010568480713	TCGA-06-1806-01	0	1	1	2	PASS	2850	TCGA-06-1806	GBM	47	MALE	WHITE	NA	NA	Glioblastoma Multiforme (GBM)	NA	2009	NA	-17296	Dead	WITH TUMOR	NA	466	NA	Progression of Disease	NA	NA	256	Progressive Disease	NA	NA	1	466	1	466	NA	NA	1	256	
80	TCGA-06-2557	0	4	0	2	2	0	0	1	3	32	2	0	0	21	0	0	TCGA-06-2557-01	158	0.4881128264681826	80	TCGA-06-2557-01	9	6	11	0.1450617090708798	TCGA-06-2557-01	3	4	2	9	PASS	2851	TCGA-06-2557	GBM	76	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-27980	Dead	WITH TUMOR	33	33	NA	NA	NA	NA	NA	NA	NA	NA	1	33	1	33	NA	NA	1	33	
80	TCGA-06-2558	1	4	0	0	0	0	0	0	0	64	6	0	3	25	0	0	TCGA-06-2558-01	190	0.4548961337183355	121	TCGA-06-2558-01	7	6	37	0.1582611355097918	TCGA-06-2558-01	4	6	5	15	PASS	2852	TCGA-06-2558	GBM	75	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-27511	Dead	NA	23	380	NA	NA	NA	NA	NA	NA	NA	NA	1	380	NA	380	NA	NA	0	380	
80	TCGA-06-2559	0	6	0	1	1	0	2	0	5	46	2	0	0	22	1	0	TCGA-06-2559-01	175	0.1218875939013252	95	TCGA-06-2559-01	4	3	8	0.0607678477195653	TCGA-06-2559-01	2	2	2	6	PASS	2853	TCGA-06-2559	GBM	83	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-30580	Dead	WITH TUMOR	150	150	NA	NA	NA	NA	NA	NA	NA	NA	1	150	1	150	NA	NA	1	150	
50	TCGA-06-2561	1	3	0	0	4	0	0	0	0	29	3	0	0	6	1	0	TCGA-06-2561-01	172	0.386474047134337	115	TCGA-06-2561-01	13	10	29	0.22261953606296914	TCGA-06-2561-01	3	1	2	6	PASS	2854	TCGA-06-2561	GBM	53	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-19505	Dead	WITH TUMOR	NA	537	NA	Recurrence	NA	NA	78	NA	NA	NA	1	537	1	537	NA	NA	1	78	
80	TCGA-06-2562	2	1	0	1	3	0	0	0	1	50	4	0	1	17	1	0	TCGA-06-2562-01	150	0.198867922539416	85	TCGA-06-2562-01	8	8	18	0.1222768825057706	TCGA-06-2562-01	3	4	3	10	PASS	2855	TCGA-06-2562	GBM	81	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-29753	Dead	WITH TUMOR	NA	382	NA	Progression of Disease	NA	NA	151	NA	NA	NA	1	382	1	382	NA	NA	1	151	
70	TCGA-06-2563	0	7	0	1	2	0	0	0	2	60	2	0	2	18	1	0	TCGA-06-2563-01	139	0.1772380790326534	70	TCGA-06-2563-01	8	4	22	0.06858910331891195	TCGA-06-2563-01	4	6	3	13	PASS	2856	TCGA-06-2563	GBM	72	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-26643	Alive	WITH TUMOR	932	NA	NA	NA	NA	NA	554	NA	NA	NA	0	932	0	932	NA	NA	1	554	
50	TCGA-06-2564	0	3	1	1	1	1	0	0	1	48	4	0	1	20	0	0	TCGA-06-2564-01	178	0.11335703026637887	115	TCGA-06-2564-01	4	3	17	0.0586263843316497	TCGA-06-2564-01	0	0	0	0	PASS	2857	TCGA-06-2564	GBM	50	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-18435	Alive	WITH TUMOR	181	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	181	0	181	NA	NA	0	181	
60	TCGA-06-2565	0	6	0	1	3	0	0	0	2	37	3	0	1	14	2	0	TCGA-06-2565-01	229	0.14057370248450454	140	TCGA-06-2565-01	8	7	34	0.14175685932308024	TCGA-06-2565-01	3	4	4	11	PASS	2858	TCGA-06-2565	GBM	59	MALE	ASIAN	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-21559	Dead	WITH TUMOR	NA	506	NA	Progression of Disease	NA	NA	178	NA	NA	NA	1	506	1	506	NA	NA	1	178	
30	TCGA-06-2566	2	23	0	11	5	6	0	2	7	173	12	0	7	57	11	0	TCGA-06-2566-01	115	0.0989213217034339	61	TCGA-06-2566-01	0	1	24	0.03650745043994482	TCGA-06-2566-01	1	2	1	4	mutation call filter	2859	TCGA-06-2566	GBM	23	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-8428	Dead	WITH TUMOR	182	182	NA	NA	NA	NA	NA	NA	NA	NA	1	182	1	182	NA	NA	1	182	
70	TCGA-06-2567	0	3	0	1	3	0	0	0	6	37	4	0	0	21	2	0	TCGA-06-2567-01	98	0.1879358005217158	43	TCGA-06-2567-01	5	5	11	0.1009926858855049	TCGA-06-2567-01	1	2	2	5	PASS	2860	TCGA-06-2567	GBM	65	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-23759	Dead	WITH TUMOR	133	133	NA	NA	NA	NA	NA	NA	NA	NA	1	133	1	133	NA	NA	1	133	
30	TCGA-06-2569	1	0	0	0	1	1	3	0	1	27	0	0	1	7	0	0	TCGA-06-2569-01	330	0.5997797324701591	236	TCGA-06-2569-01	13	43	42	0.3972413227586321	TCGA-06-2569-01	17	7	7	31	PASS	2861	TCGA-06-2569	GBM	24	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-8922	Alive	WITH TUMOR	13	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	13	0	13	NA	NA	0	13	
30	TCGA-06-2570	0	1	1	0	1	0	0	0	1	33	0	0	0	10	0	0	TCGA-06-2570-01	127	0.0939332702717658	74	TCGA-06-2570-01	1	2	8	0.03894906041740232	TCGA-06-2570-01	3	3	3	9	PASS	2862	TCGA-06-2570	GBM	21	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-7936	Alive	TUMOR FREE	958	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	958	0	958	NA	NA	0	958	
50	TCGA-06-5408	1	5	0	1	0	1	0	0	1	40	0	0	1	18	0	0	TCGA-06-5408-01	110	0.5766431385108954	55	TCGA-06-5408-01	6	6	19	0.1351178477085138	TCGA-06-5408-01	4	3	3	10	PASS	2863	TCGA-06-5408	GBM	54	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-20063	Dead	WITH TUMOR	342	357	NA	Progression of Disease	NA	NA	158	NA	NA	NA	1	357	1	357	NA	NA	1	158	
70	TCGA-06-5410	0	1	0	1	0	0	0	0	0	17	4	0	0	10	0	0	TCGA-06-5410-01	46	0.1642364599440023	10	TCGA-06-5410	0	0	0	0	TCGA-06-5410	0	0	0	0	PASS	2864	TCGA-06-5410	GBM	72	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-26395	Dead	WITH TUMOR	108	108	NA	NA	NA	NA	NA	NA	NA	NA	1	108	1	108	NA	NA	1	108	
50	TCGA-06-5411	1	0	0	0	0	0	0	0	3	23	4	0	1	11	0	0	TCGA-06-5411-01	79	0.22843051430535305	29	TCGA-06-5411-01	6	6	10	0.16647458480005256	TCGA-06-5411-01	0	1	2	3	PASS	2865	TCGA-06-5411	GBM	51	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-18832	Dead	WITH TUMOR	254	254	NA	Progression of Disease	NA	NA	214	NA	NA	NA	1	254	1	254	NA	NA	1	214	
80	TCGA-06-5412	0	1	0	1	4	1	0	0	1	43	4	0	0	17	0	0	TCGA-06-5412-01	56	0.18522316435047376	18	TCGA-06-5412-01	7	6	7	0.16706433949446214	TCGA-06-5412-01	0	0	0	0	PASS	2866	TCGA-06-5412	GBM	78	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-28762	Dead	WITH TUMOR	138	138	NA	Progression of Disease	NA	NA	88	NA	NA	NA	1	138	1	138	NA	NA	1	88	
70	TCGA-06-5413	1	1	0	2	2	1	0	0	0	36	2	0	3	14	0	0	TCGA-06-5413-01	166	0.1804256318311195	118	TCGA-06-5413-01	6	4	47	0.13292148111664484	TCGA-06-5413-01	3	3	2	8	PASS	2867	TCGA-06-5413	GBM	67	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-24477	Alive	WITH TUMOR	268	NA	NA	Progression of Disease	NA	NA	195	NA	NA	NA	0	268	0	268	NA	NA	1	195	
60	TCGA-06-5414	0	2	0	0	2	0	0	0	0	27	2	0	0	13	2	0	TCGA-06-5414-01	81	0.1864636150888951	37	TCGA-06-5414-01	8	5	14	0.06090836647785764	TCGA-06-5414-01	1	1	1	3	PASS	2868	TCGA-06-5414	GBM	61	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-22527	Alive	WITH TUMOR	273	NA	NA	Progression of Disease	NA	NA	167	NA	NA	NA	0	273	0	273	NA	NA	1	167	
60	TCGA-06-5415	0	4	1	0	3	0	0	0	1	36	3	0	0	16	1	0	TCGA-06-5415-01	208	0.2606744543202065	117	TCGA-06-5415-01	9	7	22	0.11774680854334893	TCGA-06-5415-01	3	6	4	13	PASS	2869	TCGA-06-5415	GBM	60	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-22213	Alive	WITH TUMOR	260	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	260	0	260	NA	NA	0	260	
30	TCGA-06-5416	60	966	53	328	3	38	0	0	478	10817	1008	3	190	4124	230	9	TCGA-06-5416-01	111	0.7817142710021998	52	TCGA-06-5416-01	8	11	7	0.015384914310556106	TCGA-06-5416-01	3	4	1	8	hypermutated sample	2870	TCGA-06-5416	GBM	23	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-8533	Alive	WITH TUMOR	204	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	204	0	204	NA	NA	0	204	
50	TCGA-06-5417	1	0	1	2	5	1	1	0	1	42	2	0	0	17	0	0	TCGA-06-5417	0	0	0	TCGA-06-5417	0	0	0	0	TCGA-06-5417	0	0	0	0	PASS	2871	TCGA-06-5417	GBM	45	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-16572	Alive	WITH TUMOR	155	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	155	0	155	NA	NA	0	155	
80	TCGA-06-5418	0	3	0	3	1	2	1	0	2	31	2	0	0	17	0	0	TCGA-06-5418-01	138	0.1835259624609708	76	TCGA-06-5418-01	7	6	15	0.11238213780228558	TCGA-06-5418-01	2	3	3	8	PASS	2872	TCGA-06-5418	GBM	75	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-27584	Dead	WITH TUMOR	83	83	NA	NA	NA	NA	NA	NA	NA	NA	1	83	1	83	NA	NA	1	83	
60	TCGA-06-5856	0	3	0	1	1	0	1	0	3	52	0	0	0	12	0	0	TCGA-06-5856-01	303	0.8524913765658841	189	TCGA-06-5856-01	12	10	61	0.31528937200295504	TCGA-06-5856-01	2	2	8	12	PASS	2873	TCGA-06-5856	GBM	58	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-21232	Dead	WITH TUMOR	114	114	NA	NA	NA	NA	NA	NA	NA	NA	1	114	1	114	NA	NA	1	114	
50	TCGA-06-5858	0	8	0	2	0	1	0	0	7	153	6	0	1	78	1	0	TCGA-06-5858-01	50	0.07998932283593176	12	TCGA-06-5858-01	3	20	27	0.9156778544945942	TCGA-06-5858-01	1	0	0	1	PASS	2874	TCGA-06-5858	GBM	45	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-16662	Alive	WITH TUMOR	187	NA	NA	Progression of Disease	NA	NA	97	NA	NA	NA	0	187	0	187	NA	NA	1	97	
60	TCGA-06-5859	0	1	0	1	3	0	0	0	0	36	2	0	1	13	1	0	TCGA-06-5859-01	201	0.9455046555651482	120	TCGA-06-5859-01	10	10	48	0.2853306402344536	TCGA-06-5859-01	15	11	11	37	PASS	2875	TCGA-06-5859	GBM	63	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2011	NA	-23211	Alive	WITH TUMOR	139	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	139	0	139	NA	NA	0	139	
60	TCGA-06-6388	0	2	0	3	0	0	0	0	1	37	3	0	2	18	5	0	TCGA-06-6388-01	102	0.16558182148462675	53	TCGA-06-6388-01	8	4	21	0.07977694771989594	TCGA-06-6388-01	2	2	3	7	PASS	2876	TCGA-06-6388	GBM	64	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2011	NA	-23519	Dead	WITH TUMOR	120	159	NA	Progression of Disease	NA	NA	85	NA	NA	NA	1	159	1	159	NA	NA	1	85	
50	TCGA-06-6389	0	4	0	0	1	0	0	0	0	34	0	0	2	14	0	0	TCGA-06-6389-01	89	0.6131075166711263	35	TCGA-06-6389-01	12	16	32	0.3532887930327517	TCGA-06-6389-01	5	9	6	20	PASS	2877	TCGA-06-6389	GBM	49	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2011	NA	-18248	Alive	WITH TUMOR	237	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	237	0	237	NA	NA	0	237	
60	TCGA-06-6390	1	4	0	3	1	0	1	0	1	33	0	0	2	17	0	0	TCGA-06-6390-01	247	0.3502736614821184	181	TCGA-06-6390-01	13	9	29	0.15840001378049282	TCGA-06-6390-01	2	3	0	5	PASS	2878	TCGA-06-6390	GBM	58	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2011	NA	-21328	Dead	WITH TUMOR	164	164	NA	NA	NA	NA	NA	NA	NA	NA	1	164	1	164	NA	NA	1	164	
40	TCGA-06-6391	1	2	1	1	0	0	0	0	2	51	4	0	0	21	1	0	TCGA-06-6391	0	0	0	TCGA-06-6391	0	0	0	0	TCGA-06-6391-01	8	9	2	19	PASS	2879	TCGA-06-6391	GBM	44	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2011	NA	-16206	Dead	WITH TUMOR	NA	45	NA	NA	NA	NA	NA	NA	NA	NA	1	45	1	45	NA	NA	1	45	
60	TCGA-06-6693	1	1	0	1	2	0	0	0	3	34	6	0	3	17	1	0	TCGA-06-6693-01	117	0.8756484359931777	64	TCGA-06-6693-01	8	11	38	0.2426876043715893	TCGA-06-6693-01	6	3	7	16	PASS	2880	TCGA-06-6693	GBM	64	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1993	NA	-23585	Dead	WITH TUMOR	15	3667	NA	NA	NA	NA	NA	NA	NA	NA	1	3667	1	3667	NA	NA	1	3667	
80	TCGA-06-6694	1	3	0	1	3	0	0	0	3	59	4	0	1	43	4	0	TCGA-06-6694-01	152	0.7609256949931468	91	TCGA-06-6694-01	16	21	23	0.1980439232022075	TCGA-06-6694-01	9	6	6	21	PASS	2881	TCGA-06-6694	GBM	76	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1994	NA	-27909	Dead	WITH TUMOR	224	224	NA	NA	NA	NA	NA	NA	NA	NA	1	224	1	224	NA	NA	1	224	
60	TCGA-06-6695	0	7	0	0	0	2	1	1	1	44	0	0	2	15	3	0	TCGA-06-6695-01	155	0.1715012094498304	82	TCGA-06-6695-01	9	5	29	0.07021484019191879	TCGA-06-6695-01	4	5	3	12	PASS	2882	TCGA-06-6695	GBM	64	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-23426	Alive	WITH TUMOR	253	NA	NA	Progression of Disease	NA	NA	133	NA	NA	NA	0	253	0	253	NA	NA	1	133	
70	TCGA-06-6697	0	3	0	0	1	0	0	0	0	55	3	0	1	15	1	0	TCGA-06-6697-01	78	0.20475227782043146	31	TCGA-06-6697-01	9	8	19	0.13400544414642288	TCGA-06-6697-01	5	3	1	9	PASS	2883	TCGA-06-6697	GBM	65	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-23763	Alive	WITH TUMOR	391	NA	NA	Progression of Disease	NA	NA	306	NA	NA	NA	0	391	0	391	NA	NA	1	306	
50	TCGA-06-6698	0	2	0	0	1	0	0	0	1	28	2	0	0	10	2	0	TCGA-06-6698-01	106	0.3313507278390848	54	TCGA-06-6698-01	6	20	37	0.8911746753661248	TCGA-06-6698-01	1	1	0	2	PASS	2884	TCGA-06-6698	GBM	53	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2011	NA	-19591	Alive	WITH TUMOR	145	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	145	0	145	NA	NA	0	145	
60	TCGA-06-6699	0	2	0	1	0	0	0	0	1	48	2	0	1	17	1	1	TCGA-06-6699-01	202	0.16450296304649484	123	TCGA-06-6699-01	7	5	23	0.10216789794949688	TCGA-06-6699-01	3	1	4	8	PASS	2885	TCGA-06-6699	GBM	58	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2011	NA	-21190	Alive	WITH TUMOR	47	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	47	0	47	NA	NA	0	47	
80	TCGA-06-6700	0	1	0	2	0	0	0	0	2	41	3	0	1	17	1	0	TCGA-06-6700-01	119	0.14897874878421774	70	TCGA-06-6700-01	4	4	11	0.07776040660683516	TCGA-06-6700-01	3	2	2	7	PASS	2886	TCGA-06-6700	GBM	76	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2011	NA	-27850	Alive	WITH TUMOR	145	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	145	0	145	NA	NA	0	145	
60	TCGA-06-6701	0	0	1	1	2	0	1	0	4	27	2	0	2	11	0	0	TCGA-06-6701-01	80	0.0498322295899148	36	TCGA-06-6701-01	0	3	4	0.028183960898628325	TCGA-06-6701-01	1	4	2	7	PASS	2887	TCGA-06-6701	GBM	60	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2011	NA	-22051	Alive	WITH TUMOR	151	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	151	0	151	NA	NA	0	151	
30	TCGA-06-A5U0	0	2	0	1	1	2	0	0	0	25	3	0	1	12	0	0	TCGA-06-A5U0-01	118	0.6650692271754772	59	TCGA-06-A5U0-01	6	10	34	0.14784501067107894	TCGA-06-A5U0-01	9	3	6	18	PASS	2888	TCGA-06-A5U0	GBM	21	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2012	NA	-7958	Alive	WITH TUMOR	815	NA	NA	Progression of Disease	NA	NA	100	Progressive Disease	NA	NA	0	815	0	815	NA	NA	1	100	
80	TCGA-06-A5U1	0	1	0	6	1	0	0	0	1	45	5	0	2	36	0	0	TCGA-06-A5U1-01	230	0.5479188451124585	160	TCGA-06-A5U1-01	9	8	132	0.22515802986807928	TCGA-06-A5U1-01	5	5	7	17	PASS	2889	TCGA-06-A5U1	GBM	78	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2011	NA	-28545	Dead	WITH TUMOR	NA	57	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	57	1	57	NA	NA	1	57	
80	TCGA-06-A6S0	0	3	0	1	3	0	1	0	3	46	2	0	3	24	2	0	TCGA-06-A6S0-01	183	0.20631361709637247	117	TCGA-06-A6S0-01	4	7	71	0.12853173498908144	TCGA-06-A6S0-01	3	1	4	8	PASS	2890	TCGA-06-A6S0	GBM	79	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2011	NA	-29037	Dead	WITH TUMOR	NA	95	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	95	1	95	NA	NA	1	95	
50	TCGA-06-A6S1	0	1	0	2	1	0	0	0	0	39	3	0	1	9	2	0	TCGA-06-A6S1-01	161	0.6857111253515451	98	TCGA-06-A6S1-01	9	8	76	0.20161248764893366	TCGA-06-A6S1-01	1	3	2	6	PASS	2891	TCGA-06-A6S1	GBM	53	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2012	NA	-19443	Dead	WITH TUMOR	NA	78	NA	Progression of Disease	NA	NA	46	Progressive Disease	NA	NA	1	78	1	78	NA	NA	1	46	
60	TCGA-06-A7TK	0	4	0	0	3	0	2	0	0	46	0	0	1	17	1	0	TCGA-06-A7TK-01	76	0.1954287989869446	30	TCGA-06-A7TK-01	8	7	42	0.14472295483598396	TCGA-06-A7TK-01	1	2	1	4	PASS	2892	TCGA-06-A7TK	GBM	64	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2013	NA	-23674	Dead	WITH TUMOR	NA	444	NA	Progression of Disease	NA	NA	342	Progressive Disease	NA	NA	1	444	1	444	NA	NA	1	342	
30	TCGA-06-A7TL	0	1	0	1	0	0	2	0	1	23	2	0	0	8	0	0	TCGA-06-A7TL-01	212	0.2685645752912709	140	TCGA-06-A7TL-01	4	5	45	0.11213716346651764	TCGA-06-A7TL-01	9	3	6	18	PASS	2893	TCGA-06-A7TL	GBM	30	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2013	NA	-11297	Alive	WITH TUMOR	539	NA	NA	Progression of Disease	NA	NA	188	Stable Disease	NA	NA	0	539	0	539	NA	NA	1	188	
60	TCGA-08-0244	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0244-01	551	0.1920342967018065	478	TCGA-08-0244-01	5	5	13	0.1007290578339748	TCGA-08-0244-01	2	2	2	6	PASS	2894	TCGA-08-0244	GBM	62	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-22684	Dead	WITH TUMOR	690	690	NA	Recurrence	NA	NA	484	NA	NA	NA	1	690	1	690	NA	NA	1	484	
30	TCGA-08-0245	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0245-01	502	0.9293196875989432	396	TCGA-08-0245-01	11	15	37	0.3147021075006897	TCGA-08-0245-01	11	7	14	32	PASS	2895	TCGA-08-0245	GBM	31	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-11613	Dead	WITH TUMOR	1057	1151	NA	Progression of Disease	NA	NA	463	NA	NA	NA	1	1151	1	1151	NA	NA	1	463	
60	TCGA-08-0246	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0246-01	400	0.7305953726926396	330	TCGA-08-0246-01	21	26	8	0.04064058185539147	TCGA-08-0246-01	1	1	3	5	PASS	2896	TCGA-08-0246	GBM	57	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-20974	Dead	WITH TUMOR	119	127	NA	Progression of Disease	NA	NA	103	NA	NA	NA	1	127	1	127	NA	NA	1	103	
70	TCGA-08-0344	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0344-01	441	0.06690709001785848	381	TCGA-08-0344-01	2	2	6	0.07812097806892143	TCGA-08-0344-01	3	2	3	8	PASS	2897	TCGA-08-0344	GBM	66	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1992	NA	-24253	Dead	WITH TUMOR	3310	3524	NA	Recurrence	NA	NA	1880	NA	NA	NA	1	3524	1	3524	NA	NA	1	1880	
70	TCGA-08-0345	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0345-01	92	0.1755244427471231	38	TCGA-08-0345-01	6	5	12	0.07766775386633938	TCGA-08-0345-01	1	0	0	1	PASS	2898	TCGA-08-0345	GBM	71	FEMALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	1992	NA	-25960	Dead	WITH TUMOR	53	53	NA	NA	NA	NA	NA	NA	NA	NA	1	53	1	53	NA	NA	1	53	
70	TCGA-08-0346	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0346-01	146	0.2546905304619456	79	TCGA-08-0346-01	8	4	8	0.05256020041080077	TCGA-08-0346-01	0	0	0	0	PASS	2899	TCGA-08-0346	GBM	69	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	1993	NA	-25409	Dead	WITH TUMOR	132	256	NA	Progression of Disease	NA	NA	75	NA	NA	NA	1	256	1	256	NA	NA	1	75	
50	TCGA-08-0347	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0347-01	192	0.17028146910615868	132	TCGA-08-0347-01	5	5	23	0.1102444808309043	TCGA-08-0347-01	1	1	2	4	PASS	2900	TCGA-08-0347	GBM	50	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	1993	NA	-18384	Dead	WITH TUMOR	419	782	NA	Progression of Disease	NA	NA	59	NA	NA	NA	1	782	1	782	NA	NA	1	59	
60	TCGA-08-0348	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0348-01	340	0.17073159919665712	261	TCGA-08-0348-01	5	3	14	0.1205144993235874	TCGA-08-0348-01	0	5	2	7	PASS	2901	TCGA-08-0348	GBM	63	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-23373	Dead	WITH TUMOR	316	370	NA	Recurrence	NA	NA	198	NA	NA	NA	1	370	1	370	NA	NA	1	198	
50	TCGA-08-0349	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0349-01	131	0.2546570611511049	69	TCGA-08-0349-01	8	13	13	0.2873429329566166	TCGA-08-0349-01	1	1	5	7	PASS	2902	TCGA-08-0349	GBM	46	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-16964	Dead	WITH TUMOR	231	298	NA	Progression of Disease	NA	NA	93	NA	NA	NA	1	298	1	298	NA	NA	1	93	
30	TCGA-08-0350	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0350-01	195	0.27353320051627616	125	TCGA-08-0350-01	5	10	13	0.05204042858541039	TCGA-08-0350-01	5	8	3	16	PASS	2903	TCGA-08-0350	GBM	32	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-11905	Dead	WITH TUMOR	104	889	NA	Recurrence	NA	NA	439	NA	NA	NA	1	889	1	889	NA	NA	1	439	
40	TCGA-08-0351	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0351-01	320	0.11334451408388813	237	TCGA-08-0351-01	3	6	24	0.06116504724903665	TCGA-08-0351-01	9	8	3	20	PASS	2904	TCGA-08-0351	GBM	40	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-14838	Dead	WITH TUMOR	1637	1987	NA	Recurrence	NA	NA	1542	NA	NA	NA	1	1987	1	1987	NA	NA	1	1542	
80	TCGA-08-0352	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0352-01	125	0.15778395997447311	55	TCGA-08-0352-01	8	5	10	0.06183511451670741	TCGA-08-0352-01	1	1	0	2	PASS	2905	TCGA-08-0352	GBM	79	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-29106	Dead	WITH TUMOR	39	39	NA	NA	NA	NA	NA	NA	NA	NA	1	39	1	39	NA	NA	1	39	
60	TCGA-08-0353	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0353-01	557	0.22545172630636925	466	TCGA-08-0353-01	5	6	9	0.1343726541196673	TCGA-08-0353-01	4	6	6	16	PASS	2906	TCGA-08-0353	GBM	58	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-21332	Dead	WITH TUMOR	195	256	NA	Progression of Disease	NA	NA	164	NA	NA	NA	1	256	1	256	NA	NA	1	164	
50	TCGA-08-0354	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0354-01	325	0.17610633492208208	251	TCGA-08-0354-01	6	5	12	0.11337491733840513	TCGA-08-0354-01	3	1	1	5	PASS	2907	TCGA-08-0354	GBM	52	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-19199	Dead	WITH TUMOR	458	546	NA	Progression of Disease	NA	NA	253	NA	NA	NA	1	546	1	546	NA	NA	1	253	
30	TCGA-08-0355	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0355-01	177	0.2457230449647185	109	TCGA-08-0355-01	7	6	12	0.12156200921643776	TCGA-08-0355-01	2	1	1	4	PASS	2908	TCGA-08-0355	GBM	30	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-11099	Dead	WITH TUMOR	685	747	NA	Recurrence	NA	NA	519	NA	NA	NA	1	747	1	747	NA	NA	1	519	
60	TCGA-08-0356	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0356-01	115	0.15538648459273266	55	TCGA-08-0356-01	8	4	11	0.06286230136695346	TCGA-08-0356-01	2	2	1	5	PASS	2909	TCGA-08-0356	GBM	59	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-21900	Dead	WITH TUMOR	447	946	NA	Recurrence	NA	NA	447	NA	NA	NA	1	946	1	946	NA	NA	1	447	
50	TCGA-08-0357	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0357-01	127	0.15255942774460654	56	TCGA-08-0357-01	6	3	12	0.07171082235510523	TCGA-08-0357-01	1	2	1	4	PASS	2910	TCGA-08-0357	GBM	49	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-18144	Dead	WITH TUMOR	1084	1143	NA	Recurrence	NA	NA	155	NA	NA	NA	1	1143	1	1143	NA	NA	1	155	
50	TCGA-08-0358	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0358-01	219	0.3345277049535685	146	TCGA-08-0358-01	6	5	27	0.12356542240603112	TCGA-08-0358-01	5	4	4	13	PASS	2911	TCGA-08-0358	GBM	50	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-18383	Dead	WITH TUMOR	594	678	NA	Recurrence	NA	NA	264	NA	NA	NA	1	678	1	678	NA	NA	1	264	
60	TCGA-08-0359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0359-01	529	0.18684541661399492	451	TCGA-08-0359-01	6	5	17	0.13038847342380314	TCGA-08-0359-01	3	1	3	7	PASS	2912	TCGA-08-0359	GBM	59	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-21748	Dead	WITH TUMOR	29	103	NA	NA	NA	NA	NA	NA	NA	NA	1	103	1	103	NA	NA	1	103	
80	TCGA-08-0360	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0360	0	0	0	TCGA-08-0360	0	0	0	0	TCGA-08-0360	0	0	0	0	PASS	2913	TCGA-08-0360	GBM	76	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-27895	Dead	WITH TUMOR	352	468	NA	Recurrence	NA	NA	112	NA	NA	NA	1	468	1	468	NA	NA	1	112	
70	TCGA-08-0373	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0373	0	0	0	TCGA-08-0373	0	0	0	0	TCGA-08-0373	0	0	0	0	PASS	2914	TCGA-08-0373	GBM	69	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	1994	NA	-25274	Dead	WITH TUMOR	134	134	NA	NA	NA	NA	NA	NA	NA	NA	1	134	1	134	NA	NA	1	134	
50	TCGA-08-0375	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0375-01	350	0.20011997979267893	267	TCGA-08-0375-01	10	6	14	0.10491614366267857	TCGA-08-0375-01	2	0	3	5	PASS	2915	TCGA-08-0375	GBM	51	FEMALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	1994	NA	-18941	Dead	WITH TUMOR	279	372	NA	Recurrence	NA	NA	161	NA	NA	NA	1	372	1	372	NA	NA	1	161	
70	TCGA-08-0380	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0380-01	720	0.17811617497164592	640	TCGA-08-0380-01	6	5	3	0.1247868918240313	TCGA-08-0380-01	0	1	1	2	PASS	2916	TCGA-08-0380	GBM	74	FEMALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	1997	NA	-27277	Dead	WITH TUMOR	330	454	NA	Progression of Disease	NA	NA	151	NA	NA	NA	1	454	1	454	NA	NA	1	151	
70	TCGA-08-0385	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0385	0	0	0	TCGA-08-0385	0	0	0	0	TCGA-08-0385	0	0	0	0	PASS	2917	TCGA-08-0385	GBM	71	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-26234	Dead	WITH TUMOR	31	82	NA	NA	NA	NA	NA	NA	NA	NA	1	82	1	82	NA	NA	1	82	
70	TCGA-08-0386	0	1	0	0	0	0	0	0	1	9	0	0	0	8	0	0	TCGA-08-0386-01	184	0.868004492459202	113	TCGA-08-0386-01	7	8	31	0.13449987187617266	TCGA-08-0386-01	4	7	5	16	PASS	2918	TCGA-08-0386	GBM	74	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-27053	Dead	WITH TUMOR	478	548	NA	Recurrence	NA	NA	427	NA	NA	NA	1	548	1	548	NA	NA	1	427	
60	TCGA-08-0389	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0389-01	378	0.15211662953296393	309	TCGA-08-0389-01	6	4	10	0.10137865832149323	TCGA-08-0389-01	1	0	1	2	PASS	2919	TCGA-08-0389	GBM	59	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-21638	Dead	WITH TUMOR	97	467	NA	NA	NA	NA	NA	NA	NA	NA	1	467	1	467	NA	NA	1	467	
70	TCGA-08-0390	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0390-01	181	0.22311216265113604	97	TCGA-08-0390-01	5	5	12	0.12504230463308902	TCGA-08-0390-01	3	4	3	10	PASS	2920	TCGA-08-0390	GBM	69	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-25304	Dead	WITH TUMOR	322	425	NA	NA	NA	NA	NA	NA	NA	NA	1	425	1	425	NA	NA	1	425	
60	TCGA-08-0392	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0392-01	190	0.3354979105511774	121	TCGA-08-0392-01	6	6	16	0.10588401538932868	TCGA-08-0392-01	4	3	5	12	PASS	2921	TCGA-08-0392	GBM	60	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-22056	Dead	WITH TUMOR	9	22	NA	NA	NA	NA	NA	NA	NA	NA	1	22	1	22	NA	NA	1	22	
60	TCGA-08-0509	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0509-01	112	0.1688801114083769	59	TCGA-08-0509-01	8	4	10	0.100197562125821	TCGA-08-0509-01	0	2	1	3	PASS	2922	TCGA-08-0509	GBM	63	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	1999	NA	-23273	Dead	WITH TUMOR	17	382	NA	NA	NA	NA	NA	NA	NA	NA	1	382	1	382	NA	NA	1	382	
80	TCGA-08-0510	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0510-01	241	0.9206701070099832	165	TCGA-08-0510-01	22	16	33	0.14935795559554024	TCGA-08-0510-01	3	5	2	10	PASS	2923	TCGA-08-0510	GBM	75	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-27675	Dead	WITH TUMOR	107	130	NA	Recurrence	NA	NA	90	NA	NA	NA	1	130	1	130	NA	NA	1	90	
70	TCGA-08-0511	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0511	0	0	0	TCGA-08-0511	0	0	0	0	TCGA-08-0511	0	0	0	0	PASS	2924	TCGA-08-0511	GBM	69	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-25300	Dead	WITH TUMOR	235	235	NA	NA	NA	NA	NA	NA	NA	NA	1	235	1	235	NA	NA	1	235	
50	TCGA-08-0512	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0512-01	100	0.2443243576644812	48	TCGA-08-0512-01	7	6	15	0.2107228585555393	TCGA-08-0512-01	3	2	3	8	PASS	2925	TCGA-08-0512	GBM	48	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-17821	Dead	WITH TUMOR	358	1282	NA	Progression of Disease	NA	NA	231	NA	NA	NA	1	1282	1	1282	NA	NA	1	231	
70	TCGA-08-0514	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0514-01	283	0.29168592112340724	212	TCGA-08-0514-01	7	7	54	0.14766932567204089	TCGA-08-0514-01	5	1	5	11	PASS	2926	TCGA-08-0514	GBM	69	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-25457	Dead	WITH TUMOR	259	337	NA	NA	NA	NA	NA	NA	NA	NA	1	337	1	337	NA	NA	1	337	
20	TCGA-08-0516	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0516-01	108	0.4930095464873407	49	TCGA-08-0516-01	1	3	7	0.05256629198809417	TCGA-08-0516-01	4	4	3	11	PASS	2927	TCGA-08-0516	GBM	14	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-5309	Dead	WITH TUMOR	561	596	NA	Progression of Disease	NA	NA	40	NA	NA	NA	1	596	1	596	NA	NA	1	40	
30	TCGA-08-0517	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0517-01	216	0.8315698667015219	133	TCGA-08-0517-01	6	8	27	0.18253027100016286	TCGA-08-0517-01	14	13	8	35	PASS	2928	TCGA-08-0517	GBM	34	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1996	NA	-12771	Dead	WITH TUMOR	1770	1785	NA	Recurrence	NA	NA	1024	NA	NA	NA	1	1785	1	1785	NA	NA	1	1024	
60	TCGA-08-0518	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0518-01	237	0.18476510331603774	140	TCGA-08-0518-01	6	6	18	0.04846940149925436	TCGA-08-0518-01	3	9	3	15	PASS	2929	TCGA-08-0518	GBM	60	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-21995	Dead	WITH TUMOR	39	588	NA	Progression of Disease	NA	NA	134	NA	NA	NA	1	588	1	588	NA	NA	1	134	
70	TCGA-08-0520	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0520-01	137	0.8225315401775343	73	TCGA-08-0520-01	8	8	30	0.1791553947436297	TCGA-08-0520-01	7	4	5	16	PASS	2930	TCGA-08-0520	GBM	70	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-25766	Dead	WITH TUMOR	327	327	NA	Recurrence	NA	NA	105	NA	NA	NA	1	327	1	327	NA	NA	1	105	
20	TCGA-08-0521	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0521-01	61	0.04658990133462625	22	TCGA-08-0521-01	0	0	19	0.007682866228070537	TCGA-08-0521-01	1	1	1	3	PASS	2931	TCGA-08-0521	GBM	17	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-6377	Dead	WITH TUMOR	146	146	NA	Progression of Disease	NA	NA	125	NA	NA	NA	1	146	1	146	NA	NA	1	125	
60	TCGA-08-0522	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0522	0	0	0	TCGA-08-0522	0	0	0	0	TCGA-08-0522	0	0	0	0	PASS	2932	TCGA-08-0522	GBM	61	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-22414	Dead	WITH TUMOR	555	635	NA	Progression of Disease	NA	NA	266	NA	NA	NA	1	635	1	635	NA	NA	1	266	
20	TCGA-08-0524	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0524-01	120	0.12258478460199247	53	TCGA-08-0524-01	3	13	17	0.26164092468742944	TCGA-08-0524-01	4	4	8	16	PASS	2933	TCGA-08-0524	GBM	17	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-6464	Dead	WITH TUMOR	199	221	NA	Progression of Disease	NA	NA	61	NA	NA	NA	1	221	1	221	NA	NA	1	61	
50	TCGA-08-0525	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0525-01	116	0.5760827715137756	53	TCGA-08-0525-01	11	8	16	0.18772142644659465	TCGA-08-0525-01	4	6	8	18	PASS	2934	TCGA-08-0525	GBM	52	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-19013	Dead	WITH TUMOR	486	486	NA	Progression of Disease	NA	NA	343	NA	NA	NA	1	486	1	486	NA	NA	1	343	
60	TCGA-08-0529	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0529-01	171	0.15307672239688508	101	TCGA-08-0529-01	7	5	20	0.06678945232853832	TCGA-08-0529-01	1	1	1	3	PASS	2935	TCGA-08-0529	GBM	56	FEMALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-20556	Dead	WITH TUMOR	527	560	NA	Recurrence	NA	NA	328	NA	NA	NA	1	560	1	560	NA	NA	1	328	
60	TCGA-08-0531	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-08-0531-01	163	0.2898326099370324	86	TCGA-08-0531-01	6	4	22	0.05320857018350655	TCGA-08-0531-01	1	2	1	4	PASS	2936	TCGA-08-0531	GBM	64	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-23482	Dead	WITH TUMOR	168	230	NA	NA	NA	NA	NA	NA	NA	NA	1	230	1	230	NA	NA	1	230	
80	TCGA-12-0615	0	8	0	0	0	2	0	0	1	51	1	0	1	18	2	0	TCGA-12-0615-01	175	0.8302947484711868	102	TCGA-12-0615-01	7	8	28	0.2420096472450401	TCGA-12-0615-01	7	10	6	23	PASS	2937	TCGA-12-0615	GBM	78	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-28583	Dead	WITH TUMOR	426	467	NA	Progression of Disease	NA	NA	160	NA	NA	NA	1	467	1	467	NA	NA	1	160	
40	TCGA-12-0616	0	1	0	5	0	1	0	0	2	34	0	0	1	13	1	0	TCGA-12-0616-01	209	0.3415510572811605	141	TCGA-12-0616-01	4	2	15	0.11023638943418612	TCGA-12-0616-01	5	3	4	12	PASS	2938	TCGA-12-0616	GBM	36	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-13451	Dead	WITH TUMOR	439	448	NA	Progression of Disease	NA	NA	398	NA	NA	NA	1	448	1	448	NA	NA	1	398	
50	TCGA-12-0618	0	3	1	3	1	2	0	0	1	35	3	0	1	7	2	0	TCGA-12-0618-01	125	0.19645413579375315	64	TCGA-12-0618-01	7	7	7	0.11932631404163073	TCGA-12-0618-01	2	2	3	7	PASS	2939	TCGA-12-0618	GBM	49	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-18071	Dead	NA	50	395	NA	NA	NA	NA	NA	NA	NA	NA	1	395	NA	395	NA	NA	0	395	
60	TCGA-12-0619	0	3	0	1	1	2	0	0	0	42	7	1	0	14	0	0	TCGA-12-0619-01	270	0.5962423170300502	187	TCGA-12-0619-01	9	6	47	0.16852679531944914	TCGA-12-0619-01	0	3	2	5	PASS	2940	TCGA-12-0619	GBM	60	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-21920	Dead	WITH TUMOR	316	1062	NA	Progression of Disease	NA	NA	203	NA	NA	NA	1	1062	1	1062	NA	NA	1	203	
60	TCGA-12-0620	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-0620-01	123	0.16636250376880882	69	TCGA-12-0620-01	6	6	26	0.14448453174039402	TCGA-12-0620-01	2	6	3	11	PASS	2941	TCGA-12-0620	GBM	57	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-21069	Dead	WITH TUMOR	181	318	NA	NA	NA	NA	NA	NA	NA	NA	1	318	1	318	NA	NA	1	318	
70	TCGA-12-0653	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-0653	0	0	0	TCGA-12-0653	0	0	0	0	TCGA-12-0653	0	0	0	0	PASS	2942	TCGA-12-0653	GBM	65	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-23952	Dead	WITH TUMOR	NA	320	NA	Progression of Disease	NA	NA	267	NA	NA	NA	1	320	1	320	NA	NA	1	267	Redacted
50	TCGA-12-0654	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-0654-01	98	0.22367334582810128	41	TCGA-12-0654-01	9	7	8	0.151522223600015	TCGA-12-0654-01	3	0	4	7	PASS	2943	TCGA-12-0654	GBM	48	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-17625	Dead	WITH TUMOR	218	231	NA	Progression of Disease	NA	NA	216	NA	NA	NA	1	231	1	231	NA	NA	1	216	
50	TCGA-12-0656	0	4	0	1	2	2	0	0	2	42	2	0	1	20	2	0	TCGA-12-0656-01	190	0.18539645188761072	129	TCGA-12-0656-01	6	15	35	0.2105637716790821	TCGA-12-0656-01	4	2	5	11	mutation call filter	2944	TCGA-12-0656	GBM	48	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	1997	NA	-17865	Dead	WITH TUMOR	2005	2883	NA	Progression of Disease	NA	NA	1467	NA	NA	NA	1	2883	1	2883	NA	NA	1	1467	
70	TCGA-12-0657	0	3	1	0	2	1	0	0	1	52	1	0	2	28	1	0	TCGA-12-0657-01	145	0.14312604692135988	94	TCGA-12-0657-01	6	4	22	0.05664847316991908	TCGA-12-0657-01	5	1	2	8	mutation call filter	2945	TCGA-12-0657	GBM	69	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1996	NA	-25413	Dead	WITH TUMOR	3	3	NA	NA	NA	NA	NA	NA	NA	NA	1	3	1	3	NA	NA	1	3	
50	TCGA-12-0662	1	0	0	0	1	1	0	0	1	26	1	0	1	4	3	0	TCGA-12-0662-01	204	0.3109930193940428	123	TCGA-12-0662-01	8	6	33	0.13378105848833474	TCGA-12-0662-01	3	1	3	7	mutation call filter	2946	TCGA-12-0662	GBM	51	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-18717	Dead	WITH TUMOR	1161	1161	NA	Progression of Disease	NA	NA	600	NA	NA	NA	1	1161	1	1161	NA	NA	1	600	
60	TCGA-12-0670	0	4	0	2	1	4	0	0	2	44	1	0	1	25	3	0	TCGA-12-0670-01	291	0.2132712172257685	181	TCGA-12-0670-01	9	11	49	0.23861617200332216	TCGA-12-0670-01	2	5	4	11	mutation call filter	2947	TCGA-12-0670	GBM	60	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-22189	Dead	NA	790	790	NA	Progression of Disease	NA	NA	379	NA	NA	NA	1	790	NA	790	NA	NA	1	379	
70	TCGA-12-0688	0	5	0	4	3	0	0	0	8	33	2	0	1	25	0	0	TCGA-12-0688-01	159	0.14545751013897526	99	TCGA-12-0688-01	8	4	18	0.060173098544076875	TCGA-12-0688-01	1	2	0	3	PASS	2948	TCGA-12-0688	GBM	74	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-27085	Dead	WITH TUMOR	734	811	NA	Progression of Disease	NA	NA	228	NA	NA	NA	1	811	1	811	NA	NA	1	228	
60	TCGA-12-0691	0	5	0	3	0	1	1	0	1	52	2	0	0	15	1	0	TCGA-12-0691-01	290	0.4010455407235637	213	TCGA-12-0691-01	7	10	68	0.20918194793419306	TCGA-12-0691-01	10	12	7	29	mutation call filter	2949	TCGA-12-0691	GBM	63	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1999	NA	-23019	Dead	WITH TUMOR	186	369	NA	Progression of Disease	NA	NA	98	NA	NA	NA	1	369	1	369	NA	NA	1	98	
80	TCGA-12-0692	0	7	0	1	3	1	0	0	2	55	2	0	0	20	2	0	TCGA-12-0692-01	84	0.2585705350693023	35	TCGA-12-0692-01	6	5	12	0.08354385425828299	TCGA-12-0692-01	2	4	2	8	PASS	2950	TCGA-12-0692	GBM	75	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-27519	Dead	WITH TUMOR	80	111	NA	Progression of Disease	NA	NA	35	NA	NA	NA	1	111	1	111	NA	NA	1	35	
50	TCGA-12-0703	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-0703-01	85	0.15105510883571135	33	TCGA-12-0703-01	8	4	11	0.06574149568601607	TCGA-12-0703-01	1	1	1	3	PASS	2951	TCGA-12-0703	GBM	46	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1996	NA	-17125	Dead	WITH TUMOR	551	620	NA	Progression of Disease	NA	NA	208	NA	NA	NA	1	620	1	620	NA	NA	1	208	
60	TCGA-12-0707	0	1	2	2	0	1	0	0	1	60	5	0	0	21	2	0	TCGA-12-0707-01	124	0.21192633040101624	57	TCGA-12-0707-01	10	6	19	0.12105309462785105	TCGA-12-0707-01	2	2	2	6	mutation call filter	2952	TCGA-12-0707	GBM	55	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1997	NA	-20136	Dead	NA	0	864	NA	NA	NA	NA	NA	NA	NA	NA	1	864	NA	864	NA	NA	0	864	
50	TCGA-12-0769	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-0769-01	125	0.16838644312646206	54	TCGA-12-0769-01	7	4	12	0.09092063877166943	TCGA-12-0769-01	1	3	1	5	PASS	2953	TCGA-12-0769	GBM	52	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-19171	Dead	WITH TUMOR	378	458	NA	Progression of Disease	NA	NA	378	NA	NA	NA	1	458	1	458	NA	NA	1	378	
50	TCGA-12-0772	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-0772-01	147	0.22397130974002016	74	TCGA-12-0772-01	5	4	10	0.09606740581241588	TCGA-12-0772-01	3	2	2	7	PASS	2954	TCGA-12-0772	GBM	46	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-17019	Dead	WITH TUMOR	1615	1638	NA	Progression of Disease	NA	NA	607	NA	NA	NA	1	1638	1	1638	NA	NA	1	607	
30	TCGA-12-0773	0	5	0	3	1	2	0	0	0	43	5	0	6	20	0	0	TCGA-12-0773-01	70	0.14656880250099544	23	TCGA-12-0773-01	4	5	5	0.04272124147015687	TCGA-12-0773-01	3	6	2	11	mutation call filter	2955	TCGA-12-0773	GBM	24	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-8849	Dead	WITH TUMOR	1311	1315	NA	Progression of Disease	NA	NA	725	NA	NA	NA	1	1315	1	1315	NA	NA	1	725	
80	TCGA-12-0775	1	15	1	4	3	1	1	0	5	161	9	0	5	73	2	1	TCGA-12-0775-01	225	0.14114865663897275	157	TCGA-12-0775-01	4	3	33	0.08367591504180241	TCGA-12-0775-01	1	3	2	6	mutation call filter	2956	TCGA-12-0775	GBM	75	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-27565	Dead	WITH TUMOR	167	232	NA	Progression of Disease	NA	NA	94	NA	NA	NA	1	232	1	232	NA	NA	1	94	
50	TCGA-12-0776	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-0776-01	211	0.3961016601382977	135	TCGA-12-0776-01	10	8	38	0.23558002157690244	TCGA-12-0776-01	5	7	8	20	PASS	2957	TCGA-12-0776	GBM	52	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-19228	Dead	WITH TUMOR	277	296	NA	Progression of Disease	NA	NA	127	NA	NA	NA	1	296	1	296	NA	NA	1	127	
50	TCGA-12-0778	2	27	1	9	6	7	1	0	12	274	9	0	3	83	5	1	TCGA-12-0778-01	184	0.3606209029283216	102	TCGA-12-0778-01	13	9	24	0.0929897098143669	TCGA-12-0778-01	2	4	6	12	mutation call filter	2958	TCGA-12-0778	GBM	53	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-19460	Dead	WITH TUMOR	452	454	NA	Progression of Disease	NA	NA	232	NA	NA	NA	1	454	1	454	NA	NA	1	232	
50	TCGA-12-0780	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-0780-01	207	0.1838786055281891	144	TCGA-12-0780-01	9	6	28	0.08707283724438605	TCGA-12-0780-01	3	1	2	6	PASS	2959	TCGA-12-0780	GBM	51	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-18646	Dead	WITH TUMOR	434	452	NA	Progression of Disease	NA	NA	91	NA	NA	NA	1	452	1	452	NA	NA	1	91	
50	TCGA-12-0818	2	16	3	5	3	6	0	0	6	114	7	0	3	29	3	0	TCGA-12-0818-01	185	0.25834643122192985	130	TCGA-12-0818-01	4	7	30	0.03249817574242292	TCGA-12-0818-01	5	5	1	11	mutation call filter	2960	TCGA-12-0818	GBM	45	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1994	NA	-16666	Dead	NA	2791	2791	NA	NA	NA	NA	NA	NA	NA	NA	1	2791	NA	2791	NA	NA	0	2791	
50	TCGA-12-0819	0	3	0	0	1	2	0	0	1	46	2	0	0	14	5	0	TCGA-12-0819-01	138	0.2884228533964095	75	TCGA-12-0819-01	11	7	16	0.11986069747310595	TCGA-12-0819-01	2	2	4	8	mutation call filter	2961	TCGA-12-0819	GBM	49	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	1995	NA	-18160	Dead	WITH TUMOR	754	754	NA	Recurrence	NA	NA	428	NA	NA	NA	1	754	1	754	NA	NA	1	428	
40	TCGA-12-0820	0	9	0	2	4	4	1	0	2	65	4	0	0	21	3	0	TCGA-12-0820-01	221	0.15517948614199967	136	TCGA-12-0820-01	7	6	25	0.07006286695619827	TCGA-12-0820-01	6	3	5	14	mutation call filter	2962	TCGA-12-0820	GBM	40	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1997	NA	-14878	Dead	WITH TUMOR	562	562	NA	Recurrence	NA	NA	272	NA	NA	NA	1	562	1	562	NA	NA	1	272	
60	TCGA-12-0821	0	3	0	5	2	0	0	0	2	44	6	0	4	21	3	1	TCGA-12-0821-01	167	0.6937291873347409	93	TCGA-12-0821-01	8	5	27	0.16957182894782818	TCGA-12-0821-01	2	3	2	7	PASS	2963	TCGA-12-0821	GBM	62	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-22949	Dead	WITH TUMOR	323	323	NA	Recurrence	NA	NA	259	NA	NA	NA	1	323	1	323	NA	NA	1	259	
50	TCGA-12-0822	1	7	1	3	2	9	0	0	1	59	2	0	0	14	1	0	TCGA-12-0822-01	137	0.2244588921237741	76	TCGA-12-0822-01	6	4	15	0.061026724101988325	TCGA-12-0822-01	1	1	0	2	mutation call filter	2964	TCGA-12-0822	GBM	46	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-16803	Dead	WITH TUMOR	715	715	NA	Recurrence	NA	NA	91	NA	NA	NA	1	715	1	715	NA	NA	1	91	
40	TCGA-12-0826	1	10	1	4	1	1	0	0	0	57	5	0	2	17	2	0	TCGA-12-0826-01	140	0.6442691969622479	84	TCGA-12-0826-01	25	51	2	0.05234745936188576	TCGA-12-0826-01	5	1	0	6	mutation call filter	2965	TCGA-12-0826	GBM	38	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1999	NA	-13887	Dead	NA	845	845	NA	NA	NA	NA	NA	NA	NA	NA	1	845	NA	845	NA	NA	0	845	
40	TCGA-12-0827	0	4	0	3	0	1	0	0	1	35	0	0	0	16	1	0	TCGA-12-0827-01	691	0.5333086592891377	519	TCGA-12-0827-01	10	10	162	0.2829335325502076	TCGA-12-0827-01	8	10	8	26	mutation call filter	2966	TCGA-12-0827	GBM	38	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1999	NA	-14093	Dead	WITH TUMOR	1179	1179	NA	NA	NA	NA	NA	NA	NA	NA	1	1179	1	1179	NA	NA	1	1179	
60	TCGA-12-0828	0	6	0	5	0	7	0	0	7	84	4	0	2	24	3	0	TCGA-12-0828-01	80	0.10577970843089396	29	TCGA-12-0828-01	4	2	7	0.051041683235762664	TCGA-12-0828-01	0	0	0	0	mutation call filter	2967	TCGA-12-0828	GBM	57	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-20909	Dead	WITH TUMOR	272	272	NA	Progression of Disease	NA	NA	13	NA	NA	NA	1	272	1	272	NA	NA	1	13	
80	TCGA-12-0829	0	53	6	25	18	15	4	2	29	519	28	0	12	168	16	1	TCGA-12-0829-01	177	0.1875006602174884	100	TCGA-12-0829-01	8	5	12	0.08693315966681645	TCGA-12-0829-01	1	2	1	4	mutation call filter	2968	TCGA-12-0829	GBM	75	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-27471	Dead	WITH TUMOR	626	626	NA	Recurrence	NA	NA	473	NA	NA	NA	1	626	1	626	NA	NA	1	473	
50	TCGA-12-1088	0	7	0	2	5	0	0	0	6	84	5	0	2	23	4	0	TCGA-12-1088-01	199	0.3641664069859115	117	TCGA-12-1088-01	8	15	24	0.2459549281665292	TCGA-12-1088-01	5	7	6	18	mutation call filter	2969	TCGA-12-1088	GBM	53	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1989	NA	-19667	Dead	NA	3881	3881	NA	NA	NA	NA	NA	NA	NA	NA	1	3881	NA	3881	NA	NA	0	3881	
60	TCGA-12-1089	2	8	0	8	2	1	0	0	8	110	9	0	1	26	5	0	TCGA-12-1089-01	1964	0.14258005810441646	1871	TCGA-12-1089-01	4	5	169	0.1039358110296136	TCGA-12-1089-01	2	8	4	14	mutation call filter	2970	TCGA-12-1089	GBM	64	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-23419	Dead	WITH TUMOR	177	177	NA	NA	NA	NA	NA	NA	NA	NA	1	177	1	177	NA	NA	1	177	
60	TCGA-12-1090	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-1090-01	213	0.17976933320074925	135	TCGA-12-1090-01	4	24	52	0.8777065711392812	TCGA-12-1090-01	2	2	1	5	PASS	2971	TCGA-12-1090	GBM	58	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-21377	Dead	WITH TUMOR	190	231	NA	NA	NA	NA	NA	NA	NA	NA	1	231	1	231	NA	NA	1	231	
20	TCGA-12-1091	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-1091-01	237	0.9477833436617366	158	TCGA-12-1091-01	8	6	57	0.1716441669459792	TCGA-12-1091-01	3	3	2	8	PASS	2972	TCGA-12-1091	GBM	10	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2001	NA	-3982	Dead	WITH TUMOR	929	1010	NA	Recurrence	NA	NA	56	NA	NA	NA	1	1010	1	1010	NA	NA	1	56	
60	TCGA-12-1092	0	4	0	1	2	2	0	0	4	36	6	0	1	9	5	0	TCGA-12-1092-01	112	0.27897576133450297	57	TCGA-12-1092-01	8	12	18	0.18736853803131828	TCGA-12-1092-01	3	2	3	8	mutation call filter	2973	TCGA-12-1092	GBM	58	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-21411	Dead	WITH TUMOR	658	661	NA	Recurrence	NA	NA	637	NA	NA	NA	1	661	1	661	NA	NA	1	637	
70	TCGA-12-1093	0	10	1	2	3	0	0	0	4	70	6	0	1	26	3	0	TCGA-12-1093-01	89	0.25679786269514354	39	TCGA-12-1093-01	9	9	19	0.1987050082295544	TCGA-12-1093-01	5	6	5	16	mutation call filter	2974	TCGA-12-1093	GBM	66	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-24297	Dead	WITH TUMOR	364	486	NA	Recurrence	NA	NA	322	NA	NA	NA	1	486	1	486	NA	NA	1	322	
60	TCGA-12-1094	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-1094-01	125	0.18055456835055314	66	TCGA-12-1094-01	8	6	6	0.09443417053604483	TCGA-12-1094-01	0	2	0	2	PASS	2975	TCGA-12-1094	GBM	56	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-20586	Dead	WITH TUMOR	346	372	NA	Recurrence	NA	NA	186	NA	NA	NA	1	372	1	372	NA	NA	1	186	
70	TCGA-12-1095	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-1095-01	116	0.19292009247240727	56	TCGA-12-1095-01	6	7	14	0.12390332614532913	TCGA-12-1095-01	6	3	5	14	PASS	2976	TCGA-12-1095	GBM	65	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-23775	Dead	WITH TUMOR	482	482	NA	Progression of Disease	NA	NA	96	NA	NA	NA	1	482	1	482	NA	NA	1	96	
60	TCGA-12-1096	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-1096-01	105	0.3397658615621212	50	TCGA-12-1096-01	12	7	11	0.1191410405431847	TCGA-12-1096-01	1	0	1	2	PASS	2977	TCGA-12-1096	GBM	55	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-20321	Dead	WITH TUMOR	NA	277	NA	Recurrence	NA	NA	270	NA	NA	NA	1	277	1	277	NA	NA	1	270	
60	TCGA-12-1097	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-1097-01	100	0.2987360526185974	52	TCGA-12-1097-01	8	6	11	0.13355022764823204	TCGA-12-1097-01	2	1	4	7	PASS	2978	TCGA-12-1097	GBM	61	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-22526	Dead	WITH TUMOR	442	442	NA	Progression of Disease	NA	NA	166	NA	NA	NA	1	442	1	442	NA	NA	1	166	
80	TCGA-12-1098	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-1098-01	310	0.3027620046369082	233	TCGA-12-1098-01	9	10	58	0.1286955327765658	TCGA-12-1098-01	9	6	8	23	PASS	2979	TCGA-12-1098	GBM	75	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-27726	Dead	WITH TUMOR	121	121	NA	Recurrence	NA	NA	93	NA	NA	NA	1	121	1	121	NA	NA	1	93	
70	TCGA-12-1099	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-12-1099-01	1127	0.6408604462762199	874	TCGA-12-1099-01	14	16	136	0.0706022134909697	TCGA-12-1099-01	4	3	0	7	PASS	2980	TCGA-12-1099	GBM	68	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-25034	Dead	WITH TUMOR	104	126	NA	Recurrence	NA	NA	62	NA	NA	NA	1	126	1	126	NA	NA	1	62	
60	TCGA-12-1597	0	3	0	2	5	0	0	0	4	57	2	0	4	22	0	0	TCGA-12-1597	0	0	0	TCGA-12-1597	0	0	0	0	TCGA-12-1597	0	0	0	0	PASS	2981	TCGA-12-1597	GBM	62	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-22865	Dead	WITH TUMOR	427	675	NA	Progression of Disease	NA	NA	180	NA	NA	NA	1	675	1	675	NA	NA	1	180	
80	TCGA-12-1598	0	4	0	1	2	1	0	0	3	60	3	1	3	16	0	0	TCGA-12-1598-01	264	0.6626033017408984	164	TCGA-12-1598-01	11	9	58	0.20021826078946847	TCGA-12-1598-01	3	3	7	13	mutation call filter	2982	TCGA-12-1598	GBM	75	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-27730	Dead	WITH TUMOR	287	476	NA	NA	NA	NA	NA	NA	NA	NA	1	476	1	476	NA	NA	1	476	
50	TCGA-12-1599	0	3	0	0	1	0	0	0	2	26	1	0	2	19	0	0	TCGA-12-1599-01	77	0.13738712593096514	25	TCGA-12-1599-01	6	4	13	0.06640332125641403	TCGA-12-1599-01	0	2	1	3	mutation call filter	2983	TCGA-12-1599	GBM	47	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-17432	Dead	WITH TUMOR	769	781	NA	Progression of Disease	NA	NA	89	NA	NA	NA	1	781	1	781	NA	NA	1	89	
90	TCGA-12-1600	2	2	0	1	1	1	0	0	3	49	3	0	3	22	6	0	TCGA-12-1600-01	144	0.4387315862691046	82	TCGA-12-1600-01	9	8	16	0.13311197682739814	TCGA-12-1600-01	1	2	1	4	mutation call filter	2984	TCGA-12-1600	GBM	86	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-31419	Dead	WITH TUMOR	414	448	NA	Progression of Disease	NA	NA	404	NA	NA	NA	1	448	1	448	NA	NA	1	404	
60	TCGA-12-1602	0	0	0	2	0	1	0	0	4	39	2	0	1	16	0	0	TCGA-12-1602-01	195	0.6124805636273855	129	TCGA-12-1602-01	23	18	60	0.18023023404664426	TCGA-12-1602-01	8	5	3	16	mutation call filter	2985	TCGA-12-1602	GBM	58	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-21492	Dead	WITH TUMOR	195	206	NA	Progression of Disease	NA	NA	140	NA	NA	NA	1	206	1	206	NA	NA	1	140	
50	TCGA-12-3644	1	8	0	2	0	0	0	0	5	102	5	0	1	39	3	0	TCGA-12-3644-01	154	0.3260491467762813	100	TCGA-12-3644-01	8	11	11	0.2476979853701536	TCGA-12-3644-01	0	1	1	2	mutation call filter	2986	TCGA-12-3644	GBM	47	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-17468	Dead	WITH TUMOR	1807	1818	NA	Progression of Disease	NA	NA	1142	NA	NA	NA	1	1818	1	1818	NA	NA	1	1142	
60	TCGA-12-3646	0	7	0	0	2	0	0	0	3	64	6	0	2	18	0	0	TCGA-12-3646-01	127	0.7574961336814702	61	TCGA-12-3646-01	5	4	17	0.1258883097991875	TCGA-12-3646-01	1	0	0	1	mutation call filter	2987	TCGA-12-3646	GBM	59	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-21855	Dead	WITH TUMOR	1315	1339	NA	Progression of Disease	NA	NA	1315	NA	NA	NA	1	1339	1	1339	NA	NA	1	1315	
60	TCGA-12-3648	0	2	1	1	2	0	0	0	2	34	1	0	1	24	1	0	TCGA-12-3648-01	184	0.16304047945863828	101	TCGA-12-3648-01	8	4	13	0.06278656129799727	TCGA-12-3648-01	0	2	0	2	mutation call filter	2988	TCGA-12-3648	GBM	61	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-22463	Dead	WITH TUMOR	784	819	NA	Progression of Disease	NA	NA	86	NA	NA	NA	1	819	1	819	NA	NA	1	86	
80	TCGA-12-3649	0	2	0	2	2	0	0	0	0	66	6	0	0	16	2	0	TCGA-12-3649-01	230	0.17575433369893806	160	TCGA-12-3649-01	6	6	29	0.09969608383207247	TCGA-12-3649-01	3	6	2	11	PASS	2989	TCGA-12-3649	GBM	76	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-27846	Dead	WITH TUMOR	351	463	NA	Progression of Disease	NA	NA	351	NA	NA	NA	1	463	1	463	NA	NA	1	351	
50	TCGA-12-3650	0	4	0	2	0	0	0	0	0	39	6	0	1	15	0	0	TCGA-12-3650-01	157	0.12970130306888886	78	TCGA-12-3650-01	6	3	14	0.05598547609474787	TCGA-12-3650-01	0	0	0	0	PASS	2990	TCGA-12-3650	GBM	46	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-17138	Dead	WITH TUMOR	333	333	NA	Progression of Disease	NA	NA	239	NA	NA	NA	1	333	1	333	NA	NA	1	239	
80	TCGA-12-3651	2	9	0	3	0	1	0	0	5	94	7	0	0	27	1	0	TCGA-12-3651-01	373	0.32128366432783645	289	TCGA-12-3651-01	8	6	57	0.1447242915202165	TCGA-12-3651-01	8	6	4	18	mutation call filter	2991	TCGA-12-3651	GBM	77	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-28277	Dead	WITH TUMOR	358	386	NA	Progression of Disease	NA	NA	358	NA	NA	NA	1	386	1	386	NA	NA	1	358	
60	TCGA-12-3652	0	2	0	1	0	0	1	0	3	46	4	1	1	22	1	0	TCGA-12-3652-01	200	0.7755885504349407	126	TCGA-12-3652-01	8	5	47	0.12281364856454058	TCGA-12-3652-01	2	3	2	7	PASS	2992	TCGA-12-3652	GBM	60	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-21920	Dead	WITH TUMOR	1050	1062	NA	Progression of Disease	NA	NA	203	NA	NA	NA	1	1062	1	1062	NA	NA	1	203	
30	TCGA-12-3653	0	0	0	1	1	1	0	0	1	23	2	0	0	4	0	0	TCGA-12-3653-01	144	0.947695710580956	78	TCGA-12-3653-01	22	14	22	0.1814632650383004	TCGA-12-3653-01	1	6	5	12	PASS	2993	TCGA-12-3653	GBM	34	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-12529	Dead	WITH TUMOR	357	442	NA	Progression of Disease	NA	NA	224	NA	NA	NA	1	442	1	442	NA	NA	1	224	
60	TCGA-12-5295	0	2	0	2	3	0	0	0	2	60	2	0	2	20	0	0	TCGA-12-5295-01	103	0.2783692735472857	46	TCGA-12-5295-01	8	10	20	0.17473282051933686	TCGA-12-5295-01	8	4	2	14	PASS	2994	TCGA-12-5295	GBM	60	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-22161	Dead	WITH TUMOR	399	454	NA	Progression of Disease	NA	NA	399	NA	NA	NA	1	454	1	454	NA	NA	1	399	
60	TCGA-12-5299	0	4	0	1	0	0	0	0	2	30	2	0	2	11	1	0	TCGA-12-5299-01	59	0.16305410431171266	15	TCGA-12-5299-01	6	6	7	0.1014888962295088	TCGA-12-5299-01	2	0	3	5	PASS	2995	TCGA-12-5299	GBM	56	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-20463	Dead	WITH TUMOR	98	98	NA	NA	NA	NA	NA	NA	NA	NA	1	98	1	98	NA	NA	1	98	
60	TCGA-12-5301	0	4	0	2	0	2	0	0	1	51	5	0	1	26	0	0	TCGA-12-5301-01	179	0.15538983861076386	105	TCGA-12-5301-01	4	4	34	0.09765124450155653	TCGA-12-5301-01	6	3	4	13	PASS	2996	TCGA-12-5301	GBM	59	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-21768	Dead	WITH TUMOR	62	62	NA	NA	NA	NA	NA	NA	NA	NA	1	62	1	62	NA	NA	1	62	
50	TCGA-14-0736	0	6	0	3	1	0	0	0	4	85	10	0	0	30	4	0	TCGA-14-0736-01	277	0.9441642419087296	187	TCGA-14-0736-02	10	13	23	0.2837855381381675	TCGA-14-0736-02	2	4	2	8	mutation call filter	2997	TCGA-14-0736	GBM	49	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	1999	NA	-18219	Dead	WITH TUMOR	460	460	NA	Recurrence	NA	NA	128	NA	NA	NA	1	460	1	460	NA	NA	1	128	
70	TCGA-14-0740	0	1	1	1	1	0	0	0	1	38	3	0	3	12	1	0	TCGA-14-0740-01	318	0.9322567117333268	215	TCGA-14-0740-01	17	13	58	0.1478927990464326	TCGA-14-0740-01	7	2	6	15	PASS	2998	TCGA-14-0740	GBM	70	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-25627	Dead	WITH TUMOR	364	364	NA	NA	NA	NA	NA	NA	NA	NA	1	364	1	364	NA	NA	1	364	
50	TCGA-14-0781	0	1	0	1	3	0	0	0	0	23	2	0	0	8	0	0	TCGA-14-0781-01	84	0.10213208247688824	35	TCGA-14-0781-01	4	3	3	0.05044718411753559	TCGA-14-0781-01	0	1	0	1	PASS	2999	TCGA-14-0781	GBM	49	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-17903	Dead	WITH TUMOR	29	29	NA	NA	NA	NA	NA	NA	NA	NA	1	29	1	29	NA	NA	1	29	
40	TCGA-14-0783	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-14-0783-01	153	0.4998207144058086	78	TCGA-14-0783-01	17	48	12	0.1126284262037244	TCGA-14-0783-01	4	0	2	6	PASS	3000	TCGA-14-0783	GBM	36	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2000	NA	-13159	Dead	WITH TUMOR	189	189	NA	NA	NA	NA	NA	NA	NA	NA	1	189	1	189	NA	NA	1	189	
50	TCGA-14-0786	0	3	0	3	1	0	0	0	0	29	0	0	5	11	2	0	TCGA-14-0786-01	135	0.14346951827974633	79	TCGA-14-0786-01	7	6	22	0.09825447767675582	TCGA-14-0786-01	4	1	2	7	PASS	3001	TCGA-14-0786	GBM	50	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-18592	Dead	WITH TUMOR	701	701	NA	Recurrence	NA	NA	127	NA	NA	NA	1	701	1	701	NA	NA	1	127	
70	TCGA-14-0787	1	4	0	0	1	0	1	0	2	26	1	0	1	12	0	0	TCGA-14-0787-01	203	0.21296331094000776	118	TCGA-14-0787-01	8	6	24	0.13463708557389878	TCGA-14-0787-01	5	4	4	13	PASS	3002	TCGA-14-0787	GBM	69	MALE	ASIAN	NA	NA	Untreated primary (de novo) GBM	NA	1999	NA	-25326	Dead	NA	68	68	NA	NA	NA	NA	NA	NA	NA	NA	1	68	NA	68	NA	NA	0	68	
50	TCGA-14-0789	0	3	0	2	1	1	3	0	4	46	6	0	3	25	2	0	TCGA-14-0789-01	81	0.12618423941706086	23	TCGA-14-0789-01	6	3	10	0.05363762197928936	TCGA-14-0789-01	0	0	0	0	PASS	3003	TCGA-14-0789	GBM	54	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-20050	Dead	NA	342	342	NA	Progression of Disease	NA	NA	105	NA	NA	NA	1	342	NA	342	NA	NA	1	105	
60	TCGA-14-0790	1	5	0	1	0	1	1	0	2	50	0	0	2	22	1	0	TCGA-14-0790-01	146	0.19940884227398745	85	TCGA-14-0790-01	6	4	27	0.08947706397353658	TCGA-14-0790-01	0	6	3	9	PASS	3004	TCGA-14-0790	GBM	64	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-23674	Dead	WITH TUMOR	419	419	NA	NA	NA	NA	NA	NA	NA	NA	1	419	1	419	NA	NA	1	419	
70	TCGA-14-0812	0	2	1	1	2	1	2	0	6	65	5	0	0	14	2	0	TCGA-14-0812-01	176	0.3645312893539165	103	TCGA-14-0812-01	4	3	21	0.12539666093663288	TCGA-14-0812-01	3	0	1	4	mutation call filter	3005	TCGA-14-0812	GBM	65	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-24085	Dead	WITH TUMOR	99	99	NA	NA	NA	NA	NA	NA	NA	NA	1	99	1	99	NA	NA	1	99	
80	TCGA-14-0813	1	9	0	7	4	0	0	0	2	74	2	0	3	29	3	0	TCGA-14-0813-01	150	0.3771703646572448	84	TCGA-14-0813-01	8	7	29	0.1305087689419557	TCGA-14-0813-01	3	3	1	7	PASS	3006	TCGA-14-0813	GBM	78	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-28582	Dead	NA	41	41	NA	NA	NA	NA	NA	NA	NA	NA	1	41	NA	41	NA	NA	0	41	
70	TCGA-14-0817	0	4	0	4	2	0	1	0	0	56	5	0	3	15	1	0	TCGA-14-0817-01	146	0.7290485664885114	79	TCGA-14-0817-01	7	6	20	0.15590370479928692	TCGA-14-0817-01	1	6	3	10	PASS	3007	TCGA-14-0817	GBM	69	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-25425	Dead	NA	164	164	NA	NA	NA	NA	NA	NA	NA	NA	1	164	NA	164	NA	NA	0	164	
60	TCGA-14-0862	0	1	0	0	0	0	3	0	1	30	3	0	0	12	1	0	TCGA-14-0862-01	157	0.9429979403803724	71	TCGA-14-0862-01	9	10	32	0.2811721292668866	TCGA-14-0862-01	9	6	10	25	PASS	3008	TCGA-14-0862	GBM	60	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-22179	Dead	WITH TUMOR	88	88	NA	NA	NA	NA	NA	NA	NA	NA	1	88	1	88	NA	NA	1	88	
70	TCGA-14-0865	1	3	0	2	1	3	0	0	6	55	7	0	1	12	3	0	TCGA-14-0865-01	150	0.917213626662602	90	TCGA-14-0865-01	13	12	45	0.2268900716940858	TCGA-14-0865-01	4	4	2	10	mutation call filter	3009	TCGA-14-0865	GBM	67	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-24797	Dead	WITH TUMOR	502	502	NA	Progression of Disease	NA	NA	215	NA	NA	NA	1	502	1	502	NA	NA	1	215	
60	TCGA-14-0866	1	44	1	24	6	3	4	0	21	343	16	1	3	107	7	3	TCGA-14-0866-01	109	0.14684100219133073	57	TCGA-14-0866-01	8	4	16	0.05722205948582758	TCGA-14-0866-01	0	1	0	1	mutation call filter	3010	TCGA-14-0866	GBM	55	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-20179	Dead	NA	801	801	NA	Recurrence	NA	NA	97	NA	NA	NA	1	801	NA	801	NA	NA	1	97	
70	TCGA-14-0867	3	5	0	10	5	7	1	0	4	67	7	0	2	43	4	1	TCGA-14-0867-01	114	0.8173069727337737	60	TCGA-14-0867-01	8	7	11	0.16580142489287492	TCGA-14-0867-01	0	1	1	2	mutation call filter	3011	TCGA-14-0867	GBM	67	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-24815	Dead	NA	62	62	NA	NA	NA	NA	NA	NA	NA	NA	1	62	NA	62	NA	NA	0	62	
70	TCGA-14-0871	0	4	0	1	0	2	0	0	2	43	5	0	1	11	0	0	TCGA-14-0871-01	400	0.7255383507236223	246	TCGA-14-0871-01	24	52	62	0.18081885907621745	TCGA-14-0871-01	18	9	4	31	PASS	3012	TCGA-14-0871	GBM	74	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-27387	Dead	NA	880	880	NA	NA	NA	NA	NA	NA	NA	NA	1	880	NA	880	NA	NA	0	880	
60	TCGA-14-1034	1	7	0	9	8	1	2	0	6	125	9	0	0	47	6	0	TCGA-14-1034-01	96	0.2833722091712056	46	TCGA-14-1034-02	11	11	37	0.3200845523734966	TCGA-14-1034-02	9	8	7	24	mutation call filter	3013	TCGA-14-1034	GBM	60	FEMALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	1999	NA	-22029	Dead	WITH TUMOR	485	485	NA	Progression of Disease	NA	NA	282	NA	NA	NA	1	485	1	485	NA	NA	1	282	
70	TCGA-14-1037	0	4	0	1	1	1	0	0	2	44	2	1	0	19	3	0	TCGA-14-1037-01	62	0.1621729195560317	15	TCGA-14-1037-01	6	4	8	0.1127716465213892	TCGA-14-1037-01	3	2	4	9	mutation call filter	3014	TCGA-14-1037	GBM	66	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-24426	Dead	WITH TUMOR	587	587	NA	Recurrence	NA	NA	326	NA	NA	NA	1	587	1	587	NA	NA	1	326	
60	TCGA-14-1043	0	1	0	1	2	1	0	0	1	13	2	0	1	9	0	0	TCGA-14-1043-01	90	0.12125603739773926	35	TCGA-14-1043-01	6	8	10	0.12501336719886025	TCGA-14-1043-01	2	0	0	2	PASS	3015	TCGA-14-1043	GBM	61	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-22392	Dead	WITH TUMOR	24	24	NA	NA	NA	NA	NA	NA	NA	NA	1	24	1	24	NA	NA	1	24	
50	TCGA-14-1395	0	3	0	0	4	1	0	0	0	34	4	0	2	14	2	0	TCGA-14-1395-01	169	0.17614726102831166	106	TCGA-14-1395-01	8	6	35	0.127388866986892	TCGA-14-1395-01	1	0	2	3	PASS	3016	TCGA-14-1395	GBM	52	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-19237	Dead	WITH TUMOR	42	42	NA	NA	NA	NA	NA	NA	NA	NA	1	42	1	42	NA	NA	1	42	
80	TCGA-14-1396	2	12	1	10	7	2	1	0	14	225	26	0	9	114	8	1	TCGA-14-1396-01	153	0.2720927060245573	92	TCGA-14-1396-01	6	9	28	0.10919102134314963	TCGA-14-1396-01	6	5	6	17	mutation call filter	3017	TCGA-14-1396	GBM	78	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2003	NA	-28753	Dead	WITH TUMOR	34	34	NA	NA	NA	NA	NA	NA	NA	NA	1	34	1	34	NA	NA	1	34	
50	TCGA-14-1401	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-14-1401-01	99	0.10901072574960116	47	TCGA-14-1401-01	4	2	4	0.06290997380760406	TCGA-14-1401-01	1	2	2	5	PASS	3018	TCGA-14-1401	GBM	54	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-19921	Dead	WITH TUMOR	114	114	NA	NA	NA	NA	NA	NA	NA	NA	1	114	1	114	NA	NA	1	114	
60	TCGA-14-1402	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-14-1402-01	320	0.13143921759048066	230	TCGA-14-1402-01	8	7	43	0.1178965358685034	TCGA-14-1402-01	3	2	5	10	PASS	3019	TCGA-14-1402	GBM	58	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-21421	Dead	WITH TUMOR	975	975	NA	Progression of Disease	NA	NA	333	NA	NA	NA	1	975	1	975	NA	NA	1	333	
60	TCGA-14-1450	0	3	1	1	0	0	0	0	2	45	3	0	2	16	1	0	TCGA-14-1450-01	155	0.18818427459020876	80	TCGA-14-1450-01	9	5	11	0.11422358764180005	TCGA-14-1450-01	0	0	0	0	PASS	3020	TCGA-14-1450	GBM	57	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-20960	Alive	WITH TUMOR	1788	NA	NA	Progression of Disease	NA	NA	826	NA	NA	NA	0	1788	0	1788	NA	NA	1	826	
40	TCGA-14-1451	0	6	0	0	1	1	1	0	0	25	2	0	0	12	0	0	TCGA-14-1451-01	140	0.18749406393446086	88	TCGA-14-1451-01	6	4	28	0.12224182648489088	TCGA-14-1451-01	3	2	4	9	mutation call filter	3021	TCGA-14-1451	GBM	39	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-14401	Dead	WITH TUMOR	703	703	NA	Recurrence	NA	NA	19	NA	NA	NA	1	703	1	703	NA	NA	1	19	
60	TCGA-14-1452	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-14-1452-01	151	0.1767446727459876	92	TCGA-14-1452-01	7	4	12	0.04956649967149308	TCGA-14-1452-01	3	2	2	7	PASS	3022	TCGA-14-1452	GBM	60	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-22106	Dead	WITH TUMOR	216	216	NA	Recurrence	NA	NA	172	NA	NA	NA	1	216	1	216	NA	NA	1	172	
70	TCGA-14-1453	0	4	1	1	0	0	0	0	2	52	3	0	3	15	1	0	TCGA-14-1453-01	287	0.8635010764343323	187	TCGA-14-1453-01	10	10	87	0.257475460804716	TCGA-14-1453-01	14	8	8	30	mutation call filter	3023	TCGA-14-1453	GBM	69	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-25297	Dead	WITH TUMOR	35	35	NA	NA	NA	NA	NA	NA	NA	NA	1	35	1	35	NA	NA	1	35	
50	TCGA-14-1454	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-14-1454-01	134	0.4810575157740933	67	TCGA-14-1454-01	17	22	6	0.13390368471791805	TCGA-14-1454-01	1	1	0	2	PASS	3024	TCGA-14-1454	GBM	54	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-19887	Dead	WITH TUMOR	918	918	NA	Recurrence	NA	NA	291	NA	NA	NA	1	918	1	918	NA	NA	1	291	
60	TCGA-14-1455	1	2	0	3	1	1	0	0	1	57	4	0	0	18	1	0	TCGA-14-1455-01	130	0.18969827722593066	71	TCGA-14-1455-01	5	3	19	0.08722366473354319	TCGA-14-1455-01	0	0	0	0	mutation call filter	3025	TCGA-14-1455	GBM	61	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-22562	Dead	WITH TUMOR	28	28	NA	NA	NA	NA	NA	NA	NA	NA	1	28	1	28	NA	NA	1	28	
30	TCGA-14-1456	0	2	0	1	0	0	0	0	1	25	0	0	0	4	0	0	TCGA-14-1456-01	173	0.10386621630348487	108	TCGA-14-1456-01	1	2	7	0.017265685834624633	TCGA-14-1456-01	4	2	1	7	PASS	3026	TCGA-14-1456	GBM	23	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-8710	Alive	WITH TUMOR	1246	NA	NA	Progression of Disease	NA	NA	98	NA	NA	NA	0	1246	0	1246	NA	NA	1	98	
50	TCGA-14-1458	0	9	1	6	6	4	0	0	4	153	8	0	0	53	10	0	TCGA-14-1458-01	118	0.3028814711559935	62	TCGA-14-1458-01	3	2	4	0.022309216101653314	TCGA-14-1458-01	0	0	1	1	mutation call filter	3027	TCGA-14-1458	GBM	54	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-19899	Dead	NA	187	203	NA	Recurrence	NA	NA	81	NA	NA	NA	1	203	NA	203	NA	NA	1	81	
60	TCGA-14-1459	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-14-1459-01	234	0.16811563957677786	153	TCGA-14-1459-01	4	2	22	0.06796104259973262	TCGA-14-1459-01	1	3	6	10	PASS	3028	TCGA-14-1459	GBM	63	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-23231	Dead	WITH TUMOR	378	378	NA	Progression of Disease	NA	NA	275	NA	NA	NA	1	378	1	378	NA	NA	1	275	
60	TCGA-14-1794	1	27	0	4	7	3	1	0	9	159	15	2	5	66	5	0	TCGA-14-1794-01	87	0.5046041463631314	32	TCGA-14-1794-01	5	3	12	0.05797897305004498	TCGA-14-1794-01	1	0	1	2	mutation call filter	3029	TCGA-14-1794	GBM	59	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-21628	Dead	WITH TUMOR	30	30	NA	NA	NA	NA	NA	NA	NA	NA	1	30	1	30	NA	NA	1	30	
70	TCGA-14-1795	2	34	1	24	8	5	3	0	14	280	24	1	7	136	13	2	TCGA-14-1795-01	106	0.10276301304710236	60	TCGA-14-1795-01	4	2	25	0.058411582274466425	TCGA-14-1795-01	1	1	1	3	mutation call filter	3030	TCGA-14-1795	GBM	66	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-24375	Dead	WITH TUMOR	60	60	NA	NA	NA	NA	NA	NA	NA	NA	1	60	1	60	NA	NA	1	60	
30	TCGA-14-1821	0	2	0	1	2	0	0	0	0	14	4	0	1	6	0	0	TCGA-14-1821-01	214	0.449910044207472	131	TCGA-14-1821-01	4	5	46	0.12279252426621175	TCGA-14-1821-01	9	6	4	19	mutation call filter	3031	TCGA-14-1821	GBM	31	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-11329	Dead	WITH TUMOR	541	541	NA	Recurrence	NA	NA	331	NA	NA	NA	1	541	1	541	NA	NA	1	331	
60	TCGA-14-1823	0	5	0	1	0	0	1	0	1	52	1	0	1	11	2	0	TCGA-14-1823-01	196	0.8630522727005574	124	TCGA-14-1823-01	25	35	27	0.11837072520658867	TCGA-14-1823-01	1	1	0	2	PASS	3032	TCGA-14-1823	GBM	58	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-21384	Dead	WITH TUMOR	543	543	NA	Recurrence	NA	NA	140	NA	NA	NA	1	543	1	543	NA	NA	1	140	
70	TCGA-14-1825	0	3	0	5	0	0	0	0	2	43	2	0	3	14	1	0	TCGA-14-1825-01	228	0.2813825395559288	143	TCGA-14-1825-01	7	6	41	0.08334170937941908	TCGA-14-1825-01	2	4	1	7	PASS	3033	TCGA-14-1825	GBM	70	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-25684	Dead	WITH TUMOR	NA	232	NA	Progression of Disease	NA	NA	82	NA	NA	NA	1	232	1	232	NA	NA	1	82	
50	TCGA-14-1827	0	3	0	2	3	0	0	0	3	36	3	0	1	28	1	0	TCGA-14-1827-01	168	0.14225950251242891	100	TCGA-14-1827-01	5	3	25	0.05483565293353518	TCGA-14-1827-01	1	0	2	3	mutation call filter	3034	TCGA-14-1827	GBM	51	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	1998	NA	-18828	Dead	NA	179	179	NA	NA	NA	NA	NA	NA	NA	NA	1	179	NA	179	NA	NA	0	179	
60	TCGA-14-1829	0	6	2	0	0	0	0	0	1	42	1	0	2	21	1	0	TCGA-14-1829-01	175	0.20023033709430232	102	TCGA-14-1829-01	8	5	22	0.0928901694008044	TCGA-14-1829-01	2	1	0	3	PASS	3035	TCGA-14-1829	GBM	57	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-20929	Alive	WITH TUMOR	218	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	218	0	218	NA	NA	0	218	
50	TCGA-14-2554	1	7	0	1	0	1	0	0	1	59	2	0	1	21	1	0	TCGA-14-2554-01	210	0.21350506143948675	117	TCGA-14-2554-01	10	5	18	0.07318131205267409	TCGA-14-2554-01	2	4	2	8	PASS	3036	TCGA-14-2554	GBM	52	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2002	NA	-19090	Dead	WITH TUMOR	532	532	NA	NA	NA	NA	NA	NA	NA	NA	1	532	1	532	NA	NA	1	532	
40	TCGA-14-2555	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-14-2555-01	182	0.14526744568661515	112	TCGA-14-2555-01	8	4	23	0.053747241490115484	TCGA-14-2555-01	0	0	0	0	PASS	3037	TCGA-14-2555	GBM	44	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-16259	Alive	NA	242	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	242	0	242	NA	NA	0	242	
70	TCGA-14-3476	1	6	0	0	1	0	0	0	1	50	1	0	1	25	1	0	TCGA-14-3476	0	0	0	TCGA-14-3476	0	0	0	0	TCGA-14-3476	0	0	0	0	PASS	3038	TCGA-14-3476	GBM	74	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-27172	Dead	NA	12	12	NA	Progression of Disease	NA	NA	9	NA	NA	NA	1	12	NA	12	NA	NA	1	9	
40	TCGA-14-3477	0	0	0	1	2	1	0	0	0	38	0	0	0	12	3	0	TCGA-14-3477-01	375	0.8010542712259501	269	TCGA-14-3477-01	30	51	4	0.015411129972817584	TCGA-14-3477-01	15	9	1	25	mutation call filter	3039	TCGA-14-3477	GBM	38	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-14082	Alive	WITH TUMOR	115	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	115	0	115	NA	NA	0	115	
40	TCGA-14-4157	0	1	0	2	2	0	1	0	1	29	2	0	2	6	0	0	TCGA-14-4157-01	142	0.27401408192069643	76	TCGA-14-4157-01	4	6	28	0.1068462494077668	TCGA-14-4157-01	8	7	8	23	PASS	3040	TCGA-14-4157	GBM	40	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-14816	Alive	NA	104	NA	NA	Progression of Disease	NA	NA	96	NA	NA	NA	0	104	0	104	NA	NA	1	96	
70	TCGA-15-0742	0	3	0	3	0	0	2	0	1	59	5	0	0	13	1	0	TCGA-15-0742-01	136	0.6121906494874649	82	TCGA-15-0742-01	9	6	21	0.15590585103380378	TCGA-15-0742-01	4	4	3	11	PASS	3041	TCGA-15-0742	GBM	65	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-24050	Dead	NA	NA	419	NA	Progression of Disease	NA	NA	232	NA	NA	NA	1	419	NA	419	NA	NA	1	232	
30	TCGA-15-1444	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-15-1444-01	146	0.12342986388543035	87	TCGA-15-1444-01	2	4	23	0.098724528021444	TCGA-15-1444-01	2	3	3	8	PASS	3042	TCGA-15-1444	GBM	21	MALE	WHITE	NA	NA	Glioblastoma Multiforme (GBM)	NA	2004	NA	-7827	Dead	WITH TUMOR	NA	1537	NA	Progression of Disease	NA	NA	1550	Complete Remission/Response	NA	NA	1	1537	1	1537	1	1550	1	1550	
60	TCGA-15-1446	2	19	1	8	1	1	0	0	11	149	11	0	2	47	3	0	TCGA-15-1446-01	172	0.11159979485700104	104	TCGA-15-1446-01	4	3	10	0.05612674412961837	TCGA-15-1446-01	3	1	0	4	mutation call filter	3043	TCGA-15-1446	GBM	55	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-20355	Alive	WITH TUMOR	581	NA	NA	Recurrence	NA	NA	443	NA	NA	NA	0	581	0	581	NA	NA	1	443	
40	TCGA-15-1447	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-15-1447-01	132	0.9575637526075484	76	TCGA-15-1447-01	19	30	10	0.13676819670152415	TCGA-15-1447-01	9	5	5	19	PASS	3044	TCGA-15-1447	GBM	36	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-13326	Alive	WITH TUMOR	1618	NA	NA	Recurrence	NA	NA	340	NA	NA	NA	0	1618	0	1618	NA	NA	1	340	
70	TCGA-15-1449	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-15-1449-01	174	0.5704526046938212	100	TCGA-15-1449-01	23	50	14	0.014493709817089303	TCGA-15-1449-01	2	2	1	5	PASS	3045	TCGA-15-1449	GBM	65	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-23828	Dead	WITH TUMOR	NA	404	NA	Recurrence	NA	NA	74	NA	NA	NA	1	404	1	404	NA	NA	1	74	
90	TCGA-16-0846	0	7	0	3	0	1	0	0	1	56	2	0	2	23	1	0	TCGA-16-0846-01	165	0.4852909375206697	104	TCGA-16-0846-01	18	17	28	0.07382602217813265	TCGA-16-0846-01	5	2	2	9	PASS	3046	TCGA-16-0846	GBM	85	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-31111	Dead	WITH TUMOR	119	119	NA	NA	NA	NA	NA	NA	NA	NA	1	119	1	119	NA	NA	1	119	
60	TCGA-16-0848	1	23	2	5	1	1	0	0	10	312	13	0	4	143	3	0	TCGA-16-0848-01	183	0.2505378594552853	114	TCGA-16-0848-01	6	3	6	0.050727039787200334	TCGA-16-0848-01	0	1	0	1	PASS	3047	TCGA-16-0848	GBM	57	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-20848	Dead	WITH TUMOR	302	535	NA	Recurrence	NA	NA	129	NA	NA	NA	1	535	1	535	NA	NA	1	129	
50	TCGA-16-0849	0	4	0	3	1	5	0	0	0	47	8	0	1	21	1	0	TCGA-16-0849-01	105	0.1053371927646364	54	TCGA-16-0849-01	2	3	7	0.041994435093658335	TCGA-16-0849-01	4	4	2	10	mutation call filter	3048	TCGA-16-0849	GBM	54	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-19939	Alive	NA	793	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	793	0	793	NA	NA	0	793	
50	TCGA-16-0850	0	4	1	2	0	3	0	0	5	37	5	0	0	15	3	0	TCGA-16-0850-01	216	0.9112568313915924	136	TCGA-16-0850-01	25	18	21	0.13057010940469682	TCGA-16-0850-01	10	5	3	18	mutation call filter	3049	TCGA-16-0850	GBM	52	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-19281	Dead	WITH TUMOR	496	498	NA	Recurrence	NA	NA	83	NA	NA	NA	1	498	1	498	NA	NA	1	83	
70	TCGA-16-0861	0	2	0	2	1	0	1	0	1	44	4	0	0	16	2	0	TCGA-16-0861-01	158	0.5746684893838984	84	TCGA-16-0861-01	4	7	35	0.13044702294486488	TCGA-16-0861-01	8	3	4	15	PASS	3050	TCGA-16-0861	GBM	65	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-23778	NA	NA	131	NA	NA	Recurrence	NA	NA	94	NA	NA	NA	0	131	NA	131	NA	NA	1	94	
50	TCGA-16-1045	0	5	0	2	4	0	0	0	2	60	5	0	2	26	0	0	TCGA-16-1045-01	180	0.8241812064348178	112	TCGA-16-1045-01	13	11	32	0.17100315038349684	TCGA-16-1045-01	2	1	3	6	PASS	3051	TCGA-16-1045	GBM	49	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-18195	Dead	WITH TUMOR	883	883	NA	Recurrence	NA	NA	654	NA	NA	NA	1	883	1	883	NA	NA	1	654	
70	TCGA-16-1047	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-16-1047-01	161	0.20615926613269533	100	TCGA-16-1047-01	6	3	16	0.12144806532027975	TCGA-16-1047-01	1	2	2	5	PASS	3052	TCGA-16-1047	GBM	66	FEMALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-24301	Dead	WITH TUMOR	25	139	NA	Progression of Disease	NA	NA	25	NA	NA	NA	1	139	1	139	NA	NA	1	25	
50	TCGA-16-1055	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-16-1055-01	215	0.15766388638861265	152	TCGA-16-1055-01	4	4	15	0.09493733079057418	TCGA-16-1055-01	2	8	6	16	PASS	3053	TCGA-16-1055	GBM	48	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2004	NA	-17840	Dead	WITH TUMOR	301	313	NA	Recurrence	NA	NA	288	NA	NA	NA	1	313	1	313	NA	NA	1	288	
60	TCGA-16-1056	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-16-1056-01	496	0.12670068310934884	394	TCGA-16-1056-01	5	7	60	0.1430398860240776	TCGA-16-1056-01	5	5	3	13	PASS	3054	TCGA-16-1056	GBM	55	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-20310	Dead	WITH TUMOR	406	426	NA	Recurrence	NA	NA	239	NA	NA	NA	1	426	1	426	NA	NA	1	239	
70	TCGA-16-1060	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-16-1060-01	209	0.14137135764174874	134	TCGA-16-1060-01	5	6	22	0.1657341683939393	TCGA-16-1060-01	5	4	7	16	PASS	3055	TCGA-16-1060	GBM	70	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-25813	Dead	WITH TUMOR	111	278	NA	Progression of Disease	NA	NA	111	NA	NA	NA	1	278	1	278	NA	NA	1	111	
60	TCGA-16-1062	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-16-1062-01	170	0.14622979869934605	92	TCGA-16-1062-01	7	4	20	0.062270953546661824	TCGA-16-1062-01	2	1	0	3	PASS	3056	TCGA-16-1062	GBM	57	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-21148	Dead	WITH TUMOR	556	646	NA	Progression of Disease	NA	NA	518	NA	NA	NA	1	646	1	646	NA	NA	1	518	
70	TCGA-16-1063	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-16-1063-01	187	0.1749231404620457	102	TCGA-16-1063-01	7	7	21	0.1454323298229253	TCGA-16-1063-01	4	2	6	12	PASS	3057	TCGA-16-1063	GBM	72	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-26313	Dead	WITH TUMOR	425	425	NA	Progression of Disease	NA	NA	369	NA	NA	NA	1	425	1	425	NA	NA	1	369	
40	TCGA-16-1460	0	9	0	2	1	2	2	2	7	93	5	1	0	26	4	0	TCGA-16-1460-01	125	0.04689337626913077	71	TCGA-16-1460-01	1	2	10	0.015149857469855331	TCGA-16-1460-01	5	1	1	7	mutation call filter	3058	TCGA-16-1460	GBM	36	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-13208	Alive	NA	195	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	195	0	195	NA	NA	0	195	
70	TCGA-19-0955	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-19-0955-01	98	0.2125726919354117	41	TCGA-19-0955-01	9	6	12	0.05742722768120333	TCGA-19-0955-01	3	3	3	9	PASS	3059	TCGA-19-0955	GBM	71	MALE	ASIAN	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-25974	Alive	TUMOR FREE	358	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	358	0	358	NA	NA	0	358	
50	TCGA-19-0957	1	11	0	4	3	1	0	0	6	101	10	0	0	40	5	0	TCGA-19-0957-01	134	0.2052145650352691	74	TCGA-19-0957-01	6	3	26	0.07031385900119118	TCGA-19-0957-01	0	3	1	4	mutation call filter	3060	TCGA-19-0957	GBM	48	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-17714	Dead	WITH TUMOR	666	666	NA	Recurrence	NA	NA	50	NA	NA	NA	1	666	1	666	NA	NA	1	50	
80	TCGA-19-0960	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-19-0960-01	156	0.21647861023049367	79	TCGA-19-0960-01	6	10	14	0.13245185529106335	TCGA-19-0960-01	7	8	7	22	PASS	3061	TCGA-19-0960	GBM	83	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-30364	Alive	NA	262	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	262	0	262	NA	NA	0	262	
80	TCGA-19-0962	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-19-0962-01	215	0.39428559138549335	148	TCGA-19-0962-01	6	4	19	0.11686547492909495	TCGA-19-0962-01	1	7	2	10	PASS	3062	TCGA-19-0962	GBM	77	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-28382	Dead	NA	13	20	NA	NA	NA	NA	NA	NA	NA	NA	1	20	NA	20	NA	NA	0	20	
60	TCGA-19-0963	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-19-0963-01	146	0.17015488795458775	82	TCGA-19-0963-01	5	3	15	0.09034734786608674	TCGA-19-0963-01	3	2	2	7	PASS	3063	TCGA-19-0963	GBM	61	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-22326	Dead	WITH TUMOR	434	434	NA	Recurrence	NA	NA	310	NA	NA	NA	1	434	1	434	NA	NA	1	310	
70	TCGA-19-0964	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-19-0964-01	158	0.12096282740846925	90	TCGA-19-0964-01	3	3	10	0.09285648880103664	TCGA-19-0964-01	1	2	2	5	PASS	3064	TCGA-19-0964	GBM	70	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-25800	Alive	WITH TUMOR	103	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	103	0	103	NA	NA	0	103	
70	TCGA-19-1385	0	21	1	9	7	5	0	0	11	159	10	0	0	44	5	0	TCGA-19-1385-01	103	0.20452217654072072	58	TCGA-19-1385-01	0	0	0	0.0	TCGA-19-1385-01	0	0	0	0	mutation call filter	3065	TCGA-19-1385	GBM	69	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-25459	Dead	WITH TUMOR	327	327	NA	Recurrence	NA	NA	177	NA	NA	NA	1	327	1	327	NA	NA	1	177	
50	TCGA-19-1386	0	11	0	4	7	2	1	0	5	115	13	1	4	40	4	0	TCGA-19-1386-01	182	0.16403359267063106	116	TCGA-19-1386-01	8	5	40	0.0715538999588154	TCGA-19-1386-01	2	1	0	3	mutation call filter	3066	TCGA-19-1386	GBM	51	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-18678	Dead	WITH TUMOR	276	276	NA	Recurrence	NA	NA	237	NA	NA	NA	1	276	1	276	NA	NA	1	237	
80	TCGA-19-1387	0	11	1	4	6	1	1	0	3	78	5	1	2	37	2	0	TCGA-19-1387-01	158	0.3594397798679368	88	TCGA-19-1387-01	5	4	26	0.08258838572604885	TCGA-19-1387-01	0	0	2	2	mutation call filter	3067	TCGA-19-1387	GBM	81	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-29892	Alive	WITH TUMOR	181	NA	NA	Recurrence	NA	NA	79	NA	NA	NA	0	181	0	181	NA	NA	1	79	
60	TCGA-19-1388	0	15	3	4	10	4	0	0	13	107	12	0	0	42	5	0	TCGA-19-1388-01	278	0.8816907439826162	178	TCGA-19-1388-01	22	17	47	0.201267267206782	TCGA-19-1388-01	15	15	9	39	mutation call filter	3068	TCGA-19-1388	GBM	58	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-21368	Dead	WITH TUMOR	394	394	NA	Progression of Disease	NA	NA	148	NA	NA	NA	1	394	1	394	NA	NA	1	148	
50	TCGA-19-1389	0	13	2	9	6	5	2	1	6	227	15	1	2	84	4	0	TCGA-19-1389-01	113	0.19052493619940936	65	TCGA-19-1389-01	7	6	29	0.14355267166959945	TCGA-19-1389-01	2	3	2	7	mutation call filter	3069	TCGA-19-1389	GBM	51	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-18659	Dead	WITH TUMOR	141	141	NA	Recurrence	NA	NA	81	NA	NA	NA	1	141	1	141	NA	NA	1	81	
60	TCGA-19-1390	0	9	0	2	1	0	0	0	3	85	4	0	1	39	3	0	TCGA-19-1390-01	251	0.8756504065757342	166	TCGA-19-1390-01	19	17	23	0.10884238496687147	TCGA-19-1390-01	5	5	3	13	PASS	3070	TCGA-19-1390	GBM	63	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-23063	Dead	NA	772	772	NA	NA	NA	NA	NA	NA	NA	NA	1	772	NA	772	NA	NA	0	772	
70	TCGA-19-1392	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-19-1392-01	205	0.7552530192319815	127	TCGA-19-1392-01	13	14	19	0.09429166582101192	TCGA-19-1392-01	6	5	2	13	PASS	3071	TCGA-19-1392	GBM	72	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-26593	Dead	NA	106	111	NA	NA	NA	NA	NA	NA	NA	NA	1	111	NA	111	NA	NA	0	111	
60	TCGA-19-1786	0	4	0	3	2	0	1	0	1	54	5	0	1	15	0	0	TCGA-19-1786-01	274	0.4225220149698686	183	TCGA-19-1786-01	10	8	53	0.09992696670270716	TCGA-19-1786-01	5	6	3	14	mutation call filter	3072	TCGA-19-1786	GBM	64	FEMALE	ASIAN	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-23568	Alive	TUMOR FREE	218	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	218	0	218	NA	NA	0	218	
50	TCGA-19-1787	7	37	3	14	30	8	15	0	16	494	23	0	4	251	7	0	TCGA-19-1787-01	128	0.9851639855531942	59	TCGA-19-1787-01	7	19	38	0.8363995933666637	TCGA-19-1787-01	6	3	2	11	PASS	3073	TCGA-19-1787	GBM	48	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-17894	Dead	WITH TUMOR	385	385	NA	Recurrence	NA	NA	308	NA	NA	NA	1	385	1	385	NA	NA	1	308	
40	TCGA-19-1788	2	10	0	6	7	4	2	1	5	137	13	0	1	52	5	0	TCGA-19-1788	0	0	0	TCGA-19-1788	0	0	0	0	TCGA-19-1788	0	0	0	0	mutation call filter	3074	TCGA-19-1788	GBM	39	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-14301	Dead	NA	112	112	NA	NA	NA	NA	NA	NA	NA	NA	1	112	NA	112	NA	NA	0	112	
70	TCGA-19-1789	0	5	1	2	0	2	0	0	3	50	3	0	0	30	1	0	TCGA-19-1789-01	137	0.10687187969257828	79	TCGA-19-1789-01	6	3	36	0.06371833636917608	TCGA-19-1789-01	3	3	0	6	mutation call filter	3075	TCGA-19-1789	GBM	69	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-25282	Dead	NA	99	99	NA	NA	NA	NA	NA	NA	NA	NA	1	99	NA	99	NA	NA	0	99	
60	TCGA-19-1790	1	9	0	7	5	1	1	0	5	84	8	0	1	33	2	0	TCGA-19-1790	0	0	0	TCGA-19-1790	0	0	0	0	TCGA-19-1790	0	0	0	0	PASS	3076	TCGA-19-1790	GBM	56	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-20626	Dead	WITH TUMOR	154	154	NA	Progression of Disease	NA	NA	88	NA	NA	NA	1	154	1	154	NA	NA	1	88	
80	TCGA-19-1791	0	5	1	6	1	2	0	0	4	66	3	1	2	31	3	0	TCGA-19-1791-01	97	0.17766155922861435	39	TCGA-19-1791-01	6	5	24	0.08207462952992718	TCGA-19-1791-01	2	2	1	5	mutation call filter	3077	TCGA-19-1791	GBM	82	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-30065	Alive	WITH TUMOR	4	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4	0	4	NA	NA	0	4	
60	TCGA-19-2619	0	6	0	0	2	0	1	0	1	39	3	0	2	24	2	0	TCGA-19-2619-01	316	0.2753390235587345	231	TCGA-19-2619-01	3	7	31	0.16853145466485114	TCGA-19-2619-01	6	9	7	22	PASS	3078	TCGA-19-2619	GBM	55	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-20159	Alive	WITH TUMOR	294	NA	NA	Progression of Disease	NA	NA	146	NA	NA	NA	0	294	0	294	NA	NA	1	146	
70	TCGA-19-2620	0	6	0	2	2	0	0	0	1	58	6	0	0	22	2	0	TCGA-19-2620-01	159	0.17520398931350767	104	TCGA-19-2620-01	6	8	23	0.16131568664935578	TCGA-19-2620-01	6	2	0	8	PASS	3079	TCGA-19-2620	GBM	70	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-25665	Dead	TUMOR FREE	148	148	NA	NA	NA	NA	NA	NA	NA	NA	1	148	0	148	NA	NA	0	148	
80	TCGA-19-2621	0	13	3	4	1	2	0	0	9	117	8	0	3	51	4	0	TCGA-19-2621-01	175	0.6543882113095704	110	TCGA-19-2621-01	3	2	11	0.09812173272940554	TCGA-19-2621-01	0	1	1	2	mutation call filter	3080	TCGA-19-2621	GBM	83	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-30429	Dead	NA	33	33	NA	NA	NA	NA	NA	NA	NA	NA	1	33	NA	33	NA	NA	0	33	
70	TCGA-19-2623	1	3	0	0	3	0	0	0	3	62	8	1	0	22	2	0	TCGA-19-2623-01	122	0.7291918751533993	76	TCGA-19-2623-01	10	6	11	0.19228142684377852	TCGA-19-2623-01	0	2	2	4	PASS	3081	TCGA-19-2623	GBM	65	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-23835	Alive	TUMOR FREE	229	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	229	0	229	NA	NA	0	229	
50	TCGA-19-2624	0	1	0	0	1	0	0	0	3	36	3	0	2	14	0	0	TCGA-19-2624-01	140	0.107262466211098	80	TCGA-19-2624-01	4	2	18	0.05432341860086698	TCGA-19-2624-01	0	2	0	2	PASS	3082	TCGA-19-2624	GBM	51	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-18891	Dead	TUMOR FREE	5	5	NA	NA	NA	NA	NA	NA	NA	NA	1	5	0	5	NA	NA	0	5	
80	TCGA-19-2625	0	3	0	1	2	0	2	0	4	46	1	0	0	11	2	0	TCGA-19-2625-01	247	0.5327310621732995	160	TCGA-19-2625-01	5	7	26	0.17100891058139714	TCGA-19-2625-01	4	6	2	12	PASS	3083	TCGA-19-2625	GBM	76	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-27930	Dead	TUMOR FREE	124	124	NA	NA	NA	NA	NA	NA	NA	NA	1	124	0	124	NA	NA	0	124	
60	TCGA-19-2629	0	8	1	3	14	1	10	0	1	56	3	0	1	21	3	0	TCGA-19-2629-01	112	0.7982514148313072	50	TCGA-19-2629-01	27	21	15	0.1248339714514134	TCGA-19-2629-01	9	7	4	20	PASS	3084	TCGA-19-2629	GBM	60	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-22257	Dead	WITH TUMOR	501	737	NA	Progression of Disease	NA	NA	145	NA	NA	NA	1	737	1	737	NA	NA	1	145	
70	TCGA-19-2631	1	9	2	2	4	0	1	0	4	71	6	0	0	17	1	0	TCGA-19-2631-01	169	0.14406684871707084	110	TCGA-19-2631-01	7	4	26	0.07749256918397837	TCGA-19-2631-01	2	1	1	4	PASS	3085	TCGA-19-2631	GBM	74	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-27200	Dead	TUMOR FREE	213	213	NA	NA	NA	NA	NA	NA	NA	NA	1	213	0	213	NA	NA	0	213	
40	TCGA-19-4065	1	9	0	6	3	1	0	0	5	119	3	0	0	40	6	0	TCGA-19-4065-01	136	0.6045931055719901	81	TCGA-19-4065-02	12	29	22	0.3571663505080315	TCGA-19-4065-02	2	3	3	8	mutation call filter	3086	TCGA-19-4065	GBM	36	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-13257	Alive	WITH TUMOR	214	NA	NA	Recurrence	NA	NA	70	NA	NA	NA	0	214	0	214	NA	NA	1	70	
70	TCGA-19-4068	0	3	0	1	3	0	1	0	2	39	3	0	3	28	1	0	TCGA-19-4068	0	0	0	TCGA-19-4068	0	0	0	0	TCGA-19-4068	0	0	0	0	PASS	3087	TCGA-19-4068	GBM	68	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-24945	Alive	TUMOR FREE	137	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	137	0	137	NA	NA	0	137	
50	TCGA-19-5947	0	2	0	2	0	3	0	0	3	20	0	0	0	6	1	0	TCGA-19-5947-01	298	0.4020405161409883	223	TCGA-19-5947-01	10	7	43	0.21694582645748656	TCGA-19-5947-01	2	0	2	4	PASS	3088	TCGA-19-5947	GBM	47	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-17218	Dead	WITH TUMOR	202	202	NA	Progression of Disease	NA	NA	43	NA	NA	NA	1	202	1	202	NA	NA	1	43	
50	TCGA-19-5950	0	7	1	1	1	0	1	0	2	48	3	0	0	13	2	0	TCGA-19-5950-01	242	0.15967214247369665	148	TCGA-19-5950-01	8	5	48	0.06393753220510141	TCGA-19-5950-01	2	1	0	3	PASS	3089	TCGA-19-5950	GBM	52	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-19244	Dead	WITH TUMOR	NA	523	NA	Recurrence	NA	NA	294	Progressive Disease	NA	NA	1	523	1	523	NA	NA	1	294	
80	TCGA-19-5951	0	1	1	2	2	1	1	0	0	59	3	0	2	24	1	0	TCGA-19-5951-01	124	0.096856004673754	71	TCGA-19-5951-01	5	6	28	0.12831010266877255	TCGA-19-5951-01	3	4	2	9	PASS	3090	TCGA-19-5951	GBM	76	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-27995	Dead	WITH TUMOR	244	244	NA	NA	NA	NA	NA	NA	NA	NA	1	244	1	244	NA	NA	1	244	
60	TCGA-19-5952	0	4	0	2	1	0	1	0	1	29	3	0	0	13	2	0	TCGA-19-5952-01	76	0.16256868258365334	29	TCGA-19-5952-01	6	4	10	0.11414343056956305	TCGA-19-5952-01	2	1	3	6	PASS	3091	TCGA-19-5952	GBM	62	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-22841	Dead	NA	567	575	NA	NA	NA	NA	NA	NA	NA	NA	1	575	NA	575	NA	NA	0	575	
60	TCGA-19-5953	0	4	0	1	1	0	0	0	1	37	1	0	1	24	0	0	TCGA-19-5953-01	109	0.17945035063798406	56	TCGA-19-5953-01	6	3	12	0.0764706617588069	TCGA-19-5953-01	0	5	1	6	PASS	3092	TCGA-19-5953	GBM	58	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-21204	Dead	WITH TUMOR	144	144	NA	Progression of Disease	NA	NA	119	NA	NA	NA	1	144	1	144	NA	NA	1	119	
70	TCGA-19-5954	0	3	0	5	1	1	2	0	2	58	5	0	3	25	1	0	TCGA-19-5954-01	142	0.14028138685764405	85	TCGA-19-5954-01	6	3	24	0.06834693265009036	TCGA-19-5954-01	1	5	1	7	PASS	3093	TCGA-19-5954	GBM	72	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-26355	Dead	WITH TUMOR	NA	368	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	368	1	368	NA	NA	1	368	
80	TCGA-19-5955	0	4	0	3	3	0	0	0	1	44	4	0	1	34	1	0	TCGA-19-5955-01	55	0.20414353035258045	15	TCGA-19-5955-01	8	6	11	0.1082896878941374	TCGA-19-5955-01	1	2	1	4	PASS	3094	TCGA-19-5955	GBM	83	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-30550	Dead	NA	54	54	NA	NA	NA	NA	NA	NA	NA	NA	1	54	NA	54	NA	NA	0	54	
50	TCGA-19-5956	40	440	34	161	12	36	3	0	236	5950	646	6	122	2156	183	2	TCGA-19-5956-01	98	0.4706260654078386	42	TCGA-19-5956-01	7	7	7	0.016772326842147668	TCGA-19-5956-01	5	6	0	11	hypermutated sample	3095	TCGA-19-5956	GBM	53	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-19591	Dead	WITH TUMOR	NA	684	NA	Progression of Disease	NA	NA	647	Stable Disease	NA	NA	1	684	1	684	NA	NA	1	647	
60	TCGA-19-5958	0	3	0	1	1	0	0	0	0	39	1	0	1	12	0	0	TCGA-19-5958-01	115	0.1837333706699314	61	TCGA-19-5958-01	7	8	26	0.07641024424809292	TCGA-19-5958-01	6	3	4	13	PASS	3096	TCGA-19-5958	GBM	56	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-20466	Dead	WITH TUMOR	NA	428	NA	Recurrence	NA	NA	356	Progressive Disease	NA	NA	1	428	1	428	NA	NA	1	356	
80	TCGA-19-5959	2	5	0	4	3	0	0	0	1	61	4	1	0	30	3	0	TCGA-19-5959-01	150	0.14681226474640074	86	TCGA-19-5959-01	6	5	17	0.07094847480244347	TCGA-19-5959-01	3	2	0	5	PASS	3097	TCGA-19-5959	GBM	77	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-28449	Dead	WITH TUMOR	NA	511	NA	Recurrence	NA	NA	119	Progressive Disease	NA	NA	1	511	1	511	NA	NA	1	119	
60	TCGA-19-5960	0	3	0	0	1	0	0	0	1	36	2	0	0	6	0	0	TCGA-19-5960-01	222	0.9349877377912988	143	TCGA-19-5960-01	10	11	49	0.3086938183323665	TCGA-19-5960-01	2	4	5	11	PASS	3098	TCGA-19-5960	GBM	56	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-20641	Dead	WITH TUMOR	NA	455	NA	Recurrence	NA	NA	382	Stable Disease	NA	NA	1	455	1	455	NA	NA	1	382	
40	TCGA-19-A60I	0	2	0	1	0	0	1	0	1	24	1	0	0	12	1	0	TCGA-19-A60I-01	167	0.2313024846453465	100	TCGA-19-A60I-01	8	7	52	0.12077137886034015	TCGA-19-A60I-01	2	1	5	8	PASS	3099	TCGA-19-A60I	GBM	39	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2012	NA	-14437	Alive	WITH TUMOR	541	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	541	0	541	NA	NA	0	541	
70	TCGA-19-A6J4	0	2	1	0	0	0	0	0	3	20	3	0	1	14	0	0	TCGA-19-A6J4-01	158	0.6242750782481948	91	TCGA-19-A6J4-01	25	22	88	0.23948147890561505	TCGA-19-A6J4-01	1	1	4	6	PASS	3100	TCGA-19-A6J4	GBM	68	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2013	NA	-25058	Dead	WITH TUMOR	NA	121	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	121	1	121	NA	NA	1	121	
40	TCGA-19-A6J5	1	1	0	1	1	1	0	0	2	33	3	0	2	13	1	0	TCGA-19-A6J5-01	295	0.23633618548875024	196	TCGA-19-A6J5-01	3	5	130	0.12251471066423507	TCGA-19-A6J5-01	9	7	7	23	PASS	3101	TCGA-19-A6J5	GBM	40	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2012	NA	-14970	Alive	WITH TUMOR	868	NA	NA	Progression of Disease	NA	NA	784	Stable Disease	NA	NA	0	868	0	868	NA	NA	1	784	
40	TCGA-26-1438	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-26-1438-01	184	0.19261425754168307	109	TCGA-26-1438-01	4	4	22	0.10038434499414292	TCGA-26-1438-01	4	6	5	15	PASS	3102	TCGA-26-1438	GBM	36	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-13489	Alive	WITH TUMOR	305	NA	NA	Progression of Disease	NA	NA	158	NA	NA	NA	0	305	0	305	NA	NA	1	158	
60	TCGA-26-1439	0	2	0	1	0	0	0	1	4	32	7	0	0	15	0	0	TCGA-26-1439-01	119	0.8472329440251438	64	TCGA-26-1439-01	26	12	17	0.13510250969668827	TCGA-26-1439-01	1	0	1	2	PASS	3103	TCGA-26-1439	GBM	63	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-23302	Dead	WITH TUMOR	NA	422	NA	Progression of Disease	NA	NA	284	NA	NA	NA	1	422	1	422	NA	NA	1	284	
50	TCGA-26-1440	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-26-1440-01	161	0.3195844541866518	98	TCGA-26-1440-01	8	5	9	0.08094461798433775	TCGA-26-1440-01	2	1	0	3	PASS	3104	TCGA-26-1440	GBM	48	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-17684	Alive	WITH TUMOR	296	NA	NA	Recurrence	NA	NA	233	NA	NA	NA	0	296	0	296	NA	NA	1	233	
40	TCGA-26-1442	0	3	0	1	0	1	0	0	0	37	0	0	0	14	2	0	TCGA-26-1442-01	167	0.10659405379482204	101	TCGA-26-1442-01	1	2	3	0.021058214987232145	TCGA-26-1442-01	4	2	2	8	PASS	3105	TCGA-26-1442	GBM	43	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-15950	Alive	WITH TUMOR	953	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	953	0	953	NA	NA	0	953	
60	TCGA-26-1443	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-26-1443-01	256	0.12310272627249505	193	TCGA-26-1443-01	4	4	8	0.0717448868468985	TCGA-26-1443-01	2	1	2	5	PASS	3106	TCGA-26-1443	GBM	60	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-21990	Alive	WITH TUMOR	217	NA	NA	Progression of Disease	NA	NA	217	NA	NA	NA	0	217	0	217	NA	NA	1	217	
70	TCGA-26-1799	0	5	0	5	4	1	1	0	1	57	5	0	0	25	2	0	TCGA-26-1799-01	240	0.18150967936844284	165	TCGA-26-1799-01	6	4	57	0.05941216217937272	TCGA-26-1799-01	0	2	0	2	mutation call filter	3107	TCGA-26-1799	GBM	68	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-25171	Dead	WITH TUMOR	285	285	NA	Recurrence	NA	NA	213	NA	NA	NA	1	285	1	285	NA	NA	1	213	
70	TCGA-26-5132	1	10	1	1	1	0	1	0	2	36	3	0	1	11	2	0	TCGA-26-5132-01	151	0.25496850894139217	88	TCGA-26-5132-01	6	4	21	0.11929322125765385	TCGA-26-5132-01	1	3	4	8	PASS	3108	TCGA-26-5132	GBM	74	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-27196	Alive	TUMOR FREE	286	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	286	0	286	NA	NA	0	286	
60	TCGA-26-5133	0	1	0	1	2	0	0	0	2	32	1	0	0	16	0	0	TCGA-26-5133-01	243	0.9432988701809047	152	TCGA-26-5133-01	9	7	23	0.249395832110096	TCGA-26-5133-01	4	2	10	16	PASS	3109	TCGA-26-5133	GBM	59	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-21560	Alive	TUMOR FREE	452	NA	NA	Progression of Disease	NA	NA	370	NA	NA	NA	0	452	0	452	NA	NA	1	370	
70	TCGA-26-5134	0	4	0	5	0	0	1	0	3	40	2	0	1	10	2	0	TCGA-26-5134-01	130	0.08052737141044211	70	TCGA-26-5134-01	3	2	14	0.08269203295377188	TCGA-26-5134-01	1	0	0	1	PASS	3110	TCGA-26-5134	GBM	74	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-27111	Alive	TUMOR FREE	167	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	167	0	167	NA	NA	0	167	
70	TCGA-26-5135	0	4	0	2	0	0	2	0	2	43	2	0	0	24	1	0	TCGA-26-5135-01	187	0.10762793237873301	113	TCGA-26-5135-01	4	2	28	0.05387438781049857	TCGA-26-5135-01	0	0	0	0	PASS	3111	TCGA-26-5135	GBM	72	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-26490	Dead	NA	NA	270	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	270	NA	270	NA	NA	0	270	
80	TCGA-26-5136	0	1	0	4	1	0	1	0	2	36	4	0	2	14	3	0	TCGA-26-5136-01	122	0.3737756051488425	62	TCGA-26-5136-01	11	9	10	0.16959122883782835	TCGA-26-5136-01	3	3	2	8	PASS	3112	TCGA-26-5136	GBM	78	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-28496	Dead	WITH TUMOR	NA	577	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	577	1	577	NA	NA	1	577	
70	TCGA-26-5139	1	6	0	1	1	1	0	0	4	37	1	0	3	20	2	0	TCGA-26-5139-01	121	0.12963593264709564	57	TCGA-26-5139-01	5	4	7	0.062470884177013714	TCGA-26-5139-01	0	1	0	1	PASS	3113	TCGA-26-5139	GBM	65	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-23782	Alive	WITH TUMOR	48	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	48	0	48	NA	NA	0	48	
60	TCGA-26-6173	0	0	0	1	1	0	0	0	2	25	1	0	0	13	1	0	TCGA-26-6173-01	143	0.2736330326556517	75	TCGA-26-6173-01	9	6	27	0.12300842818899127	TCGA-26-6173-01	3	4	4	11	PASS	3114	TCGA-26-6173	GBM	57	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-21093	Alive	TUMOR FREE	241	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	241	0	241	NA	NA	0	241	
70	TCGA-26-6174	1	7	0	3	0	1	0	0	2	77	4	0	0	16	1	0	TCGA-26-6174-01	82	0.167846215173613	24	TCGA-26-6174-01	3	5	11	0.09147345701304536	TCGA-26-6174-01	3	4	4	11	PASS	3115	TCGA-26-6174	GBM	65	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2011	NA	-23884	Alive	NA	71	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	71	0	71	NA	NA	0	71	
50	TCGA-26-A7UX	0	1	1	1	1	0	0	0	0	30	1	0	1	9	2	0	TCGA-26-A7UX-01	172	0.1222111933216056	113	TCGA-26-A7UX-01	4	3	64	0.07544861289994384	TCGA-26-A7UX-01	0	3	1	4	PASS	3116	TCGA-26-A7UX	GBM	47	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2013	NA	-17365	Alive	WITH TUMOR	588	NA	NA	Recurrence	NA	NA	407	Stable Disease	NA	NA	0	588	0	588	NA	NA	1	407	
60	TCGA-27-1830	0	2	0	2	0	0	0	0	1	36	4	0	3	12	1	0	TCGA-27-1830-01	225	0.4102012260790465	150	TCGA-27-1830-01	9	7	50	0.1991414298937016	TCGA-27-1830-01	2	2	1	5	PASS	3117	TCGA-27-1830	GBM	57	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-21131	Dead	WITH TUMOR	146	154	NA	Recurrence	NA	NA	124	NA	NA	NA	1	154	1	154	NA	NA	1	124	
70	TCGA-27-1831	0	5	0	0	1	2	0	0	0	43	5	0	1	10	0	0	TCGA-27-1831-01	133	0.10019800837444744	75	TCGA-27-1831-01	3	3	20	0.04444665653614757	TCGA-27-1831-01	1	2	2	5	PASS	3118	TCGA-27-1831	GBM	66	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-24447	Dead	WITH TUMOR	505	505	NA	Progression of Disease	NA	NA	144	NA	NA	NA	1	505	1	505	NA	NA	1	144	
60	TCGA-27-1832	0	3	1	2	1	1	0	0	2	26	1	1	0	12	0	0	TCGA-27-1832-01	264	0.2575972819433637	197	TCGA-27-1832-01	7	8	82	0.18906625283801407	TCGA-27-1832-01	4	3	2	9	PASS	3119	TCGA-27-1832	GBM	59	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-21678	Dead	WITH TUMOR	0	300	NA	Progression of Disease	NA	NA	176	NA	NA	NA	1	300	1	300	NA	NA	1	176	
70	TCGA-27-1833	1	9	0	3	2	0	0	0	3	42	7	0	3	20	0	0	TCGA-27-1833-01	122	0.18649004475403927	61	TCGA-27-1833-01	9	6	15	0.0972609966311923	TCGA-27-1833-01	3	2	3	8	PASS	3120	TCGA-27-1833	GBM	67	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-24592	Dead	WITH TUMOR	555	737	NA	Recurrence	NA	NA	469	NA	NA	NA	1	737	1	737	NA	NA	1	469	
60	TCGA-27-1834	1	6	1	1	0	1	0	0	2	42	1	0	0	19	0	1	TCGA-27-1834-01	166	0.5834673496263035	106	TCGA-27-1834-01	7	11	40	0.2579561930042747	TCGA-27-1834-01	2	0	0	2	PASS	3121	TCGA-27-1834	GBM	56	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2006	NA	-20568	Dead	WITH TUMOR	1008	1233	NA	Recurrence	NA	NA	335	NA	NA	NA	1	1233	1	1233	NA	NA	1	335	
50	TCGA-27-1835	0	6	0	1	3	1	0	0	1	51	5	0	0	18	2	0	TCGA-27-1835-01	555	0.1959335728594883	442	TCGA-27-1835-01	9	7	85	0.10184203056497593	TCGA-27-1835-01	2	3	3	8	PASS	3122	TCGA-27-1835	GBM	53	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-19444	Dead	WITH TUMOR	648	648	NA	Progression of Disease	NA	NA	157	NA	NA	NA	1	648	1	648	NA	NA	1	157	
30	TCGA-27-1836	0	1	0	1	3	0	0	0	0	34	1	0	0	11	0	0	TCGA-27-1836-01	216	0.06822406068934432	135	TCGA-27-1836-01	2	3	28	0.06772125694759094	TCGA-27-1836-01	4	2	3	9	PASS	3123	TCGA-27-1836	GBM	33	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-12060	Dead	WITH TUMOR	NA	914	NA	Progression of Disease	NA	NA	172	NA	NA	NA	1	914	1	914	NA	NA	1	172	
40	TCGA-27-1837	0	3	0	1	1	0	0	0	3	33	1	0	0	12	0	0	TCGA-27-1837-01	143	0.10264777931298713	81	TCGA-27-1837-01	4	3	18	0.07194202702303179	TCGA-27-1837-01	1	0	1	2	PASS	3124	TCGA-27-1837	GBM	36	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-13368	Dead	WITH TUMOR	427	427	NA	Progression of Disease	NA	NA	136	NA	NA	NA	1	427	1	427	NA	NA	1	136	
60	TCGA-27-1838	0	11	0	2	0	1	1	0	2	81	6	1	0	22	1	0	TCGA-27-1838-01	280	0.268373512582781	204	TCGA-27-1838-01	7	11	23	0.11243657074016776	TCGA-27-1838-01	7	3	5	15	PASS	3125	TCGA-27-1838	GBM	59	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-21706	Dead	WITH TUMOR	350	350	NA	Progression of Disease	NA	NA	119	NA	NA	NA	1	350	1	350	NA	NA	1	119	
50	TCGA-27-2518	0	1	0	1	0	0	0	0	1	36	3	0	1	22	1	0	TCGA-27-2518-01	213	0.12774395552020434	130	TCGA-27-2518-01	6	3	13	0.05403583834825418	TCGA-27-2518-01	0	0	0	0	PASS	3126	TCGA-27-2518	GBM	52	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-19130	Dead	WITH TUMOR	753	753	NA	Progression of Disease	NA	NA	539	NA	NA	NA	1	753	1	753	NA	NA	1	539	
50	TCGA-27-2519	0	1	0	1	2	0	1	0	2	35	1	0	3	6	2	0	TCGA-27-2519-01	148	0.33724230388278403	89	TCGA-27-2519-01	10	10	24	0.2040189007536775	TCGA-27-2519-01	3	1	3	7	PASS	3127	TCGA-27-2519	GBM	48	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-17715	Dead	WITH TUMOR	NA	550	NA	Progression of Disease	NA	NA	256	NA	NA	NA	1	550	1	550	NA	NA	1	256	
30	TCGA-27-2521	0	6	0	1	2	1	0	0	0	46	4	0	1	21	1	0	TCGA-27-2521-01	246	0.5996397002927146	166	TCGA-27-2521-01	5	8	50	0.1466541034523174	TCGA-27-2521-01	13	10	7	30	PASS	3128	TCGA-27-2521	GBM	34	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-12685	Dead	WITH TUMOR	NA	510	NA	NA	NA	NA	NA	NA	NA	NA	1	510	1	510	NA	NA	1	510	
60	TCGA-27-2523	0	5	1	1	1	0	0	0	1	38	3	0	0	14	0	0	TCGA-27-2523-01	177	0.12931784183496434	125	TCGA-27-2523-01	3	6	40	0.06870584003433725	TCGA-27-2523-01	6	6	4	16	PASS	3129	TCGA-27-2523	GBM	63	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-23034	Dead	WITH TUMOR	489	489	NA	Progression of Disease	NA	NA	402	NA	NA	NA	1	489	1	489	NA	NA	1	402	
60	TCGA-27-2524	0	1	0	3	1	0	0	0	3	32	4	0	1	14	1	0	TCGA-27-2524-01	170	0.8935090015401006	99	TCGA-27-2524-01	10	8	36	0.22122297518905004	TCGA-27-2524-01	4	6	5	15	PASS	3130	TCGA-27-2524	GBM	56	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-20555	Dead	WITH TUMOR	231	231	NA	NA	NA	NA	NA	NA	NA	NA	1	231	1	231	NA	NA	1	231	
80	TCGA-27-2526	1	5	0	1	1	0	2	1	4	40	1	0	0	10	1	0	TCGA-27-2526-01	217	0.1816267983888257	149	TCGA-27-2526-01	8	7	41	0.07915560064270212	TCGA-27-2526-01	3	1	3	7	PASS	3131	TCGA-27-2526	GBM	79	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-28977	Dead	WITH TUMOR	87	87	NA	NA	NA	NA	NA	NA	NA	NA	1	87	1	87	NA	NA	1	87	
80	TCGA-27-2527	0	4	0	1	2	0	1	0	0	53	0	0	1	16	1	0	TCGA-27-2527-01	144	0.14610058385927469	85	TCGA-27-2527-01	6	5	12	0.09321877355551336	TCGA-27-2527-01	0	1	0	1	PASS	3132	TCGA-27-2527	GBM	81	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-29619	Dead	WITH TUMOR	438	438	NA	NA	NA	NA	NA	NA	NA	NA	1	438	1	438	NA	NA	1	438	
60	TCGA-27-2528	0	1	0	0	3	1	0	1	1	44	3	0	0	12	1	0	TCGA-27-2528-01	184	0.11323369401548215	109	TCGA-27-2528-01	5	4	12	0.059259327165102335	TCGA-27-2528-01	3	4	0	7	PASS	3133	TCGA-27-2528	GBM	62	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-22867	Dead	WITH TUMOR	480	480	NA	Progression of Disease	NA	NA	72	NA	NA	NA	1	480	1	480	NA	NA	1	72	
80	TCGA-28-1745	1	2	0	1	1	0	1	0	1	54	7	0	1	13	2	0	TCGA-28-1745	0	0	0	TCGA-28-1745	0	0	0	0	TCGA-28-1745	0	0	0	0	mutation call filter	3134	TCGA-28-1745	GBM	76	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-27817	Alive	WITH TUMOR	345	NA	NA	Progression of Disease	NA	NA	317	NA	NA	NA	0	345	0	345	NA	NA	1	317	
80	TCGA-28-1746	0	7	0	3	1	1	0	0	3	56	4	0	0	31	1	0	TCGA-28-1746-01	163	0.2208735908592465	92	TCGA-28-1746-01	7	6	27	0.09084955484700208	TCGA-28-1746-01	3	2	0	5	mutation call filter	3135	TCGA-28-1746	GBM	77	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-28302	Alive	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	6	0	6	NA	NA	0	6	
40	TCGA-28-1747	1	4	1	0	4	0	0	0	1	37	2	0	1	9	0	0	TCGA-28-1747-01	244	0.10918294057987714	171	TCGA-28-1747-01	3	2	45	0.07642660486453873	TCGA-28-1747-01	2	3	1	6	PASS	3136	TCGA-28-1747	GBM	44	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-16301	Dead	NA	77	77	NA	NA	NA	NA	NA	NA	NA	NA	1	77	NA	77	NA	NA	0	77	
70	TCGA-28-1749	0	2	1	2	3	0	0	0	1	35	1	0	2	15	5	0	TCGA-28-1749-01	126	0.1505823928491321	76	TCGA-28-1749-01	8	4	20	0.05739233867043497	TCGA-28-1749-01	1	0	0	1	mutation call filter	3137	TCGA-28-1749	GBM	73	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-26765	Alive	WITH TUMOR	280	NA	NA	Progression of Disease	NA	NA	280	NA	NA	NA	0	280	0	280	NA	NA	1	280	
40	TCGA-28-1750	0	7	0	2	4	0	0	1	2	73	1	0	0	35	3	0	TCGA-28-1750-01	174	0.7205116940965425	103	TCGA-28-1750-01	19	27	46	0.23943546468772706	TCGA-28-1750-01	2	2	3	7	mutation call filter	3138	TCGA-28-1750	GBM	40	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-14817	Alive	WITH TUMOR	254	NA	NA	Progression of Disease	NA	NA	116	NA	NA	NA	0	254	0	254	NA	NA	1	116	
60	TCGA-28-1751	1	12	0	3	3	0	1	0	2	82	5	2	2	40	3	0	TCGA-28-1751-01	120	0.1843418373339424	58	TCGA-28-1751-01	10	5	13	0.06722317446727483	TCGA-28-1751-01	1	0	1	2	mutation call filter	3139	TCGA-28-1751	GBM	61	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-22291	Alive	WITH TUMOR	232	NA	NA	Progression of Disease	NA	NA	219	NA	NA	NA	0	232	0	232	NA	NA	1	219	
40	TCGA-28-1752	0	5	1	1	1	1	0	0	0	73	9	0	1	24	1	1	TCGA-28-1752-01	132	0.24176380506753506	70	TCGA-28-1752-01	7	8	28	0.17575729603128634	TCGA-28-1752-01	0	4	4	8	mutation call filter	3140	TCGA-28-1752	GBM	42	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-15565	Alive	WITH TUMOR	258	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	258	0	258	NA	NA	0	258	
50	TCGA-28-1753	0	5	0	2	1	0	0	0	1	44	2	0	0	15	0	0	TCGA-28-1753-01	143	0.12715437820469222	90	TCGA-28-1753-01	5	4	12	0.06605028159011966	TCGA-28-1753-01	1	3	0	4	PASS	3141	TCGA-28-1753	GBM	53	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-19366	Alive	WITH TUMOR	37	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	37	0	37	NA	NA	0	37	
50	TCGA-28-1755	0	4	4	4	1	1	1	0	5	65	4	1	3	21	3	0	TCGA-28-1755-01	97	0.1204663243990716	48	TCGA-28-1755-01	4	4	21	0.07998550856535945	TCGA-28-1755-01	4	3	4	11	mutation call filter	3142	TCGA-28-1755	GBM	52	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-19263	Dead	WITH TUMOR	47	47	NA	NA	NA	NA	NA	NA	NA	NA	1	47	1	47	NA	NA	1	47	
80	TCGA-28-1756	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-28-1756-01	194	0.1743372730587549	115	TCGA-28-1756-01	4	4	27	0.12769889647600474	TCGA-28-1756-01	7	7	6	20	PASS	3143	TCGA-28-1756	GBM	78	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-28649	Alive	TUMOR FREE	86	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	86	0	86	NA	NA	0	86	
70	TCGA-28-1757	1	14	0	5	4	1	0	0	11	166	12	0	1	68	4	0	TCGA-28-1757-01	186	0.14921756070114228	116	TCGA-28-1757-01	4	4	53	0.09287872659372846	TCGA-28-1757-01	2	5	3	10	mutation call filter	3144	TCGA-28-1757	GBM	71	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-26189	Alive	NA	4	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4	0	4	NA	NA	0	4	
50	TCGA-28-1760	2	37	2	11	7	0	2	2	13	249	23	1	3	98	7	3	TCGA-28-1760	0	0	0	TCGA-28-1760	0	0	0	0	TCGA-28-1760	0	0	0	0	mutation call filter	3145	TCGA-28-1760	GBM	48	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-17758	Alive	WITH TUMOR	143	NA	NA	Progression of Disease	NA	NA	105	NA	NA	NA	0	143	0	143	NA	NA	1	105	
60	TCGA-28-2499	0	2	1	0	1	0	0	0	1	26	1	0	0	4	1	0	TCGA-28-2499	0	0	0	TCGA-28-2499	0	0	0	0	TCGA-28-2499	0	0	0	0	PASS	3146	TCGA-28-2499	GBM	59	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-21838	NA	NA	95	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	95	NA	95	NA	NA	0	95	
70	TCGA-28-2502	0	1	0	1	2	0	1	0	0	35	4	0	3	20	0	0	TCGA-28-2502-01	205	0.2143977015990356	154	TCGA-28-2502-01	6	4	25	0.10928646772492018	TCGA-28-2502-01	3	4	4	11	PASS	3147	TCGA-28-2502	GBM	65	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-23807	Alive	NA	20	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	20	0	20	NA	NA	0	20	
60	TCGA-28-2506	2	27	1	11	7	2	0	0	15	245	22	1	4	101	9	0	TCGA-28-2506-01	135	0.6259328927194585	73	TCGA-28-2506-01	27	15	27	0.20815562577815933	TCGA-28-2506-01	0	0	0	0	mutation call filter	3148	TCGA-28-2506	GBM	63	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-23292	Alive	WITH TUMOR	205	NA	NA	Progression of Disease	NA	NA	84	NA	NA	NA	0	205	0	205	NA	NA	1	84	
80	TCGA-28-2509	2	5	0	5	5	0	0	1	5	40	2	0	1	15	1	0	TCGA-28-2509-01	91	0.7868872365200664	45	TCGA-28-2509-01	30	50	12	0.21769905999562905	TCGA-28-2509-01	0	0	1	1	PASS	3149	TCGA-28-2509	GBM	77	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-28240	Alive	NA	145	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	145	0	145	NA	NA	0	145	
40	TCGA-28-2512	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-28-2512	0	0	0	TCGA-28-2512	0	0	0	0	TCGA-28-2512	0	0	0	0	PASS	3150	TCGA-28-2512	GBM	37	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-13664	Dead	WITH TUMOR	343	343	NA	Progression of Disease	NA	NA	193	NA	NA	NA	1	343	1	343	NA	NA	1	193	
70	TCGA-28-2513	0	3	0	1	1	0	0	0	1	68	5	1	2	14	3	0	TCGA-28-2513-01	88	0.17099338380533274	39	TCGA-28-2513-01	8	5	11	0.07931897947418126	TCGA-28-2513-01	1	5	3	9	PASS	3151	TCGA-28-2513	GBM	69	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-25421	Alive	WITH TUMOR	222	NA	NA	Progression of Disease	NA	NA	75	NA	NA	NA	0	222	0	222	NA	NA	1	75	
50	TCGA-28-2514	0	7	0	2	0	1	1	1	2	36	4	0	1	14	3	0	TCGA-28-2514-01	238	0.7198570776859671	159	TCGA-28-2514-01	5	5	40	0.12615464248984756	TCGA-28-2514-01	2	3	2	7	PASS	3152	TCGA-28-2514	GBM	45	MALE	ASIAN	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-16737	Alive	NA	160	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	160	0	160	NA	NA	0	160	
70	TCGA-28-5204	3	4	0	2	1	0	2	0	2	33	3	0	1	8	1	0	TCGA-28-5204-01	316	0.4355147309392894	232	TCGA-28-5204-01	9	7	86	0.1874347401929508	TCGA-28-5204-01	5	4	7	16	PASS	3153	TCGA-28-5204	GBM	72	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-26490	Dead	WITH TUMOR	NA	454	NA	NA	NA	NA	NA	NA	NA	NA	1	454	1	454	NA	NA	1	454	
70	TCGA-28-5207	0	2	1	2	1	0	0	0	1	40	0	0	0	17	1	0	TCGA-28-5207-01	150	0.32465468526045393	73	TCGA-28-5207-01	6	5	19	0.10581608011895803	TCGA-28-5207-01	2	4	1	7	PASS	3154	TCGA-28-5207	GBM	71	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-25975	Dead	WITH TUMOR	275	343	NA	NA	NA	NA	NA	NA	NA	NA	1	343	1	343	NA	NA	1	343	
50	TCGA-28-5208	0	5	0	2	1	0	0	0	1	51	4	0	1	13	0	0	TCGA-28-5208-01	67	0.11870133459633556	23	TCGA-28-5208-01	6	4	9	0.08259970514975293	TCGA-28-5208-01	1	3	2	6	PASS	3155	TCGA-28-5208	GBM	52	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-19053	Dead	WITH TUMOR	NA	544	NA	NA	NA	NA	148	Progressive Disease	NA	NA	1	544	1	544	NA	NA	1	148	
70	TCGA-28-5209	1	3	1	1	3	1	0	0	1	71	6	0	2	22	0	0	TCGA-28-5209-01	126	0.22418153934399887	74	TCGA-28-5209-01	8	5	13	0.1052826462621827	TCGA-28-5209-01	2	0	3	5	PASS	3156	TCGA-28-5209	GBM	66	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-24362	Alive	NA	442	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	442	0	442	NA	NA	0	442	
40	TCGA-28-5211	4	26	0	13	1	0	0	0	28	326	31	0	6	129	15	0	TCGA-28-5211-01	126	0.12970343548849514	64	TCGA-28-5211-01	4	2	24	0.07712118131165316	TCGA-28-5211-01	2	2	2	6	PASS	3157	TCGA-28-5211	GBM	42	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-15507	Alive	WITH TUMOR	358	NA	NA	NA	NA	NA	225	NA	NA	NA	0	358	0	358	NA	NA	1	225	
70	TCGA-28-5213	0	4	1	1	0	0	0	0	5	42	1	0	0	14	1	0	TCGA-28-5213-01	137	0.2402481566256981	80	TCGA-28-5213-01	10	7	25	0.19022312877762765	TCGA-28-5213-01	3	3	3	9	PASS	3158	TCGA-28-5213	GBM	72	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-26491	Alive	WITH TUMOR	951	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	951	0	951	NA	NA	0	951	
50	TCGA-28-5214	2	4	0	3	1	0	0	0	3	26	4	0	2	17	0	0	TCGA-28-5214-01	175	0.16240874336371244	110	TCGA-28-5214-01	7	5	32	0.08094401255784947	TCGA-28-5214-01	3	2	1	6	PASS	3159	TCGA-28-5214	GBM	53	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-19520	Dead	WITH TUMOR	NA	713	NA	Locoregional Disease	NA	NA	247	NA	NA	NA	1	713	1	713	NA	NA	1	247	
60	TCGA-28-5215	0	3	0	3	0	0	0	0	3	24	2	0	1	13	0	0	TCGA-28-5215-01	81	0.5533217573290679	30	TCGA-28-5215-01	6	5	13	0.12484742881034468	TCGA-28-5215-01	2	0	1	3	PASS	3160	TCGA-28-5215	GBM	62	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-22686	Dead	WITH TUMOR	237	335	NA	NA	NA	NA	164	NA	NA	NA	1	335	1	335	NA	NA	1	164	
50	TCGA-28-5216	1	4	0	1	1	0	0	0	2	40	0	0	3	13	2	0	TCGA-28-5216-01	180	0.5267633187693321	109	TCGA-28-5216-01	7	6	31	0.14119106743409135	TCGA-28-5216-01	0	0	2	2	PASS	3161	TCGA-28-5216	GBM	52	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-19239	Alive	TUMOR FREE	415	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	415	0	415	NA	NA	0	415	
60	TCGA-28-5218	1	2	0	1	2	0	0	0	0	15	3	0	1	2	0	0	TCGA-28-5218-01	66	0.9477307740237816	24	TCGA-28-5218-01	26	26	16	0.5454444872527923	TCGA-28-5218-01	1	0	1	2	PASS	3162	TCGA-28-5218	GBM	63	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-23096	Dead	NA	128	157	NA	NA	NA	NA	NA	NA	NA	NA	1	157	NA	157	NA	NA	0	157	
50	TCGA-28-5219	0	3	0	1	2	2	0	0	2	42	0	0	2	12	1	0	TCGA-28-5219-01	119	0.29139625847122946	67	TCGA-28-5219-01	10	9	24	0.14110009815958444	TCGA-28-5219-01	3	2	1	6	PASS	3163	TCGA-28-5219	GBM	47	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-17254	Alive	TUMOR FREE	690	NA	NA	NA	NA	NA	258	NA	NA	NA	0	690	0	690	NA	NA	1	258	
70	TCGA-28-5220	0	4	0	0	0	2	0	0	1	30	0	0	1	9	0	0	TCGA-28-5220-01	193	0.933266300394672	133	TCGA-28-5220-01	8	5	35	0.23332652329806905	TCGA-28-5220-01	2	6	3	11	PASS	3164	TCGA-28-5220	GBM	67	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-24622	Dead	WITH TUMOR	NA	388	NA	NA	NA	NA	262	NA	NA	NA	1	388	1	388	NA	NA	1	262	
60	TCGA-28-6450	0	0	0	1	4	0	0	0	1	48	4	0	2	13	1	0	TCGA-28-6450-01	355	0.23336224238175834	269	TCGA-28-6450-01	7	4	39	0.07750848527887136	TCGA-28-6450-01	2	2	1	5	PASS	3165	TCGA-28-6450	GBM	60	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-22177	Dead	WITH TUMOR	165	165	NA	NA	NA	NA	NA	NA	NA	NA	1	165	1	165	NA	NA	1	165	
60	TCGA-32-1970	0	2	0	3	0	1	1	0	0	62	5	0	3	21	0	0	TCGA-32-1970-01	266	0.2876112002196008	182	TCGA-32-1970-01	6	8	30	0.18348351159209605	TCGA-32-1970-01	5	1	2	8	PASS	3166	TCGA-32-1970	GBM	59	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-21613	Dead	WITH TUMOR	468	468	NA	Progression of Disease	NA	NA	408	NA	NA	NA	1	468	1	468	NA	NA	1	408	
30	TCGA-32-1973	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-32-1973-01	201	0.8594650452672066	117	TCGA-32-1973-01	3	8	29	0.16618166678700608	TCGA-32-1973-01	10	11	11	32	PASS	3167	TCGA-32-1973	GBM	21	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-7756	Dead	WITH TUMOR	641	641	NA	Progression of Disease	NA	NA	507	NA	NA	NA	1	641	1	641	NA	NA	1	507	
70	TCGA-32-1976	1	5	0	1	3	3	2	0	4	44	1	0	2	22	2	0	TCGA-32-1976-01	131	0.4115935204250964	74	TCGA-32-1976-01	8	5	18	0.06972403964707749	TCGA-32-1976-01	4	2	3	9	mutation call filter	3168	TCGA-32-1976	GBM	65	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-23798	Dead	NA	15	15	NA	NA	NA	NA	NA	NA	NA	NA	1	15	NA	15	NA	NA	0	15	
60	TCGA-32-1977	0	7	1	3	4	0	0	1	2	58	3	0	1	28	2	0	TCGA-32-1977-01	132	0.2012983746519135	68	TCGA-32-1977-01	7	5	29	0.1156168320587933	TCGA-32-1977-01	3	4	2	9	PASS	3169	TCGA-32-1977	GBM	63	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-23205	Alive	WITH TUMOR	3	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3	0	3	NA	NA	0	3	
60	TCGA-32-1978	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-32-1978-01	250	0.456959950563772	166	TCGA-32-1978-01	7	31	94	0.8007925829101803	TCGA-32-1978-01	7	8	21	36	PASS	3170	TCGA-32-1978	GBM	57	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-21054	Dead	WITH TUMOR	482	482	NA	NA	NA	NA	NA	NA	NA	NA	1	482	1	482	NA	NA	1	482	
70	TCGA-32-1979	0	1	0	1	2	0	0	0	2	61	3	1	0	27	1	0	TCGA-32-1979-01	100	0.22354571579785235	45	TCGA-32-1979-01	10	9	11	0.05925480191895295	TCGA-32-1979-01	1	1	1	3	PASS	3171	TCGA-32-1979	GBM	69	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-25252	Dead	WITH TUMOR	593	593	NA	Progression of Disease	NA	NA	265	NA	NA	NA	1	593	1	593	NA	NA	1	265	
70	TCGA-32-1980	0	0	1	1	0	0	0	0	0	15	0	0	0	3	1	0	TCGA-32-1980-01	73	0.1220458425899554	37	TCGA-32-1980-01	6	4	4	0.15340848181892733	TCGA-32-1980-01	0	0	0	0	PASS	3172	TCGA-32-1980	GBM	72	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-26467	Dead	WITH TUMOR	36	36	NA	NA	NA	NA	NA	NA	NA	NA	1	36	1	36	NA	NA	1	36	
80	TCGA-32-1982	0	3	0	4	2	0	1	0	2	59	3	0	2	25	0	0	TCGA-32-1982-01	86	0.1315412980138501	29	TCGA-32-1982-01	6	3	12	0.058325608121449074	TCGA-32-1982-01	1	0	0	1	PASS	3173	TCGA-32-1982	GBM	76	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-27764	Dead	WITH TUMOR	142	142	NA	NA	NA	NA	NA	NA	NA	NA	1	142	1	142	NA	NA	1	142	
70	TCGA-32-1986	0	5	0	3	1	0	1	0	1	37	0	0	0	14	0	0	TCGA-32-1986-01	193	0.16013457916039694	120	TCGA-32-1986-01	5	6	26	0.08307419672220122	TCGA-32-1986-01	1	3	4	8	PASS	3174	TCGA-32-1986	GBM	68	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-25061	Dead	WITH TUMOR	386	386	NA	Progression of Disease	NA	NA	233	NA	NA	NA	1	386	1	386	NA	NA	1	233	
50	TCGA-32-1987	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-32-1987-01	288	0.2834502495024404	219	TCGA-32-1987-01	10	17	30	0.26606756613326	TCGA-32-1987-01	8	6	7	21	PASS	3175	TCGA-32-1987	GBM	49	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-18091	Dead	WITH TUMOR	452	452	NA	Recurrence	NA	NA	68	NA	NA	NA	1	452	1	452	NA	NA	1	68	
60	TCGA-32-1991	1	8	0	5	0	0	1	0	0	33	6	0	0	18	3	0	TCGA-32-1991-01	133	0.25823850108009083	66	TCGA-32-1991-01	3	5	10	0.09767329071649697	TCGA-32-1991-01	4	3	7	14	PASS	3176	TCGA-32-1991	GBM	60	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-22021	Dead	WITH TUMOR	515	515	NA	Recurrence	NA	NA	345	NA	NA	NA	1	515	1	515	NA	NA	1	345	
60	TCGA-32-2491	2	8	0	4	1	0	0	0	5	72	3	0	1	18	2	0	TCGA-32-2491-01	206	0.22716745852469605	140	TCGA-32-2491-01	12	9	13	0.16952569780107798	TCGA-32-2491-01	1	2	2	5	PASS	3177	TCGA-32-2491	GBM	63	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-23131	Dead	WITH TUMOR	372	372	NA	Recurrence	NA	NA	70	NA	NA	NA	1	372	1	372	NA	NA	1	70	
60	TCGA-32-2494	0	2	3	2	2	1	0	0	4	49	1	0	2	21	0	0	TCGA-32-2494-01	212	0.16665242880334033	140	TCGA-32-2494-01	7	5	30	0.11684068780330342	TCGA-32-2494-01	2	6	4	12	PASS	3178	TCGA-32-2494	GBM	58	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-21198	Dead	WITH TUMOR	632	632	NA	Progression of Disease	NA	NA	488	NA	NA	NA	1	632	1	632	NA	NA	1	488	
60	TCGA-32-2495	0	2	1	2	2	0	0	0	3	54	5	0	0	20	3	1	TCGA-32-2495-01	178	0.3335814069095496	113	TCGA-32-2495-01	11	10	32	0.1113203038950868	TCGA-32-2495-01	3	2	1	6	PASS	3179	TCGA-32-2495	GBM	59	FEMALE	WHITE	NA	NA	Treated primary GBM	NA	2008	NA	-21860	Dead	WITH TUMOR	457	457	NA	Recurrence	NA	NA	252	NA	NA	NA	1	457	1	457	NA	NA	1	252	
60	TCGA-32-2615	0	1	1	1	0	1	0	0	1	28	2	0	0	15	0	0	TCGA-32-2615-01	216	0.7055645799205831	145	TCGA-32-2615-01	5	6	23	0.18218915739092967	TCGA-32-2615-01	1	3	5	9	PASS	3180	TCGA-32-2615	GBM	62	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-22916	Dead	WITH TUMOR	485	485	NA	Progression of Disease	NA	NA	131	NA	NA	NA	1	485	1	485	NA	NA	1	131	
50	TCGA-32-2616	6	52	5	17	1	5	0	0	24	921	58	0	16	430	4	0	TCGA-32-2616-01	122	0.1683222674897665	65	TCGA-32-2616-01	5	8	14	0.16787321087981869	TCGA-32-2616-01	5	1	2	8	hypermutated sample	3181	TCGA-32-2616	GBM	48	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-17781	Dead	WITH TUMOR	224	224	NA	Progression of Disease	NA	NA	182	NA	NA	NA	1	224	1	224	NA	NA	1	182	
80	TCGA-32-2632	1	5	0	2	1	2	0	0	6	74	6	0	4	27	2	0	TCGA-32-2632-01	123	0.7062180457301271	53	TCGA-32-2632-01	21	18	8	0.03096602766622273	TCGA-32-2632-01	7	1	1	9	PASS	3182	TCGA-32-2632	GBM	80	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-29281	Dead	WITH TUMOR	NA	269	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	269	1	269	NA	NA	1	269	
80	TCGA-32-2634	0	1	0	1	2	0	1	0	2	34	4	0	2	12	1	0	TCGA-32-2634-01	123	0.9140230702057174	67	TCGA-32-2634-01	8	12	23	0.2611382528001342	TCGA-32-2634-01	3	4	4	11	PASS	3183	TCGA-32-2634	GBM	82	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-29964	Alive	TUMOR FREE	693	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	693	0	693	NA	NA	0	693	
70	TCGA-32-2638	0	2	1	2	2	1	0	0	2	39	3	0	1	27	1	0	TCGA-32-2638-01	169	0.15304669550623126	106	TCGA-32-2638-01	6	3	20	0.05927926309667093	TCGA-32-2638-01	1	1	0	2	PASS	3184	TCGA-32-2638	GBM	67	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-24658	Dead	WITH TUMOR	NA	766	NA	NA	NA	NA	NA	NA	NA	NA	1	766	1	766	NA	NA	1	766	
30	TCGA-32-4208	0	6	0	1	2	1	0	0	0	31	4	0	0	8	0	0	TCGA-32-4208-01	160	0.5484428282946164	90	TCGA-32-4208-01	2	5	24	0.12879716560284685	TCGA-32-4208-01	7	4	5	16	PASS	3185	TCGA-32-4208	GBM	25	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-9213	Alive	WITH TUMOR	643	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	643	0	643	NA	NA	0	643	
40	TCGA-32-4209	0	7	0	1	0	0	0	0	0	28	2	0	0	5	1	0	TCGA-32-4209	0	0	0	TCGA-32-4209	0	0	0	0	TCGA-32-4209	0	0	0	0	PASS	3186	TCGA-32-4209	GBM	40	MALE	WHITE	NA	NA	Treated primary GBM	NA	2009	NA	-14903	Dead	WITH TUMOR	NA	618	NA	Recurrence	NA	NA	94	NA	NA	NA	1	618	1	618	NA	NA	1	94	
70	TCGA-32-4210	0	6	0	1	0	0	0	0	1	64	0	0	2	28	3	0	TCGA-32-4210-01	229	0.8528794369396371	153	TCGA-32-4210-01	29	40	40	0.09671777821736707	TCGA-32-4210-01	9	3	2	14	PASS	3187	TCGA-32-4210	GBM	73	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-26768	Dead	WITH TUMOR	113	113	NA	NA	NA	NA	NA	NA	NA	NA	1	113	1	113	NA	NA	1	113	
60	TCGA-32-4211	0	3	0	2	0	1	0	0	1	57	3	0	0	24	1	0	TCGA-32-4211-01	212	0.2380881440597737	144	TCGA-32-4211-01	7	6	34	0.11248388746644154	TCGA-32-4211-01	1	3	2	6	PASS	3188	TCGA-32-4211	GBM	56	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-20748	Dead	WITH TUMOR	383	383	NA	NA	NA	NA	NA	NA	NA	NA	1	383	1	383	NA	NA	1	383	
50	TCGA-32-4213	0	4	1	2	4	1	1	0	2	49	1	0	4	16	1	0	TCGA-32-4213-01	109	0.12065480948812868	56	TCGA-32-4213-01	4	5	14	0.18199530452790866	TCGA-32-4213-01	0	2	3	5	PASS	3189	TCGA-32-4213	GBM	47	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-17237	Alive	WITH TUMOR	604	NA	NA	Recurrence	NA	NA	353	NA	NA	NA	0	604	0	604	NA	NA	1	353	
70	TCGA-32-4719	0	5	0	1	0	2	0	0	2	44	0	0	1	11	1	0	TCGA-32-4719-01	171	0.7698290821079932	103	TCGA-32-4719-01	2	2	30	0.06723111627317227	TCGA-32-4719-01	1	0	1	2	PASS	3190	TCGA-32-4719	GBM	73	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-26691	Dead	WITH TUMOR	330	330	NA	NA	NA	NA	NA	NA	NA	NA	1	330	1	330	NA	NA	1	330	
70	TCGA-32-5222	0	4	2	3	1	0	0	0	3	55	2	0	0	23	2	0	TCGA-32-5222-01	151	0.30729984999124504	97	TCGA-32-5222-01	14	9	29	0.0643965288860087	TCGA-32-5222-01	2	1	1	4	PASS	3191	TCGA-32-5222	GBM	66	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-24134	Dead	WITH TUMOR	NA	585	NA	Progression of Disease	NA	NA	118	NA	NA	NA	1	585	1	585	NA	NA	1	118	
90	TCGA-41-2571	2	4	0	2	1	0	0	0	3	34	3	0	0	18	3	0	TCGA-41-2571-01	135	0.19235785843972011	81	TCGA-41-2571-01	6	8	22	0.1749644719529915	TCGA-41-2571-01	2	5	4	11	PASS	3192	TCGA-41-2571	GBM	89	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-32612	Dead	WITH TUMOR	26	26	NA	Progression of Disease	NA	NA	26	NA	NA	NA	1	26	1	26	NA	NA	1	26	
70	TCGA-41-2572	1	9	1	2	0	1	0	0	2	44	1	0	0	19	2	0	TCGA-41-2572-01	160	0.29445903796952083	80	TCGA-41-2572-01	10	6	22	0.1385630462836626	TCGA-41-2572-01	3	3	5	11	PASS	3193	TCGA-41-2572	GBM	67	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-24505	Dead	WITH TUMOR	406	406	NA	Progression of Disease	NA	NA	122	NA	NA	NA	1	406	1	406	NA	NA	1	122	
60	TCGA-41-2573	0	6	0	2	0	1	0	0	1	35	1	0	1	12	3	0	TCGA-41-2573-01	136	0.3674927541371349	79	TCGA-41-2573-01	15	24	9	0.21498070670088426	TCGA-41-2573-01	3	2	1	6	PASS	3194	TCGA-41-2573	GBM	59	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-21911	Alive	WITH TUMOR	272	NA	NA	Progression of Disease	NA	NA	167	NA	NA	NA	0	272	0	272	NA	NA	1	167	
80	TCGA-41-2575	0	7	1	2	1	0	0	0	4	51	4	0	1	13	1	0	TCGA-41-2575-01	248	0.4540080459407752	162	TCGA-41-2575-01	7	11	41	0.1708594736646322	TCGA-41-2575-01	9	10	6	25	PASS	3195	TCGA-41-2575	GBM	75	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-27587	Dead	WITH TUMOR	290	290	NA	Progression of Disease	NA	NA	131	NA	NA	NA	1	290	1	290	NA	NA	1	131	
90	TCGA-41-3392	0	4	1	1	2	1	1	0	4	53	3	0	1	18	1	0	TCGA-41-3392-01	105	0.8788933768484545	45	TCGA-41-3392-01	5	7	23	0.17104475792427132	TCGA-41-3392-01	5	6	7	18	PASS	3196	TCGA-41-3392	GBM	88	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-32351	Dead	WITH TUMOR	30	30	NA	NA	NA	NA	NA	NA	NA	NA	1	30	1	30	NA	NA	1	30	
80	TCGA-41-3393	1	2	1	4	0	0	1	0	3	48	4	1	0	22	2	0	TCGA-41-3393-01	156	0.1667491465288008	97	TCGA-41-3393-01	8	5	19	0.0731669868585272	TCGA-41-3393-01	1	2	2	5	PASS	3197	TCGA-41-3393	GBM	81	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-29904	Dead	WITH TUMOR	135	135	NA	NA	NA	NA	NA	NA	NA	NA	1	135	1	135	NA	NA	1	135	
50	TCGA-41-3915	0	3	1	0	0	2	0	0	1	33	2	0	1	13	2	0	TCGA-41-3915-01	205	0.4875138694493139	129	TCGA-41-3915-01	7	5	29	0.1787589853463474	TCGA-41-3915-01	2	1	3	6	PASS	3198	TCGA-41-3915	GBM	48	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-17880	Dead	WITH TUMOR	NA	360	NA	Locoregional Disease	NA	NA	288	NA	NA	NA	1	360	1	360	NA	NA	1	288	
60	TCGA-41-4097	0	9	1	5	1	0	0	0	2	42	1	0	3	11	1	0	TCGA-41-4097-01	152	0.5094430538726821	81	TCGA-41-4097-01	7	6	18	0.2056278834193321	TCGA-41-4097-01	2	2	1	5	PASS	3199	TCGA-41-4097	GBM	63	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-23107	Dead	WITH TUMOR	6	6	NA	NA	NA	NA	NA	NA	NA	NA	1	6	1	6	NA	NA	1	6	
60	TCGA-41-5651	0	6	0	3	0	0	0	0	3	68	4	0	0	35	2	0	TCGA-41-5651-01	161	0.32593232886293977	94	TCGA-41-5651-01	8	7	25	0.1284930265576741	TCGA-41-5651-01	8	5	3	16	PASS	3200	TCGA-41-5651	GBM	59	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-21698	Dead	WITH TUMOR	NA	460	NA	Progression of Disease	NA	NA	210	NA	NA	NA	1	460	1	460	NA	NA	1	210	
70	TCGA-41-6646	0	2	0	2	2	0	2	0	4	38	7	0	6	8	0	0	TCGA-41-6646-01	262	0.14788038657600844	201	TCGA-41-6646-01	7	6	48	0.10271815987183468	TCGA-41-6646-01	0	4	0	4	PASS	3201	TCGA-41-6646	GBM	73	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2011	NA	-26667	Dead	WITH TUMOR	NA	379	NA	Progression of Disease	NA	NA	200	NA	NA	NA	1	379	1	379	NA	NA	1	200	
60	TCGA-4W-AA9R	1	4	0	3	2	0	0	0	2	59	2	0	1	27	1	0	TCGA-4W-AA9R-01	297	0.9392498648803416	220	TCGA-4W-AA9R-01	18	16	106	0.0824576865190162	TCGA-4W-AA9R-01	3	1	4	8	PASS	3202	TCGA-4W-AA9R	GBM	61	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2012	NA	-22317	Alive	TUMOR FREE	124	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	124	0	124	NA	NA	0	124	
70	TCGA-4W-AA9S	0	3	0	0	1	0	0	0	1	33	7	0	1	24	1	0	TCGA-4W-AA9S-01	200	0.2780673096887513	114	TCGA-4W-AA9S-01	10	9	63	0.14608532450235207	TCGA-4W-AA9S-01	3	3	1	7	PASS	3203	TCGA-4W-AA9S	GBM	69	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2013	NA	-25545	Alive	TUMOR FREE	44	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	44	0	44	NA	NA	0	44	
50	TCGA-4W-AA9T	0	1	1	0	0	0	0	1	0	43	4	0	1	14	1	0	TCGA-4W-AA9T-01	102	0.1683098036052899	50	TCGA-4W-AA9T-01	8	5	49	0.09982991915653114	TCGA-4W-AA9T-01	2	2	2	6	PASS	3204	TCGA-4W-AA9T	GBM	54	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2012	NA	-19801	Alive	TUMOR FREE	778	NA	NA	NA	NA	NA	749	Progressive Disease	NA	NA	0	778	0	778	NA	NA	1	749	
70	TCGA-74-6573	0	2	0	3	0	0	0	1	1	32	2	0	0	14	1	0	TCGA-74-6573-01	254	0.23911842865302066	188	TCGA-74-6573-01	6	7	70	0.16481412882981608	TCGA-74-6573-01	2	1	2	5	PASS	3205	TCGA-74-6573	GBM	67	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-24632	Dead	WITH TUMOR	NA	105	NA	NA	NA	NA	NA	NA	NA	NA	1	105	1	105	NA	NA	1	105	
70	TCGA-74-6575	0	8	0	0	2	3	1	0	3	69	3	0	1	39	3	0	TCGA-74-6575-01	215	0.2177417517041564	148	TCGA-74-6575-01	8	9	51	0.13724095440754638	TCGA-74-6575-01	4	5	6	15	PASS	3206	TCGA-74-6575	GBM	73	FEMALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-26827	Alive	WITH TUMOR	636	NA	NA	NA	NA	NA	93	NA	NA	NA	0	636	0	636	NA	NA	1	93	
50	TCGA-74-6577	0	6	0	2	1	0	0	1	3	80	8	0	3	20	0	1	TCGA-74-6577-01	55	0.18723733514063115	17	TCGA-74-6577-01	6	7	7	0.1455384495189821	TCGA-74-6577-01	3	2	3	8	PASS	3207	TCGA-74-6577	GBM	51	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-18740	Alive	WITH TUMOR	132	NA	NA	NA	NA	NA	132	NA	NA	NA	0	132	0	132	NA	NA	1	132	
60	TCGA-74-6578	0	1	0	1	1	0	2	0	4	55	2	0	0	16	2	0	TCGA-74-6578-01	73	0.15234283426782813	26	TCGA-74-6578-01	6	3	4	0.06212701153910648	TCGA-74-6578-01	1	0	1	2	PASS	3208	TCGA-74-6578	GBM	58	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-21464	Alive	WITH TUMOR	436	NA	NA	NA	NA	NA	222	NA	NA	NA	0	436	0	436	NA	NA	1	222	
80	TCGA-74-6581	0	2	0	4	2	0	1	0	5	29	3	0	0	13	0	0	TCGA-74-6581-01	111	0.1637562372567168	50	TCGA-74-6581-01	7	4	17	0.09208600111082424	TCGA-74-6581-01	1	2	4	7	PASS	3209	TCGA-74-6581	GBM	77	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-28263	Alive	WITH TUMOR	250	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	250	0	250	NA	NA	0	250	
60	TCGA-74-6584	0	1	0	0	1	1	0	0	0	29	0	0	0	12	1	0	TCGA-74-6584-01	179	0.2793543055638206	120	TCGA-74-6584-01	6	5	40	0.08523383606495867	TCGA-74-6584-01	4	7	3	14	PASS	3210	TCGA-74-6584	GBM	55	FEMALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-20232	Alive	WITH TUMOR	228	NA	NA	NA	NA	NA	91	NA	NA	NA	0	228	0	228	NA	NA	1	91	
80	TCGA-76-4925	0	6	0	1	2	2	0	0	3	47	1	0	1	19	3	0	TCGA-76-4925-01	187	0.5663903555941832	111	TCGA-76-4925-01	12	11	59	0.16773827968922822	TCGA-76-4925-01	8	3	5	16	PASS	3211	TCGA-76-4925	GBM	76	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-28011	Dead	NA	146	146	NA	Progression of Disease	NA	NA	88	NA	NA	NA	1	146	NA	146	NA	NA	1	88	
70	TCGA-76-4926	0	4	0	1	3	1	0	0	2	46	2	0	3	15	2	1	TCGA-76-4926-01	165	0.12057792401558295	121	TCGA-76-4926-01	5	3	16	0.06583225764086383	TCGA-76-4926-01	0	0	0	0	PASS	3212	TCGA-76-4926	GBM	68	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-25085	Dead	WITH TUMOR	138	138	NA	Progression of Disease	NA	NA	34	NA	NA	NA	1	138	1	138	NA	NA	1	34	
60	TCGA-76-4927	1	4	0	2	0	1	0	0	1	37	2	0	4	18	3	0	TCGA-76-4927	0	0	0	TCGA-76-4927	0	0	0	0	TCGA-76-4927	0	0	0	0	PASS	3213	TCGA-76-4927	GBM	58	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-21193	Dead	WITH TUMOR	535	535	NA	Progression of Disease	NA	NA	416	NA	NA	NA	1	535	1	535	NA	NA	1	416	
90	TCGA-76-4928	0	3	1	2	2	1	0	0	2	65	2	0	0	20	0	0	TCGA-76-4928-01	93	0.20918674293049966	41	TCGA-76-4928-01	7	6	7	0.08424834772759303	TCGA-76-4928-01	2	1	2	5	PASS	3214	TCGA-76-4928	GBM	85	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-31267	Dead	WITH TUMOR	94	94	NA	NA	NA	NA	NA	NA	NA	NA	1	94	1	94	NA	NA	1	94	
80	TCGA-76-4929	0	8	2	2	3	0	0	0	1	42	2	0	0	28	2	0	TCGA-76-4929-01	193	0.8176792692437705	122	TCGA-76-4929-01	31	14	37	0.2192447129500696	TCGA-76-4929-01	1	4	1	6	PASS	3215	TCGA-76-4929	GBM	76	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-27831	Dead	WITH TUMOR	111	111	NA	NA	NA	NA	NA	NA	NA	NA	1	111	1	111	NA	NA	1	111	
70	TCGA-76-4931	0	3	0	1	0	0	0	0	1	31	6	0	1	21	0	1	TCGA-76-4931-01	168	0.4782119295947953	96	TCGA-76-4931-01	5	4	19	0.1030263296760449	TCGA-76-4931-01	2	0	3	5	PASS	3216	TCGA-76-4931	GBM	70	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2005	NA	-25812	Dead	WITH TUMOR	279	279	NA	Progression of Disease	NA	NA	112	NA	NA	NA	1	279	1	279	NA	NA	1	112	
50	TCGA-76-4932	2	2	0	0	1	0	0	0	0	49	2	0	2	19	0	0	TCGA-76-4932	0	0	0	TCGA-76-4932	0	0	0	0	TCGA-76-4932	0	0	0	0	PASS	3217	TCGA-76-4932	GBM	50	FEMALE	WHITE	NA	NA	Treated primary GBM	NA	2006	NA	-18433	Dead	WITH TUMOR	1458	1458	NA	NA	NA	NA	NA	NA	NA	NA	1	1458	1	1458	NA	NA	1	1458	
70	TCGA-76-4934	1	3	0	1	1	0	0	0	2	41	5	0	2	13	0	0	TCGA-76-4934-01	162	0.7756410161893883	96	TCGA-76-4934-01	25	14	18	0.13821726419799069	TCGA-76-4934-01	4	0	0	4	PASS	3218	TCGA-76-4934	GBM	66	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-24319	Dead	TUMOR FREE	77	77	NA	NA	NA	NA	NA	NA	NA	NA	1	77	0	77	NA	NA	0	77	
50	TCGA-76-4935	0	4	1	1	1	0	0	0	3	42	2	0	0	15	0	0	TCGA-76-4935-01	119	0.279427198466587	58	TCGA-76-4935-01	5	4	11	0.10240401567799937	TCGA-76-4935-01	1	1	2	4	PASS	3219	TCGA-76-4935	GBM	52	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-19231	Dead	TUMOR FREE	NA	1121	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	1121	0	1121	NA	NA	0	1121	
60	TCGA-76-6191	0	4	1	1	3	0	1	0	1	43	2	0	0	16	1	0	TCGA-76-6191-01	154	0.2351613169877313	100	TCGA-76-6191-01	6	3	35	0.1109454392000072	TCGA-76-6191-01	2	1	1	4	PASS	3220	TCGA-76-6191	GBM	57	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-20937	Dead	WITH TUMOR	508	508	NA	Progression of Disease	NA	NA	323	NA	NA	NA	1	508	1	508	NA	NA	1	323	
70	TCGA-76-6192	0	0	0	0	0	0	0	0	2	41	3	0	0	18	2	0	TCGA-76-6192-01	59	0.10751441775183768	12	TCGA-76-6192-01	4	2	8	0.05835785136979866	TCGA-76-6192-01	0	2	0	2	PASS	3221	TCGA-76-6192	GBM	74	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-27322	Dead	WITH TUMOR	100	100	NA	Progression of Disease	NA	NA	76	NA	NA	NA	1	100	1	100	NA	NA	1	76	
80	TCGA-76-6193	0	4	1	0	2	0	0	0	0	32	4	0	1	14	1	0	TCGA-76-6193-01	89	0.17227613508473494	37	TCGA-76-6193-01	5	5	15	0.17830058804868912	TCGA-76-6193-01	2	3	5	10	PASS	3222	TCGA-76-6193	GBM	78	MALE	NA	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-28742	Dead	NA	82	82	NA	Progression of Disease	NA	NA	64	NA	NA	NA	1	82	NA	82	NA	NA	1	64	
60	TCGA-76-6280	0	3	1	3	1	0	0	1	2	40	4	0	3	13	2	0	TCGA-76-6280-01	196	0.2719152608309048	126	TCGA-76-6280-01	9	10	32	0.17024626904828216	TCGA-76-6280-01	2	4	3	9	PASS	3223	TCGA-76-6280	GBM	57	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-20931	Dead	WITH TUMOR	346	346	NA	Progression of Disease	NA	NA	108	NA	NA	NA	1	346	1	346	NA	NA	1	108	
60	TCGA-76-6282	0	2	0	1	2	0	0	0	1	38	2	0	0	13	1	1	TCGA-76-6282-01	167	0.1920617399511058	97	TCGA-76-6282-01	7	5	33	0.13985649766463842	TCGA-76-6282-01	4	0	2	6	PASS	3224	TCGA-76-6282	GBM	63	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2007	NA	-23323	Dead	WITH TUMOR	519	519	NA	Progression of Disease	NA	NA	458	NA	NA	NA	1	519	1	519	NA	NA	1	458	
70	TCGA-76-6283	0	4	0	8	5	1	2	0	4	71	6	0	3	26	2	0	TCGA-76-6283-01	120	0.3910125216275837	62	TCGA-76-6283-01	12	10	19	0.18937863351545708	TCGA-76-6283-01	1	1	1	3	PASS	3225	TCGA-76-6283	GBM	71	FEMALE	WHITE	NA	NA	Glioblastoma Multiforme (GBM)	NA	2007	NA	-26002	Dead	WITH TUMOR	NA	165	NA	NA	NA	NA	NA	NA	NA	NA	1	165	1	165	NA	NA	1	165	
60	TCGA-76-6285	1	3	0	2	1	0	0	0	2	39	5	0	1	19	3	0	TCGA-76-6285-01	186	0.9205820230546548	125	TCGA-76-6285-01	14	11	45	0.2803253934960405	TCGA-76-6285-01	7	6	5	18	PASS	3226	TCGA-76-6285	GBM	64	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2008	NA	-23674	Dead	WITH TUMOR	254	254	NA	NA	NA	NA	NA	NA	NA	NA	1	254	1	254	NA	NA	1	254	
60	TCGA-76-6286	1	5	0	0	1	0	0	0	0	54	4	0	2	24	0	0	TCGA-76-6286-01	120	0.8780762672650428	66	TCGA-76-6286-01	10	6	12	0.1648242144520421	TCGA-76-6286-01	1	0	0	1	PASS	3227	TCGA-76-6286	GBM	60	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-22173	Dead	WITH TUMOR	638	638	NA	Progression of Disease	NA	NA	180	NA	NA	NA	1	638	1	638	NA	NA	1	180	
70	TCGA-76-6656	0	8	0	1	2	0	0	0	2	69	3	0	3	31	1	0	TCGA-76-6656-01	103	0.12411167211556715	42	TCGA-76-6656-01	7	4	10	0.04732684419539825	TCGA-76-6656-01	2	2	2	6	PASS	3228	TCGA-76-6656	GBM	66	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-24265	Dead	NA	147	147	NA	NA	NA	NA	NA	NA	NA	NA	1	147	NA	147	NA	NA	0	147	
70	TCGA-76-6657	1	2	0	3	3	2	2	0	2	42	2	0	0	15	3	0	TCGA-76-6657-01	135	0.1523290780695616	77	TCGA-76-6657-01	7	6	31	0.07932157228527227	TCGA-76-6657-01	1	1	1	3	PASS	3229	TCGA-76-6657	GBM	74	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-27341	Dead	WITH TUMOR	153	153	NA	Progression of Disease	NA	NA	135	NA	NA	NA	1	153	1	153	NA	NA	1	135	
70	TCGA-76-6660	0	1	1	1	3	0	1	0	2	62	6	0	6	27	0	0	TCGA-76-6660-01	241	0.3752710632816504	156	TCGA-76-6660-01	10	14	21	0.1373871027771242	TCGA-76-6660-01	5	5	4	14	PASS	3230	TCGA-76-6660	GBM	73	MALE	WHITE	NA	NA	Glioblastoma Multiforme (GBM)	NA	2010	NA	-26913	Dead	WITH TUMOR	NA	114	NA	NA	NA	NA	NA	NA	NA	NA	1	114	1	114	NA	NA	1	114	
50	TCGA-76-6661	0	2	0	3	0	0	0	0	0	42	5	0	0	18	0	0	TCGA-76-6661-01	128	0.18370695734958475	63	TCGA-76-6661-01	8	4	16	0.06190438064611601	TCGA-76-6661-01	1	1	1	3	PASS	3231	TCGA-76-6661	GBM	54	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2011	NA	-19965	Dead	WITH TUMOR	NA	727	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	727	1	727	NA	NA	1	727	
60	TCGA-76-6662	1	0	0	1	2	1	0	1	3	28	3	0	0	12	0	0	TCGA-76-6662-01	109	0.12118323753461968	57	TCGA-76-6662-01	4	3	19	0.06862858862617571	TCGA-76-6662-01	3	3	2	8	PASS	3232	TCGA-76-6662	GBM	58	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2011	NA	-21511	Dead	WITH TUMOR	NA	1048	NA	Progression of Disease	NA	NA	205	NA	NA	NA	1	1048	1	1048	NA	NA	1	205	
40	TCGA-76-6663	0	2	0	1	3	0	0	0	1	43	2	0	2	21	0	0	TCGA-76-6663-01	69	0.1223875939752379	26	TCGA-76-6663-01	6	3	7	0.050442082618603085	TCGA-76-6663-01	1	1	0	2	PASS	3233	TCGA-76-6663	GBM	44	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2011	NA	-16126	Dead	WITH TUMOR	NA	567	NA	NA	NA	NA	NA	NA	NA	NA	1	567	1	567	NA	NA	1	567	
50	TCGA-76-6664	0	3	0	5	0	0	0	0	3	36	3	0	2	15	3	0	TCGA-76-6664-01	169	0.1512545773959124	111	TCGA-76-6664-01	7	7	40	0.08380189485495701	TCGA-76-6664-01	5	2	6	13	PASS	3234	TCGA-76-6664	GBM	49	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2011	NA	-18054	Alive	WITH TUMOR	1101	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1101	0	1101	NA	NA	0	1101	
60	TCGA-81-5910	0	1	0	1	0	2	0	0	1	36	2	0	2	16	1	0	TCGA-81-5910-01	113	0.1481334633985948	51	TCGA-81-5910-01	4	3	11	0.0887815879885584	TCGA-81-5910-01	2	2	2	6	PASS	3235	TCGA-81-5910	GBM	64	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2009	NA	-23567	Dead	WITH TUMOR	NA	49	NA	NA	NA	NA	NA	NA	NA	NA	1	49	1	49	NA	NA	1	49	
30	TCGA-81-5911	0	0	0	0	0	1	0	0	2	25	2	0	1	6	0	0	TCGA-81-5911-01	155	0.17531146963334626	80	TCGA-81-5911-01	6	4	8	0.09431080238411912	TCGA-81-5911-01	2	3	2	7	PASS	3236	TCGA-81-5911	GBM	33	MALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-12292	Alive	WITH TUMOR	539	NA	NA	Progression of Disease	NA	NA	277	NA	NA	NA	0	539	0	539	NA	NA	1	277	
50	TCGA-87-5896	0	4	1	1	0	0	0	0	0	33	8	0	0	24	1	0	TCGA-87-5896-01	146	0.1516900703394494	73	TCGA-87-5896-01	6	4	25	0.08023777512026595	TCGA-87-5896-01	3	1	3	7	PASS	3237	TCGA-87-5896	GBM	50	FEMALE	WHITE	NA	NA	Untreated primary (de novo) GBM	NA	2010	NA	-18391	Alive	TUMOR FREE	800	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	800	0	800	0	800	0	800	
70	TCGA-OX-A56R	0	3	0	2	3	1	1	0	2	31	1	0	1	8	0	0	TCGA-OX-A56R-01	148	0.9143593111347796	70	TCGA-OX-A56R-01	9	6	67	0.21884804082689396	TCGA-OX-A56R-01	4	2	4	10	PASS	3238	TCGA-OX-A56R	GBM	68	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2012	NA	-25178	Dead	WITH TUMOR	NA	180	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	180	1	180	NA	NA	1	180	
70	TCGA-RR-A6KA	0	1	0	3	1	1	0	0	0	38	4	0	0	19	2	0	TCGA-RR-A6KA-01	179	0.14216387471733696	113	TCGA-RR-A6KA-01	7	4	52	0.049230999039944025	TCGA-RR-A6KA-01	2	4	3	9	PASS	3239	TCGA-RR-A6KA	GBM	72	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2012	NA	-26582	Dead	WITH TUMOR	NA	191	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	191	1	191	NA	NA	1	191	
50	TCGA-RR-A6KB	0	1	0	2	0	0	0	0	0	37	2	0	0	14	5	0	TCGA-RR-A6KB-01	142	0.17762154015771806	79	TCGA-RR-A6KB-01	7	4	50	0.1328738689701919	TCGA-RR-A6KB-01	1	0	1	2	PASS	3240	TCGA-RR-A6KB	GBM	51	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2007	NA	-18713	Alive	NA	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
60	TCGA-RR-A6KC	0	2	0	3	1	0	0	0	1	36	2	0	0	19	0	0	TCGA-RR-A6KC-01	81	0.1545897806465615	34	TCGA-RR-A6KC-01	8	4	28	0.06353573405439647	TCGA-RR-A6KC-01	0	2	0	2	PASS	3241	TCGA-RR-A6KC	GBM	55	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Glioblastoma Multiforme (GBM)	NA	2010	NA	-20302	Dead	NA	NA	625	NA	Recurrence	NA	NA	369	Complete Remission/Response	NA	NA	1	625	NA	625	1	369	1	369	
70	TCGA-4P-AA8J	0	2	0	6	1	6	1	0	3	93	8	0	2	44	2	0	TCGA-4P-AA8J-01	203	0.2035747767981559	125	TCGA-4P-AA8J-01	6	10	105	0.15799742768596944	TCGA-4P-AA8J-01	8	8	9	25	PASS	3242	TCGA-4P-AA8J	HNSC	66	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-24222	Alive	TUMOR FREE	102	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	102	0	102	NA	NA	0	102	
70	TCGA-BA-4074	1	6	0	2	2	6	0	0	6	106	8	0	2	40	2	1	TCGA-BA-4074-01	168	0.6482955590300612	90	TCGA-BA-4074-01	14	19	42	0.4060674221292289	TCGA-BA-4074-01	12	1	14	27	PASS	3243	TCGA-BA-4074	HNSC	69	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2003	NA	-25282	Dead	WITH TUMOR	NA	462	NA	NA	Distant Metastasis	bone (humerus)	396	Complete Remission/Response	NA	NA	1	462	1	462	NA	NA	1	396	
50	TCGA-BA-4075	0	13	2	5	3	3	1	0	9	113	10	0	3	52	4	0	TCGA-BA-4075	0	0	0	TCGA-BA-4075	0	0	0	0	TCGA-BA-4075-01	15	8	8	31	PASS	3244	TCGA-BA-4075	HNSC	49	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2004	NA	-17951	Dead	WITH TUMOR	NA	283	NA	NA	Oral Cavity	NA	236	Progressive Disease	NA	NA	1	283	1	283	NA	NA	1	236	
40	TCGA-BA-4076	1	20	3	13	4	2	0	0	11	251	21	0	11	84	12	0	TCGA-BA-4076-01	254	0.6594124924794019	137	TCGA-BA-4076-01	9	21	55	0.4289466032183147	TCGA-BA-4076-01	14	3	15	32	PASS	3245	TCGA-BA-4076	HNSC	39	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2003	NA	-14405	Dead	WITH TUMOR	NA	415	NA	NA	Larynx	NA	286	Complete Remission/Response	NA	NA	1	415	1	415	NA	NA	1	286	
50	TCGA-BA-4077	1	16	1	12	7	1	3	0	11	234	20	0	5	96	6	0	TCGA-BA-4077	0	0	0	TCGA-BA-4077	0	0	0	0	TCGA-BA-4077-01	15	10	6	31	PASS	3246	TCGA-BA-4077	HNSC	45	FEMALE	WHITE	Stage IVA	Stage IVB	Head & Neck Squamous Cell Carcinoma	G2	2003	NA	-16536	Dead	WITH TUMOR	NA	1134	NA	NA	NA	NA	NA	Persistent Disease	NA	NA	1	1134	1	1134	NA	NA	1	1134	
80	TCGA-BA-4078	1	36	5	23	7	5	0	0	20	322	31	0	15	130	15	1	TCGA-BA-4078-01	123	0.9469447780397736	58	TCGA-BA-4078-01	16	17	21	0.4233095085748839	TCGA-BA-4078-01	11	5	8	24	PASS	3247	TCGA-BA-4078	HNSC	83	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2003	NA	-30480	Dead	WITH TUMOR	NA	276	NA	NA	NA	NA	NA	NA	NA	NA	1	276	1	276	NA	NA	1	276	
50	TCGA-BA-5149	0	6	0	6	5	0	1	1	1	96	6	0	2	28	0	0	TCGA-BA-5149-01	139	0.4788294911494245	66	TCGA-BA-5149-01	16	33	23	0.2495142608494724	TCGA-BA-5149-01	15	5	5	25	PASS	3248	TCGA-BA-5149	HNSC	47	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-17177	Dead	WITH TUMOR	NA	806	NA	NA	Distant Metastasis	Lung	389	Complete Remission/Response	NA	NA	1	806	1	806	NA	NA	1	389	
70	TCGA-BA-5151	0	3	0	3	1	2	0	0	2	55	7	0	3	29	2	0	TCGA-BA-5151-01	83	0.15012322235020778	38	TCGA-BA-5151-01	4	66	5	0.0970617154804776	TCGA-BA-5151-01	3	4	1	8	PASS	3249	TCGA-BA-5151	HNSC	72	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2010	NA	-26569	Alive	TUMOR FREE	722	NA	NA	NA	NA	NA	517	Complete Remission/Response	NA	NA	0	722	0	722	NA	NA	1	517	
60	TCGA-BA-5152	2	27	2	15	2	1	0	0	21	369	40	1	9	158	8	1	TCGA-BA-5152-01	98	0.44451366170636014	44	TCGA-BA-5152-01	11	18	14	0.1520953874743887	TCGA-BA-5152-01	6	3	7	16	PASS	3250	TCGA-BA-5152	HNSC	56	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-20783	Alive	TUMOR FREE	1288	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1288	0	1288	NA	NA	0	1288	
50	TCGA-BA-5153	0	3	0	0	2	0	0	0	1	35	1	0	0	10	0	0	TCGA-BA-5153-01	70	0.17731656481430444	22	TCGA-BA-5153-01	4	7	9	0.12599201035154856	TCGA-BA-5153-01	6	7	8	21	PASS	3251	TCGA-BA-5153	HNSC	51	MALE	WHITE	NA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2005	NA	-18743	Dead	WITH TUMOR	NA	1762	NA	NA	Distant Metastasis	bone (hip)	1522	Complete Remission/Response	NA	NA	1	1762	1	1762	1	1522	1	1522	
50	TCGA-BA-5555	0	4	0	5	1	2	1	0	3	113	12	0	2	29	1	0	TCGA-BA-5555-01	183	0.6962147683097321	103	TCGA-BA-5555-01	25	31	37	0.4994588153395069	TCGA-BA-5555-01	17	7	8	32	PASS	3252	TCGA-BA-5555	HNSC	54	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-19956	Alive	TUMOR FREE	520	NA	NA	NA	Oropharynx	L tonsil	248	Complete Remission/Response	NA	NA	0	520	0	520	NA	NA	1	248	
60	TCGA-BA-5556	0	7	1	1	0	4	0	0	6	114	7	0	4	36	1	0	TCGA-BA-5556-01	43	0.10084395582561276	5	TCGA-BA-5556-01	4	7	4	0.07708066219508082	TCGA-BA-5556-01	0	0	0	0	PASS	3253	TCGA-BA-5556	HNSC	58	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-21444	Alive	TUMOR FREE	725	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	725	0	725	0	725	0	725	
40	TCGA-BA-5557	0	0	0	2	0	0	1	0	2	33	1	0	0	17	2	0	TCGA-BA-5557-01	85	0.2347817624766861	36	TCGA-BA-5557-01	5	7	9	0.07564904861329995	TCGA-BA-5557-01	6	3	6	15	PASS	3254	TCGA-BA-5557	HNSC	41	FEMALE	NA	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-15247	Alive	TUMOR FREE	623	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	623	0	623	NA	NA	0	623	
70	TCGA-BA-5558	1	10	1	5	3	0	0	0	10	106	8	0	2	64	1	0	TCGA-BA-5558-01	107	0.25582178627939983	55	TCGA-BA-5558-01	9	10	19	0.13556171490318092	TCGA-BA-5558-01	11	5	7	23	PASS	3255	TCGA-BA-5558	HNSC	65	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2006	NA	-23984	Alive	TUMOR FREE	1995	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1995	0	1995	NA	NA	0	1995	
70	TCGA-BA-5559	0	2	1	5	1	0	0	0	2	53	6	1	2	24	0	0	TCGA-BA-5559-01	107	0.6216346064769309	48	TCGA-BA-5559-01	13	26	23	0.32783840925766905	TCGA-BA-5559-01	8	6	2	16	PASS	3256	TCGA-BA-5559	HNSC	71	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2006	NA	-26286	Dead	WITH TUMOR	NA	2083	NA	NA	Oropharynx	NA	1614	Complete Remission/Response	NA	NA	1	2083	1	2083	NA	NA	1	1614	
50	TCGA-BA-6868	1	7	0	4	2	1	2	0	5	121	9	0	4	46	1	0	TCGA-BA-6868-01	432	0.7305691263496824	305	TCGA-BA-6868-01	14	21	94	0.2743061967506717	TCGA-BA-6868-01	23	11	13	47	PASS	3257	TCGA-BA-6868	HNSC	53	MALE	BLACK OR AFRICAN AMERICAN	NA	Stage IVB	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-19608	Dead	WITH TUMOR	NA	472	NA	NA	Distant Metastasis	L neck subdermal mets	344	Partial Remission/Response	NA	NA	1	472	1	472	NA	NA	1	344	
60	TCGA-BA-6869	1	17	4	15	9	5	1	0	19	364	30	0	13	134	11	1	TCGA-BA-6869-01	141	0.218232386779721	70	TCGA-BA-6869-01	5	21	31	0.24023759907114495	TCGA-BA-6869-01	8	7	8	23	PASS	3258	TCGA-BA-6869	HNSC	62	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-22765	Alive	TUMOR FREE	644	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	644	0	644	0	644	0	644	
60	TCGA-BA-6870	0	2	0	5	3	5	2	0	0	65	4	0	3	26	2	0	TCGA-BA-6870-01	216	0.4614836125656802	127	TCGA-BA-6870-01	23	27	50	0.21498134382415046	TCGA-BA-6870-01	17	7	11	35	PASS	3259	TCGA-BA-6870	HNSC	60	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IVC	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-22222	Dead	NA	NA	451	NA	NA	NA	NA	NA	NA	NA	NA	1	451	NA	451	NA	NA	0	451	
80	TCGA-BA-6871	0	6	0	2	3	1	0	0	3	108	6	0	0	35	7	0	TCGA-BA-6871-01	223	0.7108008987900316	125	TCGA-BA-6871-01	20	41	23	0.13844626100365054	TCGA-BA-6871-01	14	11	4	29	PASS	3260	TCGA-BA-6871	HNSC	75	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-27708	Dead	WITH TUMOR	NA	108	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	108	1	108	NA	NA	1	108	
50	TCGA-BA-6872	0	15	0	4	6	2	2	0	7	135	6	0	5	33	4	0	TCGA-BA-6872-01	290	0.6123593075024073	167	TCGA-BA-6872-01	14	25	49	0.20411243702417725	TCGA-BA-6872-01	13	10	6	29	PASS	3261	TCGA-BA-6872	HNSC	47	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2004	NA	-17296	Dead	WITH TUMOR	NA	384	NA	NA	NA	NA	NA	NA	NA	NA	1	384	1	384	NA	NA	1	384	
30	TCGA-BA-6873	0	4	0	0	4	1	2	0	2	45	4	1	1	19	0	0	TCGA-BA-6873-01	136	0.48477905444189207	70	TCGA-BA-6873-01	19	22	10	0.06429897812791427	TCGA-BA-6873-01	11	4	4	19	PASS	3262	TCGA-BA-6873	HNSC	28	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-10512	Alive	WITH TUMOR	122	NA	NA	NA	Oral Cavity	L Tongue and bilat. neck LNs	66	Progressive Disease	NA	NA	0	122	0	122	NA	NA	1	66	
60	TCGA-BA-7269	2	4	1	1	3	1	0	0	1	69	5	0	2	25	1	0	TCGA-BA-7269-01	276	0.7134587599016159	150	TCGA-BA-7269-01	21	35	75	0.2863790997793481	TCGA-BA-7269-01	16	10	8	34	PASS	3263	TCGA-BA-7269	HNSC	61	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2010	NA	-22609	Alive	TUMOR FREE	1273	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1273	0	1273	0	1273	0	1273	
60	TCGA-BA-A4IF	1	7	0	2	3	1	1	0	1	76	6	0	1	20	1	0	TCGA-BA-A4IF-01	111	0.4480059640059485	55	TCGA-BA-A4IF-01	21	27	53	0.1918129248933962	TCGA-BA-A4IF-01	12	9	7	28	PASS	3264	TCGA-BA-A4IF	HNSC	59	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-21635	Alive	TUMOR FREE	895	NA	NA	New Primary Tumor	NA	LUL Lung	463	Complete Remission/Response	NA	NA	0	895	0	895	NA	NA	1	463	
80	TCGA-BA-A4IG	3	10	1	5	6	0	0	0	9	88	10	0	2	41	2	0	TCGA-BA-A4IG-01	165	0.4072563778288979	86	TCGA-BA-A4IG-01	6	12	89	0.2816291873986085	TCGA-BA-A4IG-01	13	12	15	40	PASS	3265	TCGA-BA-A4IG	HNSC	77	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2011	NA	-28402	Alive	TUMOR FREE	855	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	855	0	855	NA	NA	0	855	
60	TCGA-BA-A4IH	0	3	0	2	1	0	0	0	0	41	2	0	0	9	0	0	TCGA-BA-A4IH-01	154	0.8304380823284284	87	TCGA-BA-A4IH-01	9	9	96	0.2069067821256019	TCGA-BA-A4IH-01	7	3	8	18	PASS	3266	TCGA-BA-A4IH	HNSC	57	MALE	WHITE	[Discrepancy]	Stage IVA	Head & Neck Squamous Cell Carcinoma Basaloid Type	G3	2012	NA	-21094	Alive	TUMOR FREE	622	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	622	0	622	NA	NA	0	622	
50	TCGA-BA-A4II	0	6	2	0	3	1	0	0	2	74	6	0	0	35	4	0	TCGA-BA-A4II-01	224	0.32728950859352113	115	TCGA-BA-A4II-01	11	14	125	0.3786181315425298	TCGA-BA-A4II-01	14	10	11	35	PASS	3267	TCGA-BA-A4II	HNSC	46	MALE	WHITE	Stage II	Stage I	Head & Neck Squamous Cell Carcinoma	G1	2011	NA	-17011	Alive	WITH TUMOR	918	NA	NA	Locoregional Disease	Oral Cavity	L FOM	197	Complete Remission/Response	NA	NA	0	918	0	918	1	197	1	197	
60	TCGA-BA-A6D8	0	6	1	10	2	4	0	0	5	85	9	0	6	24	4	0	TCGA-BA-A6D8-01	244	0.8168212063310417	162	TCGA-BA-A6D8-01	15	23	161	0.35705135519341274	TCGA-BA-A6D8-01	21	11	12	44	PASS	3268	TCGA-BA-A6D8	HNSC	59	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-21778	Alive	WITH TUMOR	850	NA	NA	Distant Metastasis	Oral Cavity	R Floor of Mouth	849	Complete Remission/Response	NA	NA	0	850	0	850	NA	NA	1	849	
40	TCGA-BA-A6DA	3	30	4	18	23	5	1	0	27	523	37	2	17	198	20	1	TCGA-BA-A6DA-01	115	0.3386354749336668	55	TCGA-BA-A6DA-01	7	13	49	0.17647017898166514	TCGA-BA-A6DA-01	10	4	3	17	PASS	3269	TCGA-BA-A6DA	HNSC	41	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-15004	Alive	TUMOR FREE	351	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	351	0	351	NA	NA	0	351	
30	TCGA-BA-A6DB	0	1	0	0	0	0	0	0	0	16	2	0	0	5	0	0	TCGA-BA-A6DB-01	83	0.10837599344949844	30	TCGA-BA-A6DB-01	8	14	12	0.010338478176373976	TCGA-BA-A6DB-01	5	8	1	14	PASS	3270	TCGA-BA-A6DB	HNSC	24	FEMALE	WHITE	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2012	NA	-8967	Alive	WITH TUMOR	216	NA	NA	Locoregional Disease	Cervical Lymph Nodes	NA	208	Complete Remission/Response	NA	NA	0	216	0	216	1	208	1	208	
40	TCGA-BA-A6DD	0	1	0	0	0	0	0	0	1	50	0	0	0	17	3	0	TCGA-BA-A6DD-01	79	0.2367472365405913	29	TCGA-BA-A6DD-01	9	13	75	0.20864131562599625	TCGA-BA-A6DD-01	11	7	8	26	PASS	3271	TCGA-BA-A6DD	HNSC	44	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-16401	Dead	WITH TUMOR	NA	173	NA	NA	Cervical Lymph Nodes	NA	96	Progressive Disease	NA	NA	1	173	1	173	NA	NA	1	96	
70	TCGA-BA-A6DE	1	7	0	2	4	1	0	0	6	91	5	0	4	36	3	0	TCGA-BA-A6DE-01	177	0.8604979767499585	84	TCGA-BA-A6DE-01	8	17	124	0.4034229608501786	TCGA-BA-A6DE-01	18	9	14	41	PASS	3272	TCGA-BA-A6DE	HNSC	70	FEMALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-25874	Alive	TUMOR FREE	440	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	440	0	440	0	440	0	440	
80	TCGA-BA-A6DF	0	9	1	2	4	2	4	0	6	116	13	0	0	37	2	0	TCGA-BA-A6DF-01	136	0.02908578733960729	72	TCGA-BA-A6DF-01	1	7	75	0.22416824158228602	TCGA-BA-A6DF-01	0	1	0	1	PASS	3273	TCGA-BA-A6DF	HNSC	80	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-29283	Dead	TUMOR FREE	NA	238	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	238	0	238	NA	NA	0	238	
50	TCGA-BA-A6DG	1	1	0	0	0	0	0	0	3	19	3	0	0	12	0	0	TCGA-BA-A6DG-01	51	0.12151754818816207	12	TCGA-BA-A6DG-01	5	12	20	0.09492923713075796	TCGA-BA-A6DG-01	6	3	3	12	PASS	3274	TCGA-BA-A6DG	HNSC	49	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-18052	Dead	WITH TUMOR	NA	69	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	69	1	69	NA	NA	1	69	
60	TCGA-BA-A6DI	2	4	0	2	1	2	0	0	3	81	8	0	3	20	1	1	TCGA-BA-A6DI-01	106	0.4361774459252534	50	TCGA-BA-A6DI-01	12	14	109	0.4286572262192144	TCGA-BA-A6DI-01	9	5	10	24	PASS	3275	TCGA-BA-A6DI	HNSC	62	MALE	BLACK OR AFRICAN AMERICAN	NA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-22857	Dead	WITH TUMOR	NA	336	NA	NA	Larynx	NA	266	Complete Remission/Response	NA	NA	1	336	1	336	1	266	1	266	
60	TCGA-BA-A6DJ	1	9	3	9	5	4	1	0	8	195	15	0	3	93	4	1	TCGA-BA-A6DJ-01	70	0.07855288885337026	26	TCGA-BA-A6DJ-01	2	3	36	0.07661462616692212	TCGA-BA-A6DJ-01	4	3	3	10	PASS	3276	TCGA-BA-A6DJ	HNSC	62	MALE	ASIAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-22967	Dead	WITH TUMOR	NA	407	NA	NA	Distant Metastasis	Lungs	240	Complete Remission/Response	NA	NA	1	407	1	407	NA	NA	1	240	
60	TCGA-BA-A6DL	2	4	0	4	2	0	0	1	5	67	4	0	2	21	4	0	TCGA-BA-A6DL-01	109	0.6063623945423335	52	TCGA-BA-A6DL-01	19	25	81	0.2475941419597052	TCGA-BA-A6DL-01	14	7	10	31	PASS	3277	TCGA-BA-A6DL	HNSC	59	MALE	WHITE	NA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-21886	Alive	TUMOR FREE	623	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	623	0	623	0	623	0	623	
50	TCGA-BA-A8YP	0	6	3	8	2	0	1	1	10	113	7	1	3	42	5	1	TCGA-BA-A8YP-01	553	0.7111114063272508	393	TCGA-BA-A8YP-01	13	35	301	0.4580898905225684	TCGA-BA-A8YP-01	25	23	19	67	PASS	3278	TCGA-BA-A8YP	HNSC	50	MALE	BLACK OR AFRICAN AMERICAN	Stage IVB	Stage IVB	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-18355	Alive	TUMOR FREE	499	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	499	0	499	NA	NA	0	499	
70	TCGA-BB-4217	0	1	0	2	1	1	0	0	1	25	0	0	0	11	0	0	TCGA-BB-4217-01	77	0.068546844445825	28	TCGA-BB-4217-01	3	6	4	0.02740535932639531	TCGA-BB-4217-01	2	4	2	8	PASS	3279	TCGA-BB-4217	HNSC	68	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2008	NA	-25020	Alive	WITH TUMOR	187	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	187	0	187	NA	NA	0	187	
50	TCGA-BB-4223	1	18	1	8	0	2	0	0	8	157	15	0	1	65	3	0	TCGA-BB-4223-01	195	0.3978730961626112	126	TCGA-BB-4223-01	11	8	17	0.05536817036931471	TCGA-BB-4223-01	3	3	4	10	PASS	3280	TCGA-BB-4223	HNSC	48	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2003	NA	-17608	Alive	TUMOR FREE	3221	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3221	0	3221	NA	NA	0	3221	
50	TCGA-BB-4224	0	4	1	5	3	0	1	0	5	60	6	0	1	19	2	0	TCGA-BB-4224-01	208	0.4615435182014991	114	TCGA-BB-4224-01	16	37	29	0.2632129290048552	TCGA-BB-4224-01	16	9	12	37	PASS	3281	TCGA-BB-4224	HNSC	52	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2004	NA	-19119	Alive	WITH TUMOR	278	NA	NA	NA	Oral Cavity	NA	175	Progressive Disease	NA	NA	0	278	0	278	NA	NA	1	175	
70	TCGA-BB-4225	0	4	0	1	0	0	0	0	3	53	2	0	0	27	1	1	TCGA-BB-4225-01	127	0.8601086752484726	70	TCGA-BB-4225-01	25	21	22	0.17188049429775526	TCGA-BB-4225-01	5	4	2	11	PASS	3282	TCGA-BB-4225	HNSC	73	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2003	NA	-26687	Alive	WITH TUMOR	146	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	146	0	146	NA	NA	0	146	
70	TCGA-BB-4227	0	18	1	14	4	2	1	0	9	177	17	0	2	96	2	0	TCGA-BB-4227-01	255	0.6168011235571886	154	TCGA-BB-4227-01	7	14	58	0.34141161536981257	TCGA-BB-4227-01	13	10	12	35	PASS	3283	TCGA-BB-4227	HNSC	66	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-24322	Alive	WITH TUMOR	134	NA	NA	Locoregional Recurrence	Hypopharynx	NA	85	Stable Disease	NA	NA	0	134	0	134	NA	NA	1	85	
50	TCGA-BB-4228	1	2	1	2	0	0	2	0	5	30	4	0	2	9	0	0	TCGA-BB-4228-01	137	0.1662691701386284	71	TCGA-BB-4228-01	2	6	18	0.09378442760063742	TCGA-BB-4228-01	4	11	8	23	PASS	3284	TCGA-BB-4228	HNSC	50	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	GX	2010	NA	-18536	Alive	TUMOR FREE	559	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	559	0	559	0	559	0	559	
60	TCGA-BB-7861	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BB-7861-01	118	0.3293405045214619	60	TCGA-BB-7861-01	14	16	27	0.1711555290787283	TCGA-BB-7861-01	9	8	7	24	PASS	3285	TCGA-BB-7861	HNSC	56	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	NA	2011	NA	-20563	Alive	TUMOR FREE	682	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	682	0	682	0	682	0	682	
70	TCGA-BB-7862	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BB-7862-01	194	0.8296064974363009	103	TCGA-BB-7862-01	11	17	41	0.34230831558448593	TCGA-BB-7862-01	14	7	11	32	PASS	3286	TCGA-BB-7862	HNSC	67	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2011	NA	-24823	Alive	TUMOR FREE	1117	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1117	0	1117	NA	NA	0	1117	
40	TCGA-BB-7863	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BB-7863-01	100	0.12947850969605154	45	TCGA-BB-7863-01	5	8	18	0.16312372962388505	TCGA-BB-7863-01	6	4	4	14	PASS	3287	TCGA-BB-7863	HNSC	43	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-15899	Alive	TUMOR FREE	1025	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1025	0	1025	0	1025	0	1025	
60	TCGA-BB-7864	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BB-7864-01	134	0.28277129050595423	61	TCGA-BB-7864-01	7	10	22	0.1816880007663532	TCGA-BB-7864-01	9	8	7	24	PASS	3288	TCGA-BB-7864	HNSC	61	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-22317	Alive	TUMOR FREE	1527	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1527	0	1527	NA	NA	0	1527	
40	TCGA-BB-7866	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BB-7866-01	113	0.12084843898146905	52	TCGA-BB-7866-01	2	6	15	0.10381956227874774	TCGA-BB-7866-01	6	3	6	15	PASS	3289	TCGA-BB-7866	HNSC	40	MALE	WHITE	NA	Stage III	Head & Neck Squamous Cell Carcinoma	GX	2010	NA	-14810	Alive	TUMOR FREE	1368	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1368	0	1368	0	1368	0	1368	
60	TCGA-BB-7870	2	21	0	9	9	2	4	0	6	217	12	0	8	78	7	0	TCGA-BB-7870-01	280	0.705465261381762	170	TCGA-BB-7870-01	14	17	13	0.06941038597737273	TCGA-BB-7870-01	11	3	2	16	PASS	3290	TCGA-BB-7870	HNSC	58	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2009	NA	-21443	Alive	TUMOR FREE	2016	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2016	0	2016	NA	NA	0	2016	
60	TCGA-BB-7871	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BB-7871-01	170	0.4612935396699021	84	TCGA-BB-7871-01	9	17	34	0.3844765009091836	TCGA-BB-7871-01	13	10	10	33	PASS	3291	TCGA-BB-7871	HNSC	64	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-23409	Alive	WITH TUMOR	750	NA	NA	Distant Metastasis	Distant Metastasis	Pulmonary	428	Complete Remission/Response	NA	NA	0	750	0	750	NA	NA	1	428	
60	TCGA-BB-7872	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BB-7872-01	140	0.2410271020883973	66	TCGA-BB-7872-01	7	8	18	0.1570177931636433	TCGA-BB-7872-01	8	5	9	22	PASS	3292	TCGA-BB-7872	HNSC	63	MALE	ASIAN	Stage I	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2011	NA	-23185	Alive	TUMOR FREE	1168	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1168	0	1168	NA	NA	0	1168	
70	TCGA-BB-8596	0	7	0	2	1	0	0	0	3	65	5	0	2	34	1	0	TCGA-BB-8596-01	59	0.5493734601945426	17	TCGA-BB-8596-01	32	21	37	0.17602999037427008	TCGA-BB-8596-01	14	12	7	33	PASS	3293	TCGA-BB-8596	HNSC	69	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2005	NA	-25408	Alive	TUMOR FREE	2161	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2161	0	2161	NA	NA	0	2161	
80	TCGA-BB-8601	3	4	0	0	2	2	0	0	1	44	5	0	0	21	2	0	TCGA-BB-8601-01	126	0.7166421345179568	64	TCGA-BB-8601-01	15	14	102	0.4379338075660793	TCGA-BB-8601-01	9	1	5	15	PASS	3294	TCGA-BB-8601	HNSC	84	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-30721	Alive	WITH TUMOR	624	NA	NA	Locoregional Disease	Oral Cavity	NA	440	Progressive Disease	NA	NA	0	624	0	624	NA	NA	1	440	
50	TCGA-BB-A5HU	0	14	2	9	0	0	0	0	14	140	13	0	0	56	1	0	TCGA-BB-A5HU-01	148	0.4523539192578192	79	TCGA-BB-A5HU-01	16	25	61	0.18709029096085086	TCGA-BB-A5HU-01	18	12	10	40	PASS	3295	TCGA-BB-A5HU	HNSC	47	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-17502	Alive	TUMOR FREE	782	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	782	0	782	NA	NA	0	782	
60	TCGA-BB-A5HY	0	24	1	8	6	3	1	0	10	160	8	0	2	55	3	0	TCGA-BB-A5HY-01	256	0.93708977430784	161	TCGA-BB-A5HY-01	20	38	200	0.6775895009713051	TCGA-BB-A5HY-01	26	20	26	72	PASS	3296	TCGA-BB-A5HY	HNSC	64	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2012	NA	-23640	Dead	WITH TUMOR	NA	321	NA	Distant Metastasis	Distant Metastasis	Cerebellum	230	Complete Remission/Response	NA	NA	1	321	1	321	NA	NA	1	230	
70	TCGA-BB-A5HZ	1	4	0	5	6	1	2	0	1	47	3	0	2	27	0	0	TCGA-BB-A5HZ-01	74	0.4311257869435285	23	TCGA-BB-A5HZ-01	13	20	31	0.12421686754699195	TCGA-BB-A5HZ-01	13	12	3	28	PASS	3297	TCGA-BB-A5HZ	HNSC	65	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-23906	Alive	WITH TUMOR	827	NA	NA	Distant Metastasis	Distant Metastasis	Adrenal Gland	438	Complete Remission/Response	NA	NA	0	827	0	827	NA	NA	1	438	
50	TCGA-BB-A6UM	0	6	0	1	0	0	0	0	3	49	5	0	2	22	1	0	TCGA-BB-A6UM-01	110	0.15562660705878875	56	TCGA-BB-A6UM-01	3	6	30	0.11267004014359465	TCGA-BB-A6UM-01	7	5	5	17	PASS	3298	TCGA-BB-A6UM	HNSC	52	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	GX	2010	NA	-19194	Alive	TUMOR FREE	393	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	393	0	393	0	393	0	393	
60	TCGA-BB-A6UO	0	9	0	2	4	5	0	0	5	80	5	0	1	36	5	0	TCGA-BB-A6UO-01	82	0.2750370746463009	35	TCGA-BB-A6UO-01	9	9	52	0.14841326178989178	TCGA-BB-A6UO-01	7	5	9	21	PASS	3299	TCGA-BB-A6UO	HNSC	61	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-22506	Dead	WITH TUMOR	NA	268	NA	NA	Distant Metastasis	Lung	212	Complete Remission/Response	NA	NA	1	268	1	268	NA	NA	1	212	
70	TCGA-C9-A47Z	0	2	4	5	0	2	1	0	5	84	2	0	2	30	3	0	TCGA-C9-A47Z-01	99	0.8891023481185084	44	TCGA-C9-A47Z-01	19	24	39	0.12061603499071825	TCGA-C9-A47Z-01	10	7	2	19	PASS	3300	TCGA-C9-A47Z	HNSC	72	FEMALE	ASIAN	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2011	NA	-26592	Dead	TUMOR FREE	NA	191	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	191	0	191	0	191	0	191	
50	TCGA-C9-A480	0	4	0	2	2	0	0	0	1	37	2	0	1	18	0	0	TCGA-C9-A480-01	88	0.19926539102387344	31	TCGA-C9-A480-01	4	4	59	0.12487532219313666	TCGA-C9-A480-01	5	5	4	14	PASS	3301	TCGA-C9-A480	HNSC	45	FEMALE	ASIAN	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2011	NA	-16567	Alive	TUMOR FREE	386	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	386	0	386	0	386	0	386	
60	TCGA-CN-4722	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CN-4722-01	90	0.07421605624767609	41	TCGA-CN-4722-01	2	4	4	0.022063303526153842	TCGA-CN-4722-01	2	1	0	3	PASS	3302	TCGA-CN-4722	HNSC	61	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2010	NA	-22299	Alive	TUMOR FREE	1483	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1483	0	1483	0	1483	0	1483	
70	TCGA-CN-4723	4	43	4	29	8	4	1	0	37	626	77	1	8	261	12	1	TCGA-CN-4723-01	226	0.34988311649613063	137	TCGA-CN-4723-01	8	14	33	0.26082839536172264	TCGA-CN-4723-01	14	11	9	34	hypermutated sample	3303	TCGA-CN-4723	HNSC	67	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-24815	Alive	TUMOR FREE	1699	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1699	0	1699	NA	NA	0	1699	
60	TCGA-CN-4725	0	2	0	0	3	2	0	0	1	40	2	0	0	20	1	0	TCGA-CN-4725-01	175	0.8773077424489577	95	TCGA-CN-4725-01	27	24	8	0.07022866776076031	TCGA-CN-4725-01	9	6	2	17	PASS	3304	TCGA-CN-4725	HNSC	60	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-22171	Alive	TUMOR FREE	1157	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1157	0	1157	0	1157	0	1157	
70	TCGA-CN-4726	0	9	0	3	3	1	0	0	3	44	3	0	1	22	2	0	TCGA-CN-4726-01	107	0.2439739289047692	50	TCGA-CN-4726-01	7	7	17	0.1422516656342839	TCGA-CN-4726-01	11	5	6	22	PASS	3305	TCGA-CN-4726	HNSC	68	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-25194	Dead	WITH TUMOR	NA	142	NA	NA	Distant Metastasis	SKIN NECK	79	Progressive Disease	NA	NA	1	142	1	142	NA	NA	1	79	
60	TCGA-CN-4727	3	20	2	11	17	3	0	0	9	320	25	0	7	114	17	0	TCGA-CN-4727-01	165	0.5232932221488389	85	TCGA-CN-4727-01	15	26	17	0.12409931971839062	TCGA-CN-4727-01	16	6	7	29	PASS	3306	TCGA-CN-4727	HNSC	56	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-20748	Alive	TUMOR FREE	1560	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1560	0	1560	NA	NA	0	1560	
60	TCGA-CN-4728	2	4	0	5	3	5	1	0	1	97	6	0	5	35	2	0	TCGA-CN-4728-01	130	0.44262905765737803	61	TCGA-CN-4728-01	12	27	28	0.2594014754023572	TCGA-CN-4728-01	11	4	6	21	PASS	3307	TCGA-CN-4728	HNSC	56	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-20660	Alive	TUMOR FREE	1724	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1724	0	1724	NA	NA	0	1724	
70	TCGA-CN-4729	1	10	0	5	4	2	3	0	3	102	5	0	3	55	2	0	TCGA-CN-4729-01	239	0.5184071015576807	144	TCGA-CN-4729-01	21	29	40	0.25658941324797513	TCGA-CN-4729-01	20	12	7	39	PASS	3308	TCGA-CN-4729	HNSC	73	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-26713	Alive	TUMOR FREE	392	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	392	0	392	NA	NA	0	392	
60	TCGA-CN-4730	3	17	0	6	1	3	0	0	4	125	10	0	1	42	2	0	TCGA-CN-4730-01	102	0.4369767194526152	45	TCGA-CN-4730-01	19	28	11	0.2982124043354276	TCGA-CN-4730-01	7	1	6	14	PASS	3309	TCGA-CN-4730	HNSC	62	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-22828	Alive	TUMOR FREE	817	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	817	0	817	NA	NA	0	817	
60	TCGA-CN-4731	0	6	0	3	7	2	2	0	4	69	10	0	2	43	4	0	TCGA-CN-4731-01	177	0.31450812702561004	102	TCGA-CN-4731-01	9	16	24	0.2618135273655332	TCGA-CN-4731-01	8	7	7	22	PASS	3310	TCGA-CN-4731	HNSC	63	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-23194	Dead	WITH TUMOR	NA	998	NA	NA	Oral Cavity	NA	243	Persistent Disease	NA	NA	1	998	1	998	NA	NA	1	243	
60	TCGA-CN-4733	0	0	0	0	1	0	0	0	1	18	3	0	0	10	1	0	TCGA-CN-4733-01	39	8.131845838190242e-06	8	TCGA-CN-4733-01	1	3	2	0.06818032239479463	TCGA-CN-4733-01	1	0	0	1	PASS	3311	TCGA-CN-4733	HNSC	61	MALE	WHITE	Stage III	Stage I	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-22561	Alive	TUMOR FREE	1586	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1586	0	1586	0	1586	0	1586	
70	TCGA-CN-4734	1	10	0	7	2	1	0	0	9	105	12	0	0	52	4	0	TCGA-CN-4734	0	0	0	TCGA-CN-4734	0	0	0	0	TCGA-CN-4734	0	0	0	0	PASS	3312	TCGA-CN-4734	HNSC	70	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-25753	Alive	TUMOR FREE	1690	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1690	0	1690	0	1690	0	1690	
50	TCGA-CN-4735	0	14	2	0	1	0	0	0	5	107	9	0	4	41	2	1	TCGA-CN-4735-01	185	0.5702755415748086	96	TCGA-CN-4735-01	8	13	63	0.2906535448441239	TCGA-CN-4735-01	13	6	9	28	PASS	3313	TCGA-CN-4735	HNSC	52	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-19107	Alive	TUMOR FREE	1737	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1737	0	1737	NA	NA	0	1737	
70	TCGA-CN-4736	0	4	0	1	2	0	0	0	4	78	5	0	2	18	3	0	TCGA-CN-4736-01	143	0.3465443552976751	70	TCGA-CN-4736-01	4	10	17	0.17372286998198794	TCGA-CN-4736-01	8	5	6	19	PASS	3314	TCGA-CN-4736	HNSC	70	FEMALE	WHITE	NA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-25683	Dead	WITH TUMOR	NA	395	NA	NA	Cervical Lymph Nodes	R NECK	209	Complete Remission/Response	NA	NA	1	395	1	395	1	209	1	209	
20	TCGA-CN-4737	0	4	1	2	2	0	1	0	2	32	1	0	0	14	0	0	TCGA-CN-4737-01	167	0.6895243499524444	83	TCGA-CN-4737-01	24	27	18	0.11198748455765804	TCGA-CN-4737-01	10	4	5	19	PASS	3315	TCGA-CN-4737	HNSC	19	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-7301	Alive	TUMOR FREE	625	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	625	0	625	NA	NA	0	625	
50	TCGA-CN-4738	1	2	0	4	1	1	0	0	5	72	4	0	2	35	3	0	TCGA-CN-4738-01	88	0.17878691283690448	34	TCGA-CN-4738-01	8	17	15	0.2541697425786963	TCGA-CN-4738-01	9	6	6	21	PASS	3316	TCGA-CN-4738	HNSC	53	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-19621	Dead	NA	NA	436	NA	NA	NA	NA	NA	NA	NA	NA	1	436	NA	436	NA	NA	0	436	
70	TCGA-CN-4739	0	19	0	8	4	2	0	0	6	157	11	0	6	65	8	1	TCGA-CN-4739-01	105	0.4829152180783259	41	TCGA-CN-4739-01	14	13	23	0.4188242721071425	TCGA-CN-4739-01	8	2	5	15	PASS	3317	TCGA-CN-4739	HNSC	71	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-26081	Dead	WITH TUMOR	NA	1394	NA	Locoregional Recurrence	Oropharynx	"OROPHARYNX, OVERLAPPING"	1302	Complete Remission/Response	NA	NA	1	1394	1	1394	NA	NA	1	1302	
80	TCGA-CN-4740	0	8	1	1	1	2	0	0	4	117	7	0	1	39	3	0	TCGA-CN-4740-01	156	0.4674243659270535	78	TCGA-CN-4740-01	18	24	15	0.14739716700602284	TCGA-CN-4740-01	6	4	4	14	PASS	3318	TCGA-CN-4740	HNSC	79	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-29186	Dead	WITH TUMOR	NA	839	NA	NA	NA	PTERYGOID FOSSA	224	Complete Remission/Response	NA	NA	1	839	1	839	NA	NA	1	224	
80	TCGA-CN-4741	0	8	0	8	0	0	0	0	5	104	6	0	3	40	2	0	TCGA-CN-4741-01	93	0.15434911335435525	39	TCGA-CN-4741-01	4	14	9	0.06952416237032928	TCGA-CN-4741-01	5	3	3	11	PASS	3319	TCGA-CN-4741	HNSC	75	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-27506	Alive	TUMOR FREE	2239	NA	NA	Locoregional Recurrence	Cervical Lymph Nodes	R NECK	1716	Complete Remission/Response	NA	NA	0	2239	0	2239	NA	NA	1	1716	
50	TCGA-CN-4742	0	4	0	8	1	1	0	0	3	55	7	0	1	16	0	0	TCGA-CN-4742-01	144	0.5526257906276143	73	TCGA-CN-4742-01	13	24	18	0.21997707644283745	TCGA-CN-4742-01	12	9	6	27	PASS	3320	TCGA-CN-4742	HNSC	48	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2008	NA	-17793	Dead	WITH TUMOR	NA	397	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	397	1	397	NA	NA	1	397	
60	TCGA-CN-5355	2	5	0	4	1	4	0	0	2	83	4	0	3	27	3	0	TCGA-CN-5355-01	143	0.4559702264147456	78	TCGA-CN-5355-01	7	7	25	0.19777391104979264	TCGA-CN-5355-01	7	7	6	20	PASS	3321	TCGA-CN-5355	HNSC	64	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-23670	Alive	TUMOR FREE	1278	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1278	0	1278	NA	NA	0	1278	
60	TCGA-CN-5356	1	18	2	11	8	8	0	0	8	256	30	0	8	99	9	2	TCGA-CN-5356-01	148	0.6669602402460303	68	TCGA-CN-5356-01	21	22	17	0.17621840061525745	TCGA-CN-5356-01	10	9	7	26	PASS	3322	TCGA-CN-5356	HNSC	56	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-20540	Alive	TUMOR FREE	1409	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1409	0	1409	0	1409	0	1409	
60	TCGA-CN-5358	0	3	0	1	1	0	0	0	2	29	4	0	0	11	0	0	TCGA-CN-5358-01	68	0.047306116833243615	24	TCGA-CN-5358-01	0	4	6	0.07386162120103068	TCGA-CN-5358-01	0	3	2	5	PASS	3323	TCGA-CN-5358	HNSC	60	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-22138	Dead	TUMOR FREE	NA	261	NA	NA	Cervical Lymph Nodes	NA	145	Complete Remission/Response	NA	NA	1	261	0	261	1	145	1	145	
60	TCGA-CN-5359	1	12	0	6	3	0	3	0	2	116	6	0	1	42	5	0	TCGA-CN-5359-01	191	0.5402122508432602	113	TCGA-CN-5359-01	21	35	33	0.39051831718355945	TCGA-CN-5359-01	15	11	10	36	PASS	3324	TCGA-CN-5359	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-21858	Dead	WITH TUMOR	NA	377	NA	NA	Distant Metastasis	"LUNG, BONES, THUMB"	356	Complete Remission/Response	NA	NA	1	377	1	377	NA	NA	1	356	
70	TCGA-CN-5360	6	21	1	12	15	3	1	0	13	402	28	0	6	140	12	1	TCGA-CN-5360-01	92	0.9444285053170124	34	TCGA-CN-5360-01	18	15	15	0.4379655761531481	TCGA-CN-5360-01	11	3	11	25	PASS	3325	TCGA-CN-5360	HNSC	68	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-25034	Alive	TUMOR FREE	2169	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2169	0	2169	NA	NA	0	2169	
80	TCGA-CN-5361	0	8	1	2	3	3	2	0	3	73	9	0	2	46	0	0	TCGA-CN-5361	0	0	0	TCGA-CN-5361	0	0	0	0	TCGA-CN-5361	0	0	0	0	PASS	3326	TCGA-CN-5361	HNSC	80	MALE	WHITE	Stage IVA	NA	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-29383	Dead	TUMOR FREE	NA	2120	NA	New Primary Tumor	NA	NA	2062	Complete Remission/Response	NA	NA	1	2120	0	2120	NA	NA	1	2062	
50	TCGA-CN-5363	0	7	4	8	9	1	2	0	4	132	7	1	6	57	8	1	TCGA-CN-5363-01	172	0.594092300603705	99	TCGA-CN-5363-01	13	18	44	0.3476747925441727	TCGA-CN-5363-01	9	3	12	24	PASS	3327	TCGA-CN-5363	HNSC	48	MALE	BLACK OR AFRICAN AMERICAN	Stage IVB	Stage IVB	Head & Neck Squamous Cell Carcinoma	G3	2007	NA	-17635	Dead	WITH TUMOR	NA	253	NA	NA	Distant Metastasis	BONE	53	Complete Remission/Response	NA	NA	1	253	1	253	NA	NA	1	53	
60	TCGA-CN-5364	1	14	1	1	1	4	2	0	2	105	13	0	3	25	2	0	TCGA-CN-5364-01	144	0.1862021261308364	82	TCGA-CN-5364-01	5	9	29	0.14053936406333126	TCGA-CN-5364-01	15	11	8	34	PASS	3328	TCGA-CN-5364	HNSC	55	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2006	NA	-20362	Dead	TUMOR FREE	NA	493	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	493	0	493	NA	NA	0	493	
40	TCGA-CN-5365	0	4	0	3	4	1	0	0	3	60	2	0	3	19	2	0	TCGA-CN-5365-01	120	0.27227104363621896	61	TCGA-CN-5365-01	5	19	4	0.026861643400896047	TCGA-CN-5365-01	7	9	2	18	PASS	3329	TCGA-CN-5365	HNSC	38	MALE	WHITE	Stage IVB	Stage IVC	Head & Neck Squamous Cell Carcinoma	G2	2006	NA	-14190	Dead	WITH TUMOR	NA	351	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	351	1	351	NA	NA	1	351	
50	TCGA-CN-5366	0	6	0	3	1	3	1	1	4	74	7	0	1	27	2	0	TCGA-CN-5366-01	113	0.2789297190238011	46	TCGA-CN-5366-01	24	24	13	0.2878429164983996	TCGA-CN-5366-01	13	5	7	25	PASS	3330	TCGA-CN-5366	HNSC	51	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2006	NA	-18904	Dead	WITH TUMOR	NA	360	NA	NA	Cervical Lymph Nodes	L NECK	276	Complete Remission/Response	NA	NA	1	360	1	360	NA	NA	1	276	
60	TCGA-CN-5367	0	6	0	1	3	0	0	0	5	79	4	0	2	27	4	0	TCGA-CN-5367-01	162	0.3894121462631164	72	TCGA-CN-5367-01	9	14	29	0.2913543924025576	TCGA-CN-5367-01	13	5	8	26	PASS	3331	TCGA-CN-5367	HNSC	60	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2006	NA	-22246	Dead	TUMOR FREE	NA	352	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	352	0	352	NA	NA	0	352	
90	TCGA-CN-5369	0	25	1	9	27	3	4	0	12	334	28	3	7	138	5	1	TCGA-CN-5369-01	39	0.0005333549226610579	5	TCGA-CN-5369-01	0	0	4	0.04458881542685368	TCGA-CN-5369-01	2	2	2	6	PASS	3332	TCGA-CN-5369	HNSC	90	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2006	NA	-32871	Dead	TUMOR FREE	NA	380	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	380	0	380	NA	NA	0	380	
80	TCGA-CN-5370	0	4	0	1	3	4	2	0	5	77	9	0	3	24	4	0	TCGA-CN-5370-01	104	0.18668449652086566	49	TCGA-CN-5370-01	4	7	16	0.09322077215838047	TCGA-CN-5370-01	7	5	6	18	PASS	3333	TCGA-CN-5370	HNSC	78	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2006	NA	-28549	Dead	WITH TUMOR	NA	259	NA	NA	Oral Cavity	NA	123	Complete Remission/Response	NA	NA	1	259	1	259	1	123	1	123	
60	TCGA-CN-5373	3	13	0	4	3	4	0	0	5	106	12	1	2	49	0	1	TCGA-CN-5373-01	85	0.1696432793616026	35	TCGA-CN-5373-01	4	4	5	0.07543671373846485	TCGA-CN-5373-01	4	2	4	10	PASS	3334	TCGA-CN-5373	HNSC	55	FEMALE	WHITE	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2010	NA	-20143	Alive	TUMOR FREE	1584	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1584	0	1584	0	1584	0	1584	
60	TCGA-CN-5374	2	8	0	9	0	0	0	0	9	121	9	0	4	56	0	0	TCGA-CN-5374-01	81	0.4423304115918392	30	TCGA-CN-5374-01	24	28	8	0.1992407111150409	TCGA-CN-5374-01	6	1	0	7	PASS	3335	TCGA-CN-5374	HNSC	56	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2007	NA	-20464	Dead	TUMOR FREE	NA	1732	NA	NA	Distant Metastasis	lung	1369	Complete Remission/Response	NA	NA	1	1732	0	1732	NA	NA	1	1369	
50	TCGA-CN-6010	9	62	5	28	2	1	0	1	46	1366	221	2	23	634	48	5	TCGA-CN-6010-01	208	0.5782270350939566	110	TCGA-CN-6010-01	12	33	29	0.2764550930794307	TCGA-CN-6010-01	15	14	10	39	PASS	3336	TCGA-CN-6010	HNSC	53	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-19475	Alive	TUMOR FREE	1523	NA	NA	New Primary Tumor	NA	nasal cavity	540	Complete Remission/Response	NA	NA	0	1523	0	1523	NA	NA	1	540	
60	TCGA-CN-6011	1	20	2	7	2	1	0	0	16	275	27	0	7	103	7	0	TCGA-CN-6011-01	253	0.7584364999614001	140	TCGA-CN-6011-01	14	35	60	0.5001276699274682	TCGA-CN-6011-01	16	11	12	39	PASS	3337	TCGA-CN-6011	HNSC	57	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-21016	Alive	TUMOR FREE	933	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	933	0	933	NA	NA	0	933	
70	TCGA-CN-6012	0	11	1	2	2	2	2	0	1	89	13	0	0	27	1	1	TCGA-CN-6012-01	98	0.7726136315494481	36	TCGA-CN-6012-01	16	16	26	0.5193247736574407	TCGA-CN-6012-01	13	7	14	34	PASS	3338	TCGA-CN-6012	HNSC	66	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-24286	Alive	TUMOR FREE	1460	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1460	0	1460	NA	NA	0	1460	
60	TCGA-CN-6013	1	9	1	3	1	0	0	0	3	148	17	1	3	53	2	1	TCGA-CN-6013-01	114	0.37468175859596103	45	TCGA-CN-6013-01	13	12	17	0.0847795628641927	TCGA-CN-6013-01	11	5	4	20	PASS	3339	TCGA-CN-6013	HNSC	56	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-20703	Dead	WITH TUMOR	NA	727	NA	NA	Distant Metastasis	LUNG	323	Complete Remission/Response	NA	NA	1	727	1	727	NA	NA	1	323	
60	TCGA-CN-6016	0	6	1	2	1	1	0	0	4	97	3	0	1	37	2	0	TCGA-CN-6016-01	77	0.21804520523156987	32	TCGA-CN-6016-01	5	7	15	0.11887250864784042	TCGA-CN-6016-01	8	10	7	25	PASS	3340	TCGA-CN-6016	HNSC	64	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-23664	Alive	TUMOR FREE	1443	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1443	0	1443	NA	NA	0	1443	
60	TCGA-CN-6017	0	0	0	0	0	0	0	0	0	2	0	0	0	2	0	0	TCGA-CN-6017-01	35	0.00013632386811929261	2	TCGA-CN-6017-01	0	0	0	0.0	TCGA-CN-6017-01	0	0	0	0	PASS	3341	TCGA-CN-6017	HNSC	55	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-20358	Dead	TUMOR FREE	NA	853	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	853	0	853	NA	NA	0	853	
90	TCGA-CN-6018	1	7	1	1	5	1	0	1	2	83	3	0	0	36	0	0	TCGA-CN-6018-01	165	0.5896535629207433	90	TCGA-CN-6018-01	17	38	48	0.3791838301658578	TCGA-CN-6018-01	12	7	4	23	PASS	3342	TCGA-CN-6018	HNSC	85	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-31242	Dead	TUMOR FREE	NA	580	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	580	0	580	NA	NA	0	580	
60	TCGA-CN-6019	0	8	1	3	3	2	0	0	2	107	10	0	1	28	3	0	TCGA-CN-6019-01	50	0.28627031381865525	12	TCGA-CN-6019-01	11	13	13	0.3796606885053354	TCGA-CN-6019-01	5	2	7	14	PASS	3343	TCGA-CN-6019	HNSC	61	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-22485	Alive	TUMOR FREE	1038	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1038	0	1038	NA	NA	0	1038	
60	TCGA-CN-6020	2	9	2	2	3	0	1	0	6	110	8	0	2	50	0	0	TCGA-CN-6020-01	167	0.443187240851868	92	TCGA-CN-6020-01	24	38	31	0.2177244052738152	TCGA-CN-6020-01	13	6	7	26	PASS	3344	TCGA-CN-6020	HNSC	58	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-21232	Dead	TUMOR FREE	NA	205	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	205	0	205	NA	NA	0	205	
60	TCGA-CN-6021	2	12	2	8	11	4	1	1	13	218	17	0	5	72	6	0	TCGA-CN-6021-01	111	0.8147764668941211	49	TCGA-CN-6021-01	14	20	22	0.3864152036592281	TCGA-CN-6021-01	10	7	7	24	PASS	3345	TCGA-CN-6021	HNSC	63	FEMALE	WHITE	NA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-23212	Dead	WITH TUMOR	NA	276	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	276	1	276	NA	NA	1	276	
50	TCGA-CN-6022	0	2	0	0	0	0	0	1	2	54	3	0	0	30	4	0	TCGA-CN-6022-01	145	0.3342545212732966	77	TCGA-CN-6022-01	11	25	27	0.10624693358214593	TCGA-CN-6022-01	7	9	6	22	PASS	3346	TCGA-CN-6022	HNSC	49	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-17971	Dead	WITH TUMOR	NA	281	NA	NA	Cervical Lymph Nodes	NA	101	Progressive Disease	NA	NA	1	281	1	281	NA	NA	1	101	
70	TCGA-CN-6023	1	2	1	6	0	1	3	0	5	87	5	0	3	21	5	0	TCGA-CN-6023-01	176	0.7309199320861698	89	TCGA-CN-6023-01	24	32	46	0.5448752070881305	TCGA-CN-6023-01	15	12	10	37	PASS	3347	TCGA-CN-6023	HNSC	73	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2010	NA	-26769	Alive	TUMOR FREE	1584	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1584	0	1584	NA	NA	0	1584	
70	TCGA-CN-6024	0	1	1	4	4	1	1	0	5	111	6	0	3	76	3	0	TCGA-CN-6024-01	294	0.7287918702426196	180	TCGA-CN-6024-01	15	31	47	0.37427846729008335	TCGA-CN-6024-01	23	18	9	50	PASS	3348	TCGA-CN-6024	HNSC	66	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-24259	Dead	WITH TUMOR	NA	337	NA	NA	Cervical Lymph Nodes	NA	156	Progressive Disease	NA	NA	1	337	1	337	NA	NA	1	156	
50	TCGA-CN-6988	0	9	1	6	2	3	1	1	6	157	8	0	3	66	5	0	TCGA-CN-6988-01	156	0.5403436979959364	82	TCGA-CN-6988-01	18	33	17	0.2058066014243977	TCGA-CN-6988-01	11	10	6	27	PASS	3349	TCGA-CN-6988	HNSC	47	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2011	NA	-17308	Alive	TUMOR FREE	318	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	318	0	318	NA	NA	0	318	
60	TCGA-CN-6989	0	7	0	2	2	1	0	0	3	76	7	1	2	32	1	0	TCGA-CN-6989-01	168	0.5137125288268687	85	TCGA-CN-6989-01	17	26	25	0.2449488873739851	TCGA-CN-6989-01	20	14	9	43	PASS	3350	TCGA-CN-6989	HNSC	64	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-23515	Dead	WITH TUMOR	NA	980	NA	NA	NA	NA	436	Complete Remission/Response	NA	NA	1	980	1	980	NA	NA	1	436	
60	TCGA-CN-6992	0	24	1	10	8	1	1	0	20	273	16	1	9	107	7	0	TCGA-CN-6992-01	238	0.8539998391900198	134	TCGA-CN-6992-01	12	21	51	0.40904482932251457	TCGA-CN-6992-01	19	10	18	47	PASS	3351	TCGA-CN-6992	HNSC	61	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-22598	Alive	TUMOR FREE	1066	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1066	0	1066	NA	NA	0	1066	
70	TCGA-CN-6994	1	2	1	3	1	0	2	0	4	92	7	1	5	37	2	0	TCGA-CN-6994-01	149	0.6101057130980849	76	TCGA-CN-6994-01	25	24	24	0.11096414229035093	TCGA-CN-6994-01	9	6	4	19	PASS	3352	TCGA-CN-6994	HNSC	67	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-24778	Alive	TUMOR FREE	1183	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1183	0	1183	NA	NA	0	1183	
80	TCGA-CN-6995	1	15	0	4	4	2	1	0	9	173	16	0	3	52	7	0	TCGA-CN-6995-01	84	0.4908190998373021	36	TCGA-CN-6995-01	20	63	18	0.30998772658039464	TCGA-CN-6995-01	11	4	9	24	PASS	3353	TCGA-CN-6995	HNSC	78	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-28850	Dead	TUMOR FREE	NA	112	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	112	0	112	NA	NA	0	112	
60	TCGA-CN-6996	0	3	0	0	2	0	0	0	3	41	3	0	2	14	2	0	TCGA-CN-6996-01	87	0.2683668130086886	38	TCGA-CN-6996-01	5	6	13	0.1286671669317055	TCGA-CN-6996-01	6	3	4	13	PASS	3354	TCGA-CN-6996	HNSC	58	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-21447	Dead	WITH TUMOR	NA	530	NA	NA	Cervical Lymph Nodes	SUPRASTERNAL NOTCH NODE	350	Complete Remission/Response	NA	NA	1	530	1	530	NA	NA	1	350	
70	TCGA-CN-6997	0	16	1	4	3	3	2	0	7	167	12	0	2	59	4	0	TCGA-CN-6997-01	256	0.9074060822373496	151	TCGA-CN-6997-01	12	20	86	0.5066422685734859	TCGA-CN-6997-01	16	7	9	32	PASS	3355	TCGA-CN-6997	HNSC	66	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2011	NA	-24298	Dead	TUMOR FREE	NA	988	NA	NA	Distant Metastasis	LUNG	279	Complete Remission/Response	NA	NA	1	988	0	988	NA	NA	1	279	
50	TCGA-CN-6998	0	10	0	4	1	2	0	0	5	53	6	0	2	33	1	0	TCGA-CN-6998-01	69	0.4282432253743115	27	TCGA-CN-6998-01	17	49	13	0.11546817397684846	TCGA-CN-6998-01	4	2	2	8	PASS	3356	TCGA-CN-6998	HNSC	53	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-19447	Dead	WITH TUMOR	NA	357	NA	NA	Oropharynx	tonsil	244	Progressive Disease	NA	NA	1	357	1	357	NA	NA	1	244	
60	TCGA-CN-A497	1	18	1	8	13	2	0	0	19	267	15	0	7	88	14	1	TCGA-CN-A497-01	104	0.30719286990579103	48	TCGA-CN-A497-01	11	10	73	0.2448196697694892	TCGA-CN-A497-01	8	2	5	15	PASS	3357	TCGA-CN-A497	HNSC	63	MALE	[Unknown]	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-23310	Alive	TUMOR FREE	1065	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1065	0	1065	NA	NA	0	1065	
60	TCGA-CN-A498	0	10	0	1	3	2	1	0	6	86	12	0	4	32	1	1	TCGA-CN-A498-01	154	0.2755319592486113	80	TCGA-CN-A498-01	5	15	106	0.27939577003743216	TCGA-CN-A498-01	7	3	10	20	PASS	3358	TCGA-CN-A498	HNSC	61	FEMALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2011	NA	-22330	Dead	WITH TUMOR	NA	773	NA	Locoregional Recurrence	Oral Cavity	"tongue, r neck nodes"	186	Complete Remission/Response	NA	NA	1	773	1	773	1	186	1	186	
60	TCGA-CN-A499	1	4	0	1	0	0	3	0	1	29	4	0	1	12	0	0	TCGA-CN-A499-01	107	0.5629696994752847	50	TCGA-CN-A499-01	18	17	39	0.10017549851009724	TCGA-CN-A499-01	6	6	5	17	PASS	3359	TCGA-CN-A499	HNSC	60	FEMALE	WHITE	Stage II	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-21971	Alive	TUMOR FREE	717	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	717	0	717	0	717	0	717	
60	TCGA-CN-A49A	0	8	0	2	2	0	1	0	8	89	11	0	2	35	1	0	TCGA-CN-A49A-01	370	0.5673687870138862	214	TCGA-CN-A49A-01	14	27	120	0.16332410027734492	TCGA-CN-A49A-01	17	20	10	47	PASS	3360	TCGA-CN-A49A	HNSC	60	MALE	WHITE	Stage IVB	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-21995	Dead	WITH TUMOR	NA	526	NA	Distant Metastasis	Distant Metastasis	spine	344	Complete Remission/Response	NA	NA	1	526	1	526	NA	NA	1	344	
70	TCGA-CN-A49B	0	8	0	1	1	0	0	0	12	85	6	0	1	26	0	0	TCGA-CN-A49B-01	118	0.5258779199785416	53	TCGA-CN-A49B-01	7	13	55	0.1974094463753419	TCGA-CN-A49B-01	11	5	8	24	PASS	3361	TCGA-CN-A49B	HNSC	71	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2011	NA	-26155	Alive	TUMOR FREE	904	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	904	0	904	0	904	0	904	
70	TCGA-CN-A49C	0	1	0	1	3	0	2	0	3	39	3	0	0	26	1	0	TCGA-CN-A49C-01	81	0.15837061451776624	28	TCGA-CN-A49C-01	4	4	19	0.07785137910957632	TCGA-CN-A49C-01	5	1	2	8	PASS	3362	TCGA-CN-A49C	HNSC	67	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2012	NA	-24495	Alive	TUMOR FREE	645	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	645	0	645	NA	NA	0	645	
60	TCGA-CN-A63T	3	21	2	7	7	2	1	0	15	187	12	0	7	70	8	0	TCGA-CN-A63T-01	72	0.519845705213603	25	TCGA-CN-A63T-01	19	20	34	0.16884909492885722	TCGA-CN-A63T-01	14	7	6	27	PASS	3363	TCGA-CN-A63T	HNSC	60	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2011	NA	-22201	Alive	TUMOR FREE	225	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	225	0	225	NA	NA	0	225	
50	TCGA-CN-A63U	3	38	2	13	18	7	1	0	25	394	30	0	13	143	14	0	TCGA-CN-A63U-01	274	0.6668712501729238	166	TCGA-CN-A63U-01	12	14	160	0.3829625203977633	TCGA-CN-A63U-01	18	14	18	50	PASS	3364	TCGA-CN-A63U	HNSC	50	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2011	NA	-18272	Alive	TUMOR FREE	964	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	964	0	964	NA	NA	0	964	
60	TCGA-CN-A63V	0	4	0	0	2	1	1	0	4	68	4	0	1	16	2	0	TCGA-CN-A63V-01	53	0.15804559980423796	17	TCGA-CN-A63V-01	7	6	18	0.037923848619436366	TCGA-CN-A63V-01	1	0	1	2	PASS	3365	TCGA-CN-A63V	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-21734	Alive	TUMOR FREE	679	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	679	0	679	NA	NA	0	679	
50	TCGA-CN-A63W	1	25	3	12	10	0	0	0	17	302	18	1	5	112	12	0	TCGA-CN-A63W-01	127	0.7191161020997471	55	TCGA-CN-A63W-01	7	15	93	0.33418669458569616	TCGA-CN-A63W-01	16	10	12	38	PASS	3366	TCGA-CN-A63W	HNSC	48	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-17693	Dead	TUMOR FREE	NA	377	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	377	0	377	NA	NA	0	377	
50	TCGA-CN-A63Y	1	7	1	3	2	0	0	0	3	120	14	0	2	61	2	0	TCGA-CN-A63Y-01	49	0.09579741188502408	7	TCGA-CN-A63Y-01	2	2	21	0.06434551670952418	TCGA-CN-A63Y-01	5	3	0	8	PASS	3367	TCGA-CN-A63Y	HNSC	46	MALE	WHITE	Stage II	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-17125	Alive	TUMOR FREE	504	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	504	0	504	0	504	0	504	
40	TCGA-CN-A640	0	5	0	3	2	1	1	1	1	49	3	0	1	16	0	0	TCGA-CN-A640-01	65	0.2023447093339569	24	TCGA-CN-A640-01	7	11	58	0.15165932416944655	TCGA-CN-A640-01	7	3	6	16	PASS	3368	TCGA-CN-A640	HNSC	40	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-14758	Dead	TUMOR FREE	NA	134	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	134	0	134	NA	NA	0	134	
50	TCGA-CN-A641	1	12	1	8	4	4	0	0	7	160	8	0	2	58	5	1	TCGA-CN-A641-01	103	0.4024163445744499	40	TCGA-CN-A641-01	8	12	50	0.2087249362043632	TCGA-CN-A641-01	10	3	8	21	PASS	3369	TCGA-CN-A641	HNSC	47	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-17454	Alive	TUMOR FREE	367	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	367	0	367	NA	NA	0	367	
60	TCGA-CN-A642	0	2	0	2	2	0	0	0	4	61	6	0	2	18	2	0	TCGA-CN-A642-01	76	0.08241065340651225	30	TCGA-CN-A642-01	3	7	31	0.07089205492223663	TCGA-CN-A642-01	5	1	3	9	PASS	3370	TCGA-CN-A642	HNSC	57	MALE	WHITE	Stage IVB	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2012	NA	-21011	Dead	WITH TUMOR	NA	82	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	82	1	82	NA	NA	1	82	
60	TCGA-CN-A6UY	0	3	0	1	0	1	0	0	0	29	1	0	0	16	0	0	TCGA-CN-A6UY-01	106	0.1849553872955968	46	TCGA-CN-A6UY-01	8	6	41	0.0956671923109602	TCGA-CN-A6UY-01	3	4	4	11	PASS	3371	TCGA-CN-A6UY	HNSC	57	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-20967	Alive	TUMOR FREE	713	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	713	0	713	NA	NA	0	713	
60	TCGA-CN-A6V1	3	10	3	2	1	1	0	0	8	207	14	0	0	119	3	0	TCGA-CN-A6V1-01	51	6.677900305161566e-05	11	TCGA-CN-A6V1-01	1	2	25	0.020453958970104474	TCGA-CN-A6V1-01	3	1	1	5	PASS	3372	TCGA-CN-A6V1	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2013	NA	-21730	Alive	TUMOR FREE	603	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	603	0	603	NA	NA	0	603	
60	TCGA-CN-A6V3	0	9	1	6	4	0	1	0	3	176	17	0	5	74	5	1	TCGA-CN-A6V3-01	115	0.24503609623793854	62	TCGA-CN-A6V3-01	6	8	68	0.14531058800229596	TCGA-CN-A6V3-01	9	6	8	23	PASS	3373	TCGA-CN-A6V3	HNSC	61	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2012	NA	-22397	Alive	TUMOR FREE	742	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	742	0	742	NA	NA	0	742	
60	TCGA-CN-A6V6	0	6	0	5	0	1	2	0	3	52	3	0	1	25	2	0	TCGA-CN-A6V6-01	82	0.36148425011786506	33	TCGA-CN-A6V6-01	12	13	48	0.1368341100748761	TCGA-CN-A6V6-01	9	6	4	19	PASS	3374	TCGA-CN-A6V6	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2013	NA	-21811	Alive	TUMOR FREE	635	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	635	0	635	NA	NA	0	635	
40	TCGA-CN-A6V7	0	2	1	2	0	0	1	0	1	36	5	0	0	17	0	0	TCGA-CN-A6V7-01	134	0.7029621697173379	76	TCGA-CN-A6V7-01	6	10	53	0.20922836712229764	TCGA-CN-A6V7-01	9	6	10	25	PASS	3375	TCGA-CN-A6V7	HNSC	40	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2013	NA	-14895	Alive	TUMOR FREE	594	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	594	0	594	NA	NA	0	594	
80	TCGA-CQ-5323	0	1	0	2	4	3	0	0	2	41	7	0	3	19	1	0	TCGA-CQ-5323-01	203	0.2938573611036334	110	TCGA-CQ-5323-01	6	10	11	0.07375146013996252	TCGA-CQ-5323-01	9	8	4	21	PASS	3376	TCGA-CQ-5323	HNSC	82	MALE	WHITE	Stage I	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-30173	Alive	TUMOR FREE	1466	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1466	0	1466	0	1466	0	1466	
60	TCGA-CQ-5324	0	2	0	0	3	2	0	0	2	52	5	0	0	14	3	0	TCGA-CQ-5324-01	78	0.060841076808162316	32	TCGA-CQ-5324-01	1	2	7	0.05984974837012001	TCGA-CQ-5324-01	3	2	2	7	PASS	3377	TCGA-CQ-5324	HNSC	59	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-21803	Alive	TUMOR FREE	1593	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1593	0	1593	NA	NA	0	1593	
70	TCGA-CQ-5325	0	3	1	0	1	0	1	0	1	45	3	0	1	12	3	0	TCGA-CQ-5325-01	47	0.1177042155787752	10	TCGA-CQ-5325-01	3	4	6	0.06786104706044567	TCGA-CQ-5325-01	5	3	2	10	PASS	3378	TCGA-CQ-5325	HNSC	65	MALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-23833	Dead	WITH TUMOR	NA	654	NA	NA	Oral Cavity	NA	204	Complete Remission/Response	NA	NA	1	654	1	654	1	204	1	204	
70	TCGA-CQ-5326	0	12	5	5	1	2	0	0	10	153	22	1	0	77	4	0	TCGA-CQ-5326-01	131	0.3487644658315022	71	TCGA-CQ-5326-01	7	9	17	0.19278971341413007	TCGA-CQ-5326-01	11	5	8	24	PASS	3379	TCGA-CQ-5326	HNSC	67	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2007	NA	-24473	Dead	WITH TUMOR	NA	89	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	89	1	89	NA	NA	1	89	
60	TCGA-CQ-5327	2	12	1	7	5	4	2	0	13	171	12	0	3	67	4	0	TCGA-CQ-5327-01	89	0.026534598041887358	41	TCGA-CQ-5327-01	1	5	20	0.11992188194182445	TCGA-CQ-5327-01	1	1	1	3	PASS	3380	TCGA-CQ-5327	HNSC	61	FEMALE	ASIAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-22307	Alive	TUMOR FREE	1660	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1660	0	1660	NA	NA	0	1660	
50	TCGA-CQ-5329	0	0	0	1	1	0	0	0	0	23	3	0	0	7	2	0	TCGA-CQ-5329-01	131	0.9224962383907348	65	TCGA-CQ-5329-01	13	40	24	0.2527126895546967	TCGA-CQ-5329-01	13	5	2	20	PASS	3381	TCGA-CQ-5329	HNSC	46	FEMALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-17028	Alive	TUMOR FREE	2143	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2143	0	2143	0	2143	0	2143	
70	TCGA-CQ-5330	0	3	0	2	0	0	2	0	2	49	4	0	0	19	1	0	TCGA-CQ-5330-01	81	0.2968952084755873	31	TCGA-CQ-5330-01	12	11	12	0.12072032401186546	TCGA-CQ-5330-01	7	1	5	13	PASS	3382	TCGA-CQ-5330	HNSC	69	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2008	NA	-25255	Alive	TUMOR FREE	1897	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1897	0	1897	NA	NA	0	1897	
70	TCGA-CQ-5331	1	7	1	6	0	1	0	0	10	115	9	0	1	37	2	0	TCGA-CQ-5331-01	58	0.06896712212077352	18	TCGA-CQ-5331-01	1	2	7	0.0746965341504662	TCGA-CQ-5331-01	4	7	4	15	PASS	3383	TCGA-CQ-5331	HNSC	73	FEMALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-26901	Alive	TUMOR FREE	1399	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1399	0	1399	NA	NA	0	1399	
90	TCGA-CQ-5332	1	3	1	5	3	1	1	0	6	115	5	0	3	41	2	0	TCGA-CQ-5332-01	289	0.8443935416040401	173	TCGA-CQ-5332-01	15	20	64	0.3050103214514908	TCGA-CQ-5332-01	20	21	13	54	PASS	3384	TCGA-CQ-5332	HNSC	87	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-32032	Dead	NA	317	317	NA	NA	NA	NA	NA	NA	NA	NA	1	317	NA	317	NA	NA	0	317	
70	TCGA-CQ-5333	0	7	0	6	2	1	1	0	9	155	21	0	0	63	2	0	TCGA-CQ-5333-01	73	0.046445675551921216	25	TCGA-CQ-5333-01	2	5	35	0.05966621298226925	TCGA-CQ-5333-01	5	4	4	13	PASS	3385	TCGA-CQ-5333	HNSC	74	MALE	WHITE	Stage II	Stage I	Head & Neck Squamous Cell Carcinoma	G3	2008	NA	-27110	Dead	WITH TUMOR	NA	341	NA	NA	Oropharynx	NA	176	Complete Remission/Response	NA	NA	1	341	1	341	1	176	1	176	
90	TCGA-CQ-5334	0	6	0	6	6	4	2	0	4	136	15	0	2	50	1	0	TCGA-CQ-5334-01	117	0.18386902978963374	53	TCGA-CQ-5334-01	6	8	18	0.12086317670703554	TCGA-CQ-5334-01	4	7	6	17	PASS	3386	TCGA-CQ-5334	HNSC	87	MALE	WHITE	Stage IVA	Stage IVB	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-32024	Dead	WITH TUMOR	NA	129	NA	NA	Oral Cavity	NA	50	Progressive Disease	NA	NA	1	129	1	129	NA	NA	1	50	
50	TCGA-CQ-6218	2	5	0	4	3	0	0	0	5	90	15	0	4	55	4	0	TCGA-CQ-6218-01	136	0.1875366724797214	77	TCGA-CQ-6218-01	3	4	15	0.09766761592080604	TCGA-CQ-6218-01	5	4	5	14	PASS	3387	TCGA-CQ-6218	HNSC	52	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-19096	Alive	TUMOR FREE	1253	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1253	0	1253	NA	NA	0	1253	
50	TCGA-CQ-6219	0	6	0	2	0	1	0	0	1	59	6	0	1	22	0	0	TCGA-CQ-6219	0	0	0	TCGA-CQ-6219	0	0	0	0	TCGA-CQ-6219	0	0	0	0	PASS	3388	TCGA-CQ-6219	HNSC	50	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-18578	Dead	WITH TUMOR	NA	479	NA	NA	Cervical Lymph Nodes	NA	195	Complete Remission/Response	NA	NA	1	479	1	479	NA	NA	1	195	
70	TCGA-CQ-6220	2	5	0	1	0	0	0	0	2	88	6	1	1	33	2	1	TCGA-CQ-6220-01	83	0.5567154541868757	35	TCGA-CQ-6220-01	15	27	11	0.20326472678704666	TCGA-CQ-6220-01	7	4	3	14	PASS	3389	TCGA-CQ-6220	HNSC	69	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-25366	Dead	NA	NA	985	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	985	NA	985	0	985	0	985	
80	TCGA-CQ-6221	0	5	0	6	7	1	2	0	3	89	10	0	1	25	2	0	TCGA-CQ-6221	0	0	0	TCGA-CQ-6221	0	0	0	0	TCGA-CQ-6221-01	15	20	12	47	PASS	3390	TCGA-CQ-6221	HNSC	79	MALE	WHITE	NA	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2008	NA	-29026	Alive	TUMOR FREE	1000	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1000	0	1000	0	1000	0	1000	
60	TCGA-CQ-6222	0	2	0	0	1	1	0	0	0	53	5	0	1	18	1	0	TCGA-CQ-6222	0	0	0	TCGA-CQ-6222	0	0	0	0	TCGA-CQ-6222	0	0	0	0	PASS	3391	TCGA-CQ-6222	HNSC	63	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-23326	Alive	TUMOR FREE	2016	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2016	0	2016	NA	NA	0	2016	
70	TCGA-CQ-6223	0	2	0	1	1	1	0	0	3	81	6	0	1	39	3	0	TCGA-CQ-6223-01	113	0.2973358190476682	55	TCGA-CQ-6223-01	7	6	13	0.09398677288564433	TCGA-CQ-6223-01	4	1	4	9	PASS	3392	TCGA-CQ-6223	HNSC	69	MALE	WHITE	Stage II	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-25266	Alive	TUMOR FREE	1428	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1428	0	1428	NA	NA	0	1428	
50	TCGA-CQ-6224	0	2	0	1	1	0	0	0	5	47	3	0	1	25	0	0	TCGA-CQ-6224-01	132	0.4454305627465207	61	TCGA-CQ-6224-01	21	33	26	0.2891790371501389	TCGA-CQ-6224-01	14	9	7	30	PASS	3393	TCGA-CQ-6224	HNSC	52	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2009	NA	-19051	Alive	TUMOR FREE	1721	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1721	0	1721	NA	NA	0	1721	
70	TCGA-CQ-6225	0	9	1	1	11	0	5	0	5	106	6	0	1	45	7	0	TCGA-CQ-6225-01	134	0.7802402584263068	70	TCGA-CQ-6225-01	26	19	31	0.3675068187713795	TCGA-CQ-6225-01	15	9	15	39	PASS	3394	TCGA-CQ-6225	HNSC	65	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-23988	Dead	NA	NA	403	NA	NA	Oral Cavity	NA	180	Persistent Disease	NA	NA	1	403	NA	403	NA	NA	1	180	
80	TCGA-CQ-6227	0	1	1	1	1	0	0	0	2	42	6	0	0	17	1	0	TCGA-CQ-6227-01	137	0.2758843741272114	75	TCGA-CQ-6227-01	8	8	19	0.20184096833162804	TCGA-CQ-6227-01	6	3	8	17	PASS	3395	TCGA-CQ-6227	HNSC	77	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-28466	Dead	WITH TUMOR	NA	129	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	129	1	129	NA	NA	1	129	
70	TCGA-CQ-6228	1	6	1	6	1	0	0	0	1	92	7	0	1	22	4	0	TCGA-CQ-6228-01	187	0.4664183819948372	94	TCGA-CQ-6228-01	8	12	46	0.244498432135458	TCGA-CQ-6228-01	11	14	12	37	PASS	3396	TCGA-CQ-6228	HNSC	71	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-25942	Dead	NA	NA	456	NA	NA	Distant Metastasis	left axilla	273	Complete Remission/Response	NA	NA	1	456	NA	456	NA	NA	1	273	
60	TCGA-CQ-6229	0	3	0	0	2	0	0	0	1	23	1	0	0	10	0	0	TCGA-CQ-6229-01	55	0.3470592960132195	11	TCGA-CQ-6229-01	17	26	5	0.14003514674185416	TCGA-CQ-6229-01	6	2	4	12	PASS	3397	TCGA-CQ-6229	HNSC	61	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-22541	Alive	TUMOR FREE	1179	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1179	0	1179	0	1179	0	1179	
60	TCGA-CQ-7063	0	4	0	4	2	1	0	0	5	105	6	0	3	42	4	1	TCGA-CQ-7063-01	98	0.13382275921976314	54	TCGA-CQ-7063-01	4	3	36	0.028769130598581518	TCGA-CQ-7063-01	3	1	2	6	PASS	3398	TCGA-CQ-7063	HNSC	59	FEMALE	WHITE	Stage I	NA	Head & Neck Squamous Cell Carcinoma	G1	2008	NA	-21723	Alive	TUMOR FREE	2133	NA	NA	Locoregional Disease	Oral Cavity	left oral tongue	1160	Complete Remission/Response	NA	NA	0	2133	0	2133	1	1160	1	1160	
80	TCGA-CQ-7064	1	8	0	4	0	1	1	0	3	79	8	0	2	31	1	0	TCGA-CQ-7064-01	69	0.2910290035150079	23	TCGA-CQ-7064-01	5	11	49	0.33261261409691995	TCGA-CQ-7064-01	10	7	5	22	PASS	3399	TCGA-CQ-7064	HNSC	83	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-30640	Alive	TUMOR FREE	1973	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1973	0	1973	0	1973	0	1973	
40	TCGA-CQ-7065	0	1	0	2	1	1	0	0	3	26	3	0	0	9	1	0	TCGA-CQ-7065-01	135	0.2876503640146489	73	TCGA-CQ-7065-01	11	10	33	0.1968958510362941	TCGA-CQ-7065-01	6	2	5	13	PASS	3400	TCGA-CQ-7065	HNSC	40	MALE	ASIAN	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-14676	Alive	TUMOR FREE	1628	NA	NA	NA	Oral Cavity	NA	230	Complete Remission/Response	NA	NA	0	1628	0	1628	1	230	1	230	
80	TCGA-CQ-7067	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CQ-7067-01	170	0.6948534108980042	94	TCGA-CQ-7067-01	21	36	42	0.4851827754521356	TCGA-CQ-7067-01	12	8	10	30	PASS	3401	TCGA-CQ-7067	HNSC	75	FEMALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G3	2009	NA	-27707	Alive	TUMOR FREE	509	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	509	0	509	0	509	0	509	
80	TCGA-CQ-7068	0	4	1	4	3	1	0	1	2	81	5	0	4	38	0	0	TCGA-CQ-7068-01	121	0.11238581271733453	67	TCGA-CQ-7068-01	5	4	15	0.0344188620989269	TCGA-CQ-7068-01	3	3	3	9	PASS	3402	TCGA-CQ-7068	HNSC	80	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-29530	Alive	TUMOR FREE	1309	NA	NA	New Primary Tumor	Oral Cavity	left buccal mucosa	1148	Complete Remission/Response	NA	NA	0	1309	0	1309	0	1309	1	1148	
80	TCGA-CQ-7069	0	4	0	0	2	0	0	1	3	72	8	0	2	21	2	0	TCGA-CQ-7069-01	81	0.5734228830190565	26	TCGA-CQ-7069-01	12	14	83	0.4300861923557995	TCGA-CQ-7069-01	6	6	10	22	PASS	3403	TCGA-CQ-7069	HNSC	77	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-28138	Alive	TUMOR FREE	1274	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1274	0	1274	0	1274	0	1274	
80	TCGA-CQ-7071	2	21	4	9	6	3	2	0	15	366	32	0	4	102	8	1	TCGA-CQ-7071-01	86	0.000995980479681394	36	TCGA-CQ-7071-01	0	2	54	0.07175047504844652	TCGA-CQ-7071-01	2	2	2	6	PASS	3404	TCGA-CQ-7071	HNSC	76	FEMALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-27928	Alive	TUMOR FREE	1311	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1311	0	1311	NA	NA	0	1311	
50	TCGA-CQ-7072	1	4	2	5	3	1	0	0	4	101	4	0	2	19	4	1	TCGA-CQ-7072-01	103	0.8229357575416841	52	TCGA-CQ-7072-01	28	33	91	0.32934279902135033	TCGA-CQ-7072-01	16	13	9	38	PASS	3405	TCGA-CQ-7072	HNSC	51	MALE	WHITE	Stage II	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2007	NA	-18841	Alive	TUMOR FREE	2359	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2359	0	2359	NA	NA	0	2359	
60	TCGA-CQ-A4C6	1	6	0	4	0	0	0	0	11	84	6	0	1	24	4	0	TCGA-CQ-A4C6-01	82	0.3011230053447372	30	TCGA-CQ-A4C6-01	10	14	46	0.13111420418408445	TCGA-CQ-A4C6-01	9	2	6	17	PASS	3406	TCGA-CQ-A4C6	HNSC	63	MALE	ASIAN	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-23205	Alive	TUMOR FREE	1353	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1353	0	1353	0	1353	0	1353	
90	TCGA-CQ-A4C7	1	4	0	1	1	0	1	0	2	42	4	0	1	18	2	0	TCGA-CQ-A4C7	0	0	0	TCGA-CQ-A4C7	0	0	0	0	TCGA-CQ-A4C7-01	13	16	0	29	PASS	3407	TCGA-CQ-A4C7	HNSC	88	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-32194	Dead	NA	NA	353	NA	NA	Oral Cavity	left lateral flap margins overlying reconstructed mandible	207	Complete Remission/Response	NA	NA	1	353	NA	353	1	207	1	207	
60	TCGA-CQ-A4C9	0	2	0	1	2	0	0	0	3	73	5	0	2	30	2	0	TCGA-CQ-A4C9-01	108	0.5314146217971336	54	TCGA-CQ-A4C9-01	18	62	38	0.138091583227807	TCGA-CQ-A4C9-01	16	14	3	33	PASS	3408	TCGA-CQ-A4C9	HNSC	56	MALE	[Not Evaluated]	Stage III	NA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-20732	Alive	WITH TUMOR	707	NA	NA	Locoregional Disease	Oral Cavity	NA	287	Complete Remission/Response	NA	NA	0	707	0	707	1	287	1	287	
NA	TCGA-CQ-A4CA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CQ-A4CA-01	126	0.3326062213142031	54	TCGA-CQ-A4CA-01	8	18	123	0.4133180955729438	TCGA-CQ-A4CA-01	15	10	15	40	PASS	3409	TCGA-CQ-A4CA	HNSC	NA	MALE	[Not Evaluated]	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	NA	Alive	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	NA	0	NA	0	NA	0	NA	
60	TCGA-CQ-A4CB	0	4	0	2	3	1	1	0	1	76	4	1	0	17	3	1	TCGA-CQ-A4CB-01	157	0.22300939352886864	88	TCGA-CQ-A4CB-01	6	12	96	0.276879996683451	TCGA-CQ-A4CB-01	14	6	13	33	PASS	3410	TCGA-CQ-A4CB	HNSC	59	MALE	[Not Evaluated]	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-21574	Alive	TUMOR FREE	893	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	893	0	893	0	893	0	893	
70	TCGA-CQ-A4CD	0	8	0	2	2	2	0	0	8	121	14	0	2	31	4	0	TCGA-CQ-A4CD-01	133	0.2614110422702772	67	TCGA-CQ-A4CD-01	8	8	67	0.12817127692525673	TCGA-CQ-A4CD-01	11	10	12	33	PASS	3411	TCGA-CQ-A4CD	HNSC	69	MALE	WHITE	Stage IVA	Stage IVB	Head & Neck Squamous Cell Carcinoma	G3	2011	NA	-25497	Alive	TUMOR FREE	1022	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1022	0	1022	NA	NA	0	1022	
80	TCGA-CQ-A4CE	0	2	1	0	0	4	0	0	1	51	7	0	2	24	0	0	TCGA-CQ-A4CE-01	52	0.34685907519972403	12	TCGA-CQ-A4CE-01	19	20	31	0.09341701650278414	TCGA-CQ-A4CE-01	2	1	2	5	PASS	3412	TCGA-CQ-A4CE	HNSC	76	FEMALE	[Not Evaluated]	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-27793	Alive	TUMOR FREE	897	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	897	0	897	0	897	0	897	
80	TCGA-CQ-A4CG	0	3	0	1	1	2	0	0	3	61	3	0	4	21	1	0	TCGA-CQ-A4CG-01	119	0.8700581122091637	56	TCGA-CQ-A4CG-01	10	15	56	0.124062987791733	TCGA-CQ-A4CG-01	8	4	3	15	PASS	3413	TCGA-CQ-A4CG	HNSC	78	FEMALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-28637	Dead	WITH TUMOR	NA	430	NA	NA	Distant Metastasis	new primary in left upper lung lobe with metastasis to brain	350	Complete Remission/Response	NA	NA	1	430	1	430	1	350	1	350	
60	TCGA-CQ-A4CH	0	1	0	0	1	0	0	0	1	18	2	0	1	7	1	0	TCGA-CQ-A4CH-01	65	0.01941790139627497	24	TCGA-CQ-A4CH	0	0	0	0	TCGA-CQ-A4CH	0	0	0	0	PASS	3414	TCGA-CQ-A4CH	HNSC	58	MALE	ASIAN	Stage II	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-21455	Dead	WITH TUMOR	NA	379	NA	NA	NA	trachea	210	Complete Remission/Response	NA	NA	1	379	1	379	NA	NA	1	210	
70	TCGA-CQ-A4CI	0	7	1	1	1	2	0	0	2	78	7	0	3	27	2	0	TCGA-CQ-A4CI-01	216	0.931879962075938	122	TCGA-CQ-A4CI-01	10	20	162	0.4740915196115339	TCGA-CQ-A4CI-01	20	20	20	60	PASS	3415	TCGA-CQ-A4CI	HNSC	73	MALE	WHITE	Stage III	NA	Head & Neck Squamous Cell Carcinoma Basaloid Type	G3	2011	NA	-26664	Alive	WITH TUMOR	950	NA	NA	NA	Distant Metastasis	lung	517	Complete Remission/Response	NA	NA	0	950	0	950	1	517	1	517	
50	TCGA-CR-5243	0	3	0	3	2	0	0	0	2	48	5	0	0	19	0	0	TCGA-CR-5243-01	141	0.24955333741550784	79	TCGA-CR-5243-01	8	12	20	0.15755590041778247	TCGA-CR-5243-01	13	6	7	26	PASS	3416	TCGA-CR-5243	HNSC	51	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2003	NA	-18812	Alive	TUMOR FREE	2562	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2562	0	2562	NA	NA	0	2562	
50	TCGA-CR-5247	1	6	1	1	1	2	3	0	4	57	2	0	0	19	1	0	TCGA-CR-5247-01	190	0.7022072977691548	106	TCGA-CR-5247-01	22	22	35	0.31600798304947464	TCGA-CR-5247-01	18	6	7	31	PASS	3417	TCGA-CR-5247	HNSC	48	MALE	BLACK OR AFRICAN AMERICAN	NA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2006	NA	-17810	Alive	TUMOR FREE	358	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	358	0	358	0	358	0	358	
50	TCGA-CR-5248	2	20	4	9	16	2	0	0	16	272	26	0	2	100	3	0	TCGA-CR-5248-01	102	0.2623831744222312	44	TCGA-CR-5248-01	4	5	14	0.19998758651008613	TCGA-CR-5248-01	6	8	6	20	PASS	3418	TCGA-CR-5248	HNSC	53	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2006	NA	-19441	Alive	WITH TUMOR	1663	NA	NA	NA	Cervical Lymph Nodes	NA	936	Complete Remission/Response	NA	NA	0	1663	0	1663	NA	NA	1	936	
40	TCGA-CR-5249	0	3	1	0	1	0	1	0	0	21	1	0	1	16	0	0	TCGA-CR-5249-01	68	0.08786805364783036	28	TCGA-CR-5249-01	1	4	4	0.05295802320213428	TCGA-CR-5249-01	3	3	2	8	PASS	3419	TCGA-CR-5249	HNSC	35	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	GX	2007	NA	-13047	Alive	TUMOR FREE	1152	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1152	0	1152	0	1152	0	1152	
70	TCGA-CR-5250	0	3	1	2	2	0	1	0	2	27	0	0	1	9	0	1	TCGA-CR-5250-01	66	0.0634018510238885	23	TCGA-CR-5250-01	0	2	8	0.06688102242241029	TCGA-CR-5250-01	1	4	4	9	PASS	3420	TCGA-CR-5250	HNSC	71	MALE	WHITE	NA	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2009	NA	-26097	Alive	TUMOR FREE	799	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	799	0	799	0	799	0	799	
60	TCGA-CR-6467	0	1	0	4	1	1	0	0	3	26	4	0	0	18	1	0	TCGA-CR-6467-01	135	0.6458802701477663	67	TCGA-CR-6467-01	18	20	34	0.23654092786004235	TCGA-CR-6467-01	5	6	6	17	PASS	3421	TCGA-CR-6467	HNSC	59	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2006	NA	-21689	Alive	TUMOR FREE	1777	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1777	0	1777	NA	NA	0	1777	
40	TCGA-CR-6470	0	1	0	1	2	0	0	0	0	32	2	0	0	8	0	0	TCGA-CR-6470-01	73	0.1871731763533705	22	TCGA-CR-6470-01	4	5	10	0.095470706103294	TCGA-CR-6470-01	6	8	5	19	PASS	3422	TCGA-CR-6470	HNSC	38	MALE	WHITE	Stage II	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-14133	Alive	TUMOR FREE	1521	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1521	0	1521	NA	NA	0	1521	
60	TCGA-CR-6471	0	3	0	5	2	4	0	0	3	100	7	0	1	44	0	0	TCGA-CR-6471-01	79	0.12348247717191185	31	TCGA-CR-6471-01	5	5	5	0.04652913795392353	TCGA-CR-6471-01	2	0	1	3	PASS	3423	TCGA-CR-6471	HNSC	58	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-21315	Dead	WITH TUMOR	NA	1202	NA	NA	Oropharynx	NA	498	Complete Remission/Response	NA	NA	1	1202	1	1202	NA	NA	1	498	
60	TCGA-CR-6472	1	18	1	22	7	0	1	1	25	353	39	2	1	128	4	1	TCGA-CR-6472-01	177	0.9111656467241028	95	TCGA-CR-6472-01	7	10	36	0.33616202745576484	TCGA-CR-6472-01	11	11	9	31	PASS	3424	TCGA-CR-6472	HNSC	59	MALE	WHITE	NA	Stage IVB	Head & Neck Squamous Cell Carcinoma	G3	2008	NA	-21654	Alive	TUMOR FREE	1050	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1050	0	1050	NA	NA	0	1050	
70	TCGA-CR-6473	0	4	2	4	2	1	0	0	2	72	7	0	1	25	2	0	TCGA-CR-6473-01	161	0.3100175499673757	90	TCGA-CR-6473-01	8	10	15	0.18739675079789533	TCGA-CR-6473-01	8	7	8	23	PASS	3425	TCGA-CR-6473	HNSC	68	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2008	NA	-24857	Alive	TUMOR FREE	1125	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1125	0	1125	NA	NA	0	1125	
50	TCGA-CR-6474	2	7	0	1	2	2	0	0	5	78	6	0	0	27	1	0	TCGA-CR-6474-01	128	0.4361203886665194	60	TCGA-CR-6474-01	19	61	36	0.4963080211986134	TCGA-CR-6474-01	13	4	11	28	PASS	3426	TCGA-CR-6474	HNSC	51	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-18840	Dead	WITH TUMOR	NA	564	NA	NA	Cervical Lymph Nodes	Right neck	220	Complete Remission/Response	NA	NA	1	564	1	564	NA	NA	1	220	
60	TCGA-CR-6477	2	4	0	2	5	2	0	0	4	57	4	0	3	25	1	1	TCGA-CR-6477-01	151	0.4318034850859867	69	TCGA-CR-6477-01	20	34	29	0.27511309416881097	TCGA-CR-6477-01	15	5	10	30	PASS	3427	TCGA-CR-6477	HNSC	56	FEMALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-20815	Alive	TUMOR FREE	514	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	514	0	514	NA	NA	0	514	
70	TCGA-CR-6478	1	7	1	4	0	0	2	0	4	80	7	0	2	53	0	0	TCGA-CR-6478-01	225	0.4332768136357473	124	TCGA-CR-6478-01	17	28	57	0.36168429134410496	TCGA-CR-6478-01	13	7	15	35	PASS	3428	TCGA-CR-6478	HNSC	66	FEMALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-24244	Dead	NA	NA	183	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	183	NA	183	NA	NA	0	183	
50	TCGA-CR-6480	0	1	0	5	3	0	0	0	8	79	4	0	1	38	0	1	TCGA-CR-6480-01	115	0.1315273606246864	58	TCGA-CR-6480-01	1	3	16	0.07972567807033272	TCGA-CR-6480-01	6	11	6	23	PASS	3429	TCGA-CR-6480	HNSC	53	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-19472	Alive	TUMOR FREE	362	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	362	0	362	NA	NA	0	362	
50	TCGA-CR-6481	4	17	5	10	2	0	0	0	22	381	43	0	5	135	6	1	TCGA-CR-6481-01	52	0.1506632478239735	9	TCGA-CR-6481-01	4	4	8	0.12758817526750185	TCGA-CR-6481-01	5	3	3	11	PASS	3430	TCGA-CR-6481	HNSC	47	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-17203	Alive	TUMOR FREE	311	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	311	0	311	NA	NA	0	311	
60	TCGA-CR-6482	0	0	0	1	0	0	0	0	3	33	1	0	0	14	1	0	TCGA-CR-6482-01	84	0.21757443297040924	33	TCGA-CR-6482-01	8	6	5	0.05713865232387544	TCGA-CR-6482-01	4	3	3	10	PASS	3431	TCGA-CR-6482	HNSC	62	MALE	BLACK OR AFRICAN AMERICAN	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-22741	Alive	TUMOR FREE	345	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	345	0	345	NA	NA	0	345	
70	TCGA-CR-6484	0	11	1	7	1	0	0	0	10	200	18	1	1	81	4	0	TCGA-CR-6484-01	114	0.5286482124012495	48	TCGA-CR-6484-01	20	31	14	0.15388817169946853	TCGA-CR-6484-01	10	8	6	24	PASS	3432	TCGA-CR-6484	HNSC	67	FEMALE	ASIAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-24569	Alive	TUMOR FREE	354	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	354	0	354	NA	NA	0	354	
50	TCGA-CR-6487	0	8	1	1	2	0	0	1	3	99	14	1	3	28	2	0	TCGA-CR-6487-01	72	0.3538332268501572	24	TCGA-CR-6487-01	12	16	12	0.26872664524373363	TCGA-CR-6487-01	7	6	6	19	PASS	3433	TCGA-CR-6487	HNSC	50	MALE	WHITE	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-18331	Alive	TUMOR FREE	234	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	234	0	234	0	234	0	234	
70	TCGA-CR-6488	0	2	0	0	0	0	0	0	3	28	5	0	0	13	1	0	TCGA-CR-6488-01	126	0.531361474469102	60	TCGA-CR-6488-01	17	41	15	0.1961051235103981	TCGA-CR-6488-01	17	7	8	32	PASS	3434	TCGA-CR-6488	HNSC	68	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-25176	Alive	TUMOR FREE	379	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	379	0	379	0	379	0	379	
60	TCGA-CR-6491	0	6	0	3	3	4	0	0	5	96	6	0	0	51	3	0	TCGA-CR-6491-01	122	0.3656578229029592	55	TCGA-CR-6491-01	3	6	20	0.14328666760816064	TCGA-CR-6491-01	5	7	7	19	PASS	3435	TCGA-CR-6491	HNSC	60	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-22125	Alive	WITH TUMOR	693	NA	NA	New Primary Tumor	Distant Metastasis	Lung	499	Complete Remission/Response	NA	NA	0	693	0	693	NA	NA	1	499	
80	TCGA-CR-6492	0	2	0	2	0	0	0	0	2	43	7	0	0	18	0	0	TCGA-CR-6492-01	62	0.08138550674038376	18	TCGA-CR-6492	0	0	0	0	TCGA-CR-6492	0	0	0	0	PASS	3436	TCGA-CR-6492	HNSC	78	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-28600	Alive	TUMOR FREE	479	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	479	0	479	NA	NA	0	479	
70	TCGA-CR-6493	0	3	1	1	1	0	1	1	3	29	2	0	0	5	0	0	TCGA-CR-6493-01	138	0.3685136869829348	72	TCGA-CR-6493-01	11	14	15	0.13340716953818949	TCGA-CR-6493-01	11	8	6	25	PASS	3437	TCGA-CR-6493	HNSC	69	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-25432	Dead	WITH TUMOR	NA	282	NA	Locoregional Recurrence	Oral Cavity	Right gingiva	247	Complete Remission/Response	NA	NA	1	282	1	282	NA	NA	1	247	
70	TCGA-CR-7364	1	20	5	11	13	3	0	0	10	366	28	0	8	120	12	0	TCGA-CR-7364-01	74	0.2931996652140635	21	TCGA-CR-7364-01	13	13	22	0.2584987435984025	TCGA-CR-7364-01	12	3	8	23	PASS	3438	TCGA-CR-7364	HNSC	66	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-24192	Alive	TUMOR FREE	1435	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1435	0	1435	0	1435	0	1435	
60	TCGA-CR-7365	1	16	1	8	4	6	1	0	4	121	12	1	2	45	2	0	TCGA-CR-7365-01	83	0.8730064207593117	29	TCGA-CR-7365-01	22	22	20	0.2107360213208646	TCGA-CR-7365-01	8	5	5	18	PASS	3439	TCGA-CR-7365	HNSC	60	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-22101	Alive	TUMOR FREE	1191	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1191	0	1191	NA	NA	0	1191	
50	TCGA-CR-7367	0	7	0	1	1	3	1	0	3	138	11	0	2	51	2	0	TCGA-CR-7367-01	209	0.431098542279184	118	TCGA-CR-7367-01	12	30	45	0.22161173923204444	TCGA-CR-7367-01	15	16	5	36	PASS	3440	TCGA-CR-7367	HNSC	52	MALE	WHITE	Stage IVA	Stage IVB	Head & Neck Squamous Cell Carcinoma	G1	2008	NA	-19116	Alive	TUMOR FREE	1440	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1440	0	1440	NA	NA	0	1440	
50	TCGA-CR-7368	0	15	2	3	4	2	0	0	5	164	12	0	0	63	6	0	TCGA-CR-7368-01	93	0.3170518067904073	40	TCGA-CR-7368-01	7	9	23	0.1438258662877653	TCGA-CR-7368-01	12	6	8	26	PASS	3441	TCGA-CR-7368	HNSC	54	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-19876	Alive	TUMOR FREE	1245	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1245	0	1245	NA	NA	0	1245	
60	TCGA-CR-7369	0	2	0	4	2	2	0	0	1	56	5	0	0	20	1	0	TCGA-CR-7369-01	143	0.34185676465468223	70	TCGA-CR-7369-01	11	9	34	0.2581826232634173	TCGA-CR-7369-01	11	2	9	22	PASS	3442	TCGA-CR-7369	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-21897	Dead	TUMOR FREE	NA	1090	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1090	0	1090	NA	NA	0	1090	
70	TCGA-CR-7370	1	31	5	20	16	1	0	0	19	410	28	0	10	170	6	1	TCGA-CR-7370-01	233	0.7539172415250766	127	TCGA-CR-7370-01	25	31	45	0.4522586724410646	TCGA-CR-7370-01	14	9	13	36	PASS	3443	TCGA-CR-7370	HNSC	72	FEMALE	WHITE	NA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-26468	Alive	TUMOR FREE	105	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	105	0	105	0	105	0	105	
50	TCGA-CR-7371	1	14	0	7	4	1	0	0	11	240	24	0	5	94	14	1	TCGA-CR-7371-01	111	0.430337691473141	50	TCGA-CR-7371-01	9	17	28	0.35983093378728354	TCGA-CR-7371-01	12	8	10	30	PASS	3444	TCGA-CR-7371	HNSC	45	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-16568	Dead	NA	NA	94	NA	NA	NA	NA	NA	NA	NA	NA	1	94	NA	94	NA	NA	0	94	
50	TCGA-CR-7372	0	1	0	1	0	2	1	0	1	33	8	0	0	11	0	1	TCGA-CR-7372-01	94	0.5822513327296466	35	TCGA-CR-7372-01	20	25	21	0.3030494544031977	TCGA-CR-7372-01	3	6	3	12	PASS	3445	TCGA-CR-7372	HNSC	45	MALE	WHITE	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2009	NA	-16610	Alive	TUMOR FREE	759	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	759	0	759	0	759	0	759	
70	TCGA-CR-7373	1	6	0	5	3	1	0	0	5	82	9	1	0	42	1	0	TCGA-CR-7373-01	68	0.3486970371081701	20	TCGA-CR-7373-01	16	17	12	0.11448477722133885	TCGA-CR-7373-01	4	6	6	16	PASS	3446	TCGA-CR-7373	HNSC	66	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-24448	Alive	TUMOR FREE	889	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	889	0	889	NA	NA	0	889	
70	TCGA-CR-7374	1	19	2	9	6	2	2	0	12	266	28	0	8	88	8	2	TCGA-CR-7374-01	154	0.9136571927571442	77	TCGA-CR-7374-01	10	17	47	0.5035296579198922	TCGA-CR-7374-01	20	20	18	58	PASS	3447	TCGA-CR-7374	HNSC	67	FEMALE	WHITE	NA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-24558	Alive	WITH TUMOR	30	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	30	0	30	NA	NA	0	30	
80	TCGA-CR-7376	1	1	0	2	0	0	0	0	0	46	4	0	0	14	1	0	TCGA-CR-7376-01	76	0.06886357092426214	30	TCGA-CR-7376-01	2	6	19	0.15310572694536062	TCGA-CR-7376-01	2	1	1	4	PASS	3448	TCGA-CR-7376	HNSC	83	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-30670	Alive	TUMOR FREE	972	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	972	0	972	0	972	0	972	
60	TCGA-CR-7377	2	8	0	4	0	0	1	0	1	92	6	0	0	42	3	0	TCGA-CR-7377-01	79	0.2252527140249013	25	TCGA-CR-7377-01	9	13	19	0.2786976778166081	TCGA-CR-7377-01	9	3	5	17	PASS	3449	TCGA-CR-7377	HNSC	58	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2008	NA	-21371	Dead	NA	NA	279	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	279	NA	279	NA	NA	0	279	
80	TCGA-CR-7379	1	10	1	4	1	1	1	0	5	102	12	0	3	60	2	0	TCGA-CR-7379-01	120	0.37222197166546384	53	TCGA-CR-7379-01	16	26	24	0.23099523159240226	TCGA-CR-7379-01	9	10	4	23	PASS	3450	TCGA-CR-7379	HNSC	78	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-28763	Alive	TUMOR FREE	1036	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1036	0	1036	NA	NA	0	1036	
60	TCGA-CR-7380	0	1	0	2	3	6	1	0	0	68	8	0	4	23	0	0	TCGA-CR-7380-01	133	0.5610237061587198	68	TCGA-CR-7380-01	9	12	23	0.2925082541250916	TCGA-CR-7380-01	8	5	8	21	PASS	3451	TCGA-CR-7380	HNSC	58	MALE	WHITE	Stage IVB	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-21215	Dead	WITH TUMOR	NA	606	NA	NA	Distant Metastasis	Lung	561	Complete Remission/Response	NA	NA	1	606	1	606	NA	NA	1	561	
50	TCGA-CR-7382	0	3	0	3	0	1	0	0	0	67	7	0	0	22	0	0	TCGA-CR-7382-01	59	0.11903888275309445	15	TCGA-CR-7382-01	4	7	5	0.06663783218667048	TCGA-CR-7382-01	3	1	1	5	PASS	3452	TCGA-CR-7382	HNSC	49	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-18078	Alive	TUMOR FREE	796	NA	NA	NA	Oral Cavity	Tongue	614	Complete Remission/Response	NA	NA	0	796	0	796	NA	NA	1	614	
80	TCGA-CR-7383	1	8	1	5	3	1	1	1	7	84	9	0	3	32	3	0	TCGA-CR-7383-01	159	0.6724612678644951	83	TCGA-CR-7383-01	22	29	45	0.2961814823457978	TCGA-CR-7383-01	16	11	13	40	PASS	3453	TCGA-CR-7383	HNSC	79	FEMALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-29122	Dead	WITH TUMOR	NA	521	NA	NA	Oropharynx	NA	454	Complete Remission/Response	NA	NA	1	521	1	521	1	454	1	454	
40	TCGA-CR-7385	0	7	1	4	1	0	1	0	6	104	7	0	2	41	3	0	TCGA-CR-7385-01	68	0.13103692796521246	21	TCGA-CR-7385-01	3	4	13	0.11142960658397708	TCGA-CR-7385-01	6	5	4	15	PASS	3454	TCGA-CR-7385	HNSC	42	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-15477	Alive	TUMOR FREE	997	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	997	0	997	NA	NA	0	997	
70	TCGA-CR-7386	1	16	1	2	2	0	0	0	6	139	14	0	2	61	1	0	TCGA-CR-7386-01	76	0.13836380282617172	30	TCGA-CR-7386-01	7	5	9	0.11448328748125165	TCGA-CR-7386-01	4	1	4	9	PASS	3455	TCGA-CR-7386	HNSC	69	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2008	NA	-25238	Alive	WITH TUMOR	1430	NA	NA	NA	Distant Metastasis	Lung (distant mets or possible new primary)	1028	Complete Remission/Response	NA	NA	0	1430	0	1430	NA	NA	1	1028	
70	TCGA-CR-7388	8	30	1	18	13	1	1	0	24	609	51	1	12	207	24	0	TCGA-CR-7388-01	136	0.33734333849930354	58	TCGA-CR-7388-01	11	14	36	0.27978544531234634	TCGA-CR-7388-01	13	9	7	29	PASS	3456	TCGA-CR-7388	HNSC	70	FEMALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-25728	Dead	WITH TUMOR	NA	823	NA	NA	Cervical Lymph Nodes	Right neck	334	Complete Remission/Response	NA	NA	1	823	1	823	NA	NA	1	334	
60	TCGA-CR-7389	1	3	0	10	4	2	0	0	3	94	4	0	0	38	1	0	TCGA-CR-7389-01	129	0.7391799466024128	70	TCGA-CR-7389-01	24	40	23	0.2554131683617126	TCGA-CR-7389-01	14	10	8	32	PASS	3457	TCGA-CR-7389	HNSC	55	MALE	BLACK OR AFRICAN AMERICAN	NA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-20169	Alive	TUMOR FREE	392	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	392	0	392	0	392	0	392	
70	TCGA-CR-7390	0	11	2	10	4	3	1	0	10	117	11	0	2	61	4	0	TCGA-CR-7390-01	182	0.6413577146302233	93	TCGA-CR-7390-01	18	31	28	0.1608997529359591	TCGA-CR-7390-01	19	9	7	35	PASS	3458	TCGA-CR-7390	HNSC	67	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-24575	Alive	TUMOR FREE	1508	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1508	0	1508	NA	NA	0	1508	
40	TCGA-CR-7391	0	3	0	1	0	0	0	0	2	24	2	0	3	11	0	0	TCGA-CR-7391-01	47	7.577484357987007e-05	6	TCGA-CR-7391	0	0	0	0	TCGA-CR-7391	0	0	0	0	PASS	3459	TCGA-CR-7391	HNSC	36	FEMALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G1	2009	NA	-13508	Alive	TUMOR FREE	913	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	913	0	913	0	913	0	913	
70	TCGA-CR-7392	0	1	0	1	0	0	0	0	1	22	1	0	0	6	0	0	TCGA-CR-7392-01	62	0.023769323719782333	17	TCGA-CR-7392-01	4	8	8	0.15847138039020664	TCGA-CR-7392-01	2	0	1	3	PASS	3460	TCGA-CR-7392	HNSC	67	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2009	NA	-24650	Alive	TUMOR FREE	1425	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1425	0	1425	NA	NA	0	1425	
30	TCGA-CR-7393	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CR-7393-01	45	2.5213549369566434e-05	7	TCGA-CR-7393-01	0	0	0	0.0	TCGA-CR-7393-01	0	0	0	0	PASS	3461	TCGA-CR-7393	HNSC	26	MALE	WHITE	Stage III	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-9750	Alive	TUMOR FREE	993	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	993	0	993	0	993	0	993	
70	TCGA-CR-7394	0	5	0	2	0	0	0	0	10	121	11	0	1	52	4	0	TCGA-CR-7394-01	43	8.071875123613891e-05	6	TCGA-CR-7394-01	0	2	19	0.02107226043569733	TCGA-CR-7394-01	1	1	1	3	PASS	3462	TCGA-CR-7394	HNSC	70	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-25581	Alive	TUMOR FREE	1346	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1346	0	1346	NA	NA	0	1346	
80	TCGA-CR-7395	0	6	0	2	3	3	1	0	8	118	9	0	2	68	6	0	TCGA-CR-7395-01	46	0.013583307771080235	11	TCGA-CR-7395-01	1	6	7	0.11744927367952925	TCGA-CR-7395-01	4	2	2	8	PASS	3463	TCGA-CR-7395	HNSC	80	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-29527	Alive	TUMOR FREE	930	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	930	0	930	0	930	0	930	
40	TCGA-CR-7397	0	2	0	2	0	0	0	0	0	28	4	0	1	17	1	1	TCGA-CR-7397-01	96	0.23949660392359845	49	TCGA-CR-7397-01	28	39	22	0.4116548952333821	TCGA-CR-7397-01	9	5	5	19	PASS	3464	TCGA-CR-7397	HNSC	44	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-16351	Alive	TUMOR FREE	754	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	754	0	754	NA	NA	0	754	
50	TCGA-CR-7398	1	19	3	15	9	4	2	0	18	287	29	0	8	112	7	0	TCGA-CR-7398-01	142	0.8836274414832289	78	TCGA-CR-7398-01	16	21	26	0.37317003292492507	TCGA-CR-7398-01	14	4	12	30	PASS	3465	TCGA-CR-7398	HNSC	53	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-19468	Alive	TUMOR FREE	156	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	156	0	156	0	156	0	156	
60	TCGA-CR-7399	1	12	1	9	11	1	0	0	21	236	23	0	7	79	11	1	TCGA-CR-7399-01	262	0.6599779915132409	147	TCGA-CR-7399-01	19	37	52	0.4021282548961295	TCGA-CR-7399-01	25	13	11	49	PASS	3466	TCGA-CR-7399	HNSC	60	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2008	NA	-22182	Alive	TUMOR FREE	181	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	181	0	181	NA	NA	0	181	
60	TCGA-CR-7401	1	5	1	6	0	1	1	0	2	59	4	0	1	34	1	0	TCGA-CR-7401-01	67	0.1890274317635277	24	TCGA-CR-7401-01	7	11	16	0.17158746883807005	TCGA-CR-7401-01	7	2	6	15	PASS	3467	TCGA-CR-7401	HNSC	64	MALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-23420	Alive	TUMOR FREE	1077	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1077	0	1077	0	1077	0	1077	
70	TCGA-CR-7402	6	44	5	28	28	8	0	0	34	769	67	1	13	270	31	1	TCGA-CR-7402-01	133	0.2664293333937669	66	TCGA-CR-7402-01	9	13	20	0.184964042467938	TCGA-CR-7402-01	11	3	6	20	hypermutated sample	3468	TCGA-CR-7402	HNSC	68	MALE	WHITE	NA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-25138	Alive	TUMOR FREE	911	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	911	0	911	0	911	0	911	
50	TCGA-CR-7404	0	8	2	2	3	0	1	0	3	98	7	0	3	39	0	0	TCGA-CR-7404-01	87	0.3444833679953294	23	TCGA-CR-7404-01	10	11	19	0.23446550833321594	TCGA-CR-7404-01	7	4	7	18	PASS	3469	TCGA-CR-7404	HNSC	53	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-19532	Alive	WITH TUMOR	1472	NA	NA	NA	Oropharynx	NA	234	Complete Remission/Response	NA	NA	0	1472	0	1472	NA	NA	1	234	
60	TCGA-CV-5430	2	18	4	8	8	6	0	0	16	205	14	0	2	89	8	2	TCGA-CV-5430-01	255	0.7278405524704613	142	TCGA-CV-5430-01	22	28	40	0.3714187330221312	TCGA-CV-5430-01	17	11	11	39	PASS	3470	TCGA-CV-5430	HNSC	61	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	1999	NA	-22577	Alive	TUMOR FREE	4241	NA	NA	NA	Distant Metastasis	Lung	783	Complete Remission/Response	NA	NA	0	4241	0	4241	NA	NA	1	783	
70	TCGA-CV-5431	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CV-5431-01	252	0.5147870662792229	136	TCGA-CV-5431-01	13	38	44	0.3209248746966484	TCGA-CV-5431-01	21	11	12	44	PASS	3471	TCGA-CV-5431	HNSC	73	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2000	NA	-26953	Dead	TUMOR FREE	522	522	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	522	0	522	NA	NA	0	522	
70	TCGA-CV-5432	0	29	2	12	4	0	2	2	24	406	30	0	10	180	20	0	TCGA-CV-5432-01	260	0.7025483444836405	153	TCGA-CV-5432-01	21	53	54	0.4113689268056361	TCGA-CV-5432-01	28	13	15	56	PASS	3472	TCGA-CV-5432	HNSC	68	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2000	NA	-25006	Alive	TUMOR FREE	3930	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3930	0	3930	NA	NA	0	3930	
60	TCGA-CV-5434	1	10	2	9	1	2	3	0	6	213	20	0	4	62	8	0	TCGA-CV-5434-01	230	0.7495467627368039	138	TCGA-CV-5434-01	19	34	57	0.4083251572475903	TCGA-CV-5434-01	13	11	7	31	PASS	3473	TCGA-CV-5434	HNSC	60	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2000	NA	-22182	Dead	TUMOR FREE	3295	3314	NA	NA	Distant Metastasis	Lung	1859	Complete Remission/Response	NA	NA	1	3314	0	3314	NA	NA	1	1859	
60	TCGA-CV-5435	0	14	0	4	6	5	4	0	5	164	14	0	7	75	4	0	TCGA-CV-5435-01	148	0.8857552196938143	72	TCGA-CV-5435-01	19	61	21	0.2079002609906392	TCGA-CV-5435-01	10	7	4	21	PASS	3474	TCGA-CV-5435	HNSC	57	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2000	NA	-20926	Dead	WITH TUMOR	1438	2319	NA	NA	Distant Metastasis	Lung	284	NA	NA	NA	1	2319	1	2319	NA	NA	1	284	
70	TCGA-CV-5436	2	10	0	4	4	0	0	2	12	156	6	0	0	57	2	0	TCGA-CV-5436-01	221	0.34632224975197323	128	TCGA-CV-5436-01	12	15	44	0.2355911659289928	TCGA-CV-5436-01	11	6	9	26	PASS	3475	TCGA-CV-5436	HNSC	65	MALE	NA	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2001	NA	-23923	Dead	WITH TUMOR	548	584	NA	NA	NA	NA	NA	Persistent Disease	NA	NA	1	584	1	584	NA	NA	1	584	
60	TCGA-CV-5439	1	9	0	3	4	1	1	0	4	80	5	0	2	35	5	0	TCGA-CV-5439-01	63	0.5252690189742346	18	TCGA-CV-5439-01	17	17	8	0.1798636941456267	TCGA-CV-5439-01	8	5	6	19	PASS	3476	TCGA-CV-5439	HNSC	62	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2002	NA	-22686	Dead	WITH TUMOR	546	546	NA	NA	Oropharynx	NA	211	NA	NA	NA	1	546	1	546	NA	NA	1	211	
50	TCGA-CV-5440	1	14	2	7	4	1	1	0	3	87	6	0	4	32	2	0	TCGA-CV-5440-01	249	0.7425523559845544	140	TCGA-CV-5440-01	24	27	52	0.3868484782161769	TCGA-CV-5440-01	18	7	13	38	PASS	3477	TCGA-CV-5440	HNSC	52	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2002	NA	-19197	Alive	TUMOR FREE	3270	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3270	0	3270	NA	NA	0	3270	
60	TCGA-CV-5441	1	30	1	11	9	8	1	0	18	279	19	0	7	110	15	0	TCGA-CV-5441-01	156	0.4229321662044361	81	TCGA-CV-5441-01	8	12	29	0.2712421773080616	TCGA-CV-5441-01	8	7	7	22	PASS	3478	TCGA-CV-5441	HNSC	58	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2003	NA	-21305	Alive	TUMOR FREE	2886	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2886	0	2886	NA	NA	0	2886	
80	TCGA-CV-5442	1	18	1	5	2	3	0	0	14	197	17	0	4	66	2	0	TCGA-CV-5442-01	128	0.9477130551781402	63	TCGA-CV-5442-01	17	34	25	0.28348528966070835	TCGA-CV-5442-01	3	1	0	4	PASS	3479	TCGA-CV-5442	HNSC	76	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2004	NA	-28040	Alive	TUMOR FREE	2327	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2327	0	2327	NA	NA	0	2327	
60	TCGA-CV-5443	1	4	0	1	1	0	2	0	0	40	3	0	2	24	1	0	TCGA-CV-5443-01	153	0.09083046095375684	83	TCGA-CV-5443-01	1	3	20	0.08653842488148218	TCGA-CV-5443-01	7	8	5	20	PASS	3480	TCGA-CV-5443	HNSC	63	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2004	NA	-23287	Alive	TUMOR FREE	2784	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2784	0	2784	NA	NA	0	2784	
60	TCGA-CV-5444	0	8	0	6	2	0	1	0	5	94	6	0	5	53	3	1	TCGA-CV-5444-01	176	0.5909454593046549	103	TCGA-CV-5444-01	26	29	26	0.2371982949764753	TCGA-CV-5444-01	9	7	6	22	PASS	3481	TCGA-CV-5444	HNSC	64	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2004	NA	-23650	Alive	TUMOR FREE	2437	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2437	0	2437	NA	NA	0	2437	
60	TCGA-CV-5966	4	20	2	4	2	2	0	0	6	176	10	0	4	60	5	0	TCGA-CV-5966-01	180	0.4220695169228879	98	TCGA-CV-5966-01	15	22	33	0.1559499061682519	TCGA-CV-5966-01	16	13	9	38	PASS	3482	TCGA-CV-5966	HNSC	63	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2005	NA	-23119	Dead	TUMOR FREE	NA	545	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	545	0	545	NA	NA	0	545	
60	TCGA-CV-5970	0	27	2	14	2	0	2	0	17	300	18	0	8	118	8	0	TCGA-CV-5970-01	167	0.3747226943787101	100	TCGA-CV-5970-01	12	35	22	0.24651563201480625	TCGA-CV-5970-01	14	9	4	27	PASS	3483	TCGA-CV-5970	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-21890	Dead	WITH TUMOR	406	406	NA	NA	NA	NA	NA	NA	NA	NA	1	406	1	406	NA	NA	1	406	
60	TCGA-CV-5971	0	1	0	0	0	0	0	0	1	15	0	0	0	13	0	0	TCGA-CV-5971-01	59	0.0006672193638771508	13	TCGA-CV-5971-01	0	0	19	1.8948277538162478e-05	TCGA-CV-5971-01	0	0	0	0	PASS	3484	TCGA-CV-5971	HNSC	60	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-22279	Alive	TUMOR FREE	701	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	701	0	701	NA	NA	0	701	
60	TCGA-CV-5973	0	3	2	1	5	0	0	0	1	38	4	0	1	25	1	0	TCGA-CV-5973-01	283	0.5327551828308115	166	TCGA-CV-5973-01	14	33	43	0.25366561130694865	TCGA-CV-5973-01	19	10	6	35	PASS	3485	TCGA-CV-5973	HNSC	62	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2005	NA	-22771	Alive	TUMOR FREE	2641	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2641	0	2641	0	2641	0	2641	
50	TCGA-CV-5976	0	6	0	4	1	1	1	0	3	53	7	0	1	23	0	0	TCGA-CV-5976-01	120	0.2937367670242377	50	TCGA-CV-5976-01	6	8	15	0.1876949207444165	TCGA-CV-5976-01	8	4	7	19	PASS	3486	TCGA-CV-5976	HNSC	50	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2006	NA	-18267	Alive	TUMOR FREE	1478	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1478	0	1478	NA	NA	0	1478	
70	TCGA-CV-5977	0	1	0	1	2	0	1	0	2	62	3	0	3	39	0	0	TCGA-CV-5977-01	113	0.8184403278820429	51	TCGA-CV-5977-01	24	28	14	0.12401694549747196	TCGA-CV-5977-01	8	0	4	12	PASS	3487	TCGA-CV-5977	HNSC	66	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-24115	Alive	TUMOR FREE	1840	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1840	0	1840	NA	NA	0	1840	
50	TCGA-CV-5978	1	5	0	5	3	2	2	0	7	127	15	0	3	48	8	0	TCGA-CV-5978-01	225	0.4930001452168265	137	TCGA-CV-5978-01	16	31	36	0.32763029903642304	TCGA-CV-5978-01	21	18	8	47	PASS	3488	TCGA-CV-5978	HNSC	53	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVB	Stage IVB	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-19480	Dead	WITH TUMOR	215	215	NA	NA	NA	NA	NA	NA	NA	NA	1	215	1	215	NA	NA	1	215	
30	TCGA-CV-5979	0	4	0	1	0	0	0	0	2	27	2	0	0	6	0	0	TCGA-CV-5979-01	253	0.3199779200529449	143	TCGA-CV-5979-01	8	10	28	0.19865443751882192	TCGA-CV-5979-01	13	5	8	26	PASS	3489	TCGA-CV-5979	HNSC	26	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-9567	Alive	TUMOR FREE	1315	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1315	0	1315	NA	NA	0	1315	
50	TCGA-CV-6003	2	4	0	0	4	2	1	0	6	76	8	0	1	25	2	0	TCGA-CV-6003-01	136	0.7324720403364584	72	TCGA-CV-6003-01	24	25	15	0.2993863762674576	TCGA-CV-6003-01	11	2	4	17	PASS	3490	TCGA-CV-6003	HNSC	50	FEMALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-18600	Alive	TUMOR FREE	1665	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1665	0	1665	NA	NA	0	1665	
60	TCGA-CV-6433	0	1	0	2	4	0	1	0	0	39	1	0	0	17	0	0	TCGA-CV-6433-01	129	0.24563579744102204	61	TCGA-CV-6433-01	9	7	13	0.05572666952322313	TCGA-CV-6433-01	5	3	3	11	PASS	3491	TCGA-CV-6433	HNSC	57	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-20855	Alive	WITH TUMOR	641	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	641	0	641	0	641	0	641	
60	TCGA-CV-6436	0	7	0	3	0	1	2	0	3	56	7	0	1	21	2	0	TCGA-CV-6436-01	68	0.09837871396969357	22	TCGA-CV-6436-01	3	2	2	0.00033847966560319846	TCGA-CV-6436-01	1	0	0	1	PASS	3492	TCGA-CV-6436	HNSC	62	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2007	NA	-22885	Alive	TUMOR FREE	1899	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1899	0	1899	NA	NA	0	1899	
60	TCGA-CV-6441	1	14	2	13	6	2	2	0	16	166	15	0	3	70	2	0	TCGA-CV-6441-01	328	0.9243385294640416	211	TCGA-CV-6441-01	16	28	62	0.3205605889014008	TCGA-CV-6441-01	19	8	8	35	PASS	3493	TCGA-CV-6441	HNSC	60	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-22025	Dead	WITH TUMOR	NA	292	NA	Locoregional Recurrence	Oral Cavity	pharyngeal	95	Progressive Disease	NA	NA	1	292	1	292	NA	NA	1	95	
50	TCGA-CV-6933	0	23	0	6	2	2	2	2	22	232	24	4	4	78	8	0	TCGA-CV-6933-01	226	0.8160384024110975	126	TCGA-CV-6933-01	24	22	46	0.23452916904533624	TCGA-CV-6933-01	17	16	14	47	PASS	3494	TCGA-CV-6933	HNSC	53	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1998	NA	-19518	Dead	TUMOR FREE	NA	2741	NA	NA	NA	NA	NA	NA	NA	NA	1	2741	0	2741	NA	NA	0	2741	
70	TCGA-CV-6934	0	4	2	2	4	4	2	0	8	144	8	0	6	48	4	0	TCGA-CV-6934-01	65	0.1989075658967568	20	TCGA-CV-6934-01	10	10	14	0.12283349554036747	TCGA-CV-6934-01	8	6	6	20	PASS	3495	TCGA-CV-6934	HNSC	66	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1998	NA	-24180	Dead	WITH TUMOR	NA	65	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	65	1	65	NA	NA	1	65	
70	TCGA-CV-6935	4	5	4	11	4	6	8	0	12	352	18	0	4	123	8	2	TCGA-CV-6935-01	238	0.8880017879575584	142	TCGA-CV-6935-01	11	16	45	0.3350568361438294	TCGA-CV-6935-01	13	10	10	33	PASS	3496	TCGA-CV-6935	HNSC	67	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	1999	NA	-24799	Dead	WITH TUMOR	NA	295	NA	NA	NA	NA	NA	NA	NA	NA	1	295	1	295	NA	NA	1	295	
70	TCGA-CV-6936	2	30	2	10	7	2	2	0	30	453	31	0	6	170	10	0	TCGA-CV-6936-01	212	0.36615903367534497	123	TCGA-CV-6936-01	9	18	45	0.21506007414641606	TCGA-CV-6936-01	17	7	9	33	PASS	3497	TCGA-CV-6936	HNSC	68	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2004	NA	-25020	Dead	WITH TUMOR	NA	166	NA	Locoregional Recurrence	Oral Cavity	mandibular	157	Progressive Disease	NA	NA	1	166	1	166	NA	NA	1	157	
70	TCGA-CV-6937	0	8	0	7	4	1	1	0	3	130	8	0	3	43	2	0	TCGA-CV-6937-01	186	0.4915566884323811	107	TCGA-CV-6937-01	21	25	36	0.26320268385165146	TCGA-CV-6937-01	18	12	8	38	PASS	3498	TCGA-CV-6937	HNSC	71	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2003	NA	-26156	Dead	TUMOR FREE	NA	624	NA	NA	NA	NA	NA	NA	NA	NA	1	624	0	624	NA	NA	0	624	
90	TCGA-CV-6938	0	14	2	0	10	8	4	0	8	215	20	0	2	67	7	0	TCGA-CV-6938-01	55	0.005027461545734347	17	TCGA-CV-6938-01	3	2	6	0.0416543330169981	TCGA-CV-6938-01	2	2	1	5	PASS	3499	TCGA-CV-6938	HNSC	87	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	1996	NA	-31825	Dead	TUMOR FREE	NA	144	NA	NA	NA	NA	NA	NA	NA	NA	1	144	0	144	NA	NA	0	144	
60	TCGA-CV-6939	0	2	0	2	8	0	0	0	0	56	4	0	1	26	6	0	TCGA-CV-6939-01	95	0.3492351481930478	50	TCGA-CV-6939-01	5	9	17	0.16905729079313758	TCGA-CV-6939-01	4	7	3	14	PASS	3500	TCGA-CV-6939	HNSC	60	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	1994	NA	-21947	Dead	WITH TUMOR	NA	666	NA	NA	NA	NA	NA	NA	NA	NA	1	666	1	666	NA	NA	1	666	
80	TCGA-CV-6940	0	8	0	3	2	1	1	0	8	102	14	0	1	40	1	1	TCGA-CV-6940-01	150	0.8029008174869678	78	TCGA-CV-6940-01	20	28	22	0.2738116829564352	TCGA-CV-6940-01	14	9	6	29	PASS	3501	TCGA-CV-6940	HNSC	80	FEMALE	WHITE	Stage III	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2002	NA	-29382	Dead	TUMOR FREE	NA	804	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	804	0	804	0	804	0	804	
50	TCGA-CV-6941	3	12	1	4	3	1	1	0	6	126	9	1	5	56	4	0	TCGA-CV-6941-01	247	0.615166047948309	138	TCGA-CV-6941-01	16	28	55	0.3023226622132357	TCGA-CV-6941-01	19	6	12	37	PASS	3502	TCGA-CV-6941	HNSC	51	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1999	NA	-18812	Dead	TUMOR FREE	NA	342	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	342	0	342	0	342	0	342	
70	TCGA-CV-6942	0	12	1	4	5	1	0	0	14	174	15	1	3	67	5	0	TCGA-CV-6942-01	112	0.2301317099780471	55	TCGA-CV-6942-01	8	8	25	0.2139316261831119	TCGA-CV-6942-01	5	1	4	10	PASS	3503	TCGA-CV-6942	HNSC	73	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2000	NA	-26941	Alive	TUMOR FREE	4282	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4282	0	4282	0	4282	0	4282	
70	TCGA-CV-6943	0	9	0	8	1	0	2	0	2	102	20	0	0	48	6	0	TCGA-CV-6943-01	60	0.04983289694193792	19	TCGA-CV-6943-01	2	5	4	0.09396961143555284	TCGA-CV-6943-01	3	2	3	8	PASS	3504	TCGA-CV-6943	HNSC	74	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1999	NA	-27310	Dead	WITH TUMOR	NA	602	NA	NA	NA	NA	NA	NA	NA	NA	1	602	1	602	NA	NA	1	602	
40	TCGA-CV-6945	0	11	1	4	5	2	1	0	12	93	7	1	2	48	7	1	TCGA-CV-6945-01	166	0.6338990407780921	90	TCGA-CV-6945-01	27	24	34	0.2708611278158609	TCGA-CV-6945-01	13	9	8	30	PASS	3505	TCGA-CV-6945	HNSC	41	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1993	NA	-15158	Dead	WITH TUMOR	NA	366	NA	NA	NA	NA	NA	NA	NA	NA	1	366	1	366	NA	NA	1	366	
80	TCGA-CV-6948	0	13	1	4	6	4	2	0	9	136	14	0	2	64	7	1	TCGA-CV-6948-01	389	0.9150682093014564	255	TCGA-CV-6948-01	11	15	104	0.32954262829993963	TCGA-CV-6948-01	18	15	19	52	PASS	3506	TCGA-CV-6948	HNSC	79	FEMALE	WHITE	Stage IVB	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1994	NA	-29153	Dead	TUMOR FREE	NA	1289	NA	NA	NA	NA	NA	NA	NA	NA	1	1289	0	1289	NA	NA	0	1289	
60	TCGA-CV-6950	1	5	0	1	2	0	1	1	1	47	6	0	1	20	1	0	TCGA-CV-6950-01	146	0.5790525444337233	80	TCGA-CV-6950-01	21	60	16	0.2118413678631989	TCGA-CV-6950-01	13	10	3	26	PASS	3507	TCGA-CV-6950	HNSC	64	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1994	NA	-23549	Dead	WITH TUMOR	NA	459	NA	Locoregional Recurrence	Oral Cavity	Tonsil	258	Complete Remission/Response	NA	NA	1	459	1	459	NA	NA	1	258	
60	TCGA-CV-6951	2	12	0	18	8	2	0	0	18	222	14	0	0	89	4	2	TCGA-CV-6951-01	178	0.4427123214773583	105	TCGA-CV-6951-01	13	27	10	0.11823097137534495	TCGA-CV-6951-01	10	7	1	18	PASS	3508	TCGA-CV-6951	HNSC	57	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1996	NA	-21166	Dead	WITH TUMOR	NA	915	NA	NA	NA	NA	NA	NA	NA	NA	1	915	1	915	NA	NA	1	915	
70	TCGA-CV-6952	0	26	0	12	8	10	2	2	5	242	30	0	6	98	2	0	TCGA-CV-6952-01	80	0.1630911048735191	29	TCGA-CV-6952-01	5	10	16	0.1927665259838678	TCGA-CV-6952-01	6	2	4	12	PASS	3509	TCGA-CV-6952	HNSC	65	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G1	1996	NA	-23892	Dead	TUMOR FREE	NA	185	NA	NA	NA	NA	NA	NA	NA	NA	1	185	0	185	NA	NA	0	185	
80	TCGA-CV-6953	1	10	2	12	4	0	0	0	17	252	19	0	2	79	4	0	TCGA-CV-6953-01	114	0.14309091514119265	55	TCGA-CV-6953-01	4	6	26	0.10342732591330143	TCGA-CV-6953-01	6	2	5	13	PASS	3510	TCGA-CV-6953	HNSC	80	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G1	1997	NA	-29465	Dead	WITH TUMOR	NA	1641	NA	Locoregional Recurrence	Oral Cavity	oral tongue	1521	Complete Remission/Response	NA	NA	1	1641	1	1641	1	1521	1	1521	
60	TCGA-CV-6954	7	10	0	2	4	4	2	0	10	215	12	0	4	69	10	0	TCGA-CV-6954-01	158	0.4774546260671382	76	TCGA-CV-6954-01	17	31	27	0.32806725007588383	TCGA-CV-6954-01	13	2	7	22	PASS	3511	TCGA-CV-6954	HNSC	59	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1998	NA	-21557	Dead	TUMOR FREE	NA	2002	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2002	0	2002	NA	NA	0	2002	
70	TCGA-CV-6955	0	5	0	8	3	5	1	0	4	129	7	0	3	67	4	0	TCGA-CV-6955-01	53	0.006647483757273118	14	TCGA-CV-6955-01	0	2	2	0.032382138260698606	TCGA-CV-6955-01	1	1	1	3	PASS	3512	TCGA-CV-6955	HNSC	74	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2000	NA	-27261	Dead	WITH TUMOR	NA	334	NA	NA	NA	NA	NA	NA	NA	NA	1	334	1	334	NA	NA	1	334	
70	TCGA-CV-6956	0	11	0	20	10	2	2	0	14	266	16	4	8	143	6	2	TCGA-CV-6956-01	258	0.4795139203101177	168	TCGA-CV-6956-01	11	19	44	0.2305511450768505	TCGA-CV-6956-01	10	8	6	24	PASS	3513	TCGA-CV-6956	HNSC	67	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1993	NA	-24720	Dead	WITH TUMOR	NA	217	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	217	1	217	NA	NA	1	217	
50	TCGA-CV-6959	0	4	0	4	7	0	0	0	4	87	8	0	2	43	0	0	TCGA-CV-6959-01	94	0.41589672825586105	39	TCGA-CV-6959-01	14	24	10	0.16565995695431476	TCGA-CV-6959-01	7	2	3	12	PASS	3514	TCGA-CV-6959	HNSC	48	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1999	NA	-17679	Dead	WITH TUMOR	NA	256	NA	Locoregional Recurrence	NA	"Rt. Neck mass, skin"	103	NA	NA	NA	1	256	1	256	NA	NA	1	103	
50	TCGA-CV-6960	6	16	2	8	22	2	4	0	7	260	18	0	7	98	8	2	TCGA-CV-6960-01	161	0.8398919694088803	77	TCGA-CV-6960-01	9	15	26	0.3124099481921225	TCGA-CV-6960-01	13	8	13	34	PASS	3515	TCGA-CV-6960	HNSC	49	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	1999	NA	-18194	Dead	TUMOR FREE	NA	862	NA	NA	NA	NA	NA	NA	NA	NA	1	862	0	862	NA	NA	0	862	
60	TCGA-CV-6961	2	49	3	38	2	4	2	0	66	866	77	8	42	344	10	2	TCGA-CV-6961-01	174	0.25456200134209683	89	TCGA-CV-6961-01	7	16	32	0.3146322388164824	TCGA-CV-6961-01	15	8	10	33	PASS	3516	TCGA-CV-6961	HNSC	61	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	1999	NA	-22532	Dead	WITH TUMOR	NA	76	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	76	1	76	NA	NA	1	76	
70	TCGA-CV-6962	2	15	4	6	17	4	0	0	14	198	20	0	6	42	10	0	TCGA-CV-6962-01	273	0.8654070760755039	151	TCGA-CV-6962-01	28	23	60	0.5470807534874923	TCGA-CV-6962-01	15	12	12	39	PASS	3517	TCGA-CV-6962	HNSC	65	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1999	NA	-24103	Dead	TUMOR FREE	NA	126	NA	NA	NA	NA	NA	NA	NA	NA	1	126	0	126	NA	NA	0	126	
70	TCGA-CV-7089	4	16	1	8	6	4	0	0	16	279	18	0	4	100	4	0	TCGA-CV-7089-01	60	0.2337121258860681	19	TCGA-CV-7089-01	8	11	12	0.1977075530744313	TCGA-CV-7089-01	4	3	4	11	PASS	3518	TCGA-CV-7089	HNSC	74	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2001	NA	-27149	Dead	TUMOR FREE	NA	1972	NA	NA	NA	NA	NA	NA	NA	NA	1	1972	0	1972	NA	NA	0	1972	
40	TCGA-CV-7090	0	4	0	4	0	2	0	0	5	59	6	0	0	37	2	0	TCGA-CV-7090-01	154	0.5141471182969752	81	TCGA-CV-7090-01	20	32	13	0.017588826047991758	TCGA-CV-7090-01	7	7	1	15	PASS	3519	TCGA-CV-7090	HNSC	39	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2001	NA	-14515	Alive	TUMOR FREE	5252	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	5252	0	5252	0	5252	0	5252	
50	TCGA-CV-7091	2	19	7	6	6	5	2	0	12	234	20	2	2	98	8	0	TCGA-CV-7091-01	184	0.6944251678216271	88	TCGA-CV-7091-01	21	29	52	0.4296557613089541	TCGA-CV-7091-01	13	10	13	36	PASS	3520	TCGA-CV-7091	HNSC	54	MALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G3	2001	NA	-19938	Alive	TUMOR FREE	3381	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3381	0	3381	NA	NA	0	3381	
90	TCGA-CV-7095	2	22	0	21	5	2	1	0	16	352	40	0	4	141	6	0	TCGA-CV-7095-01	155	0.4550855360775125	79	TCGA-CV-7095-01	8	8	24	0.1864342103817327	TCGA-CV-7095-01	14	5	9	28	PASS	3521	TCGA-CV-7095	HNSC	87	FEMALE	NA	Stage II	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2001	NA	-32022	Dead	TUMOR FREE	NA	572	NA	NA	NA	NA	NA	NA	NA	NA	1	572	0	572	NA	NA	0	572	
50	TCGA-CV-7097	0	12	1	5	12	4	0	0	7	159	30	0	5	67	0	0	TCGA-CV-7097-01	139	0.3746869403827455	72	TCGA-CV-7097-01	3	12	39	0.244725369152008	TCGA-CV-7097-01	10	9	8	27	PASS	3522	TCGA-CV-7097	HNSC	53	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2002	NA	-19382	Dead	WITH TUMOR	NA	385	NA	NA	NA	NA	NA	NA	NA	NA	1	385	1	385	NA	NA	1	385	
90	TCGA-CV-7099	1	15	1	6	5	3	1	0	7	223	26	0	8	95	4	0	TCGA-CV-7099-01	59	0.1744574765905601	19	TCGA-CV-7099-01	5	5	12	0.09944079027771928	TCGA-CV-7099-01	5	4	3	12	PASS	3523	TCGA-CV-7099	HNSC	85	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2002	NA	-31134	Dead	TUMOR FREE	NA	243	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	243	0	243	0	243	0	243	
70	TCGA-CV-7100	0	3	0	1	2	4	0	0	2	28	0	0	0	11	0	0	TCGA-CV-7100-01	119	0.19660949890831847	53	TCGA-CV-7100-01	8	11	28	0.1613939815528438	TCGA-CV-7100-01	9	3	7	19	PASS	3524	TCGA-CV-7100	HNSC	66	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2001	NA	-24183	Dead	WITH TUMOR	NA	274	NA	NA	NA	NA	NA	NA	NA	NA	1	274	1	274	NA	NA	1	274	
80	TCGA-CV-7101	2	22	3	10	8	2	2	2	20	316	24	0	6	112	14	0	TCGA-CV-7101-01	89	0.6466099365852248	34	TCGA-CV-7101-01	22	29	26	0.3886689305160005	TCGA-CV-7101-01	13	5	9	27	PASS	3525	TCGA-CV-7101	HNSC	80	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1999	NA	-29550	Dead	TUMOR FREE	NA	160	NA	NA	NA	NA	NA	NA	NA	NA	1	160	0	160	NA	NA	0	160	
80	TCGA-CV-7102	1	11	0	4	1	2	0	0	8	144	14	0	5	55	3	0	TCGA-CV-7102-01	177	0.6274229421081321	100	TCGA-CV-7102-01	20	22	58	0.21861554507980016	TCGA-CV-7102-01	17	10	11	38	PASS	3526	TCGA-CV-7102	HNSC	76	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2000	NA	-27805	Dead	NA	NA	56	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	56	NA	56	NA	NA	0	56	
50	TCGA-CV-7103	2	8	2	7	1	3	1	0	14	112	6	0	4	49	2	0	TCGA-CV-7103-01	150	0.666104739518597	70	TCGA-CV-7103-01	10	10	30	0.26954070232701355	TCGA-CV-7103-01	8	8	8	24	PASS	3527	TCGA-CV-7103	HNSC	49	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2000	NA	-18219	Dead	WITH TUMOR	NA	1591	NA	NA	NA	NA	NA	NA	NA	NA	1	1591	1	1591	NA	NA	1	1591	
60	TCGA-CV-7104	2	8	0	6	3	2	3	0	7	92	12	0	6	34	4	1	TCGA-CV-7104-01	92	0.3378272092129762	37	TCGA-CV-7104-01	10	11	24	0.2662263764487953	TCGA-CV-7104-01	13	3	10	26	PASS	3528	TCGA-CV-7104	HNSC	61	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2000	NA	-22349	Dead	TUMOR FREE	NA	393	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	393	0	393	NA	NA	0	393	
80	TCGA-CV-7177	0	8	2	4	12	0	2	0	2	156	12	2	2	64	6	0	TCGA-CV-7177-01	117	0.3713986775052599	51	TCGA-CV-7177-01	12	17	30	0.2914580231093582	TCGA-CV-7177-01	9	4	6	19	PASS	3529	TCGA-CV-7177	HNSC	82	FEMALE	WHITE	Stage II	Stage I	Head & Neck Squamous Cell Carcinoma	G2	1999	NA	-30180	Dead	WITH TUMOR	NA	663	NA	NA	NA	NA	NA	NA	NA	NA	1	663	1	663	NA	NA	1	663	
60	TCGA-CV-7178	0	12	0	10	0	5	2	0	2	189	16	2	4	76	2	0	TCGA-CV-7178-01	187	0.9896887071985616	96	TCGA-CV-7178-01	25	30	64	0.5123745692661447	TCGA-CV-7178-01	18	12	11	41	PASS	3530	TCGA-CV-7178	HNSC	64	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2000	NA	-23430	Dead	WITH TUMOR	NA	2166	NA	NA	NA	NA	NA	NA	NA	NA	1	2166	1	2166	NA	NA	1	2166	
30	TCGA-CV-7180	0	3	0	1	1	0	0	0	1	46	1	0	1	19	0	0	TCGA-CV-7180-01	68	0.4969556217777519	23	TCGA-CV-7180-01	8	9	11	0.2620264121808897	TCGA-CV-7180-01	4	4	7	15	PASS	3531	TCGA-CV-7180	HNSC	34	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1996	NA	-12523	Dead	WITH TUMOR	NA	327	NA	NA	NA	NA	NA	NA	NA	NA	1	327	1	327	NA	NA	1	327	
50	TCGA-CV-7183	0	8	0	1	10	6	0	0	6	78	10	0	0	39	0	0	TCGA-CV-7183-01	53	0.00054539325293007	13	TCGA-CV-7183-01	0	0	19	6.531750674792697e-05	TCGA-CV-7183-01	0	0	0	0	PASS	3532	TCGA-CV-7183	HNSC	53	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2002	NA	-19358	Alive	TUMOR FREE	3981	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3981	0	3981	0	3981	0	3981	
70	TCGA-CV-7235	0	12	0	6	6	0	2	0	10	205	13	0	0	85	6	2	TCGA-CV-7235-01	180	0.6840005600683263	101	TCGA-CV-7235-01	19	34	42	0.32544647968692064	TCGA-CV-7235-01	16	11	13	40	PASS	3533	TCGA-CV-7235	HNSC	67	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2007	NA	-24800	Alive	TUMOR FREE	2347	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2347	0	2347	0	2347	0	2347	
80	TCGA-CV-7236	1	1	0	2	2	0	3	0	1	28	3	0	0	22	1	0	TCGA-CV-7236-01	52	0.304933598995993	11	TCGA-CV-7236-01	11	6	5	0.11040060722660927	TCGA-CV-7236-01	4	0	4	8	PASS	3534	TCGA-CV-7236	HNSC	77	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2007	NA	-28250	Dead	TUMOR FREE	NA	144	NA	NA	NA	NA	NA	NA	NA	NA	1	144	0	144	NA	NA	0	144	
70	TCGA-CV-7238	6	15	0	8	4	0	0	0	10	215	37	0	6	100	4	0	TCGA-CV-7238-01	49	0.14053038868224738	12	TCGA-CV-7238-01	2	9	7	0.12183781483749535	TCGA-CV-7238-01	1	0	1	2	PASS	3535	TCGA-CV-7238	HNSC	69	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-25471	Alive	TUMOR FREE	2727	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2727	0	2727	0	2727	0	2727	
60	TCGA-CV-7242	2	39	8	18	10	3	4	0	11	477	38	0	17	154	19	0	TCGA-CV-7242-01	82	0.5924207241245057	29	TCGA-CV-7242-01	9	15	25	0.40561948799523656	TCGA-CV-7242-01	11	5	6	22	PASS	3536	TCGA-CV-7242	HNSC	60	FEMALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-22136	Alive	TUMOR FREE	1095	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1095	0	1095	NA	NA	0	1095	
50	TCGA-CV-7243	0	7	1	7	3	1	1	0	4	81	3	0	2	33	1	0	TCGA-CV-7243-01	152	0.6596040011780484	86	TCGA-CV-7243-01	22	27	33	0.2016220645761936	TCGA-CV-7243-01	13	12	7	32	PASS	3537	TCGA-CV-7243	HNSC	50	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-18466	Alive	TUMOR FREE	954	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	954	0	954	NA	NA	0	954	
60	TCGA-CV-7245	8	43	4	40	18	6	0	0	44	791	64	2	22	283	25	8	TCGA-CV-7245-01	201	0.7048911217907688	111	TCGA-CV-7245-01	23	25	38	0.2344952220222656	TCGA-CV-7245-01	15	5	8	28	PASS	3538	TCGA-CV-7245	HNSC	62	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-22646	Alive	TUMOR FREE	797	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	797	0	797	NA	NA	0	797	
60	TCGA-CV-7247	4	12	0	0	12	0	0	0	4	132	7	0	0	55	6	0	TCGA-CV-7247-01	132	0.5368009631137727	64	TCGA-CV-7247-01	22	58	15	0.13732348854441634	TCGA-CV-7247-01	15	6	3	24	PASS	3539	TCGA-CV-7247	HNSC	55	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1995	NA	-20433	Dead	WITH TUMOR	NA	577	NA	NA	NA	NA	NA	NA	NA	NA	1	577	1	577	NA	NA	1	577	
60	TCGA-CV-7248	4	30	2	14	11	6	0	0	18	443	43	0	16	158	14	2	TCGA-CV-7248-01	142	0.4982739244369648	77	TCGA-CV-7248-01	14	15	39	0.4653389201288641	TCGA-CV-7248-01	11	9	13	33	PASS	3540	TCGA-CV-7248	HNSC	63	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2001	NA	-23082	Dead	TUMOR FREE	NA	521	NA	NA	NA	NA	NA	NA	NA	NA	1	521	0	521	NA	NA	0	521	
60	TCGA-CV-7250	2	24	6	18	18	6	2	0	8	415	29	0	3	182	12	0	TCGA-CV-7250-01	143	0.22309951984104026	86	TCGA-CV-7250-01	6	7	18	0.03248251890256095	TCGA-CV-7250-01	6	3	1	10	PASS	3541	TCGA-CV-7250	HNSC	64	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2000	NA	-23489	Dead	TUMOR FREE	NA	2900	NA	Distant Metastasis	Distant Metastasis	suprasternal	111	Complete Remission/Response	NA	NA	1	2900	0	2900	NA	NA	1	111	
60	TCGA-CV-7252	6	25	4	13	8	8	6	2	19	379	40	0	11	162	8	0	TCGA-CV-7252-01	103	0.11690965935812693	53	TCGA-CV-7252-01	3	4	19	0.19204006443534088	TCGA-CV-7252-01	1	1	1	3	PASS	3542	TCGA-CV-7252	HNSC	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1994	NA	-22934	Dead	WITH TUMOR	NA	151	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	151	1	151	NA	NA	1	151	
60	TCGA-CV-7253	1	10	0	5	6	4	2	0	4	135	11	1	4	43	7	1	TCGA-CV-7253-01	203	0.2553658106827285	118	TCGA-CV-7253-01	9	14	35	0.20813879563005366	TCGA-CV-7253-01	13	9	10	32	PASS	3543	TCGA-CV-7253	HNSC	58	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1993	NA	-21473	Dead	WITH TUMOR	NA	361	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	361	1	361	NA	NA	1	361	
60	TCGA-CV-7254	1	8	2	8	10	2	2	0	9	216	10	1	4	84	9	0	TCGA-CV-7254-01	257	0.8492384326944141	156	TCGA-CV-7254-01	26	38	46	0.3467283217833532	TCGA-CV-7254-01	20	18	9	47	PASS	3544	TCGA-CV-7254	HNSC	55	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	1996	NA	-20306	Dead	WITH TUMOR	NA	1459	NA	NA	NA	NA	NA	NA	NA	NA	1	1459	1	1459	NA	NA	1	1459	
30	TCGA-CV-7255	0	11	2	6	15	6	6	0	6	165	6	0	4	53	4	0	TCGA-CV-7255-01	112	0.8471523236274483	52	TCGA-CV-7255-01	27	29	14	0.1373959913514413	TCGA-CV-7255-01	11	4	4	19	PASS	3545	TCGA-CV-7255	HNSC	32	FEMALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1995	NA	-11931	Dead	WITH TUMOR	NA	64	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	64	1	64	NA	NA	1	64	
60	TCGA-CV-7261	2	12	2	14	0	4	2	0	20	292	23	0	10	105	6	0	TCGA-CV-7261-01	152	0.6427874491509814	74	TCGA-CV-7261-01	17	23	32	0.31318655988336835	TCGA-CV-7261-01	18	13	12	43	PASS	3546	TCGA-CV-7261	HNSC	57	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-20992	Alive	TUMOR FREE	1512	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1512	0	1512	NA	NA	0	1512	
60	TCGA-CV-7263	0	18	0	16	6	2	0	0	12	209	10	0	4	59	6	0	TCGA-CV-7263-01	75	0.5401278849231046	26	TCGA-CV-7263-01	25	20	13	0.1771589817418028	TCGA-CV-7263-01	5	2	2	9	PASS	3547	TCGA-CV-7263	HNSC	64	MALE	BLACK OR AFRICAN AMERICAN	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	1997	NA	-23513	Dead	WITH TUMOR	NA	560	NA	NA	NA	NA	NA	NA	NA	NA	1	560	1	560	NA	NA	1	560	
50	TCGA-CV-7406	6	27	0	5	16	0	2	0	14	280	20	0	4	132	6	0	TCGA-CV-7406-01	146	0.2822461695992312	65	TCGA-CV-7406-01	9	14	26	0.2180576632662531	TCGA-CV-7406-01	9	8	8	25	PASS	3548	TCGA-CV-7406	HNSC	49	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	GX	1999	NA	-18250	Dead	NA	NA	1748	NA	NA	NA	NA	NA	NA	NA	NA	1	1748	NA	1748	NA	NA	0	1748	
70	TCGA-CV-7407	1	5	1	1	4	1	0	0	1	89	8	0	3	42	3	0	TCGA-CV-7407-01	297	0.7154671634748924	191	TCGA-CV-7407-01	22	34	58	0.2432844669317385	TCGA-CV-7407-01	13	10	7	30	PASS	3549	TCGA-CV-7407	HNSC	67	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1992	NA	-24475	Dead	NA	NA	1081	NA	NA	NA	NA	NA	NA	NA	NA	1	1081	NA	1081	NA	NA	0	1081	
40	TCGA-CV-7409	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CV-7409-01	245	0.9594284577484768	157	TCGA-CV-7409-01	26	75	29	0.2470997304395127	TCGA-CV-7409-01	13	7	8	28	PASS	3550	TCGA-CV-7409	HNSC	43	MALE	BLACK OR AFRICAN AMERICAN	Stage IVB	Stage IVB	Head & Neck Squamous Cell Carcinoma	G3	1994	NA	-15888	Dead	NA	NA	543	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	543	NA	543	NA	NA	0	543	
60	TCGA-CV-7410	0	1	0	1	0	1	0	0	2	31	4	0	0	11	1	0	TCGA-CV-7410-01	50	0.0369110194334081	15	TCGA-CV-7410-01	2	2	19	0.013617185282312752	TCGA-CV-7410-01	2	0	1	3	PASS	3551	TCGA-CV-7410	HNSC	61	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	GX	1993	NA	-22302	Dead	WITH TUMOR	NA	6417	NA	NA	NA	NA	NA	NA	NA	NA	1	6417	1	6417	NA	NA	1	6417	
60	TCGA-CV-7411	0	7	0	3	3	2	1	0	3	89	7	0	0	37	2	0	TCGA-CV-7411-01	45	0.00016320892337231166	7	TCGA-CV-7411-01	0	3	4	0.03827967223255983	TCGA-CV-7411-01	3	3	3	9	PASS	3552	TCGA-CV-7411	HNSC	64	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	1994	NA	-23696	Dead	NA	NA	2717	NA	NA	NA	NA	NA	NA	NA	NA	1	2717	NA	2717	NA	NA	0	2717	
70	TCGA-CV-7413	0	6	6	0	0	2	2	0	6	122	6	0	0	43	0	0	TCGA-CV-7413-01	121	0.3278329075362856	57	TCGA-CV-7413-01	8	10	29	0.2831415341892196	TCGA-CV-7413-01	7	7	9	23	PASS	3553	TCGA-CV-7413	HNSC	74	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1995	NA	-27231	Dead	NA	NA	294	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	294	NA	294	0	294	0	294	
80	TCGA-CV-7414	3	10	0	8	1	1	0	0	7	203	17	0	0	85	5	0	TCGA-CV-7414-01	190	0.4067377152755982	108	TCGA-CV-7414-01	9	13	51	0.3454826379454603	TCGA-CV-7414-01	11	13	17	41	PASS	3554	TCGA-CV-7414	HNSC	78	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1995	NA	-28603	Dead	NA	NA	14	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	14	NA	14	NA	NA	0	14	
60	TCGA-CV-7415	1	12	2	3	0	1	1	0	11	177	35	0	1	73	3	2	TCGA-CV-7415-01	228	0.6861683443701062	117	TCGA-CV-7415-01	24	30	75	0.18072923122386084	TCGA-CV-7415-01	16	9	8	33	PASS	3555	TCGA-CV-7415	HNSC	60	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1995	NA	-22062	Dead	WITH TUMOR	NA	695	NA	NA	NA	NA	NA	NA	NA	NA	1	695	1	695	NA	NA	1	695	
30	TCGA-CV-7416	0	8	0	6	8	0	0	2	8	104	10	0	2	51	4	0	TCGA-CV-7416-01	199	0.7435909089150622	111	TCGA-CV-7416-01	23	38	42	0.4572603830639042	TCGA-CV-7416-01	18	5	6	29	PASS	3556	TCGA-CV-7416	HNSC	29	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	1994	NA	-10936	Dead	NA	NA	763	NA	NA	NA	NA	NA	NA	NA	NA	1	763	NA	763	NA	NA	0	763	
60	TCGA-CV-7418	0	12	0	5	6	8	2	0	10	264	10	0	2	100	8	0	TCGA-CV-7418-01	321	0.8418850869896921	192	TCGA-CV-7418-01	13	18	76	0.4754586415102382	TCGA-CV-7418-01	13	10	11	34	PASS	3557	TCGA-CV-7418	HNSC	62	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1996	NA	-22805	Dead	TUMOR FREE	NA	789	NA	Locoregional Recurrence	Hypopharynx	nasopharynx	494	Complete Remission/Response	NA	NA	1	789	0	789	NA	NA	1	494	
80	TCGA-CV-7421	1	14	1	4	1	2	0	0	10	117	30	0	2	63	4	0	TCGA-CV-7421-01	210	0.5222740312423423	110	TCGA-CV-7421-01	19	32	33	0.2775411109063404	TCGA-CV-7421-01	22	14	8	44	PASS	3558	TCGA-CV-7421	HNSC	76	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1997	NA	-27961	Dead	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	1	2	NA	2	NA	NA	0	2	
60	TCGA-CV-7422	3	5	0	1	2	1	0	0	4	101	15	0	3	40	4	0	TCGA-CV-7422-01	102	0.4632574410031424	40	TCGA-CV-7422-01	14	25	19	0.2204939854372946	TCGA-CV-7422-01	14	8	8	30	PASS	3559	TCGA-CV-7422	HNSC	60	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	1997	NA	-22098	Dead	WITH TUMOR	NA	1037	NA	Locoregional Recurrence	Larynx	tracheal	733	Complete Remission/Response	NA	NA	1	1037	1	1037	NA	NA	1	733	
70	TCGA-CV-7423	0	9	0	5	3	4	4	0	0	84	5	0	5	56	4	0	TCGA-CV-7423-01	120	0.5974908363531573	50	TCGA-CV-7423-01	19	69	25	0.11018468992824523	TCGA-CV-7423-01	11	11	7	29	PASS	3560	TCGA-CV-7423	HNSC	65	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	1997	NA	-24071	Dead	NA	NA	3059	NA	NA	NA	NA	NA	NA	NA	NA	1	3059	NA	3059	NA	NA	0	3059	
70	TCGA-CV-7424	0	19	0	9	2	3	2	0	11	286	29	0	2	112	2	2	TCGA-CV-7424-01	240	0.5800139649994266	142	TCGA-CV-7424-01	19	28	33	0.2419465260865287	TCGA-CV-7424-01	13	6	8	27	PASS	3561	TCGA-CV-7424	HNSC	67	MALE	ASIAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1997	NA	-24775	Dead	WITH TUMOR	NA	453	NA	NA	NA	NA	NA	NA	NA	NA	1	453	1	453	NA	NA	1	453	
80	TCGA-CV-7425	0	4	0	3	1	2	3	0	8	132	14	0	5	55	1	0	TCGA-CV-7425-01	134	0.10240194493182216	62	TCGA-CV-7425-01	1	7	29	0.17148343133855834	TCGA-CV-7425-01	3	3	0	6	PASS	3562	TCGA-CV-7425	HNSC	77	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2000	NA	-28368	Dead	WITH TUMOR	NA	1718	NA	NA	NA	NA	NA	NA	NA	NA	1	1718	1	1718	NA	NA	1	1718	
70	TCGA-CV-7427	0	27	3	12	3	2	0	0	22	343	37	0	6	125	2	0	TCGA-CV-7427-01	73	0.11645425455698992	23	TCGA-CV-7427-01	3	3	6	0.02459526359656191	TCGA-CV-7427-01	3	3	2	8	PASS	3563	TCGA-CV-7427	HNSC	73	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	1997	NA	-26975	Dead	TUMOR FREE	NA	4760	NA	Locoregional Recurrence	Oral Cavity	Maxilla	3282	Complete Remission/Response	NA	NA	1	4760	0	4760	1	3282	1	3282	
50	TCGA-CV-7428	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CV-7428-01	212	0.2095330218706284	131	TCGA-CV-7428	0	0	0	0	TCGA-CV-7428	0	0	0	0	PASS	3564	TCGA-CV-7428	HNSC	47	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1998	NA	-17429	Dead	WITH TUMOR	NA	1671	NA	NA	NA	NA	NA	NA	NA	NA	1	1671	1	1671	NA	NA	1	1671	
60	TCGA-CV-7429	0	2	0	2	1	2	0	0	3	38	4	0	0	17	3	0	TCGA-CV-7429-01	113	0.3071369058400272	58	TCGA-CV-7429-01	4	2	10	0.03856379582921633	TCGA-CV-7429-01	1	5	1	7	PASS	3565	TCGA-CV-7429	HNSC	55	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	1998	NA	-20188	Dead	WITH TUMOR	NA	107	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	107	1	107	NA	NA	1	107	
60	TCGA-CV-7430	0	23	0	8	8	0	0	0	4	167	10	0	8	55	6	0	TCGA-CV-7430-01	209	0.5761158231108161	112	TCGA-CV-7430-01	10	15	65	0.26573781077706154	TCGA-CV-7430-01	16	10	13	39	PASS	3566	TCGA-CV-7430	HNSC	56	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1996	NA	-20763	Dead	WITH TUMOR	NA	495	NA	NA	NA	NA	NA	NA	NA	NA	1	495	1	495	NA	NA	1	495	
80	TCGA-CV-7432	2	20	0	12	14	2	0	0	16	225	18	0	4	96	4	0	TCGA-CV-7432-01	91	0.5470683411000667	31	TCGA-CV-7432-01	14	14	15	0.1567441090417135	TCGA-CV-7432-01	5	5	6	16	PASS	3567	TCGA-CV-7432	HNSC	79	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G1	1998	NA	-28875	Dead	WITH TUMOR	NA	2570	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2570	1	2570	NA	NA	1	2570	
50	TCGA-CV-7433	0	5	0	4	4	0	0	0	1	93	8	0	1	38	2	0	TCGA-CV-7433-01	105	0.2476154454987747	44	TCGA-CV-7433-01	14	16	33	0.4600559253754196	TCGA-CV-7433-01	7	9	10	26	PASS	3568	TCGA-CV-7433	HNSC	49	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	1999	NA	-18004	Dead	WITH TUMOR	NA	601	NA	Distant Metastasis	Distant Metastasis	Lt. Deltoid	445	Progressive Disease	NA	NA	1	601	1	601	NA	NA	1	445	
60	TCGA-CV-7434	0	12	2	6	6	0	2	0	10	134	22	0	2	52	6	0	TCGA-CV-7434-01	154	0.2889391709049559	88	TCGA-CV-7434-01	10	15	29	0.13472541703431476	TCGA-CV-7434-01	11	4	8	23	PASS	3569	TCGA-CV-7434	HNSC	64	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1999	NA	-23465	Dead	TUMOR FREE	NA	218	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	218	0	218	NA	NA	0	218	
60	TCGA-CV-7435	0	10	2	3	4	6	0	0	7	136	8	0	0	41	0	0	TCGA-CV-7435-01	160	0.7495218453831606	77	TCGA-CV-7435-01	25	23	34	0.28689006781383186	TCGA-CV-7435-01	13	9	8	30	PASS	3570	TCGA-CV-7435	HNSC	57	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1999	NA	-21049	Dead	TUMOR FREE	NA	4680	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	4680	0	4680	NA	NA	0	4680	
80	TCGA-CV-7437	0	12	2	6	12	2	4	0	10	188	26	0	2	79	2	0	TCGA-CV-7437-01	205	0.9532166022990768	116	TCGA-CV-7437-01	19	37	59	0.5396715628883079	TCGA-CV-7437-01	21	16	13	50	PASS	3571	TCGA-CV-7437	HNSC	77	MALE	NA	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	GX	1996	NA	-28221	Dead	WITH TUMOR	NA	506	NA	NA	NA	NA	NA	NA	NA	NA	1	506	1	506	NA	NA	1	506	
90	TCGA-CV-7438	0	6	0	7	4	0	2	0	10	104	8	0	3	43	2	0	TCGA-CV-7438-01	96	0.2291227030352327	32	TCGA-CV-7438-01	2	12	20	0.22141612951519132	TCGA-CV-7438-01	4	5	2	11	PASS	3572	TCGA-CV-7438	HNSC	87	FEMALE	WHITE	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2000	NA	-32021	Dead	WITH TUMOR	NA	194	NA	NA	NA	NA	NA	NA	NA	NA	1	194	1	194	NA	NA	1	194	
40	TCGA-CV-7440	4	16	0	12	27	4	2	0	8	317	30	0	13	83	16	0	TCGA-CV-7440-01	155	0.5449064499394163	85	TCGA-CV-7440-01	11	30	29	0.1269856236877627	TCGA-CV-7440-01	17	17	8	42	PASS	3573	TCGA-CV-7440	HNSC	38	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	GX	2000	NA	-13992	Dead	NA	NA	675	NA	NA	NA	NA	NA	NA	NA	NA	1	675	NA	675	NA	NA	0	675	
70	TCGA-CV-7446	0	4	0	5	5	0	3	0	7	106	6	0	4	38	4	0	TCGA-CV-7446	0	0	0	TCGA-CV-7446	0	0	0	0	TCGA-CV-7446	0	0	0	0	PASS	3574	TCGA-CV-7446	HNSC	66	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1998	NA	-24170	Dead	WITH TUMOR	NA	1093	NA	NA	NA	NA	NA	NA	NA	NA	1	1093	1	1093	NA	NA	1	1093	
50	TCGA-CV-7568	9	148	10	67	3	1	1	0	94	1728	116	0	47	967	34	4	TCGA-CV-7568	0	0	0	TCGA-CV-7568	0	0	0	0	TCGA-CV-7568	0	0	0	0	hypermutated sample	3575	TCGA-CV-7568	HNSC	48	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	1995	NA	-17670	Dead	NA	NA	927	NA	NA	NA	NA	NA	NA	NA	NA	1	927	NA	927	NA	NA	0	927	
60	TCGA-CV-A45O	0	7	1	1	0	1	0	0	5	122	16	0	1	31	1	0	TCGA-CV-A45O-01	51	0.0005027621937252114	17	TCGA-CV-A45O-01	0	4	32	0.09152834694074256	TCGA-CV-A45O-01	3	1	4	8	PASS	3576	TCGA-CV-A45O	HNSC	57	MALE	WHITE	NA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1994	NA	-20868	Alive	TUMOR FREE	851	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	851	0	851	NA	NA	0	851	
80	TCGA-CV-A45P	1	10	0	8	1	1	0	0	7	125	9	0	3	49	3	0	TCGA-CV-A45P-01	51	0.049823590927719236	10	TCGA-CV-A45P-01	2	3	10	0.09254745880364657	TCGA-CV-A45P-01	1	1	1	3	PASS	3577	TCGA-CV-A45P	HNSC	82	FEMALE	WHITE	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1998	NA	-30297	Alive	WITH TUMOR	639	NA	NA	Locoregional Recurrence	Oral Cavity	Floor of mouth	639	Complete Remission/Response	NA	NA	0	639	0	639	1	639	1	639	
70	TCGA-CV-A45Q	3	16	1	14	6	0	0	0	14	207	19	0	2	90	10	2	TCGA-CV-A45Q-01	134	0.14863657818155493	74	TCGA-CV-A45Q-01	2	5	65	0.1170160931338646	TCGA-CV-A45Q-01	5	8	2	15	PASS	3578	TCGA-CV-A45Q	HNSC	69	FEMALE	WHITE	NA	Stage IVC	Head & Neck Squamous Cell Carcinoma	G1	1995	NA	-25379	Dead	TUMOR FREE	NA	5152	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	5152	0	5152	NA	NA	0	5152	
50	TCGA-CV-A45R	1	4	0	5	1	0	1	0	1	69	6	0	1	23	1	0	TCGA-CV-A45R-01	114	0.5009400527117084	51	TCGA-CV-A45R-01	17	26	78	0.20049727093514474	TCGA-CV-A45R-01	12	8	5	25	PASS	3579	TCGA-CV-A45R	HNSC	46	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G1	1997	NA	-17125	Alive	TUMOR FREE	5480	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	5480	0	5480	0	5480	0	5480	
60	TCGA-CV-A45T	1	1	0	0	0	0	0	0	0	11	0	0	0	4	0	0	TCGA-CV-A45T-01	62	3.0318389369528028e-05	22	TCGA-CV-A45T-01	4	4	16	0.006888672545232806	TCGA-CV-A45T-01	3	7	0	10	PASS	3580	TCGA-CV-A45T	HNSC	64	FEMALE	WHITE	[Discrepancy]	Stage II	Head & Neck Squamous Cell Carcinoma	G3	1998	NA	-23452	Dead	TUMOR FREE	NA	4856	NA	NA	NA	NA	NA	NA	NA	NA	1	4856	0	4856	NA	NA	0	4856	
60	TCGA-CV-A45U	3	11	2	6	3	1	1	0	9	145	19	0	1	75	1	1	TCGA-CV-A45U-01	196	0.4956770667864994	112	TCGA-CV-A45U-01	19	50	136	0.497394327742464	TCGA-CV-A45U-01	25	16	10	51	PASS	3581	TCGA-CV-A45U	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	1999	NA	-21746	Dead	WITH TUMOR	NA	1079	NA	NA	Distant Metastasis	pelvis	1064	Complete Remission/Response	NA	NA	1	1079	1	1079	NA	NA	1	1064	
90	TCGA-CV-A45V	0	7	0	6	3	4	0	0	4	78	5	0	2	33	2	0	TCGA-CV-A45V-01	79	0.05517379595715855	39	TCGA-CV-A45V-01	2	3	57	0.12588508453348812	TCGA-CV-A45V-01	4	2	4	10	PASS	3582	TCGA-CV-A45V	HNSC	87	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	1999	NA	-31936	Dead	NA	NA	32	NA	NA	NA	NA	NA	NA	NA	NA	1	32	NA	32	NA	NA	0	32	
80	TCGA-CV-A45W	5	27	3	20	14	8	1	0	16	462	47	2	14	153	12	0	TCGA-CV-A45W-01	137	0.5124602391205634	71	TCGA-CV-A45W-01	18	39	28	0.10894271560892944	TCGA-CV-A45W-01	15	15	5	35	PASS	3583	TCGA-CV-A45W	HNSC	75	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1999	NA	-27743	Dead	TUMOR FREE	NA	1398	NA	NA	NA	NA	NA	NA	NA	NA	1	1398	0	1398	NA	NA	0	1398	
50	TCGA-CV-A45X	1	5	1	2	0	1	2	0	4	77	6	0	1	46	3	0	TCGA-CV-A45X-01	133	0.4944278815990455	63	TCGA-CV-A45X-01	17	34	106	0.32461923940513066	TCGA-CV-A45X-01	13	8	7	28	PASS	3584	TCGA-CV-A45X	HNSC	47	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2000	NA	-17464	Dead	TUMOR FREE	NA	198	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	198	0	198	NA	NA	0	198	
60	TCGA-CV-A45Y	0	3	0	3	1	1	0	0	0	56	5	0	0	22	1	0	TCGA-CV-A45Y-01	80	0.1881198858814236	27	TCGA-CV-A45Y-01	2	3	23	0.02808381112206604	TCGA-CV-A45Y-01	4	3	1	8	PASS	3585	TCGA-CV-A45Y	HNSC	61	MALE	AMERICAN INDIAN OR ALASKA NATIVE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2000	NA	-22442	Dead	TUMOR FREE	NA	2703	NA	NA	NA	R. Lung	2318	Complete Remission/Response	NA	NA	1	2703	0	2703	NA	NA	1	2318	
80	TCGA-CV-A45Z	2	29	1	11	14	3	1	0	14	556	36	1	14	193	23	2	TCGA-CV-A45Z-01	68	0.2770091176964054	22	TCGA-CV-A45Z-01	18	24	13	0.04970930204447916	TCGA-CV-A45Z-01	11	15	1	27	PASS	3586	TCGA-CV-A45Z	HNSC	75	MALE	WHITE	[Discrepancy]	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2000	NA	-27397	Dead	WITH TUMOR	NA	1466	NA	NA	NA	NA	NA	NA	NA	NA	1	1466	1	1466	NA	NA	1	1466	
70	TCGA-CV-A460	1	3	0	1	2	1	0	0	3	54	5	0	0	16	1	0	TCGA-CV-A460-01	149	0.5246510311473233	69	TCGA-CV-A460-01	10	13	91	0.3581220708254582	TCGA-CV-A460-01	16	10	17	43	PASS	3587	TCGA-CV-A460	HNSC	72	MALE	WHITE	[Discrepancy]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2001	NA	-26539	Dead	[Discrepancy]	NA	1838	NA	New Primary Tumor	NA	mediastinum	1425	Complete Remission/Response	NA	NA	1	1838	NA	1838	NA	NA	1	1425	
70	TCGA-CV-A461	3	29	4	24	22	8	1	0	16	436	31	0	9	174	19	1	TCGA-CV-A461-01	97	0.2510536881227049	41	TCGA-CV-A461-01	9	12	59	0.1960902065063656	TCGA-CV-A461-01	8	5	8	21	PASS	3588	TCGA-CV-A461	HNSC	65	MALE	WHITE	NA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2004	NA	-23955	Dead	TUMOR FREE	NA	2064	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2064	0	2064	0	2064	0	2064	
80	TCGA-CV-A463	1	10	2	4	1	0	1	0	7	160	24	0	3	70	1	0	TCGA-CV-A463-01	101	0.1980676030677772	40	TCGA-CV-A463-01	7	6	69	0.10917719820604124	TCGA-CV-A463-01	1	1	4	6	PASS	3589	TCGA-CV-A463	HNSC	82	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-30095	Dead	TUMOR FREE	NA	23	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	23	0	23	NA	NA	0	23	
50	TCGA-CV-A464	0	3	0	1	1	0	0	0	1	16	0	0	0	13	3	0	TCGA-CV-A464-01	68	0.1843242088653541	25	TCGA-CV-A464-01	5	9	19	0.21325370085982706	TCGA-CV-A464-01	5	6	7	18	PASS	3590	TCGA-CV-A464	HNSC	48	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-17669	Alive	TUMOR FREE	1722	NA	NA	Locoregional Disease	NA	pterygoid	28	Complete Remission/Response	NA	NA	0	1722	0	1722	NA	NA	1	28	
30	TCGA-CV-A465	0	0	0	1	2	0	0	0	2	29	2	0	0	9	0	0	TCGA-CV-A465-01	81	0.7524807520043411	29	TCGA-CV-A465-01	26	29	70	0.2669621089014299	TCGA-CV-A465-01	14	8	9	31	PASS	3591	TCGA-CV-A465	HNSC	24	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2008	NA	-9015	Dead	TUMOR FREE	NA	215	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	215	0	215	0	215	0	215	
40	TCGA-CV-A468	1	11	0	8	0	0	0	0	14	310	19	0	6	162	6	0	TCGA-CV-A468-01	57	0.008725856755205959	17	TCGA-CV-A468	0	0	0	0	TCGA-CV-A468	0	0	0	0	PASS	3592	TCGA-CV-A468	HNSC	42	MALE	NA	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2001	NA	-15372	Dead	TUMOR FREE	NA	464	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	464	0	464	NA	NA	0	464	
80	TCGA-CV-A6JD	0	4	0	1	3	1	1	0	1	68	7	0	0	25	1	0	TCGA-CV-A6JD-01	60	0.11387346928775455	18	TCGA-CV-A6JD-01	5	9	34	0.13735576424193854	TCGA-CV-A6JD-01	5	2	4	11	PASS	3593	TCGA-CV-A6JD	HNSC	82	FEMALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2012	NA	-29988	Dead	TUMOR FREE	NA	182	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	182	0	182	NA	NA	0	182	
80	TCGA-CV-A6JE	1	8	1	5	3	4	0	0	5	98	11	0	4	39	3	0	TCGA-CV-A6JE-01	189	0.4597482775604858	99	TCGA-CV-A6JE-01	11	32	105	0.3375691874530368	TCGA-CV-A6JE-01	16	10	10	36	PASS	3594	TCGA-CV-A6JE	HNSC	78	MALE	WHITE	NA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-28658	Alive	TUMOR FREE	1075	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1075	0	1075	0	1075	0	1075	
90	TCGA-CV-A6JM	2	20	2	7	3	3	1	0	16	196	15	0	8	114	3	0	TCGA-CV-A6JM-01	272	0.9676240732871222	159	TCGA-CV-A6JM-01	21	40	199	0.5271969846306769	TCGA-CV-A6JM-01	19	18	15	52	PASS	3595	TCGA-CV-A6JM	HNSC	85	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-31147	Dead	TUMOR FREE	NA	194	NA	Locoregional Recurrence	Oropharynx	NA	107	Complete Remission/Response	NA	NA	1	194	0	194	NA	NA	1	107	
50	TCGA-CV-A6JN	1	5	0	2	1	0	0	0	1	63	5	0	1	23	0	0	TCGA-CV-A6JN-01	158	0.22163557725318345	84	TCGA-CV-A6JN-01	7	10	106	0.19816145778572766	TCGA-CV-A6JN-01	7	5	12	24	PASS	3596	TCGA-CV-A6JN	HNSC	53	MALE	WHITE	NA	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2011	NA	-19635	Alive	TUMOR FREE	906	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	906	0	906	0	906	0	906	
70	TCGA-CV-A6JO	1	2	0	3	3	2	1	0	3	58	1	0	0	15	2	0	TCGA-CV-A6JO-01	87	0.11304718724398745	37	TCGA-CV-A6JO-01	6	10	39	0.08361864122940636	TCGA-CV-A6JO-01	7	3	3	13	PASS	3597	TCGA-CV-A6JO	HNSC	69	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-25377	Dead	WITH TUMOR	NA	197	NA	NA	Oral Cavity	submandibular	127	Progressive Disease	NA	NA	1	197	1	197	NA	NA	1	127	
70	TCGA-CV-A6JT	2	1	0	0	0	0	0	0	0	41	5	0	0	16	0	0	TCGA-CV-A6JT-01	118	0.1937642686168764	54	TCGA-CV-A6JT-01	5	8	74	0.18553101026064084	TCGA-CV-A6JT-01	10	9	5	24	PASS	3598	TCGA-CV-A6JT	HNSC	65	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-23806	Alive	TUMOR FREE	852	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	852	0	852	0	852	0	852	
60	TCGA-CV-A6JU	0	5	0	2	2	10	2	0	6	91	6	0	5	41	4	1	TCGA-CV-A6JU-01	162	0.29050263788330033	91	TCGA-CV-A6JU-01	11	13	109	0.2377250475989831	TCGA-CV-A6JU-01	15	10	10	35	PASS	3599	TCGA-CV-A6JU	HNSC	61	FEMALE	WHITE	Stage IVB	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-22591	Alive	TUMOR FREE	110	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	110	0	110	NA	NA	0	110	
70	TCGA-CV-A6JY	1	3	0	2	1	1	0	0	0	75	6	0	2	21	1	0	TCGA-CV-A6JY-01	64	0.12821364262516724	18	TCGA-CV-A6JY-01	2	2	35	0.1587904244980783	TCGA-CV-A6JY-01	6	3	6	15	PASS	3600	TCGA-CV-A6JY	HNSC	69	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2011	NA	-25321	Alive	TUMOR FREE	646	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	646	0	646	NA	NA	0	646	
70	TCGA-CV-A6JZ	1	8	0	2	3	2	1	0	2	78	5	0	1	30	4	1	TCGA-CV-A6JZ-01	58	0.2555581183258516	21	TCGA-CV-A6JZ-01	12	12	56	0.19271770224160206	TCGA-CV-A6JZ-01	13	5	10	28	PASS	3601	TCGA-CV-A6JZ	HNSC	68	MALE	WHITE	Stage II	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-25182	Alive	WITH TUMOR	714	NA	NA	Locoregional Recurrence	Oral Cavity	submandibular	393	Complete Remission/Response	NA	NA	0	714	0	714	NA	NA	1	393	
60	TCGA-CV-A6K0	0	1	0	2	0	0	0	0	0	14	0	0	0	6	0	0	TCGA-CV-A6K0-01	70	0.041998316593029265	24	TCGA-CV-A6K0-01	1	10	2	0.00011410193111234904	TCGA-CV-A6K0-01	3	2	0	5	PASS	3602	TCGA-CV-A6K0	HNSC	58	MALE	WHITE	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2011	NA	-21488	Alive	TUMOR FREE	606	NA	NA	NA	Cervical Lymph Nodes	neck	146	Complete Remission/Response	NA	NA	0	606	0	606	1	146	1	146	
70	TCGA-CV-A6K1	1	28	3	12	63	17	2	0	17	342	21	0	11	144	9	0	TCGA-CV-A6K1-01	129	0.2315934364070463	68	TCGA-CV-A6K1-01	4	6	62	0.17374750108529147	TCGA-CV-A6K1-01	5	2	9	16	PASS	3603	TCGA-CV-A6K1	HNSC	65	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-23848	Alive	TUMOR FREE	685	NA	NA	New Primary Tumor	Oral Cavity	Tonsil	401	Complete Remission/Response	NA	NA	0	685	0	685	NA	NA	1	401	
80	TCGA-CV-A6K2	2	32	2	15	1	3	0	0	30	495	59	3	6	224	13	0	TCGA-CV-A6K2-01	83	0.05144542899757221	38	TCGA-CV-A6K2-01	2	2	16	0.018201023236168658	TCGA-CV-A6K2-01	3	1	1	5	PASS	3604	TCGA-CV-A6K2	HNSC	79	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2011	NA	-29114	Dead	WITH TUMOR	NA	317	NA	Locoregional Recurrence	NA	Infratemporal fossa	134	Progressive Disease	NA	NA	1	317	1	317	NA	NA	1	134	
80	TCGA-CX-7082	1	6	0	4	3	2	1	0	5	102	13	1	1	45	0	0	TCGA-CX-7082	0	0	0	TCGA-CX-7082	0	0	0	0	TCGA-CX-7082-01	16	14	11	41	PASS	3605	TCGA-CX-7082	HNSC	82	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-30174	Dead	TUMOR FREE	NA	11	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	11	0	11	NA	NA	0	11	
80	TCGA-CX-7085	0	13	0	7	0	0	1	0	4	116	8	1	3	44	2	0	TCGA-CX-7085-01	43	6.0502705783457114e-05	7	TCGA-CX-7085-01	0	0	2	0.007751509084125947	TCGA-CX-7085-01	1	1	1	3	PASS	3606	TCGA-CX-7085	HNSC	77	FEMALE	WHITE	Stage I	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-28221	Alive	WITH TUMOR	321	NA	NA	Locoregional Recurrence	Oropharynx	Submandibular gland	92	Complete Remission/Response	NA	NA	0	321	0	321	1	92	1	92	
50	TCGA-CX-7086	2	19	0	4	5	4	1	0	7	179	13	0	5	61	4	1	TCGA-CX-7086-01	333	0.6436876254044657	196	TCGA-CX-7086-01	18	29	51	0.2258682658795401	TCGA-CX-7086-01	20	15	7	42	PASS	3607	TCGA-CX-7086	HNSC	53	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-19434	Alive	TUMOR FREE	573	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	573	0	573	NA	NA	0	573	
50	TCGA-CX-7219	0	11	1	3	3	2	0	0	9	99	9	0	1	37	2	1	TCGA-CX-7219-01	127	0.6861324801927905	57	TCGA-CX-7219-01	10	15	30	0.4690423934733919	TCGA-CX-7219-01	10	10	13	33	PASS	3608	TCGA-CX-7219	HNSC	47	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-17222	Alive	TUMOR FREE	1045	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1045	0	1045	NA	NA	0	1045	
60	TCGA-CX-A4AQ	0	6	1	4	4	0	1	0	3	78	4	0	4	27	4	0	TCGA-CX-A4AQ-01	65	0.2730000254185601	15	TCGA-CX-A4AQ-01	12	13	30	0.16514647811219568	TCGA-CX-A4AQ-01	8	4	4	16	PASS	3609	TCGA-CX-A4AQ	HNSC	56	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2008	NA	-20709	Alive	TUMOR FREE	1555	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1555	0	1555	NA	NA	0	1555	
80	TCGA-D6-6515	0	1	0	0	0	1	1	0	3	32	5	0	0	18	1	0	TCGA-D6-6515-01	49	0.045619290386608384	8	TCGA-D6-6515-01	4	5	19	0.05094007896402004	TCGA-D6-6515-01	0	0	0	0	PASS	3610	TCGA-D6-6515	HNSC	82	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-30099	Dead	TUMOR FREE	NA	403	NA	NA	Cervical Lymph Nodes	NA	195	Complete Remission/Response	NA	NA	1	403	0	403	1	195	1	195	
70	TCGA-D6-6516	14	123	13	59	7	1	1	0	73	1403	79	0	32	790	23	0	TCGA-D6-6516-01	176	0.5547840965668911	93	TCGA-D6-6516-01	20	24	21	0.08083890442495613	TCGA-D6-6516-01	12	4	2	18	hypermutated sample	3611	TCGA-D6-6516	HNSC	69	MALE	WHITE	Stage I	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-25242	Alive	TUMOR FREE	773	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	773	0	773	0	773	0	773	
60	TCGA-D6-6517	2	1	1	2	1	4	0	1	5	55	1	0	4	20	0	0	TCGA-D6-6517-01	116	0.2348941967628191	58	TCGA-D6-6517-01	8	10	22	0.17966899072995848	TCGA-D6-6517-01	14	7	8	29	PASS	3612	TCGA-D6-6517	HNSC	59	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-21791	Alive	WITH TUMOR	292	NA	NA	NA	Distant Metastasis	tracheostoma	161	Progressive Disease	NA	NA	0	292	0	292	NA	NA	1	161	
50	TCGA-D6-6823	0	9	1	6	2	3	0	0	10	129	8	0	2	31	6	0	TCGA-D6-6823-01	153	0.7260153713409753	83	TCGA-D6-6823-01	19	20	23	0.2076716957164869	TCGA-D6-6823-01	11	7	10	28	PASS	3613	TCGA-D6-6823	HNSC	50	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-18611	Alive	TUMOR FREE	701	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	701	0	701	0	701	0	701	
60	TCGA-D6-6824	1	2	0	1	1	0	0	0	1	44	3	0	1	11	0	0	TCGA-D6-6824-01	55	1.7716947858644924e-05	14	TCGA-D6-6824-01	0	0	2	7.383084149917816e-06	TCGA-D6-6824-01	0	0	0	0	PASS	3614	TCGA-D6-6824	HNSC	61	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-22633	Alive	TUMOR FREE	77	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	77	0	77	NA	NA	0	77	
70	TCGA-D6-6825	0	4	0	1	3	0	0	0	0	54	6	0	0	31	2	0	TCGA-D6-6825-01	115	0.26810335195176943	61	TCGA-D6-6825-01	7	13	14	0.262364395347022	TCGA-D6-6825-01	7	5	8	20	PASS	3615	TCGA-D6-6825	HNSC	73	MALE	WHITE	Stage I	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-26976	Alive	TUMOR FREE	491	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	491	0	491	0	491	0	491	
60	TCGA-D6-6826	0	4	0	1	2	1	1	0	1	76	7	1	2	30	3	0	TCGA-D6-6826-01	225	0.5216122367084944	134	TCGA-D6-6826-01	14	35	39	0.2060901884480381	TCGA-D6-6826-01	13	13	9	35	PASS	3616	TCGA-D6-6826	HNSC	64	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-23722	Dead	TUMOR FREE	NA	348	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	348	0	348	NA	NA	0	348	
60	TCGA-D6-6827	0	0	0	1	1	1	1	0	0	12	1	0	0	4	0	0	TCGA-D6-6827-01	316	0.22216649190190407	242	TCGA-D6-6827-01	6	5	28	0.03686911230523578	TCGA-D6-6827-01	2	2	2	6	PASS	3617	TCGA-D6-6827	HNSC	55	FEMALE	WHITE	Stage I	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2011	NA	-20175	Alive	TUMOR FREE	568	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	568	0	568	0	568	0	568	
60	TCGA-D6-8568	0	4	1	7	4	4	1	0	4	78	7	0	2	22	3	0	TCGA-D6-8568-01	115	0.30735406538814913	53	TCGA-D6-8568-01	8	17	71	0.21669870994646567	TCGA-D6-8568-01	12	14	10	36	PASS	3618	TCGA-D6-8568	HNSC	62	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-22796	Alive	TUMOR FREE	759	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	759	0	759	NA	NA	0	759	
50	TCGA-D6-8569	0	6	0	5	3	0	1	0	2	99	4	0	3	40	5	0	TCGA-D6-8569-01	182	0.5391890972981753	104	TCGA-D6-8569-01	23	21	67	0.13480553770305145	TCGA-D6-8569-01	9	5	5	19	PASS	3619	TCGA-D6-8569	HNSC	52	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-19212	Alive	TUMOR FREE	770	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	770	0	770	NA	NA	0	770	
60	TCGA-D6-A4Z9	0	10	0	2	1	1	0	0	2	70	2	0	0	29	2	0	TCGA-D6-A4Z9-01	149	0.2818901149066453	85	TCGA-D6-A4Z9-01	10	14	102	0.29507226021820904	TCGA-D6-A4Z9-01	14	4	11	29	PASS	3620	TCGA-D6-A4Z9	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-21659	Alive	TUMOR FREE	539	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	539	0	539	NA	NA	0	539	
60	TCGA-D6-A4ZB	0	11	1	3	1	0	0	0	5	144	11	0	1	47	4	1	TCGA-D6-A4ZB-01	147	0.351035054303601	82	TCGA-D6-A4ZB-01	8	15	92	0.2952097852635661	TCGA-D6-A4ZB-01	12	9	9	30	PASS	3621	TCGA-D6-A4ZB	HNSC	61	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-22455	Alive	TUMOR FREE	376	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	376	0	376	0	376	0	376	
70	TCGA-D6-A6EK	1	9	0	2	8	4	0	0	8	124	16	0	2	44	3	0	TCGA-D6-A6EK-01	76	0.1087185372197964	33	TCGA-D6-A6EK-01	4	8	40	0.13717741278512768	TCGA-D6-A6EK-01	2	2	2	6	PASS	3622	TCGA-D6-A6EK	HNSC	67	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2012	NA	-24558	Alive	TUMOR FREE	875	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	875	0	875	NA	NA	0	875	
70	TCGA-D6-A6EM	1	5	0	4	2	3	0	0	1	76	4	0	0	21	4	0	TCGA-D6-A6EM-01	113	0.5520862690201346	55	TCGA-D6-A6EM-01	19	33	49	0.1279260817558969	TCGA-D6-A6EM-01	8	8	4	20	PASS	3623	TCGA-D6-A6EM	HNSC	65	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-23865	Alive	WITH TUMOR	232	NA	NA	NA	Oral Cavity	oral tongue	232	Complete Remission/Response	NA	NA	0	232	0	232	1	232	1	232	
70	TCGA-D6-A6EN	0	2	1	1	3	4	0	0	2	70	9	0	1	35	0	0	TCGA-D6-A6EN-01	82	0.09941595314295178	40	TCGA-D6-A6EN-01	3	3	33	0.034528662662330435	TCGA-D6-A6EN-01	4	2	2	8	PASS	3624	TCGA-D6-A6EN	HNSC	71	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2013	NA	-26294	Alive	TUMOR FREE	687	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	687	0	687	0	687	0	687	
40	TCGA-D6-A6EO	2	6	0	3	2	1	0	0	7	69	4	0	0	17	0	0	TCGA-D6-A6EO-01	188	0.3016829523260074	109	TCGA-D6-A6EO-01	5	20	167	0.4175781902221994	TCGA-D6-A6EO-01	18	17	12	47	PASS	3625	TCGA-D6-A6EO	HNSC	44	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-16185	Alive	TUMOR FREE	759	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	759	0	759	NA	NA	0	759	
60	TCGA-D6-A6EP	2	11	0	6	1	0	0	0	4	94	7	0	2	32	1	0	TCGA-D6-A6EP-01	332	0.8589948232779547	225	TCGA-D6-A6EP-01	20	69	180	0.3587296093066643	TCGA-D6-A6EP-01	20	12	9	41	PASS	3626	TCGA-D6-A6EP	HNSC	62	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2013	NA	-22674	Alive	TUMOR FREE	424	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	424	0	424	0	424	0	424	
60	TCGA-D6-A6EQ	2	1	1	6	3	0	0	0	3	70	4	1	2	24	0	0	TCGA-D6-A6EQ-01	182	0.4054303368452622	92	TCGA-D6-A6EQ-01	13	22	102	0.28127390714942685	TCGA-D6-A6EQ-01	18	6	9	33	PASS	3627	TCGA-D6-A6EQ	HNSC	57	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2013	NA	-20876	Alive	TUMOR FREE	368	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	368	0	368	NA	NA	0	368	
50	TCGA-D6-A6ES	2	8	3	6	2	3	0	0	11	151	9	1	2	58	3	0	TCGA-D6-A6ES-01	182	0.25571451156889435	102	TCGA-D6-A6ES-01	6	8	94	0.2102884296275518	TCGA-D6-A6ES-01	14	10	9	33	PASS	3628	TCGA-D6-A6ES	HNSC	50	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-18408	Alive	TUMOR FREE	389	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	389	0	389	NA	NA	0	389	
70	TCGA-D6-A74Q	2	18	3	17	9	0	1	0	8	312	29	2	11	138	10	1	TCGA-D6-A74Q-01	181	0.6820915864144395	107	TCGA-D6-A74Q-01	6	18	116	0.2856709275550697	TCGA-D6-A74Q-01	18	8	10	36	PASS	3629	TCGA-D6-A74Q	HNSC	67	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2013	NA	-24702	Alive	TUMOR FREE	710	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	710	0	710	NA	NA	0	710	
40	TCGA-DQ-5624	0	5	2	1	0	0	1	0	3	75	6	0	1	27	1	0	TCGA-DQ-5624-01	145	0.3066849302945921	81	TCGA-DQ-5624-01	20	67	18	0.16348460081474125	TCGA-DQ-5624-01	14	9	3	26	PASS	3630	TCGA-DQ-5624	HNSC	43	FEMALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-15867	Alive	TUMOR FREE	1778	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1778	0	1778	NA	NA	0	1778	
50	TCGA-DQ-5625	0	14	1	2	6	2	1	0	14	154	6	0	3	47	2	0	TCGA-DQ-5625-01	70	0.9369280321343968	21	TCGA-DQ-5625-01	14	18	13	0.1765530385538262	TCGA-DQ-5625-01	4	3	4	11	PASS	3631	TCGA-DQ-5625	HNSC	52	FEMALE	WHITE	NA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-19211	Dead	TUMOR FREE	NA	1133	NA	NA	Oral Cavity	NA	1058	Complete Remission/Response	NA	NA	1	1133	0	1133	1	1058	1	1058	
60	TCGA-DQ-5629	2	14	1	12	4	4	1	0	13	241	27	0	4	100	7	0	TCGA-DQ-5629-01	224	0.7501599918897679	125	TCGA-DQ-5629-01	21	34	31	0.21344849216820244	TCGA-DQ-5629-01	18	13	10	41	PASS	3632	TCGA-DQ-5629	HNSC	64	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-23550	Dead	TUMOR FREE	NA	941	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	941	0	941	NA	NA	0	941	
70	TCGA-DQ-5630	0	3	0	1	3	0	2	0	1	51	3	0	3	21	3	0	TCGA-DQ-5630-01	54	0.1388099708206748	17	TCGA-DQ-5630-01	7	13	10	0.27500817740289857	TCGA-DQ-5630-01	4	2	3	9	PASS	3633	TCGA-DQ-5630	HNSC	73	MALE	WHITE	NA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-26855	Alive	TUMOR FREE	1030	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1030	0	1030	0	1030	0	1030	
50	TCGA-DQ-5631	1	4	1	2	3	0	0	0	3	62	8	0	2	33	2	0	TCGA-DQ-5631-01	179	0.6519121625076633	96	TCGA-DQ-5631-01	18	35	15	0.2130477936771478	TCGA-DQ-5631-01	12	4	6	22	PASS	3634	TCGA-DQ-5631	HNSC	52	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2009	NA	-19172	Dead	WITH TUMOR	548	548	NA	NA	Distant Metastasis	Lung	447	Complete Remission/Response	NA	NA	1	548	1	548	NA	NA	1	447	
70	TCGA-DQ-7588	1	5	0	3	5	1	0	0	2	72	12	0	2	29	2	0	TCGA-DQ-7588-01	147	0.6714870341037281	77	TCGA-DQ-7588-01	19	23	26	0.2525868266718012	TCGA-DQ-7588-01	15	6	7	28	PASS	3635	TCGA-DQ-7588	HNSC	66	MALE	WHITE	NA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-24106	Dead	WITH TUMOR	NA	427	NA	NA	Oral Cavity	NA	79	Persistent Disease	NA	NA	1	427	1	427	NA	NA	1	79	
70	TCGA-DQ-7589	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DQ-7589-01	167	0.7175618457908058	87	TCGA-DQ-7589	0	0	0	0	TCGA-DQ-7589	0	0	0	0	PASS	3636	TCGA-DQ-7589	HNSC	70	MALE	WHITE	NA	Stage IVC	Head & Neck Squamous Cell Carcinoma	G4	2010	NA	-25606	Alive	TUMOR FREE	1409	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1409	0	1409	NA	NA	0	1409	
50	TCGA-DQ-7590	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DQ-7590-01	111	0.2631268978469535	61	TCGA-DQ-7590-01	10	8	19	0.1682494911318188	TCGA-DQ-7590-01	7	4	7	18	PASS	3637	TCGA-DQ-7590	HNSC	51	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G4	2010	NA	-18718	Alive	TUMOR FREE	1413	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1413	0	1413	NA	NA	0	1413	
60	TCGA-DQ-7591	1	3	0	0	2	0	0	0	3	27	2	0	0	10	2	0	TCGA-DQ-7591-01	201	0.2332085558740743	119	TCGA-DQ-7591-01	3	6	37	0.1660432254428824	TCGA-DQ-7591-01	10	9	6	25	PASS	3638	TCGA-DQ-7591	HNSC	62	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G4	2011	NA	-22798	Alive	TUMOR FREE	622	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	622	0	622	NA	NA	0	622	
60	TCGA-DQ-7592	0	2	0	4	3	1	1	0	5	50	7	0	2	27	1	1	TCGA-DQ-7592-01	83	0.6425260634890674	31	TCGA-DQ-7592-01	17	34	29	0.27933498275430263	TCGA-DQ-7592-01	15	10	8	33	PASS	3639	TCGA-DQ-7592	HNSC	57	MALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-21041	Alive	TUMOR FREE	1143	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1143	0	1143	NA	NA	0	1143	
60	TCGA-DQ-7593	0	1	0	2	1	1	0	0	1	17	2	0	1	7	1	1	TCGA-DQ-7593-01	75	0.1207160661503441	25	TCGA-DQ-7593-01	3	8	9	0.16524749694915342	TCGA-DQ-7593-01	3	4	4	11	PASS	3640	TCGA-DQ-7593	HNSC	58	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G4	2011	NA	-21439	Alive	TUMOR FREE	1224	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1224	0	1224	NA	NA	0	1224	
50	TCGA-DQ-7594	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DQ-7594-01	77	0.1481099263655873	30	TCGA-DQ-7594-01	3	5	13	0.15801536451758308	TCGA-DQ-7594-01	5	4	4	13	PASS	3641	TCGA-DQ-7594	HNSC	47	MALE	WHITE	NA	Stage IVB	Head & Neck Squamous Cell Carcinoma	G4	2011	NA	-17471	Alive	TUMOR FREE	1218	NA	NA	New Primary Tumor	Oral Cavity	mandibular alveolus	1084	Complete Remission/Response	NA	NA	0	1218	0	1218	NA	NA	1	1084	
50	TCGA-DQ-7595	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DQ-7595-01	165	0.21551493562134255	90	TCGA-DQ-7595-01	9	10	10	0.2097040037838899	TCGA-DQ-7595-01	8	0	8	16	PASS	3642	TCGA-DQ-7595	HNSC	53	MALE	WHITE	NA	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2011	NA	-19530	Alive	TUMOR FREE	1190	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1190	0	1190	0	1190	0	1190	
50	TCGA-DQ-7596	0	2	0	1	1	0	0	0	0	25	3	0	0	6	1	0	TCGA-DQ-7596-01	70	0.24047539796087436	24	TCGA-DQ-7596-01	6	4	9	0.07065382246396333	TCGA-DQ-7596-01	4	3	2	9	PASS	3643	TCGA-DQ-7596	HNSC	48	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G4	2011	NA	-17846	Alive	TUMOR FREE	1265	NA	NA	NA	Cervical Lymph Nodes	NA	137	Persistent Disease	NA	NA	0	1265	0	1265	NA	NA	1	137	
50	TCGA-F7-7848	0	25	3	8	10	2	0	0	14	243	12	0	8	94	10	0	TCGA-F7-7848-01	150	0.7258181487791103	70	TCGA-F7-7848-01	15	14	39	0.31854919925188163	TCGA-F7-7848-01	9	2	11	22	PASS	3644	TCGA-F7-7848	HNSC	47	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-17251	Alive	TUMOR FREE	1131	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1131	0	1131	NA	NA	0	1131	
60	TCGA-F7-8298	3	6	0	3	1	0	1	0	3	75	5	0	1	23	2	0	TCGA-F7-8298-01	147	0.370757952996924	87	TCGA-F7-8298-01	13	18	106	0.3759405806232464	TCGA-F7-8298-01	12	10	12	34	PASS	3645	TCGA-F7-8298	HNSC	58	MALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G1	2011	NA	-21445	Alive	TUMOR FREE	995	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	995	0	995	0	995	0	995	
50	TCGA-F7-8489	1	3	1	3	2	3	0	0	7	105	8	0	2	44	1	0	TCGA-F7-8489-01	59	0.09692191915165232	16	TCGA-F7-8489-01	2	4	35	0.18109717479759807	TCGA-F7-8489-01	9	12	9	30	PASS	3646	TCGA-F7-8489	HNSC	48	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2012	NA	-17873	Alive	TUMOR FREE	658	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	658	0	658	0	658	0	658	
70	TCGA-F7-A50G	0	6	1	5	0	1	1	0	1	75	9	0	2	29	0	0	TCGA-F7-A50G-01	156	0.4960794064836984	73	TCGA-F7-A50G-01	14	38	78	0.2215243165845321	TCGA-F7-A50G-01	15	7	9	31	PASS	3647	TCGA-F7-A50G	HNSC	66	MALE	WHITE	Stage III	NA	Head & Neck Squamous Cell Carcinoma	G1	2012	NA	-24285	Alive	TUMOR FREE	616	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	616	0	616	0	616	0	616	
70	TCGA-F7-A50I	1	9	2	6	4	4	0	0	2	108	7	1	1	42	3	1	TCGA-F7-A50I-01	142	0.5098212223954675	64	TCGA-F7-A50I-01	17	30	64	0.2633755263833509	TCGA-F7-A50I-01	18	15	13	46	PASS	3648	TCGA-F7-A50I	HNSC	72	MALE	WHITE	Stage IVA	NA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-26373	Alive	TUMOR FREE	92	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	92	0	92	NA	NA	0	92	
70	TCGA-F7-A50J	3	11	0	3	3	2	2	0	6	122	14	0	0	60	0	0	TCGA-F7-A50J-01	88	0.5867579004111767	33	TCGA-F7-A50J-01	23	60	60	0.2765636810523188	TCGA-F7-A50J-01	12	6	2	20	PASS	3649	TCGA-F7-A50J	HNSC	67	FEMALE	WHITE	Stage III	NA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-24758	Alive	TUMOR FREE	947	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	947	0	947	0	947	0	947	
60	TCGA-F7-A61S	0	8	0	4	3	3	0	0	4	75	6	0	1	35	3	0	TCGA-F7-A61S-01	84	0.4623981136748917	36	TCGA-F7-A61S-01	7	9	28	0.07827771273999196	TCGA-F7-A61S-01	6	7	2	15	PASS	3650	TCGA-F7-A61S	HNSC	62	MALE	WHITE	Stage III	NA	Head & Neck Squamous Cell Carcinoma	G1	2012	NA	-22655	Alive	TUMOR FREE	576	NA	NA	Locoregional Recurrence	Cervical Lymph Nodes	NA	213	Complete Remission/Response	NA	NA	0	576	0	576	1	213	1	213	
50	TCGA-F7-A61V	0	6	0	1	2	3	1	0	3	82	6	0	1	24	1	0	TCGA-F7-A61V-01	126	0.17575190972618793	67	TCGA-F7-A61V-01	3	6	53	0.13446377999899298	TCGA-F7-A61V-01	8	9	9	26	PASS	3651	TCGA-F7-A61V	HNSC	54	MALE	WHITE	Stage II	NA	Head & Neck Squamous Cell Carcinoma	G1	2012	NA	-19857	Alive	TUMOR FREE	759	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	759	0	759	0	759	0	759	
50	TCGA-F7-A61W	0	6	0	4	1	1	0	0	1	50	4	0	2	21	2	0	TCGA-F7-A61W-01	224	0.7074493163599623	136	TCGA-F7-A61W-01	5	11	142	0.283229295944481	TCGA-F7-A61W-01	14	10	13	37	PASS	3652	TCGA-F7-A61W	HNSC	51	MALE	ASIAN	Stage IVA	NA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-18879	Alive	TUMOR FREE	14	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	14	0	14	NA	NA	0	14	
50	TCGA-F7-A620	0	1	0	2	2	0	2	0	4	39	4	0	2	27	0	0	TCGA-F7-A620-01	58	0.30822021071933675	17	TCGA-F7-A620-01	9	9	39	0.2407293862093252	TCGA-F7-A620-01	6	3	8	17	PASS	3653	TCGA-F7-A620	HNSC	47	MALE	WHITE	Stage III	NA	Head & Neck Squamous Cell Carcinoma	G1	2012	NA	-17475	Alive	TUMOR FREE	543	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	543	0	543	0	543	0	543	
80	TCGA-F7-A622	0	4	1	1	4	2	0	1	3	44	2	0	0	19	0	0	TCGA-F7-A622-01	98	0.33268772424171666	48	TCGA-F7-A622-01	8	11	63	0.2318320230709781	TCGA-F7-A622-01	12	9	9	30	PASS	3654	TCGA-F7-A622	HNSC	75	MALE	WHITE	Stage III	NA	Head & Neck Squamous Cell Carcinoma	G1	2012	NA	-27456	Dead	WITH TUMOR	NA	359	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	359	1	359	NA	NA	1	359	
70	TCGA-F7-A623	1	10	0	4	2	3	2	0	8	139	13	0	7	69	2	0	TCGA-F7-A623-01	378	0.653206383845336	239	TCGA-F7-A623-01	17	67	133	0.28278283952346844	TCGA-F7-A623-01	24	26	13	63	PASS	3655	TCGA-F7-A623	HNSC	70	MALE	WHITE	Stage IVA	NA	Head & Neck Squamous Cell Carcinoma	G1	2012	NA	-25592	Alive	TUMOR FREE	616	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	616	0	616	NA	NA	0	616	
70	TCGA-F7-A624	19	216	7	79	222	56	23	1	109	2279	64	1	37	957	60	1	TCGA-F7-A624-01	69	0.12246716009625255	19	TCGA-F7-A624-01	4	2	11	0.023939520292964	TCGA-F7-A624-01	1	1	1	3	hypermutated sample	3656	TCGA-F7-A624	HNSC	73	MALE	WHITE	Stage II	NA	Head & Neck Squamous Cell Carcinoma	G3	2012	NA	-26667	Alive	TUMOR FREE	378	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	378	0	378	0	378	0	378	
80	TCGA-H7-7774	1	1	0	2	3	4	1	0	5	119	8	0	1	40	0	0	TCGA-H7-7774-01	43	0.09399257503625434	7	TCGA-H7-7774-01	3	5	19	0.012847148677319842	TCGA-H7-7774-01	1	1	1	3	PASS	3657	TCGA-H7-7774	HNSC	75	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-27519	Alive	TUMOR FREE	407	NA	NA	New Primary Tumor	Oral Cavity	hard palate (right)	252	Complete Remission/Response	NA	NA	0	407	0	407	NA	NA	1	252	
50	TCGA-H7-8501	0	8	1	6	1	0	0	0	5	118	13	0	2	38	3	0	TCGA-H7-8501-01	71	0.1108935464277925	31	TCGA-H7-8501-01	3	4	30	0.06190078178929648	TCGA-H7-8501-01	3	1	2	6	PASS	3658	TCGA-H7-8501	HNSC	54	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2012	NA	-19808	Alive	TUMOR FREE	461	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	461	0	461	NA	NA	0	461	
50	TCGA-H7-8502	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-H7-8502-01	106	0.2836530280576955	44	TCGA-H7-8502-01	9	12	55	0.24242064869675145	TCGA-H7-8502-01	11	4	11	26	PASS	3659	TCGA-H7-8502	HNSC	50	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-18286	Alive	TUMOR FREE	458	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	458	0	458	NA	NA	0	458	
40	TCGA-H7-A6C4	0	4	0	2	0	1	0	0	0	29	2	0	0	10	0	0	TCGA-H7-A6C4-01	53	0.15045172504962198	11	TCGA-H7-A6C4-01	3	4	23	0.11573781198901276	TCGA-H7-A6C4-01	3	3	5	11	PASS	3660	TCGA-H7-A6C4	HNSC	35	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-13137	Alive	TUMOR FREE	414	NA	NA	Locoregional Recurrence	Distant Metastasis	stoma site	235	Complete Remission/Response	NA	NA	0	414	0	414	NA	NA	1	235	
70	TCGA-H7-A6C5	0	5	1	4	4	2	3	0	2	67	6	0	2	36	5	0	TCGA-H7-A6C5-01	145	0.7770234258326428	73	TCGA-H7-A6C5-01	8	12	85	0.28295095097308165	TCGA-H7-A6C5-01	12	4	10	26	PASS	3661	TCGA-H7-A6C5	HNSC	65	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-23808	Alive	TUMOR FREE	642	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	642	0	642	0	642	0	642	
60	TCGA-H7-A76A	1	11	0	1	1	0	0	0	4	54	4	0	2	24	1	0	TCGA-H7-A76A-01	68	0.2783914642333541	26	TCGA-H7-A76A-01	9	13	42	0.15833772013689815	TCGA-H7-A76A-01	8	8	4	20	PASS	3662	TCGA-H7-A76A	HNSC	57	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-20946	Alive	TUMOR FREE	637	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	637	0	637	NA	NA	0	637	
60	TCGA-HD-7229	0	8	0	5	5	1	1	0	2	131	11	0	1	46	0	0	TCGA-HD-7229-01	172	0.2625972929542732	99	TCGA-HD-7229-01	6	15	38	0.22402179909793968	TCGA-HD-7229-01	12	11	7	30	PASS	3663	TCGA-HD-7229	HNSC	60	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2011	NA	-22076	Alive	WITH TUMOR	1027	NA	NA	Locoregional Recurrence	Larynx	NA	162	Progressive Disease	NA	NA	0	1027	0	1027	NA	NA	1	162	
60	TCGA-HD-7753	0	5	1	2	5	4	0	1	4	74	8	0	3	21	1	0	TCGA-HD-7753-01	276	0.7636079198512844	171	TCGA-HD-7753-01	13	13	75	0.4300821985574451	TCGA-HD-7753-01	11	10	16	37	PASS	3664	TCGA-HD-7753	HNSC	62	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-22774	Alive	TUMOR FREE	866	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	866	0	866	0	866	0	866	
70	TCGA-HD-7754	0	5	0	1	0	1	0	0	2	44	1	0	0	23	4	0	TCGA-HD-7754-01	75	0.1182145217574167	18	TCGA-HD-7754-01	4	7	6	0.047649939745233016	TCGA-HD-7754-01	7	3	3	13	PASS	3665	TCGA-HD-7754	HNSC	69	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2011	NA	-25365	Alive	TUMOR FREE	783	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	783	0	783	NA	NA	0	783	
70	TCGA-HD-7831	1	1	0	0	0	2	3	0	1	25	2	0	1	13	1	0	TCGA-HD-7831-01	112	0.4734120978976699	53	TCGA-HD-7831-01	16	18	31	0.375019133723696	TCGA-HD-7831-01	11	3	9	23	PASS	3666	TCGA-HD-7831	HNSC	74	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-27334	Alive	WITH TUMOR	667	NA	NA	Distant Metastasis	Distant Metastasis	Lung	667	Complete Remission/Response	NA	NA	0	667	0	667	NA	NA	1	667	
50	TCGA-HD-7832	0	3	0	3	2	0	1	1	4	73	4	0	4	34	0	0	TCGA-HD-7832-01	160	0.2798750030170777	96	TCGA-HD-7832-01	5	13	19	0.13727568919125274	TCGA-HD-7832-01	10	6	7	23	PASS	3667	TCGA-HD-7832	HNSC	52	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-19192	Alive	TUMOR FREE	836	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	836	0	836	NA	NA	0	836	
60	TCGA-HD-7917	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-HD-7917-01	154	0.5689264184538766	76	TCGA-HD-7917-01	8	11	18	0.27018593160179044	TCGA-HD-7917-01	6	3	9	18	PASS	3668	TCGA-HD-7917	HNSC	62	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2011	NA	-22979	Dead	TUMOR FREE	NA	836	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	836	0	836	0	836	0	836	
60	TCGA-HD-8224	0	3	0	1	0	1	4	0	6	61	4	0	3	15	2	0	TCGA-HD-8224-01	256	0.4290135042959836	155	TCGA-HD-8224-01	10	31	203	0.4818261791452547	TCGA-HD-8224-01	27	29	13	69	PASS	3669	TCGA-HD-8224	HNSC	63	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2011	NA	-23069	Dead	WITH TUMOR	NA	446	NA	Distant Metastasis	Distant Metastasis	Lung	171	Progressive Disease	NA	NA	1	446	1	446	NA	NA	1	171	
60	TCGA-HD-8314	0	4	1	1	1	0	0	0	4	56	3	0	1	21	1	0	TCGA-HD-8314-01	98	0.2801359161461301	36	TCGA-HD-8314-01	8	14	45	0.12296701905242342	TCGA-HD-8314-01	13	17	8	38	PASS	3670	TCGA-HD-8314	HNSC	58	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma Basaloid Type	G4	2012	NA	-21517	Alive	TUMOR FREE	670	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	670	0	670	0	670	0	670	
50	TCGA-HD-8634	0	4	0	3	0	3	1	0	2	56	0	0	0	21	1	0	TCGA-HD-8634-01	106	0.16127162414555682	53	TCGA-HD-8634-01	8	17	81	0.3125178214997545	TCGA-HD-8634-01	11	13	16	40	PASS	3671	TCGA-HD-8634	HNSC	51	FEMALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-18718	Dead	TUMOR FREE	NA	385	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	385	0	385	0	385	0	385	
60	TCGA-HD-8635	0	20	2	16	4	4	2	0	22	316	22	0	2	140	10	0	TCGA-HD-8635-01	174	0.3493207121374019	95	TCGA-HD-8635-01	8	15	114	0.2843920030156459	TCGA-HD-8635-01	16	11	9	36	PASS	3672	TCGA-HD-8635	HNSC	61	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-22340	Alive	TUMOR FREE	695	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	695	0	695	0	695	0	695	
40	TCGA-HD-A4C1	0	8	1	2	4	1	0	0	7	151	9	0	3	70	5	1	TCGA-HD-A4C1-01	90	0.027724714833627376	41	TCGA-HD-A4C1-01	0	3	49	0.08019664785918948	TCGA-HD-A4C1-01	4	5	3	12	PASS	3673	TCGA-HD-A4C1	HNSC	41	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2012	NA	-15096	Alive	NA	11	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	11	0	11	NA	NA	0	11	
70	TCGA-HD-A633	1	7	0	6	6	3	1	0	3	97	9	0	1	42	2	0	TCGA-HD-A633-01	115	0.2843101137920914	61	TCGA-HD-A633-01	8	13	62	0.22143745817188606	TCGA-HD-A633-01	9	5	10	24	PASS	3674	TCGA-HD-A633	HNSC	74	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-27057	Alive	WITH TUMOR	421	NA	NA	Locoregional Recurrence	Oral Cavity	Buccal Space & Infratemporal Fossa	419	Complete Remission/Response	NA	NA	0	421	0	421	NA	NA	1	419	
60	TCGA-HD-A634	0	5	0	1	5	0	0	0	2	29	1	0	2	15	1	0	TCGA-HD-A634-01	91	0.21652259988391528	40	TCGA-HD-A634-01	8	4	21	0.0242217658017348	TCGA-HD-A634-01	3	5	1	9	PASS	3675	TCGA-HD-A634	HNSC	56	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2013	NA	-20810	Dead	WITH TUMOR	NA	130	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	130	1	130	NA	NA	1	130	
80	TCGA-HD-A6HZ	0	0	0	4	4	1	0	0	2	56	10	0	1	32	0	0	TCGA-HD-A6HZ-01	264	0.582271626967338	165	TCGA-HD-A6HZ-01	17	38	105	0.3018483981125953	TCGA-HD-A6HZ-01	17	17	4	38	PASS	3676	TCGA-HD-A6HZ	HNSC	79	FEMALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-29045	Alive	TUMOR FREE	111	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	111	0	111	NA	NA	0	111	
60	TCGA-HD-A6I0	1	3	0	5	2	2	0	0	3	61	1	0	3	20	0	0	TCGA-HD-A6I0-01	122	0.22038526727904856	59	TCGA-HD-A6I0-01	7	5	48	0.019315068755882656	TCGA-HD-A6I0-01	2	0	2	4	PASS	3677	TCGA-HD-A6I0	HNSC	56	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2013	NA	-20491	Alive	TUMOR FREE	210	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	210	0	210	NA	NA	0	210	
70	TCGA-HL-7533	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-HL-7533-01	132	0.1564956394177417	67	TCGA-HL-7533-01	3	8	12	0.07085784172845076	TCGA-HL-7533-01	8	7	2	17	PASS	3678	TCGA-HL-7533	HNSC	65	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2008	NA	-23950	Alive	TUMOR FREE	1057	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1057	0	1057	NA	NA	0	1057	
50	TCGA-IQ-7630	0	9	1	7	1	0	2	0	4	97	8	0	3	39	2	0	TCGA-IQ-7630-01	114	0.263207358892615	53	TCGA-IQ-7630-01	7	14	27	0.12042228530688492	TCGA-IQ-7630-01	8	4	5	17	PASS	3679	TCGA-IQ-7630	HNSC	49	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2011	NA	-18131	Alive	TUMOR FREE	485	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	485	0	485	0	485	0	485	
60	TCGA-IQ-7631	0	2	0	2	1	0	1	0	1	19	2	0	0	15	0	0	TCGA-IQ-7631-01	67	0.13626664795627416	23	TCGA-IQ-7631-01	6	4	4	0.007196412506346949	TCGA-IQ-7631-01	1	2	1	4	PASS	3680	TCGA-IQ-7631	HNSC	60	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2011	NA	-22151	Alive	TUMOR FREE	1172	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1172	0	1172	0	1172	0	1172	
70	TCGA-IQ-7632	0	2	0	0	2	0	1	0	1	48	5	0	0	17	0	0	TCGA-IQ-7632-01	70	0.03054741176750845	26	TCGA-IQ-7632-01	9	11	14	0.4152107277315224	TCGA-IQ-7632-01	2	3	1	6	PASS	3681	TCGA-IQ-7632	HNSC	68	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2011	NA	-24986	Alive	TUMOR FREE	441	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	441	0	441	NA	NA	0	441	
60	TCGA-IQ-A61E	1	7	0	6	2	0	1	0	10	130	19	0	0	61	4	0	TCGA-IQ-A61E-01	94	0.4240925912500014	40	TCGA-IQ-A61E-01	15	21	66	0.1982293246803044	TCGA-IQ-A61E-01	13	7	6	26	PASS	3682	TCGA-IQ-A61E	HNSC	55	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-20417	Alive	TUMOR FREE	1147	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1147	0	1147	0	1147	0	1147	
60	TCGA-IQ-A61G	1	6	0	1	3	1	1	0	2	103	9	0	2	42	2	0	TCGA-IQ-A61G-01	266	0.9319036520400328	160	TCGA-IQ-A61G-01	15	38	120	0.1913983086600731	TCGA-IQ-A61G-01	16	14	9	39	PASS	3683	TCGA-IQ-A61G	HNSC	57	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-21066	Alive	WITH TUMOR	360	NA	NA	NA	Oral Cavity	NA	249	Progressive Disease	NA	NA	0	360	0	360	NA	NA	1	249	
80	TCGA-IQ-A61H	1	9	0	7	5	0	0	0	9	114	4	0	2	40	3	0	TCGA-IQ-A61H-01	208	0.4449505202888547	128	TCGA-IQ-A61H-01	12	21	146	0.5668906044236226	TCGA-IQ-A61H-01	17	13	17	47	PASS	3684	TCGA-IQ-A61H	HNSC	76	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-27990	Alive	TUMOR FREE	1138	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1138	0	1138	0	1138	0	1138	
60	TCGA-IQ-A61I	0	11	1	5	0	0	0	0	8	100	9	0	3	46	3	0	TCGA-IQ-A61I-01	82	0.2821793357695113	31	TCGA-IQ-A61I-01	8	7	36	0.1505227888855568	TCGA-IQ-A61I-01	6	4	4	14	PASS	3685	TCGA-IQ-A61I	HNSC	63	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2012	NA	-23035	Dead	TUMOR FREE	NA	2	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2	0	2	NA	NA	0	2	
50	TCGA-IQ-A61J	0	6	0	1	1	0	1	0	1	28	3	0	0	11	1	0	TCGA-IQ-A61J-01	83	0.3965046487585296	34	TCGA-IQ-A61J-01	11	11	78	0.2833902969411455	TCGA-IQ-A61J-01	7	2	5	14	PASS	3686	TCGA-IQ-A61J	HNSC	54	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2012	NA	-19913	Alive	TUMOR FREE	1021	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1021	0	1021	NA	NA	0	1021	
70	TCGA-IQ-A61K	0	0	0	2	1	1	1	0	5	52	4	0	0	21	2	0	TCGA-IQ-A61K-01	160	0.6866500552143179	82	TCGA-IQ-A61K-01	16	28	88	0.3083869495391407	TCGA-IQ-A61K-01	15	8	10	33	PASS	3687	TCGA-IQ-A61K	HNSC	70	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-25697	Dead	TUMOR FREE	NA	161	NA	NA	NA	NA	NA	NA	NA	NA	1	161	0	161	NA	NA	0	161	
70	TCGA-IQ-A61L	0	3	0	5	2	2	0	0	3	66	6	1	0	23	0	0	TCGA-IQ-A61L-01	80	0.6236881901334076	37	TCGA-IQ-A61L-01	18	21	34	0.13944590459118034	TCGA-IQ-A61L-01	10	10	2	22	PASS	3688	TCGA-IQ-A61L	HNSC	72	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2012	NA	-26506	Alive	WITH TUMOR	416	NA	NA	Locoregional Recurrence	Oral Cavity	NA	156	Progressive Disease	NA	NA	0	416	0	416	NA	NA	1	156	
40	TCGA-IQ-A61O	0	1	1	3	2	0	0	0	1	28	2	0	1	16	1	0	TCGA-IQ-A61O-01	103	0.4485056098044302	46	TCGA-IQ-A61O-01	15	31	39	0.20084065892363007	TCGA-IQ-A61O-01	14	5	7	26	PASS	3689	TCGA-IQ-A61O	HNSC	43	MALE	WHITE	Stage IVA	Stage IVA	"Head & Neck Squamous Cell Carcinoma, Spindle Cell Variant"	GX	2012	NA	-15920	Dead	TUMOR FREE	NA	421	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	421	0	421	NA	NA	0	421	
60	TCGA-IQ-A6SG	0	3	2	3	3	1	0	0	6	74	4	0	0	31	4	0	TCGA-IQ-A6SG-01	186	0.8360073929626978	103	TCGA-IQ-A6SG-01	20	64	113	0.3268877233934184	TCGA-IQ-A6SG-01	21	11	11	43	PASS	3690	TCGA-IQ-A6SG	HNSC	61	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-22529	Alive	TUMOR FREE	579	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	579	0	579	0	579	0	579	
60	TCGA-IQ-A6SH	0	11	1	2	2	2	2	0	3	51	4	0	5	26	1	0	TCGA-IQ-A6SH-01	239	0.8330590602946966	152	TCGA-IQ-A6SH-01	18	35	216	0.5370733593752902	TCGA-IQ-A6SH-01	15	13	14	42	PASS	3691	TCGA-IQ-A6SH	HNSC	55	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage IVC	Head & Neck Squamous Cell Carcinoma	G1	2013	NA	-20109	Alive	TUMOR FREE	471	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	471	0	471	NA	NA	0	471	
70	TCGA-KU-A66S	1	15	1	12	11	7	0	1	19	422	18	0	10	127	11	1	TCGA-KU-A66S-01	70	0.0820070807518274	29	TCGA-KU-A66S-01	3	3	31	0.018220424328702245	TCGA-KU-A66S-01	1	2	1	4	PASS	3692	TCGA-KU-A66S	HNSC	69	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma Basaloid Type	G2	2012	NA	-25454	Dead	WITH TUMOR	NA	406	NA	Distant Metastasis	Distant Metastasis	Brain Metastasis	389	Complete Remission/Response	NA	NA	1	406	1	406	1	389	1	389	
50	TCGA-KU-A66T	1	7	0	4	1	0	0	0	3	81	8	1	0	34	2	0	TCGA-KU-A66T-01	231	0.7832772294336012	123	TCGA-KU-A66T-01	17	32	110	0.2920915969265089	TCGA-KU-A66T-01	18	16	13	47	PASS	3693	TCGA-KU-A66T	HNSC	53	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-19405	Alive	TUMOR FREE	552	NA	NA	Locoregional Recurrence	Oral Cavity	Toungue	552	Complete Remission/Response	NA	NA	0	552	0	552	NA	NA	1	552	
60	TCGA-KU-A6H7	1	13	1	4	5	0	0	0	12	168	16	1	4	67	6	0	TCGA-KU-A6H7-01	105	0.3180690249736167	43	TCGA-KU-A6H7-06	4	6	45	0.16983302851773915	TCGA-KU-A6H7-06	8	11	9	28	mutation call filter	3694	TCGA-KU-A6H7	HNSC	55	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-20314	Alive	TUMOR FREE	586	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	586	0	586	NA	NA	0	586	
40	TCGA-KU-A6H8	0	0	0	0	1	0	0	0	0	19	1	0	0	6	1	0	TCGA-KU-A6H8-01	72	0.0009758114209208697	31	TCGA-KU-A6H8-01	0	0	7	0.016888942835648103	TCGA-KU-A6H8-01	0	2	1	3	PASS	3695	TCGA-KU-A6H8	HNSC	41	MALE	WHITE	Stage IVA	Stage I	Head & Neck Squamous Cell Carcinoma	G3	2013	NA	-15066	Dead	WITH TUMOR	NA	327	NA	Locoregional Recurrence	Oral Cavity	Right base of tongue and level 2 a cervical node	110	Progressive Disease	NA	NA	1	327	1	327	NA	NA	1	110	
50	TCGA-MT-A51W	1	8	1	1	0	3	0	0	3	54	3	0	1	18	1	0	TCGA-MT-A51W-01	106	0.2538791943398421	40	TCGA-MT-A51W-01	23	21	65	0.2206307549041508	TCGA-MT-A51W-01	11	9	6	26	PASS	3696	TCGA-MT-A51W	HNSC	52	FEMALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-19098	Alive	TUMOR FREE	437	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	437	0	437	0	437	0	437	
30	TCGA-MT-A51X	0	2	0	2	0	0	1	0	2	39	5	0	0	21	2	0	TCGA-MT-A51X-01	154	0.501809908383052	76	TCGA-MT-A51X-01	18	33	114	0.2836550048575457	TCGA-MT-A51X-01	13	7	12	32	PASS	3697	TCGA-MT-A51X	HNSC	30	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2012	NA	-10976	Alive	TUMOR FREE	242	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	242	0	242	NA	NA	0	242	
90	TCGA-MT-A67A	1	3	1	6	4	3	2	0	2	80	8	1	0	30	1	1	TCGA-MT-A67A-01	77	0.19690295934275234	25	TCGA-MT-A67A-01	9	7	40	0.06918565257278103	TCGA-MT-A67A-01	5	2	4	11	PASS	3698	TCGA-MT-A67A	HNSC	85	FEMALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-31161	Alive	TUMOR FREE	914	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	914	0	914	0	914	0	914	
60	TCGA-MT-A67D	0	4	0	2	1	3	1	0	1	77	5	0	6	32	1	0	TCGA-MT-A67D-01	121	0.2609982341137532	58	TCGA-MT-A67D-01	11	10	59	0.2227334379057453	TCGA-MT-A67D-01	9	4	10	23	PASS	3699	TCGA-MT-A67D	HNSC	55	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-20386	Alive	NA	56	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	56	0	56	0	56	0	56	
60	TCGA-MT-A67F	1	20	1	4	0	0	0	0	9	245	27	2	8	77	2	1	TCGA-MT-A67F-01	32	0.013222686574422672	1	TCGA-MT-A67F-01	1	4	8	0.016476153945827198	TCGA-MT-A67F-01	1	0	1	2	PASS	3700	TCGA-MT-A67F	HNSC	60	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-22057	Alive	TUMOR FREE	384	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	384	0	384	NA	NA	0	384	
50	TCGA-MT-A67G	0	4	0	4	0	0	0	0	0	52	0	0	0	20	0	0	TCGA-MT-A67G-01	64	0.5743729585399239	19	TCGA-MT-A67G-01	10	6	44	0.19112005496780368	TCGA-MT-A67G-01	1	2	1	4	PASS	3701	TCGA-MT-A67G	HNSC	53	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-19394	Alive	[Discrepancy]	190	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	190	0	190	NA	NA	0	190	
70	TCGA-MT-A7BN	0	2	0	2	2	1	0	0	3	43	4	0	3	19	1	0	TCGA-MT-A7BN-01	480	0.604731899914984	298	TCGA-MT-A7BN-01	19	32	144	0.2425028375097531	TCGA-MT-A7BN-01	13	7	8	28	PASS	3702	TCGA-MT-A7BN	HNSC	74	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2013	NA	-27162	Alive	WITH TUMOR	469	NA	NA	Distant Metastasis	Distant Metastasis	lung	179	Progressive Disease	NA	NA	0	469	0	469	NA	NA	1	179	
50	TCGA-MZ-A5BI	0	3	0	5	3	1	0	0	0	25	1	0	0	10	2	0	TCGA-MZ-A5BI-01	125	0.5368847608419868	58	TCGA-MZ-A5BI-01	9	18	135	0.41664534811166537	TCGA-MZ-A5BI-01	12	15	11	38	PASS	3703	TCGA-MZ-A5BI	HNSC	53	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	NA	2008	NA	-19500	Dead	NA	NA	217	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	217	NA	217	NA	NA	0	217	
70	TCGA-MZ-A6I9	0	1	0	0	1	0	2	0	3	22	4	0	0	19	1	0	TCGA-MZ-A6I9-01	1076	0.25794371357907675	961	TCGA-MZ-A6I9-01	3	14	166	0.1560901768455205	TCGA-MZ-A6I9-01	10	7	9	26	PASS	3704	TCGA-MZ-A6I9	HNSC	68	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-24939	Dead	WITH TUMOR	NA	489	NA	Distant Metastasis	Distant Metastasis	"lung, mediastinal lymph node"	246	NA	NA	NA	1	489	1	489	NA	NA	1	246	
50	TCGA-MZ-A7D7	1	13	0	5	5	0	0	0	5	110	12	0	0	56	2	0	TCGA-MZ-A7D7-01	231	0.5243443182634373	139	TCGA-MZ-A7D7-01	11	19	179	0.4612238236891481	TCGA-MZ-A7D7-01	20	18	18	56	PASS	3705	TCGA-MZ-A7D7	HNSC	51	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	NA	2013	NA	-18974	Alive	WITH TUMOR	547	NA	NA	Distant Metastasis	Distant Metastasis	lung	339	Complete Remission/Response	NA	NA	0	547	0	547	NA	NA	1	339	
50	TCGA-P3-A5Q5	0	16	2	5	2	1	0	0	12	220	17	0	0	80	4	0	TCGA-P3-A5Q5-01	57	0.13861348471387394	18	TCGA-P3-A5Q5-01	3	7	24	0.09406825147888924	TCGA-P3-A5Q5-01	6	6	4	16	PASS	3706	TCGA-P3-A5Q5	HNSC	54	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma Basaloid Type	G3	2004	NA	-19728	Alive	TUMOR FREE	910	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	910	0	910	NA	NA	0	910	
50	TCGA-P3-A5Q6	0	7	1	7	1	1	1	0	4	95	7	0	3	39	2	0	TCGA-P3-A5Q6-01	202	0.7401611641053233	103	TCGA-P3-A5Q6-01	18	36	137	0.460804017278765	TCGA-P3-A5Q6-01	25	23	14	62	PASS	3707	TCGA-P3-A5Q6	HNSC	49	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2005	NA	-17917	Dead	WITH TUMOR	NA	480	NA	NA	Distant Metastasis	Lung	280	Complete Remission/Response	NA	NA	1	480	1	480	NA	NA	1	280	
40	TCGA-P3-A5QA	0	2	0	3	1	2	1	0	0	56	4	0	0	21	0	0	TCGA-P3-A5QA-01	119	0.4562365556965799	54	TCGA-P3-A5QA-01	14	41	70	0.2911787798634632	TCGA-P3-A5QA-01	12	11	8	31	PASS	3708	TCGA-P3-A5QA	HNSC	41	MALE	[Unknown]	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2008	NA	-15125	Alive	TUMOR FREE	2182	NA	NA	Locoregional Disease	Oral Cavity	tongue	1601	Complete Remission/Response	NA	NA	0	2182	0	2182	1	1601	1	1601	
50	TCGA-P3-A5QE	0	2	0	3	1	0	0	0	2	31	3	0	0	9	0	0	TCGA-P3-A5QE-01	85	0.18586993592492815	29	TCGA-P3-A5QE-01	4	6	43	0.10825122538494857	TCGA-P3-A5QE-01	4	3	5	12	PASS	3709	TCGA-P3-A5QE	HNSC	49	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma Basaloid Type	G2	2009	NA	-18002	Alive	TUMOR FREE	1559	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1559	0	1559	0	1559	0	1559	
50	TCGA-P3-A5QF	4	32	1	19	4	0	0	0	30	286	26	2	6	121	4	0	TCGA-P3-A5QF-01	101	0.15893304719956164	43	TCGA-P3-A5QF-01	4	5	27	0.1040269499953628	TCGA-P3-A5QF-01	4	5	4	13	PASS	3710	TCGA-P3-A5QF	HNSC	49	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-18035	Dead	WITH TUMOR	NA	330	NA	NA	Distant Metastasis	Lung	140	[Unknown]	NA	NA	1	330	1	330	NA	NA	1	140	
50	TCGA-P3-A6SW	0	4	0	1	0	2	1	0	2	70	9	0	0	25	1	0	TCGA-P3-A6SW-01	52	0.2027950226904403	13	TCGA-P3-A6SW-01	7	10	29	0.118134361103231	TCGA-P3-A6SW-01	10	9	4	23	PASS	3711	TCGA-P3-A6SW	HNSC	50	MALE	WHITE	Stage IVB	Stage IVA	Head & Neck Squamous Cell Carcinoma Basaloid Type	G3	2005	NA	-18536	Alive	TUMOR FREE	1120	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1120	0	1120	NA	NA	0	1120	
70	TCGA-P3-A6SX	0	12	1	5	0	2	0	0	13	130	15	0	5	39	2	0	TCGA-P3-A6SX-01	180	0.5024248600181993	96	TCGA-P3-A6SX-01	11	18	102	0.2882946251192427	TCGA-P3-A6SX-01	15	6	11	32	PASS	3712	TCGA-P3-A6SX	HNSC	67	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2005	NA	-24715	Dead	TUMOR FREE	NA	1430	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1430	0	1430	NA	NA	0	1430	
50	TCGA-P3-A6T0	0	4	0	1	1	1	2	0	2	65	8	0	1	27	0	0	TCGA-P3-A6T0-01	104	0.2083943853553256	45	TCGA-P3-A6T0-01	4	3	30	0.06712086242089489	TCGA-P3-A6T0-01	5	2	5	12	PASS	3713	TCGA-P3-A6T0	HNSC	47	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2007	NA	-17259	Alive	TUMOR FREE	578	NA	NA	Locoregional Disease	Oral Cavity	NA	365	Complete Remission/Response	NA	NA	0	578	0	578	NA	NA	1	365	
50	TCGA-P3-A6T2	0	6	1	5	1	0	0	0	2	38	3	0	1	29	1	0	TCGA-P3-A6T2-01	119	0.2053991172574571	58	TCGA-P3-A6T2-01	9	9	25	0.06963052768915877	TCGA-P3-A6T2-01	4	0	3	7	PASS	3714	TCGA-P3-A6T2	HNSC	45	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-16588	Alive	TUMOR FREE	2298	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2298	0	2298	NA	NA	0	2298	
50	TCGA-P3-A6T3	0	7	0	6	0	0	0	0	4	83	11	0	1	27	0	0	TCGA-P3-A6T3-01	177	0.5798461376857103	95	TCGA-P3-A6T3-01	20	26	63	0.21934278432918208	TCGA-P3-A6T3-01	15	9	7	31	PASS	3715	TCGA-P3-A6T3	HNSC	49	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-18143	Dead	WITH TUMOR	NA	577	NA	Distant Metastasis	Distant Metastasis	Lung	242	Complete Remission/Response	NA	NA	1	577	1	577	NA	NA	1	242	
50	TCGA-P3-A6T4	1	10	0	8	5	1	0	0	8	96	13	0	1	47	3	0	TCGA-P3-A6T4-01	205	0.6799234771017811	117	TCGA-P3-A6T4-01	21	32	142	0.3892281854125688	TCGA-P3-A6T4-01	18	16	12	46	PASS	3716	TCGA-P3-A6T4	HNSC	54	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-20027	Dead	WITH TUMOR	NA	62	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	62	1	62	NA	NA	1	62	
80	TCGA-P3-A6T5	0	11	1	4	3	1	1	0	8	175	8	0	3	83	7	0	TCGA-P3-A6T5-01	144	0.6756577616568229	75	TCGA-P3-A6T5-01	26	56	133	0.4521405232766417	TCGA-P3-A6T5-01	15	6	4	25	PASS	3717	TCGA-P3-A6T5	HNSC	79	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-28977	Dead	WITH TUMOR	NA	882	NA	Locoregional Disease	Oral Cavity	NA	335	Complete Remission/Response	NA	NA	1	882	1	882	NA	NA	1	335	
50	TCGA-P3-A6T6	1	10	0	5	1	0	0	0	7	90	9	0	4	31	5	0	TCGA-P3-A6T6-01	199	0.2944630004645297	108	TCGA-P3-A6T6-01	0	5	73	0.18314215765023525	TCGA-P3-A6T6-01	18	17	10	45	PASS	3718	TCGA-P3-A6T6	HNSC	53	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2009	NA	-19694	Dead	WITH TUMOR	NA	395	NA	Distant Metastasis	Distant Metastasis	lung	273	Complete Remission/Response	NA	NA	1	395	1	395	NA	NA	1	273	
60	TCGA-P3-A6T7	2	8	1	5	6	4	1	0	5	102	5	0	3	42	3	0	TCGA-P3-A6T7-01	109	0.2731316556543814	47	TCGA-P3-A6T7-01	9	13	64	0.2375357557776889	TCGA-P3-A6T7-01	12	3	10	25	PASS	3719	TCGA-P3-A6T7	HNSC	55	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-20301	Dead	NA	NA	487	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	487	NA	487	NA	NA	0	487	
50	TCGA-P3-A6T8	1	8	1	2	5	2	1	0	3	68	3	0	1	17	0	1	TCGA-P3-A6T8-01	222	0.3564904998372203	125	TCGA-P3-A6T8-01	10	15	138	0.35806145980220744	TCGA-P3-A6T8-01	20	13	14	47	PASS	3720	TCGA-P3-A6T8	HNSC	54	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	NA	-19754	Alive	TUMOR FREE	400	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	400	0	400	NA	NA	0	400	
80	TCGA-QK-A64Z	0	4	1	4	1	0	1	0	2	59	7	0	0	29	1	0	TCGA-QK-A64Z-01	96	0.2327636272282959	41	TCGA-QK-A64Z-01	10	9	48	0.125896816565006	TCGA-QK-A64Z-01	8	3	8	19	PASS	3721	TCGA-QK-A64Z	HNSC	79	FEMALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2011	NA	-29037	Dead	WITH TUMOR	NA	641	NA	Locoregional Recurrence	Cervical Lymph Nodes	bilateral	553	Progressive Disease	NA	NA	1	641	1	641	NA	NA	1	553	
60	TCGA-QK-A652	1	3	0	1	1	0	0	0	2	38	3	0	0	8	1	0	TCGA-QK-A652-01	45	0.21737427216110067	12	TCGA-QK-A652-01	8	10	44	0.2419436099515017	TCGA-QK-A652-01	5	3	5	13	PASS	3722	TCGA-QK-A652	HNSC	60	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-22023	Alive	TUMOR FREE	645	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	645	0	645	0	645	0	645	
60	TCGA-QK-A6IF	0	1	1	3	0	1	0	0	0	22	0	0	1	9	0	0	TCGA-QK-A6IF-01	92	0.1549991816721053	35	TCGA-QK-A6IF-01	4	8	48	0.1911436417691528	TCGA-QK-A6IF-01	7	5	5	17	PASS	3723	TCGA-QK-A6IF	HNSC	61	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2013	NA	-22463	Alive	TUMOR FREE	704	NA	NA	Distant Metastasis	Distant Metastasis	pulmonary nodules throughout both lungs	502	Complete Remission/Response	NA	NA	0	704	0	704	NA	NA	1	502	
70	TCGA-QK-A6IG	0	5	0	4	1	0	0	0	8	92	16	0	1	29	1	0	TCGA-QK-A6IG-01	158	0.5187681491168975	93	TCGA-QK-A6IG-01	21	28	62	0.19821550921830688	TCGA-QK-A6IG-01	15	12	8	35	PASS	3724	TCGA-QK-A6IG	HNSC	69	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-25334	Dead	WITH TUMOR	NA	222	NA	Locoregional Disease	Cervical Lymph Nodes	Left level Ib lymph node	142	Progressive Disease	NA	NA	1	222	1	222	NA	NA	1	142	
70	TCGA-QK-A6IH	0	1	0	2	0	1	0	0	1	59	1	1	1	17	0	0	TCGA-QK-A6IH-01	217	0.8003338155340306	131	TCGA-QK-A6IH-01	11	12	151	0.4089798630252935	TCGA-QK-A6IH-01	12	6	18	36	PASS	3725	TCGA-QK-A6IH	HNSC	65	FEMALE	WHITE	Stage IVB	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-23936	Alive	WITH TUMOR	653	NA	NA	NA	Distant Metastasis	Lung	228	Progressive Disease	NA	NA	0	653	0	653	NA	NA	1	228	
50	TCGA-QK-A6II	1	8	1	5	3	1	2	0	6	134	2	0	2	56	5	2	TCGA-QK-A6II-01	104	0.0945107526256788	48	TCGA-QK-A6II-01	3	8	36	0.05738440443384935	TCGA-QK-A6II-01	6	2	3	11	PASS	3726	TCGA-QK-A6II	HNSC	52	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-19113	Dead	WITH TUMOR	NA	284	NA	Locoregional Recurrence	Cervical Lymph Nodes	NA	176	Progressive Disease	NA	NA	1	284	1	284	NA	NA	1	176	
70	TCGA-QK-A6IJ	1	1	0	2	0	3	0	0	0	48	5	0	1	21	3	0	TCGA-QK-A6IJ-01	152	0.32115269054938833	79	TCGA-QK-A6IJ-01	15	28	41	0.09713222077737448	TCGA-QK-A6IJ-01	12	10	4	26	PASS	3727	TCGA-QK-A6IJ	HNSC	71	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2013	NA	-25966	Alive	TUMOR FREE	387	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	387	0	387	NA	NA	0	387	
60	TCGA-QK-A6V9	0	4	0	2	1	1	0	0	4	51	6	0	1	30	0	0	TCGA-QK-A6V9-01	63	0.26594529249424315	16	TCGA-QK-A6V9-01	10	8	37	0.1574383473606031	TCGA-QK-A6V9-01	8	6	4	18	PASS	3728	TCGA-QK-A6V9	HNSC	56	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-20461	Alive	TUMOR FREE	833	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	833	0	833	0	833	0	833	
70	TCGA-QK-A6VB	1	39	2	11	51	33	11	0	17	308	9	0	9	122	10	0	TCGA-QK-A6VB-01	113	0.6881331957326392	48	TCGA-QK-A6VB-01	27	19	90	0.31437296558388433	TCGA-QK-A6VB-01	10	3	7	20	PASS	3729	TCGA-QK-A6VB	HNSC	66	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-24144	Alive	TUMOR FREE	641	NA	NA	New Primary Tumor	NA	Acute myeloid leukemia	613	Complete Remission/Response	NA	NA	0	641	0	641	NA	NA	1	613	
60	TCGA-QK-A6VC	1	12	0	2	1	0	0	0	6	166	9	0	0	52	1	0	TCGA-QK-A6VC-01	128	0.3896162290044245	67	TCGA-QK-A6VC-01	14	34	94	0.3072162172377197	TCGA-QK-A6VC-01	17	20	13	50	PASS	3730	TCGA-QK-A6VC	HNSC	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-22865	Alive	TUMOR FREE	600	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	600	0	600	NA	NA	0	600	
60	TCGA-QK-A8Z7	1	5	0	2	3	3	0	0	4	109	14	0	1	35	4	1	TCGA-QK-A8Z7-01	278	0.7164286877771561	155	TCGA-QK-A8Z7-01	10	23	123	0.2617699352748858	TCGA-QK-A8Z7-01	23	20	11	54	PASS	3731	TCGA-QK-A8Z7	HNSC	59	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma Basaloid Type	NA	2013	NA	-21711	Alive	TUMOR FREE	392	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	392	0	392	NA	NA	0	392	
60	TCGA-QK-A8Z8	1	27	3	7	19	5	0	0	17	277	29	1	9	117	6	1	TCGA-QK-A8Z8-01	232	0.4666558011140685	150	TCGA-QK-A8Z8-01	10	20	152	0.34044198687618377	TCGA-QK-A8Z8-01	13	7	9	29	PASS	3732	TCGA-QK-A8Z8	HNSC	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVC	Stage IVC	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-22107	Dead	WITH TUMOR	NA	171	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	171	1	171	NA	NA	1	171	
60	TCGA-QK-A8Z9	1	12	1	6	2	2	0	0	3	85	9	0	4	41	3	1	TCGA-QK-A8Z9-01	529	0.6361324802008644	387	TCGA-QK-A8Z9-01	18	33	197	0.36041152144653904	TCGA-QK-A8Z9-01	18	13	14	45	PASS	3733	TCGA-QK-A8Z9	HNSC	56	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-20471	Dead	WITH TUMOR	NA	449	NA	Distant Metastasis	Distant Metastasis	esophagus	205	Complete Remission/Response	NA	NA	1	449	1	449	NA	NA	1	205	
60	TCGA-QK-A8ZA	1	6	1	2	1	2	0	0	8	91	6	0	2	37	0	0	TCGA-QK-A8ZA-01	451	0.8213294816697179	302	TCGA-QK-A8ZA-01	19	25	208	0.35194149876202313	TCGA-QK-A8ZA-01	23	13	13	49	PASS	3734	TCGA-QK-A8ZA	HNSC	60	MALE	BLACK OR AFRICAN AMERICAN	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-21979	Dead	TUMOR FREE	NA	371	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	371	0	371	NA	NA	0	371	
70	TCGA-QK-A8ZB	0	3	0	1	2	0	0	0	4	79	6	0	2	28	5	0	TCGA-QK-A8ZB-01	263	0.3328320943484384	175	TCGA-QK-A8ZB-01	7	11	163	0.28370297853801485	TCGA-QK-A8ZB-01	12	9	13	34	PASS	3735	TCGA-QK-A8ZB	HNSC	68	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-25192	Alive	TUMOR FREE	542	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	542	0	542	NA	NA	0	542	
70	TCGA-QK-AA3J	1	9	1	4	2	1	2	0	6	88	4	0	1	41	3	0	TCGA-QK-AA3J-01	238	0.5791099327567364	148	TCGA-QK-AA3J-01	12	18	131	0.3369032775348324	TCGA-QK-AA3J-01	14	6	14	34	PASS	3736	TCGA-QK-AA3J	HNSC	69	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma Basaloid Type	G3	2013	NA	-25469	Alive	TUMOR FREE	466	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	466	0	466	0	466	0	466	
60	TCGA-QK-AA3K	0	3	0	1	6	1	0	0	9	71	4	0	1	29	3	0	TCGA-QK-AA3K-01	268	0.5314008973192643	187	TCGA-QK-AA3K-01	7	33	210	0.5090339040752943	TCGA-QK-AA3K-01	15	7	12	34	PASS	3737	TCGA-QK-AA3K	HNSC	60	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-22093	Alive	NA	253	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	253	0	253	NA	NA	0	253	
80	TCGA-RS-A6TO	0	11	0	3	3	1	1	0	4	122	11	0	2	57	4	0	TCGA-RS-A6TO-01	159	0.6255613834546607	91	TCGA-RS-A6TO-01	24	30	36	0.1059374779068701	TCGA-RS-A6TO-01	8	3	5	16	PASS	3738	TCGA-RS-A6TO	HNSC	82	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-30104	Dead	WITH TUMOR	NA	387	NA	Locoregional Recurrence	Oral Cavity	L floor of mouth	338	Complete Remission/Response	NA	NA	1	387	1	387	NA	NA	1	338	
60	TCGA-RS-A6TP	1	9	0	2	1	1	0	0	6	93	8	0	5	42	2	1	TCGA-RS-A6TP-01	122	0.10103666242127493	56	TCGA-RS-A6TP-01	2	6	55	0.13172500595517075	TCGA-RS-A6TP-01	7	5	5	17	PASS	3739	TCGA-RS-A6TP	HNSC	58	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2013	NA	-21393	Alive	TUMOR FREE	516	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	516	0	516	0	516	0	516	
70	TCGA-T2-A6WX	1	9	0	6	2	0	0	0	12	148	14	0	1	55	3	0	TCGA-T2-A6WX-01	46	0.1226518009132038	7	TCGA-T2-A6WX-01	4	3	13	0.041437032905671085	TCGA-T2-A6WX-01	4	2	4	10	PASS	3740	TCGA-T2-A6WX	HNSC	73	FEMALE	WHITE	NA	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2010	NA	-27005	Dead	WITH TUMOR	NA	209	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	209	1	209	NA	NA	1	209	
50	TCGA-T2-A6WZ	1	9	0	5	1	3	0	0	4	73	6	0	0	31	1	0	TCGA-T2-A6WZ-01	367	0.7738111466935821	237	TCGA-T2-A6WZ-01	20	37	231	0.4349634425637718	TCGA-T2-A6WZ-01	27	19	23	69	PASS	3741	TCGA-T2-A6WZ	HNSC	53	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-19397	Dead	WITH TUMOR	NA	484	NA	Distant Metastasis	Distant Metastasis	bilateral pulmonary nodules	229	Stable Disease	NA	NA	1	484	1	484	NA	NA	1	229	
50	TCGA-T2-A6X0	0	2	0	2	0	0	1	0	1	45	5	0	0	23	0	0	TCGA-T2-A6X0-01	163	0.28715889362730473	95	TCGA-T2-A6X0-01	2	10	67	0.1698984340019436	TCGA-T2-A6X0-01	11	12	10	33	PASS	3742	TCGA-T2-A6X0	HNSC	49	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-18114	Alive	TUMOR FREE	216	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	216	0	216	NA	NA	0	216	
80	TCGA-T2-A6X2	1	29	2	10	3	1	2	0	9	276	27	0	4	102	8	1	TCGA-T2-A6X2-01	140	0.08058983226967215	80	TCGA-T2-A6X2-01	4	7	42	0.09419643450481267	TCGA-T2-A6X2-01	5	2	5	12	PASS	3743	TCGA-T2-A6X2	HNSC	82	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2011	NA	-30013	Alive	TUMOR FREE	987	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	987	0	987	0	987	0	987	
50	TCGA-T3-A92M	2	21	3	14	1	4	0	0	21	258	34	1	7	88	5	0	TCGA-T3-A92M-01	439	0.5952727567781743	285	TCGA-T3-A92M-01	15	36	215	0.3142678196894553	TCGA-T3-A92M-01	19	20	9	48	PASS	3744	TCGA-T3-A92M	HNSC	52	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-19247	Alive	WITH TUMOR	417	NA	NA	Distant Metastasis	Distant Metastasis	(Rt) Lung	417	[Unknown]	NA	NA	0	417	0	417	NA	NA	1	417	
80	TCGA-T3-A92N	1	13	1	3	4	6	0	0	3	114	16	0	2	51	1	0	TCGA-T3-A92N-01	252	0.6167477077995664	167	TCGA-T3-A92N-01	19	32	112	0.3091958906391461	TCGA-T3-A92N-01	9	16	10	35	PASS	3745	TCGA-T3-A92N	HNSC	79	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVC	Head & Neck Squamous Cell Carcinoma	G3	2013	NA	-28879	Dead	WITH TUMOR	NA	95	NA	Distant Metastasis	Distant Metastasis	Lung	46	Progressive Disease	NA	NA	1	95	1	95	NA	NA	1	46	
60	TCGA-TN-A7HI	0	6	0	4	0	0	1	0	1	42	4	0	2	13	2	0	TCGA-TN-A7HI-01	140	0.9419498172648596	82	TCGA-TN-A7HI-01	30	35	64	0.19090832596109944	TCGA-TN-A7HI-01	3	3	0	6	PASS	3746	TCGA-TN-A7HI	HNSC	56	MALE	WHITE	Stage IVA	Stage I	Head & Neck Squamous Cell Carcinoma	G3	2013	NA	-20666	Alive	TUMOR FREE	412	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	412	0	412	NA	NA	0	412	
50	TCGA-TN-A7HJ	1	12	0	2	3	2	1	0	7	87	5	0	2	28	2	0	TCGA-TN-A7HJ-01	141	0.524120258383671	80	TCGA-TN-A7HJ-01	20	30	78	0.1920878087703249	TCGA-TN-A7HJ-01	16	21	10	47	PASS	3747	TCGA-TN-A7HJ	HNSC	51	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-18809	Alive	TUMOR FREE	403	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	403	0	403	NA	NA	0	403	
60	TCGA-TN-A7HL	4	35	5	20	1	1	1	0	30	466	52	0	9	204	9	1	TCGA-TN-A7HL-01	83	0.16450398191570126	26	TCGA-TN-A7HL-01	6	9	42	0.11807297975788952	TCGA-TN-A7HL-01	8	5	7	20	PASS	3748	TCGA-TN-A7HL	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-21731	Alive	TUMOR FREE	619	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	619	0	619	NA	NA	0	619	
60	TCGA-UF-A718	0	7	1	2	1	3	0	0	1	45	2	0	2	13	3	0	TCGA-UF-A718-01	93	0.34089914141216193	46	TCGA-UF-A718-01	8	10	64	0.23065728014085635	TCGA-UF-A718-01	11	9	9	29	PASS	3749	TCGA-UF-A718	HNSC	62	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-22836	Alive	TUMOR FREE	1971	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1971	0	1971	NA	NA	0	1971	
50	TCGA-UF-A719	1	4	1	5	4	1	0	0	2	88	5	0	0	35	3	1	TCGA-UF-A719-01	276	0.8185556209172588	176	TCGA-UF-A719	0	0	0	0	TCGA-UF-A719	0	0	0	0	PASS	3750	TCGA-UF-A719	HNSC	54	MALE	[Unknown]	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2009	NA	-19797	Alive	TUMOR FREE	1663	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1663	0	1663	0	1663	0	1663	
70	TCGA-UF-A71A	2	24	3	11	8	0	0	0	19	285	16	0	6	117	15	4	TCGA-UF-A71A-01	257	0.6803220867922544	145	TCGA-UF-A71A-06	18	40	217	0.42907020567302384	TCGA-UF-A71A-06	19	20	10	49	mutation call filter	3751	TCGA-UF-A71A	HNSC	67	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2009	NA	-24623	Dead	WITH TUMOR	NA	86	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	86	1	86	NA	NA	1	86	
50	TCGA-UF-A71B	1	8	1	3	3	2	1	0	0	109	9	0	2	51	2	0	TCGA-UF-A71B-01	111	0.4011104535003393	45	TCGA-UF-A71B-01	9	10	54	0.23473879894465505	TCGA-UF-A71B-01	11	8	9	28	PASS	3752	TCGA-UF-A71B	HNSC	50	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-18404	Alive	TUMOR FREE	1506	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1506	0	1506	NA	NA	0	1506	
50	TCGA-UF-A71D	1	31	3	10	12	6	1	0	12	312	36	0	11	145	13	0	TCGA-UF-A71D-01	151	0.4706656221716067	67	TCGA-UF-A71D-01	10	9	87	0.2408641636040436	TCGA-UF-A71D-01	13	7	13	33	PASS	3753	TCGA-UF-A71D	HNSC	54	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-19747	Alive	TUMOR FREE	1461	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1461	0	1461	NA	NA	0	1461	
60	TCGA-UF-A71E	1	18	0	5	2	1	0	0	11	121	3	0	1	58	3	0	TCGA-UF-A71E-01	148	0.7178918812176935	67	TCGA-UF-A71E-01	20	35	69	0.19091177765244927	TCGA-UF-A71E-01	10	9	7	26	PASS	3754	TCGA-UF-A71E	HNSC	63	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma Basaloid Type	G3	2010	NA	-23071	Dead	TUMOR FREE	NA	1504	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1504	0	1504	NA	NA	0	1504	
80	TCGA-UF-A7J9	2	10	2	10	7	2	1	0	5	188	16	0	4	74	5	0	TCGA-UF-A7J9-01	114	0.7078390537270074	49	TCGA-UF-A7J9-01	15	17	77	0.4311817779488159	TCGA-UF-A7J9-01	10	9	12	31	PASS	3755	TCGA-UF-A7J9	HNSC	75	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-27459	Alive	TUMOR FREE	1358	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1358	0	1358	NA	NA	0	1358	
70	TCGA-UF-A7JA	1	8	1	3	0	1	0	0	7	175	12	1	6	52	1	0	TCGA-UF-A7JA-01	143	0.4044789130464289	72	TCGA-UF-A7JA-01	19	30	80	0.2297505372083353	TCGA-UF-A7JA-01	16	12	10	38	PASS	3756	TCGA-UF-A7JA	HNSC	66	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	NA	-24121	Alive	TUMOR FREE	2265	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2265	0	2265	NA	NA	0	2265	
40	TCGA-UF-A7JC	0	2	0	0	1	0	3	0	0	44	2	0	1	15	2	0	TCGA-UF-A7JC-01	141	0.5813328890741029	75	TCGA-UF-A7JC-01	4	7	62	0.2263274579872411	TCGA-UF-A7JC-01	9	8	9	26	PASS	3757	TCGA-UF-A7JC	HNSC	42	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2012	NA	-15452	Dead	WITH TUMOR	NA	546	NA	NA	Oral Cavity	NA	229	Complete Remission/Response	NA	NA	1	546	1	546	NA	NA	1	229	
70	TCGA-UF-A7JD	0	7	1	2	3	1	1	0	2	86	3	0	2	28	4	0	TCGA-UF-A7JD-01	195	0.6157708468352032	113	TCGA-UF-A7JD-01	18	35	68	0.20790910646676766	TCGA-UF-A7JD-01	18	16	12	46	PASS	3758	TCGA-UF-A7JD	HNSC	71	MALE	[Unknown]	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2012	NA	-26101	Dead	TUMOR FREE	NA	739	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	739	0	739	NA	NA	0	739	
80	TCGA-UF-A7JF	1	17	0	6	1	4	0	0	3	74	7	0	6	33	3	0	TCGA-UF-A7JF-01	132	0.4915785987361331	72	TCGA-UF-A7JF-01	11	12	85	0.2442055605941273	TCGA-UF-A7JF-01	16	8	9	33	PASS	3759	TCGA-UF-A7JF	HNSC	80	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-29468	Alive	TUMOR FREE	1686	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1686	0	1686	NA	NA	0	1686	
60	TCGA-UF-A7JH	0	9	0	0	2	2	0	0	4	50	5	0	3	24	3	0	TCGA-UF-A7JH-01	353	0.6123987438812405	236	TCGA-UF-A7JH-01	17	31	162	0.3265632918759095	TCGA-UF-A7JH-01	16	13	8	37	PASS	3760	TCGA-UF-A7JH	HNSC	59	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2012	NA	-21558	Alive	TUMOR FREE	896	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	896	0	896	NA	NA	0	896	
70	TCGA-UF-A7JJ	0	0	0	0	2	1	0	0	0	70	5	0	2	17	2	0	TCGA-UF-A7JJ-01	89	0.1193843864820052	38	TCGA-UF-A7JJ-01	11	12	90	0.2985570719493991	TCGA-UF-A7JJ-01	11	6	10	27	PASS	3761	TCGA-UF-A7JJ	HNSC	68	MALE	[Unknown]	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2013	NA	-25201	Alive	TUMOR FREE	549	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	549	0	549	NA	NA	0	549	
60	TCGA-UF-A7JK	0	4	1	1	0	1	1	0	1	77	7	0	5	43	2	0	TCGA-UF-A7JK-01	230	0.6079036758552828	143	TCGA-UF-A7JK-01	19	36	107	0.2821838485899907	TCGA-UF-A7JK-01	20	16	14	50	PASS	3762	TCGA-UF-A7JK	HNSC	59	MALE	[Unknown]	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	NA	-21696	Dead	WITH TUMOR	NA	424	NA	NA	Larynx	NA	341	Complete Remission/Response	NA	NA	1	424	1	424	NA	NA	1	341	
80	TCGA-UF-A7JO	1	7	0	2	1	2	0	1	1	135	9	0	3	57	4	0	TCGA-UF-A7JO-01	88	0.35418594282432503	27	TCGA-UF-A7JO-01	4	9	68	0.27904461668756875	TCGA-UF-A7JO-01	14	18	14	46	PASS	3763	TCGA-UF-A7JO	HNSC	79	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	NA	-28951	Dead	WITH TUMOR	NA	631	NA	Locoregional Disease	Oral Cavity	Floor of mouth	525	Complete Remission/Response	NA	NA	1	631	1	631	NA	NA	1	525	
60	TCGA-UF-A7JS	1	3	0	4	1	2	0	0	4	50	2	0	0	20	2	0	TCGA-UF-A7JS-01	176	0.3636339728512294	86	TCGA-UF-A7JS-01	9	13	76	0.21262899840920446	TCGA-UF-A7JS-01	13	6	9	28	PASS	3764	TCGA-UF-A7JS	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-21676	Dead	WITH TUMOR	NA	680	NA	Locoregional Recurrence	Cervical Lymph Nodes	NA	519	Complete Remission/Response	NA	NA	1	680	1	680	NA	NA	1	519	
70	TCGA-UF-A7JT	1	5	0	3	3	0	2	0	8	152	10	0	3	57	3	0	TCGA-UF-A7JT-01	97	0.10634767358267433	45	TCGA-UF-A7JT-01	3	5	47	0.10692642423378344	TCGA-UF-A7JT-01	7	6	4	17	PASS	3765	TCGA-UF-A7JT	HNSC	72	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2009	NA	-26375	Dead	WITH TUMOR	NA	993	NA	NA	NA	Cervix	718	Complete Remission/Response	NA	NA	1	993	1	993	NA	NA	1	718	
60	TCGA-UF-A7JV	0	6	1	1	1	1	1	0	3	52	8	0	1	25	2	0	TCGA-UF-A7JV-01	95	0.10295311395390344	44	TCGA-UF-A7JV-01	4	4	28	0.049718306520466105	TCGA-UF-A7JV-01	4	4	3	11	PASS	3766	TCGA-UF-A7JV	HNSC	62	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	NA	-22985	Dead	WITH TUMOR	NA	90	NA	NA	Oropharynx	Oropharynx and cervical lymph node	55	Complete Remission/Response	NA	NA	1	90	1	90	NA	NA	1	55	
60	TCGA-UP-A6WW	0	1	0	1	0	2	0	0	1	31	1	0	1	12	1	0	TCGA-UP-A6WW-01	119	0.9475389427817471	60	TCGA-UP-A6WW-01	9	11	78	0.25118495463589097	TCGA-UP-A6WW-01	8	8	8	24	PASS	3767	TCGA-UP-A6WW	HNSC	58	MALE	WHITE	NA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	NA	-21427	Alive	TUMOR FREE	518	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	518	0	518	NA	NA	0	518	
60	TCGA-WA-A7GZ	5	9	1	2	4	1	3	1	5	157	14	0	6	62	3	0	TCGA-WA-A7GZ-01	378	0.6834907804605396	256	TCGA-WA-A7GZ-01	13	20	201	0.2869255166703443	TCGA-WA-A7GZ-01	21	12	10	43	PASS	3768	TCGA-WA-A7GZ	HNSC	58	MALE	WHITE	NA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012	NA	-21207	Dead	TUMOR FREE	NA	625	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	625	0	625	0	625	0	625	
70	TCGA-WA-A7H4	0	4	0	2	1	0	0	0	0	60	0	0	2	18	0	0	TCGA-WA-A7H4-01	72	0.19742174801924706	20	TCGA-WA-A7H4-01	10	23	105	0.3768040627965177	TCGA-WA-A7H4-01	12	7	15	34	PASS	3769	TCGA-WA-A7H4	HNSC	69	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2013	NA	-25363	Alive	TUMOR FREE	443	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	443	0	443	0	443	0	443	
60	TCGA-KL-8323	0	1	1	0	0	1	0	0	3	27	0	0	2	10	0	0	TCGA-KL-8323-01	88	0.9476693856549638	44	TCGA-KL-8323-01	14	9	12	0.3641230396548348	TCGA-KL-8323-01	2	2	0	4	PASS	3770	TCGA-KL-8323	KICH	57	FEMALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2000	NA	-20849	Dead	WITH TUMOR	NA	1158	NA	NA	NA	NA	758	[Unknown]	NA	NA	1	1158	1	1158	NA	NA	1	758	
70	TCGA-KL-8324	0	3	0	0	1	0	0	0	3	29	0	0	1	4	0	0	TCGA-KL-8324-01	69	0.9460949876335786	25	TCGA-KL-8324-01	16	9	10	0.5029748667510715	TCGA-KL-8324-01	0	0	0	0	PASS	3771	TCGA-KL-8324	KICH	67	FEMALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2000	NA	-24650	Alive	TUMOR FREE	4676	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4676	0	4676	NA	NA	0	4676	
60	TCGA-KL-8325	0	3	0	0	0	0	0	0	2	17	2	0	0	6	1	0	TCGA-KL-8325-01	83	0.94772425567029	36	TCGA-KL-8325-01	13	7	13	0.3793806496182545	TCGA-KL-8325-01	0	0	0	0	PASS	3772	TCGA-KL-8325	KICH	56	FEMALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2000	NA	-20768	Dead	TUMOR FREE	NA	725	NA	NA	NA	NA	NA	NA	NA	NA	1	725	0	725	NA	NA	0	725	
70	TCGA-KL-8326	0	5	0	1	1	0	0	0	2	19	2	0	0	8	0	0	TCGA-KL-8326-01	55	0.04919082978520292	17	TCGA-KL-8326-01	1	1	5	0.05187472662561532	TCGA-KL-8326-01	2	1	2	5	PASS	3773	TCGA-KL-8326	KICH	69	MALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2001	NA	-25267	Alive	TUMOR FREE	3322	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	3322	0	3322	NA	NA	0	3322	
50	TCGA-KL-8327	0	2	2	0	1	0	0	0	2	17	0	0	0	6	0	0	TCGA-KL-8327-01	63	0.8031025438675591	21	TCGA-KL-8327-01	32	15	4	0.2042851396959518	TCGA-KL-8327-01	0	0	0	0	PASS	3774	TCGA-KL-8327	KICH	46	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2001	NA	-17121	Alive	TUMOR FREE	4169	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	4169	0	4169	NA	NA	0	4169	
60	TCGA-KL-8328	1	3	0	1	0	0	0	0	0	14	5	0	0	8	0	0	TCGA-KL-8328-01	62	0.9308313200812898	14	TCGA-KL-8328-01	16	10	17	0.4574447879387698	TCGA-KL-8328-01	1	3	1	5	PASS	3775	TCGA-KL-8328	KICH	60	MALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2003	NA	-21976	Alive	TUMOR FREE	3127	NA	NA	NA	NA	NA	NA	[Not Evaluated]	NA	NA	0	3127	0	3127	NA	NA	0	3127	
60	TCGA-KL-8329	0	3	0	1	1	1	0	0	3	22	2	0	0	8	0	0	TCGA-KL-8329-01	67	0.9478119670287656	24	TCGA-KL-8329-01	13	7	11	0.38047829465066096	TCGA-KL-8329-01	1	0	1	2	PASS	3776	TCGA-KL-8329	KICH	57	FEMALE	ASIAN	Stage I	NA	Kidney Chromophobe	NA	2003	NA	-20972	Alive	TUMOR FREE	2752	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	2752	0	2752	NA	NA	0	2752	
40	TCGA-KL-8330	0	2	0	0	0	1	0	0	1	18	2	0	0	7	1	0	TCGA-KL-8330-01	75	0.9477281309253308	37	TCGA-KL-8330-01	15	9	9	0.43993253855046094	TCGA-KL-8330-01	0	0	0	0	PASS	3777	TCGA-KL-8330	KICH	44	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Kidney Chromophobe	NA	2003	NA	-16250	Alive	TUMOR FREE	3304	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	3304	0	3304	NA	NA	0	3304	
50	TCGA-KL-8331	0	5	0	0	0	1	0	0	0	17	0	0	0	13	1	0	TCGA-KL-8331-01	75	0.9477302459660066	29	TCGA-KL-8331-01	16	10	12	0.4486531311815388	TCGA-KL-8331-01	0	0	1	1	PASS	3778	TCGA-KL-8331	KICH	48	FEMALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2004	NA	-17710	Alive	TUMOR FREE	3010	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	3010	0	3010	NA	NA	0	3010	
60	TCGA-KL-8332	0	3	0	0	3	2	0	0	0	16	1	0	0	3	0	0	TCGA-KL-8332-01	43	0.94771526036562	8	TCGA-KL-8332-01	15	9	9	0.471350253745999	TCGA-KL-8332-01	0	0	0	0	PASS	3779	TCGA-KL-8332	KICH	55	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2004	NA	-20128	Alive	TUMOR FREE	2582	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	2582	0	2582	NA	NA	0	2582	
70	TCGA-KL-8333	0	3	0	1	1	0	0	0	1	13	0	0	0	6	0	0	TCGA-KL-8333-01	57	0.22609735345280935	20	TCGA-KL-8333-01	7	4	5	0.2385136285426541	TCGA-KL-8333-01	2	1	2	5	PASS	3780	TCGA-KL-8333	KICH	69	MALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2005	NA	-25229	Alive	TUMOR FREE	2991	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	2991	0	2991	NA	NA	0	2991	
40	TCGA-KL-8334	0	2	0	1	1	1	0	0	1	8	0	0	0	5	0	0	TCGA-KL-8334-01	76	0.9477271291191006	29	TCGA-KL-8334-01	12	7	8	0.3631690486760594	TCGA-KL-8334-01	0	0	0	0	PASS	3781	TCGA-KL-8334	KICH	37	FEMALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2005	NA	-13602	Alive	TUMOR FREE	2949	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	2949	0	2949	NA	NA	0	2949	
70	TCGA-KL-8335	1	5	0	4	2	0	0	1	2	33	4	0	0	13	2	0	TCGA-KL-8335-01	91	0.9477238800115328	40	TCGA-KL-8335-01	14	8	16	0.3891529040100268	TCGA-KL-8335-01	2	1	1	4	PASS	3782	TCGA-KL-8335	KICH	67	MALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2005	NA	-24832	Alive	TUMOR FREE	2815	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	2815	0	2815	NA	NA	0	2815	
50	TCGA-KL-8336	1	3	0	1	0	0	1	0	3	17	3	0	0	4	1	0	TCGA-KL-8336-01	87	0.947731240438872	39	TCGA-KL-8336-01	19	11	18	0.459866886192854	TCGA-KL-8336-01	1	0	0	1	PASS	3783	TCGA-KL-8336	KICH	51	FEMALE	WHITE	Stage IV	NA	Kidney Chromophobe	NA	2006	NA	-18821	Dead	WITH TUMOR	NA	920	NA	NA	NA	NA	47	[Unknown]	NA	NA	1	920	1	920	NA	NA	1	47	
30	TCGA-KL-8337	0	1	0	1	0	0	0	0	1	18	0	0	0	3	1	0	TCGA-KL-8337-01	94	0.954546350212093	48	TCGA-KL-8337-01	12	6	7	0.36921011734360826	TCGA-KL-8337-01	0	0	0	0	PASS	3784	TCGA-KL-8337	KICH	26	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Kidney Chromophobe	NA	2006	NA	-9819	Alive	TUMOR FREE	1364	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1364	0	1364	NA	NA	0	1364	
50	TCGA-KL-8338	0	1	0	1	0	0	0	0	1	20	1	0	0	6	2	0	TCGA-KL-8338-01	91	0.9477280443842284	35	TCGA-KL-8338-01	11	6	10	0.35150783359323123	TCGA-KL-8338-01	0	0	0	0	PASS	3785	TCGA-KL-8338	KICH	51	MALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2006	NA	-18667	Alive	TUMOR FREE	2633	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	2633	0	2633	NA	NA	0	2633	
70	TCGA-KL-8339	0	2	0	3	1	0	0	0	2	38	2	1	0	18	0	0	TCGA-KL-8339-01	152	0.9184026372248784	92	TCGA-KL-8339-01	33	13	30	0.3904872915894607	TCGA-KL-8339-01	4	5	3	12	PASS	3786	TCGA-KL-8339	KICH	67	MALE	WHITE	Stage IV	NA	Kidney Chromophobe	NA	2006	NA	-24545	Dead	WITH TUMOR	NA	855	NA	NA	NA	NA	64	[Not Evaluated]	NA	NA	1	855	1	855	NA	NA	1	64	
30	TCGA-KL-8340	0	0	0	0	0	0	0	0	0	16	0	0	0	5	0	0	TCGA-KL-8340-01	71	0.9477316392303892	22	TCGA-KL-8340-01	12	7	8	0.3631057146393191	TCGA-KL-8340-01	0	0	1	1	PASS	3787	TCGA-KL-8340	KICH	34	MALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2006	NA	-12696	Alive	TUMOR FREE	2024	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	2024	0	2024	NA	NA	0	2024	
40	TCGA-KL-8341	0	4	1	1	1	0	0	0	0	32	3	0	0	13	3	0	TCGA-KL-8341-01	218	0.8261964879944532	136	TCGA-KL-8341-01	14	9	44	0.4335108503472533	TCGA-KL-8341-01	3	6	5	14	PASS	3788	TCGA-KL-8341	KICH	41	MALE	ASIAN	Stage IV	NA	Kidney Chromophobe	NA	2006	NA	-15045	Dead	WITH TUMOR	NA	754	NA	NA	NA	NA	175	[Unknown]	NA	NA	1	754	1	754	NA	NA	1	175	
50	TCGA-KL-8342	0	1	0	0	0	0	0	0	0	21	0	0	0	5	0	0	TCGA-KL-8342-01	79	0.9476599306855648	32	TCGA-KL-8342-01	10	5	6	0.3165662377289205	TCGA-KL-8342-01	0	0	0	0	PASS	3789	TCGA-KL-8342	KICH	45	FEMALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2006	NA	-16550	Alive	TUMOR FREE	2248	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	2248	0	2248	NA	NA	0	2248	
70	TCGA-KL-8343	0	5	0	0	3	0	0	0	1	25	0	0	2	9	1	0	TCGA-KL-8343-01	43	0.4061138177186059	8	TCGA-KL-8343-01	8	5	8	0.17806894602065906	TCGA-KL-8343-01	2	1	2	5	PASS	3790	TCGA-KL-8343	KICH	72	MALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2007	NA	-26562	Dead	WITH TUMOR	NA	2172	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	2172	1	2172	NA	NA	1	2172	
50	TCGA-KL-8344	0	1	0	1	0	0	0	0	2	16	0	0	1	9	0	0	TCGA-KL-8344-01	81	0.18157280082000554	45	TCGA-KL-8344-01	4	3	4	0.1317181778928848	TCGA-KL-8344-01	0	0	0	0	PASS	3791	TCGA-KL-8344	KICH	51	MALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2007	NA	-18742	Alive	TUMOR FREE	876	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	876	0	876	NA	NA	0	876	
80	TCGA-KL-8345	0	0	0	1	1	0	0	0	0	24	1	0	0	6	4	0	TCGA-KL-8345-01	73	0.9477658342258314	26	TCGA-KL-8345-01	12	6	9	0.3663060383773256	TCGA-KL-8345-01	0	0	0	0	PASS	3792	TCGA-KL-8345	KICH	75	MALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2008	NA	-27412	Alive	TUMOR FREE	1665	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1665	0	1665	NA	NA	0	1665	
60	TCGA-KL-8346	0	1	0	0	1	0	0	0	3	17	0	0	0	5	0	0	TCGA-KL-8346-01	93	0.9476898690731844	33	TCGA-KL-8346-01	20	10	14	0.5140096187989194	TCGA-KL-8346-01	2	1	2	5	PASS	3793	TCGA-KL-8346	KICH	62	MALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2008	NA	-22651	Alive	TUMOR FREE	1897	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1897	0	1897	NA	NA	0	1897	
50	TCGA-KM-8438	0	0	0	0	4	2	0	0	0	16	2	0	1	5	0	0	TCGA-KM-8438-01	81	0.8339969473385548	33	TCGA-KM-8438-01	35	10	8	0.3792036179118967	TCGA-KM-8438-01	0	0	0	0	PASS	3794	TCGA-KM-8438	KICH	45	FEMALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2000	NA	-16683	Alive	WITH TUMOR	4622	NA	NA	NA	NA	NA	2317	Complete Remission/Response	NA	NA	0	4622	0	4622	1	2317	1	2317	
30	TCGA-KM-8439	0	1	0	2	1	0	0	0	0	11	0	0	0	1	0	0	TCGA-KM-8439-01	51	5.225574067807038e-05	13	TCGA-KM-8439-01	0	0	0	0.0	TCGA-KM-8439-01	0	0	0	0	PASS	3795	TCGA-KM-8439	KICH	30	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2011	NA	-11266	Alive	WITH TUMOR	708	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	708	0	708	NA	NA	0	708	
40	TCGA-KM-8440	0	3	0	2	1	0	0	0	1	11	2	0	0	4	1	0	TCGA-KM-8440-01	96	0.9477304399681102	42	TCGA-KM-8440-01	11	6	7	0.3514099657155753	TCGA-KM-8440-01	0	0	0	0	PASS	3796	TCGA-KM-8440	KICH	37	MALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Kidney Chromophobe	NA	2009	NA	-13860	Alive	TUMOR FREE	1366	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1366	0	1366	0	1366	0	1366	
60	TCGA-KM-8441	0	0	0	0	1	0	1	0	0	20	2	0	1	1	0	0	TCGA-KM-8441-01	51	0.00024719667747702813	11	TCGA-KM-8441-01	0	0	0	0.0	TCGA-KM-8441-01	0	0	0	0	PASS	3797	TCGA-KM-8441	KICH	61	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2011	NA	-22303	Alive	WITH TUMOR	876	NA	NA	NA	NA	NA	876	Complete Remission/Response	NA	NA	0	876	0	876	1	876	1	876	
40	TCGA-KM-8442	0	1	0	0	2	0	0	0	0	16	0	0	1	10	0	1	TCGA-KM-8442-01	77	0.947670014359815	35	TCGA-KM-8442-01	13	7	10	0.4166006494022187	TCGA-KM-8442-01	0	0	0	0	PASS	3798	TCGA-KM-8442	KICH	38	MALE	[Unknown]	Stage II	NA	Kidney Chromophobe	NA	2009	NA	-14212	Alive	TUMOR FREE	1437	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1437	0	1437	NA	NA	0	1437	
60	TCGA-KM-8443	0	2	0	0	0	1	0	0	3	29	1	0	2	4	1	0	TCGA-KM-8443-01	324	0.8597556520705079	267	TCGA-KM-8443-01	34	11	56	0.4062672027246485	TCGA-KM-8443-01	0	0	0	0	PASS	3799	TCGA-KM-8443	KICH	57	MALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2009	NA	-21183	Alive	TUMOR FREE	1520	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1520	0	1520	0	1520	0	1520	
50	TCGA-KM-8476	0	0	0	0	0	0	0	0	1	25	2	1	0	11	0	0	TCGA-KM-8476-01	69	0.9477299641270752	22	TCGA-KM-8476-01	14	8	13	0.4156662880639991	TCGA-KM-8476-01	0	0	0	0	PASS	3800	TCGA-KM-8476	KICH	47	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2002	NA	-17240	Alive	TUMOR FREE	3745	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3745	0	3745	0	3745	0	3745	
60	TCGA-KM-8477	0	1	0	0	1	1	0	0	1	14	1	0	0	11	2	0	TCGA-KM-8477-01	37	7.3388449803281025e-06	8	TCGA-KM-8477-01	0	0	0	0.0	TCGA-KM-8477-01	0	0	0	0	PASS	3801	TCGA-KM-8477	KICH	56	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2005	NA	-20491	Alive	TUMOR FREE	1553	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1553	0	1553	0	1553	0	1553	
70	TCGA-KM-8639	1	2	0	3	2	1	0	0	1	16	2	0	0	3	0	0	TCGA-KM-8639-01	45	0.096112013985042	8	TCGA-KM-8639-01	5	5	14	0.027110119742196983	TCGA-KM-8639-01	1	0	1	2	PASS	3802	TCGA-KM-8639	KICH	67	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2005	NA	-24640	Alive	TUMOR FREE	953	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	953	0	953	0	953	0	953	
40	TCGA-KM-A7Q6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-KM-A7Q6	0	0	0	TCGA-KM-A7Q6	0	0	0	0	TCGA-KM-A7Q6	0	0	0	0	PASS	3803	TCGA-KM-A7Q6	KICH	36	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2013	NA	-13269	Alive	TUMOR FREE	106	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	106	0	106	0	106	0	106	
50	TCGA-KM-A7Q7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-KM-A7Q7	0	0	0	TCGA-KM-A7Q7	0	0	0	0	TCGA-KM-A7Q7	0	0	0	0	PASS	3804	TCGA-KM-A7Q7	KICH	45	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Chromophobe	NA	2008	NA	-16479	Alive	TUMOR FREE	1688	NA	NA	NA	NA	NA	131	Complete Remission/Response	NA	NA	0	1688	0	1688	1	131	1	131	
50	TCGA-KM-A7Q8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-KM-A7Q8	0	0	0	TCGA-KM-A7Q8	0	0	0	0	TCGA-KM-A7Q8	0	0	0	0	PASS	3805	TCGA-KM-A7Q8	KICH	45	MALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2012	NA	-16784	Dead	WITH TUMOR	NA	407	NA	NA	NA	NA	246	Progressive Disease	NA	NA	1	407	1	407	NA	NA	1	246	
60	TCGA-KM-A7Q9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-KM-A7Q9	0	0	0	TCGA-KM-A7Q9	0	0	0	0	TCGA-KM-A7Q9	0	0	0	0	PASS	3806	TCGA-KM-A7Q9	KICH	55	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2012	NA	-20266	Alive	TUMOR FREE	450	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	450	0	450	0	450	0	450	
20	TCGA-KM-A7QA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-KM-A7QA	0	0	0	TCGA-KM-A7QA	0	0	0	0	TCGA-KM-A7QA	0	0	0	0	PASS	3807	TCGA-KM-A7QA	KICH	18	MALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2012	NA	-6837	Alive	TUMOR FREE	513	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	513	0	513	0	513	0	513	
50	TCGA-KM-A7QB	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-KM-A7QB	0	0	0	TCGA-KM-A7QB	0	0	0	0	TCGA-KM-A7QB	0	0	0	0	PASS	3808	TCGA-KM-A7QB	KICH	47	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Chromophobe	NA	2007	NA	-17167	Alive	TUMOR FREE	1094	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1094	0	1094	0	1094	0	1094	
30	TCGA-KM-A7QC	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-KM-A7QC	0	0	0	TCGA-KM-A7QC	0	0	0	0	TCGA-KM-A7QC	0	0	0	0	PASS	3809	TCGA-KM-A7QC	KICH	33	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2008	NA	-12381	Alive	TUMOR FREE	1961	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1961	0	1961	0	1961	0	1961	
60	TCGA-KM-A7QD	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-KM-A7QD	0	0	0	TCGA-KM-A7QD	0	0	0	0	TCGA-KM-A7QD	0	0	0	0	PASS	3810	TCGA-KM-A7QD	KICH	57	FEMALE	ASIAN	Stage I	NA	Kidney Chromophobe	NA	2010	NA	-21175	Alive	TUMOR FREE	1506	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1506	0	1506	0	1506	0	1506	
60	TCGA-KM-A7QE	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-KM-A7QE	0	0	0	TCGA-KM-A7QE	0	0	0	0	TCGA-KM-A7QE	0	0	0	0	PASS	3811	TCGA-KM-A7QE	KICH	59	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2010	NA	-21580	Alive	TUMOR FREE	1100	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1100	0	1100	0	1100	0	1100	
60	TCGA-KM-A7QG	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-KM-A7QG	0	0	0	TCGA-KM-A7QG	0	0	0	0	TCGA-KM-A7QG	0	0	0	0	PASS	3812	TCGA-KM-A7QG	KICH	55	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2009	NA	-20090	Alive	TUMOR FREE	1653	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1653	0	1653	0	1653	0	1653	
40	TCGA-KM-A7QH	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-KM-A7QH	0	0	0	TCGA-KM-A7QH	0	0	0	0	TCGA-KM-A7QH	0	0	0	0	PASS	3813	TCGA-KM-A7QH	KICH	39	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	1999	NA	-14521	Alive	WITH TUMOR	5132	NA	NA	NA	NA	NA	1772	Complete Remission/Response	NA	NA	0	5132	0	5132	1	1772	1	1772	
50	TCGA-KM-A7QI	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-KM-A7QI	0	0	0	TCGA-KM-A7QI	0	0	0	0	TCGA-KM-A7QI	0	0	0	0	PASS	3814	TCGA-KM-A7QI	KICH	50	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2007	NA	-18560	Alive	TUMOR FREE	2108	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2108	0	2108	0	2108	0	2108	
70	TCGA-KM-A7QJ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-KM-A7QJ	0	0	0	TCGA-KM-A7QJ	0	0	0	0	TCGA-KM-A7QJ	0	0	0	0	PASS	3815	TCGA-KM-A7QJ	KICH	67	MALE	ASIAN	Stage I	NA	Kidney Chromophobe	NA	2006	NA	-24510	Alive	TUMOR FREE	807	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	807	0	807	0	807	0	807	
50	TCGA-KM-A7QK	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-KM-A7QK	0	0	0	TCGA-KM-A7QK	0	0	0	0	TCGA-KM-A7QK	0	0	0	0	PASS	3816	TCGA-KM-A7QK	KICH	53	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2012	NA	-19486	Alive	WITH TUMOR	1101	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1101	0	1101	NA	NA	0	1101	
40	TCGA-KM-A7QL	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-KM-A7QL	0	0	0	TCGA-KM-A7QL	0	0	0	0	TCGA-KM-A7QL	0	0	0	0	PASS	3817	TCGA-KM-A7QL	KICH	36	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2010	NA	-13469	Alive	TUMOR FREE	730	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	730	0	730	0	730	0	730	
40	TCGA-KN-8418	0	6	1	1	0	0	1	0	0	12	0	0	0	8	0	0	TCGA-KN-8418-01	81	0.942529749957148	28	TCGA-KN-8418-01	11	6	13	0.35435249383563466	TCGA-KN-8418-01	0	0	0	0	PASS	3818	TCGA-KN-8418	KICH	41	FEMALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2002	NA	-15086	Alive	TUMOR FREE	3935	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3935	0	3935	NA	NA	0	3935	
40	TCGA-KN-8419	0	2	0	1	0	0	0	0	2	14	1	0	0	7	1	0	TCGA-KN-8419-01	95	0.9477328573725172	49	TCGA-KN-8419-01	26	14	19	4.394562377448774e-05	TCGA-KN-8419-01	0	0	0	0	PASS	3819	TCGA-KN-8419	KICH	43	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Kidney Chromophobe	NA	2004	NA	-15769	Alive	TUMOR FREE	714	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	714	0	714	0	714	0	714	
50	TCGA-KN-8421	0	5	0	1	0	0	0	0	0	11	1	0	0	10	3	0	TCGA-KN-8421-01	89	0.9477283078103176	37	TCGA-KN-8421-01	11	6	10	0.33442377346013136	TCGA-KN-8421-01	0	0	0	0	PASS	3820	TCGA-KN-8421	KICH	47	FEMALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2004	NA	-17524	Alive	TUMOR FREE	2674	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2674	0	2674	NA	NA	0	2674	
30	TCGA-KN-8422	0	1	0	0	1	0	0	1	0	16	0	0	1	3	0	0	TCGA-KN-8422-01	75	0.5533714617430346	31	TCGA-KN-8422-01	17	13	4	0.1764613230307539	TCGA-KN-8422-01	0	0	0	0	PASS	3821	TCGA-KN-8422	KICH	28	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2005	NA	-10303	Alive	TUMOR FREE	775	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	775	0	775	0	775	0	775	
40	TCGA-KN-8423	0	0	0	2	0	1	0	0	2	17	0	0	0	1	1	0	TCGA-KN-8423-01	69	0.9477291587120212	30	TCGA-KN-8423-01	20	11	12	0.5786892756515716	TCGA-KN-8423-01	0	0	0	0	PASS	3822	TCGA-KN-8423	KICH	44	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2005	NA	-16335	Alive	TUMOR FREE	788	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	788	0	788	0	788	0	788	
40	TCGA-KN-8424	0	3	0	0	2	1	1	0	2	22	2	0	0	9	1	0	TCGA-KN-8424-01	73	0.9050151951869632	25	TCGA-KN-8424-01	12	8	9	0.3614911628753334	TCGA-KN-8424-01	1	1	2	4	PASS	3823	TCGA-KN-8424	KICH	42	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2005	NA	-15384	Alive	TUMOR FREE	1983	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1983	0	1983	0	1983	0	1983	
50	TCGA-KN-8425	0	2	0	2	0	0	0	0	0	12	2	0	0	1	1	0	TCGA-KN-8425-01	74	0.7314594141216222	26	TCGA-KN-8425-01	28	15	10	0.4341019502500042	TCGA-KN-8425-01	0	0	0	0	PASS	3824	TCGA-KN-8425	KICH	53	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2005	NA	-19692	Alive	TUMOR FREE	3179	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3179	0	3179	0	3179	0	3179	
50	TCGA-KN-8426	0	4	0	1	0	0	0	0	3	29	4	0	0	9	0	0	TCGA-KN-8426-01	108	0.903191242201674	52	TCGA-KN-8426-01	23	15	20	0.5638249073852968	TCGA-KN-8426-01	3	0	2	5	PASS	3825	TCGA-KN-8426	KICH	50	MALE	WHITE	Stage IV	NA	Kidney Chromophobe	NA	2006	NA	-18345	Alive	WITH TUMOR	108	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	108	0	108	NA	NA	0	108	
50	TCGA-KN-8427	2	5	1	4	1	0	0	0	3	47	4	0	1	23	2	0	TCGA-KN-8427-01	163	0.8629640828293764	90	TCGA-KN-8427-01	25	24	30	0.5732256687557342	TCGA-KN-8427-01	7	4	4	15	PASS	3826	TCGA-KN-8427	KICH	54	MALE	WHITE	Stage IV	NA	Kidney Chromophobe	NA	2006	NA	-19854	Alive	TUMOR FREE	30	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	30	0	30	NA	NA	0	30	
70	TCGA-KN-8428	6	55	2	17	4	0	1	0	30	608	38	1	14	274	16	0	TCGA-KN-8428-01	172	0.8270360848408879	101	TCGA-KN-8428-01	26	21	32	0.39607531648080396	TCGA-KN-8428-01	13	7	2	22	hypermutated sample	3827	TCGA-KN-8428	KICH	71	MALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2006	NA	-26252	Dead	WITH TUMOR	NA	1590	NA	NA	NA	NA	478	Stable Disease	NA	NA	1	1590	1	1590	NA	NA	1	478	
40	TCGA-KN-8429	0	2	0	1	0	0	0	0	1	11	2	0	1	2	0	0	TCGA-KN-8429-01	69	0.9477282663882436	27	TCGA-KN-8429-01	14	8	10	0.3992075219728766	TCGA-KN-8429-01	0	1	0	1	PASS	3828	TCGA-KN-8429	KICH	38	FEMALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2006	NA	-13903	Alive	TUMOR FREE	2650	NA	NA	NA	NA	NA	1989	Complete Remission/Response	NA	NA	0	2650	0	2650	1	1989	1	1989	
80	TCGA-KN-8430	0	5	0	2	1	1	0	0	1	33	1	1	1	8	2	0	TCGA-KN-8430	0	0	0	TCGA-KN-8430	0	0	0	0	TCGA-KN-8430-01	0	0	0	0	PASS	3829	TCGA-KN-8430	KICH	75	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2007	NA	-27467	Dead	WITH TUMOR	NA	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	NA	1	NA	NA	NA	1	NA	
40	TCGA-KN-8431	0	1	0	1	0	1	1	0	2	12	1	0	0	4	0	0	TCGA-KN-8431-01	80	0.9477102940687784	29	TCGA-KN-8431-01	11	6	9	0.3676293424044792	TCGA-KN-8431-01	0	0	0	0	PASS	3830	TCGA-KN-8431	KICH	35	FEMALE	[Not Evaluated]	Stage II	NA	Kidney Chromophobe	NA	2007	NA	-13043	Alive	TUMOR FREE	588	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	588	0	588	NA	NA	0	588	
90	TCGA-KN-8432	0	8	0	6	1	0	3	0	3	43	4	0	0	18	2	1	TCGA-KN-8432-01	74	0.9471703107704164	28	TCGA-KN-8432-01	15	9	10	0.4508516681807576	TCGA-KN-8432-01	1	2	2	5	PASS	3831	TCGA-KN-8432	KICH	86	FEMALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2010	NA	-31591	Alive	NA	76	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	76	0	76	0	76	0	76	
50	TCGA-KN-8433	0	2	0	0	0	2	0	0	1	15	3	0	1	2	1	0	TCGA-KN-8433-01	80	0.8649239558467495	25	TCGA-KN-8433-01	15	13	22	0.6705948654066143	TCGA-KN-8433-01	2	1	5	8	PASS	3832	TCGA-KN-8433	KICH	46	FEMALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2008	NA	-17108	Alive	TUMOR FREE	341	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	341	0	341	0	341	0	341	
70	TCGA-KN-8434	0	3	0	1	0	0	2	0	2	15	2	0	0	9	0	0	TCGA-KN-8434-01	58	1.0	12	TCGA-KN-8434-01	12	7	7	0.3631191615012321	TCGA-KN-8434-01	0	0	0	0	PASS	3833	TCGA-KN-8434	KICH	65	FEMALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2009	NA	-23934	Alive	TUMOR FREE	1797	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1797	0	1797	0	1797	0	1797	
60	TCGA-KN-8435	0	2	0	4	2	0	0	0	0	20	1	0	0	3	0	0	TCGA-KN-8435-01	138	0.9476128750321252	82	TCGA-KN-8435-01	12	8	39	0.41134738128702697	TCGA-KN-8435-01	2	1	0	3	PASS	3834	TCGA-KN-8435	KICH	59	MALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2004	NA	-21891	Alive	TUMOR FREE	3498	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3498	0	3498	0	3498	0	3498	
60	TCGA-KN-8436	0	0	1	1	2	0	0	0	3	15	1	0	0	5	0	0	TCGA-KN-8436-01	77	0.9477169356012246	36	TCGA-KN-8436-01	15	9	18	0.4924602012757813	TCGA-KN-8436-01	1	2	3	6	PASS	3835	TCGA-KN-8436	KICH	62	MALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2009	NA	-22997	Alive	TUMOR FREE	1288	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1288	0	1288	0	1288	0	1288	
40	TCGA-KN-8437	0	1	0	0	0	0	0	0	1	4	0	0	0	4	0	1	TCGA-KN-8437-01	41	0.00011742413756145796	8	TCGA-KN-8437-01	0	0	19	0.00011018151832489748	TCGA-KN-8437-01	0	0	0	0	PASS	3836	TCGA-KN-8437	KICH	42	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2006	NA	-15475	Alive	TUMOR FREE	3068	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3068	0	3068	0	3068	0	3068	
50	TCGA-KO-8403	0	3	0	0	1	0	1	0	0	18	0	0	0	8	1	0	TCGA-KO-8403-01	57	0.9477263095422116	18	TCGA-KO-8403-01	12	7	9	0.3631746401427168	TCGA-KO-8403-01	0	0	0	0	PASS	3837	TCGA-KO-8403	KICH	49	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2005	NA	-18171	Alive	TUMOR FREE	3208	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3208	0	3208	NA	NA	0	3208	
80	TCGA-KO-8404	1	8	0	3	2	2	0	0	2	34	3	0	0	10	1	0	TCGA-KO-8404-01	318	0.6154614526487133	212	TCGA-KO-8404-01	11	41	96	0.5879268764870443	TCGA-KO-8404-01	12	12	8	32	PASS	3838	TCGA-KO-8404	KICH	78	MALE	WHITE	Stage IV	NA	Kidney Chromophobe	NA	2005	NA	-28705	Dead	WITH TUMOR	NA	325	NA	NA	NA	NA	148	Progressive Disease	NA	NA	1	325	1	325	NA	NA	1	148	
30	TCGA-KO-8405	0	0	1	0	0	0	0	0	1	8	1	0	1	3	1	0	TCGA-KO-8405-01	59	0.7741318357672696	15	TCGA-KO-8405-01	31	16	4	0.21347165959181144	TCGA-KO-8405-01	0	0	0	0	PASS	3839	TCGA-KO-8405	KICH	29	MALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2005	NA	-10671	Alive	TUMOR FREE	3056	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3056	0	3056	0	3056	0	3056	
20	TCGA-KO-8406	0	2	0	0	0	0	0	0	0	12	0	0	1	5	0	0	TCGA-KO-8406-01	61	0.9477283188012776	16	TCGA-KO-8406-01	12	7	8	0.3631096946091575	TCGA-KO-8406-01	0	0	0	0	PASS	3840	TCGA-KO-8406	KICH	17	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2005	NA	-6556	Alive	TUMOR FREE	3145	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3145	0	3145	0	3145	0	3145	
40	TCGA-KO-8407	0	3	0	0	0	0	0	0	1	21	1	0	1	8	0	0	TCGA-KO-8407-01	89	0.9477271620889086	39	TCGA-KO-8407-01	11	6	10	0.3513631826652027	TCGA-KO-8407-01	0	0	0	0	PASS	3841	TCGA-KO-8407	KICH	42	MALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2005	NA	-15407	Alive	TUMOR FREE	2820	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2820	0	2820	0	2820	0	2820	
50	TCGA-KO-8408	0	7	1	3	3	0	0	0	1	35	7	0	2	16	0	0	TCGA-KO-8408-01	110	0.9472118546872628	50	TCGA-KO-8408-01	16	11	19	0.4511224468685194	TCGA-KO-8408-01	4	2	3	9	PASS	3842	TCGA-KO-8408	KICH	47	MALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2004	NA	-17299	Dead	TUMOR FREE	NA	507	NA	NA	NA	NA	46	NA	NA	NA	1	507	0	507	NA	NA	1	46	
70	TCGA-KO-8409	1	2	0	2	0	0	0	0	1	12	0	0	1	7	0	0	TCGA-KO-8409-01	87	0.9477108603047529	40	TCGA-KO-8409-01	16	9	10	0.4993439207581707	TCGA-KO-8409-01	0	0	0	0	PASS	3843	TCGA-KO-8409	KICH	69	MALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2004	NA	-25419	Alive	TUMOR FREE	3180	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3180	0	3180	0	3180	0	3180	
70	TCGA-KO-8410	0	2	0	2	1	0	0	0	1	16	1	0	0	3	0	0	TCGA-KO-8410-01	87	0.9477269843107461	38	TCGA-KO-8410-01	20	11	20	0.548104176401857	TCGA-KO-8410-01	0	0	0	0	PASS	3844	TCGA-KO-8410	KICH	74	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2004	NA	-27084	Alive	TUMOR FREE	3136	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3136	0	3136	NA	NA	0	3136	
60	TCGA-KO-8411	0	2	0	1	1	0	0	0	1	10	2	0	0	10	0	0	TCGA-KO-8411-01	77	0.9477278365293316	26	TCGA-KO-8411-01	13	7	7	0.38094915006571056	TCGA-KO-8411-01	0	0	0	0	PASS	3845	TCGA-KO-8411	KICH	58	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2004	NA	-21371	Alive	TUMOR FREE	3958	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3958	0	3958	0	3958	0	3958	
50	TCGA-KO-8413	0	1	0	0	0	0	0	0	1	12	1	0	0	5	0	0	TCGA-KO-8413-01	89	0.9476946689212248	34	TCGA-KO-8413-01	17	12	13	0.5994917345453913	TCGA-KO-8413-01	0	0	0	0	PASS	3846	TCGA-KO-8413	KICH	46	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2006	NA	-17067	Alive	TUMOR FREE	3038	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3038	0	3038	0	3038	0	3038	
50	TCGA-KO-8414	0	3	0	0	1	0	0	0	0	17	2	0	0	5	0	0	TCGA-KO-8414-01	50	0.9476979033857598	7	TCGA-KO-8414-01	21	10	13	0.5136542806856251	TCGA-KO-8414-01	0	0	1	1	PASS	3847	TCGA-KO-8414	KICH	50	FEMALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2006	NA	-18502	Alive	TUMOR FREE	3212	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3212	0	3212	0	3212	0	3212	
40	TCGA-KO-8415	0	0	0	1	1	0	0	0	1	18	1	0	1	9	0	0	TCGA-KO-8415-01	121	0.9268885821190146	64	TCGA-KO-8415-01	15	8	15	0.4503966706708178	TCGA-KO-8415-01	0	0	0	0	PASS	3848	TCGA-KO-8415	KICH	44	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2007	NA	-16395	Alive	TUMOR FREE	2939	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2939	0	2939	0	2939	0	2939	
40	TCGA-KO-8416	0	2	0	2	1	0	0	0	0	15	1	0	0	6	0	0	TCGA-KO-8416-01	59	0.9477290056129992	19	TCGA-KO-8416-01	14	8	11	0.4156725238207787	TCGA-KO-8416-01	0	0	0	0	PASS	3849	TCGA-KO-8416	KICH	41	MALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2007	NA	-15261	Alive	TUMOR FREE	2752	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2752	0	2752	0	2752	0	2752	
30	TCGA-KO-8417	0	0	0	0	1	0	0	0	1	15	1	0	0	5	0	0	TCGA-KO-8417-01	63	0.9477269717601706	19	TCGA-KO-8417-01	13	7	7	0.4039331441183793	TCGA-KO-8417-01	0	0	0	0	PASS	3850	TCGA-KO-8417	KICH	30	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2007	NA	-11139	Alive	TUMOR FREE	2815	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2815	0	2815	0	2815	0	2815	
70	TCGA-NP-A5B3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-NP-A5B3	0	0	0	TCGA-NP-A5B3	0	0	0	0	TCGA-NP-A5B3	0	0	0	0	PASS	3851	TCGA-NP-A5B3	KICH	74	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Chromophobe	NA	2011	NA	-27094	Alive	TUMOR FREE	1069	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1069	0	1069	0	1069	0	1069	
80	TCGA-NP-A5GY	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-NP-A5GY	0	0	0	TCGA-NP-A5GY	0	0	0	0	TCGA-NP-A5GY	0	0	0	0	PASS	3852	TCGA-NP-A5GY	KICH	75	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2011	NA	-27464	Dead	WITH TUMOR	NA	22	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	22	1	22	NA	NA	1	22	
50	TCGA-NP-A5GZ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-NP-A5GZ	0	0	0	TCGA-NP-A5GZ	0	0	0	0	TCGA-NP-A5GZ	0	0	0	0	PASS	3853	TCGA-NP-A5GZ	KICH	50	FEMALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2011	NA	-18476	Alive	TUMOR FREE	980	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	980	0	980	0	980	0	980	
70	TCGA-NP-A5H1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-NP-A5H1	0	0	0	TCGA-NP-A5H1	0	0	0	0	TCGA-NP-A5H1	0	0	0	0	PASS	3854	TCGA-NP-A5H1	KICH	66	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2011	NA	-24299	Alive	TUMOR FREE	959	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	959	0	959	0	959	0	959	
80	TCGA-NP-A5H5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-NP-A5H5	0	0	0	TCGA-NP-A5H5	0	0	0	0	TCGA-NP-A5H5	0	0	0	0	PASS	3855	TCGA-NP-A5H5	KICH	79	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2012	NA	-29034	Alive	TUMOR FREE	6	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	6	0	6	NA	NA	0	6	
50	TCGA-NP-A5H6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-NP-A5H6	0	0	0	TCGA-NP-A5H6	0	0	0	0	TCGA-NP-A5H6	0	0	0	0	PASS	3856	TCGA-NP-A5H6	KICH	49	MALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2012	NA	-17987	Alive	TUMOR FREE	809	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	809	0	809	0	809	0	809	
40	TCGA-NP-A5H7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-NP-A5H7	0	0	0	TCGA-NP-A5H7	0	0	0	0	TCGA-NP-A5H7	0	0	0	0	PASS	3857	TCGA-NP-A5H7	KICH	40	FEMALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2011	NA	-14805	Alive	TUMOR FREE	22	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	22	0	22	0	22	0	22	
50	TCGA-UW-A72H	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A72H	0	0	0	TCGA-UW-A72H	0	0	0	0	TCGA-UW-A72H	0	0	0	0	PASS	3858	TCGA-UW-A72H	KICH	48	MALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2011	NA	-17814	Alive	TUMOR FREE	1153	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1153	0	1153	0	1153	0	1153	
50	TCGA-UW-A72I	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A72I	0	0	0	TCGA-UW-A72I	0	0	0	0	TCGA-UW-A72I	0	0	0	0	PASS	3859	TCGA-UW-A72I	KICH	50	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2011	NA	-18552	Alive	TUMOR FREE	26	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	26	0	26	0	26	0	26	
40	TCGA-UW-A72J	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A72J	0	0	0	TCGA-UW-A72J	0	0	0	0	TCGA-UW-A72J	0	0	0	0	PASS	3860	TCGA-UW-A72J	KICH	42	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Chromophobe	NA	2011	NA	-15690	Alive	TUMOR FREE	1205	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1205	0	1205	0	1205	0	1205	
50	TCGA-UW-A72K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A72K	0	0	0	TCGA-UW-A72K	0	0	0	0	TCGA-UW-A72K	0	0	0	0	PASS	3861	TCGA-UW-A72K	KICH	52	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2011	NA	-19303	Alive	TUMOR FREE	159	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	159	0	159	0	159	0	159	
50	TCGA-UW-A72L	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A72L	0	0	0	TCGA-UW-A72L	0	0	0	0	TCGA-UW-A72L	0	0	0	0	PASS	3862	TCGA-UW-A72L	KICH	51	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2012	NA	-18660	Alive	TUMOR FREE	901	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	901	0	901	0	901	0	901	
40	TCGA-UW-A72M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A72M	0	0	0	TCGA-UW-A72M	0	0	0	0	TCGA-UW-A72M	0	0	0	0	PASS	3863	TCGA-UW-A72M	KICH	44	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2012	NA	-16275	Alive	TUMOR FREE	911	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	911	0	911	0	911	0	911	
50	TCGA-UW-A72N	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A72N	0	0	0	TCGA-UW-A72N	0	0	0	0	TCGA-UW-A72N	0	0	0	0	PASS	3864	TCGA-UW-A72N	KICH	45	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2012	NA	-16744	Alive	TUMOR FREE	397	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	397	0	397	0	397	0	397	
40	TCGA-UW-A72O	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A72O	0	0	0	TCGA-UW-A72O	0	0	0	0	TCGA-UW-A72O	0	0	0	0	PASS	3865	TCGA-UW-A72O	KICH	38	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2012	NA	-13947	Alive	TUMOR FREE	633	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	633	0	633	0	633	0	633	
60	TCGA-UW-A72P	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A72P	0	0	0	TCGA-UW-A72P	0	0	0	0	TCGA-UW-A72P	0	0	0	0	PASS	3866	TCGA-UW-A72P	KICH	61	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2012	NA	-22295	Alive	TUMOR FREE	769	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	769	0	769	0	769	0	769	
60	TCGA-UW-A72Q	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A72Q	0	0	0	TCGA-UW-A72Q	0	0	0	0	TCGA-UW-A72Q	0	0	0	0	PASS	3867	TCGA-UW-A72Q	KICH	56	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2012	NA	-20700	Alive	TUMOR FREE	607	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	607	0	607	0	607	0	607	
30	TCGA-UW-A72R	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A72R	0	0	0	TCGA-UW-A72R	0	0	0	0	TCGA-UW-A72R	0	0	0	0	PASS	3868	TCGA-UW-A72R	KICH	29	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Chromophobe	NA	2013	NA	-10764	Alive	TUMOR FREE	229	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	229	0	229	0	229	0	229	
40	TCGA-UW-A72S	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A72S	0	0	0	TCGA-UW-A72S	0	0	0	0	TCGA-UW-A72S	0	0	0	0	PASS	3869	TCGA-UW-A72S	KICH	43	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2013	NA	-15877	Alive	TUMOR FREE	546	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	546	0	546	0	546	0	546	
60	TCGA-UW-A72T	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A72T	0	0	0	TCGA-UW-A72T	0	0	0	0	TCGA-UW-A72T	0	0	0	0	PASS	3870	TCGA-UW-A72T	KICH	57	MALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2013	NA	-20985	Alive	TUMOR FREE	387	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	387	0	387	0	387	0	387	
80	TCGA-UW-A7GC	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A7GC	0	0	0	TCGA-UW-A7GC	0	0	0	0	TCGA-UW-A7GC	0	0	0	0	PASS	3871	TCGA-UW-A7GC	KICH	75	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2013	NA	-27438	Dead	TUMOR FREE	NA	236	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	236	0	236	0	236	0	236	
40	TCGA-UW-A7GG	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A7GG	0	0	0	TCGA-UW-A7GG	0	0	0	0	TCGA-UW-A7GG	0	0	0	0	PASS	3872	TCGA-UW-A7GG	KICH	44	FEMALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2002	NA	-16266	Alive	TUMOR FREE	1327	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1327	0	1327	0	1327	0	1327	
60	TCGA-UW-A7GI	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A7GI	0	0	0	TCGA-UW-A7GI	0	0	0	0	TCGA-UW-A7GI	0	0	0	0	PASS	3873	TCGA-UW-A7GI	KICH	58	MALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2003	NA	-21197	Alive	TUMOR FREE	3641	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3641	0	3641	0	3641	0	3641	
50	TCGA-UW-A7GJ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A7GJ	0	0	0	TCGA-UW-A7GJ	0	0	0	0	TCGA-UW-A7GJ	0	0	0	0	PASS	3874	TCGA-UW-A7GJ	KICH	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Kidney Chromophobe	NA	2004	NA	-19258	Alive	TUMOR FREE	3614	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3614	0	3614	0	3614	0	3614	
70	TCGA-UW-A7GK	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A7GK	0	0	0	TCGA-UW-A7GK	0	0	0	0	TCGA-UW-A7GK	0	0	0	0	PASS	3875	TCGA-UW-A7GK	KICH	74	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2005	NA	-27197	Alive	TUMOR FREE	2238	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2238	0	2238	0	2238	0	2238	
50	TCGA-UW-A7GL	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A7GL	0	0	0	TCGA-UW-A7GL	0	0	0	0	TCGA-UW-A7GL	0	0	0	0	PASS	3876	TCGA-UW-A7GL	KICH	47	MALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2005	NA	-17241	Alive	TUMOR FREE	3130	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3130	0	3130	0	3130	0	3130	
30	TCGA-UW-A7GN	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A7GN	0	0	0	TCGA-UW-A7GN	0	0	0	0	TCGA-UW-A7GN	0	0	0	0	PASS	3877	TCGA-UW-A7GN	KICH	31	MALE	WHITE	Stage III	NA	Kidney Chromophobe	NA	2005	NA	-11560	Alive	TUMOR FREE	3036	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3036	0	3036	0	3036	0	3036	
40	TCGA-UW-A7GP	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A7GP	0	0	0	TCGA-UW-A7GP	0	0	0	0	TCGA-UW-A7GP	0	0	0	0	PASS	3878	TCGA-UW-A7GP	KICH	40	MALE	WHITE	Stage II	NA	Kidney Chromophobe	NA	2006	NA	-14665	Alive	TUMOR FREE	2440	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2440	0	2440	0	2440	0	2440	
40	TCGA-UW-A7GR	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A7GR	0	0	0	TCGA-UW-A7GR	0	0	0	0	TCGA-UW-A7GR	0	0	0	0	PASS	3879	TCGA-UW-A7GR	KICH	44	FEMALE	WHITE	Stage IV	NA	Kidney Chromophobe	NA	2005	NA	-16221	Alive	TUMOR FREE	3109	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3109	0	3109	NA	NA	0	3109	
80	TCGA-UW-A7GU	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A7GU	0	0	0	TCGA-UW-A7GU	0	0	0	0	TCGA-UW-A7GU	0	0	0	0	PASS	3880	TCGA-UW-A7GU	KICH	75	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Chromophobe	NA	2008	NA	-27649	Alive	TUMOR FREE	1644	NA	NA	NA	NA	NA	1439	Complete Remission/Response	NA	NA	0	1644	0	1644	1	1439	1	1439	
50	TCGA-UW-A7GX	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A7GX	0	0	0	TCGA-UW-A7GX	0	0	0	0	TCGA-UW-A7GX	0	0	0	0	PASS	3881	TCGA-UW-A7GX	KICH	45	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Kidney Chromophobe	NA	2011	NA	-16782	Alive	TUMOR FREE	1266	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1266	0	1266	0	1266	0	1266	
60	TCGA-UW-A7GY	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UW-A7GY	0	0	0	TCGA-UW-A7GY	0	0	0	0	TCGA-UW-A7GY	0	0	0	0	PASS	3882	TCGA-UW-A7GY	KICH	57	FEMALE	WHITE	Stage I	NA	Kidney Chromophobe	NA	2011	NA	-21097	Alive	TUMOR FREE	1032	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1032	0	1032	0	1032	0	1032	
70	TCGA-3Z-A93Z	2	11	0	4	6	0	1	0	4	65	5	0	0	15	3	0	TCGA-3Z-A93Z-01	63	0.22400048426612204	18	TCGA-3Z-A93Z-01	7	4	7	0.06251050907650639	TCGA-3Z-A93Z-01	1	2	2	5	PASS	3883	TCGA-3Z-A93Z	KIRC	69	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2013	NA	-25205	Alive	TUMOR FREE	385	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	385	0	385	0	385	0	385	
70	TCGA-6D-AA2E	1	6	0	3	3	0	1	0	4	18	2	0	1	11	1	0	TCGA-6D-AA2E-01	49	2.8411776075139655e-05	15	TCGA-6D-AA2E-01	0	0	7	0.0013458109903766275	TCGA-6D-AA2E-01	0	0	0	0	PASS	3884	TCGA-6D-AA2E	KIRC	68	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2013	NA	-25043	Alive	TUMOR FREE	362	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	362	0	362	NA	NA	0	362	
70	TCGA-A3-3306	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A3-3306-01	108	0.9474553351024904	61	TCGA-A3-3306-01	9	7	24	0.23259991786299725	TCGA-A3-3306-01	2	2	3	7	PASS	3885	TCGA-A3-3306	KIRC	67	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-24569	Alive	NA	1120	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1120	0	1120	NA	NA	0	1120	
70	TCGA-A3-3307	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A3-3307-01	81	0.049364427758201365	27	TCGA-A3-3307-01	1	2	2	0.02719831179667017	TCGA-A3-3307-01	2	2	1	5	PASS	3886	TCGA-A3-3307	KIRC	66	MALE	NA	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-24315	Alive	WITH TUMOR	1436	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1436	0	1436	NA	NA	0	1436	
80	TCGA-A3-3308	0	5	0	4	10	2	2	0	1	53	3	0	0	21	2	0	TCGA-A3-3308-01	114	0.08464829006790009	54	TCGA-A3-3308-01	3	5	4	0.04431520819852682	TCGA-A3-3308-01	3	1	2	6	PASS	3887	TCGA-A3-3308	KIRC	77	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-28287	Alive	TUMOR FREE	16	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	16	0	16	NA	NA	0	16	
60	TCGA-A3-3311	0	4	0	3	4	0	3	0	1	42	1	0	1	11	1	0	TCGA-A3-3311-01	129	0.17542755859749692	72	TCGA-A3-3311-01	2	2	5	0.08745323403191851	TCGA-A3-3311-01	1	4	2	7	PASS	3888	TCGA-A3-3311	KIRC	57	MALE	NA	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-21183	Dead	TUMOR FREE	NA	1191	NA	NA	NA	NA	NA	NA	NA	NA	1	1191	0	1191	NA	NA	0	1191	
60	TCGA-A3-3313	0	8	1	3	7	5	0	2	5	71	5	0	2	20	3	0	TCGA-A3-3313-01	296	0.3389342704174965	216	TCGA-A3-3313-01	7	6	66	0.11732240934466888	TCGA-A3-3313-01	4	0	5	9	PASS	3889	TCGA-A3-3313	KIRC	59	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-21556	Dead	TUMOR FREE	735	735	NA	NA	NA	NA	NA	NA	NA	NA	1	735	0	735	NA	NA	0	735	
60	TCGA-A3-3316	0	2	0	3	4	0	0	0	0	32	2	0	0	3	0	0	TCGA-A3-3316-01	106	0.6278496021578208	56	TCGA-A3-3316-01	26	24	7	0.09237788876626367	TCGA-A3-3316-01	4	2	2	8	PASS	3890	TCGA-A3-3316	KIRC	57	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-20931	Alive	TUMOR FREE	1493	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1493	0	1493	NA	NA	0	1493	
70	TCGA-A3-3317	0	9	1	5	5	1	1	0	4	48	6	0	0	23	2	0	TCGA-A3-3317-01	178	0.2886546523904205	117	TCGA-A3-3317-01	8	6	10	0.20822655807087512	TCGA-A3-3317-01	3	3	3	9	PASS	3891	TCGA-A3-3317	KIRC	67	MALE	NA	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-24803	Alive	TUMOR FREE	1491	NA	NA	NA	NA	NA	560	NA	NA	NA	0	1491	0	1491	NA	NA	1	560	
70	TCGA-A3-3319	1	13	0	2	4	2	1	0	8	55	4	0	0	19	0	0	TCGA-A3-3319-01	203	0.40334616221531133	149	TCGA-A3-3319-01	16	15	10	0.3608998696965913	TCGA-A3-3319-01	5	2	2	9	PASS	3892	TCGA-A3-3319	KIRC	70	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-25699	Alive	TUMOR FREE	1130	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1130	0	1130	NA	NA	0	1130	
50	TCGA-A3-3320	1	6	0	4	8	2	0	0	4	52	11	0	2	23	1	0	TCGA-A3-3320-01	126	0.10835175243436396	72	TCGA-A3-3320-01	1	3	6	0.0860821566007539	TCGA-A3-3320-01	3	3	3	9	PASS	3893	TCGA-A3-3320	KIRC	52	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G1	2005	NA	-19138	Alive	TUMOR FREE	1508	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1508	0	1508	NA	NA	0	1508	
50	TCGA-A3-3322	1	3	0	1	4	1	0	0	3	38	2	0	0	14	2	0	TCGA-A3-3322-01	216	0.19537624783010688	163	TCGA-A3-3322-01	7	4	3	0.07098834198894492	TCGA-A3-3322-01	0	0	0	0	PASS	3894	TCGA-A3-3322	KIRC	51	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-18754	Alive	TUMOR FREE	1478	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1478	0	1478	NA	NA	0	1478	
50	TCGA-A3-3323	0	4	0	2	7	1	0	0	0	26	6	0	0	14	2	0	TCGA-A3-3323-01	81	0.05129703655853212	27	TCGA-A3-3323-01	1	1	5	0.05401150134648334	TCGA-A3-3323-01	1	2	3	6	PASS	3895	TCGA-A3-3323	KIRC	53	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G1	2006	NA	-19456	Alive	TUMOR FREE	1106	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1106	0	1106	NA	NA	0	1106	
50	TCGA-A3-3324	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A3-3324-01	111	0.21387224605376975	61	TCGA-A3-3324-01	7	4	3	0.10205658234090967	TCGA-A3-3324-01	0	0	0	0	PASS	3896	TCGA-A3-3324	KIRC	51	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-18843	Alive	TUMOR FREE	1186	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1186	0	1186	NA	NA	0	1186	
50	TCGA-A3-3325	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A3-3325-01	119	0.5620467030910872	69	TCGA-A3-3325-01	25	14	6	0.06505986337007197	TCGA-A3-3325-01	2	2	3	7	PASS	3897	TCGA-A3-3325	KIRC	52	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-19126	Dead	TUMOR FREE	NA	1170	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	1170	0	1170	NA	NA	0	1170	
50	TCGA-A3-3326	0	6	0	4	7	0	1	0	1	29	4	0	0	20	3	0	TCGA-A3-3326-01	85	0.04185138841363467	39	TCGA-A3-3326-01	0	1	5	0.021953874006722718	TCGA-A3-3326-01	2	2	1	5	PASS	3898	TCGA-A3-3326	KIRC	47	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G1	2006	NA	-17285	Alive	TUMOR FREE	1137	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1137	0	1137	NA	NA	0	1137	
80	TCGA-A3-3328	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A3-3328	0	0	0	TCGA-A3-3328	0	0	0	0	TCGA-A3-3328	0	0	0	0	PASS	3899	TCGA-A3-3328	KIRC	79	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-29168	Alive	TUMOR FREE	1385	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1385	0	1385	0	1385	0	1385	
80	TCGA-A3-3329	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A3-3329	0	0	0	TCGA-A3-3329	0	0	0	0	TCGA-A3-3329	0	0	0	0	PASS	3900	TCGA-A3-3329	KIRC	75	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-27650	Alive	TUMOR FREE	1624	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1624	0	1624	0	1624	0	1624	
90	TCGA-A3-3331	0	3	1	3	4	2	0	0	3	69	5	0	2	26	3	0	TCGA-A3-3331-01	91	0.140401047942697	42	TCGA-A3-3331-01	4	3	2	0.08291968924379901	TCGA-A3-3331-01	1	1	2	4	mutation call filter	3901	TCGA-A3-3331	KIRC	86	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-31615	Alive	TUMOR FREE	1485	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1485	0	1485	NA	NA	0	1485	
40	TCGA-A3-3335	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A3-3335-01	97	0.1461442347321388	44	TCGA-A3-3335-01	4	4	5	0.12319052553458013	TCGA-A3-3335-01	2	1	1	4	PASS	3902	TCGA-A3-3335	KIRC	41	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G4	2006	NA	-15250	Alive	TUMOR FREE	1886	NA	NA	NA	NA	NA	1098	Complete Remission/Response	NA	NA	0	1886	0	1886	1	1098	1	1098	
80	TCGA-A3-3336	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A3-3336	0	0	0	TCGA-A3-3336	0	0	0	0	TCGA-A3-3336-01	7	6	4	17	PASS	3903	TCGA-A3-3336	KIRC	75	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G4	2007	NA	-27538	Alive	WITH TUMOR	1043	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1043	0	1043	NA	NA	0	1043	
80	TCGA-A3-3343	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A3-3343-01	95	0.05145592724069175	48	TCGA-A3-3343-01	1	2	2	0.018750926182573718	TCGA-A3-3343-01	2	2	1	5	PASS	3904	TCGA-A3-3343	KIRC	79	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-28930	Alive	TUMOR FREE	945	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	945	0	945	NA	NA	0	945	
70	TCGA-A3-3346	0	3	1	5	7	4	2	0	2	65	3	0	1	25	4	0	TCGA-A3-3346-01	129	0.9592347414019928	71	TCGA-A3-3346-01	15	12	18	0.4495930520019759	TCGA-A3-3346-01	4	2	3	9	PASS	3905	TCGA-A3-3346	KIRC	68	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-25118	Dead	WITH TUMOR	NA	137	NA	NA	NA	NA	114	Progressive Disease	NA	NA	1	137	1	137	NA	NA	1	114	
80	TCGA-A3-3347	0	2	0	2	3	0	1	0	0	27	1	0	1	11	0	0	TCGA-A3-3347-01	69	0.3909227368757055	25	TCGA-A3-3347-01	12	10	6	0.16333353426290145	TCGA-A3-3347-01	2	2	1	5	PASS	3906	TCGA-A3-3347	KIRC	76	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-27966	Dead	WITH TUMOR	NA	1610	NA	NA	NA	NA	610	NA	NA	NA	1	1610	1	1610	NA	NA	1	610	
30	TCGA-A3-3349	0	4	0	0	5	0	1	0	2	32	1	0	1	7	0	0	TCGA-A3-3349-01	76	0.03626613088904713	17	TCGA-A3-3349	0	0	0	0	TCGA-A3-3349	0	0	0	0	PASS	3907	TCGA-A3-3349	KIRC	34	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-12431	Alive	TUMOR FREE	1385	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1385	0	1385	NA	NA	0	1385	
40	TCGA-A3-3351	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A3-3351-01	90	0.09354742610883868	44	TCGA-A3-3351-01	2	3	4	0.06028064571073564	TCGA-A3-3351-01	1	1	1	3	PASS	3908	TCGA-A3-3351	KIRC	42	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-15562	Alive	TUMOR FREE	910	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	910	0	910	NA	NA	0	910	
70	TCGA-A3-3352	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A3-3352-01	85	0.27959417939674625	41	TCGA-A3-3352-01	9	7	3	0.027775835521444255	TCGA-A3-3352-01	2	1	1	4	PASS	3909	TCGA-A3-3352	KIRC	74	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	NA	Dead	TUMOR FREE	NA	561	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	561	0	561	0	561	0	561	
60	TCGA-A3-3357	0	7	0	0	3	2	0	0	5	69	5	0	1	29	1	0	TCGA-A3-3357-01	155	0.1493450966912734	100	TCGA-A3-3357-01	5	3	7	0.08639276917259515	TCGA-A3-3357-01	2	3	2	7	PASS	3910	TCGA-A3-3357	KIRC	62	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-22825	Alive	TUMOR FREE	2688	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2688	0	2688	0	2688	0	2688	
60	TCGA-A3-3358	0	6	0	5	4	1	0	0	3	50	5	0	1	22	1	0	TCGA-A3-3358-01	107	0.21102294084351916	50	TCGA-A3-3358-01	9	6	19	0.029668508417605537	TCGA-A3-3358-01	2	1	1	4	PASS	3911	TCGA-A3-3358	KIRC	57	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-21087	Alive	TUMOR FREE	1307	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1307	0	1307	NA	NA	0	1307	
80	TCGA-A3-3359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A3-3359-01	61	0.08629736144266356	22	TCGA-A3-3359-01	1	2	19	0.04371910608731985	TCGA-A3-3359-01	0	3	1	4	PASS	3912	TCGA-A3-3359	KIRC	82	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-30269	Alive	TUMOR FREE	2504	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2504	0	2504	0	2504	0	2504	
60	TCGA-A3-3362	0	3	0	0	6	0	0	0	2	38	0	0	0	14	1	0	TCGA-A3-3362-01	49	0.04684220748105256	11	TCGA-A3-3362	0	0	0	0	TCGA-A3-3362	0	0	0	0	PASS	3913	TCGA-A3-3362	KIRC	60	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-21988	Alive	TUMOR FREE	1559	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1559	0	1559	NA	NA	0	1559	
50	TCGA-A3-3363	2	3	0	2	2	0	0	0	1	39	1	0	1	9	0	0	TCGA-A3-3363-01	186	0.050961986080157305	111	TCGA-A3-3363-01	2	7	13	0.08594001674559655	TCGA-A3-3363-01	1	0	2	3	PASS	3914	TCGA-A3-3363	KIRC	50	MALE	ASIAN	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-18596	Alive	TUMOR FREE	319	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	319	0	319	NA	NA	0	319	
50	TCGA-A3-3365	0	4	0	1	5	1	0	0	0	29	1	0	0	6	2	0	TCGA-A3-3365-01	83	0.11711664210760782	37	TCGA-A3-3365	0	0	0	0	TCGA-A3-3365	0	0	0	0	PASS	3915	TCGA-A3-3365	KIRC	46	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-16915	Alive	NA	873	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	873	0	873	NA	NA	0	873	
70	TCGA-A3-3367	0	7	0	3	7	4	1	0	3	50	2	0	1	17	3	0	TCGA-A3-3367-01	103	0.06623183092290054	47	TCGA-A3-3367-01	1	2	5	0.06986160225979939	TCGA-A3-3367-01	1	2	2	5	PASS	3916	TCGA-A3-3367	KIRC	72	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-26489	Alive	TUMOR FREE	2270	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2270	0	2270	0	2270	0	2270	
50	TCGA-A3-3370	0	2	0	1	1	1	1	0	0	29	3	0	1	10	0	0	TCGA-A3-3370-01	71	0.10052877136984413	30	TCGA-A3-3370-01	1	3	6	0.07594658133668672	TCGA-A3-3370-01	2	4	3	9	PASS	3917	TCGA-A3-3370	KIRC	48	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-17621	Alive	TUMOR FREE	2274	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2274	0	2274	0	2274	0	2274	
60	TCGA-A3-3372	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A3-3372-01	74	0.6406425968096633	28	TCGA-A3-3372-01	24	20	3	0.15227277936213895	TCGA-A3-3372-01	1	0	0	1	PASS	3918	TCGA-A3-3372	KIRC	64	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-23528	Alive	TUMOR FREE	735	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	735	0	735	NA	NA	0	735	
50	TCGA-A3-3373	0	2	0	3	5	0	1	0	5	39	3	0	2	16	1	1	TCGA-A3-3373-01	65	0.13644059982965048	21	TCGA-A3-3373-01	4	5	10	0.15589079889653526	TCGA-A3-3373-01	2	1	3	6	PASS	3919	TCGA-A3-3373	KIRC	54	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-19964	Alive	TUMOR FREE	1621	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1621	0	1621	0	1621	0	1621	
50	TCGA-A3-3374	0	2	0	0	0	1	0	0	1	12	0	0	0	7	2	0	TCGA-A3-3374-01	151	0.8213094265599554	101	TCGA-A3-3374-01	33	12	8	0.30135172874029115	TCGA-A3-3374-01	0	0	0	0	PASS	3920	TCGA-A3-3374	KIRC	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-18890	Alive	NA	1314	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1314	0	1314	NA	NA	0	1314	
50	TCGA-A3-3376	0	3	0	1	4	0	0	0	4	46	0	0	0	13	2	0	TCGA-A3-3376-01	150	0.04664270799594722	92	TCGA-A3-3376-01	0	2	19	0.024132459397580942	TCGA-A3-3376-01	2	2	1	5	PASS	3921	TCGA-A3-3376	KIRC	51	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-18954	Dead	TUMOR FREE	NA	1696	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1696	0	1696	0	1696	0	1696	
60	TCGA-A3-3378	0	5	0	6	2	0	1	0	5	45	1	0	1	20	0	0	TCGA-A3-3378-01	61	0.06306903682226098	20	TCGA-A3-3378-01	2	2	3	0.0665458777505304	TCGA-A3-3378-01	2	0	1	3	PASS	3922	TCGA-A3-3378	KIRC	60	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-22090	Alive	TUMOR FREE	630	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	630	0	630	NA	NA	0	630	
50	TCGA-A3-3380	0	1	0	1	1	0	0	0	2	25	1	0	0	8	1	0	TCGA-A3-3380-01	77	0.3042762922897948	31	TCGA-A3-3380-01	10	7	8	0.04128848456919902	TCGA-A3-3380-01	4	4	2	10	PASS	3923	TCGA-A3-3380	KIRC	54	MALE	NA	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-19828	Alive	TUMOR FREE	567	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	567	0	567	NA	NA	0	567	
70	TCGA-A3-3382	0	7	0	6	6	1	3	0	5	67	8	0	4	16	2	0	TCGA-A3-3382-01	120	0.7064420571112591	61	TCGA-A3-3382-01	28	18	14	0.2365093878474925	TCGA-A3-3382-01	3	0	0	3	PASS	3924	TCGA-A3-3382	KIRC	69	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-25207	Alive	WITH TUMOR	574	NA	NA	NA	NA	NA	514	NA	NA	NA	0	574	0	574	NA	NA	1	514	
50	TCGA-A3-3383	0	1	0	1	6	2	2	0	1	30	3	0	3	14	2	0	TCGA-A3-3383-01	71	0.08025956321999038	31	TCGA-A3-3383-01	1	1	19	0.029454489710586344	TCGA-A3-3383-01	1	0	1	2	PASS	3925	TCGA-A3-3383	KIRC	52	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-19324	Alive	NA	861	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	861	0	861	NA	NA	0	861	
50	TCGA-A3-3385	0	4	0	3	6	1	0	0	4	42	3	0	0	14	3	0	TCGA-A3-3385-01	81	0.15976848988870607	30	TCGA-A3-3385-01	7	6	4	0.09193546918996057	TCGA-A3-3385-01	2	1	1	4	PASS	3926	TCGA-A3-3385	KIRC	46	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-17114	Alive	TUMOR FREE	1993	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1993	0	1993	0	1993	0	1993	
50	TCGA-A3-3387	1	4	0	4	2	1	2	0	2	61	5	0	3	18	3	0	TCGA-A3-3387-01	69	0.302369690979445	22	TCGA-A3-3387-01	3	2	7	0.05892121529194313	TCGA-A3-3387-01	2	1	1	4	PASS	3927	TCGA-A3-3387	KIRC	49	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-17920	Alive	TUMOR FREE	617	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	617	0	617	NA	NA	0	617	
50	TCGA-A3-A6NI	1	3	0	3	7	4	2	0	4	48	2	0	1	21	3	0	TCGA-A3-A6NI-01	318	0.1324237938382219	212	TCGA-A3-A6NI-01	4	5	228	0.06556044900160943	TCGA-A3-A6NI-01	9	3	4	16	PASS	3928	TCGA-A3-A6NI	KIRC	47	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2011	NA	-17190	Alive	TUMOR FREE	1018	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1018	0	1018	0	1018	0	1018	
60	TCGA-A3-A6NJ	0	12	1	2	4	4	2	0	12	74	10	0	0	22	2	0	TCGA-A3-A6NJ-01	110	0.05126378977824855	58	TCGA-A3-A6NJ-01	1	2	19	0.031362060698215816	TCGA-A3-A6NJ-01	2	1	1	4	PASS	3929	TCGA-A3-A6NJ	KIRC	57	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G1	2012	NA	-20918	Alive	TUMOR FREE	468	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	468	0	468	0	468	0	468	
50	TCGA-A3-A6NL	5	106	9	63	0	0	0	0	81	547	135	7	10	256	29	0	TCGA-A3-A6NL-01	115	0.09673349093362438	69	TCGA-A3-A6NL-01	3	2	25	0.03829073770150825	TCGA-A3-A6NL-01	2	1	1	4	PASS	3930	TCGA-A3-A6NL	KIRC	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2012	NA	-17952	Alive	TUMOR FREE	689	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	689	0	689	0	689	0	689	
80	TCGA-A3-A6NN	0	6	0	6	5	3	3	0	3	78	6	0	1	19	1	0	TCGA-A3-A6NN-01	65	0.22044931446487245	26	TCGA-A3-A6NN-01	6	3	42	0.14272864652740933	TCGA-A3-A6NN-01	2	2	1	5	PASS	3931	TCGA-A3-A6NN	KIRC	78	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2012	NA	-28689	Alive	TUMOR FREE	3	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3	0	3	0	3	0	3	
60	TCGA-A3-A8CQ	0	6	0	3	3	0	0	0	7	27	1	0	1	23	0	0	TCGA-A3-A8CQ-01	49	0.20846422905891288	11	TCGA-A3-A8CQ-01	5	4	22	0.07585809252617595	TCGA-A3-A8CQ-01	1	2	2	5	PASS	3932	TCGA-A3-A8CQ	KIRC	59	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2011	NA	-21572	Alive	TUMOR FREE	3	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	3	0	3	NA	NA	0	3	
70	TCGA-A3-A8OU	1	8	1	4	3	2	2	0	5	64	2	0	0	19	1	0	TCGA-A3-A8OU-01	58	0.022510596378028845	20	TCGA-A3-A8OU-01	0	1	11	0.034918413257243326	TCGA-A3-A8OU-01	1	1	2	4	PASS	3933	TCGA-A3-A8OU	KIRC	74	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G1	2011	NA	-27377	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	0	0	0	0	0	0	0	
80	TCGA-A3-A8OV	2	19	0	5	6	2	1	0	5	106	7	0	0	39	3	0	TCGA-A3-A8OV-01	45	0.11351630857076753	4	TCGA-A3-A8OV-01	3	2	18	0.06363209257255181	TCGA-A3-A8OV-01	1	2	2	5	PASS	3934	TCGA-A3-A8OV	KIRC	75	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2011	NA	-27526	Alive	TUMOR FREE	340	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	340	0	340	0	340	0	340	
40	TCGA-A3-A8OW	0	2	0	5	1	2	0	0	0	27	1	0	0	5	0	0	TCGA-A3-A8OW-01	65	0.058972982987755024	24	TCGA-A3-A8OW-01	1	2	12	0.03223188273964458	TCGA-A3-A8OW-01	2	1	1	4	PASS	3935	TCGA-A3-A8OW	KIRC	37	MALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2011	NA	-13546	Alive	TUMOR FREE	323	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	323	0	323	0	323	0	323	
70	TCGA-A3-A8OX	0	8	0	1	1	0	0	0	0	35	4	0	1	16	0	0	TCGA-A3-A8OX-01	53	0.00019175413761867897	17	TCGA-A3-A8OX-01	0	0	8	0.00019177486055664694	TCGA-A3-A8OX-01	0	0	0	0	PASS	3936	TCGA-A3-A8OX	KIRC	65	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2012	NA	-23998	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	0	0	0	0	0	0	0	
70	TCGA-AK-3425	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AK-3425	0	0	0	TCGA-AK-3425	0	0	0	0	TCGA-AK-3425-01	3	3	5	11	PASS	3937	TCGA-AK-3425	KIRC	68	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2000	NA	-24912	Alive	TUMOR FREE	3343	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3343	0	3343	NA	NA	0	3343	
40	TCGA-AK-3426	0	3	0	1	2	0	0	0	2	22	1	0	0	10	0	0	TCGA-AK-3426-01	47	0.27810473417636977	6	TCGA-AK-3426-01	7	6	7	0.2453328969325701	TCGA-AK-3426-01	1	2	2	5	PASS	3938	TCGA-AK-3426	KIRC	37	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-13770	Dead	WITH TUMOR	NA	885	NA	NA	NA	NA	256	NA	NA	NA	1	885	1	885	NA	NA	1	256	
70	TCGA-AK-3427	0	1	0	0	0	0	1	0	1	11	1	0	0	6	1	0	TCGA-AK-3427-01	63	0.2009228397708437	18	TCGA-AK-3427-01	8	5	4	0.13171568700955266	TCGA-AK-3427-01	0	0	0	0	PASS	3939	TCGA-AK-3427	KIRC	65	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	GX	2004	NA	-24067	Alive	TUMOR FREE	3583	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3583	0	3583	0	3583	0	3583	
60	TCGA-AK-3428	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AK-3428-01	49	0.0727290675707	15	TCGA-AK-3428-01	0	1	4	0.02163627716982096	TCGA-AK-3428-01	1	0	1	2	PASS	3940	TCGA-AK-3428	KIRC	62	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-22653	Alive	TUMOR FREE	3728	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3728	0	3728	0	3728	0	3728	
50	TCGA-AK-3429	1	2	0	1	1	0	1	0	2	20	1	0	1	11	3	0	TCGA-AK-3429-01	55	0.40095649199325706	20	TCGA-AK-3429	0	0	0	0	TCGA-AK-3429	0	0	0	0	PASS	3941	TCGA-AK-3429	KIRC	54	FEMALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-19849	Alive	TUMOR FREE	3328	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3328	0	3328	0	3328	0	3328	
60	TCGA-AK-3430	2	8	0	2	11	4	0	0	4	44	5	0	0	14	6	0	TCGA-AK-3430-01	60	0.5452700559125673	20	TCGA-AK-3430-01	18	21	4	0.07077898161865738	TCGA-AK-3430-01	2	1	1	4	PASS	3942	TCGA-AK-3430	KIRC	61	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-22612	Dead	NA	NA	480	NA	NA	NA	NA	NA	NA	NA	NA	1	480	NA	480	NA	NA	0	480	
60	TCGA-AK-3431	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AK-3431-01	54	0.0425828492730732	14	TCGA-AK-3431-01	1	1	4	0.04484477920677084	TCGA-AK-3431-01	1	2	2	5	PASS	3943	TCGA-AK-3431	KIRC	62	FEMALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-22852	Dead	TUMOR FREE	NA	2241	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2241	0	2241	0	2241	0	2241	
50	TCGA-AK-3433	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AK-3433-01	75	0.9477046910779984	30	TCGA-AK-3433-01	15	9	11	0.4993278650677575	TCGA-AK-3433-01	0	0	0	0	PASS	3944	TCGA-AK-3433	KIRC	48	FEMALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	GX	2004	NA	-17853	Alive	TUMOR FREE	3409	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3409	0	3409	0	3409	0	3409	
70	TCGA-AK-3434	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AK-3434-01	69	0.17432810164217286	26	TCGA-AK-3434-01	6	6	4	0.10638713643278104	TCGA-AK-3434-01	2	0	2	4	PASS	3945	TCGA-AK-3434	KIRC	72	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-26490	Alive	WITH TUMOR	2087	NA	NA	NA	NA	NA	1640	NA	NA	NA	0	2087	0	2087	NA	NA	1	1640	
40	TCGA-AK-3436	0	5	0	2	0	0	0	0	2	31	4	0	1	11	2	0	TCGA-AK-3436-01	87	0.5887878722671902	38	TCGA-AK-3436-01	21	32	7	0.0808278659183185	TCGA-AK-3436-01	4	3	1	8	PASS	3946	TCGA-AK-3436	KIRC	40	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-14842	Alive	TUMOR FREE	3331	NA	NA	NA	NA	NA	1189	Progressive Disease	NA	NA	0	3331	0	3331	NA	NA	1	1189	
60	TCGA-AK-3440	0	2	0	2	2	0	1	0	1	15	1	0	1	3	1	0	TCGA-AK-3440-01	63	0.9477485266254498	24	TCGA-AK-3440-01	16	9	15	0.4437052244086753	TCGA-AK-3440-01	0	0	0	0	PASS	3947	TCGA-AK-3440	KIRC	58	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-21337	Alive	TUMOR FREE	2865	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2865	0	2865	0	2865	0	2865	
50	TCGA-AK-3443	0	4	0	1	0	0	0	0	1	8	1	0	1	0	0	0	TCGA-AK-3443-01	43	0.04644012567427516	11	TCGA-AK-3443-01	2	1	19	0.04899640521365041	TCGA-AK-3443-01	0	0	0	0	PASS	3948	TCGA-AK-3443	KIRC	45	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	GX	2006	NA	-16578	Alive	TUMOR FREE	1423	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1423	0	1423	NA	NA	0	1423	
80	TCGA-AK-3444	0	4	0	2	7	2	3	0	4	74	3	0	2	24	2	0	TCGA-AK-3444-01	57	0.19125548626135275	18	TCGA-AK-3444-01	4	3	4	0.01666661289008074	TCGA-AK-3444-01	1	2	1	4	PASS	3949	TCGA-AK-3444	KIRC	80	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-29497	Alive	TUMOR FREE	1471	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1471	0	1471	NA	NA	0	1471	
70	TCGA-AK-3445	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AK-3445-01	91	0.3192023987619591	40	TCGA-AK-3445-01	11	9	8	0.1839530875130721	TCGA-AK-3445-01	4	1	2	7	PASS	3950	TCGA-AK-3445	KIRC	69	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-25494	Alive	TUMOR FREE	2392	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2392	0	2392	0	2392	0	2392	
80	TCGA-AK-3447	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AK-3447-01	100	0.9240728577859576	39	TCGA-AK-3447-01	7	4	8	0.2214288655041652	TCGA-AK-3447-01	1	0	1	2	PASS	3951	TCGA-AK-3447	KIRC	83	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-30676	Alive	TUMOR FREE	1217	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1217	0	1217	NA	NA	0	1217	
90	TCGA-AK-3450	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AK-3450-01	68	0.20112127954825032	29	TCGA-AK-3450-01	3	5	7	0.08285779789127729	TCGA-AK-3450-01	3	4	2	9	PASS	3952	TCGA-AK-3450	KIRC	85	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-31364	Alive	TUMOR FREE	1779	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1779	0	1779	NA	NA	0	1779	
50	TCGA-AK-3451	0	6	0	2	9	1	2	1	4	60	2	0	1	10	1	0	TCGA-AK-3451-01	77	0.08382590985630067	33	TCGA-AK-3451-01	2	3	5	0.06139402806556081	TCGA-AK-3451-01	2	1	1	4	PASS	3953	TCGA-AK-3451	KIRC	48	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-17859	Alive	TUMOR FREE	2868	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2868	0	2868	0	2868	0	2868	
60	TCGA-AK-3453	0	1	0	1	1	0	1	0	1	13	1	0	1	10	0	0	TCGA-AK-3453-01	45	0.9275479893585791	10	TCGA-AK-3453-01	31	25	2	0.15713075613469132	TCGA-AK-3453-01	0	0	0	0	PASS	3954	TCGA-AK-3453	KIRC	58	FEMALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-21271	Alive	TUMOR FREE	2531	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2531	0	2531	0	2531	0	2531	
80	TCGA-AK-3454	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AK-3454-01	95	0.12004971330080062	45	TCGA-AK-3454-01	1	2	12	0.07036951115588283	TCGA-AK-3454-01	3	5	3	11	PASS	3955	TCGA-AK-3454	KIRC	84	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-30862	Alive	TUMOR FREE	874	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	874	0	874	NA	NA	0	874	
70	TCGA-AK-3455	0	2	0	1	4	2	1	0	1	46	2	0	0	10	1	0	TCGA-AK-3455-01	95	0.10064923908653567	48	TCGA-AK-3455-01	3	3	7	0.05984603168090006	TCGA-AK-3455-01	2	0	1	3	PASS	3956	TCGA-AK-3455	KIRC	71	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-26221	Dead	NA	NA	683	NA	NA	NA	NA	NA	NA	NA	NA	1	683	NA	683	NA	NA	0	683	
50	TCGA-AK-3456	0	2	0	1	0	1	1	0	2	22	1	0	0	15	0	0	TCGA-AK-3456-01	66	0.03832608114239786	28	TCGA-AK-3456-01	1	1	19	0.007731926764720702	TCGA-AK-3456-01	1	0	1	2	PASS	3957	TCGA-AK-3456	KIRC	48	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-17821	Alive	NA	1143	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1143	0	1143	NA	NA	0	1143	
50	TCGA-AK-3458	0	1	0	0	2	1	1	0	1	27	0	0	1	7	1	0	TCGA-AK-3458-01	73	0.3069735838589897	36	TCGA-AK-3458-01	10	10	6	0.08896077240826544	TCGA-AK-3458-01	2	1	1	4	PASS	3958	TCGA-AK-3458	KIRC	48	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-17557	Alive	TUMOR FREE	1168	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1168	0	1168	NA	NA	0	1168	
60	TCGA-AK-3460	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AK-3460-01	61	0.12910080344668806	18	TCGA-AK-3460-01	4	2	19	0.07099294141371201	TCGA-AK-3460-01	0	0	0	0	PASS	3959	TCGA-AK-3460	KIRC	58	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-21281	Alive	TUMOR FREE	2508	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2508	0	2508	0	2508	0	2508	
70	TCGA-AK-3461	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AK-3461-01	57	0.1789077755864068	15	TCGA-AK-3461	0	0	0	0	TCGA-AK-3461	0	0	0	0	PASS	3960	TCGA-AK-3461	KIRC	72	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-26464	Alive	TUMOR FREE	2217	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2217	0	2217	0	2217	0	2217	
70	TCGA-AK-3465	0	2	0	1	3	0	0	0	0	21	1	0	1	8	0	0	TCGA-AK-3465-01	90	0.8883732757918246	42	TCGA-AK-3465-01	13	7	8	0.3770973382522662	TCGA-AK-3465-01	0	0	0	0	PASS	3961	TCGA-AK-3465	KIRC	71	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	GX	2008	NA	-26232	Alive	TUMOR FREE	369	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	369	0	369	NA	NA	0	369	
60	TCGA-AS-3777	0	3	0	1	0	0	1	0	0	17	0	0	0	6	3	0	TCGA-AS-3777-01	55	0.9477293373784604	15	TCGA-AS-3777-01	14	8	8	0.4176195571056021	TCGA-AS-3777-01	0	0	0	0	PASS	3962	TCGA-AS-3777	KIRC	63	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	NA	2009	NA	-23039	Alive	TUMOR FREE	1238	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1238	0	1238	NA	NA	0	1238	
40	TCGA-AS-3778	0	6	0	1	5	2	3	0	3	49	5	0	1	17	2	0	TCGA-AS-3778-01	64	0.02834818913516237	19	TCGA-AS-3778-01	1	1	4	0.02988845696443293	TCGA-AS-3778-01	1	0	1	2	PASS	3963	TCGA-AS-3778	KIRC	35	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G1	2010	NA	-12937	Alive	TUMOR FREE	43	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	43	0	43	NA	NA	0	43	
50	TCGA-B0-4688	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4688-01	440	0.7374059514788425	296	TCGA-B0-4688-01	12	36	124	0.5729004213384982	TCGA-B0-4688-01	21	12	12	45	PASS	3964	TCGA-B0-4688	KIRC	46	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2008	NA	-16804	Dead	WITH TUMOR	NA	101	NA	NA	NA	NA	NA	NA	NA	NA	1	101	1	101	NA	NA	1	101	
70	TCGA-B0-4690	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4690-01	180	0.44392822150029704	98	TCGA-B0-4690-01	11	13	30	0.2462905258071697	TCGA-B0-4690-01	7	6	5	18	PASS	3965	TCGA-B0-4690	KIRC	65	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2008	NA	-23985	Dead	WITH TUMOR	NA	43	NA	NA	NA	NA	NA	NA	NA	NA	1	43	1	43	NA	NA	1	43	
60	TCGA-B0-4691	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4691-01	86	0.2561272070819663	35	TCGA-B0-4691-01	8	7	9	0.13707259615247053	TCGA-B0-4691-01	2	2	3	7	PASS	3966	TCGA-B0-4691	KIRC	55	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2009	NA	-20176	Dead	WITH TUMOR	NA	139	NA	NA	NA	NA	NA	NA	NA	NA	1	139	1	139	NA	NA	1	139	
70	TCGA-B0-4693	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4693-01	67	0.10384495080342937	27	TCGA-B0-4693-01	3	3	3	0.028177503479951526	TCGA-B0-4693-01	1	1	1	3	PASS	3967	TCGA-B0-4693	KIRC	72	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2009	NA	-26659	Dead	TUMOR FREE	NA	77	NA	NA	NA	NA	NA	NA	NA	NA	1	77	0	77	NA	NA	0	77	
70	TCGA-B0-4694	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4694-01	68	0.17299278681687116	21	TCGA-B0-4694-01	5	6	5	0.12506856693539506	TCGA-B0-4694-01	3	2	2	7	PASS	3968	TCGA-B0-4694	KIRC	72	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2009	NA	-26582	Dead	TUMOR FREE	NA	106	NA	NA	NA	NA	NA	NA	NA	NA	1	106	0	106	NA	NA	0	106	
60	TCGA-B0-4696	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4696-01	340	0.8397002228106989	218	TCGA-B0-4696-01	13	51	107	0.6303947930898447	TCGA-B0-4696-01	26	19	8	53	PASS	3969	TCGA-B0-4696	KIRC	58	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2001	NA	-21317	Dead	WITH TUMOR	NA	866	NA	NA	NA	NA	794	NA	NA	NA	1	866	1	866	NA	NA	1	794	
50	TCGA-B0-4697	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4697-01	81	0.00024266971521399926	40	TCGA-B0-4697	0	0	0	0	TCGA-B0-4697	0	0	0	0	PASS	3970	TCGA-B0-4697	KIRC	46	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2003	NA	-16844	Dead	WITH TUMOR	NA	578	NA	NA	NA	NA	NA	NA	NA	NA	1	578	1	578	NA	NA	1	578	
80	TCGA-B0-4698	2	26	4	9	7	1	0	1	15	338	28	4	13	116	15	1	TCGA-B0-4698-01	109	0.4583499483819067	49	TCGA-B0-4698-01	16	32	17	0.16569994218107525	TCGA-B0-4698-01	7	8	5	20	PASS	3971	TCGA-B0-4698	KIRC	75	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2003	NA	-27417	Dead	WITH TUMOR	NA	42	NA	NA	NA	NA	NA	NA	NA	NA	1	42	1	42	NA	NA	1	42	
70	TCGA-B0-4699	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4699-01	91	0.9180632672997664	40	TCGA-B0-4699-01	15	10	15	0.44356068689989797	TCGA-B0-4699-01	1	1	2	4	PASS	3972	TCGA-B0-4699	KIRC	74	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-27225	Dead	[Discrepancy]	NA	110	NA	NA	NA	NA	NA	NA	NA	NA	1	110	NA	110	NA	NA	0	110	
60	TCGA-B0-4700	0	2	0	0	3	0	1	0	2	19	1	0	0	11	3	1	TCGA-B0-4700-01	86	0.048237632414584855	36	TCGA-B0-4700-01	0	0	19	2.6580453257792426e-05	TCGA-B0-4700-01	0	0	0	0	PASS	3973	TCGA-B0-4700	KIRC	60	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-22034	Dead	WITH TUMOR	NA	1980	NA	NA	NA	NA	NA	NA	NA	NA	1	1980	1	1980	NA	NA	1	1980	
70	TCGA-B0-4701	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4701-01	101	0.0363867657061959	46	TCGA-B0-4701-01	0	1	3	0.02011456439965157	TCGA-B0-4701-01	2	2	1	5	PASS	3974	TCGA-B0-4701	KIRC	66	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-24232	Dead	WITH TUMOR	NA	238	NA	NA	NA	NA	NA	NA	NA	NA	1	238	1	238	NA	NA	1	238	
50	TCGA-B0-4703	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4703-01	99	0.19808330085548284	46	TCGA-B0-4703-01	5	5	13	0.11355227564738893	TCGA-B0-4703-01	4	5	4	13	PASS	3975	TCGA-B0-4703	KIRC	51	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2005	NA	-18921	Dead	WITH TUMOR	NA	182	NA	NA	NA	NA	NA	NA	NA	NA	1	182	1	182	NA	NA	1	182	
60	TCGA-B0-4706	0	5	0	2	4	0	0	0	4	31	4	0	2	10	0	0	TCGA-B0-4706-01	95	0.05746724366018645	44	TCGA-B0-4706-01	1	1	19	0.03164401551408758	TCGA-B0-4706-01	2	3	1	6	PASS	3976	TCGA-B0-4706	KIRC	61	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2007	NA	-22331	Dead	TUMOR FREE	26	65	NA	NA	NA	NA	NA	NA	NA	NA	1	65	0	65	NA	NA	0	65	
60	TCGA-B0-4707	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4707-01	142	0.7171439240953192	79	TCGA-B0-4707-01	29	27	32	0.2497001709556864	TCGA-B0-4707-01	10	3	12	25	PASS	3977	TCGA-B0-4707	KIRC	63	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2008	NA	-23322	Dead	WITH TUMOR	NA	600	NA	NA	NA	NA	NA	NA	NA	NA	1	600	1	600	NA	NA	1	600	
80	TCGA-B0-4710	1	14	0	4	8	4	0	0	5	56	3	0	0	16	0	0	TCGA-B0-4710-01	59	0.518025325382877	22	TCGA-B0-4710-01	20	20	14	0.13928455883786087	TCGA-B0-4710-01	2	2	1	5	PASS	3978	TCGA-B0-4710	KIRC	75	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-27396	Alive	TUMOR FREE	1755	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1755	0	1755	0	1755	0	1755	
80	TCGA-B0-4712	0	11	0	5	3	2	1	0	6	79	3	0	1	21	4	0	TCGA-B0-4712-01	88	0.679969724108658	36	TCGA-B0-4712-01	30	29	14	0.2176094074993051	TCGA-B0-4712-01	3	1	2	6	PASS	3979	TCGA-B0-4712	KIRC	76	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-28095	Dead	WITH TUMOR	NA	1337	NA	NA	NA	NA	NA	NA	NA	NA	1	1337	1	1337	NA	NA	1	1337	
80	TCGA-B0-4713	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4713-01	111	0.35480958207048524	55	TCGA-B0-4713-01	7	10	9	0.09962753140522608	TCGA-B0-4713-01	8	4	5	17	PASS	3980	TCGA-B0-4713	KIRC	76	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-27899	Dead	WITH TUMOR	NA	202	NA	NA	NA	NA	NA	NA	NA	NA	1	202	1	202	NA	NA	1	202	
80	TCGA-B0-4714	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4714-01	75	0.12653933605679907	34	TCGA-B0-4714-01	3	3	4	0.030209111492431967	TCGA-B0-4714-01	1	2	2	5	PASS	3981	TCGA-B0-4714	KIRC	81	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-29873	Dead	WITH TUMOR	NA	99	NA	NA	NA	NA	NA	NA	NA	NA	1	99	1	99	NA	NA	1	99	
60	TCGA-B0-4718	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4718-01	123	0.13841405065143367	60	TCGA-B0-4718-01	2	4	9	0.12579107707561155	TCGA-B0-4718-01	3	3	4	10	PASS	3982	TCGA-B0-4718	KIRC	57	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-20910	Alive	WITH TUMOR	1778	NA	NA	NA	NA	NA	768	Progressive Disease	NA	NA	0	1778	0	1778	NA	NA	1	768	
50	TCGA-B0-4810	0	5	0	1	5	0	0	0	2	43	5	1	1	12	2	0	TCGA-B0-4810-01	90	0.08689816933633951	41	TCGA-B0-4810-01	1	2	11	0.07207200725732303	TCGA-B0-4810-01	1	4	2	7	PASS	3983	TCGA-B0-4810	KIRC	47	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2001	NA	-17402	Dead	WITH TUMOR	NA	478	NA	NA	NA	NA	205	NA	NA	NA	1	478	1	478	NA	NA	1	205	
50	TCGA-B0-4811	0	7	0	2	9	3	0	1	5	76	0	0	0	31	4	0	TCGA-B0-4811-01	69	0.6233435813044549	20	TCGA-B0-4811-01	26	51	3	0.08273372560215911	TCGA-B0-4811-01	1	1	0	2	PASS	3984	TCGA-B0-4811	KIRC	48	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2001	NA	-17792	Dead	WITH TUMOR	NA	1417	NA	NA	NA	NA	458	NA	NA	NA	1	1417	1	1417	NA	NA	1	458	
70	TCGA-B0-4813	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4813-01	148	0.7841914611554889	90	TCGA-B0-4813-01	6	7	28	0.2391518087728749	TCGA-B0-4813-01	7	11	10	28	PASS	3985	TCGA-B0-4813	KIRC	68	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2001	NA	-25018	Dead	TUMOR FREE	18	18	NA	NA	NA	NA	NA	NA	NA	NA	1	18	0	18	NA	NA	0	18	
60	TCGA-B0-4814	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4814-01	80	0.19957172630640566	39	TCGA-B0-4814-01	5	6	5	0.02297701240754776	TCGA-B0-4814-01	2	2	1	5	PASS	3986	TCGA-B0-4814	KIRC	58	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2001	NA	-21374	Dead	WITH TUMOR	NA	168	NA	NA	NA	NA	NA	NA	NA	NA	1	168	1	168	NA	NA	1	168	
70	TCGA-B0-4815	0	5	0	3	4	0	0	0	2	52	2	0	3	23	1	0	TCGA-B0-4815-01	61	0.4750135388964114	17	TCGA-B0-4815-01	15	11	10	0.2252970064273413	TCGA-B0-4815-01	5	4	4	13	PASS	3987	TCGA-B0-4815	KIRC	65	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2001	NA	-23873	Dead	WITH TUMOR	NA	1588	NA	NA	NA	NA	NA	NA	NA	NA	1	1588	1	1588	NA	NA	1	1588	
50	TCGA-B0-4816	0	4	0	3	3	1	0	0	2	51	0	0	1	8	1	0	TCGA-B0-4816-01	68	0.037620554126526026	19	TCGA-B0-4816-01	2	2	7	0.0396342856086704	TCGA-B0-4816-01	2	2	2	6	PASS	3988	TCGA-B0-4816	KIRC	49	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2002	NA	-18133	Dead	WITH TUMOR	NA	1371	NA	NA	NA	NA	NA	NA	NA	NA	1	1371	1	1371	NA	NA	1	1371	
80	TCGA-B0-4817	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4817-01	81	0.09174864032741853	32	TCGA-B0-4817-01	5	5	7	0.18169173643277026	TCGA-B0-4817-01	1	1	1	3	PASS	3989	TCGA-B0-4817	KIRC	81	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2002	NA	-29873	Dead	TUMOR FREE	NA	1019	NA	NA	NA	NA	NA	NA	NA	NA	1	1019	0	1019	NA	NA	0	1019	
70	TCGA-B0-4818	0	10	0	2	6	3	0	0	6	45	3	0	0	17	2	0	TCGA-B0-4818-01	72	0.04158877289300045	30	TCGA-B0-4818-01	1	2	2	0.025692100046467724	TCGA-B0-4818-01	1	2	1	4	PASS	3990	TCGA-B0-4818	KIRC	68	FEMALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2002	NA	-24853	Dead	WITH TUMOR	NA	510	NA	NA	NA	NA	127	NA	NA	NA	1	510	1	510	NA	NA	1	127	
60	TCGA-B0-4819	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4819-01	101	0.24979485596989984	52	TCGA-B0-4819-01	0	0	0	0.0	TCGA-B0-4819-01	1	1	0	2	PASS	3991	TCGA-B0-4819	KIRC	60	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2002	NA	-22220	Dead	TUMOR FREE	183	183	NA	NA	NA	NA	NA	NA	NA	NA	1	183	0	183	NA	NA	0	183	
70	TCGA-B0-4821	1	5	0	1	3	1	1	0	0	50	2	0	4	22	2	0	TCGA-B0-4821-01	95	0.5534111802549152	44	TCGA-B0-4821-01	9	14	20	0.1872072112054017	TCGA-B0-4821-01	7	3	4	14	PASS	3992	TCGA-B0-4821	KIRC	68	FEMALE	ASIAN	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2002	NA	-25013	Dead	WITH TUMOR	NA	1230	NA	NA	NA	NA	NA	NA	NA	NA	1	1230	1	1230	NA	NA	1	1230	
80	TCGA-B0-4822	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4822-01	64	0.5404785591926557	21	TCGA-B0-4822-01	26	28	2	0.10324296110276793	TCGA-B0-4822-01	1	1	0	2	PASS	3993	TCGA-B0-4822	KIRC	78	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G4	2002	NA	-28774	Dead	WITH TUMOR	NA	1111	NA	NA	NA	NA	NA	NA	NA	NA	1	1111	1	1111	NA	NA	1	1111	
90	TCGA-B0-4823	1	7	0	1	6	1	3	0	6	74	5	0	2	32	4	0	TCGA-B0-4823-01	45	0.17465624002958738	13	TCGA-B0-4823-01	6	3	19	0.0709926916570349	TCGA-B0-4823-01	0	0	0	0	PASS	3994	TCGA-B0-4823	KIRC	88	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2002	NA	-32290	Dead	TUMOR FREE	NA	454	NA	NA	NA	NA	NA	NA	NA	NA	1	454	0	454	NA	NA	0	454	
50	TCGA-B0-4824	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4824-01	107	0.06294432389051066	60	TCGA-B0-4824-01	2	2	8	0.0657951786180696	TCGA-B0-4824-01	2	1	2	5	PASS	3995	TCGA-B0-4824	KIRC	49	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2002	NA	-18132	Dead	TUMOR FREE	NA	1657	NA	NA	NA	NA	NA	NA	NA	NA	1	1657	0	1657	NA	NA	0	1657	
80	TCGA-B0-4827	0	6	1	3	6	2	0	0	3	61	1	0	3	20	2	0	TCGA-B0-4827-01	89	0.11566417167396532	38	TCGA-B0-4827-01	3	3	17	0.09975738130701174	TCGA-B0-4827-01	3	0	0	3	PASS	3996	TCGA-B0-4827	KIRC	77	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2002	NA	-28467	Dead	WITH TUMOR	NA	885	NA	NA	NA	NA	668	NA	NA	NA	1	885	1	885	NA	NA	1	668	
80	TCGA-B0-4828	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4828-01	123	0.5601872655918777	67	TCGA-B0-4828-01	6	4	8	0.045338188199334384	TCGA-B0-4828-01	2	2	1	5	PASS	3997	TCGA-B0-4828	KIRC	79	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-28948	Dead	WITH TUMOR	NA	307	NA	NA	NA	NA	NA	NA	NA	NA	1	307	1	307	NA	NA	1	307	
80	TCGA-B0-4833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4833-01	89	0.1621287650536513	41	TCGA-B0-4833-01	5	7	3	0.06982350681199011	TCGA-B0-4833-01	3	0	0	3	PASS	3998	TCGA-B0-4833	KIRC	82	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-30190	Dead	WITH TUMOR	NA	2386	NA	NA	NA	NA	NA	NA	NA	NA	1	2386	1	2386	NA	NA	1	2386	
50	TCGA-B0-4834	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4834-01	85	0.1148555032081866	39	TCGA-B0-4834-01	3	2	4	0.1006594197352084	TCGA-B0-4834-01	0	0	0	0	PASS	3999	TCGA-B0-4834	KIRC	49	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-18224	Dead	TUMOR FREE	NA	2090	NA	NA	NA	NA	NA	NA	NA	NA	1	2090	0	2090	NA	NA	0	2090	
60	TCGA-B0-4836	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4836-01	84	0.8147543621540113	35	TCGA-B0-4836-01	14	11	10	0.1762120299958858	TCGA-B0-4836-01	5	3	2	10	PASS	4000	TCGA-B0-4836	KIRC	61	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-22488	Dead	WITH TUMOR	NA	1238	NA	NA	NA	NA	NA	NA	NA	NA	1	1238	1	1238	NA	NA	1	1238	
60	TCGA-B0-4837	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4837-01	91	0.11304656817896802	46	TCGA-B0-4837-01	3	4	11	0.11798192293266607	TCGA-B0-4837-01	3	3	4	10	PASS	4001	TCGA-B0-4837	KIRC	63	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-23129	Dead	WITH TUMOR	NA	1378	NA	NA	NA	NA	1208	NA	NA	NA	1	1378	1	1378	NA	NA	1	1208	
70	TCGA-B0-4838	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4838-01	71	0.2650319151562988	28	TCGA-B0-4838-01	11	8	7	0.04588326556409414	TCGA-B0-4838-01	3	1	2	6	PASS	4002	TCGA-B0-4838	KIRC	69	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-25268	Dead	TUMOR FREE	NA	834	NA	NA	NA	NA	NA	NA	NA	NA	1	834	0	834	NA	NA	0	834	
80	TCGA-B0-4839	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4839-01	92	0.18227669112540212	52	TCGA-B0-4839-01	8	7	6	0.10872401515205933	TCGA-B0-4839-01	2	2	1	5	PASS	4003	TCGA-B0-4839	KIRC	80	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-29380	Dead	TUMOR FREE	NA	1639	NA	NA	NA	NA	NA	NA	NA	NA	1	1639	0	1639	NA	NA	0	1639	
60	TCGA-B0-4841	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4841-01	95	0.1648836907975445	47	TCGA-B0-4841-01	3	5	5	0.05376363673124436	TCGA-B0-4841-01	4	5	2	11	PASS	4004	TCGA-B0-4841	KIRC	63	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-23097	Dead	WITH TUMOR	NA	204	NA	NA	NA	NA	108	NA	NA	NA	1	204	1	204	NA	NA	1	108	
70	TCGA-B0-4842	0	2	0	1	3	2	1	0	1	45	5	0	2	9	2	0	TCGA-B0-4842-01	64	0.12124383205796754	22	TCGA-B0-4842-01	3	4	9	0.10257783032646486	TCGA-B0-4842-01	3	2	2	7	PASS	4005	TCGA-B0-4842	KIRC	73	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-27019	Dead	WITH TUMOR	NA	1724	NA	NA	NA	NA	250	NA	NA	NA	1	1724	1	1724	NA	NA	1	250	
60	TCGA-B0-4843	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4843-01	101	0.062222358594502127	58	TCGA-B0-4843-01	2	4	2	0.0628430621510842	TCGA-B0-4843-01	3	1	2	6	PASS	4006	TCGA-B0-4843	KIRC	57	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-21088	Dead	WITH TUMOR	NA	320	NA	NA	NA	NA	NA	NA	NA	NA	1	320	1	320	NA	NA	1	320	
60	TCGA-B0-4844	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4844-01	163	0.3874071392131868	99	TCGA-B0-4844-01	17	23	14	0.07567696480085716	TCGA-B0-4844-01	5	2	4	11	PASS	4007	TCGA-B0-4844	KIRC	60	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-22220	Dead	WITH TUMOR	NA	313	NA	NA	NA	NA	62	NA	NA	NA	1	313	1	313	NA	NA	1	62	
70	TCGA-B0-4845	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4845-01	77	0.9476794472433356	29	TCGA-B0-4845-01	13	9	3	0.09639361545521248	TCGA-B0-4845-01	2	1	1	4	PASS	4008	TCGA-B0-4845	KIRC	70	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-25582	Dead	WITH TUMOR	NA	1986	NA	NA	NA	NA	748	NA	NA	NA	1	1986	1	1986	NA	NA	1	748	
50	TCGA-B0-4846	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4846-01	65	0.0271011990541989	24	TCGA-B0-4846-01	1	1	19	0.028557272999821574	TCGA-B0-4846-01	0	0	1	1	PASS	4009	TCGA-B0-4846	KIRC	52	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-19139	Dead	WITH TUMOR	NA	1200	NA	NA	NA	NA	163	NA	NA	NA	1	1200	1	1200	NA	NA	1	163	
60	TCGA-B0-4847	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4847-01	61	0.0581082188041109	21	TCGA-B0-4847-01	1	2	3	0.05521251301342487	TCGA-B0-4847-01	2	2	1	5	PASS	4010	TCGA-B0-4847	KIRC	60	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-22147	Dead	[Discrepancy]	NA	793	NA	NA	NA	NA	NA	NA	NA	NA	1	793	NA	793	NA	NA	0	793	
50	TCGA-B0-4848	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4848-01	99	0.3616205754552916	42	TCGA-B0-4848-01	4	5	6	0.13735553686252386	TCGA-B0-4848-01	3	3	3	9	PASS	4011	TCGA-B0-4848	KIRC	54	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-19892	Dead	WITH TUMOR	NA	883	NA	NA	NA	NA	494	NA	NA	NA	1	883	1	883	NA	NA	1	494	
50	TCGA-B0-4849	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B0-4849-01	103	0.11018549753691333	59	TCGA-B0-4849-01	3	4	8	0.08581679812330625	TCGA-B0-4849-01	3	3	3	9	PASS	4012	TCGA-B0-4849	KIRC	51	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-18843	Dead	WITH TUMOR	NA	69	NA	NA	NA	NA	4	NA	NA	NA	1	69	1	69	NA	NA	1	4	
80	TCGA-B0-4852	2	6	0	1	8	5	0	0	8	57	3	0	0	18	7	0	TCGA-B0-4852-01	52	0.20098159738673504	8	TCGA-B0-4852-01	3	4	3	0.05408494255045704	TCGA-B0-4852-01	2	2	3	7	PASS	4013	TCGA-B0-4852	KIRC	78	FEMALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-28552	Dead	WITH TUMOR	NA	1121	NA	NA	NA	NA	860	NA	NA	NA	1	1121	1	1121	NA	NA	1	860	
80	TCGA-B0-4945	1	3	0	1	4	0	1	0	2	35	1	0	0	7	1	0	TCGA-B0-4945-01	81	0.15968760701433254	26	TCGA-B0-4945-01	4	5	8	0.14005466630921154	TCGA-B0-4945-01	4	3	4	11	PASS	4014	TCGA-B0-4945	KIRC	75	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-27523	Dead	TUMOR FREE	NA	2145	NA	NA	NA	NA	NA	NA	NA	NA	1	2145	0	2145	NA	NA	0	2145	
80	TCGA-B0-5075	0	2	0	2	5	0	3	0	3	68	5	0	2	22	1	0	TCGA-B0-5075-01	64	0.1622057525263512	26	TCGA-B0-5075-01	6	6	3	0.1457644254081161	TCGA-B0-5075-01	1	1	1	3	PASS	4015	TCGA-B0-5075	KIRC	77	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-28205	Dead	TUMOR FREE	NA	637	NA	NA	NA	NA	NA	NA	NA	NA	1	637	0	637	NA	NA	0	637	
80	TCGA-B0-5077	0	6	0	1	4	0	2	0	2	39	3	0	1	12	0	0	TCGA-B0-5077-01	90	0.17836887636124388	46	TCGA-B0-5077-01	7	6	12	0.08102997284741494	TCGA-B0-5077-01	2	2	1	5	PASS	4016	TCGA-B0-5077	KIRC	77	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-28405	Dead	TUMOR FREE	NA	1317	NA	NA	NA	NA	NA	NA	NA	NA	1	1317	0	1317	NA	NA	0	1317	
60	TCGA-B0-5080	0	2	0	1	3	0	0	0	1	52	2	0	1	17	0	0	TCGA-B0-5080-01	54	0.052353000115941614	11	TCGA-B0-5080-01	2	1	19	0.07099370460297527	TCGA-B0-5080-01	0	0	0	0	PASS	4017	TCGA-B0-5080	KIRC	63	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-23052	Dead	WITH TUMOR	NA	342	NA	NA	NA	NA	103	NA	NA	NA	1	342	1	342	NA	NA	1	103	
80	TCGA-B0-5081	0	3	0	0	3	0	0	1	1	38	4	0	0	11	0	0	TCGA-B0-5081-01	126	0.1355679700828317	58	TCGA-B0-5081-01	2	7	3	0.047696159835798564	TCGA-B0-5081-01	4	5	2	11	PASS	4018	TCGA-B0-5081	KIRC	79	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-29219	Dead	WITH TUMOR	NA	362	NA	NA	NA	NA	213	NA	NA	NA	1	362	1	362	NA	NA	1	213	
60	TCGA-B0-5083	0	0	0	1	2	0	0	0	3	17	1	0	0	8	0	0	TCGA-B0-5083	0	0	0	TCGA-B0-5083	0	0	0	0	TCGA-B0-5083	0	0	0	0	PASS	4019	TCGA-B0-5083	KIRC	63	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-23034	Dead	WITH TUMOR	NA	1045	NA	NA	NA	NA	NA	NA	NA	NA	1	1045	1	1045	NA	NA	1	1045	
30	TCGA-B0-5084	1	9	0	0	2	2	0	0	2	36	0	0	0	12	3	0	TCGA-B0-5084-01	83	0.9021620352583896	29	TCGA-B0-5084-01	11	15	21	0.4014964818585052	TCGA-B0-5084-01	6	4	5	15	PASS	4020	TCGA-B0-5084	KIRC	33	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-12219	Dead	WITH TUMOR	NA	222	NA	NA	NA	NA	65	NA	NA	NA	1	222	1	222	NA	NA	1	65	
80	TCGA-B0-5085	0	5	0	6	3	4	0	0	4	49	7	0	0	16	4	0	TCGA-B0-5085-01	75	0.04459439713692213	27	TCGA-B0-5085-01	0	2	4	0.019129516162170058	TCGA-B0-5085-01	2	2	1	5	PASS	4021	TCGA-B0-5085	KIRC	76	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-27793	Dead	TUMOR FREE	NA	770	NA	NA	NA	NA	NA	NA	NA	NA	1	770	0	770	NA	NA	0	770	
50	TCGA-B0-5088	0	3	1	1	2	1	2	0	3	49	3	0	1	20	2	0	TCGA-B0-5088-01	71	0.04207331111576774	30	TCGA-B0-5088-01	1	1	2	0.025908359104328225	TCGA-B0-5088-01	2	2	1	5	PASS	4022	TCGA-B0-5088	KIRC	53	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-19677	Dead	TUMOR FREE	NA	563	NA	NA	NA	NA	NA	NA	NA	NA	1	563	0	563	NA	NA	0	563	
50	TCGA-B0-5092	0	5	0	1	3	2	0	1	2	61	6	0	0	21	0	0	TCGA-B0-5092-01	73	0.11846237571067622	27	TCGA-B0-5092-01	3	4	3	0.06035707452724923	TCGA-B0-5092-01	3	2	1	6	PASS	4023	TCGA-B0-5092	KIRC	53	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2008	NA	-19611	Dead	WITH TUMOR	NA	459	NA	NA	NA	NA	NA	NA	NA	NA	1	459	1	459	NA	NA	1	459	
60	TCGA-B0-5094	0	4	0	2	7	1	1	0	4	64	3	0	0	14	2	0	TCGA-B0-5094-01	105	0.4115742849860986	52	TCGA-B0-5094-01	14	12	15	0.2230454909662952	TCGA-B0-5094-01	6	4	2	12	PASS	4024	TCGA-B0-5094	KIRC	62	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G2	2008	NA	-22965	Dead	WITH TUMOR	NA	333	NA	NA	NA	NA	75	NA	NA	NA	1	333	1	333	NA	NA	1	75	
80	TCGA-B0-5095	0	6	0	2	7	2	0	1	3	58	3	0	0	18	2	0	TCGA-B0-5095-01	92	0.2271108617827869	44	TCGA-B0-5095-01	5	3	12	0.14276675766353142	TCGA-B0-5095-01	2	3	4	9	PASS	4025	TCGA-B0-5095	KIRC	81	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2008	NA	-29921	Dead	TUMOR FREE	NA	245	NA	NA	NA	NA	NA	NA	NA	NA	1	245	0	245	NA	NA	0	245	
70	TCGA-B0-5096	0	2	0	2	6	2	0	0	1	59	6	0	2	30	4	1	TCGA-B0-5096-01	108	0.20014694428426305	57	TCGA-B0-5096-01	7	6	5	0.10707513767114794	TCGA-B0-5096-01	0	1	1	2	PASS	4026	TCGA-B0-5096	KIRC	72	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	GX	1998	NA	-26574	Dead	TUMOR FREE	NA	68	NA	NA	NA	NA	NA	NA	NA	NA	1	68	0	68	NA	NA	0	68	
60	TCGA-B0-5097	0	3	0	0	4	0	0	0	3	45	5	0	4	12	2	0	TCGA-B0-5097-01	67	0.15875434035604066	23	TCGA-B0-5097-01	7	5	9	0.1299114675559824	TCGA-B0-5097-01	1	2	3	6	PASS	4027	TCGA-B0-5097	KIRC	59	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-21852	Alive	WITH TUMOR	665	NA	NA	NA	NA	NA	359	NA	NA	NA	0	665	0	665	NA	NA	1	359	
50	TCGA-B0-5098	0	54	4	11	86	17	10	0	28	425	23	0	6	168	28	1	TCGA-B0-5098-01	165	0.9184071766660896	90	TCGA-B0-5098-01	6	8	31	0.27715955264743725	TCGA-B0-5098-01	2	3	4	9	PASS	4028	TCGA-B0-5098	KIRC	53	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	1998	NA	-19620	Dead	[Discrepancy]	NA	1584	NA	NA	NA	NA	NA	NA	NA	NA	1	1584	NA	1584	NA	NA	0	1584	
90	TCGA-B0-5099	0	4	0	9	8	2	1	0	2	49	5	0	3	10	2	0	TCGA-B0-5099-01	135	0.2578780783569589	71	TCGA-B0-5099-01	3	7	11	0.14006800181376314	TCGA-B0-5099-01	5	6	5	16	PASS	4029	TCGA-B0-5099	KIRC	88	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2002	NA	-32364	Dead	[Discrepancy]	NA	485	NA	NA	NA	NA	NA	NA	NA	NA	1	485	NA	485	NA	NA	0	485	
70	TCGA-B0-5100	1	0	0	1	1	0	0	0	1	23	0	0	0	11	0	0	TCGA-B0-5100-01	93	0.04852642188422377	52	TCGA-B0-5100-01	2	1	5	0.05114936869718746	TCGA-B0-5100-01	0	0	0	0	PASS	4030	TCGA-B0-5100	KIRC	72	MALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	1998	NA	-26478	Dead	WITH TUMOR	NA	1913	NA	NA	NA	NA	1426	NA	NA	NA	1	1913	1	1913	NA	NA	1	1426	
70	TCGA-B0-5102	0	0	1	0	4	1	0	0	1	34	3	0	1	8	3	0	TCGA-B0-5102-01	65	0.4023582160565736	22	TCGA-B0-5102-01	17	20	5	0.15493527344996966	TCGA-B0-5102-01	4	2	3	9	PASS	4031	TCGA-B0-5102	KIRC	74	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	1999	NA	-27152	Dead	[Discrepancy]	NA	2764	NA	NA	NA	NA	2734	NA	NA	NA	1	2764	NA	2764	NA	NA	1	2734	
90	TCGA-B0-5104	0	7	0	1	4	1	2	0	4	38	6	0	0	16	5	0	TCGA-B0-5104-01	88	0.055013613271302116	42	TCGA-B0-5104-01	1	2	4	0.028814797642391924	TCGA-B0-5104-01	2	1	1	4	PASS	4032	TCGA-B0-5104	KIRC	90	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2002	NA	-32873	Dead	TUMOR FREE	NA	2752	NA	NA	NA	NA	NA	NA	NA	NA	1	2752	0	2752	NA	NA	0	2752	
60	TCGA-B0-5106	0	4	0	0	6	0	1	0	1	58	5	0	2	20	2	0	TCGA-B0-5106-01	77	0.1543716525127728	32	TCGA-B0-5106-01	8	7	4	0.10336586866423486	TCGA-B0-5106-01	0	0	0	0	PASS	4033	TCGA-B0-5106	KIRC	64	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-23547	Dead	TUMOR FREE	NA	1598	NA	NA	NA	NA	NA	NA	NA	NA	1	1598	0	1598	NA	NA	0	1598	
70	TCGA-B0-5107	0	3	0	3	5	2	0	0	2	35	5	0	2	14	3	1	TCGA-B0-5107-01	97	0.18625723940995914	46	TCGA-B0-5107-01	6	5	17	0.1481184757093299	TCGA-B0-5107-01	1	3	3	7	PASS	4034	TCGA-B0-5107	KIRC	65	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2007	NA	-23929	Dead	WITH TUMOR	NA	927	NA	NA	NA	NA	549	NA	NA	NA	1	927	1	927	NA	NA	1	549	
50	TCGA-B0-5108	0	5	0	1	5	1	0	0	1	28	2	0	1	11	2	0	TCGA-B0-5108-01	77	0.16355959983660007	24	TCGA-B0-5108-01	5	4	6	0.10143977220093378	TCGA-B0-5108-01	2	2	2	6	PASS	4035	TCGA-B0-5108	KIRC	54	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2009	NA	-19932	Alive	TUMOR FREE	1782	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1782	0	1782	0	1782	0	1782	
70	TCGA-B0-5109	0	2	0	1	3	0	1	0	4	35	5	0	1	8	2	0	TCGA-B0-5109-01	148	0.766518892091461	78	TCGA-B0-5109-01	26	24	69	0.6470378127838113	TCGA-B0-5109-01	12	12	10	34	PASS	4036	TCGA-B0-5109	KIRC	69	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2009	NA	-25428	Dead	WITH TUMOR	NA	587	NA	NA	NA	NA	70	NA	NA	NA	1	587	1	587	NA	NA	1	70	
70	TCGA-B0-5110	0	6	0	1	8	0	2	0	3	41	2	1	0	16	1	1	TCGA-B0-5110-01	60	0.07238236047012073	18	TCGA-B0-5110-01	1	2	4	0.037815127901427714	TCGA-B0-5110-01	1	3	2	6	PASS	4037	TCGA-B0-5110	KIRC	71	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2009	NA	-25976	Alive	TUMOR FREE	2009	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2009	0	2009	0	2009	0	2009	
70	TCGA-B0-5113	0	3	0	2	2	2	0	0	2	27	1	0	0	10	1	0	TCGA-B0-5113-01	66	0.6545422449137421	25	TCGA-B0-5113-01	27	19	5	0.07821423036210665	TCGA-B0-5113-01	1	1	1	3	PASS	4038	TCGA-B0-5113	KIRC	69	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-25369	Alive	TUMOR FREE	1175	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1175	0	1175	0	1175	0	1175	
40	TCGA-B0-5115	0	1	2	1	6	1	1	0	0	35	8	0	0	6	3	0	TCGA-B0-5115-01	77	0.15410089773684332	38	TCGA-B0-5115-01	2	2	19	0.011882840665059196	TCGA-B0-5115-01	2	2	1	5	PASS	4039	TCGA-B0-5115	KIRC	43	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2009	NA	-15935	Alive	WITH TUMOR	1604	NA	NA	NA	NA	NA	75	Progressive Disease	NA	NA	0	1604	0	1604	NA	NA	1	75	
50	TCGA-B0-5116	0	4	0	1	11	1	0	0	2	41	1	0	0	16	3	0	TCGA-B0-5116-01	107	0.3754791475446017	59	TCGA-B0-5116-01	14	22	16	0.13771484189289884	TCGA-B0-5116-01	2	4	1	7	PASS	4040	TCGA-B0-5116	KIRC	52	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-19352	Alive	WITH TUMOR	1274	NA	NA	NA	NA	NA	1129	Complete Remission/Response	NA	NA	0	1274	0	1274	1	1129	1	1129	
40	TCGA-B0-5117	0	1	0	0	1	2	0	0	1	10	1	0	0	8	0	0	TCGA-B0-5117-01	110	0.9148172528457318	50	TCGA-B0-5117-01	11	7	6	0.3283939386425969	TCGA-B0-5117-01	1	0	0	1	PASS	4041	TCGA-B0-5117	KIRC	40	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-14612	Alive	TUMOR FREE	1608	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1608	0	1608	0	1608	0	1608	
60	TCGA-B0-5119	0	7	0	2	12	1	2	1	1	63	4	0	2	18	2	0	TCGA-B0-5119-01	50	0.06529875178675455	13	TCGA-B0-5119-01	2	2	3	0.0683796577890789	TCGA-B0-5119-01	2	1	2	5	PASS	4042	TCGA-B0-5119	KIRC	61	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-22607	Alive	TUMOR FREE	1552	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1552	0	1552	0	1552	0	1552	
70	TCGA-B0-5120	0	3	1	4	3	1	0	0	0	38	4	0	4	20	4	0	TCGA-B0-5120-01	53	0.12319651025506677	9	TCGA-B0-5120-01	2	2	3	0.0924774055464015	TCGA-B0-5120-01	1	2	1	4	PASS	4043	TCGA-B0-5120	KIRC	72	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-26559	Alive	TUMOR FREE	1169	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1169	0	1169	0	1169	0	1169	
60	TCGA-B0-5121	0	3	0	0	2	1	0	0	2	31	2	0	1	14	3	0	TCGA-B0-5121-01	74	0.07480622452647173	28	TCGA-B0-5121-01	1	4	5	0.053608458945524975	TCGA-B0-5121-01	2	2	3	7	PASS	4044	TCGA-B0-5121	KIRC	56	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-20635	Alive	TUMOR FREE	1485	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1485	0	1485	0	1485	0	1485	
50	TCGA-B0-5399	0	4	0	1	2	0	0	0	4	28	3	0	0	13	1	0	TCGA-B0-5399-01	43	0.07239168168920099	5	TCGA-B0-5399	0	0	0	0	TCGA-B0-5399	0	0	0	0	PASS	4045	TCGA-B0-5399	KIRC	46	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-17145	Alive	TUMOR FREE	1411	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1411	0	1411	0	1411	0	1411	
60	TCGA-B0-5400	0	0	0	0	2	0	0	0	2	29	2	0	0	13	2	0	TCGA-B0-5400-01	49	0.09873910368593393	7	TCGA-B0-5400-01	4	4	2	0.031090812208404574	TCGA-B0-5400-01	1	1	0	2	PASS	4046	TCGA-B0-5400	KIRC	59	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2008	NA	-21819	Alive	TUMOR FREE	1733	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1733	0	1733	0	1733	0	1733	
60	TCGA-B0-5402	1	2	0	1	2	0	2	0	1	44	3	0	0	4	0	2	TCGA-B0-5402-01	53	0.2813857380094171	15	TCGA-B0-5402-01	6	10	5	0.1299106944850679	TCGA-B0-5402-01	7	4	4	15	PASS	4047	TCGA-B0-5402	KIRC	64	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2010	NA	-23477	Alive	WITH TUMOR	1290	NA	NA	NA	NA	NA	444	Progressive Disease	NA	NA	0	1290	0	1290	NA	NA	1	444	
50	TCGA-B0-5690	1	3	0	0	1	0	0	0	4	49	1	0	0	18	4	0	TCGA-B0-5690-01	61	0.08178894964519523	18	TCGA-B0-5690-01	2	2	2	0.025439358832937003	TCGA-B0-5690-01	1	2	1	4	PASS	4048	TCGA-B0-5690	KIRC	53	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G1	2004	NA	-19685	Alive	WITH TUMOR	3392	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	3392	0	3392	NA	NA	0	3392	
70	TCGA-B0-5691	0	2	1	2	2	3	2	0	0	44	2	0	0	11	0	0	TCGA-B0-5691-01	87	0.08124679565559567	31	TCGA-B0-5691-01	0	3	4	0.03653742864584093	TCGA-B0-5691-01	3	4	2	9	PASS	4049	TCGA-B0-5691	KIRC	66	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2002	NA	-24120	Alive	WITH TUMOR	3431	NA	NA	NA	NA	NA	3250	NA	NA	NA	0	3431	0	3431	NA	NA	1	3250	
70	TCGA-B0-5692	0	6	0	4	8	3	3	0	1	36	5	0	1	19	0	0	TCGA-B0-5692-01	116	0.10186324128997096	67	TCGA-B0-5692-01	3	4	4	0.06348064996670294	TCGA-B0-5692-01	2	1	1	4	PASS	4050	TCGA-B0-5692	KIRC	66	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-24140	Alive	TUMOR FREE	3944	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3944	0	3944	0	3944	0	3944	
50	TCGA-B0-5693	0	2	0	1	6	1	2	0	1	28	3	0	1	6	0	0	TCGA-B0-5693-01	57	0.08725613400115922	18	TCGA-B0-5693-01	3	3	19	0.029299105593375795	TCGA-B0-5693-01	2	1	1	4	PASS	4051	TCGA-B0-5693	KIRC	47	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-17177	Alive	TUMOR FREE	4074	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4074	0	4074	0	4074	0	4074	
70	TCGA-B0-5694	0	8	2	2	7	2	2	0	1	37	4	0	0	15	1	0	TCGA-B0-5694-01	77	0.19286772343248204	32	TCGA-B0-5694-01	5	4	3	0.08305379556046362	TCGA-B0-5694-01	1	1	1	3	PASS	4052	TCGA-B0-5694	KIRC	71	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2008	NA	-26060	Dead	WITH TUMOR	NA	480	NA	NA	NA	NA	288	NA	NA	NA	1	480	1	480	NA	NA	1	288	
60	TCGA-B0-5695	0	5	0	2	4	0	0	0	3	50	4	0	1	15	3	0	TCGA-B0-5695-01	63	0.061866728597688124	18	TCGA-B0-5695-01	2	3	4	0.06525443160296339	TCGA-B0-5695-01	1	2	2	5	PASS	4053	TCGA-B0-5695	KIRC	61	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-22320	Alive	TUMOR FREE	2150	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2150	0	2150	0	2150	0	2150	
70	TCGA-B0-5696	0	2	0	0	2	3	1	0	1	38	4	0	0	14	4	0	TCGA-B0-5696-01	77	0.25479529444989063	24	TCGA-B0-5696-01	6	7	4	0.0984379639174812	TCGA-B0-5696-01	4	4	2	10	PASS	4054	TCGA-B0-5696	KIRC	69	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2007	NA	-25552	Alive	WITH TUMOR	2609	NA	NA	NA	NA	NA	1717	Complete Remission/Response	NA	NA	0	2609	0	2609	1	1717	1	1717	
50	TCGA-B0-5697	0	7	2	1	2	0	0	1	1	43	2	0	2	18	1	0	TCGA-B0-5697-01	99	0.18601080188225355	50	TCGA-B0-5697-01	7	7	13	0.16051588043380524	TCGA-B0-5697-01	2	1	1	4	PASS	4055	TCGA-B0-5697	KIRC	50	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-18486	Alive	TUMOR FREE	2630	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2630	0	2630	0	2630	0	2630	
80	TCGA-B0-5698	2	6	0	0	8	1	0	0	6	47	7	0	0	11	2	0	TCGA-B0-5698-01	33	0.13152297458739784	4	TCGA-B0-5698-01	3	3	19	0.02638691527267972	TCGA-B0-5698-01	2	2	1	5	PASS	4056	TCGA-B0-5698	KIRC	77	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-28438	Alive	TUMOR FREE	3631	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3631	0	3631	0	3631	0	3631	
50	TCGA-B0-5699	0	8	0	4	0	0	0	0	2	31	3	0	0	14	4	0	TCGA-B0-5699-01	93	0.04630445269447548	42	TCGA-B0-5699-01	1	1	11	0.048793985724288856	TCGA-B0-5699-01	1	2	2	5	PASS	4057	TCGA-B0-5699	KIRC	53	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-19647	Alive	TUMOR FREE	3841	NA	NA	NA	NA	NA	94	Complete Remission/Response	NA	NA	0	3841	0	3841	1	94	1	94	
80	TCGA-B0-5700	0	12	1	3	6	2	1	0	2	46	2	0	2	10	4	0	TCGA-B0-5700	0	0	0	TCGA-B0-5700	0	0	0	0	TCGA-B0-5700	0	0	0	0	PASS	4058	TCGA-B0-5700	KIRC	77	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2009	NA	-28184	Alive	TUMOR FREE	1790	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1790	0	1790	0	1790	0	1790	
70	TCGA-B0-5701	2	7	0	1	10	2	0	0	8	81	0	0	1	23	0	0	TCGA-B0-5701-01	83	0.27115594330127457	30	TCGA-B0-5701-01	7	7	7	0.14776792779391187	TCGA-B0-5701-01	5	6	3	14	PASS	4059	TCGA-B0-5701	KIRC	65	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2007	NA	-23915	Alive	TUMOR FREE	2461	NA	NA	NA	NA	NA	224	Complete Remission/Response	NA	NA	0	2461	0	2461	1	224	1	224	
70	TCGA-B0-5702	0	3	0	0	3	1	0	0	2	50	5	0	3	13	2	0	TCGA-B0-5702-01	66	0.09192259438036676	29	TCGA-B0-5702	0	0	0	0	TCGA-B0-5702	0	0	0	0	PASS	4060	TCGA-B0-5702	KIRC	71	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-26186	Alive	TUMOR FREE	2172	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2172	0	2172	0	2172	0	2172	
70	TCGA-B0-5703	1	6	0	3	6	2	0	0	5	49	5	0	3	16	2	0	TCGA-B0-5703-01	94	0.1884025239422643	40	TCGA-B0-5703-01	5	5	14	0.15481892891083066	TCGA-B0-5703-01	5	3	6	14	PASS	4061	TCGA-B0-5703	KIRC	73	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2009	NA	-26897	Alive	TUMOR FREE	2246	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2246	0	2246	0	2246	0	2246	
70	TCGA-B0-5705	1	3	0	4	6	2	2	0	2	49	6	0	0	24	1	0	TCGA-B0-5705-01	71	0.09391439656138376	24	TCGA-B0-5705-01	2	2	2	0.021542466235577654	TCGA-B0-5705-01	1	1	1	3	PASS	4062	TCGA-B0-5705	KIRC	65	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2002	NA	-23746	Alive	TUMOR FREE	4537	NA	NA	NA	NA	NA	842	Complete Remission/Response	NA	NA	0	4537	0	4537	1	842	1	842	
50	TCGA-B0-5706	0	2	0	1	5	0	1	0	3	39	3	0	1	17	1	0	TCGA-B0-5706-01	69	0.08437043222782359	25	TCGA-B0-5706	0	0	0	0	TCGA-B0-5706	0	0	0	0	PASS	4063	TCGA-B0-5706	KIRC	45	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-16442	Alive	TUMOR FREE	3205	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3205	0	3205	0	3205	0	3205	
40	TCGA-B0-5707	0	4	0	1	0	1	0	0	2	25	1	0	1	12	0	0	TCGA-B0-5707	0	0	0	TCGA-B0-5707	0	0	0	0	TCGA-B0-5707	0	0	0	0	PASS	4064	TCGA-B0-5707	KIRC	39	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-14598	Alive	TUMOR FREE	3744	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3744	0	3744	0	3744	0	3744	
60	TCGA-B0-5709	1	3	0	1	6	2	0	0	5	54	5	0	0	22	0	0	TCGA-B0-5709-01	87	0.11404954618700552	38	TCGA-B0-5709-01	1	3	7	0.10066638013615656	TCGA-B0-5709-01	4	4	4	12	PASS	4065	TCGA-B0-5709	KIRC	62	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-22843	Alive	TUMOR FREE	3974	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3974	0	3974	0	3974	0	3974	
60	TCGA-B0-5710	0	4	0	0	4	0	2	0	0	30	1	0	0	11	1	0	TCGA-B0-5710-01	79	0.14180718243328114	31	TCGA-B0-5710-01	3	5	5	0.07500451490593192	TCGA-B0-5710-01	2	4	2	8	PASS	4066	TCGA-B0-5710	KIRC	57	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2008	NA	-21168	Alive	WITH TUMOR	2430	NA	NA	NA	NA	NA	1441	Progressive Disease	NA	NA	0	2430	0	2430	NA	NA	1	1441	
50	TCGA-B0-5711	0	3	0	0	4	1	0	0	0	22	3	0	1	4	1	0	TCGA-B0-5711-01	55	0.08322800850297223	19	TCGA-B0-5711-01	2	3	3	0.0582955216752751	TCGA-B0-5711-01	2	2	1	5	PASS	4067	TCGA-B0-5711	KIRC	50	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-18444	Alive	WITH TUMOR	3989	NA	NA	NA	NA	NA	3766	Complete Remission/Response	NA	NA	0	3989	0	3989	1	3766	1	3766	
70	TCGA-B0-5712	0	6	1	5	13	4	0	0	5	62	7	0	0	25	4	0	TCGA-B0-5712-01	119	0.17673590895598829	65	TCGA-B0-5712-01	4	6	7	0.1535499893981184	TCGA-B0-5712-01	1	0	0	1	PASS	4068	TCGA-B0-5712	KIRC	68	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-24988	Alive	WITH TUMOR	2722	NA	NA	NA	NA	NA	725	NA	NA	NA	0	2722	0	2722	NA	NA	1	725	
80	TCGA-B0-5713	0	9	2	3	9	5	1	0	2	76	2	1	1	19	4	0	TCGA-B0-5713-01	47	0.16206216871346207	11	TCGA-B0-5713-01	5	4	3	0.05768420633462582	TCGA-B0-5713-01	1	2	2	5	PASS	4069	TCGA-B0-5713	KIRC	75	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-27644	Alive	TUMOR FREE	2782	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2782	0	2782	0	2782	0	2782	
50	TCGA-B0-5812	0	4	0	0	2	0	1	0	0	32	5	0	2	12	2	0	TCGA-B0-5812-01	89	0.04752969680476817	44	TCGA-B0-5812-01	0	2	3	0.02000743942771684	TCGA-B0-5812-01	2	2	1	5	PASS	4070	TCGA-B0-5812	KIRC	53	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-19600	Alive	TUMOR FREE	3834	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3834	0	3834	0	3834	0	3834	
60	TCGA-B2-3923	0	0	1	2	0	0	5	0	1	37	4	0	2	8	1	0	TCGA-B2-3923-01	67	0.9477296101350892	24	TCGA-B2-3923-01	10	5	5	0.3166460231142229	TCGA-B2-3923-01	0	0	0	0	PASS	4071	TCGA-B2-3923	KIRC	59	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-21793	Alive	TUMOR FREE	992	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	992	0	992	0	992	0	992	
70	TCGA-B2-3924	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B2-3924-01	45	0.18340793455445173	8	TCGA-B2-3924-01	5	4	7	0.07126517296502705	TCGA-B2-3924-01	1	0	0	1	PASS	4072	TCGA-B2-3924	KIRC	73	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-26846	Alive	TUMOR FREE	1092	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1092	0	1092	0	1092	0	1092	
70	TCGA-B2-4098	2	8	0	8	10	6	2	0	3	66	6	0	4	44	0	0	TCGA-B2-4098-01	101	0.11646075306735044	55	TCGA-B2-4098-01	4	4	7	0.09407678376653814	TCGA-B2-4098-01	3	2	4	9	PASS	4073	TCGA-B2-4098	KIRC	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-26606	Dead	TUMOR FREE	NA	51	NA	NA	NA	NA	NA	NA	NA	NA	1	51	0	51	NA	NA	0	51	
80	TCGA-B2-4099	0	2	0	2	10	5	0	0	10	90	4	0	2	37	4	0	TCGA-B2-4099-01	61	0.07114665158491014	21	TCGA-B2-4099-01	1	2	19	0.025019875796948025	TCGA-B2-4099-01	2	2	1	5	PASS	4074	TCGA-B2-4099	KIRC	83	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-30355	Alive	TUMOR FREE	972	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	972	0	972	0	972	0	972	
50	TCGA-B2-4101	0	3	0	2	6	1	1	0	2	32	3	0	0	10	4	0	TCGA-B2-4101-01	77	0.04920235687630406	35	TCGA-B2-4101-01	0	2	19	0.02022658903852318	TCGA-B2-4101-01	2	2	1	5	PASS	4075	TCGA-B2-4101	KIRC	52	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-19059	Alive	TUMOR FREE	648	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	648	0	648	0	648	0	648	
60	TCGA-B2-4102	0	3	0	3	4	0	0	0	0	55	2	0	0	22	3	0	TCGA-B2-4102-01	121	0.08184403245527509	69	TCGA-B2-4102-01	1	3	2	0.0524512694200668	TCGA-B2-4102-01	1	2	1	4	PASS	4076	TCGA-B2-4102	KIRC	61	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-22492	Alive	TUMOR FREE	952	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	952	0	952	0	952	0	952	
60	TCGA-B2-5633	0	4	0	2	2	2	2	2	11	69	8	2	4	31	2	0	TCGA-B2-5633-01	62	0.23071207691512916	14	TCGA-B2-5633-01	7	6	20	0.14749676603665332	TCGA-B2-5633-01	1	3	2	6	PASS	4077	TCGA-B2-5633	KIRC	56	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-20493	Alive	TUMOR FREE	963	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	963	0	963	0	963	0	963	
70	TCGA-B2-5635	2	11	1	8	14	2	2	0	15	76	0	0	0	31	6	2	TCGA-B2-5635-01	45	0.09139032716966614	9	TCGA-B2-5635-01	3	4	26	0.10333315361608317	TCGA-B2-5635-01	0	0	0	0	PASS	4078	TCGA-B2-5635	KIRC	74	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-27183	Alive	TUMOR FREE	755	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	755	0	755	0	755	0	755	
80	TCGA-B2-5636	4	3	0	0	0	0	1	0	0	27	0	0	0	13	2	0	TCGA-B2-5636	0	0	0	TCGA-B2-5636	0	0	0	0	TCGA-B2-5636	0	0	0	0	PASS	4079	TCGA-B2-5636	KIRC	79	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-28901	Alive	TUMOR FREE	919	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	919	0	919	0	919	0	919	
50	TCGA-B2-5639	0	14	0	6	10	0	2	0	6	72	6	0	2	26	4	0	TCGA-B2-5639-01	68	0.17152101337695272	26	TCGA-B2-5639-01	5	5	4	0.07240652184927691	TCGA-B2-5639-01	3	2	1	6	PASS	4080	TCGA-B2-5639	KIRC	46	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-17045	Dead	WITH TUMOR	NA	1003	NA	NA	NA	NA	163	Progressive Disease	NA	NA	1	1003	1	1003	NA	NA	1	163	
80	TCGA-B2-5641	0	21	0	2	10	6	2	0	10	98	8	0	2	42	2	0	TCGA-B2-5641-01	91	0.16120322961033448	42	TCGA-B2-5641-01	3	6	11	0.16710109422110547	TCGA-B2-5641-01	4	5	2	11	PASS	4081	TCGA-B2-5641	KIRC	79	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-28953	Alive	TUMOR FREE	656	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	656	0	656	0	656	0	656	
60	TCGA-B2-A4SR	2	8	0	4	8	2	3	0	0	66	4	0	4	28	0	0	TCGA-B2-A4SR-01	81	0.06454541349827833	33	TCGA-B2-A4SR-01	2	2	33	0.0671502294331002	TCGA-B2-A4SR-01	2	3	4	9	PASS	4082	TCGA-B2-A4SR	KIRC	61	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Kidney Clear Cell Renal Carcinoma	NA	2012	NA	-22637	Alive	TUMOR FREE	507	NA	NA	NA	NA	NA	266	Complete Remission/Response	NA	NA	0	507	0	507	1	266	1	266	
70	TCGA-B4-5377	0	4	0	2	4	0	1	0	2	35	4	0	0	18	4	0	TCGA-B4-5377-01	35	0.10528589454675684	6	TCGA-B4-5377-01	4	3	4	0.11108942228460736	TCGA-B4-5377-01	1	0	2	3	PASS	4083	TCGA-B4-5377	KIRC	68	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-25115	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	365	0	365	NA	NA	0	365	
60	TCGA-B4-5378	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B4-5378-01	39	4.964939453489942e-06	6	TCGA-B4-5378-01	0	0	0	0.0	TCGA-B4-5378-01	0	0	0	0	PASS	4084	TCGA-B4-5378	KIRC	62	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-22980	Alive	TUMOR FREE	175	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	175	0	175	NA	NA	0	175	
70	TCGA-B4-5832	0	4	0	1	6	1	1	1	3	53	1	1	1	19	1	0	TCGA-B4-5832-01	75	0.6157786039733832	28	TCGA-B4-5832-01	29	29	5	0.10775220385246193	TCGA-B4-5832-01	7	4	0	11	PASS	4085	TCGA-B4-5832	KIRC	65	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-23806	Alive	TUMOR FREE	155	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	155	0	155	0	155	0	155	
60	TCGA-B4-5834	1	2	0	0	1	1	0	0	2	21	1	0	0	14	1	0	TCGA-B4-5834-01	61	0.08402599173596538	25	TCGA-B4-5834-01	3	3	2	0.03204715695366951	TCGA-B4-5834-01	2	1	1	4	PASS	4086	TCGA-B4-5834	KIRC	59	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G1	2010	NA	-21713	Alive	TUMOR FREE	38	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	38	0	38	NA	NA	0	38	
60	TCGA-B4-5835	0	2	0	1	8	0	0	0	2	47	14	0	0	11	2	0	TCGA-B4-5835-01	109	0.3772817293810747	54	TCGA-B4-5835-01	12	11	25	0.20678746727782374	TCGA-B4-5835-01	6	0	5	11	PASS	4087	TCGA-B4-5835	KIRC	64	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-23408	Alive	TUMOR FREE	16	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	16	0	16	NA	NA	0	16	
60	TCGA-B4-5836	0	5	0	1	8	1	3	0	3	44	5	0	0	26	1	0	TCGA-B4-5836-01	59	0.05637808241718208	19	TCGA-B4-5836-01	2	2	2	0.05944142438940425	TCGA-B4-5836-01	1	1	1	3	PASS	4088	TCGA-B4-5836	KIRC	61	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-22341	Alive	TUMOR FREE	141	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	141	0	141	NA	NA	0	141	
50	TCGA-B4-5838	0	8	0	4	5	1	1	0	1	51	2	1	0	18	1	0	TCGA-B4-5838-01	44	0.4858400675179294	12	TCGA-B4-5838-01	24	14	2	0.05398514793668198	TCGA-B4-5838-01	3	2	1	6	PASS	4089	TCGA-B4-5838	KIRC	52	MALE	WHITE	[Discrepancy]	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-19242	Alive	WITH TUMOR	166	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	166	0	166	NA	NA	0	166	
50	TCGA-B4-5843	0	2	0	2	4	1	1	0	2	34	1	0	0	8	2	0	TCGA-B4-5843-01	55	0.2384254522621184	20	TCGA-B4-5843-01	7	5	4	0.060041712688142124	TCGA-B4-5843-01	2	0	1	3	PASS	4090	TCGA-B4-5843	KIRC	45	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-16779	Alive	TUMOR FREE	11	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	11	0	11	NA	NA	0	11	
60	TCGA-B4-5844	0	4	1	0	8	1	0	0	3	48	3	0	1	14	7	0	TCGA-B4-5844-01	37	0.031646139057687456	9	TCGA-B4-5844-01	1	1	2	0.027607865206500368	TCGA-B4-5844-01	2	2	1	5	PASS	4091	TCGA-B4-5844	KIRC	61	FEMALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G1	2010	NA	-22409	Alive	TUMOR FREE	7	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	7	0	7	NA	NA	0	7	
70	TCGA-B8-4143	1	1	0	2	3	0	0	0	3	52	4	0	1	22	1	0	TCGA-B8-4143-01	1849	0.4111452173952052	1726	TCGA-B8-4143-01	12	15	16	0.1643983178412174	TCGA-B8-4143-01	8	6	4	18	PASS	4092	TCGA-B8-4143	KIRC	66	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2002	NA	-24132	Dead	WITH TUMOR	NA	709	NA	NA	NA	NA	NA	NA	NA	NA	1	709	1	709	NA	NA	1	709	
40	TCGA-B8-4146	0	2	0	0	6	0	0	0	3	26	1	0	1	11	1	0	TCGA-B8-4146-01	75	0.10819466966956733	32	TCGA-B8-4146-01	1	4	8	0.07970477488944927	TCGA-B8-4146-01	2	6	4	12	PASS	4093	TCGA-B8-4146	KIRC	41	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2009	NA	-15063	Alive	TUMOR FREE	511	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	511	0	511	0	511	0	511	
60	TCGA-B8-4148	1	0	1	1	1	2	1	0	4	26	1	0	2	7	1	0	TCGA-B8-4148-01	66	0.08219532346342229	24	TCGA-B8-4148-01	2	3	4	0.08512011342002188	TCGA-B8-4148-01	2	0	3	5	PASS	4094	TCGA-B8-4148	KIRC	63	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2009	NA	-23062	Alive	TUMOR FREE	1520	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1520	0	1520	0	1520	0	1520	
50	TCGA-B8-4151	0	1	0	3	5	0	0	0	2	41	2	0	1	12	2	0	TCGA-B8-4151-01	85	0.03207989082208597	38	TCGA-B8-4151-01	1	2	2	0.03383562975301288	TCGA-B8-4151-01	2	1	2	5	PASS	4095	TCGA-B8-4151	KIRC	51	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2009	NA	-18760	Alive	TUMOR FREE	1299	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1299	0	1299	0	1299	0	1299	
70	TCGA-B8-4153	1	4	2	4	4	1	2	1	6	52	3	0	0	19	0	1	TCGA-B8-4153-01	60	0.01886857349754916	21	TCGA-B8-4153-01	0	1	5	0.019896284495556	TCGA-B8-4153-01	1	1	1	3	PASS	4096	TCGA-B8-4153	KIRC	74	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-27031	Alive	WITH TUMOR	762	NA	NA	NA	NA	NA	223	NA	NA	NA	0	762	0	762	NA	NA	1	223	
70	TCGA-B8-4154	1	4	0	0	3	0	0	0	4	40	2	0	4	10	2	0	TCGA-B8-4154-01	95	0.03283125833126226	40	TCGA-B8-4154-01	1	2	4	0.03423623997846422	TCGA-B8-4154-01	2	1	2	5	PASS	4097	TCGA-B8-4154	KIRC	73	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-26882	Alive	TUMOR FREE	1380	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1380	0	1380	0	1380	0	1380	
60	TCGA-B8-4619	0	4	0	0	2	0	0	0	4	35	0	0	2	2	0	0	TCGA-B8-4619-01	61	0.17918424108720374	19	TCGA-B8-4619-01	6	4	3	0.13171407503487512	TCGA-B8-4619-01	0	0	0	0	PASS	4098	TCGA-B8-4619	KIRC	58	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-21206	Alive	TUMOR FREE	523	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	523	0	523	0	523	0	523	
70	TCGA-B8-4620	0	12	0	2	14	0	0	2	5	91	0	0	0	6	0	0	TCGA-B8-4620-01	92	0.5246029247273076	50	TCGA-B8-4620-01	19	20	11	0.08832454568713129	TCGA-B8-4620-01	1	2	2	5	PASS	4099	TCGA-B8-4620	KIRC	70	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-25786	Alive	WITH TUMOR	777	NA	NA	NA	NA	NA	604	Complete Remission/Response	NA	NA	0	777	0	777	1	604	1	604	
60	TCGA-B8-4621	1	11	0	3	11	2	1	0	0	57	2	0	2	17	3	0	TCGA-B8-4621-01	108	0.2548005780676574	57	TCGA-B8-4621-01	12	7	4	0.028260082554090942	TCGA-B8-4621-01	1	1	0	2	PASS	4100	TCGA-B8-4621	KIRC	63	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-23176	Alive	TUMOR FREE	788	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	788	0	788	0	788	0	788	
60	TCGA-B8-4622	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-B8-4622-01	71	0.19110781782591846	21	TCGA-B8-4622-01	8	5	6	0.07345542008873926	TCGA-B8-4622-01	0	1	1	2	PASS	4101	TCGA-B8-4622	KIRC	57	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-21135	Alive	WITH TUMOR	1525	NA	NA	NA	NA	NA	1227	Complete Remission/Response	NA	NA	0	1525	0	1525	NA	NA	1	1227	
60	TCGA-B8-5158	0	3	0	0	5	0	0	0	1	44	2	0	1	16	4	0	TCGA-B8-5158-01	65	0.21124752182761336	26	TCGA-B8-5158-01	10	10	11	0.08456501929102304	TCGA-B8-5158-01	3	4	2	9	PASS	4102	TCGA-B8-5158	KIRC	56	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2010	NA	-20764	Alive	TUMOR FREE	1218	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1218	0	1218	0	1218	0	1218	
60	TCGA-B8-5159	0	6	0	2	3	2	1	0	3	38	5	0	0	9	0	0	TCGA-B8-5159-01	79	0.23932878548820594	36	TCGA-B8-5159-01	5	4	3	0.044184894020050006	TCGA-B8-5159-01	2	2	2	6	PASS	4103	TCGA-B8-5159	KIRC	61	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-22462	Alive	TUMOR FREE	722	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	722	0	722	0	722	0	722	
60	TCGA-B8-5162	0	2	0	3	7	0	0	0	0	56	2	0	1	16	1	0	TCGA-B8-5162-01	57	0.1605368473036991	14	TCGA-B8-5162-01	4	3	6	0.1693815367911037	TCGA-B8-5162-01	1	2	2	5	PASS	4104	TCGA-B8-5162	KIRC	62	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-23008	Alive	TUMOR FREE	36	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	36	0	36	NA	NA	0	36	
60	TCGA-B8-5163	0	3	2	3	6	1	3	0	3	48	2	0	2	19	1	0	TCGA-B8-5163-01	135	0.3006280564434003	92	TCGA-B8-5163-01	14	15	55	0.2923480446091352	TCGA-B8-5163-01	2	0	1	3	PASS	4105	TCGA-B8-5163	KIRC	63	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-23293	Alive	TUMOR FREE	822	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	822	0	822	0	822	0	822	
70	TCGA-B8-5164	1	2	0	2	9	2	2	0	2	59	7	0	0	18	3	0	TCGA-B8-5164-01	75	0.1296563671111486	32	TCGA-B8-5164-01	4	4	11	0.16597549869642758	TCGA-B8-5164-01	2	2	1	5	PASS	4106	TCGA-B8-5164	KIRC	65	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-23863	Alive	TUMOR FREE	26	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	26	0	26	NA	NA	0	26	
40	TCGA-B8-5165	0	2	0	1	0	1	0	0	0	14	2	0	0	6	1	0	TCGA-B8-5165-01	40	0.06880977779030045	7	TCGA-B8-5165-01	0	1	2	0.020399461537159932	TCGA-B8-5165-01	1	1	1	3	PASS	4107	TCGA-B8-5165	KIRC	43	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-15898	Alive	TUMOR FREE	737	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	737	0	737	0	737	0	737	
40	TCGA-B8-5545	0	3	0	1	1	0	0	0	0	15	2	0	2	9	0	0	TCGA-B8-5545-01	55	0.0498348042088024	14	TCGA-B8-5545-01	2	1	19	0.05256167001282365	TCGA-B8-5545-01	0	0	0	0	PASS	4108	TCGA-B8-5545	KIRC	42	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-15376	Alive	TUMOR FREE	1525	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1525	0	1525	0	1525	0	1525	
40	TCGA-B8-5546	0	6	0	2	0	0	0	0	2	22	0	0	0	4	2	0	TCGA-B8-5546-01	57	0.00025029651373489035	15	TCGA-B8-5546-01	0	0	0	0.0	TCGA-B8-5546-01	0	0	0	0	PASS	4109	TCGA-B8-5546	KIRC	38	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-14113	Alive	TUMOR FREE	505	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	505	0	505	NA	NA	0	505	
50	TCGA-B8-5549	0	8	2	4	10	4	2	0	2	73	2	0	2	38	4	0	TCGA-B8-5549-01	91	0.7552464155621885	37	TCGA-B8-5549-01	25	11	6	0.07210121879071962	TCGA-B8-5549-01	1	2	2	5	PASS	4110	TCGA-B8-5549	KIRC	53	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-19561	Alive	TUMOR FREE	194	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	194	0	194	0	194	0	194	
70	TCGA-B8-5550	1	10	0	3	11	3	2	0	4	76	5	0	2	23	5	0	TCGA-B8-5550-01	97	0.33687098479189603	43	TCGA-B8-5550-01	11	9	16	0.14633086332823886	TCGA-B8-5550-01	2	2	2	6	PASS	4111	TCGA-B8-5550	KIRC	71	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-25937	Alive	WITH TUMOR	1476	NA	NA	NA	NA	NA	694	Complete Remission/Response	NA	NA	0	1476	0	1476	1	694	1	694	
70	TCGA-B8-5551	0	22	2	6	10	2	2	2	6	73	8	0	1	29	2	0	TCGA-B8-5551-01	81	0.2646967008651228	41	TCGA-B8-5551-01	32	28	7	0.13536301930505332	TCGA-B8-5551-01	4	1	2	7	PASS	4112	TCGA-B8-5551	KIRC	65	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-23976	Alive	TUMOR FREE	16	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	16	0	16	NA	NA	0	16	
40	TCGA-B8-5552	0	4	0	0	0	0	0	0	2	48	4	0	0	6	0	0	TCGA-B8-5552-01	51	0.0571199713187969	14	TCGA-B8-5552-01	1	2	2	0.033318935650028886	TCGA-B8-5552-01	1	1	1	3	PASS	4113	TCGA-B8-5552	KIRC	41	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-15219	Alive	TUMOR FREE	1046	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1046	0	1046	0	1046	0	1046	
70	TCGA-B8-5553	0	5	0	2	5	2	0	0	4	41	5	0	2	9	3	0	TCGA-B8-5553-01	59	0.09102939720673764	18	TCGA-B8-5553-01	2	4	6	0.06697722229751661	TCGA-B8-5553-01	2	2	1	5	PASS	4114	TCGA-B8-5553	KIRC	67	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-24729	Alive	TUMOR FREE	435	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	435	0	435	NA	NA	0	435	
70	TCGA-B8-A54D	0	9	0	3	2	1	1	0	0	44	5	0	4	14	2	0	TCGA-B8-A54D-01	86	0.11875045985771518	38	TCGA-B8-A54D-01	2	3	33	0.09800767450319496	TCGA-B8-A54D-01	3	1	4	8	PASS	4115	TCGA-B8-A54D	KIRC	69	MALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2011	NA	-25429	Alive	TUMOR FREE	830	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	830	0	830	0	830	0	830	
60	TCGA-B8-A54E	0	5	0	0	3	0	0	0	1	38	1	0	2	10	0	0	TCGA-B8-A54E-01	57	0.09590294989563368	19	TCGA-B8-A54E-01	5	3	11	0.02532559112510073	TCGA-B8-A54E-01	1	0	1	2	PASS	4116	TCGA-B8-A54E	KIRC	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2011	NA	-22900	Alive	TUMOR FREE	909	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	909	0	909	0	909	0	909	
50	TCGA-B8-A54F	0	2	0	1	3	0	1	0	1	23	3	0	0	9	1	0	TCGA-B8-A54F-01	79	0.11643497234619785	33	TCGA-B8-A54F-01	4	3	23	0.06386518867739435	TCGA-B8-A54F-01	1	2	2	5	PASS	4117	TCGA-B8-A54F	KIRC	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2012	NA	-18028	Alive	TUMOR FREE	519	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	519	0	519	0	519	0	519	
50	TCGA-B8-A54G	1	5	0	6	1	1	1	0	4	33	1	0	0	10	1	0	TCGA-B8-A54G-01	84	0.1426929316626834	32	TCGA-B8-A54G-01	2	5	41	0.12253198030252875	TCGA-B8-A54G-01	6	4	4	14	PASS	4118	TCGA-B8-A54G	KIRC	50	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2012	NA	-18612	Alive	TUMOR FREE	53	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	53	0	53	0	53	0	53	
70	TCGA-B8-A54H	0	6	1	3	10	2	0	0	8	58	0	0	3	13	2	0	TCGA-B8-A54H-01	77	0.07121708857105734	33	TCGA-B8-A54H-01	1	2	28	0.0469777900262592	TCGA-B8-A54H-01	1	2	1	4	PASS	4119	TCGA-B8-A54H	KIRC	69	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2012	NA	-25243	Alive	TUMOR FREE	256	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	256	0	256	0	256	0	256	
50	TCGA-B8-A54I	0	9	0	3	5	1	0	0	1	47	2	0	3	18	0	0	TCGA-B8-A54I-01	87	0.5915116759947411	39	TCGA-B8-A54I-01	19	14	41	0.13512181449129193	TCGA-B8-A54I-01	2	1	3	6	PASS	4120	TCGA-B8-A54I	KIRC	48	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2012	NA	-17722	Alive	TUMOR FREE	150	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	150	0	150	0	150	0	150	
60	TCGA-B8-A54J	1	5	0	2	3	0	0	0	0	46	2	1	3	20	3	0	TCGA-B8-A54J-01	73	0.06556914770577528	29	TCGA-B8-A54J-01	1	2	14	0.030332034245824282	TCGA-B8-A54J-01	1	1	1	3	PASS	4121	TCGA-B8-A54J	KIRC	60	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2012	NA	-22071	Alive	TUMOR FREE	528	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	528	0	528	0	528	0	528	
60	TCGA-B8-A54K	1	3	0	2	1	0	0	0	2	13	2	0	0	10	1	0	TCGA-B8-A54K	0	0	0	TCGA-B8-A54K	0	0	0	0	TCGA-B8-A54K	0	0	0	0	PASS	4122	TCGA-B8-A54K	KIRC	61	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G1	2012	NA	-22627	Alive	TUMOR FREE	469	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	469	0	469	0	469	0	469	
50	TCGA-B8-A7U6	1	7	1	4	5	0	1	0	2	50	3	0	0	17	1	0	TCGA-B8-A7U6-01	91	0.03216873759271872	43	TCGA-B8-A7U6-01	1	1	12	0.02512785155058605	TCGA-B8-A7U6-01	2	2	1	5	PASS	4123	TCGA-B8-A7U6	KIRC	54	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2013	NA	-19803	Alive	TUMOR FREE	495	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	495	0	495	0	495	0	495	
60	TCGA-B8-A8YJ	0	2	0	1	0	0	0	0	2	33	2	0	0	9	0	0	TCGA-B8-A8YJ-01	55	1.794582315301095e-05	14	TCGA-B8-A8YJ-01	0	0	2	7.432625902743318e-05	TCGA-B8-A8YJ-01	0	0	0	0	PASS	4124	TCGA-B8-A8YJ	KIRC	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2013	NA	-21994	Alive	TUMOR FREE	431	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	431	0	431	0	431	0	431	
70	TCGA-BP-4158	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4158-01	67	0.1836762027911432	21	TCGA-BP-4158-01	6	3	2	0.07124915426530969	TCGA-BP-4158-01	0	0	0	0	PASS	4125	TCGA-BP-4158	KIRC	69	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2001	NA	-25210	Alive	TUMOR FREE	3377	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3377	0	3377	NA	NA	0	3377	
70	TCGA-BP-4159	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4159-01	88	0.11357691308113615	40	TCGA-BP-4159-01	3	3	3	0.024913473398173847	TCGA-BP-4159-01	3	3	1	7	PASS	4126	TCGA-BP-4159	KIRC	70	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2002	NA	-25677	Dead	WITH TUMOR	NA	2601	NA	NA	NA	NA	2352	NA	NA	NA	1	2601	1	2601	NA	NA	1	2352	
70	TCGA-BP-4160	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4160-01	107	0.10111853932730068	46	TCGA-BP-4160-01	3	3	5	0.07886616149595903	TCGA-BP-4160-01	2	1	1	4	PASS	4127	TCGA-BP-4160	KIRC	67	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2002	NA	-24720	Alive	TUMOR FREE	2881	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2881	0	2881	NA	NA	0	2881	
70	TCGA-BP-4161	0	7	0	4	6	1	0	0	4	45	3	0	0	16	3	0	TCGA-BP-4161-01	109	0.17713546761881796	64	TCGA-BP-4161-01	1	3	5	0.01781508110883953	TCGA-BP-4161-01	2	4	1	7	PASS	4128	TCGA-BP-4161	KIRC	74	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2002	NA	-27119	Alive	WITH TUMOR	2746	NA	NA	NA	NA	NA	2685	NA	NA	NA	0	2746	0	2746	NA	NA	1	2685	
70	TCGA-BP-4162	0	4	1	2	4	0	1	0	3	30	0	0	1	11	3	0	TCGA-BP-4162-01	78	0.4342789780874649	37	TCGA-BP-4162-01	10	6	2	0.021865859528644203	TCGA-BP-4162-01	2	2	1	5	PASS	4129	TCGA-BP-4162	KIRC	65	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2002	NA	-23966	Alive	TUMOR FREE	3074	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3074	0	3074	NA	NA	0	3074	
60	TCGA-BP-4163	0	5	0	0	2	0	0	0	2	36	2	0	0	12	1	0	TCGA-BP-4163-01	88	0.17744588394889574	43	TCGA-BP-4163-01	7	4	5	0.058601880067611765	TCGA-BP-4163-01	2	1	1	4	PASS	4130	TCGA-BP-4163	KIRC	60	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2002	NA	-21980	Alive	TUMOR FREE	2839	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2839	0	2839	NA	NA	0	2839	
50	TCGA-BP-4164	0	2	0	1	2	0	0	0	4	29	3	0	0	14	1	0	TCGA-BP-4164-01	78	0.9476691859681629	30	TCGA-BP-4164-01	15	11	7	0.09297369892079596	TCGA-BP-4164-01	2	0	2	4	PASS	4131	TCGA-BP-4164	KIRC	51	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2002	NA	-18898	Dead	TUMOR FREE	NA	992	NA	NA	NA	NA	NA	NA	NA	NA	1	992	0	992	NA	NA	0	992	
60	TCGA-BP-4165	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4165-01	77	0.021237942374853085	31	TCGA-BP-4165-01	1	1	3	0.02239023920614104	TCGA-BP-4165-01	0	2	1	3	PASS	4132	TCGA-BP-4165	KIRC	64	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G1	2002	NA	-23685	Alive	WITH TUMOR	3037	NA	NA	NA	NA	NA	1049	NA	NA	NA	0	3037	0	3037	NA	NA	1	1049	
70	TCGA-BP-4166	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4166-01	56	0.5933071185961295	15	TCGA-BP-4166-01	24	14	8	0.2358306476722358	TCGA-BP-4166-01	3	3	1	7	PASS	4133	TCGA-BP-4166	KIRC	69	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-25300	Alive	TUMOR FREE	13	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	13	0	13	NA	NA	0	13	
60	TCGA-BP-4167	1	4	0	5	2	0	0	0	0	49	6	0	1	15	1	0	TCGA-BP-4167-01	49	0.11935131423518935	10	TCGA-BP-4167-01	7	9	5	0.09040862852415353	TCGA-BP-4167-01	1	3	1	5	PASS	4134	TCGA-BP-4167	KIRC	59	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-21901	Alive	TUMOR FREE	2718	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2718	0	2718	NA	NA	0	2718	
80	TCGA-BP-4169	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4169-01	70	0.028132795130514	26	TCGA-BP-4169-01	1	1	6	0.0296607625997371	TCGA-BP-4169-01	1	0	3	4	PASS	4135	TCGA-BP-4169	KIRC	76	FEMALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-27778	Dead	WITH TUMOR	NA	701	NA	NA	NA	NA	78	NA	NA	NA	1	701	1	701	NA	NA	1	78	
70	TCGA-BP-4170	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4170-01	79	0.11897524175801225	34	TCGA-BP-4170-01	3	3	4	0.03210407289461178	TCGA-BP-4170-01	3	1	1	5	PASS	4136	TCGA-BP-4170	KIRC	72	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-26596	Dead	TUMOR FREE	NA	2343	NA	NA	NA	NA	NA	NA	NA	NA	1	2343	0	2343	NA	NA	0	2343	
50	TCGA-BP-4173	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4173-01	55	0.1036310440373516	15	TCGA-BP-4173	0	0	0	0	TCGA-BP-4173	0	0	0	0	PASS	4137	TCGA-BP-4173	KIRC	47	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-17449	Alive	TUMOR FREE	1893	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1893	0	1893	NA	NA	0	1893	
50	TCGA-BP-4174	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4174-01	84	0.9471023742250714	41	TCGA-BP-4174-01	17	13	5	0.07525787178258797	TCGA-BP-4174-01	4	1	2	7	PASS	4138	TCGA-BP-4174	KIRC	49	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-18054	Alive	TUMOR FREE	1879	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1879	0	1879	NA	NA	0	1879	
60	TCGA-BP-4176	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4176-01	92	0.4937317296705245	37	TCGA-BP-4176-01	19	25	4	0.0948696852749786	TCGA-BP-4176-01	3	3	2	8	PASS	4139	TCGA-BP-4176	KIRC	64	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-23609	Alive	TUMOR FREE	1955	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1955	0	1955	NA	NA	0	1955	
70	TCGA-BP-4177	0	2	0	2	0	0	0	0	0	9	0	0	0	8	0	0	TCGA-BP-4177-01	63	0.14273447594429975	24	TCGA-BP-4177-01	7	4	0	0.0	TCGA-BP-4177-01	0	0	0	0	PASS	4140	TCGA-BP-4177	KIRC	65	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-23955	Alive	TUMOR FREE	1670	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1670	0	1670	NA	NA	0	1670	
60	TCGA-BP-4325	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4325-01	73	0.1309217424628541	24	TCGA-BP-4325-01	5	4	4	0.08035277648697313	TCGA-BP-4325-01	2	0	2	4	PASS	4141	TCGA-BP-4325	KIRC	64	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2001	NA	-23588	Alive	TUMOR FREE	2964	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2964	0	2964	NA	NA	0	2964	
50	TCGA-BP-4326	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4326-01	87	0.03548631816138311	31	TCGA-BP-4326-01	1	4	4	0.08147297755819341	TCGA-BP-4326-01	4	2	4	10	PASS	4142	TCGA-BP-4326	KIRC	53	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2002	NA	-19376	Dead	WITH TUMOR	NA	1625	NA	NA	NA	NA	958	NA	NA	NA	1	1625	1	1625	NA	NA	1	958	
80	TCGA-BP-4327	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4327-01	73	0.2917780609486883	33	TCGA-BP-4327-01	4	5	6	0.14163725987506856	TCGA-BP-4327-01	1	1	2	4	PASS	4143	TCGA-BP-4327	KIRC	75	FEMALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2002	NA	-27556	Dead	TUMOR FREE	NA	109	NA	NA	NA	NA	NA	NA	NA	NA	1	109	0	109	NA	NA	0	109	
80	TCGA-BP-4329	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4329-01	99	0.13486615884375866	43	TCGA-BP-4329-01	2	3	6	0.09702120965822526	TCGA-BP-4329-01	3	2	3	8	PASS	4144	TCGA-BP-4329	KIRC	75	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2002	NA	-27699	Dead	WITH TUMOR	NA	845	NA	NA	NA	NA	134	NA	NA	NA	1	845	1	845	NA	NA	1	134	
60	TCGA-BP-4330	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4330-01	85	0.05131205482781442	39	TCGA-BP-4330-01	0	2	19	0.023501129147917646	TCGA-BP-4330-01	2	2	1	5	PASS	4145	TCGA-BP-4330	KIRC	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2002	NA	-22239	Alive	TUMOR FREE	1888	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1888	0	1888	NA	NA	0	1888	
50	TCGA-BP-4331	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4331	0	0	0	TCGA-BP-4331	0	0	0	0	TCGA-BP-4331-01	3	4	2	9	PASS	4146	TCGA-BP-4331	KIRC	52	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2002	NA	-19022	Dead	TUMOR FREE	NA	2454	NA	NA	NA	NA	NA	NA	NA	NA	1	2454	0	2454	NA	NA	0	2454	
40	TCGA-BP-4332	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4332-01	115	0.1351902974287178	62	TCGA-BP-4332-01	4	3	18	0.05047678225383012	TCGA-BP-4332-01	1	2	2	5	PASS	4147	TCGA-BP-4332	KIRC	36	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2002	NA	-13404	Alive	TUMOR FREE	1133	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1133	0	1133	NA	NA	0	1133	
60	TCGA-BP-4334	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4334-01	115	0.9477319039449544	58	TCGA-BP-4334-01	12	8	8	0.3798539237770156	TCGA-BP-4334-01	0	2	1	3	PASS	4148	TCGA-BP-4334	KIRC	56	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-20609	Dead	WITH TUMOR	NA	645	NA	NA	NA	NA	442	NA	NA	NA	1	645	1	645	NA	NA	1	442	
70	TCGA-BP-4335	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4335-01	59	0.10031326693871012	20	TCGA-BP-4335-01	2	4	3	0.02114273665386721	TCGA-BP-4335-01	2	2	1	5	PASS	4149	TCGA-BP-4335	KIRC	65	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-23860	Dead	WITH TUMOR	NA	475	NA	NA	NA	NA	160	NA	NA	NA	1	475	1	475	NA	NA	1	160	
80	TCGA-BP-4337	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4337-01	79	0.8091764907578995	31	TCGA-BP-4337-01	18	14	19	0.01988615583928508	TCGA-BP-4337-01	3	2	1	6	PASS	4150	TCGA-BP-4337	KIRC	76	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2003	NA	-27906	Dead	TUMOR FREE	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	1	2	0	2	NA	NA	0	2	
40	TCGA-BP-4338	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4338-01	98	0.8256718468375946	47	TCGA-BP-4338	0	0	0	0	TCGA-BP-4338	0	0	0	0	PASS	4151	TCGA-BP-4338	KIRC	43	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-15891	Alive	WITH TUMOR	2859	NA	NA	NA	NA	NA	1757	NA	NA	NA	0	2859	0	2859	NA	NA	1	1757	
70	TCGA-BP-4340	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4340-01	63	0.20589306331607365	17	TCGA-BP-4340-01	6	5	10	0.1291569264284868	TCGA-BP-4340-01	2	1	2	5	PASS	4152	TCGA-BP-4340	KIRC	70	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-25752	Dead	TUMOR FREE	NA	562	NA	NA	NA	NA	NA	NA	NA	NA	1	562	0	562	NA	NA	0	562	
70	TCGA-BP-4341	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4341-01	75	0.045407842454041336	26	TCGA-BP-4341-01	1	2	2	0.0479039793545537	TCGA-BP-4341-01	1	2	2	5	PASS	4153	TCGA-BP-4341	KIRC	67	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-24727	Dead	WITH TUMOR	NA	1589	NA	NA	NA	NA	NA	NA	NA	NA	1	1589	1	1589	NA	NA	1	1589	
80	TCGA-BP-4342	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4342	0	0	0	TCGA-BP-4342	0	0	0	0	TCGA-BP-4342-01	4	0	2	6	PASS	4154	TCGA-BP-4342	KIRC	79	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-29032	Dead	WITH TUMOR	NA	2256	NA	NA	NA	NA	240	NA	NA	NA	1	2256	1	2256	NA	NA	1	240	
60	TCGA-BP-4343	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4343-01	129	0.5137241723199343	67	TCGA-BP-4343-01	21	29	7	0.19836287888872234	TCGA-BP-4343-01	2	1	2	5	PASS	4155	TCGA-BP-4343	KIRC	64	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-23498	Dead	WITH TUMOR	NA	1912	NA	NA	NA	NA	330	NA	NA	NA	1	1912	1	1912	NA	NA	1	330	
80	TCGA-BP-4344	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4344	0	0	0	TCGA-BP-4344	0	0	0	0	TCGA-BP-4344-01	0	0	0	0	PASS	4156	TCGA-BP-4344	KIRC	75	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-27561	Alive	TUMOR FREE	1666	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1666	0	1666	NA	NA	0	1666	
60	TCGA-BP-4345	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4345	0	0	0	TCGA-BP-4345	0	0	0	0	TCGA-BP-4345	0	0	0	0	PASS	4157	TCGA-BP-4345	KIRC	62	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-22879	Alive	TUMOR FREE	1516	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1516	0	1516	NA	NA	0	1516	
60	TCGA-BP-4346	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4346-01	89	0.052496474079251336	44	TCGA-BP-4346-01	1	1	6	0.05535900099602635	TCGA-BP-4346-01	1	2	2	5	PASS	4158	TCGA-BP-4346	KIRC	57	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-21057	Dead	TUMOR FREE	NA	1493	NA	NA	NA	NA	NA	NA	NA	NA	1	1493	0	1493	NA	NA	0	1493	
70	TCGA-BP-4347	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4347-01	55	0.2917152858753531	17	TCGA-BP-4347-01	9	5	3	0.1546194910972212	TCGA-BP-4347-01	0	0	0	0	PASS	4159	TCGA-BP-4347	KIRC	74	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-27146	Alive	TUMOR FREE	1367	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1367	0	1367	NA	NA	0	1367	
70	TCGA-BP-4349	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4349-01	65	0.04973017823439939	25	TCGA-BP-4349-01	0	2	2	0.017990798443467716	TCGA-BP-4349-01	2	3	1	6	PASS	4160	TCGA-BP-4349	KIRC	68	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-24853	Alive	NA	372	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	372	0	372	NA	NA	0	372	
50	TCGA-BP-4351	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4351-01	102	0.6207494921909518	49	TCGA-BP-4351-01	27	13	9	0.1903049016556788	TCGA-BP-4351-01	1	0	0	1	PASS	4161	TCGA-BP-4351	KIRC	51	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-18662	Alive	WITH TUMOR	970	NA	NA	NA	NA	NA	873	NA	NA	NA	0	970	0	970	NA	NA	1	873	
70	TCGA-BP-4352	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4352-01	246	0.9342371629156608	162	TCGA-BP-4352-01	26	66	27	0.18520216636080428	TCGA-BP-4352-01	10	6	7	23	PASS	4162	TCGA-BP-4352	KIRC	74	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2007	NA	-27253	Dead	WITH TUMOR	NA	344	NA	NA	NA	NA	13	NA	NA	NA	1	344	1	344	NA	NA	1	13	
60	TCGA-BP-4353	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4353	0	0	0	TCGA-BP-4353	0	0	0	0	TCGA-BP-4353-01	0	0	0	0	PASS	4163	TCGA-BP-4353	KIRC	61	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-22415	Dead	TUMOR FREE	NA	375	NA	NA	NA	NA	NA	NA	NA	NA	1	375	0	375	NA	NA	0	375	
40	TCGA-BP-4354	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4354-01	72	0.1975526191681649	22	TCGA-BP-4354-01	6	9	9	0.18427534685483826	TCGA-BP-4354-01	3	3	3	9	PASS	4164	TCGA-BP-4354	KIRC	40	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2006	NA	-14973	Dead	WITH TUMOR	NA	1034	NA	NA	NA	NA	685	NA	NA	NA	1	1034	1	1034	NA	NA	1	685	
60	TCGA-BP-4355	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4355-01	107	0.049584310743799986	54	TCGA-BP-4355-01	0	2	19	0.020841290758209632	TCGA-BP-4355-01	2	2	1	5	PASS	4165	TCGA-BP-4355	KIRC	59	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2008	NA	-21642	Dead	NA	NA	953	NA	NA	NA	NA	NA	NA	NA	NA	1	953	NA	953	NA	NA	0	953	
60	TCGA-BP-4756	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4756-01	101	0.3289819457611373	46	TCGA-BP-4756-01	9	5	19	0.027906771006500214	TCGA-BP-4756-01	1	1	0	2	PASS	4166	TCGA-BP-4756	KIRC	62	FEMALE	ASIAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-23001	Alive	TUMOR FREE	374	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	374	0	374	NA	NA	0	374	
40	TCGA-BP-4758	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4758-01	66	0.08233779929371718	27	TCGA-BP-4758-01	2	3	2	0.07106996198474291	TCGA-BP-4758-01	3	2	0	5	PASS	4167	TCGA-BP-4758	KIRC	40	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-14824	Alive	TUMOR FREE	2208	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2208	0	2208	NA	NA	0	2208	
50	TCGA-BP-4759	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4759-01	81	0.1094061060231128	36	TCGA-BP-4759	0	0	0	0	TCGA-BP-4759	0	0	0	0	PASS	4168	TCGA-BP-4759	KIRC	50	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-18569	Alive	TUMOR FREE	2372	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2372	0	2372	NA	NA	0	2372	
70	TCGA-BP-4760	0	0	0	1	1	0	0	0	0	9	1	0	0	9	0	0	TCGA-BP-4760-01	65	6.193463608698702e-05	22	TCGA-BP-4760-01	0	0	2	3.871886204319773e-05	TCGA-BP-4760-01	0	0	0	0	PASS	4169	TCGA-BP-4760	KIRC	69	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-25268	Alive	WITH TUMOR	2361	NA	NA	NA	NA	NA	1457	NA	NA	NA	0	2361	0	2361	NA	NA	1	1457	
60	TCGA-BP-4761	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4761-01	230	0.5380216291862181	130	TCGA-BP-4761-01	12	14	47	0.31399453946575323	TCGA-BP-4761-01	10	7	10	27	PASS	4170	TCGA-BP-4761	KIRC	57	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-21019	Alive	TUMOR FREE	182	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	182	0	182	NA	NA	0	182	
40	TCGA-BP-4762	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4762-01	59	0.13322180777801876	17	TCGA-BP-4762-01	1	3	10	0.06033564767429021	TCGA-BP-4762-01	2	3	4	9	PASS	4171	TCGA-BP-4762	KIRC	42	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-15358	Dead	TUMOR FREE	NA	1343	NA	NA	NA	NA	NA	NA	NA	NA	1	1343	0	1343	NA	NA	0	1343	
80	TCGA-BP-4763	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4763-01	88	0.3062717291473965	41	TCGA-BP-4763-01	10	6	6	0.1531360142905426	TCGA-BP-4763-01	0	0	0	0	PASS	4172	TCGA-BP-4763	KIRC	79	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-29150	Dead	TUMOR FREE	NA	1270	NA	NA	NA	NA	NA	NA	NA	NA	1	1270	0	1270	NA	NA	0	1270	
40	TCGA-BP-4765	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4765-01	71	0.06460183035722182	24	TCGA-BP-4765-01	2	3	4	0.03767471661234887	TCGA-BP-4765-01	1	3	2	6	PASS	4173	TCGA-BP-4765	KIRC	43	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-15814	Alive	TUMOR FREE	2184	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2184	0	2184	NA	NA	0	2184	
40	TCGA-BP-4766	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4766-01	123	0.16182998231686746	62	TCGA-BP-4766-01	4	5	6	0.08116124372884087	TCGA-BP-4766-01	3	3	4	10	PASS	4174	TCGA-BP-4766	KIRC	43	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-15799	Alive	TUMOR FREE	1462	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1462	0	1462	NA	NA	0	1462	
70	TCGA-BP-4768	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4768-01	111	0.7309511956309274	58	TCGA-BP-4768-01	24	19	5	0.14084404788356872	TCGA-BP-4768-01	3	3	3	9	PASS	4175	TCGA-BP-4768	KIRC	72	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-26474	Alive	TUMOR FREE	400	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	400	0	400	NA	NA	0	400	
60	TCGA-BP-4769	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4769-01	45	2.8811198081973823e-05	10	TCGA-BP-4769	0	0	0	0	TCGA-BP-4769	0	0	0	0	PASS	4176	TCGA-BP-4769	KIRC	63	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-23190	Alive	TUMOR FREE	1876	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1876	0	1876	NA	NA	0	1876	
70	TCGA-BP-4770	0	4	0	2	0	0	0	0	2	49	1	0	0	15	2	0	TCGA-BP-4770-01	95	0.899947651497364	42	TCGA-BP-4770-01	14	36	54	0.8582338400872561	TCGA-BP-4770-01	10	3	1	14	PASS	4177	TCGA-BP-4770	KIRC	73	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2005	NA	-26824	Dead	WITH TUMOR	NA	329	NA	NA	NA	NA	169	NA	NA	NA	1	329	1	329	NA	NA	1	169	
60	TCGA-BP-4771	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4771-01	72	0.20541194328592846	30	TCGA-BP-4771	0	0	0	0	TCGA-BP-4771	0	0	0	0	PASS	4178	TCGA-BP-4771	KIRC	62	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2005	NA	-22771	Dead	WITH TUMOR	NA	162	NA	NA	NA	NA	23	NA	NA	NA	1	162	1	162	NA	NA	1	23	
60	TCGA-BP-4774	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4774-01	75	0.04294331165155522	26	TCGA-BP-4774-01	1	1	4	0.04437336699588843	TCGA-BP-4774-01	0	1	1	2	PASS	4179	TCGA-BP-4774	KIRC	57	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-20827	Alive	TUMOR FREE	1885	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1885	0	1885	NA	NA	0	1885	
60	TCGA-BP-4775	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4775-01	114	0.4958352485395485	60	TCGA-BP-4775-01	15	29	3	0.018741704783703586	TCGA-BP-4775-01	2	2	1	5	PASS	4180	TCGA-BP-4775	KIRC	55	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-20369	Alive	[Discrepancy]	1843	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1843	0	1843	NA	NA	0	1843	
50	TCGA-BP-4776	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4776-01	59	0.04812997190945107	21	TCGA-BP-4776-01	1	1	2	0.028109922201264743	TCGA-BP-4776-01	2	2	1	5	PASS	4181	TCGA-BP-4776	KIRC	52	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-19143	Alive	TUMOR FREE	411	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	411	0	411	NA	NA	0	411	
50	TCGA-BP-4777	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4777-01	78	0.1540228463522982	36	TCGA-BP-4777-01	3	4	3	0.13337589813856773	TCGA-BP-4777-01	2	2	1	5	PASS	4182	TCGA-BP-4777	KIRC	46	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-17133	Alive	TUMOR FREE	1731	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1731	0	1731	NA	NA	0	1731	
80	TCGA-BP-4781	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4781-01	111	0.4572839092037369	56	TCGA-BP-4781	0	0	0	0	TCGA-BP-4781	0	0	0	0	PASS	4183	TCGA-BP-4781	KIRC	78	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-28701	Alive	TUMOR FREE	2080	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2080	0	2080	NA	NA	0	2080	
60	TCGA-BP-4782	0	6	0	4	9	0	0	0	3	62	4	0	0	15	1	1	TCGA-BP-4782-01	67	0.1890812284687275	24	TCGA-BP-4782-01	5	4	4	0.04707219271735937	TCGA-BP-4782-01	3	3	2	8	PASS	4184	TCGA-BP-4782	KIRC	55	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-20102	Alive	[Discrepancy]	354	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	354	0	354	NA	NA	0	354	
70	TCGA-BP-4784	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4784-01	51	2.3583696747685932e-05	13	TCGA-BP-4784	0	0	0	0	TCGA-BP-4784	0	0	0	0	PASS	4185	TCGA-BP-4784	KIRC	67	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-24603	Alive	TUMOR FREE	1854	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1854	0	1854	NA	NA	0	1854	
60	TCGA-BP-4787	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4787-01	96	0.5032686850630979	41	TCGA-BP-4787-01	18	12	17	0.189883622214849	TCGA-BP-4787-01	7	3	5	15	PASS	4186	TCGA-BP-4787	KIRC	59	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2007	NA	-21697	Dead	WITH TUMOR	NA	480	NA	NA	NA	NA	259	NA	NA	NA	1	480	1	480	NA	NA	1	259	
50	TCGA-BP-4789	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4789-01	41	0.07946014723195867	7	TCGA-BP-4789-01	3	5	19	0.03205036890667971	TCGA-BP-4789-01	2	1	1	4	PASS	4187	TCGA-BP-4789	KIRC	48	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-17540	Alive	TUMOR FREE	1489	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1489	0	1489	NA	NA	0	1489	
80	TCGA-BP-4790	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4790-01	109	0.09534828964604172	54	TCGA-BP-4790-01	2	3	19	0.017668580342180287	TCGA-BP-4790-01	2	2	1	5	PASS	4188	TCGA-BP-4790	KIRC	76	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-28076	Dead	TUMOR FREE	NA	1111	NA	NA	NA	NA	NA	NA	NA	NA	1	1111	0	1111	NA	NA	0	1111	
70	TCGA-BP-4795	0	2	0	1	0	0	0	0	1	14	0	0	1	12	0	0	TCGA-BP-4795-01	73	0.01964663684643369	30	TCGA-BP-4795-01	1	1	12	0.020599039683785653	TCGA-BP-4795-01	2	0	1	3	PASS	4189	TCGA-BP-4795	KIRC	74	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-27162	Alive	TUMOR FREE	620	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	620	0	620	NA	NA	0	620	
30	TCGA-BP-4797	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4797-01	111	0.363773285108961	67	TCGA-BP-4797-01	16	15	3	0.027721792247309383	TCGA-BP-4797-01	3	3	1	7	PASS	4190	TCGA-BP-4797	KIRC	34	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-12508	Alive	TUMOR FREE	1107	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1107	0	1107	NA	NA	0	1107	
70	TCGA-BP-4798	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4798-01	103	0.28931255553723706	49	TCGA-BP-4798-01	13	11	9	0.11619529000462148	TCGA-BP-4798-01	2	2	4	8	PASS	4191	TCGA-BP-4798	KIRC	74	MALE	WHITE	[Discrepancy]	NA	Kidney Clear Cell Renal Carcinoma	G4	2007	NA	-27335	Dead	WITH TUMOR	NA	334	NA	NA	NA	NA	NA	NA	NA	NA	1	334	1	334	NA	NA	1	334	
70	TCGA-BP-4799	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4799-01	55	0.6327429035175435	15	TCGA-BP-4799-01	28	34	8	0.20018349293802964	TCGA-BP-4799-01	2	1	2	5	PASS	4192	TCGA-BP-4799	KIRC	70	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-25842	Dead	WITH TUMOR	NA	1133	NA	NA	NA	NA	352	NA	NA	NA	1	1133	1	1133	NA	NA	1	352	
60	TCGA-BP-4801	0	3	1	0	7	0	2	0	3	40	4	0	1	11	2	0	TCGA-BP-4801-01	74	0.09820406432268396	29	TCGA-BP-4801-01	2	2	3	0.07412121461066301	TCGA-BP-4801-01	2	1	2	5	PASS	4193	TCGA-BP-4801	KIRC	57	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-20825	Alive	TUMOR FREE	1124	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1124	0	1124	NA	NA	0	1124	
80	TCGA-BP-4803	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4803-01	57	0.3975101498511935	18	TCGA-BP-4803-01	4	4	2	0.08273586008243196	TCGA-BP-4803-01	0	0	0	0	PASS	4194	TCGA-BP-4803	KIRC	79	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2008	NA	-28934	Alive	TUMOR FREE	204	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	204	0	204	NA	NA	0	204	
60	TCGA-BP-4804	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4804-01	57	0.061892464039669665	17	TCGA-BP-4804	0	0	0	0	TCGA-BP-4804	0	0	0	0	PASS	4195	TCGA-BP-4804	KIRC	59	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2008	NA	-21727	Alive	WITH TUMOR	1459	NA	NA	NA	NA	NA	295	NA	NA	NA	0	1459	0	1459	NA	NA	1	295	
40	TCGA-BP-4807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4807-01	91	0.05038475108751432	42	TCGA-BP-4807-01	2	2	4	0.05311657875436727	TCGA-BP-4807-01	1	2	2	5	PASS	4196	TCGA-BP-4807	KIRC	42	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2008	NA	-15360	Alive	TUMOR FREE	211	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	211	0	211	NA	NA	0	211	
50	TCGA-BP-4959	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4959-01	71	0.21976801797234488	23	TCGA-BP-4959-01	5	4	4	0.14167709122932995	TCGA-BP-4959-01	2	1	2	5	PASS	4197	TCGA-BP-4959	KIRC	49	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-17968	Alive	TUMOR FREE	2660	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2660	0	2660	NA	NA	0	2660	
50	TCGA-BP-4960	0	3	0	1	4	2	2	0	1	49	2	0	2	15	1	0	TCGA-BP-4960-01	122	0.42456349464584375	65	TCGA-BP-4960-01	13	21	5	0.08686340247807271	TCGA-BP-4960-01	2	1	1	4	PASS	4198	TCGA-BP-4960	KIRC	46	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-17099	Alive	TUMOR FREE	2172	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2172	0	2172	NA	NA	0	2172	
50	TCGA-BP-4961	0	7	0	2	3	3	0	0	0	23	1	0	2	12	1	0	TCGA-BP-4961-01	56	0.10553227292732413	18	TCGA-BP-4961-01	1	1	19	0.04592615886486693	TCGA-BP-4961-01	0	1	1	2	PASS	4199	TCGA-BP-4961	KIRC	47	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-17284	Alive	TUMOR FREE	1935	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1935	0	1935	NA	NA	0	1935	
60	TCGA-BP-4962	0	3	0	3	3	2	0	0	3	34	1	0	1	3	0	1	TCGA-BP-4962-01	63	0.2833645530868136	19	TCGA-BP-4962-01	6	4	6	0.13407742025081815	TCGA-BP-4962-01	2	0	2	4	PASS	4200	TCGA-BP-4962	KIRC	58	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-21255	Alive	TUMOR FREE	1785	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1785	0	1785	NA	NA	0	1785	
60	TCGA-BP-4963	0	5	1	4	7	6	1	0	2	56	1	0	0	27	2	0	TCGA-BP-4963-01	75	0.2573291898217533	32	TCGA-BP-4963-01	8	7	5	0.11979047071992095	TCGA-BP-4963-01	4	2	3	9	PASS	4201	TCGA-BP-4963	KIRC	63	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-23373	Alive	TUMOR FREE	1834	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1834	0	1834	NA	NA	0	1834	
50	TCGA-BP-4964	0	7	0	0	6	1	1	0	5	66	5	0	2	22	2	0	TCGA-BP-4964-01	85	0.18505080815488847	26	TCGA-BP-4964-01	0	1	2	0.02288435837290201	TCGA-BP-4964-01	2	2	1	5	PASS	4202	TCGA-BP-4964	KIRC	54	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-20084	Alive	TUMOR FREE	1862	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1862	0	1862	NA	NA	0	1862	
50	TCGA-BP-4965	0	4	0	2	3	2	0	0	0	44	1	0	0	14	0	0	TCGA-BP-4965-01	64	0.11893684772920653	23	TCGA-BP-4965-01	2	4	9	0.09367570739993827	TCGA-BP-4965-01	3	3	3	9	PASS	4203	TCGA-BP-4965	KIRC	46	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-16992	Alive	TUMOR FREE	1871	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1871	0	1871	NA	NA	0	1871	
80	TCGA-BP-4967	0	2	0	5	6	5	0	0	3	42	2	0	2	20	0	0	TCGA-BP-4967-01	206	0.2488974857950269	150	TCGA-BP-4967-01	11	32	14	0.4220053994526802	TCGA-BP-4967-01	1	0	2	3	PASS	4204	TCGA-BP-4967	KIRC	76	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-27857	Alive	TUMOR FREE	205	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	205	0	205	NA	NA	0	205	
40	TCGA-BP-4968	0	2	0	0	1	2	0	0	0	33	3	0	0	13	0	0	TCGA-BP-4968-01	77	0.27065394898196143	32	TCGA-BP-4968-01	0	2	4	0.023016184523533743	TCGA-BP-4968-01	2	2	1	5	PASS	4205	TCGA-BP-4968	KIRC	40	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-14651	Alive	TUMOR FREE	1746	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1746	0	1746	NA	NA	0	1746	
60	TCGA-BP-4969	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BP-4969-01	128	0.94772938766858	77	TCGA-BP-4969-01	26	31	9	0.253543189977102	TCGA-BP-4969-01	2	2	1	5	PASS	4206	TCGA-BP-4969	KIRC	63	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-23216	Alive	TUMOR FREE	1794	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1794	0	1794	NA	NA	0	1794	
40	TCGA-BP-4970	0	0	0	0	4	0	0	0	0	23	1	0	0	6	1	0	TCGA-BP-4970-01	103	0.06767464445940727	52	TCGA-BP-4970-01	2	3	6	0.07142794881254301	TCGA-BP-4970-01	2	2	3	7	PASS	4207	TCGA-BP-4970	KIRC	44	MALE	ASIAN	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-16228	Alive	TUMOR FREE	433	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	433	0	433	NA	NA	0	433	
40	TCGA-BP-4971	0	2	0	1	3	1	0	0	0	29	2	0	0	17	1	0	TCGA-BP-4971-01	72	0.14633876219839054	25	TCGA-BP-4971-01	6	4	2	0.05997841481059382	TCGA-BP-4971-01	2	1	1	4	PASS	4208	TCGA-BP-4971	KIRC	40	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-14675	Alive	TUMOR FREE	1487	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1487	0	1487	NA	NA	0	1487	
40	TCGA-BP-4972	0	4	0	2	2	1	1	0	2	27	0	0	0	16	2	0	TCGA-BP-4972-01	55	0.08085437827250484	18	TCGA-BP-4972-01	2	3	19	0.023688509249792968	TCGA-BP-4972-01	2	2	1	5	PASS	4209	TCGA-BP-4972	KIRC	43	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-16038	Alive	TUMOR FREE	1502	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1502	0	1502	NA	NA	0	1502	
50	TCGA-BP-4973	0	3	0	0	3	2	1	0	0	22	0	0	0	4	2	0	TCGA-BP-4973-01	91	0.18017413435994745	40	TCGA-BP-4973-01	2	3	2	0.0226457418986593	TCGA-BP-4973-01	2	2	1	5	PASS	4210	TCGA-BP-4973	KIRC	47	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-17461	Alive	TUMOR FREE	1384	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1384	0	1384	NA	NA	0	1384	
60	TCGA-BP-4974	1	5	0	0	3	2	1	0	0	28	0	0	0	6	1	0	TCGA-BP-4974-01	89	0.10985293545659873	41	TCGA-BP-4974-01	2	3	6	0.08826335293984276	TCGA-BP-4974-01	2	2	2	6	PASS	4211	TCGA-BP-4974	KIRC	58	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2006	NA	-21310	Dead	WITH TUMOR	NA	211	NA	NA	NA	NA	35	NA	NA	NA	1	211	1	211	NA	NA	1	35	
40	TCGA-BP-4975	0	1	0	0	2	0	1	0	0	12	1	0	0	7	1	0	TCGA-BP-4975-01	115	0.08922755274177131	52	TCGA-BP-4975-01	2	3	3	0.06748299763889061	TCGA-BP-4975-01	1	3	2	6	PASS	4212	TCGA-BP-4975	KIRC	40	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-14710	Alive	TUMOR FREE	1433	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1433	0	1433	NA	NA	0	1433	
80	TCGA-BP-4976	0	5	0	2	12	4	1	0	2	65	2	0	0	25	1	0	TCGA-BP-4976	0	0	0	TCGA-BP-4976	0	0	0	0	TCGA-BP-4976-01	1	1	0	2	PASS	4213	TCGA-BP-4976	KIRC	77	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-28380	Alive	TUMOR FREE	1632	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1632	0	1632	NA	NA	0	1632	
60	TCGA-BP-4977	0	6	0	0	2	0	1	0	1	32	0	0	0	7	1	0	TCGA-BP-4977-01	73	0.2978712351931557	23	TCGA-BP-4977-01	12	21	2	0.0586357529332375	TCGA-BP-4977-01	3	3	1	7	PASS	4214	TCGA-BP-4977	KIRC	57	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-20950	Alive	TUMOR FREE	454	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	454	0	454	NA	NA	0	454	
80	TCGA-BP-4981	0	7	0	5	1	1	0	0	5	38	2	0	0	18	1	0	TCGA-BP-4981-01	51	0.1051838237919885	12	TCGA-BP-4981-01	2	7	6	0.08307085570231137	TCGA-BP-4981-01	3	4	3	10	PASS	4215	TCGA-BP-4981	KIRC	75	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-27676	Dead	TUMOR FREE	NA	1097	NA	NA	NA	NA	NA	NA	NA	NA	1	1097	0	1097	NA	NA	0	1097	
40	TCGA-BP-4982	0	2	0	1	1	0	0	0	2	32	3	0	0	11	0	0	TCGA-BP-4982-01	111	0.04610120486974776	53	TCGA-BP-4982-01	1	1	2	0.025140646628588743	TCGA-BP-4982-01	2	2	1	5	PASS	4216	TCGA-BP-4982	KIRC	42	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-15451	Alive	TUMOR FREE	1014	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1014	0	1014	NA	NA	0	1014	
70	TCGA-BP-4983	0	3	0	3	3	2	0	0	4	54	8	0	1	24	2	0	TCGA-BP-4983-01	102	0.35081302834989153	55	TCGA-BP-4983-01	5	4	14	0.10061544312802226	TCGA-BP-4983-01	3	2	3	8	PASS	4217	TCGA-BP-4983	KIRC	67	FEMALE	ASIAN	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2006	NA	-24558	Alive	TUMOR FREE	1413	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1413	0	1413	NA	NA	0	1413	
70	TCGA-BP-4985	0	3	1	3	5	1	2	0	4	63	2	1	1	24	2	0	TCGA-BP-4985-01	113	0.6745385477656031	62	TCGA-BP-4985-01	26	26	24	0.21652323547882849	TCGA-BP-4985-01	4	4	3	11	PASS	4218	TCGA-BP-4985	KIRC	72	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2006	NA	-26611	Dead	WITH TUMOR	NA	952	NA	NA	NA	NA	205	NA	NA	NA	1	952	1	952	NA	NA	1	205	
80	TCGA-BP-4986	0	4	0	3	3	2	0	0	1	28	2	0	0	9	1	0	TCGA-BP-4986	0	0	0	TCGA-BP-4986	0	0	0	0	TCGA-BP-4986-01	7	5	4	16	PASS	4219	TCGA-BP-4986	KIRC	75	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-27612	Alive	TUMOR FREE	785	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	785	0	785	NA	NA	0	785	
40	TCGA-BP-4987	0	4	0	0	2	0	2	0	2	16	2	0	1	9	1	0	TCGA-BP-4987-01	103	0.1170211508372483	49	TCGA-BP-4987-01	4	3	5	0.06610446181275814	TCGA-BP-4987-01	2	1	2	5	PASS	4220	TCGA-BP-4987	KIRC	41	FEMALE	ASIAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-15041	Alive	TUMOR FREE	1124	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1124	0	1124	NA	NA	0	1124	
70	TCGA-BP-4988	0	6	0	0	4	1	0	0	0	36	3	0	1	13	2	0	TCGA-BP-4988	0	0	0	TCGA-BP-4988	0	0	0	0	TCGA-BP-4988-01	1	1	1	3	PASS	4221	TCGA-BP-4988	KIRC	72	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-26576	Dead	TUMOR FREE	NA	828	NA	NA	NA	NA	NA	NA	NA	NA	1	828	0	828	NA	NA	0	828	
60	TCGA-BP-4989	0	4	1	0	2	0	0	0	2	47	5	0	0	22	2	0	TCGA-BP-4989-01	151	0.3804242517115408	98	TCGA-BP-4989-01	10	13	7	0.14622335605796355	TCGA-BP-4989-01	2	3	3	8	PASS	4222	TCGA-BP-4989	KIRC	58	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-21382	Alive	TUMOR FREE	118	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	118	0	118	NA	NA	0	118	
50	TCGA-BP-4991	0	3	0	1	3	1	2	0	2	32	3	0	0	16	0	0	TCGA-BP-4991-01	117	0.13775799273897568	58	TCGA-BP-4991-01	2	2	5	0.068373087571016	TCGA-BP-4991-01	2	3	3	8	PASS	4223	TCGA-BP-4991	KIRC	54	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-19739	Alive	TUMOR FREE	1413	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1413	0	1413	NA	NA	0	1413	
70	TCGA-BP-4992	0	3	0	1	1	1	0	0	3	33	1	0	1	9	0	0	TCGA-BP-4992-01	61	0.3755624687514394	19	TCGA-BP-4992-01	16	20	2	0.13274069041013842	TCGA-BP-4992-01	0	0	0	0	PASS	4224	TCGA-BP-4992	KIRC	66	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G4	2007	NA	-24438	Alive	TUMOR FREE	501	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	501	0	501	NA	NA	0	501	
60	TCGA-BP-4993	0	4	0	1	6	1	0	0	1	42	4	1	1	19	2	0	TCGA-BP-4993-01	65	0.06279689891988856	29	TCGA-BP-4993-01	1	1	3	0.06625079145299413	TCGA-BP-4993-01	1	2	2	5	PASS	4225	TCGA-BP-4993	KIRC	58	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-21407	Alive	TUMOR FREE	177	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	177	0	177	NA	NA	0	177	
50	TCGA-BP-4994	1	2	0	1	2	0	1	0	0	10	2	0	0	13	1	0	TCGA-BP-4994-01	63	0.9477303369177854	21	TCGA-BP-4994-01	18	10	11	0.4945199664306924	TCGA-BP-4994-01	0	0	0	0	PASS	4226	TCGA-BP-4994	KIRC	54	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-19946	Alive	TUMOR FREE	1308	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1308	0	1308	NA	NA	0	1308	
70	TCGA-BP-4995	0	0	0	0	1	0	0	0	0	31	6	0	0	19	0	0	TCGA-BP-4995	0	0	0	TCGA-BP-4995	0	0	0	0	TCGA-BP-4995-01	2	1	1	4	PASS	4227	TCGA-BP-4995	KIRC	68	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-24850	Alive	TUMOR FREE	1371	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1371	0	1371	NA	NA	0	1371	
50	TCGA-BP-4998	0	0	0	0	1	0	0	0	2	31	2	0	0	7	1	0	TCGA-BP-4998-01	59	0.13855303477980674	15	TCGA-BP-4998-01	3	2	2	0.028067150259236704	TCGA-BP-4998-01	1	2	2	5	PASS	4228	TCGA-BP-4998	KIRC	49	MALE	ASIAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-17997	Alive	TUMOR FREE	932	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	932	0	932	NA	NA	0	932	
60	TCGA-BP-4999	1	0	0	2	3	0	2	0	4	32	1	0	0	13	0	0	TCGA-BP-4999-01	80	0.12926764396225626	33	TCGA-BP-4999-01	4	2	19	0.07107294873555134	TCGA-BP-4999-01	0	0	0	0	PASS	4229	TCGA-BP-4999	KIRC	56	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-20518	Alive	TUMOR FREE	1266	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1266	0	1266	NA	NA	0	1266	
40	TCGA-BP-5000	0	5	0	1	3	1	0	0	2	25	2	0	0	14	0	1	TCGA-BP-5000-01	71	0.23716728709130586	25	TCGA-BP-5000-01	10	7	8	0.19888964202688086	TCGA-BP-5000-01	3	1	4	8	PASS	4230	TCGA-BP-5000	KIRC	40	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-14868	Alive	TUMOR FREE	563	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	563	0	563	NA	NA	0	563	
40	TCGA-BP-5001	0	0	1	1	1	0	1	0	0	26	1	0	0	11	2	0	TCGA-BP-5001-01	133	0.09212139441822974	73	TCGA-BP-5001-01	1	3	3	0.01878224079890021	TCGA-BP-5001-01	4	4	1	9	PASS	4231	TCGA-BP-5001	KIRC	43	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-15858	Alive	TUMOR FREE	1177	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1177	0	1177	NA	NA	0	1177	
50	TCGA-BP-5004	0	1	1	1	7	0	3	0	4	28	2	0	0	10	4	0	TCGA-BP-5004-01	98	0.26188609899920784	53	TCGA-BP-5004-01	7	6	14	0.19490758306894435	TCGA-BP-5004-01	4	2	4	10	PASS	4232	TCGA-BP-5004	KIRC	53	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-19383	Alive	TUMOR FREE	1126	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1126	0	1126	NA	NA	0	1126	
60	TCGA-BP-5006	0	2	2	2	3	0	2	0	2	28	1	0	0	6	4	0	TCGA-BP-5006	0	0	0	TCGA-BP-5006	0	0	0	0	TCGA-BP-5006-01	2	1	1	4	PASS	4233	TCGA-BP-5006	KIRC	61	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-22324	Alive	TUMOR FREE	840	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	840	0	840	NA	NA	0	840	
50	TCGA-BP-5007	0	2	0	1	3	0	0	0	1	21	1	0	0	9	1	0	TCGA-BP-5007-01	97	0.056975018715335266	50	TCGA-BP-5007-01	0	2	6	0.0228807284863204	TCGA-BP-5007-01	1	2	1	4	PASS	4234	TCGA-BP-5007	KIRC	45	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-16793	Alive	TUMOR FREE	1140	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1140	0	1140	NA	NA	0	1140	
50	TCGA-BP-5008	0	1	0	1	5	0	1	0	2	32	1	0	1	9	1	0	TCGA-BP-5008-01	91	0.09661858463311834	45	TCGA-BP-5008-01	2	1	7	0.08443736227330367	TCGA-BP-5008-01	2	2	1	5	PASS	4235	TCGA-BP-5008	KIRC	46	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-17008	Alive	TUMOR FREE	1071	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1071	0	1071	NA	NA	0	1071	
50	TCGA-BP-5009	0	4	0	3	3	1	2	0	1	38	1	0	0	9	2	0	TCGA-BP-5009	0	0	0	TCGA-BP-5009	0	0	0	0	TCGA-BP-5009-01	1	2	1	4	PASS	4236	TCGA-BP-5009	KIRC	52	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-19052	Dead	WITH TUMOR	NA	1092	NA	NA	NA	NA	324	NA	NA	NA	1	1092	1	1092	NA	NA	1	324	
60	TCGA-BP-5010	0	2	0	4	9	3	2	0	3	43	2	0	2	16	2	0	TCGA-BP-5010-01	76	0.0976694995263505	30	TCGA-BP-5010-01	3	4	4	0.1401411578692258	TCGA-BP-5010-01	2	2	1	5	PASS	4237	TCGA-BP-5010	KIRC	63	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2007	NA	-23130	Dead	WITH TUMOR	NA	878	NA	NA	NA	NA	582	NA	NA	NA	1	878	1	878	NA	NA	1	582	
80	TCGA-BP-5168	1	8	2	5	13	2	3	0	3	70	4	0	0	34	3	1	TCGA-BP-5168-01	54	0.09893381985620564	13	TCGA-BP-5168-01	3	2	2	0.03915204598201533	TCGA-BP-5168-01	0	1	1	2	PASS	4238	TCGA-BP-5168	KIRC	75	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2002	NA	-27692	Dead	TUMOR FREE	NA	1463	NA	NA	NA	NA	NA	NA	NA	NA	1	1463	0	1463	NA	NA	0	1463	
70	TCGA-BP-5169	0	6	0	1	3	0	1	0	2	39	3	0	2	12	3	0	TCGA-BP-5169-01	54	0.3673891287938782	17	TCGA-BP-5169-01	9	6	6	0.17679210181639438	TCGA-BP-5169-01	4	0	3	7	PASS	4239	TCGA-BP-5169	KIRC	70	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-25615	Alive	TUMOR FREE	193	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	193	0	193	NA	NA	0	193	
60	TCGA-BP-5170	1	4	0	1	5	0	0	0	1	28	2	0	1	11	1	1	TCGA-BP-5170-01	55	0.12294663776248517	22	TCGA-BP-5170-01	3	3	8	0.049643939543226934	TCGA-BP-5170-01	2	2	1	5	PASS	4240	TCGA-BP-5170	KIRC	55	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-20229	Alive	TUMOR FREE	2412	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2412	0	2412	NA	NA	0	2412	
80	TCGA-BP-5173	0	5	1	0	1	1	2	0	0	60	1	0	1	27	0	0	TCGA-BP-5173-01	69	0.7585936309836273	25	TCGA-BP-5173-01	30	19	4	0.19569904768750016	TCGA-BP-5173-01	3	0	1	4	PASS	4241	TCGA-BP-5173	KIRC	75	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-27436	Dead	TUMOR FREE	NA	62	NA	NA	NA	NA	NA	NA	NA	NA	1	62	0	62	NA	NA	0	62	
50	TCGA-BP-5174	0	3	0	0	5	2	0	0	2	26	0	0	0	7	1	0	TCGA-BP-5174-01	71	0.0936503992829522	31	TCGA-BP-5174-01	2	3	3	0.060568518566774525	TCGA-BP-5174-01	2	1	1	4	PASS	4242	TCGA-BP-5174	KIRC	45	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-16693	Alive	TUMOR FREE	2257	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2257	0	2257	NA	NA	0	2257	
60	TCGA-BP-5175	0	1	1	1	3	0	0	0	1	31	2	0	0	14	2	0	TCGA-BP-5175-01	90	0.6560160656379352	34	TCGA-BP-5175-01	23	47	5	0.1303060908444052	TCGA-BP-5175-01	2	4	2	8	PASS	4243	TCGA-BP-5175	KIRC	60	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-21949	Alive	TUMOR FREE	932	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	932	0	932	NA	NA	0	932	
80	TCGA-BP-5176	2	11	0	3	13	3	2	0	4	73	7	0	1	31	2	0	TCGA-BP-5176-01	78	0.09312820340614676	23	TCGA-BP-5176-01	1	2	2	0.03208040741460587	TCGA-BP-5176-01	2	1	1	4	PASS	4244	TCGA-BP-5176	KIRC	78	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-28727	Dead	TUMOR FREE	NA	1590	NA	NA	NA	NA	NA	NA	NA	NA	1	1590	0	1590	NA	NA	0	1590	
50	TCGA-BP-5177	1	4	0	2	7	0	0	1	1	26	2	0	3	10	0	1	TCGA-BP-5177-01	94	0.25112775400510223	47	TCGA-BP-5177-01	5	5	8	0.03224643841949116	TCGA-BP-5177-01	3	6	2	11	PASS	4245	TCGA-BP-5177	KIRC	46	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-17147	Alive	TUMOR FREE	293	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	293	0	293	NA	NA	0	293	
70	TCGA-BP-5178	0	3	0	1	3	0	2	0	4	44	3	0	0	15	1	0	TCGA-BP-5178-01	68	0.4559752724616	14	TCGA-BP-5178-01	21	20	7	0.08306634353378436	TCGA-BP-5178-01	2	1	1	4	PASS	4246	TCGA-BP-5178	KIRC	71	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-26070	Dead	WITH TUMOR	NA	1912	NA	NA	NA	NA	396	NA	NA	NA	1	1912	1	1912	NA	NA	1	396	
50	TCGA-BP-5180	0	2	0	4	4	0	0	0	2	26	3	0	0	6	1	1	TCGA-BP-5180-01	61	0.9477289196021724	19	TCGA-BP-5180-01	7	5	5	0.2370638101539134	TCGA-BP-5180-01	2	1	2	5	PASS	4247	TCGA-BP-5180	KIRC	53	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-19413	Alive	TUMOR FREE	2263	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2263	0	2263	NA	NA	0	2263	
60	TCGA-BP-5181	0	5	0	3	2	1	0	0	0	47	1	0	0	13	2	0	TCGA-BP-5181	0	0	0	TCGA-BP-5181	0	0	0	0	TCGA-BP-5181-01	3	2	2	7	PASS	4248	TCGA-BP-5181	KIRC	58	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-21514	Alive	TUMOR FREE	1495	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1495	0	1495	NA	NA	0	1495	
60	TCGA-BP-5182	1	8	0	4	5	2	1	0	1	43	7	0	0	16	1	1	TCGA-BP-5182-01	65	0.08739682342995371	23	TCGA-BP-5182-01	4	6	4	0.07716553575109063	TCGA-BP-5182-01	5	1	4	10	PASS	4249	TCGA-BP-5182	KIRC	56	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-20597	Alive	TUMOR FREE	1165	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1165	0	1165	NA	NA	0	1165	
60	TCGA-BP-5183	0	4	0	0	9	2	0	0	1	25	6	0	0	14	0	0	TCGA-BP-5183-01	55	0.3151020583598325	21	TCGA-BP-5183-01	6	5	5	0.1823058013716317	TCGA-BP-5183-01	2	1	1	4	PASS	4250	TCGA-BP-5183	KIRC	57	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-20881	Alive	TUMOR FREE	1291	NA	NA	NA	NA	NA	485	NA	NA	NA	0	1291	0	1291	NA	NA	1	485	
50	TCGA-BP-5184	0	4	0	2	2	1	1	0	2	18	0	0	0	11	0	0	TCGA-BP-5184-01	49	0.035715570478920336	7	TCGA-BP-5184-01	2	2	3	0.03763023483566028	TCGA-BP-5184-01	2	0	2	4	PASS	4251	TCGA-BP-5184	KIRC	54	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-19746	Alive	TUMOR FREE	1133	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1133	0	1133	NA	NA	0	1133	
60	TCGA-BP-5185	2	3	0	4	9	1	0	1	4	59	3	0	0	16	2	0	TCGA-BP-5185-01	100	0.6216715387349939	48	TCGA-BP-5185-01	23	13	19	0.07099368764934337	TCGA-BP-5185-01	1	0	0	1	PASS	4252	TCGA-BP-5185	KIRC	56	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-20470	Alive	WITH TUMOR	1132	NA	NA	NA	NA	NA	736	NA	NA	NA	0	1132	0	1132	NA	NA	1	736	
50	TCGA-BP-5186	0	1	0	3	1	2	0	0	1	25	2	1	2	7	1	0	TCGA-BP-5186-01	54	0.020511868907760227	11	TCGA-BP-5186-01	0	1	19	0.02147236990839787	TCGA-BP-5186-01	1	1	1	3	PASS	4253	TCGA-BP-5186	KIRC	50	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-18348	Alive	TUMOR FREE	693	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	693	0	693	NA	NA	0	693	
50	TCGA-BP-5187	0	6	0	2	1	2	0	0	3	50	3	0	0	15	3	0	TCGA-BP-5187-01	51	0.12931735605876285	15	TCGA-BP-5187-01	4	2	4	0.07131725041415736	TCGA-BP-5187-01	0	0	0	0	PASS	4254	TCGA-BP-5187	KIRC	54	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-19999	Alive	TUMOR FREE	406	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	406	0	406	NA	NA	0	406	
60	TCGA-BP-5189	0	4	0	0	9	1	0	0	2	35	1	0	0	11	1	0	TCGA-BP-5189-01	59	0.1389293748943782	22	TCGA-BP-5189-01	4	5	6	0.1529964932409901	TCGA-BP-5189-01	1	1	0	2	PASS	4255	TCGA-BP-5189	KIRC	60	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G4	2007	NA	-22156	Dead	WITH TUMOR	NA	822	NA	NA	NA	NA	634	NA	NA	NA	1	822	1	822	NA	NA	1	634	
60	TCGA-BP-5190	1	2	0	3	2	0	0	0	0	34	2	0	0	8	2	0	TCGA-BP-5190-01	60	0.07606820894267574	24	TCGA-BP-5190-01	2	2	6	0.06098344493252551	TCGA-BP-5190-01	2	1	1	4	PASS	4256	TCGA-BP-5190	KIRC	61	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-22285	Alive	TUMOR FREE	1011	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1011	0	1011	NA	NA	0	1011	
80	TCGA-BP-5191	0	5	0	2	3	2	2	0	2	39	3	0	2	13	2	0	TCGA-BP-5191-01	61	0.39908958677777534	22	TCGA-BP-5191-01	17	24	4	0.09889085848531062	TCGA-BP-5191-01	1	1	0	2	PASS	4257	TCGA-BP-5191	KIRC	79	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-29207	Alive	TUMOR FREE	967	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	967	0	967	NA	NA	0	967	
60	TCGA-BP-5192	2	3	0	1	6	0	3	0	3	31	1	1	1	15	2	0	TCGA-BP-5192-01	139	0.07238570603473524	75	TCGA-BP-5192-01	1	2	8	0.032812275612843604	TCGA-BP-5192-01	1	4	2	7	PASS	4258	TCGA-BP-5192	KIRC	59	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-21891	Alive	TUMOR FREE	714	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	714	0	714	NA	NA	0	714	
40	TCGA-BP-5194	0	1	0	0	2	0	0	0	2	20	1	0	0	10	2	0	TCGA-BP-5194-01	47	0.042727151043201926	11	TCGA-BP-5194-01	1	2	4	0.02775043919186679	TCGA-BP-5194-01	2	2	1	5	PASS	4259	TCGA-BP-5194	KIRC	39	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2008	NA	-14551	Alive	TUMOR FREE	408	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	408	0	408	NA	NA	0	408	
80	TCGA-BP-5195	0	5	1	2	6	1	0	0	2	52	4	0	1	13	1	0	TCGA-BP-5195-01	67	0.0606349169105039	22	TCGA-BP-5195-01	1	2	3	0.06388010296648479	TCGA-BP-5195-01	1	2	2	5	PASS	4260	TCGA-BP-5195	KIRC	75	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2008	NA	-27547	Alive	TUMOR FREE	749	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	749	0	749	NA	NA	0	749	
50	TCGA-BP-5196	0	5	0	0	5	4	2	0	1	28	3	0	1	16	3	0	TCGA-BP-5196-01	81	0.8040879064297966	39	TCGA-BP-5196-01	14	12	5	0.0679224920534838	TCGA-BP-5196-01	3	4	2	9	PASS	4261	TCGA-BP-5196	KIRC	53	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2008	NA	-19719	Alive	TUMOR FREE	1018	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1018	0	1018	NA	NA	0	1018	
70	TCGA-BP-5198	0	6	0	1	8	3	1	0	4	44	7	2	0	17	1	0	TCGA-BP-5198-01	118	0.4851249341413896	62	TCGA-BP-5198-01	20	22	4	0.15419416026046234	TCGA-BP-5198-01	2	2	1	5	PASS	4262	TCGA-BP-5198	KIRC	72	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2008	NA	-26360	Alive	TUMOR FREE	603	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	603	0	603	NA	NA	0	603	
60	TCGA-BP-5199	2	1	0	0	8	2	0	0	3	56	2	0	1	17	4	0	TCGA-BP-5199	0	0	0	TCGA-BP-5199	0	0	0	0	TCGA-BP-5199-01	3	3	1	7	PASS	4263	TCGA-BP-5199	KIRC	58	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G4	2006	NA	-21256	Alive	TUMOR FREE	1355	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1355	0	1355	NA	NA	0	1355	
40	TCGA-BP-5200	0	1	0	3	3	0	0	0	2	34	0	0	0	8	1	0	TCGA-BP-5200-01	51	0.6050317827599929	5	TCGA-BP-5200-01	27	15	3	0.1519769199244453	TCGA-BP-5200-01	0	0	0	0	PASS	4264	TCGA-BP-5200	KIRC	44	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G4	2008	NA	-16197	Alive	TUMOR FREE	1063	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1063	0	1063	NA	NA	0	1063	
60	TCGA-BP-5201	0	0	0	4	1	2	0	0	2	37	2	0	0	6	0	0	TCGA-BP-5201-01	115	0.641942293729857	62	TCGA-BP-5201-01	8	7	11	0.2546483294004475	TCGA-BP-5201-01	0	4	3	7	PASS	4265	TCGA-BP-5201	KIRC	63	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2008	NA	-23125	Alive	WITH TUMOR	951	NA	NA	NA	NA	NA	-19	NA	NA	NA	0	951	0	951	NA	NA	1	NA	
80	TCGA-BP-5202	0	1	0	1	3	0	1	0	1	34	1	0	2	6	2	0	TCGA-BP-5202-01	103	0.05705483289874205	52	TCGA-BP-5202-01	0	2	8	0.03179752936548002	TCGA-BP-5202-01	1	4	2	7	PASS	4266	TCGA-BP-5202	KIRC	75	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2008	NA	-27556	Alive	TUMOR FREE	29	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	29	0	29	NA	NA	0	29	
60	TCGA-CJ-4634	0	5	0	1	6	4	1	0	4	55	5	0	0	28	0	0	TCGA-CJ-4634-01	93	0.06367070799758122	51	TCGA-CJ-4634-01	2	2	2	0.06715711501445121	TCGA-CJ-4634-01	2	0	2	4	PASS	4267	TCGA-CJ-4634	KIRC	60	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-22155	Alive	TUMOR FREE	3498	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3498	0	3498	0	3498	0	3498	
50	TCGA-CJ-4635	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4635-01	100	0.545976758716122	52	TCGA-CJ-4635-01	23	21	2	0.07094418698594658	TCGA-CJ-4635-01	0	0	1	1	PASS	4268	TCGA-CJ-4635	KIRC	48	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-17620	Alive	TUMOR FREE	1416	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1416	0	1416	NA	NA	0	1416	
50	TCGA-CJ-4636	1	6	0	0	4	0	0	0	4	44	6	0	0	9	5	0	TCGA-CJ-4636-01	87	0.3062971231970964	40	TCGA-CJ-4636-01	12	9	7	0.1176004075376673	TCGA-CJ-4636-01	3	1	4	8	PASS	4269	TCGA-CJ-4636	KIRC	51	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-18878	Alive	TUMOR FREE	1924	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1924	0	1924	NA	NA	0	1924	
50	TCGA-CJ-4637	0	5	0	5	2	1	0	0	4	33	3	0	0	12	1	0	TCGA-CJ-4637-01	91	0.12186150034484725	40	TCGA-CJ-4637-01	3	3	5	0.0705599741215408	TCGA-CJ-4637-01	3	3	1	7	PASS	4270	TCGA-CJ-4637	KIRC	52	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-19101	Dead	WITH TUMOR	NA	2227	NA	NA	NA	NA	1821	NA	NA	NA	1	2227	1	2227	NA	NA	1	1821	
50	TCGA-CJ-4638	1	7	0	2	4	2	1	0	2	53	3	0	0	21	2	0	TCGA-CJ-4638-01	73	0.23971394773049645	34	TCGA-CJ-4638-01	4	4	6	0.10406113897435207	TCGA-CJ-4638-01	2	3	1	6	PASS	4271	TCGA-CJ-4638	KIRC	46	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-17110	Dead	WITH TUMOR	NA	431	NA	NA	NA	NA	70	NA	NA	NA	1	431	1	431	NA	NA	1	70	
50	TCGA-CJ-4639	0	5	0	1	4	4	1	0	2	43	5	0	1	9	2	1	TCGA-CJ-4639-01	63	0.09453833377199794	22	TCGA-CJ-4639-01	2	2	5	0.03300635235409484	TCGA-CJ-4639-01	1	2	2	5	PASS	4272	TCGA-CJ-4639	KIRC	49	FEMALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-18066	Alive	TUMOR FREE	3229	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3229	0	3229	0	3229	0	3229	
50	TCGA-CJ-4640	1	3	0	0	3	1	0	0	2	44	1	0	1	20	2	0	TCGA-CJ-4640-01	74	0.2608963954643763	30	TCGA-CJ-4640-01	8	6	12	0.20206021168606994	TCGA-CJ-4640-01	3	3	4	10	PASS	4273	TCGA-CJ-4640	KIRC	49	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-18178	Alive	TUMOR FREE	3480	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3480	0	3480	0	3480	0	3480	
60	TCGA-CJ-4641	0	2	0	3	4	0	0	0	2	39	3	0	1	16	1	0	TCGA-CJ-4641-01	78	0.08236214250543059	29	TCGA-CJ-4641	0	0	0	0	TCGA-CJ-4641	0	0	0	0	PASS	4274	TCGA-CJ-4641	KIRC	55	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2005	NA	-20410	Dead	WITH TUMOR	NA	1661	NA	NA	NA	NA	-359	NA	NA	NA	1	1661	1	1661	NA	NA	1	NA	
50	TCGA-CJ-4642	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4642	0	0	0	TCGA-CJ-4642	0	0	0	0	TCGA-CJ-4642-01	1	1	4	6	PASS	4275	TCGA-CJ-4642	KIRC	47	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-17367	Alive	TUMOR FREE	3205	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3205	0	3205	0	3205	0	3205	
70	TCGA-CJ-4643	0	8	0	6	5	3	0	1	4	60	6	0	2	25	3	0	TCGA-CJ-4643-01	74	0.08403072411364114	36	TCGA-CJ-4643-01	2	2	3	0.048253166163962906	TCGA-CJ-4643-01	3	0	2	5	PASS	4276	TCGA-CJ-4643	KIRC	67	FEMALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-24477	Alive	TUMOR FREE	1793	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1793	0	1793	NA	NA	0	1793	
50	TCGA-CJ-4644	1	5	2	4	4	0	0	0	2	43	4	1	1	16	3	0	TCGA-CJ-4644-01	74	0.44127433142488987	28	TCGA-CJ-4644-01	3	3	19	0.04309988899059165	TCGA-CJ-4644-01	0	1	1	2	PASS	4277	TCGA-CJ-4644	KIRC	48	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-17882	Dead	WITH TUMOR	NA	336	NA	NA	NA	NA	93	NA	NA	NA	1	336	1	336	NA	NA	1	93	
40	TCGA-CJ-4868	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4868-01	107	0.08007080573168826	47	TCGA-CJ-4868-01	2	3	9	0.10230231305712273	TCGA-CJ-4868-01	3	2	4	9	PASS	4278	TCGA-CJ-4868	KIRC	42	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-15601	Dead	WITH TUMOR	646	646	NA	NA	NA	NA	37	NA	NA	NA	1	646	1	646	NA	NA	1	37	
50	TCGA-CJ-4869	1	5	0	0	4	2	2	0	5	55	3	0	2	10	2	0	TCGA-CJ-4869-01	84	0.15043461466716826	42	TCGA-CJ-4869-01	2	3	6	0.09352336981832728	TCGA-CJ-4869-01	3	2	3	8	PASS	4279	TCGA-CJ-4869	KIRC	49	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-17923	Alive	WITH TUMOR	2554	NA	NA	NA	NA	NA	1754	NA	NA	NA	0	2554	0	2554	NA	NA	1	1754	
60	TCGA-CJ-4870	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4870-01	109	0.099344895099858	63	TCGA-CJ-4870	0	0	0	0	TCGA-CJ-4870	0	0	0	0	PASS	4280	TCGA-CJ-4870	KIRC	58	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-21340	Alive	TUMOR FREE	1498	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1498	0	1498	NA	NA	0	1498	
60	TCGA-CJ-4871	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4871-01	69	0.4959526224445932	29	TCGA-CJ-4871-01	1	2	3	0.024535910292391803	TCGA-CJ-4871-01	2	2	1	5	PASS	4281	TCGA-CJ-4871	KIRC	63	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-23195	Alive	TUMOR FREE	2423	NA	NA	NA	NA	NA	169	NA	NA	NA	0	2423	0	2423	NA	NA	1	169	
50	TCGA-CJ-4872	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4872-01	69	0.1951096058195155	23	TCGA-CJ-4872	0	0	0	0	TCGA-CJ-4872	0	0	0	0	PASS	4282	TCGA-CJ-4872	KIRC	51	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-18862	Alive	TUMOR FREE	1435	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1435	0	1435	NA	NA	0	1435	
90	TCGA-CJ-4873	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4873-01	72	0.4415231244608379	29	TCGA-CJ-4873-01	20	19	6	0.1291264482627601	TCGA-CJ-4873-01	4	5	2	11	PASS	4283	TCGA-CJ-4873	KIRC	85	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-31096	Alive	TUMOR FREE	2259	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2259	0	2259	NA	NA	0	2259	
70	TCGA-CJ-4874	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4874-01	64	0.054741764627137236	20	TCGA-CJ-4874-01	1	2	19	0.02614577396378928	TCGA-CJ-4874-01	2	2	1	5	PASS	4284	TCGA-CJ-4874	KIRC	73	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-26761	Alive	TUMOR FREE	2283	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2283	0	2283	NA	NA	0	2283	
70	TCGA-CJ-4875	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4875-01	81	0.23680438427996345	32	TCGA-CJ-4875-01	10	8	5	0.1020847517938412	TCGA-CJ-4875-01	1	2	0	3	PASS	4285	TCGA-CJ-4875	KIRC	67	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-24510	Dead	WITH TUMOR	NA	3554	NA	NA	NA	NA	531	Complete Remission/Response	NA	NA	1	3554	1	3554	NA	NA	1	531	
60	TCGA-CJ-4876	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4876-01	118	0.32549791291221997	62	TCGA-CJ-4876-01	9	8	12	0.2330557464749508	TCGA-CJ-4876-01	6	3	3	12	PASS	4286	TCGA-CJ-4876	KIRC	57	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-20993	Alive	TUMOR FREE	1955	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1955	0	1955	NA	NA	0	1955	
70	TCGA-CJ-4878	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4878-01	79	0.10827185448965312	27	TCGA-CJ-4878-01	3	4	6	0.09893247565001786	TCGA-CJ-4878-01	6	3	5	14	PASS	4287	TCGA-CJ-4878	KIRC	71	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-26224	Alive	TUMOR FREE	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2186	0	2186	NA	NA	0	2186	
40	TCGA-CJ-4881	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4881-01	86	0.4149235242823837	40	TCGA-CJ-4881-01	13	12	16	0.19081146894196288	TCGA-CJ-4881-01	9	6	5	20	PASS	4288	TCGA-CJ-4881	KIRC	41	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-15197	Alive	WITH TUMOR	2014	NA	NA	NA	NA	NA	1881	NA	NA	NA	0	2014	0	2014	NA	NA	1	1881	
60	TCGA-CJ-4882	0	2	0	3	8	1	0	0	4	52	8	0	2	20	1	0	TCGA-CJ-4882-01	67	0.07970513431482118	28	TCGA-CJ-4882-01	3	2	6	0.08409329216028955	TCGA-CJ-4882-01	2	0	2	4	PASS	4289	TCGA-CJ-4882	KIRC	57	MALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-21074	Alive	TUMOR FREE	1883	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1883	0	1883	NA	NA	0	1883	
70	TCGA-CJ-4884	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4884-01	70	0.14373425345887586	28	TCGA-CJ-4884-01	4	4	4	0.06680019528748124	TCGA-CJ-4884-01	4	3	2	9	PASS	4290	TCGA-CJ-4884	KIRC	72	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-26475	Alive	TUMOR FREE	1759	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1759	0	1759	NA	NA	0	1759	
60	TCGA-CJ-4885	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4885-01	68	0.3073136269967365	30	TCGA-CJ-4885-01	11	7	5	0.058821806006315314	TCGA-CJ-4885-01	1	2	2	5	PASS	4291	TCGA-CJ-4885	KIRC	64	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-23437	Alive	TUMOR FREE	3451	NA	NA	NA	NA	NA	2041	Complete Remission/Response	NA	NA	0	3451	0	3451	NA	NA	1	2041	
40	TCGA-CJ-4886	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4886-01	65	0.058992492675745065	26	TCGA-CJ-4886-01	1	2	19	0.02924794200825659	TCGA-CJ-4886-01	2	3	1	6	PASS	4292	TCGA-CJ-4886	KIRC	42	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-15698	Alive	TUMOR FREE	1952	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1952	0	1952	NA	NA	0	1952	
50	TCGA-CJ-4887	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4887-01	91	0.1826603799656288	43	TCGA-CJ-4887-01	6	4	5	0.07025328212438425	TCGA-CJ-4887-01	2	0	3	5	PASS	4293	TCGA-CJ-4887	KIRC	48	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-17611	Dead	WITH TUMOR	NA	932	NA	NA	NA	NA	322	NA	NA	NA	1	932	1	932	NA	NA	1	322	
60	TCGA-CJ-4888	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4888-01	43	0.07774723875904221	6	TCGA-CJ-4888	0	0	0	0	TCGA-CJ-4888	0	0	0	0	PASS	4294	TCGA-CJ-4888	KIRC	59	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2005	NA	-21701	Dead	WITH TUMOR	NA	1567	NA	NA	NA	NA	608	NA	NA	NA	1	1567	1	1567	NA	NA	1	608	
60	TCGA-CJ-4889	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4889-01	73	0.1347130889582938	36	TCGA-CJ-4889	0	0	0	0	TCGA-CJ-4889	0	0	0	0	PASS	4295	TCGA-CJ-4889	KIRC	63	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G4	2005	NA	-23051	Alive	TUMOR FREE	1946	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1946	0	1946	NA	NA	0	1946	
70	TCGA-CJ-4890	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4890-01	69	0.008032534033488034	22	TCGA-CJ-4890	0	0	0	0	TCGA-CJ-4890	0	0	0	0	PASS	4296	TCGA-CJ-4890	KIRC	72	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2005	NA	-26604	Alive	TUMOR FREE	3519	NA	NA	NA	NA	NA	70	Progressive Disease	NA	NA	0	3519	0	3519	NA	NA	1	70	
60	TCGA-CJ-4891	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4891-01	62	0.08409427224137231	19	TCGA-CJ-4891-01	3	2	2	0.08870658001923998	TCGA-CJ-4891-01	0	1	1	2	PASS	4297	TCGA-CJ-4891	KIRC	57	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2005	NA	-21059	Dead	TUMOR FREE	NA	819	NA	NA	NA	NA	NA	NA	NA	NA	1	819	0	819	NA	NA	0	819	
70	TCGA-CJ-4892	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4892-01	65	0.11746300387950885	18	TCGA-CJ-4892-01	3	2	8	0.05870829450118995	TCGA-CJ-4892-01	1	2	2	5	PASS	4298	TCGA-CJ-4892	KIRC	65	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-23764	Alive	TUMOR FREE	1521	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1521	0	1521	NA	NA	0	1521	
80	TCGA-CJ-4893	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4893-01	67	0.243862724660322	22	TCGA-CJ-4893-01	7	5	4	0.14960894394420993	TCGA-CJ-4893-01	3	1	2	6	PASS	4299	TCGA-CJ-4893	KIRC	76	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-27885	Alive	TUMOR FREE	750	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	750	0	750	NA	NA	0	750	
60	TCGA-CJ-4894	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4894-01	65	0.18377410699267427	25	TCGA-CJ-4894-01	4	5	10	0.16599840847183522	TCGA-CJ-4894-01	1	2	4	7	PASS	4300	TCGA-CJ-4894	KIRC	58	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-21524	Dead	WITH TUMOR	841	841	NA	NA	NA	NA	158	NA	NA	NA	1	841	1	841	NA	NA	1	158	
60	TCGA-CJ-4895	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4895-01	63	0.1189534330112628	19	TCGA-CJ-4895-01	3	3	6	0.1168276062168819	TCGA-CJ-4895-01	1	1	2	4	PASS	4301	TCGA-CJ-4895	KIRC	62	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2005	NA	-22892	Dead	WITH TUMOR	NA	1200	NA	NA	NA	NA	61	NA	NA	NA	1	1200	1	1200	NA	NA	1	61	
80	TCGA-CJ-4897	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CJ-4897-01	59	0.64382074958726	16	TCGA-CJ-4897-01	34	51	3	0.02227981987314373	TCGA-CJ-4897-01	2	2	1	5	PASS	4302	TCGA-CJ-4897	KIRC	79	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-29124	Alive	WITH TUMOR	3341	NA	NA	NA	NA	NA	1423	Complete Remission/Response	NA	NA	0	3341	0	3341	1	1423	1	1423	
40	TCGA-CJ-4899	0	2	0	1	3	1	0	0	1	28	2	0	1	10	2	0	TCGA-CJ-4899-01	99	0.1446778856392515	49	TCGA-CJ-4899-01	3	2	4	0.03219951268363151	TCGA-CJ-4899-01	1	0	1	2	PASS	4303	TCGA-CJ-4899	KIRC	42	MALE	ASIAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-15637	Alive	TUMOR FREE	1528	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1528	0	1528	NA	NA	0	1528	
70	TCGA-CJ-4900	0	2	0	0	0	0	0	0	1	41	3	0	1	8	0	0	TCGA-CJ-4900-01	87	0.13234840127830302	41	TCGA-CJ-4900-01	2	2	5	0.08140219317245458	TCGA-CJ-4900-01	5	5	4	14	PASS	4304	TCGA-CJ-4900	KIRC	69	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2006	NA	-25508	Dead	WITH TUMOR	NA	1714	NA	NA	NA	NA	NA	NA	NA	NA	1	1714	1	1714	NA	NA	1	1714	
50	TCGA-CJ-4901	1	4	0	3	5	0	1	0	0	45	1	0	0	7	2	0	TCGA-CJ-4901-01	57	0.6691162843825901	20	TCGA-CJ-4901-01	33	27	8	0.2816654270702954	TCGA-CJ-4901-01	6	2	1	9	PASS	4305	TCGA-CJ-4901	KIRC	47	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-17396	Alive	TUMOR FREE	1450	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1450	0	1450	NA	NA	0	1450	
60	TCGA-CJ-4902	0	4	0	2	5	0	1	0	4	52	2	0	2	15	1	0	TCGA-CJ-4902-01	82	0.10202198858514944	36	TCGA-CJ-4902-01	1	2	12	0.057751101271846	TCGA-CJ-4902-01	3	2	2	7	PASS	4306	TCGA-CJ-4902	KIRC	61	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-22424	Alive	TUMOR FREE	1520	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1520	0	1520	NA	NA	0	1520	
50	TCGA-CJ-4903	0	2	0	0	4	0	0	0	1	36	3	0	0	11	0	1	TCGA-CJ-4903-01	85	0.5255892588561281	43	TCGA-CJ-4903-01	1	1	11	0.0668148482507794	TCGA-CJ-4903-01	1	2	2	5	PASS	4307	TCGA-CJ-4903	KIRC	50	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-18510	Alive	TUMOR FREE	1560	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1560	0	1560	NA	NA	0	1560	
60	TCGA-CJ-4904	0	2	0	1	4	1	0	0	2	36	3	0	0	17	1	0	TCGA-CJ-4904-01	49	0.12909621329887452	9	TCGA-CJ-4904-01	4	2	2	0.07099036034438208	TCGA-CJ-4904-01	0	0	0	0	PASS	4308	TCGA-CJ-4904	KIRC	60	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-22036	Alive	WITH TUMOR	3302	NA	NA	NA	NA	NA	278	Stable Disease	NA	NA	0	3302	0	3302	NA	NA	1	278	
60	TCGA-CJ-4905	1	3	0	1	6	1	0	0	1	34	3	0	0	21	1	0	TCGA-CJ-4905-01	51	0.09595746842731767	12	TCGA-CJ-4905-01	3	3	3	0.023624926894686298	TCGA-CJ-4905-01	2	2	1	5	PASS	4309	TCGA-CJ-4905	KIRC	62	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-22864	Alive	TUMOR FREE	1496	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1496	0	1496	NA	NA	0	1496	
60	TCGA-CJ-4907	1	6	0	0	4	0	2	0	3	49	7	0	0	19	0	0	TCGA-CJ-4907-01	86	0.5351974009237885	40	TCGA-CJ-4907-01	1	4	4	0.03201463988981226	TCGA-CJ-4907-01	2	2	1	5	PASS	4310	TCGA-CJ-4907	KIRC	58	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-21208	Alive	TUMOR FREE	1499	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1499	0	1499	NA	NA	0	1499	
40	TCGA-CJ-4908	0	1	0	1	3	0	0	0	1	25	1	0	0	10	0	0	TCGA-CJ-4908-01	141	0.05967933593526696	86	TCGA-CJ-4908-01	1	2	4	0.029448057861847045	TCGA-CJ-4908-01	1	1	1	3	PASS	4311	TCGA-CJ-4908	KIRC	38	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-14226	Alive	TUMOR FREE	1531	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1531	0	1531	NA	NA	0	1531	
60	TCGA-CJ-4912	1	5	1	3	3	0	1	0	4	56	6	0	0	22	1	0	TCGA-CJ-4912-01	126	0.32147959733953274	73	TCGA-CJ-4912-01	9	10	7	0.16772951609112335	TCGA-CJ-4912-01	4	4	2	10	PASS	4312	TCGA-CJ-4912	KIRC	61	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-22623	Alive	TUMOR FREE	1657	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1657	0	1657	NA	NA	0	1657	
50	TCGA-CJ-4913	0	4	0	1	1	4	1	0	2	46	3	0	2	16	0	1	TCGA-CJ-4913-01	84	0.1069873240769257	33	TCGA-CJ-4913-01	1	2	6	0.057685270017111774	TCGA-CJ-4913-01	1	4	2	7	PASS	4313	TCGA-CJ-4913	KIRC	45	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2006	NA	-16757	Dead	WITH TUMOR	NA	1173	NA	NA	NA	NA	538	NA	NA	NA	1	1173	1	1173	NA	NA	1	538	
70	TCGA-CJ-4916	1	4	0	1	2	1	1	0	2	35	1	0	0	12	2	0	TCGA-CJ-4916-01	78	0.10494948534860843	32	TCGA-CJ-4916-01	3	3	3	0.059421434189934674	TCGA-CJ-4916-01	3	2	1	6	PASS	4314	TCGA-CJ-4916	KIRC	69	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-25470	Alive	TUMOR FREE	1373	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1373	0	1373	NA	NA	0	1373	
60	TCGA-CJ-4918	0	1	0	3	7	0	2	0	2	49	3	0	2	17	4	0	TCGA-CJ-4918-01	68	0.053517631430633816	25	TCGA-CJ-4918-01	0	2	19	0.02341299035456542	TCGA-CJ-4918-01	1	2	1	4	PASS	4315	TCGA-CJ-4918	KIRC	64	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2005	NA	-23379	Dead	WITH TUMOR	NA	93	NA	NA	NA	NA	33	NA	NA	NA	1	93	1	93	NA	NA	1	33	
60	TCGA-CJ-4920	0	8	1	4	19	4	0	0	6	94	6	0	2	27	3	1	TCGA-CJ-4920-01	51	0.07147713664874424	15	TCGA-CJ-4920-01	0	1	2	0.017735816411809782	TCGA-CJ-4920-01	0	1	1	2	PASS	4316	TCGA-CJ-4920	KIRC	64	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-23656	Dead	TUMOR FREE	NA	139	NA	NA	NA	NA	NA	NA	NA	NA	1	139	0	139	NA	NA	0	139	
60	TCGA-CJ-4923	0	5	0	1	9	1	0	0	1	38	4	0	1	12	0	0	TCGA-CJ-4923-01	107	0.1273174841366858	53	TCGA-CJ-4923-01	1	3	11	0.033498582802689365	TCGA-CJ-4923-01	3	3	2	8	PASS	4317	TCGA-CJ-4923	KIRC	63	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-23353	Dead	WITH TUMOR	NA	572	NA	NA	NA	NA	25	NA	NA	NA	1	572	1	572	NA	NA	1	25	
50	TCGA-CJ-5671	1	4	0	3	7	3	0	0	4	46	2	0	2	22	0	0	TCGA-CJ-5671-01	58	0.41153392738886996	19	TCGA-CJ-5671-01	24	18	2	0.03504451568979257	TCGA-CJ-5671-01	1	2	1	4	PASS	4318	TCGA-CJ-5671	KIRC	51	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-18954	Alive	TUMOR FREE	3987	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3987	0	3987	0	3987	0	3987	
80	TCGA-CJ-5672	1	7	0	4	8	1	2	1	5	65	5	2	1	23	1	0	TCGA-CJ-5672-01	107	0.2490377595310681	57	TCGA-CJ-5672-01	7	10	19	0.14551155319591325	TCGA-CJ-5672-01	3	4	4	11	PASS	4319	TCGA-CJ-5672	KIRC	84	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-30900	Dead	TUMOR FREE	NA	2190	NA	NA	NA	NA	NA	NA	NA	NA	1	2190	0	2190	NA	NA	0	2190	
70	TCGA-CJ-5675	1	8	0	1	6	1	1	0	1	46	5	0	1	23	0	0	TCGA-CJ-5675-01	61	0.16568653286961527	22	TCGA-CJ-5675-01	4	6	3	0.09766734349182588	TCGA-CJ-5675-01	5	3	2	10	PASS	4320	TCGA-CJ-5675	KIRC	70	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-25617	Alive	WITH TUMOR	3936	NA	NA	NA	NA	NA	900	Complete Remission/Response	NA	NA	0	3936	0	3936	1	900	1	900	
50	TCGA-CJ-5676	1	2	0	3	5	3	0	0	3	39	7	0	1	21	1	1	TCGA-CJ-5676-01	60	0.6142442865159179	25	TCGA-CJ-5676-01	7	8	2	0.058422399429601424	TCGA-CJ-5676-01	1	2	1	4	PASS	4321	TCGA-CJ-5676	KIRC	47	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-17170	Alive	WITH TUMOR	4067	NA	NA	NA	NA	NA	2219	Complete Remission/Response	NA	NA	0	4067	0	4067	1	2219	1	2219	
50	TCGA-CJ-5677	2	2	0	4	7	0	0	0	3	54	4	0	0	20	3	0	TCGA-CJ-5677-01	79	0.2457890929406148	27	TCGA-CJ-5677-01	7	6	12	0.16114681955745422	TCGA-CJ-5677-01	3	5	4	12	PASS	4322	TCGA-CJ-5677	KIRC	54	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-19849	Dead	WITH TUMOR	NA	782	NA	NA	NA	NA	288	NA	NA	NA	1	782	1	782	NA	NA	1	288	
60	TCGA-CJ-5678	0	5	2	1	7	1	1	0	1	29	4	0	1	11	0	0	TCGA-CJ-5678-01	152	0.1757686469300592	92	TCGA-CJ-5678-01	4	4	11	0.10072089678290266	TCGA-CJ-5678-01	3	1	3	7	PASS	4323	TCGA-CJ-5678	KIRC	62	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-22944	Dead	WITH TUMOR	NA	574	NA	NA	NA	NA	399	NA	NA	NA	1	574	1	574	NA	NA	1	399	
70	TCGA-CJ-5679	0	10	0	1	7	0	0	0	3	72	3	0	3	19	5	0	TCGA-CJ-5679-01	74	0.7147833730604414	28	TCGA-CJ-5679-01	25	21	16	0.2920976881318669	TCGA-CJ-5679-01	1	0	1	2	PASS	4324	TCGA-CJ-5679	KIRC	73	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2003	NA	-26858	Dead	WITH TUMOR	NA	679	NA	NA	NA	NA	595	NA	NA	NA	1	679	1	679	NA	NA	1	595	
70	TCGA-CJ-5680	0	4	0	1	2	0	0	0	2	35	1	0	1	16	4	0	TCGA-CJ-5680-01	89	0.12172607913330825	33	TCGA-CJ-5680-01	3	4	13	0.12734634365184305	TCGA-CJ-5680-01	2	2	2	6	PASS	4325	TCGA-CJ-5680	KIRC	65	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2003	NA	-23778	Dead	WITH TUMOR	NA	768	NA	NA	NA	NA	153	NA	NA	NA	1	768	1	768	NA	NA	1	153	
40	TCGA-CJ-5681	1	3	0	1	2	0	0	0	2	18	0	0	0	6	1	0	TCGA-CJ-5681-01	1155	0.07805757876927212	1090	TCGA-CJ-5681-01	0	0	56	0.028130879570561502	TCGA-CJ-5681-01	1	4	2	7	PASS	4326	TCGA-CJ-5681	KIRC	44	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-16121	Dead	WITH TUMOR	NA	552	NA	NA	NA	NA	17	NA	NA	NA	1	552	1	552	NA	NA	1	17	
60	TCGA-CJ-5682	1	9	1	1	9	1	1	0	2	54	4	0	1	15	2	0	TCGA-CJ-5682-01	61	0.5520388798627763	21	TCGA-CJ-5682-01	23	15	19	0.07099498884477445	TCGA-CJ-5682-01	0	0	0	0	PASS	4327	TCGA-CJ-5682	KIRC	60	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-22244	Alive	WITH TUMOR	3736	NA	NA	NA	NA	NA	55	Stable Disease	NA	NA	0	3736	0	3736	NA	NA	1	55	
80	TCGA-CJ-5683	0	6	0	0	6	0	1	0	1	47	1	0	1	22	0	0	TCGA-CJ-5683-01	69	0.17354158506044515	27	TCGA-CJ-5683-01	6	4	19	0.04291126117403992	TCGA-CJ-5683-01	1	2	1	4	PASS	4328	TCGA-CJ-5683	KIRC	78	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-28745	Alive	TUMOR FREE	1889	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1889	0	1889	NA	NA	0	1889	
60	TCGA-CJ-5684	0	7	0	3	0	2	0	0	0	27	3	0	0	14	1	0	TCGA-CJ-5684-01	72	0.1879124984166923	31	TCGA-CJ-5684-01	3	2	19	0.0276587757638532	TCGA-CJ-5684-01	1	1	1	3	PASS	4329	TCGA-CJ-5684	KIRC	61	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-22561	Alive	TUMOR FREE	2231	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2231	0	2231	NA	NA	0	2231	
60	TCGA-CJ-5686	0	1	0	3	8	2	0	0	4	37	5	0	1	17	3	0	TCGA-CJ-5686-01	34	0.12285305584686396	5	TCGA-CJ-5686-01	4	4	3	0.06438217666099576	TCGA-CJ-5686-01	1	1	1	3	PASS	4330	TCGA-CJ-5686	KIRC	59	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-21836	Alive	TUMOR FREE	2038	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2038	0	2038	NA	NA	0	2038	
90	TCGA-CJ-5689	0	10	0	1	7	0	1	0	0	55	8	0	0	22	1	0	TCGA-CJ-5689-01	45	0.18674919974048265	8	TCGA-CJ-5689-01	6	4	5	0.15555445543352464	TCGA-CJ-5689-01	2	1	0	3	PASS	4331	TCGA-CJ-5689	KIRC	90	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G4	2005	NA	-32872	Dead	TUMOR FREE	NA	1620	NA	NA	NA	NA	NA	NA	NA	NA	1	1620	0	1620	NA	NA	0	1620	
80	TCGA-CJ-6027	1	5	0	6	6	3	1	1	7	58	6	0	1	20	1	0	TCGA-CJ-6027-01	57	0.7907469935146211	16	TCGA-CJ-6027-01	10	8	13	0.308825880680289	TCGA-CJ-6027-01	4	5	4	13	PASS	4332	TCGA-CJ-6027	KIRC	77	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G4	2003	NA	-28359	Dead	TUMOR FREE	NA	3615	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	3615	0	3615	0	3615	0	3615	
60	TCGA-CJ-6028	0	1	2	1	3	3	0	0	3	42	3	0	1	19	2	0	TCGA-CJ-6028-01	34	0.4093236104898589	2	TCGA-CJ-6028-01	36	21	2	0.057827584957941935	TCGA-CJ-6028-01	2	0	1	3	PASS	4333	TCGA-CJ-6028	KIRC	58	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2003	NA	-21380	Dead	WITH TUMOR	NA	1625	NA	NA	NA	NA	137	NA	NA	NA	1	1625	1	1625	NA	NA	1	137	
70	TCGA-CJ-6030	0	7	0	2	11	4	0	0	0	78	6	0	0	26	4	0	TCGA-CJ-6030-01	68	0.30129358718687443	20	TCGA-CJ-6030-01	7	5	11	0.19494642329744186	TCGA-CJ-6030-01	2	1	3	6	PASS	4334	TCGA-CJ-6030	KIRC	65	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-24096	Dead	TUMOR FREE	NA	2299	NA	NA	NA	NA	NA	NA	NA	NA	1	2299	0	2299	NA	NA	0	2299	
50	TCGA-CJ-6031	0	1	0	2	9	3	1	0	3	46	5	0	2	11	1	1	TCGA-CJ-6031-01	66	0.10034479036921788	13	TCGA-CJ-6031-01	2	3	4	0.07285993516034196	TCGA-CJ-6031-01	2	2	1	5	PASS	4335	TCGA-CJ-6031	KIRC	54	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-19905	Alive	TUMOR FREE	1906	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1906	0	1906	NA	NA	0	1906	
60	TCGA-CJ-6032	0	4	1	0	3	2	0	0	2	34	3	0	1	11	1	0	TCGA-CJ-6032-01	39	0.21970368225226514	3	TCGA-CJ-6032-01	6	5	5	0.12656221602779388	TCGA-CJ-6032-01	5	3	4	12	PASS	4336	TCGA-CJ-6032	KIRC	63	FEMALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-23310	Alive	TUMOR FREE	3639	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3639	0	3639	0	3639	0	3639	
50	TCGA-CJ-6033	0	3	1	0	1	0	1	0	0	57	3	0	2	22	3	0	TCGA-CJ-6033-01	99	0.2553679641680138	46	TCGA-CJ-6033-01	5	5	6	0.1281399609392882	TCGA-CJ-6033-01	3	1	2	6	PASS	4337	TCGA-CJ-6033	KIRC	54	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-19919	Dead	WITH TUMOR	NA	224	NA	NA	NA	NA	144	NA	NA	NA	1	224	1	224	NA	NA	1	144	
70	TCGA-CW-5580	1	3	0	4	14	1	1	0	0	57	3	0	0	37	4	0	TCGA-CW-5580-01	59	0.229914661911087	18	TCGA-CW-5580-01	3	2	3	0.09541334455313727	TCGA-CW-5580-01	0	1	1	2	PASS	4338	TCGA-CW-5580	KIRC	73	FEMALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-26696	Dead	NA	NA	1964	NA	NA	NA	NA	NA	NA	NA	NA	1	1964	NA	1964	NA	NA	0	1964	
40	TCGA-CW-5581	0	3	0	0	5	1	2	0	5	42	5	0	0	10	1	0	TCGA-CW-5581-01	127	0.0972553343006953	62	TCGA-CW-5581-01	2	3	10	0.03645104714748599	TCGA-CW-5581-01	4	4	2	10	PASS	4339	TCGA-CW-5581	KIRC	44	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-16195	Alive	TUMOR FREE	2799	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2799	0	2799	NA	NA	0	2799	
50	TCGA-CW-5583	0	2	0	0	4	0	0	0	1	20	0	0	0	10	0	0	TCGA-CW-5583-01	66	0.08476555250457256	23	TCGA-CW-5583-01	3	3	19	0.03205079559860118	TCGA-CW-5583-01	2	0	1	3	PASS	4340	TCGA-CW-5583	KIRC	51	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-18666	Alive	TUMOR FREE	2489	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2489	0	2489	NA	NA	0	2489	
70	TCGA-CW-5584	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CW-5584-01	65	0.14863008649037984	24	TCGA-CW-5584-01	2	3	5	0.09097165886942074	TCGA-CW-5584-01	2	2	2	6	PASS	4341	TCGA-CW-5584	KIRC	74	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-27352	Dead	NA	NA	164	NA	NA	NA	NA	102	NA	NA	NA	1	164	NA	164	NA	NA	1	102	
50	TCGA-CW-5585	0	5	1	2	2	1	1	0	4	31	3	0	0	10	2	0	TCGA-CW-5585-01	88	0.1502758557007782	35	TCGA-CW-5585-01	4	5	10	0.07382052084980191	TCGA-CW-5585-01	4	3	3	10	PASS	4342	TCGA-CW-5585	KIRC	51	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-18898	Alive	WITH TUMOR	2609	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2609	0	2609	NA	NA	0	2609	
60	TCGA-CW-5587	0	4	0	2	7	3	1	0	2	49	2	0	0	16	3	0	TCGA-CW-5587-01	51	0.239333243751908	13	TCGA-CW-5587-01	7	5	2	0.061857956967946284	TCGA-CW-5587-01	2	0	1	3	PASS	4343	TCGA-CW-5587	KIRC	62	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-22693	Alive	TUMOR FREE	2226	NA	NA	NA	NA	NA	2003	NA	NA	NA	0	2226	0	2226	NA	NA	1	2003	
80	TCGA-CW-5588	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CW-5588-01	71	0.6148628862618257	24	TCGA-CW-5588-01	23	17	5	0.0359090402494913	TCGA-CW-5588-01	3	5	2	10	PASS	4344	TCGA-CW-5588	KIRC	78	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-28714	Alive	NA	2017	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2017	0	2017	NA	NA	0	2017	
50	TCGA-CW-5589	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CW-5589-01	83	0.09045557121802243	36	TCGA-CW-5589	0	0	0	0	TCGA-CW-5589	0	0	0	0	PASS	4345	TCGA-CW-5589	KIRC	52	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-19312	Alive	TUMOR FREE	2378	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2378	0	2378	NA	NA	0	2378	
50	TCGA-CW-5590	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CW-5590	0	0	0	TCGA-CW-5590	0	0	0	0	TCGA-CW-5590	0	0	0	0	PASS	4346	TCGA-CW-5590	KIRC	51	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2004	NA	-18905	Dead	NA	NA	1075	NA	NA	NA	NA	672	NA	NA	NA	1	1075	NA	1075	NA	NA	1	672	
60	TCGA-CW-5591	0	4	1	3	0	1	0	0	1	27	2	0	0	9	1	0	TCGA-CW-5591-01	85	0.9477236347725629	39	TCGA-CW-5591-01	26	18	5	0.05916446520794595	TCGA-CW-5591-01	1	1	1	3	PASS	4347	TCGA-CW-5591	KIRC	56	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-20712	Alive	WITH TUMOR	2271	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2271	0	2271	NA	NA	0	2271	
60	TCGA-CW-6087	0	4	1	2	2	1	0	0	4	51	4	0	1	20	0	0	TCGA-CW-6087-01	55	0.16291328306941075	12	TCGA-CW-6087	0	0	0	0	TCGA-CW-6087	0	0	0	0	PASS	4348	TCGA-CW-6087	KIRC	61	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2003	NA	-22438	Dead	TUMOR FREE	NA	41	NA	NA	NA	NA	NA	NA	NA	NA	1	41	0	41	NA	NA	0	41	
60	TCGA-CW-6088	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CW-6088-01	53	0.099586700872377	19	TCGA-CW-6088-01	3	3	11	0.1360705852957942	TCGA-CW-6088-01	2	0	0	2	PASS	4349	TCGA-CW-6088	KIRC	60	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2003	NA	-22020	Alive	TUMOR FREE	3222	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	3222	0	3222	NA	NA	0	3222	
70	TCGA-CW-6090	0	3	0	4	5	3	3	0	1	60	6	0	4	35	1	0	TCGA-CW-6090-01	79	0.8858995217464	34	TCGA-CW-6090-01	13	11	19	0.02374289536467964	TCGA-CW-6090-01	3	3	1	7	PASS	4350	TCGA-CW-6090	KIRC	68	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2003	NA	-24909	Alive	TUMOR FREE	2552	NA	NA	NA	NA	NA	2780	NA	NA	NA	0	2552	0	2552	NA	NA	1	2780	
70	TCGA-CW-6093	0	2	0	2	11	2	0	0	4	79	4	0	0	28	5	0	TCGA-CW-6093-01	72	0.07311439250864207	26	TCGA-CW-6093-01	2	2	2	0.01977166389381111	TCGA-CW-6093-01	0	1	1	2	PASS	4351	TCGA-CW-6093	KIRC	73	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G1	2004	NA	-26909	Alive	TUMOR FREE	3146	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	3146	0	3146	NA	NA	0	3146	
40	TCGA-CW-6096	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CW-6096	0	0	0	TCGA-CW-6096	0	0	0	0	TCGA-CW-6096	0	0	0	0	PASS	4352	TCGA-CW-6096	KIRC	44	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2004	NA	-16140	Alive	TUMOR FREE	2701	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	2701	0	2701	NA	NA	0	2701	
30	TCGA-CW-6097	0	1	0	0	2	1	0	0	1	19	0	0	0	5	0	0	TCGA-CW-6097-01	53	0.29987579920781426	15	TCGA-CW-6097-01	1	1	0	0.0	TCGA-CW-6097-01	1	0	0	1	PASS	4353	TCGA-CW-6097	KIRC	32	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2004	NA	-11701	Dead	WITH TUMOR	NA	571	NA	NA	NA	NA	457	NA	NA	NA	1	571	1	571	NA	NA	1	457	
80	TCGA-CZ-4853	2	10	0	2	11	2	0	0	5	73	5	0	1	26	0	0	TCGA-CZ-4853-01	76	0.11537603152192046	35	TCGA-CZ-4853-01	3	3	4	0.08880709039174957	TCGA-CZ-4853-01	1	2	1	4	PASS	4354	TCGA-CZ-4853	KIRC	82	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-30191	Alive	TUMOR FREE	774	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	774	0	774	NA	NA	0	774	
70	TCGA-CZ-4854	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CZ-4854-01	126	0.8901195205343182	68	TCGA-CZ-4854-01	32	34	19	0.2467326097790257	TCGA-CZ-4854-01	8	6	4	18	PASS	4355	TCGA-CZ-4854	KIRC	68	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-24876	Dead	TUMOR FREE	NA	1404	NA	NA	NA	NA	NA	NA	NA	NA	1	1404	0	1404	NA	NA	0	1404	
60	TCGA-CZ-4856	1	5	0	2	6	2	0	0	2	48	4	0	0	13	2	0	TCGA-CZ-4856-01	89	0.11301557147335455	41	TCGA-CZ-4856-01	3	3	3	0.02820014696662292	TCGA-CZ-4856-01	2	3	1	6	PASS	4356	TCGA-CZ-4856	KIRC	62	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-22684	Alive	NA	18	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	18	0	18	NA	NA	0	18	
60	TCGA-CZ-4857	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CZ-4857-01	82	0.2857948831285591	33	TCGA-CZ-4857-01	12	10	10	0.17904979948610694	TCGA-CZ-4857-01	6	5	2	13	PASS	4357	TCGA-CZ-4857	KIRC	56	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-20718	Dead	WITH TUMOR	NA	1432	NA	NA	NA	NA	188	NA	NA	NA	1	1432	1	1432	NA	NA	1	188	
40	TCGA-CZ-4858	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CZ-4858-01	211	0.6527739300743425	135	TCGA-CZ-4858-01	24	20	31	0.3330491286532293	TCGA-CZ-4858-01	7	7	2	16	PASS	4358	TCGA-CZ-4858	KIRC	39	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G4	2005	NA	-14343	Dead	WITH TUMOR	NA	2105	NA	NA	NA	NA	597	NA	NA	NA	1	2105	1	2105	NA	NA	1	597	
60	TCGA-CZ-4859	0	7	0	1	8	5	4	0	3	72	5	0	3	24	3	1	TCGA-CZ-4859-01	79	0.19843538752117296	29	TCGA-CZ-4859-01	4	13	9	0.2210109403689373	TCGA-CZ-4859-01	4	4	5	13	PASS	4359	TCGA-CZ-4859	KIRC	59	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-21842	Alive	TUMOR FREE	1787	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1787	0	1787	NA	NA	0	1787	
60	TCGA-CZ-4860	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CZ-4860-01	132	0.7760260692494658	78	TCGA-CZ-4860-01	23	23	10	0.12486808448644733	TCGA-CZ-4860-01	7	2	2	11	PASS	4360	TCGA-CZ-4860	KIRC	60	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2005	NA	-22115	Dead	WITH TUMOR	NA	206	NA	NA	NA	NA	NA	NA	NA	NA	1	206	1	206	NA	NA	1	206	
60	TCGA-CZ-4861	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CZ-4861-01	65	0.1410971152369021	17	TCGA-CZ-4861-01	0	2	2	0.0182841029791578	TCGA-CZ-4861-01	2	2	1	5	PASS	4361	TCGA-CZ-4861	KIRC	63	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-23053	Dead	WITH TUMOR	NA	446	NA	NA	NA	NA	NA	NA	NA	NA	1	446	1	446	NA	NA	1	446	
50	TCGA-CZ-4862	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CZ-4862-01	73	0.050506884721097337	23	TCGA-CZ-4862-01	2	1	19	0.05256100058025602	TCGA-CZ-4862-01	0	0	0	0	PASS	4362	TCGA-CZ-4862	KIRC	46	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-17077	Alive	[Discrepancy]	3271	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3271	0	3271	NA	NA	0	3271	
50	TCGA-CZ-4863	0	1	0	2	8	0	0	0	1	36	1	0	1	12	0	0	TCGA-CZ-4863-01	43	0.09683059194603337	9	TCGA-CZ-4863-01	1	1	3	0.03694618222323897	TCGA-CZ-4863-01	1	1	1	3	PASS	4363	TCGA-CZ-4863	KIRC	51	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-18730	Alive	TUMOR FREE	1928	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1928	0	1928	NA	NA	0	1928	
90	TCGA-CZ-4864	0	9	1	3	4	2	0	0	5	63	0	0	1	16	3	0	TCGA-CZ-4864-01	60	0.18489257068784126	22	TCGA-CZ-4864-01	5	3	4	0.129856207066032	TCGA-CZ-4864-01	1	2	2	5	PASS	4364	TCGA-CZ-4864	KIRC	86	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2002	NA	-31557	Dead	TUMOR FREE	2830	2830	NA	NA	NA	NA	NA	NA	NA	NA	1	2830	0	2830	NA	NA	0	2830	
70	TCGA-CZ-4865	0	6	0	1	7	0	0	0	5	66	4	0	0	19	3	0	TCGA-CZ-4865	0	0	0	TCGA-CZ-4865	0	0	0	0	TCGA-CZ-4865-01	2	1	0	3	PASS	4365	TCGA-CZ-4865	KIRC	70	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-25709	Dead	TUMOR FREE	NA	166	NA	NA	NA	NA	NA	NA	NA	NA	1	166	0	166	NA	NA	0	166	
80	TCGA-CZ-4866	0	10	0	2	3	2	0	0	1	58	2	0	1	17	4	1	TCGA-CZ-4866-01	58	0.6904065036214421	13	TCGA-CZ-4866-01	29	15	2	0.02150651905268804	TCGA-CZ-4866-01	1	1	1	3	PASS	4366	TCGA-CZ-4866	KIRC	79	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-28878	Alive	WITH TUMOR	3267	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3267	0	3267	NA	NA	0	3267	
70	TCGA-CZ-5451	1	12	0	2	8	2	0	0	4	54	8	0	1	19	3	0	TCGA-CZ-5451-01	45	0.12915501017306266	11	TCGA-CZ-5451-01	4	2	2	0.0710321024516645	TCGA-CZ-5451-01	0	0	0	0	PASS	4367	TCGA-CZ-5451	KIRC	74	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-27312	Alive	TUMOR FREE	1929	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1929	0	1929	NA	NA	0	1929	
70	TCGA-CZ-5452	0	1	0	1	4	1	0	0	0	24	3	0	0	10	0	0	TCGA-CZ-5452-01	45	0.33349145710303263	4	TCGA-CZ-5452-01	5	4	7	0.1977045230316651	TCGA-CZ-5452-01	0	2	2	4	PASS	4368	TCGA-CZ-5452	KIRC	69	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-25486	Alive	TUMOR FREE	1789	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1789	0	1789	NA	NA	0	1789	
70	TCGA-CZ-5453	0	5	1	1	8	1	1	0	5	51	3	1	0	24	5	1	TCGA-CZ-5453-01	71	0.13155516864223255	29	TCGA-CZ-5453-01	3	3	10	0.1021508882117611	TCGA-CZ-5453-01	1	3	3	7	PASS	4369	TCGA-CZ-5453	KIRC	67	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-24640	Dead	NA	NA	2419	NA	NA	NA	NA	NA	NA	NA	NA	1	2419	NA	2419	NA	NA	0	2419	
60	TCGA-CZ-5454	0	5	0	1	1	1	0	0	1	17	1	0	0	10	2	0	TCGA-CZ-5454-01	75	0.13978182734223665	30	TCGA-CZ-5454-01	4	5	3	0.022905465965923483	TCGA-CZ-5454-01	4	3	1	8	PASS	4370	TCGA-CZ-5454	KIRC	63	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-23083	Dead	WITH TUMOR	NA	722	NA	NA	NA	NA	423	NA	NA	NA	1	722	1	722	NA	NA	1	423	
60	TCGA-CZ-5455	0	4	0	1	1	0	0	0	1	33	2	0	0	12	0	0	TCGA-CZ-5455-01	71	0.11682168813230395	26	TCGA-CZ-5455-01	3	4	4	0.094064099438115	TCGA-CZ-5455-01	2	2	1	5	PASS	4371	TCGA-CZ-5455	KIRC	63	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2006	NA	-23150	Dead	WITH TUMOR	NA	561	NA	NA	NA	NA	NA	NA	NA	NA	1	561	1	561	NA	NA	1	561	
60	TCGA-CZ-5456	0	7	1	4	7	1	1	0	2	44	4	0	1	19	1	0	TCGA-CZ-5456-01	61	0.6194475230201321	18	TCGA-CZ-5456-01	31	26	11	0.14820783353777464	TCGA-CZ-5456-01	2	2	1	5	PASS	4372	TCGA-CZ-5456	KIRC	57	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-21164	Alive	WITH TUMOR	2422	NA	NA	NA	NA	NA	951	NA	NA	NA	0	2422	0	2422	NA	NA	1	951	
60	TCGA-CZ-5457	0	4	0	2	6	0	1	0	0	57	3	0	1	17	2	0	TCGA-CZ-5457-01	46	0.7638882733522591	11	TCGA-CZ-5457-01	28	25	4	0.14768884491704473	TCGA-CZ-5457-01	1	0	0	1	PASS	4373	TCGA-CZ-5457	KIRC	62	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2006	NA	-22763	Alive	WITH TUMOR	2754	NA	NA	NA	NA	NA	174	NA	NA	NA	0	2754	0	2754	NA	NA	1	174	
40	TCGA-CZ-5458	0	3	0	3	1	0	0	0	0	24	2	0	1	10	1	0	TCGA-CZ-5458-01	53	0.14333072936893007	13	TCGA-CZ-5458-01	2	4	6	0.09388136754393568	TCGA-CZ-5458-01	2	3	1	6	PASS	4374	TCGA-CZ-5458	KIRC	43	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-15790	Alive	TUMOR FREE	2789	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2789	0	2789	NA	NA	0	2789	
60	TCGA-CZ-5459	0	4	0	4	7	2	1	0	4	67	2	0	2	23	2	3	TCGA-CZ-5459-01	39	0.0676600443411192	2	TCGA-CZ-5459-01	2	1	19	0.07099416857309124	TCGA-CZ-5459-01	0	0	0	0	PASS	4375	TCGA-CZ-5459	KIRC	63	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-23318	Alive	TUMOR FREE	1683	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1683	0	1683	NA	NA	0	1683	
60	TCGA-CZ-5460	0	2	0	2	2	3	1	0	3	36	2	0	2	18	2	0	TCGA-CZ-5460-01	70	0.40941192489458106	25	TCGA-CZ-5460-01	2	3	5	0.0733727877111768	TCGA-CZ-5460-01	2	1	2	5	PASS	4376	TCGA-CZ-5460	KIRC	55	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-20392	Alive	WITH TUMOR	2873	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2873	0	2873	NA	NA	0	2873	
50	TCGA-CZ-5461	2	4	0	1	5	1	0	0	3	52	5	0	1	9	2	1	TCGA-CZ-5461-01	63	0.5888275241339376	21	TCGA-CZ-5461-01	23	46	10	0.07099817214237869	TCGA-CZ-5461-01	1	2	0	3	PASS	4377	TCGA-CZ-5461	KIRC	52	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2006	NA	-19030	Dead	WITH TUMOR	330	330	NA	NA	NA	NA	48	NA	NA	NA	1	330	1	330	NA	NA	1	48	
80	TCGA-CZ-5462	0	6	0	0	9	0	1	0	2	50	3	0	1	15	2	0	TCGA-CZ-5462-01	68	0.2515481293523467	26	TCGA-CZ-5462-01	6	6	11	0.20800970215838613	TCGA-CZ-5462-01	6	3	6	15	PASS	4378	TCGA-CZ-5462	KIRC	83	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2007	NA	-30659	Dead	WITH TUMOR	NA	311	NA	NA	NA	NA	NA	NA	NA	NA	1	311	1	311	NA	NA	1	311	
80	TCGA-CZ-5463	0	8	0	2	3	2	0	0	0	36	3	0	3	11	2	0	TCGA-CZ-5463-01	43	0.20837006209315	8	TCGA-CZ-5463-01	7	4	4	0.1546184061174268	TCGA-CZ-5463-01	0	0	0	0	PASS	4379	TCGA-CZ-5463	KIRC	76	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-27911	Alive	NA	662	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	662	0	662	NA	NA	0	662	
70	TCGA-CZ-5464	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CZ-5464-01	54	0.6352772574405736	15	TCGA-CZ-5464-01	15	8	2	0.03027352033170081	TCGA-CZ-5464-01	2	2	1	5	PASS	4380	TCGA-CZ-5464	KIRC	69	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-25463	Alive	TUMOR FREE	2128	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2128	0	2128	NA	NA	0	2128	
80	TCGA-CZ-5465	2	9	2	0	15	6	1	0	4	74	4	0	2	20	2	0	TCGA-CZ-5465-01	55	0.7521117706543511	14	TCGA-CZ-5465-01	29	49	2	0.04719859077328194	TCGA-CZ-5465-01	2	0	2	4	PASS	4381	TCGA-CZ-5465	KIRC	76	FEMALE	NA	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-27838	Dead	TUMOR FREE	NA	2564	NA	NA	NA	NA	NA	NA	NA	NA	1	2564	0	2564	NA	NA	0	2564	
70	TCGA-CZ-5466	0	3	0	0	6	2	0	0	1	47	5	0	1	19	0	0	TCGA-CZ-5466-01	54	0.30683667053090524	10	TCGA-CZ-5466-01	11	10	10	0.1540294125784679	TCGA-CZ-5466-01	6	2	4	12	PASS	4382	TCGA-CZ-5466	KIRC	67	MALE	NA	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-24669	Alive	TUMOR FREE	685	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	685	0	685	NA	NA	0	685	
90	TCGA-CZ-5467	0	4	0	0	1	1	1	0	1	41	6	0	2	21	0	0	TCGA-CZ-5467-01	47	0.12967398813001607	13	TCGA-CZ-5467-01	4	4	6	0.044998920206946486	TCGA-CZ-5467-01	2	5	3	10	PASS	4383	TCGA-CZ-5467	KIRC	86	FEMALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G4	2007	NA	-31473	Dead	WITH TUMOR	NA	73	NA	NA	NA	NA	62	NA	NA	NA	1	73	1	73	NA	NA	1	62	
80	TCGA-CZ-5468	0	6	0	4	6	2	1	0	4	99	3	0	1	33	1	0	TCGA-CZ-5468-01	119	0.6492317726750739	54	TCGA-CZ-5468-01	21	34	36	0.3579417919033392	TCGA-CZ-5468-01	11	7	8	26	PASS	4384	TCGA-CZ-5468	KIRC	84	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2007	NA	-30729	Dead	WITH TUMOR	59	59	NA	NA	NA	NA	NA	NA	NA	NA	1	59	1	59	NA	NA	1	59	
40	TCGA-CZ-5469	0	4	0	1	0	1	1	0	3	39	1	1	1	10	2	0	TCGA-CZ-5469-01	69	0.8434469737060907	26	TCGA-CZ-5469-01	31	41	8	0.17651746532910534	TCGA-CZ-5469-01	0	2	2	4	PASS	4385	TCGA-CZ-5469	KIRC	41	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-15242	Dead	WITH TUMOR	NA	946	NA	NA	NA	NA	110	NA	NA	NA	1	946	1	946	NA	NA	1	110	
70	TCGA-CZ-5470	0	5	0	2	6	0	1	0	2	32	6	0	1	13	5	0	TCGA-CZ-5470-01	81	0.18699833964263954	37	TCGA-CZ-5470-01	5	5	5	0.11268116011011665	TCGA-CZ-5470-01	2	2	2	6	PASS	4386	TCGA-CZ-5470	KIRC	72	FEMALE	NA	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G3	2008	NA	-26494	Alive	NA	386	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	386	0	386	NA	NA	0	386	
60	TCGA-CZ-5982	0	3	1	1	4	0	0	0	2	35	3	0	0	12	1	0	TCGA-CZ-5982-01	39	0.11539784331477733	6	TCGA-CZ-5982-01	2	2	2	0.06645891838180137	TCGA-CZ-5982-01	2	0	2	4	PASS	4387	TCGA-CZ-5982	KIRC	59	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2005	NA	-21592	Alive	TUMOR FREE	2439	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2439	0	2439	NA	NA	0	2439	
50	TCGA-CZ-5984	0	4	0	2	2	2	1	0	2	26	3	0	0	12	1	0	TCGA-CZ-5984-01	88	0.5580297398373999	38	TCGA-CZ-5984-01	22	22	2	0.032050895260306286	TCGA-CZ-5984-01	3	3	1	7	PASS	4388	TCGA-CZ-5984	KIRC	51	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2005	NA	-18775	Alive	TUMOR FREE	2067	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2067	0	2067	NA	NA	0	2067	
60	TCGA-CZ-5985	0	4	1	2	4	2	0	0	2	31	5	1	3	12	3	0	TCGA-CZ-5985-01	71	0.2206698527992599	28	TCGA-CZ-5985-01	6	6	12	0.20477643416937494	TCGA-CZ-5985-01	3	6	3	12	PASS	4389	TCGA-CZ-5985	KIRC	58	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-21242	Alive	TUMOR FREE	1997	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1997	0	1997	NA	NA	0	1997	
60	TCGA-CZ-5986	0	6	1	4	5	1	4	0	2	39	0	0	1	15	2	0	TCGA-CZ-5986-01	57	0.1793822987576687	11	TCGA-CZ-5986-01	6	3	2	0.12355375900280502	TCGA-CZ-5986-01	0	0	0	0	PASS	4390	TCGA-CZ-5986	KIRC	61	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2006	NA	-22456	Alive	TUMOR FREE	373	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	373	0	373	NA	NA	0	373	
60	TCGA-CZ-5987	1	5	0	2	3	1	0	0	4	35	1	0	0	13	3	0	TCGA-CZ-5987-01	77	0.7048408991499874	33	TCGA-CZ-5987-01	9	5	7	0.21513907210127506	TCGA-CZ-5987-01	0	0	0	0	PASS	4391	TCGA-CZ-5987	KIRC	60	MALE	WHITE	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-21928	Dead	WITH TUMOR	NA	445	NA	NA	NA	NA	377	NA	NA	NA	1	445	1	445	NA	NA	1	377	
40	TCGA-CZ-5988	0	3	0	0	3	1	0	0	0	30	1	0	0	16	0	0	TCGA-CZ-5988-01	69	0.14770486623030474	30	TCGA-CZ-5988-01	6	5	11	0.12412737694337628	TCGA-CZ-5988-01	2	3	2	7	PASS	4392	TCGA-CZ-5988	KIRC	38	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-14131	Alive	TUMOR FREE	693	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	693	0	693	NA	NA	0	693	
60	TCGA-CZ-5989	0	1	0	0	3	1	0	1	0	29	3	0	0	13	1	0	TCGA-CZ-5989-01	61	0.13230091350110576	24	TCGA-CZ-5989-01	3	4	6	0.08531504509198604	TCGA-CZ-5989-01	3	4	2	9	PASS	4393	TCGA-CZ-5989	KIRC	60	MALE	WHITE	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2006	NA	-22170	Alive	TUMOR FREE	1905	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1905	0	1905	NA	NA	0	1905	
60	TCGA-DV-5565	0	9	0	1	3	0	1	0	2	43	3	0	0	10	1	0	TCGA-DV-5565-01	58	0.1871810541066962	11	TCGA-DV-5565-01	7	6	6	0.13984699241252052	TCGA-DV-5565-01	4	2	6	12	PASS	4394	TCGA-DV-5565	KIRC	59	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-21642	Alive	WITH TUMOR	1329	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1329	0	1329	NA	NA	0	1329	
70	TCGA-DV-5566	0	5	0	1	2	1	0	0	1	36	3	0	1	20	2	0	TCGA-DV-5566-01	37	0.07801435438030134	10	TCGA-DV-5566-01	3	2	5	0.08231777478207353	TCGA-DV-5566-01	2	0	1	3	PASS	4395	TCGA-DV-5566	KIRC	67	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-24717	Alive	WITH TUMOR	1398	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1398	0	1398	NA	NA	0	1398	
40	TCGA-DV-5567	0	1	0	0	0	0	0	0	0	14	2	0	1	3	1	0	TCGA-DV-5567-01	69	0.00028601217714615	28	TCGA-DV-5567-01	0	0	19	0.00024956158732903987	TCGA-DV-5567-01	0	0	0	0	PASS	4396	TCGA-DV-5567	KIRC	40	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2008	NA	-14642	Alive	WITH TUMOR	2004	NA	NA	NA	NA	NA	2004	Complete Remission/Response	NA	NA	0	2004	0	2004	1	2004	1	2004	
30	TCGA-DV-5568	0	1	0	0	1	0	1	0	2	14	1	0	1	4	1	0	TCGA-DV-5568	0	0	0	TCGA-DV-5568	0	0	0	0	TCGA-DV-5568-01	3	2	2	7	PASS	4397	TCGA-DV-5568	KIRC	26	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2009	NA	-9714	Alive	WITH TUMOR	370	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	370	0	370	NA	NA	0	370	
30	TCGA-DV-5569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DV-5569-01	51	0.0527931916436844	16	TCGA-DV-5569-01	0	2	7	0.0206148986759542	TCGA-DV-5569-01	1	2	1	4	PASS	4398	TCGA-DV-5569	KIRC	29	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2009	NA	-10698	Alive	TUMOR FREE	355	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	355	0	355	NA	NA	0	355	
40	TCGA-DV-5573	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DV-5573	0	0	0	TCGA-DV-5573	0	0	0	0	TCGA-DV-5573-01	1	2	2	5	PASS	4399	TCGA-DV-5573	KIRC	41	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2008	NA	-15264	Alive	WITH TUMOR	1130	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1130	0	1130	NA	NA	0	1130	
40	TCGA-DV-5574	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DV-5574-01	45	0.21048011064264485	9	TCGA-DV-5574	0	0	0	0	TCGA-DV-5574	0	0	0	0	PASS	4400	TCGA-DV-5574	KIRC	37	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2008	NA	-13517	Alive	WITH TUMOR	2016	NA	NA	NA	NA	NA	357	Complete Remission/Response	NA	NA	0	2016	0	2016	1	357	1	357	
50	TCGA-DV-5575	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DV-5575-01	63	0.09469742942173644	22	TCGA-DV-5575-01	3	3	5	0.0981245967720607	TCGA-DV-5575-01	3	2	3	8	PASS	4401	TCGA-DV-5575	KIRC	52	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-19022	Alive	WITH TUMOR	1729	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1729	0	1729	NA	NA	0	1729	
60	TCGA-DV-5576	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DV-5576-01	95	0.048651521257610714	44	TCGA-DV-5576-01	2	2	2	0.02776993851138933	TCGA-DV-5576-01	2	2	1	5	PASS	4402	TCGA-DV-5576	KIRC	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2008	NA	-20310	Dead	WITH TUMOR	NA	727	NA	NA	NA	NA	NA	NA	NA	NA	1	727	1	727	NA	NA	1	727	
60	TCGA-DV-A4VX	0	2	0	0	7	3	0	1	3	59	5	1	1	22	3	0	TCGA-DV-A4VX-01	87	0.6620510473967768	37	TCGA-DV-A4VX-01	18	14	50	0.15937226112039354	TCGA-DV-A4VX-01	5	1	4	10	PASS	4403	TCGA-DV-A4VX	KIRC	59	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2008	NA	-21670	Dead	WITH TUMOR	NA	1626	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	1626	1	1626	NA	NA	1	1626	
50	TCGA-DV-A4VZ	0	1	0	0	0	0	1	0	2	10	0	0	0	4	0	0	TCGA-DV-A4VZ-01	49	7.079267754589535e-05	12	TCGA-DV-A4VZ-01	0	0	5	0.00012370683192944733	TCGA-DV-A4VZ-01	0	0	0	0	PASS	4404	TCGA-DV-A4VZ	KIRC	53	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2007	NA	-19560	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	365	0	365	0	365	0	365	
60	TCGA-DV-A4W0	1	4	0	2	11	1	0	0	5	63	5	0	1	28	1	0	TCGA-DV-A4W0-01	65	0.15928091606639455	22	TCGA-DV-A4W0-01	6	5	25	0.07898773306033283	TCGA-DV-A4W0-01	2	3	3	8	mutation call filter	4405	TCGA-DV-A4W0	KIRC	55	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2008	NA	-20101	Alive	WITH TUMOR	2470	NA	NA	NA	NA	NA	2008	Stable Disease	NA	NA	0	2470	0	2470	NA	NA	1	2008	
50	TCGA-EU-5904	0	0	0	2	2	1	0	0	1	30	5	0	3	14	0	0	TCGA-EU-5904-01	53	0.04378233513414336	16	TCGA-EU-5904-01	0	2	3	0.01867862382895373	TCGA-EU-5904-01	2	2	1	5	PASS	4406	TCGA-EU-5904	KIRC	47	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G1	2009	NA	-17468	Alive	TUMOR FREE	551	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	551	0	551	NA	NA	0	551	
70	TCGA-EU-5905	0	5	0	1	3	4	0	0	3	42	3	1	1	13	0	0	TCGA-EU-5905-01	75	0.9477212155838326	42	TCGA-EU-5905-01	25	30	8	0.16702141908014542	TCGA-EU-5905-01	1	1	1	3	PASS	4407	TCGA-EU-5905	KIRC	67	FEMALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-24475	Alive	TUMOR FREE	119	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	119	0	119	NA	NA	0	119	
60	TCGA-EU-5906	0	2	0	3	7	0	1	0	2	48	4	0	0	17	0	0	TCGA-EU-5906-01	55	0.04716873011692848	18	TCGA-EU-5906-01	1	1	19	0.03040794486620665	TCGA-EU-5906-01	2	1	1	4	PASS	4408	TCGA-EU-5906	KIRC	55	MALE	WHITE	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2010	NA	-20246	Alive	TUMOR FREE	206	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	206	0	206	NA	NA	0	206	
80	TCGA-EU-5907	0	0	0	2	3	1	1	1	0	31	4	0	1	12	2	0	TCGA-EU-5907-01	91	0.9274214451765472	44	TCGA-EU-5907-01	7	7	8	0.29309493880114035	TCGA-EU-5907-01	4	4	3	11	PASS	4409	TCGA-EU-5907	KIRC	81	MALE	WHITE	Stage III	NA	Kidney Clear Cell Renal Carcinoma	G3	2010	NA	-29863	Alive	TUMOR FREE	127	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	127	0	127	NA	NA	0	127	
50	TCGA-G6-A5PC	0	10	0	4	8	1	0	0	2	43	4	0	2	14	1	0	TCGA-G6-A5PC-01	67	0.1303883430172776	25	TCGA-G6-A5PC-01	2	5	63	0.07064880609288801	TCGA-G6-A5PC-01	4	4	2	10	PASS	4410	TCGA-G6-A5PC	KIRC	54	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G4	2012	NA	-20029	Dead	WITH TUMOR	NA	242	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	242	1	242	NA	NA	1	242	
60	TCGA-G6-A8L6	0	11	0	1	5	5	1	0	8	45	4	0	0	16	1	0	TCGA-G6-A8L6-01	70	0.09121667608917018	27	TCGA-G6-A8L6-01	1	3	18	0.06270020524764544	TCGA-G6-A8L6-01	1	0	1	2	PASS	4411	TCGA-G6-A8L6	KIRC	55	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Kidney Clear Cell Renal Carcinoma	G3	2013	NA	-20306	Dead	WITH TUMOR	NA	313	NA	NA	NA	NA	304	Progressive Disease	NA	NA	1	313	1	313	NA	NA	1	304	
80	TCGA-G6-A8L7	0	13	1	4	9	1	0	0	5	40	4	0	0	18	5	1	TCGA-G6-A8L7-01	72	0.2635881986078504	27	TCGA-G6-A8L7-01	10	7	59	0.1929304892040233	TCGA-G6-A8L7-01	3	3	5	11	PASS	4412	TCGA-G6-A8L7	KIRC	81	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2008	NA	-29883	Alive	TUMOR FREE	2133	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2133	0	2133	0	2133	0	2133	
60	TCGA-G6-A8L8	0	12	1	8	7	1	0	0	1	58	5	0	1	19	1	0	TCGA-G6-A8L8-01	143	0.9006953833631245	87	TCGA-G6-A8L8-01	6	6	85	0.19023642888906048	TCGA-G6-A8L8-01	6	5	9	20	PASS	4413	TCGA-G6-A8L8	KIRC	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G3	2008	NA	-22649	Dead	TUMOR FREE	NA	1091	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1091	0	1091	0	1091	0	1091	
80	TCGA-GK-A6C7	0	16	2	7	16	9	0	0	10	139	13	0	6	50	2	0	TCGA-GK-A6C7-01	63	0.12918384693355536	24	TCGA-GK-A6C7-01	3	2	32	0.09071363226801303	TCGA-GK-A6C7-01	2	2	1	5	PASS	4414	TCGA-GK-A6C7	KIRC	76	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	NA	2012	NA	-28107	Alive	TUMOR FREE	61	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	61	0	61	0	61	0	61	
40	TCGA-MM-A563	0	4	0	1	4	0	0	0	5	36	3	0	0	4	3	0	TCGA-MM-A563-01	97	0.8855922648971669	47	TCGA-MM-A563-01	8	6	71	0.23148220996180835	TCGA-MM-A563-01	1	1	2	4	PASS	4415	TCGA-MM-A563	KIRC	41	MALE	BLACK OR AFRICAN AMERICAN	[Discrepancy]	NA	Kidney Clear Cell Renal Carcinoma	G2	2012	NA	-15037	Alive	TUMOR FREE	591	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	591	0	591	0	591	0	591	
70	TCGA-MM-A564	0	7	3	5	13	1	1	0	3	57	4	0	1	21	3	0	TCGA-MM-A564-01	52	0.3339979694495833	13	TCGA-MM-A564-01	9	6	19	0.08903553427000449	TCGA-MM-A564-01	3	1	1	5	PASS	4416	TCGA-MM-A564	KIRC	68	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Kidney Clear Cell Renal Carcinoma	G2	2012	NA	-24916	Alive	TUMOR FREE	607	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	607	0	607	0	607	0	607	
60	TCGA-MM-A84U	1	10	2	12	6	0	3	0	4	60	4	0	3	17	2	0	TCGA-MM-A84U-01	115	0.18532711884469028	71	TCGA-MM-A84U-01	5	4	34	0.14053331633388158	TCGA-MM-A84U-01	1	3	1	5	PASS	4417	TCGA-MM-A84U	KIRC	58	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2013	NA	-21375	Alive	TUMOR FREE	700	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	700	0	700	0	700	0	700	
70	TCGA-MW-A4EC	1	5	1	1	4	0	0	0	2	29	0	0	1	15	2	0	TCGA-MW-A4EC-01	103	0.14067362458707974	59	TCGA-MW-A4EC-01	4	3	40	0.08377936680950145	TCGA-MW-A4EC-01	1	1	2	4	PASS	4418	TCGA-MW-A4EC	KIRC	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G2	2012	NA	-26649	Alive	TUMOR FREE	498	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	498	0	498	0	498	0	498	
50	TCGA-T7-A92I	0	2	1	1	2	1	0	0	2	30	1	0	1	6	1	0	TCGA-T7-A92I-01	77	0.07791782571316352	32	TCGA-T7-A92I-01	2	2	24	0.05460058534751129	TCGA-T7-A92I-01	2	0	2	4	PASS	4419	TCGA-T7-A92I	KIRC	47	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Clear Cell Renal Carcinoma	G1	2013	NA	-17331	Alive	TUMOR FREE	356	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	356	0	356	0	356	0	356	
50	TCGA-2K-A9WE	0	5	0	1	4	2	0	0	1	43	1	0	0	15	3	0	TCGA-2K-A9WE-01	41	0.1829520201207997	3	TCGA-2K-A9WE-01	12	9	10	0.0015215809094060071	TCGA-2K-A9WE-01	4	0	0	4	PASS	4420	TCGA-2K-A9WE	KIRP	53	MALE	WHITE	Stage II	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-19603	Alive	TUMOR FREE	214	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	214	0	214	0	214	0	214	
70	TCGA-2Z-A9J1	0	13	4	7	10	2	1	0	5	64	3	0	3	26	3	0	TCGA-2Z-A9J1-01	83	0.7496643586986727	38	TCGA-2Z-A9J1-01	13	9	18	0.08784934416964035	TCGA-2Z-A9J1-01	0	0	0	0	PASS	4421	TCGA-2Z-A9J1	KIRP	71	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-26244	Alive	TUMOR FREE	2298	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2298	0	2298	0	2298	0	2298	
70	TCGA-2Z-A9J2	0	16	1	3	4	4	2	0	3	55	4	0	2	22	2	0	TCGA-2Z-A9J2-01	69	0.2629114371444952	24	TCGA-2Z-A9J2-01	7	6	11	0.014868765908926896	TCGA-2Z-A9J2-01	3	2	2	7	PASS	4422	TCGA-2Z-A9J2	KIRP	71	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-26134	Alive	TUMOR FREE	1795	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1795	0	1795	0	1795	0	1795	
70	TCGA-2Z-A9J3	0	12	1	5	13	4	2	0	9	95	4	0	1	32	4	0	TCGA-2Z-A9J3-01	89	0.9475597628060226	30	TCGA-2Z-A9J3-01	10	10	16	0.015497834641355282	TCGA-2Z-A9J3-01	3	0	1	4	PASS	4423	TCGA-2Z-A9J3	KIRP	67	MALE	WHITE	Stage II	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-24626	Dead	WITH TUMOR	NA	1771	NA	NA	NA	NA	790	Progressive Disease	NA	NA	1	1771	1	1771	NA	NA	1	790	
80	TCGA-2Z-A9J5	1	12	0	6	12	1	0	0	5	65	5	0	1	21	2	2	TCGA-2Z-A9J5-01	53	0.9477286907367332	18	TCGA-2Z-A9J5-01	12	8	16	0.051155527701869014	TCGA-2Z-A9J5-01	0	0	0	0	PASS	4424	TCGA-2Z-A9J5	KIRP	80	MALE	WHITE	Stage II	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2006	NA	-29275	Alive	TUMOR FREE	3050	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	3050	0	3050	NA	NA	0	3050	
60	TCGA-2Z-A9J6	0	2	1	0	2	1	1	0	3	46	0	0	3	13	2	0	TCGA-2Z-A9J6-01	112	0.5944599871864414	55	TCGA-2Z-A9J6-01	11	6	7	0.01310556792934228	TCGA-2Z-A9J6-01	0	0	0	0	PASS	4425	TCGA-2Z-A9J6	KIRP	60	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-22265	Alive	TUMOR FREE	1731	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1731	0	1731	NA	NA	0	1731	
60	TCGA-2Z-A9J7	0	2	0	8	0	1	0	0	4	28	4	0	0	17	2	0	TCGA-2Z-A9J7-01	68	0.13672743711202526	22	TCGA-2Z-A9J7-01	6	5	7	0.01483925134810799	TCGA-2Z-A9J7-01	1	1	1	3	PASS	4426	TCGA-2Z-A9J7	KIRP	63	MALE	WHITE	Stage IV	Stage IV	Kidney Papillary Renal Cell Carcinoma	NA	2007	NA	-23230	Dead	WITH TUMOR	NA	139	NA	NA	NA	NA	96	Progressive Disease	NA	NA	1	139	1	139	NA	NA	1	96	
50	TCGA-2Z-A9J8	0	7	0	2	4	3	0	0	3	17	1	0	1	4	3	0	TCGA-2Z-A9J8-01	90	0.3785600793931225	43	TCGA-2Z-A9J8-01	2	3	35	0.11562805204262265	TCGA-2Z-A9J8-01	3	2	5	10	PASS	4427	TCGA-2Z-A9J8	KIRP	50	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2007	NA	-18498	Alive	WITH TUMOR	2790	NA	NA	NA	NA	NA	506	Complete Remission/Response	NA	NA	0	2790	0	2790	1	506	1	506	
80	TCGA-2Z-A9J9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-2Z-A9J9-01	73	7.311119931299131e-05	33	TCGA-2Z-A9J9-01	0	0	8	9.697355142247112e-05	TCGA-2Z-A9J9-01	0	0	0	0	PASS	4428	TCGA-2Z-A9J9	KIRP	77	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2006	NA	-28346	Alive	TUMOR FREE	2294	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2294	0	2294	0	2294	0	2294	
70	TCGA-2Z-A9JD	1	13	0	7	12	2	2	0	9	72	3	1	5	31	1	0	TCGA-2Z-A9JD-01	59	0.081879275714345	20	TCGA-2Z-A9JD-01	4	4	22	0.07216442857502378	TCGA-2Z-A9JD-01	0	0	0	0	PASS	4429	TCGA-2Z-A9JD	KIRP	66	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-24370	Alive	TUMOR FREE	1060	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1060	0	1060	NA	NA	0	1060	
60	TCGA-2Z-A9JE	2	17	0	8	10	4	2	0	2	57	9	0	0	23	2	0	TCGA-2Z-A9JE-01	85	0.0971289009856374	37	TCGA-2Z-A9JE-01	4	5	32	0.07167326152276822	TCGA-2Z-A9JE-01	0	0	0	0	PASS	4430	TCGA-2Z-A9JE	KIRP	59	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-21557	Alive	TUMOR FREE	1728	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1728	0	1728	0	1728	0	1728	
60	TCGA-2Z-A9JG	1	6	0	8	11	1	1	0	5	57	3	1	0	21	1	0	TCGA-2Z-A9JG-01	65	0.9476970122503809	24	TCGA-2Z-A9JG-01	21	33	7	0.0029660572952691106	TCGA-2Z-A9JG-01	0	0	0	0	PASS	4431	TCGA-2Z-A9JG	KIRP	64	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-23458	Alive	TUMOR FREE	1662	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1662	0	1662	0	1662	0	1662	
40	TCGA-2Z-A9JI	0	1	0	4	0	0	0	0	0	6	2	0	0	3	0	0	TCGA-2Z-A9JI-01	107	0.8828043856810452	50	TCGA-2Z-A9JI-01	17	14	87	0.3967253291476416	TCGA-2Z-A9JI-01	10	0	12	22	PASS	4432	TCGA-2Z-A9JI	KIRP	38	MALE	WHITE	Stage III	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-14196	Alive	TUMOR FREE	1567	NA	NA	NA	NA	NA	286	Complete Remission/Response	NA	NA	0	1567	0	1567	1	286	1	286	
70	TCGA-2Z-A9JJ	0	2	1	0	0	1	0	0	0	16	1	0	0	2	0	0	TCGA-2Z-A9JJ-01	86	0.12005607527270876	37	TCGA-2Z-A9JJ-01	6	4	20	0.0890819631542708	TCGA-2Z-A9JJ-01	4	3	3	10	PASS	4433	TCGA-2Z-A9JJ	KIRP	69	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-25240	Alive	TUMOR FREE	1213	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1213	0	1213	0	1213	0	1213	
50	TCGA-2Z-A9JK	3	7	1	4	10	1	1	0	5	66	0	0	0	16	0	0	TCGA-2Z-A9JK-01	77	0.08766851172925336	31	TCGA-2Z-A9JK-01	2	3	18	0.06453119330160922	TCGA-2Z-A9JK-01	2	1	1	4	PASS	4434	TCGA-2Z-A9JK	KIRP	50	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-18540	Alive	WITH TUMOR	1186	NA	NA	NA	NA	NA	324	Stable Disease	NA	NA	0	1186	0	1186	NA	NA	1	324	
50	TCGA-2Z-A9JL	2	11	0	7	4	0	0	0	9	66	2	0	2	24	2	0	TCGA-2Z-A9JL-01	85	0.07155798502758308	36	TCGA-2Z-A9JL-01	2	1	3	0.00010592947125018785	TCGA-2Z-A9JL-01	0	1	0	1	PASS	4435	TCGA-2Z-A9JL	KIRP	47	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-17367	Alive	TUMOR FREE	1006	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1006	0	1006	0	1006	0	1006	
30	TCGA-2Z-A9JM	1	6	0	4	3	3	0	0	3	39	2	0	1	18	1	0	TCGA-2Z-A9JM-01	57	0.1602025341656781	16	TCGA-2Z-A9JM-01	9	6	12	0.013738435621724924	TCGA-2Z-A9JM-01	0	0	0	0	PASS	4436	TCGA-2Z-A9JM	KIRP	28	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-10323	Alive	TUMOR FREE	934	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	934	0	934	NA	NA	0	934	
50	TCGA-2Z-A9JN	0	2	0	1	2	0	0	0	2	11	2	0	0	9	0	0	TCGA-2Z-A9JN-01	97	7.568645387675093e-05	56	TCGA-2Z-A9JN-01	0	0	5	0.0016635607656847256	TCGA-2Z-A9JN-01	0	0	0	0	PASS	4437	TCGA-2Z-A9JN	KIRP	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-18264	Alive	TUMOR FREE	740	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	740	0	740	0	740	0	740	
60	TCGA-2Z-A9JO	0	4	0	2	3	0	0	0	4	26	1	0	1	12	1	0	TCGA-2Z-A9JO-01	35	7.428138790306081e-06	6	TCGA-2Z-A9JO-01	0	0	19	0.00011190047755460953	TCGA-2Z-A9JO-01	0	0	0	0	PASS	4438	TCGA-2Z-A9JO	KIRP	56	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-20466	Alive	TUMOR FREE	949	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	949	0	949	0	949	0	949	
60	TCGA-2Z-A9JP	0	13	0	5	7	2	3	0	2	42	0	0	1	11	1	0	TCGA-2Z-A9JP-01	89	0.1886207918669206	35	TCGA-2Z-A9JP-01	10	7	23	0.09248263208294187	TCGA-2Z-A9JP-01	0	0	0	0	PASS	4439	TCGA-2Z-A9JP	KIRP	63	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-23207	Alive	TUMOR FREE	893	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	893	0	893	0	893	0	893	
70	TCGA-2Z-A9JQ	1	14	0	7	11	1	2	0	3	52	6	0	2	27	0	0	TCGA-2Z-A9JQ-01	63	0.14394587892908906	18	TCGA-2Z-A9JQ-01	6	4	6	0.0002038618261083833	TCGA-2Z-A9JQ-01	0	0	0	0	PASS	4440	TCGA-2Z-A9JQ	KIRP	66	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-24244	Alive	WITH TUMOR	778	NA	NA	NA	NA	NA	600	[Unknown]	NA	NA	0	778	0	778	NA	NA	1	600	
60	TCGA-2Z-A9JR	0	3	0	4	7	0	3	0	4	31	3	0	2	13	1	0	TCGA-2Z-A9JR-01	92	0.17000266040844192	46	TCGA-2Z-A9JR-01	6	5	7	0.0012652081392939035	TCGA-2Z-A9JR-01	1	1	0	2	PASS	4441	TCGA-2Z-A9JR	KIRP	57	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-20932	Alive	TUMOR FREE	161	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	161	0	161	NA	NA	0	161	
70	TCGA-2Z-A9JS	1	12	0	6	9	1	1	0	8	82	6	1	2	36	3	0	TCGA-2Z-A9JS-01	67	0.17880707513230232	20	TCGA-2Z-A9JS-01	9	7	32	0.07328945160301091	TCGA-2Z-A9JS-01	0	0	0	0	PASS	4442	TCGA-2Z-A9JS	KIRP	74	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-27053	Dead	TUMOR FREE	NA	492	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	492	0	492	0	492	0	492	
70	TCGA-2Z-A9JT	1	10	1	6	10	1	2	0	4	56	2	0	0	19	2	0	TCGA-2Z-A9JT-01	93	0.19355459884107284	38	TCGA-2Z-A9JT-01	11	6	7	0.012143726128984816	TCGA-2Z-A9JT-01	0	0	0	0	PASS	4443	TCGA-2Z-A9JT	KIRP	71	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-26128	Alive	TUMOR FREE	684	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	684	0	684	0	684	0	684	
70	TCGA-4A-A93W	0	14	1	8	12	1	0	0	3	68	6	0	2	27	1	0	TCGA-4A-A93W-01	63	0.10336777045677553	22	TCGA-4A-A93W-01	6	3	4	0.0002179513936228104	TCGA-4A-A93W-01	0	0	0	0	PASS	4444	TCGA-4A-A93W	KIRP	66	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-24117	Alive	TUMOR FREE	4	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4	0	4	0	4	0	4	
60	TCGA-4A-A93X	1	6	2	3	2	7	1	0	7	75	6	0	3	21	4	0	TCGA-4A-A93X-01	71	0.9336548801261444	24	TCGA-4A-A93X-01	24	25	48	0.1305584390004268	TCGA-4A-A93X-01	0	0	0	0	PASS	4445	TCGA-4A-A93X	KIRP	58	MALE	WHITE	Stage IV	Stage IV	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-21348	Alive	WITH TUMOR	390	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	390	0	390	NA	NA	0	390	
60	TCGA-4A-A93Y	1	3	0	1	0	0	0	0	3	22	3	0	0	8	2	1	TCGA-4A-A93Y-01	63	1.0345889713062984e-05	25	TCGA-4A-A93Y	0	0	0	0	TCGA-4A-A93Y	0	0	0	0	PASS	4446	TCGA-4A-A93Y	KIRP	63	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-23226	Alive	TUMOR FREE	352	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	352	0	352	0	352	0	352	
80	TCGA-5P-A9JU	0	9	1	1	12	2	2	2	3	48	6	0	4	15	4	0	TCGA-5P-A9JU-01	51	0.2332876173597138	10	TCGA-5P-A9JU-01	7	6	65	0.2006830386230743	TCGA-5P-A9JU-01	2	2	3	7	PASS	4447	TCGA-5P-A9JU	KIRP	81	MALE	WHITE	Stage III	NA	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-29594	Alive	TUMOR FREE	373	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	373	0	373	0	373	0	373	
50	TCGA-5P-A9JV	0	5	0	2	1	1	0	0	5	39	2	1	1	19	0	0	TCGA-5P-A9JV-01	51	0.06409799445163174	16	TCGA-5P-A9JV-01	2	1	18	0.052872159945960895	TCGA-5P-A9JV-01	0	0	0	0	PASS	4448	TCGA-5P-A9JV	KIRP	49	MALE	WHITE	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	2005	NA	-17973	Alive	NA	2043	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2043	0	2043	0	2043	0	2043	
60	TCGA-5P-A9JW	1	11	1	9	8	1	2	0	2	59	6	1	0	17	0	0	TCGA-5P-A9JW-01	45	0.05702412176803021	13	TCGA-5P-A9JW-01	4	2	15	0.028692424119385832	TCGA-5P-A9JW-01	0	0	0	0	PASS	4449	TCGA-5P-A9JW	KIRP	64	MALE	WHITE	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	2006	NA	-23570	Alive	NA	3241	NA	NA	NA	NA	NA	3228	Complete Remission/Response	NA	NA	0	3241	0	3241	1	3228	1	3228	
80	TCGA-5P-A9JY	0	15	0	7	16	4	3	1	7	74	3	0	0	26	4	0	TCGA-5P-A9JY-01	68	0.3334803393904618	25	TCGA-5P-A9JY-01	11	6	13	0.0181983060618484	TCGA-5P-A9JY-01	0	0	0	0	PASS	4450	TCGA-5P-A9JY	KIRP	79	MALE	WHITE	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	2006	NA	-28881	Dead	TUMOR FREE	NA	1508	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1508	0	1508	0	1508	0	1508	
50	TCGA-5P-A9JZ	1	8	2	3	4	1	1	0	0	33	2	0	0	12	0	0	TCGA-5P-A9JZ-01	176	0.04856633644459626	111	TCGA-5P-A9JZ-01	2	3	18	0.033647262223679614	TCGA-5P-A9JZ-01	0	0	0	0	PASS	4451	TCGA-5P-A9JZ	KIRP	51	FEMALE	WHITE	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	2006	NA	-18885	Alive	TUMOR FREE	2744	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2744	0	2744	0	2744	0	2744	
80	TCGA-5P-A9K0	2	9	2	7	10	2	3	0	11	57	1	0	1	24	2	0	TCGA-5P-A9K0-01	85	0.2443625598655952	35	TCGA-5P-A9K0-01	10	5	10	0.0013464902829774033	TCGA-5P-A9K0-01	0	0	0	0	PASS	4452	TCGA-5P-A9K0	KIRP	75	MALE	WHITE	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	2007	NA	-27434	Alive	NA	677	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	677	0	677	NA	NA	0	677	
60	TCGA-5P-A9K2	1	9	1	4	8	0	1	0	4	55	2	0	4	17	2	0	TCGA-5P-A9K2-01	45	0.2942761291859847	7	TCGA-5P-A9K2-01	10	5	6	0.0003663077296336576	TCGA-5P-A9K2-01	0	0	0	0	PASS	4453	TCGA-5P-A9K2	KIRP	62	MALE	WHITE	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	2007	NA	-22964	Alive	TUMOR FREE	2392	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2392	0	2392	0	2392	0	2392	
60	TCGA-5P-A9K3	1	5	0	4	3	3	1	0	5	49	4	0	0	13	2	0	TCGA-5P-A9K3-01	92	0.7723970404230485	30	TCGA-5P-A9K3-01	10	6	74	0.2132546526018851	TCGA-5P-A9K3-01	3	5	8	16	PASS	4454	TCGA-5P-A9K3	KIRP	59	MALE	WHITE	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	2007	NA	-21829	Dead	WITH TUMOR	NA	471	NA	NA	NA	NA	17	Partial Remission/Response	NA	NA	1	471	1	471	NA	NA	1	17	
50	TCGA-5P-A9K4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-5P-A9K4-01	66	0.8725091100125641	25	TCGA-5P-A9K4-01	10	6	8	0.0003132062654674331	TCGA-5P-A9K4-01	2	1	0	3	PASS	4455	TCGA-5P-A9K4	KIRP	54	MALE	WHITE	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-19986	Alive	TUMOR FREE	2184	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2184	0	2184	0	2184	0	2184	
60	TCGA-5P-A9K6	0	7	0	1	2	2	0	0	2	34	3	0	0	17	1	0	TCGA-5P-A9K6-01	67	0.15440835116909918	24	TCGA-5P-A9K6-01	8	5	4	0.00026767499248034685	TCGA-5P-A9K6-01	0	0	0	0	PASS	4456	TCGA-5P-A9K6	KIRP	64	MALE	WHITE	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-23384	Alive	NA	1914	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1914	0	1914	0	1914	0	1914	
50	TCGA-5P-A9K8	0	1	0	1	1	0	0	0	0	14	2	0	1	8	0	0	TCGA-5P-A9K8-01	39	0.9452206540728224	4	TCGA-5P-A9K8-01	6	5	30	0.182232807203401	TCGA-5P-A9K8-01	1	1	2	4	PASS	4457	TCGA-5P-A9K8	KIRP	51	FEMALE	WHITE	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-18880	Alive	TUMOR FREE	1309	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1309	0	1309	0	1309	0	1309	
60	TCGA-5P-A9K9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-5P-A9K9-01	97	0.8270174755129382	42	TCGA-5P-A9K9-01	16	14	120	0.4703829922530655	TCGA-5P-A9K9-01	8	6	6	20	PASS	4458	TCGA-5P-A9K9	KIRP	59	FEMALE	WHITE	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-21600	Dead	WITH TUMOR	NA	589	NA	NA	NA	NA	548	Complete Remission/Response	NA	NA	1	589	1	589	1	548	1	548	
60	TCGA-5P-A9KA	1	14	1	6	7	1	3	0	5	63	0	0	0	23	5	0	TCGA-5P-A9KA-01	57	0.04563571246787481	18	TCGA-5P-A9KA-01	2	1	6	0.0010181586717743383	TCGA-5P-A9KA-01	0	0	0	0	PASS	4459	TCGA-5P-A9KA	KIRP	61	MALE	WHITE	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-22545	Alive	TUMOR FREE	395	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	395	0	395	0	395	0	395	
50	TCGA-5P-A9KC	0	10	0	7	8	1	0	0	6	62	3	0	2	13	3	0	TCGA-5P-A9KC-01	69	0.14921204888126294	24	TCGA-5P-A9KC-01	6	6	15	0.027579753326189355	TCGA-5P-A9KC-01	3	1	2	6	PASS	4460	TCGA-5P-A9KC	KIRP	51	FEMALE	WHITE	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-18975	Alive	TUMOR FREE	377	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	377	0	377	0	377	0	377	
70	TCGA-5P-A9KE	0	10	1	5	5	3	0	0	3	63	2	0	2	24	1	0	TCGA-5P-A9KE-01	57	0.11243575141876444	13	TCGA-5P-A9KE-01	6	3	5	9.299181963086375e-05	TCGA-5P-A9KE-01	0	0	0	0	PASS	4461	TCGA-5P-A9KE	KIRP	70	MALE	WHITE	NA	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-25805	Alive	TUMOR FREE	824	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	824	0	824	0	824	0	824	
50	TCGA-5P-A9KF	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-5P-A9KF	0	0	0	TCGA-5P-A9KF	0	0	0	0	TCGA-5P-A9KF	0	0	0	0	PASS	4462	TCGA-5P-A9KF	KIRP	53	MALE	WHITE	NA	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-19631	Alive	TUMOR FREE	845	NA	NA	NA	NA	NA	728	[Unknown]	NA	NA	0	845	0	845	NA	NA	1	728	
80	TCGA-5P-A9KH	0	2	0	2	0	0	1	1	2	16	2	0	1	8	1	1	TCGA-5P-A9KH-01	129	0.9477260454668288	62	TCGA-5P-A9KH-01	10	5	93	0.3149431872800958	TCGA-5P-A9KH-01	0	0	0	0	PASS	4463	TCGA-5P-A9KH	KIRP	77	MALE	WHITE	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	2005	NA	-28193	Alive	TUMOR FREE	2051	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2051	0	2051	0	2051	0	2051	
40	TCGA-A4-7286	0	2	0	0	3	0	0	0	1	29	1	1	1	11	1	0	TCGA-A4-7286-01	53	0.7425279589279318	16	TCGA-A4-7286-01	23	25	8	0.20164989775489905	TCGA-A4-7286-01	0	0	0	0	PASS	4464	TCGA-A4-7286	KIRP	42	MALE	WHITE	NA	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-15631	Alive	TUMOR FREE	554	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	554	0	554	0	554	0	554	
80	TCGA-A4-7287	0	2	0	2	1	1	0	0	1	34	2	0	1	13	2	0	TCGA-A4-7287-01	98	0.9148447842879599	42	TCGA-A4-7287-01	12	10	30	0.2980139187865842	TCGA-A4-7287-01	7	0	7	14	pathology review	4465	TCGA-A4-7287	KIRP	75	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-27621	Dead	WITH TUMOR	NA	597	NA	NA	NA	NA	234	Complete Remission/Response	NA	NA	1	597	1	597	1	234	1	234	
70	TCGA-A4-7288	0	5	2	6	4	2	2	0	3	50	1	0	0	16	4	2	TCGA-A4-7288-01	49	0.13451619953328686	13	TCGA-A4-7288-01	8	7	3	0.07142314723731609	TCGA-A4-7288-01	0	0	0	0	PASS	4466	TCGA-A4-7288	KIRP	71	FEMALE	WHITE	NA	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-26268	Alive	TUMOR FREE	1857	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1857	0	1857	0	1857	0	1857	
60	TCGA-A4-7583	1	17	1	8	1	4	1	1	19	238	32	0	2	110	9	1	TCGA-A4-7583-01	91	0.2306552332656053	45	TCGA-A4-7583-01	6	4	15	0.14846594851928965	TCGA-A4-7583-01	0	0	0	0	PASS	4467	TCGA-A4-7583	KIRP	60	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-21962	Alive	TUMOR FREE	3	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3	0	3	NA	NA	0	3	
60	TCGA-A4-7584	0	7	0	3	5	4	0	1	4	46	3	0	0	18	4	0	TCGA-A4-7584-01	57	0.16917188866894867	12	TCGA-A4-7584-01	7	4	2	2.2070609305855967e-05	TCGA-A4-7584-01	0	0	0	0	PASS	4468	TCGA-A4-7584	KIRP	59	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-21782	Alive	TUMOR FREE	650	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	650	0	650	0	650	0	650	
70	TCGA-A4-7585	0	4	0	5	8	2	2	0	3	52	7	0	2	16	3	0	TCGA-A4-7585-01	63	0.07838508245159613	21	TCGA-A4-7585-01	2	1	4	0.018487912294462262	TCGA-A4-7585-01	3	2	1	6	PASS	4469	TCGA-A4-7585	KIRP	67	MALE	WHITE	Stage III	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2007	NA	-24778	Dead	TUMOR FREE	NA	1070	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1070	0	1070	0	1070	0	1070	
60	TCGA-A4-7732	1	2	0	4	11	0	2	0	4	77	2	0	2	16	4	0	TCGA-A4-7732-01	72	0.2307437839565144	32	TCGA-A4-7732-01	8	5	3	1.9780886368871828e-05	TCGA-A4-7732-01	0	0	0	0	PASS	4470	TCGA-A4-7732	KIRP	55	MALE	BLACK OR AFRICAN AMERICAN	NA	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-20226	Alive	TUMOR FREE	582	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	582	0	582	0	582	0	582	
50	TCGA-A4-7734	0	5	0	2	4	0	0	1	2	32	3	0	1	12	2	0	TCGA-A4-7734-01	53	0.10511431531988076	17	TCGA-A4-7734-01	6	3	0	0.0	TCGA-A4-7734-01	0	0	0	0	PASS	4471	TCGA-A4-7734	KIRP	53	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-19612	Alive	TUMOR FREE	27	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	27	0	27	NA	NA	0	27	
70	TCGA-A4-7828	0	1	0	0	4	1	1	0	2	21	2	0	0	7	1	0	TCGA-A4-7828-01	51	7.981353164360985e-06	13	TCGA-A4-7828-01	0	0	0	0.0	TCGA-A4-7828-01	0	0	0	0	pathology review	4472	TCGA-A4-7828	KIRP	74	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-27122	Alive	TUMOR FREE	238	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	238	0	238	0	238	0	238	
40	TCGA-A4-7915	0	2	0	0	1	0	1	0	0	23	1	0	0	6	2	0	TCGA-A4-7915-01	89	0.059336862618029326	38	TCGA-A4-7915-01	3	4	5	0.11617890062790835	TCGA-A4-7915-01	1	1	2	4	PASS	4473	TCGA-A4-7915	KIRP	35	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-12832	Alive	TUMOR FREE	7	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	7	0	7	NA	NA	0	7	
60	TCGA-A4-7996	0	6	0	4	13	3	1	0	6	51	2	0	0	23	3	0	TCGA-A4-7996-01	73	0.1433944111011373	25	TCGA-A4-7996-01	8	6	3	0.04900302423119007	TCGA-A4-7996-01	0	0	0	0	PASS	4474	TCGA-A4-7996	KIRP	61	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-22559	Alive	TUMOR FREE	506	NA	NA	NA	NA	NA	493	Complete Remission/Response	NA	NA	0	506	0	506	1	493	1	493	
70	TCGA-A4-7997	0	5	1	4	2	0	1	0	3	52	1	0	1	21	1	1	TCGA-A4-7997-01	100	0.2390280145508976	49	TCGA-A4-7997-01	10	8	22	0.0949050430725506	TCGA-A4-7997-01	2	5	3	10	PASS	4475	TCGA-A4-7997	KIRP	67	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-24486	Alive	TUMOR FREE	927	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	927	0	927	NA	NA	0	927	
70	TCGA-A4-8098	1	3	0	5	7	7	0	1	5	55	1	0	1	24	4	0	TCGA-A4-8098-01	85	0.2777291253108631	36	TCGA-A4-8098-01	9	8	50	0.12171836385926885	TCGA-A4-8098-01	3	4	3	10	PASS	4476	TCGA-A4-8098	KIRP	73	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-26685	Alive	TUMOR FREE	896	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	896	0	896	0	896	0	896	
60	TCGA-A4-8310	0	6	0	1	1	3	0	0	3	53	3	0	1	20	1	0	TCGA-A4-8310-01	69	0.23689250711739204	26	TCGA-A4-8310-01	12	7	9	0.02827365373213355	TCGA-A4-8310-01	0	0	0	0	PASS	4477	TCGA-A4-8310	KIRP	58	MALE	WHITE	Stage III	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-21312	Alive	TUMOR FREE	780	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	780	0	780	0	780	0	780	
60	TCGA-A4-8311	2	9	1	1	5	0	0	0	1	31	1	0	1	19	2	0	TCGA-A4-8311-01	57	0.9477294223972834	16	TCGA-A4-8311-01	12	7	8	0.0010611957350359481	TCGA-A4-8311-01	0	0	0	0	PASS	4478	TCGA-A4-8311	KIRP	60	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-22220	Alive	TUMOR FREE	729	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	729	0	729	0	729	0	729	
60	TCGA-A4-8312	0	1	0	0	1	0	0	0	0	10	1	0	0	5	1	0	TCGA-A4-8312-01	55	0.00011354489326518072	16	TCGA-A4-8312-01	0	0	5	0.0005016282454932119	TCGA-A4-8312-01	0	0	0	0	PASS	4479	TCGA-A4-8312	KIRP	60	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-22231	Alive	TUMOR FREE	708	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	708	0	708	0	708	0	708	
50	TCGA-A4-8515	0	4	2	3	13	2	2	0	2	70	8	0	1	22	2	2	TCGA-A4-8515-01	60	0.1916537460870724	26	TCGA-A4-8515-01	8	7	8	0.012841373536133488	TCGA-A4-8515-01	1	0	0	1	PASS	4480	TCGA-A4-8515	KIRP	47	MALE	AMERICAN INDIAN OR ALASKA NATIVE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-17345	Alive	TUMOR FREE	709	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	709	0	709	0	709	0	709	
60	TCGA-A4-8516	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A4-8516-01	63	0.947714016373602	18	TCGA-A4-8516-01	12	7	16	0.06514115617736684	TCGA-A4-8516-01	2	2	1	5	PASS	4481	TCGA-A4-8516	KIRP	62	MALE	WHITE	Stage III	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-22879	Alive	NA	23	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	23	0	23	NA	NA	0	23	
70	TCGA-A4-8517	0	2	0	3	9	2	2	0	9	53	3	0	1	28	1	0	TCGA-A4-8517-01	77	0.3205476529222012	24	TCGA-A4-8517-01	10	5	7	0.004162928727508498	TCGA-A4-8517-01	0	0	0	0	PASS	4482	TCGA-A4-8517	KIRP	71	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-26090	Alive	TUMOR FREE	597	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	597	0	597	0	597	0	597	
50	TCGA-A4-8518	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A4-8518-01	31	0.23632747859437506	2	TCGA-A4-8518-01	11	6	4	0.0004853076529318125	TCGA-A4-8518-01	1	0	0	1	PASS	4483	TCGA-A4-8518	KIRP	48	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-17713	Alive	TUMOR FREE	600	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	600	0	600	0	600	0	600	
60	TCGA-A4-8630	0	2	1	1	3	1	1	0	5	37	1	0	0	12	4	0	TCGA-A4-8630-01	55	0.9472329719980992	19	TCGA-A4-8630-01	11	8	10	0.04802121239625392	TCGA-A4-8630-01	0	0	0	0	PASS	4484	TCGA-A4-8630	KIRP	59	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-21884	Alive	TUMOR FREE	436	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	436	0	436	0	436	0	436	
80	TCGA-A4-A48D	0	10	0	3	10	3	4	1	4	62	3	0	2	31	3	1	TCGA-A4-A48D-01	69	0.15974746214664076	25	TCGA-A4-A48D-01	6	4	12	0.0012424961279970592	TCGA-A4-A48D-01	0	0	0	0	PASS	4485	TCGA-A4-A48D	KIRP	84	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-31038	Alive	TUMOR FREE	379	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	379	0	379	0	379	0	379	
70	TCGA-A4-A4ZT	2	8	0	2	3	0	2	0	8	80	4	0	0	22	4	0	TCGA-A4-A4ZT-01	45	0.9477313381100576	9	TCGA-A4-A4ZT-01	13	8	14	0.014077328772251037	TCGA-A4-A4ZT-01	0	0	0	0	PASS	4486	TCGA-A4-A4ZT	KIRP	71	FEMALE	WHITE	Stage I	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-26058	Alive	TUMOR FREE	516	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	516	0	516	0	516	0	516	
60	TCGA-A4-A57E	4	11	0	0	8	6	2	0	7	110	6	0	0	41	0	1	TCGA-A4-A57E-01	98	0.41656350259341385	44	TCGA-A4-A57E-01	16	11	40	0.19979515077833648	TCGA-A4-A57E-01	5	6	5	16	PASS	4487	TCGA-A4-A57E	KIRP	59	MALE	WHITE	Stage IV	Stage IV	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-21885	Dead	WITH TUMOR	NA	258	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	258	1	258	NA	NA	1	258	
50	TCGA-A4-A5DU	0	2	0	1	1	0	1	0	2	26	1	0	0	5	1	0	TCGA-A4-A5DU-01	81	0.9477918611013721	39	TCGA-A4-A5DU-01	15	9	8	0.012429144862574069	TCGA-A4-A5DU-01	0	0	0	0	PASS	4488	TCGA-A4-A5DU	KIRP	45	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-16779	Alive	TUMOR FREE	496	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	496	0	496	0	496	0	496	
70	TCGA-A4-A5XZ	0	16	0	9	8	3	1	0	2	91	4	0	0	28	2	0	TCGA-A4-A5XZ-01	47	0.9476717967960016	15	TCGA-A4-A5XZ-01	13	8	14	0.007434049934051736	TCGA-A4-A5XZ-01	2	1	1	4	PASS	4489	TCGA-A4-A5XZ	KIRP	65	FEMALE	WHITE	Stage II	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-24006	Alive	TUMOR FREE	479	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	479	0	479	0	479	0	479	
60	TCGA-A4-A5Y0	1	6	0	5	6	0	2	0	4	46	2	0	0	9	3	0	TCGA-A4-A5Y0-01	152	0.07769971802321017	100	TCGA-A4-A5Y0-01	3	2	26	0.04688895587325672	TCGA-A4-A5Y0-01	2	1	3	6	PASS	4490	TCGA-A4-A5Y0	KIRP	61	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-22341	Alive	TUMOR FREE	252	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	252	0	252	0	252	0	252	
80	TCGA-A4-A5Y1	0	6	0	3	4	3	0	0	5	49	6	0	1	20	2	0	TCGA-A4-A5Y1-01	122	0.9462826547408848	54	TCGA-A4-A5Y1-01	22	36	85	0.20269638967353606	TCGA-A4-A5Y1-01	9	4	7	20	PASS	4491	TCGA-A4-A5Y1	KIRP	75	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-27541	Dead	WITH TUMOR	NA	395	NA	NA	NA	NA	296	Complete Remission/Response	NA	NA	1	395	1	395	1	296	1	296	
70	TCGA-A4-A6HP	2	23	0	16	7	3	2	0	14	134	2	0	2	44	4	0	TCGA-A4-A6HP-01	45	0.1587285692180598	10	TCGA-A4-A6HP-01	6	4	9	0.0006047177586957431	TCGA-A4-A6HP-01	0	0	0	0	PASS	4492	TCGA-A4-A6HP	KIRP	66	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-24447	Alive	TUMOR FREE	379	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	379	0	379	0	379	0	379	
40	TCGA-A4-A772	0	6	1	2	4	0	0	0	2	31	2	0	0	17	1	1	TCGA-A4-A772-01	86	0.6293434771381176	34	TCGA-A4-A772-01	11	6	5	0.00023033465798368155	TCGA-A4-A772-01	0	0	0	0	PASS	4493	TCGA-A4-A772	KIRP	39	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-14278	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-A4-A7UZ	1	9	0	3	8	5	2	0	4	41	1	0	1	19	4	0	TCGA-A4-A7UZ-01	82	0.3057518786159404	29	TCGA-A4-A7UZ-01	10	8	19	0.017980192327819864	TCGA-A4-A7UZ-01	5	2	1	8	PASS	4494	TCGA-A4-A7UZ	KIRP	71	MALE	WHITE	Stage III	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-26264	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
40	TCGA-AL-3466	0	1	1	1	1	1	2	0	2	24	2	0	0	8	1	1	TCGA-AL-3466-01	470	0.9743789151339162	316	TCGA-AL-3466-01	28	24	151	0.17476975538060127	TCGA-AL-3466-01	11	7	11	29	PASS	4495	TCGA-AL-3466	KIRP	41	MALE	WHITE	Stage IV	Stage IV	Kidney Papillary Renal Cell Carcinoma	NA	2004	NA	-15181	Dead	WITH TUMOR	NA	293	NA	NA	NA	NA	138	NA	NA	NA	1	293	1	293	NA	NA	1	138	
50	TCGA-AL-3467	0	2	0	1	1	0	0	0	1	14	0	0	0	4	0	0	TCGA-AL-3467-01	41	3.318474093427969e-05	4	TCGA-AL-3467-01	0	0	14	0.0006484480913760328	TCGA-AL-3467-01	0	0	0	0	pathology review	4496	TCGA-AL-3467	KIRP	54	FEMALE	WHITE	NA	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2005	NA	-19783	Alive	TUMOR FREE	2135	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2135	0	2135	0	2135	0	2135	
70	TCGA-AL-3468	1	2	0	3	8	3	0	1	3	63	3	0	0	25	2	0	TCGA-AL-3468-01	159	0.9477926653323736	95	TCGA-AL-3468	0	0	0	0	TCGA-AL-3468-01	0	0	0	0	PASS	4497	TCGA-AL-3468	KIRP	74	MALE	WHITE	Stage II	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2005	NA	-27205	Dead	TUMOR FREE	NA	2331	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2331	0	2331	0	2331	0	2331	
70	TCGA-AL-3471	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AL-3471-01	67	0.94774022616975	29	TCGA-AL-3471	0	0	0	0	TCGA-AL-3471	0	0	0	0	PASS	4498	TCGA-AL-3471	KIRP	74	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2006	NA	-27249	Dead	TUMOR FREE	NA	1500	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	1500	0	1500	NA	NA	0	1500	
60	TCGA-AL-3472	0	3	0	0	3	2	0	0	1	37	2	0	0	10	3	0	TCGA-AL-3472-01	143	0.08204215835057388	89	TCGA-AL-3472-01	4	4	33	0.06154028911966832	TCGA-AL-3472-01	0	0	0	0	PASS	4499	TCGA-AL-3472	KIRP	57	MALE	BLACK OR AFRICAN AMERICAN	NA	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-21166	Alive	TUMOR FREE	2029	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2029	0	2029	0	2029	0	2029	
60	TCGA-AL-3473	0	2	0	0	5	2	0	0	3	35	3	0	1	11	1	0	TCGA-AL-3473-01	110	0.12168539627786926	52	TCGA-AL-3473-01	2	3	30	0.06463226773507645	TCGA-AL-3473-01	2	1	1	4	PASS	4500	TCGA-AL-3473	KIRP	55	MALE	WHITE	Stage II	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-20104	Alive	TUMOR FREE	1906	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1906	0	1906	0	1906	0	1906	
70	TCGA-AL-7173	0	5	1	3	5	0	0	0	1	46	2	0	0	15	0	0	TCGA-AL-7173-01	46	0.17903091720956593	12	TCGA-AL-7173-01	6	6	4	0.09283224812885894	TCGA-AL-7173-01	0	0	0	0	PASS	4501	TCGA-AL-7173	KIRP	72	FEMALE	WHITE	Stage IV	Stage IV	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-26326	Alive	WITH TUMOR	2060	NA	NA	NA	NA	NA	332	Progressive Disease	NA	NA	0	2060	0	2060	NA	NA	1	332	
50	TCGA-AL-A5DJ	0	5	1	1	0	0	0	0	4	26	0	0	1	10	0	0	TCGA-AL-A5DJ	0	0	0	TCGA-AL-A5DJ	0	0	0	0	TCGA-AL-A5DJ-01	8	12	11	31	PASS	4502	TCGA-AL-A5DJ	KIRP	54	FEMALE	WHITE	Stage III	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-20079	Dead	WITH TUMOR	NA	1498	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	1498	1	1498	NA	NA	1	1498	
80	TCGA-AT-A5NU	0	6	0	1	6	3	0	0	1	52	5	0	1	12	2	0	TCGA-AT-A5NU-01	45	0.9477272223923984	7	TCGA-AT-A5NU-01	14	10	7	0.0003995528383515621	TCGA-AT-A5NU-01	0	0	0	0	PASS	4503	TCGA-AT-A5NU	KIRP	77	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-28137	Alive	NA	67	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	67	0	67	NA	NA	0	67	
70	TCGA-B1-5398	0	2	0	2	9	2	0	0	9	63	9	0	2	35	5	0	TCGA-B1-5398-01	31	0.15222008183873156	4	TCGA-B1-5398-01	6	6	3	0.09941810178166824	TCGA-B1-5398-01	0	0	0	0	PASS	4504	TCGA-B1-5398	KIRP	73	MALE	WHITE	Stage III	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-26820	Alive	TUMOR FREE	1251	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1251	0	1251	0	1251	0	1251	
60	TCGA-B1-7332	0	7	0	2	5	0	1	0	2	33	1	0	0	15	0	0	TCGA-B1-7332-01	55	0.5594327216788777	20	TCGA-B1-7332-01	22	27	19	0.00021276842168441355	TCGA-B1-7332-01	1	0	0	1	PASS	4505	TCGA-B1-7332	KIRP	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-22277	Alive	TUMOR FREE	1141	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1141	0	1141	0	1141	0	1141	
80	TCGA-B1-A47M	0	24	0	4	24	6	0	0	6	121	8	2	0	54	2	2	TCGA-B1-A47M-01	60	0.14850087212050073	15	TCGA-B1-A47M-01	7	6	10	0.0012367383799928627	TCGA-B1-A47M-01	3	2	0	5	PASS	4506	TCGA-B1-A47M	KIRP	79	MALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-29068	Alive	WITH TUMOR	659	NA	NA	NA	NA	NA	408	[Unknown]	NA	NA	0	659	0	659	NA	NA	1	408	
60	TCGA-B1-A47N	0	3	0	1	2	1	0	0	2	24	1	0	0	8	1	0	TCGA-B1-A47N-01	59	0.18266138950707847	17	TCGA-B1-A47N-01	8	4	5	0.0002940869761534655	TCGA-B1-A47N-01	0	0	0	0	PASS	4507	TCGA-B1-A47N	KIRP	62	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-22800	Alive	TUMOR FREE	1110	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1110	0	1110	0	1110	0	1110	
50	TCGA-B1-A47O	0	3	0	0	0	1	0	0	2	24	0	0	0	14	0	0	TCGA-B1-A47O	0	0	0	TCGA-B1-A47O	0	0	0	0	TCGA-B1-A47O-01	1	1	0	2	PASS	4508	TCGA-B1-A47O	KIRP	54	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-19823	Alive	TUMOR FREE	842	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	842	0	842	0	842	0	842	
40	TCGA-B1-A654	0	9	0	2	2	1	3	1	5	46	3	0	1	13	0	1	TCGA-B1-A654-01	97	0.11290329724075712	51	TCGA-B1-A654-01	6	5	18	0.048416790326934085	TCGA-B1-A654-01	0	0	0	0	PASS	4509	TCGA-B1-A654	KIRP	43	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-15721	Alive	TUMOR FREE	616	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	616	0	616	0	616	0	616	
80	TCGA-B1-A655	3	12	0	4	13	1	0	1	5	56	3	0	1	28	2	0	TCGA-B1-A655-01	36	0.06993424887618141	4	TCGA-B1-A655-01	1	3	17	0.0608616574891782	TCGA-B1-A655-01	3	2	1	6	PASS	4510	TCGA-B1-A655	KIRP	77	FEMALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-28433	Alive	TUMOR FREE	510	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	510	0	510	0	510	0	510	
60	TCGA-B1-A656	0	10	1	5	6	3	1	1	11	72	8	0	2	28	3	0	TCGA-B1-A656-01	57	0.18816444552122985	23	TCGA-B1-A656-01	8	6	27	0.09982132535927668	TCGA-B1-A656-01	0	0	0	0	PASS	4511	TCGA-B1-A656	KIRP	64	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-23702	Alive	TUMOR FREE	618	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	618	0	618	0	618	0	618	
50	TCGA-B1-A657	0	9	0	9	6	1	0	1	4	56	1	0	0	23	1	1	TCGA-B1-A657-01	64	0.261477411206559	22	TCGA-B1-A657-01	9	5	15	0.002946953200673884	TCGA-B1-A657-01	1	0	0	1	PASS	4512	TCGA-B1-A657	KIRP	54	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-19806	Alive	TUMOR FREE	641	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	641	0	641	0	641	0	641	
50	TCGA-B3-3925	4	16	0	2	6	4	4	0	9	94	14	0	3	40	4	0	TCGA-B3-3925-01	59	0.1708517765172981	18	TCGA-B3-3925-01	9	5	2	0.011757590402672638	TCGA-B3-3925-01	0	0	0	0	PASS	4513	TCGA-B3-3925	KIRP	52	MALE	WHITE	Stage III	NA	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-19224	Alive	TUMOR FREE	1029	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1029	0	1029	0	1029	0	1029	
60	TCGA-B3-3926	0	1	0	1	1	0	0	0	2	10	0	0	0	0	1	0	TCGA-B3-3926-01	83	0.9477334989862422	35	TCGA-B3-3926-01	17	11	11	0.4678370187734767	TCGA-B3-3926-01	0	0	0	0	PASS	4514	TCGA-B3-3926	KIRP	59	FEMALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-21876	Alive	TUMOR FREE	883	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	883	0	883	0	883	0	883	
60	TCGA-B3-4103	0	8	0	2	8	2	2	0	6	82	2	0	2	28	0	0	TCGA-B3-4103-01	61	0.8488251522168042	19	TCGA-B3-4103-01	12	7	0	0.0	TCGA-B3-4103-01	0	0	0	0	PASS	4515	TCGA-B3-4103	KIRP	56	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-20708	Alive	TUMOR FREE	930	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	930	0	930	0	930	0	930	
80	TCGA-B3-4104	2	4	0	4	3	0	0	0	8	112	16	0	3	54	6	2	TCGA-B3-4104-01	136	0.12994326569892156	72	TCGA-B3-4104-01	3	4	14	0.043918653604335466	TCGA-B3-4104-01	4	1	2	7	pathology review	4516	TCGA-B3-4104	KIRP	75	MALE	WHITE	Stage II	NA	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-27709	Alive	TUMOR FREE	1049	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1049	0	1049	NA	NA	0	1049	
50	TCGA-B3-8121	0	2	1	2	6	2	0	0	1	21	3	0	0	8	0	0	TCGA-B3-8121-01	49	0.16664882885125476	15	TCGA-B3-8121-01	9	5	12	0.0004455891007537472	TCGA-B3-8121-01	0	0	0	0	PASS	4517	TCGA-B3-8121	KIRP	48	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-17760	Alive	TUMOR FREE	379	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	379	0	379	0	379	0	379	
40	TCGA-B3-A6W5	0	8	0	13	4	0	0	0	2	52	0	0	0	23	4	0	TCGA-B3-A6W5-01	49	0.9477282801927384	9	TCGA-B3-A6W5-01	12	8	8	0.0007061830033056858	TCGA-B3-A6W5-01	0	0	0	0	PASS	4518	TCGA-B3-A6W5	KIRP	43	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-15945	Alive	TUMOR FREE	309	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	309	0	309	0	309	0	309	
60	TCGA-B9-4113	1	5	0	3	7	2	0	1	3	37	4	0	0	19	4	0	TCGA-B9-4113-01	255	0.13256398899565586	185	TCGA-B9-4113-01	6	4	12	0.0004987327356035714	TCGA-B9-4113-01	0	0	0	0	PASS	4519	TCGA-B9-4113	KIRP	64	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2002	NA	-23613	Dead	TUMOR FREE	NA	1536	NA	NA	NA	NA	NA	NA	NA	NA	1	1536	0	1536	NA	NA	0	1536	
50	TCGA-B9-4114	1	2	0	1	6	1	1	1	2	54	3	0	0	20	0	0	TCGA-B9-4114-01	218	0.3711554386721831	150	TCGA-B9-4114-01	11	8	22	0.04378872922788536	TCGA-B9-4114-01	2	0	0	2	PASS	4520	TCGA-B9-4114	KIRP	49	MALE	BLACK OR AFRICAN AMERICAN	NA	Stage IV	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-17989	Alive	WITH TUMOR	857	NA	NA	NA	NA	NA	637	NA	NA	NA	0	857	0	857	NA	NA	1	637	
50	TCGA-B9-4115	0	14	0	4	12	0	2	2	0	75	3	0	0	37	2	1	TCGA-B9-4115-01	91	0.08200514746459799	45	TCGA-B9-4115-01	4	3	0	0.0	TCGA-B9-4115-01	0	0	0	0	PASS	4521	TCGA-B9-4115	KIRP	53	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-19571	Alive	TUMOR FREE	803	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	803	0	803	NA	NA	0	803	
80	TCGA-B9-4116	0	1	1	3	8	1	3	1	1	54	5	0	0	22	4	0	TCGA-B9-4116-01	137	0.16756828917175826	87	TCGA-B9-4116-01	5	4	18	0.10962400210478834	TCGA-B9-4116-01	1	3	3	7	PASS	4522	TCGA-B9-4116	KIRP	75	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-27692	Alive	TUMOR FREE	627	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	627	0	627	NA	NA	0	627	
50	TCGA-B9-4117	0	3	1	0	1	0	2	0	2	32	2	0	0	10	0	0	TCGA-B9-4117-01	111	0.9365382461349948	60	TCGA-B9-4117-01	37	31	10	0.09230017670064633	TCGA-B9-4117-01	3	3	2	8	PASS	4523	TCGA-B9-4117	KIRP	48	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-17622	Alive	TUMOR FREE	14	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	14	0	14	NA	NA	0	14	
40	TCGA-B9-4617	1	4	0	2	5	0	0	0	0	34	2	0	1	10	1	0	TCGA-B9-4617-01	285	0.947764664856374	206	TCGA-B9-4617-01	15	9	5	5.853090527809832e-05	TCGA-B9-4617-01	0	0	0	0	PASS	4524	TCGA-B9-4617	KIRP	41	MALE	BLACK OR AFRICAN AMERICAN	NA	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-15053	Alive	TUMOR FREE	35	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	35	0	35	NA	NA	0	35	
70	TCGA-B9-5155	0	7	0	5	7	3	1	0	3	70	5	0	1	27	1	1	TCGA-B9-5155-01	37	0.3913631144999217	6	TCGA-B9-5155-01	10	5	0	0.0	TCGA-B9-5155-01	0	0	0	0	PASS	4525	TCGA-B9-5155	KIRP	71	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-26149	Alive	TUMOR FREE	665	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	665	0	665	0	665	0	665	
50	TCGA-B9-5156	0	2	0	2	3	4	3	0	0	64	0	0	2	21	1	0	TCGA-B9-5156-01	45	0.2456152717428764	12	TCGA-B9-5156-01	10	5	19	2.157636779537246e-05	TCGA-B9-5156-01	0	0	0	0	PASS	4526	TCGA-B9-5156	KIRP	51	MALE	WHITE	NA	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-18841	Alive	TUMOR FREE	1338	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1338	0	1338	0	1338	0	1338	
60	TCGA-B9-7268	1	3	0	4	3	1	0	0	3	37	1	0	1	19	1	0	TCGA-B9-7268-01	45	0.9477295742330896	6	TCGA-B9-7268-01	12	8	0	0.0	TCGA-B9-7268-01	0	0	0	0	PASS	4527	TCGA-B9-7268	KIRP	59	MALE	WHITE	Stage II	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-21705	Alive	TUMOR FREE	671	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	671	0	671	0	671	0	671	
70	TCGA-B9-A44B	0	16	0	5	15	4	5	0	5	94	3	0	5	31	2	0	TCGA-B9-A44B-01	139	0.6629505816638277	77	TCGA-B9-A44B-01	14	15	60	0.1354731023846967	TCGA-B9-A44B-01	10	8	3	21	PASS	4528	TCGA-B9-A44B	KIRP	70	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-25763	Alive	TUMOR FREE	361	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	361	0	361	NA	NA	0	361	
50	TCGA-B9-A5W7	0	6	1	0	1	0	1	0	1	10	1	0	0	4	0	0	TCGA-B9-A5W7-01	57	0.20277025920268554	19	TCGA-B9-A5W7-01	9	5	6	0.012181457005307608	TCGA-B9-A5W7-01	0	0	0	0	PASS	4529	TCGA-B9-A5W7	KIRP	47	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-17465	Alive	TUMOR FREE	585	NA	NA	NA	NA	NA	564	Complete Remission/Response	NA	NA	0	585	0	585	1	564	1	564	
50	TCGA-B9-A5W8	1	0	0	2	4	2	3	0	0	22	3	1	0	19	3	0	TCGA-B9-A5W8-01	87	0.2217957320856492	41	TCGA-B9-A5W8-01	4	3	40	0.15082357113748887	TCGA-B9-A5W8-01	0	0	0	0	PASS	4530	TCGA-B9-A5W8	KIRP	50	MALE	BLACK OR AFRICAN AMERICAN	Stage II	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-18440	Alive	TUMOR FREE	524	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	524	0	524	0	524	0	524	
40	TCGA-B9-A5W9	0	8	0	6	4	1	0	0	2	39	2	0	0	13	0	0	TCGA-B9-A5W9-01	338	0.9476921568016176	236	TCGA-B9-A5W9-01	14	13	93	0.07577972205744199	TCGA-B9-A5W9-01	3	1	1	5	PASS	4531	TCGA-B9-A5W9	KIRP	40	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-14668	Alive	TUMOR FREE	5	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	5	0	5	0	5	0	5	
70	TCGA-B9-A69E	0	15	1	7	5	3	1	1	3	63	1	1	1	20	1	0	TCGA-B9-A69E-01	175	0.1480972124306428	112	TCGA-B9-A69E-01	3	5	62	0.14368041884918087	TCGA-B9-A69E-01	4	6	7	17	PASS	4532	TCGA-B9-A69E	KIRP	71	MALE	WHITE	Stage III	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-26198	Alive	TUMOR FREE	452	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	452	0	452	0	452	0	452	
50	TCGA-B9-A8YH	0	9	0	8	10	2	0	0	5	70	1	0	1	26	3	0	TCGA-B9-A8YH-01	69	0.9477286780609396	25	TCGA-B9-A8YH-01	10	6	8	0.0010919884147921359	TCGA-B9-A8YH-01	0	0	0	0	PASS	4533	TCGA-B9-A8YH	KIRP	52	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-19051	Alive	TUMOR FREE	532	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	532	0	532	0	532	0	532	
80	TCGA-B9-A8YI	1	14	0	6	10	3	2	0	7	76	5	2	4	24	4	0	TCGA-B9-A8YI-01	74	0.03748459363438608	26	TCGA-B9-A8YI-01	1	2	20	0.02147597585335683	TCGA-B9-A8YI-01	2	2	2	6	PASS	4534	TCGA-B9-A8YI	KIRP	79	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-28917	Alive	TUMOR FREE	374	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	374	0	374	0	374	0	374	
70	TCGA-BQ-5875	0	2	1	4	8	1	0	0	4	48	5	0	0	18	1	0	TCGA-BQ-5875-01	74	0.21465555137097636	28	TCGA-BQ-5875-01	8	12	2	0.04830274623553352	TCGA-BQ-5875-01	3	0	1	4	PASS	4535	TCGA-BQ-5875	KIRP	66	FEMALE	WHITE	Stage III	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2004	NA	-24153	Alive	TUMOR FREE	2639	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2639	0	2639	NA	NA	0	2639	
80	TCGA-BQ-5876	1	10	0	0	5	2	1	0	3	57	1	0	1	18	1	0	TCGA-BQ-5876-01	75	0.9371123046142212	28	TCGA-BQ-5876-01	7	9	12	0.27042786482504466	TCGA-BQ-5876-01	4	1	2	7	PASS	4536	TCGA-BQ-5876	KIRP	75	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2004	NA	-27409	Alive	TUMOR FREE	586	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	586	0	586	NA	NA	0	586	
60	TCGA-BQ-5877	1	1	0	2	8	5	1	0	3	52	6	0	1	13	0	0	TCGA-BQ-5877-01	147	0.29077803278630443	82	TCGA-BQ-5877-01	8	8	17	0.22464542872665413	TCGA-BQ-5877-01	3	3	5	11	PASS	4537	TCGA-BQ-5877	KIRP	60	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	Stage IV	Kidney Papillary Renal Cell Carcinoma	NA	2004	NA	-22095	Dead	WITH TUMOR	NA	270	NA	NA	NA	NA	127	NA	NA	NA	1	270	1	270	NA	NA	1	127	
80	TCGA-BQ-5878	0	4	1	6	7	1	0	0	1	67	3	0	1	36	3	0	TCGA-BQ-5878-01	163	0.04190358506637477	96	TCGA-BQ-5878-01	0	0	22	0.03150097245595503	TCGA-BQ-5878-01	3	6	1	10	PASS	4538	TCGA-BQ-5878	KIRP	79	FEMALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2005	NA	-29010	Alive	WITH TUMOR	1938	NA	NA	NA	NA	NA	1022	NA	NA	NA	0	1938	0	1938	NA	NA	1	1022	
30	TCGA-BQ-5879	0	1	0	0	2	0	0	0	1	19	0	0	1	7	0	0	TCGA-BQ-5879-01	116	0.9298192411858658	57	TCGA-BQ-5879-01	10	7	11	0.2788009014368353	TCGA-BQ-5879-01	4	2	4	10	PASS	4539	TCGA-BQ-5879	KIRP	32	FEMALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2005	NA	-11862	Dead	WITH TUMOR	NA	697	NA	NA	NA	NA	130	NA	NA	NA	1	697	1	697	NA	NA	1	130	
80	TCGA-BQ-5880	0	2	0	1	7	1	1	0	1	34	3	0	0	10	1	0	TCGA-BQ-5880-01	92	0.16845751516983404	38	TCGA-BQ-5880-01	6	7	19	0.015185729499942341	TCGA-BQ-5880-01	2	2	1	5	PASS	4540	TCGA-BQ-5880	KIRP	79	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2006	NA	-29053	Dead	WITH TUMOR	NA	1314	NA	NA	NA	NA	972	NA	NA	NA	1	1314	1	1314	NA	NA	1	972	
70	TCGA-BQ-5881	0	1	0	1	1	1	0	0	1	32	0	0	0	7	0	0	TCGA-BQ-5881-01	57	0.1797047601492364	14	TCGA-BQ-5881-01	8	6	19	0.06522232146535603	TCGA-BQ-5881-01	0	0	0	0	PASS	4541	TCGA-BQ-5881	KIRP	69	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2006	NA	-25481	Alive	TUMOR FREE	1454	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1454	0	1454	NA	NA	0	1454	
50	TCGA-BQ-5882	0	5	0	3	1	3	0	0	3	39	5	0	0	18	1	0	TCGA-BQ-5882-01	106	0.9161838767597382	50	TCGA-BQ-5882-01	14	9	16	0.40698678688903855	TCGA-BQ-5882-01	3	1	5	9	PASS	4542	TCGA-BQ-5882	KIRP	54	MALE	NA	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2007	NA	-20042	Dead	WITH TUMOR	NA	658	NA	NA	NA	NA	340	NA	NA	NA	1	658	1	658	NA	NA	1	340	
80	TCGA-BQ-5883	0	0	0	0	2	0	0	0	0	15	1	0	1	8	1	0	TCGA-BQ-5883-01	69	3.4320157511986225e-05	29	TCGA-BQ-5883-01	0	0	19	2.1207991523927608e-05	TCGA-BQ-5883-01	0	0	0	0	PASS	4543	TCGA-BQ-5883	KIRP	79	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2007	NA	-28877	Alive	TUMOR FREE	1242	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1242	0	1242	NA	NA	0	1242	
60	TCGA-BQ-5884	1	4	0	1	3	1	1	0	2	29	2	0	0	12	1	1	TCGA-BQ-5884-01	65	0.06533277709612717	28	TCGA-BQ-5884-01	3	4	2	0.04384654395165799	TCGA-BQ-5884-01	0	0	0	0	PASS	4544	TCGA-BQ-5884	KIRP	59	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-21730	Alive	TUMOR FREE	792	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	792	0	792	NA	NA	0	792	
60	TCGA-BQ-5885	1	5	0	0	7	1	0	1	4	81	5	0	1	23	4	0	TCGA-BQ-5885-01	60	0.1908797131094153	20	TCGA-BQ-5885-01	2	8	14	0.139238272797103	TCGA-BQ-5885-01	3	4	3	10	PASS	4545	TCGA-BQ-5885	KIRP	63	MALE	WHITE	Stage III	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-23173	Alive	TUMOR FREE	921	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	921	0	921	NA	NA	0	921	
80	TCGA-BQ-5886	1	2	0	1	4	0	0	0	5	48	1	0	0	10	3	0	TCGA-BQ-5886-01	55	0.11374058676849925	15	TCGA-BQ-5886-01	5	3	19	0.0034377286236677664	TCGA-BQ-5886-01	1	0	0	1	PASS	4546	TCGA-BQ-5886	KIRP	75	MALE	WHITE	Stage III	[Discrepancy]	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-27670	Alive	TUMOR FREE	792	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	792	0	792	NA	NA	0	792	
50	TCGA-BQ-5887	0	1	0	0	0	1	0	0	2	12	0	0	0	8	1	0	TCGA-BQ-5887-01	76	0.7259673002165302	28	TCGA-BQ-5887-01	14	30	15	0.4454843485751368	TCGA-BQ-5887-01	5	4	2	11	PASS	4547	TCGA-BQ-5887	KIRP	54	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-19747	Alive	TUMOR FREE	771	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	771	0	771	NA	NA	0	771	
70	TCGA-BQ-5888	0	1	0	1	1	0	0	0	0	15	1	0	0	6	1	0	TCGA-BQ-5888-01	62	0.13955763396284054	19	TCGA-BQ-5888-01	4	4	6	0.1254300807380222	TCGA-BQ-5888-01	3	3	1	7	PASS	4548	TCGA-BQ-5888	KIRP	74	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-27346	Alive	TUMOR FREE	403	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	403	0	403	NA	NA	0	403	
60	TCGA-BQ-5889	0	1	0	2	5	1	0	0	2	46	1	0	2	13	1	0	TCGA-BQ-5889-01	61	0.26073397480923355	24	TCGA-BQ-5889-01	0	0	3	7.68408313908763e-05	TCGA-BQ-5889-01	0	0	0	0	PASS	4549	TCGA-BQ-5889	KIRP	63	MALE	WHITE	Stage IV	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-23267	Dead	WITH TUMOR	NA	329	NA	NA	NA	NA	-35	NA	NA	NA	1	329	1	329	NA	NA	1	NA	
70	TCGA-BQ-5890	1	5	0	3	1	2	0	0	3	60	3	0	0	20	1	0	TCGA-BQ-5890-01	80	0.1894837086321011	29	TCGA-BQ-5890-01	4	10	13	0.1204928555089775	TCGA-BQ-5890-01	10	6	3	19	PASS	4550	TCGA-BQ-5890	KIRP	69	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-25272	Alive	TUMOR FREE	233	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	233	0	233	NA	NA	0	233	
60	TCGA-BQ-5891	0	1	1	1	1	0	0	0	0	15	1	0	2	15	1	0	TCGA-BQ-5891-01	148	0.9471917956955406	76	TCGA-BQ-5891-01	13	18	32	0.7433953641062934	TCGA-BQ-5891-01	2	0	0	2	PASS	4551	TCGA-BQ-5891	KIRP	57	FEMALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-20945	Alive	TUMOR FREE	29	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	29	0	29	NA	NA	0	29	
50	TCGA-BQ-5892	1	2	0	1	11	2	0	0	1	42	3	0	0	10	2	0	TCGA-BQ-5892-01	77	0.19173527824099465	34	TCGA-BQ-5892-01	3	4	5	0.0709925032599755	TCGA-BQ-5892-01	1	3	0	4	PASS	4552	TCGA-BQ-5892	KIRP	51	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-18785	Alive	TUMOR FREE	364	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	364	0	364	NA	NA	0	364	
60	TCGA-BQ-5893	0	4	0	2	0	1	1	0	0	32	1	0	1	16	1	0	TCGA-BQ-5893-01	83	0.26280205130325884	38	TCGA-BQ-5893-01	7	6	5	0.04052682492641791	TCGA-BQ-5893-01	3	0	1	4	PASS	4553	TCGA-BQ-5893	KIRP	61	MALE	WHITE	Stage IV	Stage IV	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-22320	Dead	WITH TUMOR	NA	241	NA	NA	NA	NA	188	NA	NA	NA	1	241	1	241	NA	NA	1	188	
40	TCGA-BQ-5894	0	3	0	1	1	0	0	1	1	24	0	0	0	2	0	0	TCGA-BQ-5894-01	89	0.5577083479821161	42	TCGA-BQ-5894-01	19	20	12	0.3678060288691892	TCGA-BQ-5894-01	0	0	0	0	PASS	4554	TCGA-BQ-5894	KIRP	42	MALE	NA	Stage IV	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-15510	Alive	WITH TUMOR	84	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	84	0	84	NA	NA	0	84	
70	TCGA-BQ-7044	0	22	2	11	5	3	2	0	11	232	30	1	3	96	6	0	TCGA-BQ-7044-01	100	0.19403104252611544	42	TCGA-BQ-7044-01	8	6	8	0.1104448974099881	TCGA-BQ-7044-01	2	0	3	5	PASS	4555	TCGA-BQ-7044	KIRP	73	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2000	NA	-26831	Alive	TUMOR FREE	3760	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3760	0	3760	NA	NA	0	3760	
80	TCGA-BQ-7045	2	8	0	5	9	4	0	0	2	66	2	0	1	25	4	0	TCGA-BQ-7045-01	101	0.17972640699140552	52	TCGA-BQ-7045-01	8	4	0	0.0	TCGA-BQ-7045-01	0	0	0	0	PASS	4556	TCGA-BQ-7045	KIRP	78	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2001	NA	-28709	Dead	TUMOR FREE	NA	1468	NA	NA	NA	NA	NA	NA	NA	NA	1	1468	0	1468	NA	NA	0	1468	
60	TCGA-BQ-7046	1	3	1	5	7	1	0	0	3	69	5	0	2	22	2	1	TCGA-BQ-7046-01	81	0.947734279926998	36	TCGA-BQ-7046-01	13	8	0	0.0	TCGA-BQ-7046-01	0	0	0	0	PASS	4557	TCGA-BQ-7046	KIRP	61	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2002	NA	-22337	Alive	TUMOR FREE	2948	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2948	0	2948	NA	NA	0	2948	
60	TCGA-BQ-7048	1	13	1	8	5	0	2	0	5	155	19	0	1	62	8	1	TCGA-BQ-7048-01	107	0.030695550043716033	49	TCGA-BQ-7048-01	0	2	10	0.025989201770906863	TCGA-BQ-7048-01	2	0	2	4	PASS	4558	TCGA-BQ-7048	KIRP	64	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2003	NA	-23460	Alive	WITH TUMOR	2839	NA	NA	NA	NA	NA	229	NA	NA	NA	0	2839	0	2839	NA	NA	1	229	
50	TCGA-BQ-7049	0	19	0	17	0	0	0	0	14	209	10	0	4	72	6	0	TCGA-BQ-7049	0	0	0	TCGA-BQ-7049	0	0	0	0	TCGA-BQ-7049-01	0	2	1	3	PASS	4559	TCGA-BQ-7049	KIRP	45	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2005	NA	-16717	Dead	TUMOR FREE	NA	1364	NA	NA	NA	NA	NA	NA	NA	NA	1	1364	0	1364	NA	NA	0	1364	
50	TCGA-BQ-7050	0	0	0	1	1	0	1	0	3	20	1	0	0	4	0	1	TCGA-BQ-7050-01	75	0.011082024672522749	29	TCGA-BQ-7050-01	1	1	3	0.011648490653325313	TCGA-BQ-7050-01	0	0	0	0	PASS	4560	TCGA-BQ-7050	KIRP	53	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2006	NA	-19550	Alive	TUMOR FREE	1864	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1864	0	1864	NA	NA	0	1864	
70	TCGA-BQ-7051	1	5	0	3	9	1	1	0	3	78	7	0	2	40	0	0	TCGA-BQ-7051-01	41	0.1901968912674044	11	TCGA-BQ-7051-01	0	0	0	0.0	TCGA-BQ-7051-01	0	0	0	0	PASS	4561	TCGA-BQ-7051	KIRP	74	MALE	WHITE	Stage II	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2007	NA	-27120	Alive	TUMOR FREE	1533	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1533	0	1533	NA	NA	0	1533	
60	TCGA-BQ-7053	0	5	0	5	5	0	1	0	5	126	14	0	2	37	3	0	TCGA-BQ-7053-01	69	0.01600310895434815	23	TCGA-BQ-7053-01	0	3	3	0.05094178858995238	TCGA-BQ-7053-01	0	1	0	1	PASS	4562	TCGA-BQ-7053	KIRP	57	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2007	NA	-20837	Alive	TUMOR FREE	1516	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1516	0	1516	NA	NA	0	1516	
70	TCGA-BQ-7055	0	2	0	0	1	0	0	0	0	9	0	0	0	2	1	0	TCGA-BQ-7055-01	75	0.07123370908252359	24	TCGA-BQ-7055-01	2	2	2	0.06885657201098214	TCGA-BQ-7055-01	2	0	2	4	PASS	4563	TCGA-BQ-7055	KIRP	73	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-26749	Alive	TUMOR FREE	799	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	799	0	799	NA	NA	0	799	
80	TCGA-BQ-7056	2	11	1	5	0	3	0	0	7	122	2	0	6	39	2	1	TCGA-BQ-7056	0	0	0	TCGA-BQ-7056	0	0	0	0	TCGA-BQ-7056-01	2	0	1	3	PASS	4564	TCGA-BQ-7056	KIRP	75	FEMALE	WHITE	Stage III	[Discrepancy]	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-27467	Alive	WITH TUMOR	612	NA	NA	NA	NA	NA	143	NA	NA	NA	0	612	0	612	NA	NA	1	143	
80	TCGA-BQ-7058	0	10	0	4	7	1	0	0	2	52	3	0	3	12	1	0	TCGA-BQ-7058-01	71	0.0721140386160425	22	TCGA-BQ-7058-01	5	6	5	0.10679236826373154	TCGA-BQ-7058-01	1	1	1	3	PASS	4565	TCGA-BQ-7058	KIRP	81	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-29856	Dead	WITH TUMOR	NA	343	NA	NA	NA	NA	50	NA	NA	NA	1	343	1	343	NA	NA	1	50	
70	TCGA-BQ-7059	2	16	0	9	4	6	0	1	11	176	8	0	5	62	6	1	TCGA-BQ-7059-01	63	0.12633408666951068	23	TCGA-BQ-7059-01	6	3	19	0.02790677135137745	TCGA-BQ-7059-01	0	0	0	0	PASS	4566	TCGA-BQ-7059	KIRP	71	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-26136	Alive	TUMOR FREE	232	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	232	0	232	NA	NA	0	232	
50	TCGA-BQ-7060	4	27	2	10	5	1	0	0	19	198	15	0	3	87	9	1	TCGA-BQ-7060-01	55	0.17969162117070808	15	TCGA-BQ-7060-01	8	4	19	1.7864211336857445e-05	TCGA-BQ-7060-01	0	0	0	0	PASS	4567	TCGA-BQ-7060	KIRP	53	MALE	AMERICAN INDIAN OR ALASKA NATIVE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-19479	Alive	TUMOR FREE	214	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	214	0	214	NA	NA	0	214	
80	TCGA-BQ-7061	0	7	1	5	4	3	0	1	3	76	4	0	0	21	4	0	TCGA-BQ-7061-01	81	0.12529784725824658	26	TCGA-BQ-7061-01	6	8	4	0.18324230822483145	TCGA-BQ-7061-01	0	0	0	0	PASS	4568	TCGA-BQ-7061	KIRP	83	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-30662	Alive	TUMOR FREE	218	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	218	0	218	NA	NA	0	218	
60	TCGA-BQ-7062	0	3	0	2	3	1	1	0	5	35	3	0	1	12	0	0	TCGA-BQ-7062-01	73	0.2657223268413067	25	TCGA-BQ-7062-01	11	6	0	0.0	TCGA-BQ-7062-01	0	0	0	0	PASS	4569	TCGA-BQ-7062	KIRP	64	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-23559	Alive	TUMOR FREE	116	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	116	0	116	NA	NA	0	116	
40	TCGA-DW-5560	0	6	0	2	3	2	0	0	2	14	1	0	1	10	1	0	TCGA-DW-5560-01	76	0.19562374420040776	34	TCGA-DW-5560-01	10	6	14	0.03315401123678049	TCGA-DW-5560-01	2	2	1	5	PASS	4570	TCGA-DW-5560	KIRP	38	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-13964	Alive	TUMOR FREE	1486	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1486	0	1486	0	1486	0	1486	
50	TCGA-DW-5561	1	5	0	1	4	1	1	0	3	27	2	0	1	9	1	0	TCGA-DW-5561-01	99	0.9477384317859436	50	TCGA-DW-5561-01	13	8	0	0.0	TCGA-DW-5561-01	0	0	0	0	PASS	4571	TCGA-DW-5561	KIRP	51	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-18744	Alive	[Discrepancy]	414	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	414	0	414	NA	NA	0	414	
50	TCGA-DW-7834	0	9	0	0	0	2	0	0	4	47	2	0	0	18	0	0	TCGA-DW-7834-01	49	0.1124135129923172	14	TCGA-DW-7834-01	6	3	0	0.0	TCGA-DW-7834-01	0	0	0	0	PASS	4572	TCGA-DW-7834	KIRP	53	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2001	NA	-19660	Alive	TUMOR FREE	3950	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3950	0	3950	NA	NA	0	3950	
60	TCGA-DW-7836	0	1	0	0	3	0	0	0	1	32	4	0	2	11	0	0	TCGA-DW-7836-01	81	0.5292758093574595	31	TCGA-DW-7836-01	10	7	4	0.06539003445739629	TCGA-DW-7836-01	0	0	0	0	PASS	4573	TCGA-DW-7836	KIRP	55	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-20269	Alive	TUMOR FREE	1093	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1093	0	1093	NA	NA	0	1093	
40	TCGA-DW-7837	0	6	1	3	2	1	0	0	3	59	9	1	2	35	0	0	TCGA-DW-7837-01	55	0.12747854451503726	17	TCGA-DW-7837-01	6	3	19	7.129253396798628e-06	TCGA-DW-7837-01	0	0	0	0	PASS	4574	TCGA-DW-7837	KIRP	43	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2007	NA	-15891	Alive	WITH TUMOR	1142	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1142	0	1142	NA	NA	0	1142	
70	TCGA-DW-7838	0	10	0	0	6	1	2	0	2	62	1	1	2	26	2	0	TCGA-DW-7838-01	49	0.2415049100648741	9	TCGA-DW-7838-01	10	5	19	5.217849145660168e-06	TCGA-DW-7838-01	0	0	0	0	PASS	4575	TCGA-DW-7838	KIRP	66	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-24247	Alive	WITH TUMOR	744	NA	NA	NA	NA	NA	380	NA	NA	NA	0	744	0	744	NA	NA	1	380	
60	TCGA-DW-7839	0	5	1	3	5	1	0	0	3	34	2	0	0	4	0	0	TCGA-DW-7839-01	65	0.027592686220258438	23	TCGA-DW-7839-01	2	1	2	5.126101223137588e-05	TCGA-DW-7839-01	0	0	0	0	PASS	4576	TCGA-DW-7839	KIRP	58	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-21347	Alive	TUMOR FREE	419	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	419	0	419	NA	NA	0	419	
60	TCGA-DW-7840	0	9	0	2	9	1	0	0	1	62	2	0	1	20	2	0	TCGA-DW-7840-01	87	0.156283886745984	44	TCGA-DW-7840-01	8	5	19	0.0279114326282858	TCGA-DW-7840-01	0	0	0	0	PASS	4577	TCGA-DW-7840	KIRP	60	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-22141	Alive	NA	114	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	114	0	114	NA	NA	0	114	
60	TCGA-DW-7841	0	3	0	3	4	2	2	0	0	32	3	0	0	10	2	0	TCGA-DW-7841-01	77	0.15054430684754694	27	TCGA-DW-7841-01	8	5	6	0.019935538338079786	TCGA-DW-7841-01	1	1	1	3	PASS	4578	TCGA-DW-7841	KIRP	61	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-22403	Alive	TUMOR FREE	445	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	445	0	445	NA	NA	0	445	
50	TCGA-DW-7842	0	3	0	0	0	1	0	0	0	19	0	0	1	4	2	0	TCGA-DW-7842-01	43	0.08185246979690003	11	TCGA-DW-7842-01	4	2	0	0.0	TCGA-DW-7842-01	0	0	0	0	PASS	4579	TCGA-DW-7842	KIRP	52	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-19166	Alive	WITH TUMOR	92	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	92	0	92	NA	NA	0	92	
40	TCGA-DW-7963	0	2	0	1	1	0	0	0	1	15	1	0	0	9	0	0	TCGA-DW-7963-01	46	0.3135185079264309	9	TCGA-DW-7963-01	10	5	6	0.0010983663375260845	TCGA-DW-7963-01	0	0	0	0	PASS	4580	TCGA-DW-7963	KIRP	43	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-15967	Alive	TUMOR FREE	1240	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1240	0	1240	0	1240	0	1240	
30	TCGA-DZ-6131	1	12	1	8	1	0	1	0	7	128	17	0	2	47	4	0	TCGA-DZ-6131-01	225	0.34508518470239946	131	TCGA-DZ-6131-01	2	3	40	0.08107302310872526	TCGA-DZ-6131-01	4	5	2	11	PASS	4581	TCGA-DZ-6131	KIRP	31	MALE	WHITE	Stage III	NA	Kidney Papillary Renal Cell Carcinoma	NA	2003	NA	-11487	Alive	TUMOR FREE	2429	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2429	0	2429	NA	NA	0	2429	
70	TCGA-DZ-6132	1	20	0	15	11	4	2	1	20	263	26	0	3	104	9	0	TCGA-DZ-6132-01	61	0.1506946299996897	20	TCGA-DZ-6132-01	7	4	3	0.031170265357716987	TCGA-DZ-6132-01	0	0	0	0	PASS	4582	TCGA-DZ-6132	KIRP	69	MALE	NA	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2003	NA	-25417	Alive	TUMOR FREE	2460	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2460	0	2460	NA	NA	0	2460	
70	TCGA-DZ-6133	8	65	14	33	10	2	2	0	39	887	84	0	17	355	32	0	TCGA-DZ-6133-01	49	0.947718217374125	9	TCGA-DZ-6133-01	15	9	19	1.9893513529318645e-05	TCGA-DZ-6133-01	0	0	0	0	PASS	4583	TCGA-DZ-6133	KIRP	66	FEMALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2004	NA	-24311	Dead	TUMOR FREE	NA	1557	NA	NA	NA	NA	NA	NA	NA	NA	1	1557	0	1557	NA	NA	0	1557	
70	TCGA-DZ-6134	0	4	0	0	0	2	0	0	6	61	4	0	0	31	0	0	TCGA-DZ-6134-01	43	0.16911789844557915	7	TCGA-DZ-6134-01	9	5	2	0.011740472226501613	TCGA-DZ-6134-01	0	0	0	0	PASS	4584	TCGA-DZ-6134	KIRP	69	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2005	NA	-25529	Alive	TUMOR FREE	1856	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1856	0	1856	NA	NA	0	1856	
50	TCGA-DZ-6135	0	12	0	5	8	0	0	0	11	110	5	0	2	57	0	0	TCGA-DZ-6135-01	32	0.030677102090858374	1	TCGA-DZ-6135-01	0	1	0	0.0	TCGA-DZ-6135-01	1	1	0	2	PASS	4585	TCGA-DZ-6135	KIRP	45	MALE	NA	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2006	NA	-16468	Alive	TUMOR FREE	2269	NA	NA	NA	NA	NA	NA	[Discrepancy]	NA	NA	0	2269	0	2269	NA	NA	0	2269	
50	TCGA-EV-5901	0	4	0	1	2	0	1	0	4	29	1	0	1	8	3	0	TCGA-EV-5901-01	62	0.11780219445858595	18	TCGA-EV-5901-01	5	3	0	0.0	TCGA-EV-5901-01	1	0	0	1	PASS	4586	TCGA-EV-5901	KIRP	47	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-17275	Alive	TUMOR FREE	1040	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1040	0	1040	NA	NA	0	1040	
60	TCGA-EV-5902	1	6	0	3	9	4	0	0	2	55	2	0	0	16	1	0	TCGA-EV-5902-01	109	0.1831945964445704	63	TCGA-EV-5902-01	9	6	2	0.07334455494242266	TCGA-EV-5902-01	0	0	0	0	PASS	4587	TCGA-EV-5902	KIRP	58	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-21344	Alive	TUMOR FREE	578	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	578	0	578	NA	NA	0	578	
60	TCGA-EV-5903	0	7	0	2	7	2	1	0	1	79	5	1	1	23	2	0	TCGA-EV-5903-01	37	0.17176330812069932	3	TCGA-EV-5903-01	9	6	19	0.02790645860195099	TCGA-EV-5903-01	0	0	0	0	PASS	4588	TCGA-EV-5903	KIRP	57	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-20888	Alive	TUMOR FREE	757	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	757	0	757	NA	NA	0	757	
40	TCGA-F9-A4JJ	0	1	3	0	0	0	1	0	0	31	1	0	1	10	1	0	TCGA-F9-A4JJ-01	85	0.9464269778534544	31	TCGA-F9-A4JJ-01	12	10	83	0.33531664195809635	TCGA-F9-A4JJ-01	4	1	6	11	PASS	4589	TCGA-F9-A4JJ	KIRP	35	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-12893	Dead	WITH TUMOR	NA	325	NA	NA	NA	NA	109	[Unknown]	NA	NA	1	325	1	325	NA	NA	1	109	
40	TCGA-F9-A7Q0	1	4	0	3	0	0	0	0	2	10	3	0	0	4	0	0	TCGA-F9-A7Q0-01	107	0.9477291210917004	53	TCGA-F9-A7Q0-01	17	11	107	0.4690239070492816	TCGA-F9-A7Q0-01	0	0	0	0	PASS	4590	TCGA-F9-A7Q0	KIRP	37	FEMALE	ASIAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-13523	Alive	TUMOR FREE	398	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	398	0	398	0	398	0	398	
80	TCGA-F9-A7VF	0	9	2	4	5	2	0	0	6	47	6	0	3	21	2	0	TCGA-F9-A7VF-01	73	0.4236815082857966	27	TCGA-F9-A7VF-01	10	7	38	0.062210528764844224	TCGA-F9-A7VF-01	0	0	0	0	PASS	4591	TCGA-F9-A7VF	KIRP	75	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-27446	Alive	TUMOR FREE	73	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	73	0	73	0	73	0	73	
40	TCGA-F9-A8NY	1	2	0	6	2	1	1	0	1	27	4	0	0	14	0	0	TCGA-F9-A8NY-01	82	0.9476327008976456	37	TCGA-F9-A8NY-01	16	9	25	0.03539098992272437	TCGA-F9-A8NY-01	2	1	3	6	PASS	4592	TCGA-F9-A8NY	KIRP	38	FEMALE	ASIAN	Stage IV	Stage IV	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-14101	Alive	TUMOR FREE	36	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	36	0	36	NA	NA	0	36	
80	TCGA-F9-A97G	0	8	0	4	6	1	4	0	4	45	0	0	0	15	5	0	TCGA-F9-A97G-01	106	0.14576407969530256	55	TCGA-F9-A97G-01	2	8	24	0.06890219618661364	TCGA-F9-A97G-01	6	7	4	17	PASS	4593	TCGA-F9-A97G	KIRP	79	MALE	ASIAN	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-29156	Alive	TUMOR FREE	13	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	13	0	13	0	13	0	13	
50	TCGA-G7-6789	0	3	0	2	2	1	0	0	2	29	2	0	0	16	1	0	TCGA-G7-6789-01	39	0.8633997504274296	2	TCGA-G7-6789-01	20	19	22	0.6356575743743547	TCGA-G7-6789-01	3	1	1	5	PASS	4594	TCGA-G7-6789	KIRP	53	FEMALE	WHITE	Stage IV	NA	Kidney Papillary Renal Cell Carcinoma	NA	2004	NA	-19593	Dead	WITH TUMOR	NA	122	NA	NA	NA	NA	NA	NA	NA	NA	1	122	1	122	NA	NA	1	122	
60	TCGA-G7-6790	1	5	0	4	2	2	1	0	3	57	8	0	1	22	0	0	TCGA-G7-6790-01	53	0.9477333013164281	18	TCGA-G7-6790-01	13	8	19	2.8799406207522747e-05	TCGA-G7-6790-01	0	0	0	0	PASS	4595	TCGA-G7-6790	KIRP	57	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2007	NA	-21169	Alive	TUMOR FREE	1575	NA	NA	NA	NA	NA	1558	NA	NA	NA	0	1575	0	1575	NA	NA	1	1558	
40	TCGA-G7-6792	0	6	0	2	2	1	0	0	3	34	3	0	0	19	3	0	TCGA-G7-6792-01	208	0.019309100591571482	166	TCGA-G7-6792-01	1	1	45	0.020054181707172044	TCGA-G7-6792-01	0	1	1	2	PASS	4596	TCGA-G7-6792	KIRP	40	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2007	NA	-14664	Alive	TUMOR FREE	2765	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2765	0	2765	0	2765	0	2765	
60	TCGA-G7-6793	3	16	0	9	0	0	0	1	12	167	17	0	5	78	7	0	TCGA-G7-6793-01	262	0.3388251834083954	166	TCGA-G7-6793-01	10	10	31	0.24585094505659416	TCGA-G7-6793-01	7	4	6	17	PASS	4597	TCGA-G7-6793	KIRP	60	FEMALE	WHITE	Stage IV	Stage IV	Kidney Papillary Renal Cell Carcinoma	NA	2007	NA	-22215	Dead	WITH TUMOR	NA	336	NA	NA	NA	NA	NA	NA	NA	NA	1	336	1	336	NA	NA	1	336	
60	TCGA-G7-6795	0	12	1	17	2	3	3	0	12	152	9	0	3	73	6	0	TCGA-G7-6795-01	49	0.9477414524120008	9	TCGA-G7-6795-01	12	8	0	0.0	TCGA-G7-6795-01	1	0	0	1	PASS	4598	TCGA-G7-6795	KIRP	56	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-20478	Alive	TUMOR FREE	1194	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1194	0	1194	NA	NA	0	1194	
60	TCGA-G7-6796	0	7	4	6	2	3	0	0	8	99	9	0	2	39	2	0	TCGA-G7-6796-01	55	0.1762876754288717	15	TCGA-G7-6796-01	8	8	7	0.17119266935837704	TCGA-G7-6796-01	0	0	0	0	PASS	4599	TCGA-G7-6796	KIRP	58	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-21252	Alive	TUMOR FREE	2173	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2173	0	2173	0	2173	0	2173	
50	TCGA-G7-6797	5	51	4	24	3	1	0	0	48	706	75	1	22	292	36	1	TCGA-G7-6797-01	81	0.20711904190446606	37	TCGA-G7-6797-01	7	5	6	0.11349459260352535	TCGA-G7-6797-01	1	1	2	4	PASS	4600	TCGA-G7-6797	KIRP	46	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-17004	Alive	TUMOR FREE	765	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	765	0	765	NA	NA	0	765	
60	TCGA-G7-7501	0	1	0	1	1	1	1	0	1	26	4	0	2	9	0	0	TCGA-G7-7501-01	104	0.9207217401883718	56	TCGA-G7-7501-01	7	5	30	0.20846838923960345	TCGA-G7-7501-01	2	2	5	9	PASS	4601	TCGA-G7-7501	KIRP	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-20165	Dead	WITH TUMOR	NA	624	NA	NA	NA	NA	110	Progressive Disease	NA	NA	1	624	1	624	NA	NA	1	110	
80	TCGA-G7-7502	0	4	0	1	7	0	0	1	5	40	2	0	0	19	3	0	TCGA-G7-7502-01	71	0.5754820585567036	19	TCGA-G7-7502-01	17	32	2	3.7191238700179147e-05	TCGA-G7-7502-01	1	1	0	2	PASS	4602	TCGA-G7-7502	KIRP	83	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-30346	Alive	TUMOR FREE	786	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	786	0	786	0	786	0	786	
40	TCGA-G7-A4TM	0	6	0	1	3	0	1	0	0	23	2	0	0	12	0	0	TCGA-G7-A4TM-01	57	0.1558071416118401	19	TCGA-G7-A4TM-01	6	6	14	0.01253520618112	TCGA-G7-A4TM-01	0	0	0	0	PASS	4603	TCGA-G7-A4TM	KIRP	40	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-14966	Alive	TUMOR FREE	768	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	768	0	768	0	768	0	768	
70	TCGA-G7-A8LB	0	21	2	5	8	5	2	0	6	72	3	0	1	14	3	0	TCGA-G7-A8LB-01	85	0.9477301275406848	35	TCGA-G7-A8LB-01	15	8	8	0.0006803163282766724	TCGA-G7-A8LB-01	0	0	0	0	PASS	4604	TCGA-G7-A8LB	KIRP	70	MALE	WHITE	Stage IV	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-25782	Alive	WITH TUMOR	547	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	547	0	547	NA	NA	0	547	
60	TCGA-G7-A8LC	0	3	0	1	1	0	0	0	4	9	0	0	0	3	0	0	TCGA-G7-A8LC-01	71	0.9476997220240068	29	TCGA-G7-A8LC-01	16	10	143	0.4784968226279143	TCGA-G7-A8LC-01	0	0	0	0	PASS	4605	TCGA-G7-A8LC	KIRP	61	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-22553	Alive	TUMOR FREE	702	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	702	0	702	0	702	0	702	
70	TCGA-G7-A8LD	0	5	0	7	2	0	1	0	1	38	2	1	0	10	0	0	TCGA-G7-A8LD-01	216	0.910712456030144	129	TCGA-G7-A8LD-01	10	19	142	0.3976528674271807	TCGA-G7-A8LD-01	16	11	15	42	PASS	4606	TCGA-G7-A8LD	KIRP	71	MALE	WHITE	Stage III	NA	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-25977	Dead	WITH TUMOR	NA	514	NA	NA	NA	NA	209	Complete Remission/Response	NA	NA	1	514	1	514	1	209	1	209	
60	TCGA-G7-A8LE	1	13	0	8	5	1	3	0	5	53	4	0	0	17	1	0	TCGA-G7-A8LE-01	57	0.08186018896443109	23	TCGA-G7-A8LE-01	4	4	31	0.0911280791266785	TCGA-G7-A8LE-01	0	0	0	0	PASS	4607	TCGA-G7-A8LE	KIRP	62	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-22810	Alive	TUMOR FREE	2453	NA	NA	NA	NA	NA	1447	Complete Remission/Response	NA	NA	0	2453	0	2453	1	1447	1	1447	
50	TCGA-GL-6846	2	18	0	9	8	2	2	2	19	248	24	0	8	115	2	0	TCGA-GL-6846-01	60	0.5465896807603686	20	TCGA-GL-6846-01	10	7	3	0.025350613247255103	TCGA-GL-6846-01	1	2	1	4	PASS	4608	TCGA-GL-6846	KIRP	52	MALE	WHITE	Stage IV	NA	Kidney Papillary Renal Cell Carcinoma	NA	1996	NA	-19012	Alive	TUMOR FREE	5925	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	5925	0	5925	NA	NA	0	5925	
60	TCGA-GL-7773	4	6	0	4	6	4	2	0	5	81	11	0	0	34	2	1	TCGA-GL-7773-01	51	0.05415569923923542	14	TCGA-GL-7773-01	2	2	7	0.05712544468436603	TCGA-GL-7773-01	1	2	1	4	PASS	4609	TCGA-GL-7773	KIRP	63	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-23239	Alive	TUMOR FREE	393	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	393	0	393	0	393	0	393	
30	TCGA-GL-7966	0	0	0	0	12	0	2	0	6	32	6	0	2	25	0	0	TCGA-GL-7966-01	129	0.9121808745363508	65	TCGA-GL-7966-01	16	13	44	0.5604666898736853	TCGA-GL-7966-01	4	1	4	9	PASS	4610	TCGA-GL-7966	KIRP	28	FEMALE	WHITE	Stage III	NA	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-10428	Alive	WITH TUMOR	112	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	112	0	112	NA	NA	0	112	
60	TCGA-GL-8500	0	22	0	13	16	6	4	0	8	106	6	0	1	36	0	0	TCGA-GL-8500-01	69	0.19857230139755447	27	TCGA-GL-8500-01	7	4	28	0.122690864666066	TCGA-GL-8500-01	0	0	0	0	PASS	4611	TCGA-GL-8500	KIRP	63	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-23338	Alive	TUMOR FREE	841	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	841	0	841	0	841	0	841	
60	TCGA-GL-A4EM	1	2	0	3	11	1	3	0	2	41	2	2	1	20	1	0	TCGA-GL-A4EM-01	55	0.2152957294252907	13	TCGA-GL-A4EM-01	10	5	9	0.0013892593932496866	TCGA-GL-A4EM-01	0	0	0	0	PASS	4612	TCGA-GL-A4EM	KIRP	61	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-22635	Alive	TUMOR FREE	32	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	32	0	32	NA	NA	0	32	
80	TCGA-GL-A59R	2	12	0	6	21	8	2	0	6	116	10	0	4	48	4	0	TCGA-GL-A59R-01	63	0.16103707702745002	20	TCGA-GL-A59R-01	6	3	0	0.0	TCGA-GL-A59R-01	0	0	0	0	PASS	4613	TCGA-GL-A59R	KIRP	79	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-29046	Alive	TUMOR FREE	378	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	378	0	378	0	378	0	378	
50	TCGA-GL-A59T	0	23	1	8	13	2	2	0	4	93	10	0	2	55	6	0	TCGA-GL-A59T-01	49	0.9477201947757962	14	TCGA-GL-A59T-01	12	9	14	0.05003965773793447	TCGA-GL-A59T-01	0	0	0	0	PASS	4614	TCGA-GL-A59T	KIRP	46	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-17142	Alive	TUMOR FREE	546	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	546	0	546	0	546	0	546	
70	TCGA-GL-A9DC	1	17	2	8	17	3	4	1	6	67	1	0	1	27	3	1	TCGA-GL-A9DC-01	63	0.11481032493690332	24	TCGA-GL-A9DC-01	7	4	9	0.014428858049499026	TCGA-GL-A9DC-01	0	0	0	0	PASS	4615	TCGA-GL-A9DC	KIRP	66	FEMALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-24348	Alive	TUMOR FREE	392	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	392	0	392	0	392	0	392	
70	TCGA-GL-A9DD	6	18	0	12	24	8	4	0	4	118	4	2	2	48	10	0	TCGA-GL-A9DD-01	47	0.2253011254080768	9	TCGA-GL-A9DD-01	10	5	15	0.002964597906647252	TCGA-GL-A9DD-01	0	0	0	0	PASS	4616	TCGA-GL-A9DD	KIRP	69	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-25483	Alive	TUMOR FREE	341	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	341	0	341	0	341	0	341	
70	TCGA-GL-A9DE	3	14	4	14	16	7	2	0	6	142	8	0	6	72	2	0	TCGA-GL-A9DE-01	161	0.0071136009096768515	114	TCGA-GL-A9DE-01	0	2	27	0.07154429165171604	TCGA-GL-A9DE-01	0	0	0	0	PASS	4617	TCGA-GL-A9DE	KIRP	74	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-27330	Alive	TUMOR FREE	496	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	496	0	496	0	496	0	496	
NA	TCGA-HE-7128	0	23	2	9	7	1	1	0	13	243	18	0	6	90	7	1	TCGA-HE-7128-01	47	0.30839404085683736	9	TCGA-HE-7128-01	14	8	0	0.0	TCGA-HE-7128-01	0	0	0	0	PASS	4618	TCGA-HE-7128	KIRP	NA	MALE	NA	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	NA	Alive	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
NA	TCGA-HE-7129	2	25	3	19	2	0	1	0	20	370	30	1	9	156	20	1	TCGA-HE-7129-01	74	0.3224462869686305	33	TCGA-HE-7129-01	3	2	5	0.01764199749954956	TCGA-HE-7129-01	2	2	2	6	PASS	4619	TCGA-HE-7129	KIRP	NA	MALE	NA	Stage II	NA	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	NA	Alive	TUMOR FREE	2492	NA	NA	NA	NA	NA	2399	Complete Remission/Response	NA	NA	0	2492	0	2492	1	2399	1	2399	
NA	TCGA-HE-7130	3	19	0	15	6	1	1	0	16	293	34	0	7	111	8	4	TCGA-HE-7130-01	244	0.8819634279869376	134	TCGA-HE-7130-01	18	26	31	0.1812493215567345	TCGA-HE-7130-01	14	8	2	24	pathology review	4620	TCGA-HE-7130	KIRP	NA	FEMALE	NA	Stage III	NA	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	NA	Alive	TUMOR FREE	1770	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1770	0	1770	0	1770	0	1770	
60	TCGA-HE-A5NF	0	7	1	0	6	1	0	0	4	53	2	0	0	15	1	1	TCGA-HE-A5NF-01	37	0.31972648182752794	8	TCGA-HE-A5NF-01	13	8	9	0.01266691483148435	TCGA-HE-A5NF-01	0	0	0	0	PASS	4621	TCGA-HE-A5NF	KIRP	58	MALE	[Not Evaluated]	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-21524	Alive	TUMOR FREE	2582	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2582	0	2582	0	2582	0	2582	
60	TCGA-HE-A5NH	0	13	0	6	6	2	1	0	5	62	0	0	3	13	4	0	TCGA-HE-A5NH-01	43	0.08201432179531269	7	TCGA-HE-A5NH-01	4	2	3	0.0006938064990001827	TCGA-HE-A5NH-01	0	0	0	0	PASS	4622	TCGA-HE-A5NH	KIRP	62	MALE	[Not Evaluated]	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-22888	Alive	TUMOR FREE	791	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	791	0	791	0	791	0	791	
70	TCGA-HE-A5NI	0	13	0	5	17	6	2	0	4	64	4	0	2	31	3	0	TCGA-HE-A5NI-01	67	0.9477338124474912	32	TCGA-HE-A5NI-01	14	8	4	7.41890933648215e-05	TCGA-HE-A5NI-01	0	0	0	0	PASS	4623	TCGA-HE-A5NI	KIRP	73	MALE	[Not Evaluated]	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-26985	Alive	TUMOR FREE	360	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	360	0	360	0	360	0	360	
60	TCGA-HE-A5NJ	2	3	0	3	2	0	1	0	1	48	5	0	0	16	0	0	TCGA-HE-A5NJ-01	74	0.24044520855190196	22	TCGA-HE-A5NJ-01	8	8	25	0.03049688730802568	TCGA-HE-A5NJ-01	5	1	1	7	PASS	4624	TCGA-HE-A5NJ	KIRP	58	MALE	[Not Evaluated]	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-21485	Alive	TUMOR FREE	1726	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1726	0	1726	0	1726	0	1726	
80	TCGA-HE-A5NK	0	11	0	5	8	3	1	0	4	64	4	0	3	24	1	0	TCGA-HE-A5NK-01	51	0.2671248597884633	17	TCGA-HE-A5NK-01	6	6	19	2.841854202136261e-05	TCGA-HE-A5NK-01	0	1	0	1	pathology review	4625	TCGA-HE-A5NK	KIRP	82	MALE	[Not Evaluated]	NA	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-30088	Alive	TUMOR FREE	2228	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2228	0	2228	0	2228	0	2228	
50	TCGA-HE-A5NL	0	7	1	2	7	3	0	0	4	51	1	0	1	26	2	0	TCGA-HE-A5NL-01	41	0.2454370618549383	9	TCGA-HE-A5NL-01	10	5	4	0.0010608543207355301	TCGA-HE-A5NL-01	0	0	0	0	PASS	4626	TCGA-HE-A5NL	KIRP	51	MALE	[Not Evaluated]	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-18913	Alive	TUMOR FREE	767	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	767	0	767	0	767	0	767	
60	TCGA-IA-A40U	0	5	0	2	3	0	0	0	3	39	2	0	1	8	2	0	TCGA-IA-A40U-01	51	0.2275980315047292	10	TCGA-IA-A40U-01	10	7	9	0.04469701865861564	TCGA-IA-A40U-01	0	0	0	0	PASS	4627	TCGA-IA-A40U	KIRP	56	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-20463	Alive	TUMOR FREE	511	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	511	0	511	0	511	0	511	
50	TCGA-IA-A40X	0	0	1	2	0	0	0	0	1	22	1	0	0	4	0	0	TCGA-IA-A40X-01	48	0.04509889317340587	12	TCGA-IA-A40X-01	0	2	8	0.005237703970572771	TCGA-IA-A40X-01	3	1	0	4	PASS	4628	TCGA-IA-A40X	KIRP	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-18239	Alive	TUMOR FREE	608	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	608	0	608	0	608	0	608	
60	TCGA-IA-A40Y	0	5	0	2	1	0	0	0	5	63	3	0	2	20	0	0	TCGA-IA-A40Y-01	99	0.7744054699741775	43	TCGA-IA-A40Y-01	28	26	109	0.4359985409114908	TCGA-IA-A40Y-01	12	10	1	23	PASS	4629	TCGA-IA-A40Y	KIRP	60	FEMALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-21996	Alive	TUMOR FREE	62	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	62	0	62	0	62	0	62	
80	TCGA-IA-A83S	2	15	1	4	14	3	0	1	6	96	6	0	0	31	3	0	TCGA-IA-A83S-01	47	0.14341213730458988	11	TCGA-IA-A83S-01	6	3	19	0.0001591700559976829	TCGA-IA-A83S-01	0	0	0	0	PASS	4630	TCGA-IA-A83S	KIRP	81	MALE	WHITE	[Discrepancy]	NA	Kidney Papillary Renal Cell Carcinoma	NA	2003	NA	-29677	Dead	NA	NA	2609	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	2609	NA	2609	NA	NA	0	2609	
80	TCGA-IA-A83T	0	7	0	4	5	2	1	0	5	35	2	0	1	18	6	1	TCGA-IA-A83T-01	60	0.12745023631436522	14	TCGA-IA-A83T-01	6	3	7	0.009266066657778257	TCGA-IA-A83T-01	0	0	1	1	PASS	4631	TCGA-IA-A83T	KIRP	80	MALE	WHITE	[Discrepancy]	NA	Kidney Papillary Renal Cell Carcinoma	NA	2005	NA	-29430	Dead	NA	NA	2684	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	2684	NA	2684	NA	NA	0	2684	
60	TCGA-IA-A83V	0	13	0	5	4	0	0	0	4	43	3	0	0	22	2	0	TCGA-IA-A83V-01	55	0.11250746172363307	15	TCGA-IA-A83V-01	6	3	11	0.0006494808827772189	TCGA-IA-A83V-01	0	0	0	0	PASS	4632	TCGA-IA-A83V	KIRP	63	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2002	NA	-23238	Dead	NA	NA	2941	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	2941	NA	2941	NA	NA	0	2941	
70	TCGA-IA-A83W	0	12	0	6	5	1	1	0	4	56	3	0	1	14	0	0	TCGA-IA-A83W-01	118	0.07982020834596715	62	TCGA-IA-A83W-01	3	3	10	0.0017256943841803438	TCGA-IA-A83W-01	3	3	0	6	PASS	4633	TCGA-IA-A83W	KIRP	70	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2003	NA	-25678	Dead	TUMOR FREE	NA	2043	NA	NA	NA	NA	1408	Complete Remission/Response	NA	NA	1	2043	0	2043	1	1408	1	1408	
80	TCGA-IZ-8195	0	13	0	10	6	4	4	0	2	98	8	0	2	40	0	0	TCGA-IZ-8195-01	61	0.13161373515145838	21	TCGA-IZ-8195-01	8	4	6	0.009436826992291043	TCGA-IZ-8195-01	0	0	1	1	PASS	4634	TCGA-IZ-8195	KIRP	82	MALE	WHITE	Stage II	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-29963	Alive	TUMOR FREE	677	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	677	0	677	0	677	0	677	
50	TCGA-IZ-8196	0	10	0	0	11	7	5	0	6	134	0	0	2	45	0	0	TCGA-IZ-8196-01	43	0.08428588812558481	8	TCGA-IZ-8196-01	4	3	8	0.0005241757542428739	TCGA-IZ-8196-01	0	0	0	0	PASS	4635	TCGA-IZ-8196	KIRP	50	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-18540	Alive	TUMOR FREE	649	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	649	0	649	0	649	0	649	
70	TCGA-IZ-A6M8	0	12	0	4	9	0	1	0	4	52	3	1	0	29	4	0	TCGA-IZ-A6M8-01	109	0.1124406893133319	56	TCGA-IZ-A6M8-01	6	3	3	1.9555942404562744e-05	TCGA-IZ-A6M8-01	0	0	0	0	PASS	4636	TCGA-IZ-A6M8	KIRP	69	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-25545	Alive	TUMOR FREE	497	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	497	0	497	0	497	0	497	
60	TCGA-IZ-A6M9	1	2	0	3	9	0	3	0	5	50	5	0	1	12	1	0	TCGA-IZ-A6M9-01	51	0.11244028186309524	11	TCGA-IZ-A6M9-01	6	5	20	0.07252745304920173	TCGA-IZ-A6M9-01	0	0	0	0	PASS	4637	TCGA-IZ-A6M9	KIRP	63	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-23149	Alive	TUMOR FREE	376	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	376	0	376	0	376	0	376	
40	TCGA-J7-6720	0	2	0	2	5	0	3	1	2	19	1	0	1	9	3	0	TCGA-J7-6720-01	51	0.08190773972532353	12	TCGA-J7-6720-01	4	3	19	1.8346348139137625e-05	TCGA-J7-6720-01	0	0	0	0	PASS	4638	TCGA-J7-6720	KIRP	42	MALE	ASIAN	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-15620	Alive	TUMOR FREE	388	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	388	0	388	0	388	0	388	
40	TCGA-J7-8537	0	7	0	1	0	1	1	0	6	30	2	0	0	8	2	0	TCGA-J7-8537-01	69	0.826268479168646	21	TCGA-J7-8537-01	13	12	61	0.34612038160346004	TCGA-J7-8537-01	7	4	8	19	PASS	4639	TCGA-J7-8537	KIRP	37	FEMALE	ASIAN	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-13628	Dead	WITH TUMOR	NA	321	NA	NA	NA	NA	220	Complete Remission/Response	NA	NA	1	321	1	321	1	220	1	220	
80	TCGA-J7-A8I2	1	10	0	7	2	1	0	0	7	39	4	0	0	13	1	0	TCGA-J7-A8I2-01	96	0.07696286188105497	36	TCGA-J7-A8I2-01	5	3	28	0.03643152099143543	TCGA-J7-A8I2-01	2	1	2	5	PASS	4640	TCGA-J7-A8I2	KIRP	75	MALE	ASIAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-27431	Alive	WITH TUMOR	307	NA	NA	NA	NA	NA	268	Complete Remission/Response	NA	NA	0	307	0	307	1	268	1	268	
90	TCGA-KV-A6GD	2	13	2	4	4	2	0	0	0	96	8	0	0	43	4	0	TCGA-KV-A6GD-01	49	0.3917356962982759	17	TCGA-KV-A6GD-01	16	8	10	0.0012678632150398587	TCGA-KV-A6GD-01	1	0	0	1	PASS	4641	TCGA-KV-A6GD	KIRP	85	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-31217	Alive	TUMOR FREE	560	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	560	0	560	0	560	0	560	
70	TCGA-KV-A6GE	0	9	0	4	1	2	0	0	2	31	2	0	1	11	1	0	TCGA-KV-A6GE-01	57	0.9477172849523928	17	TCGA-KV-A6GE-01	15	11	24	0.06698540629882792	TCGA-KV-A6GE-01	0	0	0	0	PASS	4642	TCGA-KV-A6GE	KIRP	65	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-23979	Alive	TUMOR FREE	885	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	885	0	885	0	885	0	885	
40	TCGA-KV-A74V	0	13	0	4	4	2	2	0	2	32	6	0	0	5	0	0	TCGA-KV-A74V-01	33	0.9477390073067486	6	TCGA-KV-A74V-01	13	10	29	0.10178338833552468	TCGA-KV-A74V-01	0	0	0	0	PASS	4643	TCGA-KV-A74V	KIRP	40	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-14834	Alive	TUMOR FREE	347	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	347	0	347	0	347	0	347	
50	TCGA-MH-A55W	0	5	0	2	10	0	0	0	3	57	4	0	1	25	5	0	TCGA-MH-A55W-01	58	0.9477316404359842	20	TCGA-MH-A55W-01	12	7	4	0.00030792071077767944	TCGA-MH-A55W-01	1	1	0	2	PASS	4644	TCGA-MH-A55W	KIRP	50	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-18573	Alive	TUMOR FREE	1043	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1043	0	1043	0	1043	0	1043	
70	TCGA-MH-A55Z	1	9	0	3	5	0	0	1	8	63	5	0	2	28	1	1	TCGA-MH-A55Z-01	49	0.1476223030652507	14	TCGA-MH-A55Z-01	6	4	3	9.042298633141342e-05	TCGA-MH-A55Z-01	0	0	0	0	PASS	4645	TCGA-MH-A55Z	KIRP	65	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-24017	Alive	TUMOR FREE	845	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	845	0	845	0	845	0	845	
60	TCGA-MH-A560	0	2	0	2	3	1	0	0	1	38	3	0	1	14	2	0	TCGA-MH-A560-01	70	0.13503528461635333	24	TCGA-MH-A560-01	6	5	23	0.07185256297238969	TCGA-MH-A560-01	0	0	0	0	PASS	4646	TCGA-MH-A560	KIRP	62	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-22866	Alive	TUMOR FREE	924	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	924	0	924	0	924	0	924	
70	TCGA-MH-A561	0	12	0	1	9	2	1	0	4	73	3	3	1	21	4	0	TCGA-MH-A561-01	49	0.027574677845395457	10	TCGA-MH-A561-01	2	1	11	0.0017340512362233446	TCGA-MH-A561-01	0	0	0	0	PASS	4647	TCGA-MH-A561	KIRP	66	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-24271	Alive	TUMOR FREE	841	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	841	0	841	0	841	0	841	
60	TCGA-MH-A562	0	8	0	1	5	1	0	0	5	41	1	0	0	24	0	0	TCGA-MH-A562-01	71	0.2408915686042384	32	TCGA-MH-A562-01	8	5	7	0.001033669394991161	TCGA-MH-A562-01	0	0	0	0	PASS	4648	TCGA-MH-A562	KIRP	57	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-20933	Alive	TUMOR FREE	616	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	616	0	616	0	616	0	616	
60	TCGA-MH-A854	1	14	0	5	13	2	0	0	10	100	3	0	2	25	0	0	TCGA-MH-A854-01	61	0.12697780855938773	22	TCGA-MH-A854-01	7	4	12	0.03164076373058655	TCGA-MH-A854-01	0	0	0	0	PASS	4649	TCGA-MH-A854	KIRP	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-22804	Alive	TUMOR FREE	536	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	536	0	536	0	536	0	536	
50	TCGA-MH-A855	0	2	0	3	0	0	1	0	0	26	1	0	0	6	0	0	TCGA-MH-A855-01	78	0.01323725465106852	35	TCGA-MH-A855-01	0	0	15	0.014813249065653481	TCGA-MH-A855-01	1	1	1	3	PASS	4650	TCGA-MH-A855	KIRP	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-19029	Alive	TUMOR FREE	369	NA	NA	NA	NA	NA	0	Complete Remission/Response	NA	NA	0	369	0	369	1	0	1	0	
50	TCGA-MH-A856	0	10	0	6	6	3	0	0	9	48	0	0	0	17	1	0	TCGA-MH-A856-01	79	0.048100817613262466	36	TCGA-MH-A856-01	2	2	16	0.01730843200395821	TCGA-MH-A856-01	0	2	0	2	PASS	4651	TCGA-MH-A856	KIRP	54	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-20006	Alive	TUMOR FREE	947	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	947	0	947	0	947	0	947	
60	TCGA-MH-A857	0	2	0	2	2	0	2	0	1	16	1	0	1	7	1	0	TCGA-MH-A857-01	71	0.00016821679957080402	28	TCGA-MH-A857-01	0	0	6	0.0016121757935477054	TCGA-MH-A857-01	0	0	0	0	PASS	4652	TCGA-MH-A857	KIRP	63	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-23114	Alive	TUMOR FREE	890	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	890	0	890	NA	NA	0	890	
40	TCGA-O9-A75Z	0	1	0	1	2	1	0	0	4	13	0	0	0	9	1	0	TCGA-O9-A75Z-01	43	0.08202712719516496	10	TCGA-O9-A75Z-01	4	3	11	0.0019378954028310847	TCGA-O9-A75Z-01	0	0	0	0	PASS	4653	TCGA-O9-A75Z	KIRP	44	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-16183	Alive	NA	471	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	471	0	471	NA	NA	0	471	
70	TCGA-P4-A5E6	1	10	0	4	5	2	1	0	4	68	3	0	2	18	1	0	TCGA-P4-A5E6-01	124	0.08317640659311219	68	TCGA-P4-A5E6-01	3	4	42	0.08802506229545175	TCGA-P4-A5E6-01	1	0	0	1	PASS	4654	TCGA-P4-A5E6	KIRP	67	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2004	NA	-24615	Alive	TUMOR FREE	3035	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3035	0	3035	0	3035	0	3035	
70	TCGA-P4-A5E7	3	12	1	3	12	2	1	0	1	66	4	0	0	25	2	0	TCGA-P4-A5E7-01	43	0.8379268176635782	8	TCGA-P4-A5E7-01	8	5	8	0.0020563455257789887	TCGA-P4-A5E7-01	0	0	0	0	PASS	4655	TCGA-P4-A5E7	KIRP	74	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2004	NA	-27029	Alive	TUMOR FREE	2649	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2649	0	2649	0	2649	0	2649	
60	TCGA-P4-A5E8	0	7	0	1	10	0	3	0	1	26	1	0	3	9	0	0	TCGA-P4-A5E8-01	108	0.4612080561907867	48	TCGA-P4-A5E8-01	6	8	82	0.2868416418912906	TCGA-P4-A5E8-01	2	1	4	7	PASS	4656	TCGA-P4-A5E8	KIRP	57	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2004	NA	-21132	Dead	WITH TUMOR	NA	1306	NA	NA	NA	NA	42	NA	NA	NA	1	1306	1	1306	NA	NA	1	42	
50	TCGA-P4-A5EA	0	7	0	3	17	2	2	0	4	31	4	0	4	14	3	0	TCGA-P4-A5EA-01	49	0.6089039355832839	9	TCGA-P4-A5EA-01	12	13	94	0.4618236469573401	TCGA-P4-A5EA-01	1	0	2	3	PASS	4657	TCGA-P4-A5EA	KIRP	54	FEMALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2007	NA	-19748	Dead	WITH TUMOR	NA	201	NA	NA	NA	NA	44	Complete Remission/Response	NA	NA	1	201	1	201	1	44	1	44	
80	TCGA-P4-A5EB	1	16	2	8	16	2	2	0	11	95	8	0	3	37	3	0	TCGA-P4-A5EB-01	122	0.9319112760414132	75	TCGA-P4-A5EB-01	14	16	8	0.006126374365600718	TCGA-P4-A5EB-01	0	1	1	2	PASS	4658	TCGA-P4-A5EB	KIRP	83	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2006	NA	-30395	Alive	TUMOR FREE	3015	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3015	0	3015	0	3015	0	3015	
50	TCGA-P4-A5ED	0	0	0	0	0	0	0	0	1	8	1	0	1	6	1	0	TCGA-P4-A5ED-01	91	0.013590035295767026	52	TCGA-P4-A5ED-01	0	0	28	0.014794375617453266	TCGA-P4-A5ED-01	0	2	1	3	PASS	4659	TCGA-P4-A5ED	KIRP	51	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2005	NA	-18698	Alive	TUMOR FREE	2816	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2816	0	2816	0	2816	0	2816	
70	TCGA-P4-AAVK	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-P4-AAVK-01	65	0.16281972153393973	18	TCGA-P4-AAVK-01	8	6	27	0.07225521956045297	TCGA-P4-AAVK-01	0	0	0	0	PASS	4660	TCGA-P4-AAVK	KIRP	74	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-27073	Alive	WITH TUMOR	1590	NA	NA	NA	NA	NA	232	Complete Remission/Response	NA	NA	0	1590	0	1590	1	232	1	232	
90	TCGA-P4-AAVL	0	7	1	6	7	3	1	0	3	57	2	0	2	17	2	0	TCGA-P4-AAVL-01	125	0.4471326921973252	62	TCGA-P4-AAVL-01	8	7	20	0.029380961849128227	TCGA-P4-AAVL-01	8	5	2	15	PASS	4661	TCGA-P4-AAVL	KIRP	85	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-31082	Dead	WITH TUMOR	NA	487	NA	NA	NA	NA	41	Complete Remission/Response	NA	NA	1	487	1	487	1	41	1	41	
70	TCGA-P4-AAVM	0	6	0	4	0	1	1	0	3	32	4	1	0	22	2	0	TCGA-P4-AAVM-01	73	0.09793564207346883	24	TCGA-P4-AAVM-01	4	2	6	0.0002322606672323406	TCGA-P4-AAVM-01	0	0	0	0	PASS	4662	TCGA-P4-AAVM	KIRP	69	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-25280	Alive	TUMOR FREE	1539	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1539	0	1539	0	1539	0	1539	
70	TCGA-P4-AAVO	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-P4-AAVO-01	91	0.06560213111719408	41	TCGA-P4-AAVO-01	3	2	30	0.026426326601974786	TCGA-P4-AAVO-01	2	3	1	6	PASS	4663	TCGA-P4-AAVO	KIRP	69	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2008	NA	-25354	Alive	TUMOR FREE	2400	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2400	0	2400	0	2400	0	2400	
60	TCGA-PJ-A5Z8	1	4	0	4	8	6	1	0	6	46	0	0	1	16	3	0	TCGA-PJ-A5Z8-01	37	0.1961025139322048	5	TCGA-PJ-A5Z8-01	6	4	31	0.16048481958346678	TCGA-PJ-A5Z8-01	0	2	1	3	PASS	4664	TCGA-PJ-A5Z8	KIRP	60	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-21968	Alive	TUMOR FREE	600	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	600	0	600	0	600	0	600	
80	TCGA-PJ-A5Z9	0	8	1	6	2	2	1	0	5	44	0	0	1	15	1	0	TCGA-PJ-A5Z9-01	66	0.9476778250005672	27	TCGA-PJ-A5Z9-01	15	8	14	0.014277161383661013	TCGA-PJ-A5Z9-01	0	0	0	0	PASS	4665	TCGA-PJ-A5Z9	KIRP	80	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-29365	Alive	TUMOR FREE	540	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	540	0	540	0	540	0	540	
80	TCGA-PJ-A8JU	2	11	0	4	9	1	3	0	7	66	5	0	0	26	3	0	TCGA-PJ-A8JU	0	0	0	TCGA-PJ-A8JU	0	0	0	0	TCGA-PJ-A8JU	0	0	0	0	PASS	4666	TCGA-PJ-A8JU	KIRP	81	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-29830	Alive	TUMOR FREE	380	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	380	0	380	0	380	0	380	
60	TCGA-Q2-A5QZ	1	7	1	2	7	2	0	0	1	53	2	0	1	17	4	0	TCGA-Q2-A5QZ-01	206	0.8219626180033195	119	TCGA-Q2-A5QZ-01	11	9	118	0.310574047152514	TCGA-Q2-A5QZ-01	8	3	11	22	PASS	4667	TCGA-Q2-A5QZ	KIRP	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-22531	Alive	NA	428	NA	NA	NA	NA	NA	412	Complete Remission/Response	NA	NA	0	428	0	428	1	412	1	412	
50	TCGA-SX-A71R	0	6	1	0	2	1	1	0	5	33	3	0	0	13	0	0	TCGA-SX-A71R-01	59	0.17069622877726945	17	TCGA-SX-A71R-01	8	5	11	0.01770310648422227	TCGA-SX-A71R-01	1	1	1	3	PASS	4668	TCGA-SX-A71R	KIRP	51	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-18742	Alive	TUMOR FREE	1457	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1457	0	1457	0	1457	0	1457	
70	TCGA-SX-A71S	1	25	1	7	7	7	1	0	7	92	6	1	0	38	0	0	TCGA-SX-A71S-01	59	0.08226987077138079	23	TCGA-SX-A71S-01	4	2	6	0.00022765360402361284	TCGA-SX-A71S-01	0	0	0	0	PASS	4669	TCGA-SX-A71S	KIRP	66	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-24211	Alive	TUMOR FREE	1504	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1504	0	1504	0	1504	0	1504	
60	TCGA-SX-A71U	3	10	0	3	8	4	3	0	9	53	8	0	2	27	5	1	TCGA-SX-A71U-01	51	0.2983473105054653	13	TCGA-SX-A71U-01	10	7	16	0.014772443591378172	TCGA-SX-A71U-01	0	0	0	0	PASS	4670	TCGA-SX-A71U	KIRP	57	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-21079	Alive	TUMOR FREE	1357	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1357	0	1357	0	1357	0	1357	
80	TCGA-SX-A71V	0	10	2	6	9	2	1	0	5	83	4	0	2	25	1	1	TCGA-SX-A71V-01	66	0.9478168839195409	29	TCGA-SX-A71V-01	14	7	11	0.014185301301814904	TCGA-SX-A71V-01	0	2	1	3	PASS	4671	TCGA-SX-A71V	KIRP	80	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-29332	Alive	TUMOR FREE	876	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	876	0	876	0	876	0	876	
70	TCGA-SX-A71W	0	5	0	6	3	0	1	0	1	28	1	0	0	9	1	0	TCGA-SX-A71W	0	0	0	TCGA-SX-A71W	0	0	0	0	TCGA-SX-A71W	0	0	0	0	PASS	4672	TCGA-SX-A71W	KIRP	66	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-24110	Alive	TUMOR FREE	1076	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1076	0	1076	0	1076	0	1076	
70	TCGA-SX-A7SL	0	9	0	8	11	2	3	0	6	65	2	1	0	22	1	1	TCGA-SX-A7SL-01	92	0.12804220978957134	46	TCGA-SX-A7SL-01	6	8	41	0.15043083889625086	TCGA-SX-A7SL-01	2	1	1	4	PASS	4673	TCGA-SX-A7SL	KIRP	74	MALE	[Not Evaluated]	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-27063	Alive	TUMOR FREE	823	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	823	0	823	0	823	0	823	
60	TCGA-SX-A7SM	0	7	0	1	14	2	1	1	10	51	0	0	0	20	3	0	TCGA-SX-A7SM-01	51	0.13760531440349358	13	TCGA-SX-A7SM-01	5	5	33	0.11265458590876055	TCGA-SX-A7SM-01	0	0	0	0	PASS	4674	TCGA-SX-A7SM	KIRP	60	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	Stage IV	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-22044	Dead	WITH TUMOR	NA	363	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	363	1	363	NA	NA	1	363	
50	TCGA-SX-A7SN	0	10	1	7	8	2	0	0	4	80	7	0	0	22	2	0	TCGA-SX-A7SN-01	33	0.1764887517693102	6	TCGA-SX-A7SN-01	7	5	3	0.00014089890690508868	TCGA-SX-A7SN-01	0	0	0	0	PASS	4675	TCGA-SX-A7SN	KIRP	52	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-19116	Alive	TUMOR FREE	578	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	578	0	578	0	578	0	578	
60	TCGA-SX-A7SO	0	1	0	1	3	1	1	0	3	34	5	0	0	11	1	0	TCGA-SX-A7SO-01	56	0.042918970335036916	17	TCGA-SX-A7SO-01	3	2	22	0.04683399325631602	TCGA-SX-A7SO-01	0	0	1	1	PASS	4676	TCGA-SX-A7SO	KIRP	64	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	-23534	Alive	TUMOR FREE	1257	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1257	0	1257	0	1257	0	1257	
70	TCGA-SX-A7SP	0	13	0	3	8	0	1	1	4	57	2	0	0	22	3	0	TCGA-SX-A7SP-01	57	0.30087084273807746	17	TCGA-SX-A7SP-01	10	5	7	0.0005066943759545236	TCGA-SX-A7SP-01	0	0	0	0	PASS	4677	TCGA-SX-A7SP	KIRP	66	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-24382	Dead	TUMOR FREE	NA	496	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	496	0	496	0	496	0	496	
50	TCGA-SX-A7SQ	2	11	2	6	8	1	0	1	5	56	2	1	1	38	1	0	TCGA-SX-A7SQ-01	51	0.8643769057262136	11	TCGA-SX-A7SQ-01	15	8	2	7.106056344659547e-05	TCGA-SX-A7SQ-01	0	0	0	0	PASS	4678	TCGA-SX-A7SQ	KIRP	48	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-17696	Alive	TUMOR FREE	1266	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1266	0	1266	0	1266	0	1266	
70	TCGA-SX-A7SR	0	19	3	6	12	2	1	0	3	61	2	0	1	18	0	0	TCGA-SX-A7SR-01	93	0.8622966957579219	40	TCGA-SX-A7SR-01	12	6	20	0.009426831890607884	TCGA-SX-A7SR-01	0	1	1	2	PASS	4679	TCGA-SX-A7SR	KIRP	66	MALE	WHITE	Stage II	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-24237	Alive	TUMOR FREE	805	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	805	0	805	0	805	0	805	
70	TCGA-SX-A7SS	0	13	0	4	7	10	0	0	6	75	5	0	0	24	4	0	TCGA-SX-A7SS-01	85	0.947725610302074	39	TCGA-SX-A7SS-01	16	11	29	0.0743897588144196	TCGA-SX-A7SS-01	2	2	2	6	PASS	4680	TCGA-SX-A7SS	KIRP	67	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-24660	Alive	TUMOR FREE	1615	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1615	0	1615	0	1615	0	1615	
50	TCGA-SX-A7SU	0	4	1	2	2	0	0	2	5	35	1	1	0	7	2	0	TCGA-SX-A7SU-01	49	0.08186811097715742	11	TCGA-SX-A7SU-01	4	3	19	3.5728742709408203e-05	TCGA-SX-A7SU-01	0	0	0	0	PASS	4681	TCGA-SX-A7SU	KIRP	47	MALE	[Not Evaluated]	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2010	NA	-17349	Alive	TUMOR FREE	1331	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1331	0	1331	0	1331	0	1331	
80	TCGA-UN-AAZ9	0	6	0	1	1	1	1	0	1	17	4	0	0	4	1	0	TCGA-UN-AAZ9-01	98	0.947698214747798	47	TCGA-UN-AAZ9-01	14	9	109	0.42816405356049175	TCGA-UN-AAZ9-01	0	0	1	1	PASS	4682	TCGA-UN-AAZ9	KIRP	76	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-27851	Alive	TUMOR FREE	548	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	548	0	548	0	548	0	548	
80	TCGA-UZ-A9PJ	0	11	3	8	3	1	2	0	1	40	0	0	2	20	3	0	TCGA-UZ-A9PJ-01	65	0.08188062223473923	23	TCGA-UZ-A9PJ-01	4	2	10	0.008718087139756057	TCGA-UZ-A9PJ-01	0	0	1	1	PASS	4683	TCGA-UZ-A9PJ	KIRP	78	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-28490	Dead	NA	NA	797	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	797	NA	797	0	797	0	797	
70	TCGA-UZ-A9PK	0	10	1	7	6	3	1	0	3	49	4	0	1	18	2	0	TCGA-UZ-A9PK-01	45	0.3446556591620419	11	TCGA-UZ-A9PK-01	9	5	2	6.407984057368259e-05	TCGA-UZ-A9PK-01	0	0	0	0	PASS	4684	TCGA-UZ-A9PK	KIRP	71	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-25933	Alive	TUMOR FREE	3571	NA	NA	NA	NA	NA	3157	Complete Remission/Response	NA	NA	0	3571	0	3571	1	3157	1	3157	
60	TCGA-UZ-A9PL	0	6	1	5	9	1	0	0	7	46	5	0	0	20	1	0	TCGA-UZ-A9PL-01	63	0.13856646049131702	22	TCGA-UZ-A9PL-01	6	3	8	0.0027200002125080088	TCGA-UZ-A9PL-01	0	0	0	0	PASS	4685	TCGA-UZ-A9PL	KIRP	59	MALE	WHITE	Stage II	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-21550	Alive	TUMOR FREE	3152	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3152	0	3152	0	3152	0	3152	
60	TCGA-UZ-A9PM	1	6	0	5	2	0	1	0	4	44	0	0	3	16	4	0	TCGA-UZ-A9PM-01	36	0.14816052980486086	4	TCGA-UZ-A9PM-01	7	5	6	0.003229879616012881	TCGA-UZ-A9PM-01	1	0	0	1	PASS	4686	TCGA-UZ-A9PM	KIRP	62	MALE	WHITE	Stage II	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-22646	Alive	TUMOR FREE	3811	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3811	0	3811	0	3811	0	3811	
50	TCGA-UZ-A9PN	1	11	0	3	5	1	1	0	7	44	1	1	2	13	2	1	TCGA-UZ-A9PN-01	81	0.1689484517730616	28	TCGA-UZ-A9PN-01	7	7	37	0.11735227463070658	TCGA-UZ-A9PN-01	2	2	3	7	PASS	4687	TCGA-UZ-A9PN	KIRP	54	MALE	WHITE	Stage III	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-19724	Dead	WITH TUMOR	NA	1136	NA	NA	NA	NA	679	Complete Remission/Response	NA	NA	1	1136	1	1136	1	679	1	679	
80	TCGA-UZ-A9PO	0	14	0	9	9	1	2	0	6	69	4	0	3	20	3	0	TCGA-UZ-A9PO-01	90	0.2549560130774061	44	TCGA-UZ-A9PO-01	11	6	7	0.0013040130371842972	TCGA-UZ-A9PO-01	0	0	0	0	PASS	4688	TCGA-UZ-A9PO	KIRP	80	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-29220	Alive	TUMOR FREE	1911	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1911	0	1911	0	1911	0	1911	
60	TCGA-UZ-A9PP	0	6	0	7	2	2	1	0	8	62	4	0	1	15	3	0	TCGA-UZ-A9PP-01	57	0.20616500306024388	16	TCGA-UZ-A9PP-01	8	8	33	0.12431818945746248	TCGA-UZ-A9PP-01	0	0	0	0	PASS	4689	TCGA-UZ-A9PP	KIRP	60	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-21915	Alive	TUMOR FREE	3010	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3010	0	3010	0	3010	0	3010	
60	TCGA-UZ-A9PQ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UZ-A9PQ-01	180	0.946220495272638	102	TCGA-UZ-A9PQ	0	0	0	0	TCGA-UZ-A9PQ	0	0	0	0	PASS	4690	TCGA-UZ-A9PQ	KIRP	59	MALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-21550	Dead	WITH TUMOR	NA	2624	NA	NA	NA	NA	2148	Complete Remission/Response	NA	NA	1	2624	1	2624	1	2148	1	2148	
80	TCGA-UZ-A9PR	0	13	0	6	11	1	2	0	5	77	6	0	1	25	1	1	TCGA-UZ-A9PR-01	57	0.0818782732714044	17	TCGA-UZ-A9PR-01	4	3	4	0.00013033187271130757	TCGA-UZ-A9PR-01	0	0	0	0	PASS	4691	TCGA-UZ-A9PR	KIRP	84	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-30681	Alive	TUMOR FREE	2627	NA	NA	NA	NA	NA	2494	Complete Remission/Response	NA	NA	0	2627	0	2627	1	2494	1	2494	
60	TCGA-UZ-A9PS	2	37	3	9	22	7	3	1	18	163	7	0	5	67	2	0	TCGA-UZ-A9PS-01	79	0.15756362504753402	34	TCGA-UZ-A9PS-01	7	5	10	0.014520250203205215	TCGA-UZ-A9PS-01	2	3	1	6	mutation call filter	4692	TCGA-UZ-A9PS	KIRP	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-22646	Alive	TUMOR FREE	2167	NA	NA	NA	NA	NA	55	Complete Remission/Response	NA	NA	0	2167	0	2167	1	55	1	55	
80	TCGA-UZ-A9PU	0	5	0	2	9	3	1	1	2	40	1	0	2	9	1	0	TCGA-UZ-A9PU-01	58	0.1797423401749228	14	TCGA-UZ-A9PU-01	7	7	27	0.0616499904691379	TCGA-UZ-A9PU-01	1	0	0	1	PASS	4693	TCGA-UZ-A9PU	KIRP	77	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-28124	Dead	TUMOR FREE	NA	933	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	933	0	933	0	933	0	933	
70	TCGA-UZ-A9PV	0	4	0	2	6	2	0	0	2	39	3	0	0	15	2	0	TCGA-UZ-A9PV-01	93	0.8928420092946371	40	TCGA-UZ-A9PV-01	10	6	9	0.0011302792349842405	TCGA-UZ-A9PV-01	0	0	0	0	PASS	4694	TCGA-UZ-A9PV	KIRP	65	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-23741	Alive	TUMOR FREE	1444	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1444	0	1444	0	1444	0	1444	
70	TCGA-UZ-A9PX	1	11	0	7	5	6	2	0	6	75	2	0	0	27	4	0	TCGA-UZ-A9PX-01	61	0.7992784234184618	17	TCGA-UZ-A9PX-01	9	6	9	0.0011844712806869835	TCGA-UZ-A9PX-01	0	0	0	0	PASS	4695	TCGA-UZ-A9PX	KIRP	73	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-26663	Alive	TUMOR FREE	1981	NA	NA	NA	NA	NA	308	Complete Remission/Response	NA	NA	0	1981	0	1981	1	308	1	308	
70	TCGA-UZ-A9PZ	0	5	0	5	3	0	0	0	3	33	3	0	0	16	0	1	TCGA-UZ-A9PZ-01	43	0.5325141833716787	4	TCGA-UZ-A9PZ-01	11	9	14	0.04846726254935605	TCGA-UZ-A9PZ-01	0	0	0	0	PASS	4696	TCGA-UZ-A9PZ	KIRP	65	MALE	WHITE	Stage III	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-23741	Alive	TUMOR FREE	657	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	657	0	657	0	657	0	657	
60	TCGA-UZ-A9Q0	0	7	1	2	6	0	1	0	4	42	2	0	2	15	1	0	TCGA-UZ-A9Q0-01	62	0.2840153537828208	21	TCGA-UZ-A9Q0-01	10	6	12	0.002344965825658967	TCGA-UZ-A9Q0-01	1	0	0	1	PASS	4697	TCGA-UZ-A9Q0	KIRP	60	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-21915	Alive	TUMOR FREE	3368	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3368	0	3368	0	3368	0	3368	
90	TCGA-UZ-A9Q1	1	5	2	6	4	2	2	0	4	50	4	0	0	32	3	0	TCGA-UZ-A9Q1-01	35	0.3673962759675443	2	TCGA-UZ-A9Q1-01	8	6	17	0.04828966216704729	TCGA-UZ-A9Q1-01	0	0	0	0	PASS	4698	TCGA-UZ-A9Q1	KIRP	88	FEMALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	NA	NA	-32142	Alive	TUMOR FREE	1562	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1562	0	1562	0	1562	0	1562	
70	TCGA-V9-A7HT	0	9	1	3	5	5	3	0	1	60	0	0	1	18	0	0	TCGA-V9-A7HT-01	70	0.8418814842399788	25	TCGA-V9-A7HT-01	25	33	29	0.09946529848159212	TCGA-V9-A7HT-01	0	2	1	3	PASS	4699	TCGA-V9-A7HT	KIRP	67	MALE	BLACK OR AFRICAN AMERICAN	Stage II	Stage II	Kidney Papillary Renal Cell Carcinoma	NA	2009	NA	-24610	Alive	TUMOR FREE	965	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	965	0	965	0	965	0	965	
60	TCGA-WN-A9G9	0	5	0	5	6	4	2	0	4	40	4	0	1	19	1	0	TCGA-WN-A9G9-01	76	0.06412518655167325	31	TCGA-WN-A9G9-01	3	3	36	0.07524070816959033	TCGA-WN-A9G9-01	4	3	3	10	PASS	4700	TCGA-WN-A9G9	KIRP	55	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	NA	Alive	TUMOR FREE	791	NA	NA	NA	NA	NA	791	Complete Remission/Response	NA	NA	0	791	0	791	1	791	1	791	
60	TCGA-WN-AB4C	1	15	0	7	2	2	3	0	7	63	6	0	1	24	3	0	TCGA-WN-AB4C-01	64	0.12447535765652235	20	TCGA-WN-AB4C-01	5	3	8	0.007180393128100792	TCGA-WN-AB4C-01	1	0	1	2	PASS	4701	TCGA-WN-AB4C	KIRP	60	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma	NA	2011	NA	NA	Alive	WITH TUMOR	1188	NA	NA	NA	NA	NA	1157	Complete Remission/Response	NA	NA	0	1188	0	1188	1	1157	1	1157	
60	TCGA-Y8-A894	0	18	0	8	7	3	1	0	5	51	9	0	2	20	2	0	TCGA-Y8-A894-01	74	0.022080607935983213	32	TCGA-Y8-A894-01	0	0	11	0.012314084514332262	TCGA-Y8-A894-01	1	3	1	5	PASS	4702	TCGA-Y8-A894	KIRP	57	FEMALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-20964	Alive	TUMOR FREE	567	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	567	0	567	0	567	0	567	
70	TCGA-Y8-A895	3	17	2	6	5	5	2	0	9	64	8	0	2	24	2	0	TCGA-Y8-A895-01	57	0.27276749203242445	20	TCGA-Y8-A895-01	10	7	9	0.012243636061287463	TCGA-Y8-A895-01	0	0	0	0	PASS	4703	TCGA-Y8-A895	KIRP	74	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-27139	Alive	TUMOR FREE	484	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	484	0	484	0	484	0	484	
60	TCGA-Y8-A896	1	9	4	10	6	3	2	0	3	75	3	0	1	24	3	0	TCGA-Y8-A896-01	59	0.21759440344305	19	TCGA-Y8-A896-01	8	5	31	0.15256551105891605	TCGA-Y8-A896-01	0	0	0	0	PASS	4704	TCGA-Y8-A896	KIRP	62	MALE	WHITE	Stage III	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-22750	Alive	TUMOR FREE	567	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	567	0	567	0	567	0	567	
70	TCGA-Y8-A897	1	12	1	9	5	2	1	0	4	46	4	0	1	16	2	0	TCGA-Y8-A897-01	73	0.06351435498766142	24	TCGA-Y8-A897-01	3	4	23	0.04915731022362483	TCGA-Y8-A897-01	0	0	0	0	PASS	4705	TCGA-Y8-A897	KIRP	68	FEMALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-25047	Alive	TUMOR FREE	549	NA	NA	NA	NA	NA	450	Complete Remission/Response	NA	NA	0	549	0	549	1	450	1	450	
70	TCGA-Y8-A898	0	4	0	1	7	3	1	0	2	54	4	0	0	15	4	0	TCGA-Y8-A898-01	63	0.11242092775858956	19	TCGA-Y8-A898-01	6	3	10	0.00027139436902919717	TCGA-Y8-A898-01	0	0	0	0	PASS	4706	TCGA-Y8-A898	KIRP	69	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-25344	Alive	TUMOR FREE	475	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	475	0	475	0	475	0	475	
60	TCGA-Y8-A8RY	0	21	4	20	18	2	0	0	4	84	6	0	4	39	0	0	TCGA-Y8-A8RY-01	51	0.12782854857501788	10	TCGA-Y8-A8RY-01	6	6	12	0.01286618097593696	TCGA-Y8-A8RY-01	0	1	1	2	PASS	4707	TCGA-Y8-A8RY	KIRP	63	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2012	NA	-23192	Alive	TUMOR FREE	769	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	769	0	769	0	769	0	769	
60	TCGA-Y8-A8RZ	0	11	2	8	2	0	5	0	6	100	8	0	2	26	6	0	TCGA-Y8-A8RZ-01	85	0.08588043016593327	41	TCGA-Y8-A8RZ-01	2	2	43	0.07552546931499007	TCGA-Y8-A8RZ-01	4	3	3	10	PASS	4708	TCGA-Y8-A8RZ	KIRP	55	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-20386	Alive	TUMOR FREE	205	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	205	0	205	0	205	0	205	
60	TCGA-Y8-A8S0	1	6	2	8	2	0	1	0	4	58	6	0	0	22	2	0	TCGA-Y8-A8S0-01	57	0.17597253202207688	19	TCGA-Y8-A8S0-01	8	4	12	0.0007553610054257424	TCGA-Y8-A8S0-01	0	0	0	0	PASS	4709	TCGA-Y8-A8S0	KIRP	58	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-21383	Alive	TUMOR FREE	183	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	183	0	183	0	183	0	183	
60	TCGA-Y8-A8S1	0	4	2	4	6	0	0	0	8	91	4	0	7	24	0	0	TCGA-Y8-A8S1-01	51	0.07634033917907239	15	TCGA-Y8-A8S1-01	2	3	34	0.08339973505131197	TCGA-Y8-A8S1-01	4	2	3	9	PASS	4710	TCGA-Y8-A8S1	KIRP	61	MALE	WHITE	Stage I	NA	Kidney Papillary Renal Cell Carcinoma	NA	2013	NA	-22319	Alive	TUMOR FREE	404	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	404	0	404	0	404	0	404	
50	TCGA-AB-2802	0	1	1	0	0	0	0	0	0	9	0	0	0	4	0	0	TCGA-AB-2802	0	0	0	TCGA-AB-2802	0	0	0	0	TCGA-AB-2802	0	0	0	0	PASS	4711	TCGA-AB-2802	LAML	50	MALE	WHITE	NA	NA	NA	NA	2001	NA	-18385	Dead	NA	NA	365	NA	NA	NA	NA	NA	NA	NA	NA	1	365	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2803	1	2	0	0	1	0	0	0	0	12	0	0	0	3	0	0	TCGA-AB-2803-03	67	2.316281700061388e-05	25	TCGA-AB-2803-03	0	0	22	0.001952637493769385	TCGA-AB-2803-03	0	0	0	0	PASS	4712	TCGA-AB-2803	LAML	61	FEMALE	WHITE	NA	NA	NA	NA	2001	NA	-22584	Dead	NA	NA	792	NA	NA	NA	NA	NA	NA	NA	NA	1	792	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-2804	1	4	0	1	0	1	0	0	2	31	5	1	0	6	13	0	TCGA-AB-2804-03	99	4.602481030754839e-05	49	TCGA-AB-2804	0	0	0	0	TCGA-AB-2804	0	0	0	0	PASS	4713	TCGA-AB-2804	LAML	30	MALE	WHITE	NA	NA	NA	NA	2001	NA	-11203	Alive	NA	2557	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2557	0	NA	NA	NA	NA	NA	
80	TCGA-AB-2805	0	10	1	2	0	2	0	0	0	38	5	0	0	15	8	0	TCGA-AB-2805-03	70	0.025313329108237786	23	TCGA-AB-2805-03	0	0	25	0.014965690757361427	TCGA-AB-2805-03	1	2	1	4	PASS	4714	TCGA-AB-2805	LAML	77	MALE	WHITE	NA	NA	NA	NA	2002	NA	-28124	Dead	NA	NA	577	NA	NA	NA	NA	NA	NA	NA	NA	1	577	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2806	3	25	2	15	15	27	0	0	20	417	31	0	11	150	10	1	TCGA-AB-2806-03	65	0.04350515221521138	23	TCGA-AB-2806-03	1	2	11	0.012815358133102616	TCGA-AB-2806-03	1	1	1	3	PASS	4715	TCGA-AB-2806	LAML	46	MALE	WHITE	NA	NA	NA	NA	2002	NA	-16892	Dead	NA	NA	945	NA	NA	NA	NA	NA	NA	NA	NA	1	945	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2807	1	9	1	3	4	6	2	0	10	196	17	1	3	90	9	0	TCGA-AB-2807-03	97	0.011148668690881922	45	TCGA-AB-2807-03	1	1	15	0.00044612278415470587	TCGA-AB-2807-03	0	0	0	0	PASS	4716	TCGA-AB-2807	LAML	68	FEMALE	WHITE	NA	NA	NA	NA	2002	NA	-25143	Dead	NA	NA	181	NA	NA	NA	NA	NA	NA	NA	NA	1	181	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-2808	2	45	3	22	37	84	0	0	30	581	34	2	10	243	25	0	TCGA-AB-2808-03	50	0.00020616408869246898	13	TCGA-AB-2808-03	0	0	16	0.0245769957299405	TCGA-AB-2808-03	0	1	1	2	hypermutated sample	4717	TCGA-AB-2808	LAML	23	MALE	WHITE	NA	NA	NA	NA	2002	NA	-8521	Alive	NA	2861	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2861	0	NA	NA	NA	NA	NA	
60	TCGA-AB-2809	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	TCGA-AB-2809-03	53	0.002295609175854711	11	TCGA-AB-2809-03	0	0	7	0.0024537171492684177	TCGA-AB-2809-03	0	0	0	0	PASS	4718	TCGA-AB-2809	LAML	64	FEMALE	WHITE	NA	NA	NA	NA	2002	NA	-23679	Dead	NA	NA	62	NA	NA	NA	NA	NA	NA	NA	NA	1	62	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2810	0	0	0	0	0	0	0	0	0	4	1	0	0	5	0	0	TCGA-AB-2810-03	121	0.0009072272953498154	58	TCGA-AB-2810-03	0	0	8	0.001031074159600532	TCGA-AB-2810-03	0	0	0	0	PASS	4719	TCGA-AB-2810	LAML	76	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	NA	NA	2002	NA	-27971	Dead	NA	NA	31	NA	NA	NA	NA	NA	NA	NA	NA	1	31	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2811	0	1	0	0	0	1	0	0	0	3	0	0	0	3	0	0	TCGA-AB-2811-03	81	2.1085145795178534e-05	39	TCGA-AB-2811	0	0	0	0	TCGA-AB-2811	0	0	0	0	PASS	4720	TCGA-AB-2811	LAML	81	MALE	WHITE	NA	NA	NA	NA	2002	NA	-29766	Dead	NA	NA	243	NA	NA	NA	NA	NA	NA	NA	NA	1	243	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-2812	0	0	0	2	0	0	0	0	0	2	0	0	0	0	0	0	TCGA-AB-2812-03	107	8.096640215632553e-05	62	TCGA-AB-2812-03	0	2	23	0.035455770769993136	TCGA-AB-2812-03	0	0	0	0	PASS	4721	TCGA-AB-2812	LAML	25	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	NA	NA	2004	NA	-9253	Dead	NA	NA	366	NA	NA	NA	NA	NA	NA	NA	NA	1	366	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2813	0	1	0	0	1	0	0	0	0	11	0	0	0	4	0	0	TCGA-AB-2813-03	85	0.8368114127725663	41	TCGA-AB-2813-03	4	4	61	0.10187714334187076	TCGA-AB-2813-03	2	0	4	6	PASS	4722	TCGA-AB-2813	LAML	78	MALE	WHITE	NA	NA	NA	NA	2005	NA	-28581	Dead	NA	NA	31	NA	NA	NA	NA	NA	NA	NA	NA	1	31	NA	NA	NA	NA	NA	NA	
40	TCGA-AB-2814	0	0	0	1	0	0	0	0	1	7	1	0	0	3	0	0	TCGA-AB-2814-03	41	0.00012573448953086773	5	TCGA-AB-2814-03	0	0	7	0.00031572713240391733	TCGA-AB-2814-03	0	0	0	0	PASS	4723	TCGA-AB-2814	LAML	39	FEMALE	WHITE	NA	NA	NA	NA	2003	NA	-14427	Dead	NA	NA	792	NA	NA	NA	NA	NA	NA	NA	NA	1	792	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2815	0	1	0	0	0	1	0	0	0	1	0	0	0	1	0	0	TCGA-AB-2815-03	85	0.00014763359156662345	30	TCGA-AB-2815	0	0	0	0	TCGA-AB-2815	0	0	0	0	PASS	4724	TCGA-AB-2815	LAML	49	MALE	WHITE	NA	NA	NA	NA	2004	NA	-17988	Dead	NA	NA	822	NA	NA	NA	NA	NA	NA	NA	NA	1	822	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2816	0	0	0	0	0	0	0	0	0	3	0	0	0	1	0	0	TCGA-AB-2816-03	69	1.7509708488695755e-05	28	TCGA-AB-2816-03	0	0	6	0.00922739686262117	TCGA-AB-2816-03	0	0	1	1	PASS	4725	TCGA-AB-2816	LAML	57	FEMALE	WHITE	NA	NA	NA	NA	2003	NA	-20939	Dead	NA	NA	245	NA	NA	NA	NA	NA	NA	NA	NA	1	245	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2817	0	2	0	0	0	1	0	0	1	10	0	0	0	1	0	0	TCGA-AB-2817-03	85	0.054378396884075086	30	TCGA-AB-2817-03	2	1	33	0.05751867402204298	TCGA-AB-2817-03	0	0	0	0	PASS	4726	TCGA-AB-2817	LAML	64	MALE	WHITE	NA	NA	NA	NA	2005	NA	-23376	Dead	NA	NA	273	NA	NA	NA	NA	NA	NA	NA	NA	1	273	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2818	1	1	0	0	0	0	0	0	0	6	1	0	1	4	0	0	TCGA-AB-2818-03	75	0.0006862885787859981	31	TCGA-AB-2818-03	0	0	19	0.0015883884091758785	TCGA-AB-2818-03	0	0	0	0	PASS	4727	TCGA-AB-2818	LAML	62	FEMALE	ASIAN	NA	NA	NA	NA	2002	NA	-22707	Dead	NA	NA	303	NA	NA	NA	NA	NA	NA	NA	NA	1	303	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2819	0	0	0	0	0	2	0	0	1	10	1	0	0	6	0	0	TCGA-AB-2819-03	45	1.152369628027588e-05	7	TCGA-AB-2819-03	0	0	7	0.0011905593119303519	TCGA-AB-2819-03	1	0	0	1	PASS	4728	TCGA-AB-2819	LAML	52	FEMALE	WHITE	NA	NA	NA	NA	2003	NA	-19054	Alive	NA	2496	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2496	0	NA	NA	NA	NA	NA	
80	TCGA-AB-2820	0	1	0	0	0	2	0	0	0	3	2	0	1	1	0	0	TCGA-AB-2820-03	93	0.9477328911285141	45	TCGA-AB-2820-03	11	10	19	0.0045399009774973464	TCGA-AB-2820-03	1	2	0	3	PASS	4729	TCGA-AB-2820	LAML	76	MALE	WHITE	NA	NA	NA	NA	2003	NA	-27971	Dead	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2821	0	0	0	1	0	1	0	0	1	15	1	0	1	3	0	0	TCGA-AB-2821-03	77	0.049906047983914584	37	TCGA-AB-2821-03	2	1	7	0.00025863311029224097	TCGA-AB-2821-03	0	0	0	0	PASS	4730	TCGA-AB-2821	LAML	64	MALE	WHITE	NA	NA	NA	NA	2005	NA	-23527	Dead	NA	NA	822	NA	NA	NA	NA	NA	NA	NA	NA	1	822	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2822	0	3	0	0	0	0	0	0	0	14	1	0	2	6	1	0	TCGA-AB-2822-03	60	0.0498956399002216	15	TCGA-AB-2822-03	2	1	11	0.003009109815699043	TCGA-AB-2822-03	0	0	0	0	PASS	4731	TCGA-AB-2822	LAML	65	MALE	WHITE	NA	NA	NA	NA	2003	NA	-24017	Dead	NA	NA	973	NA	NA	NA	NA	NA	NA	NA	NA	1	973	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2823	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2823-03	67	0.022448818939105428	29	TCGA-AB-2823-03	0	0	14	0.0006628704184666423	TCGA-AB-2823-03	1	2	0	3	PASS	4732	TCGA-AB-2823	LAML	61	FEMALE	WHITE	NA	NA	NA	NA	2006	NA	-22522	Dead	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2824	0	15	0	2	0	0	0	0	4	24	1	0	0	2	25	0	TCGA-AB-2824-03	64	3.500151379859313e-05	21	TCGA-AB-2824-03	0	0	19	0.001838930423805104	TCGA-AB-2824-03	0	0	0	0	PASS	4733	TCGA-AB-2824	LAML	45	MALE	WHITE	NA	NA	NA	NA	2004	NA	-16437	Dead	NA	NA	30	NA	NA	NA	NA	NA	NA	NA	NA	1	30	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-2825	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2825-03	63	0.0003757437472292748	19	TCGA-AB-2825-03	0	0	11	0.0006909977476709151	TCGA-AB-2825-03	0	0	0	0	PASS	4734	TCGA-AB-2825	LAML	31	FEMALE	WHITE	NA	NA	NA	NA	2006	NA	-11384	Dead	NA	NA	212	NA	NA	NA	NA	NA	NA	NA	NA	1	212	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2826	3	26	1	9	22	54	1	0	15	507	30	0	4	206	10	1	TCGA-AB-2826-03	65	8.519757350950545e-05	22	TCGA-AB-2826-03	0	4	138	0.04419348328905405	TCGA-AB-2826-03	11	9	0	20	PASS	4735	TCGA-AB-2826	LAML	64	FEMALE	WHITE	NA	NA	NA	NA	2002	NA	-23468	Dead	NA	NA	731	NA	NA	NA	NA	NA	NA	NA	NA	1	731	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-2827	0	7	0	0	0	0	0	0	1	22	1	0	0	9	21	0	TCGA-AB-2827-03	66	0.00014371965026948702	29	TCGA-AB-2827-03	0	0	6	0.0003131464947617817	TCGA-AB-2827-03	0	0	0	0	PASS	4736	TCGA-AB-2827	LAML	33	MALE	WHITE	NA	NA	NA	NA	2003	NA	-12237	Dead	NA	NA	273	NA	NA	NA	NA	NA	NA	NA	NA	1	273	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2828	6	35	3	16	23	81	2	1	28	578	31	0	13	245	15	0	TCGA-AB-2828-03	63	0.0009761149846647123	22	TCGA-AB-2828-03	0	0	5	0.0010635225760532619	TCGA-AB-2828-03	0	0	0	0	hypermutated sample	4737	TCGA-AB-2828	LAML	55	MALE	WHITE	NA	NA	NA	NA	2003	NA	-20393	Alive	NA	2284	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2284	0	NA	NA	NA	NA	NA	
50	TCGA-AB-2829	1	1	0	0	0	0	0	0	0	17	1	0	0	3	5	0	TCGA-AB-2829-03	178	0.1445564870443539	115	TCGA-AB-2829-03	3	4	63	0.0981960084433376	TCGA-AB-2829-03	4	4	4	12	PASS	4738	TCGA-AB-2829	LAML	50	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	NA	NA	2004	NA	-18386	Dead	NA	NA	273	NA	NA	NA	NA	NA	NA	NA	NA	1	273	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2830	0	3	0	0	0	0	0	0	1	12	0	0	0	3	12	0	TCGA-AB-2830-03	46	0.027033626159746967	10	TCGA-AB-2830-03	1	1	10	0.000521905146267379	TCGA-AB-2830-03	1	0	0	1	PASS	4739	TCGA-AB-2830	LAML	64	FEMALE	WHITE	NA	NA	NA	NA	2005	NA	-23404	Dead	NA	NA	275	NA	NA	NA	NA	NA	NA	NA	NA	1	275	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2831	0	1	0	0	0	2	0	0	0	2	0	0	1	0	0	0	TCGA-AB-2831-03	49	1.9391708724068274e-05	16	TCGA-AB-2831	0	0	0	0	TCGA-AB-2831	0	0	0	0	PASS	4740	TCGA-AB-2831	LAML	59	MALE	WHITE	NA	NA	NA	NA	2004	NA	-21550	Dead	NA	NA	640	NA	NA	NA	NA	NA	NA	NA	NA	1	640	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2832	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2832-03	73	5.8443957616229467e-05	24	TCGA-AB-2832-03	0	0	11	0.00041736470230011735	TCGA-AB-2832-03	0	0	0	0	PASS	4741	TCGA-AB-2832	LAML	60	FEMALE	WHITE	NA	NA	NA	NA	2005	NA	-21915	Dead	NA	NA	365	NA	NA	NA	NA	NA	NA	NA	NA	1	365	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2833	1	11	1	7	10	43	0	0	16	361	23	2	6	191	12	0	TCGA-AB-2833	0	0	0	TCGA-AB-2833	0	0	0	0	TCGA-AB-2833	0	0	0	0	PASS	4742	TCGA-AB-2833	LAML	77	MALE	WHITE	NA	NA	NA	NA	2002	NA	-28308	Dead	NA	NA	456	NA	NA	NA	NA	NA	NA	NA	NA	1	456	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-2834	0	8	0	0	0	0	0	0	4	13	0	0	0	0	17	0	TCGA-AB-2834-03	109	0.00028842448923707545	61	TCGA-AB-2834-03	0	0	10	0.0005336557917338296	TCGA-AB-2834-03	0	0	0	0	PASS	4743	TCGA-AB-2834	LAML	33	MALE	WHITE	NA	NA	NA	NA	2004	NA	-12266	Dead	NA	NA	245	NA	NA	NA	NA	NA	NA	NA	NA	1	245	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2835	0	0	0	0	0	0	0	0	0	1	0	0	0	3	4	0	TCGA-AB-2835-03	61	0.0005265500441513672	19	TCGA-AB-2835-03	0	0	8	0.000276534632587545	TCGA-AB-2835-03	0	0	0	0	PASS	4744	TCGA-AB-2835	LAML	48	MALE	WHITE	NA	NA	NA	NA	2005	NA	-17624	Alive	NA	1673	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1673	0	NA	NA	NA	NA	NA	
40	TCGA-AB-2836	0	1	0	0	0	0	0	0	0	3	1	0	1	0	2	0	TCGA-AB-2836-03	55	0.00010814051496671472	20	TCGA-AB-2836	0	0	0	0	TCGA-AB-2836	0	0	0	0	PASS	4745	TCGA-AB-2836	LAML	35	MALE	WHITE	NA	NA	NA	NA	2005	NA	-12904	Dead	NA	NA	518	NA	NA	NA	NA	NA	NA	NA	NA	1	518	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2837	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2837-03	59	5.3564577546318e-06	19	TCGA-AB-2837	0	0	0	0	TCGA-AB-2837	0	0	0	0	PASS	4746	TCGA-AB-2837	LAML	66	FEMALE	WHITE	NA	NA	NA	NA	2002	NA	-24381	Dead	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2838	0	0	1	0	0	1	0	0	0	15	0	0	0	5	0	0	TCGA-AB-2838-03	99	0.20175828456615266	52	TCGA-AB-2838-03	7	6	56	0.11084949241414913	TCGA-AB-2838-03	2	3	3	8	PASS	4747	TCGA-AB-2838	LAML	67	MALE	WHITE	NA	NA	NA	NA	2002	NA	-24503	Dead	NA	NA	365	NA	NA	NA	NA	NA	NA	NA	NA	1	365	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2839	0	0	0	0	0	0	0	0	1	10	0	0	0	0	0	0	TCGA-AB-2839-03	51	2.9897821067970885e-05	13	TCGA-AB-2839	0	0	0	0	TCGA-AB-2839	0	0	0	0	PASS	4748	TCGA-AB-2839	LAML	51	FEMALE	WHITE	NA	NA	NA	NA	2003	NA	-18963	Dead	NA	NA	486	NA	NA	NA	NA	NA	NA	NA	NA	1	486	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2840	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2840-03	47	0.0001631375621767855	10	TCGA-AB-2840-03	0	0	7	0.00042382365079621297	TCGA-AB-2840-03	0	0	0	0	PASS	4749	TCGA-AB-2840	LAML	74	MALE	WHITE	NA	NA	NA	NA	2003	NA	-27243	Dead	NA	NA	28	NA	NA	NA	NA	NA	NA	NA	NA	1	28	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2841	1	0	0	0	0	1	0	0	0	9	0	0	1	2	3	0	TCGA-AB-2841-03	69	1.957508017834415e-05	23	TCGA-AB-2841-03	0	0	7	0.00013316142017001957	TCGA-AB-2841-03	0	0	0	0	PASS	4750	TCGA-AB-2841	LAML	51	FEMALE	WHITE	NA	NA	NA	NA	2004	NA	-18809	Dead	NA	NA	1401	NA	NA	NA	NA	NA	NA	NA	NA	1	1401	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2842	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2842-03	49	9.19768009196626e-05	8	TCGA-AB-2842-03	0	0	11	0.011749649627183471	TCGA-AB-2842-03	0	0	1	1	PASS	4751	TCGA-AB-2842	LAML	65	MALE	WHITE	NA	NA	NA	NA	2004	NA	-23741	Dead	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2843	0	1	0	0	1	0	0	0	2	11	0	0	0	6	8	0	TCGA-AB-2843	0	0	0	TCGA-AB-2843	0	0	0	0	TCGA-AB-2843	0	0	0	0	PASS	4752	TCGA-AB-2843	LAML	77	MALE	WHITE	NA	NA	NA	NA	2004	NA	-28275	Dead	NA	NA	215	NA	NA	NA	NA	NA	NA	NA	NA	1	215	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2844	0	1	0	0	0	0	0	0	0	5	0	0	0	0	8	0	TCGA-AB-2844-03	41	2.5683952938702358e-05	8	TCGA-AB-2844-03	0	0	9	0.0007649403569690062	TCGA-AB-2844-03	0	0	0	0	PASS	4753	TCGA-AB-2844	LAML	63	MALE	WHITE	NA	NA	NA	NA	2005	NA	-23254	Dead	NA	NA	122	NA	NA	NA	NA	NA	NA	NA	NA	1	122	NA	NA	NA	NA	NA	NA	
40	TCGA-AB-2845	0	0	0	1	0	0	0	0	0	1	0	0	0	1	0	0	TCGA-AB-2845-03	49	5.548220799078341e-05	9	TCGA-AB-2845-03	0	0	16	0.011877403787149146	TCGA-AB-2845-03	0	0	1	1	PASS	4754	TCGA-AB-2845	LAML	37	FEMALE	WHITE	NA	NA	NA	NA	2002	NA	-13728	Dead	NA	NA	304	NA	NA	NA	NA	NA	NA	NA	NA	1	304	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2846	0	6	0	2	0	1	0	1	3	19	2	0	0	2	14	0	TCGA-AB-2846-03	47	4.2382950196315803e-05	15	TCGA-AB-2846-03	0	0	13	0.0007457011341372189	TCGA-AB-2846-03	0	0	0	0	PASS	4755	TCGA-AB-2846	LAML	57	FEMALE	WHITE	NA	NA	NA	NA	2005	NA	-20910	Dead	NA	NA	1402	NA	NA	NA	NA	NA	NA	NA	NA	1	1402	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2847	0	3	0	1	0	0	0	0	0	8	1	0	0	4	7	0	TCGA-AB-2847	0	0	0	TCGA-AB-2847	0	0	0	0	TCGA-AB-2847	0	0	0	0	PASS	4756	TCGA-AB-2847	LAML	53	MALE	WHITE	NA	NA	NA	NA	2004	NA	-19481	Dead	NA	NA	608	NA	NA	NA	NA	NA	NA	NA	NA	1	608	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2848	0	2	0	1	0	0	0	0	0	3	0	0	0	0	6	0	TCGA-AB-2848-03	69	0.00014158223414543689	20	TCGA-AB-2848	0	0	0	0	TCGA-AB-2848	0	0	0	0	PASS	4757	TCGA-AB-2848	LAML	62	MALE	WHITE	NA	NA	NA	NA	2005	NA	-22980	Dead	NA	NA	455	NA	NA	NA	NA	NA	NA	NA	NA	1	455	NA	NA	NA	NA	NA	NA	
40	TCGA-AB-2849	0	1	1	1	0	2	0	0	0	23	2	0	0	10	1	0	TCGA-AB-2849-03	82	0.09855036336487404	32	TCGA-AB-2849-03	4	2	19	0.0331959712265644	TCGA-AB-2849-03	2	2	3	7	PASS	4758	TCGA-AB-2849	LAML	39	MALE	WHITE	NA	NA	NA	NA	2004	NA	-14520	Alive	NA	2220	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2220	0	NA	NA	NA	NA	NA	
70	TCGA-AB-2850	0	1	0	0	1	0	0	0	0	12	1	0	0	3	1	0	TCGA-AB-2850-03	63	5.4388941835047745e-05	18	TCGA-AB-2850-03	0	0	15	0.0010824957235075617	TCGA-AB-2850-03	0	0	0	0	PASS	4759	TCGA-AB-2850	LAML	72	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	NA	NA	2003	NA	-26298	Dead	NA	NA	61	NA	NA	NA	NA	NA	NA	NA	NA	1	61	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2851	0	8	0	0	0	0	0	0	3	24	0	1	0	1	22	1	TCGA-AB-2851-03	47	3.978397954263668e-05	8	TCGA-AB-2851-03	0	0	9	0.0006505887070143867	TCGA-AB-2851-03	0	0	0	0	PASS	4760	TCGA-AB-2851	LAML	66	FEMALE	WHITE	NA	NA	NA	NA	2005	NA	-24319	Dead	NA	NA	242	NA	NA	NA	NA	NA	NA	NA	NA	1	242	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2853	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2853-03	43	0.00010761576651997227	8	TCGA-AB-2853-03	0	0	7	0.001468750438070655	TCGA-AB-2853-03	0	0	0	0	PASS	4761	TCGA-AB-2853	LAML	51	MALE	WHITE	NA	NA	NA	NA	2003	NA	-18720	Dead	NA	NA	89	NA	NA	NA	NA	NA	NA	NA	NA	1	89	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2854	3	20	1	4	7	15	0	0	10	243	19	0	1	112	13	0	TCGA-AB-2854-03	75	0.00017113581582350095	28	TCGA-AB-2854-03	0	0	21	0.0013699197089688047	TCGA-AB-2854-03	0	0	0	0	PASS	4762	TCGA-AB-2854	LAML	51	FEMALE	WHITE	NA	NA	NA	NA	2003	NA	-18809	Dead	NA	NA	366	NA	NA	NA	NA	NA	NA	NA	NA	1	366	NA	NA	NA	NA	NA	NA	
20	TCGA-AB-2855	0	6	0	2	1	0	0	0	1	7	0	0	0	2	16	0	TCGA-AB-2855-03	136	0.12278357634433207	78	TCGA-AB-2855-03	7	4	27	0.019653519623452475	TCGA-AB-2855-03	2	0	2	4	PASS	4763	TCGA-AB-2855	LAML	18	MALE	WHITE	NA	NA	NA	NA	2004	NA	-6636	Dead	NA	NA	212	NA	NA	NA	NA	NA	NA	NA	NA	1	212	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2856	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2856-03	59	6.8206325860088504e-06	20	TCGA-AB-2856-03	0	2	14	0.034885095880038436	TCGA-AB-2856-03	0	0	0	0	PASS	4764	TCGA-AB-2856	LAML	63	MALE	WHITE	NA	NA	NA	NA	2006	NA	-23317	Dead	NA	NA	150	NA	NA	NA	NA	NA	NA	NA	NA	1	150	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2857	1	3	0	0	0	2	0	0	2	24	3	2	0	10	7	0	TCGA-AB-2857-03	89	0.2490867981296971	28	TCGA-AB-2857-03	3	3	45	0.12256333087693234	TCGA-AB-2857-03	4	0	2	6	PASS	4765	TCGA-AB-2857	LAML	54	MALE	WHITE	NA	NA	NA	NA	2005	NA	-19905	Dead	NA	NA	306	NA	NA	NA	NA	NA	NA	NA	NA	1	306	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2858	0	1	0	0	0	0	0	0	0	6	1	0	0	1	0	0	TCGA-AB-2858-03	59	0.00016115633777629738	21	TCGA-AB-2858-03	0	0	9	0.0015224655988493802	TCGA-AB-2858-03	0	0	0	0	PASS	4766	TCGA-AB-2858	LAML	75	FEMALE	WHITE	NA	NA	NA	NA	2004	NA	-27547	Dead	NA	NA	577	NA	NA	NA	NA	NA	NA	NA	NA	1	577	NA	NA	NA	NA	NA	NA	
40	TCGA-AB-2859	0	7	0	1	1	1	0	0	3	8	2	0	1	4	7	0	TCGA-AB-2859-03	67	0.0002857257531924216	24	TCGA-AB-2859-03	0	0	9	0.0002724857895920731	TCGA-AB-2859-03	0	0	0	0	PASS	4767	TCGA-AB-2859	LAML	40	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	NA	NA	2005	NA	-14671	Dead	NA	NA	304	NA	NA	NA	NA	NA	NA	NA	NA	1	304	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2860	1	3	0	1	1	0	0	0	1	16	0	0	0	7	9	0	TCGA-AB-2860-03	100	0.1292363637721732	49	TCGA-AB-2860-03	5	5	74	0.12112173172595404	TCGA-AB-2860-03	1	3	4	8	PASS	4768	TCGA-AB-2860	LAML	60	FEMALE	WHITE	NA	NA	NA	NA	2003	NA	-22035	Dead	NA	NA	427	NA	NA	NA	NA	NA	NA	NA	NA	1	427	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2861	1	1	0	1	0	1	0	0	2	16	4	0	0	4	3	0	TCGA-AB-2861-03	75	0.050379835905681514	21	TCGA-AB-2861-03	2	1	20	0.0010509300614109224	TCGA-AB-2861-03	0	0	0	0	PASS	4769	TCGA-AB-2861	LAML	76	MALE	WHITE	NA	NA	NA	NA	2005	NA	-27940	Dead	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-2862	0	3	1	0	0	0	0	0	0	10	1	0	2	6	7	0	TCGA-AB-2862-03	63	0.00013996500246986658	20	TCGA-AB-2862-03	0	0	6	0.00020940315617854952	TCGA-AB-2862-03	0	0	0	0	PASS	4770	TCGA-AB-2862	LAML	33	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	NA	NA	2005	NA	-12266	Alive	NA	1430	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1430	0	NA	NA	NA	NA	NA	
60	TCGA-AB-2863	0	0	0	0	0	0	0	0	0	4	0	0	0	0	1	0	TCGA-AB-2863-03	47	0.04981491010924819	12	TCGA-AB-2863-03	2	3	7	0.000227874734883341	TCGA-AB-2863-03	0	0	0	0	PASS	4771	TCGA-AB-2863	LAML	63	MALE	WHITE	NA	NA	NA	NA	2003	NA	-23132	Dead	NA	NA	31	NA	NA	NA	NA	NA	NA	NA	NA	1	31	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2864	0	7	0	1	0	1	0	0	2	16	1	0	0	1	13	0	TCGA-AB-2864-03	51	0.049819877954655055	12	TCGA-AB-2864-03	2	1	10	0.0005077905130471492	TCGA-AB-2864-03	2	1	0	3	PASS	4772	TCGA-AB-2864	LAML	54	FEMALE	WHITE	NA	NA	NA	NA	2005	NA	-19724	Dead	NA	NA	577	NA	NA	NA	NA	NA	NA	NA	NA	1	577	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2865	0	0	0	0	0	0	0	0	0	3	0	0	0	4	0	0	TCGA-AB-2865-03	75	0.07847137017193215	30	TCGA-AB-2865-03	3	3	10	0.001654374576910694	TCGA-AB-2865-03	1	0	0	1	PASS	4773	TCGA-AB-2865	LAML	75	MALE	WHITE	NA	NA	NA	NA	2005	NA	-27486	Dead	NA	NA	61	NA	NA	NA	NA	NA	NA	NA	NA	1	61	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2866	0	6	0	1	0	0	0	0	2	4	0	0	0	2	11	0	TCGA-AB-2866-03	70	0.00026592462060304314	29	TCGA-AB-2866	0	0	0	0	TCGA-AB-2866	0	0	0	0	PASS	4774	TCGA-AB-2866	LAML	67	MALE	WHITE	NA	NA	NA	NA	2005	NA	-24684	Dead	NA	NA	153	NA	NA	NA	NA	NA	NA	NA	NA	1	153	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2867	1	10	0	1	0	1	0	0	7	27	0	1	2	6	60	0	TCGA-AB-2867-03	43	6.057597094353992e-06	11	TCGA-AB-2867-03	0	0	27	0.011098610851156305	TCGA-AB-2867-03	0	0	1	1	PASS	4775	TCGA-AB-2867	LAML	66	FEMALE	WHITE	NA	NA	NA	NA	2002	NA	-24257	Dead	NA	NA	184	NA	NA	NA	NA	NA	NA	NA	NA	1	184	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2868	0	25	0	3	0	0	0	0	12	61	0	2	0	5	105	0	TCGA-AB-2868-03	106	0.19357424420646965	49	TCGA-AB-2868-03	8	9	45	0.09257845781794644	TCGA-AB-2868-03	6	3	5	14	PASS	4776	TCGA-AB-2868	LAML	77	MALE	WHITE	NA	NA	NA	NA	2002	NA	-28216	Dead	NA	NA	151	NA	NA	NA	NA	NA	NA	NA	NA	1	151	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2869	1	2	0	0	1	1	1	0	1	0	0	0	0	2	0	0	TCGA-AB-2869-03	69	2.506963685921589e-05	33	TCGA-AB-2869-03	0	0	12	0.0002451590403703575	TCGA-AB-2869-03	0	0	0	0	PASS	4777	TCGA-AB-2869	LAML	64	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	NA	NA	2009	NA	-23679	Alive	NA	243	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	243	0	NA	NA	NA	NA	NA	
80	TCGA-AB-2870	0	1	0	1	0	0	0	0	1	1	0	0	0	1	3	0	TCGA-AB-2870-03	69	9.874381657475955e-05	29	TCGA-AB-2870-03	0	0	11	0.0004135956976287456	TCGA-AB-2870-03	0	0	0	0	PASS	4778	TCGA-AB-2870	LAML	76	MALE	WHITE	NA	NA	NA	NA	2007	NA	-27787	Dead	NA	NA	153	NA	NA	NA	NA	NA	NA	NA	NA	1	153	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2871	2	1	0	0	1	1	0	0	1	14	2	0	0	2	5	0	TCGA-AB-2871-03	79	4.361389668309967e-05	38	TCGA-AB-2871	0	0	0	0	TCGA-AB-2871	0	0	0	0	PASS	4779	TCGA-AB-2871	LAML	51	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	NA	NA	2009	NA	-18689	Alive	NA	153	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	153	0	NA	NA	NA	NA	NA	
40	TCGA-AB-2872	0	3	0	1	0	1	0	0	0	21	1	0	0	2	8	0	TCGA-AB-2872-03	69	0.018806270056312788	26	TCGA-AB-2872-03	0	0	22	0.020094980416164643	TCGA-AB-2872-03	0	3	2	5	PASS	4780	TCGA-AB-2872	LAML	42	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	NA	NA	2008	NA	-15461	Alive	NA	638	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	638	0	NA	NA	NA	NA	NA	
50	TCGA-AB-2873	0	2	0	0	0	2	0	0	0	1	1	0	0	0	4	0	TCGA-AB-2873-03	45	0.00024105325382736432	9	TCGA-AB-2873-03	0	0	5	0.00014590398553220206	TCGA-AB-2873-03	0	0	0	0	PASS	4781	TCGA-AB-2873	LAML	51	FEMALE	WHITE	NA	NA	NA	NA	2009	NA	-18689	Alive	NA	273	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	273	0	NA	NA	NA	NA	NA	
60	TCGA-AB-2874	0	3	1	0	0	0	0	0	1	7	0	0	0	2	8	0	TCGA-AB-2874-03	91	0.062017585684639776	46	TCGA-AB-2874-03	2	3	21	0.05780782514824245	TCGA-AB-2874-03	0	0	2	2	PASS	4782	TCGA-AB-2874	LAML	59	MALE	WHITE	NA	NA	NA	NA	2009	NA	-21764	Alive	NA	396	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	396	0	NA	NA	NA	NA	NA	
40	TCGA-AB-2875	0	2	0	2	0	0	0	0	1	13	1	0	0	2	7	0	TCGA-AB-2875-03	79	7.364041045997732e-05	29	TCGA-AB-2875-03	0	0	6	0.0009705961639644502	TCGA-AB-2875-03	0	0	0	0	PASS	4783	TCGA-AB-2875	LAML	43	MALE	WHITE	NA	NA	NA	NA	2009	NA	-16010	Alive	NA	212	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	212	0	NA	NA	NA	NA	NA	
50	TCGA-AB-2876	0	2	1	0	0	0	0	0	1	2	0	0	0	0	10	0	TCGA-AB-2876	0	0	0	TCGA-AB-2876	0	0	0	0	TCGA-AB-2876	0	0	0	0	PASS	4784	TCGA-AB-2876	LAML	45	FEMALE	WHITE	NA	NA	NA	NA	2006	NA	-16648	Alive	NA	1219	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1219	0	NA	NA	NA	NA	NA	
60	TCGA-AB-2877	0	2	0	0	0	0	0	0	0	17	0	0	1	3	0	0	TCGA-AB-2877-03	51	1.1651969772568658e-05	10	TCGA-AB-2877	0	0	0	0	TCGA-AB-2877	0	0	0	0	PASS	4785	TCGA-AB-2877	LAML	60	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-21946	Alive	NA	638	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	638	0	NA	NA	NA	NA	NA	
50	TCGA-AB-2878	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2878-03	99	0.1625791738272876	51	TCGA-AB-2878-03	3	5	34	0.06350903127197872	TCGA-AB-2878-03	3	5	3	11	PASS	4786	TCGA-AB-2878	LAML	47	FEMALE	WHITE	NA	NA	NA	NA	2006	NA	-17501	Dead	NA	NA	365	NA	NA	NA	NA	NA	NA	NA	NA	1	365	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2879	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	TCGA-AB-2879-03	63	7.02096507465712e-05	21	TCGA-AB-2879-03	0	0	18	0.009539990876207318	TCGA-AB-2879-03	0	0	1	1	PASS	4787	TCGA-AB-2879	LAML	68	FEMALE	WHITE	NA	NA	NA	NA	2009	NA	-25141	Alive	NA	245	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	245	0	NA	NA	NA	NA	NA	
30	TCGA-AB-2880	0	0	0	0	0	1	0	0	0	3	0	0	0	0	1	0	TCGA-AB-2880-03	63	9.821562738253758e-06	22	TCGA-AB-2880-03	0	0	18	0.013747255082237541	TCGA-AB-2880-03	1	1	1	3	PASS	4788	TCGA-AB-2880	LAML	24	MALE	WHITE	NA	NA	NA	NA	2009	NA	-8827	Dead	NA	424	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2881	0	2	0	0	0	1	0	0	0	4	0	0	0	0	3	0	TCGA-AB-2881-03	47	2.252061341489747e-05	12	TCGA-AB-2881	0	0	0	0	TCGA-AB-2881	0	0	0	0	PASS	4789	TCGA-AB-2881	LAML	48	FEMALE	WHITE	NA	NA	NA	NA	2009	NA	-17808	Alive	NA	393	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	393	0	NA	NA	NA	NA	NA	
70	TCGA-AB-2882	0	0	0	0	0	0	0	0	1	5	1	0	0	1	0	0	TCGA-AB-2882-03	60	0.06493812301939296	16	TCGA-AB-2882-03	2	1	24	0.058198855647936976	TCGA-AB-2882-03	0	0	0	0	PASS	4790	TCGA-AB-2882	LAML	73	FEMALE	WHITE	NA	NA	NA	NA	2006	NA	-26844	Dead	NA	NA	365	NA	NA	NA	NA	NA	NA	NA	NA	1	365	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2883	0	1	0	0	0	0	0	0	0	8	0	0	0	0	10	0	TCGA-AB-2883-03	126	0.947744744151954	65	TCGA-AB-2883-03	36	14	17	0.0010735115979030444	TCGA-AB-2883-03	1	1	0	2	PASS	4791	TCGA-AB-2883	LAML	60	MALE	WHITE	NA	NA	NA	NA	2008	NA	-22067	Alive	NA	730	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	730	0	NA	NA	NA	NA	NA	
40	TCGA-AB-2884	0	2	0	0	0	0	0	0	0	7	0	0	0	2	3	0	TCGA-AB-2884-03	45	7.996882243780568e-06	12	TCGA-AB-2884	0	0	0	0	TCGA-AB-2884	0	0	0	0	PASS	4792	TCGA-AB-2884	LAML	44	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-16285	Dead	NA	NA	731	NA	NA	NA	NA	NA	NA	NA	NA	1	731	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2885	0	1	0	0	0	0	0	0	0	29	1	0	0	8	2	0	TCGA-AB-2885-03	112	0.8515982917166784	60	TCGA-AB-2885-03	8	5	71	0.20432206462544386	TCGA-AB-2885-03	2	4	2	8	PASS	4793	TCGA-AB-2885	LAML	71	MALE	WHITE	NA	NA	NA	NA	2009	NA	-26176	Dead	NA	NA	214	NA	NA	NA	NA	NA	NA	NA	NA	1	214	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-2886	0	4	0	1	0	1	0	0	0	10	0	0	1	3	13	0	TCGA-AB-2886-03	83	0.011640495551461605	34	TCGA-AB-2886-03	0	0	21	0.022410913146511426	TCGA-AB-2886-03	0	1	1	2	PASS	4794	TCGA-AB-2886	LAML	26	MALE	WHITE	NA	NA	NA	NA	2009	NA	-9497	Alive	NA	181	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	181	0	NA	NA	NA	NA	NA	
60	TCGA-AB-2887	0	0	0	0	0	0	0	0	0	2	0	0	0	1	0	0	TCGA-AB-2887-03	75	0.058223675467493324	30	TCGA-AB-2887-03	1	1	43	0.0648118947205313	TCGA-AB-2887-03	3	2	2	7	PASS	4795	TCGA-AB-2887	LAML	60	FEMALE	WHITE	NA	NA	NA	NA	2009	NA	-21946	Dead	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2888	0	0	0	0	0	0	0	0	2	6	0	0	0	4	1	0	TCGA-AB-2888-03	71	0.0001385906426101374	29	TCGA-AB-2888-03	0	0	14	0.003114375867142493	TCGA-AB-2888-03	0	0	0	0	PASS	4796	TCGA-AB-2888	LAML	57	MALE	WHITE	NA	NA	NA	NA	2009	NA	-20879	Alive	NA	334	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	334	0	NA	NA	NA	NA	NA	
60	TCGA-AB-2889	0	1	0	0	0	0	0	0	0	2	0	0	0	0	0	0	TCGA-AB-2889-03	59	0.00017924026850233492	18	TCGA-AB-2889-03	0	0	7	0.0003691937142277237	TCGA-AB-2889-03	0	0	0	0	PASS	4797	TCGA-AB-2889	LAML	55	MALE	WHITE	NA	NA	NA	NA	2009	NA	-20150	Alive	NA	304	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	304	0	NA	NA	NA	NA	NA	
70	TCGA-AB-2890	0	1	0	0	0	0	0	0	0	5	0	0	0	2	0	0	TCGA-AB-2890-03	65	0.0483022388943532	25	TCGA-AB-2890-03	2	1	10	0.0007405380174535375	TCGA-AB-2890-03	0	0	0	0	PASS	4798	TCGA-AB-2890	LAML	69	MALE	WHITE	NA	NA	NA	NA	2009	NA	-25234	Dead	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	NA	NA	NA	NA	NA	NA	
40	TCGA-AB-2891	0	0	0	2	0	1	0	0	0	9	0	0	0	0	3	0	TCGA-AB-2891	0	0	0	TCGA-AB-2891	0	0	0	0	TCGA-AB-2891	0	0	0	0	PASS	4799	TCGA-AB-2891	LAML	42	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	NA	NA	2009	NA	-15400	Dead	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	
40	TCGA-AB-2892	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2892-03	83	9.817987861352736e-05	39	TCGA-AB-2892-03	0	0	15	0.0022952308248532995	TCGA-AB-2892-03	0	0	0	0	PASS	4800	TCGA-AB-2892	LAML	42	FEMALE	WHITE	NA	NA	NA	NA	2006	NA	-15614	Alive	NA	943	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	943	0	NA	NA	NA	NA	NA	
50	TCGA-AB-2893	0	0	0	0	0	0	0	0	0	2	0	0	0	2	0	0	TCGA-AB-2893-03	53	9.997968474588841e-05	15	TCGA-AB-2893-03	0	0	18	0.0017986378563344175	TCGA-AB-2893-03	0	0	0	0	PASS	4801	TCGA-AB-2893	LAML	45	MALE	WHITE	NA	NA	NA	NA	2006	NA	-16617	Dead	NA	NA	212	NA	NA	NA	NA	NA	NA	NA	NA	1	212	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2894	0	0	0	0	0	0	0	0	0	1	0	0	0	3	0	0	TCGA-AB-2894-03	69	0.05435516298960348	29	TCGA-AB-2894-03	2	1	40	0.06784825250351367	TCGA-AB-2894-03	0	0	2	2	PASS	4802	TCGA-AB-2894	LAML	50	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-18323	Dead	NA	NA	181	NA	NA	NA	NA	NA	NA	NA	NA	1	181	NA	NA	NA	NA	NA	NA	
40	TCGA-AB-2895	0	0	0	0	0	2	0	0	0	11	0	0	0	8	1	0	TCGA-AB-2895-03	49	0.0003380377638335395	12	TCGA-AB-2895-03	0	2	22	0.03620446311177762	TCGA-AB-2895-03	0	0	0	0	PASS	4803	TCGA-AB-2895	LAML	41	FEMALE	WHITE	NA	NA	NA	NA	2009	NA	-15310	Dead	NA	NA	153	NA	NA	NA	NA	NA	NA	NA	NA	1	153	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-2896	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	TCGA-AB-2896-03	75	7.082362865709332e-05	29	TCGA-AB-2896-03	0	2	44	0.03639117197221616	TCGA-AB-2896-03	2	0	1	3	PASS	4804	TCGA-AB-2896	LAML	21	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-7882	Dead	NA	NA	214	NA	NA	NA	NA	NA	NA	NA	NA	1	214	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2897	0	2	0	2	0	0	0	0	0	9	0	0	0	2	3	0	TCGA-AB-2897-03	82	0.0005090435072760077	30	TCGA-AB-2897-03	0	0	33	0.0023983853180637553	TCGA-AB-2897-03	0	0	0	0	PASS	4805	TCGA-AB-2897	LAML	50	FEMALE	WHITE	NA	NA	NA	NA	2009	NA	-18413	Alive	NA	243	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	243	0	NA	NA	NA	NA	NA	
70	TCGA-AB-2898	0	1	0	2	0	1	1	0	2	17	0	1	1	9	20	0	TCGA-AB-2898-03	67	0.051008557991534025	19	TCGA-AB-2898-03	2	1	20	0.00158795199065652	TCGA-AB-2898-03	0	0	0	0	PASS	4806	TCGA-AB-2898	LAML	69	FEMALE	WHITE	NA	NA	NA	NA	2009	NA	-25326	Alive	NA	393	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	393	0	NA	NA	NA	NA	NA	
80	TCGA-AB-2899	0	0	0	1	0	0	0	0	1	11	0	0	0	3	0	0	TCGA-AB-2899-03	57	0.04574636616732294	15	TCGA-AB-2899-03	1	2	32	0.014301159599032496	TCGA-AB-2899-03	0	0	0	0	PASS	4807	TCGA-AB-2899	LAML	76	FEMALE	WHITE	NA	NA	NA	NA	2006	NA	-27787	Dead	NA	NA	671	NA	NA	NA	NA	NA	NA	NA	NA	1	671	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2900	0	3	0	0	0	0	0	0	1	4	1	0	1	1	8	0	TCGA-AB-2900-03	67	5.5061436114831396e-05	22	TCGA-AB-2900-03	0	0	11	0.0004966094847710916	TCGA-AB-2900-03	0	0	0	0	PASS	4808	TCGA-AB-2900	LAML	70	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	NA	NA	2009	NA	-25627	Dead	NA	NA	184	NA	NA	NA	NA	NA	NA	NA	NA	1	184	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-2901	0	2	0	0	0	1	0	0	2	1	1	0	0	1	5	1	TCGA-AB-2901-03	105	0.1119461695793762	49	TCGA-AB-2901-03	5	3	19	0.001066933651972849	TCGA-AB-2901-03	1	0	0	1	PASS	4809	TCGA-AB-2901	LAML	27	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	NA	NA	2009	NA	-10046	Alive	NA	59	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	59	0	NA	NA	NA	NA	NA	
80	TCGA-AB-2903	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	TCGA-AB-2903-03	35	2.341591811674849e-06	6	TCGA-AB-2903-03	0	0	6	0.0009231314615112373	TCGA-AB-2903-03	0	0	0	0	PASS	4810	TCGA-AB-2903	LAML	76	FEMALE	WHITE	NA	NA	NA	NA	2006	NA	-27971	Dead	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2904	0	4	0	1	0	1	0	0	1	24	0	1	0	9	20	0	TCGA-AB-2904-03	142	0.18318482503072214	80	TCGA-AB-2904-03	5	8	50	0.07563835885167823	TCGA-AB-2904-03	7	6	4	17	PASS	4811	TCGA-AB-2904	LAML	65	MALE	WHITE	NA	NA	NA	NA	2008	NA	-23833	Dead	NA	NA	517	NA	NA	NA	NA	NA	NA	NA	NA	1	517	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2905	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2905-03	83	0.00010023562398850924	44	TCGA-AB-2905	0	0	0	0	TCGA-AB-2905	0	0	0	0	PASS	4812	TCGA-AB-2905	LAML	48	MALE	WHITE	NA	NA	NA	NA	2005	NA	-17869	Alive	NA	1611	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1611	0	NA	NA	NA	NA	NA	
60	TCGA-AB-2906	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2906-03	59	1.0056195144164217e-05	19	TCGA-AB-2906	0	0	0	0	TCGA-AB-2906	0	0	0	0	PASS	4813	TCGA-AB-2906	LAML	59	MALE	WHITE	NA	NA	NA	NA	2008	NA	-21581	Alive	NA	577	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	577	0	NA	NA	NA	NA	NA	
70	TCGA-AB-2907	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2907-03	65	2.995828954307555e-05	23	TCGA-AB-2907	0	0	0	0	TCGA-AB-2907	0	0	0	0	PASS	4814	TCGA-AB-2907	LAML	69	MALE	WHITE	NA	NA	NA	NA	2008	NA	-25264	Dead	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2908	0	1	0	0	0	1	0	0	0	11	0	0	0	2	0	0	TCGA-AB-2908-03	100	0.0933139586808416	47	TCGA-AB-2908-03	3	6	26	0.057219211286492565	TCGA-AB-2908-03	0	4	2	6	PASS	4815	TCGA-AB-2908	LAML	81	MALE	WHITE	NA	NA	NA	NA	2008	NA	-29769	Dead	NA	NA	31	NA	NA	NA	NA	NA	NA	NA	NA	1	31	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-2909	0	0	0	1	0	0	0	0	0	2	0	0	0	2	0	0	TCGA-AB-2909-03	55	0.006512949298684741	15	TCGA-AB-2909-03	0	0	13	0.00757143839176474	TCGA-AB-2909-03	0	1	1	2	PASS	4816	TCGA-AB-2909	LAML	22	MALE	ASIAN	NA	NA	NA	NA	2009	NA	-8220	Alive	NA	30	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	30	0	NA	NA	NA	NA	NA	
60	TCGA-AB-2910	0	1	0	0	1	2	0	0	0	11	1	0	0	0	0	0	TCGA-AB-2910-03	76	0.04823038543664231	29	TCGA-AB-2910-03	2	2	16	0.0016560697583647606	TCGA-AB-2910-03	2	0	0	2	PASS	4817	TCGA-AB-2910	LAML	61	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-22311	Dead	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2911	0	2	0	0	0	1	0	0	0	6	1	0	0	4	4	0	TCGA-AB-2911-03	89	0.0006308903202731839	43	TCGA-AB-2911-03	0	0	17	0.0019575564541884105	TCGA-AB-2911-03	0	0	0	0	PASS	4818	TCGA-AB-2911	LAML	51	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	NA	NA	2006	NA	-18689	Alive	NA	1186	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1186	0	NA	NA	NA	NA	NA	
60	TCGA-AB-2912	0	4	0	0	0	1	0	0	2	21	1	0	0	3	21	0	TCGA-AB-2912-03	129	0.050083041600014484	69	TCGA-AB-2912-03	2	1	14	0.0023293261060214608	TCGA-AB-2912-03	1	0	0	1	PASS	4819	TCGA-AB-2912	LAML	63	MALE	WHITE	NA	NA	NA	NA	2007	NA	-23345	Dead	NA	NA	274	NA	NA	NA	NA	NA	NA	NA	NA	1	274	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2913	0	2	0	0	0	0	0	0	0	11	0	0	1	3	2	0	TCGA-AB-2913-03	95	0.0500257027492741	45	TCGA-AB-2913-03	2	1	31	0.04367753240981127	TCGA-AB-2913-03	3	2	3	8	PASS	4820	TCGA-AB-2913	LAML	61	MALE	WHITE	NA	NA	NA	NA	2006	NA	-22553	Alive	NA	1216	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1216	0	NA	NA	NA	NA	NA	
30	TCGA-AB-2914	0	2	0	2	0	2	1	0	2	8	0	0	0	1	7	0	TCGA-AB-2914-03	51	0.00033730973018671317	15	TCGA-AB-2914	0	0	0	0	TCGA-AB-2914	0	0	0	0	PASS	4821	TCGA-AB-2914	LAML	22	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-8280	Alive	NA	792	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	792	0	NA	NA	NA	NA	NA	
70	TCGA-AB-2915	0	3	1	0	0	1	0	0	1	12	1	0	0	14	0	0	TCGA-AB-2915-03	56	0.05540897210414493	12	TCGA-AB-2915-03	1	5	8	0.009718082116063585	TCGA-AB-2915-03	0	3	1	4	PASS	4822	TCGA-AB-2915	LAML	73	FEMALE	WHITE	NA	NA	NA	NA	2009	NA	-26968	Dead	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2916	0	1	0	1	0	2	0	0	1	7	1	0	0	3	5	0	TCGA-AB-2916-03	75	0.04613232710151607	29	TCGA-AB-2916-03	2	1	7	0.0006610672402476959	TCGA-AB-2916-03	0	0	0	0	PASS	4823	TCGA-AB-2916	LAML	48	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-17866	Alive	NA	882	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	882	0	NA	NA	NA	NA	NA	
40	TCGA-AB-2917	0	0	0	0	0	1	0	0	1	9	2	0	0	2	0	0	TCGA-AB-2917-03	73	0.1327322421589294	28	TCGA-AB-2917-03	7	7	8	0.007028463501441986	TCGA-AB-2917-03	1	0	1	2	PASS	4824	TCGA-AB-2917	LAML	41	FEMALE	WHITE	NA	NA	NA	NA	2006	NA	-15128	Alive	NA	1216	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1216	0	NA	NA	NA	NA	NA	
50	TCGA-AB-2918	2	3	0	3	0	0	0	0	2	15	0	0	0	6	0	0	TCGA-AB-2918	0	0	0	TCGA-AB-2918	0	0	0	0	TCGA-AB-2918	0	0	0	0	PASS	4825	TCGA-AB-2918	LAML	47	FEMALE	WHITE	NA	NA	NA	NA	2009	NA	-17198	Dead	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2919	0	0	0	0	0	1	0	0	1	11	1	0	0	5	0	0	TCGA-AB-2919-03	63	0.00012297605395979443	25	TCGA-AB-2919-03	0	0	10	0.00046224434500494416	TCGA-AB-2919-03	0	0	0	0	PASS	4826	TCGA-AB-2919	LAML	54	FEMALE	WHITE	NA	NA	NA	NA	2009	NA	-19724	Alive	NA	61	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	61	0	NA	NA	NA	NA	NA	
40	TCGA-AB-2920	0	1	0	0	0	1	0	0	0	4	0	0	0	1	5	0	TCGA-AB-2920-03	161	0.17410780301655032	96	TCGA-AB-2920-03	6	4	68	0.11432499736278455	TCGA-AB-2920-03	2	2	1	5	PASS	4827	TCGA-AB-2920	LAML	44	MALE	WHITE	NA	NA	NA	NA	2007	NA	-16071	Dead	NA	NA	366	NA	NA	NA	NA	NA	NA	NA	NA	1	366	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2921	0	0	0	0	0	0	0	0	0	3	0	0	0	1	0	0	TCGA-AB-2921-03	45	0.001413166346206352	10	TCGA-AB-2921-03	0	0	10	0.0018655499324862184	TCGA-AB-2921-03	0	0	0	0	PASS	4828	TCGA-AB-2921	LAML	56	FEMALE	WHITE	NA	NA	NA	NA	2009	NA	-20454	Dead	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2922	0	0	0	0	0	0	0	0	1	2	0	0	0	1	0	0	TCGA-AB-2922-03	55	5.3501275421389615e-05	18	TCGA-AB-2922-03	0	2	17	0.012643384193500608	TCGA-AB-2922-03	0	0	0	0	PASS	4829	TCGA-AB-2922	LAML	83	MALE	WHITE	NA	NA	NA	NA	2008	NA	-30438	Dead	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2923	0	3	0	0	0	0	0	0	0	5	1	0	0	4	0	0	TCGA-AB-2923-03	53	0.029992525893710445	17	TCGA-AB-2923-03	0	1	18	0.028439923070510763	TCGA-AB-2923-03	2	2	2	6	PASS	4830	TCGA-AB-2923	LAML	78	MALE	WHITE	NA	NA	NA	NA	2008	NA	-28551	Dead	NA	NA	31	NA	NA	NA	NA	NA	NA	NA	NA	1	31	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2924	0	0	0	0	0	0	0	0	0	6	0	0	0	1	0	0	TCGA-AB-2924-03	63	2.8692536299957716e-05	24	TCGA-AB-2924-03	0	0	7	0.01096617356671303	TCGA-AB-2924-03	1	1	1	3	PASS	4831	TCGA-AB-2924	LAML	59	MALE	WHITE	NA	NA	NA	NA	2009	NA	-21825	Alive	NA	90	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	90	0	NA	NA	NA	NA	NA	
60	TCGA-AB-2925	0	2	0	0	0	2	0	0	0	15	0	0	1	1	1	0	TCGA-AB-2925-03	69	7.137902222392864e-05	24	TCGA-AB-2925-03	0	0	17	0.0007363553654248694	TCGA-AB-2925-03	0	0	0	0	PASS	4832	TCGA-AB-2925	LAML	57	MALE	WHITE	NA	NA	NA	NA	2007	NA	-20850	Dead	NA	NA	243	NA	NA	NA	NA	NA	NA	NA	NA	1	243	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2926	0	7	1	1	0	0	0	0	4	2	1	1	0	3	11	0	TCGA-AB-2926-03	85	0.05001650059232162	33	TCGA-AB-2926-03	2	1	17	0.0004139054625443822	TCGA-AB-2926-03	0	0	0	0	PASS	4833	TCGA-AB-2926	LAML	57	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-20820	Dead	NA	NA	457	NA	NA	NA	NA	NA	NA	NA	NA	1	457	NA	NA	NA	NA	NA	NA	
90	TCGA-AB-2927	0	1	0	1	0	1	0	0	0	14	2	0	0	6	1	0	TCGA-AB-2927-03	41	7.027739395104258e-05	8	TCGA-AB-2927-03	0	0	15	0.003135858878095493	TCGA-AB-2927-03	0	0	0	0	PASS	4834	TCGA-AB-2927	LAML	88	FEMALE	WHITE	NA	NA	NA	NA	2009	NA	-32326	Dead	NA	NA	90	NA	NA	NA	NA	NA	NA	NA	NA	1	90	NA	NA	NA	NA	NA	NA	
40	TCGA-AB-2928	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	TCGA-AB-2928-03	133	0.05510946244877868	80	TCGA-AB-2928-03	2	1	46	0.058030333753223126	TCGA-AB-2928-03	0	0	0	0	PASS	4835	TCGA-AB-2928	LAML	43	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	NA	NA	2010	NA	-15890	Dead	NA	59	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2929	0	6	0	0	0	1	1	0	1	6	2	0	0	2	19	0	TCGA-AB-2929-03	60	0.1297624444716297	21	TCGA-AB-2929-03	4	3	43	0.10443890026059904	TCGA-AB-2929-03	3	1	4	8	PASS	4836	TCGA-AB-2929	LAML	71	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-26054	Dead	NA	NA	123	NA	NA	NA	NA	NA	NA	NA	NA	1	123	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2930	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	TCGA-AB-2930-03	39	8.455084208825969e-05	5	TCGA-AB-2930-03	0	0	16	0.0011915724742444724	TCGA-AB-2930-03	0	0	0	0	PASS	4837	TCGA-AB-2930	LAML	63	FEMALE	WHITE	NA	NA	NA	NA	2009	NA	-23011	Dead	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2931	0	1	0	0	0	1	0	0	1	6	0	0	0	5	0	0	TCGA-AB-2931-03	61	1.8482287449738214e-05	19	TCGA-AB-2931-03	0	2	27	0.03567113364256549	TCGA-AB-2931-03	0	0	0	0	PASS	4838	TCGA-AB-2931	LAML	75	MALE	WHITE	NA	NA	NA	NA	2007	NA	-27485	Dead	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2932	0	2	0	0	0	0	0	0	0	2	0	0	2	0	0	0	TCGA-AB-2932-03	73	0.00035707768103317985	29	TCGA-AB-2932-03	0	0	16	0.009625701998160329	TCGA-AB-2932-03	0	0	1	1	PASS	4839	TCGA-AB-2932	LAML	62	MALE	WHITE	NA	NA	NA	NA	2008	NA	-22738	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	NA	NA	NA	NA	NA	
60	TCGA-AB-2933	0	1	0	0	0	0	0	0	0	2	0	0	0	0	0	0	TCGA-AB-2933-03	58	0.0603551974957255	14	TCGA-AB-2933-03	2	1	16	0.008509860490502594	TCGA-AB-2933-03	1	0	1	2	PASS	4840	TCGA-AB-2933	LAML	58	MALE	WHITE	NA	NA	NA	NA	2007	NA	-21396	Dead	NA	NA	122	NA	NA	NA	NA	NA	NA	NA	NA	1	122	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2934	0	5	0	1	0	1	0	0	3	7	0	0	4	1	0	0	TCGA-AB-2934-03	73	3.410529056192782e-05	27	TCGA-AB-2934-03	0	0	19	0.0005183366310127479	TCGA-AB-2934-03	0	0	0	0	PASS	4841	TCGA-AB-2934	LAML	65	MALE	WHITE	NA	NA	NA	NA	2010	NA	-23956	Alive	NA	28	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	28	0	NA	NA	NA	NA	NA	
70	TCGA-AB-2935	0	0	0	1	0	0	0	0	0	17	1	0	0	4	0	0	TCGA-AB-2935-03	84	0.20566012516291668	36	TCGA-AB-2935-03	6	5	53	0.12530533620918033	TCGA-AB-2935-03	5	10	5	20	PASS	4842	TCGA-AB-2935	LAML	66	MALE	WHITE	NA	NA	NA	NA	2007	NA	-24349	Dead	NA	NA	61	NA	NA	NA	NA	NA	NA	NA	NA	1	61	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2936	1	2	0	1	0	0	0	0	1	7	2	0	0	13	0	0	TCGA-AB-2936-03	55	3.3246785219655065e-05	17	TCGA-AB-2936	0	0	0	0	TCGA-AB-2936	0	0	0	0	PASS	4843	TCGA-AB-2936	LAML	61	FEMALE	WHITE	NA	NA	NA	NA	2010	NA	-22280	Alive	NA	59	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	59	0	NA	NA	NA	NA	NA	
40	TCGA-AB-2937	0	1	0	0	0	0	0	0	0	5	1	0	0	0	0	0	TCGA-AB-2937-03	69	0.00046141890936220653	22	TCGA-AB-2937-03	0	0	13	0.003141942510864764	TCGA-AB-2937-03	0	0	0	0	PASS	4844	TCGA-AB-2937	LAML	36	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-13149	Dead	NA	NA	215	NA	NA	NA	NA	NA	NA	NA	NA	1	215	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2938	1	6	0	1	3	0	0	0	0	23	2	1	0	6	11	0	TCGA-AB-2938-03	117	0.08377950136829658	54	TCGA-AB-2938-03	0	3	56	0.05472531464186685	TCGA-AB-2938-03	7	8	4	19	PASS	4845	TCGA-AB-2938	LAML	76	MALE	WHITE	NA	NA	NA	NA	2005	NA	-27881	Dead	NA	NA	304	NA	NA	NA	NA	NA	NA	NA	NA	1	304	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2939	0	4	1	0	0	3	0	0	4	16	0	0	0	4	0	0	TCGA-AB-2939-03	142	0.366543689262836	93	TCGA-AB-2939-03	1	3	60	0.07333317764095942	TCGA-AB-2939-03	3	3	3	9	PASS	4846	TCGA-AB-2939	LAML	72	MALE	WHITE	NA	NA	NA	NA	2008	NA	-26512	Alive	NA	455	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	455	0	NA	NA	NA	NA	NA	
40	TCGA-AB-2940	0	3	0	0	0	0	0	0	2	5	1	0	0	2	3	0	TCGA-AB-2940-03	49	0.01125161646838003	11	TCGA-AB-2940-03	1	1	26	0.0063753802676201	TCGA-AB-2940-03	0	0	0	0	PASS	4847	TCGA-AB-2940	LAML	35	MALE	WHITE	NA	NA	NA	NA	2006	NA	-12876	Dead	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2941	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2941-03	85	0.8606474192734133	37	TCGA-AB-2941	0	0	0	0	TCGA-AB-2941	0	0	0	0	PASS	4848	TCGA-AB-2941	LAML	73	MALE	WHITE	NA	NA	NA	NA	2006	NA	-26998	Dead	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2942	0	4	0	0	0	1	0	0	0	3	1	0	0	1	1	0	TCGA-AB-2942-03	83	7.920987132699663e-05	37	TCGA-AB-2942	0	0	0	0	TCGA-AB-2942	0	0	0	0	PASS	4849	TCGA-AB-2942	LAML	67	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-24776	Alive	NA	641	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	641	0	NA	NA	NA	NA	NA	
70	TCGA-AB-2943	0	9	1	1	0	0	0	0	3	14	2	0	2	8	0	0	TCGA-AB-2943-03	72	0.2462535439844337	19	TCGA-AB-2943-03	3	6	32	0.05135269049770702	TCGA-AB-2943-03	0	2	2	4	PASS	4850	TCGA-AB-2943	LAML	70	FEMALE	WHITE	NA	NA	NA	NA	2010	NA	-25568	Dead	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2944	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	TCGA-AB-2944-03	59	0.05463920124697861	21	TCGA-AB-2944-03	2	1	28	0.05896438864584546	TCGA-AB-2944-03	0	0	2	2	PASS	4851	TCGA-AB-2944	LAML	48	MALE	WHITE	NA	NA	NA	NA	2010	NA	-17622	Dead	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2945	0	1	0	0	0	0	0	0	0	4	0	0	0	0	0	0	TCGA-AB-2945-03	156	0.04712551095392109	97	TCGA-AB-2945-03	1	1	5	0.00028535028709882613	TCGA-AB-2945-03	1	0	0	1	PASS	4852	TCGA-AB-2945	LAML	65	FEMALE	WHITE	NA	NA	NA	NA	2006	NA	-23984	Dead	NA	NA	243	NA	NA	NA	NA	NA	NA	NA	NA	1	243	NA	NA	NA	NA	NA	NA	
40	TCGA-AB-2946	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2946-03	45	0.007990423853907283	5	TCGA-AB-2946-03	1	0	12	0.01033976719305388	TCGA-AB-2946-03	0	0	1	1	PASS	4853	TCGA-AB-2946	LAML	41	MALE	WHITE	NA	NA	NA	NA	2010	NA	-15156	Alive	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	NA	NA	
50	TCGA-AB-2947	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2947-03	59	7.907074410872133e-06	23	TCGA-AB-2947-03	0	0	17	0.002971488506236445	TCGA-AB-2947-03	0	0	0	0	PASS	4854	TCGA-AB-2947	LAML	52	MALE	WHITE	NA	NA	NA	NA	2009	NA	-19146	Alive	NA	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	NA	NA	NA	NA	NA	
70	TCGA-AB-2948	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	TCGA-AB-2948-03	57	1.968830919880419e-05	15	TCGA-AB-2948-03	0	0	57	0.00254494915688169	TCGA-AB-2948-03	0	0	0	0	PASS	4855	TCGA-AB-2948	LAML	67	MALE	WHITE	NA	NA	NA	NA	2007	NA	-24714	Dead	NA	NA	580	NA	NA	NA	NA	NA	NA	NA	NA	1	580	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2949	1	1	0	0	0	0	0	0	1	15	1	0	0	2	1	0	TCGA-AB-2949-03	57	0.06707089475615516	17	TCGA-AB-2949-03	1	1	20	0.0027872327061519465	TCGA-AB-2949-03	0	0	0	0	PASS	4856	TCGA-AB-2949	LAML	58	MALE	WHITE	NA	NA	NA	NA	2008	NA	-21336	Alive	NA	699	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	699	0	NA	NA	NA	NA	NA	
30	TCGA-AB-2950	0	2	0	3	0	0	0	0	2	23	3	0	0	12	0	0	TCGA-AB-2950-03	97	0.0001674985718078338	45	TCGA-AB-2950-03	0	0	16	0.0006623457700077298	TCGA-AB-2950-03	0	0	0	0	PASS	4857	TCGA-AB-2950	LAML	34	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-12693	Alive	NA	306	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	306	0	NA	NA	NA	NA	NA	
60	TCGA-AB-2952	0	2	0	0	0	1	0	0	0	5	0	0	0	0	6	0	TCGA-AB-2952-03	92	0.20714459581085976	38	TCGA-AB-2952-03	2	3	57	0.09916793598558432	TCGA-AB-2952-03	2	2	3	7	PASS	4858	TCGA-AB-2952	LAML	60	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-22188	Dead	NA	NA	31	NA	NA	NA	NA	NA	NA	NA	NA	1	31	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2954	0	2	0	0	0	0	0	0	1	5	0	1	0	0	11	0	TCGA-AB-2954-03	77	0.015400058958203816	32	TCGA-AB-2954-03	0	0	31	0.0049126507566512176	TCGA-AB-2954-03	0	2	0	2	PASS	4859	TCGA-AB-2954	LAML	55	FEMALE	WHITE	NA	NA	NA	NA	2006	NA	-20211	Alive	NA	1492	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1492	0	NA	NA	NA	NA	NA	
60	TCGA-AB-2955	0	2	0	0	0	2	0	0	2	2	0	0	0	0	3	0	TCGA-AB-2955-03	122	0.059122912102715815	59	TCGA-AB-2955	0	0	0	0	TCGA-AB-2955	0	0	0	0	PASS	4860	TCGA-AB-2955	LAML	56	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-20484	Dead	NA	NA	489	NA	NA	NA	NA	NA	NA	NA	NA	1	489	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2956	0	3	0	0	0	1	0	0	0	11	2	1	0	5	13	0	TCGA-AB-2956-03	55	0.02019476668457481	19	TCGA-AB-2956-03	2	1	2	0.0018157273930642047	TCGA-AB-2956-03	0	0	0	0	PASS	4861	TCGA-AB-2956	LAML	61	MALE	WHITE	NA	NA	NA	NA	2007	NA	-22523	Dead	NA	NA	183	NA	NA	NA	NA	NA	NA	NA	NA	1	183	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-2957	0	1	0	0	0	0	0	0	0	4	0	0	0	0	5	0	TCGA-AB-2957-03	71	0.00026669189239534056	26	TCGA-AB-2957	0	0	0	0	TCGA-AB-2957	0	0	0	0	PASS	4862	TCGA-AB-2957	LAML	31	MALE	WHITE	NA	NA	NA	NA	2007	NA	-11626	Alive	NA	609	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	609	0	NA	NA	NA	NA	NA	
70	TCGA-AB-2959	0	1	0	0	0	0	0	0	0	23	0	0	0	5	1	0	TCGA-AB-2959-03	65	0.03292308631179718	18	TCGA-AB-2959-03	0	0	12	0.003807017110094129	TCGA-AB-2959-03	1	0	0	1	PASS	4863	TCGA-AB-2959	LAML	71	MALE	WHITE	NA	NA	NA	NA	2007	NA	-26114	Dead	NA	NA	489	NA	NA	NA	NA	NA	NA	NA	NA	1	489	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2963	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2963-03	49	1.2503076968387242e-05	9	TCGA-AB-2963	0	0	0	0	TCGA-AB-2963	0	0	0	0	PASS	4864	TCGA-AB-2963	LAML	56	MALE	WHITE	NA	NA	NA	NA	2002	NA	-20485	Dead	NA	NA	1642	NA	NA	NA	NA	NA	NA	NA	NA	1	1642	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2964	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2964-03	47	4.319266817036107e-05	9	TCGA-AB-2964	0	0	0	0	TCGA-AB-2964	0	0	0	0	PASS	4865	TCGA-AB-2964	LAML	58	FEMALE	WHITE	NA	NA	NA	NA	2006	NA	-21184	Alive	NA	1277	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1277	0	NA	NA	NA	NA	NA	
60	TCGA-AB-2965	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2965-03	71	4.993522003422674e-05	29	TCGA-AB-2965	0	0	0	0	TCGA-AB-2965	0	0	0	0	PASS	4866	TCGA-AB-2965	LAML	60	MALE	WHITE	NA	NA	NA	NA	2006	NA	-22006	Dead	NA	NA	335	NA	NA	NA	NA	NA	NA	NA	NA	1	335	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2966	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2966-03	61	0.0005560853529751594	14	TCGA-AB-2966	0	0	0	0	TCGA-AB-2966	0	0	0	0	PASS	4867	TCGA-AB-2966	LAML	57	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-20880	Dead	NA	NA	854	NA	NA	NA	NA	NA	NA	NA	NA	1	854	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2967	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2967-03	75	0.0009399631468937672	25	TCGA-AB-2967	0	0	0	0	TCGA-AB-2967	0	0	0	0	PASS	4868	TCGA-AB-2967	LAML	58	MALE	WHITE	NA	NA	NA	NA	2007	NA	-21214	Alive	NA	1035	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1035	0	NA	NA	NA	NA	NA	
80	TCGA-AB-2968	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2968-03	45	0.00041453606551520325	7	TCGA-AB-2968	0	0	0	0	TCGA-AB-2968	0	0	0	0	PASS	4869	TCGA-AB-2968	LAML	79	MALE	WHITE	NA	NA	NA	NA	2007	NA	-28975	Dead	NA	NA	458	NA	NA	NA	NA	NA	NA	NA	NA	1	458	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2969	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2969-03	55	1.6599490033491542e-05	16	TCGA-AB-2969	0	0	0	0	TCGA-AB-2969	0	0	0	0	PASS	4870	TCGA-AB-2969	LAML	55	MALE	WHITE	NA	NA	NA	NA	2006	NA	-20331	Alive	NA	1127	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1127	0	NA	NA	NA	NA	NA	
30	TCGA-AB-2970	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2970-03	73	0.00010582038271619076	30	TCGA-AB-2970	0	0	0	0	TCGA-AB-2970	0	0	0	0	PASS	4871	TCGA-AB-2970	LAML	34	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-12569	Dead	NA	NA	305	NA	NA	NA	NA	NA	NA	NA	NA	1	305	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2971	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2971-03	45	0.0022886270518489623	9	TCGA-AB-2971	0	0	0	0	TCGA-AB-2971	0	0	0	0	PASS	4872	TCGA-AB-2971	LAML	76	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-27790	Dead	NA	NA	792	NA	NA	NA	NA	NA	NA	NA	NA	1	792	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2972	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2972-03	65	0.0002607731639718773	17	TCGA-AB-2972	0	0	0	0	TCGA-AB-2972	0	0	0	0	PASS	4873	TCGA-AB-2972	LAML	82	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-30134	Dead	NA	NA	30	NA	NA	NA	NA	NA	NA	NA	NA	1	30	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2973	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2973-03	53	0.0002944350253097116	13	TCGA-AB-2973	0	0	0	0	TCGA-AB-2973	0	0	0	0	PASS	4874	TCGA-AB-2973	LAML	68	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-24837	Dead	NA	NA	609	NA	NA	NA	NA	NA	NA	NA	NA	1	609	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2974	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2974-03	55	1.4470361801616682e-05	12	TCGA-AB-2974	0	0	0	0	TCGA-AB-2974	0	0	0	0	PASS	4875	TCGA-AB-2974	LAML	67	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-24715	Dead	NA	NA	92	NA	NA	NA	NA	NA	NA	NA	NA	1	92	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2975	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2975-03	83	6.315743834952651e-05	34	TCGA-AB-2975	0	0	0	0	TCGA-AB-2975	0	0	0	0	PASS	4876	TCGA-AB-2975	LAML	54	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	NA	NA	2007	NA	-20057	Dead	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2976	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2976-03	73	3.799906909428776e-05	34	TCGA-AB-2976	0	0	0	0	TCGA-AB-2976	0	0	0	0	PASS	4877	TCGA-AB-2976	LAML	53	MALE	WHITE	NA	NA	NA	NA	2007	NA	-19570	Dead	NA	NA	915	NA	NA	NA	NA	NA	NA	NA	NA	1	915	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2977	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2977-03	53	0.0001216706134632138	12	TCGA-AB-2977	0	0	0	0	TCGA-AB-2977	0	0	0	0	PASS	4878	TCGA-AB-2977	LAML	71	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-26053	Dead	NA	NA	31	NA	NA	NA	NA	NA	NA	NA	NA	1	31	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2978	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2978-03	45	1.3334631372480856e-05	10	TCGA-AB-2978	0	0	0	0	TCGA-AB-2978	0	0	0	0	PASS	4879	TCGA-AB-2978	LAML	61	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-22402	Alive	NA	699	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	699	0	NA	NA	NA	NA	NA	
30	TCGA-AB-2979	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2979	0	0	0	TCGA-AB-2979	0	0	0	0	TCGA-AB-2979	0	0	0	0	PASS	4880	TCGA-AB-2979	LAML	30	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-11262	Alive	NA	671	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	671	0	NA	NA	NA	NA	NA	
50	TCGA-AB-2980	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2980-03	84	8.634395443639046e-05	38	TCGA-AB-2980	0	0	0	0	TCGA-AB-2980	0	0	0	0	PASS	4881	TCGA-AB-2980	LAML	50	MALE	WHITE	NA	NA	NA	NA	2008	NA	-18506	Alive	NA	699	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	699	0	NA	NA	NA	NA	NA	
40	TCGA-AB-2981	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2981	0	0	0	TCGA-AB-2981	0	0	0	0	TCGA-AB-2981	0	0	0	0	PASS	4882	TCGA-AB-2981	LAML	35	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-13027	Alive	NA	487	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	487	0	NA	NA	NA	NA	NA	
30	TCGA-AB-2982	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2982-03	81	0.0001156511454284592	39	TCGA-AB-2982	0	0	0	0	TCGA-AB-2982	0	0	0	0	PASS	4883	TCGA-AB-2982	LAML	29	FEMALE	NA	NA	NA	NA	NA	2007	NA	-10807	Alive	NA	150	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	150	0	NA	NA	NA	NA	NA	
50	TCGA-AB-2983	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2983-03	45	4.092652647465688e-05	9	TCGA-AB-2983	0	0	0	0	TCGA-AB-2983	0	0	0	0	PASS	4884	TCGA-AB-2983	LAML	45	MALE	WHITE	NA	NA	NA	NA	2006	NA	-16589	Dead	NA	NA	335	NA	NA	NA	NA	NA	NA	NA	NA	1	335	NA	NA	NA	NA	NA	NA	
40	TCGA-AB-2984	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2984-03	67	3.51687644351144e-05	24	TCGA-AB-2984	0	0	0	0	TCGA-AB-2984	0	0	0	0	PASS	4885	TCGA-AB-2984	LAML	38	MALE	WHITE	NA	NA	NA	NA	2006	NA	-14123	Alive	NA	1157	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1157	0	NA	NA	NA	NA	NA	
80	TCGA-AB-2985	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2985-03	51	2.416500682887062e-05	16	TCGA-AB-2985	0	0	0	0	TCGA-AB-2985	0	0	0	0	PASS	4886	TCGA-AB-2985	LAML	81	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-29890	Dead	NA	NA	273	NA	NA	NA	NA	NA	NA	NA	NA	1	273	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-2986	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2986-03	57	9.050986042725655e-05	22	TCGA-AB-2986	0	0	0	0	TCGA-AB-2986	0	0	0	0	PASS	4887	TCGA-AB-2986	LAML	31	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-11596	Dead	NA	NA	212	NA	NA	NA	NA	NA	NA	NA	NA	1	212	NA	NA	NA	NA	NA	NA	
80	TCGA-AB-2987	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2987-03	89	5.9714352126861365e-05	40	TCGA-AB-2987	0	0	0	0	TCGA-AB-2987	0	0	0	0	PASS	4888	TCGA-AB-2987	LAML	75	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-27667	Dead	NA	NA	184	NA	NA	NA	NA	NA	NA	NA	NA	1	184	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2988	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2988-03	50	3.5772405206924684e-05	11	TCGA-AB-2988	0	0	0	0	TCGA-AB-2988	0	0	0	0	PASS	4889	TCGA-AB-2988	LAML	67	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-24717	Dead	NA	NA	30	NA	NA	NA	NA	NA	NA	NA	NA	1	30	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-2989	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2989-03	41	0.00017459624753388497	3	TCGA-AB-2989	0	0	0	0	TCGA-AB-2989	0	0	0	0	PASS	4890	TCGA-AB-2989	LAML	29	MALE	WHITE	NA	NA	NA	NA	2008	NA	-10774	Dead	NA	NA	365	NA	NA	NA	NA	NA	NA	NA	NA	1	365	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-2990	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2990-03	31	6.789187141680498e-06	2	TCGA-AB-2990	0	0	0	0	TCGA-AB-2990	0	0	0	0	PASS	4891	TCGA-AB-2990	LAML	51	MALE	WHITE	NA	NA	NA	NA	2008	NA	-18962	Alive	NA	457	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	457	0	NA	NA	NA	NA	NA	
40	TCGA-AB-2991	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2991-03	55	2.5473756261461225e-05	13	TCGA-AB-2991	0	0	0	0	TCGA-AB-2991	0	0	0	0	PASS	4892	TCGA-AB-2991	LAML	40	FEMALE	WHITE	NA	NA	NA	NA	2004	NA	-14885	Alive	NA	1826	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1826	0	NA	NA	NA	NA	NA	
30	TCGA-AB-2992	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2992-03	73	0.00047522644423242687	28	TCGA-AB-2992	0	0	0	0	TCGA-AB-2992	0	0	0	0	PASS	4893	TCGA-AB-2992	LAML	32	FEMALE	WHITE	NA	NA	NA	NA	2003	NA	-11839	Dead	NA	NA	1706	NA	NA	NA	NA	NA	NA	NA	NA	1	1706	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2993	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2993-03	85	2.1263452603877994e-05	43	TCGA-AB-2993	0	0	0	0	TCGA-AB-2993	0	0	0	0	PASS	4894	TCGA-AB-2993	LAML	57	FEMALE	WHITE	NA	NA	NA	NA	2004	NA	-21124	Dead	NA	NA	761	NA	NA	NA	NA	NA	NA	NA	NA	1	761	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-2994	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2994-03	37	7.741947545538036e-06	8	TCGA-AB-2994	0	0	0	0	TCGA-AB-2994	0	0	0	0	PASS	4895	TCGA-AB-2994	LAML	25	MALE	WHITE	NA	NA	NA	NA	2005	NA	-9436	Alive	NA	1798	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1798	0	NA	NA	NA	NA	NA	
60	TCGA-AB-2995	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2995-03	47	0.0004310225248267174	10	TCGA-AB-2995	0	0	0	0	TCGA-AB-2995	0	0	0	0	PASS	4896	TCGA-AB-2995	LAML	63	MALE	WHITE	NA	NA	NA	NA	2005	NA	-23164	Alive	NA	1551	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1551	0	NA	NA	NA	NA	NA	
70	TCGA-AB-2996	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2996-03	77	8.45679107656979e-05	33	TCGA-AB-2996	0	0	0	0	TCGA-AB-2996	0	0	0	0	PASS	4897	TCGA-AB-2996	LAML	74	MALE	WHITE	NA	NA	NA	NA	2005	NA	-27364	Alive	NA	1581	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1581	0	NA	NA	NA	NA	NA	
30	TCGA-AB-2997	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2997-03	49	0.00010280716196139912	10	TCGA-AB-2997	0	0	0	0	TCGA-AB-2997	0	0	0	0	PASS	4898	TCGA-AB-2997	LAML	25	FEMALE	WHITE	NA	NA	NA	NA	2006	NA	-9162	Dead	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	
70	TCGA-AB-2998	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2998-03	49	1.4416844759082544e-05	13	TCGA-AB-2998	0	0	0	0	TCGA-AB-2998	0	0	0	0	PASS	4899	TCGA-AB-2998	LAML	68	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-24837	Dead	NA	NA	31	NA	NA	NA	NA	NA	NA	NA	NA	1	31	NA	NA	NA	NA	NA	NA	
60	TCGA-AB-2999	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-2999-03	95	4.3961025716224155e-05	47	TCGA-AB-2999	0	0	0	0	TCGA-AB-2999	0	0	0	0	PASS	4900	TCGA-AB-2999	LAML	62	MALE	WHITE	NA	NA	NA	NA	2004	NA	-22980	Alive	NA	1735	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1735	0	NA	NA	NA	NA	NA	
30	TCGA-AB-3000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-3000-03	117	0.00022143650709879672	56	TCGA-AB-3000	0	0	0	0	TCGA-AB-3000	0	0	0	0	PASS	4901	TCGA-AB-3000	LAML	25	MALE	WHITE	NA	NA	NA	NA	2006	NA	-9251	Alive	NA	1249	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1249	0	NA	NA	NA	NA	NA	
30	TCGA-AB-3001	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-3001-03	41	2.0318160576703346e-05	7	TCGA-AB-3001	0	0	0	0	TCGA-AB-3001	0	0	0	0	PASS	4902	TCGA-AB-3001	LAML	31	FEMALE	WHITE	NA	NA	NA	NA	2005	NA	-11446	Alive	NA	1581	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1581	0	NA	NA	NA	NA	NA	
70	TCGA-AB-3002	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-3002-03	55	0.0001821327516113505	11	TCGA-AB-3002	0	0	0	0	TCGA-AB-3002	0	0	0	0	PASS	4903	TCGA-AB-3002	LAML	68	MALE	WHITE	NA	NA	NA	NA	2005	NA	-25171	Dead	NA	NA	1431	NA	NA	NA	NA	NA	NA	NA	NA	1	1431	NA	NA	NA	NA	NA	NA	
50	TCGA-AB-3005	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-3005-03	95	0.00014203909034198145	45	TCGA-AB-3005	0	0	0	0	TCGA-AB-3005	0	0	0	0	PASS	4904	TCGA-AB-3005	LAML	45	MALE	WHITE	NA	NA	NA	NA	2003	NA	-16528	Alive	NA	2100	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2100	0	NA	NA	NA	NA	NA	
60	TCGA-AB-3006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-3006-03	67	4.528691282525189e-05	20	TCGA-AB-3006	0	0	0	0	TCGA-AB-3006	0	0	0	0	PASS	4905	TCGA-AB-3006	LAML	61	MALE	WHITE	NA	NA	NA	NA	2006	NA	-22464	Dead	NA	NA	485	NA	NA	NA	NA	NA	NA	NA	NA	1	485	NA	NA	NA	NA	NA	NA	
40	TCGA-AB-3007	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-3007-03	91	0.07140639040964285	40	TCGA-AB-3007	0	0	0	0	TCGA-AB-3007	0	0	0	0	PASS	4906	TCGA-AB-3007	LAML	35	MALE	WHITE	NA	NA	NA	NA	2005	NA	-13029	Alive	NA	1581	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1581	0	NA	NA	NA	NA	NA	
30	TCGA-AB-3008	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-3008-03	73	3.6145478908269467e-05	23	TCGA-AB-3008	0	0	0	0	TCGA-AB-3008	0	0	0	0	PASS	4907	TCGA-AB-3008	LAML	22	MALE	WHITE	NA	NA	NA	NA	2005	NA	-8159	Dead	NA	NA	822	NA	NA	NA	NA	NA	NA	NA	NA	1	822	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-3009	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-3009-03	81	0.0005338372109866594	31	TCGA-AB-3009	0	0	0	0	TCGA-AB-3009	0	0	0	0	PASS	4908	TCGA-AB-3009	LAML	23	MALE	NA	NA	NA	NA	NA	2005	NA	-8676	Dead	NA	NA	577	NA	NA	NA	NA	NA	NA	NA	NA	1	577	NA	NA	NA	NA	NA	NA	
30	TCGA-AB-3011	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-3011-03	83	4.7516088793860086e-05	36	TCGA-AB-3011	0	0	0	0	TCGA-AB-3011	0	0	0	0	PASS	4909	TCGA-AB-3011	LAML	21	FEMALE	WHITE	NA	NA	NA	NA	2005	NA	-7916	Alive	NA	1885	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1885	0	NA	NA	NA	NA	NA	
50	TCGA-AB-3012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AB-3012-03	33	6.271245031774882e-05	2	TCGA-AB-3012	0	0	0	0	TCGA-AB-3012	0	0	0	0	PASS	4910	TCGA-AB-3012	LAML	53	MALE	WHITE	NA	NA	NA	NA	2004	NA	-19543	Alive	NA	1887	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1887	0	NA	NA	NA	NA	NA	
30	TCGA-CS-4938	0	3	1	0	1	0	0	0	0	11	1	0	0	5	1	0	TCGA-CS-4938-01	76	0.06941174786208143	28	TCGA-CS-4938-01	1	2	10	0.01811769427758823	TCGA-CS-4938-01	3	1	1	5	PASS	4911	TCGA-CS-4938	LGG	31	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2005	NA	-11509	Alive	WITH TUMOR	3574	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	3574	0	3574	NA	NA	0	3574	
70	TCGA-CS-4941	0	2	0	0	0	0	0	0	3	38	4	0	1	9	2	1	TCGA-CS-4941-01	105	0.22414923861647576	50	TCGA-CS-4941-01	7	4	17	0.09282505213472253	TCGA-CS-4941-01	0	1	1	2	PASS	4912	TCGA-CS-4941	LGG	67	MALE	WHITE	NA	NA	Astrocytoma	G3	2005	NA	-24578	Dead	WITH TUMOR	NA	234	NA	NA	NA	NA	9	Stable Disease	NA	NA	1	234	1	234	NA	NA	1	9	
40	TCGA-CS-4942	0	2	0	0	1	0	0	0	0	25	0	0	2	8	0	0	TCGA-CS-4942-01	57	0.09369345146751527	17	TCGA-CS-4942-01	2	2	4	0.026796672279840027	TCGA-CS-4942-01	3	2	1	6	PASS	4913	TCGA-CS-4942	LGG	44	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Astrocytoma	G3	2006	NA	-16297	Dead	WITH TUMOR	NA	1335	NA	NA	NA	NA	1184	Progressive Disease	NA	NA	1	1335	1	1335	NA	NA	1	1184	
40	TCGA-CS-4943	0	2	0	0	0	0	1	0	0	22	1	0	1	12	0	0	TCGA-CS-4943-01	192	0.2599383454643754	121	TCGA-CS-4943-01	5	10	28	0.10483330782810538	TCGA-CS-4943-01	12	9	3	24	PASS	4914	TCGA-CS-4943	LGG	37	MALE	WHITE	NA	NA	Astrocytoma	G3	2009	NA	-13565	Dead	WITH TUMOR	NA	1106	NA	NA	NA	NA	NA	NA	NA	NA	1	1106	1	1106	NA	NA	1	1106	
50	TCGA-CS-4944	0	0	0	0	1	1	0	0	0	19	0	0	0	3	0	0	TCGA-CS-4944-01	65	0.06030701534032463	20	TCGA-CS-4944-01	1	1	5	0.0602593740033107	TCGA-CS-4944-01	2	3	2	7	PASS	4915	TCGA-CS-4944	LGG	50	MALE	WHITE	NA	NA	Astrocytoma	G2	2010	NA	-18494	Alive	WITH TUMOR	1828	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1828	0	1828	NA	NA	0	1828	
50	TCGA-CS-5390	1	2	0	0	3	0	3	0	1	31	4	0	1	9	2	0	TCGA-CS-5390-01	51	0.0593449793300152	11	TCGA-CS-5390-01	2	2	5	0.06710476654952073	TCGA-CS-5390-01	3	1	3	7	PASS	4916	TCGA-CS-5390	LGG	47	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2005	NA	-17460	Alive	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	NA	0	NA	0	NA	0	NA	
40	TCGA-CS-5393	0	2	0	0	1	0	0	0	0	22	1	0	0	10	0	0	TCGA-CS-5393-01	145	0.057788395008759236	91	TCGA-CS-5393-01	0	7	15	0.0069910557123179645	TCGA-CS-5393-01	6	2	0	8	PASS	4917	TCGA-CS-5393	LGG	39	MALE	WHITE	NA	NA	Astrocytoma	G3	2008	NA	-14418	Alive	TUMOR FREE	1222	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1222	0	1222	0	1222	0	1222	
40	TCGA-CS-5394	0	1	0	2	1	2	1	0	0	17	1	0	0	6	0	0	TCGA-CS-5394-01	61	0.059023708651495976	20	TCGA-CS-5394-01	1	3	6	0.0975017906132874	TCGA-CS-5394-01	2	0	1	3	PASS	4918	TCGA-CS-5394	LGG	40	MALE	WHITE	NA	NA	Astrocytoma	G3	2005	NA	-14920	Alive	NA	8	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	8	0	8	NA	NA	0	8	
40	TCGA-CS-5395	0	6	0	1	0	0	0	1	4	36	2	0	1	5	1	0	TCGA-CS-5395-01	94	0.18612316058815626	42	TCGA-CS-5395-01	8	5	13	0.07481639500223378	TCGA-CS-5395-01	2	4	3	9	PASS	4919	TCGA-CS-5395	LGG	43	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Oligodendroglioma	G2	2007	NA	-15848	Dead	WITH TUMOR	NA	639	NA	NA	NA	NA	287	Progressive Disease	NA	NA	1	639	1	639	NA	NA	1	287	
50	TCGA-CS-5396	1	2	0	0	1	0	0	0	2	26	0	0	0	8	0	0	TCGA-CS-5396-01	71	0.2133542078361392	24	TCGA-CS-5396-01	6	4	6	0.08408665854674655	TCGA-CS-5396-01	1	0	2	3	PASS	4920	TCGA-CS-5396	LGG	53	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2010	NA	-19399	Alive	WITH TUMOR	1631	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1631	0	1631	NA	NA	0	1631	
50	TCGA-CS-5397	0	5	0	0	2	0	1	0	2	26	3	0	3	16	0	0	TCGA-CS-5397-01	175	0.30573906567729786	96	TCGA-CS-5397-01	9	6	38	0.16117822694597514	TCGA-CS-5397-01	4	3	3	10	PASS	4921	TCGA-CS-5397	LGG	54	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2010	NA	-19866	Dead	WITH TUMOR	NA	194	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	194	1	194	NA	NA	1	194	
60	TCGA-CS-6186	0	2	0	4	1	0	0	0	2	43	4	0	0	16	1	0	TCGA-CS-6186-01	94	0.1517732569277693	34	TCGA-CS-6186-01	7	5	13	0.07343620440257398	TCGA-CS-6186-01	2	1	2	5	PASS	4922	TCGA-CS-6186	LGG	58	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2009	NA	-21321	Dead	WITH TUMOR	NA	538	NA	NA	NA	NA	188	Progressive Disease	NA	NA	1	538	1	538	NA	NA	1	188	
50	TCGA-CS-6188	1	3	0	0	1	0	1	0	0	31	1	0	1	18	1	0	TCGA-CS-6188-01	109	0.1800718961176019	61	TCGA-CS-6188-01	6	5	22	0.0611164554502581	TCGA-CS-6188-01	5	4	2	11	PASS	4923	TCGA-CS-6188	LGG	48	MALE	WHITE	NA	NA	Astrocytoma	G3	2009	NA	-17729	Dead	WITH TUMOR	NA	814	NA	NA	NA	NA	647	Progressive Disease	NA	NA	1	814	1	814	NA	NA	1	647	
30	TCGA-CS-6290	0	0	0	0	0	0	0	0	0	17	3	0	0	6	0	0	TCGA-CS-6290-01	64	0.057426925364992165	19	TCGA-CS-6290-01	0	2	19	0.0013793594204505534	TCGA-CS-6290-01	2	1	0	3	PASS	4924	TCGA-CS-6290	LGG	31	MALE	NA	NA	NA	Astrocytoma	G3	2009	NA	-11666	Dead	NA	NA	1137	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	1137	NA	1137	NA	NA	0	1137	
50	TCGA-CS-6665	1	3	1	3	2	0	1	0	0	54	4	0	0	24	0	0	TCGA-CS-6665-01	98	0.6704224066737837	36	TCGA-CS-6665-01	19	18	14	0.10952487156258484	TCGA-CS-6665-01	8	5	5	18	PASS	4925	TCGA-CS-6665	LGG	51	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2010	NA	-18977	Alive	WITH TUMOR	1568	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1568	0	1568	NA	NA	0	1568	
30	TCGA-CS-6666	0	3	0	1	0	1	0	0	0	40	1	1	0	7	0	0	TCGA-CS-6666-01	199	0.445056498410562	131	TCGA-CS-6666-01	8	18	39	0.0958292128319116	TCGA-CS-6666-01	14	11	3	28	PASS	4926	TCGA-CS-6666	LGG	22	MALE	WHITE	NA	NA	Astrocytoma	G3	2010	NA	-8340	Alive	TUMOR FREE	1428	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1428	0	1428	NA	NA	0	1428	
40	TCGA-CS-6667	0	1	0	0	1	0	0	0	2	19	1	0	0	8	0	1	TCGA-CS-6667-01	81	0.06671281328075072	28	TCGA-CS-6667-01	1	1	2	0.0010393811484455788	TCGA-CS-6667-01	1	0	0	1	PASS	4927	TCGA-CS-6667	LGG	39	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2010	NA	-14375	Alive	WITH TUMOR	1469	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1469	0	1469	NA	NA	0	1469	
60	TCGA-CS-6668	0	0	0	4	0	1	0	1	1	18	1	0	1	6	1	0	TCGA-CS-6668-01	63	0.1704310612123878	24	TCGA-CS-6668-01	2	4	6	0.08114174773683462	TCGA-CS-6668-01	4	1	3	8	PASS	4928	TCGA-CS-6668	LGG	57	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-20836	Alive	WITH TUMOR	1519	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1519	0	1519	NA	NA	0	1519	
30	TCGA-CS-6669	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	TCGA-CS-6669-01	51	9.890803003070588e-06	10	TCGA-CS-6669-01	0	0	0	0.0	TCGA-CS-6669-01	0	0	0	0	mutation call filter	4929	TCGA-CS-6669	LGG	26	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-9809	Alive	WITH TUMOR	1494	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1494	0	1494	NA	NA	0	1494	
40	TCGA-CS-6670	0	3	0	1	0	1	0	0	1	27	1	0	0	12	2	0	TCGA-CS-6670-01	73	0.14461503847043833	29	TCGA-CS-6670-01	2	2	4	0.053862776119641805	TCGA-CS-6670-01	2	0	2	4	PASS	4930	TCGA-CS-6670	LGG	43	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2011	NA	-16066	Alive	WITH TUMOR	1426	NA	NA	NA	NA	NA	NA	[Discrepancy]	NA	NA	0	1426	0	1426	NA	NA	0	1426	
40	TCGA-DB-5270	0	3	1	0	1	1	0	0	0	16	1	0	1	8	1	0	TCGA-DB-5270-01	72	0.06138198589157917	34	TCGA-DB-5270-01	2	1	6	0.007449220272046033	TCGA-DB-5270-01	2	0	0	2	PASS	4931	TCGA-DB-5270	LGG	38	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2002	NA	-13904	Alive	TUMOR FREE	3733	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3733	0	3733	0	3733	0	3733	
30	TCGA-DB-5273	0	0	0	0	0	0	0	0	0	9	2	0	0	8	0	0	TCGA-DB-5273-01	58	0.017349201450820792	18	TCGA-DB-5273-01	1	1	7	0.012429593195933036	TCGA-DB-5273-01	4	0	1	5	PASS	4932	TCGA-DB-5273	LGG	33	MALE	WHITE	NA	NA	Astrocytoma	G3	2006	NA	-12152	Alive	TUMOR FREE	2493	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2493	0	2493	0	2493	0	2493	
40	TCGA-DB-5274	1	1	0	1	7	2	4	0	2	26	3	0	1	19	2	0	TCGA-DB-5274-01	45	0.27843799461450763	13	TCGA-DB-5274-01	2	2	2	0.05385110292931142	TCGA-DB-5274-01	2	0	2	4	PASS	4933	TCGA-DB-5274	LGG	37	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2006	NA	-13680	Alive	TUMOR FREE	2289	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2289	0	2289	0	2289	0	2289	
40	TCGA-DB-5275	0	1	0	2	4	0	3	0	0	27	2	0	1	6	2	0	TCGA-DB-5275-01	192	0.5517556741026811	133	TCGA-DB-5275-01	3	5	46	0.1371796946767111	TCGA-DB-5275-01	5	5	6	16	PASS	4934	TCGA-DB-5275	LGG	36	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2006	NA	-13371	Alive	TUMOR FREE	1458	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1458	0	1458	0	1458	0	1458	
30	TCGA-DB-5276	0	1	0	2	4	0	1	0	1	9	1	0	0	3	0	0	TCGA-DB-5276-01	43	0.0030220134505805087	10	TCGA-DB-5276-01	0	0	3	0.0018697275461095368	TCGA-DB-5276-01	1	0	0	1	PASS	4935	TCGA-DB-5276	LGG	32	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2007	NA	-11738	Alive	TUMOR FREE	2218	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2218	0	2218	0	2218	0	2218	
30	TCGA-DB-5277	0	3	0	1	1	1	0	0	1	30	3	0	1	13	1	0	TCGA-DB-5277-01	373	0.8785290644020991	262	TCGA-DB-5277-01	9	10	89	0.3225516070177621	TCGA-DB-5277-01	11	15	13	39	PASS	4936	TCGA-DB-5277	LGG	34	MALE	WHITE	NA	NA	Astrocytoma	G3	2007	NA	-12725	Dead	WITH TUMOR	NA	1547	NA	NA	NA	NA	1156	Complete Remission/Response	NA	NA	1	1547	1	1547	1	1156	1	1156	
20	TCGA-DB-5278	0	0	0	0	0	0	0	0	0	8	0	0	0	0	0	0	TCGA-DB-5278-01	59	0.05927696816137797	17	TCGA-DB-5278-01	2	2	3	0.05388810999059007	TCGA-DB-5278-01	2	0	2	4	PASS	4937	TCGA-DB-5278	LGG	17	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2007	NA	-6480	Alive	WITH TUMOR	2772	NA	NA	NA	NA	NA	507	Stable Disease	NA	NA	0	2772	0	2772	NA	NA	1	507	
60	TCGA-DB-5279	0	4	0	1	1	0	0	0	3	29	5	0	1	20	1	0	TCGA-DB-5279-01	73	0.947121948097094	25	TCGA-DB-5279-01	15	12	3	0.05442854318868443	TCGA-DB-5279-01	2	0	2	4	PASS	4938	TCGA-DB-5279	LGG	59	MALE	NA	NA	NA	Oligodendroglioma	G2	2007	NA	-21908	Alive	TUMOR FREE	1354	NA	NA	NA	NA	NA	695	Complete Remission/Response	NA	NA	0	1354	0	1354	1	695	1	695	
40	TCGA-DB-5280	0	0	0	0	2	0	0	0	1	22	0	0	1	5	0	0	TCGA-DB-5280-01	46	0.0285383554363132	13	TCGA-DB-5280-01	0	1	19	0.030103449063746106	TCGA-DB-5280-01	1	1	1	3	PASS	4939	TCGA-DB-5280	LGG	43	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2007	NA	-15836	Alive	TUMOR FREE	1112	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1112	0	1112	0	1112	0	1112	
60	TCGA-DB-5281	0	2	0	1	2	1	0	0	4	41	4	0	1	11	2	0	TCGA-DB-5281-01	229	0.32261375683022475	182	TCGA-DB-5281-01	6	8	85	0.22347904010418612	TCGA-DB-5281-01	9	8	5	22	PASS	4940	TCGA-DB-5281	LGG	61	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2006	NA	-22342	Alive	WITH TUMOR	2381	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	2381	0	2381	NA	NA	0	2381	
30	TCGA-DB-A4X9	0	1	1	0	2	2	0	0	1	16	2	0	0	7	1	0	TCGA-DB-A4X9-01	44	0.09574057972029444	8	TCGA-DB-A4X9-01	4	2	8	0.013346498503031018	TCGA-DB-A4X9-01	2	1	1	4	PASS	4941	TCGA-DB-A4X9	LGG	33	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2010	NA	-12131	Alive	TUMOR FREE	1412	NA	NA	NA	NA	NA	501	Complete Remission/Response	NA	NA	0	1412	0	1412	1	501	1	501	
30	TCGA-DB-A4XA	1	0	0	0	0	1	1	0	0	14	0	0	0	3	0	0	TCGA-DB-A4XA-01	74	0.2690370041314708	35	TCGA-DB-A4XA-01	2	2	20	0.05527679258522028	TCGA-DB-A4XA-01	2	0	2	4	PASS	4942	TCGA-DB-A4XA	LGG	30	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2012	NA	-11195	Alive	WITH TUMOR	573	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	573	0	573	NA	NA	0	573	
40	TCGA-DB-A4XB	0	0	0	2	1	0	0	0	0	29	0	0	0	6	0	1	TCGA-DB-A4XB-01	69	0.07343301139884419	24	TCGA-DB-A4XB-01	0	5	15	0.029441277453485425	TCGA-DB-A4XB-01	7	5	3	15	PASS	4943	TCGA-DB-A4XB	LGG	38	MALE	WHITE	NA	NA	Astrocytoma	G3	2011	NA	-13990	Alive	TUMOR FREE	919	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	919	0	919	NA	NA	0	919	
30	TCGA-DB-A4XC	0	1	0	0	3	0	2	0	0	13	1	0	0	2	0	0	TCGA-DB-A4XC-01	82	0.022485092068756356	42	TCGA-DB-A4XC-01	0	3	14	0.02961233938252187	TCGA-DB-A4XC-01	5	3	2	10	PASS	4944	TCGA-DB-A4XC	LGG	26	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2010	NA	-9705	Alive	TUMOR FREE	1421	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1421	0	1421	NA	NA	0	1421	
30	TCGA-DB-A4XD	0	0	0	1	3	0	0	0	1	28	1	0	0	5	1	0	TCGA-DB-A4XD-01	76	0.046454775179902284	31	TCGA-DB-A4XD-01	0	1	7	0.010110599917874476	TCGA-DB-A4XD-01	2	1	1	4	PASS	4945	TCGA-DB-A4XD	LGG	32	MALE	WHITE	NA	NA	Astrocytoma	G3	2010	NA	-11741	Alive	TUMOR FREE	1210	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1210	0	1210	0	1210	0	1210	
30	TCGA-DB-A4XE	1	0	0	0	1	0	0	0	0	22	0	0	0	8	1	0	TCGA-DB-A4XE-01	52	0.2595780259591136	16	TCGA-DB-A4XE-01	5	4	7	0.0010978602704978942	TCGA-DB-A4XE-01	2	0	0	2	PASS	4946	TCGA-DB-A4XE	LGG	27	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2011	NA	-10150	Alive	TUMOR FREE	1139	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1139	0	1139	0	1139	0	1139	
40	TCGA-DB-A4XF	1	2	0	1	3	0	3	0	1	20	1	0	0	10	2	0	TCGA-DB-A4XF-01	97	0.05650418314216804	47	TCGA-DB-A4XF-01	0	2	17	0.0467391653392553	TCGA-DB-A4XF-01	3	4	3	10	PASS	4947	TCGA-DB-A4XF	LGG	41	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2011	NA	-15066	Alive	TUMOR FREE	1021	NA	NA	NA	NA	NA	468	Stable Disease	NA	NA	0	1021	0	1021	NA	NA	1	468	
30	TCGA-DB-A4XG	0	0	0	3	3	0	1	0	0	17	0	0	0	6	0	0	TCGA-DB-A4XG-01	45	0.12435768381991492	7	TCGA-DB-A4XG-01	4	3	17	0.10557712261663536	TCGA-DB-A4XG-01	4	2	4	10	PASS	4948	TCGA-DB-A4XG	LGG	34	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2006	NA	-12550	Alive	WITH TUMOR	2219	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	2219	0	2219	NA	NA	0	2219	
50	TCGA-DB-A4XH	1	1	0	1	1	1	0	1	0	32	3	0	0	18	0	0	TCGA-DB-A4XH-01	67	0.8983878058528384	21	TCGA-DB-A4XH-01	2	2	24	0.0566849269378733	TCGA-DB-A4XH-01	1	1	2	4	PASS	4949	TCGA-DB-A4XH	LGG	53	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2011	NA	-19710	Alive	TUMOR FREE	962	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	962	0	962	NA	NA	0	962	
70	TCGA-DB-A64L	1	2	0	1	3	0	0	0	1	67	1	0	0	19	2	1	TCGA-DB-A64L-01	55	0.3122841752259558	14	TCGA-DB-A64L-01	13	10	23	0.06489693370197247	TCGA-DB-A64L-01	6	2	3	11	PASS	4950	TCGA-DB-A64L	LGG	67	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-24690	Alive	WITH TUMOR	736	NA	NA	NA	NA	NA	724	Complete Remission/Response	NA	NA	0	736	0	736	1	724	1	724	
60	TCGA-DB-A64O	1	3	0	1	3	0	0	0	1	18	1	0	1	3	0	0	TCGA-DB-A64O-01	66	0.2044879730489108	18	TCGA-DB-A64O-01	8	5	45	0.15959611973591073	TCGA-DB-A64O-01	1	0	0	1	PASS	4951	TCGA-DB-A64O	LGG	59	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2011	NA	-21811	Dead	WITH TUMOR	NA	775	NA	NA	NA	NA	430	Stable Disease	NA	NA	1	775	1	775	NA	NA	1	430	
40	TCGA-DB-A64P	0	0	0	1	2	0	0	0	1	20	4	0	2	3	0	0	TCGA-DB-A64P-01	61	0.0912797759505618	13	TCGA-DB-A64P-01	3	3	15	0.06497684347991341	TCGA-DB-A64P-01	4	2	3	9	PASS	4952	TCGA-DB-A64P	LGG	40	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2012	NA	-14936	Alive	TUMOR FREE	916	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	916	0	916	0	916	0	916	
30	TCGA-DB-A64Q	0	1	0	1	1	0	0	0	0	16	1	0	0	5	1	0	TCGA-DB-A64Q-01	94	0.08815237339040351	44	TCGA-DB-A64Q-01	3	5	23	0.05859207883908596	TCGA-DB-A64Q-01	5	2	2	9	PASS	4953	TCGA-DB-A64Q	LGG	31	FEMALE	[Unknown]	NA	NA	Oligoastrocytoma	G2	2012	NA	-11637	Alive	TUMOR FREE	182	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	182	0	182	NA	NA	0	182	
30	TCGA-DB-A64R	1	0	0	0	0	0	0	0	0	14	1	0	0	1	0	0	TCGA-DB-A64R-01	69	0.07555736761729816	21	TCGA-DB-A64R-01	2	2	15	0.06402221432756441	TCGA-DB-A64R-01	1	1	2	4	PASS	4954	TCGA-DB-A64R	LGG	24	FEMALE	[Not Evaluated]	NA	NA	Oligodendroglioma	G2	2012	NA	-8947	Alive	TUMOR FREE	955	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	955	0	955	0	955	0	955	
30	TCGA-DB-A64S	0	0	0	1	1	0	1	0	1	8	2	0	1	0	0	0	TCGA-DB-A64S-01	49	8.709663806529271e-06	14	TCGA-DB-A64S-01	0	0	5	0.00029240158884317547	TCGA-DB-A64S-01	0	0	0	0	PASS	4955	TCGA-DB-A64S	LGG	20	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2012	NA	-7389	Alive	TUMOR FREE	835	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	835	0	835	0	835	0	835	
40	TCGA-DB-A64U	0	1	1	1	2	0	0	0	0	6	0	1	0	5	1	0	TCGA-DB-A64U-01	65	0.05970005796581322	28	TCGA-DB-A64U-01	2	4	34	0.08527684806870409	TCGA-DB-A64U-01	3	0	3	6	PASS	4956	TCGA-DB-A64U	LGG	38	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2011	NA	-14019	Alive	TUMOR FREE	846	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	846	0	846	0	846	0	846	
50	TCGA-DB-A64V	0	0	0	1	3	0	0	0	1	23	1	0	0	11	1	0	TCGA-DB-A64V-01	83	0.07717303104387488	29	TCGA-DB-A64V-01	2	2	26	0.06399879479265938	TCGA-DB-A64V-01	3	2	2	7	PASS	4957	TCGA-DB-A64V	LGG	54	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-19950	Alive	TUMOR FREE	889	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	889	0	889	NA	NA	0	889	
70	TCGA-DB-A64W	0	2	0	1	1	2	0	0	1	33	4	0	1	11	0	0	TCGA-DB-A64W-01	77	0.12379568518368655	25	TCGA-DB-A64W-01	5	5	36	0.13984327955759185	TCGA-DB-A64W-01	5	3	6	14	PASS	4958	TCGA-DB-A64W	LGG	65	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2012	NA	-23936	Dead	TUMOR FREE	NA	438	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	438	0	438	NA	NA	0	438	
60	TCGA-DB-A64X	1	5	0	0	2	0	0	0	3	60	2	0	0	26	0	0	TCGA-DB-A64X-01	129	0.08311910289816206	71	TCGA-DB-A64X-01	0	0	32	0.03717960546088761	TCGA-DB-A64X-01	4	6	1	11	PASS	4959	TCGA-DB-A64X	LGG	56	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-20625	Alive	TUMOR FREE	563	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	563	0	563	NA	NA	0	563	
60	TCGA-DB-A75K	0	1	1	2	0	3	2	0	1	25	3	0	0	10	2	0	TCGA-DB-A75K-01	69	0.07057345120866418	28	TCGA-DB-A75K-01	2	2	27	0.06738260170106654	TCGA-DB-A75K-01	1	3	3	7	PASS	4960	TCGA-DB-A75K	LGG	55	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2013	NA	-20241	Alive	TUMOR FREE	368	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	368	0	368	0	368	0	368	
40	TCGA-DB-A75L	0	2	0	0	0	2	0	0	0	33	1	0	0	11	0	0	TCGA-DB-A75L-01	91	0.12520993732871755	38	TCGA-DB-A75L-01	4	7	23	0.046929647490284686	TCGA-DB-A75L-01	9	4	4	17	PASS	4961	TCGA-DB-A75L	LGG	36	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-13338	Alive	TUMOR FREE	342	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	342	0	342	0	342	0	342	
50	TCGA-DB-A75M	1	0	0	1	1	0	0	0	0	22	1	0	0	3	1	0	TCGA-DB-A75M-01	51	0.015790073484060026	17	TCGA-DB-A75M-01	1	1	12	0.009690669204511738	TCGA-DB-A75M-01	2	0	1	3	PASS	4962	TCGA-DB-A75M	LGG	47	MALE	WHITE	NA	NA	Astrocytoma	G2	2013	NA	-17289	Alive	TUMOR FREE	544	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	544	0	544	0	544	0	544	
30	TCGA-DB-A75O	0	1	0	0	0	2	0	0	0	13	0	0	0	3	0	0	TCGA-DB-A75O-01	165	0.09839960420263184	100	TCGA-DB-A75O-01	2	5	11	0.011233585219376663	TCGA-DB-A75O-01	6	3	1	10	PASS	4963	TCGA-DB-A75O	LGG	29	MALE	WHITE	NA	NA	Astrocytoma	G3	2010	NA	-10812	Alive	NA	935	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	935	0	935	NA	NA	0	935	
30	TCGA-DB-A75P	0	0	0	0	0	0	0	0	0	5	0	0	0	1	0	0	TCGA-DB-A75P-01	65	0.04829163910950879	21	TCGA-DB-A75P-01	2	2	19	7.717804211486825e-05	TCGA-DB-A75P-01	0	0	0	0	PASS	4964	TCGA-DB-A75P	LGG	25	FEMALE	[Unknown]	NA	NA	Astrocytoma	G2	2013	NA	-9413	Alive	TUMOR FREE	492	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	492	0	492	0	492	0	492	
40	TCGA-DH-5140	0	0	0	2	4	0	0	0	1	21	0	0	0	9	1	0	TCGA-DH-5140-01	122	0.8245013570544526	56	TCGA-DH-5140-01	13	12	22	0.05636302927367344	TCGA-DH-5140-01	2	0	1	3	PASS	4965	TCGA-DH-5140	LGG	38	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2007	NA	-13943	Dead	WITH TUMOR	NA	607	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	607	1	607	NA	NA	1	607	
30	TCGA-DH-5141	0	1	0	0	1	0	0	0	0	22	2	0	0	6	1	0	TCGA-DH-5141-01	95	0.056322043093573984	45	TCGA-DH-5141-01	2	2	3	0.05442925805231015	TCGA-DH-5141-01	2	0	2	4	PASS	4966	TCGA-DH-5141	LGG	32	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2005	NA	-11846	Alive	NA	968	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	968	0	968	NA	NA	0	968	
30	TCGA-DH-5142	1	2	0	0	0	1	0	0	0	31	2	0	0	12	0	0	TCGA-DH-5142-01	82	0.1420795823081729	39	TCGA-DH-5142-01	5	7	11	0.061522995247544864	TCGA-DH-5142-01	4	3	2	9	PASS	4967	TCGA-DH-5142	LGG	29	MALE	WHITE	NA	NA	Astrocytoma	G3	2008	NA	-10678	Alive	WITH TUMOR	1943	NA	NA	NA	NA	NA	1627	Stable Disease	NA	NA	0	1943	0	1943	NA	NA	1	1627	
30	TCGA-DH-5143	0	1	0	2	1	0	0	0	2	25	0	0	0	5	1	0	TCGA-DH-5143-01	39	0.029462768132576693	5	TCGA-DH-5143-01	1	2	0	0.0	TCGA-DH-5143-01	0	0	0	0	PASS	4968	TCGA-DH-5143	LGG	30	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2009	NA	-11291	Alive	WITH TUMOR	1401	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1401	0	1401	NA	NA	0	1401	
60	TCGA-DH-5144	0	7	0	3	0	0	0	0	0	31	1	0	0	10	3	0	TCGA-DH-5144-01	70	0.15850604828541975	27	TCGA-DH-5144-01	2	2	4	0.06130558380240145	TCGA-DH-5144-01	3	1	3	7	PASS	4969	TCGA-DH-5144	LGG	56	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2009	NA	-20558	Alive	TUMOR FREE	748	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	748	0	748	0	748	0	748	
70	TCGA-DH-A669	1	2	1	5	2	2	0	0	1	89	4	0	2	30	5	0	TCGA-DH-A669-01	321	0.5867344025164977	247	TCGA-DH-A669-02	28	22	118	0.19445772093626856	TCGA-DH-A669-02	4	1	3	8	mutation call filter	4970	TCGA-DH-A669	LGG	70	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2007	NA	-25809	Dead	TUMOR FREE	NA	919	NA	NA	NA	NA	260	Stable Disease	NA	NA	1	919	0	919	NA	NA	1	260	
50	TCGA-DH-A66B	0	4	0	3	6	1	5	0	1	29	1	0	2	8	1	0	TCGA-DH-A66B-01	126	0.470042641006414	58	TCGA-DH-A66B-01	10	15	109	0.3456550481730056	TCGA-DH-A66B-01	15	6	13	34	PASS	4971	TCGA-DH-A66B	LGG	52	MALE	WHITE	NA	NA	Astrocytoma	G3	2010	NA	-19156	Alive	WITH TUMOR	1279	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1279	0	1279	NA	NA	0	1279	
40	TCGA-DH-A66D	0	2	0	1	2	1	0	0	0	38	2	0	2	4	0	0	TCGA-DH-A66D-01	67	0.2058378905810468	22	TCGA-DH-A66D-01	4	7	19	0.029482642450416086	TCGA-DH-A66D-01	5	5	1	11	PASS	4972	TCGA-DH-A66D	LGG	43	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-15866	Alive	WITH TUMOR	846	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	846	0	846	NA	NA	0	846	
50	TCGA-DH-A66F	0	0	0	2	1	0	0	0	0	14	2	0	0	3	0	1	TCGA-DH-A66F-01	63	0.1056768421743186	20	TCGA-DH-A66F-01	2	2	23	0.05565809953338783	TCGA-DH-A66F-01	1	1	2	4	PASS	4973	TCGA-DH-A66F	LGG	49	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-18193	Alive	TUMOR FREE	523	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	523	0	523	0	523	0	523	
50	TCGA-DH-A66G	0	1	0	1	1	0	0	0	0	28	0	0	0	11	3	0	TCGA-DH-A66G-01	72	0.234595989619356	30	TCGA-DH-A66G-01	5	6	51	0.1653973754798431	TCGA-DH-A66G-01	6	5	2	13	PASS	4974	TCGA-DH-A66G	LGG	49	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2013	NA	-18199	Alive	WITH TUMOR	523	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	523	0	523	NA	NA	0	523	
60	TCGA-DH-A7UR	0	3	0	1	8	0	3	0	2	39	4	0	2	22	3	0	TCGA-DH-A7UR-01	53	0.09609027123592476	12	TCGA-DH-A7UR-01	3	5	14	0.06914572478963414	TCGA-DH-A7UR-01	3	2	3	8	PASS	4975	TCGA-DH-A7UR	LGG	59	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2008	NA	-21803	Alive	TUMOR FREE	1650	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1650	0	1650	0	1650	0	1650	
50	TCGA-DH-A7US	1	2	0	0	1	0	0	0	0	25	2	0	0	11	1	0	TCGA-DH-A7US-01	50	0.0611696991114827	14	TCGA-DH-A7US-01	2	2	17	0.05572408609844686	TCGA-DH-A7US-01	2	0	2	4	PASS	4976	TCGA-DH-A7US	LGG	50	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2013	NA	-18429	Alive	WITH TUMOR	706	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	706	0	706	NA	NA	0	706	
30	TCGA-DH-A7UT	0	2	0	0	0	0	0	0	2	18	0	0	0	4	0	0	TCGA-DH-A7UT-01	63	0.2048403021004724	19	TCGA-DH-A7UT-01	7	4	26	0.054971961448119805	TCGA-DH-A7UT-01	4	1	4	9	PASS	4977	TCGA-DH-A7UT	LGG	30	MALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-11014	Dead	WITH TUMOR	NA	531	NA	NA	NA	NA	404	Stable Disease	NA	NA	1	531	1	531	NA	NA	1	404	
40	TCGA-DH-A7UU	0	3	0	0	1	1	0	0	2	36	3	0	0	15	1	0	TCGA-DH-A7UU-01	88	0.11696716781442247	38	TCGA-DH-A7UU-01	4	5	23	0.09025795747667267	TCGA-DH-A7UU-01	7	2	5	14	PASS	4978	TCGA-DH-A7UU	LGG	43	MALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-16037	Alive	WITH TUMOR	417	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	417	0	417	NA	NA	0	417	
50	TCGA-DH-A7UV	0	2	0	2	4	0	2	0	2	25	0	0	0	6	0	1	TCGA-DH-A7UV-01	56	0.08039635042640977	17	TCGA-DH-A7UV-01	2	3	13	0.0214410418387166	TCGA-DH-A7UV-01	5	2	2	9	PASS	4979	TCGA-DH-A7UV	LGG	49	MALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-18161	Alive	WITH TUMOR	566	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	566	0	566	NA	NA	0	566	
30	TCGA-DU-5847	0	4	0	3	0	1	0	0	0	27	2	0	0	10	4	0	TCGA-DU-5847-01	95	0.9300776699993726	48	TCGA-DU-5847-01	7	8	29	0.2256241822851271	TCGA-DU-5847-01	5	3	3	11	PASS	4980	TCGA-DU-5847	LGG	34	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2009	NA	-12606	Alive	WITH TUMOR	548	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	548	0	548	NA	NA	0	548	
50	TCGA-DU-5849	0	4	1	1	0	0	0	0	0	26	2	0	0	11	1	1	TCGA-DU-5849-01	79	0.10456073594899803	28	TCGA-DU-5849-01	3	4	7	0.08498139003383147	TCGA-DU-5849-01	5	3	4	12	PASS	4981	TCGA-DU-5849	LGG	48	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2010	NA	-17663	Alive	TUMOR FREE	443	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	443	0	443	NA	NA	0	443	
40	TCGA-DU-5851	0	1	0	0	1	0	0	0	2	17	3	0	0	9	0	0	TCGA-DU-5851-01	57	0.06412143362028863	19	TCGA-DU-5851-01	0	3	10	0.0675670310352752	TCGA-DU-5851-01	5	4	3	12	PASS	4982	TCGA-DU-5851	LGG	40	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2010	NA	-14802	Alive	WITH TUMOR	531	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	531	0	531	NA	NA	0	531	
60	TCGA-DU-5852	0	3	0	2	0	0	1	0	2	55	6	0	4	22	1	0	TCGA-DU-5852-01	130	0.2449860053631699	69	TCGA-DU-5852-01	6	4	26	0.11552810959490352	TCGA-DU-5852-01	3	3	1	7	PASS	4983	TCGA-DU-5852	LGG	61	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2010	NA	-22348	Dead	WITH TUMOR	NA	205	NA	NA	NA	NA	24	Progressive Disease	NA	NA	1	205	1	205	NA	NA	1	24	
30	TCGA-DU-5853	1	0	0	0	0	0	0	0	0	15	0	0	0	5	2	0	TCGA-DU-5853-01	60	0.10034163762546028	25	TCGA-DU-5853-01	0	0	6	0.009637341438475971	TCGA-DU-5853-01	2	0	0	2	PASS	4984	TCGA-DU-5853	LGG	29	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2010	NA	-10624	Alive	WITH TUMOR	407	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	407	0	407	NA	NA	0	407	
60	TCGA-DU-5854	0	2	0	0	2	0	0	0	1	38	2	0	1	12	0	0	TCGA-DU-5854-01	118	0.16518172491001118	70	TCGA-DU-5854-01	7	6	25	0.07580665057578309	TCGA-DU-5854-01	2	2	2	6	PASS	4985	TCGA-DU-5854	LGG	57	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2010	NA	-21106	Alive	WITH TUMOR	257	NA	NA	NA	NA	NA	202	Progressive Disease	NA	NA	0	257	0	257	NA	NA	1	202	
50	TCGA-DU-5855	1	2	0	0	1	0	0	0	2	42	2	0	2	22	0	0	TCGA-DU-5855-01	117	0.1019525835019621	65	TCGA-DU-5855-01	1	4	16	0.07647367293986196	TCGA-DU-5855-01	7	6	4	17	PASS	4986	TCGA-DU-5855	LGG	49	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2010	NA	-18234	Alive	WITH TUMOR	207	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	207	0	207	NA	NA	0	207	
30	TCGA-DU-5870	0	0	0	1	3	2	0	0	5	44	3	0	1	14	0	0	TCGA-DU-5870-01	55	0.08792081055225615	15	TCGA-DU-5870-02	1	3	26	0.07287870911004132	TCGA-DU-5870-02	2	2	3	7	mutation call filter	4987	TCGA-DU-5870	LGG	34	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	1995	NA	-12764	Alive	WITH TUMOR	5546	NA	NA	NA	NA	NA	4347	Progressive Disease	NA	NA	0	5546	0	5546	NA	NA	1	4347	
40	TCGA-DU-5871	0	2	0	1	1	0	0	0	1	27	0	1	0	6	0	0	TCGA-DU-5871-01	89	0.21654709017253806	40	TCGA-DU-5871-01	1	1	0	0.0	TCGA-DU-5871-01	0	0	0	0	PASS	4988	TCGA-DU-5871	LGG	37	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2009	NA	-13673	Alive	TUMOR FREE	576	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	576	0	576	NA	NA	0	576	
40	TCGA-DU-5872	0	2	0	0	0	0	0	0	0	26	4	0	0	12	0	0	TCGA-DU-5872-01	74	0.10067973720399648	28	TCGA-DU-5872-02	0	0	11	0.002456494683472449	TCGA-DU-5872-02	0	0	0	0	mutation call filter	4989	TCGA-DU-5872	LGG	43	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Oligoastrocytoma	G2	2009	NA	-15986	Alive	WITH TUMOR	532	NA	NA	NA	NA	NA	265	Progressive Disease	NA	NA	0	532	0	532	NA	NA	1	265	
60	TCGA-DU-5874	1	2	1	1	1	0	0	1	3	29	2	0	1	14	3	1	TCGA-DU-5874-01	83	0.0763731687778476	37	TCGA-DU-5874-01	2	2	7	0.06997517028274418	TCGA-DU-5874-01	3	1	3	7	PASS	4990	TCGA-DU-5874	LGG	62	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2010	NA	-22847	Alive	TUMOR FREE	461	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	461	0	461	NA	NA	0	461	
40	TCGA-DU-6392	37	605	37	212	56	133	1	0	357	9642	664	8	142	3744	262	6	TCGA-DU-6392-01	85	0.14677312512207488	31	TCGA-DU-6392-01	2	1	3	0.0012087419643877378	TCGA-DU-6392-01	1	2	0	3	hypermutated sample	4991	TCGA-DU-6392	LGG	35	FEMALE	WHITE	NA	NA	Astrocytoma	G3	1993	NA	-12836	Alive	TUMOR FREE	6423	NA	NA	NA	NA	NA	950	Progressive Disease	NA	NA	0	6423	0	6423	NA	NA	1	950	
70	TCGA-DU-6393	0	2	0	0	1	0	0	1	3	23	1	0	0	9	0	0	TCGA-DU-6393-01	59	0.24158824199336604	15	TCGA-DU-6393-01	8	6	6	0.12103774482596395	TCGA-DU-6393-01	3	1	3	7	PASS	4992	TCGA-DU-6393	LGG	66	MALE	WHITE	NA	NA	Oligodendroglioma	G3	1993	NA	-24282	Dead	NA	NA	1585	NA	NA	NA	NA	NA	NA	NA	NA	1	1585	NA	1585	NA	NA	0	1585	
50	TCGA-DU-6394	0	0	1	1	5	0	7	0	0	14	2	0	0	6	3	0	TCGA-DU-6394-01	103	0.09283556680838438	50	TCGA-DU-6394-01	2	2	5	0.06598999415970679	TCGA-DU-6394-01	3	1	3	7	PASS	4993	TCGA-DU-6394	LGG	53	MALE	WHITE	NA	NA	Oligodendroglioma	G3	1994	NA	-19541	Dead	WITH TUMOR	NA	682	NA	NA	NA	NA	353	Progressive Disease	NA	NA	1	682	1	682	NA	NA	1	353	
30	TCGA-DU-6395	0	2	0	0	2	0	0	0	1	20	0	0	0	10	0	0	TCGA-DU-6395-01	75	0.09583419905728313	28	TCGA-DU-6395-01	3	3	9	0.02292332362318137	TCGA-DU-6395-01	5	3	1	9	PASS	4994	TCGA-DU-6395	LGG	31	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	1994	NA	-11584	Dead	WITH TUMOR	NA	1491	NA	NA	NA	NA	1197	Progressive Disease	NA	NA	1	1491	1	1491	NA	NA	1	1197	
30	TCGA-DU-6396	0	3	0	2	0	1	0	0	0	32	2	0	0	14	0	0	TCGA-DU-6396-01	110	0.20420548120393145	57	TCGA-DU-6396-01	2	8	9	0.050693567903328	TCGA-DU-6396-01	13	7	2	22	PASS	4995	TCGA-DU-6396	LGG	31	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	1996	NA	-11427	Dead	WITH TUMOR	NA	2286	NA	NA	NA	NA	106	Progressive Disease	NA	NA	1	2286	1	2286	NA	NA	1	106	
50	TCGA-DU-6397	0	5	1	3	20	3	8	0	1	50	2	0	1	17	3	0	TCGA-DU-6397-01	93	0.14195872108519794	39	TCGA-DU-6397-02	4	4	44	0.14556436783204016	TCGA-DU-6397-02	5	6	4	15	mutation call filter	4996	TCGA-DU-6397	LGG	45	MALE	WHITE	NA	NA	Oligodendroglioma	G3	1997	NA	-16695	Dead	WITH TUMOR	NA	1401	NA	NA	NA	NA	837	Progressive Disease	NA	NA	1	1401	1	1401	NA	NA	1	837	
50	TCGA-DU-6399	0	5	1	0	4	0	0	0	1	39	1	0	2	20	1	0	TCGA-DU-6399-01	123	0.1478223236231035	67	TCGA-DU-6399-01	1	6	0	0.0	TCGA-DU-6399-01	6	5	0	11	PASS	4997	TCGA-DU-6399	LGG	54	MALE	WHITE	NA	NA	Oligodendroglioma	G2	1998	NA	-19906	Dead	WITH TUMOR	NA	2000	NA	NA	NA	NA	1629	Progressive Disease	NA	NA	1	2000	1	2000	NA	NA	1	1629	
70	TCGA-DU-6400	0	1	0	0	3	0	0	0	1	38	1	0	0	12	1	0	TCGA-DU-6400-01	62	0.6283624410537691	18	TCGA-DU-6400-01	3	3	7	0.08861853224421612	TCGA-DU-6400-01	2	0	2	4	PASS	4998	TCGA-DU-6400	LGG	66	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	1998	NA	-24122	Dead	WITH TUMOR	NA	37	NA	NA	NA	NA	NA	NA	NA	NA	1	37	1	37	NA	NA	1	37	
30	TCGA-DU-6401	0	0	0	1	1	1	0	0	0	22	0	0	1	6	0	0	TCGA-DU-6401-01	93	0.17617135473749268	35	TCGA-DU-6401-01	2	6	14	0.156157687678433	TCGA-DU-6401-01	3	5	5	13	PASS	4999	TCGA-DU-6401	LGG	31	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	1998	NA	-11595	Dead	WITH TUMOR	NA	2660	NA	NA	NA	NA	1886	Progressive Disease	NA	NA	1	2660	1	2660	NA	NA	1	1886	
50	TCGA-DU-6402	0	2	0	2	1	0	0	0	1	39	4	0	1	13	0	0	TCGA-DU-6402-01	152	0.15773260292019828	87	TCGA-DU-6402-01	5	4	34	0.1009336813416267	TCGA-DU-6402-01	5	7	1	13	PASS	5000	TCGA-DU-6402	LGG	52	MALE	WHITE	NA	NA	Astrocytoma	G3	1998	NA	-19207	Dead	WITH TUMOR	NA	214	NA	NA	NA	NA	103	Progressive Disease	NA	NA	1	214	1	214	NA	NA	1	103	
60	TCGA-DU-6403	1	2	0	1	2	1	0	0	5	47	2	0	2	13	2	0	TCGA-DU-6403-01	103	0.1223339459505596	50	TCGA-DU-6403-01	4	3	11	0.07047030280656674	TCGA-DU-6403-01	5	3	3	11	PASS	5001	TCGA-DU-6403	LGG	60	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	1999	NA	-22031	Dead	WITH TUMOR	NA	354	NA	NA	NA	NA	NA	NA	NA	NA	1	354	1	354	NA	NA	1	354	
30	TCGA-DU-6404	0	5	1	2	4	0	0	0	8	76	4	0	1	29	1	0	TCGA-DU-6404-01	54	0.10950009774634964	11	TCGA-DU-6404-01	2	6	2	0.011585678884607941	TCGA-DU-6404-01	1	0	0	1	mutation call filter	5002	TCGA-DU-6404	LGG	24	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2000	NA	-9021	Dead	WITH TUMOR	NA	4068	NA	NA	NA	NA	1154	Progressive Disease	NA	NA	1	4068	1	4068	NA	NA	1	1154	
50	TCGA-DU-6405	0	4	0	0	3	2	0	0	1	37	4	0	0	13	1	0	TCGA-DU-6405-01	115	0.1384208250380036	56	TCGA-DU-6405-01	4	4	25	0.11996563845849385	TCGA-DU-6405-01	3	1	2	6	PASS	5003	TCGA-DU-6405	LGG	51	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2000	NA	-18686	Dead	WITH TUMOR	NA	605	NA	NA	NA	NA	486	Progressive Disease	NA	NA	1	605	1	605	NA	NA	1	486	
60	TCGA-DU-6406	0	0	0	0	0	0	0	0	0	4	1	0	0	0	0	0	TCGA-DU-6406-01	188	0.14669033067190726	122	TCGA-DU-6406-01	8	4	31	0.05397442305367836	TCGA-DU-6406-01	0	0	0	0	PASS	5004	TCGA-DU-6406	LGG	59	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2001	NA	-21634	Dead	NA	NA	512	NA	NA	NA	NA	NA	NA	NA	NA	1	512	NA	512	NA	NA	0	512	
40	TCGA-DU-6407	4	120	6	62	6	0	2	0	76	1482	53	0	24	765	69	0	TCGA-DU-6407-01	79	0.2309103987057381	31	TCGA-DU-6407-01	7	4	15	0.05271273073646782	TCGA-DU-6407-01	5	6	1	12	mutation call filter	5005	TCGA-DU-6407	LGG	35	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2001	NA	-13021	Dead	WITH TUMOR	NA	2875	NA	NA	NA	NA	2397	Progressive Disease	NA	NA	1	2875	1	2875	NA	NA	1	2397	
30	TCGA-DU-6408	0	0	0	0	1	0	0	0	0	23	0	0	1	7	1	0	TCGA-DU-6408-01	66	0.2295825624798645	18	TCGA-DU-6408-01	1	4	4	0.041884944660787835	TCGA-DU-6408-01	5	5	3	13	PASS	5006	TCGA-DU-6408	LGG	23	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	1998	NA	-8752	Dead	NA	NA	3470	NA	NA	NA	NA	2097	Progressive Disease	NA	NA	1	3470	NA	3470	NA	NA	1	2097	
60	TCGA-DU-6410	1	1	0	1	0	0	1	0	0	35	3	0	0	12	0	0	TCGA-DU-6410-01	69	0.1806581721715954	24	TCGA-DU-6410-01	6	4	7	0.11765837581568195	TCGA-DU-6410-01	4	0	4	8	PASS	5007	TCGA-DU-6410	LGG	56	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2010	NA	-20567	Alive	WITH TUMOR	242	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	242	0	242	NA	NA	0	242	
30	TCGA-DU-6542	0	1	0	0	1	0	0	0	1	20	0	0	0	8	1	0	TCGA-DU-6542-01	287	0.16013513470356386	221	TCGA-DU-6542-01	1	3	12	0.07696493817439852	TCGA-DU-6542-01	6	5	4	15	PASS	5008	TCGA-DU-6542	LGG	25	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2011	NA	-9380	Alive	WITH TUMOR	73	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	73	0	73	NA	NA	0	73	
60	TCGA-DU-7006	0	3	0	2	1	1	0	0	2	49	7	0	3	11	0	0	TCGA-DU-7006-01	87	0.561054812404127	31	TCGA-DU-7006-01	6	5	16	0.15086982801321394	TCGA-DU-7006-01	3	6	4	13	PASS	5009	TCGA-DU-7006	LGG	60	FEMALE	WHITE	NA	NA	Astrocytoma	G3	1995	NA	-21990	Dead	WITH TUMOR	NA	349	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	349	1	349	NA	NA	1	349	
30	TCGA-DU-7007	0	0	0	0	1	0	1	0	2	29	3	0	1	13	1	0	TCGA-DU-7007-01	60	0.4917023107552171	15	TCGA-DU-7007-01	2	9	8	0.10085694205862523	TCGA-DU-7007-01	7	3	5	15	PASS	5010	TCGA-DU-7007	LGG	33	MALE	WHITE	NA	NA	Astrocytoma	G2	1997	NA	-12245	Dead	NA	NA	1915	NA	NA	NA	NA	NA	NA	NA	NA	1	1915	NA	1915	NA	NA	0	1915	
40	TCGA-DU-7008	0	1	0	1	0	1	2	0	1	24	1	0	2	12	0	0	TCGA-DU-7008-01	110	0.140094912660165	56	TCGA-DU-7008-01	0	1	13	0.009306271794987086	TCGA-DU-7008-01	3	2	0	5	PASS	5011	TCGA-DU-7008	LGG	41	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	1998	NA	-15289	Alive	TUMOR FREE	4752	NA	NA	NA	NA	NA	330	Progressive Disease	NA	NA	0	4752	0	4752	NA	NA	1	330	
30	TCGA-DU-7009	1	2	1	0	1	1	0	0	1	17	1	0	1	2	0	0	TCGA-DU-7009-01	75	0.11339012663418667	29	TCGA-DU-7009-01	4	3	4	0.08180161028841001	TCGA-DU-7009-01	2	2	2	6	PASS	5012	TCGA-DU-7009	LGG	32	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2000	NA	-11854	Dead	WITH TUMOR	NA	4695	NA	NA	NA	NA	2960	Progressive Disease	NA	NA	1	4695	1	4695	NA	NA	1	2960	
60	TCGA-DU-7010	0	5	1	2	4	0	0	0	3	78	1	1	0	23	0	0	TCGA-DU-7010-01	272	0.8454330006988581	185	TCGA-DU-7010-01	18	24	13	0.03585756559090438	TCGA-DU-7010-01	11	9	1	21	PASS	5013	TCGA-DU-7010	LGG	58	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2001	NA	-21199	Dead	WITH TUMOR	NA	456	NA	NA	NA	NA	193	Progressive Disease	NA	NA	1	456	1	456	NA	NA	1	193	
30	TCGA-DU-7011	0	0	0	0	1	0	0	0	1	14	2	0	0	4	0	0	TCGA-DU-7011-01	53	0.05471647966480092	12	TCGA-DU-7011-01	2	3	2	0.01938271421664248	TCGA-DU-7011-01	0	1	1	2	PASS	5014	TCGA-DU-7011	LGG	25	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2000	NA	-9322	Dead	WITH TUMOR	NA	3200	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	3200	1	3200	NA	NA	1	3200	
70	TCGA-DU-7012	0	2	0	1	2	0	0	0	1	43	2	0	3	24	0	0	TCGA-DU-7012-01	87	0.19971835273700356	42	TCGA-DU-7012-01	7	6	15	0.15361552473752965	TCGA-DU-7012-01	4	3	4	11	PASS	5015	TCGA-DU-7012	LGG	74	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Astrocytoma	G3	2001	NA	-27039	Dead	WITH TUMOR	NA	199	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	199	1	199	NA	NA	1	199	
60	TCGA-DU-7013	0	2	0	1	1	0	0	0	0	32	3	0	1	12	1	0	TCGA-DU-7013-01	127	0.2126241990308313	61	TCGA-DU-7013-01	8	6	5	0.05291886506786159	TCGA-DU-7013-01	2	0	0	2	PASS	5016	TCGA-DU-7013	LGG	59	MALE	WHITE	NA	NA	Astrocytoma	G3	2001	NA	-21824	Dead	WITH TUMOR	NA	269	NA	NA	NA	NA	187	Progressive Disease	NA	NA	1	269	1	269	NA	NA	1	187	
60	TCGA-DU-7014	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DU-7014-01	81	0.3650262138663716	25	TCGA-DU-7014-01	4	3	2	0.014358404030270716	TCGA-DU-7014-01	2	1	1	4	PASS	5017	TCGA-DU-7014	LGG	59	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2001	NA	-21865	Dead	WITH TUMOR	NA	3571	NA	NA	NA	NA	3437	Progressive Disease	NA	NA	1	3571	1	3571	NA	NA	1	3437	
40	TCGA-DU-7015	0	0	0	0	1	0	0	0	0	27	2	0	1	5	1	0	TCGA-DU-7015-01	123	0.15432537954501713	63	TCGA-DU-7015-01	3	5	9	0.014450208759465271	TCGA-DU-7015-01	7	6	0	13	PASS	5018	TCGA-DU-7015	LGG	41	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2004	NA	-15041	Alive	WITH TUMOR	2761	NA	NA	NA	NA	NA	591	Progressive Disease	NA	NA	0	2761	0	2761	NA	NA	1	591	
60	TCGA-DU-7018	0	2	0	0	4	0	0	0	0	28	1	0	1	12	0	1	TCGA-DU-7018-01	49	0.2378365618765788	9	TCGA-DU-7018-01	6	5	4	0.1253743447856498	TCGA-DU-7018-01	3	0	2	5	PASS	5019	TCGA-DU-7018	LGG	57	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2006	NA	-21019	Dead	WITH TUMOR	NA	933	NA	NA	NA	NA	338	Progressive Disease	NA	NA	1	933	1	933	NA	NA	1	338	
40	TCGA-DU-7019	0	1	0	1	4	0	5	0	0	22	0	0	1	12	2	0	TCGA-DU-7019-01	115	0.0585494243256136	63	TCGA-DU-7019-01	1	3	13	0.030521994115200606	TCGA-DU-7019-01	5	3	2	10	PASS	5020	TCGA-DU-7019	LGG	39	MALE	WHITE	NA	NA	Oligoastrocytoma	[Discrepancy]	2009	NA	-14279	Alive	TUMOR FREE	800	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	800	0	800	NA	NA	0	800	
50	TCGA-DU-7290	0	1	1	0	1	0	0	0	0	28	2	0	1	7	1	0	TCGA-DU-7290-01	97	0.2006393364405452	52	TCGA-DU-7290-01	7	5	15	0.13080402485713938	TCGA-DU-7290-01	1	0	0	1	PASS	5021	TCGA-DU-7290	LGG	45	FEMALE	WHITE	NA	NA	Astrocytoma	G3	1995	NA	-16667	Dead	WITH TUMOR	NA	315	NA	NA	NA	NA	NA	NA	NA	NA	1	315	1	315	NA	NA	1	315	
70	TCGA-DU-7292	0	1	0	2	0	0	0	1	4	32	4	0	0	18	0	1	TCGA-DU-7292-01	97	0.12158354826298425	44	TCGA-DU-7292-01	4	4	14	0.10161983827484272	TCGA-DU-7292-01	3	2	5	10	PASS	5022	TCGA-DU-7292	LGG	69	MALE	WHITE	NA	NA	Astrocytoma	G3	1997	NA	-25266	Dead	WITH TUMOR	NA	242	NA	NA	NA	NA	91	Progressive Disease	NA	NA	1	242	1	242	NA	NA	1	91	
50	TCGA-DU-7294	2	18	2	15	0	0	0	0	13	323	104	2	2	133	11	0	TCGA-DU-7294-01	75	0.22679984006263915	31	TCGA-DU-7294-01	4	3	8	0.13706608622520924	TCGA-DU-7294-01	4	2	3	9	PASS	5023	TCGA-DU-7294	LGG	53	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2003	NA	-19616	Alive	TUMOR FREE	2869	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	2869	0	2869	NA	NA	0	2869	
40	TCGA-DU-7298	0	14	0	5	2	0	0	0	14	212	65	0	5	82	8	2	TCGA-DU-7298-01	94	0.2560797395591673	40	TCGA-DU-7298-01	4	8	11	0.14634524314605268	TCGA-DU-7298-01	9	7	8	24	PASS	5024	TCGA-DU-7298	LGG	38	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Astrocytoma	G3	2006	NA	-14205	Dead	WITH TUMOR	NA	576	NA	NA	NA	NA	200	Progressive Disease	NA	NA	1	576	1	576	NA	NA	1	200	
30	TCGA-DU-7299	0	0	0	0	6	0	4	0	2	18	1	0	2	6	1	0	TCGA-DU-7299-01	122	0.08243785529210401	59	TCGA-DU-7299-01	3	6	7	0.0570116704582376	TCGA-DU-7299-01	4	2	1	7	PASS	5025	TCGA-DU-7299	LGG	33	MALE	WHITE	NA	NA	Astrocytoma	G3	2006	NA	-12266	Dead	WITH TUMOR	NA	1339	NA	NA	NA	NA	675	Progressive Disease	NA	NA	1	1339	1	1339	NA	NA	1	675	
50	TCGA-DU-7300	0	1	0	2	10	0	10	0	1	28	0	0	1	12	1	0	TCGA-DU-7300-01	72	0.0809253233422776	23	TCGA-DU-7300-01	4	3	6	0.08388981893443576	TCGA-DU-7300-01	1	0	2	3	PASS	5026	TCGA-DU-7300	LGG	53	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2006	NA	-19610	Dead	WITH TUMOR	NA	1886	NA	NA	NA	NA	317	Progressive Disease	NA	NA	1	1886	1	1886	NA	NA	1	317	
50	TCGA-DU-7301	0	2	0	1	3	0	1	0	0	21	1	0	1	6	0	0	TCGA-DU-7301-01	103	0.11330469696377295	53	TCGA-DU-7301-01	1	4	7	0.07275805533779472	TCGA-DU-7301-01	4	6	3	13	PASS	5027	TCGA-DU-7301	LGG	53	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2006	NA	-19644	Dead	WITH TUMOR	NA	788	NA	NA	NA	NA	366	Progressive Disease	NA	NA	1	788	1	788	NA	NA	1	366	
50	TCGA-DU-7302	0	1	0	3	12	0	9	0	0	22	2	0	1	4	2	0	TCGA-DU-7302-01	75	0.8568837807540753	33	TCGA-DU-7302-01	4	4	7	0.14141306933137235	TCGA-DU-7302-01	5	2	5	12	PASS	5028	TCGA-DU-7302	LGG	48	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2006	NA	-17656	Alive	WITH TUMOR	1834	NA	NA	NA	NA	NA	1374	Progressive Disease	NA	NA	0	1834	0	1834	NA	NA	1	1374	
40	TCGA-DU-7304	0	1	0	4	2	1	2	0	1	90	3	0	1	35	6	0	TCGA-DU-7304-01	104	0.1764075160926558	48	TCGA-DU-7304-02	3	14	100	0.13291520831337605	TCGA-DU-7304-02	13	10	8	31	mutation call filter	5029	TCGA-DU-7304	LGG	43	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2008	NA	-15931	Dead	WITH TUMOR	NA	709	NA	NA	NA	NA	309	Progressive Disease	NA	NA	1	709	1	709	NA	NA	1	309	
70	TCGA-DU-7306	1	6	0	1	2	1	0	0	0	50	2	0	0	15	2	0	TCGA-DU-7306-01	114	0.10633018314979656	56	TCGA-DU-7306-01	2	5	8	0.034408161499646935	TCGA-DU-7306-01	7	5	2	14	PASS	5030	TCGA-DU-7306	LGG	67	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2008	NA	-24800	Alive	WITH TUMOR	1277	NA	NA	NA	NA	NA	1250	Progressive Disease	NA	NA	0	1277	0	1277	NA	NA	1	1250	
40	TCGA-DU-7309	0	1	0	0	1	0	0	0	2	35	2	0	0	9	0	0	TCGA-DU-7309-01	67	0.09224713213177736	17	TCGA-DU-7309-01	0	0	4	0.02959040371061718	TCGA-DU-7309-01	3	3	2	8	PASS	5031	TCGA-DU-7309	LGG	41	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2011	NA	-15197	Alive	WITH TUMOR	84	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	84	0	84	NA	NA	0	84	
60	TCGA-DU-8158	0	2	0	1	1	1	0	0	1	37	1	0	0	6	0	0	TCGA-DU-8158-01	98	0.7531838776096172	47	TCGA-DU-8158-01	11	8	27	0.30948451609646943	TCGA-DU-8158-01	0	1	3	4	PASS	5032	TCGA-DU-8158	LGG	57	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2001	NA	-21129	Dead	WITH TUMOR	NA	155	NA	NA	NA	NA	NA	NA	NA	NA	1	155	1	155	NA	NA	1	155	
60	TCGA-DU-8161	0	5	0	1	0	2	0	0	1	30	3	0	0	15	1	0	TCGA-DU-8161-01	108	0.2654796304501201	59	TCGA-DU-8161-01	9	7	26	0.19409678469939548	TCGA-DU-8161-01	4	3	5	12	PASS	5033	TCGA-DU-8161	LGG	63	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2009	NA	-23064	Dead	WITH TUMOR	NA	722	NA	NA	NA	NA	111	Progressive Disease	NA	NA	1	722	1	722	NA	NA	1	111	
60	TCGA-DU-8162	0	1	0	0	0	0	0	0	0	21	0	0	0	12	1	0	TCGA-DU-8162-01	110	0.04130242669425837	52	TCGA-DU-8162-01	3	2	5	0.0001200042665259272	TCGA-DU-8162-01	1	1	0	2	PASS	5034	TCGA-DU-8162	LGG	61	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2011	NA	-22596	Dead	WITH TUMOR	NA	444	NA	NA	NA	NA	402	Progressive Disease	NA	NA	1	444	1	444	NA	NA	1	402	
30	TCGA-DU-8163	0	0	0	0	0	0	0	0	3	10	3	0	0	8	0	0	TCGA-DU-8163-01	49	0.05442146521632512	11	TCGA-DU-8163-01	2	2	2	1.9919997525767944e-05	TCGA-DU-8163-01	0	0	0	0	PASS	5035	TCGA-DU-8163	LGG	29	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2011	NA	-10824	Alive	WITH TUMOR	629	NA	NA	NA	NA	NA	509	Progressive Disease	NA	NA	0	629	0	629	NA	NA	1	509	
50	TCGA-DU-8164	1	0	0	3	1	0	0	0	2	29	3	0	1	4	0	0	TCGA-DU-8164-01	64	0.0732559151504891	19	TCGA-DU-8164-01	2	2	4	0.05444910170189991	TCGA-DU-8164-01	2	0	2	4	PASS	5036	TCGA-DU-8164	LGG	51	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-18735	Alive	TUMOR FREE	651	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	651	0	651	NA	NA	0	651	
60	TCGA-DU-8165	0	4	0	2	2	0	0	0	4	58	0	0	3	19	0	0	TCGA-DU-8165-01	90	0.7251491973025043	41	TCGA-DU-8165-01	26	43	9	0.1147806928709386	TCGA-DU-8165-01	2	0	0	2	PASS	5037	TCGA-DU-8165	LGG	60	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2011	NA	-21964	Alive	TUMOR FREE	582	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	582	0	582	NA	NA	0	582	
30	TCGA-DU-8166	0	1	0	1	0	1	0	0	1	25	0	0	0	8	1	0	TCGA-DU-8166-01	80	0.08643551253639688	27	TCGA-DU-8166-01	3	2	6	0.016846011901860053	TCGA-DU-8166-01	1	0	1	2	PASS	5038	TCGA-DU-8166	LGG	29	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2012	NA	-10641	Alive	WITH TUMOR	516	NA	NA	NA	NA	NA	193	Progressive Disease	NA	NA	0	516	0	516	NA	NA	1	193	
70	TCGA-DU-8167	0	8	0	1	3	0	0	0	1	45	1	0	0	24	1	0	TCGA-DU-8167-01	104	0.19683131269110635	48	TCGA-DU-8167-01	5	7	3	0.012277975186782208	TCGA-DU-8167-01	6	4	1	11	PASS	5039	TCGA-DU-8167	LGG	69	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2012	NA	-25262	Alive	TUMOR FREE	471	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	471	0	471	NA	NA	0	471	
60	TCGA-DU-8168	0	3	0	0	7	0	13	0	1	39	0	0	1	20	0	0	TCGA-DU-8168-01	93	0.7569283313651891	43	TCGA-DU-8168-01	2	3	7	0.09240283125976016	TCGA-DU-8168-01	2	4	4	10	PASS	5040	TCGA-DU-8168	LGG	55	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2012	NA	-20136	Alive	TUMOR FREE	431	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	431	0	431	NA	NA	0	431	
30	TCGA-DU-A5TP	0	1	0	0	1	0	0	0	0	23	3	0	1	8	0	0	TCGA-DU-A5TP-01	89	0.05538018429993368	32	TCGA-DU-A5TP-01	1	4	13	0.028218253003424187	TCGA-DU-A5TP-01	5	4	3	12	PASS	5041	TCGA-DU-A5TP	LGG	33	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-12111	Alive	TUMOR FREE	1012	NA	NA	NA	NA	NA	203	[Discrepancy]	NA	NA	0	1012	0	1012	NA	NA	1	203	
50	TCGA-DU-A5TR	0	4	0	1	0	0	0	0	0	39	1	0	0	4	0	0	TCGA-DU-A5TR-01	65	0.09812023005509704	20	TCGA-DU-A5TR-01	5	3	24	0.040645764496116704	TCGA-DU-A5TR-01	6	1	3	10	PASS	5042	TCGA-DU-A5TR	LGG	51	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2012	NA	-18791	Alive	TUMOR FREE	908	NA	NA	NA	NA	NA	848	[Discrepancy]	NA	NA	0	908	0	908	NA	NA	1	848	
40	TCGA-DU-A5TS	1	3	0	0	1	1	2	0	1	24	4	0	0	10	4	0	TCGA-DU-A5TS-01	116	0.33198444506300945	64	TCGA-DU-A5TS-01	2	5	31	0.06922155174839847	TCGA-DU-A5TS-01	7	2	3	12	PASS	5043	TCGA-DU-A5TS	LGG	42	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Oligodendroglioma	G2	2012	NA	-15650	Alive	TUMOR FREE	964	NA	NA	NA	NA	NA	551	Stable Disease	NA	NA	0	964	0	964	NA	NA	1	551	
70	TCGA-DU-A5TT	0	3	0	2	0	0	2	0	3	41	0	0	0	19	1	0	TCGA-DU-A5TT-01	83	0.7999132233761801	35	TCGA-DU-A5TT-01	30	43	16	0.06416460355166707	TCGA-DU-A5TT-01	2	3	2	7	PASS	5044	TCGA-DU-A5TT	LGG	70	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2013	NA	-25726	Alive	WITH TUMOR	743	NA	NA	NA	NA	NA	584	[Discrepancy]	NA	NA	0	743	0	743	NA	NA	1	584	
60	TCGA-DU-A5TU	4	0	1	1	1	0	0	0	0	34	3	0	1	12	2	0	TCGA-DU-A5TU-01	88	0.2253252279092312	37	TCGA-DU-A5TU-01	3	5	33	0.09976694735370567	TCGA-DU-A5TU-01	8	7	6	21	PASS	5045	TCGA-DU-A5TU	LGG	62	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2013	NA	-22811	Alive	WITH TUMOR	796	NA	NA	NA	NA	NA	186	Progressive Disease	NA	NA	0	796	0	796	NA	NA	1	186	
30	TCGA-DU-A5TW	0	0	0	2	2	0	1	0	1	37	3	0	2	15	2	0	TCGA-DU-A5TW-01	112	0.2076638438035813	65	TCGA-DU-A5TW-01	4	11	6	0.0069483866383928715	TCGA-DU-A5TW-01	5	5	1	11	PASS	5046	TCGA-DU-A5TW	LGG	33	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Astrocytoma	G3	2012	NA	-12107	Alive	WITH TUMOR	760	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	760	0	760	NA	NA	0	760	
50	TCGA-DU-A5TY	1	2	0	0	2	0	0	0	1	45	3	0	2	14	0	0	TCGA-DU-A5TY-01	314	0.2676446345504207	219	TCGA-DU-A5TY-01	13	11	44	0.10317742889828556	TCGA-DU-A5TY-01	4	4	2	10	PASS	5047	TCGA-DU-A5TY	LGG	46	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-16945	Dead	WITH TUMOR	NA	1033	NA	NA	NA	NA	526	[Discrepancy]	NA	NA	1	1033	1	1033	NA	NA	1	526	
40	TCGA-DU-A6S2	0	0	0	1	0	1	0	0	1	13	0	0	0	4	0	0	TCGA-DU-A6S2-01	83	0.06004023510110223	38	TCGA-DU-A6S2-01	2	3	14	0.055605095781960434	TCGA-DU-A6S2-01	2	0	2	4	PASS	5048	TCGA-DU-A6S2	LGG	37	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Oligodendroglioma	G2	2013	NA	-13597	Alive	TUMOR FREE	777	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	777	0	777	NA	NA	0	777	
60	TCGA-DU-A6S3	1	1	0	1	3	0	7	0	3	18	1	0	1	5	0	0	TCGA-DU-A6S3-01	61	0.19517981664138356	18	TCGA-DU-A6S3-01	2	2	40	0.07268977475949162	TCGA-DU-A6S3-01	3	0	3	6	PASS	5049	TCGA-DU-A6S3	LGG	60	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2013	NA	-22038	Alive	TUMOR FREE	656	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	656	0	656	NA	NA	0	656	
40	TCGA-DU-A6S6	0	0	0	0	2	0	0	0	1	11	1	0	0	4	0	0	TCGA-DU-A6S6-01	83	0.14614103271387066	34	TCGA-DU-A6S6-01	2	3	10	0.05502974745976882	TCGA-DU-A6S6-01	3	1	2	6	PASS	5050	TCGA-DU-A6S6	LGG	35	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2007	NA	-12809	Alive	TUMOR FREE	2893	NA	NA	NA	NA	NA	2267	[Discrepancy]	NA	NA	0	2893	0	2893	NA	NA	1	2267	
30	TCGA-DU-A6S7	0	4	0	0	3	0	0	0	0	23	2	0	0	8	0	0	TCGA-DU-A6S7-01	56	0.2369430184652097	19	TCGA-DU-A6S7-01	6	8	5	0.006039413384689466	TCGA-DU-A6S7-01	5	1	1	7	PASS	5051	TCGA-DU-A6S7	LGG	27	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-10170	Alive	TUMOR FREE	638	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	638	0	638	NA	NA	0	638	
70	TCGA-DU-A6S8	0	3	0	0	4	0	2	0	1	47	0	0	0	10	1	0	TCGA-DU-A6S8-01	95	0.9476519516650884	43	TCGA-DU-A6S8-01	7	7	38	0.2035835021864937	TCGA-DU-A6S8-01	3	2	2	7	PASS	5052	TCGA-DU-A6S8	LGG	74	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2013	NA	-27084	Alive	WITH TUMOR	678	NA	NA	NA	NA	NA	641	Progressive Disease	NA	NA	0	678	0	678	NA	NA	1	641	
90	TCGA-DU-A76K	0	6	0	3	3	0	0	0	0	43	1	0	4	11	0	0	TCGA-DU-A76K-01	84	0.2170077705266061	38	TCGA-DU-A76K-01	10	7	35	0.11655407546616152	TCGA-DU-A76K-01	0	5	3	8	PASS	5053	TCGA-DU-A76K	LGG	87	MALE	WHITE	NA	NA	Oligodendroglioma	G2	1999	NA	-31776	Dead	WITH TUMOR	NA	347	NA	NA	NA	NA	203	Progressive Disease	NA	NA	1	347	1	347	NA	NA	1	203	
50	TCGA-DU-A76L	1	1	0	1	2	0	0	0	2	32	1	0	0	10	1	0	TCGA-DU-A76L-01	77	0.1625568766362479	27	TCGA-DU-A76L-01	8	5	34	0.09209907100363188	TCGA-DU-A76L-01	0	1	1	2	PASS	5054	TCGA-DU-A76L	LGG	54	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2000	NA	-19823	Dead	WITH TUMOR	NA	814	NA	NA	NA	NA	410	Progressive Disease	NA	NA	1	814	1	814	NA	NA	1	410	
30	TCGA-DU-A76O	0	1	0	1	1	0	0	0	1	22	1	0	1	7	0	0	TCGA-DU-A76O-01	78	0.09032193782709608	33	TCGA-DU-A76O-01	2	3	7	0.01861000709561839	TCGA-DU-A76O-01	4	3	2	9	PASS	5055	TCGA-DU-A76O	LGG	30	MALE	WHITE	NA	NA	Astrocytoma	G2	2013	NA	-10960	Alive	WITH TUMOR	522	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	522	0	522	NA	NA	0	522	
50	TCGA-DU-A76R	0	1	1	0	1	0	0	0	0	34	1	0	0	14	1	0	TCGA-DU-A76R-01	88	0.9254065079664592	40	TCGA-DU-A76R-01	3	3	29	0.09805495406517993	TCGA-DU-A76R-01	2	1	5	8	PASS	5056	TCGA-DU-A76R	LGG	51	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2006	NA	-18939	Dead	WITH TUMOR	NA	648	NA	NA	NA	NA	338	Progressive Disease	NA	NA	1	648	1	648	NA	NA	1	338	
70	TCGA-DU-A7T6	0	4	0	5	5	0	1	0	2	99	4	0	2	20	1	0	TCGA-DU-A7T6-01	62	0.8263635466475445	19	TCGA-DU-A7T6-01	15	54	4	0.00019969995030195	TCGA-DU-A7T6-01	2	0	0	2	PASS	5057	TCGA-DU-A7T6	LGG	73	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2002	NA	-26766	Dead	WITH TUMOR	NA	547	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	547	1	547	NA	NA	1	547	
40	TCGA-DU-A7T8	0	1	0	2	1	0	0	0	0	14	1	0	0	3	0	0	TCGA-DU-A7T8-01	83	0.14078572644546905	31	TCGA-DU-A7T8-01	1	3	5	0.0019542586573995328	TCGA-DU-A7T8-01	3	2	0	5	PASS	5058	TCGA-DU-A7T8	LGG	35	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2003	NA	-13108	Dead	WITH TUMOR	NA	4229	NA	NA	NA	NA	3009	Stable Disease	NA	NA	1	4229	1	4229	NA	NA	1	3009	
30	TCGA-DU-A7TA	0	2	0	0	5	1	4	0	3	24	5	0	0	3	0	0	TCGA-DU-A7TA-01	204	0.32796815486257697	140	TCGA-DU-A7TA-01	10	12	28	0.04147476823902802	TCGA-DU-A7TA-01	8	12	4	24	PASS	5059	TCGA-DU-A7TA	LGG	32	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2007	NA	-11764	Alive	TUMOR FREE	2565	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	2565	0	2565	NA	NA	0	2565	
60	TCGA-DU-A7TB	1	2	0	0	2	0	0	0	1	24	2	0	2	7	2	0	TCGA-DU-A7TB-01	61	0.038380945253961886	19	TCGA-DU-A7TB-01	1	1	5	0.007813680939099208	TCGA-DU-A7TB-01	2	2	0	4	PASS	5060	TCGA-DU-A7TB	LGG	56	MALE	ASIAN	NA	NA	Oligodendroglioma	G2	2010	NA	-20704	Alive	TUMOR FREE	1567	NA	NA	NA	NA	NA	74	Progressive Disease	NA	NA	0	1567	0	1567	NA	NA	1	74	
30	TCGA-DU-A7TC	0	1	0	1	2	0	2	0	2	19	1	0	1	7	1	0	TCGA-DU-A7TC-01	213	0.1256219527163476	168	TCGA-DU-A7TC-01	3	4	35	0.06373832996503621	TCGA-DU-A7TC-01	5	5	4	14	PASS	5061	TCGA-DU-A7TC	LGG	32	MALE	WHITE	NA	NA	Astrocytoma	G2	2011	NA	-11884	Alive	WITH TUMOR	1137	NA	NA	NA	NA	NA	1114	[Discrepancy]	NA	NA	0	1137	0	1137	NA	NA	1	1114	
50	TCGA-DU-A7TD	0	1	1	0	1	0	0	0	1	34	1	0	0	16	0	0	TCGA-DU-A7TD-01	97	0.15410147459193324	36	TCGA-DU-A7TD-01	6	4	25	0.10096838792454584	TCGA-DU-A7TD-01	0	0	0	0	PASS	5062	TCGA-DU-A7TD	LGG	52	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2012	NA	-19025	Dead	WITH TUMOR	NA	228	NA	NA	NA	NA	188	Progressive Disease	NA	NA	1	228	1	228	NA	NA	1	188	
40	TCGA-DU-A7TG	0	1	0	0	1	0	0	0	0	8	0	0	0	4	0	0	TCGA-DU-A7TG-01	39	0.09451038377775108	5	TCGA-DU-A7TG-01	2	3	2	0.0002022724498135806	TCGA-DU-A7TG-01	1	1	0	2	PASS	5063	TCGA-DU-A7TG	LGG	40	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2008	NA	-14671	Dead	NA	NA	1351	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	1351	NA	1351	NA	NA	0	1351	
30	TCGA-DU-A7TI	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DU-A7TI-01	75	0.08352388616990282	28	TCGA-DU-A7TI-01	1	5	6	0.00755606987376067	TCGA-DU-A7TI-01	6	7	1	14	PASS	5064	TCGA-DU-A7TI	LGG	32	MALE	WHITE	NA	NA	Astrocytoma	G3	1998	NA	-11906	Dead	WITH TUMOR	NA	1183	NA	NA	NA	NA	822	Progressive Disease	NA	NA	1	1183	1	1183	NA	NA	1	822	
60	TCGA-DU-A7TJ	0	6	0	4	1	0	0	0	2	30	3	0	0	11	2	0	TCGA-DU-A7TJ-01	238	0.17605532199062182	160	TCGA-DU-A7TJ-01	5	6	91	0.11750977589441595	TCGA-DU-A7TJ-01	6	4	6	16	PASS	5065	TCGA-DU-A7TJ	LGG	55	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Astrocytoma	G3	2013	NA	-20394	Alive	WITH TUMOR	17	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	17	0	17	NA	NA	0	17	
40	TCGA-E1-5302	0	3	0	2	2	0	0	0	0	27	1	0	1	10	0	0	TCGA-E1-5302-01	87	0.2510939385619275	40	TCGA-E1-5302-01	1	3	7	0.032522537308159225	TCGA-E1-5302-01	3	4	2	9	PASS	5066	TCGA-E1-5302	LGG	41	MALE	WHITE	NA	NA	Astrocytoma	G3	1998	NA	-15230	Dead	WITH TUMOR	NA	1525	NA	NA	NA	NA	1242	Stable Disease	NA	NA	1	1525	1	1525	NA	NA	1	1242	
40	TCGA-E1-5303	0	1	0	2	0	2	1	0	1	23	2	0	0	4	1	0	TCGA-E1-5303-01	61	0.0922867749148472	22	TCGA-E1-5303-01	2	3	0	0.0	TCGA-E1-5303-01	5	4	0	9	PASS	5067	TCGA-E1-5303	LGG	38	MALE	WHITE	NA	NA	Astrocytoma	G3	1998	NA	-14212	Dead	WITH TUMOR	NA	2052	NA	NA	NA	NA	156	Progressive Disease	NA	NA	1	2052	1	2052	NA	NA	1	156	
40	TCGA-E1-5304	0	1	0	0	0	1	0	0	0	27	2	0	0	7	1	0	TCGA-E1-5304-01	927	0.8430537291244404	758	TCGA-E1-5304-01	22	23	126	0.15255627980843908	TCGA-E1-5304-01	15	22	5	42	PASS	5068	TCGA-E1-5304	LGG	42	MALE	WHITE	NA	NA	Astrocytoma	G3	1999	NA	-15481	Dead	WITH TUMOR	NA	1251	NA	NA	NA	NA	903	Stable Disease	NA	NA	1	1251	1	1251	NA	NA	1	903	
30	TCGA-E1-5305	0	2	0	0	1	1	5	0	1	20	0	0	1	4	1	0	TCGA-E1-5305-01	92	0.1643528565063158	38	TCGA-E1-5305-01	2	4	12	0.09397796130096972	TCGA-E1-5305-01	6	6	6	18	PASS	5069	TCGA-E1-5305	LGG	34	MALE	WHITE	NA	NA	Astrocytoma	G3	2000	NA	-12655	Dead	WITH TUMOR	NA	2433	NA	NA	NA	NA	1604	Stable Disease	NA	NA	1	2433	1	2433	NA	NA	1	1604	
60	TCGA-E1-5307	1	2	0	3	3	0	0	0	1	56	2	0	1	19	1	0	TCGA-E1-5307-01	108	0.27829896232527623	51	TCGA-E1-5307-01	7	12	24	0.13942593625444868	TCGA-E1-5307-01	10	12	4	26	PASS	5070	TCGA-E1-5307	LGG	62	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2000	NA	-22837	Dead	WITH TUMOR	NA	1762	NA	NA	NA	NA	1452	Stable Disease	NA	NA	1	1762	1	1762	NA	NA	1	1452	
30	TCGA-E1-5311	1	2	0	0	0	0	0	0	0	17	0	0	0	3	0	0	TCGA-E1-5311-01	49	0.3083090339547189	9	TCGA-E1-5311-01	3	3	4	0.08307379943663043	TCGA-E1-5311-01	2	0	2	4	PASS	5071	TCGA-E1-5311	LGG	31	MALE	WHITE	NA	NA	Oligodendroglioma	G3	1994	NA	-11332	Dead	WITH TUMOR	NA	4084	NA	NA	NA	NA	2602	Stable Disease	NA	NA	1	4084	1	4084	NA	NA	1	2602	
40	TCGA-E1-5318	0	3	1	0	1	1	0	0	2	33	2	0	1	6	0	0	TCGA-E1-5318-01	113	0.07943783841920493	48	TCGA-E1-5318-01	2	3	3	0.05388935110237953	TCGA-E1-5318-01	2	0	2	4	PASS	5072	TCGA-E1-5318	LGG	42	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	1997	NA	-15372	Dead	WITH TUMOR	2379	2379	NA	NA	NA	NA	362	Progressive Disease	NA	NA	1	2379	1	2379	NA	NA	1	362	
50	TCGA-E1-5319	0	2	0	0	6	0	2	0	1	26	0	0	1	13	0	0	TCGA-E1-5319-01	61	0.060609259906794576	16	TCGA-E1-5319-01	2	2	4	0.06354071999418287	TCGA-E1-5319-01	1	2	3	6	PASS	5073	TCGA-E1-5319	LGG	48	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	1998	NA	-17612	Dead	WITH TUMOR	NA	2907	NA	NA	NA	NA	923	Stable Disease	NA	NA	1	2907	1	2907	NA	NA	1	923	
40	TCGA-E1-5322	0	2	0	1	3	0	0	0	2	21	0	0	1	6	1	0	TCGA-E1-5322-01	72	0.22125738627865785	30	TCGA-E1-5322-01	3	5	9	0.06076420218205157	TCGA-E1-5322-01	5	3	4	12	PASS	5074	TCGA-E1-5322	LGG	38	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	1999	NA	-13903	Dead	NA	NA	3978	NA	NA	NA	NA	1085	Stable Disease	NA	NA	1	3978	NA	3978	NA	NA	1	1085	
60	TCGA-E1-A7YD	0	2	0	2	1	1	0	0	1	44	2	0	4	19	1	1	TCGA-E1-A7YD-01	145	0.6186925797773555	79	TCGA-E1-A7YD-01	19	20	34	0.1099052064833835	TCGA-E1-A7YD-01	6	3	2	11	PASS	5075	TCGA-E1-A7YD	LGG	57	MALE	WHITE	NA	NA	Astrocytoma	G3	1998	NA	-21020	Dead	WITH TUMOR	NA	435	NA	NA	NA	NA	284	Stable Disease	NA	NA	1	435	1	435	NA	NA	1	284	
30	TCGA-E1-A7YE	0	0	0	1	0	0	0	0	3	56	3	0	3	21	3	0	TCGA-E1-A7YE-01	97	0.8637550405889892	38	TCGA-E1-A7YE-01	4	5	46	0.1608789677414909	TCGA-E1-A7YE-01	9	4	6	19	PASS	5076	TCGA-E1-A7YE	LGG	32	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2001	NA	-11971	Dead	WITH TUMOR	NA	886	NA	NA	NA	NA	188	Stable Disease	NA	NA	1	886	1	886	NA	NA	1	188	
50	TCGA-E1-A7YH	0	1	0	0	1	0	0	0	1	21	2	0	2	7	1	0	TCGA-E1-A7YH-01	63	0.06328285602897965	26	TCGA-E1-A7YH-01	0	2	19	0.05279191377258989	TCGA-E1-A7YH-01	3	1	2	6	PASS	5077	TCGA-E1-A7YH	LGG	47	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2005	NA	-17465	Dead	WITH TUMOR	NA	2835	NA	NA	NA	NA	689	Stable Disease	NA	NA	1	2835	1	2835	NA	NA	1	689	
30	TCGA-E1-A7YI	0	0	0	1	2	0	0	0	0	36	4	0	1	8	2	0	TCGA-E1-A7YI-01	157	0.18997173057283426	86	TCGA-E1-A7YI-01	3	8	63	0.10400294166948816	TCGA-E1-A7YI-01	9	7	4	20	PASS	5078	TCGA-E1-A7YI	LGG	33	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2008	NA	-12229	Dead	WITH TUMOR	NA	111	NA	NA	NA	NA	56	[Unknown]	NA	NA	1	111	1	111	NA	NA	1	56	
60	TCGA-E1-A7YJ	0	4	0	0	2	0	1	0	2	25	3	0	0	21	1	0	TCGA-E1-A7YJ-01	134	0.16585624127814325	66	TCGA-E1-A7YJ-01	9	8	67	0.14667280997851234	TCGA-E1-A7YJ-01	6	1	4	11	PASS	5079	TCGA-E1-A7YJ	LGG	55	MALE	WHITE	NA	NA	Astrocytoma	G3	2008	NA	-20180	Dead	WITH TUMOR	NA	592	NA	NA	NA	NA	516	Stable Disease	NA	NA	1	592	1	592	NA	NA	1	516	
50	TCGA-E1-A7YK	0	3	0	5	1	0	0	0	4	45	1	0	0	12	2	0	TCGA-E1-A7YK-01	83	0.21495838497007305	33	TCGA-E1-A7YK-01	7	59	2	3.964312313549776e-05	TCGA-E1-A7YK-01	7	8	0	15	PASS	5080	TCGA-E1-A7YK	LGG	52	MALE	WHITE	NA	NA	Astrocytoma	G3	2009	NA	-19236	Dead	NA	NA	378	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	378	NA	378	NA	NA	0	378	
50	TCGA-E1-A7YL	0	2	0	0	3	0	1	0	3	44	3	0	0	14	0	0	TCGA-E1-A7YL-01	302	0.2388012414727312	223	TCGA-E1-A7YL-01	11	9	82	0.13470858562099688	TCGA-E1-A7YL-01	2	2	3	7	PASS	5081	TCGA-E1-A7YL	LGG	46	MALE	WHITE	NA	NA	Astrocytoma	G3	2009	NA	-16982	Dead	WITH TUMOR	NA	492	NA	NA	NA	NA	91	Progressive Disease	NA	NA	1	492	1	492	NA	NA	1	91	
60	TCGA-E1-A7YM	0	1	0	0	1	0	1	0	0	30	1	0	1	18	0	0	TCGA-E1-A7YM-01	63	0.18652498229810852	17	TCGA-E1-A7YM-01	6	4	31	0.1207312902534242	TCGA-E1-A7YM-01	2	5	1	8	PASS	5082	TCGA-E1-A7YM	LGG	63	MALE	WHITE	NA	NA	Astrocytoma	G3	2010	NA	-23263	Dead	WITH TUMOR	NA	648	NA	NA	NA	NA	88	Progressive Disease	NA	NA	1	648	1	648	NA	NA	1	88	
60	TCGA-E1-A7YN	0	3	0	1	1	1	0	0	0	44	6	0	1	24	0	1	TCGA-E1-A7YN-01	58	0.1500859007584343	17	TCGA-E1-A7YN-01	5	4	23	0.10487267293163673	TCGA-E1-A7YN-01	3	2	3	8	PASS	5083	TCGA-E1-A7YN	LGG	63	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2010	NA	-23180	Dead	WITH TUMOR	NA	727	NA	NA	NA	NA	420	Stable Disease	NA	NA	1	727	1	727	NA	NA	1	420	
50	TCGA-E1-A7YO	0	0	0	0	1	1	0	0	0	24	1	0	0	6	2	0	TCGA-E1-A7YO-01	64	0.06294662744005644	18	TCGA-E1-A7YO-01	2	3	12	0.05548750889670626	TCGA-E1-A7YO-01	2	0	2	4	PASS	5084	TCGA-E1-A7YO	LGG	45	MALE	WHITE	NA	NA	Oligodendroglioma	G3	1995	NA	-16770	Dead	WITH TUMOR	NA	2282	NA	NA	NA	NA	1977	Stable Disease	NA	NA	1	2282	1	2282	NA	NA	1	1977	
60	TCGA-E1-A7YQ	0	6	0	1	2	0	1	0	0	29	1	0	0	8	1	0	TCGA-E1-A7YQ-01	89	0.7210932592731059	41	TCGA-E1-A7YQ-01	28	18	77	0.3810027183130207	TCGA-E1-A7YQ-01	2	3	4	9	PASS	5085	TCGA-E1-A7YQ	LGG	58	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Oligodendroglioma	G3	2000	NA	-21341	Dead	WITH TUMOR	NA	1578	NA	NA	NA	NA	580	Stable Disease	NA	NA	1	1578	1	1578	NA	NA	1	580	
70	TCGA-E1-A7YS	0	3	1	2	2	0	0	1	4	41	1	0	2	14	4	0	TCGA-E1-A7YS-01	83	0.947117951428924	38	TCGA-E1-A7YS-01	24	12	34	0.09931258601938793	TCGA-E1-A7YS-01	4	0	4	8	PASS	5086	TCGA-E1-A7YS	LGG	71	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Oligodendroglioma	G3	2007	NA	-26159	Dead	WITH TUMOR	NA	466	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	466	1	466	NA	NA	1	466	
40	TCGA-E1-A7YU	1	0	0	0	0	0	0	0	0	19	0	0	0	7	1	0	TCGA-E1-A7YU-01	73	0.040411502335195616	20	TCGA-E1-A7YU-01	0	2	15	0.02208973994808832	TCGA-E1-A7YU-01	8	4	3	15	PASS	5087	TCGA-E1-A7YU	LGG	42	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	1996	NA	-15345	Dead	WITH TUMOR	NA	23	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	23	1	23	NA	NA	1	23	
30	TCGA-E1-A7YV	0	3	0	1	5	0	0	0	2	31	2	0	0	18	0	0	TCGA-E1-A7YV-01	83	0.6712533110254661	35	TCGA-E1-A7YV-01	10	10	27	0.09992179344869953	TCGA-E1-A7YV-01	8	7	6	21	PASS	5088	TCGA-E1-A7YV	LGG	26	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2010	NA	-9546	Dead	WITH TUMOR	NA	987	NA	NA	NA	NA	97	Progressive Disease	NA	NA	1	987	1	987	NA	NA	1	97	
30	TCGA-E1-A7YW	0	0	0	0	1	2	0	0	0	16	0	0	0	8	0	0	TCGA-E1-A7YW-01	46	0.07043658152307787	10	TCGA-E1-A7YW-01	2	4	11	0.005214531172713718	TCGA-E1-A7YW-01	7	2	0	9	PASS	5089	TCGA-E1-A7YW	LGG	28	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2002	NA	-10571	Dead	WITH TUMOR	NA	1120	NA	NA	NA	NA	409	Progressive Disease	NA	NA	1	1120	1	1120	NA	NA	1	409	
30	TCGA-E1-A7YY	0	0	0	0	0	0	1	0	0	6	0	0	0	2	1	0	TCGA-E1-A7YY-01	47	0.06894206110225354	10	TCGA-E1-A7YY-01	2	2	19	0.07188175072893288	TCGA-E1-A7YY-01	2	4	3	9	PASS	5090	TCGA-E1-A7YY	LGG	27	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	1998	NA	-9867	Dead	WITH TUMOR	NA	4445	NA	NA	NA	NA	958	Stable Disease	NA	NA	1	4445	1	4445	NA	NA	1	958	
60	TCGA-E1-A7Z2	0	1	0	1	2	0	0	0	0	27	1	0	0	14	0	0	TCGA-E1-A7Z2-01	203	0.22938095399131894	134	TCGA-E1-A7Z2-01	7	9	103	0.16778711582485614	TCGA-E1-A7Z2-01	3	4	7	14	PASS	5091	TCGA-E1-A7Z2	LGG	58	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-21341	Dead	WITH TUMOR	NA	398	NA	NA	NA	NA	213	Progressive Disease	NA	NA	1	398	1	398	NA	NA	1	213	
30	TCGA-E1-A7Z3	1	1	0	0	3	0	4	0	1	16	0	0	1	10	1	1	TCGA-E1-A7Z3-01	62	0.07432746792777825	18	TCGA-E1-A7Z3-01	1	3	7	0.006696130711959458	TCGA-E1-A7Z3-01	2	2	1	5	PASS	5092	TCGA-E1-A7Z3	LGG	31	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Astrocytoma	G2	1992	NA	-11330	Dead	WITH TUMOR	NA	2235	NA	NA	NA	NA	1569	Progressive Disease	NA	NA	1	2235	1	2235	NA	NA	1	1569	
40	TCGA-E1-A7Z4	0	2	0	0	1	1	0	0	1	14	2	0	0	5	0	0	TCGA-E1-A7Z4-01	64	0.09721100818974752	22	TCGA-E1-A7Z4-01	1	2	19	0.04069289683111317	TCGA-E1-A7Z4-01	4	4	3	11	PASS	5093	TCGA-E1-A7Z4	LGG	35	MALE	WHITE	NA	NA	Astrocytoma	G2	1999	NA	-12849	Dead	WITH TUMOR	NA	4412	NA	NA	NA	NA	846	Progressive Disease	NA	NA	1	4412	1	4412	NA	NA	1	846	
40	TCGA-E1-A7Z6	0	3	0	1	1	0	0	0	0	15	1	0	0	9	0	0	TCGA-E1-A7Z6-01	63	0.025972382057820518	17	TCGA-E1-A7Z6-01	1	2	15	0.019984028160950004	TCGA-E1-A7Z6-01	3	3	2	8	PASS	5094	TCGA-E1-A7Z6	LGG	41	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2009	NA	-14985	Dead	WITH TUMOR	NA	984	NA	NA	NA	NA	294	Progressive Disease	NA	NA	1	984	1	984	NA	NA	1	294	
50	TCGA-EZ-7264	0	1	0	0	0	0	1	0	0	26	1	0	2	7	1	0	TCGA-EZ-7264-01	48	0.947111641630776	8	TCGA-EZ-7264-01	5	5	8	0.17729813595767807	TCGA-EZ-7264-01	4	1	4	9	PASS	5095	TCGA-EZ-7264	LGG	47	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-17432	Alive	WITH TUMOR	1201	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1201	0	1201	NA	NA	0	1201	
30	TCGA-F6-A8O3	0	0	0	1	1	0	0	0	2	16	1	0	0	7	2	0	TCGA-F6-A8O3-01	65	0.7205265775433691	23	TCGA-F6-A8O3-01	4	3	39	0.1260907314443177	TCGA-F6-A8O3-01	2	0	2	4	PASS	5096	TCGA-F6-A8O3	LGG	34	MALE	ASIAN	NA	NA	Oligodendroglioma	G2	2013	NA	-12578	Alive	TUMOR FREE	7	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	7	0	7	0	7	0	7	
40	TCGA-F6-A8O4	0	3	0	0	2	1	0	0	0	26	0	0	1	7	0	0	TCGA-F6-A8O4-01	77	0.1161017503196999	36	TCGA-F6-A8O4-01	0	3	8	0.013124190788666782	TCGA-F6-A8O4-01	4	4	1	9	PASS	5097	TCGA-F6-A8O4	LGG	44	MALE	ASIAN	NA	NA	Astrocytoma	G2	2013	NA	-16202	Alive	TUMOR FREE	6	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	6	0	6	0	6	0	6	
50	TCGA-FG-5962	1	1	0	1	2	0	1	0	0	32	2	0	1	7	0	0	TCGA-FG-5962-01	81	0.5153295199871234	30	TCGA-FG-5962-01	3	3	4	0.08958066325580204	TCGA-FG-5962-01	2	0	2	4	PASS	5098	TCGA-FG-5962	LGG	54	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2009	NA	-19818	Alive	WITH TUMOR	1453	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1453	0	1453	NA	NA	0	1453	
30	TCGA-FG-5963	0	0	0	0	1	2	0	0	0	51	2	0	0	5	4	0	TCGA-FG-5963-01	461	0.30112560467790417	377	TCGA-FG-5963-02	30	10	268	0.29551861524547873	TCGA-FG-5963-02	12	8	14	34	mutation call filter	5099	TCGA-FG-5963	LGG	23	MALE	WHITE	NA	NA	Astrocytoma	G3	2009	NA	-8571	Dead	WITH TUMOR	NA	775	NA	NA	NA	NA	395	Progressive Disease	NA	NA	1	775	1	775	NA	NA	1	395	
60	TCGA-FG-5964	0	2	0	2	6	1	8	0	0	21	2	0	0	7	1	0	TCGA-FG-5964-01	72	0.17596880454744662	25	TCGA-FG-5964-01	5	6	8	0.1664170477567313	TCGA-FG-5964-01	4	2	4	10	PASS	5100	TCGA-FG-5964	LGG	62	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2010	NA	-22735	Alive	WITH TUMOR	1588	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1588	0	1588	NA	NA	0	1588	
40	TCGA-FG-5965	0	1	1	2	3	1	0	0	6	85	4	0	0	34	5	0	TCGA-FG-5965-01	87	0.08230646188694522	38	TCGA-FG-5965-01	2	6	14	0.04359103298995961	TCGA-FG-5965-01	7	3	4	14	mutation call filter	5101	TCGA-FG-5965	LGG	39	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2008	NA	-14249	Dead	WITH TUMOR	NA	1120	NA	NA	NA	NA	715	Stable Disease	NA	NA	1	1120	1	1120	NA	NA	1	715	
60	TCGA-FG-6688	1	3	0	1	4	0	1	0	1	46	7	0	3	18	0	0	TCGA-FG-6688-01	57	0.13708665835296385	19	TCGA-FG-6688-01	4	3	8	0.08647689951816548	TCGA-FG-6688-01	1	3	2	6	PASS	5102	TCGA-FG-6688	LGG	59	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Astrocytoma	G3	2010	NA	-21745	Alive	WITH TUMOR	571	NA	NA	NA	NA	NA	405	Progressive Disease	NA	NA	0	571	0	571	NA	NA	1	405	
30	TCGA-FG-6689	0	0	0	0	1	1	1	0	0	17	4	0	1	5	0	0	TCGA-FG-6689-01	53	0.0696657436239815	15	TCGA-FG-6689-01	3	3	3	0.0678833566956087	TCGA-FG-6689-01	3	0	3	6	PASS	5103	TCGA-FG-6689	LGG	30	MALE	WHITE	NA	NA	Astrocytoma	G2	2011	NA	-11312	Alive	WITH TUMOR	454	NA	NA	NA	NA	NA	119	Progressive Disease	NA	NA	0	454	0	454	NA	NA	1	119	
70	TCGA-FG-6690	0	2	0	0	0	0	0	0	2	29	2	0	0	9	0	0	TCGA-FG-6690-01	95	0.054411715282822036	44	TCGA-FG-6690-01	0	1	5	0.002659846925234137	TCGA-FG-6690-01	2	1	0	3	PASS	5104	TCGA-FG-6690	LGG	70	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-25667	Alive	WITH TUMOR	1294	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1294	0	1294	NA	NA	0	1294	
30	TCGA-FG-6691	0	4	0	0	0	1	1	0	2	13	1	0	0	5	0	0	TCGA-FG-6691-01	64	0.09317283748576928	27	TCGA-FG-6691-01	3	2	4	0.0013233352241262188	TCGA-FG-6691-01	1	1	0	2	PASS	5105	TCGA-FG-6691	LGG	23	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2011	NA	-8403	Alive	WITH TUMOR	1257	NA	NA	NA	NA	NA	913	Complete Remission/Response	NA	NA	0	1257	0	1257	1	913	1	913	
60	TCGA-FG-6692	1	6	1	1	1	0	0	0	2	58	1	0	1	30	1	0	TCGA-FG-6692-01	98	0.17542857563873118	48	TCGA-FG-6692-01	7	4	17	0.07649262180820142	TCGA-FG-6692-01	2	0	1	3	PASS	5106	TCGA-FG-6692	LGG	63	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2011	NA	-23374	Dead	WITH TUMOR	NA	561	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	561	1	561	NA	NA	1	561	
30	TCGA-FG-7634	0	0	0	0	1	0	0	0	1	14	1	0	1	6	0	0	TCGA-FG-7634-01	75	0.335227529734767	26	TCGA-FG-7634-01	2	2	4	0.05553678241014063	TCGA-FG-7634-01	1	0	2	3	PASS	5107	TCGA-FG-7634	LGG	28	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2008	NA	-10476	Alive	WITH TUMOR	467	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	467	0	467	NA	NA	0	467	
50	TCGA-FG-7636	0	2	0	2	2	1	0	0	2	33	1	0	0	11	1	1	TCGA-FG-7636-01	135	0.2418840758148125	79	TCGA-FG-7636-01	3	4	4	0.0030506430405169444	TCGA-FG-7636-01	5	1	0	6	PASS	5108	TCGA-FG-7636	LGG	48	MALE	WHITE	NA	NA	Astrocytoma	G3	2011	NA	-17843	Alive	TUMOR FREE	544	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	544	0	544	0	544	0	544	
50	TCGA-FG-7637	0	1	0	0	1	1	0	0	3	22	5	0	0	9	0	0	TCGA-FG-7637	0	0	0	TCGA-FG-7637	0	0	0	0	TCGA-FG-7637	0	0	0	0	PASS	5109	TCGA-FG-7637	LGG	49	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2009	NA	-18084	Alive	WITH TUMOR	1219	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1219	0	1219	NA	NA	0	1219	
30	TCGA-FG-7638	0	0	0	0	0	0	0	0	1	14	0	0	0	9	0	0	TCGA-FG-7638-01	83	0.16728688665034858	39	TCGA-FG-7638-01	2	2	4	0.05382495353576989	TCGA-FG-7638-01	2	0	3	5	PASS	5110	TCGA-FG-7638	LGG	31	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2011	NA	-11528	Alive	WITH TUMOR	686	NA	NA	NA	NA	NA	407	Stable Disease	NA	NA	0	686	0	686	NA	NA	1	407	
30	TCGA-FG-7641	0	0	0	0	0	0	0	0	1	25	0	0	0	9	0	0	TCGA-FG-7641-01	55	0.1209994399380786	16	TCGA-FG-7641-01	3	3	3	0.08958326782801204	TCGA-FG-7641-01	2	0	2	4	PASS	5111	TCGA-FG-7641	LGG	31	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-11357	Alive	TUMOR FREE	627	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	627	0	627	0	627	0	627	
50	TCGA-FG-7643	0	2	1	0	0	2	0	0	2	40	4	0	1	19	0	0	TCGA-FG-7643-01	57	0.15727994038038073	15	TCGA-FG-7643-01	7	5	3	0.08674469688336188	TCGA-FG-7643-01	1	1	1	3	PASS	5112	TCGA-FG-7643	LGG	49	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2011	NA	-18206	Alive	WITH TUMOR	611	NA	NA	NA	NA	NA	254	Stable Disease	NA	NA	0	611	0	611	NA	NA	1	254	
30	TCGA-FG-8181	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	TCGA-FG-8181-01	43	6.9838521770822145e-06	10	TCGA-FG-8181-01	0	0	0	0.0	TCGA-FG-8181-01	0	0	0	0	PASS	5113	TCGA-FG-8181	LGG	23	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2012	NA	-8642	Alive	WITH TUMOR	862	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	862	0	862	NA	NA	0	862	
40	TCGA-FG-8182	0	1	0	0	0	2	0	0	0	22	2	0	1	10	2	0	TCGA-FG-8182-01	47	0.019481441410774892	11	TCGA-FG-8182-01	2	3	3	0.028973326816967168	TCGA-FG-8182-01	3	2	1	6	PASS	5114	TCGA-FG-8182	LGG	35	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-12972	Alive	WITH TUMOR	416	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	416	0	416	NA	NA	0	416	
40	TCGA-FG-8185	0	1	0	0	1	0	0	0	0	34	0	0	0	15	0	0	TCGA-FG-8185-01	130	0.1350441237635399	72	TCGA-FG-8185-01	1	4	6	0.03276547586581495	TCGA-FG-8185-01	6	3	2	11	PASS	5115	TCGA-FG-8185	LGG	37	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-13621	Alive	TUMOR FREE	433	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	433	0	433	0	433	0	433	
40	TCGA-FG-8186	1	0	0	1	0	0	0	0	0	30	2	0	0	7	1	0	TCGA-FG-8186-01	66	0.07737377079371162	18	TCGA-FG-8186-01	2	4	3	0.054429125839554816	TCGA-FG-8186-01	3	1	2	6	PASS	5116	TCGA-FG-8186	LGG	42	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2011	NA	-15431	Alive	WITH TUMOR	487	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	487	0	487	NA	NA	0	487	
30	TCGA-FG-8187	0	0	0	1	0	0	1	0	0	11	1	0	1	8	0	0	TCGA-FG-8187-01	67	0.057260413247248974	25	TCGA-FG-8187-01	2	2	2	0.05385345412147555	TCGA-FG-8187-01	2	0	2	4	PASS	5117	TCGA-FG-8187	LGG	31	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2011	NA	-11684	Alive	TUMOR FREE	611	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	611	0	611	0	611	0	611	
40	TCGA-FG-8188	0	0	0	0	2	0	0	0	0	24	1	0	0	14	1	0	TCGA-FG-8188-01	61	0.0996644185361746	19	TCGA-FG-8188-01	2	5	4	0.012314973155018644	TCGA-FG-8188-01	5	5	0	10	PASS	5118	TCGA-FG-8188	LGG	41	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2012	NA	-15051	Alive	WITH TUMOR	455	NA	NA	NA	NA	NA	384	Stable Disease	NA	NA	0	455	0	455	NA	NA	1	384	
30	TCGA-FG-8189	0	0	0	0	0	0	0	0	0	7	0	0	0	3	1	0	TCGA-FG-8189-01	57	6.081761425261478e-06	16	TCGA-FG-8189	0	0	0	0	TCGA-FG-8189	0	0	0	0	PASS	5119	TCGA-FG-8189	LGG	33	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-12384	Alive	WITH TUMOR	685	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	685	0	685	NA	NA	0	685	
30	TCGA-FG-8191	0	0	0	1	0	0	0	0	1	19	1	0	1	7	3	0	TCGA-FG-8191-01	54	0.03941587807369	13	TCGA-FG-8191-01	0	2	3	0.020348620413261687	TCGA-FG-8191-01	1	1	1	3	PASS	5120	TCGA-FG-8191	LGG	30	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2011	NA	-11252	Alive	WITH TUMOR	992	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	992	0	992	NA	NA	0	992	
30	TCGA-FG-A4MT	0	0	0	1	2	0	0	0	1	32	2	0	0	5	0	0	TCGA-FG-A4MT-01	64	0.12848642934953122	18	TCGA-FG-A4MT-02	1	3	25	0.06954630185738607	TCGA-FG-A4MT-02	3	1	4	8	mutation call filter	5121	TCGA-FG-A4MT	LGG	27	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2010	NA	-10082	Alive	TUMOR FREE	1164	NA	NA	NA	NA	NA	499	Complete Remission/Response	NA	NA	0	1164	0	1164	1	499	1	499	
60	TCGA-FG-A4MU	0	1	0	0	1	1	0	0	0	47	2	0	1	25	0	0	TCGA-FG-A4MU-01	96	0.14798698841522198	43	TCGA-FG-A4MU-01	8	4	17	0.05137948127003211	TCGA-FG-A4MU-01	0	2	0	2	PASS	5122	TCGA-FG-A4MU	LGG	58	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2012	NA	-21450	Alive	WITH TUMOR	326	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	326	0	326	NA	NA	0	326	
60	TCGA-FG-A4MW	0	3	0	1	3	1	2	0	2	47	3	0	2	33	3	1	TCGA-FG-A4MW-01	99	0.1685542603702926	40	TCGA-FG-A4MW-01	7	5	24	0.10084583773936527	TCGA-FG-A4MW-01	2	2	2	6	PASS	5123	TCGA-FG-A4MW	LGG	63	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2012	NA	-23077	Dead	WITH TUMOR	NA	559	NA	NA	NA	NA	226	Stable Disease	NA	NA	1	559	1	559	NA	NA	1	226	
50	TCGA-FG-A4MX	0	2	0	0	1	0	0	0	1	22	1	0	0	2	0	0	TCGA-FG-A4MX-01	94	0.03382242245307098	51	TCGA-FG-A4MX-01	0	1	28	0.04199064274295347	TCGA-FG-A4MX-01	3	2	3	8	PASS	5124	TCGA-FG-A4MX	LGG	47	MALE	WHITE	NA	NA	Astrocytoma	G2	2012	NA	-17381	Alive	TUMOR FREE	569	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	569	0	569	0	569	0	569	
40	TCGA-FG-A4MY	0	1	2	0	1	1	0	0	0	24	0	0	1	6	0	0	TCGA-FG-A4MY-01	84	0.2250193597668077	35	TCGA-FG-A4MY-01	2	4	9	0.012747235768962594	TCGA-FG-A4MY-01	10	11	1	22	PASS	5125	TCGA-FG-A4MY	LGG	44	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2012	NA	-16310	Alive	WITH TUMOR	721	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	721	0	721	NA	NA	0	721	
50	TCGA-FG-A60J	0	2	0	0	0	0	0	0	0	31	3	0	1	9	2	0	TCGA-FG-A60J-01	57	0.05394683599032641	15	TCGA-FG-A60J-01	2	4	8	0.04802720404062615	TCGA-FG-A60J-01	1	1	0	2	PASS	5126	TCGA-FG-A60J	LGG	47	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2012	NA	-17339	Alive	TUMOR FREE	449	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	449	0	449	0	449	0	449	
30	TCGA-FG-A60K	0	1	0	0	0	2	1	0	2	20	0	0	0	2	0	0	TCGA-FG-A60K-01	81	0.08987963889090514	35	TCGA-FG-A60K-01	2	3	14	0.0545279822208395	TCGA-FG-A60K-01	2	0	2	4	PASS	5127	TCGA-FG-A60K	LGG	34	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2012	NA	-12445	Alive	WITH TUMOR	542	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	542	0	542	NA	NA	0	542	
30	TCGA-FG-A60L	0	2	0	0	0	1	0	0	2	20	2	0	1	3	1	0	TCGA-FG-A60L-01	109	0.10799425650736584	55	TCGA-FG-A60L-01	3	5	34	0.060196122493681725	TCGA-FG-A60L-01	5	2	2	9	PASS	5128	TCGA-FG-A60L	LGG	34	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2012	NA	-12580	Alive	TUMOR FREE	655	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	655	0	655	0	655	0	655	
60	TCGA-FG-A6IZ	0	1	0	1	2	0	2	0	2	48	2	0	0	22	2	0	TCGA-FG-A6IZ-01	61	0.8894278134259294	20	TCGA-FG-A6IZ-01	3	3	39	0.11419549842564453	TCGA-FG-A6IZ-01	2	1	3	6	PASS	5129	TCGA-FG-A6IZ	LGG	60	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2013	NA	-22275	Alive	TUMOR FREE	457	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	457	0	457	0	457	0	457	
40	TCGA-FG-A6J1	0	3	0	0	0	1	0	0	0	19	1	0	0	14	1	0	TCGA-FG-A6J1-01	59	0.1689485896455875	19	TCGA-FG-A6J1-01	4	4	13	0.054913742173949	TCGA-FG-A6J1-01	2	0	2	4	PASS	5130	TCGA-FG-A6J1	LGG	44	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2013	NA	-16106	Alive	WITH TUMOR	500	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	500	0	500	NA	NA	0	500	
50	TCGA-FG-A6J3	0	2	1	3	0	1	1	0	3	62	4	0	3	19	0	0	TCGA-FG-A6J3-01	289	0.7598136159445722	181	TCGA-FG-A6J3-01	8	16	64	0.06975223799870703	TCGA-FG-A6J3-01	14	17	3	34	PASS	5131	TCGA-FG-A6J3	LGG	52	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-19138	Alive	WITH TUMOR	677	NA	NA	NA	NA	NA	285	Progressive Disease	NA	NA	0	677	0	677	NA	NA	1	285	
30	TCGA-FG-A70Y	0	0	1	0	0	0	1	0	1	14	1	0	1	5	0	0	TCGA-FG-A70Y-01	74	0.05369490766412946	33	TCGA-FG-A70Y-01	0	1	22	0.02205580158295093	TCGA-FG-A70Y-01	2	5	1	8	PASS	5132	TCGA-FG-A70Y	LGG	20	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-7421	Alive	WITH TUMOR	868	NA	NA	NA	NA	NA	490	Complete Remission/Response	NA	NA	0	868	0	868	1	490	1	490	
50	TCGA-FG-A70Z	0	5	0	1	0	0	0	0	3	38	5	0	2	23	3	1	TCGA-FG-A70Z-01	189	0.14353462734973452	125	TCGA-FG-A70Z-01	5	3	62	0.09324746581344856	TCGA-FG-A70Z-01	0	1	0	1	PASS	5133	TCGA-FG-A70Z	LGG	53	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Oligoastrocytoma	G3	2011	NA	-19717	Alive	WITH TUMOR	328	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	328	0	328	NA	NA	0	328	
50	TCGA-FG-A710	0	2	1	0	1	0	1	0	1	27	4	0	1	14	0	0	TCGA-FG-A710-01	79	0.060682201301914276	30	TCGA-FG-A710-01	2	2	21	0.05578198031268435	TCGA-FG-A710-01	1	1	2	4	PASS	5134	TCGA-FG-A710	LGG	50	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-18415	Alive	WITH TUMOR	1115	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1115	0	1115	NA	NA	0	1115	
30	TCGA-FG-A711	1	4	0	0	2	0	0	0	3	30	2	0	0	12	2	0	TCGA-FG-A711-01	61	0.06251436917128414	20	TCGA-FG-A711-01	1	3	15	0.04107643008020192	TCGA-FG-A711-01	6	5	3	14	PASS	5135	TCGA-FG-A711	LGG	33	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2010	NA	-12248	Dead	WITH TUMOR	NA	1481	NA	NA	NA	NA	347	Progressive Disease	NA	NA	1	1481	1	1481	NA	NA	1	347	
70	TCGA-FG-A713	0	1	0	0	2	0	0	0	0	21	1	0	1	13	1	0	TCGA-FG-A713-01	54	0.0968775170089452	15	TCGA-FG-A713-01	2	3	13	0.05501766333012088	TCGA-FG-A713-01	3	1	2	6	PASS	5136	TCGA-FG-A713	LGG	74	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2013	NA	-27232	Alive	TUMOR FREE	622	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	622	0	622	0	622	0	622	
40	TCGA-FG-A87N	0	1	0	1	1	1	1	0	1	19	1	0	0	10	3	0	TCGA-FG-A87N-01	94	0.07281859822283432	45	TCGA-FG-A87N-01	2	7	38	0.06957608649842359	TCGA-FG-A87N-01	3	4	5	12	PASS	5137	TCGA-FG-A87N	LGG	37	FEMALE	ASIAN	NA	NA	Astrocytoma	G3	2013	NA	-13606	Alive	WITH TUMOR	567	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	567	0	567	NA	NA	0	567	
60	TCGA-FG-A87Q	0	2	0	1	1	1	0	0	2	51	1	0	2	20	1	0	TCGA-FG-A87Q-01	133	0.1964709258118489	63	TCGA-FG-A87Q-01	8	6	55	0.11662391280646715	TCGA-FG-A87Q-01	4	4	2	10	PASS	5138	TCGA-FG-A87Q	LGG	61	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-22565	Alive	TUMOR FREE	174	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	174	0	174	0	174	0	174	
30	TCGA-FN-7833	0	0	0	1	2	2	0	0	0	17	0	0	0	4	0	0	TCGA-FN-7833-01	100	0.02122074421624253	46	TCGA-FN-7833-01	0	1	2	0.02071675361378317	TCGA-FN-7833-01	1	1	1	3	PASS	5139	TCGA-FN-7833	LGG	25	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2011	NA	-9228	Alive	TUMOR FREE	837	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	837	0	837	0	837	0	837	
50	TCGA-HT-7467	1	1	0	0	2	1	0	0	0	23	4	0	0	7	0	0	TCGA-HT-7467-01	75	0.11672098174948252	30	TCGA-HT-7467-01	4	4	4	0.05446963889201264	TCGA-HT-7467-01	2	0	2	4	PASS	5140	TCGA-HT-7467	LGG	54	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-19944	Alive	TUMOR FREE	3	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3	0	3	0	3	0	3	
30	TCGA-HT-7468	0	1	0	0	1	0	0	0	0	13	1	0	0	2	0	0	TCGA-HT-7468-01	80	0.21228239613194885	33	TCGA-HT-7468-01	3	3	5	0.08234725442473033	TCGA-HT-7468-01	2	0	2	4	PASS	5141	TCGA-HT-7468	LGG	30	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2011	NA	-11209	Alive	TUMOR FREE	203	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	203	0	203	NA	NA	0	203	
30	TCGA-HT-7469	1	2	0	1	3	0	0	0	0	20	2	0	0	19	2	1	TCGA-HT-7469-01	110	0.8701155825868566	48	TCGA-HT-7469-01	5	7	6	0.08754425462929748	TCGA-HT-7469-01	8	6	4	18	PASS	5142	TCGA-HT-7469	LGG	30	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2011	NA	-11097	Dead	WITH TUMOR	NA	351	NA	NA	NA	NA	92	Progressive Disease	NA	NA	1	351	1	351	NA	NA	1	92	
40	TCGA-HT-7470	0	1	0	0	1	2	0	0	0	33	3	0	0	12	0	0	TCGA-HT-7470-01	163	0.09994918262631636	95	TCGA-HT-7470-01	3	5	2	0.00047279874308939446	TCGA-HT-7470-01	6	8	0	14	PASS	5143	TCGA-HT-7470	LGG	37	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2011	NA	-13611	Dead	TUMOR FREE	NA	1220	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1220	0	1220	0	1220	0	1220	
40	TCGA-HT-7471	0	0	0	1	1	1	0	0	0	11	3	0	1	8	0	0	TCGA-HT-7471-01	65	0.9476526862028948	20	TCGA-HT-7471-01	2	2	5	0.05389870883446087	TCGA-HT-7471-01	2	0	2	4	PASS	5144	TCGA-HT-7471	LGG	37	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2010	NA	-13564	Alive	TUMOR FREE	4	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4	0	4	NA	NA	0	4	
40	TCGA-HT-7472	0	3	1	0	2	0	0	0	1	14	1	0	0	8	0	0	TCGA-HT-7472-01	131	0.05534253653832763	79	TCGA-HT-7472-01	0	0	4	0.018404213084259945	TCGA-HT-7472-01	2	2	1	5	PASS	5145	TCGA-HT-7472	LGG	38	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2010	NA	-13968	Alive	TUMOR FREE	1	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1	0	1	NA	NA	0	1	
30	TCGA-HT-7473	1	0	0	0	0	1	0	0	3	17	0	0	0	4	0	0	TCGA-HT-7473-01	149	0.1466657238454857	96	TCGA-HT-7473-01	4	3	4	0.012377862739016062	TCGA-HT-7473-01	6	3	1	10	PASS	5146	TCGA-HT-7473	LGG	28	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2010	NA	-10306	Alive	TUMOR FREE	503	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	503	0	503	0	503	0	503	
50	TCGA-HT-7474	0	1	0	2	1	1	1	0	0	19	0	0	1	9	0	0	TCGA-HT-7474-01	65	0.11733169243956328	24	TCGA-HT-7474-01	2	3	4	0.02338458094860064	TCGA-HT-7474-01	2	2	1	5	PASS	5147	TCGA-HT-7474	LGG	52	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2011	NA	-19149	Alive	TUMOR FREE	114	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	114	0	114	NA	NA	0	114	
70	TCGA-HT-7475	0	3	0	1	5	0	0	0	3	38	2	0	0	15	3	0	TCGA-HT-7475-01	128	0.1845572922519284	66	TCGA-HT-7475-01	4	10	11	0.11967928606243465	TCGA-HT-7475-01	9	7	6	22	PASS	5148	TCGA-HT-7475	LGG	67	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2010	NA	-24686	Alive	TUMOR FREE	530	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	530	0	530	0	530	0	530	
30	TCGA-HT-7476	1	1	0	1	1	0	0	0	3	30	3	0	2	7	1	1	TCGA-HT-7476-01	132	0.23881188787269705	79	TCGA-HT-7476-01	3	2	18	0.03586866788677192	TCGA-HT-7476-01	5	2	1	8	PASS	5149	TCGA-HT-7476	LGG	26	MALE	WHITE	NA	NA	Astrocytoma	G2	2011	NA	-9614	Alive	TUMOR FREE	199	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	199	0	199	NA	NA	0	199	
60	TCGA-HT-7477	0	4	0	0	0	0	0	0	1	38	0	0	1	15	1	0	TCGA-HT-7477-01	543	0.8602895289335497	408	TCGA-HT-7477-01	13	29	98	0.0610618274320356	TCGA-HT-7477-01	19	12	3	34	PASS	5150	TCGA-HT-7477	LGG	62	MALE	WHITE	NA	NA	Astrocytoma	G3	2011	NA	-22948	Alive	TUMOR FREE	738	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	738	0	738	0	738	0	738	
40	TCGA-HT-7478	1	0	1	2	1	0	0	0	0	22	1	0	0	5	1	0	TCGA-HT-7478-01	60	0.08970868823563455	19	TCGA-HT-7478-01	2	2	6	0.05910963496080712	TCGA-HT-7478-01	6	3	3	12	PASS	5151	TCGA-HT-7478	LGG	36	MALE	WHITE	NA	NA	Astrocytoma	G2	2011	NA	-13216	Alive	TUMOR FREE	194	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	194	0	194	0	194	0	194	
40	TCGA-HT-7479	1	8	0	1	2	0	0	0	1	20	0	0	1	5	0	0	TCGA-HT-7479-01	50	0.06519627032298655	15	TCGA-HT-7479-01	3	2	19	0.00035793073994145523	TCGA-HT-7479-01	0	0	0	0	PASS	5152	TCGA-HT-7479	LGG	44	MALE	WHITE	NA	NA	Astrocytoma	G3	2011	NA	-16137	Alive	TUMOR FREE	1227	NA	NA	NA	NA	NA	705	Complete Remission/Response	NA	NA	0	1227	0	1227	1	705	1	705	
30	TCGA-HT-7480	0	2	0	1	2	0	0	0	0	21	1	0	0	11	1	0	TCGA-HT-7480-01	50	0.2182455453994622	13	TCGA-HT-7480-01	3	3	4	0.08319680504121084	TCGA-HT-7480-01	2	0	2	4	PASS	5153	TCGA-HT-7480	LGG	33	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2005	NA	-12291	Alive	WITH TUMOR	2287	NA	NA	NA	NA	NA	1943	Stable Disease	NA	NA	0	2287	0	2287	NA	NA	1	1943	
40	TCGA-HT-7481	0	1	0	1	0	0	5	0	1	24	1	0	0	2	0	0	TCGA-HT-7481-01	57	0.05168565302412465	16	TCGA-HT-7481-01	2	2	7	0.05449861154081463	TCGA-HT-7481-01	2	0	2	4	PASS	5154	TCGA-HT-7481	LGG	39	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2006	NA	-14306	Alive	WITH TUMOR	2918	NA	NA	NA	NA	NA	880	Stable Disease	NA	NA	0	2918	0	2918	NA	NA	1	880	
20	TCGA-HT-7482	0	3	0	0	0	0	0	0	1	12	1	1	0	6	0	0	TCGA-HT-7482-01	61	0.11167063092117553	18	TCGA-HT-7482-01	4	4	4	0.05095585084992458	TCGA-HT-7482-01	1	1	1	3	PASS	5155	TCGA-HT-7482	LGG	18	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2005	NA	-6857	Alive	TUMOR FREE	3253	NA	NA	NA	NA	NA	374	Partial Remission/Response	NA	NA	0	3253	0	3253	NA	NA	1	374	
20	TCGA-HT-7483	0	0	0	0	0	0	0	0	0	15	2	0	0	4	1	0	TCGA-HT-7483-01	84	0.04261188956108145	33	TCGA-HT-7483-01	1	2	10	0.02147756589885496	TCGA-HT-7483-01	4	3	2	9	PASS	5156	TCGA-HT-7483	LGG	14	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	1998	NA	-5267	Alive	TUMOR FREE	5255	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	5255	0	5255	0	5255	0	5255	
40	TCGA-HT-7485	0	3	0	1	0	0	0	0	0	12	1	0	0	2	0	0	TCGA-HT-7485-01	67	0.013419597046757176	25	TCGA-HT-7485-01	0	0	10	0.013730215672419516	TCGA-HT-7485-01	2	1	1	4	PASS	5157	TCGA-HT-7485	LGG	42	MALE	WHITE	NA	NA	Astrocytoma	G2	2006	NA	-15589	Alive	TUMOR FREE	122	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	122	0	122	0	122	0	122	
30	TCGA-HT-7601	0	0	0	0	1	0	0	0	0	19	1	0	1	8	1	1	TCGA-HT-7601-01	49	0.045283085865416815	12	TCGA-HT-7601-01	1	2	6	0.025833326163500283	TCGA-HT-7601-01	3	2	2	7	PASS	5158	TCGA-HT-7601	LGG	30	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2008	NA	-10989	Alive	TUMOR FREE	153	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	153	0	153	NA	NA	0	153	
30	TCGA-HT-7602	0	0	0	0	0	0	0	0	1	9	2	0	0	2	0	0	TCGA-HT-7602-01	73	0.0006776265282880475	28	TCGA-HT-7602-01	0	0	19	1.3178472665825813e-05	TCGA-HT-7602-01	0	0	0	0	PASS	5159	TCGA-HT-7602	LGG	21	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2008	NA	-7946	Alive	TUMOR FREE	908	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	908	0	908	NA	NA	0	908	
30	TCGA-HT-7603	0	1	0	0	0	0	0	0	1	23	4	0	0	9	0	0	TCGA-HT-7603-01	86	0.03814790925598615	40	TCGA-HT-7603-01	0	1	12	0.031939284698173434	TCGA-HT-7603-01	1	4	3	8	PASS	5160	TCGA-HT-7603	LGG	29	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2008	NA	-10883	Alive	TUMOR FREE	705	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	705	0	705	0	705	0	705	
50	TCGA-HT-7604	0	1	0	0	1	1	1	0	3	33	3	0	0	13	0	0	TCGA-HT-7604-01	109	0.11137980057750974	49	TCGA-HT-7604-01	1	2	13	0.01152441858776926	TCGA-HT-7604-01	3	4	1	8	PASS	5161	TCGA-HT-7604	LGG	50	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Astrocytoma	G2	2003	NA	-18443	Alive	TUMOR FREE	3725	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	3725	0	3725	NA	NA	0	3725	
40	TCGA-HT-7605	0	0	0	0	1	0	0	0	0	21	3	0	0	12	2	0	TCGA-HT-7605-01	85	0.06741959916042987	38	TCGA-HT-7605-01	2	2	3	0.05443072573398844	TCGA-HT-7605-01	2	0	2	4	PASS	5162	TCGA-HT-7605	LGG	38	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2008	NA	-13892	Alive	NA	139	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	139	0	139	NA	NA	0	139	
30	TCGA-HT-7606	0	4	0	1	1	0	0	0	0	23	0	0	0	12	0	0	TCGA-HT-7606-01	94	0.9668311487059849	36	TCGA-HT-7606-01	2	6	19	0.14040896828767596	TCGA-HT-7606-01	8	6	7	21	PASS	5163	TCGA-HT-7606	LGG	30	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2008	NA	-11233	Alive	TUMOR FREE	526	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	526	0	526	0	526	0	526	
60	TCGA-HT-7607	0	4	0	0	1	0	0	0	0	27	1	0	0	6	0	0	TCGA-HT-7607-01	59	0.08438245982776307	17	TCGA-HT-7607-01	3	3	3	0.06358189212229909	TCGA-HT-7607-01	3	1	3	7	PASS	5164	TCGA-HT-7607	LGG	61	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2008	NA	-22585	Dead	WITH TUMOR	NA	96	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	96	1	96	NA	NA	1	96	
60	TCGA-HT-7608	0	2	0	1	0	2	0	0	0	14	1	0	0	9	2	0	TCGA-HT-7608-01	61	0.059850655841859786	24	TCGA-HT-7608-01	2	2	2	0.05442967248623848	TCGA-HT-7608-01	2	0	2	4	PASS	5165	TCGA-HT-7608	LGG	61	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Oligoastrocytoma	G2	2007	NA	-22302	Alive	TUMOR FREE	671	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	671	0	671	NA	NA	0	671	
30	TCGA-HT-7609	0	1	0	1	0	0	0	0	0	23	1	0	0	9	1	0	TCGA-HT-7609-01	66	0.08073152807951929	22	TCGA-HT-7609-01	0	1	3	0.025245506811602543	TCGA-HT-7609-01	2	1	1	4	PASS	5166	TCGA-HT-7609	LGG	34	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2007	NA	-12607	Alive	TUMOR FREE	1399	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1399	0	1399	NA	NA	0	1399	
30	TCGA-HT-7610	0	2	0	0	0	0	0	0	0	10	4	0	0	5	1	0	TCGA-HT-7610-01	60	0.04033399436447644	16	TCGA-HT-7610-01	0	2	3	0.008765235093308213	TCGA-HT-7610-01	3	2	1	6	PASS	5167	TCGA-HT-7610	LGG	25	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2007	NA	-9447	Alive	TUMOR FREE	1706	NA	NA	NA	NA	NA	1205	Stable Disease	NA	NA	0	1706	0	1706	NA	NA	1	1205	
40	TCGA-HT-7611	0	3	2	1	2	0	0	0	0	22	4	0	2	5	0	0	TCGA-HT-7611-01	123	0.049404964014295435	74	TCGA-HT-7611-01	1	4	20	0.025271858989102548	TCGA-HT-7611-01	4	4	1	9	PASS	5168	TCGA-HT-7611	LGG	36	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2007	NA	-13314	Alive	TUMOR FREE	1752	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1752	0	1752	0	1752	0	1752	
80	TCGA-HT-7616	0	2	0	1	3	1	0	0	2	33	3	0	2	11	2	0	TCGA-HT-7616-01	65	0.30796328205990303	21	TCGA-HT-7616-01	4	4	5	0.10715620610070722	TCGA-HT-7616-01	2	1	3	6	PASS	5169	TCGA-HT-7616	LGG	75	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2007	NA	-27685	Dead	WITH TUMOR	NA	7	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	7	1	7	NA	NA	1	7	
40	TCGA-HT-7620	0	0	0	0	0	0	1	0	1	13	3	0	0	4	1	0	TCGA-HT-7620-01	70	0.0543536863559469	24	TCGA-HT-7620-01	2	2	3	0.056891467395924177	TCGA-HT-7620-01	1	0	2	3	PASS	5170	TCGA-HT-7620	LGG	40	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2007	NA	-14659	Alive	TUMOR FREE	434	NA	NA	NA	NA	NA	280	Complete Remission/Response	NA	NA	0	434	0	434	1	280	1	280	
30	TCGA-HT-7676	1	0	0	2	1	0	0	0	0	12	0	0	0	5	0	0	TCGA-HT-7676-01	54	0.03592366145996316	17	TCGA-HT-7676-01	0	1	5	0.006818039464868386	TCGA-HT-7676-01	6	3	1	10	PASS	5171	TCGA-HT-7676	LGG	26	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2009	NA	-9667	Alive	TUMOR FREE	5	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	5	0	5	NA	NA	0	5	
50	TCGA-HT-7677	0	2	0	3	5	0	0	0	1	30	1	0	0	11	1	0	TCGA-HT-7677-01	52	0.07729955922798959	13	TCGA-HT-7677-01	2	3	2	0.05385240604822639	TCGA-HT-7677-01	2	1	2	5	PASS	5172	TCGA-HT-7677	LGG	53	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2009	NA	-19610	Alive	[Discrepancy]	494	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	494	0	494	NA	NA	0	494	
30	TCGA-HT-7680	0	0	0	0	0	0	0	0	0	2	0	0	0	2	0	0	TCGA-HT-7680-01	93	4.784195986401392e-05	51	TCGA-HT-7680-01	0	0	2	1.2229958605684705e-05	TCGA-HT-7680-01	0	0	0	0	PASS	5173	TCGA-HT-7680	LGG	32	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2010	NA	-11970	Alive	TUMOR FREE	23	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	23	0	23	NA	NA	0	23	
30	TCGA-HT-7681	0	1	0	0	0	1	0	0	1	8	2	0	0	6	0	0	TCGA-HT-7681-01	49	0.06562668300087354	9	TCGA-HT-7681-01	2	2	15	0.055917550459871165	TCGA-HT-7681-01	2	0	2	4	PASS	5174	TCGA-HT-7681	LGG	29	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2009	NA	-10790	Alive	TUMOR FREE	1359	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1359	0	1359	0	1359	0	1359	
60	TCGA-HT-7684	1	0	1	1	2	0	0	0	1	30	3	0	2	7	0	0	TCGA-HT-7684-01	39	0.046140660310517334	4	TCGA-HT-7684-01	2	1	2	0.00050527197630723	TCGA-HT-7684-01	0	0	0	0	PASS	5175	TCGA-HT-7684	LGG	58	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2008	NA	-21352	Alive	TUMOR FREE	184	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	184	0	184	0	184	0	184	
30	TCGA-HT-7686	1	0	0	1	1	0	0	0	1	18	0	0	0	5	0	0	TCGA-HT-7686-01	169	0.12051300794728285	106	TCGA-HT-7686-01	3	4	17	0.05315213438044455	TCGA-HT-7686-01	4	2	2	8	PASS	5176	TCGA-HT-7686	LGG	29	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2008	NA	-10724	Alive	TUMOR FREE	1300	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1300	0	1300	0	1300	0	1300	
70	TCGA-HT-7687	0	3	3	0	2	0	0	0	2	34	0	0	1	14	2	0	TCGA-HT-7687-01	51	0.10880081904279304	15	TCGA-HT-7687-01	2	2	3	0.054508111751465305	TCGA-HT-7687-01	2	0	2	4	PASS	5177	TCGA-HT-7687	LGG	74	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2010	NA	-27186	Alive	TUMOR FREE	3	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	3	0	3	NA	NA	0	3	
60	TCGA-HT-7688	0	2	0	1	8	0	4	0	4	66	2	0	1	23	2	0	TCGA-HT-7688-01	128	0.4484316216102787	72	TCGA-HT-7688-01	8	13	3	0.03316613732560361	TCGA-HT-7688-01	8	6	1	15	PASS	5178	TCGA-HT-7688	LGG	59	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2009	NA	-21844	Alive	TUMOR FREE	964	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	964	0	964	0	964	0	964	
60	TCGA-HT-7689	0	1	0	1	1	0	2	0	0	42	2	0	0	18	1	0	TCGA-HT-7689-01	95	0.4258178552778027	41	TCGA-HT-7689-01	2	4	9	0.09806752242686133	TCGA-HT-7689-01	5	1	5	11	PASS	5179	TCGA-HT-7689	LGG	58	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2009	NA	-21331	Alive	TUMOR FREE	455	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	455	0	455	0	455	0	455	
30	TCGA-HT-7690	1	0	0	0	1	0	1	0	0	18	1	0	0	5	0	0	TCGA-HT-7690-01	102	0.19402517294318414	56	TCGA-HT-7690-01	2	3	26	0.12638027187921885	TCGA-HT-7690-01	7	6	7	20	PASS	5180	TCGA-HT-7690	LGG	29	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2009	NA	-10673	Alive	TUMOR FREE	3	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3	0	3	NA	NA	0	3	
30	TCGA-HT-7691	0	0	0	0	0	0	0	0	0	4	1	0	0	4	0	0	TCGA-HT-7691-01	43	0.0007949370584391798	8	TCGA-HT-7691-01	0	0	0	0.0	TCGA-HT-7691-01	0	0	0	0	PASS	5181	TCGA-HT-7691	LGG	31	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2008	NA	-11465	Alive	TUMOR FREE	3	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3	0	3	NA	NA	0	3	
40	TCGA-HT-7692	1	0	0	2	2	0	1	0	1	17	1	0	0	9	0	0	TCGA-HT-7692-01	75	0.9471171179477486	22	TCGA-HT-7692-01	4	3	4	0.08267992858049866	TCGA-HT-7692-01	2	0	2	4	PASS	5182	TCGA-HT-7692	LGG	43	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2009	NA	-15727	Alive	TUMOR FREE	90	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	90	0	90	0	90	0	90	
50	TCGA-HT-7693	0	2	0	2	1	0	0	0	0	30	1	0	1	13	1	0	TCGA-HT-7693-01	72	0.09530862170793868	31	TCGA-HT-7693-01	4	3	9	0.029905418559839258	TCGA-HT-7693-01	4	2	1	7	PASS	5183	TCGA-HT-7693	LGG	51	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2008	NA	-18956	Alive	TUMOR FREE	533	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	533	0	533	NA	NA	0	533	
60	TCGA-HT-7694	0	0	1	1	6	1	2	0	2	21	2	0	0	11	0	0	TCGA-HT-7694-01	54	0.05171838376219541	12	TCGA-HT-7694-01	2	2	3	0.05449001000582762	TCGA-HT-7694-01	2	0	2	4	PASS	5184	TCGA-HT-7694	LGG	60	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2008	NA	-21930	Alive	TUMOR FREE	210	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	210	0	210	0	210	0	210	
30	TCGA-HT-7695	0	0	0	1	0	0	0	0	2	13	1	0	1	13	0	0	TCGA-HT-7695-01	52	0.05923117783058152	15	TCGA-HT-7695-01	2	2	4	0.05384188894867893	TCGA-HT-7695-01	2	0	3	5	PASS	5185	TCGA-HT-7695	LGG	29	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2009	NA	-10827	Alive	TUMOR FREE	442	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	442	0	442	0	442	0	442	
60	TCGA-HT-7854	0	1	0	0	0	3	0	0	0	19	1	0	1	8	0	0	TCGA-HT-7854-01	55	0.0004436587053233548	20	TCGA-HT-7854-01	0	0	4	0.0004569839089494032	TCGA-HT-7854-01	0	0	0	0	PASS	5186	TCGA-HT-7854	LGG	62	MALE	WHITE	NA	NA	Astrocytoma	G2	2010	NA	-22738	Alive	TUMOR FREE	1201	NA	NA	NA	NA	NA	1147	Stable Disease	NA	NA	0	1201	0	1201	NA	NA	1	1147	
40	TCGA-HT-7855	0	3	0	3	7	1	7	0	1	17	3	0	0	11	0	0	TCGA-HT-7855-01	60	0.11498302280358615	21	TCGA-HT-7855-01	1	1	9	0.00600442011186324	TCGA-HT-7855-01	2	1	1	4	PASS	5187	TCGA-HT-7855	LGG	39	MALE	WHITE	NA	NA	Astrocytoma	G3	2008	NA	-14496	Alive	TUMOR FREE	585	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	585	0	585	0	585	0	585	
40	TCGA-HT-7856	0	1	1	0	0	0	0	0	0	8	1	0	0	6	1	0	TCGA-HT-7856-01	65	0.13142949811964744	20	TCGA-HT-7856-01	4	5	6	0.00015511568192590005	TCGA-HT-7856-01	2	2	0	4	PASS	5188	TCGA-HT-7856	LGG	35	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2008	NA	-13145	Alive	TUMOR FREE	1189	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1189	0	1189	0	1189	0	1189	
30	TCGA-HT-7857	1	2	0	0	2	0	1	0	1	7	4	0	0	6	1	0	TCGA-HT-7857-01	41	0.11875722975735845	7	TCGA-HT-7857-01	5	8	10	0.04544005353416128	TCGA-HT-7857-01	6	10	2	18	PASS	5189	TCGA-HT-7857	LGG	24	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2006	NA	-8912	Alive	TUMOR FREE	7	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	7	0	7	NA	NA	0	7	
30	TCGA-HT-7858	0	1	0	1	1	0	0	0	0	15	0	0	1	7	1	0	TCGA-HT-7858-01	57	0.016324728594097743	21	TCGA-HT-7858-01	1	0	11	0.0211721467327428	TCGA-HT-7858-01	2	2	3	7	PASS	5190	TCGA-HT-7858	LGG	28	MALE	WHITE	NA	NA	Astrocytoma	G2	2007	NA	-10422	Alive	TUMOR FREE	1540	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1540	0	1540	0	1540	0	1540	
60	TCGA-HT-7860	0	6	2	2	1	1	1	0	1	51	5	0	4	28	3	0	TCGA-HT-7860-01	76	0.17127553637998472	28	TCGA-HT-7860-01	9	5	25	0.07011246036100832	TCGA-HT-7860-01	0	1	0	1	PASS	5191	TCGA-HT-7860	LGG	60	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2009	NA	-22034	Alive	TUMOR FREE	15	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	15	0	15	NA	NA	0	15	
30	TCGA-HT-7873	0	2	0	1	2	1	0	0	0	20	1	0	0	9	1	0	TCGA-HT-7873-01	149	0.13169098109399408	87	TCGA-HT-7873-01	2	6	38	0.08792541417733918	TCGA-HT-7873-01	14	8	6	28	PASS	5192	TCGA-HT-7873	LGG	29	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2011	NA	-10805	Alive	WITH TUMOR	718	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	718	0	718	NA	NA	0	718	
40	TCGA-HT-7874	0	0	0	0	0	1	0	0	0	22	0	0	1	6	0	0	TCGA-HT-7874-01	33	0.05156318766203564	3	TCGA-HT-7874-01	2	2	15	0.06364398138205513	TCGA-HT-7874-01	1	1	2	4	PASS	5193	TCGA-HT-7874	LGG	41	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2008	NA	-15045	Alive	TUMOR FREE	1130	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1130	0	1130	0	1130	0	1130	
60	TCGA-HT-7875	0	1	0	2	7	0	4	0	1	22	1	0	1	9	0	0	TCGA-HT-7875-01	47	0.0759447173735163	10	TCGA-HT-7875-01	2	7	22	0.08651214847013664	TCGA-HT-7875-01	2	2	3	7	PASS	5194	TCGA-HT-7875	LGG	56	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2008	NA	-20613	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	10	0	10	NA	NA	0	10	
30	TCGA-HT-7877	0	0	0	1	1	0	0	0	0	9	1	0	0	8	0	0	TCGA-HT-7877-01	35	0.051028283288845004	4	TCGA-HT-7877-01	2	2	10	0.06611331054757301	TCGA-HT-7877-01	1	1	3	5	PASS	5195	TCGA-HT-7877	LGG	20	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-7581	Alive	TUMOR FREE	4	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4	0	4	NA	NA	0	4	
30	TCGA-HT-7879	0	1	0	1	2	0	0	0	1	13	1	0	1	3	0	0	TCGA-HT-7879-01	77	0.09910834556672216	33	TCGA-HT-7879-01	1	3	6	0.012446474501200618	TCGA-HT-7879-01	3	5	1	9	PASS	5196	TCGA-HT-7879	LGG	31	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2011	NA	-11622	Alive	TUMOR FREE	112	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	112	0	112	0	112	0	112	
30	TCGA-HT-7880	0	0	0	0	1	0	0	0	0	6	1	0	0	3	0	0	TCGA-HT-7880-01	35	5.525045999710831e-06	7	TCGA-HT-7880-01	0	0	9	0.010144274645756905	TCGA-HT-7880-01	0	0	1	1	PASS	5197	TCGA-HT-7880	LGG	30	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2011	NA	-11043	Alive	TUMOR FREE	162	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	162	0	162	NA	NA	0	162	
40	TCGA-HT-7881	0	2	0	0	1	0	0	0	0	8	1	0	1	10	0	0	TCGA-HT-7881-01	89	0.06255457587267474	41	TCGA-HT-7881-01	2	2	12	0.05557443356587135	TCGA-HT-7881-01	2	0	2	4	PASS	5198	TCGA-HT-7881	LGG	38	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Oligodendroglioma	G2	2011	NA	-14171	Alive	TUMOR FREE	1079	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1079	0	1079	0	1079	0	1079	
70	TCGA-HT-7882	0	3	0	0	1	0	2	0	3	36	3	0	0	16	2	0	TCGA-HT-7882-01	57	0.1704435421816677	15	TCGA-HT-7882-01	8	5	11	0.07605902563158991	TCGA-HT-7882-01	1	2	2	5	PASS	5199	TCGA-HT-7882	LGG	66	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2010	NA	-24450	Dead	WITH TUMOR	NA	113	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	113	1	113	NA	NA	1	113	
40	TCGA-HT-7884	0	4	0	1	1	2	0	1	0	31	1	0	0	10	0	0	TCGA-HT-7884-01	50	0.10851219913703353	12	TCGA-HT-7884-01	2	3	19	2.9589594642105932e-05	TCGA-HT-7884-01	1	3	0	4	PASS	5200	TCGA-HT-7884	LGG	44	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2011	NA	-16280	Alive	[Discrepancy]	343	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	343	0	343	NA	NA	0	343	
30	TCGA-HT-7902	0	2	0	0	1	0	0	0	0	23	4	0	0	4	0	0	TCGA-HT-7902-01	67	0.13644413664261318	25	TCGA-HT-7902-01	6	10	21	0.07912796948564517	TCGA-HT-7902-01	5	4	2	11	PASS	5201	TCGA-HT-7902	LGG	30	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2009	NA	-11118	Alive	TUMOR FREE	956	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	956	0	956	NA	NA	0	956	
60	TCGA-HT-8010	0	0	0	0	1	0	0	0	2	10	0	0	0	4	0	0	TCGA-HT-8010-01	51	0.06120004857577571	11	TCGA-HT-8010-01	2	3	13	0.06311420777262153	TCGA-HT-8010-01	1	1	2	4	PASS	5202	TCGA-HT-8010	LGG	64	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-23680	Alive	TUMOR FREE	50	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	50	0	50	NA	NA	0	50	
60	TCGA-HT-8011	0	3	0	2	1	0	0	0	0	32	3	0	1	15	1	0	TCGA-HT-8011-01	85	0.18203212012495895	36	TCGA-HT-8011-01	6	4	26	0.06940322591103751	TCGA-HT-8011-01	2	6	2	10	PASS	5203	TCGA-HT-8011	LGG	55	MALE	WHITE	NA	NA	Astrocytoma	G3	2009	NA	-20175	Alive	WITH TUMOR	494	NA	NA	NA	NA	NA	278	Stable Disease	NA	NA	0	494	0	494	NA	NA	1	278	
30	TCGA-HT-8012	0	0	0	2	4	0	3	0	1	13	0	0	0	9	1	0	TCGA-HT-8012-01	55	0.1300868076793677	16	TCGA-HT-8012-01	3	3	24	0.08415386502840297	TCGA-HT-8012-01	2	0	3	5	PASS	5204	TCGA-HT-8012	LGG	30	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2010	NA	-11295	Alive	WITH TUMOR	286	NA	NA	NA	NA	NA	133	Stable Disease	NA	NA	0	286	0	286	NA	NA	1	133	
40	TCGA-HT-8013	0	1	0	0	1	0	0	0	0	26	1	0	1	3	0	0	TCGA-HT-8013-01	40	0.18172888883216248	5	TCGA-HT-8013-01	4	2	7	0.004336168253582677	TCGA-HT-8013-01	1	1	0	2	PASS	5205	TCGA-HT-8013	LGG	37	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2005	NA	-13753	Dead	WITH TUMOR	NA	1933	NA	NA	NA	NA	1306	Stable Disease	NA	NA	1	1933	1	1933	NA	NA	1	1306	
30	TCGA-HT-8015	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	TCGA-HT-8015-01	61	0.00022608652133559716	19	TCGA-HT-8015-01	0	0	10	0.0011238744592093253	TCGA-HT-8015-01	0	0	0	0	PASS	5206	TCGA-HT-8015	LGG	21	MALE	WHITE	NA	NA	Astrocytoma	G2	2008	NA	-7760	Alive	TUMOR FREE	3	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3	0	3	0	3	0	3	
40	TCGA-HT-8018	0	0	0	1	0	0	1	0	2	18	2	0	0	2	0	0	TCGA-HT-8018-01	36	0.04559619685665428	5	TCGA-HT-8018-01	3	5	9	0.015825995626250876	TCGA-HT-8018-01	2	2	1	5	PASS	5207	TCGA-HT-8018	LGG	40	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2010	NA	-14910	Dead	TUMOR FREE	NA	1152	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	1152	0	1152	NA	NA	0	1152	
30	TCGA-HT-8019	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-HT-8019-01	35	2.4662831740541985e-05	6	TCGA-HT-8019	0	0	0	0	TCGA-HT-8019	0	0	0	0	PASS	5208	TCGA-HT-8019	LGG	34	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2009	NA	-12669	Alive	TUMOR FREE	1004	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1004	0	1004	0	1004	0	1004	
50	TCGA-HT-8104	0	3	0	3	1	0	0	0	3	47	5	0	3	19	1	0	TCGA-HT-8104-01	143	0.23667026305412864	60	TCGA-HT-8104-01	7	4	28	0.1105596767849996	TCGA-HT-8104-01	3	4	4	11	PASS	5209	TCGA-HT-8104	LGG	51	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2010	NA	-18748	Alive	TUMOR FREE	372	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	372	0	372	NA	NA	0	372	
50	TCGA-HT-8105	0	4	0	0	8	1	6	1	1	28	2	0	2	9	1	0	TCGA-HT-8105-01	41	0.05104626233822854	6	TCGA-HT-8105-01	2	3	15	0.05543106984412149	TCGA-HT-8105-01	2	0	3	5	PASS	5210	TCGA-HT-8105	LGG	54	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2011	NA	-20041	Alive	TUMOR FREE	190	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	190	0	190	NA	NA	0	190	
50	TCGA-HT-8106	0	1	1	1	0	0	0	0	1	24	1	0	1	11	3	0	TCGA-HT-8106-01	41	0.048867432992995084	9	TCGA-HT-8106-01	7	7	14	0.05707617409403299	TCGA-HT-8106-01	10	9	5	24	PASS	5211	TCGA-HT-8106	LGG	53	MALE	WHITE	NA	NA	Astrocytoma	G3	2010	NA	-19555	Alive	TUMOR FREE	3	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	3	0	3	NA	NA	0	3	
60	TCGA-HT-8107	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	0	TCGA-HT-8107-01	59	0.00011491873907827758	21	TCGA-HT-8107-01	0	0	4	0.00017019302340540732	TCGA-HT-8107-01	0	0	0	0	PASS	5212	TCGA-HT-8107	LGG	62	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-22880	Alive	TUMOR FREE	14	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	14	0	14	NA	NA	0	14	
30	TCGA-HT-8108	0	3	0	1	1	1	0	0	1	14	0	0	0	7	0	0	TCGA-HT-8108-01	87	0.12325368557845914	39	TCGA-HT-8108-01	0	3	23	0.05133817081530305	TCGA-HT-8108-01	7	5	4	16	PASS	5213	TCGA-HT-8108	LGG	26	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-9539	Alive	TUMOR FREE	76	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	76	0	76	NA	NA	0	76	
60	TCGA-HT-8109	0	1	1	2	2	0	0	0	1	28	3	0	1	12	0	0	TCGA-HT-8109-01	58	0.10227177237399818	18	TCGA-HT-8109-01	2	2	29	0.07702548560894938	TCGA-HT-8109-01	2	2	3	7	PASS	5214	TCGA-HT-8109	LGG	64	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2011	NA	-23486	Alive	TUMOR FREE	169	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	169	0	169	NA	NA	0	169	
60	TCGA-HT-8110	0	3	0	0	2	0	0	0	0	24	1	0	1	15	2	1	TCGA-HT-8110-01	65	0.13957699509603605	18	TCGA-HT-8110-01	5	3	33	0.0904843678871135	TCGA-HT-8110-01	0	2	1	3	PASS	5215	TCGA-HT-8110	LGG	57	MALE	WHITE	NA	NA	Astrocytoma	G3	2011	NA	-21183	Alive	TUMOR FREE	419	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	419	0	419	0	419	0	419	
30	TCGA-HT-8111	0	0	0	1	1	0	0	0	0	13	1	0	0	3	0	0	TCGA-HT-8111-01	64	0.09075832959032787	21	TCGA-HT-8111-01	4	6	4	0.012255238174783328	TCGA-HT-8111-01	8	2	2	12	PASS	5216	TCGA-HT-8111	LGG	32	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2011	NA	-11810	Alive	NA	7	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	7	0	7	NA	NA	0	7	
50	TCGA-HT-8113	0	3	0	0	1	1	0	0	1	15	1	0	0	8	0	0	TCGA-HT-8113-01	45	0.08450112716123255	9	TCGA-HT-8113-01	1	1	31	0.056024064399644656	TCGA-HT-8113-01	1	1	1	3	PASS	5217	TCGA-HT-8113	LGG	49	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Oligodendroglioma	G2	2006	NA	-18173	Alive	TUMOR FREE	900	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	900	0	900	0	900	0	900	
40	TCGA-HT-8114	0	1	0	1	1	1	0	0	1	14	0	0	0	4	1	0	TCGA-HT-8114-01	65	0.05412120106191273	20	TCGA-HT-8114-01	0	3	6	0.02222830648204101	TCGA-HT-8114-01	4	2	2	8	PASS	5218	TCGA-HT-8114	LGG	36	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2011	NA	-13198	Alive	TUMOR FREE	1040	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1040	0	1040	0	1040	0	1040	
30	TCGA-HT-8558	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	TCGA-HT-8558	0	0	0	TCGA-HT-8558	0	0	0	0	TCGA-HT-8558	0	0	0	0	PASS	5219	TCGA-HT-8558	LGG	29	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-10950	Alive	TUMOR FREE	418	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	418	0	418	0	418	0	418	
30	TCGA-HT-8563	0	2	0	1	0	0	0	0	1	18	3	0	1	13	1	0	TCGA-HT-8563-01	97	0.2085818428850386	39	TCGA-HT-8563-01	2	7	26	0.11215185159947366	TCGA-HT-8563-01	8	6	8	22	PASS	5220	TCGA-HT-8563	LGG	30	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2011	NA	-11305	Alive	TUMOR FREE	860	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	860	0	860	0	860	0	860	
50	TCGA-HT-8564	1	37	1	13	52	10	24	0	16	337	20	0	10	203	8	0	TCGA-HT-8564-01	65	0.7649491844745273	18	TCGA-HT-8564-01	25	19	52	0.25473864190254397	TCGA-HT-8564-01	2	1	4	7	PASS	5221	TCGA-HT-8564	LGG	47	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-17499	Alive	WITH TUMOR	478	NA	NA	NA	NA	NA	120	Progressive Disease	NA	NA	0	478	0	478	NA	NA	1	120	
60	TCGA-HT-A4DS	0	2	1	1	1	0	0	0	0	30	0	0	0	10	1	0	TCGA-HT-A4DS-01	105	0.501760982929146	50	TCGA-HT-A4DS-01	14	17	87	0.35193974630601216	TCGA-HT-A4DS-01	3	2	2	7	PASS	5222	TCGA-HT-A4DS	LGG	55	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-20296	Alive	TUMOR FREE	7	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	7	0	7	NA	NA	0	7	
50	TCGA-HT-A4DV	0	0	0	3	0	0	0	0	0	13	0	0	1	6	0	0	TCGA-HT-A4DV-01	49	0.051041685416615135	14	TCGA-HT-A4DV	0	0	0	0	TCGA-HT-A4DV	0	0	0	0	PASS	5223	TCGA-HT-A4DV	LGG	51	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2012	NA	-18799	Alive	TUMOR FREE	792	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	792	0	792	0	792	0	792	
30	TCGA-HT-A5R5	0	0	0	0	1	0	0	0	0	24	3	0	1	8	1	0	TCGA-HT-A5R5-01	87	0.0615099796492859	35	TCGA-HT-A5R5-01	3	7	8	0.01935043776083175	TCGA-HT-A5R5-01	5	2	2	9	PASS	5224	TCGA-HT-A5R5	LGG	33	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-12403	Alive	TUMOR FREE	4	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4	0	4	0	4	0	4	
30	TCGA-HT-A5R7	0	1	0	0	1	1	0	0	0	27	1	0	0	10	0	0	TCGA-HT-A5R7-01	147	0.3536865305214017	73	TCGA-HT-A5R7-01	1	3	3	9.792099799979241e-05	TCGA-HT-A5R7-01	4	1	0	5	PASS	5225	TCGA-HT-A5R7	LGG	33	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-12092	Alive	TUMOR FREE	615	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	615	0	615	0	615	0	615	
50	TCGA-HT-A5R9	0	4	0	2	2	0	5	0	2	31	0	0	0	8	1	0	TCGA-HT-A5R9-01	83	0.1705286322225172	35	TCGA-HT-A5R9-01	6	4	40	0.12373991898623715	TCGA-HT-A5R9-01	2	0	2	4	PASS	5226	TCGA-HT-A5R9	LGG	48	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2012	NA	-17775	Alive	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2	0	2	NA	NA	0	2	
70	TCGA-HT-A5RA	2	3	0	2	1	0	1	0	2	36	2	0	0	19	1	0	TCGA-HT-A5RA-01	229	0.1775290588875634	150	TCGA-HT-A5RA-01	7	9	70	0.2015101748146092	TCGA-HT-A5RA-01	3	4	3	10	PASS	5227	TCGA-HT-A5RA	LGG	65	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-23769	Alive	WITH TUMOR	832	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	832	0	832	NA	NA	0	832	
30	TCGA-HT-A5RB	0	1	0	0	2	0	0	0	2	17	0	0	1	5	0	0	TCGA-HT-A5RB-01	75	0.07820811523689139	28	TCGA-HT-A5RB-01	0	1	18	0.04733948330081933	TCGA-HT-A5RB-01	3	1	3	7	PASS	5228	TCGA-HT-A5RB	LGG	24	MALE	WHITE	NA	NA	Astrocytoma	G2	2011	NA	-8820	Alive	NA	3	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3	0	3	NA	NA	0	3	
70	TCGA-HT-A5RC	0	3	0	2	1	0	1	0	7	41	1	1	1	11	2	0	TCGA-HT-A5RC-01	152	0.15303551210807487	73	TCGA-HT-A5RC-01	7	5	40	0.08298615502041763	TCGA-HT-A5RC-01	2	2	2	6	PASS	5229	TCGA-HT-A5RC	LGG	70	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-25772	Dead	WITH TUMOR	NA	162	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	162	1	162	NA	NA	1	162	
50	TCGA-HT-A614	0	1	0	3	1	0	0	0	3	28	5	0	0	9	0	0	TCGA-HT-A614-01	214	0.11426410626061015	150	TCGA-HT-A614-01	2	3	89	0.05627269788101728	TCGA-HT-A614-01	4	4	2	10	PASS	5230	TCGA-HT-A614	LGG	47	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2013	NA	-17392	Alive	WITH TUMOR	82	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	82	0	82	NA	NA	0	82	
40	TCGA-HT-A615	0	1	0	1	1	0	0	0	1	26	1	0	0	7	2	0	TCGA-HT-A615-01	65	0.09593882144892148	21	TCGA-HT-A615-01	2	4	21	0.07459815134879702	TCGA-HT-A615-01	4	2	3	9	PASS	5231	TCGA-HT-A615	LGG	38	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-13892	Alive	TUMOR FREE	515	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	515	0	515	0	515	0	515	
40	TCGA-HT-A616	0	0	0	1	0	1	0	0	1	18	2	0	0	10	1	0	TCGA-HT-A616-01	62	0.10116256411231438	22	TCGA-HT-A616-01	3	4	19	0.02668649091115709	TCGA-HT-A616-01	5	1	2	8	PASS	5232	TCGA-HT-A616	LGG	36	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2013	NA	-13222	Alive	NA	55	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	55	0	55	NA	NA	0	55	
50	TCGA-HT-A617	0	0	1	1	0	0	0	0	1	18	1	0	0	8	0	0	TCGA-HT-A617-01	146	0.2721024247670633	72	TCGA-HT-A617-01	11	8	4	0.00025838476404000364	TCGA-HT-A617-01	1	0	0	1	PASS	5233	TCGA-HT-A617	LGG	47	MALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	NA	Oligodendroglioma	G2	2010	NA	-17331	Alive	NA	491	NA	NA	NA	NA	NA	395	Progressive Disease	NA	NA	0	491	0	491	NA	NA	1	395	
40	TCGA-HT-A618	0	3	0	0	1	1	0	0	2	14	3	0	1	9	1	0	TCGA-HT-A618-01	119	0.38156074329605133	60	TCGA-HT-A618-01	6	11	26	0.02317384348857516	TCGA-HT-A618-01	3	5	2	10	PASS	5234	TCGA-HT-A618	LGG	37	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-13595	Alive	TUMOR FREE	512	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	512	0	512	0	512	0	512	
50	TCGA-HT-A619	0	3	0	1	2	3	1	0	2	36	3	0	2	15	1	0	TCGA-HT-A619	0	0	0	TCGA-HT-A619	0	0	0	0	TCGA-HT-A619-01	6	6	3	15	PASS	5235	TCGA-HT-A619	LGG	51	FEMALE	ASIAN	NA	NA	Oligodendroglioma	G3	2012	NA	-18857	Alive	TUMOR FREE	651	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	651	0	651	0	651	0	651	
30	TCGA-HT-A61A	0	0	0	0	0	0	0	0	0	7	0	0	0	1	0	0	TCGA-HT-A61A	0	0	0	TCGA-HT-A61A	0	0	0	0	TCGA-HT-A61A	0	0	0	0	PASS	5236	TCGA-HT-A61A	LGG	20	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2013	NA	-7664	Alive	TUMOR FREE	194	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	194	0	194	0	194	0	194	
30	TCGA-HT-A61B	0	0	0	0	0	1	0	0	0	34	4	0	0	8	0	1	TCGA-HT-A61B-01	225	0.3923727259310859	155	TCGA-HT-A61B-01	8	9	62	0.08277870639333368	TCGA-HT-A61B-01	8	5	3	16	PASS	5237	TCGA-HT-A61B	LGG	22	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-8335	Alive	TUMOR FREE	533	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	533	0	533	0	533	0	533	
70	TCGA-HT-A61C	0	3	0	0	1	0	2	0	0	33	1	0	0	9	1	0	TCGA-HT-A61C-01	89	0.18718340259618185	35	TCGA-HT-A61C-01	5	5	35	0.1310145054913618	TCGA-HT-A61C-01	3	2	3	8	PASS	5238	TCGA-HT-A61C	LGG	66	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2013	NA	-24276	Dead	WITH TUMOR	NA	537	NA	NA	NA	NA	476	Complete Remission/Response	NA	NA	1	537	1	537	1	476	1	476	
60	TCGA-HT-A74H	0	3	0	1	4	0	0	0	1	40	1	0	0	16	0	0	TCGA-HT-A74H-01	98	0.18226627512770224	43	TCGA-HT-A74H-01	7	8	2	0.00013495508839838664	TCGA-HT-A74H-01	2	5	0	7	PASS	5239	TCGA-HT-A74H	LGG	62	MALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-22850	Alive	NA	74	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	74	0	74	NA	NA	0	74	
30	TCGA-HT-A74J	0	0	0	0	0	0	0	0	1	23	2	0	0	3	1	0	TCGA-HT-A74J-01	75	0.14664205667674665	31	TCGA-HT-A74J-01	4	2	18	0.005482416073099736	TCGA-HT-A74J-01	2	1	0	3	PASS	5240	TCGA-HT-A74J	LGG	33	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2013	NA	-12393	Alive	NA	320	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	320	0	320	NA	NA	0	320	
60	TCGA-HT-A74K	0	1	0	0	0	3	1	0	0	25	0	0	0	10	0	0	TCGA-HT-A74K-01	91	0.2928430836079253	40	TCGA-HT-A74K-01	5	7	19	0.0660254694728243	TCGA-HT-A74K-01	3	1	4	8	PASS	5241	TCGA-HT-A74K	LGG	58	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2012	NA	-21189	Alive	TUMOR FREE	467	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	467	0	467	0	467	0	467	
30	TCGA-HT-A74L	0	0	0	0	0	0	0	0	0	11	0	0	0	5	2	0	TCGA-HT-A74L-01	77	0.14463413165289415	28	TCGA-HT-A74L-01	5	6	24	0.08688724648746557	TCGA-HT-A74L-01	4	1	2	7	PASS	5242	TCGA-HT-A74L	LGG	22	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2013	NA	-8240	Alive	WITH TUMOR	336	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	336	0	336	NA	NA	0	336	
30	TCGA-HT-A74O	0	0	0	1	1	0	1	0	1	16	1	0	0	7	0	0	TCGA-HT-A74O-01	89	0.12489944047896373	34	TCGA-HT-A74O-01	1	3	17	0.0204420261392528	TCGA-HT-A74O-01	7	4	1	12	PASS	5243	TCGA-HT-A74O	LGG	34	MALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-12460	Alive	NA	3	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3	0	3	NA	NA	0	3	
40	TCGA-HW-7486	0	1	0	0	0	0	0	0	1	9	1	0	1	7	0	0	TCGA-HW-7486-01	41	0.05102588330741418	8	TCGA-HW-7486-01	2	2	2	0.05385110292931142	TCGA-HW-7486-01	2	0	2	4	PASS	5244	TCGA-HW-7486	LGG	37	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2010	NA	-13546	Alive	TUMOR FREE	1721	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1721	0	1721	NA	NA	0	1721	
40	TCGA-HW-7487	0	2	0	0	0	0	0	0	1	13	1	0	1	6	0	0	TCGA-HW-7487-01	49	0.11593638821991445	14	TCGA-HW-7487-01	4	4	3	0.05389380670116738	TCGA-HW-7487-01	2	0	2	4	PASS	5245	TCGA-HW-7487	LGG	39	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2010	NA	-14535	Alive	WITH TUMOR	1382	NA	NA	NA	NA	NA	840	Progressive Disease	NA	NA	0	1382	0	1382	NA	NA	1	840	
40	TCGA-HW-7489	0	2	0	0	0	1	0	0	0	14	2	0	2	6	3	0	TCGA-HW-7489-01	89	0.0836819335186927	42	TCGA-HW-7489-01	0	2	19	0.00028301862638999397	TCGA-HW-7489-01	3	6	0	9	PASS	5246	TCGA-HW-7489	LGG	38	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2011	NA	-14201	Dead	WITH TUMOR	NA	1262	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	1262	1	1262	NA	NA	1	1262	
40	TCGA-HW-7490	0	4	1	4	10	1	5	0	5	75	12	0	0	26	1	0	TCGA-HW-7490-01	74	0.04593016101922024	30	TCGA-HW-7490-01	2	2	5	0.011840585927720628	TCGA-HW-7490-01	1	0	0	1	PASS	5247	TCGA-HW-7490	LGG	41	MALE	WHITE	NA	NA	Astrocytoma	G2	2011	NA	-15092	Alive	WITH TUMOR	1387	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	1387	0	1387	NA	NA	0	1387	
40	TCGA-HW-7491	0	4	0	0	0	1	1	0	1	12	0	0	0	4	2	0	TCGA-HW-7491-01	106	0.9471160470804734	48	TCGA-HW-7491-01	7	5	7	0.1860908485425312	TCGA-HW-7491-01	3	0	3	6	PASS	5248	TCGA-HW-7491	LGG	35	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2009	NA	-12874	Alive	WITH TUMOR	2078	NA	NA	NA	NA	NA	2197	Progressive Disease	NA	NA	0	2078	0	2078	NA	NA	1	2197	
40	TCGA-HW-7493	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-HW-7493-01	58	0.06207731228201111	16	TCGA-HW-7493-01	0	1	19	0.0039557866450114654	TCGA-HW-7493-01	2	1	0	3	PASS	5249	TCGA-HW-7493	LGG	40	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2009	NA	-14767	Alive	WITH TUMOR	2107	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	2107	0	2107	NA	NA	0	2107	
50	TCGA-HW-7495	0	0	0	2	1	0	0	0	0	15	1	0	0	4	1	0	TCGA-HW-7495-01	44	0.07838109335994141	10	TCGA-HW-7495-01	2	3	2	0.05385184677116835	TCGA-HW-7495-01	2	1	2	5	PASS	5250	TCGA-HW-7495	LGG	45	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-16460	Alive	WITH TUMOR	1078	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	1078	0	1078	NA	NA	0	1078	
30	TCGA-HW-8319	0	2	0	0	1	0	0	0	1	23	1	0	1	11	0	0	TCGA-HW-8319-01	47	0.08910812552952713	12	TCGA-HW-8319-01	3	2	10	0.025606011014044413	TCGA-HW-8319-01	2	2	2	6	PASS	5251	TCGA-HW-8319	LGG	34	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2011	NA	-12557	Dead	WITH TUMOR	NA	1209	NA	NA	NA	NA	997	Partial Remission/Response	NA	NA	1	1209	1	1209	NA	NA	1	997	
40	TCGA-HW-8320	1	0	0	1	2	0	0	0	0	20	2	0	0	13	0	1	TCGA-HW-8320-01	45	0.036359868539756486	9	TCGA-HW-8320-01	3	6	4	0.038515335035811435	TCGA-HW-8320-01	2	5	2	9	PASS	5252	TCGA-HW-8320	LGG	36	MALE	WHITE	NA	NA	Astrocytoma	G3	2011	NA	-13503	Alive	WITH TUMOR	1217	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1217	0	1217	NA	NA	0	1217	
30	TCGA-HW-8321	0	2	1	0	0	1	0	0	3	28	2	0	1	7	0	0	TCGA-HW-8321-01	99	0.13336741040389366	46	TCGA-HW-8321-01	0	1	18	0.047173203380846455	TCGA-HW-8321-01	5	3	3	11	PASS	5253	TCGA-HW-8321	LGG	31	MALE	WHITE	NA	NA	Astrocytoma	G3	2011	NA	-11474	Alive	WITH TUMOR	1294	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1294	0	1294	NA	NA	0	1294	
40	TCGA-HW-8322	0	0	1	1	3	0	0	0	0	20	0	0	1	4	1	0	TCGA-HW-8322-01	45	0.11567659120642385	12	TCGA-HW-8322-01	2	7	15	0.07741925137841943	TCGA-HW-8322-01	6	4	4	14	PASS	5254	TCGA-HW-8322	LGG	39	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-14548	Alive	WITH TUMOR	758	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	758	0	758	NA	NA	0	758	
70	TCGA-HW-A5KJ	0	0	1	1	11	0	13	0	0	17	0	0	1	7	2	0	TCGA-HW-A5KJ-01	82	0.10413319865150804	31	TCGA-HW-A5KJ-01	2	4	17	0.07150174400470034	TCGA-HW-A5KJ-01	3	2	3	8	PASS	5255	TCGA-HW-A5KJ	LGG	68	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2012	NA	-24966	Dead	WITH TUMOR	NA	962	NA	NA	NA	NA	615	Progressive Disease	NA	NA	1	962	1	962	NA	NA	1	615	
60	TCGA-HW-A5KK	0	1	0	3	3	0	0	0	1	31	2	0	0	10	0	0	TCGA-HW-A5KK-01	119	0.16016037412091078	63	TCGA-HW-A5KK-01	7	5	23	0.14415099993906896	TCGA-HW-A5KK-01	2	1	3	6	PASS	5256	TCGA-HW-A5KK	LGG	64	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-23484	Dead	WITH TUMOR	NA	388	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	388	1	388	NA	NA	1	388	
40	TCGA-HW-A5KL	1	0	0	1	1	1	0	0	0	19	0	0	0	1	0	0	TCGA-HW-A5KL-01	49	0.010042103136375723	7	TCGA-HW-A5KL-01	0	0	5	0.006655251881063	TCGA-HW-A5KL-01	1	0	1	2	PASS	5257	TCGA-HW-A5KL	LGG	42	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2012	NA	-15513	Alive	WITH TUMOR	878	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	878	0	878	NA	NA	0	878	
40	TCGA-HW-A5KM	0	0	1	1	1	0	2	0	1	14	1	0	0	5	0	0	TCGA-HW-A5KM-01	86	0.05082152384923709	40	TCGA-HW-A5KM-01	2	3	12	0.017071833897539815	TCGA-HW-A5KM-01	4	4	1	9	PASS	5258	TCGA-HW-A5KM	LGG	35	MALE	WHITE	NA	NA	Astrocytoma	G2	2012	NA	-12845	Alive	WITH TUMOR	630	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	630	0	630	NA	NA	0	630	
40	TCGA-IK-7675	0	1	0	1	1	0	0	0	0	34	4	0	0	9	0	0	TCGA-IK-7675-01	148	0.8465064219721303	72	TCGA-IK-7675-01	2	3	24	0.1370093122718215	TCGA-IK-7675-01	9	11	6	26	PASS	5259	TCGA-IK-7675	LGG	43	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2009	NA	-15900	Dead	WITH TUMOR	NA	578	NA	NA	NA	NA	123	Progressive Disease	NA	NA	1	578	1	578	NA	NA	1	123	
60	TCGA-IK-8125	0	1	0	1	2	1	0	0	3	38	5	0	0	15	2	0	TCGA-IK-8125-01	58	0.15356860383646448	14	TCGA-IK-8125-01	2	2	6	0.05386545377884407	TCGA-IK-8125-01	2	0	2	4	PASS	5260	TCGA-IK-8125	LGG	62	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2009	NA	-22745	Alive	TUMOR FREE	1301	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1301	0	1301	0	1301	0	1301	
30	TCGA-KT-A74X	0	2	1	0	0	0	1	0	1	7	0	0	0	4	0	0	TCGA-KT-A74X-01	47	0.3269105208818128	9	TCGA-KT-A74X-01	3	4	29	0.1315926873687019	TCGA-KT-A74X-01	1	3	3	7	PASS	5261	TCGA-KT-A74X	LGG	26	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2013	NA	-9590	Alive	WITH TUMOR	438	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	438	0	438	NA	NA	0	438	
50	TCGA-KT-A7W1	0	3	0	1	0	1	0	0	3	33	4	0	0	15	0	0	TCGA-KT-A7W1-01	97	0.13074368083329246	40	TCGA-KT-A7W1-01	6	3	26	0.057571984056004014	TCGA-KT-A7W1-01	1	1	1	3	PASS	5262	TCGA-KT-A7W1	LGG	45	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-16560	Alive	TUMOR FREE	438	NA	NA	NA	NA	NA	84	Progressive Disease	NA	NA	0	438	0	438	NA	NA	1	84	
30	TCGA-P5-A5ET	0	1	1	2	1	0	6	0	0	14	1	0	1	4	1	0	TCGA-P5-A5ET-01	75	0.060169346742456026	28	TCGA-P5-A5ET-01	2	2	10	0.05533321204409082	TCGA-P5-A5ET-01	2	0	2	4	PASS	5263	TCGA-P5-A5ET	LGG	27	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-10027	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
40	TCGA-P5-A5EU	0	1	0	1	0	0	0	0	2	20	2	0	0	7	2	0	TCGA-P5-A5EU-01	166	0.9475339600273864	94	TCGA-P5-A5EU-01	5	11	77	0.22333120650929514	TCGA-P5-A5EU-01	14	8	14	36	PASS	5264	TCGA-P5-A5EU	LGG	35	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-12851	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
40	TCGA-P5-A5EV	0	7	0	6	1	0	0	0	3	79	2	0	3	17	2	0	TCGA-P5-A5EV-01	94	0.13640954890803114	35	TCGA-P5-A5EV-01	4	6	35	0.09943658518914536	TCGA-P5-A5EV-01	6	1	5	12	PASS	5265	TCGA-P5-A5EV	LGG	39	MALE	WHITE	NA	NA	Astrocytoma	G2	2012	NA	-14310	Alive	WITH TUMOR	7	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	7	0	7	NA	NA	0	7	
30	TCGA-P5-A5EW	0	3	0	1	2	0	0	0	0	13	1	0	0	5	1	0	TCGA-P5-A5EW-01	54	0.04158678076965548	12	TCGA-P5-A5EW-01	0	1	5	0.014642337043118275	TCGA-P5-A5EW-01	2	1	1	4	PASS	5266	TCGA-P5-A5EW	LGG	20	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2012	NA	-7612	Alive	TUMOR FREE	204	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	204	0	204	NA	NA	0	204	
40	TCGA-P5-A5EX	0	2	0	0	0	1	2	0	2	17	1	0	0	6	0	0	TCGA-P5-A5EX-01	63	0.1674837738090426	18	TCGA-P5-A5EX-01	4	5	20	0.1087121310064781	TCGA-P5-A5EX-01	4	2	3	9	PASS	5267	TCGA-P5-A5EX	LGG	41	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2012	NA	-15091	Alive	TUMOR FREE	243	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	243	0	243	NA	NA	0	243	
30	TCGA-P5-A5EY	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	TCGA-P5-A5EY-01	73	5.357528327304532e-05	24	TCGA-P5-A5EY-01	0	0	3	0.0007131178200335742	TCGA-P5-A5EY-01	0	0	0	0	PASS	5268	TCGA-P5-A5EY	LGG	21	MALE	WHITE	NA	NA	Astrocytoma	G2	2012	NA	-7716	Alive	NA	72	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	72	0	72	NA	NA	0	72	
40	TCGA-P5-A5EZ	0	3	0	0	1	0	0	0	0	34	1	0	2	12	0	0	TCGA-P5-A5EZ-01	184	0.3492081835326698	105	TCGA-P5-A5EZ-01	2	4	42	0.07234007748194063	TCGA-P5-A5EZ-01	8	4	5	17	PASS	5269	TCGA-P5-A5EZ	LGG	39	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-14375	Alive	TUMOR FREE	70	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	70	0	70	NA	NA	0	70	
30	TCGA-P5-A5F0	0	1	1	0	2	0	2	0	0	23	3	0	0	6	1	0	TCGA-P5-A5F0-01	78	0.10656666523719424	32	TCGA-P5-A5F0-01	4	3	23	0.0561100173130273	TCGA-P5-A5F0-01	2	0	2	4	PASS	5270	TCGA-P5-A5F0	LGG	33	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-12157	Alive	[Discrepancy]	287	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	287	0	287	NA	NA	0	287	
30	TCGA-P5-A5F1	0	2	0	2	0	0	0	0	2	14	3	0	3	4	0	0	TCGA-P5-A5F1-01	76	0.0861059083028383	32	TCGA-P5-A5F1-01	2	3	8	0.0005844538227795544	TCGA-P5-A5F1-01	2	1	0	3	PASS	5271	TCGA-P5-A5F1	LGG	30	MALE	WHITE	NA	NA	Astrocytoma	G2	2012	NA	-11070	Alive	TUMOR FREE	179	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	179	0	179	NA	NA	0	179	
40	TCGA-P5-A5F2	0	1	0	0	0	1	0	0	0	23	2	0	1	7	1	1	TCGA-P5-A5F2-01	82	0.1079837206921974	33	TCGA-P5-A5F2-01	1	8	29	0.08530878552264705	TCGA-P5-A5F2-01	10	7	5	22	PASS	5272	TCGA-P5-A5F2	LGG	36	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2012	NA	-13396	Alive	WITH TUMOR	242	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	242	0	242	NA	NA	0	242	
40	TCGA-P5-A5F4	0	0	0	1	1	0	0	0	0	28	1	0	0	12	0	0	TCGA-P5-A5F4-01	120	0.21140596232686554	52	TCGA-P5-A5F4-01	5	8	11	0.02064160472787824	TCGA-P5-A5F4-01	8	10	2	20	PASS	5273	TCGA-P5-A5F4	LGG	35	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2012	NA	-12851	Alive	[Discrepancy]	231	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	231	0	231	NA	NA	0	231	
30	TCGA-P5-A5F6	0	1	0	0	0	0	0	0	0	1	0	0	1	1	0	0	TCGA-P5-A5F6-01	54	0.9477278177490952	16	TCGA-P5-A5F6-01	18	11	86	0.4848090310973398	TCGA-P5-A5F6-01	0	1	1	2	PASS	5274	TCGA-P5-A5F6	LGG	26	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-9575	Alive	TUMOR FREE	39	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	39	0	39	NA	NA	0	39	
70	TCGA-P5-A72U	0	4	0	1	0	0	0	1	1	42	3	0	1	18	2	0	TCGA-P5-A72U-01	91	0.15197940400702933	38	TCGA-P5-A72U-01	7	4	42	0.08326859963171514	TCGA-P5-A72U-01	2	3	1	6	PASS	5275	TCGA-P5-A72U	LGG	71	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2013	NA	-26002	Alive	TUMOR FREE	7	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	7	0	7	0	7	0	7	
40	TCGA-P5-A72W	0	0	0	0	2	0	0	0	1	33	1	0	0	7	0	0	TCGA-P5-A72W-01	118	0.4060272031954602	56	TCGA-P5-A72W-01	4	5	24	0.0875134808450179	TCGA-P5-A72W-01	7	4	1	12	PASS	5276	TCGA-P5-A72W	LGG	35	MALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-12848	Alive	TUMOR FREE	317	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	317	0	317	0	317	0	317	
30	TCGA-P5-A72X	0	0	0	0	1	0	0	0	0	10	0	0	0	1	1	0	TCGA-P5-A72X-01	65	0.015630599557109968	24	TCGA-P5-A72X-01	1	1	12	0.005513137922331509	TCGA-P5-A72X-01	1	0	0	1	PASS	5277	TCGA-P5-A72X	LGG	21	MALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-7913	Alive	TUMOR FREE	403	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	403	0	403	0	403	0	403	
60	TCGA-P5-A72Z	0	0	0	1	1	0	0	0	0	24	1	0	1	9	1	0	TCGA-P5-A72Z-01	45	0.7602911919620332	10	TCGA-P5-A72Z-01	6	4	20	0.13332074146678088	TCGA-P5-A72Z-01	2	0	2	4	PASS	5278	TCGA-P5-A72Z	LGG	64	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2013	NA	-23482	Alive	TUMOR FREE	354	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	354	0	354	0	354	0	354	
30	TCGA-P5-A730	0	0	0	0	1	0	0	0	0	15	5	0	0	4	0	0	TCGA-P5-A730-01	53	0.05999324886624415	13	TCGA-P5-A730-01	2	2	25	0.05581119276661698	TCGA-P5-A730-01	2	0	2	4	PASS	5279	TCGA-P5-A730	LGG	22	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2013	NA	-8043	Alive	TUMOR FREE	333	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	333	0	333	0	333	0	333	
60	TCGA-P5-A731	0	1	0	0	1	1	0	0	1	19	1	0	1	5	0	0	TCGA-P5-A731-01	64	0.04841421201695873	21	TCGA-P5-A731-01	0	4	33	0.04064233339446626	TCGA-P5-A731-01	3	5	4	12	PASS	5280	TCGA-P5-A731	LGG	59	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2013	NA	-21715	Alive	TUMOR FREE	274	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	274	0	274	NA	NA	0	274	
50	TCGA-P5-A733	0	3	0	1	2	0	1	0	1	31	2	0	1	9	0	0	TCGA-P5-A733-01	87	0.17951747561055156	33	TCGA-P5-A733-01	2	4	18	0.0426131673138547	TCGA-P5-A733-01	5	4	2	11	PASS	5281	TCGA-P5-A733	LGG	52	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2013	NA	-19142	Alive	TUMOR FREE	414	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	414	0	414	0	414	0	414	
40	TCGA-P5-A735	0	0	0	1	3	1	0	0	0	19	0	0	1	4	1	0	TCGA-P5-A735-01	75	0.03044928686335164	34	TCGA-P5-A735-01	0	2	24	0.04034897005166364	TCGA-P5-A735-01	2	1	0	3	PASS	5282	TCGA-P5-A735	LGG	38	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2013	NA	-14152	Alive	TUMOR FREE	292	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	292	0	292	0	292	0	292	
40	TCGA-P5-A736	0	1	0	0	4	0	1	0	0	19	2	0	0	8	0	0	TCGA-P5-A736-01	75	0.03701625591788919	31	TCGA-P5-A736-01	0	4	5	0.00031865284959688454	TCGA-P5-A736-01	3	2	0	5	PASS	5283	TCGA-P5-A736	LGG	44	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-16300	Alive	TUMOR FREE	230	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	230	0	230	0	230	0	230	
50	TCGA-P5-A737	0	2	0	1	1	0	0	0	0	20	1	0	0	6	0	0	TCGA-P5-A737-01	41	0.4837329357068583	6	TCGA-P5-A737-01	3	3	24	0.09039961422089728	TCGA-P5-A737-01	1	1	2	4	PASS	5284	TCGA-P5-A737	LGG	47	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2012	NA	-17390	Alive	TUMOR FREE	372	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	372	0	372	0	372	0	372	
40	TCGA-P5-A77W	0	2	0	1	5	1	1	0	0	18	3	0	2	6	0	0	TCGA-P5-A77W-01	45	0.8982846072203557	10	TCGA-P5-A77W-01	8	8	17	0.07364813126845385	TCGA-P5-A77W-01	2	2	4	8	PASS	5285	TCGA-P5-A77W	LGG	37	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2013	NA	-13545	Alive	TUMOR FREE	584	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	584	0	584	0	584	0	584	
60	TCGA-P5-A77X	0	1	2	0	6	0	3	0	2	17	0	0	0	10	1	0	TCGA-P5-A77X-01	57	0.10272975122222644	16	TCGA-P5-A77X-01	4	4	31	0.08675721326098675	TCGA-P5-A77X-01	2	0	3	5	PASS	5286	TCGA-P5-A77X	LGG	55	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2013	NA	-20128	Alive	TUMOR FREE	105	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	105	0	105	0	105	0	105	
40	TCGA-P5-A780	0	2	0	3	0	0	0	0	0	39	4	0	2	19	0	0	TCGA-P5-A780-01	135	0.3965393058951822	70	TCGA-P5-A780-01	10	15	17	0.023694952657025058	TCGA-P5-A780-01	9	6	1	16	PASS	5287	TCGA-P5-A780	LGG	44	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-16161	Alive	TUMOR FREE	72	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	72	0	72	0	72	0	72	
30	TCGA-P5-A781	0	0	0	3	1	0	0	0	2	13	0	0	0	4	0	0	TCGA-P5-A781-01	69	0.06456682737607605	26	TCGA-P5-A781-01	2	2	24	0.0687713667719964	TCGA-P5-A781-01	1	3	3	7	PASS	5288	TCGA-P5-A781	LGG	34	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-12757	Alive	TUMOR FREE	134	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	134	0	134	0	134	0	134	
40	TCGA-QH-A65R	0	1	0	0	4	0	0	0	0	29	1	0	0	6	0	0	TCGA-QH-A65R-01	68	0.1243759269178878	22	TCGA-QH-A65R-01	4	4	33	0.0842542883805821	TCGA-QH-A65R-01	2	0	2	4	PASS	5289	TCGA-QH-A65R	LGG	38	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2013	NA	-14073	Alive	WITH TUMOR	461	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	461	0	461	NA	NA	0	461	
30	TCGA-QH-A65S	0	0	0	0	1	2	0	0	1	14	0	0	0	5	1	0	TCGA-QH-A65S-01	96	0.23819245578644604	50	TCGA-QH-A65S-01	5	5	31	0.05310916710259237	TCGA-QH-A65S-01	8	1	3	12	PASS	5290	TCGA-QH-A65S	LGG	32	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2013	NA	-11861	Alive	[Discrepancy]	77	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	77	0	77	NA	NA	0	77	
40	TCGA-QH-A65V	0	3	0	2	1	0	0	0	2	18	1	0	1	3	0	0	TCGA-QH-A65V-01	67	0.05116618412677222	27	TCGA-QH-A65V-01	2	2	22	0.05800188315620306	TCGA-QH-A65V-01	2	0	2	4	PASS	5291	TCGA-QH-A65V	LGG	43	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2013	NA	-15850	Alive	WITH TUMOR	384	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	384	0	384	NA	NA	0	384	
30	TCGA-QH-A65X	0	3	0	1	3	0	2	0	2	15	2	0	0	5	0	0	TCGA-QH-A65X-01	61	0.09726213779213833	19	TCGA-QH-A65X-01	4	3	23	0.06383857086388597	TCGA-QH-A65X-01	1	1	3	5	PASS	5292	TCGA-QH-A65X	LGG	28	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2013	NA	-10440	Alive	TUMOR FREE	482	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	482	0	482	NA	NA	0	482	
50	TCGA-QH-A65Z	0	4	0	1	4	2	2	0	0	17	1	0	0	7	0	1	TCGA-QH-A65Z-01	67	0.13405527368842546	18	TCGA-QH-A65Z-01	3	3	33	0.10024115668746954	TCGA-QH-A65Z-01	2	0	3	5	PASS	5293	TCGA-QH-A65Z	LGG	54	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2013	NA	-19921	Alive	TUMOR FREE	427	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	427	0	427	NA	NA	0	427	
40	TCGA-QH-A6CS	0	1	0	0	1	1	0	0	1	16	0	0	0	7	0	0	TCGA-QH-A6CS-01	73	0.2522249001481322	31	TCGA-QH-A6CS-01	11	45	19	9.094634111465072e-05	TCGA-QH-A6CS-01	2	0	0	2	PASS	5294	TCGA-QH-A6CS	LGG	41	MALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-15092	Alive	WITH TUMOR	588	NA	NA	NA	NA	NA	498	Stable Disease	NA	NA	0	588	0	588	NA	NA	1	498	
50	TCGA-QH-A6CU	0	0	0	0	1	0	0	0	0	11	1	0	0	3	0	0	TCGA-QH-A6CU-01	65	0.0833792456035169	22	TCGA-QH-A6CU-01	2	3	28	0.05742004036856072	TCGA-QH-A6CU-01	3	2	3	8	PASS	5295	TCGA-QH-A6CU	LGG	52	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2013	NA	-19149	Alive	TUMOR FREE	451	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	451	0	451	NA	NA	0	451	
50	TCGA-QH-A6CV	0	3	0	0	0	0	0	0	0	38	8	0	1	26	2	0	TCGA-QH-A6CV-01	138	0.7023384138476727	70	TCGA-QH-A6CV-01	33	50	33	0.08458917084782815	TCGA-QH-A6CV-01	4	5	0	9	PASS	5296	TCGA-QH-A6CV	LGG	51	MALE	ASIAN	NA	NA	Oligoastrocytoma	G3	2013	NA	-18955	Alive	WITH TUMOR	442	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	442	0	442	NA	NA	0	442	
40	TCGA-QH-A6CW	1	1	0	0	5	0	5	0	1	32	1	0	1	6	1	0	TCGA-QH-A6CW-01	61	0.06031617309513153	18	TCGA-QH-A6CW-01	0	0	9	0.01060321215654308	TCGA-QH-A6CW-01	4	4	1	9	PASS	5297	TCGA-QH-A6CW	LGG	43	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2013	NA	-15847	Alive	TUMOR FREE	414	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	414	0	414	NA	NA	0	414	
70	TCGA-QH-A6CX	0	2	0	1	1	0	0	0	2	27	3	0	2	10	0	0	TCGA-QH-A6CX-01	90	0.13536878023484136	45	TCGA-QH-A6CX-01	4	6	19	9.366650304664471e-05	TCGA-QH-A6CX-01	1	1	0	2	PASS	5298	TCGA-QH-A6CX	LGG	66	MALE	WHITE	NA	NA	Astrocytoma	G2	2013	NA	-24252	Dead	WITH TUMOR	NA	372	NA	NA	NA	NA	273	Complete Remission/Response	NA	NA	1	372	1	372	1	273	1	273	
40	TCGA-QH-A6CY	0	2	0	0	0	0	0	0	0	14	1	0	0	5	0	0	TCGA-QH-A6CY-01	43	0.08486436615221295	5	TCGA-QH-A6CY-01	3	3	22	0.09942397952728338	TCGA-QH-A6CY-01	0	1	2	3	PASS	5299	TCGA-QH-A6CY	LGG	38	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2013	NA	-14140	Alive	WITH TUMOR	408	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	408	0	408	NA	NA	0	408	
40	TCGA-QH-A6CZ	0	1	0	1	1	1	0	0	0	26	4	0	1	10	1	0	TCGA-QH-A6CZ-01	61	0.21848018205536215	20	TCGA-QH-A6CZ-01	4	5	24	0.08721269259889403	TCGA-QH-A6CZ-01	2	0	2	4	PASS	5300	TCGA-QH-A6CZ	LGG	38	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2013	NA	-14007	Alive	TUMOR FREE	279	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	279	0	279	NA	NA	0	279	
30	TCGA-QH-A6X3	0	3	0	0	3	0	1	0	1	19	0	0	0	2	0	0	TCGA-QH-A6X3-01	54	0.03765303264061727	18	TCGA-QH-A6X3-01	0	1	8	0.02247396401090426	TCGA-QH-A6X3-01	4	3	2	9	PASS	5301	TCGA-QH-A6X3	LGG	27	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2013	NA	-10184	Alive	TUMOR FREE	313	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	313	0	313	0	313	0	313	
50	TCGA-QH-A6X4	1	1	0	1	2	0	0	0	1	20	1	0	0	7	0	0	TCGA-QH-A6X4-01	59	0.18403167488032615	18	TCGA-QH-A6X4-01	3	4	38	0.13267261850248202	TCGA-QH-A6X4-01	3	2	4	9	PASS	5302	TCGA-QH-A6X4	LGG	47	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2013	NA	-17258	Alive	TUMOR FREE	442	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	442	0	442	0	442	0	442	
60	TCGA-QH-A6X5	0	0	1	0	5	0	2	0	2	17	0	0	0	7	0	0	TCGA-QH-A6X5-01	57	0.05609596204931249	17	TCGA-QH-A6X5-01	2	2	15	0.05513459054288583	TCGA-QH-A6X5-01	2	0	2	4	PASS	5303	TCGA-QH-A6X5	LGG	58	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2013	NA	-21239	Alive	NA	497	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	497	0	497	NA	NA	0	497	
60	TCGA-QH-A6X8	0	0	0	2	0	0	1	0	0	21	0	0	1	12	2	0	TCGA-QH-A6X8-01	49	0.21296969981148087	10	TCGA-QH-A6X8-01	4	4	33	0.15794599619239574	TCGA-QH-A6X8-01	2	2	5	9	PASS	5304	TCGA-QH-A6X8	LGG	56	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2013	NA	-20771	Alive	WITH TUMOR	509	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	509	0	509	NA	NA	0	509	
70	TCGA-QH-A6X9	2	2	1	1	2	2	0	0	1	40	1	0	1	13	0	0	TCGA-QH-A6X9-01	107	0.09161926746805242	55	TCGA-QH-A6X9-01	1	6	22	0.036435083039450235	TCGA-QH-A6X9-01	7	7	3	17	PASS	5305	TCGA-QH-A6X9	LGG	73	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2013	NA	-26992	Alive	NA	58	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	58	0	58	NA	NA	0	58	
30	TCGA-QH-A6XA	1	0	0	0	1	0	0	0	0	8	0	0	0	5	0	0	TCGA-QH-A6XA-01	85	0.09437526437739964	39	TCGA-QH-A6XA-01	2	7	6	0.007328267204215905	TCGA-QH-A6XA-01	4	5	1	10	PASS	5306	TCGA-QH-A6XA	LGG	23	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2013	NA	-8508	Alive	TUMOR FREE	502	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	502	0	502	0	502	0	502	
50	TCGA-QH-A6XC	0	2	0	2	4	0	0	0	3	32	3	0	1	16	2	0	TCGA-QH-A6XC-01	88	0.14497192721650734	35	TCGA-QH-A6XC-01	8	5	22	0.06549967841923446	TCGA-QH-A6XC-01	2	1	0	3	PASS	5307	TCGA-QH-A6XC	LGG	48	MALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-17692	Alive	WITH TUMOR	508	NA	NA	NA	NA	NA	438	Complete Remission/Response	NA	NA	0	508	0	508	1	438	1	438	
30	TCGA-QH-A86X	0	0	0	1	1	0	0	0	0	13	2	0	0	4	2	0	TCGA-QH-A86X-01	89	0.06351258206133914	40	TCGA-QH-A86X-01	2	5	15	0.05627668267575666	TCGA-QH-A86X-01	2	0	2	4	PASS	5308	TCGA-QH-A86X	LGG	33	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2013	NA	-12385	Alive	TUMOR FREE	337	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	337	0	337	0	337	0	337	
40	TCGA-QH-A870	0	0	0	0	3	0	0	0	0	13	2	0	0	7	2	0	TCGA-QH-A870-01	65	0.0875765978002304	21	TCGA-QH-A870-01	0	3	17	0.0633831961991239	TCGA-QH-A870-01	5	7	4	16	PASS	5309	TCGA-QH-A870	LGG	38	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2013	NA	-14082	Alive	WITH TUMOR	395	NA	NA	NA	NA	NA	335	Complete Remission/Response	NA	NA	0	395	0	395	1	335	1	335	
40	TCGA-R8-A6MK	0	0	0	1	6	0	3	0	1	15	1	0	0	10	0	0	TCGA-R8-A6MK-01	51	0.08347456657154276	6	TCGA-R8-A6MK-01	2	3	13	0.06827973028426629	TCGA-R8-A6MK-01	2	2	3	7	PASS	5310	TCGA-R8-A6MK	LGG	40	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2005	NA	-14716	Alive	NA	2702	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	2702	0	2702	NA	NA	0	2702	
50	TCGA-R8-A6ML	0	1	0	1	1	1	0	0	0	16	0	0	0	3	0	0	TCGA-R8-A6ML-01	75	0.09891901273227036	33	TCGA-R8-A6ML-01	2	2	32	0.05615565647001775	TCGA-R8-A6ML-01	2	0	2	4	PASS	5311	TCGA-R8-A6ML	LGG	52	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2005	NA	-19185	Alive	NA	2860	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	2860	0	2860	NA	NA	0	2860	
50	TCGA-R8-A6MO	0	1	0	0	0	0	0	0	3	23	2	0	1	12	1	0	TCGA-R8-A6MO-01	76	0.060003798204419874	26	TCGA-R8-A6MO-01	2	2	26	0.06263956066051474	TCGA-R8-A6MO-01	2	2	2	6	PASS	5312	TCGA-R8-A6MO	LGG	53	FEMALE	ASIAN	NA	NA	Oligodendroglioma	G2	2009	NA	-19432	Alive	NA	993	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	993	0	993	NA	NA	0	993	
50	TCGA-R8-A73M	0	2	0	2	1	0	0	0	0	23	0	0	0	8	1	0	TCGA-R8-A73M	0	0	0	TCGA-R8-A73M	0	0	0	0	TCGA-R8-A73M-01	2	2	3	7	PASS	5313	TCGA-R8-A73M	LGG	48	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2008	NA	-17610	Alive	NA	1806	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1806	0	1806	NA	NA	0	1806	
50	TCGA-RY-A83X	0	2	0	1	1	0	0	0	0	11	1	0	0	10	0	1	TCGA-RY-A83X-01	66	0.1948916147284643	21	TCGA-RY-A83X-01	3	4	22	0.10160312630952176	TCGA-RY-A83X-01	3	1	5	9	PASS	5314	TCGA-RY-A83X	LGG	46	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-16911	Alive	TUMOR FREE	939	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	939	0	939	NA	NA	0	939	
50	TCGA-RY-A83Y	0	1	0	1	5	0	0	0	0	20	6	0	1	8	0	0	TCGA-RY-A83Y-01	61	0.059311675734102814	17	TCGA-RY-A83Y-01	2	2	23	0.056384122843001726	TCGA-RY-A83Y-01	1	1	3	5	PASS	5315	TCGA-RY-A83Y	LGG	45	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-16470	Alive	TUMOR FREE	166	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	166	0	166	NA	NA	0	166	
50	TCGA-RY-A83Z	1	3	0	2	2	1	1	1	0	39	2	0	2	12	0	0	TCGA-RY-A83Z-01	126	0.9126105812602164	71	TCGA-RY-A83Z-01	4	6	54	0.18429588665346214	TCGA-RY-A83Z-01	11	9	12	32	PASS	5316	TCGA-RY-A83Z	LGG	54	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-19903	Alive	WITH TUMOR	301	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	301	0	301	NA	NA	0	301	
50	TCGA-RY-A840	0	1	0	1	0	0	0	0	3	11	1	0	0	6	0	0	TCGA-RY-A840-01	55	0.15237244992722476	10	TCGA-RY-A840-01	4	7	27	0.11592952527979215	TCGA-RY-A840-01	4	1	4	9	PASS	5317	TCGA-RY-A840	LGG	47	MALE	[Unknown]	NA	NA	Oligodendroglioma	G3	2012	NA	-17501	Alive	WITH TUMOR	854	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	854	0	854	NA	NA	0	854	
30	TCGA-RY-A843	0	0	0	0	0	1	0	0	0	18	0	0	0	7	1	0	TCGA-RY-A843-01	49	2.900892850469073e-05	15	TCGA-RY-A843-01	0	0	8	0.00037240488550194516	TCGA-RY-A843-01	0	0	0	0	PASS	5318	TCGA-RY-A843	LGG	30	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-11083	Alive	WITH TUMOR	63	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	63	0	63	NA	NA	0	63	
40	TCGA-RY-A845	1	0	0	0	0	0	0	0	0	23	1	0	0	8	0	0	TCGA-RY-A845-01	62	0.05556611004505742	22	TCGA-RY-A845-01	2	1	7	0.006886692521554485	TCGA-RY-A845-01	1	0	1	2	PASS	5319	TCGA-RY-A845	LGG	40	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2013	NA	-14617	Alive	TUMOR FREE	596	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	596	0	596	NA	NA	0	596	
50	TCGA-RY-A847	0	1	0	0	1	1	0	0	0	12	0	1	1	5	0	0	TCGA-RY-A847-01	59	0.08214231517616456	16	TCGA-RY-A847-01	2	2	13	0.05564753802509472	TCGA-RY-A847-01	2	0	2	4	PASS	5320	TCGA-RY-A847	LGG	45	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-16732	Alive	TUMOR FREE	933	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	933	0	933	NA	NA	0	933	
50	TCGA-S9-A6TS	0	4	0	1	0	0	0	0	1	57	3	0	0	17	4	1	TCGA-S9-A6TS-01	83	0.2273622033275517	34	TCGA-S9-A6TS-01	1	2	17	0.04893428090258111	TCGA-S9-A6TS-01	2	1	2	5	PASS	5321	TCGA-S9-A6TS	LGG	48	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2006	NA	-17857	Dead	WITH TUMOR	NA	1891	NA	NA	NA	NA	1324	Progressive Disease	NA	NA	1	1891	1	1891	NA	NA	1	1324	
40	TCGA-S9-A6TU	1	4	0	0	0	0	0	0	0	15	1	0	0	6	0	0	TCGA-S9-A6TU-01	69	0.021349265403140062	25	TCGA-S9-A6TU-01	1	1	5	0.00702535110890754	TCGA-S9-A6TU-01	3	2	1	6	PASS	5322	TCGA-S9-A6TU	LGG	38	MALE	WHITE	NA	NA	Astrocytoma	G2	2007	NA	-14108	Alive	WITH TUMOR	2650	NA	NA	NA	NA	NA	1475	Partial Remission/Response	NA	NA	0	2650	0	2650	NA	NA	1	1475	
50	TCGA-S9-A6TV	0	1	0	0	0	0	0	0	1	30	1	0	0	5	1	0	TCGA-S9-A6TV-01	92	0.2464144878614151	36	TCGA-S9-A6TV-01	0	3	40	0.11159409665909777	TCGA-S9-A6TV-01	5	6	5	16	PASS	5323	TCGA-S9-A6TV	LGG	50	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2010	NA	-18321	Alive	TUMOR FREE	571	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	571	0	571	0	571	0	571	
40	TCGA-S9-A6TW	0	2	1	1	2	1	7	0	0	20	1	0	0	6	0	0	TCGA-S9-A6TW-01	54	0.2281563419067463	16	TCGA-S9-A6TW-01	10	6	44	0.1843370717439467	TCGA-S9-A6TW-01	1	2	3	6	PASS	5324	TCGA-S9-A6TW	LGG	40	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2011	NA	-14679	Alive	TUMOR FREE	1250	NA	NA	NA	NA	NA	861	Partial Remission/Response	NA	NA	0	1250	0	1250	NA	NA	1	861	
50	TCGA-S9-A6TX	0	1	0	2	2	1	0	0	0	31	0	0	0	8	1	0	TCGA-S9-A6TX-01	75	0.0972564408181266	25	TCGA-S9-A6TX-01	4	5	40	0.1127177936318114	TCGA-S9-A6TX-01	4	0	4	8	PASS	5325	TCGA-S9-A6TX	LGG	46	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2011	NA	-17025	Alive	WITH TUMOR	1245	NA	NA	NA	NA	NA	856	Complete Remission/Response	NA	NA	0	1245	0	1245	1	856	1	856	
50	TCGA-S9-A6TY	0	1	0	1	0	0	0	0	0	16	1	0	0	9	0	0	TCGA-S9-A6TY-01	63	0.21534116193381825	15	TCGA-S9-A6TY-01	8	9	30	0.11044376619778054	TCGA-S9-A6TY-01	3	1	4	8	PASS	5326	TCGA-S9-A6TY	LGG	50	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-18564	Alive	WITH TUMOR	1076	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1076	0	1076	NA	NA	0	1076	
40	TCGA-S9-A6TZ	0	0	0	0	1	0	0	0	2	24	0	0	0	17	1	0	TCGA-S9-A6TZ-01	61	0.06466547081442435	18	TCGA-S9-A6TZ-01	1	2	24	0.049958778314567284	TCGA-S9-A6TZ-01	4	2	2	8	PASS	5327	TCGA-S9-A6TZ	LGG	39	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2011	NA	-14592	Alive	WITH TUMOR	1120	NA	NA	NA	NA	NA	552	Partial Remission/Response	NA	NA	0	1120	0	1120	NA	NA	1	552	
50	TCGA-S9-A6U0	0	0	0	0	0	0	0	0	1	34	1	0	1	10	0	0	TCGA-S9-A6U0-01	103	0.11214701196967808	48	TCGA-S9-A6U0-01	4	3	11	0.0018596896149801953	TCGA-S9-A6U0-01	1	2	0	3	PASS	5328	TCGA-S9-A6U0	LGG	46	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-16890	Dead	WITH TUMOR	NA	742	NA	NA	NA	NA	692	Partial Remission/Response	NA	NA	1	742	1	742	NA	NA	1	692	
30	TCGA-S9-A6U1	0	1	0	2	2	0	0	0	1	12	1	0	0	9	0	1	TCGA-S9-A6U1-01	75	0.02756236389490362	25	TCGA-S9-A6U1-01	2	3	7	0.01226065973730026	TCGA-S9-A6U1-01	2	0	1	3	PASS	5329	TCGA-S9-A6U1	LGG	22	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-8271	Alive	TUMOR FREE	785	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	785	0	785	0	785	0	785	
50	TCGA-S9-A6U2	0	1	0	1	0	0	0	0	0	20	2	0	0	7	1	0	TCGA-S9-A6U2-01	57	0.0972265820165854	15	TCGA-S9-A6U2-01	3	3	19	0.08461285433301755	TCGA-S9-A6U2-01	2	0	2	4	PASS	5330	TCGA-S9-A6U2	LGG	48	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-17800	Alive	WITH TUMOR	908	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	908	0	908	NA	NA	0	908	
30	TCGA-S9-A6U5	0	1	0	0	2	1	2	0	0	14	0	0	0	8	0	0	TCGA-S9-A6U5-01	46	0.051559712331957316	9	TCGA-S9-A6U5-01	2	2	12	0.05567362029991716	TCGA-S9-A6U5-01	2	0	2	4	PASS	5331	TCGA-S9-A6U5	LGG	33	MALE	WHITE	NA	NA	Astrocytoma	G2	2011	NA	-12417	Alive	TUMOR FREE	992	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	992	0	992	0	992	0	992	
30	TCGA-S9-A6U6	0	1	0	2	1	1	0	0	2	31	1	0	0	5	1	0	TCGA-S9-A6U6-01	70	0.037587794151234484	23	TCGA-S9-A6U6-01	1	6	13	0.014442601574032632	TCGA-S9-A6U6-01	4	3	1	8	PASS	5332	TCGA-S9-A6U6	LGG	28	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-10253	Alive	TUMOR FREE	1069	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1069	0	1069	0	1069	0	1069	
30	TCGA-S9-A6U8	0	1	0	1	0	0	0	0	0	16	2	0	1	3	0	0	TCGA-S9-A6U8-01	55	2.442806751400069e-05	19	TCGA-S9-A6U8-01	0	1	3	0.0066463178229049895	TCGA-S9-A6U8-01	1	0	1	2	PASS	5333	TCGA-S9-A6U8	LGG	24	MALE	WHITE	NA	NA	Astrocytoma	G2	2005	NA	-9044	Dead	WITH TUMOR	NA	2988	NA	NA	NA	NA	367	Partial Remission/Response	NA	NA	1	2988	1	2988	NA	NA	1	367	
40	TCGA-S9-A6U9	0	0	1	0	3	0	0	0	0	13	0	0	0	11	2	0	TCGA-S9-A6U9-01	130	0.05215191914028803	73	TCGA-S9-A6U9-01	0	0	16	0.010466676723823736	TCGA-S9-A6U9-01	2	0	1	3	PASS	5334	TCGA-S9-A6U9	LGG	36	MALE	WHITE	NA	NA	Astrocytoma	G3	2006	NA	-13460	Alive	WITH TUMOR	2918	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	2918	0	2918	NA	NA	0	2918	
70	TCGA-S9-A6UA	0	3	0	0	3	1	0	0	1	29	1	0	0	11	2	0	TCGA-S9-A6UA-01	57	0.1522299290352014	9	TCGA-S9-A6UA-01	5	7	11	0.04962697112358458	TCGA-S9-A6UA-01	8	7	3	18	PASS	5335	TCGA-S9-A6UA	LGG	66	MALE	WHITE	NA	NA	Astrocytoma	G3	2008	NA	-24242	Dead	WITH TUMOR	NA	178	NA	NA	NA	NA	161	Progressive Disease	NA	NA	1	178	1	178	NA	NA	1	161	
50	TCGA-S9-A6UB	0	1	0	0	1	1	0	0	2	18	1	0	0	11	0	1	TCGA-S9-A6UB-01	77	0.13495756528830066	34	TCGA-S9-A6UB-01	3	3	26	0.08396296017726451	TCGA-S9-A6UB-01	4	1	4	9	PASS	5336	TCGA-S9-A6UB	LGG	52	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2005	NA	-19223	Alive	TUMOR FREE	3761	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3761	0	3761	0	3761	0	3761	
60	TCGA-S9-A6WD	0	4	0	2	1	0	2	0	1	18	1	0	2	15	0	0	TCGA-S9-A6WD-01	69	0.1909673514242804	22	TCGA-S9-A6WD-01	6	25	16	0.1291894653371289	TCGA-S9-A6WD-01	6	4	4	14	PASS	5337	TCGA-S9-A6WD	LGG	58	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2008	NA	-21231	Alive	WITH TUMOR	2289	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	2289	0	2289	NA	NA	0	2289	
30	TCGA-S9-A6WE	0	1	0	1	2	0	0	0	0	7	0	0	0	4	1	0	TCGA-S9-A6WE-01	83	0.0711730823086621	29	TCGA-S9-A6WE-01	2	2	15	0.05628001229579396	TCGA-S9-A6WE-01	2	0	2	4	PASS	5338	TCGA-S9-A6WE	LGG	34	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2004	NA	-12488	Alive	WITH TUMOR	4113	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	4113	0	4113	NA	NA	0	4113	
30	TCGA-S9-A6WG	0	0	0	1	0	0	0	0	1	18	4	0	0	4	0	0	TCGA-S9-A6WG-01	75	0.03098267218394352	28	TCGA-S9-A6WG-01	0	1	4	0.000215590732988024	TCGA-S9-A6WG-01	6	5	0	11	PASS	5339	TCGA-S9-A6WG	LGG	31	MALE	WHITE	NA	NA	Astrocytoma	G3	2007	NA	-11509	Alive	WITH TUMOR	2602	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	2602	0	2602	NA	NA	0	2602	
70	TCGA-S9-A6WH	0	5	0	2	4	1	1	1	3	59	4	0	0	20	2	1	TCGA-S9-A6WH-01	87	0.2730192925967494	36	TCGA-S9-A6WH-01	10	7	11	0.05514849188762206	TCGA-S9-A6WH-01	4	0	2	6	PASS	5340	TCGA-S9-A6WH	LGG	73	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2011	NA	-26904	Alive	WITH TUMOR	1173	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1173	0	1173	NA	NA	0	1173	
60	TCGA-S9-A6WI	0	2	0	1	1	0	1	0	2	18	0	0	0	6	2	0	TCGA-S9-A6WI-01	37	0.005283907779682471	2	TCGA-S9-A6WI-01	2	2	12	0.07365814388627764	TCGA-S9-A6WI-01	0	4	3	7	PASS	5341	TCGA-S9-A6WI	LGG	56	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2006	NA	-20609	Alive	WITH TUMOR	2585	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	2585	0	2585	NA	NA	0	2585	
50	TCGA-S9-A6WL	0	2	1	1	10	1	7	0	0	32	4	0	1	11	3	0	TCGA-S9-A6WL-01	46	0.18199618332557368	9	TCGA-S9-A6WL-01	7	5	36	0.15466763116250462	TCGA-S9-A6WL-01	3	0	2	5	PASS	5342	TCGA-S9-A6WL	LGG	52	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-19234	Alive	WITH TUMOR	946	NA	NA	NA	NA	NA	240	Progressive Disease	NA	NA	0	946	0	946	NA	NA	1	240	
60	TCGA-S9-A6WM	0	2	0	1	2	0	1	0	1	48	3	0	0	14	1	0	TCGA-S9-A6WM-01	137	0.672846007844889	70	TCGA-S9-A6WM-01	9	6	48	0.18397320896839853	TCGA-S9-A6WM-01	0	0	4	4	PASS	5343	TCGA-S9-A6WM	LGG	59	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-21761	Alive	WITH TUMOR	604	NA	NA	NA	NA	NA	505	Partial Remission/Response	NA	NA	0	604	0	604	NA	NA	1	505	
40	TCGA-S9-A6WN	0	4	0	1	3	1	2	0	0	26	0	0	2	5	0	0	TCGA-S9-A6WN-01	52	0.08439676111647543	12	TCGA-S9-A6WN-01	4	3	18	0.0917756295272714	TCGA-S9-A6WN-01	2	2	2	6	PASS	5344	TCGA-S9-A6WN	LGG	38	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-13961	Alive	WITH TUMOR	805	NA	NA	NA	NA	NA	303	Progressive Disease	NA	NA	0	805	0	805	NA	NA	1	303	
30	TCGA-S9-A6WO	0	1	0	0	1	0	0	0	0	21	5	0	0	6	2	0	TCGA-S9-A6WO-01	65	0.08873919249737534	23	TCGA-S9-A6WO-01	3	7	5	0.006775125872098321	TCGA-S9-A6WO-01	5	5	1	11	PASS	5345	TCGA-S9-A6WO	LGG	29	MALE	WHITE	NA	NA	Astrocytoma	G2	2013	NA	-10933	Alive	WITH TUMOR	566	NA	NA	NA	NA	NA	187	Progressive Disease	NA	NA	0	566	0	566	NA	NA	1	187	
40	TCGA-S9-A6WP	0	1	0	1	7	0	4	0	2	18	2	0	2	7	2	0	TCGA-S9-A6WP-01	74	0.13238963765860642	29	TCGA-S9-A6WP-01	3	4	24	0.12187248048231587	TCGA-S9-A6WP-01	6	4	4	14	PASS	5346	TCGA-S9-A6WP	LGG	42	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2013	NA	-15658	Alive	WITH TUMOR	567	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	567	0	567	NA	NA	0	567	
60	TCGA-S9-A6WQ	0	0	0	1	2	0	0	0	0	31	3	0	2	10	0	0	TCGA-S9-A6WQ-01	81	0.05463854032782557	36	TCGA-S9-A6WQ-01	1	2	17	0.05702009267244936	TCGA-S9-A6WQ-01	3	2	3	8	PASS	5347	TCGA-S9-A6WQ	LGG	57	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2013	NA	-21133	Alive	WITH TUMOR	428	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	428	0	428	NA	NA	0	428	
50	TCGA-S9-A7IQ	0	0	0	1	0	1	0	0	2	14	1	0	0	1	0	0	TCGA-S9-A7IQ-01	63	0.1155555490878515	19	TCGA-S9-A7IQ-01	4	3	17	0.06310064489506036	TCGA-S9-A7IQ-01	1	1	2	4	PASS	5348	TCGA-S9-A7IQ	LGG	45	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2011	NA	-16512	Alive	WITH TUMOR	1099	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1099	0	1099	NA	NA	0	1099	
30	TCGA-S9-A7IS	0	2	0	1	2	0	1	0	0	40	3	0	2	12	1	0	TCGA-S9-A7IS-01	135	0.2396187368114956	72	TCGA-S9-A7IS-01	2	3	52	0.1157273140551986	TCGA-S9-A7IS-01	6	7	7	20	PASS	5349	TCGA-S9-A7IS	LGG	33	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2004	NA	-12402	Dead	WITH TUMOR	NA	241	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	241	1	241	NA	NA	1	241	
60	TCGA-S9-A7IX	0	2	0	0	0	0	2	0	0	22	2	0	0	9	1	0	TCGA-S9-A7IX-01	95	0.2715104881381503	34	TCGA-S9-A7IX-01	10	7	47	0.2086337259863215	TCGA-S9-A7IX-01	1	5	4	10	PASS	5350	TCGA-S9-A7IX	LGG	57	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-21095	Dead	WITH TUMOR	NA	819	NA	NA	NA	NA	350	Progressive Disease	NA	NA	1	819	1	819	NA	NA	1	350	
40	TCGA-S9-A7IY	0	1	0	0	3	2	0	0	0	18	1	0	1	4	1	0	TCGA-S9-A7IY-01	65	0.05929364835554288	22	TCGA-S9-A7IY-01	2	3	9	0.05652478436461573	TCGA-S9-A7IY-01	1	0	2	3	PASS	5351	TCGA-S9-A7IY	LGG	39	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2012	NA	-14422	Alive	WITH TUMOR	715	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	715	0	715	NA	NA	0	715	
50	TCGA-S9-A7IZ	0	1	0	1	4	0	1	1	2	20	1	0	1	12	1	0	TCGA-S9-A7IZ-01	146	0.2403876875319365	86	TCGA-S9-A7IZ-01	2	6	30	0.03979240328490855	TCGA-S9-A7IZ-01	10	7	3	20	PASS	5352	TCGA-S9-A7IZ	LGG	48	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-17874	Alive	WITH TUMOR	608	NA	NA	NA	NA	NA	467	Partial Remission/Response	NA	NA	0	608	0	608	NA	NA	1	467	
30	TCGA-S9-A7J0	0	1	0	1	2	0	0	0	1	28	3	0	0	14	2	0	TCGA-S9-A7J0-01	145	0.5249847525189929	88	TCGA-S9-A7J0-01	7	15	42	0.11098277088159536	TCGA-S9-A7J0-01	16	12	7	35	PASS	5353	TCGA-S9-A7J0	LGG	30	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2013	NA	-10989	Alive	WITH TUMOR	609	NA	NA	NA	NA	NA	390	Partial Remission/Response	NA	NA	0	609	0	609	NA	NA	1	390	
40	TCGA-S9-A7J1	0	0	0	0	3	0	1	0	0	19	0	0	0	5	1	0	TCGA-S9-A7J1-01	61	0.06801087199122788	20	TCGA-S9-A7J1-01	2	2	20	0.0803294663127132	TCGA-S9-A7J1-01	2	4	4	10	PASS	5354	TCGA-S9-A7J1	LGG	43	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2013	NA	-15926	Alive	WITH TUMOR	249	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	249	0	249	NA	NA	0	249	
30	TCGA-S9-A7J2	0	0	0	0	1	0	0	0	1	7	1	0	1	2	0	0	TCGA-S9-A7J2-01	47	0.07161614317139423	9	TCGA-S9-A7J2-01	2	3	13	0.05498068253801743	TCGA-S9-A7J2-01	2	0	2	4	PASS	5355	TCGA-S9-A7J2	LGG	25	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2013	NA	-9345	Alive	WITH TUMOR	62	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	62	0	62	NA	NA	0	62	
50	TCGA-S9-A7J3	0	2	0	1	2	1	1	0	1	18	2	0	0	6	2	0	TCGA-S9-A7J3-01	81	0.11070891964487818	32	TCGA-S9-A7J3-01	2	2	21	0.07051291916003614	TCGA-S9-A7J3-01	3	0	3	6	PASS	5356	TCGA-S9-A7J3	LGG	52	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2013	NA	-19056	Alive	WITH TUMOR	629	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	629	0	629	NA	NA	0	629	
50	TCGA-S9-A7QW	0	0	0	0	0	2	1	0	0	24	2	0	0	19	0	0	TCGA-S9-A7QW-01	85	0.23068615600458764	34	TCGA-S9-A7QW-01	2	5	19	0.014508286372303015	TCGA-S9-A7QW-01	6	6	1	13	PASS	5357	TCGA-S9-A7QW	LGG	54	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-19869	Alive	WITH TUMOR	458	NA	NA	NA	NA	NA	382	Complete Remission/Response	NA	NA	0	458	0	458	1	382	1	382	
40	TCGA-S9-A7QX	0	0	0	1	1	0	0	0	0	23	0	0	0	7	1	0	TCGA-S9-A7QX-01	111	0.16757560920829614	65	TCGA-S9-A7QX-01	1	4	21	0.027736112213837504	TCGA-S9-A7QX-01	6	6	2	14	PASS	5358	TCGA-S9-A7QX	LGG	36	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-13332	Alive	WITH TUMOR	564	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	564	0	564	NA	NA	0	564	
40	TCGA-S9-A7QY	0	3	0	1	0	0	0	0	2	31	2	0	1	15	2	0	TCGA-S9-A7QY-01	104	0.19198700226379126	44	TCGA-S9-A7QY-01	5	5	31	0.1293900997350894	TCGA-S9-A7QY-01	4	2	4	10	PASS	5359	TCGA-S9-A7QY	LGG	35	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2012	NA	-12853	Alive	WITH TUMOR	863	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	863	0	863	NA	NA	0	863	
40	TCGA-S9-A7QZ	0	0	0	0	11	0	13	0	1	30	1	0	0	12	2	1	TCGA-S9-A7QZ-01	43	0.11021851423453187	7	TCGA-S9-A7QZ-01	3	4	9	0.055247420164187336	TCGA-S9-A7QZ-01	3	1	2	6	PASS	5360	TCGA-S9-A7QZ	LGG	41	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-15300	Alive	WITH TUMOR	826	NA	NA	NA	NA	NA	774	Partial Remission/Response	NA	NA	0	826	0	826	NA	NA	1	774	
40	TCGA-S9-A7R1	0	0	0	0	0	0	1	0	0	16	2	0	0	1	1	0	TCGA-S9-A7R1-01	47	0.1615256086584831	8	TCGA-S9-A7R1-01	6	5	26	0.07674564934802297	TCGA-S9-A7R1-01	7	4	4	15	PASS	5361	TCGA-S9-A7R1	LGG	35	MALE	WHITE	NA	NA	Oligodendroglioma	G2	1999	NA	-12828	Dead	WITH TUMOR	NA	5166	NA	NA	NA	NA	3637	Stable Disease	NA	NA	1	5166	1	5166	NA	NA	1	3637	
70	TCGA-S9-A7R2	0	3	2	1	0	0	0	0	2	30	5	0	0	14	0	0	TCGA-S9-A7R2-01	95	0.14615102027080296	46	TCGA-S9-A7R2-01	5	4	46	0.09893232028928664	TCGA-S9-A7R2-01	1	4	2	7	PASS	5362	TCGA-S9-A7R2	LGG	69	MALE	WHITE	NA	NA	Astrocytoma	G3	2008	NA	-25419	Dead	WITH TUMOR	NA	316	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	316	1	316	NA	NA	1	316	
30	TCGA-S9-A7R3	0	3	0	1	1	0	1	0	0	23	1	0	0	5	0	0	TCGA-S9-A7R3-01	179	0.06243733513286224	122	TCGA-S9-A7R3-01	0	4	70	0.04145016410681305	TCGA-S9-A7R3-01	5	5	2	12	PASS	5363	TCGA-S9-A7R3	LGG	28	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2006	NA	-10342	Alive	TUMOR FREE	3013	NA	NA	NA	NA	NA	970	Partial Remission/Response	NA	NA	0	3013	0	3013	NA	NA	1	970	
50	TCGA-S9-A7R4	0	1	0	1	0	0	0	0	1	21	1	0	2	7	0	0	TCGA-S9-A7R4-01	70	0.002434649181573978	30	TCGA-S9-A7R4-01	0	1	13	0.01423433934143031	TCGA-S9-A7R4-01	2	2	1	5	PASS	5364	TCGA-S9-A7R4	LGG	46	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-17134	Alive	WITH TUMOR	914	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	914	0	914	NA	NA	0	914	
30	TCGA-S9-A7R7	0	1	0	0	3	1	1	0	2	14	2	0	0	5	1	0	TCGA-S9-A7R7-01	87	0.1015511684777804	42	TCGA-S9-A7R7-01	3	5	32	0.0928352024091491	TCGA-S9-A7R7-01	6	8	5	19	PASS	5365	TCGA-S9-A7R7	LGG	27	MALE	WHITE	NA	NA	Astrocytoma	G2	2006	NA	-10108	Alive	WITH TUMOR	3000	NA	NA	NA	NA	NA	144	Progressive Disease	NA	NA	0	3000	0	3000	NA	NA	1	144	
40	TCGA-S9-A7R8	0	1	1	0	1	0	0	0	0	27	2	0	1	10	0	0	TCGA-S9-A7R8-01	62	0.0965704308395138	15	TCGA-S9-A7R8-01	1	3	19	0.07297465209926962	TCGA-S9-A7R8-01	5	3	4	12	PASS	5366	TCGA-S9-A7R8	LGG	44	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2004	NA	-16275	Dead	WITH TUMOR	NA	961	NA	NA	NA	NA	698	Progressive Disease	NA	NA	1	961	1	961	NA	NA	1	698	
70	TCGA-S9-A89V	0	1	0	0	3	2	0	0	1	32	1	0	1	12	3	0	TCGA-S9-A89V-01	97	0.2514975176447445	41	TCGA-S9-A89V-01	9	13	15	0.03537170794402328	TCGA-S9-A89V-01	8	6	1	15	PASS	5367	TCGA-S9-A89V	LGG	70	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-25570	Alive	WITH TUMOR	569	NA	NA	NA	NA	NA	129	Progressive Disease	NA	NA	0	569	0	569	NA	NA	1	129	
40	TCGA-S9-A89Z	0	0	0	0	1	1	0	0	2	52	2	0	0	12	2	0	TCGA-S9-A89Z-01	111	0.4484958805094237	50	TCGA-S9-A89Z-01	7	7	40	0.11600906995736535	TCGA-S9-A89Z-01	11	5	4	20	PASS	5368	TCGA-S9-A89Z	LGG	40	MALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-14858	Alive	WITH TUMOR	623	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	623	0	623	NA	NA	0	623	
40	TCGA-TM-A7C3	0	4	0	0	0	0	1	0	1	49	6	0	0	18	0	0	TCGA-TM-A7C3-01	161	0.30537690444913085	104	TCGA-TM-A7C3-01	6	3	47	0.05649333895399671	TCGA-TM-A7C3-01	1	1	2	4	PASS	5369	TCGA-TM-A7C3	LGG	43	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2009	NA	-16021	Dead	WITH TUMOR	NA	1666	NA	NA	NA	NA	713	Complete Remission/Response	NA	NA	1	1666	1	1666	1	713	1	713	
40	TCGA-TM-A7C4	0	3	0	1	1	0	0	0	0	33	1	0	0	8	1	0	TCGA-TM-A7C4-01	72	0.09291647474700986	22	TCGA-TM-A7C4-01	1	4	22	0.07188269013072375	TCGA-TM-A7C4-01	5	4	3	12	PASS	5370	TCGA-TM-A7C4	LGG	39	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2010	NA	-14603	Alive	TUMOR FREE	1470	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1470	0	1470	0	1470	0	1470	
30	TCGA-TM-A7C5	0	4	0	2	1	0	0	0	1	20	4	0	0	5	0	0	TCGA-TM-A7C5-01	45	0.7861760404724686	9	TCGA-TM-A7C5-01	5	4	34	0.15286686423472892	TCGA-TM-A7C5-01	2	0	3	5	PASS	5371	TCGA-TM-A7C5	LGG	30	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2010	NA	-11286	Alive	TUMOR FREE	1500	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1500	0	1500	0	1500	0	1500	
40	TCGA-TM-A7CA	1	2	0	1	4	1	2	0	0	24	3	0	0	8	1	0	TCGA-TM-A7CA-01	37	0.05704820232636601	4	TCGA-TM-A7CA-01	1	2	9	0.01837639712503768	TCGA-TM-A7CA-01	4	3	1	8	PASS	5372	TCGA-TM-A7CA	LGG	44	MALE	WHITE	NA	NA	Astrocytoma	G2	2011	NA	-16415	Alive	TUMOR FREE	1058	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1058	0	1058	0	1058	0	1058	
40	TCGA-TM-A7CF	0	0	0	0	1	0	0	0	2	53	0	0	2	6	2	0	TCGA-TM-A7CF-01	283	0.12590321977512148	191	TCGA-TM-A7CF-02	5	2	86	0.1095917415899106	TCGA-TM-A7CF-02	4	2	3	9	mutation call filter	5373	TCGA-TM-A7CF	LGG	41	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2009	NA	-15178	Alive	WITH TUMOR	1989	NA	NA	NA	NA	NA	924	Complete Remission/Response	NA	NA	0	1989	0	1989	1	924	1	924	
40	TCGA-TM-A84B	0	0	0	1	0	0	1	0	0	26	1	0	1	16	2	0	TCGA-TM-A84B-01	230	0.20414318836457487	133	TCGA-TM-A84B-01	6	7	83	0.0964080824086487	TCGA-TM-A84B-01	4	3	3	10	PASS	5374	TCGA-TM-A84B	LGG	40	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-14933	Dead	WITH TUMOR	NA	758	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	758	1	758	NA	NA	1	758	
30	TCGA-TM-A84C	0	1	0	0	0	1	0	0	0	16	0	0	0	3	0	0	TCGA-TM-A84C-01	51	7.968338836079898e-06	12	TCGA-TM-A84C-01	0	0	2	0.00023019457582336078	TCGA-TM-A84C-01	0	0	0	0	PASS	5375	TCGA-TM-A84C	LGG	32	MALE	WHITE	NA	NA	Astrocytoma	G2	2012	NA	-11849	Dead	WITH TUMOR	NA	492	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	492	1	492	NA	NA	1	492	
50	TCGA-TM-A84F	0	0	0	0	1	3	1	0	0	13	0	0	0	3	0	0	TCGA-TM-A84F-01	51	0.048662187374407175	10	TCGA-TM-A84F-01	1	3	12	0.04291481616943906	TCGA-TM-A84F-01	2	2	1	5	PASS	5376	TCGA-TM-A84F	LGG	48	MALE	WHITE	NA	NA	Astrocytoma	G3	2009	NA	-17744	Alive	TUMOR FREE	1796	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1796	0	1796	0	1796	0	1796	
50	TCGA-TM-A84G	0	3	0	2	1	1	1	0	2	21	3	0	0	7	0	0	TCGA-TM-A84G-01	71	0.13018239211658625	28	TCGA-TM-A84G-01	2	4	33	0.1194452325439042	TCGA-TM-A84G-01	1	3	3	7	PASS	5377	TCGA-TM-A84G	LGG	54	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2010	NA	-20014	Alive	TUMOR FREE	1236	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1236	0	1236	0	1236	0	1236	
40	TCGA-TM-A84H	0	3	1	0	4	0	1	0	1	36	2	0	0	5	0	0	TCGA-TM-A84H-01	96	0.2372712376582431	50	TCGA-TM-A84H-01	4	9	16	0.04827800881080846	TCGA-TM-A84H-01	9	6	4	19	PASS	5378	TCGA-TM-A84H	LGG	44	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2012	NA	-16277	Alive	TUMOR FREE	926	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	926	0	926	0	926	0	926	
30	TCGA-TM-A84I	1	2	0	0	2	0	0	0	3	32	1	0	0	5	0	0	TCGA-TM-A84I-01	580	0.5980054274339585	457	TCGA-TM-A84I-01	11	11	85	0.03502376435335893	TCGA-TM-A84I-01	8	4	3	15	PASS	5379	TCGA-TM-A84I	LGG	30	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-11221	Alive	TUMOR FREE	854	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	854	0	854	0	854	0	854	
60	TCGA-TM-A84J	0	2	0	0	1	0	1	0	3	32	0	0	1	15	1	0	TCGA-TM-A84J-01	193	0.21453948010121934	132	TCGA-TM-A84J-01	7	7	22	0.0505448749766128	TCGA-TM-A84J-01	1	1	0	2	PASS	5380	TCGA-TM-A84J	LGG	63	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2012	NA	-23091	Alive	WITH TUMOR	735	NA	NA	NA	NA	NA	454	Progressive Disease	NA	NA	0	735	0	735	NA	NA	1	454	
30	TCGA-TM-A84L	0	1	0	0	1	1	0	0	1	17	1	0	0	4	1	0	TCGA-TM-A84L-01	80	0.03965348185998074	24	TCGA-TM-A84L-01	0	1	21	0.03632013143195477	TCGA-TM-A84L-01	1	3	2	6	PASS	5381	TCGA-TM-A84L	LGG	31	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2010	NA	-11498	Dead	WITH TUMOR	NA	1242	NA	NA	NA	NA	987	Complete Remission/Response	NA	NA	1	1242	1	1242	1	987	1	987	
40	TCGA-TM-A84M	0	2	0	0	1	0	0	0	2	24	1	0	1	6	0	0	TCGA-TM-A84M-01	84	0.14116347986649402	37	TCGA-TM-A84M-01	2	3	23	0.0557531409650675	TCGA-TM-A84M-01	3	1	2	6	PASS	5382	TCGA-TM-A84M	LGG	40	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2012	NA	-14660	Alive	TUMOR FREE	754	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	754	0	754	0	754	0	754	
60	TCGA-TM-A84O	0	0	0	0	1	2	0	0	0	20	1	0	0	9	1	0	TCGA-TM-A84O-01	47	0.05923527711644901	10	TCGA-TM-A84O-01	2	2	12	0.05571012171002188	TCGA-TM-A84O-01	2	0	2	4	PASS	5383	TCGA-TM-A84O	LGG	61	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2011	NA	-22327	Dead	WITH TUMOR	NA	1011	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1011	1	1011	NA	NA	1	1011	
30	TCGA-TM-A84Q	0	2	1	0	1	1	1	0	0	26	1	0	0	6	0	0	TCGA-TM-A84Q-01	106	0.197602597327688	49	TCGA-TM-A84Q-01	2	5	23	0.015721908050652784	TCGA-TM-A84Q-01	7	5	2	14	PASS	5384	TCGA-TM-A84Q	LGG	31	MALE	WHITE	NA	NA	Astrocytoma	G2	2012	NA	-11668	Alive	TUMOR FREE	772	NA	NA	NA	NA	NA	455	Complete Remission/Response	NA	NA	0	772	0	772	1	455	1	455	
50	TCGA-TM-A84R	0	0	0	0	0	0	0	0	0	9	0	0	0	5	0	0	TCGA-TM-A84R-01	51	0.08531916939098297	18	TCGA-TM-A84R-01	2	2	22	0.056429129711725125	TCGA-TM-A84R-01	2	0	3	5	PASS	5385	TCGA-TM-A84R	LGG	46	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-16843	Alive	TUMOR FREE	566	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	566	0	566	0	566	0	566	
40	TCGA-TM-A84S	0	1	0	1	0	0	0	0	1	12	1	0	0	9	0	0	TCGA-TM-A84S-01	59	0.10448207023835812	15	TCGA-TM-A84S-01	3	3	21	0.09887685948564162	TCGA-TM-A84S-01	2	0	3	5	PASS	5386	TCGA-TM-A84S	LGG	36	MALE	WHITE	NA	NA	Oligodendroglioma	G3	2013	NA	-13424	Alive	TUMOR FREE	454	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	454	0	454	0	454	0	454	
20	TCGA-TM-A84T	0	0	0	0	1	0	0	0	1	21	1	0	0	2	0	0	TCGA-TM-A84T-01	78	0.14557199513986874	31	TCGA-TM-A84T-01	0	0	24	0.027356096461004047	TCGA-TM-A84T-01	6	3	2	11	PASS	5387	TCGA-TM-A84T	LGG	19	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2012	NA	-6994	Alive	WITH TUMOR	724	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	724	0	724	NA	NA	0	724	
30	TCGA-TQ-A7RF	0	1	0	1	1	0	0	0	0	21	0	0	1	8	1	0	TCGA-TQ-A7RF-01	99	0.1275824333735258	44	TCGA-TQ-A7RF-01	1	3	23	0.08965011846174549	TCGA-TQ-A7RF-01	8	6	6	20	PASS	5388	TCGA-TQ-A7RF	LGG	27	FEMALE	WHITE	NA	NA	Oligodendroglioma	G3	2012	NA	-9919	Alive	WITH TUMOR	650	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	650	0	650	NA	NA	0	650	
40	TCGA-TQ-A7RG	0	2	0	0	0	2	0	0	1	16	3	0	1	11	1	0	TCGA-TQ-A7RG-01	59	0.06454514844233257	16	TCGA-TQ-A7RG-01	2	3	19	0.055185614709579625	TCGA-TQ-A7RG-01	2	0	2	4	PASS	5389	TCGA-TQ-A7RG	LGG	36	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2012	NA	-13227	Alive	WITH TUMOR	599	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	599	0	599	NA	NA	0	599	
40	TCGA-TQ-A7RH	0	0	0	1	1	0	1	0	3	28	5	0	1	14	0	0	TCGA-TQ-A7RH-01	151	0.25534606919364056	90	TCGA-TQ-A7RH-01	6	9	68	0.16103961326207686	TCGA-TQ-A7RH-01	8	8	6	22	PASS	5390	TCGA-TQ-A7RH	LGG	39	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Oligoastrocytoma	G2	2013	NA	-14524	Alive	WITH TUMOR	486	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	486	0	486	NA	NA	0	486	
40	TCGA-TQ-A7RI	1	4	1	2	3	0	0	0	4	18	2	0	1	2	1	0	TCGA-TQ-A7RI-01	57	0.1400441465284346	15	TCGA-TQ-A7RI-01	5	4	23	0.080629057090479	TCGA-TQ-A7RI-01	4	0	3	7	PASS	5391	TCGA-TQ-A7RI	LGG	37	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-13799	Alive	TUMOR FREE	62	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	62	0	62	NA	NA	0	62	
30	TCGA-TQ-A7RJ	0	5	0	0	1	0	1	0	1	34	3	0	1	15	1	0	TCGA-TQ-A7RJ-01	67	0.07152417480382586	24	TCGA-TQ-A7RJ-01	0	2	10	0.0054281282043021324	TCGA-TQ-A7RJ-01	4	4	0	8	PASS	5392	TCGA-TQ-A7RJ	LGG	25	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2011	NA	-9209	Alive	WITH TUMOR	1229	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1229	0	1229	NA	NA	0	1229	
30	TCGA-TQ-A7RK	1	1	0	2	5	0	2	0	4	35	4	0	0	11	1	0	TCGA-TQ-A7RK-01	97	0.1123914216440427	41	TCGA-TQ-A7RK-01	1	2	24	0.0425513479803588	TCGA-TQ-A7RK-01	8	4	2	14	mutation call filter	5393	TCGA-TQ-A7RK	LGG	29	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2010	NA	-10742	Alive	TUMOR FREE	1341	NA	NA	NA	NA	NA	858	Complete Remission/Response	NA	NA	0	1341	0	1341	1	858	1	858	
40	TCGA-TQ-A7RM	0	7	0	3	2	0	0	0	1	53	2	0	0	13	0	0	TCGA-TQ-A7RM-01	177	0.3903845351323704	98	TCGA-TQ-A7RM-01	9	18	69	0.1621279927672617	TCGA-TQ-A7RM-01	18	16	5	39	PASS	5394	TCGA-TQ-A7RM	LGG	41	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G3	2011	NA	-15154	Alive	WITH TUMOR	1116	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1116	0	1116	NA	NA	0	1116	
30	TCGA-TQ-A7RN	0	1	0	2	0	0	0	0	1	25	0	0	2	6	1	0	TCGA-TQ-A7RN-01	51	0.10677848526122817	10	TCGA-TQ-A7RN-01	2	2	16	0.055506620713457605	TCGA-TQ-A7RN-01	2	0	3	5	PASS	5395	TCGA-TQ-A7RN	LGG	32	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-11823	Alive	WITH TUMOR	1026	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1026	0	1026	NA	NA	0	1026	
30	TCGA-TQ-A7RO	0	0	0	2	0	0	0	0	0	17	0	0	1	6	0	0	TCGA-TQ-A7RO-01	76	0.1748561273074585	26	TCGA-TQ-A7RO-01	4	5	14	0.05516808108307285	TCGA-TQ-A7RO-01	4	2	3	9	PASS	5396	TCGA-TQ-A7RO	LGG	29	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Oligoastrocytoma	G2	2011	NA	-10890	Alive	WITH TUMOR	949	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	949	0	949	NA	NA	0	949	
70	TCGA-TQ-A7RP	0	0	0	0	0	0	0	0	1	31	7	0	0	13	1	0	TCGA-TQ-A7RP-01	47	0.16920197253752767	6	TCGA-TQ-A7RP-01	8	5	2	4.484496032277243e-05	TCGA-TQ-A7RP-01	2	0	0	2	PASS	5397	TCGA-TQ-A7RP	LGG	66	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Oligoastrocytoma	G2	2012	NA	-24109	Alive	WITH TUMOR	914	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	914	0	914	NA	NA	0	914	
40	TCGA-TQ-A7RQ	0	2	0	1	2	0	1	0	1	20	1	0	1	8	1	1	TCGA-TQ-A7RQ-01	43	0.11042507321708316	5	TCGA-TQ-A7RQ-01	4	3	14	0.054868977724440264	TCGA-TQ-A7RQ-01	2	0	2	4	PASS	5398	TCGA-TQ-A7RQ	LGG	38	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-14187	Alive	TUMOR FREE	795	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	795	0	795	0	795	0	795	
40	TCGA-TQ-A7RR	2	3	1	0	3	0	0	0	1	22	0	0	1	8	1	0	TCGA-TQ-A7RR-01	67	0.2468082979786574	26	TCGA-TQ-A7RR-01	6	8	13	0.054092422719812835	TCGA-TQ-A7RR-01	9	5	2	16	PASS	5399	TCGA-TQ-A7RR	LGG	38	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2012	NA	-14022	Alive	TUMOR FREE	787	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	787	0	787	NA	NA	0	787	
30	TCGA-TQ-A7RS	0	1	0	0	1	1	0	0	0	13	1	0	0	4	0	0	TCGA-TQ-A7RS-01	69	0.07245654515343115	24	TCGA-TQ-A7RS-01	2	3	19	0.055769266275603836	TCGA-TQ-A7RS-01	2	0	3	5	PASS	5400	TCGA-TQ-A7RS	LGG	25	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2012	NA	-9172	Alive	TUMOR FREE	-1	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	0	0	0	0	0	0	0	
50	TCGA-TQ-A7RU	0	2	1	0	0	0	0	0	1	24	1	0	0	8	0	0	TCGA-TQ-A7RU-01	49	0.18648949201024695	10	TCGA-TQ-A7RU-01	2	2	10	0.05506974629873485	TCGA-TQ-A7RU-01	2	0	2	4	PASS	5401	TCGA-TQ-A7RU	LGG	51	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-18990	Alive	WITH TUMOR	1032	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1032	0	1032	NA	NA	0	1032	
30	TCGA-TQ-A7RV	0	4	2	0	5	0	3	0	1	34	3	0	0	8	4	0	TCGA-TQ-A7RV-01	135	0.053044063474255804	77	TCGA-TQ-A7RV-02	1	3	32	0.022077725035167858	TCGA-TQ-A7RV-02	8	0	1	9	mutation call filter	5402	TCGA-TQ-A7RV	LGG	27	MALE	WHITE	NA	NA	Astrocytoma	G2	2009	NA	-10167	Alive	WITH TUMOR	1868	NA	NA	NA	NA	NA	530	Partial Remission/Response	NA	NA	0	1868	0	1868	NA	NA	1	530	
30	TCGA-TQ-A7RW	0	1	1	4	0	0	0	1	3	39	1	0	0	16	0	0	TCGA-TQ-A7RW-01	169	0.21128948479365328	97	TCGA-TQ-A7RW-01	4	5	39	0.09953216520612736	TCGA-TQ-A7RW-01	6	7	7	20	PASS	5403	TCGA-TQ-A7RW	LGG	32	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2010	NA	-11804	Dead	WITH TUMOR	NA	821	NA	NA	NA	NA	511	Progressive Disease	NA	NA	1	821	1	821	NA	NA	1	511	
40	TCGA-TQ-A8XE	0	1	0	2	3	0	0	0	1	57	3	0	0	12	3	0	TCGA-TQ-A8XE-01	135	0.14359607089950852	85	TCGA-TQ-A8XE-02	2	5	49	0.07341084689445752	TCGA-TQ-A8XE-02	7	4	6	17	mutation call filter	5404	TCGA-TQ-A8XE	LGG	42	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2010	NA	-15629	Dead	WITH TUMOR	NA	954	NA	NA	NA	NA	455	Partial Remission/Response	NA	NA	1	954	1	954	NA	NA	1	455	
50	TCGA-VM-A8C8	0	2	0	2	1	0	0	0	1	30	2	0	0	15	0	0	TCGA-VM-A8C8-01	133	0.3305782551043158	72	TCGA-VM-A8C8-01	10	12	78	0.234676721191436	TCGA-VM-A8C8-01	7	6	5	18	PASS	5405	TCGA-VM-A8C8	LGG	50	FEMALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-18494	Alive	NA	1397	NA	NA	NA	NA	NA	456	[Unknown]	NA	NA	0	1397	0	1397	NA	NA	1	456	
40	TCGA-VM-A8C9	0	1	0	0	0	0	0	0	0	5	0	0	0	2	0	0	TCGA-VM-A8C9-01	59	0.06270273340587901	26	TCGA-VM-A8C9-01	2	1	5	0.0009898949024926178	TCGA-VM-A8C9-01	0	0	0	0	PASS	5406	TCGA-VM-A8C9	LGG	37	FEMALE	[Not Evaluated]	NA	NA	Astrocytoma	G2	2011	NA	-13663	Alive	TUMOR FREE	1314	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1314	0	1314	0	1314	0	1314	
50	TCGA-VM-A8CA	0	0	0	0	1	0	0	0	0	22	2	0	2	7	0	0	TCGA-VM-A8CA-01	45	0.4325495815908707	11	TCGA-VM-A8CA-01	19	15	25	0.0836654865014757	TCGA-VM-A8CA-01	2	0	2	4	PASS	5407	TCGA-VM-A8CA	LGG	54	MALE	[Unknown]	NA	NA	Oligodendroglioma	G2	2011	NA	-19991	Alive	WITH TUMOR	411	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	411	0	411	NA	NA	0	411	
30	TCGA-VM-A8CB	0	2	0	0	1	0	0	0	1	23	0	0	0	6	0	0	TCGA-VM-A8CB-01	68	0.2402815468529037	19	TCGA-VM-A8CB-01	4	4	31	0.0984707178274565	TCGA-VM-A8CB-01	1	2	3	6	PASS	5408	TCGA-VM-A8CB	LGG	33	MALE	[Unknown]	NA	NA	Oligodendroglioma	G3	2011	NA	-12340	Alive	TUMOR FREE	3	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	3	0	3	NA	NA	0	3	
60	TCGA-VM-A8CD	0	2	0	0	1	0	1	0	0	18	0	1	2	8	0	0	TCGA-VM-A8CD-01	119	0.9207470592270596	63	TCGA-VM-A8CD-01	8	6	67	0.21725359498567687	TCGA-VM-A8CD-01	2	1	2	5	PASS	5409	TCGA-VM-A8CD	LGG	58	MALE	WHITE	NA	NA	Astrocytoma	G3	2012	NA	-21200	Dead	WITH TUMOR	NA	240	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	240	1	240	NA	NA	1	240	
30	TCGA-VM-A8CE	1	0	0	0	0	0	0	0	1	14	0	0	2	4	0	0	TCGA-VM-A8CE-01	57	0.05986349993809504	16	TCGA-VM-A8CE-01	2	2	13	0.05760335443393101	TCGA-VM-A8CE-01	2	0	2	4	PASS	5410	TCGA-VM-A8CE	LGG	25	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2011	NA	-9363	Alive	WITH TUMOR	1191	NA	NA	NA	NA	NA	815	[Unknown]	NA	NA	0	1191	0	1191	NA	NA	1	815	
40	TCGA-VM-A8CF	0	1	0	0	1	0	1	0	0	30	0	0	0	16	1	0	TCGA-VM-A8CF-01	115	0.3760618548957345	57	TCGA-VM-A8CF-01	10	11	9	0.017358755198346114	TCGA-VM-A8CF-01	6	6	1	13	PASS	5411	TCGA-VM-A8CF	LGG	44	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-16334	Alive	TUMOR FREE	609	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	609	0	609	NA	NA	0	609	
30	TCGA-VM-A8CH	0	1	0	0	1	0	0	0	1	6	0	0	0	8	0	0	TCGA-VM-A8CH-01	49	0.01714319325737897	14	TCGA-VM-A8CH-01	1	1	7	0.003097895178208594	TCGA-VM-A8CH-01	1	0	0	1	PASS	5412	TCGA-VM-A8CH	LGG	24	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2013	NA	-9005	Alive	TUMOR FREE	714	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	714	0	714	0	714	0	714	
40	TCGA-VV-A829	0	2	0	0	1	0	0	0	2	27	1	0	2	5	0	0	TCGA-VV-A829-01	76	0.2873571438096772	28	TCGA-VV-A829-01	5	5	26	0.12219705611250953	TCGA-VV-A829-01	3	0	3	6	PASS	5413	TCGA-VV-A829	LGG	44	MALE	WHITE	NA	NA	Oligoastrocytoma	G3	2011	NA	-16163	Alive	TUMOR FREE	1127	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1127	0	1127	NA	NA	0	1127	
40	TCGA-VV-A86M	0	1	0	0	1	0	0	0	0	11	0	0	0	3	1	0	TCGA-VV-A86M-01	62	0.13148686755212902	22	TCGA-VV-A86M-01	0	2	20	0.044469786596715084	TCGA-VV-A86M-01	4	3	3	10	PASS	5414	TCGA-VV-A86M	LGG	36	FEMALE	[Not Evaluated]	NA	NA	Astrocytoma	G3	2013	NA	-13453	Alive	TUMOR FREE	487	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	487	0	487	NA	NA	0	487	
40	TCGA-VW-A7QS	0	3	0	0	3	0	1	0	2	27	2	0	2	12	0	0	TCGA-VW-A7QS-01	103	0.1354492345569517	44	TCGA-VW-A7QS-01	2	3	21	0.07121382560774968	TCGA-VW-A7QS-01	4	3	3	10	PASS	5415	TCGA-VW-A7QS	LGG	35	FEMALE	ASIAN	NA	NA	Oligodendroglioma	G3	2011	NA	-12820	Alive	WITH TUMOR	706	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	706	0	706	NA	NA	0	706	
70	TCGA-VW-A8FI	1	1	1	1	1	0	0	0	2	45	2	0	1	21	1	0	TCGA-VW-A8FI-01	125	0.19100863281146307	55	TCGA-VW-A8FI-01	4	2	18	0.06832933605303927	TCGA-VW-A8FI-01	1	0	2	3	PASS	5416	TCGA-VW-A8FI	LGG	66	MALE	WHITE	NA	NA	Astrocytoma	G3	2013	NA	-24411	Dead	WITH TUMOR	NA	245	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	245	1	245	NA	NA	1	245	
50	TCGA-W9-A837	0	0	0	0	3	0	0	0	0	22	1	0	0	8	1	0	TCGA-W9-A837-01	56	0.10035878198501053	13	TCGA-W9-A837-01	2	2	17	0.06356337061090181	TCGA-W9-A837-01	1	1	2	4	PASS	5417	TCGA-W9-A837	LGG	47	MALE	WHITE	NA	NA	Oligodendroglioma	G2	2010	NA	NA	Alive	WITH TUMOR	1553	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1553	0	1553	NA	NA	0	1553	
70	TCGA-WH-A86K	0	0	0	0	3	0	0	0	1	31	3	0	3	14	0	0	TCGA-WH-A86K-01	169	0.16656682958353194	99	TCGA-WH-A86K-01	1	3	42	0.04076246383213203	TCGA-WH-A86K-01	3	1	0	4	PASS	5418	TCGA-WH-A86K	LGG	65	MALE	WHITE	NA	NA	Astrocytoma	G2	2013	NA	-24055	Alive	WITH TUMOR	405	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	405	0	405	NA	NA	0	405	
30	TCGA-WY-A858	0	0	0	1	5	0	4	0	1	22	1	0	0	9	1	0	TCGA-WY-A858-01	55	0.12006823207431253	15	TCGA-WY-A858-01	2	2	15	0.037505066166302455	TCGA-WY-A858-01	2	0	2	4	PASS	5419	TCGA-WY-A858	LGG	32	FEMALE	WHITE	NA	NA	Astrocytoma	G3	2010	NA	-11855	Alive	TUMOR FREE	1337	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1337	0	1337	0	1337	0	1337	
30	TCGA-WY-A859	0	0	0	2	1	0	0	0	0	27	0	0	1	5	1	0	TCGA-WY-A859-01	149	0.25299427962954385	99	TCGA-WY-A859-01	2	4	84	0.13465092072495266	TCGA-WY-A859-01	9	4	6	19	PASS	5420	TCGA-WY-A859	LGG	34	FEMALE	WHITE	NA	NA	Astrocytoma	G2	2010	NA	-12631	Alive	WITH TUMOR	1213	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1213	0	1213	NA	NA	0	1213	
30	TCGA-WY-A85A	0	0	0	0	3	0	0	0	0	9	0	0	0	6	1	0	TCGA-WY-A85A-01	85	0.06388613158885627	38	TCGA-WY-A85A-01	1	2	17	0.012320250221313108	TCGA-WY-A85A-01	0	0	1	1	PASS	5421	TCGA-WY-A85A	LGG	20	MALE	WHITE	NA	NA	Astrocytoma	G2	2010	NA	-7380	Alive	TUMOR FREE	1320	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1320	0	1320	NA	NA	0	1320	
30	TCGA-WY-A85B	0	1	0	0	0	1	0	0	1	12	0	0	1	3	0	0	TCGA-WY-A85B-01	122	0.2312763288403474	68	TCGA-WY-A85B-01	0	0	12	0.010327980683911005	TCGA-WY-A85B-01	3	0	1	4	PASS	5422	TCGA-WY-A85B	LGG	24	MALE	WHITE	NA	NA	Astrocytoma	G2	2010	NA	-8817	Alive	TUMOR FREE	1393	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1393	0	1393	0	1393	0	1393	
40	TCGA-WY-A85C	0	3	0	0	4	0	0	0	0	18	5	0	3	5	0	0	TCGA-WY-A85C-01	135	0.05271011005610078	75	TCGA-WY-A85C-01	0	2	23	0.036748055789204016	TCGA-WY-A85C-01	3	4	2	9	PASS	5423	TCGA-WY-A85C	LGG	36	MALE	WHITE	NA	NA	Astrocytoma	G2	2010	NA	-13506	Alive	WITH TUMOR	1426	NA	NA	NA	NA	NA	809	Progressive Disease	NA	NA	0	1426	0	1426	NA	NA	1	809	
60	TCGA-WY-A85D	0	2	0	1	0	1	0	0	1	27	2	0	2	11	1	0	TCGA-WY-A85D-01	69	0.0954779866023376	27	TCGA-WY-A85D-01	0	2	29	0.07181246751434019	TCGA-WY-A85D-01	5	9	4	18	PASS	5424	TCGA-WY-A85D	LGG	60	MALE	WHITE	NA	NA	Oligoastrocytoma	G2	2010	NA	-21979	Alive	WITH TUMOR	1147	NA	NA	NA	NA	NA	887	Partial Remission/Response	NA	NA	0	1147	0	1147	NA	NA	1	887	
50	TCGA-WY-A85E	0	6	0	0	1	0	0	0	1	47	7	0	0	21	1	0	TCGA-WY-A85E-01	290	0.21036482813725504	228	TCGA-WY-A85E-01	5	6	67	0.08806511935405757	TCGA-WY-A85E-01	10	13	6	29	PASS	5425	TCGA-WY-A85E	LGG	48	FEMALE	WHITE	NA	NA	Oligoastrocytoma	G2	2011	NA	-17878	Alive	WITH TUMOR	633	NA	NA	NA	NA	NA	532	Partial Remission/Response	NA	NA	0	633	0	633	NA	NA	1	532	
NA	TCGA-2V-A95S	1	14	0	6	3	0	1	0	4	74	5	0	4	33	2	0	TCGA-2V-A95S-01	84	0.245784404807332	30	TCGA-2V-A95S-01	4	8	18	0.035302557735598344	TCGA-2V-A95S-01	7	4	3	14	PASS	5426	TCGA-2V-A95S	LIHC	NA	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	NA	NA	NA	Alive	WITH TUMOR	NA	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	NA	0	NA	0	NA	0	NA	
60	TCGA-2Y-A9GS	0	8	0	7	2	2	0	0	1	57	2	0	0	14	2	0	TCGA-2Y-A9GS-01	109	0.7194765408227801	58	TCGA-2Y-A9GS-01	10	8	72	0.2419914999445114	TCGA-2Y-A9GS-01	4	0	5	9	PASS	5427	TCGA-2Y-A9GS	LIHC	58	MALE	WHITE	[Discrepancy]	NA	Hepatocellular Carcinoma	G2	2006	NA	-21318	Dead	WITH TUMOR	NA	724	NA	Extrahepatic Recurrence	Lung	NA	102	NA	NA	R0	1	724	1	724	1	102	1	102	
50	TCGA-2Y-A9GT	1	9	0	4	3	0	1	0	3	73	3	0	2	20	3	1	TCGA-2Y-A9GT-01	83	0.062187446393712535	36	TCGA-2Y-A9GT-01	1	1	15	0.008328343165642054	TCGA-2Y-A9GT-01	1	0	1	2	PASS	5428	TCGA-2Y-A9GT	LIHC	51	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2006	NA	-18768	Dead	WITH TUMOR	NA	1624	NA	Locoregional Recurrence	Liver	NA	1083	NA	NA	R0	1	1624	1	1624	1	1083	1	1083	
60	TCGA-2Y-A9GU	0	18	0	7	3	4	0	0	8	118	8	1	1	43	4	0	TCGA-2Y-A9GU-01	120	0.3175059088190518	55	TCGA-2Y-A9GU-01	11	13	13	0.04270102515220413	TCGA-2Y-A9GU-01	8	6	3	17	PASS	5429	TCGA-2Y-A9GU	LIHC	55	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2009	NA	-20187	Alive	TUMOR FREE	1939	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1939	0	1939	0	1939	0	1939	
50	TCGA-2Y-A9GV	0	7	0	4	0	2	1	0	3	55	2	0	1	14	1	0	TCGA-2Y-A9GV-01	85	0.09279072646913414	38	TCGA-2Y-A9GV-01	2	2	25	0.07509687638218875	TCGA-2Y-A9GV-01	3	9	7	19	PASS	5430	TCGA-2Y-A9GV	LIHC	54	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2007	NA	-20011	Dead	WITH TUMOR	NA	2532	NA	New Primary Tumor	"Other, specify"	Renal met from prior lung primary	1745	NA	NA	R0	1	2532	1	2532	0	2532	1	1745	
60	TCGA-2Y-A9GW	0	6	1	4	3	1	0	0	5	64	1	0	1	26	0	0	TCGA-2Y-A9GW-01	81	0.7762337558346188	33	TCGA-2Y-A9GW-01	7	11	29	0.02156134450133856	TCGA-2Y-A9GW-01	7	4	1	12	PASS	5431	TCGA-2Y-A9GW	LIHC	64	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2007	NA	-23587	Dead	WITH TUMOR	NA	1271	NA	Locoregional Recurrence	Liver	NA	1229	NA	NA	R0	1	1271	1	1271	1	1229	1	1229	
70	TCGA-2Y-A9GX	0	2	1	1	3	0	0	0	2	46	3	0	1	17	3	0	TCGA-2Y-A9GX-01	40	0.17467408780216476	5	TCGA-2Y-A9GX-01	3	4	29	0.0625284063310831	TCGA-2Y-A9GX-01	8	5	5	18	PASS	5432	TCGA-2Y-A9GX	LIHC	68	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2007	NA	-24963	Alive	WITH TUMOR	2442	NA	NA	Locoregional Recurrence	Liver	NA	2133	NA	NA	R1	0	2442	0	2442	NA	NA	1	2133	
60	TCGA-2Y-A9GY	3	7	1	6	4	1	0	0	6	53	4	0	2	22	2	1	TCGA-2Y-A9GY-01	203	0.69687355817412	115	TCGA-2Y-A9GY-01	27	24	77	0.1858276958060915	TCGA-2Y-A9GY-01	10	8	6	24	PASS	5433	TCGA-2Y-A9GY	LIHC	64	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G3	2007	NA	-23435	Dead	WITH TUMOR	NA	757	NA	Extrahepatic Recurrence	Lung	NA	637	NA	NA	R0	1	757	1	757	1	637	1	637	
80	TCGA-2Y-A9GZ	0	14	1	6	4	2	0	0	4	68	6	0	1	31	4	0	TCGA-2Y-A9GZ-01	353	0.8904208283629073	225	TCGA-2Y-A9GZ-01	16	16	38	0.07098497257992993	TCGA-2Y-A9GZ-01	6	11	5	22	PASS	5434	TCGA-2Y-A9GZ	LIHC	82	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2007	NA	-30082	Dead	WITH TUMOR	NA	848	NA	Locoregional Recurrence	Liver	NA	719	NA	NA	R0	1	848	1	848	1	719	1	719	
50	TCGA-2Y-A9H0	0	15	5	5	2	2	0	0	5	58	4	1	1	18	4	0	TCGA-2Y-A9H0-01	620	0.20610159261576894	439	TCGA-2Y-A9H0-01	8	8	83	0.10413607015923812	TCGA-2Y-A9H0-01	7	4	5	16	PASS	5435	TCGA-2Y-A9H0	LIHC	49	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G1	2004	NA	-18109	Alive	TUMOR FREE	3675	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	3675	0	3675	0	3675	0	3675	
60	TCGA-2Y-A9H1	3	10	2	6	4	0	1	0	9	103	7	0	2	30	4	0	TCGA-2Y-A9H1-01	93	0.39079107712057454	37	TCGA-2Y-A9H1-01	5	7	18	0.03375037011504013	TCGA-2Y-A9H1-01	4	3	2	9	PASS	5436	TCGA-2Y-A9H1	LIHC	58	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2010	NA	-21222	Dead	WITH TUMOR	NA	1229	NA	Locoregional Recurrence	Liver	NA	321	NA	NA	R0	1	1229	1	1229	1	321	1	321	
60	TCGA-2Y-A9H2	0	2	0	3	3	2	2	0	3	39	4	0	0	14	2	1	TCGA-2Y-A9H2-01	142	0.8013140900615449	85	TCGA-2Y-A9H2-01	25	65	55	0.14143905075744362	TCGA-2Y-A9H2-01	15	11	8	34	PASS	5437	TCGA-2Y-A9H2	LIHC	64	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2010	NA	-23653	Alive	TUMOR FREE	1731	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1731	0	1731	0	1731	0	1731	
50	TCGA-2Y-A9H3	0	21	4	16	2	2	0	0	8	139	11	0	1	49	11	0	TCGA-2Y-A9H3-01	158	0.591576832711818	84	TCGA-2Y-A9H3-01	21	17	49	0.0717541039860109	TCGA-2Y-A9H3-01	10	10	2	22	PASS	5438	TCGA-2Y-A9H3	LIHC	45	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G1	2010	NA	-16443	Alive	TUMOR FREE	1516	NA	NA	Locoregional Recurrence	Liver	NA	22	NA	NA	R0	0	1516	0	1516	1	22	1	22	
70	TCGA-2Y-A9H4	1	11	1	5	3	3	0	0	3	54	2	0	2	17	3	0	TCGA-2Y-A9H4-01	186	0.2818485344059405	112	TCGA-2Y-A9H4-01	5	4	49	0.11568062745674484	TCGA-2Y-A9H4-01	7	6	6	19	PASS	5439	TCGA-2Y-A9H4	LIHC	68	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Hepatocellular Carcinoma	G2	2010	NA	-25096	Alive	TUMOR FREE	1452	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1452	0	1452	0	1452	0	1452	
60	TCGA-2Y-A9H5	0	11	0	4	4	2	1	0	7	57	4	0	1	26	2	0	TCGA-2Y-A9H5-01	88	0.5256772530324866	41	TCGA-2Y-A9H5-01	7	8	52	0.17299322823317026	TCGA-2Y-A9H5-01	7	9	9	25	PASS	5440	TCGA-2Y-A9H5	LIHC	59	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2010	NA	-21818	Dead	WITH TUMOR	NA	555	NA	Locoregional Recurrence	Liver	NA	258	NA	NA	R0	1	555	1	555	1	258	1	258	
70	TCGA-2Y-A9H6	1	8	1	8	3	0	2	0	1	43	2	0	1	22	2	0	TCGA-2Y-A9H6-01	239	0.2604119138333977	137	TCGA-2Y-A9H6-01	6	6	69	0.17076794723745808	TCGA-2Y-A9H6-01	8	3	7	18	PASS	5441	TCGA-2Y-A9H6	LIHC	68	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-24982	Alive	NA	357	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	357	0	357	0	357	0	357	
80	TCGA-2Y-A9H7	3	11	1	3	4	0	2	0	1	66	2	1	3	15	1	0	TCGA-2Y-A9H7-01	101	0.16075498697923996	47	TCGA-2Y-A9H7-01	5	4	51	0.11194899229378097	TCGA-2Y-A9H7-01	4	3	3	10	PASS	5442	TCGA-2Y-A9H7	LIHC	81	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-29752	Alive	WITH TUMOR	1168	NA	NA	Locoregional Recurrence	Liver	NA	1117	NA	NA	R0	0	1168	0	1168	1	1117	1	1117	
90	TCGA-2Y-A9H8	1	8	2	10	2	1	0	0	2	58	2	0	2	25	3	0	TCGA-2Y-A9H8-01	176	0.5458655740633981	102	TCGA-2Y-A9H8-01	15	28	119	0.3541880396424225	TCGA-2Y-A9H8-01	17	10	13	40	PASS	5443	TCGA-2Y-A9H8	LIHC	85	FEMALE	WHITE	[Discrepancy]	NA	Hepatocellular Carcinoma	G2	2011	NA	-31322	Dead	WITH TUMOR	NA	633	NA	Extrahepatic Recurrence	"Other, specify"	Kidney	398	NA	NA	R0	1	633	1	633	1	398	1	398	
70	TCGA-2Y-A9H9	1	19	1	2	5	0	2	0	5	99	11	1	2	36	2	0	TCGA-2Y-A9H9-01	348	0.26326483981690263	232	TCGA-2Y-A9H9-01	3	5	45	0.04975574324547302	TCGA-2Y-A9H9-01	2	5	4	11	PASS	5444	TCGA-2Y-A9H9	LIHC	70	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-25670	Alive	WITH TUMOR	697	NA	NA	Locoregional Recurrence	Liver	NA	59	NA	NA	R0	0	697	0	697	1	59	1	59	
70	TCGA-2Y-A9HA	0	23	2	10	6	0	2	0	8	116	9	0	1	37	6	0	TCGA-2Y-A9HA-01	215	0.3649294104473356	133	TCGA-2Y-A9HA-01	5	8	75	0.1379213782442869	TCGA-2Y-A9HA-01	7	6	8	21	PASS	5445	TCGA-2Y-A9HA	LIHC	70	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2012	NA	-25892	Dead	WITH TUMOR	NA	36	NA	NA	NA	NA	NA	NA	NA	R0	1	36	1	36	NA	NA	1	36	
70	TCGA-2Y-A9HB	1	11	2	4	2	1	1	0	4	57	2	0	0	29	3	0	TCGA-2Y-A9HB-01	78	0.15851270731414854	36	TCGA-2Y-A9HB-01	7	7	23	0.04101588866467519	TCGA-2Y-A9HB-01	3	1	2	6	PASS	5446	TCGA-2Y-A9HB	LIHC	66	MALE	[Not Evaluated]	Stage I	NA	Hepatocellular Carcinoma	G2	2012	NA	-24359	Alive	TUMOR FREE	260	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	260	0	260	0	260	0	260	
70	TCGA-3K-AAZ8	1	16	2	7	3	1	1	0	10	109	6	0	1	40	6	0	TCGA-3K-AAZ8-01	77	0.9475351843920076	31	TCGA-3K-AAZ8-01	20	17	11	0.015899021665053803	TCGA-3K-AAZ8-01	5	1	1	7	PASS	5447	TCGA-3K-AAZ8	LIHC	65	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Hepatocellular Carcinoma	G1	2013	NA	-24046	Alive	WITH TUMOR	396	NA	NA	Locoregional Recurrence	Liver	NA	151	NA	NA	RX	0	396	0	396	NA	NA	1	151	
70	TCGA-4R-AA8I	9	154	9	63	115	26	8	1	69	852	33	0	21	309	19	0	TCGA-4R-AA8I-01	164	0.18190211366152964	85	TCGA-4R-AA8I-01	1	2	53	0.10679211076803344	TCGA-4R-AA8I-01	4	7	5	16	hypermutated sample	5448	TCGA-4R-AA8I	LIHC	66	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-24279	Dead	WITH TUMOR	NA	262	NA	Locoregional Recurrence	Liver	NA	158	NA	NA	R0	1	262	1	262	1	158	1	158	
60	TCGA-5C-A9VG	1	9	1	13	4	2	1	0	13	105	7	0	1	60	6	0	TCGA-5C-A9VG-01	83	0.6521566204327435	31	TCGA-5C-A9VG-01	21	19	9	0.02583538591221009	TCGA-5C-A9VG-01	3	7	3	13	PASS	5449	TCGA-5C-A9VG	LIHC	58	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-21273	Alive	TUMOR FREE	328	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	328	0	328	0	328	0	328	
70	TCGA-5C-A9VH	0	12	1	8	7	0	0	0	4	81	3	0	2	23	2	0	TCGA-5C-A9VH-01	82	0.3419375599945554	28	TCGA-5C-A9VH-01	6	6	37	0.11753874981069855	TCGA-5C-A9VH-01	5	2	5	12	PASS	5450	TCGA-5C-A9VH	LIHC	70	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2013	NA	-25608	Alive	TUMOR FREE	322	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	322	0	322	0	322	0	322	
60	TCGA-5C-AAPD	1	4	0	1	3	3	2	0	4	50	3	0	1	19	6	0	TCGA-5C-AAPD-01	146	0.8167825838068269	75	TCGA-5C-AAPD-01	12	13	88	0.3448808028591112	TCGA-5C-AAPD-01	12	6	10	28	PASS	5451	TCGA-5C-AAPD	LIHC	61	MALE	ASIAN	Stage II	NA	Hepatocholangiocarcinoma (Mixed)	G1	2013	NA	-22552	Alive	TUMOR FREE	20	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	20	0	20	0	20	0	20	
60	TCGA-5R-AA1C	0	13	1	11	1	2	2	0	3	72	5	0	1	27	3	2	TCGA-5R-AA1C-01	106	0.8201823845149293	48	TCGA-5R-AA1C-01	11	8	32	0.060181184281777336	TCGA-5R-AA1C-01	4	1	2	7	PASS	5452	TCGA-5R-AA1C	LIHC	57	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-21073	Alive	TUMOR FREE	520	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	520	0	520	0	520	0	520	
20	TCGA-5R-AA1D	0	1	0	2	0	0	0	0	1	14	1	0	0	8	0	0	TCGA-5R-AA1D-01	45	0.1090285630002092	5	TCGA-5R-AA1D-01	4	2	12	0.05238025753743274	TCGA-5R-AA1D-01	1	0	0	1	PASS	5453	TCGA-5R-AA1D	LIHC	17	FEMALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2013	NA	-6545	Alive	TUMOR FREE	449	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	449	0	449	0	449	0	449	
70	TCGA-5R-AAAM	0	9	0	6	2	1	0	0	11	66	8	0	2	23	2	0	TCGA-5R-AAAM-01	105	0.16448548961610865	61	TCGA-5R-AAAM-01	4	3	33	0.07277409501950527	TCGA-5R-AAAM-01	4	3	5	12	PASS	5454	TCGA-5R-AAAM	LIHC	65	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-24020	Dead	TUMOR FREE	NA	46	NA	NA	NA	NA	NA	NA	NA	R0	1	46	0	46	0	46	0	46	
70	TCGA-BC-4072	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BC-4072-01	131	0.2563150668272907	68	TCGA-BC-4072	0	0	0	0	TCGA-BC-4072	0	0	0	0	PASS	5455	TCGA-BC-4072	LIHC	74	FEMALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2005	NA	-27162	Dead	WITH TUMOR	NA	1490	NA	Extrahepatic Recurrence	Lymph Node(s)	NA	475	NA	NA	R1	1	1490	1	1490	NA	NA	1	475	
70	TCGA-BC-4073	0	22	1	1	2	0	2	0	5	108	8	0	5	48	2	0	TCGA-BC-4073-01	617	0.07475711846519963	489	TCGA-BC-4073-01	1	3	162	0.0678044089117723	TCGA-BC-4073-01	6	4	2	12	PASS	5456	TCGA-BC-4073	LIHC	73	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2009	NA	-26795	Alive	WITH TUMOR	849	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	849	0	849	NA	NA	0	849	
70	TCGA-BC-A10Q	1	2	0	2	3	0	1	0	0	27	2	0	0	14	1	0	TCGA-BC-A10Q-01	100	0.6241963324197174	47	TCGA-BC-A10Q-01	22	61	9	0.1257105132383813	TCGA-BC-A10Q-01	7	3	5	15	pathology review	5457	TCGA-BC-A10Q	LIHC	72	FEMALE	WHITE	NA	NA	Hepatocellular Carcinoma	NA	1998	NA	-26400	Dead	WITH TUMOR	NA	1135	NA	Intrahepatic Recurrence	NA	NA	340	NA	NA	R1	1	1135	1	1135	NA	NA	1	340	
70	TCGA-BC-A10R	0	4	0	3	0	4	0	0	3	95	6	0	0	27	2	0	TCGA-BC-A10R-01	533	0.7030436563941729	379	TCGA-BC-A10R-01	22	30	68	0.2287018711659726	TCGA-BC-A10R-01	10	9	7	26	PASS	5458	TCGA-BC-A10R	LIHC	66	FEMALE	WHITE	NA	NA	Hepatocellular Carcinoma	G2	1999	NA	-24274	Dead	WITH TUMOR	NA	308	NA	Intrahepatic Recurrence	NA	NA	199	NA	NA	R0	1	308	1	308	1	199	1	199	
80	TCGA-BC-A10S	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BC-A10S-01	96	0.2052613559984475	42	TCGA-BC-A10S-01	8	8	8	0.1806900554513274	TCGA-BC-A10S-01	4	0	3	7	PASS	5459	TCGA-BC-A10S	LIHC	81	MALE	WHITE	NA	NA	Hepatocellular Carcinoma	G1	1999	NA	-29842	Dead	WITH TUMOR	NA	1423	NA	Intrahepatic Recurrence	NA	NA	1130	NA	NA	R0	1	1423	1	1423	1	1130	1	1130	
80	TCGA-BC-A10T	2	12	0	5	2	0	0	0	3	57	2	1	2	26	3	0	TCGA-BC-A10T-01	558	0.2627496042054087	375	TCGA-BC-A10T-01	3	8	44	0.14707659829527156	TCGA-BC-A10T-01	12	12	9	33	PASS	5460	TCGA-BC-A10T	LIHC	76	MALE	WHITE	NA	NA	Hepatocellular Carcinoma	G1	2000	NA	-27944	Dead	WITH TUMOR	NA	837	NA	Extrahepatic Recurrence	Pulmonary	NA	598	NA	NA	R1	1	837	1	837	NA	NA	1	598	
70	TCGA-BC-A10U	1	16	1	3	7	3	0	0	3	104	9	0	3	28	5	0	TCGA-BC-A10U-01	121	0.3541160551245503	60	TCGA-BC-A10U-01	9	8	15	0.10989347567830574	TCGA-BC-A10U-01	4	5	4	13	PASS	5461	TCGA-BC-A10U	LIHC	69	MALE	WHITE	NA	NA	Hepatocellular Carcinoma	G2	2000	NA	-25305	Dead	WITH TUMOR	NA	837	NA	Intrahepatic Recurrence	NA	NA	586	NA	NA	R1	1	837	1	837	NA	NA	1	586	
50	TCGA-BC-A10W	0	12	2	3	2	3	1	0	5	79	4	0	2	34	3	0	TCGA-BC-A10W-01	132	0.2761095023336415	61	TCGA-BC-A10W-01	4	14	11	0.12969412826107232	TCGA-BC-A10W-01	8	9	7	24	PASS	5462	TCGA-BC-A10W	LIHC	50	MALE	ASIAN	NA	NA	Hepatocellular Carcinoma	G3	2002	NA	-18562	Dead	WITH TUMOR	NA	91	NA	NA	NA	NA	NA	NA	NA	R1	1	91	1	91	NA	NA	1	91	
50	TCGA-BC-A10X	0	1	0	0	0	0	0	0	0	1	0	0	0	3	0	0	TCGA-BC-A10X-01	67	8.488672483018105e-05	28	TCGA-BC-A10X-01	0	0	3	6.478512605622908e-05	TCGA-BC-A10X-01	0	0	0	0	PASS	5463	TCGA-BC-A10X	LIHC	52	FEMALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2002	NA	-19140	Dead	TUMOR FREE	NA	770	NA	NA	NA	NA	NA	NA	NA	R0	1	770	0	770	0	770	0	770	
80	TCGA-BC-A10Y	0	9	1	2	1	0	0	0	4	47	3	0	0	20	1	1	TCGA-BC-A10Y-01	767	0.2805787226264024	603	TCGA-BC-A10Y-01	2	7	51	0.11261908730081555	TCGA-BC-A10Y-01	7	15	7	29	PASS	5464	TCGA-BC-A10Y	LIHC	76	MALE	WHITE	NA	NA	Hepatocellular Carcinoma	G3	2002	NA	-28049	Dead	WITH TUMOR	NA	711	NA	Intrahepatic Recurrence	NA	NA	400	NA	NA	R0	1	711	1	711	1	400	1	400	
60	TCGA-BC-A10Z	2	19	5	5	16	2	1	0	7	134	10	0	3	44	2	1	TCGA-BC-A10Z-01	786	0.20120688144166826	604	TCGA-BC-A10Z-01	2	5	63	0.06609628066677628	TCGA-BC-A10Z-01	4	9	6	19	PASS	5465	TCGA-BC-A10Z	LIHC	62	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2003	NA	-22913	Dead	TUMOR FREE	NA	34	NA	NA	NA	NA	NA	NA	NA	R0	1	34	0	34	0	34	0	34	
50	TCGA-BC-A110	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BC-A110-01	111	4.1720539750671255e-05	61	TCGA-BC-A110-01	0	0	19	2.8235086658949506e-06	TCGA-BC-A110-01	0	0	0	0	PASS	5466	TCGA-BC-A110	LIHC	51	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Hepatocellular Carcinoma	G1	2003	NA	-18951	Dead	WITH TUMOR	NA	2116	NA	Extrahepatic Recurrence	"Other, specify"	spleen	2057	NA	NA	R0	1	2116	1	2116	1	2057	1	2057	
80	TCGA-BC-A112	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BC-A112-01	195	0.8893399305634275	103	TCGA-BC-A112-01	23	24	18	0.06096476357997355	TCGA-BC-A112-01	8	7	3	18	PASS	5467	TCGA-BC-A112	LIHC	80	MALE	WHITE	NA	NA	Hepatocellular Carcinoma	G2	2009	NA	-29511	Dead	TUMOR FREE	NA	153	NA	NA	NA	NA	NA	NA	NA	R0	1	153	0	153	0	153	0	153	
60	TCGA-BC-A216	0	9	0	4	1	0	1	1	1	55	4	0	0	17	3	0	TCGA-BC-A216-01	567	0.20920491834003294	386	TCGA-BC-A216-01	5	5	93	0.08408172626926362	TCGA-BC-A216-01	7	7	6	20	PASS	5468	TCGA-BC-A216	LIHC	62	FEMALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2008	NA	-22968	Alive	TUMOR FREE	1351	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1351	0	1351	0	1351	0	1351	
80	TCGA-BC-A217	1	16	0	6	3	0	0	0	7	87	3	0	4	31	1	0	TCGA-BC-A217-01	574	0.7918826096852647	395	TCGA-BC-A217-01	23	19	16	0.07037000550602189	TCGA-BC-A217-01	14	16	4	34	PASS	5469	TCGA-BC-A217	LIHC	75	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G3	2010	NA	-27411	Dead	TUMOR FREE	NA	1397	NA	NA	NA	NA	NA	NA	NA	R0	1	1397	0	1397	0	1397	0	1397	
70	TCGA-BC-A3KF	2	13	1	9	3	1	0	0	4	70	3	0	2	29	2	0	TCGA-BC-A3KF-01	157	0.7008155386925023	76	TCGA-BC-A3KF-01	7	12	47	0.2572627947887209	TCGA-BC-A3KF-01	15	9	10	34	PASS	5470	TCGA-BC-A3KF	LIHC	66	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-24328	Alive	TUMOR FREE	8	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	8	0	8	0	8	0	8	
70	TCGA-BC-A3KG	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BC-A3KG-01	477	0.4612753201540453	342	TCGA-BC-A3KG-01	7	11	75	0.1716090571995756	TCGA-BC-A3KG-01	8	8	8	24	PASS	5471	TCGA-BC-A3KG	LIHC	68	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G3	2011	NA	-25061	Alive	WITH TUMOR	680	NA	NA	Intrahepatic Recurrence	Liver	NA	209	NA	NA	R0	0	680	0	680	1	209	1	209	
70	TCGA-BC-A5W4	0	10	0	2	2	0	1	0	3	55	3	0	1	18	3	0	TCGA-BC-A5W4-01	249	0.9445109708169008	185	TCGA-BC-A5W4-01	16	14	104	0.22835273443477025	TCGA-BC-A5W4-01	11	8	11	30	PASS	5472	TCGA-BC-A5W4	LIHC	69	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2012	NA	-25503	Dead	TUMOR FREE	NA	547	NA	Locoregional Recurrence	NA	NA	384	NA	NA	R1	1	547	0	547	NA	NA	1	384	
60	TCGA-BC-A69H	0	16	1	8	2	0	0	0	6	84	5	0	3	36	3	0	TCGA-BC-A69H-01	142	0.541832318763759	82	TCGA-BC-A69H-01	18	61	55	0.2148908128846493	TCGA-BC-A69H-01	13	4	6	23	PASS	5473	TCGA-BC-A69H	LIHC	64	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G3	2013	NA	-23380	Alive	TUMOR FREE	444	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	444	0	444	0	444	0	444	
70	TCGA-BC-A69I	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BC-A69I-01	89	0.1851219791039886	37	TCGA-BC-A69I-01	5	4	17	0.05582055652610589	TCGA-BC-A69I-01	4	1	2	7	PASS	5474	TCGA-BC-A69I	LIHC	69	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2013	NA	-25370	Alive	TUMOR FREE	387	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	387	0	387	0	387	0	387	
70	TCGA-BC-A8YO	0	14	0	4	6	1	1	0	3	49	3	1	1	19	0	1	TCGA-BC-A8YO-01	506	0.14613848469420188	362	TCGA-BC-A8YO-01	3	7	96	0.0945350594005098	TCGA-BC-A8YO-01	6	5	8	19	PASS	5475	TCGA-BC-A8YO	LIHC	66	FEMALE	WHITE	Stage IIIC	NA	Hepatocellular Carcinoma	G3	2013	NA	-24189	Alive	WITH TUMOR	562	NA	NA	Locoregional Recurrence	Liver	NA	220	NA	NA	R0	0	562	0	562	1	220	1	220	
70	TCGA-BD-A2L6	0	10	1	6	3	5	1	0	1	55	4	1	1	16	1	0	TCGA-BD-A2L6-01	170	0.15352430875125742	87	TCGA-BD-A2L6-01	6	6	18	0.04574767602663725	TCGA-BD-A2L6-01	2	7	4	13	PASS	5476	TCGA-BD-A2L6	LIHC	69	MALE	WHITE	NA	NA	Hepatocellular Carcinoma	G2	2011	NA	-25489	Alive	WITH TUMOR	1363	NA	NA	Intrahepatic Recurrence	Liver	NA	415	NA	NA	R0	0	1363	0	1363	1	415	1	415	
80	TCGA-BD-A3EP	2	12	0	4	5	2	0	0	0	91	6	0	1	21	2	0	TCGA-BD-A3EP-01	120	0.5189022181147568	61	TCGA-BD-A3EP-01	25	54	17	0.170394799737855	TCGA-BD-A3EP-01	6	6	6	18	PASS	5477	TCGA-BD-A3EP	LIHC	75	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Hepatocellular Carcinoma	G2	2010	NA	-27756	Alive	TUMOR FREE	409	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	409	0	409	0	409	0	409	
60	TCGA-BD-A3ER	1	9	1	2	1	1	1	0	2	38	6	0	1	16	2	0	TCGA-BD-A3ER	0	0	0	TCGA-BD-A3ER	0	0	0	0	TCGA-BD-A3ER-01	2	3	1	6	PASS	5478	TCGA-BD-A3ER	LIHC	62	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2011	NA	-22657	Alive	WITH TUMOR	1115	NA	NA	Locoregional Recurrence	Liver	NA	226	NA	NA	R0	0	1115	0	1115	1	226	1	226	
50	TCGA-BW-A5NO	0	11	0	2	3	0	1	0	3	97	6	0	1	33	4	0	TCGA-BW-A5NO-01	469	0.6716699145078351	318	TCGA-BW-A5NO-01	21	54	41	0.08304550461947215	TCGA-BW-A5NO-01	14	8	3	25	PASS	5479	TCGA-BW-A5NO	LIHC	50	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2010	NA	-18510	Alive	TUMOR FREE	20	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	20	0	20	NA	NA	0	20	
30	TCGA-BW-A5NP	0	10	0	3	1	1	0	1	3	63	5	0	0	21	0	0	TCGA-BW-A5NP-01	154	0.7382378323674316	73	TCGA-BW-A5NP	0	0	0	0	TCGA-BW-A5NP	0	0	0	0	PASS	5480	TCGA-BW-A5NP	LIHC	26	FEMALE	WHITE	Stage IV	NA	Hepatocellular Carcinoma	G3	2010	NA	-9809	Alive	WITH TUMOR	0	NA	NA	Extrahepatic Recurrence	Liver	NA	102	NA	NA	RX	0	0	0	0	NA	NA	1	102	
60	TCGA-BW-A5NQ	0	9	0	4	2	3	1	1	5	74	7	0	1	30	1	1	TCGA-BW-A5NQ-01	57	0.8807272867543416	15	TCGA-BW-A5NQ-01	34	39	11	0.021038969559430645	TCGA-BW-A5NQ-01	2	0	1	3	PASS	5481	TCGA-BW-A5NQ	LIHC	63	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2010	NA	-23353	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	0	0	0	NA	NA	0	0	
50	TCGA-CC-5258	0	16	2	13	8	1	0	0	6	105	4	0	0	26	8	0	TCGA-CC-5258-01	191	0.44587565720816136	110	TCGA-CC-5258-01	11	18	42	0.2230802232286805	TCGA-CC-5258-01	11	12	3	26	PASS	5482	TCGA-CC-5258	LIHC	48	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G2	2010	NA	-17586	Dead	TUMOR FREE	NA	129	NA	NA	NA	NA	NA	NA	NA	RX	1	129	0	129	NA	NA	0	129	
60	TCGA-CC-5259	0	12	0	4	4	0	0	0	11	112	13	0	5	38	4	1	TCGA-CC-5259	0	0	0	TCGA-CC-5259	0	0	0	0	TCGA-CC-5259	0	0	0	0	PASS	5483	TCGA-CC-5259	LIHC	60	FEMALE	ASIAN	Stage IIIC	NA	Hepatocellular Carcinoma	G2	2010	NA	-21946	Alive	WITH TUMOR	250	NA	NA	Locoregional Recurrence	Liver	NA	180	NA	NA	R0	0	250	0	250	1	180	1	180	
60	TCGA-CC-5260	0	8	0	6	4	1	1	0	5	42	1	0	1	15	3	0	TCGA-CC-5260-01	164	0.3173789817439736	89	TCGA-CC-5260-01	7	7	29	0.1868227093933197	TCGA-CC-5260-01	7	4	6	17	PASS	5484	TCGA-CC-5260	LIHC	61	FEMALE	ASIAN	Stage IIIC	NA	Hepatocellular Carcinoma	G1	2010	NA	-22345	Dead	TUMOR FREE	NA	87	NA	NA	NA	NA	NA	NA	NA	RX	1	87	0	87	NA	NA	0	87	
40	TCGA-CC-5261	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CC-5261-01	122	0.4561239442361083	70	TCGA-CC-5261-01	15	28	32	0.2397702921490792	TCGA-CC-5261-01	15	7	6	28	PASS	5485	TCGA-CC-5261	LIHC	44	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G2	2010	NA	-16373	Dead	TUMOR FREE	NA	97	NA	NA	NA	NA	NA	NA	NA	RX	1	97	0	97	NA	NA	0	97	
70	TCGA-CC-5262	2	13	2	6	2	2	0	0	5	104	9	0	1	34	7	0	TCGA-CC-5262-01	79	0.14581773507841225	33	TCGA-CC-5262-01	5	6	9	0.09691105886065672	TCGA-CC-5262-01	8	3	3	14	PASS	5486	TCGA-CC-5262	LIHC	67	MALE	ASIAN	Stage IIIC	NA	Hepatocellular Carcinoma	G1	2010	NA	-24787	Dead	TUMOR FREE	NA	103	NA	NA	NA	NA	NA	NA	NA	NA	1	103	0	103	NA	NA	0	103	
40	TCGA-CC-5263	1	15	1	6	3	0	0	0	3	89	13	0	0	37	2	1	TCGA-CC-5263-01	515	0.39003990375761627	348	TCGA-CC-5263-01	8	11	72	0.18151321906874485	TCGA-CC-5263-01	10	12	12	34	PASS	5487	TCGA-CC-5263	LIHC	35	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G1	2010	NA	-12863	Dead	TUMOR FREE	NA	129	NA	NA	NA	NA	NA	NA	NA	RX	1	129	0	129	NA	NA	0	129	
70	TCGA-CC-5264	0	8	2	0	3	1	0	0	9	71	9	0	1	29	3	1	TCGA-CC-5264-01	160	0.8176399813424505	79	TCGA-CC-5264-01	24	25	33	0.37145913295042776	TCGA-CC-5264-01	10	7	9	26	PASS	5488	TCGA-CC-5264	LIHC	71	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2010	NA	-25979	Dead	TUMOR FREE	NA	102	NA	NA	NA	NA	NA	NA	NA	RX	1	102	0	102	NA	NA	0	102	
30	TCGA-CC-A123	0	8	0	6	2	1	2	0	5	62	5	0	1	22	2	0	TCGA-CC-A123	0	0	0	TCGA-CC-A123	0	0	0	0	TCGA-CC-A123	0	0	0	0	PASS	5489	TCGA-CC-A123	LIHC	24	FEMALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G1	2010	NA	-9107	Alive	WITH TUMOR	219	NA	NA	New Primary Tumor	Lung	NA	145	NA	NA	RX	0	219	0	219	NA	NA	1	145	
50	TCGA-CC-A1HT	0	6	1	6	4	1	0	0	9	73	5	0	0	22	4	0	TCGA-CC-A1HT-01	120	0.210070667383722	61	TCGA-CC-A1HT-01	14	21	17	0.17459587591929776	TCGA-CC-A1HT-01	11	8	7	26	PASS	5490	TCGA-CC-A1HT	LIHC	50	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2010	NA	-18553	Dead	TUMOR FREE	NA	101	NA	NA	NA	NA	NA	NA	NA	NA	1	101	0	101	NA	NA	0	101	
50	TCGA-CC-A3M9	1	9	1	5	1	2	0	0	4	110	5	0	1	45	4	1	TCGA-CC-A3M9-01	188	0.598569729077126	101	TCGA-CC-A3M9-01	23	36	49	0.27758048971583577	TCGA-CC-A3M9-01	14	11	12	37	PASS	5491	TCGA-CC-A3M9	LIHC	45	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2011	NA	-16460	Dead	WITH TUMOR	NA	300	NA	Locoregional Recurrence	NA	NA	219	NA	NA	R0	1	300	1	300	1	219	1	219	
60	TCGA-CC-A3MA	0	5	1	1	2	1	1	0	5	35	1	0	0	14	1	0	TCGA-CC-A3MA-01	167	0.8914306772221016	91	TCGA-CC-A3MA-01	8	12	46	0.2747725057534207	TCGA-CC-A3MA-01	16	7	12	35	PASS	5492	TCGA-CC-A3MA	LIHC	61	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2011	NA	-22375	Dead	WITH TUMOR	NA	303	NA	Locoregional Recurrence	NA	NA	261	NA	NA	R0	1	303	1	303	1	261	1	261	
40	TCGA-CC-A3MB	0	6	1	1	2	0	1	0	2	62	4	0	1	26	2	0	TCGA-CC-A3MB-01	157	0.5737920512948085	89	TCGA-CC-A3MB-01	20	33	29	0.24911098092354386	TCGA-CC-A3MB-01	13	11	3	27	PASS	5493	TCGA-CC-A3MB	LIHC	36	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G1	2011	NA	-13255	Dead	WITH TUMOR	NA	315	NA	New Primary Tumor	Lung	NA	260	NA	NA	R0	1	315	1	315	0	315	1	260	
50	TCGA-CC-A3MC	1	11	1	4	4	2	0	0	4	79	8	0	2	25	3	1	TCGA-CC-A3MC-01	114	0.5713694968533336	53	TCGA-CC-A3MC-01	6	10	12	0.08542591694030464	TCGA-CC-A3MC-01	10	10	5	25	PASS	5494	TCGA-CC-A3MC	LIHC	54	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2011	NA	-20067	Alive	WITH TUMOR	363	NA	NA	Locoregional Recurrence	Liver	NA	297	NA	NA	R0	0	363	0	363	1	297	1	297	
60	TCGA-CC-A5UC	0	6	1	0	2	0	0	0	3	42	2	0	2	19	2	0	TCGA-CC-A5UC-01	79	0.5082759285976676	32	TCGA-CC-A5UC-01	19	21	33	0.1034652234243486	TCGA-CC-A5UC-01	9	5	5	19	PASS	5495	TCGA-CC-A5UC	LIHC	63	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2012	NA	-23156	Dead	WITH TUMOR	NA	347	NA	New Primary Tumor	Lung	NA	312	NA	NA	R0	1	347	1	347	0	347	1	312	
50	TCGA-CC-A5UD	0	12	2	10	5	1	0	0	10	157	13	0	4	57	7	2	TCGA-CC-A5UD-01	96	0.9463476092883576	45	TCGA-CC-A5UD-01	19	33	58	0.2277895106155738	TCGA-CC-A5UD-01	13	4	6	23	PASS	5496	TCGA-CC-A5UD	LIHC	45	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2012	NA	-16702	Dead	WITH TUMOR	NA	304	NA	Locoregional Recurrence	NA	NA	182	NA	NA	R0	1	304	1	304	1	182	1	182	
50	TCGA-CC-A5UE	1	9	1	8	3	3	1	0	5	106	6	0	5	30	1	1	TCGA-CC-A5UE-01	85	0.7918839273540462	31	TCGA-CC-A5UE-01	25	42	45	0.16922521715981656	TCGA-CC-A5UE-01	16	12	6	34	PASS	5497	TCGA-CC-A5UE	LIHC	48	MALE	ASIAN	Stage IIIB	NA	Hepatocellular Carcinoma	G2	2012	NA	-17805	Dead	WITH TUMOR	NA	272	NA	Locoregional Recurrence	NA	NA	175	NA	NA	R0	1	272	1	272	1	175	1	175	
60	TCGA-CC-A7IE	1	32	0	9	6	2	1	0	14	127	7	0	2	44	9	0	TCGA-CC-A7IE-01	146	0.8551152088322853	88	TCGA-CC-A7IE-01	20	18	69	0.10007995632037114	TCGA-CC-A7IE-01	11	11	6	28	PASS	5498	TCGA-CC-A7IE	LIHC	57	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2012	NA	-20985	Dead	WITH TUMOR	NA	217	NA	New Primary Tumor	Lung	NA	169	NA	NA	R0	1	217	1	217	0	217	1	169	
60	TCGA-CC-A7IF	2	18	3	9	3	2	1	0	9	98	4	0	4	31	3	0	TCGA-CC-A7IF-01	122	0.3336086315581576	50	TCGA-CC-A7IF-01	11	12	41	0.07966800115918597	TCGA-CC-A7IF-01	10	7	6	23	PASS	5499	TCGA-CC-A7IF	LIHC	59	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G1	2013	NA	-21845	Dead	WITH TUMOR	NA	649	NA	New Primary Tumor	Lung	NA	254	NA	NA	R0	1	649	1	649	0	649	1	254	
50	TCGA-CC-A7IG	2	17	0	9	3	1	1	1	10	116	8	0	3	38	1	1	TCGA-CC-A7IG-01	143	0.7497520413783817	77	TCGA-CC-A7IG-01	18	45	91	0.31658354630092905	TCGA-CC-A7IG-01	26	22	15	63	PASS	5500	TCGA-CC-A7IG	LIHC	47	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-17453	Dead	WITH TUMOR	NA	299	NA	Locoregional Recurrence	NA	NA	195	NA	NA	R0	1	299	1	299	1	195	1	195	
60	TCGA-CC-A7IH	5	90	5	47	5	4	6	0	32	594	37	0	16	233	29	0	TCGA-CC-A7IH-01	152	0.8395053765778993	84	TCGA-CC-A7IH-01	7	7	40	0.042006411971038944	TCGA-CC-A7IH-01	6	3	2	11	hypermutated sample	5501	TCGA-CC-A7IH	LIHC	58	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G1	2013	NA	-21381	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	365	0	365	0	365	0	365	
50	TCGA-CC-A7II	2	9	0	18	3	1	3	0	10	127	8	0	4	46	2	0	TCGA-CC-A7II-01	168	0.7372837454584996	88	TCGA-CC-A7II-01	27	45	21	0.026951593964667325	TCGA-CC-A7II-01	15	8	2	25	PASS	5502	TCGA-CC-A7II	LIHC	54	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2013	NA	-20079	Alive	WITH TUMOR	399	NA	NA	Locoregional Recurrence	NA	NA	278	NA	NA	R0	0	399	0	399	1	278	1	278	
60	TCGA-CC-A7IJ	0	13	0	10	4	1	0	0	6	125	5	0	1	41	4	0	TCGA-CC-A7IJ-01	316	0.8267133527627447	186	TCGA-CC-A7IJ-01	12	31	173	0.3572398394014903	TCGA-CC-A7IJ-01	16	10	5	31	PASS	5503	TCGA-CC-A7IJ	LIHC	56	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2013	NA	-20751	Alive	TUMOR FREE	382	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	382	0	382	0	382	0	382	
60	TCGA-CC-A7IK	2	32	2	18	3	3	0	0	12	250	18	1	3	81	9	0	TCGA-CC-A7IK-01	151	0.7753043089660983	80	TCGA-CC-A7IK-01	27	48	18	0.035699434901615895	TCGA-CC-A7IK-01	8	3	3	14	PASS	5504	TCGA-CC-A7IK	LIHC	59	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2013	NA	-21552	Dead	WITH TUMOR	NA	262	NA	Locoregional Recurrence	NA	NA	150	NA	NA	R0	1	262	1	262	1	150	1	150	
60	TCGA-CC-A7IL	0	17	1	11	4	0	1	0	6	79	4	0	0	32	6	0	TCGA-CC-A7IL-01	103	0.7973156144986292	50	TCGA-CC-A7IL-01	21	32	42	0.10080797540910667	TCGA-CC-A7IL-01	8	5	6	19	PASS	5505	TCGA-CC-A7IL	LIHC	61	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G1	2013	NA	-22319	Dead	WITH TUMOR	NA	278	NA	Locoregional Recurrence	NA	NA	179	NA	NA	R0	1	278	1	278	1	179	1	179	
20	TCGA-CC-A8HS	0	4	0	6	1	0	0	0	1	45	2	0	3	10	0	0	TCGA-CC-A8HS	0	0	0	TCGA-CC-A8HS	0	0	0	0	TCGA-CC-A8HS	0	0	0	0	PASS	5506	TCGA-CC-A8HS	LIHC	18	MALE	ASIAN	Stage IIIC	NA	Hepatocellular Carcinoma	G1	2013	NA	-6617	Dead	WITH TUMOR	NA	300	NA	Locoregional Recurrence	NA	NA	201	NA	NA	R0	1	300	1	300	1	201	1	201	
70	TCGA-CC-A8HT	1	30	2	6	6	0	0	0	11	160	12	0	2	56	5	0	TCGA-CC-A8HT-01	161	0.20752399382795866	83	TCGA-CC-A8HT-01	8	7	48	0.12212712964428045	TCGA-CC-A8HT-01	5	2	6	13	PASS	5507	TCGA-CC-A8HT	LIHC	74	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2013	NA	-27334	Dead	WITH TUMOR	NA	140	NA	Locoregional Recurrence	NA	NA	83	NA	NA	R0	1	140	1	140	1	83	1	83	
40	TCGA-CC-A8HU	0	8	1	8	2	0	2	0	7	76	6	0	2	26	1	0	TCGA-CC-A8HU-01	163	0.4898213629333084	79	TCGA-CC-A8HU-01	17	21	78	0.30667057116930074	TCGA-CC-A8HU-01	16	7	11	34	PASS	5508	TCGA-CC-A8HU	LIHC	39	FEMALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2013	NA	-14367	Dead	WITH TUMOR	NA	344	NA	Locoregional Recurrence	NA	NA	301	NA	NA	R0	1	344	1	344	1	301	1	301	
50	TCGA-CC-A8HV	0	21	1	10	4	1	0	0	5	111	8	0	9	39	0	0	TCGA-CC-A8HV-01	400	0.8147939754257115	254	TCGA-CC-A8HV-01	28	23	128	0.2453061471537268	TCGA-CC-A8HV-01	14	12	13	39	PASS	5509	TCGA-CC-A8HV	LIHC	51	FEMALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-18935	Dead	WITH TUMOR	NA	279	NA	Locoregional Recurrence	NA	NA	149	NA	NA	R0	1	279	1	279	1	149	1	149	
60	TCGA-CC-A9FS	0	18	1	6	1	1	2	0	2	85	8	0	2	27	1	1	TCGA-CC-A9FS-01	81	0.7244390838172051	38	TCGA-CC-A9FS-01	9	13	67	0.2511633156027648	TCGA-CC-A9FS-01	11	3	9	23	PASS	5510	TCGA-CC-A9FS	LIHC	55	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-20157	Alive	WITH TUMOR	211	NA	NA	New Primary Tumor	Lung	NA	109	NA	NA	R0	0	211	0	211	0	211	1	109	
50	TCGA-CC-A9FU	0	6	0	5	1	2	0	0	6	39	2	0	2	11	2	0	TCGA-CC-A9FU-01	161	0.9200254425182354	89	TCGA-CC-A9FU-01	17	24	75	0.21847423739884256	TCGA-CC-A9FU-01	10	7	14	31	PASS	5511	TCGA-CC-A9FU	LIHC	52	FEMALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2013	NA	-19326	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	0	0	0	0	0	0	0	
60	TCGA-CC-A9FV	0	4	1	6	2	0	0	0	2	12	0	0	0	6	1	0	TCGA-CC-A9FV-01	50	3.198273963498758e-05	10	TCGA-CC-A9FV-01	0	0	4	0.00018557068901812687	TCGA-CC-A9FV-01	0	0	0	0	PASS	5512	TCGA-CC-A9FV	LIHC	57	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2013	NA	-21044	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	0	0	0	0	0	0	0	
70	TCGA-CC-A9FW	1	20	1	9	3	2	1	0	9	114	10	0	2	38	4	0	TCGA-CC-A9FW-01	129	0.7092358751632459	68	TCGA-CC-A9FW-01	23	22	64	0.33724140661047225	TCGA-CC-A9FW-01	8	7	6	21	PASS	5513	TCGA-CC-A9FW	LIHC	68	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2013	NA	-24891	Alive	WITH TUMOR	248	NA	NA	Locoregional Recurrence	NA	NA	153	NA	NA	R0	0	248	0	248	1	153	1	153	
60	TCGA-DD-A113	4	45	0	14	6	2	0	0	10	234	16	0	2	97	8	0	TCGA-DD-A113-01	165	0.8392694823765465	89	TCGA-DD-A113-01	23	64	36	0.20057953515843727	TCGA-DD-A113-01	12	9	10	31	PASS	5514	TCGA-DD-A113	LIHC	55	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G3	2006	NA	-20188	Alive	WITH TUMOR	2425	NA	NA	Intrahepatic Recurrence	Liver	NA	1676	NA	NA	R0	0	2425	0	2425	1	1676	1	1676	
40	TCGA-DD-A114	4	21	0	2	8	2	2	0	19	157	22	0	6	54	6	0	TCGA-DD-A114-01	97	0.3621535542402726	47	TCGA-DD-A114-01	9	8	14	0.2318040110141383	TCGA-DD-A114-01	5	2	4	11	PASS	5515	TCGA-DD-A114	LIHC	42	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Hepatocellular Carcinoma	G3	2005	NA	-15410	Dead	TUMOR FREE	NA	1149	NA	NA	NA	NA	NA	NA	NA	R0	1	1149	0	1149	0	1149	0	1149	
50	TCGA-DD-A115	3	8	4	8	6	2	0	0	5	130	6	0	0	60	12	2	TCGA-DD-A115-01	457	0.640926079969469	318	TCGA-DD-A115-01	10	14	40	0.11651736788459408	TCGA-DD-A115-01	9	11	6	26	PASS	5516	TCGA-DD-A115	LIHC	53	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2002	NA	-19697	Dead	WITH TUMOR	NA	2542	NA	Intrahepatic Recurrence	Liver	NA	469	NA	NA	R0	1	2542	1	2542	1	469	1	469	
70	TCGA-DD-A116	3	16	0	5	5	1	1	0	6	90	3	1	4	35	2	0	TCGA-DD-A116-01	165	0.4701118381151452	95	TCGA-DD-A116-01	9	9	33	0.2078517082390205	TCGA-DD-A116-01	9	4	3	16	PASS	5517	TCGA-DD-A116	LIHC	68	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2002	NA	-24934	Dead	TUMOR FREE	NA	1622	NA	Extrahepatic Recurrence	"Other, specify"	sternum	828	NA	NA	R0	1	1622	0	1622	1	828	1	828	Redacted
80	TCGA-DD-A118	1	7	1	3	3	2	0	0	4	90	8	1	2	36	3	0	TCGA-DD-A118-01	172	0.5316310970094192	95	TCGA-DD-A118-01	18	28	14	0.15096496344433027	TCGA-DD-A118-01	7	8	4	19	PASS	5518	TCGA-DD-A118	LIHC	77	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2003	NA	-28406	Alive	NA	3437	NA	NA	Extrahepatic Recurrence	"Other, specify"	"lateral to the C-loop of the duodenum, anterior to the right  kidney"	658	NA	NA	R0	0	3437	0	3437	1	658	1	658	
40	TCGA-DD-A119	0	13	0	9	3	0	0	0	0	111	10	0	2	40	0	2	TCGA-DD-A119-01	97	0.4168122503699176	46	TCGA-DD-A119-01	6	9	8	0.07384011747053285	TCGA-DD-A119-01	8	5	4	17	PASS	5519	TCGA-DD-A119	LIHC	40	MALE	ASIAN	Stage IV	NA	Hepatocellular Carcinoma	G3	2003	NA	-14613	Dead	NA	NA	223	NA	NA	NA	NA	NA	NA	NA	R2	1	223	NA	223	NA	NA	0	223	
70	TCGA-DD-A11A	1	10	0	5	1	1	0	2	4	108	4	0	1	39	4	0	TCGA-DD-A11A-01	386	0.9318011917930988	226	TCGA-DD-A11A-01	15	34	32	0.035987690143297835	TCGA-DD-A11A-01	22	21	3	46	PASS	5520	TCGA-DD-A11A	LIHC	67	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Hepatocellular Carcinoma	G3	2004	NA	-24646	Alive	NA	79	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	79	0	79	0	79	0	79	
70	TCGA-DD-A11B	2	11	2	9	6	0	0	0	9	71	6	0	2	35	2	0	TCGA-DD-A11B-01	78	0.9114173602811392	30	TCGA-DD-A11B-01	9	6	13	0.18753932394848555	TCGA-DD-A11B-01	4	1	2	7	PASS	5521	TCGA-DD-A11B	LIHC	73	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2005	NA	-26857	Dead	TUMOR FREE	NA	14	NA	NA	NA	NA	NA	NA	NA	RX	1	14	0	14	NA	NA	0	14	
70	TCGA-DD-A11C	1	5	0	5	3	0	0	0	2	71	3	1	4	35	2	0	TCGA-DD-A11C-01	752	0.5373510654124335	577	TCGA-DD-A11C-01	5	11	119	0.1780805194611877	TCGA-DD-A11C-01	13	19	8	40	PASS	5522	TCGA-DD-A11C	LIHC	69	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2006	NA	-25403	Alive	TUMOR FREE	662	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	662	0	662	NA	NA	0	662	
60	TCGA-DD-A11D	0	15	0	3	7	1	2	0	10	92	2	0	2	44	6	0	TCGA-DD-A11D-01	552	0.17880289641824065	489	TCGA-DD-A11D-01	7	5	32	0.016037091658830716	TCGA-DD-A11D-01	2	1	2	5	PASS	5523	TCGA-DD-A11D	LIHC	57	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2006	NA	-21003	Dead	WITH TUMOR	NA	1560	NA	Intrahepatic Recurrence	Liver	NA	498	NA	NA	R0	1	1560	1	1560	1	498	1	498	
70	TCGA-DD-A1E9	0	10	0	1	1	0	1	0	5	50	1	0	4	24	0	0	TCGA-DD-A1E9-01	95	0.4844289705652278	47	TCGA-DD-A1E9-01	32	13	2	0.01560599565468875	TCGA-DD-A1E9-01	3	0	1	4	PASS	5524	TCGA-DD-A1E9	LIHC	70	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2002	NA	-25808	Dead	NA	NA	2759	NA	Intrahepatic Recurrence	Liver	NA	720	NA	NA	R0	1	2759	NA	2759	1	720	1	720	
70	TCGA-DD-A1EA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DD-A1EA-01	79	0.12473468305822052	29	TCGA-DD-A1EA-01	5	4	4	0.0076914332411365935	TCGA-DD-A1EA-01	2	0	1	3	PASS	5525	TCGA-DD-A1EA	LIHC	68	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G2	2002	NA	-24925	Alive	WITH TUMOR	2415	NA	NA	Locoregional Recurrence	Liver	NA	754	NA	NA	R0	0	2415	0	2415	1	754	1	754	
70	TCGA-DD-A1EB	1	15	0	11	4	2	2	0	16	136	6	0	5	46	5	1	TCGA-DD-A1EB-01	394	0.11175488446365456	290	TCGA-DD-A1EB-01	3	4	42	0.06351063438710224	TCGA-DD-A1EB-01	10	8	4	22	PASS	5526	TCGA-DD-A1EB	LIHC	72	FEMALE	NA	Stage I	NA	Hepatocellular Carcinoma	G2	2001	NA	-26471	Alive	[Discrepancy]	2017	NA	NA	Intrahepatic Recurrence	Liver	NA	505	NA	NA	R0	0	2017	0	2017	1	505	1	505	
30	TCGA-DD-A1EC	0	3	1	3	0	0	0	0	1	19	2	0	0	8	1	0	TCGA-DD-A1EC-01	137	0.2165448883417609	87	TCGA-DD-A1EC-01	8	6	17	0.04059859167415485	TCGA-DD-A1EC-01	2	6	3	11	PASS	5527	TCGA-DD-A1EC	LIHC	20	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2004	NA	-7363	Alive	NA	602	NA	NA	Extrahepatic Recurrence	"Other, specify"	peritoneal	299	NA	NA	R0	0	602	0	602	1	299	1	299	
70	TCGA-DD-A1ED	0	2	0	3	2	0	1	0	0	20	1	0	1	7	3	0	TCGA-DD-A1ED-01	41	3.54438884836305e-05	9	TCGA-DD-A1ED-01	0	0	19	3.0448326467159198e-05	TCGA-DD-A1ED-01	0	0	0	0	PASS	5528	TCGA-DD-A1ED	LIHC	68	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2006	NA	-25039	Alive	TUMOR FREE	2301	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2301	0	2301	0	2301	0	2301	
70	TCGA-DD-A1EE	1	8	2	7	12	8	1	1	9	581	38	0	4	54	20	2	TCGA-DD-A1EE-01	60	0.19886544183453272	19	TCGA-DD-A1EE-01	6	6	6	0.053682523695453815	TCGA-DD-A1EE-01	4	1	2	7	PASS	5529	TCGA-DD-A1EE	LIHC	73	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2006	NA	-26858	Dead	WITH TUMOR	NA	349	NA	Intrahepatic Recurrence	Liver	NA	44	NA	NA	R0	1	349	1	349	1	44	1	44	
60	TCGA-DD-A1EF	1	16	1	6	2	1	1	0	7	95	5	0	2	46	4	0	TCGA-DD-A1EF-01	152	0.7100277145615406	78	TCGA-DD-A1EF-01	29	46	17	0.19229452859339305	TCGA-DD-A1EF-01	10	10	4	24	PASS	5530	TCGA-DD-A1EF	LIHC	57	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2007	NA	-21165	Dead	WITH TUMOR	NA	394	NA	NA	NA	NA	NA	NA	NA	R0	1	394	1	394	NA	NA	1	394	
80	TCGA-DD-A1EG	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DD-A1EG-01	68	0.4589199401741354	19	TCGA-DD-A1EG-01	21	58	6	0.05712205158478428	TCGA-DD-A1EG-01	10	1	3	14	PASS	5531	TCGA-DD-A1EG	LIHC	76	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2007	NA	-28108	Dead	WITH TUMOR	NA	1372	NA	Intrahepatic Recurrence	Liver	NA	875	NA	NA	R0	1	1372	1	1372	1	875	1	875	
30	TCGA-DD-A1EH	1	2	0	1	1	3	0	0	0	30	4	0	0	11	0	0	TCGA-DD-A1EH-01	53	0.4639929700072206	15	TCGA-DD-A1EH-01	6	6	8	0.1533319993629305	TCGA-DD-A1EH-01	4	2	3	9	PASS	5532	TCGA-DD-A1EH	LIHC	23	MALE	WHITE	Stage III	NA	Hepatocellular Carcinoma	G3	2008	NA	-8499	Alive	WITH TUMOR	1495	NA	NA	Intrahepatic Recurrence	Liver	NA	120	NA	NA	R0	0	1495	0	1495	1	120	1	120	
50	TCGA-DD-A1EI	1	8	0	2	3	1	1	1	2	41	4	0	1	11	3	0	TCGA-DD-A1EI-01	155	0.40167121524569743	86	TCGA-DD-A1EI-01	14	19	39	0.14635233697551742	TCGA-DD-A1EI-01	10	3	5	18	PASS	5533	TCGA-DD-A1EI	LIHC	46	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2008	NA	-17097	Alive	TUMOR FREE	183	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	183	0	183	0	183	0	183	
70	TCGA-DD-A1EJ	0	6	0	2	4	1	0	1	7	47	2	0	3	16	3	0	TCGA-DD-A1EJ-01	145	0.5413679437547323	73	TCGA-DD-A1EJ-01	11	11	16	0.09073912239475597	TCGA-DD-A1EJ-01	5	8	3	16	PASS	5534	TCGA-DD-A1EJ	LIHC	71	FEMALE	WHITE	Stage IIIC	NA	Hepatocellular Carcinoma	G2	2008	NA	-26009	Dead	WITH TUMOR	NA	1005	NA	Intrahepatic Recurrence	Liver	NA	263	NA	NA	R0	1	1005	1	1005	1	263	1	263	
60	TCGA-DD-A1EK	1	4	0	4	0	1	0	0	4	53	4	0	1	18	4	0	TCGA-DD-A1EK-01	451	0.17589367200398126	330	TCGA-DD-A1EK-01	5	7	44	0.11953426350189587	TCGA-DD-A1EK-01	6	3	6	15	PASS	5535	TCGA-DD-A1EK	LIHC	64	FEMALE	WHITE	Stage IVB	NA	Hepatocellular Carcinoma	G2	2008	NA	-23437	Dead	WITH TUMOR	NA	558	NA	Locoregional Recurrence	Liver	NA	167	NA	NA	R0	1	558	1	558	NA	NA	1	167	
30	TCGA-DD-A1EL	1	14	1	3	1	1	0	0	4	78	3	0	3	31	3	0	TCGA-DD-A1EL-01	136	0.6844948857880645	77	TCGA-DD-A1EL-01	11	12	28	0.2263695331566725	TCGA-DD-A1EL-01	14	10	9	33	PASS	5536	TCGA-DD-A1EL	LIHC	23	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Hepatocellular Carcinoma	G3	2009	NA	-8573	Dead	WITH TUMOR	NA	415	NA	NA	NA	NA	NA	NA	NA	R0	1	415	1	415	NA	NA	1	415	
80	TCGA-DD-A39V	1	5	2	1	4	1	0	0	1	57	6	0	1	19	0	0	TCGA-DD-A39V-01	89	0.8596464209727172	34	TCGA-DD-A39V-01	12	9	16	0.036102463739185166	TCGA-DD-A39V-01	2	2	2	6	PASS	5537	TCGA-DD-A39V	LIHC	77	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G3	2000	NA	-28254	Dead	WITH TUMOR	NA	643	NA	Extrahepatic Recurrence	"Other, specify"	second or third rib posteriorly	455	NA	NA	R0	1	643	1	643	1	455	1	455	
30	TCGA-DD-A39W	0	3	0	0	1	0	0	0	2	29	3	0	1	13	3	0	TCGA-DD-A39W-01	71	0.09473483204193893	27	TCGA-DD-A39W-01	1	2	6	0.0071520033046967016	TCGA-DD-A39W-01	5	2	0	7	PASS	5538	TCGA-DD-A39W	LIHC	29	FEMALE	WHITE	Stage III	NA	Hepatocellular Carcinoma	G2	1995	NA	-10699	Dead	NA	NA	827	NA	NA	NA	NA	NA	NA	NA	R0	1	827	NA	827	0	827	0	827	
80	TCGA-DD-A39X	0	5	1	1	2	0	0	1	2	55	6	0	0	14	1	0	TCGA-DD-A39X-01	104	0.6124175652255073	52	TCGA-DD-A39X-01	1	6	33	0.1123001531187263	TCGA-DD-A39X-01	7	5	4	16	PASS	5539	TCGA-DD-A39X	LIHC	78	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	1998	NA	-28528	Dead	WITH TUMOR	NA	1694	NA	Intrahepatic Recurrence	Liver	NA	1032	NA	NA	R0	1	1694	1	1694	1	1032	1	1032	
70	TCGA-DD-A39Y	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DD-A39Y-01	119	0.9476061058269593	61	TCGA-DD-A39Y-01	26	17	20	0.06628679000080838	TCGA-DD-A39Y-01	6	6	6	18	PASS	5540	TCGA-DD-A39Y	LIHC	67	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2002	NA	-24769	Dead	TUMOR FREE	NA	171	NA	NA	NA	NA	NA	NA	NA	R0	1	171	0	171	0	171	0	171	
40	TCGA-DD-A39Z	1	8	0	5	3	0	0	0	3	58	6	1	2	20	3	0	TCGA-DD-A39Z-01	50	0.27782301603640963	15	TCGA-DD-A39Z-01	9	6	15	0.1025659013179567	TCGA-DD-A39Z-01	7	1	3	11	PASS	5541	TCGA-DD-A39Z	LIHC	43	FEMALE	NA	Stage II	NA	Hepatocellular Carcinoma	G2	1996	NA	-15930	Dead	TUMOR FREE	NA	601	NA	NA	NA	NA	NA	NA	NA	R0	1	601	0	601	0	601	0	601	
70	TCGA-DD-A3A0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DD-A3A0-01	229	0.2170020032620248	140	TCGA-DD-A3A0-01	5	11	38	0.15972132142748866	TCGA-DD-A3A0-01	10	7	6	23	PASS	5542	TCGA-DD-A3A0	LIHC	70	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2001	NA	-25889	Dead	WITH TUMOR	NA	785	NA	New Primary Tumor	NA	NA	359	NA	NA	R0	1	785	1	785	0	785	1	359	
70	TCGA-DD-A3A1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DD-A3A1-01	153	0.3078448515265769	70	TCGA-DD-A3A1-01	8	7	28	0.10825974984012424	TCGA-DD-A3A1-01	5	6	3	14	PASS	5543	TCGA-DD-A3A1	LIHC	65	MALE	NA	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2001	NA	-24046	Dead	TUMOR FREE	NA	233	NA	NA	NA	NA	NA	NA	NA	R0	1	233	0	233	0	233	0	233	
80	TCGA-DD-A3A2	0	5	0	2	2	0	1	1	5	59	6	0	2	19	2	0	TCGA-DD-A3A2-01	47	0.057240338347883314	10	TCGA-DD-A3A2-01	2	1	5	0.0034448794776382186	TCGA-DD-A3A2-01	1	0	0	1	PASS	5544	TCGA-DD-A3A2	LIHC	76	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	1998	NA	-27930	Dead	TUMOR FREE	NA	2131	NA	NA	NA	NA	NA	NA	NA	R0	1	2131	0	2131	0	2131	0	2131	
50	TCGA-DD-A3A3	0	5	1	2	3	3	1	0	2	40	1	0	0	24	1	0	TCGA-DD-A3A3-01	118	0.5822295047643045	59	TCGA-DD-A3A3-01	8	9	7	0.030761700288899345	TCGA-DD-A3A3-01	5	0	3	8	PASS	5545	TCGA-DD-A3A3	LIHC	45	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	1999	NA	-16708	Dead	NA	NA	535	NA	NA	NA	NA	NA	NA	NA	R0	1	535	NA	535	0	535	0	535	
40	TCGA-DD-A3A4	0	5	0	2	2	0	0	0	0	30	3	0	0	10	4	0	TCGA-DD-A3A4-01	64	0.056447787948148476	18	TCGA-DD-A3A4-01	2	4	9	0.0691315266130365	TCGA-DD-A3A4-01	4	2	2	8	PASS	5546	TCGA-DD-A3A4	LIHC	37	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G3	1998	NA	-13739	Dead	WITH TUMOR	NA	612	NA	Intrahepatic Recurrence	Liver	NA	87	NA	NA	R0	1	612	1	612	1	87	1	87	
70	TCGA-DD-A3A5	0	6	1	2	2	1	0	0	3	51	7	0	3	20	1	0	TCGA-DD-A3A5-01	437	0.22013892236545404	299	TCGA-DD-A3A5-01	6	8	48	0.08951867513129037	TCGA-DD-A3A5-01	6	6	5	17	PASS	5547	TCGA-DD-A3A5	LIHC	66	FEMALE	WHITE	Stage III	NA	Hepatocellular Carcinoma	G2	1996	NA	-24288	Dead	WITH TUMOR	NA	3125	NA	Intrahepatic Recurrence	Liver	NA	84	NA	NA	R0	1	3125	1	3125	1	84	1	84	
70	TCGA-DD-A3A6	0	0	0	1	1	1	0	0	0	23	2	0	0	5	1	0	TCGA-DD-A3A6-01	47	0.046785890198094655	13	TCGA-DD-A3A6-01	1	1	3	0.011596532203828669	TCGA-DD-A3A6-01	0	0	0	0	pathology review	5548	TCGA-DD-A3A6	LIHC	72	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	1997	NA	-26319	Dead	TUMOR FREE	NA	3258	NA	NA	NA	NA	NA	NA	NA	R0	1	3258	0	3258	0	3258	0	3258	
70	TCGA-DD-A3A7	0	11	0	4	2	3	1	0	10	97	5	0	3	35	9	0	TCGA-DD-A3A7-01	239	0.9463892797065164	149	TCGA-DD-A3A7-01	29	26	46	0.13636982818824092	TCGA-DD-A3A7-01	13	11	8	32	PASS	5549	TCGA-DD-A3A7	LIHC	67	MALE	[Unknown]	Stage IIIB	NA	Hepatocellular Carcinoma	G3	1998	NA	-24599	Dead	WITH TUMOR	NA	419	NA	Intrahepatic Recurrence	Liver	NA	144	NA	NA	R0	1	419	1	419	1	144	1	144	
80	TCGA-DD-A3A8	0	17	1	6	1	2	0	0	5	99	6	1	3	42	2	0	TCGA-DD-A3A8-01	88	0.22423144849617774	44	TCGA-DD-A3A8-01	5	5	15	0.0865086939767416	TCGA-DD-A3A8-01	6	4	4	14	PASS	5550	TCGA-DD-A3A8	LIHC	75	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2001	NA	-27524	Dead	TUMOR FREE	NA	11	NA	NA	NA	NA	NA	NA	NA	R0	1	11	0	11	0	11	0	11	
60	TCGA-DD-A3A9	1	36	2	17	6	0	0	0	22	299	15	1	12	119	11	0	TCGA-DD-A3A9-01	166	0.6335206338795193	104	TCGA-DD-A3A9-01	21	66	64	0.15381013418394182	TCGA-DD-A3A9-01	8	6	6	20	PASS	5551	TCGA-DD-A3A9	LIHC	64	FEMALE	WHITE	Stage IVB	NA	Hepatocellular Carcinoma	G2	2001	NA	-23526	Dead	WITH TUMOR	NA	931	NA	Extrahepatic Recurrence	Lung	NA	289	NA	NA	R0	1	931	1	931	NA	NA	1	289	
70	TCGA-DD-A4NA	0	1	0	1	2	0	0	0	2	24	2	0	0	10	0	0	TCGA-DD-A4NA-01	240	0.8041460364658402	137	TCGA-DD-A4NA-01	13	13	93	0.21305418383811084	TCGA-DD-A4NA-01	11	4	9	24	PASS	5552	TCGA-DD-A4NA	LIHC	67	FEMALE	WHITE	Stage IIIC	NA	Hepatocellular Carcinoma	G3	2009	NA	-24603	Alive	TUMOR FREE	1008	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1008	0	1008	0	1008	0	1008	
30	TCGA-DD-A4NB	0	3	1	4	5	1	1	0	0	17	0	0	0	9	0	0	TCGA-DD-A4NB-01	85	0.16607031991751933	33	TCGA-DD-A4NB-01	0	0	12	0.0021831812739696	TCGA-DD-A4NB-01	0	0	0	0	PASS	5553	TCGA-DD-A4NB	LIHC	25	MALE	WHITE	Stage I	NA	Fibrolamellar Carcinoma	G2	2011	NA	-9426	Alive	TUMOR FREE	989	NA	NA	Extrahepatic Recurrence	"Other, specify"	retroperitoneal lymph nodes	912	NA	NA	R0	0	989	0	989	1	912	1	912	
60	TCGA-DD-A4ND	0	4	0	5	1	0	1	0	1	44	5	0	0	14	1	0	TCGA-DD-A4ND-01	84	0.3984979130702416	28	TCGA-DD-A4ND-01	15	12	36	0.14139255118883062	TCGA-DD-A4ND-01	6	3	5	14	PASS	5554	TCGA-DD-A4ND	LIHC	56	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2007	NA	-20782	Alive	TUMOR FREE	2746	NA	NA	New Primary Tumor	"Other, specify"	breast cancer	15	NA	NA	R0	0	2746	0	2746	0	2746	1	15	
80	TCGA-DD-A4NE	1	4	1	2	4	1	1	0	3	36	5	0	0	18	4	0	TCGA-DD-A4NE	0	0	0	TCGA-DD-A4NE	0	0	0	0	TCGA-DD-A4NE	0	0	0	0	PASS	5555	TCGA-DD-A4NE	LIHC	75	FEMALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2011	NA	-27549	Dead	WITH TUMOR	NA	660	NA	Locoregional Recurrence	Liver	NA	190	NA	NA	R0	1	660	1	660	1	190	1	190	
70	TCGA-DD-A4NF	0	14	0	4	2	1	0	0	2	108	5	0	3	31	2	0	TCGA-DD-A4NF-01	57	0.11885416873823135	16	TCGA-DD-A4NF-01	2	3	5	0.00528288022492149	TCGA-DD-A4NF-01	1	3	0	4	PASS	5556	TCGA-DD-A4NF	LIHC	72	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-26330	Alive	WITH TUMOR	942	NA	NA	Extrahepatic Recurrence	Bone	NA	656	NA	NA	R0	0	942	0	942	1	656	1	656	
80	TCGA-DD-A4NG	0	14	4	3	5	7	2	0	8	106	12	0	2	34	2	0	TCGA-DD-A4NG	0	0	0	TCGA-DD-A4NG	0	0	0	0	TCGA-DD-A4NG	0	0	0	0	PASS	5557	TCGA-DD-A4NG	LIHC	77	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2011	NA	-28234	Dead	WITH TUMOR	NA	802	NA	Locoregional Recurrence	Liver	NA	430	NA	NA	R0	1	802	1	802	1	430	1	430	
70	TCGA-DD-A4NH	0	8	2	2	7	2	0	2	7	77	6	2	0	22	2	0	TCGA-DD-A4NH-01	72	0.3747660620960731	24	TCGA-DD-A4NH-01	11	10	52	0.2643352593067911	TCGA-DD-A4NH-01	8	4	11	23	PASS	5558	TCGA-DD-A4NH	LIHC	65	FEMALE	WHITE	Stage IIIB	NA	Hepatocellular Carcinoma	G3	2011	NA	-23865	Alive	WITH TUMOR	917	NA	NA	Extrahepatic Recurrence	Lung	NA	161	NA	NA	R0	0	917	0	917	1	161	1	161	
70	TCGA-DD-A4NI	5	29	5	12	5	3	4	0	14	257	6	0	6	85	16	0	TCGA-DD-A4NI-01	59	0.6552623551934841	17	TCGA-DD-A4NI-01	4	6	13	0.012446137046037043	TCGA-DD-A4NI-01	4	3	1	8	PASS	5559	TCGA-DD-A4NI	LIHC	67	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2011	NA	-24516	Alive	TUMOR FREE	816	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	816	0	816	0	816	0	816	
50	TCGA-DD-A4NJ	4	14	0	8	4	2	0	0	8	137	4	0	4	40	4	0	TCGA-DD-A4NJ-01	95	0.5248202484785865	38	TCGA-DD-A4NJ	0	0	0	0	TCGA-DD-A4NJ	0	0	0	0	PASS	5560	TCGA-DD-A4NJ	LIHC	54	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2011	NA	-19964	Alive	WITH TUMOR	928	NA	NA	Intrahepatic Recurrence	Liver	NA	549	NA	NA	R0	0	928	0	928	1	549	1	549	
80	TCGA-DD-A4NK	2	18	2	8	4	3	2	0	8	113	10	0	10	58	12	0	TCGA-DD-A4NK-01	60	0.3441230144117593	16	TCGA-DD-A4NK-01	9	6	27	0.05566710085002938	TCGA-DD-A4NK-01	4	2	2	8	PASS	5561	TCGA-DD-A4NK	LIHC	80	FEMALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2004	NA	-29244	Dead	WITH TUMOR	NA	1210	NA	Intrahepatic Recurrence	Liver	NA	89	NA	NA	R0	1	1210	1	1210	1	89	1	89	
50	TCGA-DD-A4NL	0	0	0	0	1	0	1	0	0	27	0	0	2	9	0	0	TCGA-DD-A4NL-01	53	2.0632949702430912e-05	16	TCGA-DD-A4NL-01	0	0	8	0.0012667667824328595	TCGA-DD-A4NL-01	0	0	0	0	PASS	5562	TCGA-DD-A4NL	LIHC	46	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2007	NA	-16874	Alive	TUMOR FREE	1711	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1711	0	1711	0	1711	0	1711	
60	TCGA-DD-A4NN	0	14	2	8	8	6	2	0	6	83	2	0	0	30	0	0	TCGA-DD-A4NN-01	108	0.4451384466068737	55	TCGA-DD-A4NN-01	8	12	60	0.22061139504359364	TCGA-DD-A4NN-01	7	15	12	34	PASS	5563	TCGA-DD-A4NN	LIHC	56	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2004	NA	-20548	Dead	WITH TUMOR	NA	899	NA	Extrahepatic Recurrence	Lung	NA	166	NA	NA	R0	1	899	1	899	1	166	1	166	
70	TCGA-DD-A4NO	0	10	0	6	2	5	2	0	5	87	6	2	0	27	4	0	TCGA-DD-A4NO-01	117	0.7922382219849156	62	TCGA-DD-A4NO-01	19	36	35	0.05684184622368355	TCGA-DD-A4NO-01	6	3	2	11	PASS	5564	TCGA-DD-A4NO	LIHC	65	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2007	NA	-24090	Alive	WITH TUMOR	2245	NA	NA	Locoregional Recurrence	Liver	NA	990	NA	NA	R0	0	2245	0	2245	1	990	1	990	
30	TCGA-DD-A4NP	0	2	2	0	5	0	2	1	0	38	2	0	0	17	3	0	TCGA-DD-A4NP-01	55	0.03890447216550141	17	TCGA-DD-A4NP-01	2	1	2	6.656934786045671e-05	TCGA-DD-A4NP-01	0	0	0	0	PASS	5565	TCGA-DD-A4NP	LIHC	32	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2005	NA	-11838	Alive	TUMOR FREE	3308	NA	NA	Intrahepatic Recurrence	Liver	NA	1286	NA	NA	R0	0	3308	0	3308	1	1286	1	1286	
60	TCGA-DD-A4NQ	0	14	0	2	6	4	4	0	10	143	7	0	0	46	4	0	TCGA-DD-A4NQ-01	63	0.35427728979319345	21	TCGA-DD-A4NQ-01	11	15	64	0.2478679319560051	TCGA-DD-A4NQ-01	5	4	5	14	PASS	5566	TCGA-DD-A4NQ	LIHC	60	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G3	2007	NA	-22111	Dead	WITH TUMOR	NA	373	NA	Intrahepatic Recurrence	Liver	NA	126	NA	NA	R0	1	373	1	373	1	126	1	126	
90	TCGA-DD-A4NR	2	18	0	6	8	0	2	0	1	88	10	0	0	31	0	3	TCGA-DD-A4NR-01	71	0.18709119552316247	26	TCGA-DD-A4NR-01	7	5	28	0.03919155205462956	TCGA-DD-A4NR-01	5	5	4	14	PASS	5567	TCGA-DD-A4NR	LIHC	85	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2005	NA	-31386	Dead	TUMOR FREE	NA	9	NA	NA	NA	NA	NA	NA	NA	R0	1	9	0	9	0	9	0	9	
60	TCGA-DD-A4NS	2	12	4	5	2	2	1	0	0	97	4	0	5	30	1	0	TCGA-DD-A4NS-01	45	0.10833719211450987	11	TCGA-DD-A4NS-01	3	6	19	0.03672050648492347	TCGA-DD-A4NS-01	5	2	1	8	PASS	5568	TCGA-DD-A4NS	LIHC	61	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2005	NA	-22638	Dead	WITH TUMOR	NA	2456	NA	Extrahepatic Recurrence	Bone	NA	893	NA	NA	R0	1	2456	1	2456	1	893	1	893	
60	TCGA-DD-A4NV	0	25	2	16	4	2	4	0	6	228	12	0	4	74	6	0	TCGA-DD-A4NV-01	61	0.9535630177498352	18	TCGA-DD-A4NV-01	17	34	37	0.14401784162264414	TCGA-DD-A4NV-01	3	1	4	8	PASS	5569	TCGA-DD-A4NV	LIHC	61	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G1	2007	NA	-22438	Alive	TUMOR FREE	2398	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2398	0	2398	0	2398	0	2398	
70	TCGA-DD-A73A	0	5	0	5	4	2	0	1	1	79	2	0	1	26	2	0	TCGA-DD-A73A-01	149	0.09076708463384912	83	TCGA-DD-A73A-01	1	3	37	0.032772922005622644	TCGA-DD-A73A-01	4	6	2	12	PASS	5570	TCGA-DD-A73A	LIHC	71	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2012	NA	-26136	Alive	TUMOR FREE	728	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	728	0	728	0	728	0	728	
70	TCGA-DD-A73B	0	10	0	3	0	0	0	0	7	63	6	1	2	19	2	0	TCGA-DD-A73B-01	123	0.9463041687334433	59	TCGA-DD-A73B-01	7	12	93	0.3327219112628397	TCGA-DD-A73B-01	13	11	14	38	PASS	5571	TCGA-DD-A73B	LIHC	72	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2012	NA	-26390	Dead	WITH TUMOR	NA	283	NA	Locoregional Recurrence	Liver	NA	240	NA	NA	R0	1	283	1	283	1	240	1	240	
70	TCGA-DD-A73C	1	4	0	5	6	0	2	0	2	62	5	0	0	31	2	0	TCGA-DD-A73C-01	71	0.04672197424732228	25	TCGA-DD-A73C-01	2	2	15	0.015660478238278142	TCGA-DD-A73C-01	1	0	1	2	PASS	5572	TCGA-DD-A73C	LIHC	65	FEMALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G1	2012	NA	-23782	Alive	WITH TUMOR	701	NA	NA	Locoregional Recurrence	Liver	NA	566	NA	NA	R0	0	701	0	701	1	566	1	566	
70	TCGA-DD-A73D	0	16	1	4	5	0	0	0	2	57	2	0	0	16	3	0	TCGA-DD-A73D-01	128	0.9469517555064688	69	TCGA-DD-A73D-01	9	14	22	0.013777685360339362	TCGA-DD-A73D-01	5	3	2	10	PASS	5573	TCGA-DD-A73D	LIHC	68	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G1	2012	NA	-24941	Alive	WITH TUMOR	693	NA	NA	Intrahepatic Recurrence	Liver	NA	592	NA	NA	R0	0	693	0	693	1	592	1	592	
70	TCGA-DD-A73E	0	20	1	7	3	0	1	0	5	103	4	0	2	43	5	0	TCGA-DD-A73E-01	80	0.3853259651680099	37	TCGA-DD-A73E-01	13	11	26	0.07961152765472332	TCGA-DD-A73E-01	6	6	5	17	PASS	5574	TCGA-DD-A73E	LIHC	66	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2012	NA	-24377	Alive	TUMOR FREE	44	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	44	0	44	0	44	0	44	
80	TCGA-DD-A73F	1	12	1	6	1	0	0	0	4	62	2	0	1	33	2	1	TCGA-DD-A73F-01	543	0.18082091723909247	372	TCGA-DD-A73F-01	1	4	120	0.09676200805138843	TCGA-DD-A73F-01	4	10	6	20	PASS	5575	TCGA-DD-A73F	LIHC	77	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2010	NA	-28234	Alive	TUMOR FREE	1085	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1085	0	1085	0	1085	0	1085	
70	TCGA-DD-A73G	1	8	1	4	1	3	1	0	6	88	7	0	0	39	1	0	TCGA-DD-A73G-01	640	0.8521262658098053	493	TCGA-DD-A73G-01	19	22	120	0.09115264350829816	TCGA-DD-A73G-01	13	11	5	29	PASS	5576	TCGA-DD-A73G	LIHC	73	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2005	NA	-26949	Alive	TUMOR FREE	3478	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	3478	0	3478	0	3478	0	3478	
80	TCGA-DD-AA3A	1	4	1	2	4	0	0	0	8	33	2	0	2	18	1	0	TCGA-DD-AA3A-01	152	0.3893670130156012	95	TCGA-DD-AA3A-01	11	11	76	0.2111042468002012	TCGA-DD-AA3A-01	6	5	6	17	PASS	5577	TCGA-DD-AA3A	LIHC	81	FEMALE	WHITE	Stage I	NA	Hepatocholangiocarcinoma (Mixed)	G4	2009	NA	-29712	Dead	TUMOR FREE	NA	410	NA	NA	NA	NA	NA	NA	NA	R0	1	410	0	410	0	410	0	410	
70	TCGA-DD-AAC8	2	66	2	21	5	2	1	0	24	434	28	1	5	128	28	1	TCGA-DD-AAC8-01	120	0.4637444620056026	63	TCGA-DD-AAC8-01	17	31	26	0.04660653858593242	TCGA-DD-AAC8-01	5	4	2	11	PASS	5578	TCGA-DD-AAC8	LIHC	72	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2008	NA	-26322	Dead	TUMOR FREE	NA	16	NA	NA	NA	NA	NA	NA	NA	R0	1	16	0	16	0	16	0	16	
50	TCGA-DD-AAC9	2	10	2	4	2	1	0	1	4	71	3	0	0	18	2	0	TCGA-DD-AAC9-01	89	0.09999710865034687	41	TCGA-DD-AAC9-01	2	6	22	0.04946840327077368	TCGA-DD-AAC9-01	3	4	2	9	PASS	5579	TCGA-DD-AAC9	LIHC	51	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2008	NA	-18911	Alive	TUMOR FREE	347	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	347	0	347	0	347	0	347	
70	TCGA-DD-AACA	2	36	1	11	3	2	3	0	19	207	15	0	2	60	3	0	TCGA-DD-AACA-01	148	0.16604747485748414	69	TCGA-DD-AACA-01	4	6	26	0.06880746689089773	TCGA-DD-AACA-01	8	6	5	19	mutation call filter	5580	TCGA-DD-AACA	LIHC	65	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2008	NA	-23973	Alive	WITH TUMOR	2301	NA	NA	Locoregional Recurrence	Liver	NA	776	NA	NA	R0	0	2301	0	2301	1	776	1	776	
70	TCGA-DD-AACB	0	18	0	4	7	2	1	0	8	70	2	0	3	34	0	0	TCGA-DD-AACB-01	160	0.6181290855939433	84	TCGA-DD-AACB-01	18	29	52	0.17331181406842375	TCGA-DD-AACB-01	8	6	5	19	PASS	5581	TCGA-DD-AACB	LIHC	74	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2008	NA	-27103	Alive	TUMOR FREE	2324	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2324	0	2324	0	2324	0	2324	
60	TCGA-DD-AACC	0	14	0	3	3	0	1	0	2	81	1	0	0	25	3	0	TCGA-DD-AACC-01	120	0.2067777513585661	59	TCGA-DD-AACC-01	5	6	53	0.1276747769143932	TCGA-DD-AACC-01	13	7	8	28	PASS	5582	TCGA-DD-AACC	LIHC	61	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2008	NA	-22499	Dead	WITH TUMOR	NA	1685	NA	Locoregional Recurrence	Liver	NA	537	NA	NA	R0	1	1685	1	1685	1	537	1	537	
50	TCGA-DD-AACD	1	13	1	6	2	3	3	0	8	70	1	0	1	26	3	1	TCGA-DD-AACD-01	303	0.2274837144323795	212	TCGA-DD-AACD-01	7	7	90	0.06904145931899554	TCGA-DD-AACD-01	5	4	4	13	PASS	5583	TCGA-DD-AACD	LIHC	48	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G4	2008	NA	-17828	Dead	WITH TUMOR	NA	381	NA	Locoregional Recurrence	Lung	NA	151	NA	NA	R0	1	381	1	381	1	151	1	151	
60	TCGA-DD-AACE	0	14	1	12	3	0	1	0	7	62	2	1	0	19	2	0	TCGA-DD-AACE-01	87	0.7183879063346688	33	TCGA-DD-AACE-01	21	37	19	0.024049477973249928	TCGA-DD-AACE-01	4	1	1	6	PASS	5584	TCGA-DD-AACE	LIHC	62	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2008	NA	-22727	Alive	TUMOR FREE	2184	NA	NA	Intrahepatic Recurrence	Liver	NA	1279	NA	NA	R0	0	2184	0	2184	1	1279	1	1279	
70	TCGA-DD-AACF	4	21	0	7	10	0	2	0	4	98	3	0	0	33	4	0	TCGA-DD-AACF-01	128	0.3111440720857089	55	TCGA-DD-AACF-01	10	11	53	0.1307212156658439	TCGA-DD-AACF-01	5	5	4	14	PASS	5585	TCGA-DD-AACF	LIHC	68	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2008	NA	-25172	Dead	WITH TUMOR	NA	365	NA	Locoregional Recurrence	Liver	NA	119	NA	NA	R0	1	365	1	365	1	119	1	119	
50	TCGA-DD-AACG	0	16	2	3	4	1	3	0	4	78	6	0	1	30	2	0	TCGA-DD-AACG-01	237	0.8685244089735354	149	TCGA-DD-AACG-01	18	26	72	0.12597517827529356	TCGA-DD-AACG-01	13	5	8	26	PASS	5586	TCGA-DD-AACG	LIHC	52	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G4	2008	NA	-19174	Dead	WITH TUMOR	NA	469	NA	Intrahepatic Recurrence	Liver	NA	125	NA	NA	R0	1	469	1	469	1	125	1	125	
70	TCGA-DD-AACH	1	13	1	12	7	0	1	0	8	71	4	0	0	20	5	1	TCGA-DD-AACH-01	214	0.32858933503347604	116	TCGA-DD-AACH-01	6	18	98	0.23851334949846945	TCGA-DD-AACH-01	19	19	14	52	PASS	5587	TCGA-DD-AACH	LIHC	69	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2008	NA	-25544	Dead	TUMOR FREE	NA	195	NA	Intrahepatic Recurrence	Liver	NA	83	NA	NA	R0	1	195	0	195	1	83	1	83	
70	TCGA-DD-AACI	2	48	2	20	8	1	0	1	27	284	19	0	6	115	12	1	TCGA-DD-AACI-01	288	0.9129726175271642	205	TCGA-DD-AACI-01	25	28	29	0.06242780042866448	TCGA-DD-AACI-01	10	12	3	25	PASS	5588	TCGA-DD-AACI	LIHC	69	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2008	NA	-25236	Alive	WITH TUMOR	1618	NA	NA	Intrahepatic Recurrence	Liver	NA	1432	NA	NA	R0	0	1618	0	1618	1	1432	1	1432	
80	TCGA-DD-AACJ	2	15	1	8	4	1	1	0	5	79	3	0	4	29	2	0	TCGA-DD-AACJ-01	146	0.9147464418800598	83	TCGA-DD-AACJ-01	10	10	31	0.040759308867461916	TCGA-DD-AACJ-01	4	1	3	8	PASS	5589	TCGA-DD-AACJ	LIHC	75	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G2	2008	NA	-27528	Alive	WITH TUMOR	2102	NA	NA	Locoregional Recurrence	Liver	NA	100	NA	NA	R0	0	2102	0	2102	1	100	1	100	
70	TCGA-DD-AACK	4	14	1	4	2	1	3	1	7	102	16	0	6	42	0	0	TCGA-DD-AACK-01	106	0.0427244560388932	48	TCGA-DD-AACK-01	1	1	14	0.016136028667065736	TCGA-DD-AACK-01	2	3	1	6	PASS	5590	TCGA-DD-AACK	LIHC	70	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2008	NA	-25796	Alive	TUMOR FREE	9	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	9	0	9	0	9	0	9	
70	TCGA-DD-AACL	1	39	1	10	3	1	1	0	14	225	23	0	4	94	11	0	TCGA-DD-AACL-01	170	0.2333440847804609	105	TCGA-DD-AACL-01	6	8	65	0.16454975292555912	TCGA-DD-AACL-01	5	4	5	14	PASS	5591	TCGA-DD-AACL	LIHC	66	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2008	NA	-24355	Dead	NA	NA	107	NA	NA	NA	NA	NA	NA	NA	R0	1	107	NA	107	0	107	0	107	
50	TCGA-DD-AACM	0	3	0	6	4	0	1	0	4	44	3	1	2	16	1	0	TCGA-DD-AACM-01	158	0.26296013259600953	84	TCGA-DD-AACM-01	7	10	70	0.16903341043413167	TCGA-DD-AACM-01	11	6	7	24	PASS	5592	TCGA-DD-AACM	LIHC	48	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2009	NA	-17590	Alive	WITH TUMOR	1769	NA	NA	Extrahepatic Recurrence	Lung	NA	1097	NA	NA	R0	0	1769	0	1769	1	1097	1	1097	
30	TCGA-DD-AACN	1	6	0	2	2	0	0	0	1	37	1	0	0	9	3	1	TCGA-DD-AACN-01	133	0.5404303012004129	69	TCGA-DD-AACN-01	14	17	77	0.2034456757788433	TCGA-DD-AACN-01	8	5	7	20	PASS	5593	TCGA-DD-AACN	LIHC	32	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2009	NA	-12007	Alive	WITH TUMOR	1302	NA	NA	Intrahepatic Recurrence	Liver	NA	357	NA	NA	R0	0	1302	0	1302	1	357	1	357	
40	TCGA-DD-AACO	0	9	0	3	4	1	1	0	4	30	3	0	0	11	2	0	TCGA-DD-AACO-01	156	0.6231290672390739	98	TCGA-DD-AACO-01	10	11	43	0.0985482744571193	TCGA-DD-AACO-01	6	4	7	17	PASS	5594	TCGA-DD-AACO	LIHC	40	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2009	NA	-14796	Alive	WITH TUMOR	1876	NA	NA	Intrahepatic Recurrence	Liver	NA	479	NA	NA	R0	0	1876	0	1876	1	479	1	479	
60	TCGA-DD-AACP	2	28	3	8	6	0	1	0	11	151	4	0	2	64	4	1	TCGA-DD-AACP-01	119	0.761864379881507	60	TCGA-DD-AACP-01	21	24	34	0.1662527692994938	TCGA-DD-AACP-01	4	3	3	10	PASS	5595	TCGA-DD-AACP	LIHC	64	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2009	NA	-23728	Alive	NA	415	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	415	0	415	0	415	0	415	
50	TCGA-DD-AACQ	2	28	1	7	10	0	1	0	12	162	15	1	6	56	9	1	TCGA-DD-AACQ-01	133	0.17515033946389766	62	TCGA-DD-AACQ-01	4	5	34	0.09537644306305294	TCGA-DD-AACQ-01	11	8	7	26	PASS	5596	TCGA-DD-AACQ	LIHC	50	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2009	NA	-18429	Dead	WITH TUMOR	NA	432	NA	Locoregional Recurrence	Liver	NA	105	NA	NA	R0	1	432	1	432	1	105	1	105	
40	TCGA-DD-AACS	0	6	0	1	0	0	1	0	1	43	0	0	2	12	1	0	TCGA-DD-AACS-01	159	0.4260187356608699	85	TCGA-DD-AACS-01	6	10	69	0.17054251918273244	TCGA-DD-AACS-01	14	10	9	33	PASS	5597	TCGA-DD-AACS	LIHC	39	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2009	NA	-14473	Alive	TUMOR FREE	1804	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1804	0	1804	0	1804	0	1804	
70	TCGA-DD-AACT	2	26	1	19	8	1	0	0	9	147	10	0	2	61	12	0	TCGA-DD-AACT-01	122	0.9230363690559056	57	TCGA-DD-AACT-01	12	10	13	0.013120725887004869	TCGA-DD-AACT-01	3	4	1	8	PASS	5598	TCGA-DD-AACT	LIHC	69	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2010	NA	-25292	Alive	TUMOR FREE	1562	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1562	0	1562	0	1562	0	1562	
60	TCGA-DD-AACU	1	15	2	8	2	0	0	0	8	98	6	0	0	25	7	0	TCGA-DD-AACU-01	137	0.810807003987611	74	TCGA-DD-AACU-01	25	16	96	0.23645418735464704	TCGA-DD-AACU-01	8	8	5	21	PASS	5599	TCGA-DD-AACU	LIHC	59	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2010	NA	-21606	Alive	TUMOR FREE	1567	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1567	0	1567	0	1567	0	1567	
50	TCGA-DD-AACV	0	18	1	8	2	1	1	0	6	86	7	0	1	23	3	0	TCGA-DD-AACV-01	269	0.9286866532578686	162	TCGA-DD-AACV-01	8	8	96	0.20282315540934948	TCGA-DD-AACV-01	9	8	8	25	PASS	5600	TCGA-DD-AACV	LIHC	53	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2010	NA	-19660	Alive	WITH TUMOR	1531	NA	NA	Intrahepatic Recurrence	Liver	NA	344	NA	NA	R0	0	1531	0	1531	1	344	1	344	
40	TCGA-DD-AACW	0	5	1	2	3	1	2	0	4	39	4	0	1	9	0	0	TCGA-DD-AACW-01	96	0.653212043181157	37	TCGA-DD-AACW-01	5	5	52	0.14816620307167536	TCGA-DD-AACW-01	8	3	4	15	PASS	5601	TCGA-DD-AACW	LIHC	43	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2010	NA	-15872	Alive	TUMOR FREE	1424	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1424	0	1424	0	1424	0	1424	
70	TCGA-DD-AACX	1	11	0	4	4	2	2	1	6	94	7	0	3	35	2	1	TCGA-DD-AACX-01	142	0.11157238288927483	78	TCGA-DD-AACX-01	5	5	27	0.05891931905127246	TCGA-DD-AACX-01	6	2	4	12	PASS	5602	TCGA-DD-AACX	LIHC	66	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2010	NA	-24329	Alive	WITH TUMOR	170	NA	NA	Extrahepatic Recurrence	"Other, specify"	lymph node	42	NA	NA	R0	0	170	0	170	1	42	1	42	
60	TCGA-DD-AACY	0	8	1	2	5	1	1	1	5	69	0	0	0	28	4	0	TCGA-DD-AACY-01	160	0.2827266715303242	75	TCGA-DD-AACY-01	6	9	27	0.09535721080823008	TCGA-DD-AACY-01	6	11	5	22	PASS	5603	TCGA-DD-AACY	LIHC	61	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2010	NA	-22332	Alive	WITH TUMOR	1450	NA	NA	Intrahepatic Recurrence	Liver	NA	776	NA	NA	R0	0	1450	0	1450	1	776	1	776	
60	TCGA-DD-AACZ	1	15	4	11	1	2	0	0	11	137	8	1	3	41	6	0	TCGA-DD-AACZ-01	219	0.6468600706285189	122	TCGA-DD-AACZ-01	23	33	109	0.19584541797326652	TCGA-DD-AACZ-01	13	8	8	29	PASS	5604	TCGA-DD-AACZ	LIHC	63	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G4	2010	NA	-23230	Dead	TUMOR FREE	NA	171	NA	Locoregional Recurrence	Liver	NA	88	NA	NA	R0	1	171	0	171	1	88	1	88	
70	TCGA-DD-AAD0	0	11	0	7	5	0	1	0	6	81	12	0	2	26	3	1	TCGA-DD-AAD0-01	143	0.16635560898776902	65	TCGA-DD-AAD0-01	4	6	47	0.08384284212120775	TCGA-DD-AAD0-01	8	9	6	23	PASS	5605	TCGA-DD-AAD0	LIHC	73	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2010	NA	-26781	Alive	WITH TUMOR	137	NA	NA	Intrahepatic Recurrence	Liver	NA	47	NA	NA	R0	0	137	0	137	1	47	1	47	
50	TCGA-DD-AAD1	0	21	2	6	4	0	0	0	3	101	2	0	2	45	5	0	TCGA-DD-AAD1-01	104	0.2350992477279047	42	TCGA-DD-AAD1-01	7	8	34	0.08121696656061457	TCGA-DD-AAD1-01	9	6	5	20	PASS	5606	TCGA-DD-AAD1	LIHC	51	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G4	2010	NA	-18794	Alive	WITH TUMOR	564	NA	NA	Intrahepatic Recurrence	Liver	NA	127	NA	NA	R1	0	564	0	564	NA	NA	1	127	
70	TCGA-DD-AAD2	0	11	0	3	1	2	0	0	5	66	5	0	1	22	1	0	TCGA-DD-AAD2-01	111	0.15704989448212153	59	TCGA-DD-AAD2-01	5	6	26	0.0205570160536115	TCGA-DD-AAD2-01	5	2	1	8	PASS	5607	TCGA-DD-AAD2	LIHC	66	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2010	NA	-24221	Alive	TUMOR FREE	658	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	658	0	658	0	658	0	658	
40	TCGA-DD-AAD3	1	9	0	8	1	0	0	0	1	58	4	0	0	25	2	1	TCGA-DD-AAD3-01	165	0.2486455268132025	98	TCGA-DD-AAD3-01	8	9	67	0.17275238839741475	TCGA-DD-AAD3-01	10	4	7	21	PASS	5608	TCGA-DD-AAD3	LIHC	43	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-15706	Alive	TUMOR FREE	1295	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1295	0	1295	0	1295	0	1295	
50	TCGA-DD-AAD5	0	15	1	4	11	3	2	1	4	91	5	1	3	43	5	0	TCGA-DD-AAD5-01	227	0.5277086168068914	139	TCGA-DD-AAD5-01	16	23	63	0.097860785143423	TCGA-DD-AAD5-01	16	13	5	34	PASS	5609	TCGA-DD-AAD5	LIHC	54	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2011	NA	-19748	Alive	WITH TUMOR	1345	NA	NA	Intrahepatic Recurrence	Liver	NA	130	NA	NA	R0	0	1345	0	1345	1	130	1	130	
70	TCGA-DD-AAD6	0	14	1	9	4	0	0	0	4	84	3	0	0	32	4	0	TCGA-DD-AAD6-01	140	0.2922507662562893	73	TCGA-DD-AAD6-01	9	12	37	0.12787010886355948	TCGA-DD-AAD6-01	5	7	3	15	PASS	5610	TCGA-DD-AAD6	LIHC	66	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2011	NA	-24185	Alive	TUMOR FREE	672	NA	NA	Locoregional Recurrence	Liver	NA	50	NA	NA	R0	0	672	0	672	1	50	1	50	
70	TCGA-DD-AAD8	1	13	1	5	3	0	1	0	7	88	8	0	3	32	6	0	TCGA-DD-AAD8-01	132	0.9098286266430656	63	TCGA-DD-AAD8-01	17	17	48	0.13457984224525815	TCGA-DD-AAD8-01	8	3	3	14	PASS	5611	TCGA-DD-AAD8	LIHC	73	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-26781	Alive	TUMOR FREE	1219	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1219	0	1219	0	1219	0	1219	
70	TCGA-DD-AADA	1	20	1	7	1	1	3	1	5	101	4	0	1	29	1	0	TCGA-DD-AADA-01	133	0.2454655810881979	52	TCGA-DD-AADA-01	8	13	24	0.050411989767978935	TCGA-DD-AADA-01	8	6	4	18	PASS	5612	TCGA-DD-AADA	LIHC	66	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2011	NA	-24288	Alive	TUMOR FREE	1233	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1233	0	1233	0	1233	0	1233	
50	TCGA-DD-AADB	1	12	1	13	1	0	0	0	5	96	8	0	1	43	7	0	TCGA-DD-AADB-01	149	0.7759539370185963	77	TCGA-DD-AADB-01	9	8	90	0.1993717197645474	TCGA-DD-AADB-01	8	2	7	17	PASS	5613	TCGA-DD-AADB	LIHC	51	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G4	2011	NA	-18728	Alive	TUMOR FREE	1242	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1242	0	1242	0	1242	0	1242	
50	TCGA-DD-AADC	1	12	3	3	1	4	0	0	5	66	5	0	0	21	3	0	TCGA-DD-AADC-01	318	0.4547382450675192	206	TCGA-DD-AADC-01	10	16	114	0.2986238007685222	TCGA-DD-AADC-01	13	13	13	39	PASS	5614	TCGA-DD-AADC	LIHC	53	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2011	NA	-19527	Dead	WITH TUMOR	NA	425	NA	Intrahepatic Recurrence	Liver	NA	101	NA	NA	R0	1	425	1	425	1	101	1	101	
50	TCGA-DD-AADD	0	12	2	5	2	3	1	0	4	70	3	0	1	22	3	1	TCGA-DD-AADD-01	148	0.5447696628040646	84	TCGA-DD-AADD-01	16	55	50	0.20968546988460715	TCGA-DD-AADD-01	10	3	3	16	PASS	5615	TCGA-DD-AADD	LIHC	51	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G4	2011	NA	-18752	Alive	TUMOR FREE	1231	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1231	0	1231	0	1231	0	1231	
50	TCGA-DD-AADE	1	13	0	4	6	2	4	0	5	87	7	1	2	35	3	0	TCGA-DD-AADE-01	151	0.07283001306405508	85	TCGA-DD-AADE-01	3	4	31	0.02188163193839041	TCGA-DD-AADE-01	2	1	2	5	PASS	5616	TCGA-DD-AADE	LIHC	50	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G4	2011	NA	-18482	Alive	WITH TUMOR	1202	NA	NA	Intrahepatic Recurrence	Liver	NA	168	NA	NA	R0	0	1202	0	1202	1	168	1	168	
60	TCGA-DD-AADF	2	30	3	15	8	0	0	0	6	182	11	0	4	59	5	1	TCGA-DD-AADF-01	665	0.3861375120120065	428	TCGA-DD-AADF-01	11	28	98	0.09538462835870982	TCGA-DD-AADF-01	16	18	5	39	PASS	5617	TCGA-DD-AADF	LIHC	64	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G4	2011	NA	-23614	Dead	TUMOR FREE	NA	115	NA	NA	NA	NA	NA	NA	NA	R0	1	115	0	115	0	115	0	115	
70	TCGA-DD-AADG	1	22	1	13	6	2	4	0	9	129	11	1	3	41	5	1	TCGA-DD-AADG-01	154	0.17958680388303996	92	TCGA-DD-AADG-01	6	6	39	0.04459797676398463	TCGA-DD-AADG-01	6	3	4	13	PASS	5618	TCGA-DD-AADG	LIHC	70	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2011	NA	-25887	Alive	TUMOR FREE	1145	NA	NA	Intrahepatic Recurrence	Liver	NA	270	NA	NA	R0	0	1145	0	1145	1	270	1	270	
40	TCGA-DD-AADI	0	10	0	9	2	1	0	0	10	83	11	0	1	35	5	0	TCGA-DD-AADI-01	116	0.26746577285212325	57	TCGA-DD-AADI-01	5	5	39	0.10908174917202544	TCGA-DD-AADI-01	4	3	6	13	PASS	5619	TCGA-DD-AADI	LIHC	43	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2011	NA	-15928	Alive	TUMOR FREE	1085	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1085	0	1085	0	1085	0	1085	
70	TCGA-DD-AADJ	1	9	0	3	5	0	1	0	3	50	1	0	0	15	3	0	TCGA-DD-AADJ-01	447	0.20608297411555124	333	TCGA-DD-AADJ-01	5	4	193	0.11670625100041702	TCGA-DD-AADJ-01	6	3	5	14	PASS	5620	TCGA-DD-AADJ	LIHC	70	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2011	NA	-25863	Alive	TUMOR FREE	1066	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1066	0	1066	0	1066	0	1066	
70	TCGA-DD-AADK	1	7	0	2	3	1	1	0	2	49	3	0	3	14	1	0	TCGA-DD-AADK-01	86	0.3121557720151201	35	TCGA-DD-AADK-01	9	11	59	0.25816496365526403	TCGA-DD-AADK-01	6	5	6	17	PASS	5621	TCGA-DD-AADK	LIHC	68	FEMALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2011	NA	-25046	Alive	TUMOR FREE	1049	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1049	0	1049	0	1049	0	1049	
60	TCGA-DD-AADL	0	10	0	10	5	3	0	0	4	104	8	0	1	33	2	0	TCGA-DD-AADL-01	189	0.8394903060372173	121	TCGA-DD-AADL-01	14	16	52	0.18556997117146304	TCGA-DD-AADL-01	5	5	9	19	PASS	5622	TCGA-DD-AADL	LIHC	58	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G4	2012	NA	-21512	Alive	TUMOR FREE	636	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	636	0	636	0	636	0	636	
60	TCGA-DD-AADM	2	35	1	12	11	5	3	1	14	140	5	0	2	55	2	0	TCGA-DD-AADM-01	171	0.280164940926809	97	TCGA-DD-AADM-01	5	13	49	0.1132838495400556	TCGA-DD-AADM-01	13	9	9	31	PASS	5623	TCGA-DD-AADM	LIHC	58	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2012	NA	-21349	Dead	TUMOR FREE	NA	12	NA	NA	NA	NA	NA	NA	NA	R0	1	12	0	12	0	12	0	12	
60	TCGA-DD-AADN	1	13	0	2	3	1	0	0	7	85	8	0	1	31	3	0	TCGA-DD-AADN-01	233	0.4675537130022171	133	TCGA-DD-AADN-01	17	28	69	0.14758339607633958	TCGA-DD-AADN-01	11	8	5	24	PASS	5624	TCGA-DD-AADN	LIHC	59	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G4	2012	NA	-21632	Alive	TUMOR FREE	898	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	898	0	898	0	898	0	898	
60	TCGA-DD-AADO	1	33	1	13	6	3	3	0	11	171	12	1	2	70	2	0	TCGA-DD-AADO-01	230	0.8491906659703793	149	TCGA-DD-AADO-01	20	25	75	0.15916995006304518	TCGA-DD-AADO-01	15	15	8	38	PASS	5625	TCGA-DD-AADO	LIHC	55	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2013	NA	-20139	Alive	TUMOR FREE	453	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	453	0	453	0	453	0	453	
50	TCGA-DD-AADP	0	13	0	4	1	0	0	1	5	86	5	0	2	24	4	0	TCGA-DD-AADP-01	165	0.8536004697875739	86	TCGA-DD-AADP-01	7	8	71	0.20587006410507244	TCGA-DD-AADP-01	10	4	9	23	PASS	5626	TCGA-DD-AADP	LIHC	45	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2013	NA	-16760	Alive	TUMOR FREE	458	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	458	0	458	0	458	0	458	
60	TCGA-DD-AADQ	0	19	1	19	5	2	1	0	9	92	6	0	0	34	6	0	TCGA-DD-AADQ-01	154	0.20735583022975546	78	TCGA-DD-AADQ-01	8	10	65	0.13185532579505854	TCGA-DD-AADQ-01	3	1	5	9	PASS	5627	TCGA-DD-AADQ	LIHC	59	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2013	NA	-21756	Alive	TUMOR FREE	436	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	436	0	436	0	436	0	436	
60	TCGA-DD-AADR	0	17	1	9	3	2	2	0	11	65	9	1	1	29	2	0	TCGA-DD-AADR-01	103	0.5891696404354991	54	TCGA-DD-AADR	0	0	0	0	TCGA-DD-AADR	0	0	0	0	PASS	5628	TCGA-DD-AADR	LIHC	58	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2009	NA	-21217	Alive	TUMOR FREE	2028	NA	NA	Intrahepatic Recurrence	Liver	NA	1700	NA	NA	R0	0	2028	0	2028	1	1700	1	1700	
60	TCGA-DD-AADS	1	20	0	8	5	2	0	0	6	112	8	0	1	39	8	0	TCGA-DD-AADS-01	102	0.08795519857620443	39	TCGA-DD-AADS-01	5	4	30	0.014009450219710505	TCGA-DD-AADS-01	0	0	0	0	PASS	5629	TCGA-DD-AADS	LIHC	63	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2013	NA	-23227	Alive	TUMOR FREE	474	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	474	0	474	0	474	0	474	
60	TCGA-DD-AADU	1	15	1	14	3	0	0	0	9	75	3	0	3	24	1	1	TCGA-DD-AADU-01	90	0.9473854120878854	40	TCGA-DD-AADU-01	26	11	15	0.010831625662298852	TCGA-DD-AADU-01	6	6	1	13	PASS	5630	TCGA-DD-AADU	LIHC	60	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2013	NA	-21940	Alive	TUMOR FREE	554	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	554	0	554	0	554	0	554	
50	TCGA-DD-AADV	1	13	1	8	2	1	0	0	5	85	4	1	3	31	1	1	TCGA-DD-AADV-01	243	0.7727798833553117	142	TCGA-DD-AADV-01	6	8	117	0.2675933916255193	TCGA-DD-AADV-01	7	8	8	23	PASS	5631	TCGA-DD-AADV	LIHC	50	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2013	NA	-18300	Alive	TUMOR FREE	574	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	574	0	574	0	574	0	574	
50	TCGA-DD-AADW	0	9	1	1	0	1	1	0	4	41	0	0	0	15	2	0	TCGA-DD-AADW-01	165	0.4365690069947079	84	TCGA-DD-AADW-01	5	9	95	0.1786739340339911	TCGA-DD-AADW-01	14	14	9	37	PASS	5632	TCGA-DD-AADW	LIHC	48	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2013	NA	-17781	Alive	TUMOR FREE	587	NA	NA	Locoregional Recurrence	Liver	NA	386	NA	NA	R0	0	587	0	587	1	386	1	386	
60	TCGA-DD-AADY	0	5	1	4	0	3	0	0	4	40	3	0	0	10	2	0	TCGA-DD-AADY-01	175	0.9463098800459516	92	TCGA-DD-AADY-01	9	12	106	0.31824767995088504	TCGA-DD-AADY-01	12	6	12	30	PASS	5633	TCGA-DD-AADY	LIHC	55	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2013	NA	-20233	Alive	TUMOR FREE	555	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	555	0	555	0	555	0	555	
50	TCGA-DD-AAE0	1	8	1	6	2	0	0	0	0	54	3	0	4	26	0	0	TCGA-DD-AAE0-01	143	0.4978864724069302	78	TCGA-DD-AAE0-01	18	33	62	0.1487070006075482	TCGA-DD-AAE0-01	10	4	7	21	PASS	5634	TCGA-DD-AAE0	LIHC	45	FEMALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G4	2013	NA	-16732	Alive	TUMOR FREE	555	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	555	0	555	0	555	0	555	
50	TCGA-DD-AAE1	0	7	2	2	1	0	3	0	1	33	5	0	0	16	2	0	TCGA-DD-AAE1-01	95	0.2582633021748387	44	TCGA-DD-AAE1-01	5	8	30	0.13834848152509374	TCGA-DD-AAE1-01	8	5	3	16	PASS	5635	TCGA-DD-AAE1	LIHC	52	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2013	NA	-19073	Alive	TUMOR FREE	552	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	552	0	552	0	552	0	552	
50	TCGA-DD-AAE2	0	24	2	3	3	1	1	0	8	68	2	1	1	28	4	1	TCGA-DD-AAE2-01	515	0.6220506659554712	352	TCGA-DD-AAE2-01	5	4	132	0.1751426429095833	TCGA-DD-AAE2-01	5	10	10	25	PASS	5636	TCGA-DD-AAE2	LIHC	51	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2013	NA	-18695	Alive	TUMOR FREE	638	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	638	0	638	0	638	0	638	
50	TCGA-DD-AAE3	3	24	0	15	9	1	2	1	10	127	5	0	2	39	5	0	TCGA-DD-AAE3-01	203	0.6932852555734625	138	TCGA-DD-AAE3-01	27	51	57	0.1951144669304976	TCGA-DD-AAE3-01	10	9	2	21	PASS	5637	TCGA-DD-AAE3	LIHC	50	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2013	NA	-18271	Alive	TUMOR FREE	566	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	566	0	566	0	566	0	566	
50	TCGA-DD-AAE4	2	9	0	6	2	1	1	0	3	47	4	0	0	27	1	0	TCGA-DD-AAE4-01	408	0.11705123861036225	295	TCGA-DD-AAE4-01	2	4	58	0.07704249795428805	TCGA-DD-AAE4-01	4	6	5	15	PASS	5638	TCGA-DD-AAE4	LIHC	49	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G1	2013	NA	-18009	Alive	WITH TUMOR	608	NA	NA	Locoregional Recurrence	Liver	NA	111	NA	NA	R0	0	608	0	608	1	111	1	111	
60	TCGA-DD-AAE6	0	8	1	3	1	2	1	0	4	54	8	0	4	39	3	1	TCGA-DD-AAE6-01	152	0.4515583427735668	80	TCGA-DD-AAE6-01	9	18	48	0.1455937746434731	TCGA-DD-AAE6-01	19	13	9	41	PASS	5639	TCGA-DD-AAE6	LIHC	59	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2012	NA	-21764	Alive	WITH TUMOR	141	NA	NA	Intrahepatic Recurrence	Liver	NA	105	NA	NA	R0	0	141	0	141	1	105	1	105	
70	TCGA-DD-AAE7	0	37	1	17	14	0	3	1	17	196	13	0	5	74	7	0	TCGA-DD-AAE7-01	84	0.04747007395525689	37	TCGA-DD-AAE7-01	2	2	17	0.02058524364871329	TCGA-DD-AAE7-01	4	2	2	8	PASS	5640	TCGA-DD-AAE7	LIHC	72	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2012	NA	-26568	Alive	TUMOR FREE	644	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	644	0	644	0	644	0	644	
50	TCGA-DD-AAE8	0	7	0	3	2	0	0	0	7	57	1	0	1	19	2	0	TCGA-DD-AAE8-01	98	0.4714891131689055	43	TCGA-DD-AAE8-01	12	11	68	0.27409406102625145	TCGA-DD-AAE8-01	9	6	12	27	PASS	5641	TCGA-DD-AAE8	LIHC	45	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2012	NA	-16549	Alive	TUMOR FREE	664	NA	NA	Locoregional Recurrence	Liver	NA	28	NA	NA	R0	0	664	0	664	1	28	1	28	
70	TCGA-DD-AAE9	1	16	0	11	3	2	1	0	7	87	3	0	6	28	2	0	TCGA-DD-AAE9-01	134	0.9472206145573976	70	TCGA-DD-AAE9-01	14	14	56	0.1653895240584138	TCGA-DD-AAE9-01	4	1	4	9	PASS	5642	TCGA-DD-AAE9	LIHC	69	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2012	NA	-25451	Alive	TUMOR FREE	722	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	722	0	722	0	722	0	722	
70	TCGA-DD-AAEA	1	29	1	5	6	3	2	0	16	145	4	0	3	39	6	0	TCGA-DD-AAEA-01	153	0.28768806228431826	89	TCGA-DD-AAEA-01	9	9	34	0.09370804527678016	TCGA-DD-AAEA-01	7	7	5	19	PASS	5643	TCGA-DD-AAEA	LIHC	65	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2012	NA	-24027	Alive	TUMOR FREE	575	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	575	0	575	0	575	0	575	
60	TCGA-DD-AAEB	3	26	2	8	6	5	1	0	6	97	6	1	4	27	4	0	TCGA-DD-AAEB-01	125	0.14463782278676318	60	TCGA-DD-AAEB-01	5	5	30	0.040154788189274745	TCGA-DD-AAEB-01	3	1	3	7	PASS	5644	TCGA-DD-AAEB	LIHC	60	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2012	NA	-22121	Alive	TUMOR FREE	478	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	478	0	478	0	478	0	478	
50	TCGA-DD-AAED	0	13	0	2	2	0	0	0	3	54	2	0	1	24	2	0	TCGA-DD-AAED-01	188	0.8949900007892747	119	TCGA-DD-AAED-01	8	8	65	0.21556759208724235	TCGA-DD-AAED-01	5	5	10	20	PASS	5645	TCGA-DD-AAED	LIHC	51	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2012	NA	-18722	Alive	WITH TUMOR	763	NA	NA	Intrahepatic Recurrence	Liver	NA	198	NA	NA	R0	0	763	0	763	1	198	1	198	
60	TCGA-DD-AAEE	1	13	0	6	3	0	1	0	6	62	2	0	2	30	4	0	TCGA-DD-AAEE-01	172	0.4033436516415209	92	TCGA-DD-AAEE-01	8	13	69	0.2138835978759319	TCGA-DD-AAEE-01	12	10	10	32	PASS	5646	TCGA-DD-AAEE	LIHC	55	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G4	2012	NA	-20396	Alive	WITH TUMOR	810	NA	NA	Intrahepatic Recurrence	Liver	NA	224	NA	NA	R0	0	810	0	810	1	224	1	224	
60	TCGA-DD-AAEG	2	19	0	4	3	0	2	0	8	89	4	0	1	31	3	0	TCGA-DD-AAEG-01	214	0.31293893482183405	131	TCGA-DD-AAEG-01	7	10	82	0.1212162354412797	TCGA-DD-AAEG-01	8	7	3	18	PASS	5647	TCGA-DD-AAEG	LIHC	59	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2012	NA	-21853	Alive	TUMOR FREE	719	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	719	0	719	0	719	0	719	
70	TCGA-DD-AAEH	0	9	0	7	5	1	2	0	3	67	3	0	2	29	3	1	TCGA-DD-AAEH-01	129	0.22141203477442176	62	TCGA-DD-AAEH-01	7	6	45	0.08264314696576923	TCGA-DD-AAEH-01	8	2	4	14	PASS	5648	TCGA-DD-AAEH	LIHC	73	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2012	NA	-26894	Alive	TUMOR FREE	784	NA	NA	Extrahepatic Recurrence	Bone	NA	644	NA	NA	R0	0	784	0	784	1	644	1	644	
70	TCGA-DD-AAEI	0	10	0	10	7	2	0	0	5	96	2	0	2	26	2	0	TCGA-DD-AAEI-01	192	0.15286888362034534	120	TCGA-DD-AAEI-01	4	5	57	0.06153185653039912	TCGA-DD-AAEI-01	5	6	5	16	PASS	5649	TCGA-DD-AAEI	LIHC	72	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2010	NA	-26465	Alive	WITH TUMOR	1531	NA	NA	Extrahepatic Recurrence	Bone	NA	491	NA	NA	R0	0	1531	0	1531	1	491	1	491	
50	TCGA-DD-AAEK	0	4	1	4	1	2	2	0	8	62	3	0	3	25	8	0	TCGA-DD-AAEK-01	120	0.5975112297492324	58	TCGA-DD-AAEK-01	17	17	57	0.19823499481051213	TCGA-DD-AAEK-01	15	9	5	29	PASS	5650	TCGA-DD-AAEK	LIHC	51	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2010	NA	-18757	Alive	TUMOR FREE	1067	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1067	0	1067	0	1067	0	1067	
50	TCGA-DD-AAVP	0	11	0	8	2	2	0	1	7	61	3	0	1	27	3	0	TCGA-DD-AAVP-01	146	0.2374940031234308	80	TCGA-DD-AAVP-01	5	8	48	0.12408677995185152	TCGA-DD-AAVP-01	11	8	9	28	PASS	5651	TCGA-DD-AAVP	LIHC	48	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G1	2007	NA	-17833	Alive	TUMOR FREE	2752	NA	NA	Locoregional Recurrence	Liver	NA	903	NA	NA	R0	0	2752	0	2752	1	903	1	903	
40	TCGA-DD-AAVQ	0	5	2	1	1	0	0	0	3	48	2	0	0	17	1	0	TCGA-DD-AAVQ-01	83	0.5307300824868371	32	TCGA-DD-AAVQ-01	14	12	25	0.11841324128242313	TCGA-DD-AAVQ-01	8	3	7	18	PASS	5652	TCGA-DD-AAVQ	LIHC	38	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2007	NA	-13911	Alive	TUMOR FREE	2728	NA	NA	Locoregional Recurrence	Liver	NA	1509	NA	NA	R0	0	2728	0	2728	1	1509	1	1509	
40	TCGA-DD-AAVR	0	8	1	4	1	1	2	0	6	45	5	0	0	26	2	0	TCGA-DD-AAVR-01	215	0.1556983079983487	115	TCGA-DD-AAVR-01	4	7	34	0.03357810285097822	TCGA-DD-AAVR-01	7	4	2	13	PASS	5653	TCGA-DD-AAVR	LIHC	44	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2007	NA	-16157	Alive	TUMOR FREE	2513	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2513	0	2513	0	2513	0	2513	
60	TCGA-DD-AAVS	0	7	3	1	3	1	0	0	3	38	4	0	0	11	1	1	TCGA-DD-AAVS-01	90	0.34522446706643645	36	TCGA-DD-AAVS-01	7	9	54	0.1897153445414668	TCGA-DD-AAVS-01	10	4	6	20	PASS	5654	TCGA-DD-AAVS	LIHC	56	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2007	NA	-20586	Alive	TUMOR FREE	1823	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1823	0	1823	0	1823	0	1823	
50	TCGA-DD-AAVU	0	7	0	4	2	1	0	0	2	44	4	0	0	22	3	0	TCGA-DD-AAVU-01	153	0.9169266837535608	87	TCGA-DD-AAVU-01	33	13	70	0.1915344174958854	TCGA-DD-AAVU-01	5	3	8	16	PASS	5655	TCGA-DD-AAVU	LIHC	46	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G2	2008	NA	-16889	Alive	TUMOR FREE	2202	NA	NA	Intrahepatic Recurrence	Liver	NA	1630	NA	NA	R0	0	2202	0	2202	1	1630	1	1630	
60	TCGA-DD-AAVV	0	13	4	9	5	0	1	0	9	115	5	0	1	31	3	1	TCGA-DD-AAVV-01	163	0.7223079722090235	101	TCGA-DD-AAVV-01	21	24	51	0.23805867308383194	TCGA-DD-AAVV-01	11	13	5	29	PASS	5656	TCGA-DD-AAVV	LIHC	56	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2007	NA	-20751	Alive	TUMOR FREE	2455	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2455	0	2455	0	2455	0	2455	
40	TCGA-DD-AAVW	0	3	0	2	1	1	2	0	1	30	2	0	0	10	0	1	TCGA-DD-AAVW-01	182	0.35499111983027504	107	TCGA-DD-AAVW-01	8	11	85	0.2227971195718373	TCGA-DD-AAVW-01	11	10	8	29	PASS	5657	TCGA-DD-AAVW	LIHC	35	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2008	NA	-12986	Alive	TUMOR FREE	2317	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2317	0	2317	0	2317	0	2317	
40	TCGA-DD-AAVX	0	11	0	9	1	0	1	0	7	56	3	0	1	27	2	0	TCGA-DD-AAVX-01	83	0.12422463922151535	30	TCGA-DD-AAVX-01	2	3	21	0.034583022239371965	TCGA-DD-AAVX-01	3	4	1	8	PASS	5658	TCGA-DD-AAVX	LIHC	38	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G2	2008	NA	-14016	Alive	WITH TUMOR	1718	NA	NA	Intrahepatic Recurrence	Liver	NA	393	NA	NA	R0	0	1718	0	1718	1	393	1	393	
60	TCGA-DD-AAVY	1	11	0	4	3	0	0	0	5	71	6	0	5	27	2	0	TCGA-DD-AAVY-01	147	0.3012356555088189	88	TCGA-DD-AAVY-01	9	9	41	0.060103330315639275	TCGA-DD-AAVY-01	6	1	3	10	PASS	5659	TCGA-DD-AAVY	LIHC	56	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2009	NA	-20709	Alive	TUMOR FREE	1970	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1970	0	1970	0	1970	0	1970	
40	TCGA-DD-AAVZ	0	5	2	3	2	3	0	0	3	28	4	0	0	19	0	0	TCGA-DD-AAVZ-01	138	0.3353666628353781	82	TCGA-DD-AAVZ-01	6	6	65	0.16145833958493433	TCGA-DD-AAVZ-01	5	5	7	17	PASS	5660	TCGA-DD-AAVZ	LIHC	38	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2009	NA	-14005	Alive	TUMOR FREE	1900	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1900	0	1900	0	1900	0	1900	
50	TCGA-DD-AAW0	0	10	1	6	3	0	1	1	2	76	3	0	2	25	5	0	TCGA-DD-AAW0-01	137	0.28602728655688264	83	TCGA-DD-AAW0-01	8	10	71	0.20740018883439854	TCGA-DD-AAW0-01	10	6	7	23	PASS	5661	TCGA-DD-AAW0	LIHC	54	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2009	NA	-19981	Alive	TUMOR FREE	2015	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2015	0	2015	0	2015	0	2015	
60	TCGA-DD-AAW1	1	12	2	7	5	3	2	1	7	80	8	0	3	32	4	1	TCGA-DD-AAW1-01	36	0.19643512283584752	5	TCGA-DD-AAW1-01	3	4	19	0.00638051003058304	TCGA-DD-AAW1-01	3	1	1	5	PASS	5662	TCGA-DD-AAW1	LIHC	55	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2009	NA	-20288	Alive	TUMOR FREE	1989	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1989	0	1989	0	1989	0	1989	
70	TCGA-DD-AAW2	0	23	0	11	3	1	0	0	12	100	3	0	4	30	5	0	TCGA-DD-AAW2-01	143	0.8233660075229707	79	TCGA-DD-AAW2-01	9	9	21	0.053544180883033116	TCGA-DD-AAW2-01	4	2	2	8	PASS	5663	TCGA-DD-AAW2	LIHC	69	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2009	NA	-25420	Alive	WITH TUMOR	1855	NA	NA	Intrahepatic Recurrence	Liver	NA	391	NA	NA	R0	0	1855	0	1855	1	391	1	391	
70	TCGA-DD-AAW3	1	10	0	11	2	3	1	0	2	75	4	0	0	29	1	0	TCGA-DD-AAW3-01	69	0.2248259272733432	20	TCGA-DD-AAW3-01	8	8	25	0.10280591683273313	TCGA-DD-AAW3-01	6	3	4	13	PASS	5664	TCGA-DD-AAW3	LIHC	69	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2009	NA	-25254	Alive	TUMOR FREE	1633	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1633	0	1633	0	1633	0	1633	
50	TCGA-ED-A459	1	16	1	4	5	1	2	0	18	183	15	0	3	64	9	1	TCGA-ED-A459-01	348	0.8820000877114141	260	TCGA-ED-A459-01	18	21	196	0.28171251366740513	TCGA-ED-A459-01	16	16	10	42	PASS	5665	TCGA-ED-A459	LIHC	47	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G2	2012	NA	-17402	Alive	TUMOR FREE	910	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	910	0	910	0	910	0	910	
60	TCGA-ED-A4XI	2	15	1	6	1	0	0	0	4	126	6	0	4	31	5	0	TCGA-ED-A4XI-01	81	0.1038108663184748	27	TCGA-ED-A4XI-01	1	1	32	0.030845535488844895	TCGA-ED-A4XI-01	5	5	2	12	PASS	5666	TCGA-ED-A4XI	LIHC	58	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2012	NA	-21497	Alive	TUMOR FREE	819	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	819	0	819	0	819	0	819	
60	TCGA-ED-A5KG	0	1	0	1	0	1	0	0	1	15	0	0	0	15	0	0	TCGA-ED-A5KG-01	53	0.02097472525764661	10	TCGA-ED-A5KG-01	0	0	14	0.002238929212269352	TCGA-ED-A5KG-01	0	0	0	0	PASS	5667	TCGA-ED-A5KG	LIHC	60	FEMALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G2	2012	NA	-22258	Alive	WITH TUMOR	854	NA	NA	New Primary Tumor	"Other, specify"	Kidney	110	NA	NA	R0	0	854	0	854	0	854	1	110	
70	TCGA-ED-A627	0	0	0	0	0	0	1	0	1	1	0	0	0	2	0	0	TCGA-ED-A627-01	57	9.723608996840641e-05	23	TCGA-ED-A627-01	0	0	7	0.00258615707857038	TCGA-ED-A627-01	0	0	0	0	PASS	5668	TCGA-ED-A627	LIHC	74	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2012	NA	-27303	Alive	TUMOR FREE	423	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	423	0	423	0	423	0	423	
40	TCGA-ED-A66X	1	0	0	2	0	1	0	0	1	41	2	0	1	16	0	0	TCGA-ED-A66X-01	83	0.5269915725035076	42	TCGA-ED-A66X-01	22	62	7	0.000873528968720469	TCGA-ED-A66X-01	9	3	0	12	PASS	5669	TCGA-ED-A66X	LIHC	35	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2013	NA	-12947	Alive	TUMOR FREE	406	NA	NA	Intrahepatic Recurrence	Liver	NA	124	NA	NA	R0	0	406	0	406	1	124	1	124	
50	TCGA-ED-A66Y	1	12	0	1	1	1	1	0	4	71	8	0	2	16	5	0	TCGA-ED-A66Y-01	121	0.8433688788600578	58	TCGA-ED-A66Y-01	17	16	31	0.07974566565836996	TCGA-ED-A66Y-01	6	4	5	15	PASS	5670	TCGA-ED-A66Y	LIHC	51	FEMALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2013	NA	-18797	Dead	TUMOR FREE	NA	296	NA	NA	NA	NA	NA	NA	NA	R0	1	296	0	296	0	296	0	296	
50	TCGA-ED-A7PX	1	4	0	4	0	2	0	0	0	25	2	0	0	7	0	0	TCGA-ED-A7PX-01	280	0.8000777307490294	168	TCGA-ED-A7PX-01	6	11	121	0.2772822975559356	TCGA-ED-A7PX-01	10	13	13	36	PASS	5671	TCGA-ED-A7PX	LIHC	48	FEMALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2013	NA	-17638	Alive	TUMOR FREE	6	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	6	0	6	0	6	0	6	
30	TCGA-ED-A7PY	0	7	2	3	0	0	0	0	0	25	4	0	0	8	0	0	TCGA-ED-A7PY-01	78	0.3651167659874589	25	TCGA-ED-A7PY-01	8	12	40	0.13310974388620742	TCGA-ED-A7PY-01	6	6	6	18	PASS	5672	TCGA-ED-A7PY	LIHC	20	FEMALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2013	NA	-7556	Alive	TUMOR FREE	390	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	390	0	390	0	390	0	390	
60	TCGA-ED-A7PZ	0	34	6	11	3	2	3	0	9	215	6	0	2	58	10	0	TCGA-ED-A7PZ-01	187	0.8463106032192003	106	TCGA-ED-A7PZ-01	21	65	67	0.2015091634813904	TCGA-ED-A7PZ-01	12	6	7	25	PASS	5673	TCGA-ED-A7PZ	LIHC	61	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-22601	Alive	TUMOR FREE	6	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	6	0	6	0	6	0	6	
30	TCGA-ED-A7XO	0	4	0	4	1	1	0	0	1	51	2	0	1	15	1	0	TCGA-ED-A7XO-01	203	0.5308319311695637	126	TCGA-ED-A7XO-01	6	8	121	0.22882575477328124	TCGA-ED-A7XO-01	8	8	9	25	PASS	5674	TCGA-ED-A7XO	LIHC	29	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2013	NA	-10828	Alive	WITH TUMOR	427	NA	NA	Locoregional Recurrence	Liver	NA	262	NA	NA	R0	0	427	0	427	1	262	1	262	
50	TCGA-ED-A7XP	0	9	0	0	5	0	0	0	1	49	4	0	0	18	2	0	TCGA-ED-A7XP-01	109	0.2889640021722908	47	TCGA-ED-A7XP-01	7	10	74	0.21944916365952	TCGA-ED-A7XP-01	9	13	5	27	PASS	5675	TCGA-ED-A7XP	LIHC	53	FEMALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2013	NA	-19504	Alive	WITH TUMOR	400	NA	NA	Locoregional Recurrence	Liver	NA	187	NA	NA	R0	0	400	0	400	1	187	1	187	
60	TCGA-ED-A82E	0	4	0	2	0	2	0	0	3	23	0	0	0	11	2	0	TCGA-ED-A82E-01	184	0.667570370289177	99	TCGA-ED-A82E-01	23	14	65	0.2026159731894284	TCGA-ED-A82E-01	11	10	8	29	PASS	5676	TCGA-ED-A82E	LIHC	60	FEMALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2013	NA	-22234	Alive	TUMOR FREE	408	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	408	0	408	0	408	0	408	
60	TCGA-ED-A8O5	2	10	0	8	2	0	0	0	4	91	10	0	3	37	5	0	TCGA-ED-A8O5-01	110	0.25751020767016125	62	TCGA-ED-A8O5-01	8	8	47	0.16821472097593587	TCGA-ED-A8O5-01	6	1	7	14	PASS	5677	TCGA-ED-A8O5	LIHC	59	FEMALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2013	NA	-21648	Alive	TUMOR FREE	406	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	406	0	406	0	406	0	406	
50	TCGA-ED-A8O6	0	4	1	1	2	2	2	0	4	50	5	0	3	23	0	0	TCGA-ED-A8O6-01	129	0.5896190684240744	60	TCGA-ED-A8O6-01	25	20	63	0.20347908890089988	TCGA-ED-A8O6-01	11	5	7	23	PASS	5678	TCGA-ED-A8O6	LIHC	50	FEMALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2013	NA	-18572	Dead	TUMOR FREE	NA	56	NA	NA	NA	NA	NA	NA	NA	R0	1	56	0	56	0	56	0	56	
50	TCGA-ED-A97K	1	7	1	2	3	1	0	0	2	39	2	0	0	10	1	0	TCGA-ED-A97K-01	182	0.827746077953864	115	TCGA-ED-A97K-01	31	18	99	0.3717706643000757	TCGA-ED-A97K-01	16	14	16	46	PASS	5679	TCGA-ED-A97K	LIHC	54	MALE	ASIAN	Stage IIIA	NA	Hepatocholangiocarcinoma (Mixed)	G2	2013	NA	-20073	Alive	TUMOR FREE	6	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	6	0	6	0	6	0	6	
60	TCGA-EP-A12J	0	7	0	2	3	2	0	0	2	40	4	0	2	20	1	0	TCGA-EP-A12J-01	123	0.19812276675490634	61	TCGA-EP-A12J-01	4	5	8	0.06744666868383886	TCGA-EP-A12J-01	5	1	3	9	PASS	5680	TCGA-EP-A12J	LIHC	62	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Hepatocellular Carcinoma	G1	2010	NA	-22997	Alive	TUMOR FREE	570	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	570	0	570	0	570	0	570	
70	TCGA-EP-A26S	0	14	6	6	6	0	2	0	16	159	4	0	8	75	0	0	TCGA-EP-A26S-01	97	0.08447615988589076	42	TCGA-EP-A26S-01	3	3	3	0.017128239235125894	TCGA-EP-A26S-01	4	0	1	5	PASS	5681	TCGA-EP-A26S	LIHC	70	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-25677	Alive	TUMOR FREE	608	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	608	0	608	NA	NA	0	608	
50	TCGA-EP-A2KA	1	8	1	6	2	2	3	0	4	87	6	0	4	34	3	0	TCGA-EP-A2KA-01	1020	0.6898621201322498	774	TCGA-EP-A2KA-01	5	6	77	0.06519644562863011	TCGA-EP-A2KA-01	9	2	3	14	PASS	5682	TCGA-EP-A2KA	LIHC	52	FEMALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2011	NA	-19214	Dead	WITH TUMOR	NA	627	NA	Extrahepatic Recurrence	Lung	NA	293	NA	NA	R0	1	627	1	627	1	293	1	293	
50	TCGA-EP-A2KB	1	17	0	2	1	1	0	0	1	65	7	0	1	27	1	1	TCGA-EP-A2KB-01	58	0.6426658919761558	20	TCGA-EP-A2KB-01	9	8	12	0.2362809327272647	TCGA-EP-A2KB-01	3	1	1	5	PASS	5683	TCGA-EP-A2KB	LIHC	46	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-16835	Dead	WITH TUMOR	NA	596	NA	Intrahepatic Recurrence	Liver	NA	161	NA	NA	R0	1	596	1	596	1	161	1	161	
60	TCGA-EP-A2KC	2	4	1	2	3	0	0	0	3	66	4	0	0	29	4	2	TCGA-EP-A2KC-01	84	0.5112036457231925	40	TCGA-EP-A2KC-01	9	7	8	0.023241348632373062	TCGA-EP-A2KC-01	3	0	2	5	PASS	5684	TCGA-EP-A2KC	LIHC	62	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Hepatocellular Carcinoma	G3	2011	NA	-22677	Dead	TUMOR FREE	NA	19	NA	NA	NA	NA	NA	NA	NA	R0	1	19	0	19	0	19	0	19	
80	TCGA-EP-A3JL	0	11	1	3	1	1	1	0	2	74	4	0	1	20	3	1	TCGA-EP-A3JL-01	47	0.6562962558701253	9	TCGA-EP-A3JL-01	31	16	3	0.07583556954358461	TCGA-EP-A3JL-01	4	1	1	6	PASS	5685	TCGA-EP-A3JL	LIHC	76	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-27886	Alive	TUMOR FREE	303	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	303	0	303	NA	NA	0	303	
70	TCGA-EP-A3RK	2	5	2	10	0	4	0	0	2	98	2	0	2	36	0	2	TCGA-EP-A3RK-01	58	0.23315319264790474	17	TCGA-EP-A3RK-01	8	8	11	0.17651147948382953	TCGA-EP-A3RK-01	6	7	4	17	PASS	5686	TCGA-EP-A3RK	LIHC	73	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2012	NA	-26985	Alive	WITH TUMOR	363	NA	NA	Locoregional Recurrence	Liver	NA	320	NA	NA	NA	0	363	0	363	NA	NA	1	320	
80	TCGA-ES-A2HS	0	7	1	1	1	1	2	0	3	52	5	0	1	27	4	0	TCGA-ES-A2HS-01	117	0.7117575180209099	53	TCGA-ES-A2HS-01	25	56	7	0.120867431523419	TCGA-ES-A2HS-01	6	1	2	9	PASS	5687	TCGA-ES-A2HS	LIHC	80	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2008	NA	-29268	Dead	TUMOR FREE	NA	688	NA	NA	NA	NA	NA	NA	NA	R0	1	688	0	688	0	688	0	688	
50	TCGA-ES-A2HT	2	11	0	4	1	0	0	0	2	63	2	0	0	23	1	0	TCGA-ES-A2HT-01	81	0.14887616014835714	35	TCGA-ES-A2HT-01	38	9	2	0.015389476960570182	TCGA-ES-A2HT-01	2	0	1	3	PASS	5688	TCGA-ES-A2HT	LIHC	54	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Hepatocellular Carcinoma	G2	2007	NA	-20023	Dead	TUMOR FREE	NA	438	NA	NA	NA	NA	NA	NA	NA	R0	1	438	0	438	0	438	0	438	
70	TCGA-FV-A23B	0	12	1	4	2	2	3	0	4	88	10	0	1	37	2	0	TCGA-FV-A23B-01	130	0.20188924084590493	70	TCGA-FV-A23B-01	6	6	15	0.1297615050545417	TCGA-FV-A23B-01	9	6	4	19	PASS	5689	TCGA-FV-A23B	LIHC	70	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	NA	2005	NA	-25788	Dead	WITH TUMOR	NA	1852	NA	Locoregional Recurrence	Liver	NA	1453	NA	NA	R0	1	1852	1	1852	1	1453	1	1453	
80	TCGA-FV-A2QQ	0	14	2	5	8	1	0	0	7	99	4	0	0	40	1	1	TCGA-FV-A2QQ-01	95	0.3696781400910743	46	TCGA-FV-A2QQ-01	4	4	14	0.0745088583009223	TCGA-FV-A2QQ-01	4	4	4	12	PASS	5690	TCGA-FV-A2QQ	LIHC	80	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-29354	Alive	TUMOR FREE	729	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	729	0	729	0	729	0	729	
80	TCGA-FV-A2QR	1	13	2	6	4	0	4	0	7	90	3	0	4	32	3	0	TCGA-FV-A2QR-01	159	0.2605710204554613	82	TCGA-FV-A2QR-01	5	8	43	0.13309095036571192	TCGA-FV-A2QR-01	10	10	7	27	PASS	5691	TCGA-FV-A2QR	LIHC	75	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2006	NA	NA	Dead	WITH TUMOR	NA	581	NA	Extrahepatic Recurrence	NA	NA	561	NA	NA	RX	1	581	1	581	NA	NA	1	561	
80	TCGA-FV-A3I0	0	5	0	3	2	1	0	0	4	69	3	0	2	22	1	0	TCGA-FV-A3I0-01	149	0.868953451143626	91	TCGA-FV-A3I0-01	19	53	38	0.19383866263712649	TCGA-FV-A3I0-01	11	9	10	30	pathology review	5692	TCGA-FV-A3I0	LIHC	76	FEMALE	WHITE	Stage II	NA	Hepatocholangiocarcinoma (Mixed)	G2	2011	NA	-28101	Alive	WITH TUMOR	848	NA	NA	Intrahepatic Recurrence	Liver	NA	159	NA	NA	R0	0	848	0	848	1	159	1	159	
80	TCGA-FV-A3I1	4	16	0	10	2	4	1	0	12	116	6	0	2	39	4	0	TCGA-FV-A3I1-01	141	0.3129498742454617	79	TCGA-FV-A3I1-01	9	9	43	0.21666163255337198	TCGA-FV-A3I1-01	6	5	4	15	PASS	5693	TCGA-FV-A3I1	LIHC	81	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2011	NA	NA	Dead	TUMOR FREE	NA	247	NA	NA	NA	NA	NA	NA	NA	R0	1	247	0	247	0	247	0	247	
80	TCGA-FV-A3R2	1	6	1	5	3	0	0	0	3	59	7	0	1	27	4	0	TCGA-FV-A3R2-01	103	0.401820246363477	43	TCGA-FV-A3R2-01	14	10	17	0.16733955687256333	TCGA-FV-A3R2-01	7	1	4	12	PASS	5694	TCGA-FV-A3R2	LIHC	75	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	NA	2005	NA	-27530	Dead	TUMOR FREE	NA	194	NA	NA	NA	NA	NA	NA	NA	R0	1	194	0	194	0	194	0	194	
40	TCGA-FV-A3R3	2	6	1	2	2	1	0	0	0	47	3	0	0	14	0	0	TCGA-FV-A3R3-01	43	0.0968577974281839	9	TCGA-FV-A3R3-01	1	4	3	0.024627856313393603	TCGA-FV-A3R3-01	3	3	1	7	PASS	5695	TCGA-FV-A3R3	LIHC	38	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2012	NA	-14231	Dead	TUMOR FREE	NA	366	NA	NA	NA	NA	NA	NA	NA	R0	1	366	0	366	0	366	0	366	
50	TCGA-FV-A495	2	19	0	6	5	2	5	0	12	169	14	0	2	51	8	0	TCGA-FV-A495-01	339	0.19412059591600733	210	TCGA-FV-A495-01	5	4	90	0.07781840948903652	TCGA-FV-A495-01	6	8	6	20	PASS	5696	TCGA-FV-A495	LIHC	51	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2012	NA	-18740	Alive	TUMOR FREE	1	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1	0	1	0	1	0	1	
80	TCGA-FV-A496	0	17	4	16	6	0	6	0	12	200	10	0	0	57	4	0	TCGA-FV-A496-01	517	0.9733182990263411	361	TCGA-FV-A496-01	9	16	96	0.10422089314492428	TCGA-FV-A496-01	18	20	5	43	PASS	5697	TCGA-FV-A496	LIHC	84	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2012	NA	-30950	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	10	0	10	0	10	0	10	
80	TCGA-FV-A4ZP	0	9	0	6	4	0	1	0	4	78	3	0	1	27	2	2	TCGA-FV-A4ZP-01	217	0.5437370633215847	118	TCGA-FV-A4ZP-01	17	22	53	0.08424385236802646	TCGA-FV-A4ZP-01	9	6	3	18	PASS	5698	TCGA-FV-A4ZP	LIHC	78	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2005	NA	-28771	Dead	TUMOR FREE	NA	2486	NA	NA	NA	NA	NA	NA	NA	R1	1	2486	0	2486	NA	NA	0	2486	
50	TCGA-FV-A4ZQ	0	8	0	3	1	0	0	0	9	57	7	0	1	24	3	0	TCGA-FV-A4ZQ-01	120	0.9476795861384408	52	TCGA-FV-A4ZQ-01	12	15	55	0.10944306055831723	TCGA-FV-A4ZQ-01	6	5	4	15	PASS	5699	TCGA-FV-A4ZQ	LIHC	52	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2012	NA	-19090	Alive	TUMOR FREE	12	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	12	0	12	0	12	0	12	
60	TCGA-G3-A25S	1	7	0	4	4	2	0	0	8	113	15	0	0	40	2	2	TCGA-G3-A25S-01	228	0.9353563006993812	134	TCGA-G3-A25S-01	27	39	26	0.2715269625782259	TCGA-G3-A25S-01	15	5	6	26	PASS	5700	TCGA-G3-A25S	LIHC	64	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2009	NA	-23571	Dead	WITH TUMOR	NA	416	NA	Extrahepatic Recurrence	"Other, specify"	Bone and Lung	37	NA	NA	R1	1	416	1	416	NA	NA	1	37	
50	TCGA-G3-A25T	0	4	0	4	5	0	0	0	4	54	3	0	1	20	2	0	TCGA-G3-A25T-01	63	0.530182167617516	23	TCGA-G3-A25T-01	19	23	6	0.11285902041947787	TCGA-G3-A25T-01	5	4	4	13	PASS	5701	TCGA-G3-A25T	LIHC	45	FEMALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2007	NA	-16461	Alive	WITH TUMOR	1553	NA	NA	Intrahepatic Recurrence	Liver	NA	452	NA	NA	R0	0	1553	0	1553	1	452	1	452	
60	TCGA-G3-A25U	0	10	0	6	0	1	2	0	5	75	11	0	2	32	5	1	TCGA-G3-A25U-01	157	0.366826553723321	92	TCGA-G3-A25U-01	6	9	22	0.15437389597905898	TCGA-G3-A25U-01	6	6	7	19	PASS	5702	TCGA-G3-A25U	LIHC	63	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2007	NA	-23207	Alive	TUMOR FREE	1636	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1636	0	1636	0	1636	0	1636	
70	TCGA-G3-A25V	1	11	0	0	5	1	0	1	6	57	5	0	1	19	2	1	TCGA-G3-A25V-01	45	0.027641481586283604	7	TCGA-G3-A25V-01	0	0	19	0.0017812013109660954	TCGA-G3-A25V-01	1	0	0	1	PASS	5703	TCGA-G3-A25V	LIHC	68	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2010	NA	-25144	Alive	WITH TUMOR	860	NA	NA	Intrahepatic Recurrence	Liver	NA	489	NA	NA	R0	0	860	0	860	1	489	1	489	
80	TCGA-G3-A25W	0	9	1	2	4	0	1	0	3	83	8	0	0	30	3	0	TCGA-G3-A25W-01	109	0.3037502953365792	49	TCGA-G3-A25W-01	9	5	12	0.03957515288073943	TCGA-G3-A25W-01	5	4	3	12	PASS	5704	TCGA-G3-A25W	LIHC	79	FEMALE	WHITE	Stage IIIB	NA	Hepatocellular Carcinoma	G2	2010	NA	-29018	Alive	TUMOR FREE	935	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	935	0	935	0	935	0	935	
70	TCGA-G3-A25X	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-G3-A25X-01	1859	0.601141569291893	1517	TCGA-G3-A25X	0	0	0	0	TCGA-G3-A25X	0	0	0	0	PASS	5705	TCGA-G3-A25X	LIHC	73	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2007	NA	-26988	Alive	TUMOR FREE	1779	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1779	0	1779	0	1779	0	1779	
50	TCGA-G3-A25Y	0	6	1	2	1	0	0	0	5	86	4	0	3	17	3	0	TCGA-G3-A25Y-01	128	0.3026069671586643	66	TCGA-G3-A25Y-01	3	8	19	0.18949725108188065	TCGA-G3-A25Y-01	9	16	7	32	PASS	5706	TCGA-G3-A25Y	LIHC	52	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2006	NA	-19055	Dead	WITH TUMOR	NA	452	NA	Locoregional Recurrence	Liver	NA	355	NA	NA	R0	1	452	1	452	1	355	1	355	
60	TCGA-G3-A25Z	1	6	0	1	3	0	0	0	1	75	6	0	1	28	0	0	TCGA-G3-A25Z-01	149	0.3177080850762815	79	TCGA-G3-A25Z-01	7	5	20	0.08869071962160513	TCGA-G3-A25Z-01	5	3	4	12	PASS	5707	TCGA-G3-A25Z	LIHC	58	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2010	NA	-21509	Alive	TUMOR FREE	655	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	655	0	655	0	655	0	655	
80	TCGA-G3-A3CG	0	21	1	7	5	1	2	0	7	73	8	0	0	38	3	0	TCGA-G3-A3CG	0	0	0	TCGA-G3-A3CG	0	0	0	0	TCGA-G3-A3CG-01	4	1	3	8	PASS	5708	TCGA-G3-A3CG	LIHC	80	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-29432	Alive	WITH TUMOR	673	NA	NA	Intrahepatic Recurrence	Liver	NA	329	NA	NA	R1	0	673	0	673	NA	NA	1	329	
50	TCGA-G3-A3CH	1	3	0	3	1	0	0	0	4	31	3	0	0	13	1	0	TCGA-G3-A3CH-01	83	0.23035403229280965	32	TCGA-G3-A3CH-01	5	6	15	0.10616617129792212	TCGA-G3-A3CH-01	6	2	4	12	PASS	5709	TCGA-G3-A3CH	LIHC	53	MALE	ASIAN	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2010	NA	-19473	Alive	WITH TUMOR	780	NA	NA	Intrahepatic Recurrence	Liver	NA	116	NA	NA	R0	0	780	0	780	1	116	1	116	
70	TCGA-G3-A3CI	1	1	0	1	0	0	0	0	1	17	0	0	1	6	0	0	TCGA-G3-A3CI-01	61	0.016386814702029254	18	TCGA-G3-A3CI-01	0	0	5	0.017265345677044703	TCGA-G3-A3CI-01	0	1	1	2	PASS	5710	TCGA-G3-A3CI	LIHC	71	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-26224	Alive	TUMOR FREE	180	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	180	0	180	0	180	0	180	
50	TCGA-G3-A3CJ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-G3-A3CJ-01	83	0.14900845801034635	32	TCGA-G3-A3CJ-01	36	13	11	0.017430859710561963	TCGA-G3-A3CJ-01	6	1	1	8	PASS	5711	TCGA-G3-A3CJ	LIHC	52	MALE	AMERICAN INDIAN OR ALASKA NATIVE	Stage II	NA	Hepatocellular Carcinoma	G2	2011	NA	-19305	Alive	WITH TUMOR	594	NA	NA	Extrahepatic Recurrence	Lung	NA	296	NA	NA	R0	0	594	0	594	1	296	1	296	
60	TCGA-G3-A3CK	0	16	1	11	7	1	2	0	13	169	10	2	4	57	8	1	TCGA-G3-A3CK-01	62	0.07814349899927775	18	TCGA-G3-A3CK-01	1	2	4	0.0020047523649708745	TCGA-G3-A3CK-01	2	2	0	4	PASS	5712	TCGA-G3-A3CK	LIHC	61	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-22462	Alive	TUMOR FREE	585	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	585	0	585	0	585	0	585	
40	TCGA-G3-A5SI	0	4	0	3	1	2	0	0	4	26	5	0	1	13	0	0	TCGA-G3-A5SI-01	105	0.32095583056584315	46	TCGA-G3-A5SI-01	5	11	43	0.14371738310336105	TCGA-G3-A5SI-01	12	14	6	32	PASS	5713	TCGA-G3-A5SI	LIHC	44	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G2	2011	NA	-16126	Dead	WITH TUMOR	NA	768	NA	Intrahepatic Recurrence	Liver	NA	348	NA	NA	R0	1	768	1	768	1	348	1	348	
60	TCGA-G3-A5SJ	0	12	0	3	4	0	1	0	3	85	6	0	1	23	2	0	TCGA-G3-A5SJ-01	91	0.20519754537432747	34	TCGA-G3-A5SJ-01	7	6	41	0.10172479912692828	TCGA-G3-A5SJ-01	5	3	4	12	PASS	5714	TCGA-G3-A5SJ	LIHC	59	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2012	NA	-21848	Alive	TUMOR FREE	698	NA	NA	Intrahepatic Recurrence	Liver	NA	308	NA	NA	R0	0	698	0	698	1	308	1	308	
60	TCGA-G3-A5SK	0	16	0	4	3	0	2	1	5	74	4	0	4	25	3	0	TCGA-G3-A5SK	0	0	0	TCGA-G3-A5SK	0	0	0	0	TCGA-G3-A5SK	0	0	0	0	PASS	5715	TCGA-G3-A5SK	LIHC	58	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2012	NA	-21320	Alive	WITH TUMOR	744	NA	NA	Intrahepatic Recurrence	Liver	NA	483	NA	NA	R0	0	744	0	744	1	483	1	483	
70	TCGA-G3-A5SL	1	7	0	12	6	4	0	0	5	105	5	0	3	25	5	0	TCGA-G3-A5SL-01	100	0.3786216237661627	49	TCGA-G3-A5SL-01	6	9	29	0.060887487399324265	TCGA-G3-A5SL-01	4	1	2	7	PASS	5716	TCGA-G3-A5SL	LIHC	70	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2012	NA	-25671	Alive	TUMOR FREE	621	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	621	0	621	0	621	0	621	
60	TCGA-G3-A5SM	1	12	1	4	2	1	1	0	5	94	4	0	0	45	8	0	TCGA-G3-A5SM-01	58	0.4969956153663205	22	TCGA-G3-A5SM-01	22	27	16	0.09050546075378997	TCGA-G3-A5SM-01	4	2	3	9	PASS	5717	TCGA-G3-A5SM	LIHC	58	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G3	2012	NA	-21236	Alive	TUMOR FREE	520	NA	NA	Intrahepatic Recurrence	Liver	NA	252	NA	NA	R0	0	520	0	520	1	252	1	252	
70	TCGA-G3-A6UC	0	16	1	4	3	2	1	1	7	94	5	1	2	42	1	0	TCGA-G3-A6UC-01	148	0.2503607812209441	80	TCGA-G3-A6UC-01	7	7	50	0.05926419549702928	TCGA-G3-A6UC-01	6	1	2	9	PASS	5718	TCGA-G3-A6UC	LIHC	65	MALE	WHITE	Stage IIIB	NA	Hepatocellular Carcinoma	G2	2012	NA	-23793	Alive	WITH TUMOR	671	NA	NA	Intrahepatic Recurrence	Liver	NA	639	NA	NA	R0	0	671	0	671	1	639	1	639	
80	TCGA-G3-A7M5	2	19	1	5	12	0	0	1	12	132	13	0	3	54	6	0	TCGA-G3-A7M5-01	95	0.9523193301526685	45	TCGA-G3-A7M5-01	18	16	47	0.18159352742925453	TCGA-G3-A7M5-01	3	1	2	6	PASS	5719	TCGA-G3-A7M5	LIHC	76	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2013	NA	-27963	Alive	TUMOR FREE	447	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	447	0	447	0	447	0	447	
60	TCGA-G3-A7M6	1	11	0	6	3	1	0	0	11	70	3	0	1	25	5	0	TCGA-G3-A7M6-01	124	0.2775815587682325	64	TCGA-G3-A7M6-01	8	9	55	0.13110546582688215	TCGA-G3-A7M6-01	10	5	6	21	PASS	5720	TCGA-G3-A7M6	LIHC	60	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2013	NA	-22205	Alive	WITH TUMOR	632	NA	NA	Locoregional Recurrence	Liver	NA	293	NA	NA	R0	0	632	0	632	1	293	1	293	
70	TCGA-G3-A7M7	0	8	1	1	0	0	0	0	5	58	6	0	0	21	2	0	TCGA-G3-A7M7-01	122	0.06982654451934829	62	TCGA-G3-A7M7-01	2	3	17	0.015722145016040932	TCGA-G3-A7M7-01	2	0	1	3	PASS	5721	TCGA-G3-A7M7	LIHC	65	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2013	NA	-24002	Alive	TUMOR FREE	361	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	361	0	361	0	361	0	361	
30	TCGA-G3-A7M8	0	2	0	2	1	0	0	0	1	19	3	0	0	8	0	0	TCGA-G3-A7M8-01	55	3.059272855621811e-05	17	TCGA-G3-A7M8-01	0	0	2	6.157062578076311e-05	TCGA-G3-A7M8-01	0	0	0	0	PASS	5722	TCGA-G3-A7M8	LIHC	31	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G1	2013	NA	-11527	Alive	TUMOR FREE	430	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	430	0	430	NA	NA	0	430	
70	TCGA-G3-A7M9	0	15	1	4	8	1	1	0	5	105	4	1	2	33	3	0	TCGA-G3-A7M9-01	154	0.6620355920510258	83	TCGA-G3-A7M9-01	16	57	57	0.17825653685530732	TCGA-G3-A7M9-01	15	6	10	31	PASS	5723	TCGA-G3-A7M9	LIHC	70	MALE	WHITE	Stage IIIB	NA	Hepatocellular Carcinoma	G2	2013	NA	-25588	Dead	NA	NA	56	NA	NA	NA	NA	NA	NA	NA	R0	1	56	NA	56	0	56	0	56	
50	TCGA-G3-AAUZ	0	7	1	5	3	0	2	0	5	69	4	0	2	17	2	0	TCGA-G3-AAUZ-01	277	0.20249538668574926	183	TCGA-G3-AAUZ-01	8	6	47	0.07307142940650913	TCGA-G3-AAUZ-01	5	1	7	13	PASS	5724	TCGA-G3-AAUZ	LIHC	48	MALE	[Unknown]	Stage I	NA	Hepatocellular Carcinoma	G2	2013	NA	-17760	Alive	TUMOR FREE	480	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	480	0	480	0	480	0	480	
60	TCGA-G3-AAV0	1	18	1	21	10	5	0	2	4	129	8	0	4	52	6	0	TCGA-G3-AAV0-01	103	0.17676248470660078	46	TCGA-G3-AAV0-01	4	5	16	0.040445387349385235	TCGA-G3-AAV0-01	7	7	2	16	PASS	5725	TCGA-G3-AAV0	LIHC	58	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2013	NA	-21249	Alive	TUMOR FREE	476	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	476	0	476	0	476	0	476	
50	TCGA-G3-AAV1	0	7	1	4	4	1	0	0	6	43	2	0	1	17	1	0	TCGA-G3-AAV1-01	127	0.8178032434782331	63	TCGA-G3-AAV1-01	17	16	32	0.10149993302656997	TCGA-G3-AAV1-01	12	10	5	27	PASS	5726	TCGA-G3-AAV1	LIHC	51	MALE	ASIAN	Stage IIIC	NA	Hepatocellular Carcinoma	G3	2013	NA	-18973	Dead	WITH TUMOR	NA	359	NA	Locoregional Recurrence	Liver	NA	49	NA	NA	R0	1	359	1	359	1	49	1	49	
50	TCGA-G3-AAV2	0	5	1	9	0	0	2	0	6	39	2	0	0	17	3	0	TCGA-G3-AAV2-01	78	0.21328413211654665	33	TCGA-G3-AAV2-01	5	7	21	0.059403080824438875	TCGA-G3-AAV2-01	5	5	3	13	PASS	5727	TCGA-G3-AAV2	LIHC	50	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2013	NA	-18363	Alive	TUMOR FREE	372	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	372	0	372	0	372	0	372	
60	TCGA-G3-AAV3	2	13	1	7	3	3	1	0	2	66	6	1	1	19	2	0	TCGA-G3-AAV3-01	69	0.21060887285662847	21	TCGA-G3-AAV3-01	6	5	23	0.07121223376557162	TCGA-G3-AAV3-01	5	1	2	8	PASS	5728	TCGA-G3-AAV3	LIHC	58	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-21449	Alive	TUMOR FREE	412	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	412	0	412	0	412	0	412	
80	TCGA-G3-AAV4	0	18	1	12	2	0	3	0	6	87	4	0	1	40	6	0	TCGA-G3-AAV4-01	73	0.8081685235480056	25	TCGA-G3-AAV4-01	12	10	25	0.07948637526929936	TCGA-G3-AAV4-01	7	2	3	12	PASS	5729	TCGA-G3-AAV4	LIHC	83	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2012	NA	-30466	Dead	TUMOR FREE	NA	27	NA	NA	NA	NA	NA	NA	NA	R0	1	27	0	27	0	27	0	27	
70	TCGA-G3-AAV5	0	13	2	7	0	2	2	0	1	62	8	0	1	22	2	0	TCGA-G3-AAV5-01	80	0.9408688845390756	31	TCGA-G3-AAV5-01	11	7	19	0.023098720712169167	TCGA-G3-AAV5-01	4	1	2	7	PASS	5730	TCGA-G3-AAV5	LIHC	67	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-24655	Alive	WITH TUMOR	354	NA	NA	Locoregional Recurrence	Liver	NA	117	NA	NA	R0	0	354	0	354	1	117	1	117	
50	TCGA-G3-AAV6	1	9	1	1	1	0	3	1	4	57	3	0	1	34	1	0	TCGA-G3-AAV6-01	104	0.7783343531526669	45	TCGA-G3-AAV6-01	24	58	37	0.14998121360465713	TCGA-G3-AAV6-01	14	12	3	29	PASS	5731	TCGA-G3-AAV6	LIHC	53	FEMALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2013	NA	-19556	Dead	WITH TUMOR	NA	65	NA	Intrahepatic Recurrence	Liver	NA	44	NA	NA	R0	1	65	1	65	1	44	1	44	
40	TCGA-G3-AAV7	0	14	1	7	3	1	2	0	6	62	7	0	1	24	1	0	TCGA-G3-AAV7-01	107	0.9324759782590574	48	TCGA-G3-AAV7-01	12	11	78	0.36899474656437176	TCGA-G3-AAV7-01	8	5	10	23	PASS	5732	TCGA-G3-AAV7	LIHC	38	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-14229	Alive	TUMOR FREE	361	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	361	0	361	0	361	0	361	
60	TCGA-GJ-A3OU	0	3	0	3	1	1	0	0	2	49	3	0	1	13	2	0	TCGA-GJ-A3OU-01	69	0.2764332551337861	28	TCGA-GJ-A3OU-01	7	10	48	0.13022137585615065	TCGA-GJ-A3OU-01	4	3	8	15	PASS	5733	TCGA-GJ-A3OU	LIHC	59	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-21671	Alive	[Discrepancy]	879	NA	NA	Intrahepatic Recurrence	Liver	NA	879	NA	NA	RX	0	879	0	879	NA	NA	1	879	
80	TCGA-GJ-A6C0	0	29	1	8	0	0	1	0	9	115	10	2	0	58	2	0	TCGA-GJ-A6C0-01	687	0.1583937990399655	483	TCGA-GJ-A6C0-01	3	5	149	0.09302465428177152	TCGA-GJ-A6C0-01	9	10	4	23	pathology review	5734	TCGA-GJ-A6C0	LIHC	75	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2012	NA	-27626	Dead	NA	NA	31	NA	NA	NA	NA	NA	NA	NA	RX	1	31	NA	31	NA	NA	0	31	
70	TCGA-GJ-A9DB	0	7	1	10	2	0	0	0	7	66	5	0	2	32	1	0	TCGA-GJ-A9DB-01	140	0.25877240711839	72	TCGA-GJ-A9DB-01	6	5	44	0.0787539588966304	TCGA-GJ-A9DB-01	3	2	4	9	PASS	5735	TCGA-GJ-A9DB	LIHC	68	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2013	NA	-25020	Dead	NA	NA	67	NA	NA	NA	NA	NA	NA	NA	R0	1	67	NA	67	0	67	0	67	
80	TCGA-HP-A5MZ	0	4	0	1	2	1	0	0	3	39	2	0	0	14	1	0	TCGA-HP-A5MZ-01	43	0.15518995388746204	11	TCGA-HP-A5MZ-01	5	5	9	0.0008669302150479415	TCGA-HP-A5MZ-01	2	0	0	2	PASS	5736	TCGA-HP-A5MZ	LIHC	78	MALE	[Not Evaluated]	Stage I	NA	Hepatocellular Carcinoma	G2	NA	NA	-22702	Dead	TUMOR FREE	NA	91	NA	NA	NA	NA	NA	NA	NA	R0	1	91	0	91	0	91	0	91	
90	TCGA-HP-A5N0	1	9	2	4	7	0	0	0	4	114	3	0	3	37	2	0	TCGA-HP-A5N0-01	89	0.20197066432263505	40	TCGA-HP-A5N0-01	5	5	38	0.1101730211262358	TCGA-HP-A5N0-01	6	8	5	19	PASS	5737	TCGA-HP-A5N0	LIHC	90	FEMALE	[Not Evaluated]	NA	NA	Hepatocellular Carcinoma	NA	NA	NA	-32120	Dead	WITH TUMOR	NA	1147	NA	Locoregional Recurrence	Liver	NA	179	NA	NA	R0	1	1147	1	1147	1	179	1	179	
60	TCGA-K7-A5RF	0	7	2	4	0	0	0	0	2	94	6	0	2	46	2	0	TCGA-K7-A5RF-01	51	7.443642422459765e-05	12	TCGA-K7-A5RF	0	0	0	0	TCGA-K7-A5RF	0	0	0	0	PASS	5738	TCGA-K7-A5RF	LIHC	64	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2012	NA	-23557	Alive	TUMOR FREE	631	NA	NA	Intrahepatic Recurrence	Liver	NA	205	NA	NA	R0	0	631	0	631	1	205	1	205	
70	TCGA-K7-A5RG	0	29	4	4	4	2	0	0	14	214	14	2	0	54	4	0	TCGA-K7-A5RG-01	50	0.22665678529825625	13	TCGA-K7-A5RG-01	6	7	3	0.0008576995768827684	TCGA-K7-A5RG-01	4	2	0	6	PASS	5739	TCGA-K7-A5RG	LIHC	66	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Hepatocellular Carcinoma	G1	2012	NA	-24218	Alive	TUMOR FREE	519	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	519	0	519	0	519	0	519	
70	TCGA-K7-A6G5	1	10	0	2	1	3	0	0	9	54	8	0	0	30	4	0	TCGA-K7-A6G5-01	92	0.14817619522398698	45	TCGA-K7-A6G5-01	3	4	28	0.027461657517701858	TCGA-K7-A6G5-01	2	2	1	5	PASS	5740	TCGA-K7-A6G5	LIHC	66	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2013	NA	-24233	Alive	TUMOR FREE	512	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	512	0	512	NA	NA	0	512	
60	TCGA-K7-AAU7	1	8	1	7	3	1	1	0	4	57	3	0	3	21	0	0	TCGA-K7-AAU7-01	114	0.1309973437100391	59	TCGA-K7-AAU7-01	6	6	37	0.058205340109014236	TCGA-K7-AAU7-01	6	2	3	11	PASS	5741	TCGA-K7-AAU7	LIHC	61	MALE	WHITE	Stage II	NA	Hepatocholangiocarcinoma (Mixed)	G2	2013	NA	-22476	Alive	WITH TUMOR	359	NA	NA	Intrahepatic Recurrence	Liver	NA	58	NA	NA	RX	0	359	0	359	NA	NA	1	58	
70	TCGA-KR-A7K0	0	13	2	4	2	1	2	0	6	67	6	0	0	34	1	0	TCGA-KR-A7K0-01	54	0.040319225270640684	20	TCGA-KR-A7K0-01	2	2	15	0.007108024082149346	TCGA-KR-A7K0-01	2	1	1	4	PASS	5742	TCGA-KR-A7K0	LIHC	65	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2013	NA	-23974	Dead	TUMOR FREE	NA	65	NA	NA	NA	NA	NA	NA	NA	R0	1	65	0	65	0	65	0	65	
60	TCGA-KR-A7K2	0	8	1	5	2	0	1	0	1	39	2	0	1	23	1	0	TCGA-KR-A7K2-01	66	0.8541306026402045	21	TCGA-KR-A7K2-01	20	19	26	0.03277201552112625	TCGA-KR-A7K2-01	3	4	2	9	pathology review	5743	TCGA-KR-A7K2	LIHC	64	MALE	WHITE	Stage I	NA	Hepatocholangiocarcinoma (Mixed)	G1	2013	NA	-23699	Alive	TUMOR FREE	829	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	829	0	829	0	829	0	829	
60	TCGA-KR-A7K7	0	4	1	6	4	1	0	0	2	51	6	0	2	14	0	0	TCGA-KR-A7K7-01	69	0.9266884604110256	30	TCGA-KR-A7K7-01	20	34	27	0.0220947052184484	TCGA-KR-A7K7-01	3	0	1	4	PASS	5744	TCGA-KR-A7K7	LIHC	61	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G1	2012	NA	-22587	Alive	WITH TUMOR	951	NA	NA	Extrahepatic Recurrence	"Other, specify"	Adrenal bilateral	239	NA	NA	R0	0	951	0	951	1	239	1	239	
60	TCGA-KR-A7K8	1	6	1	2	1	1	0	0	7	41	6	0	0	15	1	0	TCGA-KR-A7K8-01	493	0.2537293510312601	314	TCGA-KR-A7K8-01	4	6	5	9.574923925651028e-05	TCGA-KR-A7K8-01	10	14	0	24	PASS	5745	TCGA-KR-A7K8	LIHC	57	MALE	[Unknown]	Stage I	NA	Hepatocellular Carcinoma	G1	2012	NA	-20914	Alive	TUMOR FREE	906	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	906	0	906	0	906	0	906	
80	TCGA-LG-A6GG	4	34	2	21	5	0	0	0	17	311	12	2	6	112	26	0	TCGA-LG-A6GG-01	209	0.9313094874028868	128	TCGA-LG-A6GG-01	16	15	78	0.11322540241967373	TCGA-LG-A6GG-01	4	6	6	16	PASS	5746	TCGA-LG-A6GG	LIHC	79	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-28871	Alive	TUMOR FREE	387	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	387	0	387	0	387	0	387	
50	TCGA-LG-A9QC	0	7	1	4	4	0	0	0	3	36	0	0	0	17	1	0	TCGA-LG-A9QC-01	108	0.2744472596663025	52	TCGA-LG-A9QC-01	7	5	47	0.18890475114987704	TCGA-LG-A9QC-01	6	4	3	13	PASS	5747	TCGA-LG-A9QC	LIHC	48	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2013	NA	-17842	Alive	TUMOR FREE	425	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	425	0	425	0	425	0	425	
70	TCGA-LG-A9QD	1	17	2	7	6	1	1	0	7	82	5	0	3	39	4	0	TCGA-LG-A9QD-01	80	0.0995199494998264	32	TCGA-LG-A9QD-01	3	3	25	0.0286189851126722	TCGA-LG-A9QD-01	5	1	1	7	PASS	5748	TCGA-LG-A9QD	LIHC	68	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2013	NA	-24969	Alive	WITH TUMOR	366	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	366	0	366	0	366	0	366	
60	TCGA-MI-A75C	1	14	1	13	7	0	0	1	8	90	7	0	3	28	2	0	TCGA-MI-A75C-01	82	0.13848902755404874	39	TCGA-MI-A75C-01	5	8	25	0.06363167761187437	TCGA-MI-A75C-01	6	2	2	10	PASS	5749	TCGA-MI-A75C	LIHC	64	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2012	NA	-23441	Alive	TUMOR FREE	291	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	291	0	291	0	291	0	291	
60	TCGA-MI-A75E	0	21	4	5	6	1	2	0	4	103	4	0	2	39	1	0	TCGA-MI-A75E-01	91	0.22889661645845835	39	TCGA-MI-A75E-01	6	7	9	0.0006103813934483466	TCGA-MI-A75E-01	3	3	0	6	PASS	5750	TCGA-MI-A75E	LIHC	61	MALE	WHITE	Stage IIIC	NA	Hepatocellular Carcinoma	G2	2013	NA	-22457	Alive	TUMOR FREE	507	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	507	0	507	0	507	0	507	
60	TCGA-MI-A75G	3	27	1	10	12	5	2	0	11	190	10	1	3	57	4	0	TCGA-MI-A75G-01	140	0.7438276180423641	74	TCGA-MI-A75G-01	14	17	44	0.09480781814803224	TCGA-MI-A75G-01	5	1	4	10	PASS	5751	TCGA-MI-A75G	LIHC	63	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2012	NA	-23284	Alive	TUMOR FREE	698	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	698	0	698	0	698	0	698	
80	TCGA-MI-A75H	1	13	1	8	5	2	1	0	7	101	9	0	4	42	3	0	TCGA-MI-A75H-01	63	0.15879957979951906	20	TCGA-MI-A75H-01	5	5	23	0.05989722423273421	TCGA-MI-A75H-01	6	1	2	9	PASS	5752	TCGA-MI-A75H	LIHC	77	MALE	WHITE	NA	NA	Hepatocellular Carcinoma	NA	2012	NA	-28371	Alive	WITH TUMOR	747	NA	NA	Locoregional Recurrence	Liver	NA	301	NA	NA	R0	0	747	0	747	1	301	1	301	
60	TCGA-MI-A75I	1	17	0	4	5	2	0	0	12	133	8	0	2	46	7	1	TCGA-MI-A75I-01	99	0.37067282985236655	41	TCGA-MI-A75I-01	11	11	58	0.1942552751645467	TCGA-MI-A75I-01	5	1	7	13	PASS	5753	TCGA-MI-A75I	LIHC	61	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Hepatocellular Carcinoma	G1	2011	NA	-22341	Alive	NA	630	NA	NA	NA	Liver	NA	265	NA	NA	R0	0	630	0	630	1	265	1	265	
60	TCGA-MR-A520	0	4	0	1	0	0	0	0	1	16	0	0	0	11	1	0	TCGA-MR-A520-01	51	9.553519696393904e-06	18	TCGA-MR-A520-01	0	0	5	0.0011475419775544412	TCGA-MR-A520-01	0	0	0	0	PASS	5754	TCGA-MR-A520	LIHC	58	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2012	NA	-21398	Alive	TUMOR FREE	229	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	229	0	229	NA	NA	0	229	
30	TCGA-MR-A8JO	0	3	0	3	2	1	0	0	0	27	2	0	1	5	1	0	TCGA-MR-A8JO-01	69	0.20588312230035832	20	TCGA-MR-A8JO-01	6	8	28	0.12683423144463338	TCGA-MR-A8JO-01	4	4	3	11	PASS	5755	TCGA-MR-A8JO	LIHC	34	MALE	WHITE	Stage I	NA	Fibrolamellar Carcinoma	G3	2013	NA	-12669	Alive	TUMOR FREE	330	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	330	0	330	NA	NA	0	330	
70	TCGA-NI-A4U2	0	19	2	8	6	0	0	2	17	185	12	0	0	67	12	0	TCGA-NI-A4U2-01	167	0.12686928485968504	93	TCGA-NI-A4U2-01	4	4	47	0.07255568825058609	TCGA-NI-A4U2-01	7	5	5	17	PASS	5756	TCGA-NI-A4U2	LIHC	71	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G1	2005	NA	-26011	Dead	WITH TUMOR	NA	1791	NA	Locoregional Recurrence	Liver	NA	106	NA	NA	R0	1	1791	1	1791	1	106	1	106	
70	TCGA-NI-A8LF	0	13	0	9	1	2	0	0	7	83	5	0	4	29	3	0	TCGA-NI-A8LF-01	426	0.6064794309060303	306	TCGA-NI-A8LF-01	18	23	115	0.1288342401659111	TCGA-NI-A8LF-01	25	17	9	51	PASS	5757	TCGA-NI-A8LF	LIHC	74	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2012	NA	-27162	Alive	TUMOR FREE	799	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	799	0	799	0	799	0	799	
50	TCGA-O8-A75V	0	12	0	2	3	1	1	0	5	54	6	1	1	34	2	0	TCGA-O8-A75V-01	88	0.3519681949555652	37	TCGA-O8-A75V-01	8	11	29	0.06633043532565769	TCGA-O8-A75V-01	6	8	4	18	PASS	5758	TCGA-O8-A75V	LIHC	54	MALE	[Unknown]	Stage I	NA	Hepatocellular Carcinoma	G2	2013	NA	-19850	Alive	TUMOR FREE	538	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	538	0	538	NA	NA	0	538	
60	TCGA-PD-A5DF	1	7	0	3	4	0	2	0	1	34	2	0	1	11	0	0	TCGA-PD-A5DF-01	390	0.24180437062752855	254	TCGA-PD-A5DF-01	3	6	74	0.10667373657771054	TCGA-PD-A5DF-01	8	14	6	28	PASS	5759	TCGA-PD-A5DF	LIHC	58	FEMALE	WHITE	Stage IIIB	NA	Hepatocellular Carcinoma	G2	2007	NA	-21414	Dead	WITH TUMOR	NA	639	NA	NA	NA	NA	NA	NA	NA	NA	1	639	1	639	NA	NA	1	639	
50	TCGA-QA-A7B7	1	13	1	9	1	0	2	0	5	70	5	0	4	29	0	0	TCGA-QA-A7B7-01	231	0.9071767565022744	122	TCGA-QA-A7B7-01	8	11	90	0.2209660205849794	TCGA-QA-A7B7-01	9	6	8	23	PASS	5760	TCGA-QA-A7B7	LIHC	48	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-17636	Alive	WITH TUMOR	94	NA	NA	Locoregional Recurrence	Liver	NA	88	NA	NA	RX	0	94	0	94	NA	NA	1	88	
30	TCGA-RC-A6M3	1	4	1	5	1	1	0	0	3	64	2	1	0	22	3	0	TCGA-RC-A6M3-01	251	0.6312164402417756	164	TCGA-RC-A6M3-01	23	23	93	0.17234940590118855	TCGA-RC-A6M3-01	8	12	4	24	PASS	5761	TCGA-RC-A6M3	LIHC	24	MALE	AMERICAN INDIAN OR ALASKA NATIVE	Stage II	NA	Hepatocellular Carcinoma	G3	2009	NA	-8899	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	0	0	0	0	0	0	0	
70	TCGA-RC-A6M4	1	22	2	6	1	1	0	0	13	136	7	0	2	58	8	1	TCGA-RC-A6M4-01	156	0.9458525311788548	81	TCGA-RC-A6M4-01	17	13	32	0.10778127572893917	TCGA-RC-A6M4-01	9	6	4	19	PASS	5762	TCGA-RC-A6M4	LIHC	74	FEMALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2010	NA	-27327	Alive	NA	22	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	22	0	22	NA	NA	0	22	
30	TCGA-RC-A6M5	0	4	1	2	1	0	0	0	0	21	1	0	0	5	0	0	TCGA-RC-A6M5-01	65	0.09788650151598613	19	TCGA-RC-A6M5-01	15	10	5	0.028106729829984075	TCGA-RC-A6M5-01	3	4	0	7	PASS	5763	TCGA-RC-A6M5	LIHC	20	FEMALE	WHITE	Stage IVA	NA	Fibrolamellar Carcinoma	G2	2012	NA	-7634	Alive	NA	15	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	15	0	15	NA	NA	0	15	
80	TCGA-RC-A6M6	0	25	1	3	10	5	3	1	8	144	9	0	1	40	5	0	TCGA-RC-A6M6-01	346	0.32953970903253416	216	TCGA-RC-A6M6-01	5	13	118	0.2004721447624968	TCGA-RC-A6M6-01	17	15	10	42	PASS	5764	TCGA-RC-A6M6	LIHC	75	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G3	2011	NA	-27649	Alive	NA	9	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	9	0	9	NA	NA	0	9	
50	TCGA-RC-A7S9	0	7	1	4	2	2	0	0	2	49	1	0	1	17	3	0	TCGA-RC-A7S9-01	116	0.16460265939236152	63	TCGA-RC-A7S9-01	5	9	42	0.05232481394152329	TCGA-RC-A7S9-01	6	9	4	19	PASS	5765	TCGA-RC-A7S9	LIHC	47	FEMALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2012	NA	-17403	Alive	TUMOR FREE	640	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	640	0	640	0	640	0	640	
50	TCGA-RC-A7SB	1	4	0	2	4	0	0	0	2	45	3	0	0	24	4	0	TCGA-RC-A7SB-01	142	0.941311587422615	73	TCGA-RC-A7SB-01	5	5	65	0.1809588401224073	TCGA-RC-A7SB-01	6	4	9	19	PASS	5766	TCGA-RC-A7SB	LIHC	53	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G2	2012	NA	-19698	Alive	TUMOR FREE	588	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	588	0	588	0	588	0	588	
70	TCGA-RC-A7SF	0	4	2	0	5	0	1	0	3	65	2	0	0	23	1	0	TCGA-RC-A7SF-01	105	0.2628846383699253	51	TCGA-RC-A7SF-01	10	11	49	0.13907561707030724	TCGA-RC-A7SF-01	7	1	5	13	PASS	5767	TCGA-RC-A7SF	LIHC	66	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2012	NA	-24432	Alive	WITH TUMOR	579	NA	NA	Locoregional Recurrence	Liver	NA	502	NA	NA	R0	0	579	0	579	1	502	1	502	
40	TCGA-RC-A7SH	0	8	1	4	1	0	1	0	1	52	5	1	0	20	2	1	TCGA-RC-A7SH-01	132	0.7618820411732328	68	TCGA-RC-A7SH-01	7	8	72	0.2242355040224273	TCGA-RC-A7SH-01	10	8	8	26	PASS	5768	TCGA-RC-A7SH	LIHC	42	MALE	ASIAN	Stage II	NA	Hepatocellular Carcinoma	G3	2012	NA	-15560	Alive	WITH TUMOR	468	NA	NA	Extrahepatic Recurrence	Lung	NA	91	NA	NA	R0	0	468	0	468	1	91	1	91	
60	TCGA-RC-A7SK	2	16	0	11	2	4	1	0	6	116	5	0	2	48	5	0	TCGA-RC-A7SK-01	179	0.9443590229704684	97	TCGA-RC-A7SK-01	18	20	19	0.0901807652653056	TCGA-RC-A7SK-01	9	9	2	20	PASS	5769	TCGA-RC-A7SK	LIHC	59	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G3	2013	NA	-21814	Alive	TUMOR FREE	472	NA	NA	Intrahepatic Recurrence	Liver	NA	312	NA	NA	R0	0	472	0	472	1	312	1	312	
70	TCGA-RG-A7D4	1	8	0	2	5	0	0	0	4	77	1	0	0	34	5	0	TCGA-RG-A7D4-01	100	0.6977430162918061	51	TCGA-RG-A7D4-01	31	58	29	0.06597897198606502	TCGA-RG-A7D4-01	14	8	7	29	PASS	5770	TCGA-RG-A7D4	LIHC	69	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Hepatocellular Carcinoma	G2	2012	NA	-25302	Alive	TUMOR FREE	1098	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1098	0	1098	0	1098	0	1098	
70	TCGA-T1-A6J8	1	7	0	5	6	0	0	0	2	67	1	0	1	27	3	0	TCGA-T1-A6J8	0	0	0	TCGA-T1-A6J8	0	0	0	0	TCGA-T1-A6J8-01	7	3	9	19	PASS	5771	TCGA-T1-A6J8	LIHC	68	MALE	WHITE	NA	NA	Hepatocellular Carcinoma	G2	2013	NA	-24853	Alive	TUMOR FREE	23	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	23	0	23	NA	NA	0	23	
60	TCGA-UB-A7MA	0	5	0	2	4	2	0	0	3	61	0	0	0	40	3	0	TCGA-UB-A7MA-01	235	0.5044270170453641	124	TCGA-UB-A7MA-01	14	59	61	0.12112461337682875	TCGA-UB-A7MA-01	16	17	9	42	pathology review	5772	TCGA-UB-A7MA	LIHC	62	FEMALE	WHITE	Stage II	NA	Hepatocholangiocarcinoma (Mixed)	G2	2013	NA	-22843	Alive	WITH TUMOR	848	NA	NA	Intrahepatic Recurrence	Liver	NA	221	NA	NA	R1	0	848	0	848	NA	NA	1	221	
30	TCGA-UB-A7MB	8	185	6	66	11	0	1	0	60	1138	67	3	22	431	74	0	TCGA-UB-A7MB-01	239	0.6632674855609614	162	TCGA-UB-A7MB-01	4	9	110	0.17423544778476102	TCGA-UB-A7MB-01	14	7	8	29	hypermutated sample	5773	TCGA-UB-A7MB	LIHC	24	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G3	2013	NA	-8951	Alive	WITH TUMOR	601	NA	NA	Intrahepatic Recurrence	Liver	NA	48	NA	NA	R0	0	601	0	601	1	48	1	48	
60	TCGA-UB-A7MC	1	11	0	7	5	1	0	0	3	51	2	1	0	16	1	0	TCGA-UB-A7MC-01	133	0.4561821633972992	61	TCGA-UB-A7MC-01	15	28	51	0.15600498289838516	TCGA-UB-A7MC-01	8	7	5	20	PASS	5774	TCGA-UB-A7MC	LIHC	59	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2013	NA	-21733	Alive	WITH TUMOR	500	NA	NA	Extrahepatic Recurrence	"Other, specify"	Adrenal glands	359	NA	NA	R0	0	500	0	500	1	359	1	359	
70	TCGA-UB-A7MD	1	12	1	3	3	1	3	0	7	92	1	1	0	33	3	0	TCGA-UB-A7MD-01	73	0.2212565945187502	24	TCGA-UB-A7MD-01	6	6	25	0.057139326840571575	TCGA-UB-A7MD-01	5	1	3	9	PASS	5775	TCGA-UB-A7MD	LIHC	67	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Hepatocellular Carcinoma	G3	2013	NA	-24717	Dead	TUMOR FREE	NA	52	NA	NA	NA	NA	NA	NA	NA	R0	1	52	0	52	0	52	0	52	
50	TCGA-UB-A7ME	0	13	2	3	2	1	1	0	4	67	3	1	2	26	4	0	TCGA-UB-A7ME-01	143	0.6595147731831342	68	TCGA-UB-A7ME-01	25	35	61	0.1310265504659823	TCGA-UB-A7ME-01	20	10	6	36	PASS	5776	TCGA-UB-A7ME	LIHC	51	MALE	ASIAN	Stage I	NA	Hepatocellular Carcinoma	G2	2013	NA	-18846	Alive	TUMOR FREE	486	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	486	0	486	0	486	0	486	
60	TCGA-UB-A7MF	1	14	2	6	6	1	0	0	7	80	4	0	0	25	6	1	TCGA-UB-A7MF-01	109	0.7959253563646752	47	TCGA-UB-A7MF-01	12	20	36	0.09897327774721522	TCGA-UB-A7MF-01	12	12	5	29	PASS	5777	TCGA-UB-A7MF	LIHC	56	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2013	NA	-20815	Dead	WITH TUMOR	NA	214	NA	Intrahepatic Recurrence	Liver	NA	133	NA	NA	R0	1	214	1	214	1	133	1	133	
60	TCGA-UB-AA0U	0	9	0	4	0	3	3	1	3	57	4	0	1	31	2	1	TCGA-UB-AA0U-01	91	0.51538596943919	37	TCGA-UB-AA0U-01	18	22	48	0.14621308367727998	TCGA-UB-AA0U-01	16	13	12	41	PASS	5778	TCGA-UB-AA0U	LIHC	60	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-21985	Alive	TUMOR FREE	327	NA	NA	Intrahepatic Recurrence	Liver	NA	106	NA	NA	R1	0	327	0	327	NA	NA	1	106	
70	TCGA-UB-AA0V	0	4	1	3	0	0	0	0	2	33	3	0	1	18	0	0	TCGA-UB-AA0V-01	41	4.1712648839477334e-05	8	TCGA-UB-AA0V-01	0	0	6	0.0013142142114170752	TCGA-UB-AA0V-01	0	0	0	0	PASS	5779	TCGA-UB-AA0V	LIHC	69	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2013	NA	-25340	Alive	TUMOR FREE	314	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	314	0	314	0	314	0	314	
70	TCGA-WJ-A86L	1	16	3	11	9	0	1	0	6	100	7	0	1	33	2	0	TCGA-WJ-A86L-01	429	0.16020007376990614	286	TCGA-WJ-A86L-01	4	4	64	0.08704873200706102	TCGA-WJ-A86L-01	9	10	4	23	PASS	5780	TCGA-WJ-A86L	LIHC	68	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2013	NA	-25018	Alive	TUMOR FREE	345	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	345	0	345	0	345	0	345	
70	TCGA-WQ-A9G7	8	50	6	21	50	15	11	0	20	336	16	0	8	183	13	0	TCGA-WQ-A9G7-01	124	0.6212398252714204	65	TCGA-WQ-A9G7-01	21	24	91	0.2905148179716522	TCGA-WQ-A9G7-01	13	7	14	34	PASS	5781	TCGA-WQ-A9G7	LIHC	71	FEMALE	WHITE	NA	NA	Hepatocellular Carcinoma	G3	2013	NA	NA	Alive	TUMOR FREE	30	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	30	0	30	0	30	0	30	
60	TCGA-WQ-AB4B	0	12	1	2	4	1	2	0	2	56	1	0	2	21	2	0	TCGA-WQ-AB4B-01	74	0.6698968681884597	28	TCGA-WQ-AB4B-01	24	18	15	0.03343832789722118	TCGA-WQ-AB4B-01	4	3	2	9	PASS	5782	TCGA-WQ-AB4B	LIHC	62	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-22769	Alive	WITH TUMOR	395	NA	NA	Intrahepatic Recurrence	NA	NA	273	NA	NA	R0	0	395	0	395	1	273	1	273	
60	TCGA-WX-AA44	1	11	1	6	2	1	0	0	4	60	3	0	2	27	2	0	TCGA-WX-AA44-01	132	0.3651769635133011	69	TCGA-WX-AA44-01	5	10	47	0.05813959961475515	TCGA-WX-AA44-01	6	6	3	15	PASS	5783	TCGA-WX-AA44	LIHC	64	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G3	2011	NA	-23654	Alive	WITH TUMOR	615	NA	NA	Intrahepatic Recurrence	Liver	NA	246	NA	NA	RX	0	615	0	615	NA	NA	1	246	
60	TCGA-WX-AA46	1	6	0	4	1	0	0	0	5	50	7	0	0	16	2	0	TCGA-WX-AA46-01	75	0.05433366920889224	32	TCGA-WX-AA46-01	2	2	17	0.02807309708779952	TCGA-WX-AA46-01	1	3	1	5	PASS	5784	TCGA-WX-AA46	LIHC	61	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G1	2012	NA	-22639	Alive	TUMOR FREE	756	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	756	0	756	0	756	0	756	
30	TCGA-WX-AA47	0	4	0	3	1	1	1	0	5	31	3	0	0	10	1	0	TCGA-WX-AA47-01	101	0.2300200961704305	48	TCGA-WX-AA47-01	6	5	33	0.05900153994702888	TCGA-WX-AA47-01	3	1	2	6	PASS	5785	TCGA-WX-AA47	LIHC	33	FEMALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G2	2012	NA	-12056	Dead	WITH TUMOR	NA	556	NA	Intrahepatic Recurrence	Liver	NA	103	NA	NA	R0	1	556	1	556	1	103	1	103	
40	TCGA-XR-A8TC	0	4	0	4	1	1	1	0	4	46	3	0	0	12	1	0	TCGA-XR-A8TC	0	0	0	TCGA-XR-A8TC	0	0	0	0	TCGA-XR-A8TC	0	0	0	0	PASS	5786	TCGA-XR-A8TC	LIHC	43	FEMALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2011	NA	-15817	Alive	WITH TUMOR	1339	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1339	0	1339	0	1339	0	1339	
50	TCGA-XR-A8TD	0	0	0	3	1	0	0	0	1	47	2	0	2	18	1	0	TCGA-XR-A8TD-01	387	0.2392832522025429	256	TCGA-XR-A8TD-01	8	8	107	0.12712285439621007	TCGA-XR-A8TD-01	9	11	9	29	PASS	5787	TCGA-XR-A8TD	LIHC	49	FEMALE	WHITE	Stage IIIB	NA	Hepatocellular Carcinoma	G3	2012	NA	-17908	Alive	TUMOR FREE	1030	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1030	0	1030	0	1030	0	1030	
20	TCGA-XR-A8TE	1	3	0	1	1	0	0	0	2	10	0	0	1	7	1	0	TCGA-XR-A8TE-01	88	0.298920884065182	32	TCGA-XR-A8TE-01	6	7	20	0.0879819014797655	TCGA-XR-A8TE-01	1	3	0	4	PASS	5788	TCGA-XR-A8TE	LIHC	16	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G1	2012	NA	-5862	Alive	WITH TUMOR	925	NA	NA	Intrahepatic Recurrence	Liver	NA	210	NA	NA	R0	0	925	0	925	1	210	1	210	
70	TCGA-XR-A8TF	0	17	1	8	7	1	1	0	5	111	7	0	6	40	8	0	TCGA-XR-A8TF-01	167	0.5164889931180959	107	TCGA-XR-A8TF-01	17	20	72	0.1585075981680389	TCGA-XR-A8TF-01	2	8	4	14	PASS	5789	TCGA-XR-A8TF	LIHC	74	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G1	2012	NA	-27145	Dead	TUMOR FREE	NA	693	NA	Intrahepatic Recurrence	Liver	NA	231	NA	NA	R0	1	693	0	693	1	231	1	231	
60	TCGA-XR-A8TG	1	12	1	7	2	3	1	0	4	63	6	0	0	30	3	0	TCGA-XR-A8TG-01	794	0.232144822834168	586	TCGA-XR-A8TG-01	5	6	122	0.08424273417500064	TCGA-XR-A8TG-01	5	10	5	20	PASS	5790	TCGA-XR-A8TG	LIHC	58	MALE	WHITE	Stage I	NA	Hepatocellular Carcinoma	G2	2012	NA	-21544	Alive	TUMOR FREE	898	NA	NA	Intrahepatic Recurrence	Liver	NA	350	NA	NA	R0	0	898	0	898	1	350	1	350	
70	TCGA-YA-A8S7	1	16	0	4	4	1	2	0	6	60	1	0	1	24	1	0	TCGA-YA-A8S7-01	99	0.4981750475586123	42	TCGA-YA-A8S7-01	24	26	30	0.1773494065780143	TCGA-YA-A8S7-01	10	6	3	19	PASS	5791	TCGA-YA-A8S7	LIHC	68	MALE	WHITE	Stage IIIA	NA	Hepatocellular Carcinoma	G3	2012	NA	-25188	Dead	WITH TUMOR	NA	412	NA	Extrahepatic Recurrence	Brain	NA	398	NA	NA	R0	1	412	1	412	1	398	1	398	
60	TCGA-ZP-A9CV	1	15	3	5	5	1	2	0	4	88	5	0	2	32	2	0	TCGA-ZP-A9CV-01	62	0.1530112523917888	18	TCGA-ZP-A9CV-01	4	5	17	0.03352307031902794	TCGA-ZP-A9CV-01	2	1	2	5	PASS	5792	TCGA-ZP-A9CV	LIHC	59	MALE	WHITE	NA	NA	Hepatocellular Carcinoma	G1	2011	NA	-21633	Dead	WITH TUMOR	NA	1088	NA	NA	NA	NA	NA	NA	NA	R0	1	1088	1	1088	NA	NA	1	1088	
70	TCGA-ZP-A9CY	0	7	0	7	3	1	1	0	7	69	6	0	1	21	1	0	TCGA-ZP-A9CY-01	75	0.030374178120789814	26	TCGA-ZP-A9CY-01	0	0	12	0.009964338762976158	TCGA-ZP-A9CY-01	2	3	1	6	PASS	5793	TCGA-ZP-A9CY	LIHC	66	FEMALE	WHITE	NA	NA	Hepatocellular Carcinoma	G1	2011	NA	-24223	Alive	TUMOR FREE	782	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	782	0	782	0	782	0	782	
70	TCGA-ZP-A9CZ	0	6	1	6	1	0	0	0	4	41	2	0	0	17	3	1	TCGA-ZP-A9CZ-01	91	0.2515912103552346	35	TCGA-ZP-A9CZ-01	4	7	45	0.1416702424360057	TCGA-ZP-A9CZ-01	12	12	6	30	PASS	5794	TCGA-ZP-A9CZ	LIHC	72	MALE	ASIAN	NA	NA	Hepatocellular Carcinoma	G1	2011	NA	-26403	Alive	TUMOR FREE	706	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	706	0	706	0	706	0	706	
70	TCGA-ZP-A9D0	1	5	0	2	4	1	1	0	3	42	2	1	0	18	1	0	TCGA-ZP-A9D0-01	128	0.17480344000821382	54	TCGA-ZP-A9D0-01	4	4	41	0.1413154112552245	TCGA-ZP-A9D0-01	3	14	6	23	PASS	5795	TCGA-ZP-A9D0	LIHC	67	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Hepatocellular Carcinoma	G1	2011	NA	-24525	Alive	TUMOR FREE	1091	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1091	0	1091	0	1091	0	1091	
60	TCGA-ZP-A9D1	1	15	0	8	1	0	0	0	10	109	3	0	2	43	5	0	TCGA-ZP-A9D1-01	56	0.5519386443250621	21	TCGA-ZP-A9D1-01	16	25	37	0.17862701401843648	TCGA-ZP-A9D1-01	5	7	2	14	PASS	5796	TCGA-ZP-A9D1	LIHC	56	FEMALE	WHITE	NA	NA	Hepatocellular Carcinoma	G2	2012	NA	-20584	Alive	TUMOR FREE	21	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	21	0	21	0	21	0	21	
50	TCGA-ZP-A9D2	0	11	1	1	3	0	0	0	3	45	6	0	1	11	1	1	TCGA-ZP-A9D2-01	144	0.5871421582227796	83	TCGA-ZP-A9D2-01	10	11	122	0.3537306656701841	TCGA-ZP-A9D2-01	5	3	4	12	PASS	5797	TCGA-ZP-A9D2	LIHC	51	MALE	WHITE	NA	NA	Hepatocellular Carcinoma	G2	2012	NA	-18717	Dead	WITH TUMOR	NA	765	NA	Intrahepatic Recurrence	Liver	NA	315	NA	NA	R0	1	765	1	765	1	315	1	315	
60	TCGA-ZP-A9D4	0	9	1	3	2	0	0	0	4	56	2	0	1	20	3	0	TCGA-ZP-A9D4-01	201	0.14138966598491304	140	TCGA-ZP-A9D4-01	5	4	43	0.04288432334894463	TCGA-ZP-A9D4-01	3	3	2	8	PASS	5798	TCGA-ZP-A9D4	LIHC	64	FEMALE	WHITE	NA	NA	Hepatocellular Carcinoma	G1	2012	NA	-23656	Alive	TUMOR FREE	395	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	395	0	395	0	395	0	395	
70	TCGA-ZS-A9CD	2	13	0	7	4	1	0	0	5	80	6	0	2	30	1	0	TCGA-ZS-A9CD-01	77	0.1593146675053948	27	TCGA-ZS-A9CD-01	3	3	8	0.014951189403645463	TCGA-ZS-A9CD-01	4	1	1	6	PASS	5799	TCGA-ZS-A9CD	LIHC	73	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2010	NA	-26915	Dead	NA	NA	1386	NA	Intrahepatic Recurrence	Liver	NA	371	NA	NA	R0	1	1386	NA	1386	1	371	1	371	
80	TCGA-ZS-A9CE	0	14	0	8	6	2	3	1	11	93	9	0	2	29	1	0	TCGA-ZS-A9CE-01	118	0.7733218334069762	57	TCGA-ZS-A9CE-01	14	13	31	0.07414701831846901	TCGA-ZS-A9CE-01	6	7	4	17	PASS	5800	TCGA-ZS-A9CE	LIHC	79	FEMALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G1	2011	NA	-29051	Alive	TUMOR FREE	1241	NA	NA	New Primary Tumor	"Other, specify"	Right Temple	892	NA	NA	R0	0	1241	0	1241	0	1241	1	892	
60	TCGA-ZS-A9CF	2	41	0	12	8	3	0	0	11	169	16	0	3	68	6	0	TCGA-ZS-A9CF-01	863	0.8504773795313347	639	TCGA-ZS-A9CF-02	10	15	143	0.1583354467016634	TCGA-ZS-A9CF-02	17	24	7	48	mutation call filter	5801	TCGA-ZS-A9CF	LIHC	64	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2008	NA	-23510	Alive	TUMOR FREE	2412	NA	NA	Intrahepatic Recurrence	Liver	NA	636	NA	NA	R0	0	2412	0	2412	1	636	1	636	
60	TCGA-ZS-A9CG	0	6	1	5	2	1	0	0	2	64	1	0	1	20	5	0	TCGA-ZS-A9CG-01	57	0.23573712746783546	19	TCGA-ZS-A9CG-01	5	6	23	0.11629926215250948	TCGA-ZS-A9CG-01	2	3	1	6	PASS	5802	TCGA-ZS-A9CG	LIHC	55	MALE	WHITE	Stage II	NA	Hepatocellular Carcinoma	G2	2013	NA	-20100	Alive	TUMOR FREE	341	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	341	0	341	0	341	0	341	
70	TCGA-05-4244	1	12	3	4	3	3	1	0	8	163	10	1	6	49	6	0	TCGA-05-4244-01	186	0.5751868916628284	110	TCGA-05-4244-01	17	29	21	0.10646225961758612	TCGA-05-4244-01	14	8	6	28	PASS	5803	TCGA-05-4244	LUAD	70	MALE	NA	Stage IV	NA	Lung Adenocarcinoma	NA	2009	NA	-25752	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
80	TCGA-05-4245	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-05-4245	0	0	0	TCGA-05-4245	0	0	0	0	TCGA-05-4245	0	0	0	0	PASS	5804	TCGA-05-4245	LUAD	81	MALE	NA	Stage IIIA	NA	Lung Adenocarcinoma	NA	2009	NA	-29647	Alive	TUMOR FREE	730	NA	NA	NA	NA	NA	334	NA	NA	NA	0	730	0	730	NA	NA	1	334	
70	TCGA-05-4249	1	15	1	8	7	3	1	0	10	253	26	0	10	70	8	0	TCGA-05-4249-01	97	0.6430591493473211	49	TCGA-05-4249-01	24	23	15	0.1435428724217687	TCGA-05-4249-01	4	3	3	10	PASS	5805	TCGA-05-4249	LUAD	67	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2007	NA	-24532	Alive	TUMOR FREE	1523	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1523	0	1523	NA	NA	0	1523	
80	TCGA-05-4250	1	21	3	7	10	3	2	0	16	270	17	0	8	95	8	0	TCGA-05-4250-01	125	0.5379844079955657	68	TCGA-05-4250-01	17	27	22	0.3292566679561192	TCGA-05-4250-01	4	6	4	14	pathology review	5806	TCGA-05-4250	LUAD	79	FEMALE	NA	Stage IIIA	NA	Lung Adenocarcinoma	NA	2007	NA	-29068	Dead	NA	NA	121	NA	NA	NA	NA	NA	NA	NA	NA	1	121	NA	121	NA	NA	0	121	
70	TCGA-05-4382	7	71	8	44	28	10	0	0	54	1328	113	1	26	411	53	1	TCGA-05-4382-01	194	0.4953050392941275	106	TCGA-05-4382-01	22	39	31	0.31984640922996355	TCGA-05-4382-01	16	10	7	33	hypermutated sample	5807	TCGA-05-4382	LUAD	68	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	-24868	Alive	TUMOR FREE	607	NA	NA	Distant Metastasis	NA	NA	334	Complete Remission/Response	NA	NA	0	607	0	607	1	334	1	334	
70	TCGA-05-4384	0	4	1	4	4	0	0	0	2	100	9	1	6	40	3	0	TCGA-05-4384-01	59	0.06606350560917934	17	TCGA-05-4384-01	1	4	3	0.019193188232306743	TCGA-05-4384-01	4	2	2	8	PASS	5808	TCGA-05-4384	LUAD	66	MALE	NA	Stage IIIA	NA	Lung Adenocarcinoma	NA	2009	NA	-24411	Alive	WITH TUMOR	426	NA	NA	Distant Metastasis	NA	NA	183	Progressive Disease	NA	NA	0	426	0	426	NA	NA	1	183	
70	TCGA-05-4389	0	12	1	8	5	2	0	0	5	187	7	0	2	72	4	0	TCGA-05-4389-01	251	0.8140696343659948	158	TCGA-05-4389-01	20	25	39	0.2440152441695072	TCGA-05-4389-01	17	16	12	45	PASS	5809	TCGA-05-4389	LUAD	70	MALE	NA	Stage IA	NA	Lung Adenocarcinoma	NA	2005	NA	-25660	Alive	TUMOR FREE	1369	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1369	0	1369	NA	NA	0	1369	
60	TCGA-05-4390	1	33	3	19	22	4	1	0	15	438	33	0	11	149	13	0	TCGA-05-4390-01	163	0.6931165842551545	93	TCGA-05-4390-01	21	36	14	0.054043287275811216	TCGA-05-4390-01	15	10	2	27	PASS	5810	TCGA-05-4390	LUAD	58	FEMALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2005	NA	-21430	Alive	TUMOR FREE	1126	NA	NA	NA	NA	NA	395	Progressive Disease	NA	NA	0	1126	0	1126	NA	NA	1	395	
80	TCGA-05-4395	2	21	2	8	0	1	2	0	14	197	20	0	6	78	8	0	TCGA-05-4395-01	197	0.6335702164452544	111	TCGA-05-4395-01	25	32	45	0.41815020318237067	TCGA-05-4395-01	17	7	12	36	PASS	5811	TCGA-05-4395	LUAD	76	MALE	NA	Stage IIIB	NA	Lung Adenocarcinoma	NA	2006	NA	-27971	Dead	TUMOR FREE	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	0	0	NA	NA	0	0	
80	TCGA-05-4396	5	81	6	43	6	0	0	0	57	1099	130	2	18	453	34	4	TCGA-05-4396-01	200	0.6992002592087313	115	TCGA-05-4396-01	11	10	31	0.25021719490638905	TCGA-05-4396-01	5	2	6	13	PASS	5812	TCGA-05-4396	LUAD	76	MALE	NA	Stage IIIB	NA	Lung Adenocarcinoma	NA	2006	NA	-28094	Dead	NA	NA	303	NA	NA	NA	NA	NA	NA	NA	NA	1	303	NA	303	NA	NA	0	303	
70	TCGA-05-4397	2	47	6	21	25	5	2	0	33	628	59	0	16	200	14	3	TCGA-05-4397-01	241	0.3297293662585878	146	TCGA-05-4397-01	7	8	56	0.1716788141083312	TCGA-05-4397-01	17	15	11	43	pathology review	5813	TCGA-05-4397	LUAD	65	MALE	NA	Stage IIB	NA	Lung Adenocarcinoma	NA	2006	NA	-23833	Dead	NA	NA	731	NA	NA	NA	NA	NA	NA	NA	NA	1	731	NA	731	NA	NA	0	731	
50	TCGA-05-4398	4	40	1	23	20	5	1	0	15	564	38	0	13	223	34	0	TCGA-05-4398-01	235	0.4866075491279093	140	TCGA-05-4398-01	23	54	57	0.3220951239507413	TCGA-05-4398-01	18	16	13	47	PASS	5814	TCGA-05-4398	LUAD	47	FEMALE	NA	Stage IIIB	NA	Lung Adenocarcinoma	NA	2006	NA	-17471	Alive	TUMOR FREE	1431	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1431	0	1431	0	1431	0	1431	
60	TCGA-05-4402	1	5	0	0	4	1	1	0	3	101	7	0	1	36	3	1	TCGA-05-4402-01	99	0.7141842528056451	48	TCGA-05-4402-01	31	21	16	0.19827838183809884	TCGA-05-4402-01	10	4	7	21	PASS	5815	TCGA-05-4402	LUAD	57	FEMALE	NA	Stage IV	NA	Lung Adenocarcinoma	NA	2007	NA	-20819	Dead	TUMOR FREE	NA	244	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	244	0	244	NA	NA	0	244	
80	TCGA-05-4403	0	7	0	6	3	2	2	0	4	104	11	0	1	37	2	0	TCGA-05-4403-01	87	0.027215039453800813	31	TCGA-05-4403-01	1	4	7	0.05773625658569834	TCGA-05-4403-01	3	3	4	10	PASS	5816	TCGA-05-4403	LUAD	76	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2006	NA	-27881	Alive	NA	578	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	578	0	578	NA	NA	0	578	
70	TCGA-05-4405	1	8	0	11	9	3	0	0	13	311	31	0	5	113	6	0	TCGA-05-4405-01	143	0.5062043144374561	76	TCGA-05-4405-01	24	31	24	0.29380467598854304	TCGA-05-4405-01	11	3	7	21	PASS	5817	TCGA-05-4405	LUAD	74	FEMALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2006	NA	-27241	Alive	TUMOR FREE	610	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	610	0	610	NA	NA	0	610	
60	TCGA-05-4410	4	33	6	17	18	3	1	1	32	876	67	2	19	310	35	1	TCGA-05-4410-01	95	0.4528305493902154	32	TCGA-05-4410-01	18	66	19	0.29966591191334835	TCGA-05-4410-01	18	7	7	32	hypermutated sample	5818	TCGA-05-4410	LUAD	62	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2007	NA	-22888	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
60	TCGA-05-4415	1	10	1	5	4	2	1	0	3	161	7	0	4	56	8	0	TCGA-05-4415-01	171	0.8154061653783541	96	TCGA-05-4415-01	20	20	27	0.13160914073078053	TCGA-05-4415-01	13	4	7	24	PASS	5819	TCGA-05-4415	LUAD	57	MALE	NA	Stage IIIB	NA	Lung Adenocarcinoma	NA	2008	NA	-20880	Dead	WITH TUMOR	NA	91	NA	NA	NA	NA	60	Progressive Disease	NA	NA	1	91	1	91	NA	NA	1	60	
50	TCGA-05-4417	3	8	0	12	8	4	0	1	9	236	17	0	3	81	14	0	TCGA-05-4417-01	85	0.5519829069608698	34	TCGA-05-4417-01	19	34	11	0.12841864567258954	TCGA-05-4417-01	8	10	4	22	PASS	5820	TCGA-05-4417	LUAD	51	FEMALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2008	NA	-18780	Alive	TUMOR FREE	455	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	455	0	455	NA	NA	0	455	
70	TCGA-05-4418	2	12	1	9	3	5	2	0	9	214	11	0	9	69	5	0	TCGA-05-4418-01	65	0.22372985189116415	20	TCGA-05-4418-01	6	6	7	0.13732873043456298	TCGA-05-4418-01	2	2	1	5	PASS	5821	TCGA-05-4418	LUAD	69	MALE	NA	Stage IIIA	NA	Lung Adenocarcinoma	NA	2008	NA	-25417	Dead	NA	NA	274	NA	NA	NA	NA	NA	NA	NA	NA	1	274	NA	274	NA	NA	0	274	
40	TCGA-05-4420	0	19	2	9	6	1	0	0	11	216	20	1	7	84	8	0	TCGA-05-4420-01	243	0.8092575992966567	153	TCGA-05-4420-01	22	32	31	0.16755516699313686	TCGA-05-4420-01	19	18	9	46	PASS	5822	TCGA-05-4420	LUAD	41	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2008	NA	-15159	Alive	TUMOR FREE	912	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	912	0	912	0	912	0	912	
70	TCGA-05-4422	0	2	0	0	2	0	2	0	2	30	5	0	2	13	1	0	TCGA-05-4422-01	281	0.2309126888385113	180	TCGA-05-4422-01	7	7	41	0.1308035343419766	TCGA-05-4422-01	8	6	6	20	PASS	5823	TCGA-05-4422	LUAD	68	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2008	NA	-24837	Alive	NA	365	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	365	0	365	NA	NA	0	365	
70	TCGA-05-4424	3	29	2	22	18	3	2	0	22	581	41	1	16	196	19	3	TCGA-05-4424-01	111	0.6216725406560127	51	TCGA-05-4424-01	19	62	14	0.10282455237465776	TCGA-05-4424-01	14	11	4	29	PASS	5824	TCGA-05-4424	LUAD	70	MALE	NA	Stage IIB	NA	Lung Adenocarcinoma	NA	2008	NA	-25689	Alive	WITH TUMOR	913	NA	NA	Distant Metastasis	NA	NA	153	Progressive Disease	NA	NA	0	913	0	913	NA	NA	1	153	
70	TCGA-05-4425	0	3	0	0	1	2	0	0	0	34	3	0	1	14	0	0	TCGA-05-4425-01	83	0.2352348198571377	35	TCGA-05-4425-01	10	7	10	0.16403307735015432	TCGA-05-4425-01	4	2	4	10	PASS	5825	TCGA-05-4425	LUAD	70	FEMALE	NA	Stage IV	NA	Lung Adenocarcinoma	NA	2008	NA	-25902	Alive	NA	669	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	669	0	669	NA	NA	0	669	
70	TCGA-05-4426	0	3	2	1	1	0	0	0	0	37	5	0	1	7	1	0	TCGA-05-4426-01	133	0.1485411677938925	76	TCGA-05-4426-01	4	6	15	0.10905007137215487	TCGA-05-4426-01	5	4	5	14	PASS	5826	TCGA-05-4426	LUAD	71	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2008	NA	-26084	Alive	TUMOR FREE	791	NA	NA	NA	NA	NA	457	Complete Remission/Response	NA	NA	0	791	0	791	1	457	1	457	
70	TCGA-05-4427	4	42	6	26	25	3	1	0	36	809	63	1	21	255	31	1	TCGA-05-4427-01	192	0.5539078547441151	102	TCGA-05-4427-01	20	55	7	0.12283948617406652	TCGA-05-4427-01	18	11	5	34	pathology review	5827	TCGA-05-4427	LUAD	65	FEMALE	NA	Stage IIB	NA	Lung Adenocarcinoma	NA	2008	NA	-23893	Alive	TUMOR FREE	791	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	791	0	791	0	791	0	791	
60	TCGA-05-4430	0	10	1	3	4	2	1	0	10	232	15	0	6	77	5	1	TCGA-05-4430-01	133	0.2994125438392193	77	TCGA-05-4430-01	20	28	19	0.18638959674092026	TCGA-05-4430-01	11	4	5	20	PASS	5828	TCGA-05-4430	LUAD	59	FEMALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2008	NA	-21884	Alive	TUMOR FREE	761	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	761	0	761	NA	NA	0	761	
70	TCGA-05-4432	1	33	0	19	13	5	1	0	23	446	39	0	14	180	22	1	TCGA-05-4432-01	267	0.6420102193043901	157	TCGA-05-4432-01	21	32	27	0.13832128860347928	TCGA-05-4432-01	15	10	4	29	PASS	5829	TCGA-05-4432	LUAD	66	MALE	NA	Stage IIB	NA	Lung Adenocarcinoma	NA	2008	NA	-24350	Alive	TUMOR FREE	761	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	761	0	761	0	761	0	761	
80	TCGA-05-4433	0	3	0	0	0	1	0	0	1	29	2	0	0	10	0	0	TCGA-05-4433-01	127	0.1889019762295406	63	TCGA-05-4433-01	6	9	19	0.14609096633061952	TCGA-05-4433-01	7	2	8	17	PASS	5830	TCGA-05-4433	LUAD	82	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2008	NA	-30194	Alive	TUMOR FREE	730	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	730	0	730	NA	NA	0	730	
70	TCGA-05-4434	0	2	0	2	4	1	0	1	0	33	4	0	0	17	1	0	TCGA-05-4434-01	182	0.24077942766226884	116	TCGA-05-4434-01	2	6	34	0.1204678553302232	TCGA-05-4434-01	5	9	5	19	pathology review	5831	TCGA-05-4434	LUAD	67	FEMALE	NA	Stage IV	NA	Lung Adenocarcinoma	NA	2008	NA	-24472	Dead	NA	NA	457	NA	NA	NA	NA	NA	NA	NA	NA	1	457	NA	457	NA	NA	0	457	
70	TCGA-05-5420	1	4	1	2	2	0	1	0	2	73	6	0	1	28	0	0	TCGA-05-5420	0	0	0	TCGA-05-5420	0	0	0	0	TCGA-05-5420-01	5	4	6	15	PASS	5832	TCGA-05-5420	LUAD	67	MALE	NA	Stage IIIA	NA	Lung Adenocarcinoma	NA	2008	NA	-24472	Alive	WITH TUMOR	457	NA	NA	NA	NA	NA	245	Progressive Disease	NA	NA	0	457	0	457	NA	NA	1	245	
70	TCGA-05-5423	1	6	1	3	0	1	0	0	4	119	11	0	2	35	4	2	TCGA-05-5423-01	112	0.8001089273857048	47	TCGA-05-5423-01	15	34	40	0.5661378113557817	TCGA-05-5423-01	7	4	1	12	PASS	5833	TCGA-05-5423	LUAD	65	MALE	NA	Stage IIB	NA	Lung Adenocarcinoma	NA	2006	NA	-23863	Alive	TUMOR FREE	151	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	151	0	151	NA	NA	0	151	
70	TCGA-05-5425	1	14	1	17	14	3	1	0	19	455	44	0	9	154	17	1	TCGA-05-5425-01	123	0.6619548826948701	59	TCGA-05-5425-01	2	22	77	0.9591891017309138	TCGA-05-5425-01	14	2	5	21	PASS	5834	TCGA-05-5425	LUAD	68	MALE	NA	Stage IIB	NA	Lung Adenocarcinoma	NA	2009	NA	-25020	Alive	WITH TUMOR	882	NA	NA	NA	NA	NA	486	NA	NA	NA	0	882	0	882	NA	NA	1	486	
60	TCGA-05-5428	1	15	3	5	8	2	0	0	16	290	29	0	5	103	11	0	TCGA-05-5428-01	223	0.6123017458463778	130	TCGA-05-5428-01	20	33	26	0.2348983995882054	TCGA-05-5428-01	18	13	10	41	PASS	5835	TCGA-05-5428	LUAD	57	MALE	NA	Stage IIA	NA	Lung Adenocarcinoma	NA	2010	NA	-21061	Alive	TUMOR FREE	670	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	670	0	670	0	670	0	670	
60	TCGA-05-5429	0	0	0	1	0	2	0	0	2	26	5	0	1	12	1	0	TCGA-05-5429-01	93	0.29601628625585497	35	TCGA-05-5429-01	8	10	11	0.13417243439089244	TCGA-05-5429-01	6	2	6	14	PASS	5836	TCGA-05-5429	LUAD	60	MALE	NA	Stage IIIA	NA	Lung Adenocarcinoma	NA	2010	NA	-22066	Dead	TUMOR FREE	NA	275	NA	NA	NA	NA	NA	NA	NA	NA	1	275	0	275	NA	NA	0	275	
70	TCGA-05-5715	1	10	0	4	3	2	1	1	4	88	7	0	3	34	1	0	TCGA-05-5715-01	199	0.9098250389423332	126	TCGA-05-5715-01	10	9	29	0.2721767612255818	TCGA-05-5715-01	3	5	3	11	PASS	5837	TCGA-05-5715	LUAD	69	FEMALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2010	NA	-25383	Alive	TUMOR FREE	62	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	62	0	62	NA	NA	0	62	
60	TCGA-35-3615	0	10	0	2	2	2	0	0	7	88	9	0	4	28	1	0	TCGA-35-3615-01	138	0.17954880550776992	85	TCGA-35-3615-01	5	5	14	0.08363001664352664	TCGA-35-3615-01	4	2	1	7	PASS	5838	TCGA-35-3615	LUAD	57	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2007	NA	-21076	Alive	TUMOR FREE	14	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	14	0	14	NA	NA	0	14	
70	TCGA-35-4122	3	19	1	8	7	0	1	0	11	255	16	1	6	87	7	3	TCGA-35-4122-01	137	0.4183777905270621	69	TCGA-35-4122-01	23	26	29	0.25820987721582034	TCGA-35-4122-01	12	14	9	35	pathology review	5839	TCGA-35-4122	LUAD	69	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-25491	Alive	TUMOR FREE	225	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	225	0	225	NA	NA	0	225	
40	TCGA-35-4123	1	20	2	9	2	3	0	0	12	210	19	0	5	95	9	0	TCGA-35-4123-01	136	0.4701569024179602	83	TCGA-35-4123-01	14	12	32	0.2458787997561425	TCGA-35-4123-01	8	6	9	23	pathology review	5840	TCGA-35-4123	LUAD	38	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-14064	Alive	TUMOR FREE	182	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	182	0	182	NA	NA	0	182	
60	TCGA-35-5375	0	19	0	23	7	4	2	0	9	326	26	0	10	102	17	0	TCGA-35-5375-01	247	0.7299022800048554	147	TCGA-35-5375-01	26	63	51	0.4152922565981816	TCGA-35-5375-01	16	20	9	45	pathology review	5841	TCGA-35-5375	LUAD	61	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2010	NA	-22628	Alive	TUMOR FREE	264	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	264	0	264	NA	NA	0	264	
70	TCGA-38-4625	2	41	2	17	8	2	2	0	26	453	40	2	11	155	20	2	TCGA-38-4625-01	229	0.5666536081920415	144	TCGA-38-4625-01	16	39	37	0.3340012446927337	TCGA-38-4625-01	19	12	9	40	pathology review	5842	TCGA-38-4625	LUAD	66	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2002	NA	-24241	Alive	NA	2973	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2973	0	2973	0	2973	0	2973	
60	TCGA-38-4626	0	9	0	6	9	1	0	0	10	202	16	1	5	76	10	0	TCGA-38-4626-01	101	0.026528074559224516	50	TCGA-38-4626-01	2	3	19	0.0020304431177708615	TCGA-38-4626-01	4	4	0	8	PASS	5843	TCGA-38-4626	LUAD	57	FEMALE	WHITE	[Discrepancy]	NA	Lung Adenocarcinoma	NA	2003	NA	-20903	Alive	TUMOR FREE	3674	NA	NA	New Primary Tumor	NA	NA	2518	Complete Remission/Response	NA	NA	0	3674	0	3674	0	3674	1	2518	
60	TCGA-38-4627	0	2	0	0	1	0	0	0	1	24	3	0	0	5	1	0	TCGA-38-4627-01	91	0.31869782571774125	38	TCGA-38-4627-01	9	10	7	0.15783397790541734	TCGA-38-4627-01	1	2	1	4	PASS	5844	TCGA-38-4627	LUAD	64	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2003	NA	-23510	Dead	NA	NA	1147	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1147	NA	1147	0	1147	0	1147	
70	TCGA-38-4628	0	6	0	5	3	1	3	0	4	97	7	0	2	29	1	0	TCGA-38-4628-01	329	0.7575259277497416	205	TCGA-38-4628-01	24	53	40	0.3586562869312413	TCGA-38-4628-01	23	13	10	46	PASS	5845	TCGA-38-4628	LUAD	65	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2002	NA	-24057	Dead	WITH TUMOR	NA	1492	NA	NA	NA	NA	1083	Complete Remission/Response	NA	NA	1	1492	1	1492	1	1083	1	1083	
70	TCGA-38-4629	1	22	1	8	11	6	2	0	11	214	16	1	5	71	7	1	TCGA-38-4629	0	0	0	TCGA-38-4629	0	0	0	0	TCGA-38-4629-01	14	6	12	32	pathology review	5846	TCGA-38-4629	LUAD	68	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2003	NA	-25104	Dead	WITH TUMOR	NA	864	NA	NA	NA	NA	379	Complete Remission/Response	NA	NA	1	864	1	864	1	379	1	379	
80	TCGA-38-4630	1	7	2	2	2	2	3	0	7	90	11	0	4	39	3	0	TCGA-38-4630	0	0	0	TCGA-38-4630	0	0	0	0	TCGA-38-4630-01	13	11	16	40	pathology review	5847	TCGA-38-4630	LUAD	75	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2000	NA	-27667	Dead	WITH TUMOR	NA	1073	NA	NA	NA	NA	524	Complete Remission/Response	NA	NA	1	1073	1	1073	1	524	1	524	
70	TCGA-38-4631	3	32	2	25	19	5	0	0	25	563	59	0	10	201	31	2	TCGA-38-4631-01	316	0.6140737617509945	189	TCGA-38-4631-01	20	37	38	0.277878145542343	TCGA-38-4631-01	14	17	11	42	PASS	5848	TCGA-38-4631	LUAD	72	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	1997	NA	-26538	Dead	WITH TUMOR	NA	354	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	354	1	354	NA	NA	1	354	
40	TCGA-38-4632	4	23	1	18	14	5	1	0	22	422	33	1	6	123	20	0	TCGA-38-4632-01	229	0.644232907953584	147	TCGA-38-4632-01	23	32	19	0.1604546599840286	TCGA-38-4632-01	19	15	6	40	PASS	5849	TCGA-38-4632	LUAD	42	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Lung Adenocarcinoma	NA	1998	NA	-15418	Dead	WITH TUMOR	NA	1357	NA	NA	NA	NA	680	Complete Remission/Response	NA	NA	1	1357	1	1357	NA	NA	1	680	
70	TCGA-38-6178	0	4	0	0	2	0	1	0	2	53	7	0	0	24	3	0	TCGA-38-6178-01	206	0.7631488774949899	120	TCGA-38-6178-01	22	52	41	0.4562199250520824	TCGA-38-6178-01	15	10	5	30	PASS	5850	TCGA-38-6178	LUAD	70	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2010	NA	-25593	Alive	WITH TUMOR	448	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	448	0	448	NA	NA	0	448	
70	TCGA-38-7271	0	3	0	2	1	0	0	0	0	69	11	1	1	25	5	0	TCGA-38-7271-01	49	0.10569844826631887	13	TCGA-38-7271-01	2	2	19	1.9026874590312685e-05	TCGA-38-7271-01	1	1	0	2	PASS	5851	TCGA-38-7271	LUAD	72	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2006	NA	-26440	Dead	WITH TUMOR	NA	800	NA	NA	NA	NA	304	Complete Remission/Response	NA	NA	1	800	1	800	1	304	1	304	
80	TCGA-38-A44F	0	0	0	0	0	0	0	0	0	9	2	0	0	8	0	0	TCGA-38-A44F-01	33	3.917458236643566e-06	5	TCGA-38-A44F-01	1	1	6	0.0013234153509497765	TCGA-38-A44F-01	0	0	0	0	PASS	5852	TCGA-38-A44F	LUAD	80	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-29534	Alive	TUMOR FREE	133	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	133	0	133	0	133	0	133	
70	TCGA-44-2655	0	6	1	5	5	1	0	0	9	141	9	0	3	52	7	0	TCGA-44-2655-01	78	0.1490192089392197	27	TCGA-44-2655-01	4	6	3	0.0722296092308378	TCGA-44-2655-01	3	2	0	5	PASS	5853	TCGA-44-2655	LUAD	65	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2009	NA	-23854	Alive	TUMOR FREE	1324	NA	NA	New Primary Tumor	NA	NA	1009	Complete Remission/Response	NA	NA	0	1324	0	1324	0	1324	1	1009	
60	TCGA-44-2656	2	69	8	69	35	9	2	0	42	1257	130	0	41	465	58	2	TCGA-44-2656-01	177	0.6544673509786999	98	TCGA-44-2656-01	19	31	167	0.3478117351932425	TCGA-44-2656-01	18	18	15	51	hypermutated sample	5854	TCGA-44-2656	LUAD	59	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	-21766	Alive	TUMOR FREE	1429	NA	NA	New Primary Tumor	NA	NA	568	Complete Remission/Response	NA	NA	0	1429	0	1429	0	1429	1	568	
70	TCGA-44-2657	2	42	4	27	14	0	0	0	31	634	34	0	9	233	27	2	TCGA-44-2657-01	116	0.4273098664457925	52	TCGA-44-2657-01	10	12	24	0.4027422441463879	TCGA-44-2657-01	10	7	11	28	PASS	5855	TCGA-44-2657	LUAD	74	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	-27298	Alive	TUMOR FREE	1351	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1351	0	1351	0	1351	0	1351	
70	TCGA-44-2659	2	33	1	25	28	6	2	0	13	648	50	0	18	194	36	2	TCGA-44-2659-01	136	0.7016393842526158	64	TCGA-44-2659-01	25	34	18	0.1993874164207856	TCGA-44-2659-01	8	2	7	17	PASS	5856	TCGA-44-2659	LUAD	65	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2009	NA	-23808	Alive	TUMOR FREE	1367	NA	NA	Locoregional Recurrence	NA	NA	1146	Complete Remission/Response	NA	NA	0	1367	0	1367	1	1146	1	1146	
70	TCGA-44-2661	0	4	0	0	2	2	2	0	2	62	0	0	0	34	0	0	TCGA-44-2661	0	0	0	TCGA-44-2661	0	0	0	0	TCGA-44-2661-01	3	4	3	10	PASS	5857	TCGA-44-2661	LUAD	69	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2009	NA	-25313	Alive	TUMOR FREE	1159	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1159	0	1159	0	1159	0	1159	
70	TCGA-44-2662	0	19	2	18	6	2	4	0	14	320	16	4	6	131	11	0	TCGA-44-2662-01	214	0.6313253646033095	131	TCGA-44-2662-01	24	25	109	0.2619716704648506	TCGA-44-2662-01	16	5	13	34	PASS	5858	TCGA-44-2662	LUAD	65	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	-24014	Alive	TUMOR FREE	1280	NA	NA	NA	NA	NA	245	Progressive Disease	NA	NA	0	1280	0	1280	NA	NA	1	245	
70	TCGA-44-2664	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-44-2664	0	0	0	TCGA-44-2664	0	0	0	0	TCGA-44-2664	0	0	0	0	PASS	5859	TCGA-44-2664	LUAD	66	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2009	NA	-24468	Alive	TUMOR FREE	1251	NA	NA	Distant Metastasis	NA	NA	813	Complete Remission/Response	NA	NA	0	1251	0	1251	1	813	1	813	
60	TCGA-44-2665	0	9	0	3	0	0	0	0	4	68	4	0	2	37	4	0	TCGA-44-2665-01	151	0.2699831556919509	86	TCGA-44-2665-01	7	11	67	0.1227404605481943	TCGA-44-2665-01	9	7	6	22	PASS	5860	TCGA-44-2665	LUAD	55	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2009	NA	-20349	Alive	TUMOR FREE	1301	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1301	0	1301	NA	NA	0	1301	
40	TCGA-44-2666	0	2	0	2	0	0	0	0	2	70	2	0	0	8	0	0	TCGA-44-2666-01	76	0.0705089395923791	32	TCGA-44-2666-01	2	4	36	0.10194927150249702	TCGA-44-2666-01	1	4	3	8	PASS	5861	TCGA-44-2666	LUAD	43	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	-15970	Dead	WITH TUMOR	97	97	NA	NA	NA	NA	NA	NA	NA	NA	1	97	1	97	NA	NA	1	97	
50	TCGA-44-2668	4	25	2	24	15	2	0	2	12	522	59	0	6	205	30	2	TCGA-44-2668-01	153	0.3890663873120603	76	TCGA-44-2668-01	11	16	93	0.2353223665764669	TCGA-44-2668-01	10	13	10	33	pathology review	5862	TCGA-44-2668	LUAD	51	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	-18856	Dead	WITH TUMOR	NA	761	NA	NA	NA	NA	433	Complete Remission/Response	NA	NA	1	761	1	761	1	433	1	433	
70	TCGA-44-3396	2	10	2	11	8	6	0	2	10	312	22	0	4	107	8	2	TCGA-44-3396-01	111	0.16076097156569613	50	TCGA-44-3396-01	6	5	3	0.04687826496006504	TCGA-44-3396-01	5	2	3	10	PASS	5863	TCGA-44-3396	LUAD	74	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2009	NA	-27073	Alive	TUMOR FREE	1130	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1130	0	1130	0	1130	0	1130	
80	TCGA-44-3398	2	28	0	19	6	6	0	0	14	295	22	0	4	116	8	0	TCGA-44-3398-01	56	0.13894228221882174	17	TCGA-44-3398-01	2	4	0	0.0	TCGA-44-3398-01	1	2	0	3	pathology review	5864	TCGA-44-3398	LUAD	77	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2009	NA	-28392	Alive	TUMOR FREE	1163	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1163	0	1163	0	1163	0	1163	
30	TCGA-44-3917	0	8	2	3	4	0	0	0	10	172	15	1	3	58	5	0	TCGA-44-3917-01	256	0.6467414595168253	147	TCGA-44-3917-01	19	25	199	0.4297992792952227	TCGA-44-3917-01	16	11	21	48	PASS	5865	TCGA-44-3917	LUAD	33	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	-12179	Alive	TUMOR FREE	1183	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1183	0	1183	0	1183	0	1183	
60	TCGA-44-3918	4	60	8	64	42	13	0	0	64	1491	109	4	32	461	67	2	TCGA-44-3918-01	233	0.5767503744439627	146	TCGA-44-3918-01	12	20	156	0.40855282326162895	TCGA-44-3918-01	18	22	18	58	pathology review	5866	TCGA-44-3918	LUAD	60	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-22236	Alive	WITH TUMOR	1036	NA	NA	NA	NA	NA	511	Complete Remission/Response	NA	NA	0	1036	0	1036	1	511	1	511	
70	TCGA-44-3919	0	4	0	6	4	0	2	0	6	89	4	0	2	27	2	0	TCGA-44-3919-01	121	0.31090371015827184	66	TCGA-44-3919-01	6	7	20	0.1085790009893136	TCGA-44-3919-01	6	5	5	16	PASS	5867	TCGA-44-3919	LUAD	71	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-26081	Dead	WITH TUMOR	NA	1026	NA	Locoregional Recurrence	NA	NA	921	Complete Remission/Response	NA	NA	1	1026	1	1026	1	921	1	921	
60	TCGA-44-4112	6	51	16	40	34	10	0	0	31	709	60	4	21	267	28	0	TCGA-44-4112-01	99	0.2930120632885741	40	TCGA-44-4112-01	6	12	37	0.13934922382203782	TCGA-44-4112-01	2	9	9	20	PASS	5868	TCGA-44-4112	LUAD	60	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2010	NA	-22106	Dead	WITH TUMOR	NA	808	NA	NA	NA	NA	619	Complete Remission/Response	NA	NA	1	808	1	808	1	619	1	619	
50	TCGA-44-5643	2	6	2	8	6	0	2	0	10	183	28	0	6	81	4	0	TCGA-44-5643-01	193	0.9470379585934778	123	TCGA-44-5643-01	19	24	42	0.5924621803996971	TCGA-44-5643-01	13	4	7	24	pathology review	5869	TCGA-44-5643	LUAD	53	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Lung Adenocarcinoma	NA	2010	NA	-19426	Alive	TUMOR FREE	1013	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1013	0	1013	NA	NA	0	1013	
50	TCGA-44-5644	4	90	8	46	51	16	2	0	50	1527	114	2	24	488	58	2	TCGA-44-5644-01	597	0.6902032768848332	390	TCGA-44-5644-01	16	33	117	0.3828682315816824	TCGA-44-5644-01	25	28	20	73	pathology review	5870	TCGA-44-5644	LUAD	51	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2010	NA	-18644	Alive	TUMOR FREE	863	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	863	0	863	0	863	0	863	
60	TCGA-44-5645	0	2	0	0	0	0	0	2	2	54	12	0	1	16	3	0	TCGA-44-5645-01	176	0.947717141467022	108	TCGA-44-5645-01	10	15	57	0.1515656145551049	TCGA-44-5645-01	4	4	2	10	PASS	5871	TCGA-44-5645	LUAD	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-22471	Alive	TUMOR FREE	852	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	852	0	852	0	852	0	852	
60	TCGA-44-6144	0	26	0	13	6	0	0	0	11	355	22	0	2	126	8	0	TCGA-44-6144-01	118	0.5622241226418293	60	TCGA-44-6144-01	8	9	9	0.1807081844353132	TCGA-44-6144-01	9	3	4	16	PASS	5872	TCGA-44-6144	LUAD	58	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-21283	Alive	WITH TUMOR	723	NA	NA	NA	NA	NA	399	Complete Remission/Response	NA	NA	0	723	0	723	1	399	1	399	
60	TCGA-44-6145	8	35	0	6	14	0	1	0	14	496	44	0	8	159	20	2	TCGA-44-6145-01	62	0.315869856769163	24	TCGA-44-6145-01	16	14	18	0.469975262986206	TCGA-44-6145-01	3	2	3	8	PASS	5873	TCGA-44-6145	LUAD	62	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-22745	Alive	TUMOR FREE	595	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	595	0	595	0	595	0	595	
60	TCGA-44-6146	0	0	0	1	2	0	2	0	0	59	12	0	0	24	0	0	TCGA-44-6146-01	74	0.3223023931531785	24	TCGA-44-6146-01	5	6	28	0.13134766514506893	TCGA-44-6146-01	4	2	5	11	PASS	5874	TCGA-44-6146	LUAD	64	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2010	NA	-23378	Alive	TUMOR FREE	728	NA	NA	Locoregional Recurrence	NA	NA	631	Complete Remission/Response	NA	NA	0	728	0	728	1	631	1	631	
70	TCGA-44-6147	2	12	2	6	6	2	0	0	0	181	8	0	11	110	0	0	TCGA-44-6147-01	83	0.5862664362089971	34	TCGA-44-6147	0	0	0	0	TCGA-44-6147-01	4	2	3	9	PASS	5875	TCGA-44-6147	LUAD	67	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-24631	Alive	TUMOR FREE	845	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	845	0	845	0	845	0	845	
60	TCGA-44-6148	0	0	0	0	2	0	0	0	0	11	0	0	0	6	0	0	TCGA-44-6148-01	67	0.02755831602287568	18	TCGA-44-6148-01	2	2	0	0.0	TCGA-44-6148-01	0	0	0	0	PASS	5876	TCGA-44-6148	LUAD	60	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-22138	Alive	TUMOR FREE	704	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	704	0	704	0	704	0	704	
60	TCGA-44-6774	4	27	8	14	12	0	0	0	14	463	64	0	16	164	12	0	TCGA-44-6774-01	136	0.32798056795112746	63	TCGA-44-6774-01	4	8	12	0.1182681270848926	TCGA-44-6774-01	4	6	4	14	PASS	5877	TCGA-44-6774	LUAD	56	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2011	NA	-20462	Alive	TUMOR FREE	658	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	658	0	658	0	658	0	658	
70	TCGA-44-6775	0	4	2	9	0	3	2	0	2	102	9	0	2	37	5	0	TCGA-44-6775-01	94	0.6163645084668478	39	TCGA-44-6775-01	26	35	65	0.25820962581849816	TCGA-44-6775-01	13	6	8	27	PASS	5878	TCGA-44-6775	LUAD	72	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-26415	Alive	WITH TUMOR	705	NA	NA	Locoregional Recurrence	NA	NA	684	Complete Remission/Response	NA	NA	0	705	0	705	1	684	1	684	
60	TCGA-44-6776	0	28	2	9	12	6	2	0	17	320	26	2	18	101	0	0	TCGA-44-6776-01	62	0.1665379604635701	18	TCGA-44-6776-01	4	5	7	0.12330671130626893	TCGA-44-6776-01	5	5	4	14	PASS	5879	TCGA-44-6776	LUAD	60	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2005	NA	-22150	Alive	TUMOR FREE	2616	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2616	0	2616	0	2616	0	2616	
90	TCGA-44-6777	8	42	1	17	11	10	5	0	33	584	39	0	14	197	18	2	TCGA-44-6777-01	72	0.4380261707012209	24	TCGA-44-6777-01	19	18	13	0.3711066457919999	TCGA-44-6777-01	7	1	4	12	PASS	5880	TCGA-44-6777	LUAD	85	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2006	NA	-31234	Dead	TUMOR FREE	NA	987	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	987	0	987	0	987	0	987	
60	TCGA-44-6778	2	42	6	12	23	7	0	0	31	611	32	0	24	210	14	0	TCGA-44-6778-01	268	0.7848876136668406	173	TCGA-44-6778-01	25	23	54	0.3181283193330692	TCGA-44-6778-01	20	10	8	38	pathology review	5881	TCGA-44-6778	LUAD	59	MALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2007	NA	-21725	Alive	TUMOR FREE	1864	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1864	0	1864	0	1864	0	1864	
50	TCGA-44-6779	0	4	2	5	4	1	0	0	1	79	6	0	3	27	1	0	TCGA-44-6779-01	154	0.6733319875125695	84	TCGA-44-6779-01	17	15	43	0.4806426988544886	TCGA-44-6779-01	12	10	11	33	PASS	5882	TCGA-44-6779	LUAD	50	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2008	NA	-18469	Dead	WITH TUMOR	NA	500	NA	NA	NA	NA	232	Progressive Disease	NA	NA	1	500	1	500	NA	NA	1	232	
70	TCGA-44-7659	4	14	0	9	14	2	2	0	6	234	12	0	8	74	8	0	TCGA-44-7659-01	72	0.15976936172571216	24	TCGA-44-7659-01	4	4	3	0.07638569972700973	TCGA-44-7659-01	6	3	3	12	PASS	5883	TCGA-44-7659	LUAD	70	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-25730	Alive	TUMOR FREE	691	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	691	0	691	0	691	0	691	
70	TCGA-44-7660	12	50	6	24	22	2	0	0	12	571	34	6	7	204	20	2	TCGA-44-7660-01	288	0.7765664625243249	184	TCGA-44-7660-01	25	18	67	0.4103301830343953	TCGA-44-7660-01	15	11	15	41	pathology review	5884	TCGA-44-7660	LUAD	72	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-26594	Alive	WITH TUMOR	592	NA	NA	Locoregional Recurrence	NA	NA	253	Progressive Disease	NA	NA	0	592	0	592	NA	NA	1	253	
70	TCGA-44-7661	8	23	6	19	14	3	2	0	22	468	34	0	10	162	16	0	TCGA-44-7661-01	52	0.1368534908007586	15	TCGA-44-7661-01	5	5	3	0.06793821792056742	TCGA-44-7661-01	3	2	1	6	pathology review	5885	TCGA-44-7661	LUAD	69	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-25483	Dead	WITH TUMOR	NA	557	NA	Locoregional Recurrence	NA	NA	335	Complete Remission/Response	NA	NA	1	557	1	557	1	335	1	335	
60	TCGA-44-7662	0	64	0	27	21	4	0	0	39	944	70	2	6	266	24	0	TCGA-44-7662-01	150	0.6231195069205765	73	TCGA-44-7662-01	25	28	58	0.4758193823400104	TCGA-44-7662-01	16	10	13	39	PASS	5886	TCGA-44-7662	LUAD	61	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-22543	Alive	TUMOR FREE	218	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	218	0	218	0	218	0	218	
50	TCGA-44-7667	0	38	6	30	18	8	4	0	27	726	61	0	7	236	28	0	TCGA-44-7667-01	252	0.6354453117169195	144	TCGA-44-7667-01	23	55	53	0.16688206831207658	TCGA-44-7667-01	14	16	6	36	pathology review	5887	TCGA-44-7667	LUAD	49	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2009	NA	-18062	Alive	TUMOR FREE	1097	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1097	0	1097	0	1097	0	1097	
60	TCGA-44-7669	0	47	6	20	25	7	0	0	26	699	66	2	14	220	30	2	TCGA-44-7669-01	338	0.7012084187312171	244	TCGA-44-7669-01	22	23	60	0.2682791350914508	TCGA-44-7669-01	16	11	10	37	pathology review	5888	TCGA-44-7669	LUAD	59	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Lung Adenocarcinoma	NA	2010	NA	-21893	Dead	WITH TUMOR	NA	574	NA	NA	NA	NA	390	Complete Remission/Response	NA	NA	1	574	1	574	1	390	1	390	
50	TCGA-44-7670	0	102	4	62	56	20	4	0	73	1698	158	2	42	570	50	2	TCGA-44-7670-01	778	0.8159413832131077	521	TCGA-44-7670-01	27	55	142	0.3284837308040053	TCGA-44-7670-01	24	15	14	53	hypermutated sample	5889	TCGA-44-7670	LUAD	47	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2010	NA	-17392	Alive	TUMOR FREE	882	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	882	0	882	0	882	0	882	
60	TCGA-44-7671	2	33	5	12	20	2	2	0	20	331	28	0	13	126	12	0	TCGA-44-7671-01	108	0.4351425938160529	50	TCGA-44-7671-01	16	21	11	0.11325981414434826	TCGA-44-7671-01	5	3	4	12	PASS	5890	TCGA-44-7671	LUAD	64	MALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Adenocarcinoma	NA	2010	NA	-23538	Alive	WITH TUMOR	889	NA	NA	Locoregional Recurrence	NA	NA	883	Complete Remission/Response	NA	NA	0	889	0	889	1	883	1	883	
50	TCGA-44-7672	0	6	2	4	12	2	0	0	6	261	22	0	5	94	9	0	TCGA-44-7672-01	154	0.4139440745504587	71	TCGA-44-7672-01	22	35	22	0.18419937890017826	TCGA-44-7672-01	13	8	7	28	PASS	5891	TCGA-44-7672	LUAD	52	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-19200	Alive	TUMOR FREE	719	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	719	0	719	0	719	0	719	
50	TCGA-44-8117	0	28	2	23	23	4	0	0	20	573	52	0	13	205	18	0	TCGA-44-8117-01	196	0.6811455209034041	113	TCGA-44-8117-01	20	33	47	0.28291282447156346	TCGA-44-8117-01	18	11	9	38	PASS	5892	TCGA-44-8117	LUAD	54	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-19855	Alive	TUMOR FREE	385	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	385	0	385	0	385	0	385	
70	TCGA-44-8119	3	17	4	11	14	7	2	0	11	502	33	0	13	173	10	0	TCGA-44-8119-01	253	0.6784251391329841	155	TCGA-44-8119-01	25	51	51	0.2580069142526256	TCGA-44-8119-01	14	12	9	35	PASS	5893	TCGA-44-8119	LUAD	73	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2012	NA	-27003	Alive	TUMOR FREE	285	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	285	0	285	0	285	0	285	
60	TCGA-44-8120	4	26	3	15	21	7	0	0	12	450	37	1	6	182	19	0	TCGA-44-8120-01	135	0.7016360308737043	78	TCGA-44-8120-01	13	14	42	0.4051085643159769	TCGA-44-8120-01	9	3	10	22	PASS	5894	TCGA-44-8120	LUAD	58	MALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-21188	Alive	TUMOR FREE	260	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	260	0	260	0	260	0	260	
70	TCGA-44-A479	0	21	2	4	8	4	0	0	7	248	10	1	4	75	8	0	TCGA-44-A479-01	112	0.3769751620692767	56	TCGA-44-A479-01	8	15	50	0.18472320231102413	TCGA-44-A479-01	11	11	9	31	PASS	5895	TCGA-44-A479	LUAD	73	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-27024	Alive	TUMOR FREE	486	NA	NA	New Primary Tumor	NA	NA	437	Complete Remission/Response	NA	NA	0	486	0	486	0	486	1	437	
80	TCGA-44-A47A	1	7	0	8	6	1	0	1	6	175	17	1	3	49	5	0	TCGA-44-A47A-01	50	0.6801948488590605	10	TCGA-44-A47A-01	23	22	12	0.025891455285579058	TCGA-44-A47A-01	7	7	2	16	PASS	5896	TCGA-44-A47A	LUAD	78	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-28782	Alive	WITH TUMOR	466	NA	NA	Distant Metastasis	NA	NA	397	Complete Remission/Response	NA	NA	0	466	0	466	1	397	1	397	
80	TCGA-44-A47B	0	4	0	4	1	2	0	0	3	33	3	0	0	13	1	0	TCGA-44-A47B-01	189	0.4574204756748936	113	TCGA-44-A47B-01	18	20	59	0.08770911681955851	TCGA-44-A47B-01	7	4	3	14	PASS	5897	TCGA-44-A47B	LUAD	79	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-28869	Alive	TUMOR FREE	287	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	287	0	287	0	287	0	287	
70	TCGA-44-A47F	0	2	0	2	1	1	0	0	0	73	3	0	0	33	2	0	TCGA-44-A47F-01	75	0.6896736483967986	29	TCGA-44-A47F-01	27	61	57	0.2437984989285898	TCGA-44-A47F-01	11	4	2	17	PASS	5898	TCGA-44-A47F	LUAD	74	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2012	NA	-27122	Alive	TUMOR FREE	337	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	337	0	337	0	337	0	337	
70	TCGA-44-A47G	2	2	0	1	0	2	0	0	3	65	6	1	1	17	3	0	TCGA-44-A47G-01	41	0.00033237234822068443	4	TCGA-44-A47G-01	3	4	12	0.029637167005762768	TCGA-44-A47G-01	5	14	2	21	PASS	5899	TCGA-44-A47G	LUAD	73	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-26800	Alive	TUMOR FREE	351	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	351	0	351	0	351	0	351	
70	TCGA-44-A4SS	1	15	3	13	10	3	1	0	18	384	31	0	5	114	12	0	TCGA-44-A4SS-01	69	0.312693679724721	23	TCGA-44-A4SS-01	16	25	39	0.136012227106934	TCGA-44-A4SS-01	13	23	8	44	PASS	5900	TCGA-44-A4SS	LUAD	73	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-26991	Alive	TUMOR FREE	415	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	415	0	415	0	415	0	415	
70	TCGA-44-A4SU	0	4	0	3	3	0	0	0	5	119	9	0	4	45	1	0	TCGA-44-A4SU-01	161	0.5716483258533612	91	TCGA-44-A4SU-01	12	38	106	0.4687647164586696	TCGA-44-A4SU-01	8	8	13	29	PASS	5901	TCGA-44-A4SU	LUAD	67	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-24820	Dead	WITH TUMOR	NA	409	NA	Locoregional Recurrence	NA	NA	260	Complete Remission/Response	NA	NA	1	409	1	409	1	260	1	260	
70	TCGA-49-4486	0	11	2	2	3	1	0	0	9	127	9	0	0	57	2	1	TCGA-49-4486-01	208	0.1468415480893493	131	TCGA-49-4486-01	2	2	14	0.03161798303020106	TCGA-49-4486-01	5	2	2	9	PASS	5902	TCGA-49-4486	LUAD	72	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	1992	NA	-26415	Dead	WITH TUMOR	NA	2318	NA	Distant Metastasis	NA	NA	2045	Complete Remission/Response	NA	NA	1	2318	1	2318	1	2045	1	2045	
70	TCGA-49-4487	0	11	0	8	11	1	1	0	5	291	23	1	3	104	13	1	TCGA-49-4487-01	128	0.5071650968538113	62	TCGA-49-4487-01	27	36	17	0.1647562560765624	TCGA-49-4487-01	17	9	3	29	PASS	5903	TCGA-49-4487	LUAD	72	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	1992	NA	-26583	Dead	WITH TUMOR	NA	855	NA	NA	NA	NA	697	Complete Remission/Response	NA	NA	1	855	1	855	1	697	1	697	
70	TCGA-49-4488	0	16	0	7	7	2	0	0	5	226	21	0	4	77	11	1	TCGA-49-4488-01	311	0.7784967437890605	187	TCGA-49-4488-01	25	55	90	0.36132859774608267	TCGA-49-4488-01	30	13	16	59	PASS	5904	TCGA-49-4488	LUAD	74	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	1992	NA	-27332	Dead	NA	NA	869	NA	NA	NA	NA	634	NA	NA	NA	1	869	NA	869	NA	NA	1	634	
50	TCGA-49-4490	1	4	0	1	0	1	0	0	0	46	1	0	1	18	0	0	TCGA-49-4490-01	169	0.5810690666712107	109	TCGA-49-4490-01	29	48	29	0.2450016381001888	TCGA-49-4490-01	14	8	6	28	PASS	5905	TCGA-49-4490	LUAD	45	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	1993	NA	-16634	Dead	WITH TUMOR	NA	385	NA	NA	NA	NA	NA	NA	NA	NA	1	385	1	385	NA	NA	1	385	
80	TCGA-49-4494	1	13	1	3	4	0	0	0	6	148	10	0	3	52	7	0	TCGA-49-4494-01	139	0.3318585024934893	72	TCGA-49-4494-01	3	9	19	0.2271031399220907	TCGA-49-4494-01	3	6	6	15	PASS	5906	TCGA-49-4494	LUAD	77	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	1995	NA	-28387	Dead	WITH TUMOR	NA	1081	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1081	1	1081	NA	NA	1	1081	
70	TCGA-49-4501	0	6	0	1	0	0	3	1	1	41	1	0	0	23	2	0	TCGA-49-4501-01	255	0.5956938084078973	151	TCGA-49-4501-01	19	28	53	0.31611124242728245	TCGA-49-4501-01	12	9	7	28	PASS	5907	TCGA-49-4501	LUAD	67	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	1996	NA	-24817	Dead	WITH TUMOR	NA	1421	NA	NA	NA	NA	545	Complete Remission/Response	NA	NA	1	1421	1	1421	1	545	1	545	
60	TCGA-49-4505	2	12	1	8	4	2	3	0	7	164	8	0	2	66	5	0	TCGA-49-4505-01	207	0.5899150741217268	120	TCGA-49-4505-01	21	29	24	0.21125609112979504	TCGA-49-4505-01	13	12	5	30	PASS	5908	TCGA-49-4505	LUAD	61	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	1996	NA	-22628	Dead	WITH TUMOR	NA	428	NA	Distant Metastasis|New Primary Tumor	NA	NA	417	Complete Remission/Response	NA	NA	1	428	1	428	1	417	1	417	
70	TCGA-49-4506	0	3	0	0	3	3	0	0	1	92	14	0	0	32	3	0	TCGA-49-4506-01	117	0.3108065783168084	60	TCGA-49-4506-01	20	27	15	0.3265619000570171	TCGA-49-4506-01	4	1	4	9	PASS	5909	TCGA-49-4506	LUAD	68	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	1997	NA	-25132	Dead	[Discrepancy]	NA	999	NA	Locoregional Recurrence	NA	NA	692	Complete Remission/Response	NA	NA	1	999	NA	999	1	692	1	692	
70	TCGA-49-4507	1	12	1	8	2	3	1	0	5	160	11	0	5	51	3	0	TCGA-49-4507-01	280	0.5545879091655117	186	TCGA-49-4507-01	12	38	47	0.28065629208434795	TCGA-49-4507-01	16	13	13	42	PASS	5910	TCGA-49-4507	LUAD	73	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	1997	NA	-26851	Dead	WITH TUMOR	NA	268	NA	NA	NA	NA	158	Progressive Disease	NA	NA	1	268	1	268	NA	NA	1	158	
50	TCGA-49-4510	0	9	0	1	0	0	2	0	3	49	6	0	1	14	0	1	TCGA-49-4510-01	184	0.6531900214183579	108	TCGA-49-4510-01	23	22	26	0.2824858118656469	TCGA-49-4510-01	8	6	7	21	PASS	5911	TCGA-49-4510	LUAD	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Lung Adenocarcinoma	NA	2001	NA	-18762	Dead	WITH TUMOR	NA	896	NA	Distant Metastasis	NA	NA	502	Stable Disease	NA	NA	1	896	1	896	NA	NA	1	502	
70	TCGA-49-4512	0	3	1	1	1	1	1	0	3	32	0	0	0	13	3	0	TCGA-49-4512-01	172	0.4599296962899852	104	TCGA-49-4512-01	31	48	37	0.3692407794640193	TCGA-49-4512-01	12	9	4	25	PASS	5912	TCGA-49-4512	LUAD	69	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2007	NA	-25502	Dead	WITH TUMOR	157	905	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	905	1	905	NA	NA	1	905	
80	TCGA-49-4514	2	19	2	12	9	2	0	0	11	250	19	1	3	96	9	1	TCGA-49-4514-01	194	0.3888776643372212	117	TCGA-49-4514-01	8	7	47	0.2922256938012166	TCGA-49-4514-01	11	13	7	31	PASS	5913	TCGA-49-4514	LUAD	79	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2007	NA	-28908	Alive	TUMOR FREE	1700	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1700	0	1700	0	1700	0	1700	
70	TCGA-49-6742	0	19	2	12	4	1	1	0	9	209	14	0	6	85	0	1	TCGA-49-6742-01	120	0.7965443398338146	58	TCGA-49-6742-01	19	15	13	0.06862186158775811	TCGA-49-6742-01	4	2	3	9	PASS	5914	TCGA-49-6742	LUAD	70	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2010	NA	-25839	Dead	WITH TUMOR	NA	488	NA	NA	NA	NA	214	Progressive Disease	NA	NA	1	488	1	488	NA	NA	1	214	
80	TCGA-49-6743	4	31	1	27	22	5	0	0	25	590	50	0	9	228	18	0	TCGA-49-6743-01	147	0.6112483084604009	83	TCGA-49-6743-01	23	29	35	0.2693475927432883	TCGA-49-6743-01	12	10	11	33	pathology review	5915	TCGA-49-6743	LUAD	81	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2010	NA	-29807	Alive	TUMOR FREE	1621	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1621	0	1621	0	1621	0	1621	
60	TCGA-49-6744	1	4	0	4	3	2	0	0	6	186	22	0	5	64	7	0	TCGA-49-6744-01	145	0.43959410605025817	86	TCGA-49-6744-01	5	10	24	0.1669327965611582	TCGA-49-6744-01	9	8	9	26	PASS	5916	TCGA-49-6744	LUAD	64	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2010	NA	-23484	Alive	TUMOR FREE	1683	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1683	0	1683	0	1683	0	1683	
80	TCGA-49-6745	0	6	0	3	0	1	1	0	11	106	10	0	3	32	6	0	TCGA-49-6745-01	118	0.30523245689701706	61	TCGA-49-6745-01	10	20	15	0.12047806695770982	TCGA-49-6745-01	4	3	4	11	PASS	5917	TCGA-49-6745	LUAD	82	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2011	NA	-30133	Alive	TUMOR FREE	522	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	522	0	522	NA	NA	0	522	
70	TCGA-49-6761	3	20	1	7	3	1	0	0	10	229	33	0	10	95	12	0	TCGA-49-6761-01	83	0.4410633651498089	33	TCGA-49-6761-01	16	35	17	0.2898643460058525	TCGA-49-6761-01	9	7	8	24	PASS	5918	TCGA-49-6761	LUAD	68	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2009	NA	-24849	Alive	TUMOR FREE	354	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	354	0	354	0	354	0	354	
50	TCGA-49-6767	1	20	4	15	7	3	0	0	16	360	32	1	7	150	13	3	TCGA-49-6767-01	172	0.5818403426084131	84	TCGA-49-6767-01	23	33	43	0.3370413601026986	TCGA-49-6767-01	11	9	10	30	PASS	5919	TCGA-49-6767	LUAD	46	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2010	NA	-17108	Alive	TUMOR FREE	677	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	677	0	677	NA	NA	0	677	
60	TCGA-49-AAQV	0	0	0	3	2	0	0	0	1	62	1	0	0	19	2	0	TCGA-49-AAQV-01	136	0.35965609828717443	77	TCGA-49-AAQV-01	10	11	92	0.23305273201293114	TCGA-49-AAQV-01	15	10	12	37	PASS	5920	TCGA-49-AAQV	LUAD	63	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Lung Adenocarcinoma	NA	2012	NA	-23370	Dead	TUMOR FREE	NA	677	NA	Distant Metastasis	NA	NA	509	Complete Remission/Response	NA	NA	1	677	0	677	1	509	1	509	
60	TCGA-49-AAR0	0	5	0	3	2	0	0	0	5	107	10	0	3	42	2	0	TCGA-49-AAR0-01	254	0.5206710508667212	161	TCGA-49-AAR0-01	15	12	172	0.4386601609887108	TCGA-49-AAR0-01	10	9	19	38	PASS	5921	TCGA-49-AAR0	LUAD	57	MALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2002	NA	-20932	Alive	TUMOR FREE	4765	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4765	0	4765	0	4765	0	4765	
60	TCGA-49-AAR2	1	15	2	9	12	3	0	0	14	307	31	1	4	100	5	1	TCGA-49-AAR2-01	159	0.28049840873562937	90	TCGA-49-AAR2-01	9	10	68	0.187358711726439	TCGA-49-AAR2-01	6	3	10	19	PASS	5922	TCGA-49-AAR2	LUAD	64	MALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	-23479	Alive	TUMOR FREE	2224	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2224	0	2224	0	2224	0	2224	
70	TCGA-49-AAR3	0	2	0	5	2	0	0	0	5	117	4	0	4	30	5	0	TCGA-49-AAR3-01	61	0.20808598313902085	13	TCGA-49-AAR3-01	10	13	101	0.39962811118174507	TCGA-49-AAR3-01	4	7	10	21	PASS	5923	TCGA-49-AAR3	LUAD	69	MALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Lung Adenocarcinoma	NA	2008	NA	-25469	Alive	[Discrepancy]	1893	NA	NA	Locoregional Recurrence	NA	NA	1893	Complete Remission/Response	NA	NA	0	1893	0	1893	1	1893	1	1893	
50	TCGA-49-AAR4	0	23	4	10	13	1	0	0	12	462	32	0	9	141	16	5	TCGA-49-AAR4-01	105	0.1544053284064405	49	TCGA-49-AAR4-01	8	10	87	0.2315965045486684	TCGA-49-AAR4-01	7	4	10	21	PASS	5924	TCGA-49-AAR4	LUAD	51	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Lung Adenocarcinoma	NA	2006	NA	-18939	Dead	WITH TUMOR	NA	879	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	879	1	879	NA	NA	1	879	
60	TCGA-49-AAR9	4	30	5	17	13	3	1	0	21	488	37	2	10	187	13	0	TCGA-49-AAR9-01	461	0.4965384286904031	297	TCGA-49-AAR9-01	11	26	300	0.5101908598003857	TCGA-49-AAR9-01	21	15	16	52	PASS	5925	TCGA-49-AAR9	LUAD	61	MALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Lung Adenocarcinoma	NA	1999	NA	-22510	Dead	WITH TUMOR	NA	260	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	260	1	260	NA	NA	1	260	
50	TCGA-49-AARE	4	49	3	45	22	8	2	0	39	1037	78	1	17	370	36	1	TCGA-49-AARE-01	229	0.6804569950890963	124	TCGA-49-AARE-01	19	35	93	0.2737178660049013	TCGA-49-AARE-01	15	11	9	35	hypermutated sample	5926	TCGA-49-AARE	LUAD	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	1999	NA	-18893	Dead	WITH TUMOR	NA	1229	NA	Locoregional Recurrence	NA	NA	388	Complete Remission/Response	NA	NA	1	1229	1	1229	1	388	1	388	
60	TCGA-49-AARN	2	30	3	21	12	3	1	0	18	618	35	1	19	172	16	2	TCGA-49-AARN-01	114	0.3140251749892176	62	TCGA-49-AARN-01	7	8	63	0.16967130825299573	TCGA-49-AARN-01	6	4	10	20	PASS	5927	TCGA-49-AARN	LUAD	56	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2000	NA	-20605	Dead	NA	NA	1135	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1135	NA	1135	0	1135	0	1135	
40	TCGA-49-AARO	3	26	2	9	10	1	0	0	15	462	37	0	9	153	24	0	TCGA-49-AARO-01	202	0.6196562160294871	112	TCGA-49-AARO-01	21	35	96	0.18505914427361367	TCGA-49-AARO-01	16	11	10	37	PASS	5928	TCGA-49-AARO	LUAD	39	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2003	NA	-14527	Alive	WITH TUMOR	3759	NA	NA	Locoregional Recurrence	NA	NA	1144	Complete Remission/Response	NA	NA	0	3759	0	3759	1	1144	1	1144	
40	TCGA-49-AARQ	2	31	4	17	8	3	0	0	22	551	56	0	13	180	17	0	TCGA-49-AARQ-01	226	0.6241178802322488	137	TCGA-49-AARQ-01	17	35	89	0.20846335569380714	TCGA-49-AARQ-01	19	13	7	39	PASS	5929	TCGA-49-AARQ	LUAD	41	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Lung Adenocarcinoma	NA	1996	NA	-15065	Alive	TUMOR FREE	6732	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	6732	0	6732	0	6732	0	6732	
70	TCGA-49-AARR	0	0	0	0	0	0	0	0	0	2	0	0	0	1	0	0	TCGA-49-AARR-01	83	9.306048817180236e-05	30	TCGA-49-AARR-01	0	0	10	0.0003667702975947038	TCGA-49-AARR-01	0	0	0	0	PASS	5930	TCGA-49-AARR	LUAD	68	MALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2001	NA	-24942	Alive	WITH TUMOR	4992	NA	NA	New Primary Tumor	NA	NA	1099	Complete Remission/Response	NA	NA	0	4992	0	4992	1	4812	1	1099	
50	TCGA-4B-A93V	0	6	2	6	2	0	0	0	2	111	6	0	4	31	4	0	TCGA-4B-A93V-01	206	0.9133414725923736	119	TCGA-4B-A93V-01	26	31	128	0.42834101648364215	TCGA-4B-A93V-01	15	11	10	36	PASS	5931	TCGA-4B-A93V	LUAD	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2013	NA	-19035	Dead	WITH TUMOR	NA	300	NA	Distant Metastasis	NA	NA	251	Progressive Disease	NA	NA	1	300	1	300	NA	NA	1	251	
70	TCGA-50-5044	0	2	0	0	2	0	0	0	6	111	5	0	1	53	3	1	TCGA-50-5044-01	63	0.08570146032755685	21	TCGA-50-5044-01	1	4	4	0.09560418862691304	TCGA-50-5044-01	2	2	2	6	PASS	5932	TCGA-50-5044	LUAD	72	FEMALE	WHITE	Stage IIIB	NA	Lung Adenocarcinoma	NA	2002	NA	-26567	Dead	WITH TUMOR	NA	624	NA	Distant Metastasis	NA	NA	483	Progressive Disease	NA	NA	1	624	1	624	NA	NA	1	483	
60	TCGA-50-5045	0	8	1	7	10	2	0	0	8	248	22	0	2	68	8	1	TCGA-50-5045-01	75	0.2085334285107112	33	TCGA-50-5045-01	3	25	14	0.2414554565216733	TCGA-50-5045-01	5	4	2	11	PASS	5933	TCGA-50-5045	LUAD	57	FEMALE	BLACK OR AFRICAN AMERICAN	[Discrepancy]	NA	Lung Adenocarcinoma	NA	2004	NA	-20961	Dead	WITH TUMOR	NA	2174	NA	Locoregional Recurrence	NA	NA	1433	Progressive Disease	NA	NA	1	2174	1	2174	NA	NA	1	1433	
70	TCGA-50-5049	1	37	2	18	23	6	0	0	21	638	50	0	11	211	22	1	TCGA-50-5049-01	132	0.4696443018660787	70	TCGA-50-5049-01	15	22	35	0.4944350733289457	TCGA-50-5049-01	11	7	8	26	PASS	5934	TCGA-50-5049	LUAD	70	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2006	NA	-25577	Alive	WITH TUMOR	3094	NA	NA	Locoregional Recurrence	NA	NA	1568	Progressive Disease	NA	NA	0	3094	0	3094	NA	NA	1	1568	
40	TCGA-50-5051	1	7	0	2	3	2	0	0	0	90	4	0	0	40	4	0	TCGA-50-5051-01	99	0.5897833619666233	40	TCGA-50-5051-01	22	29	12	0.13596322947209047	TCGA-50-5051-01	3	3	1	7	PASS	5935	TCGA-50-5051	LUAD	42	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2007	NA	-15585	Dead	WITH TUMOR	NA	478	NA	Distant Metastasis	NA	NA	184	Progressive Disease	NA	NA	1	478	1	478	NA	NA	1	184	
80	TCGA-50-5055	0	1	0	0	1	0	0	0	0	19	1	0	1	1	0	0	TCGA-50-5055-01	96	0.03769436603496242	47	TCGA-50-5055-01	1	5	5	0.0609688918710731	TCGA-50-5055-01	1	0	1	2	PASS	5936	TCGA-50-5055	LUAD	79	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2008	NA	-28988	Dead	WITH TUMOR	NA	1830	NA	Locoregional Recurrence|Distant Metastasis	NA	NA	771	Stable Disease	NA	NA	1	1830	1	1830	NA	NA	1	771	
70	TCGA-50-5066	0	24	9	6	16	2	1	0	29	530	36	0	8	150	14	0	TCGA-50-5066-01	110	0.3269093112954061	59	TCGA-50-5066-02	20	53	85	0.5656481898921074	TCGA-50-5066-02	21	18	14	53	pathology review	5937	TCGA-50-5066	LUAD	72	MALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	-26385	Alive	TUMOR FREE	1442	NA	NA	Distant Metastasis	NA	NA	477	Complete Remission/Response	NA	NA	0	1442	0	1442	1	477	1	477	
60	TCGA-50-5068	0	5	0	4	2	0	2	0	2	77	2	0	1	27	3	0	TCGA-50-5068-01	92	0.6944254833058532	45	TCGA-50-5068-01	32	21	29	0.4260526688112132	TCGA-50-5068-01	6	3	5	14	PASS	5938	TCGA-50-5068	LUAD	59	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2003	NA	-21728	Dead	WITH TUMOR	1499	1499	NA	Distant Metastasis	NA	NA	686	Progressive Disease	NA	NA	1	1499	1	1499	NA	NA	1	686	
70	TCGA-50-5072	1	7	1	2	7	2	1	0	9	126	11	0	2	42	7	0	TCGA-50-5072-01	78	0.5413084998777055	29	TCGA-50-5072-01	27	35	11	0.2008496891789872	TCGA-50-5072-01	7	5	4	16	PASS	5939	TCGA-50-5072	LUAD	74	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2009	NA	-27036	Dead	WITH TUMOR	NA	250	NA	Distant Metastasis	NA	NA	213	Progressive Disease	NA	NA	1	250	1	250	NA	NA	1	213	
50	TCGA-50-5930	4	56	3	31	19	9	0	0	26	879	79	2	30	306	30	3	TCGA-50-5930-01	235	0.23014336703554414	151	TCGA-50-5930-01	2	26	85	0.9944370680001556	TCGA-50-5930-01	9	2	13	24	hypermutated sample	5940	TCGA-50-5930	LUAD	47	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2001	NA	-17238	Dead	WITH TUMOR	NA	282	NA	Distant Metastasis	NA	NA	177	Progressive Disease	NA	NA	1	282	1	282	NA	NA	1	177	
80	TCGA-50-5931	1	17	1	13	9	1	1	0	9	236	18	1	2	79	10	0	TCGA-50-5931-01	219	0.7348834511969051	133	TCGA-50-5931-01	12	13	40	0.23670488994562736	TCGA-50-5931-01	9	2	7	18	PASS	5941	TCGA-50-5931	LUAD	75	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2001	NA	-27733	Dead	WITH TUMOR	NA	434	NA	Distant Metastasis	NA	NA	425	Progressive Disease	NA	NA	1	434	1	434	NA	NA	1	425	
80	TCGA-50-5932	0	3	0	2	4	0	0	0	3	57	5	0	4	17	3	0	TCGA-50-5932-01	175	0.9471979617626302	100	TCGA-50-5932-01	11	11	36	0.3003983997880239	TCGA-50-5932-01	10	7	8	25	PASS	5942	TCGA-50-5932	LUAD	75	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2001	NA	-27454	Dead	WITH TUMOR	1091	1235	NA	Locoregional Recurrence	NA	NA	1090	Progressive Disease	NA	NA	1	1235	1	1235	NA	NA	1	1090	
70	TCGA-50-5933	2	16	2	11	12	5	1	0	19	429	27	0	9	144	9	1	TCGA-50-5933-01	146	0.492472980747438	70	TCGA-50-5933-01	24	45	23	0.1198746539381912	TCGA-50-5933-01	12	7	6	25	PASS	5943	TCGA-50-5933	LUAD	72	MALE	WHITE	Stage IIIB	NA	Lung Adenocarcinoma	NA	2001	NA	-26377	Dead	TUMOR FREE	2370	2393	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2393	0	2393	0	2393	0	2393	
90	TCGA-50-5935	0	2	0	2	1	0	0	0	3	81	3	0	3	25	5	0	TCGA-50-5935-01	140	0.5026409604664696	79	TCGA-50-5935-01	21	37	26	0.15589405726564273	TCGA-50-5935-01	8	3	2	13	PASS	5944	TCGA-50-5935	LUAD	86	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2006	NA	-31610	Dead	TUMOR FREE	653	653	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	653	0	653	0	653	0	653	
60	TCGA-50-5936	0	8	0	2	1	2	0	0	3	95	8	0	1	31	0	0	TCGA-50-5936-01	171	0.8024043809967348	106	TCGA-50-5936-01	14	13	51	0.3761568412078245	TCGA-50-5936-01	8	8	11	27	PASS	5945	TCGA-50-5936	LUAD	58	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2007	NA	-21238	Dead	WITH TUMOR	NA	257	NA	NA	NA	NA	150	Progressive Disease	NA	NA	1	257	1	257	NA	NA	1	150	
90	TCGA-50-5939	0	5	0	4	1	1	2	0	6	63	6	0	3	18	1	0	TCGA-50-5939-01	119	0.2383534332612751	59	TCGA-50-5939-01	7	11	30	0.28179671857474625	TCGA-50-5939-01	12	10	13	35	PASS	5946	TCGA-50-5939	LUAD	85	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2008	NA	-31236	Dead	TUMOR FREE	NA	460	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	460	0	460	0	460	0	460	
60	TCGA-50-5941	2	24	2	8	12	3	0	0	15	314	23	0	3	105	11	0	TCGA-50-5941-01	164	0.5345951729440269	94	TCGA-50-5941-01	32	32	12	0.11650076825852575	TCGA-50-5941-01	15	10	4	29	PASS	5947	TCGA-50-5941	LUAD	55	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2010	NA	-20350	Alive	TUMOR FREE	1474	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1474	0	1474	0	1474	0	1474	
70	TCGA-50-5942	0	1	0	0	1	1	0	0	2	49	5	0	0	13	3	0	TCGA-50-5942-01	65	0.04833119899707339	21	TCGA-50-5942-01	2	2	3	0.05098433396508011	TCGA-50-5942-01	2	0	2	4	PASS	5948	TCGA-50-5942	LUAD	67	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2009	NA	-24781	Alive	WITH TUMOR	1847	NA	NA	Locoregional Recurrence	NA	NA	1378	Stable Disease	NA	NA	0	1847	0	1847	NA	NA	1	1378	
70	TCGA-50-5944	0	3	0	3	1	0	0	0	4	47	5	0	4	20	0	0	TCGA-50-5944-01	315	0.6180059200967815	185	TCGA-50-5944-01	17	27	54	0.08133783574354779	TCGA-50-5944-01	13	8	2	23	PASS	5949	TCGA-50-5944	LUAD	69	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-25440	Alive	TUMOR FREE	1750	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1750	0	1750	0	1750	0	1750	
60	TCGA-50-5946	3	67	9	36	32	5	8	0	22	1010	72	0	18	394	43	4	TCGA-50-5946-01	138	0.8916844925487231	65	TCGA-50-5946-02	20	41	47	0.2712567410783663	TCGA-50-5946-02	17	15	8	40	mutation call filter	5950	TCGA-50-5946	LUAD	62	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-22852	Alive	WITH TUMOR	1617	NA	NA	Distant Metastasis	NA	NA	221	Progressive Disease	NA	NA	0	1617	0	1617	NA	NA	1	221	
70	TCGA-50-6590	1	30	5	13	18	5	1	0	25	724	49	1	22	235	21	0	TCGA-50-6590-01	124	0.3657935751465143	65	TCGA-50-6590-01	19	33	34	0.4926628051801429	TCGA-50-6590-01	11	9	7	27	pathology review	5951	TCGA-50-6590	LUAD	72	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2005	NA	-26444	Dead	TUMOR FREE	NA	1288	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1288	0	1288	0	1288	0	1288	
60	TCGA-50-6591	0	5	0	0	1	2	2	1	0	47	1	0	0	15	2	0	TCGA-50-6591-01	317	0.8124277671944224	207	TCGA-50-6591-01	28	58	56	0.31447460623503953	TCGA-50-6591-01	14	8	7	29	pathology review	5952	TCGA-50-6591	LUAD	63	FEMALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2007	NA	-23067	Dead	WITH TUMOR	NA	119	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	119	1	119	NA	NA	1	119	
70	TCGA-50-6592	1	16	1	8	7	2	1	0	4	225	20	0	7	74	7	1	TCGA-50-6592-01	175	0.3979155641859026	82	TCGA-50-6592-01	14	33	49	0.5498816138459363	TCGA-50-6592-01	12	12	9	33	pathology review	5953	TCGA-50-6592	LUAD	71	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2007	NA	-26191	Dead	WITH TUMOR	NA	777	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	777	1	777	NA	NA	1	777	
50	TCGA-50-6593	1	9	0	8	5	1	0	0	4	244	23	0	4	91	8	0	TCGA-50-6593-01	126	0.795681692387923	74	TCGA-50-6593-01	29	36	31	0.2701734334870174	TCGA-50-6593-01	13	8	7	28	PASS	5954	TCGA-50-6593	LUAD	49	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2008	NA	-18152	Dead	WITH TUMOR	NA	336	NA	Distant Metastasis	NA	NA	266	Progressive Disease	NA	NA	1	336	1	336	NA	NA	1	266	
80	TCGA-50-6594	2	27	3	11	20	5	0	1	19	394	46	1	6	127	15	0	TCGA-50-6594-01	310	0.9595323456107367	202	TCGA-50-6594-01	17	27	76	0.3196596179787127	TCGA-50-6594-01	20	12	15	47	pathology review	5955	TCGA-50-6594	LUAD	79	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Lung Adenocarcinoma	NA	2009	NA	-28924	Dead	WITH TUMOR	NA	370	NA	Distant Metastasis	NA	NA	285	Progressive Disease	NA	NA	1	370	1	370	NA	NA	1	285	
70	TCGA-50-6595	0	2	0	1	2	0	0	0	4	84	6	0	0	24	2	0	TCGA-50-6595-01	67	0.07364235687580999	22	TCGA-50-6595-01	12	35	13	0.37521902983433997	TCGA-50-6595-01	5	3	4	12	PASS	5956	TCGA-50-6595	LUAD	74	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2009	NA	-27197	Dead	WITH TUMOR	NA	189	NA	Distant Metastasis	NA	NA	182	Progressive Disease	NA	NA	1	189	1	189	NA	NA	1	182	
80	TCGA-50-6597	0	6	1	3	0	0	0	0	4	42	6	0	1	14	4	0	TCGA-50-6597-01	301	0.7283956917878682	202	TCGA-50-6597-01	15	23	27	0.1880592944840699	TCGA-50-6597-01	8	6	8	22	PASS	5957	TCGA-50-6597	LUAD	79	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2007	NA	-29195	Dead	TUMOR FREE	NA	1268	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	1268	0	1268	NA	NA	0	1268	
80	TCGA-50-6673	0	4	0	3	4	2	1	1	7	68	6	1	0	22	0	0	TCGA-50-6673-01	197	0.4971195270174661	105	TCGA-50-6673-01	18	17	36	0.12599584655030907	TCGA-50-6673-01	8	4	4	16	PASS	5958	TCGA-50-6673	LUAD	84	FEMALE	WHITE	Stage I	NA	Lung Adenocarcinoma	NA	2004	NA	-30689	Dead	NA	NA	22	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	22	NA	22	NA	NA	0	22	
60	TCGA-50-7109	1	11	0	7	5	3	0	0	8	206	16	0	2	64	5	1	TCGA-50-7109-01	245	0.6236290766200513	153	TCGA-50-7109-01	21	38	44	0.19092910197153665	TCGA-50-7109-01	14	13	3	30	PASS	5959	TCGA-50-7109	LUAD	60	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-21979	Dead	WITH TUMOR	NA	308	NA	Distant Metastasis	NA	NA	15	Progressive Disease	NA	NA	1	308	1	308	NA	NA	1	15	
60	TCGA-50-8457	0	3	0	2	0	2	1	0	1	41	7	0	0	13	2	0	TCGA-50-8457-01	42	0.18927433491954776	5	TCGA-50-8457-01	3	5	13	0.04937307961661132	TCGA-50-8457-01	4	2	3	9	PASS	5960	TCGA-50-8457	LUAD	63	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-23055	Alive	TUMOR FREE	1125	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1125	0	1125	0	1125	0	1125	
70	TCGA-50-8459	2	10	0	2	3	1	0	0	3	65	6	0	1	30	1	0	TCGA-50-8459-01	52	0.049622277463880315	12	TCGA-50-8459-01	4	3	28	0.11909328350875532	TCGA-50-8459-01	1	3	3	7	PASS	5961	TCGA-50-8459	LUAD	68	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2012	NA	-24859	Alive	WITH TUMOR	1119	NA	NA	Locoregional Recurrence	NA	NA	432	Progressive Disease	NA	NA	0	1119	0	1119	NA	NA	1	432	
70	TCGA-50-8460	1	2	1	0	0	1	0	1	0	26	2	0	0	5	0	0	TCGA-50-8460-01	81	0.20047644124329328	40	TCGA-50-8460-01	8	6	28	0.142927971368199	TCGA-50-8460-01	4	3	1	8	PASS	5962	TCGA-50-8460	LUAD	74	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-27270	Alive	TUMOR FREE	829	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	829	0	829	0	829	0	829	
40	TCGA-53-7624	5	41	2	14	16	7	1	0	23	641	46	1	18	222	19	1	TCGA-53-7624-01	427	0.7124525983503351	275	TCGA-53-7624-01	18	29	92	0.39655519580565984	TCGA-53-7624-01	24	25	17	66	pathology review	5963	TCGA-53-7624	LUAD	40	FEMALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2008	NA	-14794	Dead	WITH TUMOR	NA	1043	NA	Distant Metastasis	NA	NA	400	Progressive Disease	NA	NA	1	1043	1	1043	NA	NA	1	400	
80	TCGA-53-7626	4	55	8	22	7	2	0	0	30	868	114	0	15	346	43	3	TCGA-53-7626-01	99	0.4120080541253013	45	TCGA-53-7626-01	10	11	26	0.305206797728185	TCGA-53-7626-01	12	6	8	26	PASS	5964	TCGA-53-7626	LUAD	76	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2008	NA	-28024	Dead	WITH TUMOR	NA	929	NA	Locoregional Recurrence	NA	NA	865	Progressive Disease	NA	NA	1	929	1	929	NA	NA	1	865	
50	TCGA-53-7813	0	10	1	3	6	3	0	0	7	112	13	0	3	30	8	1	TCGA-53-7813-01	104	0.5076226912621399	43	TCGA-53-7813-01	20	24	14	0.1256781525647802	TCGA-53-7813-01	9	10	5	24	PASS	5965	TCGA-53-7813	LUAD	51	FEMALE	WHITE	Stage IIIB	NA	Lung Adenocarcinoma	NA	2008	NA	-18875	Alive	TUMOR FREE	424	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	424	0	424	NA	NA	0	424	
60	TCGA-53-A4EZ	0	40	3	16	6	5	1	0	23	385	29	0	12	153	18	1	TCGA-53-A4EZ-01	182	0.7101601600367787	109	TCGA-53-A4EZ-01	23	31	126	0.4017071866051724	TCGA-53-A4EZ-01	18	9	17	44	PASS	5966	TCGA-53-A4EZ	LUAD	63	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2012	NA	-23201	Alive	TUMOR FREE	1071	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1071	0	1071	NA	NA	0	1071	
70	TCGA-55-1592	7	26	3	21	8	3	1	0	20	440	26	0	10	143	7	0	TCGA-55-1592-01	272	0.7726030748565667	155	TCGA-55-1592-01	22	28	31	0.2279607746785308	TCGA-55-1592-01	16	19	8	43	PASS	5967	TCGA-55-1592	LUAD	65	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2005	NA	NA	Dead	WITH TUMOR	NA	701	NA	NA	NA	NA	452	Complete Remission/Response	NA	NA	1	701	1	701	1	452	1	452	
70	TCGA-55-1594	1	11	1	2	2	2	1	0	6	146	10	0	2	58	4	0	TCGA-55-1594-01	181	0.6569207428501765	100	TCGA-55-1594-01	23	30	43	0.3136011512360176	TCGA-55-1594-01	16	7	10	33	PASS	5968	TCGA-55-1594	LUAD	68	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2005	NA	-25008	Alive	TUMOR FREE	1178	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1178	0	1178	NA	NA	0	1178	
70	TCGA-55-1595	2	19	1	6	5	3	0	0	11	252	25	0	4	97	9	0	TCGA-55-1595-01	295	0.7808218147676158	199	TCGA-55-1595-01	25	35	20	0.12326914679767978	TCGA-55-1595-01	15	16	3	34	PASS	5969	TCGA-55-1595	LUAD	74	FEMALE	ASIAN	Stage IA	NA	Lung Adenocarcinoma	NA	2004	NA	NA	Alive	TUMOR FREE	1479	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1479	0	1479	0	1479	0	1479	
60	TCGA-55-1596	1	5	2	8	4	1	0	0	9	148	14	1	5	40	3	0	TCGA-55-1596-01	134	0.7975147738975427	63	TCGA-55-1596-01	28	22	23	0.3436731930918655	TCGA-55-1596-01	12	6	6	24	PASS	5970	TCGA-55-1596	LUAD	55	MALE	ASIAN	Stage IIB	NA	Lung Adenocarcinoma	NA	2004	NA	-20381	Alive	TUMOR FREE	2065	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2065	0	2065	0	2065	0	2065	
60	TCGA-55-5899	0	14	1	10	6	2	1	0	12	340	25	0	10	126	12	2	TCGA-55-5899-01	348	0.809169908369756	232	TCGA-55-5899-01	19	32	76	0.3526239956999466	TCGA-55-5899-01	19	10	16	45	pathology review	5971	TCGA-55-5899	LUAD	58	MALE	WHITE	[Discrepancy]	NA	Lung Adenocarcinoma	NA	2010	NA	NA	Alive	TUMOR FREE	930	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	930	0	930	0	930	0	930	
60	TCGA-55-6543	0	0	0	0	2	0	0	0	1	19	2	0	0	4	0	0	TCGA-55-6543-01	70	0.3564153722588737	30	TCGA-55-6543-01	10	18	16	0.21541939534020912	TCGA-55-6543-01	2	1	1	4	PASS	5972	TCGA-55-6543	LUAD	60	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	NA	Alive	TUMOR FREE	435	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	435	0	435	0	435	0	435	
60	TCGA-55-6642	0	3	2	5	5	0	0	0	3	100	10	0	5	38	5	1	TCGA-55-6642-01	98	0.3983225271969417	40	TCGA-55-6642-01	15	35	11	0.17582534488831367	TCGA-55-6642-01	13	14	7	34	PASS	5973	TCGA-55-6642	LUAD	63	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2006	NA	-23107	Alive	TUMOR FREE	2449	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2449	0	2449	0	2449	0	2449	
70	TCGA-55-6712	2	9	2	5	5	1	1	0	7	101	13	0	2	59	7	0	TCGA-55-6712-01	137	0.4403222791435988	68	TCGA-55-6712-01	21	28	21	0.1743404239428442	TCGA-55-6712-01	10	11	6	27	PASS	5974	TCGA-55-6712	LUAD	71	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2010	NA	NA	Dead	WITH TUMOR	NA	171	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	171	1	171	NA	NA	1	171	
60	TCGA-55-6968	2	18	6	19	10	1	0	0	23	400	35	0	6	153	10	1	TCGA-55-6968-01	233	0.9067517177246814	145	TCGA-55-6968-01	12	16	71	0.3789225766153484	TCGA-55-6968-01	13	11	10	34	pathology review	5975	TCGA-55-6968	LUAD	61	MALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2004	NA	-22344	Dead	WITH TUMOR	NA	1293	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	1293	1	1293	NA	NA	1	1293	
50	TCGA-55-6969	1	17	0	14	9	6	0	0	10	371	30	0	11	143	11	0	TCGA-55-6969-01	148	0.2718589662445579	71	TCGA-55-6969-01	24	39	24	0.34830676438618025	TCGA-55-6969-01	13	15	10	38	pathology review	5976	TCGA-55-6969	LUAD	52	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2004	NA	-19270	Alive	TUMOR FREE	1239	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1239	0	1239	NA	NA	0	1239	
70	TCGA-55-6970	1	7	0	2	3	1	0	0	4	143	16	0	1	38	11	0	TCGA-55-6970-01	124	0.8344052630020559	62	TCGA-55-6970-01	13	18	27	0.6949313752497931	TCGA-55-6970-01	7	4	5	16	PASS	5977	TCGA-55-6970	LUAD	67	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2004	NA	-24773	Dead	WITH TUMOR	NA	464	NA	Locoregional Recurrence	NA	NA	457	Stable Disease	NA	NA	1	464	1	464	NA	NA	1	457	
60	TCGA-55-6971	2	8	1	11	3	0	0	0	7	173	20	0	5	65	5	0	TCGA-55-6971-01	153	0.4566986169761944	76	TCGA-55-6971-01	22	28	15	0.11287245069950436	TCGA-55-6971-01	7	8	3	18	PASS	5978	TCGA-55-6971	LUAD	59	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2010	NA	-21734	Alive	TUMOR FREE	1400	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1400	0	1400	0	1400	0	1400	
70	TCGA-55-6972	1	8	2	6	6	2	1	0	10	224	19	0	6	88	7	1	TCGA-55-6972-01	155	0.5887911094620455	88	TCGA-55-6972-01	18	18	14	0.12187631423279773	TCGA-55-6972-01	8	7	6	21	PASS	5979	TCGA-55-6972	LUAD	72	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2005	NA	-26625	Dead	TUMOR FREE	NA	1632	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1632	0	1632	0	1632	0	1632	
60	TCGA-55-6975	0	5	0	1	4	2	0	0	5	69	6	0	2	18	2	0	TCGA-55-6975-01	137	0.5650434225983431	79	TCGA-55-6975-01	13	10	36	0.3257683114093033	TCGA-55-6975-01	8	6	10	24	PASS	5980	TCGA-55-6975	LUAD	61	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2004	NA	NA	Dead	WITH TUMOR	NA	118	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	118	1	118	NA	NA	1	118	
80	TCGA-55-6978	0	5	0	3	2	0	0	0	3	45	5	0	1	16	1	0	TCGA-55-6978-01	81	0.10192086958194513	32	TCGA-55-6978-01	4	12	14	0.22000236503023587	TCGA-55-6978-01	5	2	2	9	PASS	5981	TCGA-55-6978	LUAD	81	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2010	NA	NA	Dead	WITH TUMOR	NA	176	NA	NA	NA	NA	42	Progressive Disease	NA	NA	1	176	1	176	NA	NA	1	42	
60	TCGA-55-6979	2	25	1	17	4	0	0	0	27	469	34	0	9	173	15	0	TCGA-55-6979-01	93	0.2946602365735532	43	TCGA-55-6979-01	13	10	20	0.3724717027995552	TCGA-55-6979-01	4	4	3	11	PASS	5982	TCGA-55-6979	LUAD	59	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2006	NA	-21780	Dead	WITH TUMOR	NA	237	NA	Distant Metastasis	NA	NA	195	Progressive Disease	NA	NA	1	237	1	237	NA	NA	1	195	
60	TCGA-55-6980	0	1	0	1	1	1	1	0	1	26	1	0	0	8	0	0	TCGA-55-6980-01	61	0.4171551654862292	19	TCGA-55-6980-01	15	16	17	0.2509312697345057	TCGA-55-6980-01	4	1	2	7	PASS	5983	TCGA-55-6980	LUAD	56	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2006	NA	NA	Alive	TUMOR FREE	2109	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2109	0	2109	0	2109	0	2109	
50	TCGA-55-6981	3	13	1	7	2	0	1	0	7	180	11	0	4	70	4	0	TCGA-55-6981-01	120	0.448060640031808	66	TCGA-55-6981-01	24	30	17	0.19058574794440306	TCGA-55-6981-01	10	7	4	21	PASS	5984	TCGA-55-6981	LUAD	53	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2005	NA	-19497	Dead	TUMOR FREE	NA	1379	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1379	0	1379	0	1379	0	1379	
80	TCGA-55-6982	0	8	0	6	4	1	0	1	14	188	11	0	3	73	2	0	TCGA-55-6982-01	127	0.4468192107456656	79	TCGA-55-6982-01	22	34	29	0.20189049385529947	TCGA-55-6982-01	6	4	9	19	PASS	5985	TCGA-55-6982	LUAD	79	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2004	NA	NA	Dead	WITH TUMOR	NA	995	NA	Distant Metastasis	NA	NA	183	Progressive Disease	NA	NA	1	995	1	995	NA	NA	1	183	
80	TCGA-55-6983	0	4	1	5	5	0	0	0	2	89	9	0	1	27	2	0	TCGA-55-6983-01	55	0.34625982843554937	17	TCGA-55-6983-01	6	7	7	0.1075397233603916	TCGA-55-6983-01	1	1	0	2	PASS	5986	TCGA-55-6983	LUAD	81	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2005	NA	NA	Alive	TUMOR FREE	2823	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2823	0	2823	0	2823	0	2823	
70	TCGA-55-6984	0	1	0	0	2	0	0	0	0	26	2	0	2	18	2	0	TCGA-55-6984-01	109	0.16088386723706416	45	TCGA-55-6984-01	6	7	13	0.05708494866489374	TCGA-55-6984-01	7	2	3	12	PASS	5987	TCGA-55-6984	LUAD	71	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2006	NA	NA	Dead	WITH TUMOR	NA	760	NA	NA	NA	NA	724	Complete Remission/Response	NA	NA	1	760	1	760	1	724	1	724	
60	TCGA-55-6985	2	20	4	17	8	2	0	0	15	379	28	0	8	130	15	0	TCGA-55-6985-01	99	0.4374391969882662	46	TCGA-55-6985-01	13	14	31	0.3084688888855129	TCGA-55-6985-01	8	9	7	24	PASS	5988	TCGA-55-6985	LUAD	58	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2004	NA	-21381	Alive	TUMOR FREE	1233	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1233	0	1233	0	1233	0	1233	
70	TCGA-55-6986	0	2	0	0	1	1	0	0	0	19	1	0	0	11	0	0	TCGA-55-6986-01	59	0.04099407555554768	13	TCGA-55-6986-01	0	1	4	0.043170314968246436	TCGA-55-6986-01	2	4	3	9	PASS	5989	TCGA-55-6986	LUAD	74	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2004	NA	NA	Alive	TUMOR FREE	3261	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3261	0	3261	0	3261	0	3261	
80	TCGA-55-6987	1	6	0	5	3	0	0	0	9	183	23	0	1	62	2	0	TCGA-55-6987-01	125	0.18282786004716592	71	TCGA-55-6987-01	7	32	23	0.5795169816281046	TCGA-55-6987-01	5	7	5	17	pathology review	5990	TCGA-55-6987	LUAD	77	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2006	NA	-28382	Alive	TUMOR FREE	2137	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2137	0	2137	0	2137	0	2137	
80	TCGA-55-7227	2	7	0	2	3	1	1	0	5	129	8	1	2	50	3	1	TCGA-55-7227	0	0	0	TCGA-55-7227	0	0	0	0	TCGA-55-7227	0	0	0	0	PASS	5991	TCGA-55-7227	LUAD	77	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2011	NA	-28458	Dead	WITH TUMOR	NA	952	NA	Locoregional Recurrence	NA	NA	255	Complete Remission/Response	NA	NA	1	952	1	952	1	255	1	255	
70	TCGA-55-7281	3	60	2	24	28	10	2	0	12	745	61	0	12	234	13	2	TCGA-55-7281-01	73	0.5188604228276648	27	TCGA-55-7281-01	18	25	22	0.215291549794944	TCGA-55-7281-01	6	1	5	12	PASS	5992	TCGA-55-7281	LUAD	70	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-25870	Alive	WITH TUMOR	872	NA	NA	Distant Metastasis	NA	NA	339	Complete Remission/Response	NA	NA	0	872	0	872	1	339	1	339	
80	TCGA-55-7283	2	25	4	16	7	0	0	0	18	359	40	0	8	118	10	0	TCGA-55-7283-01	177	0.6431037711032261	105	TCGA-55-7283-01	18	68	12	0.09337689460036296	TCGA-55-7283-01	10	10	3	23	PASS	5993	TCGA-55-7283	LUAD	76	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2011	NA	-27946	Alive	WITH TUMOR	609	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	609	0	609	NA	NA	0	609	
70	TCGA-55-7284	0	2	0	0	1	0	0	0	0	36	3	0	0	16	0	0	TCGA-55-7284-01	54	0.2404536506013911	14	TCGA-55-7284-01	10	7	4	0.016304681395655628	TCGA-55-7284-01	5	4	2	11	PASS	5994	TCGA-55-7284	LUAD	74	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2011	NA	-27087	Dead	WITH TUMOR	NA	243	NA	Distant Metastasis	NA	NA	231	Complete Remission/Response	NA	NA	1	243	1	243	1	231	1	231	
60	TCGA-55-7570	2	38	4	18	24	8	0	2	24	601	46	0	20	195	16	0	TCGA-55-7570-01	131	0.6034636434378357	62	TCGA-55-7570-01	10	13	34	0.3125018106947929	TCGA-55-7570-01	12	3	9	24	pathology review	5995	TCGA-55-7570	LUAD	60	MALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-22218	Alive	TUMOR FREE	824	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	824	0	824	0	824	0	824	
70	TCGA-55-7573	0	5	0	1	3	1	1	0	1	41	3	0	1	12	1	0	TCGA-55-7573-01	181	0.5872668785492879	98	TCGA-55-7573-01	16	31	22	0.3260076165236864	TCGA-55-7573-01	13	9	7	29	PASS	5996	TCGA-55-7573	LUAD	72	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-26302	Alive	TUMOR FREE	487	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	487	0	487	0	487	0	487	
60	TCGA-55-7574	2	13	2	12	6	0	2	0	13	434	40	0	4	135	4	2	TCGA-55-7574-01	136	0.1186247129040453	84	TCGA-55-7574-01	11	36	31	0.3612173113712713	TCGA-55-7574-01	5	2	8	15	PASS	5997	TCGA-55-7574	LUAD	64	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-23703	Dead	WITH TUMOR	NA	995	NA	Distant Metastasis	NA	NA	478	Complete Remission/Response	NA	NA	1	995	1	995	1	478	1	478	
50	TCGA-55-7576	6	32	2	17	14	4	2	0	34	639	45	0	14	221	14	2	TCGA-55-7576-01	274	0.7972003420235906	182	TCGA-55-7576-01	19	35	61	0.3445310942438145	TCGA-55-7576-01	22	21	10	53	PASS	5998	TCGA-55-7576	LUAD	54	MALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-19917	Alive	TUMOR FREE	670	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	670	0	670	0	670	0	670	
80	TCGA-55-7724	1	5	0	9	2	1	1	0	5	185	21	0	1	55	4	0	TCGA-55-7724-01	45	0.33881017106929245	5	TCGA-55-7724-01	11	10	13	0.31959355305708925	TCGA-55-7724-01	6	5	5	16	PASS	5999	TCGA-55-7724	LUAD	76	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-27891	Alive	TUMOR FREE	705	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	705	0	705	0	705	0	705	
70	TCGA-55-7725	0	3	1	4	7	3	0	0	2	92	8	0	1	41	4	0	TCGA-55-7725-01	100	0.13877940556697718	57	TCGA-55-7725-01	6	6	10	0.07077441469523288	TCGA-55-7725-01	7	4	4	15	PASS	6000	TCGA-55-7725	LUAD	68	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-24848	Alive	TUMOR FREE	442	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	442	0	442	0	442	0	442	
70	TCGA-55-7726	0	5	0	2	2	0	1	0	2	91	10	1	1	28	3	0	TCGA-55-7726-01	95	0.5453607106128506	37	TCGA-55-7726-01	23	62	34	0.30021399682877875	TCGA-55-7726-01	14	3	7	24	PASS	6001	TCGA-55-7726	LUAD	72	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-26451	Alive	TUMOR FREE	652	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	652	0	652	0	652	0	652	
70	TCGA-55-7727	1	5	1	6	4	0	0	0	5	195	13	0	8	78	5	1	TCGA-55-7727-01	122	0.3570165130442749	58	TCGA-55-7727-01	12	13	30	0.2434500533986027	TCGA-55-7727-01	8	9	7	24	PASS	6002	TCGA-55-7727	LUAD	70	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2011	NA	-25929	Alive	TUMOR FREE	119	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	119	0	119	0	119	0	119	
60	TCGA-55-7728	0	5	0	3	1	0	0	0	6	74	7	0	3	21	3	1	TCGA-55-7728-01	81	0.0596101107493968	34	TCGA-55-7728-01	1	2	12	0.04280629617336437	TCGA-55-7728-01	3	4	4	11	PASS	6003	TCGA-55-7728	LUAD	64	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-23505	Alive	TUMOR FREE	704	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	704	0	704	0	704	0	704	
80	TCGA-55-7815	1	6	0	6	1	0	1	0	5	113	6	0	3	42	3	0	TCGA-55-7815-01	83	0.2818558653342841	36	TCGA-55-7815-01	25	22	12	0.1086069549070638	TCGA-55-7815-01	9	10	4	23	PASS	6004	TCGA-55-7815	LUAD	76	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-28119	Alive	WITH TUMOR	773	NA	NA	Locoregional Recurrence	NA	NA	466	Complete Remission/Response	NA	NA	0	773	0	773	1	466	1	466	
50	TCGA-55-7816	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	TCGA-55-7816	0	0	0	TCGA-55-7816	0	0	0	0	TCGA-55-7816	0	0	0	0	PASS	6005	TCGA-55-7816	LUAD	49	FEMALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2011	NA	-18170	Dead	WITH TUMOR	NA	468	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	468	1	468	NA	NA	1	468	
60	TCGA-55-7903	1	6	0	4	9	1	1	0	5	118	3	0	2	47	4	1	TCGA-55-7903-01	245	0.4289551636255406	138	TCGA-55-7903-01	7	10	47	0.18218854385727776	TCGA-55-7903-01	10	5	8	23	PASS	6006	TCGA-55-7903	LUAD	64	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-23509	Alive	TUMOR FREE	567	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	567	0	567	0	567	0	567	
80	TCGA-55-7907	4	44	6	30	23	6	0	0	38	900	85	0	24	298	33	1	TCGA-55-7907-01	215	0.7034745673772103	119	TCGA-55-7907-01	24	26	48	0.2262523472794509	TCGA-55-7907-01	15	10	7	32	hypermutated sample	6007	TCGA-55-7907	LUAD	77	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-28201	Dead	WITH TUMOR	NA	343	NA	Distant Metastasis	NA	NA	294	Complete Remission/Response	NA	NA	1	343	1	343	1	294	1	294	
50	TCGA-55-7910	1	9	2	3	6	1	0	0	4	249	21	0	3	69	9	0	TCGA-55-7910-01	263	0.7699270975032704	165	TCGA-55-7910-01	20	26	75	0.2198506719731836	TCGA-55-7910-01	16	17	9	42	pathology review	6008	TCGA-55-7910	LUAD	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-18289	Alive	WITH TUMOR	1040	NA	NA	NA	NA	NA	1018	Complete Remission/Response	NA	NA	0	1040	0	1040	1	1018	1	1018	
70	TCGA-55-7911	0	4	3	6	4	2	1	0	5	179	12	0	6	62	7	0	TCGA-55-7911-01	92	0.43098459721511856	44	TCGA-55-7911-01	14	17	8	0.056378287406838964	TCGA-55-7911-01	7	3	2	12	PASS	6009	TCGA-55-7911	LUAD	70	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-25746	Alive	TUMOR FREE	537	NA	NA	New Primary Tumor	NA	NA	515	Complete Remission/Response	NA	NA	0	537	0	537	0	537	1	515	
60	TCGA-55-7913	1	16	1	11	7	1	0	0	11	271	19	0	8	94	5	0	TCGA-55-7913-01	136	0.5387080213058925	66	TCGA-55-7913-01	19	38	14	0.26471974971109197	TCGA-55-7913-01	11	11	10	32	PASS	6010	TCGA-55-7913	LUAD	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-22326	Dead	WITH TUMOR	NA	561	NA	Distant Metastasis	NA	NA	480	Complete Remission/Response	NA	NA	1	561	1	561	1	480	1	480	
70	TCGA-55-7914	0	4	2	2	5	2	0	0	2	144	7	0	2	48	2	1	TCGA-55-7914-01	104	0.3852270941393227	42	TCGA-55-7914-01	9	10	26	0.1955741617845811	TCGA-55-7914-01	9	8	9	26	PASS	6011	TCGA-55-7914	LUAD	71	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-26105	Dead	WITH TUMOR	NA	187	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	187	1	187	NA	NA	1	187	
80	TCGA-55-7994	6	62	7	41	45	11	3	1	43	1180	98	1	28	403	37	2	TCGA-55-7994-01	320	0.6023254100366857	212	TCGA-55-7994-01	16	35	134	0.4019488436016659	TCGA-55-7994-01	25	14	12	51	pathology review	6012	TCGA-55-7994	LUAD	81	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2011	NA	-29858	Alive	TUMOR FREE	603	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	603	0	603	0	603	0	603	
70	TCGA-55-7995	0	26	2	21	14	2	2	0	24	534	26	2	10	169	15	0	TCGA-55-7995-01	281	0.7259537968204766	188	TCGA-55-7995-01	23	39	115	0.4820085953158227	TCGA-55-7995-01	19	16	15	50	pathology review	6013	TCGA-55-7995	LUAD	73	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-26837	Alive	TUMOR FREE	889	NA	NA	Locoregional Recurrence	NA	NA	468	Complete Remission/Response	NA	NA	0	889	0	889	1	468	1	468	
60	TCGA-55-8085	1	9	1	8	5	0	0	0	11	191	18	0	2	82	7	1	TCGA-55-8085-01	283	0.280172842290479	187	TCGA-55-8085-01	6	9	33	0.10225635748605186	TCGA-55-8085-01	11	8	6	25	PASS	6014	TCGA-55-8085	LUAD	64	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-23596	Alive	TUMOR FREE	904	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	904	0	904	0	904	0	904	
60	TCGA-55-8087	0	1	1	1	1	2	1	0	1	28	1	0	1	6	0	0	TCGA-55-8087-01	89	0.09960660072920954	40	TCGA-55-8087-01	5	4	17	0.055803284708374486	TCGA-55-8087-01	5	2	2	9	PASS	6015	TCGA-55-8087	LUAD	59	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-21655	Alive	TUMOR FREE	462	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	462	0	462	0	462	0	462	
60	TCGA-55-8089	5	57	3	37	11	6	0	0	40	949	77	1	17	347	27	0	TCGA-55-8089-01	125	0.2561681652186928	54	TCGA-55-8089-01	11	17	30	0.35800972262419417	TCGA-55-8089-01	10	7	7	24	hypermutated sample	6016	TCGA-55-8089	LUAD	56	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-20576	Dead	TUMOR FREE	NA	702	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	702	0	702	0	702	0	702	
80	TCGA-55-8090	0	6	1	4	2	0	1	0	2	66	5	0	4	25	3	0	TCGA-55-8090-01	57	0.4345092050540433	14	TCGA-55-8090-01	14	13	10	0.05697613852646567	TCGA-55-8090-01	4	4	1	9	PASS	6017	TCGA-55-8090	LUAD	80	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-29235	Dead	WITH TUMOR	NA	598	NA	Distant Metastasis	NA	NA	548	Complete Remission/Response	NA	NA	1	598	1	598	1	548	1	548	
70	TCGA-55-8091	0	1	0	0	0	0	0	0	1	29	0	0	0	6	0	1	TCGA-55-8091-01	49	0.5050402259222776	11	TCGA-55-8091-01	13	12	14	0.27598972233333	TCGA-55-8091-01	5	4	5	14	PASS	6018	TCGA-55-8091	LUAD	74	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-27385	Alive	TUMOR FREE	600	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	600	0	600	0	600	0	600	
80	TCGA-55-8092	0	30	1	18	13	2	0	0	21	424	30	1	9	182	11	0	TCGA-55-8092-01	143	0.5018228959245981	78	TCGA-55-8092-01	16	73	43	0.317949771020026	TCGA-55-8092-01	18	13	7	38	PASS	6019	TCGA-55-8092	LUAD	75	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2012	NA	-27597	Dead	WITH TUMOR	NA	154	NA	Locoregional Recurrence	NA	NA	127	Complete Remission/Response	NA	NA	1	154	1	154	1	127	1	127	
50	TCGA-55-8094	0	21	2	13	11	5	1	0	12	338	23	0	11	128	16	1	TCGA-55-8094-01	278	0.9661967984712924	169	TCGA-55-8094-01	18	41	44	0.21058391801259066	TCGA-55-8094-01	17	12	8	37	PASS	6020	TCGA-55-8094	LUAD	51	MALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2012	NA	-18903	Alive	WITH TUMOR	541	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	541	0	541	NA	NA	0	541	
70	TCGA-55-8096	0	10	0	1	2	0	1	0	2	114	12	0	1	36	3	0	TCGA-55-8096-01	70	0.3387393070179255	23	TCGA-55-8096-01	24	38	22	0.4631442959021122	TCGA-55-8096-01	10	7	7	24	PASS	6021	TCGA-55-8096	LUAD	67	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-24684	Dead	WITH TUMOR	NA	719	NA	Distant Metastasis	NA	NA	566	Complete Remission/Response	NA	NA	1	719	1	719	1	566	1	566	
60	TCGA-55-8097	0	7	1	3	5	1	0	0	7	87	3	0	3	30	2	0	TCGA-55-8097-01	70	0.24282311263426154	30	TCGA-55-8097-01	6	4	14	0.027998475968849527	TCGA-55-8097-01	3	0	2	5	PASS	6022	TCGA-55-8097	LUAD	60	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-22260	Alive	TUMOR FREE	476	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	476	0	476	0	476	0	476	
70	TCGA-55-8203	1	17	2	10	8	1	0	0	9	344	18	0	12	115	10	1	TCGA-55-8203-01	105	0.5238989341724362	55	TCGA-55-8203-01	20	20	17	0.1212579016673742	TCGA-55-8203-01	7	4	4	15	PASS	6023	TCGA-55-8203	LUAD	69	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-25477	Alive	TUMOR FREE	547	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	547	0	547	0	547	0	547	
90	TCGA-55-8204	1	4	1	7	2	0	0	0	7	168	13	0	5	59	7	0	TCGA-55-8204-01	80	0.3277568840461498	31	TCGA-55-8204-01	10	14	15	0.32389225465540744	TCGA-55-8204-01	9	3	10	22	PASS	6024	TCGA-55-8204	LUAD	87	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-31818	Alive	TUMOR FREE	515	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	515	0	515	0	515	0	515	
80	TCGA-55-8205	2	22	1	13	20	2	2	0	16	396	31	1	6	147	16	1	TCGA-55-8205-01	80	0.3684210089535159	33	TCGA-55-8205-01	22	73	20	0.26020427538062946	TCGA-55-8205-01	9	1	6	16	PASS	6025	TCGA-55-8205	LUAD	76	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2012	NA	-28063	Alive	WITH TUMOR	599	NA	NA	Distant Metastasis	NA	NA	495	Progressive Disease	NA	NA	0	599	0	599	NA	NA	1	495	
60	TCGA-55-8206	0	1	0	1	2	0	1	0	2	22	2	0	1	9	0	0	TCGA-55-8206-01	95	0.5522026969268892	54	TCGA-55-8206-01	20	18	8	0.1329981569874916	TCGA-55-8206-01	2	1	1	4	PASS	6026	TCGA-55-8206	LUAD	56	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-20690	Alive	TUMOR FREE	888	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	888	0	888	0	888	0	888	
70	TCGA-55-8207	0	20	2	9	7	8	1	0	12	242	14	0	1	87	4	0	TCGA-55-8207-01	103	0.4613832770615125	44	TCGA-55-8207-01	15	25	20	0.26915256599931925	TCGA-55-8207-01	10	8	5	23	PASS	6027	TCGA-55-8207	LUAD	73	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-26897	Alive	TUMOR FREE	977	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	977	0	977	0	977	0	977	
70	TCGA-55-8208	2	11	3	7	4	1	0	0	10	279	22	0	0	105	7	0	TCGA-55-8208-01	60	0.06293492052918451	23	TCGA-55-8208-01	9	15	7	0.18601895211403616	TCGA-55-8208-01	6	8	4	18	PASS	6028	TCGA-55-8208	LUAD	73	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-26716	Alive	WITH TUMOR	674	NA	NA	Distant Metastasis	NA	NA	511	Complete Remission/Response	NA	NA	0	674	0	674	1	511	1	511	
60	TCGA-55-8299	2	15	0	12	0	0	0	0	12	326	24	0	8	104	13	0	TCGA-55-8299-01	81	0.0047268674010771065	31	TCGA-55-8299	0	0	0	0	TCGA-55-8299	0	0	0	0	PASS	6029	TCGA-55-8299	LUAD	61	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-22626	Dead	WITH TUMOR	NA	469	NA	Distant Metastasis	NA	NA	274	Complete Remission/Response	NA	NA	1	469	1	469	1	274	1	274	
60	TCGA-55-8301	1	16	0	17	11	4	4	0	9	217	12	0	6	79	11	0	TCGA-55-8301-01	104	0.3364181056567633	51	TCGA-55-8301-01	8	27	27	0.3977996907112849	TCGA-55-8301-01	9	6	7	22	PASS	6030	TCGA-55-8301	LUAD	58	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-21535	Alive	WITH TUMOR	534	NA	NA	Locoregional Recurrence	NA	NA	238	Complete Remission/Response	NA	NA	0	534	0	534	1	238	1	238	
50	TCGA-55-8302	4	35	3	20	15	8	2	0	15	525	43	0	11	177	19	1	TCGA-55-8302-01	74	0.4900735799130558	28	TCGA-55-8302-01	12	17	82	0.42656143676811775	TCGA-55-8302-01	8	5	6	19	PASS	6031	TCGA-55-8302	LUAD	54	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-20011	Alive	TUMOR FREE	478	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	478	0	478	0	478	0	478	
60	TCGA-55-8505	0	3	1	0	0	0	0	0	0	25	3	0	1	15	0	0	TCGA-55-8505-01	76	0.2477318400130968	33	TCGA-55-8505-01	6	8	65	0.24571603066253125	TCGA-55-8505-01	2	6	5	13	PASS	6032	TCGA-55-8505	LUAD	62	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2012	NA	-22676	Alive	TUMOR FREE	440	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	440	0	440	0	440	0	440	
60	TCGA-55-8506	5	73	12	61	87	40	18	0	43	1278	92	1	27	489	49	5	TCGA-55-8506-01	384	0.42755540398723735	271	TCGA-55-8506-01	13	23	106	0.1737271876796771	TCGA-55-8506-01	19	9	9	37	hypermutated sample	6033	TCGA-55-8506	LUAD	62	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2012	NA	-22850	Alive	NA	11	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	11	0	11	NA	NA	0	11	
50	TCGA-55-8507	6	42	4	38	28	3	2	0	27	759	45	1	19	252	29	1	TCGA-55-8507-01	235	0.8546638185514762	140	TCGA-55-8507-01	22	38	119	0.25949643751620965	TCGA-55-8507-01	17	19	10	46	hypermutated sample	6034	TCGA-55-8507	LUAD	53	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-19390	Alive	TUMOR FREE	418	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	418	0	418	0	418	0	418	
60	TCGA-55-8508	2	9	2	7	8	1	0	1	6	134	14	0	3	49	4	0	TCGA-55-8508-01	141	0.5674210072498362	78	TCGA-55-8508-01	13	32	80	0.275975861972978	TCGA-55-8508-01	18	11	7	36	PASS	6035	TCGA-55-8508	LUAD	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Lung Adenocarcinoma	NA	2012	NA	-22159	Alive	TUMOR FREE	617	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	617	0	617	0	617	0	617	
60	TCGA-55-8510	3	17	2	7	8	2	0	0	4	235	16	0	10	93	10	1	TCGA-55-8510-01	77	0.4425034902562066	29	TCGA-55-8510-01	25	31	94	0.42010623846979694	TCGA-55-8510-01	19	11	12	42	PASS	6036	TCGA-55-8510	LUAD	55	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-20410	Alive	TUMOR FREE	539	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	539	0	539	0	539	0	539	
70	TCGA-55-8511	2	27	3	18	17	6	0	0	12	437	36	0	7	159	15	0	TCGA-55-8511-01	220	0.5836925766517269	128	TCGA-55-8511-01	20	29	157	0.3357628152865413	TCGA-55-8511-01	27	22	15	64	PASS	6037	TCGA-55-8511	LUAD	73	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-26986	Alive	WITH TUMOR	552	NA	NA	NA	NA	NA	460	Complete Remission/Response	NA	NA	0	552	0	552	1	460	1	460	
40	TCGA-55-8512	0	3	0	0	2	0	0	0	2	31	1	0	2	13	0	0	TCGA-55-8512-01	81	0.18949252175845732	28	TCGA-55-8512-01	9	7	50	0.17294681781210294	TCGA-55-8512-01	5	3	8	16	PASS	6038	TCGA-55-8512	LUAD	41	MALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2012	NA	-15266	Dead	WITH TUMOR	NA	607	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	607	1	607	NA	NA	1	607	
80	TCGA-55-8513	0	0	0	1	0	0	0	0	2	6	0	0	0	0	0	0	TCGA-55-8513-01	23	0.0	0	TCGA-55-8513-01	0	0	5	0.001009462978722795	TCGA-55-8513-01	0	0	0	0	PASS	6039	TCGA-55-8513	LUAD	77	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2012	NA	-28284	Alive	WITH TUMOR	791	NA	NA	Distant Metastasis	NA	NA	317	Complete Remission/Response	NA	NA	0	791	0	791	1	317	1	317	
70	TCGA-55-8514	0	17	2	11	12	2	0	0	8	205	17	0	9	77	9	0	TCGA-55-8514-01	166	0.8013074423426959	91	TCGA-55-8514-01	26	19	136	0.3755802237271238	TCGA-55-8514-01	17	13	10	40	PASS	6040	TCGA-55-8514	LUAD	70	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-25608	Alive	TUMOR FREE	520	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	520	0	520	0	520	0	520	
80	TCGA-55-8614	1	9	1	8	5	3	1	1	7	177	9	0	6	76	7	0	TCGA-55-8614-01	117	0.5747268158955913	56	TCGA-55-8614-01	23	28	56	0.208142204278892	TCGA-55-8614-01	13	7	10	30	PASS	6041	TCGA-55-8614	LUAD	76	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-27924	Alive	TUMOR FREE	536	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	536	0	536	0	536	0	536	
70	TCGA-55-8615	0	13	1	8	3	0	1	0	4	87	6	0	0	47	2	0	TCGA-55-8615-01	254	0.8246893348878578	171	TCGA-55-8615-01	23	44	92	0.27421062192717666	TCGA-55-8615-01	28	19	9	56	PASS	6042	TCGA-55-8615	LUAD	67	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2012	NA	-24786	Alive	WITH TUMOR	446	NA	NA	Distant Metastasis	NA	NA	224	Complete Remission/Response	NA	NA	0	446	0	446	1	224	1	224	
60	TCGA-55-8616	1	28	0	18	5	7	0	0	17	367	32	0	4	125	16	1	TCGA-55-8616-01	94	0.6375684433372399	38	TCGA-55-8616-01	22	30	88	0.3200333607389245	TCGA-55-8616-01	16	6	9	31	PASS	6043	TCGA-55-8616	LUAD	58	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-21225	Alive	TUMOR FREE	48	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	48	0	48	NA	NA	0	48	
70	TCGA-55-8619	0	2	0	0	0	0	0	0	0	18	1	0	0	5	1	0	TCGA-55-8619-01	43	0.044711972305015016	6	TCGA-55-8619-01	1	4	6	0.00029821120631178	TCGA-55-8619-01	0	3	0	3	PASS	6044	TCGA-55-8619	LUAD	72	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2012	NA	-26616	Alive	TUMOR FREE	416	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	416	0	416	0	416	0	416	
60	TCGA-55-8620	3	24	3	13	16	3	1	0	15	356	35	0	14	137	19	0	TCGA-55-8620-01	238	0.7303740872703135	148	TCGA-55-8620-01	15	38	150	0.30211803983738866	TCGA-55-8620-01	13	10	12	35	PASS	6045	TCGA-55-8620	LUAD	60	MALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2012	NA	-22091	Dead	WITH TUMOR	NA	375	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	375	1	375	NA	NA	1	375	
80	TCGA-55-8621	0	5	0	0	1	0	0	0	0	59	5	0	0	18	3	0	TCGA-55-8621-01	43	0.008661261428977659	9	TCGA-55-8621-01	1	3	21	0.034226821186163305	TCGA-55-8621-01	4	1	3	8	PASS	6046	TCGA-55-8621	LUAD	75	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-27485	Alive	TUMOR FREE	515	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	515	0	515	0	515	0	515	
60	TCGA-55-A48X	3	18	1	7	4	3	1	0	10	311	30	1	4	93	8	0	TCGA-55-A48X-01	53	0.3021368289972644	8	TCGA-55-A48X-01	13	13	47	0.31471246256239943	TCGA-55-A48X-01	7	5	7	19	PASS	6047	TCGA-55-A48X	LUAD	63	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2012	NA	-23341	Alive	TUMOR FREE	689	NA	NA	New Primary Tumor	NA	NA	615	Complete Remission/Response	NA	NA	0	689	0	689	0	689	1	615	
70	TCGA-55-A48Y	1	17	0	12	3	2	0	0	19	272	22	0	2	94	7	0	TCGA-55-A48Y-01	118	0.29244137861641833	53	TCGA-55-A48Y-01	6	8	41	0.16309710863268378	TCGA-55-A48Y-01	11	6	6	23	PASS	6048	TCGA-55-A48Y	LUAD	69	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2012	NA	-25384	Alive	TUMOR FREE	630	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	630	0	630	0	630	0	630	
60	TCGA-55-A48Z	1	2	0	3	1	0	0	0	2	36	3	0	1	17	3	0	TCGA-55-A48Z-01	119	0.6195687110247303	57	TCGA-55-A48Z-01	17	31	71	0.2555941833059835	TCGA-55-A48Z-01	13	9	7	29	PASS	6049	TCGA-55-A48Z	LUAD	60	FEMALE	WHITE	Stage IIIB	NA	Lung Adenocarcinoma	NA	2012	NA	-22056	Alive	WITH TUMOR	651	NA	NA	Distant Metastasis	NA	NA	536	Stable Disease	NA	NA	0	651	0	651	NA	NA	1	536	
80	TCGA-55-A490	7	58	8	43	30	11	2	0	38	1007	87	2	22	346	38	1	TCGA-55-A490-01	300	0.5891892805942319	185	TCGA-55-A490-01	18	41	113	0.27004063672339323	TCGA-55-A490-01	22	19	13	54	hypermutated sample	6050	TCGA-55-A490	LUAD	78	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2012	NA	-28728	Dead	TUMOR FREE	NA	99	NA	NA	NA	NA	NA	NA	NA	NA	1	99	0	99	NA	NA	0	99	
80	TCGA-55-A491	0	20	1	6	6	2	1	0	11	289	25	0	4	103	9	0	TCGA-55-A491-01	106	0.6706864987825973	47	TCGA-55-A491-01	26	34	73	0.3002475096737689	TCGA-55-A491-01	16	12	11	39	PASS	6051	TCGA-55-A491	LUAD	81	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-29593	Alive	TUMOR FREE	626	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	626	0	626	0	626	0	626	
70	TCGA-55-A492	1	9	0	8	15	1	0	0	8	218	16	1	5	89	4	1	TCGA-55-A492-01	74	0.4212735103119524	26	TCGA-55-A492-01	12	12	16	0.05544246896280056	TCGA-55-A492-01	5	5	1	11	PASS	6052	TCGA-55-A492	LUAD	70	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-25719	Alive	TUMOR FREE	596	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	596	0	596	0	596	0	596	
50	TCGA-55-A493	1	12	1	7	7	0	0	0	4	204	16	0	5	84	6	0	TCGA-55-A493-01	82	0.3562553367439821	34	TCGA-55-A493-01	16	20	77	0.41938519629041576	TCGA-55-A493-01	8	9	6	23	PASS	6053	TCGA-55-A493	LUAD	54	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-20027	Alive	TUMOR FREE	28	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	28	0	28	NA	NA	0	28	
60	TCGA-55-A494	1	15	2	6	5	0	1	0	10	183	13	1	7	59	5	1	TCGA-55-A494-01	104	0.91178549693892	51	TCGA-55-A494-01	28	30	22	0.06733819636836222	TCGA-55-A494-01	8	11	3	22	PASS	6054	TCGA-55-A494	LUAD	61	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-22540	Alive	TUMOR FREE	481	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	481	0	481	0	481	0	481	
90	TCGA-55-A4DF	3	31	2	25	5	1	0	0	32	576	60	1	13	220	22	0	TCGA-55-A4DF-01	132	0.497624646695075	70	TCGA-55-A4DF-01	13	38	77	0.4968916663166236	TCGA-55-A4DF-01	20	14	10	44	PASS	6055	TCGA-55-A4DF	LUAD	88	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-32432	Dead	WITH TUMOR	NA	614	NA	Distant Metastasis	NA	NA	515	Complete Remission/Response	NA	NA	1	614	1	614	1	515	1	515	
70	TCGA-55-A4DG	3	42	2	20	23	4	1	0	18	536	45	0	10	160	14	2	TCGA-55-A4DG-01	128	0.8429775021121801	64	TCGA-55-A4DG-01	22	70	95	0.2656285457708189	TCGA-55-A4DG-01	17	10	11	38	PASS	6056	TCGA-55-A4DG	LUAD	71	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-26044	Alive	TUMOR FREE	608	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	608	0	608	0	608	0	608	
80	TCGA-55-A57B	0	1	1	3	2	0	1	0	1	34	2	0	1	6	0	0	TCGA-55-A57B-01	105	0.5877645304166812	45	TCGA-55-A57B-01	21	23	129	0.603041511634734	TCGA-55-A57B-01	5	8	8	21	PASS	6057	TCGA-55-A57B	LUAD	80	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-29452	Alive	TUMOR FREE	546	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	546	0	546	0	546	0	546	
70	TCGA-62-8394	1	9	4	4	3	0	0	0	3	106	7	0	1	39	1	0	TCGA-62-8394-01	132	0.6620173601288817	67	TCGA-62-8394-01	17	31	56	0.2695504916443223	TCGA-62-8394-01	15	12	3	30	PASS	6058	TCGA-62-8394	LUAD	65	FEMALE	WHITE	Stage IIIB	NA	Lung Adenocarcinoma	NA	2008	NA	-23758	Dead	TUMOR FREE	NA	139	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	139	0	139	0	139	0	139	
80	TCGA-62-8395	0	2	0	0	5	0	1	0	3	60	6	0	0	19	1	0	TCGA-62-8395-01	119	0.21570804684902292	68	TCGA-62-8395-01	6	8	55	0.16810163246408769	TCGA-62-8395-01	7	7	8	22	PASS	6059	TCGA-62-8395	LUAD	80	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2009	NA	-29311	Alive	WITH TUMOR	1216	NA	NA	Locoregional Recurrence	NA	NA	395	Complete Remission/Response	NA	NA	0	1216	0	1216	1	395	1	395	
70	TCGA-62-8397	0	2	0	0	2	1	1	0	1	18	1	0	1	8	1	0	TCGA-62-8397-01	80	0.8664050932045129	29	TCGA-62-8397-01	23	16	38	0.1315453975914287	TCGA-62-8397-01	4	5	5	14	PASS	6060	TCGA-62-8397	LUAD	70	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2008	NA	-25728	Alive	TUMOR FREE	1289	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1289	0	1289	0	1289	0	1289	
60	TCGA-62-8398	0	3	0	2	2	0	0	0	4	65	5	0	0	24	1	0	TCGA-62-8398-01	149	0.6585783284936401	79	TCGA-62-8398-01	24	24	55	0.20857569729559694	TCGA-62-8398-01	8	6	5	19	PASS	6061	TCGA-62-8398	LUAD	55	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2007	NA	-20197	Dead	TUMOR FREE	NA	444	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	444	0	444	0	444	0	444	
60	TCGA-62-8399	1	27	4	20	6	4	2	0	14	401	35	3	8	140	9	0	TCGA-62-8399-01	78	0.6561835166703093	31	TCGA-62-8399-01	13	32	65	0.4857640973333263	TCGA-62-8399-01	15	13	9	37	PASS	6062	TCGA-62-8399	LUAD	62	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2006	NA	-22952	Alive	TUMOR FREE	2696	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2696	0	2696	0	2696	0	2696	
70	TCGA-62-8402	0	3	1	3	0	0	1	0	3	35	2	1	4	23	0	0	TCGA-62-8402-01	95	0.7687702741003751	43	TCGA-62-8402-01	31	55	104	0.5487253360885002	TCGA-62-8402-01	9	6	4	19	PASS	6063	TCGA-62-8402	LUAD	73	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2008	NA	-26934	Dead	WITH TUMOR	NA	1498	NA	Distant Metastasis	NA	NA	772	Complete Remission/Response	NA	NA	1	1498	1	1498	1	772	1	772	
70	TCGA-62-A46O	2	38	5	22	29	1	1	1	24	672	55	0	20	238	22	3	TCGA-62-A46O-01	299	0.7415404217063171	185	TCGA-62-A46O-01	14	35	114	0.25130418003142424	TCGA-62-A46O-01	26	27	9	62	hypermutated sample	6064	TCGA-62-A46O	LUAD	65	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2006	NA	-24050	Dead	WITH TUMOR	NA	1454	NA	Locoregional Recurrence|Distant Metastasis	NA	NA	943	Complete Remission/Response	NA	NA	1	1454	1	1454	1	943	1	943	
70	TCGA-62-A46P	1	20	2	6	5	1	1	1	10	218	22	1	7	66	3	0	TCGA-62-A46P-01	104	0.26538503156538346	52	TCGA-62-A46P-01	6	7	57	0.1087397877615584	TCGA-62-A46P-01	6	4	6	16	PASS	6065	TCGA-62-A46P	LUAD	65	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2006	NA	-23993	Dead	TUMOR FREE	NA	594	NA	Distant Metastasis	NA	NA	267	Complete Remission/Response	NA	NA	1	594	0	594	1	267	1	267	
50	TCGA-62-A46R	0	6	0	3	7	3	0	0	5	139	15	1	2	36	3	0	TCGA-62-A46R-01	53	0.6038081996820814	17	TCGA-62-A46R-01	24	31	58	0.3343348129536634	TCGA-62-A46R-01	10	6	4	20	PASS	6066	TCGA-62-A46R	LUAD	54	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2006	NA	-20063	Dead	TUMOR FREE	NA	1725	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1725	0	1725	0	1725	0	1725	
70	TCGA-62-A46S	0	8	0	4	2	1	0	0	3	96	6	0	3	36	4	0	TCGA-62-A46S-01	123	0.4866676829361338	60	TCGA-62-A46S-01	17	22	36	0.13189979351431685	TCGA-62-A46S-01	12	7	7	26	PASS	6067	TCGA-62-A46S	LUAD	73	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2007	NA	-26825	Dead	WITH TUMOR	NA	1653	NA	Locoregional Recurrence|Distant Metastasis	NA	NA	527	Complete Remission/Response	NA	NA	1	1653	1	1653	1	527	1	527	
70	TCGA-62-A46U	0	2	0	1	1	0	1	0	0	36	1	0	0	12	0	0	TCGA-62-A46U-01	95	0.3211336146597145	41	TCGA-62-A46U-01	16	23	54	0.1683716513376506	TCGA-62-A46U-01	14	11	9	34	PASS	6068	TCGA-62-A46U	LUAD	71	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2007	NA	-25998	Alive	TUMOR FREE	2067	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2067	0	2067	0	2067	0	2067	
80	TCGA-62-A46V	0	1	0	3	2	0	0	1	2	43	3	0	1	15	3	0	TCGA-62-A46V-01	100	0.3400100196369295	45	TCGA-62-A46V-01	6	10	55	0.21555074743333744	TCGA-62-A46V-01	9	11	10	30	PASS	6069	TCGA-62-A46V	LUAD	78	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2007	NA	-28495	Alive	TUMOR FREE	2199	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2199	0	2199	0	2199	0	2199	
70	TCGA-62-A46Y	0	1	0	1	3	1	1	0	0	26	4	0	1	8	0	0	TCGA-62-A46Y-01	66	0.269687836588537	18	TCGA-62-A46Y-01	6	5	28	0.08169044412573087	TCGA-62-A46Y-01	5	3	6	14	PASS	6070	TCGA-62-A46Y	LUAD	70	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2008	NA	-25905	Dead	WITH TUMOR	NA	414	NA	Distant Metastasis	NA	NA	314	Complete Remission/Response	NA	NA	1	414	1	414	1	314	1	314	
80	TCGA-62-A470	0	4	3	0	4	1	2	0	5	85	10	0	4	33	3	0	TCGA-62-A470-01	151	0.5991457606070991	76	TCGA-62-A470-01	23	24	77	0.27750372886742497	TCGA-62-A470-01	13	6	11	30	PASS	6071	TCGA-62-A470	LUAD	84	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	-30689	Dead	WITH TUMOR	NA	1194	NA	Locoregional Recurrence	NA	NA	539	Complete Remission/Response	NA	NA	1	1194	1	1194	1	539	1	539	
60	TCGA-62-A471	1	8	0	5	2	0	0	0	6	79	4	0	6	38	1	0	TCGA-62-A471-01	149	0.6147064206314719	86	TCGA-62-A471-01	24	32	104	0.3989886442171309	TCGA-62-A471-01	16	4	13	33	PASS	6072	TCGA-62-A471	LUAD	64	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2010	NA	-23689	Alive	TUMOR FREE	1246	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1246	0	1246	0	1246	0	1246	
70	TCGA-62-A472	0	0	0	4	5	1	0	0	2	43	3	0	0	19	1	0	TCGA-62-A472-01	81	0.6512867065458132	29	TCGA-62-A472-01	21	21	51	0.2476089949249403	TCGA-62-A472-01	8	3	4	15	PASS	6073	TCGA-62-A472	LUAD	70	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2011	NA	-25893	Alive	WITH TUMOR	910	NA	NA	Locoregional Recurrence	NA	NA	290	Complete Remission/Response	NA	NA	0	910	0	910	1	290	1	290	
60	TCGA-64-1676	0	31	3	10	9	2	1	0	18	466	35	0	9	154	18	0	TCGA-64-1676-01	192	0.7762948992310307	113	TCGA-64-1676-01	16	18	48	0.4258984670121129	TCGA-64-1676-01	13	8	13	34	PASS	6074	TCGA-64-1676	LUAD	58	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2005	NA	-21428	Alive	TUMOR FREE	1728	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1728	0	1728	0	1728	0	1728	
80	TCGA-64-1677	0	7	2	1	5	0	0	0	5	173	9	1	3	64	4	0	TCGA-64-1677-01	93	0.4236157659916648	38	TCGA-64-1677-01	21	31	17	0.2450796045900603	TCGA-64-1677-01	10	14	6	30	mutation call filter	6075	TCGA-64-1677	LUAD	77	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2005	NA	-28482	Dead	NA	NA	628	NA	NA	NA	NA	360	NA	NA	NA	1	628	NA	628	NA	NA	1	360	
70	TCGA-64-1678	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-64-1678-01	270	0.5555695408599584	165	TCGA-64-1678-01	12	29	31	0.2267088794196633	TCGA-64-1678-01	18	13	9	40	PASS	6076	TCGA-64-1678	LUAD	70	FEMALE	WHITE	[Discrepancy]	NA	Lung Adenocarcinoma	NA	2006	NA	-25931	Alive	TUMOR FREE	1189	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1189	0	1189	0	1189	0	1189	
60	TCGA-64-1679	3	11	5	7	8	7	1	0	15	404	35	1	11	126	20	1	TCGA-64-1679-01	98	0.4953956596357417	42	TCGA-64-1679-01	25	26	24	0.35125071778751704	TCGA-64-1679-01	9	7	5	21	PASS	6077	TCGA-64-1679	LUAD	58	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2007	NA	-21310	Alive	TUMOR FREE	2488	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2488	0	2488	0	2488	0	2488	
60	TCGA-64-1680	1	4	0	2	1	0	2	0	4	46	5	0	0	16	1	0	TCGA-64-1680-01	94	0.947114589725234	35	TCGA-64-1680-01	18	18	4	0.031483645076211784	TCGA-64-1680-01	6	3	0	9	PASS	6078	TCGA-64-1680	LUAD	63	MALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2007	NA	-23267	Alive	TUMOR FREE	1126	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1126	0	1126	NA	NA	0	1126	
60	TCGA-64-1681	1	5	0	4	1	1	2	0	3	63	8	0	0	21	1	0	TCGA-64-1681-01	156	0.5181575182764718	81	TCGA-64-1681-01	26	40	27	0.24560433884347355	TCGA-64-1681-01	14	8	4	26	PASS	6079	TCGA-64-1681	LUAD	61	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2008	NA	-22525	Dead	NA	NA	1167	NA	NA	NA	NA	439	NA	NA	NA	1	1167	NA	1167	NA	NA	1	439	
60	TCGA-64-5774	1	8	2	3	6	2	0	0	5	109	6	0	3	38	1	0	TCGA-64-5774-01	223	0.7998623690648302	131	TCGA-64-5774-01	19	30	46	0.34357550143012056	TCGA-64-5774-01	18	14	10	42	PASS	6080	TCGA-64-5774	LUAD	60	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2004	NA	-22059	Alive	TUMOR FREE	2676	NA	NA	NA	NA	NA	246	Complete Remission/Response	NA	NA	0	2676	0	2676	1	246	1	246	
70	TCGA-64-5775	1	25	2	10	21	4	0	0	20	352	29	1	11	130	15	1	TCGA-64-5775-01	158	0.5252241633293693	83	TCGA-64-5775-01	14	38	18	0.1817297435668758	TCGA-64-5775-01	9	3	4	16	PASS	6081	TCGA-64-5775	LUAD	71	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2005	NA	-26058	Dead	WITH TUMOR	NA	62	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	62	1	62	NA	NA	1	62	
60	TCGA-64-5778	5	28	1	16	14	5	1	0	11	367	25	0	11	112	11	0	TCGA-64-5778-01	116	0.8392103957392574	52	TCGA-64-5778-01	10	13	24	0.30702471706620504	TCGA-64-5778-01	10	6	11	27	PASS	6082	TCGA-64-5778	LUAD	60	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2008	NA	-21927	Alive	WITH TUMOR	1305	NA	NA	Distant Metastasis	NA	NA	962	Complete Remission/Response	NA	NA	0	1305	0	1305	1	962	1	962	
60	TCGA-64-5779	0	17	0	10	10	3	1	0	8	280	19	0	4	94	5	2	TCGA-64-5779-01	287	0.6970471343827601	177	TCGA-64-5779-01	19	33	57	0.3346047603197068	TCGA-64-5779-01	20	10	14	44	pathology review	6083	TCGA-64-5779	LUAD	61	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2009	NA	-22305	Alive	TUMOR FREE	864	NA	NA	Distant Metastasis	NA	NA	795	Stable Disease	NA	NA	0	864	0	864	NA	NA	1	795	
60	TCGA-64-5781	3	45	5	39	34	8	2	0	36	860	79	0	16	311	27	0	TCGA-64-5781-01	37	0.3709166902721728	3	TCGA-64-5781-01	11	18	16	0.3361428545531839	TCGA-64-5781-01	6	3	6	15	hypermutated sample	6084	TCGA-64-5781	LUAD	55	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2007	NA	-20219	Alive	TUMOR FREE	1559	NA	NA	NA	NA	NA	96	Progressive Disease	NA	NA	0	1559	0	1559	NA	NA	1	96	
70	TCGA-64-5815	3	6	3	0	4	0	0	0	6	123	15	0	6	52	3	0	TCGA-64-5815-01	92	0.30699084839715296	34	TCGA-64-5815-01	8	9	20	0.19925580126910966	TCGA-64-5815-01	12	9	10	31	pathology review	6085	TCGA-64-5815	LUAD	74	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2009	NA	-27280	Alive	TUMOR FREE	866	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	866	0	866	0	866	0	866	
70	TCGA-67-3770	1	11	0	10	4	2	1	0	6	162	10	0	10	57	6	0	TCGA-67-3770-01	188	0.8774114134125364	120	TCGA-67-3770-01	16	18	38	0.4252433066136994	TCGA-67-3770-01	14	7	11	32	PASS	6086	TCGA-67-3770	LUAD	70	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2009	NA	-25658	Alive	TUMOR FREE	610	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	610	0	610	NA	NA	0	610	
80	TCGA-67-3771	5	49	6	34	37	4	2	0	41	795	71	0	18	297	22	1	TCGA-67-3771-01	231	0.703392997691323	134	TCGA-67-3771-01	21	37	37	0.3327339718792827	TCGA-67-3771-01	22	20	9	51	hypermutated sample	6087	TCGA-67-3771	LUAD	77	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2009	NA	-28406	Alive	TUMOR FREE	610	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	610	0	610	NA	NA	0	610	
80	TCGA-67-3772	2	3	0	2	5	0	0	0	0	50	3	0	0	17	2	0	TCGA-67-3772-01	124	0.5487614861849256	66	TCGA-67-3772-01	10	10	30	0.27249991980656074	TCGA-67-3772-01	7	2	3	12	mutation call filter	6088	TCGA-67-3772	LUAD	82	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	-29989	Alive	TUMOR FREE	573	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	573	0	573	NA	NA	0	573	
80	TCGA-67-3773	1	9	0	4	4	0	0	0	2	83	6	0	0	20	3	0	TCGA-67-3773-01	163	0.1535222995423372	91	TCGA-67-3773-01	5	6	8	0.10227562286799224	TCGA-67-3773-01	5	3	4	12	PASS	6089	TCGA-67-3773	LUAD	84	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	-30706	Alive	TUMOR FREE	427	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	427	0	427	NA	NA	0	427	
70	TCGA-67-3774	0	11	0	9	3	0	0	0	4	82	7	0	2	36	1	0	TCGA-67-3774-01	127	0.24669816008989526	73	TCGA-67-3774-01	7	6	23	0.2064347633460749	TCGA-67-3774-01	4	2	4	10	PASS	6090	TCGA-67-3774	LUAD	73	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	-26704	Alive	TUMOR FREE	385	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	385	0	385	NA	NA	0	385	
60	TCGA-67-3776	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-67-3776	0	0	0	TCGA-67-3776	0	0	0	0	TCGA-67-3776	0	0	0	0	PASS	6091	TCGA-67-3776	LUAD	57	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2009	NA	-20940	Alive	TUMOR FREE	61	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	61	0	61	NA	NA	0	61	
70	TCGA-67-4679	1	15	2	9	9	3	0	0	11	211	26	0	5	76	11	0	TCGA-67-4679-01	68	0.16936174547330932	21	TCGA-67-4679-01	2	3	5	0.045208021254222734	TCGA-67-4679-01	6	8	2	16	PASS	6092	TCGA-67-4679	LUAD	69	MALE	WHITE	[Discrepancy]	NA	Lung Adenocarcinoma	NA	2009	NA	-25202	Alive	TUMOR FREE	448	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	448	0	448	NA	NA	0	448	
50	TCGA-67-6215	0	5	1	0	0	0	0	1	1	96	2	0	5	25	2	0	TCGA-67-6215-01	93	0.633681816549124	51	TCGA-67-6215-01	7	9	17	0.06144301499829177	TCGA-67-6215-01	6	2	2	10	PASS	6093	TCGA-67-6215	LUAD	52	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2010	NA	-19310	Alive	TUMOR FREE	174	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	174	0	174	0	174	0	174	
60	TCGA-67-6216	1	2	0	1	3	1	1	0	3	28	5	0	0	6	1	0	TCGA-67-6216-01	110	0.14890580563750433	58	TCGA-67-6216-01	2	2	19	0.03246303589488826	TCGA-67-6216-01	2	2	2	6	PASS	6094	TCGA-67-6216	LUAD	57	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-20967	Alive	TUMOR FREE	141	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	141	0	141	0	141	0	141	
70	TCGA-67-6217	1	9	0	6	3	1	0	0	3	153	11	0	3	48	8	0	TCGA-67-6217-01	234	0.6090493043801133	147	TCGA-67-6217-01	22	46	27	0.17884779122419453	TCGA-67-6217-01	15	14	6	35	PASS	6095	TCGA-67-6217	LUAD	73	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2010	NA	-26920	Alive	WITH TUMOR	422	NA	NA	NA	NA	NA	296	Progressive Disease	NA	NA	0	422	0	422	NA	NA	1	296	
70	TCGA-69-7760	0	3	1	2	3	0	3	0	1	51	5	0	2	22	1	0	TCGA-69-7760-01	217	0.5582325212627748	127	TCGA-69-7760-01	20	37	55	0.2604003893373953	TCGA-69-7760-01	15	12	9	36	PASS	6096	TCGA-69-7760	LUAD	73	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2011	NA	-26777	Alive	TUMOR FREE	202	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	202	0	202	NA	NA	0	202	
80	TCGA-69-7761	0	3	0	0	3	0	0	0	2	22	3	0	0	6	1	0	TCGA-69-7761-01	102	0.14744438502538804	41	TCGA-69-7761-01	15	15	21	0.0689864846608817	TCGA-69-7761-01	8	1	2	11	PASS	6097	TCGA-69-7761	LUAD	84	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-31041	Alive	TUMOR FREE	186	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	186	0	186	NA	NA	0	186	
70	TCGA-69-7763	1	3	0	3	2	0	0	0	4	56	7	0	2	28	0	0	TCGA-69-7763-01	103	0.5989998712737292	60	TCGA-69-7763-01	24	30	36	0.3584001014792116	TCGA-69-7763-01	9	9	5	23	PASS	6098	TCGA-69-7763	LUAD	69	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-25316	Alive	NA	690	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	690	0	690	NA	NA	0	690	
80	TCGA-69-7764	1	5	1	1	2	0	0	0	3	70	3	0	1	29	3	0	TCGA-69-7764-01	144	0.6613802124412528	76	TCGA-69-7764-01	8	10	42	0.25405364453686724	TCGA-69-7764-01	7	6	7	20	PASS	6099	TCGA-69-7764	LUAD	75	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-27693	Alive	TUMOR FREE	414	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	414	0	414	NA	NA	0	414	
60	TCGA-69-7765	0	16	2	10	12	2	1	0	11	475	41	1	8	181	11	0	TCGA-69-7765-01	77	0.24815799132371216	33	TCGA-69-7765-01	9	10	14	0.1404606269208067	TCGA-69-7765-01	6	3	5	14	PASS	6100	TCGA-69-7765	LUAD	56	MALE	BLACK OR AFRICAN AMERICAN	[Discrepancy]	NA	Lung Adenocarcinoma	NA	2011	NA	-20625	Alive	NA	165	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	165	0	165	NA	NA	0	165	
40	TCGA-69-7973	1	6	1	5	8	2	1	0	5	199	20	0	3	66	5	0	TCGA-69-7973-01	147	0.7088975210681133	85	TCGA-69-7973-01	23	23	15	0.0661224712531501	TCGA-69-7973-01	9	11	2	22	pathology review	6101	TCGA-69-7973	LUAD	42	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-15355	Alive	TUMOR FREE	230	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	230	0	230	0	230	0	230	
50	TCGA-69-7974	1	17	2	15	10	5	0	1	18	412	33	0	11	123	15	1	TCGA-69-7974-01	105	0.24457356434815725	54	TCGA-69-7974-01	21	63	29	0.3441928724928101	TCGA-69-7974-01	12	9	6	27	pathology review	6102	TCGA-69-7974	LUAD	54	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2011	NA	-20021	Alive	WITH TUMOR	184	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	184	0	184	NA	NA	0	184	
60	TCGA-69-7978	2	24	1	9	9	2	0	0	14	464	47	0	9	190	15	0	TCGA-69-7978-01	120	0.3790514172892015	55	TCGA-69-7978-01	16	29	32	0.2622078100663515	TCGA-69-7978-01	13	7	5	25	pathology review	6103	TCGA-69-7978	LUAD	59	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2011	NA	-21785	Alive	[Discrepancy]	134	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	134	0	134	NA	NA	0	134	
70	TCGA-69-7979	9	56	7	41	24	9	1	1	35	1120	101	2	30	362	45	3	TCGA-69-7979-01	975	0.7849635376730751	690	TCGA-69-7979-01	23	61	207	0.27450525873988	TCGA-69-7979-01	27	18	11	56	pathology review	6104	TCGA-69-7979	LUAD	71	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-26180	Alive	NA	408	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	408	0	408	NA	NA	0	408	
70	TCGA-69-7980	1	26	6	9	22	6	2	2	22	618	46	0	10	210	27	4	TCGA-69-7980-01	275	0.927228997741636	175	TCGA-69-7980-01	22	60	111	0.4899612207197962	TCGA-69-7980-01	24	13	12	49	PASS	6105	TCGA-69-7980	LUAD	70	FEMALE	WHITE	Stage I	NA	Lung Adenocarcinoma	NA	2011	NA	-25583	Alive	TUMOR FREE	411	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	411	0	411	0	411	0	411	
60	TCGA-69-8253	2	10	2	4	1	0	2	0	4	117	8	0	11	50	1	1	TCGA-69-8253-01	96	0.4349236654199256	39	TCGA-69-8253-01	16	20	12	0.05954230038756784	TCGA-69-8253-01	8	3	3	14	PASS	6106	TCGA-69-8253	LUAD	59	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Lung Adenocarcinoma	NA	2012	NA	-21771	Alive	TUMOR FREE	426	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	426	0	426	0	426	0	426	
90	TCGA-69-8254	0	2	1	2	3	0	1	0	7	58	7	0	2	13	5	0	TCGA-69-8254-01	44	0.16900459691562175	10	TCGA-69-8254-01	1	2	7	0.05193724727802727	TCGA-69-8254-01	2	3	3	8	PASS	6107	TCGA-69-8254	LUAD	85	MALE	WHITE	NA	NA	Lung Adenocarcinoma	NA	2012	NA	-31134	Alive	TUMOR FREE	409	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	409	0	409	0	409	0	409	
70	TCGA-69-8255	2	18	1	8	11	4	0	0	8	224	22	0	10	70	6	0	TCGA-69-8255-01	252	0.6095269328503921	144	TCGA-69-8255-01	20	38	86	0.3417216852018101	TCGA-69-8255-01	23	16	11	50	PASS	6108	TCGA-69-8255	LUAD	71	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-26289	Alive	NA	129	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	129	0	129	NA	NA	0	129	
80	TCGA-69-8453	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-69-8453-01	137	0.11876580898518226	83	TCGA-69-8453-01	6	7	10	0.05242803872275373	TCGA-69-8453-01	5	2	0	7	PASS	6109	TCGA-69-8453	LUAD	77	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2012	NA	-28413	Alive	WITH TUMOR	813	NA	NA	Locoregional Recurrence	NA	NA	344	Stable Disease	NA	NA	0	813	0	813	NA	NA	1	344	
60	TCGA-69-A59K	0	35	2	19	10	3	0	0	21	371	33	0	10	135	15	0	TCGA-69-A59K-01	226	0.8331243258295332	133	TCGA-69-A59K	0	0	0	0	TCGA-69-A59K	0	0	0	0	PASS	6110	TCGA-69-A59K	LUAD	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Lung Adenocarcinoma	NA	2012	NA	-22093	Alive	TUMOR FREE	591	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	591	0	591	NA	NA	0	591	
50	TCGA-71-6725	0	4	0	2	0	1	0	0	3	48	1	0	2	21	0	0	TCGA-71-6725-01	210	0.9292850349577668	127	TCGA-71-6725-01	21	37	55	0.3300749983751017	TCGA-71-6725-01	21	14	7	42	PASS	6111	TCGA-71-6725	LUAD	48	FEMALE	ASIAN	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-17793	Alive	WITH TUMOR	256	NA	NA	Locoregional Recurrence	NA	NA	164	Progressive Disease	NA	NA	0	256	0	256	NA	NA	1	164	
60	TCGA-71-8520	0	4	0	0	2	2	0	0	2	67	5	0	2	25	3	0	TCGA-71-8520	0	0	0	TCGA-71-8520	0	0	0	0	TCGA-71-8520	0	0	0	0	PASS	6112	TCGA-71-8520	LUAD	60	FEMALE	ASIAN	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-21921	Dead	WITH TUMOR	NA	210	NA	Locoregional Recurrence	NA	NA	179	Complete Remission/Response	NA	NA	1	210	1	210	1	179	1	179	
80	TCGA-73-4658	1	16	0	4	2	2	1	0	8	269	32	1	9	101	8	1	TCGA-73-4658-01	73	0.20971063565457504	23	TCGA-73-4658-01	8	13	8	0.1278107914758872	TCGA-73-4658-01	8	5	4	17	PASS	6113	TCGA-73-4658	LUAD	80	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2004	NA	-29508	Dead	TUMOR FREE	1600	1600	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1600	0	1600	0	1600	0	1600	
70	TCGA-73-4659	1	17	0	3	7	2	1	0	7	158	13	0	9	61	6	0	TCGA-73-4659-01	132	0.3388923634876165	73	TCGA-73-4659-01	24	22	18	0.12287829126704668	TCGA-73-4659-01	10	3	3	16	PASS	6114	TCGA-73-4659	LUAD	66	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2006	NA	-24253	Dead	WITH TUMOR	711	711	NA	NA	NA	NA	35	Progressive Disease	NA	NA	1	711	1	711	NA	NA	1	35	
70	TCGA-73-4662	0	10	2	8	5	1	2	0	11	176	11	0	4	52	6	1	TCGA-73-4662-01	190	0.6753180419315874	107	TCGA-73-4662-01	14	34	27	0.26267794864356164	TCGA-73-4662-01	17	9	10	36	PASS	6115	TCGA-73-4662	LUAD	65	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2007	NA	-23762	Alive	TUMOR FREE	2515	NA	NA	NA	NA	NA	21	Complete Remission/Response	NA	NA	0	2515	0	2515	1	21	1	21	
50	TCGA-73-4666	3	17	2	11	9	2	0	0	11	299	19	0	9	107	11	0	TCGA-73-4666-01	104	0.6387538476355566	46	TCGA-73-4666-01	22	31	20	0.30608589987237433	TCGA-73-4666-01	8	3	6	17	PASS	6116	TCGA-73-4666	LUAD	52	FEMALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2009	NA	-19074	Alive	TUMOR FREE	800	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	800	0	800	NA	NA	0	800	
70	TCGA-73-4668	4	27	1	13	11	4	1	0	18	399	45	2	15	110	16	0	TCGA-73-4668-01	226	0.6373504409177753	132	TCGA-73-4668-01	24	22	45	0.29696047041163537	TCGA-73-4668-01	17	5	13	35	PASS	6117	TCGA-73-4668	LUAD	66	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	Stage IIB	NA	Lung Adenocarcinoma	NA	2009	NA	-24255	Alive	WITH TUMOR	467	NA	NA	NA	NA	NA	236	Complete Remission/Response	NA	NA	0	467	0	467	1	236	1	236	
70	TCGA-73-4670	3	26	5	11	12	4	0	2	18	272	23	0	8	84	9	0	TCGA-73-4670-01	272	0.7045332878728018	176	TCGA-73-4670-01	26	33	49	0.4072558697706214	TCGA-73-4670-01	13	5	9	27	PASS	6118	TCGA-73-4670	LUAD	69	FEMALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2010	NA	-25526	Alive	WITH TUMOR	131	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	131	0	131	NA	NA	0	131	
60	TCGA-73-4675	0	5	0	1	4	2	2	0	1	47	4	0	0	24	3	0	TCGA-73-4675-01	123	0.7748661545167596	69	TCGA-73-4675-01	24	18	20	0.10835033718565744	TCGA-73-4675-01	6	5	2	13	PASS	6119	TCGA-73-4675	LUAD	59	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2010	NA	-21614	Dead	TUMOR FREE	NA	922	NA	Locoregional Recurrence	NA	NA	361	Progressive Disease	NA	NA	1	922	0	922	NA	NA	1	361	
50	TCGA-73-4676	0	5	0	3	4	0	1	0	1	69	8	0	0	28	1	0	TCGA-73-4676-01	166	0.9121222096776236	90	TCGA-73-4676-01	9	22	54	0.7564970628368244	TCGA-73-4676-01	10	3	7	20	PASS	6120	TCGA-73-4676	LUAD	45	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2010	NA	-16746	Dead	WITH TUMOR	NA	281	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	281	1	281	NA	NA	1	281	
70	TCGA-73-4677	1	13	2	6	3	1	0	0	9	199	15	0	1	61	5	0	TCGA-73-4677-01	67	0.38302608420083495	21	TCGA-73-4677-01	14	18	9	0.13269404106793994	TCGA-73-4677-01	2	2	5	9	PASS	6121	TCGA-73-4677	LUAD	74	MALE	WHITE	[Discrepancy]	NA	Lung Adenocarcinoma	NA	2010	NA	-27381	Dead	WITH TUMOR	NA	38	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	38	1	38	NA	NA	1	38	
60	TCGA-73-7498	0	5	1	5	6	1	1	0	4	84	3	0	4	34	1	0	TCGA-73-7498-01	100	0.2879955368056361	46	TCGA-73-7498-01	7	4	22	0.08770538198923787	TCGA-73-7498-01	4	3	3	10	PASS	6122	TCGA-73-7498	LUAD	58	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-21527	Alive	TUMOR FREE	1189	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1189	0	1189	0	1189	0	1189	
80	TCGA-73-7499	1	2	0	0	1	0	0	0	2	60	2	0	1	16	1	0	TCGA-73-7499-01	166	0.6651011977722601	93	TCGA-73-7499-01	23	30	73	0.5081146365160771	TCGA-73-7499-01	16	9	10	35	PASS	6123	TCGA-73-7499	LUAD	81	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2010	NA	-29683	Dead	TUMOR FREE	NA	1531	NA	Distant Metastasis	NA	NA	1447	Complete Remission/Response	NA	NA	1	1531	0	1531	1	1447	1	1447	
40	TCGA-73-A9RS	5	47	7	20	27	5	0	0	33	715	58	1	16	248	28	1	TCGA-73-A9RS-01	293	0.8619653998569267	199	TCGA-73-A9RS-01	18	36	108	0.2745887471935291	TCGA-73-A9RS-01	17	17	11	45	hypermutated sample	6124	TCGA-73-A9RS	LUAD	41	MALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Lung Adenocarcinoma	NA	2013	NA	-15162	Dead	WITH TUMOR	NA	340	NA	Locoregional Recurrence	NA	NA	107	Progressive Disease	NA	NA	1	340	1	340	NA	NA	1	107	
NA	TCGA-75-5122	0	2	2	2	3	1	2	0	5	103	3	0	2	47	2	0	TCGA-75-5122-01	115	0.2329163837091996	60	TCGA-75-5122-01	9	13	20	0.262836464125859	TCGA-75-5122-01	7	4	6	17	PASS	6125	TCGA-75-5122	LUAD	NA	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2005	NA	NA	Dead	WITH TUMOR	NA	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	NA	1	NA	NA	NA	1	NA	
NA	TCGA-75-5125	0	4	0	5	4	4	2	0	7	136	8	1	2	48	7	0	TCGA-75-5125-01	100	0.5789497743596582	45	TCGA-75-5125-01	20	69	22	0.3175428989610541	TCGA-75-5125-01	12	8	8	28	pathology review	6126	TCGA-75-5125	LUAD	NA	MALE	NA	Stage IIB	NA	Lung Adenocarcinoma	NA	NA	NA	NA	Dead	WITH TUMOR	NA	2027	NA	NA	NA	NA	1752	Complete Remission/Response	NA	NA	1	2027	1	2027	1	1752	1	1752	
NA	TCGA-75-5126	0	31	2	13	12	3	1	0	22	502	43	2	5	185	17	0	TCGA-75-5126-01	94	0.20116158669035605	36	TCGA-75-5126-01	7	18	10	0.2062788573647224	TCGA-75-5126-01	7	6	4	17	PASS	6127	TCGA-75-5126	LUAD	NA	FEMALE	NA	Stage IIIA	NA	Lung Adenocarcinoma	NA	2007	NA	NA	Alive	WITH TUMOR	NA	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	NA	0	NA	NA	NA	0	NA	
NA	TCGA-75-5146	0	9	1	9	6	3	0	0	5	144	12	0	4	52	4	0	TCGA-75-5146-01	191	0.7931926458319513	121	TCGA-75-5146-01	9	9	39	0.2842680725220684	TCGA-75-5146-01	5	5	8	18	PASS	6128	TCGA-75-5146	LUAD	NA	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	NA	NA	NA	Alive	TUMOR FREE	2368	NA	NA	New Primary Tumor	NA	NA	1773	Complete Remission/Response	NA	NA	0	2368	0	2368	0	2368	1	1773	
NA	TCGA-75-5147	0	1	0	1	1	2	0	0	0	33	1	0	1	8	2	0	TCGA-75-5147-01	157	0.5327707387371243	84	TCGA-75-5147-01	15	24	24	0.1955911386743327	TCGA-75-5147-01	13	7	8	28	PASS	6129	TCGA-75-5147	LUAD	NA	FEMALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	NA	NA	NA	Alive	TUMOR FREE	1333	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1333	0	1333	0	1333	0	1333	
NA	TCGA-75-6203	0	2	0	1	1	0	0	0	0	10	0	0	0	7	0	0	TCGA-75-6203-01	57	0.25322303292653303	13	TCGA-75-6203-01	10	9	3	0.03679014617890015	TCGA-75-6203-01	2	1	2	5	PASS	6130	TCGA-75-6203	LUAD	NA	FEMALE	NA	Stage IIIA	NA	Lung Adenocarcinoma	NA	2008	NA	NA	Alive	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	NA	0	NA	0	NA	0	NA	
NA	TCGA-75-6205	0	2	0	3	0	0	1	0	1	43	3	0	0	10	0	0	TCGA-75-6205-01	130	0.18343630976508804	68	TCGA-75-6205-01	24	23	25	0.5193955391660404	TCGA-75-6205-01	4	3	3	10	PASS	6131	TCGA-75-6205	LUAD	NA	FEMALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2006	NA	NA	Dead	WITH TUMOR	NA	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	NA	1	NA	NA	NA	1	NA	
NA	TCGA-75-6206	0	2	2	4	0	1	0	0	1	72	7	0	0	20	1	0	TCGA-75-6206-01	111	0.4202757988864321	53	TCGA-75-6206-01	16	25	9	0.11901807835283205	TCGA-75-6206-01	7	1	6	14	PASS	6132	TCGA-75-6206	LUAD	NA	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	NA	NA	NA	Alive	TUMOR FREE	2590	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2590	0	2590	0	2590	0	2590	
NA	TCGA-75-6207	1	5	0	2	1	0	2	0	1	52	5	0	1	17	0	0	TCGA-75-6207-01	302	0.629429186399765	184	TCGA-75-6207-01	11	12	61	0.2807285444318412	TCGA-75-6207-01	12	9	14	35	PASS	6133	TCGA-75-6207	LUAD	NA	MALE	NA	Stage IIIA	NA	Lung Adenocarcinoma	NA	2007	NA	NA	Dead	NA	NA	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	NA	NA	NA	0	NA	0	NA	
NA	TCGA-75-6211	3	15	0	10	6	3	0	0	12	290	27	3	7	87	8	0	TCGA-75-6211-01	348	0.6506297265429036	224	TCGA-75-6211-01	17	29	71	0.3323320204331168	TCGA-75-6211-01	16	17	6	39	PASS	6134	TCGA-75-6211	LUAD	NA	FEMALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	NA	Dead	WITH TUMOR	NA	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	NA	1	NA	NA	NA	1	NA	
NA	TCGA-75-6212	0	0	0	1	1	0	2	0	0	16	2	0	1	4	0	0	TCGA-75-6212-01	65	0.3728092765491113	23	TCGA-75-6212-01	19	33	19	0.031066389465419394	TCGA-75-6212-01	0	0	0	0	PASS	6135	TCGA-75-6212	LUAD	NA	FEMALE	NA	Stage IIB	NA	Lung Adenocarcinoma	NA	NA	NA	NA	Dead	WITH TUMOR	NA	1516	NA	New Primary Tumor	NA	NA	1340	Complete Remission/Response	NA	NA	1	1516	1	1516	0	1516	1	1340	
NA	TCGA-75-6214	2	42	1	14	15	3	0	0	22	562	43	3	19	185	13	1	TCGA-75-6214-01	201	0.7915197862108722	128	TCGA-75-6214-01	21	38	64	0.3324703798629099	TCGA-75-6214-01	19	12	10	41	PASS	6136	TCGA-75-6214	LUAD	NA	FEMALE	NA	Stage IIIA	NA	Lung Adenocarcinoma	NA	NA	NA	NA	Dead	WITH TUMOR	NA	1115	NA	Distant Metastasis	NA	NA	419	Complete Remission/Response	NA	NA	1	1115	1	1115	1	419	1	419	
NA	TCGA-75-7025	0	3	0	0	1	0	1	0	0	25	3	0	0	12	1	0	TCGA-75-7025-01	61	0.5242345440519124	19	TCGA-75-7025-01	19	14	9	0.1215857497849602	TCGA-75-7025-01	3	3	1	7	PASS	6137	TCGA-75-7025	LUAD	NA	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	NA	NA	NA	Alive	TUMOR FREE	3305	NA	NA	Locoregional Recurrence|Distant Metastasis	NA	NA	1481	Complete Remission/Response	NA	NA	0	3305	0	3305	1	1481	1	1481	
NA	TCGA-75-7027	0	10	3	16	5	3	1	0	5	183	12	1	4	75	5	0	TCGA-75-7027-01	94	0.7210031733356365	37	TCGA-75-7027-01	23	28	23	0.3051574654262842	TCGA-75-7027-01	7	1	2	10	PASS	6138	TCGA-75-7027	LUAD	NA	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	NA	NA	NA	Alive	TUMOR FREE	3059	NA	NA	Locoregional Recurrence	NA	NA	2949	Complete Remission/Response	NA	NA	0	3059	0	3059	1	2949	1	2949	
NA	TCGA-75-7030	0	0	0	0	0	0	0	0	0	13	1	0	0	4	1	0	TCGA-75-7030-01	51	1.0394684116725606e-05	11	TCGA-75-7030	0	0	0	0	TCGA-75-7030	0	0	0	0	PASS	6139	TCGA-75-7030	LUAD	NA	MALE	NA	Stage IIB	NA	Lung Adenocarcinoma	NA	2007	NA	NA	Alive	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	NA	0	NA	0	NA	0	NA	
NA	TCGA-75-7031	3	6	0	6	8	2	2	0	9	155	13	1	4	67	3	0	TCGA-75-7031-01	347	0.7408545569436326	210	TCGA-75-7031-01	18	24	53	0.14000894140626802	TCGA-75-7031-01	20	13	11	44	PASS	6140	TCGA-75-7031	LUAD	NA	FEMALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2008	NA	NA	Alive	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
60	TCGA-78-7143	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-78-7143-01	107	0.3843638701383293	48	TCGA-78-7143-01	26	65	13	0.1232440947464122	TCGA-78-7143-01	13	7	8	28	PASS	6141	TCGA-78-7143	LUAD	62	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	1992	NA	-22673	Dead	[Discrepancy]	NA	4961	NA	NA	NA	NA	1500	NA	NA	NA	1	4961	NA	4961	NA	NA	1	1500	
50	TCGA-78-7145	1	7	0	3	6	0	0	0	7	156	15	0	9	55	7	0	TCGA-78-7145-01	278	0.6069335094761676	175	TCGA-78-7145-01	20	25	43	0.15963642716670476	TCGA-78-7145-01	12	9	5	26	PASS	6142	TCGA-78-7145	LUAD	52	FEMALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2000	NA	-19080	Dead	WITH TUMOR	NA	826	NA	NA	NA	NA	422	NA	NA	NA	1	826	1	826	NA	NA	1	422	
70	TCGA-78-7146	3	16	2	14	8	1	1	0	25	304	16	1	11	110	6	0	TCGA-78-7146-01	406	0.9279192838633828	271	TCGA-78-7146-01	17	41	61	0.2785310363827561	TCGA-78-7146-01	22	17	11	50	pathology review	6143	TCGA-78-7146	LUAD	71	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	1999	NA	-26272	Dead	NA	NA	173	NA	NA	NA	NA	NA	NA	NA	NA	1	173	NA	173	NA	NA	0	173	
70	TCGA-78-7147	1	17	2	9	10	4	0	0	10	257	25	0	5	111	6	0	TCGA-78-7147-01	400	0.6339523422441407	258	TCGA-78-7147-01	21	27	73	0.22188345597199885	TCGA-78-7147-01	17	12	11	40	PASS	6144	TCGA-78-7147	LUAD	67	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2001	NA	-24809	Dead	WITH TUMOR	NA	586	NA	NA	NA	NA	578	NA	NA	NA	1	586	1	586	NA	NA	1	578	
70	TCGA-78-7148	2	11	2	5	8	1	0	0	4	186	10	0	6	57	7	1	TCGA-78-7148-01	116	0.4392873428585092	61	TCGA-78-7148-01	6	5	15	0.19638633266577005	TCGA-78-7148-01	3	1	2	6	PASS	6145	TCGA-78-7148	LUAD	71	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2001	NA	-25990	Dead	NA	NA	626	NA	NA	NA	NA	182	NA	NA	NA	1	626	NA	626	NA	NA	1	182	
70	TCGA-78-7149	0	11	1	4	2	1	0	0	8	119	14	0	1	44	0	0	TCGA-78-7149-01	171	0.6514063414341126	104	TCGA-78-7149-01	21	19	36	0.1810790856553992	TCGA-78-7149-01	7	4	3	14	PASS	6146	TCGA-78-7149	LUAD	71	MALE	WHITE	Stage IIIB	NA	Lung Adenocarcinoma	NA	2002	NA	-26285	Alive	NA	3940	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3940	0	3940	0	3940	0	3940	
60	TCGA-78-7150	0	12	3	15	11	1	0	0	12	313	29	0	2	129	8	0	TCGA-78-7150-01	283	0.5433055460240521	160	TCGA-78-7150-01	15	36	62	0.4294934286981745	TCGA-78-7150-01	24	15	16	55	PASS	6147	TCGA-78-7150	LUAD	59	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2002	NA	-21891	Dead	WITH TUMOR	NA	666	NA	NA	NA	NA	139	NA	NA	NA	1	666	1	666	NA	NA	1	139	
70	TCGA-78-7152	2	14	1	8	4	5	0	0	3	157	11	0	4	59	2	0	TCGA-78-7152-01	113	0.17260569604140874	59	TCGA-78-7152-01	6	4	23	0.09355343288545273	TCGA-78-7152-01	5	6	7	18	PASS	6148	TCGA-78-7152	LUAD	65	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2003	NA	-23782	Dead	WITH TUMOR	NA	1215	NA	NA	NA	NA	1202	Complete Remission/Response	NA	NA	1	1215	1	1215	1	1202	1	1202	
70	TCGA-78-7153	0	5	1	4	3	0	2	0	2	98	5	0	4	35	6	0	TCGA-78-7153-01	195	0.4177505989155895	122	TCGA-78-7153-01	16	16	11	0.02129532787089272	TCGA-78-7153-01	4	1	1	6	PASS	6149	TCGA-78-7153	LUAD	65	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2003	NA	-23922	Alive	NA	3635	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3635	0	3635	0	3635	0	3635	
70	TCGA-78-7154	1	14	3	12	1	3	1	0	10	182	10	0	4	93	3	1	TCGA-78-7154-01	356	0.7146083120031308	232	TCGA-78-7154-01	22	65	91	0.4691326041901195	TCGA-78-7154-01	21	15	13	49	PASS	6150	TCGA-78-7154	LUAD	72	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2003	NA	-26481	Dead	NA	NA	593	NA	NA	NA	NA	NA	NA	NA	NA	1	593	NA	593	NA	NA	0	593	
70	TCGA-78-7155	6	59	10	50	51	3	8	1	46	1202	83	2	32	335	48	3	TCGA-78-7155-01	503	0.8822310385980686	334	TCGA-78-7155-01	18	41	126	0.4939693131070105	TCGA-78-7155-01	29	27	22	78	hypermutated sample	6151	TCGA-78-7155	LUAD	68	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2005	NA	-24863	Dead	NA	NA	1171	NA	NA	NA	NA	209	NA	NA	NA	1	1171	NA	1171	NA	NA	1	209	
60	TCGA-78-7156	1	28	1	11	9	1	0	1	20	253	27	1	4	70	11	0	TCGA-78-7156-01	99	0.1115072043526367	48	TCGA-78-7156-01	4	5	14	0.06612753824709285	TCGA-78-7156-01	6	2	4	12	PASS	6152	TCGA-78-7156	LUAD	62	MALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2006	NA	-22720	Dead	NA	NA	976	NA	NA	NA	NA	NA	NA	NA	NA	1	976	NA	976	NA	NA	0	976	
60	TCGA-78-7158	2	14	1	9	8	1	0	0	9	209	17	0	3	67	11	0	TCGA-78-7158-01	97	0.17042302874484094	39	TCGA-78-7158-01	4	4	6	0.04938366968555008	TCGA-78-7158-01	2	1	2	5	PASS	6153	TCGA-78-7158	LUAD	59	FEMALE	WHITE	Stage IIIB	NA	Lung Adenocarcinoma	NA	2007	NA	-21742	Dead	WITH TUMOR	NA	179	NA	NA	NA	NA	132	Progressive Disease	NA	NA	1	179	1	179	NA	NA	1	132	
60	TCGA-78-7159	2	11	2	10	10	4	0	0	13	252	21	0	5	94	12	0	TCGA-78-7159-01	121	0.5376007408451037	56	TCGA-78-7159-01	22	29	10	0.07138315817071864	TCGA-78-7159-01	16	8	3	27	PASS	6154	TCGA-78-7159	LUAD	60	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2008	NA	-22261	Alive	NA	1974	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1974	0	1974	0	1974	0	1974	
60	TCGA-78-7160	0	1	0	0	1	0	0	0	2	39	5	0	0	21	4	0	TCGA-78-7160-01	78	0.29390224550933874	32	TCGA-78-7160-01	16	11	14	0.4217346783026881	TCGA-78-7160-01	5	2	4	11	PASS	6155	TCGA-78-7160	LUAD	61	MALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2008	NA	-22385	Dead	NA	NA	697	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	697	NA	697	NA	NA	0	697	
70	TCGA-78-7161	2	6	1	6	5	0	0	0	6	153	5	1	2	61	7	1	TCGA-78-7161-01	338	0.6077448029701374	225	TCGA-78-7161-01	9	35	57	0.1420617119766895	TCGA-78-7161-01	21	31	8	60	PASS	6156	TCGA-78-7161	LUAD	69	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2011	NA	-25294	Dead	WITH TUMOR	NA	291	NA	NA	NA	NA	162	Progressive Disease	NA	NA	1	291	1	291	NA	NA	1	162	
80	TCGA-78-7162	0	2	0	2	2	1	0	0	1	67	3	0	2	26	0	0	TCGA-78-7162-01	62	0.12235155171450116	22	TCGA-78-7162-01	5	5	6	0.054165863924986825	TCGA-78-7162-01	4	3	2	9	PASS	6157	TCGA-78-7162	LUAD	75	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	1991	NA	-27593	Dead	NA	NA	3169	NA	NA	NA	NA	2218	NA	NA	NA	1	3169	NA	3169	NA	NA	1	2218	
60	TCGA-78-7163	0	4	0	2	0	1	1	0	1	39	8	0	0	17	0	0	TCGA-78-7163-01	118	0.8976746762580435	68	TCGA-78-7163-01	27	36	16	0.12201210530083367	TCGA-78-7163-01	6	4	2	12	PASS	6158	TCGA-78-7163	LUAD	60	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	1992	NA	-22002	Alive	TUMOR FREE	7248	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	7248	0	7248	0	7248	0	7248	
80	TCGA-78-7166	1	12	0	5	6	2	0	0	5	165	13	0	2	68	6	0	TCGA-78-7166-01	59	0.09351098239799067	14	TCGA-78-7166-01	3	5	6	0.029535524618097837	TCGA-78-7166-01	5	4	3	12	PASS	6159	TCGA-78-7166	LUAD	84	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2002	NA	-30869	Dead	NA	NA	258	NA	NA	NA	NA	NA	NA	NA	NA	1	258	NA	258	NA	NA	0	258	
80	TCGA-78-7167	0	3	2	8	2	1	1	0	3	85	9	0	6	38	2	0	TCGA-78-7167-01	185	0.9060549756382426	107	TCGA-78-7167-01	17	22	33	0.11113955674104613	TCGA-78-7167-01	15	14	8	37	PASS	6160	TCGA-78-7167	LUAD	77	MALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2002	NA	-28295	Dead	WITH TUMOR	NA	2681	NA	NA	NA	NA	726	NA	NA	NA	1	2681	1	2681	NA	NA	1	726	
50	TCGA-78-7220	2	52	6	35	24	2	0	1	18	622	57	0	18	233	24	1	TCGA-78-7220-01	237	0.910962817264144	131	TCGA-78-7220-01	28	33	63	0.44261531221631056	TCGA-78-7220-01	21	10	10	41	pathology review	6161	TCGA-78-7220	LUAD	53	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2000	NA	-19480	Dead	WITH TUMOR	NA	807	NA	NA	NA	NA	531	NA	NA	NA	1	807	1	807	NA	NA	1	531	
50	TCGA-78-7535	0	8	0	4	3	1	0	0	6	130	4	0	6	61	6	0	TCGA-78-7535-01	143	0.8146715209738806	78	TCGA-78-7535-01	30	22	37	0.5287969881428429	TCGA-78-7535-01	11	2	8	21	PASS	6162	TCGA-78-7535	LUAD	45	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2000	NA	-16571	Dead	WITH TUMOR	NA	949	NA	NA	NA	NA	809	Stable Disease	NA	NA	1	949	1	949	NA	NA	1	809	
70	TCGA-78-7536	2	32	5	13	10	2	1	0	24	505	46	1	14	185	22	2	TCGA-78-7536-01	455	0.7373017301567533	302	TCGA-78-7536-01	16	41	124	0.3759682749009323	TCGA-78-7536-01	21	35	10	66	PASS	6163	TCGA-78-7536	LUAD	69	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2001	NA	-25558	Dead	WITH TUMOR	NA	244	NA	NA	NA	NA	231	Progressive Disease	NA	NA	1	244	1	244	NA	NA	1	231	
70	TCGA-78-7537	2	6	1	4	7	3	1	0	6	107	10	1	1	30	4	0	TCGA-78-7537-01	72	0.1284911193574981	29	TCGA-78-7537-01	2	3	8	0.01912587421414093	TCGA-78-7537-01	2	1	2	5	PASS	6164	TCGA-78-7537	LUAD	72	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	2002	NA	-26610	Dead	NA	NA	1622	NA	NA	NA	NA	NA	NA	NA	NA	1	1622	NA	1622	NA	NA	0	1622	
80	TCGA-78-7539	1	21	2	16	6	1	1	0	15	373	34	0	10	136	9	0	TCGA-78-7539-01	268	0.7789683299854316	163	TCGA-78-7539-01	13	30	51	0.17328002697051048	TCGA-78-7539-01	16	20	6	42	PASS	6165	TCGA-78-7539	LUAD	75	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-27445	Alive	NA	791	NA	NA	Distant Metastasis	NA	NA	688	Complete Remission/Response	NA	NA	0	791	0	791	1	688	1	688	
70	TCGA-78-7540	3	12	1	4	0	1	0	0	8	181	34	0	6	89	6	1	TCGA-78-7540-01	83	0.19476422880254746	32	TCGA-78-7540-01	6	13	20	0.1826513708288998	TCGA-78-7540-01	6	5	6	17	PASS	6166	TCGA-78-7540	LUAD	66	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	1999	NA	-24440	Dead	NA	NA	1197	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1197	NA	1197	0	1197	0	1197	
60	TCGA-78-7542	1	23	5	15	11	3	0	0	15	282	22	0	5	106	7	0	TCGA-78-7542-01	227	0.6063850961660738	119	TCGA-78-7542-01	28	52	30	0.4012222904931828	TCGA-78-7542-01	16	6	9	31	PASS	6167	TCGA-78-7542	LUAD	56	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	1993	NA	-20763	Dead	NA	NA	321	NA	NA	NA	NA	NA	NA	NA	NA	1	321	NA	321	NA	NA	0	321	
70	TCGA-78-7633	0	9	1	3	4	1	1	0	6	123	12	0	3	42	5	0	TCGA-78-7633-01	86	0.3106551241147103	38	TCGA-78-7633-01	9	9	5	0.0951399550624328	TCGA-78-7633-01	6	1	1	8	PASS	6168	TCGA-78-7633	LUAD	67	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	-24713	Dead	WITH TUMOR	NA	1528	NA	Locoregional Recurrence	NA	NA	1450	Complete Remission/Response	NA	NA	1	1528	1	1528	1	1450	1	1450	
60	TCGA-78-8640	1	38	5	27	14	4	2	0	24	551	42	2	17	187	23	0	TCGA-78-8640-01	158	0.5130371716572093	83	TCGA-78-8640-01	15	42	89	0.2338539948538833	TCGA-78-8640-01	18	24	7	49	PASS	6169	TCGA-78-8640	LUAD	59	MALE	[Not Evaluated]	Stage IIA	NA	Lung Adenocarcinoma	NA	1994	NA	-21832	Alive	TUMOR FREE	7062	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	7062	0	7062	0	7062	0	7062	
60	TCGA-78-8648	0	0	0	1	0	0	0	0	1	12	1	0	0	1	1	0	TCGA-78-8648-01	45	1.5366799551397612e-05	10	TCGA-78-8648	0	0	0	0	TCGA-78-8648	0	0	0	0	PASS	6170	TCGA-78-8648	LUAD	58	FEMALE	[Not Evaluated]	Stage IIB	NA	Lung Adenocarcinoma	NA	2002	NA	-21443	Dead	NA	NA	1209	NA	Locoregional Recurrence	NA	NA	720	[Unknown]	NA	NA	1	1209	NA	1209	NA	NA	1	720	
80	TCGA-78-8655	0	6	0	5	4	0	2	0	5	80	8	0	4	28	0	0	TCGA-78-8655-01	107	0.3723961700092092	47	TCGA-78-8655-01	10	12	55	0.11177335766636554	TCGA-78-8655-01	12	5	3	20	PASS	6171	TCGA-78-8655	LUAD	77	FEMALE	[Not Evaluated]	Stage IA	NA	Lung Adenocarcinoma	NA	2003	NA	-28379	Alive	NA	2360	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2360	0	2360	0	2360	0	2360	
70	TCGA-78-8660	1	11	1	3	5	2	2	0	8	188	12	0	2	72	12	0	TCGA-78-8660-01	100	0.21492951647829114	35	TCGA-78-8660-01	8	12	59	0.22963938466360595	TCGA-78-8660-01	9	8	7	24	PASS	6172	TCGA-78-8660	LUAD	69	MALE	[Not Evaluated]	Stage IIB	NA	Lung Adenocarcinoma	NA	2005	NA	-25422	Dead	WITH TUMOR	NA	321	NA	Distant Metastasis	NA	NA	242	[Unknown]	NA	NA	1	321	1	321	NA	NA	1	242	
50	TCGA-78-8662	5	57	10	34	17	4	0	0	44	872	66	1	22	308	29	5	TCGA-78-8662-01	350	0.9549412839987502	221	TCGA-78-8662-01	19	31	229	0.5439572871579649	TCGA-78-8662-01	27	24	17	68	hypermutated sample	6173	TCGA-78-8662	LUAD	53	FEMALE	[Not Evaluated]	Stage IB	NA	Lung Adenocarcinoma	NA	2000	NA	-19563	Dead	NA	NA	3361	NA	Locoregional Recurrence	NA	NA	3044	Complete Remission/Response	NA	NA	1	3361	NA	3361	1	3044	1	3044	
NA	TCGA-80-5607	0	5	2	5	0	2	0	0	6	91	16	0	1	32	2	0	TCGA-80-5607-01	73	0.09901064647642116	25	TCGA-80-5607-01	3	2	7	0.04341215834343977	TCGA-80-5607-01	2	0	1	3	PASS	6174	TCGA-80-5607	LUAD	NA	FEMALE	NA	Stage IIB	NA	Lung Adenocarcinoma	NA	2007	NA	NA	Alive	WITH TUMOR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
NA	TCGA-80-5608	2	12	2	9	2	2	1	0	12	277	46	0	8	118	11	1	TCGA-80-5608-01	149	0.5122442332044573	84	TCGA-80-5608-01	15	32	20	0.24153868393057634	TCGA-80-5608-01	12	6	8	26	PASS	6175	TCGA-80-5608	LUAD	NA	FEMALE	NA	Stage IA	NA	Lung Adenocarcinoma	NA	NA	NA	NA	Alive	TUMOR FREE	2832	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2832	0	2832	0	2832	0	2832	
NA	TCGA-80-5611	1	9	0	9	9	1	1	0	4	166	8	0	3	48	3	0	TCGA-80-5611-01	236	0.6798567017051315	126	TCGA-80-5611-01	14	32	62	0.3714834477867697	TCGA-80-5611-01	19	19	16	54	pathology review	6176	TCGA-80-5611	LUAD	NA	MALE	NA	Stage IB	NA	Lung Adenocarcinoma	NA	NA	NA	NA	Alive	TUMOR FREE	2595	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2595	0	2595	0	2595	0	2595	
60	TCGA-83-5908	2	8	1	5	6	0	0	0	10	177	18	1	2	64	8	0	TCGA-83-5908-01	64	0.4217363896605985	23	TCGA-83-5908-01	15	15	25	0.42807293075836095	TCGA-83-5908-01	5	5	6	16	PASS	6177	TCGA-83-5908	LUAD	59	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2009	NA	-21760	Alive	TUMOR FREE	824	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	824	0	824	NA	NA	0	824	
50	TCGA-86-6562	0	4	1	4	0	0	0	1	2	46	3	0	2	13	1	0	TCGA-86-6562-01	111	0.51425324958411	61	TCGA-86-6562-01	17	27	18	0.2339013126135968	TCGA-86-6562-01	8	3	5	16	PASS	6178	TCGA-86-6562	LUAD	52	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-19301	Dead	WITH TUMOR	NA	376	NA	NA	NA	NA	274	Progressive Disease	NA	NA	1	376	1	376	NA	NA	1	274	
70	TCGA-86-6851	4	34	1	28	19	7	1	0	23	714	60	1	20	233	26	4	TCGA-86-6851-01	138	0.6186894224654577	74	TCGA-86-6851-01	18	28	42	0.31184398268427205	TCGA-86-6851-01	16	11	11	38	hypermutated sample	6179	TCGA-86-6851	LUAD	73	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-26808	Alive	TUMOR FREE	179	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	179	0	179	0	179	0	179	
70	TCGA-86-7701	2	22	4	14	3	1	0	0	22	312	40	2	6	139	8	0	TCGA-86-7701-01	186	0.5876753402395778	117	TCGA-86-7701-01	19	24	68	0.2920015458407153	TCGA-86-7701-01	8	12	6	26	pathology review	6180	TCGA-86-7701	LUAD	66	MALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2011	NA	-24209	Alive	WITH TUMOR	947	NA	NA	Distant Metastasis	NA	NA	424	Complete Remission/Response	NA	NA	0	947	0	947	NA	NA	1	424	
70	TCGA-86-7711	0	20	2	6	20	4	0	0	11	331	35	0	10	146	6	0	TCGA-86-7711-01	141	0.5211120623931038	71	TCGA-86-7711-01	16	21	44	0.4529865870897365	TCGA-86-7711-01	13	16	14	43	pathology review	6181	TCGA-86-7711	LUAD	70	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-25719	Dead	WITH TUMOR	NA	1046	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	1046	1	1046	NA	NA	1	1046	
70	TCGA-86-7713	0	24	2	8	14	0	2	0	4	250	24	0	2	79	6	2	TCGA-86-7713-01	182	0.8531805576697563	107	TCGA-86-7713-01	14	22	22	0.2014360437496256	TCGA-86-7713-01	14	13	8	35	PASS	6182	TCGA-86-7713	LUAD	70	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-25791	Alive	TUMOR FREE	1157	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1157	0	1157	0	1157	0	1157	
60	TCGA-86-7714	0	3	0	0	3	1	2	0	1	59	3	0	2	23	0	0	TCGA-86-7714-01	54	0.06392249692905984	14	TCGA-86-7714-01	3	2	4	0.06742373876502843	TCGA-86-7714-01	1	0	1	2	PASS	6183	TCGA-86-7714	LUAD	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Lung Adenocarcinoma	NA	2011	NA	-22619	Dead	WITH TUMOR	NA	625	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	625	1	625	NA	NA	1	625	
70	TCGA-86-7953	0	4	0	1	0	1	0	0	0	44	3	0	1	12	0	0	TCGA-86-7953-01	238	0.7152947175471315	135	TCGA-86-7953-01	24	21	63	0.3213150248470859	TCGA-86-7953-01	15	9	15	39	pathology review	6184	TCGA-86-7953	LUAD	69	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-25315	Alive	TUMOR FREE	997	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	997	0	997	0	997	0	997	
70	TCGA-86-7954	0	8	1	7	1	2	0	0	6	163	14	0	6	81	5	1	TCGA-86-7954-01	252	0.5257977511021417	154	TCGA-86-7954-01	27	61	27	0.17861146015038826	TCGA-86-7954-01	14	17	1	32	pathology review	6185	TCGA-86-7954	LUAD	68	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-25062	Alive	TUMOR FREE	605	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	605	0	605	0	605	0	605	
60	TCGA-86-7955	1	8	0	6	6	2	2	0	8	238	20	0	9	83	7	2	TCGA-86-7955-01	345	0.6855598393983233	223	TCGA-86-7955-01	22	35	144	0.4823732098465202	TCGA-86-7955-01	22	8	11	41	pathology review	6186	TCGA-86-7955	LUAD	62	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-22772	Alive	TUMOR FREE	1072	NA	NA	Locoregional Recurrence	NA	NA	820	Complete Remission/Response	NA	NA	0	1072	0	1072	1	820	1	820	
60	TCGA-86-8054	1	14	1	8	5	2	0	0	4	174	13	1	7	51	4	0	TCGA-86-8054-01	221	0.8222482955019466	128	TCGA-86-8054-01	19	31	44	0.28264701944157283	TCGA-86-8054-01	16	10	7	33	PASS	6187	TCGA-86-8054	LUAD	61	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2011	NA	-22584	Alive	TUMOR FREE	1148	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1148	0	1148	0	1148	0	1148	
80	TCGA-86-8055	0	2	0	2	0	0	0	0	2	41	1	0	1	16	0	0	TCGA-86-8055-01	116	0.6500647002388589	58	TCGA-86-8055-01	20	71	24	0.32556457004303496	TCGA-86-8055-01	12	6	6	24	PASS	6188	TCGA-86-8055	LUAD	79	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-29124	Dead	TUMOR FREE	NA	124	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	124	0	124	0	124	0	124	
60	TCGA-86-8056	0	8	0	6	3	2	1	0	4	233	15	0	3	70	3	0	TCGA-86-8056-01	200	0.12415732897951501	118	TCGA-86-8056-01	3	5	30	0.11311395510473066	TCGA-86-8056-01	4	5	7	16	PASS	6189	TCGA-86-8056	LUAD	63	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2011	NA	-23369	Alive	TUMOR FREE	139	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	139	0	139	0	139	0	139	
60	TCGA-86-8073	5	54	6	32	20	11	2	0	38	1158	94	2	20	413	37	2	TCGA-86-8073-01	108	0.24779807234827106	46	TCGA-86-8073-01	9	10	24	0.1977910989257388	TCGA-86-8073-01	7	4	11	22	hypermutated sample	6190	TCGA-86-8073	LUAD	58	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-21214	Alive	TUMOR FREE	740	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	740	0	740	0	740	0	740	
60	TCGA-86-8074	0	0	0	1	2	0	1	0	1	53	4	0	2	17	3	0	TCGA-86-8074-01	176	0.7345833126612589	115	TCGA-86-8074-01	18	66	57	0.4613447018430316	TCGA-86-8074-01	17	18	11	46	PASS	6191	TCGA-86-8074	LUAD	62	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-22862	Alive	TUMOR FREE	24	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	24	0	24	NA	NA	0	24	
70	TCGA-86-8075	0	4	0	1	3	1	1	0	0	42	0	0	0	14	1	0	TCGA-86-8075-01	156	0.6976259082462496	91	TCGA-86-8075-01	27	60	31	0.3255545945965758	TCGA-86-8075-01	16	6	7	29	PASS	6192	TCGA-86-8075	LUAD	66	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-24402	Dead	TUMOR FREE	NA	694	NA	Locoregional Recurrence	NA	NA	199	Complete Remission/Response	NA	NA	1	694	0	694	1	199	1	199	
40	TCGA-86-8076	0	0	0	0	0	0	0	0	0	59	4	0	2	18	1	0	TCGA-86-8076-01	36	0.051834983414998835	2	TCGA-86-8076-01	1	3	2	0.00013065190419054844	TCGA-86-8076-01	2	2	0	4	PASS	6193	TCGA-86-8076	LUAD	42	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-15605	Alive	TUMOR FREE	993	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	993	0	993	0	993	0	993	
60	TCGA-86-8278	0	4	0	11	0	0	0	0	4	81	9	0	1	33	3	0	TCGA-86-8278-01	84	0.5997067610593038	40	TCGA-86-8278-01	8	10	35	0.2140446224338257	TCGA-86-8278-01	5	3	7	15	PASS	6194	TCGA-86-8278	LUAD	63	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2011	NA	-23117	Alive	WITH TUMOR	944	NA	NA	NA	NA	NA	29	Complete Remission/Response	NA	NA	0	944	0	944	1	29	1	29	
50	TCGA-86-8279	2	25	2	11	8	4	0	0	22	393	31	1	10	133	13	0	TCGA-86-8279-01	153	0.6879637061849504	82	TCGA-86-8279-01	28	42	67	0.5017621124600661	TCGA-86-8279-01	21	12	7	40	PASS	6195	TCGA-86-8279	LUAD	46	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-17032	Alive	TUMOR FREE	949	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	949	0	949	0	949	0	949	
50	TCGA-86-8280	0	2	0	1	0	0	1	0	1	42	0	0	0	9	0	0	TCGA-86-8280-01	169	0.7186021955398809	105	TCGA-86-8280-01	23	34	39	0.23800011807703345	TCGA-86-8280-01	12	4	3	19	PASS	6196	TCGA-86-8280	LUAD	54	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-19977	Alive	TUMOR FREE	701	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	701	0	701	0	701	0	701	
80	TCGA-86-8281	0	24	0	12	7	3	0	0	10	188	20	1	1	76	6	0	TCGA-86-8281-01	69	0.148562819471873	24	TCGA-86-8281-01	3	5	8	0.04495000777352831	TCGA-86-8281-01	5	2	2	9	PASS	6197	TCGA-86-8281	LUAD	75	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-27409	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	0	0	0	0	0	0	0	
40	TCGA-86-8358	8	69	13	38	18	10	1	0	37	811	79	2	19	284	22	0	TCGA-86-8358-01	429	0.7384309502073698	277	TCGA-86-8358-01	21	35	196	0.29794278464243	TCGA-86-8358-01	23	27	20	70	hypermutated sample	6198	TCGA-86-8358	LUAD	44	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-16409	Alive	TUMOR FREE	653	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	653	0	653	0	653	0	653	
50	TCGA-86-8359	1	7	0	5	4	3	1	0	5	123	6	0	2	48	6	0	TCGA-86-8359-01	114	0.6622239649037991	57	TCGA-86-8359-01	16	37	70	0.2267058855405029	TCGA-86-8359-01	17	17	10	44	PASS	6199	TCGA-86-8359	LUAD	52	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2012	NA	-19088	Dead	TUMOR FREE	NA	444	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	444	0	444	NA	NA	0	444	
60	TCGA-86-8585	1	28	4	21	17	6	1	0	16	454	29	0	7	137	18	3	TCGA-86-8585-01	94	0.6263613328675713	31	TCGA-86-8585-01	21	30	88	0.4735693534444846	TCGA-86-8585-01	22	15	15	52	PASS	6200	TCGA-86-8585	LUAD	57	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-20918	Alive	TUMOR FREE	353	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	353	0	353	0	353	0	353	
60	TCGA-86-8668	0	3	0	1	2	0	0	0	1	28	3	0	0	11	0	0	TCGA-86-8668-01	106	0.26707353487940416	51	TCGA-86-8668-01	10	13	44	0.12355820382706667	TCGA-86-8668-01	5	10	4	19	PASS	6201	TCGA-86-8668	LUAD	61	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-22383	Alive	TUMOR FREE	423	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	423	0	423	0	423	0	423	
60	TCGA-86-8669	1	6	1	5	5	1	2	0	3	99	6	0	1	48	3	0	TCGA-86-8669-01	153	0.6442534017698859	73	TCGA-86-8669-01	20	24	54	0.15659874308011426	TCGA-86-8669-01	18	15	6	39	PASS	6202	TCGA-86-8669	LUAD	64	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-23443	Alive	TUMOR FREE	938	NA	NA	Distant Metastasis	NA	NA	849	Complete Remission/Response	NA	NA	0	938	0	938	1	849	1	849	
70	TCGA-86-8671	0	0	0	0	0	0	0	0	0	31	2	0	0	14	0	0	TCGA-86-8671-01	55	0.003191839867106046	16	TCGA-86-8671-01	0	0	4	0.0003041629800097247	TCGA-86-8671-01	1	0	0	1	PASS	6203	TCGA-86-8671	LUAD	72	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2012	NA	-26448	Alive	TUMOR FREE	839	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	839	0	839	0	839	0	839	
60	TCGA-86-8672	0	7	2	14	6	5	2	0	8	219	19	0	11	92	8	1	TCGA-86-8672-01	126	0.4781164041406017	54	TCGA-86-8672-01	21	33	101	0.4138337357855936	TCGA-86-8672-01	15	8	13	36	PASS	6204	TCGA-86-8672	LUAD	59	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2012	NA	-21682	Dead	TUMOR FREE	NA	19	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	19	0	19	0	19	0	19	
60	TCGA-86-8673	4	20	6	12	21	1	1	0	14	365	40	0	7	130	9	1	TCGA-86-8673-01	327	0.7281260148382692	201	TCGA-86-8673-01	30	40	160	0.4460423983068332	TCGA-86-8673-01	20	20	13	53	PASS	6205	TCGA-86-8673	LUAD	61	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-22571	Alive	TUMOR FREE	862	NA	NA	Locoregional Recurrence	NA	NA	636	Complete Remission/Response	NA	NA	0	862	0	862	1	636	1	636	
50	TCGA-86-8674	2	19	1	8	10	1	0	0	10	218	28	0	3	91	8	0	TCGA-86-8674-01	61	0.1476539611442651	24	TCGA-86-8674-01	5	5	21	0.045323442627385566	TCGA-86-8674-01	3	0	2	5	PASS	6206	TCGA-86-8674	LUAD	50	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2012	NA	-18479	Alive	TUMOR FREE	806	NA	NA	Locoregional Recurrence	NA	NA	334	Complete Remission/Response	NA	NA	0	806	0	806	1	334	1	334	
80	TCGA-86-A456	1	13	2	6	5	3	0	0	8	281	28	0	6	101	8	0	TCGA-86-A456-01	62	0.40317277688716174	16	TCGA-86-A456-01	8	12	52	0.2437609808624703	TCGA-86-A456-01	7	8	10	25	PASS	6207	TCGA-86-A456	LUAD	78	FEMALE	ASIAN	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-28533	Alive	TUMOR FREE	896	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	896	0	896	0	896	0	896	
50	TCGA-86-A4D0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-86-A4D0-01	178	0.4878728926690531	103	TCGA-86-A4D0-01	10	10	81	0.18913782798603346	TCGA-86-A4D0-01	7	10	8	25	PASS	6208	TCGA-86-A4D0	LUAD	48	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2012	NA	-17607	Dead	TUMOR FREE	NA	116	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	116	0	116	0	116	0	116	
60	TCGA-86-A4JF	6	81	4	31	86	35	18	0	45	991	59	0	21	404	25	0	TCGA-86-A4JF-01	75	0.17295406437658492	27	TCGA-86-A4JF-01	18	19	21	0.0777889300136214	TCGA-86-A4JF-01	11	4	4	19	hypermutated sample	6209	TCGA-86-A4JF	LUAD	56	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2012	NA	-20491	Dead	WITH TUMOR	NA	737	NA	Distant Metastasis	NA	NA	436	Complete Remission/Response	NA	NA	1	737	1	737	1	436	1	436	
60	TCGA-86-A4P7	1	3	0	3	3	0	1	0	2	53	6	0	3	12	2	0	TCGA-86-A4P7-01	48	0.06182268555272447	9	TCGA-86-A4P7-01	6	13	38	0.2300082757550936	TCGA-86-A4P7-01	11	15	6	32	PASS	6210	TCGA-86-A4P7	LUAD	63	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-23330	Alive	TUMOR FREE	415	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	415	0	415	0	415	0	415	
60	TCGA-86-A4P8	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	TCGA-86-A4P8-01	43	6.877967321709142e-05	12	TCGA-86-A4P8-01	0	0	15	0.002086711737498205	TCGA-86-A4P8-01	0	0	0	0	PASS	6211	TCGA-86-A4P8	LUAD	59	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2012	NA	-21738	Alive	TUMOR FREE	805	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	805	0	805	0	805	0	805	
70	TCGA-91-6828	3	21	2	8	22	6	0	0	27	463	38	0	10	123	9	0	TCGA-91-6828-01	127	0.5229426360491685	60	TCGA-91-6828-01	30	57	18	0.05516033095413008	TCGA-91-6828-01	12	7	3	22	PASS	6212	TCGA-91-6828	LUAD	70	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-25870	Alive	TUMOR FREE	323	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	323	0	323	0	323	0	323	
80	TCGA-91-6829	1	45	5	22	12	4	0	0	20	494	44	0	12	163	23	4	TCGA-91-6829-01	179	0.6359339901613671	93	TCGA-91-6829-01	17	36	47	0.4810456927359673	TCGA-91-6829-01	23	20	16	59	PASS	6213	TCGA-91-6829	LUAD	78	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2001	NA	-28841	Dead	TUMOR FREE	NA	1258	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	1258	0	1258	NA	NA	0	1258	
70	TCGA-91-6830	1	12	0	6	2	4	0	0	8	209	16	0	4	84	6	0	TCGA-91-6830-01	60	0.2531437179281173	20	TCGA-91-6830-01	11	9	12	0.3333603192292792	TCGA-91-6830-01	6	5	8	19	pathology review	6214	TCGA-91-6830	LUAD	65	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2002	NA	-23922	Alive	WITH TUMOR	60	NA	NA	Distant Metastasis	NA	NA	18	[Unknown]	NA	NA	0	60	0	60	NA	NA	1	18	
70	TCGA-91-6831	0	11	1	9	9	4	0	0	6	224	10	0	7	71	10	0	TCGA-91-6831-01	224	0.6258049461018835	122	TCGA-91-6831-01	16	32	47	0.2895071348901768	TCGA-91-6831-01	16	15	8	39	pathology review	6215	TCGA-91-6831	LUAD	66	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2001	NA	-24436	Alive	TUMOR FREE	310	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	310	0	310	0	310	0	310	
80	TCGA-91-6835	0	5	1	2	1	0	0	0	1	70	7	0	2	28	1	0	TCGA-91-6835-01	63	0.4235509749599606	21	TCGA-91-6835-01	13	18	16	0.3470062962501537	TCGA-91-6835-01	7	10	6	23	PASS	6216	TCGA-91-6835	LUAD	81	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-29887	Alive	TUMOR FREE	79	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	79	0	79	0	79	0	79	
50	TCGA-91-6836	0	22	5	16	7	5	2	0	20	384	35	1	15	140	17	1	TCGA-91-6836-01	395	0.6476847883595037	279	TCGA-91-6836-01	20	29	72	0.22902218237401645	TCGA-91-6836-01	16	15	11	42	pathology review	6217	TCGA-91-6836	LUAD	52	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2010	NA	-19216	Alive	TUMOR FREE	417	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	417	0	417	0	417	0	417	
60	TCGA-91-6840	1	6	1	2	3	2	0	0	11	112	5	0	2	36	2	0	TCGA-91-6840-01	253	0.8082564152803062	155	TCGA-91-6840-01	21	34	106	0.3553312446445589	TCGA-91-6840-01	19	9	11	39	PASS	6218	TCGA-91-6840	LUAD	59	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-21854	Alive	TUMOR FREE	372	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	372	0	372	0	372	0	372	
60	TCGA-91-6847	0	6	1	6	2	1	0	0	6	56	7	0	2	37	1	0	TCGA-91-6847-01	335	0.7797812432065229	210	TCGA-91-6847-01	25	61	47	0.3957568383063576	TCGA-91-6847-01	12	6	6	24	PASS	6219	TCGA-91-6847	LUAD	62	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2002	NA	-22862	Alive	WITH TUMOR	842	NA	NA	Distant Metastasis	NA	NA	772	Progressive Disease	NA	NA	0	842	0	842	NA	NA	1	772	
60	TCGA-91-6848	7	23	3	12	14	1	0	0	12	485	34	2	12	176	19	1	TCGA-91-6848-01	289	0.4416949472114032	176	TCGA-91-6848-01	15	69	78	0.4957123214150601	TCGA-91-6848-01	22	25	16	63	pathology review	6220	TCGA-91-6848	LUAD	59	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2009	NA	-21829	Alive	TUMOR FREE	224	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	224	0	224	0	224	0	224	
80	TCGA-91-6849	0	8	1	6	4	0	0	0	3	88	6	1	5	32	7	1	TCGA-91-6849-01	89	0.15547254159734614	39	TCGA-91-6849-01	4	5	11	0.11681263629101313	TCGA-91-6849-01	5	6	7	18	PASS	6221	TCGA-91-6849	LUAD	75	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Lung Adenocarcinoma	NA	2009	NA	-27676	Alive	NA	35	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	35	0	35	NA	NA	0	35	
60	TCGA-91-7771	0	7	0	5	7	0	1	0	5	165	8	0	3	54	3	1	TCGA-91-7771-01	329	0.5676382315597447	202	TCGA-91-7771-01	20	63	59	0.12929450090314887	TCGA-91-7771-01	18	13	5	36	PASS	6222	TCGA-91-7771	LUAD	62	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2011	NA	-22926	Alive	TUMOR FREE	492	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	492	0	492	0	492	0	492	
60	TCGA-91-8496	0	1	0	0	2	2	0	0	1	24	4	0	2	10	0	0	TCGA-91-8496-01	65	0.23425231781936895	28	TCGA-91-8496-01	4	7	12	0.01429466562235683	TCGA-91-8496-01	4	8	1	13	PASS	6223	TCGA-91-8496	LUAD	63	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-23358	Alive	TUMOR FREE	505	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	505	0	505	0	505	0	505	
80	TCGA-91-8497	0	2	0	2	2	0	0	1	3	34	1	0	1	14	0	0	TCGA-91-8497-01	81	0.09603486829610272	37	TCGA-91-8497-01	1	4	31	0.09909133457070657	TCGA-91-8497-01	5	9	6	20	PASS	6224	TCGA-91-8497	LUAD	75	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-27632	Dead	TUMOR FREE	NA	434	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	434	0	434	0	434	0	434	
80	TCGA-91-8499	0	23	3	12	9	4	2	0	12	235	23	0	6	80	4	2	TCGA-91-8499-01	487	0.9129893900995236	305	TCGA-91-8499-01	16	39	217	0.378744712241494	TCGA-91-8499-01	24	29	12	65	PASS	6225	TCGA-91-8499	LUAD	76	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-27853	Alive	NA	36	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	36	0	36	NA	NA	0	36	
60	TCGA-91-A4BC	3	23	0	9	10	1	0	0	11	344	29	0	7	124	15	0	TCGA-91-A4BC-01	60	0.26425145633996866	17	TCGA-91-A4BC-01	24	41	116	0.4937244956775052	TCGA-91-A4BC-01	18	22	12	52	PASS	6226	TCGA-91-A4BC	LUAD	59	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2012	NA	-21565	Alive	NA	44	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	44	0	44	NA	NA	0	44	
80	TCGA-91-A4BD	1	0	0	3	0	1	0	0	1	14	1	0	0	7	0	0	TCGA-91-A4BD-01	45	0.13698664460748314	6	TCGA-91-A4BD-01	6	4	22	0.07926519777098412	TCGA-91-A4BD-01	2	0	2	4	PASS	6227	TCGA-91-A4BD	LUAD	78	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2012	NA	-28544	Alive	TUMOR FREE	603	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	603	0	603	0	603	0	603	
80	TCGA-93-7347	2	5	0	2	2	3	0	0	2	92	7	0	4	30	2	0	TCGA-93-7347-01	57	0.21010996804115975	15	TCGA-93-7347-01	6	8	11	0.09852444550257286	TCGA-93-7347-01	3	3	4	10	PASS	6228	TCGA-93-7347	LUAD	76	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-27949	Alive	TUMOR FREE	683	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	683	0	683	0	683	0	683	
80	TCGA-93-7348	0	2	0	6	0	0	0	0	10	178	12	2	10	43	8	2	TCGA-93-7348-01	58	0.4282566000929379	14	TCGA-93-7348-01	12	9	12	0.3092852183814269	TCGA-93-7348-01	6	4	5	15	PASS	6229	TCGA-93-7348	LUAD	75	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-27456	Alive	TUMOR FREE	531	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	531	0	531	0	531	0	531	
80	TCGA-93-8067	7	17	3	25	5	2	0	0	19	390	37	0	10	159	10	2	TCGA-93-8067-01	465	0.6175409508966303	356	TCGA-93-8067-01	19	55	168	0.3250936277232258	TCGA-93-8067-01	19	14	7	40	PASS	6230	TCGA-93-8067	LUAD	77	MALE	ASIAN	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-28453	Alive	TUMOR FREE	186	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	186	0	186	0	186	0	186	
70	TCGA-93-A4JN	0	4	0	4	2	1	1	0	2	60	7	0	0	21	0	0	TCGA-93-A4JN-01	90	0.6466137981201381	35	TCGA-93-A4JN-01	25	28	70	0.2467683961155961	TCGA-93-A4JN-01	6	6	11	23	PASS	6231	TCGA-93-A4JN	LUAD	71	MALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2012	NA	-26273	Alive	WITH TUMOR	718	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	718	0	718	NA	NA	0	718	
70	TCGA-93-A4JO	0	2	0	0	1	0	0	0	1	44	7	0	0	11	1	0	TCGA-93-A4JO-01	77	0.4543065064941285	33	TCGA-93-A4JO-01	16	30	92	0.4806993273166834	TCGA-93-A4JO-01	12	13	4	29	PASS	6232	TCGA-93-A4JO	LUAD	70	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-25898	Dead	TUMOR FREE	NA	33	NA	NA	NA	NA	NA	NA	NA	NA	1	33	0	33	NA	NA	0	33	
60	TCGA-93-A4JP	1	2	0	2	2	0	0	0	2	46	6	0	2	22	0	0	TCGA-93-A4JP-01	88	0.16517597810081353	32	TCGA-93-A4JP-01	10	19	54	0.18257928334934925	TCGA-93-A4JP-01	17	11	4	32	PASS	6233	TCGA-93-A4JP	LUAD	64	MALE	ASIAN	Stage IV	NA	Lung Adenocarcinoma	NA	2012	NA	-23620	Alive	WITH TUMOR	578	NA	NA	Distant Metastasis	NA	NA	497	Partial Remission/Response	NA	NA	0	578	0	578	NA	NA	1	497	
50	TCGA-93-A4JQ	1	2	0	0	0	0	0	0	5	95	6	1	2	32	1	0	TCGA-93-A4JQ-01	115	0.24644124040095935	56	TCGA-93-A4JQ-01	21	42	47	0.1616359290400283	TCGA-93-A4JQ-01	22	30	9	61	PASS	6234	TCGA-93-A4JQ	LUAD	49	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-17951	Alive	TUMOR FREE	526	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	526	0	526	0	526	0	526	
50	TCGA-95-7039	6	58	3	24	36	17	0	0	37	1020	89	0	22	334	31	2	TCGA-95-7039-01	358	0.6034750143446519	248	TCGA-95-7039-01	19	47	39	0.09815444432521993	TCGA-95-7039-01	21	23	3	47	hypermutated sample	6235	TCGA-95-7039	LUAD	54	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2011	NA	-19981	Alive	WITH TUMOR	1272	NA	NA	Locoregional Recurrence	NA	NA	1258	Complete Remission/Response	NA	NA	0	1272	0	1272	1	1258	1	1258	
60	TCGA-95-7043	5	36	6	22	37	13	0	0	28	858	76	1	23	283	27	0	TCGA-95-7043-01	362	0.9889756170019464	235	TCGA-95-7043-01	15	62	73	0.5372763099538018	TCGA-95-7043-01	25	14	15	54	hypermutated sample	6236	TCGA-95-7043	LUAD	63	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-23165	Dead	WITH TUMOR	NA	503	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	503	1	503	NA	NA	1	503	
70	TCGA-95-7562	0	17	3	11	19	2	20	0	10	312	25	0	9	75	10	0	TCGA-95-7562-01	128	0.7308033365092191	66	TCGA-95-7562-01	27	57	30	0.4141025330877735	TCGA-95-7562-01	9	9	5	23	PASS	6237	TCGA-95-7562	LUAD	71	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-26000	Dead	TUMOR FREE	NA	87	NA	NA	NA	NA	NA	[Not Evaluated]	NA	NA	1	87	0	87	NA	NA	0	87	
60	TCGA-95-7567	2	50	5	20	12	36	0	0	23	707	45	2	12	266	25	1	TCGA-95-7567-01	285	0.8512074607951876	192	TCGA-95-7567-01	15	35	71	0.2440596180562501	TCGA-95-7567-01	21	10	11	42	hypermutated sample	6238	TCGA-95-7567	LUAD	61	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2011	NA	-22437	Alive	TUMOR FREE	568	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	568	0	568	NA	NA	0	568	
70	TCGA-95-7944	1	11	1	9	3	0	1	0	12	184	12	1	1	74	3	0	TCGA-95-7944-01	112	0.5854080339411255	56	TCGA-95-7944-01	13	11	43	0.4565102974379501	TCGA-95-7944-01	9	6	6	21	pathology review	6239	TCGA-95-7944	LUAD	71	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-26003	Alive	TUMOR FREE	377	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	377	0	377	NA	NA	0	377	
70	TCGA-95-7947	0	21	5	15	9	6	0	0	14	415	25	2	6	154	11	0	TCGA-95-7947-01	138	0.4522422811091653	63	TCGA-95-7947-01	11	18	27	0.26926999972053106	TCGA-95-7947-01	13	8	14	35	PASS	6240	TCGA-95-7947	LUAD	67	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-24752	Alive	TUMOR FREE	477	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	477	0	477	0	477	0	477	
40	TCGA-95-7948	0	5	1	5	2	0	1	0	5	124	14	0	3	27	2	0	TCGA-95-7948-01	127	0.928173622071249	66	TCGA-95-7948-01	17	25	30	0.2621646932590549	TCGA-95-7948-01	8	10	7	25	PASS	6241	TCGA-95-7948	LUAD	42	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-15363	Alive	TUMOR FREE	476	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	476	0	476	0	476	0	476	
70	TCGA-95-8039	0	1	0	4	5	0	1	0	3	74	4	0	0	30	2	0	TCGA-95-8039-01	55	0.3488279682189144	13	TCGA-95-8039-01	9	12	15	0.28334695349287864	TCGA-95-8039-01	7	6	6	19	PASS	6242	TCGA-95-8039	LUAD	72	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-26317	Alive	TUMOR FREE	830	NA	NA	Locoregional Recurrence	NA	NA	228	Complete Remission/Response	NA	NA	0	830	0	830	1	228	1	228	
70	TCGA-95-8494	0	5	0	1	1	0	0	0	3	77	7	0	2	36	3	0	TCGA-95-8494-01	139	0.8632007325171164	80	TCGA-95-8494-01	21	27	66	0.17052113076252132	TCGA-95-8494-01	17	12	10	39	PASS	6243	TCGA-95-8494	LUAD	67	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2012	NA	-24773	Alive	NA	84	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	84	0	84	0	84	0	84	
70	TCGA-95-A4VK	1	11	1	8	6	0	0	0	7	193	13	0	12	63	9	0	TCGA-95-A4VK-01	225	0.1907568754706292	141	TCGA-95-A4VK-01	7	8	62	0.09433761605548667	TCGA-95-A4VK-01	11	3	3	17	PASS	6244	TCGA-95-A4VK	LUAD	74	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2012	NA	-27040	Alive	WITH TUMOR	651	NA	NA	Distant Metastasis	NA	NA	496	Stable Disease	NA	NA	0	651	0	651	NA	NA	1	496	
60	TCGA-95-A4VN	0	25	4	9	7	3	1	0	24	356	36	1	5	121	11	2	TCGA-95-A4VN-01	75	0.2999443561878506	25	TCGA-95-A4VN-01	27	39	31	0.16122871740144984	TCGA-95-A4VN-01	12	11	6	29	PASS	6245	TCGA-95-A4VN	LUAD	62	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2012	NA	-22927	Alive	TUMOR FREE	553	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	553	0	553	NA	NA	0	553	
70	TCGA-95-A4VP	0	8	0	4	2	1	1	0	3	99	3	0	4	37	3	1	TCGA-95-A4VP-01	115	0.6905688768686422	56	TCGA-95-A4VP-01	21	37	85	0.3996716098626872	TCGA-95-A4VP-01	9	9	6	24	PASS	6246	TCGA-95-A4VP	LUAD	66	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2012	NA	-24130	Alive	WITH TUMOR	605	NA	NA	Distant Metastasis	NA	NA	216	Stable Disease	NA	NA	0	605	0	605	NA	NA	1	216	
80	TCGA-97-7546	2	18	1	7	7	1	0	0	8	213	19	1	6	74	7	0	TCGA-97-7546-01	66	0.537158512991416	23	TCGA-97-7546-01	6	6	9	0.1926298798533123	TCGA-97-7546-01	5	2	4	11	PASS	6247	TCGA-97-7546	LUAD	76	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2008	NA	-27913	Alive	WITH TUMOR	1285	NA	NA	New Primary Tumor	NA	NA	1255	Progressive Disease	NA	NA	0	1285	0	1285	NA	NA	1	1255	
70	TCGA-97-7547	2	5	0	7	6	0	0	0	4	137	11	0	5	59	4	0	TCGA-97-7547-01	179	0.5327210014458943	107	TCGA-97-7547-01	17	22	17	0.2281207748466472	TCGA-97-7547-01	8	2	4	14	PASS	6248	TCGA-97-7547	LUAD	67	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2007	NA	-24737	Alive	WITH TUMOR	1965	NA	NA	NA	NA	NA	775	Progressive Disease	NA	NA	0	1965	0	1965	NA	NA	1	775	
70	TCGA-97-7552	0	0	0	0	3	0	0	0	1	28	3	0	2	19	1	0	TCGA-97-7552-01	50	0.01470330109451688	10	TCGA-97-7552-01	3	2	7	0.05054257843443146	TCGA-97-7552-01	1	2	1	4	PASS	6249	TCGA-97-7552	LUAD	70	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2007	NA	-25578	Alive	TUMOR FREE	1932	NA	NA	NA	NA	NA	798	Stable Disease	NA	NA	0	1932	0	1932	NA	NA	1	798	
60	TCGA-97-7553	0	0	0	2	4	0	2	0	3	29	6	0	0	11	1	0	TCGA-97-7553-01	72	0.376378995869552	23	TCGA-97-7553-01	15	20	23	0.6576831847956415	TCGA-97-7553-01	8	3	5	16	PASS	6250	TCGA-97-7553	LUAD	58	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2007	NA	-21518	Alive	TUMOR FREE	1870	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1870	0	1870	0	1870	0	1870	
80	TCGA-97-7554	1	18	2	19	11	5	0	0	17	357	24	0	5	125	10	1	TCGA-97-7554-01	165	0.6666446880870247	97	TCGA-97-7554-01	27	56	32	0.19398623194584536	TCGA-97-7554-01	16	15	6	37	PASS	6251	TCGA-97-7554	LUAD	83	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2010	NA	-30327	Alive	TUMOR FREE	775	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	775	0	775	0	775	0	775	
70	TCGA-97-7937	0	12	2	11	20	1	1	0	13	367	35	1	7	106	11	0	TCGA-97-7937-01	184	0.7038989038509275	108	TCGA-97-7937-01	26	38	36	0.18355048818198447	TCGA-97-7937-01	11	5	5	21	PASS	6252	TCGA-97-7937	LUAD	65	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-23919	Alive	TUMOR FREE	564	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	564	0	564	NA	NA	0	564	
80	TCGA-97-7938	1	17	3	14	7	2	0	0	7	312	28	0	6	107	11	0	TCGA-97-7938-01	74	0.2291793230732528	27	TCGA-97-7938-01	7	8	14	0.09076428837770574	TCGA-97-7938-01	7	3	6	16	PASS	6253	TCGA-97-7938	LUAD	76	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-27980	Dead	TUMOR FREE	NA	18	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	18	0	18	0	18	0	18	
70	TCGA-97-7941	0	4	1	2	4	0	0	0	2	71	10	0	2	30	1	0	TCGA-97-7941-01	61	0.02679568668271407	23	TCGA-97-7941-01	2	1	8	0.04067113731827795	TCGA-97-7941-01	2	0	1	3	PASS	6254	TCGA-97-7941	LUAD	72	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-26298	Alive	TUMOR FREE	484	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	484	0	484	0	484	0	484	
80	TCGA-97-8171	0	3	0	2	1	0	1	0	0	49	4	0	0	14	1	0	TCGA-97-8171-01	377	0.26128333936822595	324	TCGA-97-8171-01	6	10	100	0.0524755822283448	TCGA-97-8171-01	4	7	1	12	PASS	6255	TCGA-97-8171	LUAD	81	MALE	ASIAN	Stage IV	NA	Lung Adenocarcinoma	NA	2011	NA	-29627	Alive	WITH TUMOR	568	NA	NA	Distant Metastasis	NA	NA	441	Progressive Disease	NA	NA	0	568	0	568	NA	NA	1	441	
80	TCGA-97-8172	0	10	0	13	13	4	0	0	4	198	22	0	5	72	8	1	TCGA-97-8172-01	85	0.3323795288349364	35	TCGA-97-8172-01	13	11	6	0.046176521277264855	TCGA-97-8172-01	5	0	2	7	PASS	6256	TCGA-97-8172	LUAD	75	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-27416	Alive	TUMOR FREE	545	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	545	0	545	0	545	0	545	
70	TCGA-97-8174	3	8	1	2	5	0	0	0	7	133	12	0	0	44	5	0	TCGA-97-8174-01	209	0.4887301393603077	138	TCGA-97-8174-01	20	19	55	0.16491364284032892	TCGA-97-8174-01	10	13	9	32	PASS	6257	TCGA-97-8174	LUAD	67	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-24725	Dead	NA	NA	164	NA	NA	NA	NA	NA	NA	NA	NA	1	164	NA	164	NA	NA	0	164	
60	TCGA-97-8175	1	1	1	2	1	1	0	0	1	23	2	0	2	8	0	0	TCGA-97-8175-01	149	0.2356898073587934	87	TCGA-97-8175-01	8	8	37	0.07519382311291102	TCGA-97-8175-01	4	2	5	11	PASS	6258	TCGA-97-8175	LUAD	55	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-20206	Alive	TUMOR FREE	551	NA	NA	Locoregional Recurrence	NA	NA	294	Complete Remission/Response	NA	NA	0	551	0	551	1	294	1	294	
60	TCGA-97-8176	0	6	1	4	3	0	1	0	7	111	14	1	3	47	5	0	TCGA-97-8176-01	92	0.30096114493536635	37	TCGA-97-8176-01	8	9	43	0.17548296701050872	TCGA-97-8176-01	7	2	4	13	PASS	6259	TCGA-97-8176	LUAD	63	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2012	NA	-23170	Dead	TUMOR FREE	NA	468	NA	Distant Metastasis	NA	NA	39	Stable Disease	NA	NA	1	468	0	468	NA	NA	1	39	
60	TCGA-97-8177	1	1	0	1	2	0	0	0	0	29	0	0	0	15	1	0	TCGA-97-8177-01	230	0.4852270327345855	135	TCGA-97-8177-01	19	27	53	0.4122326738493299	TCGA-97-8177-01	11	11	10	32	PASS	6260	TCGA-97-8177	LUAD	59	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-21648	Alive	TUMOR FREE	499	NA	NA	NA	NA	NA	NA	[Not Evaluated]	NA	NA	0	499	0	499	NA	NA	0	499	
70	TCGA-97-8179	0	9	2	9	7	2	0	0	4	124	10	1	5	41	6	0	TCGA-97-8179-01	80	0.846907189898341	36	TCGA-97-8179-01	30	22	35	0.5602509450560974	TCGA-97-8179-01	9	2	8	19	PASS	6261	TCGA-97-8179	LUAD	72	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-26305	Alive	TUMOR FREE	435	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	435	0	435	0	435	0	435	
80	TCGA-97-8547	0	2	2	0	1	2	1	0	0	44	4	0	0	18	1	0	TCGA-97-8547-01	250	0.4003305756889966	164	TCGA-97-8547-01	10	14	100	0.2806059357978839	TCGA-97-8547-01	9	11	11	31	PASS	6262	TCGA-97-8547	LUAD	78	FEMALE	[Not Evaluated]	Stage IIIA	NA	Lung Adenocarcinoma	NA	2012	NA	-28801	Alive	TUMOR FREE	657	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	657	0	657	0	657	0	657	
60	TCGA-97-8552	2	1	0	1	0	0	2	0	0	17	3	0	0	4	1	0	TCGA-97-8552-01	99	0.3364099133867114	47	TCGA-97-8552-01	21	53	87	0.4131313716946516	TCGA-97-8552-01	9	10	7	26	PASS	6263	TCGA-97-8552	LUAD	55	FEMALE	WHITE	Stage I	NA	Lung Adenocarcinoma	NA	2012	NA	-20331	Alive	TUMOR FREE	626	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	626	0	626	0	626	0	626	
80	TCGA-97-A4LX	0	9	2	5	0	1	0	0	4	132	11	1	4	50	1	0	TCGA-97-A4LX-01	62	0.23649330646515954	20	TCGA-97-A4LX-01	14	14	77	0.3097049328739187	TCGA-97-A4LX-01	6	12	9	27	PASS	6264	TCGA-97-A4LX	LUAD	81	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-29915	Alive	TUMOR FREE	614	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	614	0	614	0	614	0	614	
60	TCGA-97-A4M0	1	33	4	9	10	2	0	0	10	299	22	0	4	110	12	0	TCGA-97-A4M0-01	174	0.6627916415676566	104	TCGA-97-A4M0-01	16	15	82	0.1510764711183329	TCGA-97-A4M0-01	10	8	8	26	PASS	6265	TCGA-97-A4M0	LUAD	60	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2012	NA	-22206	Alive	TUMOR FREE	652	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	652	0	652	0	652	0	652	
50	TCGA-97-A4M1	1	4	0	0	0	0	1	0	2	37	1	0	0	10	0	0	TCGA-97-A4M1-01	201	0.6556901884662271	111	TCGA-97-A4M1-01	20	29	86	0.1574255874027755	TCGA-97-A4M1-01	10	8	2	20	PASS	6266	TCGA-97-A4M1	LUAD	52	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-19272	Alive	TUMOR FREE	601	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	601	0	601	0	601	0	601	
70	TCGA-97-A4M2	0	0	0	0	0	0	0	0	0	25	1	0	0	6	0	0	TCGA-97-A4M2-01	74	0.05907597753864655	32	TCGA-97-A4M2-01	1	2	6	0.0005493183279622382	TCGA-97-A4M2-01	1	2	0	3	PASS	6267	TCGA-97-A4M2	LUAD	66	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-24313	Alive	TUMOR FREE	624	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	624	0	624	0	624	0	624	
70	TCGA-97-A4M3	1	10	0	6	5	1	0	0	9	168	9	1	4	38	6	0	TCGA-97-A4M3-01	301	0.2457371911006653	210	TCGA-97-A4M3-01	5	8	124	0.16183167309875854	TCGA-97-A4M3-01	11	11	9	31	PASS	6268	TCGA-97-A4M3	LUAD	69	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-25384	Alive	TUMOR FREE	540	NA	NA	New Primary Tumor	NA	NA	54	Complete Remission/Response	NA	NA	0	540	0	540	0	540	1	54	
80	TCGA-97-A4M5	0	5	1	3	1	0	1	0	5	116	22	0	2	38	2	0	TCGA-97-A4M5-01	65	0.12192319277040682	24	TCGA-97-A4M5-01	6	6	48	0.2245468470703897	TCGA-97-A4M5-01	5	7	9	21	PASS	6269	TCGA-97-A4M5	LUAD	83	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-30665	Alive	TUMOR FREE	634	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	634	0	634	0	634	0	634	
50	TCGA-97-A4M6	0	3	0	0	2	1	1	0	2	23	1	0	0	12	1	0	TCGA-97-A4M6-01	97	0.4443233110402244	43	TCGA-97-A4M6-01	9	7	85	0.2713641365085558	TCGA-97-A4M6-01	7	5	6	18	PASS	6270	TCGA-97-A4M6	LUAD	45	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-16764	Alive	TUMOR FREE	568	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	568	0	568	0	568	0	568	
70	TCGA-97-A4M7	0	14	1	6	12	3	0	0	13	235	11	1	2	94	9	1	TCGA-97-A4M7-01	116	0.4520938740825689	59	TCGA-97-A4M7-01	9	9	53	0.15440637039659585	TCGA-97-A4M7-01	6	9	5	20	PASS	6271	TCGA-97-A4M7	LUAD	74	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-27062	Alive	TUMOR FREE	629	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	629	0	629	0	629	0	629	
70	TCGA-99-7458	1	21	2	12	21	5	2	0	11	367	32	1	6	130	11	0	TCGA-99-7458-01	72	0.2945330760349948	27	TCGA-99-7458-01	13	12	17	0.2737595064426346	TCGA-99-7458-01	3	3	6	12	PASS	6272	TCGA-99-7458	LUAD	74	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2010	NA	-27359	Alive	WITH TUMOR	747	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	747	0	747	NA	NA	0	747	
70	TCGA-99-8025	2	16	3	14	8	3	0	0	13	392	21	2	10	123	9	1	TCGA-99-8025-01	240	0.7247759339834665	147	TCGA-99-8025-01	20	56	44	0.3363916911265055	TCGA-99-8025-01	23	12	9	44	PASS	6273	TCGA-99-8025	LUAD	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Lung Adenocarcinoma	NA	2010	NA	-26634	Alive	TUMOR FREE	1060	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1060	0	1060	0	1060	0	1060	
50	TCGA-99-8028	1	14	0	11	2	1	1	0	5	335	26	1	6	120	24	2	TCGA-99-8028-01	104	0.06519180491819845	49	TCGA-99-8028-01	3	4	8	0.06619350145001703	TCGA-99-8028-01	5	7	1	13	PASS	6274	TCGA-99-8028	LUAD	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-18542	Alive	TUMOR FREE	1118	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1118	0	1118	0	1118	0	1118	
60	TCGA-99-8032	1	16	2	4	12	5	0	0	13	295	41	0	4	104	11	2	TCGA-99-8032-01	90	0.3130969632187	39	TCGA-99-8032-01	18	21	12	0.11919576940123827	TCGA-99-8032-01	8	8	6	22	PASS	6275	TCGA-99-8032	LUAD	61	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-22635	Alive	TUMOR FREE	44	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	44	0	44	0	44	0	44	
70	TCGA-99-8033	1	4	2	5	6	2	0	0	5	136	17	0	1	50	2	0	TCGA-99-8033-01	86	0.6410608802566753	34	TCGA-99-8033-01	21	23	25	0.3429461614654163	TCGA-99-8033-01	10	13	8	31	PASS	6276	TCGA-99-8033	LUAD	74	FEMALE	WHITE	Stage IV	NA	Lung Adenocarcinoma	NA	2011	NA	-27342	Dead	WITH TUMOR	NA	656	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	656	1	656	NA	NA	1	656	
70	TCGA-99-AA5R	0	3	0	0	1	0	0	0	2	44	8	0	1	14	1	0	TCGA-99-AA5R-01	109	0.005606250087233044	49	TCGA-99-AA5R-01	0	0	5	0.00010649805622640828	TCGA-99-AA5R-01	0	0	0	0	PASS	6277	TCGA-99-AA5R	LUAD	70	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2013	NA	-25778	Alive	TUMOR FREE	658	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	658	0	658	0	658	0	658	
70	TCGA-J2-8192	0	4	0	2	2	1	2	0	0	57	5	0	2	20	2	0	TCGA-J2-8192-01	101	0.4957744799068517	46	TCGA-J2-8192-01	16	35	38	0.2586761678575332	TCGA-J2-8192-01	9	6	5	20	PASS	6278	TCGA-J2-8192	LUAD	65	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-23892	Alive	TUMOR FREE	739	NA	NA	Locoregional Recurrence	NA	NA	482	Progressive Disease	NA	NA	0	739	0	739	NA	NA	1	482	
70	TCGA-J2-8194	0	6	2	4	2	0	1	0	5	127	8	0	0	39	4	0	TCGA-J2-8194-01	54	0.4360798329057482	15	TCGA-J2-8194-01	15	28	3	0.054233903601524636	TCGA-J2-8194-01	3	2	2	7	PASS	6279	TCGA-J2-8194	LUAD	69	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2011	NA	-25441	Alive	WITH TUMOR	724	NA	NA	Distant Metastasis	NA	NA	470	Progressive Disease	NA	NA	0	724	0	724	NA	NA	1	470	
60	TCGA-J2-A4AD	0	18	1	11	9	2	1	0	11	253	19	3	2	94	8	0	TCGA-J2-A4AD-01	130	0.5647080525575328	70	TCGA-J2-A4AD-01	8	9	76	0.2665928168390896	TCGA-J2-A4AD-01	8	8	7	23	PASS	6280	TCGA-J2-A4AD	LUAD	61	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-22414	Dead	WITH TUMOR	NA	550	NA	Locoregional Recurrence|Distant Metastasis	NA	NA	524	[Unknown]	NA	NA	1	550	1	550	NA	NA	1	524	
80	TCGA-J2-A4AE	0	1	0	1	2	0	0	0	3	36	1	0	0	18	2	0	TCGA-J2-A4AE-01	113	0.2693914463176085	61	TCGA-J2-A4AE-01	7	9	39	0.07576473211374428	TCGA-J2-A4AE-01	5	7	4	16	PASS	6281	TCGA-J2-A4AE	LUAD	77	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-28163	Alive	TUMOR FREE	1079	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1079	0	1079	0	1079	0	1079	
70	TCGA-J2-A4AG	0	1	0	6	6	0	0	0	1	66	7	0	1	29	2	1	TCGA-J2-A4AG-01	59	0.1564023465571686	21	TCGA-J2-A4AG-01	4	5	34	0.07810066373827775	TCGA-J2-A4AG-01	4	2	2	8	PASS	6282	TCGA-J2-A4AG	LUAD	66	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-24224	Alive	TUMOR FREE	988	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	988	0	988	0	988	0	988	
50	TCGA-L4-A4E5	2	18	2	6	6	0	0	0	13	248	24	3	4	92	11	0	TCGA-L4-A4E5-01	194	0.9944379749040874	107	TCGA-L4-A4E5-01	17	19	156	0.4904081832193442	TCGA-L4-A4E5-01	16	11	20	47	PASS	6283	TCGA-L4-A4E5	LUAD	48	FEMALE	WHITE	Stage I	NA	Lung Adenocarcinoma	NA	2012	NA	-17680	Alive	TUMOR FREE	578	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	578	0	578	0	578	0	578	
70	TCGA-L4-A4E6	0	2	0	0	0	0	0	0	0	10	0	0	0	9	0	0	TCGA-L4-A4E6-01	33	9.806559097866613e-07	3	TCGA-L4-A4E6	0	0	0	0	TCGA-L4-A4E6	0	0	0	0	PASS	6284	TCGA-L4-A4E6	LUAD	67	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-24631	Alive	TUMOR FREE	435	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	435	0	435	0	435	0	435	
60	TCGA-L9-A443	1	16	1	12	7	3	0	0	6	195	17	1	1	50	10	0	TCGA-L9-A443-01	70	0.5363760721050208	21	TCGA-L9-A443-01	22	25	39	0.13353431453880046	TCGA-L9-A443-01	13	9	8	30	PASS	6285	TCGA-L9-A443	LUAD	63	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-23062	Dead	TUMOR FREE	NA	193	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	193	0	193	0	193	0	193	
60	TCGA-L9-A444	5	28	2	20	15	3	0	0	20	421	34	0	5	157	13	0	TCGA-L9-A444-01	157	0.6660891539199681	88	TCGA-L9-A444-01	30	29	122	0.4366315506292326	TCGA-L9-A444-01	20	11	15	46	PASS	6286	TCGA-L9-A444	LUAD	60	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-22202	Alive	TUMOR FREE	307	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	307	0	307	0	307	0	307	
80	TCGA-L9-A50W	0	0	0	0	0	0	0	0	0	26	3	0	0	5	2	0	TCGA-L9-A50W-01	136	0.419106312028926	70	TCGA-L9-A50W-01	10	8	71	0.17860441991629675	TCGA-L9-A50W-01	6	5	10	21	PASS	6287	TCGA-L9-A50W	LUAD	75	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Lung Adenocarcinoma	NA	2012	NA	-27414	Dead	WITH TUMOR	NA	442	NA	Distant Metastasis	NA	NA	389	Complete Remission/Response	NA	NA	1	442	1	442	1	389	1	389	
40	TCGA-L9-A5IP	0	11	1	4	8	2	1	0	9	221	10	0	3	84	12	0	TCGA-L9-A5IP-01	167	0.9402754790382029	95	TCGA-L9-A5IP-01	26	30	235	0.7014972837573489	TCGA-L9-A5IP-01	14	6	12	32	PASS	6288	TCGA-L9-A5IP	LUAD	40	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Lung Adenocarcinoma	NA	2012	NA	-14681	Dead	WITH TUMOR	NA	58	NA	Locoregional Recurrence|Distant Metastasis	NA	NA	49	Progressive Disease	NA	NA	1	58	1	58	NA	NA	1	49	
60	TCGA-L9-A743	0	9	0	3	1	0	0	0	4	106	7	0	0	39	2	0	TCGA-L9-A743-01	121	0.1980133389718747	67	TCGA-L9-A743-01	16	60	45	0.07105449354824228	TCGA-L9-A743-01	28	18	5	51	PASS	6289	TCGA-L9-A743	LUAD	56	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Lung Adenocarcinoma	NA	2013	NA	-20780	Alive	TUMOR FREE	664	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	664	0	664	0	664	0	664	
70	TCGA-L9-A7SV	4	64	5	44	20	7	0	0	64	1202	110	4	25	474	36	2	TCGA-L9-A7SV-01	406	0.7984852109477422	276	TCGA-L9-A7SV-01	19	42	138	0.2404228973747151	TCGA-L9-A7SV-01	21	17	10	48	hypermutated sample	6290	TCGA-L9-A7SV	LUAD	69	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Lung Adenocarcinoma	NA	2013	NA	-25298	Alive	TUMOR FREE	565	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	565	0	565	0	565	0	565	
60	TCGA-L9-A8F4	4	35	3	23	15	4	1	0	22	590	48	1	18	207	24	1	TCGA-L9-A8F4-01	236	0.5032476284156515	140	TCGA-L9-A8F4-01	23	28	118	0.373988989271721	TCGA-L9-A8F4-01	16	7	14	37	PASS	6291	TCGA-L9-A8F4	LUAD	64	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Adenocarcinoma	NA	2013	NA	-23617	Alive	TUMOR FREE	476	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	476	0	476	NA	NA	0	476	
60	TCGA-MN-A4N1	1	32	1	13	11	2	0	0	17	351	27	2	14	123	11	1	TCGA-MN-A4N1-01	293	0.6642496431802936	190	TCGA-MN-A4N1-01	23	62	140	0.31951803435287657	TCGA-MN-A4N1-01	28	21	15	64	PASS	6292	TCGA-MN-A4N1	LUAD	60	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-21939	Alive	TUMOR FREE	827	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	827	0	827	0	827	0	827	
60	TCGA-MN-A4N4	7	64	7	46	32	7	1	0	49	1150	103	1	29	392	38	2	TCGA-MN-A4N4-01	117	0.6027837610725169	54	TCGA-MN-A4N4-01	19	79	40	0.17791729654885138	TCGA-MN-A4N4-01	24	19	8	51	hypermutated sample	6293	TCGA-MN-A4N4	LUAD	57	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2010	NA	-20888	Alive	TUMOR FREE	1175	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1175	0	1175	0	1175	0	1175	
60	TCGA-MN-A4N5	4	25	0	15	12	4	0	0	20	337	29	0	9	110	16	1	TCGA-MN-A4N5-01	233	0.6186786329534163	136	TCGA-MN-A4N5-01	19	31	104	0.28853890010347544	TCGA-MN-A4N5-01	18	8	13	39	PASS	6294	TCGA-MN-A4N5	LUAD	63	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-23257	Alive	TUMOR FREE	84	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	84	0	84	0	84	0	84	
70	TCGA-MP-A4SV	3	17	0	9	6	2	0	0	19	258	16	0	8	100	12	0	TCGA-MP-A4SV-01	120	0.37766306312396414	54	TCGA-MP-A4SV-01	21	38	61	0.17020008469493042	TCGA-MP-A4SV-01	21	16	5	42	PASS	6295	TCGA-MP-A4SV	LUAD	67	MALE	[Unknown]	Stage IB	NA	Lung Adenocarcinoma	NA	2001	NA	-24516	Dead	NA	NA	2620	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2620	NA	2620	0	2620	0	2620	
50	TCGA-MP-A4SW	0	3	0	0	1	0	0	0	2	49	6	0	0	26	2	0	TCGA-MP-A4SW-01	147	0.38152881416031337	81	TCGA-MP-A4SW-01	7	15	80	0.2152119188581081	TCGA-MP-A4SW-01	14	14	11	39	PASS	6296	TCGA-MP-A4SW	LUAD	53	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2002	NA	-19640	Dead	NA	NA	1778	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1778	NA	1778	0	1778	0	1778	
60	TCGA-MP-A4SY	1	9	1	7	1	0	1	0	4	140	10	0	5	35	5	1	TCGA-MP-A4SY-01	46	0.3175081802959044	8	TCGA-MP-A4SY-01	9	8	26	0.124081148021341	TCGA-MP-A4SY-01	3	9	4	16	PASS	6297	TCGA-MP-A4SY	LUAD	61	MALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2002	NA	-22448	Dead	TUMOR FREE	NA	1501	NA	Locoregional Recurrence	NA	NA	489	Complete Remission/Response	NA	NA	1	1501	0	1501	1	489	1	489	
70	TCGA-MP-A4T2	0	3	0	6	1	0	0	0	1	62	9	0	3	26	1	0	TCGA-MP-A4T2-01	70	0.4439072629435511	26	TCGA-MP-A4T2-01	19	56	17	0.07156994893244918	TCGA-MP-A4T2-01	3	2	1	6	PASS	6298	TCGA-MP-A4T2	LUAD	71	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2003	NA	-26010	Dead	WITH TUMOR	NA	1136	NA	Distant Metastasis	NA	NA	575	Complete Remission/Response	NA	NA	1	1136	1	1136	1	575	1	575	
70	TCGA-MP-A4T4	1	15	1	11	8	3	0	0	9	311	23	1	5	101	8	0	TCGA-MP-A4T4-01	100	0.33549385433333445	38	TCGA-MP-A4T4	0	0	0	0	TCGA-MP-A4T4	0	0	0	0	PASS	6299	TCGA-MP-A4T4	LUAD	68	FEMALE	WHITE	Stage IIB	NA	Lung Adenocarcinoma	NA	2004	NA	-25052	Dead	NA	NA	2617	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2617	NA	2617	0	2617	0	2617	
80	TCGA-MP-A4T6	0	4	0	6	0	0	1	0	4	52	5	0	0	24	0	0	TCGA-MP-A4T6-01	128	0.806012465583809	67	TCGA-MP-A4T6	0	0	0	0	TCGA-MP-A4T6	0	0	0	0	PASS	6300	TCGA-MP-A4T6	LUAD	76	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2005	NA	-27993	Dead	TUMOR FREE	NA	1790	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1790	0	1790	0	1790	0	1790	
80	TCGA-MP-A4T7	0	4	0	5	1	0	1	0	0	111	10	0	2	26	2	0	TCGA-MP-A4T7-01	54	0.4996009937643163	14	TCGA-MP-A4T7-01	19	21	43	0.1960407071492805	TCGA-MP-A4T7-01	7	6	5	18	PASS	6301	TCGA-MP-A4T7	LUAD	75	FEMALE	[Unknown]	Stage IV	NA	Lung Adenocarcinoma	NA	2005	NA	-27603	Dead	NA	NA	167	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	167	NA	167	NA	NA	0	167	
70	TCGA-MP-A4T8	0	5	1	3	3	2	1	0	6	91	7	0	7	28	3	0	TCGA-MP-A4T8-01	214	0.5209541031471875	132	TCGA-MP-A4T8-01	13	32	60	0.13437013096421851	TCGA-MP-A4T8-01	16	9	7	32	PASS	6302	TCGA-MP-A4T8	LUAD	68	MALE	[Unknown]	Stage IIIA	NA	Lung Adenocarcinoma	NA	2006	NA	-25069	Dead	NA	NA	161	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	161	NA	161	NA	NA	0	161	
50	TCGA-MP-A4T9	0	2	0	1	0	0	1	0	0	26	2	0	0	16	0	0	TCGA-MP-A4T9-01	48	0.1834521097832052	12	TCGA-MP-A4T9-01	10	17	73	0.311133728561018	TCGA-MP-A4T9-01	13	13	11	37	PASS	6303	TCGA-MP-A4T9	LUAD	54	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2006	NA	-19767	Dead	WITH TUMOR	NA	1265	NA	Locoregional Recurrence|Distant Metastasis	NA	NA	341	Complete Remission/Response	NA	NA	1	1265	1	1265	1	341	1	341	
80	TCGA-MP-A4TA	1	22	3	7	7	1	1	0	8	259	34	0	8	108	6	2	TCGA-MP-A4TA-01	69	0.22097820751011307	22	TCGA-MP-A4TA-01	11	14	74	0.40835945721996336	TCGA-MP-A4TA-01	7	10	13	30	PASS	6304	TCGA-MP-A4TA	LUAD	75	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2006	NA	-27513	Dead	WITH TUMOR	NA	950	NA	Distant Metastasis	NA	NA	725	Complete Remission/Response	NA	NA	1	950	1	950	1	725	1	725	
80	TCGA-MP-A4TC	1	18	2	7	8	1	1	0	10	191	20	0	3	71	5	0	TCGA-MP-A4TC-01	144	0.6858476559639286	74	TCGA-MP-A4TC-01	12	21	185	0.6357377640156013	TCGA-MP-A4TC-01	10	1	12	23	PASS	6305	TCGA-MP-A4TC	LUAD	77	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2008	NA	-28471	Dead	TUMOR FREE	NA	74	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	74	0	74	0	74	0	74	
70	TCGA-MP-A4TD	1	4	1	2	4	0	1	0	2	59	3	0	2	26	3	0	TCGA-MP-A4TD-01	83	0.3467251606789561	31	TCGA-MP-A4TD	0	0	0	0	TCGA-MP-A4TD	0	0	0	0	PASS	6306	TCGA-MP-A4TD	LUAD	71	MALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2008	NA	-25983	Dead	NA	NA	307	NA	Locoregional Recurrence	NA	NA	226	Complete Remission/Response	NA	NA	1	307	NA	307	1	226	1	226	
60	TCGA-MP-A4TE	0	10	0	3	4	1	0	0	3	107	6	0	5	36	5	1	TCGA-MP-A4TE-01	145	0.4502837301101445	72	TCGA-MP-A4TE-01	18	29	58	0.15735589141897552	TCGA-MP-A4TE-01	8	5	3	16	PASS	6307	TCGA-MP-A4TE	LUAD	56	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2010	NA	-20627	Dead	WITH TUMOR	NA	896	NA	Locoregional Recurrence	NA	NA	226	Complete Remission/Response	NA	NA	1	896	1	896	1	226	1	226	
60	TCGA-MP-A4TF	1	33	4	14	12	1	0	0	15	325	29	1	6	115	6	1	TCGA-MP-A4TF-01	161	0.7576951812378571	91	TCGA-MP-A4TF-01	28	55	94	0.3758592881697477	TCGA-MP-A4TF-01	22	19	11	52	PASS	6308	TCGA-MP-A4TF	LUAD	58	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2010	NA	-21387	Dead	WITH TUMOR	NA	336	NA	Distant Metastasis	NA	NA	195	Partial Remission/Response	NA	NA	1	336	1	336	NA	NA	1	195	
70	TCGA-MP-A4TH	0	8	0	3	4	1	0	0	1	86	12	0	3	23	4	0	TCGA-MP-A4TH-01	80	0.2304825169901065	29	TCGA-MP-A4TH-01	6	5	39	0.07650821330444914	TCGA-MP-A4TH-01	6	6	4	16	PASS	6309	TCGA-MP-A4TH	LUAD	70	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2012	NA	-25759	Alive	TUMOR FREE	741	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	741	0	741	0	741	0	741	
70	TCGA-MP-A4TI	0	9	2	3	0	0	0	0	4	181	19	0	6	89	4	1	TCGA-MP-A4TI-01	80	0.172183187435926	22	TCGA-MP-A4TI-01	8	14	84	0.2496033563431406	TCGA-MP-A4TI-01	13	19	12	44	PASS	6310	TCGA-MP-A4TI	LUAD	72	MALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2010	NA	-26565	Dead	WITH TUMOR	NA	429	NA	Locoregional Recurrence|Distant Metastasis	NA	NA	84	[Unknown]	NA	NA	1	429	1	429	NA	NA	1	84	
60	TCGA-MP-A4TJ	1	5	0	1	3	0	0	0	2	74	5	0	1	24	2	0	TCGA-MP-A4TJ-01	106	0.3543447890749443	49	TCGA-MP-A4TJ	0	0	0	0	TCGA-MP-A4TJ	0	0	0	0	PASS	6311	TCGA-MP-A4TJ	LUAD	62	FEMALE	[Unknown]	Stage IA	NA	Lung Adenocarcinoma	NA	2006	NA	-22875	Dead	NA	NA	339	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	339	NA	339	0	339	0	339	
60	TCGA-MP-A4TK	2	19	1	13	7	1	2	0	11	268	21	0	3	95	13	0	TCGA-MP-A4TK-01	313	0.53964290075017	200	TCGA-MP-A4TK-01	18	38	172	0.4013728857961452	TCGA-MP-A4TK-01	23	17	21	61	PASS	6312	TCGA-MP-A4TK	LUAD	56	FEMALE	[Unknown]	Stage IIB	NA	Lung Adenocarcinoma	NA	2002	NA	-20581	Dead	WITH TUMOR	NA	582	NA	Distant Metastasis	NA	NA	397	Complete Remission/Response	NA	NA	1	582	1	582	1	397	1	397	
80	TCGA-MP-A5C7	0	8	0	2	2	3	0	0	3	48	2	0	1	32	2	0	TCGA-MP-A5C7-01	137	0.2192519208273294	61	TCGA-MP-A5C7-01	6	6	64	0.12886230903022902	TCGA-MP-A5C7-01	7	2	5	14	PASS	6313	TCGA-MP-A5C7	LUAD	76	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2008	NA	-28015	Alive	TUMOR FREE	2248	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2248	0	2248	0	2248	0	2248	
50	TCGA-NJ-A4YF	1	51	3	23	17	5	0	0	18	453	45	2	19	152	17	1	TCGA-NJ-A4YF-01	665	0.6879980881760764	484	TCGA-NJ-A4YF-01	18	36	287	0.4392931173036829	TCGA-NJ-A4YF-01	28	22	13	63	PASS	6314	TCGA-NJ-A4YF	LUAD	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2007	NA	-18584	Alive	TUMOR FREE	2161	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	2161	0	2161	NA	NA	0	2161	
70	TCGA-NJ-A4YG	2	11	1	5	1	2	0	0	8	116	9	0	3	41	3	0	TCGA-NJ-A4YG-01	79	0.24141877089579236	36	TCGA-NJ-A4YG-01	8	15	43	0.15434959661085512	TCGA-NJ-A4YG-01	7	2	3	12	PASS	6315	TCGA-NJ-A4YG	LUAD	65	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2008	NA	-23812	Alive	TUMOR FREE	2261	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	2261	0	2261	NA	NA	0	2261	
90	TCGA-NJ-A4YI	3	29	0	8	14	2	2	0	16	328	28	1	7	126	16	0	TCGA-NJ-A4YI-01	80	0.8202363042535188	34	TCGA-NJ-A4YI-01	18	21	40	0.14184063554415186	TCGA-NJ-A4YI-01	11	5	6	22	PASS	6316	TCGA-NJ-A4YI	LUAD	87	FEMALE	WHITE	Stage IIIA	NA	Lung Adenocarcinoma	NA	2009	NA	-31867	Dead	NA	NA	4	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	4	NA	4	NA	NA	0	4	
50	TCGA-NJ-A4YP	2	32	2	18	7	1	0	0	19	387	57	1	8	159	9	0	TCGA-NJ-A4YP-01	68	0.14868536820038075	26	TCGA-NJ-A4YP-01	8	14	24	0.0874159235899019	TCGA-NJ-A4YP-01	4	1	3	8	PASS	6317	TCGA-NJ-A4YP	LUAD	52	MALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2011	NA	-19106	Alive	TUMOR FREE	50	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	50	0	50	NA	NA	0	50	
70	TCGA-NJ-A4YQ	5	60	5	25	33	4	1	0	31	843	78	2	29	290	29	1	TCGA-NJ-A4YQ-01	148	0.5059401289084126	77	TCGA-NJ-A4YQ-01	15	15	133	0.4049417587988908	TCGA-NJ-A4YQ-01	12	14	14	40	hypermutated sample	6318	TCGA-NJ-A4YQ	LUAD	69	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-25427	Alive	TUMOR FREE	1432	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1432	0	1432	NA	NA	0	1432	
80	TCGA-NJ-A55A	1	6	1	2	2	1	0	0	6	92	1	1	3	34	0	0	TCGA-NJ-A55A-01	45	0.07559013094607911	6	TCGA-NJ-A55A-01	1	1	11	0.0038154178535621712	TCGA-NJ-A55A-01	1	1	0	2	PASS	6319	TCGA-NJ-A55A	LUAD	76	FEMALE	WHITE	Stage IB	NA	Lung Adenocarcinoma	NA	2009	NA	-28022	Alive	TUMOR FREE	15	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	15	0	15	NA	NA	0	15	
60	TCGA-NJ-A55O	0	1	0	4	2	2	0	0	5	107	11	0	2	35	1	0	TCGA-NJ-A55O-01	86	0.07704715690243535	36	TCGA-NJ-A55O	0	0	0	0	TCGA-NJ-A55O	0	0	0	0	PASS	6320	TCGA-NJ-A55O	LUAD	56	FEMALE	WHITE	Stage IIA	NA	Lung Adenocarcinoma	NA	2011	NA	-20628	Alive	TUMOR FREE	13	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	13	0	13	NA	NA	0	13	
70	TCGA-NJ-A55R	0	11	2	4	8	2	0	0	10	191	16	0	4	77	12	1	TCGA-NJ-A55R-01	62	0.18380251631631486	21	TCGA-NJ-A55R-01	21	21	29	0.14561812732580467	TCGA-NJ-A55R-01	8	7	3	18	PASS	6321	TCGA-NJ-A55R	LUAD	67	MALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2011	NA	-24738	Alive	TUMOR FREE	603	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	603	0	603	NA	NA	0	603	
50	TCGA-NJ-A7XG	0	0	0	1	3	1	0	0	0	22	1	0	0	18	0	0	TCGA-NJ-A7XG-01	116	0.5475797327775107	55	TCGA-NJ-A7XG-01	16	16	29	0.03457117289594934	TCGA-NJ-A7XG-01	6	10	1	17	PASS	6322	TCGA-NJ-A7XG	LUAD	49	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Lung Adenocarcinoma	NA	2013	NA	-18127	Alive	WITH TUMOR	617	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	617	0	617	NA	NA	0	617	
70	TCGA-O1-A52J	0	7	0	6	5	1	1	0	6	130	9	0	3	48	4	1	TCGA-O1-A52J-01	321	0.6816310993881461	224	TCGA-O1-A52J-01	29	23	155	0.2790378488506326	TCGA-O1-A52J-01	12	8	9	29	PASS	6323	TCGA-O1-A52J	LUAD	74	FEMALE	WHITE	Stage IA	NA	Lung Adenocarcinoma	NA	2007	NA	-27223	Dead	WITH TUMOR	NA	1798	NA	Locoregional Recurrence	NA	NA	898	[Unknown]	NA	NA	1	1798	1	1798	NA	NA	1	898	
70	TCGA-S2-AA1A	0	3	0	2	2	0	0	0	4	89	10	0	1	33	2	0	TCGA-S2-AA1A-01	112	0.484895311610474	60	TCGA-S2-AA1A-01	16	17	42	0.09862929691623773	TCGA-S2-AA1A-01	3	4	5	12	PASS	6324	TCGA-S2-AA1A	LUAD	68	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Adenocarcinoma	NA	2013	NA	-24903	Alive	TUMOR FREE	513	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	513	0	513	0	513	0	513	
70	TCGA-18-3406	1	18	1	6	2	0	0	0	13	221	15	1	6	104	5	1	TCGA-18-3406-01	272	0.5194279125984279	156	TCGA-18-3406-01	8	11	54	0.3576315099074568	TCGA-18-3406-01	14	12	14	40	PASS	6325	TCGA-18-3406	LUSC	67	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-24477	Dead	WITH TUMOR	NA	371	NA	Locoregional Recurrence	NA	NA	357	Progressive Disease	NA	NA	1	371	1	371	NA	NA	1	357	
70	TCGA-18-3407	1	12	0	5	3	0	0	0	10	260	27	0	2	93	4	0	TCGA-18-3407-01	115	0.613492295321283	60	TCGA-18-3407-01	25	18	20	0.2099191469613237	TCGA-18-3407-01	9	4	5	18	PASS	6326	TCGA-18-3407	LUSC	72	MALE	ASIAN	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-26615	Dead	TUMOR FREE	NA	136	NA	NA	NA	NA	NA	NA	NA	NA	1	136	0	136	NA	NA	0	136	
80	TCGA-18-3408	0	5	1	5	3	3	1	0	2	81	8	0	1	26	2	0	TCGA-18-3408-01	127	0.3729604611816172	61	TCGA-18-3408-01	5	5	16	0.15783025133170556	TCGA-18-3408-01	4	3	4	11	PASS	6327	TCGA-18-3408	LUSC	77	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-28171	Dead	WITH TUMOR	NA	2304	NA	Locoregional Recurrence	NA	NA	1793	[Unknown]	NA	NA	1	2304	1	2304	NA	NA	1	1793	
70	TCGA-18-3409	23	188	10	90	11	2	1	1	122	2309	137	0	57	1347	39	1	TCGA-18-3409	0	0	0	TCGA-18-3409	0	0	0	0	TCGA-18-3409-01	3	3	1	7	hypermutated sample	6328	TCGA-18-3409	LUSC	74	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-27154	Alive	TUMOR FREE	3747	NA	NA	New Primary Tumor	NA	NA	2291	Complete Remission/Response	NA	NA	0	3747	0	3747	0	3747	1	2291	
80	TCGA-18-3410	2	23	1	16	5	0	0	0	14	278	23	0	1	114	4	1	TCGA-18-3410-01	199	0.5585900225642659	112	TCGA-18-3410-01	20	19	29	0.23608954774709565	TCGA-18-3410-01	6	6	8	20	PASS	6329	TCGA-18-3410	LUSC	81	MALE	NA	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-29827	Dead	TUMOR FREE	NA	146	NA	NA	NA	NA	NA	NA	NA	NA	1	146	0	146	NA	NA	0	146	
60	TCGA-18-3411	2	18	0	14	3	0	1	0	22	330	28	0	5	121	6	1	TCGA-18-3411-01	308	0.7180637246183952	206	TCGA-18-3411-01	19	57	54	0.4328581733630655	TCGA-18-3411-01	23	16	11	50	PASS	6330	TCGA-18-3411	LUSC	63	FEMALE	NA	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-23370	Alive	TUMOR FREE	3576	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	3576	0	3576	NA	NA	0	3576	
50	TCGA-18-3412	0	15	0	4	2	1	0	0	6	191	23	1	6	69	7	0	TCGA-18-3412-01	295	0.8488561926332668	172	TCGA-18-3412-01	17	40	42	0.18530615444693951	TCGA-18-3412-01	16	17	9	42	PASS	6331	TCGA-18-3412	LUSC	52	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-19025	Dead	WITH TUMOR	NA	345	NA	Distant Metastasis	NA	NA	273	Progressive Disease	NA	NA	1	345	1	345	NA	NA	1	273	
70	TCGA-18-3414	1	11	2	13	3	5	1	0	8	304	27	0	3	90	4	2	TCGA-18-3414-01	308	0.5199584183468405	191	TCGA-18-3414-01	11	17	43	0.19082717963565565	TCGA-18-3414-01	13	6	7	26	PASS	6332	TCGA-18-3414	LUSC	73	MALE	ASIAN	Stage IV	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-26938	Dead	TUMOR FREE	NA	716	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	716	0	716	NA	NA	0	716	
80	TCGA-18-3415	3	11	1	3	4	1	3	0	13	145	12	0	5	53	5	0	TCGA-18-3415-01	356	0.7077612500439254	216	TCGA-18-3415-01	17	40	83	0.44000989504283294	TCGA-18-3415-01	18	20	10	48	PASS	6333	TCGA-18-3415	LUSC	77	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-28430	Dead	TUMOR FREE	NA	2803	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2803	0	2803	0	2803	0	2803	
80	TCGA-18-3416	4	36	2	11	7	2	0	0	22	492	51	0	12	190	15	2	TCGA-18-3416-01	361	0.7688482517100204	223	TCGA-18-3416-01	19	32	74	0.4568333099868353	TCGA-18-3416-01	22	19	18	59	PASS	6334	TCGA-18-3416	LUSC	83	MALE	NA	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-30435	Dead	WITH TUMOR	NA	973	NA	Distant Metastasis	NA	NA	940	Complete Remission/Response	NA	NA	1	973	1	973	1	940	1	940	
70	TCGA-18-3417	0	13	0	8	8	1	0	0	11	211	21	0	9	77	7	0	TCGA-18-3417-01	245	0.7445685772464218	144	TCGA-18-3417-01	29	66	62	0.5329188707477077	TCGA-18-3417-01	20	9	12	41	PASS	6335	TCGA-18-3417	LUSC	65	MALE	NA	Stage IV	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-24019	Dead	TUMOR FREE	NA	1097	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1097	0	1097	NA	NA	0	1097	
70	TCGA-18-3419	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-18-3419-01	256	0.32915239364571314	149	TCGA-18-3419-01	11	11	36	0.20468246995657025	TCGA-18-3419-01	11	8	11	30	PASS	6336	TCGA-18-3419	LUSC	73	MALE	NA	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-26813	Alive	TUMOR FREE	2811	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2811	0	2811	0	2811	0	2811	
70	TCGA-18-3421	1	27	2	15	9	1	1	0	18	463	52	1	12	157	16	1	TCGA-18-3421-01	300	0.6046250179506859	179	TCGA-18-3421-01	13	31	71	0.3993784622918205	TCGA-18-3421-01	24	32	10	66	PASS	6337	TCGA-18-3421	LUSC	65	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-23972	Alive	TUMOR FREE	2645	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2645	0	2645	0	2645	0	2645	
60	TCGA-18-4083	2	29	4	12	4	1	0	0	16	289	25	0	8	81	10	1	TCGA-18-4083-01	364	0.7682361400079594	219	TCGA-18-4083-01	14	35	59	0.3247030738738248	TCGA-18-4083-01	21	21	8	50	PASS	6338	TCGA-18-4083	LUSC	63	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-23125	Dead	TUMOR FREE	NA	188	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	188	0	188	NA	NA	0	188	
60	TCGA-18-4086	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-18-4086-01	237	0.32943505925907696	157	TCGA-18-4086-01	4	9	25	0.21830207919176686	TCGA-18-4086-01	13	10	9	32	PASS	6339	TCGA-18-4086	LUSC	64	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-23731	Dead	TUMOR FREE	NA	85	NA	NA	NA	NA	NA	NA	NA	NA	1	85	0	85	NA	NA	0	85	
70	TCGA-18-4721	2	11	1	5	2	2	1	0	7	128	12	0	4	54	6	1	TCGA-18-4721-01	213	0.4775596936161845	130	TCGA-18-4721-01	9	18	57	0.5010345784649843	TCGA-18-4721-01	19	12	20	51	PASS	6340	TCGA-18-4721	LUSC	74	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-27076	Alive	TUMOR FREE	4694	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4694	0	4694	0	4694	0	4694	
60	TCGA-18-5592	2	20	3	17	14	0	1	0	8	228	10	2	6	65	6	1	TCGA-18-5592-01	172	0.9097078864999912	89	TCGA-18-5592-01	12	17	29	0.4284457091582355	TCGA-18-5592-01	11	9	8	28	PASS	6341	TCGA-18-5592	LUSC	57	MALE	NA	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-21020	Alive	TUMOR FREE	1519	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1519	0	1519	NA	NA	0	1519	
50	TCGA-18-5595	1	16	2	14	1	1	0	0	11	170	22	0	5	72	6	0	TCGA-18-5595	0	0	0	TCGA-18-5595	0	0	0	0	TCGA-18-5595-01	4	4	4	12	PASS	6342	TCGA-18-5595	LUSC	50	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-18611	Dead	NA	NA	827	NA	NA	NA	NA	NA	NA	NA	NA	1	827	NA	827	NA	NA	0	827	
60	TCGA-21-1070	6	39	1	16	16	2	2	0	13	430	34	1	13	121	20	2	TCGA-21-1070	0	0	0	TCGA-21-1070	0	0	0	0	TCGA-21-1070-01	13	14	14	41	PASS	6343	TCGA-21-1070	LUSC	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2000	NA	-22273	Alive	TUMOR FREE	3636	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3636	0	3636	NA	NA	0	3636	
70	TCGA-21-1071	0	7	0	5	3	0	0	0	6	148	6	0	2	39	5	1	TCGA-21-1071-01	163	0.5404295022257112	87	TCGA-21-1071-01	25	57	32	0.3673981543812089	TCGA-21-1071-01	9	5	8	22	PASS	6344	TCGA-21-1071	LUSC	67	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-24515	Dead	WITH TUMOR	1426	1426	NA	NA	NA	NA	993	NA	NA	NA	1	1426	1	1426	NA	NA	1	993	
80	TCGA-21-1072	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-21-1072-01	154	0.8245899982029601	85	TCGA-21-1072-01	19	31	31	0.37922200722248617	TCGA-21-1072-01	17	12	14	43	PASS	6345	TCGA-21-1072	LUSC	75	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-27397	Alive	TUMOR FREE	3016	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3016	0	3016	NA	NA	0	3016	
60	TCGA-21-1075	0	16	1	3	5	2	1	0	6	153	13	0	3	50	1	0	TCGA-21-1075-01	177	0.574625323720656	104	TCGA-21-1075-01	19	27	53	0.3882319379175229	TCGA-21-1075-01	15	4	11	30	mutation call filter	6346	TCGA-21-1075	LUSC	57	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-21093	Alive	TUMOR FREE	2134	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2134	0	2134	NA	NA	0	2134	
50	TCGA-21-1076	2	16	2	5	7	1	1	0	6	246	18	1	11	88	13	2	TCGA-21-1076-01	78	0.4799752305013135	28	TCGA-21-1076-01	32	19	24	0.4291859998281416	TCGA-21-1076-01	10	6	6	22	PASS	6347	TCGA-21-1076	LUSC	54	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-19863	Alive	TUMOR FREE	1852	NA	NA	NA	NA	NA	1575	NA	NA	NA	0	1852	0	1852	NA	NA	1	1575	
60	TCGA-21-1077	4	16	1	8	8	3	0	0	9	162	21	0	6	64	5	0	TCGA-21-1077	0	0	0	TCGA-21-1077	0	0	0	0	TCGA-21-1077-01	12	12	6	30	PASS	6348	TCGA-21-1077	LUSC	64	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-23523	Dead	WITH TUMOR	1058	1058	NA	NA	NA	NA	644	NA	NA	NA	1	1058	1	1058	NA	NA	1	644	
80	TCGA-21-1078	0	8	0	2	2	2	2	0	3	60	6	0	0	19	1	0	TCGA-21-1078	0	0	0	TCGA-21-1078	0	0	0	0	TCGA-21-1078-01	2	1	2	5	PASS	6349	TCGA-21-1078	LUSC	77	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-28125	Dead	WITH TUMOR	469	474	NA	NA	NA	NA	257	NA	NA	NA	1	474	1	474	NA	NA	1	257	
70	TCGA-21-1079	7	94	14	41	7	1	1	0	71	1275	88	0	40	753	26	1	TCGA-21-1079-01	149	0.6655911900235965	73	TCGA-21-1079-01	19	37	21	0.15031702853445852	TCGA-21-1079-01	16	12	8	36	mutation call filter	6350	TCGA-21-1079	LUSC	71	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	1995	NA	-26176	Dead	WITH TUMOR	965	965	NA	NA	NA	NA	317	NA	NA	NA	1	965	1	965	NA	NA	1	317	
70	TCGA-21-1080	8	39	4	19	106	26	8	0	30	698	43	0	17	284	19	3	TCGA-21-1080-01	163	0.8451106722252716	87	TCGA-21-1080-01	13	17	42	0.3212561604035905	TCGA-21-1080-01	16	5	11	32	mutation call filter	6351	TCGA-21-1080	LUSC	66	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	1996	NA	-24253	Alive	TUMOR FREE	3724	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3724	0	3724	NA	NA	0	3724	
70	TCGA-21-1081	2	15	0	7	4	0	1	0	5	166	12	0	3	48	3	0	TCGA-21-1081-01	161	0.8290661552947857	87	TCGA-21-1081-01	31	28	50	0.638498737598807	TCGA-21-1081-01	12	6	13	31	PASS	6352	TCGA-21-1081	LUSC	69	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	1996	NA	-25440	Dead	WITH TUMOR	284	284	NA	NA	NA	NA	NA	NA	NA	NA	1	284	1	284	NA	NA	1	284	
60	TCGA-21-1082	1	25	1	14	13	0	1	0	9	287	29	1	11	114	6	0	TCGA-21-1082-01	185	0.8345952950110028	99	TCGA-21-1082-01	10	15	55	0.4219534706056269	TCGA-21-1082-01	18	12	16	46	PASS	6353	TCGA-21-1082	LUSC	61	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	1997	NA	-22492	Alive	TUMOR FREE	3644	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3644	0	3644	NA	NA	0	3644	
80	TCGA-21-1083	0	48	6	29	20	3	0	0	26	567	45	0	14	167	15	3	TCGA-21-1083	0	0	0	TCGA-21-1083	0	0	0	0	TCGA-21-1083-01	19	14	13	46	PASS	6354	TCGA-21-1083	LUSC	75	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	1997	NA	-27708	Dead	TUMOR FREE	267	1315	NA	NA	NA	NA	NA	NA	NA	NA	1	1315	0	1315	NA	NA	0	1315	
70	TCGA-21-5782	2	16	2	11	10	0	2	1	14	293	29	0	5	103	13	0	TCGA-21-5782-01	239	0.3803199885728671	139	TCGA-21-5782-01	9	13	47	0.3214156346784335	TCGA-21-5782-01	18	19	15	52	PASS	6355	TCGA-21-5782	LUSC	68	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-24969	Dead	NA	962	962	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	962	NA	962	0	962	0	962	
80	TCGA-21-5783	1	18	4	9	10	3	2	0	14	311	30	1	7	129	12	2	TCGA-21-5783-01	389	0.5027591442526589	269	TCGA-21-5783-01	17	34	138	0.35271561397394263	TCGA-21-5783-01	19	7	8	34	PASS	6356	TCGA-21-5783	LUSC	76	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-27904	Dead	NA	NA	2680	NA	NA	NA	NA	NA	NA	NA	NA	1	2680	NA	2680	NA	NA	0	2680	
80	TCGA-21-5784	0	7	1	4	0	2	0	0	1	168	10	0	6	54	9	1	TCGA-21-5784-01	88	0.2180672148116576	32	TCGA-21-5784-01	12	34	14	0.4479860897260661	TCGA-21-5784-01	5	4	5	14	PASS	6357	TCGA-21-5784	LUSC	80	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-29362	Alive	TUMOR FREE	1268	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1268	0	1268	0	1268	0	1268	
60	TCGA-21-5786	1	19	5	5	11	0	1	0	11	314	25	0	8	92	6	1	TCGA-21-5786-01	217	0.813619674782605	118	TCGA-21-5786-01	24	33	47	0.5242674016960437	TCGA-21-5786-01	21	9	16	46	PASS	6358	TCGA-21-5786	LUSC	64	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-23649	Alive	TUMOR FREE	1032	NA	NA	Locoregional Recurrence	NA	NA	817	Complete Remission/Response	NA	NA	0	1032	0	1032	1	817	1	817	
70	TCGA-21-5787	0	20	5	12	12	5	0	1	7	314	30	0	7	108	9	2	TCGA-21-5787-01	294	0.8441244073439558	188	TCGA-21-5787-01	23	36	68	0.4606220278183682	TCGA-21-5787-01	20	18	12	50	PASS	6359	TCGA-21-5787	LUSC	65	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-24071	Dead	WITH TUMOR	329	329	NA	NA	NA	NA	103	Progressive Disease	NA	NA	1	329	1	329	NA	NA	1	103	
80	TCGA-21-A5DI	0	3	0	6	4	3	0	0	5	102	6	1	6	40	2	1	TCGA-21-A5DI	0	0	0	TCGA-21-A5DI	0	0	0	0	TCGA-21-A5DI-01	11	7	8	26	PASS	6360	TCGA-21-A5DI	LUSC	77	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-28374	Alive	TUMOR FREE	979	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	979	0	979	0	979	0	979	
70	TCGA-22-0940	1	16	1	6	10	2	1	0	10	169	10	0	5	53	5	0	TCGA-22-0940-01	169	0.3777523827359355	92	TCGA-22-0940-01	11	16	42	0.3720684842285914	TCGA-22-0940-01	15	11	14	40	PASS	6361	TCGA-22-0940	LUSC	71	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2000	NA	-26272	Dead	WITH TUMOR	608	669	NA	NA	NA	NA	NA	NA	NA	NA	1	669	1	669	NA	NA	1	669	
60	TCGA-22-0944	1	9	0	3	3	1	1	0	6	93	7	0	4	40	2	0	TCGA-22-0944-01	147	0.6754070857667674	69	TCGA-22-0944-01	10	13	38	0.3628995083141072	TCGA-22-0944-01	15	8	13	36	PASS	6362	TCGA-22-0944	LUSC	61	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2000	NA	-22329	Dead	TUMOR FREE	223	223	NA	NA	NA	NA	NA	NA	NA	NA	1	223	0	223	NA	NA	0	223	
80	TCGA-22-1000	0	4	0	1	1	1	0	0	2	78	6	0	1	26	4	0	TCGA-22-1000-01	76	0.21528780793098212	24	TCGA-22-1000-01	11	10	13	0.31718707092882537	TCGA-22-1000-01	4	2	3	9	PASS	6363	TCGA-22-1000	LUSC	76	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2000	NA	-27901	Dead	WITH TUMOR	NA	454	NA	NA	NA	NA	263	Complete Remission/Response	NA	NA	1	454	1	454	1	263	1	263	
70	TCGA-22-1002	0	14	1	9	6	1	0	0	11	184	17	0	5	56	2	0	TCGA-22-1002-01	115	0.26956383844018866	53	TCGA-22-1002-01	9	7	19	0.2420001019898279	TCGA-22-1002-01	6	2	7	15	PASS	6364	TCGA-22-1002	LUSC	69	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-25359	Dead	TUMOR FREE	131	131	NA	NA	NA	NA	NA	NA	NA	NA	1	131	0	131	NA	NA	0	131	
60	TCGA-22-1005	1	12	1	4	4	0	1	0	7	217	15	0	4	83	5	1	TCGA-22-1005-01	103	0.0029389744724135428	50	TCGA-22-1005-01	4	7	9	0.12138464768184118	TCGA-22-1005-01	3	4	4	11	PASS	6365	TCGA-22-1005	LUSC	63	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-23322	Dead	TUMOR FREE	1953	1953	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1953	0	1953	0	1953	0	1953	
70	TCGA-22-1011	0	3	2	4	1	1	0	0	3	84	7	0	1	27	4	0	TCGA-22-1011-01	58	0.5074921569239171	18	TCGA-22-1011-01	18	12	14	0.4991862720022697	TCGA-22-1011-01	4	2	4	10	PASS	6366	TCGA-22-1011	LUSC	73	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-26732	Dead	TUMOR FREE	53	53	NA	NA	NA	NA	NA	NA	NA	NA	1	53	0	53	NA	NA	0	53	
80	TCGA-22-1012	3	19	1	8	9	1	1	0	19	195	16	0	5	74	9	0	TCGA-22-1012-01	199	0.6729607485127278	120	TCGA-22-1012-01	22	26	32	0.3256033279380024	TCGA-22-1012-01	21	19	9	49	PASS	6367	TCGA-22-1012	LUSC	80	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-29273	Dead	TUMOR FREE	NA	429	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	429	0	429	0	429	0	429	
70	TCGA-22-1016	2	14	3	12	9	1	0	0	11	259	31	0	11	96	11	0	TCGA-22-1016-01	147	0.5404464471601216	83	TCGA-22-1016-01	22	34	32	0.4855619688054644	TCGA-22-1016-01	16	8	10	34	PASS	6368	TCGA-22-1016	LUSC	65	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-24078	Dead	TUMOR FREE	802	822	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	822	0	822	0	822	0	822	
60	TCGA-22-1017	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-22-1017-01	249	0.5203557282028964	151	TCGA-22-1017-01	10	34	39	0.21047902672369773	TCGA-22-1017-01	16	16	10	42	PASS	6369	TCGA-22-1017	LUSC	62	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	1999	NA	-22880	Dead	WITH TUMOR	NA	1485	NA	Locoregional Recurrence|Distant Metastasis	NA	NA	904	Complete Remission/Response	NA	NA	1	1485	1	1485	1	904	1	904	
80	TCGA-22-4591	0	14	1	8	3	0	2	0	8	159	7	0	3	71	4	0	TCGA-22-4591-01	516	0.6386440648143197	355	TCGA-22-4591-01	19	72	173	0.39640499583584055	TCGA-22-4591-01	20	16	16	52	PASS	6370	TCGA-22-4591	LUSC	80	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-29250	Dead	WITH TUMOR	623	623	NA	NA	NA	NA	443	Partial Remission/Response	NA	NA	1	623	1	623	NA	NA	1	443	
80	TCGA-22-4593	2	11	0	10	5	1	2	0	6	142	6	0	2	54	6	0	TCGA-22-4593-01	315	0.6640202304976485	201	TCGA-22-4593-01	17	31	57	0.29251903419740605	TCGA-22-4593-01	14	10	7	31	PASS	6371	TCGA-22-4593	LUSC	77	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-28385	Dead	TUMOR FREE	1067	1067	NA	NA	NA	NA	NA	NA	NA	NA	1	1067	0	1067	NA	NA	0	1067	
60	TCGA-22-4594	2	20	4	6	9	1	0	0	14	274	18	0	3	90	9	1	TCGA-22-4594-01	315	0.6341418850866951	204	TCGA-22-4594-01	23	52	96	0.26400379610978403	TCGA-22-4594-01	24	24	3	51	PASS	6372	TCGA-22-4594	LUSC	60	FEMALE	NA	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-22115	Dead	NA	1470	1470	NA	NA	NA	NA	NA	NA	NA	NA	1	1470	NA	1470	NA	NA	0	1470	
60	TCGA-22-4595	3	21	2	9	11	2	3	0	15	240	12	0	7	92	8	1	TCGA-22-4595-01	435	0.9384971642616308	286	TCGA-22-4595-01	11	19	258	0.6033664767081179	TCGA-22-4595-01	24	32	24	80	PASS	6373	TCGA-22-4595	LUSC	57	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-21146	Dead	WITH TUMOR	734	734	NA	NA	NA	NA	250	Complete Remission/Response	NA	NA	1	734	1	734	1	250	1	250	
70	TCGA-22-4596	1	6	0	2	1	0	0	0	5	112	5	0	2	38	5	0	TCGA-22-4596-01	74	0.2569974196866333	25	TCGA-22-4596-01	6	7	4	0.00023269286249978955	TCGA-22-4596-01	7	5	0	12	PASS	6374	TCGA-22-4596	LUSC	69	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-25448	Dead	TUMOR FREE	17	17	NA	NA	NA	NA	NA	NA	NA	NA	1	17	0	17	NA	NA	0	17	
70	TCGA-22-4599	1	24	1	7	6	4	2	0	12	269	20	0	8	100	12	0	TCGA-22-4599-01	162	0.7101198942476264	78	TCGA-22-4599-01	28	31	23	0.4864774759967286	TCGA-22-4599-01	17	4	12	33	PASS	6375	TCGA-22-4599	LUSC	73	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-26925	Dead	NA	1161	1161	NA	NA	NA	NA	NA	NA	NA	NA	1	1161	NA	1161	NA	NA	0	1161	
70	TCGA-22-4601	0	9	2	11	8	0	1	0	10	136	7	0	3	53	5	1	TCGA-22-4601-01	178	0.6024971549138154	98	TCGA-22-4601-01	8	12	36	0.3532120672810377	TCGA-22-4601-01	16	17	12	45	PASS	6376	TCGA-22-4601	LUSC	73	FEMALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-26937	Dead	WITH TUMOR	1057	1057	NA	NA	NA	NA	525	NA	NA	NA	1	1057	1	1057	NA	NA	1	525	
70	TCGA-22-4604	2	15	1	7	10	0	2	1	14	188	12	0	7	54	9	0	TCGA-22-4604-01	377	0.6642225300151812	247	TCGA-22-4604-01	21	61	0	0.0	TCGA-22-4604-01	18	16	0	34	PASS	6377	TCGA-22-4604	LUSC	73	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-26952	Dead	WITH TUMOR	NA	399	NA	NA	NA	NA	306	NA	NA	NA	1	399	1	399	NA	NA	1	306	
80	TCGA-22-4605	0	3	1	1	0	2	1	0	2	78	1	0	1	24	4	0	TCGA-22-4605-01	74	0.4644449038083575	25	TCGA-22-4605-01	22	24	11	0.2026380114419853	TCGA-22-4605-01	7	4	3	14	PASS	6378	TCGA-22-4605	LUSC	78	FEMALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-28623	Dead	TUMOR FREE	NA	974	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	974	0	974	0	974	0	974	
80	TCGA-22-4607	1	4	0	3	0	1	2	0	1	54	4	0	2	12	3	0	TCGA-22-4607-01	262	0.7689297574596534	159	TCGA-22-4607-01	12	10	90	0.3113449730113469	TCGA-22-4607-01	7	3	4	14	PASS	6379	TCGA-22-4607	LUSC	75	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-27601	Dead	TUMOR FREE	587	587	NA	NA	NA	NA	NA	NA	NA	NA	1	587	0	587	NA	NA	0	587	
80	TCGA-22-4609	2	14	0	4	1	2	1	0	5	154	10	1	6	62	3	0	TCGA-22-4609-01	80	0.3661456471885939	35	TCGA-22-4609-01	14	17	19	0.3405901793611544	TCGA-22-4609-01	10	2	11	23	PASS	6380	TCGA-22-4609	LUSC	81	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-29844	Dead	TUMOR FREE	NA	291	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	291	0	291	0	291	0	291	
70	TCGA-22-4613	1	34	5	18	21	6	1	0	28	485	33	0	13	166	14	1	TCGA-22-4613-01	305	0.5577466967416111	172	TCGA-22-4613-01	12	14	37	0.3145237475756981	TCGA-22-4613-01	17	11	14	42	PASS	6381	TCGA-22-4613	LUSC	73	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-26722	Dead	NA	358	358	NA	NA	NA	NA	NA	NA	NA	NA	1	358	NA	358	NA	NA	0	358	
80	TCGA-22-5471	2	14	2	4	4	0	0	0	5	182	22	0	3	63	6	1	TCGA-22-5471-01	178	0.6629038010684334	84	TCGA-22-5471-01	19	35	33	0.2831397337825823	TCGA-22-5471-01	21	13	14	48	PASS	6382	TCGA-22-5471	LUSC	75	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-27749	Alive	NA	1845	NA	NA	NA	NA	NA	229	Complete Remission/Response	NA	NA	0	1845	0	1845	1	229	1	229	
70	TCGA-22-5472	2	16	3	8	4	2	2	0	10	286	25	1	7	147	8	1	TCGA-22-5472-01	79	0.4944140350526939	31	TCGA-22-5472-01	9	6	7	0.2281909711095336	TCGA-22-5472-01	3	1	3	7	PASS	6383	TCGA-22-5472	LUSC	67	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-24482	Dead	TUMOR FREE	NA	1975	NA	NA	NA	NA	746	Complete Remission/Response	NA	NA	1	1975	0	1975	1	746	1	746	
80	TCGA-22-5473	4	44	6	23	20	4	0	0	27	573	50	2	14	253	23	0	TCGA-22-5473-01	304	0.7242582379677354	195	TCGA-22-5473-01	19	38	76	0.4645200120302868	TCGA-22-5473-01	19	13	13	45	hypermutated sample	6384	TCGA-22-5473	LUSC	78	MALE	WHITE	[Discrepancy]	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-28826	Dead	TUMOR FREE	NA	1933	NA	NA	NA	NA	1655	Complete Remission/Response	NA	NA	1	1933	0	1933	1	1655	1	1655	
70	TCGA-22-5474	0	5	1	5	3	2	0	0	3	68	6	1	1	18	2	0	TCGA-22-5474-01	117	0.5265756416033706	61	TCGA-22-5474-01	9	21	36	0.4598760174623721	TCGA-22-5474-01	8	4	6	18	PASS	6385	TCGA-22-5474	LUSC	74	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-27271	Dead	TUMOR FREE	445	445	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	445	0	445	0	445	0	445	
70	TCGA-22-5477	1	8	2	3	2	1	0	0	5	132	8	0	1	62	0	0	TCGA-22-5477-01	206	0.8171127354902825	108	TCGA-22-5477-01	16	30	53	0.3468013631047905	TCGA-22-5477-01	19	12	14	45	PASS	6386	TCGA-22-5477	LUSC	65	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-24055	Dead	NA	1346	1346	NA	NA	NA	NA	511	Complete Remission/Response	NA	NA	1	1346	NA	1346	1	511	1	511	
80	TCGA-22-5478	0	9	1	8	8	3	1	0	9	135	8	1	3	52	3	1	TCGA-22-5478-01	197	0.6948605348180008	114	TCGA-22-5478-01	24	31	22	0.2789738673941774	TCGA-22-5478-01	14	5	3	22	PASS	6387	TCGA-22-5478	LUSC	79	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-28978	Dead	TUMOR FREE	24	24	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	24	0	24	0	24	0	24	
60	TCGA-22-5479	2	24	3	14	4	1	0	0	21	409	20	2	7	161	13	1	TCGA-22-5479-01	69	0.4986874011293809	24	TCGA-22-5479-01	32	25	8	0.11654349193740544	TCGA-22-5479-01	10	4	4	18	PASS	6388	TCGA-22-5479	LUSC	64	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-23563	Dead	NA	NA	2625	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	2625	NA	2625	NA	NA	0	2625	
70	TCGA-22-5480	1	11	0	6	4	1	0	0	6	122	6	1	3	43	3	0	TCGA-22-5480-01	156	0.4366605393999126	84	TCGA-22-5480-01	9	14	28	0.28212714171710523	TCGA-22-5480-01	8	4	3	15	PASS	6389	TCGA-22-5480	LUSC	66	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-24245	Dead	WITH TUMOR	2170	2170	NA	NA	NA	NA	1779	Complete Remission/Response	NA	NA	1	2170	1	2170	1	1779	1	1779	
70	TCGA-22-5481	1	14	1	9	8	3	2	1	13	236	19	0	8	76	5	0	TCGA-22-5481-01	298	0.5991979032024697	190	TCGA-22-5481-01	15	30	42	0.25489384387135755	TCGA-22-5481-01	22	18	12	52	PASS	6390	TCGA-22-5481	LUSC	72	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-26419	Dead	NA	NA	2409	NA	NA	NA	NA	346	Complete Remission/Response	NA	NA	1	2409	NA	2409	1	346	1	346	
80	TCGA-22-5482	1	8	1	4	4	0	1	0	8	129	8	0	1	48	2	0	TCGA-22-5482-01	147	0.4908422936952726	81	TCGA-22-5482-01	14	43	38	0.44483402016940177	TCGA-22-5482-01	15	8	8	31	PASS	6391	TCGA-22-5482	LUSC	81	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-29657	Dead	TUMOR FREE	357	357	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	357	0	357	0	357	0	357	
70	TCGA-22-5483	1	12	2	6	6	1	0	0	8	186	8	0	7	66	6	0	TCGA-22-5483-01	136	0.85131619722854	67	TCGA-22-5483-01	26	23	30	0.3348166220023588	TCGA-22-5483-01	16	6	11	33	PASS	6392	TCGA-22-5483	LUSC	74	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-27109	Dead	WITH TUMOR	573	573	NA	NA	NA	NA	568	Complete Remission/Response	NA	NA	1	573	1	573	1	568	1	568	
60	TCGA-22-5485	0	6	0	3	10	3	2	1	8	168	7	0	0	59	4	0	TCGA-22-5485-01	179	0.667190948657145	101	TCGA-22-5485-01	13	16	35	0.3379470062879673	TCGA-22-5485-01	12	6	6	24	PASS	6393	TCGA-22-5485	LUSC	58	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-21488	Dead	WITH TUMOR	916	916	NA	NA	NA	NA	840	Complete Remission/Response	NA	NA	1	916	1	916	1	840	1	840	
60	TCGA-22-5489	1	9	1	7	7	1	0	0	4	190	16	0	5	70	7	0	TCGA-22-5489-01	225	0.3991147041892079	132	TCGA-22-5489-01	11	18	47	0.4028672317356092	TCGA-22-5489-01	14	10	7	31	PASS	6394	TCGA-22-5489	LUSC	64	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-23618	Dead	WITH TUMOR	1912	1912	NA	NA	NA	NA	428	Complete Remission/Response	NA	NA	1	1912	1	1912	1	428	1	428	
70	TCGA-22-5491	2	18	3	11	8	1	0	0	14	254	25	0	8	81	6	0	TCGA-22-5491-01	225	0.7405558739166163	136	TCGA-22-5491-01	16	22	26	0.2184656535883511	TCGA-22-5491-01	17	11	8	36	PASS	6395	TCGA-22-5491	LUSC	74	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-27145	Dead	NA	1713	1713	NA	NA	NA	NA	NA	NA	NA	NA	1	1713	NA	1713	NA	NA	0	1713	
70	TCGA-22-5492	0	18	0	4	5	1	0	0	10	164	16	0	6	65	11	0	TCGA-22-5492-01	161	0.3539914105795611	84	TCGA-22-5492-01	9	16	31	0.3295536161352434	TCGA-22-5492-01	12	8	13	33	PASS	6396	TCGA-22-5492	LUSC	73	FEMALE	NA	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-26838	Dead	NA	506	506	NA	NA	NA	NA	NA	NA	NA	NA	1	506	NA	506	NA	NA	0	506	
70	TCGA-22-A5C4	1	36	1	6	22	4	1	0	12	265	21	1	3	87	10	0	TCGA-22-A5C4-01	432	0.6412930828342248	273	TCGA-22-A5C4-01	17	36	116	0.5955133506419333	TCGA-22-A5C4-01	17	16	21	54	PASS	6397	TCGA-22-A5C4	LUSC	70	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-25629	Alive	TUMOR FREE	671	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	671	0	671	0	671	0	671	
70	TCGA-33-4532	1	27	3	14	4	1	1	0	15	293	28	1	12	102	8	1	TCGA-33-4532-01	481	0.6389800686140839	324	TCGA-33-4532-01	24	52	150	0.2520762313782537	TCGA-33-4532-01	20	14	11	45	PASS	6398	TCGA-33-4532	LUSC	68	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-25169	Dead	TUMOR FREE	NA	3924	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	3924	0	3924	0	3924	0	3924	
80	TCGA-33-4533	5	22	1	5	9	1	0	0	15	225	19	0	8	70	7	2	TCGA-33-4533-01	689	0.7220758095407305	558	TCGA-33-4533-01	10	47	218	0.500331363544837	TCGA-33-4533-01	12	11	9	32	PASS	6399	TCGA-33-4533	LUSC	76	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-28001	Alive	TUMOR FREE	4068	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4068	0	4068	0	4068	0	4068	
70	TCGA-33-4538	2	5	0	6	3	0	1	0	3	142	13	0	4	50	7	2	TCGA-33-4538-01	376	0.6789161246057549	261	TCGA-33-4538-01	20	24	108	0.3726392468327874	TCGA-33-4538-01	12	12	12	36	PASS	6400	TCGA-33-4538	LUSC	66	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-24174	Dead	NA	NA	2979	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2979	NA	2979	0	2979	0	2979	
70	TCGA-33-4547	0	11	1	7	5	0	1	0	5	146	18	0	1	58	4	1	TCGA-33-4547-01	393	0.4465729114505216	261	TCGA-33-4547-01	13	18	169	0.3378081875146122	TCGA-33-4547-01	19	11	12	42	PASS	6401	TCGA-33-4547	LUSC	68	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-25056	Alive	TUMOR FREE	2419	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2419	0	2419	0	2419	0	2419	
40	TCGA-33-4566	2	70	6	34	30	10	0	0	38	1007	90	1	25	339	41	2	TCGA-33-4566-01	193	0.9747415059163316	100	TCGA-33-4566-01	19	38	50	0.4534515725627003	TCGA-33-4566-01	18	11	16	45	hypermutated sample	6402	TCGA-33-4566	LUSC	40	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	1996	NA	-14643	Dead	NA	NA	5287	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	5287	NA	5287	NA	NA	0	5287	
60	TCGA-33-4582	0	8	0	7	3	2	0	0	7	147	13	0	3	65	2	0	TCGA-33-4582-01	277	0.8117472275517583	158	TCGA-33-4582-01	15	40	48	0.3767743460537909	TCGA-33-4582-01	25	29	18	72	PASS	6403	TCGA-33-4582	LUSC	55	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2000	NA	-20402	Dead	WITH TUMOR	NA	3149	NA	Locoregional Recurrence	NA	NA	2923	Complete Remission/Response	NA	NA	1	3149	1	3149	1	2923	1	2923	
70	TCGA-33-4583	3	40	4	15	15	4	1	0	23	435	38	0	14	168	14	2	TCGA-33-4583-01	181	0.6481372142997461	98	TCGA-33-4583-01	26	25	31	0.35816797064974554	TCGA-33-4583-01	9	3	7	19	PASS	6404	TCGA-33-4583	LUSC	73	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	1999	NA	-26799	Dead	TUMOR FREE	NA	4601	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	4601	0	4601	0	4601	0	4601	
60	TCGA-33-4586	3	18	1	5	9	3	1	0	11	267	20	0	8	118	11	1	TCGA-33-4586-01	219	0.7187085320339016	118	TCGA-33-4586-01	24	21	46	0.4552010507571178	TCGA-33-4586-01	17	5	11	33	PASS	6405	TCGA-33-4586	LUSC	57	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-21148	Dead	NA	NA	428	NA	Locoregional Recurrence	NA	NA	169	Complete Remission/Response	NA	NA	1	428	NA	428	1	169	1	169	
60	TCGA-33-4587	0	12	0	4	8	3	0	0	5	164	14	0	9	72	12	0	TCGA-33-4587-01	221	0.8057256578352447	121	TCGA-33-4587-01	18	25	37	0.18430172169170905	TCGA-33-4587-01	19	18	7	44	PASS	6406	TCGA-33-4587	LUSC	63	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-23062	Dead	WITH TUMOR	NA	1656	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	1656	1	1656	NA	NA	1	1656	
60	TCGA-33-4589	0	4	0	2	3	0	0	0	5	84	10	0	1	33	2	0	TCGA-33-4589-01	94	0.417831175322736	39	TCGA-33-4589-01	26	59	11	0.1094378311668312	TCGA-33-4589-01	10	6	5	21	PASS	6407	TCGA-33-4589	LUSC	62	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	1992	NA	-22754	Dead	TUMOR FREE	NA	47	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	47	0	47	0	47	0	47	
70	TCGA-33-6737	3	19	0	19	5	2	0	0	15	335	34	0	11	129	9	0	TCGA-33-6737	0	0	0	TCGA-33-6737	0	0	0	0	TCGA-33-6737-01	15	10	4	29	PASS	6408	TCGA-33-6737	LUSC	71	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-26033	Dead	WITH TUMOR	NA	601	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	601	1	601	NA	NA	1	601	
80	TCGA-33-6738	4	16	0	8	6	1	3	0	8	260	20	0	7	102	12	0	TCGA-33-6738-01	130	0.6214716534711575	56	TCGA-33-6738-01	18	18	24	0.3294153228332554	TCGA-33-6738-01	14	3	10	27	PASS	6409	TCGA-33-6738	LUSC	80	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-29368	Alive	TUMOR FREE	1927	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1927	0	1927	0	1927	0	1927	
60	TCGA-33-A4WN	1	13	0	6	3	0	2	0	12	152	11	0	3	57	5	0	TCGA-33-A4WN-01	137	0.43595672962288456	64	TCGA-33-A4WN-01	6	14	107	0.2474075159844937	TCGA-33-A4WN-01	13	9	8	30	PASS	6410	TCGA-33-A4WN	LUSC	60	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-22268	Dead	TUMOR FREE	NA	143	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	143	0	143	0	143	0	143	
70	TCGA-33-A5GW	2	11	3	7	4	0	1	1	9	140	10	0	2	61	7	0	TCGA-33-A5GW-01	147	0.9327617085459962	88	TCGA-33-A5GW-01	10	12	123	0.3823542461562651	TCGA-33-A5GW-01	10	13	10	33	PASS	6411	TCGA-33-A5GW	LUSC	67	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-24586	Dead	TUMOR FREE	NA	9	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	9	0	9	0	9	0	9	
60	TCGA-33-AAS8	0	6	0	5	7	1	1	0	5	185	9	0	8	64	7	0	TCGA-33-AAS8-01	218	0.8593451516591603	140	TCGA-33-AAS8-01	10	11	133	0.356361954175551	TCGA-33-AAS8-01	6	8	11	25	PASS	6412	TCGA-33-AAS8	LUSC	59	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	1998	NA	-21675	Dead	TUMOR FREE	NA	1114	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1114	0	1114	0	1114	0	1114	
70	TCGA-33-AASB	0	19	2	8	12	3	1	0	11	292	26	0	7	85	11	0	TCGA-33-AASB-01	262	0.5900811615463841	159	TCGA-33-AASB-01	16	35	175	0.4372086620682977	TCGA-33-AASB-01	21	15	17	53	PASS	6413	TCGA-33-AASB	LUSC	66	MALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-24183	Dead	WITH TUMOR	NA	211	NA	Distant Metastasis	NA	NA	30	Progressive Disease	NA	NA	1	211	1	211	NA	NA	1	30	
80	TCGA-33-AASD	1	12	1	7	10	2	0	0	10	282	11	0	7	118	11	0	TCGA-33-AASD-01	251	0.7533591943798733	162	TCGA-33-AASD-01	26	27	156	0.4176766198504698	TCGA-33-AASD-01	23	8	15	46	PASS	6414	TCGA-33-AASD	LUSC	83	MALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-30623	Dead	WITH TUMOR	NA	3376	NA	Locoregional Recurrence	NA	NA	1912	Progressive Disease	NA	NA	1	3376	1	3376	NA	NA	1	1912	
70	TCGA-33-AASI	0	24	1	10	6	3	0	0	12	312	28	0	6	97	11	1	TCGA-33-AASI-01	137	0.7786361488810328	64	TCGA-33-AASI-01	12	15	142	0.4064711406683708	TCGA-33-AASI-01	13	9	14	36	PASS	6415	TCGA-33-AASI	LUSC	65	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-23965	Dead	WITH TUMOR	NA	1344	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	1344	1	1344	NA	NA	1	1344	
60	TCGA-33-AASJ	0	7	0	1	3	1	2	0	1	142	14	0	1	58	4	1	TCGA-33-AASJ-01	328	0.5901311429779145	201	TCGA-33-AASJ-01	19	31	155	0.3654703494729927	TCGA-33-AASJ-01	19	12	14	45	PASS	6416	TCGA-33-AASJ	LUSC	60	MALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	1999	NA	-22179	Dead	WITH TUMOR	NA	3600	NA	Locoregional Recurrence	NA	NA	1135	Complete Remission/Response	NA	NA	1	3600	1	3600	1	1135	1	1135	
60	TCGA-33-AASL	0	11	2	6	5	1	0	0	7	248	16	0	4	86	2	0	TCGA-33-AASL-01	249	0.7071089458110711	160	TCGA-33-AASL-01	13	19	206	0.44962562744740503	TCGA-33-AASL-01	22	19	20	61	PASS	6417	TCGA-33-AASL	LUSC	57	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2000	NA	-20940	Dead	WITH TUMOR	NA	826	NA	Locoregional Recurrence	NA	NA	149	Progressive Disease	NA	NA	1	826	1	826	NA	NA	1	149	
70	TCGA-34-2596	1	27	0	12	5	5	1	0	9	184	13	1	6	76	5	1	TCGA-34-2596-01	211	0.9341783227996654	122	TCGA-34-2596-01	16	18	48	0.5766072067812565	TCGA-34-2596-01	15	7	12	34	PASS	6418	TCGA-34-2596	LUSC	70	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-25574	Dead	TUMOR FREE	80	80	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	80	0	80	0	80	0	80	
80	TCGA-34-2600	3	23	1	13	3	1	0	0	13	349	39	0	6	118	11	0	TCGA-34-2600-01	240	0.8552500151856299	147	TCGA-34-2600-01	19	32	36	0.4617327272734734	TCGA-34-2600-01	13	11	10	34	PASS	6419	TCGA-34-2600	LUSC	76	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2000	NA	-28072	Dead	TUMOR FREE	1874	1874	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1874	0	1874	0	1874	0	1874	
80	TCGA-34-2604	0	35	4	16	11	2	0	1	23	466	34	0	10	154	24	0	TCGA-34-2604-01	141	0.5265086497448261	86	TCGA-34-2604-01	24	38	29	0.3687315154975089	TCGA-34-2604-01	16	7	8	31	PASS	6420	TCGA-34-2604	LUSC	81	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	1999	NA	-29827	Dead	TUMOR FREE	958	958	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	958	0	958	0	958	0	958	
80	TCGA-34-2605	3	19	1	16	5	1	1	1	10	290	16	0	5	111	9	0	TCGA-34-2605-01	272	0.7912412261880263	160	TCGA-34-2605-01	23	53	41	0.5628571430938529	TCGA-34-2605-01	20	12	8	40	PASS	6421	TCGA-34-2605	LUSC	76	MALE	WHITE	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-27833	Dead	WITH TUMOR	881	881	NA	NA	NA	NA	394	Complete Remission/Response	NA	NA	1	881	1	881	1	394	1	394	
80	TCGA-34-2608	1	9	3	2	2	1	2	0	7	106	10	1	4	44	5	0	TCGA-34-2608-01	97	0.3056992997678804	44	TCGA-34-2608-01	8	8	7	0.14634668749591667	TCGA-34-2608-01	7	2	4	13	PASS	6422	TCGA-34-2608	LUSC	84	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	1999	NA	-30958	Dead	TUMOR FREE	1000	1000	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1000	0	1000	0	1000	0	1000	
80	TCGA-34-2609	1	13	2	6	4	2	1	1	6	196	12	0	4	60	8	0	TCGA-34-2609-01	340	0.5712008247912188	228	TCGA-34-2609-01	18	36	51	0.2724561445456816	TCGA-34-2609-01	17	19	6	42	PASS	6423	TCGA-34-2609	LUSC	81	MALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-29871	Dead	WITH TUMOR	951	951	NA	NA	NA	NA	387	Complete Remission/Response	NA	NA	1	951	1	951	1	387	1	387	
70	TCGA-34-5231	6	32	6	22	14	5	1	1	24	506	42	0	8	194	10	0	TCGA-34-5231-01	191	0.7120037148085091	101	TCGA-34-5231-01	27	25	29	0.2931381881048739	TCGA-34-5231-01	16	10	11	37	PASS	6424	TCGA-34-5231	LUSC	72	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-26525	Dead	TUMOR FREE	NA	1984	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	1984	0	1984	NA	NA	0	1984	
80	TCGA-34-5232	1	13	1	1	5	0	0	0	7	150	6	0	1	77	3	0	TCGA-34-5232-01	68	0.23522942309877856	20	TCGA-34-5232-01	8	5	8	0.1549210846002908	TCGA-34-5232-01	2	3	5	10	PASS	6425	TCGA-34-5232	LUSC	75	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-27633	Alive	TUMOR FREE	2471	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2471	0	2471	0	2471	0	2471	
70	TCGA-34-5234	2	8	0	2	4	2	0	0	6	138	11	0	4	49	5	1	TCGA-34-5234-01	49	0.024690370770183698	13	TCGA-34-5234-01	3	6	6	0.19293459053381265	TCGA-34-5234-01	2	4	1	7	PASS	6426	TCGA-34-5234	LUSC	71	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-26072	Alive	TUMOR FREE	2271	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2271	0	2271	0	2271	0	2271	
60	TCGA-34-5236	2	7	1	4	7	1	0	0	9	164	9	0	5	65	7	0	TCGA-34-5236-01	107	0.516456172253496	40	TCGA-34-5236-01	17	60	24	0.3682445899331545	TCGA-34-5236-01	14	6	7	27	PASS	6427	TCGA-34-5236	LUSC	60	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-21935	Dead	WITH TUMOR	NA	276	NA	Locoregional Recurrence	NA	NA	113	Progressive Disease	NA	NA	1	276	1	276	NA	NA	1	113	
80	TCGA-34-5239	2	17	1	5	4	2	1	1	11	191	9	0	3	63	11	0	TCGA-34-5239-01	76	0.398616716433678	26	TCGA-34-5239-01	21	29	15	0.33997501523445384	TCGA-34-5239-01	4	2	5	11	PASS	6428	TCGA-34-5239	LUSC	75	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-27528	Alive	WITH TUMOR	1834	NA	NA	Distant Metastasis	NA	NA	1530	Complete Remission/Response	NA	NA	0	1834	0	1834	1	1530	1	1530	
70	TCGA-34-5240	1	10	0	4	7	2	0	0	7	119	9	0	8	56	5	0	TCGA-34-5240-01	140	0.8187386990035029	61	TCGA-34-5240-01	28	27	36	0.5669008035810108	TCGA-34-5240-01	14	6	7	27	PASS	6429	TCGA-34-5240	LUSC	73	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-26735	Alive	TUMOR FREE	1541	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1541	0	1541	0	1541	0	1541	
80	TCGA-34-5241	0	12	2	10	2	2	1	0	6	145	14	1	5	60	4	0	TCGA-34-5241-01	188	0.521293776219161	93	TCGA-34-5241-01	13	14	20	0.06295667265966433	TCGA-34-5241-01	10	3	1	14	PASS	6430	TCGA-34-5241	LUSC	79	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-29098	Dead	TUMOR FREE	NA	515	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	515	0	515	NA	NA	0	515	
70	TCGA-34-5927	0	13	1	7	8	3	0	0	4	211	15	0	2	72	4	0	TCGA-34-5927-01	145	0.9356332059064612	79	TCGA-34-5927-01	9	14	34	0.4246129964256015	TCGA-34-5927-01	6	3	8	17	PASS	6431	TCGA-34-5927	LUSC	70	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-25857	Alive	TUMOR FREE	1361	NA	NA	Distant Metastasis	NA	NA	245	[Unknown]	NA	NA	0	1361	0	1361	NA	NA	1	245	
80	TCGA-34-5928	1	22	1	5	0	2	0	0	10	284	26	1	3	104	4	1	TCGA-34-5928-01	236	0.6526398285636347	149	TCGA-34-5928-01	27	58	71	0.5216640290382705	TCGA-34-5928-01	24	15	22	61	PASS	6432	TCGA-34-5928	LUSC	83	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-30334	Alive	TUMOR FREE	1196	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1196	0	1196	0	1196	0	1196	
80	TCGA-34-5929	0	11	0	6	1	0	0	0	6	170	16	1	4	62	6	1	TCGA-34-5929-01	115	0.9313885349597354	51	TCGA-34-5929-01	11	14	27	0.3836778046128989	TCGA-34-5929-01	8	3	7	18	PASS	6433	TCGA-34-5929	LUSC	78	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-28844	Dead	TUMOR FREE	NA	151	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	151	0	151	NA	NA	0	151	
70	TCGA-34-7107	6	31	2	14	21	5	0	0	14	384	34	0	8	181	11	0	TCGA-34-7107-01	161	0.7257966717732849	78	TCGA-34-7107-01	22	29	26	0.3757394944915647	TCGA-34-7107-01	17	8	7	32	PASS	6434	TCGA-34-7107	LUSC	70	MALE	WHITE	Stage II	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-25677	Dead	NA	NA	34	NA	NA	NA	NA	NA	NA	NA	NA	1	34	NA	34	NA	NA	0	34	
60	TCGA-34-8454	3	29	2	21	8	4	0	1	22	414	33	1	7	175	11	0	TCGA-34-8454-01	122	0.31693570828779755	70	TCGA-34-8454-01	7	19	103	0.3683389790657503	TCGA-34-8454-01	17	9	9	35	PASS	6435	TCGA-34-8454	LUSC	62	FEMALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-22913	Alive	TUMOR FREE	1180	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1180	0	1180	0	1180	0	1180	
70	TCGA-34-8455	2	25	0	19	13	3	0	0	17	374	32	0	11	121	18	1	TCGA-34-8455-01	74	0.681277366342802	26	TCGA-34-8455-01	24	17	41	0.2350567732544183	TCGA-34-8455-01	7	4	5	16	PASS	6436	TCGA-34-8455	LUSC	67	MALE	WHITE	Stage IV	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-24624	Dead	WITH TUMOR	NA	123	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	123	1	123	NA	NA	1	123	
70	TCGA-34-8456	1	2	0	1	0	0	0	0	2	30	2	0	1	10	1	1	TCGA-34-8456-01	124	0.7421470086968408	52	TCGA-34-8456-01	23	22	60	0.22984515694089025	TCGA-34-8456-01	19	11	9	39	PASS	6437	TCGA-34-8456	LUSC	71	FEMALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26183	Alive	TUMOR FREE	804	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	804	0	804	0	804	0	804	
80	TCGA-34-A5IX	3	24	2	10	11	0	2	0	5	211	14	0	5	70	8	3	TCGA-34-A5IX-01	297	0.7613825738710406	209	TCGA-34-A5IX-01	27	22	194	0.4419171468344035	TCGA-34-A5IX-01	13	12	16	41	PASS	6438	TCGA-34-A5IX	LUSC	80	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-29391	Alive	TUMOR FREE	1031	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1031	0	1031	0	1031	0	1031	
50	TCGA-37-3783	3	23	5	15	7	4	1	0	20	284	24	0	10	118	2	0	TCGA-37-3783-01	415	0.41126087541829975	282	TCGA-37-3783-01	10	20	168	0.2452372460720892	TCGA-37-3783-01	17	15	10	42	PASS	6439	TCGA-37-3783	LUSC	51	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-18728	Alive	TUMOR FREE	122	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	122	0	122	NA	NA	0	122	
70	TCGA-37-3789	3	35	5	15	7	3	0	0	29	545	74	0	11	201	36	1	TCGA-37-3789-01	233	0.3570374073040153	135	TCGA-37-3789-01	9	14	61	0.2826376365263405	TCGA-37-3789-01	22	8	13	43	PASS	6440	TCGA-37-3789	LUSC	65	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-23782	Alive	TUMOR FREE	13	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	13	0	13	NA	NA	0	13	
70	TCGA-37-3792	8	33	4	14	21	5	0	0	22	740	68	1	19	251	34	0	TCGA-37-3792-01	118	0.6177460175267472	67	TCGA-37-3792-01	23	33	21	0.3673081726886511	TCGA-37-3792-01	12	7	7	26	hypermutated sample	6441	TCGA-37-3792	LUSC	69	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-25502	Alive	TUMOR FREE	12	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	12	0	12	NA	NA	0	12	
50	TCGA-37-4129	0	0	0	0	1	0	0	0	0	2	0	0	0	4	0	0	TCGA-37-4129-01	45	0.09847514673071484	10	TCGA-37-4129-01	4	3	3	0.1038808316086031	TCGA-37-4129-01	0	0	0	0	PASS	6442	TCGA-37-4129	LUSC	52	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-19154	Alive	TUMOR FREE	242	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	242	0	242	0	242	0	242	
60	TCGA-37-4130	8	74	7	27	21	6	0	0	42	867	67	3	20	280	34	1	TCGA-37-4130-01	282	0.70534865823725	172	TCGA-37-4130-01	23	60	61	0.4143140785311035	TCGA-37-4130-01	25	22	16	63	hypermutated sample	6443	TCGA-37-4130	LUSC	56	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-20652	Alive	TUMOR FREE	247	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	247	0	247	NA	NA	0	247	
60	TCGA-37-4132	0	24	2	11	8	0	0	0	11	245	12	0	8	69	9	0	TCGA-37-4132-01	117	0.2896536216795324	58	TCGA-37-4132-01	7	10	21	0.2297374346108199	TCGA-37-4132-01	7	2	9	18	PASS	6444	TCGA-37-4132	LUSC	61	FEMALE	WHITE	Stage IV	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-22520	Alive	TUMOR FREE	227	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	227	0	227	NA	NA	0	227	
60	TCGA-37-4133	1	32	1	6	6	2	1	0	10	203	18	2	8	82	4	1	TCGA-37-4133-01	224	0.7065479466677165	139	TCGA-37-4133-01	17	36	34	0.2377905758356572	TCGA-37-4133-01	19	8	7	34	PASS	6445	TCGA-37-4133	LUSC	63	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-23083	Alive	TUMOR FREE	238	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	238	0	238	NA	NA	0	238	
70	TCGA-37-4135	0	28	2	6	8	4	0	0	15	228	17	0	7	87	5	0	TCGA-37-4135-01	405	0.9364938112789736	262	TCGA-37-4135-01	25	29	100	0.4758785092180076	TCGA-37-4135-01	21	13	14	48	PASS	6446	TCGA-37-4135	LUSC	68	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-25041	Alive	TUMOR FREE	207	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	207	0	207	NA	NA	0	207	
70	TCGA-37-4141	3	17	1	8	14	3	3	0	9	269	18	1	5	74	5	0	TCGA-37-4141-01	147	0.847247082579369	80	TCGA-37-4141-01	14	11	24	0.4195632573365694	TCGA-37-4141-01	9	6	7	22	PASS	6447	TCGA-37-4141	LUSC	65	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-24048	Alive	TUMOR FREE	12	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	12	0	12	NA	NA	0	12	
60	TCGA-37-5819	4	38	4	22	19	6	1	0	19	574	62	0	10	182	16	1	TCGA-37-5819-01	424	0.8243812961448219	274	TCGA-37-5819-01	20	31	128	0.5430003583363149	TCGA-37-5819-01	27	23	13	63	PASS	6448	TCGA-37-5819	LUSC	64	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-23726	Alive	TUMOR FREE	103	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	103	0	103	NA	NA	0	103	
50	TCGA-37-A5EL	1	25	1	21	16	1	1	0	8	320	20	1	4	128	8	0	TCGA-37-A5EL-01	165	0.8174120239031393	78	TCGA-37-A5EL-01	21	30	105	0.4236087178821433	TCGA-37-A5EL-01	20	27	16	63	PASS	6449	TCGA-37-A5EL	LUSC	53	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-19371	Dead	WITH TUMOR	NA	1143	NA	Distant Metastasis	NA	NA	946	[Discrepancy]	NA	NA	1	1143	1	1143	NA	NA	1	946	
50	TCGA-37-A5EM	4	21	1	9	12	2	0	0	6	245	17	1	5	117	8	0	TCGA-37-A5EM	0	0	0	TCGA-37-A5EM	0	0	0	0	TCGA-37-A5EM	0	0	0	0	PASS	6450	TCGA-37-A5EM	LUSC	49	MALE	WHITE	Stage II	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-18011	Alive	TUMOR FREE	867	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	867	0	867	0	867	0	867	
60	TCGA-37-A5EN	2	10	1	9	4	2	0	0	9	183	11	0	2	67	6	0	TCGA-37-A5EN-01	185	0.7162588809518148	93	TCGA-37-A5EN-01	18	27	82	0.28192993620784745	TCGA-37-A5EN-01	16	10	10	36	PASS	6451	TCGA-37-A5EN	LUSC	59	MALE	WHITE	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-21600	Alive	TUMOR FREE	660	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	660	0	660	0	660	0	660	
70	TCGA-39-5011	4	24	3	16	11	7	1	0	14	497	38	0	9	168	22	0	TCGA-39-5011-01	248	0.6865366761084704	149	TCGA-39-5011-01	17	19	62	0.566382034646007	TCGA-39-5011-01	18	13	24	55	PASS	6452	TCGA-39-5011	LUSC	70	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-25788	Alive	TUMOR FREE	4053	NA	NA	NA	NA	NA	565	Complete Remission/Response	NA	NA	0	4053	0	4053	1	565	1	565	
40	TCGA-39-5016	2	32	3	14	13	1	0	0	17	270	18	0	7	118	8	0	TCGA-39-5016-01	189	0.7380283202894667	100	TCGA-39-5016-01	23	33	32	0.31627724098570714	TCGA-39-5016-01	17	20	7	44	PASS	6453	TCGA-39-5016	LUSC	44	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-16306	Alive	TUMOR FREE	3850	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3850	0	3850	0	3850	0	3850	
70	TCGA-39-5019	1	7	1	3	6	0	0	0	7	137	11	0	5	52	5	0	TCGA-39-5019-01	173	0.6401160087259051	96	TCGA-39-5019-01	9	22	62	0.8351609419631464	TCGA-39-5019-01	9	6	8	23	PASS	6454	TCGA-39-5019	LUSC	70	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-25756	Alive	TUMOR FREE	3387	NA	NA	NA	NA	NA	378	Complete Remission/Response	NA	NA	0	3387	0	3387	1	378	1	378	
70	TCGA-39-5021	0	4	1	3	4	0	0	0	4	120	6	0	2	55	4	0	TCGA-39-5021-01	323	0.5713227983796707	248	TCGA-39-5021-01	12	23	29	0.3491993706688993	TCGA-39-5021-01	12	3	9	24	PASS	6455	TCGA-39-5021	LUSC	70	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-25895	Dead	WITH TUMOR	2057	2086	NA	NA	NA	NA	1875	Complete Remission/Response	NA	NA	1	2086	1	2086	1	1875	1	1875	
80	TCGA-39-5022	0	8	2	6	1	1	0	0	6	170	9	0	2	51	2	1	TCGA-39-5022-01	66	0.13150055937236088	16	TCGA-39-5022-01	7	13	11	0.3091920172917452	TCGA-39-5022-01	6	6	3	15	PASS	6456	TCGA-39-5022	LUSC	76	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-27856	Dead	TUMOR FREE	NA	1679	NA	NA	NA	NA	1448	NA	NA	NA	1	1679	0	1679	NA	NA	1	1448	
70	TCGA-39-5024	2	5	0	7	2	0	0	0	11	157	10	0	5	66	7	0	TCGA-39-5024-01	94	0.2727271831624165	44	TCGA-39-5024-01	4	22	25	0.2695027379675359	TCGA-39-5024-01	11	8	7	26	PASS	6457	TCGA-39-5024	LUSC	65	FEMALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-23975	Alive	TUMOR FREE	2510	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2510	0	2510	0	2510	0	2510	
70	TCGA-39-5027	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-39-5027-01	105	0.8634975006821481	38	TCGA-39-5027-01	15	13	21	0.3588069481730542	TCGA-39-5027-01	15	5	15	35	PASS	6458	TCGA-39-5027	LUSC	73	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-26714	Alive	WITH TUMOR	3108	NA	NA	New Primary Tumor	NA	NA	3081	Complete Remission/Response	NA	NA	0	3108	0	3108	0	3108	1	3081	
80	TCGA-39-5028	1	9	1	3	1	0	1	0	6	138	12	0	2	46	7	0	TCGA-39-5028-01	89	0.3639305854046821	42	TCGA-39-5028-01	29	18	6	0.15974464455088014	TCGA-39-5028-01	10	9	2	21	PASS	6459	TCGA-39-5028	LUSC	75	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-27707	Dead	NA	52	52	NA	NA	NA	NA	NA	NA	NA	NA	1	52	NA	52	NA	NA	0	52	
70	TCGA-39-5029	0	10	0	3	1	1	0	0	6	116	9	0	0	37	4	0	TCGA-39-5029-01	265	0.5151567992621896	170	TCGA-39-5029-01	16	18	74	0.4684828801655813	TCGA-39-5029-01	17	13	13	43	PASS	6460	TCGA-39-5029	LUSC	67	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-24713	Dead	WITH TUMOR	NA	740	NA	NA	NA	NA	491	Stable Disease	NA	NA	1	740	1	740	NA	NA	1	491	
80	TCGA-39-5030	0	7	1	4	7	3	1	0	8	184	12	0	0	65	2	0	TCGA-39-5030-01	69	0.29408297481790424	21	TCGA-39-5030-01	12	9	10	0.2336176615253468	TCGA-39-5030-01	6	0	6	12	PASS	6461	TCGA-39-5030	LUSC	81	FEMALE	ASIAN	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-29893	Dead	NA	59	59	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	59	NA	59	0	59	0	59	
80	TCGA-39-5031	1	35	2	14	18	1	15	0	36	472	48	1	7	189	13	1	TCGA-39-5031-01	159	0.5448010094872634	77	TCGA-39-5031-01	19	26	36	0.4041712596696124	TCGA-39-5031-01	17	15	13	45	PASS	6462	TCGA-39-5031	LUSC	76	FEMALE	NA	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-28106	Dead	TUMOR FREE	NA	1841	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1841	0	1841	0	1841	0	1841	
70	TCGA-39-5034	8	43	2	19	14	2	1	0	19	447	47	1	12	167	24	2	TCGA-39-5034-01	371	0.5066392212545415	250	TCGA-39-5034-01	14	34	105	0.3752050976980444	TCGA-39-5034-01	19	6	12	37	PASS	6463	TCGA-39-5034	LUSC	73	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-26682	Dead	NA	1107	1107	NA	NA	NA	NA	352	Complete Remission/Response	NA	NA	1	1107	NA	1107	1	352	1	352	
70	TCGA-39-5035	0	9	1	4	1	0	0	0	3	125	5	0	2	47	5	1	TCGA-39-5035-01	243	0.643091172042484	147	TCGA-39-5035-01	17	26	40	0.2570810181203557	TCGA-39-5035-01	13	9	4	26	PASS	6464	TCGA-39-5035	LUSC	72	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-26383	Alive	TUMOR FREE	2080	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2080	0	2080	0	2080	0	2080	
70	TCGA-39-5036	1	14	1	5	6	3	0	0	9	211	15	0	4	62	10	0	TCGA-39-5036-01	215	0.5961659277829602	135	TCGA-39-5036-01	18	16	26	0.3933636618543117	TCGA-39-5036-01	9	6	9	24	PASS	6465	TCGA-39-5036	LUSC	73	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-26963	Alive	TUMOR FREE	2165	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2165	0	2165	0	2165	0	2165	
70	TCGA-39-5037	1	12	2	10	5	1	1	0	5	179	11	0	6	68	9	0	TCGA-39-5037-01	261	0.7151055487781962	166	TCGA-39-5037-01	22	63	43	0.3299251932921156	TCGA-39-5037-01	25	27	3	55	PASS	6466	TCGA-39-5037	LUSC	65	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-23868	Alive	TUMOR FREE	1690	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1690	0	1690	0	1690	0	1690	
80	TCGA-39-5039	0	10	1	7	4	0	0	0	6	128	10	0	0	52	7	0	TCGA-39-5039-01	71	0.23196594360110784	20	TCGA-39-5039-01	11	18	11	0.3468753350765133	TCGA-39-5039-01	3	1	5	9	PASS	6467	TCGA-39-5039	LUSC	76	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-27781	Dead	TUMOR FREE	544	544	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	544	0	544	0	544	0	544	
60	TCGA-39-5040	1	13	0	16	21	7	2	0	8	352	26	0	8	162	15	2	TCGA-39-5040-01	139	0.5388111592573578	77	TCGA-39-5040-01	15	29	29	0.35017023275187725	TCGA-39-5040-01	15	9	7	31	PASS	6468	TCGA-39-5040	LUSC	59	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-21790	Dead	WITH TUMOR	NA	519	NA	NA	NA	NA	442	Stable Disease	NA	NA	1	519	1	519	NA	NA	1	442	
60	TCGA-43-2576	2	28	3	16	9	2	0	1	15	396	42	1	9	125	17	3	TCGA-43-2576-01	293	0.561748469253215	191	TCGA-43-2576-01	29	23	69	0.387438095373966	TCGA-43-2576-01	17	11	11	39	PASS	6469	TCGA-43-2576	LUSC	62	FEMALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-22805	Alive	TUMOR FREE	1223	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1223	0	1223	0	1223	0	1223	
60	TCGA-43-2578	0	27	2	8	8	0	1	0	10	259	14	0	6	94	11	1	TCGA-43-2578-01	225	0.7353346672965656	127	TCGA-43-2578-01	9	26	74	0.5848602422933235	TCGA-43-2578-01	21	18	14	53	PASS	6470	TCGA-43-2578	LUSC	59	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-21747	Dead	TUMOR FREE	NA	684	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	684	0	684	0	684	0	684	
50	TCGA-43-2581	7	55	5	27	13	2	0	0	32	724	55	1	15	208	18	2	TCGA-43-2581-01	142	0.5342616645685885	86	TCGA-43-2581-01	19	20	25	0.1792347693143767	TCGA-43-2581-01	11	2	4	17	hypermutated sample	6471	TCGA-43-2581	LUSC	47	FEMALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-17447	Alive	TUMOR FREE	1176	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1176	0	1176	0	1176	0	1176	
50	TCGA-43-3394	0	20	2	7	10	8	2	1	16	278	30	0	10	107	13	0	TCGA-43-3394-01	210	0.7930164920228335	123	TCGA-43-3394-01	25	24	39	0.44390824835477255	TCGA-43-3394-01	20	11	8	39	PASS	6472	TCGA-43-3394	LUSC	52	MALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-19310	Dead	WITH TUMOR	NA	1190	NA	NA	NA	NA	552	Complete Remission/Response	NA	NA	1	1190	1	1190	1	552	1	552	
70	TCGA-43-3920	2	39	2	21	10	3	0	0	36	760	63	0	24	279	18	0	TCGA-43-3920-01	214	0.7240461083540088	116	TCGA-43-3920-01	20	31	39	0.3328925357876442	TCGA-43-3920-01	17	9	9	35	PASS	6473	TCGA-43-3920	LUSC	71	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-26059	Alive	TUMOR FREE	1007	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1007	0	1007	0	1007	0	1007	
80	TCGA-43-5668	6	59	10	18	29	12	4	0	42	1001	84	0	27	368	46	0	TCGA-43-5668-01	225	0.6183894439040306	131	TCGA-43-5668-01	18	34	66	0.33366547052556456	TCGA-43-5668-01	23	8	13	44	PASS	6474	TCGA-43-5668	LUSC	78	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-28635	Dead	WITH TUMOR	NA	559	NA	NA	NA	NA	470	Complete Remission/Response	NA	NA	1	559	1	559	1	470	1	470	
70	TCGA-43-5670	0	24	2	5	6	0	2	0	9	220	14	0	4	70	2	0	TCGA-43-5670-01	370	0.938598723261975	221	TCGA-43-5670-01	20	35	102	0.41776083040537504	TCGA-43-5670-01	17	9	6	32	PASS	6475	TCGA-43-5670	LUSC	70	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-25652	Alive	TUMOR FREE	849	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	849	0	849	0	849	0	849	
70	TCGA-43-6143	2	42	6	12	26	2	2	0	22	490	40	0	10	165	20	4	TCGA-43-6143-01	410	0.778791318585587	281	TCGA-43-6143-01	18	34	91	0.28777684246603863	TCGA-43-6143-01	18	14	11	43	PASS	6476	TCGA-43-6143	LUSC	70	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-25820	Alive	TUMOR FREE	699	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	699	0	699	0	699	0	699	
70	TCGA-43-6647	0	5	2	4	4	0	0	0	16	236	28	2	14	92	12	0	TCGA-43-6647-01	100	0.2742313545886028	35	TCGA-43-6647-01	9	11	27	0.3484561375934657	TCGA-43-6647-01	7	7	5	19	PASS	6477	TCGA-43-6647	LUSC	69	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-25378	Alive	TUMOR FREE	757	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	757	0	757	0	757	0	757	
60	TCGA-43-6770	4	21	3	10	19	0	4	0	10	345	18	0	4	121	14	0	TCGA-43-6770-01	246	0.7086948892867427	158	TCGA-43-6770-01	8	16	72	0.3579813747816142	TCGA-43-6770-01	27	28	14	69	PASS	6478	TCGA-43-6770	LUSC	59	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-21683	Alive	TUMOR FREE	653	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	653	0	653	0	653	0	653	
90	TCGA-43-6771	2	16	8	10	8	0	0	0	15	310	24	4	10	104	14	2	TCGA-43-6771-01	151	0.4528996571663617	83	TCGA-43-6771-01	6	12	24	0.26041064862268115	TCGA-43-6771-01	6	3	4	13	PASS	6479	TCGA-43-6771	LUSC	85	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-31052	Dead	WITH TUMOR	NA	166	NA	NA	NA	NA	154	Progressive Disease	NA	NA	1	166	1	166	NA	NA	1	154	
80	TCGA-43-6773	4	2	0	5	6	2	0	0	2	97	8	0	0	37	3	0	TCGA-43-6773-01	46	0.011647502234304243	10	TCGA-43-6773-01	4	10	5	0.15492725570353827	TCGA-43-6773-01	1	3	1	5	PASS	6480	TCGA-43-6773	LUSC	76	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-28036	Dead	TUMOR FREE	NA	116	NA	NA	NA	NA	NA	NA	NA	NA	1	116	0	116	NA	NA	0	116	
70	TCGA-43-7656	0	30	0	24	6	7	0	0	11	555	41	0	13	188	20	0	TCGA-43-7656-01	172	0.916594515088486	98	TCGA-43-7656-01	13	17	47	0.40098556945551617	TCGA-43-7656-01	13	9	9	31	PASS	6481	TCGA-43-7656	LUSC	71	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-25991	Alive	TUMOR FREE	596	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	596	0	596	0	596	0	596	
70	TCGA-43-7657	0	22	1	12	8	4	0	0	6	203	14	0	2	66	12	0	TCGA-43-7657-01	232	0.7282805530730309	136	TCGA-43-7657-01	22	37	60	0.4424542630020755	TCGA-43-7657-01	16	9	15	40	PASS	6482	TCGA-43-7657	LUSC	68	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-25042	Alive	TUMOR FREE	236	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	236	0	236	0	236	0	236	
80	TCGA-43-7658	0	19	2	16	8	8	0	0	14	316	20	0	10	129	2	2	TCGA-43-7658-01	258	0.601519103471969	157	TCGA-43-7658-01	18	30	41	0.2777314111155858	TCGA-43-7658-01	19	12	11	42	PASS	6483	TCGA-43-7658	LUSC	75	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-27734	Dead	WITH TUMOR	NA	2378	NA	Distant Metastasis|New Primary Tumor	NA	NA	2305	Complete Remission/Response	NA	NA	1	2378	1	2378	1	2305	1	2305	
70	TCGA-43-8115	0	3	1	7	3	1	0	0	6	164	6	0	5	62	5	0	TCGA-43-8115-01	134	0.4561286909009966	70	TCGA-43-8115-01	10	18	34	0.3721122922332655	TCGA-43-8115-01	11	14	10	35	PASS	6484	TCGA-43-8115	LUSC	72	FEMALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26406	Alive	TUMOR FREE	407	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	407	0	407	NA	NA	0	407	
70	TCGA-43-8116	1	16	1	9	7	1	0	0	10	290	18	0	5	111	3	0	TCGA-43-8116-01	173	0.6586248820729574	94	TCGA-43-8116-01	12	20	55	0.4247708740040802	TCGA-43-8116-01	17	14	12	43	PASS	6485	TCGA-43-8116	LUSC	73	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26790	Alive	TUMOR FREE	358	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	358	0	358	0	358	0	358	
60	TCGA-43-8118	6	50	0	45	16	2	6	0	68	962	85	0	27	319	29	4	TCGA-43-8118-01	544	0.5450899247420112	439	TCGA-43-8118-01	14	32	190	0.3122861577631045	TCGA-43-8118-01	23	20	15	58	PASS	6486	TCGA-43-8118	LUSC	55	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-20224	Dead	NA	NA	89	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	89	NA	89	NA	NA	0	89	
70	TCGA-43-A474	2	18	2	8	5	2	0	0	11	279	26	0	7	117	8	0	TCGA-43-A474-01	240	0.5863173343148781	133	TCGA-43-A474-01	19	37	144	0.3598006643448083	TCGA-43-A474-01	21	11	11	43	PASS	6487	TCGA-43-A474	LUSC	66	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-24286	Alive	TUMOR FREE	353	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	353	0	353	0	353	0	353	
70	TCGA-43-A475	0	9	0	3	10	1	2	0	7	197	11	0	5	68	5	1	TCGA-43-A475-01	79	0.4156019161961819	25	TCGA-43-A475-01	14	30	134	0.6451759873807281	TCGA-43-A475-01	16	14	15	45	PASS	6488	TCGA-43-A475	LUSC	67	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-24680	Alive	TUMOR FREE	296	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	296	0	296	0	296	0	296	
80	TCGA-43-A56U	3	11	2	7	4	0	0	0	4	197	20	0	4	70	1	0	TCGA-43-A56U-01	50	0.044060376945560725	9	TCGA-43-A56U-01	5	9	38	0.2234496054265828	TCGA-43-A56U-01	10	15	11	36	PASS	6489	TCGA-43-A56U	LUSC	76	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-27847	Alive	TUMOR FREE	432	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	432	0	432	0	432	0	432	
60	TCGA-43-A56V	3	11	0	5	2	3	0	0	4	162	9	0	6	74	5	0	TCGA-43-A56V-01	141	0.791600233873963	64	TCGA-43-A56V-01	17	15	114	0.4444788004214084	TCGA-43-A56V-01	14	5	13	32	PASS	6490	TCGA-43-A56V	LUSC	61	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-22475	Alive	WITH TUMOR	366	NA	NA	Locoregional Recurrence|Distant Metastasis	NA	NA	355	Complete Remission/Response	NA	NA	0	366	0	366	1	355	1	355	
60	TCGA-46-3765	1	25	4	16	3	1	1	0	26	385	36	0	8	169	15	2	TCGA-46-3765-01	274	0.5491484374935617	163	TCGA-46-3765-01	15	27	60	0.3224516232022761	TCGA-46-3765-01	20	12	12	44	PASS	6491	TCGA-46-3765	LUSC	59	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-21762	Alive	TUMOR FREE	405	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	405	0	405	0	405	0	405	
60	TCGA-46-3766	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-46-3766-01	115	0.2810203811612688	56	TCGA-46-3766-01	11	11	15	0.2361660354493625	TCGA-46-3766-01	6	5	5	16	PASS	6492	TCGA-46-3766	LUSC	62	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-22707	Alive	TUMOR FREE	370	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	370	0	370	0	370	0	370	
80	TCGA-46-3767	1	6	0	4	3	0	0	0	12	206	23	0	5	77	8	0	TCGA-46-3767-01	85	0.23392939746501154	32	TCGA-46-3767-01	10	21	14	0.4061616239554956	TCGA-46-3767-01	9	10	3	22	PASS	6493	TCGA-46-3767	LUSC	76	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-27912	Alive	TUMOR FREE	396	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	396	0	396	0	396	0	396	
60	TCGA-46-3768	4	26	4	13	11	2	1	0	18	301	23	1	5	122	7	0	TCGA-46-3768-01	146	0.8653600607258997	71	TCGA-46-3768-01	27	25	42	0.44401615252571	TCGA-46-3768-01	13	6	11	30	PASS	6494	TCGA-46-3768	LUSC	58	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-21307	Dead	TUMOR FREE	4	299	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	299	0	299	0	299	0	299	
60	TCGA-46-3769	2	48	4	16	13	2	2	0	42	688	72	2	23	297	22	1	TCGA-46-3769-01	434	0.8526739203971732	279	TCGA-46-3769-01	18	70	126	0.5256025066194171	TCGA-46-3769-01	32	30	17	79	hypermutated sample	6495	TCGA-46-3769	LUSC	57	MALE	WHITE	[Discrepancy]	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-20941	Alive	TUMOR FREE	135	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	135	0	135	0	135	0	135	
70	TCGA-46-6025	2	10	1	6	8	0	4	1	3	154	9	0	2	48	2	0	TCGA-46-6025-01	225	0.8843790530109191	124	TCGA-46-6025-01	19	38	98	0.6007719504010552	TCGA-46-6025-01	23	33	17	73	PASS	6496	TCGA-46-6025	LUSC	71	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-26168	Alive	TUMOR FREE	324	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	324	0	324	0	324	0	324	
80	TCGA-46-6026	1	13	0	7	6	2	2	0	8	159	13	2	3	55	6	1	TCGA-46-6026-01	228	0.9999643423335508	148	TCGA-46-6026-01	26	29	44	0.20553173212753484	TCGA-46-6026-01	13	11	7	31	PASS	6497	TCGA-46-6026	LUSC	81	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-29890	Alive	TUMOR FREE	423	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	423	0	423	0	423	0	423	
70	TCGA-51-4079	4	23	2	18	13	5	0	0	19	310	28	0	7	107	3	0	TCGA-51-4079-01	269	0.7128812632839266	170	TCGA-51-4079-01	8	10	25	0.2876339101196683	TCGA-51-4079-01	12	12	12	36	PASS	6498	TCGA-51-4079	LUSC	73	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-26899	Dead	NA	NA	12	NA	NA	NA	NA	NA	NA	NA	NA	1	12	NA	12	NA	NA	0	12	
70	TCGA-51-4080	0	13	0	11	7	1	2	0	11	219	18	0	7	66	12	0	TCGA-51-4080-01	165	0.4960627654249629	94	TCGA-51-4080-01	10	9	21	0.19853773167502203	TCGA-51-4080-01	7	7	7	21	PASS	6499	TCGA-51-4080	LUSC	65	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-24054	Dead	TUMOR FREE	NA	12	NA	NA	NA	NA	NA	NA	NA	NA	1	12	0	12	NA	NA	0	12	
60	TCGA-51-4081	1	8	1	4	4	2	0	0	5	162	9	0	2	50	8	0	TCGA-51-4081-01	171	0.9013784186360948	105	TCGA-51-4081-01	17	24	26	0.29235356516559	TCGA-51-4081-01	16	6	10	32	PASS	6500	TCGA-51-4081	LUSC	55	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-20261	Alive	TUMOR FREE	911	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	911	0	911	NA	NA	0	911	
70	TCGA-51-6867	2	36	6	23	12	1	3	0	24	494	31	0	12	153	19	0	TCGA-51-6867	0	0	0	TCGA-51-6867	0	0	0	0	TCGA-51-6867	0	0	0	0	PASS	6501	TCGA-51-6867	LUSC	72	FEMALE	WHITE	Stage I	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-26523	Dead	WITH TUMOR	NA	1856	NA	NA	NA	NA	788	Complete Remission/Response	NA	NA	1	1856	1	1856	1	788	1	788	
60	TCGA-52-7622	0	16	4	2	6	1	0	0	10	201	21	0	3	83	6	0	TCGA-52-7622-01	126	0.42117360239800267	63	TCGA-52-7622-01	14	16	31	0.3098230135520381	TCGA-52-7622-01	10	5	9	24	PASS	6502	TCGA-52-7622	LUSC	62	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-22807	Alive	TUMOR FREE	862	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	862	0	862	0	862	0	862	
70	TCGA-52-7809	0	9	0	9	4	2	0	0	8	194	18	0	6	63	4	0	TCGA-52-7809-01	219	0.8321986597044494	118	TCGA-52-7809-01	17	36	89	0.5450118172727738	TCGA-52-7809-01	21	19	12	52	PASS	6503	TCGA-52-7809	LUSC	74	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-27233	Dead	WITH TUMOR	NA	166	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	166	1	166	NA	NA	1	166	
60	TCGA-52-7810	2	28	3	18	7	2	1	1	12	310	38	0	4	117	9	2	TCGA-52-7810-01	334	0.8273027824832354	204	TCGA-52-7810-01	22	24	82	0.35088884290012345	TCGA-52-7810-01	26	20	18	64	PASS	6504	TCGA-52-7810	LUSC	60	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-22241	Alive	TUMOR FREE	923	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	923	0	923	0	923	0	923	
70	TCGA-52-7811	0	6	0	3	2	1	0	0	4	125	5	0	1	47	5	0	TCGA-52-7811-01	87	0.4943031203783828	39	TCGA-52-7811-01	14	54	18	0.22212724921321475	TCGA-52-7811-01	12	7	5	24	PASS	6505	TCGA-52-7811	LUSC	67	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-24782	Dead	WITH TUMOR	NA	266	NA	Distant Metastasis	NA	NA	153	Progressive Disease	NA	NA	1	266	1	266	NA	NA	1	153	
70	TCGA-52-7812	2	13	2	9	8	1	2	0	11	221	16	0	4	97	8	1	TCGA-52-7812-01	167	0.35601519742556725	90	TCGA-52-7812-01	7	12	41	0.2690386579495066	TCGA-52-7812-01	13	11	12	36	PASS	6506	TCGA-52-7812	LUSC	68	MALE	WHITE	[Discrepancy]	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-24887	Dead	WITH TUMOR	NA	835	NA	Distant Metastasis	NA	NA	791	Progressive Disease	NA	NA	1	835	1	835	NA	NA	1	791	
60	TCGA-56-1622	0	23	0	6	5	2	0	0	10	162	9	1	6	67	9	0	TCGA-56-1622-01	172	0.8273905636997892	95	TCGA-56-1622-01	18	21	65	0.5044449037556452	TCGA-56-1622-01	17	11	18	46	PASS	6507	TCGA-56-1622	LUSC	58	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-21371	Dead	WITH TUMOR	NA	881	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	881	1	881	NA	NA	1	881	
70	TCGA-56-5897	2	4	1	2	3	0	0	0	2	72	9	0	1	33	0	0	TCGA-56-5897-01	88	0.3023357575488404	35	TCGA-56-5897-01	12	11	19	0.3065409182148319	TCGA-56-5897-01	5	7	6	18	PASS	6508	TCGA-56-5897	LUSC	74	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-27118	Alive	TUMOR FREE	378	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	378	0	378	0	378	0	378	
70	TCGA-56-5898	1	7	0	1	1	0	0	0	3	117	8	0	4	39	2	0	TCGA-56-5898-01	223	0.7335363313494743	140	TCGA-56-5898-01	28	20	42	0.35784921392706165	TCGA-56-5898-01	10	8	8	26	PASS	6509	TCGA-56-5898	LUSC	69	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-25441	Alive	TUMOR FREE	555	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	555	0	555	0	555	0	555	
80	TCGA-56-6545	0	12	1	7	4	0	0	0	8	237	22	0	7	74	6	1	TCGA-56-6545-01	189	0.6654645542363052	91	TCGA-56-6545-01	20	32	39	0.4413072771203113	TCGA-56-6545-01	20	13	13	46	PASS	6510	TCGA-56-6545	LUSC	77	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-28400	Alive	TUMOR FREE	666	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	666	0	666	0	666	0	666	
70	TCGA-56-6546	2	19	0	11	15	4	2	0	6	267	18	0	9	87	9	0	TCGA-56-6546-01	70	0.2646594858504828	21	TCGA-56-6546-01	11	14	21	0.3038214103177627	TCGA-56-6546-01	6	4	4	14	PASS	6511	TCGA-56-6546	LUSC	67	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-24594	Alive	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
80	TCGA-56-7221	2	15	0	10	8	1	1	0	10	213	17	0	4	96	6	0	TCGA-56-7221-01	110	0.5660545267408338	48	TCGA-56-7221-01	14	18	41	0.40309210553332747	TCGA-56-7221-01	8	5	10	23	PASS	6512	TCGA-56-7221	LUSC	79	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-28873	Alive	TUMOR FREE	608	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	608	0	608	0	608	0	608	
60	TCGA-56-7222	2	32	8	22	34	17	4	0	31	564	51	4	16	234	18	4	TCGA-56-7222-01	130	0.9072351189462976	63	TCGA-56-7222-01	25	27	24	0.3784688747894766	TCGA-56-7222-01	17	6	7	30	PASS	6513	TCGA-56-7222	LUSC	60	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-22097	Dead	WITH TUMOR	NA	562	NA	NA	NA	NA	427	Complete Remission/Response	NA	NA	1	562	1	562	1	427	1	427	
70	TCGA-56-7223	4	17	1	7	7	2	0	0	11	217	10	0	10	86	12	1	TCGA-56-7223-01	290	0.9377323135019864	181	TCGA-56-7223-01	20	31	52	0.3702571993632491	TCGA-56-7223-01	16	13	9	38	PASS	6514	TCGA-56-7223	LUSC	66	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-24288	Dead	WITH TUMOR	NA	442	NA	Locoregional Recurrence	NA	NA	132	Progressive Disease	NA	NA	1	442	1	442	NA	NA	1	132	
60	TCGA-56-7579	4	26	0	12	14	2	0	0	15	372	32	0	14	151	16	0	TCGA-56-7579-01	222	0.6100509500587351	131	TCGA-56-7579-01	12	16	49	0.3005834074338416	TCGA-56-7579-01	18	15	16	49	PASS	6515	TCGA-56-7579	LUSC	61	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-22632	Dead	WITH TUMOR	NA	951	NA	Locoregional Recurrence	NA	NA	149	Progressive Disease	NA	NA	1	951	1	951	NA	NA	1	149	
80	TCGA-56-7580	0	18	0	10	6	0	0	0	4	215	22	0	4	77	6	0	TCGA-56-7580-01	142	0.7112143429174066	80	TCGA-56-7580-01	31	21	24	0.3210473935814825	TCGA-56-7580-01	7	0	8	15	PASS	6516	TCGA-56-7580	LUSC	84	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-30740	Alive	TUMOR FREE	925	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	925	0	925	0	925	0	925	
80	TCGA-56-7582	0	12	0	6	8	0	2	0	8	268	14	0	4	83	16	0	TCGA-56-7582-01	113	0.7446695539907222	60	TCGA-56-7582-01	23	25	26	0.493813182338441	TCGA-56-7582-01	13	10	9	32	PASS	6517	TCGA-56-7582	LUSC	83	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-30678	Alive	TUMOR FREE	601	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	601	0	601	0	601	0	601	
70	TCGA-56-7730	2	20	1	13	7	2	1	0	11	300	24	0	9	87	7	1	TCGA-56-7730-01	315	0.7447778823089323	189	TCGA-56-7730-01	20	30	57	0.3962591364456123	TCGA-56-7730-01	19	10	9	38	PASS	6518	TCGA-56-7730	LUSC	73	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26699	Dead	WITH TUMOR	NA	198	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	198	1	198	NA	NA	1	198	
70	TCGA-56-7731	0	30	8	26	10	2	0	0	28	567	41	0	14	198	26	0	TCGA-56-7731-01	49	0.2242395034959468	9	TCGA-56-7731-01	10	12	6	0.1961383708696265	TCGA-56-7731-01	3	0	1	4	PASS	6519	TCGA-56-7731	LUSC	66	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-24441	Dead	TUMOR FREE	NA	3	NA	NA	NA	NA	NA	NA	NA	NA	1	3	0	3	NA	NA	0	3	
80	TCGA-56-7822	2	35	8	20	8	0	2	0	21	574	50	0	19	202	10	2	TCGA-56-7822-01	117	0.5700093622641021	56	TCGA-56-7822-01	25	25	20	0.30343855092315103	TCGA-56-7822-01	17	8	9	34	PASS	6520	TCGA-56-7822	LUSC	75	MALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-27755	Dead	WITH TUMOR	NA	532	NA	NA	NA	NA	301	[Unknown]	NA	NA	1	532	1	532	NA	NA	1	301	
60	TCGA-56-7823	2	11	3	9	7	1	0	0	9	210	13	0	12	79	7	1	TCGA-56-7823-01	179	0.9398781899511479	90	TCGA-56-7823-01	8	16	32	0.3732228547791389	TCGA-56-7823-01	14	7	9	30	PASS	6521	TCGA-56-7823	LUSC	58	FEMALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-21344	Alive	TUMOR FREE	1011	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1011	0	1011	0	1011	0	1011	
80	TCGA-56-8082	2	8	0	7	6	1	1	0	4	166	12	1	6	71	4	0	TCGA-56-8082-01	199	0.940578556801352	104	TCGA-56-8082-01	14	20	46	0.4282537082275142	TCGA-56-8082-01	11	9	14	34	PASS	6522	TCGA-56-8082	LUSC	80	FEMALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-29440	Alive	TUMOR FREE	455	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	455	0	455	0	455	0	455	
60	TCGA-56-8083	1	5	1	3	8	2	0	1	4	117	13	0	1	51	4	1	TCGA-56-8083-01	154	0.3901073248430595	76	TCGA-56-8083-01	8	10	23	0.2296857735030249	TCGA-56-8083-01	13	10	13	36	PASS	6523	TCGA-56-8083	LUSC	56	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-20696	Alive	TUMOR FREE	150	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	150	0	150	NA	NA	0	150	
70	TCGA-56-8201	0	4	1	1	6	0	1	0	2	131	5	0	3	46	6	0	TCGA-56-8201-01	96	0.3724745549894123	38	TCGA-56-8201-01	22	28	27	0.4586138543514456	TCGA-56-8201-01	12	2	8	22	PASS	6524	TCGA-56-8201	LUSC	74	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-27211	Dead	WITH TUMOR	NA	397	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	397	1	397	NA	NA	1	397	
70	TCGA-56-8304	6	14	2	3	6	2	1	0	9	183	22	0	0	57	11	0	TCGA-56-8304-01	81	0.6355110698978924	31	TCGA-56-8304-01	13	15	78	0.4492002972117666	TCGA-56-8304-01	13	9	15	37	PASS	6525	TCGA-56-8304	LUSC	73	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26803	Alive	TUMOR FREE	106	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	106	0	106	0	106	0	106	
70	TCGA-56-8305	0	21	3	13	7	2	1	0	8	292	24	1	7	115	10	0	TCGA-56-8305-01	218	0.6717473229193056	132	TCGA-56-8305-01	18	21	46	0.3150116740250733	TCGA-56-8305-01	15	8	9	32	PASS	6526	TCGA-56-8305	LUSC	72	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26428	Alive	TUMOR FREE	105	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	105	0	105	0	105	0	105	
60	TCGA-56-8307	3	21	1	12	11	2	0	0	14	326	19	1	7	104	18	0	TCGA-56-8307-01	108	0.8113480192953446	45	TCGA-56-8307-01	26	15	28	0.21604272986975945	TCGA-56-8307-01	7	6	7	20	PASS	6527	TCGA-56-8307	LUSC	55	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-20411	Alive	TUMOR FREE	818	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	818	0	818	0	818	0	818	
80	TCGA-56-8308	0	9	1	9	8	3	1	0	4	276	18	0	5	105	8	2	TCGA-56-8308-01	202	0.6108591099683756	104	TCGA-56-8308-01	17	27	34	0.28846104505411024	TCGA-56-8308-01	17	15	6	38	PASS	6528	TCGA-56-8308	LUSC	79	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-29139	Alive	WITH TUMOR	517	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	517	0	517	NA	NA	0	517	
70	TCGA-56-8309	0	1	0	4	2	0	0	0	2	117	4	0	2	27	5	0	TCGA-56-8309-01	72	0.3493220244319638	27	TCGA-56-8309-01	12	11	20	0.2798246734022134	TCGA-56-8309-01	8	3	9	20	PASS	6529	TCGA-56-8309	LUSC	66	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-24382	Alive	TUMOR FREE	428	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	428	0	428	0	428	0	428	
80	TCGA-56-8503	0	6	0	6	2	0	0	0	5	128	6	0	4	44	10	0	TCGA-56-8503-01	1123	0.10231697853778993	1043	TCGA-56-8503-01	17	19	474	0.4886438816590303	TCGA-56-8503-01	11	15	21	47	PASS	6530	TCGA-56-8503	LUSC	76	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-28095	Alive	TUMOR FREE	41	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	41	0	41	NA	NA	0	41	
70	TCGA-56-8504	0	19	6	8	13	4	2	0	4	373	22	0	10	132	12	0	TCGA-56-8504-01	86	0.7135915191416573	30	TCGA-56-8504-01	27	64	115	0.4626777894640712	TCGA-56-8504-01	20	6	9	35	PASS	6531	TCGA-56-8504	LUSC	74	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-27210	Alive	TUMOR FREE	510	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	510	0	510	0	510	0	510	
70	TCGA-56-8622	4	17	0	33	12	6	0	0	6	327	24	4	12	149	8	0	TCGA-56-8622-01	141	0.2568539712303949	81	TCGA-56-8622-01	8	10	42	0.15990694133934544	TCGA-56-8622-01	9	7	6	22	PASS	6532	TCGA-56-8622	LUSC	68	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-24861	Alive	TUMOR FREE	55	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	55	0	55	NA	NA	0	55	
70	TCGA-56-8623	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-56-8623-01	37	0.00011508780671601887	4	TCGA-56-8623-01	0	0	12	0.05246774249169375	TCGA-56-8623-01	0	0	0	0	PASS	6533	TCGA-56-8623	LUSC	71	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-26231	Dead	TUMOR FREE	NA	692	NA	New Primary Tumor	NA	NA	645	Complete Remission/Response	NA	NA	1	692	0	692	0	692	1	645	
80	TCGA-56-8624	2	10	2	10	6	0	0	0	14	184	12	2	4	69	6	0	TCGA-56-8624-01	46	0.4763882424350298	7	TCGA-56-8624-01	18	16	33	0.17398446477925428	TCGA-56-8624-01	7	7	5	19	PASS	6534	TCGA-56-8624	LUSC	84	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-30798	Alive	TUMOR FREE	420	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	420	0	420	0	420	0	420	
70	TCGA-56-8625	2	42	6	28	10	2	0	0	25	646	62	0	14	277	31	0	TCGA-56-8625-01	198	0.3555956587646859	117	TCGA-56-8625-01	6	11	107	0.3418717021934802	TCGA-56-8625-01	12	17	17	46	PASS	6535	TCGA-56-8625	LUSC	66	FEMALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-24188	Dead	WITH TUMOR	NA	315	NA	Distant Metastasis	NA	NA	272	Progressive Disease	NA	NA	1	315	1	315	NA	NA	1	272	
60	TCGA-56-8626	1	11	2	11	7	3	1	0	14	188	15	0	2	73	6	0	TCGA-56-8626-01	159	0.3657247146498746	80	TCGA-56-8626-01	14	15	85	0.24248794685934946	TCGA-56-8626-01	11	7	11	29	PASS	6536	TCGA-56-8626	LUSC	59	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-21908	Dead	TUMOR FREE	NA	302	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	302	0	302	0	302	0	302	
80	TCGA-56-8628	4	49	2	27	36	4	6	0	28	640	46	2	24	188	24	0	TCGA-56-8628-01	145	0.39222173238011626	70	TCGA-56-8628-01	16	11	140	0.28388236088012897	TCGA-56-8628-01	10	3	11	24	PASS	6537	TCGA-56-8628	LUSC	78	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-28805	Alive	TUMOR FREE	616	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	616	0	616	0	616	0	616	
60	TCGA-56-8629	0	20	0	16	15	3	2	0	14	330	38	0	9	114	16	0	TCGA-56-8629-01	191	0.7574550589061614	106	TCGA-56-8629-01	22	31	104	0.4620258961503842	TCGA-56-8629-01	21	17	17	55	PASS	6538	TCGA-56-8629	LUSC	63	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-23346	Alive	TUMOR FREE	481	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	481	0	481	0	481	0	481	
70	TCGA-56-A49D	1	17	2	3	4	0	2	2	8	227	18	1	11	83	6	0	TCGA-56-A49D-01	191	0.8597673773201256	104	TCGA-56-A49D-01	18	22	228	0.6217201992500331	TCGA-56-A49D-01	19	11	22	52	PASS	6539	TCGA-56-A49D	LUSC	67	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-24745	Alive	TUMOR FREE	637	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	637	0	637	0	637	0	637	
60	TCGA-56-A4BW	1	12	1	11	6	2	2	0	8	177	12	0	2	63	7	0	TCGA-56-A4BW-01	198	0.4895070365039619	98	TCGA-56-A4BW-01	16	20	148	0.32202817569911785	TCGA-56-A4BW-01	21	7	13	41	PASS	6540	TCGA-56-A4BW	LUSC	55	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-20301	Alive	TUMOR FREE	585	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	585	0	585	0	585	0	585	
70	TCGA-56-A4BX	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-56-A4BX-01	129	0.7213885309274098	56	TCGA-56-A4BX-01	17	35	55	0.32122159279502177	TCGA-56-A4BX-01	14	9	8	31	PASS	6541	TCGA-56-A4BX	LUSC	70	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-25745	Alive	TUMOR FREE	405	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	405	0	405	0	405	0	405	
70	TCGA-56-A4BY	0	6	0	5	3	2	0	0	7	104	12	1	3	47	2	1	TCGA-56-A4BY-01	151	0.4732999975460018	76	TCGA-56-A4BY-01	15	17	69	0.2079262879048504	TCGA-56-A4BY-01	13	13	8	34	PASS	6542	TCGA-56-A4BY	LUSC	66	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-24445	Dead	WITH TUMOR	NA	543	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	543	1	543	NA	NA	1	543	
80	TCGA-56-A4ZJ	1	5	0	5	1	1	0	0	5	85	8	0	1	31	3	0	TCGA-56-A4ZJ-01	75	0.29122776647899723	20	TCGA-56-A4ZJ-01	9	13	52	0.25428686401946576	TCGA-56-A4ZJ-01	11	7	9	27	PASS	6543	TCGA-56-A4ZJ	LUSC	75	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-27516	Alive	TUMOR FREE	640	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	640	0	640	0	640	0	640	
80	TCGA-56-A4ZK	0	22	4	6	6	2	0	0	6	184	12	0	8	52	4	0	TCGA-56-A4ZK-01	225	0.7193654059703855	131	TCGA-56-A4ZK	0	0	0	0	TCGA-56-A4ZK	0	0	0	0	PASS	6544	TCGA-56-A4ZK	LUSC	76	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-28039	Alive	TUMOR FREE	570	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	570	0	570	0	570	0	570	
80	TCGA-56-A5DR	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-56-A5DR-01	82	0.7177705319709105	24	TCGA-56-A5DR	0	0	0	0	TCGA-56-A5DR	0	0	0	0	PASS	6545	TCGA-56-A5DR	LUSC	81	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-29828	Alive	TUMOR FREE	4	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4	0	4	0	4	0	4	
70	TCGA-56-A5DS	2	8	1	7	6	0	0	0	6	166	10	1	3	60	1	0	TCGA-56-A5DS-01	46	0.3253495230506366	9	TCGA-56-A5DS-01	12	10	23	0.1987266817434352	TCGA-56-A5DS-01	7	3	6	16	PASS	6546	TCGA-56-A5DS	LUSC	72	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-26355	Alive	TUMOR FREE	8	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	8	0	8	0	8	0	8	
80	TCGA-56-A62T	4	22	2	14	10	3	1	0	16	386	31	0	14	124	18	0	TCGA-56-A62T-01	210	0.7144338650851892	139	TCGA-56-A62T-01	25	54	152	0.4214221841961551	TCGA-56-A62T-01	13	5	4	22	PASS	6547	TCGA-56-A62T	LUSC	78	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2013	NA	-28522	Alive	TUMOR FREE	440	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	440	0	440	0	440	0	440	
80	TCGA-58-8386	0	12	0	6	6	5	2	0	9	193	14	0	6	69	10	0	TCGA-58-8386-01	210	0.5977296628190191	109	TCGA-58-8386-01	20	33	43	0.3743189152143517	TCGA-58-8386-01	20	13	15	48	PASS	6548	TCGA-58-8386	LUSC	75	MALE	[Not Evaluated]	Stage IV	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-27455	Dead	TUMOR FREE	NA	1	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1	0	1	NA	NA	0	1	
60	TCGA-58-8387	3	9	0	5	3	1	0	0	8	127	14	0	9	57	3	0	TCGA-58-8387-01	172	0.4086585616671361	79	TCGA-58-8387-01	10	17	43	0.3147778231630812	TCGA-58-8387-01	16	12	15	43	PASS	6549	TCGA-58-8387	LUSC	60	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-21952	Dead	TUMOR FREE	NA	403	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	403	0	403	0	403	0	403	
60	TCGA-58-8388	0	17	1	6	5	0	0	0	2	131	17	0	2	48	4	0	TCGA-58-8388-01	100	0.43468494487904985	44	TCGA-58-8388-01	11	13	54	0.2555151987780108	TCGA-58-8388-01	6	3	12	21	PASS	6550	TCGA-58-8388	LUSC	60	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-21949	Dead	TUMOR FREE	NA	412	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	412	0	412	0	412	0	412	
70	TCGA-58-8390	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-58-8390-01	141	0.9067141825303762	69	TCGA-58-8390-01	15	18	71	0.3629549630992854	TCGA-58-8390-01	12	8	14	34	PASS	6551	TCGA-58-8390	LUSC	70	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-25827	Alive	TUMOR FREE	911	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	911	0	911	0	911	0	911	
60	TCGA-58-8391	2	16	2	8	8	3	1	0	15	263	18	1	11	89	7	1	TCGA-58-8391-01	220	0.6453707820270831	123	TCGA-58-8391-01	14	34	104	0.2942506472194702	TCGA-58-8391-01	18	23	15	56	PASS	6552	TCGA-58-8391	LUSC	57	FEMALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-21102	Alive	WITH TUMOR	2167	NA	NA	Distant Metastasis|New Primary Tumor	NA	NA	2033	Complete Remission/Response	NA	NA	0	2167	0	2167	1	2033	1	2033	
70	TCGA-58-8392	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-58-8392-01	239	0.9046331619583718	152	TCGA-58-8392	0	0	0	0	TCGA-58-8392	0	0	0	0	PASS	6553	TCGA-58-8392	LUSC	70	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-25710	Dead	WITH TUMOR	NA	501	NA	Distant Metastasis	NA	NA	96	Complete Remission/Response	NA	NA	1	501	1	501	1	96	1	96	
70	TCGA-58-8393	1	8	0	2	1	0	2	0	9	221	18	0	2	78	4	1	TCGA-58-8393-01	74	0.5876623290531288	30	TCGA-58-8393-01	21	26	86	0.4150985213544122	TCGA-58-8393-01	10	5	6	21	PASS	6554	TCGA-58-8393	LUSC	68	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-25132	Alive	TUMOR FREE	1058	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1058	0	1058	0	1058	0	1058	
60	TCGA-58-A46J	0	7	0	4	9	2	0	0	4	135	11	0	2	52	2	1	TCGA-58-A46J-01	111	0.3799065096481908	49	TCGA-58-A46J-01	11	17	2	4.4918916808254774e-05	TCGA-58-A46J-01	9	4	0	13	PASS	6555	TCGA-58-A46J	LUSC	64	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-23653	Alive	TUMOR FREE	2589	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2589	0	2589	0	2589	0	2589	
60	TCGA-58-A46K	0	10	3	5	1	0	0	0	7	106	9	0	7	43	6	0	TCGA-58-A46K-01	151	0.8408101558927129	77	TCGA-58-A46K-01	20	19	143	0.5790564752873422	TCGA-58-A46K-01	16	9	16	41	PASS	6556	TCGA-58-A46K	LUSC	59	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-21867	Dead	WITH TUMOR	NA	1045	NA	Locoregional Recurrence|Distant Metastasis	NA	NA	735	Complete Remission/Response	NA	NA	1	1045	1	1045	1	735	1	735	
70	TCGA-58-A46L	0	11	0	3	2	1	0	0	6	190	11	0	2	52	8	1	TCGA-58-A46L-01	256	0.4466341212870088	143	TCGA-58-A46L-01	10	16	179	0.4450056825146012	TCGA-58-A46L-01	20	15	22	57	PASS	6557	TCGA-58-A46L	LUSC	73	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-26685	Alive	TUMOR FREE	1723	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1723	0	1723	0	1723	0	1723	
60	TCGA-58-A46M	1	22	3	19	12	1	2	2	12	295	26	0	12	131	11	2	TCGA-58-A46M-01	268	0.7258424688646649	156	TCGA-58-A46M-01	19	70	210	0.5032199551342436	TCGA-58-A46M-01	30	19	23	72	PASS	6558	TCGA-58-A46M	LUSC	61	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-22592	Alive	TUMOR FREE	1072	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1072	0	1072	0	1072	0	1072	
50	TCGA-58-A46N	1	15	1	8	6	1	0	1	6	148	12	0	5	62	8	0	TCGA-58-A46N-01	205	0.9464852747781594	109	TCGA-58-A46N-01	15	16	176	0.5899161895429382	TCGA-58-A46N-01	12	6	12	30	PASS	6559	TCGA-58-A46N	LUSC	52	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-19050	Alive	WITH TUMOR	910	NA	NA	Locoregional Recurrence	NA	NA	630	Complete Remission/Response	NA	NA	0	910	0	910	1	630	1	630	
70	TCGA-60-2695	1	12	0	9	5	1	0	0	6	167	14	0	7	52	4	1	TCGA-60-2695-01	206	0.9357975765471052	119	TCGA-60-2695-01	22	36	30	0.2585810500462847	TCGA-60-2695-01	11	7	4	22	PASS	6560	TCGA-60-2695	LUSC	74	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-27211	Alive	TUMOR FREE	642	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	642	0	642	0	642	0	642	
80	TCGA-60-2696	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-60-2696	0	0	0	TCGA-60-2696	0	0	0	0	TCGA-60-2696-01	9	2	1	12	PASS	6561	TCGA-60-2696	LUSC	76	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-27991	Dead	NA	109	109	NA	NA	NA	NA	NA	NA	NA	NA	1	109	NA	109	NA	NA	0	109	
40	TCGA-60-2697	0	1	1	0	0	0	0	0	0	15	0	0	2	5	0	0	TCGA-60-2697-01	78	0.01696810307038755	31	TCGA-60-2697-01	1	2	19	1.1009895023020864e-06	TCGA-60-2697-01	0	0	0	0	PASS	6562	TCGA-60-2697	LUSC	41	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	1992	NA	-14984	Dead	WITH TUMOR	NA	372	NA	NA	NA	NA	200	Complete Remission/Response	NA	NA	1	372	1	372	1	200	1	200	
60	TCGA-60-2698	7	61	4	27	15	2	1	0	44	845	83	2	17	295	18	1	TCGA-60-2698-01	290	0.6439270316871308	172	TCGA-60-2698-01	21	61	64	0.33363303155676266	TCGA-60-2698-01	27	16	16	59	hypermutated sample	6563	TCGA-60-2698	LUSC	62	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	1993	NA	-22800	Dead	WITH TUMOR	NA	311	NA	NA	NA	NA	114	NA	NA	NA	1	311	1	311	NA	NA	1	114	
70	TCGA-60-2703	2	12	0	8	9	1	1	0	3	245	14	1	4	80	7	1	TCGA-60-2703-01	111	0.6072820866905254	47	TCGA-60-2703-01	23	23	25	0.3954486213024239	TCGA-60-2703-01	15	4	9	28	PASS	6564	TCGA-60-2703	LUSC	73	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-27003	Dead	NA	NA	2945	NA	NA	NA	NA	1757	Complete Remission/Response	NA	NA	1	2945	NA	2945	1	1757	1	1757	
70	TCGA-60-2704	1	9	1	7	3	0	0	0	3	153	5	0	3	68	5	2	TCGA-60-2704-01	83	0.4590105981724298	25	TCGA-60-2704-01	27	33	27	0.4933721540553597	TCGA-60-2704-01	11	2	5	18	PASS	6565	TCGA-60-2704	LUSC	73	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-26927	Dead	WITH TUMOR	NA	1154	NA	NA	NA	NA	532	NA	NA	NA	1	1154	1	1154	NA	NA	1	532	
60	TCGA-60-2706	0	0	0	1	0	0	0	0	0	12	0	0	0	1	0	0	TCGA-60-2706-01	421	0.6824516929758396	298	TCGA-60-2706-01	22	24	101	0.4515903856854753	TCGA-60-2706-01	20	15	10	45	mutation call filter	6566	TCGA-60-2706	LUSC	58	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-21477	Alive	TUMOR FREE	2820	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2820	0	2820	0	2820	0	2820	
70	TCGA-60-2707	0	8	1	6	1	0	0	0	6	81	6	0	2	29	4	0	TCGA-60-2707-01	147	0.5280369640722671	80	TCGA-60-2707-01	6	6	15	0.14953717638982408	TCGA-60-2707-01	7	3	6	16	PASS	6567	TCGA-60-2707	LUSC	70	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-25758	Dead	WITH TUMOR	NA	667	NA	NA	NA	NA	579	Complete Remission/Response	NA	NA	1	667	1	667	1	579	1	579	
60	TCGA-60-2708	1	10	0	5	11	1	2	0	11	156	11	1	3	62	0	0	TCGA-60-2708-01	199	0.8250440033721627	124	TCGA-60-2708-01	33	29	39	0.4519207455042735	TCGA-60-2708-01	11	3	5	19	PASS	6568	TCGA-60-2708	LUSC	64	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-23691	Alive	TUMOR FREE	2447	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2447	0	2447	0	2447	0	2447	
70	TCGA-60-2709	3	8	2	7	4	0	1	0	5	122	11	0	2	50	6	0	TCGA-60-2709-01	132	0.10468307155378916	64	TCGA-60-2709-01	31	26	14	0.3586829630582158	TCGA-60-2709-01	11	8	5	24	PASS	6569	TCGA-60-2709	LUSC	69	MALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-25453	Alive	TUMOR FREE	1505	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1505	0	1505	0	1505	0	1505	
70	TCGA-60-2710	1	8	0	7	5	2	2	0	1	165	10	1	4	51	7	0	TCGA-60-2710-01	142	0.39914335931349104	81	TCGA-60-2710-01	12	14	25	0.2752684710387442	TCGA-60-2710-01	12	6	11	29	PASS	6570	TCGA-60-2710	LUSC	67	FEMALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-24669	Alive	TUMOR FREE	2024	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2024	0	2024	0	2024	0	2024	
60	TCGA-60-2711	0	4	0	2	2	1	3	0	8	87	10	1	5	42	0	0	TCGA-60-2711-01	307	0.6590036965789744	187	TCGA-60-2711-01	21	30	27	0.2253793920605115	TCGA-60-2711-01	19	16	6	41	PASS	6571	TCGA-60-2711	LUSC	64	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-23651	Alive	TUMOR FREE	1260	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1260	0	1260	0	1260	0	1260	
80	TCGA-60-2712	0	9	0	4	3	2	2	0	2	65	7	0	0	24	3	0	TCGA-60-2712	0	0	0	TCGA-60-2712	0	0	0	0	TCGA-60-2712-01	12	9	6	27	PASS	6572	TCGA-60-2712	LUSC	79	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-29131	Dead	NA	274	274	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	274	NA	274	0	274	0	274	
60	TCGA-60-2713	1	20	3	6	6	0	0	0	7	186	17	1	5	73	5	0	TCGA-60-2713-01	221	0.9280027534053732	114	TCGA-60-2713-01	13	16	55	0.4375185380082498	TCGA-60-2713-01	19	7	19	45	PASS	6573	TCGA-60-2713	LUSC	64	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-23630	Alive	NA	1731	NA	NA	NA	NA	NA	1356	Complete Remission/Response	NA	NA	0	1731	0	1731	1	1356	1	1356	
70	TCGA-60-2714	2	50	2	30	17	7	0	0	30	691	47	0	18	209	27	0	TCGA-60-2714-01	247	0.6625233361573628	162	TCGA-60-2714-01	25	56	38	0.436007409950974	TCGA-60-2714-01	22	12	14	48	hypermutated sample	6574	TCGA-60-2714	LUSC	66	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-24169	Alive	TUMOR FREE	1531	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1531	0	1531	0	1531	0	1531	
50	TCGA-60-2715	0	4	2	2	3	0	0	0	2	101	12	0	1	37	1	0	TCGA-60-2715	0	0	0	TCGA-60-2715	0	0	0	0	TCGA-60-2715-01	8	6	14	28	PASS	6575	TCGA-60-2715	LUSC	51	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-18990	Dead	WITH TUMOR	NA	1075	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	1075	1	1075	NA	NA	1	1075	
40	TCGA-60-2716	0	0	0	0	1	0	0	0	1	13	1	0	1	5	1	0	TCGA-60-2716-01	81	4.8647737055261933e-05	33	TCGA-60-2716-01	0	0	19	7.952094729086023e-06	TCGA-60-2716-01	0	0	0	0	PASS	6576	TCGA-60-2716	LUSC	39	MALE	NA	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-14345	Alive	TUMOR FREE	1475	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1475	0	1475	0	1475	0	1475	
80	TCGA-60-2719	0	19	1	12	5	1	0	1	12	165	4	0	8	59	2	0	TCGA-60-2719-01	239	0.8691300197039092	136	TCGA-60-2719-01	14	16	48	0.3874801491944695	TCGA-60-2719-01	13	5	12	30	PASS	6577	TCGA-60-2719	LUSC	83	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-30379	Alive	TUMOR FREE	1297	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1297	0	1297	0	1297	0	1297	
60	TCGA-60-2720	2	20	1	8	10	2	0	0	8	337	30	0	10	99	10	2	TCGA-60-2720-01	71	0.4133466751177318	21	TCGA-60-2720-01	13	14	18	0.4016049843688008	TCGA-60-2720-01	7	7	5	19	PASS	6578	TCGA-60-2720	LUSC	60	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-22238	Alive	TUMOR FREE	97	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	97	0	97	NA	NA	0	97	
70	TCGA-60-2721	1	13	1	6	4	0	0	0	6	154	17	1	9	57	5	1	TCGA-60-2721-01	180	0.4310914101583476	99	TCGA-60-2721-01	10	13	38	0.3016015741169861	TCGA-60-2721-01	11	6	7	24	PASS	6579	TCGA-60-2721	LUSC	73	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-27007	Alive	TUMOR FREE	983	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	983	0	983	0	983	0	983	
70	TCGA-60-2722	2	16	0	13	5	1	0	0	9	233	26	1	9	75	11	2	TCGA-60-2722-01	325	0.7848810888886631	202	TCGA-60-2722-01	17	27	58	0.3475163716264221	TCGA-60-2722-01	16	6	9	31	PASS	6580	TCGA-60-2722	LUSC	66	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-24267	Alive	TUMOR FREE	908	NA	NA	NA	NA	NA	851	Complete Remission/Response	NA	NA	0	908	0	908	1	851	1	851	
70	TCGA-60-2723	0	25	2	13	12	3	1	0	9	220	10	0	4	67	11	1	TCGA-60-2723-01	202	0.7551606602852754	102	TCGA-60-2723-01	21	32	58	0.4613901988887778	TCGA-60-2723-01	16	11	15	42	PASS	6581	TCGA-60-2723	LUSC	74	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-27225	Alive	TUMOR FREE	1092	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1092	0	1092	0	1092	0	1092	
50	TCGA-60-2724	0	23	1	8	6	4	0	0	14	268	14	0	10	96	12	0	TCGA-60-2724-01	145	0.4672592506754306	69	TCGA-60-2724-01	11	12	35	0.3595041207342881	TCGA-60-2724-01	11	3	7	21	PASS	6582	TCGA-60-2724	LUSC	47	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-17462	Alive	TUMOR FREE	717	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	717	0	717	NA	NA	0	717	
70	TCGA-60-2725	0	8	0	3	5	0	0	0	5	118	4	0	4	45	4	0	TCGA-60-2725-01	258	0.5264253751640856	171	TCGA-60-2725-01	14	15	111	0.35925785542716665	TCGA-60-2725-01	10	2	14	26	PASS	6583	TCGA-60-2725	LUSC	74	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-27073	Alive	TUMOR FREE	816	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	816	0	816	0	816	0	816	
60	TCGA-60-2726	2	26	0	15	4	2	1	0	12	241	14	0	15	100	8	1	TCGA-60-2726-01	169	0.7722193183545406	87	TCGA-60-2726-01	21	34	25	0.2733170301249532	TCGA-60-2726-01	16	7	11	34	PASS	6584	TCGA-60-2726	LUSC	56	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-20618	Dead	TUMOR FREE	358	358	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	358	0	358	0	358	0	358	
NA	TCGA-63-5128	0	22	1	4	9	1	2	0	10	234	20	0	4	73	10	0	TCGA-63-5128-01	195	0.7388094638442027	111	TCGA-63-5128-01	24	21	39	0.4472507651403186	TCGA-63-5128-01	15	7	10	32	PASS	6585	TCGA-63-5128	LUSC	NA	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	NA	Dead	WITH TUMOR	NA	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	NA	1	NA	NA	NA	1	NA	
NA	TCGA-63-5131	0	22	0	11	6	1	0	0	13	250	14	0	2	72	11	1	TCGA-63-5131-01	303	0.6204453268937322	181	TCGA-63-5131-01	16	28	85	0.3597183138994347	TCGA-63-5131-01	25	20	17	62	PASS	6586	TCGA-63-5131	LUSC	NA	MALE	NA	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	NA	Dead	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	NA	0	NA	0	NA	0	NA	
NA	TCGA-63-6202	3	13	2	7	9	3	2	1	10	275	18	1	2	81	14	0	TCGA-63-6202-01	124	0.5947228066185479	55	TCGA-63-6202-01	15	40	49	0.5389410673115108	TCGA-63-6202-01	16	11	8	35	PASS	6587	TCGA-63-6202	LUSC	NA	MALE	NA	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	NA	Alive	TUMOR FREE	1602	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1602	0	1602	0	1602	0	1602	
NA	TCGA-63-7020	1	12	1	4	5	3	1	0	7	153	11	0	4	59	9	0	TCGA-63-7020-01	129	0.7316415421551802	65	TCGA-63-7020-01	31	24	28	0.4981946794876694	TCGA-63-7020-01	11	7	7	25	PASS	6588	TCGA-63-7020	LUSC	NA	MALE	NA	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	NA	Alive	TUMOR FREE	2133	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2133	0	2133	0	2133	0	2133	
NA	TCGA-63-7021	3	13	2	4	7	1	0	0	4	203	15	1	7	66	14	0	TCGA-63-7021-01	96	0.18663260471412704	45	TCGA-63-7021-01	6	7	17	0.16685962434075655	TCGA-63-7021-01	8	4	3	15	PASS	6589	TCGA-63-7021	LUSC	NA	MALE	NA	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	NA	Alive	TUMOR FREE	2142	NA	NA	New Primary Tumor	NA	NA	1503	Complete Remission/Response	NA	NA	0	2142	0	2142	0	2142	1	1503	
NA	TCGA-63-7022	0	7	1	4	4	2	0	0	11	138	18	0	1	61	6	0	TCGA-63-7022-01	81	0.2438384520583775	32	TCGA-63-7022-01	4	10	8	0.2334209795599801	TCGA-63-7022-01	3	2	2	7	PASS	6590	TCGA-63-7022	LUSC	NA	FEMALE	NA	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	NA	Alive	TUMOR FREE	2073	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2073	0	2073	0	2073	0	2073	
NA	TCGA-63-7023	0	7	2	4	7	1	0	0	0	110	7	1	8	49	4	0	TCGA-63-7023-01	285	0.929490273122102	176	TCGA-63-7023-01	12	14	74	0.35561798652106263	TCGA-63-7023-01	15	7	16	38	PASS	6591	TCGA-63-7023	LUSC	NA	MALE	NA	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	NA	Alive	TUMOR FREE	1682	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1682	0	1682	0	1682	0	1682	
NA	TCGA-63-A5M9	0	4	1	4	3	0	1	0	7	83	5	0	3	28	2	0	TCGA-63-A5M9-01	206	0.8180903589817377	126	TCGA-63-A5M9-01	19	31	162	0.5934972227439655	TCGA-63-A5M9-01	28	24	17	69	PASS	6592	TCGA-63-A5M9	LUSC	NA	FEMALE	[Not Evaluated]	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	NA	Alive	NA	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
60	TCGA-63-A5MB	3	15	2	9	10	4	1	0	9	268	22	0	6	83	2	0	TCGA-63-A5MB-01	364	0.7712752180631219	235	TCGA-63-A5MB-01	19	33	212	0.534401474151206	TCGA-63-A5MB-01	26	26	22	74	PASS	6593	TCGA-63-A5MB	LUSC	62	MALE	[Not Evaluated]	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-22930	Alive	TUMOR FREE	3123	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3123	0	3123	0	3123	0	3123	
70	TCGA-63-A5MG	0	9	1	4	2	0	0	0	2	83	6	0	3	28	3	2	TCGA-63-A5MG-01	58	0.29169988101731176	15	TCGA-63-A5MG-01	11	14	44	0.3876311722702929	TCGA-63-A5MG-01	4	5	6	15	PASS	6594	TCGA-63-A5MG	LUSC	68	MALE	[Not Evaluated]	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-24957	Alive	TUMOR FREE	2148	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2148	0	2148	0	2148	0	2148	
70	TCGA-63-A5MH	0	12	3	10	11	0	0	0	8	177	9	1	7	56	2	0	TCGA-63-A5MH-01	123	0.9470894240607672	59	TCGA-63-A5MH-01	19	18	122	0.586625016188609	TCGA-63-A5MH-01	11	6	12	29	PASS	6595	TCGA-63-A5MH	LUSC	68	MALE	[Not Evaluated]	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-25159	Alive	TUMOR FREE	2026	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2026	0	2026	0	2026	0	2026	
70	TCGA-63-A5MI	2	12	0	6	2	2	2	1	6	163	14	0	4	59	5	0	TCGA-63-A5MI-01	218	0.6553328059313671	128	TCGA-63-A5MI-01	19	32	114	0.34446186172433074	TCGA-63-A5MI-01	21	18	14	53	PASS	6596	TCGA-63-A5MI	LUSC	65	MALE	[Not Evaluated]	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-24040	Alive	TUMOR FREE	1784	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1784	0	1784	0	1784	0	1784	
50	TCGA-63-A5MJ	0	10	1	5	5	4	0	0	5	138	9	0	7	59	9	0	TCGA-63-A5MJ-01	165	0.6791886142856418	82	TCGA-63-A5MJ-01	23	29	76	0.2843994078080445	TCGA-63-A5MJ-01	21	15	11	47	PASS	6597	TCGA-63-A5MJ	LUSC	54	MALE	[Not Evaluated]	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-20018	Alive	TUMOR FREE	1824	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1824	0	1824	0	1824	0	1824	
70	TCGA-63-A5ML	3	13	1	6	6	5	2	0	5	187	16	1	4	65	5	2	TCGA-63-A5ML-01	138	0.8116696990836875	63	TCGA-63-A5ML-01	22	33	103	0.4283657382760505	TCGA-63-A5ML-01	15	12	13	40	PASS	6598	TCGA-63-A5ML	LUSC	68	MALE	[Not Evaluated]	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-24947	Alive	TUMOR FREE	1386	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1386	0	1386	0	1386	0	1386	
70	TCGA-63-A5MM	4	48	1	26	76	22	7	0	39	906	41	1	12	348	13	1	TCGA-63-A5MM-01	99	0.08562883704807529	46	TCGA-63-A5MM-01	5	8	68	0.1398543791796099	TCGA-63-A5MM-01	3	3	3	9	hypermutated sample	6599	TCGA-63-A5MM	LUSC	69	FEMALE	[Not Evaluated]	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-25348	Dead	WITH TUMOR	NA	456	NA	NA	NA	NA	218	Complete Remission/Response	NA	NA	1	456	1	456	1	218	1	218	
80	TCGA-63-A5MN	0	0	1	2	0	2	0	0	0	29	4	0	0	12	0	0	TCGA-63-A5MN-01	43	0.12737262050090062	4	TCGA-63-A5MN-01	6	11	38	0.15662980214671834	TCGA-63-A5MN-01	6	4	2	12	PASS	6600	TCGA-63-A5MN	LUSC	78	FEMALE	[Not Evaluated]	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-28677	Dead	WITH TUMOR	NA	345	NA	NA	NA	NA	320	Complete Remission/Response	NA	NA	1	345	1	345	1	320	1	320	
60	TCGA-63-A5MP	0	8	0	6	4	2	0	0	8	140	13	0	0	55	5	0	TCGA-63-A5MP-01	121	0.4924157050849779	55	TCGA-63-A5MP-01	13	36	87	0.34025439548476705	TCGA-63-A5MP-01	19	25	16	60	PASS	6601	TCGA-63-A5MP	LUSC	56	MALE	[Not Evaluated]	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-20818	Alive	WITH TUMOR	769	NA	NA	Locoregional Recurrence	NA	NA	511	Complete Remission/Response	NA	NA	0	769	0	769	1	511	1	511	
70	TCGA-63-A5MR	1	6	1	4	3	3	0	0	5	130	20	0	3	54	5	0	TCGA-63-A5MR-01	109	0.5975187282499406	46	TCGA-63-A5MR-01	21	29	77	0.4270243726087399	TCGA-63-A5MR-01	10	2	9	21	PASS	6602	TCGA-63-A5MR	LUSC	70	FEMALE	[Not Evaluated]	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-25879	Alive	TUMOR FREE	2716	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2716	0	2716	0	2716	0	2716	
80	TCGA-63-A5MS	1	19	1	6	15	4	1	0	11	313	19	0	10	102	8	0	TCGA-63-A5MS-01	80	0.4491477058660457	23	TCGA-63-A5MS-01	24	43	57	0.445059026657724	TCGA-63-A5MS-01	20	24	12	56	PASS	6603	TCGA-63-A5MS	LUSC	78	MALE	[Not Evaluated]	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-28827	Alive	TUMOR FREE	2381	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2381	0	2381	0	2381	0	2381	
70	TCGA-63-A5MT	0	11	0	5	5	1	1	0	14	179	11	1	5	64	8	0	TCGA-63-A5MT-01	135	0.51916307116695	64	TCGA-63-A5MT-01	9	18	87	0.3790491722796416	TCGA-63-A5MT-01	13	13	9	35	PASS	6604	TCGA-63-A5MT	LUSC	74	MALE	[Not Evaluated]	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-27263	Alive	WITH TUMOR	498	NA	NA	Distant Metastasis	NA	NA	427	Complete Remission/Response	NA	NA	0	498	0	498	1	427	1	427	
50	TCGA-63-A5MU	3	7	0	6	5	2	3	0	5	160	24	2	3	61	4	0	TCGA-63-A5MU-01	149	0.6908597293343957	74	TCGA-63-A5MU-01	16	70	84	0.21419066863389166	TCGA-63-A5MU-01	8	6	7	21	PASS	6605	TCGA-63-A5MU	LUSC	48	MALE	[Not Evaluated]	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-17801	Dead	WITH TUMOR	NA	NA	NA	Distant Metastasis	NA	NA	420	Complete Remission/Response	NA	NA	1	NA	1	NA	1	420	1	420	
70	TCGA-63-A5MV	0	8	0	4	3	0	1	0	5	90	8	0	1	33	6	0	TCGA-63-A5MV-01	124	0.4246231714437157	66	TCGA-63-A5MV-01	13	22	91	0.260774303389721	TCGA-63-A5MV-01	19	10	12	41	PASS	6606	TCGA-63-A5MV	LUSC	69	MALE	[Not Evaluated]	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-25505	Alive	TUMOR FREE	1100	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1100	0	1100	0	1100	0	1100	
80	TCGA-63-A5MW	1	12	4	14	11	4	0	0	24	367	25	1	7	127	7	1	TCGA-63-A5MW-01	314	0.6617849104644754	199	TCGA-63-A5MW-01	19	31	115	0.1998924082300184	TCGA-63-A5MW-01	14	15	5	34	PASS	6607	TCGA-63-A5MW	LUSC	76	MALE	[Not Evaluated]	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-27892	Alive	TUMOR FREE	1639	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1639	0	1639	0	1639	0	1639	
60	TCGA-63-A5MY	0	12	1	4	6	0	0	0	7	131	10	0	2	49	2	0	TCGA-63-A5MY-01	402	0.9273383171684536	263	TCGA-63-A5MY-01	10	17	208	0.33766786155934625	TCGA-63-A5MY-01	21	14	19	54	PASS	6608	TCGA-63-A5MY	LUSC	63	MALE	[Not Evaluated]	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	NA	NA	-23276	Alive	TUMOR FREE	1052	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1052	0	1052	0	1052	0	1052	
60	TCGA-66-2727	1	15	3	4	8	0	1	0	9	256	22	0	4	107	6	0	TCGA-66-2727-01	414	0.7500421239546408	290	TCGA-66-2727-01	15	27	105	0.229679302698596	TCGA-66-2727-01	23	19	14	56	PASS	6609	TCGA-66-2727	LUSC	55	FEMALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-20150	Dead	NA	NA	516	NA	NA	NA	NA	NA	NA	NA	NA	1	516	NA	516	NA	NA	0	516	
60	TCGA-66-2734	5	25	1	9	6	1	0	0	22	434	34	0	11	144	22	1	TCGA-66-2734-01	62	0.572899294659639	18	TCGA-66-2734-01	14	11	11	0.31147406197966154	TCGA-66-2734-01	5	1	5	11	PASS	6610	TCGA-66-2734	LUSC	62	FEMALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-22919	Alive	TUMOR FREE	1311	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1311	0	1311	NA	NA	0	1311	
70	TCGA-66-2737	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-66-2737-01	117	0.4799690617382722	55	TCGA-66-2737-01	6	7	14	0.16970140909200288	TCGA-66-2737-01	9	11	9	29	PASS	6611	TCGA-66-2737	LUSC	72	MALE	NA	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-26390	Alive	TUMOR FREE	61	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	61	0	61	NA	NA	0	61	
70	TCGA-66-2742	0	8	0	9	6	1	1	0	5	179	20	0	4	75	5	0	TCGA-66-2742-01	148	0.5666723242117478	74	TCGA-66-2742-01	21	26	27	0.3793245526095536	TCGA-66-2742-01	12	5	4	21	PASS	6612	TCGA-66-2742	LUSC	70	MALE	NA	Stage IV	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-25688	Alive	TUMOR FREE	641	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	641	0	641	NA	NA	0	641	
70	TCGA-66-2744	3	16	2	11	6	1	1	0	19	284	24	0	8	99	6	0	TCGA-66-2744-01	271	0.6861738038740949	166	TCGA-66-2744-01	9	40	78	0.5053886871780361	TCGA-66-2744-01	16	17	12	45	PASS	6613	TCGA-66-2744	LUSC	71	MALE	NA	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-26084	Alive	TUMOR FREE	30	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	30	0	30	NA	NA	0	30	
70	TCGA-66-2753	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-66-2753-01	191	0.7084950673120819	105	TCGA-66-2753-01	18	23	23	0.2343358750192469	TCGA-66-2753-01	14	12	10	36	PASS	6614	TCGA-66-2753	LUSC	69	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-25506	Alive	TUMOR FREE	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
70	TCGA-66-2754	1	20	3	9	5	2	1	0	10	283	20	0	3	111	9	0	TCGA-66-2754-01	589	0.9179683175042064	388	TCGA-66-2754-01	12	32	125	0.4331067302885292	TCGA-66-2754-01	19	15	8	42	PASS	6615	TCGA-66-2754	LUSC	67	MALE	NA	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-24471	Alive	TUMOR FREE	61	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	61	0	61	NA	NA	0	61	
60	TCGA-66-2755	0	21	2	8	2	4	1	0	13	158	9	1	5	71	6	1	TCGA-66-2755-01	115	0.474451356079124	54	TCGA-66-2755-01	17	26	26	0.25387964108166433	TCGA-66-2755-01	13	7	7	27	PASS	6616	TCGA-66-2755	LUSC	63	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-23348	Alive	TUMOR FREE	28	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	28	0	28	NA	NA	0	28	
70	TCGA-66-2756	2	23	3	15	13	3	0	0	13	404	30	1	12	122	14	2	TCGA-66-2756-01	399	0.8434344018903729	269	TCGA-66-2756-01	24	73	50	0.2340771071046076	TCGA-66-2756-01	15	22	10	47	PASS	6617	TCGA-66-2756	LUSC	68	MALE	NA	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-24929	Alive	TUMOR FREE	30	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	30	0	30	NA	NA	0	30	
70	TCGA-66-2757	0	23	1	11	7	0	0	0	10	191	11	0	3	57	17	1	TCGA-66-2757-01	213	0.8750688429562512	131	TCGA-66-2757-01	15	17	35	0.3614366241981129	TCGA-66-2757-01	13	5	11	29	PASS	6618	TCGA-66-2757	LUSC	65	FEMALE	NA	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-24014	Dead	WITH TUMOR	NA	1338	NA	NA	NA	NA	912	NA	NA	NA	1	1338	1	1338	NA	NA	1	912	
70	TCGA-66-2758	2	27	1	10	8	2	6	0	17	250	14	1	6	101	4	1	TCGA-66-2758-01	369	0.8048190070660293	235	TCGA-66-2758-01	16	30	96	0.5178697607970592	TCGA-66-2758-01	29	25	13	67	PASS	6619	TCGA-66-2758	LUSC	71	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-26209	Alive	TUMOR FREE	639	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	639	0	639	0	639	0	639	
70	TCGA-66-2759	2	22	2	14	10	2	1	0	24	322	28	0	8	121	10	0	TCGA-66-2759-01	224	0.6287543050067542	117	TCGA-66-2759-01	19	37	41	0.1736298682021152	TCGA-66-2759-01	21	15	8	44	PASS	6620	TCGA-66-2759	LUSC	66	MALE	NA	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-24287	Alive	TUMOR FREE	762	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	762	0	762	0	762	0	762	
60	TCGA-66-2763	1	23	2	15	6	4	0	0	12	304	29	1	6	95	10	0	TCGA-66-2763-01	229	0.8310757163721789	116	TCGA-66-2763-01	8	14	49	0.4389563675994479	TCGA-66-2763-01	18	10	15	43	PASS	6621	TCGA-66-2763	LUSC	63	FEMALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-23315	Alive	TUMOR FREE	30	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	30	0	30	NA	NA	0	30	
60	TCGA-66-2765	0	3	0	4	3	1	0	0	5	71	6	0	3	19	3	0	TCGA-66-2765-01	79	0.34299472566176603	33	TCGA-66-2765-01	10	9	17	0.21997965885071905	TCGA-66-2765-01	7	5	7	19	PASS	6622	TCGA-66-2765	LUSC	64	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-23465	Alive	TUMOR FREE	61	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	61	0	61	NA	NA	0	61	
50	TCGA-66-2766	3	31	5	13	4	3	1	0	24	286	20	0	7	109	10	1	TCGA-66-2766-01	443	0.7534855421384724	272	TCGA-66-2766-01	13	37	103	0.5157606121652294	TCGA-66-2766-01	28	30	19	77	PASS	6623	TCGA-66-2766	LUSC	54	MALE	NA	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-19814	Alive	TUMOR FREE	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
60	TCGA-66-2767	0	21	1	5	9	2	0	0	15	253	19	0	8	90	9	0	TCGA-66-2767-01	172	0.5507354590972322	96	TCGA-66-2767-01	19	32	35	0.35249413309896205	TCGA-66-2767-01	17	12	16	45	PASS	6624	TCGA-66-2767	LUSC	62	MALE	NA	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-22888	Alive	TUMOR FREE	61	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	61	0	61	NA	NA	0	61	
60	TCGA-66-2768	0	12	0	5	7	2	0	1	8	186	20	1	4	65	5	0	TCGA-66-2768-01	238	0.25155093763449593	148	TCGA-66-2768-01	6	12	39	0.21538198266139869	TCGA-66-2768-01	12	8	12	32	mutation call filter	6625	TCGA-66-2768	LUSC	57	MALE	NA	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-20970	Alive	TUMOR FREE	61	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	61	0	61	NA	NA	0	61	
80	TCGA-66-2769	2	13	0	8	6	3	2	0	12	287	20	0	9	103	5	0	TCGA-66-2769-01	193	0.4645129970941814	106	TCGA-66-2769-01	20	30	40	0.20369055346510812	TCGA-66-2769-01	18	9	5	32	PASS	6626	TCGA-66-2769	LUSC	75	MALE	NA	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-27515	Dead	NA	NA	215	NA	NA	NA	NA	NA	NA	NA	NA	1	215	NA	215	NA	NA	0	215	
80	TCGA-66-2770	0	17	6	4	4	6	0	0	17	175	13	0	5	84	4	0	TCGA-66-2770-01	101	0.5145305265097391	48	TCGA-66-2770-01	9	10	26	0.3448177060780309	TCGA-66-2770-01	6	4	6	16	PASS	6627	TCGA-66-2770	LUSC	79	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-28945	Alive	NA	700	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	700	0	700	NA	NA	0	700	
60	TCGA-66-2771	1	13	1	4	4	0	1	0	13	211	22	0	2	85	2	1	TCGA-66-2771-01	184	0.5413313014036264	101	TCGA-66-2771-01	11	14	51	0.40990799339575296	TCGA-66-2771-01	11	7	9	27	PASS	6628	TCGA-66-2771	LUSC	60	MALE	NA	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-22219	Alive	TUMOR FREE	578	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	578	0	578	0	578	0	578	
70	TCGA-66-2773	3	34	3	20	6	1	0	0	17	438	43	2	8	186	12	1	TCGA-66-2773-01	215	0.8161864754379301	132	TCGA-66-2773-01	20	32	100	0.2443611863007692	TCGA-66-2773-01	14	12	4	30	PASS	6629	TCGA-66-2773	LUSC	69	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-25355	Dead	TUMOR FREE	NA	92	NA	NA	NA	NA	NA	NA	NA	NA	1	92	0	92	NA	NA	0	92	
70	TCGA-66-2777	1	6	0	6	6	0	0	0	4	129	9	0	3	55	3	0	TCGA-66-2777-01	380	0.6381740659122138	261	TCGA-66-2777-01	27	26	128	0.3804627002039385	TCGA-66-2777-01	16	15	10	41	PASS	6630	TCGA-66-2777	LUSC	71	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-26085	Alive	TUMOR FREE	61	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	61	0	61	NA	NA	0	61	
70	TCGA-66-2778	0	12	2	8	1	1	0	0	9	103	6	0	2	45	1	0	TCGA-66-2778-01	78	0.3066102196308367	28	TCGA-66-2778-01	10	16	22	0.3747608027882472	TCGA-66-2778-01	9	3	7	19	PASS	6631	TCGA-66-2778	LUSC	68	FEMALE	NA	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-25080	Alive	TUMOR FREE	578	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	578	0	578	0	578	0	578	
70	TCGA-66-2780	0	8	0	5	5	1	0	0	6	104	9	0	2	42	2	1	TCGA-66-2780-01	181	0.7332025739545922	104	TCGA-66-2780-01	16	17	43	0.4242296315330972	TCGA-66-2780-01	14	9	9	32	PASS	6632	TCGA-66-2780	LUSC	65	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-23955	Dead	NA	NA	366	NA	NA	NA	NA	NA	NA	NA	NA	1	366	NA	366	NA	NA	0	366	
70	TCGA-66-2781	0	7	1	2	6	0	0	0	9	108	4	1	2	33	2	0	TCGA-66-2781-01	316	0.8097022145018605	199	TCGA-66-2781-01	22	29	84	0.4238491897610393	TCGA-66-2781-01	22	13	17	52	PASS	6633	TCGA-66-2781	LUSC	67	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-24471	Alive	TUMOR FREE	121	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	121	0	121	NA	NA	0	121	
70	TCGA-66-2782	1	23	1	16	8	1	0	0	20	270	18	2	9	105	10	0	TCGA-66-2782-01	122	0.6124129802709987	59	TCGA-66-2782-01	13	11	38	0.2497043910578957	TCGA-66-2782-01	9	3	6	18	PASS	6634	TCGA-66-2782	LUSC	71	MALE	NA	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-26237	Dead	WITH TUMOR	NA	365	NA	NA	NA	NA	304	Progressive Disease	NA	NA	1	365	1	365	NA	NA	1	304	
70	TCGA-66-2783	3	23	2	8	6	1	1	0	11	178	16	0	7	53	6	1	TCGA-66-2783-01	418	0.3125285745124705	318	TCGA-66-2783-01	11	19	88	0.2970684743202072	TCGA-66-2783-01	13	8	11	32	PASS	6635	TCGA-66-2783	LUSC	67	MALE	NA	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-24686	Alive	TUMOR FREE	759	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	759	0	759	0	759	0	759	
70	TCGA-66-2785	1	89	8	41	14	2	1	0	53	889	79	3	21	265	20	4	TCGA-66-2785-01	207	0.6496411686174632	122	TCGA-66-2785-01	17	31	35	0.323221490164648	TCGA-66-2785-01	14	15	5	34	hypermutated sample	6636	TCGA-66-2785	LUSC	65	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-23772	Alive	TUMOR FREE	60	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	60	0	60	NA	NA	0	60	
70	TCGA-66-2786	0	15	1	7	6	1	0	0	8	170	18	1	2	55	9	0	TCGA-66-2786-01	184	0.8422038532843955	98	TCGA-66-2786-01	16	13	29	0.3465015818365681	TCGA-66-2786-01	11	4	11	26	PASS	6637	TCGA-66-2786	LUSC	68	FEMALE	NA	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-25051	Alive	TUMOR FREE	790	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	790	0	790	NA	NA	0	790	
60	TCGA-66-2787	3	26	3	17	9	3	1	0	22	459	37	1	13	145	16	1	TCGA-66-2787-01	236	0.7009818553835985	143	TCGA-66-2787-01	24	31	54	0.4349510894297229	TCGA-66-2787-01	18	14	12	44	PASS	6638	TCGA-66-2787	LUSC	57	MALE	NA	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-21124	Alive	TUMOR FREE	1217	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1217	0	1217	NA	NA	0	1217	
60	TCGA-66-2788	1	9	1	5	5	0	0	0	10	164	14	0	6	51	4	0	TCGA-66-2788-01	168	0.35862608094702403	98	TCGA-66-2788-01	12	15	38	0.3524888724062953	TCGA-66-2788-01	10	4	5	19	PASS	6639	TCGA-66-2788	LUSC	56	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-20637	Alive	TUMOR FREE	699	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	699	0	699	NA	NA	0	699	
70	TCGA-66-2789	1	17	4	13	5	3	2	1	11	292	25	1	8	108	7	0	TCGA-66-2789-01	210	0.5056021094555511	132	TCGA-66-2789-01	14	16	59	0.3340782416034657	TCGA-66-2789-01	20	10	14	44	PASS	6640	TCGA-66-2789	LUSC	73	MALE	NA	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-26753	Dead	TUMOR FREE	NA	123	NA	NA	NA	NA	NA	NA	NA	NA	1	123	0	123	NA	NA	0	123	
70	TCGA-66-2790	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-66-2790-01	326	0.8189999543066085	225	TCGA-66-2790-01	12	13	74	0.38804387889257297	TCGA-66-2790-01	17	9	13	39	PASS	6641	TCGA-66-2790	LUSC	72	MALE	NA	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-26420	Alive	WITH TUMOR	699	NA	NA	NA	NA	NA	699	Progressive Disease	NA	NA	0	699	0	699	NA	NA	1	699	
70	TCGA-66-2791	2	16	1	12	11	3	0	0	13	260	25	0	8	114	6	0	TCGA-66-2791-01	198	0.8014739651343445	116	TCGA-66-2791-01	13	16	55	0.5098693156768069	TCGA-66-2791-01	16	18	16	50	PASS	6642	TCGA-66-2791	LUSC	66	MALE	NA	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-24138	Dead	NA	NA	153	NA	NA	NA	NA	NA	NA	NA	NA	1	153	NA	153	NA	NA	0	153	
60	TCGA-66-2792	1	9	1	5	1	1	3	0	3	126	14	1	4	55	3	0	TCGA-66-2792-01	214	0.8040445553294019	118	TCGA-66-2792-01	23	28	44	0.4978298975497005	TCGA-66-2792-01	19	12	11	42	PASS	6643	TCGA-66-2792	LUSC	58	MALE	NA	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-21428	Alive	TUMOR FREE	913	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	913	0	913	0	913	0	913	
70	TCGA-66-2793	1	18	1	12	9	1	0	0	10	244	9	0	8	76	7	1	TCGA-66-2793-01	622	0.8759338837633486	426	TCGA-66-2793-01	26	27	224	0.3892384980910375	TCGA-66-2793-01	23	20	14	57	PASS	6644	TCGA-66-2793	LUSC	68	MALE	NA	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-25111	Dead	TUMOR FREE	NA	306	NA	NA	NA	NA	NA	NA	NA	NA	1	306	0	306	NA	NA	0	306	
60	TCGA-66-2794	1	7	0	6	1	2	0	0	4	128	12	0	5	39	1	1	TCGA-66-2794-01	365	0.3826222201984613	248	TCGA-66-2794-01	10	20	181	0.3606681876502565	TCGA-66-2794-01	16	13	10	39	PASS	6645	TCGA-66-2794	LUSC	64	MALE	NA	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-23710	Alive	TUMOR FREE	1645	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1645	0	1645	0	1645	0	1645	
70	TCGA-66-2795	3	18	2	8	8	2	2	0	9	352	27	0	7	120	9	1	TCGA-66-2795-01	330	0.4830193442861965	194	TCGA-66-2795-01	8	13	52	0.2866060431250877	TCGA-66-2795-01	19	11	9	39	PASS	6646	TCGA-66-2795	LUSC	68	MALE	NA	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-24897	Alive	TUMOR FREE	122	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	122	0	122	NA	NA	0	122	
70	TCGA-66-2800	1	10	1	10	3	1	0	0	9	146	15	0	4	57	7	1	TCGA-66-2800-01	347	0.8002575741716406	227	TCGA-66-2800-01	24	26	167	0.49035112063216	TCGA-66-2800-01	20	10	16	46	PASS	6647	TCGA-66-2800	LUSC	70	MALE	NA	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-25810	Alive	TUMOR FREE	1492	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1492	0	1492	NA	NA	0	1492	
60	TCGA-68-7755	2	10	1	9	12	2	1	0	9	211	14	0	5	76	7	0	TCGA-68-7755-01	271	0.8285727086070492	153	TCGA-68-7755-01	14	21	49	0.34400758555909555	TCGA-68-7755-01	18	9	8	35	PASS	6648	TCGA-68-7755	LUSC	60	FEMALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-21936	Alive	TUMOR FREE	83	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	83	0	83	NA	NA	0	83	
80	TCGA-68-7756	0	3	1	3	11	0	9	0	6	79	4	0	2	26	0	0	TCGA-68-7756-01	67	0.5997317860847354	21	TCGA-68-7756-01	8	8	7	0.2300156284232097	TCGA-68-7756-01	4	0	3	7	PASS	6649	TCGA-68-7756	LUSC	84	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-30763	Alive	NA	202	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	202	0	202	NA	NA	0	202	
70	TCGA-68-7757	2	5	2	8	5	2	1	0	5	252	19	0	3	74	9	0	TCGA-68-7757-01	94	0.4521433374682987	38	TCGA-68-7757-01	12	14	25	0.4568317383200107	TCGA-68-7757-01	13	4	13	30	PASS	6650	TCGA-68-7757	LUSC	74	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-27272	Alive	NA	211	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	211	0	211	NA	NA	0	211	
70	TCGA-68-8250	1	15	1	9	6	1	0	0	7	238	19	1	3	77	9	0	TCGA-68-8250-01	271	0.6751101833636453	176	TCGA-68-8250-01	19	34	46	0.3968088138122935	TCGA-68-8250-01	18	19	8	45	PASS	6651	TCGA-68-8250	LUSC	66	MALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-24118	Alive	TUMOR FREE	244	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	244	0	244	NA	NA	0	244	
80	TCGA-68-8251	1	15	2	14	5	0	1	0	5	238	20	0	1	94	5	0	TCGA-68-8251-01	176	0.5451378062993029	96	TCGA-68-8251-01	24	21	47	0.3462520032827884	TCGA-68-8251-01	7	6	9	22	PASS	6652	TCGA-68-8251	LUSC	78	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-28739	Alive	TUMOR FREE	406	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	406	0	406	NA	NA	0	406	
70	TCGA-68-A59I	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-68-A59I-01	151	0.4803920788034016	80	TCGA-68-A59I-01	15	20	144	0.5017975921233659	TCGA-68-A59I-01	12	9	17	38	PASS	6653	TCGA-68-A59I	LUSC	73	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-26839	Alive	WITH TUMOR	492	NA	NA	New Primary Tumor	NA	NA	159	Stable Disease	NA	NA	0	492	0	492	NA	NA	1	159	
70	TCGA-68-A59J	0	13	1	12	17	2	1	1	10	284	19	0	6	116	8	0	TCGA-68-A59J-01	222	0.6153532910367913	116	TCGA-68-A59J-01	19	30	131	0.4277319152186777	TCGA-68-A59J-01	20	14	20	54	PASS	6654	TCGA-68-A59J	LUSC	74	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-27031	Alive	TUMOR FREE	448	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	448	0	448	0	448	0	448	
70	TCGA-6A-AB49	2	21	5	9	12	0	1	0	12	318	25	0	3	89	11	1	TCGA-6A-AB49-01	322	0.6508794323101348	191	TCGA-6A-AB49-01	17	35	238	0.5064054871431861	TCGA-6A-AB49-01	21	14	10	45	PASS	6655	TCGA-6A-AB49	LUSC	73	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	NA	Dead	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	NA	0	NA	NA	NA	0	NA	
50	TCGA-70-6722	3	16	1	4	11	3	0	0	6	235	18	0	5	71	9	1	TCGA-70-6722-01	182	0.4827037723329087	92	TCGA-70-6722-01	22	32	42	0.4474170328167112	TCGA-70-6722-01	18	12	10	40	PASS	6656	TCGA-70-6722	LUSC	47	MALE	ASIAN	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-17328	Alive	WITH TUMOR	367	NA	NA	Locoregional Recurrence	NA	NA	293	Progressive Disease	NA	NA	0	367	0	367	NA	NA	1	293	
70	TCGA-70-6723	0	2	1	5	4	1	1	0	3	91	5	0	3	29	3	0	TCGA-70-6723-01	355	0.9563994766012048	217	TCGA-70-6723-01	13	38	81	0.4586975766836799	TCGA-70-6723-01	26	11	19	56	PASS	6657	TCGA-70-6723	LUSC	65	MALE	ASIAN	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-24035	Alive	WITH TUMOR	375	NA	NA	Locoregional Recurrence	NA	NA	312	Progressive Disease	NA	NA	0	375	0	375	NA	NA	1	312	
80	TCGA-77-6842	2	25	0	12	16	2	2	0	30	610	46	0	10	199	27	2	TCGA-77-6842-01	172	0.7023311095766991	89	TCGA-77-6842-01	22	34	34	0.2695526347466847	TCGA-77-6842-01	12	8	8	28	PASS	6658	TCGA-77-6842	LUSC	79	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2000	NA	-28861	Dead	NA	NA	899	NA	NA	NA	NA	201	NA	NA	NA	1	899	NA	899	NA	NA	1	201	
70	TCGA-77-6843	7	19	4	4	2	0	10	0	10	265	22	0	4	101	12	0	TCGA-77-6843-01	190	0.4439047586002952	105	TCGA-77-6843-01	8	10	45	0.25276113466440714	TCGA-77-6843-01	7	5	8	20	PASS	6659	TCGA-77-6843	LUSC	74	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-27291	Dead	NA	NA	2224	NA	NA	NA	NA	NA	NA	NA	NA	1	2224	NA	2224	NA	NA	0	2224	
70	TCGA-77-6844	2	14	2	11	12	2	2	0	11	302	14	0	20	119	8	0	TCGA-77-6844-01	119	0.36551191818402573	57	TCGA-77-6844-01	11	13	22	0.2605285658361294	TCGA-77-6844-01	14	6	10	30	PASS	6660	TCGA-77-6844	LUSC	74	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-27220	Dead	NA	NA	2284	NA	NA	NA	NA	1788	Complete Remission/Response	NA	NA	1	2284	NA	2284	1	1788	1	1788	
70	TCGA-77-6845	4	35	6	11	16	6	4	4	12	389	22	0	12	140	4	2	TCGA-77-6845-01	254	0.7820890512044417	144	TCGA-77-6845-01	16	27	67	0.399648389433905	TCGA-77-6845-01	27	31	12	70	PASS	6661	TCGA-77-6845	LUSC	69	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-25321	Dead	NA	NA	708	NA	NA	NA	NA	NA	NA	NA	NA	1	708	NA	708	NA	NA	0	708	
70	TCGA-77-7138	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-77-7138-01	213	0.6734685274462661	133	TCGA-77-7138	0	0	0	0	TCGA-77-7138	0	0	0	0	PASS	6662	TCGA-77-7138	LUSC	67	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	1999	NA	-24594	Dead	NA	NA	340	NA	NA	NA	NA	NA	NA	NA	NA	1	340	NA	340	NA	NA	0	340	
60	TCGA-77-7139	2	22	0	21	6	0	2	0	7	273	30	0	8	112	8	0	TCGA-77-7139-01	176	0.6086687736201915	89	TCGA-77-7139-01	19	25	27	0.3042635254555059	TCGA-77-7139-01	13	7	7	27	PASS	6663	TCGA-77-7139	LUSC	56	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-20632	Alive	NA	4261	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4261	0	4261	0	4261	0	4261	
70	TCGA-77-7140	2	23	0	8	18	1	4	0	18	284	8	0	6	104	16	0	TCGA-77-7140-01	477	0.9669391830909528	288	TCGA-77-7140-01	16	38	139	0.6039488725965889	TCGA-77-7140-01	30	29	26	85	PASS	6664	TCGA-77-7140	LUSC	69	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-25303	Dead	NA	NA	632	NA	NA	NA	NA	250	NA	NA	NA	1	632	NA	632	NA	NA	1	250	
60	TCGA-77-7141	2	28	1	15	6	2	0	0	24	558	35	0	9	206	13	0	TCGA-77-7141-01	242	0.8109724749416606	151	TCGA-77-7141-01	22	28	45	0.2793684984857974	TCGA-77-7141-01	20	16	11	47	PASS	6665	TCGA-77-7141	LUSC	64	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-23584	Alive	NA	15	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	15	0	15	NA	NA	0	15	
60	TCGA-77-7142	0	13	1	2	5	0	0	0	11	202	21	0	7	73	10	1	TCGA-77-7142-01	245	0.6362551422859263	141	TCGA-77-7142-01	20	31	71	0.4077896851034082	TCGA-77-7142-01	19	13	9	41	PASS	6666	TCGA-77-7142	LUSC	59	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-21796	Alive	TUMOR FREE	2227	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2227	0	2227	NA	NA	0	2227	
60	TCGA-77-7335	0	14	1	4	5	1	0	1	5	177	12	0	6	78	6	0	TCGA-77-7335-01	114	0.3211113956536418	56	TCGA-77-7335-01	12	11	15	0.2264242550937168	TCGA-77-7335-01	11	6	8	25	PASS	6667	TCGA-77-7335	LUSC	62	FEMALE	WHITE	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	1996	NA	-22863	Dead	NA	NA	2133	NA	NA	NA	NA	NA	NA	NA	NA	1	2133	NA	2133	NA	NA	0	2133	
70	TCGA-77-7337	0	16	2	14	13	2	4	0	10	254	18	0	6	100	9	2	TCGA-77-7337-01	169	0.5782117331230364	78	TCGA-77-7337-01	14	17	35	0.41645055201594144	TCGA-77-7337-01	21	17	16	54	PASS	6668	TCGA-77-7337	LUSC	65	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2000	NA	-24065	Dead	NA	NA	3253	NA	NA	NA	NA	NA	NA	NA	NA	1	3253	NA	3253	NA	NA	0	3253	
60	TCGA-77-7338	0	5	0	0	3	1	0	0	3	100	7	1	3	48	5	0	TCGA-77-7338-01	122	0.3854357199167941	61	TCGA-77-7338-01	9	9	22	0.23870264972596505	TCGA-77-7338-01	9	9	9	27	PASS	6669	TCGA-77-7338	LUSC	64	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	1995	NA	-23480	Dead	NA	NA	5	NA	NA	NA	NA	NA	NA	NA	NA	1	5	NA	5	NA	NA	0	5	
80	TCGA-77-7463	2	17	1	17	12	5	0	0	13	314	12	0	7	107	12	1	TCGA-77-7463-01	140	0.6658524469922956	66	TCGA-77-7463-01	26	61	33	0.3975065346873744	TCGA-77-7463-01	18	14	11	43	PASS	6670	TCGA-77-7463	LUSC	75	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-27520	Dead	NA	NA	1423	NA	NA	NA	NA	NA	NA	NA	NA	1	1423	NA	1423	NA	NA	0	1423	
60	TCGA-77-7465	2	14	4	7	11	4	1	0	14	289	32	1	13	106	7	1	TCGA-77-7465-01	218	0.8888872628353819	114	TCGA-77-7465-01	17	17	74	0.5271708893743238	TCGA-77-7465-01	19	14	17	50	PASS	6671	TCGA-77-7465	LUSC	58	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-21548	Alive	NA	990	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	990	0	990	0	990	0	990	
70	TCGA-77-8007	1	2	1	4	1	1	0	0	0	72	7	0	0	28	4	0	TCGA-77-8007-01	161	0.4642867392347857	84	TCGA-77-8007-01	22	33	31	0.4030353092673587	TCGA-77-8007-01	15	9	9	33	PASS	6672	TCGA-77-8007	LUSC	68	MALE	NA	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-25102	Dead	NA	NA	198	NA	NA	NA	NA	139	NA	NA	NA	1	198	NA	198	NA	NA	1	139	
70	TCGA-77-8008	0	4	1	1	3	1	0	0	10	126	10	0	3	58	7	0	TCGA-77-8008-01	81	0.3569191340068798	28	TCGA-77-8008-01	14	15	16	0.24376495172868826	TCGA-77-8008-01	7	3	7	17	PASS	6673	TCGA-77-8008	LUSC	68	MALE	NA	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-24948	Dead	NA	NA	2639	NA	NA	NA	NA	NA	NA	NA	NA	1	2639	NA	2639	NA	NA	0	2639	
70	TCGA-77-8009	1	12	1	5	5	2	0	0	6	136	8	0	4	37	7	0	TCGA-77-8009-01	467	0.86978898590277	273	TCGA-77-8009-01	24	43	150	0.3910720936366989	TCGA-77-8009-01	26	22	16	64	PASS	6674	TCGA-77-8009	LUSC	68	MALE	NA	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-25037	Dead	NA	NA	1695	NA	NA	NA	NA	607	Complete Remission/Response	NA	NA	1	1695	NA	1695	1	607	1	607	
60	TCGA-77-8128	3	15	0	10	6	1	1	0	8	232	17	0	9	85	6	0	TCGA-77-8128-01	136	0.5734816083449674	65	TCGA-77-8128-01	16	34	33	0.4782271297708067	TCGA-77-8128-01	14	10	10	34	PASS	6675	TCGA-77-8128	LUSC	60	MALE	[Not Evaluated]	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	1999	NA	-21986	Dead	NA	NA	1150	NA	NA	NA	NA	NA	NA	NA	NA	1	1150	NA	1150	NA	NA	0	1150	
70	TCGA-77-8130	0	3	1	2	4	2	1	0	6	146	8	0	0	59	1	0	TCGA-77-8130-01	183	0.6672507534128607	103	TCGA-77-8130-01	27	26	25	0.2691093513344865	TCGA-77-8130-01	17	6	11	34	PASS	6676	TCGA-77-8130	LUSC	69	MALE	[Not Evaluated]	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2000	NA	-25260	Alive	TUMOR FREE	4765	NA	NA	New Primary Tumor	NA	NA	4471	Complete Remission/Response	NA	NA	0	4765	0	4765	0	4765	1	4471	
70	TCGA-77-8131	0	2	0	0	2	1	1	0	0	52	3	0	1	27	2	0	TCGA-77-8131-01	71	0.08361236965596643	21	TCGA-77-8131-01	10	10	15	0.3310672097733127	TCGA-77-8131-01	6	3	7	16	PASS	6677	TCGA-77-8131	LUSC	72	MALE	[Not Evaluated]	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2000	NA	-26611	Dead	NA	NA	383	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	383	NA	383	NA	NA	0	383	
70	TCGA-77-8133	2	15	1	8	10	3	0	0	5	286	25	0	9	110	11	1	TCGA-77-8133-01	116	0.6248395968050303	47	TCGA-77-8133-01	21	29	18	0.222132878709993	TCGA-77-8133-01	10	2	7	19	PASS	6678	TCGA-77-8133	LUSC	74	MALE	[Not Evaluated]	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-27139	Dead	NA	NA	1640	NA	NA	NA	NA	NA	NA	NA	NA	1	1640	NA	1640	NA	NA	0	1640	
70	TCGA-77-8136	2	14	3	12	2	1	0	0	12	350	25	0	8	130	8	0	TCGA-77-8136-01	133	0.6745004194924732	60	TCGA-77-8136-01	14	17	33	0.5333884489981345	TCGA-77-8136-01	15	14	13	42	PASS	6679	TCGA-77-8136	LUSC	74	FEMALE	[Not Evaluated]	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-27193	Dead	NA	NA	1189	NA	Distant Metastasis	NA	NA	301	NA	NA	NA	1	1189	NA	1189	NA	NA	1	301	
70	TCGA-77-8138	0	4	2	1	4	0	0	0	2	81	5	0	0	29	3	0	TCGA-77-8138-01	64	0.5589910772225606	20	TCGA-77-8138-01	25	30	12	0.2874884521925084	TCGA-77-8138-01	11	5	6	22	PASS	6680	TCGA-77-8138	LUSC	74	MALE	[Not Evaluated]	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-27225	Dead	WITH TUMOR	NA	539	NA	Locoregional Recurrence	NA	NA	289	NA	NA	NA	1	539	1	539	NA	NA	1	289	
70	TCGA-77-8139	1	8	0	2	7	1	0	0	4	170	9	0	2	58	11	0	TCGA-77-8139-01	140	0.3865229864070816	75	TCGA-77-8139-01	25	28	21	0.2474758712061157	TCGA-77-8139-01	13	5	8	26	PASS	6681	TCGA-77-8139	LUSC	72	MALE	[Not Evaluated]	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-26464	Alive	TUMOR FREE	3166	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3166	0	3166	0	3166	0	3166	
70	TCGA-77-8140	0	12	0	17	11	1	2	0	13	301	12	0	4	97	6	2	TCGA-77-8140-01	191	0.4778204862350372	109	TCGA-77-8140-01	14	14	43	0.37257879337494737	TCGA-77-8140-01	15	6	10	31	PASS	6682	TCGA-77-8140	LUSC	66	FEMALE	[Not Evaluated]	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2003	NA	-24415	Dead	NA	NA	351	NA	NA	NA	NA	NA	NA	NA	NA	1	351	NA	351	NA	NA	0	351	
80	TCGA-77-8143	0	4	2	2	2	0	0	0	4	123	8	0	2	37	1	1	TCGA-77-8143-01	138	0.5731229917262863	61	TCGA-77-8143-01	20	21	28	0.3289015319046181	TCGA-77-8143-01	13	3	7	23	PASS	6683	TCGA-77-8143	LUSC	76	MALE	[Not Evaluated]	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-27772	Dead	WITH TUMOR	NA	803	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	803	1	803	NA	NA	1	803	
70	TCGA-77-8144	1	10	3	8	11	5	0	0	15	305	26	0	4	103	11	0	TCGA-77-8144-01	192	0.8436963790409551	90	TCGA-77-8144-01	13	20	42	0.2431696143587342	TCGA-77-8144-01	19	10	10	39	PASS	6684	TCGA-77-8144	LUSC	70	MALE	[Not Evaluated]	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2004	NA	-25796	Alive	NA	833	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	833	0	833	0	833	0	833	
70	TCGA-77-8145	0	2	0	3	4	2	0	0	2	107	11	0	1	24	1	0	TCGA-77-8145-01	154	0.4561601255088532	77	TCGA-77-8145-01	13	15	36	0.2098385874694472	TCGA-77-8145-01	12	5	11	28	PASS	6685	TCGA-77-8145	LUSC	73	MALE	[Not Evaluated]	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2000	NA	-26707	Dead	NA	NA	212	NA	Distant Metastasis	NA	NA	136	[Unknown]	NA	NA	1	212	NA	212	NA	NA	1	136	
70	TCGA-77-8146	1	5	0	3	2	1	0	0	6	128	6	0	5	47	3	1	TCGA-77-8146	0	0	0	TCGA-77-8146	0	0	0	0	TCGA-77-8146	0	0	0	0	PASS	6686	TCGA-77-8146	LUSC	72	MALE	[Not Evaluated]	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-26533	Alive	NA	3189	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3189	0	3189	0	3189	0	3189	
70	TCGA-77-8148	1	12	1	9	9	1	0	0	14	196	15	0	5	74	4	0	TCGA-77-8148-01	234	0.7057743753257848	125	TCGA-77-8148-01	20	26	41	0.27535323854628146	TCGA-77-8148-01	17	15	13	45	PASS	6687	TCGA-77-8148	LUSC	68	MALE	[Not Evaluated]	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-24918	Alive	NA	2023	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2023	0	2023	0	2023	0	2023	
60	TCGA-77-8150	0	0	0	5	7	3	2	0	3	93	9	0	2	37	2	1	TCGA-77-8150-01	151	0.8837818060014515	83	TCGA-77-8150-01	21	20	23	0.30109940211659386	TCGA-77-8150-01	17	9	7	33	PASS	6688	TCGA-77-8150	LUSC	64	MALE	[Not Evaluated]	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-23474	Dead	WITH TUMOR	NA	1655	NA	Locoregional Recurrence	NA	NA	1278	NA	NA	NA	1	1655	1	1655	NA	NA	1	1278	
80	TCGA-77-8153	3	13	2	7	4	1	0	0	6	130	8	0	0	50	4	1	TCGA-77-8153-01	287	0.9299995580997579	197	TCGA-77-8153-01	13	19	178	0.4395550237266129	TCGA-77-8153-01	15	12	12	39	PASS	6689	TCGA-77-8153	LUSC	77	FEMALE	[Not Evaluated]	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-28253	Alive	TUMOR FREE	1992	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1992	0	1992	0	1992	0	1992	
70	TCGA-77-8154	0	9	1	9	7	0	0	0	3	160	13	0	3	55	6	0	TCGA-77-8154-01	158	0.6689194195888459	78	TCGA-77-8154-01	11	14	30	0.3194889741947347	TCGA-77-8154-01	15	10	11	36	PASS	6690	TCGA-77-8154	LUSC	67	MALE	[Not Evaluated]	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-24640	Alive	TUMOR FREE	1841	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1841	0	1841	0	1841	0	1841	
60	TCGA-77-8156	1	9	0	9	2	2	0	0	1	164	9	0	1	75	4	0	TCGA-77-8156-01	126	0.5666733061401944	59	TCGA-77-8156-01	23	35	36	0.5237439633223991	TCGA-77-8156-01	17	13	8	38	PASS	6691	TCGA-77-8156	LUSC	60	MALE	[Not Evaluated]	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-22198	Alive	NA	1106	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1106	0	1106	0	1106	0	1106	
60	TCGA-77-A5FZ	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	TCGA-77-A5FZ-01	67	9.029520440696125e-05	23	TCGA-77-A5FZ-01	0	0	8	0.00036984860686691603	TCGA-77-A5FZ-01	0	0	0	0	PASS	6692	TCGA-77-A5FZ	LUSC	64	MALE	[Not Evaluated]	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2001	NA	-23436	Dead	NA	NA	3838	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	3838	NA	3838	0	3838	0	3838	
80	TCGA-77-A5G1	0	14	1	5	3	0	1	0	5	121	13	0	3	36	4	0	TCGA-77-A5G1-01	80	0.2465420240523409	31	TCGA-77-A5G1-01	12	12	55	0.26873392380101624	TCGA-77-A5G1-01	6	5	6	17	PASS	6693	TCGA-77-A5G1	LUSC	75	MALE	[Not Evaluated]	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-27555	Alive	NA	4026	NA	NA	New Primary Tumor	NA	NA	2197	Complete Remission/Response	NA	NA	0	4026	0	4026	0	4026	1	2197	
60	TCGA-77-A5G3	4	18	7	17	17	9	3	0	22	462	40	0	16	186	8	2	TCGA-77-A5G3-01	240	0.6509088510572507	138	TCGA-77-A5G3-01	17	33	60	0.21424634008065485	TCGA-77-A5G3-01	23	22	7	52	PASS	6694	TCGA-77-A5G3	LUSC	63	MALE	[Not Evaluated]	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2002	NA	-23171	Alive	TUMOR FREE	4570	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4570	0	4570	0	4570	0	4570	
70	TCGA-77-A5G6	5	17	3	12	16	5	1	0	16	362	30	1	9	151	13	1	TCGA-77-A5G6-01	245	0.6143489812510563	156	TCGA-77-A5G6-01	18	28	74	0.2766692528272777	TCGA-77-A5G6-01	18	15	10	43	PASS	6695	TCGA-77-A5G6	LUSC	66	MALE	[Not Evaluated]	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-24215	Dead	WITH TUMOR	NA	678	NA	Locoregional Recurrence	NA	NA	392	Complete Remission/Response	NA	NA	1	678	1	678	1	392	1	392	
60	TCGA-77-A5G7	0	4	0	1	2	0	2	0	5	74	4	0	2	39	1	0	TCGA-77-A5G7-01	128	0.5302938232862755	59	TCGA-77-A5G7-01	13	14	76	0.32019324842348285	TCGA-77-A5G7-01	12	9	13	34	PASS	6696	TCGA-77-A5G7	LUSC	63	MALE	[Not Evaluated]	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-23090	Dead	NA	NA	180	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	180	NA	180	0	180	0	180	
70	TCGA-77-A5G8	2	12	0	5	3	1	1	0	5	171	15	1	2	63	6	2	TCGA-77-A5G8-01	101	0.6603131390970868	40	TCGA-77-A5G8-01	23	36	62	0.3891447098814579	TCGA-77-A5G8-01	20	11	10	41	PASS	6697	TCGA-77-A5G8	LUSC	70	MALE	[Not Evaluated]	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-25921	Alive	NA	1884	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1884	0	1884	NA	NA	0	1884	
80	TCGA-77-A5GA	1	9	2	6	6	0	0	0	4	109	14	0	2	40	7	1	TCGA-77-A5GA	0	0	0	TCGA-77-A5GA	0	0	0	0	TCGA-77-A5GA-01	11	10	7	28	PASS	6698	TCGA-77-A5GA	LUSC	76	MALE	[Not Evaluated]	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-27762	Alive	NA	1280	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1280	0	1280	0	1280	0	1280	
90	TCGA-77-A5GB	1	8	0	4	2	0	1	0	8	99	8	0	3	39	1	0	TCGA-77-A5GB-01	57	0.29472053624111866	18	TCGA-77-A5GB-01	9	11	54	0.3763386234035777	TCGA-77-A5GB-01	8	6	9	23	PASS	6699	TCGA-77-A5GB	LUSC	90	MALE	[Not Evaluated]	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-32872	Dead	NA	NA	937	NA	New Primary Tumor	NA	NA	229	Complete Remission/Response	NA	NA	1	937	NA	937	0	937	1	229	
70	TCGA-77-A5GF	0	3	1	5	5	1	0	0	3	91	7	0	5	30	4	0	TCGA-77-A5GF-01	185	0.9183886072606371	114	TCGA-77-A5GF-01	26	24	116	0.5069154356477671	TCGA-77-A5GF-01	14	10	13	37	PASS	6700	TCGA-77-A5GF	LUSC	70	MALE	[Not Evaluated]	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-25654	Dead	WITH TUMOR	NA	840	NA	Locoregional Recurrence	NA	NA	722	Complete Remission/Response	NA	NA	1	840	1	840	1	722	1	722	
80	TCGA-77-A5GH	0	9	0	14	6	3	1	1	8	213	15	1	4	74	5	1	TCGA-77-A5GH-01	253	0.5495305608482098	150	TCGA-77-A5GH-01	15	18	120	0.4180522253536517	TCGA-77-A5GH-01	18	10	11	39	PASS	6701	TCGA-77-A5GH	LUSC	81	MALE	[Not Evaluated]	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-29843	Alive	NA	1182	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1182	0	1182	0	1182	0	1182	
NA	TCGA-79-5596	1	12	1	6	5	2	2	0	5	144	16	0	6	64	8	0	TCGA-79-5596-01	165	0.7663541892504705	83	TCGA-79-5596-01	9	12	30	0.2654018931237581	TCGA-79-5596-01	16	7	12	35	PASS	6702	TCGA-79-5596	LUSC	NA	MALE	NA	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	NA	Alive	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
60	TCGA-85-6175	1	2	1	1	0	0	1	0	1	29	4	0	0	15	1	0	TCGA-85-6175-01	121	0.4073779834435961	61	TCGA-85-6175-01	23	33	16	0.27154236930092823	TCGA-85-6175-01	9	4	6	19	PASS	6703	TCGA-85-6175	LUSC	63	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-23228	Dead	WITH TUMOR	NA	294	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	294	1	294	NA	NA	1	294	
60	TCGA-85-6560	2	22	1	12	10	6	3	0	11	341	23	1	13	94	8	2	TCGA-85-6560-01	229	0.7554408686165306	127	TCGA-85-6560-01	25	31	66	0.3909134272736079	TCGA-85-6560-01	14	7	10	31	PASS	6704	TCGA-85-6560	LUSC	59	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-21768	Alive	TUMOR FREE	1259	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1259	0	1259	0	1259	0	1259	
70	TCGA-85-6561	2	40	1	24	9	3	2	0	43	931	132	0	16	379	39	1	TCGA-85-6561-01	102	0.673918560100744	48	TCGA-85-6561-01	12	15	24	0.3966077920323676	TCGA-85-6561-01	10	5	14	29	PASS	6705	TCGA-85-6561	LUSC	66	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-24234	Alive	TUMOR FREE	1224	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1224	0	1224	0	1224	0	1224	
60	TCGA-85-6798	1	12	0	12	4	3	0	0	5	221	11	0	6	77	7	2	TCGA-85-6798-01	138	0.6970987327851796	57	TCGA-85-6798-01	19	34	42	0.4320626285229792	TCGA-85-6798-01	18	11	9	38	PASS	6706	TCGA-85-6798	LUSC	57	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-20837	Dead	WITH TUMOR	NA	195	NA	Distant Metastasis	NA	NA	180	Complete Remission/Response	NA	NA	1	195	1	195	1	180	1	180	
60	TCGA-85-7696	4	4	0	4	5	2	0	0	10	167	11	0	3	71	3	0	TCGA-85-7696-01	130	0.7556918086772743	63	TCGA-85-7696-01	9	14	23	0.2754505471237771	TCGA-85-7696-01	13	7	12	32	PASS	6707	TCGA-85-7696	LUSC	64	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-23413	Alive	TUMOR FREE	1111	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1111	0	1111	0	1111	0	1111	
50	TCGA-85-7697	1	13	1	7	10	3	1	0	10	222	12	0	3	79	3	0	TCGA-85-7697-01	107	0.3125452909644317	40	TCGA-85-7697-01	12	15	25	0.3844404860697592	TCGA-85-7697-01	11	7	9	27	PASS	6708	TCGA-85-7697	LUSC	49	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-17921	Alive	TUMOR FREE	1063	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1063	0	1063	0	1063	0	1063	
50	TCGA-85-7698	0	5	0	1	3	2	1	0	8	103	7	1	1	40	4	0	TCGA-85-7698-01	173	0.6940307807698358	95	TCGA-85-7698-01	8	15	39	0.3277899229369689	TCGA-85-7698-01	17	9	13	39	PASS	6709	TCGA-85-7698	LUSC	48	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-17651	Alive	TUMOR FREE	952	NA	NA	Distant Metastasis	NA	NA	650	Complete Remission/Response	NA	NA	0	952	0	952	1	650	1	650	
70	TCGA-85-7699	2	12	1	5	2	0	0	0	3	143	9	0	6	51	12	0	TCGA-85-7699-01	111	0.8484207462575535	45	TCGA-85-7699-01	14	16	18	0.4055345594196755	TCGA-85-7699-01	11	8	8	27	PASS	6710	TCGA-85-7699	LUSC	73	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26965	Dead	WITH TUMOR	NA	1001	NA	Distant Metastasis	NA	NA	760	Complete Remission/Response	NA	NA	1	1001	1	1001	1	760	1	760	
60	TCGA-85-7710	0	26	2	12	12	0	0	0	20	310	18	0	10	97	10	0	TCGA-85-7710-01	124	0.7282163868368009	57	TCGA-85-7710-01	8	12	18	0.3043759303253117	TCGA-85-7710-01	12	9	7	28	PASS	6711	TCGA-85-7710	LUSC	59	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-21790	Alive	TUMOR FREE	42	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	42	0	42	0	42	0	42	
50	TCGA-85-7843	3	11	1	9	5	1	0	0	7	191	15	0	2	57	7	0	TCGA-85-7843-01	341	0.7797233436283987	216	TCGA-85-7843-01	23	48	87	0.322649132139245	TCGA-85-7843-01	22	19	16	57	PASS	6712	TCGA-85-7843	LUSC	50	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-18353	Alive	NA	35	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	35	0	35	NA	NA	0	35	
70	TCGA-85-7844	0	9	1	7	7	3	0	0	7	131	8	0	4	46	6	0	TCGA-85-7844-01	122	0.4537564952323321	61	TCGA-85-7844-01	20	24	27	0.3039407200821037	TCGA-85-7844-01	13	9	9	31	PASS	6713	TCGA-85-7844	LUSC	71	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26141	Alive	TUMOR FREE	911	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	911	0	911	0	911	0	911	
50	TCGA-85-7950	1	11	2	5	7	0	3	0	8	212	13	0	3	71	7	0	TCGA-85-7950-01	188	0.6848731266859382	105	TCGA-85-7950-01	26	27	65	0.456098162263129	TCGA-85-7950-01	17	9	11	37	PASS	6714	TCGA-85-7950	LUSC	46	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-16975	Alive	TUMOR FREE	576	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	576	0	576	0	576	0	576	
60	TCGA-85-8048	0	2	0	3	0	0	0	0	4	106	4	0	0	32	2	0	TCGA-85-8048-01	95	0.343990503317204	44	TCGA-85-8048-01	9	20	19	0.3317236200634928	TCGA-85-8048-01	9	7	9	25	PASS	6715	TCGA-85-8048	LUSC	62	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-22907	Alive	TUMOR FREE	765	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	765	0	765	0	765	0	765	
60	TCGA-85-8049	0	12	3	5	7	1	1	0	5	163	18	0	4	57	5	0	TCGA-85-8049-01	72	0.4180756382988201	22	TCGA-85-8049-01	28	31	10	0.2354688940491487	TCGA-85-8049-01	6	5	5	16	PASS	6716	TCGA-85-8049	LUSC	57	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-20995	Alive	TUMOR FREE	579	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	579	0	579	0	579	0	579	
50	TCGA-85-8052	1	1	0	9	6	1	0	0	2	98	6	0	1	37	2	0	TCGA-85-8052-01	102	0.6251333762940552	51	TCGA-85-8052-01	22	25	11	0.2707644299880511	TCGA-85-8052-01	6	4	5	15	PASS	6717	TCGA-85-8052	LUSC	53	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-19671	Alive	TUMOR FREE	734	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	734	0	734	0	734	0	734	
70	TCGA-85-8070	0	11	0	7	7	4	2	0	8	180	11	0	4	47	9	1	TCGA-85-8070-01	227	0.8699231671735259	121	TCGA-85-8070-01	8	15	53	0.34090674727860737	TCGA-85-8070-01	18	14	13	45	PASS	6718	TCGA-85-8070	LUSC	71	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26183	Alive	TUMOR FREE	960	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	960	0	960	0	960	0	960	
50	TCGA-85-8071	1	18	1	16	4	3	0	1	19	281	18	0	5	110	17	0	TCGA-85-8071-01	238	0.95270909491057	134	TCGA-85-8071-01	11	20	62	0.4214175408659165	TCGA-85-8071-01	10	4	14	28	PASS	6719	TCGA-85-8071	LUSC	52	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-19158	Alive	TUMOR FREE	815	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	815	0	815	0	815	0	815	
60	TCGA-85-8072	0	2	0	2	2	0	2	0	5	151	7	0	3	54	4	0	TCGA-85-8072-01	187	0.6803112478609653	99	TCGA-85-8072-01	19	31	20	0.18059987983133768	TCGA-85-8072-01	18	12	7	37	PASS	6720	TCGA-85-8072	LUSC	60	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-22069	Alive	TUMOR FREE	932	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	932	0	932	0	932	0	932	
60	TCGA-85-8276	1	12	1	12	4	3	1	0	10	212	13	2	4	81	4	1	TCGA-85-8276-01	416	0.5510895877563569	279	TCGA-85-8276-01	24	29	122	0.28000973868315754	TCGA-85-8276-01	22	19	15	56	PASS	6721	TCGA-85-8276	LUSC	62	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-22707	Alive	WITH TUMOR	1050	NA	NA	Distant Metastasis	NA	NA	1048	Complete Remission/Response	NA	NA	0	1050	0	1050	1	1048	1	1048	
70	TCGA-85-8277	2	15	1	4	7	0	0	0	10	172	14	0	3	73	9	0	TCGA-85-8277-01	277	0.8388188372583212	149	TCGA-85-8277-01	18	36	72	0.4889405368668802	TCGA-85-8277-01	21	14	15	50	PASS	6722	TCGA-85-8277	LUSC	70	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-25793	Dead	TUMOR FREE	NA	307	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	307	0	307	0	307	0	307	
70	TCGA-85-8287	0	8	0	5	6	1	1	0	2	207	15	0	1	66	12	1	TCGA-85-8287-01	178	0.6036452244042338	95	TCGA-85-8287-01	20	28	45	0.3738707133773017	TCGA-85-8287-01	13	13	3	29	PASS	6723	TCGA-85-8287	LUSC	72	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26401	Dead	TUMOR FREE	NA	23	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	23	0	23	0	23	0	23	
70	TCGA-85-8288	3	7	1	8	9	5	0	0	7	173	19	0	5	80	6	0	TCGA-85-8288-01	109	0.9163246484681334	45	TCGA-85-8288-01	12	10	23	0.33135096543292714	TCGA-85-8288-01	8	3	9	20	PASS	6724	TCGA-85-8288	LUSC	70	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-25629	Dead	TUMOR FREE	NA	402	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	402	0	402	0	402	0	402	
60	TCGA-85-8350	3	16	2	8	2	1	1	0	17	221	21	0	6	98	10	2	TCGA-85-8350-01	176	0.5284011108498374	102	TCGA-85-8350-01	21	25	40	0.2602145415543438	TCGA-85-8350-01	9	8	6	23	PASS	6725	TCGA-85-8350	LUSC	61	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-22526	Alive	TUMOR FREE	683	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	683	0	683	0	683	0	683	
70	TCGA-85-8351	2	5	0	2	3	1	0	0	2	108	10	0	4	53	3	0	TCGA-85-8351-01	188	0.4349404303936031	101	TCGA-85-8351-01	15	29	27	0.3365238741235141	TCGA-85-8351-01	10	6	4	20	PASS	6726	TCGA-85-8351	LUSC	72	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26437	Alive	TUMOR FREE	510	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	510	0	510	0	510	0	510	
70	TCGA-85-8352	1	12	0	13	7	3	3	0	7	204	17	1	6	58	12	0	TCGA-85-8352-01	237	0.9001896820029736	128	TCGA-85-8352-01	17	39	187	0.4417233624066684	TCGA-85-8352-01	20	10	17	47	PASS	6727	TCGA-85-8352	LUSC	67	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-24788	Dead	WITH TUMOR	NA	161	NA	Distant Metastasis	NA	NA	128	Complete Remission/Response	NA	NA	1	161	1	161	1	128	1	128	
70	TCGA-85-8353	0	11	0	9	5	0	0	0	4	141	9	0	1	46	2	0	TCGA-85-8353-01	121	0.7862277016786332	60	TCGA-85-8353-01	14	17	35	0.5049760467428862	TCGA-85-8353-01	14	7	10	31	PASS	6728	TCGA-85-8353	LUSC	72	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26549	Dead	WITH TUMOR	NA	94	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	94	1	94	NA	NA	1	94	
50	TCGA-85-8354	1	11	0	8	5	2	1	1	13	160	7	1	3	67	4	0	TCGA-85-8354-01	410	0.7165294725629705	253	TCGA-85-8354-01	14	33	144	0.2480183450738314	TCGA-85-8354-01	23	24	10	57	PASS	6729	TCGA-85-8354	LUSC	53	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-19692	Alive	TUMOR FREE	995	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	995	0	995	0	995	0	995	
60	TCGA-85-8355	0	6	1	5	6	1	1	0	7	168	17	0	6	71	5	0	TCGA-85-8355-01	79	0.09941654771675708	26	TCGA-85-8355-01	9	19	27	0.5458894581958412	TCGA-85-8355-01	10	4	8	22	PASS	6730	TCGA-85-8355	LUSC	63	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-23227	Alive	TUMOR FREE	61	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	61	0	61	0	61	0	61	
70	TCGA-85-8479	0	7	1	3	2	0	2	0	3	84	6	0	0	44	1	0	TCGA-85-8479-01	169	0.921808871143277	83	TCGA-85-8479-01	10	14	98	0.3918635294427627	TCGA-85-8479-01	16	11	12	39	PASS	6731	TCGA-85-8479	LUSC	66	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-24350	Alive	TUMOR FREE	468	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	468	0	468	0	468	0	468	
70	TCGA-85-8481	3	18	1	5	9	4	0	0	10	227	18	0	11	89	8	0	TCGA-85-8481-01	117	0.2964431425562312	55	TCGA-85-8481-01	13	22	102	0.3957747572173418	TCGA-85-8481-01	15	9	17	41	PASS	6732	TCGA-85-8481	LUSC	70	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-25782	Dead	TUMOR FREE	NA	236	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	236	0	236	NA	NA	0	236	
50	TCGA-85-8580	0	11	1	7	8	3	0	0	10	204	18	1	9	80	5	0	TCGA-85-8580-01	105	0.4119335692284123	48	TCGA-85-8580-01	11	17	88	0.3979954057832403	TCGA-85-8580-01	17	13	13	43	PASS	6733	TCGA-85-8580	LUSC	52	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-19301	Alive	TUMOR FREE	1113	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1113	0	1113	0	1113	0	1113	
50	TCGA-85-8582	1	13	2	13	9	2	0	0	6	262	18	0	5	71	8	0	TCGA-85-8582-01	152	0.1677263612719824	88	TCGA-85-8582-01	25	40	93	0.3314611820102781	TCGA-85-8582-01	16	11	11	38	PASS	6734	TCGA-85-8582	LUSC	49	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-18168	Alive	TUMOR FREE	1160	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1160	0	1160	0	1160	0	1160	
70	TCGA-85-8584	1	17	3	9	5	2	1	0	7	186	17	0	6	80	7	0	TCGA-85-8584-01	133	0.24281748413849666	75	TCGA-85-8584-01	7	14	107	0.17032828247834844	TCGA-85-8584-01	11	8	10	29	PASS	6735	TCGA-85-8584	LUSC	71	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-26081	Dead	TUMOR FREE	NA	383	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	383	0	383	0	383	0	383	
70	TCGA-85-8664	1	15	3	9	8	2	1	1	13	164	12	0	4	57	5	0	TCGA-85-8664-01	148	0.7293360422118914	69	TCGA-85-8664-01	25	33	80	0.3875107160653072	TCGA-85-8664-01	14	9	8	31	PASS	6736	TCGA-85-8664	LUSC	73	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26954	Dead	WITH TUMOR	NA	550	NA	Distant Metastasis	NA	NA	434	Complete Remission/Response	NA	NA	1	550	1	550	1	434	1	434	
70	TCGA-85-8666	0	11	1	7	5	1	0	0	10	183	9	0	3	66	8	0	TCGA-85-8666-01	116	0.6357856721828075	57	TCGA-85-8666-01	26	30	95	0.33234140062817724	TCGA-85-8666-01	17	14	10	41	PASS	6737	TCGA-85-8666	LUSC	65	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-23906	Dead	TUMOR FREE	NA	687	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	687	0	687	0	687	0	687	
70	TCGA-85-A4CL	5	45	3	28	10	3	1	0	32	602	46	2	20	245	8	0	TCGA-85-A4CL-01	231	0.6215523604199771	140	TCGA-85-A4CL-01	10	15	144	0.3068103703585865	TCGA-85-A4CL-01	16	12	8	36	hypermutated sample	6738	TCGA-85-A4CL	LUSC	65	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-24005	Dead	TUMOR FREE	NA	921	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	921	0	921	0	921	0	921	
60	TCGA-85-A4CN	2	11	1	4	3	0	0	1	7	138	9	0	2	56	9	0	TCGA-85-A4CN-01	131	0.9431636226977952	60	TCGA-85-A4CN-01	15	19	164	0.5662641339500433	TCGA-85-A4CN-01	12	5	16	33	PASS	6739	TCGA-85-A4CN	LUSC	56	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-20490	Alive	TUMOR FREE	1038	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1038	0	1038	0	1038	0	1038	
70	TCGA-85-A4JB	1	30	7	11	17	1	1	0	14	367	21	0	7	115	14	1	TCGA-85-A4JB-01	193	0.6566539101993705	110	TCGA-85-A4JB-01	22	26	104	0.30857993268047385	TCGA-85-A4JB-01	22	16	13	51	PASS	6740	TCGA-85-A4JB	LUSC	74	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-27315	Alive	TUMOR FREE	942	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	942	0	942	0	942	0	942	
80	TCGA-85-A4JC	2	11	2	7	0	4	0	0	12	186	21	0	5	76	6	0	TCGA-85-A4JC-01	94	0.6725348981883176	39	TCGA-85-A4JC-01	22	16	8	0.0011525990705911384	TCGA-85-A4JC-01	10	7	0	17	PASS	6741	TCGA-85-A4JC	LUSC	84	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-30942	Dead	WITH TUMOR	NA	604	NA	Locoregional Recurrence	NA	NA	548	Complete Remission/Response	NA	NA	1	604	1	604	1	548	1	548	
60	TCGA-85-A4PA	0	1	0	3	0	0	0	0	0	7	0	0	0	5	0	0	TCGA-85-A4PA-01	69	0.00021868460188706034	20	TCGA-85-A4PA-01	0	0	16	0.001137939168540345	TCGA-85-A4PA-01	0	0	0	0	PASS	6742	TCGA-85-A4PA	LUSC	61	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-22614	Alive	TUMOR FREE	741	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	741	0	741	0	741	0	741	
70	TCGA-85-A4QQ	0	19	1	15	8	0	1	0	16	240	15	0	2	82	7	0	TCGA-85-A4QQ-01	92	0.443621863362241	41	TCGA-85-A4QQ-01	12	14	69	0.3336976983846957	TCGA-85-A4QQ-01	16	8	12	36	PASS	6743	TCGA-85-A4QQ	LUSC	68	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-25065	Dead	TUMOR FREE	NA	927	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	927	0	927	0	927	0	927	
70	TCGA-85-A4QR	1	13	0	8	4	2	0	0	6	181	13	1	5	47	7	0	TCGA-85-A4QR-01	219	0.7918409412173377	115	TCGA-85-A4QR-01	23	28	125	0.42248005330732624	TCGA-85-A4QR-01	23	20	19	62	PASS	6744	TCGA-85-A4QR	LUSC	67	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-24756	Alive	TUMOR FREE	600	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	600	0	600	0	600	0	600	
50	TCGA-85-A50M	1	3	0	1	2	2	1	1	1	56	6	0	2	33	2	0	TCGA-85-A50M-01	158	0.6424959736749563	84	TCGA-85-A50M-01	21	59	108	0.3280531835749334	TCGA-85-A50M-01	24	19	9	52	PASS	6745	TCGA-85-A50M	LUSC	47	MALE	ASIAN	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-17429	Dead	TUMOR FREE	NA	826	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	826	0	826	0	826	0	826	
60	TCGA-85-A50Z	2	29	4	10	10	2	0	0	13	348	22	0	11	126	10	1	TCGA-85-A50Z-01	162	0.3837062801413202	94	TCGA-85-A50Z-01	8	15	116	0.3744490341200497	TCGA-85-A50Z-01	17	18	18	53	PASS	6746	TCGA-85-A50Z	LUSC	57	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-20941	Alive	TUMOR FREE	493	NA	NA	New Primary Tumor	NA	NA	462	Complete Remission/Response	NA	NA	0	493	0	493	0	493	1	462	
70	TCGA-85-A510	0	6	2	8	4	2	0	0	6	109	6	1	4	42	4	0	TCGA-85-A510-01	156	0.8702830273740078	76	TCGA-85-A510-01	23	32	58	0.3023468355504245	TCGA-85-A510-01	12	13	6	31	PASS	6747	TCGA-85-A510	LUSC	74	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-27067	Alive	TUMOR FREE	482	NA	NA	Distant Metastasis	NA	NA	363	Complete Remission/Response	NA	NA	0	482	0	482	1	363	1	363	
60	TCGA-85-A511	1	21	1	11	2	1	0	0	7	149	9	2	5	55	6	0	TCGA-85-A511-01	102	0.5390064480445403	41	TCGA-85-A511-01	19	36	68	0.27375447025293936	TCGA-85-A511-01	17	16	11	44	PASS	6748	TCGA-85-A511	LUSC	62	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-22759	Dead	WITH TUMOR	NA	455	NA	Distant Metastasis	NA	NA	390	Complete Remission/Response	NA	NA	1	455	1	455	1	390	1	390	
50	TCGA-85-A512	0	6	0	2	5	3	1	0	6	124	12	0	6	45	1	0	TCGA-85-A512-01	173	0.9469540153815448	95	TCGA-85-A512-01	11	18	138	0.4512231260684411	TCGA-85-A512-01	19	14	15	48	PASS	6749	TCGA-85-A512	LUSC	46	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-16811	Alive	TUMOR FREE	465	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	465	0	465	0	465	0	465	
60	TCGA-85-A513	0	0	0	1	0	0	0	0	0	21	1	0	0	5	0	0	TCGA-85-A513-01	112	0.1478745560382983	43	TCGA-85-A513-01	4	7	48	0.1285187864559936	TCGA-85-A513-01	7	9	8	24	PASS	6750	TCGA-85-A513	LUSC	60	FEMALE	ASIAN	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-21967	Alive	TUMOR FREE	910	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	910	0	910	0	910	0	910	
60	TCGA-85-A53L	0	7	1	3	4	0	1	0	5	164	7	0	2	50	5	0	TCGA-85-A53L-01	172	0.6010238403980034	88	TCGA-85-A53L-01	14	19	140	0.481024066100273	TCGA-85-A53L-01	18	17	18	53	PASS	6751	TCGA-85-A53L	LUSC	63	MALE	ASIAN	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-23065	Alive	TUMOR FREE	377	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	377	0	377	0	377	0	377	
60	TCGA-85-A5B5	6	13	3	7	11	3	0	0	8	294	31	0	7	98	2	1	TCGA-85-A5B5-01	161	0.8450320352545861	82	TCGA-85-A5B5-01	26	38	97	0.3448823096419943	TCGA-85-A5B5-01	20	16	13	49	PASS	6752	TCGA-85-A5B5	LUSC	58	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-21450	Alive	TUMOR FREE	111	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	111	0	111	0	111	0	111	
60	TCGA-90-6837	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-90-6837-01	37	5.125815020734562e-06	7	TCGA-90-6837	0	0	0	0	TCGA-90-6837	0	0	0	0	PASS	6753	TCGA-90-6837	LUSC	64	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-23511	Alive	TUMOR FREE	758	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	758	0	758	0	758	0	758	
70	TCGA-90-7766	0	15	0	4	8	6	0	0	6	184	8	2	6	44	6	0	TCGA-90-7766-01	118	0.87462932119958	65	TCGA-90-7766-01	12	11	53	0.3170014267164918	TCGA-90-7766-01	12	3	7	22	PASS	6754	TCGA-90-7766	LUSC	66	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-24354	Alive	WITH TUMOR	289	NA	NA	Locoregional Recurrence	NA	NA	289	Progressive Disease	NA	NA	0	289	0	289	NA	NA	1	289	
60	TCGA-90-7767	0	10	0	4	4	2	0	0	8	181	6	0	6	66	3	0	TCGA-90-7767-01	160	0.7721045001554202	78	TCGA-90-7767-01	21	41	36	0.43030679839201424	TCGA-90-7767-01	19	13	11	43	PASS	6755	TCGA-90-7767	LUSC	56	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-20534	Alive	TUMOR FREE	89	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	89	0	89	NA	NA	0	89	
60	TCGA-90-7769	0	41	7	34	26	16	0	0	19	847	56	4	24	237	20	0	TCGA-90-7769-01	140	0.9375217021887564	63	TCGA-90-7769-01	17	38	31	0.3240180976929669	TCGA-90-7769-01	17	15	10	42	PASS	6756	TCGA-90-7769	LUSC	55	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-20276	Alive	TUMOR FREE	358	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	358	0	358	0	358	0	358	
70	TCGA-90-7964	10	45	10	27	24	8	2	0	24	755	37	0	17	258	14	0	TCGA-90-7964-01	140	0.6177224484899899	72	TCGA-90-7964-01	11	9	45	0.2884994292622314	TCGA-90-7964-01	8	7	10	25	PASS	6757	TCGA-90-7964	LUSC	70	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-25646	Alive	TUMOR FREE	428	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	428	0	428	0	428	0	428	
70	TCGA-90-A4ED	6	106	16	67	4	0	0	1	58	1469	75	1	41	899	15	5	TCGA-90-A4ED-01	71	0.591775415829181	32	TCGA-90-A4ED-01	17	53	32	0.08444656855893569	TCGA-90-A4ED-01	13	10	5	28	hypermutated sample	6758	TCGA-90-A4ED	LUSC	69	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-25453	Alive	TUMOR FREE	615	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	615	0	615	0	615	0	615	
50	TCGA-90-A4EE	1	22	2	9	4	2	0	0	12	274	29	0	5	93	8	2	TCGA-90-A4EE-01	185	0.9354676005093988	106	TCGA-90-A4EE-01	19	17	186	0.5152552363132263	TCGA-90-A4EE-01	12	9	12	33	PASS	6759	TCGA-90-A4EE	LUSC	53	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-19676	Alive	TUMOR FREE	688	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	688	0	688	0	688	0	688	
60	TCGA-90-A59Q	4	19	2	7	8	2	1	0	8	211	17	0	1	80	8	0	TCGA-90-A59Q-01	94	0.7120525972953331	51	TCGA-90-A59Q-01	26	19	77	0.25856275633977194	TCGA-90-A59Q-01	9	8	11	28	PASS	6760	TCGA-90-A59Q	LUSC	61	FEMALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-22420	Dead	WITH TUMOR	NA	322	NA	Distant Metastasis	NA	NA	274	Complete Remission/Response	NA	NA	1	322	1	322	1	274	1	274	
50	TCGA-92-7340	0	52	6	50	11	4	0	0	36	659	40	0	12	256	18	0	TCGA-92-7340-01	80	0.3683781410327849	26	TCGA-92-7340-01	6	14	9	0.2552964193364337	TCGA-92-7340-01	2	6	4	12	PASS	6761	TCGA-92-7340	LUSC	45	FEMALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-16447	Alive	WITH TUMOR	82	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	82	0	82	NA	NA	0	82	
70	TCGA-92-7341	0	12	2	4	5	0	1	0	12	263	17	0	11	103	7	0	TCGA-92-7341-01	260	0.8627223616741807	155	TCGA-92-7341-01	23	31	60	0.4243333808921738	TCGA-92-7341-01	19	15	13	47	PASS	6762	TCGA-92-7341	LUSC	71	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26134	Alive	WITH TUMOR	106	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	106	0	106	NA	NA	0	106	
50	TCGA-92-8063	2	9	0	8	15	3	0	0	15	300	15	1	7	81	8	0	TCGA-92-8063-01	195	0.6105952875299441	111	TCGA-92-8063-01	14	14	54	0.3880173871640505	TCGA-92-8063-01	15	7	14	36	PASS	6763	TCGA-92-8063	LUSC	52	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-19193	Alive	TUMOR FREE	122	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	122	0	122	0	122	0	122	
60	TCGA-92-8064	0	11	0	7	10	2	0	0	7	164	15	0	7	59	6	1	TCGA-92-8064-01	156	0.6464810036949568	77	TCGA-92-8064-01	23	27	25	0.4677789399749463	TCGA-92-8064-01	17	8	12	37	PASS	6764	TCGA-92-8064	LUSC	58	MALE	WHITE	[Discrepancy]	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-21417	Alive	TUMOR FREE	160	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	160	0	160	0	160	0	160	
70	TCGA-92-8065	1	10	2	11	1	0	0	0	12	201	22	0	2	93	2	0	TCGA-92-8065-01	208	0.4085900460652964	115	TCGA-92-8065-01	10	13	60	0.3213542633469447	TCGA-92-8065-01	17	14	12	43	PASS	6765	TCGA-92-8065	LUSC	74	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-27049	Alive	TUMOR FREE	70	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	70	0	70	0	70	0	70	
70	TCGA-94-7033	0	5	0	3	1	0	4	0	3	109	6	2	1	32	2	1	TCGA-94-7033-01	140	0.3493802080426721	74	TCGA-94-7033-01	7	14	41	0.3433323441163709	TCGA-94-7033-01	18	16	10	44	PASS	6766	TCGA-94-7033	LUSC	73	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26948	Alive	TUMOR FREE	640	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	640	0	640	0	640	0	640	
70	TCGA-94-7557	0	12	1	2	2	1	0	0	4	72	5	0	1	41	1	0	TCGA-94-7557-01	277	0.7477762498301429	152	TCGA-94-7557-01	28	23	70	0.3410309079481621	TCGA-94-7557-01	12	12	6	30	PASS	6767	TCGA-94-7557	LUSC	73	MALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26802	Dead	TUMOR FREE	NA	5	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	5	0	5	0	5	0	5	
80	TCGA-94-7943	0	5	0	3	1	1	1	0	5	154	15	0	3	68	3	0	TCGA-94-7943-01	218	0.7805462318317228	120	TCGA-94-7943-01	26	23	60	0.3195346068606452	TCGA-94-7943-01	16	5	3	24	PASS	6768	TCGA-94-7943	LUSC	80	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-29282	Alive	WITH TUMOR	559	NA	NA	Locoregional Recurrence	NA	NA	556	Complete Remission/Response	NA	NA	0	559	0	559	1	556	1	556	
60	TCGA-94-8035	0	7	0	0	8	1	0	0	0	158	9	0	2	69	7	0	TCGA-94-8035-01	155	0.4673214875464706	80	TCGA-94-8035-01	11	9	43	0.3795682784120512	TCGA-94-8035-01	11	7	16	34	PASS	6769	TCGA-94-8035	LUSC	64	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-23399	Alive	TUMOR FREE	122	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	122	0	122	0	122	0	122	
70	TCGA-94-8490	3	75	8	37	30	55	6	0	37	664	33	3	18	274	21	1	TCGA-94-8490-01	108	0.4296008025274506	45	TCGA-94-8490-01	8	11	66	0.2840841263442881	TCGA-94-8490-01	15	6	9	30	hypermutated sample	6770	TCGA-94-8490	LUSC	70	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-25588	Alive	TUMOR FREE	153	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	153	0	153	NA	NA	0	153	
70	TCGA-94-8491	0	35	3	16	15	2	1	1	14	416	38	1	13	132	16	0	TCGA-94-8491-01	180	0.5302698349814422	97	TCGA-94-8491-01	7	16	141	0.4155112231229184	TCGA-94-8491-01	23	27	14	64	PASS	6771	TCGA-94-8491	LUSC	73	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-26698	Alive	TUMOR FREE	810	NA	NA	Distant Metastasis	NA	NA	641	Progressive Disease	NA	NA	0	810	0	810	NA	NA	1	641	
70	TCGA-94-A4VJ	0	16	1	16	6	1	1	0	12	325	25	1	8	103	7	0	TCGA-94-A4VJ-01	184	0.6767825830793177	92	TCGA-94-A4VJ-01	19	39	82	0.1843345497274972	TCGA-94-A4VJ-01	20	14	6	40	PASS	6772	TCGA-94-A4VJ	LUSC	71	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-25991	Alive	TUMOR FREE	430	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	430	0	430	0	430	0	430	
60	TCGA-94-A5I4	1	23	1	7	4	1	0	0	7	188	17	0	6	63	5	1	TCGA-94-A5I4-01	220	0.8824552528894112	125	TCGA-94-A5I4-01	25	27	168	0.5261803088291399	TCGA-94-A5I4-01	18	9	19	46	PASS	6773	TCGA-94-A5I4	LUSC	61	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-22299	Alive	WITH TUMOR	491	NA	NA	Distant Metastasis	NA	NA	314	Complete Remission/Response	NA	NA	0	491	0	491	1	314	1	314	
60	TCGA-94-A5I6	2	9	2	7	3	0	1	0	7	135	4	0	6	42	6	0	TCGA-94-A5I6-01	110	0.6972646884802483	43	TCGA-94-A5I6-01	26	35	82	0.3247475454296963	TCGA-94-A5I6-01	15	11	11	37	PASS	6774	TCGA-94-A5I6	LUSC	62	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-22949	Alive	WITH TUMOR	538	NA	NA	Distant Metastasis	NA	NA	481	Progressive Disease	NA	NA	0	538	0	538	NA	NA	1	481	
80	TCGA-96-7544	7	13	2	10	6	1	1	0	9	313	31	1	9	98	11	0	TCGA-96-7544-01	254	0.76764036627537	145	TCGA-96-7544-01	12	15	67	0.3952680456163934	TCGA-96-7544-01	18	15	17	50	PASS	6775	TCGA-96-7544	LUSC	83	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-30548	Dead	TUMOR FREE	NA	2160	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2160	0	2160	0	2160	0	2160	
70	TCGA-96-7545	0	2	1	5	3	1	1	0	5	93	5	0	4	33	6	0	TCGA-96-7545-01	132	0.5347446843457411	56	TCGA-96-7545-01	11	14	28	0.4342537042167925	TCGA-96-7545-01	16	7	12	35	PASS	6776	TCGA-96-7545	LUSC	73	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-26729	Dead	NA	NA	1736	NA	Locoregional Recurrence	NA	NA	1693	Progressive Disease	NA	NA	1	1736	NA	1736	NA	NA	1	1693	
70	TCGA-96-8169	0	7	1	3	4	1	0	0	10	121	14	0	1	52	6	0	TCGA-96-8169-01	93	0.5167615928856388	39	TCGA-96-8169-01	14	14	31	0.3269010912219954	TCGA-96-8169-01	11	2	9	22	PASS	6777	TCGA-96-8169	LUSC	67	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-24674	Alive	TUMOR FREE	557	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	557	0	557	0	557	0	557	
80	TCGA-96-8170	1	11	0	8	3	4	0	0	7	202	17	0	9	72	4	2	TCGA-96-8170-01	76	0.2695387122791473	36	TCGA-96-8170-01	12	11	17	0.1832028569192706	TCGA-96-8170-01	7	1	5	13	PASS	6778	TCGA-96-8170	LUSC	75	FEMALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-27558	Alive	TUMOR FREE	531	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	531	0	531	0	531	0	531	
70	TCGA-96-A4JK	3	30	4	20	9	3	4	0	17	384	26	2	8	132	12	1	TCGA-96-A4JK	0	0	0	TCGA-96-A4JK	0	0	0	0	TCGA-96-A4JK-01	20	11	16	47	PASS	6779	TCGA-96-A4JK	LUSC	65	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-23974	Alive	TUMOR FREE	589	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	589	0	589	0	589	0	589	
80	TCGA-96-A4JL	0	3	0	2	3	1	1	0	1	46	4	0	1	16	1	0	TCGA-96-A4JL-01	75	0.2569755191901683	28	TCGA-96-A4JL-01	7	8	33	0.12754411632892212	TCGA-96-A4JL-01	9	13	8	30	PASS	6780	TCGA-96-A4JL	LUSC	78	FEMALE	ASIAN	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-28686	Alive	TUMOR FREE	842	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	842	0	842	0	842	0	842	
70	TCGA-98-7454	2	16	0	8	10	0	0	0	18	332	24	0	8	104	10	0	TCGA-98-7454-01	40	0.19210742512364967	9	TCGA-98-7454-01	16	15	13	0.5362736860263929	TCGA-98-7454-01	0	1	1	2	PASS	6781	TCGA-98-7454	LUSC	73	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26827	Alive	TUMOR FREE	652	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	652	0	652	0	652	0	652	
60	TCGA-98-8020	0	3	0	2	1	0	0	0	0	86	0	0	1	25	1	0	TCGA-98-8020-01	302	0.6372259383862093	193	TCGA-98-8020-01	20	29	53	0.2633016533754547	TCGA-98-8020-01	17	11	14	42	PASS	6782	TCGA-98-8020	LUSC	56	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-20509	Dead	WITH TUMOR	NA	84	NA	Distant Metastasis	NA	NA	11	[Unknown]	NA	NA	1	84	1	84	NA	NA	1	11	
80	TCGA-98-8021	3	23	4	20	6	0	0	0	24	814	68	0	5	311	18	3	TCGA-98-8021-01	158	0.7722784352997715	81	TCGA-98-8021-01	13	16	30	0.3374144598769814	TCGA-98-8021-01	9	4	7	20	hypermutated sample	6783	TCGA-98-8021	LUSC	75	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-27738	Alive	TUMOR FREE	937	NA	NA	Locoregional Recurrence	NA	NA	918	Complete Remission/Response	NA	NA	0	937	0	937	1	918	1	918	
60	TCGA-98-8022	1	5	1	8	5	1	1	0	8	189	15	1	4	71	7	0	TCGA-98-8022-01	150	0.6311511366877227	69	TCGA-98-8022-01	20	24	39	0.3269874955055596	TCGA-98-8022-01	11	10	9	30	PASS	6784	TCGA-98-8022	LUSC	61	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-22487	Dead	TUMOR FREE	NA	933	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	933	0	933	0	933	0	933	
70	TCGA-98-8023	1	5	0	5	4	0	1	0	4	148	12	0	4	69	4	2	TCGA-98-8023-01	142	0.5852094289610605	60	TCGA-98-8023-01	19	28	35	0.5708946997696962	TCGA-98-8023-01	16	15	11	42	PASS	6785	TCGA-98-8023	LUSC	70	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-25732	Alive	TUMOR FREE	649	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	649	0	649	0	649	0	649	
70	TCGA-98-A538	3	58	4	18	18	5	1	0	23	498	42	1	14	166	20	0	TCGA-98-A538-01	254	0.8187024541074606	159	TCGA-98-A538-01	22	35	139	0.4129336819707735	TCGA-98-A538-01	17	6	13	36	PASS	6786	TCGA-98-A538	LUSC	67	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-24698	Alive	TUMOR FREE	826	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	826	0	826	0	826	0	826	
60	TCGA-98-A539	0	10	0	10	6	0	1	0	9	137	11	1	2	44	5	1	TCGA-98-A539-01	99	0.4312080285128333	43	TCGA-98-A539-01	20	25	47	0.2252544811951672	TCGA-98-A539-01	11	5	8	24	PASS	6787	TCGA-98-A539	LUSC	63	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-23098	Alive	WITH TUMOR	173	NA	NA	Locoregional Recurrence	NA	NA	173	NA	NA	NA	0	173	0	173	NA	NA	1	173	
70	TCGA-98-A53A	2	20	1	8	26	3	7	0	17	240	12	1	4	78	14	1	TCGA-98-A53A-01	293	0.9468738475989198	170	TCGA-98-A53A-01	14	15	160	0.3644076379151127	TCGA-98-A53A-01	15	13	16	44	PASS	6788	TCGA-98-A53A	LUSC	70	MALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-25662	Dead	NA	NA	552	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	552	NA	552	0	552	0	552	
70	TCGA-98-A53B	0	11	2	6	7	5	0	0	2	117	12	0	4	36	3	0	TCGA-98-A53B-01	246	0.7863174344297063	137	TCGA-98-A53B-01	28	29	174	0.4624600663667029	TCGA-98-A53B-01	21	14	12	47	PASS	6789	TCGA-98-A53B	LUSC	69	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-25390	Dead	TUMOR FREE	NA	61	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	61	0	61	0	61	0	61	
80	TCGA-98-A53C	0	1	1	0	0	0	0	0	0	2	0	0	0	0	0	0	TCGA-98-A53C-01	57	0.0003799182854304341	19	TCGA-98-A53C-01	0	0	7	0.00040553964409384337	TCGA-98-A53C-01	0	0	0	0	PASS	6790	TCGA-98-A53C	LUSC	77	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-28146	Alive	TUMOR FREE	822	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	822	0	822	0	822	0	822	
70	TCGA-98-A53D	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-98-A53D-01	57	2.943947396575443e-05	14	TCGA-98-A53D-01	0	0	4	0.05200012139328245	TCGA-98-A53D-01	0	0	0	0	PASS	6791	TCGA-98-A53D	LUSC	68	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-24891	Dead	WITH TUMOR	NA	645	NA	Locoregional Recurrence	NA	NA	413	Complete Remission/Response	NA	NA	1	645	1	645	1	413	1	413	
80	TCGA-98-A53H	0	2	0	1	0	0	0	0	1	27	0	0	0	5	1	0	TCGA-98-A53H-01	51	3.358458563498933e-05	14	TCGA-98-A53H-01	0	0	9	0.0012022738788347409	TCGA-98-A53H-01	0	0	0	0	PASS	6792	TCGA-98-A53H	LUSC	76	FEMALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-27928	Alive	NA	618	NA	NA	New Primary Tumor	NA	NA	427	Complete Remission/Response	NA	NA	0	618	0	618	0	618	1	427	
60	TCGA-98-A53I	2	34	6	12	10	3	3	0	17	279	22	0	6	105	11	0	TCGA-98-A53I-01	101	0.5652720302470936	40	TCGA-98-A53I-01	11	18	89	0.3681380044793981	TCGA-98-A53I-01	14	7	13	34	PASS	6793	TCGA-98-A53I	LUSC	64	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-23502	Alive	TUMOR FREE	565	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	565	0	565	0	565	0	565	
80	TCGA-98-A53J	0	11	0	4	2	0	0	0	1	85	4	1	3	36	2	0	TCGA-98-A53J-01	93	0.7824501041594316	41	TCGA-98-A53J-01	28	19	76	0.30951345966014904	TCGA-98-A53J-01	10	5	10	25	PASS	6794	TCGA-98-A53J	LUSC	77	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-28485	Alive	TUMOR FREE	630	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	630	0	630	0	630	0	630	
70	TCGA-J1-A4AH	0	6	0	3	2	0	1	0	6	157	9	0	7	44	2	0	TCGA-J1-A4AH-01	292	0.6975773258292288	175	TCGA-J1-A4AH-01	23	36	166	0.3392817212511726	TCGA-J1-A4AH-01	19	13	10	42	PASS	6795	TCGA-J1-A4AH	LUSC	70	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-25893	Alive	TUMOR FREE	581	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	581	0	581	0	581	0	581	
70	TCGA-L3-A4E7	0	5	0	6	2	0	0	0	1	80	3	0	2	28	1	0	TCGA-L3-A4E7-01	86	0.5470272285899569	31	TCGA-L3-A4E7-01	9	12	78	0.29894812290189443	TCGA-L3-A4E7-01	11	7	12	30	PASS	6796	TCGA-L3-A4E7	LUSC	71	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-26232	Alive	TUMOR FREE	392	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	392	0	392	0	392	0	392	
50	TCGA-L3-A524	2	21	1	9	11	0	0	0	8	258	15	0	6	100	13	1	TCGA-L3-A524-01	490	0.7887732168615356	316	TCGA-L3-A524-01	22	36	195	0.2764746152094901	TCGA-L3-A524-01	20	14	9	43	PASS	6797	TCGA-L3-A524	LUSC	45	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-16765	Dead	TUMOR FREE	NA	490	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	490	0	490	0	490	0	490	
70	TCGA-LA-A446	2	10	1	16	9	1	1	1	12	264	12	0	8	84	10	1	TCGA-LA-A446-01	262	0.7077524407990164	162	TCGA-LA-A446-01	16	31	148	0.3808027722584181	TCGA-LA-A446-01	18	17	17	52	PASS	6798	TCGA-LA-A446	LUSC	68	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-25199	Alive	TUMOR FREE	401	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	401	0	401	0	401	0	401	
70	TCGA-LA-A7SW	0	4	0	3	0	0	1	0	3	74	5	0	5	31	2	0	TCGA-LA-A7SW-01	608	0.6030810106373339	396	TCGA-LA-A7SW-01	9	46	301	0.4754906750371122	TCGA-LA-A7SW-01	22	22	20	64	PASS	6799	TCGA-LA-A7SW	LUSC	71	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2013	NA	-26116	Dead	WITH TUMOR	NA	408	NA	Locoregional Recurrence	NA	NA	235	NA	NA	NA	1	408	1	408	NA	NA	1	235	
50	TCGA-MF-A522	1	44	6	30	6	2	2	0	31	415	28	1	5	189	8	0	TCGA-MF-A522-01	198	0.8181143614293086	114	TCGA-MF-A522-01	30	54	99	0.26650861290016004	TCGA-MF-A522-01	25	9	9	43	PASS	6800	TCGA-MF-A522	LUSC	54	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-20051	Dead	WITH TUMOR	NA	360	NA	Distant Metastasis	NA	NA	173	Partial Remission/Response	NA	NA	1	360	1	360	NA	NA	1	173	
80	TCGA-NC-A5HD	4	24	1	14	13	3	0	0	20	364	34	1	12	84	9	1	TCGA-NC-A5HD-01	219	0.8011086396064157	128	TCGA-NC-A5HD-01	22	34	163	0.5179700633544073	TCGA-NC-A5HD-01	19	14	13	46	PASS	6801	TCGA-NC-A5HD	LUSC	79	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-28916	Dead	TUMOR FREE	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	1	2	0	2	NA	NA	0	2	
60	TCGA-NC-A5HE	0	5	0	11	3	0	0	0	6	160	13	0	2	54	4	1	TCGA-NC-A5HE-01	146	0.4225106342308048	72	TCGA-NC-A5HE-01	12	16	119	0.4370167550132661	TCGA-NC-A5HE-01	11	9	17	37	PASS	6802	TCGA-NC-A5HE	LUSC	60	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-22179	Alive	TUMOR FREE	2336	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2336	0	2336	0	2336	0	2336	
70	TCGA-NC-A5HF	1	16	1	7	9	4	0	0	10	190	15	0	0	72	3	1	TCGA-NC-A5HF-01	201	0.927155463831418	121	TCGA-NC-A5HF-01	12	14	118	0.35830665013293617	TCGA-NC-A5HF-01	12	5	10	27	PASS	6803	TCGA-NC-A5HF	LUSC	74	MALE	WHITE	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-27038	Dead	WITH TUMOR	NA	138	NA	Distant Metastasis	NA	NA	132	Progressive Disease	NA	NA	1	138	1	138	NA	NA	1	132	
60	TCGA-NC-A5HG	4	39	3	11	6	1	0	1	26	456	37	2	11	192	12	1	TCGA-NC-A5HG-01	212	0.9174677654610968	118	TCGA-NC-A5HG-01	19	27	127	0.4048462481413701	TCGA-NC-A5HG-01	17	8	13	38	PASS	6804	TCGA-NC-A5HG	LUSC	59	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-21608	Alive	TUMOR FREE	1963	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1963	0	1963	0	1963	0	1963	
50	TCGA-NC-A5HH	1	19	4	10	7	2	0	0	6	273	19	1	8	95	10	0	TCGA-NC-A5HH-01	208	0.9997897829873156	119	TCGA-NC-A5HH-01	8	33	186	0.6708769323680179	TCGA-NC-A5HH-01	22	16	21	59	PASS	6805	TCGA-NC-A5HH	LUSC	53	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-19485	Alive	TUMOR FREE	37	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	37	0	37	0	37	0	37	
70	TCGA-NC-A5HI	3	21	0	18	9	6	1	0	10	315	33	1	13	122	11	1	TCGA-NC-A5HI-01	153	0.6899069845690499	85	TCGA-NC-A5HI-01	12	15	109	0.3916088807468162	TCGA-NC-A5HI-01	15	9	16	40	PASS	6806	TCGA-NC-A5HI	LUSC	68	FEMALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-24981	Alive	TUMOR FREE	1743	NA	NA	New Primary Tumor	NA	NA	70	Complete Remission/Response	NA	NA	0	1743	0	1743	0	1743	1	70	
60	TCGA-NC-A5HJ	5	12	1	13	7	3	0	0	6	327	13	1	8	109	10	2	TCGA-NC-A5HJ-01	102	0.3157562681907105	39	TCGA-NC-A5HJ-01	17	35	75	0.36543766685382	TCGA-NC-A5HJ-01	24	24	14	62	PASS	6807	TCGA-NC-A5HJ	LUSC	59	MALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2009	NA	-21730	Dead	WITH TUMOR	NA	418	NA	New Primary Tumor	NA	NA	328	Complete Remission/Response	NA	NA	1	418	1	418	0	418	1	328	
60	TCGA-NC-A5HK	3	16	1	12	4	2	1	0	3	220	16	0	10	56	7	1	TCGA-NC-A5HK-01	246	0.7524388154029671	141	TCGA-NC-A5HK-01	15	34	170	0.5288648691448187	TCGA-NC-A5HK-01	21	18	19	58	PASS	6808	TCGA-NC-A5HK	LUSC	58	FEMALE	WHITE	Stage IIB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-21531	Alive	TUMOR FREE	128	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	128	0	128	0	128	0	128	
70	TCGA-NC-A5HL	0	13	1	5	3	1	1	0	11	160	7	0	9	63	3	0	TCGA-NC-A5HL-01	331	0.8313831745444269	193	TCGA-NC-A5HL-01	16	42	206	0.5478195686624989	TCGA-NC-A5HL-01	27	20	20	67	PASS	6809	TCGA-NC-A5HL	LUSC	73	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-26977	Dead	TUMOR FREE	NA	88	NA	NA	NA	NA	NA	NA	NA	NA	1	88	0	88	NA	NA	0	88	
80	TCGA-NC-A5HM	0	15	2	14	9	1	2	0	9	225	20	1	8	58	6	0	TCGA-NC-A5HM-01	136	0.7888817233813334	65	TCGA-NC-A5HM-01	15	15	94	0.3895460618783885	TCGA-NC-A5HM-01	13	9	13	35	PASS	6810	TCGA-NC-A5HM	LUSC	76	MALE	WHITE	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-27938	Alive	TUMOR FREE	1212	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1212	0	1212	0	1212	0	1212	
80	TCGA-NC-A5HN	2	29	4	17	10	2	4	0	14	452	20	0	11	180	17	0	TCGA-NC-A5HN-01	416	0.7243615389802817	266	TCGA-NC-A5HN-01	14	36	148	0.27902315782577153	TCGA-NC-A5HN-01	24	17	10	51	PASS	6811	TCGA-NC-A5HN	LUSC	77	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2010	NA	-28151	Alive	TUMOR FREE	1499	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1499	0	1499	0	1499	0	1499	
70	TCGA-NC-A5HO	0	16	3	5	7	1	2	1	8	191	21	1	6	53	7	0	TCGA-NC-A5HO-01	120	0.925827368445672	53	TCGA-NC-A5HO-01	13	14	102	0.4248191562359999	TCGA-NC-A5HO-01	15	14	14	43	PASS	6812	TCGA-NC-A5HO	LUSC	70	FEMALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-25694	Alive	TUMOR FREE	1336	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1336	0	1336	0	1336	0	1336	
70	TCGA-NC-A5HP	2	21	3	18	6	3	1	0	22	282	34	0	6	115	9	3	TCGA-NC-A5HP-01	122	0.7193985844472919	53	TCGA-NC-A5HP-01	18	28	66	0.3488527044708588	TCGA-NC-A5HP-01	13	10	9	32	PASS	6813	TCGA-NC-A5HP	LUSC	69	MALE	WHITE	Stage IV	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-25286	Dead	WITH TUMOR	NA	770	NA	Distant Metastasis	NA	NA	317	Progressive Disease	NA	NA	1	770	1	770	NA	NA	1	317	
70	TCGA-NC-A5HQ	0	15	4	7	7	2	2	0	16	264	18	0	11	86	11	0	TCGA-NC-A5HQ-01	177	0.7001157642109705	89	TCGA-NC-A5HQ-01	22	41	108	0.2655110860372531	TCGA-NC-A5HQ-01	15	14	8	37	PASS	6814	TCGA-NC-A5HQ	LUSC	70	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-25781	Dead	NA	NA	448	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	448	NA	448	0	448	0	448	
80	TCGA-NC-A5HR	5	17	1	6	8	2	0	0	7	254	20	2	9	79	12	0	TCGA-NC-A5HR-01	157	0.8417507072932944	79	TCGA-NC-A5HR-01	17	18	139	0.489717334446508	TCGA-NC-A5HR-01	17	5	18	40	PASS	6815	TCGA-NC-A5HR	LUSC	75	FEMALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-27629	Alive	TUMOR FREE	1244	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1244	0	1244	0	1244	0	1244	
70	TCGA-NC-A5HT	1	16	1	6	9	4	1	1	9	261	16	1	6	92	8	0	TCGA-NC-A5HT-01	168	0.40294838395069055	86	TCGA-NC-A5HT-01	12	16	104	0.3476782035477434	TCGA-NC-A5HT-01	20	11	17	48	PASS	6816	TCGA-NC-A5HT	LUSC	69	MALE	WHITE	Stage IIIA	NA	Lung Squamous Cell Carcinoma	NA	2012	NA	-25466	Alive	WITH TUMOR	804	NA	NA	Locoregional Recurrence	NA	NA	203	Complete Remission/Response	NA	NA	0	804	0	804	1	203	1	203	
80	TCGA-NK-A5CR	0	16	5	9	7	5	2	0	10	237	11	1	5	79	11	0	TCGA-NK-A5CR-01	146	0.8018868560312641	82	TCGA-NK-A5CR-01	15	25	92	0.30798219134908805	TCGA-NK-A5CR-01	21	13	10	44	PASS	6817	TCGA-NK-A5CR	LUSC	77	MALE	[Unknown]	Stage IB	NA	Lung Squamous Cell Carcinoma	NA	2007	NA	-28126	Alive	TUMOR FREE	2542	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	2542	0	2542	NA	NA	0	2542	
70	TCGA-NK-A5CT	4	13	0	4	9	2	0	0	9	258	17	0	5	95	2	1	TCGA-NK-A5CT-01	116	0.917036701036803	53	TCGA-NK-A5CT-01	18	14	88	0.40724415977130396	TCGA-NK-A5CT-01	7	2	8	17	PASS	6818	TCGA-NK-A5CT	LUSC	70	MALE	WHITE	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2008	NA	-25726	Alive	WITH TUMOR	1997	NA	NA	Locoregional Recurrence	NA	NA	1990	Stable Disease	NA	NA	0	1997	0	1997	NA	NA	1	1990	
70	TCGA-NK-A5CX	1	10	0	10	6	0	0	0	2	130	9	0	3	44	6	2	TCGA-NK-A5CX-01	80	0.5202787563503061	30	TCGA-NK-A5CX-01	22	59	2	1.5516399697233453e-05	TCGA-NK-A5CX-01	6	6	0	12	PASS	6819	TCGA-NK-A5CX	LUSC	73	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-26879	Alive	TUMOR FREE	111	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	111	0	111	NA	NA	0	111	
60	TCGA-NK-A5D1	1	5	0	3	3	0	0	0	1	95	8	0	1	46	1	0	TCGA-NK-A5D1	0	0	0	TCGA-NK-A5D1	0	0	0	0	TCGA-NK-A5D1-01	16	9	8	33	PASS	6820	TCGA-NK-A5D1	LUSC	57	MALE	WHITE	Stage IIA	NA	Lung Squamous Cell Carcinoma	NA	2011	NA	-20909	Alive	WITH TUMOR	511	NA	NA	Distant Metastasis	NA	NA	151	Progressive Disease	NA	NA	0	511	0	511	NA	NA	1	151	
70	TCGA-NK-A7XE	0	9	0	2	0	0	2	0	8	84	4	0	0	23	2	0	TCGA-NK-A7XE-01	187	0.9273684891510978	108	TCGA-NK-A7XE-01	13	23	223	0.6666518842446243	TCGA-NK-A7XE-01	20	11	12	43	PASS	6821	TCGA-NK-A7XE	LUSC	66	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Lung Squamous Cell Carcinoma	NA	2013	NA	-24319	Alive	TUMOR FREE	13	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	13	0	13	NA	NA	0	13	
80	TCGA-O2-A52N	3	30	4	16	13	3	0	0	10	387	29	0	11	130	15	1	TCGA-O2-A52N-01	343	0.7574102375085454	201	TCGA-O2-A52N-01	21	78	190	0.3927443079228056	TCGA-O2-A52N-01	23	14	15	52	PASS	6822	TCGA-O2-A52N	LUSC	78	MALE	WHITE	Stage I	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-28520	Dead	TUMOR FREE	NA	1006	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	1006	0	1006	NA	NA	0	1006	
40	TCGA-O2-A52Q	2	36	4	34	16	9	2	0	36	755	65	0	17	254	28	0	TCGA-O2-A52Q-01	151	0.5141242183884487	85	TCGA-O2-A52Q-01	17	35	129	0.33928911104909165	TCGA-O2-A52Q-01	15	13	12	40	hypermutated sample	6823	TCGA-O2-A52Q	LUSC	44	FEMALE	WHITE	Stage III	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-16429	Dead	WITH TUMOR	NA	113	NA	Distant Metastasis	NA	NA	87	[Unknown]	NA	NA	1	113	1	113	NA	NA	1	87	
60	TCGA-O2-A52S	1	27	3	11	9	2	1	0	21	275	31	0	7	90	8	1	TCGA-O2-A52S-01	281	0.9097861053349358	183	TCGA-O2-A52S-01	14	17	173	0.4394739923670933	TCGA-O2-A52S-01	11	10	18	39	PASS	6824	TCGA-O2-A52S	LUSC	57	FEMALE	WHITE	Stage III	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-21182	Dead	WITH TUMOR	NA	387	NA	Distant Metastasis	NA	NA	246	[Unknown]	NA	NA	1	387	1	387	NA	NA	1	246	
80	TCGA-O2-A52V	2	20	1	14	5	1	1	0	6	193	11	2	4	78	5	1	TCGA-O2-A52V-01	145	0.4885444282971316	80	TCGA-O2-A52V-01	12	10	103	0.3310416115021248	TCGA-O2-A52V-01	9	6	11	26	PASS	6825	TCGA-O2-A52V	LUSC	75	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-27449	Dead	TUMOR FREE	NA	1335	NA	Distant Metastasis	NA	NA	690	[Unknown]	NA	NA	1	1335	0	1335	NA	NA	1	690	
60	TCGA-O2-A52W	2	3	2	7	11	0	13	0	5	70	7	0	0	36	6	0	TCGA-O2-A52W-01	84	0.7537071743381272	30	TCGA-O2-A52W-01	28	21	56	0.34240296192078146	TCGA-O2-A52W-01	11	3	7	21	PASS	6826	TCGA-O2-A52W	LUSC	63	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Lung Squamous Cell Carcinoma	NA	2006	NA	-23156	Dead	TUMOR FREE	NA	261	NA	NA	NA	NA	NA	NA	NA	NA	1	261	0	261	NA	NA	0	261	
70	TCGA-O2-A5IB	2	12	0	9	8	3	0	0	6	186	11	0	6	71	13	2	TCGA-O2-A5IB-01	157	0.9901497358607052	83	TCGA-O2-A5IB-01	9	12	79	0.3001730119348538	TCGA-O2-A5IB-01	14	15	15	44	PASS	6827	TCGA-O2-A5IB	LUSC	71	FEMALE	WHITE	Stage III	NA	Lung Squamous Cell Carcinoma	NA	2005	NA	-26211	Dead	WITH TUMOR	NA	340	NA	Distant Metastasis	NA	NA	253	[Unknown]	NA	NA	1	340	1	340	NA	NA	1	253	
80	TCGA-XC-AA0X	1	9	0	3	4	1	1	0	6	141	12	0	4	53	2	1	TCGA-XC-AA0X-01	158	0.30627586927640743	82	TCGA-XC-AA0X-01	19	35	104	0.3017692816073521	TCGA-XC-AA0X-01	23	17	15	55	PASS	6828	TCGA-XC-AA0X	LUSC	77	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	Lung Squamous Cell Carcinoma	NA	2013	NA	-28211	Dead	TUMOR FREE	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	1	6	0	6	NA	NA	0	6	
60	TCGA-3H-AB3K	0	1	0	0	1	0	0	0	1	14	1	0	0	4	0	0	TCGA-3H-AB3K-01	71	0.09674721864692416	24	TCGA-3H-AB3K-01	4	5	40	0.11576330609762756	TCGA-3H-AB3K-01	6	3	5	14	PASS	6829	TCGA-3H-AB3K	MESO	64	MALE	WHITE	Stage II	NA	Diffuse malignant mesothelioma - NOS	NA	2008	NA	-23591	Dead	WITH TUMOR	NA	1715	NA	Distant Metastasis	Contralateral Pleura	NA	841	NA	NA	NA	1	1715	1	1715	NA	NA	1	841	
60	TCGA-3H-AB3L	0	1	0	2	2	0	1	0	5	13	0	0	0	10	4	0	TCGA-3H-AB3L-01	111	0.8830607016547286	53	TCGA-3H-AB3L-01	11	11	80	0.3348661932376293	TCGA-3H-AB3L-01	14	5	13	32	PASS	6830	TCGA-3H-AB3L	MESO	60	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2008	NA	-21972	Dead	WITH TUMOR	NA	361	NA	Intrapleural Progression	Ipsilateral Pleura	NA	222	NA	NA	NA	1	361	1	361	NA	NA	1	222	
50	TCGA-3H-AB3M	0	4	2	2	1	0	0	0	2	25	1	0	0	22	0	0	TCGA-3H-AB3M-01	329	0.9225465897620988	237	TCGA-3H-AB3M-01	6	10	182	0.32117221685928243	TCGA-3H-AB3M-01	8	14	16	38	PASS	6831	TCGA-3H-AB3M	MESO	53	FEMALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2008	NA	-19503	Dead	WITH TUMOR	NA	885	NA	Distant Metastasis	Lung	NA	107	NA	NA	NA	1	885	1	885	NA	NA	1	107	
60	TCGA-3H-AB3O	0	0	0	0	0	0	0	0	1	1	0	0	0	2	0	0	TCGA-3H-AB3O-01	61	2.783758882768693e-05	17	TCGA-3H-AB3O	0	0	0	0	TCGA-3H-AB3O	0	0	0	0	PASS	6832	TCGA-3H-AB3O	MESO	58	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2008	NA	-21423	Dead	WITH TUMOR	NA	1302	NA	Intrapleural Progression	Ipsilateral Pleura	NA	627	NA	NA	NA	1	1302	1	1302	NA	NA	1	627	
70	TCGA-3H-AB3S	0	6	3	7	1	1	0	0	1	34	3	0	1	20	3	0	TCGA-3H-AB3S-01	182	0.11645633425968012	123	TCGA-3H-AB3S-01	3	4	68	0.09638975778085478	TCGA-3H-AB3S-01	2	6	4	12	PASS	6833	TCGA-3H-AB3S	MESO	69	MALE	WHITE	Stage II	NA	Epithelioid mesothelioma	NA	2009	NA	-25471	Dead	WITH TUMOR	NA	385	NA	Locoregional Recurrence	"Other, specify"	Ipsilateral Chest Cavity AND Ipsilateral Lymph Nodes AND Ipsilateral Chest Wall	186	NA	NA	[Unknown]	1	385	1	385	NA	NA	1	186	
80	TCGA-3H-AB3T	1	2	0	0	3	0	1	0	1	27	1	0	0	13	0	0	TCGA-3H-AB3T-01	91	0.2902560022663682	35	TCGA-3H-AB3T-01	9	13	101	0.3420877653076003	TCGA-3H-AB3T-01	4	7	8	19	PASS	6834	TCGA-3H-AB3T	MESO	79	MALE	WHITE	Stage I	NA	Biphasic mesothelioma	NA	2009	NA	-28925	Dead	WITH TUMOR	NA	414	NA	Intrapleural Progression	"Other, specify"	Ipsilateral Chest Cavity AND Ipsilateral Lymph Nodes AND Ipsilateral Chest Wall	312	NA	NA	NA	1	414	1	414	NA	NA	1	312	
70	TCGA-3H-AB3U	0	0	0	2	3	0	0	0	0	21	2	0	0	7	0	0	TCGA-3H-AB3U-01	149	0.9470856805738678	100	TCGA-3H-AB3U-01	19	36	33	0.02018570680430334	TCGA-3H-AB3U-01	3	3	1	7	PASS	6835	TCGA-3H-AB3U	MESO	71	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2009	NA	-26220	Dead	WITH TUMOR	NA	826	NA	Intrapleural Progression	Ipsilateral Pleura	NA	108	NA	NA	[Unknown]	1	826	1	826	NA	NA	1	108	
60	TCGA-3H-AB3X	0	0	0	2	2	0	0	0	1	16	2	0	1	5	1	0	TCGA-3H-AB3X-01	103	0.2972055744689852	38	TCGA-3H-AB3X-01	6	9	59	0.14584505487997762	TCGA-3H-AB3X-01	11	5	8	24	PASS	6836	TCGA-3H-AB3X	MESO	62	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2010	NA	-22702	Alive	TUMOR FREE	1490	NA	NA	NA	NA	NA	NA	NA	NA	[Unknown]	0	1490	0	1490	NA	NA	0	1490	
80	TCGA-3U-A98D	1	3	0	3	2	0	2	0	1	22	2	0	1	12	2	0	TCGA-3U-A98D-01	307	0.8709630844203695	228	TCGA-3U-A98D-01	11	11	185	0.3770172110022799	TCGA-3U-A98D-01	8	12	14	34	PASS	6837	TCGA-3U-A98D	MESO	80	MALE	WHITE	Stage III	NA	Biphasic mesothelioma	NA	2012	NA	-29500	Dead	NA	NA	142	NA	Locoregional Recurrence	Ipsilateral Chest Wall	NA	125	NA	NA	NA	1	142	NA	142	NA	NA	1	125	
70	TCGA-3U-A98E	0	4	1	0	2	0	0	0	2	25	3	0	2	8	1	0	TCGA-3U-A98E-01	84	0.11273118604849555	44	TCGA-3U-A98E-01	4	4	44	0.08602849747394141	TCGA-3U-A98E-01	2	4	2	8	PASS	6838	TCGA-3U-A98E	MESO	71	FEMALE	WHITE	Stage IV	NA	Epithelioid mesothelioma	NA	2010	NA	-26264	Alive	WITH TUMOR	1916	NA	NA	Intrapleural Progression	NA	NA	1257	NA	NA	NA	0	1916	0	1916	NA	NA	1	1257	
70	TCGA-3U-A98F	0	3	1	3	3	1	0	0	1	25	2	0	0	16	1	0	TCGA-3U-A98F-01	187	0.7757294617079491	119	TCGA-3U-A98F-01	28	12	104	0.2240985306613027	TCGA-3U-A98F-01	4	2	2	8	PASS	6839	TCGA-3U-A98F	MESO	73	MALE	WHITE	Stage III	NA	Biphasic mesothelioma	NA	2012	NA	-26926	Dead	WITH TUMOR	NA	536	NA	Intrapleural Progression	NA	NA	365	NA	NA	NA	1	536	1	536	NA	NA	1	365	
70	TCGA-3U-A98G	0	0	0	2	0	0	0	0	0	3	0	0	0	0	0	0	TCGA-3U-A98G-01	47	4.954741593719383e-05	13	TCGA-3U-A98G-01	0	0	4	0.0009747326845806187	TCGA-3U-A98G-01	0	0	0	0	PASS	6840	TCGA-3U-A98G	MESO	71	MALE	WHITE	Stage IV	NA	Biphasic mesothelioma	NA	2012	NA	-26185	Dead	WITH TUMOR	NA	630	NA	Intrapleural Progression	NA	NA	497	NA	NA	R0	1	630	1	630	NA	NA	1	497	
60	TCGA-3U-A98H	2	1	1	0	2	2	0	0	0	5	2	1	0	6	2	0	TCGA-3U-A98H-01	73	0.08628357381626017	24	TCGA-3U-A98H-01	3	2	28	0.03731327117509348	TCGA-3U-A98H-01	0	3	1	4	PASS	6841	TCGA-3U-A98H	MESO	57	MALE	WHITE	Stage IV	NA	Biphasic mesothelioma	NA	2010	NA	-21034	Dead	WITH TUMOR	NA	1156	NA	Intrapleural Progression	NA	NA	798	NA	NA	NA	1	1156	1	1156	NA	NA	1	798	
70	TCGA-3U-A98I	1	1	0	0	2	0	0	0	2	32	4	0	0	14	0	0	TCGA-3U-A98I-01	164	0.7425922072497348	102	TCGA-3U-A98I-01	9	10	115	0.2745388754254524	TCGA-3U-A98I-01	9	7	7	23	PASS	6842	TCGA-3U-A98I	MESO	68	MALE	WHITE	Stage IV	NA	Biphasic mesothelioma	NA	2013	NA	-25108	Dead	WITH TUMOR	NA	860	NA	Intrapleural Progression	NA	NA	404	NA	NA	NA	1	860	1	860	NA	NA	1	404	
60	TCGA-3U-A98J	0	0	2	1	1	0	0	0	2	20	0	0	2	6	0	0	TCGA-3U-A98J-01	94	0.21860105779950748	43	TCGA-3U-A98J-01	7	7	40	0.12522128333597027	TCGA-3U-A98J-01	4	4	5	13	PASS	6843	TCGA-3U-A98J	MESO	55	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2012	NA	-20338	Dead	WITH TUMOR	NA	741	NA	NA	NA	NA	NA	NA	NA	NA	1	741	1	741	NA	NA	1	741	
60	TCGA-LK-A4NW	0	2	1	1	0	0	1	0	3	18	4	0	0	9	2	0	TCGA-LK-A4NW-01	107	0.2757899847274518	47	TCGA-LK-A4NW-01	11	14	78	0.2671183198981004	TCGA-LK-A4NW-01	8	7	6	21	PASS	6844	TCGA-LK-A4NW	MESO	60	MALE	WHITE	Stage IV	NA	Diffuse malignant mesothelioma - NOS	NA	2007	NA	-21922	Dead	WITH TUMOR	NA	546	NA	NA	NA	NA	NA	NA	NA	RX	1	546	1	546	NA	NA	1	546	
70	TCGA-LK-A4NY	0	3	0	4	2	0	0	0	1	42	2	0	0	11	2	0	TCGA-LK-A4NY-01	141	0.2968599020322361	66	TCGA-LK-A4NY-01	2	8	59	0.15426192507092715	TCGA-LK-A4NY-01	11	15	11	37	PASS	6845	TCGA-LK-A4NY	MESO	66	FEMALE	WHITE	Stage III	NA	Biphasic mesothelioma	NA	2009	NA	-24391	Dead	TUMOR FREE	NA	168	NA	NA	NA	NA	NA	NA	NA	R0	1	168	0	168	0	168	0	168	
80	TCGA-LK-A4NZ	0	4	0	0	0	2	0	0	1	23	2	0	2	7	0	0	TCGA-LK-A4NZ-01	123	0.10330554898921344	69	TCGA-LK-A4NZ-01	4	3	44	0.06989635695735966	TCGA-LK-A4NZ-01	1	8	4	13	PASS	6846	TCGA-LK-A4NZ	MESO	75	MALE	WHITE	Stage II	NA	Epithelioid mesothelioma	NA	2009	NA	-27720	Dead	WITH TUMOR	NA	244	NA	NA	NA	NA	NA	NA	NA	R2	1	244	1	244	NA	NA	1	244	
80	TCGA-LK-A4O0	0	3	0	0	0	0	0	0	5	28	2	0	3	15	0	0	TCGA-LK-A4O0-01	177	0.9184689044118528	112	TCGA-LK-A4O0-01	17	11	172	0.5120460577447864	TCGA-LK-A4O0-01	8	18	19	45	PASS	6847	TCGA-LK-A4O0	MESO	81	MALE	WHITE	Stage IA	NA	Sarcomatoid mesothelioma	NA	2009	NA	-29798	Dead	TUMOR FREE	NA	185	NA	NA	NA	NA	NA	NA	NA	R0	1	185	0	185	0	185	0	185	
60	TCGA-LK-A4O2	0	0	0	2	1	1	0	0	2	20	2	0	0	10	2	0	TCGA-LK-A4O2-01	213	0.40810666222954173	142	TCGA-LK-A4O2-01	10	11	118	0.2887285231485032	TCGA-LK-A4O2-01	8	9	9	26	PASS	6848	TCGA-LK-A4O2	MESO	56	FEMALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2011	NA	-20757	Dead	WITH TUMOR	NA	57	NA	NA	NA	NA	NA	NA	NA	R2	1	57	1	57	NA	NA	1	57	
70	TCGA-LK-A4O4	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	TCGA-LK-A4O4-01	37	1.675460950192907e-05	7	TCGA-LK-A4O4-01	0	0	5	0.0005398814173232519	TCGA-LK-A4O4-01	0	0	0	0	mutation call filter	6849	TCGA-LK-A4O4	MESO	69	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2008	NA	-25298	Dead	TUMOR FREE	NA	949	NA	NA	NA	NA	NA	NA	NA	R0	1	949	0	949	0	949	0	949	
70	TCGA-LK-A4O5	1	3	0	2	2	0	0	0	2	31	2	0	2	15	1	0	TCGA-LK-A4O5-01	146	0.2812937234643503	81	TCGA-LK-A4O5-01	3	4	72	0.11321707210105016	TCGA-LK-A4O5-01	2	7	5	14	PASS	6850	TCGA-LK-A4O5	MESO	68	FEMALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2011	NA	-25000	Dead	WITH TUMOR	NA	387	NA	NA	NA	NA	NA	NA	NA	R1	1	387	1	387	NA	NA	1	387	
70	TCGA-LK-A4O6	0	0	1	2	2	0	0	0	3	22	2	0	0	4	2	0	TCGA-LK-A4O6-01	51	0.2788518017180145	15	TCGA-LK-A4O6-01	9	7	39	0.19701877610653692	TCGA-LK-A4O6-01	4	4	4	12	PASS	6851	TCGA-LK-A4O6	MESO	66	FEMALE	WHITE	Stage III	NA	Biphasic mesothelioma	NA	2012	NA	-24449	Dead	WITH TUMOR	NA	448	NA	NA	NA	NA	NA	NA	NA	RX	1	448	1	448	NA	NA	1	448	
60	TCGA-LK-A4O7	0	3	0	7	2	0	1	0	1	28	4	0	0	9	0	0	TCGA-LK-A4O7-01	158	0.9475114420367544	100	TCGA-LK-A4O7-01	10	9	123	0.3453152475723532	TCGA-LK-A4O7-01	7	11	5	23	PASS	6852	TCGA-LK-A4O7	MESO	64	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2012	NA	-23606	Dead	WITH TUMOR	NA	350	NA	NA	NA	NA	NA	NA	NA	R0	1	350	1	350	NA	NA	1	350	
60	TCGA-MQ-A4KX	0	0	0	1	0	0	0	0	1	15	1	0	0	9	2	0	TCGA-MQ-A4KX-01	50	0.12708711407973433	14	TCGA-MQ-A4KX-01	3	4	23	0.08702567501623591	TCGA-MQ-A4KX-01	3	5	4	12	PASS	6853	TCGA-MQ-A4KX	MESO	55	MALE	WHITE	Stage I	NA	Epithelioid mesothelioma	NA	2002	NA	-20336	Dead	NA	NA	2459	NA	Distant Metastasis	"Other, specify"	IPSILATERAL CHEST	471	NA	NA	R0	1	2459	NA	2459	1	471	1	471	
50	TCGA-MQ-A4LC	0	1	0	2	0	0	1	0	0	18	3	0	0	5	0	0	TCGA-MQ-A4LC-01	92	0.10176224171555412	37	TCGA-MQ-A4LC-01	2	5	34	0.09578807830980304	TCGA-MQ-A4LC-01	3	8	5	16	PASS	6854	TCGA-MQ-A4LC	MESO	54	MALE	WHITE	Stage II	NA	Epithelioid mesothelioma	NA	2001	NA	-19866	Dead	TUMOR FREE	NA	2790	NA	Locoregional Recurrence	Ipsilateral Chest Cavity	NA	1908	NA	NA	R0	1	2790	0	2790	1	1908	1	1908	
60	TCGA-MQ-A4LI	0	2	1	4	1	0	0	0	1	28	3	0	0	7	1	0	TCGA-MQ-A4LI-01	96	0.7931364274480407	47	TCGA-MQ-A4LI-01	12	10	90	0.2985628711844716	TCGA-MQ-A4LI-01	5	2	7	14	PASS	6855	TCGA-MQ-A4LI	MESO	60	FEMALE	WHITE	Stage II	NA	Epithelioid mesothelioma	NA	1999	NA	-21951	Dead	WITH TUMOR	NA	572	NA	Distant Metastasis	"Other, specify"	Chest	416	NA	NA	R1	1	572	1	572	NA	NA	1	416	
50	TCGA-MQ-A4LJ	0	0	1	2	2	0	0	0	1	13	2	0	1	8	0	0	TCGA-MQ-A4LJ-01	147	0.1855452392301489	93	TCGA-MQ-A4LJ-01	5	7	76	0.13700364505242893	TCGA-MQ-A4LJ-01	3	7	4	14	PASS	6856	TCGA-MQ-A4LJ	MESO	53	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	1999	NA	-19437	Dead	NA	NA	709	NA	Intrapleural Progression	"Other, specify"	Ipsilateral chest	409	NA	NA	[Unknown]	1	709	NA	709	NA	NA	1	409	
70	TCGA-MQ-A4LM	0	4	0	1	2	1	0	0	1	26	2	0	0	14	2	0	TCGA-MQ-A4LM-01	86	0.34876328098961223	35	TCGA-MQ-A4LM-01	9	9	73	0.32339831082634457	TCGA-MQ-A4LM-01	7	9	8	24	PASS	6857	TCGA-MQ-A4LM	MESO	67	MALE	WHITE	Stage III	NA	Biphasic mesothelioma	NA	2002	NA	-24704	Dead	NA	NA	158	NA	Intrapleural Progression	"Other, specify"	CONTRALATERAL EFFUSION	113	NA	NA	[Unknown]	1	158	NA	158	NA	NA	1	113	
70	TCGA-MQ-A4LP	0	2	0	3	2	0	1	0	4	36	4	0	1	15	0	0	TCGA-MQ-A4LP-01	173	0.9326061310268644	103	TCGA-MQ-A4LP-01	8	11	125	0.2852718388962713	TCGA-MQ-A4LP-01	6	8	7	21	PASS	6858	TCGA-MQ-A4LP	MESO	67	MALE	WHITE	Stage III	NA	Biphasic mesothelioma	NA	2000	NA	-24652	Dead	NA	NA	527	NA	NA	NA	NA	NA	NA	NA	[Unknown]	1	527	NA	527	NA	NA	0	527	
60	TCGA-MQ-A4LV	0	3	0	0	0	0	0	0	3	39	2	0	0	7	2	0	TCGA-MQ-A4LV-01	187	0.22355457868810955	118	TCGA-MQ-A4LV-01	3	6	100	0.18659576997424612	TCGA-MQ-A4LV-01	5	9	11	25	PASS	6859	TCGA-MQ-A4LV	MESO	63	MALE	WHITE	Stage III	NA	Biphasic mesothelioma	NA	2002	NA	-23110	Dead	TUMOR FREE	NA	107	NA	Intrapleural Progression	Ipsilateral Pleura	NA	99	NA	NA	R0	1	107	0	107	1	99	1	99	
80	TCGA-MQ-A6BL	2	1	0	2	3	1	0	0	3	30	4	0	1	14	0	1	TCGA-MQ-A6BL-01	93	0.2444131147698715	36	TCGA-MQ-A6BL-01	6	9	75	0.2705703116355657	TCGA-MQ-A6BL-01	5	5	5	15	PASS	6860	TCGA-MQ-A6BL	MESO	78	MALE	WHITE	Stage II	NA	Biphasic mesothelioma	NA	2007	NA	-28590	Dead	NA	NA	333	NA	Distant Metastasis	"Other, specify"	Bone (Scapula)	186	NA	NA	[Unknown]	1	333	NA	333	NA	NA	1	186	
70	TCGA-MQ-A6BN	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-MQ-A6BN-01	104	0.07671482756578768	48	TCGA-MQ-A6BN	0	0	0	0	TCGA-MQ-A6BN	0	0	0	0	PASS	6861	TCGA-MQ-A6BN	MESO	73	FEMALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2007	NA	-26790	Dead	TUMOR FREE	NA	757	NA	Distant Metastasis	"Other, specify"	Chest Wall	485	NA	NA	R0	1	757	0	757	1	485	1	485	
60	TCGA-MQ-A6BQ	0	2	0	1	1	1	0	0	2	19	1	0	0	2	1	0	TCGA-MQ-A6BQ-01	58	0.10407412377442156	14	TCGA-MQ-A6BQ-01	5	6	25	0.0978441172052738	TCGA-MQ-A6BQ-01	6	3	5	14	PASS	6862	TCGA-MQ-A6BQ	MESO	58	MALE	WHITE	Stage II	NA	Epithelioid mesothelioma	NA	2009	NA	-21236	Alive	WITH TUMOR	2359	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	2359	0	2359	NA	NA	0	2359	
60	TCGA-MQ-A6BR	1	0	0	1	3	0	0	0	0	9	1	0	1	4	0	0	TCGA-MQ-A6BR-01	60	0.16044024197376555	18	TCGA-MQ-A6BR-01	5	24	226	0.9352426297514342	TCGA-MQ-A6BR-01	2	1	0	3	PASS	6863	TCGA-MQ-A6BR	MESO	55	FEMALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2008	NA	-20134	Alive	WITH TUMOR	2090	NA	NA	Distant Metastasis	"Other, specify"	Chest Wall	665	NA	NA	RX	0	2090	0	2090	NA	NA	1	665	
60	TCGA-MQ-A6BS	0	1	1	1	1	1	0	0	1	31	2	0	1	13	0	1	TCGA-MQ-A6BS-01	164	0.9193592071036482	95	TCGA-MQ-A6BS-01	21	37	77	0.14515860551850435	TCGA-MQ-A6BS-01	11	13	6	30	PASS	6864	TCGA-MQ-A6BS	MESO	55	MALE	WHITE	Stage II	NA	Epithelioid mesothelioma	NA	2012	NA	-20384	Dead	TUMOR FREE	NA	608	NA	NA	NA	NA	NA	NA	NA	R0	1	608	0	608	0	608	0	608	
70	TCGA-NQ-A57I	0	4	1	2	3	0	1	0	2	33	1	0	6	14	0	0	TCGA-NQ-A57I-01	110	0.5278556021193413	55	TCGA-NQ-A57I-01	17	25	106	0.38499491996583335	TCGA-NQ-A57I-01	7	5	5	17	PASS	6865	TCGA-NQ-A57I	MESO	71	MALE	WHITE	Stage IB	NA	Biphasic mesothelioma	NA	2012	NA	-26212	Dead	WITH TUMOR	NA	20	NA	NA	NA	NA	NA	NA	NA	R2	1	20	1	20	NA	NA	1	20	
70	TCGA-NQ-A638	0	4	1	2	1	1	1	0	3	32	4	0	1	18	1	0	TCGA-NQ-A638-01	147	0.4036336713343146	84	TCGA-NQ-A638-01	15	26	76	0.13914863814410214	TCGA-NQ-A638-01	9	12	8	29	PASS	6866	TCGA-NQ-A638	MESO	66	MALE	WHITE	Stage II	NA	Epithelioid mesothelioma	NA	2012	NA	-24410	Alive	TUMOR FREE	-8	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	0	0	0	0	0	0	0	
60	TCGA-SC-A6LM	0	2	0	4	0	0	0	0	1	27	3	0	0	8	0	0	TCGA-SC-A6LM-01	175	0.17365057200677486	103	TCGA-SC-A6LM-01	3	5	95	0.15751102748650853	TCGA-SC-A6LM-01	7	9	5	21	PASS	6867	TCGA-SC-A6LM	MESO	64	FEMALE	WHITE	Stage IV	NA	Epithelioid mesothelioma	NA	2010	NA	-23400	Dead	WITH TUMOR	NA	881	NA	Locoregional Recurrence	"Other, specify"	Ipsilateral Chest Cavity AND Other	363	NA	NA	R2	1	881	1	881	NA	NA	1	363	
80	TCGA-SC-A6LN	0	1	0	2	3	0	2	0	1	18	2	0	2	15	0	0	TCGA-SC-A6LN-01	143	0.9471254379267012	77	TCGA-SC-A6LN-01	9	12	102	0.3517648311192809	TCGA-SC-A6LN-01	6	5	10	21	PASS	6868	TCGA-SC-A6LN	MESO	76	MALE	ASIAN	Stage III	NA	Biphasic mesothelioma	NA	2012	NA	-27917	Dead	TUMOR FREE	NA	414	NA	NA	NA	NA	NA	NA	NA	R0	1	414	0	414	0	414	0	414	
60	TCGA-SC-A6LP	0	2	0	4	0	1	0	0	3	10	2	0	0	4	3	0	TCGA-SC-A6LP-01	54	0.06224232729153336	12	TCGA-SC-A6LP-01	3	23	151	0.8787788382479911	TCGA-SC-A6LP-01	2	5	2	9	PASS	6869	TCGA-SC-A6LP	MESO	58	MALE	WHITE	Stage II	NA	Biphasic mesothelioma	NA	2012	NA	-21411	Dead	WITH TUMOR	NA	78	NA	NA	NA	NA	NA	NA	NA	RX	1	78	1	78	NA	NA	1	78	
60	TCGA-SC-A6LQ	0	2	0	5	1	0	1	0	2	25	2	0	0	6	1	0	TCGA-SC-A6LQ-01	76	0.24389219613022656	30	TCGA-SC-A6LQ-01	4	5	46	0.1001857714649481	TCGA-SC-A6LQ-01	5	3	7	15	PASS	6870	TCGA-SC-A6LQ	MESO	60	FEMALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2012	NA	-22014	Dead	WITH TUMOR	NA	297	NA	Distant Metastasis	Abdomen	NA	238	NA	NA	R0	1	297	1	297	1	238	1	238	
70	TCGA-SC-A6LR	1	3	2	1	2	0	1	0	1	35	1	0	1	12	1	0	TCGA-SC-A6LR-01	73	0.9471435574964088	25	TCGA-SC-A6LR-01	25	17	10	0.02045812632377373	TCGA-SC-A6LR-01	7	6	1	14	PASS	6871	TCGA-SC-A6LR	MESO	73	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2012	NA	-26773	Alive	TUMOR FREE	1168	NA	NA	NA	NA	NA	NA	NA	NA	R2	0	1168	0	1168	NA	NA	0	1168	
50	TCGA-SC-AA5Z	0	4	1	1	2	1	0	0	0	13	1	0	0	6	0	0	TCGA-SC-AA5Z-01	47	0.24595732742767845	10	TCGA-SC-AA5Z-01	31	20	115	0.6251638928519997	TCGA-SC-AA5Z-01	3	4	6	13	PASS	6872	TCGA-SC-AA5Z	MESO	54	MALE	WHITE	Stage IV	NA	Epithelioid mesothelioma	NA	2013	NA	-19746	Alive	WITH TUMOR	664	NA	NA	NA	NA	NA	NA	NA	NA	R2	0	664	0	664	NA	NA	0	664	
70	TCGA-SH-A7BC	0	1	2	1	0	1	0	0	2	23	0	0	0	8	1	1	TCGA-SH-A7BC-01	152	0.5061368375909782	102	TCGA-SH-A7BC-01	11	10	129	0.3703532888891246	TCGA-SH-A7BC-01	4	10	12	26	PASS	6873	TCGA-SH-A7BC	MESO	66	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2011	NA	-24459	Dead	WITH TUMOR	NA	727	NA	Locoregional Recurrence	"Other, specify"	Ipsilateral Chest Cavity AND Ipsilateral Lymph Nodes	507	NA	NA	R2	1	727	1	727	NA	NA	1	507	
70	TCGA-SH-A7BD	0	4	1	5	2	2	0	0	1	16	1	0	3	6	0	0	TCGA-SH-A7BD-01	185	0.7800231500286546	124	TCGA-SH-A7BD-01	1	4	82	0.1245896130996478	TCGA-SH-A7BD-01	2	11	6	19	PASS	6874	TCGA-SH-A7BD	MESO	68	MALE	WHITE	Stage IV	NA	Epithelioid mesothelioma	NA	2012	NA	-25019	Dead	WITH TUMOR	NA	459	NA	Locoregional Recurrence	"Other, specify"	Ipsilateral Chest Cavity AND Ipsilateral Lymph Nodes AND Ipsilateral Chest Wall	200	NA	NA	R2	1	459	1	459	NA	NA	1	200	
70	TCGA-SH-A7BH	0	2	0	2	0	0	0	0	4	40	2	0	3	15	1	0	TCGA-SH-A7BH-01	78	0.7736941634377127	27	TCGA-SH-A7BH-01	30	13	63	0.3765740216091432	TCGA-SH-A7BH-01	1	1	1	3	PASS	6875	TCGA-SH-A7BH	MESO	65	FEMALE	WHITE	Stage III	NA	Biphasic mesothelioma	NA	2012	NA	-23850	Dead	WITH TUMOR	NA	243	NA	Locoregional Recurrence	"Other, specify"	Ipsilateral Chest Cavity AND Ipsilateral Chest Wall	125	NA	NA	R2	1	243	1	243	NA	NA	1	125	
70	TCGA-SH-A9CT	0	3	0	5	1	0	0	0	1	21	3	0	1	14	0	0	TCGA-SH-A9CT-01	221	0.9458202287211256	160	TCGA-SH-A9CT-01	8	14	124	0.2653449309878126	TCGA-SH-A9CT-01	9	12	11	32	PASS	6876	TCGA-SH-A9CT	MESO	67	MALE	WHITE	Stage II	NA	Epithelioid mesothelioma	NA	2013	NA	-24528	Dead	WITH TUMOR	NA	449	NA	NA	NA	NA	NA	NA	NA	NA	1	449	1	449	NA	NA	1	449	
60	TCGA-SH-A9CU	1	4	0	4	1	0	1	0	6	31	1	0	0	11	1	1	TCGA-SH-A9CU-01	212	0.7380474658524413	145	TCGA-SH-A9CU-01	24	18	124	0.2461268511003236	TCGA-SH-A9CU-01	5	17	10	32	PASS	6877	TCGA-SH-A9CU	MESO	60	MALE	WHITE	Stage IV	NA	Epithelioid mesothelioma	NA	2013	NA	-22135	Dead	WITH TUMOR	NA	732	NA	NA	NA	NA	NA	NA	NA	RX	1	732	1	732	NA	NA	1	732	
60	TCGA-TS-A7OU	1	1	0	2	1	1	1	0	2	27	1	0	1	13	0	1	TCGA-TS-A7OU-01	161	0.1015581073407235	99	TCGA-TS-A7OU-01	2	3	67	0.0538293302467701	TCGA-TS-A7OU-01	3	8	2	13	PASS	6878	TCGA-TS-A7OU	MESO	56	MALE	WHITE	Stage IV	NA	Epithelioid mesothelioma	NA	2007	NA	-20747	Dead	NA	NA	1675	NA	NA	NA	NA	NA	NA	NA	NA	1	1675	NA	1675	NA	NA	0	1675	
60	TCGA-TS-A7OY	2	2	0	1	0	0	0	0	0	18	2	0	1	6	0	0	TCGA-TS-A7OY-01	74	0.13720661179315596	29	TCGA-TS-A7OY-01	4	6	50	0.16136464463939734	TCGA-TS-A7OY-01	2	4	6	12	PASS	6879	TCGA-TS-A7OY	MESO	62	MALE	WHITE	Stage IV	NA	Epithelioid mesothelioma	NA	2009	NA	-22720	Dead	NA	NA	255	NA	NA	NA	NA	NA	NA	NA	[Unknown]	1	255	NA	255	NA	NA	0	255	
70	TCGA-TS-A7OZ	0	5	0	2	0	0	2	0	1	32	7	0	0	16	0	0	TCGA-TS-A7OZ-01	281	0.6634550938904059	204	TCGA-TS-A7OZ-01	5	8	153	0.2282903084893905	TCGA-TS-A7OZ-01	10	15	13	38	PASS	6880	TCGA-TS-A7OZ	MESO	67	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2010	NA	-24745	Dead	NA	NA	844	NA	NA	NA	NA	NA	NA	NA	NA	1	844	NA	844	NA	NA	0	844	
40	TCGA-TS-A7P0	1	4	0	2	3	1	1	0	1	42	4	0	2	11	3	0	TCGA-TS-A7P0-01	195	0.6241695859100458	137	TCGA-TS-A7P0-01	16	29	104	0.22756782567341605	TCGA-TS-A7P0-01	18	18	9	45	PASS	6881	TCGA-TS-A7P0	MESO	42	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2010	NA	-15656	Dead	NA	NA	1261	NA	Locoregional Recurrence	Ipsilateral Chest Cavity	NA	277	NA	NA	[Unknown]	1	1261	NA	1261	NA	NA	1	277	
50	TCGA-TS-A7P1	0	3	1	0	3	0	1	0	2	14	1	0	2	7	0	0	TCGA-TS-A7P1-01	114	0.9235529538417449	59	TCGA-TS-A7P1-01	5	6	78	0.1829709895412419	TCGA-TS-A7P1-01	6	8	11	25	PASS	6882	TCGA-TS-A7P1	MESO	52	MALE	WHITE	Stage I	NA	Epithelioid mesothelioma	NA	2010	NA	-19191	Dead	NA	NA	563	NA	NA	NA	NA	494	NA	NA	[Unknown]	1	563	NA	563	NA	NA	1	494	
60	TCGA-TS-A7P3	0	3	0	0	1	0	0	0	1	14	2	0	0	10	1	0	TCGA-TS-A7P3-01	136	0.06754594760128978	88	TCGA-TS-A7P3-01	2	4	61	0.08232065921240743	TCGA-TS-A7P3-01	1	5	5	11	PASS	6883	TCGA-TS-A7P3	MESO	57	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2011	NA	-20964	Dead	NA	NA	689	NA	NA	NA	NA	NA	NA	NA	[Unknown]	1	689	NA	689	NA	NA	0	689	
60	TCGA-TS-A7P6	0	3	0	1	1	0	0	0	1	19	0	0	0	7	1	0	TCGA-TS-A7P6-01	107	0.5698112215195166	53	TCGA-TS-A7P6-01	8	9	110	0.3746199995236541	TCGA-TS-A7P6-01	8	9	10	27	PASS	6884	TCGA-TS-A7P6	MESO	61	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2011	NA	-22338	Dead	NA	NA	283	NA	NA	NA	NA	NA	NA	NA	[Unknown]	1	283	NA	283	NA	NA	0	283	
60	TCGA-TS-A7P7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-TS-A7P7-01	255	0.8618805767573509	170	TCGA-TS-A7P7	0	0	0	0	TCGA-TS-A7P7	0	0	0	0	PASS	6885	TCGA-TS-A7P7	MESO	62	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2012	NA	-22670	Dead	NA	NA	591	NA	NA	NA	NA	NA	NA	NA	NA	1	591	NA	591	NA	NA	0	591	
80	TCGA-TS-A7P8	0	1	0	0	1	1	1	0	1	36	1	0	1	12	1	0	TCGA-TS-A7P8-01	39	9.776597502714797e-06	7	TCGA-TS-A7P8-01	0	0	6	0.009131678077873948	TCGA-TS-A7P8-01	0	0	1	1	PASS	6886	TCGA-TS-A7P8	MESO	80	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2012	NA	-29464	Dead	NA	NA	457	NA	NA	"Other, specify"	Ipsilateral Chest Cavity	301	NA	NA	[Unknown]	1	457	NA	457	NA	NA	1	301	
60	TCGA-TS-A7PB	0	0	2	0	2	1	0	0	1	26	2	0	1	12	1	0	TCGA-TS-A7PB-01	154	0.14940297638239927	97	TCGA-TS-A7PB-01	1	3	85	0.08885509385726867	TCGA-TS-A7PB-01	3	4	5	12	PASS	6887	TCGA-TS-A7PB	MESO	62	MALE	WHITE	Stage III	NA	Biphasic mesothelioma	NA	2011	NA	-22822	Dead	NA	NA	982	NA	NA	NA	NA	NA	NA	NA	[Unknown]	1	982	NA	982	NA	NA	0	982	
70	TCGA-TS-A8AF	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-TS-A8AF-01	288	0.5222074710667587	198	TCGA-TS-A8AF	0	0	0	0	TCGA-TS-A8AF	0	0	0	0	PASS	6888	TCGA-TS-A8AF	MESO	69	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2007	NA	-25486	Dead	NA	NA	358	NA	NA	NA	NA	325	NA	NA	[Unknown]	1	358	NA	358	NA	NA	1	325	
60	TCGA-TS-A8AI	2	5	0	3	1	0	0	0	1	20	4	0	1	14	0	0	TCGA-TS-A8AI-01	242	0.7999915932419562	155	TCGA-TS-A8AI-01	4	6	144	0.2645917718396033	TCGA-TS-A8AI-01	7	13	14	34	PASS	6889	TCGA-TS-A8AI	MESO	58	MALE	WHITE	Stage IV	NA	Epithelioid mesothelioma	NA	2009	NA	-21323	Dead	NA	NA	328	NA	NA	NA	NA	NA	NA	NA	[Unknown]	1	328	NA	328	NA	NA	0	328	
80	TCGA-TS-A8AS	0	3	0	1	0	0	1	0	0	16	1	0	1	5	1	0	TCGA-TS-A8AS-01	40	0.040346214306739764	7	TCGA-TS-A8AS-01	3	4	29	0.10228392473967347	TCGA-TS-A8AS-01	2	1	4	7	PASS	6890	TCGA-TS-A8AS	MESO	77	MALE	WHITE	Stage IA	NA	Epithelioid mesothelioma	NA	2011	NA	-28273	Dead	NA	NA	795	NA	NA	NA	NA	NA	NA	NA	[Unknown]	1	795	NA	795	NA	NA	0	795	
60	TCGA-TS-A8AV	0	0	0	0	0	0	0	0	0	9	1	0	0	3	0	0	TCGA-TS-A8AV-01	47	7.663790979829483e-05	6	TCGA-TS-A8AV	0	0	0	0	TCGA-TS-A8AV	0	0	0	0	PASS	6891	TCGA-TS-A8AV	MESO	55	MALE	WHITE	Stage III	NA	Sarcomatoid mesothelioma	NA	2011	NA	-20437	Dead	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	[Unknown]	1	NA	NA	NA	NA	NA	0	NA	
50	TCGA-TS-A8AY	0	1	0	0	0	1	1	0	1	11	0	0	0	5	0	0	TCGA-TS-A8AY-01	271	0.8598702586478891	193	TCGA-TS-A8AY-01	7	10	135	0.2680486223418708	TCGA-TS-A8AY-01	9	11	12	32	PASS	6892	TCGA-TS-A8AY	MESO	48	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Epithelioid mesothelioma	NA	2013	NA	-17894	Dead	NA	NA	469	NA	NA	NA	NA	NA	NA	NA	[Unknown]	1	469	NA	469	NA	NA	0	469	
50	TCGA-UD-AABY	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-UD-AABY-01	152	0.056391147165216385	89	TCGA-UD-AABY	0	0	0	0	TCGA-UD-AABY	0	0	0	0	PASS	6893	TCGA-UD-AABY	MESO	50	MALE	WHITE	Stage III	NA	Diffuse malignant mesothelioma - NOS	NA	1999	NA	-18315	Dead	WITH TUMOR	NA	843	NA	Intrapleural Progression	Ipsilateral Pleura	NA	47	NA	NA	RX	1	843	1	843	NA	NA	1	47	
50	TCGA-UD-AABZ	0	5	0	4	0	1	0	0	3	31	6	0	1	5	1	0	TCGA-UD-AABZ-01	151	0.7860787095789771	92	TCGA-UD-AABZ-01	9	10	102	0.2794447745656936	TCGA-UD-AABZ-01	7	12	13	32	PASS	6894	TCGA-UD-AABZ	MESO	46	MALE	WHITE	Stage II	NA	Epithelioid mesothelioma	NA	2004	NA	-16913	Dead	WITH TUMOR	NA	197	NA	NA	NA	NA	NA	NA	NA	RX	1	197	1	197	NA	NA	1	197	
70	TCGA-UD-AAC1	1	24	0	6	12	5	5	0	13	224	10	1	3	124	1	0	TCGA-UD-AAC1-01	79	0.3271643852139621	40	TCGA-UD-AAC1-01	4	21	161	0.8785293722446504	TCGA-UD-AAC1-01	0	0	3	3	PASS	6895	TCGA-UD-AAC1	MESO	71	FEMALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2005	NA	-26057	Dead	WITH TUMOR	NA	789	NA	Intrapleural Progression	Ipsilateral Pleura	NA	85	NA	NA	R2	1	789	1	789	NA	NA	1	85	
70	TCGA-UD-AAC4	1	2	0	2	1	1	1	0	3	25	3	0	1	8	2	0	TCGA-UD-AAC4-01	262	0.09504468717700194	180	TCGA-UD-AAC4-01	3	6	93	0.09166547889502036	TCGA-UD-AAC4-01	6	10	4	20	PASS	6896	TCGA-UD-AAC4	MESO	65	MALE	WHITE	Stage III	NA	Diffuse malignant mesothelioma - NOS	NA	2004	NA	-23949	Dead	WITH TUMOR	NA	719	NA	Intrapleural Progression	Ipsilateral Pleura	NA	267	NA	NA	R2	1	719	1	719	NA	NA	1	267	
70	TCGA-UD-AAC5	1	0	0	3	0	0	1	0	1	17	0	0	0	9	3	1	TCGA-UD-AAC5-01	312	0.5188751999034791	219	TCGA-UD-AAC5-01	11	21	143	0.2112144787854485	TCGA-UD-AAC5-01	3	11	8	22	PASS	6897	TCGA-UD-AAC5	MESO	66	MALE	WHITE	Stage I	NA	Epithelioid mesothelioma	NA	2005	NA	-24314	Dead	WITH TUMOR	NA	253	NA	Distant Metastasis	Abdomen	NA	230	NA	NA	RX	1	253	1	253	NA	NA	1	230	
70	TCGA-UD-AAC6	0	1	0	3	1	0	1	0	2	25	1	0	0	11	1	0	TCGA-UD-AAC6-01	197	0.40555817239836345	141	TCGA-UD-AAC6-01	10	9	78	0.09262249546096553	TCGA-UD-AAC6-01	6	10	5	21	PASS	6898	TCGA-UD-AAC6	MESO	67	MALE	WHITE	Stage II	NA	Biphasic mesothelioma	NA	2006	NA	-24571	Dead	WITH TUMOR	NA	456	NA	Intrapleural Progression	Ipsilateral Pleura	NA	126	NA	NA	R2	1	456	1	456	NA	NA	1	126	
50	TCGA-UD-AAC7	0	3	0	0	1	1	0	0	2	12	1	0	0	8	2	0	TCGA-UD-AAC7-01	204	0.7520021565567427	131	TCGA-UD-AAC7-01	7	7	110	0.2492653034148095	TCGA-UD-AAC7-01	6	6	5	17	PASS	6899	TCGA-UD-AAC7	MESO	47	MALE	WHITE	Stage II	NA	Epithelioid mesothelioma	NA	2008	NA	-17299	Dead	WITH TUMOR	NA	406	NA	Intrapleural Progression	Ipsilateral Pleura	NA	265	NA	NA	R2	1	406	1	406	NA	NA	1	265	
60	TCGA-UT-A88C	1	2	0	2	0	0	0	0	4	12	2	0	0	10	2	0	TCGA-UT-A88C-01	84	0.3057496180967965	40	TCGA-UT-A88C-01	10	8	44	0.07156584441876998	TCGA-UT-A88C-01	3	4	3	10	PASS	6900	TCGA-UT-A88C	MESO	62	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2012	NA	-23002	Dead	WITH TUMOR	NA	863	NA	Intrapleural Progression	"Other, specify"	Mediastinum and Contralateral pleura	479	NA	NA	R0	1	863	1	863	1	479	1	479	
70	TCGA-UT-A88D	0	1	0	2	2	0	0	0	2	24	3	0	1	7	1	0	TCGA-UT-A88D-01	93	0.03851524331223663	41	TCGA-UT-A88D-01	1	1	33	0.0818089743577476	TCGA-UT-A88D-01	1	4	4	9	PASS	6901	TCGA-UT-A88D	MESO	66	MALE	WHITE	Stage II	NA	Epithelioid mesothelioma	NA	2012	NA	-24300	Dead	TUMOR FREE	NA	823	NA	NA	NA	NA	NA	NA	NA	R0	1	823	0	823	0	823	0	823	
70	TCGA-UT-A88E	0	4	1	2	1	0	2	0	1	35	2	0	0	17	1	0	TCGA-UT-A88E-01	242	0.6872539820796632	163	TCGA-UT-A88E-01	6	10	97	0.1730256665130276	TCGA-UT-A88E-01	8	13	9	30	PASS	6902	TCGA-UT-A88E	MESO	74	MALE	WHITE	Stage I	NA	Epithelioid mesothelioma	NA	2012	NA	-27347	Dead	WITH TUMOR	NA	434	NA	Intrapleural Progression	"Other, specify"	chest wall musculature invasion	121	NA	NA	RX	1	434	1	434	NA	NA	1	121	
70	TCGA-UT-A88G	1	1	1	2	3	0	0	0	1	23	1	0	1	9	2	0	TCGA-UT-A88G-01	151	0.9828429095072504	81	TCGA-UT-A88G-01	28	20	159	0.5098139295131843	TCGA-UT-A88G-01	7	4	9	20	PASS	6903	TCGA-UT-A88G	MESO	73	MALE	WHITE	Stage III	NA	Biphasic mesothelioma	NA	2012	NA	-26704	Dead	WITH TUMOR	NA	76	NA	Intrapleural Progression	"Other, specify"	Right Hemithorax	44	NA	NA	RX	1	76	1	76	NA	NA	1	44	
80	TCGA-UT-A97Y	0	3	0	0	1	0	0	0	1	17	0	0	1	15	2	0	TCGA-UT-A97Y-01	62	0.1149167872716269	18	TCGA-UT-A97Y-01	6	6	44	0.19814969851653744	TCGA-UT-A97Y-01	2	6	6	14	PASS	6904	TCGA-UT-A97Y	MESO	81	FEMALE	WHITE	Stage I	NA	Epithelioid mesothelioma	NA	2011	NA	-29905	Dead	WITH TUMOR	NA	144	NA	NA	NA	NA	NA	NA	NA	RX	1	144	1	144	NA	NA	1	144	
60	TCGA-XT-AASU	0	6	0	6	0	2	0	0	4	38	1	0	1	8	0	0	TCGA-XT-AASU-01	249	0.17283648495424042	163	TCGA-XT-AASU-01	3	4	118	0.1324177148664262	TCGA-XT-AASU-01	6	11	6	23	PASS	6905	TCGA-XT-AASU	MESO	60	MALE	WHITE	Stage III	NA	Biphasic mesothelioma	NA	2005	NA	-22021	Dead	WITH TUMOR	NA	142	NA	Locoregional Recurrence	Ipsilateral Chest Cavity	NA	133	NA	NA	R0	1	142	1	142	1	133	1	133	
30	TCGA-YS-A95B	0	1	0	3	0	0	0	0	0	13	1	0	0	10	0	0	TCGA-YS-A95B-01	137	0.24824751324218916	76	TCGA-YS-A95B-01	6	8	71	0.12311277113724185	TCGA-YS-A95B-01	5	7	4	16	PASS	6906	TCGA-YS-A95B	MESO	28	FEMALE	WHITE	Stage IV	NA	Epithelioid mesothelioma	NA	2009	NA	-10510	Dead	WITH TUMOR	NA	39	NA	NA	NA	NA	NA	NA	NA	R2	1	39	1	39	NA	NA	1	39	
50	TCGA-YS-A95C	2	0	0	2	0	0	1	0	2	18	0	0	0	6	0	0	TCGA-YS-A95C-01	129	0.2287738451969625	79	TCGA-YS-A95C-01	8	11	48	0.15988613945131813	TCGA-YS-A95C-01	5	4	7	16	PASS	6907	TCGA-YS-A95C	MESO	54	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2013	NA	-19818	Dead	TUMOR FREE	NA	133	NA	NA	NA	NA	NA	NA	NA	R0	1	133	0	133	0	133	0	133	
70	TCGA-YS-AA4M	0	1	0	2	2	0	0	0	2	15	1	0	0	5	1	0	TCGA-YS-AA4M-01	68	0.033639876747352526	26	TCGA-YS-AA4M-01	3	7	23	0.12662855030941692	TCGA-YS-AA4M-01	1	5	1	7	PASS	6908	TCGA-YS-AA4M	MESO	66	MALE	WHITE	Stage IV	NA	Diffuse malignant mesothelioma - NOS	NA	2013	NA	-24176	Dead	WITH TUMOR	NA	84	NA	Distant Metastasis	Bone	NA	-131	NA	NA	R2	1	84	1	84	NA	NA	1	NA	
40	TCGA-ZN-A9VO	1	2	0	1	0	0	0	0	2	18	2	1	2	8	0	0	TCGA-ZN-A9VO-01	158	0.8057995684918551	97	TCGA-ZN-A9VO-01	7	7	59	0.18347088245905005	TCGA-ZN-A9VO-01	5	9	9	23	PASS	6909	TCGA-ZN-A9VO	MESO	36	MALE	WHITE	Stage IV	NA	Epithelioid mesothelioma	NA	2011	NA	-13243	Alive	TUMOR FREE	261	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	261	0	261	NA	NA	0	261	
50	TCGA-ZN-A9VP	0	1	1	2	1	0	0	0	1	13	6	0	0	9	0	0	TCGA-ZN-A9VP-01	189	0.3732100054416124	122	TCGA-ZN-A9VP-01	12	19	99	0.29329769467063804	TCGA-ZN-A9VP-01	13	7	12	32	PASS	6910	TCGA-ZN-A9VP	MESO	51	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2012	NA	-18697	Alive	TUMOR FREE	228	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	228	0	228	NA	NA	0	228	
60	TCGA-ZN-A9VQ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-ZN-A9VQ-01	104	0.6997593138486584	55	TCGA-ZN-A9VQ-01	4	6	63	0.11101344516359098	TCGA-ZN-A9VQ-01	7	6	7	20	PASS	6911	TCGA-ZN-A9VQ	MESO	61	MALE	WHITE	Stage I	NA	Biphasic mesothelioma	NA	2012	NA	-22443	Alive	WITH TUMOR	499	NA	NA	Intrapleural Progression	"Other, specify"	Right chest wall	313	NA	NA	NA	0	499	0	499	NA	NA	1	313	
70	TCGA-ZN-A9VS	0	1	2	6	1	2	0	0	1	29	0	0	0	9	0	0	TCGA-ZN-A9VS-01	103	0.2549541515594807	49	TCGA-ZN-A9VS-01	9	9	39	0.0859514164230008	TCGA-ZN-A9VS-01	3	5	3	11	PASS	6912	TCGA-ZN-A9VS	MESO	67	MALE	WHITE	Stage III	NA	Epithelioid mesothelioma	NA	2011	NA	-24490	Alive	WITH TUMOR	1228	NA	NA	Intrapleural Progression	Ipsilateral Pleura	NA	1025	NA	NA	NA	0	1228	0	1228	NA	NA	1	1025	
70	TCGA-ZN-A9VU	0	3	0	2	2	0	0	0	2	32	1	0	3	5	0	0	TCGA-ZN-A9VU-01	110	0.16278651625781304	64	TCGA-ZN-A9VU-01	5	9	49	0.10942025212015484	TCGA-ZN-A9VU-01	3	5	3	11	PASS	6913	TCGA-ZN-A9VU	MESO	70	MALE	WHITE	Stage II	NA	Epithelioid mesothelioma	NA	2012	NA	-25714	Alive	TUMOR FREE	977	NA	NA	Intrapleural Progression	"Other, specify"	left chest wall	585	NA	NA	NA	0	977	0	977	NA	NA	1	585	
70	TCGA-ZN-A9VV	0	1	0	0	6	0	0	0	3	23	3	0	0	4	1	0	TCGA-ZN-A9VV-01	125	0.029357039424333063	73	TCGA-ZN-A9VV-01	1	2	22	0.0313437204661325	TCGA-ZN-A9VV-01	0	2	1	3	PASS	6914	TCGA-ZN-A9VV	MESO	68	MALE	WHITE	Stage III	NA	Biphasic mesothelioma	NA	2010	NA	-25096	Alive	WITH TUMOR	1309	NA	NA	Intrapleural Progression	Ipsilateral Pleura	NA	676	NA	NA	NA	0	1309	0	1309	NA	NA	1	676	
60	TCGA-ZN-A9VW	1	4	0	2	2	0	0	0	1	49	3	0	0	9	0	0	TCGA-ZN-A9VW-01	293	0.19415790425644347	218	TCGA-ZN-A9VW-01	5	7	112	0.160631936655302	TCGA-ZN-A9VW-01	6	7	10	23	PASS	6915	TCGA-ZN-A9VW	MESO	61	MALE	WHITE	Stage IV	NA	Biphasic mesothelioma	NA	2010	NA	-22588	Dead	WITH TUMOR	NA	84	NA	Intrapleural Progression	"Other, specify"	right chest wall	-30	NA	NA	NA	1	84	1	84	NA	NA	1	NA	
80	TCGA-04-1331	0	8	1	4	5	6	1	0	5	110	9	0	1	40	3	0	TCGA-04-1331-01	271	0.8913239842886681	172	TCGA-04-1331-01	7	15	52	0.3550889866082236	TCGA-04-1331-01	16	21	10	47	PASS	6916	TCGA-04-1331	OV	78	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-28848	Dead	WITH TUMOR	1224	1336	NA	Recurrence	NA	NA	459	Complete Remission/Response	NA	NA	1	1336	1	1336	1	459	1	459	Redacted
70	TCGA-04-1332	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1332-01	216	0.6920220823338395	121	TCGA-04-1332-01	15	37	33	0.23424535008159195	TCGA-04-1332-01	14	16	7	37	PASS	6917	TCGA-04-1332	OV	70	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-25786	Dead	WITH TUMOR	1247	1247	NA	Recurrence	NA	NA	393	NA	NA	NA	1	1247	1	1247	NA	NA	1	393	Redacted
60	TCGA-04-1335	0	3	0	0	1	0	0	0	1	14	0	0	3	7	0	0	TCGA-04-1335-01	270	0.9999992639363628	181	TCGA-04-1335-01	6	15	38	0.3334036366467081	TCGA-04-1335-01	19	16	16	51	PASS	6918	TCGA-04-1335	OV	60	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Serous Cystadenocarcinoma	G2	2005	NA	-21963	Dead	WITH TUMOR	NA	55	NA	NA	NA	NA	NA	NA	NA	NA	1	55	1	55	NA	NA	1	55	Redacted
60	TCGA-04-1336	0	5	0	1	5	1	1	0	1	49	5	0	1	15	5	0	TCGA-04-1336-01	227	0.9474634406072908	120	TCGA-04-1336-01	7	18	48	0.35725092475804643	TCGA-04-1336-01	21	14	11	46	PASS	6919	TCGA-04-1336	OV	55	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2005	NA	-20271	Alive	TUMOR FREE	1495	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1495	0	1495	0	1495	0	1495	Redacted
80	TCGA-04-1337	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1337-01	121	0.44489299341855537	54	TCGA-04-1337-01	15	27	16	0.23058806751619115	TCGA-04-1337-01	10	5	7	22	PASS	6920	TCGA-04-1337	OV	78	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2005	NA	-28626	Dead	WITH TUMOR	NA	61	NA	NA	NA	NA	NA	NA	NA	NA	1	61	1	61	NA	NA	1	61	Redacted
80	TCGA-04-1338	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1338-01	528	0.7564148202382653	355	TCGA-04-1338-01	14	35	96	0.3270458937453272	TCGA-04-1338-01	27	43	16	86	PASS	6921	TCGA-04-1338	OV	78	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-28789	Alive	WITH TUMOR	1418	NA	NA	Recurrence	NA	NA	380	NA	NA	NA	0	1418	0	1418	NA	NA	1	380	Redacted
90	TCGA-04-1341	0	5	0	1	3	1	1	0	0	22	1	0	0	7	1	0	TCGA-04-1341-01	354	0.9319183025896984	249	TCGA-04-1341-01	19	42	79	0.3229263670161411	TCGA-04-1341-01	20	12	9	41	PASS	6922	TCGA-04-1341	OV	85	FEMALE	WHITE	NA	NA	Serous Cystadenocarcinoma	G3	2006	NA	-31215	Alive	NA	33	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	33	0	33	0	33	0	33	Redacted
80	TCGA-04-1342	0	15	2	10	2	5	0	0	13	146	12	1	3	63	2	0	TCGA-04-1342-01	238	0.7891168431545038	129	TCGA-04-1342-01	12	24	34	0.23018791660695925	TCGA-04-1342-01	12	14	4	30	PASS	6923	TCGA-04-1342	OV	80	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G2	2006	NA	-29501	Dead	WITH TUMOR	NA	563	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	563	1	563	NA	NA	1	563	Redacted
70	TCGA-04-1343	0	5	1	6	3	2	1	0	2	76	7	0	2	39	2	0	TCGA-04-1343-01	249	0.6827140138454747	145	TCGA-04-1343-01	23	36	52	0.2880894939083865	TCGA-04-1343-01	15	10	5	30	PASS	6924	TCGA-04-1343	OV	72	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2002	NA	-26428	Dead	WITH TUMOR	NA	361	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	361	1	361	NA	NA	1	361	Redacted
70	TCGA-04-1346	0	5	0	5	2	2	1	0	5	41	0	0	1	15	3	0	TCGA-04-1346-01	235	0.6982154396518538	141	TCGA-04-1346-01	19	72	42	0.2922798654592808	TCGA-04-1346-01	17	13	4	34	PASS	6925	TCGA-04-1346	OV	73	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2003	NA	-26865	Alive	TUMOR FREE	1993	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1993	0	1993	0	1993	0	1993	Redacted
80	TCGA-04-1347	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1347-01	277	0.8384044526592664	173	TCGA-04-1347-01	21	69	36	0.26503744054840506	TCGA-04-1347-01	18	23	5	46	PASS	6926	TCGA-04-1347	OV	81	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2004	NA	-29695	Alive	TUMOR FREE	1919	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1919	0	1919	NA	NA	0	1919	Redacted
40	TCGA-04-1348	0	4	0	2	0	0	0	0	4	47	1	0	0	13	11	0	TCGA-04-1348-01	699	0.6381041882550945	503	TCGA-04-1348-01	5	12	125	0.2356601880737656	TCGA-04-1348-01	17	12	11	40	PASS	6927	TCGA-04-1348	OV	44	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2004	NA	-16236	Dead	WITH TUMOR	NA	1483	NA	Recurrence	NA	NA	575	Complete Remission/Response	NA	NA	1	1483	1	1483	1	575	1	575	
70	TCGA-04-1349	0	6	0	0	0	1	0	0	8	47	4	1	0	14	6	0	TCGA-04-1349-01	178	0.7860923526154946	102	TCGA-04-1349-01	27	18	31	0.3371298235034022	TCGA-04-1349-01	14	7	11	32	PASS	6928	TCGA-04-1349	OV	69	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2004	NA	-25213	Dead	WITH TUMOR	NA	656	NA	Recurrence	NA	NA	428	Complete Remission/Response	NA	NA	1	656	1	656	NA	NA	1	428	
50	TCGA-04-1350	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1350-01	148	0.667070621817522	78	TCGA-04-1350-01	24	25	21	0.3006348394206801	TCGA-04-1350-01	9	5	1	15	PASS	6929	TCGA-04-1350	OV	46	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-16942	Dead	WITH TUMOR	NA	1946	NA	Recurrence	NA	NA	111	Stable Disease	NA	NA	1	1946	1	1946	NA	NA	1	111	
80	TCGA-04-1351	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1351-01	223	0.6931119724684603	122	TCGA-04-1351-01	20	70	49	0.2693309636556183	TCGA-04-1351-01	19	15	5	39	PASS	6930	TCGA-04-1351	OV	76	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2004	NA	-28045	Alive	TUMOR FREE	1991	NA	NA	Recurrence	NA	NA	1658	Complete Remission/Response	NA	NA	0	1991	0	1991	1	1658	1	1658	
60	TCGA-04-1353	0	1	0	7	0	0	2	0	0	11	0	0	1	7	0	0	TCGA-04-1353-01	365	0.4277729471167631	244	TCGA-04-1353-01	2	11	56	0.2637013689867672	TCGA-04-1353-01	23	28	14	65	PASS	6931	TCGA-04-1353	OV	64	FEMALE	ASIAN	NA	Stage IIIC	Serous Cystadenocarcinoma	NA	2003	NA	-23611	Alive	NA	16	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	16	0	16	NA	NA	0	16	
60	TCGA-04-1356	1	8	0	3	2	1	1	0	4	79	5	0	3	26	0	0	TCGA-04-1356-01	396	0.7922004110104823	248	TCGA-04-1356-01	16	27	127	0.4400615307184947	TCGA-04-1356-01	29	27	22	78	PASS	6932	TCGA-04-1356	OV	62	FEMALE	WHITE	NA	Stage IIC	Serous Cystadenocarcinoma	G3	2004	NA	-22855	Dead	WITH TUMOR	NA	1499	NA	Recurrence	NA	NA	156	Progressive Disease	NA	NA	1	1499	1	1499	NA	NA	1	156	
50	TCGA-04-1357	1	2	0	3	4	2	0	0	1	68	8	0	2	22	4	0	TCGA-04-1357-01	187	0.6138937836452181	100	TCGA-04-1357-01	12	30	22	0.1890655395642254	TCGA-04-1357-01	23	26	9	58	PASS	6933	TCGA-04-1357	OV	52	FEMALE	NA	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2005	NA	-18999	Alive	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
70	TCGA-04-1360	0	9	1	3	4	1	0	0	8	112	2	0	1	34	1	0	TCGA-04-1360-01	335	0.8321399286623241	226	TCGA-04-1360-01	17	30	70	0.3819041541910832	TCGA-04-1360-01	24	35	10	69	PASS	6934	TCGA-04-1360	OV	65	FEMALE	NA	NA	Stage IA	Serous Cystadenocarcinoma	G3	2005	NA	-23993	Alive	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
60	TCGA-04-1361	0	11	1	4	1	2	0	0	4	101	4	0	2	38	10	0	TCGA-04-1361-01	239	0.6125192297975981	137	TCGA-04-1361-01	8	16	71	0.3747174826396261	TCGA-04-1361-01	20	26	18	64	PASS	6935	TCGA-04-1361	OV	57	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2005	NA	-20860	Alive	NA	989	NA	NA	Recurrence	NA	NA	927	Stable Disease	NA	NA	0	989	0	989	NA	NA	1	927	
60	TCGA-04-1362	0	3	0	1	2	1	2	0	5	50	5	1	2	15	6	0	TCGA-04-1362-01	310	0.8400545149936121	191	TCGA-04-1362-01	16	38	58	0.3135070888079489	TCGA-04-1362-01	31	29	12	72	PASS	6936	TCGA-04-1362	OV	59	FEMALE	WHITE	NA	Stage IIC	Serous Cystadenocarcinoma	G3	2002	NA	-21745	Dead	WITH TUMOR	NA	1348	NA	Recurrence	NA	NA	223	NA	NA	NA	1	1348	1	1348	NA	NA	1	223	
60	TCGA-04-1364	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1364-01	345	0.8333225584528671	207	TCGA-04-1364-01	31	51	49	0.1350198777511934	TCGA-04-1364-01	19	14	3	36	PASS	6937	TCGA-04-1364	OV	61	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-22294	Dead	WITH TUMOR	NA	1024	NA	Recurrence	NA	NA	288	Progressive Disease	NA	NA	1	1024	1	1024	NA	NA	1	288	
90	TCGA-04-1365	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1365-01	345	0.844703374703612	204	TCGA-04-1365-01	9	15	69	0.29717882021551323	TCGA-04-1365-01	15	17	15	47	PASS	6938	TCGA-04-1365	OV	87	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2003	NA	-31925	Alive	WITH TUMOR	2329	NA	NA	Recurrence	NA	NA	1328	Complete Remission/Response	NA	NA	0	2329	0	2329	1	1328	1	1328	
50	TCGA-04-1367	1	9	2	7	6	7	1	0	9	92	6	1	1	31	1	1	TCGA-04-1367-01	213	0.9526905998234101	127	TCGA-04-1367-01	10	12	44	0.3031171295787249	TCGA-04-1367-01	13	11	9	33	PASS	6939	TCGA-04-1367	OV	50	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-18577	Alive	WITH TUMOR	3145	NA	NA	Progression of Disease	NA	NA	2997	Complete Remission/Response	NA	NA	0	3145	0	3145	1	2997	1	2997	
50	TCGA-04-1369	0	6	0	2	3	0	1	0	2	74	4	0	4	25	4	1	TCGA-04-1369	0	0	0	TCGA-04-1369	0	0	0	0	TCGA-04-1369	0	0	0	0	PASS	6940	TCGA-04-1369	OV	53	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2004	NA	-19571	Dead	WITH TUMOR	NA	642	NA	Progression of Disease	NA	NA	315	NA	NA	NA	1	642	1	642	NA	NA	1	315	
50	TCGA-04-1370	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1370	0	0	0	TCGA-04-1370	0	0	0	0	TCGA-04-1370	0	0	0	0	PASS	6941	TCGA-04-1370	OV	52	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-19329	Alive	NA	1824	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1824	0	1824	NA	NA	0	1824	
60	TCGA-04-1371	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1371-01	415	0.7546011601948871	270	TCGA-04-1371-01	21	40	60	0.31728482140349423	TCGA-04-1371-01	15	19	7	41	PASS	6942	TCGA-04-1371	OV	58	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-21243	Alive	TUMOR FREE	2506	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2506	0	2506	NA	NA	0	2506	
50	TCGA-04-1514	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1514-01	285	0.8621902723884581	175	TCGA-04-1514-01	14	28	75	0.3175093890637408	TCGA-04-1514-01	19	12	11	42	PASS	6943	TCGA-04-1514	OV	45	FEMALE	WHITE	NA	Stage IIIA	Serous Cystadenocarcinoma	G2	2004	NA	-16725	Dead	TUMOR FREE	NA	1720	NA	Recurrence	NA	NA	1221	Complete Remission/Response	NA	NA	1	1720	0	1720	1	1221	1	1221	
50	TCGA-04-1516	0	6	0	3	2	0	1	0	2	45	2	0	0	9	2	0	TCGA-04-1516-01	443	0.7508409318543071	289	TCGA-04-1516-01	10	48	88	0.4594618086041346	TCGA-04-1516-01	26	31	17	74	PASS	6944	TCGA-04-1516	OV	48	FEMALE	WHITE	NA	Stage IA	Serous Cystadenocarcinoma	G3	2006	NA	-17768	Alive	TUMOR FREE	1265	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1265	0	1265	0	1265	0	1265	
80	TCGA-04-1517	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1517-01	475	0.9176385569004442	309	TCGA-04-1517-01	30	34	79	0.3163285946002645	TCGA-04-1517-01	19	14	12	45	PASS	6945	TCGA-04-1517	OV	79	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-29045	Dead	WITH TUMOR	NA	608	NA	Recurrence	NA	NA	349	Complete Remission/Response	NA	NA	1	608	1	608	1	349	1	349	
50	TCGA-04-1519	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1519-01	203	0.9999974363743456	116	TCGA-04-1519-01	12	8	22	0.2971014493519131	TCGA-04-1519-01	3	2	3	8	PASS	6946	TCGA-04-1519	OV	48	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-17671	Alive	NA	24	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	24	0	24	NA	NA	0	24	
50	TCGA-04-1525	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1525-01	334	0.6692667518189048	188	TCGA-04-1525-01	18	29	31	0.21703249459608204	TCGA-04-1525-01	14	11	3	28	PASS	6947	TCGA-04-1525	OV	47	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-17469	Dead	WITH TUMOR	1167	1167	NA	Recurrence	NA	NA	213	Complete Remission/Response	NA	NA	1	1167	1	1167	1	213	1	213	
70	TCGA-04-1530	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1530-01	176	0.6303758704878919	90	TCGA-04-1530-01	18	62	37	0.2303485580396677	TCGA-04-1530-01	24	27	11	62	PASS	6948	TCGA-04-1530	OV	68	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1995	NA	-25013	Dead	WITH TUMOR	NA	3622	NA	Recurrence	NA	NA	350	Complete Remission/Response	NA	NA	1	3622	1	3622	1	350	1	350	
60	TCGA-04-1536	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1536-01	399	0.8548781232969845	264	TCGA-04-1536-01	12	43	80	0.2888677538931434	TCGA-04-1536-01	26	26	10	62	PASS	6949	TCGA-04-1536	OV	60	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IV	Serous Cystadenocarcinoma	G3	2001	NA	-21939	Dead	WITH TUMOR	NA	885	NA	Recurrence	NA	NA	498	NA	NA	NA	1	885	1	885	NA	NA	1	498	
50	TCGA-04-1542	0	5	0	1	1	2	0	0	1	55	4	0	0	12	1	0	TCGA-04-1542-01	266	0.7555971683158199	173	TCGA-04-1542-01	25	32	36	0.3211944876263315	TCGA-04-1542-01	15	14	8	37	PASS	6950	TCGA-04-1542	OV	52	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G2	2001	NA	-19263	Dead	WITH TUMOR	NA	2561	NA	Recurrence	NA	NA	1020	Complete Remission/Response	NA	NA	1	2561	1	2561	1	1020	1	1020	
60	TCGA-04-1638	1	4	0	3	2	1	0	0	3	47	1	0	2	15	0	0	TCGA-04-1638-01	256	0.9220256664973931	167	TCGA-04-1638-01	27	19	19	0.1883986977357648	TCGA-04-1638-01	12	6	5	23	PASS	6951	TCGA-04-1638	OV	57	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IV	Serous Cystadenocarcinoma	G3	2002	NA	-20987	Dead	TUMOR FREE	NA	1686	NA	Recurrence	NA	NA	298	NA	NA	NA	1	1686	0	1686	NA	NA	1	298	
50	TCGA-04-1644	0	1	0	1	0	0	0	0	0	31	3	0	0	7	1	0	TCGA-04-1644-01	324	0.8686627078440232	225	TCGA-04-1644-01	9	11	40	0.2964671596865171	TCGA-04-1644-01	14	8	8	30	PASS	6952	TCGA-04-1644	OV	48	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-17725	Dead	WITH TUMOR	NA	1487	NA	Progression of Disease	NA	NA	634	Partial Remission/Response	NA	NA	1	1487	1	1487	NA	NA	1	634	
60	TCGA-04-1646	0	7	0	1	1	1	0	0	1	21	1	0	0	10	0	0	TCGA-04-1646-01	241	0.8592032432860635	138	TCGA-04-1646-01	15	13	35	0.4017775492144817	TCGA-04-1646-01	11	7	9	27	PASS	6953	TCGA-04-1646	OV	60	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-22207	Dead	WITH TUMOR	NA	848	NA	Recurrence	NA	NA	508	NA	NA	NA	1	848	1	848	NA	NA	1	508	
60	TCGA-04-1648	0	11	1	3	3	2	0	0	4	60	4	1	2	32	0	0	TCGA-04-1648-01	174	0.9316708437135574	92	TCGA-04-1648-01	9	11	34	0.2666276522046616	TCGA-04-1648-01	7	2	5	14	PASS	6954	TCGA-04-1648	OV	57	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2003	NA	-21113	Dead	NA	NA	871	NA	Recurrence	NA	NA	412	NA	NA	NA	1	871	NA	871	NA	NA	1	412	
70	TCGA-04-1649	0	10	0	1	2	2	0	0	3	73	7	0	2	19	2	0	TCGA-04-1649-01	298	0.7024798631874046	191	TCGA-04-1649-01	24	34	77	0.29378139173350953	TCGA-04-1649-01	15	7	1	23	PASS	6955	TCGA-04-1649	OV	74	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-27165	Alive	NA	1966	NA	NA	Recurrence	NA	NA	1672	NA	NA	NA	0	1966	0	1966	NA	NA	1	1672	
50	TCGA-04-1651	1	7	0	4	1	3	0	0	4	56	11	0	3	28	2	1	TCGA-04-1651-01	299	0.9399373619912508	178	TCGA-04-1651-01	5	14	54	0.36263617326474895	TCGA-04-1651-01	22	30	19	71	PASS	6956	TCGA-04-1651	OV	53	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-19628	Dead	NA	NA	1102	NA	Recurrence	NA	NA	990	NA	NA	NA	1	1102	NA	1102	NA	NA	1	990	
80	TCGA-04-1652	0	4	1	0	2	0	1	0	3	63	1	0	2	36	2	0	TCGA-04-1652-01	169	0.6515546818586924	70	TCGA-04-1652-01	15	30	23	0.11985537681839885	TCGA-04-1652-01	13	10	3	26	PASS	6957	TCGA-04-1652	OV	76	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2004	NA	-28101	Dead	WITH TUMOR	NA	969	NA	Recurrence	NA	NA	880	Complete Remission/Response	NA	NA	1	969	1	969	1	880	1	880	
70	TCGA-04-1654	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-04-1654-01	285	0.8513075169279531	160	TCGA-04-1654-01	4	18	64	0.3686738687913856	TCGA-04-1654-01	20	28	22	70	PASS	6958	TCGA-04-1654	OV	69	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	1999	NA	-25387	Dead	NA	NA	1451	NA	Recurrence	NA	NA	808	NA	NA	NA	1	1451	NA	1451	NA	NA	1	808	
50	TCGA-04-1655	0	8	0	5	0	2	1	0	6	68	6	0	0	21	0	0	TCGA-04-1655-01	166	0.8897081868152614	99	TCGA-04-1655-01	29	53	30	0.29006161436545325	TCGA-04-1655-01	14	10	2	26	PASS	6959	TCGA-04-1655	OV	49	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G2	1999	NA	-17988	Dead	NA	NA	1380	NA	Recurrence	NA	NA	819	NA	NA	NA	1	1380	NA	1380	NA	NA	1	819	
80	TCGA-09-0364	0	0	0	0	0	3	1	0	0	1	0	0	0	0	0	0	TCGA-09-0364-01	404	0.5766472607479202	264	TCGA-09-0364-01	11	30	79	0.3283268973706165	TCGA-09-0364-01	16	23	11	50	PASS	6960	TCGA-09-0364	OV	80	FEMALE	WHITE	NA	Stage IIC	Serous Cystadenocarcinoma	G3	1998	NA	-29262	Dead	WITH TUMOR	NA	887	NA	Recurrence	NA	NA	395	Complete Remission/Response	NA	NA	1	887	1	887	1	395	1	395	
70	TCGA-09-0365	1	3	0	2	0	2	1	0	2	45	6	0	0	15	1	0	TCGA-09-0365-01	156	0.6770853062891447	81	TCGA-09-0365-01	24	56	26	0.286422044583836	TCGA-09-0365-01	10	3	0	13	PASS	6961	TCGA-09-0365	OV	70	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-25703	Dead	WITH TUMOR	NA	288	NA	Recurrence	NA	NA	251	Complete Remission/Response	NA	NA	1	288	1	288	1	251	1	251	
60	TCGA-09-0366	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-09-0366-01	187	0.632246802202901	108	TCGA-09-0366-01	18	29	38	0.2215835146062476	TCGA-09-0366-01	13	4	4	21	PASS	6962	TCGA-09-0366	OV	55	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-20440	Dead	WITH TUMOR	NA	1757	NA	Recurrence	NA	NA	190	Stable Disease	NA	NA	1	1757	1	1757	NA	NA	1	190	
70	TCGA-09-0367	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-09-0367-01	418	0.8071606306041221	267	TCGA-09-0367-01	12	54	36	0.2123689931661669	TCGA-09-0367-01	28	40	10	78	PASS	6963	TCGA-09-0367	OV	67	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-24473	Dead	WITH TUMOR	NA	547	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	547	1	547	NA	NA	1	547	
60	TCGA-09-0369	0	3	1	5	0	6	0	0	4	86	7	0	0	25	3	0	TCGA-09-0369-01	323	0.9713848957385636	216	TCGA-09-0369-01	15	37	65	0.3758816110250718	TCGA-09-0369-01	21	17	7	45	PASS	6964	TCGA-09-0369	OV	56	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-20705	Dead	WITH TUMOR	NA	1082	NA	Recurrence	NA	NA	274	Complete Remission/Response	NA	NA	1	1082	1	1082	1	274	1	274	
50	TCGA-09-1659	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-09-1659-01	385	0.9211813953602236	227	TCGA-09-1659-01	17	38	55	0.19793563391286206	TCGA-09-1659-01	16	9	10	35	PASS	6965	TCGA-09-1659	OV	51	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	NA	-18733	Dead	WITH TUMOR	NA	304	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	304	1	304	NA	NA	1	304	
80	TCGA-09-1661	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-09-1661-01	323	0.844562786169083	210	TCGA-09-1661-01	24	57	64	0.3728732536797571	TCGA-09-1661-01	18	5	3	26	PASS	6966	TCGA-09-1661	OV	75	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-27486	Dead	WITH TUMOR	NA	1169	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	1169	1	1169	NA	NA	1	1169	
60	TCGA-09-1662	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-09-1662-01	394	0.8394647443358069	275	TCGA-09-1662-01	4	12	53	0.27008945497603354	TCGA-09-1662-01	19	26	13	58	PASS	6967	TCGA-09-1662	OV	58	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2001	NA	-21246	Dead	WITH TUMOR	NA	2717	NA	Recurrence	NA	NA	1046	Complete Remission/Response	NA	NA	1	2717	1	2717	NA	NA	1	1046	
40	TCGA-09-1664	0	2	0	0	0	1	0	0	0	8	1	0	0	6	1	0	TCGA-09-1664-01	73	0.118685603415643	27	TCGA-09-1664-01	2	5	10	0.09605566403023397	TCGA-09-1664-01	4	3	5	12	PASS	6968	TCGA-09-1664	OV	37	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G1	2002	NA	-13739	Dead	NA	NA	2279	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2279	NA	2279	0	2279	0	2279	
70	TCGA-09-1665	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-09-1665-01	896	0.983544181835355	591	TCGA-09-1665-01	12	39	210	0.4539376028871345	TCGA-09-1665-01	31	30	23	84	PASS	6969	TCGA-09-1665	OV	73	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2002	NA	-27010	Dead	WITH TUMOR	NA	1266	NA	Recurrence	NA	NA	468	Complete Remission/Response	NA	NA	1	1266	1	1266	1	468	1	468	
60	TCGA-09-1666	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-09-1666-01	335	0.980519959962295	213	TCGA-09-1666-01	3	16	55	0.3997094136498078	TCGA-09-1666-01	26	23	15	64	PASS	6970	TCGA-09-1666	OV	57	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-21066	Alive	WITH TUMOR	1752	NA	NA	Recurrence	NA	NA	480	Complete Remission/Response	NA	NA	0	1752	0	1752	1	480	1	480	
60	TCGA-09-1667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-09-1667-01	401	0.8585544489007109	245	TCGA-09-1667-01	17	34	46	0.16746810436548548	TCGA-09-1667-01	21	18	7	46	PASS	6971	TCGA-09-1667	OV	61	FEMALE	WHITE	NA	Stage IIC	Serous Cystadenocarcinoma	G2	2004	NA	-22306	Alive	WITH TUMOR	1882	NA	NA	Recurrence	NA	NA	460	Complete Remission/Response	NA	NA	0	1882	0	1882	1	460	1	460	
60	TCGA-09-1668	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-09-1668-01	220	0.7388472534795005	123	TCGA-09-1668-01	18	25	44	0.3504583080809152	TCGA-09-1668-01	20	25	11	56	PASS	6972	TCGA-09-1668	OV	57	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-20972	Alive	WITH TUMOR	1684	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1684	0	1684	0	1684	0	1684	
50	TCGA-09-1669	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-09-1669-01	368	0.8123762397199672	238	TCGA-09-1669-01	7	15	46	0.27685404918495793	TCGA-09-1669-01	19	18	13	50	PASS	6973	TCGA-09-1669	OV	54	FEMALE	WHITE	NA	Stage IIIA	Serous Cystadenocarcinoma	G3	2004	NA	-20052	Alive	WITH TUMOR	928	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	928	0	928	0	928	0	928	
60	TCGA-09-1670	0	2	0	2	0	0	1	0	0	24	2	0	1	6	2	0	TCGA-09-1670-01	96	0.8475135504359066	42	TCGA-09-1670	0	0	0	0	TCGA-09-1670	0	0	0	0	PASS	6974	TCGA-09-1670	OV	57	FEMALE	WHITE	NA	Stage IIIA	Serous Cystadenocarcinoma	G3	2005	NA	-21147	Alive	WITH TUMOR	547	NA	NA	Recurrence	NA	NA	547	Complete Remission/Response	NA	NA	0	547	0	547	1	547	1	547	
80	TCGA-09-1672	0	3	0	1	4	1	0	0	1	17	0	0	0	9	0	0	TCGA-09-1672-01	104	0.6556481344704953	50	TCGA-09-1672-01	25	26	5	0.1234549061358763	TCGA-09-1672-01	1	0	1	2	PASS	6975	TCGA-09-1672	OV	78	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G1	2008	NA	-28556	Alive	TUMOR FREE	178	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	178	0	178	NA	NA	0	178	
50	TCGA-09-1673	0	5	1	0	1	1	0	0	3	38	1	0	1	8	1	0	TCGA-09-1673-01	1099	0.6029839702422931	765	TCGA-09-1673-01	17	18	103	0.16086528990421184	TCGA-09-1673-01	21	4	7	32	PASS	6976	TCGA-09-1673	OV	50	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2008	NA	-18599	Alive	WITH TUMOR	92	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	92	0	92	NA	NA	0	92	
80	TCGA-09-1674	0	7	0	2	4	3	0	0	3	96	5	0	0	30	1	0	TCGA-09-1674-01	332	0.8921166049622313	222	TCGA-09-1674-01	24	30	33	0.3064239282106841	TCGA-09-1674-01	21	14	6	41	PASS	6977	TCGA-09-1674	OV	79	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-28878	Alive	WITH TUMOR	260	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	260	0	260	0	260	0	260	
50	TCGA-09-1675	1	11	0	2	1	0	3	0	0	50	1	0	2	15	1	0	TCGA-09-1675-01	345	0.9552415708423804	219	TCGA-09-1675-01	6	15	70	0.39186317348013866	TCGA-09-1675-01	19	29	20	68	PASS	6978	TCGA-09-1675	OV	50	FEMALE	NA	NA	Stage IC	Serous Cystadenocarcinoma	G2	2001	NA	-18596	Alive	TUMOR FREE	2967	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2967	0	2967	0	2967	0	2967	
70	TCGA-09-2043	1	9	0	4	4	0	1	0	3	91	6	0	3	23	3	0	TCGA-09-2043-01	537	0.6260612651230885	374	TCGA-09-2043-01	9	46	114	0.4819278853272668	TCGA-09-2043-01	25	28	19	72	PASS	6979	TCGA-09-2043	OV	69	FEMALE	WHITE	NA	Stage IC	Serous Cystadenocarcinoma	G3	2009	NA	-25480	Alive	TUMOR FREE	188	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	188	0	188	0	188	0	188	
80	TCGA-09-2044	6	59	5	33	15	1	2	0	56	1668	129	1	17	897	32	5	TCGA-09-2044-01	572	0.9130772695410024	381	TCGA-09-2044-01	9	19	131	0.4129951511151972	TCGA-09-2044-01	28	28	22	78	PASS	6980	TCGA-09-2044	OV	77	FEMALE	ASIAN	NA	Stage IIB	Serous Cystadenocarcinoma	G3	2009	NA	-28231	Alive	TUMOR FREE	186	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	186	0	186	0	186	0	186	
50	TCGA-09-2045	0	2	0	3	2	0	0	0	4	35	3	0	0	11	1	0	TCGA-09-2045	0	0	0	TCGA-09-2045	0	0	0	0	TCGA-09-2045-01	18	23	8	49	PASS	6981	TCGA-09-2045	OV	50	FEMALE	ASIAN	NA	Stage IV	Serous Cystadenocarcinoma	G2	1996	NA	-18285	Dead	WITH TUMOR	NA	1069	NA	Recurrence	NA	NA	631	Stable Disease	NA	NA	1	1069	1	1069	NA	NA	1	631	
60	TCGA-09-2048	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-09-2048	0	0	0	TCGA-09-2048	0	0	0	0	TCGA-09-2048-01	27	44	28	99	PASS	6982	TCGA-09-2048	OV	63	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-23043	Dead	WITH TUMOR	NA	138	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	138	1	138	NA	NA	1	138	
60	TCGA-09-2049	0	5	0	5	10	3	3	0	4	108	8	1	4	37	2	0	TCGA-09-2049-01	229	0.7741708396173785	126	TCGA-09-2049-01	14	34	36	0.233986933460828	TCGA-09-2049-01	28	31	7	66	PASS	6983	TCGA-09-2049	OV	64	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-23410	Alive	WITH TUMOR	3419	NA	NA	Recurrence	NA	NA	953	Complete Remission/Response	NA	NA	0	3419	0	3419	1	953	1	953	
70	TCGA-09-2050	0	7	0	5	7	0	1	0	10	82	8	0	3	36	5	0	TCGA-09-2050-01	362	0.9351424719846892	245	TCGA-09-2050-01	10	16	73	0.4432286842021497	TCGA-09-2050-01	19	22	17	58	PASS	6984	TCGA-09-2050	OV	65	FEMALE	WHITE	NA	Stage IIA	Serous Cystadenocarcinoma	G2	2003	NA	-23987	Alive	TUMOR FREE	2163	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2163	0	2163	0	2163	0	2163	
40	TCGA-09-2051	0	15	1	9	5	4	2	0	7	201	12	0	6	59	6	0	TCGA-09-2051-01	492	0.7832803334646334	325	TCGA-09-2051-01	14	35	108	0.4437643150185123	TCGA-09-2051-01	24	30	17	71	PASS	6985	TCGA-09-2051	OV	42	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-15650	Alive	TUMOR FREE	1919	NA	NA	Recurrence	NA	NA	583	Complete Remission/Response	NA	NA	0	1919	0	1919	1	583	1	583	
70	TCGA-09-2053	0	5	0	2	2	3	0	0	3	60	4	0	1	20	4	0	TCGA-09-2053-01	346	0.9012692933025072	216	TCGA-09-2053-01	16	17	79	0.4122082475525301	TCGA-09-2053-01	16	8	7	31	PASS	6986	TCGA-09-2053	OV	72	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-26433	Alive	TUMOR FREE	1209	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1209	0	1209	0	1209	0	1209	
60	TCGA-09-2054	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-09-2054-01	467	0.8977360764266722	301	TCGA-09-2054-01	16	43	65	0.2793037402552648	TCGA-09-2054-01	17	19	10	46	PASS	6987	TCGA-09-2054	OV	58	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-21285	Dead	WITH TUMOR	637	637	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	637	1	637	NA	NA	1	637	
50	TCGA-09-2055	0	8	2	1	4	0	1	1	1	86	6	0	4	30	1	0	TCGA-09-2055-01	209	0.6477962731140298	120	TCGA-09-2055-01	6	16	31	0.2709236806828214	TCGA-09-2055-01	24	20	9	53	PASS	6988	TCGA-09-2055	OV	48	FEMALE	WHITE	NA	Stage IC	Serous Cystadenocarcinoma	G3	2007	NA	-17545	Alive	TUMOR FREE	819	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	819	0	819	0	819	0	819	
60	TCGA-09-2056	0	4	0	1	4	4	0	0	1	74	4	1	2	13	3	0	TCGA-09-2056	0	0	0	TCGA-09-2056	0	0	0	0	TCGA-09-2056-01	18	19	15	52	PASS	6989	TCGA-09-2056	OV	62	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-22864	Alive	TUMOR FREE	379	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	379	0	379	0	379	0	379	
60	TCGA-10-0925	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-10-0925-01	200	0.9506012760246496	118	TCGA-10-0925-01	4	8	24	0.2162638083006828	TCGA-10-0925-01	17	16	12	45	PASS	6990	TCGA-10-0925	OV	58	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G1	2000	NA	-21498	Dead	WITH TUMOR	1652	1652	NA	Recurrence	NA	NA	558	Partial Remission/Response	NA	NA	1	1652	1	1652	NA	NA	1	558	
60	TCGA-10-0926	0	2	0	0	0	0	0	0	0	17	1	0	0	9	0	0	TCGA-10-0926-01	160	0.9205095442037601	89	TCGA-10-0926-01	20	29	34	0.2479260724756413	TCGA-10-0926-01	7	3	2	12	PASS	6991	TCGA-10-0926	OV	63	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-23307	Dead	WITH TUMOR	788	788	NA	Recurrence	NA	NA	287	Complete Remission/Response	NA	NA	1	788	1	788	1	287	1	287	
70	TCGA-10-0927	0	0	0	0	1	0	0	0	2	15	1	0	0	6	0	1	TCGA-10-0927-01	217	0.9155031600108215	128	TCGA-10-0927-01	20	32	37	0.3577387850310132	TCGA-10-0927-01	8	6	5	19	PASS	6992	TCGA-10-0927	OV	65	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2000	NA	-23982	Dead	WITH TUMOR	2478	2490	NA	Recurrence	NA	NA	1001	Complete Remission/Response	NA	NA	1	2490	1	2490	1	1001	1	1001	
70	TCGA-10-0928	0	1	0	0	1	1	0	0	2	3	0	0	0	4	0	0	TCGA-10-0928-01	416	0.9753936053487544	252	TCGA-10-0928-01	7	23	112	0.5258982561028824	TCGA-10-0928-01	35	41	22	98	PASS	6993	TCGA-10-0928	OV	71	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-26066	Dead	WITH TUMOR	563	563	NA	NA	NA	NA	NA	NA	NA	NA	1	563	1	563	NA	NA	1	563	
70	TCGA-10-0930	1	11	0	10	5	4	4	0	8	119	8	3	3	34	13	0	TCGA-10-0930-01	419	0.8194997177841931	275	TCGA-10-0930-01	16	31	104	0.3845568101496785	TCGA-10-0930-01	30	38	16	84	PASS	6994	TCGA-10-0930	OV	70	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-25737	Dead	WITH TUMOR	1011	1040	NA	Recurrence	NA	NA	680	Complete Remission/Response	NA	NA	1	1040	1	1040	1	680	1	680	
40	TCGA-10-0931	0	5	1	1	0	3	1	0	2	44	6	0	1	18	0	1	TCGA-10-0931-01	219	0.7109378919118261	123	TCGA-10-0931-01	6	19	49	0.3844403548406168	TCGA-10-0931-01	25	21	16	62	PASS	6995	TCGA-10-0931	OV	44	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-16262	Dead	WITH TUMOR	982	1000	NA	Recurrence	NA	NA	300	Complete Remission/Response	NA	NA	1	1000	1	1000	1	300	1	300	
80	TCGA-10-0933	0	4	0	1	2	0	0	0	1	60	3	0	7	31	2	0	TCGA-10-0933-01	216	0.9472465482666292	127	TCGA-10-0933-01	27	43	25	0.2713650032136041	TCGA-10-0933-01	15	7	6	28	PASS	6996	TCGA-10-0933	OV	77	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-28433	Dead	WITH TUMOR	356	446	NA	Recurrence	NA	NA	356	Complete Remission/Response	NA	NA	1	446	1	446	1	356	1	356	
50	TCGA-10-0934	0	1	0	0	0	0	0	0	2	13	0	0	0	4	1	0	TCGA-10-0934-01	363	0.12828185625673222	243	TCGA-10-0934-01	0	3	17	0.0806854832198184	TCGA-10-0934-01	3	9	5	17	PASS	6997	TCGA-10-0934	OV	50	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-18602	Dead	WITH TUMOR	119	204	NA	Recurrence	NA	NA	111	Progressive Disease	NA	NA	1	204	1	204	NA	NA	1	111	
70	TCGA-10-0935	1	5	0	2	2	0	1	0	2	40	2	0	2	11	3	0	TCGA-10-0935-01	189	0.6515355621229351	106	TCGA-10-0935-01	18	32	31	0.1888034610228713	TCGA-10-0935-01	11	17	2	30	PASS	6998	TCGA-10-0935	OV	68	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-25098	Dead	WITH TUMOR	1078	1078	NA	NA	NA	NA	NA	NA	NA	NA	1	1078	1	1078	NA	NA	1	1078	
70	TCGA-10-0936	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-10-0936-01	469	0.9480537082719266	301	TCGA-10-0936-01	28	29	42	0.13117502844918685	TCGA-10-0936-01	13	12	3	28	PASS	6999	TCGA-10-0936	OV	69	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-25454	Dead	WITH TUMOR	1089	1123	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	1123	1	1123	NA	NA	1	1123	
40	TCGA-10-0937	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	TCGA-10-0937-01	224	0.8560585680770699	117	TCGA-10-0937-01	4	16	42	0.2980835513236275	TCGA-10-0937-01	25	29	14	68	PASS	7000	TCGA-10-0937	OV	44	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-16222	Dead	WITH TUMOR	460	608	NA	Recurrence	NA	NA	235	Complete Remission/Response	NA	NA	1	608	1	608	1	235	1	235	
80	TCGA-10-0938	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-10-0938-01	269	0.9748176730081934	190	TCGA-10-0938-01	20	63	45	0.16922345666598604	TCGA-10-0938-01	16	9	5	30	PASS	7001	TCGA-10-0938	OV	80	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-29558	Dead	WITH TUMOR	604	636	NA	Progression of Disease	NA	NA	362	Progressive Disease	NA	NA	1	636	1	636	NA	NA	1	362	
60	TCGA-13-0714	0	0	0	0	0	0	0	0	0	7	0	0	0	0	0	0	TCGA-13-0714-01	336	0.3801306310806009	218	TCGA-13-0714-01	5	18	96	0.33286418161390785	TCGA-13-0714-01	28	35	20	83	PASS	7002	TCGA-13-0714	OV	55	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2000	NA	-20109	Dead	WITH TUMOR	189	189	NA	Progression of Disease	NA	NA	110	Progressive Disease	NA	NA	1	189	1	189	NA	NA	1	110	
50	TCGA-13-0717	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	TCGA-13-0717-01	368	0.8773718924994685	225	TCGA-13-0717	0	0	0	0	TCGA-13-0717	0	0	0	0	PASS	7003	TCGA-13-0717	OV	54	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-20042	Dead	WITH TUMOR	748	748	NA	Recurrence	NA	NA	294	Complete Remission/Response	NA	NA	1	748	1	748	1	294	1	294	
50	TCGA-13-0720	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0720-01	178	0.9802037813567389	88	TCGA-13-0720-01	5	15	37	0.3894876633925152	TCGA-13-0720-01	17	23	12	52	PASS	7004	TCGA-13-0720	OV	48	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-17799	Dead	WITH TUMOR	1355	1355	NA	Recurrence	NA	NA	292	Complete Remission/Response	NA	NA	1	1355	1	1355	1	292	1	292	
60	TCGA-13-0723	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0723-01	426	0.6889446195673121	260	TCGA-13-0723-01	21	30	65	0.282469725018745	TCGA-13-0723-01	16	11	13	40	PASS	7005	TCGA-13-0723	OV	63	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-23094	Dead	WITH TUMOR	1204	1204	NA	Progression of Disease	NA	NA	210	Progressive Disease	NA	NA	1	1204	1	1204	NA	NA	1	210	
70	TCGA-13-0724	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0724-01	586	0.9309487723502049	386	TCGA-13-0724-01	22	35	84	0.2587613376786375	TCGA-13-0724-01	15	10	7	32	PASS	7006	TCGA-13-0724	OV	72	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2002	NA	-26342	Dead	WITH TUMOR	83	83	NA	Progression of Disease	NA	NA	83	Progressive Disease	NA	NA	1	83	1	83	NA	NA	1	83	
40	TCGA-13-0725	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0725-01	186	0.9444678442834084	100	TCGA-13-0725-01	5	11	39	0.3002883322296908	TCGA-13-0725-01	22	20	18	60	PASS	7007	TCGA-13-0725	OV	44	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-16086	Dead	WITH TUMOR	377	377	NA	Recurrence	NA	NA	190	Complete Remission/Response	NA	NA	1	377	1	377	1	190	1	190	
60	TCGA-13-0726	0	5	0	1	2	3	0	0	2	64	3	0	1	18	6	0	TCGA-13-0726-01	232	0.4896045176569761	152	TCGA-13-0726-01	8	15	46	0.2960583365041752	TCGA-13-0726-01	15	22	9	46	PASS	7008	TCGA-13-0726	OV	55	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	GX	2002	NA	-20134	Dead	WITH TUMOR	946	949	NA	Recurrence	NA	NA	392	Complete Remission/Response	NA	NA	1	949	1	949	1	392	1	392	
70	TCGA-13-0727	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0727-01	270	0.6390344391593953	157	TCGA-13-0727-01	20	30	33	0.2118148402798675	TCGA-13-0727-01	9	4	2	15	PASS	7009	TCGA-13-0727	OV	71	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-26185	Dead	WITH TUMOR	462	462	NA	Recurrence	NA	NA	253	Complete Remission/Response	NA	NA	1	462	1	462	1	253	1	253	
70	TCGA-13-0730	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0730-01	263	0.6767235972492656	161	TCGA-13-0730-01	23	36	37	0.2425362632214053	TCGA-13-0730-01	23	16	5	44	PASS	7010	TCGA-13-0730	OV	71	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-26086	Dead	NA	NA	542	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	542	NA	542	NA	NA	0	542	
40	TCGA-13-0751	1	7	0	3	2	1	0	0	5	39	4	0	2	20	1	0	TCGA-13-0751-01	400	0.9809875874764248	248	TCGA-13-0751-01	22	34	64	0.2186921363864804	TCGA-13-0751-01	15	22	4	41	PASS	7011	TCGA-13-0751	OV	44	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	GX	1999	NA	-16304	Dead	WITH TUMOR	1678	1678	NA	Recurrence	NA	NA	653	Complete Remission/Response	NA	NA	1	1678	1	1678	1	653	1	653	
80	TCGA-13-0755	1	8	0	2	3	0	1	0	4	91	7	0	0	31	3	0	TCGA-13-0755-01	297	0.941463263502938	181	TCGA-13-0755-01	5	11	54	0.2715987134884464	TCGA-13-0755-01	19	25	10	54	PASS	7012	TCGA-13-0755	OV	75	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2003	NA	-27438	Dead	WITH TUMOR	76	76	NA	Progression of Disease	NA	NA	34	Progressive Disease	NA	NA	1	76	1	76	NA	NA	1	34	
70	TCGA-13-0757	0	4	1	2	3	4	0	0	6	74	4	0	2	26	4	0	TCGA-13-0757-01	393	0.8668036881609131	274	TCGA-13-0757-01	26	63	34	0.22832234619272235	TCGA-13-0757-01	17	17	5	39	PASS	7013	TCGA-13-0757	OV	71	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-25999	Dead	WITH TUMOR	340	340	NA	Recurrence	NA	NA	293	Complete Remission/Response	NA	NA	1	340	1	340	1	293	1	293	
60	TCGA-13-0758	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0758-01	362	0.8231372371631572	222	TCGA-13-0758-01	20	25	56	0.28502892669265584	TCGA-13-0758-01	26	31	16	73	PASS	7014	TCGA-13-0758	OV	60	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2005	NA	-22088	Dead	WITH TUMOR	346	346	NA	Progression of Disease	NA	NA	212	Partial Remission/Response	NA	NA	1	346	1	346	NA	NA	1	212	
60	TCGA-13-0760	0	7	2	7	3	3	4	0	8	146	9	0	0	48	6	0	TCGA-13-0760-01	931	0.9561225018930024	593	TCGA-13-0760-01	13	45	196	0.4072737678909	TCGA-13-0760-01	26	35	18	79	PASS	7015	TCGA-13-0760	OV	63	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2006	NA	-23036	Dead	NA	351	351	NA	NA	NA	NA	NA	NA	NA	NA	1	351	NA	351	NA	NA	0	351	
50	TCGA-13-0761	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0761-01	297	0.5989836794733044	177	TCGA-13-0761-01	9	22	53	0.30782094688702744	TCGA-13-0761-01	21	27	13	61	PASS	7016	TCGA-13-0761	OV	51	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2006	NA	-18697	Dead	WITH TUMOR	NA	1156	NA	Recurrence	NA	NA	424	Complete Remission/Response	NA	NA	1	1156	1	1156	NA	NA	1	424	
70	TCGA-13-0762	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0762-01	290	0.8278580834522511	176	TCGA-13-0762-01	23	61	80	0.2041627086636261	TCGA-13-0762-01	14	18	8	40	PASS	7017	TCGA-13-0762	OV	65	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-23960	Alive	WITH TUMOR	3400	NA	NA	NA	NA	NA	1003	Complete Remission/Response	NA	NA	0	3400	0	3400	1	1003	1	1003	
60	TCGA-13-0764	0	2	0	0	1	1	0	0	2	30	1	1	1	5	2	0	TCGA-13-0764-01	574	0.7286270331763545	367	TCGA-13-0764-01	15	79	92	0.2977304567881079	TCGA-13-0764-01	28	18	11	57	PASS	7018	TCGA-13-0764	OV	62	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2006	NA	-22965	Dead	WITH TUMOR	NA	1881	NA	Recurrence	NA	NA	272	Partial Remission/Response	NA	NA	1	1881	1	1881	NA	NA	1	272	
50	TCGA-13-0765	0	7	1	1	1	0	0	1	1	25	1	0	1	9	1	0	TCGA-13-0765	0	0	0	TCGA-13-0765	0	0	0	0	TCGA-13-0765	0	0	0	0	PASS	7019	TCGA-13-0765	OV	50	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-18574	Dead	WITH TUMOR	NA	1389	NA	Recurrence	NA	NA	668	Complete Remission/Response	NA	NA	1	1389	1	1389	1	668	1	668	
40	TCGA-13-0766	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0766-01	360	0.9159985926679378	233	TCGA-13-0766-01	5	21	99	0.4141860430801356	TCGA-13-0766-01	28	27	18	73	PASS	7020	TCGA-13-0766	OV	42	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-15571	Dead	WITH TUMOR	NA	1725	NA	Recurrence	NA	NA	628	Complete Remission/Response	NA	NA	1	1725	1	1725	1	628	1	628	
70	TCGA-13-0768	0	1	0	0	1	1	0	0	1	17	1	0	1	11	1	0	TCGA-13-0768-01	195	0.3310839746519158	95	TCGA-13-0768-01	12	26	37	0.3579993949033156	TCGA-13-0768-01	19	6	12	37	PASS	7021	TCGA-13-0768	OV	73	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-26999	Dead	WITH TUMOR	NA	1784	NA	NA	NA	NA	398	Complete Remission/Response	NA	NA	1	1784	1	1784	1	398	1	398	
60	TCGA-13-0791	0	7	0	3	2	1	0	1	2	79	5	0	6	24	5	0	TCGA-13-0791-01	1122	0.4580900146161946	784	TCGA-13-0791-01	8	10	136	0.2381586283329402	TCGA-13-0791-01	16	16	11	43	PASS	7022	TCGA-13-0791	OV	58	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-21380	Dead	WITH TUMOR	NA	1224	NA	Recurrence	NA	NA	281	Complete Remission/Response	NA	NA	1	1224	1	1224	1	281	1	281	
40	TCGA-13-0792	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0792-01	517	0.9534669889443486	333	TCGA-13-0792-01	15	37	88	0.35104101251361985	TCGA-13-0792-01	29	38	12	79	PASS	7023	TCGA-13-0792	OV	40	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-14729	Alive	WITH TUMOR	3602	NA	NA	Recurrence	NA	NA	816	Complete Remission/Response	NA	NA	0	3602	0	3602	1	816	1	816	
40	TCGA-13-0793	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0793-01	232	0.9995927849815126	137	TCGA-13-0793-01	11	14	48	0.4112381919928686	TCGA-13-0793-01	16	15	11	42	PASS	7024	TCGA-13-0793	OV	40	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2006	NA	-14708	Alive	WITH TUMOR	3263	NA	NA	Recurrence	NA	NA	351	Complete Remission/Response	NA	NA	0	3263	0	3263	NA	NA	1	351	
60	TCGA-13-0794	0	2	0	0	0	0	0	0	0	28	1	0	0	4	0	0	TCGA-13-0794-01	651	0.9292996554647792	421	TCGA-13-0794-01	17	19	74	0.09879337634446113	TCGA-13-0794-01	16	19	5	40	PASS	7025	TCGA-13-0794	OV	60	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-21945	Dead	WITH TUMOR	NA	1919	NA	Recurrence	NA	NA	845	Complete Remission/Response	NA	NA	1	1919	1	1919	1	845	1	845	
70	TCGA-13-0795	0	10	0	1	3	0	1	0	6	71	2	1	0	22	3	0	TCGA-13-0795-01	244	0.6826232415667843	148	TCGA-13-0795-01	21	77	26	0.13749716003879314	TCGA-13-0795-01	19	15	4	38	PASS	7026	TCGA-13-0795	OV	66	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-24403	Dead	WITH TUMOR	NA	619	NA	Recurrence	NA	NA	325	Complete Remission/Response	NA	NA	1	619	1	619	1	325	1	325	
50	TCGA-13-0797	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0797-01	354	0.8909037692605872	216	TCGA-13-0797-01	7	13	55	0.3264712324778755	TCGA-13-0797-01	21	19	10	50	PASS	7027	TCGA-13-0797	OV	49	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-18051	Alive	WITH TUMOR	2121	NA	NA	NA	NA	NA	525	Complete Remission/Response	NA	NA	0	2121	0	2121	1	525	1	525	
40	TCGA-13-0799	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0799-01	291	0.9384168126023956	182	TCGA-13-0799-01	6	20	37	0.29554480101167724	TCGA-13-0799-01	21	20	15	56	PASS	7028	TCGA-13-0799	OV	44	FEMALE	ASIAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-16171	Alive	TUMOR FREE	2535	NA	NA	NA	NA	NA	1262	Complete Remission/Response	NA	NA	0	2535	0	2535	1	1262	1	1262	
50	TCGA-13-0800	0	7	1	8	4	2	1	1	12	96	10	0	3	36	3	0	TCGA-13-0800-01	293	0.8189491140080202	192	TCGA-13-0800-01	29	25	39	0.13126959081016987	TCGA-13-0800-01	9	6	3	18	PASS	7029	TCGA-13-0800	OV	52	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-19087	Alive	TUMOR FREE	2661	NA	NA	NA	NA	NA	1396	Complete Remission/Response	NA	NA	0	2661	0	2661	1	1396	1	1396	
50	TCGA-13-0801	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0801-01	539	0.9821910707305258	358	TCGA-13-0801-01	9	16	95	0.4490497955071725	TCGA-13-0801-01	21	31	21	73	PASS	7030	TCGA-13-0801	OV	46	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-16812	Dead	WITH TUMOR	NA	1399	NA	NA	NA	NA	345	Complete Remission/Response	NA	NA	1	1399	1	1399	1	345	1	345	
80	TCGA-13-0802	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0802-01	351	0.5944655864407429	218	TCGA-13-0802-01	13	35	27	0.1931089331251551	TCGA-13-0802-01	19	17	7	43	PASS	7031	TCGA-13-0802	OV	79	FEMALE	ASIAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-29075	Dead	WITH TUMOR	NA	1552	NA	NA	NA	NA	510	Complete Remission/Response	NA	NA	1	1552	1	1552	1	510	1	510	
80	TCGA-13-0803	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0803-01	561	0.8619891111015486	398	TCGA-13-0803-01	18	38	66	0.1878934952958783	TCGA-13-0803-01	17	21	8	46	PASS	7032	TCGA-13-0803	OV	81	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-29685	Dead	WITH TUMOR	1334	1334	NA	Recurrence	NA	NA	337	Complete Remission/Response	NA	NA	1	1334	1	1334	1	337	1	337	
70	TCGA-13-0804	0	4	0	2	3	1	1	0	1	28	1	0	2	9	0	0	TCGA-13-0804-01	231	0.9993412666595384	126	TCGA-13-0804-01	14	17	38	0.3344206198805492	TCGA-13-0804-01	8	9	10	27	PASS	7033	TCGA-13-0804	OV	73	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-27021	Dead	WITH TUMOR	1073	1073	NA	Recurrence	NA	NA	329	Complete Remission/Response	NA	NA	1	1073	1	1073	1	329	1	329	
60	TCGA-13-0805	0	2	0	0	1	0	0	0	2	23	2	0	0	7	0	0	TCGA-13-0805-01	176	0.939180062544968	96	TCGA-13-0805-01	9	14	38	0.3765181159767913	TCGA-13-0805-01	14	15	13	42	PASS	7034	TCGA-13-0805	OV	57	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-21014	Dead	WITH TUMOR	1073	1074	NA	Progression of Disease	NA	NA	177	Progressive Disease	NA	NA	1	1074	1	1074	NA	NA	1	177	
50	TCGA-13-0807	2	32	1	11	0	5	1	0	13	250	22	0	6	105	6	0	TCGA-13-0807-01	508	0.5746499047606551	320	TCGA-13-0807-01	16	30	105	0.27141621398314536	TCGA-13-0807-01	14	8	7	29	PASS	7035	TCGA-13-0807	OV	54	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-19890	Dead	NA	414	414	NA	NA	NA	NA	NA	NA	NA	NA	1	414	NA	414	NA	NA	0	414	
60	TCGA-13-0883	1	2	0	0	0	4	0	0	2	32	2	0	0	3	0	0	TCGA-13-0883-01	143	0.6933695743582955	73	TCGA-13-0883-01	13	29	29	0.2610958446102139	TCGA-13-0883-01	18	25	6	49	PASS	7036	TCGA-13-0883	OV	61	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-22395	Dead	WITH TUMOR	2097	2097	NA	Recurrence	NA	NA	819	Complete Remission/Response	NA	NA	1	2097	1	2097	1	819	1	819	
40	TCGA-13-0884	0	6	0	2	6	0	2	0	4	90	7	0	3	29	6	0	TCGA-13-0884-01	132	0.7174280022246596	68	TCGA-13-0884-01	22	59	19	0.22815206892680825	TCGA-13-0884-01	22	19	4	45	PASS	7037	TCGA-13-0884	OV	39	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-14538	Dead	WITH TUMOR	3260	3260	NA	Recurrence	NA	NA	1251	Complete Remission/Response	NA	NA	1	3260	1	3260	1	1251	1	1251	
70	TCGA-13-0885	0	8	1	4	5	2	4	0	12	157	6	0	4	54	3	0	TCGA-13-0885-01	223	0.8272882848999574	117	TCGA-13-0885-01	23	64	49	0.32201810377009416	TCGA-13-0885-01	28	33	7	68	PASS	7038	TCGA-13-0885	OV	70	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-25763	Alive	NA	3388	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3388	0	3388	0	3388	0	3388	
70	TCGA-13-0886	1	2	1	2	5	2	0	0	4	30	0	0	1	16	0	1	TCGA-13-0886-01	209	0.6688904332049495	124	TCGA-13-0886-01	7	13	39	0.2957330748029828	TCGA-13-0886-01	15	25	13	53	PASS	7039	TCGA-13-0886	OV	67	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-24724	Alive	TUMOR FREE	4665	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4665	0	4665	0	4665	0	4665	
40	TCGA-13-0887	0	10	0	4	5	4	2	0	3	120	5	0	2	48	5	0	TCGA-13-0887-01	398	0.8634207088202931	244	TCGA-13-0887-01	3	15	101	0.3862874278876103	TCGA-13-0887-01	21	36	19	76	PASS	7040	TCGA-13-0887	OV	42	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-15669	Dead	WITH TUMOR	2028	2028	NA	Recurrence	NA	NA	514	Complete Remission/Response	NA	NA	1	2028	1	2028	1	514	1	514	
80	TCGA-13-0888	0	14	0	4	2	3	1	0	7	145	11	1	2	67	3	0	TCGA-13-0888-01	470	0.9339537516901694	320	TCGA-13-0888-01	25	64	93	0.4839267387145111	TCGA-13-0888-01	18	10	0	28	mutation call filter	7041	TCGA-13-0888	OV	78	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-28498	Dead	TUMOR FREE	NA	2811	NA	NA	NA	NA	NA	[Discrepancy]	NA	NA	1	2811	0	2811	NA	NA	0	2811	
80	TCGA-13-0889	1	13	0	1	0	1049	0	0	17	4	8	0	2	1	10	0	TCGA-13-0889-01	259	0.8068285614065771	156	TCGA-13-0889-01	4	9	45	0.22881591715891936	TCGA-13-0889-01	15	14	9	38	hypermutated sample	7042	TCGA-13-0889	OV	75	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	GX	2003	NA	-27674	Dead	TUMOR FREE	NA	2894	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2894	0	2894	NA	NA	0	2894	
60	TCGA-13-0890	0	5	0	1	5	3	1	0	2	60	1	0	1	17	4	0	TCGA-13-0890-01	252	0.9246292581128629	138	TCGA-13-0890-01	12	18	79	0.5638732976855384	TCGA-13-0890-01	20	20	17	57	PASS	7043	TCGA-13-0890	OV	56	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-20770	Alive	TUMOR FREE	4424	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4424	0	4424	0	4424	0	4424	
70	TCGA-13-0891	0	2	0	0	2	2	1	0	1	20	0	0	0	5	2	0	TCGA-13-0891-01	530	0.9188954998000329	356	TCGA-13-0891-01	25	18	79	0.2750671688401945	TCGA-13-0891-01	16	8	5	29	PASS	7044	TCGA-13-0891	OV	73	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2003	NA	-26886	Dead	WITH TUMOR	NA	3128	NA	Recurrence	NA	NA	762	Complete Remission/Response	NA	NA	1	3128	1	3128	NA	NA	1	762	
50	TCGA-13-0893	0	6	1	2	2	0	1	0	3	70	3	0	2	18	3	0	TCGA-13-0893-01	527	0.6674608353426045	325	TCGA-13-0893-01	6	34	100	0.2701903544018047	TCGA-13-0893-01	26	36	15	77	PASS	7045	TCGA-13-0893	OV	48	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-17573	Dead	WITH TUMOR	1319	1319	NA	Recurrence	NA	NA	461	Partial Remission/Response	NA	NA	1	1319	1	1319	NA	NA	1	461	
50	TCGA-13-0894	2	5	1	6	1	3	1	0	1	95	4	0	1	27	3	0	TCGA-13-0894	0	0	0	TCGA-13-0894	0	0	0	0	TCGA-13-0894	0	0	0	0	PASS	7046	TCGA-13-0894	OV	53	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-19466	Dead	WITH TUMOR	1509	1509	NA	Recurrence	NA	NA	565	Complete Remission/Response	NA	NA	1	1509	1	1509	1	565	1	565	
50	TCGA-13-0897	0	4	0	0	4	1	1	0	1	42	3	0	1	13	3	0	TCGA-13-0897-01	302	0.5074376529252036	173	TCGA-13-0897-01	7	18	59	0.27660722198193965	TCGA-13-0897-01	21	27	11	59	PASS	7047	TCGA-13-0897	OV	54	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-19894	Dead	WITH TUMOR	NA	2182	NA	Recurrence	NA	NA	554	Complete Remission/Response	NA	NA	1	2182	1	2182	1	554	1	554	
60	TCGA-13-0899	0	4	0	1	1	0	0	0	3	19	1	0	2	6	0	0	TCGA-13-0899-01	212	0.7242419945365137	120	TCGA-13-0899-01	23	67	25	0.1853937825333729	TCGA-13-0899-01	14	7	6	27	PASS	7048	TCGA-13-0899	OV	60	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-22031	Dead	WITH TUMOR	NA	2012	NA	Recurrence	NA	NA	547	Complete Remission/Response	NA	NA	1	2012	1	2012	1	547	1	547	
60	TCGA-13-0900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0900-01	380	0.8985431433570201	241	TCGA-13-0900-01	4	13	88	0.36161404928847096	TCGA-13-0900-01	23	29	17	69	PASS	7049	TCGA-13-0900	OV	59	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-21698	Alive	TUMOR FREE	4077	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4077	0	4077	0	4077	0	4077	
40	TCGA-13-0901	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0901-01	434	0.669516444116227	276	TCGA-13-0901-01	17	30	49	0.1118110980088044	TCGA-13-0901-01	19	12	3	34	PASS	7050	TCGA-13-0901	OV	41	FEMALE	ASIAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-15333	Alive	WITH TUMOR	589	NA	NA	Recurrence	NA	NA	390	Complete Remission/Response	NA	NA	0	589	0	589	1	390	1	390	
40	TCGA-13-0903	1	25	1	12	3	5	4	0	18	211	8	0	4	68	5	0	TCGA-13-0903-01	283	0.960198903315876	162	TCGA-13-0903-01	7	14	71	0.3284247671633044	TCGA-13-0903-01	22	22	17	61	PASS	7051	TCGA-13-0903	OV	42	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2004	NA	-15705	Alive	TUMOR FREE	3887	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3887	0	3887	NA	NA	0	3887	
60	TCGA-13-0904	0	7	0	1	1	1	0	0	0	38	1	0	0	15	2	0	TCGA-13-0904-01	548	0.7866928141073606	373	TCGA-13-0904-01	13	38	114	0.3997675954751918	TCGA-13-0904-01	28	45	13	86	PASS	7052	TCGA-13-0904	OV	63	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-23278	Dead	WITH TUMOR	NA	1532	NA	Progression of Disease	NA	NA	330	Partial Remission/Response	NA	NA	1	1532	1	1532	NA	NA	1	330	
50	TCGA-13-0905	0	4	0	5	1	4	1	0	1	63	3	0	0	30	3	0	TCGA-13-0905-01	308	0.8748078227257602	183	TCGA-13-0905-01	4	13	76	0.3347959530607667	TCGA-13-0905-01	23	47	22	92	PASS	7053	TCGA-13-0905	OV	51	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-18757	Alive	WITH TUMOR	3746	NA	NA	NA	NA	NA	1535	Complete Remission/Response	NA	NA	0	3746	0	3746	1	1535	1	1535	
50	TCGA-13-0906	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0906-01	200	0.9181436003519404	111	TCGA-13-0906-01	4	21	42	0.35764229524653435	TCGA-13-0906-01	24	23	14	61	PASS	7054	TCGA-13-0906	OV	50	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-18383	Alive	TUMOR FREE	3619	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3619	0	3619	0	3619	0	3619	
60	TCGA-13-0908	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0908-01	210	0.5017514235202226	109	TCGA-13-0908-01	6	11	36	0.2484714891988011	TCGA-13-0908-01	20	29	13	62	PASS	7055	TCGA-13-0908	OV	58	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2005	NA	-21422	Dead	WITH TUMOR	NA	1843	NA	Recurrence	NA	NA	552	Complete Remission/Response	NA	NA	1	1843	1	1843	NA	NA	1	552	
60	TCGA-13-0910	0	5	0	0	2	2	0	0	6	47	2	0	0	15	3	0	TCGA-13-0910-01	337	0.9476976546955344	222	TCGA-13-0910-01	13	15	61	0.3650922971018146	TCGA-13-0910-01	10	11	3	24	PASS	7056	TCGA-13-0910	OV	58	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-21473	Alive	WITH TUMOR	3548	NA	NA	NA	NA	NA	1212	Complete Remission/Response	NA	NA	0	3548	0	3548	1	1212	1	1212	
60	TCGA-13-0911	0	2	0	1	1	2	0	0	0	9	1	0	1	4	0	0	TCGA-13-0911-01	237	0.6530325528988272	140	TCGA-13-0911-01	22	25	52	0.3731404167462434	TCGA-13-0911-01	14	10	5	29	PASS	7057	TCGA-13-0911	OV	55	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2005	NA	-20276	Dead	WITH TUMOR	NA	1355	NA	Progression of Disease	NA	NA	279	Partial Remission/Response	NA	NA	1	1355	1	1355	NA	NA	1	279	
60	TCGA-13-0912	0	4	0	4	2	2	1	0	2	33	0	0	1	13	1	0	TCGA-13-0912-01	227	0.9607088717002574	130	TCGA-13-0912-01	8	8	51	0.1975661307396371	TCGA-13-0912-01	12	6	4	22	PASS	7058	TCGA-13-0912	OV	58	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-21427	Dead	WITH TUMOR	NA	1145	NA	Recurrence	NA	NA	469	Complete Remission/Response	NA	NA	1	1145	1	1145	1	469	1	469	
50	TCGA-13-0913	0	3	0	1	4	0	2	0	3	29	1	0	0	11	0	0	TCGA-13-0913-01	335	0.9541008901674042	217	TCGA-13-0913-01	5	18	81	0.3950892566627153	TCGA-13-0913-01	21	28	22	71	PASS	7059	TCGA-13-0913	OV	53	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-19573	Alive	WITH TUMOR	3325	NA	NA	Recurrence	NA	NA	871	Complete Remission/Response	NA	NA	0	3325	0	3325	1	871	1	871	
50	TCGA-13-0916	0	5	0	1	1	2	0	0	3	22	2	0	0	7	1	0	TCGA-13-0916-01	293	1.0	176	TCGA-13-0916-01	9	18	93	0.5023427697407692	TCGA-13-0916-01	26	19	21	66	PASS	7060	TCGA-13-0916	OV	49	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-18189	Alive	TUMOR FREE	1785	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1785	0	1785	0	1785	0	1785	
50	TCGA-13-0919	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0919-01	173	0.7688505018924029	93	TCGA-13-0919-01	22	23	36	0.27387663049774713	TCGA-13-0919-01	19	20	9	48	PASS	7061	TCGA-13-0919	OV	52	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-19337	Alive	TUMOR FREE	2571	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2571	0	2571	0	2571	0	2571	
70	TCGA-13-0920	2	12	1	3	9	1	4	0	7	234	15	0	7	83	7	1	TCGA-13-0920-01	563	0.8241912932774977	357	TCGA-13-0920	0	0	0	0	TCGA-13-0920	0	0	0	0	PASS	7062	TCGA-13-0920	OV	65	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-24064	Dead	WITH TUMOR	NA	1484	NA	Recurrence	NA	NA	297	Complete Remission/Response	NA	NA	1	1484	1	1484	1	297	1	297	
70	TCGA-13-0921	0	3	1	1	0	2	0	0	3	25	1	0	0	17	0	0	TCGA-13-0921-01	454	0.7885347001851895	307	TCGA-13-0921-01	17	41	84	0.15687980081539687	TCGA-13-0921-01	12	12	8	32	PASS	7063	TCGA-13-0921	OV	72	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-26606	Dead	TUMOR FREE	NA	1483	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1483	0	1483	0	1483	0	1483	
70	TCGA-13-0923	0	1	0	0	3	0	1	0	2	43	4	1	1	7	1	0	TCGA-13-0923-01	364	0.7530868887866196	241	TCGA-13-0923-01	8	38	67	0.31290480347794297	TCGA-13-0923-01	24	33	10	67	PASS	7064	TCGA-13-0923	OV	74	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-27081	Alive	TUMOR FREE	2547	NA	NA	NA	NA	NA	1719	Complete Remission/Response	NA	NA	0	2547	0	2547	1	1719	1	1719	
50	TCGA-13-0924	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-0924-01	116	0.8758271804389527	56	TCGA-13-0924-01	11	14	33	0.4092347498751894	TCGA-13-0924-01	19	22	17	58	PASS	7065	TCGA-13-0924	OV	45	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2008	NA	-16670	Alive	WITH TUMOR	2614	NA	NA	NA	NA	NA	962	Complete Remission/Response	NA	NA	0	2614	0	2614	NA	NA	1	962	
50	TCGA-13-1403	0	3	0	4	0	1	2	0	2	53	3	0	1	16	4	0	TCGA-13-1403-01	294	0.4483395418514835	166	TCGA-13-1403-01	10	21	65	0.2817270118385736	TCGA-13-1403-01	18	18	15	51	PASS	7066	TCGA-13-1403	OV	48	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-17697	Dead	WITH TUMOR	NA	2345	NA	NA	NA	NA	418	Complete Remission/Response	NA	NA	1	2345	1	2345	1	418	1	418	
50	TCGA-13-1404	0	5	1	1	1	0	2	0	6	43	4	0	0	12	4	0	TCGA-13-1404-01	293	0.9799207546734175	181	TCGA-13-1404-01	9	15	68	0.3831590662438753	TCGA-13-1404-01	23	25	16	64	PASS	7067	TCGA-13-1404	OV	48	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-17784	Alive	WITH TUMOR	2469	NA	NA	NA	NA	NA	1581	Complete Remission/Response	NA	NA	0	2469	0	2469	1	1581	1	1581	
50	TCGA-13-1405	1	1	0	3	2	2	1	0	3	40	5	0	1	12	3	1	TCGA-13-1405-01	455	0.9502624623318584	319	TCGA-13-1405-01	13	10	109	0.34582007256426983	TCGA-13-1405-01	7	5	3	15	PASS	7068	TCGA-13-1405	OV	49	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2008	NA	-18218	Dead	WITH TUMOR	NA	868	NA	NA	NA	NA	228	Complete Remission/Response	NA	NA	1	868	1	868	NA	NA	1	228	
50	TCGA-13-1407	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-1407-01	303	0.8228975519907425	193	TCGA-13-1407-01	26	34	44	0.16357537829720345	TCGA-13-1407-01	18	8	6	32	PASS	7069	TCGA-13-1407	OV	51	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-18896	Alive	WITH TUMOR	2534	NA	NA	NA	NA	NA	1333	Complete Remission/Response	NA	NA	0	2534	0	2534	1	1333	1	1333	
60	TCGA-13-1408	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-1408-01	259	0.8067353243557979	145	TCGA-13-1408-01	19	69	31	0.1681113074118908	TCGA-13-1408-01	28	32	7	67	PASS	7070	TCGA-13-1408	OV	59	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-21635	Dead	WITH TUMOR	NA	1680	NA	NA	NA	NA	765	Partial Remission/Response	NA	NA	1	1680	1	1680	NA	NA	1	765	
70	TCGA-13-1409	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-1409-01	160	0.9523918325982326	89	TCGA-13-1409-01	23	59	19	0.2069806965654282	TCGA-13-1409-01	10	7	3	20	PASS	7071	TCGA-13-1409	OV	73	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-26836	Dead	WITH TUMOR	NA	1742	NA	NA	NA	NA	690	NA	NA	NA	1	1742	1	1742	NA	NA	1	690	
60	TCGA-13-1410	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-1410-01	330	0.9573251245692358	199	TCGA-13-1410-01	29	69	48	0.25962853450434376	TCGA-13-1410-01	20	14	6	40	PASS	7072	TCGA-13-1410	OV	57	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	GX	2008	NA	-20950	Alive	WITH TUMOR	2464	NA	NA	NA	NA	NA	319	Complete Remission/Response	NA	NA	0	2464	0	2464	NA	NA	1	319	
80	TCGA-13-1411	0	5	0	1	1	3	2	0	3	44	2	1	0	19	8	0	TCGA-13-1411-01	178	0.643359554328076	95	TCGA-13-1411-01	24	37	30	0.2833262487905926	TCGA-13-1411-01	13	10	6	29	PASS	7073	TCGA-13-1411	OV	81	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-29874	Dead	WITH TUMOR	NA	531	NA	NA	NA	NA	238	Partial Remission/Response	NA	NA	1	531	1	531	NA	NA	1	238	
40	TCGA-13-1412	0	9	2	0	1	0	2	0	5	38	3	0	3	24	6	0	TCGA-13-1412-01	202	0.494805672055975	109	TCGA-13-1412-01	6	16	39	0.2543670741560338	TCGA-13-1412-01	22	30	10	62	PASS	7074	TCGA-13-1412	OV	41	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2008	NA	-15119	Dead	WITH TUMOR	NA	984	NA	NA	NA	NA	409	Complete Remission/Response	NA	NA	1	984	1	984	NA	NA	1	409	
50	TCGA-13-1477	1	10	2	2	0	10	1	0	8	167	15	0	4	76	4	0	TCGA-13-1477-01	92	0.18248076296903204	48	TCGA-13-1477-01	4	4	8	0.05803583996017751	TCGA-13-1477-01	4	4	2	10	PASS	7075	TCGA-13-1477	OV	49	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G2	2000	NA	-18111	Dead	WITH TUMOR	1662	1662	NA	Progression of Disease	NA	NA	235	Progressive Disease	NA	NA	1	1662	1	1662	NA	NA	1	235	
80	TCGA-13-1481	3	23	0	7	9	1	3	0	12	188	14	0	4	48	13	0	TCGA-13-1481-01	280	0.6293539732272111	161	TCGA-13-1481-01	7	17	73	0.3821614076634281	TCGA-13-1481-01	18	27	17	62	PASS	7076	TCGA-13-1481	OV	76	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2000	NA	-27898	Dead	TUMOR FREE	2648	2648	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2648	0	2648	0	2648	0	2648	
50	TCGA-13-1482	0	7	0	1	2	3	1	0	1	39	4	0	1	15	7	0	TCGA-13-1482-01	262	0.8568717843464397	159	TCGA-13-1482-01	4	16	52	0.3369704137951204	TCGA-13-1482-01	22	19	10	51	PASS	7077	TCGA-13-1482	OV	52	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G2	2000	NA	-19178	Dead	WITH TUMOR	1877	1877	NA	Recurrence	NA	NA	602	Partial Remission/Response	NA	NA	1	1877	1	1877	NA	NA	1	602	
60	TCGA-13-1483	1	5	1	0	5	0	3	0	2	62	4	0	1	17	2	0	TCGA-13-1483-01	202	0.6345903458589818	112	TCGA-13-1483-01	8	15	47	0.28318882714015065	TCGA-13-1483-01	20	20	14	54	PASS	7078	TCGA-13-1483	OV	61	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-22342	Dead	WITH TUMOR	895	895	NA	Recurrence	NA	NA	297	Partial Remission/Response	NA	NA	1	895	1	895	NA	NA	1	297	
60	TCGA-13-1484	0	4	1	2	1	2	0	0	2	35	3	0	0	15	1	0	TCGA-13-1484-01	170	0.7894101321064303	103	TCGA-13-1484-01	28	34	36	0.37936855536144654	TCGA-13-1484-01	10	7	5	22	PASS	7079	TCGA-13-1484	OV	62	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-22698	Dead	WITH TUMOR	NA	3785	NA	Recurrence	NA	NA	497	Complete Remission/Response	NA	NA	1	3785	1	3785	1	497	1	497	
50	TCGA-13-1485	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-1485-01	111	0.8461403068489894	57	TCGA-13-1485-01	10	8	4	0.017050000568965714	TCGA-13-1485-01	2	0	2	4	PASS	7080	TCGA-13-1485	OV	48	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G2	2001	NA	-17642	Dead	WITH TUMOR	629	629	NA	Progression of Disease	NA	NA	170	Partial Remission/Response	NA	NA	1	629	1	629	NA	NA	1	170	
70	TCGA-13-1487	0	2	0	3	1	0	0	0	1	18	0	0	1	8	1	0	TCGA-13-1487-01	514	0.9470414119720943	362	TCGA-13-1487-01	20	37	121	0.2521869513711812	TCGA-13-1487-01	14	10	5	29	PASS	7081	TCGA-13-1487	OV	74	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	GX	2002	NA	-27176	Dead	WITH TUMOR	681	681	NA	Recurrence	NA	NA	412	Complete Remission/Response	NA	NA	1	681	1	681	NA	NA	1	412	
60	TCGA-13-1488	2	18	0	4	2	0	0	0	5	132	12	0	5	42	3	0	TCGA-13-1488-01	370	0.679700013080846	216	TCGA-13-1488-01	14	33	43	0.1260840706234923	TCGA-13-1488-01	19	28	7	54	PASS	7082	TCGA-13-1488	OV	59	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2002	NA	-21726	Dead	WITH TUMOR	2154	2154	NA	Recurrence	NA	NA	351	Complete Remission/Response	NA	NA	1	2154	1	2154	NA	NA	1	351	
70	TCGA-13-1489	0	3	0	0	3	2	0	0	1	47	2	0	1	14	5	0	TCGA-13-1489-01	451	0.9555906224841276	294	TCGA-13-1489-01	19	20	96	0.4966393948975485	TCGA-13-1489-01	31	26	20	77	PASS	7083	TCGA-13-1489	OV	70	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2002	NA	-25768	Dead	TUMOR FREE	NA	2553	NA	Recurrence	NA	NA	806	Complete Remission/Response	NA	NA	1	2553	0	2553	1	806	1	806	
60	TCGA-13-1491	0	2	0	3	0	2	0	0	1	47	3	0	1	12	1	0	TCGA-13-1491-01	263	0.9476150515970344	163	TCGA-13-1491-01	14	15	67	0.5055208197325267	TCGA-13-1491-01	12	12	7	31	PASS	7084	TCGA-13-1491	OV	55	FEMALE	ASIAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-20262	Dead	WITH TUMOR	1595	1595	NA	Recurrence	NA	NA	508	Partial Remission/Response	NA	NA	1	1595	1	1595	NA	NA	1	508	
70	TCGA-13-1492	0	2	0	0	3	0	1	0	0	10	1	0	0	5	1	0	TCGA-13-1492-01	220	0.9474868781140052	134	TCGA-13-1492-01	14	11	38	0.3280091319488971	TCGA-13-1492-01	11	4	8	23	PASS	7085	TCGA-13-1492	OV	66	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-24332	Dead	TUMOR FREE	NA	3819	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	3819	0	3819	0	3819	0	3819	
40	TCGA-13-1494	0	4	0	6	0	4	5	0	5	62	5	0	1	26	0	0	TCGA-13-1494-01	362	0.9772785051044074	229	TCGA-13-1494-01	6	18	92	0.4977788741247781	TCGA-13-1494-01	25	27	29	81	PASS	7086	TCGA-13-1494	OV	43	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2004	NA	-15993	Dead	WITH TUMOR	NA	2856	NA	Recurrence	NA	NA	693	Complete Remission/Response	NA	NA	1	2856	1	2856	NA	NA	1	693	
60	TCGA-13-1495	0	1	0	0	0	0	0	0	1	17	1	0	0	6	1	0	TCGA-13-1495-01	549	0.8499066760204864	390	TCGA-13-1495-01	17	21	80	0.2681644762376237	TCGA-13-1495-01	20	8	6	34	PASS	7087	TCGA-13-1495	OV	60	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2004	NA	-22046	Dead	WITH TUMOR	NA	2749	NA	Recurrence	NA	NA	977	Complete Remission/Response	NA	NA	1	2749	1	2749	1	977	1	977	
70	TCGA-13-1496	0	3	0	2	1	3	1	0	1	56	4	0	2	20	1	0	TCGA-13-1496-01	364	0.6204166374220988	224	TCGA-13-1496-01	20	24	47	0.1943743236351092	TCGA-13-1496-01	20	8	8	36	PASS	7088	TCGA-13-1496	OV	65	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-23993	Dead	NA	129	129	NA	NA	NA	NA	NA	NA	NA	NA	1	129	NA	129	NA	NA	0	129	
50	TCGA-13-1497	1	6	0	5	6	0	3	0	3	120	8	0	2	38	5	1	TCGA-13-1497-01	569	0.8856776542222384	371	TCGA-13-1497-01	7	42	129	0.4621851987780129	TCGA-13-1497-01	29	38	15	82	PASS	7089	TCGA-13-1497	OV	47	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-17528	Alive	TUMOR FREE	3871	NA	NA	Recurrence	NA	NA	813	Complete Remission/Response	NA	NA	0	3871	0	3871	1	813	1	813	
70	TCGA-13-1498	0	13	0	4	5	3	4	0	2	93	13	1	4	45	5	0	TCGA-13-1498-01	463	0.8623547120815197	328	TCGA-13-1498-01	5	12	111	0.3177098279111723	TCGA-13-1498-01	23	29	17	69	PASS	7090	TCGA-13-1498	OV	73	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-26820	Dead	WITH TUMOR	NA	2012	NA	Progression of Disease	NA	NA	534	Partial Remission/Response	NA	NA	1	2012	1	2012	NA	NA	1	534	
60	TCGA-13-1499	1	10	0	3	1	2	1	0	6	62	5	0	1	23	1	0	TCGA-13-1499-01	213	0.7072673648289004	122	TCGA-13-1499-01	16	31	43	0.27536870983703604	TCGA-13-1499-01	16	27	10	53	PASS	7091	TCGA-13-1499	OV	56	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-20668	Alive	WITH TUMOR	3500	NA	NA	Recurrence	NA	NA	583	Complete Remission/Response	NA	NA	0	3500	0	3500	1	583	1	583	
70	TCGA-13-1500	0	9	0	2	2	3	0	0	2	74	0	0	2	27	4	0	TCGA-13-1500-01	185	0.8121054942089037	105	TCGA-13-1500-01	10	13	31	0.2461437005217036	TCGA-13-1500-01	11	8	6	25	PASS	7092	TCGA-13-1500	OV	71	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-26172	Dead	WITH TUMOR	425	425	NA	Recurrence	NA	NA	253	Partial Remission/Response	NA	NA	1	425	1	425	NA	NA	1	253	
50	TCGA-13-1501	1	5	0	1	1	1	1	0	5	71	4	0	3	22	2	0	TCGA-13-1501-01	454	0.5427691682466299	275	TCGA-13-1501-01	7	14	83	0.3511238928031743	TCGA-13-1501-01	24	27	15	66	PASS	7093	TCGA-13-1501	OV	50	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2006	NA	-18393	Dead	WITH TUMOR	NA	1314	NA	Progression of Disease	NA	NA	392	Partial Remission/Response	NA	NA	1	1314	1	1314	NA	NA	1	392	
70	TCGA-13-1504	0	5	0	2	0	0	1	0	0	38	1	0	0	11	1	0	TCGA-13-1504-01	374	0.7442696209181395	226	TCGA-13-1504-01	23	62	56	0.2327383575338516	TCGA-13-1504-01	21	16	4	41	PASS	7094	TCGA-13-1504	OV	68	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-25008	Dead	WITH TUMOR	NA	1059	NA	NA	NA	NA	548	Complete Remission/Response	NA	NA	1	1059	1	1059	1	548	1	548	
60	TCGA-13-1505	0	1	0	1	5	3	0	0	3	58	6	0	1	26	1	0	TCGA-13-1505-01	320	0.8337962247037807	192	TCGA-13-1505-01	8	14	52	0.2927519890726724	TCGA-13-1505-01	15	19	10	44	PASS	7095	TCGA-13-1505	OV	63	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-23238	Alive	WITH TUMOR	1998	NA	NA	NA	NA	NA	1561	Complete Remission/Response	NA	NA	0	1998	0	1998	1	1561	1	1561	
50	TCGA-13-1506	0	3	0	1	0	1	0	0	1	22	1	0	2	4	1	0	TCGA-13-1506-01	597	0.5463802911378959	399	TCGA-13-1506-01	16	27	55	0.11620484548742292	TCGA-13-1506-01	16	15	3	34	PASS	7096	TCGA-13-1506	OV	45	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-16734	Dead	WITH TUMOR	NA	1039	NA	NA	NA	NA	666	Complete Remission/Response	NA	NA	1	1039	1	1039	1	666	1	666	
80	TCGA-13-1507	0	9	1	3	3	1	0	0	1	75	3	0	0	23	3	0	TCGA-13-1507-01	324	0.5350898083418074	212	TCGA-13-1507-01	19	33	45	0.1999616184265363	TCGA-13-1507-01	12	12	8	32	PASS	7097	TCGA-13-1507	OV	77	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-28445	Dead	WITH TUMOR	NA	1993	NA	NA	NA	NA	324	Complete Remission/Response	NA	NA	1	1993	1	1993	1	324	1	324	
60	TCGA-13-1509	2	7	2	1	4	0	1	0	3	79	3	0	2	22	4	1	TCGA-13-1509-01	427	0.8807580428582655	274	TCGA-13-1509-01	7	13	111	0.389574675971052	TCGA-13-1509-01	19	26	20	65	PASS	7098	TCGA-13-1509	OV	64	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2008	NA	-23481	Alive	WITH TUMOR	2438	NA	NA	NA	NA	NA	578	Complete Remission/Response	NA	NA	0	2438	0	2438	NA	NA	1	578	
60	TCGA-13-1510	0	2	0	2	1	1	0	0	3	41	1	0	1	9	1	0	TCGA-13-1510-01	482	0.8038484621420734	313	TCGA-13-1510-01	8	12	118	0.3818302919348512	TCGA-13-1510-01	25	32	16	73	PASS	7099	TCGA-13-1510	OV	62	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-22708	Dead	WITH TUMOR	NA	1359	NA	NA	NA	NA	1189	NA	NA	NA	1	1359	1	1359	NA	NA	1	1189	
50	TCGA-13-1511	1	1	0	0	0	0	0	0	4	19	1	0	0	5	1	0	TCGA-13-1511-01	719	0.3213805325500049	496	TCGA-13-1511-01	5	9	116	0.21050602055221465	TCGA-13-1511-01	16	12	8	36	PASS	7100	TCGA-13-1511	OV	52	FEMALE	ASIAN	NA	Stage IV	Serous Cystadenocarcinoma	G3	2008	NA	-19258	Dead	WITH TUMOR	NA	1650	NA	NA	NA	NA	459	Partial Remission/Response	NA	NA	1	1650	1	1650	NA	NA	1	459	
50	TCGA-13-1512	0	7	0	1	2	4	1	0	2	49	1	0	2	20	1	0	TCGA-13-1512-01	343	0.9473837299793376	207	TCGA-13-1512-01	7	18	89	0.5071130248802271	TCGA-13-1512-01	29	26	17	72	PASS	7101	TCGA-13-1512	OV	49	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-18134	Alive	WITH TUMOR	442	NA	NA	NA	NA	NA	427	NA	NA	NA	0	442	0	442	NA	NA	1	427	
60	TCGA-13-1817	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-1817-01	140	0.9472687300189864	58	TCGA-13-1817-01	19	15	33	0.4784126795473657	TCGA-13-1817-01	8	3	6	17	PASS	7102	TCGA-13-1817	OV	56	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-20771	Dead	WITH TUMOR	1024	1024	NA	Recurrence	NA	NA	541	Partial Remission/Response	NA	NA	1	1024	1	1024	NA	NA	1	541	
60	TCGA-13-1819	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-1819-01	486	0.8460331339336279	307	TCGA-13-1819-01	8	20	112	0.42517031987217696	TCGA-13-1819-01	28	34	24	86	PASS	7103	TCGA-13-1819	OV	59	FEMALE	WHITE	NA	Stage IIC	Serous Cystadenocarcinoma	G3	2004	NA	-21635	Dead	WITH TUMOR	NA	2025	NA	Recurrence	NA	NA	429	Complete Remission/Response	NA	NA	1	2025	1	2025	1	429	1	429	
60	TCGA-13-2057	2	10	0	15	3	0	0	0	2	156	11	0	2	62	3	0	TCGA-13-2057-01	554	0.8506661018512874	402	TCGA-13-2057-01	28	61	60	0.2701834891815305	TCGA-13-2057-01	27	22	10	59	PASS	7104	TCGA-13-2057	OV	59	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-21554	Alive	WITH TUMOR	2434	NA	NA	NA	NA	NA	897	Complete Remission/Response	NA	NA	0	2434	0	2434	1	897	1	897	
50	TCGA-13-2059	0	9	0	2	3	0	2	0	2	76	2	0	0	31	3	0	TCGA-13-2059-01	1071	0.8320469586104231	858	TCGA-13-2059-01	13	34	137	0.43226486135242825	TCGA-13-2059-01	31	34	20	85	PASS	7105	TCGA-13-2059	OV	50	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-18449	Alive	WITH TUMOR	2387	NA	NA	NA	NA	NA	1005	Complete Remission/Response	NA	NA	0	2387	0	2387	1	1005	1	1005	
50	TCGA-13-2060	1	3	0	5	2	0	1	0	3	58	5	0	1	18	1	0	TCGA-13-2060-01	500	0.7658689631437801	336	TCGA-13-2060-01	20	38	68	0.2604346857273208	TCGA-13-2060-01	29	12	11	52	PASS	7106	TCGA-13-2060	OV	51	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2009	NA	-18635	Alive	WITH TUMOR	2369	NA	NA	NA	NA	NA	1475	Complete Remission/Response	NA	NA	0	2369	0	2369	NA	NA	1	1475	
60	TCGA-13-2061	0	11	0	5	5	0	3	0	2	95	2	0	2	29	0	0	TCGA-13-2061-01	562	0.7593161138356852	400	TCGA-13-2061-01	10	34	127	0.4301830259984093	TCGA-13-2061-01	30	36	13	79	PASS	7107	TCGA-13-2061	OV	58	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-21543	Alive	TUMOR FREE	2339	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2339	0	2339	0	2339	0	2339	
70	TCGA-13-2065	1	2	0	3	3	0	0	0	4	38	2	0	2	14	1	0	TCGA-13-2065-01	401	0.8155721229720958	278	TCGA-13-2065-01	19	26	47	0.4365542830293575	TCGA-13-2065-01	21	27	17	65	PASS	7108	TCGA-13-2065	OV	71	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-25973	Alive	WITH TUMOR	1993	NA	NA	NA	NA	NA	946	Complete Remission/Response	NA	NA	0	1993	0	1993	1	946	1	946	
50	TCGA-13-2066	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-13-2066	0	0	0	TCGA-13-2066	0	0	0	0	TCGA-13-2066	0	0	0	0	PASS	7109	TCGA-13-2066	OV	49	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2009	NA	-18170	Dead	WITH TUMOR	NA	2133	NA	NA	NA	NA	1028	Complete Remission/Response	NA	NA	1	2133	1	2133	NA	NA	1	1028	
60	TCGA-13-2071	0	3	3	1	2	0	1	0	2	41	4	0	1	19	2	1	TCGA-13-2071-01	315	0.5462997700200005	187	TCGA-13-2071-01	6	17	81	0.3662836148185849	TCGA-13-2071-01	25	35	19	79	PASS	7110	TCGA-13-2071	OV	63	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2009	NA	-23367	Dead	WITH TUMOR	NA	773	NA	NA	NA	NA	322	Complete Remission/Response	NA	NA	1	773	1	773	NA	NA	1	322	
70	TCGA-13-A5FT	1	32	0	6	3	2	1	0	4	64	2	0	6	15	1	0	TCGA-13-A5FT-01	1002	0.8959100142985074	726	TCGA-13-A5FT-01	8	13	308	0.3229411992179455	TCGA-13-A5FT-01	21	17	7	45	PASS	7111	TCGA-13-A5FT	OV	67	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-24743	Alive	TUMOR FREE	2143	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2143	0	2143	0	2143	0	2143	
60	TCGA-13-A5FU	1	14	2	7	0	0	0	0	1	63	1	0	4	22	4	1	TCGA-13-A5FU-01	290	0.7197536385397268	166	TCGA-13-A5FU-01	17	31	89	0.16537239075862087	TCGA-13-A5FU-01	18	16	8	42	PASS	7112	TCGA-13-A5FU	OV	60	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IV	Serous Cystadenocarcinoma	G3	2009	NA	-22256	Dead	WITH TUMOR	NA	256	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	256	1	256	NA	NA	1	256	
60	TCGA-20-0987	0	0	1	0	2	4	0	0	0	25	2	0	0	14	2	0	TCGA-20-0987-01	825	0.5418646030487081	592	TCGA-20-0987-01	6	12	103	0.2363546729616477	TCGA-20-0987-01	19	8	9	36	PASS	7113	TCGA-20-0987	OV	61	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-22287	Dead	WITH TUMOR	NA	701	NA	Recurrence	NA	NA	442	NA	NA	NA	1	701	1	701	NA	NA	1	442	Redacted
70	TCGA-20-0990	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-20-0990-01	465	0.6846930260718267	292	TCGA-20-0990-01	19	29	64	0.2532894278335624	TCGA-20-0990-01	19	10	5	34	PASS	7114	TCGA-20-0990	OV	74	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-27170	Alive	WITH TUMOR	789	NA	NA	Recurrence	NA	NA	871	NA	NA	NA	0	789	0	789	NA	NA	1	871	Redacted
80	TCGA-20-0991	0	16	0	5	2	5	1	0	10	189	3	0	4	86	5	1	TCGA-20-0991-01	226	0.6446699601282664	126	TCGA-20-0991-01	21	27	16	0.1112471594817792	TCGA-20-0991-01	16	10	2	28	PASS	7115	TCGA-20-0991	OV	78	FEMALE	WHITE	NA	Stage IIB	Serous Cystadenocarcinoma	G3	2006	NA	-28694	Alive	TUMOR FREE	797	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	797	0	797	0	797	0	797	Redacted
60	TCGA-20-0996	0	1	0	0	2	2	0	0	0	25	1	0	1	5	3	0	TCGA-20-0996-01	109	0.0008039416847988673	49	TCGA-20-0996	0	0	0	0	TCGA-20-0996	0	0	0	0	PASS	7116	TCGA-20-0996	OV	59	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2001	NA	-21572	Alive	WITH TUMOR	2196	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2196	0	2196	NA	NA	0	2196	
60	TCGA-20-1682	2	5	0	1	2	1	2	0	3	75	4	0	0	21	4	1	TCGA-20-1682-01	274	0.9581018706361624	165	TCGA-20-1682-01	10	19	70	0.5102320277338259	TCGA-20-1682-01	23	19	16	58	PASS	7117	TCGA-20-1682	OV	56	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	GX	2007	NA	-20583	Alive	TUMOR FREE	837	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	837	0	837	0	837	0	837	
70	TCGA-20-1683	2	11	0	5	2	1	0	1	6	75	4	0	2	29	1	0	TCGA-20-1683-01	388	0.7254960384836817	256	TCGA-20-1683-01	19	36	73	0.3186777834881909	TCGA-20-1683-01	17	8	8	33	PASS	7118	TCGA-20-1683	OV	65	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-24006	Alive	TUMOR FREE	772	NA	NA	Recurrence	NA	NA	618	Stable Disease	NA	NA	0	772	0	772	NA	NA	1	618	
50	TCGA-20-1684	0	5	0	1	0	4	1	0	3	25	5	0	1	13	1	0	TCGA-20-1684-01	1052	0.8095099404646275	748	TCGA-20-1684-01	14	36	130	0.23063775213863635	TCGA-20-1684-01	19	7	3	29	PASS	7119	TCGA-20-1684	OV	51	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-18755	Alive	TUMOR FREE	581	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	581	0	581	0	581	0	581	
50	TCGA-20-1685	0	15	0	1	1	0	2	0	6	49	5	0	2	22	0	0	TCGA-20-1685-01	269	0.6594608500387111	160	TCGA-20-1685-01	13	28	53	0.28150616238785825	TCGA-20-1685-01	24	26	8	58	PASS	7120	TCGA-20-1685	OV	45	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-16745	Alive	TUMOR FREE	508	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	508	0	508	0	508	0	508	
80	TCGA-20-1686	1	14	1	2	2	0	2	0	4	80	6	0	0	25	3	0	TCGA-20-1686-01	353	0.7966686041633418	201	TCGA-20-1686-01	20	33	57	0.15555585223919252	TCGA-20-1686-01	15	13	7	35	PASS	7121	TCGA-20-1686	OV	75	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-27588	Alive	TUMOR FREE	89	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	89	0	89	0	89	0	89	
50	TCGA-20-1687	1	9	0	2	3	0	0	0	5	52	5	0	1	22	3	0	TCGA-20-1687-01	268	0.951541529683158	160	TCGA-20-1687-01	13	24	37	0.225722967051441	TCGA-20-1687-01	29	29	13	71	PASS	7122	TCGA-20-1687	OV	46	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2008	NA	-16961	Alive	TUMOR FREE	81	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	81	0	81	NA	NA	0	81	
50	TCGA-23-1021	1	1	2	3	4	1	2	0	3	71	4	1	5	26	1	0	TCGA-23-1021-01	244	0.875297338106491	151	TCGA-23-1021-01	14	14	65	0.5403167016470704	TCGA-23-1021-01	14	17	13	44	PASS	7123	TCGA-23-1021	OV	45	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2004	NA	-16484	Dead	WITH TUMOR	1446	1446	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	1446	1	1446	NA	NA	1	1446	Redacted
70	TCGA-23-1022	0	12	1	6	5	4	2	0	5	177	8	0	1	53	7	0	TCGA-23-1022-01	437	0.8514266563866654	286	TCGA-23-1022-01	12	38	70	0.2729678828277434	TCGA-23-1022-01	29	43	14	86	PASS	7124	TCGA-23-1022	OV	67	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-24798	Dead	WITH TUMOR	NA	1511	NA	Recurrence	NA	NA	450	Complete Remission/Response	NA	NA	1	1511	1	1511	1	450	1	450	Redacted
70	TCGA-23-1023	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-23-1023-01	253	0.2528208090743807	152	TCGA-23-1023-01	5	13	28	0.2430959015755557	TCGA-23-1023-01	16	18	8	42	PASS	7125	TCGA-23-1023	OV	65	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-23826	Alive	WITH TUMOR	1233	NA	NA	Recurrence	NA	NA	490	Complete Remission/Response	NA	NA	0	1233	0	1233	1	490	1	490	
50	TCGA-23-1024	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-23-1024-01	325	0.5907029341838987	206	TCGA-23-1024-01	16	30	29	0.10221210515329494	TCGA-23-1024-01	19	16	3	38	PASS	7126	TCGA-23-1024	OV	52	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2007	NA	-19052	Alive	TUMOR FREE	468	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	468	0	468	NA	NA	0	468	Redacted
50	TCGA-23-1026	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-23-1026-01	303	0.35071396880679684	185	TCGA-23-1026-01	4	16	62	0.2960094767530213	TCGA-23-1026-01	25	24	14	63	PASS	7127	TCGA-23-1026	OV	45	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-16442	Alive	WITH TUMOR	816	NA	NA	Recurrence	NA	NA	797	Complete Remission/Response	NA	NA	0	816	0	816	1	797	1	797	Redacted
50	TCGA-23-1027	0	5	0	2	0	6	0	0	2	45	2	0	0	10	3	0	TCGA-23-1027-01	450	0.9637527531186864	323	TCGA-23-1027-01	7	17	49	0.3692987413051193	TCGA-23-1027-01	23	24	18	65	PASS	7128	TCGA-23-1027	OV	48	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-17588	Dead	NA	966	976	NA	Recurrence	NA	NA	114	Progressive Disease	NA	NA	1	976	NA	976	NA	NA	1	114	Redacted
40	TCGA-23-1028	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-23-1028-01	322	0.9633503422758258	194	TCGA-23-1028-01	4	15	72	0.4365232838288742	TCGA-23-1028-01	31	26	17	74	PASS	7129	TCGA-23-1028	OV	43	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-16018	Alive	WITH TUMOR	1503	NA	NA	Recurrence	NA	NA	133	Complete Remission/Response	NA	NA	0	1503	0	1503	1	133	1	133	Redacted
50	TCGA-23-1029	1	7	0	5	3	0	2	0	3	59	6	0	0	25	2	0	TCGA-23-1029-01	175	0.7343704684585284	90	TCGA-23-1029-01	7	13	30	0.2917832927180797	TCGA-23-1029-01	19	17	8	44	PASS	7130	TCGA-23-1029	OV	46	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-16889	Alive	TUMOR FREE	268	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	268	0	268	0	268	0	268	
60	TCGA-23-1030	0	1	0	3	0	3	0	0	1	41	3	0	0	14	1	0	TCGA-23-1030-01	390	0.6532448353183212	244	TCGA-23-1030-01	17	34	44	0.13603496700901166	TCGA-23-1030-01	13	8	3	24	PASS	7131	TCGA-23-1030	OV	64	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-23416	Alive	TUMOR FREE	886	NA	NA	Recurrence	NA	NA	544	Complete Remission/Response	NA	NA	0	886	0	886	1	544	1	544	Redacted
60	TCGA-23-1031	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-23-1031-01	250	0.7780658091693088	143	TCGA-23-1031-01	13	35	43	0.26230812758625355	TCGA-23-1031-01	26	34	10	70	PASS	7132	TCGA-23-1031	OV	60	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2003	NA	-22225	Dead	WITH TUMOR	575	575	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	575	1	575	NA	NA	1	575	Redacted
70	TCGA-23-1032	0	15	1	8	4	6	0	0	16	145	7	0	8	84	5	0	TCGA-23-1032-01	523	0.8907484886766021	368	TCGA-23-1032-01	14	26	84	0.21613672448345872	TCGA-23-1032-01	21	20	6	47	PASS	7133	TCGA-23-1032	OV	73	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IV	Serous Cystadenocarcinoma	G3	2002	NA	-26715	Dead	WITH TUMOR	68	84	NA	NA	NA	NA	NA	NA	NA	NA	1	84	1	84	NA	NA	1	84	Redacted
60	TCGA-23-1107	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-23-1107	0	0	0	TCGA-23-1107	0	0	0	0	TCGA-23-1107	0	0	0	0	PASS	7134	TCGA-23-1107	OV	59	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	1999	NA	-21561	Dead	WITH TUMOR	9	9	NA	NA	NA	NA	NA	NA	NA	NA	1	9	1	9	NA	NA	1	9	Redacted
60	TCGA-23-1109	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-23-1109-01	316	0.6427985331676578	202	TCGA-23-1109-01	19	25	45	0.17002112069514866	TCGA-23-1109-01	13	12	5	30	PASS	7135	TCGA-23-1109	OV	62	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-23002	Dead	WITH TUMOR	1562	1562	NA	Recurrence	NA	NA	987	Partial Remission/Response	NA	NA	1	1562	1	1562	NA	NA	1	987	Redacted
40	TCGA-23-1110	2	10	1	5	4	0	0	0	5	97	6	2	5	36	8	0	TCGA-23-1110-01	375	0.6674250194662287	247	TCGA-23-1110-01	13	29	56	0.2900377620221768	TCGA-23-1110-01	21	30	8	59	PASS	7136	TCGA-23-1110	OV	42	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-15383	Alive	TUMOR FREE	1658	NA	NA	Recurrence	NA	NA	326	Complete Remission/Response	NA	NA	0	1658	0	1658	1	326	1	326	Redacted
60	TCGA-23-1111	0	3	0	1	1	0	0	0	4	48	7	0	0	20	0	0	TCGA-23-1111-01	290	0.6865633174619534	193	TCGA-23-1111-01	25	54	25	0.13208777158770352	TCGA-23-1111-01	15	5	2	22	PASS	7137	TCGA-23-1111	OV	63	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-23171	Alive	NA	98	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	98	0	98	NA	NA	0	98	
50	TCGA-23-1113	0	1	0	1	2	2	1	0	1	45	3	0	3	10	2	0	TCGA-23-1113-01	177	0.9475927389800872	110	TCGA-23-1113-01	15	11	26	0.3667712154704941	TCGA-23-1113-01	3	2	2	7	PASS	7138	TCGA-23-1113	OV	48	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2002	NA	-17791	Dead	WITH TUMOR	NA	949	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	949	1	949	NA	NA	1	949	Redacted
60	TCGA-23-1114	3	10	0	7	9	2	1	0	5	109	3	1	0	35	4	0	TCGA-23-1114-01	344	0.8719392278018181	215	TCGA-23-1114-01	23	65	39	0.14216473830379964	TCGA-23-1114-01	20	24	3	47	PASS	7139	TCGA-23-1114	OV	55	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-20409	Dead	WITH TUMOR	2089	2089	NA	Recurrence	NA	NA	634	Complete Remission/Response	NA	NA	1	2089	1	2089	1	634	1	634	
80	TCGA-23-1116	2	13	1	8	3	1	0	1	10	157	13	0	6	76	5	0	TCGA-23-1116-01	278	0.634504887078319	161	TCGA-23-1116-01	19	29	24	0.10182877104838003	TCGA-23-1116-01	17	13	2	32	PASS	7140	TCGA-23-1116	OV	83	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-30464	Dead	WITH TUMOR	NA	592	NA	Recurrence	NA	NA	286	Complete Remission/Response	NA	NA	1	592	1	592	1	286	1	286	Redacted
40	TCGA-23-1117	0	13	0	2	6	2	3	0	8	123	8	0	1	46	3	0	TCGA-23-1117-01	451	0.7108345933162842	284	TCGA-23-1117-01	11	28	96	0.37626856723664176	TCGA-23-1117-01	33	35	15	83	PASS	7141	TCGA-23-1117	OV	42	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	NA	-15690	Dead	WITH TUMOR	NA	1013	NA	Recurrence	NA	NA	418	Complete Remission/Response	NA	NA	1	1013	1	1013	1	418	1	418	Redacted
50	TCGA-23-1118	1	6	0	2	4	2	3	0	5	76	5	0	4	18	9	0	TCGA-23-1118-01	458	0.7657569542838736	304	TCGA-23-1118-01	6	14	96	0.31121034304526163	TCGA-23-1118-01	23	25	18	66	PASS	7142	TCGA-23-1118	OV	45	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-16471	Alive	TUMOR FREE	2616	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2616	0	2616	0	2616	0	2616	Redacted
60	TCGA-23-1119	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-23-1119-01	285	0.8685888922401475	173	TCGA-23-1119-01	17	53	21	0.13856824740872084	TCGA-23-1119-01	25	30	5	60	PASS	7143	TCGA-23-1119	OV	64	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	NA	-23686	Alive	TUMOR FREE	3953	NA	NA	Recurrence	NA	NA	3378	Complete Remission/Response	NA	NA	0	3953	0	3953	1	3378	1	3378	Redacted
60	TCGA-23-1120	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-23-1120-01	404	0.9818556471613048	255	TCGA-23-1120-01	6	13	68	0.2956072784832983	TCGA-23-1120-01	22	24	13	59	PASS	7144	TCGA-23-1120	OV	60	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-22148	Alive	NA	130	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	130	0	130	0	130	0	130	Redacted
50	TCGA-23-1121	3	21	0	10	13	2	2	0	14	291	20	0	9	75	13	0	TCGA-23-1121-01	920	0.9468114659553843	632	TCGA-23-1121-01	15	43	168	0.3279101284973606	TCGA-23-1121-01	31	34	14	79	PASS	7145	TCGA-23-1121	OV	51	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-18983	Alive	NA	194	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	194	0	194	NA	NA	0	194	Redacted
50	TCGA-23-1122	1	7	0	1	7	4	1	0	5	125	5	0	1	35	9	1	TCGA-23-1122-01	285	0.8281404162777735	166	TCGA-23-1122	0	0	0	0	TCGA-23-1122	0	0	0	0	PASS	7146	TCGA-23-1122	OV	53	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	NA	-19537	Dead	WITH TUMOR	NA	1189	NA	Recurrence	NA	NA	447	Complete Remission/Response	NA	NA	1	1189	1	1189	1	447	1	447	Redacted
60	TCGA-23-1123	1	6	0	2	1	2	0	0	5	72	3	0	1	14	6	0	TCGA-23-1123-01	399	0.9040335045349372	267	TCGA-23-1123-01	19	31	49	0.20625741946523435	TCGA-23-1123-01	14	18	6	38	PASS	7147	TCGA-23-1123	OV	59	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	NA	-21552	Dead	WITH TUMOR	NA	1018	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	1018	1	1018	NA	NA	1	1018	Redacted
60	TCGA-23-1124	0	14	1	6	3	0	1	0	5	135	1	1	2	39	8	0	TCGA-23-1124-01	515	0.7617635754776114	321	TCGA-23-1124-01	9	37	98	0.3295752750426407	TCGA-23-1124-01	35	29	14	78	PASS	7148	TCGA-23-1124	OV	62	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-23005	Dead	WITH TUMOR	NA	1768	NA	Recurrence	NA	NA	641	Complete Remission/Response	NA	NA	1	1768	1	1768	1	641	1	641	Redacted
60	TCGA-23-1809	0	0	0	1	3	0	0	0	2	40	2	0	1	12	1	0	TCGA-23-1809-01	382	0.9994281931522851	238	TCGA-23-1809-01	22	65	56	0.36391713192631797	TCGA-23-1809-01	25	15	14	54	PASS	7149	TCGA-23-1809	OV	63	FEMALE	WHITE	NA	Stage IIC	Serous Cystadenocarcinoma	G3	2009	NA	-23111	Alive	NA	16	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	16	0	16	NA	NA	0	16	
60	TCGA-23-2072	0	2	0	1	0	0	0	0	3	41	4	0	1	17	2	1	TCGA-23-2072-01	407	0.9151351477378906	257	TCGA-23-2072-01	21	34	90	0.2991224203999749	TCGA-23-2072-01	13	7	5	25	PASS	7150	TCGA-23-2072	OV	58	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2000	NA	-21523	Dead	WITH TUMOR	NA	759	NA	Recurrence	NA	NA	476	Complete Remission/Response	NA	NA	1	759	1	759	NA	NA	1	476	
50	TCGA-23-2077	0	3	0	7	1	2	1	0	6	96	6	0	2	35	3	0	TCGA-23-2077-01	282	0.8961550416429128	172	TCGA-23-2077-01	15	57	48	0.3169713342178958	TCGA-23-2077-01	31	31	11	73	PASS	7151	TCGA-23-2077	OV	45	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-16552	Alive	TUMOR FREE	3525	NA	NA	Recurrence	NA	NA	1232	Complete Remission/Response	NA	NA	0	3525	0	3525	1	1232	1	1232	
70	TCGA-23-2078	4	20	0	8	4	1	1	0	9	158	12	0	4	57	6	0	TCGA-23-2078-01	435	0.4810798991947525	287	TCGA-23-2078-01	7	16	77	0.3440740175366185	TCGA-23-2078-01	23	22	12	57	PASS	7152	TCGA-23-2078	OV	66	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-24223	Alive	TUMOR FREE	2661	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2661	0	2661	0	2661	0	2661	
50	TCGA-23-2079	0	3	0	1	3	0	0	0	3	47	4	0	1	16	2	0	TCGA-23-2079-01	220	0.9810007355319368	127	TCGA-23-2079-01	20	47	47	0.3565093434139037	TCGA-23-2079-01	30	25	16	71	PASS	7153	TCGA-23-2079	OV	46	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-17122	Alive	TUMOR FREE	2788	NA	NA	Recurrence	NA	NA	283	Complete Remission/Response	NA	NA	0	2788	0	2788	1	283	1	283	
50	TCGA-23-2081	0	6	0	3	3	3	0	0	4	47	5	0	1	17	3	0	TCGA-23-2081-01	212	0.9937845569513803	125	TCGA-23-2081-01	7	15	53	0.2915351769798604	TCGA-23-2081-01	20	22	15	57	PASS	7154	TCGA-23-2081	OV	49	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2000	NA	-18162	Dead	WITH TUMOR	NA	2342	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	2342	1	2342	NA	NA	1	2342	
50	TCGA-23-2084	0	8	0	3	1	3	2	0	11	118	3	0	1	37	15	1	TCGA-23-2084-01	229	0.7561357483650333	139	TCGA-23-2084-01	19	25	43	0.3134247311007901	TCGA-23-2084-01	23	27	6	56	PASS	7155	TCGA-23-2084	OV	45	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2000	NA	-16493	Dead	WITH TUMOR	NA	1516	NA	Recurrence	NA	NA	619	Complete Remission/Response	NA	NA	1	1516	1	1516	NA	NA	1	619	
90	TCGA-23-2641	0	5	1	3	7	0	1	0	2	66	3	0	3	31	4	0	TCGA-23-2641-01	252	0.9372195702104392	151	TCGA-23-2641-01	8	15	57	0.40221939203993456	TCGA-23-2641-01	20	28	17	65	PASS	7156	TCGA-23-2641	OV	85	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-31232	Alive	NA	84	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	84	0	84	NA	NA	0	84	
70	TCGA-23-2643	0	6	0	4	3	0	1	0	4	37	5	0	2	11	1	0	TCGA-23-2643-01	531	0.8372044067329667	408	TCGA-23-2643-01	27	30	54	0.2637611837292607	TCGA-23-2643-01	11	12	5	28	PASS	7157	TCGA-23-2643	OV	74	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-27093	Alive	TUMOR FREE	143	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	143	0	143	0	143	0	143	
50	TCGA-23-2645	1	9	1	4	6	1	3	0	1	93	6	0	3	36	7	0	TCGA-23-2645-01	440	0.7110462608451432	305	TCGA-23-2645-01	15	35	104	0.3510979149680585	TCGA-23-2645-01	25	39	13	77	PASS	7158	TCGA-23-2645	OV	54	FEMALE	ASIAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-19758	Alive	NA	137	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	137	0	137	NA	NA	0	137	
50	TCGA-23-2647	0	1	0	4	5	2	1	0	1	48	0	0	1	14	0	0	TCGA-23-2647	0	0	0	TCGA-23-2647	0	0	0	0	TCGA-23-2647	0	0	0	0	PASS	7159	TCGA-23-2647	OV	49	FEMALE	ASIAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-18205	Alive	NA	135	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	135	0	135	NA	NA	0	135	
60	TCGA-23-2649	0	10	3	7	6	1	1	0	8	98	9	1	0	28	3	0	TCGA-23-2649	0	0	0	TCGA-23-2649	0	0	0	0	TCGA-23-2649	0	0	0	0	PASS	7160	TCGA-23-2649	OV	60	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-22210	Alive	NA	116	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	116	0	116	NA	NA	0	116	
80	TCGA-24-0966	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-0966-01	301	0.5606299612593528	184	TCGA-24-0966-01	6	8	32	0.1596472703007464	TCGA-24-0966-01	14	8	8	30	PASS	7161	TCGA-24-0966	OV	78	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-28529	Alive	WITH TUMOR	232	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	232	0	232	NA	NA	0	232	
60	TCGA-24-0968	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-0968-01	349	0.6270398794721193	206	TCGA-24-0968-01	21	36	68	0.21593081076481188	TCGA-24-0968-01	22	27	10	59	PASS	7162	TCGA-24-0968	OV	59	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-21664	Dead	WITH TUMOR	598	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	NA	1	NA	NA	NA	1	NA	Redacted
60	TCGA-24-0970	0	1	3	1	0	3	1	0	2	24	3	0	1	12	2	0	TCGA-24-0970-01	515	0.8608717428345697	341	TCGA-24-0970-01	16	19	111	0.4300732384960119	TCGA-24-0970-01	17	9	6	32	PASS	7163	TCGA-24-0970	OV	63	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-23276	Dead	WITH TUMOR	354	354	NA	Recurrence	NA	NA	280	Partial Remission/Response	NA	NA	1	354	1	354	NA	NA	1	280	Redacted
60	TCGA-24-0975	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-0975-01	107	0.3800258964621918	46	TCGA-24-0975-01	8	15	29	0.372133684828844	TCGA-24-0975-01	23	22	17	62	PASS	7164	TCGA-24-0975	OV	58	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-21417	Dead	WITH TUMOR	663	663	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	663	1	663	NA	NA	1	663	Redacted
50	TCGA-24-0979	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-0979-01	413	0.7591537535904934	262	TCGA-24-0979-01	13	36	32	0.18434344862020388	TCGA-24-0979-01	22	37	9	68	PASS	7165	TCGA-24-0979	OV	53	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2003	NA	-19595	Dead	WITH TUMOR	1264	1264	NA	Recurrence	NA	NA	428	Complete Remission/Response	NA	NA	1	1264	1	1264	NA	NA	1	428	Redacted
50	TCGA-24-0980	0	7	0	0	1	4	0	0	1	50	2	0	4	19	1	0	TCGA-24-0980-01	140	0.7160592230774226	66	TCGA-24-0980-01	6	8	25	0.2220588284468386	TCGA-24-0980-01	12	10	8	30	PASS	7166	TCGA-24-0980	OV	53	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-19579	Dead	WITH TUMOR	233	233	NA	Recurrence	NA	NA	145	Progressive Disease	NA	NA	1	233	1	233	NA	NA	1	145	
80	TCGA-24-0982	0	7	1	0	1	4	0	0	3	56	0	0	1	19	0	0	TCGA-24-0982-01	236	0.8468335671385707	135	TCGA-24-0982-01	23	41	43	0.3029486867053465	TCGA-24-0982-01	16	16	9	41	PASS	7167	TCGA-24-0982	OV	77	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-28201	Dead	WITH TUMOR	679	679	NA	Recurrence	NA	NA	153	Complete Remission/Response	NA	NA	1	679	1	679	1	153	1	153	
50	TCGA-24-1103	0	0	0	2	2	0	0	0	2	56	2	0	1	24	3	0	TCGA-24-1103-01	325	0.9409595362922328	192	TCGA-24-1103-01	4	14	53	0.35018762653135715	TCGA-24-1103-01	22	28	15	65	PASS	7168	TCGA-24-1103	OV	50	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-18583	Dead	WITH TUMOR	1646	1646	NA	Recurrence	NA	NA	678	Complete Remission/Response	NA	NA	1	1646	1	1646	1	678	1	678	Redacted
60	TCGA-24-1104	0	9	0	2	1	2	1	0	4	82	2	0	0	26	2	0	TCGA-24-1104-01	212	0.6396513852834156	110	TCGA-24-1104-01	8	18	48	0.3508683022138327	TCGA-24-1104-01	20	30	12	62	PASS	7169	TCGA-24-1104	OV	56	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2001	NA	-20527	Dead	WITH TUMOR	1933	1933	NA	Recurrence	NA	NA	959	Complete Remission/Response	NA	NA	1	1933	1	1933	NA	NA	1	959	Redacted
40	TCGA-24-1105	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1105-01	268	0.7321498448795616	168	TCGA-24-1105-01	20	23	30	0.20399300684106408	TCGA-24-1105-01	15	5	3	23	PASS	7170	TCGA-24-1105	OV	36	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-13187	Dead	WITH TUMOR	1442	1442	NA	Recurrence	NA	NA	470	Complete Remission/Response	NA	NA	1	1442	1	1442	1	470	1	470	Redacted
50	TCGA-24-1413	0	9	0	0	1	2	0	0	1	42	2	0	1	9	0	0	TCGA-24-1413-01	143	0.8482777831263163	66	TCGA-24-1413-01	12	16	29	0.34080702003392443	TCGA-24-1413-01	13	8	10	31	PASS	7171	TCGA-24-1413	OV	51	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-18846	Alive	TUMOR FREE	192	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	192	0	192	0	192	0	192	
30	TCGA-24-1416	0	0	0	1	3	1	1	0	0	14	0	0	0	8	0	0	TCGA-24-1416-01	109	0.9477104294845712	45	TCGA-24-1416-01	12	12	21	0.19815616990155932	TCGA-24-1416-01	6	5	4	15	PASS	7172	TCGA-24-1416	OV	34	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2008	NA	-12772	Alive	TUMOR FREE	194	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	194	0	194	NA	NA	0	194	
50	TCGA-24-1417	0	9	0	2	1	1	0	0	3	68	5	0	0	28	3	0	TCGA-24-1417-01	290	0.7278175204123201	178	TCGA-24-1417-01	15	32	60	0.3714075022430123	TCGA-24-1417-01	27	24	17	68	PASS	7173	TCGA-24-1417	OV	54	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2008	NA	-19775	Alive	TUMOR FREE	238	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	238	0	238	NA	NA	0	238	
70	TCGA-24-1418	0	5	0	0	1	2	0	0	1	58	4	0	1	15	0	0	TCGA-24-1418-01	295	0.7886611504522735	174	TCGA-24-1418-01	20	29	45	0.2556473521954609	TCGA-24-1418-01	15	14	6	35	PASS	7174	TCGA-24-1418	OV	68	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-24842	Alive	TUMOR FREE	243	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	243	0	243	0	243	0	243	
60	TCGA-24-1419	0	5	0	0	1	4	1	0	1	36	4	0	1	9	0	0	TCGA-24-1419-01	139	0.9572076753683381	71	TCGA-24-1419-01	7	12	27	0.2616944935342025	TCGA-24-1419-01	13	11	4	28	PASS	7175	TCGA-24-1419	OV	62	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-22659	Alive	TUMOR FREE	239	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	239	0	239	0	239	0	239	
80	TCGA-24-1422	1	12	4	5	2	2	0	0	4	151	3	0	2	52	4	0	TCGA-24-1422-01	425	0.7673345835886997	274	TCGA-24-1422-01	12	34	73	0.33013633807512216	TCGA-24-1422-01	26	35	17	78	PASS	7176	TCGA-24-1422	OV	82	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-30234	Dead	NA	23	23	NA	NA	NA	NA	NA	NA	NA	NA	1	23	NA	23	NA	NA	0	23	
60	TCGA-24-1423	0	6	0	4	3	2	1	0	3	73	3	0	2	25	4	0	TCGA-24-1423-01	299	0.7128272570753028	180	TCGA-24-1423-01	14	15	56	0.3094661633288452	TCGA-24-1423-01	22	19	14	55	PASS	7177	TCGA-24-1423	OV	61	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-22281	Alive	TUMOR FREE	190	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	190	0	190	0	190	0	190	
70	TCGA-24-1424	0	6	0	0	2	1	1	0	5	57	5	0	0	20	2	0	TCGA-24-1424-01	398	0.7674232170003772	240	TCGA-24-1424-01	24	68	37	0.1630674857453566	TCGA-24-1424-01	24	20	4	48	PASS	7178	TCGA-24-1424	OV	67	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-24545	Alive	TUMOR FREE	183	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	183	0	183	0	183	0	183	
50	TCGA-24-1425	0	9	1	0	1	1	0	0	2	71	5	1	3	32	1	0	TCGA-24-1425-01	258	0.913994065844796	152	TCGA-24-1425-01	10	18	51	0.3967630974366041	TCGA-24-1425-01	22	23	14	59	PASS	7179	TCGA-24-1425	OV	45	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-16764	Alive	TUMOR FREE	181	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	181	0	181	0	181	0	181	
40	TCGA-24-1426	2	16	1	7	6	3	1	0	5	119	10	0	4	43	3	0	TCGA-24-1426-01	562	0.935782549263004	398	TCGA-24-1426-01	14	16	84	0.41371392485222935	TCGA-24-1426-01	8	7	7	22	PASS	7180	TCGA-24-1426	OV	43	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-15949	Alive	TUMOR FREE	163	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	163	0	163	0	163	0	163	
60	TCGA-24-1427	0	5	0	0	1	1	1	0	2	52	3	0	0	18	5	0	TCGA-24-1427-01	417	0.6888421173271834	282	TCGA-24-1427-01	17	40	72	0.3059723389209983	TCGA-24-1427-01	27	20	16	63	PASS	7181	TCGA-24-1427	OV	58	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-21423	Alive	WITH TUMOR	147	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	147	0	147	NA	NA	0	147	
50	TCGA-24-1428	1	8	0	2	9	3	2	0	4	64	1	0	0	19	3	0	TCGA-24-1428-01	412	0.8568293179374011	235	TCGA-24-1428-01	12	26	101	0.5587058814077323	TCGA-24-1428-01	32	28	24	84	PASS	7182	TCGA-24-1428	OV	50	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-18306	Alive	WITH TUMOR	529	NA	NA	Recurrence	NA	NA	448	Complete Remission/Response	NA	NA	0	529	0	529	1	448	1	448	
70	TCGA-24-1430	0	1	0	2	0	0	0	0	2	50	1	0	0	9	0	0	TCGA-24-1430-01	190	0.9287417026418184	94	TCGA-24-1430-01	6	20	50	0.40485984588185703	TCGA-24-1430-01	25	24	19	68	PASS	7183	TCGA-24-1430	OV	68	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-24939	Dead	WITH TUMOR	863	863	NA	Recurrence	NA	NA	449	Complete Remission/Response	NA	NA	1	863	1	863	1	449	1	449	
70	TCGA-24-1431	1	3	0	0	2	2	1	0	5	88	8	0	1	26	2	0	TCGA-24-1431-01	324	0.9445371199802146	210	TCGA-24-1431-01	21	39	58	0.152298465049198	TCGA-24-1431-01	15	10	4	29	PASS	7184	TCGA-24-1431	OV	67	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-24758	Dead	WITH TUMOR	583	567	NA	Recurrence	NA	NA	199	NA	NA	NA	1	567	1	567	NA	NA	1	199	
60	TCGA-24-1434	0	5	0	7	5	5	2	1	1	53	3	0	1	21	1	0	TCGA-24-1434-01	306	0.899648966324362	192	TCGA-24-1434-01	19	35	42	0.2314659185606088	TCGA-24-1434-01	13	10	3	26	PASS	7185	TCGA-24-1434	OV	59	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-21810	Dead	WITH TUMOR	568	568	NA	Recurrence	NA	NA	337	Partial Remission/Response	NA	NA	1	568	1	568	NA	NA	1	337	
60	TCGA-24-1435	1	9	1	2	7	1	1	0	7	85	3	0	1	20	2	0	TCGA-24-1435-01	390	0.9310188925020978	251	TCGA-24-1435-01	8	22	61	0.26619215179197797	TCGA-24-1435-01	26	28	15	69	PASS	7186	TCGA-24-1435	OV	57	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-21107	Dead	WITH TUMOR	1324	1324	NA	Recurrence	NA	NA	505	Complete Remission/Response	NA	NA	1	1324	1	1324	1	505	1	505	
60	TCGA-24-1436	0	7	0	5	3	3	1	0	3	71	6	0	2	30	3	0	TCGA-24-1436-01	369	0.8687960245238804	217	TCGA-24-1436-01	26	37	52	0.3028710784730805	TCGA-24-1436-01	17	15	9	41	PASS	7187	TCGA-24-1436	OV	57	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-20881	Dead	WITH TUMOR	260	260	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	260	1	260	NA	NA	1	260	
70	TCGA-24-1463	0	8	0	2	2	0	3	0	4	56	4	0	1	13	0	0	TCGA-24-1463-01	212	0.9470800025709084	125	TCGA-24-1463-01	13	19	46	0.3953341619853335	TCGA-24-1463-01	20	21	13	54	PASS	7188	TCGA-24-1463	OV	70	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-25734	Dead	WITH TUMOR	2218	2218	NA	Recurrence	NA	NA	971	Complete Remission/Response	NA	NA	1	2218	1	2218	1	971	1	971	
70	TCGA-24-1464	2	6	0	0	3	0	0	0	2	44	5	0	0	21	3	0	TCGA-24-1464-01	210	0.7246735943806782	115	TCGA-24-1464-01	9	16	42	0.2792763295148955	TCGA-24-1464-01	9	10	6	25	PASS	7189	TCGA-24-1464	OV	70	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	NA	-25874	Dead	WITH TUMOR	379	379	NA	Recurrence	NA	NA	323	NA	NA	NA	1	379	1	379	NA	NA	1	323	
70	TCGA-24-1466	0	5	0	0	2	1	0	0	3	61	1	0	1	16	0	0	TCGA-24-1466-01	974	0.7583344162770174	716	TCGA-24-1466-01	17	23	169	0.2672854113519537	TCGA-24-1466-01	22	9	13	44	PASS	7190	TCGA-24-1466	OV	74	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	NA	-27307	Dead	WITH TUMOR	1373	1373	NA	Recurrence	NA	NA	491	Complete Remission/Response	NA	NA	1	1373	1	1373	1	491	1	491	
50	TCGA-24-1467	0	0	0	0	2	0	0	0	0	7	1	0	0	2	0	0	TCGA-24-1467-01	245	0.44993870351055376	137	TCGA-24-1467-01	13	16	31	0.1746502354891408	TCGA-24-1467-01	11	10	6	27	PASS	7191	TCGA-24-1467	OV	51	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	NA	-18652	Dead	WITH TUMOR	3224	3224	NA	Recurrence	NA	NA	1253	Complete Remission/Response	NA	NA	1	3224	1	3224	1	1253	1	1253	
70	TCGA-24-1469	1	22	1	7	2	0	2	0	8	212	4	0	8	74	1	0	TCGA-24-1469-01	607	0.5843112914520311	388	TCGA-24-1469-01	12	67	150	0.4273120595840492	TCGA-24-1469-01	22	21	11	54	PASS	7192	TCGA-24-1469	OV	71	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-25937	Alive	TUMOR FREE	277	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	277	0	277	0	277	0	277	
50	TCGA-24-1470	0	6	0	0	4	0	1	0	4	54	3	0	1	22	0	0	TCGA-24-1470-01	394	0.5883342414429565	249	TCGA-24-1470-01	5	21	80	0.3964438145259413	TCGA-24-1470-01	24	26	19	69	PASS	7193	TCGA-24-1470	OV	54	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2009	NA	-20007	Alive	TUMOR FREE	105	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	105	0	105	0	105	0	105	
60	TCGA-24-1471	0	6	0	1	1	3	0	0	2	33	4	0	0	10	2	0	TCGA-24-1471-01	173	0.9170230870629305	104	TCGA-24-1471-01	25	30	12	0.2204279648952292	TCGA-24-1471-01	4	3	1	8	PASS	7194	TCGA-24-1471	OV	60	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-22081	Alive	NA	36	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	36	0	36	NA	NA	0	36	
60	TCGA-24-1474	1	4	0	1	3	5	0	0	0	64	5	0	4	17	2	0	TCGA-24-1474-01	431	0.9549966058398308	283	TCGA-24-1474-01	27	68	64	0.1468739728189687	TCGA-24-1474-01	17	17	2	36	PASS	7195	TCGA-24-1474	OV	57	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-20902	Dead	WITH TUMOR	676	676	NA	Recurrence	NA	NA	332	Partial Remission/Response	NA	NA	1	676	1	676	NA	NA	1	332	
70	TCGA-24-1544	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1544-01	348	0.6522306872217277	233	TCGA-24-1544-01	23	29	34	0.1902530004562789	TCGA-24-1544-01	15	13	5	33	PASS	7196	TCGA-24-1544	OV	71	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-26141	Dead	WITH TUMOR	820	820	NA	Progression of Disease	NA	NA	643	Partial Remission/Response	NA	NA	1	820	1	820	NA	NA	1	643	
70	TCGA-24-1545	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1545-01	175	0.6350507108947506	90	TCGA-24-1545-01	18	27	39	0.3760539121649342	TCGA-24-1545-01	10	8	7	25	PASS	7197	TCGA-24-1545	OV	69	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	NA	-25460	Dead	WITH TUMOR	1746	1746	NA	Recurrence	NA	NA	861	Complete Remission/Response	NA	NA	1	1746	1	1746	1	861	1	861	
50	TCGA-24-1546	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1546-01	325	0.870328260452203	191	TCGA-24-1546-01	7	14	85	0.4353955746458576	TCGA-24-1546-01	24	25	18	67	PASS	7198	TCGA-24-1546	OV	46	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	NA	-17130	Dead	NA	1955	1955	NA	NA	NA	NA	NA	NA	NA	NA	1	1955	NA	1955	NA	NA	0	1955	
60	TCGA-24-1548	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1548-01	268	0.924397185359102	174	TCGA-24-1548-01	25	21	49	0.5042150797043572	TCGA-24-1548-01	9	2	4	15	PASS	7199	TCGA-24-1548	OV	57	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	NA	-20945	Dead	WITH TUMOR	493	493	NA	Recurrence	NA	NA	207	Complete Remission/Response	NA	NA	1	493	1	493	1	207	1	207	
60	TCGA-24-1549	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1549-01	445	0.8335417812949747	290	TCGA-24-1549-01	13	16	81	0.2320955498933199	TCGA-24-1549-01	14	9	8	31	PASS	7200	TCGA-24-1549	OV	58	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	1997	NA	-21432	Dead	WITH TUMOR	1721	1721	NA	Recurrence	NA	NA	1042	Complete Remission/Response	NA	NA	1	1721	1	1721	1	1042	1	1042	
50	TCGA-24-1550	0	3	1	5	1	1	1	0	2	54	5	0	4	8	1	0	TCGA-24-1550-01	458	0.9241440053239424	294	TCGA-24-1550-01	6	19	105	0.439982175910584	TCGA-24-1550-01	23	21	20	64	PASS	7201	TCGA-24-1550	OV	49	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	NA	-18049	Dead	WITH TUMOR	1249	1249	NA	Recurrence	NA	NA	892	Complete Remission/Response	NA	NA	1	1249	1	1249	1	892	1	892	
50	TCGA-24-1551	0	3	0	3	1	0	0	0	1	38	0	0	1	13	1	0	TCGA-24-1551-01	1108	0.3956523655497401	826	TCGA-24-1551-01	11	9	151	0.2346966534997764	TCGA-24-1551-01	17	14	2	33	PASS	7202	TCGA-24-1551	OV	53	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	NA	-19661	Dead	WITH TUMOR	1579	1579	NA	Recurrence	NA	NA	764	Complete Remission/Response	NA	NA	1	1579	1	1579	1	764	1	764	
80	TCGA-24-1552	1	5	1	0	2	7	0	0	2	41	3	0	0	10	1	0	TCGA-24-1552-01	359	0.9457341092057324	230	TCGA-24-1552-01	18	34	26	0.1977269821371961	TCGA-24-1552-01	13	10	4	27	PASS	7203	TCGA-24-1552	OV	77	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	NA	-28129	Dead	WITH TUMOR	1259	1259	NA	Recurrence	NA	NA	403	Complete Remission/Response	NA	NA	1	1259	1	1259	1	403	1	403	
50	TCGA-24-1553	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1553-01	491	0.507107476818155	314	TCGA-24-1553-01	10	42	153	0.4699383248679945	TCGA-24-1553-01	23	13	12	48	PASS	7204	TCGA-24-1553	OV	53	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	1997	NA	-19393	Dead	WITH TUMOR	1767	1767	NA	Recurrence	NA	NA	553	Complete Remission/Response	NA	NA	1	1767	1	1767	1	553	1	553	
50	TCGA-24-1555	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1555-01	202	0.4026269541314877	126	TCGA-24-1555-01	7	10	35	0.17325461997311714	TCGA-24-1555-01	12	18	8	38	PASS	7205	TCGA-24-1555	OV	50	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	NA	-18404	Dead	WITH TUMOR	2692	2692	NA	Recurrence	NA	NA	1577	Complete Remission/Response	NA	NA	1	2692	1	2692	1	1577	1	1577	
50	TCGA-24-1556	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1556-01	336	0.7355387890615994	199	TCGA-24-1556-01	6	33	52	0.2542695678871001	TCGA-24-1556-01	25	38	15	78	PASS	7206	TCGA-24-1556	OV	50	FEMALE	WHITE	NA	Stage IIB	Serous Cystadenocarcinoma	G3	2000	NA	-18517	Dead	WITH TUMOR	2148	2148	NA	Recurrence	NA	NA	539	Complete Remission/Response	NA	NA	1	2148	1	2148	1	539	1	539	
50	TCGA-24-1557	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1557-01	537	0.7598698987271425	341	TCGA-24-1557-01	11	32	86	0.3029429828936637	TCGA-24-1557-01	30	34	14	78	PASS	7207	TCGA-24-1557	OV	49	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-17943	Dead	WITH TUMOR	1213	1213	NA	Progression of Disease	NA	NA	447	Partial Remission/Response	NA	NA	1	1213	1	1213	NA	NA	1	447	
70	TCGA-24-1558	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1558-01	393	0.6467882121846567	230	TCGA-24-1558-01	18	32	51	0.1875356291472033	TCGA-24-1558-01	18	15	6	39	PASS	7208	TCGA-24-1558	OV	73	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-27004	Dead	WITH TUMOR	594	594	NA	Recurrence	NA	NA	273	Partial Remission/Response	NA	NA	1	594	1	594	NA	NA	1	273	
50	TCGA-24-1560	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1560-01	82	0.560705812203559	34	TCGA-24-1560	0	0	0	0	TCGA-24-1560	0	0	0	0	PASS	7209	TCGA-24-1560	OV	51	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G4	1999	NA	-18671	Dead	WITH TUMOR	1341	1341	NA	Recurrence	NA	NA	143	Complete Remission/Response	NA	NA	1	1341	1	1341	1	143	1	143	
70	TCGA-24-1562	0	2	0	0	0	2	0	0	1	23	2	0	0	9	1	1	TCGA-24-1562-01	204	0.9460393480434356	124	TCGA-24-1562-01	14	11	44	0.2872792975990138	TCGA-24-1562-01	11	9	9	29	PASS	7210	TCGA-24-1562	OV	67	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-24747	Dead	WITH TUMOR	1384	1384	NA	Recurrence	NA	NA	229	Complete Remission/Response	NA	NA	1	1384	1	1384	1	229	1	229	
70	TCGA-24-1563	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1563-01	313	0.6695913431975062	198	TCGA-24-1563-01	7	12	44	0.26405065212826684	TCGA-24-1563-01	21	26	10	57	PASS	7211	TCGA-24-1563	OV	66	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-24274	Dead	WITH TUMOR	1451	1451	NA	Recurrence	NA	NA	396	Complete Remission/Response	NA	NA	1	1451	1	1451	1	396	1	396	
70	TCGA-24-1564	1	1	1	1	0	1	0	0	0	48	1	0	0	12	3	0	TCGA-24-1564-01	195	0.6282556933338879	112	TCGA-24-1564-01	20	35	48	0.3010342543386469	TCGA-24-1564-01	12	11	6	29	PASS	7212	TCGA-24-1564	OV	67	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	NA	-24668	Dead	WITH TUMOR	787	787	NA	Recurrence	NA	NA	221	Complete Remission/Response	NA	NA	1	787	1	787	1	221	1	221	
70	TCGA-24-1565	0	3	0	2	2	3	0	0	1	25	2	0	1	14	4	0	TCGA-24-1565-01	110	0.19043791772248936	50	TCGA-24-1565-01	7	8	11	0.1203090007923026	TCGA-24-1565-01	7	4	6	17	PASS	7213	TCGA-24-1565	OV	74	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	NA	-27048	Dead	WITH TUMOR	312	312	NA	Recurrence	NA	NA	145	Partial Remission/Response	NA	NA	1	312	1	312	NA	NA	1	145	
50	TCGA-24-1567	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1567-01	338	0.9525707514225916	196	TCGA-24-1567-01	9	22	73	0.4759538688236003	TCGA-24-1567-01	27	30	17	74	PASS	7214	TCGA-24-1567	OV	54	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	1999	NA	-19843	Dead	WITH TUMOR	524	524	NA	Recurrence	NA	NA	319	NA	NA	NA	1	524	1	524	NA	NA	1	319	
50	TCGA-24-1603	1	2	0	0	1	4	0	0	2	32	2	0	1	11	0	0	TCGA-24-1603-01	194	0.93259729391388	107	TCGA-24-1603-01	10	11	45	0.3196058675868593	TCGA-24-1603-01	13	10	8	31	PASS	7215	TCGA-24-1603	OV	53	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	1996	NA	-19681	Dead	WITH TUMOR	2742	2742	NA	Recurrence	NA	NA	992	Complete Remission/Response	NA	NA	1	2742	1	2742	1	992	1	992	
70	TCGA-24-1604	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1604-01	254	0.7066643141430109	152	TCGA-24-1604-01	18	35	52	0.21384684473628668	TCGA-24-1604-01	25	19	6	50	PASS	7216	TCGA-24-1604	OV	66	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1996	NA	-24471	Dead	WITH TUMOR	2688	2688	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2688	1	2688	NA	NA	1	2688	
60	TCGA-24-1614	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1614-01	301	0.8402041906847089	167	TCGA-24-1614-01	16	22	64	0.4261572850092301	TCGA-24-1614-01	28	27	20	75	PASS	7217	TCGA-24-1614	OV	57	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-20993	Dead	WITH TUMOR	1470	1470	NA	Recurrence	NA	NA	644	Complete Remission/Response	NA	NA	1	1470	1	1470	1	644	1	644	
60	TCGA-24-1616	0	3	0	2	0	0	1	0	1	51	5	0	1	14	1	0	TCGA-24-1616-01	272	0.6830734632588871	168	TCGA-24-1616-01	18	25	27	0.1888328249407935	TCGA-24-1616-01	11	13	4	28	PASS	7218	TCGA-24-1616	OV	56	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-20785	Dead	WITH TUMOR	1163	1163	NA	Recurrence	NA	NA	405	Complete Remission/Response	NA	NA	1	1163	1	1163	1	405	1	405	
50	TCGA-24-1842	0	3	0	3	4	1	1	0	1	46	2	0	1	11	2	0	TCGA-24-1842-01	573	0.8696563022146585	412	TCGA-24-1842-01	16	23	109	0.2497815794353952	TCGA-24-1842-01	21	11	7	39	PASS	7219	TCGA-24-1842	OV	49	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-18227	Alive	TUMOR FREE	253	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	253	0	253	0	253	0	253	
70	TCGA-24-1843	0	9	0	4	2	1	0	0	4	72	2	0	2	21	2	0	TCGA-24-1843-01	452	0.7666522516382562	277	TCGA-24-1843-01	17	32	68	0.17556290519800316	TCGA-24-1843-01	12	6	3	21	PASS	7220	TCGA-24-1843	OV	66	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-24469	Alive	NA	106	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	106	0	106	0	106	0	106	
60	TCGA-24-1844	0	16	0	5	3	0	2	1	5	130	12	0	6	36	4	0	TCGA-24-1844-01	202	0.8158940768787308	110	TCGA-24-1844-01	19	31	18	0.09305056410588856	TCGA-24-1844-01	19	20	5	44	PASS	7221	TCGA-24-1844	OV	64	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-23542	Alive	NA	113	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	113	0	113	NA	NA	0	113	
40	TCGA-24-1845	1	13	1	3	9	2	4	0	15	150	5	0	1	43	6	0	TCGA-24-1845-01	303	0.7792769734683125	175	TCGA-24-1845-01	12	79	59	0.3438382121769569	TCGA-24-1845-01	27	45	11	83	PASS	7222	TCGA-24-1845	OV	42	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-15599	Alive	NA	116	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	116	0	116	NA	NA	0	116	
50	TCGA-24-1846	1	15	1	5	4	2	3	0	5	84	7	0	2	26	4	0	TCGA-24-1846-01	242	0.9914678221967252	134	TCGA-24-1846-01	10	17	56	0.4776177341167022	TCGA-24-1846-01	21	21	16	58	PASS	7223	TCGA-24-1846	OV	45	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-16534	Alive	NA	133	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	133	0	133	NA	NA	0	133	
50	TCGA-24-1847	1	5	1	2	1	0	2	0	2	84	3	0	0	31	3	0	TCGA-24-1847-01	392	0.7089610660037934	244	TCGA-24-1847-01	13	32	43	0.23609375292490364	TCGA-24-1847-01	25	33	9	67	PASS	7224	TCGA-24-1847	OV	45	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2009	NA	-16529	Alive	TUMOR FREE	343	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	343	0	343	NA	NA	0	343	
80	TCGA-24-1849	0	9	2	1	5	3	0	0	3	102	2	0	3	32	4	1	TCGA-24-1849-01	161	0.426385845435794	89	TCGA-24-1849-01	3	12	31	0.3215286629859501	TCGA-24-1849-01	19	25	13	57	PASS	7225	TCGA-24-1849	OV	80	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-29555	Alive	TUMOR FREE	176	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	176	0	176	0	176	0	176	
70	TCGA-24-1850	0	9	1	2	4	3	1	0	1	72	6	0	1	22	2	0	TCGA-24-1850-01	501	0.9099647275707582	299	TCGA-24-1850-01	22	36	121	0.3705958537972998	TCGA-24-1850-01	21	19	13	53	PASS	7226	TCGA-24-1850	OV	72	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-26369	Alive	TUMOR FREE	168	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	168	0	168	0	168	0	168	
60	TCGA-24-1852	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1852-01	374	0.7043918619614284	238	TCGA-24-1852-01	20	66	65	0.20421002944897035	TCGA-24-1852-01	20	16	7	43	PASS	7227	TCGA-24-1852	OV	55	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	NA	-20390	Dead	WITH TUMOR	2201	2201	NA	Recurrence	NA	NA	1009	Complete Remission/Response	NA	NA	1	2201	1	2201	1	1009	1	1009	
70	TCGA-24-1920	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1920-01	1386	0.6970531943861776	984	TCGA-24-1920	0	0	0	0	TCGA-24-1920	0	0	0	0	PASS	7228	TCGA-24-1920	OV	74	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-27042	Alive	TUMOR FREE	298	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	298	0	298	0	298	0	298	
50	TCGA-24-1923	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1923-01	206	0.6079213559310072	116	TCGA-24-1923-01	29	17	19	0.31083835896817075	TCGA-24-1923-01	9	5	1	15	PASS	7229	TCGA-24-1923	OV	51	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-18628	Dead	WITH TUMOR	690	690	NA	Recurrence	NA	NA	343	Complete Remission/Response	NA	NA	1	690	1	690	1	343	1	343	
70	TCGA-24-1924	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1924-01	388	0.7988438537787428	240	TCGA-24-1924	0	0	0	0	TCGA-24-1924	0	0	0	0	PASS	7230	TCGA-24-1924	OV	65	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-23801	Dead	WITH TUMOR	919	919	NA	Recurrence	NA	NA	320	Complete Remission/Response	NA	NA	1	919	1	919	1	320	1	320	
60	TCGA-24-1927	0	15	0	5	3	2	0	0	3	87	8	0	3	38	5	2	TCGA-24-1927-01	388	0.9371901396512102	244	TCGA-24-1927-01	7	12	72	0.3018498206351615	TCGA-24-1927-01	22	24	12	58	PASS	7231	TCGA-24-1927	OV	59	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-21719	Dead	WITH TUMOR	500	500	NA	Recurrence	NA	NA	290	Complete Remission/Response	NA	NA	1	500	1	500	1	290	1	290	
80	TCGA-24-1928	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1928-01	378	0.8811202274800349	270	TCGA-24-1928-01	20	28	25	0.14483321206196262	TCGA-24-1928-01	14	6	3	23	PASS	7232	TCGA-24-1928	OV	77	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	NA	-28126	Dead	WITH TUMOR	336	336	NA	Recurrence	NA	NA	70	Progressive Disease	NA	NA	1	336	1	336	NA	NA	1	70	
50	TCGA-24-1930	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-1930-01	278	0.7302677930067869	169	TCGA-24-1930-01	17	29	42	0.2748792793767565	TCGA-24-1930-01	19	21	7	47	PASS	7233	TCGA-24-1930	OV	53	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	NA	-19387	Dead	WITH TUMOR	2467	2467	NA	Recurrence	NA	NA	544	Complete Remission/Response	NA	NA	1	2467	1	2467	1	544	1	544	
50	TCGA-24-2019	1	3	0	1	0	5	0	0	1	41	2	0	0	16	1	0	TCGA-24-2019-01	425	0.7852839451743279	252	TCGA-24-2019-01	21	34	71	0.2706910195446036	TCGA-24-2019-01	18	11	4	33	PASS	7234	TCGA-24-2019	OV	46	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-17009	Alive	NA	148	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	148	0	148	NA	NA	0	148	
70	TCGA-24-2020	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-2020-01	504	0.9143709672786129	337	TCGA-24-2020-01	22	55	111	0.4516089729624928	TCGA-24-2020-01	29	32	8	69	PASS	7235	TCGA-24-2020	OV	67	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1994	NA	-24682	Dead	WITH TUMOR	4624	4624	NA	Recurrence	NA	NA	723	Complete Remission/Response	NA	NA	1	4624	1	4624	1	723	1	723	
50	TCGA-24-2023	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-2023-01	946	0.9853722965894364	679	TCGA-24-2023-01	14	11	167	0.361484700629802	TCGA-24-2023-01	14	6	15	35	PASS	7236	TCGA-24-2023	OV	54	FEMALE	WHITE	NA	Stage IIIA	Serous Cystadenocarcinoma	G3	1994	NA	-19901	Dead	WITH TUMOR	1364	1364	NA	Recurrence	NA	NA	1069	Complete Remission/Response	NA	NA	1	1364	1	1364	1	1069	1	1069	
70	TCGA-24-2024	0	7	0	6	3	3	2	0	5	75	11	0	2	29	1	2	TCGA-24-2024-01	313	0.9471369286476786	211	TCGA-24-2024-01	5	9	46	0.3052525624846709	TCGA-24-2024-01	17	28	14	59	PASS	7237	TCGA-24-2024	OV	72	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1994	NA	-26476	Dead	WITH TUMOR	1769	1769	NA	Recurrence	NA	NA	421	Complete Remission/Response	NA	NA	1	1769	1	1769	1	421	1	421	
80	TCGA-24-2026	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-2026-01	696	0.7345826248843317	458	TCGA-24-2026-01	28	50	86	0.15793056779635306	TCGA-24-2026-01	12	12	6	30	PASS	7238	TCGA-24-2026	OV	79	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1995	NA	-29050	Dead	NA	1059	1059	NA	NA	NA	NA	NA	NA	NA	NA	1	1059	NA	1059	NA	NA	0	1059	
50	TCGA-24-2027	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-2027-01	386	0.9360118911748774	255	TCGA-24-2027-01	11	15	65	0.4031616186723521	TCGA-24-2027-01	24	25	14	63	PASS	7239	TCGA-24-2027	OV	51	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	1995	NA	-18835	Dead	WITH TUMOR	3337	3337	NA	Recurrence	NA	NA	617	Complete Remission/Response	NA	NA	1	3337	1	3337	NA	NA	1	617	
80	TCGA-24-2029	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-2029-01	211	0.7445906514726428	121	TCGA-24-2029-01	10	11	32	0.2837229720662774	TCGA-24-2029-01	8	8	5	21	PASS	7240	TCGA-24-2029	OV	75	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1995	NA	-27527	Dead	WITH TUMOR	439	439	NA	Recurrence	NA	NA	372	Complete Remission/Response	NA	NA	1	439	1	439	1	372	1	372	
90	TCGA-24-2030	2	3	0	2	4	2	1	0	0	58	3	0	0	19	2	0	TCGA-24-2030-01	623	0.6553917993194084	409	TCGA-24-2030-01	9	40	80	0.28507686215955785	TCGA-24-2030-01	22	21	13	56	PASS	7241	TCGA-24-2030	OV	87	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1995	NA	-31900	Dead	WITH TUMOR	1641	1701	NA	Recurrence	NA	NA	646	Complete Remission/Response	NA	NA	1	1701	1	1701	1	646	1	646	
90	TCGA-24-2033	0	5	0	6	5	1	1	0	2	85	11	0	3	30	1	0	TCGA-24-2033-01	280	0.6867224037281131	161	TCGA-24-2033-01	13	27	36	0.17434600551578147	TCGA-24-2033-01	16	21	3	40	PASS	7242	TCGA-24-2033	OV	87	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1995	NA	-31977	Dead	WITH TUMOR	562	562	NA	Recurrence	NA	NA	351	Partial Remission/Response	NA	NA	1	562	1	562	NA	NA	1	351	
70	TCGA-24-2035	1	5	0	3	2	3	3	0	6	105	10	0	1	34	4	0	TCGA-24-2035-01	241	0.3683812257252014	143	TCGA-24-2035-01	5	16	60	0.2871164663803009	TCGA-24-2035-01	18	26	14	58	PASS	7243	TCGA-24-2035	OV	65	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1996	NA	-23855	Dead	WITH TUMOR	857	857	NA	Recurrence	NA	NA	287	Partial Remission/Response	NA	NA	1	857	1	857	NA	NA	1	287	
50	TCGA-24-2036	0	2	1	3	3	1	0	0	1	47	2	0	1	6	2	0	TCGA-24-2036	0	0	0	TCGA-24-2036	0	0	0	0	TCGA-24-2036-01	19	17	13	49	PASS	7244	TCGA-24-2036	OV	50	FEMALE	WHITE	NA	Stage IIIA	Serous Cystadenocarcinoma	G3	1996	NA	-18582	Dead	WITH TUMOR	1947	1947	NA	Recurrence	NA	NA	914	Complete Remission/Response	NA	NA	1	1947	1	1947	1	914	1	914	
70	TCGA-24-2038	0	2	0	0	0	0	0	0	0	12	0	0	0	6	0	0	TCGA-24-2038-01	66	0.8571615472917256	25	TCGA-24-2038-01	7	4	3	0.0007370543296436568	TCGA-24-2038-01	1	0	0	1	PASS	7245	TCGA-24-2038	OV	68	FEMALE	WHITE	NA	Stage IIIA	Serous Cystadenocarcinoma	GB	2000	NA	-24957	Dead	WITH TUMOR	1354	1354	NA	Recurrence	NA	NA	1169	Complete Remission/Response	NA	NA	1	1354	1	1354	1	1169	1	1169	
70	TCGA-24-2254	0	5	0	1	4	2	0	0	0	53	2	0	3	18	6	0	TCGA-24-2254-01	274	0.947692577558086	161	TCGA-24-2254-01	12	18	65	0.4730300209481198	TCGA-24-2254-01	23	20	16	59	PASS	7246	TCGA-24-2254	OV	66	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-24407	Dead	WITH TUMOR	1736	1736	NA	Recurrence	NA	NA	606	Complete Remission/Response	NA	NA	1	1736	1	1736	1	606	1	606	
70	TCGA-24-2260	0	0	0	2	7	1	0	0	2	61	3	0	3	23	1	0	TCGA-24-2260-01	428	0.7152707938236071	260	TCGA-24-2260-01	20	37	115	0.4066046846184788	TCGA-24-2260-01	23	13	11	47	PASS	7247	TCGA-24-2260	OV	74	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	1992	NA	-27112	Dead	WITH TUMOR	1100	1100	NA	Recurrence	NA	NA	667	Complete Remission/Response	NA	NA	1	1100	1	1100	1	667	1	667	
80	TCGA-24-2261	0	3	0	0	1	1	0	0	0	43	5	0	1	21	0	0	TCGA-24-2261-01	268	0.8390110475373688	161	TCGA-24-2261-01	16	32	64	0.4138229320031979	TCGA-24-2261-01	15	7	10	32	PASS	7248	TCGA-24-2261	OV	76	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1992	NA	-27897	Dead	WITH TUMOR	24	24	NA	NA	NA	NA	NA	NA	NA	NA	1	24	1	24	NA	NA	1	24	
60	TCGA-24-2262	1	8	0	2	2	2	0	0	5	80	6	0	0	35	5	0	TCGA-24-2262-01	569	0.3875138878496691	400	TCGA-24-2262-01	6	12	103	0.2676345608321926	TCGA-24-2262-01	13	14	11	38	PASS	7249	TCGA-24-2262	OV	57	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1992	NA	-20861	Dead	WITH TUMOR	11	11	NA	NA	NA	NA	NA	NA	NA	NA	1	11	1	11	NA	NA	1	11	
60	TCGA-24-2267	0	4	0	2	5	1	4	0	3	108	3	0	1	30	4	0	TCGA-24-2267-01	354	0.7944044457463025	225	TCGA-24-2267-01	10	35	59	0.2142053862452487	TCGA-24-2267-01	20	41	9	70	PASS	7250	TCGA-24-2267	OV	58	FEMALE	WHITE	NA	Stage IIB	Serous Cystadenocarcinoma	G3	1993	NA	-21293	Dead	WITH TUMOR	1446	1446	NA	Recurrence	NA	NA	512	Complete Remission/Response	NA	NA	1	1446	1	1446	1	512	1	512	
60	TCGA-24-2271	0	3	0	2	3	1	1	0	2	37	9	0	0	16	0	0	TCGA-24-2271-01	180	0.8743082736124387	106	TCGA-24-2271-01	10	19	32	0.4401874339620461	TCGA-24-2271-01	9	8	3	20	PASS	7251	TCGA-24-2271	OV	55	FEMALE	ASIAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-20399	Dead	WITH TUMOR	962	962	NA	Recurrence	NA	NA	827	NA	NA	NA	1	962	1	962	NA	NA	1	827	
70	TCGA-24-2280	1	18	0	6	3	2	1	0	11	162	15	0	3	64	2	0	TCGA-24-2280-01	449	0.9580209195560618	281	TCGA-24-2280-01	12	76	50	0.17795830728180154	TCGA-24-2280-01	28	35	5	68	PASS	7252	TCGA-24-2280	OV	74	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-27356	Alive	WITH TUMOR	2143	NA	NA	Recurrence	NA	NA	535	Complete Remission/Response	NA	NA	0	2143	0	2143	1	535	1	535	
70	TCGA-24-2281	1	10	2	2	2	2	0	0	4	75	2	0	2	23	4	0	TCGA-24-2281-01	342	0.6347949431959532	222	TCGA-24-2281-01	11	27	33	0.15541775680314185	TCGA-24-2281-01	11	15	5	31	PASS	7253	TCGA-24-2281	OV	68	FEMALE	WHITE	NA	Stage IIA	Serous Cystadenocarcinoma	G3	2006	NA	-25019	Alive	TUMOR FREE	1357	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1357	0	1357	0	1357	0	1357	
70	TCGA-24-2288	0	16	1	5	2	0	0	0	9	168	7	1	2	47	4	1	TCGA-24-2288-01	521	0.7344843495890419	320	TCGA-24-2288-01	19	61	121	0.42569712488961137	TCGA-24-2288-01	27	26	22	75	PASS	7254	TCGA-24-2288	OV	70	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-25831	Dead	WITH TUMOR	25	25	NA	NA	NA	NA	NA	NA	NA	NA	1	25	1	25	NA	NA	1	25	
70	TCGA-24-2289	1	9	0	8	4	1	3	0	3	144	12	0	3	38	3	0	TCGA-24-2289-01	764	0.9520826159675386	496	TCGA-24-2289-01	15	44	186	0.5282188979029588	TCGA-24-2289-01	30	28	17	75	PASS	7255	TCGA-24-2289	OV	68	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	1997	NA	-25191	Dead	WITH TUMOR	2049	2049	NA	Recurrence	NA	NA	568	Complete Remission/Response	NA	NA	1	2049	1	2049	NA	NA	1	568	
60	TCGA-24-2290	1	2	1	4	4	0	2	0	1	46	1	0	3	22	1	0	TCGA-24-2290-01	362	0.9602833428372126	235	TCGA-24-2290-01	7	26	73	0.3692137009118231	TCGA-24-2290-01	25	31	16	72	PASS	7256	TCGA-24-2290	OV	56	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	NA	-20530	Dead	WITH TUMOR	1102	1102	NA	Recurrence	NA	NA	324	Complete Remission/Response	NA	NA	1	1102	1	1102	1	324	1	324	
50	TCGA-24-2293	0	8	1	5	3	1	0	1	5	101	8	0	0	30	6	0	TCGA-24-2293-01	261	0.6543812122366988	159	TCGA-24-2293-01	23	28	66	0.4346753530339625	TCGA-24-2293-01	16	19	5	40	PASS	7257	TCGA-24-2293	OV	47	FEMALE	WHITE	NA	NA	Serous Cystadenocarcinoma	G3	1995	NA	-17235	Dead	NA	506	506	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	506	NA	506	NA	NA	0	506	
70	TCGA-24-2295	0	1	0	2	0	2	1	0	4	83	6	0	0	26	1	0	TCGA-24-2295-01	291	0.6909736378015252	177	TCGA-24-2295-01	22	69	36	0.08952377034287874	TCGA-24-2295-01	20	16	1	37	PASS	7258	TCGA-24-2295	OV	69	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1995	NA	-25416	Dead	WITH TUMOR	1007	1007	NA	Recurrence	NA	NA	281	Complete Remission/Response	NA	NA	1	1007	1	1007	1	281	1	281	
60	TCGA-24-2297	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-24-2297-01	533	0.8461667239170192	350	TCGA-24-2297-01	1	32	162	0.5720779673852046	TCGA-24-2297-01	28	34	30	92	PASS	7259	TCGA-24-2297	OV	56	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1993	NA	-20487	Dead	NA	1699	1699	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1699	NA	1699	0	1699	0	1699	
60	TCGA-24-2298	0	7	0	3	1	0	0	0	10	112	10	0	1	45	1	0	TCGA-24-2298-01	717	0.9288160167370104	452	TCGA-24-2298-01	14	33	166	0.5046789953475024	TCGA-24-2298-01	32	21	19	72	PASS	7260	TCGA-24-2298	OV	55	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1993	NA	-20453	Dead	WITH TUMOR	1620	1620	NA	Recurrence	NA	NA	469	Complete Remission/Response	NA	NA	1	1620	1	1620	1	469	1	469	
70	TCGA-25-1312	0	1	0	0	1	0	0	0	1	18	0	0	2	7	0	0	TCGA-25-1312-01	311	0.7112369115946575	196	TCGA-25-1312-01	26	32	54	0.2818689590240175	TCGA-25-1312-01	15	8	2	25	PASS	7261	TCGA-25-1312	OV	69	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2001	NA	-25537	Dead	NA	31	31	NA	NA	NA	NA	NA	NA	NA	NA	1	31	NA	31	NA	NA	0	31	
60	TCGA-25-1313	1	7	0	4	9	3	0	0	12	143	9	0	1	54	12	0	TCGA-25-1313-01	232	0.7978725955925864	126	TCGA-25-1313-01	12	33	68	0.3162813340949679	TCGA-25-1313-01	29	31	16	76	PASS	7262	TCGA-25-1313	OV	62	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2000	NA	-22982	Dead	WITH TUMOR	820	820	NA	Recurrence	NA	NA	394	Complete Remission/Response	NA	NA	1	820	1	820	NA	NA	1	394	
40	TCGA-25-1314	1	4	0	2	4	2	0	0	3	65	7	0	3	24	2	0	TCGA-25-1314-01	353	0.7153641032169225	224	TCGA-25-1314-01	10	39	51	0.2988869147811574	TCGA-25-1314-01	22	27	10	59	PASS	7263	TCGA-25-1314	OV	42	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2000	NA	-15462	Dead	WITH TUMOR	974	1004	NA	Progression of Disease	NA	NA	274	Partial Remission/Response	NA	NA	1	1004	1	1004	NA	NA	1	274	
50	TCGA-25-1315	0	12	2	0	2	0	0	0	3	62	3	0	1	10	3	0	TCGA-25-1315-01	451	0.9003251639338578	300	TCGA-25-1315-01	6	17	56	0.277938433623025	TCGA-25-1315-01	21	21	10	52	PASS	7264	TCGA-25-1315	OV	50	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-18263	Dead	WITH TUMOR	1553	1583	NA	Progression of Disease	NA	NA	153	Partial Remission/Response	NA	NA	1	1583	1	1583	NA	NA	1	153	
60	TCGA-25-1316	0	2	0	0	4	0	0	0	3	11	1	0	0	6	0	0	TCGA-25-1316-01	72	0.9471947240324236	28	TCGA-25-1316-01	19	34	2	0.028808082762372938	TCGA-25-1316-01	1	0	0	1	PASS	7265	TCGA-25-1316	OV	55	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-20331	Dead	WITH TUMOR	1126	1279	NA	Progression of Disease	NA	NA	276	Progressive Disease	NA	NA	1	1279	1	1279	NA	NA	1	276	
70	TCGA-25-1317	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1317-01	155	0.7481578403582437	87	TCGA-25-1317-01	27	29	26	0.32577659503394923	TCGA-25-1317-01	7	4	0	11	PASS	7266	TCGA-25-1317	OV	66	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-24199	Dead	NA	NA	61	NA	NA	NA	NA	NA	NA	NA	NA	1	61	NA	61	NA	NA	0	61	
50	TCGA-25-1318	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1318-01	246	0.7610521701132478	150	TCGA-25-1318-01	23	51	44	0.2703058190810672	TCGA-25-1318-01	25	25	7	57	PASS	7267	TCGA-25-1318	OV	54	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-19755	Dead	WITH TUMOR	1064	1064	NA	Recurrence	NA	NA	185	Partial Remission/Response	NA	NA	1	1064	1	1064	NA	NA	1	185	
70	TCGA-25-1319	0	2	0	1	0	0	0	0	1	53	4	0	1	10	2	0	TCGA-25-1319-01	320	0.7332897544050999	198	TCGA-25-1319-01	18	30	34	0.06782205734676802	TCGA-25-1319-01	11	7	1	19	PASS	7268	TCGA-25-1319	OV	73	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-26786	Dead	NA	1977	1977	NA	Recurrence	NA	NA	730	NA	NA	NA	1	1977	NA	1977	NA	NA	1	730	
70	TCGA-25-1320	0	7	1	3	5	2	2	1	4	90	9	0	1	36	4	0	TCGA-25-1320-01	325	0.7832227725619209	200	TCGA-25-1320-01	25	47	25	0.07442991234899568	TCGA-25-1320-01	20	9	0	29	PASS	7269	TCGA-25-1320	OV	65	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-24018	Dead	WITH TUMOR	1124	1155	NA	Recurrence	NA	NA	424	Progressive Disease	NA	NA	1	1155	1	1155	NA	NA	1	424	
70	TCGA-25-1321	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1321-01	195	0.8966752218639954	100	TCGA-25-1321-01	24	56	47	0.4008365796522047	TCGA-25-1321-01	21	13	11	45	PASS	7270	TCGA-25-1321	OV	65	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-23987	Dead	WITH TUMOR	1033	1033	NA	Recurrence	NA	NA	454	Complete Remission/Response	NA	NA	1	1033	1	1033	1	454	1	454	
60	TCGA-25-1322	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1322-01	498	0.8542873367138578	348	TCGA-25-1322-01	17	11	86	0.3350266224005385	TCGA-25-1322-01	15	10	3	28	PASS	7271	TCGA-25-1322	OV	62	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2001	NA	-22646	Dead	WITH TUMOR	91	91	NA	NA	NA	NA	NA	NA	NA	NA	1	91	1	91	NA	NA	1	91	
70	TCGA-25-1323	1	10	0	0	0	2	0	0	2	71	4	1	0	21	4	0	TCGA-25-1323-01	398	0.7936240818867509	249	TCGA-25-1323-01	24	70	63	0.3440616343071689	TCGA-25-1323-01	22	16	4	42	PASS	7272	TCGA-25-1323	OV	72	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-26602	Dead	WITH TUMOR	365	395	NA	Progression of Disease	NA	NA	365	Complete Remission/Response	NA	NA	1	395	1	395	1	365	1	365	
70	TCGA-25-1324	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1324	0	0	0	TCGA-25-1324	0	0	0	0	TCGA-25-1324	0	0	0	0	PASS	7273	TCGA-25-1324	OV	74	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-27090	Dead	NA	1035	1035	NA	NA	NA	NA	NA	NA	NA	NA	1	1035	NA	1035	NA	NA	0	1035	
80	TCGA-25-1325	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1325	0	0	0	TCGA-25-1325	0	0	0	0	TCGA-25-1325	0	0	0	0	PASS	7274	TCGA-25-1325	OV	77	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2002	NA	-28183	Dead	NA	976	976	NA	NA	NA	NA	NA	NA	NA	NA	1	976	NA	976	NA	NA	0	976	
60	TCGA-25-1326	1	17	3	9	4	4	1	0	9	223	13	1	4	68	8	0	TCGA-25-1326	0	0	0	TCGA-25-1326	0	0	0	0	TCGA-25-1326	0	0	0	0	PASS	7275	TCGA-25-1326	OV	61	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-22339	Dead	WITH TUMOR	945	1249	NA	Recurrence	NA	NA	396	Partial Remission/Response	NA	NA	1	1249	1	1249	NA	NA	1	396	
40	TCGA-25-1328	0	2	0	1	0	0	0	0	0	29	2	0	3	10	1	0	TCGA-25-1328	0	0	0	TCGA-25-1328	0	0	0	0	TCGA-25-1328	0	0	0	0	PASS	7276	TCGA-25-1328	OV	38	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-13911	Dead	WITH TUMOR	1979	2009	NA	Recurrence	NA	NA	244	Partial Remission/Response	NA	NA	1	2009	1	2009	NA	NA	1	244	
80	TCGA-25-1329	0	5	0	3	4	3	0	0	0	44	9	0	2	14	0	0	TCGA-25-1329-01	221	0.7518001826027232	129	TCGA-25-1329-01	20	29	13	0.08910525208469211	TCGA-25-1329-01	8	9	1	18	PASS	7277	TCGA-25-1329	OV	76	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-28093	Dead	NA	90	457	NA	NA	NA	NA	NA	NA	NA	NA	1	457	NA	457	NA	NA	0	457	
70	TCGA-25-1623	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1623-01	177	0.37834484207272256	95	TCGA-25-1623-01	11	37	30	0.41446041250368654	TCGA-25-1623-01	12	6	7	25	PASS	7278	TCGA-25-1623	OV	71	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2006	NA	-26060	Dead	WITH TUMOR	565	565	NA	Recurrence	NA	NA	342	Complete Remission/Response	NA	NA	1	565	1	565	NA	NA	1	342	
70	TCGA-25-1625	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1625-01	240	0.42501489428756617	137	TCGA-25-1625-01	5	16	42	0.2901890875313527	TCGA-25-1625-01	20	18	14	52	PASS	7279	TCGA-25-1625	OV	66	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-24298	Dead	WITH TUMOR	548	840	NA	Recurrence	NA	NA	526	Stable Disease	NA	NA	1	840	1	840	NA	NA	1	526	
70	TCGA-25-1626	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1626-01	92	0.5540117363022845	41	TCGA-25-1626-01	25	37	25	0.5536354124085199	TCGA-25-1626-01	8	9	2	19	PASS	7280	TCGA-25-1626	OV	65	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-23932	Dead	WITH TUMOR	481	518	NA	Recurrence	NA	NA	318	Partial Remission/Response	NA	NA	1	518	1	518	NA	NA	1	318	
70	TCGA-25-1627	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1627-01	388	0.7951333263458437	272	TCGA-25-1627-01	11	38	75	0.4641850267281846	TCGA-25-1627-01	18	8	8	34	PASS	7281	TCGA-25-1627	OV	73	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-26784	Dead	NA	11	394	NA	NA	NA	NA	NA	NA	NA	NA	1	394	NA	394	NA	NA	0	394	
70	TCGA-25-1628	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1628-01	174	0.6766563148921939	101	TCGA-25-1628-01	28	31	19	0.22611756239564115	TCGA-25-1628-01	6	6	3	15	PASS	7282	TCGA-25-1628	OV	67	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-24488	Dead	WITH TUMOR	627	627	NA	Recurrence	NA	NA	287	Stable Disease	NA	NA	1	627	1	627	NA	NA	1	287	
70	TCGA-25-1630	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1630-01	356	0.61718138840502	208	TCGA-25-1630-01	10	23	81	0.31154425929954743	TCGA-25-1630-01	25	24	13	62	PASS	7283	TCGA-25-1630	OV	73	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-27006	Dead	NA	239	1162	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1162	NA	1162	0	1162	0	1162	
70	TCGA-25-1631	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1631-01	161	0.8869936860836011	90	TCGA-25-1631-01	8	11	17	0.2430211621794617	TCGA-25-1631-01	7	7	5	19	PASS	7284	TCGA-25-1631	OV	73	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-26687	Dead	TUMOR FREE	9	9	NA	NA	NA	NA	NA	NA	NA	NA	1	9	0	9	NA	NA	0	9	
70	TCGA-25-1632	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1632-01	308	0.9484887974460432	191	TCGA-25-1632-01	10	20	27	0.17232937347718644	TCGA-25-1632-01	18	21	7	46	PASS	7285	TCGA-25-1632	OV	68	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2002	NA	-24993	Dead	WITH TUMOR	1732	1799	NA	Recurrence	NA	NA	537	Complete Remission/Response	NA	NA	1	1799	1	1799	NA	NA	1	537	
60	TCGA-25-1633	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1633-01	231	0.9890265749062236	139	TCGA-25-1633-01	20	34	34	0.3624637947280528	TCGA-25-1633-01	15	9	9	33	PASS	7286	TCGA-25-1633	OV	64	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-23407	Dead	WITH TUMOR	1843	1891	NA	Recurrence	NA	NA	616	Complete Remission/Response	NA	NA	1	1891	1	1891	1	616	1	616	
80	TCGA-25-1634	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1634-01	278	0.7446209130988144	186	TCGA-25-1634-01	29	68	23	0.18308114553873495	TCGA-25-1634-01	11	11	2	24	PASS	7287	TCGA-25-1634	OV	75	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-27749	Dead	WITH TUMOR	1081	1091	NA	Recurrence	NA	NA	380	Complete Remission/Response	NA	NA	1	1091	1	1091	1	380	1	380	
70	TCGA-25-1635	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1635-01	208	0.9093148132722608	127	TCGA-25-1635-01	21	33	21	0.34429952144292153	TCGA-25-1635-01	15	11	7	33	PASS	7288	TCGA-25-1635	OV	71	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-26200	Dead	WITH TUMOR	1558	1583	NA	Recurrence	NA	NA	614	Complete Remission/Response	NA	NA	1	1583	1	1583	1	614	1	614	
60	TCGA-25-1870	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1870-01	343	0.7508857147298581	207	TCGA-25-1870-01	25	50	16	0.1102044437493316	TCGA-25-1870-01	9	4	2	15	PASS	7289	TCGA-25-1870	OV	59	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1994	NA	-21550	Dead	WITH TUMOR	455	455	NA	Recurrence	NA	NA	243	Partial Remission/Response	NA	NA	1	455	1	455	NA	NA	1	243	
70	TCGA-25-1871	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1871-01	315	0.9319970945790864	190	TCGA-25-1871-01	28	47	63	0.247659847397802	TCGA-25-1871-01	23	11	5	39	PASS	7290	TCGA-25-1871	OV	70	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1993	NA	-25627	Dead	WITH TUMOR	760	760	NA	Recurrence	NA	NA	230	Progressive Disease	NA	NA	1	760	1	760	NA	NA	1	230	
80	TCGA-25-1877	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1877-01	484	0.938984821758186	318	TCGA-25-1877-01	22	36	82	0.4052213403567511	TCGA-25-1877-01	17	9	8	34	PASS	7291	TCGA-25-1877	OV	81	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1993	NA	-29615	Dead	WITH TUMOR	549	730	NA	Recurrence	NA	NA	549	Complete Remission/Response	NA	NA	1	730	1	730	1	549	1	549	
60	TCGA-25-1878	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-1878-01	198	0.7777929237741935	114	TCGA-25-1878-01	22	77	36	0.2750533729355327	TCGA-25-1878-01	23	22	10	55	PASS	7292	TCGA-25-1878	OV	60	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1994	NA	-22035	Dead	WITH TUMOR	2587	2587	NA	Recurrence	NA	NA	971	Complete Remission/Response	NA	NA	1	2587	1	2587	1	971	1	971	
60	TCGA-25-2042	0	9	1	3	2	0	1	0	5	94	11	0	2	42	4	0	TCGA-25-2042-01	204	0.4395329887490661	114	TCGA-25-2042-01	7	16	48	0.35522777711219544	TCGA-25-2042-01	22	20	9	51	PASS	7293	TCGA-25-2042	OV	60	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-22127	Dead	WITH TUMOR	396	396	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	396	1	396	NA	NA	1	396	
80	TCGA-25-2390	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-25-2390	0	0	0	TCGA-25-2390	0	0	0	0	TCGA-25-2390	0	0	0	0	PASS	7294	TCGA-25-2390	OV	80	FEMALE	NA	NA	NA	Serous Cystadenocarcinoma	NA	2003	NA	-29257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	
60	TCGA-25-2391	2	3	1	1	1	2	1	0	2	66	4	0	1	14	0	0	TCGA-25-2391-01	280	0.916487523272977	187	TCGA-25-2391-01	5	15	56	0.31744891130548875	TCGA-25-2391-01	20	16	13	49	PASS	7295	TCGA-25-2391	OV	57	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-20939	Dead	TUMOR FREE	1492	1492	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1492	0	1492	0	1492	0	1492	
80	TCGA-25-2392	0	11	0	3	4	1	1	0	7	97	4	0	2	38	4	0	TCGA-25-2392-01	694	0.854676739851422	524	TCGA-25-2392-01	22	66	53	0.1959372853462636	TCGA-25-2392-01	23	23	9	55	PASS	7296	TCGA-25-2392	OV	75	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2003	NA	-27667	Dead	NA	31	31	NA	NA	NA	NA	NA	NA	NA	NA	1	31	NA	31	NA	NA	0	31	
80	TCGA-25-2393	0	2	1	4	1	2	3	0	4	57	5	0	2	17	1	0	TCGA-25-2393-01	503	0.8355825102537259	317	TCGA-25-2393-01	13	40	73	0.17573702116687864	TCGA-25-2393-01	17	10	6	33	PASS	7297	TCGA-25-2393	OV	81	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-29585	Dead	WITH TUMOR	1157	1157	NA	Recurrence	NA	NA	305	Partial Remission/Response	NA	NA	1	1157	1	1157	NA	NA	1	305	
70	TCGA-25-2396	0	2	0	2	0	1	1	0	2	28	2	0	0	15	0	0	TCGA-25-2396-01	355	0.6271316470762469	227	TCGA-25-2396-01	14	33	53	0.2746504709976097	TCGA-25-2396-01	16	6	7	29	PASS	7298	TCGA-25-2396	OV	71	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-26145	Dead	NA	92	92	NA	NA	NA	NA	NA	NA	NA	NA	1	92	NA	92	NA	NA	0	92	
60	TCGA-25-2397	1	10	1	1	4	0	0	0	6	96	17	0	4	37	3	0	TCGA-25-2397-01	569	0.8172755946377469	384	TCGA-25-2397-01	4	20	115	0.4259700213350187	TCGA-25-2397-01	30	26	19	75	PASS	7299	TCGA-25-2397	OV	59	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2004	NA	-21581	Dead	NA	365	365	NA	NA	NA	NA	NA	NA	NA	NA	1	365	NA	365	NA	NA	0	365	
70	TCGA-25-2398	0	19	1	3	3	1	0	0	14	139	31	1	9	75	5	1	TCGA-25-2398-01	320	0.7477910636660902	204	TCGA-25-2398-01	19	66	25	0.1154425596858	TCGA-25-2398-01	20	10	2	32	PASS	7300	TCGA-25-2398	OV	71	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-26267	Dead	WITH TUMOR	1369	1369	NA	Recurrence	NA	NA	577	Complete Remission/Response	NA	NA	1	1369	1	1369	1	577	1	577	
80	TCGA-25-2399	0	0	0	0	1	0	0	0	0	46	2	0	0	13	1	0	TCGA-25-2399-01	242	0.6857250083210539	152	TCGA-25-2399-01	8	9	52	0.17882645227431573	TCGA-25-2399-01	10	6	5	21	PASS	7301	TCGA-25-2399	OV	80	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-29373	Dead	WITH TUMOR	608	608	NA	Recurrence	NA	NA	243	Partial Remission/Response	NA	NA	1	608	1	608	NA	NA	1	243	
80	TCGA-25-2400	0	6	1	1	3	3	2	0	3	77	2	0	5	32	4	1	TCGA-25-2400-01	487	0.7885412407282396	308	TCGA-25-2400-01	22	71	54	0.27913391815821365	TCGA-25-2400-01	20	9	8	37	PASS	7302	TCGA-25-2400	OV	76	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-27789	Dead	WITH TUMOR	1278	1278	NA	Recurrence	NA	NA	577	Complete Remission/Response	NA	NA	1	1278	1	1278	1	577	1	577	
60	TCGA-25-2401	0	2	2	0	0	1	1	0	8	65	4	1	0	28	2	0	TCGA-25-2401-01	308	0.4222827471384265	188	TCGA-25-2401-01	8	14	64	0.27624012552929256	TCGA-25-2401-01	21	25	14	60	PASS	7303	TCGA-25-2401	OV	64	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-23711	Dead	NA	90	90	NA	NA	NA	NA	NA	NA	NA	NA	1	90	NA	90	NA	NA	0	90	
40	TCGA-25-2404	0	0	0	4	1	0	1	0	2	51	2	1	0	11	2	0	TCGA-25-2404-01	213	0.583560030147232	127	TCGA-25-2404-01	15	28	28	0.2458303909095021	TCGA-25-2404-01	16	17	9	42	PASS	7304	TCGA-25-2404	OV	38	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-14184	Dead	WITH TUMOR	883	883	NA	Recurrence	NA	NA	426	Complete Remission/Response	NA	NA	1	883	1	883	1	426	1	426	
40	TCGA-25-2408	0	1	0	1	1	0	0	0	0	13	2	0	0	6	0	0	TCGA-25-2408-01	98	0.18535366834496955	48	TCGA-25-2408-01	6	5	4	0.1054389870485118	TCGA-25-2408-01	4	3	3	10	PASS	7305	TCGA-25-2408	OV	37	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G2	2005	NA	-13606	Dead	WITH TUMOR	943	943	NA	Recurrence	NA	NA	334	Partial Remission/Response	NA	NA	1	943	1	943	NA	NA	1	334	
70	TCGA-25-2409	0	1	0	2	1	0	0	0	1	26	0	0	1	10	1	0	TCGA-25-2409	0	0	0	TCGA-25-2409	0	0	0	0	TCGA-25-2409-01	14	15	10	39	PASS	7306	TCGA-25-2409	OV	71	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2005	NA	-26267	Dead	WITH TUMOR	821	821	NA	Recurrence	NA	NA	304	Complete Remission/Response	NA	NA	1	821	1	821	NA	NA	1	304	
40	TCGA-29-1688	0	8	0	2	1	1	1	0	1	50	3	0	2	16	1	0	TCGA-29-1688-01	277	0.8287745795685256	149	TCGA-29-1688-01	5	15	38	0.2945369536812702	TCGA-29-1688-01	23	25	14	62	PASS	7307	TCGA-29-1688	OV	39	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	1992	NA	-14574	Dead	WITH TUMOR	2400	2400	NA	Recurrence	NA	NA	184	Stable Disease	NA	NA	1	2400	1	2400	NA	NA	1	184	
70	TCGA-29-1690	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-29-1690-01	84	0.16187807692979386	39	TCGA-29-1690-01	4	3	3	0.04739310406113522	TCGA-29-1690-01	1	2	1	4	PASS	7308	TCGA-29-1690	OV	66	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	1993	NA	-24319	Dead	WITH TUMOR	1360	1448	NA	NA	NA	NA	NA	NA	NA	NA	1	1448	1	1448	NA	NA	1	1448	
50	TCGA-29-1691	0	12	0	9	7	5	1	0	2	170	6	0	5	49	11	0	TCGA-29-1691-01	444	0.8207863929674094	283	TCGA-29-1691-01	8	38	85	0.3694884437835961	TCGA-29-1691-01	28	48	19	95	PASS	7309	TCGA-29-1691	OV	51	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	1995	NA	-18664	Dead	WITH TUMOR	1435	1470	NA	Recurrence	NA	NA	613	Complete Remission/Response	NA	NA	1	1470	1	1470	1	613	1	613	
60	TCGA-29-1692	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-29-1692-01	340	0.6654963106825506	201	TCGA-29-1692-01	12	34	76	0.4552372909871184	TCGA-29-1692-01	26	24	8	58	PASS	7310	TCGA-29-1692	OV	58	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	1997	NA	-21193	Dead	WITH TUMOR	2872	2872	NA	Recurrence	NA	NA	544	Complete Remission/Response	NA	NA	1	2872	1	2872	1	544	1	544	
70	TCGA-29-1693	0	8	0	3	6	1	4	0	5	82	3	0	1	28	5	0	TCGA-29-1693-01	381	0.948744893175216	231	TCGA-29-1693-01	13	20	71	0.33957021203322524	TCGA-29-1693-01	18	15	12	45	PASS	7311	TCGA-29-1693	OV	72	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-26300	Alive	WITH TUMOR	3096	NA	NA	Recurrence	NA	NA	694	Complete Remission/Response	NA	NA	0	3096	0	3096	1	694	1	694	
50	TCGA-29-1694	1	3	0	0	3	0	1	0	2	26	3	0	1	9	4	0	TCGA-29-1694-01	296	0.8950874044662328	176	TCGA-29-1694-01	8	13	48	0.30591309902492964	TCGA-29-1694-01	19	18	12	49	PASS	7312	TCGA-29-1694	OV	45	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	GX	2002	NA	-16523	Dead	WITH TUMOR	NA	1187	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	1187	1	1187	NA	NA	1	1187	
60	TCGA-29-1695	0	8	1	4	3	0	2	0	4	41	5	0	2	20	2	0	TCGA-29-1695-01	398	0.7305186917832156	247	TCGA-29-1695-01	26	44	52	0.1741002486179032	TCGA-29-1695-01	18	8	3	29	PASS	7313	TCGA-29-1695	OV	62	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2003	NA	-22895	Dead	NA	24	1229	NA	NA	NA	NA	NA	NA	NA	NA	1	1229	NA	1229	NA	NA	0	1229	
40	TCGA-29-1696	1	10	0	0	1	2	0	0	2	44	2	0	1	16	1	0	TCGA-29-1696-01	177	0.97472567394544	91	TCGA-29-1696-01	2	13	37	0.238847372134323	TCGA-29-1696-01	18	22	12	52	PASS	7314	TCGA-29-1696	OV	43	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2003	NA	-15818	Dead	WITH TUMOR	1025	1032	NA	Recurrence	NA	NA	342	Partial Remission/Response	NA	NA	1	1032	1	1032	NA	NA	1	342	
60	TCGA-29-1697	0	3	0	2	2	3	0	0	0	23	2	0	1	11	1	0	TCGA-29-1697-01	551	0.9110442152688888	370	TCGA-29-1697-01	12	20	78	0.4782337877128724	TCGA-29-1697-01	15	8	6	29	PASS	7315	TCGA-29-1697	OV	62	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-22933	Dead	WITH TUMOR	949	949	NA	Recurrence	NA	NA	500	Complete Remission/Response	NA	NA	1	949	1	949	1	500	1	500	
50	TCGA-29-1698	0	11	0	0	3	0	1	0	3	74	4	0	1	20	0	0	TCGA-29-1698-01	375	0.7803604152774786	251	TCGA-29-1698-01	24	61	36	0.2561986738019022	TCGA-29-1698-01	25	15	8	48	PASS	7316	TCGA-29-1698	OV	53	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-19611	Alive	WITH TUMOR	2078	NA	NA	Recurrence	NA	NA	181	Complete Remission/Response	NA	NA	0	2078	0	2078	1	181	1	181	
60	TCGA-29-1699	0	10	0	3	1	1	0	0	2	58	2	0	1	20	2	0	TCGA-29-1699-01	353	0.7657214506258806	208	TCGA-29-1699-01	18	51	42	0.14002359973987713	TCGA-29-1699-01	22	15	3	40	PASS	7317	TCGA-29-1699	OV	57	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-21130	Dead	NA	16	1106	NA	NA	NA	NA	NA	NA	NA	NA	1	1106	NA	1106	NA	NA	0	1106	
60	TCGA-29-1701	0	9	0	1	2	5	0	0	4	64	2	0	1	20	3	0	TCGA-29-1701-01	379	0.7120783332513535	244	TCGA-29-1701-01	22	38	47	0.2571946320257761	TCGA-29-1701-01	19	14	10	43	PASS	7318	TCGA-29-1701	OV	56	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-20737	Dead	WITH TUMOR	514	515	NA	Recurrence	NA	NA	298	Partial Remission/Response	NA	NA	1	515	1	515	NA	NA	1	298	
80	TCGA-29-1702	0	4	0	4	4	0	1	0	2	38	3	0	1	17	1	0	TCGA-29-1702-01	795	0.8547149976218567	584	TCGA-29-1702-01	20	34	102	0.19963023502565053	TCGA-29-1702-01	21	12	12	45	PASS	7319	TCGA-29-1702	OV	84	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-30910	Dead	WITH TUMOR	568	728	NA	Recurrence	NA	NA	286	Complete Remission/Response	NA	NA	1	728	1	728	1	286	1	286	
60	TCGA-29-1703	1	14	0	1	2	0	0	0	4	53	3	0	2	22	6	0	TCGA-29-1703-01	349	0.9653637557865128	220	TCGA-29-1703-01	17	32	32	0.1573253751292259	TCGA-29-1703-01	14	11	5	30	PASS	7320	TCGA-29-1703	OV	56	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2005	NA	-20622	Dead	WITH TUMOR	1815	1815	NA	Recurrence	NA	NA	324	Complete Remission/Response	NA	NA	1	1815	1	1815	1	324	1	324	
60	TCGA-29-1704	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-29-1704-01	545	0.5772223549058477	374	TCGA-29-1704-01	6	14	82	0.3030648411752072	TCGA-29-1704-01	22	24	15	61	PASS	7321	TCGA-29-1704	OV	61	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-22511	Alive	WITH TUMOR	1587	NA	NA	Recurrence	NA	NA	568	Complete Remission/Response	NA	NA	0	1587	0	1587	1	568	1	568	
50	TCGA-29-1705	0	6	0	1	2	0	1	0	1	31	1	0	1	21	1	0	TCGA-29-1705-01	325	0.7941646291119049	187	TCGA-29-1705-01	6	17	66	0.3561528154184436	TCGA-29-1705-01	20	25	12	57	PASS	7322	TCGA-29-1705	OV	47	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2005	NA	-17530	Dead	WITH TUMOR	555	555	NA	Recurrence	NA	NA	283	Complete Remission/Response	NA	NA	1	555	1	555	1	283	1	283	
40	TCGA-29-1707	0	6	0	2	1	0	1	0	5	41	2	0	0	15	1	0	TCGA-29-1707-01	325	0.890389013377024	193	TCGA-29-1707-01	8	18	61	0.35620300766313584	TCGA-29-1707-01	21	18	14	53	PASS	7323	TCGA-29-1707	OV	41	FEMALE	WHITE	NA	Stage IIC	Serous Cystadenocarcinoma	G3	2006	NA	-15017	Alive	NA	1277	NA	NA	Recurrence	NA	NA	1201	Complete Remission/Response	NA	NA	0	1277	0	1277	1	1201	1	1201	
50	TCGA-29-1710	0	3	0	0	3	0	0	0	4	36	3	0	1	16	0	0	TCGA-29-1710-01	176	0.4822361835343595	87	TCGA-29-1710-01	11	40	59	0.3646489261674965	TCGA-29-1710-01	11	6	4	21	PASS	7324	TCGA-29-1710	OV	54	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2006	NA	-19969	Dead	WITH TUMOR	889	951	NA	Recurrence	NA	NA	315	Partial Remission/Response	NA	NA	1	951	1	951	NA	NA	1	315	
50	TCGA-29-1711	0	15	1	2	4	0	2	0	5	51	2	0	1	13	2	0	TCGA-29-1711-01	562	0.943250162663677	362	TCGA-29-1711-01	4	18	117	0.3417771897677792	TCGA-29-1711-01	26	31	19	76	PASS	7325	TCGA-29-1711	OV	45	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2006	NA	-16485	Alive	TUMOR FREE	1053	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1053	0	1053	0	1053	0	1053	
80	TCGA-29-1761	2	12	0	6	7	1	2	0	3	161	5	0	5	58	4	1	TCGA-29-1761-01	684	0.7943640488688173	448	TCGA-29-1761-01	18	41	113	0.31063209343022763	TCGA-29-1761-01	24	16	9	49	PASS	7326	TCGA-29-1761	OV	80	FEMALE	ASIAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	NA	-29337	Dead	WITH TUMOR	517	528	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	528	1	528	NA	NA	1	528	
60	TCGA-29-1762	1	10	0	2	3	1	2	0	4	50	10	0	3	17	1	0	TCGA-29-1762-01	231	0.9415377778312112	129	TCGA-29-1762-01	14	15	42	0.407644587092634	TCGA-29-1762-01	19	15	12	46	PASS	7327	TCGA-29-1762	OV	59	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G2	1998	NA	-21879	Dead	WITH TUMOR	2606	2634	NA	Recurrence	NA	NA	1375	Complete Remission/Response	NA	NA	1	2634	1	2634	NA	NA	1	1375	
40	TCGA-29-1763	0	18	1	0	6	3	2	1	6	123	5	0	5	55	4	0	TCGA-29-1763-01	554	0.8553701845979207	391	TCGA-29-1763-01	17	31	66	0.499249005016678	TCGA-29-1763-01	22	28	19	69	PASS	7328	TCGA-29-1763	OV	43	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIC	Serous Cystadenocarcinoma	G2	2004	NA	-16021	Alive	WITH TUMOR	2032	NA	NA	Recurrence	NA	NA	428	Complete Remission/Response	NA	NA	0	2032	0	2032	1	428	1	428	
50	TCGA-29-1764	0	8	0	3	3	2	1	0	4	78	5	0	1	24	3	1	TCGA-29-1764-01	142	0.8271122394129728	77	TCGA-29-1764-01	16	22	30	0.3167826862459899	TCGA-29-1764-01	21	26	9	56	PASS	7329	TCGA-29-1764	OV	49	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2004	NA	-18012	Alive	WITH TUMOR	1914	NA	NA	Recurrence	NA	NA	792	Complete Remission/Response	NA	NA	0	1914	0	1914	1	792	1	792	
70	TCGA-29-1766	1	5	0	0	2	2	1	1	3	57	6	1	0	29	2	0	TCGA-29-1766-01	289	0.7089154700638131	172	TCGA-29-1766-01	22	54	44	0.39030576293868463	TCGA-29-1766-01	18	13	5	36	PASS	7330	TCGA-29-1766	OV	74	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2006	NA	-27359	Dead	WITH TUMOR	1190	1199	NA	Recurrence	NA	NA	672	Progressive Disease	NA	NA	1	1199	1	1199	NA	NA	1	672	
50	TCGA-29-1768	0	0	1	2	3	3	0	0	1	35	3	0	0	12	2	0	TCGA-29-1768-01	184	0.5552963082948671	100	TCGA-29-1768-01	7	15	36	0.3213008916164236	TCGA-29-1768-01	20	22	12	54	PASS	7331	TCGA-29-1768	OV	50	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2006	NA	-18396	Dead	WITH TUMOR	950	952	NA	Recurrence	NA	NA	547	Stable Disease	NA	NA	1	952	1	952	NA	NA	1	547	
40	TCGA-29-1769	0	12	0	2	1	0	1	0	5	69	4	0	1	19	1	0	TCGA-29-1769-01	326	0.837457801129928	198	TCGA-29-1769-01	8	21	87	0.4387933678993435	TCGA-29-1769-01	17	27	15	59	PASS	7332	TCGA-29-1769	OV	40	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-14754	Alive	TUMOR FREE	699	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	699	0	699	0	699	0	699	
50	TCGA-29-1770	0	10	0	3	1	5	2	1	11	108	9	0	10	47	2	0	TCGA-29-1770-01	256	0.8153350946879551	153	TCGA-29-1770-01	15	28	38	0.3423510034173668	TCGA-29-1770-01	20	28	12	60	PASS	7333	TCGA-29-1770	OV	54	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2007	NA	-20015	Alive	WITH TUMOR	741	NA	NA	Recurrence	NA	NA	377	Complete Remission/Response	NA	NA	0	741	0	741	1	377	1	377	
80	TCGA-29-1771	0	1	0	1	1	1	0	0	0	20	1	0	1	4	1	0	TCGA-29-1771-01	109	0.7075878560231785	39	TCGA-29-1771-01	5	4	15	0.13839244760251873	TCGA-29-1771-01	2	3	3	8	PASS	7334	TCGA-29-1771	OV	76	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2007	NA	-28093	Alive	WITH TUMOR	686	NA	NA	Recurrence	NA	NA	595	Complete Remission/Response	NA	NA	0	686	0	686	1	595	1	595	
80	TCGA-29-1774	0	3	0	1	1	1	1	0	6	36	4	0	3	15	0	0	TCGA-29-1774-01	181	0.5129717917899196	106	TCGA-29-1774-01	14	40	44	0.3648382456333305	TCGA-29-1774-01	12	8	5	25	PASS	7335	TCGA-29-1774	OV	82	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-29991	Alive	WITH TUMOR	527	NA	NA	Recurrence	NA	NA	234	Progressive Disease	NA	NA	0	527	0	527	NA	NA	1	234	
50	TCGA-29-1775	1	13	0	2	5	1	0	0	4	96	7	1	3	36	6	0	TCGA-29-1775-01	291	0.7750073507408157	174	TCGA-29-1775-01	15	27	58	0.2879996493056153	TCGA-29-1775-01	23	24	9	56	PASS	7336	TCGA-29-1775	OV	51	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2008	NA	-18943	Alive	WITH TUMOR	376	NA	NA	Recurrence	NA	NA	341	Complete Remission/Response	NA	NA	0	376	0	376	1	341	1	341	
60	TCGA-29-1776	0	4	0	6	5	1	1	0	0	41	4	0	2	7	3	0	TCGA-29-1776-01	222	0.9546902138663628	125	TCGA-29-1776-01	7	13	28	0.2927846383417203	TCGA-29-1776-01	17	20	11	48	PASS	7337	TCGA-29-1776	OV	63	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-23016	Alive	WITH TUMOR	360	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	360	0	360	NA	NA	0	360	
50	TCGA-29-1777	3	11	0	6	5	1	3	0	11	105	7	0	0	35	4	0	TCGA-29-1777-01	396	0.89639352256697	253	TCGA-29-1777-01	7	14	106	0.4218575676094362	TCGA-29-1777-01	31	23	20	74	PASS	7338	TCGA-29-1777	OV	47	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2008	NA	-17356	Alive	WITH TUMOR	374	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	374	0	374	NA	NA	0	374	
80	TCGA-29-1778	0	7	0	0	2	0	0	0	3	38	5	0	3	23	1	0	TCGA-29-1778-01	435	0.9637393535408584	253	TCGA-29-1778-01	23	59	76	0.2557604395163776	TCGA-29-1778-01	22	10	2	34	PASS	7339	TCGA-29-1778	OV	77	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-28147	Alive	TUMOR FREE	454	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	454	0	454	0	454	0	454	
70	TCGA-29-1781	1	13	0	5	5	2	1	0	5	80	4	0	2	21	3	1	TCGA-29-1781-01	510	0.9434394072960623	316	TCGA-29-1781-01	9	15	126	0.4616291844447602	TCGA-29-1781-01	27	27	18	72	PASS	7340	TCGA-29-1781	OV	69	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-25404	Alive	TUMOR FREE	255	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	255	0	255	0	255	0	255	
60	TCGA-29-1783	1	6	0	0	1	2	0	0	3	67	3	0	2	17	0	0	TCGA-29-1783-01	275	0.7257831198638435	167	TCGA-29-1783-01	25	38	31	0.1942840701936044	TCGA-29-1783-01	13	7	2	22	PASS	7341	TCGA-29-1783	OV	58	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-21284	Alive	TUMOR FREE	220	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	220	0	220	NA	NA	0	220	
60	TCGA-29-1784	0	6	0	3	2	4	0	0	5	109	8	0	1	31	3	0	TCGA-29-1784-01	349	0.7178781516495494	220	TCGA-29-1784-01	12	34	55	0.3014078767327438	TCGA-29-1784-01	25	42	8	75	PASS	7342	TCGA-29-1784	OV	55	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-20210	Alive	TUMOR FREE	163	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	163	0	163	0	163	0	163	
60	TCGA-29-1785	0	4	0	3	4	2	0	1	3	48	2	0	3	20	4	0	TCGA-29-1785-01	426	0.4406516185195311	289	TCGA-29-1785-01	2	9	60	0.19480472141958846	TCGA-29-1785-01	14	20	8	42	PASS	7343	TCGA-29-1785	OV	55	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-20417	Dead	NA	1053	1104	NA	Recurrence	NA	NA	473	Complete Remission/Response	NA	NA	1	1104	NA	1104	1	473	1	473	
80	TCGA-29-2414	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-29-2414-01	352	0.6972540154399499	223	TCGA-29-2414	0	0	0	0	TCGA-29-2414-01	21	35	7	63	PASS	7344	TCGA-29-2414	OV	75	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	1998	NA	-27417	Dead	WITH TUMOR	2621	2621	NA	Recurrence	NA	NA	552	Complete Remission/Response	NA	NA	1	2621	1	2621	1	552	1	552	
60	TCGA-29-2425	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-29-2425-01	269	0.9151157360939194	162	TCGA-29-2425-01	20	33	36	0.2379470215153341	TCGA-29-2425-01	23	37	8	68	PASS	7345	TCGA-29-2425	OV	60	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2004	NA	-22089	Alive	TUMOR FREE	1977	NA	NA	Progression of Disease	NA	NA	1577	Complete Remission/Response	NA	NA	0	1977	0	1977	1	1577	1	1577	
60	TCGA-29-2427	0	3	0	4	4	2	0	0	4	54	3	1	0	20	4	0	TCGA-29-2427-01	155	0.9309543099295828	84	TCGA-29-2427-01	10	11	31	0.2902943440912599	TCGA-29-2427-01	12	14	14	40	PASS	7346	TCGA-29-2427	OV	60	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-21940	Alive	WITH TUMOR	1900	NA	NA	Recurrence	NA	NA	1582	Complete Remission/Response	NA	NA	0	1900	0	1900	1	1582	1	1582	
60	TCGA-29-2428	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-29-2428-01	260	0.6948996395555405	149	TCGA-29-2428-01	27	22	56	0.3915418199517586	TCGA-29-2428-01	12	11	3	26	PASS	7347	TCGA-29-2428	OV	58	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-21392	Alive	TUMOR FREE	1372	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1372	0	1372	0	1372	0	1372	
80	TCGA-29-2429	0	9	0	7	3	2	1	0	4	60	2	0	1	27	1	0	TCGA-29-2429-01	620	0.6469862999121785	410	TCGA-29-2429-01	6	28	97	0.34506061056029563	TCGA-29-2429-01	21	16	11	48	PASS	7348	TCGA-29-2429	OV	79	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-29156	Dead	WITH TUMOR	NA	421	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	421	1	421	NA	NA	1	421	
60	TCGA-29-2431	0	4	0	2	3	0	0	0	3	34	0	0	3	9	0	0	TCGA-29-2431-01	393	0.5729855776989574	236	TCGA-29-2431-01	16	34	54	0.18625615921687333	TCGA-29-2431-01	16	18	5	39	PASS	7349	TCGA-29-2431	OV	59	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2006	NA	-21833	Alive	WITH TUMOR	1285	NA	NA	Recurrence	NA	NA	960	Complete Remission/Response	NA	NA	0	1285	0	1285	1	960	1	960	
60	TCGA-29-2432	0	8	0	3	5	0	1	0	6	65	4	0	1	33	3	0	TCGA-29-2432-01	199	0.888338613782939	114	TCGA-29-2432-01	22	35	33	0.3231659849340415	TCGA-29-2432-01	19	23	7	49	PASS	7350	TCGA-29-2432	OV	61	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-22605	Dead	WITH TUMOR	360	653	NA	Recurrence	NA	NA	174	Progressive Disease	NA	NA	1	653	1	653	NA	NA	1	174	
60	TCGA-29-2433	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-29-2433	0	0	0	TCGA-29-2433	0	0	0	0	TCGA-29-2433	0	0	0	0	PASS	7351	TCGA-29-2433	OV	61	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-22315	Alive	TUMOR FREE	620	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	620	0	620	0	620	0	620	
50	TCGA-29-2434	1	10	1	7	6	0	3	0	6	93	3	0	1	23	3	0	TCGA-29-2434-01	685	0.7082469016292308	461	TCGA-29-2434-01	7	39	154	0.4223304188066744	TCGA-29-2434-01	29	34	17	80	PASS	7352	TCGA-29-2434	OV	52	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-18997	Alive	TUMOR FREE	349	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	349	0	349	0	349	0	349	
80	TCGA-29-2435	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-29-2435	0	0	0	TCGA-29-2435	0	0	0	0	TCGA-29-2435	0	0	0	0	PASS	7353	TCGA-29-2435	OV	78	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2009	NA	-28779	Alive	NA	34	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	34	0	34	NA	NA	0	34	
40	TCGA-29-2436	0	0	0	0	0	0	0	0	1	6	0	0	1	6	0	0	TCGA-29-2436-01	130	0.16364042066389595	63	TCGA-29-2436-01	1	7	12	0.06945748845233474	TCGA-29-2436-01	5	7	5	17	PASS	7354	TCGA-29-2436	OV	36	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2009	NA	-13346	Alive	TUMOR FREE	297	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	297	0	297	0	297	0	297	
70	TCGA-29-A5NZ	0	13	0	3	1	0	0	0	2	39	5	0	1	19	3	0	TCGA-29-A5NZ-01	462	0.9879027435293916	307	TCGA-29-A5NZ-01	24	29	102	0.1431163696116483	TCGA-29-A5NZ-01	15	11	6	32	PASS	7355	TCGA-29-A5NZ	OV	66	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2011	NA	-24161	Dead	WITH TUMOR	NA	1088	NA	Recurrence	NA	NA	358	Complete Remission/Response	NA	NA	1	1088	1	1088	1	358	1	358	
70	TCGA-30-1714	0	5	1	1	5	3	1	0	5	52	3	0	1	13	4	1	TCGA-30-1714-01	426	0.6491914188037597	278	TCGA-30-1714-01	22	32	66	0.06785344726496083	TCGA-30-1714-01	19	15	1	35	PASS	7356	TCGA-30-1714	OV	68	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2001	NA	-25032	Dead	WITH TUMOR	1158	1158	NA	Recurrence	NA	NA	241	Complete Remission/Response	NA	NA	1	1158	1	1158	NA	NA	1	241	
40	TCGA-30-1718	2	10	1	3	3	5	0	0	9	124	8	0	3	46	3	0	TCGA-30-1718-01	450	0.8977883083649677	279	TCGA-30-1718-01	21	61	54	0.2430925837108568	TCGA-30-1718-01	30	36	7	73	PASS	7357	TCGA-30-1718	OV	44	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-16400	Dead	WITH TUMOR	1579	1579	NA	Recurrence	NA	NA	896	NA	NA	NA	1	1579	1	1579	NA	NA	1	896	
60	TCGA-30-1853	0	3	0	0	1	1	0	0	3	36	4	1	1	15	0	0	TCGA-30-1853-01	304	0.945959953434245	181	TCGA-30-1853-01	17	37	55	0.2581236110097608	TCGA-30-1853-01	13	5	5	23	PASS	7358	TCGA-30-1853	OV	58	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	NA	-21404	Dead	WITH TUMOR	1103	1103	NA	Recurrence	NA	NA	634	Complete Remission/Response	NA	NA	1	1103	1	1103	1	634	1	634	
60	TCGA-30-1855	0	11	0	6	2	0	1	0	3	91	3	0	2	36	8	0	TCGA-30-1855-01	349	0.8723231086179742	223	TCGA-30-1855-01	15	42	72	0.36410188626735696	TCGA-30-1855-01	25	26	17	68	PASS	7359	TCGA-30-1855	OV	61	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-22394	Dead	WITH TUMOR	75	75	NA	NA	NA	NA	NA	NA	NA	NA	1	75	1	75	NA	NA	1	75	
60	TCGA-30-1856	0	5	0	4	2	1	0	0	1	54	2	0	1	15	2	0	TCGA-30-1856-01	662	0.5972736316442077	454	TCGA-30-1856-01	21	47	257	0.9821597228482468	TCGA-30-1856-01	25	12	28	65	PASS	7360	TCGA-30-1856	OV	56	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-20626	Dead	WITH TUMOR	477	477	NA	Recurrence	NA	NA	220	Partial Remission/Response	NA	NA	1	477	1	477	NA	NA	1	220	
60	TCGA-30-1857	2	14	0	3	10	0	6	0	2	76	5	0	1	18	4	0	TCGA-30-1857-01	322	0.6881879310601676	197	TCGA-30-1857-01	8	14	48	0.35580091124504737	TCGA-30-1857-01	19	27	12	58	PASS	7361	TCGA-30-1857	OV	64	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2001	NA	-23689	Dead	WITH TUMOR	8	8	NA	NA	NA	NA	NA	NA	NA	NA	1	8	1	8	NA	NA	1	8	
60	TCGA-30-1859	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-30-1859-01	267	0.6352922171403075	155	TCGA-30-1859-01	19	30	18	0.09420660266351197	TCGA-30-1859-01	11	8	3	22	PASS	7362	TCGA-30-1859	OV	56	FEMALE	WHITE	NA	NA	Serous Cystadenocarcinoma	G3	2002	NA	-20498	Dead	WITH TUMOR	1463	1463	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	1463	1	1463	NA	NA	1	1463	
60	TCGA-30-1860	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-30-1860-01	646	0.9942689095801563	430	TCGA-30-1860-01	8	22	139	0.5115310573482427	TCGA-30-1860-01	29	38	31	98	PASS	7363	TCGA-30-1860	OV	58	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-21406	Dead	WITH TUMOR	1366	1366	NA	Recurrence	NA	NA	397	Complete Remission/Response	NA	NA	1	1366	1	1366	1	397	1	397	
70	TCGA-30-1861	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-30-1861-01	406	0.946043100706222	255	TCGA-30-1861-01	17	40	94	0.4166349191924272	TCGA-30-1861-01	29	37	14	80	PASS	7364	TCGA-30-1861	OV	74	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-27103	Dead	NA	1058	1058	NA	NA	NA	NA	NA	NA	NA	NA	1	1058	NA	1058	NA	NA	0	1058	
70	TCGA-30-1862	0	2	0	2	0	1	0	0	5	37	4	0	2	7	2	0	TCGA-30-1862-01	290	0.9468066032610244	172	TCGA-30-1862-01	17	42	75	0.24928730402253546	TCGA-30-1862-01	16	7	9	32	PASS	7365	TCGA-30-1862	OV	65	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G2	2003	NA	-23895	Dead	WITH TUMOR	186	186	NA	NA	NA	NA	NA	NA	NA	NA	1	186	1	186	NA	NA	1	186	
60	TCGA-30-1866	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-30-1866-01	378	0.9090317434738494	245	TCGA-30-1866-01	17	28	30	0.07157044743680034	TCGA-30-1866-01	15	6	3	24	PASS	7366	TCGA-30-1866	OV	61	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G2	2003	NA	-22562	Dead	WITH TUMOR	1114	1114	NA	Recurrence	NA	NA	285	Complete Remission/Response	NA	NA	1	1114	1	1114	NA	NA	1	285	
50	TCGA-30-1867	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-30-1867-01	266	0.5789809622426187	140	TCGA-30-1867-01	15	29	40	0.181176464568872	TCGA-30-1867-01	17	12	7	36	PASS	7367	TCGA-30-1867	OV	46	FEMALE	NA	NA	Stage IV	Serous Cystadenocarcinoma	GX	2004	NA	-17159	Dead	WITH TUMOR	37	37	NA	NA	NA	NA	NA	NA	NA	NA	1	37	1	37	NA	NA	1	37	
50	TCGA-30-1869	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-30-1869	0	0	0	TCGA-30-1869	0	0	0	0	TCGA-30-1869	0	0	0	0	PASS	7368	TCGA-30-1869	OV	50	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2004	NA	-18398	Dead	WITH TUMOR	1563	1563	NA	Recurrence	NA	NA	767	Complete Remission/Response	NA	NA	1	1563	1	1563	NA	NA	1	767	
60	TCGA-30-1880	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-30-1880-01	210	0.9477858241272028	126	TCGA-30-1880-01	11	8	27	0.237988122057724	TCGA-30-1880-01	3	2	5	10	PASS	7369	TCGA-30-1880	OV	56	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	NA	-20525	Dead	WITH TUMOR	1751	1751	NA	Recurrence	NA	NA	348	Partial Remission/Response	NA	NA	1	1751	1	1751	NA	NA	1	348	
70	TCGA-30-1887	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-30-1887-01	252	0.5126526163208108	154	TCGA-30-1887-01	16	36	40	0.35124550853389824	TCGA-30-1887-01	13	3	5	21	PASS	7370	TCGA-30-1887	OV	67	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2005	NA	-24495	Dead	WITH TUMOR	738	738	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	738	1	738	NA	NA	1	738	
60	TCGA-30-1891	0	4	0	2	3	3	1	0	0	53	9	0	0	19	5	0	TCGA-30-1891-01	329	0.9881744605633834	213	TCGA-30-1891-01	7	18	92	0.4677025909966121	TCGA-30-1891-01	24	31	17	72	PASS	7371	TCGA-30-1891	OV	61	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2004	NA	-22344	Dead	WITH TUMOR	914	914	NA	Recurrence	NA	NA	181	Partial Remission/Response	NA	NA	1	914	1	914	NA	NA	1	181	
50	TCGA-30-1892	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-30-1892-01	243	0.3795319480337881	151	TCGA-30-1892-01	12	25	33	0.1946406853380105	TCGA-30-1892-01	14	17	9	40	PASS	7372	TCGA-30-1892	OV	52	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-19256	Dead	WITH TUMOR	1484	1484	NA	Recurrence	NA	NA	253	Complete Remission/Response	NA	NA	1	1484	1	1484	1	253	1	253	
50	TCGA-31-1944	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-31-1944-01	338	0.6752937266188124	212	TCGA-31-1944-01	10	18	64	0.32509243302633034	TCGA-31-1944-01	18	26	12	56	PASS	7373	TCGA-31-1944	OV	47	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-17207	Alive	WITH TUMOR	1386	NA	NA	Recurrence	NA	NA	678	Complete Remission/Response	NA	NA	0	1386	0	1386	1	678	1	678	
30	TCGA-31-1946	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-31-1946-01	401	0.4418144330463429	257	TCGA-31-1946-01	6	19	65	0.3070566922571972	TCGA-31-1946-01	19	23	18	60	PASS	7374	TCGA-31-1946	OV	30	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-11146	Alive	WITH TUMOR	918	NA	NA	Recurrence	NA	NA	664	NA	NA	NA	0	918	0	918	NA	NA	1	664	
80	TCGA-31-1950	0	2	1	1	2	0	0	0	6	54	2	1	0	29	2	0	TCGA-31-1950-01	236	0.6636021987187882	141	TCGA-31-1950-01	20	30	62	0.3446836632557849	TCGA-31-1950-01	15	8	4	27	PASS	7375	TCGA-31-1950	OV	76	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2007	NA	-28100	Alive	WITH TUMOR	571	NA	NA	Recurrence	NA	NA	349	Partial Remission/Response	NA	NA	0	571	0	571	NA	NA	1	349	
60	TCGA-31-1951	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-31-1951-01	511	0.4073430089337816	349	TCGA-31-1951-01	7	15	73	0.21951105893722506	TCGA-31-1951-01	15	11	10	36	PASS	7376	TCGA-31-1951	OV	58	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-21352	Alive	WITH TUMOR	684	NA	NA	Recurrence	NA	NA	659	NA	NA	NA	0	684	0	684	NA	NA	1	659	
50	TCGA-31-1953	0	1	1	6	2	3	0	0	2	46	1	0	1	13	5	0	TCGA-31-1953-01	673	0.8873211000509608	484	TCGA-31-1953-01	16	20	80	0.14804247422732647	TCGA-31-1953-01	17	17	5	39	PASS	7377	TCGA-31-1953	OV	52	FEMALE	ASIAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-19064	Alive	WITH TUMOR	204	NA	NA	Recurrence	NA	NA	70	Progressive Disease	NA	NA	0	204	0	204	NA	NA	1	70	
40	TCGA-31-1955	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-31-1955-01	257	0.9303458222557884	163	TCGA-31-1955-01	10	13	43	0.32830555985853305	TCGA-31-1955-01	16	14	11	41	PASS	7378	TCGA-31-1955	OV	43	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-15926	Alive	WITH TUMOR	1293	NA	NA	Recurrence	NA	NA	918	NA	NA	NA	0	1293	0	1293	NA	NA	1	918	Redacted
60	TCGA-31-1956	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-31-1956-01	264	0.8043350859395711	152	TCGA-31-1956-01	7	15	37	0.2897961197604839	TCGA-31-1956-01	18	14	13	45	PASS	7379	TCGA-31-1956	OV	60	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2005	NA	-22100	Alive	WITH TUMOR	1342	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1342	0	1342	NA	NA	0	1342	Redacted
50	TCGA-31-1959	0	9	0	6	4	0	2	0	2	54	0	1	1	19	5	1	TCGA-31-1959-01	316	0.9701180337950972	184	TCGA-31-1959-01	12	19	103	0.5827597068328674	TCGA-31-1959-01	20	17	29	66	PASS	7380	TCGA-31-1959	OV	49	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G2	2009	NA	-18247	Alive	WITH TUMOR	67	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	67	0	67	NA	NA	0	67	
50	TCGA-36-1568	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-36-1568-01	307	0.3814534669352915	180	TCGA-36-1568-01	6	16	45	0.26493235895530665	TCGA-36-1568-01	23	29	12	64	PASS	7381	TCGA-36-1568	OV	52	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-19311	Alive	WITH TUMOR	875	NA	NA	Recurrence	NA	NA	548	Partial Remission/Response	NA	NA	0	875	0	875	NA	NA	1	548	
50	TCGA-36-1569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-36-1569-01	138	0.7049349932418404	68	TCGA-36-1569-01	22	57	25	0.3378895163686571	TCGA-36-1569-01	16	20	4	40	PASS	7382	TCGA-36-1569	OV	52	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-19151	Alive	NA	885	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	885	0	885	NA	NA	0	885	
50	TCGA-36-1570	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-36-1570-01	392	0.4952247120737794	232	TCGA-36-1570-01	5	15	45	0.2511414670203579	TCGA-36-1570-01	22	25	12	59	PASS	7383	TCGA-36-1570	OV	49	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-17956	Alive	WITH TUMOR	655	NA	NA	Recurrence	NA	NA	375	Partial Remission/Response	NA	NA	0	655	0	655	NA	NA	1	375	
50	TCGA-36-1571	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-36-1571-01	322	0.5846374039155832	207	TCGA-36-1571-01	20	35	37	0.2056256845927328	TCGA-36-1571-01	14	6	5	25	PASS	7384	TCGA-36-1571	OV	53	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2007	NA	-19608	Dead	WITH TUMOR	695	695	NA	Recurrence	NA	NA	375	Complete Remission/Response	NA	NA	1	695	1	695	1	375	1	375	
50	TCGA-36-1574	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-36-1574-01	330	0.9388238337880731	201	TCGA-36-1574-01	7	15	59	0.3786615986687287	TCGA-36-1574-01	23	22	18	63	PASS	7385	TCGA-36-1574	OV	48	FEMALE	ASIAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-17847	Alive	WITH TUMOR	686	NA	NA	Recurrence	NA	NA	648	Complete Remission/Response	NA	NA	0	686	0	686	1	648	1	648	
80	TCGA-36-1575	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-36-1575-01	382	0.9980399051785772	255	TCGA-36-1575-01	17	31	57	0.2516461702565668	TCGA-36-1575-01	11	8	8	27	PASS	7386	TCGA-36-1575	OV	83	FEMALE	NA	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2006	NA	-30592	Alive	TUMOR FREE	260	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	260	0	260	NA	NA	0	260	
80	TCGA-36-1576	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-36-1576-01	197	0.6355846120770843	113	TCGA-36-1576-01	23	72	17	0.12149784216923315	TCGA-36-1576-01	15	5	6	26	PASS	7387	TCGA-36-1576	OV	76	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-27778	Alive	WITH TUMOR	915	NA	NA	Recurrence	NA	NA	817	Complete Remission/Response	NA	NA	0	915	0	915	1	817	1	817	
40	TCGA-36-1577	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-36-1577-01	316	0.9577468322821292	193	TCGA-36-1577-01	7	17	69	0.41927094158018463	TCGA-36-1577-01	27	25	19	71	PASS	7388	TCGA-36-1577	OV	43	FEMALE	ASIAN	NA	Stage IIC	Serous Cystadenocarcinoma	G2	2007	NA	-15804	Alive	TUMOR FREE	783	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	783	0	783	0	783	0	783	
60	TCGA-36-1578	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-36-1578-01	623	0.9916638162595118	402	TCGA-36-1578-01	10	42	137	0.4289916219407364	TCGA-36-1578-01	28	39	19	86	PASS	7389	TCGA-36-1578	OV	63	FEMALE	ASIAN	NA	Stage IV	Serous Cystadenocarcinoma	G3	2007	NA	-23329	Alive	WITH TUMOR	847	NA	NA	Recurrence	NA	NA	310	NA	NA	NA	0	847	0	847	NA	NA	1	310	
80	TCGA-36-1580	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-36-1580-01	326	0.8422015256522126	210	TCGA-36-1580-01	21	60	65	0.2718292357672261	TCGA-36-1580-01	21	16	11	48	PASS	7390	TCGA-36-1580	OV	82	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-29992	Dead	WITH TUMOR	737	737	NA	Recurrence	NA	NA	440	NA	NA	NA	1	737	1	737	NA	NA	1	440	
60	TCGA-36-1581	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-36-1581-01	496	0.8095210065087178	326	TCGA-36-1581-01	21	39	66	0.25720559052730085	TCGA-36-1581-01	15	11	10	36	PASS	7391	TCGA-36-1581	OV	63	FEMALE	WHITE	NA	Stage IIC	Serous Cystadenocarcinoma	G3	2007	NA	-23272	Alive	WITH TUMOR	751	NA	NA	Recurrence	NA	NA	702	Complete Remission/Response	NA	NA	0	751	0	751	1	702	1	702	
70	TCGA-36-2529	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-36-2529-01	322	0.7743128219630686	196	TCGA-36-2529	0	0	0	0	TCGA-36-2529	0	0	0	0	PASS	7392	TCGA-36-2529	OV	71	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-26092	Alive	WITH TUMOR	1066	NA	NA	Recurrence	NA	NA	567	Complete Remission/Response	NA	NA	0	1066	0	1066	1	567	1	567	
40	TCGA-36-2530	0	9	0	6	2	0	2	0	3	56	3	0	2	16	4	0	TCGA-36-2530-01	508	0.6831374948102591	344	TCGA-36-2530-01	7	15	85	0.3069886736564933	TCGA-36-2530-01	27	31	15	73	PASS	7393	TCGA-36-2530	OV	38	FEMALE	ASIAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-13885	Alive	WITH TUMOR	1004	NA	NA	Recurrence	NA	NA	630	Complete Remission/Response	NA	NA	0	1004	0	1004	1	630	1	630	
60	TCGA-36-2532	1	5	0	2	2	0	0	0	1	39	3	0	0	14	2	0	TCGA-36-2532-01	476	0.7004125286692171	335	TCGA-36-2532-01	11	10	91	0.2453296269157796	TCGA-36-2532-01	12	9	8	29	PASS	7394	TCGA-36-2532	OV	61	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-22333	Alive	WITH TUMOR	897	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	897	0	897	NA	NA	0	897	
60	TCGA-36-2533	0	4	1	4	15	0	11	0	1	61	4	0	0	18	7	0	TCGA-36-2533-01	262	0.7676956354913971	147	TCGA-36-2533-01	14	24	50	0.27644399705781525	TCGA-36-2533-01	21	32	10	63	PASS	7395	TCGA-36-2533	OV	55	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-20187	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	
70	TCGA-36-2534	0	6	0	7	6	1	0	0	6	110	5	0	3	37	4	0	TCGA-36-2534-01	477	0.8775536514372348	292	TCGA-36-2534-01	4	20	126	0.4025060505731071	TCGA-36-2534-01	24	28	23	75	PASS	7396	TCGA-36-2534	OV	72	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-26621	Alive	WITH TUMOR	907	NA	NA	Progression of Disease	NA	NA	383	Partial Remission/Response	NA	NA	0	907	0	907	NA	NA	1	383	
40	TCGA-36-2537	1	4	0	0	1	0	2	0	3	32	1	0	0	16	3	0	TCGA-36-2537-01	282	0.7522322938079757	182	TCGA-36-2537-01	4	7	52	0.2315550775078064	TCGA-36-2537-01	21	17	9	47	PASS	7397	TCGA-36-2537	OV	39	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-14595	Alive	WITH TUMOR	788	NA	NA	Progression of Disease	NA	NA	431	Partial Remission/Response	NA	NA	0	788	0	788	NA	NA	1	431	
40	TCGA-36-2538	0	7	0	1	1	0	0	0	1	37	4	0	0	11	2	0	TCGA-36-2538-01	301	0.998758366102536	178	TCGA-36-2538-01	8	19	69	0.4186236146885246	TCGA-36-2538-01	22	28	19	69	PASS	7398	TCGA-36-2538	OV	37	FEMALE	NA	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2008	NA	-13681	Alive	WITH TUMOR	763	NA	NA	Recurrence	NA	NA	523	Complete Remission/Response	NA	NA	0	763	0	763	1	523	1	523	
30	TCGA-36-2540	0	0	0	0	0	0	0	0	1	4	0	0	0	2	1	0	TCGA-36-2540-01	188	0.07390964567372216	130	TCGA-36-2540-01	3	3	8	0.07767650915451206	TCGA-36-2540-01	2	1	4	7	PASS	7399	TCGA-36-2540	OV	26	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G1	2008	NA	-9760	Alive	WITH TUMOR	724	NA	NA	Recurrence	NA	NA	665	Complete Remission/Response	NA	NA	0	724	0	724	1	665	1	665	
60	TCGA-36-2542	0	7	2	3	6	0	1	0	4	60	4	0	3	20	4	0	TCGA-36-2542-01	429	0.7512956764425259	292	TCGA-36-2542-01	8	20	64	0.3197827984760906	TCGA-36-2542-01	19	17	14	50	PASS	7400	TCGA-36-2542	OV	59	FEMALE	ASIAN	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2008	NA	-21902	Alive	TUMOR FREE	657	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	657	0	657	0	657	0	657	
90	TCGA-36-2543	0	4	0	3	0	0	1	0	2	58	2	0	3	17	4	0	TCGA-36-2543-01	487	0.8657526928304445	325	TCGA-36-2543-01	23	25	163	0.4530392860538917	TCGA-36-2543-01	25	21	18	64	PASS	7401	TCGA-36-2543	OV	85	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-31211	Dead	WITH TUMOR	68	68	NA	Progression of Disease	NA	NA	27	Progressive Disease	NA	NA	1	68	1	68	NA	NA	1	27	
60	TCGA-36-2544	0	5	0	3	2	0	1	0	4	52	4	0	2	14	2	0	TCGA-36-2544-01	577	0.4774153642423226	377	TCGA-36-2544-01	3	20	118	0.3224676892183983	TCGA-36-2544-01	25	27	15	67	PASS	7402	TCGA-36-2544	OV	58	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-21384	Alive	WITH TUMOR	638	NA	NA	Progression of Disease	NA	NA	325	Partial Remission/Response	NA	NA	0	638	0	638	NA	NA	1	325	
40	TCGA-36-2545	0	5	0	8	6	0	4	0	8	49	2	0	1	16	2	0	TCGA-36-2545-01	270	0.8614344129663164	154	TCGA-36-2545-01	4	12	49	0.31037297716608697	TCGA-36-2545-01	25	31	17	73	PASS	7403	TCGA-36-2545	OV	42	FEMALE	NA	NA	Stage IIIA	Serous Cystadenocarcinoma	G3	2008	NA	-15444	Alive	TUMOR FREE	557	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	557	0	557	NA	NA	0	557	
60	TCGA-36-2547	0	17	1	12	9	1	1	0	10	117	7	1	3	34	1	0	TCGA-36-2547-01	698	0.7392277450901511	466	TCGA-36-2547-01	9	35	153	0.4228145512684403	TCGA-36-2547-01	37	36	18	91	PASS	7404	TCGA-36-2547	OV	64	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-23706	Alive	NA	624	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	624	0	624	NA	NA	0	624	
60	TCGA-36-2548	0	4	0	4	3	0	0	0	1	45	3	0	0	13	3	0	TCGA-36-2548-01	554	0.7084714399362534	374	TCGA-36-2548-01	23	28	56	0.3188579268797516	TCGA-36-2548-01	14	8	4	26	PASS	7405	TCGA-36-2548	OV	57	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-20897	Alive	WITH TUMOR	431	NA	NA	Recurrence	NA	NA	395	NA	NA	NA	0	431	0	431	NA	NA	1	395	
50	TCGA-36-2549	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-36-2549-01	1455	0.4223049992507064	1280	TCGA-36-2549-01	6	13	77	0.2484283169022753	TCGA-36-2549-01	21	25	12	58	PASS	7406	TCGA-36-2549	OV	54	FEMALE	NA	NA	Stage IIC	Serous Cystadenocarcinoma	G3	2008	NA	-20076	Alive	TUMOR FREE	184	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	184	0	184	NA	NA	0	184	
60	TCGA-36-2551	0	1	0	1	0	1	0	0	2	23	1	0	1	19	0	0	TCGA-36-2551-01	484	0.7807688837384286	307	TCGA-36-2551-01	25	66	56	0.13556563254220602	TCGA-36-2551-01	24	22	8	54	PASS	7407	TCGA-36-2551	OV	57	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-21045	Alive	WITH TUMOR	492	NA	NA	Recurrence	NA	NA	338	Complete Remission/Response	NA	NA	0	492	0	492	1	338	1	338	
60	TCGA-36-2552	0	4	0	5	1	1	0	0	0	48	2	0	1	24	0	0	TCGA-36-2552-01	366	0.9085955224954152	252	TCGA-36-2552-01	21	66	49	0.283516440469216	TCGA-36-2552-01	23	15	8	46	PASS	7408	TCGA-36-2552	OV	64	FEMALE	NA	NA	Stage IIC	Serous Cystadenocarcinoma	G3	2009	NA	-23379	Alive	TUMOR FREE	349	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	349	0	349	NA	NA	0	349	
60	TCGA-3P-A9WA	1	49	2	8	7	0	1	0	2	86	9	0	2	36	4	0	TCGA-3P-A9WA-01	371	0.9350849709621368	222	TCGA-3P-A9WA-01	11	17	149	0.33763097081484544	TCGA-3P-A9WA-01	15	17	9	41	PASS	7409	TCGA-3P-A9WA	OV	55	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIB	Serous Cystadenocarcinoma	G3	2013	NA	-20211	Alive	TUMOR FREE	420	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	420	0	420	0	420	0	420	
50	TCGA-42-2582	1	9	1	5	3	0	2	0	5	104	2	0	2	20	2	1	TCGA-42-2582-01	392	0.4166176350205285	252	TCGA-42-2582-01	3	12	40	0.1410766336932882	TCGA-42-2582-01	18	26	6	50	PASS	7410	TCGA-42-2582	OV	49	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-17961	Dead	WITH TUMOR	NA	1447	NA	Recurrence	NA	NA	616	Stable Disease	NA	NA	1	1447	1	1447	NA	NA	1	616	
80	TCGA-42-2587	0	14	1	5	7	0	1	1	7	122	4	0	2	34	1	0	TCGA-42-2587-01	1205	0.5833732504946382	900	TCGA-42-2587-01	18	40	51	0.16666871771654912	TCGA-42-2587-01	31	38	11	80	PASS	7411	TCGA-42-2587	OV	75	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-27510	Alive	TUMOR FREE	722	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	722	0	722	0	722	0	722	
60	TCGA-42-2588	0	4	0	1	3	1	0	0	1	29	0	0	0	11	0	0	TCGA-42-2588-01	699	0.4349911035660705	476	TCGA-42-2588-01	5	13	81	0.1764340674048556	TCGA-42-2588-01	23	16	8	47	PASS	7412	TCGA-42-2588	OV	61	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2009	NA	-22377	Dead	WITH TUMOR	NA	880	NA	Progression of Disease	NA	NA	112	Progressive Disease	NA	NA	1	880	1	880	NA	NA	1	112	
50	TCGA-42-2589	1	6	2	4	2	0	2	1	2	85	3	0	2	23	2	0	TCGA-42-2589-01	494	0.987838873375788	310	TCGA-42-2589-01	6	14	112	0.4105935206833991	TCGA-42-2589-01	29	24	17	70	PASS	7413	TCGA-42-2589	OV	54	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-19852	Alive	WITH TUMOR	1278	NA	NA	Recurrence	NA	NA	364	Complete Remission/Response	NA	NA	0	1278	0	1278	1	364	1	364	
60	TCGA-42-2590	2	13	0	2	2	0	0	0	4	45	2	0	0	14	1	0	TCGA-42-2590-01	249	0.4218924145640508	153	TCGA-42-2590-01	3	15	37	0.2565503014246762	TCGA-42-2590-01	18	24	12	54	PASS	7414	TCGA-42-2590	OV	57	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G2	2009	NA	-20965	Dead	WITH TUMOR	NA	317	NA	Progression of Disease	NA	NA	226	Progressive Disease	NA	NA	1	317	1	317	NA	NA	1	226	
50	TCGA-42-2591	0	7	0	8	0	0	4	0	2	57	1	0	2	24	0	1	TCGA-42-2591-01	450	0.9961575870504592	276	TCGA-42-2591-01	7	20	120	0.4950757432992956	TCGA-42-2591-01	26	34	26	86	PASS	7415	TCGA-42-2591	OV	51	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	GX	2009	NA	-18654	Alive	TUMOR FREE	1240	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1240	0	1240	0	1240	0	1240	
70	TCGA-42-2593	0	3	0	5	1	0	0	0	2	35	1	0	1	15	1	0	TCGA-42-2593-01	1024	0.5590279114029151	848	TCGA-42-2593-01	18	34	96	0.22038034312006624	TCGA-42-2593-01	17	14	7	38	PASS	7416	TCGA-42-2593	OV	67	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-24823	Dead	WITH TUMOR	NA	45	NA	NA	NA	NA	NA	NA	NA	NA	1	45	1	45	NA	NA	1	45	
50	TCGA-57-1582	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-57-1582-01	429	0.7602119668913646	281	TCGA-57-1582-01	15	64	76	0.3377340047457766	TCGA-57-1582-01	31	30	11	72	PASS	7417	TCGA-57-1582	OV	50	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	NA	Dead	WITH TUMOR	731	731	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	731	1	731	NA	NA	1	731	
60	TCGA-57-1583	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-57-1583-01	613	0.6256547045032671	402	TCGA-57-1583-01	17	30	71	0.2305853887994303	TCGA-57-1583-01	18	14	7	39	PASS	7418	TCGA-57-1583	OV	57	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-21167	Dead	WITH TUMOR	346	346	NA	NA	NA	NA	NA	NA	NA	NA	1	346	1	346	NA	NA	1	346	
50	TCGA-57-1584	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-57-1584-01	187	1.0	113	TCGA-57-1584-01	10	12	20	0.3128075240708111	TCGA-57-1584-01	15	17	7	39	PASS	7419	TCGA-57-1584	OV	47	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-17263	Alive	WITH TUMOR	643	NA	NA	Recurrence	NA	NA	530	NA	NA	NA	0	643	0	643	NA	NA	1	530	
60	TCGA-57-1585	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-57-1585-01	461	0.7813977278305633	308	TCGA-57-1585-01	21	48	68	0.2392637607287075	TCGA-57-1585-01	27	38	9	74	PASS	7420	TCGA-57-1585	OV	57	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-20862	Dead	WITH TUMOR	53	53	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	53	1	53	NA	NA	1	53	
70	TCGA-57-1586	0	3	0	0	0	0	0	0	3	6	1	0	0	3	0	0	TCGA-57-1586-01	404	0.9999188756860417	255	TCGA-57-1586-01	25	39	77	0.25369305968426165	TCGA-57-1586-01	18	11	12	41	PASS	7421	TCGA-57-1586	OV	66	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-24304	Alive	WITH TUMOR	679	NA	NA	Recurrence	NA	NA	259	NA	NA	NA	0	679	0	679	NA	NA	1	259	
60	TCGA-57-1992	2	14	0	3	5	6	1	1	5	115	6	0	4	42	4	1	TCGA-57-1992-01	262	0.9475525491373624	163	TCGA-57-1992-01	16	22	61	0.5166334492539755	TCGA-57-1992-01	15	9	16	40	PASS	7422	TCGA-57-1992	OV	62	FEMALE	NA	NA	Stage IC	Serous Cystadenocarcinoma	G3	2006	NA	NA	Alive	TUMOR FREE	882	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	882	0	882	0	882	0	882	
60	TCGA-57-1993	0	5	0	3	3	6	0	0	3	67	6	0	2	25	4	1	TCGA-57-1993-01	460	0.662043998563521	281	TCGA-57-1993-01	19	71	34	0.05206257946798526	TCGA-57-1993-01	18	9	1	28	PASS	7423	TCGA-57-1993	OV	56	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-20498	Alive	TUMOR FREE	763	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	763	0	763	NA	NA	0	763	
60	TCGA-57-1994	0	7	0	4	1	1	2	0	2	50	2	0	1	13	13	0	TCGA-57-1994-01	313	0.6914569410164589	201	TCGA-57-1994-01	13	36	45	0.2612021217305809	TCGA-57-1994-01	18	21	10	49	PASS	7424	TCGA-57-1994	OV	63	FEMALE	WHITE	NA	NA	Serous Cystadenocarcinoma	NA	2004	NA	-23062	Alive	NA	761	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	761	0	761	NA	NA	0	761	
60	TCGA-59-2348	0	7	1	3	3	1	0	0	5	83	5	0	4	34	4	0	TCGA-59-2348-01	482	0.6789549439938972	310	TCGA-59-2348-01	11	31	54	0.24752469635504545	TCGA-59-2348-01	17	35	9	61	PASS	7425	TCGA-59-2348	OV	59	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1994	NA	NA	Alive	TUMOR FREE	5481	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	5481	0	5481	0	5481	0	5481	
70	TCGA-59-2349	3	42	7	10	49	11	8	0	22	670	49	0	7	327	6	0	TCGA-59-2349-01	104	0.054439742234236414	47	TCGA-59-2349	0	0	0	0	TCGA-59-2349	0	0	0	0	hypermutated sample	7426	TCGA-59-2349	OV	71	FEMALE	NA	NA	Stage IA	Serous Cystadenocarcinoma	G3	1994	NA	NA	Dead	NA	NA	2437	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2437	NA	2437	0	2437	0	2437	
40	TCGA-59-2350	1	5	0	0	3	0	0	0	2	30	0	0	1	15	0	0	TCGA-59-2350-01	201	0.936503073957017	124	TCGA-59-2350-01	14	13	33	0.3537226709780507	TCGA-59-2350-01	8	3	4	15	PASS	7427	TCGA-59-2350	OV	44	FEMALE	NA	NA	Stage IV	Serous Cystadenocarcinoma	G3	1995	NA	NA	Dead	WITH TUMOR	NA	679	NA	Progression of Disease	NA	NA	211	Partial Remission/Response	NA	NA	1	679	1	679	NA	NA	1	211	
50	TCGA-59-2351	0	7	0	3	4	1	1	0	2	96	5	0	2	28	8	0	TCGA-59-2351-01	216	0.7107763377039656	118	TCGA-59-2351-01	16	25	39	0.3285834694790117	TCGA-59-2351-01	22	23	13	58	PASS	7428	TCGA-59-2351	OV	51	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	NA	Alive	TUMOR FREE	3532	NA	NA	Progression of Disease	NA	NA	2139	Complete Remission/Response	NA	NA	0	3532	0	3532	1	2139	1	2139	
80	TCGA-59-2352	0	8	0	4	2	0	1	0	2	75	2	0	3	25	2	0	TCGA-59-2352-01	366	0.8686757302646945	250	TCGA-59-2352-01	18	34	50	0.20928723188901588	TCGA-59-2352-01	20	17	4	41	PASS	7429	TCGA-59-2352	OV	78	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	NA	Dead	WITH TUMOR	NA	286	NA	NA	NA	NA	NA	NA	NA	NA	1	286	1	286	NA	NA	1	286	
60	TCGA-59-2354	2	5	0	2	1	1	1	0	4	52	5	0	3	34	3	0	TCGA-59-2354-01	298	0.7517104801789642	200	TCGA-59-2354-01	9	12	60	0.33390331591669553	TCGA-59-2354-01	17	22	14	53	PASS	7430	TCGA-59-2354	OV	63	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	NA	Dead	WITH TUMOR	NA	1046	NA	Progression of Disease	NA	NA	462	Stable Disease	NA	NA	1	1046	1	1046	NA	NA	1	462	
60	TCGA-59-2355	0	0	0	0	0	1	0	0	2	23	3	0	2	6	1	0	TCGA-59-2355-01	192	0.5654881311329165	95	TCGA-59-2355-01	10	10	38	0.27181608912074084	TCGA-59-2355-01	14	7	9	30	PASS	7431	TCGA-59-2355	OV	58	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2006	NA	NA	Dead	WITH TUMOR	NA	65	NA	NA	NA	NA	NA	NA	NA	NA	1	65	1	65	NA	NA	1	65	
40	TCGA-59-2363	0	2	2	2	0	1	1	0	4	67	4	0	5	27	2	0	TCGA-59-2363-01	491	0.9481588475407836	329	TCGA-59-2363-01	12	19	104	0.5016956459204206	TCGA-59-2363-01	22	21	12	55	PASS	7432	TCGA-59-2363	OV	40	FEMALE	ASIAN	NA	Stage IIIA	Serous Cystadenocarcinoma	G3	2007	NA	NA	Alive	TUMOR FREE	165	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	165	0	165	0	165	0	165	
70	TCGA-59-2372	1	7	1	4	1	0	0	0	1	69	4	0	0	24	4	0	TCGA-59-2372-01	293	0.6650351391615793	190	TCGA-59-2372-01	20	32	56	0.3149481351607565	TCGA-59-2372-01	17	19	8	44	PASS	7433	TCGA-59-2372	OV	73	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2005	NA	NA	Dead	NA	NA	1363	NA	NA	NA	NA	NA	NA	NA	NA	1	1363	NA	1363	NA	NA	0	1363	
60	TCGA-59-A5PD	2	50	2	18	3	0	1	0	11	110	12	2	6	46	2	0	TCGA-59-A5PD-01	447	0.9251292540110468	300	TCGA-59-A5PD-01	16	35	259	0.5315090597359583	TCGA-59-A5PD-01	33	35	18	86	PASS	7434	TCGA-59-A5PD	OV	55	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IC	Serous Cystadenocarcinoma	G3	2011	NA	-20263	Dead	WITH TUMOR	NA	624	NA	Recurrence	NA	NA	145	Complete Remission/Response	NA	NA	1	624	1	624	1	145	1	145	
60	TCGA-5X-AA5U	3	5	0	1	1	0	0	1	4	22	3	0	1	10	1	0	TCGA-5X-AA5U-01	273	0.9051900563793908	161	TCGA-5X-AA5U-01	27	33	90	0.22001604634280664	TCGA-5X-AA5U-01	18	10	6	34	PASS	7435	TCGA-5X-AA5U	OV	61	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIC	Serous Cystadenocarcinoma	GX	2013	NA	-22438	Alive	TUMOR FREE	361	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	361	0	361	0	361	0	361	
40	TCGA-61-1721	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-61-1721-01	89	5.00072366059266e-05	41	TCGA-61-1721	0	0	0	0	TCGA-61-1721	0	0	0	0	PASS	7436	TCGA-61-1721	OV	38	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G1	2008	NA	-13894	Alive	TUMOR FREE	338	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	338	0	338	NA	NA	0	338	
90	TCGA-61-1722	1	8	0	2	3	0	0	0	4	86	5	0	3	28	2	0	TCGA-61-1722-01	302	0.7198227864432589	183	TCGA-61-1722-01	11	40	77	0.3740662056248341	TCGA-61-1722-01	16	14	14	44	mutation call filter	7437	TCGA-61-1722	OV	89	FEMALE	WHITE	NA	Stage IB	Serous Cystadenocarcinoma	G3	2008	NA	-32853	Alive	WITH TUMOR	246	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	246	0	246	NA	NA	0	246	
50	TCGA-61-1724	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-61-1724-01	555	0.9912603472218418	363	TCGA-61-1724-01	9	22	104	0.5027908354639865	TCGA-61-1724-01	27	23	23	73	PASS	7438	TCGA-61-1724	OV	47	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-17168	Dead	WITH TUMOR	637	637	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	637	1	637	NA	NA	1	637	
40	TCGA-61-1725	0	3	0	1	1	0	0	0	3	57	6	0	3	17	2	0	TCGA-61-1725-01	212	0.854837593160049	112	TCGA-61-1725-01	6	15	38	0.3268606408262351	TCGA-61-1725-01	17	21	18	56	PASS	7439	TCGA-61-1725	OV	40	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-14782	Alive	WITH TUMOR	956	NA	NA	Recurrence	NA	NA	844	Stable Disease	NA	NA	0	956	0	956	NA	NA	1	844	
70	TCGA-61-1727	0	9	0	5	2	1	3	0	3	112	7	0	2	31	5	0	TCGA-61-1727-01	341	0.8975164693965965	214	TCGA-61-1727-01	11	36	70	0.2500096056216708	TCGA-61-1727-01	28	34	14	76	PASS	7440	TCGA-61-1727	OV	74	FEMALE	WHITE	NA	Stage IC	Serous Cystadenocarcinoma	G3	2007	NA	-27203	Alive	TUMOR FREE	564	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	564	0	564	0	564	0	564	
60	TCGA-61-1728	0	3	0	4	2	5	2	0	4	43	5	0	0	22	5	1	TCGA-61-1728-01	351	0.6172846642731895	217	TCGA-61-1728-01	19	26	45	0.14737022799158386	TCGA-61-1728-01	13	16	4	33	PASS	7441	TCGA-61-1728	OV	59	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2007	NA	-21582	Alive	TUMOR FREE	848	NA	NA	Recurrence	NA	NA	533	Complete Remission/Response	NA	NA	0	848	0	848	NA	NA	1	533	
80	TCGA-61-1730	0	2	0	3	1	2	1	0	2	55	5	0	1	16	2	0	TCGA-61-1730-01	132	0.9101515236848404	66	TCGA-61-1730-01	25	27	20	0.17051276142502025	TCGA-61-1730-01	10	5	2	17	PASS	7442	TCGA-61-1730	OV	78	FEMALE	WHITE	NA	Stage IC	Serous Cystadenocarcinoma	G3	2007	NA	-28508	Dead	WITH TUMOR	132	132	NA	NA	NA	NA	NA	NA	NA	NA	1	132	1	132	NA	NA	1	132	
70	TCGA-61-1733	0	5	1	3	0	0	0	0	0	38	5	0	1	17	1	0	TCGA-61-1733-01	165	0.9470126359247854	85	TCGA-61-1733-01	25	36	32	0.1640529865246959	TCGA-61-1733-01	10	4	3	17	PASS	7443	TCGA-61-1733	OV	71	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-26180	Alive	WITH TUMOR	967	NA	NA	Recurrence	NA	NA	175	Stable Disease	NA	NA	0	967	0	967	NA	NA	1	175	
50	TCGA-61-1734	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-61-1734-01	255	0.8390310570884197	157	TCGA-61-1734-01	5	14	66	0.3477488380563915	TCGA-61-1734-01	20	22	12	54	PASS	7444	TCGA-61-1734	OV	52	FEMALE	WHITE	NA	Stage IC	Serous Cystadenocarcinoma	G3	2006	NA	-19026	Alive	TUMOR FREE	866	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	866	0	866	0	866	0	866	
50	TCGA-61-1736	0	7	0	1	1	1	0	0	3	45	1	0	2	15	2	0	TCGA-61-1736-01	414	0.9484571424536904	277	TCGA-61-1736-01	10	10	70	0.2819897189928586	TCGA-61-1736-01	11	8	4	23	PASS	7445	TCGA-61-1736	OV	45	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-16613	Dead	WITH TUMOR	1484	1484	NA	Recurrence	NA	NA	764	Complete Remission/Response	NA	NA	1	1484	1	1484	1	764	1	764	
40	TCGA-61-1737	0	12	0	0	3	2	3	0	3	112	1	0	3	32	4	0	TCGA-61-1737-01	206	0.8638215268836753	117	TCGA-61-1737-01	10	18	43	0.35124110485269555	TCGA-61-1737-01	19	29	16	64	PASS	7446	TCGA-61-1737	OV	42	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2005	NA	-15515	Alive	TUMOR FREE	1364	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1364	0	1364	NA	NA	0	1364	
60	TCGA-61-1738	1	7	0	1	3	0	1	0	2	44	5	0	1	16	0	0	TCGA-61-1738-01	511	0.6658721108461587	310	TCGA-61-1738-01	3	9	68	0.13881223926533728	TCGA-61-1738-01	13	10	8	31	PASS	7447	TCGA-61-1738	OV	60	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-21965	Dead	WITH TUMOR	1089	1089	NA	Recurrence	NA	NA	276	Progressive Disease	NA	NA	1	1089	1	1089	NA	NA	1	276	
70	TCGA-61-1740	1	19	3	6	4	1	3	0	13	155	8	0	5	57	12	0	TCGA-61-1740-01	312	0.9018587520392816	187	TCGA-61-1740-01	7	21	112	0.5414051250123036	TCGA-61-1740-01	26	32	22	80	PASS	7448	TCGA-61-1740	OV	71	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	NA	-26169	Dead	WITH TUMOR	74	74	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	74	1	74	NA	NA	1	74	
80	TCGA-61-1741	0	2	0	0	3	1	0	0	1	28	1	0	0	10	2	0	TCGA-61-1741-01	244	0.8005504373908289	144	TCGA-61-1741-01	20	32	34	0.2842819878370625	TCGA-61-1741-01	18	12	3	33	PASS	7449	TCGA-61-1741	OV	76	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2004	NA	-27762	Dead	WITH TUMOR	1024	1024	NA	Recurrence	NA	NA	488	Complete Remission/Response	NA	NA	1	1024	1	1024	1	488	1	488	
50	TCGA-61-1743	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-61-1743-01	301	0.8334626557168124	185	TCGA-61-1743-01	31	49	37	0.12320045405612792	TCGA-61-1743-01	17	12	5	34	PASS	7450	TCGA-61-1743	OV	53	FEMALE	WHITE	NA	Stage IIC	Serous Cystadenocarcinoma	G2	2004	NA	-19365	Dead	WITH TUMOR	1329	1329	NA	Recurrence	NA	NA	809	Complete Remission/Response	NA	NA	1	1329	1	1329	1	809	1	809	
50	TCGA-61-1895	0	10	0	1	3	4	1	0	1	59	4	0	1	12	5	0	TCGA-61-1895-01	231	0.9977489871292002	132	TCGA-61-1895-01	6	21	59	0.4362104643632836	TCGA-61-1895-01	25	34	21	80	PASS	7451	TCGA-61-1895	OV	52	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2009	NA	-19060	Alive	TUMOR FREE	44	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	44	0	44	NA	NA	0	44	
80	TCGA-61-1899	1	5	0	2	1	1	1	0	2	48	4	0	3	23	3	0	TCGA-61-1899-01	317	0.7769661746724588	189	TCGA-61-1899-01	21	40	41	0.2334559056617477	TCGA-61-1899-01	22	9	3	34	PASS	7452	TCGA-61-1899	OV	81	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-29692	Alive	TUMOR FREE	256	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	256	0	256	0	256	0	256	
50	TCGA-61-1900	1	6	0	2	8	0	3	0	3	58	7	0	4	19	5	0	TCGA-61-1900-01	338	0.5085593586335138	200	TCGA-61-1900-01	9	21	82	0.3811603401921592	TCGA-61-1900-01	28	35	21	84	PASS	7453	TCGA-61-1900	OV	51	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2008	NA	-18963	Alive	TUMOR FREE	176	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	176	0	176	NA	NA	0	176	
70	TCGA-61-1901	0	8	1	2	3	1	1	0	3	37	4	0	2	14	1	0	TCGA-61-1901-01	149	0.9132654332880942	82	TCGA-61-1901-01	4	11	39	0.2998946147462013	TCGA-61-1901-01	17	20	13	50	PASS	7454	TCGA-61-1901	OV	65	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2008	NA	-24042	Dead	WITH TUMOR	347	347	NA	Progression of Disease	NA	NA	329	Stable Disease	NA	NA	1	347	1	347	NA	NA	1	329	
60	TCGA-61-1903	1	10	2	2	3	0	0	0	9	40	6	0	5	7	4	0	TCGA-61-1903-01	333	0.8365550112603812	213	TCGA-61-1903-01	7	14	62	0.34093499312974385	TCGA-61-1903-01	24	23	12	59	PASS	7455	TCGA-61-1903	OV	55	FEMALE	WHITE	NA	Stage IB	Serous Cystadenocarcinoma	G3	2007	NA	-20381	Alive	TUMOR FREE	396	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	396	0	396	0	396	0	396	
60	TCGA-61-1904	3	25	0	7	15	1	1	0	3	100	8	0	2	49	4	0	TCGA-61-1904-01	141	0.6731856346266195	69	TCGA-61-1904-01	27	66	39	0.3357191784017612	TCGA-61-1904-01	14	10	2	26	PASS	7456	TCGA-61-1904	OV	60	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-22009	Alive	TUMOR FREE	276	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	276	0	276	0	276	0	276	
60	TCGA-61-1906	0	7	1	4	2	0	0	0	1	44	5	0	0	19	4	0	TCGA-61-1906-01	229	0.8966537653846496	142	TCGA-61-1906-01	29	18	53	0.4507559165640677	TCGA-61-1906-01	12	13	5	30	PASS	7457	TCGA-61-1906	OV	55	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-20378	Dead	WITH TUMOR	1038	1038	NA	Recurrence	NA	NA	236	Complete Remission/Response	NA	NA	1	1038	1	1038	1	236	1	236	
60	TCGA-61-1907	0	7	0	4	5	1	1	0	6	91	4	0	0	33	4	0	TCGA-61-1907-01	222	0.7311420600462206	120	TCGA-61-1907-01	15	32	49	0.3493834733553419	TCGA-61-1907-01	26	29	9	64	PASS	7458	TCGA-61-1907	OV	63	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-23204	Alive	WITH TUMOR	952	NA	NA	Recurrence	NA	NA	743	Stable Disease	NA	NA	0	952	0	952	NA	NA	1	743	
60	TCGA-61-1910	1	20	1	6	0	2	0	0	9	78	3	0	2	42	2	0	TCGA-61-1910-01	509	0.4175938857901317	348	TCGA-61-1910-01	6	13	92	0.2520320753785268	TCGA-61-1910-01	21	24	13	58	PASS	7459	TCGA-61-1910	OV	56	FEMALE	WHITE	NA	Stage IIC	Serous Cystadenocarcinoma	G3	2006	NA	-20779	Alive	TUMOR FREE	1127	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1127	0	1127	0	1127	0	1127	
60	TCGA-61-1911	0	5	0	2	1	2	0	0	2	25	3	0	2	20	2	0	TCGA-61-1911-01	340	0.5643758355875462	212	TCGA-61-1911-01	7	40	63	0.3919291241825963	TCGA-61-1911-01	10	14	5	29	PASS	7460	TCGA-61-1911	OV	55	FEMALE	WHITE	NA	Stage IIA	Serous Cystadenocarcinoma	G3	2005	NA	-20144	Alive	WITH TUMOR	1293	NA	NA	Recurrence	NA	NA	844	Complete Remission/Response	NA	NA	0	1293	0	1293	1	844	1	844	
50	TCGA-61-1913	1	7	0	6	0	0	1	0	1	35	2	0	4	15	2	0	TCGA-61-1913-01	297	0.9472844583447162	168	TCGA-61-1913-01	5	14	82	0.3677418147456071	TCGA-61-1913-01	20	22	16	58	PASS	7461	TCGA-61-1913	OV	48	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2005	NA	-17575	Alive	TUMOR FREE	1488	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1488	0	1488	0	1488	0	1488	
70	TCGA-61-1914	1	12	1	3	4	1	0	0	3	94	12	0	2	29	1	1	TCGA-61-1914-01	187	0.7207677215645533	101	TCGA-61-1914-01	9	13	43	0.3224864473387044	TCGA-61-1914-01	20	17	14	51	PASS	7462	TCGA-61-1914	OV	65	FEMALE	NA	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-23850	Alive	WITH TUMOR	1722	NA	NA	Recurrence	NA	NA	1674	Complete Remission/Response	NA	NA	0	1722	0	1722	1	1674	1	1674	
50	TCGA-61-1915	1	7	1	2	4	1	1	0	4	63	4	0	1	33	5	0	TCGA-61-1915-01	185	0.6868124414978761	101	TCGA-61-1915-01	16	30	18	0.1921184005794448	TCGA-61-1915-01	21	27	6	54	PASS	7463	TCGA-61-1915	OV	50	FEMALE	WHITE	NA	Stage IIC	Serous Cystadenocarcinoma	G3	2003	NA	-18424	Alive	TUMOR FREE	2061	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2061	0	2061	0	2061	0	2061	
50	TCGA-61-1916	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-61-1916	0	0	0	TCGA-61-1916	0	0	0	0	TCGA-61-1916	0	0	0	0	PASS	7464	TCGA-61-1916	OV	53	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2002	NA	-19463	Dead	NA	475	475	NA	Recurrence	NA	NA	326	NA	NA	NA	1	475	NA	475	NA	NA	1	326	
60	TCGA-61-1917	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-61-1917-01	916	0.8304258445349527	605	TCGA-61-1917-01	13	34	182	0.4468451524817821	TCGA-61-1917-01	29	41	23	93	PASS	7465	TCGA-61-1917	OV	60	FEMALE	WHITE	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2002	NA	-21972	Dead	NA	1321	1321	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1321	NA	1321	0	1321	0	1321	
50	TCGA-61-1918	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-61-1918-01	760	0.7043921461148991	530	TCGA-61-1918-01	13	26	70	0.11786418616865713	TCGA-61-1918-01	19	17	5	41	PASS	7466	TCGA-61-1918	OV	45	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	2002	NA	-16689	Dead	WITH TUMOR	479	479	NA	Recurrence	NA	NA	413	Complete Remission/Response	NA	NA	1	479	1	479	NA	NA	1	413	
60	TCGA-61-1919	0	6	0	1	0	1	1	0	1	60	4	1	2	18	12	0	TCGA-61-1919-01	396	0.851192107326132	244	TCGA-61-1919-01	20	44	44	0.17506168965907362	TCGA-61-1919-01	18	19	6	43	PASS	7467	TCGA-61-1919	OV	58	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2001	NA	-21199	Dead	NA	1161	1161	NA	Recurrence	NA	NA	439	Complete Remission/Response	NA	NA	1	1161	NA	1161	1	439	1	439	
40	TCGA-61-1995	0	3	0	1	3	3	1	0	0	33	2	0	0	6	2	0	TCGA-61-1995-01	84	0.9456860032563256	36	TCGA-61-1995-01	14	8	13	0.3229667461506455	TCGA-61-1995-01	0	1	0	1	PASS	7468	TCGA-61-1995	OV	43	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-16016	Alive	WITH TUMOR	61	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	61	0	61	NA	NA	0	61	
50	TCGA-61-1998	5	14	0	13	6	5	1	0	3	172	16	1	2	79	5	0	TCGA-61-1998-01	239	0.4032577155052292	134	TCGA-61-1998-01	9	11	30	0.2496904286625549	TCGA-61-1998-01	17	19	8	44	PASS	7469	TCGA-61-1998	OV	48	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-17855	Alive	WITH TUMOR	168	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	168	0	168	NA	NA	0	168	
70	TCGA-61-2000	0	2	0	2	0	1	0	0	2	62	3	0	3	24	1	1	TCGA-61-2000-01	846	0.3820557292010288	600	TCGA-61-2000-01	8	14	118	0.2432190458426545	TCGA-61-2000-01	19	14	10	43	PASS	7470	TCGA-61-2000	OV	67	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-24723	Alive	WITH TUMOR	441	NA	NA	Recurrence	NA	NA	339	Stable Disease	NA	NA	0	441	0	441	NA	NA	1	339	
50	TCGA-61-2002	1	1	0	3	1	0	0	0	0	38	5	0	0	13	0	0	TCGA-61-2002-01	260	0.7135119855411216	145	TCGA-61-2002-01	6	15	57	0.3395492256154621	TCGA-61-2002-01	26	27	18	71	PASS	7471	TCGA-61-2002	OV	46	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-17115	Alive	WITH TUMOR	547	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	547	0	547	NA	NA	0	547	
50	TCGA-61-2003	0	6	0	0	4	0	2	0	4	85	4	0	2	27	1	0	TCGA-61-2003-01	204	0.8782055675463085	116	TCGA-61-2003-01	26	63	40	0.3084040187068357	TCGA-61-2003-01	10	13	2	25	PASS	7472	TCGA-61-2003	OV	53	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2008	NA	-19605	Alive	WITH TUMOR	122	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	122	0	122	NA	NA	0	122	
40	TCGA-61-2008	0	3	0	3	5	1	1	0	5	60	3	0	0	19	5	0	TCGA-61-2008-01	318	0.7492013829824001	188	TCGA-61-2008-01	12	35	33	0.1994131337568854	TCGA-61-2008-01	21	39	8	68	PASS	7473	TCGA-61-2008	OV	40	FEMALE	ASIAN	NA	Stage IIC	Serous Cystadenocarcinoma	G2	2007	NA	-14791	Alive	WITH TUMOR	932	NA	NA	Recurrence	NA	NA	818	Complete Remission/Response	NA	NA	0	932	0	932	1	818	1	818	
70	TCGA-61-2009	0	5	0	1	5	1	0	0	5	75	3	0	1	12	2	0	TCGA-61-2009-01	119	0.8400365212113909	55	TCGA-61-2009-01	27	68	28	0.2448162215624889	TCGA-61-2009-01	8	6	3	17	PASS	7474	TCGA-61-2009	OV	65	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-23772	Alive	WITH TUMOR	1212	NA	NA	Recurrence	NA	NA	101	Complete Remission/Response	NA	NA	0	1212	0	1212	1	101	1	101	
80	TCGA-61-2012	1	7	0	3	3	2	2	0	4	123	8	0	1	46	5	0	TCGA-61-2012-01	313	0.7315561510895179	191	TCGA-61-2012-01	19	40	77	0.3251615956608894	TCGA-61-2012-01	20	10	5	35	PASS	7475	TCGA-61-2012	OV	81	FEMALE	WHITE	NA	Stage IIC	Serous Cystadenocarcinoma	G2	2006	NA	-29830	Alive	NA	932	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	932	0	932	NA	NA	0	932	
50	TCGA-61-2016	0	3	1	2	0	2	0	0	1	26	3	0	0	8	0	0	TCGA-61-2016-01	174	0.8938112561793409	89	TCGA-61-2016-01	10	11	45	0.3527776197599647	TCGA-61-2016-01	11	12	11	34	PASS	7476	TCGA-61-2016	OV	51	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	NA	-18788	Dead	WITH TUMOR	NA	36	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	36	1	36	NA	NA	1	36	
60	TCGA-61-2017	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-61-2017-01	65	0.035026343816113706	23	TCGA-61-2017-01	1	1	10	0.03224145566092845	TCGA-61-2017-01	3	1	2	6	PASS	7477	TCGA-61-2017	OV	64	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G1	2005	NA	-23509	Alive	WITH TUMOR	1398	NA	NA	Recurrence	NA	NA	1006	Complete Remission/Response	NA	NA	0	1398	0	1398	1	1006	1	1006	
60	TCGA-61-2018	0	9	1	8	2	6	1	0	4	84	10	0	0	27	2	0	TCGA-61-2018-01	272	0.9292379167405644	158	TCGA-61-2018-01	5	18	71	0.3812734119010097	TCGA-61-2018-01	30	35	16	81	PASS	7478	TCGA-61-2018	OV	62	FEMALE	WHITE	NA	Stage IC	Serous Cystadenocarcinoma	G3	2005	NA	-22929	Alive	TUMOR FREE	1381	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1381	0	1381	0	1381	0	1381	
50	TCGA-61-2087	1	3	1	1	5	3	0	0	2	61	3	0	2	24	3	0	TCGA-61-2087-01	381	0.984304641583818	252	TCGA-61-2087-01	7	14	77	0.3755968291531653	TCGA-61-2087-01	18	21	17	56	PASS	7479	TCGA-61-2087	OV	49	FEMALE	WHITE	NA	Stage IC	Serous Cystadenocarcinoma	G3	2009	NA	-18182	Alive	TUMOR FREE	146	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	146	0	146	0	146	0	146	
50	TCGA-61-2088	0	1	0	2	0	1	1	0	1	16	0	0	0	5	0	0	TCGA-61-2088-01	201	0.6884362942323301	123	TCGA-61-2088-01	22	31	18	0.15738626333522454	TCGA-61-2088-01	8	5	3	16	PASS	7480	TCGA-61-2088	OV	51	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	NA	-18770	Alive	TUMOR FREE	145	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	145	0	145	NA	NA	0	145	
60	TCGA-61-2092	0	5	0	1	1	2	0	0	3	49	5	0	1	23	1	0	TCGA-61-2092-01	365	0.28275452996375045	249	TCGA-61-2092-01	1	1	15	0.02883732325215588	TCGA-61-2092-01	3	3	3	9	PASS	7481	TCGA-61-2092	OV	57	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	NA	-21072	Alive	TUMOR FREE	1573	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1573	0	1573	0	1573	0	1573	
60	TCGA-61-2094	0	2	0	2	1	4	0	0	3	60	3	0	1	17	1	0	TCGA-61-2094-01	220	0.8746689778301658	131	TCGA-61-2094-01	10	11	35	0.30951244470033235	TCGA-61-2094-01	9	10	9	28	PASS	7482	TCGA-61-2094	OV	63	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	NA	-23273	Alive	TUMOR FREE	2182	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2182	0	2182	0	2182	0	2182	
50	TCGA-61-2095	0	18	1	11	4	3	3	0	9	167	10	1	2	72	4	1	TCGA-61-2095-01	88	0.02447805129775442	41	TCGA-61-2095-01	2	2	11	0.025586426540715485	TCGA-61-2095-01	3	1	2	6	PASS	7483	TCGA-61-2095	OV	54	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2003	NA	-19797	Dead	WITH TUMOR	NA	1875	NA	Recurrence	NA	NA	445	Complete Remission/Response	NA	NA	1	1875	1	1875	1	445	1	445	
60	TCGA-61-2096	0	4	0	4	3	1	1	0	3	101	6	0	2	26	5	0	TCGA-61-2096-01	440	0.9163840992114825	293	TCGA-61-2096-01	7	15	101	0.35787987329987314	TCGA-61-2096-01	20	20	16	56	PASS	7484	TCGA-61-2096	OV	56	FEMALE	WHITE	NA	Stage IC	Serous Cystadenocarcinoma	G2	2003	NA	-20663	Alive	TUMOR FREE	1776	NA	NA	Recurrence	NA	NA	421	Progressive Disease	NA	NA	0	1776	0	1776	NA	NA	1	421	
70	TCGA-61-2097	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-61-2097-01	192	0.8370856471296707	111	TCGA-61-2097-01	20	24	50	0.4552262988580342	TCGA-61-2097-01	20	22	13	55	PASS	7485	TCGA-61-2097	OV	71	FEMALE	WHITE	NA	Stage IIC	Serous Cystadenocarcinoma	G2	2003	NA	-25961	Alive	TUMOR FREE	1844	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1844	0	1844	0	1844	0	1844	
60	TCGA-61-2098	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-61-2098-01	259	0.7123159889545632	169	TCGA-61-2098-01	20	73	58	0.4494272877493782	TCGA-61-2098-01	20	12	6	38	PASS	7486	TCGA-61-2098	OV	62	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	2003	NA	-22876	Alive	TUMOR FREE	1993	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1993	0	1993	0	1993	0	1993	
60	TCGA-61-2101	0	2	0	3	3	0	0	0	3	34	6	0	1	19	0	0	TCGA-61-2101-01	204	0.6642747020219144	120	TCGA-61-2101-01	22	69	38	0.3970015904522097	TCGA-61-2101-01	11	5	4	20	PASS	7487	TCGA-61-2101	OV	55	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G2	1999	NA	-20287	Dead	WITH TUMOR	NA	1688	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	1688	1	1688	NA	NA	1	1688	
70	TCGA-61-2102	0	3	0	0	1	1	1	0	1	61	2	0	2	23	1	0	TCGA-61-2102-01	357	0.886245140593812	216	TCGA-61-2102-01	18	38	94	0.28241030132671063	TCGA-61-2102-01	18	10	6	34	PASS	7488	TCGA-61-2102	OV	74	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-27256	Dead	WITH TUMOR	197	197	NA	NA	NA	NA	NA	NA	NA	NA	1	197	1	197	NA	NA	1	197	
50	TCGA-61-2104	0	4	0	3	2	0	0	0	3	58	4	0	2	25	1	0	TCGA-61-2104-01	261	0.7113758254087711	159	TCGA-61-2104-01	12	36	38	0.2737809479046118	TCGA-61-2104-01	24	32	9	65	PASS	7489	TCGA-61-2104	OV	53	FEMALE	WHITE	NA	Stage IIC	Serous Cystadenocarcinoma	G2	2003	NA	-19432	Alive	NA	2338	NA	NA	Recurrence	NA	NA	1680	Complete Remission/Response	NA	NA	0	2338	0	2338	1	1680	1	1680	
40	TCGA-61-2109	0	3	1	4	5	0	0	0	3	70	3	0	1	15	2	0	TCGA-61-2109-01	302	0.9668337264355692	176	TCGA-61-2109-01	9	19	70	0.41661561370564704	TCGA-61-2109-01	22	27	15	64	PASS	7490	TCGA-61-2109	OV	40	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	NA	-14900	Dead	WITH TUMOR	629	629	NA	Recurrence	NA	NA	465	NA	NA	NA	1	629	1	629	NA	NA	1	465	
60	TCGA-61-2110	0	6	0	1	1	3	1	0	1	73	10	0	3	18	3	0	TCGA-61-2110-01	139	0.9362364043776495	65	TCGA-61-2110-01	16	11	21	0.3123306029584511	TCGA-61-2110-01	5	4	1	10	PASS	7491	TCGA-61-2110	OV	56	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	NA	1998	NA	-20718	Dead	WITH TUMOR	1354	1354	NA	Recurrence	NA	NA	213	Progressive Disease	NA	NA	1	1354	1	1354	NA	NA	1	213	
60	TCGA-61-2111	1	5	0	5	4	1	0	0	1	91	6	0	0	23	3	1	TCGA-61-2111-01	216	0.6070720171392936	120	TCGA-61-2111	0	0	0	0	TCGA-61-2111	0	0	0	0	PASS	7492	TCGA-61-2111	OV	61	FEMALE	WHITE	NA	Stage IV	Serous Cystadenocarcinoma	G3	1998	NA	-22517	Alive	WITH TUMOR	3825	NA	NA	Recurrence	NA	NA	2205	Complete Remission/Response	NA	NA	0	3825	0	3825	NA	NA	1	2205	
50	TCGA-61-2113	3	14	1	8	8	6	1	2	9	190	15	0	5	91	1	0	TCGA-61-2113-01	213	0.7324496529031354	119	TCGA-61-2113-01	28	61	20	0.13544469684757365	TCGA-61-2113-01	13	11	4	28	PASS	7493	TCGA-61-2113	OV	53	FEMALE	WHITE	NA	Stage IIC	Serous Cystadenocarcinoma	G3	1999	NA	-19722	Dead	NA	676	676	NA	Recurrence	NA	NA	291	NA	NA	NA	1	676	NA	676	NA	NA	1	291	
60	TCGA-61-2610	0	13	0	3	6	0	0	0	8	75	4	0	2	23	4	0	TCGA-61-2610	0	0	0	TCGA-61-2610-02	8	21	65	0.3753041061188596	TCGA-61-2610-02	25	35	20	80	PASS	7494	TCGA-61-2610	OV	61	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	NA	-22481	Dead	WITH TUMOR	1579	1579	NA	Recurrence	NA	NA	524	Stable Disease	NA	NA	1	1579	1	1579	NA	NA	1	524	
40	TCGA-61-2611	2	10	0	2	1	0	1	0	1	56	4	0	1	19	3	0	TCGA-61-2611	0	0	0	TCGA-61-2611-02	13	34	39	0.3162200615613867	TCGA-61-2611-02	24	28	15	67	PASS	7495	TCGA-61-2611	OV	40	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	NA	-14782	Dead	WITH TUMOR	483	483	NA	Recurrence	NA	NA	383	Complete Remission/Response	NA	NA	1	483	1	483	1	383	1	383	
60	TCGA-61-2612	0	10	0	1	0	0	0	0	3	32	2	0	1	13	2	0	TCGA-61-2612-01	246	0.7886191251303022	156	TCGA-61-2612-01	24	63	32	0.2844515923249475	TCGA-61-2612-01	17	13	6	36	PASS	7496	TCGA-61-2612	OV	63	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	NA	-23074	Dead	WITH TUMOR	193	193	NA	Recurrence	NA	NA	179	Stable Disease	NA	NA	1	193	1	193	NA	NA	1	179	
70	TCGA-61-2613	0	13	0	0	1	0	4	0	6	61	6	0	0	19	4	0	TCGA-61-2613-01	344	0.7088285120258149	209	TCGA-61-2613-01	8	16	66	0.32861569048273537	TCGA-61-2613-01	13	15	6	34	PASS	7497	TCGA-61-2613	OV	73	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	NA	-26779	Dead	WITH TUMOR	945	945	NA	Recurrence	NA	NA	358	Stable Disease	NA	NA	1	945	1	945	NA	NA	1	358	
70	TCGA-61-2614	0	3	0	0	2	0	1	0	6	42	4	0	0	13	1	2	TCGA-61-2614-01	228	0.9591309115647992	141	TCGA-61-2614-01	28	63	46	0.30342478464658296	TCGA-61-2614-01	17	8	1	26	PASS	7498	TCGA-61-2614	OV	71	FEMALE	WHITE	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	NA	-26142	Dead	WITH TUMOR	262	262	NA	Recurrence	NA	NA	38	Stable Disease	NA	NA	1	262	1	262	NA	NA	1	38	
50	TCGA-OY-A56P	0	8	2	3	1	0	0	0	0	28	1	0	1	11	2	1	TCGA-OY-A56P-01	291	0.7516841878697328	190	TCGA-OY-A56P-01	27	56	73	0.19134241157859408	TCGA-OY-A56P-01	17	9	5	31	PASS	7499	TCGA-OY-A56P	OV	48	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIB	Serous Cystadenocarcinoma	G3	2010	NA	-17580	Alive	WITH TUMOR	1207	NA	NA	Recurrence	NA	NA	794	Complete Remission/Response	NA	NA	0	1207	0	1207	1	794	1	794	
80	TCGA-OY-A56Q	4	14	0	3	3	1	0	0	1	43	1	0	1	18	2	0	TCGA-OY-A56Q-01	181	0.7690838692278188	115	TCGA-OY-A56Q-01	28	52	61	0.16879153233949645	TCGA-OY-A56Q-01	13	5	1	19	PASS	7500	TCGA-OY-A56Q	OV	78	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIA	Serous Cystadenocarcinoma	G3	2012	NA	-28623	Alive	TUMOR FREE	576	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	576	0	576	0	576	0	576	
60	TCGA-VG-A8LO	1	20	1	3	3	0	2	0	3	62	2	0	1	16	2	1	TCGA-VG-A8LO-01	476	0.503988159501552	326	TCGA-VG-A8LO-01	8	20	178	0.3132713506975615	TCGA-VG-A8LO-01	20	24	15	59	PASS	7501	TCGA-VG-A8LO	OV	55	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IV	Serous Cystadenocarcinoma	GB	2013	NA	-20274	Dead	WITH TUMOR	NA	24	NA	NA	NA	NA	NA	NA	NA	NA	1	24	1	24	NA	NA	1	24	
70	TCGA-WR-A838	0	13	1	2	2	1	0	0	2	35	4	0	2	20	0	0	TCGA-WR-A838-01	236	0.7377493754462149	126	TCGA-WR-A838-01	20	26	18	0.04057615457929068	TCGA-WR-A838-01	15	9	2	26	PASS	7502	TCGA-WR-A838	OV	72	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous Cystadenocarcinoma	G3	2013	NA	-26418	Dead	WITH TUMOR	NA	304	NA	Progression of Disease	NA	NA	245	Progressive Disease	NA	NA	1	304	1	304	NA	NA	1	245	
70	TCGA-2J-AAB1	0	2	1	0	2	3	0	0	2	54	2	0	2	12	0	0	TCGA-2J-AAB1-01	85	0.0696767958453351	32	TCGA-2J-AAB1-01	2	1	32	0.10420346329365156	TCGA-2J-AAB1-01	2	2	4	8	PASS	7503	TCGA-2J-AAB1	PAAD	65	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma-Other Subtype	G3	2012	NA	-23962	Dead	TUMOR FREE	NA	66	Pancreatic Cancer	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	66	1	66	0	66	0	66	
50	TCGA-2J-AAB4	0	0	0	1	2	0	1	0	1	23	1	0	0	13	0	0	TCGA-2J-AAB4-01	69	0.22402421854374316	29	TCGA-2J-AAB4-01	6	9	73	0.18056546706883425	TCGA-2J-AAB4-01	13	6	10	29	PASS	7504	TCGA-2J-AAB4	PAAD	48	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma-Other Subtype	G2	2012	NA	-17794	Alive	TUMOR FREE	729	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	729	0	729	0	729	0	729	
80	TCGA-2J-AAB6	1	1	0	1	0	1	1	0	2	51	6	0	0	18	0	0	TCGA-2J-AAB6-01	175	0.999644315909467	103	TCGA-2J-AAB6-01	13	34	131	0.2554087506211889	TCGA-2J-AAB6-01	8	1	5	14	PASS	7505	TCGA-2J-AAB6	PAAD	75	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-27600	Dead	WITH TUMOR	NA	293	Pancreatic Cancer	Distant Metastasis	Liver	NA	169	Progressive Disease	NA	NA	1	293	1	293	NA	NA	1	169	
70	TCGA-2J-AAB8	0	4	0	2	2	1	0	0	1	31	6	0	0	16	2	0	TCGA-2J-AAB8-01	128	0.22861696372470036	68	TCGA-2J-AAB8-01	9	10	81	0.2707581928371359	TCGA-2J-AAB8-01	10	7	10	27	PASS	7506	TCGA-2J-AAB8	PAAD	71	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2012	NA	-26028	Alive	TUMOR FREE	80	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	80	0	80	NA	NA	0	80	
70	TCGA-2J-AAB9	0	2	0	0	0	0	0	0	0	11	1	0	1	10	1	0	TCGA-2J-AAB9-01	46	0.007903919787077713	8	TCGA-2J-AAB9-01	0	0	6	0.0002842525836335942	TCGA-2J-AAB9-01	0	0	0	0	PASS	7507	TCGA-2J-AAB9	PAAD	70	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2012	NA	-25920	Dead	WITH TUMOR	NA	627	Pancreatic Cancer	Distant Metastasis	Liver	NA	521	Complete Remission/Response	NA	NA	1	627	1	627	1	521	1	521	
60	TCGA-2J-AABA	0	3	0	0	5	0	1	0	0	20	4	0	1	8	1	0	TCGA-2J-AABA-01	76	0.1839302068002952	27	TCGA-2J-AABA-01	6	5	47	0.1742428520855894	TCGA-2J-AABA-01	6	3	6	15	PASS	7508	TCGA-2J-AABA	PAAD	55	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-20133	Dead	WITH TUMOR	NA	607	Pancreatic Cancer	Distant Metastasis	"Other, specify"	subcut nodule	160	Progressive Disease	NA	NA	1	607	1	607	NA	NA	1	160	
70	TCGA-2J-AABE	0	3	1	0	1	0	1	0	5	24	1	0	1	11	2	0	TCGA-2J-AABE-01	96	0.21874366768615972	39	TCGA-2J-AABE-01	5	7	51	0.11292436032347322	TCGA-2J-AABE-01	7	3	6	16	PASS	7509	TCGA-2J-AABE	PAAD	73	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-26943	Alive	TUMOR FREE	676	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	676	0	676	0	676	0	676	
70	TCGA-2J-AABF	0	3	0	3	0	1	0	0	0	38	5	0	1	16	1	0	TCGA-2J-AABF-01	111	0.20843585296881176	49	TCGA-2J-AABF-01	9	9	71	0.18529691207413465	TCGA-2J-AABF-01	4	6	5	15	PASS	7510	TCGA-2J-AABF	PAAD	73	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2012	NA	-26936	Dead	WITH TUMOR	NA	691	Pancreatic Cancer	Distant Metastasis	"Other, specify"	Liver/lung	443	Progressive Disease	NA	NA	1	691	1	691	NA	NA	1	443	
60	TCGA-2J-AABH	0	2	1	1	2	0	0	0	1	32	2	0	0	14	0	0	TCGA-2J-AABH-01	123	0.3236820909035833	61	TCGA-2J-AABH-01	11	13	83	0.2631822628741967	TCGA-2J-AABH-01	15	6	12	33	PASS	7511	TCGA-2J-AABH	PAAD	61	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma-Other Subtype	G3	2011	NA	-22425	Alive	WITH TUMOR	1287	NA	NA	Distant Metastasis	"Other, specify"	perigastric mass	1287	Complete Remission/Response	NA	NA	0	1287	0	1287	1	1287	1	1287	
60	TCGA-2J-AABI	0	2	0	0	1	1	0	0	0	26	1	0	1	8	1	0	TCGA-2J-AABI-01	120	0.9367003872456721	54	TCGA-2J-AABI-01	13	12	74	0.2999845238945873	TCGA-2J-AABI-01	8	1	9	18	PASS	7512	TCGA-2J-AABI	PAAD	55	FEMALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma-Other Subtype	G3	2011	NA	-20316	Alive	WITH TUMOR	969	NA	NA	Distant Metastasis	Liver	NA	728	Progressive Disease	NA	NA	0	969	0	969	NA	NA	1	728	
70	TCGA-2J-AABK	0	3	0	5	1	0	0	0	1	29	4	0	0	15	0	0	TCGA-2J-AABK-01	58	0.06397075088768286	14	TCGA-2J-AABK	0	0	0	0	TCGA-2J-AABK	0	0	0	0	PASS	7513	TCGA-2J-AABK	PAAD	71	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-26188	Alive	TUMOR FREE	484	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	484	0	484	0	484	0	484	
40	TCGA-2J-AABO	0	2	0	2	1	2	0	0	2	62	0	0	1	16	0	0	TCGA-2J-AABO-01	109	0.4213629655557792	49	TCGA-2J-AABO-01	22	28	35	0.11975348417303522	TCGA-2J-AABO-01	13	3	6	22	PASS	7514	TCGA-2J-AABO	PAAD	43	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-15869	Alive	WITH TUMOR	440	NA	NA	Distant Metastasis	Liver	NA	439	Progressive Disease	NA	NA	0	440	0	440	NA	NA	1	439	
60	TCGA-2J-AABP	0	4	0	3	0	0	0	0	2	87	5	0	2	26	1	0	TCGA-2J-AABP-01	390	0.699558109144949	266	TCGA-2J-AABP-01	18	33	405	0.8116593472452921	TCGA-2J-AABP-01	28	19	15	62	pathology review	7515	TCGA-2J-AABP	PAAD	58	FEMALE	WHITE	Stage IIB	NA	Pancreas-Undifferentiated Carcinoma	G4	2013	NA	-21484	Alive	TUMOR FREE	463	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	463	0	463	0	463	0	463	
60	TCGA-2J-AABR	0	1	0	1	0	0	0	0	0	6	0	0	0	2	1	0	TCGA-2J-AABR-01	47	0.0010051424665288703	9	TCGA-2J-AABR	0	0	0	0	TCGA-2J-AABR	0	0	0	0	PASS	7516	TCGA-2J-AABR	PAAD	60	FEMALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2013	NA	-22131	Alive	WITH TUMOR	438	NA	NA	Distant Metastasis	Liver	NA	327	Progressive Disease	NA	NA	0	438	0	438	NA	NA	1	327	
70	TCGA-2J-AABT	0	0	0	4	2	2	0	0	2	21	3	0	1	6	1	0	TCGA-2J-AABT-01	87	0.16570439952818056	42	TCGA-2J-AABT-01	8	9	42	0.08965825040417717	TCGA-2J-AABT-01	5	1	4	10	PASS	7517	TCGA-2J-AABT	PAAD	72	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-26379	Alive	NA	319	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	319	0	319	NA	NA	0	319	
60	TCGA-2J-AABU	0	2	0	1	1	0	0	0	1	21	1	0	0	14	1	0	TCGA-2J-AABU-01	115	0.5960315853389652	55	TCGA-2J-AABU-01	8	12	69	0.2671151949216936	TCGA-2J-AABU-01	13	6	10	29	PASS	7518	TCGA-2J-AABU	PAAD	56	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2012	NA	-20641	Dead	WITH TUMOR	NA	277	Pancreatic Cancer	Distant Metastasis	Liver	NA	154	Progressive Disease	NA	NA	1	277	1	277	NA	NA	1	154	
70	TCGA-2J-AABV	0	2	0	0	0	0	0	0	0	10	0	0	0	5	0	0	TCGA-2J-AABV-01	76	0.0040394352491040465	29	TCGA-2J-AABV-01	0	0	15	0.010963833963231836	TCGA-2J-AABV-01	1	0	1	2	PASS	7519	TCGA-2J-AABV	PAAD	74	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G4	2012	NA	-27082	Dead	WITH TUMOR	NA	652	Pancreatic Cancer	Distant Metastasis	Liver	NA	126	Progressive Disease	NA	NA	1	652	1	652	NA	NA	1	126	
80	TCGA-2L-AAQA	0	6	0	1	2	0	1	0	2	47	3	0	1	18	2	0	TCGA-2L-AAQA-01	130	0.1979946734401587	63	TCGA-2L-AAQA-01	5	5	41	0.15799331566771466	TCGA-2L-AAQA-01	7	4	7	18	PASS	7520	TCGA-2L-AAQA	PAAD	76	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2010	NA	-28074	Dead	WITH TUMOR	NA	143	Pancreatic Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	143	1	143	NA	NA	1	143	
60	TCGA-2L-AAQE	1	4	1	1	2	0	0	0	1	30	2	0	0	8	0	0	TCGA-2L-AAQE-01	117	0.6921757959937537	65	TCGA-2L-AAQE-01	27	19	68	0.19530602157094185	TCGA-2L-AAQE-01	10	4	9	23	PASS	7521	TCGA-2L-AAQE	PAAD	56	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-20618	Dead	WITH TUMOR	NA	684	Pancreatic Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	684	1	684	NA	NA	1	684	
70	TCGA-2L-AAQI	0	1	0	2	0	0	0	0	1	25	4	0	0	12	1	0	TCGA-2L-AAQI-01	89	0.2982259414728711	34	TCGA-2L-AAQI-01	9	9	83	0.2581693559205542	TCGA-2L-AAQI-01	7	7	7	21	PASS	7522	TCGA-2L-AAQI	PAAD	66	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2011	NA	-24381	Dead	WITH TUMOR	NA	103	Pancreatic Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	103	1	103	NA	NA	1	103	
50	TCGA-2L-AAQJ	0	5	0	6	2	3	0	1	3	67	7	0	4	16	0	0	TCGA-2L-AAQJ-01	113	0.24081858695513614	51	TCGA-2L-AAQJ-01	6	8	67	0.16969687671891634	TCGA-2L-AAQJ-01	9	10	7	26	PASS	7523	TCGA-2L-AAQJ	PAAD	49	FEMALE	WHITE	Stage III	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2010	NA	-18103	Dead	WITH TUMOR	NA	394	Pancreatic Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	394	1	394	NA	NA	1	394	
80	TCGA-2L-AAQL	0	2	0	3	1	2	1	0	3	43	2	0	1	16	1	0	TCGA-2L-AAQL-01	86	0.23500619043009474	35	TCGA-2L-AAQL-01	21	19	72	0.250814591558613	TCGA-2L-AAQL-01	7	5	11	23	PASS	7524	TCGA-2L-AAQL	PAAD	82	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2011	NA	-30092	Dead	WITH TUMOR	NA	292	Pancreatic Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	292	1	292	NA	NA	1	292	
50	TCGA-2L-AAQM	0	3	0	1	3	0	0	0	0	31	1	0	2	8	1	0	TCGA-2L-AAQM-01	82	0.947740977807114	34	TCGA-2L-AAQM-01	38	12	136	0.546084328762684	TCGA-2L-AAQM-01	1	1	1	3	pathology review	7525	TCGA-2L-AAQM	PAAD	52	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma-Other Subtype	G1	2010	NA	-19315	Alive	TUMOR FREE	1383	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1383	0	1383	NA	NA	0	1383	
60	TCGA-3A-A9I5	1	2	0	2	2	1	2	0	3	22	3	0	1	7	0	0	TCGA-3A-A9I5-01	99	0.2758327243401033	45	TCGA-3A-A9I5-01	4	9	64	0.1979435047320772	TCGA-3A-A9I5-01	10	7	8	25	PASS	7526	TCGA-3A-A9I5	PAAD	57	MALE	WHITE	[Discrepancy]	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2009	NA	-21175	Alive	TUMOR FREE	1794	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1794	0	1794	0	1794	0	1794	
50	TCGA-3A-A9I7	0	1	0	1	0	0	0	0	1	13	0	0	0	8	0	0	TCGA-3A-A9I7-01	65	0.0003117943405790311	22	TCGA-3A-A9I7-01	0	0	10	0.0102273427905198	TCGA-3A-A9I7-01	2	3	0	5	PASS	7527	TCGA-3A-A9I7	PAAD	45	MALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2010	NA	-16766	Alive	WITH TUMOR	1323	NA	NA	Locoregional Recurrence	Peritoneal Surfaces	NA	1309	[Unknown]	NA	NA	0	1323	0	1323	NA	NA	1	1309	
70	TCGA-3A-A9I9	0	9	1	6	2	0	0	0	7	83	3	0	2	25	4	0	TCGA-3A-A9I9-01	199	0.2952588693439805	112	TCGA-3A-A9I9-01	5	11	121	0.2279554651601	TCGA-3A-A9I9-01	15	14	14	43	PASS	7528	TCGA-3A-A9I9	PAAD	67	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-24731	Dead	WITH TUMOR	NA	634	Pancreatic Cancer	Locoregional Recurrence	Liver	NA	513	Stable Disease	NA	NA	1	634	1	634	NA	NA	1	513	
70	TCGA-3A-A9IB	0	0	0	2	2	0	2	0	2	27	2	0	2	11	0	0	TCGA-3A-A9IB-01	178	0.3774093003849571	113	TCGA-3A-A9IB-01	10	13	124	0.23330819330350466	TCGA-3A-A9IB-01	12	11	9	32	PASS	7529	TCGA-3A-A9IB	PAAD	69	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2011	NA	-25312	Dead	NA	NA	224	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	224	NA	224	NA	NA	0	224	
60	TCGA-3A-A9IC	0	2	0	2	1	0	0	0	4	29	1	0	1	10	0	0	TCGA-3A-A9IC-01	128	0.3547494462703626	60	TCGA-3A-A9IC-01	12	15	93	0.2940944084056246	TCGA-3A-A9IC-01	13	5	10	28	PASS	7530	TCGA-3A-A9IC	PAAD	61	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-22400	Dead	WITH TUMOR	NA	738	Pancreatic Cancer	NA	NA	NA	NA	Stable Disease	NA	NA	1	738	1	738	NA	NA	1	738	
70	TCGA-3A-A9IH	0	5	0	2	0	2	0	0	1	43	0	0	1	12	1	0	TCGA-3A-A9IH-01	172	0.23224050961266576	118	TCGA-3A-A9IH-01	8	6	70	0.15943178468474145	TCGA-3A-A9IH-01	3	0	8	11	PASS	7531	TCGA-3A-A9IH	PAAD	66	FEMALE	WHITE	Stage IA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-24174	Alive	WITH TUMOR	1021	NA	NA	Distant Metastasis	Lung	NA	763	Stable Disease	NA	NA	0	1021	0	1021	NA	NA	1	763	
70	TCGA-3A-A9IJ	0	1	0	2	0	0	0	0	0	9	1	0	0	6	1	0	TCGA-3A-A9IJ-01	59	2.219068085833698e-05	19	TCGA-3A-A9IJ-01	0	0	10	0.00036880344462210087	TCGA-3A-A9IJ-01	0	0	0	0	pathology review	7532	TCGA-3A-A9IJ	PAAD	65	MALE	WHITE	Stage IB	NA	Pancreas-Adenocarcinoma-Other Subtype	G1	2009	NA	-23791	Alive	TUMOR FREE	1854	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1854	0	1854	0	1854	0	1854	
40	TCGA-3A-A9IL	0	1	0	2	0	0	0	0	1	5	0	0	0	2	0	0	TCGA-3A-A9IL-01	55	0.9365942902658264	17	TCGA-3A-A9IL-01	24	20	37	0.2979843293939385	TCGA-3A-A9IL-01	0	0	1	1	pathology review	7533	TCGA-3A-A9IL	PAAD	39	FEMALE	WHITE	Stage I	NA	Pancreas-Adenocarcinoma-Other Subtype	G1	2007	NA	-14599	Alive	TUMOR FREE	2741	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	2741	0	2741	NA	NA	0	2741	
60	TCGA-3A-A9IN	0	1	0	0	5	0	1	0	2	20	3	0	0	6	2	0	TCGA-3A-A9IN-01	77	0.9477309235654244	25	TCGA-3A-A9IN-01	18	12	121	0.5932584356481123	TCGA-3A-A9IN-01	1	1	1	3	pathology review	7534	TCGA-3A-A9IN	PAAD	62	FEMALE	WHITE	Stage IB	NA	Pancreas-Adenocarcinoma-Other Subtype	G2	2008	NA	-22799	Alive	TUMOR FREE	2084	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2084	0	2084	0	2084	0	2084	
60	TCGA-3A-A9IO	0	1	0	0	2	0	0	0	1	5	0	0	0	4	0	0	TCGA-3A-A9IO-01	61	0.9478164290806104	18	TCGA-3A-A9IO-01	20	33	30	0.17192491173798458	TCGA-3A-A9IO-01	0	0	0	0	pathology review	7535	TCGA-3A-A9IO	PAAD	55	MALE	WHITE	NA	NA	Pancreas-Adenocarcinoma-Other Subtype	G1	2009	NA	-20451	Alive	TUMOR FREE	1942	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1942	0	1942	NA	NA	0	1942	
60	TCGA-3A-A9IR	0	0	0	3	1	0	0	0	0	9	1	0	1	10	0	0	TCGA-3A-A9IR-01	85	0.049398219742569964	33	TCGA-3A-A9IR-01	2	2	47	0.0490797520415644	TCGA-3A-A9IR-01	2	3	3	8	pathology review	7536	TCGA-3A-A9IR	PAAD	64	FEMALE	WHITE	Stage IB	NA	Pancreas-Adenocarcinoma-Other Subtype	G1	2010	NA	-23406	Alive	TUMOR FREE	1542	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1542	0	1542	0	1542	0	1542	
70	TCGA-3A-A9IS	0	4	0	1	5	0	2	0	4	23	1	0	0	8	3	0	TCGA-3A-A9IS-01	111	0.9424927859062096	58	TCGA-3A-A9IS-01	24	26	62	0.22563280360794824	TCGA-3A-A9IS-01	1	0	2	3	pathology review	7537	TCGA-3A-A9IS	PAAD	67	MALE	WHITE	Stage IB	NA	Pancreas-Adenocarcinoma-Other Subtype	G1	2010	NA	-24621	Alive	TUMOR FREE	998	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	998	0	998	0	998	0	998	
70	TCGA-3A-A9IU	0	1	0	0	0	1	0	0	0	27	3	0	0	11	1	0	TCGA-3A-A9IU-01	86	0.18212497452107385	36	TCGA-3A-A9IU-01	9	8	42	0.1450856307468927	TCGA-3A-A9IU-01	7	1	5	13	PASS	7538	TCGA-3A-A9IU	PAAD	65	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2011	NA	-23998	Dead	WITH TUMOR	NA	458	Pancreatic Cancer	Distant Metastasis	Liver	NA	371	[Unknown]	NA	NA	1	458	1	458	NA	NA	1	371	
60	TCGA-3A-A9IV	0	4	0	0	1	0	2	0	2	35	1	0	2	8	2	0	TCGA-3A-A9IV-01	121	0.9480934057958512	57	TCGA-3A-A9IV-01	32	17	122	0.5575528847467854	TCGA-3A-A9IV-01	7	2	2	11	pathology review	7539	TCGA-3A-A9IV	PAAD	59	FEMALE	WHITE	Stage IB	NA	Pancreas-Adenocarcinoma-Other Subtype	G1	2011	NA	-21732	Alive	TUMOR FREE	1103	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1103	0	1103	0	1103	0	1103	
40	TCGA-3A-A9IX	0	0	0	1	1	0	0	0	1	21	0	0	0	0	0	0	TCGA-3A-A9IX-01	78	0.00015792174563870816	30	TCGA-3A-A9IX-01	0	0	13	0.0014162532533561454	TCGA-3A-A9IX-01	1	2	0	3	PASS	7540	TCGA-3A-A9IX	PAAD	40	MALE	WHITE	Stage IA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-14729	Alive	TUMOR FREE	1037	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1037	0	1037	0	1037	0	1037	
50	TCGA-3A-A9IZ	2	4	0	0	3	1	0	0	2	42	3	0	2	16	0	0	TCGA-3A-A9IZ-01	188	0.2827242614524382	107	TCGA-3A-A9IZ-01	6	10	87	0.2053227952243796	TCGA-3A-A9IZ-01	9	13	10	32	PASS	7541	TCGA-3A-A9IZ	PAAD	47	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-17294	Dead	WITH TUMOR	NA	308	Pancreatic Cancer	Locoregional Recurrence	Tumor Bed	NA	109	Progressive Disease	NA	NA	1	308	1	308	NA	NA	1	109	
80	TCGA-3A-A9J0	0	3	0	6	2	2	1	0	2	65	5	0	0	27	1	0	TCGA-3A-A9J0-01	203	0.6513368353243767	116	TCGA-3A-A9J0-01	24	27	125	0.31213369981892936	TCGA-3A-A9J0-01	9	5	8	22	PASS	7542	TCGA-3A-A9J0	PAAD	75	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-27453	Alive	WITH TUMOR	743	NA	NA	Distant Metastasis	Lung	NA	363	Progressive Disease	NA	NA	0	743	0	743	NA	NA	1	363	
70	TCGA-3E-AAAY	1	2	1	1	1	0	0	0	1	16	2	0	0	13	1	0	TCGA-3E-AAAY-01	57	0.00032792357056350024	15	TCGA-3E-AAAY	0	0	0	0	TCGA-3E-AAAY	0	0	0	0	PASS	7543	TCGA-3E-AAAY	PAAD	67	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2008	NA	-24760	Alive	[Discrepancy]	2285	NA	NA	Distant Metastasis	Lung	NA	987	Complete Remission/Response	NA	NA	0	2285	0	2285	1	987	1	987	
70	TCGA-3E-AAAZ	1	4	0	3	0	0	0	0	2	38	6	0	0	11	2	0	TCGA-3E-AAAZ-01	54	0.2532677469980744	13	TCGA-3E-AAAZ-01	9	5	49	0.2389004736325198	TCGA-3E-AAAZ-01	2	1	2	5	PASS	7544	TCGA-3E-AAAZ	PAAD	71	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2008	NA	-26234	Dead	WITH TUMOR	NA	2182	"Other, specify"	New Primary Tumor	Lung	NA	1600	[Unknown]	NA	NA	1	2182	0	2182	NA	NA	1	1600	
60	TCGA-F2-6879	0	0	0	0	2	0	1	0	1	27	2	0	0	14	1	0	TCGA-F2-6879-01	202	0.2789509261693224	115	TCGA-F2-6879-01	9	8	36	0.17303129187285698	TCGA-F2-6879-01	8	3	7	18	PASS	7545	TCGA-F2-6879	PAAD	57	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma-Other Subtype	G2	2009	NA	-20984	Dead	WITH TUMOR	NA	334	NA	Distant Metastasis	NA	NA	183	Complete Remission/Response	NA	NA	1	334	1	334	1	183	1	183	
70	TCGA-F2-6880	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-F2-6880-01	49	2.2189170377438395e-05	16	TCGA-F2-6880-01	0	0	19	1.4327670418104626e-05	TCGA-F2-6880-01	0	0	0	0	PASS	7546	TCGA-F2-6880	PAAD	70	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2009	NA	-25809	Alive	TUMOR FREE	295	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	295	0	295	0	295	0	295	
50	TCGA-F2-7273	0	0	2	0	0	0	0	0	1	2	0	0	0	0	0	0	TCGA-F2-7273-01	65	3.149173980548574e-05	18	TCGA-F2-7273-01	0	0	0	0.0	TCGA-F2-7273-01	0	0	0	0	pathology review	7547	TCGA-F2-7273	PAAD	54	MALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2011	NA	-20071	Dead	WITH TUMOR	NA	592	Pancreatic Cancer	Distant Metastasis	Liver	NA	256	Progressive Disease	NA	NA	1	592	1	592	NA	NA	1	256	
60	TCGA-F2-7276	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-F2-7276-01	85	0.0001409628485010604	36	TCGA-F2-7276-01	0	0	2	3.699704955074637e-05	TCGA-F2-7276-01	0	0	0	0	PASS	7548	TCGA-F2-7276	PAAD	64	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2011	NA	-23713	Dead	WITH TUMOR	NA	216	Pancreatic Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	216	1	216	NA	NA	1	216	
80	TCGA-F2-A44G	0	3	0	2	1	0	0	0	3	29	6	0	0	11	1	0	TCGA-F2-A44G-01	136	0.0856124567260864	83	TCGA-F2-A44G-01	4	3	56	0.08854742353564403	TCGA-F2-A44G-01	4	2	2	8	PASS	7549	TCGA-F2-A44G	PAAD	79	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-29150	Dead	WITH TUMOR	NA	233	Pancreatic Cancer	Locoregional Recurrence	"Other, specify"	malignant ascites	214	Complete Remission/Response	NA	NA	1	233	1	233	1	214	1	214	
70	TCGA-F2-A44H	0	1	0	1	0	1	0	0	1	13	1	0	0	8	1	0	TCGA-F2-A44H-01	55	0.15580420413027116	15	TCGA-F2-A44H-01	10	7	27	0.23435772863141197	TCGA-F2-A44H-01	1	1	4	6	PASS	7550	TCGA-F2-A44H	PAAD	65	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-24007	Alive	TUMOR FREE	586	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	586	0	586	0	586	0	586	
80	TCGA-F2-A7TX	0	2	0	3	0	2	0	0	1	35	2	0	1	11	2	0	TCGA-F2-A7TX-01	79	0.18429146263030904	32	TCGA-F2-A7TX-01	9	16	109	0.35833643217632866	TCGA-F2-A7TX-01	12	11	6	29	PASS	7551	TCGA-F2-A7TX	PAAD	77	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2013	NA	-28239	Dead	WITH TUMOR	NA	95	Pancreatic Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	95	1	95	NA	NA	1	95	
80	TCGA-F2-A8YN	0	5	2	3	2	1	1	0	2	41	6	0	0	17	0	0	TCGA-F2-A8YN-01	130	0.6274787985658415	72	TCGA-F2-A8YN-01	8	8	97	0.2143971613953731	TCGA-F2-A8YN-01	9	3	11	23	PASS	7552	TCGA-F2-A8YN	PAAD	76	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-28047	Alive	WITH TUMOR	517	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	517	0	517	NA	NA	0	517	
70	TCGA-FB-A4P5	0	0	0	0	0	0	0	0	1	7	1	0	1	1	0	0	TCGA-FB-A4P5-01	59	4.700650899988518e-05	19	TCGA-FB-A4P5-01	0	0	8	0.00045599766036466397	TCGA-FB-A4P5-01	0	0	0	0	PASS	7553	TCGA-FB-A4P5	PAAD	69	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-25412	Dead	WITH TUMOR	NA	179	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	179	1	179	NA	NA	1	179	
50	TCGA-FB-A4P6	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	TCGA-FB-A4P6	0	0	0	TCGA-FB-A4P6	0	0	0	0	TCGA-FB-A4P6	0	0	0	0	PASS	7554	TCGA-FB-A4P6	PAAD	54	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2012	NA	-19904	Alive	TUMOR FREE	767	NA	NA	Locoregional Recurrence	NA	NA	620	Complete Remission/Response	NA	NA	0	767	0	767	1	620	1	620	
70	TCGA-FB-A545	0	5	0	1	0	2	1	0	1	33	1	0	0	3	0	0	TCGA-FB-A545-01	109	0.6135276138124862	52	TCGA-FB-A545-01	25	16	64	0.2737323035977099	TCGA-FB-A545-01	8	3	8	19	PASS	7555	TCGA-FB-A545	PAAD	72	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-26635	Dead	TUMOR FREE	NA	732	Pancreatic Cancer	Distant Metastasis	Liver	NA	378	Complete Remission/Response	NA	NA	1	732	1	732	1	378	1	378	
70	TCGA-FB-A5VM	0	5	0	2	1	0	1	1	1	37	1	0	1	21	1	0	TCGA-FB-A5VM-01	66	0.22072887159257973	24	TCGA-FB-A5VM-01	8	11	44	0.26261381728923605	TCGA-FB-A5VM-01	6	6	5	17	PASS	7556	TCGA-FB-A5VM	PAAD	74	MALE	WHITE	Stage IB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2012	NA	-27362	Dead	WITH TUMOR	NA	498	Pancreatic Cancer	Distant Metastasis	Liver	NA	177	Progressive Disease	NA	NA	1	498	1	498	NA	NA	1	177	
70	TCGA-FB-A78T	0	2	0	2	1	1	1	0	3	32	4	0	1	13	0	0	TCGA-FB-A78T-01	130	0.24024545796853775	71	TCGA-FB-A78T-01	8	9	69	0.10698173874927742	TCGA-FB-A78T-01	4	2	6	12	PASS	7557	TCGA-FB-A78T	PAAD	71	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-26179	Dead	NA	NA	375	Pancreatic Cancer	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	375	1	375	0	375	0	375	
50	TCGA-FB-A7DR	2	5	0	2	3	1	0	0	2	26	2	0	1	13	1	0	TCGA-FB-A7DR-01	60	0.011766965995626226	19	TCGA-FB-A7DR-01	15	15	105	0.525065356991849	TCGA-FB-A7DR-01	9	9	17	35	pathology review	7558	TCGA-FB-A7DR	PAAD	48	MALE	ASIAN	Stage IIA	NA	Pancreas-Colloid (mucinous non-cystic) Carcinoma	G2	2012	NA	-17649	Dead	TUMOR FREE	NA	353	Pancreatic Cancer	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	353	1	353	0	353	0	353	
70	TCGA-FB-AAPP	1	3	0	2	1	3	1	0	2	98	6	0	5	35	1	0	TCGA-FB-AAPP-01	120	0.7790732644114511	58	TCGA-FB-AAPP-01	19	15	33	0.05414289930036677	TCGA-FB-AAPP-01	4	4	3	11	pathology review	7559	TCGA-FB-AAPP	PAAD	71	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2009	NA	-26239	Dead	WITH TUMOR	NA	485	Pancreatic Cancer	Distant Metastasis	Lung	NA	150	Progressive Disease	NA	NA	1	485	1	485	NA	NA	1	150	
70	TCGA-FB-AAPQ	0	3	1	3	2	0	0	0	2	32	3	0	2	11	0	0	TCGA-FB-AAPQ-01	101	0.20499398828816412	42	TCGA-FB-AAPQ-01	5	7	68	0.17014110956169	TCGA-FB-AAPQ-01	10	10	9	29	PASS	7560	TCGA-FB-AAPQ	PAAD	65	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2008	NA	-24078	Dead	NA	NA	1130	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	1130	NA	1130	NA	NA	0	1130	
60	TCGA-FB-AAPS	0	2	0	1	0	0	0	0	1	29	1	0	0	6	0	0	TCGA-FB-AAPS-01	65	5.022172446974322e-05	19	TCGA-FB-AAPS-01	0	0	6	0.001117149049348842	TCGA-FB-AAPS-01	0	0	0	0	PASS	7561	TCGA-FB-AAPS	PAAD	62	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2008	NA	-22981	Alive	NA	228	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	228	0	228	NA	NA	0	228	
40	TCGA-FB-AAPU	0	3	0	3	4	1	1	0	3	68	1	0	2	20	3	0	TCGA-FB-AAPU-01	112	0.29768571682455397	52	TCGA-FB-AAPU-01	4	5	54	0.18972079429782995	TCGA-FB-AAPU-01	15	15	8	38	PASS	7562	TCGA-FB-AAPU	PAAD	41	FEMALE	ASIAN	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2008	NA	-15129	Dead	WITH TUMOR	NA	381	Pancreatic Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	381	1	381	NA	NA	1	381	
70	TCGA-FB-AAPY	0	0	0	1	1	1	0	0	0	28	1	0	0	8	0	0	TCGA-FB-AAPY-01	78	0.11467659137507155	29	TCGA-FB-AAPY-01	4	5	24	0.12101107676249682	TCGA-FB-AAPY-01	3	1	4	8	PASS	7563	TCGA-FB-AAPY	PAAD	71	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2007	NA	-26085	Dead	TUMOR FREE	NA	1059	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1059	0	1059	0	1059	0	1059	
50	TCGA-FB-AAPZ	0	2	0	1	1	1	0	0	0	27	3	0	0	10	2	0	TCGA-FB-AAPZ-01	234	0.7493391334331583	134	TCGA-FB-AAPZ-01	21	19	147	0.27694984533569234	TCGA-FB-AAPZ-01	13	5	11	29	PASS	7564	TCGA-FB-AAPZ	PAAD	54	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2008	NA	-19847	Alive	TUMOR FREE	716	NA	NA	Distant Metastasis	"Other, specify"	Adrenal and right buttock	716	Complete Remission/Response	NA	NA	0	716	0	716	1	716	1	716	
70	TCGA-FB-AAQ0	0	3	0	1	1	0	0	0	1	41	1	0	0	15	0	0	TCGA-FB-AAQ0-01	195	0.6248272578315909	113	TCGA-FB-AAQ0-01	6	6	76	0.15705871030590207	TCGA-FB-AAQ0-01	5	4	4	13	PASS	7565	TCGA-FB-AAQ0	PAAD	68	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2011	NA	-24988	Dead	TUMOR FREE	NA	473	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	473	0	473	0	473	0	473	
50	TCGA-FB-AAQ1	0	0	0	1	0	2	0	1	0	26	2	0	0	21	0	0	TCGA-FB-AAQ1-01	85	0.5466756386741434	25	TCGA-FB-AAQ1-01	26	19	68	0.2405465746593673	TCGA-FB-AAQ1-01	7	6	12	25	PASS	7566	TCGA-FB-AAQ1	PAAD	49	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-18172	Dead	WITH TUMOR	NA	123	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	123	1	123	NA	NA	1	123	
80	TCGA-FB-AAQ2	0	3	0	0	2	0	1	0	0	31	1	0	1	10	0	0	TCGA-FB-AAQ2-01	118	0.2780482758545266	58	TCGA-FB-AAQ2-01	16	15	54	0.15529230008969785	TCGA-FB-AAQ2-01	9	7	9	25	PASS	7567	TCGA-FB-AAQ2	PAAD	81	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2011	NA	-29585	Dead	WITH TUMOR	NA	153	NA	Distant Metastasis	Liver	NA	92	Partial Remission/Response	NA	NA	1	153	1	153	NA	NA	1	92	
70	TCGA-FB-AAQ3	0	3	0	1	1	2	0	0	1	26	3	0	0	11	0	0	TCGA-FB-AAQ3-01	106	0.14038085875774725	45	TCGA-FB-AAQ3-01	4	9	58	0.17904770851451576	TCGA-FB-AAQ3-01	6	6	9	21	PASS	7568	TCGA-FB-AAQ3	PAAD	65	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2010	NA	-23953	Dead	TUMOR FREE	NA	31	Surgical Complications	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	31	0	31	0	31	0	31	
90	TCGA-FB-AAQ6	1	3	0	2	1	2	0	1	5	46	5	0	2	19	1	0	TCGA-FB-AAQ6-01	104	0.29934440633023074	46	TCGA-FB-AAQ6-01	7	6	58	0.18606051959666284	TCGA-FB-AAQ6-01	11	4	8	23	PASS	7569	TCGA-FB-AAQ6	PAAD	85	MALE	WHITE	Stage IA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-31319	Dead	WITH TUMOR	NA	244	Pancreatic Cancer	Locoregional Recurrence	Peritoneal Surfaces	NA	213	Progressive Disease	NA	NA	1	244	1	244	NA	NA	1	213	
60	TCGA-FZ-5919	0	2	1	2	0	1	1	0	1	33	2	0	0	14	0	0	TCGA-FZ-5919-01	64	0.12273779104261814	16	TCGA-FZ-5919-01	8	5	9	0.18107207597932434	TCGA-FZ-5919-01	3	1	4	8	PASS	7570	TCGA-FZ-5919	PAAD	59	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2007	NA	-21611	Dead	WITH TUMOR	NA	741	Pancreatic Cancer	Distant Metastasis	Liver	NA	55	Progressive Disease	NA	NA	1	741	1	741	NA	NA	1	55	
50	TCGA-FZ-5920	1	1	0	2	4	1	0	1	1	43	3	0	0	14	0	0	TCGA-FZ-5920-01	156	0.4368981781948042	91	TCGA-FZ-5920-01	19	34	21	0.25601894722181856	TCGA-FZ-5920-01	8	3	5	16	PASS	7571	TCGA-FZ-5920	PAAD	52	MALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2007	NA	-19287	Dead	NA	NA	61	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	61	NA	61	NA	NA	0	61	
90	TCGA-FZ-5921	1	5	0	1	0	1	1	0	0	60	6	0	0	24	2	0	TCGA-FZ-5921-01	71	0.2326717385012741	24	TCGA-FZ-5921-01	13	14	14	0.26371078409551185	TCGA-FZ-5921-01	3	3	2	8	PASS	7572	TCGA-FZ-5921	PAAD	85	FEMALE	[Unknown]	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	GX	2007	NA	-31074	Dead	WITH TUMOR	NA	155	NA	Locoregional Recurrence	Peritoneal Surfaces	NA	103	Progressive Disease	NA	NA	1	155	1	155	NA	NA	1	103	
80	TCGA-FZ-5922	0	4	1	2	2	1	0	0	1	29	3	0	0	8	1	0	TCGA-FZ-5922-01	92	0.11770583631686728	37	TCGA-FZ-5922-01	3	3	14	0.12150379207991185	TCGA-FZ-5922-01	3	2	3	8	PASS	7573	TCGA-FZ-5922	PAAD	81	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2007	NA	-29633	Dead	WITH TUMOR	NA	1101	Pancreatic Cancer	Distant Metastasis	Peritoneal Surfaces	NA	740	Progressive Disease	NA	NA	1	1101	1	1101	NA	NA	1	740	
70	TCGA-FZ-5923	0	6	1	0	0	1	1	0	1	58	5	0	1	19	1	0	TCGA-FZ-5923-01	58	0.16979760630790308	20	TCGA-FZ-5923-01	3	4	6	0.05383322468717272	TCGA-FZ-5923-01	3	2	3	8	PASS	7574	TCGA-FZ-5923	PAAD	71	MALE	WHITE	Stage IV	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2008	NA	-26216	Dead	WITH TUMOR	NA	619	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	619	1	619	NA	NA	1	619	
80	TCGA-FZ-5924	0	4	0	2	1	2	0	0	3	24	2	0	1	14	1	0	TCGA-FZ-5924-01	147	0.8853440337323878	82	TCGA-FZ-5924-01	33	14	24	0.3032191108990777	TCGA-FZ-5924-01	9	5	9	23	PASS	7575	TCGA-FZ-5924	PAAD	83	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2008	NA	-30571	Dead	WITH TUMOR	NA	480	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	480	1	480	NA	NA	1	480	
70	TCGA-FZ-5926	0	2	2	0	0	0	0	0	3	29	5	0	0	14	1	0	TCGA-FZ-5926-01	67	0.058859523909369764	23	TCGA-FZ-5926-01	16	23	4	0.08615328793149077	TCGA-FZ-5926-01	4	1	1	6	PASS	7576	TCGA-FZ-5926	PAAD	73	FEMALE	WHITE	Stage III	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2001	NA	-26881	Dead	WITH TUMOR	NA	541	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	541	1	541	NA	NA	1	541	
60	TCGA-H6-8124	0	2	0	6	2	2	6	0	2	56	2	0	0	16	4	0	TCGA-H6-8124-01	142	0.8639158113547983	71	TCGA-H6-8124-01	11	9	81	0.2683981437427389	TCGA-H6-8124-01	4	2	6	12	PASS	7577	TCGA-H6-8124	PAAD	56	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2011	NA	-20741	Alive	WITH TUMOR	392	NA	NA	Distant Metastasis	Liver	NA	259	Complete Remission/Response	NA	NA	0	392	0	392	1	259	1	259	
90	TCGA-H6-A45N	0	0	0	4	2	0	0	0	0	42	0	0	0	9	0	0	TCGA-H6-A45N-01	48	0.059390373030730616	10	TCGA-H6-A45N-01	0	0	9	0.0028356884628355197	TCGA-H6-A45N-01	1	0	0	1	PASS	7578	TCGA-H6-A45N	PAAD	88	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma-Other Subtype	G3	2012	NA	-32475	Dead	WITH TUMOR	NA	421	Pancreatic Cancer	Locoregional Recurrence	Tumor Bed	NA	363	Progressive Disease	NA	NA	1	421	1	421	NA	NA	1	363	
50	TCGA-H8-A6C1	0	0	0	1	1	1	0	0	0	18	2	0	1	8	0	0	TCGA-H8-A6C1-01	176	0.2186326775322281	108	TCGA-H8-A6C1-01	6	4	85	0.15212728129645153	TCGA-H8-A6C1-01	9	7	10	26	pathology review	7579	TCGA-H8-A6C1	PAAD	53	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma-Other Subtype	G2	2012	NA	-19677	Alive	WITH TUMOR	671	NA	NA	Distant Metastasis	Liver	NA	455	[Discrepancy]	NA	NA	0	671	0	671	NA	NA	1	455	
50	TCGA-HV-A5A3	2	1	0	0	2	0	0	0	2	50	8	0	4	20	0	0	TCGA-HV-A5A3-01	117	0.3206834900798136	48	TCGA-HV-A5A3-01	11	13	57	0.19412686320651493	TCGA-HV-A5A3-01	15	14	11	40	PASS	7580	TCGA-HV-A5A3	PAAD	50	MALE	ASIAN	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-18475	Dead	TUMOR FREE	NA	128	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	128	0	128	0	128	0	128	
70	TCGA-HV-A5A4	0	1	0	3	2	1	1	0	0	31	2	0	0	9	0	0	TCGA-HV-A5A4-01	68	0.0985934132241177	29	TCGA-HV-A5A4-01	3	3	26	0.06305847974090277	TCGA-HV-A5A4-01	4	5	4	13	PASS	7581	TCGA-HV-A5A4	PAAD	72	FEMALE	ASIAN	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-26311	Alive	NA	232	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	232	0	232	0	232	0	232	
60	TCGA-HV-A5A5	0	1	0	0	0	0	0	0	1	18	0	0	0	8	0	0	TCGA-HV-A5A5-01	80	0.060728945056554386	28	TCGA-HV-A5A5	0	0	0	0	TCGA-HV-A5A5	0	0	0	0	PASS	7582	TCGA-HV-A5A5	PAAD	61	FEMALE	ASIAN	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-22329	Alive	NA	289	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	289	0	289	0	289	0	289	
70	TCGA-HV-A5A6	0	2	0	2	1	1	2	0	1	32	2	0	3	15	2	0	TCGA-HV-A5A6-01	113	0.5356645813891819	54	TCGA-HV-A5A6-01	17	17	48	0.14717456280612334	TCGA-HV-A5A6-01	12	3	6	21	PASS	7583	TCGA-HV-A5A6	PAAD	65	FEMALE	ASIAN	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2001	NA	-24025	Dead	WITH TUMOR	NA	2036	Other malignancy	Distant Metastasis	Lung	NA	1511	Complete Remission/Response	NA	NA	1	2036	0	2036	1	1511	1	1511	
70	TCGA-HV-A7OL	2	2	1	1	2	1	0	0	0	43	2	0	0	11	2	0	TCGA-HV-A7OL-01	92	0.11533597511258292	38	TCGA-HV-A7OL-01	7	6	45	0.12209777387475584	TCGA-HV-A7OL-01	5	1	4	10	PASS	7584	TCGA-HV-A7OL	PAAD	70	MALE	ASIAN	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-25768	Alive	NA	252	NA	NA	Distant Metastasis	Non-regional / Distant Lymph Nodes	NA	123	Stable Disease	NA	NA	0	252	0	252	NA	NA	1	123	
70	TCGA-HV-A7OP	0	3	1	4	4	2	0	2	3	63	2	1	0	34	1	0	TCGA-HV-A7OP-01	121	0.9207991364154768	61	TCGA-HV-A7OP-01	18	14	70	0.2703948118926349	TCGA-HV-A7OP-01	8	4	8	20	pathology review	7585	TCGA-HV-A7OP	PAAD	72	MALE	ASIAN	Stage IIB	NA	Pancreas-Adenocarcinoma-Other Subtype	GX	2012	NA	-26322	Alive	NA	978	NA	NA	Distant Metastasis	Liver	NA	342	[Discrepancy]	NA	NA	0	978	0	978	NA	NA	1	342	
50	TCGA-HV-AA8V	0	2	0	0	0	0	1	0	0	28	0	0	0	12	1	0	TCGA-HV-AA8V-01	107	0.007458376033995857	56	TCGA-HV-AA8V	0	0	0	0	TCGA-HV-AA8V	0	0	0	0	PASS	7586	TCGA-HV-AA8V	PAAD	50	MALE	ASIAN	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2012	NA	-18357	Alive	NA	920	NA	NA	Distant Metastasis	"Other, specify"	bone	526	[Discrepancy]	NA	NA	0	920	0	920	NA	NA	1	526	
80	TCGA-HV-AA8X	0	3	0	3	2	2	1	0	3	37	2	0	1	16	2	0	TCGA-HV-AA8X-01	124	0.23148588930882305	65	TCGA-HV-AA8X-01	6	8	57	0.16218661019445205	TCGA-HV-AA8X-01	11	6	7	24	PASS	7587	TCGA-HV-AA8X	PAAD	75	FEMALE	ASIAN	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-27662	Dead	WITH TUMOR	NA	532	NA	Distant Metastasis	"Other, specify"	Omentum	375	[Discrepancy]	NA	NA	1	532	1	532	NA	NA	1	375	
80	TCGA-HZ-7289	0	6	0	1	2	0	0	0	5	57	6	0	1	23	2	0	TCGA-HZ-7289-01	132	0.6443768574649678	62	TCGA-HZ-7289-01	20	20	12	0.08171147238966102	TCGA-HZ-7289-01	12	7	5	24	pathology review	7588	TCGA-HZ-7289	PAAD	77	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma-Other Subtype	G1	2010	NA	-28174	Dead	WITH TUMOR	NA	661	Pancreatic Cancer	Distant Metastasis	Liver	NA	228	[Unknown]	NA	NA	1	661	1	661	NA	NA	1	228	
70	TCGA-HZ-7918	1	13	1	6	7	0	0	0	0	100	3	0	3	33	5	0	TCGA-HZ-7918-01	148	0.4178139041379457	76	TCGA-HZ-7918-01	6	15	47	0.3319458873170953	TCGA-HZ-7918-01	18	21	11	50	pathology review	7589	TCGA-HZ-7918	PAAD	72	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2011	NA	-26573	Alive	WITH TUMOR	969	NA	NA	Distant Metastasis	Liver	NA	542	Complete Remission/Response	NA	NA	0	969	0	969	1	542	1	542	
50	TCGA-HZ-7919	0	4	1	4	0	0	0	0	0	44	3	0	1	17	1	0	TCGA-HZ-7919-01	99	0.15207778138372038	44	TCGA-HZ-7919-01	7	12	38	0.29627512799390043	TCGA-HZ-7919-01	7	4	9	20	PASS	7590	TCGA-HZ-7919	PAAD	52	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-19064	Dead	WITH TUMOR	NA	593	Pancreatic Cancer	NA	NA	NA	NA	[Unknown]	NA	NA	1	593	1	593	NA	NA	1	593	
70	TCGA-HZ-7920	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	TCGA-HZ-7920-01	59	6.610202258965206e-05	20	TCGA-HZ-7920-01	0	0	0	0.0	TCGA-HZ-7920-01	0	0	0	0	pathology review	7591	TCGA-HZ-7920	PAAD	71	MALE	WHITE	Stage IB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-26167	Dead	TUMOR FREE	NA	236	"Other, non-malignant disease"	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	236	0	236	0	236	0	236	
60	TCGA-HZ-7922	0	0	0	0	2	1	0	0	1	36	2	0	0	10	1	0	TCGA-HZ-7922-01	126	0.6220125963920404	64	TCGA-HZ-7922-01	25	19	41	0.37903874604559296	TCGA-HZ-7922-01	11	4	12	27	PASS	7592	TCGA-HZ-7922	PAAD	61	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2011	NA	-22413	Alive	NA	4	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4	0	4	NA	NA	0	4	
70	TCGA-HZ-7923	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-HZ-7923-01	39	6.087889119162589e-06	5	TCGA-HZ-7923	0	0	0	0	TCGA-HZ-7923	0	0	0	0	PASS	7593	TCGA-HZ-7923	PAAD	65	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-23760	Alive	TUMOR FREE	314	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	314	0	314	0	314	0	314	
60	TCGA-HZ-7924	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	TCGA-HZ-7924-01	35	0.00015090603333250182	3	TCGA-HZ-7924-01	0	0	0	0.0	TCGA-HZ-7924-01	0	0	0	0	pathology review	7594	TCGA-HZ-7924	PAAD	60	FEMALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-22090	Alive	WITH TUMOR	840	NA	NA	Distant Metastasis	NA	Liver	831	Complete Remission/Response	NA	NA	0	840	0	840	1	831	1	831	
70	TCGA-HZ-7925	0	2	2	0	0	1	0	1	0	16	2	0	0	10	1	0	TCGA-HZ-7925-01	62	0.1478676708857313	18	TCGA-HZ-7925-01	9	9	12	0.2920398536863884	TCGA-HZ-7925-01	5	5	5	15	PASS	7595	TCGA-HZ-7925	PAAD	66	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-24150	Dead	WITH TUMOR	NA	614	Pancreatic Cancer	Locoregional Recurrence	"Other, specify"	Regional LNs	364	Complete Remission/Response	NA	NA	1	614	1	614	1	364	1	364	
60	TCGA-HZ-7926	0	3	0	2	0	3	0	0	1	25	6	0	0	15	0	0	TCGA-HZ-7926-01	51	4.360626103128368e-05	14	TCGA-HZ-7926	0	0	0	0	TCGA-HZ-7926	0	0	0	0	PASS	7596	TCGA-HZ-7926	PAAD	57	MALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2011	NA	-21024	Dead	WITH TUMOR	NA	518	Pancreatic Cancer	Distant Metastasis	Lung	NA	340	Progressive Disease	NA	NA	1	518	1	518	NA	NA	1	340	
70	TCGA-HZ-8001	0	1	0	1	1	1	0	0	1	37	3	0	0	14	1	0	TCGA-HZ-8001-01	66	0.06507769332922161	18	TCGA-HZ-8001	0	0	0	0	TCGA-HZ-8001	0	0	0	0	PASS	7597	TCGA-HZ-8001	PAAD	69	MALE	WHITE	Stage III	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-25227	Alive	TUMOR FREE	706	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	706	0	706	0	706	0	706	
60	TCGA-HZ-8002	0	1	1	0	0	0	0	0	0	12	1	0	0	6	0	0	TCGA-HZ-8002-01	49	5.7769792271174144e-05	10	TCGA-HZ-8002-01	0	0	2	4.721725812579315e-05	TCGA-HZ-8002-01	0	0	0	0	PASS	7598	TCGA-HZ-8002	PAAD	61	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-22433	Dead	WITH TUMOR	NA	366	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	366	1	366	NA	NA	1	366	
70	TCGA-HZ-8003	0	1	0	1	0	0	0	0	1	9	0	0	0	8	1	0	TCGA-HZ-8003-01	78	0.0014015139511587196	29	TCGA-HZ-8003	0	0	0	0	TCGA-HZ-8003	0	0	0	0	PASS	7599	TCGA-HZ-8003	PAAD	65	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-23868	Dead	WITH TUMOR	NA	596	Pancreatic Cancer	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	596	1	596	NA	NA	1	596	
80	TCGA-HZ-8005	0	3	1	1	4	0	0	0	4	45	3	1	0	18	3	0	TCGA-HZ-8005-01	163	0.5770350653658283	101	TCGA-HZ-8005-01	22	25	37	0.11444507996997492	TCGA-HZ-8005-01	9	10	5	24	PASS	7600	TCGA-HZ-8005	PAAD	81	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2012	NA	-29674	Dead	WITH TUMOR	NA	120	Pancreatic Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	120	1	120	NA	NA	1	120	
50	TCGA-HZ-8315	1	4	0	0	2	0	1	0	3	45	3	0	2	21	2	0	TCGA-HZ-8315-01	56	0.09489616861577922	19	TCGA-HZ-8315-01	5	4	31	0.11075865162484487	TCGA-HZ-8315-01	2	1	2	5	PASS	7601	TCGA-HZ-8315	PAAD	54	FEMALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-19839	Dead	WITH TUMOR	NA	299	Pancreatic Cancer	NA	NA	NA	NA	[Unknown]	NA	NA	1	299	1	299	NA	NA	1	299	
70	TCGA-HZ-8317	0	1	0	0	0	0	0	0	0	8	0	0	1	4	0	0	TCGA-HZ-8317-01	51	1.5732367637323333e-05	9	TCGA-HZ-8317-01	0	0	6	0.00028752496262412407	TCGA-HZ-8317-01	0	0	0	0	PASS	7602	TCGA-HZ-8317	PAAD	69	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2012	NA	-25214	Dead	WITH TUMOR	NA	378	Pancreatic Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	378	1	378	NA	NA	1	378	
70	TCGA-HZ-8519	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-HZ-8519-01	63	0.003307360820811823	19	TCGA-HZ-8519-01	0	0	4	0.000995870428292732	TCGA-HZ-8519-01	0	0	0	0	PASS	7603	TCGA-HZ-8519	PAAD	73	MALE	WHITE	Stage IA	NA	Pancreas-Adenocarcinoma-Other Subtype	G3	2012	NA	-26947	Alive	TUMOR FREE	454	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	454	0	454	0	454	0	454	
60	TCGA-HZ-8636	0	5	0	1	1	0	0	2	3	44	1	0	0	10	0	0	TCGA-HZ-8636-01	110	0.4881953166297127	55	TCGA-HZ-8636-01	10	10	83	0.2601526260577561	TCGA-HZ-8636-01	10	10	11	31	PASS	7604	TCGA-HZ-8636	PAAD	58	FEMALE	WHITE	Stage IV	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2012	NA	-21501	Dead	WITH TUMOR	NA	545	Pancreatic Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	545	1	545	NA	NA	1	545	
80	TCGA-HZ-8637	0	6	1	3	0	0	0	0	1	27	0	0	0	10	0	0	TCGA-HZ-8637-01	78	0.239130309400588	33	TCGA-HZ-8637-01	8	7	50	0.2054379276198416	TCGA-HZ-8637-01	9	12	5	26	PASS	7605	TCGA-HZ-8637	PAAD	76	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2012	NA	-27929	Dead	TUMOR FREE	NA	517	"Other, non-malignant disease"	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	517	0	517	0	517	0	517	
80	TCGA-HZ-8638	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	TCGA-HZ-8638-01	31	8.536908519342549e-06	3	TCGA-HZ-8638-01	0	0	6	0.0011110110305653606	TCGA-HZ-8638-01	0	0	0	0	pathology review	7606	TCGA-HZ-8638	PAAD	84	FEMALE	WHITE	Stage IA	NA	Pancreas-Colloid (mucinous non-cystic) Carcinoma	GX	2012	NA	-30821	Dead	TUMOR FREE	NA	151	Surgical Complications	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	151	0	151	0	151	0	151	
60	TCGA-HZ-A49G	0	5	0	0	1	0	0	0	0	32	1	0	0	8	1	0	TCGA-HZ-A49G-01	58	0.0548472667079353	18	TCGA-HZ-A49G-01	0	0	9	0.000623547458454466	TCGA-HZ-A49G-01	0	0	0	0	PASS	7607	TCGA-HZ-A49G	PAAD	58	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-21491	Alive	WITH TUMOR	660	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	660	0	660	NA	NA	0	660	
70	TCGA-HZ-A49H	0	0	0	1	1	0	0	0	0	7	0	0	1	2	0	0	TCGA-HZ-A49H-01	43	1.611188584031533e-05	6	TCGA-HZ-A49H-01	0	0	6	0.00011091306067383389	TCGA-HZ-A49H-01	0	0	0	0	PASS	7608	TCGA-HZ-A49H	PAAD	68	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-24891	Alive	TUMOR FREE	491	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	491	0	491	0	491	0	491	
80	TCGA-HZ-A49I	0	2	1	4	2	0	1	0	1	36	1	0	1	13	3	0	TCGA-HZ-A49I-01	98	0.0926238654662879	39	TCGA-HZ-A49I-01	5	6	57	0.15923455711747833	TCGA-HZ-A49I-01	9	3	11	23	PASS	7609	TCGA-HZ-A49I	PAAD	77	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-28454	Dead	WITH TUMOR	NA	308	Pancreatic Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	308	1	308	NA	NA	1	308	
80	TCGA-HZ-A4BH	1	3	0	2	1	0	0	0	0	54	2	0	1	19	0	0	TCGA-HZ-A4BH-01	148	0.23211015137365804	90	TCGA-HZ-A4BH-01	7	12	98	0.2528426103512513	TCGA-HZ-A4BH-01	14	5	7	26	PASS	7610	TCGA-HZ-A4BH	PAAD	75	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2011	NA	-27637	Alive	WITH TUMOR	194	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	194	0	194	NA	NA	0	194	
70	TCGA-HZ-A4BK	0	3	0	1	2	0	0	0	1	47	1	0	0	13	1	0	TCGA-HZ-A4BK-01	103	0.34179109978177463	46	TCGA-HZ-A4BK-01	23	21	29	0.08226170183535668	TCGA-HZ-A4BK-01	12	7	6	25	PASS	7611	TCGA-HZ-A4BK	PAAD	72	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma-Other Subtype	G3	2012	NA	-26503	Alive	WITH TUMOR	657	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	657	0	657	NA	NA	0	657	
80	TCGA-HZ-A77O	0	1	0	2	0	0	0	0	3	21	1	0	0	6	0	0	TCGA-HZ-A77O-01	86	0.6477131939993707	38	TCGA-HZ-A77O-01	32	16	78	0.3987175046436182	TCGA-HZ-A77O-01	7	4	15	26	PASS	7612	TCGA-HZ-A77O	PAAD	77	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-28434	Dead	WITH TUMOR	NA	160	Pancreatic Cancer	Locoregional Recurrence	Peritoneal Surfaces	NA	98	Complete Remission/Response	NA	NA	1	160	1	160	1	98	1	98	
80	TCGA-HZ-A77P	0	5	0	2	1	1	0	0	3	35	2	0	1	11	1	0	TCGA-HZ-A77P-01	61	0.14288966578488266	17	TCGA-HZ-A77P-01	4	9	35	0.12323201355502852	TCGA-HZ-A77P-01	8	7	2	17	PASS	7613	TCGA-HZ-A77P	PAAD	77	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma-Other Subtype	G1	2013	NA	-28403	Alive	TUMOR FREE	330	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	330	0	330	0	330	0	330	
60	TCGA-HZ-A77Q	0	3	0	2	3	1	1	0	1	37	1	0	2	13	4	0	TCGA-HZ-A77Q-01	47	0.08911018687670892	9	TCGA-HZ-A77Q-01	4	6	48	0.12454813004326812	TCGA-HZ-A77Q-01	5	2	6	13	PASS	7614	TCGA-HZ-A77Q	PAAD	55	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma-Other Subtype	G2	2013	NA	-20366	Alive	TUMOR FREE	33	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	33	0	33	NA	NA	0	33	
80	TCGA-HZ-A8P0	0	2	0	1	3	1	0	0	2	22	1	0	1	21	0	0	TCGA-HZ-A8P0-01	77	0.14029024572122592	29	TCGA-HZ-A8P0-01	3	6	31	0.09617105654427303	TCGA-HZ-A8P0-01	5	6	4	15	PASS	7615	TCGA-HZ-A8P0	PAAD	76	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2013	NA	-27850	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	0	0	0	NA	NA	0	0	
80	TCGA-HZ-A8P1	0	3	1	0	4	1	0	0	0	36	2	0	2	26	2	0	TCGA-HZ-A8P1-01	55	0.24203184840316466	13	TCGA-HZ-A8P1-01	6	6	45	0.16783170514220122	TCGA-HZ-A8P1-01	3	2	4	9	PASS	7616	TCGA-HZ-A8P1	PAAD	81	MALE	WHITE	Stage IB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2013	NA	-29631	Alive	TUMOR FREE	7	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	7	0	7	NA	NA	0	7	
70	TCGA-HZ-A9TJ	0	13	0	0	5	0	2	0	2	106	11	0	7	46	4	0	TCGA-HZ-A9TJ-01	144	0.6624185920433658	78	TCGA-HZ-A9TJ-06	17	27	95	0.2498630859637748	TCGA-HZ-A9TJ-06	16	10	6	32	mutation call filter	7617	TCGA-HZ-A9TJ	PAAD	70	MALE	WHITE	Stage IV	NA	Pancreas-Adenocarcinoma-Other Subtype	G2	2013	NA	-25849	Alive	WITH TUMOR	603	NA	NA	Distant Metastasis	Peritoneal Surfaces	NA	555	[Unknown]	NA	NA	0	603	0	603	NA	NA	1	555	
70	TCGA-IB-7644	0	2	0	1	0	0	1	0	1	22	1	0	1	7	0	0	TCGA-IB-7644-01	64	0.11674784527314153	20	TCGA-IB-7644-01	6	6	14	0.08031330358356499	TCGA-IB-7644-01	7	5	6	18	PASS	7618	TCGA-IB-7644	PAAD	65	FEMALE	WHITE	Stage IV	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-24043	Dead	WITH TUMOR	NA	394	Pancreatic Cancer	Distant Metastasis	"Other, specify"	"Omentum, Peritoneal surface, Non regional Lymph nodes"	306	Progressive Disease	NA	NA	1	394	1	394	NA	NA	1	306	
40	TCGA-IB-7645	0	0	0	2	0	0	0	0	1	29	3	0	0	14	1	0	TCGA-IB-7645-01	71	0.07255144078555921	24	TCGA-IB-7645-01	0	0	19	9.319870750771796e-06	TCGA-IB-7645-01	0	0	0	0	PASS	7619	TCGA-IB-7645	PAAD	44	FEMALE	[Unknown]	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2007	NA	-16126	Dead	WITH TUMOR	NA	1502	Pancreatic Cancer	Distant Metastasis	Liver	NA	984	Progressive Disease	NA	NA	1	1502	1	1502	NA	NA	1	984	
60	TCGA-IB-7646	0	1	0	2	2	2	1	0	0	48	3	0	0	14	1	0	TCGA-IB-7646-01	218	0.6565316778859052	146	TCGA-IB-7646-01	24	24	90	0.28071994205375905	TCGA-IB-7646-01	10	8	10	28	PASS	7620	TCGA-IB-7646	PAAD	60	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2007	NA	-22148	Dead	WITH TUMOR	NA	145	Pancreatic Cancer	Locoregional Recurrence	Liver	NA	132	Progressive Disease	NA	NA	1	145	1	145	NA	NA	1	132	
40	TCGA-IB-7647	0	5	0	0	0	2	0	0	2	38	3	1	2	16	1	0	TCGA-IB-7647-01	82	0.2713156266890916	27	TCGA-IB-7647-01	9	8	16	0.196054784704784	TCGA-IB-7647-01	5	2	7	14	PASS	7621	TCGA-IB-7647	PAAD	41	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2008	NA	-15188	Dead	WITH TUMOR	NA	666	Pancreatic Cancer	Distant Metastasis	Liver	NA	390	Progressive Disease	NA	NA	1	666	1	666	NA	NA	1	390	
70	TCGA-IB-7649	0	3	0	0	1	0	0	0	0	34	2	0	0	7	1	0	TCGA-IB-7649-01	68	0.06285270393009347	24	TCGA-IB-7649-01	12	9	15	0.2254994826905116	TCGA-IB-7649-01	2	1	1	4	PASS	7622	TCGA-IB-7649	PAAD	73	FEMALE	[Unknown]	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2007	NA	-26773	Dead	NA	NA	467	NA	Distant Metastasis	Liver	NA	282	Partial Remission/Response	NA	NA	1	467	NA	467	NA	NA	1	282	
60	TCGA-IB-7651	81	1053	81	415	11	42	1	0	572	12907	862	5	238	5057	340	8	TCGA-IB-7651-01	36	0.15919325789596586	5	TCGA-IB-7651-01	2	1	2	5.754877559149791e-05	TCGA-IB-7651-01	0	0	0	0	hypermutated sample	7623	TCGA-IB-7651	PAAD	64	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2009	NA	-23580	Dead	WITH TUMOR	NA	603	Pancreatic Cancer	Locoregional Recurrence	NA	NA	492	Complete Remission/Response	NA	NA	1	603	1	603	1	492	1	492	
50	TCGA-IB-7652	0	3	1	2	6	1	2	0	5	72	4	0	1	22	1	0	TCGA-IB-7652-01	135	0.3630831975270004	63	TCGA-IB-7652-01	6	7	30	0.1911077054867791	TCGA-IB-7652-01	15	23	10	48	PASS	7624	TCGA-IB-7652	PAAD	49	FEMALE	ASIAN	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-18129	Alive	TUMOR FREE	1116	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1116	0	1116	0	1116	0	1116	
80	TCGA-IB-7654	0	2	1	3	1	1	0	0	2	27	3	0	1	15	0	0	TCGA-IB-7654	0	0	0	TCGA-IB-7654	0	0	0	0	TCGA-IB-7654	0	0	0	0	PASS	7625	TCGA-IB-7654	PAAD	80	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2008	NA	-29292	Dead	WITH TUMOR	NA	476	Other malignancy	NA	NA	NA	NA	Progressive Disease	NA	NA	1	476	0	476	NA	NA	1	476	
80	TCGA-IB-7885	0	1	0	1	0	1	0	0	1	29	1	0	2	17	1	0	TCGA-IB-7885-01	47	0.0017492765009022482	10	TCGA-IB-7885-01	8	7	10	0.18931281935321687	TCGA-IB-7885-01	4	3	6	13	PASS	7626	TCGA-IB-7885	PAAD	78	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2010	NA	-28554	Alive	TUMOR FREE	1257	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1257	0	1257	0	1257	0	1257	
80	TCGA-IB-7886	0	3	0	1	0	3	0	0	1	35	1	0	0	15	1	0	TCGA-IB-7886-01	104	0.912664688937104	42	TCGA-IB-7886-01	20	35	34	0.2043751887231224	TCGA-IB-7886-01	9	2	7	18	PASS	7627	TCGA-IB-7886	PAAD	80	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2010	NA	-29319	Dead	TUMOR FREE	NA	123	"Other, non-malignant disease"	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	123	0	123	0	123	0	123	
60	TCGA-IB-7887	0	2	0	1	0	2	0	0	1	18	4	0	0	6	0	0	TCGA-IB-7887-01	88	0.2905132799496215	28	TCGA-IB-7887-01	8	11	36	0.2651439456912965	TCGA-IB-7887-01	13	8	15	36	PASS	7628	TCGA-IB-7887	PAAD	62	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2009	NA	-22990	Dead	NA	NA	110	Pancreatic Cancer	NA	NA	NA	NA	[Unknown]	NA	NA	1	110	1	110	NA	NA	0	110	
70	TCGA-IB-7888	0	0	0	0	0	0	0	0	1	29	2	0	1	11	0	0	TCGA-IB-7888-01	85	0.002784466733719032	41	TCGA-IB-7888-01	0	0	2	7.836463947239905e-06	TCGA-IB-7888-01	0	0	0	0	PASS	7629	TCGA-IB-7888	PAAD	66	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2008	NA	-24117	Dead	WITH TUMOR	NA	1332	Pancreatic Cancer	Distant Metastasis	"Other, specify"	Retroperitoneum	427	Stable Disease	NA	NA	1	1332	1	1332	NA	NA	1	427	
90	TCGA-IB-7889	0	2	0	1	0	2	0	0	1	31	4	0	2	15	1	0	TCGA-IB-7889-01	55	0.05818439017078325	12	TCGA-IB-7889-01	5	13	10	0.19683163096564088	TCGA-IB-7889-01	4	3	4	11	PASS	7630	TCGA-IB-7889	PAAD	85	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2011	NA	-31393	Dead	WITH TUMOR	NA	481	Pancreatic Cancer	Locoregional Recurrence	NA	NA	352	Progressive Disease	NA	NA	1	481	1	481	NA	NA	1	352	
70	TCGA-IB-7890	0	1	0	1	1	0	0	0	0	55	3	0	0	20	0	0	TCGA-IB-7890-01	115	0.40469099749839904	67	TCGA-IB-7890-01	19	29	37	0.19262314358324675	TCGA-IB-7890-01	7	4	6	17	PASS	7631	TCGA-IB-7890	PAAD	73	MALE	[Unknown]	Stage IB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2008	NA	-26747	Dead	WITH TUMOR	NA	598	Pancreatic Cancer	Distant Metastasis	Liver	NA	519	Progressive Disease	NA	NA	1	598	1	598	NA	NA	1	519	
50	TCGA-IB-7891	1	4	0	2	0	1	0	0	1	26	2	0	1	14	1	0	TCGA-IB-7891-01	48	0.01998843294217999	11	TCGA-IB-7891-01	4	6	0	0.0	TCGA-IB-7891-01	4	0	0	4	PASS	7632	TCGA-IB-7891	PAAD	49	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2011	NA	-18202	Dead	WITH TUMOR	NA	913	Pancreatic Cancer	Distant Metastasis	"Other, specify"	Lung and Liver	525	Complete Remission/Response	NA	NA	1	913	1	913	1	525	1	525	
60	TCGA-IB-7893	1	1	0	1	1	1	0	0	3	30	0	0	0	9	0	0	TCGA-IB-7893-01	128	0.4897703962344642	69	TCGA-IB-7893-01	26	26	40	0.23932984033073346	TCGA-IB-7893-01	5	3	7	15	PASS	7633	TCGA-IB-7893	PAAD	64	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2009	NA	-23703	Dead	WITH TUMOR	NA	117	Pancreatic Cancer	Distant Metastasis	Peritoneal Surfaces	NA	80	Progressive Disease	NA	NA	1	117	1	117	NA	NA	1	80	
50	TCGA-IB-7897	0	0	0	0	0	0	0	0	0	1	1	0	0	5	0	0	TCGA-IB-7897-01	55	5.110403094087422e-06	15	TCGA-IB-7897-01	0	0	0	0.0	TCGA-IB-7897-01	0	0	0	0	PASS	7634	TCGA-IB-7897	PAAD	53	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2008	NA	-19718	Dead	WITH TUMOR	NA	486	Pancreatic Cancer	Locoregional Recurrence|Distant Metastasis	Liver	NA	397	Progressive Disease	NA	NA	1	486	1	486	NA	NA	1	397	
80	TCGA-IB-8126	0	0	0	0	0	0	0	0	0	11	1	0	0	4	0	0	TCGA-IB-8126-01	66	0.002859168718788599	23	TCGA-IB-8126-01	0	0	8	0.002572768996295729	TCGA-IB-8126-01	0	0	0	0	PASS	7635	TCGA-IB-8126	PAAD	79	FEMALE	WHITE	Stage III	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2011	NA	-29213	Alive	WITH TUMOR	462	NA	NA	Distant Metastasis	Lung	NA	83	Partial Remission/Response	NA	NA	0	462	0	462	NA	NA	1	83	
60	TCGA-IB-8127	1	2	0	1	1	1	0	0	2	20	4	0	3	22	1	0	TCGA-IB-8127-01	96	0.6570343878284342	46	TCGA-IB-8127-01	26	24	54	0.2384119182447229	TCGA-IB-8127-01	12	7	12	31	PASS	7636	TCGA-IB-8127	PAAD	59	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-21676	Alive	WITH TUMOR	522	NA	NA	Locoregional Recurrence|Distant Metastasis	"Other, specify"	Tumor Bed and Liver	486	Complete Remission/Response	NA	NA	0	522	0	522	1	486	1	486	
70	TCGA-IB-A5SO	0	2	0	2	3	0	0	0	1	21	4	0	1	8	0	0	TCGA-IB-A5SO-01	58	0.004304812622445853	17	TCGA-IB-A5SO-01	0	0	7	0.0002267839372780756	TCGA-IB-A5SO-01	0	0	0	0	PASS	7637	TCGA-IB-A5SO	PAAD	71	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-26129	Dead	WITH TUMOR	NA	365	Pancreatic Cancer	Locoregional Recurrence	Peritoneal Surfaces	NA	276	Progressive Disease	NA	NA	1	365	1	365	NA	NA	1	276	
80	TCGA-IB-A5SP	0	1	1	1	3	2	1	0	0	32	1	0	2	15	1	0	TCGA-IB-A5SP-01	108	0.6815106923877864	47	TCGA-IB-A5SP-01	11	8	71	0.2314275871323029	TCGA-IB-A5SP-01	3	0	3	6	PASS	7638	TCGA-IB-A5SP	PAAD	77	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2011	NA	-28317	Alive	WITH TUMOR	482	NA	NA	Locoregional Recurrence	"Other, specify"	Superior Mesenteric Artery	300	[Unknown]	NA	NA	0	482	0	482	NA	NA	1	300	
60	TCGA-IB-A5SQ	0	1	0	2	2	1	0	0	2	31	1	0	1	10	0	0	TCGA-IB-A5SQ-01	35	0.0023558982246020274	6	TCGA-IB-A5SQ-01	0	0	4	0.0010416035676458458	TCGA-IB-A5SQ-01	0	0	0	0	PASS	7639	TCGA-IB-A5SQ	PAAD	56	FEMALE	WHITE	Stage IB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-20760	Dead	WITH TUMOR	NA	219	NA	Distant Metastasis	Lung	NA	197	Complete Remission/Response	NA	NA	1	219	1	219	1	197	1	197	
60	TCGA-IB-A5SS	0	2	0	2	2	0	0	0	0	31	3	0	3	10	0	0	TCGA-IB-A5SS-01	79	0.2516676511645245	28	TCGA-IB-A5SS-01	7	10	57	0.21298332406784865	TCGA-IB-A5SS-01	8	3	6	17	PASS	7640	TCGA-IB-A5SS	PAAD	64	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2011	NA	-23431	Dead	WITH TUMOR	NA	460	Pancreatic Cancer	Distant Metastasis	Liver	NA	66	Complete Remission/Response	NA	NA	1	460	1	460	1	66	1	66	
60	TCGA-IB-A5ST	0	0	0	0	0	0	0	0	0	7	0	0	0	4	0	0	TCGA-IB-A5ST-01	69	2.1814524869097435e-05	23	TCGA-IB-A5ST-01	0	0	7	0.000938392703007647	TCGA-IB-A5ST-01	0	0	0	0	PASS	7641	TCGA-IB-A5ST	PAAD	64	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-23672	Alive	TUMOR FREE	635	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	635	0	635	0	635	0	635	
60	TCGA-IB-A6UF	0	3	0	2	5	0	0	0	2	39	1	0	1	17	2	0	TCGA-IB-A6UF-01	167	0.2740340189044241	88	TCGA-IB-A6UF-01	13	12	83	0.2317645982506429	TCGA-IB-A6UF-01	7	2	6	15	PASS	7642	TCGA-IB-A6UF	PAAD	63	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-23152	Alive	WITH TUMOR	666	NA	NA	Distant Metastasis	Liver	NA	593	Partial Remission/Response	NA	NA	0	666	0	666	NA	NA	1	593	
70	TCGA-IB-A6UG	0	7	0	3	2	0	0	0	1	50	4	1	0	22	4	0	TCGA-IB-A6UG-01	75	0.4114383886496653	26	TCGA-IB-A6UG-01	21	27	45	0.2382084278138044	TCGA-IB-A6UG-01	13	7	8	28	PASS	7643	TCGA-IB-A6UG	PAAD	65	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2012	NA	-23751	Dead	WITH TUMOR	NA	41	"Other, non-malignant disease"	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	41	0	41	NA	NA	1	41	
60	TCGA-IB-A7LX	4	5	0	2	1	1	0	0	3	33	2	0	4	14	2	0	TCGA-IB-A7LX-01	195	0.74497057549697	109	TCGA-IB-A7LX-01	13	15	142	0.4592924886610107	TCGA-IB-A7LX-01	14	10	20	44	PASS	7644	TCGA-IB-A7LX	PAAD	57	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-20898	Dead	WITH TUMOR	NA	250	Pancreatic Cancer	Distant Metastasis	Liver	NA	7	Progressive Disease	NA	NA	1	250	1	250	NA	NA	1	7	
80	TCGA-IB-A7M4	0	2	1	1	2	2	0	0	5	54	4	0	2	16	1	0	TCGA-IB-A7M4-01	126	0.20004938738265	68	TCGA-IB-A7M4-01	7	8	54	0.11058902025312756	TCGA-IB-A7M4-01	8	3	5	16	PASS	7645	TCGA-IB-A7M4	PAAD	81	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2013	NA	-29792	Alive	TUMOR FREE	483	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	483	0	483	0	483	0	483	
80	TCGA-IB-AAUM	0	0	0	1	0	0	0	0	1	20	0	0	0	4	0	0	TCGA-IB-AAUM-01	55	2.7664264887168818e-05	18	TCGA-IB-AAUM-01	0	0	4	0.00014054995321128902	TCGA-IB-AAUM-01	0	0	0	0	PASS	7646	TCGA-IB-AAUM	PAAD	76	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2013	NA	-28013	Alive	WITH TUMOR	8	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	8	0	8	NA	NA	0	8	
70	TCGA-IB-AAUN	0	3	0	2	1	2	1	0	1	23	3	0	0	6	0	0	TCGA-IB-AAUN-01	76	0.519325816791104	27	TCGA-IB-AAUN-01	9	8	58	0.2384099661115805	TCGA-IB-AAUN-01	8	2	9	19	PASS	7647	TCGA-IB-AAUN	PAAD	74	FEMALE	WHITE	Stage IB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-27128	Dead	NA	NA	144	NA	Locoregional Recurrence	"Other, specify"	NA	131	Complete Remission/Response	NA	NA	1	144	NA	144	1	131	1	131	
60	TCGA-IB-AAUO	0	6	0	1	1	2	0	0	3	32	4	0	1	14	1	0	TCGA-IB-AAUO-01	127	0.22458229206409594	69	TCGA-IB-AAUO-01	8	7	84	0.2052669805412984	TCGA-IB-AAUO-01	4	9	5	18	PASS	7648	TCGA-IB-AAUO	PAAD	64	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2013	NA	-23622	Dead	WITH TUMOR	NA	239	NA	Distant Metastasis	Liver	NA	74	Partial Remission/Response	NA	NA	1	239	1	239	NA	NA	1	74	
70	TCGA-IB-AAUP	0	4	0	2	0	0	0	0	0	33	2	0	0	11	1	0	TCGA-IB-AAUP-01	56	0.03125996142762101	16	TCGA-IB-AAUP-01	0	0	3	0.00014305560139492844	TCGA-IB-AAUP-01	0	1	0	1	PASS	7649	TCGA-IB-AAUP	PAAD	68	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-24864	Alive	TUMOR FREE	431	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	431	0	431	0	431	0	431	
50	TCGA-IB-AAUQ	1	2	0	1	1	0	1	0	1	48	1	0	0	15	1	1	TCGA-IB-AAUQ-01	90	0.22544634620743695	34	TCGA-IB-AAUQ-01	8	8	69	0.2120362836817528	TCGA-IB-AAUQ-01	5	5	7	17	PASS	7650	TCGA-IB-AAUQ	PAAD	50	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-18315	Dead	WITH TUMOR	NA	183	Pancreatic Cancer	Distant Metastasis	Non-regional / Distant Lymph Nodes	NA	107	Partial Remission/Response	NA	NA	1	183	1	183	NA	NA	1	107	
70	TCGA-IB-AAUR	0	0	0	0	0	0	0	0	1	4	0	0	0	4	0	0	TCGA-IB-AAUR-01	57	2.165094020756217e-05	20	TCGA-IB-AAUR-01	0	0	14	0.0022131080661992766	TCGA-IB-AAUR-01	0	0	0	0	PASS	7651	TCGA-IB-AAUR	PAAD	67	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2013	NA	-24576	Alive	WITH TUMOR	338	NA	NA	Locoregional Recurrence	Tumor Bed	NA	318	Partial Remission/Response	NA	NA	0	338	0	338	NA	NA	1	318	
80	TCGA-IB-AAUS	0	0	0	1	0	0	0	0	0	5	0	0	0	1	0	0	TCGA-IB-AAUS-01	51	1.9579630978869397e-05	11	TCGA-IB-AAUS-01	0	0	2	3.422149398045141e-05	TCGA-IB-AAUS-01	0	0	0	0	PASS	7652	TCGA-IB-AAUS	PAAD	84	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-30684	Alive	WITH TUMOR	225	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	225	0	225	NA	NA	0	225	
70	TCGA-IB-AAUT	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-IB-AAUT-01	38	0.001271200526617366	2	TCGA-IB-AAUT-01	0	0	5	0.00015998297602877194	TCGA-IB-AAUT-01	0	0	0	0	PASS	7653	TCGA-IB-AAUT	PAAD	65	MALE	WHITE	Stage IIB	NA	Pancreas-Colloid (mucinous non-cystic) Carcinoma	G1	2013	NA	-23801	Alive	TUMOR FREE	287	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	287	0	287	0	287	0	287	
40	TCGA-IB-AAUU	0	4	0	3	1	3	1	0	2	34	0	0	2	15	1	0	TCGA-IB-AAUU-01	110	0.5668852051253606	53	TCGA-IB-AAUU-01	23	24	42	0.1602127145013323	TCGA-IB-AAUU-01	13	8	8	29	PASS	7654	TCGA-IB-AAUU	PAAD	35	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2013	NA	-13127	Alive	TUMOR FREE	245	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	245	0	245	0	245	0	245	
50	TCGA-IB-AAUV	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	TCGA-IB-AAUV-01	57	7.817107022497062e-05	16	TCGA-IB-AAUV	0	0	0	0	TCGA-IB-AAUV	0	0	0	0	pathology review	7655	TCGA-IB-AAUV	PAAD	49	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-18059	Alive	TUMOR FREE	404	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	404	0	404	0	404	0	404	
60	TCGA-IB-AAUW	0	2	0	0	0	0	0	0	0	0	0	0	0	2	0	0	TCGA-IB-AAUW-01	47	0.00011509345260908975	6	TCGA-IB-AAUW	0	0	0	0	TCGA-IB-AAUW	0	0	0	0	pathology review	7656	TCGA-IB-AAUW	PAAD	63	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2013	NA	-23306	Dead	WITH TUMOR	NA	230	NA	Locoregional Recurrence	Tumor Bed	NA	185	Complete Remission/Response	NA	NA	1	230	1	230	1	185	1	185	
50	TCGA-L1-A7W4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-L1-A7W4-01	183	0.29884281066677754	91	TCGA-L1-A7W4	0	0	0	0	TCGA-L1-A7W4	0	0	0	0	PASS	7657	TCGA-L1-A7W4	PAAD	48	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2013	NA	-17821	Dead	WITH TUMOR	NA	278	Pancreatic Cancer	Distant Metastasis	Liver	NA	129	Progressive Disease	NA	NA	1	278	1	278	NA	NA	1	129	
70	TCGA-LB-A7SX	3	7	1	2	2	1	0	0	8	72	7	0	5	37	1	0	TCGA-LB-A7SX-01	202	0.8459666058309713	107	TCGA-LB-A7SX-01	14	12	122	0.3722274413370808	TCGA-LB-A7SX-01	11	6	13	30	PASS	7658	TCGA-LB-A7SX	PAAD	74	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-27295	Dead	NA	NA	393	"Other, non-malignant disease"	NA	NA	NA	NA	Stable Disease	NA	NA	1	393	0	393	NA	NA	0	393	
60	TCGA-LB-A8F3	1	4	0	0	1	2	0	0	3	31	2	1	0	9	1	0	TCGA-LB-A8F3-01	114	0.5000935461101575	56	TCGA-LB-A8F3-01	23	24	92	0.26623941790903205	TCGA-LB-A8F3-01	10	5	5	20	PASS	7659	TCGA-LB-A8F3	PAAD	64	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2013	NA	-23624	Alive	TUMOR FREE	379	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	379	0	379	NA	NA	0	379	
60	TCGA-LB-A9Q5	0	2	0	0	0	0	0	0	0	20	2	0	0	3	0	0	TCGA-LB-A9Q5-01	61	4.7458609346801877e-05	19	TCGA-LB-A9Q5	0	0	0	0	TCGA-LB-A9Q5	0	0	0	0	PASS	7660	TCGA-LB-A9Q5	PAAD	63	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2013	NA	-23218	Dead	WITH TUMOR	NA	313	Pancreatic Cancer	Locoregional Recurrence	"Other, specify"	omentum	290	[Unknown]	NA	NA	1	313	1	313	NA	NA	1	290	
50	TCGA-M8-A5N4	1	3	1	1	1	1	1	0	2	30	1	0	1	12	0	0	TCGA-M8-A5N4-01	125	0.33781837204188564	66	TCGA-M8-A5N4-01	22	14	56	0.11883260051961946	TCGA-M8-A5N4-01	7	16	6	29	PASS	7661	TCGA-M8-A5N4	PAAD	48	FEMALE	[Not Evaluated]	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	NA	NA	-17628	Alive	WITH TUMOR	584	NA	NA	Locoregional Recurrence	"Other, specify"	retroperitoneal recurrence around the supramesenteric artery and vein and some para aortic nodes	416	Partial Remission/Response	NA	NA	0	584	0	584	NA	NA	1	416	
80	TCGA-OE-A75W	0	3	0	4	3	0	0	0	3	63	6	0	4	20	1	0	TCGA-OE-A75W-01	119	0.7454848470917994	57	TCGA-OE-A75W-01	8	12	90	0.3022087001664974	TCGA-OE-A75W-01	9	7	10	26	PASS	7662	TCGA-OE-A75W	PAAD	75	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2013	NA	-27684	Dead	NA	NA	267	NA	Distant Metastasis	Liver	NA	146	Progressive Disease	NA	NA	1	267	NA	267	NA	NA	1	146	
40	TCGA-PZ-A5RE	0	1	0	0	0	6	2	0	2	50	2	0	0	8	0	0	TCGA-PZ-A5RE-01	97	0.19268359894120546	45	TCGA-PZ-A5RE-01	9	13	72	0.2171050583267806	TCGA-PZ-A5RE-01	4	2	9	15	PASS	7663	TCGA-PZ-A5RE	PAAD	44	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2012	NA	-16255	Dead	WITH TUMOR	NA	470	Pancreatic Cancer	Distant Metastasis	Liver	NA	393	[Unknown]	NA	NA	1	470	1	470	NA	NA	1	393	
60	TCGA-Q3-A5QY	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	TCGA-Q3-A5QY-01	41	1.9538580785067166e-05	10	TCGA-Q3-A5QY-01	0	0	11	0.0005974429812454071	TCGA-Q3-A5QY-01	0	0	0	0	PASS	7664	TCGA-Q3-A5QY	PAAD	58	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-21277	Alive	NA	416	NA	NA	NA	NA	NA	NA	[Discrepancy]	NA	NA	0	416	0	416	NA	NA	0	416	
60	TCGA-Q3-AA2A	0	0	2	1	0	0	0	0	0	17	1	0	1	6	0	0	TCGA-Q3-AA2A-01	102	0.1679705086530344	51	TCGA-Q3-AA2A-01	4	3	46	0.07508320223449015	TCGA-Q3-AA2A-01	4	3	5	12	PASS	7665	TCGA-Q3-AA2A	PAAD	64	FEMALE	WHITE	Stage IB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2013	NA	-23685	Alive	TUMOR FREE	95	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	95	0	95	NA	NA	0	95	
80	TCGA-RB-A7B8	0	2	0	2	1	0	0	0	4	33	2	0	1	19	0	0	TCGA-RB-A7B8-01	103	0.1555789453444831	38	TCGA-RB-A7B8-01	5	6	24	0.022083407029244263	TCGA-RB-A7B8-01	2	4	2	8	PASS	7666	TCGA-RB-A7B8	PAAD	81	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma-Other Subtype	G2	2013	NA	-29585	Dead	TUMOR FREE	NA	466	Pancreatic Cancer	Locoregional Recurrence	NA	NA	449	Complete Remission/Response	NA	NA	1	466	1	466	1	449	1	449	
40	TCGA-RB-AA9M	0	0	0	2	0	0	0	0	0	16	1	0	0	10	0	0	TCGA-RB-AA9M-01	65	6.951985297732431e-05	21	TCGA-RB-AA9M	0	0	0	0	TCGA-RB-AA9M	0	0	0	0	PASS	7667	TCGA-RB-AA9M	PAAD	43	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2013	NA	-15807	Alive	WITH TUMOR	286	NA	NA	Distant Metastasis	Liver	NA	258	Progressive Disease	NA	NA	0	286	0	286	NA	NA	1	258	
60	TCGA-RL-AAAS	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-RL-AAAS-01	55	0.0001275091776949837	12	TCGA-RL-AAAS	0	0	0	0	TCGA-RL-AAAS	0	0	0	0	PASS	7668	TCGA-RL-AAAS	PAAD	60	FEMALE	WHITE	Stage IB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-22126	Alive	TUMOR FREE	9	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	9	0	9	0	9	0	9	
70	TCGA-S4-A8RM	0	1	0	0	3	1	0	1	2	24	1	0	0	20	0	0	TCGA-S4-A8RM-01	61	0.2704899757545585	17	TCGA-S4-A8RM-01	7	6	23	0.13412489235211186	TCGA-S4-A8RM-01	7	1	7	15	PASS	7669	TCGA-S4-A8RM	PAAD	67	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2013	NA	-24589	Alive	TUMOR FREE	737	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	737	0	737	0	737	0	737	
80	TCGA-S4-A8RO	0	6	0	0	2	2	1	0	2	39	4	0	0	26	0	0	TCGA-S4-A8RO-01	202	0.3337730537725383	116	TCGA-S4-A8RO-01	6	7	75	0.14236140906233538	TCGA-S4-A8RO-01	10	7	7	24	PASS	7670	TCGA-S4-A8RO	PAAD	75	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-27645	Alive	WITH TUMOR	525	NA	NA	Distant Metastasis	Lung	NA	291	Complete Remission/Response	NA	NA	0	525	0	525	1	291	1	291	
80	TCGA-S4-A8RP	1	3	1	1	0	1	0	0	1	25	2	0	1	8	0	0	TCGA-S4-A8RP-01	98	0.2669493207582632	47	TCGA-S4-A8RP-01	5	11	62	0.2336109479490293	TCGA-S4-A8RP-01	10	8	9	27	PASS	7671	TCGA-S4-A8RP	PAAD	77	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2010	NA	-28353	Dead	NA	NA	702	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	702	NA	702	NA	NA	0	702	
80	TCGA-US-A774	0	2	0	1	0	0	0	0	0	12	2	0	1	7	1	0	TCGA-US-A774-01	45	0.0001622519495317775	8	TCGA-US-A774-01	0	0	12	0.002351372124998871	TCGA-US-A774-01	1	1	0	2	PASS	7672	TCGA-US-A774	PAAD	76	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2011	NA	-27957	Dead	WITH TUMOR	NA	695	Pancreatic Cancer	Distant Metastasis	Liver	NA	366	Progressive Disease	NA	NA	1	695	1	695	NA	NA	1	366	
60	TCGA-US-A776	0	5	0	3	1	0	1	0	1	76	4	0	2	23	0	0	TCGA-US-A776-01	96	0.5594941584933475	39	TCGA-US-A776-01	4	3	29	0.11102202340275356	TCGA-US-A776-01	8	5	6	19	PASS	7673	TCGA-US-A776	PAAD	61	MALE	WHITE	Stage IIA	NA	Pancreas-Colloid (mucinous non-cystic) Carcinoma	G2	2011	NA	-22283	Alive	TUMOR FREE	1216	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1216	0	1216	0	1216	0	1216	
50	TCGA-US-A779	0	3	0	1	1	1	0	0	0	22	1	0	1	8	1	1	TCGA-US-A779-01	108	0.1916587043013161	62	TCGA-US-A779-01	6	5	81	0.18251015033114512	TCGA-US-A779-01	6	2	4	12	PASS	7674	TCGA-US-A779	PAAD	54	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2011	NA	-20051	Dead	WITH TUMOR	NA	511	Pancreatic Cancer	NA	NA	NA	NA	NA	NA	NA	1	511	1	511	NA	NA	1	511	
70	TCGA-US-A77E	1	6	1	1	1	0	2	0	0	64	6	0	1	13	0	0	TCGA-US-A77E-01	67	0.07897684174230826	22	TCGA-US-A77E-01	5	3	28	0.03684039288084898	TCGA-US-A77E-01	3	1	3	7	PASS	7675	TCGA-US-A77E	PAAD	73	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma-Other Subtype	G3	2012	NA	-26745	Dead	WITH TUMOR	NA	430	Pancreatic Cancer	Distant Metastasis	Liver	NA	166	NA	NA	NA	1	430	1	430	NA	NA	1	166	
60	TCGA-US-A77G	0	2	0	1	2	1	1	0	0	21	2	0	1	11	0	0	TCGA-US-A77G-01	74	0.14544860379767596	26	TCGA-US-A77G-01	5	5	43	0.13080925104297272	TCGA-US-A77G-01	9	6	9	24	PASS	7676	TCGA-US-A77G	PAAD	64	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2010	NA	-23443	Dead	TUMOR FREE	NA	12	Surgical Complications	NA	NA	NA	NA	NA	NA	NA	1	12	0	12	NA	NA	0	12	
80	TCGA-US-A77J	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-US-A77J-01	41	1.5361987820474027e-05	8	TCGA-US-A77J	0	0	0	0	TCGA-US-A77J	0	0	0	0	PASS	7677	TCGA-US-A77J	PAAD	81	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2010	NA	-29904	Dead	WITH TUMOR	NA	568	Pancreatic Cancer	NA	NA	NA	NA	NA	NA	NA	1	568	1	568	NA	NA	1	568	
70	TCGA-XD-AAUG	0	1	0	0	1	0	0	0	0	15	1	0	0	8	0	0	TCGA-XD-AAUG-01	39	5.7007523191199265e-05	7	TCGA-XD-AAUG-01	1	2	37	0.04634771171085958	TCGA-XD-AAUG-01	2	3	2	7	PASS	7678	TCGA-XD-AAUG	PAAD	66	FEMALE	WHITE	Stage IV	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-24291	Alive	TUMOR FREE	420	NA	NA	NA	NA	NA	NA	[Discrepancy]	NA	NA	0	420	0	420	NA	NA	0	420	
60	TCGA-XD-AAUH	0	0	0	0	0	1	0	0	0	11	3	0	0	7	0	0	TCGA-XD-AAUH-01	61	8.07979411425945e-05	18	TCGA-XD-AAUH	0	0	0	0	TCGA-XD-AAUH	0	0	0	0	PASS	7679	TCGA-XD-AAUH	PAAD	57	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-20858	Alive	NA	395	NA	NA	New Primary Tumor	"Other, specify"	Left shoulder	87	[Unknown]	NA	NA	0	395	0	395	NA	NA	1	87	
50	TCGA-XD-AAUI	0	2	0	1	1	0	0	0	2	29	6	0	2	9	0	0	TCGA-XD-AAUI-01	144	0.08247465947040078	69	TCGA-XD-AAUI-01	7	17	127	0.3334991940629782	TCGA-XD-AAUI-01	12	7	12	31	PASS	7680	TCGA-XD-AAUI	PAAD	50	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-18607	Dead	WITH TUMOR	NA	366	Pancreatic Cancer	Distant Metastasis	Liver	NA	175	Progressive Disease	NA	NA	1	366	1	366	NA	NA	1	175	
60	TCGA-XD-AAUL	0	1	0	2	1	0	0	0	0	22	3	0	1	14	0	0	TCGA-XD-AAUL-01	123	0.15412816634469298	54	TCGA-XD-AAUL-01	4	5	51	0.14847627528379048	TCGA-XD-AAUL-01	5	5	5	15	PASS	7681	TCGA-XD-AAUL	PAAD	56	MALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-20607	Alive	TUMOR FREE	498	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	498	0	498	0	498	0	498	
70	TCGA-XN-A8T3	0	2	1	3	1	1	0	0	2	36	6	0	0	11	0	0	TCGA-XN-A8T3-01	77	0.19698243489107764	29	TCGA-XN-A8T3-01	25	21	57	0.17741221514372507	TCGA-XN-A8T3-01	8	2	7	17	PASS	7682	TCGA-XN-A8T3	PAAD	67	MALE	WHITE	Stage IB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2012	NA	-24810	Alive	WITH TUMOR	951	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	951	0	951	NA	NA	0	951	
50	TCGA-XN-A8T5	0	0	0	2	0	0	0	0	1	8	1	0	3	6	0	0	TCGA-XN-A8T5-01	77	4.231024045663444e-05	30	TCGA-XN-A8T5-01	0	0	7	0.00027092810897884595	TCGA-XN-A8T5-01	0	0	0	0	PASS	7683	TCGA-XN-A8T5	PAAD	53	FEMALE	WHITE	Stage IB	NA	Pancreas-Adenocarcinoma-Other Subtype	G2	2012	NA	-19707	Alive	WITH TUMOR	720	NA	NA	Distant Metastasis	Liver	NA	242	Progressive Disease	NA	NA	0	720	0	720	NA	NA	1	242	
60	TCGA-YB-A89D	1	1	0	3	1	0	0	1	1	28	5	0	0	9	0	0	TCGA-YB-A89D-01	84	0.15115803541465733	36	TCGA-YB-A89D-01	21	18	46	0.12763788750412566	TCGA-YB-A89D-01	7	4	5	16	PASS	7684	TCGA-YB-A89D	PAAD	59	MALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G2	2013	NA	-21792	Alive	TUMOR FREE	350	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	350	0	350	0	350	0	350	
70	TCGA-YH-A8SY	0	6	0	2	0	0	2	0	0	33	9	0	2	21	1	0	TCGA-YH-A8SY-01	135	0.4040922535102643	71	TCGA-YH-A8SY-01	7	10	85	0.25206851163116906	TCGA-YH-A8SY-01	7	5	9	21	PASS	7685	TCGA-YH-A8SY	PAAD	73	FEMALE	WHITE	[Discrepancy]	NA	[Discrepancy]	G2	2011	NA	-26859	Alive	NA	388	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	388	0	388	NA	NA	0	388	
60	TCGA-YY-A8LH	1	4	0	3	3	2	0	0	2	46	4	0	1	24	1	0	TCGA-YY-A8LH-01	92	0.3534656327721559	39	TCGA-YY-A8LH-01	8	6	50	0.17800100459306856	TCGA-YY-A8LH-01	7	2	5	14	PASS	7686	TCGA-YY-A8LH	PAAD	61	FEMALE	WHITE	Stage IIB	NA	Pancreas-Adenocarcinoma Ductal Type	G3	2009	NA	-22376	Alive	TUMOR FREE	2016	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2016	0	2016	0	2016	0	2016	
70	TCGA-Z5-AAPL	0	0	0	1	0	0	0	0	0	6	0	0	0	1	1	0	TCGA-Z5-AAPL-01	65	4.560866838878426e-05	23	TCGA-Z5-AAPL	0	0	0	0	TCGA-Z5-AAPL	0	0	0	0	PASS	7687	TCGA-Z5-AAPL	PAAD	74	FEMALE	WHITE	Stage IIA	NA	Pancreas-Adenocarcinoma Ductal Type	G1	2013	NA	-27152	Alive	TUMOR FREE	467	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	467	0	467	0	467	0	467	
80	TCGA-P7-A5NX	0	0	0	0	1	0	0	0	0	16	0	0	1	2	0	0	TCGA-P7-A5NX	0	0	0	TCGA-P7-A5NX	0	0	0	0	TCGA-P7-A5NX	0	0	0	0	PASS	7688	TCGA-P7-A5NX	PCPG	78	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-28497	Alive	TUMOR FREE	818	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	818	0	818	0	818	0	818	
30	TCGA-P7-A5NY	0	0	0	0	0	0	0	0	0	7	2	0	0	2	0	0	TCGA-P7-A5NY-01	42	0.07506325928755438	7	TCGA-P7-A5NY-05	19	14	30	0.09265378760454726	TCGA-P7-A5NY-05	2	0	1	3	mutation call filter	7689	TCGA-P7-A5NY	PCPG	21	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-7834	Alive	TUMOR FREE	957	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	957	0	957	0	957	0	957	
50	TCGA-P8-A5KC	0	0	0	0	0	0	0	0	2	22	0	0	0	8	0	0	TCGA-P8-A5KC-01	47	0.00037631591608397534	9	TCGA-P8-A5KC-01	0	0	6	0.00047608049070053563	TCGA-P8-A5KC-01	0	0	0	0	PASS	7690	TCGA-P8-A5KC	PCPG	48	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-17790	Alive	TUMOR FREE	883	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	883	0	883	0	883	0	883	
40	TCGA-P8-A5KD	0	0	0	0	0	2	0	0	2	10	2	0	0	6	0	0	TCGA-P8-A5KD-01	69	0.2174577523349132	25	TCGA-P8-A5KD-01	9	6	36	0.1414288898753645	TCGA-P8-A5KD-01	5	0	4	9	PASS	7691	TCGA-P8-A5KD	PCPG	35	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-12954	Alive	TUMOR FREE	123	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	123	0	123	NA	NA	0	123	
70	TCGA-P8-A6RX	0	0	0	0	0	0	0	0	0	17	3	0	0	2	0	0	TCGA-P8-A6RX-01	76	0.23629756587479706	37	TCGA-P8-A6RX-01	6	4	48	0.1591165395269905	TCGA-P8-A6RX-01	0	3	1	4	PASS	7692	TCGA-P8-A6RX	PCPG	65	MALE	WHITE	NA	NA	Paraganglioma	NA	2013	NA	-23825	Alive	TUMOR FREE	540	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	540	0	540	NA	NA	0	540	
60	TCGA-P8-A6RY	0	0	0	1	0	0	0	0	0	4	0	0	0	4	0	0	TCGA-P8-A6RY-01	45	0.057064154549547975	9	TCGA-P8-A6RY-01	3	2	23	0.061192016445223936	TCGA-P8-A6RY-01	0	0	0	0	PASS	7693	TCGA-P8-A6RY	PCPG	55	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-20109	Alive	TUMOR FREE	179	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	179	0	179	NA	NA	0	179	
60	TCGA-PR-A5PF	0	1	0	2	1	0	0	0	0	15	0	0	0	7	0	0	TCGA-PR-A5PF-01	125	0.7339533883229205	57	TCGA-PR-A5PF-01	8	9	54	0.1995503995058064	TCGA-PR-A5PF-01	7	4	10	21	PASS	7694	TCGA-PR-A5PF	PCPG	62	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-22987	Alive	TUMOR FREE	546	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	546	0	546	0	546	0	546	
40	TCGA-PR-A5PG	0	2	0	1	0	0	0	0	0	14	0	0	0	5	0	0	TCGA-PR-A5PG-01	50	0.13597242268459728	13	TCGA-PR-A5PG-01	5	6	28	0.09460164614887524	TCGA-PR-A5PG-01	6	2	4	12	PASS	7695	TCGA-PR-A5PG	PCPG	42	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2007	NA	-15577	Alive	WITH TUMOR	2485	NA	NA	Distant Metastasis	Bone	NA	2278	Complete Remission/Response	NA	NA	0	2485	0	2485	1	2278	1	2278	
50	TCGA-PR-A5PH	0	2	0	0	0	0	0	0	0	7	1	0	0	3	0	0	TCGA-PR-A5PH-01	85	0.07388394820148064	24	TCGA-PR-A5PH-01	2	2	33	0.07775393060885945	TCGA-PR-A5PH-01	2	1	1	4	PASS	7696	TCGA-PR-A5PH	PCPG	47	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2007	NA	-17347	Alive	TUMOR FREE	854	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	854	0	854	0	854	0	854	
40	TCGA-QR-A6GO	0	1	0	0	0	1	0	0	0	10	0	0	0	1	0	0	TCGA-QR-A6GO-01	45	0.2180866777765832	7	TCGA-QR-A6GO-01	6	5	36	0.16918605476465035	TCGA-QR-A6GO-01	4	0	4	8	PASS	7697	TCGA-QR-A6GO	PCPG	43	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2009	NA	-15799	Alive	TUMOR FREE	1065	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1065	0	1065	0	1065	0	1065	
30	TCGA-QR-A6GR	0	1	0	0	0	0	0	0	1	11	0	0	1	2	1	0	TCGA-QR-A6GR-01	104	0.06488095782015553	47	TCGA-QR-A6GR-01	2	4	32	0.06932103659825671	TCGA-QR-A6GR-01	2	3	4	9	PASS	7698	TCGA-QR-A6GR	PCPG	30	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2009	NA	-11089	Alive	TUMOR FREE	703	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	703	0	703	0	703	0	703	
50	TCGA-QR-A6GS	0	2	0	1	0	0	0	0	0	8	0	0	0	2	1	0	TCGA-QR-A6GS-01	83	0.08085612008938069	32	TCGA-QR-A6GS-01	2	3	22	0.07764528278192713	TCGA-QR-A6GS-01	3	4	5	12	PASS	7699	TCGA-QR-A6GS	PCPG	51	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2007	NA	-18798	Alive	TUMOR FREE	38	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	38	0	38	0	38	0	38	
60	TCGA-QR-A6GT	0	0	0	1	2	0	0	2	1	18	2	0	1	9	0	0	TCGA-QR-A6GT-01	46	0.23866764483298594	12	TCGA-QR-A6GT-01	6	4	46	0.18585368445633046	TCGA-QR-A6GT-01	3	1	3	7	PASS	7700	TCGA-QR-A6GT	PCPG	63	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2002	NA	-23208	Alive	WITH TUMOR	4185	NA	NA	Distant Metastasis	Liver	NA	1476	Progressive Disease	NA	NA	0	4185	0	4185	NA	NA	1	1476	
30	TCGA-QR-A6GU	0	2	0	0	0	0	0	0	2	14	2	0	0	2	0	0	TCGA-QR-A6GU-01	52	0.12055646512427065	16	TCGA-QR-A6GU-01	5	4	14	0.05616827299864226	TCGA-QR-A6GU-01	1	0	3	4	PASS	7701	TCGA-QR-A6GU	PCPG	31	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2008	NA	-11592	Alive	TUMOR FREE	1791	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1791	0	1791	0	1791	0	1791	
50	TCGA-QR-A6GW	0	2	0	0	1	0	1	0	1	13	1	0	0	2	0	0	TCGA-QR-A6GW	0	0	0	TCGA-QR-A6GW	0	0	0	0	TCGA-QR-A6GW	0	0	0	0	PASS	7702	TCGA-QR-A6GW	PCPG	53	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2009	NA	-19639	Alive	TUMOR FREE	491	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	491	0	491	0	491	0	491	
30	TCGA-QR-A6GX	0	0	0	0	0	0	0	0	0	12	0	0	0	3	0	0	TCGA-QR-A6GX-01	92	0.5356242013773411	40	TCGA-QR-A6GX-01	20	17	17	0.04419434968599401	TCGA-QR-A6GX-01	3	0	1	4	PASS	7703	TCGA-QR-A6GX	PCPG	28	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pheochromocytoma	NA	2011	NA	-10548	Alive	TUMOR FREE	579	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	579	0	579	0	579	0	579	
40	TCGA-QR-A6GY	0	0	0	0	0	0	1	0	1	15	0	0	0	6	0	0	TCGA-QR-A6GY-01	70	0.11131131564426494	24	TCGA-QR-A6GY-01	5	5	34	0.10764741669081053	TCGA-QR-A6GY-01	4	2	5	11	PASS	7704	TCGA-QR-A6GY	PCPG	37	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2006	NA	-13612	Alive	TUMOR FREE	32	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	32	0	32	0	32	0	32	
30	TCGA-QR-A6GZ	0	0	0	0	1	0	0	0	0	6	0	0	1	5	1	0	TCGA-QR-A6GZ-01	46	0.5439721397622566	12	TCGA-QR-A6GZ-01	23	13	26	0.1294536629355988	TCGA-QR-A6GZ-01	1	2	1	4	mutation call filter	7705	TCGA-QR-A6GZ	PCPG	31	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2009	NA	-11573	Alive	TUMOR FREE	928	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	928	0	928	0	928	0	928	
50	TCGA-QR-A6H0	0	1	0	1	0	0	0	0	0	4	0	0	0	2	0	0	TCGA-QR-A6H0-01	40	0.0679484530222576	8	TCGA-QR-A6H0-01	2	2	18	0.07224751628012016	TCGA-QR-A6H0-01	2	1	2	5	PASS	7706	TCGA-QR-A6H0	PCPG	53	MALE	WHITE	NA	NA	Paraganglioma; Extra-adrenal Pheochromocytoma	NA	2012	NA	-19372	Alive	TUMOR FREE	280	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	280	0	280	0	280	0	280	
60	TCGA-QR-A6H1	1	0	0	1	0	2	0	0	0	11	0	0	1	2	1	0	TCGA-QR-A6H1-01	62	0.12859161642308206	20	TCGA-QR-A6H1-01	5	4	22	0.09619139775520164	TCGA-QR-A6H1-01	3	1	4	8	PASS	7707	TCGA-QR-A6H1	PCPG	55	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2009	NA	-20295	Alive	TUMOR FREE	431	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	431	0	431	0	431	0	431	
30	TCGA-QR-A6H2	0	0	0	0	0	0	0	0	1	8	0	0	0	3	0	0	TCGA-QR-A6H2-01	63	0.18443984699167332	23	TCGA-QR-A6H2-01	1	3	25	0.05730958434916701	TCGA-QR-A6H2-01	2	2	4	8	PASS	7708	TCGA-QR-A6H2	PCPG	33	MALE	ASIAN	NA	NA	Pheochromocytoma	NA	2003	NA	-12281	Alive	TUMOR FREE	302	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	302	0	302	0	302	0	302	
40	TCGA-QR-A6H3	0	1	0	0	0	0	0	0	0	3	0	0	0	3	0	0	TCGA-QR-A6H3-01	55	0.08426076266143785	15	TCGA-QR-A6H3-01	2	1	26	0.09048377237707596	TCGA-QR-A6H3-01	0	0	0	0	PASS	7709	TCGA-QR-A6H3	PCPG	41	MALE	WHITE	NA	NA	Paraganglioma	NA	2013	NA	-15106	Alive	TUMOR FREE	434	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	434	0	434	0	434	0	434	
60	TCGA-QR-A6H4	1	1	0	1	1	0	0	0	2	10	0	0	0	3	0	0	TCGA-QR-A6H4	0	0	0	TCGA-QR-A6H4	0	0	0	0	TCGA-QR-A6H4	0	0	0	0	PASS	7710	TCGA-QR-A6H4	PCPG	56	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2007	NA	-20492	Alive	TUMOR FREE	2661	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2661	0	2661	0	2661	0	2661	
30	TCGA-QR-A6H5	0	0	0	0	0	0	0	0	0	6	0	0	0	1	1	0	TCGA-QR-A6H5-01	49	0.11336844441522607	15	TCGA-QR-A6H5-01	4	2	30	0.12125278006101595	TCGA-QR-A6H5-01	0	0	0	0	PASS	7711	TCGA-QR-A6H5	PCPG	30	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pheochromocytoma	NA	2008	NA	-10987	Alive	TUMOR FREE	959	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	959	0	959	0	959	0	959	
30	TCGA-QR-A6H6	0	0	0	1	1	0	0	0	0	6	0	0	0	2	0	0	TCGA-QR-A6H6-01	55	0.26115590504742475	14	TCGA-QR-A6H6-01	5	5	41	0.15388627292986434	TCGA-QR-A6H6-01	5	0	4	9	PASS	7712	TCGA-QR-A6H6	PCPG	27	MALE	WHITE	NA	NA	Paraganglioma	NA	2012	NA	-10180	Alive	TUMOR FREE	474	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	474	0	474	0	474	0	474	
30	TCGA-QR-A6ZZ	0	0	0	0	0	0	0	0	0	12	1	0	0	2	0	0	TCGA-QR-A6ZZ	0	0	0	TCGA-QR-A6ZZ	0	0	0	0	TCGA-QR-A6ZZ	0	0	0	0	PASS	7713	TCGA-QR-A6ZZ	PCPG	30	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-11075	Alive	TUMOR FREE	48	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	48	0	48	0	48	0	48	
70	TCGA-QR-A700	0	1	0	1	0	0	0	0	2	30	3	0	0	7	2	0	TCGA-QR-A700-01	1851	0.7242050102671918	1713	TCGA-QR-A700-01	25	21	608	0.2248976062912406	TCGA-QR-A700-01	5	3	10	18	PASS	7714	TCGA-QR-A700	PCPG	67	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-24734	Alive	WITH TUMOR	978	NA	NA	Distant Metastasis	Lung	NA	606	Progressive Disease	NA	NA	0	978	0	978	NA	NA	1	606	
80	TCGA-QR-A702	0	1	0	1	0	1	0	0	0	6	0	0	0	3	0	0	TCGA-QR-A702-01	161	0.7351545919956245	84	TCGA-QR-A702-01	3	4	44	0.11922726806927035	TCGA-QR-A702-01	6	3	5	14	PASS	7715	TCGA-QR-A702	PCPG	75	FEMALE	WHITE	NA	NA	Paraganglioma	NA	2010	NA	-27395	Alive	TUMOR FREE	39	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	39	0	39	0	39	0	39	
30	TCGA-QR-A703	0	0	0	0	0	0	0	0	0	3	1	0	0	1	0	0	TCGA-QR-A703	0	0	0	TCGA-QR-A703	0	0	0	0	TCGA-QR-A703	0	0	0	0	PASS	7716	TCGA-QR-A703	PCPG	23	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2008	NA	-8421	Alive	TUMOR FREE	1167	NA	NA	New Primary Tumor	"Other, specify"	Left Adrenal Pheochromocytoma	0	Complete Remission/Response	NA	NA	0	1167	0	1167	0	1167	1	0	
60	TCGA-QR-A705	0	0	0	2	1	0	0	0	0	6	0	0	0	4	1	0	TCGA-QR-A705	0	0	0	TCGA-QR-A705	0	0	0	0	TCGA-QR-A705	0	0	0	0	PASS	7717	TCGA-QR-A705	PCPG	63	FEMALE	WHITE	NA	NA	Paraganglioma; Extra-adrenal Pheochromocytoma	NA	2010	NA	-23086	Alive	TUMOR FREE	317	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	317	0	317	0	317	0	317	
50	TCGA-QR-A706	0	0	0	0	0	0	0	0	0	8	0	0	0	3	0	0	TCGA-QR-A706-01	1820	0.045964384962793384	1693	TCGA-QR-A706-01	2	2	634	0.06866965811151045	TCGA-QR-A706-01	7	2	1	10	PASS	7718	TCGA-QR-A706	PCPG	50	FEMALE	WHITE	NA	NA	Paraganglioma	NA	2012	NA	-18585	Alive	TUMOR FREE	125	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	125	0	125	0	125	0	125	
40	TCGA-QR-A707	0	1	0	0	0	0	0	0	0	9	0	0	0	3	0	0	TCGA-QR-A707	0	0	0	TCGA-QR-A707	0	0	0	0	TCGA-QR-A707	0	0	0	0	PASS	7719	TCGA-QR-A707	PCPG	43	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2010	NA	-15870	Alive	TUMOR FREE	398	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	398	0	398	0	398	0	398	
40	TCGA-QR-A708	1	0	0	1	2	0	0	0	0	13	0	0	2	3	0	0	TCGA-QR-A708	0	0	0	TCGA-QR-A708	0	0	0	0	TCGA-QR-A708	0	0	0	0	PASS	7720	TCGA-QR-A708	PCPG	44	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-16170	Alive	TUMOR FREE	35	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	35	0	35	0	35	0	35	
50	TCGA-QR-A70A	0	1	0	0	0	0	0	0	0	7	0	0	0	5	0	0	TCGA-QR-A70A	0	0	0	TCGA-QR-A70A	0	0	0	0	TCGA-QR-A70A	0	0	0	0	PASS	7721	TCGA-QR-A70A	PCPG	54	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2006	NA	-19755	Alive	TUMOR FREE	2119	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2119	0	2119	0	2119	0	2119	
50	TCGA-QR-A70C	0	1	0	1	0	0	0	0	0	6	2	0	0	5	0	0	TCGA-QR-A70C-01	82	0.020436053768745282	27	TCGA-QR-A70C-01	0	0	5	0.0010513210612407957	TCGA-QR-A70C-01	0	0	0	0	PASS	7722	TCGA-QR-A70C	PCPG	51	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pheochromocytoma	NA	2004	NA	-18628	Alive	TUMOR FREE	3534	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3534	0	3534	0	3534	0	3534	
40	TCGA-QR-A70D	0	0	0	0	0	0	0	0	0	6	0	0	0	5	0	1	TCGA-QR-A70D-01	54	0.14297192986951027	17	TCGA-QR-A70D-01	4	2	32	0.11678891574946362	TCGA-QR-A70D-01	2	0	1	3	PASS	7723	TCGA-QR-A70D	PCPG	39	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Paraganglioma	NA	2012	NA	-14412	Alive	TUMOR FREE	7	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	7	0	7	0	7	0	7	
30	TCGA-QR-A70E	0	1	0	0	0	0	1	0	0	8	0	0	0	3	0	0	TCGA-QR-A70E-01	65	0.1679051746202743	24	TCGA-QR-A70E-01	3	4	42	0.15100076606127916	TCGA-QR-A70E-01	0	0	0	0	PASS	7724	TCGA-QR-A70E	PCPG	31	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-11400	Alive	TUMOR FREE	192	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	192	0	192	0	192	0	192	
50	TCGA-QR-A70G	0	0	0	0	0	0	0	0	1	11	1	0	0	7	0	0	TCGA-QR-A70G-01	85	0.01145548399335828	32	TCGA-QR-A70G-01	1	1	14	0.012854682591024005	TCGA-QR-A70G-01	0	0	0	0	PASS	7725	TCGA-QR-A70G	PCPG	54	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pheochromocytoma	NA	2011	NA	-19914	Alive	TUMOR FREE	71	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	71	0	71	0	71	0	71	
40	TCGA-QR-A70H	0	0	0	0	1	0	0	0	0	10	0	0	0	3	0	0	TCGA-QR-A70H-01	99	0.6420728897951207	42	TCGA-QR-A70H-01	5	4	53	0.1398238274274334	TCGA-QR-A70H-01	3	4	4	11	PASS	7726	TCGA-QR-A70H	PCPG	36	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2007	NA	-13314	Alive	TUMOR FREE	816	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	816	0	816	0	816	0	816	
30	TCGA-QR-A70I	0	2	0	0	0	0	0	0	0	4	0	0	0	0	0	0	TCGA-QR-A70I-01	91	0.023773068168793043	39	TCGA-QR-A70I-01	2	1	27	0.014827278840418472	TCGA-QR-A70I-01	2	1	1	4	PASS	7727	TCGA-QR-A70I	PCPG	24	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Paraganglioma	NA	2010	NA	-9070	Alive	TUMOR FREE	910	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	910	0	910	0	910	0	910	
40	TCGA-QR-A70J	0	1	0	1	0	0	0	0	0	10	1	0	1	5	0	0	TCGA-QR-A70J-01	51	0.15422624827456294	11	TCGA-QR-A70J-01	6	4	45	0.16375964479939584	TCGA-QR-A70J-01	2	0	2	4	PASS	7728	TCGA-QR-A70J	PCPG	42	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-15420	Alive	TUMOR FREE	399	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	399	0	399	0	399	0	399	
60	TCGA-QR-A70K	0	4	0	1	0	0	0	0	0	21	1	0	0	6	0	0	TCGA-QR-A70K-01	105	0.9665035888098528	50	TCGA-QR-A70K-01	11	9	71	0.2140942951562956	TCGA-QR-A70K-01	8	2	6	16	PASS	7729	TCGA-QR-A70K	PCPG	61	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-22519	Alive	TUMOR FREE	274	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	274	0	274	0	274	0	274	
40	TCGA-QR-A70M	0	0	0	0	0	0	0	0	0	7	1	0	1	2	0	0	TCGA-QR-A70M	0	0	0	TCGA-QR-A70M	0	0	0	0	TCGA-QR-A70M	0	0	0	0	PASS	7730	TCGA-QR-A70M	PCPG	38	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2010	NA	-14091	Alive	TUMOR FREE	1034	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1034	0	1034	0	1034	0	1034	
30	TCGA-QR-A70N	0	1	0	0	1	0	0	0	2	11	1	0	0	2	0	0	TCGA-QR-A70N-01	90	0.6389868840519448	41	TCGA-QR-A70N-01	27	12	49	0.134035543058892	TCGA-QR-A70N-01	0	0	0	0	PASS	7731	TCGA-QR-A70N	PCPG	32	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pheochromocytoma	NA	2008	NA	-11781	Alive	TUMOR FREE	43	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	43	0	43	0	43	0	43	
40	TCGA-QR-A70O	1	1	2	0	1	0	0	0	0	11	0	0	0	1	1	0	TCGA-QR-A70O	0	0	0	TCGA-QR-A70O	0	0	0	0	TCGA-QR-A70O	0	0	0	0	PASS	7732	TCGA-QR-A70O	PCPG	35	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-13076	Alive	TUMOR FREE	111	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	111	0	111	0	111	0	111	
50	TCGA-QR-A70P	0	1	0	2	0	0	0	0	1	19	1	0	1	8	1	0	TCGA-QR-A70P-01	53	0.1440132468892826	15	TCGA-QR-A70P-01	4	4	26	0.09635006806119296	TCGA-QR-A70P-01	2	2	3	7	PASS	7733	TCGA-QR-A70P	PCPG	45	FEMALE	WHITE	NA	NA	Paraganglioma	NA	2004	NA	-16655	Dead	WITH TUMOR	NA	3563	NA	Locoregional Disease	"Other, specify"	L jugular area	648	Progressive Disease	NA	NA	1	3563	1	3563	NA	NA	1	648	
30	TCGA-QR-A70Q	0	1	0	1	0	0	0	0	0	8	0	0	0	0	1	0	TCGA-QR-A70Q	0	0	0	TCGA-QR-A70Q	0	0	0	0	TCGA-QR-A70Q	0	0	0	0	PASS	7734	TCGA-QR-A70Q	PCPG	33	MALE	WHITE	NA	NA	Paraganglioma; Extra-adrenal Pheochromocytoma	NA	2012	NA	-12394	Alive	TUMOR FREE	140	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	140	0	140	0	140	0	140	
40	TCGA-QR-A70R	0	2	0	1	0	0	0	0	0	7	1	0	1	2	0	0	TCGA-QR-A70R-01	1649	0.6159500956619319	1572	TCGA-QR-A70R	0	0	0	0	TCGA-QR-A70R	0	0	0	0	PASS	7735	TCGA-QR-A70R	PCPG	43	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-15917	Alive	TUMOR FREE	432	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	432	0	432	0	432	0	432	
40	TCGA-QR-A70T	0	0	0	0	1	0	0	0	0	9	0	0	1	6	0	0	TCGA-QR-A70T	0	0	0	TCGA-QR-A70T	0	0	0	0	TCGA-QR-A70T	0	0	0	0	PASS	7736	TCGA-QR-A70T	PCPG	40	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Paraganglioma	NA	2011	NA	-14780	Alive	TUMOR FREE	267	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	267	0	267	0	267	0	267	
50	TCGA-QR-A70U	0	0	0	0	2	0	0	0	0	13	2	0	0	4	1	0	TCGA-QR-A70U	0	0	0	TCGA-QR-A70U	0	0	0	0	TCGA-QR-A70U	0	0	0	0	PASS	7737	TCGA-QR-A70U	PCPG	46	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2009	NA	-17062	Alive	TUMOR FREE	1473	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1473	0	1473	0	1473	0	1473	
70	TCGA-QR-A70V	1	0	1	0	1	0	0	0	0	11	1	0	0	2	0	0	TCGA-QR-A70V	0	0	0	TCGA-QR-A70V	0	0	0	0	TCGA-QR-A70V	0	0	0	0	PASS	7738	TCGA-QR-A70V	PCPG	66	FEMALE	[Unknown]	NA	NA	Pheochromocytoma	NA	2012	NA	-24437	Alive	TUMOR FREE	2	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2	0	2	0	2	0	2	
40	TCGA-QR-A70W	0	0	0	0	1	0	0	0	0	3	0	0	0	1	1	0	TCGA-QR-A70W-01	54	0.935573672943362	13	TCGA-QR-A70W-01	5	7	32	0.15410342763985338	TCGA-QR-A70W-01	5	1	5	11	PASS	7739	TCGA-QR-A70W	PCPG	40	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2009	NA	-14613	Alive	TUMOR FREE	1271	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1271	0	1271	0	1271	0	1271	
50	TCGA-QR-A70X	0	1	0	0	0	0	0	0	1	5	0	0	0	3	0	0	TCGA-QR-A70X-01	326	0.09182644193237068	264	TCGA-QR-A70X-01	3	2	78	0.08756040621349402	TCGA-QR-A70X-01	3	0	3	6	PASS	7740	TCGA-QR-A70X	PCPG	46	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pheochromocytoma	NA	2012	NA	-16828	Alive	TUMOR FREE	183	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	183	0	183	0	183	0	183	
50	TCGA-QR-A7IN	0	1	0	0	0	0	0	0	1	6	0	0	2	4	0	0	TCGA-QR-A7IN-01	90	0.7002258364285401	36	TCGA-QR-A7IN-01	9	7	11	0.025237457263445392	TCGA-QR-A7IN-01	2	1	3	6	PASS	7741	TCGA-QR-A7IN	PCPG	52	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pheochromocytoma	NA	2011	NA	-19237	Alive	TUMOR FREE	377	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	377	0	377	0	377	0	377	
30	TCGA-QR-A7IP	0	0	0	0	0	0	0	0	0	10	1	0	1	2	0	0	TCGA-QR-A7IP-01	50	0.9476173251911006	12	TCGA-QR-A7IP-01	11	9	21	0.06255896639603355	TCGA-QR-A7IP-01	2	1	2	5	PASS	7742	TCGA-QR-A7IP	PCPG	30	MALE	WHITE	NA	NA	Paraganglioma	NA	2012	NA	-11051	Alive	TUMOR FREE	546	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	546	0	546	0	546	0	546	
40	TCGA-QT-A5XJ	0	3	0	1	0	2	0	0	2	16	2	0	0	7	1	0	TCGA-QT-A5XJ-01	211	0.9208314705893548	130	TCGA-QT-A5XJ-01	3	4	70	0.1956576880457513	TCGA-QT-A5XJ-01	4	4	3	11	PASS	7743	TCGA-QT-A5XJ	PCPG	42	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pheochromocytoma	NA	2011	NA	-15535	Alive	WITH TUMOR	1102	NA	NA	Distant Metastasis	"Other, specify"	Bilateral Breasts SubQ Tissue	77	Progressive Disease	NA	NA	0	1102	0	1102	NA	NA	1	77	
60	TCGA-QT-A5XK	0	0	0	0	0	0	0	0	0	7	1	0	0	4	0	0	TCGA-QT-A5XK-01	111	0.9214667189959456	45	TCGA-QT-A5XK-01	6	5	50	0.1781802434723087	TCGA-QT-A5XK-01	4	0	4	8	PASS	7744	TCGA-QT-A5XK	PCPG	56	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pheochromocytoma	NA	2011	NA	-20724	Alive	TUMOR FREE	211	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	211	0	211	0	211	0	211	
30	TCGA-QT-A5XL	0	0	0	0	0	0	0	0	1	4	0	0	0	3	0	0	TCGA-QT-A5XL-01	113	0.11825742905039008	51	TCGA-QT-A5XL-01	1	3	27	0.07686996136531081	TCGA-QT-A5XL-01	5	6	5	16	PASS	7745	TCGA-QT-A5XL	PCPG	27	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2010	NA	-10028	Alive	TUMOR FREE	55	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	55	0	55	0	55	0	55	
40	TCGA-QT-A5XM	1	0	0	0	0	0	0	0	0	7	0	0	0	3	0	0	TCGA-QT-A5XM-01	83	0.189171324186614	24	TCGA-QT-A5XM-01	4	5	59	0.14914344041313593	TCGA-QT-A5XM-01	3	1	3	7	PASS	7746	TCGA-QT-A5XM	PCPG	43	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-15915	Alive	TUMOR FREE	22	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	22	0	22	0	22	0	22	
50	TCGA-QT-A5XN	0	0	0	0	1	0	0	0	2	7	0	0	0	6	0	1	TCGA-QT-A5XN-01	148	0.9460976866815376	74	TCGA-QT-A5XN-01	6	6	66	0.1862781246796008	TCGA-QT-A5XN-01	4	6	8	18	PASS	7747	TCGA-QT-A5XN	PCPG	51	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pheochromocytoma	NA	2010	NA	-18812	Alive	TUMOR FREE	766	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	766	0	766	0	766	0	766	
60	TCGA-QT-A5XO	0	1	0	0	2	0	0	0	0	19	0	0	0	6	0	0	TCGA-QT-A5XO-01	212	0.6157339616296921	124	TCGA-QT-A5XO-01	2	3	44	0.1077656938048206	TCGA-QT-A5XO-01	6	7	6	19	PASS	7748	TCGA-QT-A5XO	PCPG	63	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pheochromocytoma	NA	2012	NA	-23154	Alive	TUMOR FREE	70	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	70	0	70	0	70	0	70	
60	TCGA-QT-A5XP	0	0	0	1	1	0	0	0	2	12	0	0	0	5	1	0	TCGA-QT-A5XP-01	97	0.2013474169227628	39	TCGA-QT-A5XP-01	4	5	40	0.11014113571230597	TCGA-QT-A5XP-01	3	5	5	13	PASS	7749	TCGA-QT-A5XP	PCPG	57	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pheochromocytoma	NA	2012	NA	-21072	Alive	TUMOR FREE	134	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	134	0	134	0	134	0	134	
40	TCGA-QT-A69Q	0	1	0	0	0	0	1	0	0	9	0	0	0	2	0	0	TCGA-QT-A69Q-01	48	0.9477296286653284	10	TCGA-QT-A69Q-01	18	29	34	0.12256402692037333	TCGA-QT-A69Q-01	1	0	0	1	PASS	7750	TCGA-QT-A69Q	PCPG	40	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-14866	Alive	TUMOR FREE	24	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	24	0	24	0	24	0	24	
60	TCGA-QT-A7U0	0	1	0	0	0	0	0	0	0	3	0	0	0	3	0	0	TCGA-QT-A7U0-01	39	0.07834948356912673	4	TCGA-QT-A7U0-01	4	3	17	0.025999099485444512	TCGA-QT-A7U0-01	2	0	2	4	PASS	7751	TCGA-QT-A7U0	PCPG	56	MALE	WHITE	NA	NA	Paraganglioma; Extra-adrenal Pheochromocytoma	NA	2013	NA	-20538	Alive	TUMOR FREE	398	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	398	0	398	0	398	0	398	
50	TCGA-RM-A68T	0	0	0	0	1	0	0	0	1	7	1	0	0	3	0	0	TCGA-RM-A68T-01	71	0.13037660615028066	29	TCGA-RM-A68T-01	4	2	34	0.13830335223004295	TCGA-RM-A68T-01	0	0	0	0	PASS	7752	TCGA-RM-A68T	PCPG	46	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Paraganglioma	NA	2007	NA	-17065	Alive	TUMOR FREE	2372	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2372	0	2372	0	2372	0	2372	
40	TCGA-RM-A68W	0	0	0	1	0	0	0	0	0	6	0	0	0	2	0	0	TCGA-RM-A68W-01	70	0.14036945872260342	28	TCGA-RM-A68W-01	5	7	34	0.10500544145350472	TCGA-RM-A68W-01	4	2	4	10	PASS	7753	TCGA-RM-A68W	PCPG	41	FEMALE	WHITE	NA	NA	Paraganglioma; Extra-adrenal Pheochromocytoma	NA	2010	NA	-15273	Alive	TUMOR FREE	28	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	28	0	28	0	28	0	28	
50	TCGA-RT-A6Y9	0	0	0	0	0	1	0	0	0	3	0	0	0	2	0	0	TCGA-RT-A6Y9-01	47	0.07829004599814639	8	TCGA-RT-A6Y9-01	2	1	14	0.07144565887652858	TCGA-RT-A6Y9-01	0	0	0	0	PASS	7754	TCGA-RT-A6Y9	PCPG	50	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2005	NA	-18594	Alive	TUMOR FREE	3293	NA	NA	New Primary Tumor	"Other, specify"	left thigh	3282	Complete Remission/Response	NA	NA	0	3293	0	3293	0	3293	1	3282	
70	TCGA-RT-A6YA	0	1	0	0	0	0	0	0	0	20	0	0	0	3	0	0	TCGA-RT-A6YA-01	38	0.8155200474683143	2	TCGA-RT-A6YA-01	13	10	12	0.05414292372215797	TCGA-RT-A6YA-01	5	0	3	8	PASS	7755	TCGA-RT-A6YA	PCPG	71	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2009	NA	-26095	Alive	TUMOR FREE	1540	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1540	0	1540	0	1540	0	1540	
30	TCGA-RT-A6YC	0	0	0	0	0	1	0	0	0	2	0	0	1	1	0	0	TCGA-RT-A6YC-01	89	0.1306088595747773	35	TCGA-RT-A6YC-01	3	3	22	0.0698300659556143	TCGA-RT-A6YC-01	2	2	2	6	PASS	7756	TCGA-RT-A6YC	PCPG	31	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-11572	Alive	TUMOR FREE	246	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	246	0	246	0	246	0	246	
40	TCGA-RW-A67V	0	2	0	0	0	0	0	0	0	10	1	0	0	2	0	0	TCGA-RW-A67V-01	75	0.07495765841007307	18	TCGA-RW-A67V-01	1	3	38	0.10636807168380012	TCGA-RW-A67V-01	3	2	4	9	PASS	7757	TCGA-RW-A67V	PCPG	44	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2004	NA	-16139	Alive	TUMOR FREE	2643	NA	NA	Locoregional Disease	"Other, specify"	Left adrenal	551	Progressive Disease	NA	NA	0	2643	0	2643	NA	NA	1	551	
50	TCGA-RW-A67W	0	1	0	0	0	0	0	0	0	8	0	0	0	2	0	0	TCGA-RW-A67W-01	84	0.1079884477790026	34	TCGA-RW-A67W-01	2	3	54	0.11798312246117296	TCGA-RW-A67W-01	2	4	6	12	PASS	7758	TCGA-RW-A67W	PCPG	46	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2010	NA	-16983	Alive	TUMOR FREE	604	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	604	0	604	0	604	0	604	
50	TCGA-RW-A67X	0	0	0	1	0	0	0	1	0	7	2	0	0	4	0	0	TCGA-RW-A67X-01	62	0.2119303417969628	20	TCGA-RW-A67X-01	9	5	28	0.120218433703739	TCGA-RW-A67X-01	1	0	2	3	PASS	7759	TCGA-RW-A67X	PCPG	47	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2003	NA	-17307	Alive	TUMOR FREE	89	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	89	0	89	0	89	0	89	
40	TCGA-RW-A67Y	0	2	0	0	1	0	0	0	0	6	1	0	0	6	0	0	TCGA-RW-A67Y-01	96	0.9471260251837026	39	TCGA-RW-A67Y-01	5	6	63	0.20625358081198092	TCGA-RW-A67Y-01	2	6	5	13	PASS	7760	TCGA-RW-A67Y	PCPG	43	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-15729	Alive	TUMOR FREE	216	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	216	0	216	0	216	0	216	
60	TCGA-RW-A680	0	0	0	1	0	0	1	0	4	19	0	0	1	8	1	0	TCGA-RW-A680-01	44	0.14292870445808414	10	TCGA-RW-A680-01	4	2	30	0.11608006011167472	TCGA-RW-A680-01	2	0	1	3	PASS	7761	TCGA-RW-A680	PCPG	57	FEMALE	WHITE	NA	NA	Paraganglioma; Extra-adrenal Pheochromocytoma	NA	2011	NA	-21010	Alive	TUMOR FREE	1449	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1449	0	1449	0	1449	0	1449	
60	TCGA-RW-A681	0	0	0	0	2	0	0	0	1	17	0	0	0	5	2	0	TCGA-RW-A681-01	114	0.7016750855401068	51	TCGA-RW-A681-01	21	13	49	0.10094817668028064	TCGA-RW-A681-01	2	2	3	7	PASS	7762	TCGA-RW-A681	PCPG	56	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-20812	Alive	TUMOR FREE	1141	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1141	0	1141	0	1141	0	1141	
60	TCGA-RW-A684	0	1	0	0	2	0	0	0	0	7	1	0	0	9	0	0	TCGA-RW-A684-01	80	0.13309176808130266	24	TCGA-RW-A684-01	3	3	23	0.07045048546219156	TCGA-RW-A684-01	2	1	2	5	PASS	7763	TCGA-RW-A684	PCPG	64	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-23440	Alive	TUMOR FREE	32	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	32	0	32	0	32	0	32	
70	TCGA-RW-A685	0	0	0	0	0	0	0	0	0	9	0	0	0	4	0	0	TCGA-RW-A685-01	54	0.12260973758879833	11	TCGA-RW-A685-01	4	3	26	0.0988023990422908	TCGA-RW-A685-01	3	1	3	7	PASS	7764	TCGA-RW-A685	PCPG	70	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-25790	Alive	TUMOR FREE	26	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	26	0	26	0	26	0	26	
60	TCGA-RW-A686	0	2	0	0	1	0	2	0	0	14	1	0	0	7	0	0	TCGA-RW-A686-01	95	0.04374619982719758	31	TCGA-RW-A686-06	1	1	14	0.04850335543610016	TCGA-RW-A686-06	2	1	1	4	mutation call filter	7765	TCGA-RW-A686	PCPG	62	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-22718	Alive	TUMOR FREE	587	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	587	0	587	0	587	0	587	
70	TCGA-RW-A688	0	0	0	0	2	0	0	0	0	10	0	0	1	4	0	0	TCGA-RW-A688-01	110	0.20014508986415824	48	TCGA-RW-A688-01	4	4	28	0.09778712956670613	TCGA-RW-A688-01	6	5	4	15	PASS	7766	TCGA-RW-A688	PCPG	69	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-25216	Alive	TUMOR FREE	37	NA	NA	New Primary Tumor	Lung	NA	27	Complete Remission/Response	NA	NA	0	37	0	37	0	37	1	27	
60	TCGA-RW-A689	0	1	0	1	1	0	0	0	1	6	1	0	1	3	1	0	TCGA-RW-A689-01	50	0.27809114983444944	13	TCGA-RW-A689-01	5	4	44	0.17827288679682432	TCGA-RW-A689-01	0	2	4	6	PASS	7767	TCGA-RW-A689	PCPG	58	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-21402	Alive	TUMOR FREE	828	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	828	0	828	0	828	0	828	
20	TCGA-RW-A68A	0	1	0	0	0	0	0	0	0	4	0	0	0	4	0	0	TCGA-RW-A68A-01	62	0.9038832545722918	18	TCGA-RW-A68A-01	8	7	60	0.2568490058333405	TCGA-RW-A68A-01	2	2	3	7	PASS	7768	TCGA-RW-A68A	PCPG	19	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-7248	Alive	TUMOR FREE	762	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	762	0	762	0	762	0	762	
30	TCGA-RW-A68B	1	0	0	0	0	0	0	0	1	5	0	0	0	0	0	0	TCGA-RW-A68B-01	49	0.12195767427347727	12	TCGA-RW-A68B-01	4	3	30	0.08383274712039708	TCGA-RW-A68B-01	2	0	2	4	PASS	7769	TCGA-RW-A68B	PCPG	31	MALE	[Not Evaluated]	NA	NA	Pheochromocytoma	NA	2013	NA	-11557	Alive	TUMOR FREE	727	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	727	0	727	0	727	0	727	
40	TCGA-RW-A68C	0	0	0	0	0	0	0	0	1	10	0	0	0	2	0	0	TCGA-RW-A68C-01	61	0.4630359517096233	22	TCGA-RW-A68C-01	5	3	38	0.1844991448047427	TCGA-RW-A68C-01	0	2	2	4	PASS	7770	TCGA-RW-A68C	PCPG	43	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-15962	Alive	TUMOR FREE	191	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	191	0	191	0	191	0	191	
30	TCGA-RW-A68D	0	1	0	1	0	0	0	0	1	8	2	0	0	2	0	0	TCGA-RW-A68D-01	140	0.1153317669921378	70	TCGA-RW-A68D-01	3	3	27	0.04225022059984692	TCGA-RW-A68D-01	5	3	3	11	PASS	7771	TCGA-RW-A68D	PCPG	31	FEMALE	ASIAN	NA	NA	Pheochromocytoma	NA	2006	NA	-11438	Alive	TUMOR FREE	2214	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2214	0	2214	0	2214	0	2214	
50	TCGA-RW-A68F	0	1	0	0	1	0	0	0	0	8	0	0	0	7	0	0	TCGA-RW-A68F-01	63	0.11682331280895232	19	TCGA-RW-A68F-01	5	4	17	0.05712286958108528	TCGA-RW-A68F-01	2	0	1	3	PASS	7772	TCGA-RW-A68F	PCPG	51	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2010	NA	-18974	Alive	TUMOR FREE	1354	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1354	0	1354	0	1354	0	1354	
50	TCGA-RW-A68G	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	TCGA-RW-A68G-01	65	0.08645538535595139	19	TCGA-RW-A68G-01	3	5	24	0.07860430209828392	TCGA-RW-A68G-01	4	1	3	8	PASS	7773	TCGA-RW-A68G	PCPG	49	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-17959	Alive	TUMOR FREE	1274	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1274	0	1274	0	1274	0	1274	
70	TCGA-RW-A7CZ	1	0	0	0	0	0	0	0	0	8	1	0	1	7	0	0	TCGA-RW-A7CZ-01	55	0.113343649140615	16	TCGA-RW-A7CZ-01	4	4	12	0.048584734141137086	TCGA-RW-A7CZ-01	0	0	0	0	PASS	7774	TCGA-RW-A7CZ	PCPG	72	FEMALE	WHITE	NA	NA	Paraganglioma; Extra-adrenal Pheochromocytoma	NA	2013	NA	-26657	Alive	TUMOR FREE	422	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	422	0	422	0	422	0	422	
50	TCGA-RW-A7D0	0	0	0	0	1	0	0	0	0	4	2	0	0	3	2	0	TCGA-RW-A7D0-01	73	0.10173461198145507	31	TCGA-RW-A7D0-01	3	4	33	0.1207905105123989	TCGA-RW-A7D0-01	2	3	2	7	PASS	7775	TCGA-RW-A7D0	PCPG	47	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-17422	Alive	TUMOR FREE	352	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	352	0	352	0	352	0	352	
70	TCGA-RW-A8AZ	0	0	0	0	2	0	0	0	0	19	1	0	0	9	1	0	TCGA-RW-A8AZ-01	168	0.1376984726398353	95	TCGA-RW-A8AZ-01	4	5	61	0.09502783733078736	TCGA-RW-A8AZ-01	7	4	5	16	PASS	7776	TCGA-RW-A8AZ	PCPG	66	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-24268	Dead	TUMOR FREE	NA	88	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	88	0	88	NA	NA	0	88	
40	TCGA-RX-A8JQ	0	0	0	1	0	0	0	0	0	10	0	0	0	1	0	0	TCGA-RX-A8JQ-01	53	0.1082511144039344	17	TCGA-RX-A8JQ-01	3	3	17	0.04440204009499947	TCGA-RX-A8JQ-01	2	1	1	4	PASS	7777	TCGA-RX-A8JQ	PCPG	44	MALE	WHITE	NA	NA	Paraganglioma	NA	2013	NA	-16182	Alive	TUMOR FREE	611	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	611	0	611	0	611	0	611	
60	TCGA-S7-A7WL	0	1	0	0	3	0	0	0	2	8	0	0	0	4	0	0	TCGA-S7-A7WL-01	82	0.26954176402593605	31	TCGA-S7-A7WL-01	8	9	44	0.15441866833705867	TCGA-S7-A7WL-01	5	6	6	17	PASS	7778	TCGA-S7-A7WL	PCPG	59	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-21643	Alive	TUMOR FREE	961	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	961	0	961	0	961	0	961	
80	TCGA-S7-A7WM	0	2	0	1	0	1	0	0	1	11	1	0	0	3	0	0	TCGA-S7-A7WM-01	82	0.12849151693765254	28	TCGA-S7-A7WM-01	4	6	19	0.07399959730635515	TCGA-S7-A7WM-01	3	5	4	12	PASS	7779	TCGA-S7-A7WM	PCPG	76	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-27984	Alive	TUMOR FREE	1112	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1112	0	1112	0	1112	0	1112	
40	TCGA-S7-A7WN	0	0	0	0	0	0	0	0	0	4	0	0	0	3	1	0	TCGA-S7-A7WN-01	53	0.1478137620061788	16	TCGA-S7-A7WN-01	4	4	32	0.09555353839740274	TCGA-S7-A7WN-01	4	4	3	11	PASS	7780	TCGA-S7-A7WN	PCPG	40	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-14611	Alive	TUMOR FREE	1133	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1133	0	1133	0	1133	0	1133	
80	TCGA-S7-A7WO	0	0	0	0	0	0	0	0	1	3	0	0	0	1	0	0	TCGA-S7-A7WO-01	57	2.569783444607813e-05	15	TCGA-S7-A7WO-01	0	0	6	0.00011132650198740069	TCGA-S7-A7WO-01	0	0	0	0	PASS	7781	TCGA-S7-A7WO	PCPG	76	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-28114	Alive	TUMOR FREE	1080	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1080	0	1080	0	1080	0	1080	
30	TCGA-S7-A7WP	0	0	0	0	0	0	0	0	0	3	0	0	0	1	0	0	TCGA-S7-A7WP-01	47	0.1335409723444667	9	TCGA-S7-A7WP-01	6	5	27	0.13513967316169925	TCGA-S7-A7WP-01	0	0	0	0	PASS	7782	TCGA-S7-A7WP	PCPG	25	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-9241	Alive	TUMOR FREE	944	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	944	0	944	0	944	0	944	
20	TCGA-S7-A7WQ	2	0	0	0	0	0	0	0	0	8	1	0	0	3	0	0	TCGA-S7-A7WQ-01	61	0.881222401019078	15	TCGA-S7-A7WQ-01	10	7	19	0.12024213172886468	TCGA-S7-A7WQ-01	0	0	2	2	PASS	7783	TCGA-S7-A7WQ	PCPG	19	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-7269	Alive	TUMOR FREE	820	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	820	0	820	0	820	0	820	
30	TCGA-S7-A7WR	0	0	0	0	0	0	0	0	0	3	0	0	0	1	0	0	TCGA-S7-A7WR-01	84	0.9471940204211808	34	TCGA-S7-A7WR-01	8	6	72	0.2525375274868577	TCGA-S7-A7WR-01	1	1	2	4	PASS	7784	TCGA-S7-A7WR	PCPG	32	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-12011	Alive	TUMOR FREE	1238	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1238	0	1238	0	1238	0	1238	
70	TCGA-S7-A7WT	0	0	0	0	1	0	1	0	0	12	1	0	0	6	2	0	TCGA-S7-A7WT-01	111	0.09045614472320393	47	TCGA-S7-A7WT-01	3	3	46	0.08726060225178316	TCGA-S7-A7WT-01	3	1	5	9	PASS	7785	TCGA-S7-A7WT	PCPG	74	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-27311	Alive	TUMOR FREE	1301	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1301	0	1301	0	1301	0	1301	
60	TCGA-S7-A7WU	0	1	0	0	0	0	0	0	0	2	0	0	0	2	0	0	TCGA-S7-A7WU-01	29	0.04604941248754029	3	TCGA-S7-A7WU-01	2	1	9	0.048735388408496304	TCGA-S7-A7WU-01	0	0	0	0	PASS	7786	TCGA-S7-A7WU	PCPG	63	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-23187	Alive	TUMOR FREE	928	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	928	0	928	0	928	0	928	
40	TCGA-S7-A7WV	0	0	0	0	0	0	0	0	0	5	0	0	0	1	0	0	TCGA-S7-A7WV-01	55	1.3221426042427445e-05	15	TCGA-S7-A7WV-01	1	1	11	0.02983264997827289	TCGA-S7-A7WV-01	1	0	1	2	PASS	7787	TCGA-S7-A7WV	PCPG	35	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-12893	Alive	TUMOR FREE	849	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	849	0	849	0	849	0	849	
30	TCGA-S7-A7WW	0	0	0	1	0	0	0	0	0	7	0	0	0	2	1	0	TCGA-S7-A7WW-01	52	0.2050396532241991	16	TCGA-S7-A7WW-01	10	7	12	0.05703062186267499	TCGA-S7-A7WW-01	1	0	1	2	PASS	7788	TCGA-S7-A7WW	PCPG	34	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-12729	Alive	TUMOR FREE	706	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	706	0	706	0	706	0	706	
50	TCGA-S7-A7WX	1	0	0	0	0	0	0	0	0	2	2	1	0	3	0	0	TCGA-S7-A7WX-01	81	0.15988035937160855	32	TCGA-S7-A7WX-01	4	4	29	0.10134820638287947	TCGA-S7-A7WX-01	4	0	4	8	PASS	7789	TCGA-S7-A7WX	PCPG	52	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-19190	Alive	TUMOR FREE	770	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	770	0	770	0	770	0	770	
80	TCGA-S7-A7X0	0	0	0	0	0	0	0	0	2	14	0	0	0	4	1	0	TCGA-S7-A7X0-01	48	0.16387389970466198	6	TCGA-S7-A7X0-01	6	5	7	0.04828835817857681	TCGA-S7-A7X0-01	2	1	1	4	PASS	7790	TCGA-S7-A7X0	PCPG	75	FEMALE	WHITE	NA	NA	Paraganglioma; Extra-adrenal Pheochromocytoma	NA	2013	NA	-27729	Alive	TUMOR FREE	546	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	546	0	546	0	546	0	546	
30	TCGA-S7-A7X1	0	0	0	0	0	0	0	0	0	7	0	0	0	1	0	0	TCGA-S7-A7X1-01	51	0.4796835912952333	14	TCGA-S7-A7X1-01	6	3	31	0.15034862245252356	TCGA-S7-A7X1-01	0	0	0	0	PASS	7791	TCGA-S7-A7X1	PCPG	23	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-8426	Alive	TUMOR FREE	576	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	576	0	576	0	576	0	576	
60	TCGA-S7-A7X2	0	0	0	0	1	0	0	0	0	10	1	1	0	6	0	0	TCGA-S7-A7X2-01	69	0.2100298428601722	20	TCGA-S7-A7X2-01	5	4	34	0.11102913442012216	TCGA-S7-A7X2-01	4	0	4	8	PASS	7792	TCGA-S7-A7X2	PCPG	57	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-21054	Alive	TUMOR FREE	736	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	736	0	736	0	736	0	736	
50	TCGA-SA-A6C2	0	1	0	0	2	1	0	0	0	18	1	0	1	6	0	0	TCGA-SA-A6C2-01	51	1.0442196200927583e-05	15	TCGA-SA-A6C2-01	0	0	9	0.0002537323928123037	TCGA-SA-A6C2-01	0	0	0	0	PASS	7793	TCGA-SA-A6C2	PCPG	46	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Paraganglioma; Extra-adrenal Pheochromocytoma	NA	2012	NA	-16805	Alive	TUMOR FREE	296	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	296	0	296	0	296	0	296	
50	TCGA-SP-A6QC	0	0	0	2	0	0	0	0	1	8	0	0	0	2	0	0	TCGA-SP-A6QC-01	46	0.17072682469824516	10	TCGA-SP-A6QC-01	5	4	21	0.11161908778999574	TCGA-SP-A6QC-01	2	1	2	5	PASS	7794	TCGA-SP-A6QC	PCPG	46	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2004	NA	-16891	Alive	TUMOR FREE	3491	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3491	0	3491	0	3491	0	3491	
30	TCGA-SP-A6QD	0	0	0	0	1	0	0	0	0	5	0	0	0	1	0	0	TCGA-SP-A6QD-01	71	0.15037826954702496	26	TCGA-SP-A6QD-01	3	4	33	0.057366836534423836	TCGA-SP-A6QD-01	3	2	1	6	PASS	7795	TCGA-SP-A6QD	PCPG	26	MALE	[Not Evaluated]	NA	NA	Pheochromocytoma	NA	2004	NA	-9829	Alive	TUMOR FREE	3323	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3323	0	3323	0	3323	0	3323	
50	TCGA-SP-A6QF	0	1	0	0	1	0	0	0	0	12	0	0	0	5	0	0	TCGA-SP-A6QF-01	103	0.2355073825483852	46	TCGA-SP-A6QF-01	5	7	43	0.17990891701989975	TCGA-SP-A6QF-01	4	3	7	14	PASS	7796	TCGA-SP-A6QF	PCPG	48	MALE	ASIAN	NA	NA	Pheochromocytoma	NA	2007	NA	-17795	Alive	TUMOR FREE	2513	NA	NA	New Primary Tumor	"Other, specify"	Thyroid	588	Complete Remission/Response	NA	NA	0	2513	0	2513	0	2513	1	588	
40	TCGA-SP-A6QG	1	0	0	0	0	0	0	0	0	4	0	0	0	3	0	0	TCGA-SP-A6QG-01	93	0.9476237457000596	45	TCGA-SP-A6QG-01	5	5	52	0.19527262919608032	TCGA-SP-A6QG-01	3	0	4	7	PASS	7797	TCGA-SP-A6QG	PCPG	35	FEMALE	WHITE	NA	NA	Paraganglioma	NA	2008	NA	-12874	Alive	TUMOR FREE	2417	NA	NA	New Primary Tumor	"Other, specify"	"Breast, left"	626	Complete Remission/Response	NA	NA	0	2417	0	2417	0	2417	1	626	
40	TCGA-SP-A6QH	0	0	0	0	0	0	0	0	0	7	0	0	2	4	0	0	TCGA-SP-A6QH	0	0	0	TCGA-SP-A6QH	0	0	0	0	TCGA-SP-A6QH	0	0	0	0	PASS	7798	TCGA-SP-A6QH	PCPG	35	FEMALE	ASIAN	NA	NA	Pheochromocytoma	NA	2008	NA	-12876	Alive	TUMOR FREE	2203	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2203	0	2203	0	2203	0	2203	
50	TCGA-SP-A6QI	0	0	0	0	0	0	0	0	1	3	1	0	0	2	0	0	TCGA-SP-A6QI-01	78	0.16332203438935042	30	TCGA-SP-A6QI-01	3	3	28	0.09566095259743396	TCGA-SP-A6QI-01	2	1	4	7	PASS	7799	TCGA-SP-A6QI	PCPG	47	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2005	NA	-17167	Alive	TUMOR FREE	3347	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3347	0	3347	0	3347	0	3347	
60	TCGA-SP-A6QJ	0	0	0	0	2	0	0	0	1	9	0	0	0	2	0	0	TCGA-SP-A6QJ-01	66	0.23476340684518274	23	TCGA-SP-A6QJ-01	3	4	29	0.11308398354959773	TCGA-SP-A6QJ-01	3	3	3	9	PASS	7800	TCGA-SP-A6QJ	PCPG	64	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-23406	Alive	TUMOR FREE	472	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	472	0	472	0	472	0	472	
50	TCGA-SP-A6QK	0	0	0	0	1	0	0	0	1	7	0	0	0	3	0	0	TCGA-SP-A6QK-01	63	0.0995608834405136	23	TCGA-SP-A6QK-01	4	7	30	0.08224060675488473	TCGA-SP-A6QK-01	2	0	2	4	PASS	7801	TCGA-SP-A6QK	PCPG	46	FEMALE	ASIAN	NA	NA	Pheochromocytoma	NA	2005	NA	-16923	Alive	TUMOR FREE	3384	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3384	0	3384	0	3384	0	3384	
50	TCGA-SQ-A6I4	0	0	0	0	0	0	2	0	0	8	0	0	0	4	0	0	TCGA-SQ-A6I4-01	47	0.08750171882425202	10	TCGA-SQ-A6I4-01	2	2	24	0.08253715836329327	TCGA-SQ-A6I4-01	1	1	2	4	PASS	7802	TCGA-SQ-A6I4	PCPG	53	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-19399	Alive	TUMOR FREE	43	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	43	0	43	NA	NA	0	43	
40	TCGA-SQ-A6I6	0	0	0	0	0	1	0	0	0	12	0	0	0	5	0	1	TCGA-SQ-A6I6-01	68	0.8273079835231875	22	TCGA-SQ-A6I6-01	6	4	46	0.15578216479536294	TCGA-SQ-A6I6-01	1	0	3	4	PASS	7803	TCGA-SQ-A6I6	PCPG	39	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-14451	Alive	TUMOR FREE	3	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	3	0	3	NA	NA	0	3	
30	TCGA-SR-A6MP	0	0	0	1	0	0	0	0	1	19	1	0	0	5	0	0	TCGA-SR-A6MP-01	208	0.3247977127899269	167	TCGA-SR-A6MP-01	6	5	93	0.12775784015703215	TCGA-SR-A6MP-01	6	0	2	8	PASS	7804	TCGA-SR-A6MP	PCPG	30	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2009	NA	-11050	Alive	TUMOR FREE	1558	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1558	0	1558	0	1558	0	1558	
60	TCGA-SR-A6MQ	0	1	0	0	0	0	0	0	2	6	0	0	1	4	0	0	TCGA-SR-A6MQ-01	97	0.8631639106158231	43	TCGA-SR-A6MQ-01	5	6	51	0.18596784818652487	TCGA-SR-A6MQ-01	6	5	8	19	PASS	7805	TCGA-SR-A6MQ	PCPG	61	FEMALE	ASIAN	NA	NA	Paraganglioma	NA	2008	NA	-22621	Alive	TUMOR FREE	2087	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2087	0	2087	0	2087	0	2087	
40	TCGA-SR-A6MR	0	0	0	0	0	0	0	0	0	8	1	0	0	0	0	0	TCGA-SR-A6MR	0	0	0	TCGA-SR-A6MR	0	0	0	0	TCGA-SR-A6MR	0	0	0	0	PASS	7806	TCGA-SR-A6MR	PCPG	41	MALE	WHITE	NA	NA	Paraganglioma	NA	2007	NA	-14991	Alive	WITH TUMOR	2409	NA	NA	New Primary Tumor	Retroperitoneum	NA	928	Stable Disease	NA	NA	0	2409	0	2409	NA	NA	1	928	
40	TCGA-SR-A6MS	0	1	0	0	0	0	0	0	1	2	0	0	0	3	2	0	TCGA-SR-A6MS-01	64	0.15200159315553294	22	TCGA-SR-A6MS-01	6	12	56	0.19213044983370986	TCGA-SR-A6MS-01	5	2	3	10	PASS	7807	TCGA-SR-A6MS	PCPG	35	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2007	NA	-12979	Alive	TUMOR FREE	2492	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2492	0	2492	0	2492	0	2492	
60	TCGA-SR-A6MT	0	1	0	0	0	0	0	0	0	5	2	0	0	3	0	0	TCGA-SR-A6MT-01	71	0.9477347266950442	20	TCGA-SR-A6MT-01	24	13	4	0.00023496909991359044	TCGA-SR-A6MT-01	0	0	0	0	PASS	7808	TCGA-SR-A6MT	PCPG	57	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2004	NA	-20944	Alive	TUMOR FREE	3247	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3247	0	3247	0	3247	0	3247	
50	TCGA-SR-A6MU	0	1	0	0	0	0	0	0	0	9	1	0	1	2	0	0	TCGA-SR-A6MU-01	70	0.22892813585621144	28	TCGA-SR-A6MU-01	4	3	27	0.06414635249772667	TCGA-SR-A6MU-01	2	0	2	4	PASS	7809	TCGA-SR-A6MU	PCPG	49	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2004	NA	-18073	Alive	TUMOR FREE	3362	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3362	0	3362	0	3362	0	3362	
40	TCGA-SR-A6MV	0	1	0	0	0	0	0	0	0	7	0	0	0	1	2	0	TCGA-SR-A6MV-01	439	0.3291116136991258	382	TCGA-SR-A6MV-01	10	9	57	0.05981812594313946	TCGA-SR-A6MV-01	3	1	3	7	PASS	7810	TCGA-SR-A6MV	PCPG	35	FEMALE	WHITE	NA	NA	Paraganglioma	NA	2004	NA	-13074	Alive	WITH TUMOR	3682	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	3682	0	3682	NA	NA	0	3682	
60	TCGA-SR-A6MX	0	7	0	5	4	0	0	0	1	45	2	0	0	26	0	0	TCGA-SR-A6MX-01	109	0.9303659515953308	47	TCGA-SR-A6MX-06	8	11	76	0.28121916657680496	TCGA-SR-A6MX-06	12	9	9	30	mutation call filter	7811	TCGA-SR-A6MX	PCPG	55	MALE	WHITE	NA	NA	Paraganglioma	NA	2013	NA	-20186	Dead	WITH TUMOR	NA	95	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	95	1	95	NA	NA	1	95	
50	TCGA-SR-A6MY	0	0	0	0	0	0	0	0	0	5	0	0	0	2	1	0	TCGA-SR-A6MY-01	87	0.3957923892123394	34	TCGA-SR-A6MY-01	3	3	59	0.1582700342842793	TCGA-SR-A6MY-01	5	5	8	18	PASS	7812	TCGA-SR-A6MY	PCPG	54	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-19892	Alive	TUMOR FREE	750	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	750	0	750	0	750	0	750	
50	TCGA-SR-A6MZ	0	0	0	0	0	0	0	0	0	3	0	0	1	3	1	0	TCGA-SR-A6MZ-01	80	0.300942256347956	35	TCGA-SR-A6MZ-01	7	6	31	0.09629259217727547	TCGA-SR-A6MZ-01	4	4	4	12	PASS	7813	TCGA-SR-A6MZ	PCPG	46	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-16802	Alive	TUMOR FREE	797	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	797	0	797	0	797	0	797	
50	TCGA-SR-A6N0	0	1	0	0	1	0	0	0	0	6	1	0	0	1	0	0	TCGA-SR-A6N0-01	45	0.2664625635837436	11	TCGA-SR-A6N0-01	11	6	14	0.04896961982148548	TCGA-SR-A6N0-01	0	0	0	0	PASS	7814	TCGA-SR-A6N0	PCPG	45	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2010	NA	-16489	Alive	TUMOR FREE	1509	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1509	0	1509	0	1509	0	1509	
50	TCGA-TT-A6YJ	0	1	0	0	1	0	0	0	0	6	0	0	0	1	1	0	TCGA-TT-A6YJ-01	1558	0.9396318514963634	1461	TCGA-TT-A6YJ-01	4	4	341	0.16536246476512295	TCGA-TT-A6YJ-01	4	3	8	15	PASS	7815	TCGA-TT-A6YJ	PCPG	45	FEMALE	[Unknown]	NA	NA	Pheochromocytoma	NA	2011	NA	-16475	Alive	TUMOR FREE	132	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	132	0	132	0	132	0	132	
60	TCGA-TT-A6YK	0	2	0	0	0	0	0	0	0	8	0	0	0	6	0	0	TCGA-TT-A6YK-01	54	0.15805821916283447	16	TCGA-TT-A6YK-01	7	7	10	0.01916010986004961	TCGA-TT-A6YK-01	5	1	1	7	PASS	7816	TCGA-TT-A6YK	PCPG	61	MALE	WHITE	NA	NA	Paraganglioma; Extra-adrenal Pheochromocytoma	NA	2011	NA	-22500	Alive	TUMOR FREE	1136	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1136	0	1136	0	1136	0	1136	
40	TCGA-TT-A6YN	0	0	0	0	0	0	0	0	0	3	0	0	0	3	0	0	TCGA-TT-A6YN-01	102	0.17544938492621415	36	TCGA-TT-A6YN-01	5	5	38	0.1016237677214099	TCGA-TT-A6YN-01	5	1	5	11	PASS	7817	TCGA-TT-A6YN	PCPG	37	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-13605	Alive	TUMOR FREE	606	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	606	0	606	0	606	0	606	
60	TCGA-TT-A6YO	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	TCGA-TT-A6YO-01	304	0.0003999459038003366	242	TCGA-TT-A6YO-01	0	0	22	0.002467596097195509	TCGA-TT-A6YO-01	0	0	0	0	PASS	7818	TCGA-TT-A6YO	PCPG	64	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pheochromocytoma	NA	2013	NA	-23554	Alive	TUMOR FREE	405	NA	NA	Biochemical evidence of disease	NA	NA	377	Complete Remission/Response	NA	NA	0	405	0	405	1	377	1	377	
20	TCGA-TT-A6YP	0	0	0	0	0	0	0	0	0	6	0	0	0	5	0	0	TCGA-TT-A6YP-01	64	0.23359289368945615	20	TCGA-TT-A6YP-01	6	3	45	0.1880041809124805	TCGA-TT-A6YP-01	0	0	3	3	PASS	7819	TCGA-TT-A6YP	PCPG	19	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-7240	Alive	TUMOR FREE	1292	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1292	0	1292	0	1292	0	1292	
30	TCGA-W2-A7H5	0	0	0	0	0	0	0	0	1	3	0	0	0	3	0	0	TCGA-W2-A7H5-01	51	0.6816287728967062	11	TCGA-W2-A7H5-01	25	20	21	0.17111792117502514	TCGA-W2-A7H5-01	2	0	0	2	PASS	7820	TCGA-W2-A7H5	PCPG	25	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-9363	Alive	TUMOR FREE	611	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	611	0	611	0	611	0	611	
60	TCGA-W2-A7H7	0	0	0	0	0	0	0	0	0	9	1	0	0	5	0	0	TCGA-W2-A7H7-01	109	0.8238523935341608	42	TCGA-W2-A7H7-01	7	6	61	0.20295361746209634	TCGA-W2-A7H7-01	6	3	8	17	PASS	7821	TCGA-W2-A7H7	PCPG	59	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-21711	Alive	TUMOR FREE	522	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	522	0	522	0	522	0	522	
60	TCGA-W2-A7HA	0	1	1	1	0	0	0	0	1	16	0	0	0	9	0	0	TCGA-W2-A7HA-01	59	0.4804970014934997	16	TCGA-W2-A7HA-01	5	5	37	0.14822187848975735	TCGA-W2-A7HA-01	2	0	2	4	PASS	7822	TCGA-W2-A7HA	PCPG	63	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	NA	Pheochromocytoma	NA	2011	NA	-23059	Alive	TUMOR FREE	36	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	36	0	36	0	36	0	36	
30	TCGA-W2-A7HB	0	0	0	0	0	0	1	0	0	6	2	0	0	3	0	0	TCGA-W2-A7HB-01	99	0.7593264211716783	44	TCGA-W2-A7HB-01	6	8	43	0.1980354388420764	TCGA-W2-A7HB-01	2	2	2	6	PASS	7823	TCGA-W2-A7HB	PCPG	24	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-8979	Alive	TUMOR FREE	604	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	604	0	604	0	604	0	604	
70	TCGA-W2-A7HC	0	1	0	1	0	0	0	0	0	16	0	0	0	4	0	0	TCGA-W2-A7HC-01	76	0.3523565012834136	23	TCGA-W2-A7HC-01	6	6	52	0.15554360570298353	TCGA-W2-A7HC-01	5	0	6	11	PASS	7824	TCGA-W2-A7HC	PCPG	67	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-24834	Alive	TUMOR FREE	439	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	439	0	439	0	439	0	439	
80	TCGA-W2-A7HD	1	2	0	1	0	0	0	0	0	13	0	0	0	2	0	0	TCGA-W2-A7HD-01	85	0.7915169654503749	34	TCGA-W2-A7HD-01	4	5	36	0.13374303559806344	TCGA-W2-A7HD-01	3	1	3	7	PASS	7825	TCGA-W2-A7HD	PCPG	76	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-27962	Alive	TUMOR FREE	561	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	561	0	561	0	561	0	561	
80	TCGA-W2-A7HE	0	0	0	0	0	0	0	0	0	3	0	0	0	3	0	0	TCGA-W2-A7HE-01	47	0.14459479626702484	13	TCGA-W2-A7HE-01	6	4	22	0.06915108744442962	TCGA-W2-A7HE-01	2	0	2	4	PASS	7826	TCGA-W2-A7HE	PCPG	80	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-29241	Alive	TUMOR FREE	505	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	505	0	505	0	505	0	505	
30	TCGA-W2-A7HF	0	1	0	0	0	0	0	0	0	5	0	0	0	0	0	0	TCGA-W2-A7HF-01	77	0.9477275362239904	26	TCGA-W2-A7HF-01	6	6	59	0.20766710952509093	TCGA-W2-A7HF-01	2	2	3	7	PASS	7827	TCGA-W2-A7HF	PCPG	28	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pheochromocytoma	NA	2013	NA	-10436	Alive	TUMOR FREE	538	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	538	0	538	0	538	0	538	
70	TCGA-W2-A7HH	0	0	1	0	0	0	0	0	0	9	0	0	0	3	0	0	TCGA-W2-A7HH-01	41	5.443158038079005e-05	8	TCGA-W2-A7HH-01	0	0	6	0.00021034219043779585	TCGA-W2-A7HH-01	0	0	0	0	PASS	7828	TCGA-W2-A7HH	PCPG	69	FEMALE	WHITE	NA	NA	Paraganglioma	NA	2012	NA	-25291	Alive	TUMOR FREE	779	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	779	0	779	0	779	0	779	
40	TCGA-W2-A7UY	0	3	0	0	0	0	0	0	0	14	1	0	0	8	0	0	TCGA-W2-A7UY-01	78	0.947542634519128	27	TCGA-W2-A7UY-01	11	10	51	0.2736496210606021	TCGA-W2-A7UY-01	6	1	9	16	PASS	7829	TCGA-W2-A7UY	PCPG	44	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-16335	Alive	TUMOR FREE	450	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	450	0	450	NA	NA	0	450	
50	TCGA-WB-A80K	0	2	1	0	0	0	0	0	1	12	0	0	0	1	0	0	TCGA-WB-A80K-01	69	0.17248567608514956	26	TCGA-WB-A80K-01	5	4	24	0.08095535382348464	TCGA-WB-A80K-01	2	1	2	5	PASS	7830	TCGA-WB-A80K	PCPG	49	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-18033	Alive	TUMOR FREE	1255	NA	NA	Distant Metastasis	Lymph Node(s)	NA	772	Complete Remission/Response	NA	NA	0	1255	0	1255	1	772	1	772	
30	TCGA-WB-A80L	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	TCGA-WB-A80L-01	79	0.9470453693778222	31	TCGA-WB-A80L-01	15	15	40	0.12801790839574229	TCGA-WB-A80L-01	3	1	1	5	PASS	7831	TCGA-WB-A80L	PCPG	30	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-10980	Alive	TUMOR FREE	1042	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1042	0	1042	0	1042	0	1042	
60	TCGA-WB-A80M	0	0	0	0	0	0	1	0	1	6	0	0	0	2	1	0	TCGA-WB-A80M-01	97	0.8679455588965215	31	TCGA-WB-A80M-01	3	4	33	0.1396539892576366	TCGA-WB-A80M-01	3	2	4	9	PASS	7832	TCGA-WB-A80M	PCPG	63	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-23163	Alive	TUMOR FREE	136	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	136	0	136	0	136	0	136	
50	TCGA-WB-A80N	0	1	0	0	0	0	0	0	1	10	0	0	0	2	0	0	TCGA-WB-A80N-01	69	0.10124795136508123	23	TCGA-WB-A80N-01	4	4	27	0.09942879373501423	TCGA-WB-A80N-01	1	2	3	6	PASS	7833	TCGA-WB-A80N	PCPG	54	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-19980	Alive	TUMOR FREE	144	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	144	0	144	0	144	0	144	
80	TCGA-WB-A80O	0	0	0	0	0	0	0	0	0	9	0	0	0	3	0	0	TCGA-WB-A80O-01	54	0.12429843622598702	13	TCGA-WB-A80O-01	5	4	30	0.10506659524102666	TCGA-WB-A80O-01	4	1	3	8	PASS	7834	TCGA-WB-A80O	PCPG	83	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-30555	Alive	TUMOR FREE	776	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	776	0	776	0	776	0	776	
30	TCGA-WB-A80P	0	0	0	0	0	0	0	0	1	3	0	0	0	1	1	0	TCGA-WB-A80P-01	55	0.21672025142944354	17	TCGA-WB-A80P-01	1	2	19	0.06648811108096715	TCGA-WB-A80P-01	3	0	3	6	PASS	7835	TCGA-WB-A80P	PCPG	20	MALE	WHITE	NA	NA	Paraganglioma; Extra-adrenal Pheochromocytoma	NA	1988	NA	-7608	Alive	WITH TUMOR	9634	NA	NA	Distant Metastasis	Bone	NA	6866	Progressive Disease	NA	NA	0	9634	0	9634	NA	NA	1	6866	
60	TCGA-WB-A80Q	0	0	1	1	0	0	0	0	0	13	0	0	0	3	0	0	TCGA-WB-A80Q-01	53	0.00014792046389450802	17	TCGA-WB-A80Q-01	0	0	8	0.0007301195376841927	TCGA-WB-A80Q-01	0	0	0	0	PASS	7836	TCGA-WB-A80Q	PCPG	64	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2003	NA	-23653	Alive	TUMOR FREE	3880	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3880	0	3880	0	3880	0	3880	
60	TCGA-WB-A80V	0	1	0	0	0	0	0	0	0	15	2	0	0	3	0	0	TCGA-WB-A80V-01	54	0.9473200473022808	11	TCGA-WB-A80V-01	8	6	47	0.2300741119612509	TCGA-WB-A80V-01	3	0	3	6	PASS	7837	TCGA-WB-A80V	PCPG	63	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-23254	Alive	TUMOR FREE	887	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	887	0	887	0	887	0	887	
60	TCGA-WB-A80Y	0	0	0	1	1	0	0	0	0	6	0	0	0	1	0	0	TCGA-WB-A80Y-01	104	0.07536227069058696	36	TCGA-WB-A80Y-01	2	2	18	0.07154909708891652	TCGA-WB-A80Y-01	2	4	4	10	PASS	7838	TCGA-WB-A80Y	PCPG	59	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-21902	Dead	TUMOR FREE	NA	596	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	596	0	596	0	596	0	596	
40	TCGA-WB-A814	0	0	0	0	0	0	0	0	0	8	1	0	0	0	0	0	TCGA-WB-A814-01	67	0.10276839371483522	30	TCGA-WB-A814-01	3	2	27	0.09956212674479864	TCGA-WB-A814-01	4	5	7	16	PASS	7839	TCGA-WB-A814	PCPG	35	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Paraganglioma; Extra-adrenal Pheochromocytoma	NA	2008	NA	-12936	Alive	TUMOR FREE	2252	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2252	0	2252	0	2252	0	2252	
70	TCGA-WB-A815	0	0	0	0	1	0	0	0	0	15	1	0	0	6	0	0	TCGA-WB-A815-01	76	0.32769132812759577	33	TCGA-WB-A815-01	10	10	49	0.18181183164985484	TCGA-WB-A815-01	6	1	4	11	PASS	7840	TCGA-WB-A815	PCPG	68	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2010	NA	-24859	Alive	TUMOR FREE	1630	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1630	0	1630	0	1630	0	1630	
40	TCGA-WB-A816	0	0	0	0	0	0	0	0	0	9	1	0	0	1	1	0	TCGA-WB-A816-01	52	0.11161586339961638	8	TCGA-WB-A816-01	4	4	29	0.11611995528818835	TCGA-WB-A816-01	4	0	4	8	PASS	7841	TCGA-WB-A816	PCPG	42	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2010	NA	-15400	Alive	TUMOR FREE	1254	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1254	0	1254	0	1254	0	1254	
30	TCGA-WB-A817	0	1	0	0	0	0	1	0	0	7	0	0	0	2	0	0	TCGA-WB-A817-01	55	4.278480865744625e-05	14	TCGA-WB-A817-01	0	2	16	0.03283071460582964	TCGA-WB-A817-01	0	0	0	0	PASS	7842	TCGA-WB-A817	PCPG	27	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-9981	Alive	TUMOR FREE	1310	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1310	0	1310	0	1310	0	1310	
40	TCGA-WB-A818	0	0	0	0	1	0	0	0	1	7	0	0	0	0	1	0	TCGA-WB-A818-01	89	0.1804399855024678	31	TCGA-WB-A818-01	3	3	33	0.10260769018577116	TCGA-WB-A818-01	3	2	3	8	PASS	7843	TCGA-WB-A818	PCPG	37	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-13596	Alive	TUMOR FREE	1288	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1288	0	1288	0	1288	0	1288	
40	TCGA-WB-A819	0	0	0	0	0	0	0	0	0	6	0	0	0	3	0	0	TCGA-WB-A819-01	57	0.35415361022201536	13	TCGA-WB-A819-01	4	3	32	0.15734683261962484	TCGA-WB-A819-01	1	0	2	3	PASS	7844	TCGA-WB-A819	PCPG	36	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-13233	Alive	TUMOR FREE	1031	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1031	0	1031	0	1031	0	1031	
70	TCGA-WB-A81A	0	0	0	0	0	0	0	0	0	6	0	0	0	4	0	0	TCGA-WB-A81A-01	82	0.4310947994567836	30	TCGA-WB-A81A-01	10	8	14	0.02567841953699863	TCGA-WB-A81A-01	4	1	2	7	PASS	7845	TCGA-WB-A81A	PCPG	65	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-23966	Alive	TUMOR FREE	735	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	735	0	735	0	735	0	735	
80	TCGA-WB-A81D	0	2	0	0	0	0	0	0	0	13	0	0	0	4	0	0	TCGA-WB-A81D-01	117	0.1305028415598126	50	TCGA-WB-A81D-01	1	3	35	0.06827745116734077	TCGA-WB-A81D-01	5	8	4	17	PASS	7846	TCGA-WB-A81D	PCPG	82	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-30101	Alive	TUMOR FREE	1090	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1090	0	1090	0	1090	0	1090	
50	TCGA-WB-A81E	0	0	0	0	0	0	0	0	1	15	1	0	0	3	1	0	TCGA-WB-A81E-01	52	0.1205177836757395	17	TCGA-WB-A81E-01	3	2	23	0.1268194984113057	TCGA-WB-A81E-01	1	1	1	3	PASS	7847	TCGA-WB-A81E	PCPG	47	FEMALE	WHITE	NA	NA	Paraganglioma; Extra-adrenal Pheochromocytoma	NA	2011	NA	-17407	Alive	WITH TUMOR	1476	NA	NA	Locoregional Disease	Lymph Node(s)	NA	887	Complete Remission/Response	NA	NA	0	1476	0	1476	1	887	1	887	
40	TCGA-WB-A81F	0	0	0	1	0	0	0	0	0	4	0	0	0	1	0	0	TCGA-WB-A81F-01	110	0.10518085528985592	64	TCGA-WB-A81F-01	2	3	64	0.12028963195878208	TCGA-WB-A81F-01	4	4	6	14	PASS	7848	TCGA-WB-A81F	PCPG	40	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2009	NA	-14933	Alive	TUMOR FREE	1737	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1737	0	1737	0	1737	0	1737	
30	TCGA-WB-A81G	0	0	0	0	0	0	0	0	0	7	0	0	1	4	2	0	TCGA-WB-A81G-01	53	0.1113115824324964	10	TCGA-WB-A81G-01	3	4	34	0.1311294533111309	TCGA-WB-A81G-01	3	0	2	5	PASS	7849	TCGA-WB-A81G	PCPG	25	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-9248	Alive	TUMOR FREE	1179	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1179	0	1179	0	1179	0	1179	
40	TCGA-WB-A81H	0	3	0	0	3	0	0	0	0	8	0	0	0	3	0	0	TCGA-WB-A81H-01	46	0.0872112022158067	8	TCGA-WB-A81H-01	4	4	18	0.08265478233051883	TCGA-WB-A81H-01	1	2	2	5	PASS	7850	TCGA-WB-A81H	PCPG	44	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2009	NA	-16425	Alive	TUMOR FREE	1946	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1946	0	1946	0	1946	0	1946	
60	TCGA-WB-A81I	0	0	0	0	1	0	1	0	0	7	0	0	0	4	1	0	TCGA-WB-A81I-01	67	0.029555677664817637	17	TCGA-WB-A81I-01	1	1	16	0.031425914942077415	TCGA-WB-A81I-01	2	2	2	6	PASS	7851	TCGA-WB-A81I	PCPG	64	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-23566	Alive	TUMOR FREE	679	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	679	0	679	0	679	0	679	
40	TCGA-WB-A81J	0	0	0	0	0	0	0	0	1	8	0	0	0	0	2	0	TCGA-WB-A81J-01	223	0.09768569823102237	172	TCGA-WB-A81J-01	4	3	50	0.0623814760658101	TCGA-WB-A81J-01	4	2	3	9	PASS	7852	TCGA-WB-A81J	PCPG	40	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-14665	Alive	TUMOR FREE	741	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	741	0	741	0	741	0	741	
50	TCGA-WB-A81K	0	2	0	1	0	0	0	0	1	6	0	0	0	1	0	0	TCGA-WB-A81K-01	126	0.7810041774062023	56	TCGA-WB-A81K-01	2	5	54	0.15529249706536796	TCGA-WB-A81K-01	4	7	7	18	PASS	7853	TCGA-WB-A81K	PCPG	45	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2010	NA	-16483	Alive	TUMOR FREE	1218	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1218	0	1218	0	1218	0	1218	
40	TCGA-WB-A81M	0	1	0	0	0	1	0	0	0	7	0	0	1	4	1	0	TCGA-WB-A81M-01	61	0.06288966301230656	20	TCGA-WB-A81M-01	2	4	17	0.0757265650050513	TCGA-WB-A81M-01	3	3	4	10	PASS	7854	TCGA-WB-A81M	PCPG	42	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2010	NA	-15505	Alive	TUMOR FREE	1394	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1394	0	1394	0	1394	0	1394	
30	TCGA-WB-A81N	0	0	0	0	1	0	0	0	1	2	0	0	1	3	0	0	TCGA-WB-A81N-01	64	0.083489297465925	22	TCGA-WB-A81N-01	4	3	30	0.06618052745426907	TCGA-WB-A81N-01	2	2	3	7	PASS	7855	TCGA-WB-A81N	PCPG	28	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2010	NA	-10283	Alive	TUMOR FREE	1887	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1887	0	1887	0	1887	0	1887	
70	TCGA-WB-A81P	0	0	0	1	0	0	0	0	1	18	1	0	0	3	1	0	TCGA-WB-A81P-01	92	0.14290032312442705	36	TCGA-WB-A81P-01	2	4	29	0.0931287113093246	TCGA-WB-A81P-01	2	4	4	10	PASS	7856	TCGA-WB-A81P	PCPG	73	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2011	NA	-26867	Alive	TUMOR FREE	395	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	395	0	395	0	395	0	395	
40	TCGA-WB-A81Q	0	1	0	0	0	0	0	0	2	17	1	0	0	5	0	0	TCGA-WB-A81Q-01	98	0.21266261019169325	43	TCGA-WB-A81Q-01	7	8	50	0.14660622996894926	TCGA-WB-A81Q-01	6	1	4	11	PASS	7857	TCGA-WB-A81Q	PCPG	44	MALE	WHITE	NA	NA	Pheochromocytoma	NA	1997	NA	-16422	Dead	WITH TUMOR	NA	755	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	755	1	755	NA	NA	1	755	
60	TCGA-WB-A81R	0	1	1	2	0	0	0	0	1	7	0	0	1	3	0	0	TCGA-WB-A81R-01	92	0.9470889334442992	38	TCGA-WB-A81R-01	5	6	58	0.15818211380825425	TCGA-WB-A81R-01	5	2	5	12	PASS	7858	TCGA-WB-A81R	PCPG	55	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-20438	Alive	TUMOR FREE	49	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	49	0	49	0	49	0	49	
60	TCGA-WB-A81S	0	0	0	0	0	0	0	0	1	8	0	1	0	5	1	0	TCGA-WB-A81S-01	110	0.9610848521152976	44	TCGA-WB-A81S-01	12	16	36	0.13882288985355262	TCGA-WB-A81S-01	7	7	5	19	PASS	7859	TCGA-WB-A81S	PCPG	59	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2012	NA	-21587	Alive	TUMOR FREE	723	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	723	0	723	0	723	0	723	
50	TCGA-WB-A81T	0	2	0	0	0	0	0	0	0	14	0	0	0	5	1	0	TCGA-WB-A81T-01	59	0.17367261653133048	15	TCGA-WB-A81T-01	6	8	45	0.1718552435082263	TCGA-WB-A81T-01	7	3	7	17	PASS	7860	TCGA-WB-A81T	PCPG	45	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-16506	Alive	TUMOR FREE	776	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	776	0	776	0	776	0	776	
60	TCGA-WB-A81V	0	0	0	1	1	1	0	0	1	6	1	0	0	7	0	0	TCGA-WB-A81V-01	60	0.13084064489543318	20	TCGA-WB-A81V-01	4	2	21	0.10713400086109563	TCGA-WB-A81V-01	1	2	2	5	PASS	7861	TCGA-WB-A81V	PCPG	57	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2006	NA	-21106	Alive	TUMOR FREE	2161	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2161	0	2161	0	2161	0	2161	
40	TCGA-WB-A81W	0	0	0	0	0	0	1	0	0	13	0	0	2	6	0	0	TCGA-WB-A81W-01	130	0.2910990327882938	67	TCGA-WB-A81W-01	7	4	55	0.1481180988063045	TCGA-WB-A81W-01	2	1	3	6	PASS	7862	TCGA-WB-A81W	PCPG	41	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2007	NA	-15001	Alive	TUMOR FREE	2379	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2379	0	2379	0	2379	0	2379	
40	TCGA-WB-A820	0	2	0	0	0	0	0	0	0	9	0	0	0	6	0	0	TCGA-WB-A820	0	0	0	TCGA-WB-A820	0	0	0	0	TCGA-WB-A820-01	16	10	13	39	PASS	7863	TCGA-WB-A820	PCPG	40	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2004	NA	-14949	Dead	WITH TUMOR	NA	309	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	309	1	309	NA	NA	1	309	
70	TCGA-WB-A821	0	2	0	0	0	0	0	0	1	23	0	0	0	5	1	0	TCGA-WB-A821-01	83	0.6869991117362627	40	TCGA-WB-A821-01	25	18	15	0.04912639462218426	TCGA-WB-A821-01	0	0	0	0	PASS	7864	TCGA-WB-A821	PCPG	73	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2006	NA	-26805	Alive	TUMOR FREE	2832	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2832	0	2832	0	2832	0	2832	
30	TCGA-WB-A822	0	0	0	0	0	0	1	0	0	4	0	0	0	3	0	0	TCGA-WB-A822-01	56	0.11165247690313504	13	TCGA-WB-A822-01	4	4	30	0.10885561493816724	TCGA-WB-A822-01	4	0	4	8	PASS	7865	TCGA-WB-A822	PCPG	23	MALE	WHITE	NA	NA	Pheochromocytoma	NA	2006	NA	-8708	Alive	WITH TUMOR	3138	NA	NA	Distant Metastasis	Bone	NA	69	Progressive Disease	NA	NA	0	3138	0	3138	NA	NA	1	69	
30	TCGA-XG-A823	0	0	0	0	0	0	0	0	1	5	0	0	0	5	0	1	TCGA-XG-A823-01	65	0.11343058196059352	19	TCGA-XG-A823-01	2	1	11	0.04873314670951536	TCGA-XG-A823-01	0	0	0	0	PASS	7866	TCGA-XG-A823	PCPG	25	FEMALE	WHITE	NA	NA	Pheochromocytoma	NA	2013	NA	-9149	Alive	TUMOR FREE	614	NA	NA	New Primary Tumor	"Other, specify"	Carotid Body	190	Complete Remission/Response	NA	NA	0	614	0	614	0	614	1	190	
50	TCGA-2A-A8VL	0	2	0	2	0	0	0	0	1	19	1	0	0	9	1	1	TCGA-2A-A8VL-01	117	0.03001346395846268	62	TCGA-2A-A8VL-01	0	0	38	0.03325677659824336	TCGA-2A-A8VL-01	2	3	2	7	PASS	7867	TCGA-2A-A8VL	PRAD	51	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-18658	Alive	TUMOR FREE	621	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	621	0	621	NA	NA	0	621	
60	TCGA-2A-A8VO	2	2	1	0	3	0	0	0	0	22	2	0	0	9	0	0	TCGA-2A-A8VO-01	89	0.021067480476793084	44	TCGA-2A-A8VO-01	0	0	27	0.02346149984855491	TCGA-2A-A8VO-01	0	3	2	5	PASS	7868	TCGA-2A-A8VO	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-20958	Alive	TUMOR FREE	1701	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1701	0	1701	NA	NA	0	1701	
50	TCGA-2A-A8VT	0	5	0	0	0	0	0	0	1	33	4	0	0	11	1	0	TCGA-2A-A8VT-01	104	0.758442951952473	50	TCGA-2A-A8VT-01	14	12	49	0.07682369450488054	TCGA-2A-A8VT-01	7	7	5	19	PASS	7869	TCGA-2A-A8VT	PRAD	47	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-17365	Alive	[Discrepancy]	1373	NA	NA	NA	NA	NA	NA	[Discrepancy]	NA	NA	0	1373	0	1373	NA	NA	0	1373	
50	TCGA-2A-A8VV	1	0	1	0	0	0	0	0	1	21	2	0	0	5	1	0	TCGA-2A-A8VV-01	122	0.059009485481976924	67	TCGA-2A-A8VV-01	0	0	22	0.011447328342610372	TCGA-2A-A8VV-01	0	0	0	0	PASS	7870	TCGA-2A-A8VV	PRAD	52	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-19065	Alive	TUMOR FREE	671	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	671	0	671	NA	NA	0	671	
70	TCGA-2A-A8VX	0	2	0	0	2	0	1	0	1	25	1	0	0	5	1	0	TCGA-2A-A8VX-01	402	0.07583312477816005	325	TCGA-2A-A8VX-01	2	1	146	0.04555300612009613	TCGA-2A-A8VX-01	1	4	1	6	RNA degradation	7871	TCGA-2A-A8VX	PRAD	70	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-25904	Alive	TUMOR FREE	1378	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1378	0	1378	NA	NA	0	1378	
50	TCGA-2A-A8W1	0	0	0	0	0	0	0	0	2	23	0	0	0	4	0	0	TCGA-2A-A8W1-01	378	0.11009283099571797	301	TCGA-2A-A8W1-01	2	2	129	0.07735590342332599	TCGA-2A-A8W1-01	1	6	3	10	PASS	7872	TCGA-2A-A8W1	PRAD	54	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-19964	Alive	NA	112	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	112	0	112	NA	NA	0	112	
70	TCGA-2A-A8W3	0	3	0	0	1	2	0	0	2	29	1	0	2	12	1	0	TCGA-2A-A8W3-01	117	0.07759300783437044	65	TCGA-2A-A8W3-01	1	2	52	0.054693786906963436	TCGA-2A-A8W3-01	5	3	3	11	PASS	7873	TCGA-2A-A8W3	PRAD	69	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-25557	Alive	[Discrepancy]	863	NA	NA	Biochemical evidence of disease	NA	NA	198	NA	NA	NA	0	863	0	863	NA	NA	1	198	
60	TCGA-2A-AAYF	1	1	0	0	0	0	0	0	0	14	0	0	0	8	0	0	TCGA-2A-AAYF-01	113	0.02216923380914356	48	TCGA-2A-AAYF-01	0	0	25	0.023313501398678525	TCGA-2A-AAYF-01	0	4	2	6	PASS	7874	TCGA-2A-AAYF	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-20866	Alive	TUMOR FREE	1364	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1364	0	1364	0	1364	0	1364	
60	TCGA-2A-AAYO	0	0	0	0	2	1	0	0	1	16	0	0	0	3	1	0	TCGA-2A-AAYO-01	81	0.02080002641456992	42	TCGA-2A-AAYO-01	1	1	16	0.023113037845543208	TCGA-2A-AAYO-01	1	2	3	6	PASS	7875	TCGA-2A-AAYO	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21183	Alive	TUMOR FREE	1272	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1272	0	1272	0	1272	0	1272	
60	TCGA-2A-AAYU	0	1	0	0	1	0	0	0	0	19	1	0	0	9	0	0	TCGA-2A-AAYU-01	163	0.040026506332037866	96	TCGA-2A-AAYU-01	1	1	65	0.041095849485843716	TCGA-2A-AAYU-01	2	3	2	7	PASS	7876	TCGA-2A-AAYU	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-20582	Alive	TUMOR FREE	615	NA	NA	NA	NA	NA	NA	[Discrepancy]	NA	NA	0	615	0	615	NA	NA	0	615	
60	TCGA-4L-AA1F	0	1	0	0	2	0	0	0	1	18	5	0	0	8	0	0	TCGA-4L-AA1F-01	148	0.3825828237624436	75	TCGA-4L-AA1F-01	14	21	63	0.1015234489063782	TCGA-4L-AA1F-01	14	18	5	37	PASS	7877	TCGA-4L-AA1F	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-23665	Alive	TUMOR FREE	350	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	350	0	350	0	350	0	350	
70	TCGA-CH-5737	0	3	0	3	3	1	1	0	0	39	0	0	1	18	2	0	TCGA-CH-5737-01	272	0.057399061227404076	200	TCGA-CH-5737-01	1	1	83	0.0600535361747688	TCGA-CH-5737-01	0	8	4	12	PASS	7878	TCGA-CH-5737	PRAD	73	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-26753	Alive	TUMOR FREE	91	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	91	0	91	NA	NA	0	91	
70	TCGA-CH-5738	0	3	0	0	0	1	0	0	4	13	1	0	0	4	0	0	TCGA-CH-5738-01	63	0.0011158413782365632	19	TCGA-CH-5738-01	0	0	10	0.001481116846857858	TCGA-CH-5738-01	0	0	0	0	PASS	7879	TCGA-CH-5738	PRAD	72	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-26329	Alive	TUMOR FREE	212	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	212	0	212	0	212	0	212	
70	TCGA-CH-5739	0	5	0	1	0	0	0	0	0	30	3	0	0	11	1	0	TCGA-CH-5739-01	100	0.08821162900625383	49	TCGA-CH-5739-01	4	2	51	0.046542437976066095	TCGA-CH-5739-01	3	1	4	8	PASS	7880	TCGA-CH-5739	PRAD	65	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-23953	Alive	TUMOR FREE	671	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	671	0	671	0	671	0	671	
60	TCGA-CH-5740	0	2	0	0	2	0	0	0	1	16	1	0	0	4	2	0	TCGA-CH-5740-01	149	0.07601159361624818	85	TCGA-CH-5740-01	0	0	58	0.06357448535216371	TCGA-CH-5740-01	4	7	3	14	PASS	7881	TCGA-CH-5740	PRAD	57	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-20880	Alive	TUMOR FREE	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
60	TCGA-CH-5741	0	2	0	3	0	1	0	0	4	14	5	0	0	5	1	0	TCGA-CH-5741-01	103	0.0575927516077595	48	TCGA-CH-5741-01	0	1	39	0.06029156848954575	TCGA-CH-5741-01	1	7	4	12	PASS	7882	TCGA-CH-5741	PRAD	56	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-20759	Alive	TUMOR FREE	395	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	395	0	395	0	395	0	395	
70	TCGA-CH-5743	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CH-5743-01	45	4.124286374304909e-05	15	TCGA-CH-5743	0	0	0	0	TCGA-CH-5743	0	0	0	0	PASS	7883	TCGA-CH-5743	PRAD	66	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-24321	Alive	TUMOR FREE	425	NA	NA	New Primary Tumor	NA	NA	425	Complete Remission/Response	NA	NA	0	425	0	425	0	425	1	425	
60	TCGA-CH-5744	0	4	0	1	1	0	0	0	1	19	0	1	0	11	0	0	TCGA-CH-5744-01	136	0.05048446493205712	85	TCGA-CH-5744-01	1	2	74	0.05349869674457715	TCGA-CH-5744-01	5	3	4	12	PASS	7884	TCGA-CH-5744	PRAD	64	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-23621	Alive	TUMOR FREE	60	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	60	0	60	NA	NA	0	60	
70	TCGA-CH-5745	0	3	0	1	1	0	0	0	1	23	0	0	0	6	0	0	TCGA-CH-5745	0	0	0	TCGA-CH-5745	0	0	0	0	TCGA-CH-5745	0	0	0	0	PASS	7885	TCGA-CH-5745	PRAD	68	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-24837	Alive	TUMOR FREE	91	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	91	0	91	NA	NA	0	91	
60	TCGA-CH-5746	1	1	0	0	0	0	0	0	0	9	0	0	0	3	0	0	TCGA-CH-5746-01	71	0.012522738298017352	34	TCGA-CH-5746-01	0	0	18	0.012392649198748712	TCGA-CH-5746-01	1	1	1	3	PASS	7886	TCGA-CH-5746	PRAD	57	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-20941	Alive	TUMOR FREE	731	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	731	0	731	0	731	0	731	
60	TCGA-CH-5748	0	0	0	3	0	0	0	0	0	31	1	0	0	16	1	0	TCGA-CH-5748-01	81	0.031112120675296038	30	TCGA-CH-5748-01	0	0	23	0.02240345139963265	TCGA-CH-5748-01	0	6	1	7	PASS	7887	TCGA-CH-5748	PRAD	64	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-23649	Alive	WITH TUMOR	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
70	TCGA-CH-5750	0	4	0	2	3	2	0	0	0	25	2	0	1	14	1	0	TCGA-CH-5750-01	59	0.011795693480118734	15	TCGA-CH-5750-01	0	0	8	0.011541678957889831	TCGA-CH-5750-01	0	1	1	2	PASS	7888	TCGA-CH-5750	PRAD	72	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-26389	Alive	TUMOR FREE	396	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	396	0	396	0	396	0	396	
70	TCGA-CH-5751	0	5	0	0	1	0	0	0	1	26	2	0	2	6	0	0	TCGA-CH-5751-01	270	0.5297939392506712	155	TCGA-CH-5751-01	4	6	97	0.17975742159323602	TCGA-CH-5751-01	7	9	10	26	PASS	7889	TCGA-CH-5751	PRAD	68	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-24957	Alive	WITH TUMOR	1065	NA	NA	Distant Metastasis	Bone	NA	365	Complete Remission/Response	NA	NA	0	1065	0	1065	1	365	1	365	
70	TCGA-CH-5752	0	4	1	1	5	2	1	0	3	27	1	0	1	12	2	0	TCGA-CH-5752-01	141	0.03190409480861909	69	TCGA-CH-5752-01	0	0	47	0.031827383770402416	TCGA-CH-5752-01	0	2	1	3	PASS	7890	TCGA-CH-5752	PRAD	66	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-24290	Alive	TUMOR FREE	943	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	943	0	943	0	943	0	943	
70	TCGA-CH-5753	1	3	0	0	3	0	0	1	0	38	3	0	0	7	2	0	TCGA-CH-5753-01	72	0.22259341620770368	24	TCGA-CH-5753-01	5	6	44	0.12386251134214545	TCGA-CH-5753-01	7	4	6	17	PASS	7891	TCGA-CH-5753	PRAD	70	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-25780	Alive	TUMOR FREE	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
70	TCGA-CH-5754	0	3	0	3	2	0	2	0	6	68	4	0	1	32	1	0	TCGA-CH-5754-01	148	0.21369360812534893	83	TCGA-CH-5754-01	3	6	75	0.12914441831559445	TCGA-CH-5754-01	8	18	9	35	PASS	7892	TCGA-CH-5754	PRAD	65	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-23803	Alive	WITH TUMOR	62	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	62	0	62	NA	NA	0	62	
60	TCGA-CH-5761	0	2	0	1	3	1	0	0	1	40	1	0	1	17	1	0	TCGA-CH-5761-01	230	0.3394343578284745	135	TCGA-CH-5761-01	8	9	86	0.21698993326399332	TCGA-CH-5761-01	9	11	12	32	PASS	7893	TCGA-CH-5761	PRAD	61	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-22433	Alive	TUMOR FREE	28	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	28	0	28	NA	NA	0	28	
60	TCGA-CH-5762	0	6	0	3	3	1	1	0	2	53	1	0	0	16	1	0	TCGA-CH-5762-01	129	0.13883957310237607	62	TCGA-CH-5762-01	1	5	42	0.06903161173083193	TCGA-CH-5762-01	8	15	3	26	PASS	7894	TCGA-CH-5762	PRAD	60	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2005	NA	-22068	Alive	[Discrepancy]	1339	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1339	0	1339	0	1339	0	1339	
70	TCGA-CH-5763	0	1	0	1	0	0	0	0	0	16	0	0	1	5	0	0	TCGA-CH-5763-01	49	3.693499777613954e-05	12	TCGA-CH-5763	0	0	0	0	TCGA-CH-5763	0	0	0	0	PASS	7895	TCGA-CH-5763	PRAD	66	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-24380	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	365	0	365	0	365	0	365	
70	TCGA-CH-5764	1	1	0	1	1	0	0	0	0	29	2	0	0	3	1	1	TCGA-CH-5764-01	102	0.05776853060277477	46	TCGA-CH-5764-01	2	3	41	0.060460929925515626	TCGA-CH-5764-01	3	4	3	10	PASS	7896	TCGA-CH-5764	PRAD	66	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-24257	Alive	TUMOR FREE	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
60	TCGA-CH-5765	0	4	0	0	0	0	1	0	2	22	3	0	0	13	1	0	TCGA-CH-5765-01	130	0.054432766321545	71	TCGA-CH-5765-01	1	2	39	0.05690965239515392	TCGA-CH-5765-01	1	5	3	9	PASS	7897	TCGA-CH-5765	PRAD	55	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-20364	Alive	TUMOR FREE	700	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	700	0	700	0	700	0	700	
60	TCGA-CH-5766	0	1	0	0	0	0	0	1	1	27	1	0	0	11	0	0	TCGA-CH-5766-01	125	0.1778000098101559	65	TCGA-CH-5766-01	3	3	72	0.08849167022935145	TCGA-CH-5766-01	4	8	7	19	PASS	7898	TCGA-CH-5766	PRAD	55	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-20392	Alive	TUMOR FREE	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
70	TCGA-CH-5767	0	0	0	0	0	1	0	0	4	31	3	0	1	7	0	0	TCGA-CH-5767-01	230	0.08390467529124397	168	TCGA-CH-5767-01	1	1	47	0.053291739803894365	TCGA-CH-5767-01	2	3	3	8	PASS	7899	TCGA-CH-5767	PRAD	66	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-24287	Alive	TUMOR FREE	458	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	458	0	458	0	458	0	458	
70	TCGA-CH-5768	0	2	0	2	0	0	0	0	2	36	3	0	0	15	0	0	TCGA-CH-5768-01	158	0.1014923193855013	89	TCGA-CH-5768-01	0	0	61	0.052921754231060825	TCGA-CH-5768-01	1	3	3	7	PASS	7900	TCGA-CH-5768	PRAD	72	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-26480	Alive	TUMOR FREE	731	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	731	0	731	0	731	0	731	
50	TCGA-CH-5769	1	2	1	1	6	2	0	0	4	89	6	0	0	39	1	1	TCGA-CH-5769-01	175	0.028362799640800775	111	TCGA-CH-5769-01	0	0	66	0.030545651246809	TCGA-CH-5769-01	1	3	2	6	PASS	7901	TCGA-CH-5769	PRAD	48	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-17807	Alive	WITH TUMOR	62	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	62	0	62	NA	NA	0	62	
60	TCGA-CH-5771	0	3	1	1	1	0	1	0	0	23	1	0	0	4	0	0	TCGA-CH-5771-01	86	0.035652174432845	39	TCGA-CH-5771	0	0	0	0	TCGA-CH-5771	0	0	0	0	PASS	7902	TCGA-CH-5771	PRAD	63	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-23101	Alive	TUMOR FREE	396	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	396	0	396	0	396	0	396	
60	TCGA-CH-5772	1	4	0	0	1	0	0	0	2	36	6	0	1	22	1	0	TCGA-CH-5772-01	75	0.09023224823673827	26	TCGA-CH-5772-01	0	1	17	0.015330590309962325	TCGA-CH-5772-01	0	3	1	4	PASS	7903	TCGA-CH-5772	PRAD	63	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-23194	Alive	TUMOR FREE	486	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	486	0	486	0	486	0	486	
70	TCGA-CH-5788	0	5	1	0	1	0	0	0	2	27	1	0	1	15	0	0	TCGA-CH-5788-01	417	0.26705101308433865	318	TCGA-CH-5788-01	6	9	162	0.1331681542470423	TCGA-CH-5788-01	8	13	7	28	PASS	7904	TCGA-CH-5788	PRAD	69	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-25233	Alive	WITH TUMOR	821	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	821	0	821	NA	NA	0	821	
60	TCGA-CH-5789	0	0	0	1	0	0	0	0	0	2	0	0	1	4	1	0	TCGA-CH-5789-01	53	5.8874495957655824e-06	12	TCGA-CH-5789-01	0	0	7	0.0007764437822781154	TCGA-CH-5789-01	0	0	0	0	PASS	7905	TCGA-CH-5789	PRAD	61	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-22494	Alive	TUMOR FREE	304	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	304	0	304	0	304	0	304	
60	TCGA-CH-5790	0	3	0	1	0	0	0	0	0	18	1	0	1	6	0	0	TCGA-CH-5790-01	97	0.033568356208970265	50	TCGA-CH-5790-01	1	2	35	0.03633485326350065	TCGA-CH-5790-01	2	4	2	8	PASS	7906	TCGA-CH-5790	PRAD	64	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-23529	Alive	TUMOR FREE	974	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	974	0	974	0	974	0	974	
70	TCGA-CH-5791	0	2	0	0	1	0	2	0	1	31	1	0	1	10	1	0	TCGA-CH-5791-01	155	0.2470074814404289	96	TCGA-CH-5791-01	1	2	89	0.0806213648564021	TCGA-CH-5791-01	4	3	5	12	PASS	7907	TCGA-CH-5791	PRAD	72	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-26390	Alive	NA	1004	NA	NA	New Primary Tumor	NA	NA	396	Complete Remission/Response	NA	NA	0	1004	0	1004	0	1004	1	396	
60	TCGA-CH-5792	0	1	0	0	3	0	0	0	4	27	3	0	1	10	0	0	TCGA-CH-5792-01	207	0.0872962131745907	148	TCGA-CH-5792-01	0	0	94	0.09782216225447618	TCGA-CH-5792-01	1	11	7	19	PASS	7908	TCGA-CH-5792	PRAD	57	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-21002	Alive	WITH TUMOR	91	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	91	0	91	NA	NA	0	91	
70	TCGA-CH-5794	0	3	0	0	0	1	1	0	0	20	1	0	3	12	0	0	TCGA-CH-5794-01	139	0.0440334158706514	82	TCGA-CH-5794-01	0	1	41	0.04629272306621356	TCGA-CH-5794-01	0	3	1	4	PASS	7909	TCGA-CH-5794	PRAD	65	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-23924	Alive	TUMOR FREE	882	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	882	0	882	0	882	0	882	
50	TCGA-EJ-5494	0	2	0	0	1	0	0	0	1	24	1	1	0	9	0	0	TCGA-EJ-5494-01	59	0.0008188084656487772	15	TCGA-EJ-5494-01	0	0	5	0.0013290559735119494	TCGA-EJ-5494-01	0	0	0	0	PASS	7910	TCGA-EJ-5494	PRAD	50	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-18596	Alive	TUMOR FREE	1477	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1477	0	1477	0	1477	0	1477	
70	TCGA-EJ-5495	0	4	1	4	4	1	1	0	1	53	5	0	6	18	4	0	TCGA-EJ-5495-01	78	0.12194481825742115	30	TCGA-EJ-5495-01	4	3	13	0.06583391160652997	TCGA-EJ-5495-01	8	6	3	17	PASS	7911	TCGA-EJ-5495	PRAD	68	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-24904	Alive	TUMOR FREE	1760	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1760	0	1760	0	1760	0	1760	
60	TCGA-EJ-5496	0	0	0	0	0	0	0	0	0	28	2	0	0	9	1	1	TCGA-EJ-5496-01	89	0.06872773625382263	39	TCGA-EJ-5496-01	2	2	12	0.04678646515131638	TCGA-EJ-5496-01	3	7	3	13	PASS	7912	TCGA-EJ-5496	PRAD	59	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-21897	Alive	TUMOR FREE	595	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	595	0	595	0	595	0	595	
50	TCGA-EJ-5497	0	2	0	1	3	0	0	0	1	14	0	0	0	7	0	0	TCGA-EJ-5497-01	63	0.028312580160956263	20	TCGA-EJ-5497-01	0	0	8	0.013986196957315634	TCGA-EJ-5497-01	2	7	0	9	PASS	7913	TCGA-EJ-5497	PRAD	47	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-17523	Alive	TUMOR FREE	405	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	405	0	405	0	405	0	405	
60	TCGA-EJ-5498	0	5	0	1	0	0	0	0	2	26	1	0	1	12	0	0	TCGA-EJ-5498-01	54	0.031808823724132025	16	TCGA-EJ-5498-01	2	1	6	0.033408527215701235	TCGA-EJ-5498-01	0	0	0	0	PASS	7914	TCGA-EJ-5498	PRAD	56	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-20472	Alive	TUMOR FREE	1720	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1720	0	1720	0	1720	0	1720	
60	TCGA-EJ-5499	0	6	0	2	2	0	0	0	1	28	0	0	1	8	0	0	TCGA-EJ-5499-01	136	0.04378283448947366	77	TCGA-EJ-5499-01	1	1	34	0.045521196815238106	TCGA-EJ-5499-01	2	4	2	8	PASS	7915	TCGA-EJ-5499	PRAD	61	MALE	ASIAN	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-22286	Alive	TUMOR FREE	1415	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1415	0	1415	0	1415	0	1415	
60	TCGA-EJ-5501	0	1	0	0	2	1	1	0	1	13	0	0	0	8	0	0	TCGA-EJ-5501-01	123	0.07089761845396113	74	TCGA-EJ-5501-01	2	3	34	0.07367503673326722	TCGA-EJ-5501-01	2	6	4	12	PASS	7916	TCGA-EJ-5501	PRAD	55	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-20409	Alive	TUMOR FREE	1365	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1365	0	1365	0	1365	0	1365	
50	TCGA-EJ-5502	0	0	0	0	0	0	0	0	0	10	1	0	0	2	0	0	TCGA-EJ-5502-01	87	6.402785175968079e-05	40	TCGA-EJ-5502-01	0	0	0	0.0	TCGA-EJ-5502-01	0	0	0	0	PASS	7917	TCGA-EJ-5502	PRAD	50	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-18447	Alive	TUMOR FREE	1171	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1171	0	1171	0	1171	0	1171	
50	TCGA-EJ-5503	0	0	0	0	0	0	0	0	1	7	0	0	0	0	0	0	TCGA-EJ-5503-01	41	0.00016795550478762006	8	TCGA-EJ-5503-01	0	0	0	0.0	TCGA-EJ-5503-01	0	0	0	0	PASS	7918	TCGA-EJ-5503	PRAD	50	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-18395	Alive	TUMOR FREE	1391	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1391	0	1391	0	1391	0	1391	
70	TCGA-EJ-5504	0	1	0	1	0	0	0	0	5	36	3	0	1	14	0	0	TCGA-EJ-5504-01	169	0.16952396996583285	107	TCGA-EJ-5504-01	2	4	49	0.13505329715692813	TCGA-EJ-5504-01	3	11	11	25	PASS	7919	TCGA-EJ-5504	PRAD	65	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-24072	Alive	WITH TUMOR	1427	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	1427	0	1427	NA	NA	0	1427	
60	TCGA-EJ-5505	0	4	0	1	1	0	0	0	2	25	1	0	0	6	0	0	TCGA-EJ-5505-01	183	0.042133586620972455	123	TCGA-EJ-5505-01	0	0	28	0.04046044565645291	TCGA-EJ-5505-01	0	7	3	10	PASS	7920	TCGA-EJ-5505	PRAD	57	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-21164	Alive	TUMOR FREE	922	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	922	0	922	0	922	0	922	
70	TCGA-EJ-5506	0	1	0	1	0	0	0	0	0	7	1	0	0	4	0	0	TCGA-EJ-5506-01	47	6.197799485501488e-06	10	TCGA-EJ-5506	0	0	0	0	TCGA-EJ-5506	0	0	0	0	PASS	7921	TCGA-EJ-5506	PRAD	67	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-24617	Alive	TUMOR FREE	1381	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1381	0	1381	0	1381	0	1381	
50	TCGA-EJ-5507	1	1	0	1	1	0	0	0	1	25	2	0	0	7	1	0	TCGA-EJ-5507-01	136	0.7185911219350232	67	TCGA-EJ-5507-01	4	8	37	0.1754627969782762	TCGA-EJ-5507-01	4	3	9	16	PASS	7922	TCGA-EJ-5507	PRAD	54	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-19759	Alive	TUMOR FREE	1457	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1457	0	1457	0	1457	0	1457	
70	TCGA-EJ-5508	0	2	0	1	0	0	1	0	1	19	0	0	0	9	0	0	TCGA-EJ-5508-01	70	0.01356567400654042	26	TCGA-EJ-5508-01	0	0	6	0.012552819646398056	TCGA-EJ-5508-01	2	1	1	4	PASS	7923	TCGA-EJ-5508	PRAD	65	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-23758	Alive	TUMOR FREE	1965	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1965	0	1965	0	1965	0	1965	
60	TCGA-EJ-5509	0	1	0	2	0	0	0	0	0	18	1	0	0	9	0	0	TCGA-EJ-5509-01	376	0.18417500022667307	303	TCGA-EJ-5509-01	2	1	78	0.08767793817470666	TCGA-EJ-5509-01	0	11	4	15	PASS	7924	TCGA-EJ-5509	PRAD	63	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-23368	Alive	TUMOR FREE	1464	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1464	0	1464	0	1464	0	1464	
50	TCGA-EJ-5510	0	0	0	0	1	0	0	0	0	17	1	0	1	7	0	0	TCGA-EJ-5510-01	82	0.10847181644821452	37	TCGA-EJ-5510-01	2	3	19	0.06513879676511958	TCGA-EJ-5510-01	5	5	5	15	PASS	7925	TCGA-EJ-5510	PRAD	48	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-17895	Alive	TUMOR FREE	1887	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1887	0	1887	0	1887	0	1887	
60	TCGA-EJ-5511	0	3	1	3	1	2	0	0	0	30	1	0	1	13	2	0	TCGA-EJ-5511-01	70	0.18054689130234794	28	TCGA-EJ-5511-01	3	3	9	0.07783267677597107	TCGA-EJ-5511-01	4	3	4	11	PASS	7926	TCGA-EJ-5511	PRAD	55	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-20409	Alive	TUMOR FREE	1476	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1476	0	1476	0	1476	0	1476	
50	TCGA-EJ-5512	0	0	0	1	0	0	0	0	2	10	2	0	1	3	1	0	TCGA-EJ-5512-01	117	0.030881798231002525	64	TCGA-EJ-5512-01	0	0	22	0.03247416449891447	TCGA-EJ-5512-01	0	5	2	7	PASS	7927	TCGA-EJ-5512	PRAD	46	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-17127	Alive	TUMOR FREE	1733	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1733	0	1733	0	1733	0	1733	
70	TCGA-EJ-5514	0	4	0	1	2	0	0	0	1	24	0	0	0	11	1	0	TCGA-EJ-5514-01	152	0.38602174486413793	82	TCGA-EJ-5514-01	4	5	27	0.09977138691275572	TCGA-EJ-5514-01	4	10	5	19	PASS	7928	TCGA-EJ-5514	PRAD	66	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-24165	Alive	TUMOR FREE	1829	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1829	0	1829	0	1829	0	1829	
60	TCGA-EJ-5515	0	1	0	0	0	0	0	0	0	12	1	0	0	2	0	0	TCGA-EJ-5515-01	47	3.2263414075002835e-05	11	TCGA-EJ-5515	0	0	0	0	TCGA-EJ-5515	0	0	0	0	PASS	7929	TCGA-EJ-5515	PRAD	60	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-22097	Alive	TUMOR FREE	1832	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1832	0	1832	0	1832	0	1832	
50	TCGA-EJ-5516	0	0	0	1	0	0	0	0	3	20	2	0	0	7	0	0	TCGA-EJ-5516-01	166	0.04895728409016325	99	TCGA-EJ-5516-01	1	1	33	0.05155709240863946	TCGA-EJ-5516-01	2	1	1	4	PASS	7930	TCGA-EJ-5516	PRAD	49	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-17980	Alive	TUMOR FREE	1889	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1889	0	1889	0	1889	0	1889	
60	TCGA-EJ-5517	0	3	1	2	3	0	0	0	2	16	0	0	0	7	0	0	TCGA-EJ-5517-01	97	0.0708408189454588	44	TCGA-EJ-5517-01	0	1	8	0.03317143032241035	TCGA-EJ-5517-01	2	3	2	7	PASS	7931	TCGA-EJ-5517	PRAD	55	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-20422	Alive	TUMOR FREE	1889	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1889	0	1889	0	1889	0	1889	
70	TCGA-EJ-5518	0	5	0	1	0	0	0	0	2	25	4	0	0	11	2	0	TCGA-EJ-5518-01	687	0.32519206448925225	566	TCGA-EJ-5518-01	1	6	58	0.12330741386574234	TCGA-EJ-5518-01	8	10	8	26	PASS	7932	TCGA-EJ-5518	PRAD	66	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-24313	Alive	WITH TUMOR	2118	NA	NA	Distant Metastasis	Bone	NA	2104	Progressive Disease	NA	NA	0	2118	0	2118	NA	NA	1	2104	
60	TCGA-EJ-5519	0	6	0	1	3	3	0	1	0	57	4	1	2	28	1	1	TCGA-EJ-5519-01	196	0.1289037161323311	130	TCGA-EJ-5519-01	4	4	45	0.1107244650799071	TCGA-EJ-5519-01	5	11	10	26	PASS	7933	TCGA-EJ-5519	PRAD	64	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-23669	Alive	TUMOR FREE	1962	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1962	0	1962	0	1962	0	1962	
60	TCGA-EJ-5521	0	4	0	1	1	3	0	0	2	34	2	0	0	19	0	0	TCGA-EJ-5521-01	145	0.14220545687646804	81	TCGA-EJ-5521-01	0	3	28	0.05866277730371312	TCGA-EJ-5521-01	4	5	3	12	PASS	7934	TCGA-EJ-5521	PRAD	63	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-23304	Alive	TUMOR FREE	2279	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2279	0	2279	0	2279	0	2279	
50	TCGA-EJ-5522	3	1	1	0	0	0	0	0	0	14	0	0	1	12	0	1	TCGA-EJ-5522-01	124	0.024455901258093663	75	TCGA-EJ-5522-01	0	1	33	0.025504519080127658	TCGA-EJ-5522-01	1	0	1	2	PASS	7935	TCGA-EJ-5522	PRAD	51	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-18802	Alive	TUMOR FREE	2079	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2079	0	2079	0	2079	0	2079	
60	TCGA-EJ-5524	1	1	0	1	0	0	0	0	1	35	0	0	0	9	1	0	TCGA-EJ-5524-01	325	0.11622514099603733	256	TCGA-EJ-5524-01	0	3	45	0.09383805772786832	TCGA-EJ-5524-01	7	6	5	18	PASS	7936	TCGA-EJ-5524	PRAD	57	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-20854	Alive	WITH TUMOR	1882	NA	NA	Locoregional Recurrence	NA	NA	265	Progressive Disease	NA	NA	0	1882	0	1882	NA	NA	1	265	
70	TCGA-EJ-5525	1	6	1	2	4	0	1	1	2	44	6	0	1	15	1	1	TCGA-EJ-5525-01	169	0.21721667832086705	100	TCGA-EJ-5525-01	5	7	24	0.13229869557023224	TCGA-EJ-5525-01	7	10	6	23	PASS	7937	TCGA-EJ-5525	PRAD	67	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-24535	Alive	WITH TUMOR	1115	NA	NA	Distant Metastasis	Bone	NA	546	Progressive Disease	NA	NA	0	1115	0	1115	NA	NA	1	546	
60	TCGA-EJ-5526	0	1	0	1	2	0	1	0	1	23	0	0	0	7	3	0	TCGA-EJ-5526-01	123	0.12077979009109	59	TCGA-EJ-5526-01	4	3	33	0.04862540654225836	TCGA-EJ-5526-01	3	4	3	10	PASS	7938	TCGA-EJ-5526	PRAD	56	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-20558	Alive	WITH TUMOR	1909	NA	NA	Locoregional Recurrence	NA	NA	537	Progressive Disease	NA	NA	0	1909	0	1909	NA	NA	1	537	
70	TCGA-EJ-5527	0	2	0	1	3	0	1	0	4	21	1	0	0	15	1	0	TCGA-EJ-5527-01	98	0.14748133482260725	40	TCGA-EJ-5527-01	2	3	18	0.06504858643513434	TCGA-EJ-5527-01	4	7	4	15	PASS	7939	TCGA-EJ-5527	PRAD	69	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-25234	Alive	TUMOR FREE	1778	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1778	0	1778	0	1778	0	1778	
60	TCGA-EJ-5530	0	3	0	3	0	0	0	0	1	42	4	0	0	13	0	0	TCGA-EJ-5530-01	61	0.015010838990908944	19	TCGA-EJ-5530-01	1	1	2	0.01581897955095665	TCGA-EJ-5530-01	1	0	1	2	PASS	7940	TCGA-EJ-5530	PRAD	61	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-22316	Alive	TUMOR FREE	1832	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1832	0	1832	0	1832	0	1832	
60	TCGA-EJ-5531	0	2	0	0	2	1	0	0	2	22	3	0	0	6	1	0	TCGA-EJ-5531-01	91	0.04586391686582169	35	TCGA-EJ-5531-01	2	1	10	0.05511259238463175	TCGA-EJ-5531-01	1	9	4	14	PASS	7941	TCGA-EJ-5531	PRAD	62	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-22760	Alive	TUMOR FREE	1273	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1273	0	1273	0	1273	0	1273	
60	TCGA-EJ-5532	0	3	0	1	3	0	0	0	3	15	0	0	0	10	0	0	TCGA-EJ-5532-01	67	0.0722213947782854	22	TCGA-EJ-5532-01	3	2	8	0.02507386847576928	TCGA-EJ-5532-01	2	0	2	4	PASS	7942	TCGA-EJ-5532	PRAD	57	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-21110	Alive	TUMOR FREE	1828	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1828	0	1828	0	1828	0	1828	
60	TCGA-EJ-5542	1	1	0	1	1	0	0	0	5	20	0	0	0	8	1	0	TCGA-EJ-5542-01	134	0.09199474093905534	81	TCGA-EJ-5542-01	2	1	33	0.02778619003797664	TCGA-EJ-5542-01	2	1	1	4	PASS	7943	TCGA-EJ-5542	PRAD	60	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-21942	Alive	TUMOR FREE	1513	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1513	0	1513	0	1513	0	1513	
70	TCGA-EJ-7115	0	8	0	3	4	0	2	0	0	41	8	0	0	15	4	0	TCGA-EJ-7115-01	164	0.06245560544718776	111	TCGA-EJ-7115-01	1	1	53	0.06672419642599556	TCGA-EJ-7115-01	1	5	4	10	PASS	7944	TCGA-EJ-7115	PRAD	65	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-23986	Alive	TUMOR FREE	2687	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2687	0	2687	0	2687	0	2687	
60	TCGA-EJ-7123	0	8	4	2	6	2	0	0	3	85	7	0	0	33	3	0	TCGA-EJ-7123-01	113	0.1797813847517671	68	TCGA-EJ-7123-01	4	3	17	0.0996170543863671	TCGA-EJ-7123-01	3	9	4	16	PASS	7945	TCGA-EJ-7123	PRAD	59	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-21741	Alive	TUMOR FREE	2572	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2572	0	2572	0	2572	0	2572	
40	TCGA-EJ-7125	0	8	0	14	0	2	0	0	16	140	9	0	4	44	5	0	TCGA-EJ-7125-01	61	0.05339382558106424	16	TCGA-EJ-7125-01	0	0	2	0.0036993289019767272	TCGA-EJ-7125-01	0	1	0	1	PASS	7946	TCGA-EJ-7125	PRAD	44	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2005	NA	-16425	Alive	TUMOR FREE	2850	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2850	0	2850	0	2850	0	2850	
70	TCGA-EJ-7218	0	0	0	3	0	0	0	0	1	21	3	0	0	7	0	0	TCGA-EJ-7218-01	138	0.06046985941926621	90	TCGA-EJ-7218-01	0	0	53	0.04566502756007092	TCGA-EJ-7218-01	0	6	4	10	PASS	7947	TCGA-EJ-7218	PRAD	71	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-26181	Alive	TUMOR FREE	2542	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2542	0	2542	0	2542	0	2542	
60	TCGA-EJ-7312	0	1	0	1	0	0	0	0	2	17	2	0	1	10	1	0	TCGA-EJ-7312	0	0	0	TCGA-EJ-7312	0	0	0	0	TCGA-EJ-7312-01	2	13	8	23	PASS	7948	TCGA-EJ-7312	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21292	Alive	TUMOR FREE	1099	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1099	0	1099	0	1099	0	1099	
60	TCGA-EJ-7314	0	4	0	2	5	0	0	0	0	45	6	0	0	20	2	0	TCGA-EJ-7314-01	73	0.0946731507807958	27	TCGA-EJ-7314-01	1	2	19	0.028266790262969486	TCGA-EJ-7314-01	3	0	2	5	PASS	7949	TCGA-EJ-7314	PRAD	62	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-22766	Alive	TUMOR FREE	1150	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1150	0	1150	0	1150	0	1150	
70	TCGA-EJ-7315	0	6	0	2	0	2	0	0	2	35	2	0	2	9	2	2	TCGA-EJ-7315-01	156	0.09102235889794336	93	TCGA-EJ-7315-01	1	3	50	0.08382920071161583	TCGA-EJ-7315-01	3	8	5	16	PASS	7950	TCGA-EJ-7315	PRAD	68	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-25154	Alive	TUMOR FREE	1008	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1008	0	1008	0	1008	0	1008	
70	TCGA-EJ-7317	0	2	0	0	4	0	0	0	0	55	2	0	0	30	2	0	TCGA-EJ-7317-01	67	0.02806100397857021	31	TCGA-EJ-7317-01	0	0	4	0.01894946260144116	TCGA-EJ-7317-01	0	1	1	2	PASS	7951	TCGA-EJ-7317	PRAD	71	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-26064	Alive	TUMOR FREE	771	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	771	0	771	0	771	0	771	
50	TCGA-EJ-7318	0	0	1	0	1	0	0	0	1	26	2	0	0	6	2	0	TCGA-EJ-7318-01	81	0.030942193011698583	31	TCGA-EJ-7318-01	1	1	25	0.03440759229001426	TCGA-EJ-7318-01	2	1	2	5	PASS	7952	TCGA-EJ-7318	PRAD	51	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-18686	Alive	TUMOR FREE	1029	NA	NA	Locoregional Recurrence	NA	NA	380	Partial Remission/Response	NA	NA	0	1029	0	1029	NA	NA	1	380	
60	TCGA-EJ-7321	0	0	0	0	2	0	0	0	1	25	2	0	0	11	0	0	TCGA-EJ-7321-01	57	0.04422065799945914	14	TCGA-EJ-7321-01	0	2	2	0.001396790696885098	TCGA-EJ-7321-01	2	5	0	7	PASS	7953	TCGA-EJ-7321	PRAD	57	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21108	Alive	TUMOR FREE	824	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	824	0	824	0	824	0	824	
60	TCGA-EJ-7325	0	2	0	0	2	0	0	0	1	13	2	0	0	9	0	0	TCGA-EJ-7325-01	171	0.045675469524225534	113	TCGA-EJ-7325-01	1	1	65	0.047715244059180886	TCGA-EJ-7325-01	2	2	3	7	RNA degradation	7954	TCGA-EJ-7325	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-23029	Alive	TUMOR FREE	1070	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1070	0	1070	0	1070	0	1070	
60	TCGA-EJ-7327	0	0	0	4	8	2	0	0	0	42	0	0	0	14	4	0	TCGA-EJ-7327-01	132	0.0191489944819858	67	TCGA-EJ-7327-01	0	0	32	0.019472860412455783	TCGA-EJ-7327-01	0	2	1	3	PASS	7955	TCGA-EJ-7327	PRAD	61	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-22475	Alive	TUMOR FREE	923	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	923	0	923	0	923	0	923	
70	TCGA-EJ-7328	0	2	0	2	0	2	0	0	3	46	2	0	2	26	0	0	TCGA-EJ-7328-01	76	0.036216392241893186	24	TCGA-EJ-7328-01	0	1	13	0.03661633351986166	TCGA-EJ-7328-01	3	5	3	11	PASS	7956	TCGA-EJ-7328	PRAD	70	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-25756	Alive	TUMOR FREE	842	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	842	0	842	0	842	0	842	
70	TCGA-EJ-7330	0	0	0	0	2	0	0	0	0	60	4	0	4	24	8	0	TCGA-EJ-7330-01	273	0.2126309697348444	208	TCGA-EJ-7330-01	4	4	111	0.15477889911366013	TCGA-EJ-7330-01	1	18	10	29	PASS	7957	TCGA-EJ-7330	PRAD	68	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-25050	Alive	TUMOR FREE	191	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	191	0	191	NA	NA	0	191	
60	TCGA-EJ-7331	0	3	0	0	4	0	0	0	2	38	0	0	0	17	2	0	TCGA-EJ-7331-01	79	0.032189904918515456	31	TCGA-EJ-7331-01	0	0	19	0.03382782339919433	TCGA-EJ-7331-01	0	7	2	9	PASS	7958	TCGA-EJ-7331	PRAD	64	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-23458	Alive	TUMOR FREE	742	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	742	0	742	0	742	0	742	
70	TCGA-EJ-7781	2	2	0	0	4	6	2	0	0	94	2	0	0	35	0	0	TCGA-EJ-7781-01	64	0.10651186464500696	17	TCGA-EJ-7781-01	1	2	6	0.038245605374759815	TCGA-EJ-7781-01	3	2	3	8	PASS	7959	TCGA-EJ-7781	PRAD	65	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-23937	Alive	TUMOR FREE	1073	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1073	0	1073	0	1073	0	1073	
70	TCGA-EJ-7782	2	51	2	11	57	19	5	0	20	511	21	0	5	252	13	0	TCGA-EJ-7782-01	531	0.13743922773016312	454	TCGA-EJ-7782-01	2	3	169	0.10124127918810737	TCGA-EJ-7782-01	1	13	6	20	PASS	7960	TCGA-EJ-7782	PRAD	71	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-25965	Alive	TUMOR FREE	1167	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1167	0	1167	0	1167	0	1167	
70	TCGA-EJ-7783	0	6	0	2	2	0	0	0	0	63	2	0	0	22	3	0	TCGA-EJ-7783-01	62	0.05275731990949093	19	TCGA-EJ-7783-01	2	2	6	0.031065493136958864	TCGA-EJ-7783-01	2	1	2	5	PASS	7961	TCGA-EJ-7783	PRAD	70	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-25600	Alive	TUMOR FREE	787	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	787	0	787	0	787	0	787	
60	TCGA-EJ-7784	0	2	0	2	2	6	0	0	3	54	8	0	4	19	2	0	TCGA-EJ-7784-01	72	0.3147948932813803	23	TCGA-EJ-7784-01	7	10	12	0.039903424233225744	TCGA-EJ-7784-01	8	8	2	18	PASS	7962	TCGA-EJ-7784	PRAD	63	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-23183	Alive	TUMOR FREE	781	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	781	0	781	0	781	0	781	
50	TCGA-EJ-7785	0	0	0	0	2	0	0	0	0	30	2	0	0	14	0	0	TCGA-EJ-7785-01	98	0.020588671033110014	44	TCGA-EJ-7785-01	0	0	26	0.02131453216261224	TCGA-EJ-7785-01	2	1	1	4	PASS	7963	TCGA-EJ-7785	PRAD	54	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-19939	Alive	TUMOR FREE	1177	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1177	0	1177	0	1177	0	1177	
60	TCGA-EJ-7786	0	4	0	0	2	2	0	0	4	54	2	0	0	14	0	0	TCGA-EJ-7786-01	74	0.08387366171726954	27	TCGA-EJ-7786-01	1	2	5	0.062036505980473264	TCGA-EJ-7786-01	2	4	2	8	PASS	7964	TCGA-EJ-7786	PRAD	62	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-22793	Alive	TUMOR FREE	1096	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1096	0	1096	0	1096	0	1096	
50	TCGA-EJ-7788	1	3	0	1	1	0	0	0	2	25	1	0	2	12	0	0	TCGA-EJ-7788-01	106	0.11532691443444618	52	TCGA-EJ-7788-01	0	1	23	0.03249226265881245	TCGA-EJ-7788-01	0	2	2	4	PASS	7965	TCGA-EJ-7788	PRAD	53	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-19623	Alive	TUMOR FREE	859	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	859	0	859	0	859	0	859	
70	TCGA-EJ-7789	0	0	0	2	4	0	0	1	0	49	0	0	0	18	2	0	TCGA-EJ-7789-01	665	0.3925726331809136	568	TCGA-EJ-7789-01	7	7	203	0.1494769935464942	TCGA-EJ-7789-01	6	13	7	26	PASS	7966	TCGA-EJ-7789	PRAD	66	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-24107	Alive	TUMOR FREE	1105	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1105	0	1105	0	1105	0	1105	
70	TCGA-EJ-7791	0	0	0	0	0	1	0	0	0	15	0	0	0	6	1	0	TCGA-EJ-7791-01	39	8.068304330354916e-05	7	TCGA-EJ-7791	0	0	0	0	TCGA-EJ-7791	0	0	0	0	PASS	7967	TCGA-EJ-7791	PRAD	67	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-24621	Alive	TUMOR FREE	1118	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1118	0	1118	0	1118	0	1118	
50	TCGA-EJ-7792	0	2	0	0	0	0	0	0	0	32	0	0	0	3	2	0	TCGA-EJ-7792-01	67	0.025409348774270427	26	TCGA-EJ-7792-01	0	0	6	0.010024952622110206	TCGA-EJ-7792-01	2	2	1	5	PASS	7968	TCGA-EJ-7792	PRAD	53	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-19454	Alive	TUMOR FREE	1396	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1396	0	1396	0	1396	0	1396	
50	TCGA-EJ-7793	0	0	0	0	1	0	0	0	0	10	0	0	0	2	0	0	TCGA-EJ-7793-01	47	0.003053967066872692	14	TCGA-EJ-7793-01	0	0	5	0.0031312804010134396	TCGA-EJ-7793-01	0	0	0	0	PASS	7969	TCGA-EJ-7793	PRAD	49	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-17982	Alive	TUMOR FREE	114	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	114	0	114	0	114	0	114	
70	TCGA-EJ-7794	0	2	0	1	2	0	2	0	0	21	0	0	0	8	0	0	TCGA-EJ-7794-01	95	0.03724115551916789	46	TCGA-EJ-7794-01	0	1	16	0.03920278678547612	TCGA-EJ-7794-01	0	7	2	9	PASS	7970	TCGA-EJ-7794	PRAD	67	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-24478	Alive	TUMOR FREE	1306	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1306	0	1306	0	1306	0	1306	
50	TCGA-EJ-7797	0	3	0	0	1	0	0	0	0	22	2	0	0	6	0	0	TCGA-EJ-7797-01	68	0.014963575826233371	28	TCGA-EJ-7797-01	1	1	10	0.015757487272367414	TCGA-EJ-7797-01	1	1	2	4	PASS	7971	TCGA-EJ-7797	PRAD	53	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-19616	Alive	TUMOR FREE	983	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	983	0	983	0	983	0	983	
60	TCGA-EJ-8468	0	2	0	2	2	2	0	0	2	36	2	0	0	16	2	0	TCGA-EJ-8468-01	166	0.08191927835282632	104	TCGA-EJ-8468-01	0	2	61	0.06196425483441843	TCGA-EJ-8468-01	1	6	5	12	PASS	7972	TCGA-EJ-8468	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-23371	Alive	TUMOR FREE	2347	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2347	0	2347	0	2347	0	2347	
50	TCGA-EJ-8469	0	1	0	2	0	1	0	0	0	24	0	0	0	7	1	0	TCGA-EJ-8469-01	239	0.1830874026806545	178	TCGA-EJ-8469-01	5	5	111	0.08319957600945023	TCGA-EJ-8469-01	5	4	4	13	PASS	7973	TCGA-EJ-8469	PRAD	46	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-17014	Alive	WITH TUMOR	2324	NA	NA	Locoregional Recurrence	NA	NA	1925	Partial Remission/Response	NA	NA	0	2324	0	2324	NA	NA	1	1925	
60	TCGA-EJ-8470	0	1	0	0	1	0	0	0	0	17	3	0	0	7	0	0	TCGA-EJ-8470-01	358	0.09882325175569527	285	TCGA-EJ-8470-01	1	2	183	0.10095320397417508	TCGA-EJ-8470-01	2	12	6	20	PASS	7974	TCGA-EJ-8470	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-21209	Alive	TUMOR FREE	1159	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1159	0	1159	0	1159	0	1159	
60	TCGA-EJ-8472	2	2	0	0	2	0	0	0	6	76	6	0	1	20	0	0	TCGA-EJ-8472-01	159	0.34677641918173896	93	TCGA-EJ-8472-01	11	14	67	0.07420899121468344	TCGA-EJ-8472-01	12	6	6	24	PASS	7975	TCGA-EJ-8472	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-23104	Alive	TUMOR FREE	756	NA	NA	Biochemical evidence of disease	NA	NA	196	Partial Remission/Response	NA	NA	0	756	0	756	NA	NA	1	196	
70	TCGA-EJ-8474	0	4	2	3	4	2	0	0	2	69	8	0	0	37	0	0	TCGA-EJ-8474-01	96	0.043425678817294186	43	TCGA-EJ-8474-01	0	0	24	0.0045569522310503685	TCGA-EJ-8474-01	0	0	0	0	PASS	7976	TCGA-EJ-8474	PRAD	69	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-25561	Alive	TUMOR FREE	766	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	766	0	766	0	766	0	766	
70	TCGA-EJ-A46B	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	TCGA-EJ-A46B-01	41	4.471388570501772e-05	7	TCGA-EJ-A46B-01	0	0	4	0.0011333636317413852	TCGA-EJ-A46B-01	0	0	0	0	pathology review	7977	TCGA-EJ-A46B	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-24305	Alive	TUMOR FREE	657	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	657	0	657	0	657	0	657	
50	TCGA-EJ-A46D	0	1	0	1	0	0	0	0	0	9	2	0	0	3	0	0	TCGA-EJ-A46D-01	55	0.005623679874362405	20	TCGA-EJ-A46D-01	0	2	22	0.03840903598010592	TCGA-EJ-A46D-01	3	4	3	10	PASS	7978	TCGA-EJ-A46D	PRAD	53	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-19466	Alive	TUMOR FREE	626	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	626	0	626	0	626	0	626	
60	TCGA-EJ-A46E	0	0	0	1	0	0	0	0	0	5	0	0	0	1	0	0	TCGA-EJ-A46E-01	39	2.8354466443006164e-05	6	TCGA-EJ-A46E	0	0	0	0	TCGA-EJ-A46E	0	0	0	0	pathology review	7979	TCGA-EJ-A46E	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21054	Alive	TUMOR FREE	524	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	524	0	524	0	524	0	524	
60	TCGA-EJ-A46F	0	1	0	0	3	0	1	0	2	23	3	0	1	12	0	0	TCGA-EJ-A46F-01	133	0.14461457618189918	69	TCGA-EJ-A46F-01	4	5	48	0.04182596481839568	TCGA-EJ-A46F-01	4	6	3	13	RNA degradation	7980	TCGA-EJ-A46F	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21160	Alive	TUMOR FREE	783	NA	NA	Biochemical evidence of disease	NA	NA	215	Partial Remission/Response	NA	NA	0	783	0	783	NA	NA	1	215	
70	TCGA-EJ-A46G	0	3	0	1	1	1	0	0	2	39	3	0	1	19	2	0	TCGA-EJ-A46G-01	730	0.6611203516409735	571	TCGA-EJ-A46G-01	2	2	71	0.019287817039209558	TCGA-EJ-A46G-01	9	5	1	15	PASS	7981	TCGA-EJ-A46G	PRAD	71	MALE	NA	NA	NA	"Prostate Adenocarcinoma, Other Subtype"	NA	2012	NA	-26219	Alive	TUMOR FREE	668	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	668	0	668	0	668	0	668	
60	TCGA-EJ-A46H	0	0	0	0	0	0	0	0	0	2	0	0	0	1	0	0	TCGA-EJ-A46H-01	39	4.082828503397964e-06	9	TCGA-EJ-A46H-01	0	0	5	0.00019830069118512242	TCGA-EJ-A46H-01	0	0	0	0	pathology review	7982	TCGA-EJ-A46H	PRAD	60	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-22059	Alive	TUMOR FREE	724	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	724	0	724	0	724	0	724	
60	TCGA-EJ-A46I	0	0	0	0	0	0	0	0	1	7	0	0	0	1	0	0	TCGA-EJ-A46I-01	59	5.245665274879174e-05	17	TCGA-EJ-A46I	0	0	0	0	TCGA-EJ-A46I	0	0	0	0	PASS	7983	TCGA-EJ-A46I	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21046	Alive	TUMOR FREE	668	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	668	0	668	0	668	0	668	
60	TCGA-EJ-A65B	0	0	0	2	1	0	1	0	0	28	3	0	0	3	1	0	TCGA-EJ-A65B-01	53	0.026735988061995158	14	TCGA-EJ-A65B-01	3	2	26	0.116092341103377	TCGA-EJ-A65B-01	4	10	7	21	RNA degradation	7984	TCGA-EJ-A65B	PRAD	55	MALE	NA	NA	NA	"Prostate Adenocarcinoma, Other Subtype"	NA	2012	NA	-20204	Alive	TUMOR FREE	710	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	710	0	710	0	710	0	710	
70	TCGA-EJ-A65D	0	3	0	2	1	1	0	0	2	31	1	0	1	6	0	1	TCGA-EJ-A65D-01	135	0.10296095701507982	73	TCGA-EJ-A65D-01	2	2	41	0.05036986909165602	TCGA-EJ-A65D-01	2	6	4	12	RNA degradation	7985	TCGA-EJ-A65D	PRAD	66	MALE	NA	NA	NA	"Prostate Adenocarcinoma, Other Subtype"	NA	2012	NA	-24297	Alive	TUMOR FREE	393	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	393	0	393	0	393	0	393	
70	TCGA-EJ-A65E	0	3	0	1	1	0	0	0	3	27	1	0	0	13	1	0	TCGA-EJ-A65E-01	187	0.03943231145967847	126	TCGA-EJ-A65E-01	1	1	74	0.040701137278052	TCGA-EJ-A65E-01	0	1	2	3	PASS	7986	TCGA-EJ-A65E	PRAD	67	MALE	NA	NA	NA	"Prostate Adenocarcinoma, Other Subtype"	NA	2012	NA	-24558	Alive	TUMOR FREE	417	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	417	0	417	0	417	0	417	
60	TCGA-EJ-A65F	2	2	0	1	1	1	2	1	4	57	2	0	2	17	2	0	TCGA-EJ-A65F-01	107	0.15952802418985065	47	TCGA-EJ-A65F-01	2	5	34	0.0408759815170456	TCGA-EJ-A65F-01	11	12	4	27	PASS	7987	TCGA-EJ-A65F	PRAD	59	MALE	NA	NA	NA	"Prostate Adenocarcinoma, Other Subtype"	NA	2012	NA	-21681	Alive	[Discrepancy]	560	NA	NA	Biochemical evidence of disease	NA	NA	75	Progressive Disease	NA	NA	0	560	0	560	NA	NA	1	75	
60	TCGA-EJ-A65G	0	0	0	0	0	0	0	0	0	17	2	0	0	4	0	0	TCGA-EJ-A65G-01	69	4.371856433642832e-05	28	TCGA-EJ-A65G-01	0	0	13	0.01074314784999977	TCGA-EJ-A65G-01	0	0	1	1	PASS	7988	TCGA-EJ-A65G	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-20821	Alive	TUMOR FREE	666	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	666	0	666	0	666	0	666	
60	TCGA-EJ-A65J	1	2	0	2	0	2	0	0	0	26	2	0	0	13	0	0	TCGA-EJ-A65J-01	218	0.10254858281650643	154	TCGA-EJ-A65J-01	0	2	67	0.044928978637807856	TCGA-EJ-A65J-01	1	8	4	13	PASS	7989	TCGA-EJ-A65J	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-22904	Alive	TUMOR FREE	451	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	451	0	451	0	451	0	451	
70	TCGA-EJ-A65M	0	1	0	1	1	0	0	0	2	26	3	0	1	10	1	0	TCGA-EJ-A65M-01	235	0.20071121304123835	157	TCGA-EJ-A65M-01	0	0	87	0.07897678041427716	TCGA-EJ-A65M-01	0	9	4	13	RNA degradation	7990	TCGA-EJ-A65M	PRAD	65	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-23767	Alive	TUMOR FREE	230	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	230	0	230	0	230	0	230	
70	TCGA-EJ-A6RA	0	0	0	0	0	0	0	0	0	10	0	0	0	5	0	0	TCGA-EJ-A6RA-01	55	1.8257263207111066e-05	13	TCGA-EJ-A6RA-01	0	0	5	0.0009648161670079599	TCGA-EJ-A6RA-01	0	0	0	0	PASS	7991	TCGA-EJ-A6RA	PRAD	70	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-25679	Alive	TUMOR FREE	353	NA	NA	Locoregional Recurrence	NA	NA	353	Partial Remission/Response	NA	NA	0	353	0	353	NA	NA	1	353	
60	TCGA-EJ-A6RC	0	0	0	0	0	0	0	0	0	19	1	1	0	7	0	0	TCGA-EJ-A6RC-01	61	0.00015905426468557242	20	TCGA-EJ-A6RC-01	0	0	6	0.00046355897361875906	TCGA-EJ-A6RC-01	0	0	0	0	PASS	7992	TCGA-EJ-A6RC	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-23598	Alive	TUMOR FREE	873	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	873	0	873	0	873	0	873	
60	TCGA-EJ-A7NF	0	1	0	0	0	0	1	0	2	12	1	0	1	8	0	0	TCGA-EJ-A7NF-01	82	0.042650772466804605	32	TCGA-EJ-A7NF-01	0	1	27	0.018638737016358417	TCGA-EJ-A7NF-01	2	2	2	6	PASS	7993	TCGA-EJ-A7NF	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-20587	Alive	TUMOR FREE	250	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	250	0	250	0	250	0	250	
60	TCGA-EJ-A7NG	0	0	0	0	0	0	0	0	0	2	0	0	0	2	0	0	TCGA-EJ-A7NG-01	53	8.451275457897881e-06	19	TCGA-EJ-A7NG-01	0	0	7	0.0002250502993271009	TCGA-EJ-A7NG-01	0	0	0	0	PASS	7994	TCGA-EJ-A7NG	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-23458	Alive	TUMOR FREE	432	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	432	0	432	0	432	0	432	
60	TCGA-EJ-A7NH	0	0	0	0	0	0	0	0	1	15	3	0	0	4	1	0	TCGA-EJ-A7NH-01	87	0.13836067875960475	36	TCGA-EJ-A7NH-01	4	4	66	0.08597720385009743	TCGA-EJ-A7NH-01	3	3	5	11	PASS	7995	TCGA-EJ-A7NH	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-20734	Alive	TUMOR FREE	474	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	474	0	474	0	474	0	474	
60	TCGA-EJ-A7NJ	1	0	0	0	0	0	0	0	0	8	0	0	0	0	0	0	TCGA-EJ-A7NJ-01	53	2.725940001340997e-05	19	TCGA-EJ-A7NJ-01	0	0	6	0.0010391001766458165	TCGA-EJ-A7NJ-01	0	0	0	0	PASS	7996	TCGA-EJ-A7NJ	PRAD	59	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-21748	Alive	TUMOR FREE	197	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	197	0	197	0	197	0	197	
60	TCGA-EJ-A7NK	0	0	0	1	0	0	0	0	2	2	0	0	1	0	1	0	TCGA-EJ-A7NK-01	49	0.00012818843419092795	11	TCGA-EJ-A7NK-01	0	0	8	0.0010559858625470474	TCGA-EJ-A7NK-01	0	0	0	0	PASS	7997	TCGA-EJ-A7NK	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-21530	Alive	TUMOR FREE	476	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	476	0	476	0	476	0	476	
60	TCGA-EJ-A7NM	0	5	0	0	0	0	1	0	3	39	4	0	2	12	0	1	TCGA-EJ-A7NM-01	146	0.07378468575775632	83	TCGA-EJ-A7NM-01	1	2	62	0.05962981574620725	TCGA-EJ-A7NM-01	2	5	4	11	PASS	7998	TCGA-EJ-A7NM	PRAD	64	MALE	NA	NA	NA	"Prostate Adenocarcinoma, Other Subtype"	NA	2013	NA	-23603	Alive	TUMOR FREE	128	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	128	0	128	0	128	0	128	
60	TCGA-EJ-A7NN	0	3	1	1	0	0	0	0	2	30	1	0	0	7	1	0	TCGA-EJ-A7NN	0	0	0	TCGA-EJ-A7NN	0	0	0	0	TCGA-EJ-A7NN	0	0	0	0	PASS	7999	TCGA-EJ-A7NN	PRAD	61	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-22499	Alive	TUMOR FREE	197	NA	NA	Biochemical evidence of disease	NA	NA	197	Complete Remission/Response	NA	NA	0	197	0	197	1	197	1	197	
60	TCGA-EJ-A8FN	0	1	0	1	1	1	0	0	0	28	2	0	1	10	1	0	TCGA-EJ-A8FN-01	115	0.08361890256423822	73	TCGA-EJ-A8FN-01	2	1	32	0.030731313121654717	TCGA-EJ-A8FN-01	0	6	2	8	PASS	8000	TCGA-EJ-A8FN	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-21506	Alive	TUMOR FREE	329	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	329	0	329	0	329	0	329	
50	TCGA-EJ-A8FO	0	1	0	0	0	0	0	0	1	14	0	0	0	4	0	0	TCGA-EJ-A8FO-01	47	5.533333291631253e-06	12	TCGA-EJ-A8FO-01	0	0	7	0.0002721453348993808	TCGA-EJ-A8FO-01	0	0	0	0	pathology review	8001	TCGA-EJ-A8FO	PRAD	51	MALE	NA	NA	NA	"Prostate Adenocarcinoma, Other Subtype"	NA	2013	NA	-18875	Alive	TUMOR FREE	282	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	282	0	282	0	282	0	282	
60	TCGA-EJ-A8FP	0	0	0	1	0	0	0	0	0	8	0	0	0	0	0	0	TCGA-EJ-A8FP-01	70	0.00012455015472101805	26	TCGA-EJ-A8FP-01	0	0	7	0.00042504708448695125	TCGA-EJ-A8FP-01	0	0	0	0	pathology review	8002	TCGA-EJ-A8FP	PRAD	59	MALE	NA	NA	NA	"Prostate Adenocarcinoma, Other Subtype"	NA	2013	NA	-21769	Alive	TUMOR FREE	299	NA	NA	Biochemical evidence of disease	NA	NA	117	Complete Remission/Response	NA	NA	0	299	0	299	1	117	1	117	
70	TCGA-EJ-A8FS	0	2	1	0	2	1	0	0	0	21	4	0	1	9	0	0	TCGA-EJ-A8FS-01	99	0.0934187376475391	41	TCGA-EJ-A8FS-01	2	4	29	0.08049293225868576	TCGA-EJ-A8FS-01	4	7	5	16	PASS	8003	TCGA-EJ-A8FS	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-24380	Alive	TUMOR FREE	266	NA	NA	Biochemical evidence of disease	NA	NA	216	Complete Remission/Response	NA	NA	0	266	0	266	1	216	1	216	
60	TCGA-EJ-A8FU	0	0	0	0	0	0	0	0	0	8	0	0	0	4	0	0	TCGA-EJ-A8FU-01	59	3.1012226867020504e-05	20	TCGA-EJ-A8FU-01	0	0	11	0.000365064846161434	TCGA-EJ-A8FU-01	0	0	0	0	PASS	8004	TCGA-EJ-A8FU	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-23472	Alive	TUMOR FREE	138	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	138	0	138	0	138	0	138	
60	TCGA-EJ-AB20	0	0	0	0	1	0	0	0	0	12	0	0	0	4	0	0	TCGA-EJ-AB20-01	89	0.0543252862039192	37	TCGA-EJ-AB20-01	2	1	10	0.00045316940118242616	TCGA-EJ-AB20-01	0	0	0	0	RNA degradation	8005	TCGA-EJ-AB20	PRAD	61	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-22626	Alive	TUMOR FREE	131	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	131	0	131	0	131	0	131	
50	TCGA-EJ-AB27	0	2	0	0	0	0	0	0	1	13	1	0	0	13	0	0	TCGA-EJ-AB27-01	123	0.050890325326916466	68	TCGA-EJ-AB27-01	1	1	31	0.013991375941444685	TCGA-EJ-AB27-01	2	2	1	5	PASS	8006	TCGA-EJ-AB27	PRAD	51	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-18648	Alive	TUMOR FREE	145	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	145	0	145	0	145	0	145	
50	TCGA-FC-7708	0	0	1	0	1	1	1	0	1	20	1	0	0	11	2	0	TCGA-FC-7708-01	156	0.04832186656426312	92	TCGA-FC-7708-01	1	2	39	0.03997399191274347	TCGA-FC-7708-01	2	1	3	6	PASS	8007	TCGA-FC-7708	PRAD	52	MALE	ASIAN	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-19144	Alive	TUMOR FREE	864	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	864	0	864	0	864	0	864	
60	TCGA-FC-7961	0	5	0	4	2	3	0	0	0	34	2	0	0	13	2	0	TCGA-FC-7961-01	146	0.3710954352452087	80	TCGA-FC-7961-01	11	14	66	0.1376450020255067	TCGA-FC-7961-01	8	16	11	35	PASS	8008	TCGA-FC-7961	PRAD	62	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-22888	Alive	TUMOR FREE	469	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	469	0	469	0	469	0	469	
70	TCGA-FC-A4JI	0	3	0	3	1	0	1	0	0	21	1	0	0	13	0	0	TCGA-FC-A4JI-01	620	0.6276996309700619	478	TCGA-FC-A4JI-01	16	30	162	0.1974942108663316	TCGA-FC-A4JI-01	17	17	11	45	PASS	8009	TCGA-FC-A4JI	PRAD	70	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-25931	Alive	TUMOR FREE	877	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	877	0	877	0	877	0	877	
50	TCGA-FC-A5OB	0	0	0	3	1	1	0	0	0	19	2	0	1	9	1	0	TCGA-FC-A5OB-01	162	0.03262069607324228	113	TCGA-FC-A5OB-01	0	1	42	0.036280353260000175	TCGA-FC-A5OB-01	1	7	3	11	PASS	8010	TCGA-FC-A5OB	PRAD	53	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-19413	Alive	WITH TUMOR	680	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	680	0	680	NA	NA	0	680	
70	TCGA-FC-A66V	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	TCGA-FC-A66V-01	39	2.109253650729641e-05	5	TCGA-FC-A66V-01	0	0	4	0.00026914743609372706	TCGA-FC-A66V-01	0	0	0	0	RNA degradation	8011	TCGA-FC-A66V	PRAD	74	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-27282	Alive	TUMOR FREE	524	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	524	0	524	0	524	0	524	
80	TCGA-FC-A6HD	0	1	1	1	2	0	1	0	0	23	0	0	0	13	0	0	TCGA-FC-A6HD-01	64	0.010066823517059613	21	TCGA-FC-A6HD-01	0	0	15	0.012823572614762656	TCGA-FC-A6HD-01	1	1	1	3	RNA degradation	8012	TCGA-FC-A6HD	PRAD	77	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-28197	Alive	TUMOR FREE	789	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	789	0	789	0	789	0	789	
70	TCGA-FC-A8O0	0	1	0	0	0	0	0	0	1	11	3	0	0	2	0	0	TCGA-FC-A8O0-01	59	7.15222041139774e-05	17	TCGA-FC-A8O0-01	0	0	4	0.00015386699264174355	TCGA-FC-A8O0-01	0	0	0	0	PASS	8013	TCGA-FC-A8O0	PRAD	68	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-25115	Alive	TUMOR FREE	616	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	616	0	616	0	616	0	616	
70	TCGA-G9-6329	0	0	0	0	0	0	0	0	3	21	3	0	1	8	0	0	TCGA-G9-6329-01	49	0.07149404638480418	16	TCGA-G9-6329-01	4	3	5	0.06405090256061326	TCGA-G9-6329-01	2	0	2	4	PASS	8014	TCGA-G9-6329	PRAD	67	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-24797	Alive	TUMOR FREE	1266	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1266	0	1266	0	1266	0	1266	
60	TCGA-G9-6332	0	1	0	2	0	0	0	0	4	38	0	0	6	12	2	0	TCGA-G9-6332-01	132	0.08222483181474756	81	TCGA-G9-6332-01	0	1	33	0.04439072575113005	TCGA-G9-6332-01	2	3	3	8	pathology review	8015	TCGA-G9-6332	PRAD	55	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2005	NA	-20166	Alive	WITH TUMOR	2657	NA	NA	Biochemical evidence of disease	NA	NA	1180	Complete Remission/Response	NA	NA	0	2657	0	2657	1	1180	1	1180	
70	TCGA-G9-6333	0	5	0	4	0	2	0	0	2	50	2	0	0	25	2	0	TCGA-G9-6333-01	189	0.04639227498554365	134	TCGA-G9-6333-01	1	1	33	0.04741912957961876	TCGA-G9-6333-01	0	4	2	6	PASS	8016	TCGA-G9-6333	PRAD	66	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-24249	Alive	TUMOR FREE	2465	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2465	0	2465	0	2465	0	2465	
60	TCGA-G9-6336	0	2	0	0	0	0	0	0	0	15	0	0	1	5	0	0	TCGA-G9-6336-01	43	0.0011285537570520905	10	TCGA-G9-6336	0	0	0	0	TCGA-G9-6336	0	0	0	0	PASS	8017	TCGA-G9-6336	PRAD	57	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-20851	Alive	TUMOR FREE	2068	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2068	0	2068	0	2068	0	2068	
60	TCGA-G9-6338	0	3	0	2	1	1	0	0	0	30	6	0	1	8	1	0	TCGA-G9-6338-01	273	0.1674695919834555	211	TCGA-G9-6338-01	0	3	60	0.08728897406943341	TCGA-G9-6338-01	1	8	5	14	RNA degradation	8018	TCGA-G9-6338	PRAD	61	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-22360	Alive	TUMOR FREE	2028	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2028	0	2028	0	2028	0	2028	
60	TCGA-G9-6339	0	2	0	2	0	0	0	0	1	34	3	0	1	9	1	0	TCGA-G9-6339-01	117	0.036776569690412986	65	TCGA-G9-6339-01	2	2	41	0.036666835369790526	TCGA-G9-6339-01	2	0	2	4	RNA degradation	8019	TCGA-G9-6339	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-21305	Alive	TUMOR FREE	2551	NA	NA	Biochemical evidence of disease	NA	NA	1634	Complete Remission/Response	NA	NA	0	2551	0	2551	1	1634	1	1634	
60	TCGA-G9-6342	2	8	0	4	1	0	0	0	4	80	5	0	2	54	5	0	TCGA-G9-6342-01	81	0.055939021892561266	34	TCGA-G9-6342-01	1	1	17	0.059007638453529986	TCGA-G9-6342-01	3	6	5	14	PASS	8020	TCGA-G9-6342	PRAD	61	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-22472	Alive	TUMOR FREE	1696	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1696	0	1696	0	1696	0	1696	
60	TCGA-G9-6343	0	2	0	2	1	0	0	0	1	22	1	1	1	12	0	1	TCGA-G9-6343-01	71	0.03144415818185552	31	TCGA-G9-6343-01	1	3	2	0.029447401659614375	TCGA-G9-6343-01	0	1	1	2	RNA degradation	8021	TCGA-G9-6343	PRAD	62	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-22843	Alive	TUMOR FREE	2450	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2450	0	2450	0	2450	0	2450	
60	TCGA-G9-6347	0	3	0	2	0	0	0	0	0	15	0	0	0	7	0	0	TCGA-G9-6347-01	61	6.322106301052798e-05	19	TCGA-G9-6347-01	0	0	8	0.0005318707967308548	TCGA-G9-6347-01	0	0	0	0	RNA degradation	8022	TCGA-G9-6347	PRAD	59	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-21721	Alive	TUMOR FREE	2089	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2089	0	2089	0	2089	0	2089	
70	TCGA-G9-6348	0	4	0	0	4	0	0	0	2	52	2	0	2	30	6	0	TCGA-G9-6348-01	87	0.08202779282837433	39	TCGA-G9-6348-01	1	4	13	0.08638444394193819	TCGA-G9-6348-01	2	5	4	11	RNA degradation	8023	TCGA-G9-6348	PRAD	68	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-24936	Alive	TUMOR FREE	1515	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1515	0	1515	0	1515	0	1515	
50	TCGA-G9-6351	1	4	1	6	0	0	0	0	2	117	7	0	0	43	2	0	TCGA-G9-6351-01	53	0.033481230224174374	14	TCGA-G9-6351-01	0	1	7	0.03530509109039099	TCGA-G9-6351-01	0	2	2	4	PASS	8024	TCGA-G9-6351	PRAD	51	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-18723	Alive	TUMOR FREE	2048	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2048	0	2048	0	2048	0	2048	
60	TCGA-G9-6353	0	0	0	0	0	0	0	0	0	10	0	0	0	5	0	0	TCGA-G9-6353-01	45	2.094797075019843e-05	10	TCGA-G9-6353-01	0	0	0	0.0	TCGA-G9-6353-01	0	0	0	0	PASS	8025	TCGA-G9-6353	PRAD	58	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-21221	Alive	TUMOR FREE	1542	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1542	0	1542	0	1542	0	1542	
60	TCGA-G9-6354	0	2	1	1	0	0	0	0	1	19	1	0	0	9	1	0	TCGA-G9-6354-01	82	0.05874816457246498	31	TCGA-G9-6354-01	3	3	46	0.06080949283958476	TCGA-G9-6354-01	2	2	2	6	RNA degradation	8026	TCGA-G9-6354	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-20403	Alive	TUMOR FREE	2066	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2066	0	2066	0	2066	0	2066	
60	TCGA-G9-6356	0	2	0	0	0	2	0	0	2	33	6	0	0	10	6	0	TCGA-G9-6356-01	61	0.03559852748777256	13	TCGA-G9-6356-01	2	2	3	0.012383848184795808	TCGA-G9-6356-01	1	1	1	3	PASS	8027	TCGA-G9-6356	PRAD	60	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-22010	Alive	TUMOR FREE	1434	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1434	0	1434	0	1434	0	1434	
60	TCGA-G9-6361	1	0	0	0	1	0	0	0	2	26	3	0	0	8	2	0	TCGA-G9-6361-01	216	0.10454983974763904	154	TCGA-G9-6361-01	1	1	56	0.04823731629704319	TCGA-G9-6361-01	0	4	3	7	PASS	8028	TCGA-G9-6361	PRAD	61	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-22565	Alive	TUMOR FREE	1415	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1415	0	1415	0	1415	0	1415	
60	TCGA-G9-6362	0	3	0	0	0	0	0	0	3	35	6	0	0	31	0	0	TCGA-G9-6362-01	106	0.07860721116887234	53	TCGA-G9-6362-01	2	2	12	0.036882330288061586	TCGA-G9-6362-01	3	2	2	7	RNA degradation	8029	TCGA-G9-6362	PRAD	57	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-21149	Alive	WITH TUMOR	1443	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	1443	0	1443	NA	NA	0	1443	
60	TCGA-G9-6363	1	3	1	4	0	0	1	1	1	50	6	0	0	8	2	0	TCGA-G9-6363-01	114	0.08571307332435864	59	TCGA-G9-6363-01	1	3	31	0.05363131291799675	TCGA-G9-6363-01	3	8	3	14	PASS	8030	TCGA-G9-6363	PRAD	64	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-23480	Alive	TUMOR FREE	1378	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1378	0	1378	0	1378	0	1378	
70	TCGA-G9-6364	0	4	0	4	4	2	0	0	2	36	0	0	0	10	0	0	TCGA-G9-6364-01	95	0.0368402912381166	55	TCGA-G9-6364-01	2	2	17	0.038840926040112335	TCGA-G9-6364-01	2	2	2	6	PASS	8031	TCGA-G9-6364	PRAD	72	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-26603	Alive	TUMOR FREE	1198	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1198	0	1198	0	1198	0	1198	
70	TCGA-G9-6365	0	2	2	0	0	0	2	0	2	43	0	0	2	8	4	0	TCGA-G9-6365-01	57	0.014247136761106316	16	TCGA-G9-6365-01	0	0	3	0.014998399460400722	TCGA-G9-6365-01	0	2	1	3	PASS	8032	TCGA-G9-6365	PRAD	71	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-26207	Alive	TUMOR FREE	1363	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1363	0	1363	0	1363	0	1363	
60	TCGA-G9-6366	0	1	0	1	1	0	1	0	0	23	3	0	1	8	0	0	TCGA-G9-6366-01	149	0.1160406811286415	90	TCGA-G9-6366-01	1	4	14	0.03142312472361514	TCGA-G9-6366-01	4	4	2	10	PASS	8033	TCGA-G9-6366	PRAD	61	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-22428	Alive	NA	1947	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1947	0	1947	0	1947	0	1947	
60	TCGA-G9-6367	0	0	0	0	0	0	0	0	0	3	0	0	0	2	0	0	TCGA-G9-6367-01	47	8.689883137092357e-06	10	TCGA-G9-6367-01	0	0	0	0.0	TCGA-G9-6367-01	0	0	0	0	PASS	8034	TCGA-G9-6367	PRAD	60	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-22176	Alive	WITH TUMOR	1222	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	1222	0	1222	NA	NA	0	1222	
60	TCGA-G9-6369	0	1	0	0	0	0	1	0	1	29	1	0	0	9	0	0	TCGA-G9-6369-01	335	0.11077097028104144	247	TCGA-G9-6369-01	1	0	62	0.07631413596412509	TCGA-G9-6369-01	2	10	4	16	RNA degradation	8035	TCGA-G9-6369	PRAD	55	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-20238	Alive	TUMOR FREE	1215	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1215	0	1215	0	1215	0	1215	
50	TCGA-G9-6370	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	TCGA-G9-6370-01	49	1.6479735666445313e-05	11	TCGA-G9-6370-01	0	0	0	0.0	TCGA-G9-6370-01	0	0	0	0	PASS	8036	TCGA-G9-6370	PRAD	52	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-19149	Alive	TUMOR FREE	1156	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1156	0	1156	0	1156	0	1156	
60	TCGA-G9-6371	0	2	0	4	2	0	0	0	0	26	0	0	0	5	0	0	TCGA-G9-6371-01	57	0.06806366277637013	17	TCGA-G9-6371-01	3	2	19	0.014284904425749216	TCGA-G9-6371-01	1	0	1	2	PASS	8037	TCGA-G9-6371	PRAD	58	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-21365	Alive	TUMOR FREE	1226	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1226	0	1226	0	1226	0	1226	
70	TCGA-G9-6373	0	2	0	2	0	2	0	0	0	38	0	0	2	16	0	0	TCGA-G9-6373-01	97	0.14568121283860594	49	TCGA-G9-6373-01	7	5	24	0.06852658199539094	TCGA-G9-6373-01	4	0	3	7	RNA degradation	8038	TCGA-G9-6373	PRAD	68	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-24887	Alive	TUMOR FREE	811	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	811	0	811	0	811	0	811	
60	TCGA-G9-6377	0	2	0	2	0	1	0	0	5	42	2	1	1	21	1	0	TCGA-G9-6377-01	91	0.16674325499500184	40	TCGA-G9-6377-01	3	2	20	0.06733506443778144	TCGA-G9-6377-01	5	4	3	12	PASS	8039	TCGA-G9-6377	PRAD	61	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-22419	Alive	TUMOR FREE	958	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	958	0	958	0	958	0	958	
50	TCGA-G9-6378	0	0	0	1	0	1	1	0	2	19	0	0	1	13	1	0	TCGA-G9-6378-01	83	0.04524212595135448	36	TCGA-G9-6378-01	2	2	9	0.04751203009838582	TCGA-G9-6378-01	2	1	2	5	PASS	8040	TCGA-G9-6378	PRAD	54	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-19879	Alive	TUMOR FREE	1155	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1155	0	1155	0	1155	0	1155	
70	TCGA-G9-6379	0	2	0	1	1	0	0	0	2	20	0	0	0	8	0	0	TCGA-G9-6379-01	151	0.07382346235984633	82	TCGA-G9-6379-01	2	3	48	0.07535092048927243	TCGA-G9-6379-01	6	11	5	22	RNA degradation	8041	TCGA-G9-6379	PRAD	68	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-25126	Alive	TUMOR FREE	1778	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1778	0	1778	0	1778	0	1778	
50	TCGA-G9-6384	0	0	0	0	1	0	0	0	4	36	4	0	2	10	0	0	TCGA-G9-6384-01	57	0.05371645740155159	18	TCGA-G9-6384-01	1	2	13	0.056923556282551774	TCGA-G9-6384-01	4	5	5	14	PASS	8042	TCGA-G9-6384	PRAD	53	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-19620	Alive	TUMOR FREE	765	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	765	0	765	0	765	0	765	
70	TCGA-G9-6385	0	0	0	4	0	0	0	0	2	16	2	0	0	8	0	0	TCGA-G9-6385-01	55	4.2059104432915113e-05	20	TCGA-G9-6385-01	0	0	0	0.0	TCGA-G9-6385-01	0	0	0	0	PASS	8043	TCGA-G9-6385	PRAD	66	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-24399	Alive	TUMOR FREE	830	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	830	0	830	0	830	0	830	
70	TCGA-G9-6494	0	6	0	0	6	0	0	0	0	44	4	0	0	16	4	0	TCGA-G9-6494-01	115	0.11019577711914587	55	TCGA-G9-6494-01	5	3	26	0.06864871525050936	TCGA-G9-6494-01	5	4	5	14	PASS	8044	TCGA-G9-6494	PRAD	66	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-24381	Alive	WITH TUMOR	1771	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	1771	0	1771	NA	NA	0	1771	
60	TCGA-G9-6496	0	10	0	2	2	0	2	0	2	59	2	0	4	19	2	0	TCGA-G9-6496-01	324	0.08739583584881098	252	TCGA-G9-6496-01	1	2	46	0.062180642606914936	TCGA-G9-6496-01	5	6	3	14	RNA degradation	8045	TCGA-G9-6496	PRAD	61	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-22602	Alive	TUMOR FREE	1726	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1726	0	1726	0	1726	0	1726	
50	TCGA-G9-6498	0	0	1	1	1	1	0	0	0	17	0	0	0	8	0	0	TCGA-G9-6498-01	65	0.010919701808389163	27	TCGA-G9-6498-01	0	0	15	0.012600261760581882	TCGA-G9-6498-01	0	2	1	3	RNA degradation	8046	TCGA-G9-6498	PRAD	53	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-19568	Alive	TUMOR FREE	1952	NA	NA	Biochemical evidence of disease	NA	NA	1342	Complete Remission/Response	NA	NA	0	1952	0	1952	1	1342	1	1342	
70	TCGA-G9-6499	0	10	0	4	6	2	0	0	4	56	0	0	2	25	0	0	TCGA-G9-6499-01	199	0.4745458882744691	147	TCGA-G9-6499-01	20	20	17	0.10453749762167976	TCGA-G9-6499-01	10	15	5	30	PASS	8047	TCGA-G9-6499	PRAD	66	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-24388	Alive	TUMOR FREE	1543	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1543	0	1543	0	1543	0	1543	
50	TCGA-G9-7509	0	0	0	1	0	0	2	0	0	16	0	0	0	6	2	0	TCGA-G9-7509-01	127	0.06721193706577529	74	TCGA-G9-7509-01	0	0	16	0.012004564283159852	TCGA-G9-7509-01	1	2	0	3	PASS	8048	TCGA-G9-7509	PRAD	48	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-17538	Alive	TUMOR FREE	1610	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1610	0	1610	0	1610	0	1610	
70	TCGA-G9-7510	0	1	0	1	0	0	1	0	0	30	2	0	1	9	1	0	TCGA-G9-7510-01	84	0.1169940049549149	35	TCGA-G9-7510-01	4	4	24	0.0913099500081813	TCGA-G9-7510-01	3	5	3	11	PASS	8049	TCGA-G9-7510	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-24187	Alive	TUMOR FREE	1185	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1185	0	1185	0	1185	0	1185	
60	TCGA-G9-7519	0	0	1	1	3	1	0	0	0	26	2	0	1	5	0	0	TCGA-G9-7519-01	52	0.033009838393366034	15	TCGA-G9-7519-01	1	1	3	0.03479203794280924	TCGA-G9-7519-01	0	0	0	0	PASS	8050	TCGA-G9-7519	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-21276	Alive	TUMOR FREE	849	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	849	0	849	0	849	0	849	
50	TCGA-G9-7521	0	2	0	2	0	0	0	0	0	19	1	0	3	7	0	0	TCGA-G9-7521-01	133	0.3836612277704233	77	TCGA-G9-7521-01	14	16	13	0.09050114359761326	TCGA-G9-7521-01	9	9	5	23	PASS	8051	TCGA-G9-7521	PRAD	52	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-19216	Alive	[Discrepancy]	942	NA	NA	NA	NA	NA	NA	[Discrepancy]	NA	NA	0	942	0	942	NA	NA	0	942	
50	TCGA-G9-7522	0	0	0	0	1	0	0	0	0	5	2	0	0	2	0	0	TCGA-G9-7522-01	59	0.013995844889627504	18	TCGA-G9-7522-01	0	0	10	0.005399471022450301	TCGA-G9-7522-01	0	0	0	0	PASS	8052	TCGA-G9-7522	PRAD	49	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-18033	Alive	TUMOR FREE	1078	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1078	0	1078	0	1078	0	1078	
40	TCGA-G9-7523	0	0	0	0	0	0	0	0	0	12	0	0	0	8	0	0	TCGA-G9-7523-01	83	0.15744826006217036	38	TCGA-G9-7523-01	7	4	10	0.16224721262118305	TCGA-G9-7523-01	0	0	0	0	PASS	8053	TCGA-G9-7523	PRAD	44	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-16269	Alive	TUMOR FREE	857	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	857	0	857	0	857	0	857	
60	TCGA-G9-7525	0	2	0	0	2	0	1	0	0	28	1	0	1	7	0	1	TCGA-G9-7525-01	253	0.058259924220844965	186	TCGA-G9-7525-01	1	2	74	0.031145082997026043	TCGA-G9-7525-01	2	2	1	5	RNA degradation	8054	TCGA-G9-7525	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-23481	Alive	TUMOR FREE	994	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	994	0	994	0	994	0	994	
50	TCGA-G9-A9S0	0	1	0	2	1	0	0	0	0	20	2	0	0	2	1	0	TCGA-G9-A9S0-01	92	0.25805587739048946	35	TCGA-G9-A9S0-01	4	5	54	0.11882487644454552	TCGA-G9-A9S0-01	5	7	10	22	PASS	8055	TCGA-G9-A9S0	PRAD	53	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-19530	Dead	WITH TUMOR	NA	791	Prostate Cancer	Distant Metastasis	Bone	NA	423	Progressive Disease	NA	NA	1	791	1	791	NA	NA	1	423	
60	TCGA-G9-A9S4	0	1	1	2	3	0	1	0	0	28	0	0	0	11	0	0	TCGA-G9-A9S4	0	0	0	TCGA-G9-A9S4	0	0	0	0	TCGA-G9-A9S4	0	0	0	0	PASS	8056	TCGA-G9-A9S4	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-22684	Alive	TUMOR FREE	906	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	906	0	906	0	906	0	906	
60	TCGA-G9-A9S7	0	2	0	0	0	0	0	0	0	22	0	0	0	8	1	0	TCGA-G9-A9S7-01	135	0.1183180012343973	78	TCGA-G9-A9S7-01	2	3	61	0.06695125128884638	TCGA-G9-A9S7-01	5	2	5	12	PASS	8057	TCGA-G9-A9S7	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-20213	Alive	WITH TUMOR	728	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	728	0	728	NA	NA	0	728	
70	TCGA-H9-7775	0	2	0	0	1	0	0	0	0	23	2	0	1	14	0	0	TCGA-H9-7775-01	85	0.03106896910346188	42	TCGA-H9-7775-01	1	1	20	0.032713271673852316	TCGA-H9-7775-01	2	3	2	7	PASS	8058	TCGA-H9-7775	PRAD	68	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-24898	Alive	TUMOR FREE	185	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	185	0	185	0	185	0	185	
60	TCGA-H9-A6BX	0	0	0	0	0	0	0	0	0	4	1	0	0	2	0	0	TCGA-H9-A6BX-01	57	3.498312144993137e-05	15	TCGA-H9-A6BX-01	0	0	7	0.0004989614365717161	TCGA-H9-A6BX-01	0	0	0	0	pathology review	8059	TCGA-H9-A6BX	PRAD	60	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-22039	Alive	TUMOR FREE	941	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	941	0	941	0	941	0	941	
60	TCGA-H9-A6BY	0	1	0	1	1	3	0	0	0	21	0	0	1	8	1	0	TCGA-H9-A6BY-01	61	0.019041690625841757	27	TCGA-H9-A6BY-01	0	0	11	0.019834542955216698	TCGA-H9-A6BY-01	0	2	1	3	RNA degradation	8060	TCGA-H9-A6BY	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-23297	Alive	NA	112	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	112	0	112	NA	NA	0	112	
60	TCGA-HC-7075	1	2	1	0	1	0	1	0	0	25	3	0	0	5	0	0	TCGA-HC-7075-01	91	0.005842615053977948	49	TCGA-HC-7075-01	0	0	19	0.006015777860185197	TCGA-HC-7075-01	0	0	0	0	PASS	8061	TCGA-HC-7075	PRAD	63	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	NA	Alive	TUMOR FREE	601	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	601	0	601	0	601	0	601	
60	TCGA-HC-7077	0	1	0	0	5	0	0	0	4	38	2	0	2	13	3	0	TCGA-HC-7077-01	190	0.0962180103911334	116	TCGA-HC-7077-01	2	2	28	0.06507687749134608	TCGA-HC-7077-01	1	4	3	8	PASS	8062	TCGA-HC-7077	PRAD	64	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-23636	Alive	TUMOR FREE	2115	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2115	0	2115	0	2115	0	2115	
70	TCGA-HC-7078	0	2	0	0	0	0	0	0	2	27	1	0	1	7	0	0	TCGA-HC-7078-01	134	0.2709419387329683	81	TCGA-HC-7078-01	6	9	34	0.1621328156878817	TCGA-HC-7078-01	9	7	7	23	PASS	8063	TCGA-HC-7078	PRAD	69	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-25402	Alive	TUMOR FREE	1985	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1985	0	1985	0	1985	0	1985	
50	TCGA-HC-7079	0	0	0	0	0	0	0	0	0	0	0	0	0	4	0	0	TCGA-HC-7079-01	55	1.9927550045749403e-05	17	TCGA-HC-7079-01	0	0	19	1.4230007764586472e-05	TCGA-HC-7079-01	0	0	0	0	mutation call filter	8064	TCGA-HC-7079	PRAD	51	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-18734	Alive	WITH TUMOR	1184	NA	NA	Biochemical evidence of disease	NA	NA	380	Partial Remission/Response	NA	NA	0	1184	0	1184	NA	NA	1	380	
70	TCGA-HC-7080	1	2	0	1	1	1	1	0	4	24	3	0	0	15	0	0	TCGA-HC-7080-01	547	0.5605920365184537	441	TCGA-HC-7080-01	0	1	126	0.10554022614700924	TCGA-HC-7080-01	1	9	6	16	PASS	8065	TCGA-HC-7080	PRAD	66	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-24243	Alive	TUMOR FREE	1106	NA	NA	New Primary Tumor	NA	NA	894	Complete Remission/Response	NA	NA	0	1106	0	1106	0	1106	1	894	
60	TCGA-HC-7081	0	5	0	2	2	0	0	0	4	73	3	0	1	25	2	0	TCGA-HC-7081-01	105	0.026533388265181517	49	TCGA-HC-7081-01	0	0	26	0.02788049916366276	TCGA-HC-7081-01	2	2	1	5	PASS	8066	TCGA-HC-7081	PRAD	62	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	NA	Alive	WITH TUMOR	1136	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1136	0	1136	NA	NA	0	1136	
60	TCGA-HC-7209	0	3	0	2	1	0	0	0	1	13	2	0	0	5	0	0	TCGA-HC-7209-01	133	0.04226511105656473	78	TCGA-HC-7209-01	0	0	43	0.04426160629981343	TCGA-HC-7209-01	4	7	2	13	PASS	8067	TCGA-HC-7209	PRAD	60	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-22129	Alive	TUMOR FREE	440	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	440	0	440	0	440	0	440	
70	TCGA-HC-7210	0	2	0	1	3	0	1	0	0	20	3	0	1	12	1	0	TCGA-HC-7210-01	158	0.07431966476759838	92	TCGA-HC-7210-01	0	0	33	0.05951177654265603	TCGA-HC-7210-01	1	10	5	16	PASS	8068	TCGA-HC-7210	PRAD	74	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-27343	Alive	TUMOR FREE	868	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	868	0	868	0	868	0	868	
60	TCGA-HC-7211	1	1	0	0	0	1	0	0	1	20	0	0	0	4	0	0	TCGA-HC-7211-01	87	0.04833502239099358	35	TCGA-HC-7211-01	2	1	11	0.05036221927693548	TCGA-HC-7211-01	2	3	2	7	PASS	8069	TCGA-HC-7211	PRAD	62	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-22768	Alive	TUMOR FREE	1221	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1221	0	1221	0	1221	0	1221	
60	TCGA-HC-7212	0	0	0	0	1	1	0	0	0	22	5	0	0	8	1	0	TCGA-HC-7212-01	71	0.12086919326573987	23	TCGA-HC-7212-01	0	4	15	0.08914081572389854	TCGA-HC-7212-01	4	6	5	15	PASS	8070	TCGA-HC-7212	PRAD	56	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-20576	Alive	TUMOR FREE	870	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	870	0	870	0	870	0	870	
50	TCGA-HC-7213	0	0	0	3	1	1	0	0	2	30	0	0	0	16	1	0	TCGA-HC-7213-01	124	0.8549345437423943	61	TCGA-HC-7213-01	13	12	23	0.08744266461177569	TCGA-HC-7213-01	8	7	4	19	PASS	8071	TCGA-HC-7213	PRAD	53	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-19699	Alive	TUMOR FREE	1219	NA	NA	Biochemical evidence of disease	NA	NA	170	Partial Remission/Response	NA	NA	0	1219	0	1219	NA	NA	1	170	
50	TCGA-HC-7230	0	1	0	0	0	0	0	0	2	18	1	0	0	9	1	0	TCGA-HC-7230-01	76	0.05479897115555337	32	TCGA-HC-7230-01	2	2	14	0.05539041233308088	TCGA-HC-7230-01	1	1	4	6	PASS	8072	TCGA-HC-7230	PRAD	50	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-18577	Alive	TUMOR FREE	1001	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1001	0	1001	0	1001	0	1001	
70	TCGA-HC-7231	0	0	0	1	1	1	0	0	2	26	2	0	0	17	1	0	TCGA-HC-7231-01	104	0.0964725998035131	51	TCGA-HC-7231-01	0	0	21	0.03708298201164535	TCGA-HC-7231-01	0	7	3	10	PASS	8073	TCGA-HC-7231	PRAD	66	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-24278	Alive	TUMOR FREE	939	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	939	0	939	0	939	0	939	
70	TCGA-HC-7232	0	2	1	1	0	0	0	0	1	23	0	0	0	13	0	0	TCGA-HC-7232-01	98	0.12823327838995915	44	TCGA-HC-7232-01	2	3	22	0.08851086229022254	TCGA-HC-7232-01	3	8	6	17	PASS	8074	TCGA-HC-7232	PRAD	66	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-24324	Alive	WITH TUMOR	1161	NA	NA	Biochemical evidence of disease	NA	NA	766	Complete Remission/Response	NA	NA	0	1161	0	1161	1	766	1	766	
70	TCGA-HC-7233	1	2	0	1	1	0	0	0	0	25	2	0	0	11	1	0	TCGA-HC-7233-01	55	0.0009204604993804172	15	TCGA-HC-7233-01	0	0	3	0.0004926240037334411	TCGA-HC-7233-01	0	0	0	0	PASS	8075	TCGA-HC-7233	PRAD	73	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	NA	Alive	TUMOR FREE	1355	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1355	0	1355	0	1355	0	1355	
60	TCGA-HC-7736	0	0	0	2	3	0	0	0	1	15	1	0	0	3	0	0	TCGA-HC-7736-01	248	0.12460463085835373	183	TCGA-HC-7736-01	1	2	81	0.13075688183569298	TCGA-HC-7736-01	2	12	8	22	PASS	8076	TCGA-HC-7736	PRAD	59	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-21703	Alive	TUMOR FREE	1103	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1103	0	1103	0	1103	0	1103	
60	TCGA-HC-7737	0	1	0	3	0	1	0	0	0	17	0	0	0	2	0	0	TCGA-HC-7737-01	87	0.08371935001168553	40	TCGA-HC-7737-01	1	3	11	0.0883808428817369	TCGA-HC-7737-01	2	3	4	9	PASS	8077	TCGA-HC-7737	PRAD	55	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-20122	Alive	TUMOR FREE	1090	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1090	0	1090	0	1090	0	1090	
60	TCGA-HC-7738	0	0	2	3	2	0	2	0	0	57	4	0	0	13	2	0	TCGA-HC-7738-01	71	0.02754569189417699	33	TCGA-HC-7738-01	0	2	10	0.02895702500603952	TCGA-HC-7738-01	0	4	2	6	pathology review	8078	TCGA-HC-7738	PRAD	58	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21195	Alive	WITH TUMOR	964	NA	NA	Biochemical evidence of disease	"Other, specify"	biochemical recurrence only	420	Partial Remission/Response	NA	NA	0	964	0	964	NA	NA	1	420	
60	TCGA-HC-7740	0	0	0	0	0	0	2	0	6	30	2	0	0	15	0	0	TCGA-HC-7740-01	53	0.00019936682757858392	17	TCGA-HC-7740-01	0	0	19	1.5650190507171346e-05	TCGA-HC-7740-01	0	0	0	0	PASS	8079	TCGA-HC-7740	PRAD	59	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21883	Alive	TUMOR FREE	717	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	717	0	717	0	717	0	717	
70	TCGA-HC-7741	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-HC-7741	0	0	0	TCGA-HC-7741	0	0	0	0	TCGA-HC-7741	0	0	0	0	PASS	8080	TCGA-HC-7741	PRAD	67	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-24608	Alive	TUMOR FREE	2725	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2725	0	2725	0	2725	0	2725	
60	TCGA-HC-7742	0	6	0	0	1	0	2	0	1	50	2	0	4	16	0	0	TCGA-HC-7742-01	89	0.21117157730914565	42	TCGA-HC-7742-01	5	5	28	0.10285046930247006	TCGA-HC-7742-01	7	3	6	16	PASS	8081	TCGA-HC-7742	PRAD	58	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21323	Alive	WITH TUMOR	938	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	938	0	938	NA	NA	0	938	
50	TCGA-HC-7744	0	0	1	2	1	1	0	0	0	30	0	0	1	1	0	0	TCGA-HC-7744-01	135	0.06302691146742433	82	TCGA-HC-7744-01	0	0	43	0.01825518807666655	TCGA-HC-7744-01	0	2	1	3	PASS	8082	TCGA-HC-7744	PRAD	46	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-17065	Alive	TUMOR FREE	531	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	531	0	531	0	531	0	531	
70	TCGA-HC-7745	0	2	0	4	0	0	0	0	0	46	0	0	0	24	2	0	TCGA-HC-7745-01	118	0.15177306177372155	56	TCGA-HC-7745-01	3	4	32	0.1020722384411372	TCGA-HC-7745-01	7	12	8	27	pathology review	8083	TCGA-HC-7745	PRAD	65	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-24078	Alive	TUMOR FREE	721	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	721	0	721	0	721	0	721	
50	TCGA-HC-7747	0	2	0	4	0	2	0	0	0	53	4	0	2	23	0	0	TCGA-HC-7747-01	151	0.06522298993506223	92	TCGA-HC-7747-01	0	0	43	0.06874299645596595	TCGA-HC-7747-01	3	9	3	15	PASS	8084	TCGA-HC-7747	PRAD	52	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-19188	Alive	TUMOR FREE	748	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	748	0	748	0	748	0	748	
60	TCGA-HC-7748	0	1	0	1	2	0	0	0	2	21	0	0	0	6	0	0	TCGA-HC-7748-01	83	0.04501081075883292	33	TCGA-HC-7748-01	1	2	21	0.04367289798804702	TCGA-HC-7748-01	4	2	4	10	PASS	8085	TCGA-HC-7748	PRAD	60	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-22072	Alive	TUMOR FREE	792	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	792	0	792	0	792	0	792	
70	TCGA-HC-7749	0	3	0	2	1	2	0	0	2	39	5	0	0	5	1	0	TCGA-HC-7749-01	109	0.11075158521189872	57	TCGA-HC-7749-01	0	1	18	0.033318737175000536	TCGA-HC-7749-01	0	4	3	7	PASS	8086	TCGA-HC-7749	PRAD	70	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-25688	Alive	TUMOR FREE	724	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	724	0	724	0	724	0	724	
50	TCGA-HC-7750	0	1	0	0	1	0	0	0	0	14	1	0	0	4	0	0	TCGA-HC-7750-01	71	0.006600491502455607	21	TCGA-HC-7750-01	0	0	2	0.006723930703224819	TCGA-HC-7750-01	0	2	1	3	PASS	8087	TCGA-HC-7750	PRAD	50	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-18580	Alive	TUMOR FREE	522	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	522	0	522	0	522	0	522	
60	TCGA-HC-7752	0	2	0	2	0	4	0	0	0	53	10	0	0	10	0	0	TCGA-HC-7752-01	142	0.025094866188550877	88	TCGA-HC-7752-01	0	1	44	0.021324462853662345	TCGA-HC-7752-01	0	2	2	4	RNA degradation	8088	TCGA-HC-7752	PRAD	61	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-22366	Alive	TUMOR FREE	782	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	782	0	782	0	782	0	782	
50	TCGA-HC-7817	0	1	0	1	1	0	0	0	1	14	2	0	0	7	0	0	TCGA-HC-7817-01	65	0.0018614168156121688	27	TCGA-HC-7817-01	0	0	10	0.0014140512115640757	TCGA-HC-7817-01	0	0	0	0	pathology review	8089	TCGA-HC-7817	PRAD	52	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-19207	Alive	TUMOR FREE	928	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	928	0	928	0	928	0	928	
70	TCGA-HC-7818	0	1	0	0	2	0	0	0	1	21	1	0	0	5	0	0	TCGA-HC-7818-01	55	8.310358796000218e-05	16	TCGA-HC-7818	0	0	0	0	TCGA-HC-7818	0	0	0	0	PASS	8090	TCGA-HC-7818	PRAD	66	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-24391	Alive	TUMOR FREE	938	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	938	0	938	0	938	0	938	
50	TCGA-HC-7819	0	0	0	2	4	2	2	0	2	39	0	0	2	6	0	0	TCGA-HC-7819-01	94	0.07702255501036008	38	TCGA-HC-7819-01	1	2	10	0.042830159272373255	TCGA-HC-7819-01	4	2	2	8	pathology review	8091	TCGA-HC-7819	PRAD	53	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-19663	Alive	TUMOR FREE	543	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	543	0	543	0	543	0	543	
70	TCGA-HC-7820	0	2	0	2	4	0	2	0	2	48	6	0	2	10	0	0	TCGA-HC-7820-01	69	0.03859896033750526	32	TCGA-HC-7820-01	2	1	15	0.04042910341505849	TCGA-HC-7820-01	0	3	0	3	PASS	8092	TCGA-HC-7820	PRAD	72	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-26576	Alive	TUMOR FREE	747	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	747	0	747	0	747	0	747	
50	TCGA-HC-7821	0	1	0	1	0	0	0	0	1	22	1	0	0	10	0	0	TCGA-HC-7821-01	219	0.6717975476324544	158	TCGA-HC-7821-01	4	4	50	0.10467617498424392	TCGA-HC-7821-01	3	3	5	11	PASS	8093	TCGA-HC-7821	PRAD	54	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-19894	Alive	WITH TUMOR	956	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	956	0	956	0	956	0	956	
50	TCGA-HC-8212	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-HC-8212	0	0	0	TCGA-HC-8212	0	0	0	0	TCGA-HC-8212	0	0	0	0	PASS	8094	TCGA-HC-8212	PRAD	53	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-19539	Alive	TUMOR FREE	2179	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2179	0	2179	0	2179	0	2179	
50	TCGA-HC-8213	0	2	0	0	1	0	0	0	0	16	0	0	0	3	0	0	TCGA-HC-8213-01	121	0.008283222676221502	63	TCGA-HC-8213-01	0	0	32	0.011973943585860623	TCGA-HC-8213-01	0	1	0	1	PASS	8095	TCGA-HC-8213	PRAD	48	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-17673	Alive	TUMOR FREE	589	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	589	0	589	0	589	0	589	
60	TCGA-HC-8216	0	4	0	4	0	0	1	0	1	88	6	0	0	31	3	0	TCGA-HC-8216-01	123	0.2966671082982044	66	TCGA-HC-8216-01	5	10	69	0.1953999409851105	TCGA-HC-8216-01	7	8	8	23	PASS	8096	TCGA-HC-8216	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21428	Alive	TUMOR FREE	682	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	682	0	682	0	682	0	682	
50	TCGA-HC-8256	0	1	0	1	1	0	1	0	0	20	0	0	1	11	0	0	TCGA-HC-8256-01	83	0.06353702335896963	47	TCGA-HC-8256-01	2	2	20	0.03393439101944537	TCGA-HC-8256-01	3	3	2	8	PASS	8097	TCGA-HC-8256	PRAD	53	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-19598	Alive	TUMOR FREE	860	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	860	0	860	0	860	0	860	
70	TCGA-HC-8257	0	1	1	1	3	0	0	0	0	34	0	0	0	18	1	0	TCGA-HC-8257-01	265	0.08162990791481058	203	TCGA-HC-8257-01	0	0	75	0.07376255233943926	TCGA-HC-8257-01	2	5	2	9	PASS	8098	TCGA-HC-8257	PRAD	70	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-25629	Alive	TUMOR FREE	726	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	726	0	726	0	726	0	726	
60	TCGA-HC-8258	0	0	0	0	0	0	0	0	0	18	0	1	0	1	0	0	TCGA-HC-8258-01	45	7.364793933814923e-06	10	TCGA-HC-8258	0	0	0	0	TCGA-HC-8258	0	0	0	0	PASS	8099	TCGA-HC-8258	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-20703	Alive	TUMOR FREE	847	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	847	0	847	0	847	0	847	
50	TCGA-HC-8259	0	1	0	0	2	1	0	0	0	38	3	0	1	15	0	0	TCGA-HC-8259-01	87	0.0033557448013906486	36	TCGA-HC-8259-01	0	0	7	0.003486169335799612	TCGA-HC-8259-01	0	0	0	0	pathology review	8100	TCGA-HC-8259	PRAD	50	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-18309	Alive	TUMOR FREE	924	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	924	0	924	0	924	0	924	
40	TCGA-HC-8260	0	1	0	0	0	0	0	0	0	8	1	0	0	3	0	0	TCGA-HC-8260-01	51	0.00025142120787452607	9	TCGA-HC-8260-01	0	0	19	1.3906857638194677e-06	TCGA-HC-8260-01	0	0	0	0	PASS	8101	TCGA-HC-8260	PRAD	43	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-15884	Alive	TUMOR FREE	686	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	686	0	686	0	686	0	686	
50	TCGA-HC-8261	0	1	0	1	0	0	0	0	0	17	3	0	2	11	0	0	TCGA-HC-8261-01	142	0.08512460226555467	84	TCGA-HC-8261-01	0	0	29	0.033090659100061884	TCGA-HC-8261-01	0	4	1	5	PASS	8102	TCGA-HC-8261	PRAD	48	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-17874	Alive	TUMOR FREE	546	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	546	0	546	0	546	0	546	
60	TCGA-HC-8262	0	2	0	2	0	0	0	0	3	24	3	0	0	11	1	0	TCGA-HC-8262-01	113	0.04473110627776917	69	TCGA-HC-8262-01	1	2	39	0.04704252545914978	TCGA-HC-8262-01	2	2	3	7	PASS	8103	TCGA-HC-8262	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-20946	Alive	TUMOR FREE	679	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	679	0	679	0	679	0	679	
60	TCGA-HC-8264	3	3	0	1	1	0	0	0	1	33	0	0	0	9	1	0	TCGA-HC-8264-01	111	0.06988872040538754	63	TCGA-HC-8264-01	1	2	34	0.04479448252548039	TCGA-HC-8264-01	3	8	4	15	PASS	8104	TCGA-HC-8264	PRAD	60	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-22177	Alive	WITH TUMOR	48	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	48	0	48	NA	NA	0	48	
70	TCGA-HC-8265	1	3	0	2	5	1	0	0	0	41	4	0	0	18	2	0	TCGA-HC-8265-01	568	0.16931644403243634	437	TCGA-HC-8265-01	1	0	18	0.007866346553956469	TCGA-HC-8265-01	5	3	0	8	PASS	8105	TCGA-HC-8265	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-24382	Alive	TUMOR FREE	483	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	483	0	483	0	483	0	483	
60	TCGA-HC-8266	0	1	1	0	1	0	0	0	0	20	1	0	1	7	0	0	TCGA-HC-8266-01	57	0.3037886440578547	18	TCGA-HC-8266-01	8	13	13	0.2481896008168869	TCGA-HC-8266-01	4	3	7	14	PASS	8106	TCGA-HC-8266	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-20280	Alive	WITH TUMOR	473	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	473	0	473	NA	NA	0	473	
50	TCGA-HC-A48F	1	2	0	1	0	1	0	0	0	17	0	0	0	9	0	0	TCGA-HC-A48F-01	147	0.7393895051161259	85	TCGA-HC-A48F-01	5	7	91	0.1770840115967892	TCGA-HC-A48F-01	5	8	10	23	PASS	8107	TCGA-HC-A48F	PRAD	47	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-17434	Alive	TUMOR FREE	680	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	680	0	680	0	680	0	680	
60	TCGA-HC-A4ZV	0	7	0	4	3	1	0	0	5	92	5	1	4	27	4	0	TCGA-HC-A4ZV-01	223	0.3915290412056308	127	TCGA-HC-A4ZV-01	5	11	72	0.1524410479479525	TCGA-HC-A4ZV-01	12	21	11	44	PASS	8108	TCGA-HC-A4ZV	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-20634	Alive	WITH TUMOR	23	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	23	0	23	NA	NA	0	23	
70	TCGA-HC-A631	1	0	1	2	0	1	0	0	6	24	4	0	0	12	2	0	TCGA-HC-A631-01	164	0.3393196778730333	108	TCGA-HC-A631-01	3	2	52	0.07403398309659483	TCGA-HC-A631-01	4	6	1	11	PASS	8109	TCGA-HC-A631	PRAD	67	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-24749	Alive	WITH TUMOR	54	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	54	0	54	NA	NA	0	54	
70	TCGA-HC-A632	1	1	1	0	0	0	0	0	0	30	1	0	0	11	0	0	TCGA-HC-A632-01	197	0.8800687978316889	123	TCGA-HC-A632-01	3	2	78	0.131853200839125	TCGA-HC-A632-01	7	11	7	25	PASS	8110	TCGA-HC-A632	PRAD	68	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-24916	Alive	TUMOR FREE	61	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	61	0	61	NA	NA	0	61	
60	TCGA-HC-A6AL	0	3	0	3	2	1	0	0	3	31	1	1	2	15	1	0	TCGA-HC-A6AL-01	60	0.07112862912298341	20	TCGA-HC-A6AL-01	1	1	23	0.03556803314459609	TCGA-HC-A6AL-01	3	3	3	9	RNA degradation	8111	TCGA-HC-A6AL	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-23618	Alive	TUMOR FREE	67	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	67	0	67	NA	NA	0	67	
70	TCGA-HC-A6AN	0	1	0	1	1	0	0	1	2	27	1	0	1	8	0	0	TCGA-HC-A6AN-01	108	0.08503347171854966	58	TCGA-HC-A6AN-01	3	3	58	0.0909653636837397	TCGA-HC-A6AN-01	7	2	4	13	RNA degradation	8112	TCGA-HC-A6AN	PRAD	67	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-24697	Alive	WITH TUMOR	49	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	49	0	49	NA	NA	0	49	
50	TCGA-HC-A6AO	1	3	0	1	0	0	0	0	0	23	1	0	0	19	1	0	TCGA-HC-A6AO-01	109	0.10615602646041156	60	TCGA-HC-A6AO-01	2	2	43	0.07534708582723405	TCGA-HC-A6AO-01	3	11	5	19	RNA degradation	8113	TCGA-HC-A6AO	PRAD	52	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-19298	Alive	TUMOR FREE	530	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	530	0	530	0	530	0	530	
60	TCGA-HC-A6AP	0	0	0	0	0	1	0	0	0	26	2	0	0	4	0	0	TCGA-HC-A6AP-01	71	0.04853846742935645	29	TCGA-HC-A6AP-01	0	0	29	0.056680596013992675	TCGA-HC-A6AP-01	0	10	4	14	RNA degradation	8114	TCGA-HC-A6AP	PRAD	61	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-22318	Alive	NA	71	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	71	0	71	NA	NA	0	71	
60	TCGA-HC-A6AQ	0	1	0	1	1	0	0	0	0	19	0	0	0	11	0	0	TCGA-HC-A6AQ-01	56	0.013011196327742074	17	TCGA-HC-A6AQ-01	0	1	12	0.01112835178115068	TCGA-HC-A6AQ-01	0	1	1	2	RNA degradation	8115	TCGA-HC-A6AQ	PRAD	60	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-22208	Alive	TUMOR FREE	106	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	106	0	106	NA	NA	0	106	
70	TCGA-HC-A6AS	0	1	0	0	0	0	0	0	0	18	4	0	1	5	1	0	TCGA-HC-A6AS-01	61	0.0021400521762776105	19	TCGA-HC-A6AS	0	0	0	0	TCGA-HC-A6AS	0	0	0	0	RNA degradation	8116	TCGA-HC-A6AS	PRAD	70	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-25661	Alive	TUMOR FREE	44	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	44	0	44	NA	NA	0	44	
60	TCGA-HC-A6HX	0	1	0	0	0	1	0	0	0	17	2	0	0	5	1	0	TCGA-HC-A6HX-01	108	0.0051404860014325855	48	TCGA-HC-A6HX-01	0	3	23	0.032327477397759916	TCGA-HC-A6HX-01	3	2	3	8	RNA degradation	8117	TCGA-HC-A6HX	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-20263	Alive	TUMOR FREE	38	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	38	0	38	NA	NA	0	38	
50	TCGA-HC-A6HY	0	0	0	1	0	0	0	0	0	19	3	0	0	5	1	0	TCGA-HC-A6HY-01	71	0.040841742269352915	25	TCGA-HC-A6HY-01	1	2	20	0.044056872455513436	TCGA-HC-A6HY-01	3	4	3	10	RNA degradation	8118	TCGA-HC-A6HY	PRAD	51	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-18779	Alive	TUMOR FREE	134	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	134	0	134	NA	NA	0	134	
70	TCGA-HC-A76W	0	1	0	1	1	0	1	0	0	25	3	0	0	16	0	0	TCGA-HC-A76W-01	64	0.1822813138786223	24	TCGA-HC-A76W-01	0	0	31	0.01969443624213744	TCGA-HC-A76W-01	1	2	1	4	PASS	8119	TCGA-HC-A76W	PRAD	73	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-26755	Alive	WITH TUMOR	213	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	213	0	213	NA	NA	0	213	
60	TCGA-HC-A76X	0	0	1	1	1	0	0	0	0	26	2	0	0	4	1	0	TCGA-HC-A76X-01	81	0.004105705479113759	42	TCGA-HC-A76X-01	0	0	19	0.003957799672226194	TCGA-HC-A76X-01	0	0	0	0	PASS	8120	TCGA-HC-A76X	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-22756	Alive	TUMOR FREE	150	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	150	0	150	NA	NA	0	150	
60	TCGA-HC-A8CY	0	2	0	1	0	1	0	0	2	21	1	0	0	13	0	0	TCGA-HC-A8CY-01	123	0.212163728114928	71	TCGA-HC-A8CY-01	4	4	37	0.033822875557077026	TCGA-HC-A8CY-01	5	2	2	9	PASS	8121	TCGA-HC-A8CY	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-23154	Alive	WITH TUMOR	290	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	290	0	290	NA	NA	0	290	
60	TCGA-HC-A8D0	0	1	0	1	1	0	1	0	0	21	3	0	0	10	0	0	TCGA-HC-A8D0-01	128	0.041433751524722284	74	TCGA-HC-A8D0-01	2	1	56	0.043138333529436884	TCGA-HC-A8D0-01	2	3	1	6	PASS	8122	TCGA-HC-A8D0	PRAD	61	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-22465	Alive	TUMOR FREE	775	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	775	0	775	0	775	0	775	
70	TCGA-HC-A8D1	0	1	0	0	0	0	0	0	2	21	0	0	0	6	0	0	TCGA-HC-A8D1-01	59	0.010828790074502378	21	TCGA-HC-A8D1-01	0	0	21	0.011533854081900429	TCGA-HC-A8D1-01	0	1	0	1	PASS	8123	TCGA-HC-A8D1	PRAD	68	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-25137	Alive	TUMOR FREE	573	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	573	0	573	0	573	0	573	
60	TCGA-HC-A9TE	0	0	0	1	2	0	1	0	1	38	3	0	2	17	0	0	TCGA-HC-A9TE-01	252	0.6361513712587117	156	TCGA-HC-A9TE-01	18	27	54	0.09368995851157733	TCGA-HC-A9TE-01	16	18	5	39	PASS	8124	TCGA-HC-A9TE	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-23543	Alive	WITH TUMOR	587	NA	NA	Biochemical evidence of disease	"Other, specify"	Biochemical	216	Partial Remission/Response	NA	NA	0	587	0	587	NA	NA	1	216	
60	TCGA-HC-A9TH	0	0	0	0	2	0	0	0	0	40	2	0	1	15	2	0	TCGA-HC-A9TH-01	163	0.11938652828648633	87	TCGA-HC-A9TH-01	0	4	61	0.08611393706167735	TCGA-HC-A9TH-01	1	5	5	11	PASS	8125	TCGA-HC-A9TH	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-21460	Alive	WITH TUMOR	844	NA	NA	Biochemical evidence of disease	"Other, specify"	Biochemical	351	Partial Remission/Response	NA	NA	0	844	0	844	NA	NA	1	351	
60	TCGA-HI-7168	0	5	2	2	0	1	0	0	0	32	3	0	0	18	1	1	TCGA-HI-7168-01	190	0.6591959220909474	108	TCGA-HI-7168-01	26	15	40	0.1005710552575492	TCGA-HI-7168-01	11	8	4	23	PASS	8126	TCGA-HI-7168	PRAD	62	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2005	NA	-22881	Alive	WITH TUMOR	3323	NA	NA	Biochemical evidence of disease	Bone	NA	2505	Stable Disease	NA	NA	0	3323	0	3323	NA	NA	1	2505	
60	TCGA-HI-7169	0	1	0	0	1	0	0	0	0	25	1	0	0	17	0	0	TCGA-HI-7169-01	55	0.0008889160022170347	14	TCGA-HI-7169-01	0	0	4	0.0009127884490616426	TCGA-HI-7169-01	0	0	0	0	RNA degradation	8127	TCGA-HI-7169	PRAD	55	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-20133	Alive	TUMOR FREE	2684	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2684	0	2684	0	2684	0	2684	
60	TCGA-HI-7170	2	2	0	0	1	1	1	0	1	19	2	0	0	6	2	0	TCGA-HI-7170-01	51	0.0427682527453552	9	TCGA-HI-7170-01	3	2	2	0.043361302371044456	TCGA-HI-7170-01	1	0	1	2	PASS	8128	TCGA-HI-7170	PRAD	58	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-21199	Alive	TUMOR FREE	2522	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2522	0	2522	0	2522	0	2522	
60	TCGA-HI-7171	0	1	1	1	0	0	0	0	0	23	3	0	1	12	2	0	TCGA-HI-7171-01	191	0.5702838920951168	122	TCGA-HI-7171-01	2	3	55	0.11481885532456168	TCGA-HI-7171-01	2	9	8	19	PASS	8129	TCGA-HI-7171	PRAD	56	MALE	WHITE	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-20776	Dead	WITH TUMOR	NA	1329	[Unknown]	NA	NA	NA	NA	Stable Disease	NA	NA	1	1329	1	1329	NA	NA	1	1329	
50	TCGA-J4-8198	0	1	1	0	1	0	0	0	0	23	1	0	2	7	1	0	TCGA-J4-8198-01	101	0.07530299171274729	51	TCGA-J4-8198-01	2	1	18	0.022083478871542203	TCGA-J4-8198-01	0	2	1	3	PASS	8130	TCGA-J4-8198	PRAD	49	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-17935	Alive	TUMOR FREE	614	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	614	0	614	0	614	0	614	
50	TCGA-J4-8200	0	0	0	0	0	1	0	1	0	13	3	0	0	3	0	0	TCGA-J4-8200-01	65	0.033984881970647376	25	TCGA-J4-8200-01	0	1	12	0.011943263525457722	TCGA-J4-8200-01	2	4	1	7	PASS	8131	TCGA-J4-8200	PRAD	47	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-17167	Alive	TUMOR FREE	1218	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1218	0	1218	0	1218	0	1218	
70	TCGA-J4-A67K	0	1	0	0	2	0	0	0	2	23	1	0	0	5	0	0	TCGA-J4-A67K-01	78	0.008401229676034315	34	TCGA-J4-A67K-01	0	0	15	0.008031105582609619	TCGA-J4-A67K-01	0	0	0	0	RNA degradation	8132	TCGA-J4-A67K	PRAD	68	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-24908	Alive	TUMOR FREE	1004	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1004	0	1004	0	1004	0	1004	
50	TCGA-J4-A67L	0	0	0	0	0	0	0	0	1	22	3	0	1	10	0	0	TCGA-J4-A67L-01	112	0.06061776767163252	56	TCGA-J4-A67L-01	1	2	34	0.041850431977729335	TCGA-J4-A67L-01	4	4	2	10	RNA degradation	8133	TCGA-J4-A67L	PRAD	54	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-20034	Alive	TUMOR FREE	770	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	770	0	770	0	770	0	770	
60	TCGA-J4-A67M	0	1	0	1	2	0	0	0	1	23	2	0	2	13	1	0	TCGA-J4-A67M-01	67	0.10602546783709543	19	TCGA-J4-A67M-01	1	3	33	0.06557093728797829	TCGA-J4-A67M-01	1	9	3	13	RNA degradation	8134	TCGA-J4-A67M	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-20211	Alive	TUMOR FREE	941	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	941	0	941	0	941	0	941	
60	TCGA-J4-A67N	0	2	0	1	1	1	0	0	0	18	0	0	0	8	1	0	TCGA-J4-A67N-01	208	0.1075397636602499	149	TCGA-J4-A67N-01	2	2	98	0.1048588329307465	TCGA-J4-A67N-01	4	8	4	16	RNA degradation	8135	TCGA-J4-A67N	PRAD	61	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-22420	Alive	WITH TUMOR	937	NA	NA	Biochemical evidence of disease	NA	NA	442	Partial Remission/Response	NA	NA	0	937	0	937	NA	NA	1	442	
60	TCGA-J4-A67O	0	2	0	0	0	0	0	0	2	14	0	0	0	8	0	0	TCGA-J4-A67O-01	44	0.005459905170080426	9	TCGA-J4-A67O-01	1	2	19	0.025854686245196924	TCGA-J4-A67O-01	2	3	2	7	RNA degradation	8136	TCGA-J4-A67O	PRAD	59	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-21714	Alive	TUMOR FREE	839	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	839	0	839	0	839	0	839	
80	TCGA-J4-A67Q	0	0	0	0	1	0	0	0	0	17	0	0	0	9	0	0	TCGA-J4-A67Q-01	41	0.00016534000419266514	7	TCGA-J4-A67Q-01	0	1	13	0.03971045413482989	TCGA-J4-A67Q-01	1	1	1	3	RNA degradation	8137	TCGA-J4-A67Q	PRAD	77	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-28447	Alive	TUMOR FREE	975	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	975	0	975	0	975	0	975	
70	TCGA-J4-A67R	0	1	0	1	0	0	0	0	0	11	3	0	0	6	0	0	TCGA-J4-A67R-01	61	4.4646934989101386e-05	21	TCGA-J4-A67R-01	0	0	5	0.00024076454019263086	TCGA-J4-A67R-01	0	0	0	0	RNA degradation	8138	TCGA-J4-A67R	PRAD	65	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-23807	Alive	TUMOR FREE	910	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	910	0	910	0	910	0	910	
60	TCGA-J4-A67S	0	0	0	0	0	0	0	0	0	14	4	0	0	3	0	0	TCGA-J4-A67S-01	93	0.07537703338342781	47	TCGA-J4-A67S-01	1	1	53	0.07784154981271571	TCGA-J4-A67S-01	2	7	5	14	RNA degradation	8139	TCGA-J4-A67S	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-23332	Alive	WITH TUMOR	833	NA	NA	Biochemical evidence of disease	NA	NA	708	Complete Remission/Response	NA	NA	0	833	0	833	1	708	1	708	
60	TCGA-J4-A67T	0	3	0	1	3	1	0	0	1	9	1	0	0	6	0	1	TCGA-J4-A67T-01	73	0.005574678399449553	21	TCGA-J4-A67T-01	0	0	22	0.005904800645483739	TCGA-J4-A67T-01	0	0	0	0	PASS	8140	TCGA-J4-A67T	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-23211	Alive	TUMOR FREE	183	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	183	0	183	0	183	0	183	
70	TCGA-J4-A6G1	0	0	0	0	0	0	0	0	0	13	0	0	0	6	0	0	TCGA-J4-A6G1-01	59	0.0005793459336984574	18	TCGA-J4-A6G1-01	0	0	10	0.0006050799477970893	TCGA-J4-A6G1-01	0	0	0	0	PASS	8141	TCGA-J4-A6G1	PRAD	68	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-24945	Alive	TUMOR FREE	769	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	769	0	769	0	769	0	769	
60	TCGA-J4-A6G3	0	2	2	0	3	0	0	0	0	17	0	0	0	5	2	0	TCGA-J4-A6G3-01	57	5.448786287125831e-05	14	TCGA-J4-A6G3	0	0	0	0	TCGA-J4-A6G3	0	0	0	0	PASS	8142	TCGA-J4-A6G3	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-20836	Alive	WITH TUMOR	849	NA	NA	Biochemical evidence of disease	NA	NA	618	Partial Remission/Response	NA	NA	0	849	0	849	NA	NA	1	618	
50	TCGA-J4-A6M7	0	0	0	0	0	0	0	0	0	11	1	0	0	10	0	0	TCGA-J4-A6M7-01	79	0.0035800132824464212	37	TCGA-J4-A6M7-01	0	0	18	0.003707087407366607	TCGA-J4-A6M7-01	0	0	0	0	PASS	8143	TCGA-J4-A6M7	PRAD	53	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-19640	Alive	TUMOR FREE	512	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	512	0	512	0	512	0	512	
60	TCGA-J4-A83I	0	4	0	0	0	2	0	0	1	18	0	0	1	10	1	0	TCGA-J4-A83I-01	150	0.14493156389725545	85	TCGA-J4-A83I-01	0	2	56	0.08697309610376881	TCGA-J4-A83I-01	4	10	7	21	PASS	8144	TCGA-J4-A83I	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-23240	Alive	TUMOR FREE	685	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	685	0	685	0	685	0	685	
70	TCGA-J4-A83J	0	3	0	0	2	0	3	0	2	29	4	0	0	19	1	0	TCGA-J4-A83J-01	440	0.2244322066580026	369	TCGA-J4-A83J-01	1	3	187	0.11521934189080625	TCGA-J4-A83J-01	2	14	7	23	pathology review	8145	TCGA-J4-A83J	PRAD	68	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-24960	Alive	TUMOR FREE	696	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	696	0	696	0	696	0	696	
50	TCGA-J4-A83K	1	0	0	0	1	0	0	0	1	21	1	0	0	8	0	0	TCGA-J4-A83K-01	57	0.0005036385424313501	13	TCGA-J4-A83K-01	0	0	8	0.0011274477524437128	TCGA-J4-A83K-01	0	0	0	0	PASS	8146	TCGA-J4-A83K	PRAD	52	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-19299	Alive	TUMOR FREE	328	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	328	0	328	0	328	0	328	
60	TCGA-J4-A83L	0	0	0	0	1	0	0	0	0	14	0	0	1	11	0	0	TCGA-J4-A83L-01	55	0.009866248481990534	12	TCGA-J4-A83L-01	0	0	16	0.010629509164731992	TCGA-J4-A83L-01	2	1	1	4	PASS	8147	TCGA-J4-A83L	PRAD	61	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-22338	Alive	TUMOR FREE	720	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	720	0	720	0	720	0	720	
60	TCGA-J4-A83M	0	0	0	1	0	0	0	0	0	26	3	0	1	10	1	0	TCGA-J4-A83M-01	89	0.010662226320875491	44	TCGA-J4-A83M-01	0	0	32	0.01305609241236233	TCGA-J4-A83M-01	0	0	0	0	PASS	8148	TCGA-J4-A83M	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-23624	Alive	NA	543	NA	NA	Biochemical evidence of disease	NA	NA	521	Complete Remission/Response	NA	NA	0	543	0	543	1	521	1	521	
60	TCGA-J4-A83N	0	0	0	0	1	0	0	0	1	14	0	0	1	9	0	0	TCGA-J4-A83N-01	60	0.03513360447368759	15	TCGA-J4-A83N-01	1	4	32	0.07209474252895222	TCGA-J4-A83N-01	3	4	3	10	PASS	8149	TCGA-J4-A83N	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-20841	Alive	TUMOR FREE	992	NA	NA	New Primary Tumor	NA	NA	433	Complete Remission/Response	NA	NA	0	992	0	992	0	992	1	433	
70	TCGA-J4-AATV	0	0	0	0	0	0	0	0	0	1	1	0	1	2	1	0	TCGA-J4-AATV-01	41	0.00015616001548993583	8	TCGA-J4-AATV-01	0	0	5	0.00048256615405652326	TCGA-J4-AATV-01	0	0	0	0	PASS	8150	TCGA-J4-AATV	PRAD	71	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-25943	Alive	WITH TUMOR	553	NA	NA	NA	NA	NA	NA	[Discrepancy]	NA	NA	0	553	0	553	NA	NA	0	553	
70	TCGA-J4-AATZ	1	3	0	0	0	1	0	0	0	34	0	0	0	9	0	0	TCGA-J4-AATZ-01	154	0.19035059421133665	84	TCGA-J4-AATZ-01	1	2	55	0.04313043575865585	TCGA-J4-AATZ-01	2	7	2	11	PASS	8151	TCGA-J4-AATZ	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-24226	Alive	WITH TUMOR	412	NA	NA	Biochemical evidence of disease	NA	NA	79	Complete Remission/Response	NA	NA	0	412	0	412	1	79	1	79	
60	TCGA-J4-AAU2	0	0	0	0	1	2	0	0	0	21	2	0	0	7	0	0	TCGA-J4-AAU2-01	55	0.007549269986546763	12	TCGA-J4-AAU2-01	0	0	5	0.00014287310035616735	TCGA-J4-AAU2-01	0	0	0	0	PASS	8152	TCGA-J4-AAU2	PRAD	59	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-21656	Alive	TUMOR FREE	825	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	825	0	825	0	825	0	825	
60	TCGA-J9-A52B	0	1	0	3	2	0	0	0	2	23	4	0	3	4	2	0	TCGA-J9-A52B-01	100	0.6703370350448034	47	TCGA-J9-A52B-01	5	4	48	0.08294546274154448	TCGA-J9-A52B-01	2	0	2	4	PASS	8153	TCGA-J9-A52B	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-22849	Alive	NA	422	NA	NA	Biochemical evidence of disease	NA	NA	57	Complete Remission/Response	NA	NA	0	422	0	422	1	57	1	57	
60	TCGA-J9-A52C	0	27	0	5	44	10	11	0	23	387	22	0	4	213	5	1	TCGA-J9-A52C-01	57	0.032078776040827275	19	TCGA-J9-A52C-01	1	1	15	0.036534607268829414	TCGA-J9-A52C-01	0	2	1	3	RNA degradation	8154	TCGA-J9-A52C	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-20966	Alive	NA	178	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	178	0	178	NA	NA	0	178	
70	TCGA-J9-A52D	0	2	0	0	3	0	2	0	0	28	2	0	0	13	0	0	TCGA-J9-A52D	0	0	0	TCGA-J9-A52D	0	0	0	0	TCGA-J9-A52D	0	0	0	0	PASS	8155	TCGA-J9-A52D	PRAD	71	MALE	NA	NA	NA	"Prostate Adenocarcinoma, Other Subtype"	NA	2012	NA	-26023	Alive	TUMOR FREE	212	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	212	0	212	NA	NA	0	212	
70	TCGA-J9-A52E	0	3	0	0	0	0	0	0	0	21	1	0	0	8	0	0	TCGA-J9-A52E-01	143	0.5272621015618375	86	TCGA-J9-A52E-01	16	13	61	0.1111549217717508	TCGA-J9-A52E-01	15	15	6	36	RNA degradation	8156	TCGA-J9-A52E	PRAD	65	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-23741	Alive	TUMOR FREE	323	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	323	0	323	NA	NA	0	323	
70	TCGA-J9-A8CK	0	2	0	0	1	0	0	0	2	18	0	0	1	3	1	0	TCGA-J9-A8CK-01	124	0.05250492001273272	67	TCGA-J9-A8CK-01	0	1	50	0.05485533376645313	TCGA-J9-A8CK-01	0	7	3	10	PASS	8157	TCGA-J9-A8CK	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-24285	Alive	TUMOR FREE	321	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	321	0	321	NA	NA	0	321	
70	TCGA-J9-A8CL	0	3	0	4	0	0	0	0	0	36	5	0	1	19	1	0	TCGA-J9-A8CL-01	485	0.4666797607301403	343	TCGA-J9-A8CL-01	3	3	82	0.08910140977590801	TCGA-J9-A8CL-01	6	5	6	17	PASS	8158	TCGA-J9-A8CL	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-24145	Alive	WITH TUMOR	405	NA	NA	Biochemical evidence of disease	NA	NA	132	[Unknown]	NA	NA	0	405	0	405	NA	NA	1	132	
70	TCGA-J9-A8CM	0	10	0	0	2	1	1	0	0	55	2	0	1	22	3	0	TCGA-J9-A8CM-01	119	0.1941502060603053	54	TCGA-J9-A8CM-01	1	3	36	0.08670788120638527	TCGA-J9-A8CM-01	7	11	5	23	PASS	8159	TCGA-J9-A8CM	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-24118	Alive	WITH TUMOR	463	NA	NA	Biochemical evidence of disease	NA	NA	344	Partial Remission/Response	NA	NA	0	463	0	463	NA	NA	1	344	
50	TCGA-J9-A8CN	0	1	1	1	0	0	0	0	1	18	0	0	0	5	0	0	TCGA-J9-A8CN-01	143	0.1263833557240766	90	TCGA-J9-A8CN-01	1	1	46	0.050978976946885995	TCGA-J9-A8CN-01	2	7	4	13	PASS	8160	TCGA-J9-A8CN	PRAD	53	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-19662	Alive	TUMOR FREE	1237	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1237	0	1237	0	1237	0	1237	
70	TCGA-J9-A8CP	0	1	0	0	1	1	0	0	2	22	1	0	0	9	1	0	TCGA-J9-A8CP-01	379	0.12777005662813776	316	TCGA-J9-A8CP-01	1	3	136	0.10853325746331384	TCGA-J9-A8CP-01	3	10	6	19	PASS	8161	TCGA-J9-A8CP	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-24299	Alive	TUMOR FREE	386	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	386	0	386	0	386	0	386	
70	TCGA-KC-A4BL	0	2	0	0	1	0	0	0	1	12	1	0	0	7	1	0	TCGA-KC-A4BL-01	45	8.358279677954288e-06	8	TCGA-KC-A4BL-01	0	0	0	0.0	TCGA-KC-A4BL-01	0	0	0	0	PASS	8162	TCGA-KC-A4BL	PRAD	65	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-24081	Alive	WITH TUMOR	934	NA	NA	Biochemical evidence of disease	NA	NA	193	Partial Remission/Response	NA	NA	0	934	0	934	NA	NA	1	193	
60	TCGA-KC-A4BN	1	2	0	0	0	0	0	0	1	19	0	0	0	3	1	0	TCGA-KC-A4BN-01	59	4.4995282307083755e-05	16	TCGA-KC-A4BN-01	0	0	8	0.0010317419550172626	TCGA-KC-A4BN-01	0	0	0	0	PASS	8163	TCGA-KC-A4BN	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-20392	Alive	TUMOR FREE	1815	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1815	0	1815	0	1815	0	1815	
60	TCGA-KC-A4BO	0	1	0	0	0	0	0	0	0	2	0	0	0	0	0	0	TCGA-KC-A4BO-01	57	0.00017466256307928956	16	TCGA-KC-A4BO	0	0	0	0	TCGA-KC-A4BO	0	0	0	0	PASS	8164	TCGA-KC-A4BO	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-20368	Alive	TUMOR FREE	607	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	607	0	607	0	607	0	607	
80	TCGA-KC-A4BR	0	0	0	0	1	0	0	0	0	7	0	0	0	2	0	0	TCGA-KC-A4BR-01	43	1.104494295274048e-05	9	TCGA-KC-A4BR	0	0	0	0	TCGA-KC-A4BR	0	0	0	0	PASS	8165	TCGA-KC-A4BR	PRAD	75	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-27741	Alive	WITH TUMOR	1349	NA	NA	Biochemical evidence of disease	NA	NA	1022	Complete Remission/Response	NA	NA	0	1349	0	1349	1	1022	1	1022	
70	TCGA-KC-A4BV	0	1	0	0	1	3	0	0	0	29	1	0	1	4	0	0	TCGA-KC-A4BV-01	300	0.13271042357359442	238	TCGA-KC-A4BV-01	2	3	141	0.10442138985736787	TCGA-KC-A4BV-01	3	8	5	16	PASS	8166	TCGA-KC-A4BV	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-24138	Alive	WITH TUMOR	1328	NA	NA	Biochemical evidence of disease	NA	NA	1328	Complete Remission/Response	NA	NA	0	1328	0	1328	1	1328	1	1328	
70	TCGA-KC-A7F3	0	2	0	0	0	1	1	0	1	20	1	0	0	11	0	0	TCGA-KC-A7F3-01	313	0.056365711549408525	251	TCGA-KC-A7F3-01	0	0	144	0.059062953771235036	TCGA-KC-A7F3-01	0	8	2	10	PASS	8167	TCGA-KC-A7F3	PRAD	67	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-24676	Alive	TUMOR FREE	665	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	665	0	665	0	665	0	665	
50	TCGA-KC-A7F5	0	1	0	0	2	1	1	0	1	23	2	0	0	5	0	0	TCGA-KC-A7F5	0	0	0	TCGA-KC-A7F5	0	0	0	0	TCGA-KC-A7F5	0	0	0	0	RNA degradation	8168	TCGA-KC-A7F5	PRAD	54	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-20015	Alive	TUMOR FREE	91	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	91	0	91	0	91	0	91	
60	TCGA-KC-A7F6	0	1	0	1	1	0	0	0	1	20	0	0	0	7	0	0	TCGA-KC-A7F6-01	70	0.07970934410093505	25	TCGA-KC-A7F6-01	2	2	17	0.04930508727766007	TCGA-KC-A7F6-01	3	6	2	11	PASS	8169	TCGA-KC-A7F6	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-23367	Alive	TUMOR FREE	263	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	263	0	263	0	263	0	263	
60	TCGA-KC-A7FA	0	1	1	0	1	3	0	0	2	29	3	0	0	10	1	0	TCGA-KC-A7FA-01	140	0.5659409029362841	84	TCGA-KC-A7FA-01	3	2	57	0.07413114838935111	TCGA-KC-A7FA-01	4	2	3	9	PASS	8170	TCGA-KC-A7FA	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-23208	Alive	TUMOR FREE	598	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	598	0	598	0	598	0	598	
60	TCGA-KC-A7FD	0	2	0	2	3	0	0	0	2	30	3	0	2	11	2	0	TCGA-KC-A7FD-01	77	0.015290379354334959	28	TCGA-KC-A7FD-01	1	1	17	0.015226862413810738	TCGA-KC-A7FD-01	0	0	1	1	PASS	8171	TCGA-KC-A7FD	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-22745	Alive	TUMOR FREE	270	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	270	0	270	0	270	0	270	
60	TCGA-KC-A7FE	0	0	0	0	0	0	0	0	1	5	1	0	0	1	1	0	TCGA-KC-A7FE-01	58	0.0052097623214273645	18	TCGA-KC-A7FE	0	0	0	0	TCGA-KC-A7FE	0	0	0	0	PASS	8172	TCGA-KC-A7FE	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-22718	Alive	TUMOR FREE	352	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	352	0	352	0	352	0	352	
60	TCGA-KK-A59V	5	49	3	18	130	29	11	0	21	550	28	0	4	259	9	0	TCGA-KK-A59V-01	111	0.07709098958052052	65	TCGA-KK-A59V-01	1	1	44	0.028787466481739764	TCGA-KK-A59V-01	1	3	2	6	RNA degradation	8173	TCGA-KK-A59V	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2005	NA	-23483	Alive	TUMOR FREE	3440	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3440	0	3440	0	3440	0	3440	
60	TCGA-KK-A59X	1	3	0	1	3	1	0	0	1	37	2	0	0	10	2	0	TCGA-KK-A59X-01	783	0.9748596486053209	693	TCGA-KK-A59X-01	1	4	251	0.16664557121765294	TCGA-KK-A59X-01	0	13	10	23	PASS	8174	TCGA-KK-A59X	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-20416	Alive	WITH TUMOR	2535	NA	NA	Locoregional Recurrence	"Other, specify"	Bladder	2233	[Unknown]	NA	NA	0	2535	0	2535	NA	NA	1	2233	
60	TCGA-KK-A59Y	0	1	0	1	1	0	0	1	1	19	2	0	0	5	0	0	TCGA-KK-A59Y-01	120	0.11047804072089527	67	TCGA-KK-A59Y-01	2	2	53	0.0579637786371953	TCGA-KK-A59Y-01	1	6	4	11	PASS	8175	TCGA-KK-A59Y	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-20768	Alive	TUMOR FREE	1968	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1968	0	1968	0	1968	0	1968	
70	TCGA-KK-A59Z	1	1	0	1	1	2	1	0	1	44	1	0	0	11	0	0	TCGA-KK-A59Z-01	200	0.4753180346017783	130	TCGA-KK-A59Z-01	14	17	54	0.07125354293090908	TCGA-KK-A59Z-01	5	10	4	19	PASS	8176	TCGA-KK-A59Z	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-24306	Alive	TUMOR FREE	2628	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2628	0	2628	NA	NA	0	2628	
70	TCGA-KK-A5A1	0	8	0	1	5	5	1	0	2	71	6	0	1	27	4	0	TCGA-KK-A5A1	0	0	0	TCGA-KK-A5A1	0	0	0	0	TCGA-KK-A5A1	0	0	0	0	PASS	8177	TCGA-KK-A5A1	PRAD	72	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2003	NA	-26415	Dead	NA	NA	2469	NA	Locoregional Recurrence	NA	NA	203	Partial Remission/Response	NA	NA	1	2469	NA	2469	NA	NA	1	203	
50	TCGA-KK-A6DY	0	1	0	1	1	0	0	0	0	23	2	0	0	6	1	0	TCGA-KK-A6DY-01	92	0.14229595257124275	41	TCGA-KK-A6DY-01	6	7	28	0.10844827076118647	TCGA-KK-A6DY-01	6	4	7	17	PASS	8178	TCGA-KK-A6DY	PRAD	50	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2002	NA	-18420	Alive	WITH TUMOR	4295	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4295	0	4295	NA	NA	0	4295	
60	TCGA-KK-A6E0	0	0	0	2	4	0	2	0	0	14	1	0	0	13	0	0	TCGA-KK-A6E0-01	728	0.4974962936858242	623	TCGA-KK-A6E0-01	1	1	309	0.1596540409991392	TCGA-KK-A6E0-01	2	15	8	25	PASS	8179	TCGA-KK-A6E0	PRAD	59	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21700	Alive	TUMOR FREE	1483	NA	NA	Biochemical evidence of disease	NA	NA	941	Complete Remission/Response	NA	NA	0	1483	0	1483	1	941	1	941	
60	TCGA-KK-A6E1	0	0	0	0	0	2	0	0	0	19	1	0	0	8	0	0	TCGA-KK-A6E1-01	217	0.8287682751119176	136	TCGA-KK-A6E1-01	7	10	76	0.17250381642729642	TCGA-KK-A6E1-01	7	14	9	30	PASS	8180	TCGA-KK-A6E1	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-21063	Alive	TUMOR FREE	2198	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2198	0	2198	0	2198	0	2198	
50	TCGA-KK-A6E2	0	2	0	3	0	1	0	0	0	29	5	0	0	12	0	0	TCGA-KK-A6E2-01	114	0.015612969062357446	63	TCGA-KK-A6E2-01	0	0	28	0.015778698860342322	TCGA-KK-A6E2-01	1	3	2	6	PASS	8181	TCGA-KK-A6E2	PRAD	54	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2000	NA	-19974	Alive	TUMOR FREE	5024	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	5024	0	5024	0	5024	0	5024	
60	TCGA-KK-A6E3	0	0	0	1	2	1	0	0	1	28	1	0	1	13	0	0	TCGA-KK-A6E3-01	59	0.0002866342913236913	19	TCGA-KK-A6E3-01	0	0	5	0.00023773812979983798	TCGA-KK-A6E3-01	0	0	0	0	RNA degradation	8182	TCGA-KK-A6E3	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2004	NA	-20547	Alive	TUMOR FREE	2056	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2056	0	2056	NA	NA	0	2056	
70	TCGA-KK-A6E4	0	1	0	1	1	0	0	0	1	25	3	0	1	16	0	0	TCGA-KK-A6E4-01	69	0.15319255864428566	23	TCGA-KK-A6E4-01	0	0	36	0.0706224830692264	TCGA-KK-A6E4-01	1	6	5	12	RNA degradation	8183	TCGA-KK-A6E4	PRAD	69	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2004	NA	-25338	Dead	TUMOR FREE	NA	3502	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	3502	0	3502	0	3502	0	3502	
60	TCGA-KK-A6E5	0	1	0	0	3	0	0	0	0	15	1	0	0	4	1	0	TCGA-KK-A6E5-01	250	0.12770792516494364	182	TCGA-KK-A6E5-01	1	3	97	0.09690606831345286	TCGA-KK-A6E5-01	4	11	7	22	PASS	8184	TCGA-KK-A6E5	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-23144	Alive	TUMOR FREE	2073	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2073	0	2073	0	2073	0	2073	
70	TCGA-KK-A6E6	1	3	0	0	0	1	1	0	2	32	0	0	0	16	0	0	TCGA-KK-A6E6-01	152	0.5535347532858397	89	TCGA-KK-A6E6-01	9	11	21	0.03056163396855852	TCGA-KK-A6E6-01	10	9	1	20	PASS	8185	TCGA-KK-A6E6	PRAD	69	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2002	NA	-25320	Alive	TUMOR FREE	3447	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3447	0	3447	NA	NA	0	3447	
50	TCGA-KK-A6E7	0	1	0	1	0	2	0	0	1	22	0	0	0	9	0	0	TCGA-KK-A6E7-01	83	0.2007418804519248	35	TCGA-KK-A6E7-01	6	6	30	0.06015581828569225	TCGA-KK-A6E7-01	3	3	3	9	RNA degradation	8186	TCGA-KK-A6E7	PRAD	46	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-17074	Alive	WITH TUMOR	2760	NA	NA	Biochemical evidence of disease	NA	NA	925	Partial Remission/Response	NA	NA	0	2760	0	2760	NA	NA	1	925	
70	TCGA-KK-A6E8	0	0	1	1	1	0	2	0	0	34	1	0	0	10	0	0	TCGA-KK-A6E8-01	358	0.2537269534919693	294	TCGA-KK-A6E8-01	7	7	108	0.09468464681886414	TCGA-KK-A6E8-01	4	14	5	23	RNA degradation	8187	TCGA-KK-A6E8	PRAD	68	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-25026	Alive	TUMOR FREE	1770	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1770	0	1770	NA	NA	0	1770	
60	TCGA-KK-A7AP	0	1	1	0	3	0	0	0	1	26	1	0	0	9	1	0	TCGA-KK-A7AP-01	128	0.24307136113394906	70	TCGA-KK-A7AP-01	4	4	48	0.10030186416572058	TCGA-KK-A7AP-01	8	12	7	27	PASS	8188	TCGA-KK-A7AP	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-20403	Alive	NA	196	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	196	0	196	NA	NA	0	196	
60	TCGA-KK-A7AQ	0	0	0	0	0	0	0	0	0	33	0	0	0	5	0	0	TCGA-KK-A7AQ-01	545	0.28635810978058746	457	TCGA-KK-A7AQ-01	1	2	212	0.1143288259254638	TCGA-KK-A7AQ-01	2	6	4	12	RNA degradation	8189	TCGA-KK-A7AQ	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-22731	Alive	TUMOR FREE	1610	NA	NA	Biochemical evidence of disease	NA	NA	1217	Complete Remission/Response	NA	NA	0	1610	0	1610	1	1217	1	1217	
60	TCGA-KK-A7AU	0	0	0	1	0	0	0	0	1	14	2	0	0	9	1	0	TCGA-KK-A7AU-01	154	0.11955153893935795	91	TCGA-KK-A7AU-01	2	5	55	0.05708165366287943	TCGA-KK-A7AU-01	4	6	3	13	PASS	8190	TCGA-KK-A7AU	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-23118	Alive	TUMOR FREE	1775	NA	NA	Biochemical evidence of disease	NA	NA	207	Progressive Disease	NA	NA	0	1775	0	1775	NA	NA	1	207	
60	TCGA-KK-A7AV	0	2	0	0	0	0	1	0	2	11	2	0	0	7	0	0	TCGA-KK-A7AV-01	64	0.12702840890654482	22	TCGA-KK-A7AV-01	2	3	29	0.050405306724734984	TCGA-KK-A7AV-01	3	6	4	13	PASS	8191	TCGA-KK-A7AV	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-21192	Alive	TUMOR FREE	822	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	822	0	822	0	822	0	822	
60	TCGA-KK-A7AW	0	2	0	1	0	0	0	0	1	21	2	0	2	9	2	0	TCGA-KK-A7AW-01	83	0.0819615370982644	37	TCGA-KK-A7AW-01	1	1	22	0.020864572472632573	TCGA-KK-A7AW-01	2	4	1	7	RNA degradation	8192	TCGA-KK-A7AW	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-20869	Alive	TUMOR FREE	1054	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1054	0	1054	NA	NA	0	1054	
60	TCGA-KK-A7AY	1	2	0	0	5	0	0	0	1	31	4	0	0	8	1	0	TCGA-KK-A7AY-01	141	0.06416016336522685	79	TCGA-KK-A7AY-01	0	1	51	0.03529648838963097	TCGA-KK-A7AY-01	4	6	2	12	RNA degradation	8193	TCGA-KK-A7AY	PRAD	60	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-22220	Alive	TUMOR FREE	1754	NA	NA	Biochemical evidence of disease	NA	NA	1124	Complete Remission/Response	NA	NA	0	1754	0	1754	1	1124	1	1124	
60	TCGA-KK-A7AZ	0	1	0	0	1	2	0	0	1	25	3	0	0	7	1	0	TCGA-KK-A7AZ-01	123	0.11265624103808658	68	TCGA-KK-A7AZ-01	4	2	60	0.05135275225475417	TCGA-KK-A7AZ-01	3	5	2	10	RNA degradation	8194	TCGA-KK-A7AZ	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-20507	Alive	NA	1519	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1519	0	1519	NA	NA	0	1519	
70	TCGA-KK-A7B0	0	1	0	1	1	0	0	0	0	22	4	0	1	10	0	0	TCGA-KK-A7B0-01	139	0.14510837830035844	77	TCGA-KK-A7B0-01	2	3	58	0.09353522920511917	TCGA-KK-A7B0-01	0	8	6	14	RNA degradation	8195	TCGA-KK-A7B0	PRAD	67	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-24756	Alive	TUMOR FREE	1329	NA	NA	Biochemical evidence of disease	NA	NA	606	Stable Disease	NA	NA	0	1329	0	1329	NA	NA	1	606	
70	TCGA-KK-A7B1	0	0	0	0	0	0	0	0	0	16	2	0	0	3	1	0	TCGA-KK-A7B1-01	125	0.033900107304235726	71	TCGA-KK-A7B1-01	0	0	47	0.02750055739840839	TCGA-KK-A7B1-01	0	3	0	3	PASS	8196	TCGA-KK-A7B1	PRAD	65	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-23803	Alive	NA	1063	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1063	0	1063	0	1063	0	1063	
70	TCGA-KK-A7B2	1	0	0	0	1	0	0	0	0	14	0	1	0	5	0	0	TCGA-KK-A7B2-01	41	0.014418320014076454	5	TCGA-KK-A7B2-01	0	0	8	0.00015045573115271015	TCGA-KK-A7B2-01	0	0	0	0	RNA degradation	8197	TCGA-KK-A7B2	PRAD	68	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-24845	Alive	WITH TUMOR	1099	NA	NA	Biochemical evidence of disease	NA	NA	692	Stable Disease	NA	NA	0	1099	0	1099	NA	NA	1	692	
60	TCGA-KK-A7B3	0	1	0	3	1	0	1	0	2	25	1	0	1	8	0	0	TCGA-KK-A7B3-01	125	0.13866563268978682	66	TCGA-KK-A7B3-01	1	4	38	0.04774093225976367	TCGA-KK-A7B3-01	1	8	3	12	PASS	8198	TCGA-KK-A7B3	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-22830	Alive	TUMOR FREE	899	NA	NA	Biochemical evidence of disease	NA	NA	294	Complete Remission/Response	NA	NA	0	899	0	899	1	294	1	294	
60	TCGA-KK-A7B4	0	7	0	0	1	1	0	0	0	21	2	0	1	13	0	0	TCGA-KK-A7B4-01	183	0.5439133559226262	120	TCGA-KK-A7B4-01	4	5	71	0.14049074308262618	TCGA-KK-A7B4-01	3	8	6	17	PASS	8199	TCGA-KK-A7B4	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-23644	Alive	WITH TUMOR	987	NA	NA	Biochemical evidence of disease	NA	NA	637	Stable Disease	NA	NA	0	987	0	987	NA	NA	1	637	
60	TCGA-KK-A8I4	0	2	0	0	2	0	0	0	0	16	1	0	3	9	0	0	TCGA-KK-A8I4-01	148	0.35631420856177953	85	TCGA-KK-A8I4-01	11	19	102	0.17368232856560145	TCGA-KK-A8I4-01	12	9	7	28	PASS	8200	TCGA-KK-A8I4	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-23706	Alive	WITH TUMOR	2259	NA	NA	Distant Metastasis	Bone	NA	1162	Progressive Disease	NA	NA	0	2259	0	2259	NA	NA	1	1162	
60	TCGA-KK-A8I5	0	3	0	1	2	0	0	0	0	28	1	0	0	12	1	0	TCGA-KK-A8I5-01	211	0.10060316636131383	146	TCGA-KK-A8I5-01	0	2	87	0.08479028497340291	TCGA-KK-A8I5-01	2	9	2	13	PASS	8201	TCGA-KK-A8I5	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-20337	Alive	TUMOR FREE	3096	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3096	0	3096	0	3096	0	3096	
60	TCGA-KK-A8I6	0	1	0	1	0	0	0	0	0	21	1	0	0	12	1	0	TCGA-KK-A8I6-01	127	0.11685369473299187	74	TCGA-KK-A8I6-01	0	2	28	0.043536931093986105	TCGA-KK-A8I6-01	1	6	2	9	PASS	8202	TCGA-KK-A8I6	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21499	Alive	TUMOR FREE	668	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	668	0	668	0	668	0	668	
60	TCGA-KK-A8I7	0	1	0	2	0	0	0	0	0	13	2	0	1	6	0	0	TCGA-KK-A8I7-01	143	0.10926498613049808	82	TCGA-KK-A8I7-01	2	4	61	0.08104297465454939	TCGA-KK-A8I7-01	4	7	4	15	pathology review	8203	TCGA-KK-A8I7	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-20256	Alive	TUMOR FREE	2002	NA	NA	Biochemical evidence of disease	NA	NA	1088	Progressive Disease	NA	NA	0	2002	0	2002	NA	NA	1	1088	
70	TCGA-KK-A8I8	0	5	0	1	0	0	0	0	1	14	2	0	0	6	0	0	TCGA-KK-A8I8-01	146	0.1017089268450155	86	TCGA-KK-A8I8-01	2	4	49	0.0644235466308917	TCGA-KK-A8I8-01	5	2	5	12	PASS	8204	TCGA-KK-A8I8	PRAD	69	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-25546	Alive	TUMOR FREE	967	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	967	0	967	0	967	0	967	
60	TCGA-KK-A8I9	0	1	1	2	2	0	0	0	1	31	2	0	0	11	1	0	TCGA-KK-A8I9-01	170	0.13007995580925036	110	TCGA-KK-A8I9-01	0	1	44	0.06991871135280361	TCGA-KK-A8I9-01	0	9	4	13	PASS	8205	TCGA-KK-A8I9	PRAD	61	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-22295	Alive	WITH TUMOR	1001	NA	NA	Biochemical evidence of disease	NA	NA	940	Complete Remission/Response	NA	NA	0	1001	0	1001	1	940	1	940	
70	TCGA-KK-A8IA	0	1	1	0	1	2	0	0	0	27	1	0	0	10	0	0	TCGA-KK-A8IA-01	115	0.5541588004277659	55	TCGA-KK-A8IA-01	2	3	59	0.1103919384720318	TCGA-KK-A8IA-01	4	5	5	14	PASS	8206	TCGA-KK-A8IA	PRAD	69	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-25284	Alive	NA	1931	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1931	0	1931	NA	NA	0	1931	
70	TCGA-KK-A8IB	0	2	0	0	1	0	1	0	1	34	3	0	0	15	0	0	TCGA-KK-A8IB-01	253	0.3187149475449545	189	TCGA-KK-A8IB-01	7	7	11	0.0005425770966363022	TCGA-KK-A8IB-01	3	15	0	18	PASS	8207	TCGA-KK-A8IB	PRAD	65	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-24041	Alive	NA	83	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	83	0	83	NA	NA	0	83	
50	TCGA-KK-A8IC	0	0	0	0	0	0	0	0	1	15	0	0	0	4	0	0	TCGA-KK-A8IC-01	134	0.18457285024956155	83	TCGA-KK-A8IC-01	5	5	81	0.15986250682041664	TCGA-KK-A8IC-01	7	8	11	26	PASS	8208	TCGA-KK-A8IC	PRAD	54	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-19902	Alive	WITH TUMOR	2051	NA	NA	Biochemical evidence of disease	NA	NA	1060	Progressive Disease	NA	NA	0	2051	0	2051	NA	NA	1	1060	
70	TCGA-KK-A8ID	0	0	0	3	4	2	2	0	1	38	1	0	2	21	0	0	TCGA-KK-A8ID-01	818	0.5044830819304468	581	TCGA-KK-A8ID-01	2	1	33	0.013359608576491178	TCGA-KK-A8ID-01	7	6	1	14	PASS	8209	TCGA-KK-A8ID	PRAD	70	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-25851	Alive	TUMOR FREE	2107	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2107	0	2107	0	2107	0	2107	
60	TCGA-KK-A8IF	0	1	0	1	1	0	1	0	0	21	2	0	0	11	0	0	TCGA-KK-A8IF-01	490	0.3405899205349145	414	TCGA-KK-A8IF-01	9	7	198	0.10225668309650753	TCGA-KK-A8IF-01	3	14	7	24	PASS	8210	TCGA-KK-A8IF	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-20888	Alive	WITH TUMOR	804	NA	NA	Biochemical evidence of disease	NA	NA	648	[Unknown]	NA	NA	0	804	0	804	NA	NA	1	648	
60	TCGA-KK-A8IG	0	2	0	0	1	0	0	0	0	26	3	0	2	11	0	0	TCGA-KK-A8IG-01	124	0.227729798980932	71	TCGA-KK-A8IG-01	6	5	72	0.1373761931828366	TCGA-KK-A8IG-01	5	5	7	17	PASS	8211	TCGA-KK-A8IG	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-20266	Alive	TUMOR FREE	2505	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2505	0	2505	0	2505	0	2505	
50	TCGA-KK-A8IH	0	0	0	2	2	1	2	0	1	14	1	0	0	7	0	0	TCGA-KK-A8IH-01	316	0.18152125546540124	240	TCGA-KK-A8IH-01	1	2	93	0.0789731694164694	TCGA-KK-A8IH-01	4	1	2	7	PASS	8212	TCGA-KK-A8IH	PRAD	50	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-18560	Alive	TUMOR FREE	2013	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2013	0	2013	0	2013	0	2013	
60	TCGA-KK-A8II	0	2	0	0	1	1	0	0	4	23	4	0	0	12	0	0	TCGA-KK-A8II-01	201	0.1725034089022293	134	TCGA-KK-A8II-01	1	1	79	0.04878542884153875	TCGA-KK-A8II-01	3	2	3	8	PASS	8213	TCGA-KK-A8II	PRAD	61	MALE	NA	NA	NA	"Prostate Adenocarcinoma, Other Subtype"	NA	2004	NA	-22460	Dead	WITH TUMOR	NA	3467	[Unknown]	Biochemical evidence of disease	NA	NA	626	Progressive Disease	NA	NA	1	3467	1	3467	NA	NA	1	626	
60	TCGA-KK-A8IJ	0	2	0	0	3	0	0	0	0	20	0	0	0	11	1	0	TCGA-KK-A8IJ-01	122	0.036024771929576815	73	TCGA-KK-A8IJ-01	1	2	49	0.03739523377442961	TCGA-KK-A8IJ-01	2	2	2	6	PASS	8214	TCGA-KK-A8IJ	PRAD	59	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-21793	Alive	NA	1559	NA	NA	New Primary Tumor	"Other, specify"	Melanoma in situ of the right midback	307	[Unknown]	NA	NA	0	1559	0	1559	NA	NA	1	307	
60	TCGA-KK-A8IK	0	0	0	1	1	0	2	0	1	20	2	0	0	12	2	0	TCGA-KK-A8IK-01	164	0.5823511420869216	81	TCGA-KK-A8IK-01	14	17	47	0.11160752496881067	TCGA-KK-A8IK-01	11	12	8	31	PASS	8215	TCGA-KK-A8IK	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-20594	Alive	TUMOR FREE	2052	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2052	0	2052	0	2052	0	2052	
70	TCGA-KK-A8IL	0	1	0	0	1	0	0	0	4	26	0	0	0	18	0	0	TCGA-KK-A8IL-01	71	0.016568561371775113	26	TCGA-KK-A8IL-01	0	0	8	0.010273272536692636	TCGA-KK-A8IL-01	0	1	1	2	PASS	8216	TCGA-KK-A8IL	PRAD	65	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-23849	Dead	NA	NA	628	[Unknown]	NA	NA	NA	NA	[Unknown]	NA	NA	1	628	NA	628	NA	NA	0	628	
60	TCGA-KK-A8IM	0	1	1	1	2	0	0	0	0	18	3	0	0	3	2	0	TCGA-KK-A8IM-01	155	0.05710660491578909	96	TCGA-KK-A8IM-01	1	2	77	0.06185956679145967	TCGA-KK-A8IM-01	3	3	5	11	pathology review	8217	TCGA-KK-A8IM	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-20425	Alive	TUMOR FREE	1915	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1915	0	1915	0	1915	0	1915	
60	TCGA-M7-A71Y	0	2	0	0	1	0	0	0	0	12	1	0	0	7	0	0	TCGA-M7-A71Y-01	45	0.01197599112886188	10	TCGA-M7-A71Y-01	3	4	23	0.0642405174489722	TCGA-M7-A71Y-01	2	2	3	7	PASS	8218	TCGA-M7-A71Y	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-20357	Alive	TUMOR FREE	493	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	493	0	493	0	493	0	493	
60	TCGA-M7-A71Z	0	1	0	0	1	1	0	0	1	21	0	0	0	9	0	0	TCGA-M7-A71Z-01	151	0.048304280563675285	95	TCGA-M7-A71Z-01	1	2	62	0.051821230436435516	TCGA-M7-A71Z-01	3	1	2	6	RNA degradation	8219	TCGA-M7-A71Z	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-22785	Alive	TUMOR FREE	643	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	643	0	643	0	643	0	643	
50	TCGA-M7-A720	0	0	0	0	0	1	0	0	0	5	0	0	0	4	0	0	TCGA-M7-A720-01	53	2.3721124257615484e-05	14	TCGA-M7-A720-01	0	0	12	0.004034672837592072	TCGA-M7-A720-01	0	0	0	0	PASS	8220	TCGA-M7-A720	PRAD	53	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-19642	Alive	TUMOR FREE	384	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	384	0	384	0	384	0	384	
70	TCGA-M7-A721	0	1	1	2	0	0	0	0	0	28	1	0	2	9	0	0	TCGA-M7-A721-01	104	0.06505240758941905	59	TCGA-M7-A721-01	0	2	42	0.09710164818612264	TCGA-M7-A721-01	0	10	4	14	PASS	8221	TCGA-M7-A721	PRAD	70	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-25585	Alive	TUMOR FREE	400	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	400	0	400	0	400	0	400	
70	TCGA-M7-A722	0	1	0	0	1	1	1	0	0	27	0	0	0	4	1	0	TCGA-M7-A722-01	163	0.06577637001197803	102	TCGA-M7-A722-01	0	2	38	0.05532355481160402	TCGA-M7-A722-01	0	6	3	9	PASS	8222	TCGA-M7-A722	PRAD	65	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-23880	Alive	TUMOR FREE	1060	NA	NA	Biochemical evidence of disease	NA	NA	559	Partial Remission/Response	NA	NA	0	1060	0	1060	NA	NA	1	559	
50	TCGA-M7-A723	0	0	0	0	0	0	0	0	0	3	0	0	0	3	0	0	TCGA-M7-A723-01	57	0.00012422731379139052	18	TCGA-M7-A723	0	0	0	0	TCGA-M7-A723	0	0	0	0	RNA degradation	8223	TCGA-M7-A723	PRAD	54	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-20064	Alive	TUMOR FREE	763	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	763	0	763	0	763	0	763	
60	TCGA-M7-A724	0	0	0	0	2	1	1	0	1	20	3	0	0	8	0	0	TCGA-M7-A724-01	813	0.13331039995628993	722	TCGA-M7-A724-01	2	3	269	0.09110010316815496	TCGA-M7-A724-01	3	9	3	15	RNA degradation	8224	TCGA-M7-A724	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-23595	Alive	WITH TUMOR	889	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	889	0	889	NA	NA	0	889	
60	TCGA-M7-A725	0	0	0	1	0	0	0	0	2	24	1	0	1	8	1	0	TCGA-M7-A725-01	101	0.21268183760003864	46	TCGA-M7-A725-01	5	6	61	0.11035397458114436	TCGA-M7-A725-01	4	5	6	15	PASS	8225	TCGA-M7-A725	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-20474	Alive	TUMOR FREE	573	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	573	0	573	0	573	0	573	
60	TCGA-MG-AAMC	0	0	1	0	1	0	0	0	0	20	1	0	0	4	0	0	TCGA-MG-AAMC-01	113	0.0697632757361022	56	TCGA-MG-AAMC-01	3	3	62	0.06685900545906416	TCGA-MG-AAMC-01	4	1	5	10	RNA degradation	8226	TCGA-MG-AAMC	PRAD	59	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-21846	Alive	TUMOR FREE	173	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	173	0	173	0	173	0	173	
60	TCGA-QU-A6IL	0	2	0	0	2	0	1	0	1	16	1	0	1	16	0	0	TCGA-QU-A6IL-01	436	0.1231964507169782	371	TCGA-QU-A6IL-01	2	3	170	0.08385400184160742	TCGA-QU-A6IL-01	2	6	3	11	RNA degradation	8227	TCGA-QU-A6IL	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2002	NA	-23710	Alive	TUMOR FREE	97	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	97	0	97	0	97	0	97	
60	TCGA-QU-A6IM	0	2	0	0	3	0	0	0	2	54	2	0	0	15	2	0	TCGA-QU-A6IM-01	212	0.0852104345197545	155	TCGA-QU-A6IM-01	1	3	83	0.061435092422849766	TCGA-QU-A6IM-01	2	7	5	14	RNA degradation	8228	TCGA-QU-A6IM	PRAD	59	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2003	NA	-21792	Alive	TUMOR FREE	1247	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1247	0	1247	0	1247	0	1247	
60	TCGA-QU-A6IN	0	2	0	0	0	0	0	0	1	19	1	0	1	11	0	0	TCGA-QU-A6IN-01	87	0.035459442081119966	39	TCGA-QU-A6IN-01	0	0	34	0.03765577932000577	TCGA-QU-A6IN-01	2	6	3	11	RNA degradation	8229	TCGA-QU-A6IN	PRAD	61	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2003	NA	-22286	Alive	TUMOR FREE	4264	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4264	0	4264	0	4264	0	4264	
50	TCGA-QU-A6IO	0	5	0	4	1	0	0	0	2	24	0	0	1	11	0	0	TCGA-QU-A6IO-01	139	0.1077075893602285	90	TCGA-QU-A6IO-01	2	2	65	0.05632622060939066	TCGA-QU-A6IO-01	3	3	4	10	RNA degradation	8230	TCGA-QU-A6IO	PRAD	53	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2003	NA	-19564	Alive	TUMOR FREE	3716	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3716	0	3716	0	3716	0	3716	
70	TCGA-QU-A6IP	0	1	0	0	1	0	1	0	1	10	1	0	1	4	0	0	TCGA-QU-A6IP-01	51	0.0020962966294876305	14	TCGA-QU-A6IP-01	0	0	8	0.002139355451684435	TCGA-QU-A6IP-01	0	0	0	0	PASS	8231	TCGA-QU-A6IP	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2004	NA	-24212	Alive	TUMOR FREE	2620	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2620	0	2620	0	2620	0	2620	
60	TCGA-SU-A7E7	0	1	0	2	1	0	0	0	0	18	0	0	0	6	1	0	TCGA-SU-A7E7-01	88	0.04742015773430401	36	TCGA-SU-A7E7-01	0	3	38	0.0520740895386564	TCGA-SU-A7E7-01	5	4	4	13	PASS	8232	TCGA-SU-A7E7	PRAD	60	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-22185	Alive	TUMOR FREE	551	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	551	0	551	0	551	0	551	
70	TCGA-TK-A8OK	1	1	0	1	2	0	0	0	2	34	0	0	0	12	0	0	TCGA-TK-A8OK-01	165	0.10185512760561163	101	TCGA-TK-A8OK-01	2	3	73	0.07440742224559037	TCGA-TK-A8OK-01	3	6	4	13	PASS	8233	TCGA-TK-A8OK	PRAD	73	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-26976	Alive	TUMOR FREE	27	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	27	0	27	NA	NA	0	27	
60	TCGA-TP-A8TT	0	1	0	1	1	1	0	0	1	19	1	0	1	7	1	0	TCGA-TP-A8TT-01	234	0.07411839791276473	160	TCGA-TP-A8TT-01	0	2	90	0.06591253116891067	TCGA-TP-A8TT-01	4	7	3	14	PASS	8234	TCGA-TP-A8TT	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-23476	Alive	NA	526	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	526	0	526	NA	NA	0	526	
60	TCGA-TP-A8TV	0	2	0	0	2	0	0	0	1	30	0	0	0	13	2	0	TCGA-TP-A8TV-01	454	0.4651762609674236	376	TCGA-TP-A8TV-01	1	2	145	0.0876519564853447	TCGA-TP-A8TV-01	2	7	6	15	PASS	8235	TCGA-TP-A8TV	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-22872	Alive	TUMOR FREE	610	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	610	0	610	0	610	0	610	
70	TCGA-V1-A8MF	0	1	0	1	0	1	0	0	0	25	3	0	3	3	0	0	TCGA-V1-A8MF-01	131	0.0886400227129187	74	TCGA-V1-A8MF-01	2	3	41	0.03785337665867178	TCGA-V1-A8MF-01	4	4	3	11	PASS	8236	TCGA-V1-A8MF	PRAD	65	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-24090	Alive	NA	1449	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1449	0	1449	0	1449	0	1449	
50	TCGA-V1-A8MG	0	0	0	0	1	0	0	0	0	22	0	0	1	6	0	0	TCGA-V1-A8MG-01	202	0.21419820685683652	137	TCGA-V1-A8MG-01	5	6	77	0.11011282714069848	TCGA-V1-A8MG-01	5	9	8	22	PASS	8237	TCGA-V1-A8MG	PRAD	53	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-19710	Alive	NA	857	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	857	0	857	0	857	0	857	
60	TCGA-V1-A8MJ	0	0	0	0	0	0	0	0	0	15	0	0	0	5	0	0	TCGA-V1-A8MJ-01	65	0.07928662411456905	16	TCGA-V1-A8MJ-01	3	4	44	0.08235761483390483	TCGA-V1-A8MJ-01	4	6	5	15	PASS	8238	TCGA-V1-A8MJ	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-21535	Alive	NA	1791	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	1791	0	1791	NA	NA	0	1791	
40	TCGA-V1-A8MK	0	0	0	0	0	0	0	0	0	8	1	0	0	2	0	0	TCGA-V1-A8MK-01	111	4.4595515184372304e-05	59	TCGA-V1-A8MK	0	0	0	0	TCGA-V1-A8MK	0	0	0	0	pathology review	8239	TCGA-V1-A8MK	PRAD	41	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-15330	Alive	NA	508	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	508	0	508	0	508	0	508	
60	TCGA-V1-A8ML	0	0	0	0	0	1	0	0	0	6	2	0	1	4	1	0	TCGA-V1-A8ML-01	82	0.015865492700543517	37	TCGA-V1-A8ML-01	1	1	20	0.016484952775432292	TCGA-V1-A8ML-01	1	2	1	4	PASS	8240	TCGA-V1-A8ML	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-23360	Alive	NA	448	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	448	0	448	0	448	0	448	
60	TCGA-V1-A8MM	0	1	0	0	2	0	1	0	2	11	1	0	2	8	0	0	TCGA-V1-A8MM-01	214	0.12185961178485152	148	TCGA-V1-A8MM-01	1	1	84	0.09147039559414996	TCGA-V1-A8MM-01	2	12	6	20	RNA degradation	8241	TCGA-V1-A8MM	PRAD	60	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-22265	Alive	NA	1195	NA	NA	Biochemical evidence of disease	NA	NA	990	Complete Remission/Response	NA	NA	0	1195	0	1195	1	990	1	990	
60	TCGA-V1-A8MU	1	2	0	0	2	2	0	0	2	15	1	0	0	12	1	0	TCGA-V1-A8MU-01	109	0.05282488123321926	60	TCGA-V1-A8MU-01	0	1	45	0.055404175742135776	TCGA-V1-A8MU-01	2	5	4	11	PASS	8242	TCGA-V1-A8MU	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-20805	Alive	NA	1876	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	1876	0	1876	NA	NA	0	1876	
60	TCGA-V1-A8WL	0	1	0	1	0	0	0	0	1	23	1	0	0	6	1	0	TCGA-V1-A8WL-01	89	0.04965063981655864	35	TCGA-V1-A8WL-01	1	1	34	0.0389997844122972	TCGA-V1-A8WL-01	3	2	2	7	PASS	8243	TCGA-V1-A8WL	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-23725	Alive	NA	1948	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1948	0	1948	0	1948	0	1948	
50	TCGA-V1-A8WN	0	1	0	1	0	0	0	0	1	10	0	0	0	6	0	1	TCGA-V1-A8WN-01	69	0.011840592455500893	30	TCGA-V1-A8WN-01	0	0	10	0.003936809642029454	TCGA-V1-A8WN-01	0	0	0	0	PASS	8244	TCGA-V1-A8WN	PRAD	47	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-17520	Alive	NA	924	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	924	0	924	0	924	0	924	
60	TCGA-V1-A8WS	0	0	1	0	0	0	0	0	0	22	1	0	1	6	0	0	TCGA-V1-A8WS-01	116	0.11921805034863656	64	TCGA-V1-A8WS-01	0	1	48	0.03810205198564417	TCGA-V1-A8WS-01	0	3	2	5	PASS	8245	TCGA-V1-A8WS	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-20805	Alive	NA	474	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	474	0	474	NA	NA	0	474	
50	TCGA-V1-A8WV	0	2	0	1	3	1	0	0	2	32	0	0	1	8	2	0	TCGA-V1-A8WV-01	148	0.6338992031654224	77	TCGA-V1-A8WV-01	21	23	70	0.1699986967883208	TCGA-V1-A8WV-01	13	16	8	37	PASS	8246	TCGA-V1-A8WV	PRAD	52	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-19345	Alive	NA	686	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	686	0	686	0	686	0	686	
60	TCGA-V1-A8WW	0	3	0	0	0	0	0	0	2	27	3	0	0	8	1	0	TCGA-V1-A8WW-01	143	0.4605097823343674	72	TCGA-V1-A8WW-01	2	2	50	0.06521412221011644	TCGA-V1-A8WW-01	4	6	2	12	PASS	8247	TCGA-V1-A8WW	PRAD	59	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-21900	Alive	NA	1078	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1078	0	1078	0	1078	0	1078	
50	TCGA-V1-A8X3	0	0	0	0	0	0	0	0	2	18	4	0	2	8	0	0	TCGA-V1-A8X3-01	59	0.061200922168482774	19	TCGA-V1-A8X3-01	1	2	22	0.05642346867114986	TCGA-V1-A8X3-01	3	3	4	10	PASS	8248	TCGA-V1-A8X3	PRAD	51	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-18980	Alive	NA	202	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	202	0	202	0	202	0	202	
60	TCGA-V1-A9O5	0	5	0	0	6	0	4	0	2	55	4	0	0	17	2	0	TCGA-V1-A9O5-01	148	0.35192308959569585	87	TCGA-V1-A9O5-06	19	20	70	0.12258060280660373	TCGA-V1-A9O5-06	11	11	7	29	mutation call filter	8249	TCGA-V1-A9O5	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-23725	Alive	NA	1932	NA	NA	Biochemical evidence of disease	NA	NA	124	Complete Remission/Response	NA	NA	0	1932	0	1932	1	124	1	124	
60	TCGA-V1-A9O7	0	2	0	2	1	0	0	0	3	18	1	0	1	9	1	0	TCGA-V1-A9O7-01	109	0.2453447295736571	53	TCGA-V1-A9O7-01	5	8	46	0.0962323658779502	TCGA-V1-A9O7-01	9	8	7	24	PASS	8250	TCGA-V1-A9O7	PRAD	60	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-22265	Alive	NA	2499	NA	NA	Biochemical evidence of disease	NA	NA	819	Progressive Disease	NA	NA	0	2499	0	2499	NA	NA	1	819	
60	TCGA-V1-A9O9	0	0	0	0	3	0	0	0	0	21	0	0	1	12	2	0	TCGA-V1-A9O9-01	131	0.11990539985844045	65	TCGA-V1-A9O9-01	1	1	50	0.07470767167418887	TCGA-V1-A9O9-01	4	8	3	15	PASS	8251	TCGA-V1-A9O9	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-20805	Alive	NA	2870	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2870	0	2870	0	2870	0	2870	
60	TCGA-V1-A9OA	0	0	1	0	1	1	0	0	1	15	0	0	0	3	0	0	TCGA-V1-A9OA-01	88	0.16665146454558974	38	TCGA-V1-A9OA-01	3	4	50	0.10117900784316894	TCGA-V1-A9OA-01	8	11	7	26	PASS	8252	TCGA-V1-A9OA	PRAD	61	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-22630	Alive	NA	636	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	636	0	636	0	636	0	636	
50	TCGA-V1-A9OF	0	2	0	1	1	0	1	0	0	10	0	0	1	1	1	0	TCGA-V1-A9OF-01	107	0.02232850438068076	59	TCGA-V1-A9OF-01	0	0	28	0.02402376008401412	TCGA-V1-A9OF-01	0	2	1	3	PASS	8253	TCGA-V1-A9OF	PRAD	49	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-18250	Alive	NA	1184	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1184	0	1184	0	1184	0	1184	
60	TCGA-V1-A9OH	0	1	0	0	7	0	0	0	1	41	3	0	1	14	0	0	TCGA-V1-A9OH-01	72	0.0932025786686725	23	TCGA-V1-A9OH-01	0	2	24	0.05539162214843135	TCGA-V1-A9OH-01	4	6	4	14	PASS	8254	TCGA-V1-A9OH	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-23360	Alive	NA	2403	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2403	0	2403	0	2403	0	2403	
70	TCGA-V1-A9OL	0	1	0	3	0	0	0	0	1	22	4	0	1	12	1	0	TCGA-V1-A9OL-01	231	0.380601091498917	146	TCGA-V1-A9OL-01	3	6	104	0.14235260211549655	TCGA-V1-A9OL-01	7	17	11	35	PASS	8255	TCGA-V1-A9OL	PRAD	65	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-24090	Alive	NA	1913	NA	NA	Biochemical evidence of disease	NA	NA	105	Complete Remission/Response	NA	NA	0	1913	0	1913	1	105	1	105	
70	TCGA-V1-A9OQ	0	1	0	1	2	1	0	0	0	38	3	1	0	10	1	0	TCGA-V1-A9OQ-01	167	0.04821027672357607	110	TCGA-V1-A9OQ-01	0	1	58	0.05112767401772246	TCGA-V1-A9OQ-01	0	5	4	9	PASS	8256	TCGA-V1-A9OQ	PRAD	67	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-24820	Alive	NA	371	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	371	0	371	0	371	0	371	
60	TCGA-V1-A9OT	0	7	0	1	0	1	1	0	0	18	0	0	0	8	1	0	TCGA-V1-A9OT-01	115	0.05005642983633271	56	TCGA-V1-A9OT-01	0	1	40	0.05156627984375416	TCGA-V1-A9OT-01	0	6	3	9	RNA degradation	8257	TCGA-V1-A9OT	PRAD	61	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-22630	Alive	NA	476	NA	NA	Biochemical evidence of disease	NA	NA	292	Progressive Disease	NA	NA	0	476	0	476	NA	NA	1	292	
60	TCGA-V1-A9OX	0	0	0	0	0	0	1	0	0	18	0	0	1	11	0	0	TCGA-V1-A9OX-01	248	0.13696109779805335	179	TCGA-V1-A9OX-01	3	2	123	0.08658924321788991	TCGA-V1-A9OX-01	0	8	6	14	PASS	8258	TCGA-V1-A9OX	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-20805	Alive	NA	1134	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1134	0	1134	NA	NA	0	1134	
60	TCGA-V1-A9OY	0	2	0	1	1	0	0	0	1	12	0	0	0	5	2	0	TCGA-V1-A9OY-01	104	0.02287870688257728	51	TCGA-V1-A9OY-01	0	0	23	0.02421422127278976	TCGA-V1-A9OY-01	0	4	2	6	PASS	8259	TCGA-V1-A9OY	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-21170	Alive	NA	1067	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1067	0	1067	0	1067	0	1067	
50	TCGA-V1-A9Z7	0	2	0	1	1	2	0	0	0	20	0	0	0	9	2	0	TCGA-V1-A9Z7-01	358	0.20034640939667628	280	TCGA-V1-A9Z7-01	4	4	122	0.08208533728524504	TCGA-V1-A9Z7-01	5	5	3	13	PASS	8260	TCGA-V1-A9Z7	PRAD	54	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-20075	Alive	NA	874	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	874	0	874	0	874	0	874	
60	TCGA-V1-A9Z8	0	1	0	0	3	1	1	0	1	19	1	0	0	8	1	0	TCGA-V1-A9Z8-01	136	0.09431809261422787	72	TCGA-V1-A9Z8-01	1	2	48	0.036313845525105616	TCGA-V1-A9Z8-01	1	6	2	9	PASS	8261	TCGA-V1-A9Z8	PRAD	59	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-21900	Alive	TUMOR FREE	827	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	827	0	827	0	827	0	827	
60	TCGA-V1-A9Z9	0	1	0	0	4	1	0	0	0	21	2	0	0	9	0	0	TCGA-V1-A9Z9-01	175	0.06236065535607995	119	TCGA-V1-A9Z9-01	0	0	69	0.0660375273980182	TCGA-V1-A9Z9-01	0	12	4	16	PASS	8262	TCGA-V1-A9Z9	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-23360	Alive	TUMOR FREE	540	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	540	0	540	0	540	0	540	
60	TCGA-V1-A9ZG	0	0	0	1	1	0	0	0	0	21	1	0	0	10	0	0	TCGA-V1-A9ZG-01	177	0.026898059259995843	119	TCGA-V1-A9ZG-01	1	1	70	0.028584943638899282	TCGA-V1-A9ZG-01	0	1	1	2	PASS	8263	TCGA-V1-A9ZG	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-23725	Alive	TUMOR FREE	1517	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1517	0	1517	0	1517	0	1517	
70	TCGA-V1-A9ZI	0	2	0	0	3	0	2	0	1	19	2	0	1	8	1	0	TCGA-V1-A9ZI-01	134	0.2040228011852196	71	TCGA-V1-A9ZI-01	7	7	54	0.10599446518872713	TCGA-V1-A9ZI-01	4	4	5	13	PASS	8264	TCGA-V1-A9ZI	PRAD	68	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-25185	Alive	NA	1640	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	1640	0	1640	NA	NA	0	1640	
70	TCGA-V1-A9ZK	0	0	1	0	2	0	0	0	0	17	3	0	1	3	0	0	TCGA-V1-A9ZK-01	99	0.07500813318106847	46	TCGA-V1-A9ZK-01	1	4	49	0.1452113689990771	TCGA-V1-A9ZK-01	5	15	10	30	PASS	8265	TCGA-V1-A9ZK	PRAD	68	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-25185	Alive	TUMOR FREE	1383	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1383	0	1383	0	1383	0	1383	
70	TCGA-V1-A9ZR	1	4	0	0	1	0	0	0	3	29	1	0	2	7	2	0	TCGA-V1-A9ZR-01	150	0.07274934388389526	91	TCGA-V1-A9ZR-01	0	1	84	0.07533811060468186	TCGA-V1-A9ZR-01	2	10	4	16	PASS	8266	TCGA-V1-A9ZR	PRAD	68	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	NA	NA	-25185	Alive	TUMOR FREE	1361	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1361	0	1361	0	1361	0	1361	
60	TCGA-VN-A88I	0	0	0	0	0	1	0	0	0	12	1	0	0	3	0	0	TCGA-VN-A88I-01	57	0.0034189796065987924	18	TCGA-VN-A88I-01	0	0	14	0.006191773722876462	TCGA-VN-A88I-01	0	0	0	0	PASS	8267	TCGA-VN-A88I	PRAD	59	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21576	Alive	WITH TUMOR	269	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	269	0	269	NA	NA	0	269	
60	TCGA-VN-A88K	0	1	0	0	0	0	0	0	0	20	2	0	0	4	0	0	TCGA-VN-A88K-01	114	0.1866598659439182	62	TCGA-VN-A88K-01	3	4	57	0.09863256234587127	TCGA-VN-A88K-01	7	5	5	17	PASS	8268	TCGA-VN-A88K	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21524	Alive	NA	776	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	776	0	776	0	776	0	776	
50	TCGA-VN-A88L	1	0	0	0	0	0	0	0	0	12	2	0	1	14	0	0	TCGA-VN-A88L-01	104	0.04294556465550099	57	TCGA-VN-A88L-01	0	0	40	0.045756220898899636	TCGA-VN-A88L-01	1	9	1	11	PASS	8269	TCGA-VN-A88L	PRAD	54	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-20026	Alive	TUMOR FREE	746	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	746	0	746	0	746	0	746	
60	TCGA-VN-A88M	0	0	0	0	0	0	0	0	2	15	0	0	0	8	1	0	TCGA-VN-A88M-01	92	0.06853342896504826	40	TCGA-VN-A88M-01	0	0	10	0.005637014850992338	TCGA-VN-A88M-01	0	0	0	0	RNA degradation	8270	TCGA-VN-A88M	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-20157	Alive	TUMOR FREE	189	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	189	0	189	0	189	0	189	
60	TCGA-VN-A88N	0	1	0	0	1	0	0	0	0	19	1	0	0	5	1	0	TCGA-VN-A88N-01	67	0.01747320073145099	21	TCGA-VN-A88N-01	0	1	25	0.019985255389487804	TCGA-VN-A88N-01	1	2	2	5	PASS	8271	TCGA-VN-A88N	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-22695	Alive	TUMOR FREE	766	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	766	0	766	0	766	0	766	
50	TCGA-VN-A88O	0	2	0	1	0	1	1	0	2	24	2	0	0	12	1	0	TCGA-VN-A88O-01	66	0.06658941080242124	21	TCGA-VN-A88O-01	2	2	20	0.059825458422879924	TCGA-VN-A88O-01	2	2	3	7	PASS	8272	TCGA-VN-A88O	PRAD	49	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-17945	Alive	TUMOR FREE	481	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	481	0	481	0	481	0	481	
60	TCGA-VN-A88P	0	3	1	2	2	0	1	0	1	29	2	0	0	11	0	0	TCGA-VN-A88P-01	142	0.1704763589381988	94	TCGA-VN-A88P-01	2	2	53	0.04904558106034775	TCGA-VN-A88P-01	3	3	3	9	PASS	8273	TCGA-VN-A88P	PRAD	60	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21916	Alive	TUMOR FREE	1260	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1260	0	1260	0	1260	0	1260	
60	TCGA-VN-A88Q	0	1	0	2	1	0	0	0	1	29	1	0	1	11	1	0	TCGA-VN-A88Q-01	103	0.06064722181016606	57	TCGA-VN-A88Q-01	2	2	40	0.0278732930266356	TCGA-VN-A88Q-01	2	1	1	4	PASS	8274	TCGA-VN-A88Q	PRAD	60	MALE	NA	NA	NA	"Prostate Adenocarcinoma, Other Subtype"	NA	2010	NA	-22087	Alive	TUMOR FREE	1366	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1366	0	1366	0	1366	0	1366	
50	TCGA-VN-A88R	0	1	1	0	1	0	0	0	2	16	3	0	0	3	2	0	TCGA-VN-A88R-01	342	0.15493892625888614	251	TCGA-VN-A88R-01	1	2	129	0.09664506526903764	TCGA-VN-A88R-01	2	13	7	22	PASS	8275	TCGA-VN-A88R	PRAD	53	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-19513	Alive	NA	784	NA	NA	Biochemical evidence of disease	NA	NA	512	Partial Remission/Response	NA	NA	0	784	0	784	NA	NA	1	512	
70	TCGA-VN-A943	0	3	0	0	0	0	0	0	2	20	0	0	0	7	2	0	TCGA-VN-A943-01	365	0.13516205240416174	302	TCGA-VN-A943-01	0	0	98	0.038878238579121975	TCGA-VN-A943-01	1	4	3	8	PASS	8276	TCGA-VN-A943	PRAD	71	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-26162	Alive	TUMOR FREE	496	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	496	0	496	0	496	0	496	
60	TCGA-VP-A872	0	0	0	2	1	3	0	0	0	20	1	0	0	5	0	0	TCGA-VP-A872-01	124	0.4784034992437954	68	TCGA-VP-A872-01	4	4	51	0.11486143291697395	TCGA-VP-A872-01	4	6	5	15	PASS	8277	TCGA-VP-A872	PRAD	60	MALE	NA	NA	NA	"Prostate Adenocarcinoma, Other Subtype"	NA	2005	NA	-22098	Alive	TUMOR FREE	3631	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3631	0	3631	0	3631	0	3631	
70	TCGA-VP-A875	0	4	0	2	1	0	0	0	2	25	1	0	0	16	0	0	TCGA-VP-A875-01	176	0.6405752525204287	109	TCGA-VP-A875-01	0	0	29	0.01953859746927641	TCGA-VP-A875-01	3	1	0	4	PASS	8278	TCGA-VP-A875	PRAD	67	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2005	NA	-24742	Alive	TUMOR FREE	2309	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2309	0	2309	0	2309	0	2309	
50	TCGA-VP-A876	0	0	0	1	0	0	0	0	0	19	1	0	0	7	0	0	TCGA-VP-A876-01	87	0.2003962838062663	44	TCGA-VP-A876-01	2	2	38	0.054160569142700135	TCGA-VP-A876-01	5	4	3	12	PASS	8279	TCGA-VP-A876	PRAD	46	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2005	NA	-16934	Alive	TUMOR FREE	3333	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3333	0	3333	0	3333	0	3333	
60	TCGA-VP-A878	0	1	0	0	3	0	0	0	0	21	2	0	0	9	1	0	TCGA-VP-A878-01	150	0.0735140053923729	94	TCGA-VP-A878-01	0	3	73	0.09270657608741938	TCGA-VP-A878-01	1	13	5	19	PASS	8280	TCGA-VP-A878	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-21402	Alive	WITH TUMOR	3130	NA	NA	Biochemical evidence of disease	NA	NA	98	Partial Remission/Response	NA	NA	0	3130	0	3130	NA	NA	1	98	
70	TCGA-VP-A879	0	2	2	1	1	0	1	0	0	36	2	0	0	9	0	0	TCGA-VP-A879-01	57	0.007891479344164494	17	TCGA-VP-A879-01	0	0	13	0.011182836763455837	TCGA-VP-A879-01	1	1	1	3	PASS	8281	TCGA-VP-A879	PRAD	70	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2006	NA	-25799	Dead	TUMOR FREE	NA	728	[Unknown]	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	728	0	728	0	728	0	728	
60	TCGA-VP-A87B	1	1	0	0	0	0	0	0	0	33	2	0	0	4	1	0	TCGA-VP-A87B-01	333	0.15003405371306486	260	TCGA-VP-A87B-01	2	2	120	0.07397867457429487	TCGA-VP-A87B-01	0	9	4	13	PASS	8282	TCGA-VP-A87B	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-23271	Alive	WITH TUMOR	2722	NA	NA	New Primary Tumor	Lung	NA	2473	Complete Remission/Response	NA	NA	0	2722	0	2722	0	2722	1	2473	
70	TCGA-VP-A87C	0	0	0	1	1	1	0	0	2	17	0	0	0	4	1	0	TCGA-VP-A87C-01	119	0.06477263032265848	71	TCGA-VP-A87C-01	3	3	63	0.06780757211742093	TCGA-VP-A87C-01	4	0	3	7	PASS	8283	TCGA-VP-A87C	PRAD	67	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-24608	Alive	TUMOR FREE	1690	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1690	0	1690	0	1690	0	1690	
50	TCGA-VP-A87D	0	1	0	1	2	0	1	0	2	43	4	0	0	12	1	0	TCGA-VP-A87D-01	173	0.17242675401876273	99	TCGA-VP-A87D-01	2	3	60	0.074596822662248	TCGA-VP-A87D-01	2	7	5	14	PASS	8284	TCGA-VP-A87D	PRAD	54	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	-19818	Alive	TUMOR FREE	1853	NA	NA	Biochemical evidence of disease	NA	NA	1194	Complete Remission/Response	NA	NA	0	1853	0	1853	1	1194	1	1194	
60	TCGA-VP-A87E	0	1	0	2	0	0	0	0	0	19	1	0	1	5	0	0	TCGA-VP-A87E-01	69	4.806637724990205e-05	29	TCGA-VP-A87E-01	0	0	5	0.0005560325754580573	TCGA-VP-A87E-01	0	0	0	0	PASS	8285	TCGA-VP-A87E	PRAD	59	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-21811	Alive	TUMOR FREE	2037	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2037	0	2037	0	2037	0	2037	
80	TCGA-VP-A87H	0	1	1	0	2	2	0	0	1	23	0	0	0	6	0	0	TCGA-VP-A87H-01	83	0.6981553597205357	43	TCGA-VP-A87H-01	11	12	40	0.07684569055593791	TCGA-VP-A87H-01	2	4	3	9	PASS	8286	TCGA-VP-A87H	PRAD	76	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-28060	Alive	TUMOR FREE	663	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	663	0	663	0	663	0	663	
60	TCGA-VP-A87J	0	4	0	0	0	0	0	0	3	24	3	0	0	8	0	0	TCGA-VP-A87J-01	117	0.06325011105114886	60	TCGA-VP-A87J-01	3	3	61	0.06867312006050796	TCGA-VP-A87J-01	3	2	4	9	PASS	8287	TCGA-VP-A87J	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-20792	Alive	TUMOR FREE	1774	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1774	0	1774	0	1774	0	1774	
60	TCGA-VP-A87K	0	0	0	0	0	0	0	0	1	23	4	0	0	8	1	0	TCGA-VP-A87K-01	99	0.3766555350351564	49	TCGA-VP-A87K-01	4	4	48	0.07697113836486702	TCGA-VP-A87K-01	4	5	6	15	PASS	8288	TCGA-VP-A87K	PRAD	63	MALE	NA	NA	NA	"Prostate Adenocarcinoma, Other Subtype"	NA	2010	NA	-23030	Alive	TUMOR FREE	1306	NA	NA	Biochemical evidence of disease	NA	NA	533	Complete Remission/Response	NA	NA	0	1306	0	1306	1	533	1	533	
70	TCGA-VP-AA1N	0	1	0	0	2	0	2	0	4	23	1	0	0	9	0	0	TCGA-VP-AA1N-01	390	0.8687984505974812	294	TCGA-VP-AA1N-01	16	12	139	0.10035613629226038	TCGA-VP-AA1N-01	8	18	9	35	PASS	8289	TCGA-VP-AA1N	PRAD	70	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-25781	Alive	TUMOR FREE	1365	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1365	0	1365	0	1365	0	1365	
70	TCGA-WW-A8ZI	0	0	0	0	0	0	0	0	3	24	0	0	1	9	1	0	TCGA-WW-A8ZI-01	152	0.18780401865562268	96	TCGA-WW-A8ZI-01	2	1	69	0.0911735047081108	TCGA-WW-A8ZI-01	3	4	3	10	PASS	8290	TCGA-WW-A8ZI	PRAD	70	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-25593	Alive	TUMOR FREE	449	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	449	0	449	0	449	0	449	
70	TCGA-X4-A8KQ	0	2	0	0	2	1	0	0	2	30	3	0	2	12	1	0	TCGA-X4-A8KQ-01	111	0.17483489897373766	56	TCGA-X4-A8KQ-01	5	7	47	0.0964335993509173	TCGA-X4-A8KQ-01	6	6	5	17	RNA degradation	8291	TCGA-X4-A8KQ	PRAD	65	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-23999	Alive	WITH TUMOR	1383	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	1383	0	1383	NA	NA	0	1383	
60	TCGA-X4-A8KS	0	2	0	1	0	1	0	0	1	20	0	0	0	4	1	0	TCGA-X4-A8KS-01	115	0.06685582847148994	63	TCGA-X4-A8KS-01	2	1	13	0.024833097692253968	TCGA-X4-A8KS-01	0	4	2	6	PASS	8292	TCGA-X4-A8KS	PRAD	61	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-22571	Alive	TUMOR FREE	979	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	979	0	979	NA	NA	0	979	
70	TCGA-XA-A8JR	0	1	0	0	2	1	0	0	1	12	3	0	0	8	1	0	TCGA-XA-A8JR-01	100	0.030556491634444093	49	TCGA-XA-A8JR-01	0	0	28	0.03166569233438174	TCGA-XA-A8JR-01	0	3	2	5	PASS	8293	TCGA-XA-A8JR	PRAD	68	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-25090	Alive	TUMOR FREE	376	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	376	0	376	0	376	0	376	
70	TCGA-XJ-A83F	0	0	0	0	1	0	1	0	0	27	0	0	0	8	0	0	TCGA-XJ-A83F-01	182	0.0834968747928204	126	TCGA-XJ-A83F-01	3	4	71	0.08899685222170388	TCGA-XJ-A83F-01	4	5	6	15	RNA degradation	8294	TCGA-XJ-A83F	PRAD	67	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	NA	Alive	TUMOR FREE	1127	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1127	0	1127	0	1127	0	1127	
50	TCGA-XJ-A83G	0	1	0	2	1	0	1	0	2	17	1	0	1	6	0	0	TCGA-XJ-A83G-01	231	0.17925289489680712	172	TCGA-XJ-A83G-01	0	3	91	0.11786227791562975	TCGA-XJ-A83G-01	1	11	9	21	PASS	8295	TCGA-XJ-A83G	PRAD	51	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	NA	Alive	TUMOR FREE	1461	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1461	0	1461	0	1461	0	1461	
60	TCGA-XJ-A83H	0	1	1	0	1	0	2	0	2	27	1	0	1	7	2	0	TCGA-XJ-A83H-01	106	0.1622389919926714	67	TCGA-XJ-A83H-01	2	2	40	0.047010988814680105	TCGA-XJ-A83H-01	1	4	3	8	PASS	8296	TCGA-XJ-A83H	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	NA	Alive	NA	1280	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1280	0	1280	NA	NA	0	1280	
60	TCGA-XJ-A9DI	0	1	0	0	0	0	0	0	1	15	2	0	1	4	0	0	TCGA-XJ-A9DI-01	57	0.0002747042758883644	22	TCGA-XJ-A9DI-01	0	0	4	0.000995599909767308	TCGA-XJ-A9DI-01	0	0	0	0	PASS	8297	TCGA-XJ-A9DI	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	NA	Alive	TUMOR FREE	1461	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1461	0	1461	0	1461	0	1461	
60	TCGA-XJ-A9DK	0	0	0	0	0	0	0	0	0	4	0	0	0	1	0	0	TCGA-XJ-A9DK-01	49	6.294778685727667e-06	12	TCGA-XJ-A9DK-01	0	0	6	0.0002898031053933968	TCGA-XJ-A9DK-01	0	0	0	0	PASS	8298	TCGA-XJ-A9DK	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	NA	Alive	TUMOR FREE	275	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	275	0	275	0	275	0	275	
50	TCGA-XJ-A9DQ	0	0	0	0	0	0	0	0	0	8	1	0	0	2	0	0	TCGA-XJ-A9DQ-01	43	0.01769570789240411	4	TCGA-XJ-A9DQ-01	0	0	4	0.00019588430371944799	TCGA-XJ-A9DQ-01	0	0	0	0	RNA degradation	8299	TCGA-XJ-A9DQ	PRAD	48	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2007	NA	NA	Alive	NA	91	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	91	0	91	NA	NA	0	91	
50	TCGA-XJ-A9DX	0	1	0	2	3	4	0	0	3	48	5	0	3	12	0	0	TCGA-XJ-A9DX-01	1108	0.8730228480681228	816	TCGA-XJ-A9DX-01	6	2	72	0.04419358583243351	TCGA-XJ-A9DX-01	18	16	3	37	RNA degradation	8300	TCGA-XJ-A9DX	PRAD	51	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	NA	Alive	TUMOR FREE	973	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	973	0	973	NA	NA	0	973	
80	TCGA-XK-AAIR	0	1	0	1	1	1	0	0	1	21	0	0	0	8	1	0	TCGA-XK-AAIR-01	243	0.06921763807886447	179	TCGA-XK-AAIR-01	2	2	104	0.07465109077608352	TCGA-XK-AAIR-01	3	4	5	12	PASS	8301	TCGA-XK-AAIR	PRAD	75	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-27703	Alive	TUMOR FREE	972	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	972	0	972	0	972	0	972	
60	TCGA-XK-AAIV	0	2	1	2	0	0	0	0	1	40	3	0	3	6	0	0	TCGA-XK-AAIV-01	189	0.5048526923966021	116	TCGA-XK-AAIV-01	19	25	76	0.1950956854833115	TCGA-XK-AAIV-01	15	18	10	43	PASS	8302	TCGA-XK-AAIV	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-23325	Alive	TUMOR FREE	1133	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1133	0	1133	0	1133	0	1133	
80	TCGA-XK-AAIW	32	336	19	102	50	45	1	0	226	5623	340	0	96	2633	102	7	TCGA-XK-AAIW-01	83	0.027178734244719463	28	TCGA-XK-AAIW-01	1	1	8	0.028627230133357582	TCGA-XK-AAIW-01	0	2	1	3	hypermutated sample	8303	TCGA-XK-AAIW	PRAD	78	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-28721	Alive	TUMOR FREE	1218	NA	NA	New Primary Tumor	NA	NA	427	Complete Remission/Response	NA	NA	0	1218	0	1218	0	1218	1	427	
60	TCGA-XK-AAJ3	0	2	1	3	3	1	0	0	2	39	2	0	1	12	3	0	TCGA-XK-AAJ3	0	0	0	TCGA-XK-AAJ3	0	0	0	0	TCGA-XK-AAJ3	0	0	0	0	PASS	8304	TCGA-XK-AAJ3	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-20604	Alive	TUMOR FREE	1262	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1262	0	1262	0	1262	0	1262	
60	TCGA-XK-AAJA	0	3	0	1	3	0	0	0	2	36	0	0	0	13	1	0	TCGA-XK-AAJA-01	856	0.2854774328670889	716	TCGA-XK-AAJA-01	0	2	357	0.10654271904386554	TCGA-XK-AAJA-01	0	4	3	7	PASS	8305	TCGA-XK-AAJA	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-22771	Alive	NA	930	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	930	0	930	0	930	0	930	
70	TCGA-XK-AAJP	0	1	0	4	0	0	0	0	2	29	2	0	0	11	0	0	TCGA-XK-AAJP-01	372	0.3964068914426253	296	TCGA-XK-AAJP-01	1	3	138	0.11500032631267194	TCGA-XK-AAJP-01	2	10	7	19	PASS	8306	TCGA-XK-AAJP	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-24320	Alive	TUMOR FREE	1259	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1259	0	1259	0	1259	0	1259	
60	TCGA-XK-AAJR	0	1	1	0	4	1	0	0	0	15	2	0	0	13	1	0	TCGA-XK-AAJR-01	134	0.09925414072323216	82	TCGA-XK-AAJR-01	2	2	66	0.10582395516939062	TCGA-XK-AAJR-01	3	10	9	22	PASS	8307	TCGA-XK-AAJR	PRAD	61	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-22643	Alive	TUMOR FREE	1124	NA	NA	Biochemical evidence of disease	NA	NA	131	Complete Remission/Response	NA	NA	0	1124	0	1124	1	131	1	131	
80	TCGA-XK-AAJT	0	1	0	0	0	1	0	0	1	24	1	0	0	7	1	0	TCGA-XK-AAJT-01	676	0.404207681440637	550	TCGA-XK-AAJT-01	5	5	257	0.1592682278343909	TCGA-XK-AAJT-01	4	14	10	28	PASS	8308	TCGA-XK-AAJT	PRAD	75	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-27428	Alive	TUMOR FREE	1434	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1434	0	1434	NA	NA	0	1434	
70	TCGA-XK-AAJU	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	TCGA-XK-AAJU-01	83	4.4525542813871696e-05	34	TCGA-XK-AAJU-01	0	0	8	0.0025476532156465327	TCGA-XK-AAJU-01	0	0	0	0	mutation call filter	8309	TCGA-XK-AAJU	PRAD	65	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-23958	Alive	TUMOR FREE	1576	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1576	0	1576	0	1576	0	1576	
60	TCGA-XK-AAK1	0	0	1	0	1	0	1	1	2	26	2	0	1	12	1	0	TCGA-XK-AAK1	0	0	0	TCGA-XK-AAK1	0	0	0	0	TCGA-XK-AAK1	0	0	0	0	RNA degradation	8310	TCGA-XK-AAK1	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-22965	Alive	TUMOR FREE	979	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	979	0	979	0	979	0	979	
60	TCGA-XQ-A8TA	0	3	0	2	0	1	0	0	4	95	7	0	1	27	3	0	TCGA-XQ-A8TA-01	466	0.9491186888012858	339	TCGA-XQ-A8TA-01	5	10	194	0.2564841155165267	TCGA-XQ-A8TA-01	18	28	12	58	PASS	8311	TCGA-XQ-A8TA	PRAD	59	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-21889	Dead	WITH TUMOR	NA	146	Prostate Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	146	1	146	NA	NA	1	146	
70	TCGA-XQ-A8TB	0	1	0	1	1	0	2	0	0	21	0	0	0	10	0	0	TCGA-XQ-A8TB-01	178	0.06521130624936594	121	TCGA-XQ-A8TB-01	1	1	82	0.08510495441593409	TCGA-XQ-A8TB-01	2	9	5	16	PASS	8312	TCGA-XQ-A8TB	PRAD	67	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-24623	Alive	TUMOR FREE	770	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	770	0	770	0	770	0	770	
70	TCGA-Y6-A8TL	0	1	0	1	1	1	0	0	1	22	3	0	0	4	0	0	TCGA-Y6-A8TL-01	221	0.04713451170974608	158	TCGA-Y6-A8TL-01	0	0	79	0.047747623600518777	TCGA-Y6-A8TL-01	0	6	2	8	PASS	8313	TCGA-Y6-A8TL	PRAD	65	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-23776	Alive	TUMOR FREE	992	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	992	0	992	NA	NA	0	992	
70	TCGA-Y6-A9XI	0	2	0	0	1	1	0	0	1	35	1	0	0	13	1	0	TCGA-Y6-A9XI-01	111	0.08533028739696011	53	TCGA-Y6-A9XI-01	1	2	32	0.07588376061870214	TCGA-Y6-A9XI-01	3	7	6	16	PASS	8314	TCGA-Y6-A9XI	PRAD	72	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-26471	Alive	TUMOR FREE	526	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	526	0	526	0	526	0	526	
70	TCGA-YJ-A8SW	0	2	1	4	3	0	0	0	0	48	2	0	1	16	1	0	TCGA-YJ-A8SW-01	1186	0.9428571743667721	867	TCGA-YJ-A8SW-01	6	5	79	0.05213002801226077	TCGA-YJ-A8SW-01	8	11	3	22	PASS	8315	TCGA-YJ-A8SW	PRAD	67	MALE	NA	NA	NA	"Prostate Adenocarcinoma, Other Subtype"	NA	2008	NA	NA	Alive	NA	148	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	148	0	148	NA	NA	0	148	
60	TCGA-YL-A8HJ	0	0	0	0	0	0	0	0	1	28	0	0	1	9	1	0	TCGA-YL-A8HJ-01	69	0.0091491417492051	27	TCGA-YL-A8HJ-01	0	0	17	0.010664896927025087	TCGA-YL-A8HJ-01	0	1	0	1	PASS	8316	TCGA-YL-A8HJ	PRAD	58	MALE	NA	NA	NA	"Prostate Adenocarcinoma, Other Subtype"	NA	2009	NA	-21416	Alive	TUMOR FREE	1611	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1611	0	1611	0	1611	0	1611	
60	TCGA-YL-A8HK	0	1	0	0	0	1	0	0	0	13	2	0	0	8	0	0	TCGA-YL-A8HK-01	99	0.14116791037346724	46	TCGA-YL-A8HK-01	3	4	71	0.14372042091834022	TCGA-YL-A8HK-01	8	11	10	29	PASS	8317	TCGA-YL-A8HK	PRAD	59	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-21850	Alive	WITH TUMOR	1491	NA	NA	Biochemical evidence of disease	NA	NA	1376	Complete Remission/Response	NA	NA	0	1491	0	1491	1	1376	1	1376	
60	TCGA-YL-A8HL	0	0	0	0	0	0	0	0	3	16	1	0	1	5	0	0	TCGA-YL-A8HL-01	152	0.09250808017522394	88	TCGA-YL-A8HL-01	1	3	63	0.07185194786914895	TCGA-YL-A8HL-01	5	5	5	15	PASS	8318	TCGA-YL-A8HL	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-21249	Alive	NA	1565	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1565	0	1565	NA	NA	0	1565	
70	TCGA-YL-A8HM	0	4	0	3	2	1	0	0	0	30	1	0	0	12	0	0	TCGA-YL-A8HM-01	738	0.3642770366108082	601	TCGA-YL-A8HM-01	7	27	259	0.13015946042288806	TCGA-YL-A8HM-01	9	14	6	29	PASS	8319	TCGA-YL-A8HM	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-24121	Alive	WITH TUMOR	1482	NA	NA	Biochemical evidence of disease	NA	NA	1473	Complete Remission/Response	NA	NA	0	1482	0	1482	1	1473	1	1473	
70	TCGA-YL-A8HO	0	1	0	1	1	0	0	0	2	23	3	0	0	14	1	0	TCGA-YL-A8HO-01	293	0.5003422371966381	236	TCGA-YL-A8HO-01	9	11	166	0.2075185699888594	TCGA-YL-A8HO-01	7	8	12	27	PASS	8320	TCGA-YL-A8HO	PRAD	67	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-24509	Alive	WITH TUMOR	2304	NA	NA	Biochemical evidence of disease	NA	NA	1068	Stable Disease	NA	NA	0	2304	0	2304	NA	NA	1	1068	
70	TCGA-YL-A8S8	0	4	1	0	1	2	0	0	0	27	7	0	2	7	1	0	TCGA-YL-A8S8-01	335	0.4301852276658597	242	TCGA-YL-A8S8-01	8	15	151	0.15575716888887914	TCGA-YL-A8S8-01	7	12	11	30	PASS	8321	TCGA-YL-A8S8	PRAD	68	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-25119	Alive	WITH TUMOR	1890	NA	NA	Biochemical evidence of disease	NA	NA	679	Stable Disease	NA	NA	0	1890	0	1890	NA	NA	1	679	
60	TCGA-YL-A8S9	0	2	0	0	1	1	0	0	1	25	1	1	2	8	0	0	TCGA-YL-A8S9-01	108	0.12336164465549455	52	TCGA-YL-A8S9-01	4	5	42	0.07484206959619309	TCGA-YL-A8S9-01	5	3	4	12	PASS	8322	TCGA-YL-A8S9	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-23204	Alive	NA	1842	NA	NA	Locoregional Recurrence	NA	NA	1006	Stable Disease	NA	NA	0	1842	0	1842	NA	NA	1	1006	
70	TCGA-YL-A8SA	0	1	0	0	1	0	0	0	0	23	1	0	1	12	0	0	TCGA-YL-A8SA-01	131	0.0816218984516872	74	TCGA-YL-A8SA-01	1	1	65	0.08549236334895799	TCGA-YL-A8SA-01	3	7	4	14	PASS	8323	TCGA-YL-A8SA	PRAD	69	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-25340	Alive	NA	512	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	512	0	512	NA	NA	0	512	
60	TCGA-YL-A8SB	0	1	0	2	3	0	0	1	1	19	2	0	0	6	0	0	TCGA-YL-A8SB-01	66	0.2026664631165933	23	TCGA-YL-A8SB-01	4	3	35	0.06859488924377634	TCGA-YL-A8SB-01	3	2	4	9	PASS	8324	TCGA-YL-A8SB	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-22991	Alive	WITH TUMOR	1719	NA	NA	Biochemical evidence of disease	NA	NA	1384	Stable Disease	NA	NA	0	1719	0	1719	NA	NA	1	1384	
70	TCGA-YL-A8SC	1	1	0	1	1	0	0	0	1	31	4	0	0	12	1	0	TCGA-YL-A8SC-01	130	0.19578331647474626	76	TCGA-YL-A8SC-01	6	5	60	0.10057059791545056	TCGA-YL-A8SC-01	3	2	5	10	PASS	8325	TCGA-YL-A8SC	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-24206	Alive	WITH TUMOR	1261	NA	NA	Biochemical evidence of disease	NA	NA	152	Partial Remission/Response	NA	NA	0	1261	0	1261	NA	NA	1	152	
60	TCGA-YL-A8SF	0	1	0	0	0	0	0	0	1	13	0	0	0	5	0	0	TCGA-YL-A8SF-01	157	0.14357787403802744	96	TCGA-YL-A8SF-01	3	4	89	0.102059722255085	TCGA-YL-A8SF-01	3	10	4	17	PASS	8326	TCGA-YL-A8SF	PRAD	62	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-22844	Alive	NA	1373	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1373	0	1373	NA	NA	0	1373	
70	TCGA-YL-A8SH	0	0	0	0	1	0	0	0	1	31	0	0	0	6	0	0	TCGA-YL-A8SH-01	243	0.07030844479105487	180	TCGA-YL-A8SH-01	0	3	97	0.09197771366960222	TCGA-YL-A8SH-01	0	9	5	14	PASS	8327	TCGA-YL-A8SH	PRAD	69	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-25395	Dead	TUMOR FREE	NA	875	"Other, non-malignant disease"	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	875	0	875	0	875	0	875	
70	TCGA-YL-A8SI	0	0	0	0	1	0	0	0	0	19	1	0	1	4	0	0	TCGA-YL-A8SI-01	46	0.014605507038224554	16	TCGA-YL-A8SI-01	0	0	21	0.03050837484073945	TCGA-YL-A8SI-01	0	4	1	5	PASS	8328	TCGA-YL-A8SI	PRAD	69	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-25292	Alive	TUMOR FREE	1614	NA	NA	Biochemical evidence of disease	NA	NA	1423	Complete Remission/Response	NA	NA	0	1614	0	1614	1	1423	1	1423	
60	TCGA-YL-A8SJ	0	0	0	0	0	1	0	0	0	23	2	0	0	11	0	0	TCGA-YL-A8SJ-01	93	0.3051564943198683	40	TCGA-YL-A8SJ-01	2	4	59	0.10711460166665462	TCGA-YL-A8SJ-01	5	8	6	19	PASS	8329	TCGA-YL-A8SJ	PRAD	60	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-21916	Alive	WITH TUMOR	1395	NA	NA	Biochemical evidence of disease	NA	NA	752	Complete Remission/Response	NA	NA	0	1395	0	1395	1	752	1	752	
70	TCGA-YL-A8SK	1	0	0	2	2	0	0	0	0	26	2	0	1	11	0	0	TCGA-YL-A8SK-01	143	0.22538163096121025	89	TCGA-YL-A8SK-01	3	5	61	0.10240975260725001	TCGA-YL-A8SK-01	7	9	6	22	PASS	8330	TCGA-YL-A8SK	PRAD	67	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-24759	Alive	NA	1408	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1408	0	1408	NA	NA	0	1408	
70	TCGA-YL-A8SL	0	0	0	3	2	0	1	0	1	34	2	0	0	8	0	0	TCGA-YL-A8SL-01	162	0.9476952423915244	104	TCGA-YL-A8SL-01	13	14	56	0.09216341024211193	TCGA-YL-A8SL-01	8	15	3	26	PASS	8331	TCGA-YL-A8SL	PRAD	74	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-27033	Alive	TUMOR FREE	987	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	987	0	987	0	987	0	987	
60	TCGA-YL-A8SO	0	1	1	0	1	1	0	0	1	26	3	0	0	14	0	0	TCGA-YL-A8SO-01	330	0.26416782116202897	261	TCGA-YL-A8SO-01	4	6	137	0.13000014605358226	TCGA-YL-A8SO-01	5	13	8	26	PASS	8332	TCGA-YL-A8SO	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2004	NA	-23584	Alive	NA	3479	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	3479	0	3479	NA	NA	0	3479	
60	TCGA-YL-A8SP	0	1	0	2	0	0	0	0	0	19	1	0	0	10	0	0	TCGA-YL-A8SP-01	177	0.10461896234888712	111	TCGA-YL-A8SP-01	2	4	76	0.07336323392059899	TCGA-YL-A8SP-01	5	5	5	15	PASS	8333	TCGA-YL-A8SP	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-21455	Alive	WITH TUMOR	2366	NA	NA	Biochemical evidence of disease	NA	NA	2036	Stable Disease	NA	NA	0	2366	0	2366	NA	NA	1	2036	
60	TCGA-YL-A8SQ	0	4	0	0	3	1	1	0	0	28	0	0	0	10	0	0	TCGA-YL-A8SQ-01	191	0.598243213975595	133	TCGA-YL-A8SQ-01	20	19	68	0.072812363999007	TCGA-YL-A8SQ-01	10	11	3	24	PASS	8334	TCGA-YL-A8SQ	PRAD	61	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-22482	Alive	WITH TUMOR	2083	NA	NA	Biochemical evidence of disease	NA	NA	329	Stable Disease	NA	NA	0	2083	0	2083	NA	NA	1	329	
60	TCGA-YL-A8SR	0	1	0	1	1	1	0	0	1	21	2	0	0	3	0	0	TCGA-YL-A8SR-01	232	0.2575307852063781	172	TCGA-YL-A8SR-01	4	3	106	0.12452792156882166	TCGA-YL-A8SR-01	3	10	8	21	PASS	8335	TCGA-YL-A8SR	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-23488	Alive	NA	273	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	273	0	273	NA	NA	0	273	
70	TCGA-YL-A9WH	0	1	0	2	1	0	0	0	0	42	3	0	0	21	3	0	TCGA-YL-A9WH-01	129	0.6339143841521911	65	TCGA-YL-A9WH-01	20	21	63	0.12196043690725705	TCGA-YL-A9WH-01	10	12	8	30	PASS	8336	TCGA-YL-A9WH	PRAD	67	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-24755	Alive	NA	427	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	427	0	427	NA	NA	0	427	
60	TCGA-YL-A9WI	0	2	0	0	2	0	0	0	1	32	1	0	2	12	0	0	TCGA-YL-A9WI-01	443	0.38800084847967975	363	TCGA-YL-A9WI-01	11	11	166	0.1313439778303916	TCGA-YL-A9WI-01	3	12	6	21	PASS	8337	TCGA-YL-A9WI	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-23184	Alive	TUMOR FREE	1623	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1623	0	1623	NA	NA	0	1623	
50	TCGA-YL-A9WJ	0	0	0	0	0	0	1	0	0	18	3	0	0	5	0	0	TCGA-YL-A9WJ-01	96	0.0873297541940111	49	TCGA-YL-A9WJ-01	2	2	45	0.06003754186565372	TCGA-YL-A9WJ-01	3	5	6	14	PASS	8338	TCGA-YL-A9WJ	PRAD	47	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-17322	Dead	WITH TUMOR	NA	1855	Prostate Cancer	Distant Metastasis	"Other, specify"	Neck	1476	Progressive Disease	NA	NA	1	1855	1	1855	NA	NA	1	1476	
60	TCGA-YL-A9WK	0	1	0	0	1	0	0	0	2	24	2	0	0	7	0	0	TCGA-YL-A9WK-01	184	0.346576600556958	128	TCGA-YL-A9WK-01	7	8	84	0.14675047542560254	TCGA-YL-A9WK-01	5	3	5	13	PASS	8339	TCGA-YL-A9WK	PRAD	63	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2008	NA	-23272	Alive	WITH TUMOR	2136	NA	NA	Biochemical evidence of disease	NA	NA	1009	Stable Disease	NA	NA	0	2136	0	2136	NA	NA	1	1009	
60	TCGA-YL-A9WL	0	3	0	2	0	0	0	0	1	22	0	0	0	5	3	0	TCGA-YL-A9WL-01	200	0.8142555424322561	118	TCGA-YL-A9WL-01	1	3	88	0.1403343461447588	TCGA-YL-A9WL-01	5	10	8	23	PASS	8340	TCGA-YL-A9WL	PRAD	59	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21626	Alive	WITH TUMOR	740	NA	NA	Biochemical evidence of disease	NA	NA	740	Complete Remission/Response	NA	NA	0	740	0	740	1	740	1	740	
70	TCGA-YL-A9WX	0	0	0	1	0	0	0	0	0	4	0	0	0	7	1	0	TCGA-YL-A9WX-01	56	0.03504919712667761	15	TCGA-YL-A9WX-01	2	5	36	0.08467500739766418	TCGA-YL-A9WX-01	3	4	6	13	PASS	8341	TCGA-YL-A9WX	PRAD	68	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2009	NA	-25008	Alive	WITH TUMOR	1518	NA	NA	Biochemical evidence of disease	NA	NA	1506	Stable Disease	NA	NA	0	1518	0	1518	NA	NA	1	1506	
60	TCGA-YL-A9WY	0	1	0	1	0	0	0	0	0	29	0	0	0	10	0	0	TCGA-YL-A9WY-01	161	0.18794697675723834	92	TCGA-YL-A9WY-01	12	12	56	0.11707868655957475	TCGA-YL-A9WY-01	12	13	7	32	PASS	8342	TCGA-YL-A9WY	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21164	Alive	WITH TUMOR	1098	NA	NA	Biochemical evidence of disease	NA	NA	765	Stable Disease	NA	NA	0	1098	0	1098	NA	NA	1	765	
70	TCGA-ZG-A8QW	0	1	0	1	0	2	0	0	0	25	0	0	1	15	1	0	TCGA-ZG-A8QW-01	119	0.0134233129165302	63	TCGA-ZG-A8QW-01	1	2	85	0.05321558579529585	TCGA-ZG-A8QW-01	1	4	2	7	PASS	8343	TCGA-ZG-A8QW	PRAD	72	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-26632	Alive	TUMOR FREE	94	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	94	0	94	NA	NA	0	94	
60	TCGA-ZG-A8QX	0	0	0	0	1	0	0	0	0	24	0	0	1	8	2	0	TCGA-ZG-A8QX-01	107	0.0890151753816208	57	TCGA-ZG-A8QX-01	0	0	39	0.0507968741292545	TCGA-ZG-A8QX-01	0	7	4	11	PASS	8344	TCGA-ZG-A8QX	PRAD	56	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-20683	Alive	TUMOR FREE	442	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	442	0	442	NA	NA	0	442	
70	TCGA-ZG-A8QY	0	5	1	2	5	0	1	0	2	39	2	0	1	14	4	0	TCGA-ZG-A8QY-01	327	0.12751850698806966	242	TCGA-ZG-A8QY-01	0	1	122	0.12014962847744234	TCGA-ZG-A8QY-01	0	15	10	25	PASS	8345	TCGA-ZG-A8QY	PRAD	67	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-24731	Alive	WITH TUMOR	404	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	404	0	404	NA	NA	0	404	
70	TCGA-ZG-A8QZ	1	0	0	0	1	0	0	0	0	22	2	0	0	9	0	0	TCGA-ZG-A8QZ-01	136	0.09635887001461728	77	TCGA-ZG-A8QZ-01	2	1	53	0.04271536634935797	TCGA-ZG-A8QZ-01	0	5	2	7	PASS	8346	TCGA-ZG-A8QZ	PRAD	65	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-23980	Alive	TUMOR FREE	308	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	308	0	308	NA	NA	0	308	
70	TCGA-ZG-A9KY	0	4	1	0	5	5	0	0	1	42	2	0	0	19	1	0	TCGA-ZG-A9KY-01	577	0.3467161238087135	430	TCGA-ZG-A9KY-01	5	3	94	0.13621918530521065	TCGA-ZG-A9KY-01	13	4	7	24	PASS	8347	TCGA-ZG-A9KY	PRAD	73	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-27000	Alive	NA	130	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	130	0	130	NA	NA	0	130	
70	TCGA-ZG-A9L0	0	1	0	2	3	0	0	0	2	30	2	0	0	9	0	0	TCGA-ZG-A9L0-01	488	0.6545590707728249	401	TCGA-ZG-A9L0-01	4	6	194	0.21090780025333172	TCGA-ZG-A9L0-01	3	13	14	30	PASS	8348	TCGA-ZG-A9L0	PRAD	71	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-26055	Alive	TUMOR FREE	355	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	355	0	355	NA	NA	0	355	
70	TCGA-ZG-A9L1	0	2	0	3	2	1	0	0	0	19	1	0	1	9	0	1	TCGA-ZG-A9L1-01	127	0.8652670508050175	67	TCGA-ZG-A9L1-01	12	13	57	0.08966093301557039	TCGA-ZG-A9L1-01	7	9	4	20	PASS	8349	TCGA-ZG-A9L1	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2010	NA	-24214	Alive	WITH TUMOR	1302	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1302	0	1302	NA	NA	0	1302	
70	TCGA-ZG-A9L2	0	0	1	0	1	3	0	0	1	20	1	0	0	4	0	0	TCGA-ZG-A9L2-01	118	0.09775189790627016	63	TCGA-ZG-A9L2-01	3	2	48	0.07999537391006625	TCGA-ZG-A9L2-01	4	6	3	13	PASS	8350	TCGA-ZG-A9L2	PRAD	70	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-25573	Alive	WITH TUMOR	1154	NA	NA	Biochemical evidence of disease	NA	NA	180	Stable Disease	NA	NA	0	1154	0	1154	NA	NA	1	180	
60	TCGA-ZG-A9L4	0	1	0	0	0	0	0	0	0	21	2	0	0	7	1	0	TCGA-ZG-A9L4-01	55	0.04980208139681392	17	TCGA-ZG-A9L4-01	2	3	23	0.06909714163533938	TCGA-ZG-A9L4-01	3	3	4	10	PASS	8351	TCGA-ZG-A9L4	PRAD	61	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-22388	Alive	NA	1108	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1108	0	1108	NA	NA	0	1108	
60	TCGA-ZG-A9L5	0	1	2	0	1	1	0	0	1	36	3	0	0	14	1	0	TCGA-ZG-A9L5-01	129	0.6749391742911548	59	TCGA-ZG-A9L5-01	16	24	26	0.04168740584255454	TCGA-ZG-A9L5-01	12	16	2	30	PASS	8352	TCGA-ZG-A9L5	PRAD	58	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-21293	Alive	WITH TUMOR	908	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	908	0	908	NA	NA	0	908	
60	TCGA-ZG-A9L6	0	2	0	1	1	0	0	0	1	24	0	0	1	14	1	0	TCGA-ZG-A9L6-01	138	0.07945856452591184	78	TCGA-ZG-A9L6-01	1	1	53	0.05383028242595171	TCGA-ZG-A9L6-01	1	5	3	9	PASS	8353	TCGA-ZG-A9L6	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-23681	Alive	WITH TUMOR	687	NA	NA	Biochemical evidence of disease	NA	NA	664	Partial Remission/Response	NA	NA	0	687	0	687	NA	NA	1	664	
60	TCGA-ZG-A9L9	1	1	0	1	0	0	0	0	1	32	0	0	1	12	1	0	TCGA-ZG-A9L9-01	235	0.5749744796021612	144	TCGA-ZG-A9L9-01	12	16	89	0.1270633582254506	TCGA-ZG-A9L9-01	13	15	5	33	RNA degradation	8354	TCGA-ZG-A9L9	PRAD	60	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-22108	Alive	WITH TUMOR	617	NA	NA	Biochemical evidence of disease	NA	NA	51	Progressive Disease	NA	NA	0	617	0	617	NA	NA	1	51	
70	TCGA-ZG-A9LB	0	0	0	2	0	0	1	0	2	46	3	0	1	14	0	0	TCGA-ZG-A9LB-01	105	0.6327032764381839	53	TCGA-ZG-A9LB-01	19	26	44	0.1052498262078922	TCGA-ZG-A9LB-01	11	4	4	19	RNA degradation	8355	TCGA-ZG-A9LB	PRAD	72	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-26447	Alive	WITH TUMOR	583	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	583	0	583	NA	NA	0	583	
70	TCGA-ZG-A9LM	0	0	0	0	1	0	1	0	0	21	7	0	1	10	0	0	TCGA-ZG-A9LM-01	149	0.6667830577646557	77	TCGA-ZG-A9LM-01	11	11	110	0.21924813546204064	TCGA-ZG-A9LM-01	6	8	8	22	RNA degradation	8356	TCGA-ZG-A9LM	PRAD	72	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-26377	Alive	TUMOR FREE	378	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	378	0	378	0	378	0	378	
60	TCGA-ZG-A9LN	0	1	0	0	2	0	0	0	1	26	3	0	1	13	1	0	TCGA-ZG-A9LN-01	556	0.15730527102580702	399	TCGA-ZG-A9LN-01	1	1	35	0.011601772585220308	TCGA-ZG-A9LN-01	7	7	0	14	PASS	8357	TCGA-ZG-A9LN	PRAD	57	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-21050	Alive	WITH TUMOR	115	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	115	0	115	NA	NA	0	115	
60	TCGA-ZG-A9LS	0	1	0	2	1	0	1	0	3	14	0	0	0	5	1	0	TCGA-ZG-A9LS-01	102	0.27909961791320714	48	TCGA-ZG-A9LS-01	7	11	57	0.13288801658482366	TCGA-ZG-A9LS-01	8	8	8	24	PASS	8358	TCGA-ZG-A9LS	PRAD	64	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-23540	Alive	TUMOR FREE	516	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	516	0	516	0	516	0	516	
70	TCGA-ZG-A9LU	0	2	0	0	1	0	0	0	1	13	3	0	0	11	0	0	TCGA-ZG-A9LU-01	90	0.21950759268341785	36	TCGA-ZG-A9LU-01	13	17	84	0.2832026786121665	TCGA-ZG-A9LU-01	10	12	11	33	RNA degradation	8359	TCGA-ZG-A9LU	PRAD	67	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-24742	Alive	WITH TUMOR	579	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	579	0	579	NA	NA	0	579	
60	TCGA-ZG-A9LY	0	2	0	1	1	0	0	0	1	28	2	0	0	7	1	1	TCGA-ZG-A9LY-01	156	0.18690357953566125	91	TCGA-ZG-A9LY-01	4	5	70	0.0715870891007256	TCGA-ZG-A9LY-01	8	11	3	22	PASS	8360	TCGA-ZG-A9LY	PRAD	60	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-21942	Alive	TUMOR FREE	370	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	370	0	370	0	370	0	370	
70	TCGA-ZG-A9LZ	0	0	0	1	0	0	0	0	1	26	3	0	0	9	0	0	TCGA-ZG-A9LZ-01	185	0.5457091430150559	123	TCGA-ZG-A9LZ-01	3	6	100	0.14053149662839445	TCGA-ZG-A9LZ-01	7	5	6	18	PASS	8361	TCGA-ZG-A9LZ	PRAD	66	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2011	NA	-24132	Alive	WITH TUMOR	692	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	692	0	692	NA	NA	0	692	
70	TCGA-ZG-A9M4	0	0	1	1	2	0	1	0	1	23	4	0	0	11	1	0	TCGA-ZG-A9M4-01	232	0.8670059951801372	145	TCGA-ZG-A9M4-01	20	23	59	0.14539121256880652	TCGA-ZG-A9M4-01	14	16	11	41	PASS	8362	TCGA-ZG-A9M4	PRAD	65	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-24030	Alive	WITH TUMOR	547	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	547	0	547	NA	NA	0	547	
70	TCGA-ZG-A9MC	0	1	0	0	1	0	0	0	0	26	1	0	0	5	0	0	TCGA-ZG-A9MC-01	71	0.0882100469065101	25	TCGA-ZG-A9MC-01	2	4	49	0.0852448964511625	TCGA-ZG-A9MC-01	6	7	7	20	PASS	8363	TCGA-ZG-A9MC	PRAD	69	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2012	NA	-25477	Alive	WITH TUMOR	455	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	455	0	455	NA	NA	0	455	
70	TCGA-ZG-A9N3	0	1	0	1	1	0	2	0	6	43	0	0	0	23	0	0	TCGA-ZG-A9N3-01	225	0.5979515256948987	133	TCGA-ZG-A9N3-01	18	35	102	0.1812473400539632	TCGA-ZG-A9N3-01	15	14	10	39	PASS	8364	TCGA-ZG-A9N3	PRAD	73	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-26902	Alive	WITH TUMOR	349	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	349	0	349	NA	NA	0	349	
60	TCGA-ZG-A9ND	0	0	0	0	5	0	0	0	4	17	2	0	0	4	0	0	TCGA-ZG-A9ND-01	316	0.5465073437613619	247	TCGA-ZG-A9ND-01	2	4	135	0.1371527207685348	TCGA-ZG-A9ND-01	3	7	9	19	PASS	8365	TCGA-ZG-A9ND	PRAD	55	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-20428	Alive	TUMOR FREE	410	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	410	0	410	0	410	0	410	
70	TCGA-ZG-A9NI	0	1	0	0	1	1	0	0	3	69	5	1	0	20	4	0	TCGA-ZG-A9NI-01	75	0.3986007832016764	25	TCGA-ZG-A9NI-01	7	14	33	0.06929453704835133	TCGA-ZG-A9NI-01	19	21	5	45	PASS	8366	TCGA-ZG-A9NI	PRAD	73	MALE	NA	NA	NA	Prostate Adenocarcinoma Acinar Type	NA	2013	NA	-26697	Alive	TUMOR FREE	132	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	132	0	132	0	132	0	132	
60	TCGA-AF-2687	0	10	0	2	0	0	1	0	3	89	5	0	0	31	0	0	TCGA-AF-2687-01	174	0.6386293097009552	115	TCGA-AF-2687-01	24	33	13	0.10926877977915224	TCGA-AF-2687-01	4	7	1	12	PASS	8367	TCGA-AF-2687	READ	57	MALE	WHITE	Stage IIIC	NA	Rectal Adenocarcinoma	NA	2009	NA	-21098	Alive	TUMOR FREE	1427	NA	NA	NA	NA	NA	1267	Complete Remission/Response	NA	NA	0	1427	0	1427	1	1267	1	1267	
40	TCGA-AF-2689	0	4	0	4	0	0	0	0	4	42	6	0	2	21	4	0	TCGA-AF-2689-01	173	0.4763695546314404	89	TCGA-AF-2689-01	18	17	25	0.18012887050851106	TCGA-AF-2689-01	6	5	3	14	mutation call filter	8368	TCGA-AF-2689	READ	41	FEMALE	WHITE	Stage IV	NA	Rectal Adenocarcinoma	NA	2009	NA	-15082	Dead	WITH TUMOR	NA	1201	NA	NA	NA	NA	301	NA	NA	NA	1	1201	1	1201	NA	NA	1	301	
80	TCGA-AF-2690	0	3	3	0	1	0	0	0	0	60	7	0	2	30	1	0	TCGA-AF-2690-01	196	0.5622798602107189	123	TCGA-AF-2690-01	25	28	23	0.2776022559474003	TCGA-AF-2690-01	8	4	3	15	PASS	8369	TCGA-AF-2690	READ	76	FEMALE	WHITE	Stage IIIC	NA	Rectal Adenocarcinoma	NA	2009	NA	-28119	Dead	TUMOR FREE	NA	524	NA	NA	NA	NA	NA	NA	NA	NA	1	524	0	524	NA	NA	0	524	
50	TCGA-AF-2691	0	6	0	5	0	0	0	0	4	57	4	0	0	14	6	0	TCGA-AF-2691-01	129	0.458679750982231	67	TCGA-AF-2691-01	11	13	14	0.2499563766609345	TCGA-AF-2691-01	6	4	7	17	mutation call filter	8370	TCGA-AF-2691	READ	48	FEMALE	WHITE	Stage I	NA	Rectal Adenocarcinoma	NA	2009	NA	-17759	Alive	TUMOR FREE	1309	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1309	0	1309	0	1309	0	1309	
50	TCGA-AF-2692	0	2	0	0	0	0	0	2	0	18	2	0	0	22	0	0	TCGA-AF-2692-01	180	0.9174328515885268	99	TCGA-AF-2692-01	16	35	8	0.13619456206821692	TCGA-AF-2692-01	8	9	3	20	mutation call filter	8371	TCGA-AF-2692	READ	54	FEMALE	WHITE	Stage IIA	NA	NA	NA	2009	NA	-19830	Alive	WITH TUMOR	412	NA	NA	Metastatic	NA	NA	327	NA	NA	NA	0	412	0	412	NA	NA	1	327	
80	TCGA-AF-2693	0	10	3	5	0	0	0	0	8	66	7	0	1	31	6	0	TCGA-AF-2693-01	275	0.4893533516315094	171	TCGA-AF-2693-01	8	9	39	0.21637275431143035	TCGA-AF-2693-01	9	5	8	22	PASS	8372	TCGA-AF-2693	READ	75	MALE	WHITE	Stage I	NA	NA	NA	2009	NA	-27443	Alive	TUMOR FREE	1155	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1155	0	1155	NA	NA	0	1155	
50	TCGA-AF-3400	0	1	0	0	2	0	0	0	4	34	0	0	0	10	0	2	TCGA-AF-3400-01	103	0.32253695680882344	44	TCGA-AF-3400-01	21	28	18	0.23201703818572	TCGA-AF-3400-01	6	4	3	13	mutation call filter	8373	TCGA-AF-3400	READ	54	MALE	WHITE	Stage IIA	NA	Rectal Mucinous Adenocarcinoma	NA	2009	NA	-19826	Alive	TUMOR FREE	1049	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1049	0	1049	NA	NA	0	1049	
50	TCGA-AF-3911	1	7	0	2	1	1	0	0	2	71	7	0	2	35	0	0	TCGA-AF-3911-01	188	0.4699850759681158	110	TCGA-AF-3911-01	20	37	18	0.11953973443677528	TCGA-AF-3911-01	12	3	5	20	PASS	8374	TCGA-AF-3911	READ	48	MALE	WHITE	Stage IIIC	NA	Rectal Adenocarcinoma	NA	2009	NA	-17609	Alive	WITH TUMOR	1148	NA	NA	NA	NA	NA	695	Complete Remission/Response	NA	NA	0	1148	0	1148	1	695	1	695	
60	TCGA-AF-3913	0	11	1	2	2	1	0	0	11	79	9	0	2	40	3	0	TCGA-AF-3913	0	0	0	TCGA-AF-3913	0	0	0	0	TCGA-AF-3913-01	8	4	9	21	mutation call filter	8375	TCGA-AF-3913	READ	60	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	Rectal Adenocarcinoma	NA	2009	NA	-21970	Dead	WITH TUMOR	NA	316	NA	NA	NA	NA	NA	NA	NA	NA	1	316	1	316	NA	NA	1	316	
40	TCGA-AF-3914	1	10	1	6	0	1	0	0	7	109	3	0	2	40	1	0	TCGA-AF-3914	0	0	0	TCGA-AF-3914	0	0	0	0	TCGA-AF-3914	0	0	0	0	mutation call filter	8376	TCGA-AF-3914	READ	39	MALE	WHITE	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2010	NA	-14426	Alive	WITH TUMOR	1146	NA	NA	Locoregional Disease	NA	NA	846	Complete Remission/Response	NA	NA	0	1146	0	1146	1	846	1	846	
80	TCGA-AF-4110	0	10	1	4	0	3	0	0	1	75	5	0	0	34	2	0	TCGA-AF-4110-01	179	0.6025553936508921	115	TCGA-AF-4110-01	23	22	38	0.17838792735560485	TCGA-AF-4110-01	9	7	7	23	PASS	8377	TCGA-AF-4110	READ	77	MALE	WHITE	Stage IVA	NA	NA	NA	2010	NA	-28289	Alive	TUMOR FREE	912	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	912	0	912	NA	NA	0	912	
70	TCGA-AF-5654	2	17	4	8	2	2	2	0	8	217	14	0	4	85	2	0	TCGA-AF-5654-01	139	0.22278916731295825	67	TCGA-AF-5654-01	8	6	17	0.03490611160340152	TCGA-AF-5654-01	1	1	1	3	PASS	8378	TCGA-AF-5654	READ	73	FEMALE	WHITE	Stage I	NA	Rectal Adenocarcinoma	NA	2010	NA	-26738	Dead	TUMOR FREE	NA	512	NA	NA	NA	NA	NA	NA	NA	NA	1	512	0	512	NA	NA	0	512	
70	TCGA-AF-6136	0	7	1	4	2	2	0	0	7	97	6	0	2	47	1	0	TCGA-AF-6136-01	80	0.6887940989572532	35	TCGA-AF-6136-01	27	28	14	0.2369460190981065	TCGA-AF-6136-01	9	4	7	20	PASS	8379	TCGA-AF-6136	READ	72	FEMALE	WHITE	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2011	NA	-26490	Alive	WITH TUMOR	741	NA	NA	NA	NA	NA	199	Progressive Disease	NA	NA	0	741	0	741	NA	NA	1	199	
70	TCGA-AF-6655	1	5	0	5	5	0	1	0	2	57	2	0	1	20	0	0	TCGA-AF-6655-01	107	0.6534035603333401	53	TCGA-AF-6655-01	19	20	20	0.1912477084910005	TCGA-AF-6655-01	5	2	3	10	PASS	8380	TCGA-AF-6655	READ	66	MALE	WHITE	Stage IIIA	NA	Rectal Adenocarcinoma	NA	2010	NA	-24417	Alive	TUMOR FREE	609	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	609	0	609	0	609	0	609	
40	TCGA-AF-6672	0	3	0	4	1	2	1	0	5	68	3	0	5	26	1	0	TCGA-AF-6672-01	165	0.5115769677537049	99	TCGA-AF-6672-01	21	28	23	0.10512559886479414	TCGA-AF-6672-01	11	6	5	22	PASS	8381	TCGA-AF-6672	READ	43	MALE	WHITE	Stage IV	NA	Rectal Adenocarcinoma	NA	2011	NA	-15965	Alive	WITH TUMOR	748	NA	NA	Metastatic	NA	NA	279	Progressive Disease	NA	NA	0	748	0	748	NA	NA	1	279	
60	TCGA-AF-A56K	0	11	0	5	1	0	1	0	4	73	10	0	3	26	1	0	TCGA-AF-A56K-01	142	0.43450353665936414	83	TCGA-AF-A56K-01	14	29	59	0.18401515528662094	TCGA-AF-A56K-01	10	7	4	21	PASS	8382	TCGA-AF-A56K	READ	56	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Rectal Adenocarcinoma	NA	2006	NA	-20527	Alive	TUMOR FREE	2635	NA	NA	Locoregional Disease	NA	NA	1217	Complete Remission/Response	NA	NA	0	2635	0	2635	1	1217	1	1217	
50	TCGA-AF-A56L	1	12	2	8	0	1	0	1	2	103	9	0	5	39	1	0	TCGA-AF-A56L-01	185	0.7024627426540524	117	TCGA-AF-A56L-01	20	20	46	0.14737806966974895	TCGA-AF-A56L-01	5	5	2	12	PASS	8383	TCGA-AF-A56L	READ	48	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	Rectal Adenocarcinoma	NA	2008	NA	-17734	Alive	TUMOR FREE	2007	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2007	0	2007	0	2007	0	2007	
50	TCGA-AF-A56N	3	23	0	9	2	2	1	0	7	108	9	0	3	47	5	0	TCGA-AF-A56N-01	162	0.24271238868540526	105	TCGA-AF-A56N-01	6	11	72	0.2151816527609621	TCGA-AF-A56N-01	6	3	3	12	PASS	8384	TCGA-AF-A56N	READ	47	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	Rectal Adenocarcinoma	NA	2012	NA	-17480	Alive	TUMOR FREE	360	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	360	0	360	0	360	0	360	
90	TCGA-AG-3574	0	4	0	2	0	1	0	0	1	10	0	0	0	4	0	0	TCGA-AG-3574-01	93	0.24083651364609385	47	TCGA-AG-3574-01	10	6	8	0.040199142561504135	TCGA-AG-3574-01	1	0	1	2	mutation call filter	8385	TCGA-AG-3574	READ	89	FEMALE	NA	Stage II	NA	Rectal Adenocarcinoma	NA	2005	NA	-32781	Dead	WITH TUMOR	NA	1096	NA	NA	NA	NA	NA	NA	NA	NA	1	1096	1	1096	NA	NA	1	1096	
50	TCGA-AG-3575	0	1	0	1	0	0	0	0	0	16	0	0	0	8	0	0	TCGA-AG-3575-01	120	0.22322266585783132	64	TCGA-AG-3575-01	8	10	14	0.1892926078586098	TCGA-AG-3575-01	4	2	3	9	mutation call filter	8386	TCGA-AG-3575	READ	51	MALE	NA	Stage II	NA	Rectal Adenocarcinoma	NA	2006	NA	-18932	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	365	0	365	NA	NA	0	365	
80	TCGA-AG-3578	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-3578-01	123	0.9469011798032869	59	TCGA-AG-3578-01	17	18	13	0.18294975560605994	TCGA-AG-3578-01	12	4	8	24	PASS	8387	TCGA-AG-3578	READ	76	FEMALE	NA	Stage IIA	NA	Rectal Mucinous Adenocarcinoma	NA	2007	NA	-27851	Alive	TUMOR FREE	974	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	974	0	974	NA	NA	0	974	
70	TCGA-AG-3580	0	0	0	0	0	0	0	0	0	14	0	0	0	8	1	0	TCGA-AG-3580-01	63	0.035267958973656026	19	TCGA-AG-3580-01	2	1	19	0.014668127495109257	TCGA-AG-3580-01	0	1	1	2	mutation call filter	8388	TCGA-AG-3580	READ	67	MALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2007	NA	-24775	Alive	TUMOR FREE	244	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	244	0	244	NA	NA	0	244	
60	TCGA-AG-3581	0	0	0	0	1	0	0	0	1	12	3	0	0	5	0	0	TCGA-AG-3581-01	125	0.25389101159062005	75	TCGA-AG-3581-01	12	9	18	0.14997020785254822	TCGA-AG-3581-01	4	3	3	10	mutation call filter	8389	TCGA-AG-3581	READ	63	MALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2007	NA	-23345	Alive	TUMOR FREE	215	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	215	0	215	NA	NA	0	215	
80	TCGA-AG-3582	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-3582-01	206	0.4200468014435361	120	TCGA-AG-3582-01	15	67	28	0.4327814497755023	TCGA-AG-3582-01	10	6	4	20	PASS	8390	TCGA-AG-3582	READ	75	MALE	NA	Stage IV	NA	Rectal Adenocarcinoma	NA	2007	NA	-27636	Dead	WITH TUMOR	NA	1096	NA	NA	NA	NA	NA	NA	NA	NA	1	1096	1	1096	NA	NA	1	1096	
70	TCGA-AG-3583	0	0	0	1	1	0	0	0	0	19	2	0	0	9	0	0	TCGA-AG-3583-01	124	0.2789249255266712	62	TCGA-AG-3583-01	11	10	8	0.09033822859251234	TCGA-AG-3583-01	2	1	2	5	mutation call filter	8391	TCGA-AG-3583	READ	66	MALE	NA	Stage IV	NA	Rectal Mucinous Adenocarcinoma	NA	2008	NA	-24107	Dead	WITH TUMOR	NA	610	NA	NA	NA	NA	NA	NA	NA	NA	1	610	1	610	NA	NA	1	610	
60	TCGA-AG-3584	0	1	0	1	0	0	0	0	0	19	1	0	0	6	0	0	TCGA-AG-3584-01	131	0.4529621071498834	62	TCGA-AG-3584-01	13	19	26	0.2992654222505039	TCGA-AG-3584-01	11	3	9	23	mutation call filter	8392	TCGA-AG-3584	READ	60	MALE	NA	Stage IV	NA	Rectal Adenocarcinoma	NA	2008	NA	-22189	Dead	WITH TUMOR	NA	730	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	730	1	730	NA	NA	1	730	
70	TCGA-AG-3586	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-3586-01	302	0.13334864160104254	220	TCGA-AG-3586-01	5	4	59	0.038473587679997055	TCGA-AG-3586-01	1	1	1	3	PASS	8393	TCGA-AG-3586	READ	72	FEMALE	NA	Stage III	NA	NA	NA	2006	NA	-26542	Alive	WITH TUMOR	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
70	TCGA-AG-3587	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-3587-01	220	0.8293182503378056	136	TCGA-AG-3587-01	22	73	11	0.19707018510116373	TCGA-AG-3587-01	14	14	4	32	PASS	8394	TCGA-AG-3587	READ	65	MALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2007	NA	-24075	Alive	TUMOR FREE	1400	NA	NA	NA	NA	NA	1216	[Unknown]	NA	NA	0	1400	0	1400	NA	NA	1	1216	
70	TCGA-AG-3591	2	11	1	2	2	2	0	0	2	61	6	0	2	25	0	0	TCGA-AG-3591-01	204	0.9104185115409814	138	TCGA-AG-3591-01	22	22	9	0.09301532096187133	TCGA-AG-3591-01	13	9	6	28	PASS	8395	TCGA-AG-3591	READ	66	FEMALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2007	NA	-24167	Alive	TUMOR FREE	1035	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1035	0	1035	0	1035	0	1035	
70	TCGA-AG-3592	1	32	0	6	1	4	1	0	7	219	18	0	2	77	7	0	TCGA-AG-3592-01	310	0.8596581956400117	214	TCGA-AG-3592-01	26	27	28	0.13025491625269586	TCGA-AG-3592-01	7	5	3	15	PASS	8396	TCGA-AG-3592	READ	68	MALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2007	NA	-25141	Alive	TUMOR FREE	1035	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1035	0	1035	NA	NA	0	1035	
70	TCGA-AG-3593	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-3593-01	240	0.8847177005251634	155	TCGA-AG-3593-01	25	24	25	0.17226833497147967	TCGA-AG-3593-01	8	1	4	13	PASS	8397	TCGA-AG-3593	READ	72	FEMALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2007	NA	-26480	Alive	TUMOR FREE	1035	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1035	0	1035	0	1035	0	1035	
80	TCGA-AG-3594	0	1	0	0	1	0	0	0	0	10	0	0	0	5	1	0	TCGA-AG-3594-01	211	0.2989807309244226	122	TCGA-AG-3594-01	9	11	41	0.2614396963539005	TCGA-AG-3594-01	6	6	7	19	mutation call filter	8398	TCGA-AG-3594	READ	77	MALE	NA	Stage IIA	NA	Rectal Mucinous Adenocarcinoma	NA	2007	NA	-28277	Dead	WITH TUMOR	NA	61	NA	NA	NA	NA	NA	NA	NA	NA	1	61	1	61	NA	NA	1	61	
70	TCGA-AG-3598	1	3	0	0	0	1	0	0	0	19	1	0	0	5	0	0	TCGA-AG-3598-01	138	0.19346678380646298	72	TCGA-AG-3598-01	7	6	14	0.0685963718847199	TCGA-AG-3598-01	3	5	0	8	mutation call filter	8399	TCGA-AG-3598	READ	69	MALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2007	NA	-25324	Alive	TUMOR FREE	1522	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1522	0	1522	NA	NA	0	1522	
70	TCGA-AG-3599	0	2	0	0	1	0	0	0	0	18	2	0	0	8	0	0	TCGA-AG-3599-01	91	0.0925530909136875	42	TCGA-AG-3599-01	3	2	4	0.028343358324259937	TCGA-AG-3599-01	1	1	1	3	mutation call filter	8400	TCGA-AG-3599	READ	70	MALE	NA	Stage I	NA	NA	NA	2007	NA	-25749	Alive	TUMOR FREE	366	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	366	0	366	NA	NA	0	366	
60	TCGA-AG-3600	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-3600-01	224	0.8809536856436828	131	TCGA-AG-3600-01	18	41	42	0.29367643826626194	TCGA-AG-3600-01	18	24	9	51	PASS	8401	TCGA-AG-3600	READ	62	MALE	NA	Stage IIIC	NA	Rectal Adenocarcinoma	NA	2007	NA	-22767	Alive	TUMOR FREE	184	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	184	0	184	0	184	0	184	
70	TCGA-AG-3601	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-3601-01	425	0.6661807454683296	290	TCGA-AG-3601-01	19	27	67	0.17810213678755973	TCGA-AG-3601-01	11	8	5	24	PASS	8402	TCGA-AG-3601	READ	68	MALE	NA	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2007	NA	-24837	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-AG-3602	0	1	0	1	0	1	0	0	0	14	0	0	0	2	0	0	TCGA-AG-3602-01	104	0.8124853762570047	45	TCGA-AG-3602-01	12	13	17	0.30894242776728753	TCGA-AG-3602-01	4	3	8	15	mutation call filter	8403	TCGA-AG-3602	READ	66	FEMALE	NA	Stage IIIC	NA	Rectal Adenocarcinoma	NA	2007	NA	-24350	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
90	TCGA-AG-3605	0	1	0	0	0	0	0	0	1	8	1	0	0	5	0	0	TCGA-AG-3605-01	143	0.21643299897740606	85	TCGA-AG-3605-01	9	8	18	0.1423699613496369	TCGA-AG-3605-01	5	4	4	13	mutation call filter	8404	TCGA-AG-3605	READ	85	FEMALE	NA	Stage IV	NA	Rectal Adenocarcinoma	NA	2008	NA	-31078	Alive	WITH TUMOR	30	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	30	0	30	NA	NA	0	30	
80	TCGA-AG-3608	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-3608-01	114	0.1312378968877671	65	TCGA-AG-3608-01	7	7	6	0.08467648475059103	TCGA-AG-3608-01	3	1	3	7	PASS	8405	TCGA-AG-3608	READ	79	FEMALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2008	NA	-29008	Alive	TUMOR FREE	485	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	485	0	485	NA	NA	0	485	
70	TCGA-AG-3609	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-3609-01	310	0.9807264111433209	193	TCGA-AG-3609-01	24	33	80	0.5111789709468153	TCGA-AG-3609-01	11	12	7	30	PASS	8406	TCGA-AG-3609	READ	65	FEMALE	NA	Stage IIIC	NA	Rectal Adenocarcinoma	NA	2008	NA	-23925	Alive	TUMOR FREE	608	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	608	0	608	0	608	0	608	
70	TCGA-AG-3611	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-3611	0	0	0	TCGA-AG-3611	0	0	0	0	TCGA-AG-3611-01	7	2	4	13	PASS	8407	TCGA-AG-3611	READ	72	MALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2009	NA	-26420	Alive	TUMOR FREE	424	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	424	0	424	0	424	0	424	
60	TCGA-AG-3612	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-3612	0	0	0	TCGA-AG-3612	0	0	0	0	TCGA-AG-3612-01	5	6	4	15	PASS	8408	TCGA-AG-3612	READ	55	FEMALE	NA	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2009	NA	-20242	Alive	TUMOR FREE	608	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	608	0	608	0	608	0	608	
90	TCGA-AG-3725	0	8	2	4	2	0	0	0	2	77	8	0	1	25	2	0	TCGA-AG-3725-01	102	0.5504764100049976	53	TCGA-AG-3725-01	21	67	13	0.3437867485661428	TCGA-AG-3725-01	7	5	4	16	PASS	8409	TCGA-AG-3725	READ	90	FEMALE	NA	Stage III	NA	Rectal Adenocarcinoma	NA	2005	NA	-32872	Alive	TUMOR FREE	638	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	638	0	638	NA	NA	0	638	
60	TCGA-AG-3726	1	10	0	9	3	3	5	1	4	118	6	0	2	37	7	0	TCGA-AG-3726-01	212	0.2250689439273296	150	TCGA-AG-3726-01	8	10	22	0.10188983489179188	TCGA-AG-3726-01	8	6	4	18	mutation call filter	8410	TCGA-AG-3726	READ	63	FEMALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2006	NA	-23345	Alive	TUMOR FREE	243	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	243	0	243	NA	NA	0	243	
80	TCGA-AG-3727	1	7	0	3	1	3	0	0	4	73	5	0	0	18	1	0	TCGA-AG-3727-01	163	0.2010997542805628	86	TCGA-AG-3727-01	6	10	19	0.16848117753152667	TCGA-AG-3727-01	9	11	8	28	mutation call filter	8411	TCGA-AG-3727	READ	78	FEMALE	NA	Stage III	NA	Rectal Adenocarcinoma	NA	2006	NA	-28641	Alive	WITH TUMOR	30	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	30	0	30	NA	NA	0	30	
70	TCGA-AG-3728	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-3728-01	130	0.5049546691517852	62	TCGA-AG-3728-01	20	36	40	0.31913266154508874	TCGA-AG-3728-01	7	3	4	14	PASS	8412	TCGA-AG-3728	READ	73	MALE	NA	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2006	NA	-26906	Alive	WITH TUMOR	912	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	912	0	912	0	912	0	912	
70	TCGA-AG-3731	0	12	0	5	4	1	3	0	3	114	11	0	4	47	1	0	TCGA-AG-3731-01	265	0.4276809167948559	166	TCGA-AG-3731-01	15	17	45	0.14743613770561206	TCGA-AG-3731-01	9	9	5	23	PASS	8413	TCGA-AG-3731	READ	65	MALE	NA	Stage IV	NA	Rectal Adenocarcinoma	NA	2004	NA	-23923	Alive	TUMOR FREE	1126	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1126	0	1126	NA	NA	0	1126	
80	TCGA-AG-3732	1	8	0	1	10	0	3	1	4	58	5	1	2	24	0	0	TCGA-AG-3732-01	128	0.875047428545937	67	TCGA-AG-3732-01	13	8	25	0.2993520214435699	TCGA-AG-3732-01	8	8	11	27	PASS	8414	TCGA-AG-3732	READ	78	FEMALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2005	NA	-28521	Alive	TUMOR FREE	1003	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1003	0	1003	0	1003	0	1003	
90	TCGA-AG-3742	0	5	0	4	4	1	0	1	5	119	6	0	5	48	2	0	TCGA-AG-3742-01	135	0.27295138481104764	70	TCGA-AG-3742-01	10	10	15	0.13863261169849206	TCGA-AG-3742-01	8	4	4	16	PASS	8415	TCGA-AG-3742	READ	85	FEMALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2004	NA	-31078	Alive	WITH TUMOR	30	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	30	0	30	NA	NA	0	30	
60	TCGA-AG-3878	0	7	0	4	3	2	0	0	5	79	13	0	0	20	0	0	TCGA-AG-3878-01	43	0.1440470231610292	6	TCGA-AG-3878-01	8	4	0	0.0	TCGA-AG-3878-01	0	0	0	0	mutation call filter	8416	TCGA-AG-3878	READ	64	MALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2007	NA	-23527	Alive	WITH TUMOR	30	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	30	0	30	NA	NA	0	30	
80	TCGA-AG-3881	0	16	1	6	3	0	0	0	7	97	7	0	4	41	2	0	TCGA-AG-3881-01	173	0.9521134933668272	94	TCGA-AG-3881-01	20	38	21	0.16684797624611972	TCGA-AG-3881-01	12	7	2	21	mutation call filter	8417	TCGA-AG-3881	READ	83	FEMALE	NA	Stage IIA	NA	NA	NA	2008	NA	-30467	Alive	TUMOR FREE	579	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	579	0	579	NA	NA	0	579	
70	TCGA-AG-3882	0	6	1	0	0	2	1	0	4	69	3	0	0	22	2	0	TCGA-AG-3882-01	244	0.4370160123965068	188	TCGA-AG-3882-01	15	29	46	0.14826926761707232	TCGA-AG-3882-01	4	3	2	9	mutation call filter	8418	TCGA-AG-3882	READ	66	FEMALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2008	NA	-24198	Alive	TUMOR FREE	608	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	608	0	608	NA	NA	0	608	
70	TCGA-AG-3883	0	11	0	3	1	1	2	1	8	102	6	0	4	37	2	0	TCGA-AG-3883-01	299	0.4784662336726535	192	TCGA-AG-3883-01	17	32	44	0.18745941761175167	TCGA-AG-3883-01	15	10	7	32	mutation call filter	8419	TCGA-AG-3883	READ	69	MALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2008	NA	-25415	Alive	WITH TUMOR	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
70	TCGA-AG-3885	1	6	1	1	4	2	1	0	4	74	4	0	2	28	2	0	TCGA-AG-3885-01	228	0.4796800133600298	150	TCGA-AG-3885-01	16	30	18	0.1519864855110608	TCGA-AG-3885-01	7	3	2	12	mutation call filter	8420	TCGA-AG-3885	READ	71	FEMALE	NA	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2008	NA	-26145	Alive	TUMOR FREE	546	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	546	0	546	0	546	0	546	
70	TCGA-AG-3887	0	12	0	3	2	1	0	1	1	57	3	0	2	21	2	0	TCGA-AG-3887-01	98	0.18545603021385432	44	TCGA-AG-3887-01	9	6	8	0.09582826139369806	TCGA-AG-3887-01	3	2	3	8	mutation call filter	8421	TCGA-AG-3887	READ	68	MALE	NA	Stage IIA	NA	Rectal Mucinous Adenocarcinoma	NA	2009	NA	-24960	Alive	WITH TUMOR	1124	NA	NA	NA	NA	NA	1064	NA	NA	NA	0	1124	0	1124	NA	NA	1	1064	
60	TCGA-AG-3890	1	13	0	4	2	2	0	0	6	87	0	0	0	29	0	1	TCGA-AG-3890-01	185	0.5011529418166446	125	TCGA-AG-3890-01	10	9	60	0.38811508561867103	TCGA-AG-3890-01	7	9	10	26	mutation call filter	8422	TCGA-AG-3890	READ	62	MALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2009	NA	-22950	Alive	TUMOR FREE	518	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	518	0	518	NA	NA	0	518	
70	TCGA-AG-3891	3	70	9	25	32	64	1	2	38	390	17	1	13	152	17	1	TCGA-AG-3891	0	0	0	TCGA-AG-3891	0	0	0	0	TCGA-AG-3891	0	0	0	0	mutation call filter	8423	TCGA-AG-3891	READ	66	FEMALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2009	NA	-24411	Alive	TUMOR FREE	548	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	548	0	548	NA	NA	0	548	
60	TCGA-AG-3892	25	363	9	69	4	4	0	0	107	2084	346	6	60	494	35	1	TCGA-AG-3892-01	49	0.00031827906911928287	14	TCGA-AG-3892-01	0	0	3	0.0002915360478379649	TCGA-AG-3892-01	0	0	0	0	mutation call filter	8424	TCGA-AG-3892	READ	57	FEMALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2009	NA	-20880	Alive	TUMOR FREE	396	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	396	0	396	0	396	0	396	
70	TCGA-AG-3893	0	6	2	2	3	2	0	0	5	106	3	0	3	42	2	0	TCGA-AG-3893-01	156	0.32696535272072474	72	TCGA-AG-3893-01	10	13	30	0.14033036225206433	TCGA-AG-3893-01	11	6	6	23	mutation call filter	8425	TCGA-AG-3893	READ	74	MALE	NA	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2009	NA	-27272	Alive	TUMOR FREE	1065	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1065	0	1065	0	1065	0	1065	
70	TCGA-AG-3894	2	11	1	1	3	0	1	0	6	77	7	0	1	33	0	0	TCGA-AG-3894-01	79	0.054762326731649866	31	TCGA-AG-3894-01	3	2	5	0.0004087813854368501	TCGA-AG-3894-01	0	0	0	0	mutation call filter	8426	TCGA-AG-3894	READ	65	MALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2009	NA	-23954	Alive	TUMOR FREE	426	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	426	0	426	0	426	0	426	
90	TCGA-AG-3896	0	11	1	5	0	0	1	1	2	99	6	0	2	30	3	0	TCGA-AG-3896-01	145	0.9009666759326176	76	TCGA-AG-3896-01	20	37	19	0.22140721648648248	TCGA-AG-3896-01	7	4	1	12	mutation call filter	8427	TCGA-AG-3896	READ	85	FEMALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2009	NA	-31046	Alive	WITH TUMOR	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
60	TCGA-AG-3898	0	8	0	2	2	2	0	0	7	84	6	0	3	43	3	0	TCGA-AG-3898-01	216	0.4321933982836393	138	TCGA-AG-3898-01	17	16	17	0.0580038893019099	TCGA-AG-3898-01	7	8	2	17	mutation call filter	8428	TCGA-AG-3898	READ	61	MALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2006	NA	-22492	Alive	WITH TUMOR	1461	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1461	0	1461	NA	NA	0	1461	
70	TCGA-AG-3901	0	6	0	1	1	2	0	1	5	47	3	0	0	23	0	0	TCGA-AG-3901-01	57	0.10298717877978014	17	TCGA-AG-3901-01	3	3	7	0.08620962455077907	TCGA-AG-3901-01	1	2	2	5	mutation call filter	8429	TCGA-AG-3901	READ	67	FEMALE	NA	Stage IIIB	NA	Rectal Mucinous Adenocarcinoma	NA	2007	NA	-24502	Alive	WITH TUMOR	761	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	761	0	761	NA	NA	0	761	
60	TCGA-AG-3902	2	15	0	2	1	1	2	0	5	95	15	0	1	40	5	0	TCGA-AG-3902-01	139	0.26898471546986663	74	TCGA-AG-3902-01	12	12	15	0.13842196257249467	TCGA-AG-3902-01	13	3	9	25	mutation call filter	8430	TCGA-AG-3902	READ	61	MALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2007	NA	-22492	Alive	TUMOR FREE	974	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	974	0	974	NA	NA	0	974	
70	TCGA-AG-3906	10	71	1	8	8	45	0	0	30	376	13	2	5	140	11	1	TCGA-AG-3906	0	0	0	TCGA-AG-3906	0	0	0	0	TCGA-AG-3906	0	0	0	0	mutation call filter	8431	TCGA-AG-3906	READ	67	FEMALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2008	NA	-24806	Alive	TUMOR FREE	608	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	608	0	608	NA	NA	0	608	
70	TCGA-AG-3909	0	6	0	1	4	1	0	0	1	62	4	0	3	17	1	0	TCGA-AG-3909-01	131	0.4578288591657077	69	TCGA-AG-3909-01	20	18	10	0.14815951018412518	TCGA-AG-3909-01	7	1	4	12	mutation call filter	8432	TCGA-AG-3909	READ	69	FEMALE	NA	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2008	NA	-25537	Alive	TUMOR FREE	608	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	608	0	608	0	608	0	608	
60	TCGA-AG-3999	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-3999-01	210	0.5893562626512454	118	TCGA-AG-3999-01	15	33	17	0.1637014029274083	TCGA-AG-3999-01	8	10	6	24	PASS	8433	TCGA-AG-3999	READ	61	FEMALE	NA	Stage IIIC	NA	Rectal Adenocarcinoma	NA	2008	NA	-22311	Alive	TUMOR FREE	853	NA	NA	NA	NA	NA	791	Progressive Disease	NA	NA	0	853	0	853	NA	NA	1	791	
70	TCGA-AG-4001	1	12	0	3	6	2	0	0	4	81	9	0	2	36	2	1	TCGA-AG-4001-01	126	0.6956962360788187	59	TCGA-AG-4001-01	21	30	10	0.13385045118679714	TCGA-AG-4001-01	10	7	3	20	mutation call filter	8434	TCGA-AG-4001	READ	74	FEMALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2009	NA	-27302	Alive	TUMOR FREE	1096	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1096	0	1096	NA	NA	0	1096	
60	TCGA-AG-4005	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-4005-01	135	0.4101949789364915	78	TCGA-AG-4005-01	16	32	22	0.1820209320062359	TCGA-AG-4005-01	7	6	3	16	PASS	8435	TCGA-AG-4005	READ	64	MALE	NA	Stage IV	NA	Rectal Adenocarcinoma	NA	2007	NA	-23407	Alive	TUMOR FREE	427	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	427	0	427	NA	NA	0	427	
90	TCGA-AG-4007	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-4007-01	420	0.9972704878125659	336	TCGA-AG-4007-01	25	24	34	0.08509894118898906	TCGA-AG-4007-01	11	6	6	23	PASS	8436	TCGA-AG-4007	READ	87	MALE	NA	Stage IV	NA	Rectal Adenocarcinoma	NA	2007	NA	-31776	Alive	WITH TUMOR	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
60	TCGA-AG-4008	2	5	1	4	3	1	1	1	3	72	4	0	2	24	1	0	TCGA-AG-4008-01	131	0.312662293629038	71	TCGA-AG-4008-01	14	18	21	0.1402136648096119	TCGA-AG-4008-01	9	4	5	18	mutation call filter	8437	TCGA-AG-4008	READ	63	MALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2008	NA	-23192	Alive	TUMOR FREE	518	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	518	0	518	0	518	0	518	
80	TCGA-AG-4009	0	14	0	4	4	2	2	0	7	91	12	0	0	50	0	0	TCGA-AG-4009	0	0	0	TCGA-AG-4009	0	0	0	0	TCGA-AG-4009	0	0	0	0	mutation call filter	8438	TCGA-AG-4009	READ	83	MALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2009	NA	-30559	Alive	TUMOR FREE	426	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	426	0	426	NA	NA	0	426	
90	TCGA-AG-4015	0	9	0	1	3	1	3	0	2	74	5	0	2	25	1	0	TCGA-AG-4015-01	359	0.6692833611106956	260	TCGA-AG-4015-01	21	36	33	0.14165041968304048	TCGA-AG-4015-01	10	8	7	25	mutation call filter	8439	TCGA-AG-4015	READ	85	FEMALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2009	NA	-31291	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
80	TCGA-AG-4021	0	10	2	3	2	1	0	0	3	119	7	0	3	44	5	0	TCGA-AG-4021-01	171	0.9184515212278452	98	TCGA-AG-4021-01	11	11	37	0.2294775938379411	TCGA-AG-4021-01	8	6	10	24	PASS	8440	TCGA-AG-4021	READ	84	FEMALE	NA	Stage IV	NA	Rectal Adenocarcinoma	NA	2005	NA	-31015	Dead	WITH TUMOR	NA	121	NA	NA	NA	NA	0	NA	NA	NA	1	121	1	121	NA	NA	1	0	
60	TCGA-AG-4022	0	4	1	2	4	0	0	1	3	70	6	0	1	29	2	0	TCGA-AG-4022-01	110	0.7896197979544034	56	TCGA-AG-4022-01	31	36	14	0.2576578030266803	TCGA-AG-4022-01	2	1	1	4	PASS	8441	TCGA-AG-4022	READ	59	FEMALE	NA	Stage II	NA	Rectal Adenocarcinoma	NA	2006	NA	-21823	Alive	TUMOR FREE	1400	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1400	0	1400	0	1400	0	1400	
40	TCGA-AG-A002	76	1591	43	364	24	26	4	0	665	9599	1452	7	239	2730	242	7	TCGA-AG-A002-01	123	0.0004549714779111062	67	TCGA-AG-A002-01	0	0	19	0.0001434050784522084	TCGA-AG-A002-01	0	0	0	0	mutation call filter	8442	TCGA-AG-A002	READ	35	MALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2009	NA	-13090	Alive	TUMOR FREE	638	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	638	0	638	0	638	0	638	
50	TCGA-AG-A008	1	13	0	3	4	0	0	0	5	55	6	0	0	18	0	0	TCGA-AG-A008-01	71	0.9478903383910658	28	TCGA-AG-A008-01	17	11	5	0.0479835918124424	TCGA-AG-A008-01	1	1	2	4	mutation call filter	8443	TCGA-AG-A008	READ	50	FEMALE	NA	Stage I	NA	Rectal Mucinous Adenocarcinoma	NA	2009	NA	-18416	Alive	TUMOR FREE	424	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	424	0	424	0	424	0	424	
50	TCGA-AG-A00C	0	7	0	5	4	3	0	1	7	105	11	0	3	38	4	0	TCGA-AG-A00C-01	184	0.15619525883989782	113	TCGA-AG-A00C-01	7	9	28	0.16774343013832768	TCGA-AG-A00C-01	5	2	1	8	mutation call filter	8444	TCGA-AG-A00C	READ	49	FEMALE	NA	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2007	NA	-18201	Alive	TUMOR FREE	183	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	183	0	183	0	183	0	183	
80	TCGA-AG-A00H	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-A00H	0	0	0	TCGA-AG-A00H	0	0	0	0	TCGA-AG-A00H-01	3	1	3	7	PASS	8445	TCGA-AG-A00H	READ	75	MALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2008	NA	-27485	Alive	WITH TUMOR	790	NA	NA	NA	NA	NA	790	Progressive Disease	NA	NA	0	790	0	790	NA	NA	1	790	
70	TCGA-AG-A00Y	1	52	3	9	8	5	4	2	16	276	24	1	7	135	6	0	TCGA-AG-A00Y-01	1336	0.4408655264388008	1223	TCGA-AG-A00Y-01	8	14	115	0.2075225907199653	TCGA-AG-A00Y-01	10	7	10	27	mutation call filter	8446	TCGA-AG-A00Y	READ	68	MALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2008	NA	-24837	Alive	TUMOR FREE	700	NA	NA	NA	NA	NA	123	Complete Remission/Response	NA	NA	0	700	0	700	1	123	1	123	
80	TCGA-AG-A011	1	6	1	6	2	2	0	0	2	84	10	0	0	31	3	0	TCGA-AG-A011-01	232	0.3312398331489307	139	TCGA-AG-A011-01	12	12	34	0.2547972331581343	TCGA-AG-A011-01	10	8	7	25	mutation call filter	8447	TCGA-AG-A011	READ	80	MALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2009	NA	-29463	Alive	TUMOR FREE	1126	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1126	0	1126	NA	NA	0	1126	
90	TCGA-AG-A014	1	24	0	5	0	3	2	0	3	117	8	0	6	44	0	1	TCGA-AG-A014	0	0	0	TCGA-AG-A014	0	0	0	0	TCGA-AG-A014-01	7	1	4	12	mutation call filter	8448	TCGA-AG-A014	READ	86	MALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2009	NA	-31718	Alive	WITH TUMOR	485	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	485	0	485	NA	NA	0	485	
60	TCGA-AG-A015	1	8	0	4	2	3	0	0	4	75	8	1	2	27	2	0	TCGA-AG-A015-01	104	0.9473264403424048	53	TCGA-AG-A015-01	14	12	5	0.048765898607868695	TCGA-AG-A015-01	4	0	1	5	mutation call filter	8449	TCGA-AG-A015	READ	64	FEMALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2009	NA	-23496	Alive	TUMOR FREE	1096	NA	NA	NA	NA	NA	518	NA	NA	NA	0	1096	0	1096	NA	NA	1	518	
60	TCGA-AG-A016	1	8	2	1	0	2	1	0	5	65	4	0	0	38	1	0	TCGA-AG-A016-01	176	0.9473935942980496	111	TCGA-AG-A016-01	12	35	39	0.3385764162744752	TCGA-AG-A016-01	7	4	3	14	mutation call filter	8450	TCGA-AG-A016	READ	55	MALE	NA	Stage IV	NA	Rectal Adenocarcinoma	NA	2009	NA	-20178	Alive	WITH TUMOR	276	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	276	0	276	NA	NA	0	276	
60	TCGA-AG-A01J	0	6	1	2	2	1	1	0	5	74	9	0	3	33	1	0	TCGA-AG-A01J-01	78	0.18564992953718815	32	TCGA-AG-A01J-01	9	11	10	0.12697515786610272	TCGA-AG-A01J-01	4	1	4	9	mutation call filter	8451	TCGA-AG-A01J	READ	59	FEMALE	NA	Stage IIA	NA	Rectal Adenocarcinoma	NA	2009	NA	-21581	Alive	WITH TUMOR	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
60	TCGA-AG-A01L	0	9	0	2	1	1	0	0	2	49	9	0	1	17	1	0	TCGA-AG-A01L-01	120	0.9000462331022927	59	TCGA-AG-A01L-01	21	17	8	0.07767282701034235	TCGA-AG-A01L-01	3	1	1	5	mutation call filter	8452	TCGA-AG-A01L	READ	58	MALE	NA	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2009	NA	-21369	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-AG-A01N	0	11	0	8	1	5	0	0	2	85	8	0	2	26	1	1	TCGA-AG-A01N-01	75	0.9273956761823801	25	TCGA-AG-A01N-01	26	24	10	0.11480873910801755	TCGA-AG-A01N-01	6	3	4	13	mutation call filter	8453	TCGA-AG-A01N	READ	68	FEMALE	NA	Stage IV	NA	Rectal Adenocarcinoma	NA	2009	NA	-25049	Alive	WITH TUMOR	943	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	943	0	943	NA	NA	0	943	
70	TCGA-AG-A01W	0	13	0	7	7	0	0	0	7	110	4	0	3	43	2	0	TCGA-AG-A01W-01	199	0.5422098344497391	131	TCGA-AG-A01W-01	15	31	42	0.15010440156119506	TCGA-AG-A01W-01	12	9	7	28	mutation call filter	8454	TCGA-AG-A01W	READ	67	FEMALE	NA	Stage II	NA	Rectal Adenocarcinoma	NA	2004	NA	-24745	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
50	TCGA-AG-A01Y	0	5	1	3	2	0	0	0	2	67	3	0	2	30	2	1	TCGA-AG-A01Y-01	187	0.3662708786074007	91	TCGA-AG-A01Y-01	11	17	32	0.28982910484268165	TCGA-AG-A01Y-01	13	6	11	30	mutation call filter	8455	TCGA-AG-A01Y	READ	49	FEMALE	NA	Stage II	NA	Rectal Adenocarcinoma	NA	2004	NA	-18112	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
60	TCGA-AG-A020	0	3	3	3	0	2	1	0	2	68	8	1	4	25	0	0	TCGA-AG-A020-01	161	0.3812637360556677	97	TCGA-AG-A020-01	8	8	29	0.12133159215787452	TCGA-AG-A020-01	5	5	5	15	mutation call filter	8456	TCGA-AG-A020	READ	57	FEMALE	NA	Stage III	NA	Rectal Mucinous Adenocarcinoma	NA	2005	NA	-20851	Alive	WITH TUMOR	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
60	TCGA-AG-A023	1	9	1	4	2	3	1	0	3	56	8	0	2	26	1	0	TCGA-AG-A023	0	0	0	TCGA-AG-A023	0	0	0	0	TCGA-AG-A023-01	5	3	3	11	mutation call filter	8457	TCGA-AG-A023	READ	62	FEMALE	NA	Stage IV	NA	Rectal Adenocarcinoma	NA	2005	NA	-22830	Dead	WITH TUMOR	NA	1581	NA	NA	NA	NA	822	NA	NA	NA	1	1581	1	1581	NA	NA	1	822	
60	TCGA-AG-A025	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-A025-01	39	0.033275091026555126	6	TCGA-AG-A025-01	1	1	19	0.00035115535835131566	TCGA-AG-A025-01	0	0	0	0	PASS	8458	TCGA-AG-A025	READ	62	FEMALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2006	NA	-22952	Alive	WITH TUMOR	1520	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1520	0	1520	NA	NA	0	1520	
70	TCGA-AG-A026	1	19	0	8	3	3	2	1	11	179	8	0	4	57	5	0	TCGA-AG-A026-01	241	0.4293497815018297	162	TCGA-AG-A026-01	19	34	39	0.3321458151263661	TCGA-AG-A026-01	7	2	5	14	mutation call filter	8459	TCGA-AG-A026	READ	66	MALE	NA	Stage II	NA	Rectal Adenocarcinoma	NA	2006	NA	-24413	Dead	WITH TUMOR	NA	59	NA	NA	NA	NA	NA	NA	NA	NA	1	59	1	59	NA	NA	1	59	
70	TCGA-AG-A02G	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AG-A02G-01	144	0.5273600471104737	74	TCGA-AG-A02G-01	19	29	26	0.2021512143661313	TCGA-AG-A02G-01	9	5	8	22	PASS	8460	TCGA-AG-A02G	READ	66	MALE	NA	Stage IV	NA	Rectal Adenocarcinoma	NA	2007	NA	-24259	Dead	WITH TUMOR	NA	1185	NA	NA	NA	NA	578	Partial Remission/Response	NA	NA	1	1185	1	1185	NA	NA	1	578	
70	TCGA-AG-A02N	9	95	1	33	128	28	18	0	59	819	62	0	23	391	19	2	TCGA-AG-A02N-01	111	0.09796983674040494	58	TCGA-AG-A02N-01	4	4	13	0.013103401736933955	TCGA-AG-A02N-01	1	1	0	2	mutation call filter	8461	TCGA-AG-A02N	READ	67	MALE	NA	Stage II	NA	Rectal Adenocarcinoma	NA	2005	NA	-24687	Alive	WITH TUMOR	1885	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1885	0	1885	NA	NA	0	1885	
80	TCGA-AG-A02X	2	7	0	3	2	1	0	0	8	104	14	0	1	52	2	0	TCGA-AG-A02X-01	171	1.0	104	TCGA-AG-A02X-01	18	25	34	0.304494136337134	TCGA-AG-A02X-01	13	3	6	22	mutation call filter	8462	TCGA-AG-A02X	READ	77	MALE	NA	Stage I	NA	Rectal Adenocarcinoma	NA	2007	NA	-28399	Alive	WITH TUMOR	1247	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1247	0	1247	NA	NA	0	1247	
70	TCGA-AG-A032	0	6	0	4	0	0	0	1	1	62	12	0	1	24	1	1	TCGA-AG-A032-01	129	0.9207329404657736	71	TCGA-AG-A032-01	24	30	5	0.05107577360016586	TCGA-AG-A032-01	6	6	1	13	mutation call filter	8463	TCGA-AG-A032	READ	68	MALE	NA	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2007	NA	-24865	Alive	WITH TUMOR	1157	NA	NA	NA	NA	NA	792	Partial Remission/Response	NA	NA	0	1157	0	1157	NA	NA	1	792	
70	TCGA-AG-A036	0	20	0	7	2	1	1	0	5	149	10	1	4	56	5	0	TCGA-AG-A036	0	0	0	TCGA-AG-A036	0	0	0	0	TCGA-AG-A036	0	0	0	0	mutation call filter	8464	TCGA-AG-A036	READ	71	MALE	NA	Stage III	NA	Rectal Adenocarcinoma	NA	2002	NA	-26206	Alive	TUMOR FREE	3562	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3562	0	3562	0	3562	0	3562	
60	TCGA-AH-6544	1	9	3	5	1	0	0	0	5	117	7	0	2	44	3	0	TCGA-AH-6544-01	133	0.5528601948159997	69	TCGA-AH-6544-01	18	30	26	0.23763992746454554	TCGA-AH-6544-01	11	5	6	22	PASS	8465	TCGA-AH-6544	READ	60	MALE	WHITE	NA	NA	Rectal Adenocarcinoma	NA	2010	NA	-21977	Alive	WITH TUMOR	1173	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1173	0	1173	NA	NA	0	1173	
80	TCGA-AH-6547	0	0	0	0	0	0	0	0	0	12	0	0	0	1	0	0	TCGA-AH-6547-01	44	0.042640503325875545	7	TCGA-AH-6547-01	2	3	19	1.5665782955851903e-05	TCGA-AH-6547-01	2	1	0	3	PASS	8466	TCGA-AH-6547	READ	79	FEMALE	WHITE	NA	NA	Rectal Adenocarcinoma	NA	2010	NA	-29030	Dead	TUMOR FREE	NA	76	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	76	0	76	0	76	0	76	
70	TCGA-AH-6549	1	11	1	2	3	1	0	0	4	68	3	0	5	32	0	0	TCGA-AH-6549	0	0	0	TCGA-AH-6549	0	0	0	0	TCGA-AH-6549	0	0	0	0	PASS	8467	TCGA-AH-6549	READ	66	MALE	WHITE	NA	NA	Rectal Adenocarcinoma	NA	2010	NA	-24337	Alive	TUMOR FREE	532	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	532	0	532	0	532	0	532	
50	TCGA-AH-6643	1	6	0	4	0	1	0	0	8	87	9	0	0	43	1	0	TCGA-AH-6643-01	126	0.5070591939354503	66	TCGA-AH-6643-01	19	24	25	0.32252394453111866	TCGA-AH-6643-01	7	2	3	12	PASS	8468	TCGA-AH-6643	READ	50	MALE	WHITE	Stage IIIC	NA	Rectal Adenocarcinoma	NA	2010	NA	-18273	Dead	WITH TUMOR	NA	1314	NA	NA	NA	NA	1026	Complete Remission/Response	NA	NA	1	1314	1	1314	1	1026	1	1026	
70	TCGA-AH-6644	1	12	2	5	4	3	0	0	5	93	5	0	3	33	0	0	TCGA-AH-6644-01	89	0.8742153117997946	39	TCGA-AH-6644-01	31	27	11	0.11850837947655556	TCGA-AH-6644-01	6	5	6	17	PASS	8469	TCGA-AH-6644	READ	73	MALE	WHITE	NA	NA	Rectal Adenocarcinoma	NA	2010	NA	-26892	Alive	TUMOR FREE	838	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	838	0	838	0	838	0	838	
50	TCGA-AH-6897	1	6	0	2	2	2	1	0	4	85	5	0	0	42	3	0	TCGA-AH-6897-01	143	0.34291064019665896	82	TCGA-AH-6897-01	13	20	14	0.07502908774999924	TCGA-AH-6897-01	4	7	4	15	PASS	8470	TCGA-AH-6897	READ	48	MALE	WHITE	Stage I	NA	Rectal Adenocarcinoma	NA	2010	NA	-17536	Alive	TUMOR FREE	804	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	804	0	804	0	804	0	804	
50	TCGA-AH-6903	0	5	0	2	1	1	0	0	4	60	5	0	1	25	2	0	TCGA-AH-6903-01	85	0.032942737380319165	36	TCGA-AH-6903-01	2	1	7	0.012279753949952834	TCGA-AH-6903-01	0	2	1	3	PASS	8471	TCGA-AH-6903	READ	46	MALE	WHITE	Stage IIIB	NA	Rectal Mucinous Adenocarcinoma	NA	2010	NA	-17030	Alive	TUMOR FREE	592	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	592	0	592	0	592	0	592	
70	TCGA-BM-6198	1	17	0	5	4	2	0	0	6	100	5	1	1	40	5	0	TCGA-BM-6198	0	0	0	TCGA-BM-6198	0	0	0	0	TCGA-BM-6198	0	0	0	0	PASS	8472	TCGA-BM-6198	READ	73	MALE	WHITE	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2010	NA	-26837	Alive	TUMOR FREE	646	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	646	0	646	0	646	0	646	
40	TCGA-CI-6619	1	6	0	4	2	0	0	0	5	64	3	1	4	24	1	0	TCGA-CI-6619-01	61	0.50957824358424	18	TCGA-CI-6619-01	25	54	4	0.1077037683485339	TCGA-CI-6619-01	5	1	3	9	PASS	8473	TCGA-CI-6619	READ	41	MALE	WHITE	Stage IV	NA	Rectal Adenocarcinoma	NA	2010	NA	-15322	Alive	NA	184	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	184	0	184	NA	NA	0	184	
40	TCGA-CI-6620	1	9	0	4	2	3	0	0	4	44	1	0	3	24	2	0	TCGA-CI-6620-01	84	0.2650786799893213	36	TCGA-CI-6620-01	9	7	8	0.15931222553024066	TCGA-CI-6620-01	5	3	3	11	PASS	8474	TCGA-CI-6620	READ	41	FEMALE	WHITE	Stage IVA	NA	Rectal Adenocarcinoma	NA	2010	NA	-15322	Alive	WITH TUMOR	1009	NA	NA	NA	NA	NA	90	Progressive Disease	NA	NA	0	1009	0	1009	NA	NA	1	90	
60	TCGA-CI-6621	2	9	2	3	2	2	0	0	4	90	8	0	2	38	5	0	TCGA-CI-6621-01	145	0.3729908793318916	86	TCGA-CI-6621-01	20	21	20	0.21118044754451595	TCGA-CI-6621-01	10	6	7	23	PASS	8475	TCGA-CI-6621	READ	63	MALE	WHITE	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2010	NA	-23240	Alive	NA	419	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	419	0	419	NA	NA	0	419	
70	TCGA-CI-6622	0	5	0	4	0	1	0	1	6	81	7	0	1	49	3	0	TCGA-CI-6622-01	92	0.12746466771700646	43	TCGA-CI-6622-01	7	8	10	0.06541499230755228	TCGA-CI-6622-01	3	2	3	8	PASS	8476	TCGA-CI-6622	READ	74	MALE	WHITE	Stage IIB	NA	Rectal Adenocarcinoma	NA	2010	NA	-27336	Alive	TUMOR FREE	1362	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1362	0	1362	NA	NA	0	1362	
40	TCGA-CI-6623	0	8	0	1	4	0	0	0	4	61	1	0	3	27	1	0	TCGA-CI-6623-01	88	0.7069543953870958	41	TCGA-CI-6623-01	25	26	12	0.28960984645867943	TCGA-CI-6623-01	7	5	1	13	PASS	8477	TCGA-CI-6623	READ	44	MALE	WHITE	Stage I	NA	Rectal Adenocarcinoma	NA	2011	NA	-16177	Alive	TUMOR FREE	1443	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1443	0	1443	NA	NA	0	1443	
50	TCGA-CI-6624	0	29	4	6	4	1	1	0	14	225	15	0	2	74	3	0	TCGA-CI-6624-01	129	0.4515120395563509	61	TCGA-CI-6624-01	17	39	29	0.2755494836353372	TCGA-CI-6624-01	13	7	4	24	PASS	8478	TCGA-CI-6624	READ	53	FEMALE	WHITE	Stage I	NA	Rectal Adenocarcinoma	NA	2011	NA	-19419	Alive	NA	1466	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	1466	0	1466	NA	NA	0	1466	
80	TCGA-CL-4957	0	12	2	5	2	2	0	0	5	64	10	0	2	29	1	0	TCGA-CL-4957-01	278	0.4427037467368661	198	TCGA-CL-4957-01	13	30	40	0.0810120288016041	TCGA-CL-4957-01	8	13	4	25	PASS	8479	TCGA-CL-4957	READ	79	FEMALE	NA	[Discrepancy]	NA	Rectal Adenocarcinoma	NA	2008	NA	-29081	Alive	NA	425	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	425	0	425	0	425	0	425	
70	TCGA-CL-5917	0	7	0	4	1	1	1	0	1	59	6	0	1	26	2	0	TCGA-CL-5917-01	110	0.9385435536634232	49	TCGA-CL-5917-01	31	35	20	0.4178610048843884	TCGA-CL-5917-01	5	7	3	15	PASS	8480	TCGA-CL-5917	READ	71	FEMALE	WHITE	Stage IIIC	NA	Rectal Adenocarcinoma	NA	2006	NA	-26084	Alive	TUMOR FREE	2376	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2376	0	2376	0	2376	0	2376	
90	TCGA-CL-5918	3	16	1	3	1	0	1	0	9	99	9	0	5	38	3	0	TCGA-CL-5918-01	97	0.3410512006741345	48	TCGA-CL-5918-01	12	14	21	0.1454991660374785	TCGA-CL-5918-01	4	4	4	12	PASS	8481	TCGA-CL-5918	READ	90	FEMALE	WHITE	Stage IIA	NA	Rectal Adenocarcinoma	NA	2008	NA	-32873	Alive	TUMOR FREE	218	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	218	0	218	0	218	0	218	
50	TCGA-DC-4745	0	4	1	5	2	0	1	0	2	59	3	0	1	20	2	0	TCGA-DC-4745-01	344	0.7911458794039314	258	TCGA-DC-4745-01	16	34	84	0.29757812083117224	TCGA-DC-4745-01	13	7	4	24	PASS	8482	TCGA-DC-4745	READ	49	FEMALE	WHITE	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2010	NA	-17958	Alive	TUMOR FREE	639	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	639	0	639	0	639	0	639	
60	TCGA-DC-4749	0	5	1	3	1	0	1	0	2	59	6	0	1	27	0	0	TCGA-DC-4749-01	225	0.4851702851119701	142	TCGA-DC-4749-01	20	25	30	0.24553580361417565	TCGA-DC-4749-01	8	1	4	13	PASS	8483	TCGA-DC-4749	READ	57	MALE	WHITE	Stage I	NA	Rectal Adenocarcinoma	NA	2010	NA	-21092	Alive	TUMOR FREE	762	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	762	0	762	0	762	0	762	
70	TCGA-DC-5337	0	6	0	7	2	3	1	0	2	80	3	0	0	38	3	0	TCGA-DC-5337-01	62	0.05449322327427028	19	TCGA-DC-5337-01	2	2	3	0.007025482650077177	TCGA-DC-5337-01	1	1	1	3	PASS	8484	TCGA-DC-5337	READ	69	MALE	WHITE	Stage I	NA	Rectal Adenocarcinoma	NA	2010	NA	-25202	Alive	TUMOR FREE	792	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	792	0	792	NA	NA	0	792	
60	TCGA-DC-5869	1	6	0	2	2	1	0	0	4	66	3	0	2	30	1	0	TCGA-DC-5869-01	109	0.7788678382078308	58	TCGA-DC-5869-01	25	61	19	0.02914918162630819	TCGA-DC-5869-01	2	1	0	3	PASS	8485	TCGA-DC-5869	READ	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2010	NA	-22676	Alive	TUMOR FREE	943	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	943	0	943	NA	NA	0	943	
60	TCGA-DC-6154	0	5	1	0	1	0	0	0	2	86	7	0	0	34	0	0	TCGA-DC-6154-01	126	0.9476982319757048	66	TCGA-DC-6154-01	16	27	30	0.2543267691773771	TCGA-DC-6154-01	9	1	5	15	PASS	8486	TCGA-DC-6154	READ	57	FEMALE	WHITE	Stage IVA	NA	Rectal Adenocarcinoma	NA	2010	NA	-21093	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	365	0	365	NA	NA	0	365	
30	TCGA-DC-6155	0	7	0	2	1	1	0	0	2	46	2	0	2	18	2	0	TCGA-DC-6155-01	190	0.8635432841111214	109	TCGA-DC-6155-01	20	33	13	0.12305616117470712	TCGA-DC-6155-01	6	4	3	13	PASS	8487	TCGA-DC-6155	READ	31	FEMALE	WHITE	Stage IIIA	NA	Rectal Adenocarcinoma	NA	2010	NA	-11381	Alive	TUMOR FREE	425	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	425	0	425	NA	NA	0	425	
60	TCGA-DC-6156	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DC-6156-01	111	0.7285362897065716	58	TCGA-DC-6156-01	29	66	19	0.30074275894095776	TCGA-DC-6156-01	11	9	6	26	PASS	8488	TCGA-DC-6156	READ	62	MALE	WHITE	Stage IVA	NA	Rectal Adenocarcinoma	NA	2010	NA	-22706	Alive	WITH TUMOR	943	NA	NA	NA	NA	NA	30	NA	NA	NA	0	943	0	943	NA	NA	1	30	
50	TCGA-DC-6157	0	12	2	4	0	1	2	0	8	69	8	0	4	23	3	0	TCGA-DC-6157-01	110	0.7531185736200156	56	TCGA-DC-6157-01	25	38	8	0.044611760744221296	TCGA-DC-6157-01	7	4	1	12	PASS	8489	TCGA-DC-6157	READ	48	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Rectal Adenocarcinoma	NA	2009	NA	-17807	Alive	TUMOR FREE	1581	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1581	0	1581	NA	NA	0	1581	
70	TCGA-DC-6158	0	14	0	3	2	0	0	0	6	66	15	0	3	34	0	0	TCGA-DC-6158-01	189	0.5063480038488433	131	TCGA-DC-6158-01	22	31	55	0.37062720549907296	TCGA-DC-6158-01	13	3	9	25	PASS	8490	TCGA-DC-6158	READ	70	MALE	WHITE	Stage I	NA	Rectal Adenocarcinoma	NA	2010	NA	-25842	Dead	TUMOR FREE	NA	334	NA	NA	NA	NA	NA	NA	NA	NA	1	334	0	334	NA	NA	0	334	
70	TCGA-DC-6160	0	5	1	5	3	2	0	0	3	67	5	0	1	24	1	0	TCGA-DC-6160-01	149	0.2773617659178459	87	TCGA-DC-6160-01	9	9	36	0.2603140049948734	TCGA-DC-6160-01	6	4	7	17	PASS	8491	TCGA-DC-6160	READ	68	MALE	WHITE	Stage I	NA	Rectal Adenocarcinoma	NA	2009	NA	-24990	Alive	TUMOR FREE	1339	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1339	0	1339	NA	NA	0	1339	
70	TCGA-DC-6681	0	7	2	2	0	4	0	0	2	55	6	0	4	26	1	0	TCGA-DC-6681-01	68	0.12523854808303958	24	TCGA-DC-6681-01	4	2	6	0.03856597828438912	TCGA-DC-6681-01	1	1	1	3	PASS	8492	TCGA-DC-6681	READ	70	FEMALE	WHITE	Stage IVA	NA	Rectal Adenocarcinoma	NA	2011	NA	-25659	Alive	TUMOR FREE	790	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	790	0	790	NA	NA	0	790	
60	TCGA-DC-6682	1	11	2	4	2	3	0	0	7	98	9	0	4	54	3	0	TCGA-DC-6682-01	240	0.5412987828100327	153	TCGA-DC-6682-01	25	27	44	0.164861462069787	TCGA-DC-6682-01	9	5	6	20	PASS	8493	TCGA-DC-6682	READ	57	MALE	WHITE	Stage IIA	NA	Rectal Adenocarcinoma	NA	2011	NA	-21062	Alive	TUMOR FREE	762	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	762	0	762	NA	NA	0	762	
40	TCGA-DC-6683	0	3	0	2	2	1	0	0	2	60	4	0	0	25	4	0	TCGA-DC-6683-01	86	0.4105535840139361	39	TCGA-DC-6683-01	19	28	7	0.09263801251719332	TCGA-DC-6683-01	7	4	4	15	PASS	8494	TCGA-DC-6683	READ	43	MALE	WHITE	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2011	NA	-15918	Alive	TUMOR FREE	762	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	762	0	762	NA	NA	0	762	
50	TCGA-DT-5265	0	2	0	7	1	3	0	0	4	66	9	0	0	28	2	0	TCGA-DT-5265-01	162	0.3700773851586197	92	TCGA-DT-5265-01	7	10	37	0.1822298561704956	TCGA-DT-5265-01	6	2	5	13	PASS	8495	TCGA-DT-5265	READ	51	MALE	ASIAN	Stage II	NA	Rectal Mucinous Adenocarcinoma	NA	2010	NA	-18669	Alive	TUMOR FREE	384	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	384	0	384	0	384	0	384	
60	TCGA-DY-A0XA	1	10	0	4	0	0	0	0	4	118	10	0	2	33	1	0	TCGA-DY-A0XA-01	164	0.3870221022058896	95	TCGA-DY-A0XA-01	13	17	37	0.13508888521672066	TCGA-DY-A0XA-01	8	4	7	19	PASS	8496	TCGA-DY-A0XA	READ	57	FEMALE	WHITE	Stage IIA	NA	Rectal Adenocarcinoma	NA	2001	NA	-21115	Alive	NA	3846	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3846	0	3846	NA	NA	0	3846	
70	TCGA-DY-A1DC	2	15	0	5	0	3	1	0	5	119	9	0	0	27	5	0	TCGA-DY-A1DC-01	181	0.2979171182031049	103	TCGA-DY-A1DC-01	11	13	19	0.11919647910069815	TCGA-DY-A1DC-01	7	4	5	16	PASS	8497	TCGA-DY-A1DC	READ	72	FEMALE	WHITE	Stage IIA	NA	Rectal Adenocarcinoma	NA	2000	NA	-26436	Dead	NA	NA	1258	NA	Locoregional Disease	NA	NA	630	NA	NA	NA	1	1258	NA	1258	NA	NA	1	630	
80	TCGA-DY-A1DD	1	16	0	6	3	3	0	0	6	106	4	0	1	35	1	0	TCGA-DY-A1DD-01	167	0.3510399031856292	101	TCGA-DY-A1DD-01	13	22	26	0.3177941636159774	TCGA-DY-A1DD-01	6	1	5	12	PASS	8498	TCGA-DY-A1DD	READ	77	FEMALE	WHITE	Stage IIIB	NA	Rectal Adenocarcinoma	NA	1999	NA	-28159	Dead	NA	1741	1741	NA	NA	NA	NA	NA	NA	NA	NA	1	1741	NA	1741	NA	NA	0	1741	
60	TCGA-DY-A1DE	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DY-A1DE-01	276	0.6815193555267189	152	TCGA-DY-A1DE-01	21	32	32	0.21876440161709146	TCGA-DY-A1DE-01	12	10	8	30	PASS	8499	TCGA-DY-A1DE	READ	56	FEMALE	WHITE	Stage IIA	NA	Rectal Adenocarcinoma	NA	2001	NA	-20504	Alive	NA	3932	NA	NA	NA	NA	NA	3316	NA	NA	NA	0	3932	0	3932	NA	NA	1	3316	
70	TCGA-DY-A1DF	0	11	0	6	1	2	0	1	2	110	7	1	1	42	3	0	TCGA-DY-A1DF-01	255	0.6559681913854248	177	TCGA-DY-A1DF-01	21	23	55	0.2901090259421075	TCGA-DY-A1DF-01	5	5	5	15	PASS	8500	TCGA-DY-A1DF	READ	73	FEMALE	WHITE	Stage IIIC	NA	Rectal Adenocarcinoma	NA	2001	NA	-26763	Dead	NA	734	734	NA	NA	NA	NA	NA	NA	NA	NA	1	734	NA	734	NA	NA	0	734	
80	TCGA-DY-A1DG	1	13	3	7	1	1	2	1	5	137	7	0	2	56	3	0	TCGA-DY-A1DG-01	216	0.4355082032937485	123	TCGA-DY-A1DG-01	17	29	40	0.2239148097616621	TCGA-DY-A1DG-01	14	12	9	35	PASS	8501	TCGA-DY-A1DG	READ	75	MALE	WHITE	Stage IVA	NA	Rectal Adenocarcinoma	NA	2000	NA	-27396	Dead	NA	NA	1566	NA	NA	NA	NA	592	NA	NA	NA	1	1566	NA	1566	NA	NA	1	592	
80	TCGA-DY-A1H8	1	7	1	2	1	2	0	0	3	76	9	0	4	22	1	0	TCGA-DY-A1H8-01	150	0.26244734967973954	80	TCGA-DY-A1H8-01	7	7	18	0.09831991234388547	TCGA-DY-A1H8-01	6	8	5	19	PASS	8502	TCGA-DY-A1H8	READ	77	FEMALE	WHITE	Stage IIIA	NA	Rectal Adenocarcinoma	NA	2000	NA	-28459	Dead	NA	992	992	NA	NA	NA	NA	NA	NA	NA	NA	1	992	NA	992	NA	NA	0	992	
50	TCGA-EF-5830	0	7	0	4	1	0	0	0	1	60	5	0	1	20	1	0	TCGA-EF-5830-01	188	0.3637926521790072	102	TCGA-EF-5830-01	10	10	25	0.15499251773719394	TCGA-EF-5830-01	7	6	3	16	PASS	8503	TCGA-EF-5830	READ	54	MALE	WHITE	Stage IIB	NA	Rectal Adenocarcinoma	NA	2010	NA	-19802	Alive	TUMOR FREE	106	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	106	0	106	NA	NA	0	106	
70	TCGA-EF-5831	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-EF-5831-01	203	0.4997730350569241	113	TCGA-EF-5831-01	15	35	33	0.2204203029023954	TCGA-EF-5831-01	16	10	8	34	PASS	8504	TCGA-EF-5831	READ	72	MALE	WHITE	Stage IIA	NA	Rectal Adenocarcinoma	NA	2010	NA	-26331	Alive	TUMOR FREE	127	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	127	0	127	NA	NA	0	127	
80	TCGA-EI-6506	1	11	1	6	5	1	1	0	4	107	6	0	0	39	2	0	TCGA-EI-6506-01	117	0.32817949169924604	50	TCGA-EI-6506-01	10	13	21	0.22129754419598527	TCGA-EI-6506-01	6	4	2	12	PASS	8505	TCGA-EI-6506	READ	78	FEMALE	WHITE	Stage IIA	NA	Rectal Adenocarcinoma	NA	2010	NA	-28587	Alive	TUMOR FREE	625	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	625	0	625	NA	NA	0	625	
60	TCGA-EI-6507	13	99	6	32	137	44	11	0	45	683	30	1	10	304	15	1	TCGA-EI-6507-01	60	0.047535951470878114	21	TCGA-EI-6507-01	2	1	5	0.0024064857393813754	TCGA-EI-6507-01	0	0	0	0	hypermutated sample	8506	TCGA-EI-6507	READ	60	MALE	WHITE	Stage IIA	NA	Rectal Adenocarcinoma	NA	2010	NA	-22176	Alive	TUMOR FREE	607	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	607	0	607	NA	NA	0	607	
50	TCGA-EI-6508	0	7	1	4	1	2	2	0	5	88	7	0	1	28	1	0	TCGA-EI-6508-01	271	0.2664272729576624	185	TCGA-EI-6508-01	5	9	74	0.1923538219020464	TCGA-EI-6508-01	10	15	10	35	PASS	8507	TCGA-EI-6508	READ	48	FEMALE	WHITE	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2010	NA	-17827	Alive	TUMOR FREE	636	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	636	0	636	NA	NA	0	636	
50	TCGA-EI-6509	0	8	0	0	1	3	0	0	2	45	2	0	3	17	0	0	TCGA-EI-6509-01	113	0.2606812426559722	56	TCGA-EI-6509-01	8	8	20	0.1851379251949935	TCGA-EI-6509-01	3	4	7	14	PASS	8508	TCGA-EI-6509	READ	53	MALE	WHITE	Stage IIIC	NA	Rectal Adenocarcinoma	NA	2010	NA	-19666	Alive	WITH TUMOR	517	NA	NA	Metastatic	NA	NA	90	NA	NA	NA	0	517	0	517	NA	NA	1	90	
80	TCGA-EI-6510	0	13	0	5	7	0	1	0	5	82	7	0	4	39	2	0	TCGA-EI-6510-01	79	0.7108647488552947	34	TCGA-EI-6510-01	10	8	2	0.0336588105661171	TCGA-EI-6510-01	1	5	1	7	PASS	8509	TCGA-EI-6510	READ	77	FEMALE	WHITE	[Discrepancy]	NA	Rectal Adenocarcinoma	NA	2010	NA	-28328	Alive	TUMOR FREE	556	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	556	0	556	NA	NA	0	556	
50	TCGA-EI-6511	0	4	0	0	2	1	0	0	3	67	6	0	4	22	1	0	TCGA-EI-6511-01	120	0.3251956872877171	62	TCGA-EI-6511-01	12	16	23	0.24498374951046906	TCGA-EI-6511-01	8	2	6	16	PASS	8510	TCGA-EI-6511	READ	52	MALE	WHITE	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2010	NA	-19237	Alive	TUMOR FREE	482	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	482	0	482	NA	NA	0	482	
60	TCGA-EI-6512	2	10	0	5	3	2	2	0	7	99	7	0	5	40	2	0	TCGA-EI-6512-01	139	0.3895468119533505	69	TCGA-EI-6512-01	16	27	21	0.30297430570953665	TCGA-EI-6512-01	2	1	1	4	PASS	8511	TCGA-EI-6512	READ	64	FEMALE	WHITE	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2010	NA	-23537	Alive	TUMOR FREE	538	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	538	0	538	NA	NA	0	538	
60	TCGA-EI-6513	1	24	2	2	0	3	3	0	4	124	6	0	4	31	2	0	TCGA-EI-6513-01	187	0.4579923157141855	110	TCGA-EI-6513-01	12	14	42	0.2192677402265696	TCGA-EI-6513-01	5	4	6	15	PASS	8512	TCGA-EI-6513	READ	59	MALE	WHITE	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2010	NA	-21776	Alive	TUMOR FREE	497	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	497	0	497	NA	NA	0	497	
60	TCGA-EI-6514	1	6	0	7	1	1	0	0	4	86	9	0	1	35	4	0	TCGA-EI-6514-01	92	0.7773631992799968	50	TCGA-EI-6514-01	25	19	10	0.1500991853529914	TCGA-EI-6514-01	5	5	1	11	PASS	8513	TCGA-EI-6514	READ	59	FEMALE	WHITE	Stage IIA	NA	Rectal Adenocarcinoma	NA	2010	NA	-21618	Alive	TUMOR FREE	496	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	496	0	496	NA	NA	0	496	
60	TCGA-EI-6881	1	7	1	2	1	0	0	0	3	89	7	0	0	35	4	0	TCGA-EI-6881-01	68	0.5472358814165422	19	TCGA-EI-6881-01	18	15	12	0.14280856991862534	TCGA-EI-6881-01	3	0	3	6	PASS	8514	TCGA-EI-6881	READ	60	MALE	WHITE	Stage IIIA	NA	Rectal Adenocarcinoma	NA	2010	NA	-22057	Alive	TUMOR FREE	499	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	499	0	499	NA	NA	0	499	
60	TCGA-EI-6882	11	103	3	34	138	36	12	1	56	955	47	0	18	439	20	1	TCGA-EI-6882-01	78	0.04189407340071556	36	TCGA-EI-6882-01	1	1	8	0.008065283262538405	TCGA-EI-6882-01	1	1	1	3	hypermutated sample	8515	TCGA-EI-6882	READ	59	MALE	WHITE	Stage IIA	NA	Rectal Mucinous Adenocarcinoma	NA	2011	NA	-21682	Alive	TUMOR FREE	262	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	262	0	262	NA	NA	0	262	
60	TCGA-EI-6883	0	8	2	1	3	1	2	0	3	77	5	0	1	22	2	0	TCGA-EI-6883-01	216	0.41444037554524943	143	TCGA-EI-6883-01	16	16	56	0.1943625312726097	TCGA-EI-6883-01	7	3	6	16	PASS	8516	TCGA-EI-6883	READ	63	MALE	WHITE	Stage IIC	NA	Rectal Adenocarcinoma	NA	2011	NA	-23268	Alive	TUMOR FREE	350	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	350	0	350	NA	NA	0	350	
70	TCGA-EI-6884	0	10	0	4	2	1	1	0	4	84	10	1	3	33	5	0	TCGA-EI-6884-01	91	0.2805251998986539	38	TCGA-EI-6884-01	11	15	13	0.1300491026121807	TCGA-EI-6884-01	7	4	3	14	PASS	8517	TCGA-EI-6884	READ	71	MALE	WHITE	Stage IIIA	NA	Rectal Adenocarcinoma	NA	2011	NA	-25995	Alive	TUMOR FREE	328	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	328	0	328	NA	NA	0	328	
60	TCGA-EI-6885	1	10	1	1	1	2	0	0	2	83	6	0	1	31	2	0	TCGA-EI-6885-01	142	0.7197191640904446	82	TCGA-EI-6885-01	28	33	48	0.13510973475763302	TCGA-EI-6885-01	8	8	2	18	PASS	8518	TCGA-EI-6885	READ	57	FEMALE	WHITE	Stage IV	NA	Rectal Adenocarcinoma	NA	2011	NA	-21140	Alive	WITH TUMOR	415	NA	NA	Locoregional Disease	NA	NA	295	NA	NA	NA	0	415	0	415	NA	NA	1	295	
30	TCGA-EI-6917	30	515	26	103	4	8	0	0	198	4321	527	5	93	1434	55	1	TCGA-EI-6917-01	113	0.0009292586269208012	62	TCGA-EI-6917-01	0	0	5	0.00027900825985078463	TCGA-EI-6917-01	0	0	0	0	hypermutated sample	8519	TCGA-EI-6917	READ	33	MALE	WHITE	Stage IIIA	NA	Rectal Adenocarcinoma	NA	2010	NA	-12113	Alive	TUMOR FREE	531	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	531	0	531	NA	NA	0	531	
60	TCGA-EI-7002	1	14	0	7	1	1	1	0	7	139	10	0	2	46	3	0	TCGA-EI-7002-01	166	0.6394950376477408	98	TCGA-EI-7002-01	21	29	38	0.3636059765069339	TCGA-EI-7002-01	13	12	5	30	PASS	8520	TCGA-EI-7002	READ	58	MALE	WHITE	Stage IV	NA	Rectal Adenocarcinoma	NA	2011	NA	-21192	Alive	TUMOR FREE	364	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	364	0	364	NA	NA	0	364	
40	TCGA-EI-7004	0	16	0	5	1	1	1	0	4	76	5	0	2	30	0	1	TCGA-EI-7004-01	202	0.34566292585541164	107	TCGA-EI-7004-01	8	18	51	0.32019295438063416	TCGA-EI-7004-01	25	21	15	61	PASS	8521	TCGA-EI-7004	READ	37	FEMALE	WHITE	[Discrepancy]	NA	Rectal Mucinous Adenocarcinoma	NA	2011	NA	-13566	Alive	TUMOR FREE	257	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	257	0	257	NA	NA	0	257	
80	TCGA-F5-6464	0	14	0	3	0	2	1	0	6	76	3	0	5	20	0	0	TCGA-F5-6464-01	98	0.8413500493680519	37	TCGA-F5-6464-01	28	13	15	0.04504981392886468	TCGA-F5-6464-01	6	7	3	16	PASS	8522	TCGA-F5-6464	READ	77	FEMALE	WHITE	Stage IIIC	NA	Rectal Adenocarcinoma	NA	2011	NA	-28168	Dead	NA	NA	303	NA	NA	NA	NA	NA	NA	NA	NA	1	303	NA	303	NA	NA	0	303	
60	TCGA-F5-6465	1	5	0	5	2	0	0	0	4	82	7	0	0	26	7	0	TCGA-F5-6465-01	146	0.5436150215305409	89	TCGA-F5-6465-01	14	10	23	0.06040055516187584	TCGA-F5-6465-01	3	1	0	4	PASS	8523	TCGA-F5-6465	READ	64	FEMALE	WHITE	Stage IIA	NA	Rectal Adenocarcinoma	NA	2010	NA	-23432	Alive	TUMOR FREE	1506	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1506	0	1506	0	1506	0	1506	
60	TCGA-F5-6571	0	6	0	6	3	0	2	0	2	64	11	0	1	17	1	0	TCGA-F5-6571-01	146	0.6438569668433014	89	TCGA-F5-6571-01	11	11	15	0.20360271114120645	TCGA-F5-6571-01	3	5	4	12	PASS	8524	TCGA-F5-6571	READ	62	FEMALE	WHITE	Stage IIA	NA	Rectal Adenocarcinoma	NA	2011	NA	-22666	Alive	WITH TUMOR	1288	NA	NA	Metastatic	NA	NA	122	Complete Remission/Response	NA	NA	0	1288	0	1288	1	122	1	122	
70	TCGA-F5-6702	0	6	0	4	2	1	1	0	3	55	2	0	0	24	2	0	TCGA-F5-6702-01	95	0.6075281063892214	46	TCGA-F5-6702-01	28	31	18	0.34013251421721225	TCGA-F5-6702-01	6	1	3	10	PASS	8525	TCGA-F5-6702	READ	71	MALE	WHITE	Stage IVA	NA	Rectal Adenocarcinoma	NA	2010	NA	-26123	Alive	WITH TUMOR	452	NA	NA	NA	NA	NA	368	Progressive Disease	NA	NA	0	452	0	452	NA	NA	1	368	
70	TCGA-F5-6811	1	5	1	3	1	2	0	0	1	75	3	0	2	34	2	0	TCGA-F5-6811-01	125	0.5106612247600911	66	TCGA-F5-6811-01	18	33	22	0.2083806838447805	TCGA-F5-6811-01	7	5	5	17	PASS	8526	TCGA-F5-6811	READ	72	FEMALE	WHITE	Stage IIA	NA	Rectal Adenocarcinoma	NA	2011	NA	-26575	Alive	TUMOR FREE	979	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	979	0	979	0	979	0	979	
70	TCGA-F5-6812	0	7	0	2	3	0	0	0	2	79	3	0	1	23	1	1	TCGA-F5-6812-01	103	0.35610744019395363	45	TCGA-F5-6812-01	11	19	12	0.3218027500955881	TCGA-F5-6812-01	8	4	5	17	PASS	8527	TCGA-F5-6812	READ	67	MALE	WHITE	Stage IIA	NA	Rectal Adenocarcinoma	NA	2011	NA	-24490	Alive	TUMOR FREE	1110	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1110	0	1110	0	1110	0	1110	
70	TCGA-F5-6813	0	8	1	6	2	2	0	0	3	106	9	0	2	41	2	1	TCGA-F5-6813-01	144	0.4175281791001712	88	TCGA-F5-6813-01	16	18	37	0.3078083047300516	TCGA-F5-6813-01	10	5	5	20	PASS	8528	TCGA-F5-6813	READ	70	MALE	WHITE	Stage IIIC	NA	Rectal Adenocarcinoma	NA	2011	NA	-25651	Dead	WITH TUMOR	NA	598	NA	NA	NA	NA	65	[Unknown]	NA	NA	1	598	1	598	NA	NA	1	65	
60	TCGA-F5-6814	60	1110	44	244	4	11	0	0	404	8146	1086	14	148	2043	149	2	TCGA-F5-6814-01	186	0.09191573002638699	100	TCGA-F5-6814-01	0	0	12	0.01852101445119506	TCGA-F5-6814-01	3	3	1	7	hypermutated sample	8529	TCGA-F5-6814	READ	57	MALE	WHITE	Stage IIA	NA	Rectal Adenocarcinoma	NA	2011	NA	-20828	Alive	TUMOR FREE	1131	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1131	0	1131	0	1131	0	1131	
60	TCGA-F5-6861	2	5	0	0	3	0	0	0	4	85	4	0	2	27	2	0	TCGA-F5-6861-01	57	0.06959465624881914	14	TCGA-F5-6861-01	4	4	2	0.06522845079254723	TCGA-F5-6861-01	0	0	0	0	PASS	8530	TCGA-F5-6861	READ	60	FEMALE	WHITE	Stage IIA	NA	Rectal Adenocarcinoma	NA	2011	NA	-21936	Alive	TUMOR FREE	1160	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1160	0	1160	0	1160	0	1160	
70	TCGA-F5-6863	1	5	0	4	0	1	0	1	3	56	7	0	1	22	4	0	TCGA-F5-6863-01	148	0.6809195890346789	74	TCGA-F5-6863-01	17	18	24	0.15746659231362367	TCGA-F5-6863-01	9	7	2	18	PASS	8531	TCGA-F5-6863	READ	71	FEMALE	WHITE	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2011	NA	-25936	Dead	WITH TUMOR	NA	361	NA	NA	NA	NA	191	[Unknown]	NA	NA	1	361	1	361	NA	NA	1	191	
70	TCGA-F5-6864	0	10	2	6	4	1	0	0	6	123	3	0	6	34	1	1	TCGA-F5-6864-01	151	0.3439909013526401	78	TCGA-F5-6864-01	10	19	28	0.1826889396440623	TCGA-F5-6864-01	9	11	7	27	PASS	8532	TCGA-F5-6864	READ	74	FEMALE	WHITE	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2011	NA	-27058	Alive	TUMOR FREE	379	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	379	0	379	0	379	0	379	
70	TCGA-G5-6233	0	16	2	4	4	4	1	0	6	132	4	0	0	43	3	0	TCGA-G5-6233	0	0	0	TCGA-G5-6233	0	0	0	0	TCGA-G5-6233-01	6	5	5	16	PASS	8533	TCGA-G5-6233	READ	74	MALE	WHITE	[Discrepancy]	NA	Rectal Adenocarcinoma	NA	2009	NA	-27190	Dead	WITH TUMOR	NA	556	NA	NA	NA	NA	92	NA	NA	NA	1	556	1	556	NA	NA	1	92	
70	TCGA-G5-6235	1	8	0	4	1	2	0	0	3	108	6	0	1	31	4	0	TCGA-G5-6235	0	0	0	TCGA-G5-6235	0	0	0	0	TCGA-G5-6235-01	4	4	2	10	PASS	8534	TCGA-G5-6235	READ	72	MALE	WHITE	Stage IIIB	NA	Rectal Adenocarcinoma	NA	2007	NA	-26348	Alive	TUMOR FREE	1696	NA	NA	NA	NA	NA	1042	NA	NA	NA	0	1696	0	1696	NA	NA	1	1042	
60	TCGA-G5-6572	0	8	0	7	5	7	0	0	7	100	9	0	5	48	3	0	TCGA-G5-6572	0	0	0	TCGA-G5-6572	0	0	0	0	TCGA-G5-6572-01	6	4	4	14	mutation call filter	8535	TCGA-G5-6572	READ	56	MALE	WHITE	NA	NA	Rectal Adenocarcinoma	NA	2004	NA	-20475	Dead	TUMOR FREE	NA	1432	NA	NA	NA	NA	NA	NA	NA	NA	1	1432	0	1432	NA	NA	0	1432	
70	TCGA-G5-6641	0	7	1	3	1	1	2	1	0	81	4	0	1	30	3	0	TCGA-G5-6641-01	127	0.5493664878625519	67	TCGA-G5-6641-01	6	8	23	0.1516800156681071	TCGA-G5-6641-01	7	4	5	16	PASS	8536	TCGA-G5-6641	READ	67	MALE	WHITE	Stage IIIA	NA	Rectal Mucinous Adenocarcinoma	NA	2009	NA	-24486	Alive	TUMOR FREE	804	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	804	0	804	NA	NA	0	804	
70	TCGA-3B-A9HI	0	6	0	3	4	0	0	0	0	33	2	0	1	11	0	0	TCGA-3B-A9HI-01	492	0.6779319488016331	362	TCGA-3B-A9HI-01	21	28	122	0.1758530092308595	TCGA-3B-A9HI-01	20	19	11	50	PASS	8537	TCGA-3B-A9HI	SARC	68	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2009	NA	-24984	Alive	WITH TUMOR	1521	NA	NA	Locoregional Recurrence	NA	NA	606	NA	Positive	R1	0	1521	0	1521	NA	NA	1	606	
70	TCGA-3B-A9HJ	0	4	0	2	0	0	0	0	1	16	1	0	1	7	1	0	TCGA-3B-A9HJ-01	265	0.00524752431660282	194	TCGA-3B-A9HJ-01	0	0	20	0.000465426758033051	TCGA-3B-A9HJ-01	0	0	0	0	pathology review	8538	TCGA-3B-A9HJ	SARC	68	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2011	NA	-24962	Alive	TUMOR FREE	1104	NA	NA	NA	NA	NA	NA	NA	[Unknown]	RX	0	1104	0	1104	NA	NA	0	1104	
70	TCGA-3B-A9HL	2	5	0	4	0	0	0	0	4	45	1	0	1	10	2	0	TCGA-3B-A9HL-01	769	0.6817628555296481	592	TCGA-3B-A9HL-01	7	8	83	0.06237693048955049	TCGA-3B-A9HL-01	15	11	2	28	PASS	8539	TCGA-3B-A9HL	SARC	67	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2011	NA	-24628	Dead	TUMOR FREE	NA	599	NA	Locoregional Recurrence	"Other, specify"	Retroperitoneum	229	NA	Positive	R1	1	599	0	599	NA	NA	1	229	
80	TCGA-3B-A9HO	0	7	0	3	1	1	0	0	2	51	1	0	4	18	2	0	TCGA-3B-A9HO-01	752	0.3346025665880038	579	TCGA-3B-A9HO-01	10	13	92	0.07937533595162159	TCGA-3B-A9HO-01	6	2	4	12	PASS	8540	TCGA-3B-A9HO	SARC	75	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2012	NA	-27664	Alive	TUMOR FREE	959	NA	NA	New Primary Tumor	"Other, specify"	Abdominal Wall	595	NA	Positive	R1	0	959	0	959	NA	NA	1	595	
60	TCGA-3B-A9HP	0	9	0	2	3	0	0	0	2	40	7	0	1	10	3	0	TCGA-3B-A9HP-01	111	0.17623200681768764	59	TCGA-3B-A9HP-01	7	8	48	0.0904964912923768	TCGA-3B-A9HP-01	6	2	3	11	PASS	8541	TCGA-3B-A9HP	SARC	57	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2007	NA	-21094	Dead	WITH TUMOR	NA	1627	NA	Distant Metastasis	Lung	NA	517	NA	Positive	R1	1	1627	1	1627	NA	NA	1	517	
70	TCGA-3B-A9HQ	1	15	0	3	6	0	1	0	8	50	2	0	1	15	5	0	TCGA-3B-A9HQ-01	95	0.2615799579968491	44	TCGA-3B-A9HQ-01	6	7	57	0.1714621057588908	TCGA-3B-A9HQ-01	4	6	5	15	PASS	8542	TCGA-3B-A9HQ	SARC	66	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2007	NA	-24386	Alive	NA	2085	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	2085	0	2085	0	2085	0	2085	
40	TCGA-3B-A9HR	1	11	1	5	1	0	0	0	5	27	1	0	0	7	0	0	TCGA-3B-A9HR-01	202	0.6428460671153486	122	TCGA-3B-A9HR-01	22	27	65	0.19284847404058308	TCGA-3B-A9HR-01	17	12	8	37	PASS	8543	TCGA-3B-A9HR	SARC	38	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Leiomyosarcoma (LMS)	NA	2007	NA	-14041	Dead	WITH TUMOR	NA	2694	NA	Distant Metastasis	Lung	NA	496	NA	Negative	R0	1	2694	1	2694	1	496	1	496	
60	TCGA-3B-A9HS	1	13	0	3	0	1	0	0	2	53	5	0	0	17	0	0	TCGA-3B-A9HS-01	733	0.624813447219989	547	TCGA-3B-A9HS-01	15	28	117	0.15629483786848772	TCGA-3B-A9HS-01	17	19	8	44	PASS	8544	TCGA-3B-A9HS	SARC	60	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2008	NA	-21946	Dead	WITH TUMOR	NA	1366	NA	Locoregional Recurrence	NA	NA	139	NA	Negative	R0	1	1366	1	1366	1	139	1	139	
50	TCGA-3B-A9HT	3	81	2	8	26	19	3	0	15	241	9	0	6	90	1	0	TCGA-3B-A9HT-01	107	0.1429946237839872	49	TCGA-3B-A9HT-01	1	22	6	0.00036919748466186775	TCGA-3B-A9HT-01	0	0	0	0	PASS	8545	TCGA-3B-A9HT	SARC	53	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-19637	Alive	TUMOR FREE	1665	NA	NA	New Primary Tumor	Liver	NA	670	NA	Negative	R0	0	1665	0	1665	0	1665	1	670	
50	TCGA-3B-A9HU	0	12	1	0	1	0	0	0	1	25	0	0	2	11	1	0	TCGA-3B-A9HU-01	111	0.9253038234624784	54	TCGA-3B-A9HU-01	5	7	72	0.19929965924226228	TCGA-3B-A9HU-01	8	3	9	20	PASS	8546	TCGA-3B-A9HU	SARC	53	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-19669	Alive	WITH TUMOR	768	NA	NA	Distant Metastasis	Lung	NA	631	NA	Negative	R0	0	768	0	768	1	631	1	631	
50	TCGA-3B-A9HV	1	13	2	2	2	0	2	0	5	38	1	0	1	12	2	0	TCGA-3B-A9HV-01	286	0.9310627471444984	187	TCGA-3B-A9HV-01	2	4	103	0.11852224032293684	TCGA-3B-A9HV-01	9	10	5	24	PASS	8547	TCGA-3B-A9HV	SARC	48	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-17638	Dead	WITH TUMOR	NA	437	NA	Distant Metastasis	Lung	NA	41	NA	Negative	RX	1	437	1	437	NA	NA	1	41	
70	TCGA-3B-A9HX	2	8	0	2	2	0	0	0	2	35	2	0	0	13	0	0	TCGA-3B-A9HX-01	415	0.6824172412456956	316	TCGA-3B-A9HX-01	24	20	253	0.3213497626160019	TCGA-3B-A9HX-01	11	9	11	31	PASS	8548	TCGA-3B-A9HX	SARC	70	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-25627	Alive	TUMOR FREE	1303	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1303	0	1303	0	1303	0	1303	
50	TCGA-3B-A9HY	0	14	0	2	1	0	0	0	2	41	3	0	1	20	0	0	TCGA-3B-A9HY-01	143	0.9419179739327682	76	TCGA-3B-A9HY-01	7	6	69	0.1912506508381164	TCGA-3B-A9HY-01	8	1	6	15	PASS	8549	TCGA-3B-A9HY	SARC	49	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-18109	Alive	TUMOR FREE	314	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	314	0	314	0	314	0	314	
70	TCGA-3B-A9HZ	1	8	0	6	0	0	1	0	2	23	1	0	2	16	1	0	TCGA-3B-A9HZ-01	122	0.5160628068245882	55	TCGA-3B-A9HZ-01	4	7	69	0.17733231876418834	TCGA-3B-A9HZ-01	7	3	6	16	PASS	8550	TCGA-3B-A9HZ	SARC	66	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-24433	Alive	WITH TUMOR	1170	NA	NA	Distant Metastasis	Lung	NA	309	NA	Positive	R1	0	1170	0	1170	NA	NA	1	309	
30	TCGA-3B-A9I0	0	6	0	1	0	0	1	0	3	25	3	0	0	5	0	0	TCGA-3B-A9I0-01	124	0.6177701717337525	64	TCGA-3B-A9I0-01	4	6	58	0.1422036950248489	TCGA-3B-A9I0-01	7	5	5	17	PASS	8551	TCGA-3B-A9I0	SARC	33	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-12148	Alive	WITH TUMOR	1096	NA	NA	Distant Metastasis	Liver	NA	503	NA	Negative	R0	0	1096	0	1096	1	503	1	503	
60	TCGA-3B-A9I1	0	10	0	1	0	1	0	0	4	23	5	0	1	9	0	0	TCGA-3B-A9I1-01	229	0.622272715649973	159	TCGA-3B-A9I1-01	19	18	83	0.15329728917173785	TCGA-3B-A9I1-01	9	5	5	19	PASS	8552	TCGA-3B-A9I1	SARC	56	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	-20629	Dead	WITH TUMOR	NA	567	NA	Distant Metastasis	"Other, specify"	Pelvis	192	NA	Negative	RX	1	567	1	567	NA	NA	1	192	
60	TCGA-3B-A9I3	2	7	2	4	0	0	0	0	2	41	0	0	6	13	2	0	TCGA-3B-A9I3-01	114	0.7271174969865714	57	TCGA-3B-A9I3-01	11	13	126	0.4038585770186564	TCGA-3B-A9I3-01	11	9	14	34	PASS	8553	TCGA-3B-A9I3	SARC	62	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	-22985	Alive	TUMOR FREE	808	NA	NA	New Primary Tumor	"Other, specify"	Axillary Lymph Node	87	NA	Positive	R1	0	808	0	808	NA	NA	1	87	
70	TCGA-3R-A8YX	0	14	2	11	2	0	0	0	2	58	4	0	2	17	1	0	TCGA-3R-A8YX-01	471	0.6804939360410401	321	TCGA-3R-A8YX-01	21	39	118	0.15648229740524688	TCGA-3R-A8YX-01	21	21	9	51	PASS	8554	TCGA-3R-A8YX	SARC	66	MALE	[Not Evaluated]	NA	NA	Dedifferentiated liposarcoma	NA	2013	NA	-24412	Dead	WITH TUMOR	NA	17	NA	NA	NA	NA	NA	NA	Positive	R2	1	17	1	17	NA	NA	1	17	
80	TCGA-DX-A1KU	3	11	1	0	1	0	0	0	5	44	0	0	0	12	1	0	TCGA-DX-A1KU-01	644	0.3804308263069957	474	TCGA-DX-A1KU-01	19	25	122	0.14522510730199406	TCGA-DX-A1KU-01	6	8	2	16	PASS	8555	TCGA-DX-A1KU	SARC	82	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2010	NA	-30054	Dead	WITH TUMOR	NA	427	NA	Distant Metastasis	"Other, specify"	Abdomen	94	NA	NA	R2	1	427	1	427	NA	NA	1	94	
70	TCGA-DX-A1KW	0	4	2	0	1	0	0	0	4	31	1	0	2	14	0	0	TCGA-DX-A1KW-01	509	0.6517847363757223	359	TCGA-DX-A1KW-01	25	23	182	0.19243561140569865	TCGA-DX-A1KW-01	13	7	7	27	PASS	8556	TCGA-DX-A1KW	SARC	67	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2009	NA	-24647	Dead	NA	NA	995	NA	NA	NA	NA	NA	NA	NA	R1	1	995	NA	995	NA	NA	0	995	
70	TCGA-DX-A1KX	1	17	0	2	2	0	0	0	9	59	8	0	4	25	0	0	TCGA-DX-A1KX-01	757	0.7747671048173573	550	TCGA-DX-A1KX-01	21	59	414	0.5936893038220583	TCGA-DX-A1KX-01	32	32	7	71	PASS	8557	TCGA-DX-A1KX	SARC	67	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2009	NA	-24784	Alive	TUMOR FREE	2087	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2087	0	2087	0	2087	0	2087	
70	TCGA-DX-A1KY	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DX-A1KY-01	781	0.6624249895817927	602	TCGA-DX-A1KY-01	15	42	446	0.5954987380979277	TCGA-DX-A1KY-01	22	15	17	54	PASS	8558	TCGA-DX-A1KY	SARC	66	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2009	NA	-24281	Dead	WITH TUMOR	NA	391	NA	Distant Metastasis	NA	NA	205	NA	NA	R1	1	391	1	391	NA	NA	1	205	
70	TCGA-DX-A1KZ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DX-A1KZ-01	822	0.4023390884991456	599	TCGA-DX-A1KZ-01	7	14	75	0.0435977052701402	TCGA-DX-A1KZ-01	10	16	1	27	PASS	8559	TCGA-DX-A1KZ	SARC	66	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2009	NA	-24362	Alive	WITH TUMOR	1372	NA	NA	Locoregional Recurrence	"Other, specify"	NA	1294	NA	NA	R1	0	1372	0	1372	NA	NA	1	1294	
60	TCGA-DX-A1L0	2	17	3	5	1	0	0	0	6	61	5	0	1	24	3	0	TCGA-DX-A1L0-01	1000	0.9432683203619492	761	TCGA-DX-A1L0-01	12	36	348	0.2255436763046884	TCGA-DX-A1L0-01	25	28	8	61	PASS	8560	TCGA-DX-A1L0	SARC	58	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2008	NA	-21434	Dead	WITH TUMOR	NA	564	NA	Locoregional Recurrence	NA	NA	103	NA	NA	R1	1	564	1	564	NA	NA	1	103	
60	TCGA-DX-A1L1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DX-A1L1-01	188	0.4230830997010957	112	TCGA-DX-A1L1-01	11	28	195	0.6184213790197554	TCGA-DX-A1L1-01	16	16	8	40	PASS	8561	TCGA-DX-A1L1	SARC	60	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2008	NA	-22218	Dead	WITH TUMOR	NA	1649	NA	Locoregional Recurrence	NA	NA	349	NA	NA	R0	1	1649	1	1649	1	349	1	349	
80	TCGA-DX-A1L2	1	32	2	7	0	1	0	1	8	104	4	1	4	45	4	0	TCGA-DX-A1L2-01	466	0.5596870001068133	309	TCGA-DX-A1L2-01	10	29	108	0.20408351097124608	TCGA-DX-A1L2-01	14	16	9	39	pathology review	8562	TCGA-DX-A1L2	SARC	78	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2008	NA	-28692	Alive	WITH TUMOR	2586	NA	NA	Locoregional Recurrence	NA	NA	1480	NA	NA	R0	0	2586	0	2586	1	1480	1	1480	
60	TCGA-DX-A1L3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DX-A1L3-01	261	0.04992481475932381	178	TCGA-DX-A1L3-01	1	2	22	0.02361703082932563	TCGA-DX-A1L3-01	4	0	1	5	PASS	8563	TCGA-DX-A1L3	SARC	60	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2009	NA	-22240	Dead	WITH TUMOR	NA	1020	NA	Locoregional Recurrence	NA	NA	437	NA	NA	R1	1	1020	1	1020	NA	NA	1	437	
60	TCGA-DX-A1L4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DX-A1L4-01	395	0.01094832926522654	306	TCGA-DX-A1L4-01	0	0	51	0.004069959944694033	TCGA-DX-A1L4-01	0	3	0	3	PASS	8564	TCGA-DX-A1L4	SARC	60	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2009	NA	-22195	Alive	WITH TUMOR	2036	NA	NA	Locoregional Recurrence	NA	NA	340	NA	NA	R0	0	2036	0	2036	1	340	1	340	
60	TCGA-DX-A23R	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DX-A23R-01	530	0.7370097326667824	371	TCGA-DX-A23R-01	3	6	139	0.13403701857714506	TCGA-DX-A23R-01	10	6	5	21	PASS	8565	TCGA-DX-A23R	SARC	55	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2002	NA	-20442	Alive	TUMOR FREE	2271	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	2271	0	2271	NA	NA	0	2271	
40	TCGA-DX-A23T	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DX-A23T-01	600	0.1050187803187186	444	TCGA-DX-A23T-01	0	2	50	0.0031049284985360326	TCGA-DX-A23T-01	1	4	0	5	PASS	8566	TCGA-DX-A23T	SARC	40	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2006	NA	-14892	Dead	WITH TUMOR	NA	160	NA	Locoregional Recurrence	NA	NA	104	NA	NA	R1	1	160	1	160	NA	NA	1	104	
80	TCGA-DX-A23U	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DX-A23U-01	243	0.013714412431868472	170	TCGA-DX-A23U-01	0	0	18	0.0009069507908372627	TCGA-DX-A23U-01	1	0	0	1	PASS	8567	TCGA-DX-A23U	SARC	81	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2003	NA	-29905	Dead	WITH TUMOR	NA	2324	NA	Locoregional Recurrence	NA	NA	873	NA	NA	R1	1	2324	1	2324	NA	NA	1	873	
60	TCGA-DX-A23V	1	3	0	0	0	0	0	0	1	13	0	0	2	4	0	0	TCGA-DX-A23V-01	303	0.03150963098153239	215	TCGA-DX-A23V-01	0	1	15	0.013420741029298022	TCGA-DX-A23V-01	1	1	1	3	PASS	8568	TCGA-DX-A23V	SARC	57	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2003	NA	-21155	Dead	WITH TUMOR	NA	2034	NA	Locoregional Recurrence	NA	NA	378	NA	NA	R1	1	2034	1	2034	NA	NA	1	378	
80	TCGA-DX-A23Y	0	6	0	0	1	0	0	0	4	33	1	0	2	14	3	0	TCGA-DX-A23Y-01	783	0.7022007092882232	574	TCGA-DX-A23Y-01	18	25	203	0.15887204106345315	TCGA-DX-A23Y-01	21	15	9	45	PASS	8569	TCGA-DX-A23Y	SARC	80	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2006	NA	-29272	Dead	WITH TUMOR	NA	191	NA	Locoregional Recurrence	NA	NA	172	NA	NA	R1	1	191	1	191	NA	NA	1	172	
70	TCGA-DX-A23Z	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DX-A23Z-01	575	0.06356461131256809	433	TCGA-DX-A23Z	0	0	0	0	TCGA-DX-A23Z	0	0	0	0	PASS	8570	TCGA-DX-A23Z	SARC	74	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2006	NA	-27357	Dead	WITH TUMOR	NA	846	NA	Locoregional Recurrence	NA	NA	751	NA	NA	R1	1	846	1	846	NA	NA	1	751	
50	TCGA-DX-A240	0	10	0	2	1	0	0	0	0	14	2	0	1	6	0	0	TCGA-DX-A240-01	380	0.10817374553013796	277	TCGA-DX-A240-01	1	1	10	0.0002802358924979729	TCGA-DX-A240-01	0	0	0	0	PASS	8571	TCGA-DX-A240	SARC	51	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2006	NA	-18721	Alive	TUMOR FREE	1834	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1834	0	1834	0	1834	0	1834	
60	TCGA-DX-A2IZ	1	14	1	3	3	0	1	0	1	32	1	0	0	13	0	0	TCGA-DX-A2IZ-01	497	0.15805219249441607	378	TCGA-DX-A2IZ-01	7	5	109	0.11618271675757125	TCGA-DX-A2IZ-01	4	0	0	4	PASS	8572	TCGA-DX-A2IZ	SARC	60	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2007	NA	-22245	Alive	TUMOR FREE	261	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	261	0	261	0	261	0	261	
60	TCGA-DX-A2J0	0	9	1	1	2	0	0	0	2	29	3	0	2	10	0	0	TCGA-DX-A2J0-01	807	0.763058043461813	647	TCGA-DX-A2J0-01	8	7	157	0.1729966316169397	TCGA-DX-A2J0-01	5	2	7	14	PASS	8573	TCGA-DX-A2J0	SARC	61	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2005	NA	-22369	Dead	WITH TUMOR	NA	295	NA	Locoregional Recurrence	NA	NA	213	NA	NA	R1	1	295	1	295	NA	NA	1	213	
50	TCGA-DX-A2J1	0	7	1	1	0	0	0	0	1	20	3	0	0	9	0	0	TCGA-DX-A2J1-01	266	0.015545278905307653	175	TCGA-DX-A2J1-01	0	0	4	0.00012154985654430052	TCGA-DX-A2J1-01	0	0	0	0	PASS	8574	TCGA-DX-A2J1	SARC	53	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2007	NA	-19707	Alive	TUMOR FREE	2901	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	2901	0	2901	NA	NA	0	2901	
60	TCGA-DX-A2J4	2	4	0	1	1	1	0	0	3	16	3	0	1	10	0	0	TCGA-DX-A2J4-01	311	0.007840226752614405	220	TCGA-DX-A2J4-01	0	0	21	0.0006304291891727425	TCGA-DX-A2J4-01	0	0	0	0	PASS	8575	TCGA-DX-A2J4	SARC	60	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2008	NA	-22131	Alive	TUMOR FREE	2408	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2408	0	2408	0	2408	0	2408	
80	TCGA-DX-A3LS	2	7	0	2	2	0	0	0	0	36	1	0	1	18	2	0	TCGA-DX-A3LS-01	716	0.2879573387161814	520	TCGA-DX-A3LS-01	10	11	184	0.2353725696018868	TCGA-DX-A3LS-01	13	2	7	22	PASS	8576	TCGA-DX-A3LS	SARC	78	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2011	NA	-28649	Dead	WITH TUMOR	NA	275	NA	Distant Metastasis	Lung	NA	114	NA	NA	R1	1	275	1	275	NA	NA	1	114	
60	TCGA-DX-A3LT	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DX-A3LT-01	530	0.6951132389830247	408	TCGA-DX-A3LT-01	9	14	167	0.21810308744593654	TCGA-DX-A3LT-01	9	5	7	21	PASS	8577	TCGA-DX-A3LT	SARC	62	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2011	NA	-22837	Alive	WITH TUMOR	1492	NA	NA	Locoregional Recurrence	NA	NA	568	NA	Negative	R0	0	1492	0	1492	1	568	1	568	
60	TCGA-DX-A3LU	0	11	0	0	0	0	1	0	0	26	0	0	0	11	0	1	TCGA-DX-A3LU-01	362	0.06748084614699383	259	TCGA-DX-A3LU-01	1	3	23	0.02392449951801617	TCGA-DX-A3LU-01	2	5	1	8	PASS	8578	TCGA-DX-A3LU	SARC	60	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2007	NA	-21915	Alive	TUMOR FREE	2641	NA	NA	Locoregional Recurrence	"Other, specify"	Retroperitoneum	290	NA	Positive	R1	0	2641	0	2641	NA	NA	1	290	
40	TCGA-DX-A3LW	0	8	0	0	0	0	0	0	2	25	0	0	0	10	0	0	TCGA-DX-A3LW-01	437	0.22465231890007947	317	TCGA-DX-A3LW-01	2	3	70	0.060078960267786835	TCGA-DX-A3LW-01	7	4	4	15	PASS	8579	TCGA-DX-A3LW	SARC	43	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2004	NA	-15969	Alive	WITH TUMOR	4150	NA	NA	Locoregional Recurrence	NA	NA	1125	NA	Positive	R1	0	4150	0	4150	NA	NA	1	1125	
70	TCGA-DX-A3LY	6	10	0	1	3	0	0	0	4	36	4	0	2	14	0	0	TCGA-DX-A3LY-01	828	0.605059651688871	631	TCGA-DX-A3LY-01	9	18	139	0.056122590113351085	TCGA-DX-A3LY-01	13	12	2	27	PASS	8580	TCGA-DX-A3LY	SARC	66	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2011	NA	-24166	Alive	TUMOR FREE	1017	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1017	0	1017	0	1017	0	1017	
80	TCGA-DX-A3M1	0	11	2	2	1	1	0	0	6	60	2	0	2	15	0	0	TCGA-DX-A3M1-01	1613	0.8867898222703328	1301	TCGA-DX-A3M1-01	5	17	213	0.1777365143696121	TCGA-DX-A3M1-01	15	20	7	42	PASS	8581	TCGA-DX-A3M1	SARC	79	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2010	NA	-28932	Alive	WITH TUMOR	1359	NA	NA	Locoregional Recurrence	"Other, specify"	Retroperitoneum	1212	NA	Positive	R2	0	1359	0	1359	NA	NA	1	1212	
60	TCGA-DX-A3M2	1	13	3	3	1	0	0	0	6	85	3	0	3	35	1	0	TCGA-DX-A3M2-01	220	0.4747332683746179	125	TCGA-DX-A3M2-01	18	32	30	0.29375908838048675	TCGA-DX-A3M2-01	21	17	9	47	PASS	8582	TCGA-DX-A3M2	SARC	59	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2011	NA	-21689	Alive	WITH TUMOR	1055	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	1055	0	1055	NA	NA	0	1055	
50	TCGA-DX-A3U5	0	7	0	2	0	0	0	0	1	26	0	0	0	7	0	0	TCGA-DX-A3U5-01	684	0.2808993312307714	503	TCGA-DX-A3U5-01	5	8	107	0.22248188939501945	TCGA-DX-A3U5-01	18	15	6	39	PASS	8583	TCGA-DX-A3U5	SARC	52	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2011	NA	-19088	Alive	TUMOR FREE	969	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	969	0	969	NA	NA	0	969	
60	TCGA-DX-A3U6	0	1	0	0	0	0	0	0	0	2	0	0	0	1	0	0	TCGA-DX-A3U6-01	255	0.013392036850559523	152	TCGA-DX-A3U6-01	0	0	36	0.010518517186655729	TCGA-DX-A3U6-01	1	1	1	3	PASS	8584	TCGA-DX-A3U6	SARC	63	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2011	NA	-23193	Dead	WITH TUMOR	NA	1088	NA	Locoregional Recurrence	NA	NA	160	NA	Negative	R0	1	1088	1	1088	1	160	1	160	
70	TCGA-DX-A3U7	0	14	0	2	1	1	0	0	2	27	2	0	1	8	0	0	TCGA-DX-A3U7-01	386	0.6909151101708862	266	TCGA-DX-A3U7-01	18	28	193	0.3220779258448937	TCGA-DX-A3U7-01	26	17	12	55	PASS	8585	TCGA-DX-A3U7	SARC	67	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2009	NA	-24723	Dead	WITH TUMOR	NA	1552	NA	Distant Metastasis	Lung	NA	349	NA	Negative	R0	1	1552	1	1552	1	349	1	349	
40	TCGA-DX-A3U8	1	14	1	3	1	0	0	0	3	21	2	0	2	13	1	0	TCGA-DX-A3U8-01	67	0.23151488175232424	25	TCGA-DX-A3U8-01	8	4	11	0.03072983858576214	TCGA-DX-A3U8-01	0	2	3	5	PASS	8586	TCGA-DX-A3U8	SARC	43	MALE	[Unknown]	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-15751	Dead	WITH TUMOR	NA	138	NA	Distant Metastasis	Lung	NA	128	NA	NA	R0	1	138	1	138	1	128	1	128	
80	TCGA-DX-A3U9	1	14	1	1	2	1	0	0	7	45	3	0	1	25	1	0	TCGA-DX-A3U9-01	186	0.7305420691265897	107	TCGA-DX-A3U9-01	12	12	116	0.295168500923618	TCGA-DX-A3U9-01	15	9	12	36	PASS	8587	TCGA-DX-A3U9	SARC	84	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2005	NA	-31010	Dead	WITH TUMOR	NA	456	NA	Locoregional Recurrence	NA	NA	203	NA	NA	R1	1	456	1	456	NA	NA	1	203	
50	TCGA-DX-A3UA	1	9	0	3	0	0	0	0	1	25	1	0	0	5	0	0	TCGA-DX-A3UA-01	327	0.8380786398180236	252	TCGA-DX-A3UA-01	6	6	145	0.19090210124058785	TCGA-DX-A3UA-01	8	6	10	24	PASS	8588	TCGA-DX-A3UA	SARC	47	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2009	NA	-17342	Dead	[Discrepancy]	NA	325	NA	NA	NA	NA	NA	NA	NA	R0	1	325	NA	325	0	325	0	325	
50	TCGA-DX-A3UB	0	5	0	1	2	0	0	0	1	9	0	0	0	5	0	0	TCGA-DX-A3UB-01	72	0.02950885831986569	25	TCGA-DX-A3UB-01	1	2	25	0.0322832737017091	TCGA-DX-A3UB-01	2	2	3	7	PASS	8589	TCGA-DX-A3UB	SARC	54	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2009	NA	-19862	Alive	TUMOR FREE	2247	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	2247	0	2247	0	2247	0	2247	
40	TCGA-DX-A3UC	3	9	0	2	0	0	1	0	0	27	0	0	4	11	0	0	TCGA-DX-A3UC-01	111	0.9602899710832452	50	TCGA-DX-A3UC-01	6	7	48	0.16332710641488007	TCGA-DX-A3UC-01	9	4	9	22	PASS	8590	TCGA-DX-A3UC	SARC	37	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2009	NA	-13745	Alive	WITH TUMOR	2085	NA	NA	Distant Metastasis	Lung	NA	176	NA	Negative	R0	0	2085	0	2085	1	176	1	176	
60	TCGA-DX-A3UD	1	15	1	3	1	1	0	0	3	19	2	0	0	8	2	0	TCGA-DX-A3UD-01	147	0.9401642517140038	82	TCGA-DX-A3UD-01	18	21	122	0.30860772692153005	TCGA-DX-A3UD-01	12	11	6	29	PASS	8591	TCGA-DX-A3UD	SARC	56	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-20703	Alive	WITH TUMOR	1534	NA	NA	Locoregional Recurrence	NA	NA	603	NA	Negative	R0	0	1534	0	1534	1	603	1	603	
70	TCGA-DX-A3UE	2	15	2	3	0	1	1	0	7	50	2	0	4	19	0	0	TCGA-DX-A3UE-01	134	0.9245336999646032	69	TCGA-DX-A3UE-01	6	8	84	0.1510437425207598	TCGA-DX-A3UE-01	8	5	8	21	PASS	8592	TCGA-DX-A3UE	SARC	66	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2007	NA	-24388	Dead	WITH TUMOR	NA	1061	NA	Distant Metastasis	NA	NA	224	NA	NA	R0	1	1061	1	1061	1	224	1	224	
70	TCGA-DX-A3UF	1	16	0	0	0	1	0	0	2	46	1	0	1	11	0	0	TCGA-DX-A3UF-01	191	0.846663398726148	119	TCGA-DX-A3UF-01	11	10	107	0.3450549320629973	TCGA-DX-A3UF-01	14	7	14	35	PASS	8593	TCGA-DX-A3UF	SARC	65	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2007	NA	-23993	Dead	WITH TUMOR	NA	2599	NA	Locoregional Recurrence	NA	NA	964	NA	Positive	R1	1	2599	1	2599	NA	NA	1	964	
40	TCGA-DX-A48J	0	5	0	1	0	0	0	0	1	15	1	0	2	3	1	0	TCGA-DX-A48J-01	105	0.7133403122069798	52	TCGA-DX-A48J-01	1	4	57	0.12201852258903664	TCGA-DX-A48J-01	3	10	9	22	PASS	8594	TCGA-DX-A48J	SARC	44	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Leiomyosarcoma (LMS)	NA	2003	NA	-16279	Dead	WITH TUMOR	NA	296	NA	Locoregional Recurrence	NA	NA	97	NA	NA	R0	1	296	1	296	1	97	1	97	
70	TCGA-DX-A48K	0	4	0	0	0	0	1	0	2	21	1	0	4	4	0	0	TCGA-DX-A48K-01	180	0.4568104426750823	107	TCGA-DX-A48K-01	8	7	66	0.15766774075463055	TCGA-DX-A48K-01	8	2	6	16	PASS	8595	TCGA-DX-A48K	SARC	65	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-23756	Alive	TUMOR FREE	1399	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1399	0	1399	0	1399	0	1399	
50	TCGA-DX-A48L	3	11	1	3	3	0	1	0	7	40	3	0	5	19	0	0	TCGA-DX-A48L-01	240	0.7483408898799138	157	TCGA-DX-A48L-01	5	7	107	0.2171417153526112	TCGA-DX-A48L-01	5	6	5	16	PASS	8596	TCGA-DX-A48L	SARC	49	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-18113	Dead	WITH TUMOR	NA	738	NA	Distant Metastasis	Lung	NA	316	NA	NA	R0	1	738	1	738	1	316	1	316	
50	TCGA-DX-A48N	0	15	1	2	1	1	0	0	1	26	0	1	1	7	3	0	TCGA-DX-A48N-01	465	0.22130145368942766	317	TCGA-DX-A48N-01	2	12	32	0.03714391486320336	TCGA-DX-A48N-01	11	7	4	22	PASS	8597	TCGA-DX-A48N	SARC	47	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2012	NA	-17364	Alive	TUMOR FREE	1073	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	1073	0	1073	NA	NA	0	1073	
60	TCGA-DX-A48O	0	17	0	0	3	0	0	0	2	48	6	1	8	15	1	0	TCGA-DX-A48O-01	108	0.9475268326721824	47	TCGA-DX-A48O-01	5	9	56	0.2346572615282381	TCGA-DX-A48O-01	11	8	12	31	PASS	8598	TCGA-DX-A48O	SARC	63	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-23364	Alive	TUMOR FREE	1605	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1605	0	1605	0	1605	0	1605	
50	TCGA-DX-A48P	0	15	0	3	1	1	2	0	3	32	1	0	4	19	2	0	TCGA-DX-A48P-01	93	0.756878674533418	34	TCGA-DX-A48P-01	7	6	58	0.1670278156626562	TCGA-DX-A48P-01	7	3	7	17	PASS	8599	TCGA-DX-A48P	SARC	54	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-19794	Alive	TUMOR FREE	1400	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1400	0	1400	0	1400	0	1400	
40	TCGA-DX-A48R	1	8	2	1	1	1	2	0	5	37	3	0	1	12	2	0	TCGA-DX-A48R-01	188	0.8405624344192293	104	TCGA-DX-A48R-01	6	9	105	0.2665764782945816	TCGA-DX-A48R-01	11	8	10	29	PASS	8600	TCGA-DX-A48R	SARC	41	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2002	NA	-15107	Alive	WITH TUMOR	805	NA	NA	Locoregional Recurrence	NA	NA	315	NA	Positive	R1	0	805	0	805	NA	NA	1	315	
60	TCGA-DX-A48U	2	12	0	2	3	0	0	0	2	15	3	0	0	6	1	1	TCGA-DX-A48U-01	117	0.9476052726934332	58	TCGA-DX-A48U-01	4	6	60	0.1568297396536772	TCGA-DX-A48U-01	8	6	8	22	PASS	8601	TCGA-DX-A48U	SARC	57	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2005	NA	-20853	Alive	TUMOR FREE	3310	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	3310	0	3310	0	3310	0	3310	
80	TCGA-DX-A48V	1	19	1	2	0	0	0	0	0	35	1	0	3	8	1	0	TCGA-DX-A48V-01	96	0.8962421727153624	37	TCGA-DX-A48V-01	7	8	64	0.2267079247898868	TCGA-DX-A48V-01	9	4	9	22	PASS	8602	TCGA-DX-A48V	SARC	78	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-28754	Alive	TUMOR FREE	1820	NA	NA	Distant Metastasis	"Other, specify"	Flank	1407	NA	Negative	R0	0	1820	0	1820	1	1407	1	1407	
60	TCGA-DX-A6B7	0	23	1	0	1	1	0	0	1	21	1	0	0	11	0	0	TCGA-DX-A6B7-01	149	0.9099603167678209	86	TCGA-DX-A6B7-01	4	4	50	0.1402596638061122	TCGA-DX-A6B7-01	6	3	5	14	PASS	8603	TCGA-DX-A6B7	SARC	55	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	-20365	Alive	TUMOR FREE	1143	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1143	0	1143	0	1143	0	1143	
80	TCGA-DX-A6B8	3	10	0	1	0	2	0	0	6	38	2	0	0	17	1	0	TCGA-DX-A6B8-01	368	0.9293273248789616	263	TCGA-DX-A6B8-01	16	16	247	0.4947978156465228	TCGA-DX-A6B8-01	15	10	14	39	pathology review	8604	TCGA-DX-A6B8	SARC	80	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2002	NA	-29513	Dead	WITH TUMOR	NA	485	NA	Distant Metastasis	Lung	NA	42	NA	Positive	R0	1	485	1	485	1	42	1	42	
50	TCGA-DX-A6B9	0	4	0	1	0	0	0	0	0	13	1	0	0	5	0	0	TCGA-DX-A6B9-01	183	0.7891330555532278	132	TCGA-DX-A6B9-01	2	3	55	0.12627617648222886	TCGA-DX-A6B9-01	4	4	5	13	PASS	8605	TCGA-DX-A6B9	SARC	45	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	-16561	Alive	TUMOR FREE	1138	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1138	0	1138	0	1138	0	1138	
50	TCGA-DX-A6BA	0	13	1	0	4	0	1	1	1	37	1	0	1	12	1	0	TCGA-DX-A6BA-01	157	0.9040657187841378	84	TCGA-DX-A6BA-01	27	15	64	0.24212761149021106	TCGA-DX-A6BA-01	11	11	8	30	PASS	8606	TCGA-DX-A6BA	SARC	53	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2008	NA	-19455	Alive	WITH TUMOR	2515	NA	NA	Locoregional Recurrence	NA	NA	408	NA	Negative	R0	0	2515	0	2515	1	408	1	408	
70	TCGA-DX-A6BB	3	7	0	2	0	0	0	0	1	36	4	0	0	14	0	0	TCGA-DX-A6BB-01	117	0.3676009086870364	51	TCGA-DX-A6BB-01	8	10	38	0.09425003511463403	TCGA-DX-A6BB-01	7	5	7	19	PASS	8607	TCGA-DX-A6BB	SARC	74	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	-27150	Alive	WITH TUMOR	1105	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	1105	0	1105	NA	NA	0	1105	
80	TCGA-DX-A6BE	0	9	0	1	1	0	0	0	1	24	1	0	1	4	0	0	TCGA-DX-A6BE-01	392	0.010505409453252712	270	TCGA-DX-A6BE-01	0	0	30	0.0007634867879021227	TCGA-DX-A6BE-01	0	0	0	0	PASS	8608	TCGA-DX-A6BE	SARC	77	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2011	NA	-28368	Alive	TUMOR FREE	881	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	881	0	881	0	881	0	881	
80	TCGA-DX-A6BF	2	28	2	1	2	1	0	0	2	56	3	0	2	19	2	1	TCGA-DX-A6BF-01	504	0.4795066728864025	367	TCGA-DX-A6BF-01	13	17	61	0.09220813802878017	TCGA-DX-A6BF-01	14	11	3	28	PASS	8609	TCGA-DX-A6BF	SARC	82	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2012	NA	-30071	Alive	WITH TUMOR	972	NA	NA	Locoregional Recurrence	"Other, specify"	NA	947	NA	Positive	R1	0	972	0	972	NA	NA	1	947	
50	TCGA-DX-A6BG	1	4	0	1	2	0	0	0	1	14	0	0	0	7	0	0	TCGA-DX-A6BG-01	523	0.0366058953864545	368	TCGA-DX-A6BG-01	2	3	39	0.0016030596677890625	TCGA-DX-A6BG-01	1	1	0	2	PASS	8610	TCGA-DX-A6BG	SARC	51	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2012	NA	-18682	Alive	WITH TUMOR	1121	NA	NA	Locoregional Recurrence	NA	NA	149	NA	Negative	R0	0	1121	0	1121	1	149	1	149	
30	TCGA-DX-A6BH	0	5	0	3	0	0	0	0	1	12	1	0	1	2	0	0	TCGA-DX-A6BH-01	329	0.0427395118686724	230	TCGA-DX-A6BH-01	1	1	46	0.03249300836340774	TCGA-DX-A6BH-01	1	0	2	3	PASS	8611	TCGA-DX-A6BH	SARC	34	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2012	NA	-12742	Alive	WITH TUMOR	821	NA	NA	Locoregional Recurrence	NA	NA	232	NA	Positive	R1	0	821	0	821	NA	NA	1	232	
90	TCGA-DX-A6BK	1	16	1	4	1	0	0	0	2	39	7	0	1	16	3	0	TCGA-DX-A6BK-01	246	0.26276960745773104	154	TCGA-DX-A6BK-01	5	6	95	0.17304699960105552	TCGA-DX-A6BK-01	8	4	6	18	PASS	8612	TCGA-DX-A6BK	SARC	85	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2009	NA	-31159	Dead	TUMOR FREE	NA	492	NA	NA	NA	NA	NA	NA	Positive	R1	1	492	0	492	NA	NA	0	492	
90	TCGA-DX-A6YQ	4	23	2	4	0	0	1	0	5	71	5	0	1	31	1	0	TCGA-DX-A6YQ-01	411	0.912890532108194	285	TCGA-DX-A6YQ-01	18	30	260	0.5289763785066798	TCGA-DX-A6YQ-01	28	16	23	67	PASS	8613	TCGA-DX-A6YQ	SARC	86	FEMALE	[Unknown]	NA	NA	Myxofibrosarcoma	NA	2011	NA	-31421	Dead	TUMOR FREE	NA	93	NA	NA	NA	NA	NA	NA	Negative	R0	1	93	0	93	0	93	0	93	
80	TCGA-DX-A6YR	0	23	2	2	0	0	0	0	3	57	5	0	3	24	0	0	TCGA-DX-A6YR-01	730	0.7584980083596216	525	TCGA-DX-A6YR-01	16	34	282	0.32081143336575463	TCGA-DX-A6YR-01	24	15	14	53	PASS	8614	TCGA-DX-A6YR	SARC	75	MALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2011	NA	-27434	Alive	TUMOR FREE	1247	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1247	0	1247	0	1247	0	1247	
60	TCGA-DX-A6YS	6	74	3	21	2	0	1	0	14	365	6	1	10	70	9	0	TCGA-DX-A6YS-01	600	0.6324806654825627	438	TCGA-DX-A6YS-01	10	36	157	0.21564321779957216	TCGA-DX-A6YS-01	24	24	11	59	PASS	8615	TCGA-DX-A6YS	SARC	61	MALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2008	NA	-22310	Alive	TUMOR FREE	2381	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	2381	0	2381	0	2381	0	2381	
30	TCGA-DX-A6YT	12	93	2	22	0	0	0	0	32	551	8	0	3	99	9	2	TCGA-DX-A6YT-01	215	0.9061273920011368	133	TCGA-DX-A6YT-01	30	15	104	0.28955354099610314	TCGA-DX-A6YT-01	13	9	12	34	PASS	8616	TCGA-DX-A6YT	SARC	31	FEMALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2008	NA	-11633	Alive	TUMOR FREE	2044	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	2044	0	2044	0	2044	0	2044	
50	TCGA-DX-A6YU	0	10	1	1	2	0	1	0	2	31	2	0	0	13	0	0	TCGA-DX-A6YU-01	393	0.8244206566390672	289	TCGA-DX-A6YU-01	23	29	206	0.4117568945059745	TCGA-DX-A6YU-01	19	15	19	53	PASS	8617	TCGA-DX-A6YU	SARC	50	FEMALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2012	NA	-18351	Alive	TUMOR FREE	1045	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1045	0	1045	0	1045	0	1045	
70	TCGA-DX-A6YV	11	158	11	51	0	0	0	0	58	1126	17	2	24	190	21	0	TCGA-DX-A6YV-01	268	0.9888729783639226	174	TCGA-DX-A6YV-01	22	32	163	0.3781906141436219	TCGA-DX-A6YV-01	16	10	10	36	PASS	8618	TCGA-DX-A6YV	SARC	74	MALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2008	NA	-27053	Dead	WITH TUMOR	NA	1536	NA	Distant Metastasis	"Other, specify"	Groin - lymph nodes	516	NA	Negative	R0	1	1536	1	1536	1	516	1	516	
70	TCGA-DX-A6YX	0	20	0	2	2	0	1	0	1	39	1	0	4	19	0	0	TCGA-DX-A6YX-01	294	0.9458303130512574	189	TCGA-DX-A6YX-01	24	23	243	0.5490590706805194	TCGA-DX-A6YX-01	12	11	20	43	PASS	8619	TCGA-DX-A6YX	SARC	68	FEMALE	[Unknown]	NA	NA	Myxofibrosarcoma	NA	2005	NA	-24871	Dead	WITH TUMOR	NA	513	NA	Distant Metastasis	Lung	NA	200	NA	Negative	R0	1	513	1	513	1	200	1	200	
60	TCGA-DX-A6YZ	2	19	0	2	0	0	0	0	2	63	4	0	4	20	0	1	TCGA-DX-A6YZ-01	364	0.7526330002584404	235	TCGA-DX-A6YZ-01	19	27	99	0.2374971462257433	TCGA-DX-A6YZ-01	17	15	11	43	pathology review	8620	TCGA-DX-A6YZ	SARC	59	MALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2007	NA	-21886	Alive	TUMOR FREE	2625	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	2625	0	2625	0	2625	0	2625	
80	TCGA-DX-A6Z0	1	15	0	2	0	2	0	0	5	29	1	0	2	19	2	0	TCGA-DX-A6Z0-01	247	0.5911907702479949	154	TCGA-DX-A6Z0-01	15	55	234	0.7774908063591079	TCGA-DX-A6Z0-01	23	12	5	40	PASS	8621	TCGA-DX-A6Z0	SARC	78	FEMALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2006	NA	-28796	Dead	TUMOR FREE	NA	1953	NA	NA	NA	NA	NA	NA	Positive	R1	1	1953	0	1953	NA	NA	0	1953	
80	TCGA-DX-A6Z2	2	7	2	4	3	1	0	0	3	50	4	0	1	14	2	0	TCGA-DX-A6Z2-01	155	0.37849213191258096	90	TCGA-DX-A6Z2-01	9	10	74	0.1619906954021891	TCGA-DX-A6Z2-01	9	2	10	21	PASS	8622	TCGA-DX-A6Z2	SARC	82	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2007	NA	-30042	Alive	WITH TUMOR	3079	NA	NA	Distant Metastasis	Lung	NA	2659	NA	Positive	R0	0	3079	0	3079	1	2659	1	2659	
90	TCGA-DX-A7EF	0	16	0	2	0	0	0	0	4	35	2	0	1	16	2	0	TCGA-DX-A7EF-01	588	0.8167729006153265	436	TCGA-DX-A7EF-01	23	47	183	0.21257858583407604	TCGA-DX-A7EF-01	21	20	13	54	PASS	8623	TCGA-DX-A7EF	SARC	88	FEMALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2005	NA	-32302	Dead	WITH TUMOR	NA	648	NA	Distant Metastasis	Lung	NA	294	NA	Positive	R0	1	648	1	648	1	294	1	294	
80	TCGA-DX-A7EI	4	8	0	2	0	0	0	0	1	31	2	0	1	7	0	0	TCGA-DX-A7EI-01	486	0.6716337374893838	335	TCGA-DX-A7EI-01	23	19	124	0.290222948006346	TCGA-DX-A7EI-01	11	8	10	29	PASS	8624	TCGA-DX-A7EI	SARC	78	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2003	NA	-28610	Dead	WITH TUMOR	NA	1049	NA	Locoregional Recurrence	"Other, specify"	Retroperitoneum	828	NA	Positive	R1	1	1049	1	1049	NA	NA	1	828	
60	TCGA-DX-A7EL	0	14	1	2	2	0	1	0	0	35	0	0	2	12	1	0	TCGA-DX-A7EL-01	224	0.2418876040368016	159	TCGA-DX-A7EL-01	3	4	91	0.0907484753270426	TCGA-DX-A7EL-01	7	15	7	29	PASS	8625	TCGA-DX-A7EL	SARC	56	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2007	NA	-20767	Alive	TUMOR FREE	2291	NA	NA	Distant Metastasis	Lung	NA	2249	NA	Positive	R0	0	2291	0	2291	1	2249	1	2249	
60	TCGA-DX-A7EM	0	22	0	1	1	0	0	0	5	46	1	0	4	15	2	0	TCGA-DX-A7EM-01	149	0.9911132473596348	79	TCGA-DX-A7EM-01	16	27	69	0.18901762131821886	TCGA-DX-A7EM-01	6	3	3	12	PASS	8626	TCGA-DX-A7EM	SARC	61	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-22531	Alive	TUMOR FREE	1892	NA	NA	NA	NA	NA	NA	NA	Positive	R0	0	1892	0	1892	0	1892	0	1892	
50	TCGA-DX-A7EN	2	8	0	4	0	0	0	0	0	22	2	0	1	4	1	0	TCGA-DX-A7EN-01	142	0.9999769878352416	80	TCGA-DX-A7EN-01	6	9	73	0.22476696509836971	TCGA-DX-A7EN-01	8	6	5	19	PASS	8627	TCGA-DX-A7EN	SARC	53	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	-19588	Alive	WITH TUMOR	923	NA	NA	Distant Metastasis	Lung	NA	352	NA	Positive	R0	0	923	0	923	1	352	1	352	
30	TCGA-DX-A7EO	0	14	2	1	1	0	1	0	2	14	0	0	2	5	0	0	TCGA-DX-A7EO-01	45	0.08987109538327576	9	TCGA-DX-A7EO-01	3	2	21	0.10016093078759694	TCGA-DX-A7EO-01	1	0	2	3	PASS	8628	TCGA-DX-A7EO	SARC	20	FEMALE	WHITE	NA	NA	Synovial Sarcoma - Biphasic	NA	2002	NA	-7604	Alive	TUMOR FREE	4627	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	4627	0	4627	0	4627	0	4627	
70	TCGA-DX-A7EQ	1	8	1	2	1	0	0	0	1	28	4	0	2	10	1	0	TCGA-DX-A7EQ-01	45	0.015027297475547978	10	TCGA-DX-A7EQ-01	1	1	14	0.014267192545061732	TCGA-DX-A7EQ-01	2	0	2	4	PASS	8629	TCGA-DX-A7EQ	SARC	72	MALE	WHITE	NA	NA	Synovial Sarcoma - Monophasic	NA	2006	NA	-26503	Dead	WITH TUMOR	NA	897	NA	Distant Metastasis	Lung	NA	251	NA	Negative	R0	1	897	1	897	1	251	1	251	
70	TCGA-DX-A7ER	1	5	0	4	1	0	0	0	2	26	2	0	2	5	0	1	TCGA-DX-A7ER-01	83	0.0009684335042854807	36	TCGA-DX-A7ER-01	0	0	13	0.0004799770014629623	TCGA-DX-A7ER-01	0	0	0	0	PASS	8630	TCGA-DX-A7ER	SARC	69	MALE	WHITE	NA	NA	Synovial Sarcoma - Monophasic	NA	2008	NA	-25363	Dead	TUMOR FREE	NA	1466	NA	NA	NA	NA	NA	NA	Negative	R0	1	1466	0	1466	0	1466	0	1466	
50	TCGA-DX-A7ES	1	9	0	2	1	0	0	0	4	24	4	0	2	16	0	0	TCGA-DX-A7ES-01	290	0.018302943412903956	189	TCGA-DX-A7ES-01	1	1	14	0.0012078101528992962	TCGA-DX-A7ES-01	1	1	0	2	PASS	8631	TCGA-DX-A7ES	SARC	50	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2013	NA	-18528	Alive	TUMOR FREE	610	NA	NA	NA	NA	NA	NA	NA	Positive	R0	0	610	0	610	0	610	0	610	
70	TCGA-DX-A7ET	2	11	0	0	1	0	0	0	4	30	6	1	1	11	0	1	TCGA-DX-A7ET-01	238	0.7810386815244594	148	TCGA-DX-A7ET-01	22	39	143	0.3674953553216227	TCGA-DX-A7ET-01	18	7	16	41	PASS	8632	TCGA-DX-A7ET	SARC	71	MALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2013	NA	-26193	Alive	TUMOR FREE	463	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	463	0	463	0	463	0	463	
80	TCGA-DX-A7EU	6	16	1	2	0	1	0	0	2	64	1	0	2	21	2	0	TCGA-DX-A7EU	0	0	0	TCGA-DX-A7EU	0	0	0	0	TCGA-DX-A7EU	0	0	0	0	PASS	8633	TCGA-DX-A7EU	SARC	79	FEMALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2013	NA	-29211	Alive	TUMOR FREE	721	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	721	0	721	0	721	0	721	
80	TCGA-DX-A8BG	3	27	0	3	0	0	0	0	5	63	6	0	5	26	3	0	TCGA-DX-A8BG-01	400	0.7596339917757823	263	TCGA-DX-A8BG-01	12	66	100	0.22203494848929992	TCGA-DX-A8BG-01	28	24	14	66	pathology review	8634	TCGA-DX-A8BG	SARC	83	FEMALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2013	NA	-30333	Alive	TUMOR FREE	546	NA	NA	Distant Metastasis	Lung	NA	330	NA	Negative	R0	0	546	0	546	1	330	1	330	
90	TCGA-DX-A8BH	1	13	1	4	1	1	0	0	6	49	5	0	3	18	2	0	TCGA-DX-A8BH-01	350	0.6787722982429367	247	TCGA-DX-A8BH-01	20	29	95	0.22122786975236333	TCGA-DX-A8BH-01	20	16	10	46	PASS	8635	TCGA-DX-A8BH	SARC	86	MALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2013	NA	-31770	Dead	WITH TUMOR	NA	439	NA	Distant Metastasis	"Other, specify"	Pleura	272	NA	Positive	R0	1	439	1	439	1	272	1	272	
80	TCGA-DX-A8BJ	1	14	1	5	2	0	2	0	6	58	4	0	2	17	2	0	TCGA-DX-A8BJ-01	371	0.6856411143135914	254	TCGA-DX-A8BJ-01	18	53	368	0.8337332507762474	TCGA-DX-A8BJ-01	16	13	7	36	PASS	8636	TCGA-DX-A8BJ	SARC	76	MALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2011	NA	-28091	Dead	TUMOR FREE	NA	284	NA	NA	NA	NA	NA	NA	Negative	R0	1	284	0	284	0	284	0	284	
60	TCGA-DX-A8BK	1	1	0	1	1	0	0	0	2	21	0	0	1	8	1	0	TCGA-DX-A8BK-01	498	0.6998198048598836	354	TCGA-DX-A8BK-01	16	30	113	0.12781217786285493	TCGA-DX-A8BK-01	19	20	6	45	PASS	8637	TCGA-DX-A8BK	SARC	61	FEMALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2009	NA	-22407	Alive	TUMOR FREE	1885	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1885	0	1885	0	1885	0	1885	
60	TCGA-DX-A8BL	2	22	1	4	0	0	1	0	5	64	4	0	4	30	4	0	TCGA-DX-A8BL-01	547	0.8173633789100309	386	TCGA-DX-A8BL-01	14	32	189	0.2397729304477452	TCGA-DX-A8BL-01	17	20	12	49	PASS	8638	TCGA-DX-A8BL	SARC	59	MALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2011	NA	-21728	Alive	TUMOR FREE	1373	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1373	0	1373	0	1373	0	1373	
60	TCGA-DX-A8BM	3	17	1	2	1	1	0	0	5	59	5	0	2	20	2	0	TCGA-DX-A8BM-01	880	0.714163755755878	649	TCGA-DX-A8BM-01	13	34	205	0.2054450426746703	TCGA-DX-A8BM-01	24	26	10	60	PASS	8639	TCGA-DX-A8BM	SARC	60	MALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2011	NA	-22152	Alive	TUMOR FREE	1456	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1456	0	1456	0	1456	0	1456	
80	TCGA-DX-A8BN	0	11	0	1	0	0	0	0	0	34	3	0	0	13	0	0	TCGA-DX-A8BN-01	267	0.8050703517690707	171	TCGA-DX-A8BN-01	12	18	93	0.18719111248410136	TCGA-DX-A8BN-01	17	13	11	41	PASS	8640	TCGA-DX-A8BN	SARC	78	FEMALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2011	NA	-28760	Alive	TUMOR FREE	1161	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	1161	0	1161	NA	NA	0	1161	
70	TCGA-DX-A8BO	0	12	0	4	1	0	1	0	2	22	2	0	0	12	2	0	TCGA-DX-A8BO-01	209	0.7653859375689607	119	TCGA-DX-A8BO-01	10	13	144	0.394094257947714	TCGA-DX-A8BO-01	14	18	20	52	PASS	8641	TCGA-DX-A8BO	SARC	67	FEMALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2011	NA	-24513	Alive	TUMOR FREE	1240	NA	NA	Locoregional Recurrence	"Other, specify"	Calf	333	NA	Positive	R1	0	1240	0	1240	NA	NA	1	333	
90	TCGA-DX-A8BP	11	185	10	51	0	0	2	0	41	515	23	1	26	306	16	2	TCGA-DX-A8BP-01	112	0.4064865560301531	49	TCGA-DX-A8BP-01	12	13	67	0.27900510091197395	TCGA-DX-A8BP-01	12	9	11	32	pathology review	8642	TCGA-DX-A8BP	SARC	85	MALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2009	NA	-31382	Alive	WITH TUMOR	428	NA	NA	Distant Metastasis	Lung	NA	216	NA	Positive	R1	0	428	0	428	NA	NA	1	216	
60	TCGA-DX-A8BQ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DX-A8BQ	0	0	0	TCGA-DX-A8BQ	0	0	0	0	TCGA-DX-A8BQ	0	0	0	0	PASS	8643	TCGA-DX-A8BQ	SARC	63	MALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2010	NA	-23027	Alive	TUMOR FREE	1579	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1579	0	1579	0	1579	0	1579	
60	TCGA-DX-A8BR	1	7	0	2	1	0	0	0	3	33	3	0	1	13	1	0	TCGA-DX-A8BR-01	933	0.7141100739412132	712	TCGA-DX-A8BR-01	6	12	343	0.2683728205841789	TCGA-DX-A8BR-01	14	19	14	47	PASS	8644	TCGA-DX-A8BR	SARC	63	FEMALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2002	NA	-23302	Alive	TUMOR FREE	4573	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	4573	0	4573	0	4573	0	4573	
70	TCGA-DX-A8BS	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DX-A8BS-01	468	0.8026449666508956	326	TCGA-DX-A8BS	0	0	0	0	TCGA-DX-A8BS	0	0	0	0	PASS	8645	TCGA-DX-A8BS	SARC	68	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2006	NA	-25023	Dead	TUMOR FREE	NA	850	NA	NA	NA	NA	NA	NA	Positive	R0	1	850	0	850	0	850	0	850	
60	TCGA-DX-A8BT	1	23	0	7	0	0	0	0	4	60	8	0	1	30	2	1	TCGA-DX-A8BT-01	259	0.41919393792787535	171	TCGA-DX-A8BT-01	8	29	290	0.8559471054410984	TCGA-DX-A8BT-01	18	8	1	27	PASS	8646	TCGA-DX-A8BT	SARC	63	FEMALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2011	NA	-23204	Alive	TUMOR FREE	1230	NA	NA	Locoregional Recurrence	"Other, specify"	Axilla	668	NA	Positive	R1	0	1230	0	1230	NA	NA	1	668	
60	TCGA-DX-A8BU	2	20	1	3	5	1	0	0	5	65	3	0	1	25	1	0	TCGA-DX-A8BU-01	500	0.8432339007064295	367	TCGA-DX-A8BU-01	11	16	255	0.3432758421092566	TCGA-DX-A8BU-01	17	13	17	47	PASS	8647	TCGA-DX-A8BU	SARC	58	MALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2006	NA	-21470	Dead	WITH TUMOR	NA	1116	NA	Distant Metastasis	Lung	NA	107	NA	Positive	R1	1	1116	1	1116	NA	NA	1	107	
60	TCGA-DX-A8BV	1	22	1	6	1	0	0	0	4	52	2	0	3	20	0	0	TCGA-DX-A8BV-01	279	0.5084503907092139	182	TCGA-DX-A8BV-01	15	29	112	0.17492296624605058	TCGA-DX-A8BV-01	27	20	11	58	PASS	8648	TCGA-DX-A8BV	SARC	57	MALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2004	NA	-21005	Dead	WITH TUMOR	NA	1845	NA	Locoregional Recurrence	"Other, specify"	Retroperitoneum	357	NA	Negative	R0	1	1845	1	1845	1	357	1	357	
50	TCGA-DX-A8BX	1	17	0	2	3	1	0	0	4	52	2	0	2	32	2	0	TCGA-DX-A8BX-01	211	0.947917986720978	133	TCGA-DX-A8BX-01	24	34	208	0.525633963472704	TCGA-DX-A8BX-01	9	9	4	22	PASS	8649	TCGA-DX-A8BX	SARC	52	MALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2006	NA	-19339	Dead	WITH TUMOR	NA	591	NA	NA	NA	NA	NA	NA	Negative	R0	1	591	1	591	NA	NA	1	591	
80	TCGA-DX-A8BZ	0	10	0	3	2	0	0	0	9	34	0	0	1	21	1	0	TCGA-DX-A8BZ-01	145	0.7665346777195406	79	TCGA-DX-A8BZ-01	7	8	65	0.21617027211619896	TCGA-DX-A8BZ-01	8	12	11	31	PASS	8650	TCGA-DX-A8BZ	SARC	78	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Leiomyosarcoma (LMS)	NA	2013	NA	-28853	Dead	WITH TUMOR	NA	200	NA	Distant Metastasis	Lung	NA	90	NA	Positive	R0	1	200	1	200	1	90	1	90	
70	TCGA-DX-AATS	0	21	1	5	2	0	0	0	4	69	6	0	3	27	3	0	TCGA-DX-AATS-01	728	0.8336956733855702	552	TCGA-DX-AATS-01	21	61	380	0.5775890322869682	TCGA-DX-AATS-01	28	27	11	66	pathology review	8651	TCGA-DX-AATS	SARC	72	MALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2008	NA	-26624	Dead	TUMOR FREE	NA	35	NA	NA	NA	NA	NA	NA	Positive	R1	1	35	0	35	NA	NA	0	35	
60	TCGA-DX-AB2E	19	235	17	50	12	0	0	0	76	683	39	0	42	421	18	1	TCGA-DX-AB2E-01	218	0.6679737687499133	124	TCGA-DX-AB2E-01	28	43	84	0.2899392138645324	TCGA-DX-AB2E-01	17	8	11	36	hypermutated sample	8652	TCGA-DX-AB2E	SARC	60	MALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2013	NA	-22117	Alive	WITH TUMOR	541	NA	NA	Distant Metastasis	Lung	NA	132	NA	Positive	R0	0	541	0	541	1	132	1	132	
80	TCGA-DX-AB2F	0	15	0	3	2	0	0	0	1	35	0	0	1	8	0	0	TCGA-DX-AB2F-01	569	0.8337521829526892	404	TCGA-DX-AB2F-01	9	16	75	0.10367294799944107	TCGA-DX-AB2F-01	17	10	5	32	PASS	8653	TCGA-DX-AB2F	SARC	76	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2013	NA	-27840	Alive	TUMOR FREE	365	NA	NA	NA	NA	NA	NA	NA	Positive	R0	0	365	0	365	0	365	0	365	
40	TCGA-DX-AB2G	0	1	0	7	1	1	0	0	0	28	1	1	0	8	1	0	TCGA-DX-AB2G-01	436	0.10395405730029536	325	TCGA-DX-AB2G	0	0	0	0	TCGA-DX-AB2G	0	0	0	0	PASS	8654	TCGA-DX-AB2G	SARC	36	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2013	NA	-13239	Alive	TUMOR FREE	478	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	478	0	478	0	478	0	478	
80	TCGA-DX-AB2H	1	10	0	3	6	0	0	0	5	30	2	0	1	11	0	0	TCGA-DX-AB2H-01	452	0.7707086543063509	324	TCGA-DX-AB2H-01	2	5	146	0.1274885090128816	TCGA-DX-AB2H-01	8	10	5	23	PASS	8655	TCGA-DX-AB2H	SARC	80	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2013	NA	-29569	Alive	TUMOR FREE	482	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	482	0	482	0	482	0	482	
70	TCGA-DX-AB2J	2	10	0	3	2	0	0	0	3	25	0	0	0	10	2	0	TCGA-DX-AB2J-01	133	0.10165274170053032	76	TCGA-DX-AB2J-01	5	5	46	0.06494445759708302	TCGA-DX-AB2J-01	3	0	6	9	pathology review	8656	TCGA-DX-AB2J	SARC	71	FEMALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2006	NA	-26154	Dead	WITH TUMOR	NA	1235	NA	NA	NA	NA	NA	NA	Positive	R1	1	1235	1	1235	NA	NA	1	1235	
40	TCGA-DX-AB2L	0	8	0	0	0	0	0	0	0	12	2	0	0	1	0	0	TCGA-DX-AB2L-01	67	2.7815013576595313e-05	20	TCGA-DX-AB2L	0	0	0	0	TCGA-DX-AB2L	0	0	0	0	PASS	8657	TCGA-DX-AB2L	SARC	35	MALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2009	NA	-12974	Alive	TUMOR FREE	2007	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	2007	0	2007	NA	NA	0	2007	
80	TCGA-DX-AB2O	2	16	0	4	2	0	2	0	5	57	3	0	2	20	0	0	TCGA-DX-AB2O-01	1140	0.6912983352177647	903	TCGA-DX-AB2O-01	19	25	318	0.26132586866546365	TCGA-DX-AB2O-01	14	16	11	41	PASS	8658	TCGA-DX-AB2O	SARC	78	FEMALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2007	NA	-28757	Alive	TUMOR FREE	2619	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	2619	0	2619	0	2619	0	2619	
80	TCGA-DX-AB2P	0	14	0	1	2	1	0	0	2	30	6	0	2	14	2	0	TCGA-DX-AB2P-01	338	0.6159064255249066	235	TCGA-DX-AB2P-01	12	12	177	0.3777771916637285	TCGA-DX-AB2P-01	15	12	17	44	PASS	8659	TCGA-DX-AB2P	SARC	79	MALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2005	NA	-29136	Dead	WITH TUMOR	NA	367	NA	Locoregional Recurrence	NA	NA	161	NA	Negative	R0	1	367	1	367	1	161	1	161	
70	TCGA-DX-AB2Q	7	28	1	2	2	1	1	0	2	63	5	0	3	23	2	0	TCGA-DX-AB2Q-01	461	0.7229896263431546	289	TCGA-DX-AB2Q-01	19	51	244	0.4531350325115574	TCGA-DX-AB2Q-01	31	20	19	70	PASS	8660	TCGA-DX-AB2Q	SARC	65	FEMALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2009	NA	-23748	Alive	TUMOR FREE	2030	NA	NA	Distant Metastasis	"Other, specify"	inguinal lymph node	490	NA	Negative	R0	0	2030	0	2030	1	490	1	490	
50	TCGA-DX-AB2S	0	13	0	0	0	0	0	0	1	13	0	0	0	6	0	0	TCGA-DX-AB2S-01	200	0.04093393551656197	125	TCGA-DX-AB2S	0	0	0	0	TCGA-DX-AB2S	0	0	0	0	PASS	8661	TCGA-DX-AB2S	SARC	53	FEMALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2005	NA	-19708	Alive	TUMOR FREE	280	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	280	0	280	0	280	0	280	
50	TCGA-DX-AB2T	1	14	0	1	2	0	0	0	5	50	5	0	2	19	0	1	TCGA-DX-AB2T-01	627	0.9188790496130635	496	TCGA-DX-AB2T-01	14	17	258	0.2034157226554264	TCGA-DX-AB2T-01	26	23	12	61	PASS	8662	TCGA-DX-AB2T	SARC	54	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Myxofibrosarcoma	NA	2008	NA	-19749	Alive	TUMOR FREE	2369	NA	NA	Distant Metastasis	Lung	NA	784	NA	Negative	R0	0	2369	0	2369	1	784	1	784	
80	TCGA-DX-AB2V	1	19	0	3	1	0	1	0	5	69	1	0	6	34	3	0	TCGA-DX-AB2V-01	441	0.8051949315434628	316	TCGA-DX-AB2V-01	21	32	423	0.7624472795310041	TCGA-DX-AB2V-01	16	12	7	35	PASS	8663	TCGA-DX-AB2V	SARC	81	MALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2006	NA	-29716	Alive	TUMOR FREE	3241	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	3241	0	3241	0	3241	0	3241	
60	TCGA-DX-AB2W	4	19	2	5	2	0	1	0	9	116	7	0	5	31	5	0	TCGA-DX-AB2W-01	571	0.8634877237956046	376	TCGA-DX-AB2W-01	17	33	267	0.5181253460548184	TCGA-DX-AB2W-01	28	28	23	79	PASS	8664	TCGA-DX-AB2W	SARC	62	FEMALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2006	NA	-22951	Alive	TUMOR FREE	3238	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	3238	0	3238	0	3238	0	3238	
70	TCGA-DX-AB2X	3	14	2	4	1	1	0	0	3	33	5	0	2	15	2	0	TCGA-DX-AB2X-01	252	0.8806625453226712	154	TCGA-DX-AB2X-01	27	36	196	0.5422590746688726	TCGA-DX-AB2X-01	21	8	18	47	PASS	8665	TCGA-DX-AB2X	SARC	73	FEMALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2010	NA	-26736	Dead	WITH TUMOR	NA	404	NA	Locoregional Recurrence	NA	NA	111	NA	Negative	R0	1	404	1	404	1	111	1	111	
90	TCGA-DX-AB2Z	4	19	0	3	0	0	0	0	2	63	3	0	3	22	1	1	TCGA-DX-AB2Z-01	225	0.5324174114500317	144	TCGA-DX-AB2Z-01	14	38	131	0.21648096582573528	TCGA-DX-AB2Z-01	27	23	8	58	PASS	8666	TCGA-DX-AB2Z	SARC	87	FEMALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2010	NA	-31780	Alive	TUMOR FREE	1533	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1533	0	1533	0	1533	0	1533	
50	TCGA-DX-AB30	0	7	0	0	2	1	0	0	3	10	0	0	1	6	1	0	TCGA-DX-AB30-01	162	0.17075445983090673	99	TCGA-DX-AB30-01	4	24	260	0.926490760857182	TCGA-DX-AB30-01	4	2	0	6	pathology review	8667	TCGA-DX-AB30	SARC	53	FEMALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2004	NA	-19698	Dead	WITH TUMOR	NA	695	NA	Distant Metastasis	Lung	NA	504	NA	Negative	R0	1	695	1	695	1	504	1	504	
50	TCGA-DX-AB32	4	49	2	8	7	0	1	0	18	234	12	0	15	117	5	0	TCGA-DX-AB32-01	349	0.9164813303506184	245	TCGA-DX-AB32-01	10	14	214	0.3543646410379438	TCGA-DX-AB32-01	16	17	18	51	PASS	8668	TCGA-DX-AB32	SARC	51	MALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2006	NA	-18631	Alive	TUMOR FREE	3102	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	3102	0	3102	0	3102	0	3102	
70	TCGA-DX-AB35	0	11	0	0	0	0	0	0	3	42	2	0	0	6	1	0	TCGA-DX-AB35-01	215	0.7018435686606413	156	TCGA-DX-AB35-01	20	15	15	0.13198611308179478	TCGA-DX-AB35-01	11	12	4	27	PASS	8669	TCGA-DX-AB35	SARC	65	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2012	NA	-24026	Alive	WITH TUMOR	928	NA	NA	Locoregional Recurrence	"Other, specify"	Retroperitoneum	284	NA	Negative	R0	0	928	0	928	1	284	1	284	
90	TCGA-DX-AB36	1	7	0	0	0	0	0	0	2	24	4	0	0	11	0	0	TCGA-DX-AB36-01	469	0.158507641428387	325	TCGA-DX-AB36-01	2	2	36	0.026267965369698158	TCGA-DX-AB36-01	3	2	1	6	PASS	8670	TCGA-DX-AB36	SARC	86	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2008	NA	-31704	Dead	NA	NA	1825	NA	NA	NA	NA	NA	NA	Positive	R1	1	1825	NA	1825	NA	NA	0	1825	
70	TCGA-DX-AB37	6	18	0	4	2	0	0	0	0	42	1	0	3	22	3	0	TCGA-DX-AB37-01	559	0.28001212642789075	428	TCGA-DX-AB37-01	3	6	71	0.061355726216303724	TCGA-DX-AB37-01	3	9	4	16	PASS	8671	TCGA-DX-AB37	SARC	73	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2003	NA	-26696	Dead	NA	NA	2575	NA	NA	NA	NA	NA	NA	Negative	R0	1	2575	NA	2575	0	2575	0	2575	
80	TCGA-DX-AB3A	1	14	0	0	2	0	1	0	3	32	4	0	1	10	0	0	TCGA-DX-AB3A-01	706	0.2657456965257253	515	TCGA-DX-AB3A-01	5	10	90	0.09995167696065893	TCGA-DX-AB3A-01	11	5	7	23	PASS	8672	TCGA-DX-AB3A	SARC	80	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2009	NA	-29230	Dead	WITH TUMOR	NA	978	NA	Locoregional Recurrence	NA	NA	533	NA	Negative	R0	1	978	1	978	1	533	1	533	
30	TCGA-DX-AB3B	3	8	0	0	0	0	0	0	2	27	0	0	2	9	1	0	TCGA-DX-AB3B-01	146	0.0882094525906466	84	TCGA-DX-AB3B-01	2	1	26	0.058138258489012974	TCGA-DX-AB3B-01	0	2	1	3	PASS	8673	TCGA-DX-AB3B	SARC	28	FEMALE	WHITE	NA	NA	Synovial Sarcoma - Monophasic	NA	2009	NA	-10337	Alive	TUMOR FREE	1548	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1548	0	1548	0	1548	0	1548	
30	TCGA-DX-AB3C	1	8	0	2	1	0	0	0	4	18	1	0	1	7	0	0	TCGA-DX-AB3C-01	119	0.8120844415692122	66	TCGA-DX-AB3C-01	4	4	40	0.1038967864155803	TCGA-DX-AB3C-01	2	2	3	7	PASS	8674	TCGA-DX-AB3C	SARC	27	MALE	WHITE	NA	NA	Synovial Sarcoma - Monophasic	NA	2008	NA	-10034	Alive	WITH TUMOR	2169	NA	NA	Distant Metastasis	Lung	NA	567	NA	Positive	R0	0	2169	0	2169	1	567	1	567	
60	TCGA-FX-A2QS	4	23	4	9	2	4	2	0	2	83	10	0	8	37	4	0	TCGA-FX-A2QS-01	1310	0.5780185126264116	1000	TCGA-FX-A2QS-01	13	35	38	0.007770331331858803	TCGA-FX-A2QS-01	17	11	0	28	PASS	8675	TCGA-FX-A2QS	SARC	61	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2011	NA	-22422	Alive	TUMOR FREE	1495	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1495	0	1495	0	1495	0	1495	
50	TCGA-FX-A3NJ	1	5	2	1	1	0	1	0	0	13	1	0	3	5	0	0	TCGA-FX-A3NJ-01	80	0.17295688844995882	28	TCGA-FX-A3NJ-01	1	4	22	0.07919608762105375	TCGA-FX-A3NJ-01	4	4	4	12	PASS	8676	TCGA-FX-A3NJ	SARC	54	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-19903	Alive	TUMOR FREE	947	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	947	0	947	0	947	0	947	
50	TCGA-FX-A3NK	0	9	1	2	1	0	0	0	0	26	1	0	1	7	0	0	TCGA-FX-A3NK-01	529	0.2085421299784424	390	TCGA-FX-A3NK-01	5	11	114	0.18732337937658167	TCGA-FX-A3NK-01	7	3	11	21	PASS	8677	TCGA-FX-A3NK	SARC	53	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2011	NA	-19533	Alive	TUMOR FREE	505	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	505	0	505	0	505	0	505	
70	TCGA-FX-A3RE	2	27	0	8	1	0	0	0	3	94	5	0	6	40	3	0	TCGA-FX-A3RE-01	193	0.8283045246405183	115	TCGA-FX-A3RE-01	11	13	58	0.2576171151419053	TCGA-FX-A3RE-01	12	13	12	37	PASS	8678	TCGA-FX-A3RE	SARC	65	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-23757	Alive	TUMOR FREE	660	NA	NA	NA	NA	NA	NA	NA	[Unknown]	RX	0	660	0	660	NA	NA	0	660	
90	TCGA-FX-A3TO	2	18	1	6	0	0	0	0	8	45	5	2	2	27	2	0	TCGA-FX-A3TO-01	983	0.8271137429003659	724	TCGA-FX-A3TO-01	19	61	169	0.2299680570013372	TCGA-FX-A3TO-01	30	24	4	58	PASS	8679	TCGA-FX-A3TO	SARC	87	MALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2012	NA	-31868	Alive	TUMOR FREE	618	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	618	0	618	NA	NA	0	618	
60	TCGA-FX-A48G	2	19	0	5	5	0	0	0	10	44	2	0	2	24	4	0	TCGA-FX-A48G-01	295	0.931926245788193	192	TCGA-FX-A48G-01	6	11	175	0.2764648898573712	TCGA-FX-A48G-01	13	10	13	36	PASS	8680	TCGA-FX-A48G	SARC	56	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-20756	Dead	WITH TUMOR	NA	605	NA	Distant Metastasis	Lung	NA	168	NA	[Unknown]	RX	1	605	1	605	NA	NA	1	168	
50	TCGA-FX-A76Y	0	7	0	2	1	0	0	0	3	28	0	0	0	8	0	0	TCGA-FX-A76Y-01	170	0.19967108219508986	118	TCGA-FX-A76Y-01	1	5	86	0.10288049046215417	TCGA-FX-A76Y-01	4	3	4	11	PASS	8681	TCGA-FX-A76Y	SARC	49	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2013	NA	-18181	Alive	TUMOR FREE	471	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	471	0	471	0	471	0	471	
30	TCGA-FX-A8OO	1	11	0	0	0	0	0	0	1	29	2	0	2	5	0	0	TCGA-FX-A8OO-01	40	0.034117529508168286	6	TCGA-FX-A8OO-01	1	1	7	0.0026932926007506683	TCGA-FX-A8OO-01	1	0	0	1	PASS	8682	TCGA-FX-A8OO	SARC	31	FEMALE	WHITE	NA	NA	Sarcoma; synovial; poorly differentiated	NA	2013	NA	-11376	Dead	TUMOR FREE	NA	245	NA	NA	NA	NA	NA	NA	Negative	R0	1	245	0	245	0	245	0	245	
80	TCGA-HB-A2OT	1	15	0	5	4	0	0	0	4	53	4	0	3	17	1	0	TCGA-HB-A2OT-01	143	0.7147423627877748	85	TCGA-HB-A2OT-01	15	17	68	0.4070696333129749	TCGA-HB-A2OT-01	7	5	8	20	PASS	8683	TCGA-HB-A2OT	SARC	78	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2009	NA	-28632	Alive	TUMOR FREE	2057	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	2057	0	2057	0	2057	0	2057	
50	TCGA-HB-A3L4	0	10	0	1	3	0	0	0	0	21	1	0	1	13	3	0	TCGA-HB-A3L4-01	281	0.9999838026467064	184	TCGA-HB-A3L4-01	5	9	128	0.2762038083181906	TCGA-HB-A3L4-01	14	16	14	44	PASS	8684	TCGA-HB-A3L4	SARC	46	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2009	NA	-17044	Dead	WITH TUMOR	NA	1061	NA	Distant Metastasis	Lung	NA	326	NA	Negative	R0	1	1061	1	1061	1	326	1	326	
80	TCGA-HB-A3YV	1	11	0	0	1	0	0	0	3	46	1	0	1	15	1	0	TCGA-HB-A3YV-01	711	0.8069161938560241	502	TCGA-HB-A3YV-01	13	18	95	0.20232353519334892	TCGA-HB-A3YV-01	19	15	9	43	PASS	8685	TCGA-HB-A3YV	SARC	75	MALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2012	NA	-27583	Dead	WITH TUMOR	NA	139	NA	NA	NA	NA	NA	NA	Positive	R1	1	139	1	139	NA	NA	1	139	
60	TCGA-HB-A43Z	0	17	0	5	2	0	0	0	6	47	4	0	2	13	2	1	TCGA-HB-A43Z-01	450	0.9843813827454864	302	TCGA-HB-A43Z-01	17	30	307	0.4559378076009539	TCGA-HB-A43Z-01	20	14	19	53	PASS	8686	TCGA-HB-A43Z	SARC	58	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	-21233	Alive	WITH TUMOR	1126	NA	NA	Distant Metastasis	Lung	NA	894	NA	Negative	R0	0	1126	0	1126	1	894	1	894	
60	TCGA-HB-A5W3	1	4	0	0	0	1	0	0	4	22	2	0	1	12	1	0	TCGA-HB-A5W3-01	169	0.9085722737551232	93	TCGA-HB-A5W3-01	6	9	84	0.29939605084387105	TCGA-HB-A5W3-01	13	6	13	32	PASS	8687	TCGA-HB-A5W3	SARC	58	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-21416	Dead	WITH TUMOR	NA	384	NA	NA	NA	NA	NA	NA	Negative	R0	1	384	1	384	NA	NA	1	384	
70	TCGA-HS-A5N7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-HS-A5N7-01	139	0.9947903786862335	68	TCGA-HS-A5N7-01	9	9	90	0.28690530318804136	TCGA-HS-A5N7-01	9	4	9	22	PASS	8688	TCGA-HS-A5N7	SARC	67	FEMALE	[Not Evaluated]	NA	NA	Leiomyosarcoma (LMS)	NA	NA	NA	-24775	Alive	TUMOR FREE	1013	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1013	0	1013	0	1013	0	1013	
70	TCGA-HS-A5N8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-HS-A5N8-01	194	0.6928383307160184	100	TCGA-HS-A5N8-01	15	25	187	0.5078860412064726	TCGA-HS-A5N8-01	22	18	17	57	PASS	8689	TCGA-HS-A5N8	SARC	69	FEMALE	[Not Evaluated]	NA	NA	Leiomyosarcoma (LMS)	NA	NA	NA	-25549	Dead	WITH TUMOR	NA	22	NA	NA	NA	NA	NA	NA	[Unknown]	R2	1	22	1	22	NA	NA	1	22	
60	TCGA-HS-A5N9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-HS-A5N9	0	0	0	TCGA-HS-A5N9	0	0	0	0	TCGA-HS-A5N9	0	0	0	0	PASS	8690	TCGA-HS-A5N9	SARC	58	FEMALE	[Not Evaluated]	NA	NA	Leiomyosarcoma (LMS)	NA	NA	NA	-21463	Alive	TUMOR FREE	1585	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1585	0	1585	0	1585	0	1585	
70	TCGA-HS-A5NA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-HS-A5NA-01	186	0.3084369528194409	117	TCGA-HS-A5NA	0	0	0	0	TCGA-HS-A5NA	0	0	0	0	PASS	8691	TCGA-HS-A5NA	SARC	65	FEMALE	[Not Evaluated]	NA	NA	Leiomyosarcoma (LMS)	NA	NA	NA	-24025	Alive	WITH TUMOR	298	NA	NA	NA	NA	NA	NA	NA	[Unknown]	RX	0	298	0	298	NA	NA	0	298	
40	TCGA-IE-A3OV	1	11	0	1	2	0	0	0	1	28	1	0	0	14	1	1	TCGA-IE-A3OV-01	425	0.6666486925670123	318	TCGA-IE-A3OV-01	17	22	104	0.21842870662478814	TCGA-IE-A3OV-01	18	12	7	37	PASS	8692	TCGA-IE-A3OV	SARC	42	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2004	NA	-15607	Dead	WITH TUMOR	NA	2448	NA	Distant Metastasis	Lung	NA	490	NA	Negative	R0	1	2448	1	2448	1	490	1	490	
40	TCGA-IE-A4EH	0	5	0	1	1	0	0	0	3	22	0	0	0	11	0	0	TCGA-IE-A4EH-01	159	0.9469909453204992	85	TCGA-IE-A4EH-01	7	9	91	0.2563236620152565	TCGA-IE-A4EH-01	14	9	10	33	PASS	8693	TCGA-IE-A4EH	SARC	35	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-12871	Alive	TUMOR FREE	819	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	819	0	819	0	819	0	819	
70	TCGA-IE-A4EI	0	2	0	2	2	0	0	0	3	21	0	0	1	10	0	0	TCGA-IE-A4EI-01	92	0.9215966949399432	37	TCGA-IE-A4EI-01	17	30	104	0.4699806079400178	TCGA-IE-A4EI-01	9	11	12	32	PASS	8694	TCGA-IE-A4EI	SARC	67	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	-24663	Alive	TUMOR FREE	594	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	594	0	594	0	594	0	594	
80	TCGA-IE-A4EJ	0	10	0	8	1	0	0	0	3	38	3	0	5	20	1	0	TCGA-IE-A4EJ-01	325	0.8059135436268587	211	TCGA-IE-A4EJ-01	20	36	113	0.2581197011461245	TCGA-IE-A4EJ-01	25	18	9	52	PASS	8695	TCGA-IE-A4EJ	SARC	84	FEMALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2012	NA	-30858	Alive	TUMOR FREE	98	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	98	0	98	NA	NA	0	98	
50	TCGA-IE-A4EK	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-IE-A4EK-01	85	0.09024882071623908	35	TCGA-IE-A4EK-01	2	6	27	0.07927077722216913	TCGA-IE-A4EK-01	5	6	4	15	PASS	8696	TCGA-IE-A4EK	SARC	54	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	-19815	Alive	NA	42	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	42	0	42	NA	NA	0	42	
70	TCGA-IE-A6BZ	0	17	0	0	0	0	1	0	2	30	4	0	4	15	4	0	TCGA-IE-A6BZ-01	236	0.9612907314604237	131	TCGA-IE-A6BZ-01	25	28	97	0.3173118298792543	TCGA-IE-A6BZ-01	18	24	8	50	PASS	8697	TCGA-IE-A6BZ	SARC	65	FEMALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2012	NA	-23756	Alive	TUMOR FREE	605	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	605	0	605	0	605	0	605	
70	TCGA-IF-A3RQ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-IF-A3RQ-01	664	0.4730872370776725	458	TCGA-IF-A3RQ	0	0	0	0	TCGA-IF-A3RQ	0	0	0	0	PASS	8698	TCGA-IF-A3RQ	SARC	70	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	1998	NA	-25680	Dead	WITH TUMOR	NA	1129	NA	Locoregional Recurrence	"Other, specify"	retroperitoneum	441	NA	Negative	R0	1	1129	1	1129	1	441	1	441	
80	TCGA-IF-A4AJ	1	6	1	3	0	0	0	0	2	35	8	0	2	14	1	0	TCGA-IF-A4AJ-01	121	0.8919970556044442	49	TCGA-IF-A4AJ-01	25	28	109	0.4373562723127627	TCGA-IF-A4AJ-01	18	5	9	32	PASS	8699	TCGA-IF-A4AJ	SARC	80	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	1995	NA	-29469	Dead	WITH TUMOR	NA	767	NA	Distant Metastasis	Lung	NA	560	NA	Negative	R0	1	767	1	767	1	560	1	560	
80	TCGA-IF-A4AK	1	5	0	0	2	0	0	0	2	27	1	0	0	4	1	0	TCGA-IF-A4AK	0	0	0	TCGA-IF-A4AK	0	0	0	0	TCGA-IF-A4AK	0	0	0	0	PASS	8700	TCGA-IF-A4AK	SARC	82	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-30141	Alive	TUMOR FREE	1590	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1590	0	1590	0	1590	0	1590	
60	TCGA-IS-A3K6	1	4	0	4	2	0	0	0	2	27	3	0	0	8	0	0	TCGA-IS-A3K6-01	193	0.15492993170946026	125	TCGA-IS-A3K6-01	1	3	39	0.08292343319627582	TCGA-IS-A3K6-01	6	6	4	16	PASS	8701	TCGA-IS-A3K6	SARC	55	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2000	NA	-20205	Dead	WITH TUMOR	NA	858	NA	NA	NA	NA	NA	NA	NA	R2	1	858	1	858	NA	NA	1	858	
60	TCGA-IS-A3K7	1	20	1	5	0	1	0	0	7	84	11	1	5	30	2	0	TCGA-IS-A3K7-01	388	0.9515377179829904	285	TCGA-IS-A3K7-01	15	14	131	0.3910695343853333	TCGA-IS-A3K7-01	11	11	15	37	PASS	8702	TCGA-IS-A3K7	SARC	63	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2000	NA	-23022	Alive	TUMOR FREE	5204	NA	NA	Distant Metastasis	Lung	NA	119	NA	NA	R0	0	5204	0	5204	1	119	1	119	
40	TCGA-IS-A3K8	0	2	0	2	1	1	0	0	0	10	1	0	1	4	0	0	TCGA-IS-A3K8-01	99	0.12875774637063253	46	TCGA-IS-A3K8-01	3	3	19	0.08326478534254121	TCGA-IS-A3K8-01	1	0	3	4	pathology review	8703	TCGA-IS-A3K8	SARC	44	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2002	NA	-16265	Alive	TUMOR FREE	4845	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	4845	0	4845	0	4845	0	4845	
70	TCGA-IS-A3KA	0	13	0	8	1	0	0	0	8	48	3	0	2	15	3	0	TCGA-IS-A3KA-01	309	0.6630899037522889	211	TCGA-IS-A3KA-01	16	25	65	0.14286457568262373	TCGA-IS-A3KA-01	14	20	8	42	pathology review	8704	TCGA-IS-A3KA	SARC	73	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2004	NA	-26775	Dead	WITH TUMOR	NA	413	NA	Distant Metastasis	Lung	NA	76	NA	NA	R0	1	413	1	413	1	76	1	76	
50	TCGA-IW-A3M4	0	5	0	1	2	0	0	0	1	15	3	0	0	5	1	0	TCGA-IW-A3M4-01	83	0.9471480976792928	33	TCGA-IW-A3M4-01	6	6	19	0.18115949586080868	TCGA-IW-A3M4-01	5	5	7	17	PASS	8705	TCGA-IW-A3M4	SARC	48	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2005	NA	-17721	Alive	TUMOR FREE	2615	NA	NA	Locoregional Disease	NA	NA	2207	NA	NA	R0	0	2615	0	2615	1	2207	1	2207	
80	TCGA-IW-A3M5	3	5	0	2	4	0	0	0	1	33	0	0	2	19	1	0	TCGA-IW-A3M5-01	316	0.6673688143440354	184	TCGA-IW-A3M5-01	20	24	81	0.342215533603517	TCGA-IW-A3M5-01	19	10	7	36	pathology review	8706	TCGA-IW-A3M5	SARC	76	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-27869	Dead	WITH TUMOR	NA	180	NA	Distant Metastasis	Lung	NA	9	NA	Negative	R0	1	180	1	180	1	9	1	9	
60	TCGA-IW-A3M6	2	13	0	1	2	1	1	0	6	42	2	0	3	21	2	0	TCGA-IW-A3M6-01	179	0.8650464548517971	98	TCGA-IW-A3M6-01	8	11	62	0.3494202846678529	TCGA-IW-A3M6-01	12	14	15	41	PASS	8707	TCGA-IW-A3M6	SARC	59	FEMALE	ASIAN	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-21674	Alive	TUMOR FREE	688	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	688	0	688	0	688	0	688	
60	TCGA-JV-A5VE	0	18	1	4	0	1	0	0	1	36	2	0	1	11	1	0	TCGA-JV-A5VE-01	299	0.8345181813932819	194	TCGA-JV-A5VE-01	8	11	125	0.2522563180706969	TCGA-JV-A5VE-01	12	9	13	34	PASS	8708	TCGA-JV-A5VE	SARC	60	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	-21933	Alive	TUMOR FREE	499	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	499	0	499	0	499	0	499	
70	TCGA-JV-A5VF	0	9	0	2	2	0	0	0	2	23	3	1	1	4	0	0	TCGA-JV-A5VF-01	174	0.9137728398925042	96	TCGA-JV-A5VF-01	22	29	107	0.3022429268535059	TCGA-JV-A5VF-01	18	12	9	39	pathology review	8709	TCGA-JV-A5VF	SARC	69	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	-25505	Dead	WITH TUMOR	NA	32	NA	NA	NA	NA	NA	NA	Positive	R2	1	32	1	32	NA	NA	1	32	
40	TCGA-JV-A75J	2	9	1	2	0	1	0	0	6	21	2	0	1	12	0	0	TCGA-JV-A75J-01	456	0.30861175791412104	303	TCGA-JV-A75J-01	6	12	173	0.15789601810227955	TCGA-JV-A75J-01	13	2	9	24	PASS	8710	TCGA-JV-A75J	SARC	43	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2013	NA	-16001	Dead	WITH TUMOR	NA	119	NA	NA	NA	NA	NA	NA	Positive	R2	1	119	1	119	NA	NA	1	119	
60	TCGA-K1-A3PN	6	13	0	2	0	1	2	0	10	64	4	0	4	24	2	0	TCGA-K1-A3PN-01	90	0.5794379253897797	33	TCGA-K1-A3PN-02	6	7	24	0.173727671191273	TCGA-K1-A3PN-02	7	2	6	15	mutation call filter	8711	TCGA-K1-A3PN	SARC	64	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2006	NA	-23631	Alive	TUMOR FREE	3080	NA	NA	NA	NA	NA	1033	NA	Negative	R0	0	3080	0	3080	1	1033	1	1033	
40	TCGA-K1-A3PO	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-K1-A3PO-01	75	0.026317646863193128	34	TCGA-K1-A3PO-01	1	1	14	0.02771477095159625	TCGA-K1-A3PO-01	0	0	1	1	PASS	8712	TCGA-K1-A3PO	SARC	42	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-15494	Alive	TUMOR FREE	1622	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1622	0	1622	0	1622	0	1622	
70	TCGA-K1-A42W	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-K1-A42W-01	132	0.812085113055701	70	TCGA-K1-A42W-01	22	24	90	0.3778260464035759	TCGA-K1-A42W-01	7	6	2	15	PASS	8713	TCGA-K1-A42W	SARC	65	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2009	NA	-23910	Alive	WITH TUMOR	1891	NA	NA	Distant Metastasis	Liver	NA	826	NA	Negative	R0	0	1891	0	1891	1	826	1	826	
60	TCGA-K1-A42X	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-K1-A42X-01	210	0.9479771113468196	125	TCGA-K1-A42X-02	4	7	98	0.17974953979137848	TCGA-K1-A42X-02	12	12	13	37	PASS	8714	TCGA-K1-A42X	SARC	62	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2003	NA	-22680	Alive	WITH TUMOR	3765	NA	NA	Locoregional Recurrence	"Other, specify"	adjeacent area	2036	NA	Negative	R0	0	3765	0	3765	1	2036	1	2036	
50	TCGA-K1-A6RT	1	12	2	3	1	1	0	0	4	48	1	0	3	25	1	0	TCGA-K1-A6RT-01	87	0.013899206552353185	42	TCGA-K1-A6RT	0	0	0	0	TCGA-K1-A6RT	0	0	0	0	pathology review	8715	TCGA-K1-A6RT	SARC	48	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	-17739	Alive	WITH TUMOR	528	NA	NA	Distant Metastasis	Lung	NA	129	NA	Negative	R0	0	528	0	528	1	129	1	129	
70	TCGA-K1-A6RU	1	7	0	2	1	0	0	0	4	21	3	0	1	13	1	0	TCGA-K1-A6RU-01	689	0.6658244761237103	557	TCGA-K1-A6RU-01	13	23	155	0.09128982673283258	TCGA-K1-A6RU-01	21	23	4	48	PASS	8716	TCGA-K1-A6RU	SARC	66	FEMALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2013	NA	-24356	Dead	WITH TUMOR	NA	711	NA	Distant Metastasis	Bone	NA	142	NA	Positive	R1	1	711	1	711	NA	NA	1	142	
70	TCGA-K1-A6RV	3	14	0	3	1	1	1	0	3	59	2	0	3	18	3	0	TCGA-K1-A6RV-01	647	0.7415588828474403	497	TCGA-K1-A6RV-01	16	30	271	0.3458860343164321	TCGA-K1-A6RV-01	25	15	15	55	PASS	8717	TCGA-K1-A6RV	SARC	67	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2013	NA	-24701	Alive	WITH TUMOR	158	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	158	0	158	NA	NA	0	158	
60	TCGA-KD-A5QS	1	21	0	7	4	1	0	0	5	58	2	0	5	14	5	0	TCGA-KD-A5QS-01	529	0.8494049494894449	362	TCGA-KD-A5QS-01	14	27	227	0.32049614376816643	TCGA-KD-A5QS-01	28	29	19	76	PASS	8718	TCGA-KD-A5QS	SARC	55	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2009	NA	-20410	Dead	WITH TUMOR	NA	1941	NA	Distant Metastasis	Bone	NA	351	NA	[Unknown]	RX	1	1941	1	1941	NA	NA	1	351	
70	TCGA-KD-A5QT	0	4	0	2	1	1	1	0	0	27	1	0	1	10	0	0	TCGA-KD-A5QT-01	248	0.9050508170943706	164	TCGA-KD-A5QT-01	4	7	116	0.15935705050735008	TCGA-KD-A5QT-01	10	9	7	26	PASS	8719	TCGA-KD-A5QT	SARC	69	FEMALE	[Not Evaluated]	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-25249	Alive	TUMOR FREE	499	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	499	0	499	0	499	0	499	
40	TCGA-KD-A5QU	1	13	0	2	1	0	0	0	0	58	3	0	3	10	1	0	TCGA-KD-A5QU-01	143	0.8080229638840091	82	TCGA-KD-A5QU-01	16	16	116	0.4960676789374918	TCGA-KD-A5QU-01	10	8	19	37	PASS	8720	TCGA-KD-A5QU	SARC	41	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-15018	Dead	WITH TUMOR	NA	1073	NA	Distant Metastasis	Lung	NA	1060	NA	Negative	R0	1	1073	1	1073	1	1060	1	1060	
70	TCGA-KF-A41W	0	13	3	11	4	0	0	0	11	68	6	0	4	38	6	0	TCGA-KF-A41W-01	363	0.8958356535883054	273	TCGA-KF-A41W-01	21	30	251	0.4396127187759008	TCGA-KF-A41W-01	25	14	12	51	PASS	8721	TCGA-KF-A41W	SARC	71	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	-25969	Alive	TUMOR FREE	356	NA	NA	NA	NA	NA	NA	NA	Negative	RX	0	356	0	356	NA	NA	0	356	
80	TCGA-LI-A67I	0	12	1	0	4	0	0	0	3	40	1	0	3	8	0	0	TCGA-LI-A67I-01	204	0.9480461937053096	115	TCGA-LI-A67I-01	13	28	156	0.5108529495325487	TCGA-LI-A67I-01	18	7	14	39	pathology review	8722	TCGA-LI-A67I	SARC	75	FEMALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2013	NA	-27671	Alive	TUMOR FREE	922	NA	NA	Distant Metastasis	Lung	NA	574	NA	Positive	RX	0	922	0	922	NA	NA	1	574	
70	TCGA-LI-A9QH	0	27	1	5	1	1	0	0	6	73	6	0	7	30	6	0	TCGA-LI-A9QH-01	348	0.6449135046581982	227	TCGA-LI-A9QH-01	15	36	193	0.2987130992154708	TCGA-LI-A9QH-01	27	14	13	54	PASS	8723	TCGA-LI-A9QH	SARC	72	FEMALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2013	NA	-26468	Dead	TUMOR FREE	NA	540	NA	Distant Metastasis	Lung	NA	426	NA	Negative	R2	1	540	0	540	NA	NA	1	426	
60	TCGA-MB-A5Y8	0	4	0	0	0	0	0	0	0	24	0	0	2	5	0	0	TCGA-MB-A5Y8-01	184	0.9624791472433673	115	TCGA-MB-A5Y8-01	14	14	103	0.31731126074484484	TCGA-MB-A5Y8-01	10	12	14	36	PASS	8724	TCGA-MB-A5Y8	SARC	60	FEMALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2012	NA	-22115	Alive	TUMOR FREE	773	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	773	0	773	0	773	0	773	
90	TCGA-MB-A5Y9	0	5	0	1	0	0	0	0	2	27	2	0	0	10	0	0	TCGA-MB-A5Y9-01	99	0.2223046774085314	42	TCGA-MB-A5Y9-01	9	22	66	0.296738662473413	TCGA-MB-A5Y9-01	13	16	6	35	PASS	8725	TCGA-MB-A5Y9	SARC	90	MALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2012	NA	-32873	Alive	WITH TUMOR	252	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	252	0	252	NA	NA	0	252	
60	TCGA-MB-A5YA	1	12	1	1	1	0	0	0	0	24	2	0	1	10	0	0	TCGA-MB-A5YA-01	65	0.07759017116678656	22	TCGA-MB-A5YA-01	2	3	27	0.06910600208374328	TCGA-MB-A5YA-01	3	1	2	6	PASS	8726	TCGA-MB-A5YA	SARC	63	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	-23115	Alive	TUMOR FREE	15	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	15	0	15	0	15	0	15	
50	TCGA-MB-A8JK	0	17	0	4	4	0	0	0	6	25	1	0	3	7	0	0	TCGA-MB-A8JK-01	308	0.6226501973898521	194	TCGA-MB-A8JK-01	16	29	128	0.2356343519037012	TCGA-MB-A8JK-01	20	16	14	50	PASS	8727	TCGA-MB-A8JK	SARC	49	MALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2013	NA	-18177	Alive	TUMOR FREE	661	NA	NA	NA	NA	NA	NA	NA	Negative	RX	0	661	0	661	NA	NA	0	661	
50	TCGA-MB-A8JL	1	10	0	1	1	0	0	0	2	31	1	0	2	6	1	0	TCGA-MB-A8JL-01	177	0.7430617385301896	117	TCGA-MB-A8JL-01	7	6	99	0.1437082355332222	TCGA-MB-A8JL-01	6	2	4	12	pathology review	8728	TCGA-MB-A8JL	SARC	53	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2013	NA	-19510	Alive	TUMOR FREE	600	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	600	0	600	0	600	0	600	
60	TCGA-MJ-A68H	3	8	0	2	0	1	1	0	5	38	2	0	0	16	0	0	TCGA-MJ-A68H-01	166	0.6347066363436881	102	TCGA-MJ-A68H-01	19	21	41	0.11174037834704616	TCGA-MJ-A68H-01	7	10	3	20	PASS	8729	TCGA-MJ-A68H	SARC	57	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Leiomyosarcoma (LMS)	NA	2013	NA	-21105	Alive	TUMOR FREE	456	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	456	0	456	0	456	0	456	
60	TCGA-MJ-A68J	0	5	0	1	0	0	0	0	1	9	0	0	0	3	0	0	TCGA-MJ-A68J-01	89	0.060765215891117476	45	TCGA-MJ-A68J-01	2	1	19	0.01149239984914438	TCGA-MJ-A68J-01	0	1	0	1	PASS	8730	TCGA-MJ-A68J	SARC	55	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Myxofibrosarcoma	NA	2012	NA	-20100	Alive	WITH TUMOR	547	NA	NA	New Primary Tumor	"Other, specify"	Foot	268	NA	Positive	R1	0	547	0	547	NA	NA	1	268	
30	TCGA-MJ-A850	0	9	0	1	0	1	0	0	2	16	0	0	0	7	0	0	TCGA-MJ-A850-01	45	4.754654736562692e-05	10	TCGA-MJ-A850-01	0	0	10	0.001157344834572475	TCGA-MJ-A850-01	0	0	0	0	PASS	8731	TCGA-MJ-A850	SARC	28	MALE	WHITE	NA	NA	Synovial Sarcoma - Monophasic	NA	2013	NA	-10451	Alive	TUMOR FREE	681	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	681	0	681	NA	NA	0	681	
40	TCGA-MO-A47P	0	1	0	1	1	0	0	0	1	9	0	0	0	0	2	0	TCGA-MO-A47P-01	45	3.4198281722162126e-05	9	TCGA-MO-A47P-01	0	0	9	0.001323972450405009	TCGA-MO-A47P-01	0	0	0	0	PASS	8732	TCGA-MO-A47P	SARC	37	FEMALE	ASIAN	NA	NA	Dedifferentiated liposarcoma	NA	2012	NA	-13765	Alive	TUMOR FREE	352	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	352	0	352	0	352	0	352	
80	TCGA-MO-A47R	0	9	0	1	1	2	0	0	4	23	3	0	3	4	3	0	TCGA-MO-A47R-01	148	0.675544811500124	101	TCGA-MO-A47R-01	24	24	23	0.02780977683050336	TCGA-MO-A47R-01	5	8	1	14	PASS	8733	TCGA-MO-A47R	SARC	75	FEMALE	ASIAN	NA	NA	Leiomyosarcoma (LMS)	NA	2010	NA	-27731	Dead	WITH TUMOR	NA	318	NA	Distant Metastasis	Brain	NA	259	NA	NA	R0	1	318	1	318	1	259	1	259	
40	TCGA-N1-A6IA	0	11	1	1	2	0	1	0	3	25	3	0	1	10	0	0	TCGA-N1-A6IA-01	316	0.5682376862351294	214	TCGA-N1-A6IA-01	20	25	124	0.12424283415556707	TCGA-N1-A6IA-01	15	12	10	37	PASS	8734	TCGA-N1-A6IA	SARC	41	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-15112	Dead	WITH TUMOR	NA	224	NA	Distant Metastasis	Lung	NA	116	NA	[Unknown]	RX	1	224	1	224	NA	NA	1	116	
60	TCGA-PC-A5DK	0	1	0	0	0	0	1	0	0	15	0	0	1	4	1	0	TCGA-PC-A5DK-01	75	0.08650768956354518	31	TCGA-PC-A5DK-01	2	3	18	0.071779079583571	TCGA-PC-A5DK-01	4	3	5	12	PASS	8735	TCGA-PC-A5DK	SARC	63	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2004	NA	-23019	Alive	TUMOR FREE	3740	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	3740	0	3740	0	3740	0	3740	
70	TCGA-PC-A5DL	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-PC-A5DL-01	84	0.6004368017820866	38	TCGA-PC-A5DL-01	23	18	30	0.12061028312548455	TCGA-PC-A5DL-01	9	3	7	19	PASS	8736	TCGA-PC-A5DL	SARC	67	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2004	NA	-24761	Dead	NA	NA	1142	NA	NA	NA	NA	NA	NA	NA	RX	1	1142	NA	1142	NA	NA	0	1142	
70	TCGA-PC-A5DM	2	5	0	3	1	0	0	0	2	32	2	0	1	11	4	0	TCGA-PC-A5DM	0	0	0	TCGA-PC-A5DM	0	0	0	0	TCGA-PC-A5DM	0	0	0	0	PASS	8737	TCGA-PC-A5DM	SARC	73	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2005	NA	-26699	Dead	NA	NA	193	NA	NA	NA	NA	NA	NA	Positive	R1	1	193	NA	193	NA	NA	0	193	
80	TCGA-PC-A5DN	0	9	1	1	2	1	0	2	5	43	2	0	2	9	0	0	TCGA-PC-A5DN-01	417	0.10798332539596513	335	TCGA-PC-A5DN-01	1	1	16	0.0030611750985810073	TCGA-PC-A5DN-01	1	1	0	2	PASS	8738	TCGA-PC-A5DN	SARC	77	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2005	NA	-28421	Dead	TUMOR FREE	NA	1175	NA	NA	NA	NA	NA	NA	NA	R1	1	1175	0	1175	NA	NA	0	1175	
60	TCGA-PC-A5DO	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-PC-A5DO-01	167	0.9042725582080268	87	TCGA-PC-A5DO-01	6	11	103	0.3182922555567781	TCGA-PC-A5DO-01	12	10	14	36	PASS	8739	TCGA-PC-A5DO	SARC	59	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2006	NA	-21606	Dead	WITH TUMOR	NA	2464	NA	NA	NA	NA	NA	NA	Negative	R1	1	2464	1	2464	NA	NA	1	2464	
70	TCGA-PC-A5DP	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-PC-A5DP	0	0	0	TCGA-PC-A5DP	0	0	0	0	TCGA-PC-A5DP	0	0	0	0	PASS	8740	TCGA-PC-A5DP	SARC	72	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2007	NA	-26414	Dead	WITH TUMOR	NA	550	NA	NA	NA	NA	NA	NA	NA	R1	1	550	1	550	NA	NA	1	550	
60	TCGA-PT-A8TR	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-PT-A8TR	0	0	0	TCGA-PT-A8TR	0	0	0	0	TCGA-PT-A8TR	0	0	0	0	PASS	8741	TCGA-PT-A8TR	SARC	57	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2013	NA	-20985	Alive	TUMOR FREE	813	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	813	0	813	NA	NA	0	813	
70	TCGA-QC-A6FX	1	14	0	4	2	0	1	0	4	30	3	0	2	14	2	0	TCGA-QC-A6FX-01	561	0.5637369046105077	422	TCGA-QC-A6FX-01	9	36	504	0.8061461607757328	TCGA-QC-A6FX-01	24	17	5	46	PASS	8742	TCGA-QC-A6FX	SARC	68	MALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2013	NA	-25113	Alive	TUMOR FREE	637	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	637	0	637	0	637	0	637	
80	TCGA-QC-A7B5	27	501	39	120	9	1	2	0	147	1603	94	0	65	904	25	2	TCGA-QC-A7B5-01	60	0.6417449478003987	17	TCGA-QC-A7B5-01	14	13	37	0.12073042583557166	TCGA-QC-A7B5-01	8	6	5	19	pathology review	8743	TCGA-QC-A7B5	SARC	75	MALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2013	NA	-27556	Alive	TUMOR FREE	398	NA	NA	New Primary Tumor	"Other, specify"	skin	259	NA	Positive	RX	0	398	0	398	NA	NA	1	259	
50	TCGA-QC-AA9N	0	10	0	1	2	0	0	0	2	30	1	1	4	14	2	0	TCGA-QC-AA9N-01	455	0.945290366340538	329	TCGA-QC-AA9N-01	6	21	234	0.451029718809397	TCGA-QC-AA9N-01	22	20	20	62	pathology review	8744	TCGA-QC-AA9N	SARC	53	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2013	NA	-19395	Alive	TUMOR FREE	537	NA	NA	NA	NA	NA	NA	NA	Negative	RX	0	537	0	537	NA	NA	0	537	
40	TCGA-QQ-A5V2	0	6	0	0	0	0	0	0	1	15	1	1	0	4	0	0	TCGA-QQ-A5V2-01	53	6.395352837354399e-05	18	TCGA-QQ-A5V2-01	0	0	5	0.00024659593884360833	TCGA-QQ-A5V2-01	0	0	0	0	pathology review	8745	TCGA-QQ-A5V2	SARC	42	MALE	WHITE	NA	NA	Giant cell 'MFH' / Undifferentiated pleomorphic sarcoma with giant cells	NA	2006	NA	-15420	Alive	NA	56	NA	NA	NA	NA	NA	NA	NA	[Unknown]	R1	0	56	0	56	NA	NA	0	56	
80	TCGA-QQ-A5V9	1	16	0	2	1	0	1	0	3	53	4	0	2	18	1	0	TCGA-QQ-A5V9-01	198	0.4993389582377475	113	TCGA-QQ-A5V9-01	28	60	184	0.6223391220516857	TCGA-QQ-A5V9-01	22	8	12	42	PASS	8746	TCGA-QQ-A5V9	SARC	76	MALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	1997	NA	-27977	Dead	WITH TUMOR	NA	1424	NA	Distant Metastasis	Lung	NA	405	NA	Negative	R0	1	1424	1	1424	1	405	1	405	
60	TCGA-QQ-A5VA	1	17	1	1	0	1	1	0	0	38	6	0	2	16	1	0	TCGA-QQ-A5VA-01	395	0.3395176497833246	267	TCGA-QQ-A5VA-01	7	38	284	0.7086244463313052	TCGA-QQ-A5VA-01	24	14	27	65	pathology review	8747	TCGA-QQ-A5VA	SARC	60	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	1996	NA	-22231	Dead	WITH TUMOR	NA	550	NA	NA	NA	NA	NA	NA	Negative	RX	1	550	1	550	NA	NA	1	550	
50	TCGA-QQ-A5VB	1	17	3	6	6	1	0	0	4	40	1	0	2	18	3	0	TCGA-QQ-A5VB-01	245	0.5940417621104239	136	TCGA-QQ-A5VB-01	18	50	330	0.854736216991779	TCGA-QQ-A5VB-01	26	18	8	52	PASS	8748	TCGA-QQ-A5VB	SARC	53	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	1994	NA	-19654	Dead	WITH TUMOR	NA	1478	NA	Locoregional Recurrence	"Other, specify"	Left Pelvis	111	NA	Positive	R1	1	1478	1	1478	NA	NA	1	111	
60	TCGA-QQ-A5VC	3	13	1	3	2	0	0	0	1	55	1	0	1	18	0	1	TCGA-QQ-A5VC-01	353	0.8649353742263403	224	TCGA-QQ-A5VC-01	21	34	249	0.6578309586416428	TCGA-QQ-A5VC-01	30	13	29	72	PASS	8749	TCGA-QQ-A5VC	SARC	63	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-23357	Alive	TUMOR FREE	1092	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1092	0	1092	0	1092	0	1092	
50	TCGA-QQ-A5VD	3	84	9	21	3	0	0	0	19	290	28	0	17	173	9	0	TCGA-QQ-A5VD-01	68	0.14868453268316162	22	TCGA-QQ-A5VD-01	4	3	38	0.13436410129171095	TCGA-QQ-A5VD-01	3	3	3	9	pathology review	8750	TCGA-QQ-A5VD	SARC	52	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-19004	Alive	TUMOR FREE	1129	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1129	0	1129	0	1129	0	1129	
70	TCGA-QQ-A8VB	1	10	3	4	2	0	0	0	7	59	5	0	2	9	2	0	TCGA-QQ-A8VB-01	151	0.9511173531164058	93	TCGA-QQ-A8VB-01	20	29	67	0.2329932535276748	TCGA-QQ-A8VB-01	6	7	3	16	PASS	8751	TCGA-QQ-A8VB	SARC	68	FEMALE	WHITE	NA	NA	Malignant Peripheral Nerve Sheath Tumors (MPNST)	NA	1998	NA	-24916	Alive	TUMOR FREE	5723	NA	NA	New Primary Tumor	"Other, specify"	gastrointestinal	2682	NA	Negative	RX	0	5723	0	5723	NA	NA	1	2682	
60	TCGA-QQ-A8VD	0	10	0	0	0	0	0	0	0	11	1	0	0	6	0	0	TCGA-QQ-A8VD-01	67	0.0001632058925576282	24	TCGA-QQ-A8VD-01	0	0	8	0.00019461679892508683	TCGA-QQ-A8VD-01	0	0	0	0	pathology review	8752	TCGA-QQ-A8VD	SARC	56	MALE	WHITE	NA	NA	Desmoid Tumor	NA	2003	NA	-20729	Alive	WITH TUMOR	3964	NA	NA	Locoregional Recurrence	"Other, specify"	left abdominal wall	499	NA	Positive	RX	0	3964	0	3964	NA	NA	1	499	
70	TCGA-QQ-A8VF	17	210	7	32	92	23	6	0	40	588	27	0	23	267	10	0	TCGA-QQ-A8VF-01	219	0.91942694181124	134	TCGA-QQ-A8VF-01	31	23	221	0.7046194772801927	TCGA-QQ-A8VF-01	10	5	5	20	hypermutated sample	8753	TCGA-QQ-A8VF	SARC	70	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2005	NA	-25682	Alive	TUMOR FREE	3406	NA	NA	NA	NA	NA	NA	NA	Negative	RX	0	3406	0	3406	NA	NA	0	3406	
50	TCGA-QQ-A8VG	2	99	6	13	2	1	0	0	25	311	24	0	19	190	1	2	TCGA-QQ-A8VG-01	55	0.019377056182725682	17	TCGA-QQ-A8VG-01	1	6	32	0.11705755482068345	TCGA-QQ-A8VG-01	2	1	1	4	pathology review	8754	TCGA-QQ-A8VG	SARC	52	MALE	WHITE	NA	NA	Malignant Peripheral Nerve Sheath Tumors (MPNST)	NA	2009	NA	-19304	Dead	WITH TUMOR	NA	1970	NA	New Primary Tumor	Liver	NA	1852	NA	Negative	RX	1	1970	1	1970	NA	NA	1	1852	
30	TCGA-QQ-A8VH	1	20	1	3	0	0	0	0	2	42	6	0	1	9	2	0	TCGA-QQ-A8VH-01	382	0.7725877977277379	250	TCGA-QQ-A8VH-01	5	21	201	0.3440248650023938	TCGA-QQ-A8VH-01	22	9	19	50	PASS	8755	TCGA-QQ-A8VH	SARC	31	FEMALE	WHITE	NA	NA	Malignant Peripheral Nerve Sheath Tumors (MPNST)	NA	2010	NA	-11599	Dead	WITH TUMOR	NA	320	NA	Locoregional Recurrence	"Other, specify"	Spine T6 to apical lung	197	NA	Positive	RX	1	320	1	320	NA	NA	1	197	
60	TCGA-RN-A68Q	0	9	0	2	0	0	0	1	2	14	0	0	1	5	0	0	TCGA-RN-A68Q-01	37	9.021990666858123e-06	5	TCGA-RN-A68Q-01	0	0	19	1.4269211453309815e-05	TCGA-RN-A68Q-01	0	0	0	0	PASS	8756	TCGA-RN-A68Q	SARC	62	FEMALE	WHITE	NA	NA	Malignant Peripheral Nerve Sheath Tumors (MPNST)	NA	2010	NA	-22981	Alive	TUMOR FREE	22	NA	NA	NA	NA	NA	NA	NA	[Unknown]	RX	0	22	0	22	NA	NA	0	22	
50	TCGA-RN-AAAQ	1	13	3	5	1	0	1	0	2	35	2	0	2	12	3	0	TCGA-RN-AAAQ-01	290	0.7614448431995753	191	TCGA-RN-AAAQ-01	27	25	88	0.17374565699881742	TCGA-RN-AAAQ-01	16	11	7	34	pathology review	8757	TCGA-RN-AAAQ	SARC	52	MALE	WHITE	NA	NA	Malignant Peripheral Nerve Sheath Tumors (MPNST)	NA	2013	NA	-19123	Alive	WITH TUMOR	510	NA	NA	Locoregional Recurrence	"Other, specify"	Left Shoulder	307	NA	[Unknown]	NA	0	510	0	510	NA	NA	1	307	
50	TCGA-SG-A6Z4	1	14	1	1	0	0	0	0	2	40	3	0	3	10	2	0	TCGA-SG-A6Z4-01	188	0.8496836796837126	108	TCGA-SG-A6Z4-01	19	24	114	0.3220364715288879	TCGA-SG-A6Z4-01	18	17	16	51	PASS	8758	TCGA-SG-A6Z4	SARC	47	MALE	WHITE	NA	NA	Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma	NA	2013	NA	-17368	Alive	WITH TUMOR	576	NA	NA	Distant Metastasis	Lung	NA	105	NA	Negative	R1	0	576	0	576	NA	NA	1	105	
40	TCGA-SG-A6Z7	3	19	0	1	0	0	0	0	5	44	4	1	3	11	1	1	TCGA-SG-A6Z7-01	643	0.8173450422583302	438	TCGA-SG-A6Z7-01	20	23	160	0.17386163748898695	TCGA-SG-A6Z7-01	19	6	9	34	PASS	8759	TCGA-SG-A6Z7	SARC	44	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2004	NA	-16188	Dead	TUMOR FREE	NA	118	NA	NA	NA	NA	NA	NA	[Unknown]	RX	1	118	0	118	NA	NA	0	118	
80	TCGA-SG-A849	0	14	0	2	0	0	0	0	2	40	4	0	0	20	1	0	TCGA-SG-A849-01	145	0.6415925005993218	82	TCGA-SG-A849-01	23	31	104	0.3630861958741184	TCGA-SG-A849-01	14	20	11	45	PASS	8760	TCGA-SG-A849	SARC	78	MALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2013	NA	-28498	Alive	TUMOR FREE	533	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	533	0	533	NA	NA	0	533	
30	TCGA-SI-A71O	0	24	3	8	1	3	2	0	5	66	6	0	4	25	1	0	TCGA-SI-A71O-01	494	0.7705771124963003	342	TCGA-SI-A71O-06	7	13	243	0.4058036108569573	TCGA-SI-A71O-06	22	20	22	64	mutation call filter	8761	TCGA-SI-A71O	SARC	29	MALE	WHITE	NA	NA	Malignant Peripheral Nerve Sheath Tumors (MPNST)	NA	2013	NA	-10710	Dead	WITH TUMOR	NA	694	NA	Distant Metastasis	Lung	NA	264	NA	Positive	RX	1	694	1	694	NA	NA	1	264	
50	TCGA-SI-A71P	0	7	0	2	0	1	0	0	4	32	1	0	1	6	0	0	TCGA-SI-A71P-01	84	0.43958198793463865	37	TCGA-SI-A71P-01	23	19	46	0.2010430546305162	TCGA-SI-A71P-01	13	7	11	31	PASS	8762	TCGA-SI-A71P	SARC	50	MALE	WHITE	NA	NA	Malignant Peripheral Nerve Sheath Tumors (MPNST)	NA	2012	NA	-18367	Alive	TUMOR FREE	771	NA	NA	NA	NA	NA	NA	NA	[Unknown]	RX	0	771	0	771	NA	NA	0	771	
30	TCGA-SI-A71Q	2	5	0	0	1	0	0	0	3	25	3	0	1	14	0	0	TCGA-SI-A71Q-01	709	0.6279706235648665	524	TCGA-SI-A71Q-01	20	30	216	0.2121974988537932	TCGA-SI-A71Q-01	20	10	12	42	PASS	8763	TCGA-SI-A71Q	SARC	34	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Malignant Peripheral Nerve Sheath Tumors (MPNST)	NA	2012	NA	-12559	Alive	TUMOR FREE	996	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	996	0	996	0	996	0	996	
80	TCGA-SI-AA8B	0	16	0	2	3	1	0	0	5	34	5	0	0	13	0	0	TCGA-SI-AA8B-01	293	0.7814688295395164	202	TCGA-SI-AA8B-01	20	29	128	0.30169416249746145	TCGA-SI-AA8B-01	16	18	8	42	PASS	8764	TCGA-SI-AA8B	SARC	80	FEMALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2013	NA	-29315	Dead	WITH TUMOR	NA	262	NA	NA	NA	NA	NA	NA	Positive	R1	1	262	1	262	NA	NA	1	262	
30	TCGA-SI-AA8C	2	6	0	3	1	0	0	0	0	11	0	0	0	5	0	0	TCGA-SI-AA8C-01	288	0.8372495487855034	196	TCGA-SI-AA8C-01	6	8	141	0.17728146365517114	TCGA-SI-AA8C-01	8	3	12	23	PASS	8765	TCGA-SI-AA8C	SARC	20	FEMALE	WHITE	NA	NA	Malignant Peripheral Nerve Sheath Tumors (MPNST)	NA	2013	NA	-7530	Alive	WITH TUMOR	597	NA	NA	Distant Metastasis	Lung	NA	273	NA	Positive	R1	0	597	0	597	NA	NA	1	273	
50	TCGA-UE-A6QT	0	1	0	1	0	0	0	0	0	13	0	0	0	6	0	0	TCGA-UE-A6QT-01	80	0.12430008987274407	32	TCGA-UE-A6QT-01	8	24	211	0.9248116570381356	TCGA-UE-A6QT-01	2	1	4	7	pathology review	8766	TCGA-UE-A6QT	SARC	50	FEMALE	ASIAN	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2013	NA	-18516	Alive	TUMOR FREE	402	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	402	0	402	0	402	0	402	
90	TCGA-UE-A6QU	2	12	2	3	1	0	0	0	4	46	2	0	6	20	1	0	TCGA-UE-A6QU-01	386	0.7269699538489417	240	TCGA-UE-A6QU-01	15	33	235	0.4779098491815449	TCGA-UE-A6QU-01	28	17	22	67	pathology review	8767	TCGA-UE-A6QU	SARC	90	FEMALE	ASIAN	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2013	NA	-32872	Alive	TUMOR FREE	408	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	408	0	408	0	408	0	408	
70	TCGA-VT-A80G	2	28	0	6	0	0	0	0	1	65	2	0	3	23	1	0	TCGA-VT-A80G-01	640	0.9584076511654992	485	TCGA-VT-A80G-01	14	32	314	0.3599308690526187	TCGA-VT-A80G-01	23	19	11	53	PASS	8768	TCGA-VT-A80G	SARC	66	MALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2013	NA	-24128	Alive	WITH TUMOR	326	NA	NA	Distant Metastasis	Lung	NA	26	NA	Negative	R0	0	326	0	326	1	26	1	26	
50	TCGA-VT-A80J	2	31	4	12	1	0	0	0	15	85	6	0	2	35	6	0	TCGA-VT-A80J-01	252	0.5316131355029373	163	TCGA-VT-A80J-02	15	34	234	0.3865805641845944	TCGA-VT-A80J-02	21	22	15	58	mutation call filter	8769	TCGA-VT-A80J	SARC	49	FEMALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2012	NA	-17925	Alive	TUMOR FREE	796	NA	NA	Distant Metastasis	"Other, specify"	inguinal lymph node	355	NA	Negative	R0	0	796	0	796	1	355	1	355	
70	TCGA-VT-AB3D	2	19	1	3	0	0	0	0	3	43	3	0	0	21	2	0	TCGA-VT-AB3D-01	195	0.4008270038880314	124	TCGA-VT-AB3D-01	6	11	138	0.2429039070799892	TCGA-VT-AB3D-01	15	13	11	39	PASS	8770	TCGA-VT-AB3D	SARC	71	MALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2013	NA	-26100	Alive	TUMOR FREE	379	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	379	0	379	0	379	0	379	
70	TCGA-WK-A8XO	0	11	1	3	1	1	0	0	1	34	3	0	0	15	1	0	TCGA-WK-A8XO-01	364	0.2471515085352532	252	TCGA-WK-A8XO-01	7	10	64	0.19080569670165906	TCGA-WK-A8XO-01	8	3	8	19	PASS	8771	TCGA-WK-A8XO	SARC	66	FEMALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2010	NA	-24201	Dead	WITH TUMOR	NA	363	NA	Locoregional Recurrence	"Other, specify"	Abdominal	105	NA	Negative	R0	1	363	1	363	1	105	1	105	
60	TCGA-WK-A8XQ	0	12	1	0	0	0	0	0	4	21	3	0	2	7	1	0	TCGA-WK-A8XQ-01	69	0.00017283369542445612	22	TCGA-WK-A8XQ	0	0	0	0	TCGA-WK-A8XQ	0	0	0	0	PASS	8772	TCGA-WK-A8XQ	SARC	57	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2009	NA	-20891	Dead	WITH TUMOR	NA	146	NA	Locoregional Recurrence	"Other, specify"	Abdominal/retroperitoneal	27	NA	Positive	R2	1	146	1	146	NA	NA	1	27	
60	TCGA-WK-A8XS	0	14	0	5	1	1	0	0	3	43	1	0	2	15	0	0	TCGA-WK-A8XS-01	199	0.7927383500716233	127	TCGA-WK-A8XS-01	23	20	101	0.2919323632239669	TCGA-WK-A8XS-01	17	12	15	44	PASS	8773	TCGA-WK-A8XS	SARC	58	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2008	NA	-21521	Alive	TUMOR FREE	2579	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	2579	0	2579	0	2579	0	2579	
40	TCGA-WK-A8XT	0	9	0	2	3	0	0	0	5	40	2	0	4	16	0	0	TCGA-WK-A8XT-01	59	0.06926023266967997	18	TCGA-WK-A8XT-01	2	2	16	0.07341531939662242	TCGA-WK-A8XT-01	2	0	2	4	PASS	8774	TCGA-WK-A8XT	SARC	40	FEMALE	WHITE	NA	NA	Synovial Sarcoma - Monophasic	NA	2008	NA	-14958	Dead	WITH TUMOR	NA	1262	NA	Locoregional Recurrence	"Other, specify"	Flank	599	NA	Negative	R0	1	1262	1	1262	1	599	1	599	
70	TCGA-WK-A8XX	0	13	0	1	1	0	1	0	1	44	2	0	1	19	2	0	TCGA-WK-A8XX-01	189	0.8491562274518559	113	TCGA-WK-A8XX-01	19	21	67	0.1158994306206489	TCGA-WK-A8XX-01	16	13	7	36	PASS	8775	TCGA-WK-A8XX	SARC	70	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2007	NA	-25701	Dead	WITH TUMOR	NA	1164	NA	Locoregional Recurrence	"Other, specify"	Retroperitoneum	111	NA	Negative	R0	1	1164	1	1164	1	111	1	111	
50	TCGA-WK-A8XY	2	21	0	2	2	0	0	0	3	40	5	0	4	12	1	0	TCGA-WK-A8XY-01	137	0.947436966790372	67	TCGA-WK-A8XY-01	11	12	105	0.32853472745040285	TCGA-WK-A8XY-01	16	6	16	38	PASS	8776	TCGA-WK-A8XY	SARC	53	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2007	NA	-19597	Dead	WITH TUMOR	NA	1991	NA	Locoregional Recurrence	"Other, specify"	Intraabdominal	103	NA	Positive	R1	1	1991	1	1991	NA	NA	1	103	
60	TCGA-WK-A8XZ	0	13	0	2	2	0	0	0	3	28	0	0	2	11	2	1	TCGA-WK-A8XZ	0	0	0	TCGA-WK-A8XZ	0	0	0	0	TCGA-WK-A8XZ	0	0	0	0	PASS	8777	TCGA-WK-A8XZ	SARC	56	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2007	NA	-20460	Dead	WITH TUMOR	NA	1722	NA	Distant Metastasis	"Other, specify"	Scalp	89	NA	Negative	R0	1	1722	1	1722	1	89	1	89	
50	TCGA-WK-A8Y0	1	5	0	4	3	0	0	0	3	32	6	0	6	17	0	0	TCGA-WK-A8Y0-01	390	0.8330661323113973	286	TCGA-WK-A8Y0-01	28	17	202	0.34976019248056284	TCGA-WK-A8Y0-01	12	5	9	26	PASS	8778	TCGA-WK-A8Y0	SARC	49	FEMALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2010	NA	-18233	Dead	WITH TUMOR	NA	688	NA	Distant Metastasis	Lung	NA	111	NA	Negative	R0	1	688	1	688	1	111	1	111	
60	TCGA-WP-A9GB	3	38	3	8	7	0	1	0	10	116	8	0	5	24	2	0	TCGA-WP-A9GB-01	330	0.8048839675021116	208	TCGA-WP-A9GB-01	17	32	148	0.23091329833109744	TCGA-WP-A9GB-01	18	23	14	55	PASS	8779	TCGA-WP-A9GB	SARC	59	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	NA	Dead	WITH TUMOR	NA	261	NA	Distant Metastasis	Lung	NA	214	NA	Negative	RX	1	261	1	261	NA	NA	1	214	
50	TCGA-X2-A95T	1	12	0	4	18	0	3	0	1	31	0	0	4	15	4	0	TCGA-X2-A95T-01	187	0.9412770092062326	101	TCGA-X2-A95T-01	6	9	83	0.1805972906659003	TCGA-X2-A95T-01	12	10	11	33	PASS	8780	TCGA-X2-A95T	SARC	49	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2009	NA	-18079	Alive	TUMOR FREE	1927	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1927	0	1927	0	1927	0	1927	
90	TCGA-X6-A7W8	4	21	0	4	3	0	1	0	4	46	3	0	2	27	0	0	TCGA-X6-A7W8-01	630	0.9275824999870595	442	TCGA-X6-A7W8-01	11	33	340	0.5337145854338878	TCGA-X6-A7W8-01	31	33	17	81	PASS	8781	TCGA-X6-A7W8	SARC	89	MALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2011	NA	-32848	Dead	WITH TUMOR	NA	804	NA	Distant Metastasis	Lung	NA	146	NA	Positive	R1	1	804	1	804	NA	NA	1	146	
90	TCGA-X6-A7WA	5	75	8	23	1	0	1	0	29	445	12	0	7	88	5	0	TCGA-X6-A7WA-01	134	0.14335156047773878	83	TCGA-X6-A7WA-01	3	5	58	0.10066397774749328	TCGA-X6-A7WA-01	4	2	3	9	PASS	8782	TCGA-X6-A7WA	SARC	90	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2012	NA	-32872	Alive	TUMOR FREE	1092	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	1092	0	1092	NA	NA	0	1092	
60	TCGA-X6-A7WB	2	65	6	21	1	0	0	0	15	329	12	0	10	65	3	0	TCGA-X6-A7WB-01	245	0.947073085543956	169	TCGA-X6-A7WB-01	11	11	131	0.25582674528315075	TCGA-X6-A7WB-01	9	11	15	35	PASS	8783	TCGA-X6-A7WB	SARC	58	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-21467	Dead	WITH TUMOR	NA	550	NA	Distant Metastasis	Lung	NA	104	NA	Positive	R1	1	550	1	550	NA	NA	1	104	
70	TCGA-X6-A7WC	0	21	0	6	6	0	0	0	8	65	3	0	1	27	2	0	TCGA-X6-A7WC-01	479	0.7411115704983997	324	TCGA-X6-A7WC-01	13	39	143	0.16355227248275914	TCGA-X6-A7WC-01	24	27	10	61	PASS	8784	TCGA-X6-A7WC	SARC	74	MALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-27252	Alive	TUMOR FREE	1379	NA	NA	Distant Metastasis	Lung	NA	301	NA	Negative	R0	0	1379	0	1379	1	301	1	301	
60	TCGA-X6-A7WD	1	13	1	6	0	0	1	0	5	30	1	0	0	16	0	0	TCGA-X6-A7WD-01	248	0.5983886926607882	154	TCGA-X6-A7WD-01	1	2	108	0.10998250794726064	TCGA-X6-A7WD-01	7	9	9	25	PASS	8785	TCGA-X6-A7WD	SARC	63	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2013	NA	-23341	Alive	WITH TUMOR	938	NA	NA	Distant Metastasis	Lung	NA	558	NA	Negative	R0	0	938	0	938	1	558	1	558	
60	TCGA-X6-A8C2	2	18	0	7	8	0	1	0	7	59	5	1	2	18	1	0	TCGA-X6-A8C2-01	619	0.7778056761268115	459	TCGA-X6-A8C2-01	16	41	204	0.2356614897750852	TCGA-X6-A8C2-01	22	28	15	65	PASS	8786	TCGA-X6-A8C2	SARC	56	MALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2012	NA	-20507	Alive	WITH TUMOR	1070	NA	NA	New Primary Tumor	Lung	NA	7	NA	Positive	R1	0	1070	0	1070	NA	NA	1	7	
60	TCGA-X6-A8C3	0	21	3	3	1	0	0	1	2	43	2	0	1	24	3	0	TCGA-X6-A8C3-01	176	0.5794885073951588	102	TCGA-X6-A8C3-01	18	37	117	0.3050898854450235	TCGA-X6-A8C3-01	25	19	12	56	PASS	8787	TCGA-X6-A8C3	SARC	59	FEMALE	ASIAN	NA	NA	Myxofibrosarcoma	NA	2013	NA	-21751	Alive	TUMOR FREE	583	NA	NA	NA	NA	NA	NA	NA	Positive	R1	0	583	0	583	NA	NA	0	583	
70	TCGA-X6-A8C4	3	19	0	6	0	0	0	0	3	59	0	0	4	16	4	0	TCGA-X6-A8C4-01	447	0.8233547207705547	316	TCGA-X6-A8C4-01	17	35	245	0.3860477241715615	TCGA-X6-A8C4-01	26	27	20	73	PASS	8788	TCGA-X6-A8C4	SARC	70	FEMALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2013	NA	-25896	Dead	WITH TUMOR	NA	628	NA	Distant Metastasis	Lung	NA	71	NA	Positive	R1	1	628	1	628	NA	NA	1	71	
60	TCGA-X6-A8C5	2	10	2	4	1	0	1	0	6	50	3	0	3	16	1	0	TCGA-X6-A8C5-01	138	0.7946120618540413	80	TCGA-X6-A8C5-01	4	5	70	0.16054585592040138	TCGA-X6-A8C5-01	4	6	7	17	PASS	8789	TCGA-X6-A8C5	SARC	63	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Leiomyosarcoma (LMS)	NA	2011	NA	-23350	Alive	TUMOR FREE	1547	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	1547	0	1547	0	1547	0	1547	
60	TCGA-X6-A8C6	1	21	2	1	5	1	0	0	4	50	4	0	4	14	3	0	TCGA-X6-A8C6-01	744	0.6936377387489119	548	TCGA-X6-A8C6-01	21	63	220	0.273391131719932	TCGA-X6-A8C6-01	32	19	13	64	pathology review	8790	TCGA-X6-A8C6	SARC	55	MALE	WHITE	NA	NA	Myxofibrosarcoma	NA	2011	NA	-20090	Dead	WITH TUMOR	NA	1067	NA	Distant Metastasis	Bone	"& leg, opposite thigh"	408	NA	Positive	R1	1	1067	1	1067	NA	NA	1	408	
30	TCGA-X6-A8C7	0	6	0	5	0	1	0	0	4	11	1	0	0	3	2	0	TCGA-X6-A8C7-01	71	0.03670092583848475	28	TCGA-X6-A8C7-01	1	1	29	0.04103868425239093	TCGA-X6-A8C7-01	2	1	2	5	PASS	8791	TCGA-X6-A8C7	SARC	24	FEMALE	WHITE	NA	NA	Synovial Sarcoma - Biphasic	NA	2013	NA	-9104	Alive	TUMOR FREE	896	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	896	0	896	0	896	0	896	
50	TCGA-X9-A971	0	20	1	2	2	0	0	0	3	43	1	0	0	9	1	0	TCGA-X9-A971-01	271	0.8352370047680561	153	TCGA-X9-A971-01	7	9	113	0.2472733673072136	TCGA-X9-A971-01	12	8	10	30	PASS	8792	TCGA-X9-A971	SARC	52	FEMALE	WHITE	NA	NA	Leiomyosarcoma (LMS)	NA	2013	NA	-19207	Alive	WITH TUMOR	831	NA	NA	Distant Metastasis	Lung	NA	224	NA	Negative	R0	0	831	0	831	1	224	1	224	
60	TCGA-X9-A973	0	15	0	3	0	0	1	0	4	34	3	0	0	10	0	0	TCGA-X9-A973-01	116	0.5443961714800104	61	TCGA-X9-A973-01	6	22	215	0.8485283502806291	TCGA-X9-A973-01	4	3	4	11	pathology review	8793	TCGA-X9-A973	SARC	55	MALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2011	NA	-20146	Alive	WITH TUMOR	1108	NA	NA	Distant Metastasis	Lung	NA	119	NA	Negative	R0	0	1108	0	1108	1	119	1	119	
30	TCGA-Z4-A8JB	1	10	0	0	0	0	0	0	0	19	3	0	1	3	0	0	TCGA-Z4-A8JB-01	39	0.07116081576728125	9	TCGA-Z4-A8JB-01	0	0	12	0.022444972397943668	TCGA-Z4-A8JB-01	0	2	2	4	pathology review	8794	TCGA-Z4-A8JB	SARC	24	FEMALE	WHITE	NA	NA	Desmoid Tumor	NA	2013	NA	-9123	Alive	TUMOR FREE	133	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	133	0	133	0	133	0	133	
40	TCGA-Z4-A9VC	1	7	3	2	1	1	1	0	3	23	0	0	0	8	0	0	TCGA-Z4-A9VC-01	41	8.51116475945058e-05	9	TCGA-Z4-A9VC-01	0	0	4	0.00012888956356016656	TCGA-Z4-A9VC-01	0	0	0	0	pathology review	8795	TCGA-Z4-A9VC	SARC	37	MALE	WHITE	NA	NA	Dedifferentiated liposarcoma	NA	2013	NA	-13576	Alive	TUMOR FREE	407	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	407	0	407	0	407	0	407	
40	TCGA-Z4-AAPF	1	3	0	1	0	0	0	0	1	15	2	0	0	8	2	0	TCGA-Z4-AAPF-01	73	0.9794074934776176	27	TCGA-Z4-AAPF-01	11	10	15	0.037477076789728316	TCGA-Z4-AAPF-01	4	2	3	9	PASS	8796	TCGA-Z4-AAPF	SARC	35	FEMALE	WHITE	NA	NA	Sarcoma; synovial; poorly differentiated	NA	2013	NA	-12959	Alive	TUMOR FREE	485	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	485	0	485	0	485	0	485	
60	TCGA-Z4-AAPG	1	7	0	2	0	0	0	0	2	37	2	0	4	17	0	1	TCGA-Z4-AAPG-01	241	0.6810222643292849	141	TCGA-Z4-AAPG-01	18	26	206	0.4098214759428715	TCGA-Z4-AAPG-01	15	13	15	43	PASS	8797	TCGA-Z4-AAPG	SARC	64	FEMALE	WHITE	NA	NA	Undifferentiated Pleomorphic Sarcoma (UPS)	NA	2013	NA	-23390	Alive	TUMOR FREE	486	NA	NA	NA	NA	NA	NA	NA	Negative	R0	0	486	0	486	0	486	0	486	
70	TCGA-3N-A9WB	0	7	1	5	0	1	0	0	4	129	7	0	4	64	2	0	TCGA-3N-A9WB-06	92	0.2390560876217252	40	TCGA-3N-A9WB-06	9	9	18	0.04647697883846127	TCGA-3N-A9WB-06	5	4	3	12	PASS	8798	TCGA-3N-A9WB	SKCM	71	MALE	WHITE	Stage IA	NA	NA	NA	2012	NA	-26176	Dead	WITH TUMOR	NA	518	NA	Locoregional Recurrence	"Other, Specify"	Axillary	426	NA	NA	NA	1	518	1	518	NA	NA	1	426	
80	TCGA-3N-A9WC	5	94	5	34	9	1	1	0	68	1376	99	1	42	857	22	5	TCGA-3N-A9WC-06	163	0.3502451080809676	91	TCGA-3N-A9WC-06	8	15	92	0.2515796632592657	TCGA-3N-A9WC-06	16	11	14	41	hypermutated sample	8799	TCGA-3N-A9WC	SKCM	82	MALE	WHITE	Stage IIA	NA	NA	NA	2009	NA	-30286	Alive	WITH TUMOR	2022	NA	NA	Distant Metastasis	Lung	NA	1705	NA	NA	NA	0	2022	0	2022	NA	NA	1	1705	
80	TCGA-3N-A9WD	2	43	2	23	4	2	0	0	25	713	47	0	14	384	12	2	TCGA-3N-A9WD-06	82	0.3073789163558989	34	TCGA-3N-A9WD-06	10	15	84	0.3368749820168386	TCGA-3N-A9WD-06	1	3	1	5	PASS	8800	TCGA-3N-A9WD	SKCM	82	MALE	WHITE	Stage IIIA	NA	NA	NA	2013	NA	-30163	Dead	WITH TUMOR	NA	395	NA	Distant Metastasis	Brain	NA	306	NA	NA	NA	1	395	1	395	NA	NA	1	306	
50	TCGA-BF-A1PU	9	48	6	31	0	0	0	0	58	1165	167	0	12	462	60	8	TCGA-BF-A1PU	0	0	0	TCGA-BF-A1PU-01	8	9	29	0.27274830111637954	TCGA-BF-A1PU-01	6	5	8	19	PASS	8801	TCGA-BF-A1PU	SKCM	46	FEMALE	WHITE	Stage IIC	NA	NA	NA	2010	NA	-17025	Alive	TUMOR FREE	387	NA	NA	Distant Metastasis	Lung	NA	484	NA	NA	NA	0	387	0	387	NA	NA	1	484	
70	TCGA-BF-A1PV	1	19	1	7	0	1	1	0	6	238	8	0	6	113	4	0	TCGA-BF-A1PV	0	0	0	TCGA-BF-A1PV-01	6	4	5	0.038163917180462775	TCGA-BF-A1PV-01	2	0	1	3	PASS	8802	TCGA-BF-A1PV	SKCM	74	FEMALE	WHITE	Stage IIC	NA	NA	NA	2010	NA	-27124	Alive	TUMOR FREE	14	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	14	0	14	NA	NA	0	14	
60	TCGA-BF-A1PX	4	23	4	17	0	0	0	0	26	597	74	0	6	310	13	0	TCGA-BF-A1PX	0	0	0	TCGA-BF-A1PX-01	8	5	7	0.2123681388802404	TCGA-BF-A1PX-01	2	2	2	6	PASS	8803	TCGA-BF-A1PX	SKCM	56	MALE	WHITE	Stage IIIB	NA	NA	NA	2010	NA	-20626	Dead	TUMOR FREE	NA	282	NA	NA	NA	NA	NA	NA	NA	NA	1	282	0	282	NA	NA	0	282	
70	TCGA-BF-A1PZ	6	76	7	40	3	1	0	1	63	1343	185	2	27	647	53	6	TCGA-BF-A1PZ	0	0	0	TCGA-BF-A1PZ-01	8	21	18	0.4174563844214726	TCGA-BF-A1PZ-01	6	1	3	10	PASS	8804	TCGA-BF-A1PZ	SKCM	71	FEMALE	WHITE	Stage IIB	NA	NA	NA	2010	NA	-26240	Alive	TUMOR FREE	853	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	853	0	853	NA	NA	0	853	
80	TCGA-BF-A1Q0	8	142	8	75	3	3	0	0	85	2260	209	3	43	1019	111	3	TCGA-BF-A1Q0	0	0	0	TCGA-BF-A1Q0-01	19	49	42	0.20904475902040204	TCGA-BF-A1Q0-01	20	18	6	44	PASS	8805	TCGA-BF-A1Q0	SKCM	80	MALE	WHITE	Stage IIC	NA	NA	NA	2010	NA	-29380	Alive	TUMOR FREE	831	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	831	0	831	NA	NA	0	831	
40	TCGA-BF-A3DJ	1	11	2	5	0	0	0	0	4	107	8	0	5	52	5	0	TCGA-BF-A3DJ	0	0	0	TCGA-BF-A3DJ-01	11	11	35	0.2706616611625915	TCGA-BF-A3DJ-01	6	0	4	10	PASS	8806	TCGA-BF-A3DJ	SKCM	36	FEMALE	WHITE	Stage IIIB	NA	NA	NA	2011	NA	-13332	Alive	TUMOR FREE	464	NA	NA	Distant Metastasis	Liver	NA	217	NA	NA	NA	0	464	0	464	NA	NA	1	217	
80	TCGA-BF-A3DL	4	19	2	12	4	2	0	0	12	343	16	0	6	193	3	0	TCGA-BF-A3DL	0	0	0	TCGA-BF-A3DL-01	18	16	11	0.18669326913971565	TCGA-BF-A3DL-01	3	2	6	11	PASS	8807	TCGA-BF-A3DL	SKCM	84	FEMALE	WHITE	Stage IIIB	NA	NA	NA	2011	NA	-30805	Alive	TUMOR FREE	769	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	769	0	769	NA	NA	0	769	
60	TCGA-BF-A3DM	4	25	3	12	0	2	0	0	15	345	22	0	9	215	7	0	TCGA-BF-A3DM	0	0	0	TCGA-BF-A3DM-01	6	6	33	0.14543583892677844	TCGA-BF-A3DM-01	2	0	1	3	PASS	8808	TCGA-BF-A3DM	SKCM	63	MALE	WHITE	Stage IIA	NA	NA	NA	2011	NA	-23076	Alive	TUMOR FREE	601	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	601	0	601	NA	NA	0	601	
80	TCGA-BF-A3DN	1	3	1	3	1	0	0	0	1	61	2	0	4	30	5	0	TCGA-BF-A3DN	0	0	0	TCGA-BF-A3DN-01	23	28	24	0.308270340105653	TCGA-BF-A3DN-01	5	3	1	9	PASS	8809	TCGA-BF-A3DN	SKCM	81	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2011	NA	-29801	Alive	TUMOR FREE	717	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	717	0	717	NA	NA	0	717	
70	TCGA-BF-A5EO	1	45	5	19	3	0	0	0	23	469	29	0	7	252	11	0	TCGA-BF-A5EO	0	0	0	TCGA-BF-A5EO-01	8	7	42	0.17889826896685798	TCGA-BF-A5EO-01	6	3	5	14	PASS	8810	TCGA-BF-A5EO	SKCM	65	MALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-23940	Alive	TUMOR FREE	703	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	703	0	703	NA	NA	0	703	
80	TCGA-BF-A5EP	2	8	0	1	1	0	0	0	8	129	9	0	5	60	2	0	TCGA-BF-A5EP	0	0	0	TCGA-BF-A5EP-01	29	17	81	0.3894081664301133	TCGA-BF-A5EP-01	12	13	15	40	PASS	8811	TCGA-BF-A5EP	SKCM	75	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-27622	Alive	TUMOR FREE	335	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	335	0	335	NA	NA	0	335	
60	TCGA-BF-A5EQ	6	29	5	11	3	0	0	0	17	460	26	0	11	242	8	0	TCGA-BF-A5EQ	0	0	0	TCGA-BF-A5EQ-01	16	13	69	0.04533255910385813	TCGA-BF-A5EQ-01	5	5	2	12	PASS	8812	TCGA-BF-A5EQ	SKCM	63	MALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-23353	Alive	TUMOR FREE	323	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	323	0	323	NA	NA	0	323	
60	TCGA-BF-A5ER	1	19	0	6	4	1	1	0	9	140	5	0	5	87	5	0	TCGA-BF-A5ER	0	0	0	TCGA-BF-A5ER-01	10	8	35	0.1136107099785802	TCGA-BF-A5ER-01	10	3	2	15	PASS	8813	TCGA-BF-A5ER	SKCM	63	MALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-23199	Alive	TUMOR FREE	327	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	327	0	327	NA	NA	0	327	
80	TCGA-BF-A5ES	0	42	4	17	4	0	0	0	16	378	22	0	10	225	4	0	TCGA-BF-A5ES	0	0	0	TCGA-BF-A5ES-01	2	2	32	0.03572774046141067	TCGA-BF-A5ES-01	4	7	2	13	PASS	8814	TCGA-BF-A5ES	SKCM	76	FEMALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-28092	Alive	TUMOR FREE	490	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	490	0	490	NA	NA	0	490	
80	TCGA-BF-A9VF	1	2	1	3	1	0	0	0	6	60	8	0	1	45	1	0	TCGA-BF-A9VF	0	0	0	TCGA-BF-A9VF-01	16	16	96	0.3742762409174533	TCGA-BF-A9VF-01	6	0	6	12	PASS	8815	TCGA-BF-A9VF	SKCM	77	MALE	WHITE	Stage IIC	NA	NA	NA	2013	NA	-28312	Alive	TUMOR FREE	440	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	440	0	440	NA	NA	0	440	
70	TCGA-BF-AAOU	1	14	3	10	0	0	0	0	11	239	18	0	5	154	3	0	TCGA-BF-AAOU	0	0	0	TCGA-BF-AAOU-01	12	12	69	0.3470825084628931	TCGA-BF-AAOU-01	4	0	5	9	PASS	8816	TCGA-BF-AAOU	SKCM	73	FEMALE	WHITE	Stage IIC	NA	NA	NA	2013	NA	-26750	Alive	TUMOR FREE	476	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	476	0	476	NA	NA	0	476	
80	TCGA-BF-AAOX	5	70	8	29	2	2	2	1	44	952	55	0	22	529	18	1	TCGA-BF-AAOX	0	0	0	TCGA-BF-AAOX-01	5	7	37	0.10446164244605824	TCGA-BF-AAOX-01	11	3	6	20	PASS	8817	TCGA-BF-AAOX	SKCM	83	MALE	WHITE	Stage IIC	NA	NA	NA	2013	NA	-30318	Alive	TUMOR FREE	444	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	444	0	444	NA	NA	0	444	
40	TCGA-BF-AAP0	1	22	2	8	1	1	0	0	8	354	22	0	6	216	6	1	TCGA-BF-AAP0-06	80	0.27521940697461594	31	TCGA-BF-AAP0-06	6	8	55	0.21516829144961647	TCGA-BF-AAP0-06	8	8	6	22	PASS	8818	TCGA-BF-AAP0	SKCM	40	FEMALE	WHITE	Stage IV	NA	NA	NA	2013	NA	-14773	Alive	TUMOR FREE	454	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	454	0	454	NA	NA	0	454	
90	TCGA-BF-AAP1	5	61	3	24	3	1	0	0	34	631	37	0	19	400	10	0	TCGA-BF-AAP1	0	0	0	TCGA-BF-AAP1-01	18	14	66	0.13865813491794546	TCGA-BF-AAP1-01	9	5	5	19	PASS	8819	TCGA-BF-AAP1	SKCM	86	MALE	WHITE	Stage IIC	NA	NA	NA	2013	NA	-31666	Alive	TUMOR FREE	409	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	409	0	409	NA	NA	0	409	
60	TCGA-BF-AAP2	3	84	3	28	0	2	2	0	36	1019	66	1	19	568	13	3	TCGA-BF-AAP2	0	0	0	TCGA-BF-AAP2-01	2	5	74	0.11341698075604442	TCGA-BF-AAP2-01	6	5	5	16	PASS	8820	TCGA-BF-AAP2	SKCM	62	MALE	WHITE	Stage IIB	NA	NA	NA	2013	NA	-22734	Alive	TUMOR FREE	405	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	405	0	405	NA	NA	0	405	
60	TCGA-BF-AAP4	3	31	6	17	4	0	0	0	35	617	39	0	11	366	8	0	TCGA-BF-AAP4	0	0	0	TCGA-BF-AAP4-01	20	25	33	0.09440453874828712	TCGA-BF-AAP4-01	10	9	1	20	PASS	8821	TCGA-BF-AAP4	SKCM	61	MALE	WHITE	Stage IIC	NA	NA	NA	2013	NA	-22303	Alive	TUMOR FREE	335	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	335	0	335	NA	NA	0	335	
60	TCGA-BF-AAP6	1	3	0	2	1	0	0	0	2	55	1	0	1	27	0	0	TCGA-BF-AAP6	0	0	0	TCGA-BF-AAP6-01	13	11	97	0.17485797176487688	TCGA-BF-AAP6-01	7	9	4	20	PASS	8822	TCGA-BF-AAP6	SKCM	55	MALE	WHITE	Stage III	NA	NA	NA	2013	NA	-20384	Alive	TUMOR FREE	325	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	325	0	325	NA	NA	0	325	
80	TCGA-BF-AAP7	1	17	2	9	3	0	1	1	13	351	19	1	6	196	4	1	TCGA-BF-AAP7	0	0	0	TCGA-BF-AAP7-01	5	4	35	0.13197492324926227	TCGA-BF-AAP7-01	3	5	4	12	PASS	8823	TCGA-BF-AAP7	SKCM	76	FEMALE	WHITE	Stage IIC	NA	NA	NA	2013	NA	-28073	Alive	TUMOR FREE	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	318	0	318	NA	NA	0	318	
60	TCGA-BF-AAP8	0	2	0	0	0	1	0	0	0	10	0	0	0	2	1	0	TCGA-BF-AAP8	0	0	0	TCGA-BF-AAP8-01	7	9	32	0.12640409927305168	TCGA-BF-AAP8-01	6	4	2	12	PASS	8824	TCGA-BF-AAP8	SKCM	58	MALE	WHITE	Stage IIC	NA	NA	NA	2013	NA	-21414	Alive	TUMOR FREE	447	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	447	0	447	NA	NA	0	447	
80	TCGA-D3-A1Q1	1	27	3	20	1	1	0	0	23	414	44	0	6	161	13	1	TCGA-D3-A1Q1-06	343	0.7330696878149286	229	TCGA-D3-A1Q1-06	27	34	48	0.2853126521645689	TCGA-D3-A1Q1-06	10	7	8	25	PASS	8825	TCGA-D3-A1Q1	SKCM	79	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2004	NA	-29212	Dead	WITH TUMOR	NA	504	NA	Locoregional Recurrence	NA	NA	58	NA	NA	NA	1	504	1	504	NA	NA	1	58	
60	TCGA-D3-A1Q3	4	62	2	39	4	0	0	0	49	1195	179	1	19	600	45	3	TCGA-D3-A1Q3-06	305	0.8044178203571359	192	TCGA-D3-A1Q3-06	9	10	20	0.04374798965837224	TCGA-D3-A1Q3-06	5	3	2	10	PASS	8826	TCGA-D3-A1Q3	SKCM	64	MALE	WHITE	Stage IIC	NA	NA	NA	2001	NA	-23604	Dead	WITH TUMOR	NA	507	NA	NA	NA	NA	NA	NA	NA	NA	1	507	1	507	NA	NA	1	507	
50	TCGA-D3-A1Q4	1	28	1	13	3	0	0	0	12	252	21	0	9	153	4	2	TCGA-D3-A1Q4-06	62	0.3723695245671804	21	TCGA-D3-A1Q4-06	13	14	14	0.3258286171964855	TCGA-D3-A1Q4-06	7	4	6	17	PASS	8827	TCGA-D3-A1Q4	SKCM	53	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2003	NA	-19687	Alive	TUMOR FREE	3408	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3408	0	3408	NA	NA	0	3408	
60	TCGA-D3-A1Q5	0	25	3	9	2	0	1	0	12	268	17	0	9	148	5	3	TCGA-D3-A1Q5-06	208	0.9024957654133444	125	TCGA-D3-A1Q5-06	21	24	54	0.2957149111788826	TCGA-D3-A1Q5-06	5	3	4	12	PASS	8828	TCGA-D3-A1Q5	SKCM	60	MALE	WHITE	I/II NOS	NA	NA	NA	1996	NA	-22200	Dead	NA	NA	3424	NA	Locoregional Recurrence	NA	NA	2452	NA	NA	NA	1	3424	NA	3424	NA	NA	1	2452	
60	TCGA-D3-A1Q6	6	61	4	39	2	0	0	0	36	845	68	0	14	540	19	1	TCGA-D3-A1Q6-06	87	0.4477287028468685	42	TCGA-D3-A1Q6-06	18	21	14	0.06348245767425671	TCGA-D3-A1Q6-06	4	7	3	14	PASS	8829	TCGA-D3-A1Q6	SKCM	55	MALE	WHITE	Stage III	NA	NA	NA	2003	NA	-20230	Dead	TUMOR FREE	NA	2184	NA	Regional lymph node	NA	NA	48	NA	NA	NA	1	2184	0	2184	NA	NA	1	48	
40	TCGA-D3-A1Q7	1	5	0	3	2	0	0	0	1	66	5	0	2	46	4	0	TCGA-D3-A1Q7-06	81	0.1809763778052987	40	TCGA-D3-A1Q7-06	6	8	7	0.15407743406462765	TCGA-D3-A1Q7-06	3	2	3	8	PASS	8830	TCGA-D3-A1Q7	SKCM	42	FEMALE	WHITE	Stage IB	NA	NA	NA	2002	NA	-15531	Alive	TUMOR FREE	4053	NA	NA	Distant Metastasis	"Other, Specify"	soft tissue left buttock	921	NA	NA	NA	0	4053	0	4053	NA	NA	1	921	
30	TCGA-D3-A1Q8	0	15	0	8	1	0	0	0	2	180	14	0	4	102	5	0	TCGA-D3-A1Q8-06	111	0.8026612575854148	53	TCGA-D3-A1Q8-06	9	8	22	0.2657327644099573	TCGA-D3-A1Q8-06	4	5	4	13	PASS	8831	TCGA-D3-A1Q8	SKCM	33	MALE	WHITE	Stage IV	NA	NA	NA	2004	NA	-12330	Dead	WITH TUMOR	NA	854	NA	Distant Metastasis	Lung	NA	147	NA	NA	NA	1	854	1	854	NA	NA	1	147	
70	TCGA-D3-A1Q9	0	2	0	2	0	1	0	0	2	27	2	0	0	8	0	0	TCGA-D3-A1Q9-06	487	0.7044478373145564	344	TCGA-D3-A1Q9-06	21	19	85	0.2128660904777502	TCGA-D3-A1Q9-06	11	13	7	31	PASS	8832	TCGA-D3-A1Q9	SKCM	72	MALE	WHITE	Stage IIIB	NA	NA	NA	2005	NA	-26471	Dead	WITH TUMOR	NA	961	NA	Regional lymph node	NA	NA	44	NA	NA	NA	1	961	1	961	NA	NA	1	44	
60	TCGA-D3-A1QA	7	52	7	38	1	1	1	0	45	979	81	0	25	530	34	1	TCGA-D3-A1QA-06	90	0.2271780826483649	37	TCGA-D3-A1QA-06	7	7	8	0.06850696990128158	TCGA-D3-A1QA-06	5	4	3	12	PASS	8833	TCGA-D3-A1QA	SKCM	55	MALE	WHITE	Stage IB	NA	NA	NA	2005	NA	-20223	Alive	WITH TUMOR	2765	NA	NA	Distant Metastasis	Lung	NA	1393	NA	NA	NA	0	2765	0	2765	NA	NA	1	1393	
80	TCGA-D3-A1QB	3	21	1	19	1	0	0	0	9	312	25	0	6	177	7	0	TCGA-D3-A1QB-06	80	0.13063352447692875	37	TCGA-D3-A1QB-06	3	8	7	0.045198239776831184	TCGA-D3-A1QB-06	4	3	3	10	PASS	8834	TCGA-D3-A1QB	SKCM	75	FEMALE	WHITE	Stage III	NA	NA	NA	2005	NA	-27566	Alive	TUMOR FREE	2912	NA	NA	Locoregional Recurrence	NA	NA	0	NA	NA	NA	0	2912	0	2912	NA	NA	1	0	
70	TCGA-D3-A2J6	9	72	8	39	0	0	0	0	50	1235	118	2	15	535	57	2	TCGA-D3-A2J6-06	397	0.939294653636716	270	TCGA-D3-A2J6-06	12	14	119	0.3537326697178368	TCGA-D3-A2J6-06	12	9	14	35	PASS	8835	TCGA-D3-A2J6	SKCM	65	MALE	WHITE	Stage IIB	NA	NA	NA	2002	NA	-24066	Dead	WITH TUMOR	NA	1321	NA	New primary melanoma	NA	NA	448	NA	NA	NA	1	1321	1	1321	NA	NA	1	448	
70	TCGA-D3-A2J7	0	15	4	9	1	1	0	0	14	314	23	0	3	164	5	0	TCGA-D3-A2J7-06	75	0.3402782690369158	26	TCGA-D3-A2J7-06	10	12	14	0.3258580696191775	TCGA-D3-A2J7-06	6	8	6	20	PASS	8836	TCGA-D3-A2J7	SKCM	67	MALE	WHITE	Stage IIIC	NA	NA	NA	2003	NA	-24692	Dead	WITH TUMOR	NA	3136	NA	Regional lymph node	NA	NA	13	NA	NA	NA	1	3136	1	3136	NA	NA	1	13	
50	TCGA-D3-A2J8	2	48	3	31	2	0	1	0	56	839	61	0	7	417	28	2	TCGA-D3-A2J8-06	54	0.1276941846815489	19	TCGA-D3-A2J8-06	4	6	3	0.08745635602839141	TCGA-D3-A2J8-06	3	5	3	11	PASS	8837	TCGA-D3-A2J8	SKCM	48	MALE	WHITE	Stage IB	NA	NA	NA	2003	NA	-17626	Dead	WITH TUMOR	NA	1992	NA	Locoregional Recurrence	NA	NA	1737	NA	NA	NA	1	1992	1	1992	NA	NA	1	1737	
80	TCGA-D3-A2J9	0	14	0	6	0	0	0	0	6	181	22	0	2	91	9	0	TCGA-D3-A2J9-06	56	0.11649308617650105	14	TCGA-D3-A2J9-06	6	10	19	0.007272035310058511	TCGA-D3-A2J9-06	0	3	1	4	PASS	8838	TCGA-D3-A2J9	SKCM	75	MALE	WHITE	Stage IIIC	NA	NA	NA	2003	NA	-27428	Dead	WITH TUMOR	NA	723	NA	Distant Metastasis	Lung	NA	231	NA	NA	NA	1	723	1	723	NA	NA	1	231	
70	TCGA-D3-A2JA	2	19	2	10	3	0	0	0	19	286	13	0	7	147	2	1	TCGA-D3-A2JA-06	270	0.8136250599860034	192	TCGA-D3-A2JA-06	29	35	32	0.2190298011084238	TCGA-D3-A2JA-06	7	6	5	18	PASS	8839	TCGA-D3-A2JA	SKCM	68	MALE	WHITE	Stage IIIA	NA	NA	NA	2003	NA	-25085	Alive	TUMOR FREE	3514	NA	NA	Regional lymph node	NA	NA	40	NA	NA	NA	0	3514	0	3514	NA	NA	1	40	
70	TCGA-D3-A2JB	0	34	4	23	0	0	0	0	27	758	79	1	16	348	38	2	TCGA-D3-A2JB-06	100	0.17040729096036636	50	TCGA-D3-A2JB-06	6	11	15	0.11344662598108107	TCGA-D3-A2JB-06	3	5	1	9	PASS	8840	TCGA-D3-A2JB	SKCM	70	FEMALE	BLACK OR AFRICAN AMERICAN	Stage 0	NA	NA	NA	1997	NA	-25784	Dead	TUMOR FREE	NA	5110	NA	Locoregional Recurrence	NA	NA	3035	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
50	TCGA-D3-A2JC	13	116	11	56	1	0	0	0	97	2568	369	3	30	1045	150	2	TCGA-D3-A2JC-06	419	0.7052237849632479	292	TCGA-D3-A2JC-06	22	25	88	0.397595499902716	TCGA-D3-A2JC-06	9	13	13	35	PASS	8841	TCGA-D3-A2JC	SKCM	53	FEMALE	WHITE	Stage III	NA	NA	NA	2006	NA	-19644	Alive	TUMOR FREE	2639	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2639	0	2639	NA	NA	0	2639	
60	TCGA-D3-A2JD	4	53	8	27	0	1	0	0	52	1051	100	1	12	533	43	2	TCGA-D3-A2JD-06	85	0.5587742365299848	38	TCGA-D3-A2JD-06	19	30	11	0.20807311723726865	TCGA-D3-A2JD-06	9	8	0	17	PASS	8842	TCGA-D3-A2JD	SKCM	58	MALE	WHITE	Stage IIIC	NA	NA	NA	2007	NA	-21440	Dead	WITH TUMOR	NA	361	NA	Distant Metastasis	Liver	NA	85	NA	NA	NA	1	361	1	361	NA	NA	1	85	
80	TCGA-D3-A2JE	5	23	0	14	6	3	4	0	7	222	20	1	7	158	9	0	TCGA-D3-A2JE-06	134	0.9627559595415686	62	TCGA-D3-A2JE-06	24	23	26	0.10090354174425603	TCGA-D3-A2JE-06	11	11	4	26	PASS	8843	TCGA-D3-A2JE	SKCM	75	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2009	NA	-27604	Dead	WITH TUMOR	NA	841	NA	NA	NA	NA	149	NA	NA	NA	1	841	1	841	NA	NA	1	149	
70	TCGA-D3-A2JF	5	75	12	37	3	0	0	0	55	1093	91	0	29	574	12	1	TCGA-D3-A2JF-06	119	0.5058460338508731	53	TCGA-D3-A2JF-06	17	20	11	0.09650521360701277	TCGA-D3-A2JF-06	7	6	5	18	PASS	8844	TCGA-D3-A2JF	SKCM	74	MALE	WHITE	Stage IA	NA	NA	NA	2008	NA	-27255	Alive	TUMOR FREE	1888	NA	NA	New primary melanoma	NA	NA	25	NA	NA	NA	0	1888	0	1888	NA	NA	1	25	
30	TCGA-D3-A2JG	2	36	1	23	2	0	0	0	28	508	41	0	14	239	17	1	TCGA-D3-A2JG-06	229	0.345351924137464	150	TCGA-D3-A2JG-06	8	10	55	0.28445072095268137	TCGA-D3-A2JG-06	6	3	2	11	PASS	8845	TCGA-D3-A2JG	SKCM	30	FEMALE	WHITE	Stage IIIA	NA	NA	NA	2001	NA	-11105	Dead	WITH TUMOR	NA	3453	NA	Distant Metastasis	"Other, Specify"	"Left ischial rectal fossa, soft tissue"	3279	NA	NA	NA	1	3453	1	3453	NA	NA	1	3279	
70	TCGA-D3-A2JH	3	34	6	20	2	1	1	0	22	584	38	0	10	311	16	2	TCGA-D3-A2JH-06	51	0.03066032838447409	11	TCGA-D3-A2JH-06	2	2	0	0.0	TCGA-D3-A2JH-06	0	2	0	2	PASS	8846	TCGA-D3-A2JH	SKCM	68	MALE	WHITE	Stage IB	NA	NA	NA	2010	NA	-24882	Alive	TUMOR FREE	1280	NA	NA	Distant Metastasis	Brain	NA	569	NA	NA	NA	0	1280	0	1280	NA	NA	1	569	
30	TCGA-D3-A2JK	3	59	4	22	1	0	0	0	28	690	56	1	5	307	12	1	TCGA-D3-A2JK-06	100	0.12629848230723156	53	TCGA-D3-A2JK-06	5	3	12	0.11520489971202914	TCGA-D3-A2JK-06	4	0	2	6	PASS	8847	TCGA-D3-A2JK	SKCM	24	MALE	WHITE	Stage IIIC	NA	NA	NA	2005	NA	-8952	Dead	WITH TUMOR	NA	368	NA	Distant Metastasis	Lung	NA	261	NA	NA	NA	1	368	1	368	NA	NA	1	261	
40	TCGA-D3-A2JL	7	74	9	52	2	1	2	0	42	1049	94	0	26	483	34	4	TCGA-D3-A2JL-06	89	0.7649399307928565	36	TCGA-D3-A2JL-06	25	24	13	0.17778018856231276	TCGA-D3-A2JL-06	11	5	4	20	PASS	8848	TCGA-D3-A2JL	SKCM	43	FEMALE	WHITE	I/II NOS	NA	NA	NA	1999	NA	-15710	Alive	TUMOR FREE	5219	NA	NA	Distant Metastasis	Lung	NA	2638	NA	NA	NA	0	5219	0	5219	NA	NA	1	2638	
50	TCGA-D3-A2JN	2	37	3	28	3	1	2	0	34	626	65	0	23	309	24	1	TCGA-D3-A2JN-06	85	0.7166918234535454	32	TCGA-D3-A2JN-06	24	24	18	0.3697957306231315	TCGA-D3-A2JN-06	12	8	4	24	PASS	8849	TCGA-D3-A2JN	SKCM	46	FEMALE	WHITE	Stage III	NA	NA	NA	2007	NA	-17128	Dead	TUMOR FREE	NA	2022	NA	NA	NA	NA	NA	NA	NA	NA	1	2022	0	2022	NA	NA	0	2022	
50	TCGA-D3-A2JO	7	68	14	31	4	2	2	0	66	1112	117	2	16	547	37	1	TCGA-D3-A2JO-06	188	0.5105357303748559	100	TCGA-D3-A2JO-06	22	18	34	0.16258514926498868	TCGA-D3-A2JO-06	9	9	6	24	PASS	8850	TCGA-D3-A2JO	SKCM	50	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2008	NA	-18577	Alive	WITH TUMOR	2010	NA	NA	Distant Metastasis	"Other, Specify"	"Chest wall, soft tissue"	50	NA	NA	NA	0	2010	0	2010	NA	NA	1	50	
40	TCGA-D3-A2JP	16	126	14	56	5	0	1	0	96	3445	459	3	56	1356	169	10	TCGA-D3-A2JP-06	98	0.4979197281425913	45	TCGA-D3-A2JP-06	19	18	22	0.14041160659586108	TCGA-D3-A2JP-06	8	7	3	18	PASS	8851	TCGA-D3-A2JP	SKCM	37	MALE	WHITE	Stage IIIC	NA	NA	NA	2008	NA	-13552	Alive	WITH TUMOR	1812	NA	NA	Distant Metastasis	Liver	NA	227	NA	NA	NA	0	1812	0	1812	NA	NA	1	227	
60	TCGA-D3-A3BZ	2	3	0	0	0	1	0	0	3	58	3	0	1	12	1	0	TCGA-D3-A3BZ-06	155	0.10559576389067757	96	TCGA-D3-A3BZ-06	0	0	9	0.008303133909640435	TCGA-D3-A3BZ-06	0	0	1	1	PASS	8852	TCGA-D3-A3BZ	SKCM	63	MALE	WHITE	Stage IIB	NA	NA	NA	2002	NA	-23286	Alive	TUMOR FREE	3976	NA	NA	NA	NA	NA	2340	NA	NA	NA	0	3976	0	3976	NA	NA	1	2340	
NA	TCGA-D3-A3C1	0	7	1	5	2	2	0	0	2	117	10	2	1	57	2	0	TCGA-D3-A3C1-06	292	0.7471955738980612	185	TCGA-D3-A3C1-06	26	20	24	0.1741256928684886	TCGA-D3-A3C1-06	5	4	2	11	PASS	8853	TCGA-D3-A3C1	SKCM	NA	MALE	WHITE	I/II NOS	NA	NA	NA	1998	NA	NA	Alive	WITH TUMOR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
NA	TCGA-D3-A3C3	2	14	2	2	2	0	1	0	5	197	16	0	6	93	6	1	TCGA-D3-A3C3-06	173	0.37851420785650103	104	TCGA-D3-A3C3-06	12	21	26	0.2015065122128542	TCGA-D3-A3C3-06	5	8	2	15	PASS	8854	TCGA-D3-A3C3	SKCM	NA	FEMALE	WHITE	I/II NOS	NA	NA	NA	1985	NA	NA	Alive	WITH TUMOR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
50	TCGA-D3-A3C6	5	33	2	21	2	0	0	0	29	483	72	0	6	227	18	1	TCGA-D3-A3C6-06	136	0.8918912153795335	78	TCGA-D3-A3C6-06	9	13	23	0.4187362701388145	TCGA-D3-A3C6-06	6	6	9	21	PASS	8855	TCGA-D3-A3C6	SKCM	54	FEMALE	WHITE	Stage IB	NA	NA	NA	2006	NA	-19858	Dead	WITH TUMOR	NA	1766	NA	Distant Metastasis	Lung	NA	1441	NA	NA	NA	1	1766	1	1766	NA	NA	1	1441	
60	TCGA-D3-A3C7	8	73	3	43	2	1	1	0	71	1280	98	1	30	616	42	4	TCGA-D3-A3C7-06	177	0.9251536952753762	101	TCGA-D3-A3C7-06	9	9	42	0.2378305583985565	TCGA-D3-A3C7-06	7	9	7	23	PASS	8856	TCGA-D3-A3C7	SKCM	57	FEMALE	WHITE	Stage III	NA	NA	NA	2009	NA	-20979	Alive	TUMOR FREE	1429	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1429	0	1429	NA	NA	0	1429	
60	TCGA-D3-A3C8	6	44	3	21	0	1	0	0	50	1263	204	1	14	542	72	2	TCGA-D3-A3C8-06	33	1.2410674775404063e-06	4	TCGA-D3-A3C8-06	0	0	0	0.0	TCGA-D3-A3C8-06	0	0	0	0	PASS	8857	TCGA-D3-A3C8	SKCM	58	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2009	NA	-21281	Alive	WITH TUMOR	1409	NA	NA	Distant Metastasis	"Other, Specify"	"Lymph nodes, neck"	55	NA	NA	NA	0	1409	0	1409	NA	NA	1	55	
40	TCGA-D3-A3CB	6	27	3	17	0	0	1	0	25	468	45	0	5	237	12	0	TCGA-D3-A3CB-06	53	0.21160858271744298	17	TCGA-D3-A3CB-06	11	15	7	0.17414031335603186	TCGA-D3-A3CB-06	2	0	1	3	PASS	8858	TCGA-D3-A3CB	SKCM	39	MALE	WHITE	I/II NOS	NA	NA	NA	1999	NA	-14563	Alive	TUMOR FREE	5065	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	5065	0	5065	NA	NA	0	5065	
70	TCGA-D3-A3CC	1	2	0	1	0	2	0	0	6	75	6	0	2	31	1	2	TCGA-D3-A3CC-06	319	0.7046276789297614	211	TCGA-D3-A3CC-06	21	23	77	0.17585825190960405	TCGA-D3-A3CC-06	10	10	9	29	PASS	8859	TCGA-D3-A3CC	SKCM	69	FEMALE	WHITE	Stage IIC	NA	NA	NA	2005	NA	-25396	Alive	WITH TUMOR	2644	NA	NA	Locoregional Recurrence	NA	NA	96	NA	NA	NA	0	2644	0	2644	NA	NA	1	96	
70	TCGA-D3-A3CE	9	97	7	48	2	1	0	1	68	1737	233	1	40	680	97	5	TCGA-D3-A3CE-06	136	0.6680433496684358	71	TCGA-D3-A3CE-06	24	21	39	0.23536796280128705	TCGA-D3-A3CE-06	11	8	7	26	PASS	8860	TCGA-D3-A3CE	SKCM	74	FEMALE	WHITE	Stage III	NA	NA	NA	2001	NA	-27355	Dead	WITH TUMOR	NA	1832	NA	Regional lymph node	NA	NA	0	NA	NA	NA	1	1832	1	1832	NA	NA	1	0	
60	TCGA-D3-A3CF	2	3	0	5	0	0	0	0	3	88	10	0	0	31	4	0	TCGA-D3-A3CF-06	656	0.2926097205396867	473	TCGA-D3-A3CF-06	9	8	91	0.16568659840918956	TCGA-D3-A3CF-06	9	9	8	26	PASS	8861	TCGA-D3-A3CF	SKCM	61	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2009	NA	-22409	Dead	WITH TUMOR	NA	746	NA	Distant Metastasis	Bone	NA	129	NA	NA	NA	1	746	1	746	NA	NA	1	129	
70	TCGA-D3-A3ML	2	36	3	21	3	1	0	0	33	693	41	0	27	409	13	3	TCGA-D3-A3ML-06	156	0.3381844207969479	94	TCGA-D3-A3ML-06	8	8	19	0.08085958036811741	TCGA-D3-A3ML-06	8	9	6	23	PASS	8862	TCGA-D3-A3ML	SKCM	70	MALE	WHITE	Stage IIIA	NA	NA	NA	2003	NA	-25643	Dead	WITH TUMOR	NA	422	NA	Regional lymph node	NA	NA	32	NA	NA	NA	1	422	1	422	NA	NA	1	32	
50	TCGA-D3-A3MO	0	3	0	0	1	1	1	0	1	53	5	0	1	23	0	0	TCGA-D3-A3MO-06	178	0.30120305196005315	111	TCGA-D3-A3MO-06	5	5	33	0.13929348628834246	TCGA-D3-A3MO-06	2	2	5	9	PASS	8863	TCGA-D3-A3MO	SKCM	47	MALE	WHITE	Stage III	NA	NA	NA	2009	NA	-17220	Dead	WITH TUMOR	NA	284	NA	Distant Metastasis	Lung	NA	47	NA	NA	NA	1	284	1	284	NA	NA	1	47	
40	TCGA-D3-A3MR	5	33	8	21	5	1	0	0	32	642	42	0	19	368	14	0	TCGA-D3-A3MR-06	55	0.4763813094151231	15	TCGA-D3-A3MR-06	16	11	21	0.355472113245489	TCGA-D3-A3MR-06	2	0	3	5	PASS	8864	TCGA-D3-A3MR	SKCM	42	MALE	WHITE	Stage III	NA	NA	NA	2004	NA	-15695	Alive	TUMOR FREE	3151	NA	NA	NA	NA	NA	3108	NA	NA	NA	0	3151	0	3151	NA	NA	1	3108	
50	TCGA-D3-A3MU	1	31	5	13	1	1	1	0	10	381	20	0	11	186	9	0	TCGA-D3-A3MU-06	134	0.7780433847726428	73	TCGA-D3-A3MU-06	11	12	25	0.059083586142395124	TCGA-D3-A3MU-06	9	5	3	17	PASS	8865	TCGA-D3-A3MU	SKCM	53	MALE	WHITE	Stage IIIA	NA	NA	NA	2010	NA	-19423	Alive	WITH TUMOR	1209	NA	NA	Distant Metastasis	Brain	NA	750	NA	NA	NA	0	1209	0	1209	NA	NA	1	750	
40	TCGA-D3-A3MV	1	35	5	21	3	1	1	0	20	358	32	0	14	249	7	0	TCGA-D3-A3MV-06	115	0.9268086165084412	60	TCGA-D3-A3MV-06	24	25	38	0.5003646551540201	TCGA-D3-A3MV-06	5	3	1	9	PASS	8866	TCGA-D3-A3MV	SKCM	38	FEMALE	WHITE	Stage IIIB	NA	NA	NA	2010	NA	-14236	Alive	TUMOR FREE	1378	NA	NA	Regional lymph node	NA	NA	16	NA	NA	NA	0	1378	0	1378	NA	NA	1	16	
40	TCGA-D3-A51E	0	13	1	11	4	0	0	0	7	207	21	0	2	106	3	0	TCGA-D3-A51E-06	194	0.23980663701568186	108	TCGA-D3-A51E-06	6	8	65	0.1193242625990256	TCGA-D3-A51E-06	9	9	6	24	PASS	8867	TCGA-D3-A51E	SKCM	39	FEMALE	WHITE	I/II NOS	NA	NA	NA	1999	NA	-14305	Alive	TUMOR FREE	5318	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	5318	0	5318	NA	NA	0	5318	
50	TCGA-D3-A51F	0	1	1	4	0	0	0	0	0	92	7	0	2	55	3	0	TCGA-D3-A51F-06	45	2.039041088742951e-05	11	TCGA-D3-A51F	0	0	0	0	TCGA-D3-A51F	0	0	0	0	PASS	8868	TCGA-D3-A51F	SKCM	51	MALE	WHITE	Stage IIIC	NA	NA	NA	2009	NA	-18776	Alive	TUMOR FREE	1695	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1695	0	1695	NA	NA	0	1695	
NA	TCGA-D3-A51G	4	54	5	43	3	1	1	1	43	900	49	0	32	548	20	3	TCGA-D3-A51G-06	130	0.8836138445843237	64	TCGA-D3-A51G-06	31	60	48	0.17082168211642915	TCGA-D3-A51G-06	6	0	2	8	PASS	8869	TCGA-D3-A51G	SKCM	NA	MALE	WHITE	Stage 0	NA	NA	NA	1990	NA	NA	Alive	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
60	TCGA-D3-A51H	0	1	0	0	0	0	0	0	0	27	1	0	0	11	0	0	TCGA-D3-A51H-06	72	0.0024647924042142232	25	TCGA-D3-A51H-06	0	0	19	0.004777810481523426	TCGA-D3-A51H-06	0	0	0	0	PASS	8870	TCGA-D3-A51H	SKCM	60	MALE	WHITE	Stage IIIC	NA	NA	NA	2009	NA	-22119	Alive	TUMOR FREE	1714	NA	NA	Regional lymph node	NA	NA	838	NA	NA	NA	0	1714	0	1714	NA	NA	1	838	
20	TCGA-D3-A51J	1	18	4	8	0	0	0	0	14	348	24	0	5	181	10	0	TCGA-D3-A51J-06	65	0.31480668289022	17	TCGA-D3-A51J-06	13	10	59	0.22285784910328932	TCGA-D3-A51J-06	3	3	5	11	PASS	8871	TCGA-D3-A51J	SKCM	19	MALE	WHITE	Stage III	NA	NA	NA	2001	NA	-7194	Alive	TUMOR FREE	4414	NA	NA	Regional lymph node	NA	NA	2008	NA	NA	NA	0	4414	0	4414	NA	NA	1	2008	
50	TCGA-D3-A51K	0	1	0	3	0	0	0	0	1	20	1	0	0	5	1	0	TCGA-D3-A51K-06	247	0.3129030886677351	165	TCGA-D3-A51K-06	10	12	105	0.14053868293239238	TCGA-D3-A51K-06	7	5	4	16	PASS	8872	TCGA-D3-A51K	SKCM	51	MALE	WHITE	Stage IIIB	NA	NA	NA	2011	NA	-18971	Alive	TUMOR FREE	1002	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1002	0	1002	NA	NA	0	1002	
60	TCGA-D3-A51N	0	4	0	1	1	1	0	0	3	76	6	0	0	29	1	0	TCGA-D3-A51N-06	850	0.6240951410855456	765	TCGA-D3-A51N-06	11	13	414	0.2772843120031145	TCGA-D3-A51N-06	8	9	6	23	PASS	8873	TCGA-D3-A51N	SKCM	56	FEMALE	WHITE	Stage IV	NA	NA	NA	2012	NA	-20559	Alive	WITH TUMOR	688	NA	NA	Distant Metastasis	"Other, Specify"	Adrenal Gland	18	NA	NA	NA	0	688	0	688	NA	NA	1	18	
60	TCGA-D3-A51R	2	33	2	16	2	1	0	0	24	534	34	0	11	310	6	2	TCGA-D3-A51R-06	116	0.1933576532829911	58	TCGA-D3-A51R-06	5	8	40	0.11595874219050765	TCGA-D3-A51R-06	2	2	1	5	PASS	8874	TCGA-D3-A51R	SKCM	60	MALE	WHITE	Stage IIA	NA	NA	NA	2008	NA	-22040	Alive	WITH TUMOR	1941	NA	NA	Regional lymph node	NA	NA	1016	NA	NA	NA	0	1941	0	1941	NA	NA	1	1016	
60	TCGA-D3-A51T	9	60	7	35	0	2	1	1	37	876	66	0	23	495	11	2	TCGA-D3-A51T-06	107	0.8863482580395925	52	TCGA-D3-A51T-06	10	10	77	0.25636502220199386	TCGA-D3-A51T-06	5	1	2	8	PASS	8875	TCGA-D3-A51T	SKCM	59	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2011	NA	-21823	Alive	TUMOR FREE	818	NA	NA	New primary melanoma	NA	NA	210	NA	NA	NA	0	818	0	818	NA	NA	1	210	
70	TCGA-D3-A5GL	3	26	2	8	5	1	3	0	19	330	17	0	11	158	5	1	TCGA-D3-A5GL-06	121	0.7589787702691007	53	TCGA-D3-A5GL-06	5	8	38	0.2915363580362549	TCGA-D3-A5GL-06	4	0	3	7	PASS	8876	TCGA-D3-A5GL	SKCM	74	MALE	WHITE	Stage IB	NA	NA	NA	2003	NA	-27095	Alive	TUMOR FREE	3826	NA	NA	Distant Metastasis	"Other, Specify"	Large Intestine	1092	NA	NA	NA	0	3826	0	3826	NA	NA	1	1092	
20	TCGA-D3-A5GN	4	35	0	13	0	1	0	0	19	360	22	0	9	209	3	0	TCGA-D3-A5GN-06	90	0.5885703314132595	43	TCGA-D3-A5GN-06	27	57	30	0.2062096976165283	TCGA-D3-A5GN-06	9	4	1	14	PASS	8877	TCGA-D3-A5GN	SKCM	15	FEMALE	WHITE	Stage I	NA	NA	NA	2001	NA	-5684	Alive	TUMOR FREE	4129	NA	NA	New primary melanoma	NA	NA	1279	NA	NA	NA	0	4129	0	4129	NA	NA	1	1279	
60	TCGA-D3-A5GO	5	68	11	50	2	1	2	0	54	1193	66	1	38	689	13	3	TCGA-D3-A5GO-06	173	0.7699300781954812	113	TCGA-D3-A5GO-06	18	18	53	0.15725488960107462	TCGA-D3-A5GO-06	6	4	2	12	hypermutated sample	8878	TCGA-D3-A5GO	SKCM	61	MALE	WHITE	Stage II	NA	NA	NA	2001	NA	-22287	Alive	TUMOR FREE	4195	NA	NA	NA	NA	NA	757	NA	NA	NA	0	4195	0	4195	NA	NA	1	757	
30	TCGA-D3-A5GR	2	14	1	5	1	1	1	0	6	191	18	0	3	114	0	2	TCGA-D3-A5GR-06	97	0.35604147848676515	50	TCGA-D3-A5GR	0	0	0	0	TCGA-D3-A5GR-01	4	3	8	15	PASS	8879	TCGA-D3-A5GR	SKCM	23	FEMALE	WHITE	Stage III	NA	NA	NA	1998	NA	-8637	Alive	WITH TUMOR	5424	NA	NA	Regional lymph node	NA	NA	0	NA	NA	NA	0	5424	0	5424	NA	NA	1	0	
60	TCGA-D3-A5GS	4	26	1	10	4	0	0	0	11	292	19	0	11	176	6	1	TCGA-D3-A5GS-06	138	0.3818168861518114	78	TCGA-D3-A5GS-06	9	11	45	0.15332069932249404	TCGA-D3-A5GS-06	10	5	6	21	PASS	8880	TCGA-D3-A5GS	SKCM	58	MALE	WHITE	Stage IV	NA	NA	NA	2012	NA	-21379	Alive	WITH TUMOR	553	NA	NA	Distant Metastasis	Bone	NA	44	NA	NA	NA	0	553	0	553	NA	NA	1	44	
40	TCGA-D3-A5GT	0	0	0	0	2	1	0	0	0	17	2	0	1	5	1	0	TCGA-D3-A5GT	0	0	0	TCGA-D3-A5GT-01	20	21	32	0.12092927170724045	TCGA-D3-A5GT-01	12	7	7	26	PASS	8881	TCGA-D3-A5GT	SKCM	43	MALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-15935	Alive	WITH TUMOR	487	NA	NA	Distant Metastasis|Distant Metastasis|Regional lymph node	Lung|Liver|NA	NA|NA|NA	291	NA	NA	NA	0	487	0	487	NA	NA	1	291	
40	TCGA-D3-A5GU	1	61	10	19	5	2	2	0	20	555	49	0	8	292	9	2	TCGA-D3-A5GU-06	139	0.660508544240527	81	TCGA-D3-A5GU-06	27	21	23	0.09731777905248187	TCGA-D3-A5GU-06	5	2	0	7	PASS	8882	TCGA-D3-A5GU	SKCM	36	MALE	WHITE	Stage IB	NA	NA	NA	2002	NA	-13296	Alive	WITH TUMOR	3808	NA	NA	Distant Metastasis	Bone	NA	3074	NA	NA	NA	0	3808	0	3808	NA	NA	1	3074	
50	TCGA-D3-A8GB	5	56	3	25	3	0	0	0	49	758	58	0	15	478	16	3	TCGA-D3-A8GB-06	158	0.3579027077201547	95	TCGA-D3-A8GB-06	10	12	83	0.2309546972092993	TCGA-D3-A8GB-06	13	6	10	29	PASS	8883	TCGA-D3-A8GB	SKCM	48	MALE	WHITE	Stage IIIB	NA	NA	NA	2003	NA	-17871	Dead	WITH TUMOR	NA	938	NA	Distant Metastasis	"Other, Specify"	Soft tissue	347	NA	NA	NA	1	938	1	938	NA	NA	1	347	
50	TCGA-D3-A8GC	5	41	4	27	7	0	1	1	34	630	36	0	14	369	7	2	TCGA-D3-A8GC-06	144	0.8884185441447272	75	TCGA-D3-A8GC-06	31	24	112	0.4430667991389731	TCGA-D3-A8GC-06	4	1	6	11	PASS	8884	TCGA-D3-A8GC	SKCM	48	MALE	WHITE	Stage IIIC	NA	NA	NA	2000	NA	-17668	Dead	WITH TUMOR	NA	2421	NA	Distant Metastasis	"Other, Specify"	Supraclavicular lymph nodes	1859	NA	NA	NA	1	2421	1	2421	NA	NA	1	1859	
60	TCGA-D3-A8GD	0	4	1	3	1	0	0	0	2	91	2	0	1	25	4	0	TCGA-D3-A8GD-06	108	0.5302158511282957	58	TCGA-D3-A8GD-06	20	25	69	0.245077145151845	TCGA-D3-A8GD-06	12	7	5	24	PASS	8885	TCGA-D3-A8GD	SKCM	63	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-23109	Alive	TUMOR FREE	718	NA	NA	Distant Metastasis	"Other, Specify"	Retroperitoneal lymph nodes	147	NA	NA	NA	0	718	0	718	NA	NA	1	147	
30	TCGA-D3-A8GE	0	0	0	0	0	0	0	0	0	6	0	0	0	2	0	0	TCGA-D3-A8GE-06	61	0.0026306218344707955	23	TCGA-D3-A8GE-06	0	0	13	0.0041081035199509106	TCGA-D3-A8GE-06	0	0	0	0	PASS	8886	TCGA-D3-A8GE	SKCM	26	MALE	WHITE	Stage IV	NA	NA	NA	2012	NA	-9517	Alive	WITH TUMOR	804	NA	NA	Distant Metastasis	Lung	NA	59	NA	NA	NA	0	804	0	804	NA	NA	1	59	
70	TCGA-D3-A8GI	17	305	38	141	8	2	1	0	187	3933	217	0	111	2270	52	9	TCGA-D3-A8GI-06	190	0.8646981993530911	122	TCGA-D3-A8GI-06	24	17	26	0.05914402870599541	TCGA-D3-A8GI-06	12	4	0	16	hypermutated sample	8887	TCGA-D3-A8GI	SKCM	68	MALE	WHITE	Stage IA	NA	NA	NA	2008	NA	-25069	Dead	WITH TUMOR	NA	1780	NA	New primary melanoma	NA	NA	50	NA	NA	NA	1	1780	1	1780	NA	NA	1	50	
20	TCGA-D3-A8GJ	1	9	3	10	0	0	0	0	6	135	8	0	2	97	3	0	TCGA-D3-A8GJ-06	92	0.18602019194894945	37	TCGA-D3-A8GJ-06	5	17	78	0.2580702349406016	TCGA-D3-A8GJ-06	9	5	3	17	PASS	8888	TCGA-D3-A8GJ	SKCM	18	MALE	WHITE	Stage II	NA	NA	NA	1994	NA	-6684	Alive	TUMOR FREE	7342	NA	NA	Distant Metastasis	Brain	NA	1443	NA	NA	NA	0	7342	0	7342	NA	NA	1	1443	
50	TCGA-D3-A8GK	3	41	3	24	8	1	1	0	19	423	31	1	13	237	5	0	TCGA-D3-A8GK-06	102	0.15486184070042816	49	TCGA-D3-A8GK-06	4	5	30	0.042586615963737764	TCGA-D3-A8GK-06	6	4	2	12	PASS	8889	TCGA-D3-A8GK	SKCM	45	MALE	WHITE	Stage IIA	NA	NA	NA	2000	NA	-16569	Alive	TUMOR FREE	5177	NA	NA	Locoregional Recurrence	NA	NA	1555	NA	NA	NA	0	5177	0	5177	NA	NA	1	1555	
40	TCGA-D3-A8GL	10	117	8	50	5	0	1	0	69	1378	91	0	44	788	24	3	TCGA-D3-A8GL-06	85	0.2560827724335727	35	TCGA-D3-A8GL-06	10	9	43	0.12398522488001662	TCGA-D3-A8GL-06	9	1	3	13	hypermutated sample	8890	TCGA-D3-A8GL	SKCM	43	MALE	WHITE	Stage IIIB	NA	NA	NA	1996	NA	-15947	Dead	WITH TUMOR	NA	2711	NA	Regional lymph node	NA	NA	1333	NA	NA	NA	1	2711	1	2711	NA	NA	1	1333	
70	TCGA-D3-A8GM	26	241	21	96	68	36	5	0	148	2851	213	2	76	1562	63	6	TCGA-D3-A8GM-06	86	0.7857633456678911	35	TCGA-D3-A8GM-06	20	22	23	0.09107792031996816	TCGA-D3-A8GM-06	7	7	3	17	hypermutated sample	8891	TCGA-D3-A8GM	SKCM	73	MALE	WHITE	Stage IIB	NA	NA	NA	2005	NA	-26782	Dead	TUMOR FREE	NA	3259	NA	NA	NA	NA	NA	NA	NA	NA	1	3259	0	3259	NA	NA	0	3259	
30	TCGA-D3-A8GN	3	14	1	3	0	0	0	0	8	178	8	0	4	123	1	0	TCGA-D3-A8GN-06	102	0.4477876694740008	44	TCGA-D3-A8GN-06	22	24	67	0.18983380616349985	TCGA-D3-A8GN-06	8	6	7	21	PASS	8892	TCGA-D3-A8GN	SKCM	27	FEMALE	WHITE	I/II NOS	NA	NA	NA	2000	NA	-10185	Alive	TUMOR FREE	4897	NA	NA	Distant Metastasis	Lung	NA	787	NA	NA	NA	0	4897	0	4897	NA	NA	1	787	
NA	TCGA-D3-A8GO	3	27	2	9	3	4	1	0	22	416	33	0	16	275	4	1	TCGA-D3-A8GO-06	81	0.5643016494149209	34	TCGA-D3-A8GO-06	25	19	59	0.1843627570244462	TCGA-D3-A8GO-06	5	9	4	18	PASS	8893	TCGA-D3-A8GO	SKCM	NA	FEMALE	WHITE	I/II NOS	NA	NA	NA	1996	NA	NA	Dead	WITH TUMOR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	1	NA	NA	NA	1	NA	
80	TCGA-D3-A8GP	3	38	6	16	5	1	1	0	22	437	35	0	9	215	9	1	TCGA-D3-A8GP-06	141	0.5729525037361433	78	TCGA-D3-A8GP-06	24	23	53	0.1422482646464331	TCGA-D3-A8GP-06	4	1	1	6	PASS	8894	TCGA-D3-A8GP	SKCM	77	MALE	WHITE	Stage III	NA	NA	NA	2002	NA	-28234	Alive	TUMOR FREE	4646	NA	NA	Locoregional Recurrence	NA	NA	535	NA	NA	NA	0	4646	0	4646	NA	NA	1	535	
70	TCGA-D3-A8GQ	6	76	9	50	8	0	1	0	46	1056	63	0	37	628	19	1	TCGA-D3-A8GQ-06	66	0.94768821138605	18	TCGA-D3-A8GQ-06	11	10	29	0.05366365438595742	TCGA-D3-A8GQ-06	5	4	2	11	PASS	8895	TCGA-D3-A8GQ	SKCM	66	MALE	WHITE	Stage II	NA	NA	NA	2004	NA	-24348	Dead	WITH TUMOR	NA	884	NA	Distant Metastasis	Liver	NA	578	NA	NA	NA	1	884	1	884	NA	NA	1	578	
50	TCGA-D3-A8GR	0	18	4	15	3	1	0	0	16	284	18	0	11	153	3	0	TCGA-D3-A8GR-06	212	0.6602209767811663	132	TCGA-D3-A8GR-06	8	11	119	0.2372128666043312	TCGA-D3-A8GR-06	8	10	5	23	PASS	8896	TCGA-D3-A8GR	SKCM	54	FEMALE	WHITE	Stage 0	NA	NA	NA	1999	NA	-19973	Dead	WITH TUMOR	NA	3943	NA	Locoregional Recurrence	NA	NA	1720	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
50	TCGA-D3-A8GS	2	13	3	2	1	0	0	0	9	161	8	0	3	90	2	0	TCGA-D3-A8GS-06	93	0.4996071058729052	44	TCGA-D3-A8GS-06	16	9	75	0.32798858412483844	TCGA-D3-A8GS-06	5	8	8	21	PASS	8897	TCGA-D3-A8GS	SKCM	52	MALE	WHITE	Stage I	NA	NA	NA	1997	NA	-19127	Dead	WITH TUMOR	NA	3564	NA	Regional lymph node	NA	NA	2641	NA	NA	NA	1	3564	1	3564	NA	NA	1	2641	
30	TCGA-D3-A8GV	3	35	2	9	0	2	3	0	15	305	22	0	10	156	7	0	TCGA-D3-A8GV-06	175	0.23153423154088615	105	TCGA-D3-A8GV-06	4	9	87	0.1883447332708438	TCGA-D3-A8GV-06	9	13	8	30	PASS	8898	TCGA-D3-A8GV	SKCM	25	MALE	WHITE	I/II NOS	NA	NA	NA	1993	NA	-9344	Dead	WITH TUMOR	NA	5101	NA	Regional lymph node	NA	NA	3896	NA	NA	NA	1	5101	1	5101	NA	NA	1	3896	
40	TCGA-D9-A148	5	46	10	23	4	1	1	0	31	724	60	2	9	340	37	1	TCGA-D9-A148-06	111	0.9313460745061244	52	TCGA-D9-A148-06	21	25	21	0.20215548041125853	TCGA-D9-A148-06	15	9	5	29	PASS	8899	TCGA-D9-A148	SKCM	40	MALE	WHITE	NA	NA	NA	NA	1999	NA	-14805	Alive	WITH TUMOR	4609	NA	NA	Distant Metastasis	NA	NA	4287	NA	NA	NA	0	4609	0	4609	NA	NA	1	4287	
70	TCGA-D9-A149	2	38	4	23	1	0	0	0	32	618	72	0	5	301	18	1	TCGA-D9-A149-06	95	0.7743181163633407	36	TCGA-D9-A149-06	18	20	6	0.08199498149765072	TCGA-D9-A149-06	5	4	3	12	PASS	8900	TCGA-D9-A149	SKCM	65	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-23779	Alive	TUMOR FREE	1663	NA	NA	New primary melanoma	"Other, Specify"	NA	1290	NA	NA	NA	0	1663	0	1663	NA	NA	1	1290	
80	TCGA-D9-A1JW	4	58	6	33	4	2	1	0	24	682	38	0	15	394	17	0	TCGA-D9-A1JW-06	88	0.26573072998115643	40	TCGA-D9-A1JW-06	9	7	12	0.07197904292919532	TCGA-D9-A1JW-06	9	3	4	16	PASS	8901	TCGA-D9-A1JW	SKCM	82	MALE	WHITE	NA	NA	NA	NA	2010	NA	-30142	Alive	TUMOR FREE	111	NA	NA	Distant Metastasis	"Other, Specify"	NA	10	NA	NA	NA	0	111	0	111	NA	NA	1	10	
80	TCGA-D9-A1JX	2	11	1	6	0	1	0	0	9	183	11	0	5	78	0	0	TCGA-D9-A1JX-06	179	0.25472582626748985	98	TCGA-D9-A1JX-06	9	13	45	0.2713622093631605	TCGA-D9-A1JX-06	7	7	2	16	PASS	8902	TCGA-D9-A1JX	SKCM	80	FEMALE	WHITE	NA	NA	NA	NA	2010	NA	-29323	Dead	WITH TUMOR	NA	216	NA	Distant Metastasis	"Other, Specify"	iliac nymph nodes	195	NA	NA	NA	1	216	1	216	NA	NA	1	195	
60	TCGA-D9-A1X3	5	25	3	10	1	0	0	0	17	356	41	0	13	152	11	0	TCGA-D9-A1X3-06	246	0.8619167795222575	161	TCGA-D9-A1X3	0	0	0	0	TCGA-D9-A1X3-01	4	3	4	11	PASS	8903	TCGA-D9-A1X3	SKCM	63	MALE	WHITE	NA	NA	NA	NA	2010	NA	-23171	Alive	WITH TUMOR	551	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	551	0	551	NA	NA	0	551	
70	TCGA-D9-A3Z1	2	24	1	9	0	2	1	0	20	375	18	0	14	222	4	0	TCGA-D9-A3Z1-06	63	0.13357870925635615	20	TCGA-D9-A3Z1-06	3	4	22	0.06960218460580063	TCGA-D9-A3Z1-06	4	3	2	9	PASS	8904	TCGA-D9-A3Z1	SKCM	66	MALE	WHITE	Stage IIIC	NA	NA	NA	2011	NA	-24192	Dead	WITH TUMOR	NA	468	NA	Locoregional Recurrence	Lung	NA	335	NA	NA	NA	1	468	1	468	NA	NA	1	335	
40	TCGA-D9-A3Z3	0	9	0	5	0	0	0	0	7	110	0	0	1	54	1	0	TCGA-D9-A3Z3-06	185	0.8661426508627164	109	TCGA-D9-A3Z3-06	14	12	126	0.3473644310375068	TCGA-D9-A3Z3-06	9	7	15	31	PASS	8905	TCGA-D9-A3Z3	SKCM	39	FEMALE	WHITE	Stage IIIB	NA	NA	NA	2012	NA	-14489	Alive	TUMOR FREE	678	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	678	0	678	NA	NA	0	678	
50	TCGA-D9-A3Z4	2	9	1	4	1	0	2	0	3	114	8	0	3	64	0	0	TCGA-D9-A3Z4	0	0	0	TCGA-D9-A3Z4-01	11	17	60	0.22826676250020075	TCGA-D9-A3Z4-01	7	3	8	18	PASS	8906	TCGA-D9-A3Z4	SKCM	54	MALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-19749	Dead	WITH TUMOR	NA	519	NA	Regional lymph node	"Other, Specify"	lymph node	192	NA	NA	NA	1	519	1	519	NA	NA	1	192	
50	TCGA-D9-A4Z2	0	1	0	0	0	0	0	0	1	22	0	0	1	5	1	0	TCGA-D9-A4Z2	0	0	0	TCGA-D9-A4Z2-01	10	8	76	0.191110097570377	TCGA-D9-A4Z2-01	3	3	4	10	PASS	8907	TCGA-D9-A4Z2	SKCM	50	MALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-18462	Dead	WITH TUMOR	NA	190	NA	Distant Metastasis	Lung	NA	80	NA	NA	NA	1	190	1	190	NA	NA	1	80	
70	TCGA-D9-A4Z3	4	36	7	19	2	3	2	0	8	633	26	0	15	323	12	0	TCGA-D9-A4Z3	0	0	0	TCGA-D9-A4Z3-01	9	11	182	0.11425203949518735	TCGA-D9-A4Z3-01	6	7	6	19	PASS	8908	TCGA-D9-A4Z3	SKCM	73	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-26812	Alive	TUMOR FREE	505	NA	NA	Locoregional Recurrence	NA	NA	100	NA	NA	NA	0	505	0	505	NA	NA	1	100	
70	TCGA-D9-A4Z5	0	1	1	1	2	0	0	0	4	60	3	0	1	18	0	0	TCGA-D9-A4Z5	0	0	0	TCGA-D9-A4Z5-01	21	23	207	0.2621949092484056	TCGA-D9-A4Z5-01	22	16	14	52	PASS	8909	TCGA-D9-A4Z5	SKCM	68	MALE	WHITE	Stage IIB	NA	NA	NA	2012	NA	-24979	Alive	TUMOR FREE	218	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	218	0	218	NA	NA	0	218	
50	TCGA-D9-A4Z6	0	11	1	6	2	1	1	0	9	218	12	1	6	100	6	0	TCGA-D9-A4Z6-06	219	0.9469276658578384	145	TCGA-D9-A4Z6	0	0	0	0	TCGA-D9-A4Z6	0	0	0	0	PASS	8910	TCGA-D9-A4Z6	SKCM	54	MALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-20072	Dead	WITH TUMOR	NA	561	NA	Distant Metastasis	Brain	NA	213	NA	NA	NA	1	561	1	561	NA	NA	1	213	
80	TCGA-D9-A6E9	1	13	1	5	1	0	1	0	5	141	7	0	8	61	5	0	TCGA-D9-A6E9-06	203	0.6196473695965626	124	TCGA-D9-A6E9-06	24	20	83	0.2567570603818038	TCGA-D9-A6E9-06	9	7	7	23	PASS	8911	TCGA-D9-A6E9	SKCM	75	FEMALE	WHITE	Stage IIIA	NA	NA	NA	2013	NA	-27537	Alive	TUMOR FREE	301	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	301	0	301	NA	NA	0	301	
70	TCGA-D9-A6EA	3	32	5	13	3	1	0	0	15	499	33	0	5	284	4	0	TCGA-D9-A6EA-06	437	0.8024661907216517	324	TCGA-D9-A6EA-06	25	52	153	0.2471254628774793	TCGA-D9-A6EA-06	11	9	4	24	PASS	8912	TCGA-D9-A6EA	SKCM	70	MALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-25582	Alive	TUMOR FREE	766	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	766	0	766	NA	NA	0	766	
60	TCGA-D9-A6EC	17	238	27	95	7	1	1	0	145	3397	162	2	75	1576	55	4	TCGA-D9-A6EC-06	258	0.6838613915745895	156	TCGA-D9-A6EC-06	24	23	113	0.25115578376726205	TCGA-D9-A6EC-06	14	8	11	33	hypermutated sample	8913	TCGA-D9-A6EC	SKCM	56	MALE	WHITE	Stage IIIA	NA	NA	NA	2008	NA	-20493	Alive	TUMOR FREE	2359	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2359	0	2359	NA	NA	0	2359	
60	TCGA-D9-A6EG	1	3	1	2	2	2	0	0	2	51	8	0	3	31	2	0	TCGA-D9-A6EG-06	78	0.3233318599022199	34	TCGA-D9-A6EG-06	13	8	35	0.14872921395257852	TCGA-D9-A6EG-06	7	1	6	14	PASS	8914	TCGA-D9-A6EG	SKCM	56	MALE	WHITE	Stage IIIA	NA	NA	NA	2012	NA	-20570	Dead	NA	NA	698	NA	Distant Metastasis	Bone	NA	398	NA	NA	NA	1	698	NA	698	NA	NA	1	398	
80	TCGA-DA-A1HV	9	73	11	33	3	0	0	0	46	1133	79	0	27	649	22	2	TCGA-DA-A1HV-06	166	0.5902577101085121	97	TCGA-DA-A1HV-06	20	28	42	0.3436974827858376	TCGA-DA-A1HV-06	7	8	5	20	PASS	8915	TCGA-DA-A1HV	SKCM	75	FEMALE	WHITE	Stage IIIB	NA	NA	NA	2008	NA	-27553	Alive	TUMOR FREE	2329	NA	NA	Distant Metastasis	"Other, Specify"	mediastinum	866	NA	NA	NA	0	2329	0	2329	NA	NA	1	866	
40	TCGA-DA-A1HW	1	27	4	14	3	1	2	0	16	322	31	0	12	181	3	0	TCGA-DA-A1HW-06	332	0.8782155387209373	233	TCGA-DA-A1HW-06	14	13	89	0.4181705128154604	TCGA-DA-A1HW-06	10	4	16	30	PASS	8916	TCGA-DA-A1HW	SKCM	37	FEMALE	WHITE	Stage IIIB	NA	NA	NA	2009	NA	-13585	Alive	TUMOR FREE	820	NA	NA	NA	NA	NA	852	NA	NA	NA	0	820	0	820	NA	NA	1	852	
40	TCGA-DA-A1HY	1	26	3	25	3	0	0	0	27	561	33	0	16	306	9	1	TCGA-DA-A1HY-06	207	0.37547271390120135	132	TCGA-DA-A1HY-06	7	8	36	0.19960657330536424	TCGA-DA-A1HY-06	6	9	6	21	PASS	8917	TCGA-DA-A1HY	SKCM	42	MALE	WHITE	Stage III	NA	NA	NA	2002	NA	-15357	Alive	TUMOR FREE	4407	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4407	0	4407	NA	NA	0	4407	
60	TCGA-DA-A1I0	2	31	1	17	2	1	1	0	16	367	33	1	9	204	8	0	TCGA-DA-A1I0-06	220	0.29086570803108697	149	TCGA-DA-A1I0-06	10	10	31	0.07318412133679339	TCGA-DA-A1I0-06	7	5	3	15	PASS	8918	TCGA-DA-A1I0	SKCM	63	MALE	WHITE	Stage IV	NA	NA	NA	2008	NA	-23157	Dead	WITH TUMOR	NA	620	NA	Distant Metastasis	Brain	NA	599	NA	NA	NA	1	620	1	620	NA	NA	1	599	
60	TCGA-DA-A1I1	7	73	8	41	5	0	0	0	62	1322	131	1	21	594	50	1	TCGA-DA-A1I1-06	102	0.5308741085084261	48	TCGA-DA-A1I1-06	22	21	20	0.2478416636934497	TCGA-DA-A1I1-06	2	4	2	8	PASS	8919	TCGA-DA-A1I1	SKCM	55	MALE	WHITE	Stage III	NA	NA	NA	1996	NA	-20399	Alive	TUMOR FREE	6768	NA	NA	Distant Metastasis	"Other, Specify"	Jejunum	5591	NA	NA	NA	0	6768	0	6768	NA	NA	1	5591	
50	TCGA-DA-A1I2	0	7	0	3	0	1	0	0	5	96	5	0	3	59	3	0	TCGA-DA-A1I2-06	112	0.6356702222374845	62	TCGA-DA-A1I2-06	22	27	30	0.16460263930771205	TCGA-DA-A1I2-06	5	4	3	12	PASS	8920	TCGA-DA-A1I2	SKCM	45	MALE	WHITE	Stage III	NA	NA	NA	1996	NA	-16701	Dead	WITH TUMOR	NA	5370	NA	Regional lymph node	NA	NA	4679	NA	NA	NA	1	5370	1	5370	NA	NA	1	4679	
50	TCGA-DA-A1I4	0	20	2	6	2	0	0	0	10	204	17	1	3	102	4	0	TCGA-DA-A1I4-06	113	0.34444497122251755	57	TCGA-DA-A1I4-06	13	9	17	0.1931947142761258	TCGA-DA-A1I4-06	4	0	2	6	PASS	8921	TCGA-DA-A1I4	SKCM	51	MALE	WHITE	Stage IIIC	NA	NA	NA	2006	NA	-18961	Dead	WITH TUMOR	NA	1093	NA	Distant Metastasis	Brain	NA	889	NA	NA	NA	1	1093	1	1093	NA	NA	1	889	
30	TCGA-DA-A1I5	2	34	1	16	4	2	0	0	33	568	49	0	9	275	11	1	TCGA-DA-A1I5-06	199	0.7262692470954756	124	TCGA-DA-A1I5-06	13	8	40	0.2497481855840253	TCGA-DA-A1I5-06	4	3	4	11	PASS	8922	TCGA-DA-A1I5	SKCM	27	FEMALE	WHITE	Stage IV	NA	NA	NA	2003	NA	-10017	Alive	TUMOR FREE	4107	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4107	0	4107	NA	NA	0	4107	
60	TCGA-DA-A1I7	3	41	4	22	3	0	0	1	38	743	70	1	19	387	20	3	TCGA-DA-A1I7-06	180	0.5473622619800841	100	TCGA-DA-A1I7-06	19	31	19	0.18718658035865288	TCGA-DA-A1I7-06	8	10	7	25	PASS	8923	TCGA-DA-A1I7	SKCM	62	MALE	WHITE	Stage IIIB	NA	NA	NA	2007	NA	-22940	Alive	WITH TUMOR	2703	NA	NA	Distant Metastasis	"Other, Specify"	skin scrotum	755	NA	NA	NA	0	2703	0	2703	NA	NA	1	755	
60	TCGA-DA-A1I8	2	8	0	4	2	0	0	0	7	127	6	0	3	95	2	0	TCGA-DA-A1I8-06	169	0.7631682229511033	99	TCGA-DA-A1I8-06	29	51	15	0.20805356339318085	TCGA-DA-A1I8-06	5	4	3	12	PASS	8924	TCGA-DA-A1I8	SKCM	63	FEMALE	WHITE	Stage IIC	NA	NA	NA	2005	NA	-23286	Dead	WITH TUMOR	NA	1640	NA	Regional lymph node	NA	NA	961	NA	NA	NA	1	1640	1	1640	NA	NA	1	961	
30	TCGA-DA-A1IA	2	12	3	10	5	0	1	0	14	272	22	0	5	185	8	0	TCGA-DA-A1IA-06	207	0.5013706323394298	116	TCGA-DA-A1IA-06	14	27	13	0.13930511835184958	TCGA-DA-A1IA-06	10	12	3	25	PASS	8925	TCGA-DA-A1IA	SKCM	32	FEMALE	WHITE	Stage IIIB	NA	NA	NA	2005	NA	-11744	Dead	WITH TUMOR	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	1	2005	1	2005	NA	NA	1	2005	
70	TCGA-DA-A1IB	7	92	8	43	5	1	0	0	74	1754	245	1	21	750	80	1	TCGA-DA-A1IB-06	63	0.011435571020233062	23	TCGA-DA-A1IB-06	3	5	5	0.02862459237713211	TCGA-DA-A1IB-06	0	0	0	0	PASS	8926	TCGA-DA-A1IB	SKCM	69	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2010	NA	-25219	Alive	WITH TUMOR	825	NA	NA	Distant Metastasis	Brain	NA	243	NA	NA	NA	0	825	0	825	NA	NA	1	243	
80	TCGA-DA-A1IC	2	59	1	34	4	0	1	0	32	735	50	0	17	437	16	1	TCGA-DA-A1IC-06	97	0.25339464722244825	46	TCGA-DA-A1IC-06	8	12	6	0.2287794864566497	TCGA-DA-A1IC-06	3	1	1	5	PASS	8927	TCGA-DA-A1IC	SKCM	81	MALE	WHITE	Stage IIIB	NA	NA	NA	2005	NA	-29859	Dead	WITH TUMOR	NA	2071	NA	Distant Metastasis	Lung	NA	1930	NA	NA	NA	1	2071	1	2071	NA	NA	1	1930	
60	TCGA-DA-A3F2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DA-A3F2-06	45	4.6378683242106706e-05	10	TCGA-DA-A3F2-06	0	0	19	1.1658781307935193e-05	TCGA-DA-A3F2-06	0	0	0	0	PASS	8928	TCGA-DA-A3F2	SKCM	55	MALE	WHITE	Stage IIIB	NA	NA	NA	2010	NA	-20365	Dead	WITH TUMOR	NA	1032	NA	Distant Metastasis	"Other, Specify"	peritoneal	430	NA	NA	NA	1	1032	1	1032	NA	NA	1	430	
50	TCGA-DA-A3F3	1	10	2	9	3	0	0	0	5	236	15	0	6	110	2	0	TCGA-DA-A3F3-06	226	0.8656394325575137	139	TCGA-DA-A3F3-06	5	18	44	0.06786655602501943	TCGA-DA-A3F3-06	12	11	4	27	PASS	8929	TCGA-DA-A3F3	SKCM	52	MALE	WHITE	Stage IIIB	NA	NA	NA	2010	NA	-19330	Dead	WITH TUMOR	NA	319	NA	NA	NA	NA	NA	NA	NA	NA	1	319	1	319	NA	NA	1	319	
50	TCGA-DA-A3F5	0	13	4	13	1	0	1	0	8	253	20	0	5	135	12	0	TCGA-DA-A3F5-06	134	0.8180451706046528	63	TCGA-DA-A3F5-06	29	62	41	0.26190747433151745	TCGA-DA-A3F5-06	8	5	5	18	PASS	8930	TCGA-DA-A3F5	SKCM	45	MALE	WHITE	Stage I	NA	NA	NA	1994	NA	-16701	Dead	WITH TUMOR	NA	6873	NA	Distant Metastasis	Lung	NA	6841	NA	NA	NA	1	6873	1	6873	NA	NA	1	6841	
40	TCGA-DA-A3F8	7	54	6	26	3	1	1	0	29	900	54	0	21	534	17	4	TCGA-DA-A3F8-06	68	0.3189711687912101	22	TCGA-DA-A3F8-06	5	8	11	0.16298245422067548	TCGA-DA-A3F8-06	4	1	3	8	PASS	8931	TCGA-DA-A3F8	SKCM	39	MALE	WHITE	Stage IIIB	NA	NA	NA	2011	NA	-14327	Alive	TUMOR FREE	1319	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1319	0	1319	NA	NA	0	1319	
80	TCGA-DA-A95V	1	14	1	8	1	0	1	0	8	212	13	0	5	109	4	0	TCGA-DA-A95V-06	294	0.8311207007293595	173	TCGA-DA-A95V-06	19	75	143	0.331878513526464	TCGA-DA-A95V-06	29	27	13	69	PASS	8932	TCGA-DA-A95V	SKCM	83	FEMALE	WHITE	Stage IIC	NA	NA	NA	2009	NA	-30623	Alive	TUMOR FREE	2193	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2193	0	2193	NA	NA	0	2193	
50	TCGA-DA-A95W	0	15	0	3	1	1	0	0	3	129	5	0	5	57	3	0	TCGA-DA-A95W-06	79	0.2248822065538273	31	TCGA-DA-A95W-06	8	8	35	0.09414211185385198	TCGA-DA-A95W-06	3	1	1	5	PASS	8933	TCGA-DA-A95W	SKCM	52	MALE	WHITE	Stage IIIB	NA	NA	NA	2011	NA	-19105	Alive	TUMOR FREE	1136	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1136	0	1136	NA	NA	0	1136	
60	TCGA-DA-A95X	5	28	4	11	1	0	1	0	11	402	26	0	7	188	4	0	TCGA-DA-A95X-06	91	0.9475775308588356	40	TCGA-DA-A95X-06	12	11	102	0.3587065198298558	TCGA-DA-A95X-06	7	4	6	17	PASS	8934	TCGA-DA-A95X	SKCM	62	MALE	WHITE	Stage IB	NA	NA	NA	2009	NA	-22718	Alive	TUMOR FREE	2249	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2249	0	2249	NA	NA	0	2249	
70	TCGA-DA-A95Y	2	27	5	7	0	3	3	0	10	326	30	2	9	146	4	0	TCGA-DA-A95Y-06	163	0.5924606523169929	77	TCGA-DA-A95Y-06	11	15	50	0.1626960769341696	TCGA-DA-A95Y-06	13	16	9	38	PASS	8935	TCGA-DA-A95Y	SKCM	68	MALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-25083	Dead	WITH TUMOR	NA	430	NA	Distant Metastasis	Lung	NA	338	NA	NA	NA	1	430	1	430	NA	NA	1	338	
90	TCGA-DA-A95Z	11	128	13	70	12	2	3	0	65	1439	100	1	39	779	27	1	TCGA-DA-A95Z-06	123	0.8327442064245405	61	TCGA-DA-A95Z-06	15	35	23	0.11985755128549624	TCGA-DA-A95Z-06	14	14	2	30	hypermutated sample	8936	TCGA-DA-A95Z	SKCM	87	MALE	WHITE	Stage IV	NA	NA	NA	2013	NA	-31837	Alive	TUMOR FREE	396	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	396	0	396	NA	NA	0	396	
70	TCGA-DA-A960	2	54	3	28	4	1	1	1	26	635	36	0	15	384	9	2	TCGA-DA-A960	0	0	0	TCGA-DA-A960-01	12	18	18	0.0912253284896171	TCGA-DA-A960-01	4	3	1	8	PASS	8937	TCGA-DA-A960	SKCM	73	MALE	WHITE	Stage IIB	NA	NA	NA	2012	NA	-26708	Alive	TUMOR FREE	804	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	804	0	804	NA	NA	0	804	
50	TCGA-EB-A1NK	1	15	1	8	2	1	1	0	16	258	24	2	7	136	7	0	TCGA-EB-A1NK	0	0	0	TCGA-EB-A1NK-01	8	7	14	0.07869796085469928	TCGA-EB-A1NK-01	7	2	3	12	PASS	8938	TCGA-EB-A1NK	SKCM	48	MALE	WHITE	Stage IIC	NA	NA	NA	2010	NA	-17569	Alive	TUMOR FREE	1039	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1039	0	1039	NA	NA	0	1039	
60	TCGA-EB-A24C	2	13	1	12	0	1	0	0	18	272	17	1	3	116	14	0	TCGA-EB-A24C	0	0	0	TCGA-EB-A24C-01	10	9	44	0.3485068224027409	TCGA-EB-A24C-01	7	3	6	16	PASS	8939	TCGA-EB-A24C	SKCM	56	MALE	WHITE	NA	NA	NA	NA	2011	NA	-20539	Alive	TUMOR FREE	632	NA	NA	Regional lymph node	NA	NA	465	NA	NA	NA	0	632	0	632	NA	NA	1	465	
70	TCGA-EB-A24D	6	43	3	11	3	0	0	0	42	613	50	1	8	357	21	1	TCGA-EB-A24D	0	0	0	TCGA-EB-A24D-01	29	60	22	0.27740437546870184	TCGA-EB-A24D-01	10	5	3	18	PASS	8940	TCGA-EB-A24D	SKCM	72	MALE	WHITE	Stage IIIB	NA	NA	NA	2011	NA	-26439	Alive	TUMOR FREE	645	NA	NA	Regional lymph node	NA	NA	500	NA	NA	NA	0	645	0	645	NA	NA	1	500	
60	TCGA-EB-A299	1	32	5	21	0	1	0	0	23	502	56	1	6	253	18	2	TCGA-EB-A299	0	0	0	TCGA-EB-A299-01	8	4	8	0.09130835448324613	TCGA-EB-A299-01	3	2	1	6	PASS	8941	TCGA-EB-A299	SKCM	63	MALE	WHITE	Stage IIA	NA	NA	NA	2011	NA	-23322	Alive	TUMOR FREE	378	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	378	0	378	NA	NA	0	378	
40	TCGA-EB-A3HV	0	4	0	0	0	0	0	0	6	36	2	0	0	18	0	0	TCGA-EB-A3HV	0	0	0	TCGA-EB-A3HV-01	7	6	28	0.20873778203488247	TCGA-EB-A3HV-01	8	5	5	18	PASS	8942	TCGA-EB-A3HV	SKCM	37	MALE	WHITE	Stage IIC	NA	NA	NA	2011	NA	-13712	Alive	WITH TUMOR	39	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	39	0	39	NA	NA	0	39	
60	TCGA-EB-A3XB	3	30	1	12	1	0	0	0	30	384	26	0	13	193	7	0	TCGA-EB-A3XB	0	0	0	TCGA-EB-A3XB-01	17	16	25	0.14801873711322902	TCGA-EB-A3XB-01	6	6	4	16	PASS	8943	TCGA-EB-A3XB	SKCM	63	MALE	WHITE	Stage II	NA	NA	NA	2011	NA	-23091	Alive	TUMOR FREE	796	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	796	0	796	NA	NA	0	796	
70	TCGA-EB-A3XC	5	25	5	15	2	0	1	0	14	305	13	0	10	171	5	1	TCGA-EB-A3XC	0	0	0	TCGA-EB-A3XC-01	20	19	64	0.21414282297671786	TCGA-EB-A3XC-01	12	11	6	29	PASS	8944	TCGA-EB-A3XC	SKCM	74	MALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-27124	Alive	TUMOR FREE	650	NA	NA	Distant Metastasis|Regional lymph node	"Other, Specify|NA"	Chest wall|NA	74	NA	NA	NA	0	650	0	650	NA	NA	1	74	
50	TCGA-EB-A3XD	6	12	2	10	1	1	0	0	11	289	19	1	5	168	2	1	TCGA-EB-A3XD	0	0	0	TCGA-EB-A3XD-01	8	7	24	0.1384366950185029	TCGA-EB-A3XD-01	3	3	3	9	PASS	8945	TCGA-EB-A3XD	SKCM	53	FEMALE	WHITE	Stage IIC	NA	NA	NA	2011	NA	-19431	Alive	TUMOR FREE	1160	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1160	0	1160	NA	NA	0	1160	
80	TCGA-EB-A3XE	0	2	0	1	0	0	0	0	0	18	1	0	0	1	0	0	TCGA-EB-A3XE	0	0	0	TCGA-EB-A3XE-01	6	9	103	0.14323427028820085	TCGA-EB-A3XE-01	6	3	6	15	PASS	8946	TCGA-EB-A3XE	SKCM	77	FEMALE	WHITE	Stage IIA	NA	NA	NA	2012	NA	-28148	Alive	TUMOR FREE	180	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	180	0	180	NA	NA	0	180	
60	TCGA-EB-A3XF	0	26	2	12	1	0	1	0	10	293	24	0	4	165	5	0	TCGA-EB-A3XF	0	0	0	TCGA-EB-A3XF-01	5	8	42	0.16802282341394362	TCGA-EB-A3XF-01	6	8	5	19	PASS	8947	TCGA-EB-A3XF	SKCM	57	MALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-20910	Alive	TUMOR FREE	278	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	278	0	278	NA	NA	0	278	
60	TCGA-EB-A3Y6	1	50	2	22	1	1	0	0	29	454	23	0	5	250	9	0	TCGA-EB-A3Y6	0	0	0	TCGA-EB-A3Y6-01	9	11	106	0.28314181518826403	TCGA-EB-A3Y6-01	8	8	13	29	PASS	8948	TCGA-EB-A3Y6	SKCM	56	FEMALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-20605	Alive	TUMOR FREE	126	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	126	0	126	NA	NA	0	126	
90	TCGA-EB-A3Y7	8	59	9	25	1	0	3	0	44	847	47	1	21	448	15	3	TCGA-EB-A3Y7	0	0	0	TCGA-EB-A3Y7-01	4	5	46	0.14943658599974682	TCGA-EB-A3Y7-01	4	4	5	13	PASS	8949	TCGA-EB-A3Y7	SKCM	86	FEMALE	WHITE	Stage IIIB	NA	NA	NA	2012	NA	-31622	Dead	TUMOR FREE	NA	326	NA	NA	NA	NA	NA	NA	NA	NA	1	326	0	326	NA	NA	0	326	
90	TCGA-EB-A41A	9	146	14	58	7	4	1	0	79	1392	82	0	47	785	28	0	TCGA-EB-A41A	0	0	0	TCGA-EB-A41A-01	6	6	32	0.055345382931346686	TCGA-EB-A41A-01	4	2	3	9	hypermutated sample	8950	TCGA-EB-A41A	SKCM	90	MALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-32872	Alive	TUMOR FREE	262	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	262	0	262	NA	NA	0	262	
80	TCGA-EB-A41B	1	22	1	11	2	0	2	0	22	296	21	0	8	178	2	0	TCGA-EB-A41B	0	0	0	TCGA-EB-A41B-01	7	13	152	0.30445207324439794	TCGA-EB-A41B-01	11	8	12	31	PASS	8951	TCGA-EB-A41B	SKCM	76	FEMALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-27998	Alive	TUMOR FREE	291	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	291	0	291	NA	NA	0	291	
70	TCGA-EB-A42Y	0	1	0	0	1	0	1	0	5	58	2	0	2	10	3	0	TCGA-EB-A42Y	0	0	0	TCGA-EB-A42Y-01	6	13	93	0.18629446870032787	TCGA-EB-A42Y-01	5	3	4	12	PASS	8952	TCGA-EB-A42Y	SKCM	73	FEMALE	ASIAN	Stage IIC	NA	NA	NA	2012	NA	-26712	Dead	WITH TUMOR	NA	721	NA	Regional lymph node	NA	NA	721	NA	NA	NA	1	721	1	721	NA	NA	1	721	
50	TCGA-EB-A42Z	0	7	0	7	1	0	0	0	6	82	4	0	0	47	5	0	TCGA-EB-A42Z	0	0	0	TCGA-EB-A42Z-01	7	6	170	0.2097622422505574	TCGA-EB-A42Z-01	13	11	14	38	PASS	8953	TCGA-EB-A42Z	SKCM	49	MALE	ASIAN	Stage IIIC	NA	NA	NA	2012	NA	-18157	Alive	TUMOR FREE	441	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	441	0	441	NA	NA	0	441	
80	TCGA-EB-A430	3	20	2	9	2	4	0	0	11	307	22	0	4	150	4	1	TCGA-EB-A430	0	0	0	TCGA-EB-A430-01	13	10	43	0.2343385860111099	TCGA-EB-A430-01	5	7	8	20	PASS	8954	TCGA-EB-A430	SKCM	83	MALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-30344	Alive	TUMOR FREE	-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
30	TCGA-EB-A431	7	100	12	43	1	1	0	0	69	1284	67	0	36	772	13	0	TCGA-EB-A431	0	0	0	TCGA-EB-A431-01	17	34	104	0.3107251463837002	TCGA-EB-A431-01	20	17	9	46	hypermutated sample	8955	TCGA-EB-A431	SKCM	34	MALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-12484	Alive	TUMOR FREE	568	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	568	0	568	NA	NA	0	568	
60	TCGA-EB-A44N	0	4	0	3	3	0	0	0	4	106	11	0	4	75	3	0	TCGA-EB-A44N	0	0	0	TCGA-EB-A44N-01	0	0	17	0.0008688815561212818	TCGA-EB-A44N-01	0	0	0	0	PASS	8956	TCGA-EB-A44N	SKCM	59	MALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-21623	Dead	WITH TUMOR	NA	205	NA	Regional lymph node|Distant Metastasis|Distant Metastasis	NA|Bone|Liver	NA|NA|NA	115	NA	NA	NA	1	205	1	205	NA	NA	1	115	
70	TCGA-EB-A44O	1	32	2	19	1	0	1	0	14	371	29	0	16	210	3	2	TCGA-EB-A44O	0	0	0	TCGA-EB-A44O-01	9	13	152	0.3580384987299433	TCGA-EB-A44O-01	7	4	8	19	PASS	8957	TCGA-EB-A44O	SKCM	69	MALE	WHITE	Stage IIB	NA	NA	NA	2012	NA	-25537	Alive	WITH TUMOR	81	NA	NA	Regional lymph node	NA	NA	60	NA	NA	NA	0	81	0	81	NA	NA	1	60	
60	TCGA-EB-A44P	2	24	1	6	1	1	0	0	10	255	10	0	5	162	4	1	TCGA-EB-A44P	0	0	0	TCGA-EB-A44P-01	4	3	36	0.10258657337112713	TCGA-EB-A44P-01	2	0	4	6	PASS	8958	TCGA-EB-A44P	SKCM	58	FEMALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-21519	Alive	TUMOR FREE	741	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	741	0	741	NA	NA	0	741	
50	TCGA-EB-A44Q	0	3	0	1	0	1	0	0	1	35	4	0	0	14	1	0	TCGA-EB-A44Q-06	516	0.2321091419185307	347	TCGA-EB-A44Q-06	6	6	141	0.1020375384849443	TCGA-EB-A44Q-06	6	2	3	11	PASS	8959	TCGA-EB-A44Q	SKCM	51	FEMALE	ASIAN	Stage IIIC	NA	NA	NA	2012	NA	-18910	Alive	TUMOR FREE	422	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	422	0	422	NA	NA	0	422	
50	TCGA-EB-A44R	0	1	0	0	0	1	0	0	2	43	1	0	1	22	1	0	TCGA-EB-A44R-06	496	0.7096603314428545	346	TCGA-EB-A44R-06	22	68	111	0.1926359756623771	TCGA-EB-A44R-06	10	5	1	16	PASS	8960	TCGA-EB-A44R	SKCM	52	MALE	ASIAN	Stage IIIB	NA	NA	NA	2011	NA	-19298	Dead	TUMOR FREE	NA	315	NA	NA	NA	NA	NA	NA	NA	NA	1	315	0	315	NA	NA	0	315	
40	TCGA-EB-A4IQ	0	1	0	0	0	0	0	0	0	9	0	0	2	10	0	0	TCGA-EB-A4IQ	0	0	0	TCGA-EB-A4IQ-01	21	23	83	0.16790544179355138	TCGA-EB-A4IQ-01	15	14	8	37	PASS	8961	TCGA-EB-A4IQ	SKCM	42	FEMALE	ASIAN	Stage IIIB	NA	NA	NA	2012	NA	-15516	Dead	TUMOR FREE	NA	636	NA	Locoregional Recurrence|Regional lymph node	NA|NA	NA|NA	337	NA	NA	NA	1	636	0	636	NA	NA	1	337	
80	TCGA-EB-A4IS	1	32	6	14	1	0	1	0	18	405	27	0	9	258	5	0	TCGA-EB-A4IS	0	0	0	TCGA-EB-A4IS-01	24	17	26	0.1231093872849812	TCGA-EB-A4IS-01	3	0	0	3	PASS	8962	TCGA-EB-A4IS	SKCM	77	MALE	WHITE	Stage IIB	NA	NA	NA	2012	NA	-28315	Alive	TUMOR FREE	774	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	774	0	774	NA	NA	0	774	
70	TCGA-EB-A4OY	0	2	0	0	0	0	0	0	1	47	4	0	0	18	0	0	TCGA-EB-A4OY	0	0	0	TCGA-EB-A4OY-01	17	24	181	0.3264770222577598	TCGA-EB-A4OY-01	17	25	15	57	PASS	8963	TCGA-EB-A4OY	SKCM	65	FEMALE	WHITE	Stage IIIB	NA	NA	NA	2012	NA	-23773	Alive	TUMOR FREE	977	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	977	0	977	NA	NA	0	977	
40	TCGA-EB-A4OZ	0	0	0	0	0	0	0	0	2	9	0	0	0	4	1	0	TCGA-EB-A4OZ	0	0	0	TCGA-EB-A4OZ-01	4	5	28	0.12640716050439066	TCGA-EB-A4OZ-01	3	3	4	10	PASS	8964	TCGA-EB-A4OZ	SKCM	41	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-15337	Alive	TUMOR FREE	620	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	620	0	620	NA	NA	0	620	
80	TCGA-EB-A4P0	0	7	0	1	0	1	0	0	9	144	5	0	1	90	1	0	TCGA-EB-A4P0	0	0	0	TCGA-EB-A4P0-01	23	15	84	0.1451919775095503	TCGA-EB-A4P0-01	8	3	5	16	PASS	8965	TCGA-EB-A4P0	SKCM	82	MALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-30225	Dead	TUMOR FREE	NA	326	NA	NA	NA	NA	NA	NA	NA	NA	1	326	0	326	NA	NA	0	326	
60	TCGA-EB-A4XL	2	37	4	16	1	0	0	0	21	353	23	0	16	189	6	0	TCGA-EB-A4XL	0	0	0	TCGA-EB-A4XL-01	8	7	32	0.08977192668183813	TCGA-EB-A4XL-01	5	4	3	12	PASS	8966	TCGA-EB-A4XL	SKCM	56	FEMALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-20486	Alive	TUMOR FREE	777	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	777	0	777	NA	NA	0	777	
50	TCGA-EB-A51B	4	33	3	15	1	2	0	0	18	292	19	0	8	167	10	1	TCGA-EB-A51B	0	0	0	TCGA-EB-A51B-01	18	18	25	0.09927414106363693	TCGA-EB-A51B-01	7	5	4	16	PASS	8967	TCGA-EB-A51B	SKCM	53	MALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-19645	Alive	TUMOR FREE	931	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	931	0	931	NA	NA	0	931	
80	TCGA-EB-A550	1	9	1	7	3	1	0	0	6	111	7	0	3	53	6	0	TCGA-EB-A550	0	0	0	TCGA-EB-A550-01	5	5	64	0.14634063661784286	TCGA-EB-A550-01	4	5	4	13	PASS	8968	TCGA-EB-A550	SKCM	75	FEMALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-27556	Dead	TUMOR FREE	NA	264	NA	NA	NA	NA	NA	NA	NA	NA	1	264	0	264	NA	NA	0	264	
80	TCGA-EB-A551	4	15	2	11	1	0	0	0	9	260	18	0	9	144	5	1	TCGA-EB-A551	0	0	0	TCGA-EB-A551-01	8	15	162	0.33588205310675473	TCGA-EB-A551-01	11	20	11	42	PASS	8969	TCGA-EB-A551	SKCM	78	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-28671	Alive	TUMOR FREE	590	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	590	0	590	NA	NA	0	590	
60	TCGA-EB-A553	2	19	1	14	1	1	1	0	7	250	17	0	6	116	6	0	TCGA-EB-A553	0	0	0	TCGA-EB-A553-01	22	34	95	0.3983466989756165	TCGA-EB-A553-01	14	11	4	29	PASS	8970	TCGA-EB-A553	SKCM	62	MALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-22972	Alive	TUMOR FREE	226	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	226	0	226	NA	NA	0	226	
60	TCGA-EB-A57M	0	1	0	2	3	0	0	0	0	49	0	0	0	5	2	0	TCGA-EB-A57M	0	0	0	TCGA-EB-A57M-01	12	9	67	0.1382652420324358	TCGA-EB-A57M-01	9	6	5	20	PASS	8971	TCGA-EB-A57M	SKCM	56	MALE	ASIAN	Stage IIIB	NA	NA	NA	2012	NA	-20698	Dead	TUMOR FREE	NA	472	NA	NA	NA	NA	NA	NA	NA	NA	1	472	0	472	NA	NA	0	472	
70	TCGA-EB-A5FP	1	28	3	8	2	0	0	0	16	300	17	0	7	174	5	0	TCGA-EB-A5FP	0	0	0	TCGA-EB-A5FP-01	17	16	47	0.16152874003206574	TCGA-EB-A5FP-01	10	8	6	24	PASS	8972	TCGA-EB-A5FP	SKCM	65	FEMALE	WHITE	Stage IV	NA	NA	NA	2012	NA	-23833	Dead	WITH TUMOR	NA	454	NA	Regional lymph node|Distant Metastasis	NA|Lung	NA|NA	24	NA	NA	NA	1	454	1	454	NA	NA	1	24	
60	TCGA-EB-A5KH	0	3	0	4	0	1	0	0	2	32	2	0	0	11	0	0	TCGA-EB-A5KH-06	531	0.3266495745667363	365	TCGA-EB-A5KH-06	5	8	87	0.07966262843482844	TCGA-EB-A5KH-06	9	18	5	32	PASS	8973	TCGA-EB-A5KH	SKCM	55	MALE	ASIAN	Stage III	NA	NA	NA	2011	NA	-20424	Dead	TUMOR FREE	NA	619	NA	NA	NA	NA	NA	NA	NA	NA	1	619	0	619	NA	NA	0	619	
70	TCGA-EB-A5SE	2	23	1	4	0	0	0	0	7	216	7	0	5	130	4	0	TCGA-EB-A5SE	0	0	0	TCGA-EB-A5SE-01	7	6	53	0.15876309888192633	TCGA-EB-A5SE-01	6	6	4	16	PASS	8974	TCGA-EB-A5SE	SKCM	73	MALE	WHITE	Stage IIB	NA	NA	NA	2012	NA	-26965	Dead	WITH TUMOR	NA	401	NA	Distant Metastasis	Brain	NA	367	NA	NA	NA	1	401	1	401	NA	NA	1	367	
80	TCGA-EB-A5SF	0	1	0	1	0	2	0	0	1	21	1	0	1	14	2	0	TCGA-EB-A5SF	0	0	0	TCGA-EB-A5SF-01	12	10	89	0.3733542746870199	TCGA-EB-A5SF-01	7	5	11	23	PASS	8975	TCGA-EB-A5SF	SKCM	78	FEMALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-28772	Dead	TUMOR FREE	NA	369	NA	NA	NA	NA	NA	NA	NA	NA	1	369	0	369	NA	NA	0	369	
60	TCGA-EB-A5SG	0	11	2	1	0	0	0	0	9	208	13	0	5	117	2	1	TCGA-EB-A5SG-06	80	0.2281225294175017	31	TCGA-EB-A5SG-06	7	7	62	0.13733165886074478	TCGA-EB-A5SG-06	5	2	2	9	PASS	8976	TCGA-EB-A5SG	SKCM	57	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-20978	Alive	TUMOR FREE	2076	NA	NA	Locoregional Recurrence	NA	NA	1372	NA	NA	NA	0	2076	0	2076	NA	NA	1	1372	
60	TCGA-EB-A5SH	0	9	0	3	2	2	0	0	4	76	7	0	1	23	1	0	TCGA-EB-A5SH-06	489	0.6369756055497736	334	TCGA-EB-A5SH-06	22	29	198	0.3123182637630771	TCGA-EB-A5SH-06	10	9	8	27	PASS	8977	TCGA-EB-A5SH	SKCM	60	FEMALE	WHITE	Stage III	NA	NA	NA	2009	NA	-21920	Alive	TUMOR FREE	1643	NA	NA	Locoregional Recurrence	NA	NA	1065	NA	NA	NA	0	1643	0	1643	NA	NA	1	1065	
70	TCGA-EB-A5UL	3	28	1	8	1	0	1	0	13	349	33	0	5	187	7	0	TCGA-EB-A5UL-06	224	0.6712481136948856	120	TCGA-EB-A5UL-06	14	36	135	0.31412801500785525	TCGA-EB-A5UL-06	21	20	12	53	PASS	8978	TCGA-EB-A5UL	SKCM	71	MALE	WHITE	Stage III	NA	NA	NA	2012	NA	-26058	Alive	TUMOR FREE	891	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	891	0	891	NA	NA	0	891	
50	TCGA-EB-A5UM	1	21	1	19	4	0	1	0	12	436	22	0	8	227	6	1	TCGA-EB-A5UM	0	0	0	TCGA-EB-A5UM-01	6	6	30	0.17638118239316536	TCGA-EB-A5UM-01	7	7	7	21	PASS	8979	TCGA-EB-A5UM	SKCM	48	FEMALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-17867	Alive	TUMOR FREE	779	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	779	0	779	NA	NA	0	779	
50	TCGA-EB-A5UN	0	28	3	20	3	2	0	0	34	540	46	0	11	308	11	1	TCGA-EB-A5UN-06	74	0.35886249139780113	29	TCGA-EB-A5UN-06	11	8	38	0.1914268907689682	TCGA-EB-A5UN-06	5	2	6	13	PASS	8980	TCGA-EB-A5UN	SKCM	49	MALE	WHITE	Stage IIC	NA	NA	NA	2009	NA	-18226	Alive	NA	1792	NA	NA	Distant Metastasis	Brain	NA	1689	NA	NA	NA	0	1792	0	1792	NA	NA	1	1689	
60	TCGA-EB-A5VU	2	2	0	2	0	0	0	0	0	39	1	0	3	15	0	1	TCGA-EB-A5VU	0	0	0	TCGA-EB-A5VU-01	28	20	58	0.1147364433007102	TCGA-EB-A5VU-01	10	11	2	23	PASS	8981	TCGA-EB-A5VU	SKCM	56	MALE	ASIAN	Stage IIIB	NA	NA	NA	2012	NA	-20610	Dead	WITH TUMOR	NA	321	NA	Locoregional Recurrence	NA	NA	217	NA	NA	NA	1	321	1	321	NA	NA	1	217	
70	TCGA-EB-A5VV	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-EB-A5VV-06	39	7.230080720041584e-05	5	TCGA-EB-A5VV-06	0	0	13	0.0013458341118591534	TCGA-EB-A5VV-06	1	0	0	1	PASS	8982	TCGA-EB-A5VV	SKCM	74	FEMALE	WHITE	Stage IIIB	NA	NA	NA	2012	NA	-27364	Alive	TUMOR FREE	214	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	214	0	214	NA	NA	0	214	
60	TCGA-EB-A6L9	0	2	0	1	2	0	0	0	0	12	1	0	1	12	2	0	TCGA-EB-A6L9-06	147	0.13326482109201715	77	TCGA-EB-A6L9-06	29	27	147	0.4278260228782613	TCGA-EB-A6L9-06	17	17	18	52	PASS	8983	TCGA-EB-A6L9	SKCM	55	MALE	ASIAN	Stage IIIC	NA	NA	NA	2012	NA	-20172	Alive	TUMOR FREE	1109	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1109	0	1109	NA	NA	0	1109	
70	TCGA-EB-A6QY	2	48	5	24	3	0	0	0	28	470	13	0	9	259	14	4	TCGA-EB-A6QY	0	0	0	TCGA-EB-A6QY-01	29	19	94	0.2976629798513673	TCGA-EB-A6QY-01	9	9	7	25	PASS	8984	TCGA-EB-A6QY	SKCM	71	MALE	WHITE	Stage IIC	NA	NA	NA	2013	NA	-26216	Alive	TUMOR FREE	382	NA	NA	Regional lymph node	NA	NA	36	NA	NA	NA	0	382	0	382	NA	NA	1	36	
80	TCGA-EB-A6QZ	2	18	3	8	3	0	0	0	14	209	9	0	7	117	4	0	TCGA-EB-A6QZ	0	0	0	TCGA-EB-A6QZ-01	7	5	92	0.26582097477442795	TCGA-EB-A6QZ-01	3	5	7	15	PASS	8985	TCGA-EB-A6QZ	SKCM	76	FEMALE	WHITE	Stage IIA	NA	NA	NA	2013	NA	-28078	Dead	WITH TUMOR	NA	352	NA	Regional lymph node|Distant Metastasis	NA|Brain	NA|NA	129	NA	NA	NA	1	352	1	352	NA	NA	1	129	
60	TCGA-EB-A6R0	4	20	4	13	2	2	0	0	10	286	17	0	12	160	5	1	TCGA-EB-A6R0	0	0	0	TCGA-EB-A6R0-01	10	9	45	0.12673345282698514	TCGA-EB-A6R0-01	10	9	5	24	PASS	8986	TCGA-EB-A6R0	SKCM	58	FEMALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-21367	Dead	TUMOR FREE	NA	608	NA	NA	NA	NA	NA	NA	NA	NA	1	608	0	608	NA	NA	0	608	
60	TCGA-EB-A82B	1	2	1	2	1	2	1	0	0	32	2	1	0	23	1	1	TCGA-EB-A82B	0	0	0	TCGA-EB-A82B-01	14	25	106	0.24549923113919184	TCGA-EB-A82B-01	16	15	12	43	PASS	8987	TCGA-EB-A82B	SKCM	58	FEMALE	ASIAN	Stage III	NA	NA	NA	2013	NA	-21239	Alive	TUMOR FREE	390	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	390	0	390	NA	NA	0	390	
70	TCGA-EB-A82C	0	6	0	1	0	1	0	0	0	23	4	0	0	15	0	0	TCGA-EB-A82C	0	0	0	TCGA-EB-A82C-01	19	27	148	0.22802178601607	TCGA-EB-A82C-01	13	8	10	31	PASS	8988	TCGA-EB-A82C	SKCM	70	FEMALE	ASIAN	Stage IIC	NA	NA	NA	2013	NA	-25850	Alive	TUMOR FREE	17	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	17	0	17	NA	NA	0	17	
70	TCGA-EB-A85I	1	15	3	5	1	2	0	0	8	153	10	0	9	102	3	0	TCGA-EB-A85I	0	0	0	TCGA-EB-A85I-01	5	7	57	0.13747461025411492	TCGA-EB-A85I-01	7	10	8	25	PASS	8989	TCGA-EB-A85I	SKCM	66	MALE	WHITE	Stage IIC	NA	NA	NA	2013	NA	-24408	Alive	TUMOR FREE	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	362	0	362	NA	NA	0	362	
70	TCGA-EB-A85J	1	31	2	5	0	1	0	0	15	304	31	0	9	170	2	0	TCGA-EB-A85J	0	0	0	TCGA-EB-A85J-01	9	9	47	0.0894911237139534	TCGA-EB-A85J-01	5	2	5	12	PASS	8990	TCGA-EB-A85J	SKCM	66	FEMALE	WHITE	Stage IIB	NA	NA	NA	2013	NA	-24263	Alive	TUMOR FREE	360	NA	NA	Regional lymph node	NA	NA	138	NA	NA	NA	0	360	0	360	NA	NA	1	138	
70	TCGA-EB-A97M	0	15	1	7	1	1	0	0	12	234	11	0	10	141	0	0	TCGA-EB-A97M	0	0	0	TCGA-EB-A97M-01	12	14	69	0.17772525575778209	TCGA-EB-A97M-01	5	3	3	11	PASS	8991	TCGA-EB-A97M	SKCM	66	MALE	WHITE	Stage IIC	NA	NA	NA	2013	NA	-24228	Alive	TUMOR FREE	414	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	414	0	414	NA	NA	0	414	
50	TCGA-EE-A17X	8	40	4	20	4	0	0	0	25	607	49	0	11	330	8	1	TCGA-EE-A17X-06	76	0.07686703376532633	24	TCGA-EE-A17X-06	3	2	7	0.09170919903407496	TCGA-EE-A17X-06	2	1	2	5	PASS	8992	TCGA-EE-A17X	SKCM	54	MALE	WHITE	Stage IA	NA	NA	NA	2006	NA	-20021	Dead	WITH TUMOR	NA	907	NA	Locoregional Recurrence	NA	NA	531	NA	NA	NA	1	907	1	907	NA	NA	1	531	
70	TCGA-EE-A17Y	0	28	1	14	1	1	0	0	14	248	33	0	3	140	7	3	TCGA-EE-A17Y-06	151	0.7604020129862468	94	TCGA-EE-A17Y-06	28	20	27	0.3881244382502631	TCGA-EE-A17Y-06	8	5	7	20	PASS	8993	TCGA-EE-A17Y	SKCM	69	MALE	ASIAN	Stage IIIB	NA	NA	NA	2007	NA	-25281	Dead	WITH TUMOR	NA	828	NA	Regional lymph node	NA	NA	317	NA	NA	NA	1	828	1	828	NA	NA	1	317	
60	TCGA-EE-A17Z	5	37	4	15	3	0	1	0	39	873	147	1	11	301	66	3	TCGA-EE-A17Z-06	197	0.2314949950834839	116	TCGA-EE-A17Z-06	5	7	23	0.1378116493156599	TCGA-EE-A17Z-06	7	8	4	19	PASS	8994	TCGA-EE-A17Z	SKCM	57	MALE	WHITE	Stage IIB	NA	NA	NA	2008	NA	-20970	Dead	WITH TUMOR	NA	263	NA	Regional lymph node	NA	NA	138	NA	NA	NA	1	263	1	263	NA	NA	1	138	
70	TCGA-EE-A180	5	31	3	20	5	1	0	0	18	397	28	2	10	212	4	2	TCGA-EE-A180-06	145	0.9471845109468612	86	TCGA-EE-A180-06	20	35	25	0.15316577905225026	TCGA-EE-A180-06	6	7	4	17	PASS	8995	TCGA-EE-A180	SKCM	69	MALE	WHITE	Stage III	NA	NA	NA	2001	NA	-25523	Dead	WITH TUMOR	NA	2889	NA	New primary melanoma	NA	NA	850	NA	NA	NA	1	2889	1	2889	NA	NA	1	850	
80	TCGA-EE-A181	10	189	15	96	11	1	3	0	138	3981	353	2	62	2039	123	4	TCGA-EE-A181-06	110	0.4662168952687333	50	TCGA-EE-A181-06	18	34	23	0.17262514696013245	TCGA-EE-A181-06	9	3	3	15	hypermutated sample	8996	TCGA-EE-A181	SKCM	82	FEMALE	WHITE	Stage II	NA	NA	NA	2005	NA	-30003	Dead	TUMOR FREE	NA	1026	NA	Locoregional Recurrence	NA	NA	788	NA	NA	NA	1	1026	0	1026	NA	NA	1	788	
80	TCGA-EE-A182	12	68	7	34	11	2	0	0	57	1098	79	2	21	656	11	3	TCGA-EE-A182-06	129	0.21457717559745051	66	TCGA-EE-A182-06	6	6	29	0.14466878322248405	TCGA-EE-A182-06	7	2	2	11	PASS	8997	TCGA-EE-A182	SKCM	84	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2008	NA	-30718	Dead	WITH TUMOR	NA	447	NA	Locoregional Recurrence	NA	NA	270	NA	NA	NA	1	447	1	447	NA	NA	1	270	
50	TCGA-EE-A183	6	94	8	49	3	1	0	0	71	1830	202	1	27	815	89	4	TCGA-EE-A183-06	92	0.16147347137402476	41	TCGA-EE-A183-06	6	10	16	0.10387829189376956	TCGA-EE-A183-06	7	7	5	19	PASS	8998	TCGA-EE-A183	SKCM	48	MALE	WHITE	Stage 0	NA	NA	NA	2007	NA	-17788	Dead	WITH TUMOR	NA	818	NA	Locoregional Recurrence	NA	NA	450	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
70	TCGA-EE-A184	5	55	4	31	0	1	1	0	38	926	108	3	13	398	26	3	TCGA-EE-A184-06	435	0.3578523300116059	289	TCGA-EE-A184-06	9	13	53	0.1488505614286978	TCGA-EE-A184-06	11	4	7	22	PASS	8999	TCGA-EE-A184	SKCM	72	MALE	WHITE	Stage IB	NA	NA	NA	2003	NA	-26447	Dead	NA	NA	2073	NA	Distant Metastasis	"Other, Specify"	Right lower arm	1309	NA	NA	NA	1	2073	NA	2073	NA	NA	1	1309	
60	TCGA-EE-A185	0	18	1	4	2	0	0	0	6	165	16	0	4	84	1	1	TCGA-EE-A185-06	168	0.8953964553242312	96	TCGA-EE-A185-06	8	9	60	0.3111376701204047	TCGA-EE-A185-06	8	5	3	16	PASS	9000	TCGA-EE-A185	SKCM	55	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2008	NA	-20235	Dead	WITH TUMOR	NA	151	NA	Regional lymph node	NA	NA	85	NA	NA	NA	1	151	1	151	NA	NA	1	85	
70	TCGA-EE-A20B	1	9	1	6	1	1	0	0	12	150	5	0	5	80	7	0	TCGA-EE-A20B-06	131	0.8437085160602332	64	TCGA-EE-A20B-06	12	10	25	0.3293830374470107	TCGA-EE-A20B-06	4	8	4	16	PASS	9001	TCGA-EE-A20B	SKCM	66	FEMALE	WHITE	Stage II	NA	NA	NA	2002	NA	-24445	Alive	TUMOR FREE	4070	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4070	0	4070	NA	NA	0	4070	
60	TCGA-EE-A20C	14	127	10	73	12	2	2	0	89	1795	178	2	38	1052	36	2	TCGA-EE-A20C-06	180	0.9473080810388834	109	TCGA-EE-A20C-06	16	17	15	0.09171235047759888	TCGA-EE-A20C-06	7	8	5	20	hypermutated sample	9002	TCGA-EE-A20C	SKCM	59	MALE	WHITE	Stage 0	NA	NA	NA	1997	NA	-21660	Dead	WITH TUMOR	NA	4601	NA	New primary melanoma	NA	NA	142	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
50	TCGA-EE-A20F	6	96	11	34	5	3	1	0	53	1554	205	0	24	723	51	4	TCGA-EE-A20F-06	150	0.5452911043814596	75	TCGA-EE-A20F-06	3	8	35	0.21997775411923007	TCGA-EE-A20F-06	10	12	9	31	PASS	9003	TCGA-EE-A20F	SKCM	53	MALE	WHITE	Stage I	NA	NA	NA	2002	NA	-19372	Alive	TUMOR FREE	2785	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2785	0	2785	NA	NA	0	2785	
60	TCGA-EE-A20H	3	26	1	18	3	1	0	0	26	482	21	0	16	239	6	1	TCGA-EE-A20H-06	182	0.7619170168433951	112	TCGA-EE-A20H-06	24	24	45	0.39116802719768695	TCGA-EE-A20H-06	12	9	7	28	PASS	9004	TCGA-EE-A20H	SKCM	56	MALE	WHITE	Stage I	NA	NA	NA	1995	NA	-20476	Dead	WITH TUMOR	NA	5118	NA	Regional lymph node	NA	NA	4667	NA	NA	NA	1	5118	1	5118	NA	NA	1	4667	
80	TCGA-EE-A20I	0	1	0	2	1	0	0	0	3	19	1	0	1	11	1	0	TCGA-EE-A20I-06	619	0.9470053156992888	467	TCGA-EE-A20I-06	11	10	181	0.3575797841979797	TCGA-EE-A20I-06	8	15	17	40	PASS	9005	TCGA-EE-A20I	SKCM	79	MALE	WHITE	Stage IV	NA	NA	NA	2008	NA	-28883	Dead	WITH TUMOR	NA	412	NA	Distant Metastasis	Brain	NA	53	NA	NA	NA	1	412	1	412	NA	NA	1	53	
70	TCGA-EE-A29A	3	17	2	8	2	2	0	0	5	193	11	0	3	116	3	0	TCGA-EE-A29A-06	166	0.3626755140933728	111	TCGA-EE-A29A-06	12	12	23	0.08073602565543034	TCGA-EE-A29A-06	4	2	2	8	PASS	9006	TCGA-EE-A29A	SKCM	68	MALE	WHITE	Stage IIIA	NA	NA	NA	2003	NA	-25095	Dead	WITH TUMOR	NA	1927	NA	Locoregional Recurrence	NA	NA	867	NA	NA	NA	1	1927	1	1927	NA	NA	1	867	
70	TCGA-EE-A29B	1	23	5	16	1	1	0	1	21	452	29	0	6	222	6	1	TCGA-EE-A29B-06	114	0.16945960237759974	56	TCGA-EE-A29B-06	6	7	10	0.08650075424244366	TCGA-EE-A29B-06	4	2	5	11	PASS	9007	TCGA-EE-A29B	SKCM	67	MALE	WHITE	Stage IIB	NA	NA	NA	2004	NA	-24618	Dead	WITH TUMOR	NA	2588	NA	New primary melanoma	NA	NA	490	NA	NA	NA	1	2588	1	2588	NA	NA	1	490	
30	TCGA-EE-A29C	2	21	1	17	2	0	0	0	14	328	15	0	7	169	7	1	TCGA-EE-A29C-06	112	0.8633365000345178	52	TCGA-EE-A29C-06	15	14	31	0.4142055019084804	TCGA-EE-A29C-06	8	7	12	27	PASS	9008	TCGA-EE-A29C	SKCM	20	MALE	WHITE	Stage IB	NA	NA	NA	2007	NA	-7510	Dead	WITH TUMOR	NA	2402	NA	Regional lymph node	NA	NA	204	NA	NA	NA	1	2402	1	2402	NA	NA	1	204	
90	TCGA-EE-A29D	18	201	30	98	11	3	1	0	140	2797	187	2	83	1682	38	5	TCGA-EE-A29D-06	297	0.8323493425185323	194	TCGA-EE-A29D-06	19	26	39	0.1649809893419077	TCGA-EE-A29D-06	15	10	7	32	hypermutated sample	9009	TCGA-EE-A29D	SKCM	87	MALE	WHITE	Stage IIIC	NA	NA	NA	2008	NA	-31790	Dead	NA	NA	425	NA	NA	NA	NA	NA	NA	NA	NA	1	425	NA	425	NA	NA	0	425	
50	TCGA-EE-A29E	17	211	19	106	5	3	0	0	160	3228	237	3	74	1845	65	4	TCGA-EE-A29E-06	173	0.30549383945025355	106	TCGA-EE-A29E-06	8	16	27	0.2262723341325261	TCGA-EE-A29E-06	11	3	7	21	hypermutated sample	9010	TCGA-EE-A29E	SKCM	54	MALE	WHITE	Stage IIIB	NA	NA	NA	2008	NA	-19961	Alive	TUMOR FREE	1940	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1940	0	1940	NA	NA	0	1940	
50	TCGA-EE-A29G	5	37	9	30	1	0	0	0	25	578	68	0	11	262	16	1	TCGA-EE-A29G-06	77	0.5257786486487044	32	TCGA-EE-A29G-06	25	30	11	0.1830029268768886	TCGA-EE-A29G-06	8	8	2	18	PASS	9011	TCGA-EE-A29G	SKCM	53	MALE	WHITE	Stage IIIA	NA	NA	NA	2003	NA	-19664	Dead	WITH TUMOR	NA	2192	NA	Locoregional Recurrence	NA	NA	726	NA	NA	NA	1	2192	1	2192	NA	NA	1	726	
60	TCGA-EE-A29H	0	10	3	13	3	1	0	0	7	252	12	0	4	136	2	0	TCGA-EE-A29H-06	269	0.8580026677402691	172	TCGA-EE-A29H-06	9	7	47	0.20187593533893505	TCGA-EE-A29H-06	10	7	6	23	PASS	9012	TCGA-EE-A29H	SKCM	59	FEMALE	WHITE	Stage IA	NA	NA	NA	2008	NA	-21552	Alive	TUMOR FREE	1966	NA	NA	Distant Metastasis|Locoregional Recurrence	"Other, Specify|NA"	Perihilar lymph nodes|NA	1231	NA	NA	NA	0	1966	0	1966	NA	NA	1	1231	
80	TCGA-EE-A29L	14	141	16	71	5	0	4	0	97	1964	142	0	39	1115	49	3	TCGA-EE-A29L-06	297	0.6662465135648644	213	TCGA-EE-A29L-06	19	35	55	0.07109101337885132	TCGA-EE-A29L-06	16	9	3	28	hypermutated sample	9013	TCGA-EE-A29L	SKCM	78	MALE	WHITE	Stage IIIC	NA	NA	NA	2009	NA	-28824	Dead	NA	NA	79	NA	Distant Metastasis	Brain	NA	55	NA	NA	NA	1	79	NA	79	NA	NA	1	55	
30	TCGA-EE-A29M	13	146	8	67	9	1	0	0	79	1800	87	1	60	999	27	3	TCGA-EE-A29M-06	95	0.6968366433698198	45	TCGA-EE-A29M-06	15	12	23	0.31703418918381965	TCGA-EE-A29M-06	9	5	7	21	hypermutated sample	9014	TCGA-EE-A29M	SKCM	33	FEMALE	WHITE	Stage IB	NA	NA	NA	2007	NA	-12350	Alive	TUMOR FREE	1729	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1729	0	1729	NA	NA	0	1729	
80	TCGA-EE-A29N	2	33	2	19	9	1	1	0	23	511	36	0	16	309	14	0	TCGA-EE-A29N-06	70	0.1697691436085983	24	TCGA-EE-A29N-06	6	7	10	0.12422296090714514	TCGA-EE-A29N-06	1	4	0	5	PASS	9015	TCGA-EE-A29N	SKCM	78	MALE	WHITE	I/II NOS	NA	NA	NA	2009	NA	-28805	Dead	WITH TUMOR	NA	566	NA	New primary melanoma	NA	NA	478	NA	NA	NA	1	566	1	566	NA	NA	1	478	
70	TCGA-EE-A29P	4	18	2	10	2	1	1	0	11	366	30	0	13	203	10	1	TCGA-EE-A29P-06	94	0.5935205078952986	45	TCGA-EE-A29P-06	23	30	12	0.2333625166830236	TCGA-EE-A29P-06	7	4	4	15	PASS	9016	TCGA-EE-A29P	SKCM	73	FEMALE	WHITE	Stage IIC	NA	NA	NA	2006	NA	-26899	Alive	WITH TUMOR	1716	NA	NA	Distant Metastasis	Lung	NA	1668	NA	NA	NA	0	1716	0	1716	NA	NA	1	1668	
70	TCGA-EE-A29Q	2	36	3	22	1	1	0	0	30	540	50	0	11	274	10	0	TCGA-EE-A29Q-06	75	0.8011264600410141	34	TCGA-EE-A29Q-06	9	6	17	0.2461291628317689	TCGA-EE-A29Q-06	2	1	0	3	PASS	9017	TCGA-EE-A29Q	SKCM	70	FEMALE	WHITE	Stage IIB	NA	NA	NA	2007	NA	-25847	Dead	WITH TUMOR	NA	2030	NA	Regional lymph node|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Locoregional Recurrence|Distant Metastasis	"NA|Other, Specify|Other, Specify|Lung|Bone|NA|Brain"	NA|mediastinal lymph nodes|adrenal|NA|NA|NA|NA	1256	NA	NA	NA	1	2030	1	2030	NA	NA	1	1256	
50	TCGA-EE-A29R	4	29	2	16	0	0	0	0	29	494	33	0	18	305	10	2	TCGA-EE-A29R-06	99	0.9192330125970084	42	TCGA-EE-A29R-06	26	31	16	0.2578327341939504	TCGA-EE-A29R-06	6	0	2	8	PASS	9018	TCGA-EE-A29R	SKCM	48	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2010	NA	-17857	Alive	WITH TUMOR	440	NA	NA	Distant Metastasis	Lung	NA	426	NA	NA	NA	0	440	0	440	NA	NA	1	426	
80	TCGA-EE-A29S	9	78	4	32	0	2	1	0	58	889	69	1	27	522	20	2	TCGA-EE-A29S-06	129	0.29123573644529555	64	TCGA-EE-A29S-06	7	8	23	0.18574370403190285	TCGA-EE-A29S-06	10	7	6	23	PASS	9019	TCGA-EE-A29S	SKCM	79	MALE	WHITE	Stage IIA	NA	NA	NA	2006	NA	-29087	Dead	WITH TUMOR	NA	1864	NA	Locoregional Recurrence	NA	NA	1418	NA	NA	NA	1	1864	1	1864	NA	NA	1	1418	
50	TCGA-EE-A29T	1	18	3	10	2	2	1	1	16	290	20	0	8	155	2	0	TCGA-EE-A29T-06	105	0.7353161669684722	43	TCGA-EE-A29T-06	24	30	33	0.2484260247049333	TCGA-EE-A29T-06	14	9	6	29	PASS	9020	TCGA-EE-A29T	SKCM	51	FEMALE	WHITE	NA	NA	NA	NA	1982	NA	-18779	Alive	TUMOR FREE	11252	NA	NA	Regional lymph node	NA	NA	7483	NA	NA	NA	0	11252	0	11252	NA	NA	1	7483	
90	TCGA-EE-A29V	5	45	8	24	5	0	1	0	38	892	59	1	12	508	27	2	TCGA-EE-A29V-06	169	0.8979724047922084	90	TCGA-EE-A29V-06	7	8	40	0.2837666164697465	TCGA-EE-A29V-06	12	11	13	36	PASS	9021	TCGA-EE-A29V	SKCM	85	MALE	WHITE	Stage IIIC	NA	NA	NA	2008	NA	-31092	Dead	WITH TUMOR	NA	787	NA	Locoregional Recurrence	NA	NA	96	NA	NA	NA	1	787	1	787	NA	NA	1	96	
40	TCGA-EE-A29W	0	19	0	6	1	0	0	0	12	228	35	0	2	106	5	1	TCGA-EE-A29W-06	74	0.7265169625615036	24	TCGA-EE-A29W-06	30	39	6	0.05120647360898229	TCGA-EE-A29W-06	1	0	0	1	PASS	9022	TCGA-EE-A29W	SKCM	42	MALE	WHITE	Stage 0	NA	NA	NA	1997	NA	-15396	Alive	TUMOR FREE	5932	NA	NA	New primary melanoma	NA	NA	4408	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
60	TCGA-EE-A29X	6	60	3	36	1	0	0	0	41	866	100	0	16	397	43	1	TCGA-EE-A29X-06	126	0.9390140366276756	61	TCGA-EE-A29X-06	18	13	30	0.473774857806627	TCGA-EE-A29X-06	8	7	6	21	PASS	9023	TCGA-EE-A29X	SKCM	58	FEMALE	WHITE	Stage IB	NA	NA	NA	2009	NA	-21363	Dead	WITH TUMOR	NA	545	NA	Regional lymph node	NA	NA	391	NA	NA	NA	1	545	1	545	NA	NA	1	391	
80	TCGA-EE-A2A0	1	33	0	15	0	0	1	0	19	463	43	0	11	194	13	0	TCGA-EE-A2A0-06	86	0.2516004192611844	44	TCGA-EE-A2A0-06	10	7	19	0.17828055414526753	TCGA-EE-A2A0-06	2	6	5	13	PASS	9024	TCGA-EE-A2A0	SKCM	77	FEMALE	WHITE	Stage IIA	NA	NA	NA	2006	NA	-28319	Dead	WITH TUMOR	NA	1424	NA	Distant Metastasis	"Other, Specify"	Left Inner Canthus	1247	NA	NA	NA	1	1424	1	1424	NA	NA	1	1247	
50	TCGA-EE-A2A1	1	27	3	11	3	3	0	0	12	305	19	0	7	162	6	0	TCGA-EE-A2A1-06	62	0.14764691256856	20	TCGA-EE-A2A1-06	9	13	5	0.05850204337764394	TCGA-EE-A2A1-06	2	0	2	4	PASS	9025	TCGA-EE-A2A1	SKCM	46	MALE	WHITE	Stage IB	NA	NA	NA	2004	NA	-17109	Alive	TUMOR FREE	3527	NA	NA	Regional lymph node	NA	NA	3488	NA	NA	NA	0	3527	0	3527	NA	NA	1	3488	
70	TCGA-EE-A2A2	5	100	13	47	10	2	2	0	46	1161	85	0	35	629	22	2	TCGA-EE-A2A2-06	174	0.8001114399859458	108	TCGA-EE-A2A2-06	8	7	13	0.1822071664226444	TCGA-EE-A2A2-06	5	2	4	11	PASS	9026	TCGA-EE-A2A2	SKCM	71	MALE	WHITE	Stage IIIC	NA	NA	NA	2009	NA	-26048	Alive	TUMOR FREE	1814	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1814	0	1814	NA	NA	0	1814	
40	TCGA-EE-A2A5	1	23	2	11	2	0	1	0	16	420	37	0	7	204	3	1	TCGA-EE-A2A5-06	91	0.5618674086544266	41	TCGA-EE-A2A5-06	22	25	16	0.2779172099053356	TCGA-EE-A2A5-06	8	3	7	18	PASS	9027	TCGA-EE-A2A5	SKCM	43	MALE	WHITE	Stage IB	NA	NA	NA	2007	NA	-16041	Dead	WITH TUMOR	NA	1195	NA	Regional lymph node	NA	NA	1028	NA	NA	NA	1	1195	1	1195	NA	NA	1	1028	
40	TCGA-EE-A2A6	2	30	3	16	1	0	0	0	12	330	39	0	6	174	9	0	TCGA-EE-A2A6-06	119	0.3797373702905157	57	TCGA-EE-A2A6	0	0	0	0	TCGA-EE-A2A6-01	8	6	5	19	PASS	9028	TCGA-EE-A2A6	SKCM	43	MALE	WHITE	Stage IA	NA	NA	NA	2006	NA	-15953	Alive	TUMOR FREE	2620	NA	NA	New primary melanoma	NA	NA	1505	NA	NA	NA	0	2620	0	2620	NA	NA	1	1505	
50	TCGA-EE-A2GB	2	36	2	26	2	1	1	0	25	524	27	1	9	275	11	0	TCGA-EE-A2GB-06	228	0.6064577467396178	140	TCGA-EE-A2GB-06	17	19	36	0.16570446992511167	TCGA-EE-A2GB-06	11	9	3	23	PASS	9029	TCGA-EE-A2GB	SKCM	51	MALE	WHITE	Stage IIIB	NA	NA	NA	2007	NA	-18876	Alive	TUMOR FREE	1803	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1803	0	1803	NA	NA	0	1803	
80	TCGA-EE-A2GC	9	147	18	67	11	2	1	0	82	1770	110	1	48	1004	25	5	TCGA-EE-A2GC-06	181	0.9298710322437888	119	TCGA-EE-A2GC-06	25	12	32	0.1303240284093396	TCGA-EE-A2GC-06	6	6	3	15	hypermutated sample	9030	TCGA-EE-A2GC	SKCM	82	MALE	WHITE	Stage IIB	NA	NA	NA	2008	NA	-30084	Alive	TUMOR FREE	2051	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2051	0	2051	NA	NA	0	2051	
60	TCGA-EE-A2GD	4	24	3	12	3	0	0	0	15	440	28	0	8	236	2	1	TCGA-EE-A2GD-06	68	0.25050094374986426	24	TCGA-EE-A2GD-06	7	5	7	0.11550617240206346	TCGA-EE-A2GD-06	4	3	2	9	PASS	9031	TCGA-EE-A2GD	SKCM	58	FEMALE	WHITE	Stage IIB	NA	NA	NA	1984	NA	-21526	Dead	WITH TUMOR	NA	10346	NA	Locoregional Recurrence	NA	NA	3689	NA	NA	NA	1	10346	1	10346	NA	NA	1	3689	
40	TCGA-EE-A2GE	3	34	0	16	0	1	0	0	21	561	81	0	15	271	16	3	TCGA-EE-A2GE-06	50	0.4284621274058449	16	TCGA-EE-A2GE-06	21	21	4	0.23279209633537296	TCGA-EE-A2GE-06	2	1	1	4	PASS	9032	TCGA-EE-A2GE	SKCM	44	MALE	WHITE	Stage I	NA	NA	NA	1999	NA	-16353	Alive	TUMOR FREE	5286	NA	NA	NA|NA	NA|NA	NA|NA	5276	NA	NA	NA	0	5286	0	5286	NA	NA	1	5276	
30	TCGA-EE-A2GH	3	51	11	34	3	0	0	0	53	895	87	1	17	433	43	4	TCGA-EE-A2GH-06	115	0.7141554740789983	50	TCGA-EE-A2GH-06	13	13	31	0.5562957489196576	TCGA-EE-A2GH-06	6	8	10	24	PASS	9033	TCGA-EE-A2GH	SKCM	34	MALE	WHITE	Stage I	NA	NA	NA	1996	NA	-12727	Alive	TUMOR FREE	6699	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	6699	0	6699	NA	NA	0	6699	
40	TCGA-EE-A2GI	11	104	10	76	7	4	0	0	54	1408	101	1	31	794	23	2	TCGA-EE-A2GI-06	84	0.5680626530514624	31	TCGA-EE-A2GI-06	20	20	10	0.1482407054022942	TCGA-EE-A2GI-06	7	6	6	19	hypermutated sample	9034	TCGA-EE-A2GI	SKCM	39	MALE	WHITE	Stage IA	NA	NA	NA	2008	NA	-14498	Alive	TUMOR FREE	1482	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1482	0	1482	NA	NA	0	1482	
80	TCGA-EE-A2GJ	4	58	8	32	4	1	0	0	38	872	54	1	20	554	14	0	TCGA-EE-A2GJ-06	153	0.323859433095837	87	TCGA-EE-A2GJ-06	7	15	30	0.3296638797234621	TCGA-EE-A2GJ-06	6	9	6	21	PASS	9035	TCGA-EE-A2GJ	SKCM	83	MALE	WHITE	Stage IA	NA	NA	NA	2004	NA	-30602	Dead	WITH TUMOR	NA	3266	NA	New primary melanoma	NA	NA	733	NA	NA	NA	1	3266	1	3266	NA	NA	1	733	
50	TCGA-EE-A2GK	1	19	2	11	0	1	0	0	16	357	40	0	8	142	7	0	TCGA-EE-A2GK-06	43	0.0006596777174485483	9	TCGA-EE-A2GK-06	0	2	3	0.01173851060529646	TCGA-EE-A2GK-06	1	0	0	1	PASS	9036	TCGA-EE-A2GK	SKCM	46	FEMALE	WHITE	Stage I	NA	NA	NA	2007	NA	-16879	Alive	TUMOR FREE	1665	NA	NA	NA	NA	NA	1498	NA	NA	NA	0	1665	0	1665	NA	NA	1	1498	
40	TCGA-EE-A2GL	1	13	2	16	1	0	0	1	9	272	21	0	8	171	5	1	TCGA-EE-A2GL-06	74	0.24096862812836786	33	TCGA-EE-A2GL-06	8	4	5	0.0904905091301387	TCGA-EE-A2GL-06	1	3	1	5	PASS	9037	TCGA-EE-A2GL	SKCM	40	FEMALE	WHITE	Stage IIA	NA	NA	NA	2006	NA	-14701	Alive	WITH TUMOR	2423	NA	NA	Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis	"Lung|Other, Specify|Bone|Other, Specify|Other, Specify|Other, Specify|Other, Specify|Other, Specify|Other, Specify|Other, Specify"	NA|right anterior chest - skin and soft tissue|NA|LN left neck|left head - skin and soft tissue|spleen|left anterior chest - skin and soft tissue|LN right neck|right head - skin and soft tissue|LN left pelvic	2329	NA	NA	NA	0	2423	0	2423	NA	NA	1	2329	
70	TCGA-EE-A2GM	1	30	1	16	5	1	2	0	26	546	50	0	19	325	14	1	TCGA-EE-A2GM-06	118	0.7092053217875066	54	TCGA-EE-A2GM-06	30	16	10	0.1716786748282418	TCGA-EE-A2GM-06	4	2	0	6	PASS	9038	TCGA-EE-A2GM	SKCM	70	FEMALE	WHITE	Stage IIC	NA	NA	NA	2004	NA	-25711	Alive	TUMOR FREE	2296	NA	NA	Locoregional Recurrence	NA	NA	1218	NA	NA	NA	0	2296	0	2296	NA	NA	1	1218	
70	TCGA-EE-A2GN	8	58	3	31	3	3	0	0	44	1252	166	2	25	517	51	1	TCGA-EE-A2GN-06	163	0.9468406346851762	100	TCGA-EE-A2GN-06	18	19	18	0.1723106012836505	TCGA-EE-A2GN-06	8	6	5	19	PASS	9039	TCGA-EE-A2GN	SKCM	67	MALE	WHITE	Stage IIA	NA	NA	NA	2003	NA	-24683	Dead	WITH TUMOR	NA	3106	NA	Distant Metastasis	"Other, Specify"	adrenal gland	2422	NA	NA	NA	1	3106	1	3106	NA	NA	1	2422	
70	TCGA-EE-A2GO	13	122	14	68	6	2	1	0	77	1698	125	0	52	1045	35	4	TCGA-EE-A2GO-06	64	0.5243718529492585	21	TCGA-EE-A2GO-06	18	22	9	0.17623179419774485	TCGA-EE-A2GO-06	3	2	5	10	hypermutated sample	9040	TCGA-EE-A2GO	SKCM	66	FEMALE	WHITE	Stage II	NA	NA	NA	2002	NA	-24159	Alive	TUMOR FREE	3857	NA	NA	Regional lymph node	NA	NA	2216	NA	NA	NA	0	3857	0	3857	NA	NA	1	2216	
80	TCGA-EE-A2GP	3	32	4	20	2	2	0	0	25	467	30	0	10	274	5	1	TCGA-EE-A2GP-06	104	0.6808769844728352	43	TCGA-EE-A2GP-06	23	20	26	0.2741745277050188	TCGA-EE-A2GP-06	8	2	3	13	PASS	9041	TCGA-EE-A2GP	SKCM	80	MALE	WHITE	Stage IIIB	NA	NA	NA	2009	NA	-29501	Dead	WITH TUMOR	NA	423	NA	Distant Metastasis	Lung	NA	251	NA	NA	NA	1	423	1	423	NA	NA	1	251	
80	TCGA-EE-A2GR	2	101	16	44	15	1	1	0	66	1523	139	4	29	891	31	1	TCGA-EE-A2GR-06	129	0.8385314805456356	50	TCGA-EE-A2GR-06	9	9	15	0.02893715456439135	TCGA-EE-A2GR-06	9	4	1	14	hypermutated sample	9042	TCGA-EE-A2GR	SKCM	78	MALE	WHITE	Stage II	NA	NA	NA	2009	NA	-28510	Dead	WITH TUMOR	NA	1301	NA	NA	NA	NA	NA	NA	NA	NA	1	1301	1	1301	NA	NA	1	1301	
30	TCGA-EE-A2GS	3	14	4	8	0	0	1	0	17	278	12	0	9	134	5	0	TCGA-EE-A2GS-06	168	0.27383359089673354	101	TCGA-EE-A2GS-06	7	7	17	0.15307746876593134	TCGA-EE-A2GS-06	6	5	4	15	PASS	9043	TCGA-EE-A2GS	SKCM	28	FEMALE	WHITE	Stage IB	NA	NA	NA	2006	NA	-10421	Dead	WITH TUMOR	NA	2470	NA	Distant Metastasis	"Other, Specify"	right buttock	1565	NA	NA	NA	1	2470	1	2470	NA	NA	1	1565	
80	TCGA-EE-A2GT	4	91	11	40	2	3	0	0	57	1405	211	0	21	712	45	1	TCGA-EE-A2GT-06	80	0.1631286752422956	30	TCGA-EE-A2GT-06	5	5	12	0.13521973039717586	TCGA-EE-A2GT-06	5	5	3	13	PASS	9044	TCGA-EE-A2GT	SKCM	77	MALE	WHITE	Stage IIA	NA	NA	NA	2009	NA	-28364	Alive	WITH TUMOR	1365	NA	NA	Locoregional Recurrence	NA	NA	281	NA	NA	NA	0	1365	0	1365	NA	NA	1	281	
70	TCGA-EE-A2GU	2	35	3	17	0	2	0	0	17	471	23	0	13	256	7	1	TCGA-EE-A2GU-06	111	0.2892963572639793	50	TCGA-EE-A2GU-06	8	8	18	0.20217898411345764	TCGA-EE-A2GU-06	13	8	8	29	PASS	9045	TCGA-EE-A2GU	SKCM	65	FEMALE	WHITE	Stage IA	NA	NA	NA	2005	NA	-23784	Alive	TUMOR FREE	2884	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2884	0	2884	NA	NA	0	2884	
50	TCGA-EE-A2M5	9	121	13	55	10	0	1	0	87	1743	138	0	38	1002	32	3	TCGA-EE-A2M5-06	107	0.3210846965197748	57	TCGA-EE-A2M5-06	5	7	6	0.0541475197586544	TCGA-EE-A2M5-06	3	2	2	7	hypermutated sample	9046	TCGA-EE-A2M5	SKCM	49	MALE	WHITE	Stage I	NA	NA	NA	1999	NA	-17950	Dead	WITH TUMOR	NA	659	NA	Locoregional Recurrence	NA	NA	537	NA	NA	NA	1	659	1	659	NA	NA	1	537	
60	TCGA-EE-A2M6	4	41	4	19	5	1	1	0	29	522	32	0	9	256	11	0	TCGA-EE-A2M6-06	277	0.7471785515360235	162	TCGA-EE-A2M6-06	24	27	33	0.3119835730206323	TCGA-EE-A2M6-06	9	6	7	22	PASS	9047	TCGA-EE-A2M6	SKCM	61	MALE	WHITE	Stage I	NA	NA	NA	1997	NA	-22564	Alive	TUMOR FREE	3932	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3932	0	3932	NA	NA	0	3932	
70	TCGA-EE-A2M7	2	46	2	19	1	0	0	0	36	505	74	0	8	237	21	2	TCGA-EE-A2M7-06	228	0.5729272265628172	147	TCGA-EE-A2M7-06	25	27	70	0.14155253759595465	TCGA-EE-A2M7-06	4	5	4	13	PASS	9048	TCGA-EE-A2M7	SKCM	66	MALE	WHITE	Stage II	NA	NA	NA	1999	NA	-24371	Dead	WITH TUMOR	NA	877	NA	Distant Metastasis	"Other, Specify"	mediastinal lymph nodes	799	NA	NA	NA	1	877	1	877	NA	NA	1	799	
50	TCGA-EE-A2M8	2	39	3	20	1	0	0	0	37	700	48	1	9	278	17	2	TCGA-EE-A2M8-06	68	0.21294130346305676	25	TCGA-EE-A2M8-06	9	17	12	0.3955990843003304	TCGA-EE-A2M8-06	1	2	0	3	PASS	9049	TCGA-EE-A2M8	SKCM	54	FEMALE	WHITE	Stage III	NA	NA	NA	2000	NA	-19808	Dead	WITH TUMOR	NA	601	NA	Distant Metastasis	Brain	NA	498	NA	NA	NA	1	601	1	601	NA	NA	1	498	
70	TCGA-EE-A2MC	8	28	4	22	2	2	2	0	19	583	44	0	11	331	9	2	TCGA-EE-A2MC-06	78	0.06397148798338842	33	TCGA-EE-A2MC-06	1	2	3	0.03150746555266628	TCGA-EE-A2MC-06	3	3	2	8	PASS	9050	TCGA-EE-A2MC	SKCM	73	MALE	WHITE	Stage I	NA	NA	NA	2000	NA	-26872	Dead	TUMOR FREE	NA	1871	NA	Distant Metastasis	"Other, Specify"	right neck lymph nodes	896	NA	NA	NA	1	1871	0	1871	NA	NA	1	896	
50	TCGA-EE-A2MD	12	138	6	66	4	1	1	0	104	1898	175	1	44	1030	56	3	TCGA-EE-A2MD-06	92	0.2798264294397379	43	TCGA-EE-A2MD-06	8	10	22	0.19326800855082532	TCGA-EE-A2MD-06	10	4	7	21	hypermutated sample	9051	TCGA-EE-A2MD	SKCM	52	MALE	WHITE	Stage II	NA	NA	NA	1998	NA	-19333	Dead	WITH TUMOR	NA	1438	NA	Regional lymph node	NA	NA	1344	NA	NA	NA	1	1438	1	1438	NA	NA	1	1344	
50	TCGA-EE-A2ME	5	25	3	24	1	0	0	0	24	419	68	2	8	207	17	3	TCGA-EE-A2ME-06	147	0.014026759958268218	84	TCGA-EE-A2ME-06	0	0	3	0.0003318825491047564	TCGA-EE-A2ME-06	3	1	0	4	PASS	9052	TCGA-EE-A2ME	SKCM	51	MALE	WHITE	Stage I	NA	NA	NA	1995	NA	-18841	Dead	WITH TUMOR	NA	3141	NA	Distant Metastasis	"Other, Specify"	retroperitoneal nodule	2703	NA	NA	NA	1	3141	1	3141	NA	NA	1	2703	
40	TCGA-EE-A2MF	4	43	4	24	4	2	1	0	25	555	44	0	17	309	9	1	TCGA-EE-A2MF-06	87	0.7046445356122869	36	TCGA-EE-A2MF-06	8	8	26	0.18169420322271668	TCGA-EE-A2MF-06	6	5	6	17	PASS	9053	TCGA-EE-A2MF	SKCM	39	FEMALE	WHITE	Stage I	NA	NA	NA	1979	NA	-14312	Dead	WITH TUMOR	NA	8174	NA	New primary melanoma	NA	NA	8071	NA	NA	NA	1	8174	1	8174	NA	NA	1	8071	
30	TCGA-EE-A2MG	0	51	4	32	0	0	0	0	34	799	101	0	8	353	35	1	TCGA-EE-A2MG-06	81	0.3153652654143176	31	TCGA-EE-A2MG-06	13	10	18	0.28616016380316783	TCGA-EE-A2MG-06	1	1	2	4	PASS	9054	TCGA-EE-A2MG	SKCM	23	MALE	WHITE	Stage I	NA	NA	NA	1997	NA	-8405	Dead	WITH TUMOR	NA	3139	NA	Distant Metastasis	Lung	NA	2585	NA	NA	NA	1	3139	1	3139	NA	NA	1	2585	
70	TCGA-EE-A2MH	0	12	1	7	0	1	1	0	13	172	18	0	7	115	5	0	TCGA-EE-A2MH-06	330	0.25846010291082433	211	TCGA-EE-A2MH-06	7	7	38	0.1683125617870418	TCGA-EE-A2MH-06	6	1	1	8	PASS	9055	TCGA-EE-A2MH	SKCM	66	MALE	WHITE	Stage III	NA	NA	NA	2001	NA	-24125	Dead	WITH TUMOR	NA	516	NA	Distant Metastasis	Bone	NA	440	NA	NA	NA	1	516	1	516	NA	NA	1	440	
40	TCGA-EE-A2MI	8	48	5	23	7	2	1	0	38	830	42	0	24	482	7	1	TCGA-EE-A2MI-06	102	0.14398801415257384	46	TCGA-EE-A2MI-06	3	4	10	0.058134174216012274	TCGA-EE-A2MI-06	4	5	4	13	PASS	9056	TCGA-EE-A2MI	SKCM	43	MALE	WHITE	Stage IIB	NA	NA	NA	1986	NA	-15880	Dead	WITH TUMOR	NA	6225	NA	New primary melanoma	NA	NA	2673	NA	NA	NA	1	6225	1	6225	NA	NA	1	2673	
60	TCGA-EE-A2MJ	7	77	10	34	5	0	1	0	61	1554	119	0	32	888	23	3	TCGA-EE-A2MJ-06	61	0.25314979724842995	18	TCGA-EE-A2MJ-06	10	10	10	0.33270612292856805	TCGA-EE-A2MJ-06	2	1	1	4	hypermutated sample	9057	TCGA-EE-A2MJ	SKCM	60	MALE	WHITE	Stage III	NA	NA	NA	1999	NA	-22050	Dead	TUMOR FREE	NA	2927	NA	Regional lymph node	NA	NA	396	NA	NA	NA	1	2927	0	2927	NA	NA	1	396	
20	TCGA-EE-A2MK	4	30	4	16	2	0	0	0	21	542	50	1	11	271	13	0	TCGA-EE-A2MK-06	119	0.9471928507357016	59	TCGA-EE-A2MK-06	20	29	24	0.4461611194792588	TCGA-EE-A2MK-06	3	0	1	4	PASS	9058	TCGA-EE-A2MK	SKCM	18	FEMALE	WHITE	Stage III	NA	NA	NA	1999	NA	-6831	Alive	TUMOR FREE	5487	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	5487	0	5487	NA	NA	0	5487	
40	TCGA-EE-A2ML	1	34	4	15	2	0	1	0	20	575	55	1	10	304	8	1	TCGA-EE-A2ML-06	135	0.12525523830104768	57	TCGA-EE-A2ML-06	4	9	14	0.08644133608614016	TCGA-EE-A2ML-06	5	4	2	11	PASS	9059	TCGA-EE-A2ML	SKCM	35	MALE	WHITE	Stage II	NA	NA	NA	1994	NA	-13140	Dead	WITH TUMOR	NA	6590	NA	Distant Metastasis	Bone	NA	4983	NA	NA	NA	1	6590	1	6590	NA	NA	1	4983	
60	TCGA-EE-A2MM	6	59	8	41	2	2	0	0	54	1133	124	0	21	582	28	1	TCGA-EE-A2MM-06	160	0.7732656021197734	82	TCGA-EE-A2MM-06	13	14	25	0.14914123204480192	TCGA-EE-A2MM-06	10	5	3	18	PASS	9060	TCGA-EE-A2MM	SKCM	63	FEMALE	WHITE	Stage I	NA	NA	NA	1993	NA	-23132	Dead	WITH TUMOR	NA	5107	NA	New primary melanoma	NA	NA	1357	NA	NA	NA	1	5107	1	5107	NA	NA	1	1357	
60	TCGA-EE-A2MN	1	19	1	8	0	1	1	0	8	250	20	0	5	134	6	0	TCGA-EE-A2MN-06	124	0.32137033888108724	61	TCGA-EE-A2MN-06	9	10	20	0.14578594240914372	TCGA-EE-A2MN-06	11	9	6	26	PASS	9061	TCGA-EE-A2MN	SKCM	58	MALE	WHITE	Stage I	NA	NA	NA	2000	NA	-21202	Dead	WITH TUMOR	NA	1446	NA	Distant Metastasis	Brain	NA	969	NA	NA	NA	1	1446	1	1446	NA	NA	1	969	
30	TCGA-EE-A2MP	1	23	2	16	4	2	2	0	20	347	26	0	11	161	6	2	TCGA-EE-A2MP-06	99	0.7675120403110354	49	TCGA-EE-A2MP-06	23	15	9	0.07985748673917611	TCGA-EE-A2MP-06	12	7	3	22	PASS	9062	TCGA-EE-A2MP	SKCM	34	FEMALE	WHITE	Stage I	NA	NA	NA	1991	NA	-12474	Alive	WITH TUMOR	7563	NA	NA	Locoregional Recurrence	NA	NA	365	NA	NA	NA	0	7563	0	7563	NA	NA	1	365	
70	TCGA-EE-A2MQ	2	41	1	21	2	0	1	0	24	534	58	2	11	262	18	0	TCGA-EE-A2MQ-06	121	0.39344695265008267	65	TCGA-EE-A2MQ-06	14	12	19	0.2322738805600395	TCGA-EE-A2MQ-06	8	5	3	16	PASS	9063	TCGA-EE-A2MQ	SKCM	70	FEMALE	WHITE	Stage IIIA	NA	NA	NA	2006	NA	-25926	Dead	WITH TUMOR	NA	1315	NA	Regional lymph node	NA	NA	986	NA	NA	NA	1	1315	1	1315	NA	NA	1	986	
60	TCGA-EE-A2MR	11	145	16	81	7	0	0	0	101	2684	149	1	53	1811	33	5	TCGA-EE-A2MR-06	54	0.3905928265304384	17	TCGA-EE-A2MR-06	15	17	9	0.21022661263397088	TCGA-EE-A2MR-06	4	4	2	10	hypermutated sample	9064	TCGA-EE-A2MR	SKCM	61	MALE	WHITE	Stage I	NA	NA	NA	2002	NA	-22535	Alive	TUMOR FREE	4088	NA	NA	NA	NA	NA	3136	NA	NA	NA	0	4088	0	4088	NA	NA	1	3136	
70	TCGA-EE-A2MS	21	159	17	85	11	2	0	0	112	2214	163	1	53	1365	36	6	TCGA-EE-A2MS-06	377	0.8587986190148161	232	TCGA-EE-A2MS-06	19	39	51	0.22237091327563896	TCGA-EE-A2MS-06	23	16	12	51	hypermutated sample	9065	TCGA-EE-A2MS	SKCM	72	MALE	WHITE	Stage II	NA	NA	NA	1999	NA	-26466	Alive	TUMOR FREE	4942	NA	NA	New primary melanoma	NA	NA	1883	NA	NA	NA	0	4942	0	4942	NA	NA	1	1883	
50	TCGA-EE-A2MT	4	47	10	24	10	2	0	1	34	706	46	0	17	381	16	1	TCGA-EE-A2MT-06	113	0.13045720772681602	58	TCGA-EE-A2MT-06	2	6	8	0.08008273658894903	TCGA-EE-A2MT-06	8	5	3	16	PASS	9066	TCGA-EE-A2MT	SKCM	45	MALE	WHITE	Stage IB	NA	NA	NA	2007	NA	-16768	Alive	TUMOR FREE	2166	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2166	0	2166	NA	NA	0	2166	
70	TCGA-EE-A2MU	2	39	1	13	0	2	0	0	15	512	43	0	7	290	9	4	TCGA-EE-A2MU-06	83	0.6330489877384304	33	TCGA-EE-A2MU-06	23	31	11	0.2275059209832857	TCGA-EE-A2MU-06	5	4	2	11	PASS	9067	TCGA-EE-A2MU	SKCM	71	MALE	WHITE	Stage IA	NA	NA	NA	2005	NA	-26237	Alive	TUMOR FREE	1620	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1620	0	1620	NA	NA	0	1620	
50	TCGA-EE-A3AA	10	133	11	59	8	2	0	0	96	2425	201	4	37	1274	58	3	TCGA-EE-A3AA-06	66	0.2842853076300317	19	TCGA-EE-A3AA-06	11	10	13	0.30774971920947	TCGA-EE-A3AA-06	3	1	3	7	PASS	9068	TCGA-EE-A3AA	SKCM	47	MALE	WHITE	Stage III	NA	NA	NA	2001	NA	-17196	Alive	TUMOR FREE	3781	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3781	0	3781	NA	NA	0	3781	
30	TCGA-EE-A3AB	1	41	6	12	0	1	0	0	22	599	28	0	10	285	22	2	TCGA-EE-A3AB-06	108	0.7417179669389381	59	TCGA-EE-A3AB-06	17	18	33	0.2947726964722065	TCGA-EE-A3AB-06	10	8	9	27	PASS	9069	TCGA-EE-A3AB	SKCM	30	MALE	WHITE	Stage III	NA	NA	NA	2001	NA	-11054	Alive	TUMOR FREE	3733	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3733	0	3733	NA	NA	0	3733	
50	TCGA-EE-A3AC	8	122	9	57	4	1	2	0	67	1610	170	2	41	815	44	1	TCGA-EE-A3AC-06	120	0.12520877521893176	64	TCGA-EE-A3AC-06	5	6	15	0.06365573449979015	TCGA-EE-A3AC-06	6	0	3	9	PASS	9070	TCGA-EE-A3AC	SKCM	47	MALE	WHITE	Stage III	NA	NA	NA	2009	NA	-17319	Alive	TUMOR FREE	1948	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1948	0	1948	NA	NA	0	1948	
50	TCGA-EE-A3AD	8	76	10	40	4	0	1	0	49	1363	144	0	27	660	59	3	TCGA-EE-A3AD-06	162	0.9200279393762476	81	TCGA-EE-A3AD-06	17	22	17	0.22111829667516286	TCGA-EE-A3AD-06	14	6	7	27	PASS	9071	TCGA-EE-A3AD	SKCM	50	MALE	WHITE	Stage III	NA	NA	NA	2009	NA	-18491	Dead	WITH TUMOR	NA	875	NA	Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis	"Other, Specify|Lung|Other, Specify|Other, Specify|Brain|Liver"	spinal cord|NA|right anterior abdomen - skin and soft tissue|right anterior chest - skin and soft tissue|NA|NA	554	NA	NA	NA	1	875	1	875	NA	NA	1	554	
50	TCGA-EE-A3AE	4	85	10	51	1	1	0	1	46	1129	72	0	30	679	10	1	TCGA-EE-A3AE-06	155	0.7224852975449454	91	TCGA-EE-A3AE-06	21	63	22	0.2487785737475878	TCGA-EE-A3AE-06	6	2	5	13	PASS	9072	TCGA-EE-A3AE	SKCM	52	FEMALE	WHITE	Stage IA	NA	NA	NA	2009	NA	-19216	Alive	TUMOR FREE	1658	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1658	0	1658	NA	NA	0	1658	
50	TCGA-EE-A3AF	2	56	7	25	8	0	1	0	37	796	47	0	9	392	13	1	TCGA-EE-A3AF-06	81	0.34433861390557263	35	TCGA-EE-A3AF-06	10	7	11	0.20225769894252504	TCGA-EE-A3AF-06	6	2	5	13	PASS	9073	TCGA-EE-A3AF	SKCM	48	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2009	NA	-17731	Dead	WITH TUMOR	NA	420	NA	Locoregional Recurrence	NA	NA	201	NA	NA	NA	1	420	1	420	NA	NA	1	201	
30	TCGA-EE-A3AG	7	118	15	65	5	1	4	0	88	1733	140	0	39	1001	28	5	TCGA-EE-A3AG-06	168	0.7033978466485744	93	TCGA-EE-A3AG-06	13	31	29	0.21302349681324734	TCGA-EE-A3AG-06	17	16	6	39	hypermutated sample	9074	TCGA-EE-A3AG	SKCM	25	MALE	WHITE	Stage III	NA	NA	NA	2009	NA	-9161	Dead	WITH TUMOR	NA	1265	NA	Regional lymph node	NA	NA	229	NA	NA	NA	1	1265	1	1265	NA	NA	1	229	
30	TCGA-EE-A3AH	2	11	3	18	5	1	6	0	27	459	33	0	9	224	8	2	TCGA-EE-A3AH-06	168	0.9265749139446806	107	TCGA-EE-A3AH-06	12	11	27	0.2768065428408936	TCGA-EE-A3AH-06	7	3	4	14	PASS	9075	TCGA-EE-A3AH	SKCM	30	MALE	WHITE	Stage II	NA	NA	NA	1998	NA	-10988	Dead	WITH TUMOR	NA	4222	NA	Locoregional Recurrence	NA	NA	1981	NA	NA	NA	1	4222	1	4222	NA	NA	1	1981	
40	TCGA-EE-A3J3	0	5	1	4	0	1	0	0	3	115	13	0	6	80	1	0	TCGA-EE-A3J3-06	151	0.838928342269076	86	TCGA-EE-A3J3-06	19	25	51	0.3123734883494395	TCGA-EE-A3J3-06	7	6	7	20	PASS	9076	TCGA-EE-A3J3	SKCM	42	MALE	WHITE	Stage IB	NA	NA	NA	1986	NA	-15446	Dead	WITH TUMOR	NA	5237	NA	Regional lymph node	NA	NA	4523	NA	NA	NA	1	5237	1	5237	NA	NA	1	4523	
70	TCGA-EE-A3J4	1	19	1	9	1	2	0	0	11	248	13	0	8	109	4	0	TCGA-EE-A3J4-06	157	0.21635550687977556	95	TCGA-EE-A3J4-06	5	5	30	0.08076943182319454	TCGA-EE-A3J4-06	3	4	2	9	PASS	9077	TCGA-EE-A3J4	SKCM	72	MALE	WHITE	Stage II	NA	NA	NA	1991	NA	-26540	Dead	WITH TUMOR	NA	3869	NA	Locoregional Recurrence	NA	NA	1429	NA	NA	NA	1	3869	1	3869	NA	NA	1	1429	
70	TCGA-EE-A3J5	8	106	14	64	17	1	2	0	74	1612	106	2	50	877	33	5	TCGA-EE-A3J5-06	70	0.5166346882320222	21	TCGA-EE-A3J5-06	10	8	17	0.22093289145826164	TCGA-EE-A3J5-06	2	3	4	9	hypermutated sample	9078	TCGA-EE-A3J5	SKCM	71	MALE	WHITE	Stage III	NA	NA	NA	2000	NA	-26226	Dead	WITH TUMOR	NA	1124	NA	Locoregional Recurrence	NA	NA	467	NA	NA	NA	1	1124	1	1124	NA	NA	1	467	
40	TCGA-EE-A3J7	2	49	3	25	10	2	2	0	33	714	52	0	15	452	16	2	TCGA-EE-A3J7-06	127	0.903758104318307	60	TCGA-EE-A3J7-06	28	27	31	0.3858856352513313	TCGA-EE-A3J7-06	5	3	5	13	PASS	9079	TCGA-EE-A3J7	SKCM	43	MALE	WHITE	Stage I	NA	NA	NA	1998	NA	-15896	Alive	TUMOR FREE	1949	NA	NA	Regional lymph node	NA	NA	1270	NA	NA	NA	0	1949	0	1949	NA	NA	1	1270	
60	TCGA-EE-A3J8	1	11	3	9	0	0	0	0	8	199	14	0	7	116	5	0	TCGA-EE-A3J8-06	112	0.9475833190248214	55	TCGA-EE-A3J8-06	6	5	24	0.14241325288151438	TCGA-EE-A3J8-06	3	2	4	9	PASS	9080	TCGA-EE-A3J8	SKCM	59	MALE	WHITE	Stage IIIA	NA	NA	NA	2006	NA	-21688	Dead	TUMOR FREE	NA	1044	NA	NA	NA	NA	1035	NA	NA	NA	1	1044	0	1044	NA	NA	1	1035	
40	TCGA-EE-A3JA	11	64	7	25	3	1	1	0	39	760	36	0	18	469	12	2	TCGA-EE-A3JA-06	254	0.93848526025882	160	TCGA-EE-A3JA-06	22	38	39	0.06630817149423618	TCGA-EE-A3JA-06	5	7	3	15	PASS	9081	TCGA-EE-A3JA	SKCM	44	MALE	WHITE	Stage IB	NA	NA	NA	2006	NA	-16430	Dead	WITH TUMOR	NA	1618	NA	Regional lymph node	NA	NA	539	NA	NA	NA	1	1618	1	1618	NA	NA	1	539	
60	TCGA-EE-A3JB	6	30	6	22	3	1	0	0	22	466	29	1	13	259	12	1	TCGA-EE-A3JB-06	169	0.6123510225680088	101	TCGA-EE-A3JB-06	21	24	56	0.3208811618356308	TCGA-EE-A3JB-06	4	5	2	11	PASS	9082	TCGA-EE-A3JB	SKCM	60	FEMALE	WHITE	Stage III	NA	NA	NA	1992	NA	-22150	Alive	WITH TUMOR	6138	NA	NA	Locoregional Recurrence	NA	NA	1434	NA	NA	NA	0	6138	0	6138	NA	NA	1	1434	
70	TCGA-EE-A3JD	8	67	8	41	3	0	0	0	52	1752	121	1	33	1001	25	5	TCGA-EE-A3JD-06	69	0.045754835979206585	30	TCGA-EE-A3JD-06	4	5	2	0.05126012584862121	TCGA-EE-A3JD-06	1	1	0	2	hypermutated sample	9083	TCGA-EE-A3JD	SKCM	70	MALE	WHITE	Stage III	NA	NA	NA	2009	NA	-25930	Dead	WITH TUMOR	NA	832	NA	Distant Metastasis	Lung	NA	364	NA	NA	NA	1	832	1	832	NA	NA	1	364	
80	TCGA-EE-A3JE	4	11	1	7	1	1	0	0	14	219	11	0	0	102	6	0	TCGA-EE-A3JE-06	52	0.2728763674974241	16	TCGA-EE-A3JE-06	5	6	9	0.1785461633262649	TCGA-EE-A3JE-06	2	2	1	5	PASS	9084	TCGA-EE-A3JE	SKCM	75	MALE	WHITE	Stage IIIB	NA	NA	NA	2009	NA	-27463	Alive	TUMOR FREE	1562	NA	NA	Regional lymph node	NA	NA	194	NA	NA	NA	0	1562	0	1562	NA	NA	1	194	
50	TCGA-EE-A3JH	0	6	0	5	0	1	0	0	3	134	6	0	2	90	1	1	TCGA-EE-A3JH-06	66	0.3903475190077075	22	TCGA-EE-A3JH-06	26	26	11	0.21486440417519545	TCGA-EE-A3JH-06	5	3	3	11	PASS	9085	TCGA-EE-A3JH	SKCM	54	MALE	WHITE	Stage IB	NA	NA	NA	2003	NA	-19852	Alive	TUMOR FREE	4086	NA	NA	Regional lymph node	NA	NA	537	NA	NA	NA	0	4086	0	4086	NA	NA	1	537	
50	TCGA-EE-A3JI	5	65	13	35	70	2	5	0	56	823	65	1	29	452	12	0	TCGA-EE-A3JI-06	149	0.6612361755486336	80	TCGA-EE-A3JI-06	21	17	14	0.13651135122142058	TCGA-EE-A3JI-06	6	10	4	20	PASS	9086	TCGA-EE-A3JI	SKCM	48	MALE	WHITE	Stage I	NA	NA	NA	1999	NA	-17835	Dead	WITH TUMOR	NA	4648	NA	New primary melanoma	NA	NA	725	NA	NA	NA	1	4648	1	4648	NA	NA	1	725	
60	TCGA-ER-A193	11	91	4	44	8	3	2	0	60	1540	96	2	33	794	29	0	TCGA-ER-A193-06	183	0.8543885418243081	106	TCGA-ER-A193-06	8	10	39	0.2871145910333284	TCGA-ER-A193-06	8	4	8	20	hypermutated sample	9087	TCGA-ER-A193	SKCM	62	MALE	WHITE	Stage IIB	NA	NA	NA	2006	NA	-22702	Dead	WITH TUMOR	NA	955	NA	Distant Metastasis	Brain	NA	806	NA	NA	NA	1	955	1	955	NA	NA	1	806	
80	TCGA-ER-A194	7	73	8	41	5	0	0	0	37	1036	61	0	33	561	14	1	TCGA-ER-A194	0	0	0	TCGA-ER-A194-01	3	9	25	0.15032264689286862	TCGA-ER-A194-01	7	7	8	22	PASS	9088	TCGA-ER-A194	SKCM	77	MALE	WHITE	NA	NA	NA	NA	2005	NA	-28175	Dead	WITH TUMOR	NA	1354	NA	NA	NA	NA	NA	NA	NA	NA	1	1354	1	1354	NA	NA	1	1354	
50	TCGA-ER-A195	3	35	2	15	3	0	0	0	28	561	54	2	6	267	9	1	TCGA-ER-A195-06	164	0.17334251817846152	104	TCGA-ER-A195-06	4	5	40	0.16967429590195446	TCGA-ER-A195-06	5	6	9	20	PASS	9089	TCGA-ER-A195	SKCM	46	MALE	WHITE	NA	NA	NA	NA	2005	NA	-16948	Dead	WITH TUMOR	NA	1078	NA	NA	NA	NA	NA	NA	NA	NA	1	1078	1	1078	NA	NA	1	1078	
60	TCGA-ER-A196	2	15	1	5	3	0	0	0	7	211	22	0	4	111	11	0	TCGA-ER-A196	0	0	0	TCGA-ER-A196-01	1	9	18	0.058838319154433015	TCGA-ER-A196-01	4	4	1	9	PASS	9090	TCGA-ER-A196	SKCM	64	FEMALE	WHITE	Stage IIC	NA	NA	NA	2007	NA	-23533	Alive	TUMOR FREE	1785	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1785	0	1785	NA	NA	0	1785	
80	TCGA-ER-A197	0	0	0	1	0	0	0	0	1	42	1	0	0	10	1	1	TCGA-ER-A197-06	725	0.6055778389938955	510	TCGA-ER-A197-06	26	30	63	0.09432465754950002	TCGA-ER-A197-06	10	11	4	25	PASS	9091	TCGA-ER-A197	SKCM	83	FEMALE	WHITE	Stage IIIB	NA	NA	NA	2006	NA	-30454	Dead	WITH TUMOR	NA	424	NA	Distant Metastasis	Lung	NA	110	NA	NA	NA	1	424	1	424	NA	NA	1	110	
50	TCGA-ER-A198	4	23	1	13	1	0	0	0	16	383	23	0	8	200	7	2	TCGA-ER-A198-06	197	0.09629938647787877	134	TCGA-ER-A198-06	1	1	38	0.05160680592978555	TCGA-ER-A198-06	2	9	3	14	PASS	9092	TCGA-ER-A198	SKCM	45	MALE	WHITE	NA	NA	NA	NA	2003	NA	-16540	Dead	WITH TUMOR	NA	1544	NA	NA	NA	NA	0	NA	NA	NA	1	1544	1	1544	NA	NA	1	0	
90	TCGA-ER-A199	2	10	0	5	1	1	1	0	5	229	9	0	8	104	5	0	TCGA-ER-A199-06	86	0.6594178312946608	31	TCGA-ER-A199-06	26	15	24	0.4797085426165018	TCGA-ER-A199-06	4	4	6	14	PASS	9093	TCGA-ER-A199	SKCM	86	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2007	NA	-31661	Dead	WITH TUMOR	NA	279	NA	NA	NA	NA	119	NA	NA	NA	1	279	1	279	NA	NA	1	119	
80	TCGA-ER-A19A	2	2	1	2	0	0	0	0	6	148	5	0	1	86	0	0	TCGA-ER-A19A-06	55	6.0479565390417117e-05	19	TCGA-ER-A19A	0	0	0	0	TCGA-ER-A19A	0	0	0	0	PASS	9094	TCGA-ER-A19A	SKCM	79	MALE	WHITE	Stage IV	NA	NA	NA	2006	NA	-29167	Alive	TUMOR FREE	2365	NA	NA	NA	NA	NA	1617	NA	NA	NA	0	2365	0	2365	NA	NA	1	1617	
40	TCGA-ER-A19B	7	61	10	35	2	0	0	0	66	1250	176	3	21	598	58	3	TCGA-ER-A19B-06	157	0.5714362094548365	79	TCGA-ER-A19B-06	21	25	26	0.26464875892185724	TCGA-ER-A19B-06	10	4	5	19	PASS	9095	TCGA-ER-A19B	SKCM	42	MALE	WHITE	NA	NA	NA	NA	2000	NA	-15437	Dead	WITH TUMOR	NA	2993	NA	Regional lymph node	NA	NA	829	NA	NA	NA	1	2993	1	2993	NA	NA	1	829	
80	TCGA-ER-A19C	6	30	4	18	0	0	0	0	31	497	64	0	18	274	19	0	TCGA-ER-A19C-06	181	0.6933334668813822	111	TCGA-ER-A19C-06	16	17	32	0.3655808091207586	TCGA-ER-A19C-06	9	4	3	16	PASS	9096	TCGA-ER-A19C	SKCM	77	MALE	WHITE	Stage I	NA	NA	NA	1998	NA	-28383	Dead	WITH TUMOR	NA	1487	NA	NA	NA	NA	NA	NA	NA	NA	1	1487	1	1487	NA	NA	1	1487	
50	TCGA-ER-A19D	6	28	4	8	3	0	0	0	17	351	24	0	8	217	10	0	TCGA-ER-A19D-06	102	0.5277807153579848	45	TCGA-ER-A19D-06	13	23	11	0.16670217474997004	TCGA-ER-A19D-06	1	3	2	6	PASS	9097	TCGA-ER-A19D	SKCM	46	FEMALE	WHITE	Stage IB	NA	NA	NA	2004	NA	-16968	Dead	WITH TUMOR	NA	383	NA	Distant Metastasis	Lung	NA	357	NA	NA	NA	1	383	1	383	NA	NA	1	357	
40	TCGA-ER-A19E	2	25	3	19	4	1	1	0	23	477	40	0	11	236	6	1	TCGA-ER-A19E-06	272	0.7430768346751268	159	TCGA-ER-A19E-06	20	31	64	0.4071693400035925	TCGA-ER-A19E-06	15	14	12	41	PASS	9098	TCGA-ER-A19E	SKCM	36	FEMALE	WHITE	Stage IB	NA	NA	NA	2008	NA	-13297	Dead	WITH TUMOR	NA	396	NA	Regional lymph node	"Other, Specify"	Cervical lymphnode	64	NA	NA	NA	1	396	1	396	NA	NA	1	64	
80	TCGA-ER-A19F	7	80	10	47	4	1	2	0	56	1456	138	1	34	705	41	3	TCGA-ER-A19F-06	100	0.21962542718376826	41	TCGA-ER-A19F-06	5	5	16	0.16008706060866634	TCGA-ER-A19F-06	5	6	2	13	PASS	9099	TCGA-ER-A19F	SKCM	82	MALE	WHITE	NA	NA	NA	NA	2003	NA	-30176	Dead	TUMOR FREE	NA	802	NA	NA	NA	NA	NA	NA	NA	NA	1	802	0	802	NA	NA	0	802	
50	TCGA-ER-A19G	6	53	2	27	8	2	1	0	45	799	97	2	10	426	21	1	TCGA-ER-A19G-06	258	0.8912073246468921	167	TCGA-ER-A19G-06	24	27	47	0.206254236113916	TCGA-ER-A19G-06	4	11	4	19	PASS	9100	TCGA-ER-A19G	SKCM	48	FEMALE	WHITE	NA	NA	NA	NA	1987	NA	-17820	Alive	TUMOR FREE	9188	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	9188	0	9188	NA	NA	0	9188	
40	TCGA-ER-A19H	7	57	6	37	2	0	0	0	44	811	106	3	20	386	22	1	TCGA-ER-A19H-06	222	0.5539194633923838	132	TCGA-ER-A19H-06	17	25	48	0.3838933463682864	TCGA-ER-A19H-06	13	11	6	30	PASS	9101	TCGA-ER-A19H	SKCM	40	MALE	WHITE	NA	NA	NA	NA	1995	NA	-14935	Dead	TUMOR FREE	NA	4634	NA	NA	NA	NA	NA	NA	NA	NA	1	4634	0	4634	NA	NA	0	4634	
50	TCGA-ER-A19J	0	13	0	4	0	3	2	0	7	161	10	0	8	89	6	0	TCGA-ER-A19J-06	114	0.22487487409122872	56	TCGA-ER-A19J-06	8	15	19	0.2550464857827595	TCGA-ER-A19J-06	5	9	3	17	PASS	9102	TCGA-ER-A19J	SKCM	54	MALE	WHITE	Stage IV	NA	NA	NA	2004	NA	-19733	Dead	WITH TUMOR	196	196	NA	Distant Metastasis	Lung	NA	98	NA	NA	NA	1	196	1	196	NA	NA	1	98	
80	TCGA-ER-A19K	2	21	1	13	3	0	0	0	10	354	21	0	4	170	6	0	TCGA-ER-A19K	0	0	0	TCGA-ER-A19K-01	5	5	8	0.02439978229590993	TCGA-ER-A19K-01	5	6	2	13	PASS	9103	TCGA-ER-A19K	SKCM	79	FEMALE	WHITE	Stage IIC	NA	NA	NA	2006	NA	-28916	Dead	WITH TUMOR	NA	469	NA	Regional lymph node	"Other, Specify"	Neck- cervical lymphnode	211	NA	NA	NA	1	469	1	469	NA	NA	1	211	
40	TCGA-ER-A19L	0	2	0	1	0	0	0	0	2	51	4	0	0	29	4	1	TCGA-ER-A19L-06	289	0.8543425521642463	187	TCGA-ER-A19L-06	12	13	64	0.24025426273120976	TCGA-ER-A19L-06	9	8	13	30	PASS	9104	TCGA-ER-A19L	SKCM	35	MALE	WHITE	NA	NA	NA	NA	1994	NA	-13061	Dead	WITH TUMOR	NA	4000	NA	Distant Metastasis	Lung	NA	3689	NA	NA	NA	1	4000	1	4000	NA	NA	1	3689	
40	TCGA-ER-A19M	2	35	3	11	2	0	1	0	21	353	26	0	5	223	4	0	TCGA-ER-A19M-06	167	0.9470094117560957	96	TCGA-ER-A19M-06	17	36	114	0.2951625229306835	TCGA-ER-A19M-06	11	12	7	30	PASS	9105	TCGA-ER-A19M	SKCM	36	MALE	WHITE	Stage IB	NA	NA	NA	2006	NA	-13300	Dead	WITH TUMOR	NA	1857	NA	Locoregional Recurrence	"Other, Specify"	lt.Brachial plexus	1152	NA	NA	NA	1	1857	1	1857	NA	NA	1	1152	
50	TCGA-ER-A19N	9	63	2	37	1	0	0	0	47	974	119	2	21	513	31	2	TCGA-ER-A19N-06	92	0.37127385252481976	41	TCGA-ER-A19N-06	12	16	19	0.19511645663626068	TCGA-ER-A19N-06	8	5	5	18	PASS	9106	TCGA-ER-A19N	SKCM	47	MALE	WHITE	NA	NA	NA	NA	2008	NA	-17443	Dead	TUMOR FREE	NA	1341	NA	NA	NA	NA	0	NA	NA	NA	1	1341	0	1341	NA	NA	1	0	
60	TCGA-ER-A19O	1	16	2	11	0	1	1	0	10	193	15	0	5	90	3	0	TCGA-ER-A19O-06	76	0.17227416205777468	24	TCGA-ER-A19O-06	5	5	5	0.06752606396656621	TCGA-ER-A19O-06	9	6	3	18	PASS	9107	TCGA-ER-A19O	SKCM	56	MALE	WHITE	Stage IIIB	NA	NA	NA	2006	NA	-20740	Dead	WITH TUMOR	NA	NA	NA	Distant Metastasis	"Other, Specify"	Rt. chest wall	308	NA	NA	NA	1	NA	1	NA	NA	NA	1	308	
50	TCGA-ER-A19P	8	230	14	120	28	3	2	4	160	2245	430	4	51	967	120	15	TCGA-ER-A19P-06	28	0.3630466296409456	1	TCGA-ER-A19P-06	8	7	5	0.2364926112000382	TCGA-ER-A19P-06	2	1	1	4	PASS	9108	TCGA-ER-A19P	SKCM	47	FEMALE	WHITE	NA	NA	NA	NA	1996	NA	-17511	Dead	WITH TUMOR	NA	4930	NA	Distant Metastasis	Brain	NA	4352	NA	NA	NA	1	4930	1	4930	NA	NA	1	4352	
40	TCGA-ER-A19Q	0	21	1	9	0	0	0	0	21	413	52	2	6	183	11	0	TCGA-ER-A19Q-06	150	0.29988139631013544	81	TCGA-ER-A19Q-06	7	14	31	0.22081099243472896	TCGA-ER-A19Q-06	16	12	8	36	PASS	9109	TCGA-ER-A19Q	SKCM	37	FEMALE	WHITE	NA	NA	NA	NA	2001	NA	-13648	Dead	WITH TUMOR	NA	1548	NA	Distant Metastasis	Bone	NA	1259	NA	NA	NA	1	1548	1	1548	NA	NA	1	1259	
80	TCGA-ER-A19S	1	9	0	6	0	1	0	0	4	177	13	0	2	89	4	0	TCGA-ER-A19S-06	99	0.4326646311913776	51	TCGA-ER-A19S-06	11	17	30	0.420987737866873	TCGA-ER-A19S-06	10	9	8	27	PASS	9110	TCGA-ER-A19S	SKCM	81	FEMALE	WHITE	NA	NA	NA	NA	2008	NA	-29603	Alive	TUMOR FREE	1505	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1505	0	1505	NA	NA	0	1505	
50	TCGA-ER-A19T	1	46	5	19	2	1	0	0	24	548	60	0	14	212	19	1	TCGA-ER-A19T-06	459	0.7313933294317544	340	TCGA-ER-A19T-06	17	23	72	0.3627894308669286	TCGA-ER-A19T-06	19	20	15	54	mutation call filter	9111	TCGA-ER-A19T	SKCM	51	MALE	WHITE	Stage IV	NA	NA	NA	2006	NA	-18732	Dead	WITH TUMOR	NA	270	NA	Distant Metastasis	Brain	NA	118	NA	NA	NA	1	270	1	270	NA	NA	1	118	
50	TCGA-ER-A19W	1	23	2	7	1	1	1	0	13	246	21	0	5	168	4	1	TCGA-ER-A19W-06	163	0.3203264685551523	87	TCGA-ER-A19W-06	10	12	116	0.3123187826630783	TCGA-ER-A19W-06	11	12	12	35	PASS	9112	TCGA-ER-A19W	SKCM	48	FEMALE	WHITE	NA	NA	NA	NA	1994	NA	-17830	Dead	WITH TUMOR	NA	4507	NA	Distant Metastasis	Brain	NA	4126	NA	NA	NA	1	4507	1	4507	NA	NA	1	4126	
60	TCGA-ER-A1A1	0	30	1	24	0	0	0	0	23	613	61	0	13	265	18	0	TCGA-ER-A1A1-06	78	0.0008435491650452106	25	TCGA-ER-A1A1-06	0	0	2	0.0003201627796462853	TCGA-ER-A1A1-06	0	0	0	0	PASS	9113	TCGA-ER-A1A1	SKCM	58	MALE	WHITE	Stage IIIC	NA	NA	NA	2005	NA	-21209	Alive	TUMOR FREE	3196	NA	NA	NA	NA	NA	1971	NA	NA	NA	0	3196	0	3196	NA	NA	1	1971	
60	TCGA-ER-A2NB	0	4	1	1	2	1	0	0	5	59	3	0	0	19	1	1	TCGA-ER-A2NB	0	0	0	TCGA-ER-A2NB-01	19	55	23	0.10903709730613652	TCGA-ER-A2NB-01	8	6	4	18	PASS	9114	TCGA-ER-A2NB	SKCM	57	MALE	WHITE	Stage IIIB	NA	NA	NA	2010	NA	-20938	Dead	WITH TUMOR	NA	857	NA	NA	NA	NA	461	NA	NA	NA	1	857	1	857	NA	NA	1	461	
50	TCGA-ER-A2NC	4	18	6	12	1	0	0	0	23	309	23	0	8	182	4	1	TCGA-ER-A2NC-06	129	0.35006667609141656	64	TCGA-ER-A2NC-06	11	16	29	0.2014914415203238	TCGA-ER-A2NC-06	3	4	5	12	PASS	9115	TCGA-ER-A2NC	SKCM	50	MALE	WHITE	Stage IB	NA	NA	NA	2006	NA	-18582	Dead	WITH TUMOR	NA	1333	NA	Distant Metastasis	Bone	NA	1157	NA	NA	NA	1	1333	1	1333	NA	NA	1	1157	
60	TCGA-ER-A2ND	1	11	1	3	0	0	1	0	4	92	6	0	1	36	2	0	TCGA-ER-A2ND-06	195	0.8659127760609305	120	TCGA-ER-A2ND-06	20	25	42	0.3661398165652958	TCGA-ER-A2ND-06	14	8	17	39	PASS	9116	TCGA-ER-A2ND	SKCM	57	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2004	NA	-20867	Dead	WITH TUMOR	NA	710	NA	NA	NA	NA	NA	NA	NA	NA	1	710	1	710	NA	NA	1	710	
40	TCGA-ER-A2NE	1	6	1	6	3	1	0	0	7	138	5	0	5	63	1	0	TCGA-ER-A2NE-06	274	0.9469374777453228	170	TCGA-ER-A2NE-06	9	8	55	0.2902453121134921	TCGA-ER-A2NE-06	9	8	10	27	PASS	9117	TCGA-ER-A2NE	SKCM	39	MALE	WHITE	Stage 0	NA	NA	NA	2007	NA	-14259	Dead	WITH TUMOR	NA	613	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	
50	TCGA-ER-A2NF	3	11	3	13	0	0	0	0	24	288	19	0	7	134	6	1	TCGA-ER-A2NF-06	122	0.3195909948638405	62	TCGA-ER-A2NF-06	8	9	10	0.061162462331551135	TCGA-ER-A2NF-06	9	3	3	15	mutation call filter	9118	TCGA-ER-A2NF	SKCM	53	MALE	WHITE	Stage IIIB	NA	NA	NA	2010	NA	-19499	Dead	WITH TUMOR	NA	877	NA	NA	NA	NA	230	NA	NA	NA	1	877	1	877	NA	NA	1	230	
40	TCGA-ER-A2NG	1	14	1	8	2	0	0	0	7	208	10	0	6	104	2	1	TCGA-ER-A2NG-06	178	0.6259170187145298	93	TCGA-ER-A2NG-06	11	18	34	0.3448187697992388	TCGA-ER-A2NG-06	11	6	11	28	PASS	9119	TCGA-ER-A2NG	SKCM	43	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2009	NA	-15903	Dead	WITH TUMOR	NA	1490	NA	Distant Metastasis	"Other, Specify"	Right Deltoid	766	NA	NA	NA	1	1490	1	1490	NA	NA	1	766	
50	TCGA-ER-A2NH	3	40	2	16	2	0	0	0	35	749	94	0	7	358	25	0	TCGA-ER-A2NH-06	130	0.326654765869165	79	TCGA-ER-A2NH-06	9	7	32	0.2679511993330167	TCGA-ER-A2NH-06	6	4	7	17	PASS	9120	TCGA-ER-A2NH	SKCM	49	MALE	WHITE	Stage IIIC	NA	NA	NA	2009	NA	-18220	Alive	WITH TUMOR	1264	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1264	0	1264	NA	NA	0	1264	
30	TCGA-ER-A3ES	0	0	0	0	1	0	0	0	2	18	1	0	1	7	0	0	TCGA-ER-A3ES-06	160	0.12186890449022746	77	TCGA-ER-A3ES-06	1	3	25	0.04340333766913335	TCGA-ER-A3ES-06	8	8	5	21	PASS	9121	TCGA-ER-A3ES	SKCM	25	MALE	WHITE	NA	NA	NA	NA	1987	NA	-9366	Dead	WITH TUMOR	NA	7514	NA	NA	NA	NA	NA	NA	NA	NA	1	7514	1	7514	NA	NA	1	7514	
60	TCGA-ER-A3ET	0	3	1	2	2	0	1	0	3	77	4	0	2	24	3	0	TCGA-ER-A3ET-06	735	0.7214289160549935	525	TCGA-ER-A3ET-06	11	42	224	0.4844109270144972	TCGA-ER-A3ET-06	25	27	14	66	PASS	9122	TCGA-ER-A3ET	SKCM	64	FEMALE	WHITE	Stage IIIA	NA	NA	NA	2005	NA	-23650	Dead	WITH TUMOR	NA	2829	NA	Distant Metastasis	Lung	NA	2435	NA	NA	NA	1	2829	1	2829	NA	NA	1	2435	
60	TCGA-ER-A3EV	0	2	0	5	1	1	1	0	0	72	2	0	0	19	1	0	TCGA-ER-A3EV-06	604	0.5287707300013894	428	TCGA-ER-A3EV-06	9	17	115	0.1159828022355434	TCGA-ER-A3EV-06	13	12	7	32	PASS	9123	TCGA-ER-A3EV	SKCM	55	MALE	WHITE	Stage III	NA	NA	NA	2001	NA	-20354	Dead	WITH TUMOR	1429	1429	NA	NA	NA	NA	728	NA	NA	NA	1	1429	1	1429	NA	NA	1	728	
30	TCGA-ER-A3PL	5	20	4	12	1	0	1	0	16	264	18	0	7	173	6	0	TCGA-ER-A3PL-06	129	0.8709211553204002	64	TCGA-ER-A3PL-06	30	57	30	0.09022987972211594	TCGA-ER-A3PL-06	12	7	5	24	PASS	9124	TCGA-ER-A3PL	SKCM	30	MALE	WHITE	Stage IV	NA	NA	NA	2009	NA	-11032	Alive	WITH TUMOR	1010	NA	NA	NA	NA	NA	945	NA	NA	NA	0	1010	0	1010	NA	NA	1	945	
80	TCGA-ER-A42H	0	11	0	0	5	0	0	0	1	45	3	0	2	19	0	1	TCGA-ER-A42H	0	0	0	TCGA-ER-A42H-01	20	21	73	0.2005649703461093	TCGA-ER-A42H-01	13	15	5	33	PASS	9125	TCGA-ER-A42H	SKCM	76	MALE	WHITE	NA	NA	NA	NA	2010	NA	-28110	Dead	WITH TUMOR	NA	426	NA	NA	NA	NA	259	NA	NA	NA	1	426	1	426	NA	NA	1	259	
40	TCGA-ER-A42K	1	10	0	8	2	0	0	0	5	144	13	0	9	79	4	0	TCGA-ER-A42K-06	88	0.3171896752009525	37	TCGA-ER-A42K-06	8	12	51	0.1899237636594356	TCGA-ER-A42K-06	7	5	4	16	PASS	9126	TCGA-ER-A42K	SKCM	40	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-14628	Dead	WITH TUMOR	NA	394	NA	NA	NA	NA	206	NA	NA	NA	1	394	1	394	NA	NA	1	206	
50	TCGA-ER-A42L	4	47	6	30	2	0	0	0	33	696	50	0	13	422	6	3	TCGA-ER-A42L-06	52	0.3254094476245132	16	TCGA-ER-A42L-06	35	51	18	0.06460081944832476	TCGA-ER-A42L-06	15	6	2	23	PASS	9127	TCGA-ER-A42L	SKCM	49	MALE	WHITE	Stage II	NA	NA	NA	2001	NA	-17984	Alive	TUMOR FREE	4533	NA	NA	NA	NA	NA	3812	NA	NA	NA	0	4533	0	4533	NA	NA	1	3812	
50	TCGA-FR-A2OS	0	0	0	0	0	0	0	0	0	13	0	0	0	3	0	0	TCGA-FR-A2OS	0	0	0	TCGA-FR-A2OS-01	6	8	8	0.06863390297846493	TCGA-FR-A2OS-01	4	4	1	9	PASS	9128	TCGA-FR-A2OS	SKCM	49	FEMALE	WHITE	Stage IIC	NA	NA	NA	2008	NA	-18122	Dead	WITH TUMOR	NA	368	NA	Locoregional Recurrence	NA	NA	283	NA	NA	NA	1	368	1	368	NA	NA	1	283	
70	TCGA-FR-A3R1	4	23	4	16	2	4	0	0	13	298	20	1	9	196	4	1	TCGA-FR-A3R1	0	0	0	TCGA-FR-A3R1-01	3	5	19	0.08989986518994324	TCGA-FR-A3R1-01	5	6	5	16	PASS	9129	TCGA-FR-A3R1	SKCM	69	MALE	WHITE	Stage IIC	NA	NA	NA	2011	NA	-25271	Alive	WITH TUMOR	685	NA	NA	Locoregional Recurrence	NA	NA	678	NA	NA	NA	0	685	0	685	NA	NA	1	678	
40	TCGA-FR-A3YN	6	33	8	15	3	1	2	0	16	412	30	0	7	257	5	2	TCGA-FR-A3YN-06	110	0.9181778948429056	55	TCGA-FR-A3YN-06	32	23	30	0.10759207176618588	TCGA-FR-A3YN-06	4	2	3	9	PASS	9130	TCGA-FR-A3YN	SKCM	44	MALE	WHITE	Stage IB	NA	NA	NA	2005	NA	-16278	Alive	TUMOR FREE	2828	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2828	0	2828	NA	NA	0	2828	
NA	TCGA-FR-A3YO	4	50	10	21	0	0	1	0	28	628	45	0	20	373	17	2	TCGA-FR-A3YO-06	88	0.5644085075892448	32	TCGA-FR-A3YO-06	20	27	39	0.15818074044100755	TCGA-FR-A3YO-06	11	11	3	25	PASS	9131	TCGA-FR-A3YO	SKCM	NA	FEMALE	WHITE	I/II NOS	NA	NA	NA	2007	NA	NA	Alive	WITH TUMOR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
30	TCGA-FR-A44A	1	23	1	8	2	2	0	0	9	221	18	0	4	137	1	0	TCGA-FR-A44A-06	90	0.5060581334416201	37	TCGA-FR-A44A-06	24	20	68	0.21800180366593666	TCGA-FR-A44A-06	13	12	6	31	PASS	9132	TCGA-FR-A44A	SKCM	29	FEMALE	WHITE	Stage II	NA	NA	NA	1999	NA	-10707	Alive	TUMOR FREE	5299	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	5299	0	5299	NA	NA	0	5299	
30	TCGA-FR-A69P	2	14	3	6	0	0	0	0	11	172	10	0	5	85	0	0	TCGA-FR-A69P-06	88	0.598602720309946	39	TCGA-FR-A69P-06	22	28	61	0.2490934212396479	TCGA-FR-A69P-06	2	2	2	6	PASS	9133	TCGA-FR-A69P	SKCM	34	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2013	NA	-12679	Alive	TUMOR FREE	478	NA	NA	Regional lymph node	NA	NA	274	NA	NA	NA	0	478	0	478	NA	NA	1	274	
90	TCGA-FR-A726	47	536	47	250	11	3	1	1	261	5327	326	1	170	3137	89	17	TCGA-FR-A726	0	0	0	TCGA-FR-A726-01	5	8	64	0.12594422087112705	TCGA-FR-A726-01	12	7	6	25	hypermutated sample	9134	TCGA-FR-A726	SKCM	90	MALE	WHITE	Stage IIC	NA	NA	NA	2013	NA	-32873	Dead	WITH TUMOR	NA	305	NA	Locoregional Recurrence	NA	NA	273	NA	NA	NA	1	305	1	305	NA	NA	1	273	
50	TCGA-FR-A728	0	21	3	13	3	0	0	0	13	301	24	0	6	157	3	1	TCGA-FR-A728	0	0	0	TCGA-FR-A728-01	13	21	27	0.07838896602398501	TCGA-FR-A728-01	6	4	3	13	PASS	9135	TCGA-FR-A728	SKCM	54	FEMALE	WHITE	Stage IIIB	NA	NA	NA	2013	NA	-19936	Alive	TUMOR FREE	583	NA	NA	Locoregional Recurrence	NA	NA	64	NA	NA	NA	0	583	0	583	NA	NA	1	64	
40	TCGA-FR-A729	2	50	3	25	0	0	0	0	30	664	39	0	15	363	17	1	TCGA-FR-A729-06	161	0.8581576889661462	87	TCGA-FR-A729-06	22	62	149	0.4555975228441455	TCGA-FR-A729-06	14	12	8	34	PASS	9136	TCGA-FR-A729	SKCM	38	FEMALE	WHITE	Stage I	NA	NA	NA	1996	NA	-14043	Alive	WITH TUMOR	6716	NA	NA	Distant Metastasis	"Other, Specify"	spleen	6299	NA	NA	NA	0	6716	0	6716	NA	NA	1	6299	
50	TCGA-FR-A7U8	0	3	0	3	0	2	0	0	1	25	2	0	0	11	1	0	TCGA-FR-A7U8-06	292	0.8007546361424279	181	TCGA-FR-A7U8-06	9	8	110	0.2355952258758217	TCGA-FR-A7U8-06	11	10	5	26	PASS	9137	TCGA-FR-A7U8	SKCM	50	MALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-18346	Alive	WITH TUMOR	847	NA	NA	Distant Metastasis	Brain	NA	567	NA	NA	NA	0	847	0	847	NA	NA	1	567	
60	TCGA-FR-A7U9	6	101	11	42	1	0	0	0	68	1373	94	0	37	741	14	4	TCGA-FR-A7U9-06	107	0.2583085108665956	52	TCGA-FR-A7U9-06	15	56	35	0.09846807292734536	TCGA-FR-A7U9-06	5	7	3	15	hypermutated sample	9138	TCGA-FR-A7U9	SKCM	63	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2013	NA	-23245	Alive	TUMOR FREE	571	NA	NA	Locoregional Recurrence	NA	NA	95	NA	NA	NA	0	571	0	571	NA	NA	1	95	
70	TCGA-FR-A7UA	0	6	0	2	0	0	0	0	6	139	12	0	7	69	2	0	TCGA-FR-A7UA-06	50	0.2254314836605057	13	TCGA-FR-A7UA-06	6	14	82	0.3377463210682371	TCGA-FR-A7UA-06	10	6	4	20	PASS	9139	TCGA-FR-A7UA	SKCM	65	FEMALE	WHITE	Stage IB	NA	NA	NA	2011	NA	-24032	Alive	TUMOR FREE	1164	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1164	0	1164	NA	NA	0	1164	
80	TCGA-FR-A8YC	16	171	20	92	10	6	0	0	93	2250	146	0	64	1227	39	2	TCGA-FR-A8YC-06	132	0.6276520864187711	70	TCGA-FR-A8YC-06	12	25	22	0.060307594733170426	TCGA-FR-A8YC-06	8	7	1	16	hypermutated sample	9140	TCGA-FR-A8YC	SKCM	78	MALE	WHITE	Stage IIB	NA	NA	NA	2011	NA	-28680	Dead	WITH TUMOR	NA	1059	NA	NA	NA	NA	NA	NA	NA	NA	1	1059	1	1059	NA	NA	1	1059	
60	TCGA-FR-A8YD	0	4	0	2	1	1	0	0	4	90	4	0	2	22	8	0	TCGA-FR-A8YD-06	189	0.9124596029879879	114	TCGA-FR-A8YD-06	9	10	60	0.06601699724639197	TCGA-FR-A8YD-06	7	13	3	23	PASS	9141	TCGA-FR-A8YD	SKCM	56	FEMALE	WHITE	Stage IIC	NA	NA	NA	2011	NA	-20782	Dead	WITH TUMOR	NA	1103	NA	NA	NA	NA	NA	NA	NA	NA	1	1103	1	1103	NA	NA	1	1103	
40	TCGA-FR-A8YE	3	18	1	6	0	0	0	0	15	257	12	0	6	149	5	1	TCGA-FR-A8YE-06	89	0.12262217314458908	39	TCGA-FR-A8YE-06	7	9	30	0.0787347928951304	TCGA-FR-A8YE-06	3	1	2	6	PASS	9142	TCGA-FR-A8YE	SKCM	41	MALE	WHITE	Stage IA	NA	NA	NA	2006	NA	-15159	Alive	TUMOR FREE	3176	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3176	0	3176	NA	NA	0	3176	
50	TCGA-FS-A1YW	1	10	2	5	0	1	0	0	11	132	11	0	3	64	2	0	TCGA-FS-A1YW-06	144	0.4039003628180796	75	TCGA-FS-A1YW-06	7	10	18	0.2299271976651316	TCGA-FS-A1YW-06	7	11	5	23	PASS	9143	TCGA-FS-A1YW	SKCM	52	MALE	WHITE	Stage IB	NA	NA	NA	1987	NA	-19078	Dead	WITH TUMOR	NA	6598	NA	NA	NA	NA	NA	NA	NA	NA	1	6598	1	6598	NA	NA	1	6598	
40	TCGA-FS-A1YX	0	1	0	1	0	1	2	0	2	42	3	0	2	16	1	0	TCGA-FS-A1YX-06	183	0.8508972363920237	100	TCGA-FS-A1YX-06	12	11	36	0.4071655599025121	TCGA-FS-A1YX-06	7	3	8	18	PASS	9144	TCGA-FS-A1YX	SKCM	39	FEMALE	WHITE	Stage I	NA	NA	NA	2001	NA	-14387	Dead	WITH TUMOR	NA	1478	NA	NA	NA	NA	NA	NA	NA	NA	1	1478	1	1478	NA	NA	1	1478	
60	TCGA-FS-A1YY	2	13	1	3	1	0	1	0	6	154	9	0	2	90	1	0	TCGA-FS-A1YY-06	69	0.9464391157570964	22	TCGA-FS-A1YY-06	7	5	13	0.21654041765038515	TCGA-FS-A1YY-06	5	2	3	10	PASS	9145	TCGA-FS-A1YY	SKCM	55	FEMALE	WHITE	Stage IIA	NA	NA	NA	1987	NA	-20396	Dead	WITH TUMOR	NA	6953	NA	NA	NA	NA	6777	NA	NA	NA	1	6953	1	6953	NA	NA	1	6777	
30	TCGA-FS-A1Z0	2	58	6	29	1	0	0	0	40	923	96	0	19	375	29	1	TCGA-FS-A1Z0-06	211	0.6216506790840641	137	TCGA-FS-A1Z0-06	9	8	55	0.2441538218533074	TCGA-FS-A1Z0-06	5	5	2	12	PASS	9146	TCGA-FS-A1Z0	SKCM	32	FEMALE	WHITE	Stage IA	NA	NA	NA	1990	NA	-11815	Dead	WITH TUMOR	NA	6164	NA	Distant Metastasis	Lung	NA	5503	NA	NA	NA	1	6164	1	6164	NA	NA	1	5503	
70	TCGA-FS-A1Z3	8	47	7	23	4	1	0	1	31	780	53	0	25	421	11	0	TCGA-FS-A1Z3-06	109	0.24637963377718736	59	TCGA-FS-A1Z3-06	9	10	15	0.17617212855643374	TCGA-FS-A1Z3-06	5	3	2	10	PASS	9147	TCGA-FS-A1Z3	SKCM	72	FEMALE	WHITE	Stage IV	NA	NA	NA	2002	NA	-26435	Dead	WITH TUMOR	NA	636	NA	NA	NA	NA	276	NA	NA	NA	1	636	1	636	NA	NA	1	276	
60	TCGA-FS-A1Z4	4	24	1	11	1	2	0	0	23	514	60	0	10	232	25	0	TCGA-FS-A1Z4-06	47	0.27553573154699096	9	TCGA-FS-A1Z4-06	11	8	8	0.33316130718498754	TCGA-FS-A1Z4-06	0	2	1	3	PASS	9148	TCGA-FS-A1Z4	SKCM	62	MALE	WHITE	Stage I	NA	NA	NA	2001	NA	-22932	Dead	WITH TUMOR	NA	854	NA	NA	NA	NA	NA	NA	NA	NA	1	854	1	854	NA	NA	1	854	
20	TCGA-FS-A1Z7	1	7	3	3	0	0	0	0	3	142	7	0	2	79	3	0	TCGA-FS-A1Z7-06	73	0.29543609891162026	28	TCGA-FS-A1Z7-06	12	14	15	0.2425165531060437	TCGA-FS-A1Z7-06	2	1	3	6	PASS	9149	TCGA-FS-A1Z7	SKCM	19	MALE	WHITE	Stage IIIC	NA	NA	NA	2005	NA	-7293	Dead	WITH TUMOR	NA	237	NA	Distant Metastasis	Lung	NA	136	NA	NA	NA	1	237	1	237	NA	NA	1	136	
50	TCGA-FS-A1ZA	5	62	8	26	6	1	1	0	32	993	61	0	19	528	13	2	TCGA-FS-A1ZA-06	122	0.9190286637631032	65	TCGA-FS-A1ZA-06	19	20	15	0.14542486674800426	TCGA-FS-A1ZA-06	5	7	5	17	PASS	9150	TCGA-FS-A1ZA	SKCM	45	FEMALE	WHITE	Stage IIIB	NA	NA	NA	2003	NA	-16705	Dead	WITH TUMOR	NA	843	NA	NA	NA	NA	663	NA	NA	NA	1	843	1	843	NA	NA	1	663	
60	TCGA-FS-A1ZB	6	74	7	45	2	0	0	0	60	1057	107	1	15	517	42	4	TCGA-FS-A1ZB-06	90	0.25261127376142906	45	TCGA-FS-A1ZB-06	4	6	16	0.20383118960909224	TCGA-FS-A1ZB-06	4	5	5	14	PASS	9151	TCGA-FS-A1ZB	SKCM	57	MALE	WHITE	Stage II	NA	NA	NA	2002	NA	-20963	Dead	WITH TUMOR	NA	1486	NA	NA	NA	NA	1461	NA	NA	NA	1	1486	1	1486	NA	NA	1	1461	
50	TCGA-FS-A1ZC	2	47	9	24	3	1	0	0	29	679	38	1	22	388	13	0	TCGA-FS-A1ZC-06	215	0.4178860085574227	134	TCGA-FS-A1ZC-06	17	21	42	0.21944077828400352	TCGA-FS-A1ZC-06	4	3	3	10	PASS	9152	TCGA-FS-A1ZC	SKCM	51	MALE	WHITE	I/II NOS	NA	NA	NA	1978	NA	-18843	Dead	WITH TUMOR	NA	10870	NA	NA	NA	NA	10334	NA	NA	NA	1	10870	1	10870	NA	NA	1	10334	
60	TCGA-FS-A1ZD	3	29	1	21	1	0	2	1	23	389	39	2	12	176	14	0	TCGA-FS-A1ZD-06	247	0.6365760859714718	156	TCGA-FS-A1ZD-06	19	17	36	0.15588784043523946	TCGA-FS-A1ZD-06	7	11	4	22	PASS	9153	TCGA-FS-A1ZD	SKCM	63	MALE	WHITE	Stage IIA	NA	NA	NA	2001	NA	-23344	Dead	WITH TUMOR	NA	1628	NA	NA	NA	NA	1497	NA	NA	NA	1	1628	1	1628	NA	NA	1	1497	
40	TCGA-FS-A1ZE	1	14	1	6	3	0	1	0	1	108	3	0	4	56	3	0	TCGA-FS-A1ZE-06	242	0.20746115370719093	160	TCGA-FS-A1ZE-06	6	9	46	0.1318409439415139	TCGA-FS-A1ZE-06	9	10	6	25	PASS	9154	TCGA-FS-A1ZE	SKCM	40	MALE	WHITE	Stage IIC	NA	NA	NA	2008	NA	-14618	Dead	WITH TUMOR	NA	1413	NA	NA	NA	NA	761	NA	NA	NA	1	1413	1	1413	NA	NA	1	761	
80	TCGA-FS-A1ZF	0	19	0	8	1	0	0	0	9	183	13	0	7	107	5	0	TCGA-FS-A1ZF-06	178	0.8988345311488303	104	TCGA-FS-A1ZF-06	8	10	25	0.2296034607439173	TCGA-FS-A1ZF-06	9	5	6	20	PASS	9155	TCGA-FS-A1ZF	SKCM	78	FEMALE	WHITE	Stage IIC	NA	NA	NA	2007	NA	-28491	Dead	WITH TUMOR	NA	470	NA	NA	NA	NA	NA	NA	NA	NA	1	470	1	470	NA	NA	1	470	
60	TCGA-FS-A1ZG	6	60	4	28	2	1	1	0	62	1490	239	3	22	629	84	7	TCGA-FS-A1ZG-06	336	0.2482686061807854	220	TCGA-FS-A1ZG-06	7	8	63	0.14399812371407536	TCGA-FS-A1ZG-06	6	1	4	11	PASS	9156	TCGA-FS-A1ZG	SKCM	60	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2007	NA	-22252	Dead	WITH TUMOR	NA	295	NA	NA	NA	NA	140	NA	NA	NA	1	295	1	295	NA	NA	1	140	
70	TCGA-FS-A1ZH	0	5	2	4	0	0	0	0	3	45	6	0	0	20	2	0	TCGA-FS-A1ZH-06	88	0.9455557070982026	35	TCGA-FS-A1ZH-06	19	17	20	0.2144825716465248	TCGA-FS-A1ZH-06	4	6	3	13	PASS	9157	TCGA-FS-A1ZH	SKCM	71	FEMALE	WHITE	Stage IV	NA	NA	NA	2003	NA	-26232	Dead	WITH TUMOR	NA	996	NA	NA	NA	NA	577	NA	NA	NA	1	996	1	996	NA	NA	1	577	
80	TCGA-FS-A1ZJ	2	21	4	20	2	0	1	1	23	387	41	0	5	167	18	0	TCGA-FS-A1ZJ-06	687	0.9665290334568238	523	TCGA-FS-A1ZJ-06	13	15	149	0.2976684695495213	TCGA-FS-A1ZJ-06	17	25	14	56	PASS	9158	TCGA-FS-A1ZJ	SKCM	75	FEMALE	WHITE	Stage I	NA	NA	NA	2001	NA	-27476	Dead	WITH TUMOR	NA	1441	NA	NA	NA	NA	1225	NA	NA	NA	1	1441	1	1441	NA	NA	1	1225	
70	TCGA-FS-A1ZK	10	98	15	50	4	0	3	0	68	1306	88	1	28	790	22	0	TCGA-FS-A1ZK-06	523	0.9458424184485664	341	TCGA-FS-A1ZK-06	21	41	116	0.4139963888120542	TCGA-FS-A1ZK-06	19	11	15	45	hypermutated sample	9159	TCGA-FS-A1ZK	SKCM	68	MALE	WHITE	Stage II	NA	NA	NA	2005	NA	-24839	Dead	WITH TUMOR	NA	728	NA	NA	NA	NA	367	NA	NA	NA	1	728	1	728	NA	NA	1	367	
70	TCGA-FS-A1ZM	4	46	3	30	2	1	0	0	31	633	74	1	8	305	20	2	TCGA-FS-A1ZM-06	189	0.7571930968008388	117	TCGA-FS-A1ZM-06	22	13	40	0.025777963207692645	TCGA-FS-A1ZM-06	4	3	1	8	PASS	9160	TCGA-FS-A1ZM	SKCM	74	MALE	WHITE	Stage III	NA	NA	NA	2001	NA	-27210	Alive	TUMOR FREE	3080	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3080	0	3080	NA	NA	0	3080	
40	TCGA-FS-A1ZN	8	34	1	21	0	1	0	0	22	550	84	0	11	289	19	0	TCGA-FS-A1ZN	0	0	0	TCGA-FS-A1ZN-01	5	4	25	0.0857121888907477	TCGA-FS-A1ZN-01	3	2	1	6	PASS	9161	TCGA-FS-A1ZN	SKCM	43	MALE	WHITE	Stage IIIA	NA	NA	NA	2002	NA	-15890	Dead	WITH TUMOR	NA	730	NA	NA	NA	NA	361	NA	NA	NA	1	730	1	730	NA	NA	1	361	
50	TCGA-FS-A1ZP	5	74	7	55	0	0	0	0	50	1064	130	1	17	571	37	3	TCGA-FS-A1ZP-06	102	0.29385419674293456	44	TCGA-FS-A1ZP-06	5	9	7	0.03820841064636042	TCGA-FS-A1ZP-06	6	3	2	11	PASS	9162	TCGA-FS-A1ZP	SKCM	52	MALE	WHITE	Stage II	NA	NA	NA	1997	NA	-19175	Dead	WITH TUMOR	NA	2273	NA	NA	NA	NA	NA	NA	NA	NA	1	2273	1	2273	NA	NA	1	2273	
30	TCGA-FS-A1ZQ	7	58	6	35	1	0	0	0	38	958	119	1	18	470	44	1	TCGA-FS-A1ZQ-06	204	0.8654797572607044	107	TCGA-FS-A1ZQ-06	11	12	49	0.3471614052321383	TCGA-FS-A1ZQ-06	9	4	12	25	PASS	9163	TCGA-FS-A1ZQ	SKCM	31	MALE	WHITE	I/II NOS	NA	NA	NA	1997	NA	-11599	Dead	WITH TUMOR	NA	4062	NA	NA	NA	NA	3940	NA	NA	NA	1	4062	1	4062	NA	NA	1	3940	
40	TCGA-FS-A1ZR	4	51	5	17	0	0	0	0	42	870	116	1	15	398	29	1	TCGA-FS-A1ZR-06	102	0.5576324554578029	47	TCGA-FS-A1ZR-06	12	7	12	0.1832576829498371	TCGA-FS-A1ZR-06	3	0	2	5	PASS	9164	TCGA-FS-A1ZR	SKCM	36	MALE	WHITE	Stage II	NA	NA	NA	1995	NA	-13325	Dead	WITH TUMOR	NA	347	NA	NA	NA	NA	152	NA	NA	NA	1	347	1	347	NA	NA	1	152	
50	TCGA-FS-A1ZS	0	13	0	11	2	0	1	0	6	213	12	0	5	153	7	0	TCGA-FS-A1ZS-06	101	0.402838534228391	47	TCGA-FS-A1ZS-06	19	53	13	0.19263367989231392	TCGA-FS-A1ZS-06	5	5	1	11	PASS	9165	TCGA-FS-A1ZS	SKCM	54	MALE	WHITE	Stage I	NA	NA	NA	1998	NA	-19813	Alive	WITH TUMOR	4526	NA	NA	Regional lymph node|Regional lymph node|Distant Metastasis|Regional lymph node|Distant Metastasis|Distant Metastasis	NA|NA|Lung|NA|Lung|Liver	NA|NA|NA|NA|NA|NA	2861	NA	NA	NA	0	4526	0	4526	NA	NA	1	2861	
60	TCGA-FS-A1ZT	1	7	1	11	0	1	0	0	10	131	12	0	6	63	2	0	TCGA-FS-A1ZT-06	201	0.6917821352476917	131	TCGA-FS-A1ZT-06	4	6	28	0.12930328553935366	TCGA-FS-A1ZT-06	9	3	5	17	PASS	9166	TCGA-FS-A1ZT	SKCM	55	MALE	WHITE	Stage III	NA	NA	NA	2005	NA	-20284	Alive	TUMOR FREE	1617	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1617	0	1617	NA	NA	0	1617	
70	TCGA-FS-A1ZU	0	3	0	2	2	1	0	0	4	131	13	0	2	46	2	0	TCGA-FS-A1ZU-06	280	0.5584503708973804	182	TCGA-FS-A1ZU-06	20	29	32	0.12780501392598326	TCGA-FS-A1ZU-06	11	11	5	27	PASS	9167	TCGA-FS-A1ZU	SKCM	70	FEMALE	WHITE	Stage IIC	NA	NA	NA	2002	NA	-25856	Dead	WITH TUMOR	NA	808	NA	NA	NA	NA	679	NA	NA	NA	1	808	1	808	NA	NA	1	679	
70	TCGA-FS-A1ZW	0	41	0	22	1	2	1	0	17	535	37	0	9	275	10	1	TCGA-FS-A1ZW-06	82	0.5347344322094775	35	TCGA-FS-A1ZW-06	12	7	7	0.2208774008284214	TCGA-FS-A1ZW-06	2	3	2	7	PASS	9168	TCGA-FS-A1ZW	SKCM	65	MALE	WHITE	Stage IIIB	NA	NA	NA	2005	NA	-24087	Alive	TUMOR FREE	1505	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1505	0	1505	NA	NA	0	1505	
70	TCGA-FS-A1ZY	2	6	1	6	0	0	0	0	4	97	9	0	1	45	2	0	TCGA-FS-A1ZY-06	177	0.6051021835766176	97	TCGA-FS-A1ZY-06	19	23	25	0.1312767501300828	TCGA-FS-A1ZY-06	10	11	6	27	PASS	9169	TCGA-FS-A1ZY	SKCM	71	MALE	WHITE	Stage IIB	NA	NA	NA	2006	NA	-26197	Dead	WITH TUMOR	NA	824	NA	NA	NA	NA	NA	NA	NA	NA	1	824	1	824	NA	NA	1	824	
50	TCGA-FS-A1ZZ	8	90	15	48	3	1	1	0	60	1372	97	3	49	830	26	1	TCGA-FS-A1ZZ-06	84	0.2499828145517451	35	TCGA-FS-A1ZZ-06	5	8	10	0.17722150192847155	TCGA-FS-A1ZZ-06	6	4	3	13	hypermutated sample	9170	TCGA-FS-A1ZZ	SKCM	54	FEMALE	WHITE	Stage IIB	NA	NA	NA	2006	NA	-19733	Dead	WITH TUMOR	NA	822	NA	NA	NA	NA	NA	NA	NA	NA	1	822	1	822	NA	NA	1	822	
70	TCGA-FS-A4F0	4	43	4	23	3	0	3	0	25	415	27	0	5	219	9	0	TCGA-FS-A4F0-06	106	0.1525205126305781	45	TCGA-FS-A4F0-06	3	2	34	0.09892302392818393	TCGA-FS-A4F0-06	3	5	2	10	PASS	9171	TCGA-FS-A4F0	SKCM	67	FEMALE	WHITE	Stage IIB	NA	NA	NA	2003	NA	-24717	Alive	TUMOR FREE	2367	NA	NA	Locoregional Recurrence|Locoregional Recurrence|Locoregional Recurrence|Distant Metastasis|Distant Metastasis	"NA|NA|NA|Lung|Other, Specify"	NA|NA|NA|NA|lymphnode	872	NA	NA	NA	0	2367	0	2367	NA	NA	1	872	
50	TCGA-FS-A4F2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-FS-A4F2-06	150	0.7305531321635065	88	TCGA-FS-A4F2-06	31	20	83	0.3177112280278908	TCGA-FS-A4F2-06	15	7	7	29	PASS	9172	TCGA-FS-A4F2	SKCM	46	FEMALE	WHITE	Stage IIC	NA	NA	NA	2003	NA	-16944	Dead	WITH TUMOR	NA	1525	NA	NA	NA	NA	NA	NA	NA	NA	1	1525	1	1525	NA	NA	1	1525	
60	TCGA-FS-A4F4	0	1	0	1	1	1	0	0	2	30	5	0	0	16	1	0	TCGA-FS-A4F4-06	912	0.6815208406374262	660	TCGA-FS-A4F4-06	9	7	386	0.21057562335682348	TCGA-FS-A4F4-06	10	9	10	29	PASS	9173	TCGA-FS-A4F4	SKCM	64	MALE	WHITE	Stage II	NA	NA	NA	2001	NA	-23663	Dead	WITH TUMOR	NA	2028	NA	NA	NA	NA	NA	NA	NA	NA	1	2028	1	2028	NA	NA	1	2028	
80	TCGA-FS-A4F5	0	28	6	18	4	0	0	0	28	580	38	0	14	303	14	0	TCGA-FS-A4F5-06	92	0.7036729109070606	41	TCGA-FS-A4F5-06	23	21	56	0.17507972902034433	TCGA-FS-A4F5-06	6	7	6	19	PASS	9174	TCGA-FS-A4F5	SKCM	77	FEMALE	WHITE	Stage IB	NA	NA	NA	2005	NA	-28412	Dead	WITH TUMOR	NA	874	NA	NA	NA	NA	NA	NA	NA	NA	1	874	1	874	NA	NA	1	874	
50	TCGA-FS-A4F8	1	7	2	1	1	0	0	0	6	143	4	0	2	68	2	0	TCGA-FS-A4F8-06	82	0.5242413894762185	38	TCGA-FS-A4F8-06	13	17	120	0.5647452979515114	TCGA-FS-A4F8-06	8	13	12	33	PASS	9175	TCGA-FS-A4F8	SKCM	52	MALE	WHITE	Stage I	NA	NA	NA	1997	NA	-19137	Dead	WITH TUMOR	NA	5318	NA	NA	NA	NA	NA	NA	NA	NA	1	5318	1	5318	NA	NA	1	5318	
80	TCGA-FS-A4F9	2	24	4	11	25	1	6	0	15	313	24	1	14	183	2	0	TCGA-FS-A4F9-06	130	0.7223640907270754	68	TCGA-FS-A4F9-06	5	5	44	0.1351341878701604	TCGA-FS-A4F9-06	7	9	7	23	PASS	9176	TCGA-FS-A4F9	SKCM	80	MALE	WHITE	Stage IIIC	NA	NA	NA	2011	NA	-29324	Alive	WITH TUMOR	1035	NA	NA	Locoregional Recurrence|Distant Metastasis	NA|Brain	NA|NA	376	NA	NA	NA	0	1035	0	1035	NA	NA	1	376	
50	TCGA-FS-A4FB	2	10	1	8	2	1	0	0	7	142	8	0	5	70	0	0	TCGA-FS-A4FB-06	191	0.9259500941806552	118	TCGA-FS-A4FB-06	7	6	113	0.2200078581921099	TCGA-FS-A4FB-06	5	4	4	13	PASS	9177	TCGA-FS-A4FB	SKCM	46	FEMALE	WHITE	Stage III	NA	NA	NA	2009	NA	-16896	Dead	WITH TUMOR	NA	813	NA	NA	NA	NA	NA	NA	NA	NA	1	813	1	813	NA	NA	1	813	
80	TCGA-FS-A4FC	2	48	11	24	1	1	1	0	34	542	41	0	8	289	11	1	TCGA-FS-A4FC-06	63	0.08270660325969363	24	TCGA-FS-A4FC-06	2	4	26	0.08784212192325735	TCGA-FS-A4FC-06	3	3	4	10	PASS	9178	TCGA-FS-A4FC	SKCM	75	FEMALE	WHITE	Stage IIA	NA	NA	NA	2007	NA	-27482	Dead	WITH TUMOR	NA	1655	NA	NA	NA	NA	NA	NA	NA	NA	1	1655	1	1655	NA	NA	1	1655	
40	TCGA-FS-A4FD	1	26	6	9	0	1	0	0	9	355	14	0	9	180	2	0	TCGA-FS-A4FD-06	144	0.4023131562110699	70	TCGA-FS-A4FD-06	9	10	38	0.09373433442329608	TCGA-FS-A4FD-06	9	4	5	18	PASS	9179	TCGA-FS-A4FD	SKCM	39	MALE	WHITE	Stage IIIC	NA	NA	NA	2004	NA	-14426	Dead	WITH TUMOR	NA	2454	NA	Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis	Lung|Lung|Bone|Brain	NA|NA|NA|NA	2010	NA	NA	NA	1	2454	1	2454	NA	NA	1	2010	
60	TCGA-FW-A3I3	1	3	0	0	4	1	0	0	2	34	5	0	1	26	1	1	TCGA-FW-A3I3-06	515	0.6230176549959434	381	TCGA-FW-A3I3-06	14	24	118	0.1831273790516844	TCGA-FW-A3I3-06	12	16	7	35	PASS	9180	TCGA-FW-A3I3	SKCM	59	FEMALE	WHITE	Stage IV	NA	NA	NA	2011	NA	-21731	Alive	TUMOR FREE	531	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	531	0	531	NA	NA	0	531	
70	TCGA-FW-A3R5	163	2307	201	1102	22	8	2	2	1466	29128	1549	10	771	18176	320	56	TCGA-FW-A3R5-06	68	0.09036976281938984	23	TCGA-FW-A3R5	0	0	0	0	TCGA-FW-A3R5	0	0	0	0	hypermutated sample	9181	TCGA-FW-A3R5	SKCM	68	MALE	WHITE	Stage III	NA	NA	NA	2010	NA	-24868	Alive	TUMOR FREE	1124	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1124	0	1124	NA	NA	0	1124	
70	TCGA-FW-A3TU	5	54	6	19	3	0	0	0	20	581	42	0	17	339	6	0	TCGA-FW-A3TU-06	149	0.7953725602510211	85	TCGA-FW-A3TU-06	7	10	66	0.2262454735620857	TCGA-FW-A3TU-06	9	14	9	32	PASS	9182	TCGA-FW-A3TU	SKCM	72	FEMALE	WHITE	NA	NA	NA	NA	2007	NA	-26589	Dead	WITH TUMOR	NA	1691	NA	NA	NA	NA	NA	NA	NA	NA	1	1691	1	1691	NA	NA	1	1691	
60	TCGA-FW-A3TV	1	15	3	11	0	1	0	0	10	251	15	0	5	146	1	1	TCGA-FW-A3TV-06	59	0.3144423087121578	20	TCGA-FW-A3TV-06	5	5	26	0.19291585561168026	TCGA-FW-A3TV-06	3	6	8	17	PASS	9183	TCGA-FW-A3TV	SKCM	57	FEMALE	WHITE	Stage IIIB	NA	NA	NA	2012	NA	-20972	Alive	WITH TUMOR	411	NA	NA	Locoregional Recurrence	NA	NA	139	NA	NA	NA	0	411	0	411	NA	NA	1	139	
70	TCGA-FW-A5DX	0	16	4	5	2	1	0	0	7	140	10	0	6	81	1	0	TCGA-FW-A5DX	0	0	0	TCGA-FW-A5DX-01	29	45	101	0.496288241566998	TCGA-FW-A5DX-01	14	6	15	35	PASS	9184	TCGA-FW-A5DX	SKCM	71	MALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-26056	Alive	TUMOR FREE	640	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	640	0	640	NA	NA	0	640	
50	TCGA-FW-A5DY	0	7	0	3	0	0	1	0	6	141	8	0	3	72	2	0	TCGA-FW-A5DY-06	43	0.0004151305313123608	7	TCGA-FW-A5DY-06	1	2	11	0.0026159136896790184	TCGA-FW-A5DY-06	2	6	0	8	PASS	9185	TCGA-FW-A5DY	SKCM	48	FEMALE	WHITE	Stage III	NA	NA	NA	2012	NA	-17730	Alive	TUMOR FREE	587	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	587	0	587	NA	NA	0	587	
50	TCGA-GF-A2C7	3	29	0	14	1	2	1	0	16	333	38	0	9	142	11	0	TCGA-GF-A2C7	0	0	0	TCGA-GF-A2C7-01	14	10	16	0.17519754967273574	TCGA-GF-A2C7-01	6	3	6	15	PASS	9186	TCGA-GF-A2C7	SKCM	48	MALE	WHITE	Stage IIC	NA	NA	NA	2011	NA	-17545	Alive	TUMOR FREE	21	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	21	0	21	NA	NA	0	21	
60	TCGA-GF-A3OT	4	41	5	22	3	1	1	0	16	400	35	0	9	243	9	2	TCGA-GF-A3OT-06	95	0.07109158017015363	42	TCGA-GF-A3OT-06	2	3	43	0.10387584240741583	TCGA-GF-A3OT-06	1	2	1	4	PASS	9187	TCGA-GF-A3OT	SKCM	58	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2011	NA	-21359	Alive	WITH TUMOR	301	NA	NA	Distant Metastasis	Lung	NA	248	NA	NA	NA	0	301	0	301	NA	NA	1	248	
70	TCGA-GF-A4EO	1	16	1	6	0	1	1	0	10	190	12	0	3	104	4	0	TCGA-GF-A4EO-06	97	0.3729866596627208	46	TCGA-GF-A4EO-06	27	26	84	0.2716236404633052	TCGA-GF-A4EO-06	13	15	6	34	PASS	9188	TCGA-GF-A4EO	SKCM	74	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-27114	Alive	TUMOR FREE	591	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	591	0	591	NA	NA	0	591	
60	TCGA-GF-A6C8	0	22	4	19	0	1	1	0	8	294	14	0	6	154	8	0	TCGA-GF-A6C8-06	110	0.8947409444565751	55	TCGA-GF-A6C8-06	8	7	76	0.2943144147896474	TCGA-GF-A6C8-06	7	7	11	25	PASS	9189	TCGA-GF-A6C8	SKCM	62	FEMALE	WHITE	Stage IIB	NA	NA	NA	2012	NA	-22731	Alive	NA	62	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	62	0	62	NA	NA	0	62	
80	TCGA-GF-A6C9	15	118	13	67	11	3	0	0	97	2083	133	0	34	1272	36	4	TCGA-GF-A6C9-06	79	0.4154260224474743	27	TCGA-GF-A6C9-06	10	8	56	0.2239796829046173	TCGA-GF-A6C9-06	8	5	6	19	hypermutated sample	9190	TCGA-GF-A6C9	SKCM	78	MALE	WHITE	Stage IIIB	NA	NA	NA	2012	NA	-28774	Alive	TUMOR FREE	480	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	480	0	480	NA	NA	0	480	
40	TCGA-GF-A769	2	10	1	7	1	0	1	0	7	111	4	0	1	71	1	0	TCGA-GF-A769	0	0	0	TCGA-GF-A769-01	13	19	128	0.2270769189022213	TCGA-GF-A769-01	11	11	10	32	PASS	9191	TCGA-GF-A769	SKCM	39	MALE	WHITE	Stage IIC	NA	NA	NA	2010	NA	-14304	Dead	WITH TUMOR	NA	1070	NA	NA	NA	NA	NA	NA	NA	NA	1	1070	1	1070	NA	NA	1	1070	
50	TCGA-GN-A262	4	51	9	24	0	1	1	0	40	823	91	0	19	389	33	0	TCGA-GN-A262-06	200	0.9999462506840476	132	TCGA-GN-A262-06	10	9	34	0.3225155480872165	TCGA-GN-A262-06	4	9	11	24	PASS	9192	TCGA-GN-A262	SKCM	47	FEMALE	WHITE	NA	NA	NA	NA	2001	NA	-17239	Alive	WITH TUMOR	4255	NA	NA	Locoregional Recurrence	NA	NA	2908	NA	NA	NA	0	4255	0	4255	NA	NA	1	2908	
30	TCGA-GN-A263	1	32	2	13	2	0	1	0	20	425	24	0	7	220	12	1	TCGA-GN-A263	0	0	0	TCGA-GN-A263-01	3	2	9	0.0948895818229466	TCGA-GN-A263-01	1	0	3	4	PASS	9193	TCGA-GN-A263	SKCM	24	MALE	WHITE	Stage IV	NA	NA	NA	2004	NA	-8952	Dead	WITH TUMOR	NA	467	NA	Distant Metastasis	Liver	NA	39	NA	NA	NA	1	467	1	467	NA	NA	1	39	
60	TCGA-GN-A264	0	10	0	10	3	0	0	0	4	161	13	0	2	55	7	0	TCGA-GN-A264-06	314	0.5761776196845401	212	TCGA-GN-A264-06	16	28	40	0.11118413940033288	TCGA-GN-A264-06	10	6	4	20	PASS	9194	TCGA-GN-A264	SKCM	60	MALE	WHITE	NA	NA	NA	NA	1997	NA	-22254	Dead	WITH TUMOR	NA	3587	NA	Distant Metastasis	Lung	NA	3221	NA	NA	NA	1	3587	1	3587	NA	NA	1	3221	
50	TCGA-GN-A265	6	73	7	32	0	0	1	0	33	815	89	0	21	377	42	3	TCGA-GN-A265-06	144	0.1871638221678492	77	TCGA-GN-A265-06	15	33	24	0.2806190307536666	TCGA-GN-A265-06	13	12	8	33	PASS	9195	TCGA-GN-A265	SKCM	53	MALE	WHITE	NA	NA	NA	NA	2004	NA	-19712	Alive	TUMOR FREE	2948	NA	NA	Regional lymph node	NA	NA	99	NA	NA	NA	0	2948	0	2948	NA	NA	1	99	
50	TCGA-GN-A266	11	193	20	104	4	5	2	1	140	2967	187	2	56	1750	39	5	TCGA-GN-A266-06	155	0.6326618059491907	81	TCGA-GN-A266-06	22	23	29	0.19375598386784332	TCGA-GN-A266-06	5	5	5	15	hypermutated sample	9196	TCGA-GN-A266	SKCM	45	MALE	WHITE	NA	NA	NA	NA	2004	NA	-16456	Dead	WITH TUMOR	NA	308	NA	Distant Metastasis	Brain	NA	109	NA	NA	NA	1	308	1	308	NA	NA	1	109	
40	TCGA-GN-A267	3	26	4	17	4	0	5	0	19	334	23	0	6	202	5	1	TCGA-GN-A267-06	67	0.7640868032079176	18	TCGA-GN-A267-06	12	17	14	0.33618818890832514	TCGA-GN-A267-06	5	4	4	13	PASS	9197	TCGA-GN-A267	SKCM	38	MALE	WHITE	Stage IIIA	NA	NA	NA	2005	NA	-14055	Dead	WITH TUMOR	NA	1960	NA	Locoregional Recurrence	NA	NA	456	NA	NA	NA	1	1960	1	1960	NA	NA	1	456	
80	TCGA-GN-A268	2	18	0	9	0	2	0	0	15	292	19	1	4	149	7	0	TCGA-GN-A268-06	169	0.9233784458993896	104	TCGA-GN-A268-06	10	13	28	0.289769535263444	TCGA-GN-A268-06	9	6	8	23	PASS	9198	TCGA-GN-A268	SKCM	83	FEMALE	WHITE	Stage IIB	NA	NA	NA	2005	NA	-30430	Dead	WITH TUMOR	NA	1910	NA	Locoregional Recurrence	NA	NA	908	NA	NA	NA	1	1910	1	1910	NA	NA	1	908	
70	TCGA-GN-A269	4	24	4	17	0	1	0	0	21	536	30	0	11	344	10	2	TCGA-GN-A269	0	0	0	TCGA-GN-A269-01	8	7	4	0.07419760911910034	TCGA-GN-A269-01	1	1	2	4	PASS	9199	TCGA-GN-A269	SKCM	70	MALE	WHITE	Stage IIIC	NA	NA	NA	2006	NA	-25583	Dead	WITH TUMOR	NA	170	NA	NA	NA	NA	NA	NA	NA	NA	1	170	1	170	NA	NA	1	170	
60	TCGA-GN-A26A	3	11	0	9	0	2	0	0	22	401	39	0	9	190	6	0	TCGA-GN-A26A-06	242	0.5348883331768842	165	TCGA-GN-A26A-06	22	28	30	0.1703154942724634	TCGA-GN-A26A-06	8	2	0	10	PASS	9200	TCGA-GN-A26A	SKCM	63	FEMALE	WHITE	Stage IIIA	NA	NA	NA	2006	NA	-23288	Dead	WITH TUMOR	NA	988	NA	Distant Metastasis	Lung	NA	750	NA	NA	NA	1	988	1	988	NA	NA	1	750	
80	TCGA-GN-A26C	12	160	13	56	7	0	1	0	107	2179	164	1	56	1241	60	0	TCGA-GN-A26C	0	0	0	TCGA-GN-A26C-01	26	30	15	0.31140631854460143	TCGA-GN-A26C-01	6	6	5	17	hypermutated sample	9201	TCGA-GN-A26C	SKCM	77	MALE	WHITE	Stage IIIC	NA	NA	NA	2006	NA	-28336	Dead	WITH TUMOR	NA	821	NA	Distant Metastasis	Lung	NA	593	NA	NA	NA	1	821	1	821	NA	NA	1	593	
70	TCGA-GN-A26D	1	46	2	15	0	1	0	0	35	515	74	0	6	255	28	0	TCGA-GN-A26D-06	529	0.7323083476237908	373	TCGA-GN-A26D-06	27	19	59	0.06663724979576262	TCGA-GN-A26D-06	5	4	4	13	PASS	9202	TCGA-GN-A26D	SKCM	72	FEMALE	WHITE	Stage IIC	NA	NA	NA	2008	NA	-26494	Dead	WITH TUMOR	NA	1460	NA	Locoregional Recurrence	NA	NA	622	NA	NA	NA	1	1460	1	1460	NA	NA	1	622	
30	TCGA-GN-A4U3	2	25	2	11	0	1	0	0	16	247	10	0	16	134	3	0	TCGA-GN-A4U3-06	114	0.8317847907825399	55	TCGA-GN-A4U3-06	28	20	49	0.19601359498923576	TCGA-GN-A4U3-06	9	5	9	23	PASS	9203	TCGA-GN-A4U3	SKCM	30	MALE	WHITE	Stage III	NA	NA	NA	2004	NA	-11294	Alive	TUMOR FREE	3708	NA	NA	Distant Metastasis|Distant Metastasis	Lung|Brain	NA|NA	2274	NA	NA	NA	0	3708	0	3708	NA	NA	1	2274	
70	TCGA-GN-A4U4	6	57	7	28	5	2	0	0	33	517	36	0	18	274	6	1	TCGA-GN-A4U4-06	94	0.1337569030198219	44	TCGA-GN-A4U4-06	2	4	18	0.061872099568009924	TCGA-GN-A4U4-06	3	3	3	9	PASS	9204	TCGA-GN-A4U4	SKCM	73	MALE	WHITE	Stage IIA	NA	NA	NA	2011	NA	-26761	Alive	TUMOR FREE	1197	NA	NA	Distant Metastasis	Liver	NA	217	NA	NA	NA	0	1197	0	1197	NA	NA	1	217	
60	TCGA-GN-A4U5	0	30	2	8	1	1	0	1	14	245	17	0	5	129	6	0	TCGA-GN-A4U5	0	0	0	TCGA-GN-A4U5-01	5	8	120	0.13837054730509066	TCGA-GN-A4U5-01	5	4	2	11	PASS	9205	TCGA-GN-A4U5	SKCM	61	FEMALE	WHITE	Stage IB	NA	NA	NA	2011	NA	-22499	Alive	TUMOR FREE	1156	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1156	0	1156	NA	NA	0	1156	
60	TCGA-GN-A4U7	1	15	0	8	1	2	1	0	7	184	10	0	4	120	4	1	TCGA-GN-A4U7-06	185	0.31498703952015594	104	TCGA-GN-A4U7-06	8	6	53	0.16428650834900116	TCGA-GN-A4U7-06	6	5	5	16	PASS	9206	TCGA-GN-A4U7	SKCM	56	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2011	NA	-20458	Dead	WITH TUMOR	NA	317	NA	Distant Metastasis	Lung	NA	183	NA	NA	NA	1	317	1	317	NA	NA	1	183	
50	TCGA-GN-A4U8	1	30	2	12	2	0	2	0	20	314	25	2	14	151	6	2	TCGA-GN-A4U8-06	71	0.13758242985486044	26	TCGA-GN-A4U8-06	3	4	28	0.09034756325956683	TCGA-GN-A4U8-06	5	4	3	12	PASS	9207	TCGA-GN-A4U8	SKCM	51	MALE	WHITE	NA	NA	NA	NA	2009	NA	-18953	Alive	TUMOR FREE	1487	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1487	0	1487	NA	NA	0	1487	
70	TCGA-GN-A4U9	0	1	0	2	0	1	0	0	1	55	2	0	0	18	0	0	TCGA-GN-A4U9-06	150	0.5724037669940414	82	TCGA-GN-A4U9-06	22	33	67	0.18035435477761905	TCGA-GN-A4U9-06	7	5	5	17	PASS	9208	TCGA-GN-A4U9	SKCM	71	MALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-26118	Dead	WITH TUMOR	NA	673	NA	Locoregional Recurrence	NA	NA	151	NA	NA	NA	1	673	1	673	NA	NA	1	151	
70	TCGA-GN-A8LK	12	153	14	79	10	2	10	0	82	1491	97	0	34	821	27	3	TCGA-GN-A8LK-06	164	0.7398481474271591	83	TCGA-GN-A8LK-06	11	15	80	0.24651864953686065	TCGA-GN-A8LK-06	12	12	11	35	hypermutated sample	9209	TCGA-GN-A8LK	SKCM	70	MALE	WHITE	Stage IB	NA	NA	NA	2009	NA	-25725	Dead	WITH TUMOR	NA	1524	NA	Locoregional Recurrence	NA	NA	436	NA	NA	NA	1	1524	1	1524	NA	NA	1	436	
70	TCGA-GN-A8LL	1	7	1	2	1	1	1	0	3	40	3	0	0	17	0	0	TCGA-GN-A8LL-06	637	0.8916769758064412	454	TCGA-GN-A8LL-06	8	20	251	0.34170253839072906	TCGA-GN-A8LL-06	27	16	22	65	PASS	9210	TCGA-GN-A8LL	SKCM	68	FEMALE	WHITE	Stage IIC	NA	NA	NA	2012	NA	-25000	Dead	WITH TUMOR	NA	650	NA	NA	NA	NA	NA	NA	NA	NA	1	650	1	650	NA	NA	1	650	
70	TCGA-GN-A8LN	2	16	0	11	1	0	0	0	11	202	14	0	3	98	4	0	TCGA-GN-A8LN	0	0	0	TCGA-GN-A8LN-01	24	16	91	0.16239801099022275	TCGA-GN-A8LN-01	5	9	5	19	PASS	9211	TCGA-GN-A8LN	SKCM	68	MALE	WHITE	Stage IIC	NA	NA	NA	2013	NA	-24872	Alive	WITH TUMOR	772	NA	NA	New primary melanoma	NA	NA	186	NA	NA	NA	0	772	0	772	NA	NA	1	186	
60	TCGA-GN-A9SD	1	7	2	2	2	1	0	0	8	107	13	0	4	60	2	0	TCGA-GN-A9SD-06	74	0.3521057355283029	29	TCGA-GN-A9SD-06	8	9	55	0.3001088153408581	TCGA-GN-A9SD-06	12	12	11	35	PASS	9212	TCGA-GN-A9SD	SKCM	59	FEMALE	WHITE	Stage IA	NA	NA	NA	2009	NA	-21851	Dead	WITH TUMOR	NA	1807	NA	Locoregional Recurrence	NA	NA	1137	NA	NA	NA	1	1807	1	1807	NA	NA	1	1137	
50	TCGA-HR-A2OG	4	32	1	15	3	0	0	0	26	453	52	0	7	214	9	0	TCGA-HR-A2OG-06	92	0.6791500029736903	40	TCGA-HR-A2OG	0	0	0	0	TCGA-HR-A2OG-01	1	2	0	3	PASS	9213	TCGA-HR-A2OG	SKCM	50	FEMALE	[Not Evaluated]	NA	NA	NA	NA	NA	NA	-21767	Alive	TUMOR FREE	7	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	7	0	7	NA	NA	0	7	
50	TCGA-HR-A2OH	0	10	0	10	1	0	0	0	5	108	7	0	6	66	1	0	TCGA-HR-A2OH-06	80	0.4642905981981684	28	TCGA-HR-A2OH	0	0	0	0	TCGA-HR-A2OH-01	2	4	2	8	PASS	9214	TCGA-HR-A2OH	SKCM	46	FEMALE	[Not Evaluated]	Stage IIIB	NA	NA	NA	NA	NA	-16910	Dead	WITH TUMOR	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	1	2004	1	2004	NA	NA	1	2004	
90	TCGA-HR-A5NC	0	4	2	5	0	0	0	0	3	50	3	0	2	25	0	0	TCGA-HR-A5NC	0	0	0	TCGA-HR-A5NC-01	11	11	60	0.3420474376153614	TCGA-HR-A5NC-01	8	5	8	21	PASS	9215	TCGA-HR-A5NC	SKCM	90	FEMALE	[Not Evaluated]	NA	NA	NA	NA	NA	NA	-32871	Alive	TUMOR FREE	1000	NA	NA	Locoregional Recurrence	NA	NA	154	NA	NA	NA	0	1000	0	1000	NA	NA	1	154	
60	TCGA-IH-A3EA	7	70	2	43	5	2	1	0	53	1148	80	0	30	585	7	1	TCGA-IH-A3EA	0	0	0	TCGA-IH-A3EA-01	6	11	34	0.14273260150139488	TCGA-IH-A3EA-01	5	6	3	14	PASS	9216	TCGA-IH-A3EA	SKCM	61	MALE	WHITE	Stage IIC	NA	NA	NA	2008	NA	-22577	Alive	WITH TUMOR	524	NA	NA	Distant Metastasis	Brain	NA	314	NA	NA	NA	0	524	0	524	NA	NA	1	314	
30	TCGA-LH-A9QB	2	23	2	4	2	0	0	0	6	185	14	0	5	117	3	0	TCGA-LH-A9QB-06	154	0.9114664790884572	89	TCGA-LH-A9QB-06	8	10	95	0.2083289906462791	TCGA-LH-A9QB-06	6	5	7	18	PASS	9217	TCGA-LH-A9QB	SKCM	24	FEMALE	WHITE	NA	NA	NA	NA	1984	NA	-9058	Alive	TUMOR FREE	11217	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	11217	0	11217	NA	NA	0	11217	
50	TCGA-OD-A75X	5	68	5	46	4	1	1	0	41	784	50	0	21	428	13	2	TCGA-OD-A75X-06	197	0.8595260337054602	126	TCGA-OD-A75X-06	16	17	67	0.16796388964764775	TCGA-OD-A75X-06	9	7	5	21	PASS	9218	TCGA-OD-A75X	SKCM	49	MALE	WHITE	NA	NA	NA	NA	1989	NA	-17910	Dead	WITH TUMOR	NA	9061	NA	Distant Metastasis|Distant Metastasis|Distant Metastasis	"Brain|Other, Specify|Lung"	NA|stomach|NA	8987	NA	NA	NA	1	9061	1	9061	NA	NA	1	8987	
50	TCGA-QB-A6FS	6	52	11	39	0	0	0	0	35	880	57	0	25	504	11	0	TCGA-QB-A6FS-06	103	0.2942810359628816	43	TCGA-QB-A6FS-06	10	14	56	0.16375615981203967	TCGA-QB-A6FS-06	8	4	5	17	PASS	9219	TCGA-QB-A6FS	SKCM	49	MALE	WHITE	Stage IIIC	NA	NA	NA	2013	NA	-18134	Alive	WITH TUMOR	220	NA	NA	Distant Metastasis	"Other, Specify"	"SKIN, MID CHEST"	63	NA	NA	NA	0	220	0	220	NA	NA	1	63	
70	TCGA-QB-AA9O	8	84	3	40	5	2	0	0	63	1136	77	0	32	644	17	1	TCGA-QB-AA9O-06	318	0.7177177084808691	202	TCGA-QB-AA9O-06	15	29	147	0.17327365358465413	TCGA-QB-AA9O-06	14	17	9	40	PASS	9220	TCGA-QB-AA9O	SKCM	73	MALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-27009	Dead	WITH TUMOR	NA	549	NA	NA	NA	NA	NA	NA	NA	NA	1	549	1	549	NA	NA	1	549	
70	TCGA-RP-A690	0	0	0	0	1	0	0	0	2	11	3	0	1	4	0	0	TCGA-RP-A690-06	55	0.06422461379531834	16	TCGA-RP-A690-06	0	2	11	0.022813669566694696	TCGA-RP-A690-06	5	4	2	11	PASS	9221	TCGA-RP-A690	SKCM	66	FEMALE	WHITE	NA	NA	NA	NA	2005	NA	-24450	Alive	TUMOR FREE	6	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	6	0	6	NA	NA	0	6	
80	TCGA-RP-A693	1	47	2	27	2	0	1	0	25	614	39	0	10	324	12	0	TCGA-RP-A693-06	75	0.29638797903385744	24	TCGA-RP-A693-06	12	11	55	0.13994888549816836	TCGA-RP-A693-06	6	3	5	14	PASS	9222	TCGA-RP-A693	SKCM	77	MALE	WHITE	Stage IV	NA	NA	NA	2008	NA	-28394	Alive	TUMOR FREE	10	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	10	0	10	NA	NA	0	10	
70	TCGA-RP-A694	2	49	4	23	2	0	0	0	32	533	34	0	7	285	9	2	TCGA-RP-A694-06	103	0.21743055987897744	52	TCGA-RP-A694-06	9	10	46	0.1523519146092001	TCGA-RP-A694-06	5	4	6	15	PASS	9223	TCGA-RP-A694	SKCM	71	MALE	WHITE	Stage IV	NA	NA	NA	2009	NA	-26044	Alive	TUMOR FREE	21	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	21	0	21	NA	NA	0	21	
NA	TCGA-RP-A695	4	49	5	21	4	1	1	1	25	659	40	0	18	354	12	3	TCGA-RP-A695-06	105	0.8723249718471769	53	TCGA-RP-A695-06	17	15	38	0.11246601739628646	TCGA-RP-A695-06	4	8	4	16	PASS	9224	TCGA-RP-A695	SKCM	NA	MALE	WHITE	Stage IV	NA	NA	NA	1999	NA	NA	Alive	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
NA	TCGA-RP-A6K9	0	1	0	1	1	0	0	0	0	46	1	0	2	16	1	0	TCGA-RP-A6K9-06	85	0.929062044837507	36	TCGA-RP-A6K9-06	16	14	42	0.2026888742167853	TCGA-RP-A6K9-06	7	1	5	13	PASS	9225	TCGA-RP-A6K9	SKCM	NA	FEMALE	WHITE	NA	NA	NA	NA	2001	NA	NA	Alive	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
60	TCGA-W3-A824	4	98	2	42	20	3	5	1	58	1084	79	1	27	641	17	1	TCGA-W3-A824-06	102	0.11124154276386626	50	TCGA-W3-A824-06	3	3	16	0.0018731970912979688	TCGA-W3-A824-06	2	1	0	3	PASS	9226	TCGA-W3-A824	SKCM	63	MALE	WHITE	Stage I	NA	NA	NA	1995	NA	-23131	Alive	WITH TUMOR	6940	NA	NA	Distant Metastasis	"Other, Specify"	Spleen	2406	NA	NA	NA	0	6940	0	6940	NA	NA	1	2406	
60	TCGA-W3-A825	6	65	7	36	2	0	3	1	48	836	54	0	20	478	8	4	TCGA-W3-A825-06	162	0.5939107205262795	96	TCGA-W3-A825-06	24	22	89	0.2231833420314128	TCGA-W3-A825-06	6	4	6	16	PASS	9227	TCGA-W3-A825	SKCM	60	FEMALE	WHITE	Stage II	NA	NA	NA	1998	NA	-22097	Dead	WITH TUMOR	NA	1917	NA	NA	NA	NA	NA	NA	NA	NA	1	1917	1	1917	NA	NA	1	1917	
70	TCGA-W3-A828	6	66	7	47	11	2	1	1	56	1021	72	1	20	533	31	4	TCGA-W3-A828-06	138	0.23498573919112897	80	TCGA-W3-A828-06	2	3	50	0.09872955710744326	TCGA-W3-A828-06	8	8	7	23	PASS	9228	TCGA-W3-A828	SKCM	66	MALE	WHITE	Stage II	NA	NA	NA	1997	NA	-24258	Dead	NA	NA	3683	NA	NA	NA	NA	NA	NA	NA	NA	1	3683	NA	3683	NA	NA	0	3683	
90	TCGA-W3-AA1O	3	48	1	30	2	2	0	0	25	581	34	0	17	306	5	0	TCGA-W3-AA1O-06	161	0.9371691896076728	99	TCGA-W3-AA1O-06	10	16	50	0.10281859315473604	TCGA-W3-AA1O-06	7	5	5	17	PASS	9229	TCGA-W3-AA1O	SKCM	85	MALE	WHITE	Stage III	NA	NA	NA	1997	NA	-31351	Dead	WITH TUMOR	NA	122	NA	NA	NA	NA	NA	NA	NA	NA	1	122	1	122	NA	NA	1	122	
60	TCGA-W3-AA1Q	4	56	7	31	5	1	0	0	36	693	43	0	24	371	8	4	TCGA-W3-AA1Q-06	83	0.11234780341571207	31	TCGA-W3-AA1Q-06	4	3	25	0.011755842999623137	TCGA-W3-AA1Q-06	3	2	1	6	PASS	9230	TCGA-W3-AA1Q	SKCM	57	MALE	WHITE	Stage III	NA	NA	NA	1994	NA	-21033	Dead	WITH TUMOR	NA	2101	NA	Distant Metastasis	"Other, Specify"	Thigh	1066	NA	NA	NA	1	2101	1	2101	NA	NA	1	1066	
70	TCGA-W3-AA1R	6	81	12	45	5	3	3	0	63	1294	87	1	33	756	26	6	TCGA-W3-AA1R-06	132	0.6417490972001555	60	TCGA-W3-AA1R-06	11	14	89	0.24062882723854706	TCGA-W3-AA1R-06	10	14	11	35	hypermutated sample	9231	TCGA-W3-AA1R	SKCM	71	MALE	WHITE	Stage II	NA	NA	NA	1995	NA	-26145	Dead	WITH TUMOR	NA	3379	NA	Distant Metastasis	Lung	NA	1037	NA	NA	NA	1	3379	1	3379	NA	NA	1	1037	
60	TCGA-W3-AA1V	20	279	26	146	17	3	3	1	165	4131	270	2	93	2337	48	5	TCGA-W3-AA1V-06	426	0.9445225776345952	275	TCGA-W3-AA1V-06	16	39	105	0.1854755886006941	TCGA-W3-AA1V-06	15	15	9	39	hypermutated sample	9232	TCGA-W3-AA1V	SKCM	63	MALE	WHITE	Stage II	NA	NA	NA	1994	NA	-23314	Dead	WITH TUMOR	NA	1280	NA	Distant Metastasis	Liver	NA	1219	NA	NA	NA	1	1280	1	1280	NA	NA	1	1219	
60	TCGA-W3-AA1W	3	27	5	14	1	2	0	0	25	526	28	0	11	321	8	0	TCGA-W3-AA1W-06	80	0.2821977339714503	30	TCGA-W3-AA1W-06	9	14	39	0.1061087010038222	TCGA-W3-AA1W-06	4	3	2	9	PASS	9233	TCGA-W3-AA1W	SKCM	64	MALE	WHITE	Stage II	NA	NA	NA	1996	NA	-23711	Alive	TUMOR FREE	6666	NA	NA	Regional lymph node	NA	NA	335	NA	NA	NA	0	6666	0	6666	NA	NA	1	335	
30	TCGA-W3-AA21	4	36	3	11	2	1	0	0	9	383	29	0	13	215	6	1	TCGA-W3-AA21-06	117	0.5508208322834772	64	TCGA-W3-AA21-06	11	13	60	0.13707824685008724	TCGA-W3-AA21-06	11	5	6	22	PASS	9234	TCGA-W3-AA21	SKCM	26	MALE	WHITE	Stage I	NA	NA	NA	1994	NA	-9527	Dead	WITH TUMOR	NA	3195	NA	Distant Metastasis	"Other, Specify"	Chest	2952	NA	NA	NA	1	3195	1	3195	NA	NA	1	2952	
70	TCGA-WE-A8JZ	0	14	2	6	0	1	2	0	5	152	9	0	1	90	2	1	TCGA-WE-A8JZ-06	156	0.7840891878931526	88	TCGA-WE-A8JZ-06	29	20	84	0.24254983969851576	TCGA-WE-A8JZ-06	8	3	13	24	PASS	9235	TCGA-WE-A8JZ	SKCM	70	MALE	[Not Evaluated]	Stage IIIB	NA	NA	NA	2012	NA	-25884	Alive	TUMOR FREE	731	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	731	0	731	NA	NA	0	731	
70	TCGA-WE-A8K1	0	17	2	9	0	2	0	0	3	258	17	0	4	151	2	0	TCGA-WE-A8K1-06	160	0.2669874507174239	83	TCGA-WE-A8K1-06	5	8	75	0.12425831836555185	TCGA-WE-A8K1-06	10	12	6	28	PASS	9236	TCGA-WE-A8K1	SKCM	74	MALE	WHITE	Stage IIIC	NA	NA	NA	2010	NA	-27191	Alive	TUMOR FREE	1492	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1492	0	1492	NA	NA	0	1492	
90	TCGA-WE-A8K4	2	39	5	29	5	0	0	0	22	616	49	0	13	388	4	0	TCGA-WE-A8K4	0	0	0	TCGA-WE-A8K4-01	9	7	34	0.1916101688049038	TCGA-WE-A8K4-01	4	2	3	9	PASS	9237	TCGA-WE-A8K4	SKCM	85	MALE	WHITE	Stage IIB	NA	NA	NA	2013	NA	-31308	Alive	TUMOR FREE	614	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	614	0	614	NA	NA	0	614	
70	TCGA-WE-A8K5	6	61	10	41	2	2	0	0	48	862	49	0	28	475	13	2	TCGA-WE-A8K5-06	214	0.3290025632017608	134	TCGA-WE-A8K5-06	11	10	47	0.06620868153930992	TCGA-WE-A8K5-06	9	8	4	21	PASS	9238	TCGA-WE-A8K5	SKCM	65	MALE	WHITE	Stage IV	NA	NA	NA	2009	NA	-23837	Dead	WITH TUMOR	NA	1860	NA	Distant Metastasis	Brain	NA	1498	NA	NA	NA	1	1860	1	1860	NA	NA	1	1498	
80	TCGA-WE-A8K6	2	25	0	5	0	1	0	0	9	192	13	0	8	113	3	0	TCGA-WE-A8K6-06	136	0.5651231146863025	61	TCGA-WE-A8K6-06	22	19	61	0.14446248051924096	TCGA-WE-A8K6-06	9	4	3	16	PASS	9239	TCGA-WE-A8K6	SKCM	79	MALE	WHITE	Stage IIIB	NA	NA	NA	2013	NA	-29216	Alive	WITH TUMOR	546	NA	NA	Distant Metastasis	Liver	NA	256	NA	NA	NA	0	546	0	546	NA	NA	1	256	
70	TCGA-WE-A8ZM	0	5	1	1	0	2	0	0	1	61	6	0	1	25	2	1	TCGA-WE-A8ZM-06	420	0.9345254555328896	289	TCGA-WE-A8ZM-06	18	29	184	0.333788973251092	TCGA-WE-A8ZM-06	16	11	10	37	PASS	9240	TCGA-WE-A8ZM	SKCM	70	MALE	WHITE	Stage IIIB	NA	NA	NA	2006	NA	-25869	Alive	WITH TUMOR	3082	NA	NA	Locoregional Recurrence	NA	NA	646	NA	NA	NA	0	3082	0	3082	NA	NA	1	646	
60	TCGA-WE-A8ZN	1	5	3	1	1	1	0	0	4	124	6	0	4	78	3	0	TCGA-WE-A8ZN-06	212	0.09172982550383006	139	TCGA-WE-A8ZN-06	3	8	82	0.09675314283288798	TCGA-WE-A8ZN-06	4	4	2	10	PASS	9241	TCGA-WE-A8ZN	SKCM	57	MALE	[Not Evaluated]	Stage IIB	NA	NA	NA	2009	NA	-20942	Alive	WITH TUMOR	1794	NA	NA	NA	NA	NA	1449	NA	NA	NA	0	1794	0	1794	NA	NA	1	1449	
70	TCGA-WE-A8ZO	1	12	3	10	0	0	0	0	13	277	19	0	7	141	4	0	TCGA-WE-A8ZO-06	100	0.15373505901531856	47	TCGA-WE-A8ZO-06	6	11	72	0.32149208024121834	TCGA-WE-A8ZO-06	6	1	2	9	PASS	9242	TCGA-WE-A8ZO	SKCM	73	FEMALE	[Not Evaluated]	Stage IIIB	NA	NA	NA	2009	NA	-26946	Alive	TUMOR FREE	2145	NA	NA	Regional lymph node	NA	NA	1371	NA	NA	NA	0	2145	0	2145	NA	NA	1	1371	
50	TCGA-WE-A8ZQ	0	17	1	8	1	1	0	0	7	138	8	0	7	64	0	1	TCGA-WE-A8ZQ-06	176	0.5910476234232915	109	TCGA-WE-A8ZQ-06	19	27	81	0.18179766906093545	TCGA-WE-A8ZQ-06	6	6	5	17	PASS	9243	TCGA-WE-A8ZQ	SKCM	48	MALE	[Not Evaluated]	Stage IIA	NA	NA	NA	2009	NA	-17824	Alive	WITH TUMOR	1923	NA	NA	Distant Metastasis|Distant Metastasis	"Lung|Other, Specify"	NA|left thigh	1757	NA	NA	NA	0	1923	0	1923	NA	NA	1	1757	
50	TCGA-WE-A8ZR	0	2	0	1	0	0	0	0	1	24	1	0	0	7	1	0	TCGA-WE-A8ZR	0	0	0	TCGA-WE-A8ZR	0	0	0	0	TCGA-WE-A8ZR	0	0	0	0	PASS	9244	TCGA-WE-A8ZR	SKCM	49	MALE	WHITE	Stage IIIC	NA	NA	NA	2013	NA	-18051	Dead	WITH TUMOR	NA	274	NA	Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Locoregional Recurrence	"Liver|Lung|Bone|Other, Specify|Other, Specify"	NA|NA|NA|spleen|subcutaneous chest wall	126	NA	NA	NA	1	274	1	274	NA	NA	1	126	
30	TCGA-WE-A8ZT	1	23	7	10	0	0	1	0	20	355	21	0	6	182	4	3	TCGA-WE-A8ZT-06	105	0.14238492160575486	51	TCGA-WE-A8ZT-06	3	2	25	0.03557118921759378	TCGA-WE-A8ZT-06	2	1	1	4	PASS	9245	TCGA-WE-A8ZT	SKCM	25	FEMALE	WHITE	Stage IV	NA	NA	NA	2013	NA	-9379	Alive	TUMOR FREE	359	NA	NA	Locoregional Recurrence	NA	NA	69	NA	NA	NA	0	359	0	359	NA	NA	1	69	
50	TCGA-WE-A8ZX	6	36	5	16	1	0	0	0	15	428	24	0	13	253	7	1	TCGA-WE-A8ZX-06	212	0.8570533273682949	123	TCGA-WE-A8ZX-06	34	17	116	0.4102800132587047	TCGA-WE-A8ZX-06	3	0	10	13	PASS	9246	TCGA-WE-A8ZX	SKCM	45	MALE	WHITE	Stage IIIB	NA	NA	NA	2012	NA	-16736	Alive	TUMOR FREE	1089	NA	NA	Locoregional Recurrence	NA	NA	326	NA	NA	NA	0	1089	0	1089	NA	NA	1	326	
60	TCGA-WE-A8ZY	3	19	3	7	3	0	0	0	8	179	4	0	8	106	8	1	TCGA-WE-A8ZY-06	159	0.9392552338574076	99	TCGA-WE-A8ZY-06	24	27	78	0.267810169165365	TCGA-WE-A8ZY-06	6	4	3	13	PASS	9247	TCGA-WE-A8ZY	SKCM	62	MALE	WHITE	Stage IIA	NA	NA	NA	2010	NA	-22676	Dead	WITH TUMOR	NA	1506	NA	Distant Metastasis|NA	Liver|NA	NA|NA	1389	NA	NA	NA	1	1506	1	1506	NA	NA	1	1389	
40	TCGA-WE-AA9Y	0	2	1	2	0	0	0	0	3	58	2	0	0	34	2	0	TCGA-WE-AA9Y-06	81	0.2827984570339531	31	TCGA-WE-AA9Y-06	11	9	55	0.2675858240052605	TCGA-WE-AA9Y-06	8	3	7	18	PASS	9248	TCGA-WE-AA9Y	SKCM	37	MALE	WHITE	Stage IIIC	NA	NA	NA	2013	NA	-13850	Alive	TUMOR FREE	370	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	370	0	370	NA	NA	0	370	
50	TCGA-WE-AAA0	10	73	8	49	6	0	0	0	58	1108	67	1	30	568	13	3	TCGA-WE-AAA0-06	85	0.19142188342379415	36	TCGA-WE-AAA0-06	4	10	57	0.13794200051159244	TCGA-WE-AAA0-06	10	7	6	23	PASS	9249	TCGA-WE-AAA0	SKCM	47	MALE	WHITE	Stage IA	NA	NA	NA	2011	NA	-17261	Alive	TUMOR FREE	1229	NA	NA	Distant Metastasis|Distant Metastasis	"Other, Specify|Brain"	Spleen|NA	650	NA	NA	NA	0	1229	0	1229	NA	NA	1	650	
80	TCGA-WE-AAA3	1	30	2	8	3	0	0	0	12	269	19	0	8	177	4	1	TCGA-WE-AAA3-06	178	0.6703276689278836	120	TCGA-WE-AAA3-06	29	23	103	0.3120562258404209	TCGA-WE-AAA3-06	7	2	6	15	PASS	9250	TCGA-WE-AAA3	SKCM	84	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2013	NA	-30843	Alive	TUMOR FREE	651	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	651	0	651	NA	NA	0	651	
60	TCGA-WE-AAA4	1	9	2	2	0	0	0	0	6	184	11	0	5	87	5	0	TCGA-WE-AAA4-06	67	0.2869286971141581	26	TCGA-WE-AAA4-06	6	6	50	0.21366998367602327	TCGA-WE-AAA4-06	2	4	1	7	PASS	9251	TCGA-WE-AAA4	SKCM	56	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2012	NA	-20708	Alive	WITH TUMOR	760	NA	NA	Distant Metastasis|Locoregional Recurrence	Brain|NA	NA|NA	523	NA	NA	NA	0	760	0	760	NA	NA	1	523	
90	TCGA-XV-A9VZ	0	0	0	1	1	0	0	0	0	13	2	0	0	2	0	0	TCGA-XV-A9VZ	0	0	0	TCGA-XV-A9VZ-01	0	0	4	0.011475218170974057	TCGA-XV-A9VZ-01	0	2	1	3	PASS	9252	TCGA-XV-A9VZ	SKCM	90	FEMALE	WHITE	Stage II	NA	NA	NA	2013	NA	-32873	Alive	TUMOR FREE	11	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	11	0	11	NA	NA	0	11	
80	TCGA-XV-A9W2	0	1	0	1	0	1	0	0	2	30	2	0	1	17	3	0	TCGA-XV-A9W2	0	0	0	TCGA-XV-A9W2-01	7	14	122	0.3218515893703127	TCGA-XV-A9W2-01	10	10	10	30	PASS	9253	TCGA-XV-A9W2	SKCM	81	MALE	WHITE	Stage I	NA	NA	NA	2013	NA	-29836	Alive	TUMOR FREE	417	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	417	0	417	NA	NA	0	417	
50	TCGA-XV-A9W5	0	7	0	1	1	0	0	0	5	66	3	0	4	47	2	1	TCGA-XV-A9W5	0	0	0	TCGA-XV-A9W5-01	7	6	63	0.11125516448224418	TCGA-XV-A9W5-01	6	6	4	16	PASS	9254	TCGA-XV-A9W5	SKCM	51	MALE	WHITE	I/II NOS	NA	NA	NA	2013	NA	-18739	Alive	WITH TUMOR	392	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	392	0	392	NA	NA	0	392	
60	TCGA-XV-AAZV	0	6	1	4	0	0	0	0	3	90	3	0	0	52	0	0	TCGA-XV-AAZV	0	0	0	TCGA-XV-AAZV-01	19	12	129	0.4985863722798748	TCGA-XV-AAZV-01	6	2	9	17	PASS	9255	TCGA-XV-AAZV	SKCM	56	FEMALE	WHITE	Stage II	NA	NA	NA	2013	NA	-20545	Alive	TUMOR FREE	412	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	412	0	412	NA	NA	0	412	
60	TCGA-XV-AAZW	1	6	1	6	2	0	0	0	4	119	7	0	0	69	0	2	TCGA-XV-AAZW	0	0	0	TCGA-XV-AAZW-01	7	8	120	0.1933971699837739	TCGA-XV-AAZW-01	4	6	9	19	PASS	9256	TCGA-XV-AAZW	SKCM	62	FEMALE	WHITE	Stage II	NA	NA	NA	2013	NA	-22778	Dead	WITH TUMOR	NA	393	NA	NA	NA	NA	NA	NA	NA	NA	1	393	1	393	NA	NA	1	393	
80	TCGA-XV-AAZY	1	5	1	4	1	0	1	0	6	131	9	0	5	75	1	1	TCGA-XV-AAZY	0	0	0	TCGA-XV-AAZY-01	4	5	89	0.2011681355164535	TCGA-XV-AAZY-01	1	1	2	4	PASS	9257	TCGA-XV-AAZY	SKCM	76	FEMALE	WHITE	Stage IIIC	NA	NA	NA	2013	NA	-27938	Alive	TUMOR FREE	405	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	405	0	405	NA	NA	0	405	
50	TCGA-XV-AB01	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-XV-AB01-06	75	0.9475183916441516	25	TCGA-XV-AB01	0	0	0	0	TCGA-XV-AB01	0	0	0	0	PASS	9258	TCGA-XV-AB01	SKCM	54	FEMALE	WHITE	Stage II	NA	NA	NA	2013	NA	-20058	Alive	WITH TUMOR	403	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	403	0	403	NA	NA	0	403	
40	TCGA-YD-A89C	4	127	16	47	5	1	2	0	67	1277	86	0	42	733	22	3	TCGA-YD-A89C-06	199	0.947628629625904	118	TCGA-YD-A89C-06	8	8	33	0.07085969671538178	TCGA-YD-A89C-06	3	4	1	8	hypermutated sample	9259	TCGA-YD-A89C	SKCM	43	FEMALE	WHITE	Stage IA	NA	NA	NA	2013	NA	-15804	Alive	TUMOR FREE	210	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	210	0	210	NA	NA	0	210	
80	TCGA-YD-A9TA	11	194	23	93	12	3	1	2	128	2558	126	0	55	1436	36	1	TCGA-YD-A9TA-06	356	0.6387199588314507	233	TCGA-YD-A9TA-06	9	33	117	0.25685309290527153	TCGA-YD-A9TA-06	22	25	13	60	hypermutated sample	9260	TCGA-YD-A9TA	SKCM	75	MALE	WHITE	NA	NA	NA	NA	2010	NA	-27498	Alive	TUMOR FREE	1496	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1496	0	1496	NA	NA	0	1496	
NA	TCGA-YD-A9TB	1	21	0	5	0	1	0	0	11	259	9	0	3	158	3	0	TCGA-YD-A9TB-06	91	0.6906735575821049	37	TCGA-YD-A9TB-06	25	58	12	0.013799739583210235	TCGA-YD-A9TB-06	6	4	1	11	PASS	9261	TCGA-YD-A9TB	SKCM	NA	FEMALE	WHITE	NA	NA	NA	NA	1987	NA	NA	Alive	WITH TUMOR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
70	TCGA-YG-AA3N	7	107	12	63	1	2	0	0	66	1514	102	0	51	862	23	2	TCGA-YG-AA3N	0	0	0	TCGA-YG-AA3N-01	5	8	28	0.08193782358822539	TCGA-YG-AA3N-01	5	2	3	10	hypermutated sample	9262	TCGA-YG-AA3N	SKCM	67	MALE	[Unknown]	Stage IIC	NA	NA	NA	2013	NA	-24525	Alive	TUMOR FREE	306	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	306	0	306	NA	NA	0	306	
60	TCGA-YG-AA3O	5	58	16	17	4	1	3	0	47	856	48	0	26	448	15	2	TCGA-YG-AA3O-06	131	0.6686483381300831	69	TCGA-YG-AA3O-06	23	21	41	0.1028421053540791	TCGA-YG-AA3O-06	13	9	7	29	PASS	9263	TCGA-YG-AA3O	SKCM	62	MALE	[Unknown]	NA	NA	NA	NA	2011	NA	-22999	Dead	WITH TUMOR	NA	1154	NA	Regional lymph node	NA	NA	999	NA	NA	NA	1	1154	1	1154	NA	NA	1	999	
60	TCGA-YG-AA3P	0	9	0	0	1	2	0	0	3	60	0	0	0	26	1	0	TCGA-YG-AA3P-06	390	0.9471707202967891	294	TCGA-YG-AA3P-06	24	23	86	0.10820184562858026	TCGA-YG-AA3P-06	10	5	5	20	PASS	9264	TCGA-YG-AA3P	SKCM	63	FEMALE	[Unknown]	Stage IIB	NA	NA	NA	2013	NA	-23219	Alive	WITH TUMOR	439	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	439	0	439	NA	NA	0	439	
40	TCGA-Z2-A8RT	21	208	16	98	5	0	2	0	111	2215	131	1	64	1207	26	7	TCGA-Z2-A8RT-06	318	0.8231155394386306	209	TCGA-Z2-A8RT-06	7	10	175	0.2772283571480549	TCGA-Z2-A8RT-06	8	10	10	28	hypermutated sample	9265	TCGA-Z2-A8RT	SKCM	42	FEMALE	WHITE	Stage IIB	NA	NA	NA	2012	NA	-15342	Alive	TUMOR FREE	839	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	839	0	839	NA	NA	0	839	
60	TCGA-Z2-AA3S	2	7	4	6	0	2	0	0	12	154	10	0	3	94	3	0	TCGA-Z2-AA3S-06	256	0.9474799226084032	171	TCGA-Z2-AA3S-06	7	10	153	0.28369233351547346	TCGA-Z2-AA3S-06	7	9	11	27	PASS	9266	TCGA-Z2-AA3S	SKCM	58	MALE	WHITE	Stage IA	NA	NA	NA	2006	NA	-21318	Alive	WITH TUMOR	2950	NA	NA	Distant Metastasis	Lung	NA	2727	NA	NA	NA	0	2950	0	2950	NA	NA	1	2727	
60	TCGA-Z2-AA3V	2	23	1	6	1	0	1	0	10	323	24	1	11	190	3	1	TCGA-Z2-AA3V-06	119	0.2744297792544549	64	TCGA-Z2-AA3V-06	8	11	53	0.19656977235699785	TCGA-Z2-AA3V-06	10	6	5	21	PASS	9267	TCGA-Z2-AA3V	SKCM	57	FEMALE	WHITE	Stage IA	NA	NA	NA	2013	NA	-20937	Alive	TUMOR FREE	486	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	486	0	486	NA	NA	0	486	
70	TCGA-3M-AB46	0	13	1	5	14	1	8	1	3	127	8	0	4	40	7	1	TCGA-3M-AB46-01	169	0.5599843244145184	88	TCGA-3M-AB46-01	11	22	107	0.36420290537064776	TCGA-3M-AB46-01	15	18	18	51	PASS	9268	TCGA-3M-AB46	STAD	70	MALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2009	NA	NA	Alive	TUMOR FREE	1765	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1765	0	1765	0	1765	0	1765	
50	TCGA-3M-AB47	0	5	0	1	1	4	0	0	2	94	4	1	4	30	2	0	TCGA-3M-AB47-01	92	0.2128025650781669	43	TCGA-3M-AB47-01	6	3	27	0.03560427083406335	TCGA-3M-AB47-01	1	1	2	4	PASS	9269	TCGA-3M-AB47	STAD	51	MALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2008	NA	NA	Dead	WITH TUMOR	NA	NA	Stomach Cancer	Locoregional Recurrence	NA	NA	395	Stable Disease	NA	NA	1	NA	1	NA	NA	NA	1	395	
50	TCGA-B7-5816	3	98	2	20	183	41	14	0	41	903	28	1	14	340	25	0	TCGA-B7-5816-01	78	0.0876078017683517	34	TCGA-B7-5816-01	2	10	11	0.05887695125552071	TCGA-B7-5816-01	1	3	0	4	hypermutated sample	9270	TCGA-B7-5816	STAD	51	FEMALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2010	NA	-18698	Alive	TUMOR FREE	812	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	812	0	812	0	812	0	812	
60	TCGA-B7-5818	2	29	0	14	7	4	1	0	20	303	15	0	7	105	5	0	TCGA-B7-5818-01	106	0.2479442163359401	54	TCGA-B7-5818-01	9	10	15	0.13575597262703115	TCGA-B7-5818-01	5	1	3	9	PASS	9271	TCGA-B7-5818	STAD	62	MALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2010	NA	-22792	Alive	TUMOR FREE	356	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	356	0	356	NA	NA	0	356	
50	TCGA-B7-A5TI	3	45	4	10	73	18	11	0	25	417	22	1	9	185	6	1	TCGA-B7-A5TI-01	172	0.2772618106221729	107	TCGA-B7-A5TI-01	4	14	114	0.2464043842193436	TCGA-B7-A5TI-01	13	13	11	37	PASS	9272	TCGA-B7-A5TI	STAD	52	MALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2012	NA	-19014	Alive	TUMOR FREE	595	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	595	0	595	0	595	0	595	
70	TCGA-B7-A5TJ	0	6	1	2	15	3	1	1	5	195	11	0	9	85	1	0	TCGA-B7-A5TJ-01	152	0.6758500689287409	74	TCGA-B7-A5TJ-01	21	37	105	0.3075672192899328	TCGA-B7-A5TJ-01	8	6	0	14	PASS	9273	TCGA-B7-A5TJ	STAD	74	MALE	WHITE	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G1	2012	NA	-27057	Alive	TUMOR FREE	335	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	335	0	335	0	335	0	335	
50	TCGA-B7-A5TK	1	4	1	1	2	0	1	0	0	41	2	0	2	20	0	0	TCGA-B7-A5TK-01	37	0.1918183227485917	5	TCGA-B7-A5TK-01	10	14	48	0.21124131693701392	TCGA-B7-A5TK-01	2	2	3	7	PASS	9274	TCGA-B7-A5TK	STAD	51	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-18750	Alive	TUMOR FREE	288	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	288	0	288	0	288	0	288	
60	TCGA-B7-A5TN	0	6	0	2	4	1	0	0	3	60	3	0	0	28	1	0	TCGA-B7-A5TN-01	207	0.7859489090829813	112	TCGA-B7-A5TN-01	17	33	160	0.4086857219925453	TCGA-B7-A5TN-01	17	17	14	48	PASS	9275	TCGA-B7-A5TN	STAD	60	MALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-21962	Alive	TUMOR FREE	287	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	287	0	287	0	287	0	287	
60	TCGA-BR-4183	0	3	0	0	1	1	1	0	2	47	4	0	1	24	1	0	TCGA-BR-4183-01	346	0.610650007972812	217	TCGA-BR-4183-01	15	34	81	0.2806414490369203	TCGA-BR-4183-01	16	18	7	41	PASS	9276	TCGA-BR-4183	STAD	55	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2007	NA	-20420	Dead	NA	NA	201	NA	NA	NA	NA	NA	NA	NA	NA	1	201	NA	201	NA	NA	0	201	
70	TCGA-BR-4184	12	169	9	59	305	41	14	0	108	2582	131	1	44	1143	28	2	TCGA-BR-4184-01	109	0.2317277262063324	58	TCGA-BR-4184-01	5	5	12	0.07469223453799052	TCGA-BR-4184-01	0	0	0	0	hypermutated sample	9277	TCGA-BR-4184	STAD	70	MALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2007	NA	-25816	Dead	NA	NA	212	NA	NA	NA	NA	NA	NA	NA	NA	1	212	NA	212	NA	NA	0	212	
60	TCGA-BR-4187	0	1	0	0	1	1	1	0	1	26	1	0	3	10	0	0	TCGA-BR-4187-01	66	0.00490306627101743	24	TCGA-BR-4187-01	4	4	2	0.052636909314147835	TCGA-BR-4187-01	0	0	0	0	PASS	9278	TCGA-BR-4187	STAD	56	MALE	WHITE	NA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2008	NA	-20635	Dead	NA	NA	141	NA	NA	NA	NA	NA	NA	NA	NA	1	141	NA	141	NA	NA	0	141	
50	TCGA-BR-4188	0	4	2	1	0	1	0	0	4	97	3	0	2	31	1	0	TCGA-BR-4188-01	109	0.05339940386262937	50	TCGA-BR-4188-01	0	3	19	0.1146513215335638	TCGA-BR-4188-01	3	7	4	14	PASS	9279	TCGA-BR-4188	STAD	53	FEMALE	WHITE	NA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2008	NA	-19585	Dead	NA	NA	226	NA	NA	NA	NA	NA	NA	NA	NA	1	226	NA	226	NA	NA	0	226	
70	TCGA-BR-4191	0	13	0	6	10	0	2	0	9	163	10	0	4	53	6	2	TCGA-BR-4191-01	319	0.4410790811500884	182	TCGA-BR-4191-01	5	15	77	0.30488810071461325	TCGA-BR-4191-01	25	24	17	66	PASS	9280	TCGA-BR-4191	STAD	72	MALE	WHITE	NA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2008	NA	-26562	Dead	NA	NA	558	NA	NA	NA	NA	NA	NA	NA	NA	1	558	NA	558	NA	NA	0	558	
70	TCGA-BR-4201	3	73	6	14	278	54	21	0	37	913	57	1	18	410	18	1	TCGA-BR-4201-01	96	0.07328246047686365	42	TCGA-BR-4201-01	4	8	11	0.19886759525719105	TCGA-BR-4201-01	1	0	3	4	hypermutated sample	9281	TCGA-BR-4201	STAD	66	FEMALE	WHITE	NA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G1	2008	NA	-24354	Dead	NA	NA	940	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	940	NA	940	NA	NA	0	940	
80	TCGA-BR-4253	1	3	0	1	4	0	0	0	1	79	6	0	2	35	4	0	TCGA-BR-4253-01	76	0.02351438913772859	36	TCGA-BR-4253-01	2	6	4	0.07582318379591944	TCGA-BR-4253-01	1	1	1	3	PASS	9282	TCGA-BR-4253	STAD	80	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2008	NA	-29397	Dead	NA	NA	124	NA	NA	NA	NA	NA	NA	NA	NA	1	124	NA	124	NA	NA	0	124	
80	TCGA-BR-4255	0	4	0	0	3	0	1	0	4	37	8	0	1	25	2	1	TCGA-BR-4255-01	120	0.5354503839522358	60	TCGA-BR-4255-01	22	31	32	0.6164903919707869	TCGA-BR-4255-01	10	7	8	25	PASS	9283	TCGA-BR-4255	STAD	76	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2008	NA	-27893	Dead	NA	NA	124	NA	NA	NA	NA	NA	NA	NA	NA	1	124	NA	124	NA	NA	0	124	
80	TCGA-BR-4256	3	47	5	21	146	37	14	0	32	683	40	1	8	326	24	1	TCGA-BR-4256-01	91	0.04984739365907556	41	TCGA-BR-4256-01	5	7	3	0.05094312447584973	TCGA-BR-4256-01	1	2	0	3	hypermutated sample	9284	TCGA-BR-4256	STAD	80	MALE	WHITE	NA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2008	NA	-29441	Dead	NA	NA	284	NA	NA	NA	NA	NA	NA	NA	NA	1	284	NA	284	NA	NA	0	284	
80	TCGA-BR-4257	5	60	3	25	158	30	11	0	36	711	37	0	16	384	22	3	TCGA-BR-4257-01	169	0.8587509547558828	102	TCGA-BR-4257-01	24	37	15	0.26351061293242284	TCGA-BR-4257-01	2	0	0	2	hypermutated sample	9285	TCGA-BR-4257	STAD	79	FEMALE	WHITE	NA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2008	NA	-29014	Dead	NA	NA	294	NA	NA	NA	NA	NA	NA	NA	NA	1	294	NA	294	NA	NA	0	294	
50	TCGA-BR-4267	0	3	0	4	1	0	0	0	2	67	7	0	0	24	2	0	TCGA-BR-4267-01	188	0.3140474273205169	105	TCGA-BR-4267-01	5	12	43	0.2341379048565081	TCGA-BR-4267-01	17	19	17	53	PASS	9286	TCGA-BR-4267	STAD	51	MALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2008	NA	-18699	Dead	NA	NA	188	NA	NA	NA	NA	NA	NA	NA	NA	1	188	NA	188	NA	NA	0	188	
40	TCGA-BR-4279	1	0	0	0	3	1	0	0	1	28	2	1	2	24	3	0	TCGA-BR-4279-01	72	0.19401145156988156	21	TCGA-BR-4279-01	5	4	11	0.1588208132119718	TCGA-BR-4279-01	2	7	5	14	PASS	9287	TCGA-BR-4279	STAD	43	MALE	WHITE	Stage II	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2009	NA	-16065	Dead	NA	NA	291	NA	NA	NA	NA	NA	NA	NA	NA	1	291	NA	291	NA	NA	0	291	
80	TCGA-BR-4280	4	55	1	22	140	27	8	0	28	486	20	1	16	181	10	3	TCGA-BR-4280-01	77	0.058541679526691724	30	TCGA-BR-4280-01	3	2	9	0.0044886147151023325	TCGA-BR-4280-01	0	0	0	0	PASS	9288	TCGA-BR-4280	STAD	78	FEMALE	WHITE	Stage III	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2009	NA	-28515	Dead	NA	NA	201	NA	NA	NA	NA	NA	NA	NA	NA	1	201	NA	201	NA	NA	0	201	
70	TCGA-BR-4292	13	103	6	38	244	71	21	1	44	885	51	0	20	419	24	1	TCGA-BR-4292-01	139	0.15353119821789968	81	TCGA-BR-4292-01	4	3	3	0.059431437102747474	TCGA-BR-4292-01	2	4	3	9	hypermutated sample	9289	TCGA-BR-4292	STAD	73	FEMALE	WHITE	NA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G1	2009	NA	-26670	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-BR-4294	0	3	0	1	0	1	0	0	0	27	0	0	1	8	0	0	TCGA-BR-4294-01	117	0.9082675443113852	51	TCGA-BR-4294-01	18	11	22	0.4013002457194053	TCGA-BR-4294-01	2	0	3	5	PASS	9290	TCGA-BR-4294	STAD	65	MALE	WHITE	NA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2009	NA	-23758	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
60	TCGA-BR-4357	2	17	2	5	5	3	0	0	14	204	7	0	4	64	3	0	TCGA-BR-4357-01	1032	0.8756358909393137	697	TCGA-BR-4357-01	22	40	249	0.3337187406795293	TCGA-BR-4357-01	16	17	12	45	PASS	9291	TCGA-BR-4357	STAD	58	MALE	WHITE	NA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2008	NA	-21295	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-BR-4361	13	170	9	67	295	55	15	0	102	1776	59	1	35	773	56	2	TCGA-BR-4361-01	228	0.061226900107336286	142	TCGA-BR-4361-01	2	1	11	0.011599825489829494	TCGA-BR-4361-01	0	2	1	3	hypermutated sample	9292	TCGA-BR-4361	STAD	66	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2008	NA	-24260	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-BR-4362	9	87	9	36	248	51	23	0	55	1060	46	1	21	445	28	1	TCGA-BR-4362-01	210	0.44970010846558295	141	TCGA-BR-4362-01	10	10	10	0.09373110637904404	TCGA-BR-4362-01	1	0	0	1	hypermutated sample	9293	TCGA-BR-4362	STAD	74	FEMALE	WHITE	NA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2008	NA	-27179	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
60	TCGA-BR-4363	1	54	1	24	147	15	6	0	17	352	18	0	9	160	2	0	TCGA-BR-4363-01	175	0.09018887656477588	111	TCGA-BR-4363-01	3	4	14	0.04748027934578252	TCGA-BR-4363-01	3	0	2	5	PASS	9294	TCGA-BR-4363	STAD	60	FEMALE	WHITE	NA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2008	NA	-22196	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
90	TCGA-BR-4366	1	10	0	6	0	2	0	0	5	105	7	1	3	38	5	0	TCGA-BR-4366-01	704	0.4711147404853619	465	TCGA-BR-4366-01	7	23	227	0.519757153934726	TCGA-BR-4366-01	15	19	9	43	PASS	9295	TCGA-BR-4366	STAD	87	MALE	WHITE	NA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2008	NA	-32024	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
80	TCGA-BR-4367	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BR-4367-01	324	0.6211309746631307	217	TCGA-BR-4367-01	15	33	65	0.5392070485198728	TCGA-BR-4367-01	19	14	13	46	PASS	9296	TCGA-BR-4367	STAD	78	MALE	WHITE	NA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2008	NA	-28817	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
80	TCGA-BR-4368	5	84	4	27	204	25	10	1	47	843	49	0	11	414	15	1	TCGA-BR-4368-01	101	0.582418146017214	50	TCGA-BR-4368-01	15	8	6	0.00588590380120464	TCGA-BR-4368-01	0	1	0	1	hypermutated sample	9297	TCGA-BR-4368	STAD	78	FEMALE	WHITE	Stage IV	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2008	NA	-28770	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
80	TCGA-BR-4369	1	16	0	4	1	0	1	0	6	143	7	0	5	51	1	0	TCGA-BR-4369-01	329	0.669958778985025	209	TCGA-BR-4369-01	20	59	54	0.25014747546520066	TCGA-BR-4369-01	16	16	7	39	PASS	9298	TCGA-BR-4369	STAD	75	MALE	WHITE	NA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2008	NA	-27509	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-BR-4370	5	70	6	37	153	31	12	0	46	730	29	0	17	339	12	1	TCGA-BR-4370-01	89	0.10425300635231234	41	TCGA-BR-4370-01	4	4	2	0.04809771716699803	TCGA-BR-4370-01	0	0	0	0	hypermutated sample	9299	TCGA-BR-4370	STAD	74	FEMALE	WHITE	NA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2008	NA	-27344	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-BR-4371	1	5	0	5	0	0	2	0	7	118	14	0	2	53	2	0	TCGA-BR-4371-01	109	0.3324840734326158	51	TCGA-BR-4371-01	9	6	9	0.0124480423844727	TCGA-BR-4371-01	1	3	1	5	PASS	9300	TCGA-BR-4371	STAD	71	FEMALE	WHITE	NA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G1	2008	NA	-26290	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
80	TCGA-BR-6452	32	511	37	212	991	314	78	2	261	7838	334	10	121	3157	208	4	TCGA-BR-6452-01	51	0.050651243767058714	11	TCGA-BR-6452-01	2	2	19	7.725115768526458e-05	TCGA-BR-6452-01	0	0	0	0	hypermutated sample	9301	TCGA-BR-6452	STAD	78	FEMALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-28827	Alive	TUMOR FREE	1055	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1055	0	1055	0	1055	0	1055	
50	TCGA-BR-6453	1	5	0	3	1	0	0	0	5	150	4	0	2	55	3	0	TCGA-BR-6453-01	50	0.0967227529896925	9	TCGA-BR-6453-01	5	6	4	0.07864895904300655	TCGA-BR-6453-01	1	1	1	3	PASS	9302	TCGA-BR-6453	STAD	54	MALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-20061	Alive	TUMOR FREE	485	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	485	0	485	0	485	0	485	
60	TCGA-BR-6454	0	3	0	10	2	2	0	0	7	107	12	1	0	45	0	0	TCGA-BR-6454-01	113	0.5402122708174155	41	TCGA-BR-6454-01	21	38	34	0.3784234997043648	TCGA-BR-6454-01	17	9	8	34	PASS	9303	TCGA-BR-6454	STAD	58	MALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-21501	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
60	TCGA-BR-6455	1	3	0	1	1	0	0	0	1	64	4	0	1	40	3	0	TCGA-BR-6455-01	75	0.11804980358538025	40	TCGA-BR-6455-01	6	7	11	0.07781966521123651	TCGA-BR-6455-01	0	0	0	0	PASS	9304	TCGA-BR-6455	STAD	59	MALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-21865	Dead	WITH TUMOR	NA	422	NA	Distant Metastasis	Liver	NA	385	Stable Disease	NA	NA	1	422	1	422	NA	NA	1	385	
70	TCGA-BR-6456	0	6	0	14	2	0	2	0	3	133	8	0	2	65	6	2	TCGA-BR-6456-01	257	0.5496826555781408	158	TCGA-BR-6456-01	24	27	77	0.3070358260291637	TCGA-BR-6456-01	13	16	14	43	PASS	9305	TCGA-BR-6456	STAD	74	FEMALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-27288	Dead	TUMOR FREE	NA	526	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	526	0	526	0	526	0	526	
70	TCGA-BR-6457	0	14	0	6	2	0	2	0	2	202	6	0	2	64	2	0	TCGA-BR-6457-01	90	0.16678170454705585	34	TCGA-BR-6457-01	9	10	15	0.20161535447748968	TCGA-BR-6457-01	6	4	4	14	PASS	9306	TCGA-BR-6457	STAD	69	MALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-25396	Alive	TUMOR FREE	416	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	416	0	416	0	416	0	416	
60	TCGA-BR-6458	0	30	0	20	12	2	0	2	26	496	2	0	9	170	4	0	TCGA-BR-6458-01	249	0.5849216898256581	134	TCGA-BR-6458-01	13	36	55	0.3698330085530354	TCGA-BR-6458-01	19	23	11	53	PASS	9307	TCGA-BR-6458	STAD	57	FEMALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-21069	Dead	WITH TUMOR	NA	588	NA	Distant Metastasis	Liver	NA	574	Complete Remission/Response	NA	NA	1	588	1	588	1	574	1	574	
60	TCGA-BR-6563	0	2	0	0	0	0	1	0	0	61	3	0	1	19	1	0	TCGA-BR-6563-01	35	0.03300587625808138	5	TCGA-BR-6563-01	1	7	6	0.1855847336808262	TCGA-BR-6563-01	1	1	1	3	PASS	9308	TCGA-BR-6563	STAD	60	MALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-21936	Alive	TUMOR FREE	1190	NA	NA	New Primary Tumor	NA	NA	148	Complete Remission/Response	NA	NA	0	1190	0	1190	0	1190	1	148	
50	TCGA-BR-6564	0	4	0	2	4	4	2	0	6	42	8	0	0	22	0	0	TCGA-BR-6564-01	84	0.29009857300029684	34	TCGA-BR-6564-01	12	13	21	0.3153659670071309	TCGA-BR-6564-01	6	5	10	21	PASS	9309	TCGA-BR-6564	STAD	46	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-17129	Dead	TUMOR FREE	NA	794	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	794	0	794	0	794	0	794	
70	TCGA-BR-6565	0	4	2	2	0	1	0	0	5	116	7	0	0	36	4	0	TCGA-BR-6565-01	214	0.6638767938208685	136	TCGA-BR-6565-01	28	55	33	0.3109443284895414	TCGA-BR-6565-01	19	10	4	33	PASS	9310	TCGA-BR-6565	STAD	67	MALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-24495	Dead	WITH TUMOR	NA	279	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	279	1	279	NA	NA	1	279	
60	TCGA-BR-6566	17	111	8	44	242	36	19	0	51	1260	42	0	16	571	40	6	TCGA-BR-6566-01	59	0.17096611907839218	15	TCGA-BR-6566-01	5	7	9	0.09401728126187116	TCGA-BR-6566-01	1	0	0	1	hypermutated sample	9311	TCGA-BR-6566	STAD	64	FEMALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-23404	Alive	TUMOR FREE	997	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	997	0	997	0	997	0	997	
70	TCGA-BR-6705	0	3	0	1	0	0	0	0	1	76	5	0	4	26	1	0	TCGA-BR-6705-01	140	0.16002641294516032	77	TCGA-BR-6705-01	5	6	9	0.08552462216257779	TCGA-BR-6705-01	5	3	2	10	PASS	9312	TCGA-BR-6705	STAD	68	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-25073	Dead	WITH TUMOR	NA	779	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	779	1	779	NA	NA	1	779	
60	TCGA-BR-6706	3	17	0	2	6	2	2	0	10	356	6	0	2	97	6	0	TCGA-BR-6706-01	76	0.022823085813766863	25	TCGA-BR-6706-01	4	3	3	0.00020687003418441293	TCGA-BR-6706-01	0	0	0	0	PASS	9313	TCGA-BR-6706	STAD	63	MALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2010	NA	-23053	Dead	WITH TUMOR	NA	549	NA	Locoregional Recurrence	NA	NA	402	Complete Remission/Response	NA	NA	1	549	1	549	1	402	1	402	
80	TCGA-BR-6707	0	4	0	4	1	0	1	0	8	50	9	0	0	16	1	0	TCGA-BR-6707-01	69	0.11975103842851832	25	TCGA-BR-6707-01	8	5	3	0.08732712520804965	TCGA-BR-6707-01	1	1	1	3	PASS	9314	TCGA-BR-6707	STAD	75	MALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-27529	Alive	WITH TUMOR	491	NA	NA	Locoregional Recurrence	NA	NA	426	Complete Remission/Response	NA	NA	0	491	0	491	1	426	1	426	
60	TCGA-BR-6709	0	4	0	0	0	2	0	0	2	73	6	0	2	18	2	0	TCGA-BR-6709-01	184	0.26442703571879633	105	TCGA-BR-6709-01	7	16	60	0.3268827016126321	TCGA-BR-6709-01	12	9	14	35	pathology review	9315	TCGA-BR-6709	STAD	57	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-20935	Dead	WITH TUMOR	NA	370	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	370	1	370	NA	NA	1	370	
40	TCGA-BR-6710	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BR-6710-01	51	1.1480737692185985e-05	16	TCGA-BR-6710-01	0	0	0	0.0	TCGA-BR-6710-01	0	0	0	0	PASS	9316	TCGA-BR-6710	STAD	41	MALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-15316	Alive	TUMOR FREE	273	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	273	0	273	0	273	0	273	
70	TCGA-BR-6801	1	2	0	2	2	0	1	0	3	33	2	0	1	18	0	0	TCGA-BR-6801-01	156	0.8534337844248205	90	TCGA-BR-6801-01	7	29	70	0.9065167289299974	TCGA-BR-6801-01	6	2	1	9	PASS	9317	TCGA-BR-6801	STAD	70	MALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-25637	Alive	TUMOR FREE	1223	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1223	0	1223	0	1223	0	1223	
70	TCGA-BR-6802	4	42	1	12	103	36	4	0	19	621	44	2	12	309	14	0	TCGA-BR-6802-01	75	0.11765751065509328	26	TCGA-BR-6802-01	4	6	8	0.09683450294121984	TCGA-BR-6802-01	0	0	0	0	PASS	9318	TCGA-BR-6802	STAD	65	MALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-23915	Alive	TUMOR FREE	940	NA	NA	Distant Metastasis	Non-regional / Distant Lymph Nodes	NA	807	Complete Remission/Response	NA	NA	0	940	0	940	1	807	1	807	
50	TCGA-BR-6803	0	4	0	0	0	0	0	0	0	22	0	0	0	10	0	0	TCGA-BR-6803-01	81	0.19692480591449488	34	TCGA-BR-6803-01	4	6	10	0.2054791396305965	TCGA-BR-6803-01	1	2	2	5	PASS	9319	TCGA-BR-6803	STAD	54	FEMALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-19751	Alive	TUMOR FREE	949	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	949	0	949	0	949	0	949	
60	TCGA-BR-6852	6	95	0	43	268	56	14	0	49	1458	68	0	33	626	36	0	TCGA-BR-6852-01	91	0.05729095943097892	40	TCGA-BR-6852-01	2	4	6	0.030572694817031763	TCGA-BR-6852-01	1	1	0	2	hypermutated sample	9320	TCGA-BR-6852	STAD	64	FEMALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-23469	Alive	TUMOR FREE	1367	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1367	0	1367	0	1367	0	1367	
60	TCGA-BR-7196	0	2	2	2	2	0	0	0	1	52	7	0	0	19	2	0	TCGA-BR-7196-01	52	0.0565369579884794	13	TCGA-BR-7196-01	3	2	0	0.0	TCGA-BR-7196-01	2	2	0	4	PASS	9321	TCGA-BR-7196	STAD	64	MALE	WHITE	Stage IV	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-23611	Alive	WITH TUMOR	666	NA	NA	Distant Metastasis	Lung	NA	348	Complete Remission/Response	NA	NA	0	666	0	666	NA	NA	1	348	
70	TCGA-BR-7197	4	16	2	14	4	4	0	0	16	273	20	0	6	100	4	0	TCGA-BR-7197-01	433	0.964959148217943	286	TCGA-BR-7197-01	27	39	193	0.4023884311086074	TCGA-BR-7197-01	19	8	9	36	PASS	9322	TCGA-BR-7197	STAD	69	MALE	WHITE	Stage II	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	GX	2011	NA	-25445	Alive	TUMOR FREE	280	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	280	0	280	0	280	0	280	
80	TCGA-BR-7703	6	62	4	25	171	55	22	0	54	951	68	0	25	398	18	4	TCGA-BR-7703-01	362	0.09283855046141833	292	TCGA-BR-7703-01	0	0	131	0.04931942476281145	TCGA-BR-7703-01	0	6	2	8	PASS	9323	TCGA-BR-7703	STAD	81	MALE	WHITE	Stage IA	NA	"Stomach, Intestinal Adenocarcinoma, Papillary Type"	G2	2011	NA	-29711	Alive	TUMOR FREE	1100	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1100	0	1100	0	1100	0	1100	
70	TCGA-BR-7704	4	7	2	18	10	6	4	0	22	575	40	4	13	195	22	0	TCGA-BR-7704-01	185	0.9260658963798116	109	TCGA-BR-7704-01	17	30	89	0.4218986905519572	TCGA-BR-7704-01	8	6	4	18	pathology review	9324	TCGA-BR-7704	STAD	69	FEMALE	WHITE	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-25300	Alive	TUMOR FREE	1072	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1072	0	1072	0	1072	0	1072	
70	TCGA-BR-7707	5	51	7	19	173	44	15	0	24	954	46	0	18	417	22	2	TCGA-BR-7707-01	85	0.09832172815473128	34	TCGA-BR-7707-01	4	4	5	0.019660793692651314	TCGA-BR-7707-01	1	1	1	3	hypermutated sample	9325	TCGA-BR-7707	STAD	69	FEMALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-25325	Alive	TUMOR FREE	1090	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1090	0	1090	0	1090	0	1090	
70	TCGA-BR-7715	0	7	2	2	6	0	0	0	15	218	8	0	8	68	6	0	TCGA-BR-7715-01	515	0.7643832967958665	373	TCGA-BR-7715-01	28	39	69	0.1332474173334215	TCGA-BR-7715-01	11	7	5	23	PASS	9326	TCGA-BR-7715	STAD	65	MALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-23861	Alive	TUMOR FREE	1023	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1023	0	1023	0	1023	0	1023	
60	TCGA-BR-7716	0	13	0	4	2	0	0	0	4	255	28	0	0	89	0	0	TCGA-BR-7716-01	374	0.4999077934627335	238	TCGA-BR-7716-01	14	35	150	0.4481276414140157	TCGA-BR-7716-01	24	20	12	56	PASS	9327	TCGA-BR-7716	STAD	62	FEMALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-22829	Alive	TUMOR FREE	1210	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1210	0	1210	0	1210	0	1210	
60	TCGA-BR-7717	0	13	0	10	2	0	6	0	7	221	8	0	0	103	0	0	TCGA-BR-7717-01	206	0.8840785460932791	114	TCGA-BR-7717-01	22	36	75	0.5665681002266753	TCGA-BR-7717-01	17	23	9	49	PASS	9328	TCGA-BR-7717	STAD	63	MALE	WHITE	Stage IV	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-23102	Dead	TUMOR FREE	NA	552	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	552	0	552	NA	NA	0	552	
60	TCGA-BR-7722	0	1	0	0	1	1	0	0	3	36	1	0	0	16	1	0	TCGA-BR-7722-01	101	0.15442802246490706	47	TCGA-BR-7722-01	6	8	26	0.20341826181161612	TCGA-BR-7722-01	2	2	2	6	PASS	9329	TCGA-BR-7722	STAD	62	MALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-22701	Dead	TUMOR FREE	NA	466	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	466	0	466	0	466	0	466	
60	TCGA-BR-7723	1	6	1	4	2	0	0	0	5	127	7	1	3	51	5	0	TCGA-BR-7723-01	440	0.5843182688633575	284	TCGA-BR-7723-01	20	77	87	0.14755213925607708	TCGA-BR-7723-01	16	21	7	44	PASS	9330	TCGA-BR-7723	STAD	59	MALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-21839	Dead	WITH TUMOR	NA	874	NA	Distant Metastasis	Liver	NA	559	Complete Remission/Response	NA	NA	1	874	1	874	1	559	1	559	
70	TCGA-BR-7851	14	106	10	58	391	83	29	1	58	1854	113	2	33	960	48	2	TCGA-BR-7851-01	109	0.008126589649747044	54	TCGA-BR-7851-01	0	2	21	0.06065750380369779	TCGA-BR-7851-01	1	1	1	3	hypermutated sample	9331	TCGA-BR-7851	STAD	74	MALE	WHITE	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-27091	Dead	TUMOR FREE	574	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	NA	0	NA	0	NA	0	NA	
70	TCGA-BR-7901	0	7	1	3	1	0	1	2	4	144	7	0	2	61	1	1	TCGA-BR-7901-01	246	0.5252096790169871	140	TCGA-BR-7901-01	22	61	44	0.1501572026428957	TCGA-BR-7901-01	20	18	5	43	PASS	9332	TCGA-BR-7901	STAD	74	MALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-27031	Dead	TUMOR FREE	NA	105	NA	Locoregional Recurrence	NA	NA	91	Complete Remission/Response	NA	NA	1	105	0	105	1	91	1	91	
50	TCGA-BR-7957	0	2	0	2	0	0	2	2	4	78	12	0	2	22	0	0	TCGA-BR-7957-01	57	0.14319909811239548	18	TCGA-BR-7957-01	4	4	5	0.13078549845329626	TCGA-BR-7957-01	0	0	0	0	PASS	9333	TCGA-BR-7957	STAD	50	FEMALE	WHITE	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	GX	2011	NA	-18517	Dead	TUMOR FREE	NA	276	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	276	0	276	NA	NA	0	276	
60	TCGA-BR-7958	1	8	3	6	3	1	1	0	8	133	6	0	4	41	0	0	TCGA-BR-7958-01	85	0.19749084209970535	34	TCGA-BR-7958-01	5	7	40	0.06694687772767646	TCGA-BR-7958-01	6	10	4	20	PASS	9334	TCGA-BR-7958	STAD	60	MALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-22204	Alive	TUMOR FREE	899	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	899	0	899	0	899	0	899	
60	TCGA-BR-7959	0	3	1	5	1	0	0	0	6	82	6	0	1	23	1	0	TCGA-BR-7959-01	258	0.5866441777470017	170	TCGA-BR-7959-01	19	31	192	0.4860946575884006	TCGA-BR-7959-01	16	10	9	35	PASS	9335	TCGA-BR-7959	STAD	59	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G3	2011	NA	-21730	Alive	TUMOR FREE	1010	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1010	0	1010	0	1010	0	1010	
50	TCGA-BR-8058	1	2	0	1	0	0	0	0	0	43	2	0	1	12	1	0	TCGA-BR-8058-01	71	0.24925634745044545	28	TCGA-BR-8058-01	8	9	60	0.27605513857354325	TCGA-BR-8058-01	5	3	9	17	PASS	9336	TCGA-BR-8058	STAD	53	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-19658	Alive	TUMOR FREE	1133	NA	NA	New Primary Tumor	"Other, specify"	Rectum	89	Complete Remission/Response	NA	NA	0	1133	0	1133	0	1133	1	89	
70	TCGA-BR-8059	2	41	3	21	65	15	8	2	24	517	35	0	7	194	11	2	TCGA-BR-8059-01	81	0.2734219773023473	33	TCGA-BR-8059-01	4	13	48	0.21641919196118933	TCGA-BR-8059-01	16	23	8	47	PASS	9337	TCGA-BR-8059	STAD	72	MALE	WHITE	Stage III	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-26474	Dead	TUMOR FREE	NA	439	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	439	0	439	0	439	0	439	
80	TCGA-BR-8060	0	11	1	8	1	1	3	0	6	167	4	0	4	78	5	0	TCGA-BR-8060-01	300	0.6364313325971133	184	TCGA-BR-8060-01	18	37	142	0.33575129325016884	TCGA-BR-8060-01	18	19	16	53	pathology review	9338	TCGA-BR-8060	STAD	75	FEMALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-27561	Dead	TUMOR FREE	NA	348	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	348	0	348	0	348	0	348	
60	TCGA-BR-8077	1	6	0	1	0	1	1	1	2	101	2	0	2	28	1	0	TCGA-BR-8077-01	267	0.7658792406532619	151	TCGA-BR-8077-01	22	59	143	0.33577514989547746	TCGA-BR-8077-01	28	21	14	63	PASS	9339	TCGA-BR-8077	STAD	58	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-21413	Alive	TUMOR FREE	21	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	21	0	21	0	21	0	21	
70	TCGA-BR-8078	7	133	10	40	327	54	19	2	53	961	39	3	28	425	27	0	TCGA-BR-8078-01	79	0.13958236362110768	37	TCGA-BR-8078-01	5	3	22	0.007525774056190543	TCGA-BR-8078-01	2	0	0	2	hypermutated sample	9340	TCGA-BR-8078	STAD	70	FEMALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-25861	Alive	TUMOR FREE	900	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	900	0	900	0	900	0	900	
70	TCGA-BR-8080	1	12	0	2	1	0	0	0	5	151	9	0	1	43	1	0	TCGA-BR-8080-01	89	0.34700632055123903	32	TCGA-BR-8080-01	19	35	28	0.17878969805142966	TCGA-BR-8080-01	16	9	7	32	PASS	9341	TCGA-BR-8080	STAD	72	FEMALE	WHITE	Stage IIIC	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G3	2011	NA	-26546	Dead	TUMOR FREE	NA	292	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	292	0	292	0	292	0	292	
70	TCGA-BR-8081	4	41	5	23	103	27	9	0	22	595	44	1	16	303	12	0	TCGA-BR-8081-01	45	0.0005063304965778918	8	TCGA-BR-8081-01	0	4	11	0.06303844600781981	TCGA-BR-8081-01	0	0	0	0	hypermutated sample	9342	TCGA-BR-8081	STAD	71	FEMALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-26095	Alive	TUMOR FREE	981	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	981	0	981	0	981	0	981	
70	TCGA-BR-8284	1	18	1	6	15	6	2	0	5	243	18	0	2	110	7	0	TCGA-BR-8284-01	55	0.1732834331227557	19	TCGA-BR-8284-01	6	4	20	0.05837026172226624	TCGA-BR-8284-01	4	5	3	12	PASS	9343	TCGA-BR-8284	STAD	72	FEMALE	WHITE	Stage IIIC	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-26526	Dead	TUMOR FREE	NA	245	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	245	0	245	0	245	0	245	
60	TCGA-BR-8285	0	2	1	2	2	0	0	1	3	80	2	0	0	29	2	0	TCGA-BR-8285-01	64	0.08433065581632368	26	TCGA-BR-8285-01	4	2	18	0.011501981579707558	TCGA-BR-8285-01	2	1	1	4	PASS	9344	TCGA-BR-8285	STAD	57	FEMALE	WHITE	Stage IIIC	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-20849	Dead	TUMOR FREE	NA	17	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	17	0	17	0	17	0	17	
50	TCGA-BR-8286	1	7	0	2	2	2	0	1	4	96	3	0	0	53	2	1	TCGA-BR-8286-01	330	0.5363274582404042	211	TCGA-BR-8286-01	17	26	191	0.36964538245697376	TCGA-BR-8286-01	16	8	13	37	PASS	9345	TCGA-BR-8286	STAD	49	MALE	WHITE	Stage II	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-17966	Alive	TUMOR FREE	895	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	895	0	895	0	895	0	895	
60	TCGA-BR-8289	1	9	1	2	2	3	1	0	3	168	12	0	0	44	5	0	TCGA-BR-8289-01	502	0.6205368408976617	345	TCGA-BR-8289-01	19	61	306	0.4598190498855686	TCGA-BR-8289-01	21	18	16	55	PASS	9346	TCGA-BR-8289	STAD	57	MALE	WHITE	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-20849	Dead	TUMOR FREE	NA	81	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	81	0	81	NA	NA	0	81	
60	TCGA-BR-8291	0	0	0	1	0	0	0	0	0	22	3	1	0	6	0	0	TCGA-BR-8291-01	48	0.18076223158887705	10	TCGA-BR-8291-01	8	8	23	0.2552970024088592	TCGA-BR-8291-01	6	4	7	17	PASS	9347	TCGA-BR-8291	STAD	61	MALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	GX	2011	NA	-22552	Dead	TUMOR FREE	NA	607	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	607	0	607	0	607	0	607	
60	TCGA-BR-8295	0	1	0	3	4	1	1	0	2	33	2	0	1	15	0	0	TCGA-BR-8295-01	176	0.646678040793222	80	TCGA-BR-8295-01	22	71	58	0.19277632169652534	TCGA-BR-8295-01	7	7	6	20	PASS	9348	TCGA-BR-8295	STAD	60	FEMALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-22256	Dead	WITH TUMOR	NA	67	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	67	1	67	NA	NA	1	67	
60	TCGA-BR-8296	0	2	0	2	1	0	1	0	3	56	4	0	1	24	1	0	TCGA-BR-8296-01	88	0.4252370657603873	37	TCGA-BR-8296-01	27	40	68	0.3448809050152927	TCGA-BR-8296-01	11	11	5	27	PASS	9349	TCGA-BR-8296	STAD	58	FEMALE	WHITE	Stage IIIC	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-21527	Dead	WITH TUMOR	NA	474	NA	Distant Metastasis	Liver	NA	390	Stable Disease	NA	NA	1	474	1	474	NA	NA	1	390	
60	TCGA-BR-8297	1	12	2	5	2	3	1	0	7	183	9	0	2	68	3	0	TCGA-BR-8297-01	119	0.3690292257810434	50	TCGA-BR-8297-01	14	67	31	0.1646850895843377	TCGA-BR-8297-01	18	18	5	41	PASS	9350	TCGA-BR-8297	STAD	58	MALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Diffuse Type"	GX	2012	NA	-21224	Alive	WITH TUMOR	225	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	225	0	225	NA	NA	0	225	
70	TCGA-BR-8360	3	59	3	19	132	28	12	0	34	590	24	0	19	291	14	0	TCGA-BR-8360-01	94	0.13481225091013768	46	TCGA-BR-8360-01	2	8	51	0.13318231728490995	TCGA-BR-8360-01	9	9	2	20	hypermutated sample	9351	TCGA-BR-8360	STAD	66	MALE	WHITE	Stage IIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-24394	Alive	TUMOR FREE	188	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	188	0	188	0	188	0	188	
70	TCGA-BR-8361	9	118	7	52	226	47	22	1	57	1046	49	2	18	473	22	0	TCGA-BR-8361-01	361	0.2287175798338669	228	TCGA-BR-8361-01	5	7	131	0.16371635857781927	TCGA-BR-8361-01	11	12	4	27	hypermutated sample	9352	TCGA-BR-8361	STAD	71	FEMALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-25999	Alive	TUMOR FREE	946	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	946	0	946	0	946	0	946	
70	TCGA-BR-8362	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BR-8362-01	92	0.5406257103529455	40	TCGA-BR-8362-01	11	12	30	0.06864465519642178	TCGA-BR-8362-01	7	2	3	12	PASS	9353	TCGA-BR-8362	STAD	65	MALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-23797	Dead	WITH TUMOR	NA	398	NA	Distant Metastasis	Non-regional / Distant Lymph Nodes	NA	356	Complete Remission/Response	NA	NA	1	398	1	398	1	356	1	356	
70	TCGA-BR-8363	5	59	7	38	194	31	13	0	42	830	34	4	24	342	13	1	TCGA-BR-8363-01	42	0.06279672336376886	9	TCGA-BR-8363-01	3	3	15	0.010576647943576772	TCGA-BR-8363-01	2	3	1	6	hypermutated sample	9354	TCGA-BR-8363	STAD	73	FEMALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-26976	Dead	TUMOR FREE	NA	8	"Other, non-malignant disease"	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	8	0	8	0	8	0	8	
40	TCGA-BR-8364	0	0	1	1	0	0	0	0	1	16	1	0	0	5	0	0	TCGA-BR-8364-01	37	0.12799467262009906	6	TCGA-BR-8364-01	4	8	48	0.2514391738324289	TCGA-BR-8364-01	6	10	8	24	PASS	9355	TCGA-BR-8364	STAD	42	FEMALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-15389	Alive	TUMOR FREE	675	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	675	0	675	0	675	0	675	
70	TCGA-BR-8365	0	3	0	2	0	1	0	0	0	19	1	0	0	6	0	0	TCGA-BR-8365-01	89	0.17544071004393988	40	TCGA-BR-8365-01	7	10	63	0.2911497302635022	TCGA-BR-8365-01	9	7	7	23	PASS	9356	TCGA-BR-8365	STAD	70	FEMALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-25725	Dead	WITH TUMOR	NA	533	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	533	1	533	NA	NA	1	533	
80	TCGA-BR-8366	0	10	0	6	1	1	1	0	6	142	6	0	0	40	1	1	TCGA-BR-8366-01	53	0.1263820998133124	12	TCGA-BR-8366-01	6	3	14	0.04489807717563458	TCGA-BR-8366-01	0	0	1	1	PASS	9357	TCGA-BR-8366	STAD	80	FEMALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-29394	Alive	TUMOR FREE	29	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	29	0	29	0	29	0	29	
60	TCGA-BR-8367	0	1	1	1	1	2	1	0	4	47	4	0	1	17	0	0	TCGA-BR-8367-01	66	0.11334619291746173	25	TCGA-BR-8367-01	1	3	16	0.03829689221062385	TCGA-BR-8367-01	3	6	2	11	PASS	9358	TCGA-BR-8367	STAD	55	MALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-20441	Dead	WITH TUMOR	NA	801	NA	Distant Metastasis	"Other, specify"	"Adrenal gland, bone"	580	Complete Remission/Response	NA	NA	1	801	1	801	1	580	1	580	
80	TCGA-BR-8368	3	88	3	31	167	33	21	1	34	598	45	1	9	324	14	1	TCGA-BR-8368-01	101	0.08766952888495595	42	TCGA-BR-8368-01	2	1	36	0.0653359199878513	TCGA-BR-8368-01	2	6	4	12	hypermutated sample	9359	TCGA-BR-8368	STAD	84	FEMALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-30874	Alive	TUMOR FREE	131	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	131	0	131	0	131	0	131	
80	TCGA-BR-8369	2	5	0	5	4	1	2	0	13	166	8	0	1	53	8	0	TCGA-BR-8369-01	112	0.3923680322344916	51	TCGA-BR-8369-01	18	34	39	0.1718265928228409	TCGA-BR-8369-01	14	17	3	34	PASS	9360	TCGA-BR-8369	STAD	76	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-28051	Alive	WITH TUMOR	427	NA	NA	Distant Metastasis	"Other, specify"	Bone	419	Complete Remission/Response	NA	NA	0	427	0	427	1	419	1	419	
60	TCGA-BR-8370	1	4	2	6	1	2	3	0	5	78	4	0	0	39	4	0	TCGA-BR-8370-01	83	0.20703405547585996	31	TCGA-BR-8370-01	7	8	35	0.06678609882496107	TCGA-BR-8370-01	1	1	1	3	PASS	9361	TCGA-BR-8370	STAD	64	MALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-23636	Alive	TUMOR FREE	101	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	101	0	101	0	101	0	101	
60	TCGA-BR-8371	0	0	0	0	0	0	0	0	1	19	0	0	0	5	0	0	TCGA-BR-8371-01	49	0.00010005344371524738	8	TCGA-BR-8371-01	0	0	3	0.00016159186623042164	TCGA-BR-8371-01	0	0	0	0	PASS	9362	TCGA-BR-8371	STAD	62	MALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-22883	Dead	WITH TUMOR	NA	359	NA	Distant Metastasis	"Other, specify"	Brain	357	Progressive Disease	NA	NA	1	359	1	359	NA	NA	1	357	
60	TCGA-BR-8372	11	91	6	44	185	40	15	2	40	851	25	3	15	388	31	2	TCGA-BR-8372-01	73	0.05054556974573518	31	TCGA-BR-8372-01	2	3	36	0.07272605951053482	TCGA-BR-8372-01	0	0	0	0	hypermutated sample	9363	TCGA-BR-8372	STAD	63	MALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-23346	Alive	TUMOR FREE	951	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	951	0	951	0	951	0	951	
70	TCGA-BR-8373	0	8	0	3	5	1	0	1	2	55	9	0	1	36	2	0	TCGA-BR-8373-01	358	0.5177048606621685	245	TCGA-BR-8373-01	19	19	172	0.2829003435371754	TCGA-BR-8373-01	8	10	7	25	PASS	9364	TCGA-BR-8373	STAD	65	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-23744	Alive	TUMOR FREE	450	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	450	0	450	0	450	0	450	
60	TCGA-BR-8380	0	2	0	0	0	3	1	0	0	63	5	0	0	20	1	0	TCGA-BR-8380-01	33	3.5361649547252e-06	3	TCGA-BR-8380-01	0	2	5	0.06064165866830942	TCGA-BR-8380-01	1	1	1	3	PASS	9365	TCGA-BR-8380	STAD	55	MALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-20157	Alive	WITH TUMOR	21	NA	NA	Locoregional Recurrence	NA	NA	467	Complete Remission/Response	NA	NA	0	21	0	21	1	467	1	467	
50	TCGA-BR-8381	0	7	1	6	0	0	0	0	8	95	4	0	4	40	1	0	TCGA-BR-8381-01	85	0.2384989892238447	36	TCGA-BR-8381-01	8	6	17	0.01205235294240346	TCGA-BR-8381-01	3	4	1	8	PASS	9366	TCGA-BR-8381	STAD	51	MALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-18843	Alive	TUMOR FREE	224	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	224	0	224	0	224	0	224	
70	TCGA-BR-8382	6	40	5	25	122	22	8	0	50	626	26	1	14	275	15	0	TCGA-BR-8382-01	49	0.08298196014990437	15	TCGA-BR-8382-01	3	2	13	0.002814399734830803	TCGA-BR-8382-01	0	0	0	0	hypermutated sample	9367	TCGA-BR-8382	STAD	67	FEMALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-24737	Dead	TUMOR FREE	NA	762	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	762	0	762	0	762	0	762	
70	TCGA-BR-8384	0	2	0	2	0	0	0	0	1	43	0	0	0	14	1	0	TCGA-BR-8384-01	82	0.010613871052771515	32	TCGA-BR-8384-01	0	2	17	0.05271708210241191	TCGA-BR-8384-01	2	5	4	11	PASS	9368	TCGA-BR-8384	STAD	69	MALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-25281	Alive	TUMOR FREE	113	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	113	0	113	0	113	0	113	
60	TCGA-BR-8483	2	5	1	3	4	3	0	0	5	90	5	0	1	38	6	0	TCGA-BR-8483-01	222	0.7156265782480726	159	TCGA-BR-8483-01	23	38	89	0.27447042873542776	TCGA-BR-8483-01	9	6	3	18	PASS	9369	TCGA-BR-8483	STAD	59	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-21731	Alive	TUMOR FREE	164	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	164	0	164	NA	NA	0	164	
60	TCGA-BR-8484	0	8	0	1	0	0	0	0	3	51	4	0	2	30	2	0	TCGA-BR-8484-01	127	0.5636423175214664	62	TCGA-BR-8484-01	19	26	76	0.29476488374804816	TCGA-BR-8484-01	12	9	8	29	PASS	9370	TCGA-BR-8484	STAD	61	MALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-22583	Dead	TUMOR FREE	NA	766	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	766	0	766	0	766	0	766	
70	TCGA-BR-8485	1	9	1	7	4	1	1	0	9	254	7	2	4	90	4	1	TCGA-BR-8485-01	340	0.7156644719307397	214	TCGA-BR-8485-01	23	58	195	0.3584546562260212	TCGA-BR-8485-01	22	17	9	48	PASS	9371	TCGA-BR-8485	STAD	68	FEMALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-24845	Alive	TUMOR FREE	280	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	280	0	280	0	280	0	280	
90	TCGA-BR-8486	1	6	0	1	0	2	2	0	0	43	3	0	0	14	3	0	TCGA-BR-8486-01	258	0.5491657855587492	152	TCGA-BR-8486-01	5	12	159	0.3759879190057716	TCGA-BR-8486-01	11	10	13	34	PASS	9372	TCGA-BR-8486	STAD	90	FEMALE	WHITE	Stage IA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-32872	Alive	TUMOR FREE	615	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	615	0	615	0	615	0	615	
60	TCGA-BR-8487	12	191	10	73	465	78	16	0	104	1947	93	0	46	830	43	2	TCGA-BR-8487-01	80	0.1213380644787995	28	TCGA-BR-8487-01	4	5	26	0.08843843189247709	TCGA-BR-8487-01	2	0	0	2	hypermutated sample	9373	TCGA-BR-8487	STAD	64	FEMALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-23400	Alive	TUMOR FREE	34	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	34	0	34	0	34	0	34	
60	TCGA-BR-8588	1	6	1	3	5	0	0	0	6	87	8	0	3	38	1	0	TCGA-BR-8588-01	51	0.10541355728349633	12	TCGA-BR-8588-01	5	13	23	0.14506314855763194	TCGA-BR-8588-01	6	7	7	20	PASS	9374	TCGA-BR-8588	STAD	55	FEMALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-20177	Alive	TUMOR FREE	389	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	389	0	389	0	389	0	389	
60	TCGA-BR-8589	3	62	4	21	6	1	2	0	40	959	13	1	13	257	17	0	TCGA-BR-8589-01	78	0.1537315698280647	28	TCGA-BR-8589-01	5	8	31	0.05702645708621084	TCGA-BR-8589-01	7	5	5	17	hypermutated sample	9375	TCGA-BR-8589	STAD	56	MALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-20727	Alive	TUMOR FREE	825	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	825	0	825	0	825	0	825	
60	TCGA-BR-8590	1	4	0	4	3	1	0	0	4	102	7	0	1	36	1	1	TCGA-BR-8590-01	81	0.08022624553476045	33	TCGA-BR-8590-01	8	15	4	0.00026522216704147165	TCGA-BR-8590-01	9	14	0	23	PASS	9376	TCGA-BR-8590	STAD	62	MALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-22937	Dead	WITH TUMOR	NA	284	NA	Distant Metastasis	Lung	NA	223	Complete Remission/Response	NA	NA	1	284	1	284	1	223	1	223	
80	TCGA-BR-8591	9	89	14	46	247	57	15	0	65	963	35	0	25	430	32	0	TCGA-BR-8591-01	97	0.052501848106095865	45	TCGA-BR-8591-01	2	4	32	0.038821463888488	TCGA-BR-8591-01	0	1	1	2	hypermutated sample	9377	TCGA-BR-8591	STAD	79	MALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-29054	Alive	TUMOR FREE	856	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	856	0	856	0	856	0	856	
60	TCGA-BR-8592	0	1	0	1	0	1	0	0	1	29	1	0	1	9	0	0	TCGA-BR-8592-01	43	0.0010595569199496851	5	TCGA-BR-8592-01	0	4	24	0.04076457542446514	TCGA-BR-8592-01	2	1	2	5	PASS	9378	TCGA-BR-8592	STAD	63	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2012	NA	-23133	Dead	TUMOR FREE	NA	191	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	191	0	191	0	191	0	191	
60	TCGA-BR-8676	0	1	1	1	4	1	0	0	3	64	6	0	0	23	1	1	TCGA-BR-8676-01	74	0.08539978222070517	30	TCGA-BR-8676-01	4	2	30	0.0027253548043771943	TCGA-BR-8676-01	0	3	0	3	PASS	9379	TCGA-BR-8676	STAD	59	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-21619	Alive	TUMOR FREE	229	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	229	0	229	0	229	0	229	
70	TCGA-BR-8677	1	0	0	3	1	0	1	0	0	52	4	0	0	24	0	0	TCGA-BR-8677-01	64	0.1200369667698434	19	TCGA-BR-8677-01	3	7	55	0.1749304217451008	TCGA-BR-8677-01	7	6	6	19	PASS	9380	TCGA-BR-8677	STAD	74	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-27223	Alive	TUMOR FREE	813	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	813	0	813	0	813	0	813	
80	TCGA-BR-8678	0	5	0	2	5	1	2	0	6	86	8	0	1	28	1	0	TCGA-BR-8678-01	169	0.6515811443675155	93	TCGA-BR-8678-01	20	66	111	0.33556391028022703	TCGA-BR-8678-01	14	7	10	31	PASS	9381	TCGA-BR-8678	STAD	76	MALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-28037	Alive	TUMOR FREE	754	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	754	0	754	0	754	0	754	
60	TCGA-BR-8679	0	8	0	5	3	0	2	0	5	124	8	0	3	49	0	0	TCGA-BR-8679-01	171	0.6582948807984019	96	TCGA-BR-8679-01	31	55	115	0.3527130571953496	TCGA-BR-8679-01	8	10	4	22	PASS	9382	TCGA-BR-8679	STAD	63	FEMALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-23084	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	0	0	0	0	0	0	0	
50	TCGA-BR-8680	22	478	17	156	8	12	1	0	214	4822	476	3	112	1492	71	3	TCGA-BR-8680-01	66	0.12051335150518895	18	TCGA-BR-8680-01	2	3	32	0.06454301792564084	TCGA-BR-8680-01	7	2	5	14	hypermutated sample	9383	TCGA-BR-8680	STAD	45	MALE	ASIAN	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2012	NA	-16637	Alive	TUMOR FREE	972	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	972	0	972	NA	NA	0	972	
50	TCGA-BR-8682	0	6	1	2	3	2	0	0	1	44	7	0	1	26	1	0	TCGA-BR-8682-01	95	0.28227592706352395	40	TCGA-BR-8682-01	10	17	63	0.21161340861143954	TCGA-BR-8682-01	5	4	4	13	PASS	9384	TCGA-BR-8682	STAD	52	MALE	ASIAN	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G3	2012	NA	-19165	Alive	TUMOR FREE	991	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	991	0	991	0	991	0	991	
80	TCGA-BR-8683	1	8	1	3	3	3	2	0	7	110	9	0	3	44	2	0	TCGA-BR-8683-01	115	0.5075175610331226	53	TCGA-BR-8683-01	14	64	4	0.0019997980451835233	TCGA-BR-8683-01	16	13	0	29	PASS	9385	TCGA-BR-8683	STAD	75	MALE	ASIAN	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2012	NA	-27549	Dead	TUMOR FREE	NA	300	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	300	0	300	0	300	0	300	
70	TCGA-BR-8686	1	3	0	0	1	1	0	0	5	85	8	0	0	37	2	0	TCGA-BR-8686-01	79	0.19205576466635027	27	TCGA-BR-8686-01	13	53	42	0.1468209776193796	TCGA-BR-8686-01	16	8	7	31	PASS	9386	TCGA-BR-8686	STAD	69	MALE	ASIAN	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2012	NA	-25372	Dead	TUMOR FREE	NA	635	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	635	0	635	0	635	0	635	
70	TCGA-BR-8687	0	13	0	9	2	0	0	0	2	149	4	0	4	54	1	0	TCGA-BR-8687-01	196	0.4629999088112913	117	TCGA-BR-8687-01	15	34	76	0.21472644608778949	TCGA-BR-8687-01	17	10	7	34	PASS	9387	TCGA-BR-8687	STAD	67	FEMALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-24472	Dead	WITH TUMOR	NA	250	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	250	1	250	NA	NA	1	250	
50	TCGA-BR-8690	1	3	2	6	2	3	1	0	7	111	11	1	2	46	6	0	TCGA-BR-8690-01	113	0.36399480091050734	58	TCGA-BR-8690-01	22	33	83	0.3288266806630015	TCGA-BR-8690-01	13	16	9	38	PASS	9388	TCGA-BR-8690	STAD	54	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-19855	Alive	TUMOR FREE	325	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	325	0	325	0	325	0	325	
50	TCGA-BR-A44T	0	0	0	0	0	1	0	0	1	13	0	0	0	10	0	0	TCGA-BR-A44T-01	67	0.001886030897812272	29	TCGA-BR-A44T-01	0	0	10	0.0020083971498643877	TCGA-BR-A44T-01	0	0	0	0	PASS	9389	TCGA-BR-A44T	STAD	53	FEMALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2012	NA	-19407	Alive	WITH TUMOR	1038	NA	NA	Locoregional Recurrence	NA	NA	682	Complete Remission/Response	NA	NA	0	1038	0	1038	1	682	1	682	
70	TCGA-BR-A44U	0	2	0	3	3	0	1	0	3	69	4	0	2	32	1	0	TCGA-BR-A44U-01	197	0.322533163665687	126	TCGA-BR-A44U-01	11	14	95	0.1368999383318513	TCGA-BR-A44U-01	8	4	6	18	PASS	9390	TCGA-BR-A44U	STAD	70	MALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-25577	Dead	TUMOR FREE	NA	422	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	422	0	422	0	422	0	422	
60	TCGA-BR-A452	2	8	0	0	5	3	0	0	2	75	4	1	1	37	3	0	TCGA-BR-A452-01	424	0.6187633963820665	282	TCGA-BR-A452-01	10	13	186	0.3023180653454424	TCGA-BR-A452-01	10	6	9	25	PASS	9391	TCGA-BR-A452	STAD	57	MALE	ASIAN	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2012	NA	-21107	Dead	TUMOR FREE	NA	229	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	229	0	229	0	229	0	229	
50	TCGA-BR-A453	0	0	0	1	0	0	0	0	1	52	4	0	0	27	1	0	TCGA-BR-A453-01	56	0.0030419756818966443	10	TCGA-BR-A453-01	0	0	8	0.005766617433121722	TCGA-BR-A453-01	0	1	0	1	PASS	9392	TCGA-BR-A453	STAD	51	MALE	ASIAN	Stage IV	NA	"Stomach Adenocarcinoma, Signet Ring Type"	G3	2012	NA	-18988	Dead	TUMOR FREE	NA	185	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	185	0	185	NA	NA	0	185	
60	TCGA-BR-A4CQ	0	12	3	5	1	0	2	0	6	140	11	0	0	50	2	0	TCGA-BR-A4CQ-01	294	0.8835776201132015	181	TCGA-BR-A4CQ-01	16	41	159	0.3115439356239111	TCGA-BR-A4CQ-01	23	30	14	67	PASS	9393	TCGA-BR-A4CQ	STAD	58	MALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-21207	Alive	WITH TUMOR	1064	NA	NA	Distant Metastasis	NA	NA	962	Complete Remission/Response	NA	NA	0	1064	0	1064	1	962	1	962	
70	TCGA-BR-A4CR	0	3	0	2	5	0	0	0	4	40	3	1	1	31	0	1	TCGA-BR-A4CR-01	155	0.6042056619704254	82	TCGA-BR-A4CR-01	20	32	157	0.4928368436721796	TCGA-BR-A4CR-01	12	7	11	30	PASS	9394	TCGA-BR-A4CR	STAD	70	FEMALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-25669	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	0	0	0	0	0	0	0	
80	TCGA-BR-A4CS	1	11	1	2	7	3	1	0	3	116	9	0	3	49	3	0	TCGA-BR-A4CS-01	222	0.6609008331436952	141	TCGA-BR-A4CS-01	23	39	124	0.1667393962133175	TCGA-BR-A4CS-01	11	8	6	25	PASS	9395	TCGA-BR-A4CS	STAD	77	MALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-28211	Dead	TUMOR FREE	NA	45	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	45	0	45	0	45	0	45	
30	TCGA-BR-A4IU	0	0	0	1	1	0	0	0	0	23	0	0	0	4	0	0	TCGA-BR-A4IU-01	59	0.07518870157114338	15	TCGA-BR-A4IU-01	3	10	25	0.11070992917589123	TCGA-BR-A4IU-01	6	8	1	15	PASS	9396	TCGA-BR-A4IU	STAD	34	FEMALE	ASIAN	Stage IIIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2012	NA	-12601	Alive	TUMOR FREE	838	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	838	0	838	0	838	0	838	
50	TCGA-BR-A4IV	1	0	0	2	0	0	0	0	2	25	2	0	0	10	0	0	TCGA-BR-A4IV-01	73	0.0009150901650935803	30	TCGA-BR-A4IV-01	0	0	5	0.0010764538492434265	TCGA-BR-A4IV-01	0	0	0	0	PASS	9397	TCGA-BR-A4IV	STAD	47	MALE	ASIAN	Stage IIIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2012	NA	-17515	Dead	WITH TUMOR	NA	869	NA	Locoregional Recurrence	NA	NA	737	Complete Remission/Response	NA	NA	1	869	1	869	1	737	1	737	
60	TCGA-BR-A4IY	0	11	0	6	4	1	3	0	4	118	9	0	1	39	3	1	TCGA-BR-A4IY-01	158	0.35466650084486645	89	TCGA-BR-A4IY-01	7	11	75	0.13539080565376987	TCGA-BR-A4IY-01	19	20	6	45	PASS	9398	TCGA-BR-A4IY	STAD	58	MALE	ASIAN	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-21314	Alive	TUMOR FREE	392	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	392	0	392	0	392	0	392	
50	TCGA-BR-A4IZ	0	1	0	0	0	0	0	0	1	16	1	0	0	1	1	0	TCGA-BR-A4IZ-01	59	0.00028142492884694435	17	TCGA-BR-A4IZ-01	0	0	4	0.00014569505832710228	TCGA-BR-A4IZ-01	0	0	0	0	PASS	9399	TCGA-BR-A4IZ	STAD	45	FEMALE	ASIAN	Stage IIIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2012	NA	-16695	Dead	TUMOR FREE	NA	273	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	273	0	273	NA	NA	0	273	
60	TCGA-BR-A4J1	0	6	2	3	1	1	0	0	2	44	6	0	1	22	2	0	TCGA-BR-A4J1-01	313	0.8701521381234165	206	TCGA-BR-A4J1-01	26	30	223	0.464116855497159	TCGA-BR-A4J1-01	10	5	7	22	PASS	9400	TCGA-BR-A4J1	STAD	63	MALE	ASIAN	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-23266	Dead	NA	NA	22	[Unknown]	NA	NA	NA	NA	[Unknown]	NA	NA	1	22	NA	22	NA	NA	0	22	
70	TCGA-BR-A4J2	0	2	0	1	0	0	0	0	0	41	4	0	1	21	1	0	TCGA-BR-A4J2-01	96	0.04251889123563851	45	TCGA-BR-A4J2-01	0	0	13	0.001713933710649925	TCGA-BR-A4J2-01	1	0	0	1	PASS	9401	TCGA-BR-A4J2	STAD	70	MALE	ASIAN	Stage IIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2012	NA	-25891	Alive	TUMOR FREE	431	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	431	0	431	0	431	0	431	
40	TCGA-BR-A4J4	0	2	0	3	1	0	0	0	0	69	3	0	2	18	5	0	TCGA-BR-A4J4-01	106	0.2631797763555741	54	TCGA-BR-A4J4-01	9	12	43	0.14716298101503095	TCGA-BR-A4J4-01	5	7	5	17	PASS	9402	TCGA-BR-A4J4	STAD	39	MALE	ASIAN	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-14459	Alive	TUMOR FREE	16	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	16	0	16	NA	NA	0	16	
60	TCGA-BR-A4J5	0	5	1	3	2	0	1	0	2	72	5	0	3	23	2	0	TCGA-BR-A4J5-01	45	0.14525771323159353	9	TCGA-BR-A4J5-01	2	5	13	0.020226162569895657	TCGA-BR-A4J5-01	3	3	1	7	PASS	9403	TCGA-BR-A4J5	STAD	56	MALE	ASIAN	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G3	2012	NA	-20714	Alive	TUMOR FREE	862	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	862	0	862	0	862	0	862	
70	TCGA-BR-A4J6	0	2	0	0	0	1	0	1	1	24	2	0	1	9	0	0	TCGA-BR-A4J6-01	212	0.2623215883837859	127	TCGA-BR-A4J6-01	4	7	90	0.19242680277915947	TCGA-BR-A4J6-01	5	6	10	21	PASS	9404	TCGA-BR-A4J6	STAD	69	FEMALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-25279	Alive	TUMOR FREE	20	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	20	0	20	0	20	0	20	
50	TCGA-BR-A4J7	0	3	0	1	0	0	0	0	0	43	5	0	1	18	0	0	TCGA-BR-A4J7-01	97	0.11416243286252148	44	TCGA-BR-A4J7-01	14	22	7	0.0002616751770473168	TCGA-BR-A4J7-01	15	13	0	28	PASS	9405	TCGA-BR-A4J7	STAD	49	MALE	ASIAN	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G3	2012	NA	-17932	Alive	TUMOR FREE	989	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	989	0	989	0	989	0	989	
70	TCGA-BR-A4J8	0	4	0	1	1	1	0	0	1	65	4	0	1	40	0	0	TCGA-BR-A4J8-01	131	0.6434618957895115	69	TCGA-BR-A4J8-01	27	30	151	0.4958733080588414	TCGA-BR-A4J8-01	8	4	2	14	PASS	9406	TCGA-BR-A4J8	STAD	71	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-26048	Alive	TUMOR FREE	411	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	411	0	411	0	411	0	411	
60	TCGA-BR-A4J9	0	2	0	1	1	1	0	0	0	33	2	0	0	10	2	0	TCGA-BR-A4J9-01	56	0.11273971298743705	14	TCGA-BR-A4J9-01	0	0	13	0.012253294667783072	TCGA-BR-A4J9-01	0	2	1	3	PASS	9407	TCGA-BR-A4J9	STAD	55	MALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-20093	Alive	TUMOR FREE	14	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	14	0	14	0	14	0	14	
70	TCGA-BR-A4PD	0	11	1	0	4	1	1	0	5	125	5	0	4	44	0	0	TCGA-BR-A4PD-01	226	0.6388286168568734	139	TCGA-BR-A4PD-01	11	60	119	0.36916847877544223	TCGA-BR-A4PD-01	22	13	8	43	PASS	9408	TCGA-BR-A4PD	STAD	72	FEMALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-26334	Alive	TUMOR FREE	628	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	628	0	628	0	628	0	628	
70	TCGA-BR-A4PE	1	5	1	3	6	3	1	0	12	164	7	0	2	59	5	0	TCGA-BR-A4PE-01	256	0.5876216451935049	169	TCGA-BR-A4PE-01	19	33	98	0.21766718209526492	TCGA-BR-A4PE-01	12	6	4	22	PASS	9409	TCGA-BR-A4PE	STAD	68	FEMALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-24986	Alive	TUMOR FREE	621	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	621	0	621	0	621	0	621	
70	TCGA-BR-A4PF	0	4	0	1	3	2	1	0	2	88	5	0	2	20	2	0	TCGA-BR-A4PF-01	206	0.7146397399210906	114	TCGA-BR-A4PF-01	23	32	126	0.3391889715244741	TCGA-BR-A4PF-01	9	10	6	25	PASS	9410	TCGA-BR-A4PF	STAD	72	MALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-26412	Alive	TUMOR FREE	35	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	35	0	35	0	35	0	35	
70	TCGA-BR-A4QI	0	5	1	2	3	1	1	0	2	96	2	0	5	40	1	0	TCGA-BR-A4QI-01	1162	0.7070302366591201	870	TCGA-BR-A4QI-01	17	36	555	0.4558485814841871	TCGA-BR-A4QI-01	29	11	19	59	PASS	9411	TCGA-BR-A4QI	STAD	70	FEMALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-25928	Dead	WITH TUMOR	NA	652	NA	Distant Metastasis	"Other, specify"	Pancreas	383	Complete Remission/Response	NA	NA	1	652	1	652	1	383	1	383	
80	TCGA-BR-A4QL	9	113	5	58	343	69	28	1	67	1159	69	1	22	538	26	2	TCGA-BR-A4QL-01	121	0.056723848557029125	56	TCGA-BR-A4QL-01	2	5	37	0.04832855258518645	TCGA-BR-A4QL-01	2	2	1	5	hypermutated sample	9412	TCGA-BR-A4QL	STAD	75	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-27668	Dead	TUMOR FREE	NA	491	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	491	0	491	0	491	0	491	
70	TCGA-BR-A4QM	0	3	0	6	1	1	0	0	0	73	4	0	1	40	0	0	TCGA-BR-A4QM-01	74	0.03562383326893485	32	TCGA-BR-A4QM-01	1	3	39	0.0784377955587631	TCGA-BR-A4QM-01	3	4	5	12	PASS	9413	TCGA-BR-A4QM	STAD	65	MALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-23999	Alive	WITH TUMOR	156	NA	NA	Locoregional Recurrence	NA	NA	127	Complete Remission/Response	NA	NA	0	156	0	156	1	127	1	127	
80	TCGA-CD-5798	0	8	0	3	3	0	1	0	5	75	2	0	0	26	1	0	TCGA-CD-5798-01	81	0.014317637766242812	40	TCGA-CD-5798-01	1	2	10	0.006357493658181144	TCGA-CD-5798-01	3	1	0	4	PASS	9414	TCGA-CD-5798	STAD	82	MALE	ASIAN	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G2	2010	NA	-30310	Alive	TUMOR FREE	408	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	408	0	408	0	408	0	408	
50	TCGA-CD-5799	0	3	1	1	0	0	1	0	2	33	0	0	1	15	0	1	TCGA-CD-5799-01	205	0.5737945120490954	119	TCGA-CD-5799-01	23	17	33	0.2031945575691137	TCGA-CD-5799-01	11	5	9	25	PASS	9415	TCGA-CD-5799	STAD	45	MALE	ASIAN	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2010	NA	-16533	Alive	TUMOR FREE	396	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	396	0	396	0	396	0	396	
50	TCGA-CD-5800	1	9	1	4	1	3	0	0	2	136	5	0	2	46	2	0	TCGA-CD-5800-01	336	0.5224284764701858	192	TCGA-CD-5800-01	16	31	41	0.14843346605733074	TCGA-CD-5800-01	20	18	7	45	PASS	9416	TCGA-CD-5800	STAD	51	FEMALE	ASIAN	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Papillary Type"	G1	2010	NA	NA	Alive	TUMOR FREE	400	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	400	0	400	0	400	0	400	
70	TCGA-CD-5801	1	28	4	12	1	2	4	0	14	360	8	1	4	109	5	0	TCGA-CD-5801-01	75	0.5261659035226915	28	TCGA-CD-5801-01	29	30	3	0.0607691441483758	TCGA-CD-5801-01	3	3	1	7	PASS	9417	TCGA-CD-5801	STAD	69	MALE	ASIAN	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2010	NA	NA	Dead	WITH TUMOR	NA	401	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	401	1	401	NA	NA	1	401	
60	TCGA-CD-5802	0	3	0	3	4	1	2	0	3	35	3	0	0	16	1	0	TCGA-CD-5802-01	287	0.6488152681778601	174	TCGA-CD-5802-01	8	12	45	0.32690652734162745	TCGA-CD-5802-01	16	12	17	45	PASS	9418	TCGA-CD-5802	STAD	58	MALE	ASIAN	Stage II	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2010	NA	-21331	Alive	TUMOR FREE	406	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	406	0	406	0	406	0	406	
80	TCGA-CD-5803	1	0	0	1	0	0	1	0	1	33	1	0	1	8	0	0	TCGA-CD-5803-01	53	0.1693240081557679	12	TCGA-CD-5803-01	11	8	13	0.30053959734372465	TCGA-CD-5803-01	1	1	0	2	PASS	9419	TCGA-CD-5803	STAD	78	FEMALE	ASIAN	Stage II	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2010	NA	-28608	Dead	WITH TUMOR	NA	341	NA	Distant Metastasis	Liver	NA	300	Progressive Disease	NA	NA	1	341	1	341	NA	NA	1	300	
90	TCGA-CD-5804	0	2	1	1	1	0	2	0	2	57	3	0	1	20	6	0	TCGA-CD-5804-01	346	0.3920117599781208	209	TCGA-CD-5804-01	11	43	103	0.32892508234420337	TCGA-CD-5804-01	20	14	13	47	PASS	9420	TCGA-CD-5804	STAD	90	MALE	ASIAN	[Discrepancy]	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2010	NA	-32872	Alive	TUMOR FREE	368	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	368	0	368	0	368	0	368	
60	TCGA-CD-5813	1	13	0	4	2	4	1	1	4	134	6	0	8	48	7	0	TCGA-CD-5813	0	0	0	TCGA-CD-5813	0	0	0	0	TCGA-CD-5813	0	0	0	0	PASS	9421	TCGA-CD-5813	STAD	60	MALE	ASIAN	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G3	2010	NA	-21995	Dead	WITH TUMOR	NA	377	NA	Distant Metastasis	Liver	NA	315	Complete Remission/Response	NA	NA	1	377	1	377	1	315	1	315	
60	TCGA-CD-8524	1	4	2	4	2	2	1	0	5	123	11	0	1	42	2	0	TCGA-CD-8524-01	280	0.539179193087629	181	TCGA-CD-8524-01	15	31	219	0.4023026493393965	TCGA-CD-8524-01	13	13	6	32	PASS	9422	TCGA-CD-8524	STAD	61	FEMALE	ASIAN	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2010	NA	-22445	Alive	WITH TUMOR	388	NA	NA	Locoregional Recurrence	NA	NA	69	Complete Remission/Response	NA	NA	0	388	0	388	1	69	1	69	
80	TCGA-CD-8525	0	2	0	5	5	1	0	0	1	61	4	0	5	21	2	0	TCGA-CD-8525-01	236	0.5251909325162296	138	TCGA-CD-8525-01	17	31	173	0.4317345618262533	TCGA-CD-8525-01	21	19	11	51	PASS	9423	TCGA-CD-8525	STAD	82	FEMALE	ASIAN	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G3	2010	NA	-30004	Alive	TUMOR FREE	383	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	383	0	383	0	383	0	383	
70	TCGA-CD-8526	0	1	1	0	3	1	0	0	1	43	2	0	1	9	0	0	TCGA-CD-8526-01	185	0.5169917017369284	110	TCGA-CD-8526-01	21	32	168	0.5013077211705098	TCGA-CD-8526-01	13	7	13	33	PASS	9424	TCGA-CD-8526	STAD	73	FEMALE	ASIAN	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2010	NA	-26840	Alive	TUMOR FREE	381	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	381	0	381	0	381	0	381	
70	TCGA-CD-8527	2	8	2	11	7	4	4	0	12	174	10	0	4	81	9	0	TCGA-CD-8527-01	472	0.9437640947243564	316	TCGA-CD-8527-01	16	36	199	0.29249957861909004	TCGA-CD-8527-01	23	18	10	51	PASS	9425	TCGA-CD-8527	STAD	72	FEMALE	ASIAN	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2010	NA	-26503	Dead	WITH TUMOR	NA	218	NA	Distant Metastasis	Liver	NA	159	Complete Remission/Response	NA	NA	1	218	1	218	1	159	1	159	
40	TCGA-CD-8528	0	4	1	6	1	0	0	0	2	84	6	0	3	32	0	0	TCGA-CD-8528-01	223	0.5144814371068394	134	TCGA-CD-8528-01	21	26	71	0.14364550654570482	TCGA-CD-8528-01	7	8	6	21	PASS	9426	TCGA-CD-8528	STAD	43	FEMALE	ASIAN	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2010	NA	-15986	Alive	TUMOR FREE	375	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	375	0	375	0	375	0	375	
70	TCGA-CD-8529	1	17	2	11	12	0	4	0	12	321	18	0	6	113	7	0	TCGA-CD-8529-01	143	0.21429995021688986	84	TCGA-CD-8529-01	0	0	9	0.0012184946313598774	TCGA-CD-8529-01	3	3	0	6	PASS	9427	TCGA-CD-8529	STAD	65	MALE	ASIAN	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G2	2011	NA	-23979	Alive	TUMOR FREE	374	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	374	0	374	NA	NA	0	374	
50	TCGA-CD-8530	0	8	0	2	2	0	0	0	0	66	3	0	5	31	1	0	TCGA-CD-8530-01	168	0.4691566248265385	99	TCGA-CD-8530-01	24	47	127	0.44588083481692503	TCGA-CD-8530-01	22	19	10	51	PASS	9428	TCGA-CD-8530	STAD	51	MALE	ASIAN	Stage II	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-18992	Alive	TUMOR FREE	377	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	377	0	377	0	377	0	377	
70	TCGA-CD-8531	2	9	2	6	11	2	0	0	14	195	14	0	5	77	6	1	TCGA-CD-8531-01	77	0.04743705003396398	29	TCGA-CD-8531-01	1	1	29	0.0323860600487485	TCGA-CD-8531-01	3	5	2	10	PASS	9429	TCGA-CD-8531	STAD	66	FEMALE	ASIAN	Stage IIIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-24453	Alive	TUMOR FREE	383	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	383	0	383	0	383	0	383	
50	TCGA-CD-8532	0	2	1	1	1	2	0	0	0	26	2	0	0	19	1	0	TCGA-CD-8532-01	153	0.3511633003606717	97	TCGA-CD-8532-01	10	6	106	0.24091425424682944	TCGA-CD-8532-01	3	5	3	11	PASS	9430	TCGA-CD-8532	STAD	52	MALE	ASIAN	Stage II	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-19284	Dead	WITH TUMOR	NA	354	NA	Locoregional Recurrence	NA	NA	282	Complete Remission/Response	NA	NA	1	354	1	354	1	282	1	282	
50	TCGA-CD-8533	0	6	2	3	5	0	1	1	4	88	5	0	2	47	0	0	TCGA-CD-8533-01	272	0.6765725228767318	161	TCGA-CD-8533-01	16	33	99	0.2267942069808457	TCGA-CD-8533-01	19	12	9	40	pathology review	9431	TCGA-CD-8533	STAD	48	MALE	ASIAN	Stage II	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-17821	Alive	WITH TUMOR	468	NA	NA	Distant Metastasis	"Other, specify"	liver and lung	226	Complete Remission/Response	NA	NA	0	468	0	468	1	226	1	226	
40	TCGA-CD-8534	0	1	0	1	0	1	0	0	1	53	1	0	1	16	2	0	TCGA-CD-8534-01	119	0.8942648294378386	61	TCGA-CD-8534-01	10	10	88	0.2796504538767059	TCGA-CD-8534-01	9	3	9	21	PASS	9432	TCGA-CD-8534	STAD	41	MALE	ASIAN	Stage II	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-15227	Alive	WITH TUMOR	367	NA	NA	Distant Metastasis	"Other, specify"	"Pancreas, Transverse Colon"	201	Progressive Disease	NA	NA	0	367	0	367	NA	NA	1	201	
60	TCGA-CD-8535	0	10	1	5	3	4	3	1	13	210	10	0	2	87	2	1	TCGA-CD-8535-01	435	0.866900644965616	286	TCGA-CD-8535-01	21	40	214	0.3256024111607391	TCGA-CD-8535-01	12	8	7	27	PASS	9433	TCGA-CD-8535	STAD	59	MALE	ASIAN	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-21559	Alive	TUMOR FREE	390	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	390	0	390	0	390	0	390	
70	TCGA-CD-8536	4	45	2	28	137	36	10	0	33	598	36	0	8	237	15	1	TCGA-CD-8536-01	67	0.1051842899398137	24	TCGA-CD-8536-01	4	4	33	0.01539298405964471	TCGA-CD-8536-01	2	1	1	4	hypermutated sample	9434	TCGA-CD-8536	STAD	74	MALE	ASIAN	Stage II	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-27328	Alive	TUMOR FREE	378	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	378	0	378	0	378	0	378	
70	TCGA-CD-A486	0	5	0	0	2	2	2	1	3	73	4	0	2	24	1	0	TCGA-CD-A486-01	492	0.6233722676552987	320	TCGA-CD-A486-01	21	30	140	0.18080269783311986	TCGA-CD-A486-01	17	12	12	41	PASS	9435	TCGA-CD-A486	STAD	68	MALE	ASIAN	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-24879	Dead	WITH TUMOR	NA	192	NA	Distant Metastasis	Liver	liver and lung	79	Complete Remission/Response	NA	NA	1	192	1	192	1	79	1	79	
50	TCGA-CD-A487	0	6	0	1	2	1	0	0	3	153	2	0	3	46	1	0	TCGA-CD-A487-01	299	0.646130138243316	178	TCGA-CD-A487-01	13	35	144	0.2619867393042237	TCGA-CD-A487-01	13	17	7	37	PASS	9436	TCGA-CD-A487	STAD	51	MALE	ASIAN	Stage IIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-18694	Alive	TUMOR FREE	374	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	374	0	374	0	374	0	374	
60	TCGA-CD-A489	1	5	0	0	1	0	0	0	4	58	3	0	2	22	2	0	TCGA-CD-A489-01	173	0.8956486420247374	87	TCGA-CD-A489-01	13	12	140	0.4058899849581431	TCGA-CD-A489-01	11	8	16	35	PASS	9437	TCGA-CD-A489	STAD	58	MALE	ASIAN	Stage IIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-21517	Dead	WITH TUMOR	NA	344	NA	Locoregional Recurrence	NA	NA	277	Complete Remission/Response	NA	NA	1	344	1	344	1	277	1	277	
60	TCGA-CD-A48A	0	12	1	7	4	0	0	0	7	193	7	0	3	64	3	0	TCGA-CD-A48A-01	478	0.6868580385310267	339	TCGA-CD-A48A-01	17	51	275	0.3897114555338045	TCGA-CD-A48A-01	26	12	12	50	PASS	9438	TCGA-CD-A48A	STAD	57	MALE	ASIAN	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-20839	Alive	TUMOR FREE	378	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	378	0	378	0	378	0	378	
80	TCGA-CD-A48C	0	10	1	4	3	0	0	0	6	172	8	0	8	62	6	0	TCGA-CD-A48C-01	353	0.6671484847948581	226	TCGA-CD-A48C-01	23	68	189	0.3670189515258161	TCGA-CD-A48C-01	19	11	12	42	PASS	9439	TCGA-CD-A48C	STAD	79	FEMALE	ASIAN	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-29203	Dead	WITH TUMOR	NA	353	NA	Locoregional Recurrence	NA	NA	230	Complete Remission/Response	NA	NA	1	353	1	353	1	230	1	230	
80	TCGA-CD-A4MG	7	163	6	61	347	87	22	2	82	1584	88	1	22	680	37	1	TCGA-CD-A4MG-01	124	0.23888165770577724	57	TCGA-CD-A4MG-01	8	5	28	0.024967237673697563	TCGA-CD-A4MG-01	5	5	2	12	hypermutated sample	9440	TCGA-CD-A4MG	STAD	76	MALE	ASIAN	Stage IIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-28019	Dead	WITH TUMOR	NA	200	NA	Locoregional Recurrence	NA	NA	74	Complete Remission/Response	NA	NA	1	200	1	200	1	74	1	74	
90	TCGA-CD-A4MH	0	5	0	2	4	0	1	0	1	53	7	0	2	30	1	0	TCGA-CD-A4MH-01	275	0.6709751502734053	161	TCGA-CD-A4MH-01	26	30	157	0.3645153795914788	TCGA-CD-A4MH-01	10	5	11	26	PASS	9441	TCGA-CD-A4MH	STAD	86	FEMALE	ASIAN	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-31683	Alive	TUMOR FREE	371	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	371	0	371	0	371	0	371	
60	TCGA-CD-A4MI	2	32	4	28	133	31	8	1	27	689	33	0	12	304	13	1	TCGA-CD-A4MI-01	69	0.02130522548689977	23	TCGA-CD-A4MI-01	2	1	12	0.010818821566394262	TCGA-CD-A4MI-01	1	1	1	3	hypermutated sample	9442	TCGA-CD-A4MI	STAD	62	MALE	ASIAN	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G1	2011	NA	-22721	Dead	WITH TUMOR	NA	358	NA	Locoregional Recurrence	NA	NA	271	Complete Remission/Response	NA	NA	1	358	1	358	1	271	1	271	
60	TCGA-CD-A4MJ	1	34	5	16	127	27	9	1	22	439	18	0	9	192	14	0	TCGA-CD-A4MJ-01	69	0.050286987550335616	22	TCGA-CD-A4MJ-01	2	1	11	0.012436921698670616	TCGA-CD-A4MJ-01	1	1	1	3	PASS	9443	TCGA-CD-A4MJ	STAD	60	MALE	ASIAN	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-21932	Alive	WITH TUMOR	384	NA	NA	Locoregional Recurrence	NA	NA	69	Complete Remission/Response	NA	NA	0	384	0	384	1	69	1	69	
80	TCGA-CG-4300	0	6	0	5	1	1	3	0	6	96	8	3	2	38	2	0	TCGA-CG-4300-01	225	0.6034943831344441	133	TCGA-CG-4300	0	0	0	0	TCGA-CG-4300	0	0	0	0	PASS	9444	TCGA-CG-4300	STAD	79	MALE	NA	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2006	NA	-29128	Dead	NA	NA	609	NA	NA	NA	NA	NA	NA	NA	NA	1	609	NA	609	NA	NA	0	609	
80	TCGA-CG-4301	0	2	0	1	0	0	0	0	1	42	5	1	1	18	1	0	TCGA-CG-4301-01	285	0.4230457364894539	175	TCGA-CG-4301-01	7	20	71	0.3681795528948944	TCGA-CG-4301-01	21	14	17	52	PASS	9445	TCGA-CG-4301	STAD	75	FEMALE	NA	Stage IV	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2006	NA	-27516	Alive	WITH TUMOR	92	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	92	0	92	NA	NA	0	92	
80	TCGA-CG-4304	1	5	0	3	4	1	2	0	2	48	2	0	0	30	1	0	TCGA-CG-4304-01	304	0.2283573176883965	209	TCGA-CG-4304-01	5	5	92	0.13920003148950175	TCGA-CG-4304-01	9	11	8	28	PASS	9446	TCGA-CG-4304	STAD	84	MALE	NA	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2008	NA	-31017	Alive	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
70	TCGA-CG-4305	5	72	9	27	194	36	12	0	49	776	44	0	15	349	17	2	TCGA-CG-4305-01	101	0.19794267413193065	47	TCGA-CG-4305-01	8	9	18	0.06503312238537781	TCGA-CG-4305-01	1	0	0	1	hypermutated sample	9447	TCGA-CG-4305	STAD	69	MALE	NA	Stage II	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2008	NA	-25295	Alive	TUMOR FREE	485	NA	NA	NA	NA	NA	457	[Unknown]	NA	NA	0	485	0	485	NA	NA	1	457	
90	TCGA-CG-4306	5	72	2	31	194	51	9	2	34	709	51	0	17	328	21	0	TCGA-CG-4306-01	127	0.0020943468470626726	74	TCGA-CG-4306-01	0	2	8	0.014446453848734069	TCGA-CG-4306-01	0	0	1	1	hypermutated sample	9448	TCGA-CG-4306	STAD	90	MALE	NA	Stage IV	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2006	NA	-32871	Dead	NA	NA	31	NA	NA	NA	NA	NA	NA	NA	NA	1	31	NA	31	NA	NA	0	31	
60	TCGA-CG-4436	0	15	1	5	3	0	2	0	4	144	4	1	2	50	1	0	TCGA-CG-4436-01	120	0.8209347176717452	63	TCGA-CG-4436-01	15	25	27	0.34147627481319304	TCGA-CG-4436-01	13	11	7	31	PASS	9449	TCGA-CG-4436	STAD	57	MALE	NA	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2005	NA	-20941	Alive	TUMOR FREE	243	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	243	0	243	0	243	0	243	
80	TCGA-CG-4437	5	25	2	15	19	1	9	0	20	416	16	1	4	145	10	0	TCGA-CG-4437-01	233	0.4009271907346149	136	TCGA-CG-4437-01	8	32	55	0.1849571830768421	TCGA-CG-4437-01	25	26	8	59	PASS	9450	TCGA-CG-4437	STAD	83	MALE	NA	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2006	NA	-30467	Alive	TUMOR FREE	245	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	245	0	245	0	245	0	245	
60	TCGA-CG-4438	0	6	1	4	2	1	1	0	6	114	6	0	1	34	1	0	TCGA-CG-4438-01	277	0.8558281143445615	166	TCGA-CG-4438-01	20	31	68	0.4701475249716648	TCGA-CG-4438-01	15	11	8	34	PASS	9451	TCGA-CG-4438	STAD	56	MALE	NA	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2006	NA	-20574	Alive	NA	1645	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1645	0	1645	NA	NA	0	1645	
70	TCGA-CG-4440	1	10	1	2	2	1	1	0	4	110	2	0	1	26	1	0	TCGA-CG-4440-01	304	0.5426291368103171	177	TCGA-CG-4440-01	16	65	49	0.27951054968146544	TCGA-CG-4440-01	13	9	8	30	PASS	9452	TCGA-CG-4440	STAD	68	FEMALE	NA	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2006	NA	-25171	Dead	NA	NA	122	NA	NA	NA	NA	NA	NA	NA	NA	1	122	NA	122	NA	NA	0	122	
80	TCGA-CG-4441	0	3	0	0	0	3	2	0	6	84	3	0	3	35	1	0	TCGA-CG-4441-01	1321	0.13687812634730853	1143	TCGA-CG-4441-01	4	2	380	0.027779077596796986	TCGA-CG-4441-01	2	1	0	3	PASS	9453	TCGA-CG-4441	STAD	83	MALE	NA	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2006	NA	-30528	Dead	NA	NA	426	NA	NA	NA	NA	NA	NA	NA	NA	1	426	NA	426	NA	NA	0	426	
90	TCGA-CG-4442	11	124	10	49	291	58	10	1	70	917	43	2	22	424	25	1	TCGA-CG-4442-01	165	0.050271660813421215	100	TCGA-CG-4442-01	2	1	7	0.00040962319462281257	TCGA-CG-4442-01	0	0	0	0	hypermutated sample	9454	TCGA-CG-4442	STAD	85	MALE	NA	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2006	NA	-31350	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-CG-4443	0	3	0	3	3	0	0	0	7	72	4	0	1	31	2	0	TCGA-CG-4443-01	613	0.7111092720711364	411	TCGA-CG-4443-01	4	16	90	0.23369692019436256	TCGA-CG-4443-01	19	20	14	53	PASS	9455	TCGA-CG-4443	STAD	68	MALE	NA	Stage IA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2006	NA	-24990	Alive	NA	912	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	912	0	912	NA	NA	0	912	
80	TCGA-CG-4444	1	8	0	8	1	1	1	0	9	136	8	1	2	58	2	0	TCGA-CG-4444-01	443	0.7137898043934515	279	TCGA-CG-4444-01	18	71	107	0.4210678204885973	TCGA-CG-4444-01	21	16	6	43	PASS	9456	TCGA-CG-4444	STAD	76	MALE	NA	Stage IIIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2006	NA	-27912	Alive	TUMOR FREE	1431	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1431	0	1431	0	1431	0	1431	
80	TCGA-CG-4449	1	3	1	2	4	3	2	0	0	71	6	0	1	26	0	0	TCGA-CG-4449-01	661	0.5786093818522676	427	TCGA-CG-4449-01	9	9	103	0.3109306968580872	TCGA-CG-4449-01	15	12	11	38	PASS	9457	TCGA-CG-4449	STAD	81	MALE	NA	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G2	2007	NA	-29705	Alive	WITH TUMOR	580	NA	NA	NA	NA	NA	336	Partial Remission/Response	NA	NA	0	580	0	580	NA	NA	1	336	
70	TCGA-CG-4455	1	1	0	2	2	1	1	0	4	28	2	0	0	20	0	0	TCGA-CG-4455-01	153	0.5235637450951288	75	TCGA-CG-4455-01	21	29	13	0.18641049333873708	TCGA-CG-4455-01	5	1	4	10	PASS	9458	TCGA-CG-4455	STAD	72	MALE	NA	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G3	2008	NA	-26421	Alive	TUMOR FREE	366	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	366	0	366	0	366	0	366	
70	TCGA-CG-4460	8	116	11	37	230	57	15	1	60	1340	77	0	18	612	22	1	TCGA-CG-4460	0	0	0	TCGA-CG-4460	0	0	0	0	TCGA-CG-4460-01	12	11	2	25	hypermutated sample	9459	TCGA-CG-4460	STAD	66	FEMALE	NA	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2008	NA	-24229	Dead	WITH TUMOR	NA	669	NA	NA	NA	NA	487	Partial Remission/Response	NA	NA	1	669	1	669	NA	NA	1	487	
70	TCGA-CG-4462	1	5	1	3	0	1	1	0	3	50	6	0	2	28	0	0	TCGA-CG-4462-01	89	0.08476215191187175	40	TCGA-CG-4462-01	4	2	2	0.0265022058213684	TCGA-CG-4462-01	0	3	1	4	PASS	9460	TCGA-CG-4462	STAD	72	FEMALE	NA	Stage IV	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2008	NA	-26511	Dead	WITH TUMOR	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	1	0	1	0	NA	NA	1	0	
70	TCGA-CG-4465	2	43	3	21	115	23	5	0	19	408	21	0	11	178	11	1	TCGA-CG-4465-01	141	0.003835232659456561	75	TCGA-CG-4465-01	0	6	26	0.12313929328290955	TCGA-CG-4465-01	2	2	2	6	PASS	9461	TCGA-CG-4465	STAD	69	FEMALE	NA	Stage IV	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2008	NA	-25233	Dead	NA	NA	274	NA	NA	NA	NA	NA	NA	NA	NA	1	274	NA	274	NA	NA	0	274	
80	TCGA-CG-4466	1	11	1	5	5	2	1	0	7	155	8	0	7	57	4	0	TCGA-CG-4466-01	397	0.7577578458911147	280	TCGA-CG-4466-01	16	54	91	0.4698854845873546	TCGA-CG-4466-01	11	11	3	25	PASS	9462	TCGA-CG-4466	STAD	81	FEMALE	NA	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2009	NA	-29739	Alive	TUMOR FREE	577	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	577	0	577	0	577	0	577	
70	TCGA-CG-4469	2	16	1	5	5	2	0	0	9	255	14	0	7	81	3	0	TCGA-CG-4469-01	239	0.3337647226717619	156	TCGA-CG-4469-01	11	8	51	0.08377791100444833	TCGA-CG-4469-01	7	2	7	16	PASS	9463	TCGA-CG-4469	STAD	70	MALE	NA	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2009	NA	-25598	Dead	NA	NA	215	NA	NA	NA	NA	NA	NA	NA	NA	1	215	NA	215	NA	NA	0	215	
50	TCGA-CG-4472	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-CG-4472-01	312	0.9318249857810004	199	TCGA-CG-4472-01	22	40	69	0.4563994681263506	TCGA-CG-4472-01	17	19	11	47	PASS	9464	TCGA-CG-4472	STAD	49	MALE	NA	Stage IV	NA	NA	G3	2009	NA	-18110	Alive	WITH TUMOR	365	NA	NA	NA	NA	NA	122	Partial Remission/Response	NA	NA	0	365	0	365	NA	NA	1	122	
70	TCGA-CG-4474	0	7	0	2	6	0	0	1	2	65	5	0	2	25	4	0	TCGA-CG-4474-01	111	0.1866340010996766	56	TCGA-CG-4474-01	6	5	13	0.041728587904372	TCGA-CG-4474-01	0	2	1	3	PASS	9465	TCGA-CG-4474	STAD	67	FEMALE	NA	Stage IV	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2010	NA	-24686	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
80	TCGA-CG-4475	0	6	1	1	2	0	2	0	1	42	2	0	2	19	0	0	TCGA-CG-4475-01	351	0.5651530956674364	216	TCGA-CG-4475-01	15	37	82	0.4291665508345348	TCGA-CG-4475-01	21	23	16	60	PASS	9466	TCGA-CG-4475	STAD	76	MALE	NA	Stage IIB	NA	NA	G3	2010	NA	-28065	Alive	TUMOR FREE	699	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	699	0	699	NA	NA	0	699	
70	TCGA-CG-4476	0	6	0	3	4	0	2	0	2	91	15	0	1	26	3	0	TCGA-CG-4476-01	195	0.5771594661949154	113	TCGA-CG-4476-01	18	28	30	0.1370718125817546	TCGA-CG-4476-01	12	8	4	24	PASS	9467	TCGA-CG-4476	STAD	69	MALE	NA	Stage IIIC	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2010	NA	-25506	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
60	TCGA-CG-4477	1	8	0	4	25	35	8	10	4	42	3	0	4	19	6	0	TCGA-CG-4477-01	141	0.6932910473791057	81	TCGA-CG-4477-01	7	10	40	0.27095783474389656	TCGA-CG-4477-01	6	16	12	34	PASS	9468	TCGA-CG-4477	STAD	58	FEMALE	NA	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2008	NA	-21427	Alive	WITH TUMOR	942	NA	NA	NA	NA	NA	365	Progressive Disease	NA	NA	0	942	0	942	NA	NA	1	365	
90	TCGA-CG-5716	0	0	0	0	0	0	0	0	0	18	1	0	0	4	0	1	TCGA-CG-5716	0	0	0	TCGA-CG-5716	0	0	0	0	TCGA-CG-5716	0	0	0	0	PASS	9469	TCGA-CG-5716	STAD	86	MALE	NA	Stage IV	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2010	NA	-31411	Alive	WITH TUMOR	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
60	TCGA-CG-5717	1	6	0	3	3	1	0	0	7	105	5	1	1	35	0	0	TCGA-CG-5717-01	103	0.0430154129299792	45	TCGA-CG-5717-01	4	6	7	0.11056841291201093	TCGA-CG-5717-01	4	4	0	8	PASS	9470	TCGA-CG-5717	STAD	58	MALE	NA	Stage II	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2006	NA	-21458	Dead	WITH TUMOR	NA	212	NA	NA	NA	NA	120	Progressive Disease	NA	NA	1	212	1	212	NA	NA	1	120	
80	TCGA-CG-5718	0	6	1	2	1	1	0	0	2	68	3	0	2	24	4	0	TCGA-CG-5718-01	278	0.5242857176117627	168	TCGA-CG-5718-01	11	20	56	0.3187259511496637	TCGA-CG-5718-01	12	15	11	38	PASS	9471	TCGA-CG-5718	STAD	78	FEMALE	NA	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2008	NA	-28763	Dead	TUMOR FREE	NA	1095	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	1095	0	1095	NA	NA	0	1095	
50	TCGA-CG-5719	0	2	0	1	0	0	0	1	2	56	4	0	0	25	2	0	TCGA-CG-5719-01	144	0.3806304184309055	77	TCGA-CG-5719-01	11	12	38	0.24346674155691145	TCGA-CG-5719-01	7	6	11	24	PASS	9472	TCGA-CG-5719	STAD	54	FEMALE	NA	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G1	2010	NA	-19966	Alive	TUMOR FREE	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	31	0	31	NA	NA	0	31	
70	TCGA-CG-5720	0	7	0	0	1	0	1	0	1	62	3	0	0	29	1	1	TCGA-CG-5720-01	68	0.08026126843367455	19	TCGA-CG-5720-01	0	0	11	0.07082239118792544	TCGA-CG-5720-01	2	6	5	13	PASS	9473	TCGA-CG-5720	STAD	71	MALE	NA	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2003	NA	-26176	Dead	TUMOR FREE	NA	30	NA	NA	NA	NA	NA	NA	NA	NA	1	30	0	30	NA	NA	0	30	
60	TCGA-CG-5721	14	305	14	86	393	63	20	0	152	3025	71	5	61	1255	108	0	TCGA-CG-5721-01	72	0.0015499646074366624	20	TCGA-CG-5721-01	0	0	0	0.0	TCGA-CG-5721-01	0	0	0	0	hypermutated sample	9474	TCGA-CG-5721	STAD	58	MALE	NA	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2005	NA	-21244	Alive	TUMOR FREE	183	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	183	0	183	NA	NA	0	183	
70	TCGA-CG-5722	0	6	0	1	2	0	1	0	1	65	5	0	0	27	2	0	TCGA-CG-5722-01	68	0.19183515877496188	25	TCGA-CG-5722-01	17	11	19	6.232931673724958e-05	TCGA-CG-5722-01	1	0	0	1	PASS	9475	TCGA-CG-5722	STAD	67	FEMALE	NA	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2005	NA	-24472	Alive	WITH TUMOR	30	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	30	0	30	NA	NA	0	30	
80	TCGA-CG-5723	10	116	7	46	339	31	22	1	64	1126	49	1	27	495	32	0	TCGA-CG-5723-01	145	0.015855661326976446	88	TCGA-CG-5723-01	0	0	23	0.011721939161263564	TCGA-CG-5723-01	2	1	1	4	hypermutated sample	9476	TCGA-CG-5723	STAD	83	MALE	NA	Stage II	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2003	NA	-30376	Alive	NA	3196	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	3196	0	3196	NA	NA	0	3196	
60	TCGA-CG-5724	1	14	1	3	2	2	2	0	4	82	3	1	3	31	2	0	TCGA-CG-5724-01	263	0.5635718182799845	157	TCGA-CG-5724-01	15	30	55	0.4374306826131248	TCGA-CG-5724-01	19	14	17	50	PASS	9477	TCGA-CG-5724	STAD	59	MALE	NA	Stage IV	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2003	NA	-21762	Dead	WITH TUMOR	NA	366	NA	NA	NA	NA	122	Progressive Disease	NA	NA	1	366	1	366	NA	NA	1	122	
70	TCGA-CG-5725	1	7	0	3	18	27	9	1	3	34	3	0	2	7	6	0	TCGA-CG-5725-01	358	0.9383046364603294	240	TCGA-CG-5725-01	8	14	102	0.3714515216521632	TCGA-CG-5725-01	16	32	22	70	pathology review	9478	TCGA-CG-5725	STAD	72	MALE	NA	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2005	NA	-26329	Dead	WITH TUMOR	NA	457	NA	NA	NA	NA	153	Progressive Disease	NA	NA	1	457	1	457	NA	NA	1	153	
70	TCGA-CG-5726	6	136	3	50	256	38	24	0	65	811	36	0	21	412	23	0	TCGA-CG-5726-01	91	0.3315023658096983	38	TCGA-CG-5726-01	6	4	5	0.00020596705226565005	TCGA-CG-5726-01	0	0	0	0	hypermutated sample	9479	TCGA-CG-5726	STAD	73	MALE	NA	Stage IA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2004	NA	-26998	Dead	TUMOR FREE	NA	881	NA	NA	NA	NA	NA	NA	NA	NA	1	881	0	881	NA	NA	0	881	
70	TCGA-CG-5727	1	5	0	2	1	1	0	0	10	124	5	2	2	53	2	0	TCGA-CG-5727-01	238	0.7519739091111542	148	TCGA-CG-5727-01	30	27	29	0.13430112272709993	TCGA-CG-5727-01	9	10	6	25	PASS	9480	TCGA-CG-5727	STAD	66	MALE	NA	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2005	NA	-24289	Alive	TUMOR FREE	2405	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2405	0	2405	0	2405	0	2405	
90	TCGA-CG-5728	5	112	11	37	237	47	26	0	52	906	36	0	13	427	25	0	TCGA-CG-5728-01	96	0.07211102494109607	40	TCGA-CG-5728-01	3	4	22	0.07408940440971717	TCGA-CG-5728-01	0	1	0	1	hypermutated sample	9481	TCGA-CG-5728	STAD	88	FEMALE	NA	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2003	NA	-32293	Alive	WITH TUMOR	1980	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1980	0	1980	NA	NA	0	1980	
80	TCGA-CG-5730	1	7	2	4	1	4	1	0	8	115	5	0	7	57	1	0	TCGA-CG-5730-01	160	0.4886757843942718	85	TCGA-CG-5730-01	15	32	22	0.15565479146549907	TCGA-CG-5730-01	16	7	3	26	PASS	9482	TCGA-CG-5730	STAD	80	FEMALE	NA	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2005	NA	-29432	Alive	TUMOR FREE	122	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	122	0	122	NA	NA	0	122	
70	TCGA-CG-5732	1	2	0	1	0	2	0	0	3	46	2	0	1	24	1	0	TCGA-CG-5732-01	219	0.3872965932466003	124	TCGA-CG-5732-01	7	9	42	0.13389329537509226	TCGA-CG-5732-01	13	9	8	30	PASS	9483	TCGA-CG-5732	STAD	66	MALE	NA	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2003	NA	-24379	Dead	WITH TUMOR	NA	2100	NA	NA	NA	NA	1949	[Discrepancy]	NA	NA	1	2100	1	2100	NA	NA	1	1949	
80	TCGA-CG-5733	8	91	6	25	202	47	16	2	41	711	28	2	10	333	23	1	TCGA-CG-5733-01	106	0.1181291671991734	47	TCGA-CG-5733-01	4	4	7	0.07661357782221835	TCGA-CG-5733-01	1	2	1	4	hypermutated sample	9484	TCGA-CG-5733	STAD	83	FEMALE	NA	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2003	NA	-30650	Dead	WITH TUMOR	NA	641	NA	NA	NA	NA	427	Progressive Disease	NA	NA	1	641	1	641	NA	NA	1	427	
70	TCGA-CG-5734	0	8	0	4	3	0	0	0	4	65	5	1	1	23	1	0	TCGA-CG-5734-01	72	0.11387276741878137	27	TCGA-CG-5734-01	19	18	23	0.6179784110796396	TCGA-CG-5734-01	5	5	1	11	PASS	9485	TCGA-CG-5734	STAD	68	MALE	NA	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2005	NA	-25079	Dead	NA	NA	243	NA	NA	NA	NA	NA	NA	NA	NA	1	243	NA	243	NA	NA	0	243	
50	TCGA-D7-5577	0	4	0	2	3	1	1	0	3	102	6	0	1	29	1	0	TCGA-D7-5577-01	89	0.09389017333173268	42	TCGA-D7-5577-01	4	9	17	0.1138823724328073	TCGA-D7-5577-01	4	4	2	10	PASS	9486	TCGA-D7-5577	STAD	53	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2010	NA	-19668	Dead	WITH TUMOR	NA	782	NA	Distant Metastasis	"Other, specify"	"liver,  peritoneal surfaces, non-regional/distant lymph nodes"	376	Progressive Disease	NA	NA	1	782	1	782	NA	NA	1	376	
80	TCGA-D7-5578	2	11	1	6	4	0	1	0	6	176	9	1	6	78	1	0	TCGA-D7-5578-01	133	0.5255789330894708	68	TCGA-D7-5578-01	3	11	33	0.16637497638228604	TCGA-D7-5578-01	5	8	6	19	PASS	9487	TCGA-D7-5578	STAD	80	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2010	NA	-29390	Alive	TUMOR FREE	385	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	385	0	385	NA	NA	0	385	
70	TCGA-D7-5579	0	4	1	2	2	2	0	1	4	120	6	0	1	36	3	1	TCGA-D7-5579-01	201	0.6560182580616702	130	TCGA-D7-5579-01	23	46	26	0.14130219445635278	TCGA-D7-5579-01	16	19	6	41	PASS	9488	TCGA-D7-5579	STAD	74	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G3	2010	NA	-27175	Alive	TUMOR FREE	636	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	636	0	636	0	636	0	636	
80	TCGA-D7-6518	0	0	0	1	3	1	1	1	3	66	3	0	4	28	1	0	TCGA-D7-6518-01	131	0.3908281803690116	64	TCGA-D7-6518-01	12	18	26	0.29252194170330026	TCGA-D7-6518-01	6	3	3	12	PASS	9489	TCGA-D7-6518	STAD	75	MALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2010	NA	-27594	Alive	TUMOR FREE	582	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	582	0	582	0	582	0	582	
60	TCGA-D7-6519	0	5	0	1	3	0	0	0	4	43	2	0	1	12	0	0	TCGA-D7-6519-01	319	0.9281191917953506	199	TCGA-D7-6519-01	27	17	95	0.35153482645794354	TCGA-D7-6519-01	15	16	15	46	PASS	9490	TCGA-D7-6519	STAD	64	FEMALE	WHITE	[Discrepancy]	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2010	NA	-23413	Alive	WITH TUMOR	625	NA	NA	Distant Metastasis	Liver	cervix	429	Progressive Disease	NA	NA	0	625	0	625	NA	NA	1	429	
50	TCGA-D7-6520	1	5	0	0	0	1	1	0	1	45	4	0	0	19	2	0	TCGA-D7-6520-01	238	0.41598715781401097	147	TCGA-D7-6520-01	11	17	51	0.19232841946671825	TCGA-D7-6520-01	12	12	8	32	PASS	9491	TCGA-D7-6520	STAD	53	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2010	NA	-19467	Alive	WITH TUMOR	573	NA	NA	Distant Metastasis	Liver	NA	46	Progressive Disease	NA	NA	0	573	0	573	NA	NA	1	46	
70	TCGA-D7-6521	0	1	0	3	0	1	1	0	1	65	4	0	0	16	0	0	TCGA-D7-6521-01	129	0.6327980829696906	70	TCGA-D7-6521-01	30	37	40	0.3000630937236907	TCGA-D7-6521-01	7	7	3	17	PASS	9492	TCGA-D7-6521	STAD	65	MALE	WHITE	[Discrepancy]	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2010	NA	-23776	Alive	WITH TUMOR	564	NA	NA	Locoregional Recurrence	"Other, specify"	NA	192	Progressive Disease	NA	NA	0	564	0	564	NA	NA	1	192	
60	TCGA-D7-6522	1	2	0	0	0	1	0	0	3	39	2	0	2	15	3	0	TCGA-D7-6522-01	51	1.464850686294568e-05	11	TCGA-D7-6522-01	0	6	4	0.1592224781411448	TCGA-D7-6522-01	0	0	0	0	PASS	9493	TCGA-D7-6522	STAD	58	MALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2010	NA	-21465	Alive	TUMOR FREE	566	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	566	0	566	0	566	0	566	
50	TCGA-D7-6524	0	3	0	1	1	1	0	0	2	73	9	0	4	32	3	0	TCGA-D7-6524-01	57	0.05008402696744962	14	TCGA-D7-6524-01	3	7	3	0.09993597409187084	TCGA-D7-6524-01	1	1	0	2	PASS	9494	TCGA-D7-6524	STAD	53	MALE	WHITE	Stage II	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2010	NA	-19532	Alive	WITH TUMOR	543	NA	NA	Locoregional Recurrence	Non-regional / Distant Lymph Nodes	NA	543	Progressive Disease	NA	NA	0	543	0	543	NA	NA	1	543	
60	TCGA-D7-6525	1	9	0	4	4	1	2	0	2	124	5	1	2	56	3	0	TCGA-D7-6525-01	242	0.6024582250715199	144	TCGA-D7-6525-01	8	13	52	0.22457011663792764	TCGA-D7-6525-01	9	7	7	23	PASS	9495	TCGA-D7-6525	STAD	58	MALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2010	NA	-21223	Dead	WITH TUMOR	NA	406	NA	Distant Metastasis	NA	NA	171	Progressive Disease	NA	NA	1	406	1	406	NA	NA	1	171	
70	TCGA-D7-6526	0	11	1	7	3	4	4	0	4	168	4	1	7	67	1	0	TCGA-D7-6526-01	472	0.7488473111716109	300	TCGA-D7-6526-01	20	69	55	0.1118822318840985	TCGA-D7-6526-01	28	24	6	58	PASS	9496	TCGA-D7-6526	STAD	67	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2010	NA	-24477	Alive	TUMOR FREE	523	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	523	0	523	0	523	0	523	
60	TCGA-D7-6527	0	12	0	4	5	1	2	0	3	176	9	0	6	56	2	1	TCGA-D7-6527-01	764	0.7521348508211205	559	TCGA-D7-6527-01	25	51	57	0.14049382456144274	TCGA-D7-6527-01	19	22	10	51	PASS	9497	TCGA-D7-6527	STAD	62	MALE	WHITE	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Papillary Type"	G2	2010	NA	-22793	Dead	WITH TUMOR	NA	312	NA	Distant Metastasis	Liver	NA	75	Progressive Disease	NA	NA	1	312	1	312	NA	NA	1	75	
70	TCGA-D7-6528	1	19	3	7	6	3	0	0	11	277	12	0	6	87	4	0	TCGA-D7-6528-01	200	0.8328339793421871	112	TCGA-D7-6528-01	20	26	37	0.2914979903908915	TCGA-D7-6528-01	15	12	8	35	PASS	9498	TCGA-D7-6528	STAD	70	FEMALE	WHITE	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2010	NA	-25815	Alive	TUMOR FREE	463	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	463	0	463	0	463	0	463	
70	TCGA-D7-6815	0	5	1	10	5	4	2	2	4	96	9	0	4	48	0	0	TCGA-D7-6815-01	163	0.6571648523862854	81	TCGA-D7-6815-01	4	6	28	0.1741121025579205	TCGA-D7-6815-01	6	8	5	19	PASS	9499	TCGA-D7-6815	STAD	70	FEMALE	WHITE	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2010	NA	-25811	Alive	TUMOR FREE	486	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	486	0	486	0	486	0	486	
60	TCGA-D7-6817	1	4	0	2	1	0	0	0	7	67	1	0	0	23	2	0	TCGA-D7-6817-01	165	0.5523393455568634	89	TCGA-D7-6817-01	19	31	31	0.16071126751886125	TCGA-D7-6817-01	11	14	4	29	PASS	9500	TCGA-D7-6817	STAD	63	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2011	NA	-23142	Alive	TUMOR FREE	389	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	389	0	389	NA	NA	0	389	
50	TCGA-D7-6818	0	13	0	9	4	1	0	0	3	137	4	0	1	32	0	0	TCGA-D7-6818-01	178	0.4123153822334748	102	TCGA-D7-6818-01	13	36	50	0.3667445268485188	TCGA-D7-6818-01	13	9	6	28	PASS	9501	TCGA-D7-6818	STAD	53	MALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-19391	Dead	WITH TUMOR	NA	376	NA	Locoregional Recurrence	NA	NA	247	Progressive Disease	NA	NA	1	376	1	376	NA	NA	1	247	
60	TCGA-D7-6820	1	9	1	2	1	0	1	0	5	66	9	0	2	30	0	0	TCGA-D7-6820-01	179	0.5019916027171648	85	TCGA-D7-6820-01	16	17	49	0.5191342301974603	TCGA-D7-6820-01	11	9	13	33	PASS	9502	TCGA-D7-6820	STAD	64	MALE	WHITE	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-23486	Alive	TUMOR FREE	344	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	344	0	344	0	344	0	344	
80	TCGA-D7-6822	1	10	2	10	6	2	0	0	11	213	6	0	5	50	4	0	TCGA-D7-6822-01	637	0.5076650465182178	437	TCGA-D7-6822-01	14	28	202	0.3947182973244964	TCGA-D7-6822-01	23	14	18	55	PASS	9503	TCGA-D7-6822	STAD	77	MALE	WHITE	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-28214	Alive	TUMOR FREE	375	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	375	0	375	0	375	0	375	
40	TCGA-D7-8570	0	8	0	4	4	0	2	0	5	90	6	0	4	38	1	0	TCGA-D7-8570-01	113	0.3602176113617556	55	TCGA-D7-8570-01	8	13	65	0.1597108989445961	TCGA-D7-8570-01	14	15	9	38	PASS	9504	TCGA-D7-8570	STAD	44	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2011	NA	-16150	Alive	WITH TUMOR	752	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	752	0	752	0	752	0	752	
60	TCGA-D7-8572	0	10	0	1	2	0	1	0	2	143	5	0	1	57	4	0	TCGA-D7-8572-01	87	0.02293455078557376	42	TCGA-D7-8572-01	0	1	34	0.03445485816542748	TCGA-D7-8572-01	1	2	1	4	PASS	9505	TCGA-D7-8572	STAD	57	MALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-20870	Alive	WITH TUMOR	511	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	511	0	511	0	511	0	511	
60	TCGA-D7-8573	0	4	1	3	2	0	1	0	4	66	1	0	1	26	1	1	TCGA-D7-8573-01	142	0.3900319760620527	85	TCGA-D7-8573-01	9	25	61	0.08262860417090824	TCGA-D7-8573-01	7	6	4	17	PASS	9506	TCGA-D7-8573	STAD	57	MALE	WHITE	Stage IIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2012	NA	-20963	Alive	WITH TUMOR	593	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	593	0	593	0	593	0	593	
70	TCGA-D7-8574	0	0	0	0	0	0	0	0	1	28	3	0	1	14	2	0	TCGA-D7-8574-01	39	0.00013822217858510706	6	TCGA-D7-8574-01	1	3	15	0.05657365806461032	TCGA-D7-8574-01	1	2	0	3	PASS	9507	TCGA-D7-8574	STAD	72	MALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-26586	Alive	TUMOR FREE	523	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	523	0	523	0	523	0	523	
80	TCGA-D7-8575	1	1	0	1	0	3	2	0	3	38	5	0	0	11	1	0	TCGA-D7-8575-01	132	0.4697354840933582	63	TCGA-D7-8575-01	9	14	116	0.3560096862493082	TCGA-D7-8575-01	12	9	11	32	PASS	9508	TCGA-D7-8575	STAD	75	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2012	NA	-27712	Dead	WITH TUMOR	NA	554	NA	Distant Metastasis	Peritoneal Surfaces	NA	427	Complete Remission/Response	NA	NA	1	554	1	554	1	427	1	427	
50	TCGA-D7-8576	1	5	0	2	2	1	0	0	4	40	1	0	0	20	1	0	TCGA-D7-8576-01	109	0.6204194213382647	48	TCGA-D7-8576-01	14	18	75	0.4577914601844877	TCGA-D7-8576-01	9	10	10	29	PASS	9509	TCGA-D7-8576	STAD	54	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2012	NA	-20014	Dead	WITH TUMOR	NA	446	NA	Locoregional Recurrence|Distant Metastasis	Lung	NA	204	Complete Remission/Response	NA	NA	1	446	1	446	1	204	1	204	
70	TCGA-D7-8578	0	2	0	1	0	2	0	0	1	46	2	0	0	14	1	0	TCGA-D7-8578-01	87	0.28115230996456503	32	TCGA-D7-8578-01	12	15	45	0.2645389045649356	TCGA-D7-8578-01	4	2	5	11	PASS	9510	TCGA-D7-8578	STAD	72	MALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-26620	Alive	WITH TUMOR	643	NA	NA	Locoregional Recurrence|Distant Metastasis	Lung	NA	451	Complete Remission/Response	NA	NA	0	643	0	643	1	451	1	451	
70	TCGA-D7-8579	0	5	0	5	0	1	0	0	2	92	3	0	2	33	1	1	TCGA-D7-8579-01	69	0.06420927292522922	25	TCGA-D7-8579-01	2	5	14	0.0543254279633672	TCGA-D7-8579-01	1	4	2	7	PASS	9511	TCGA-D7-8579	STAD	66	FEMALE	WHITE	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-24120	Alive	TUMOR FREE	636	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	636	0	636	0	636	0	636	
60	TCGA-D7-A4YT	1	17	1	11	9	6	3	0	17	209	12	1	3	92	5	0	TCGA-D7-A4YT-01	183	0.4204797102855431	89	TCGA-D7-A4YT-01	3	12	89	0.2449768710082519	TCGA-D7-A4YT-01	23	29	19	71	PASS	9512	TCGA-D7-A4YT	STAD	56	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2012	NA	-20742	Alive	TUMOR FREE	434	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	434	0	434	0	434	0	434	
70	TCGA-D7-A4YU	1	3	4	3	2	1	1	1	7	196	12	0	7	48	6	0	TCGA-D7-A4YU-01	156	0.6076429449023348	91	TCGA-D7-A4YU-01	29	17	78	0.21377758944300088	TCGA-D7-A4YU-01	9	4	5	18	PASS	9513	TCGA-D7-A4YU	STAD	73	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2012	NA	-26781	Alive	WITH TUMOR	500	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	500	0	500	NA	NA	0	500	
70	TCGA-D7-A4YV	8	51	4	28	129	24	11	0	27	590	44	0	11	264	16	1	TCGA-D7-A4YV-01	53	0.11778043057205415	14	TCGA-D7-A4YV-01	6	3	12	0.0017673222551235367	TCGA-D7-A4YV-01	0	0	0	0	hypermutated sample	9514	TCGA-D7-A4YV	STAD	69	FEMALE	WHITE	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2012	NA	-25421	Dead	TUMOR FREE	NA	180	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	180	0	180	0	180	0	180	
60	TCGA-D7-A4YX	0	7	0	3	2	0	1	0	2	62	4	0	0	24	2	1	TCGA-D7-A4YX-01	170	0.14774060486269633	108	TCGA-D7-A4YX-01	7	9	101	0.13522997210093754	TCGA-D7-A4YX-01	4	2	4	10	PASS	9515	TCGA-D7-A4YX	STAD	63	MALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-23249	Alive	TUMOR FREE	1108	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1108	0	1108	0	1108	0	1108	
60	TCGA-D7-A4YY	2	42	3	17	60	27	7	1	21	297	11	1	12	171	7	1	TCGA-D7-A4YY-01	588	0.15252832110030234	457	TCGA-D7-A4YY-01	2	5	307	0.15784527134507986	TCGA-D7-A4YY-01	1	7	4	12	PASS	9516	TCGA-D7-A4YY	STAD	61	MALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-22287	Alive	TUMOR FREE	419	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	419	0	419	NA	NA	0	419	
60	TCGA-D7-A4Z0	2	14	0	6	3	1	1	0	7	263	6	0	4	66	1	0	TCGA-D7-A4Z0-01	51	0.09860822000292713	14	TCGA-D7-A4Z0-01	4	7	22	0.0569465017461432	TCGA-D7-A4Z0-01	1	3	1	5	PASS	9517	TCGA-D7-A4Z0	STAD	60	FEMALE	WHITE	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G3	2012	NA	-22129	Alive	TUMOR FREE	449	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	449	0	449	0	449	0	449	
80	TCGA-D7-A6ET	1	2	0	0	0	0	0	0	1	19	2	0	0	10	0	0	TCGA-D7-A6ET-01	43	5.7022805731822e-05	8	TCGA-D7-A6ET-01	0	0	11	0.000524542221436533	TCGA-D7-A6ET-01	0	0	0	0	PASS	9518	TCGA-D7-A6ET	STAD	76	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2012	NA	-27928	Alive	WITH TUMOR	804	NA	NA	Locoregional Recurrence	NA	NA	777	Complete Remission/Response	NA	NA	0	804	0	804	1	777	1	777	
70	TCGA-D7-A6EV	2	9	1	3	5	0	1	0	5	132	5	0	1	51	1	0	TCGA-D7-A6EV-01	250	0.7718412330553915	142	TCGA-D7-A6EV-01	22	35	185	0.4307319724420077	TCGA-D7-A6EV-01	20	20	7	47	PASS	9519	TCGA-D7-A6EV	STAD	71	FEMALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2013	NA	-26226	Alive	TUMOR FREE	342	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	342	0	342	0	342	0	342	
70	TCGA-D7-A6EX	0	3	0	3	0	1	1	0	4	101	6	0	0	36	2	0	TCGA-D7-A6EX-01	220	0.9625599060864242	119	TCGA-D7-A6EX-01	25	36	63	0.15571559540292304	TCGA-D7-A6EX-01	8	9	4	21	PASS	9520	TCGA-D7-A6EX	STAD	72	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2013	NA	-26525	Alive	TUMOR FREE	344	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	344	0	344	0	344	0	344	
70	TCGA-D7-A6EY	10	88	4	33	179	48	9	1	39	984	29	2	16	391	25	2	TCGA-D7-A6EY-01	115	0.11098430061560867	59	TCGA-D7-A6EY-01	2	3	50	0.05728239532240058	TCGA-D7-A6EY-01	3	3	2	8	hypermutated sample	9521	TCGA-D7-A6EY	STAD	72	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2013	NA	-26526	Dead	WITH TUMOR	NA	348	Stomach Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	348	1	348	NA	NA	1	348	
70	TCGA-D7-A6EZ	3	14	0	7	13	0	6	0	11	207	15	1	4	54	5	0	TCGA-D7-A6EZ-01	200	0.2055167250535534	113	TCGA-D7-A6EZ-01	3	7	77	0.11206145823613448	TCGA-D7-A6EZ-01	12	13	8	33	PASS	9522	TCGA-D7-A6EZ	STAD	66	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2013	NA	-24425	Dead	WITH TUMOR	NA	618	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	618	1	618	NA	NA	1	618	
80	TCGA-D7-A6F0	3	4	0	3	3	0	0	0	3	95	7	0	1	42	1	0	TCGA-D7-A6F0-01	594	0.6815568419075397	416	TCGA-D7-A6F0-01	20	57	297	0.3597262539657767	TCGA-D7-A6F0-01	29	14	19	62	PASS	9523	TCGA-D7-A6F0	STAD	79	FEMALE	WHITE	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2013	NA	-28923	Alive	TUMOR FREE	678	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	678	0	678	0	678	0	678	
60	TCGA-D7-A6F2	1	2	2	2	0	0	0	0	2	63	1	0	0	17	1	0	TCGA-D7-A6F2-01	210	0.6527280556547254	118	TCGA-D7-A6F2-01	23	30	98	0.2195210288301604	TCGA-D7-A6F2-01	18	10	12	40	PASS	9524	TCGA-D7-A6F2	STAD	62	MALE	WHITE	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2012	NA	-22801	Alive	TUMOR FREE	476	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	476	0	476	0	476	0	476	
60	TCGA-D7-A747	0	4	0	2	3	0	0	0	3	93	1	0	3	22	0	0	TCGA-D7-A747-01	70	0.09765251888092613	22	TCGA-D7-A747-01	10	17	38	0.18143620805090688	TCGA-D7-A747-01	8	6	3	17	PASS	9525	TCGA-D7-A747	STAD	57	MALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2013	NA	-20923	Dead	WITH TUMOR	NA	255	Stomach Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	255	1	255	NA	NA	1	255	
40	TCGA-D7-A748	0	1	0	0	0	1	0	0	1	31	4	0	0	13	1	0	TCGA-D7-A748-01	42	0.056933868980347586	5	TCGA-D7-A748-01	2	4	11	0.03591887283475087	TCGA-D7-A748-01	5	4	2	11	PASS	9526	TCGA-D7-A748	STAD	41	FEMALE	WHITE	Stage IV	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2013	NA	-15190	Dead	WITH TUMOR	NA	132	Stomach Cancer	Locoregional Recurrence|Distant Metastasis	NA	NA	99	Progressive Disease	NA	NA	1	132	1	132	NA	NA	1	99	
60	TCGA-D7-A74A	0	16	1	3	2	0	2	0	10	107	11	0	1	45	3	0	TCGA-D7-A74A-01	240	0.981325658361682	153	TCGA-D7-A74A-01	23	39	152	0.2619065674016859	TCGA-D7-A74A-01	21	13	11	45	PASS	9527	TCGA-D7-A74A	STAD	61	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2013	NA	-22435	Alive	TUMOR FREE	607	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	607	0	607	0	607	0	607	
50	TCGA-D7-A74B	0	1	1	0	2	0	0	0	0	27	1	0	0	12	2	0	TCGA-D7-A74B-01	90	0.0028621640727258093	40	TCGA-D7-A74B	0	0	0	0	TCGA-D7-A74B	0	0	0	0	PASS	9528	TCGA-D7-A74B	STAD	52	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2013	NA	-19066	Dead	WITH TUMOR	NA	217	Stomach Cancer	Locoregional Recurrence	NA	NA	174	Progressive Disease	NA	NA	1	217	1	217	NA	NA	1	174	
90	TCGA-EQ-5647	0	12	0	4	0	0	0	0	4	144	6	0	2	48	0	0	TCGA-EQ-5647-01	291	0.6986345126331343	188	TCGA-EQ-5647-01	22	25	54	0.2977051803219694	TCGA-EQ-5647-01	17	15	11	43	PASS	9529	TCGA-EQ-5647	STAD	86	FEMALE	WHITE	Stage IV	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2010	NA	-31431	Dead	WITH TUMOR	NA	19	NA	NA	NA	NA	NA	NA	NA	NA	1	19	1	19	NA	NA	1	19	
70	TCGA-EQ-8122	1	10	0	7	5	0	1	0	4	143	12	0	5	51	1	0	TCGA-EQ-8122-01	200	0.7823176588779447	118	TCGA-EQ-8122-01	23	61	166	0.5306431703272614	TCGA-EQ-8122-01	23	10	14	47	PASS	9530	TCGA-EQ-8122	STAD	71	FEMALE	WHITE	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-26289	Dead	NA	NA	243	NA	NA	NA	NA	NA	NA	NA	NA	1	243	NA	243	NA	NA	0	243	
70	TCGA-EQ-A4SO	4	14	4	8	28	5	8	0	7	249	20	0	6	92	10	0	TCGA-EQ-A4SO-01	178	0.4711991230497951	104	TCGA-EQ-A4SO-01	7	11	95	0.2552186683212977	TCGA-EQ-A4SO-01	18	24	15	57	PASS	9531	TCGA-EQ-A4SO	STAD	70	MALE	WHITE	Stage IIIB	NA	[Discrepancy]	G2	2012	NA	-25897	Alive	TUMOR FREE	494	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	494	0	494	0	494	0	494	
90	TCGA-F1-6177	5	111	7	44	220	68	12	0	48	827	45	1	21	391	13	0	TCGA-F1-6177-01	112	0.1033904362917226	63	TCGA-F1-6177-01	4	6	7	0.08927015344844305	TCGA-F1-6177-01	2	0	1	3	hypermutated sample	9532	TCGA-F1-6177	STAD	90	MALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2009	NA	-32873	Alive	TUMOR FREE	200	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	200	0	200	0	200	0	200	
80	TCGA-F1-6874	4	54	3	18	157	45	16	0	35	575	36	2	21	271	16	0	TCGA-F1-6874-01	71	0.08567262046404407	27	TCGA-F1-6874-01	4	2	9	0.05010981281842908	TCGA-F1-6874-01	1	1	3	5	hypermutated sample	9533	TCGA-F1-6874	STAD	79	MALE	WHITE	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-29083	Alive	TUMOR FREE	440	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	440	0	440	0	440	0	440	
80	TCGA-F1-6875	0	3	1	3	1	0	0	0	1	75	5	0	1	27	3	0	TCGA-F1-6875-01	241	0.9184841366327642	151	TCGA-F1-6875-01	25	38	114	0.26920438524792256	TCGA-F1-6875-01	12	5	8	25	PASS	9534	TCGA-F1-6875	STAD	79	MALE	BLACK OR AFRICAN AMERICAN	Stage IA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	1996	NA	-29209	Dead	TUMOR FREE	NA	2197	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	2197	0	2197	0	2197	0	2197	
70	TCGA-F1-A448	2	28	0	11	83	11	10	0	22	400	20	0	4	186	11	1	TCGA-F1-A448-01	95	0.11723589765003226	48	TCGA-F1-A448-01	4	2	26	0.01024810404653556	TCGA-F1-A448-01	0	2	1	3	PASS	9535	TCGA-F1-A448	STAD	70	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G3	2012	NA	-25846	Alive	TUMOR FREE	647	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	647	0	647	0	647	0	647	
70	TCGA-F1-A72C	0	2	0	1	5	1	0	0	0	37	1	0	1	20	0	0	TCGA-F1-A72C-01	122	0.3493887401712509	56	TCGA-F1-A72C-01	15	11	76	0.25781206591792394	TCGA-F1-A72C-01	9	3	7	19	PASS	9536	TCGA-F1-A72C	STAD	68	MALE	ASIAN	Stage IIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2013	NA	-25104	Alive	WITH TUMOR	346	NA	NA	Distant Metastasis	Liver	NA	343	Complete Remission/Response	NA	NA	0	346	0	346	1	343	1	343	
80	TCGA-FP-7735	0	2	0	2	4	0	0	0	6	90	2	0	0	34	4	0	TCGA-FP-7735-01	208	0.9163723328867214	122	TCGA-FP-7735	0	0	0	0	TCGA-FP-7735-01	20	6	20	46	PASS	9537	TCGA-FP-7735	STAD	77	MALE	BLACK OR AFRICAN AMERICAN	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-28232	Dead	TUMOR FREE	NA	106	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	106	0	106	0	106	0	106	
70	TCGA-FP-7829	4	24	0	14	8	6	4	0	14	379	24	0	6	152	4	0	TCGA-FP-7829-01	334	0.5814609447593312	220	TCGA-FP-7829-01	16	36	84	0.26965965210401105	TCGA-FP-7829-01	18	17	9	44	PASS	9538	TCGA-FP-7829	STAD	69	MALE	WHITE	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G2	2011	NA	-25534	Alive	TUMOR FREE	594	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	594	0	594	0	594	0	594	
80	TCGA-FP-7916	1	5	0	4	2	1	1	0	1	80	1	0	2	30	1	1	TCGA-FP-7916-01	92	0.43872332204026093	38	TCGA-FP-7916-01	21	39	20	0.2629555103912114	TCGA-FP-7916-01	5	2	3	10	PASS	9539	TCGA-FP-7916	STAD	77	MALE	ASIAN	Stage IIIC	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-28475	Dead	WITH TUMOR	NA	428	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	428	1	428	NA	NA	1	428	
80	TCGA-FP-7998	0	0	1	2	0	0	0	0	2	50	5	0	0	18	4	1	TCGA-FP-7998-01	118	0.09929973301638093	55	TCGA-FP-7998-01	6	6	19	0.17865313189179646	TCGA-FP-7998-01	6	3	2	11	PASS	9540	TCGA-FP-7998	STAD	77	MALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-28302	Alive	TUMOR FREE	678	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	678	0	678	0	678	0	678	
80	TCGA-FP-8099	1	6	0	3	2	2	0	0	3	103	7	0	3	47	1	0	TCGA-FP-8099-01	178	0.6682337284969024	101	TCGA-FP-8099-01	19	58	50	0.1614866488939222	TCGA-FP-8099-01	18	14	7	39	PASS	9541	TCGA-FP-8099	STAD	79	MALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-29129	Alive	TUMOR FREE	519	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	519	0	519	0	519	0	519	
50	TCGA-FP-8209	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	TCGA-FP-8209-01	39	9.066015466441203e-06	3	TCGA-FP-8209	0	0	0	0	TCGA-FP-8209	0	0	0	0	PASS	9542	TCGA-FP-8209	STAD	49	MALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2005	NA	-18171	Dead	WITH TUMOR	NA	1811	Stomach Cancer	Distant Metastasis	"Other, specify"	pancreas	1676	Complete Remission/Response	NA	NA	1	1811	1	1811	1	1676	1	1676	
50	TCGA-FP-8210	0	0	0	0	0	0	0	0	0	3	1	0	0	1	1	0	TCGA-FP-8210-01	45	2.456146887210725e-05	7	TCGA-FP-8210-01	0	0	3	0.00024721941772052816	TCGA-FP-8210-01	0	0	0	0	PASS	9543	TCGA-FP-8210	STAD	48	MALE	ASIAN	Stage IIIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2006	NA	-17562	Dead	WITH TUMOR	NA	153	Stomach Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	153	1	153	NA	NA	1	153	
60	TCGA-FP-8211	0	2	0	3	6	1	1	0	5	75	8	0	3	21	0	0	TCGA-FP-8211-01	213	0.9415578427478152	115	TCGA-FP-8211-01	5	18	107	0.4011858293662733	TCGA-FP-8211-01	19	23	16	58	PASS	9544	TCGA-FP-8211	STAD	62	MALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-22957	Alive	TUMOR FREE	413	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	413	0	413	0	413	0	413	
70	TCGA-FP-8631	2	2	0	3	3	4	1	0	5	67	7	0	1	35	0	0	TCGA-FP-8631-01	343	0.6017610403828383	221	TCGA-FP-8631-01	20	34	82	0.06641396778529984	TCGA-FP-8631-01	15	11	4	30	PASS	9545	TCGA-FP-8631	STAD	68	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-24898	Alive	TUMOR FREE	17	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	17	0	17	NA	NA	0	17	
60	TCGA-FP-A4BE	6	94	5	35	191	55	15	1	48	984	56	1	17	437	26	1	TCGA-FP-A4BE	0	0	0	TCGA-FP-A4BE	0	0	0	0	TCGA-FP-A4BE	0	0	0	0	hypermutated sample	9546	TCGA-FP-A4BE	STAD	55	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-20148	Alive	TUMOR FREE	337	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	337	0	337	0	337	0	337	
70	TCGA-FP-A4BF	1	5	0	1	2	0	2	0	0	82	5	0	0	30	2	0	TCGA-FP-A4BF-01	171	0.5508981665103139	85	TCGA-FP-A4BF-01	21	56	119	0.3977013087466199	TCGA-FP-A4BF-01	19	16	10	45	PASS	9547	TCGA-FP-A4BF	STAD	68	MALE	WHITE	Stage IIIA	NA	"Stomach Adenocarcinoma, Signet Ring Type"	G3	2011	NA	-25030	Dead	WITH TUMOR	NA	168	NA	Distant Metastasis	Lung	NA	159	Progressive Disease	NA	NA	1	168	1	168	NA	NA	1	159	
60	TCGA-FP-A8CX	0	5	1	1	3	0	2	0	3	73	4	1	2	23	2	0	TCGA-FP-A8CX-01	247	0.4116354791163903	158	TCGA-FP-A8CX-01	18	27	67	0.07577441321945523	TCGA-FP-A8CX-01	13	6	4	23	PASS	9548	TCGA-FP-A8CX	STAD	60	MALE	WHITE	Stage IIIC	NA	"Stomach Adenocarcinoma, Signet Ring Type"	G3	2013	NA	-22000	Alive	TUMOR FREE	7	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	7	0	7	NA	NA	0	7	
80	TCGA-FP-A9TM	0	8	2	1	3	0	0	0	4	127	8	0	4	48	8	2	TCGA-FP-A9TM-01	144	0.4128999083474426	78	TCGA-FP-A9TM-01	12	31	155	0.4313311818392532	TCGA-FP-A9TM-01	14	15	13	42	PASS	9549	TCGA-FP-A9TM	STAD	77	MALE	WHITE	[Discrepancy]	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2013	NA	-28376	Alive	TUMOR FREE	189	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	189	0	189	0	189	0	189	
NA	TCGA-HF-7131	0	5	0	3	3	0	0	0	3	70	6	0	1	28	1	0	TCGA-HF-7131	0	0	0	TCGA-HF-7131	0	0	0	0	TCGA-HF-7131-01	13	10	11	34	PASS	9550	TCGA-HF-7131	STAD	NA	FEMALE	NA	Stage IB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2007	NA	NA	Alive	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	NA	0	NA	0	NA	0	NA	
NA	TCGA-HF-7132	3	52	5	23	162	58	13	0	36	834	48	0	16	387	18	1	TCGA-HF-7132-01	74	0.11876354403499055	28	TCGA-HF-7132-01	5	5	9	0.07218194280332475	TCGA-HF-7132-01	3	0	2	5	hypermutated sample	9551	TCGA-HF-7132	STAD	NA	MALE	NA	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G2	2006	NA	NA	Alive	TUMOR FREE	2351	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2351	0	2351	0	2351	0	2351	
NA	TCGA-HF-7133	0	2	2	0	3	0	0	0	2	58	6	0	2	17	1	0	TCGA-HF-7133-01	263	0.9373472054618276	169	TCGA-HF-7133-01	10	16	94	0.3873330619746714	TCGA-HF-7133-01	22	20	22	64	PASS	9552	TCGA-HF-7133	STAD	NA	FEMALE	NA	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G2	2007	NA	NA	Alive	TUMOR FREE	1918	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1918	0	1918	NA	NA	0	1918	
NA	TCGA-HF-7134	0	10	0	5	2	1	0	0	6	233	12	0	2	84	7	0	TCGA-HF-7134-01	171	0.9476580438718044	108	TCGA-HF-7134-01	10	14	36	0.12000461736960567	TCGA-HF-7134-01	3	1	0	4	pathology review	9553	TCGA-HF-7134	STAD	NA	MALE	NA	Stage IA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2008	NA	NA	Alive	TUMOR FREE	1588	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1588	0	1588	0	1588	0	1588	
NA	TCGA-HF-7136	0	3	1	2	5	3	1	0	3	65	3	0	1	20	2	0	TCGA-HF-7136-01	283	0.5370479132903051	180	TCGA-HF-7136-01	17	33	133	0.5774166511565996	TCGA-HF-7136-01	21	15	11	47	PASS	9554	TCGA-HF-7136	STAD	NA	MALE	NA	Stage IIIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2008	NA	NA	Alive	WITH TUMOR	NA	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	NA	0	NA	NA	NA	0	NA	
80	TCGA-HF-A5NB	6	124	16	45	243	57	22	0	63	910	33	1	22	411	32	1	TCGA-HF-A5NB-01	192	0.09438065509176556	118	TCGA-HF-A5NB-01	2	4	62	0.09390310486518057	TCGA-HF-A5NB-01	1	3	1	5	hypermutated sample	9555	TCGA-HF-A5NB	STAD	75	FEMALE	[Not Evaluated]	Stage IIIC	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G3	NA	NA	-27676	Alive	TUMOR FREE	928	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	928	0	928	0	928	0	928	
70	TCGA-HJ-7597	4	35	1	12	103	22	14	0	20	504	28	0	5	272	21	0	TCGA-HJ-7597-01	67	0.4203390591538181	24	TCGA-HJ-7597-01	9	13	12	0.08463508518337125	TCGA-HJ-7597-01	4	5	2	11	hypermutated sample	9556	TCGA-HJ-7597	STAD	71	FEMALE	WHITE	Stage IB	NA	"Stomach Adenocarcinoma, Signet Ring Type"	G3	2005	NA	-26264	Dead	WITH TUMOR	NA	805	Stomach Cancer	Locoregional Recurrence	NA	NA	231	Complete Remission/Response	NA	NA	1	805	1	805	1	231	1	231	
60	TCGA-HU-8238	0	6	2	1	3	1	1	0	8	129	11	0	3	43	2	0	TCGA-HU-8238-01	111	0.3390348795591663	57	TCGA-HU-8238-01	15	13	81	0.35024481286852177	TCGA-HU-8238-01	6	10	6	22	pathology review	9557	TCGA-HU-8238	STAD	56	MALE	ASIAN	[Discrepancy]	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-20708	Alive	TUMOR FREE	46	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	46	0	46	0	46	0	46	
70	TCGA-HU-8243	0	9	1	2	0	3	3	0	6	99	6	0	2	38	2	0	TCGA-HU-8243-01	145	0.6873324832721063	77	TCGA-HU-8243-01	16	30	86	0.20318504887774647	TCGA-HU-8243-01	22	11	8	41	PASS	9558	TCGA-HU-8243	STAD	66	MALE	ASIAN	Stage IIIC	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-24187	Dead	WITH TUMOR	NA	180	Stomach Cancer	Distant Metastasis	Liver	NA	132	Partial Remission/Response	NA	NA	1	180	1	180	NA	NA	1	132	
80	TCGA-HU-8244	0	6	1	8	2	1	0	0	2	97	4	0	2	52	2	0	TCGA-HU-8244-01	103	0.20785013997090446	50	TCGA-HU-8244-01	6	6	20	0.00519255369350857	TCGA-HU-8244-01	2	0	0	2	pathology review	9559	TCGA-HU-8244	STAD	77	FEMALE	ASIAN	Stage IA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G1	2011	NA	-28184	Alive	TUMOR FREE	742	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	742	0	742	0	742	0	742	
70	TCGA-HU-8245	0	3	0	2	6	1	0	0	2	46	3	0	0	17	4	0	TCGA-HU-8245-01	124	0.58198777123684	55	TCGA-HU-8245-01	16	17	133	0.4389700103238768	TCGA-HU-8245-01	10	4	11	25	PASS	9560	TCGA-HU-8245	STAD	72	MALE	ASIAN	Stage IIA	NA	"Stomach, Intestinal Adenocarcinoma, Papillary Type"	G3	2011	NA	-26521	Alive	TUMOR FREE	552	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	552	0	552	0	552	0	552	
80	TCGA-HU-8249	0	7	1	2	2	2	1	0	4	113	6	0	0	44	0	0	TCGA-HU-8249-01	240	0.8574602775087717	145	TCGA-HU-8249-01	19	30	105	0.24105521384769274	TCGA-HU-8249-01	18	16	6	40	PASS	9561	TCGA-HU-8249	STAD	76	MALE	ASIAN	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-28012	Alive	TUMOR FREE	881	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	881	0	881	0	881	0	881	
60	TCGA-HU-8602	20	199	14	103	548	88	44	1	114	2102	92	2	46	999	64	0	TCGA-HU-8602-01	62	0.10019124537514457	18	TCGA-HU-8602-01	4	3	13	0.0007755340544829812	TCGA-HU-8602-01	1	0	0	1	hypermutated sample	9562	TCGA-HU-8602	STAD	58	FEMALE	ASIAN	Stage IIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-21522	Alive	TUMOR FREE	679	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	679	0	679	0	679	0	679	
80	TCGA-HU-8604	2	10	4	1	6	4	2	0	10	339	14	0	2	140	0	0	TCGA-HU-8604-01	144	0.4774097158028477	76	TCGA-HU-8604-01	18	27	63	0.19396848215231424	TCGA-HU-8604-01	13	8	4	25	PASS	9563	TCGA-HU-8604	STAD	82	FEMALE	ASIAN	Stage IIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-30178	Alive	TUMOR FREE	694	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	694	0	694	0	694	0	694	
70	TCGA-HU-8608	0	6	0	2	4	2	0	0	0	136	11	0	2	47	10	0	TCGA-HU-8608-01	72	0.04381876438657128	27	TCGA-HU-8608-01	3	4	35	0.0935107648865663	TCGA-HU-8608-01	4	1	3	8	PASS	9564	TCGA-HU-8608	STAD	70	MALE	ASIAN	Stage IIIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2012	NA	-25789	Alive	WITH TUMOR	641	NA	NA	Distant Metastasis	Lung	NA	277	Complete Remission/Response	NA	NA	0	641	0	641	1	277	1	277	
80	TCGA-HU-8610	0	6	1	0	0	0	2	0	4	92	8	0	0	29	2	0	TCGA-HU-8610-01	57	0.3908483552467392	17	TCGA-HU-8610-01	10	8	52	0.2400166163885148	TCGA-HU-8610-01	3	4	6	13	PASS	9565	TCGA-HU-8610	STAD	75	MALE	ASIAN	Stage IA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2012	NA	-27594	Alive	TUMOR FREE	23	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	23	0	23	NA	NA	0	23	
50	TCGA-HU-A4G2	0	3	0	2	1	1	0	0	1	32	5	0	1	21	2	0	TCGA-HU-A4G2-01	97	0.26219622192502906	51	TCGA-HU-A4G2-01	10	10	14	0.041961860901798965	TCGA-HU-A4G2-01	2	2	1	5	PASS	9566	TCGA-HU-A4G2	STAD	45	MALE	ASIAN	Stage IIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-16791	Alive	TUMOR FREE	739	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	739	0	739	0	739	0	739	
50	TCGA-HU-A4G3	0	14	0	2	10	6	4	0	6	168	2	0	0	69	0	0	TCGA-HU-A4G3-01	327	0.008123749263206378	244	TCGA-HU-A4G3	0	0	0	0	TCGA-HU-A4G3-01	0	0	0	0	PASS	9567	TCGA-HU-A4G3	STAD	54	MALE	ASIAN	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-20064	Alive	TUMOR FREE	170	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	170	0	170	NA	NA	0	170	
70	TCGA-HU-A4G6	1	1	1	0	4	0	1	0	3	63	1	1	3	24	1	0	TCGA-HU-A4G6-01	138	0.8405238152979034	80	TCGA-HU-A4G6-01	15	22	24	0.03606803596466572	TCGA-HU-A4G6-01	3	5	1	9	PASS	9568	TCGA-HU-A4G6	STAD	74	MALE	ASIAN	Stage IA	NA	"Stomach, Intestinal Adenocarcinoma, Papillary Type"	G3	2011	NA	-27208	Alive	TUMOR FREE	738	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	738	0	738	0	738	0	738	
70	TCGA-HU-A4G8	9	78	7	45	247	42	17	1	38	980	42	1	20	460	20	4	TCGA-HU-A4G8-01	140	0.11502303710555488	80	TCGA-HU-A4G8-01	4	3	41	0.021259026814489688	TCGA-HU-A4G8-01	1	3	1	5	hypermutated sample	9569	TCGA-HU-A4G8	STAD	71	FEMALE	ASIAN	Stage IIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-26254	Alive	TUMOR FREE	690	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	690	0	690	0	690	0	690	
70	TCGA-HU-A4G9	7	103	4	50	311	54	12	0	53	994	43	0	29	482	26	0	TCGA-HU-A4G9-01	71	0.8333994576841485	26	TCGA-HU-A4G9-01	6	10	83	0.2112049853811146	TCGA-HU-A4G9-01	0	0	0	0	hypermutated sample	9570	TCGA-HU-A4G9	STAD	67	FEMALE	ASIAN	Stage IA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-24753	Alive	TUMOR FREE	736	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	736	0	736	NA	NA	0	736	
70	TCGA-HU-A4GC	2	12	0	6	2	2	0	0	4	200	20	0	4	90	8	0	TCGA-HU-A4GC-01	126	0.31204723249761634	65	TCGA-HU-A4GC-01	13	41	97	0.3393117358266052	TCGA-HU-A4GC-01	18	14	12	44	PASS	9571	TCGA-HU-A4GC	STAD	74	MALE	ASIAN	Stage IIIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-27267	Alive	TUMOR FREE	99	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	99	0	99	NA	NA	0	99	
60	TCGA-HU-A4GD	1	5	0	0	0	3	1	0	7	67	3	0	1	24	1	0	TCGA-HU-A4GD-01	244	0.8068933821131343	135	TCGA-HU-A4GD-01	11	23	243	0.7475773666858009	TCGA-HU-A4GD-01	16	13	19	48	PASS	9572	TCGA-HU-A4GD	STAD	56	MALE	ASIAN	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2011	NA	-20700	Alive	WITH TUMOR	692	NA	NA	Distant Metastasis	Liver	NA	399	Progressive Disease	NA	NA	0	692	0	692	NA	NA	1	399	
70	TCGA-HU-A4GF	0	8	0	2	7	2	2	0	2	109	6	1	1	39	3	0	TCGA-HU-A4GF-01	466	0.9026169693119734	297	TCGA-HU-A4GF-01	21	38	294	0.4354019127554677	TCGA-HU-A4GF-01	23	14	15	52	PASS	9573	TCGA-HU-A4GF	STAD	69	MALE	ASIAN	Stage IIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-25223	Alive	TUMOR FREE	785	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	785	0	785	0	785	0	785	
80	TCGA-HU-A4GH	6	58	6	44	6	4	2	0	44	1389	10	2	31	317	17	0	TCGA-HU-A4GH-01	319	0.6248854743565665	186	TCGA-HU-A4GH-01	20	32	113	0.27719740742354204	TCGA-HU-A4GH-01	18	15	10	43	PASS	9574	TCGA-HU-A4GH	STAD	75	MALE	ASIAN	Stage IA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-27473	Alive	TUMOR FREE	358	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	358	0	358	0	358	0	358	
60	TCGA-HU-A4GJ	0	1	0	0	0	0	0	0	0	3	0	0	0	2	0	0	TCGA-HU-A4GJ-01	53	0.00010538226419204564	13	TCGA-HU-A4GJ	0	0	0	0	TCGA-HU-A4GJ	0	0	0	0	pathology review	9575	TCGA-HU-A4GJ	STAD	60	FEMALE	ASIAN	Stage IIIC	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-22079	Alive	WITH TUMOR	650	NA	NA	Distant Metastasis	"Other, specify"	ovary	547	Progressive Disease	NA	NA	0	650	0	650	NA	NA	1	547	
60	TCGA-HU-A4GN	8	127	12	39	323	61	43	0	63	1576	81	2	30	716	32	0	TCGA-HU-A4GN-01	47	0.00018329530816060544	10	TCGA-HU-A4GN-01	0	0	10	0.00040446715270771	TCGA-HU-A4GN-01	0	0	0	0	hypermutated sample	9576	TCGA-HU-A4GN	STAD	61	MALE	ASIAN	Stage IIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-22288	Alive	TUMOR FREE	912	NA	NA	NA	"Other, specify"	thyroid	168	Complete Remission/Response	NA	NA	0	912	0	912	1	168	1	168	
60	TCGA-HU-A4GP	2	24	4	13	6	7	0	0	14	311	12	0	4	144	4	0	TCGA-HU-A4GP-01	294	0.6370242338812022	216	TCGA-HU-A4GP-01	9	10	137	0.1853371141195076	TCGA-HU-A4GP-01	8	11	9	28	PASS	9577	TCGA-HU-A4GP	STAD	62	FEMALE	ASIAN	Stage IIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G2	2011	NA	-22711	Alive	TUMOR FREE	273	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	273	0	273	0	273	0	273	
70	TCGA-HU-A4GQ	2	86	8	45	250	66	29	0	50	1228	61	2	23	577	27	3	TCGA-HU-A4GQ-01	86	0.15126271135775587	37	TCGA-HU-A4GQ-01	6	4	15	0.0007566291562770914	TCGA-HU-A4GQ-01	2	2	0	4	hypermutated sample	9578	TCGA-HU-A4GQ	STAD	71	MALE	ASIAN	Stage IIIC	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-26200	Dead	[Discrepancy]	NA	3	Stomach Cancer	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	3	1	3	0	3	0	3	
70	TCGA-HU-A4GT	5	76	4	43	209	85	19	2	55	875	29	1	13	424	28	4	TCGA-HU-A4GT-01	127	0.18338666370903225	63	TCGA-HU-A4GT-01	5	6	21	0.012343943689123851	TCGA-HU-A4GT-01	3	2	1	6	hypermutated sample	9579	TCGA-HU-A4GT	STAD	71	FEMALE	ASIAN	Stage IIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2011	NA	-26231	Alive	TUMOR FREE	198	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	198	0	198	0	198	0	198	
70	TCGA-HU-A4GU	9	74	5	34	161	26	4	0	47	1045	49	0	16	487	16	0	TCGA-HU-A4GU-01	280	0.92341405650052	175	TCGA-HU-A4GU-01	15	37	169	0.3676427303500179	TCGA-HU-A4GU-01	16	19	14	49	hypermutated sample	9580	TCGA-HU-A4GU	STAD	73	MALE	ASIAN	Stage IIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-27024	Alive	TUMOR FREE	200	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	200	0	200	0	200	0	200	
70	TCGA-HU-A4GX	13	134	7	50	399	81	44	0	85	1574	92	2	32	742	57	0	TCGA-HU-A4GX-01	89	0.1311740073374408	46	TCGA-HU-A4GX-01	6	3	29	0.031961633965276494	TCGA-HU-A4GX-01	2	2	2	6	hypermutated sample	9581	TCGA-HU-A4GX	STAD	70	FEMALE	ASIAN	Stage IIIC	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2012	NA	-25913	Alive	TUMOR FREE	616	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	616	0	616	0	616	0	616	
80	TCGA-HU-A4GY	1	8	2	0	0	0	2	0	0	104	4	0	0	47	2	0	TCGA-HU-A4GY-01	66	0.21314771106267505	24	TCGA-HU-A4GY-01	12	23	58	0.2323266297640381	TCGA-HU-A4GY-01	7	6	6	19	PASS	9582	TCGA-HU-A4GY	STAD	76	FEMALE	ASIAN	Stage IIIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2012	NA	-28113	Alive	TUMOR FREE	8	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	8	0	8	NA	NA	0	8	
70	TCGA-HU-A4H0	1	5	1	3	3	2	0	0	3	145	7	0	1	51	2	0	TCGA-HU-A4H0-01	111	0.5776537885551599	44	TCGA-HU-A4H0-01	21	26	125	0.4788118980463578	TCGA-HU-A4H0-01	9	10	12	31	PASS	9583	TCGA-HU-A4H0	STAD	72	MALE	ASIAN	Stage IIIC	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-26317	Alive	TUMOR FREE	64	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	64	0	64	0	64	0	64	
60	TCGA-HU-A4H2	1	13	2	5	1	0	0	2	10	136	10	0	6	45	2	0	TCGA-HU-A4H2-01	416	0.6493287360516238	262	TCGA-HU-A4H2-01	17	34	122	0.13462326775808015	TCGA-HU-A4H2-01	18	14	3	35	PASS	9584	TCGA-HU-A4H2	STAD	58	FEMALE	ASIAN	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-21496	Alive	TUMOR FREE	394	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	394	0	394	0	394	0	394	
60	TCGA-HU-A4H3	6	62	6	30	166	30	18	1	37	561	28	0	14	264	20	0	TCGA-HU-A4H3-01	107	0.13903791477125746	46	TCGA-HU-A4H3-01	4	4	33	0.02441142626064776	TCGA-HU-A4H3-01	2	2	1	5	hypermutated sample	9585	TCGA-HU-A4H3	STAD	56	FEMALE	ASIAN	Stage IIIC	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-20790	Alive	WITH TUMOR	882	NA	NA	Distant Metastasis	"Other, specify"	NA	410	Progressive Disease	NA	NA	0	882	0	882	NA	NA	1	410	
50	TCGA-HU-A4H4	3	22	1	12	59	12	2	0	24	475	14	0	10	205	12	0	TCGA-HU-A4H4-01	176	0.6012952875060212	106	TCGA-HU-A4H4-01	12	34	145	0.4931486656123872	TCGA-HU-A4H4-01	15	11	5	31	PASS	9586	TCGA-HU-A4H4	STAD	53	FEMALE	ASIAN	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2011	NA	-19665	Alive	TUMOR FREE	725	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	725	0	725	0	725	0	725	
70	TCGA-HU-A4H5	1	14	3	5	9	0	7	0	7	206	15	0	6	65	9	1	TCGA-HU-A4H5-01	366	0.7432574813844142	207	TCGA-HU-A4H5-01	10	35	215	0.3854593677553165	TCGA-HU-A4H5-01	28	41	28	97	PASS	9587	TCGA-HU-A4H5	STAD	71	MALE	ASIAN	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Papillary Type"	GX	2011	NA	-26232	Alive	TUMOR FREE	724	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	724	0	724	0	724	0	724	
70	TCGA-HU-A4H6	0	7	0	4	1	1	0	0	2	90	3	0	0	43	2	0	TCGA-HU-A4H6-01	130	0.2428613352306967	62	TCGA-HU-A4H6-01	24	40	71	0.25260843571230285	TCGA-HU-A4H6-01	15	13	5	33	PASS	9588	TCGA-HU-A4H6	STAD	72	FEMALE	ASIAN	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-26445	Alive	WITH TUMOR	644	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	644	0	644	0	644	0	644	
80	TCGA-HU-A4H8	6	78	6	34	171	43	18	1	29	773	31	1	26	366	19	0	TCGA-HU-A4H8-01	99	0.05057678066732615	45	TCGA-HU-A4H8-01	2	1	24	0.009479764954847113	TCGA-HU-A4H8-01	1	0	1	2	hypermutated sample	9589	TCGA-HU-A4H8	STAD	77	MALE	ASIAN	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2012	NA	-28292	[Discrepancy]	WITH TUMOR	428	NA	NA	Distant Metastasis	NA	NA	354	Complete Remission/Response	NA	NA	0	428	NA	428	1	354	1	354	
70	TCGA-HU-A4HB	0	2	0	0	0	0	0	0	2	18	0	0	0	2	1	0	TCGA-HU-A4HB-01	87	0.009828959777985587	27	TCGA-HU-A4HB-01	0	0	5	0.00026126742405228724	TCGA-HU-A4HB-01	0	0	0	0	pathology review	9590	TCGA-HU-A4HB	STAD	68	MALE	ASIAN	Stage IIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2012	NA	-25131	Dead	WITH TUMOR	NA	477	NA	Distant Metastasis	NA	NA	390	Complete Remission/Response	NA	NA	1	477	1	477	1	390	1	390	
70	TCGA-HU-A4HD	0	7	1	1	0	4	1	0	13	137	11	1	4	52	3	0	TCGA-HU-A4HD-01	552	0.8107295994706798	360	TCGA-HU-A4HD-01	22	39	294	0.3901407493079685	TCGA-HU-A4HD-01	19	15	13	47	PASS	9591	TCGA-HU-A4HD	STAD	73	MALE	ASIAN	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2010	NA	-26699	Alive	TUMOR FREE	1016	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1016	0	1016	NA	NA	0	1016	
50	TCGA-IN-7806	0	2	2	2	4	2	0	0	2	112	12	0	2	43	6	0	TCGA-IN-7806-01	121	0.7804121804203689	57	TCGA-IN-7806-01	11	8	36	0.284557535404808	TCGA-IN-7806-01	5	6	4	15	PASS	9592	TCGA-IN-7806	STAD	50	MALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-18404	Alive	TUMOR FREE	1106	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1106	0	1106	0	1106	0	1106	
60	TCGA-IN-7808	0	1	0	7	1	4	0	2	10	164	20	0	0	55	8	0	TCGA-IN-7808-01	120	0.7794424130367682	55	TCGA-IN-7808-01	31	38	29	0.30144083530883337	TCGA-IN-7808-01	11	9	8	28	PASS	9593	TCGA-IN-7808	STAD	59	MALE	WHITE	[Discrepancy]	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-21569	Dead	WITH TUMOR	NA	105	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	105	1	105	NA	NA	1	105	
80	TCGA-IN-8462	2	7	2	0	2	4	1	0	3	89	5	0	4	33	1	1	TCGA-IN-8462-01	226	0.3298858053273381	134	TCGA-IN-8462-01	7	13	183	0.4657580132344864	TCGA-IN-8462-01	13	12	5	30	PASS	9594	TCGA-IN-8462	STAD	80	MALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-29242	Alive	WITH TUMOR	572	NA	NA	Distant Metastasis	NA	NA	270	Progressive Disease	NA	NA	0	572	0	572	NA	NA	1	270	
70	TCGA-IN-8663	8	33	4	27	0	6	2	0	15	254	12	0	5	97	4	0	TCGA-IN-8663-01	301	0.5889802476501397	193	TCGA-IN-8663-01	18	27	142	0.23237666633835816	TCGA-IN-8663-01	17	9	11	37	PASS	9595	TCGA-IN-8663	STAD	68	MALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-25172	Dead	TUMOR FREE	NA	103	"Other, non-malignant disease"	NA	NA	NA	NA	NA	NA	NA	1	103	0	103	NA	NA	0	103	
50	TCGA-IN-A6RI	0	4	1	3	1	0	0	0	2	79	4	0	2	31	2	2	TCGA-IN-A6RI-01	345	0.6417593449637529	204	TCGA-IN-A6RI-01	11	14	159	0.3142401083661378	TCGA-IN-A6RI-01	13	7	12	32	PASS	9596	TCGA-IN-A6RI	STAD	45	MALE	WHITE	Stage I	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-16788	Alive	TUMOR FREE	559	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	559	0	559	0	559	0	559	
60	TCGA-IN-A6RJ	1	7	0	1	1	0	1	0	5	102	6	0	1	43	1	0	TCGA-IN-A6RJ-01	90	0.2459795490262228	30	TCGA-IN-A6RJ-01	11	13	95	0.32725486076487004	TCGA-IN-A6RJ-01	10	11	10	31	PASS	9597	TCGA-IN-A6RJ	STAD	64	MALE	WHITE	Stage IA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-23439	Alive	TUMOR FREE	379	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	379	0	379	0	379	0	379	
80	TCGA-IN-A6RL	2	22	2	15	4	5	5	0	18	355	21	0	8	124	5	0	TCGA-IN-A6RL-01	210	0.6291253572260882	121	TCGA-IN-A6RL-01	5	14	148	0.35493688698322456	TCGA-IN-A6RL-01	22	19	16	57	PASS	9598	TCGA-IN-A6RL	STAD	84	MALE	WHITE	[Discrepancy]	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-30783	Dead	WITH TUMOR	NA	406	NA	Distant Metastasis	NA	NA	307	Complete Remission/Response	NA	NA	1	406	1	406	1	307	1	307	
70	TCGA-IN-A6RN	1	7	0	6	0	1	0	0	3	85	7	0	3	44	1	0	TCGA-IN-A6RN-01	271	0.2367108439113125	171	TCGA-IN-A6RN-01	5	9	86	0.1379689714739607	TCGA-IN-A6RN-01	11	9	8	28	PASS	9599	TCGA-IN-A6RN	STAD	72	FEMALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-26409	Alive	TUMOR FREE	594	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	594	0	594	0	594	0	594	
70	TCGA-IN-A6RO	3	15	3	12	8	2	2	0	5	232	16	0	2	75	5	0	TCGA-IN-A6RO-01	370	0.7778894904134107	234	TCGA-IN-A6RO-01	13	18	75	0.14601472587852152	TCGA-IN-A6RO-01	21	15	9	45	PASS	9600	TCGA-IN-A6RO	STAD	70	MALE	ASIAN	Stage IA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-25789	Dead	WITH TUMOR	NA	NA	[Unknown]	Distant Metastasis	NA	NA	154	[Discrepancy]	NA	NA	1	NA	1	NA	NA	NA	1	154	
60	TCGA-IN-A6RP	0	4	1	8	3	5	1	0	5	125	16	0	1	43	0	0	TCGA-IN-A6RP-01	196	0.6990277126471754	116	TCGA-IN-A6RP-01	11	22	90	0.2474464568592975	TCGA-IN-A6RP-01	17	18	11	46	PASS	9601	TCGA-IN-A6RP	STAD	63	MALE	WHITE	[Discrepancy]	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-23282	Alive	WITH TUMOR	196	NA	NA	Distant Metastasis	Liver	NA	150	Progressive Disease	NA	NA	0	196	0	196	NA	NA	1	150	
80	TCGA-IN-A6RR	1	14	1	3	1	3	1	0	4	114	8	0	3	52	3	0	TCGA-IN-A6RR-01	184	0.7531233668170445	93	TCGA-IN-A6RR-01	5	11	107	0.2706702877060105	TCGA-IN-A6RR-01	13	10	14	37	PASS	9602	TCGA-IN-A6RR	STAD	84	MALE	WHITE	[Discrepancy]	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2013	NA	-30734	Dead	TUMOR FREE	NA	205	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	205	0	205	NA	NA	0	205	
80	TCGA-IN-A6RS	0	5	0	1	1	1	1	0	4	73	5	0	3	41	2	1	TCGA-IN-A6RS-01	271	0.3504435097168439	159	TCGA-IN-A6RS-01	10	13	153	0.20137808796369785	TCGA-IN-A6RS-01	11	7	9	27	PASS	9603	TCGA-IN-A6RS	STAD	76	MALE	WHITE	Stage IA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2013	NA	-27808	Alive	TUMOR FREE	383	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	383	0	383	0	383	0	383	
60	TCGA-IN-A7NR	1	1	1	3	0	0	0	0	0	74	1	0	3	28	4	0	TCGA-IN-A7NR-01	101	0.2572508501131949	43	TCGA-IN-A7NR-01	9	16	87	0.34078953400649264	TCGA-IN-A7NR-01	17	7	12	36	PASS	9604	TCGA-IN-A7NR	STAD	64	FEMALE	WHITE	Stage IV	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2013	NA	-23415	Alive	TUMOR FREE	198	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	198	0	198	NA	NA	0	198	
70	TCGA-IN-A7NT	1	4	0	2	1	1	1	1	1	86	4	1	0	37	1	1	TCGA-IN-A7NT-01	178	0.6417427977266348	82	TCGA-IN-A7NT-01	22	25	67	0.24800268571124096	TCGA-IN-A7NT-01	15	3	10	28	PASS	9605	TCGA-IN-A7NT	STAD	73	FEMALE	WHITE	Stage IIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2013	NA	-26727	Alive	TUMOR FREE	323	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	323	0	323	0	323	0	323	
70	TCGA-IN-A7NU	1	2	0	0	2	1	1	0	4	73	3	0	2	30	2	0	TCGA-IN-A7NU-01	268	0.5176846796695468	173	TCGA-IN-A7NU-01	12	11	177	0.3735444247989185	TCGA-IN-A7NU-01	12	15	18	45	PASS	9606	TCGA-IN-A7NU	STAD	69	MALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2013	NA	-25515	Alive	WITH TUMOR	356	NA	NA	Distant Metastasis	NA	NA	337	Progressive Disease	NA	NA	0	356	0	356	NA	NA	1	337	
60	TCGA-IN-AB1V	0	0	0	2	0	0	2	0	0	44	0	0	1	26	2	0	TCGA-IN-AB1V-01	224	0.20338871657607968	120	TCGA-IN-AB1V-01	7	12	131	0.3122658009411129	TCGA-IN-AB1V-01	12	10	13	35	PASS	9607	TCGA-IN-AB1V	STAD	63	MALE	WHITE	Stage IA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2013	NA	-23030	Alive	TUMOR FREE	479	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	479	0	479	0	479	0	479	
80	TCGA-IN-AB1X	1	19	2	8	4	0	2	0	4	191	6	0	6	45	0	0	TCGA-IN-AB1X-01	290	0.099924853563411	219	TCGA-IN-AB1X-01	4	2	142	0.09231877184307133	TCGA-IN-AB1X-01	5	8	3	16	PASS	9608	TCGA-IN-AB1X	STAD	78	FEMALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2013	NA	-28493	Alive	TUMOR FREE	411	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	411	0	411	0	411	0	411	
70	TCGA-IP-7968	0	10	2	2	0	5	0	0	4	167	20	0	2	53	2	0	TCGA-IP-7968-01	346	0.21671030992345808	208	TCGA-IP-7968-01	5	19	129	0.40247886662573984	TCGA-IP-7968-01	12	5	5	22	PASS	9609	TCGA-IP-7968	STAD	74	MALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-27114	Alive	TUMOR FREE	77	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	77	0	77	NA	NA	0	77	
70	TCGA-KB-A6F5	0	3	0	4	1	2	0	0	2	45	2	0	0	28	0	0	TCGA-KB-A6F5-01	372	0.548557233021628	237	TCGA-KB-A6F5-01	23	29	185	0.28385368631784336	TCGA-KB-A6F5-01	13	12	6	31	PASS	9610	TCGA-KB-A6F5	STAD	73	MALE	[Not Evaluated]	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-26881	Alive	TUMOR FREE	169	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	169	0	169	0	169	0	169	
50	TCGA-KB-A6F7	1	4	1	3	5	2	1	0	0	74	9	0	1	30	2	0	TCGA-KB-A6F7-01	194	0.4111917926598685	107	TCGA-KB-A6F7-01	9	14	122	0.3100675346282292	TCGA-KB-A6F7-01	7	3	6	16	PASS	9611	TCGA-KB-A6F7	STAD	54	FEMALE	[Unknown]	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2009	NA	-19765	Alive	TUMOR FREE	1935	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1935	0	1935	0	1935	0	1935	
70	TCGA-KB-A93G	0	5	0	6	2	0	0	0	5	73	8	0	2	26	2	0	TCGA-KB-A93G-01	71	0.07367071519012247	26	TCGA-KB-A93G-01	10	7	33	0.11231963119775804	TCGA-KB-A93G-01	6	2	4	12	PASS	9612	TCGA-KB-A93G	STAD	68	MALE	WHITE	Stage IB	NA	"Stomach Adenocarcinoma, Signet Ring Type"	G1	2013	NA	-24924	Alive	TUMOR FREE	613	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	613	0	613	0	613	0	613	
80	TCGA-KB-A93H	0	8	2	12	1	2	1	0	8	171	9	0	10	70	3	0	TCGA-KB-A93H-01	405	0.7883267833563982	297	TCGA-KB-A93H-01	30	45	162	0.19568938230320998	TCGA-KB-A93H-01	16	9	11	36	PASS	9613	TCGA-KB-A93H	STAD	79	FEMALE	ASIAN	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G1	2011	NA	-28966	Alive	TUMOR FREE	1145	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1145	0	1145	0	1145	0	1145	
80	TCGA-KB-A93J	1	4	1	4	26	34	15	9	2	37	6	0	2	8	8	0	TCGA-KB-A93J-01	233	0.9962568948532468	138	TCGA-KB-A93J-01	6	12	150	0.3221394716318097	TCGA-KB-A93J-01	9	20	17	46	PASS	9614	TCGA-KB-A93J	STAD	78	MALE	WHITE	Stage II	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2008	NA	-28599	Alive	NA	1124	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1124	0	1124	0	1124	0	1124	
80	TCGA-MX-A5UG	0	1	0	3	0	0	0	0	0	37	1	0	0	12	2	0	TCGA-MX-A5UG-01	71	0.00013776752566283532	20	TCGA-MX-A5UG-01	0	2	20	0.034932136936166085	TCGA-MX-A5UG-01	2	1	2	5	PASS	9615	TCGA-MX-A5UG	STAD	78	MALE	ASIAN	Stage IIIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2007	NA	-28714	Dead	TUMOR FREE	NA	113	Stomach Cancer	NA	NA	NA	NA	NA	NA	NA	1	113	1	113	NA	NA	0	113	
90	TCGA-MX-A5UJ	2	75	5	38	210	60	21	0	51	917	45	0	11	444	27	0	TCGA-MX-A5UJ-01	74	0.060864844726208026	23	TCGA-MX-A5UJ-01	2	1	10	0.0006140865921335013	TCGA-MX-A5UJ-01	0	0	0	0	hypermutated sample	9616	TCGA-MX-A5UJ	STAD	86	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2012	NA	-31517	Alive	TUMOR FREE	600	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	600	0	600	0	600	0	600	
70	TCGA-MX-A663	1	2	0	4	1	0	1	0	4	72	8	0	1	14	0	1	TCGA-MX-A663-01	200	0.4869850999170959	120	TCGA-MX-A663-01	15	34	119	0.2522919651161785	TCGA-MX-A663-01	15	15	9	39	PASS	9617	TCGA-MX-A663	STAD	66	MALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-24421	Dead	WITH TUMOR	NA	300	NA	Distant Metastasis	"Other, specify"	Liver and left supraclavicular lymph node	218	Complete Remission/Response	NA	NA	1	300	1	300	1	218	1	218	
60	TCGA-MX-A666	0	10	0	1	3	3	1	0	2	90	4	0	3	31	4	0	TCGA-MX-A666-01	295	0.4044132586603844	172	TCGA-MX-A666-01	17	37	166	0.4482175320309939	TCGA-MX-A666-01	20	17	11	48	PASS	9618	TCGA-MX-A666	STAD	61	MALE	WHITE	Stage IIA	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2013	NA	-22288	Alive	TUMOR FREE	427	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	427	0	427	NA	NA	0	427	
50	TCGA-R5-A7O7	1	6	1	1	1	1	0	0	3	94	6	0	5	35	2	0	TCGA-R5-A7O7-01	302	0.598108844018701	176	TCGA-R5-A7O7-01	24	68	174	0.3824641942827462	TCGA-R5-A7O7-01	20	12	14	46	PASS	9619	TCGA-R5-A7O7	STAD	51	MALE	WHITE	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2010	NA	-18984	Alive	TUMOR FREE	1389	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1389	0	1389	NA	NA	0	1389	
70	TCGA-R5-A7ZE	1	0	0	3	3	1	1	1	4	134	8	0	6	47	2	0	TCGA-R5-A7ZE-01	432	0.7828445795778937	265	TCGA-R5-A7ZE-01	27	37	136	0.1933775803386016	TCGA-R5-A7ZE-01	15	6	7	28	PASS	9620	TCGA-R5-A7ZE	STAD	66	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2012	NA	-24328	Dead	WITH TUMOR	NA	554	[Unknown]	NA	NA	NA	NA	Progressive Disease	NA	NA	1	554	1	554	NA	NA	1	554	
70	TCGA-R5-A7ZF	0	4	1	1	0	0	3	0	2	50	5	0	1	21	1	0	TCGA-R5-A7ZF-01	87	0.4239221752533879	38	TCGA-R5-A7ZF-01	22	31	121	0.3855858083012758	TCGA-R5-A7ZF-01	12	5	5	22	PASS	9621	TCGA-R5-A7ZF	STAD	65	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2012	NA	-23908	Dead	WITH TUMOR	NA	259	Stomach Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	259	1	259	NA	NA	1	259	
40	TCGA-R5-A7ZI	3	34	3	15	102	26	19	1	27	565	32	0	14	259	14	1	TCGA-R5-A7ZI-01	97	0.3281046914851262	43	TCGA-R5-A7ZI-01	15	13	52	0.13055378276203694	TCGA-R5-A7ZI-01	1	3	1	5	hypermutated sample	9622	TCGA-R5-A7ZI	STAD	44	FEMALE	WHITE	Stage IV	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2009	NA	-16396	Alive	TUMOR FREE	2267	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2267	0	2267	NA	NA	0	2267	
70	TCGA-R5-A7ZR	0	7	1	2	0	1	0	0	3	52	5	1	1	22	0	0	TCGA-R5-A7ZR-01	258	0.8293918615837259	171	TCGA-R5-A7ZR-01	15	13	137	0.1819967223353348	TCGA-R5-A7ZR-01	8	8	7	23	PASS	9623	TCGA-R5-A7ZR	STAD	70	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2008	NA	-25795	Dead	WITH TUMOR	NA	185	[Unknown]	NA	NA	NA	NA	Progressive Disease	NA	NA	1	185	1	185	NA	NA	1	185	
50	TCGA-R5-A804	0	0	0	0	1	1	1	0	1	53	10	0	1	28	1	0	TCGA-R5-A804-01	88	0.029347353132784963	38	TCGA-R5-A804-01	0	1	56	0.10726402732735316	TCGA-R5-A804-01	6	6	4	16	PASS	9624	TCGA-R5-A804	STAD	54	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2005	NA	-20026	Dead	WITH TUMOR	NA	140	[Unknown]	NA	NA	NA	NA	Progressive Disease	NA	NA	1	140	1	140	NA	NA	1	140	
70	TCGA-R5-A805	1	3	0	5	1	0	1	0	1	111	2	0	5	28	2	0	TCGA-R5-A805-01	306	0.3470047295025221	204	TCGA-R5-A805-01	10	10	163	0.2810444981437038	TCGA-R5-A805-01	15	13	14	42	PASS	9625	TCGA-R5-A805	STAD	71	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2005	NA	-26122	Dead	WITH TUMOR	NA	281	Stomach Cancer	NA	NA	NA	NA	NA	NA	NA	1	281	1	281	NA	NA	1	281	
50	TCGA-RD-A7BS	0	4	0	1	0	0	0	0	3	37	2	0	1	22	2	0	TCGA-RD-A7BS-01	60	0.08045530917096548	19	TCGA-RD-A7BS-01	8	9	41	0.21057477545042688	TCGA-RD-A7BS-01	11	3	9	23	PASS	9626	TCGA-RD-A7BS	STAD	46	MALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2001	NA	-16847	Dead	WITH TUMOR	NA	336	Stomach Cancer	Distant Metastasis	Liver	NA	244	Complete Remission/Response	NA	NA	1	336	1	336	1	244	1	244	
70	TCGA-RD-A7BT	1	12	0	1	2	0	1	0	7	194	6	2	2	62	2	0	TCGA-RD-A7BT-01	438	0.5465659755765564	305	TCGA-RD-A7BT-01	26	48	193	0.31810748531145666	TCGA-RD-A7BT-01	15	12	6	33	PASS	9627	TCGA-RD-A7BT	STAD	66	MALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2002	NA	-24107	Dead	WITH TUMOR	NA	262	Stomach Cancer	Distant Metastasis	"Other, specify"	Adrenal gland	123	Progressive Disease	NA	NA	1	262	1	262	NA	NA	1	123	
70	TCGA-RD-A7BW	1	4	0	2	1	0	0	0	4	50	6	0	3	21	0	0	TCGA-RD-A7BW-01	84	0.011648350791706476	35	TCGA-RD-A7BW-01	3	6	36	0.1517410452743822	TCGA-RD-A7BW-01	7	11	9	27	PASS	9628	TCGA-RD-A7BW	STAD	68	FEMALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2004	NA	-25036	Dead	TUMOR FREE	NA	156	"Other, non-malignant disease"	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	156	0	156	0	156	0	156	
80	TCGA-RD-A7C1	1	16	0	6	2	1	2	1	4	231	11	0	2	71	4	0	TCGA-RD-A7C1-01	226	0.6175724020716636	119	TCGA-RD-A7C1-01	24	62	90	0.2401986330731464	TCGA-RD-A7C1-01	17	15	10	42	PASS	9629	TCGA-RD-A7C1	STAD	82	MALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2005	NA	-30171	Dead	WITH TUMOR	NA	507	Stomach Cancer	Distant Metastasis	Non-regional / Distant Lymph Nodes	NA	438	Complete Remission/Response	NA	NA	1	507	1	507	1	438	1	438	
60	TCGA-RD-A8MV	0	4	0	2	4	1	1	0	1	62	7	0	0	10	0	0	TCGA-RD-A8MV-01	127	0.348957792985472	58	TCGA-RD-A8MV-01	6	10	66	0.107020788656656	TCGA-RD-A8MV-01	15	14	6	35	PASS	9630	TCGA-RD-A8MV	STAD	56	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2001	NA	-20771	Alive	TUMOR FREE	3720	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3720	0	3720	0	3720	0	3720	
70	TCGA-RD-A8MW	0	0	0	3	4	1	0	0	1	61	1	0	2	25	1	0	TCGA-RD-A8MW-01	250	0.5124217436461699	149	TCGA-RD-A8MW-01	14	34	134	0.488923634364782	TCGA-RD-A8MW-01	21	21	13	55	PASS	9631	TCGA-RD-A8MW	STAD	72	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2004	NA	-26590	Dead	WITH TUMOR	1153	1153	Stomach Cancer	Distant Metastasis	Peritoneal Surfaces	NA	98	Complete Remission/Response	NA	NA	1	1153	1	1153	1	98	1	98	
50	TCGA-RD-A8N0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	TCGA-RD-A8N0-01	55	0.00013309519977540386	17	TCGA-RD-A8N0	0	0	0	0	TCGA-RD-A8N0	0	0	0	0	PASS	9632	TCGA-RD-A8N0	STAD	53	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2006	NA	-19491	Alive	TUMOR FREE	1236	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1236	0	1236	0	1236	0	1236	
70	TCGA-RD-A8N1	0	5	0	3	2	1	0	0	3	87	4	0	1	24	3	0	TCGA-RD-A8N1-01	133	0.4060621093750372	68	TCGA-RD-A8N1-01	17	37	168	0.4894080610439348	TCGA-RD-A8N1-01	22	25	24	71	PASS	9633	TCGA-RD-A8N1	STAD	70	MALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2001	NA	-25737	Alive	TUMOR FREE	3519	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3519	0	3519	0	3519	0	3519	
60	TCGA-RD-A8N2	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	TCGA-RD-A8N2-01	41	3.703092188211855e-05	11	TCGA-RD-A8N2	0	0	0	0	TCGA-RD-A8N2	0	0	0	0	PASS	9634	TCGA-RD-A8N2	STAD	59	FEMALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2002	NA	-21749	Alive	TUMOR FREE	3540	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3540	0	3540	0	3540	0	3540	
60	TCGA-RD-A8N4	0	2	0	0	0	0	0	0	1	4	0	0	0	2	0	0	TCGA-RD-A8N4-01	46	0.006247522047186812	11	TCGA-RD-A8N4-01	0	0	9	0.0019820633599797136	TCGA-RD-A8N4-01	0	0	0	0	PASS	9635	TCGA-RD-A8N4	STAD	58	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2006	NA	-21324	Alive	TUMOR FREE	2171	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2171	0	2171	0	2171	0	2171	
80	TCGA-RD-A8N5	0	1	0	2	0	0	1	0	1	29	2	0	0	9	0	0	TCGA-RD-A8N5-01	119	0.1757512529077648	56	TCGA-RD-A8N5-01	29	26	69	0.3070849775396462	TCGA-RD-A8N5-01	9	11	4	24	PASS	9636	TCGA-RD-A8N5	STAD	78	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G2	2006	NA	-28589	Dead	TUMOR FREE	NA	1747	"Other, non-malignant disease"	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1747	0	1747	0	1747	0	1747	
80	TCGA-RD-A8N6	0	7	0	3	8	4	2	0	5	110	13	0	2	53	3	0	TCGA-RD-A8N6-01	276	0.6326968963816854	170	TCGA-RD-A8N6-01	20	71	148	0.29817761342697685	TCGA-RD-A8N6-01	25	24	11	60	PASS	9637	TCGA-RD-A8N6	STAD	78	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2006	NA	-28834	Dead	WITH TUMOR	NA	272	Stomach Cancer	Distant Metastasis	Liver	NA	163	Complete Remission/Response	NA	NA	1	272	1	272	1	163	1	163	
60	TCGA-RD-A8N9	2	7	0	0	3	0	1	0	1	91	4	0	2	52	2	0	TCGA-RD-A8N9-01	168	0.5452565345787542	91	TCGA-RD-A8N9-01	18	41	164	0.6118003696500685	TCGA-RD-A8N9-01	23	16	10	49	PASS	9638	TCGA-RD-A8N9	STAD	63	FEMALE	ASIAN	Stage II	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2009	NA	-23059	Alive	TUMOR FREE	1083	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1083	0	1083	0	1083	0	1083	
80	TCGA-RD-A8NB	3	26	1	16	66	16	6	0	15	433	28	0	6	205	14	1	TCGA-RD-A8NB-01	53	0.04990927816961117	10	TCGA-RD-A8NB	0	0	0	0	TCGA-RD-A8NB	0	0	0	0	PASS	9639	TCGA-RD-A8NB	STAD	80	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2000	NA	-29503	Dead	WITH TUMOR	NA	513	Stomach Cancer	Distant Metastasis	Non-regional / Distant Lymph Nodes	NA	230	Partial Remission/Response	NA	NA	1	513	1	513	NA	NA	1	230	
60	TCGA-SW-A7EA	2	36	2	22	89	30	8	1	24	392	27	1	14	187	12	0	TCGA-SW-A7EA-01	95	0.07484400270687404	40	TCGA-SW-A7EA-01	2	1	27	0.02679437314150064	TCGA-SW-A7EA-01	1	4	1	6	PASS	9640	TCGA-SW-A7EA	STAD	61	FEMALE	WHITE	Stage IB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	GX	2013	NA	-22294	Alive	TUMOR FREE	579	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	579	0	579	0	579	0	579	
50	TCGA-SW-A7EB	4	7	1	3	0	2	1	0	3	115	10	0	0	36	1	0	TCGA-SW-A7EB-01	162	0.4867985669700116	85	TCGA-SW-A7EB-01	21	33	140	0.3233612676708759	TCGA-SW-A7EB-01	16	18	9	43	PASS	9641	TCGA-SW-A7EB	STAD	45	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G2	2013	NA	-16475	Alive	TUMOR FREE	176	NA	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	0	176	0	176	NA	NA	0	176	
70	TCGA-VQ-A8DL	0	8	0	2	27	41	7	12	3	42	7	0	3	19	8	1	TCGA-VQ-A8DL-01	268	0.3005974376741015	165	TCGA-VQ-A8DL-01	6	11	140	0.24015632532620115	TCGA-VQ-A8DL-01	14	26	14	54	PASS	9642	TCGA-VQ-A8DL	STAD	69	FEMALE	WHITE	Stage IIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2010	NA	-25299	Dead	TUMOR FREE	NA	28	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	28	0	28	0	28	0	28	
40	TCGA-VQ-A8DT	1	6	0	4	4	2	0	0	3	157	12	1	4	43	2	0	TCGA-VQ-A8DT-01	232	0.5938188556471979	145	TCGA-VQ-A8DT-01	3	4	59	0.0479788030490777	TCGA-VQ-A8DT-01	5	7	2	14	PASS	9643	TCGA-VQ-A8DT	STAD	43	MALE	[Unknown]	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2010	NA	-15937	Alive	WITH TUMOR	1484	NA	NA	Distant Metastasis	Liver	NA	1376	Complete Remission/Response	NA	NA	0	1484	0	1484	1	1376	1	1376	
60	TCGA-VQ-A8DU	1	5	0	1	2	0	1	0	4	123	8	0	3	28	2	0	TCGA-VQ-A8DU-01	505	0.8760304124831562	348	TCGA-VQ-A8DU-01	20	40	281	0.3491192034333593	TCGA-VQ-A8DU-01	21	25	11	57	PASS	9644	TCGA-VQ-A8DU	STAD	63	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2010	NA	-23042	Dead	WITH TUMOR	NA	166	Stomach Cancer	Distant Metastasis	Liver	NA	158	Progressive Disease	NA	NA	1	166	1	166	NA	NA	1	158	
50	TCGA-VQ-A8DV	1	1	0	0	5	2	0	1	3	47	4	0	2	20	2	0	TCGA-VQ-A8DV-01	291	0.7173305403495208	166	TCGA-VQ-A8DV-01	18	54	199	0.4295627239122511	TCGA-VQ-A8DV-01	24	26	17	67	PASS	9645	TCGA-VQ-A8DV	STAD	48	MALE	WHITE	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2010	NA	-17630	Dead	WITH TUMOR	NA	403	Stomach Cancer	Distant Metastasis	Liver	NA	288	Progressive Disease	NA	NA	1	403	1	403	NA	NA	1	288	
70	TCGA-VQ-A8DZ	1	1	0	5	1	1	0	1	3	67	2	0	5	22	1	1	TCGA-VQ-A8DZ-01	389	0.7573683012156442	265	TCGA-VQ-A8DZ-01	25	41	123	0.1761768084471068	TCGA-VQ-A8DZ-01	22	14	6	42	PASS	9646	TCGA-VQ-A8DZ	STAD	70	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	NA	"Stomach Adenocarcinoma, Signet Ring Type"	G3	2011	NA	-25863	Dead	WITH TUMOR	NA	396	Stomach Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	396	1	396	NA	NA	1	396	
70	TCGA-VQ-A8E0	1	9	1	2	1	3	0	0	0	77	8	0	3	22	0	1	TCGA-VQ-A8E0-01	581	0.8511075138032839	388	TCGA-VQ-A8E0-01	22	28	314	0.5131192446161981	TCGA-VQ-A8E0-01	15	16	14	45	PASS	9647	TCGA-VQ-A8E0	STAD	68	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-24848	Dead	WITH TUMOR	NA	562	Stomach Cancer	Distant Metastasis	Liver	NA	531	Progressive Disease	NA	NA	1	562	1	562	NA	NA	1	531	
60	TCGA-VQ-A8E2	0	4	0	2	1	3	0	0	3	105	2	0	2	30	1	0	TCGA-VQ-A8E2-01	328	0.6199620955038309	202	TCGA-VQ-A8E2-01	18	63	135	0.2613015442049491	TCGA-VQ-A8E2-01	24	18	14	56	PASS	9648	TCGA-VQ-A8E2	STAD	57	MALE	ASIAN	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-21112	Alive	TUMOR FREE	1319	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1319	0	1319	0	1319	0	1319	
80	TCGA-VQ-A8E3	6	54	3	9	110	29	7	0	30	484	25	0	6	197	18	1	TCGA-VQ-A8E3-01	186	0.4271331902476388	110	TCGA-VQ-A8E3-01	13	40	159	0.4271793723942858	TCGA-VQ-A8E3-01	13	11	8	32	PASS	9649	TCGA-VQ-A8E3	STAD	79	MALE	WHITE	Stage IIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-28919	Dead	NA	NA	661	[Unknown]	Locoregional Recurrence	NA	NA	538	[Unknown]	NA	NA	1	661	NA	661	NA	NA	1	538	
60	TCGA-VQ-A8E7	0	6	0	2	1	1	0	0	2	80	6	0	1	45	0	0	TCGA-VQ-A8E7-01	226	0.26976137213143464	124	TCGA-VQ-A8E7-01	8	14	144	0.290166251065694	TCGA-VQ-A8E7-01	9	9	9	27	PASS	9650	TCGA-VQ-A8E7	STAD	59	MALE	WHITE	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2012	NA	-21664	Alive	WITH TUMOR	1138	NA	NA	Distant Metastasis	"Other, specify"	Adrenal	1048	Stable Disease	NA	NA	0	1138	0	1138	NA	NA	1	1048	
70	TCGA-VQ-A8P2	34	334	28	147	236	158	18	2	215	5316	431	2	93	2370	138	3	TCGA-VQ-A8P2-01	203	0.050378017336400176	133	TCGA-VQ-A8P2-01	2	1	9	0.0017913913005356164	TCGA-VQ-A8P2-01	0	0	0	0	hypermutated sample	9651	TCGA-VQ-A8P2	STAD	68	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G2	2011	NA	-25129	Alive	TUMOR FREE	1160	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1160	0	1160	0	1160	0	1160	
70	TCGA-VQ-A8P3	1	15	1	12	4	2	3	0	4	241	7	1	2	75	3	0	TCGA-VQ-A8P3-01	693	0.021782838791854945	516	TCGA-VQ-A8P3-01	0	0	277	0.017010145927774327	TCGA-VQ-A8P3-01	1	1	0	2	PASS	9652	TCGA-VQ-A8P3	STAD	72	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-26582	Alive	TUMOR FREE	1132	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1132	0	1132	0	1132	0	1132	
70	TCGA-VQ-A8P5	1	13	0	5	2	3	1	1	4	175	10	0	3	49	2	0	TCGA-VQ-A8P5-01	324	0.7314611111290779	193	TCGA-VQ-A8P5-01	19	44	156	0.2484467771328183	TCGA-VQ-A8P5-01	24	18	11	53	PASS	9653	TCGA-VQ-A8P5	STAD	67	MALE	WHITE	Stage IIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2011	NA	-24571	Dead	NA	NA	235	[Unknown]	NA	NA	NA	NA	Progressive Disease	NA	NA	1	235	NA	235	NA	NA	0	235	
70	TCGA-VQ-A8P8	0	1	0	1	0	3	0	0	2	82	6	0	1	40	2	0	TCGA-VQ-A8P8-01	107	0.05544149366282864	47	TCGA-VQ-A8P8	0	0	0	0	TCGA-VQ-A8P8-01	3	4	2	9	PASS	9654	TCGA-VQ-A8P8	STAD	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-26443	Alive	TUMOR FREE	942	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	942	0	942	0	942	0	942	
70	TCGA-VQ-A8PB	3	51	5	20	137	26	9	0	38	526	27	0	9	247	7	0	TCGA-VQ-A8PB-01	85	0.10443991974034518	30	TCGA-VQ-A8PB-01	4	2	8	0.0003045084851543866	TCGA-VQ-A8PB-01	0	0	0	0	hypermutated sample	9655	TCGA-VQ-A8PB	STAD	65	FEMALE	WHITE	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Papillary Type"	G2	2011	NA	-23927	Dead	TUMOR FREE	NA	1043	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1043	0	1043	0	1043	0	1043	
70	TCGA-VQ-A8PC	1	8	0	3	2	1	0	0	0	111	4	0	0	32	2	0	TCGA-VQ-A8PC-01	153	0.4460834364114383	87	TCGA-VQ-A8PC-01	13	12	102	0.349219229235259	TCGA-VQ-A8PC-01	13	14	14	41	PASS	9656	TCGA-VQ-A8PC	STAD	65	MALE	WHITE	Stage IIIA	NA	"Stomach Adenocarcinoma, Signet Ring Type"	G3	2009	NA	-23912	Dead	WITH TUMOR	NA	1407	[Unknown]	Locoregional Recurrence	NA	NA	1287	Progressive Disease	NA	NA	1	1407	1	1407	NA	NA	1	1287	
70	TCGA-VQ-A8PD	0	1	0	2	0	0	0	0	3	71	4	0	4	20	1	0	TCGA-VQ-A8PD-01	57	0.06399212165943849	19	TCGA-VQ-A8PD-01	3	7	22	0.07530666614389807	TCGA-VQ-A8PD-01	2	0	2	4	PASS	9657	TCGA-VQ-A8PD	STAD	69	MALE	WHITE	Stage IIIC	NA	"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-25244	Dead	WITH TUMOR	NA	496	NA	Distant Metastasis	"Other, specify"	NA	134	Progressive Disease	NA	NA	1	496	1	496	NA	NA	1	134	
80	TCGA-VQ-A8PE	0	1	2	2	2	2	1	1	2	95	11	0	2	36	2	1	TCGA-VQ-A8PE-01	521	0.753518162848755	327	TCGA-VQ-A8PE-01	13	39	274	0.41776424749181307	TCGA-VQ-A8PE-01	17	18	12	47	PASS	9658	TCGA-VQ-A8PE	STAD	78	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2012	NA	-28755	Dead	WITH TUMOR	NA	675	NA	Locoregional Recurrence	NA	NA	265	Progressive Disease	NA	NA	1	675	1	675	NA	NA	1	265	
80	TCGA-VQ-A8PF	0	4	0	2	2	2	0	0	1	93	6	0	1	30	2	0	TCGA-VQ-A8PF-01	67	0.10772404584618492	20	TCGA-VQ-A8PF-01	4	2	20	0.03194210054457155	TCGA-VQ-A8PF-01	1	1	1	3	PASS	9659	TCGA-VQ-A8PF	STAD	76	MALE	[Not Evaluated]	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2012	NA	-28116	Dead	TUMOR FREE	NA	76	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	76	0	76	0	76	0	76	
60	TCGA-VQ-A8PH	0	12	1	2	7	0	3	0	10	152	9	1	6	43	8	0	TCGA-VQ-A8PH-01	379	0.5234313647029296	239	TCGA-VQ-A8PH-01	22	29	253	0.4420722462967558	TCGA-VQ-A8PH-01	17	7	7	31	PASS	9660	TCGA-VQ-A8PH	STAD	62	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2010	NA	-22940	Dead	WITH TUMOR	NA	389	NA	Locoregional Recurrence	NA	NA	377	Progressive Disease	NA	NA	1	389	1	389	NA	NA	1	377	
50	TCGA-VQ-A8PJ	1	3	1	3	0	0	1	1	6	117	5	2	6	41	3	1	TCGA-VQ-A8PJ-01	371	0.7771166648111857	220	TCGA-VQ-A8PJ-01	25	49	178	0.27697973357443817	TCGA-VQ-A8PJ-01	17	8	7	32	PASS	9661	TCGA-VQ-A8PJ	STAD	53	MALE	[Unknown]	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	GX	2011	NA	-19390	Dead	WITH TUMOR	NA	82	Stomach Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	82	1	82	NA	NA	1	82	
60	TCGA-VQ-A8PK	0	0	0	2	2	0	0	0	4	82	2	0	2	25	0	0	TCGA-VQ-A8PK-01	356	0.9363733549042488	213	TCGA-VQ-A8PK-01	18	22	324	0.599505535972265	TCGA-VQ-A8PK-01	18	12	21	51	PASS	9662	TCGA-VQ-A8PK	STAD	58	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-21419	Dead	WITH TUMOR	NA	543	Stomach Cancer	Locoregional Recurrence|Distant Metastasis	Liver	NA	263	Progressive Disease	NA	NA	1	543	1	543	NA	NA	1	263	
60	TCGA-VQ-A8PM	0	2	0	1	1	0	0	0	0	43	2	1	1	16	1	0	TCGA-VQ-A8PM-01	180	0.25263951552869424	99	TCGA-VQ-A8PM-01	9	18	152	0.3839181684243667	TCGA-VQ-A8PM-01	16	15	14	45	PASS	9663	TCGA-VQ-A8PM	STAD	56	MALE	WHITE	Stage IV	NA	"Stomach Adenocarcinoma, Signet Ring Type"	G3	2009	NA	-20665	Dead	WITH TUMOR	NA	57	"Other, non-malignant disease"	NA	NA	NA	NA	NA	NA	NA	1	57	0	57	NA	NA	1	57	
70	TCGA-VQ-A8PO	1	69	6	24	136	30	8	0	29	543	11	1	10	245	19	1	TCGA-VQ-A8PO-01	191	0.09454588773670257	113	TCGA-VQ-A8PO-01	4	4	63	0.08209888212021055	TCGA-VQ-A8PO-01	1	5	0	6	hypermutated sample	9664	TCGA-VQ-A8PO	STAD	74	MALE	WHITE	Stage IIB	NA	"Stomach Adenocarcinoma, Signet Ring Type"	G3	2008	NA	-27250	Dead	NA	NA	282	Stomach Cancer	Locoregional Recurrence	NA	NA	256	Progressive Disease	NA	NA	1	282	1	282	NA	NA	1	256	
80	TCGA-VQ-A8PP	7	91	5	32	243	42	15	0	46	945	42	2	19	427	27	2	TCGA-VQ-A8PP-01	141	0.1527065782589203	76	TCGA-VQ-A8PP-01	6	7	38	0.03865268341509199	TCGA-VQ-A8PP-01	2	1	2	5	hypermutated sample	9665	TCGA-VQ-A8PP	STAD	76	MALE	[Unknown]	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2008	NA	-27774	Dead	WITH TUMOR	NA	712	Stomach Cancer	Locoregional Recurrence	NA	NA	502	Progressive Disease	NA	NA	1	712	1	712	NA	NA	1	502	
50	TCGA-VQ-A8PQ	0	0	0	1	0	0	0	0	0	10	1	0	0	5	0	0	TCGA-VQ-A8PQ-01	110	6.945015585441761e-05	57	TCGA-VQ-A8PQ-01	0	4	51	0.026812739753243026	TCGA-VQ-A8PQ-01	6	8	2	16	PASS	9666	TCGA-VQ-A8PQ	STAD	50	FEMALE	WHITE	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2008	NA	-18318	Dead	WITH TUMOR	NA	476	Stomach Cancer	Locoregional Recurrence	NA	NA	91	Progressive Disease	NA	NA	1	476	1	476	NA	NA	1	91	
80	TCGA-VQ-A8PS	1	4	2	1	0	2	1	0	2	28	3	0	2	16	0	0	TCGA-VQ-A8PS-01	240	0.8317576987169711	134	TCGA-VQ-A8PS-01	7	16	112	0.3548853848334828	TCGA-VQ-A8PS-01	13	8	20	41	pathology review	9667	TCGA-VQ-A8PS	STAD	76	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2009	NA	-28035	Dead	WITH TUMOR	NA	406	Stomach Cancer	Distant Metastasis	Liver	NA	131	Progressive Disease	NA	NA	1	406	1	406	NA	NA	1	131	
70	TCGA-VQ-A8PT	7	96	6	29	267	47	24	1	54	839	45	1	16	401	20	0	TCGA-VQ-A8PT-01	133	0.05097133798106069	74	TCGA-VQ-A8PT-01	2	1	32	0.014923048344551697	TCGA-VQ-A8PT-01	1	0	1	2	pathology review	9668	TCGA-VQ-A8PT	STAD	65	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-23797	Alive	TUMOR FREE	900	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	900	0	900	0	900	0	900	
70	TCGA-VQ-A8PU	1	4	1	6	3	0	2	0	3	93	4	0	3	43	2	0	TCGA-VQ-A8PU-01	334	0.7320684005558631	223	TCGA-VQ-A8PU-01	14	67	147	0.2856723062850655	TCGA-VQ-A8PU-01	22	26	16	64	PASS	9669	TCGA-VQ-A8PU	STAD	72	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2012	NA	-26625	Dead	TUMOR FREE	NA	832	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	832	0	832	0	832	0	832	
50	TCGA-VQ-A8PX	3	32	2	13	88	19	6	0	17	398	12	0	12	206	20	0	TCGA-VQ-A8PX-01	107	0.4053657676888656	50	TCGA-VQ-A8PX-01	16	25	54	0.18912906680345026	TCGA-VQ-A8PX-01	5	7	4	16	PASS	9670	TCGA-VQ-A8PX	STAD	51	MALE	[Unknown]	Stage IA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2009	NA	-18902	Alive	TUMOR FREE	1964	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1964	0	1964	0	1964	0	1964	
50	TCGA-VQ-A8PY	1	7	0	1	2	2	0	0	4	65	7	0	2	28	1	0	TCGA-VQ-A8PY-01	298	0.579213766731559	194	TCGA-VQ-A8PY-01	18	33	155	0.21967706549305813	TCGA-VQ-A8PY-01	19	4	9	32	pathology review	9671	TCGA-VQ-A8PY	STAD	47	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2009	NA	-17230	Dead	TUMOR FREE	NA	436	Stomach Cancer	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	436	1	436	0	436	0	436	
60	TCGA-VQ-A8PZ	0	6	0	1	1	0	0	0	3	69	1	0	0	28	1	0	TCGA-VQ-A8PZ-01	102	0.2500823091294451	51	TCGA-VQ-A8PZ-01	7	9	81	0.3008515497139728	TCGA-VQ-A8PZ-01	8	11	12	31	pathology review	9672	TCGA-VQ-A8PZ	STAD	56	FEMALE	WHITE	Stage II	NA	"Stomach Adenocarcinoma, Signet Ring Type"	G3	2008	NA	-20735	Alive	TUMOR FREE	2233	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2233	0	2233	0	2233	0	2233	
70	TCGA-VQ-A91A	0	6	1	6	4	5	3	0	8	103	3	0	2	28	1	0	TCGA-VQ-A91A-01	221	0.536115697986448	135	TCGA-VQ-A91A-01	15	30	141	0.3411998519759405	TCGA-VQ-A91A-01	17	18	14	49	PASS	9673	TCGA-VQ-A91A	STAD	67	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Mucinous Type"	G1	2011	NA	-24670	Alive	TUMOR FREE	1200	NA	NA	New Primary Tumor	NA	NA	129	Complete Remission/Response	NA	NA	0	1200	0	1200	0	1200	1	129	
70	TCGA-VQ-A91D	9	127	9	69	342	73	19	0	66	1598	74	0	27	716	30	0	TCGA-VQ-A91D-01	127	0.07886422334277286	71	TCGA-VQ-A91D-01	0	0	34	0.031960522387250945	TCGA-VQ-A91D-01	1	3	2	6	hypermutated sample	9674	TCGA-VQ-A91D	STAD	70	MALE	WHITE	Stage IIIC	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2010	NA	-25686	Dead	WITH TUMOR	NA	356	Stomach Cancer	Locoregional Recurrence	NA	NA	351	Progressive Disease	NA	NA	1	356	1	356	NA	NA	1	351	
70	TCGA-VQ-A91E	2	43	4	21	130	16	9	0	14	533	26	1	7	222	12	1	TCGA-VQ-A91E-01	84	0.3477555939927441	37	TCGA-VQ-A91E-01	15	36	82	0.20445765876158914	TCGA-VQ-A91E-01	2	1	2	5	pathology review	9675	TCGA-VQ-A91E	STAD	67	FEMALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2013	NA	-24549	Alive	TUMOR FREE	664	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	664	0	664	0	664	0	664	
70	TCGA-VQ-A91K	3	82	6	45	221	43	17	3	42	852	48	0	25	422	15	0	TCGA-VQ-A91K-01	380	0.04012946757911737	260	TCGA-VQ-A91K-01	1	2	68	0.05158440874314423	TCGA-VQ-A91K-01	4	4	3	11	hypermutated sample	9676	TCGA-VQ-A91K	STAD	69	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2009	NA	-25424	Alive	TUMOR FREE	1862	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1862	0	1862	0	1862	0	1862	
60	TCGA-VQ-A91N	0	7	0	4	3	1	0	0	6	87	6	0	2	43	1	0	TCGA-VQ-A91N-01	900	0.671592243913046	596	TCGA-VQ-A91N-01	16	57	427	0.5402160150814753	TCGA-VQ-A91N-01	31	20	19	70	PASS	9677	TCGA-VQ-A91N	STAD	59	FEMALE	[Unknown]	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2009	NA	-21753	Dead	WITH TUMOR	NA	570	Stomach Cancer	Locoregional Recurrence	NA	NA	438	Progressive Disease	NA	NA	1	570	1	570	NA	NA	1	438	
60	TCGA-VQ-A91Q	0	4	0	8	0	1	0	1	1	83	7	0	3	30	3	0	TCGA-VQ-A91Q-01	309	0.7096356189645436	214	TCGA-VQ-A91Q-01	8	10	145	0.26314297332694025	TCGA-VQ-A91Q-01	11	13	13	37	PASS	9678	TCGA-VQ-A91Q	STAD	61	MALE	[Unknown]	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2009	NA	-22303	Dead	WITH TUMOR	NA	633	Stomach Cancer	Locoregional Recurrence	NA	NA	551	Complete Remission/Response	NA	NA	1	633	1	633	NA	NA	1	551	
60	TCGA-VQ-A91S	1	10	1	3	6	1	6	1	9	207	6	1	4	70	2	0	TCGA-VQ-A91S-01	317	0.8747740646720398	212	TCGA-VQ-A91S-01	8	39	168	0.3499781244316231	TCGA-VQ-A91S-01	25	15	9	49	PASS	9679	TCGA-VQ-A91S	STAD	63	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	GX	2012	NA	-23187	Alive	TUMOR FREE	1000	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1000	0	1000	0	1000	0	1000	
80	TCGA-VQ-A91U	2	7	0	5	3	0	1	0	1	111	9	0	2	54	4	0	TCGA-VQ-A91U-01	215	0.7760982506204713	124	TCGA-VQ-A91U-01	24	65	138	0.2752863392683507	TCGA-VQ-A91U-01	16	19	7	42	PASS	9680	TCGA-VQ-A91U	STAD	78	MALE	ASIAN	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-28791	Dead	NA	NA	52	[Unknown]	NA	NA	NA	NA	[Unknown]	NA	NA	1	52	NA	52	NA	NA	0	52	
60	TCGA-VQ-A91V	1	15	0	6	0	2	1	0	5	200	7	0	4	64	1	0	TCGA-VQ-A91V-01	210	0.6091234447434849	125	TCGA-VQ-A91V-01	9	11	142	0.2134559509921478	TCGA-VQ-A91V-01	10	6	11	27	PASS	9681	TCGA-VQ-A91V	STAD	58	MALE	[Unknown]	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-21505	Alive	WITH TUMOR	1297	NA	NA	Distant Metastasis	Lung	NA	504	Progressive Disease	NA	NA	0	1297	0	1297	NA	NA	1	504	
30	TCGA-VQ-A91W	0	1	0	1	2	1	0	0	1	33	2	0	0	12	0	0	TCGA-VQ-A91W-01	71	0.12545922931450293	26	TCGA-VQ-A91W-01	6	3	13	0.0004057602342054736	TCGA-VQ-A91W-01	0	0	0	0	PASS	9682	TCGA-VQ-A91W	STAD	30	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2009	NA	-10963	Alive	NA	1851	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1851	0	1851	0	1851	0	1851	
70	TCGA-VQ-A91X	1	7	1	3	2	6	0	0	7	170	9	0	3	53	4	0	TCGA-VQ-A91X-01	293	0.5901723239219776	176	TCGA-VQ-A91X-01	21	57	164	0.3004903955119049	TCGA-VQ-A91X-01	19	8	9	36	PASS	9683	TCGA-VQ-A91X	STAD	74	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2010	NA	-27314	Dead	TUMOR FREE	NA	289	"Other, non-malignant disease"	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	289	0	289	0	289	0	289	
70	TCGA-VQ-A91Y	0	1	0	0	1	0	0	0	4	33	4	0	2	12	0	0	TCGA-VQ-A91Y-01	242	0.4823138764507119	135	TCGA-VQ-A91Y-01	8	8	131	0.2902104491721487	TCGA-VQ-A91Y-01	12	9	11	32	PASS	9684	TCGA-VQ-A91Y	STAD	67	MALE	WHITE	Stage IIIC	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2011	NA	-24774	Dead	WITH TUMOR	NA	296	Stomach Cancer	Distant Metastasis	Lung	NA	258	Progressive Disease	NA	NA	1	296	1	296	NA	NA	1	258	
70	TCGA-VQ-A91Z	0	9	1	2	5	1	0	0	3	104	7	1	1	41	4	0	TCGA-VQ-A91Z-01	297	0.9999402242060748	193	TCGA-VQ-A91Z-01	24	35	152	0.26164299011287084	TCGA-VQ-A91Z-01	12	17	8	37	PASS	9685	TCGA-VQ-A91Z	STAD	67	FEMALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2010	NA	-24652	Alive	WITH TUMOR	1690	NA	NA	Locoregional Recurrence	NA	NA	1310	Complete Remission/Response	NA	NA	0	1690	0	1690	1	1310	1	1310	
70	TCGA-VQ-A922	0	9	2	7	0	3	0	0	6	132	7	0	3	41	2	0	TCGA-VQ-A922-01	1034	0.7112609239931009	671	TCGA-VQ-A922-01	15	55	489	0.4494734257281751	TCGA-VQ-A922-01	35	28	25	88	PASS	9686	TCGA-VQ-A922	STAD	70	MALE	[Unknown]	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2010	NA	-25700	Dead	NA	262	275	Stomach Cancer	Distant Metastasis	Liver	NA	252	Progressive Disease	NA	NA	1	275	1	275	NA	NA	1	252	
90	TCGA-VQ-A923	0	4	0	3	3	1	2	0	1	64	10	0	2	41	3	1	TCGA-VQ-A923-01	153	0.30555134633061243	83	TCGA-VQ-A923-01	14	22	35	0.013915378049723148	TCGA-VQ-A923-01	4	4	1	9	PASS	9687	TCGA-VQ-A923	STAD	90	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2008	NA	-32873	Dead	TUMOR FREE	NA	61	"Other, non-malignant disease"	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	61	0	61	0	61	0	61	
70	TCGA-VQ-A924	5	74	5	32	293	58	9	1	36	786	40	0	22	359	18	1	TCGA-VQ-A924-01	94	0.011718188490075521	41	TCGA-VQ-A924-01	1	1	14	0.012959869890048005	TCGA-VQ-A924-01	0	0	0	0	hypermutated sample	9688	TCGA-VQ-A924	STAD	69	MALE	[Unknown]	Stage II	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2008	NA	-25351	Dead	WITH TUMOR	NA	1686	Stomach Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	1686	1	1686	NA	NA	1	1686	
70	TCGA-VQ-A925	1	9	1	4	3	1	0	0	1	100	3	0	2	33	2	0	TCGA-VQ-A925-01	612	0.7646385094880439	386	TCGA-VQ-A925-01	21	51	214	0.22726786052999626	TCGA-VQ-A925-01	23	14	7	44	PASS	9689	TCGA-VQ-A925	STAD	66	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2012	NA	-24230	Dead	WITH TUMOR	NA	138	Stomach Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	138	1	138	NA	NA	1	138	
80	TCGA-VQ-A927	0	3	1	0	1	1	0	0	1	46	1	0	1	14	0	0	TCGA-VQ-A927-01	59	0.0002822087887679554	14	TCGA-VQ-A927	0	0	0	0	TCGA-VQ-A927	0	0	0	0	PASS	9690	TCGA-VQ-A927	STAD	81	MALE	WHITE	Stage IIIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G1	2013	NA	-29676	Dead	WITH TUMOR	NA	200	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	200	1	200	NA	NA	1	200	
50	TCGA-VQ-A928	0	2	0	2	0	0	0	1	1	49	1	0	2	21	0	0	TCGA-VQ-A928-01	717	0.1703452224300373	498	TCGA-VQ-A928-01	5	3	239	0.029607030136448182	TCGA-VQ-A928-01	7	2	0	9	PASS	9691	TCGA-VQ-A928	STAD	49	MALE	WHITE	Stage IV	NA	"Stomach, Intestinal Adenocarcinoma, Papillary Type"	G2	2010	NA	-18058	Dead	WITH TUMOR	NA	174	Stomach Cancer	Distant Metastasis	Liver	NA	148	Progressive Disease	NA	NA	1	174	1	174	NA	NA	1	148	
70	TCGA-VQ-A92D	0	9	1	2	4	1	2	1	7	91	8	0	2	43	2	0	TCGA-VQ-A92D-01	1559	0.7691832546927672	1091	TCGA-VQ-A92D-01	6	4	125	0.0603762467130876	TCGA-VQ-A92D-01	10	6	3	19	PASS	9692	TCGA-VQ-A92D	STAD	67	MALE	WHITE	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2009	NA	-24595	Alive	TUMOR FREE	2032	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2032	0	2032	0	2032	0	2032	
70	TCGA-VQ-A94O	1	3	0	0	2	0	0	0	3	48	2	0	0	23	1	0	TCGA-VQ-A94O-01	448	0.6970580303706768	317	TCGA-VQ-A94O-01	22	53	226	0.2891021853822362	TCGA-VQ-A94O-01	14	9	6	29	PASS	9693	TCGA-VQ-A94O	STAD	74	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-27306	Dead	WITH TUMOR	NA	640	Stomach Cancer	Distant Metastasis	Liver	NA	185	Progressive Disease	NA	NA	1	640	1	640	NA	NA	1	185	
60	TCGA-VQ-A94P	0	2	0	0	0	0	0	0	1	72	0	1	2	23	0	0	TCGA-VQ-A94P-01	73	0.00015027252774594578	27	TCGA-VQ-A94P-01	11	16	105	0.4835557159869519	TCGA-VQ-A94P-01	9	7	8	24	PASS	9694	TCGA-VQ-A94P	STAD	57	MALE	WHITE	[Discrepancy]	NA	"Stomach Adenocarcinoma, Signet Ring Type"	GX	2011	NA	-21022	Dead	WITH TUMOR	NA	81	Stomach Cancer	NA	NA	NA	NA	Progressive Disease	NA	NA	1	81	1	81	NA	NA	1	81	
60	TCGA-VQ-A94R	1	13	1	13	4	1	5	0	12	233	12	0	4	85	2	0	TCGA-VQ-A94R-01	220	0.7206821028100755	142	TCGA-VQ-A94R-01	9	35	178	0.4089986238953653	TCGA-VQ-A94R-01	11	18	6	35	PASS	9695	TCGA-VQ-A94R	STAD	63	MALE	WHITE	[Discrepancy]	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2010	NA	-23246	Dead	WITH TUMOR	NA	1294	Stomach Cancer	Locoregional Recurrence	NA	NA	1018	Progressive Disease	NA	NA	1	1294	1	1294	NA	NA	1	1018	
70	TCGA-VQ-A94T	0	7	1	4	2	0	2	0	2	53	4	0	1	28	2	0	TCGA-VQ-A94T-01	203	0.5611896743989133	128	TCGA-VQ-A94T-01	22	26	88	0.22644976611694295	TCGA-VQ-A94T-01	14	4	7	25	PASS	9696	TCGA-VQ-A94T	STAD	73	MALE	[Unknown]	Stage IIIB	NA	"Stomach, Adenocarcinoma, Diffuse Type"	G3	2011	NA	-26702	Dead	WITH TUMOR	NA	342	NA	Locoregional Recurrence	NA	NA	296	Progressive Disease	NA	NA	1	342	1	342	NA	NA	1	296	
70	TCGA-VQ-A94U	2	8	0	7	3	3	1	0	2	117	7	0	3	49	3	0	TCGA-VQ-A94U-01	221	0.8775927905257673	122	TCGA-VQ-A94U-01	21	31	136	0.3149955819018849	TCGA-VQ-A94U-01	10	7	11	28	PASS	9697	TCGA-VQ-A94U	STAD	70	MALE	WHITE	Stage IIB	NA	"Stomach Adenocarcinoma, Signet Ring Type"	G3	2012	NA	-25925	Alive	TUMOR FREE	819	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	819	0	819	0	819	0	819	
70	TCGA-VQ-AA64	0	13	2	7	18	1	7	0	11	181	15	0	6	70	6	0	TCGA-VQ-AA64-01	321	0.6135797617736383	212	TCGA-VQ-AA64-01	3	12	164	0.3203213043182058	TCGA-VQ-AA64-01	21	26	20	67	PASS	9698	TCGA-VQ-AA64	STAD	68	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-25109	Dead	WITH TUMOR	NA	560	Stomach Cancer	NA	NA	NA	NA	[Unknown]	NA	NA	1	560	1	560	NA	NA	1	560	
50	TCGA-VQ-AA68	0	6	1	8	4	1	0	0	7	139	7	0	1	39	0	0	TCGA-VQ-AA68-01	317	0.7895677383411119	209	TCGA-VQ-AA68-01	23	46	183	0.3348545434759032	TCGA-VQ-AA68-01	24	9	14	47	PASS	9699	TCGA-VQ-AA68	STAD	52	FEMALE	WHITE	Stage IIIC	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2011	NA	-19304	Alive	TUMOR FREE	1328	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1328	0	1328	0	1328	0	1328	
40	TCGA-VQ-AA69	0	2	0	0	2	0	1	0	3	49	4	0	4	21	0	0	TCGA-VQ-AA69-01	69	0.0004742276486879629	25	TCGA-VQ-AA69-01	0	0	24	0.016611187097629626	TCGA-VQ-AA69-01	3	0	1	4	PASS	9700	TCGA-VQ-AA69	STAD	35	MALE	WHITE	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-13087	Alive	TUMOR FREE	864	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	864	0	864	0	864	0	864	
60	TCGA-VQ-AA6A	0	3	1	1	2	1	0	1	4	76	3	0	0	33	2	0	TCGA-VQ-AA6A-01	367	0.7213452667644693	230	TCGA-VQ-AA6A-01	14	20	198	0.4076526948834116	TCGA-VQ-AA6A-01	18	15	12	45	PASS	9701	TCGA-VQ-AA6A	STAD	56	MALE	WHITE	Stage IIIC	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-20764	Alive	TUMOR FREE	1184	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1184	0	1184	0	1184	0	1184	
50	TCGA-VQ-AA6B	0	1	2	2	6	0	0	1	2	65	6	0	2	20	2	0	TCGA-VQ-AA6B-01	173	0.6429164199170236	97	TCGA-VQ-AA6B-01	25	24	94	0.2858454682142722	TCGA-VQ-AA6B-01	7	4	4	15	PASS	9702	TCGA-VQ-AA6B	STAD	48	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2012	NA	-17852	Alive	TUMOR FREE	1002	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1002	0	1002	0	1002	0	1002	
50	TCGA-VQ-AA6D	6	33	3	11	49	11	12	0	19	588	27	3	10	218	8	0	TCGA-VQ-AA6D-01	1116	0.363680940008164	828	TCGA-VQ-AA6D-01	8	9	256	0.1957117800939236	TCGA-VQ-AA6D-01	16	12	11	39	PASS	9703	TCGA-VQ-AA6D	STAD	52	FEMALE	[Unknown]	Stage IIIA	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G2	2013	NA	-19090	Alive	TUMOR FREE	521	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	521	0	521	0	521	0	521	
60	TCGA-VQ-AA6F	0	2	1	0	2	0	0	0	1	44	3	0	1	10	1	0	TCGA-VQ-AA6F-01	131	0.5059030179599451	58	TCGA-VQ-AA6F-01	13	21	159	0.6126065628500911	TCGA-VQ-AA6F-01	17	20	19	56	PASS	9704	TCGA-VQ-AA6F	STAD	57	MALE	WHITE	Stage IIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2010	NA	-21170	Alive	TUMOR FREE	1646	NA	NA	Locoregional Recurrence|New Primary Tumor	"Other, specify"	NA	546	Progressive Disease	NA	NA	0	1646	0	1646	NA	NA	1	546	
70	TCGA-VQ-AA6G	0	6	2	6	3	1	2	0	4	104	7	0	3	35	1	0	TCGA-VQ-AA6G-01	226	0.15923843636729607	146	TCGA-VQ-AA6G-01	3	5	94	0.09090128216539796	TCGA-VQ-AA6G-01	9	4	3	16	PASS	9705	TCGA-VQ-AA6G	STAD	68	MALE	WHITE	Stage IIA	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2011	NA	-25091	Dead	WITH TUMOR	NA	792	Stomach Cancer	Distant Metastasis	Lung	NA	469	Progressive Disease	NA	NA	1	792	1	792	NA	NA	1	469	
70	TCGA-VQ-AA6I	2	9	0	4	7	1	1	1	4	70	4	0	3	29	2	0	TCGA-VQ-AA6I-01	307	0.498698141134535	173	TCGA-VQ-AA6I-01	15	28	109	0.2003072052399779	TCGA-VQ-AA6I-01	10	7	9	26	PASS	9706	TCGA-VQ-AA6I	STAD	68	MALE	WHITE	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-25091	Dead	WITH TUMOR	NA	491	Stomach Cancer	Locoregional Recurrence	NA	NA	475	Progressive Disease	NA	NA	1	491	1	491	NA	NA	1	475	
80	TCGA-VQ-AA6J	1	4	2	1	4	0	0	0	1	115	3	2	2	47	2	0	TCGA-VQ-AA6J-01	171	0.3066345886394761	92	TCGA-VQ-AA6J-01	9	18	144	0.4156406741793293	TCGA-VQ-AA6J-01	14	12	18	44	PASS	9707	TCGA-VQ-AA6J	STAD	75	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G3	2012	NA	-27506	Alive	TUMOR FREE	838	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	838	0	838	0	838	0	838	
60	TCGA-VQ-AA6K	0	4	0	2	3	3	0	0	2	64	5	0	0	16	0	0	TCGA-VQ-AA6K-01	166	0.6153217167267666	92	TCGA-VQ-AA6K-01	14	17	150	0.4523062487249282	TCGA-VQ-AA6K-01	15	8	12	35	PASS	9708	TCGA-VQ-AA6K	STAD	59	MALE	WHITE	Stage IIIC	NA	"Stomach Adenocarcinoma, Signet Ring Type"	G3	2012	NA	-21901	Dead	WITH TUMOR	NA	378	Stomach Cancer	Locoregional Recurrence	NA	NA	332	Progressive Disease	NA	NA	1	378	1	378	NA	NA	1	332	
70	TCGA-ZA-A8F6	0	1	1	1	2	0	0	0	2	34	7	0	0	11	1	0	TCGA-ZA-A8F6-01	94	0.22445484505646696	48	TCGA-ZA-A8F6-01	7	5	32	0.029455568298803664	TCGA-ZA-A8F6-01	2	1	2	5	PASS	9709	TCGA-ZA-A8F6	STAD	71	MALE	WHITE	Stage IB	NA	"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)"	G2	2013	NA	-26122	Alive	TUMOR FREE	525	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	525	0	525	0	525	0	525	
80	TCGA-ZQ-A9CR	2	8	0	3	1	2	0	0	3	90	4	0	0	33	2	0	TCGA-ZQ-A9CR-01	192	0.5683419031358791	94	TCGA-ZQ-A9CR-01	19	36	100	0.3491408219030173	TCGA-ZQ-A9CR-01	21	16	14	51	PASS	9710	TCGA-ZQ-A9CR	STAD	79	FEMALE	WHITE	Stage IIIC	NA	"Stomach, Intestinal Adenocarcinoma, Tubular Type"	G3	2013	NA	-29107	Dead	NA	NA	24	[Unknown]	NA	NA	NA	NA	[Unknown]	NA	NA	1	24	NA	24	NA	NA	0	24	
30	TCGA-2G-AAEW	0	1	0	0	0	0	1	0	0	12	0	0	0	1	1	0	TCGA-2G-AAEW-01	69	0.4797751765592301	23	TCGA-2G-AAEW-01	18	13	10	0.044172931828985865	TCGA-2G-AAEW-01	1	2	1	4	PASS	9711	TCGA-2G-AAEW	TGCT	31	MALE	WHITE	IS	Stage IS	Seminoma; NOS	NA	2011	NA	-11325	Dead	WITH TUMOR	NA	618	Testicular Germ Cell Tumor (TGCT)	Locoregional Recurrence	Retroperitoneal lymph nodes	NA	143	NA	NA	NA	1	618	1	618	NA	NA	1	143	
40	TCGA-2G-AAEX	0	1	0	1	2	0	1	0	1	17	0	0	0	7	1	0	TCGA-2G-AAEX-01	103	0.5112242791487706	45	TCGA-2G-AAEX-01	17	25	47	0.11232620571048052	TCGA-2G-AAEX-01	9	4	3	16	PASS	9712	TCGA-2G-AAEX	TGCT	38	MALE	WHITE	IS	Stage IS	Seminoma; NOS	NA	2011	NA	-13964	Alive	TUMOR FREE	1259	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1259	0	1259	0	1259	0	1259	
30	TCGA-2G-AAF1	0	0	0	2	0	0	0	0	0	5	0	0	1	4	0	0	TCGA-2G-AAF1-01	49	0.22024257053469773	11	TCGA-2G-AAF1-01	20	19	6	0.002214557322093592	TCGA-2G-AAF1-01	7	2	0	9	PASS	9713	TCGA-2G-AAF1	TGCT	28	MALE	ASIAN	IS	Stage IS	Seminoma; NOS	NA	2011	NA	-10511	Alive	TUMOR FREE	1403	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1403	0	1403	0	1403	0	1403	
30	TCGA-2G-AAF4	0	1	1	0	2	0	0	0	0	6	0	0	0	3	0	0	TCGA-2G-AAF4-01	96	0.7317399076852346	41	TCGA-2G-AAF4-01	22	31	19	0.05175283667033138	TCGA-2G-AAF4-01	7	7	1	15	PASS	9714	TCGA-2G-AAF4	TGCT	30	MALE	WHITE	Stage I	Stage IA	Seminoma; NOS	NA	2008	NA	-10983	Alive	TUMOR FREE	2315	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2315	0	2315	0	2315	0	2315	
30	TCGA-2G-AAF6	0	4	0	0	2	0	1	0	1	13	1	0	0	2	0	0	TCGA-2G-AAF6-01	115	0.9224551015039086	58	TCGA-2G-AAF6-01	22	36	40	0.15259876348224402	TCGA-2G-AAF6-01	9	8	5	22	PASS	9715	TCGA-2G-AAF6	TGCT	28	MALE	WHITE	IS	Stage IS	Seminoma; NOS	NA	2005	NA	-10281	Alive	TUMOR FREE	3491	NA	NA	Locoregional Recurrence	Retroperitoneal lymph nodes	NA	810	Complete Remission/Response	NA	NA	0	3491	0	3491	1	810	1	810	
30	TCGA-2G-AAF8	0	2	0	1	0	0	0	0	0	8	1	0	0	8	0	0	TCGA-2G-AAF8-01	113	0.5362163994275227	51	TCGA-2G-AAF8-01	18	28	25	0.1403617830242713	TCGA-2G-AAF8-01	10	12	2	24	PASS	9716	TCGA-2G-AAF8	TGCT	33	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2004	NA	-12256	Alive	TUMOR FREE	3911	NA	NA	New Primary Tumor	Testes	NA	3149	Complete Remission/Response	NA	NA	0	3911	0	3911	1	3149	1	3149	
40	TCGA-2G-AAFE	0	6	0	3	1	0	1	0	4	44	0	0	0	6	2	0	TCGA-2G-AAFE	0	0	0	TCGA-2G-AAFE	0	0	0	0	TCGA-2G-AAFE	0	0	0	0	PASS	9717	TCGA-2G-AAFE	TGCT	37	MALE	WHITE	Stage IIA	Stage IIA	Seminoma; NOS	NA	2001	NA	-13845	Alive	TUMOR FREE	4702	NA	NA	Locoregional Recurrence	Retroperitoneal lymph nodes	NA	617	Complete Remission/Response	NA	NA	0	4702	0	4702	1	617	1	617	
30	TCGA-2G-AAFG	0	7	0	2	0	0	1	0	0	29	0	0	0	2	1	0	TCGA-2G-AAFG-01	80	0.4700051695471187	27	TCGA-2G-AAFG-05	17	31	6	0.02065300933829809	TCGA-2G-AAFG-05	7	6	1	14	mutation call filter	9718	TCGA-2G-AAFG	TGCT	30	MALE	WHITE	IS	Stage IS	Seminoma; NOS	NA	1998	NA	-11002	Alive	TUMOR FREE	6183	NA	NA	New Primary Tumor	Testes	NA	2495	Complete Remission/Response	NA	NA	0	6183	0	6183	1	2495	1	2495	
40	TCGA-2G-AAFH	0	2	0	2	1	1	0	1	0	14	2	0	0	6	0	0	TCGA-2G-AAFH-01	157	0.5752198653101159	85	TCGA-2G-AAFH-01	20	26	39	0.08943378720299906	TCGA-2G-AAFH-01	12	10	2	24	PASS	9719	TCGA-2G-AAFH	TGCT	38	MALE	WHITE	Stage IIB	Stage IIB	Seminoma; NOS	NA	2011	NA	-14120	Alive	TUMOR FREE	1375	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1375	0	1375	0	1375	0	1375	
40	TCGA-2G-AAFI	0	2	0	2	0	1	0	0	0	6	1	0	0	2	0	0	TCGA-2G-AAFI-01	121	0.8357125607865915	55	TCGA-2G-AAFI-01	27	37	95	0.1809760011172233	TCGA-2G-AAFI-01	8	5	2	15	PASS	9720	TCGA-2G-AAFI	TGCT	41	MALE	WHITE	Stage IB	Stage IB	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor	NA	2013	NA	-14976	Alive	TUMOR FREE	675	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	675	0	675	0	675	0	675	
30	TCGA-2G-AAFJ	1	1	0	0	0	0	1	0	0	16	2	0	2	5	1	0	TCGA-2G-AAFJ-01	106	0.7631238842115469	56	TCGA-2G-AAFJ-01	18	35	31	0.17046505069106244	TCGA-2G-AAFJ-01	8	6	2	16	PASS	9721	TCGA-2G-AAFJ	TGCT	23	MALE	ASIAN	[Discrepancy]	Stage I	Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Yolk Sac Tumor	NA	2013	NA	-8415	Alive	TUMOR FREE	792	NA	NA	NA	NA	NA	313	Complete Remission/Response	NA	NA	0	792	0	792	1	313	1	313	
40	TCGA-2G-AAFL	0	1	0	2	1	0	0	0	0	12	2	0	2	8	0	0	TCGA-2G-AAFL-01	61	0.09120342570789483	21	TCGA-2G-AAFL-01	27	38	50	0.31298815315786843	TCGA-2G-AAFL-01	7	3	2	12	PASS	9722	TCGA-2G-AAFL	TGCT	35	MALE	WHITE	Stage IB	Stage IB	Non-Seminoma; Embryonal Carcinoma	NA	2013	NA	-12898	Alive	TUMOR FREE	750	NA	NA	New Primary Tumor	Testes	NA	38	Complete Remission/Response	NA	NA	0	750	0	750	1	38	1	38	
30	TCGA-2G-AAFM	0	3	0	5	1	0	1	0	0	15	1	0	0	2	0	0	TCGA-2G-AAFM-01	64	0.3502257424737905	21	TCGA-2G-AAFM-01	10	38	58	0.3052990452927268	TCGA-2G-AAFM-01	12	10	6	28	PASS	9723	TCGA-2G-AAFM	TGCT	31	MALE	WHITE	Stage IIA	Stage IIA	Non-Seminoma; Embryonal Carcinoma	NA	2013	NA	-11607	Alive	TUMOR FREE	503	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	503	0	503	0	503	0	503	
30	TCGA-2G-AAFN	3	0	1	1	0	0	0	0	0	6	4	0	0	4	0	0	TCGA-2G-AAFN-01	218	0.4974599049120935	136	TCGA-2G-AAFN-01	19	33	30	0.06938091285950074	TCGA-2G-AAFN-01	4	6	1	11	PASS	9724	TCGA-2G-AAFN	TGCT	26	MALE	WHITE	Stage IIIB	Stage IIIB	Non-Seminoma; Embryonal Carcinoma	NA	2013	NA	-9805	Alive	TUMOR FREE	773	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	773	0	773	0	773	0	773	
30	TCGA-2G-AAFO	0	1	0	1	0	0	0	1	1	8	2	0	0	2	0	0	TCGA-2G-AAFO-01	76	0.4071278747478389	30	TCGA-2G-AAFO-01	19	33	74	0.2821746270253368	TCGA-2G-AAFO-01	12	13	7	32	PASS	9725	TCGA-2G-AAFO	TGCT	33	MALE	WHITE	Stage IIA	Stage IIA	Non-Seminoma; Embryonal Carcinoma	NA	2013	NA	-12298	Alive	TUMOR FREE	685	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	685	0	685	0	685	0	685	
30	TCGA-2G-AAFV	0	1	0	4	2	0	0	0	0	17	0	1	1	2	1	0	TCGA-2G-AAFV-01	112	0.9329120330526832	55	TCGA-2G-AAFV-01	26	37	133	0.4299518952152861	TCGA-2G-AAFV-01	9	7	7	23	PASS	9726	TCGA-2G-AAFV	TGCT	31	MALE	WHITE	IS	Stage IS	Non-Seminoma; Yolk Sac Tumor	NA	2011	NA	-11598	Alive	TUMOR FREE	1389	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1389	0	1389	0	1389	0	1389	
30	TCGA-2G-AAFY	0	2	0	1	0	0	0	0	0	6	1	0	0	4	0	0	TCGA-2G-AAFY-01	52	0.5004492007293021	13	TCGA-2G-AAFY-01	22	28	13	0.05222583070650686	TCGA-2G-AAFY-01	5	4	1	10	PASS	9727	TCGA-2G-AAFY	TGCT	24	MALE	WHITE	Stage IIA	Stage IIA	Non-Seminoma; Embryonal Carcinoma	NA	2011	NA	-9023	Alive	TUMOR FREE	1099	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1099	0	1099	0	1099	0	1099	
30	TCGA-2G-AAFZ	0	4	0	1	0	1	0	0	2	16	0	0	0	12	1	1	TCGA-2G-AAFZ-01	118	0.8639826867538836	66	TCGA-2G-AAFZ-01	13	34	94	0.3656744666965233	TCGA-2G-AAFZ-01	6	6	7	19	PASS	9728	TCGA-2G-AAFZ	TGCT	32	MALE	WHITE	Stage III	Stage IIIB	Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature)	NA	2011	NA	-11761	Alive	TUMOR FREE	1353	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1353	0	1353	NA	NA	0	1353	
30	TCGA-2G-AAG0	0	3	0	3	0	0	1	0	0	18	2	0	0	3	0	0	TCGA-2G-AAG0-01	137	0.5428810286629051	74	TCGA-2G-AAG0-01	18	33	53	0.10498395856062223	TCGA-2G-AAG0-01	12	10	4	26	PASS	9729	TCGA-2G-AAG0	TGCT	23	MALE	WHITE	IS	Stage IS	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature)	NA	2010	NA	-8687	Alive	TUMOR FREE	1529	NA	NA	Distant Metastasis	Lung	NA	90	Complete Remission/Response	NA	NA	0	1529	0	1529	1	90	1	90	
50	TCGA-2G-AAG3	1	1	0	1	0	0	0	0	0	11	2	0	0	5	0	0	TCGA-2G-AAG3-01	60	0.7744712429536602	22	TCGA-2G-AAG3-01	10	34	60	0.2548826239327721	TCGA-2G-AAG3-01	7	5	3	15	PASS	9730	TCGA-2G-AAG3	TGCT	53	MALE	WHITE	IS	Stage IS	Non-Seminoma; Teratoma (Mature)|Seminoma; NOS|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor	NA	2009	NA	-19583	Alive	TUMOR FREE	1593	NA	NA	New Primary Tumor	Lung	NA	181	Complete Remission/Response	NA	NA	0	1593	0	1593	0	1593	1	181	
40	TCGA-2G-AAG5	0	0	0	1	0	1	0	1	0	13	1	0	1	7	0	0	TCGA-2G-AAG5-01	120	0.3546186281601281	56	TCGA-2G-AAG5-01	8	35	117	0.43238898174962587	TCGA-2G-AAG5-01	5	4	2	11	PASS	9731	TCGA-2G-AAG5	TGCT	36	MALE	WHITE	IS	Stage IS	Non-Seminoma; Teratoma (Mature)	NA	2008	NA	-13497	Alive	TUMOR FREE	2299	NA	NA	Locoregional Recurrence	Retroperitoneal lymph nodes	NA	451	Complete Remission/Response	NA	NA	0	2299	0	2299	1	451	1	451	
30	TCGA-2G-AAG6	0	3	0	0	0	1	0	0	0	9	0	0	0	3	0	0	TCGA-2G-AAG6-01	114	0.7782091809178442	46	TCGA-2G-AAG6-01	19	32	86	0.24042473941719195	TCGA-2G-AAG6-01	6	5	2	13	PASS	9732	TCGA-2G-AAG6	TGCT	24	MALE	WHITE	IS	Stage IS	Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Yolk Sac Tumor	NA	2008	NA	-9071	Alive	TUMOR FREE	2231	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2231	0	2231	0	2231	0	2231	
30	TCGA-2G-AAG7	0	1	0	4	1	0	0	0	0	16	2	1	0	3	0	0	TCGA-2G-AAG7-01	136	0.92967547096864	73	TCGA-2G-AAG7-01	19	31	48	0.21788515936736305	TCGA-2G-AAG7-01	9	8	6	23	PASS	9733	TCGA-2G-AAG7	TGCT	33	MALE	WHITE	IS	Stage IS	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor	NA	2008	NA	-12180	Alive	TUMOR FREE	2475	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2475	0	2475	0	2475	0	2475	
30	TCGA-2G-AAG8	1	2	0	1	1	0	0	0	2	14	0	0	0	3	1	0	TCGA-2G-AAG8-01	136	0.3395660992771302	70	TCGA-2G-AAG8-01	28	52	30	0.07923637382986735	TCGA-2G-AAG8-01	13	4	1	18	PASS	9734	TCGA-2G-AAG8	TGCT	21	MALE	WHITE	Stage IB	Stage IIA	Non-Seminoma; Embryonal Carcinoma	NA	2008	NA	-7688	Alive	TUMOR FREE	2289	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2289	0	2289	0	2289	0	2289	
30	TCGA-2G-AAG9	0	1	0	2	0	0	0	0	1	13	0	0	0	7	2	0	TCGA-2G-AAG9-01	100	0.6456754174696295	42	TCGA-2G-AAG9-01	22	33	34	0.13813229763423573	TCGA-2G-AAG9-01	7	6	6	19	PASS	9735	TCGA-2G-AAG9	TGCT	25	MALE	WHITE	Stage IIIB	Stage IIIB	Seminoma; NOS	NA	2008	NA	-9210	Alive	TUMOR FREE	2234	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	2234	0	2234	NA	NA	0	2234	
40	TCGA-2G-AAGA	0	2	0	1	0	0	0	0	1	21	2	0	1	7	2	0	TCGA-2G-AAGA-01	101	0.5577137494684299	45	TCGA-2G-AAGA-01	19	32	36	0.1505293983593655	TCGA-2G-AAGA-01	10	7	0	17	PASS	9736	TCGA-2G-AAGA	TGCT	38	MALE	WHITE	Stage IIA	Stage IIA	Non-Seminoma; Embryonal Carcinoma	NA	2008	NA	-14053	Alive	TUMOR FREE	2439	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2439	0	2439	0	2439	0	2439	
30	TCGA-2G-AAGC	0	1	0	1	1	0	1	0	2	15	1	0	0	2	0	0	TCGA-2G-AAGC-01	96	0.3888927927081115	44	TCGA-2G-AAGC-01	14	30	33	0.13060270557180978	TCGA-2G-AAGC-01	5	1	1	7	PASS	9737	TCGA-2G-AAGC	TGCT	28	MALE	WHITE	IS	Stage IS	Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor	NA	2007	NA	-10518	Alive	TUMOR FREE	2585	NA	NA	Locoregional Recurrence	Retroperitoneal lymph nodes	NA	317	Complete Remission/Response	NA	NA	0	2585	0	2585	1	317	1	317	
30	TCGA-2G-AAGE	0	5	0	2	0	1	0	0	1	14	0	1	0	3	0	0	TCGA-2G-AAGE-01	149	0.7208189205887297	82	TCGA-2G-AAGE-01	23	29	78	0.28951326741507594	TCGA-2G-AAGE-01	5	6	1	12	PASS	9738	TCGA-2G-AAGE	TGCT	21	MALE	WHITE	IS	Stage IS	Non-Seminoma; Embryonal Carcinoma	NA	2007	NA	-7753	Alive	TUMOR FREE	2478	NA	NA	Locoregional Recurrence	Retroperitoneal lymph nodes	NA	121	Complete Remission/Response	NA	NA	0	2478	0	2478	1	121	1	121	
30	TCGA-2G-AAGF	0	1	0	1	0	0	1	0	1	8	2	0	1	4	0	0	TCGA-2G-AAGF-01	114	0.6739615905637125	58	TCGA-2G-AAGF-01	13	29	46	0.14140248933674762	TCGA-2G-AAGF-01	6	4	1	11	PASS	9739	TCGA-2G-AAGF	TGCT	28	MALE	WHITE	IS	Stage IS	Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor	NA	2007	NA	-10348	Alive	TUMOR FREE	2734	NA	NA	Locoregional Recurrence	Retroperitoneal lymph nodes	NA	139	Complete Remission/Response	NA	NA	0	2734	0	2734	1	139	1	139	
30	TCGA-2G-AAGG	1	7	0	0	0	0	0	0	2	33	1	0	0	8	0	0	TCGA-2G-AAGG-01	191	0.8837813689920092	114	TCGA-2G-AAGG-01	17	31	140	0.34539715323212594	TCGA-2G-AAGG-01	8	6	3	17	PASS	9740	TCGA-2G-AAGG	TGCT	20	MALE	WHITE	Stage IIIC	Stage IIIC	Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor	NA	2007	NA	-7330	Alive	TUMOR FREE	2611	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	2611	0	2611	NA	NA	0	2611	
30	TCGA-2G-AAGI	0	3	0	2	0	0	0	0	4	26	1	0	0	7	0	0	TCGA-2G-AAGI-01	147	0.979244011755846	69	TCGA-2G-AAGI-05	20	29	13	0.025276159643721933	TCGA-2G-AAGI-05	4	6	1	11	mutation call filter	9741	TCGA-2G-AAGI	TGCT	33	MALE	WHITE	IS	Stage IS	Non-Seminoma; Teratoma (Mature)|Seminoma; NOS|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor	NA	2006	NA	-12366	Alive	TUMOR FREE	3137	NA	NA	New Primary Tumor	Testes	NA	2193	Complete Remission/Response	NA	NA	0	3137	0	3137	1	2193	1	2193	
30	TCGA-2G-AAGJ	0	4	0	1	1	0	0	0	2	13	1	0	0	8	2	1	TCGA-2G-AAGJ-01	126	0.5632460262981784	66	TCGA-2G-AAGJ-01	13	34	58	0.163837661445328	TCGA-2G-AAGJ-01	13	9	4	26	PASS	9742	TCGA-2G-AAGJ	TGCT	28	MALE	BLACK OR AFRICAN AMERICAN	Stage IA	Stage IA	Non-Seminoma; Embryonal Carcinoma|Seminoma; NOS	NA	2006	NA	-10348	Alive	TUMOR FREE	2938	NA	NA	Locoregional Recurrence	Retroperitoneal lymph nodes	NA	171	Complete Remission/Response	NA	NA	0	2938	0	2938	1	171	1	171	
30	TCGA-2G-AAGK	0	0	0	0	0	0	1	0	0	7	0	0	0	2	0	0	TCGA-2G-AAGK-01	76	0.8275193538474225	28	TCGA-2G-AAGK-01	22	32	23	0.05503845140724965	TCGA-2G-AAGK-01	4	4	1	9	PASS	9743	TCGA-2G-AAGK	TGCT	20	MALE	WHITE	IS	Stage IS	Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma	NA	2005	NA	-7378	Alive	TUMOR FREE	3621	NA	NA	Locoregional Recurrence	Retroperitoneal lymph nodes	NA	713	Complete Remission/Response	NA	NA	0	3621	0	3621	1	713	1	713	
50	TCGA-2G-AAGM	0	3	0	1	3	1	1	0	1	15	0	0	0	6	0	0	TCGA-2G-AAGM-01	123	0.7828219570320872	57	TCGA-2G-AAGM-01	28	48	22	0.04171877468925397	TCGA-2G-AAGM-01	4	2	0	6	PASS	9744	TCGA-2G-AAGM	TGCT	51	MALE	WHITE	IS	Stage IS	Non-Seminoma; Yolk Sac Tumor	NA	2004	NA	-18696	Alive	TUMOR FREE	3891	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	3891	0	3891	NA	NA	0	3891	
40	TCGA-2G-AAGN	0	2	0	1	0	0	0	0	0	1	0	0	0	3	0	0	TCGA-2G-AAGN-01	101	0.5298349723324879	47	TCGA-2G-AAGN-01	22	25	16	0.10030842825354408	TCGA-2G-AAGN-01	4	1	3	8	PASS	9745	TCGA-2G-AAGN	TGCT	41	MALE	WHITE	Stage IIIB	Stage IIIB	Non-Seminoma; Embryonal Carcinoma	NA	2004	NA	-15145	Alive	TUMOR FREE	3656	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	3656	0	3656	NA	NA	0	3656	
40	TCGA-2G-AAGO	0	3	0	0	2	0	1	0	3	17	0	0	0	4	1	0	TCGA-2G-AAGO-01	157	0.47616837981272603	83	TCGA-2G-AAGO-01	13	30	91	0.2566551138030301	TCGA-2G-AAGO-01	12	11	9	32	PASS	9746	TCGA-2G-AAGO	TGCT	41	MALE	WHITE	IS	Stage IS	Non-Seminoma; Embryonal Carcinoma	NA	2003	NA	-15300	Alive	TUMOR FREE	4026	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	4026	0	4026	NA	NA	0	4026	
30	TCGA-2G-AAGP	0	4	0	1	1	0	0	0	0	18	1	0	1	7	2	0	TCGA-2G-AAGP-01	104	0.6486351125459995	50	TCGA-2G-AAGP-01	20	35	95	0.3522000845908522	TCGA-2G-AAGP-01	15	12	6	33	PASS	9747	TCGA-2G-AAGP	TGCT	33	MALE	WHITE	Stage IIA	Stage IIA	Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor	NA	2003	NA	-12202	Alive	TUMOR FREE	4018	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4018	0	4018	0	4018	0	4018	
40	TCGA-2G-AAGS	0	0	0	1	1	0	1	0	0	9	0	0	0	1	0	0	TCGA-2G-AAGS-01	128	0.4553605403996952	63	TCGA-2G-AAGS-01	16	32	37	0.09509732144423944	TCGA-2G-AAGS-01	8	7	0	15	PASS	9748	TCGA-2G-AAGS	TGCT	39	MALE	WHITE	Stage IIIB	Stage IIIB	Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor	NA	2001	NA	-14312	Alive	TUMOR FREE	4816	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4816	0	4816	0	4816	0	4816	
30	TCGA-2G-AAGT	0	0	0	1	1	0	3	0	1	13	1	0	0	3	1	0	TCGA-2G-AAGT-01	219	0.8423976834270682	130	TCGA-2G-AAGT-01	13	37	103	0.28664707969361763	TCGA-2G-AAGT-01	12	7	6	25	PASS	9749	TCGA-2G-AAGT	TGCT	30	MALE	WHITE	IS	Stage IS	Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature)	NA	2002	NA	-10967	Alive	TUMOR FREE	4406	NA	NA	Locoregional Recurrence	Retroperitoneal lymph nodes	NA	15	Complete Remission/Response	NA	NA	0	4406	0	4406	1	15	1	15	
30	TCGA-2G-AAGV	0	1	0	0	0	0	0	0	0	6	0	0	0	1	0	0	TCGA-2G-AAGV-01	62	0.8685712402075867	18	TCGA-2G-AAGV-01	20	25	39	0.21929333209436147	TCGA-2G-AAGV-01	3	1	0	4	PASS	9750	TCGA-2G-AAGV	TGCT	23	MALE	WHITE	[Discrepancy]	Stage IIA	Non-Seminoma; Teratoma (Mature)	NA	2002	NA	-8612	Alive	TUMOR FREE	4527	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4527	0	4527	0	4527	0	4527	
40	TCGA-2G-AAGW	0	1	0	2	1	0	2	0	2	17	1	1	0	7	0	0	TCGA-2G-AAGW-01	193	0.7934401749342629	108	TCGA-2G-AAGW-01	17	36	94	0.3221149577248532	TCGA-2G-AAGW-01	13	12	6	31	PASS	9751	TCGA-2G-AAGW	TGCT	38	MALE	WHITE	IS	Stage IS	Non-Seminoma; Yolk Sac Tumor	NA	2001	NA	-14197	Alive	TUMOR FREE	4899	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4899	0	4899	0	4899	0	4899	
30	TCGA-2G-AAGX	1	1	0	0	1	0	1	0	1	6	0	0	0	1	0	0	TCGA-2G-AAGX-01	67	0.3219790865313841	14	TCGA-2G-AAGX-01	14	28	18	0.08892040893622727	TCGA-2G-AAGX-01	6	6	2	14	PASS	9752	TCGA-2G-AAGX	TGCT	22	MALE	WHITE	Stage IA	Stage IA	Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor	NA	2000	NA	-8326	Alive	TUMOR FREE	5514	NA	NA	New Primary Tumor	Testes	NA	4323	Complete Remission/Response	NA	NA	0	5514	0	5514	1	4323	1	4323	
30	TCGA-2G-AAGY	2	3	0	5	0	0	1	1	1	12	0	0	0	6	1	0	TCGA-2G-AAGY-01	137	0.6226314547845044	66	TCGA-2G-AAGY-05	17	31	33	0.10121478423648472	TCGA-2G-AAGY-05	12	10	3	25	mutation call filter	9753	TCGA-2G-AAGY	TGCT	28	MALE	WHITE	IS	Stage IS	Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma	NA	2000	NA	-10338	Alive	TUMOR FREE	5329	NA	NA	New Primary Tumor	Testes	NA	623	Complete Remission/Response	NA	NA	0	5329	0	5329	1	623	1	623	
30	TCGA-2G-AAGZ	1	3	0	1	0	0	2	0	1	8	0	0	1	6	0	0	TCGA-2G-AAGZ-01	68	0.08095049936749936	25	TCGA-2G-AAGZ-01	23	36	26	0.0948617084116439	TCGA-2G-AAGZ-01	9	8	3	20	PASS	9754	TCGA-2G-AAGZ	TGCT	27	MALE	WHITE	Stage IIIA	Stage IIIA	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Choriocarcinoma|Non-Seminoma; Yolk Sac Tumor|Seminoma; NOS	NA	2000	NA	-10157	Alive	TUMOR FREE	5233	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	5233	0	5233	NA	NA	0	5233	
30	TCGA-2G-AAH0	0	0	1	1	0	0	0	0	0	8	0	1	0	4	0	0	TCGA-2G-AAH0-01	106	0.4302165318759089	46	TCGA-2G-AAH0-01	19	28	26	0.09038240501559687	TCGA-2G-AAH0-01	10	8	2	20	PASS	9755	TCGA-2G-AAH0	TGCT	30	MALE	WHITE	IS	Stage IS	Seminoma; NOS|Non-Seminoma; Embryonal Carcinoma	NA	1999	NA	-11123	Alive	TUMOR FREE	5477	NA	NA	Locoregional Recurrence	Retroperitoneal lymph nodes	NA	107	Complete Remission/Response	NA	NA	0	5477	0	5477	1	107	1	107	
30	TCGA-2G-AAH2	0	0	0	1	1	0	0	0	1	6	0	0	0	2	1	0	TCGA-2G-AAH2-01	80	0.8496871942312995	29	TCGA-2G-AAH2-01	19	33	43	0.20305925278021408	TCGA-2G-AAH2-01	4	3	2	9	PASS	9756	TCGA-2G-AAH2	TGCT	20	MALE	WHITE	IS	Stage IS	Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Seminoma; NOS	NA	1998	NA	-7635	Alive	TUMOR FREE	6060	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	6060	0	6060	0	6060	0	6060	
30	TCGA-2G-AAH3	1	3	0	2	0	0	0	0	2	24	3	0	1	6	0	0	TCGA-2G-AAH3-01	75	0.8264933640252069	28	TCGA-2G-AAH3-01	19	29	33	0.13228449378179438	TCGA-2G-AAH3-01	3	2	1	6	PASS	9757	TCGA-2G-AAH3	TGCT	20	MALE	WHITE	Stage I	Stage I	Seminoma; NOS|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor	NA	1997	NA	-7474	Alive	TUMOR FREE	1822	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1822	0	1822	0	1822	0	1822	
30	TCGA-2G-AAH4	0	3	1	1	0	0	0	0	2	10	1	0	0	6	0	0	TCGA-2G-AAH4-01	131	0.723486346793816	67	TCGA-2G-AAH4-01	16	35	38	0.11306747479833555	TCGA-2G-AAH4-01	10	7	2	19	PASS	9758	TCGA-2G-AAH4	TGCT	34	MALE	WHITE	Stage II	Stage II	Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature)|Seminoma; NOS	NA	1997	NA	-12481	Alive	TUMOR FREE	6210	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	6210	0	6210	NA	NA	0	6210	
50	TCGA-2G-AAH8	0	2	0	1	0	0	0	0	0	21	1	0	0	2	0	0	TCGA-2G-AAH8-01	138	0.62803241074393	76	TCGA-2G-AAH8-01	18	23	38	0.12101965104989812	TCGA-2G-AAH8-01	7	15	1	23	PASS	9759	TCGA-2G-AAH8	TGCT	45	MALE	WHITE	Stage IIIC	Stage IIIC	Seminoma; NOS	NA	2008	NA	-16687	Alive	TUMOR FREE	2248	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	2248	0	2248	NA	NA	0	2248	
50	TCGA-2G-AAHA	0	2	0	1	0	0	2	0	1	13	0	0	0	2	2	0	TCGA-2G-AAHA-01	78	0.9109125018068008	32	TCGA-2G-AAHA-01	25	21	15	0.0494059827073172	TCGA-2G-AAHA-01	2	0	1	3	PASS	9760	TCGA-2G-AAHA	TGCT	48	MALE	WHITE	Stage IB	Stage IIA	Seminoma; NOS	NA	2005	NA	-17658	Alive	TUMOR FREE	3349	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	3349	0	3349	NA	NA	0	3349	
30	TCGA-2G-AAHC	0	1	1	0	0	0	0	0	1	9	1	0	0	4	0	0	TCGA-2G-AAHC-01	73	0.4947334348754559	28	TCGA-2G-AAHC-01	18	38	23	0.09610761109160997	TCGA-2G-AAHC-01	7	7	3	17	PASS	9761	TCGA-2G-AAHC	TGCT	33	MALE	WHITE	IS	Stage IIA	Seminoma; NOS	NA	1999	NA	-12105	Alive	TUMOR FREE	5539	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	5539	0	5539	0	5539	0	5539	
30	TCGA-2G-AAHG	0	0	1	2	0	0	0	0	0	8	0	0	0	3	0	1	TCGA-2G-AAHG-01	92	0.9267142071427356	41	TCGA-2G-AAHG-01	19	28	48	0.23796909965059154	TCGA-2G-AAHG-01	5	4	1	10	PASS	9762	TCGA-2G-AAHG	TGCT	25	MALE	WHITE	Stage I	Stage I	Seminoma; NOS	NA	1992	NA	-9476	Alive	TUMOR FREE	1819	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1819	0	1819	0	1819	0	1819	
30	TCGA-2G-AAHL	0	2	0	1	0	0	0	0	1	13	1	0	1	3	0	0	TCGA-2G-AAHL-01	79	0.4985648518072143	32	TCGA-2G-AAHL-01	20	33	41	0.15557746304274436	TCGA-2G-AAHL-01	5	2	3	10	PASS	9763	TCGA-2G-AAHL	TGCT	26	MALE	WHITE	Stage I	Stage I	Seminoma; NOS	NA	1994	NA	-9749	Alive	TUMOR FREE	7081	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	7081	0	7081	0	7081	0	7081	
30	TCGA-2G-AAHN	0	0	0	1	2	0	1	0	0	11	3	0	0	3	0	0	TCGA-2G-AAHN-01	47	0.3675477810648928	10	TCGA-2G-AAHN-01	19	27	31	0.13450721888792275	TCGA-2G-AAHN-01	5	3	0	8	PASS	9764	TCGA-2G-AAHN	TGCT	32	MALE	WHITE	Stage I	Stage I	Seminoma; NOS	NA	1996	NA	-12028	Alive	TUMOR FREE	6445	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	6445	0	6445	0	6445	0	6445	
30	TCGA-2G-AAHP	0	5	0	0	0	0	1	0	2	26	0	0	1	3	0	0	TCGA-2G-AAHP-01	82	0.9001025430094844	27	TCGA-2G-AAHP-05	17	26	36	0.13751231031659406	TCGA-2G-AAHP-05	9	7	5	21	mutation call filter	9765	TCGA-2G-AAHP	TGCT	31	MALE	WHITE	IS	Stage IS	Seminoma; NOS	NA	1999	NA	-11649	Alive	TUMOR FREE	5667	NA	NA	New Primary Tumor	Testes	NA	816	Complete Remission/Response	NA	NA	0	5667	0	5667	1	816	1	816	
30	TCGA-2G-AAHT	0	1	0	0	1	0	1	0	1	11	0	0	0	5	0	0	TCGA-2G-AAHT-01	79	0.6342990112621479	30	TCGA-2G-AAHT-01	18	34	57	0.18214116516412285	TCGA-2G-AAHT-01	10	10	2	22	PASS	9766	TCGA-2G-AAHT	TGCT	32	MALE	WHITE	IS	Stage IS	Seminoma; NOS	NA	2013	NA	-11905	Alive	TUMOR FREE	542	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	542	0	542	0	542	0	542	
20	TCGA-2G-AAKD	0	1	0	2	1	0	0	0	0	9	1	0	0	6	0	0	TCGA-2G-AAKD-01	109	0.5185219687432151	50	TCGA-2G-AAKD-01	18	36	34	0.17281266185614574	TCGA-2G-AAKD-01	10	10	2	22	PASS	9767	TCGA-2G-AAKD	TGCT	18	MALE	WHITE	Stage III	Stage III	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor	NA	1997	NA	-6814	Alive	TUMOR FREE	6340	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	6340	0	6340	NA	NA	0	6340	
30	TCGA-2G-AAKG	0	5	1	1	4	2	1	0	2	34	1	0	0	14	3	0	TCGA-2G-AAKG-01	60	0.6619177448571663	20	TCGA-2G-AAKG-05	22	33	41	0.15119329290013067	TCGA-2G-AAKG-05	8	9	1	18	mutation call filter	9768	TCGA-2G-AAKG	TGCT	22	MALE	WHITE	Stage I	Stage I	Non-Seminoma; Embryonal Carcinoma	NA	1996	NA	-8353	Alive	TUMOR FREE	6598	NA	NA	Locoregional Recurrence	Retroperitoneal lymph nodes	NA	122	Complete Remission/Response	NA	NA	0	6598	0	6598	1	122	1	122	
20	TCGA-2G-AAKH	1	2	0	2	1	0	0	0	1	44	1	0	1	13	1	0	TCGA-2G-AAKH-01	105	0.5006001476295218	47	TCGA-2G-AAKH-01	17	72	59	0.2260076008484863	TCGA-2G-AAKH-01	20	12	5	37	PASS	9769	TCGA-2G-AAKH	TGCT	19	MALE	WHITE	Stage II	Stage II	Non-Seminoma; Embryonal Carcinoma|Seminoma; NOS	NA	1996	NA	-6954	Alive	TUMOR FREE	6862	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	6862	0	6862	0	6862	0	6862	
30	TCGA-2G-AAKL	0	3	0	3	1	0	1	0	0	20	0	0	0	0	1	0	TCGA-2G-AAKL-01	206	0.8538988844973727	120	TCGA-2G-AAKL-01	24	32	135	0.3857840329711647	TCGA-2G-AAKL-01	10	5	1	16	PASS	9770	TCGA-2G-AAKL	TGCT	26	MALE	WHITE	Stage II	Stage II	Non-Seminoma; Embryonal Carcinoma	NA	1995	NA	-9813	Alive	TUMOR FREE	7023	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	7023	0	7023	NA	NA	0	7023	
20	TCGA-2G-AAKM	0	1	0	2	1	0	0	0	1	3	0	0	0	2	0	0	TCGA-2G-AAKM-01	129	0.8212075740788349	63	TCGA-2G-AAKM-01	20	33	84	0.29890234191753234	TCGA-2G-AAKM-01	8	3	4	15	PASS	9771	TCGA-2G-AAKM	TGCT	14	MALE	WHITE	Stage II	Stage IIA	Non-Seminoma; Teratoma (Mature)|NA|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor	NA	1995	NA	-5321	Dead	TUMOR FREE	NA	6972	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	6972	0	6972	0	6972	0	6972	
30	TCGA-2G-AAL5	1	3	0	2	3	0	1	0	0	17	1	0	1	6	1	0	TCGA-2G-AAL5-01	84	0.9476280215932804	39	TCGA-2G-AAL5-01	19	37	39	0.12163711306801762	TCGA-2G-AAL5-01	5	3	3	11	PASS	9772	TCGA-2G-AAL5	TGCT	31	MALE	WHITE	Stage I	Stage I	Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Seminoma; NOS	NA	1994	NA	-11478	Alive	TUMOR FREE	7437	NA	NA	New Primary Tumor	Testes	NA	3723	Complete Remission/Response	NA	NA	0	7437	0	7437	1	3723	1	3723	
30	TCGA-2G-AAL7	0	2	1	0	0	0	0	0	3	15	0	0	1	6	1	0	TCGA-2G-AAL7-01	48	0.514876631601298	11	TCGA-2G-AAL7-01	22	30	9	0.060463404672399614	TCGA-2G-AAL7-01	2	1	0	3	PASS	9773	TCGA-2G-AAL7	TGCT	32	MALE	WHITE	IS	Stage IS	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor	NA	2003	NA	-11917	Alive	TUMOR FREE	3991	NA	NA	Locoregional Recurrence	Retroperitoneal lymph nodes	NA	2	Complete Remission/Response	NA	NA	0	3991	0	3991	1	2	1	2	
40	TCGA-2G-AALP	2	4	0	3	2	0	0	0	1	31	4	0	0	14	0	0	TCGA-2G-AALP-01	178	0.9998561654458298	104	TCGA-2G-AALP-01	25	33	59	0.15601432586837566	TCGA-2G-AALP-01	8	5	1	14	PASS	9774	TCGA-2G-AALP	TGCT	43	MALE	WHITE	Stage IIIB	Stage IIIB	Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)	NA	2007	NA	-15977	Alive	TUMOR FREE	2645	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	2645	0	2645	NA	NA	0	2645	
50	TCGA-2X-A9D5	0	0	0	2	0	0	0	0	1	8	1	0	0	6	0	1	TCGA-2X-A9D5-01	86	0.49376168793006	37	TCGA-2X-A9D5-01	19	30	32	0.118856607300594	TCGA-2X-A9D5-01	9	2	4	15	PASS	9775	TCGA-2X-A9D5	TGCT	49	MALE	WHITE	Stage I	Stage II	Seminoma; NOS	NA	2013	NA	-17969	Alive	TUMOR FREE	435	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	435	0	435	0	435	0	435	
40	TCGA-2X-A9D6	1	1	0	0	1	0	0	1	0	10	0	0	1	1	0	0	TCGA-2X-A9D6-01	65	0.3191258073833259	18	TCGA-2X-A9D6-01	13	23	28	0.11379474099667515	TCGA-2X-A9D6-01	2	2	2	6	PASS	9776	TCGA-2X-A9D6	TGCT	42	MALE	WHITE	Stage I	NA	Seminoma; NOS	NA	2013	NA	-15371	Alive	WITH TUMOR	607	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	607	0	607	0	607	0	607	
30	TCGA-4K-AA1G	0	2	0	1	0	0	0	0	0	10	2	0	0	4	0	0	TCGA-4K-AA1G-01	108	0.7099176795553774	49	TCGA-4K-AA1G-01	13	28	43	0.1263347362697892	TCGA-4K-AA1G-01	8	9	3	20	PASS	9777	TCGA-4K-AA1G	TGCT	34	MALE	WHITE	IS	Stage IS	Seminoma; NOS	NA	2013	NA	-12696	Alive	TUMOR FREE	436	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	436	0	436	0	436	0	436	
30	TCGA-4K-AA1H	0	0	0	0	0	0	0	0	1	4	0	0	1	3	0	0	TCGA-4K-AA1H-01	49	0.0005732989515834661	9	TCGA-4K-AA1H-01	4	3	29	0.11169753519541284	TCGA-4K-AA1H-01	2	0	4	6	PASS	9778	TCGA-4K-AA1H	TGCT	26	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2013	NA	-9658	Alive	TUMOR FREE	518	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	518	0	518	0	518	0	518	
30	TCGA-4K-AA1I	0	2	0	2	0	0	0	0	0	6	0	0	0	5	0	0	TCGA-4K-AA1I-01	66	0.3107636877379653	26	TCGA-4K-AA1I-01	17	32	27	0.04203953529704686	TCGA-4K-AA1I-01	10	6	3	19	PASS	9779	TCGA-4K-AA1I	TGCT	26	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2013	NA	-9679	Alive	TUMOR FREE	3	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3	0	3	NA	NA	0	3	
30	TCGA-4K-AAAL	0	1	0	2	0	0	1	0	0	10	0	1	0	8	0	0	TCGA-4K-AAAL-01	68	0.4847768757141635	20	TCGA-4K-AAAL-01	27	64	17	0.048553620859662194	TCGA-4K-AAAL-01	6	6	0	12	PASS	9780	TCGA-4K-AAAL	TGCT	31	MALE	WHITE	IS	Stage IS	Seminoma; NOS	NA	2013	NA	-11622	Alive	TUMOR FREE	483	NA	NA	Locoregional Recurrence	Lymph Node(s)	NA	147	No Measureable Tumor or Tumor Markers	NA	NA	0	483	0	483	1	147	1	147	
40	TCGA-S6-A8JW	0	1	0	0	1	0	1	0	0	5	1	0	0	2	0	0	TCGA-S6-A8JW-01	116	0.5318033521654976	58	TCGA-S6-A8JW-01	21	23	12	0.0371165069649536	TCGA-S6-A8JW-01	2	0	0	2	PASS	9781	TCGA-S6-A8JW	TGCT	37	MALE	WHITE	IS	Stage IS	Seminoma; NOS	NA	2013	NA	-13861	Alive	TUMOR FREE	698	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	698	0	698	0	698	0	698	
30	TCGA-S6-A8JX	0	1	0	0	0	0	0	0	1	5	0	0	0	2	0	0	TCGA-S6-A8JX-01	82	0.5512379706531794	32	TCGA-S6-A8JX-01	19	24	18	0.037243754511241726	TCGA-S6-A8JX-01	7	8	2	17	PASS	9782	TCGA-S6-A8JX	TGCT	27	MALE	WHITE	Stage IB	Stage IB	Seminoma; NOS	NA	2013	NA	-9963	Alive	TUMOR FREE	552	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	552	0	552	0	552	0	552	
30	TCGA-S6-A8JY	0	1	0	0	1	0	0	0	1	12	0	0	0	2	1	0	TCGA-S6-A8JY-01	128	0.5547617780757608	68	TCGA-S6-A8JY-01	19	27	62	0.2509049077071983	TCGA-S6-A8JY-01	10	6	2	18	PASS	9783	TCGA-S6-A8JY	TGCT	27	MALE	WHITE	IS	Stage IS	Seminoma; NOS	NA	2013	NA	-10219	Alive	TUMOR FREE	278	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	278	0	278	NA	NA	0	278	
30	TCGA-SB-A6J6	0	1	0	2	1	0	0	0	0	14	2	0	0	4	1	0	TCGA-SB-A6J6-01	102	0.7242540859807988	44	TCGA-SB-A6J6-01	31	47	69	0.3182182365362488	TCGA-SB-A6J6-01	13	8	2	23	PASS	9784	TCGA-SB-A6J6	TGCT	22	MALE	WHITE	Stage IA	NA	Seminoma; NOS	NA	2013	NA	-8233	Alive	TUMOR FREE	413	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	413	0	413	0	413	0	413	
40	TCGA-SB-A76C	0	0	0	0	2	0	0	0	0	11	0	0	0	2	0	0	TCGA-SB-A76C-01	77	0.4753440027240308	26	TCGA-SB-A76C-01	17	26	46	0.2427416618793172	TCGA-SB-A76C-01	9	9	3	21	PASS	9785	TCGA-SB-A76C	TGCT	38	MALE	WHITE	NA	Stage I	Seminoma; NOS	NA	2013	NA	-14023	Alive	TUMOR FREE	42	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	42	0	42	0	42	0	42	
30	TCGA-SN-A6IS	1	3	0	1	3	0	0	0	0	8	0	0	0	2	1	0	TCGA-SN-A6IS-01	126	0.4094389047972109	68	TCGA-SN-A6IS-01	16	28	56	0.2016914028601236	TCGA-SN-A6IS-01	7	7	1	15	PASS	9786	TCGA-SN-A6IS	TGCT	26	MALE	WHITE	IS	Stage IS	Seminoma; NOS|Non-Seminoma; Teratoma (Mature)	NA	2013	NA	-9618	Alive	TUMOR FREE	496	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	496	0	496	0	496	0	496	
30	TCGA-SN-A84W	0	1	0	1	3	0	0	0	0	9	0	0	1	10	0	0	TCGA-SN-A84W-01	117	0.9476295262056704	57	TCGA-SN-A84W-01	16	33	25	0.07969874690580785	TCGA-SN-A84W-01	6	3	0	9	PASS	9787	TCGA-SN-A84W	TGCT	30	MALE	WHITE	IS	NA	Seminoma; NOS|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor	NA	2013	NA	-11251	Alive	TUMOR FREE	293	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	293	0	293	0	293	0	293	
30	TCGA-SN-A84X	0	1	0	0	0	0	1	0	2	17	0	0	0	5	0	0	TCGA-SN-A84X-01	161	0.945993882539075	78	TCGA-SN-A84X-01	23	25	52	0.09637829547273688	TCGA-SN-A84X-01	9	5	4	18	PASS	9788	TCGA-SN-A84X	TGCT	21	MALE	WHITE	IS	Stage IB	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Seminoma; NOS	NA	2013	NA	-7833	Alive	TUMOR FREE	312	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	312	0	312	0	312	0	312	
20	TCGA-SN-A84Y	1	2	0	2	2	0	0	0	1	7	0	0	1	5	0	0	TCGA-SN-A84Y-01	157	0.9420720053573906	84	TCGA-SN-A84Y-01	23	29	82	0.3206366170828509	TCGA-SN-A84Y-01	7	3	5	15	PASS	9789	TCGA-SN-A84Y	TGCT	18	MALE	WHITE	IS	Stage IS	Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma	NA	2013	NA	-6805	Alive	WITH TUMOR	524	NA	NA	Distant Metastasis	"Other, specify"	bone	44	Progressive Disease	NA	NA	0	524	0	524	NA	NA	1	44	
30	TCGA-SO-A8JP	0	0	0	2	0	0	1	0	2	17	0	1	0	5	1	0	TCGA-SO-A8JP-01	151	0.7832665590967572	78	TCGA-SO-A8JP-01	20	54	36	0.09622789883222498	TCGA-SO-A8JP-01	14	14	1	29	PASS	9790	TCGA-SO-A8JP	TGCT	29	MALE	WHITE	Stage I	NA	Seminoma; NOS	NA	2013	NA	-10765	Alive	TUMOR FREE	540	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	540	0	540	0	540	0	540	
20	TCGA-VF-A8A8	0	6	0	3	1	0	1	0	3	28	3	1	0	10	0	0	TCGA-VF-A8A8-01	217	0.9073110313213908	135	TCGA-VF-A8A8-01	13	33	105	0.2416946578396721	TCGA-VF-A8A8-01	6	3	10	19	PASS	9791	TCGA-VF-A8A8	TGCT	18	MALE	WHITE	Stage IA	Stage IA	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature)	NA	2011	NA	-6822	Alive	TUMOR FREE	1131	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1131	0	1131	0	1131	0	1131	
30	TCGA-VF-A8A9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-VF-A8A9-01	94	0.4725122594085252	39	TCGA-VF-A8A9-01	18	24	42	0.10720207746567548	TCGA-VF-A8A9-01	6	5	2	13	PASS	9792	TCGA-VF-A8A9	TGCT	31	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2011	NA	-11520	Alive	TUMOR FREE	1119	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1119	0	1119	0	1119	0	1119	
50	TCGA-VF-A8AA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-VF-A8AA-01	48	0.23132574338100864	7	TCGA-VF-A8AA-01	27	22	13	0.06646662887433277	TCGA-VF-A8AA-01	3	2	0	5	PASS	9793	TCGA-VF-A8AA	TGCT	51	MALE	WHITE	Stage I	Stage I	Seminoma; NOS	NA	2011	NA	-18940	Alive	TUMOR FREE	1146	NA	NA	Locoregional Recurrence	Lymph Node(s)	NA	1059	Complete Remission/Response	NA	NA	0	1146	0	1146	1	1059	1	1059	
30	TCGA-VF-A8AB	1	0	0	1	0	0	1	0	0	11	0	0	0	3	1	0	TCGA-VF-A8AB-01	150	0.4135618782355617	86	TCGA-VF-A8AB-01	16	28	40	0.15892607806105713	TCGA-VF-A8AB-01	5	2	1	8	PASS	9794	TCGA-VF-A8AB	TGCT	31	MALE	BLACK OR AFRICAN AMERICAN	Stage IA	Stage IA	Seminoma; NOS	NA	2011	NA	-11659	Alive	TUMOR FREE	760	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	760	0	760	NA	NA	0	760	
30	TCGA-VF-A8AC	0	1	0	1	0	0	1	0	1	9	1	0	0	1	1	0	TCGA-VF-A8AC-01	62	0.5258973998722059	20	TCGA-VF-A8AC-01	23	20	16	0.07390333590280393	TCGA-VF-A8AC-01	2	0	1	3	PASS	9795	TCGA-VF-A8AC	TGCT	29	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2011	NA	-10598	Alive	TUMOR FREE	1083	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1083	0	1083	0	1083	0	1083	
40	TCGA-VF-A8AD	0	1	0	6	0	0	0	0	1	5	3	1	1	6	1	0	TCGA-VF-A8AD-01	113	0.5588690357486836	52	TCGA-VF-A8AD-01	20	32	33	0.1445050586624374	TCGA-VF-A8AD-01	11	13	4	28	PASS	9796	TCGA-VF-A8AD	TGCT	36	MALE	WHITE	Stage IB	Stage IB	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor	NA	2011	NA	-13499	Alive	WITH TUMOR	1006	NA	NA	Locoregional Recurrence	Testes	NA	276	Complete Remission/Response	NA	NA	0	1006	0	1006	1	276	1	276	
40	TCGA-VF-A8AE	0	2	0	3	0	0	0	0	2	9	1	0	0	3	0	0	TCGA-VF-A8AE-01	50	0.4031599248685511	11	TCGA-VF-A8AE-01	19	56	31	0.14482733604023168	TCGA-VF-A8AE-01	15	15	1	31	PASS	9797	TCGA-VF-A8AE	TGCT	39	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2012	NA	-14535	Alive	TUMOR FREE	727	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	727	0	727	0	727	0	727	
30	TCGA-W4-A7U2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-W4-A7U2-01	112	0.6311094461242395	48	TCGA-W4-A7U2-01	20	34	69	0.18533522736242491	TCGA-W4-A7U2-01	11	6	3	20	PASS	9798	TCGA-W4-A7U2	TGCT	26	MALE	WHITE	NA	Stage IA	Seminoma; NOS|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Embryonal Carcinoma	NA	2010	NA	-9573	Alive	TUMOR FREE	1263	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1263	0	1263	0	1263	0	1263	
30	TCGA-W4-A7U3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-W4-A7U3-01	69	0.4733649921980941	24	TCGA-W4-A7U3-01	12	28	14	0.0285309185755865	TCGA-W4-A7U3-01	4	1	0	5	PASS	9799	TCGA-W4-A7U3	TGCT	26	MALE	WHITE	NA	Stage IS	Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Choriocarcinoma	NA	2010	NA	-9581	Alive	TUMOR FREE	149	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	149	0	149	0	149	0	149	
30	TCGA-W4-A7U4	0	2	0	1	1	0	0	0	1	1	1	0	0	2	0	0	TCGA-W4-A7U4-01	95	0.591363673050335	41	TCGA-W4-A7U4-01	16	26	51	0.07792549108937845	TCGA-W4-A7U4-01	7	3	2	12	PASS	9800	TCGA-W4-A7U4	TGCT	23	MALE	WHITE	NA	Stage I	Non-Seminoma; Embryonal Carcinoma|NA	NA	2011	NA	-8518	Alive	TUMOR FREE	738	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	738	0	738	0	738	0	738	
30	TCGA-WZ-A7V3	0	3	0	0	2	0	0	1	1	10	2	0	0	6	0	0	TCGA-WZ-A7V3-01	96	0.5131393405337489	36	TCGA-WZ-A7V3-01	20	35	68	0.2551227361387566	TCGA-WZ-A7V3-01	7	3	3	13	PASS	9801	TCGA-WZ-A7V3	TGCT	20	MALE	WHITE	Stage I	NA	Seminoma; NOS	NA	2012	NA	-7325	Alive	TUMOR FREE	753	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	753	0	753	0	753	0	753	
30	TCGA-WZ-A7V4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-WZ-A7V4-01	54	0.4637731029025421	13	TCGA-WZ-A7V4-01	22	31	35	0.18002813979377014	TCGA-WZ-A7V4-01	6	4	4	14	PASS	9802	TCGA-WZ-A7V4	TGCT	28	MALE	WHITE	Stage I	NA	Seminoma; NOS	NA	2012	NA	-10262	Alive	TUMOR FREE	894	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	894	0	894	0	894	0	894	
30	TCGA-WZ-A7V5	0	4	0	1	1	0	0	0	2	33	2	0	0	5	2	0	TCGA-WZ-A7V5-01	119	0.5994211650701321	57	TCGA-WZ-A7V5-01	19	36	36	0.18191903644510785	TCGA-WZ-A7V5-01	12	17	5	34	PASS	9803	TCGA-WZ-A7V5	TGCT	27	MALE	WHITE	Stage I	NA	Seminoma; NOS	NA	2012	NA	-9886	Alive	TUMOR FREE	1061	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	1061	0	1061	0	1061	0	1061	
40	TCGA-WZ-A8D5	1	1	0	1	1	0	0	0	0	4	2	0	2	2	1	0	TCGA-WZ-A8D5-01	70	0.6014440725256167	24	TCGA-WZ-A8D5-01	20	56	17	0.06490760661735967	TCGA-WZ-A8D5-01	10	3	1	14	PASS	9804	TCGA-WZ-A8D5	TGCT	38	MALE	WHITE	[Discrepancy]	NA	Seminoma; NOS	NA	2012	NA	-13974	Alive	TUMOR FREE	774	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	774	0	774	0	774	0	774	
30	TCGA-X3-A8G4	0	2	0	2	1	0	0	0	0	20	4	0	0	10	1	0	TCGA-X3-A8G4-01	104	0.6244973754463933	45	TCGA-X3-A8G4-01	27	61	55	0.1350946599346937	TCGA-X3-A8G4-01	14	12	4	30	PASS	9805	TCGA-X3-A8G4	TGCT	33	MALE	WHITE	IS	NA	Seminoma; NOS|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Immature)	NA	2011	NA	-12117	Alive	TUMOR FREE	856	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	856	0	856	NA	NA	0	856	
30	TCGA-XE-A8H1	0	2	0	2	0	0	0	0	0	6	0	0	0	2	0	0	TCGA-XE-A8H1-01	107	0.6997300664899465	55	TCGA-XE-A8H1-01	20	37	25	0.0619383343424603	TCGA-XE-A8H1-01	6	8	1	15	PASS	9806	TCGA-XE-A8H1	TGCT	24	MALE	WHITE	IS	Stage IS	Non-Seminoma; Embryonal Carcinoma	NA	2009	NA	-8893	Alive	TUMOR FREE	209	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	209	0	209	0	209	0	209	
30	TCGA-XE-A8H4	0	0	0	0	0	0	0	0	1	9	0	0	0	4	0	0	TCGA-XE-A8H4-01	84	0.4921768791134653	33	TCGA-XE-A8H4-01	18	28	39	0.09603675084441167	TCGA-XE-A8H4-01	6	9	3	18	PASS	9807	TCGA-XE-A8H4	TGCT	23	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2008	NA	-8728	Alive	TUMOR FREE	559	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	559	0	559	0	559	0	559	
30	TCGA-XE-A8H5	0	1	0	1	0	0	1	0	0	24	3	0	0	8	0	0	TCGA-XE-A8H5-01	136	0.6115655055049377	73	TCGA-XE-A8H5-01	22	28	42	0.16505616417339364	TCGA-XE-A8H5-01	8	14	4	26	PASS	9808	TCGA-XE-A8H5	TGCT	29	MALE	[Unknown]	IS	Stage IS	Seminoma; NOS	NA	2008	NA	-10942	Alive	TUMOR FREE	1217	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	1217	0	1217	0	1217	0	1217	
40	TCGA-XE-A9SE	0	3	0	1	3	1	0	0	0	11	1	0	1	2	1	0	TCGA-XE-A9SE-01	110	0.6328819773088914	61	TCGA-XE-A9SE-01	24	26	27	0.057920225012464376	TCGA-XE-A9SE-01	5	8	0	13	PASS	9809	TCGA-XE-A9SE	TGCT	35	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2008	NA	-12850	Alive	TUMOR FREE	708	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	708	0	708	0	708	0	708	
40	TCGA-XE-AANI	0	2	0	1	2	1	1	0	0	14	3	0	0	11	1	0	TCGA-XE-AANI-01	136	0.5287673722078495	62	TCGA-XE-AANI-01	14	32	46	0.16828470776662394	TCGA-XE-AANI-01	12	8	3	23	PASS	9810	TCGA-XE-AANI	TGCT	37	MALE	WHITE	IS	Stage IS	Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma	NA	2007	NA	-13553	Alive	TUMOR FREE	1041	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	1041	0	1041	0	1041	0	1041	
40	TCGA-XE-AANJ	0	0	0	0	0	0	0	0	2	9	2	0	1	7	0	0	TCGA-XE-AANJ-01	146	0.5891701083337996	79	TCGA-XE-AANJ-01	19	38	60	0.1850879226733312	TCGA-XE-AANJ-01	12	12	4	28	PASS	9811	TCGA-XE-AANJ	TGCT	39	MALE	WHITE	IS	Stage IIIB	Seminoma; NOS	NA	2007	NA	-14314	Alive	TUMOR FREE	2007	NA	NA	Locoregional Recurrence	Lymph Node(s)	NA	328	"Normalization of Tumor Markers, but Residual Tumor Mass"	NA	NA	0	2007	0	2007	NA	NA	1	328	
30	TCGA-XE-AANR	0	1	0	3	0	0	0	0	0	12	0	0	0	3	0	0	TCGA-XE-AANR-01	64	0.4113516144987696	21	TCGA-XE-AANR-01	17	28	28	0.1311394422952134	TCGA-XE-AANR-01	2	2	1	5	PASS	9812	TCGA-XE-AANR	TGCT	23	MALE	WHITE	Stage I	Stage I	Seminoma; NOS	NA	2008	NA	-8761	Alive	TUMOR FREE	14	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	14	0	14	NA	NA	0	14	
50	TCGA-XE-AANV	0	2	0	0	1	0	0	0	0	9	1	0	0	3	0	0	TCGA-XE-AANV-01	44	0.3771134378896009	8	TCGA-XE-AANV-01	16	23	8	0.04879364312364928	TCGA-XE-AANV-01	2	1	2	5	PASS	9813	TCGA-XE-AANV	TGCT	52	MALE	[Unknown]	Stage IB	Stage IB	Seminoma; NOS	NA	2010	NA	-19112	Alive	TUMOR FREE	1701	NA	NA	Locoregional Recurrence	Lymph Node(s)	NA	1370	No Measureable Tumor or Tumor Markers	NA	NA	0	1701	0	1701	1	1370	1	1370	
30	TCGA-XE-AAO3	1	1	0	0	1	0	1	0	1	9	0	0	1	3	0	0	TCGA-XE-AAO3-01	101	0.5167650850693194	46	TCGA-XE-AAO3-01	19	26	17	0.05196993529168772	TCGA-XE-AAO3-01	4	6	1	11	PASS	9814	TCGA-XE-AAO3	TGCT	33	MALE	ASIAN	Stage I	Stage I	Seminoma; NOS	NA	2006	NA	-12095	Alive	TUMOR FREE	2857	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	2857	0	2857	NA	NA	0	2857	
40	TCGA-XE-AAO4	1	5	1	0	1	0	0	0	2	31	1	0	1	5	0	0	TCGA-XE-AAO4-01	87	0.5995107633152622	39	TCGA-XE-AAO4-01	21	22	32	0.13772793546028306	TCGA-XE-AAO4-01	4	4	4	12	PASS	9815	TCGA-XE-AAO4	TGCT	40	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2006	NA	-14930	Alive	TUMOR FREE	367	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	367	0	367	0	367	0	367	
50	TCGA-XE-AAO6	0	1	0	2	1	1	1	0	3	12	1	0	0	7	0	0	TCGA-XE-AAO6-01	128	0.6136877680773608	69	TCGA-XE-AAO6-01	20	25	16	0.056427319444449564	TCGA-XE-AAO6-01	8	9	1	18	PASS	9816	TCGA-XE-AAO6	TGCT	47	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2007	NA	-17417	Alive	TUMOR FREE	240	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	240	0	240	0	240	0	240	
30	TCGA-XE-AAOB	0	1	0	0	2	0	0	0	1	10	0	0	0	3	0	0	TCGA-XE-AAOB-01	72	0.3799682419444095	30	TCGA-XE-AAOB-01	16	32	28	0.1399108086165863	TCGA-XE-AAOB-01	3	2	3	8	PASS	9817	TCGA-XE-AAOB	TGCT	27	MALE	WHITE	IS	Stage IS	Non-Seminoma; Choriocarcinoma|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)	NA	2008	NA	-9907	Dead	WITH TUMOR	NA	513	Testicular Germ Cell Tumor (TGCT)	Distant Metastasis	Lymph Node(s)	NA	231	NA	NA	NA	1	513	1	513	NA	NA	1	231	
30	TCGA-XE-AAOC	0	0	0	2	3	0	0	0	0	15	0	0	0	6	1	0	TCGA-XE-AAOC-01	94	0.9470340616199631	40	TCGA-XE-AAOC-01	21	32	81	0.3035927394659545	TCGA-XE-AAOC-01	3	2	2	7	PASS	9818	TCGA-XE-AAOC	TGCT	31	MALE	WHITE	Stage IA	Stage IA	Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Yolk Sac Tumor	NA	2008	NA	-11566	Alive	TUMOR FREE	270	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	270	0	270	0	270	0	270	
40	TCGA-XE-AAOD	0	0	1	0	0	1	0	0	0	5	1	0	0	5	1	0	TCGA-XE-AAOD-01	83	0.1938296489713198	35	TCGA-XE-AAOD-01	17	37	44	0.17284642572631204	TCGA-XE-AAOD-01	10	9	6	25	PASS	9819	TCGA-XE-AAOD	TGCT	39	MALE	WHITE	Stage IB	Stage IB	Seminoma; NOS|Non-Seminoma; Choriocarcinoma	NA	2008	NA	-14265	Alive	TUMOR FREE	2058	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	2058	0	2058	0	2058	0	2058	
50	TCGA-XE-AAOF	0	0	0	1	1	0	0	0	2	18	0	0	0	3	1	0	TCGA-XE-AAOF-01	34	0.3563632260378312	3	TCGA-XE-AAOF-01	16	26	18	0.07000828533379919	TCGA-XE-AAOF-01	2	0	1	3	PASS	9820	TCGA-XE-AAOF	TGCT	50	MALE	ASIAN	Stage IA	Stage IA	Seminoma; NOS	NA	2009	NA	-18490	Alive	TUMOR FREE	1268	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	1268	0	1268	0	1268	0	1268	
30	TCGA-XE-AAOJ	1	1	0	2	1	0	1	0	0	11	2	0	1	6	0	0	TCGA-XE-AAOJ-01	143	0.5447761679509775	77	TCGA-XE-AAOJ-01	15	34	31	0.1005722480432062	TCGA-XE-AAOJ-01	7	8	4	19	PASS	9821	TCGA-XE-AAOJ	TGCT	24	MALE	WHITE	IS	Stage IS	Seminoma; NOS|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)	NA	2009	NA	-9046	Alive	TUMOR FREE	1550	NA	NA	Locoregional Recurrence	"Other, specify"	Mature teratoma: abdominal wall	266	"Normalization of Tumor Markers, but Residual Tumor Mass"	NA	NA	0	1550	0	1550	NA	NA	1	266	
40	TCGA-XE-AAOL	0	3	0	1	0	1	0	0	2	10	0	0	0	4	1	0	TCGA-XE-AAOL-01	203	0.8915209227834006	122	TCGA-XE-AAOL-01	27	46	74	0.21201665747235168	TCGA-XE-AAOL-01	18	12	4	34	PASS	9822	TCGA-XE-AAOL	TGCT	38	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Seminoma; NOS	NA	2008	NA	-14230	Alive	TUMOR FREE	13	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	13	0	13	NA	NA	0	13	
40	TCGA-XY-A89B	0	1	0	0	1	0	1	0	1	23	0	0	1	8	3	0	TCGA-XY-A89B-01	63	0.4948627252948605	14	TCGA-XY-A89B-01	21	31	18	0.052310863100022816	TCGA-XY-A89B-01	3	0	0	3	PASS	9823	TCGA-XY-A89B	TGCT	35	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2013	NA	-12955	Alive	TUMOR FREE	471	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	471	0	471	0	471	0	471	
70	TCGA-XY-A8S2	0	7	0	3	1	0	3	1	0	46	3	0	0	10	3	0	TCGA-XY-A8S2-01	199	0.8682608068190587	114	TCGA-XY-A8S2-01	24	32	53	0.16685920228389214	TCGA-XY-A8S2-01	6	6	1	13	PASS	9824	TCGA-XY-A8S2	TGCT	67	MALE	WHITE	Stage I	Stage I	Non-Seminoma; Embryonal Carcinoma|NA|NA|NA	NA	2012	NA	-24759	Alive	TUMOR FREE	672	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	672	0	672	0	672	0	672	
30	TCGA-XY-A8S3	0	3	0	0	1	0	1	0	1	6	0	0	0	2	0	0	TCGA-XY-A8S3-01	192	0.6436095999589029	109	TCGA-XY-A8S3-01	19	36	85	0.1777998195412163	TCGA-XY-A8S3-01	10	2	7	19	PASS	9825	TCGA-XY-A8S3	TGCT	24	MALE	WHITE	IS	Stage IS	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Choriocarcinoma	NA	2012	NA	-8835	Alive	TUMOR FREE	843	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	843	0	843	0	843	0	843	
40	TCGA-XY-A9T9	0	1	1	0	1	0	0	0	0	8	0	0	0	3	0	0	TCGA-XY-A9T9-01	75	0.4630301313316163	29	TCGA-XY-A9T9-01	21	33	31	0.13340265909188426	TCGA-XY-A9T9-01	5	6	1	12	PASS	9826	TCGA-XY-A9T9	TGCT	37	MALE	WHITE	IS	Stage IS	Seminoma; NOS	NA	2013	NA	-13604	Alive	TUMOR FREE	281	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	281	0	281	0	281	0	281	
30	TCGA-YU-A90P	0	3	0	1	0	0	0	0	0	8	2	0	0	2	0	0	TCGA-YU-A90P-01	154	0.8554678478555386	84	TCGA-YU-A90P-01	19	33	67	0.14934323894568022	TCGA-YU-A90P-01	5	5	1	11	PASS	9827	TCGA-YU-A90P	TGCT	25	MALE	WHITE	Stage IA	Stage IA	Non-Seminoma; Embryonal Carcinoma	NA	2009	NA	-9144	Alive	TUMOR FREE	2069	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	2069	0	2069	0	2069	0	2069	
30	TCGA-YU-A90Q	0	0	0	1	1	0	0	0	0	4	0	0	0	2	1	0	TCGA-YU-A90Q-01	73	0.3763493664740864	27	TCGA-YU-A90Q-01	15	21	16	0.12167691448558375	TCGA-YU-A90Q-01	0	3	1	4	PASS	9828	TCGA-YU-A90Q	TGCT	21	MALE	[Unknown]	Stage IB	Stage IB	Seminoma; NOS	NA	2008	NA	-7846	Alive	TUMOR FREE	1964	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	1964	0	1964	0	1964	0	1964	
30	TCGA-YU-A90S	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-YU-A90S-01	41	1.6344700457585887e-05	11	TCGA-YU-A90S-01	0	0	13	0.00056981871926624	TCGA-YU-A90S-01	1	0	0	1	PASS	9829	TCGA-YU-A90S	TGCT	26	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2009	NA	-9531	Alive	NA	971	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	971	0	971	NA	NA	0	971	
50	TCGA-YU-A90W	0	4	0	3	2	0	0	0	0	14	1	0	1	7	1	0	TCGA-YU-A90W-01	155	0.7814699116471508	78	TCGA-YU-A90W-01	33	43	44	0.15282116020627495	TCGA-YU-A90W-01	14	7	3	24	PASS	9830	TCGA-YU-A90W	TGCT	45	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2011	NA	-16497	Alive	TUMOR FREE	1113	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	1113	0	1113	0	1113	0	1113	
30	TCGA-YU-A90Y	0	0	0	1	0	0	1	0	0	10	3	0	0	3	0	0	TCGA-YU-A90Y-01	120	0.7602009565657613	52	TCGA-YU-A90Y-01	18	36	22	0.08522836617841062	TCGA-YU-A90Y-01	7	11	1	19	PASS	9831	TCGA-YU-A90Y	TGCT	23	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	Stage IIIC	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor	NA	2011	NA	-8460	Dead	WITH TUMOR	NA	17	Testicular Germ Cell Tumor (TGCT)	NA	NA	NA	NA	NA	NA	NA	1	17	1	17	NA	NA	1	17	
30	TCGA-YU-A912	0	2	0	3	0	0	0	0	0	12	0	0	0	2	0	0	TCGA-YU-A912-01	119	0.8226801864241415	63	TCGA-YU-A912-01	20	31	18	0.08766838489355584	TCGA-YU-A912-01	6	4	2	12	PASS	9832	TCGA-YU-A912	TGCT	34	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	Stage IIIC	Seminoma; NOS	NA	2012	NA	-12552	Alive	WITH TUMOR	866	NA	NA	NA	NA	NA	NA	"Normalization of Tumor Markers, but Residual Tumor Mass"	NA	NA	0	866	0	866	NA	NA	0	866	
30	TCGA-YU-A94D	0	4	0	2	2	0	1	0	0	15	2	0	0	4	0	0	TCGA-YU-A94D-01	72	0.17762703293745594	26	TCGA-YU-A94D-01	5	5	10	0.0005168378677628273	TCGA-YU-A94D-01	1	2	0	3	PASS	9833	TCGA-YU-A94D	TGCT	28	MALE	[Unknown]	Stage IIIB	Stage IIIB	Non-Seminoma; Teratoma (Immature)	NA	2009	NA	-10427	Alive	TUMOR FREE	2167	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	2167	0	2167	0	2167	0	2167	
70	TCGA-YU-A94I	0	5	0	2	2	0	1	0	2	34	4	0	2	8	1	0	TCGA-YU-A94I-01	228	0.90370060546107	156	TCGA-YU-A94I-01	20	31	133	0.3324565401695552	TCGA-YU-A94I-01	11	9	4	24	PASS	9834	TCGA-YU-A94I	TGCT	66	MALE	[Unknown]	Stage IA	Stage IA	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor	NA	2013	NA	-24349	Alive	TUMOR FREE	536	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	536	0	536	0	536	0	536	
30	TCGA-YU-AA4L	0	5	0	3	1	1	1	0	0	8	1	0	0	4	0	0	TCGA-YU-AA4L-01	195	0.8337633151139411	122	TCGA-YU-AA4L-01	15	36	45	0.12217738260095674	TCGA-YU-AA4L-01	7	7	3	17	PASS	9835	TCGA-YU-AA4L	TGCT	27	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	Stage IIIC	Non-Seminoma; Embryonal Carcinoma	NA	2010	NA	-9902	Alive	TUMOR FREE	1573	NA	NA	Locoregional Recurrence	Retroperitoneal lymph nodes	NA	105	NA	NA	NA	0	1573	0	1573	NA	NA	1	105	
30	TCGA-YU-AA61	0	1	0	0	0	0	0	0	1	10	0	0	0	2	1	0	TCGA-YU-AA61-01	65	0.4461112640871083	21	TCGA-YU-AA61-01	17	28	9	0.04845674796632167	TCGA-YU-AA61-01	3	2	0	5	PASS	9836	TCGA-YU-AA61	TGCT	29	MALE	WHITE	IS	Stage IS	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Immature)	NA	2011	NA	-10635	Alive	TUMOR FREE	864	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	864	0	864	0	864	0	864	
40	TCGA-ZM-AA05	0	3	0	2	1	0	0	0	3	21	0	0	0	5	0	0	TCGA-ZM-AA05-01	173	0.41335376119354	106	TCGA-ZM-AA05-01	18	22	367	0.12765641789171028	TCGA-ZM-AA05-01	19	15	4	38	PASS	9837	TCGA-ZM-AA05	TGCT	36	MALE	WHITE	Stage IIC	Stage IIC	Seminoma; NOS	NA	2011	NA	-13295	Alive	TUMOR FREE	1126	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1126	0	1126	0	1126	0	1126	
50	TCGA-ZM-AA06	0	0	0	3	1	0	1	0	3	10	2	0	0	6	1	0	TCGA-ZM-AA06-01	138	0.9176953570361496	72	TCGA-ZM-AA06-01	19	34	78	0.1747336525308883	TCGA-ZM-AA06-01	8	10	7	25	PASS	9838	TCGA-ZM-AA06	TGCT	45	MALE	WHITE	Stage IB	Stage IB	Seminoma; NOS	NA	2011	NA	-16719	Alive	TUMOR FREE	1498	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	1498	0	1498	0	1498	0	1498	
30	TCGA-ZM-AA0B	0	3	0	2	1	0	0	0	1	8	0	0	0	7	0	0	TCGA-ZM-AA0B-01	133	0.4765552353660051	66	TCGA-ZM-AA0B-01	17	34	24	0.13340765074029656	TCGA-ZM-AA0B-01	9	11	4	24	PASS	9839	TCGA-ZM-AA0B	TGCT	32	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2012	NA	-11820	Alive	TUMOR FREE	838	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	838	0	838	0	838	0	838	
30	TCGA-ZM-AA0D	0	0	0	1	1	0	0	0	0	5	1	0	0	3	0	0	TCGA-ZM-AA0D-01	89	0.4268851494873826	35	TCGA-ZM-AA0D-01	11	8	94	0.1528243738637919	TCGA-ZM-AA0D-01	10	3	7	20	PASS	9840	TCGA-ZM-AA0D	TGCT	34	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2012	NA	-12738	Alive	TUMOR FREE	848	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	848	0	848	0	848	0	848	
40	TCGA-ZM-AA0E	0	3	0	0	0	0	0	0	0	5	0	0	0	3	0	0	TCGA-ZM-AA0E-01	79	0.4000020779214158	34	TCGA-ZM-AA0E-01	18	32	55	0.2170586089180546	TCGA-ZM-AA0E-01	5	4	4	13	PASS	9841	TCGA-ZM-AA0E	TGCT	39	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2012	NA	-14255	Alive	TUMOR FREE	811	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	811	0	811	0	811	0	811	
40	TCGA-ZM-AA0F	0	0	0	0	1	0	1	0	1	3	0	0	0	2	0	0	TCGA-ZM-AA0F-01	51	0.1275457789838322	17	TCGA-ZM-AA0F-01	10	10	71	0.3299864467728045	TCGA-ZM-AA0F-01	1	2	3	6	PASS	9842	TCGA-ZM-AA0F	TGCT	35	MALE	WHITE	Stage IA	Stage IA	Seminoma; NOS	NA	2013	NA	-12973	Alive	TUMOR FREE	681	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	681	0	681	0	681	0	681	
50	TCGA-ZM-AA0H	0	3	0	3	2	0	0	0	1	25	0	0	2	15	1	0	TCGA-ZM-AA0H-01	57	0.4513970087705176	20	TCGA-ZM-AA0H-01	15	28	15	0.053804706800944034	TCGA-ZM-AA0H-01	7	6	1	14	PASS	9843	TCGA-ZM-AA0H	TGCT	50	MALE	WHITE	IS	Stage IS	Seminoma; NOS	NA	2010	NA	-18419	Alive	TUMOR FREE	1736	NA	NA	NA	NA	NA	NA	No Measureable Tumor or Tumor Markers	NA	NA	0	1736	0	1736	0	1736	0	1736	
40	TCGA-ZM-AA0N	0	5	0	1	0	0	0	0	1	12	0	0	0	5	0	0	TCGA-ZM-AA0N-01	79	0.7671830531901198	26	TCGA-ZM-AA0N-01	30	33	34	0.188438633597152	TCGA-ZM-AA0N-01	9	10	6	25	PASS	9844	TCGA-ZM-AA0N	TGCT	44	MALE	WHITE	Stage IB	Stage IB	Seminoma; NOS	NA	2013	NA	-16094	Alive	TUMOR FREE	634	NA	NA	Distant Metastasis	Retroperitoneal lymph nodes	NA	490	No Measureable Tumor or Tumor Markers	NA	NA	0	634	0	634	1	490	1	490	
70	TCGA-4C-A93U	0	2	1	1	1	1	0	0	4	38	4	0	1	19	1	0	TCGA-4C-A93U-01	117	0.07071471260136042	57	TCGA-4C-A93U-01	3	4	24	0.04143852362200267	TCGA-4C-A93U-01	2	2	2	6	PASS	9845	TCGA-4C-A93U	THCA	74	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2013	NA	-27348	Alive	TUMOR FREE	129	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	129	0	129	NA	NA	0	129	
70	TCGA-BJ-A0YZ	0	2	0	0	0	0	0	0	1	16	0	0	0	4	1	0	TCGA-BJ-A0YZ-01	49	0.007987755288965141	12	TCGA-BJ-A0YZ-01	0	1	3	0.008261630774208575	TCGA-BJ-A0YZ-01	1	0	1	2	PASS	9846	TCGA-BJ-A0YZ	THCA	65	MALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-24102	Alive	TUMOR FREE	754	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	754	0	754	0	754	0	754	
60	TCGA-BJ-A0Z0	0	0	1	1	2	0	0	0	2	24	1	0	0	4	1	0	TCGA-BJ-A0Z0-01	81	0.1024860824207893	30	TCGA-BJ-A0Z0-01	1	2	2	0.040383799281843984	TCGA-BJ-A0Z0-01	2	5	2	9	PASS	9847	TCGA-BJ-A0Z0	THCA	55	MALE	NA	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-20361	Alive	TUMOR FREE	419	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	419	0	419	0	419	0	419	
60	TCGA-BJ-A0Z2	0	1	0	0	1	0	1	0	2	14	0	0	1	6	0	0	TCGA-BJ-A0Z2-01	61	0.011035305283959088	24	TCGA-BJ-A0Z2-01	1	1	19	0.01159751677869618	TCGA-BJ-A0Z2-01	0	0	0	0	PASS	9848	TCGA-BJ-A0Z2	THCA	57	MALE	BLACK OR AFRICAN AMERICAN	Stage IVC	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-21008	Alive	WITH TUMOR	1514	NA	NA	Distant Metastasis	Bone	NA	158	NA	NA	RX	0	1514	0	1514	NA	NA	1	158	
30	TCGA-BJ-A0Z3	0	0	0	0	0	0	0	0	0	6	0	0	0	2	0	0	TCGA-BJ-A0Z3-01	59	2.699568468377686e-05	24	TCGA-BJ-A0Z3-01	0	0	0	0.0	TCGA-BJ-A0Z3-01	0	0	0	0	PASS	9849	TCGA-BJ-A0Z3	THCA	33	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-12295	Alive	TUMOR FREE	497	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	497	0	497	NA	NA	0	497	
60	TCGA-BJ-A0Z5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BJ-A0Z5-01	60	0.011003603588870156	24	TCGA-BJ-A0Z5	0	0	0	0	TCGA-BJ-A0Z5	0	0	0	0	PASS	9850	TCGA-BJ-A0Z5	THCA	58	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-21369	Alive	TUMOR FREE	448	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	448	0	448	NA	NA	0	448	
60	TCGA-BJ-A0Z9	0	0	1	0	0	0	0	0	0	15	3	0	0	3	0	0	TCGA-BJ-A0Z9-01	79	5.7293490539230894e-05	32	TCGA-BJ-A0Z9-01	0	0	0	0.0	TCGA-BJ-A0Z9-01	0	0	0	0	PASS	9851	TCGA-BJ-A0Z9	THCA	57	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2010	NA	-21061	Alive	TUMOR FREE	1257	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	1257	0	1257	NA	NA	0	1257	
70	TCGA-BJ-A0ZA	0	0	0	0	0	0	0	0	0	10	0	0	0	2	0	0	TCGA-BJ-A0ZA-01	49	8.937167567498692e-05	7	TCGA-BJ-A0ZA-01	0	0	19	1.632002420929111e-05	TCGA-BJ-A0ZA-01	0	0	0	0	PASS	9852	TCGA-BJ-A0ZA	THCA	67	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-24528	Alive	TUMOR FREE	574	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	574	0	574	0	574	0	574	
70	TCGA-BJ-A0ZB	0	4	0	0	0	1	0	0	1	32	1	1	0	9	2	0	TCGA-BJ-A0ZB-01	57	0.018293262000994282	17	TCGA-BJ-A0ZB-01	0	0	0	0.0	TCGA-BJ-A0ZB-01	0	0	0	0	PASS	9853	TCGA-BJ-A0ZB	THCA	66	MALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-24415	Alive	TUMOR FREE	122	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	122	0	122	NA	NA	0	122	
60	TCGA-BJ-A0ZC	0	0	0	0	0	0	0	0	0	7	0	0	1	3	0	0	TCGA-BJ-A0ZC-01	41	0.014757171065308631	9	TCGA-BJ-A0ZC-01	0	0	2	0.015558134882550347	TCGA-BJ-A0ZC-01	0	1	1	2	PASS	9854	TCGA-BJ-A0ZC	THCA	55	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-20282	Alive	TUMOR FREE	352	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	352	0	352	0	352	0	352	
60	TCGA-BJ-A0ZE	0	2	0	0	1	0	0	0	0	13	0	1	0	4	0	0	TCGA-BJ-A0ZE-01	37	2.461459627592253e-05	6	TCGA-BJ-A0ZE-01	0	0	19	1.7468158416523805e-05	TCGA-BJ-A0ZE-01	0	0	0	0	PASS	9855	TCGA-BJ-A0ZE	THCA	63	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-23250	Alive	TUMOR FREE	509	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	509	0	509	NA	NA	0	509	
50	TCGA-BJ-A0ZF	0	3	0	1	0	0	0	0	0	17	1	0	0	5	1	0	TCGA-BJ-A0ZF	0	0	0	TCGA-BJ-A0ZF	0	0	0	0	TCGA-BJ-A0ZF	0	0	0	0	PASS	9856	TCGA-BJ-A0ZF	THCA	54	FEMALE	WHITE	Stage II	NA	"Other, specify"	NA	2010	NA	-19978	Alive	WITH TUMOR	1217	NA	NA	Locoregional Recurrence	NA	NA	735	NA	NA	R0	0	1217	0	1217	1	735	1	735	
80	TCGA-BJ-A0ZG	0	0	0	0	0	0	0	0	0	10	0	0	1	3	0	0	TCGA-BJ-A0ZG-01	45	0.00018861150375359628	11	TCGA-BJ-A0ZG-01	0	0	19	0.00018681992770374186	TCGA-BJ-A0ZG-01	0	0	0	0	PASS	9857	TCGA-BJ-A0ZG	THCA	80	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-29375	Alive	TUMOR FREE	775	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	775	0	775	NA	NA	0	775	
50	TCGA-BJ-A0ZH	0	1	0	0	0	0	0	0	2	18	1	0	1	3	0	1	TCGA-BJ-A0ZH-01	53	0.011004141321759123	17	TCGA-BJ-A0ZH-01	0	0	0	0.0	TCGA-BJ-A0ZH-01	0	0	0	0	PASS	9858	TCGA-BJ-A0ZH	THCA	52	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2010	NA	-19114	Alive	TUMOR FREE	460	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	460	0	460	NA	NA	0	460	
40	TCGA-BJ-A0ZJ	0	0	0	1	0	0	0	0	1	1	0	0	0	1	0	0	TCGA-BJ-A0ZJ-01	47	2.8279419717936193e-05	10	TCGA-BJ-A0ZJ-01	0	0	0	0.0	TCGA-BJ-A0ZJ-01	0	0	0	0	PASS	9859	TCGA-BJ-A0ZJ	THCA	36	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-13149	Alive	TUMOR FREE	1280	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1280	0	1280	0	1280	0	1280	
30	TCGA-BJ-A18Y	0	0	0	1	0	0	0	0	0	9	0	0	1	2	0	0	TCGA-BJ-A18Y-01	53	0.011083261715143488	20	TCGA-BJ-A18Y-01	1	1	2	0.011681380718866003	TCGA-BJ-A18Y-01	0	0	0	0	PASS	9860	TCGA-BJ-A18Y	THCA	29	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-10832	Alive	TUMOR FREE	1563	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1563	0	1563	0	1563	0	1563	
60	TCGA-BJ-A18Z	0	1	0	0	0	0	0	0	2	19	1	0	0	1	0	0	TCGA-BJ-A18Z-01	37	1.4394501232051364e-05	6	TCGA-BJ-A18Z-01	0	0	0	0.0	TCGA-BJ-A18Z-01	0	0	0	0	PASS	9861	TCGA-BJ-A18Z	THCA	58	MALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-21519	Alive	TUMOR FREE	1263	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	1263	0	1263	NA	NA	0	1263	
60	TCGA-BJ-A190	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BJ-A190-01	69	0.9230235943687086	20	TCGA-BJ-A190	0	0	0	0	TCGA-BJ-A190	0	0	0	0	PASS	9862	TCGA-BJ-A190	THCA	55	MALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-20407	Alive	TUMOR FREE	626	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	626	0	626	0	626	0	626	
50	TCGA-BJ-A191	0	8	1	4	0	1	0	0	8	84	9	0	0	32	4	0	TCGA-BJ-A191-01	55	2.2358665639615687e-05	21	TCGA-BJ-A191-01	0	0	0	0.0	TCGA-BJ-A191-01	0	0	0	0	PASS	9863	TCGA-BJ-A191	THCA	49	FEMALE	WHITE	Stage I	NA	"Other, specify"	NA	2010	NA	-18162	Alive	TUMOR FREE	147	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	147	0	147	0	147	0	147	
50	TCGA-BJ-A192	1	0	0	0	1	0	0	0	0	8	2	0	1	2	0	0	TCGA-BJ-A192-01	70	0.07660272347113607	25	TCGA-BJ-A192	0	0	0	0	TCGA-BJ-A192	0	0	0	0	PASS	9864	TCGA-BJ-A192	THCA	54	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-19878	Alive	TUMOR FREE	1349	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	1349	0	1349	NA	NA	0	1349	
40	TCGA-BJ-A28R	0	0	0	2	0	0	0	0	2	16	0	0	0	4	0	0	TCGA-BJ-A28R-01	35	2.6785165904114528e-05	4	TCGA-BJ-A28R-01	0	0	19	1.8530299026751366e-05	TCGA-BJ-A28R-01	0	0	0	0	PASS	9865	TCGA-BJ-A28R	THCA	38	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-14044	Alive	TUMOR FREE	1282	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1282	0	1282	NA	NA	0	1282	
80	TCGA-BJ-A28S	0	0	0	1	2	0	0	0	0	14	0	0	1	5	2	0	TCGA-BJ-A28S-01	47	7.578384175470772e-06	14	TCGA-BJ-A28S-01	0	0	0	0.0	TCGA-BJ-A28S-01	0	0	0	0	PASS	9866	TCGA-BJ-A28S	THCA	79	MALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-29143	Alive	TUMOR FREE	640	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	640	0	640	NA	NA	0	640	
30	TCGA-BJ-A28T	0	2	0	0	0	0	0	0	4	1	0	0	0	2	0	0	TCGA-BJ-A28T-01	37	0.0001013994362669203	8	TCGA-BJ-A28T-01	0	0	2	8.406054460534363e-05	TCGA-BJ-A28T-01	0	0	0	0	PASS	9867	TCGA-BJ-A28T	THCA	34	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-12698	Alive	TUMOR FREE	1081	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1081	0	1081	NA	NA	0	1081	
80	TCGA-BJ-A28V	0	3	0	1	2	1	0	0	0	15	1	1	1	4	1	0	TCGA-BJ-A28V-01	49	1.837840421884472e-05	15	TCGA-BJ-A28V-01	0	0	0	0.0	TCGA-BJ-A28V-01	0	0	0	0	PASS	9868	TCGA-BJ-A28V	THCA	80	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-29508	Alive	TUMOR FREE	987	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	987	0	987	NA	NA	0	987	
30	TCGA-BJ-A28W	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BJ-A28W-01	55	2.1789030984663766e-05	16	TCGA-BJ-A28W	0	0	0	0	TCGA-BJ-A28W	0	0	0	0	PASS	9869	TCGA-BJ-A28W	THCA	32	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-11999	Alive	TUMOR FREE	344	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	344	0	344	NA	NA	0	344	
30	TCGA-BJ-A28X	0	2	0	2	0	0	0	0	0	10	0	0	0	2	0	0	TCGA-BJ-A28X-01	51	0.0004149944726667606	13	TCGA-BJ-A28X-01	0	0	0	0.0	TCGA-BJ-A28X-01	0	0	0	0	PASS	9870	TCGA-BJ-A28X	THCA	32	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2010	NA	-11735	Alive	TUMOR FREE	942	NA	NA	NA	NA	NA	494	NA	NA	R0	0	942	0	942	1	494	1	494	
50	TCGA-BJ-A28Z	1	1	0	2	1	0	0	0	1	13	1	0	0	12	0	0	TCGA-BJ-A28Z-01	61	0.005854446575641777	17	TCGA-BJ-A28Z	0	0	0	0	TCGA-BJ-A28Z	0	0	0	0	PASS	9871	TCGA-BJ-A28Z	THCA	46	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-16912	Alive	TUMOR FREE	337	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	337	0	337	NA	NA	0	337	
70	TCGA-BJ-A290	0	4	2	3	2	0	2	0	9	70	5	0	2	28	0	0	TCGA-BJ-A290-01	51	0.08528171856124753	12	TCGA-BJ-A290-01	2	2	0	0.0	TCGA-BJ-A290-01	1	0	0	1	PASS	9872	TCGA-BJ-A290	THCA	70	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2010	NA	-25803	Alive	WITH TUMOR	919	NA	NA	Distant Metastasis	Lung	NA	329	NA	NA	NA	0	919	0	919	NA	NA	1	329	
60	TCGA-BJ-A291	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BJ-A291-01	35	0.0002278753041768895	6	TCGA-BJ-A291-01	0	0	19	0.0002280229912836519	TCGA-BJ-A291-01	0	0	0	0	PASS	9873	TCGA-BJ-A291	THCA	56	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-20682	Alive	TUMOR FREE	696	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	696	0	696	NA	NA	0	696	
30	TCGA-BJ-A2N7	0	0	2	0	0	0	0	0	0	8	0	0	2	0	0	0	TCGA-BJ-A2N7-01	41	1.3778301642125234e-05	10	TCGA-BJ-A2N7-01	0	0	0	0.0	TCGA-BJ-A2N7-01	0	0	0	0	PASS	9874	TCGA-BJ-A2N7	THCA	30	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-11188	Alive	TUMOR FREE	559	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	559	0	559	0	559	0	559	
30	TCGA-BJ-A2N8	0	3	0	2	0	0	0	0	0	23	2	0	0	7	2	0	TCGA-BJ-A2N8-01	45	0.0003216484866049052	8	TCGA-BJ-A2N8-01	0	0	19	0.00027814673142652395	TCGA-BJ-A2N8-01	0	0	0	0	PASS	9875	TCGA-BJ-A2N8	THCA	30	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-11024	Alive	TUMOR FREE	504	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	504	0	504	NA	NA	0	504	
40	TCGA-BJ-A2N9	0	3	0	0	0	0	0	0	2	12	0	0	0	2	2	0	TCGA-BJ-A2N9-01	53	0.6232887868064091	16	TCGA-BJ-A2N9-01	8	8	4	0.10648100279202152	TCGA-BJ-A2N9-01	0	2	1	3	PASS	9876	TCGA-BJ-A2N9	THCA	42	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-15411	Alive	WITH TUMOR	623	NA	NA	Distant Metastasis	NA	NA	225	NA	NA	R1	0	623	0	623	NA	NA	1	225	
80	TCGA-BJ-A2NA	0	9	0	2	2	0	0	0	3	52	4	0	2	34	0	0	TCGA-BJ-A2NA-01	45	0.0001562651587825339	11	TCGA-BJ-A2NA-01	0	0	19	0.00015937292533109876	TCGA-BJ-A2NA-01	0	0	0	0	PASS	9877	TCGA-BJ-A2NA	THCA	77	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-28147	Alive	WITH TUMOR	577	NA	NA	Distant Metastasis	NA	NA	127	NA	NA	R1	0	577	0	577	NA	NA	1	127	
30	TCGA-BJ-A2P4	0	0	0	0	1	0	1	0	0	9	1	0	1	6	0	0	TCGA-BJ-A2P4-01	61	0.011033894910086387	20	TCGA-BJ-A2P4-01	1	1	19	0.01159747944690036	TCGA-BJ-A2P4-01	0	0	0	0	PASS	9878	TCGA-BJ-A2P4	THCA	29	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-10602	Alive	TUMOR FREE	390	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	390	0	390	0	390	0	390	
50	TCGA-BJ-A3EZ	0	0	0	0	2	0	0	0	0	17	2	0	0	6	1	0	TCGA-BJ-A3EZ-01	41	4.25136845313995e-05	9	TCGA-BJ-A3EZ-01	0	0	19	3.302604509084102e-05	TCGA-BJ-A3EZ-01	0	0	0	0	PASS	9879	TCGA-BJ-A3EZ	THCA	51	MALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-18882	Alive	TUMOR FREE	487	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	487	0	487	NA	NA	0	487	
60	TCGA-BJ-A3F0	0	0	0	0	0	1	0	0	0	10	0	0	0	5	0	0	TCGA-BJ-A3F0-01	29	0.059844523796576836	2	TCGA-BJ-A3F0-01	2	2	2	0.06314670503614422	TCGA-BJ-A3F0-01	0	0	0	0	PASS	9880	TCGA-BJ-A3F0	THCA	64	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-23545	Alive	TUMOR FREE	424	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	424	0	424	0	424	0	424	
70	TCGA-BJ-A3PR	0	2	0	0	0	0	0	0	0	13	0	0	0	8	0	0	TCGA-BJ-A3PR-01	35	6.64106734153544e-05	4	TCGA-BJ-A3PR-01	0	0	19	5.8352289846226325e-06	TCGA-BJ-A3PR-01	0	0	0	0	PASS	9881	TCGA-BJ-A3PR	THCA	69	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-25565	Alive	TUMOR FREE	1107	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1107	0	1107	0	1107	0	1107	
50	TCGA-BJ-A3PT	0	0	0	0	0	0	0	0	0	15	1	0	0	1	0	0	TCGA-BJ-A3PT-01	57	0.011020302885265131	17	TCGA-BJ-A3PT-01	1	1	2	0.011602616460965859	TCGA-BJ-A3PT-01	0	0	0	0	PASS	9882	TCGA-BJ-A3PT	THCA	51	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-18903	Alive	TUMOR FREE	709	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	709	0	709	NA	NA	0	709	
50	TCGA-BJ-A3PU	0	0	0	2	2	0	0	0	0	26	0	0	0	8	2	0	TCGA-BJ-A3PU-01	41	2.4983401684798424e-06	9	TCGA-BJ-A3PU-01	0	0	0	0.0	TCGA-BJ-A3PU-01	0	0	0	0	PASS	9883	TCGA-BJ-A3PU	THCA	52	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-19007	Alive	TUMOR FREE	567	NA	NA	Distant Metastasis	Lung	NA	174	NA	NA	R0	0	567	0	567	1	174	1	174	
80	TCGA-BJ-A45C	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BJ-A45C-01	53	0.024244864199692687	10	TCGA-BJ-A45C	0	0	0	0	TCGA-BJ-A45C	0	0	0	0	PASS	9884	TCGA-BJ-A45C	THCA	78	MALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-28490	Dead	WITH TUMOR	NA	243	NA	NA	NA	NA	NA	NA	NA	NA	1	243	1	243	NA	NA	1	243	
40	TCGA-BJ-A45D	2	0	0	4	2	0	2	0	0	16	2	0	0	4	0	0	TCGA-BJ-A45D-01	39	0.011000139434777708	8	TCGA-BJ-A45D-01	1	1	11	0.01379299680939924	TCGA-BJ-A45D-01	0	0	0	0	PASS	9885	TCGA-BJ-A45D	THCA	36	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2012	NA	-13335	Alive	TUMOR FREE	331	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	331	0	331	NA	NA	0	331	
50	TCGA-BJ-A45E	0	4	0	0	0	0	0	0	0	3	0	0	0	8	0	0	TCGA-BJ-A45E-01	41	0.13582584111427826	6	TCGA-BJ-A45E-01	7	6	12	0.002742384583340358	TCGA-BJ-A45E-01	0	0	0	0	PASS	9886	TCGA-BJ-A45E	THCA	46	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-17115	Alive	TUMOR FREE	639	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	639	0	639	NA	NA	0	639	
60	TCGA-BJ-A45F	0	0	0	2	0	0	0	0	0	20	0	0	0	2	0	0	TCGA-BJ-A45F-01	33	6.420591638719298e-06	1	TCGA-BJ-A45F-01	0	0	5	0.0025289115599268297	TCGA-BJ-A45F-01	0	0	0	0	PASS	9887	TCGA-BJ-A45F	THCA	59	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-21713	Alive	TUMOR FREE	105	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	105	0	105	NA	NA	0	105	
50	TCGA-BJ-A45G	0	0	0	0	0	0	0	0	0	18	2	0	0	10	0	0	TCGA-BJ-A45G-01	39	1.1088613321707243e-05	3	TCGA-BJ-A45G-01	0	0	0	0.0	TCGA-BJ-A45G-01	0	0	0	0	PASS	9888	TCGA-BJ-A45G	THCA	48	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2012	NA	-17831	Alive	TUMOR FREE	725	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	725	0	725	NA	NA	0	725	
50	TCGA-BJ-A45H	0	1	0	1	1	0	0	0	0	7	1	0	0	1	0	0	TCGA-BJ-A45H-01	37	1.735494616453091e-05	8	TCGA-BJ-A45H-01	0	0	3	0.00012285440680236552	TCGA-BJ-A45H-01	0	0	0	0	PASS	9889	TCGA-BJ-A45H	THCA	45	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-16541	Alive	WITH TUMOR	865	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	865	0	865	NA	NA	0	865	
50	TCGA-BJ-A45I	0	2	0	0	0	0	0	0	0	15	0	0	0	12	0	0	TCGA-BJ-A45I-01	39	8.714730115427894e-06	6	TCGA-BJ-A45I-01	0	0	10	0.0008571188176061854	TCGA-BJ-A45I-01	0	0	0	0	PASS	9890	TCGA-BJ-A45I	THCA	51	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2012	NA	-18767	Alive	TUMOR FREE	470	NA	NA	NA	NA	NA	110	NA	NA	R2	0	470	0	470	NA	NA	1	110	
40	TCGA-BJ-A45J	0	2	0	2	0	0	0	0	0	16	2	0	0	16	0	0	TCGA-BJ-A45J-01	37	3.3482408737154524e-05	4	TCGA-BJ-A45J	0	0	0	0	TCGA-BJ-A45J	0	0	0	0	PASS	9891	TCGA-BJ-A45J	THCA	39	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2012	NA	-14510	Alive	TUMOR FREE	658	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	658	0	658	NA	NA	0	658	
30	TCGA-BJ-A45K	0	0	0	0	0	2	0	0	4	12	0	0	0	8	0	0	TCGA-BJ-A45K-01	41	6.607392541410154e-05	10	TCGA-BJ-A45K-01	0	0	4	0.0014923828387873315	TCGA-BJ-A45K-01	0	0	0	0	PASS	9892	TCGA-BJ-A45K	THCA	33	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-12138	Alive	TUMOR FREE	705	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	705	0	705	NA	NA	0	705	
50	TCGA-BJ-A4O8	0	0	0	0	0	0	0	0	2	12	0	0	2	0	0	0	TCGA-BJ-A4O8-01	60	2.8464449207065802e-05	21	TCGA-BJ-A4O8-01	0	0	2	7.100245843504903e-05	TCGA-BJ-A4O8-01	0	0	0	0	PASS	9893	TCGA-BJ-A4O8	THCA	47	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-17430	Alive	TUMOR FREE	591	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	591	0	591	0	591	0	591	
50	TCGA-BJ-A4O9	4	4	0	0	0	0	0	0	2	28	6	0	2	8	2	0	TCGA-BJ-A4O9-01	53	0.010703171132719928	12	TCGA-BJ-A4O9-01	0	0	11	0.01157345095772183	TCGA-BJ-A4O9-01	1	1	1	3	PASS	9894	TCGA-BJ-A4O9	THCA	51	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2012	NA	-18938	Alive	TUMOR FREE	714	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	714	0	714	NA	NA	0	714	
30	TCGA-CE-A13K	0	1	0	1	0	0	0	0	1	7	0	0	0	5	1	0	TCGA-CE-A13K-01	55	0.0244860673503188	16	TCGA-CE-A13K-01	0	0	2	0.00029140788445936364	TCGA-CE-A13K-01	0	0	0	0	PASS	9895	TCGA-CE-A13K	THCA	30	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-11122	Alive	TUMOR FREE	385	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	385	0	385	0	385	0	385	
30	TCGA-CE-A27D	0	0	0	1	0	0	0	0	0	5	0	0	0	1	1	0	TCGA-CE-A27D-01	57	1.5468567999513365e-05	20	TCGA-CE-A27D-01	0	0	0	0.0	TCGA-CE-A27D-01	0	0	0	0	PASS	9896	TCGA-CE-A27D	THCA	28	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-10536	Alive	TUMOR FREE	374	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	374	0	374	0	374	0	374	
30	TCGA-CE-A3MD	0	0	0	1	0	0	0	0	0	8	1	0	0	2	0	0	TCGA-CE-A3MD-01	65	0.0013752727891911114	20	TCGA-CE-A3MD-01	0	0	6	0.001395750893664646	TCGA-CE-A3MD-01	0	0	0	0	PASS	9897	TCGA-CE-A3MD	THCA	31	MALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-11399	Alive	TUMOR FREE	389	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	389	0	389	0	389	0	389	
50	TCGA-CE-A3ME	0	2	0	0	0	0	0	0	0	8	1	0	0	4	1	0	TCGA-CE-A3ME-01	47	0.00020545805112801908	10	TCGA-CE-A3ME-01	0	0	19	9.063621778473446e-06	TCGA-CE-A3ME-01	0	0	0	0	PASS	9898	TCGA-CE-A3ME	THCA	51	FEMALE	ASIAN	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-18714	Alive	TUMOR FREE	379	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	379	0	379	0	379	0	379	
40	TCGA-CE-A481	0	2	0	0	1	0	0	0	1	9	0	0	0	3	0	0	TCGA-CE-A481-01	55	3.3098326055836784e-05	16	TCGA-CE-A481	0	0	0	0	TCGA-CE-A481	0	0	0	0	PASS	9899	TCGA-CE-A481	THCA	41	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-15268	Alive	TUMOR FREE	346	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	346	0	346	0	346	0	346	
30	TCGA-CE-A482	1	0	0	1	0	0	0	0	0	3	0	0	0	4	1	0	TCGA-CE-A482-01	57	0.00034295516604851737	16	TCGA-CE-A482-01	0	0	2	0.002316296239070645	TCGA-CE-A482-01	0	0	0	0	PASS	9900	TCGA-CE-A482	THCA	27	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-10192	Alive	TUMOR FREE	325	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	325	0	325	0	325	0	325	
30	TCGA-CE-A483	0	0	0	1	0	0	0	0	0	3	1	0	0	2	0	0	TCGA-CE-A483-01	53	7.854105696775188e-05	18	TCGA-CE-A483-01	0	0	9	0.0006786608785871324	TCGA-CE-A483-01	0	0	0	0	PASS	9901	TCGA-CE-A483	THCA	34	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-12768	Alive	TUMOR FREE	457	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	457	0	457	0	457	0	457	
40	TCGA-CE-A484	0	0	0	0	0	0	0	0	1	15	1	0	0	5	0	0	TCGA-CE-A484-01	53	0.013118906539342737	9	TCGA-CE-A484-01	1	1	19	0.01557427605076572	TCGA-CE-A484-01	0	0	0	0	PASS	9902	TCGA-CE-A484	THCA	37	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-13815	Alive	TUMOR FREE	378	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	378	0	378	0	378	0	378	
30	TCGA-CE-A485	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	TCGA-CE-A485-01	41	0.011158867471450774	8	TCGA-CE-A485-01	0	0	4	0.00016705020761718893	TCGA-CE-A485-01	0	0	0	0	PASS	9903	TCGA-CE-A485	THCA	32	MALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-11997	Alive	TUMOR FREE	385	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	385	0	385	0	385	0	385	
70	TCGA-DE-A0XZ	1	1	0	0	0	0	0	0	1	21	0	0	0	5	1	0	TCGA-DE-A0XZ-01	61	0.010998055975864509	26	TCGA-DE-A0XZ-01	1	1	2	0.011592529876454965	TCGA-DE-A0XZ-01	0	0	0	0	PASS	9904	TCGA-DE-A0XZ	THCA	65	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-24020	Alive	TUMOR FREE	1090	NA	NA	NA	NA	NA	204	NA	NA	R0	0	1090	0	1090	1	204	1	204	
30	TCGA-DE-A0Y2	0	1	0	2	2	0	0	0	0	10	4	0	0	8	0	0	TCGA-DE-A0Y2-01	41	5.376931628758883e-06	8	TCGA-DE-A0Y2-01	0	0	0	0.0	TCGA-DE-A0Y2-01	0	0	0	0	PASS	9905	TCGA-DE-A0Y2	THCA	30	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-11227	Alive	TUMOR FREE	658	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	658	0	658	0	658	0	658	
60	TCGA-DE-A0Y3	0	0	0	1	1	0	0	0	1	10	0	0	0	6	0	0	TCGA-DE-A0Y3-01	63	4.048779310364396e-05	24	TCGA-DE-A0Y3-01	0	0	19	1.1383347893196738e-05	TCGA-DE-A0Y3-01	0	0	0	0	PASS	9906	TCGA-DE-A0Y3	THCA	60	FEMALE	ASIAN	Stage IVC	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-22239	Alive	TUMOR FREE	1526	NA	NA	Distant Metastasis	Lung	NA	30	NA	NA	R1	0	1526	0	1526	NA	NA	1	30	
40	TCGA-DE-A2OL	0	0	0	0	1	0	0	0	0	10	0	0	0	2	0	0	TCGA-DE-A2OL-01	49	7.332530321737922e-05	13	TCGA-DE-A2OL-01	0	0	0	0.0	TCGA-DE-A2OL-01	0	0	0	0	PASS	9907	TCGA-DE-A2OL	THCA	44	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-16253	Alive	TUMOR FREE	1145	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1145	0	1145	0	1145	0	1145	
50	TCGA-DE-A3KN	0	0	0	0	0	0	0	0	1	11	0	0	0	1	0	0	TCGA-DE-A3KN-01	97	0.01708750162688499	52	TCGA-DE-A3KN-01	0	1	22	0.018032098250157627	TCGA-DE-A3KN-01	0	1	1	2	PASS	9908	TCGA-DE-A3KN	THCA	49	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-18098	Alive	TUMOR FREE	831	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	831	0	831	NA	NA	0	831	
60	TCGA-DE-A4M8	0	1	0	0	0	0	0	0	0	8	0	0	1	3	0	0	TCGA-DE-A4M8-01	47	0.010996131811606523	6	TCGA-DE-A4M8-01	1	1	11	0.01315775215586096	TCGA-DE-A4M8-01	0	0	0	0	PASS	9909	TCGA-DE-A4M8	THCA	61	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-22357	Alive	TUMOR FREE	564	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	564	0	564	0	564	0	564	
30	TCGA-DE-A4M9	0	1	0	0	0	0	0	0	0	8	0	0	0	4	0	0	TCGA-DE-A4M9-01	53	5.487207686536826e-05	16	TCGA-DE-A4M9-01	0	0	10	0.0007002296271236317	TCGA-DE-A4M9-01	0	0	0	0	PASS	9910	TCGA-DE-A4M9	THCA	28	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-10384	Alive	TUMOR FREE	573	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	573	0	573	NA	NA	0	573	
50	TCGA-DE-A4MA	1	0	0	0	0	0	0	0	0	7	1	0	0	2	0	0	TCGA-DE-A4MA-01	59	0.0002450604119987516	18	TCGA-DE-A4MA-01	0	0	5	0.0004994710565764275	TCGA-DE-A4MA-01	0	0	0	0	PASS	9911	TCGA-DE-A4MA	THCA	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-19100	Alive	TUMOR FREE	916	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	916	0	916	0	916	0	916	
80	TCGA-DE-A4MB	0	0	0	1	0	0	0	0	1	20	1	0	2	10	0	0	TCGA-DE-A4MB-01	70	0.07549405832511986	29	TCGA-DE-A4MB-01	3	4	20	0.030758748064546718	TCGA-DE-A4MB-01	2	0	1	3	PASS	9912	TCGA-DE-A4MB	THCA	79	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-29011	Alive	WITH TUMOR	352	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	352	0	352	NA	NA	0	352	
40	TCGA-DE-A4MC	0	0	0	0	0	0	0	0	3	12	0	0	0	5	0	0	TCGA-DE-A4MC-01	44	0.033750522635666816	9	TCGA-DE-A4MC-01	1	1	6	0.0010533636469321245	TCGA-DE-A4MC-01	1	0	0	1	PASS	9913	TCGA-DE-A4MC	THCA	43	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-15996	Alive	TUMOR FREE	913	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	332	NA	NA	R0	0	913	0	913	1	332	1	332	
70	TCGA-DE-A4MD	0	3	0	0	1	0	2	0	1	37	4	0	0	28	2	0	TCGA-DE-A4MD-01	49	0.060784683802555126	13	TCGA-DE-A4MD-06	2	2	3	0.030319227786410424	TCGA-DE-A4MD-06	1	1	1	3	mutation call filter	9914	TCGA-DE-A4MD	THCA	71	MALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-26179	Alive	TUMOR FREE	764	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	267	NA	NA	R0	0	764	0	764	NA	NA	1	267	
30	TCGA-DE-A69J	0	1	0	0	0	1	0	0	1	6	2	0	0	0	0	0	TCGA-DE-A69J-01	65	8.054803639329439e-05	22	TCGA-DE-A69J-01	0	0	8	0.001691812444789849	TCGA-DE-A69J-01	0	0	0	0	PASS	9915	TCGA-DE-A69J	THCA	34	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-12493	Alive	TUMOR FREE	447	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	447	0	447	0	447	0	447	
60	TCGA-DE-A69K	1	1	0	4	0	0	0	0	0	12	0	0	0	2	1	0	TCGA-DE-A69K-01	51	4.80906488134175e-05	18	TCGA-DE-A69K-01	0	0	6	0.00014884890793916592	TCGA-DE-A69K-01	0	0	0	0	PASS	9916	TCGA-DE-A69K	THCA	58	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2013	NA	-21403	Alive	WITH TUMOR	434	NA	NA	Biochemical evidence of disease	NA	NA	434	NA	NA	R1	0	434	0	434	NA	NA	1	434	
40	TCGA-DE-A7U5	0	0	0	0	0	0	0	0	0	6	0	0	0	0	0	0	TCGA-DE-A7U5-01	53	0.0001622030280307493	14	TCGA-DE-A7U5-01	0	0	4	0.0011008380300573431	TCGA-DE-A7U5-01	0	0	0	0	PASS	9917	TCGA-DE-A7U5	THCA	36	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2013	NA	-13411	Alive	NA	84	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	84	0	84	NA	NA	0	84	
90	TCGA-DJ-A13L	0	2	0	1	1	1	0	0	0	28	2	0	0	8	1	0	TCGA-DJ-A13L-01	84	0.035222459157516595	38	TCGA-DJ-A13L-01	1	1	19	0.037141842538609984	TCGA-DJ-A13L-01	0	0	1	1	PASS	9918	TCGA-DJ-A13L	THCA	85	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2010	NA	-31388	Alive	TUMOR FREE	303	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	303	0	303	0	303	0	303	
30	TCGA-DJ-A13M	0	1	0	0	0	0	0	0	1	5	1	0	1	0	0	0	TCGA-DJ-A13M-01	59	0.011472920326024387	16	TCGA-DJ-A13M-01	1	1	19	0.011597533623609569	TCGA-DJ-A13M-01	0	0	0	0	PASS	9919	TCGA-DJ-A13M	THCA	28	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-10530	Alive	TUMOR FREE	1484	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1484	0	1484	0	1484	0	1484	
60	TCGA-DJ-A13O	0	0	0	0	0	0	0	0	1	6	0	0	0	0	0	0	TCGA-DJ-A13O-01	69	6.69716827515633e-05	23	TCGA-DJ-A13O-01	0	0	0	0.0	TCGA-DJ-A13O-01	0	0	0	0	PASS	9920	TCGA-DJ-A13O	THCA	56	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-20779	Alive	TUMOR FREE	1161	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1161	0	1161	0	1161	0	1161	
50	TCGA-DJ-A13P	0	0	0	0	0	0	0	0	0	5	1	0	0	4	0	0	TCGA-DJ-A13P-01	75	0.032935955926879965	33	TCGA-DJ-A13P-01	1	1	19	0.034725881922569965	TCGA-DJ-A13P-01	0	0	0	0	PASS	9921	TCGA-DJ-A13P	THCA	52	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	1999	NA	-19297	Alive	TUMOR FREE	5150	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	5150	0	5150	0	5150	0	5150	
50	TCGA-DJ-A13R	0	1	0	0	0	0	0	0	0	8	2	0	0	4	0	0	TCGA-DJ-A13R-01	59	1.2445028421129132e-05	26	TCGA-DJ-A13R-01	0	0	0	0.0	TCGA-DJ-A13R-01	0	0	0	0	PASS	9922	TCGA-DJ-A13R	THCA	50	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-18354	Alive	TUMOR FREE	565	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	565	0	565	0	565	0	565	
20	TCGA-DJ-A13S	0	1	0	0	2	0	0	0	0	11	1	0	0	2	0	0	TCGA-DJ-A13S-01	49	3.128424875097597e-05	14	TCGA-DJ-A13S-01	0	0	0	0.0	TCGA-DJ-A13S-01	0	0	0	0	PASS	9923	TCGA-DJ-A13S	THCA	19	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-7099	Alive	TUMOR FREE	265	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	265	0	265	0	265	0	265	
40	TCGA-DJ-A13T	0	0	0	1	0	0	0	0	0	6	0	0	0	2	0	0	TCGA-DJ-A13T-01	41	0.011174611101484764	6	TCGA-DJ-A13T-01	1	1	19	0.011597347278424871	TCGA-DJ-A13T-01	0	0	0	0	PASS	9924	TCGA-DJ-A13T	THCA	37	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-13668	Alive	TUMOR FREE	1709	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1709	0	1709	0	1709	0	1709	
60	TCGA-DJ-A13U	0	0	0	1	0	0	0	0	0	10	1	0	0	5	0	0	TCGA-DJ-A13U-01	70	0.03409221140348353	27	TCGA-DJ-A13U-01	1	2	0	0.0	TCGA-DJ-A13U-01	0	0	0	0	PASS	9925	TCGA-DJ-A13U	THCA	60	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-22130	Alive	TUMOR FREE	1590	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1590	0	1590	0	1590	0	1590	
30	TCGA-DJ-A13V	0	1	1	0	0	0	0	0	0	8	0	0	0	2	0	0	TCGA-DJ-A13V-01	49	3.084296398835791e-05	10	TCGA-DJ-A13V-01	0	0	19	1.1359775814953329e-05	TCGA-DJ-A13V-01	0	0	0	0	PASS	9926	TCGA-DJ-A13V	THCA	21	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-7915	Alive	TUMOR FREE	1313	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1313	0	1313	0	1313	0	1313	
50	TCGA-DJ-A13W	0	0	0	1	0	0	0	0	0	12	0	0	0	1	1	0	TCGA-DJ-A13W-01	51	3.677994482061704e-05	12	TCGA-DJ-A13W-01	0	0	0	0.0	TCGA-DJ-A13W-01	0	0	0	0	PASS	9927	TCGA-DJ-A13W	THCA	45	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-16558	Alive	TUMOR FREE	1593	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1593	0	1593	0	1593	0	1593	
50	TCGA-DJ-A13X	0	0	0	0	0	0	0	0	0	12	0	0	0	2	0	0	TCGA-DJ-A13X-01	51	1.3779168236385666e-05	16	TCGA-DJ-A13X-01	0	0	0	0.0	TCGA-DJ-A13X-01	0	0	0	0	PASS	9928	TCGA-DJ-A13X	THCA	51	FEMALE	NA	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-18689	Alive	TUMOR FREE	253	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	253	0	253	0	253	0	253	
30	TCGA-DJ-A1QD	0	0	0	0	0	0	0	0	1	8	1	0	0	0	0	0	TCGA-DJ-A1QD-01	49	1.7013859788209343e-05	16	TCGA-DJ-A1QD-01	0	0	0	0.0	TCGA-DJ-A1QD-01	0	0	0	0	PASS	9929	TCGA-DJ-A1QD	THCA	20	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-7460	Alive	TUMOR FREE	1462	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1462	0	1462	0	1462	0	1462	
60	TCGA-DJ-A1QE	0	0	0	0	0	1	0	1	1	15	0	0	0	3	0	0	TCGA-DJ-A1QE-01	55	0.018548210594882587	17	TCGA-DJ-A1QE-01	0	0	0	0.0	TCGA-DJ-A1QE-01	0	0	0	0	PASS	9930	TCGA-DJ-A1QE	THCA	62	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2003	NA	-22645	Alive	TUMOR FREE	4134	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	4134	0	4134	0	4134	0	4134	
60	TCGA-DJ-A1QF	0	0	0	0	0	0	0	0	0	5	0	0	1	11	0	0	TCGA-DJ-A1QF-01	53	2.434100188048053e-05	19	TCGA-DJ-A1QF-01	0	0	0	0.0	TCGA-DJ-A1QF-01	0	0	0	0	PASS	9931	TCGA-DJ-A1QF	THCA	61	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-22310	Alive	TUMOR FREE	931	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	931	0	931	0	931	0	931	
60	TCGA-DJ-A1QG	0	0	0	1	0	0	0	0	0	12	1	0	0	6	0	0	TCGA-DJ-A1QG-01	73	0.011146606544956464	31	TCGA-DJ-A1QG-01	1	1	19	0.011597485829035414	TCGA-DJ-A1QG-01	0	0	0	0	PASS	9932	TCGA-DJ-A1QG	THCA	62	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-22859	Alive	TUMOR FREE	1368	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1368	0	1368	0	1368	0	1368	
60	TCGA-DJ-A1QH	0	0	0	2	1	0	1	0	0	15	0	0	0	7	0	0	TCGA-DJ-A1QH-01	33	2.4242606731570613e-06	3	TCGA-DJ-A1QH-01	0	0	0	0.0	TCGA-DJ-A1QH-01	0	0	0	0	PASS	9933	TCGA-DJ-A1QH	THCA	58	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2010	NA	-21184	Alive	WITH TUMOR	1293	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	1293	0	1293	NA	NA	0	1293	
60	TCGA-DJ-A1QI	0	1	0	0	1	0	0	0	1	7	0	0	1	2	0	0	TCGA-DJ-A1QI-01	67	0.0001208329886695067	30	TCGA-DJ-A1QI-01	0	0	19	1.996091921101373e-05	TCGA-DJ-A1QI-01	0	0	0	0	PASS	9934	TCGA-DJ-A1QI	THCA	63	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-23072	Alive	TUMOR FREE	455	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	455	0	455	0	455	0	455	
70	TCGA-DJ-A1QL	0	1	0	1	0	0	0	0	0	12	1	0	1	4	0	0	TCGA-DJ-A1QL-01	73	5.2762820181822165e-05	33	TCGA-DJ-A1QL-01	0	0	2	3.3669598121829326e-05	TCGA-DJ-A1QL-01	0	0	0	0	PASS	9935	TCGA-DJ-A1QL	THCA	70	MALE	NA	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-25713	Alive	TUMOR FREE	535	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	535	0	535	0	535	0	535	
40	TCGA-DJ-A1QM	0	0	0	1	0	0	0	0	0	9	0	0	0	5	0	0	TCGA-DJ-A1QM-01	47	1.8956630436477724e-05	10	TCGA-DJ-A1QM-01	0	0	0	0.0	TCGA-DJ-A1QM-01	0	0	0	0	PASS	9936	TCGA-DJ-A1QM	THCA	42	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-15418	Alive	TUMOR FREE	183	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	183	0	183	0	183	0	183	
40	TCGA-DJ-A1QN	0	0	0	0	1	0	0	0	0	4	1	0	0	1	0	0	TCGA-DJ-A1QN-01	77	0.034789858868808296	29	TCGA-DJ-A1QN-01	2	2	3	0.03646766353149487	TCGA-DJ-A1QN-01	2	1	2	5	PASS	9937	TCGA-DJ-A1QN	THCA	42	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-15343	Alive	TUMOR FREE	1295	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1295	0	1295	0	1295	0	1295	
70	TCGA-DJ-A1QO	0	2	0	0	1	0	0	0	1	10	2	0	0	4	0	0	TCGA-DJ-A1QO-01	39	4.10244147428317e-06	11	TCGA-DJ-A1QO-01	0	0	0	0.0	TCGA-DJ-A1QO-01	0	0	0	0	PASS	9938	TCGA-DJ-A1QO	THCA	69	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2010	NA	-25232	Alive	TUMOR FREE	1442	NA	NA	New Primary Tumor	"Other, specify"	Cecum	1062	NA	NA	R0	0	1442	0	1442	0	1442	1	1062	
40	TCGA-DJ-A1QQ	0	0	0	0	0	0	1	0	2	11	0	0	0	5	0	0	TCGA-DJ-A1QQ-01	75	6.849549519421886e-05	31	TCGA-DJ-A1QQ-01	0	0	19	0.00937544191028555	TCGA-DJ-A1QQ-01	0	2	1	3	PASS	9939	TCGA-DJ-A1QQ	THCA	43	MALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-15949	Alive	TUMOR FREE	534	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	534	0	534	0	534	0	534	
70	TCGA-DJ-A2PN	0	0	0	0	0	0	0	0	0	5	0	0	0	3	0	0	TCGA-DJ-A2PN-01	45	5.541262735970884e-05	10	TCGA-DJ-A2PN-01	0	0	0	0.0	TCGA-DJ-A2PN-01	0	0	0	0	PASS	9940	TCGA-DJ-A2PN	THCA	70	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-25690	Alive	TUMOR FREE	307	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	307	0	307	0	307	0	307	
50	TCGA-DJ-A2PO	0	0	0	0	0	0	0	0	0	6	0	0	0	1	0	0	TCGA-DJ-A2PO-01	49	0.00018934513774548152	16	TCGA-DJ-A2PO-01	0	0	0	0.0	TCGA-DJ-A2PO-01	0	0	0	0	PASS	9941	TCGA-DJ-A2PO	THCA	54	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-20058	Alive	TUMOR FREE	243	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	243	0	243	0	243	0	243	
50	TCGA-DJ-A2PP	0	0	0	1	1	0	0	0	1	11	0	0	2	6	1	0	TCGA-DJ-A2PP-01	75	0.00011495000539439624	30	TCGA-DJ-A2PP-01	0	0	3	0.0008864611687814211	TCGA-DJ-A2PP-01	1	0	0	1	PASS	9942	TCGA-DJ-A2PP	THCA	47	MALE	NA	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-17410	Alive	TUMOR FREE	930	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	930	0	930	0	930	0	930	
30	TCGA-DJ-A2PQ	1	0	0	0	0	0	1	0	0	5	0	0	1	2	0	0	TCGA-DJ-A2PQ-01	43	0.0001176311259909376	8	TCGA-DJ-A2PQ-01	0	0	2	8.181819615593227e-05	TCGA-DJ-A2PQ-01	0	0	0	0	PASS	9943	TCGA-DJ-A2PQ	THCA	26	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-9664	Alive	TUMOR FREE	1077	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1077	0	1077	0	1077	0	1077	
30	TCGA-DJ-A2PR	0	0	0	0	0	0	0	0	0	6	2	0	0	1	0	0	TCGA-DJ-A2PR-01	59	6.170342613803964e-05	21	TCGA-DJ-A2PR-01	0	0	19	5.5851801029758035e-06	TCGA-DJ-A2PR-01	0	0	0	0	PASS	9944	TCGA-DJ-A2PR	THCA	27	MALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-9914	Alive	TUMOR FREE	835	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	835	0	835	0	835	0	835	
40	TCGA-DJ-A2PS	0	0	0	0	0	0	0	0	1	4	0	0	0	3	0	0	TCGA-DJ-A2PS-01	43	2.5276298249890266e-05	14	TCGA-DJ-A2PS-01	0	0	19	1.002849709219783e-05	TCGA-DJ-A2PS-01	0	0	0	0	PASS	9945	TCGA-DJ-A2PS	THCA	40	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-14916	Alive	TUMOR FREE	797	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	797	0	797	0	797	0	797	
70	TCGA-DJ-A2PT	0	1	0	1	0	0	0	0	0	10	1	0	0	3	0	0	TCGA-DJ-A2PT-01	61	2.5188976927954294e-05	19	TCGA-DJ-A2PT-01	0	0	19	3.202227449931836e-06	TCGA-DJ-A2PT-01	0	0	0	0	PASS	9946	TCGA-DJ-A2PT	THCA	70	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2011	NA	-25837	Alive	TUMOR FREE	1181	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1181	0	1181	0	1181	0	1181	
50	TCGA-DJ-A2PU	0	0	0	0	0	0	0	0	0	8	0	0	0	2	0	0	TCGA-DJ-A2PU-01	43	1.7357698018044884e-05	7	TCGA-DJ-A2PU-01	0	0	0	0.0	TCGA-DJ-A2PU-01	0	0	0	0	PASS	9947	TCGA-DJ-A2PU	THCA	52	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-18998	Alive	TUMOR FREE	1033	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1033	0	1033	0	1033	0	1033	
50	TCGA-DJ-A2PV	0	0	0	0	0	0	0	0	0	7	1	0	0	3	0	0	TCGA-DJ-A2PV-01	33	1.8391330356699404e-05	5	TCGA-DJ-A2PV-01	1	24	19	1.8283388647235536e-05	TCGA-DJ-A2PV-01	0	0	0	0	PASS	9948	TCGA-DJ-A2PV	THCA	53	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-19547	Alive	TUMOR FREE	973	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	973	0	973	0	973	0	973	
70	TCGA-DJ-A2PW	0	0	0	1	1	0	0	0	0	14	3	0	1	4	1	0	TCGA-DJ-A2PW-01	48	0.024117489565156896	12	TCGA-DJ-A2PW-01	1	1	19	1.5066398414915006e-05	TCGA-DJ-A2PW-01	1	1	0	2	PASS	9949	TCGA-DJ-A2PW	THCA	65	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-23987	Alive	TUMOR FREE	1060	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1060	0	1060	0	1060	0	1060	
60	TCGA-DJ-A2PX	0	4	2	4	0	0	0	0	7	69	4	0	3	26	1	1	TCGA-DJ-A2PX-01	29	1.2846355000807668e-05	2	TCGA-DJ-A2PX-01	0	0	0	0.0	TCGA-DJ-A2PX-01	0	0	0	0	PASS	9950	TCGA-DJ-A2PX	THCA	55	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-20088	Alive	TUMOR FREE	881	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	881	0	881	0	881	0	881	
50	TCGA-DJ-A2PY	0	2	0	1	2	0	0	0	0	4	0	0	0	6	0	0	TCGA-DJ-A2PY-01	37	1.3142347642908584e-05	3	TCGA-DJ-A2PY-01	0	0	0	0.0	TCGA-DJ-A2PY-01	0	0	0	0	PASS	9951	TCGA-DJ-A2PY	THCA	46	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2011	NA	-17056	Alive	TUMOR FREE	267	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	267	0	267	0	267	0	267	
60	TCGA-DJ-A2PZ	0	0	0	0	1	1	0	0	0	15	1	0	0	4	0	0	TCGA-DJ-A2PZ-01	35	9.584047730073286e-06	3	TCGA-DJ-A2PZ-01	0	0	0	0.0	TCGA-DJ-A2PZ-01	0	0	0	0	PASS	9952	TCGA-DJ-A2PZ	THCA	63	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-23332	Alive	TUMOR FREE	256	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	256	0	256	0	256	0	256	
60	TCGA-DJ-A2Q0	0	0	0	0	0	0	0	1	2	22	4	0	1	9	1	0	TCGA-DJ-A2Q0-01	67	0.4010069362858125	23	TCGA-DJ-A2Q0-01	18	20	7	0.21478283885819624	TCGA-DJ-A2Q0-01	0	0	0	0	PASS	9953	TCGA-DJ-A2Q0	THCA	57	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-20973	Alive	TUMOR FREE	1045	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1045	0	1045	0	1045	0	1045	
40	TCGA-DJ-A2Q1	0	0	0	3	0	0	0	0	0	13	2	0	1	2	1	0	TCGA-DJ-A2Q1-01	53	0.00010682263082849608	12	TCGA-DJ-A2Q1-01	0	0	19	8.450550231546395e-05	TCGA-DJ-A2Q1-01	0	0	0	0	PASS	9954	TCGA-DJ-A2Q1	THCA	44	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-16371	Alive	TUMOR FREE	1148	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1148	0	1148	0	1148	0	1148	
60	TCGA-DJ-A2Q2	0	1	0	1	0	0	0	0	0	6	3	0	0	4	0	0	TCGA-DJ-A2Q2-01	67	0.032958090476046725	26	TCGA-DJ-A2Q2-01	0	0	0	0.0	TCGA-DJ-A2Q2-01	0	0	0	0	PASS	9955	TCGA-DJ-A2Q2	THCA	57	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-20951	Alive	TUMOR FREE	1337	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1337	0	1337	0	1337	0	1337	
60	TCGA-DJ-A2Q3	0	1	0	2	1	0	0	0	2	13	1	0	0	2	0	0	TCGA-DJ-A2Q3-01	45	5.954470617586855e-05	9	TCGA-DJ-A2Q3-01	0	0	0	0.0	TCGA-DJ-A2Q3-01	0	0	0	0	PASS	9956	TCGA-DJ-A2Q3	THCA	61	FEMALE	ASIAN	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2011	NA	-22637	Alive	TUMOR FREE	1224	NA	NA	New Primary Tumor	Lung	NA	385	NA	NA	R0	0	1224	0	1224	0	1224	1	385	
50	TCGA-DJ-A2Q4	0	0	0	1	0	0	0	0	0	15	1	0	0	2	0	0	TCGA-DJ-A2Q4-01	45	3.848746863470668e-06	12	TCGA-DJ-A2Q4-01	0	0	0	0.0	TCGA-DJ-A2Q4-01	0	0	0	0	PASS	9957	TCGA-DJ-A2Q4	THCA	53	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-19689	Alive	TUMOR FREE	1032	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1032	0	1032	0	1032	0	1032	
50	TCGA-DJ-A2Q5	0	1	0	0	0	0	0	0	0	8	0	0	0	0	0	0	TCGA-DJ-A2Q5-01	45	8.567414414964408e-05	11	TCGA-DJ-A2Q5-01	0	0	4	7.692503556636122e-05	TCGA-DJ-A2Q5-01	0	0	0	0	PASS	9958	TCGA-DJ-A2Q5	THCA	51	MALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-18727	Alive	TUMOR FREE	1140	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1140	0	1140	NA	NA	0	1140	
40	TCGA-DJ-A2Q6	0	0	0	0	0	0	0	0	0	3	2	0	0	2	0	0	TCGA-DJ-A2Q6-01	39	5.1268612819222774e-05	7	TCGA-DJ-A2Q6-01	0	0	0	0.0	TCGA-DJ-A2Q6-01	0	0	0	0	PASS	9959	TCGA-DJ-A2Q6	THCA	38	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-14193	Alive	TUMOR FREE	1109	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1109	0	1109	0	1109	0	1109	
50	TCGA-DJ-A2Q7	0	0	1	1	0	0	0	0	0	10	0	0	0	8	0	0	TCGA-DJ-A2Q7-01	47	0.011028631462627428	11	TCGA-DJ-A2Q7-01	1	1	2	0.01161521312767038	TCGA-DJ-A2Q7-01	0	0	0	0	PASS	9960	TCGA-DJ-A2Q7	THCA	52	FEMALE	ASIAN	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-19193	Alive	TUMOR FREE	1068	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1068	0	1068	0	1068	0	1068	
50	TCGA-DJ-A2Q8	0	1	0	0	0	0	0	0	0	5	1	0	0	3	0	0	TCGA-DJ-A2Q8-01	47	6.864476739960194e-05	12	TCGA-DJ-A2Q8-01	0	0	0	0.0	TCGA-DJ-A2Q8-01	0	0	0	0	PASS	9961	TCGA-DJ-A2Q8	THCA	47	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2011	NA	-17438	Alive	TUMOR FREE	1189	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1189	0	1189	0	1189	0	1189	
70	TCGA-DJ-A2Q9	0	0	0	0	0	0	0	0	0	14	2	0	0	2	0	0	TCGA-DJ-A2Q9-01	47	2.698683415540231e-05	11	TCGA-DJ-A2Q9	0	0	0	0	TCGA-DJ-A2Q9	0	0	0	0	PASS	9962	TCGA-DJ-A2Q9	THCA	65	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2011	NA	-23951	Alive	TUMOR FREE	1092	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1092	0	1092	0	1092	0	1092	
60	TCGA-DJ-A2QA	0	0	0	1	0	0	0	0	1	12	0	0	0	3	0	0	TCGA-DJ-A2QA-01	45	0.011017890023550327	12	TCGA-DJ-A2QA-01	1	1	19	0.011597342734317673	TCGA-DJ-A2QA-01	0	0	0	0	PASS	9963	TCGA-DJ-A2QA	THCA	56	FEMALE	ASIAN	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-20784	Alive	TUMOR FREE	1020	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1020	0	1020	0	1020	0	1020	
50	TCGA-DJ-A2QB	6	23	1	14	2	0	0	0	27	376	74	0	3	175	9	0	TCGA-DJ-A2QB-01	49	0.011013483789801626	18	TCGA-DJ-A2QB-01	1	1	19	0.011597342734317673	TCGA-DJ-A2QB-01	0	0	0	0	PASS	9964	TCGA-DJ-A2QB	THCA	53	FEMALE	ASIAN	Stage IVA	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-19601	Alive	TUMOR FREE	1070	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1070	0	1070	NA	NA	0	1070	
70	TCGA-DJ-A2QC	0	1	0	0	0	0	0	0	0	8	1	0	0	7	0	0	TCGA-DJ-A2QC-01	41	7.644498060438627e-06	10	TCGA-DJ-A2QC-01	0	0	0	0.0	TCGA-DJ-A2QC-01	0	0	0	0	PASS	9965	TCGA-DJ-A2QC	THCA	70	FEMALE	NA	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-25690	Alive	TUMOR FREE	1215	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1215	0	1215	0	1215	0	1215	
40	TCGA-DJ-A3UK	0	0	0	0	0	0	0	0	0	4	0	0	0	4	0	0	TCGA-DJ-A3UK-01	52	0.00978703143790259	13	TCGA-DJ-A3UK-01	0	0	0	0.0	TCGA-DJ-A3UK-01	0	0	0	0	PASS	9966	TCGA-DJ-A3UK	THCA	35	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-13145	Alive	TUMOR FREE	1123	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1123	0	1123	0	1123	0	1123	
50	TCGA-DJ-A3UM	0	0	0	0	1	0	0	0	1	2	0	0	0	2	0	0	TCGA-DJ-A3UM-01	61	0.00013617852916421864	13	TCGA-DJ-A3UM-01	0	0	19	2.435545601080505e-05	TCGA-DJ-A3UM-01	0	0	0	0	PASS	9967	TCGA-DJ-A3UM	THCA	45	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-16573	Alive	TUMOR FREE	944	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	944	0	944	0	944	0	944	
50	TCGA-DJ-A3UN	0	1	0	0	1	0	0	0	0	14	1	0	0	2	0	0	TCGA-DJ-A3UN-01	59	0.01100843089124607	20	TCGA-DJ-A3UN-01	1	1	19	0.011597419790717413	TCGA-DJ-A3UN-01	0	0	0	0	PASS	9968	TCGA-DJ-A3UN	THCA	51	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-18871	Alive	TUMOR FREE	986	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	986	0	986	0	986	0	986	
60	TCGA-DJ-A3UO	0	0	0	1	0	0	0	0	0	11	0	0	0	2	0	0	TCGA-DJ-A3UO-01	39	0.010993752718100543	7	TCGA-DJ-A3UO-01	1	1	19	0.011597342734317673	TCGA-DJ-A3UO-01	0	0	0	0	PASS	9969	TCGA-DJ-A3UO	THCA	63	MALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-23292	Alive	TUMOR FREE	957	NA	NA	New Primary Tumor	"Other, specify"	Prostate	641	NA	NA	R0	0	957	0	957	NA	NA	1	641	
40	TCGA-DJ-A3UP	0	0	0	0	0	0	0	0	0	9	0	0	0	4	1	0	TCGA-DJ-A3UP-01	64	0.009825299419776312	21	TCGA-DJ-A3UP-01	1	1	2	0.009925313106308571	TCGA-DJ-A3UP-01	0	0	1	1	PASS	9970	TCGA-DJ-A3UP	THCA	38	FEMALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-13899	Alive	TUMOR FREE	499	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	499	0	499	0	499	0	499	
50	TCGA-DJ-A3UQ	0	0	0	0	0	0	0	0	0	7	0	0	0	3	1	0	TCGA-DJ-A3UQ-01	73	4.8512302251961746e-05	33	TCGA-DJ-A3UQ-01	0	0	19	1.9671657922288187e-06	TCGA-DJ-A3UQ-01	0	0	0	0	PASS	9971	TCGA-DJ-A3UQ	THCA	45	FEMALE	ASIAN	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2011	NA	-16545	Alive	TUMOR FREE	595	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	595	0	595	0	595	0	595	
50	TCGA-DJ-A3UR	0	1	0	0	0	1	0	0	0	6	0	0	0	1	0	0	TCGA-DJ-A3UR-01	51	0.00011532578247340215	12	TCGA-DJ-A3UR-01	0	0	0	0.0	TCGA-DJ-A3UR-01	0	0	0	0	PASS	9972	TCGA-DJ-A3UR	THCA	51	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-18808	Alive	TUMOR FREE	1105	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1105	0	1105	0	1105	0	1105	
40	TCGA-DJ-A3US	0	0	0	0	0	0	0	0	0	7	0	0	0	1	0	0	TCGA-DJ-A3US-01	91	0.002706103524454349	43	TCGA-DJ-A3US	0	0	0	0	TCGA-DJ-A3US	0	0	0	0	PASS	9973	TCGA-DJ-A3US	THCA	37	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-13634	Alive	TUMOR FREE	998	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	998	0	998	0	998	0	998	
40	TCGA-DJ-A3UT	0	0	0	0	1	0	0	0	0	9	0	0	0	2	0	1	TCGA-DJ-A3UT-01	39	9.160525019580967e-06	6	TCGA-DJ-A3UT-01	0	0	0	0.0	TCGA-DJ-A3UT-01	0	0	0	0	PASS	9974	TCGA-DJ-A3UT	THCA	43	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-15767	Alive	TUMOR FREE	1105	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1105	0	1105	0	1105	0	1105	
50	TCGA-DJ-A3UU	0	1	0	0	1	0	0	0	1	5	0	0	0	1	0	0	TCGA-DJ-A3UU-01	61	1.18860210974291e-05	25	TCGA-DJ-A3UU-01	0	0	0	0.0	TCGA-DJ-A3UU-01	0	0	0	0	PASS	9975	TCGA-DJ-A3UU	THCA	49	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-17919	Alive	WITH TUMOR	713	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	713	0	713	NA	NA	0	713	
20	TCGA-DJ-A3UV	0	1	0	0	0	0	0	0	0	4	0	0	0	6	0	0	TCGA-DJ-A3UV	0	0	0	TCGA-DJ-A3UV	0	0	0	0	TCGA-DJ-A3UV	0	0	0	0	PASS	9976	TCGA-DJ-A3UV	THCA	18	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-6850	Alive	TUMOR FREE	1466	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1466	0	1466	0	1466	0	1466	
50	TCGA-DJ-A3UW	0	1	0	0	0	0	0	0	1	4	0	0	0	2	0	0	TCGA-DJ-A3UW-01	45	6.0844715194166885e-05	6	TCGA-DJ-A3UW-01	0	0	19	4.2285461358568976e-05	TCGA-DJ-A3UW-01	0	0	0	0	PASS	9977	TCGA-DJ-A3UW	THCA	50	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-18487	Alive	TUMOR FREE	1812	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1812	0	1812	0	1812	0	1812	
50	TCGA-DJ-A3UX	0	0	0	1	0	0	0	0	1	6	0	0	0	1	0	0	TCGA-DJ-A3UX-01	59	2.681051688701757e-05	20	TCGA-DJ-A3UX	0	0	0	0	TCGA-DJ-A3UX	0	0	0	0	PASS	9978	TCGA-DJ-A3UX	THCA	46	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-17124	Alive	WITH TUMOR	345	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	345	0	345	0	345	0	345	
30	TCGA-DJ-A3UY	0	2	0	0	0	0	0	0	0	3	1	0	0	0	0	0	TCGA-DJ-A3UY-01	47	0.0006392995174550901	12	TCGA-DJ-A3UY-01	0	0	0	0.0	TCGA-DJ-A3UY-01	0	0	0	0	PASS	9979	TCGA-DJ-A3UY	THCA	32	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-12004	Alive	TUMOR FREE	1091	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1091	0	1091	0	1091	0	1091	
70	TCGA-DJ-A3UZ	0	0	0	0	0	0	0	0	0	4	0	0	0	2	0	0	TCGA-DJ-A3UZ-01	55	0.00012648800416974952	21	TCGA-DJ-A3UZ	0	0	0	0	TCGA-DJ-A3UZ	0	0	0	0	PASS	9980	TCGA-DJ-A3UZ	THCA	70	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-25846	Alive	TUMOR FREE	1246	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1246	0	1246	0	1246	0	1246	
60	TCGA-DJ-A3V0	0	0	0	1	2	0	0	0	1	13	0	1	0	6	1	0	TCGA-DJ-A3V0-01	55	0.00025644889415722997	15	TCGA-DJ-A3V0-01	0	0	19	2.3215962576162438e-05	TCGA-DJ-A3V0-01	0	0	0	0	PASS	9981	TCGA-DJ-A3V0	THCA	56	MALE	[Unknown]	Stage IVA	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2010	NA	-20496	Alive	TUMOR FREE	1125	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1125	0	1125	NA	NA	0	1125	
40	TCGA-DJ-A3V2	0	1	0	0	0	0	0	0	0	3	0	0	0	1	0	0	TCGA-DJ-A3V2-01	39	0.0003483131827929847	10	TCGA-DJ-A3V2-01	0	0	8	0.0009606218868063258	TCGA-DJ-A3V2-01	0	0	0	0	PASS	9982	TCGA-DJ-A3V2	THCA	44	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-16382	Alive	TUMOR FREE	615	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	615	0	615	0	615	0	615	
60	TCGA-DJ-A3V3	0	0	0	2	0	0	0	0	1	5	0	0	0	1	0	0	TCGA-DJ-A3V3-01	63	0.00015125605443034814	25	TCGA-DJ-A3V3-01	0	0	11	0.0004134914237167862	TCGA-DJ-A3V3-01	0	0	0	0	PASS	9983	TCGA-DJ-A3V3	THCA	57	FEMALE	ASIAN	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-20997	Alive	TUMOR FREE	931	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	931	0	931	0	931	0	931	
60	TCGA-DJ-A3V4	0	1	0	0	0	0	0	0	0	13	0	0	0	1	1	0	TCGA-DJ-A3V4-01	39	2.939913769570063e-06	6	TCGA-DJ-A3V4-01	0	0	8	0.00037189658372358334	TCGA-DJ-A3V4-01	0	0	0	0	PASS	9984	TCGA-DJ-A3V4	THCA	60	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2011	NA	-22218	Alive	TUMOR FREE	1294	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1294	0	1294	0	1294	0	1294	
80	TCGA-DJ-A3V5	0	3	0	0	0	0	0	0	0	16	0	1	0	2	0	0	TCGA-DJ-A3V5-01	59	0.00014859749648979363	20	TCGA-DJ-A3V5-01	0	0	5	0.00034509888047142603	TCGA-DJ-A3V5-01	0	0	0	0	PASS	9985	TCGA-DJ-A3V5	THCA	76	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2011	NA	-27918	Alive	TUMOR FREE	584	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	584	0	584	NA	NA	0	584	
50	TCGA-DJ-A3V6	0	3	0	2	0	0	0	0	1	12	1	0	0	5	0	0	TCGA-DJ-A3V6	0	0	0	TCGA-DJ-A3V6	0	0	0	0	TCGA-DJ-A3V6	0	0	0	0	PASS	9986	TCGA-DJ-A3V6	THCA	54	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2011	NA	-19870	Alive	TUMOR FREE	818	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	818	0	818	0	818	0	818	
40	TCGA-DJ-A3V7	0	1	1	1	0	0	0	0	0	25	2	0	0	5	0	0	TCGA-DJ-A3V7-01	41	1.7786625882140537e-05	6	TCGA-DJ-A3V7	0	0	0	0	TCGA-DJ-A3V7	0	0	0	0	PASS	9987	TCGA-DJ-A3V7	THCA	44	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2011	NA	-16257	Alive	TUMOR FREE	706	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	706	0	706	0	706	0	706	
30	TCGA-DJ-A3V8	0	0	0	0	0	0	0	0	0	9	0	0	0	4	0	0	TCGA-DJ-A3V8-01	35	3.754123222153353e-05	3	TCGA-DJ-A3V8-01	0	0	0	0.0	TCGA-DJ-A3V8-01	0	0	0	0	PASS	9988	TCGA-DJ-A3V8	THCA	28	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2011	NA	-10398	Alive	TUMOR FREE	647	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	647	0	647	0	647	0	647	
50	TCGA-DJ-A3V9	0	0	0	0	0	0	0	0	0	5	0	0	0	1	0	0	TCGA-DJ-A3V9-01	33	1.2424803382127996e-05	2	TCGA-DJ-A3V9-01	0	0	5	0.001060153415472332	TCGA-DJ-A3V9-01	0	0	0	0	PASS	9989	TCGA-DJ-A3V9	THCA	50	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-18399	Alive	TUMOR FREE	623	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	623	0	623	NA	NA	0	623	
40	TCGA-DJ-A3VA	0	0	0	1	0	0	0	0	1	6	0	0	1	6	0	0	TCGA-DJ-A3VA-01	41	3.4507001576232404e-05	7	TCGA-DJ-A3VA	0	0	0	0	TCGA-DJ-A3VA	0	0	0	0	PASS	9990	TCGA-DJ-A3VA	THCA	39	FEMALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-14495	Alive	TUMOR FREE	755	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	755	0	755	0	755	0	755	
50	TCGA-DJ-A3VB	0	2	0	1	0	0	0	0	1	9	0	0	1	5	0	0	TCGA-DJ-A3VB-01	47	0.00024608353436049565	7	TCGA-DJ-A3VB-01	0	0	7	0.0014704969715542474	TCGA-DJ-A3VB-01	0	0	0	0	PASS	9991	TCGA-DJ-A3VB	THCA	52	MALE	[Unknown]	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2011	NA	-19248	Alive	TUMOR FREE	697	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	697	0	697	0	697	0	697	
30	TCGA-DJ-A3VD	0	2	0	0	0	0	0	0	0	8	0	0	0	0	0	0	TCGA-DJ-A3VD-01	47	2.5916956410850728e-05	13	TCGA-DJ-A3VD-01	0	0	5	0.0003584721330766359	TCGA-DJ-A3VD-01	0	0	0	0	PASS	9992	TCGA-DJ-A3VD	THCA	32	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-12019	Alive	TUMOR FREE	1238	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1238	0	1238	0	1238	0	1238	
50	TCGA-DJ-A3VE	0	0	0	0	0	0	0	0	0	8	0	0	0	5	0	0	TCGA-DJ-A3VE-01	49	1.4238087421962866e-05	13	TCGA-DJ-A3VE-01	0	0	8	0.012581250498491564	TCGA-DJ-A3VE-01	0	0	1	1	PASS	9993	TCGA-DJ-A3VE	THCA	50	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-18417	Alive	TUMOR FREE	577	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	577	0	577	0	577	0	577	
60	TCGA-DJ-A3VF	0	0	0	0	0	0	0	0	0	5	0	0	0	3	1	0	TCGA-DJ-A3VF-01	37	1.7101129836896315e-05	5	TCGA-DJ-A3VF-01	0	0	8	0.001519669641791347	TCGA-DJ-A3VF-01	0	0	0	0	PASS	9994	TCGA-DJ-A3VF	THCA	60	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2011	NA	-22234	Alive	TUMOR FREE	292	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	292	0	292	NA	NA	0	292	
40	TCGA-DJ-A3VG	0	1	0	0	0	0	0	0	1	11	2	0	0	5	0	0	TCGA-DJ-A3VG-01	43	1.6874507392568175e-05	8	TCGA-DJ-A3VG-01	0	0	7	0.001110980925224614	TCGA-DJ-A3VG-01	0	0	0	0	PASS	9995	TCGA-DJ-A3VG	THCA	40	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-14970	Alive	TUMOR FREE	1085	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1085	0	1085	0	1085	0	1085	
50	TCGA-DJ-A3VI	0	0	0	0	0	0	0	0	1	14	1	0	0	6	1	0	TCGA-DJ-A3VI-01	49	5.160289063541494e-06	13	TCGA-DJ-A3VI-01	0	0	2	7.266169129420847e-05	TCGA-DJ-A3VI-01	0	0	0	0	PASS	9996	TCGA-DJ-A3VI	THCA	52	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-19053	Alive	TUMOR FREE	95	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	95	0	95	0	95	0	95	
30	TCGA-DJ-A3VJ	0	1	0	0	0	0	0	0	0	6	0	0	1	1	0	0	TCGA-DJ-A3VJ-01	35	3.113517231379462e-06	4	TCGA-DJ-A3VJ-01	0	0	8	0.010620708067637824	TCGA-DJ-A3VJ-01	0	0	1	1	PASS	9997	TCGA-DJ-A3VJ	THCA	22	MALE	WHITE	Stage I	NA	"Other, specify"	NA	2010	NA	-8341	Alive	TUMOR FREE	1108	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1108	0	1108	0	1108	0	1108	
60	TCGA-DJ-A3VK	0	3	0	0	0	0	0	0	1	12	1	0	0	4	0	0	TCGA-DJ-A3VK-01	55	0.011004872338525288	18	TCGA-DJ-A3VK-01	1	1	20	0.0128554657976271	TCGA-DJ-A3VK-01	0	0	0	0	PASS	9998	TCGA-DJ-A3VK	THCA	63	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-23255	Alive	TUMOR FREE	753	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	753	0	753	0	753	0	753	
40	TCGA-DJ-A3VL	0	3	0	2	0	0	1	0	0	6	0	0	1	1	0	0	TCGA-DJ-A3VL-01	51	4.621783884982527e-05	16	TCGA-DJ-A3VL-01	0	0	11	0.0005245244380595116	TCGA-DJ-A3VL-01	0	0	0	0	PASS	9999	TCGA-DJ-A3VL	THCA	38	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-14219	Alive	TUMOR FREE	713	NA	NA	New Primary Tumor	"Other, specify"	Bowel	411	NA	NA	R0	0	713	0	713	0	713	1	411	
70	TCGA-DJ-A3VM	1	1	0	0	1	0	0	0	0	9	2	0	0	7	0	0	TCGA-DJ-A3VM-01	35	0.011064854841441258	5	TCGA-DJ-A3VM-01	1	1	7	0.012606547153552972	TCGA-DJ-A3VM-01	0	0	0	0	PASS	10000	TCGA-DJ-A3VM	THCA	68	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-24896	Alive	TUMOR FREE	840	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	840	0	840	0	840	0	840	
70	TCGA-DJ-A4UL	0	0	0	0	0	0	0	0	0	6	0	0	0	4	0	0	TCGA-DJ-A4UL-01	67	1.900977193111638e-05	28	TCGA-DJ-A4UL-01	0	0	7	0.0014504649923457046	TCGA-DJ-A4UL-01	0	0	0	0	PASS	10001	TCGA-DJ-A4UL	THCA	68	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-24939	Alive	TUMOR FREE	939	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	939	0	939	0	939	0	939	
20	TCGA-DJ-A4UP	0	0	0	1	0	0	0	0	1	5	0	1	0	2	0	0	TCGA-DJ-A4UP-01	33	0.00019729075990039755	3	TCGA-DJ-A4UP-01	0	0	8	0.0016616343161780034	TCGA-DJ-A4UP-01	0	0	0	0	PASS	10002	TCGA-DJ-A4UP	THCA	15	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-5655	Alive	TUMOR FREE	916	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	916	0	916	0	916	0	916	
60	TCGA-DJ-A4UQ	0	0	0	1	0	0	0	0	0	15	0	0	0	3	0	0	TCGA-DJ-A4UQ-01	49	3.8910579177822494e-05	13	TCGA-DJ-A4UQ-01	0	0	2	0.0009115635372286613	TCGA-DJ-A4UQ-01	0	0	0	0	PASS	10003	TCGA-DJ-A4UQ	THCA	60	MALE	ASIAN	Stage IVA	NA	"Other, specify"	NA	2012	NA	-22097	Alive	WITH TUMOR	1005	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1005	0	1005	NA	NA	0	1005	
40	TCGA-DJ-A4UR	0	2	0	0	0	0	0	0	1	12	0	0	1	4	0	0	TCGA-DJ-A4UR-01	65	0.030315501341823026	24	TCGA-DJ-A4UR-01	2	2	11	0.032691489951542814	TCGA-DJ-A4UR-01	2	2	2	6	PASS	10004	TCGA-DJ-A4UR	THCA	36	FEMALE	ASIAN	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2012	NA	-13463	Alive	WITH TUMOR	1058	NA	NA	Distant Metastasis	Lung	NA	113	NA	NA	R0	0	1058	0	1058	1	113	1	113	
30	TCGA-DJ-A4UT	1	2	0	2	0	0	0	0	1	25	3	0	0	8	2	0	TCGA-DJ-A4UT-01	51	2.818866858896795e-05	13	TCGA-DJ-A4UT-01	0	0	8	0.00039994362678236656	TCGA-DJ-A4UT-01	0	0	0	0	PASS	10005	TCGA-DJ-A4UT	THCA	32	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-11813	Alive	TUMOR FREE	823	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	823	0	823	0	823	0	823	
30	TCGA-DJ-A4UW	0	1	0	0	0	0	0	0	1	5	2	0	1	2	0	0	TCGA-DJ-A4UW-01	63	6.911853106945504e-05	20	TCGA-DJ-A4UW-01	0	0	5	0.00036375000260119636	TCGA-DJ-A4UW-01	0	0	0	0	PASS	10006	TCGA-DJ-A4UW	THCA	34	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2012	NA	-12563	Alive	TUMOR FREE	819	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	819	0	819	NA	NA	0	819	
40	TCGA-DJ-A4V0	0	1	0	0	0	0	0	0	0	4	0	0	0	1	0	0	TCGA-DJ-A4V0-01	66	4.378547419452922e-05	28	TCGA-DJ-A4V0-01	0	0	11	0.0012123239024710054	TCGA-DJ-A4V0-01	0	0	0	0	PASS	10007	TCGA-DJ-A4V0	THCA	36	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-13168	Alive	TUMOR FREE	1081	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1081	0	1081	0	1081	0	1081	
40	TCGA-DJ-A4V2	0	0	0	0	0	0	0	0	1	6	2	0	0	2	1	0	TCGA-DJ-A4V2-01	51	0.0001061144510120468	15	TCGA-DJ-A4V2-01	0	0	5	0.0004031235722895749	TCGA-DJ-A4V2-01	0	0	0	0	PASS	10008	TCGA-DJ-A4V2	THCA	38	FEMALE	[Not Evaluated]	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-14126	Alive	TUMOR FREE	95	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	95	0	95	0	95	0	95	
50	TCGA-DJ-A4V4	1	0	0	0	0	0	0	0	2	18	2	0	0	5	0	0	TCGA-DJ-A4V4-01	43	8.847691242401856e-06	9	TCGA-DJ-A4V4-01	0	0	5	4.012041324192877e-05	TCGA-DJ-A4V4-01	0	0	0	0	PASS	10009	TCGA-DJ-A4V4	THCA	48	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2012	NA	-17878	Alive	TUMOR FREE	481	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	481	0	481	0	481	0	481	
60	TCGA-DJ-A4V5	0	0	0	0	0	0	0	0	0	4	0	0	0	3	0	0	TCGA-DJ-A4V5-01	45	8.69701670078524e-05	12	TCGA-DJ-A4V5-01	0	0	6	0.00032349398384034486	TCGA-DJ-A4V5-01	0	0	0	0	PASS	10010	TCGA-DJ-A4V5	THCA	55	MALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-20108	Alive	TUMOR FREE	1076	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1076	0	1076	NA	NA	0	1076	
30	TCGA-DO-A1JZ	0	2	0	0	0	0	0	0	0	9	0	0	0	0	0	0	TCGA-DO-A1JZ-01	53	4.908555897887379e-05	12	TCGA-DO-A1JZ-01	0	0	2	3.504503604629449e-05	TCGA-DO-A1JZ-01	0	0	0	0	PASS	10011	TCGA-DO-A1JZ	THCA	23	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2007	NA	-8551	Alive	TUMOR FREE	1670	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	1670	0	1670	NA	NA	0	1670	
30	TCGA-DO-A1K0	0	0	0	1	0	1	0	0	1	6	0	0	0	3	0	0	TCGA-DO-A1K0-01	37	0.00017900989057761542	3	TCGA-DO-A1K0-01	0	0	0	0.0	TCGA-DO-A1K0-01	0	0	0	0	PASS	10012	TCGA-DO-A1K0	THCA	30	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-11216	Alive	WITH TUMOR	655	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	577	NA	NA	R0	0	655	0	655	1	577	1	577	
50	TCGA-DO-A2HM	1	4	0	2	0	0	0	0	4	51	6	0	1	26	2	0	TCGA-DO-A2HM-01	41	0.00039014627821422685	5	TCGA-DO-A2HM-01	0	0	0	0.0	TCGA-DO-A2HM-01	0	0	0	0	PASS	10013	TCGA-DO-A2HM	THCA	49	MALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-18068	Alive	TUMOR FREE	71	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	71	0	71	NA	NA	0	71	
40	TCGA-E3-A3DY	0	0	0	0	0	0	0	0	0	9	0	0	0	2	0	0	TCGA-E3-A3DY-01	53	4.927774163936645e-05	10	TCGA-E3-A3DY-01	0	0	2	1.5607007659483326e-05	TCGA-E3-A3DY-01	0	0	0	0	PASS	10014	TCGA-E3-A3DY	THCA	37	MALE	WHITE	Stage I	NA	"Other, specify"	NA	2007	NA	-13860	Alive	TUMOR FREE	2815	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2815	0	2815	0	2815	0	2815	
60	TCGA-E3-A3DZ	0	1	0	2	2	0	1	0	2	19	0	0	0	2	0	0	TCGA-E3-A3DZ-01	37	0.010991401358996813	5	TCGA-E3-A3DZ-01	1	1	19	0.011597495461267074	TCGA-E3-A3DZ-01	0	0	0	0	PASS	10015	TCGA-E3-A3DZ	THCA	55	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-20251	Alive	TUMOR FREE	1436	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1436	0	1436	0	1436	0	1436	
30	TCGA-E3-A3E0	0	1	0	0	0	0	0	0	1	6	0	0	0	3	0	0	TCGA-E3-A3E0-01	55	1.0743111741633928e-05	21	TCGA-E3-A3E0-01	0	0	0	0.0	TCGA-E3-A3E0-01	0	0	0	0	PASS	10016	TCGA-E3-A3E0	THCA	34	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2006	NA	-12645	Alive	TUMOR FREE	2019	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2019	0	2019	0	2019	0	2019	
50	TCGA-E3-A3E1	0	0	0	0	1	0	0	0	0	11	0	0	0	3	0	0	TCGA-E3-A3E1-01	51	3.5337956503041225e-05	13	TCGA-E3-A3E1-01	0	0	19	2.5917448817256078e-05	TCGA-E3-A3E1-01	0	0	0	0	PASS	10017	TCGA-E3-A3E1	THCA	46	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-16895	Alive	TUMOR FREE	2449	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2449	0	2449	0	2449	0	2449	
30	TCGA-E3-A3E2	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	TCGA-E3-A3E2-01	72	6.2589400816760944e-06	31	TCGA-E3-A3E2-01	0	0	0	0.0	TCGA-E3-A3E2-01	0	0	0	0	PASS	10018	TCGA-E3-A3E2	THCA	34	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2007	NA	-12714	Alive	TUMOR FREE	1922	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1922	0	1922	0	1922	0	1922	
50	TCGA-E3-A3E3	0	1	0	2	0	1	0	0	0	8	0	0	0	3	2	0	TCGA-E3-A3E3-01	39	5.522256438787222e-06	8	TCGA-E3-A3E3-01	0	0	0	0.0	TCGA-E3-A3E3-01	0	0	0	0	PASS	10019	TCGA-E3-A3E3	THCA	49	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-18140	Alive	TUMOR FREE	1595	NA	NA	Distant Metastasis	Lymph Node Only	NA	445	NA	NA	R0	0	1595	0	1595	1	445	1	445	
60	TCGA-E3-A3E5	0	0	1	1	1	0	0	0	1	7	1	0	0	3	1	0	TCGA-E3-A3E5-01	46	0.009433361608721916	15	TCGA-E3-A3E5-01	1	1	3	0.009944926659410498	TCGA-E3-A3E5-01	0	0	1	1	PASS	10020	TCGA-E3-A3E5	THCA	57	MALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-20993	Alive	TUMOR FREE	1215	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	1215	0	1215	NA	NA	0	1215	
60	TCGA-E8-A242	0	0	0	0	0	0	0	0	3	12	0	0	0	3	0	0	TCGA-E8-A242-01	57	2.1801160350888722e-05	14	TCGA-E8-A242-01	0	0	0	0.0	TCGA-E8-A242-01	0	0	0	0	PASS	10021	TCGA-E8-A242	THCA	56	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-20472	Alive	TUMOR FREE	950	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	950	0	950	NA	NA	0	950	
50	TCGA-E8-A2EA	1	22	1	12	1	0	0	0	20	269	28	1	6	112	9	2	TCGA-E8-A2EA-01	33	5.6353214979762535e-05	4	TCGA-E8-A2EA	0	0	0	0	TCGA-E8-A2EA	0	0	0	0	PASS	10022	TCGA-E8-A2EA	THCA	52	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-19159	Alive	TUMOR FREE	1085	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1085	0	1085	0	1085	0	1085	
20	TCGA-E8-A2JQ	0	2	0	0	0	0	0	0	0	34	0	0	0	8	0	0	TCGA-E8-A2JQ	0	0	0	TCGA-E8-A2JQ	0	0	0	0	TCGA-E8-A2JQ	0	0	0	0	PASS	10023	TCGA-E8-A2JQ	THCA	18	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-6684	Alive	TUMOR FREE	356	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	356	0	356	NA	NA	0	356	
60	TCGA-E8-A3X7	0	0	0	0	0	0	0	0	0	9	0	0	0	1	0	0	TCGA-E8-A3X7-01	47	4.610562832310062e-05	16	TCGA-E8-A3X7-01	0	0	8	0.0002530564501949876	TCGA-E8-A3X7-01	0	0	0	0	PASS	10024	TCGA-E8-A3X7	THCA	57	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-20983	Alive	TUMOR FREE	951	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	951	0	951	NA	NA	0	951	
40	TCGA-E8-A413	0	0	0	0	0	0	0	0	0	3	0	0	1	2	0	0	TCGA-E8-A413-01	61	0.00023919654507929984	16	TCGA-E8-A413-01	0	0	12	0.0010271154628103693	TCGA-E8-A413-01	0	0	0	0	PASS	10025	TCGA-E8-A413	THCA	38	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-13909	Alive	TUMOR FREE	912	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	912	0	912	0	912	0	912	
50	TCGA-E8-A414	0	0	0	0	0	0	0	0	0	4	0	0	0	2	2	0	TCGA-E8-A414-01	65	0.00010457853324085668	20	TCGA-E8-A414-01	0	0	10	0.0004438029044470825	TCGA-E8-A414-01	0	0	0	0	PASS	10026	TCGA-E8-A414	THCA	45	FEMALE	ASIAN	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-16754	Alive	TUMOR FREE	958	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	958	0	958	0	958	0	958	
40	TCGA-E8-A415	0	0	0	1	0	0	0	0	1	8	1	0	0	1	0	0	TCGA-E8-A415-01	43	2.140648469139816e-05	7	TCGA-E8-A415	0	0	0	0	TCGA-E8-A415	0	0	0	0	PASS	10027	TCGA-E8-A415	THCA	39	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-14288	Alive	TUMOR FREE	944	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	944	0	944	0	944	0	944	
50	TCGA-E8-A416	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	TCGA-E8-A416-01	81	0.0002383106172028468	35	TCGA-E8-A416	0	0	0	0	TCGA-E8-A416	0	0	0	0	PASS	10028	TCGA-E8-A416	THCA	51	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-18932	Alive	TUMOR FREE	952	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	952	0	952	0	952	0	952	
40	TCGA-E8-A417	0	0	0	0	1	0	0	0	0	21	2	0	0	5	1	0	TCGA-E8-A417-01	53	3.957108767311122e-05	15	TCGA-E8-A417-01	0	0	10	0.001375884510278027	TCGA-E8-A417-01	0	0	0	0	PASS	10029	TCGA-E8-A417	THCA	38	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-14019	Alive	TUMOR FREE	938	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	938	0	938	0	938	0	938	
80	TCGA-E8-A418	0	1	1	1	1	0	0	0	1	30	0	0	1	6	0	0	TCGA-E8-A418-01	39	6.462460983659166e-05	7	TCGA-E8-A418-01	0	0	6	9.847519696515676e-05	TCGA-E8-A418-01	0	0	0	0	PASS	10030	TCGA-E8-A418	THCA	75	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-27737	Alive	TUMOR FREE	92	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	92	0	92	NA	NA	0	92	
30	TCGA-E8-A419	0	0	0	2	0	0	0	0	0	6	0	0	0	3	0	0	TCGA-E8-A419-01	43	4.2436973487061976e-05	10	TCGA-E8-A419-01	0	0	7	0.0009600343774441923	TCGA-E8-A419-01	0	0	0	0	PASS	10031	TCGA-E8-A419	THCA	30	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-11306	Alive	TUMOR FREE	774	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	774	0	774	0	774	0	774	
60	TCGA-E8-A432	0	0	0	0	1	0	1	0	1	14	2	0	2	6	0	0	TCGA-E8-A432-01	77	0.2298670080656345	32	TCGA-E8-A432-01	9	8	11	0.03877918849404256	TCGA-E8-A432-01	2	2	1	5	PASS	10032	TCGA-E8-A432	THCA	57	FEMALE	ASIAN	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-20874	Alive	TUMOR FREE	931	NA	NA	Locoregional Recurrence	NA	NA	720	NA	NA	R0	0	931	0	931	1	720	1	720	
30	TCGA-E8-A433	0	0	0	0	1	1	0	0	0	10	0	0	0	1	0	0	TCGA-E8-A433-01	51	2.078826684233224e-05	13	TCGA-E8-A433	0	0	0	0	TCGA-E8-A433	0	0	0	0	PASS	10033	TCGA-E8-A433	THCA	25	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-9145	Alive	TUMOR FREE	951	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	951	0	951	0	951	0	951	
60	TCGA-E8-A434	1	0	0	0	0	0	0	0	0	2	1	0	0	3	0	0	TCGA-E8-A434-01	53	5.567276747625581e-05	16	TCGA-E8-A434-01	0	0	7	0.0011852607472655412	TCGA-E8-A434-01	0	0	0	0	PASS	10034	TCGA-E8-A434	THCA	56	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-20492	Alive	TUMOR FREE	953	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	953	0	953	0	953	0	953	
50	TCGA-E8-A436	0	0	0	1	0	0	0	0	1	11	0	0	0	5	0	0	TCGA-E8-A436-01	33	1.2923912119398177e-06	3	TCGA-E8-A436	0	0	0	0	TCGA-E8-A436	0	0	0	0	PASS	10035	TCGA-E8-A436	THCA	53	FEMALE	ASIAN	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-19640	Alive	TUMOR FREE	455	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	455	0	455	NA	NA	0	455	
60	TCGA-E8-A437	0	0	0	0	0	0	0	0	0	13	0	0	0	7	0	0	TCGA-E8-A437-01	43	1.3049367189704093e-05	10	TCGA-E8-A437-01	0	0	8	0.001320579956094854	TCGA-E8-A437-01	0	0	0	0	PASS	10036	TCGA-E8-A437	THCA	57	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-21073	Alive	TUMOR FREE	1213	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	1213	0	1213	NA	NA	0	1213	
30	TCGA-E8-A438	0	0	0	0	0	0	0	0	1	5	0	0	0	3	0	0	TCGA-E8-A438-01	41	4.493065445882093e-06	8	TCGA-E8-A438-01	0	0	3	0.00013223284374602607	TCGA-E8-A438-01	0	0	0	0	PASS	10037	TCGA-E8-A438	THCA	23	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-8752	Alive	TUMOR FREE	1019	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1019	0	1019	0	1019	0	1019	
50	TCGA-E8-A44K	0	1	0	0	0	0	0	0	0	7	0	0	1	4	0	0	TCGA-E8-A44K-01	44	0.0002997950183157835	6	TCGA-E8-A44K-01	0	0	6	0.0009138687684625867	TCGA-E8-A44K-01	0	0	0	0	PASS	10038	TCGA-E8-A44K	THCA	50	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-18472	Alive	TUMOR FREE	943	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	943	0	943	0	943	0	943	
30	TCGA-E8-A44M	0	0	0	0	0	0	0	0	1	2	1	0	1	3	0	0	TCGA-E8-A44M-01	55	3.3972031031874105e-05	21	TCGA-E8-A44M	0	0	0	0	TCGA-E8-A44M	0	0	0	0	PASS	10039	TCGA-E8-A44M	THCA	23	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-8523	Alive	TUMOR FREE	917	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	917	0	917	0	917	0	917	
70	TCGA-EL-A3CL	0	0	0	0	1	1	0	0	0	4	1	0	0	3	0	0	TCGA-EL-A3CL-01	37	0.01104178476115367	7	TCGA-EL-A3CL-01	1	1	3	0.01164903864550901	TCGA-EL-A3CL-01	0	0	0	0	PASS	10040	TCGA-EL-A3CL	THCA	70	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	1994	NA	-25761	Dead	NA	NA	963	NA	NA	NA	NA	NA	NA	NA	R0	1	963	NA	963	0	963	0	963	
60	TCGA-EL-A3CM	0	0	0	1	0	0	0	0	0	17	1	0	1	8	1	0	TCGA-EL-A3CM-01	43	9.803851787344518e-05	11	TCGA-EL-A3CM-01	0	0	2	4.939324918862735e-05	TCGA-EL-A3CM-01	0	0	0	0	PASS	10041	TCGA-EL-A3CM	THCA	64	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	1996	NA	-23406	Dead	NA	NA	813	NA	NA	NA	NA	NA	NA	NA	R1	1	813	NA	813	NA	NA	0	813	
50	TCGA-EL-A3CN	0	1	0	0	0	0	0	0	0	14	1	0	0	3	1	0	TCGA-EL-A3CN-01	49	9.166183963194554e-05	11	TCGA-EL-A3CN-01	0	0	19	3.418159281212713e-05	TCGA-EL-A3CN-01	0	0	0	0	PASS	10042	TCGA-EL-A3CN	THCA	47	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	1999	NA	-17456	Alive	TUMOR FREE	4731	NA	NA	NA	NA	NA	NA	NA	NA	R2	0	4731	0	4731	NA	NA	0	4731	
90	TCGA-EL-A3CO	0	0	1	1	1	0	0	0	0	4	0	0	0	2	1	0	TCGA-EL-A3CO-01	43	8.754620541537004e-06	11	TCGA-EL-A3CO-01	0	0	19	2.756939085281887e-06	TCGA-EL-A3CO-01	0	0	0	0	PASS	10043	TCGA-EL-A3CO	THCA	88	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	1999	NA	-32146	Dead	NA	NA	2973	NA	NA	NA	NA	NA	NA	NA	R1	1	2973	NA	2973	NA	NA	0	2973	
50	TCGA-EL-A3CP	0	0	0	1	0	0	0	0	1	5	0	0	0	4	0	0	TCGA-EL-A3CP-01	49	3.861683646775918e-05	13	TCGA-EL-A3CP-01	0	0	19	2.373277749758633e-05	TCGA-EL-A3CP-01	0	0	0	0	PASS	10044	TCGA-EL-A3CP	THCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	1999	NA	-18298	Alive	TUMOR FREE	4831	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	4831	0	4831	NA	NA	0	4831	
80	TCGA-EL-A3CR	1	0	0	1	2	0	2	0	0	22	2	0	0	8	0	0	TCGA-EL-A3CR-01	63	2.8421096817892548e-05	23	TCGA-EL-A3CR-01	0	0	0	0.0	TCGA-EL-A3CR-01	0	0	0	0	PASS	10045	TCGA-EL-A3CR	THCA	78	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2002	NA	-28785	Dead	NA	NA	233	NA	NA	NA	NA	NA	NA	NA	R1	1	233	NA	233	NA	NA	0	233	
60	TCGA-EL-A3CS	0	0	0	0	0	0	0	0	4	16	0	0	1	4	0	0	TCGA-EL-A3CS-01	51	2.4088096462048168e-05	12	TCGA-EL-A3CS-01	0	0	19	7.5021200740531635e-06	TCGA-EL-A3CS-01	0	0	0	0	PASS	10046	TCGA-EL-A3CS	THCA	62	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2004	NA	-22993	Dead	WITH TUMOR	NA	1385	NA	NA	NA	NA	NA	NA	NA	R0	1	1385	1	1385	NA	NA	1	1385	
80	TCGA-EL-A3CT	0	4	1	7	2	0	0	0	1	58	5	0	3	26	1	0	TCGA-EL-A3CT-01	57	0.00012100895596465015	14	TCGA-EL-A3CT-01	0	0	3	0.009028488964079949	TCGA-EL-A3CT-01	1	1	1	3	PASS	10047	TCGA-EL-A3CT	THCA	78	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2004	NA	-28597	Dead	NA	NA	1854	NA	NA	NA	NA	NA	NA	NA	R0	1	1854	NA	1854	NA	NA	0	1854	
70	TCGA-EL-A3CU	0	3	0	0	2	0	0	0	0	13	1	0	0	4	0	0	TCGA-EL-A3CU-01	53	7.154546756471296e-05	16	TCGA-EL-A3CU-01	0	0	19	4.950255894677508e-05	TCGA-EL-A3CU-01	0	0	0	0	PASS	10048	TCGA-EL-A3CU	THCA	70	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2000	NA	-25881	Alive	TUMOR FREE	4780	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	4780	0	4780	0	4780	0	4780	
40	TCGA-EL-A3CV	0	0	0	1	0	0	0	0	0	6	0	0	0	1	0	0	TCGA-EL-A3CV-01	71	3.5937361293282684e-05	28	TCGA-EL-A3CV-01	0	0	0	0.0	TCGA-EL-A3CV-01	0	0	0	0	PASS	10049	TCGA-EL-A3CV	THCA	40	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2005	NA	-14785	Alive	TUMOR FREE	1154	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	1154	0	1154	NA	NA	0	1154	
90	TCGA-EL-A3CW	1	0	0	0	0	0	0	0	0	4	0	0	0	4	0	0	TCGA-EL-A3CW-01	51	0.00010719235327952265	6	TCGA-EL-A3CW	0	0	0	0	TCGA-EL-A3CW	0	0	0	0	PASS	10050	TCGA-EL-A3CW	THCA	87	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2000	NA	-31934	Dead	NA	NA	1734	NA	NA	NA	NA	NA	NA	NA	R0	1	1734	NA	1734	0	1734	0	1734	
30	TCGA-EL-A3CX	0	0	0	0	1	0	0	0	0	7	1	0	0	1	0	0	TCGA-EL-A3CX-01	57	1.6114441893546872e-05	12	TCGA-EL-A3CX-01	0	0	0	0.0	TCGA-EL-A3CX-01	0	0	0	0	PASS	10051	TCGA-EL-A3CX	THCA	22	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2005	NA	-8344	Alive	TUMOR FREE	3243	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	3243	0	3243	0	3243	0	3243	
30	TCGA-EL-A3CY	0	0	0	0	0	0	0	0	0	2	0	0	0	2	0	0	TCGA-EL-A3CY-01	53	2.5981584795428185e-05	18	TCGA-EL-A3CY	0	0	0	0	TCGA-EL-A3CY	0	0	0	0	PASS	10052	TCGA-EL-A3CY	THCA	28	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2000	NA	-10423	Alive	TUMOR FREE	127	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	127	0	127	0	127	0	127	
40	TCGA-EL-A3CZ	0	1	0	0	0	1	0	0	1	4	1	0	0	2	0	0	TCGA-EL-A3CZ-01	37	6.754748229945437e-06	4	TCGA-EL-A3CZ-01	0	0	0	0.0	TCGA-EL-A3CZ-01	0	0	0	0	PASS	10053	TCGA-EL-A3CZ	THCA	37	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-13718	Alive	WITH TUMOR	2418	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	1426	NA	NA	R1	0	2418	0	2418	NA	NA	1	1426	
60	TCGA-EL-A3D0	0	0	0	0	0	1	0	0	0	13	2	0	1	9	0	0	TCGA-EL-A3D0	0	0	0	TCGA-EL-A3D0	0	0	0	0	TCGA-EL-A3D0	0	0	0	0	PASS	10054	TCGA-EL-A3D0	THCA	61	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2001	NA	-22622	Alive	WITH TUMOR	4254	NA	NA	NA	NA	NA	NA	NA	NA	R2	0	4254	0	4254	NA	NA	0	4254	
40	TCGA-EL-A3D1	0	0	0	0	1	0	0	0	0	5	0	0	1	1	0	0	TCGA-EL-A3D1-01	45	0.01105944877618528	7	TCGA-EL-A3D1-01	1	1	2	0.011626922095933185	TCGA-EL-A3D1-01	0	0	0	0	PASS	10055	TCGA-EL-A3D1	THCA	39	MALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2006	NA	-14245	Alive	TUMOR FREE	2997	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2997	0	2997	0	2997	0	2997	
60	TCGA-EL-A3D4	1	0	0	0	0	0	1	0	1	5	0	0	0	2	0	0	TCGA-EL-A3D4-01	57	0.011205538780785809	13	TCGA-EL-A3D4-01	1	1	3	0.011782840842017512	TCGA-EL-A3D4-01	0	0	0	0	PASS	10056	TCGA-EL-A3D4	THCA	62	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-22923	Alive	TUMOR FREE	2116	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2116	0	2116	NA	NA	0	2116	
40	TCGA-EL-A3D5	0	0	0	0	3	0	0	0	1	2	1	0	0	5	2	0	TCGA-EL-A3D5	0	0	0	TCGA-EL-A3D5	0	0	0	0	TCGA-EL-A3D5-01	2	0	2	4	PASS	10057	TCGA-EL-A3D5	THCA	44	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-16217	Alive	TUMOR FREE	1737	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	1737	0	1737	NA	NA	0	1737	
50	TCGA-EL-A3D6	0	3	0	0	2	1	0	0	0	18	3	0	0	7	2	0	TCGA-EL-A3D6-01	55	0.00013880063445968676	24	TCGA-EL-A3D6-01	0	0	2	0.00013187845221241586	TCGA-EL-A3D6-01	0	0	0	0	PASS	10058	TCGA-EL-A3D6	THCA	51	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	1999	NA	-18640	Alive	NA	3296	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	3296	0	3296	NA	NA	0	3296	
30	TCGA-EL-A3GO	0	0	0	0	1	0	0	0	0	9	0	0	0	1	0	0	TCGA-EL-A3GO-01	55	0.03152643691005867	16	TCGA-EL-A3GO-01	1	1	4	0.03306343293481796	TCGA-EL-A3GO-01	2	1	2	5	PASS	10059	TCGA-EL-A3GO	THCA	31	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-11604	Alive	WITH TUMOR	1973	NA	NA	Locoregional Recurrence	NA	Lt. Thyroid	6	NA	NA	R0	0	1973	0	1973	1	6	1	6	
70	TCGA-EL-A3GP	0	3	1	0	2	0	0	0	0	12	1	0	2	7	0	0	TCGA-EL-A3GP-01	92	0.18953767764944332	41	TCGA-EL-A3GP-01	8	5	4	0.1449230838170658	TCGA-EL-A3GP-01	1	0	0	1	PASS	10060	TCGA-EL-A3GP	THCA	70	MALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-25696	Alive	NA	1506	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1506	0	1506	0	1506	0	1506	
70	TCGA-EL-A3GQ	0	0	0	0	0	0	0	0	1	12	0	0	0	4	0	0	TCGA-EL-A3GQ-01	41	0.013060301120498405	6	TCGA-EL-A3GQ-01	0	0	19	0.013599708546160277	TCGA-EL-A3GQ-01	0	1	1	2	PASS	10061	TCGA-EL-A3GQ	THCA	72	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-26478	Alive	TUMOR FREE	1528	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1528	0	1528	0	1528	0	1528	
30	TCGA-EL-A3GR	0	0	0	1	2	0	0	0	1	8	0	0	1	2	1	0	TCGA-EL-A3GR-01	47	0.00023388681793400987	10	TCGA-EL-A3GR-01	0	0	3	0.00023503952655284702	TCGA-EL-A3GR-01	0	0	0	0	PASS	10062	TCGA-EL-A3GR	THCA	31	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2004	NA	-11598	Alive	TUMOR FREE	3501	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	3501	0	3501	0	3501	0	3501	
40	TCGA-EL-A3GS	0	0	0	1	0	0	0	0	1	9	0	0	0	2	1	0	TCGA-EL-A3GS-01	59	8.94940524568877e-05	18	TCGA-EL-A3GS-01	0	0	2	5.2351521844316166e-05	TCGA-EL-A3GS-01	0	0	0	0	PASS	10063	TCGA-EL-A3GS	THCA	37	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-13542	Alive	TUMOR FREE	1989	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1989	0	1989	0	1989	0	1989	
70	TCGA-EL-A3GU	0	1	0	0	2	0	0	0	2	15	1	0	0	7	0	0	TCGA-EL-A3GU-01	71	0.049850414445326056	20	TCGA-EL-A3GU-01	2	2	0	0.0	TCGA-EL-A3GU-01	2	0	0	2	PASS	10064	TCGA-EL-A3GU	THCA	72	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2002	NA	-26632	Alive	WITH TUMOR	4137	NA	NA	Distant Metastasis	Lung	NA	544	NA	NA	R0	0	4137	0	4137	1	544	1	544	
70	TCGA-EL-A3GV	0	1	0	0	1	0	0	0	1	16	0	0	0	3	1	0	TCGA-EL-A3GV-01	41	1.1394519718319192e-05	10	TCGA-EL-A3GV-01	0	0	19	6.3743587499870785e-06	TCGA-EL-A3GV-01	0	0	0	0	PASS	10065	TCGA-EL-A3GV	THCA	65	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-23787	Alive	TUMOR FREE	1532	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1532	0	1532	0	1532	0	1532	
40	TCGA-EL-A3GW	0	0	0	1	0	0	0	0	1	6	1	0	0	5	0	0	TCGA-EL-A3GW-01	35	0.010996267983033754	5	TCGA-EL-A3GW-01	1	1	2	0.011601021679876705	TCGA-EL-A3GW-01	0	0	0	0	PASS	10066	TCGA-EL-A3GW	THCA	37	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-13670	Alive	TUMOR FREE	1527	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1527	0	1527	0	1527	0	1527	
40	TCGA-EL-A3GX	0	2	0	0	0	0	1	0	1	9	0	0	0	1	0	0	TCGA-EL-A3GX-01	35	6.398946852874019e-06	4	TCGA-EL-A3GX	0	0	0	0	TCGA-EL-A3GX	0	0	0	0	PASS	10067	TCGA-EL-A3GX	THCA	41	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2000	NA	-15212	Alive	TUMOR FREE	4494	NA	NA	Locoregional Recurrence	"Other, specify"	Left Thyroid Bed	439	NA	NA	R0	0	4494	0	4494	1	439	1	439	
40	TCGA-EL-A3GY	0	0	0	0	0	1	0	0	0	11	0	0	0	3	0	0	TCGA-EL-A3GY-01	54	3.825877988776219e-05	10	TCGA-EL-A3GY-01	0	0	19	1.352280573935907e-05	TCGA-EL-A3GY-01	0	0	0	0	PASS	10068	TCGA-EL-A3GY	THCA	40	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2004	NA	-14814	Alive	WITH TUMOR	3076	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	3076	0	3076	0	3076	0	3076	
30	TCGA-EL-A3GZ	0	1	0	0	0	0	0	0	0	5	1	0	0	5	0	0	TCGA-EL-A3GZ-01	41	0.0002488935118438368	8	TCGA-EL-A3GZ	0	0	0	0	TCGA-EL-A3GZ	0	0	0	0	PASS	10069	TCGA-EL-A3GZ	THCA	34	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2001	NA	-12665	Alive	TUMOR FREE	4258	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	4258	0	4258	0	4258	0	4258	
70	TCGA-EL-A3H1	0	0	0	1	0	2	0	0	1	16	2	0	1	5	1	0	TCGA-EL-A3H1-01	63	0.0012278518017043597	21	TCGA-EL-A3H1-01	0	0	4	0.0012772358122385755	TCGA-EL-A3H1-01	0	0	0	0	PASS	10070	TCGA-EL-A3H1	THCA	66	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	1993	NA	-24328	Dead	TUMOR FREE	NA	1500	NA	NA	NA	NA	NA	NA	NA	R0	1	1500	0	1500	0	1500	0	1500	
60	TCGA-EL-A3H2	0	0	0	0	1	0	0	0	0	6	0	0	0	5	1	0	TCGA-EL-A3H2-01	48	0.05414279352903748	11	TCGA-EL-A3H2-01	1	2	6	0.05698732551627619	TCGA-EL-A3H2-01	1	2	3	6	PASS	10071	TCGA-EL-A3H2	THCA	58	MALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2002	NA	-21266	Dead	WITH TUMOR	NA	1019	NA	NA	NA	NA	NA	NA	NA	R0	1	1019	1	1019	NA	NA	1	1019	
20	TCGA-EL-A3H3	0	0	0	0	0	0	0	0	2	1	0	0	1	2	0	0	TCGA-EL-A3H3-01	39	0.00019458288132478532	7	TCGA-EL-A3H3-01	0	0	19	9.611190595998206e-06	TCGA-EL-A3H3-01	0	0	0	0	PASS	10072	TCGA-EL-A3H3	THCA	19	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-7000	Alive	TUMOR FREE	1319	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1319	0	1319	0	1319	0	1319	
50	TCGA-EL-A3H4	0	0	0	1	0	0	0	0	0	10	1	0	0	3	0	0	TCGA-EL-A3H4-01	43	1.9557585286016974e-05	8	TCGA-EL-A3H4-01	0	0	0	0.0	TCGA-EL-A3H4-01	0	0	0	0	PASS	10073	TCGA-EL-A3H4	THCA	46	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-16944	Alive	TUMOR FREE	1512	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1512	0	1512	NA	NA	0	1512	
60	TCGA-EL-A3H5	0	1	0	2	1	0	0	0	0	15	1	0	0	10	1	0	TCGA-EL-A3H5-01	45	0.05891061004339952	12	TCGA-EL-A3H5-01	2	2	19	0.015656534937605618	TCGA-EL-A3H5-01	2	0	1	3	PASS	10074	TCGA-EL-A3H5	THCA	57	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-20926	Alive	TUMOR FREE	2542	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	2542	0	2542	NA	NA	0	2542	
40	TCGA-EL-A3H7	0	0	0	0	1	0	0	0	1	16	1	0	0	6	0	1	TCGA-EL-A3H7-01	61	3.1863814003147625e-05	17	TCGA-EL-A3H7-01	0	0	0	0.0	TCGA-EL-A3H7-01	0	0	0	0	PASS	10075	TCGA-EL-A3H7	THCA	36	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2002	NA	-13407	Alive	TUMOR FREE	4228	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	4228	0	4228	0	4228	0	4228	
40	TCGA-EL-A3H8	0	1	0	0	0	0	0	0	0	6	2	0	0	3	0	0	TCGA-EL-A3H8-01	53	0.00013707445037028804	18	TCGA-EL-A3H8-01	0	0	0	0.0	TCGA-EL-A3H8-01	0	0	0	0	PASS	10076	TCGA-EL-A3H8	THCA	35	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2002	NA	-12992	Alive	TUMOR FREE	4577	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	4577	0	4577	0	4577	0	4577	
60	TCGA-EL-A3MW	0	0	0	0	0	0	0	0	1	8	0	0	0	1	0	0	TCGA-EL-A3MW-01	47	1.0057607657051054e-05	10	TCGA-EL-A3MW-01	0	0	19	2.186053104851716e-06	TCGA-EL-A3MW-01	0	0	0	0	PASS	10077	TCGA-EL-A3MW	THCA	55	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2003	NA	-20186	Alive	TUMOR FREE	3305	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	3305	0	3305	0	3305	0	3305	
70	TCGA-EL-A3MX	0	1	0	1	2	2	0	0	0	22	1	0	1	10	0	0	TCGA-EL-A3MX-01	53	0.08846035348660711	11	TCGA-EL-A3MX-01	1	2	5	0.009640773992745854	TCGA-EL-A3MX-01	2	2	1	5	PASS	10078	TCGA-EL-A3MX	THCA	66	FEMALE	WHITE	Stage IVC	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2004	NA	-24178	Dead	WITH TUMOR	NA	1753	NA	Distant Metastasis	"Other, specify"	Femur	1708	NA	NA	RX	1	1753	1	1753	NA	NA	1	1708	
80	TCGA-EL-A3MY	0	2	0	0	0	1	0	0	0	16	0	0	0	4	0	0	TCGA-EL-A3MY-01	65	2.9015757240620874e-05	20	TCGA-EL-A3MY-01	0	0	0	0.0	TCGA-EL-A3MY-01	0	0	0	0	PASS	10079	TCGA-EL-A3MY	THCA	81	MALE	WHITE	Stage IVC	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2004	NA	-29706	Dead	WITH TUMOR	NA	533	NA	NA	NA	NA	NA	NA	NA	RX	1	533	1	533	NA	NA	1	533	
70	TCGA-EL-A3MZ	0	2	0	1	1	0	1	0	2	20	2	0	0	6	0	0	TCGA-EL-A3MZ-01	44	0.04387995119086191	7	TCGA-EL-A3MZ-01	1	1	0	0.0	TCGA-EL-A3MZ-01	1	0	0	1	PASS	10080	TCGA-EL-A3MZ	THCA	66	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	1998	NA	-24208	Dead	TUMOR FREE	NA	1597	NA	NA	NA	NA	NA	NA	NA	RX	1	1597	0	1597	NA	NA	0	1597	
30	TCGA-EL-A3N2	0	0	0	0	0	0	0	0	0	9	0	0	1	1	0	0	TCGA-EL-A3N2-01	61	4.253918879148652e-05	20	TCGA-EL-A3N2-01	0	0	19	1.55036348642891e-05	TCGA-EL-A3N2-01	0	0	0	0	PASS	10081	TCGA-EL-A3N2	THCA	24	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-8989	Alive	TUMOR FREE	902	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	902	0	902	0	902	0	902	
50	TCGA-EL-A3N3	0	0	0	0	0	0	0	0	1	12	0	0	0	3	1	0	TCGA-EL-A3N3-01	39	6.474744124307663e-05	3	TCGA-EL-A3N3-01	0	0	3	6.49534117743787e-05	TCGA-EL-A3N3-01	0	0	0	0	PASS	10082	TCGA-EL-A3N3	THCA	53	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2000	NA	-19513	Alive	TUMOR FREE	5423	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	5423	0	5423	0	5423	0	5423	
50	TCGA-EL-A3T0	1	0	0	0	1	0	0	0	0	10	1	0	0	5	1	0	TCGA-EL-A3T0-01	55	0.0034566212978695103	12	TCGA-EL-A3T0	0	0	0	0	TCGA-EL-A3T0	0	0	0	0	PASS	10083	TCGA-EL-A3T0	THCA	45	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2001	NA	-16798	Alive	TUMOR FREE	4335	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	4335	0	4335	0	4335	0	4335	
40	TCGA-EL-A3T1	0	0	0	0	1	0	0	0	1	11	1	0	0	3	0	0	TCGA-EL-A3T1-01	65	3.7558471458772936e-05	20	TCGA-EL-A3T1-01	0	0	0	0.0	TCGA-EL-A3T1-01	0	0	0	0	PASS	10084	TCGA-EL-A3T1	THCA	38	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2002	NA	-14025	Alive	TUMOR FREE	3941	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	3941	0	3941	0	3941	0	3941	
60	TCGA-EL-A3T2	0	0	0	0	0	0	0	0	1	12	0	0	0	6	4	0	TCGA-EL-A3T2-01	57	0.011359837779200278	16	TCGA-EL-A3T2-01	1	1	2	0.0116250659311494	TCGA-EL-A3T2-01	0	0	0	0	PASS	10085	TCGA-EL-A3T2	THCA	55	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2002	NA	-20403	Alive	WITH TUMOR	988	NA	NA	Locoregional Recurrence	Lymph Node Only	pretracheal lymph node	903	NA	NA	R0	0	988	0	988	1	903	1	903	
60	TCGA-EL-A3T3	0	0	0	1	0	0	0	0	0	16	0	0	0	4	1	0	TCGA-EL-A3T3-01	61	0.00047967913017780235	25	TCGA-EL-A3T3-01	0	0	19	3.9016449105515615e-05	TCGA-EL-A3T3-01	0	0	0	0	PASS	10086	TCGA-EL-A3T3	THCA	63	MALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2002	NA	-23043	Alive	TUMOR FREE	4017	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	4017	0	4017	0	4017	0	4017	
30	TCGA-EL-A3T6	0	1	0	0	0	0	0	0	2	5	0	0	0	1	1	0	TCGA-EL-A3T6-01	53	5.1675220962747776e-05	20	TCGA-EL-A3T6-01	0	0	19	4.337566446944503e-05	TCGA-EL-A3T6-01	0	0	0	0	PASS	10087	TCGA-EL-A3T6	THCA	34	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2003	NA	-12777	Alive	TUMOR FREE	2988	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2988	0	2988	0	2988	0	2988	
50	TCGA-EL-A3T7	0	0	0	0	0	0	0	0	0	9	0	0	0	3	0	0	TCGA-EL-A3T7-01	51	2.3371506036532603e-05	12	TCGA-EL-A3T7-01	0	0	19	3.7241448409328485e-06	TCGA-EL-A3T7-01	0	0	0	0	PASS	10088	TCGA-EL-A3T7	THCA	47	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2004	NA	-17302	Alive	TUMOR FREE	1256	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1256	0	1256	0	1256	0	1256	
40	TCGA-EL-A3T8	0	0	0	0	0	0	0	0	0	9	0	0	0	1	0	0	TCGA-EL-A3T8-01	67	9.34004396614983e-05	21	TCGA-EL-A3T8-01	0	0	19	1.0212279013169646e-05	TCGA-EL-A3T8-01	0	0	0	0	PASS	10089	TCGA-EL-A3T8	THCA	36	MALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2005	NA	-13290	Alive	TUMOR FREE	3269	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	3269	0	3269	0	3269	0	3269	
70	TCGA-EL-A3T9	0	0	0	0	1	0	0	0	0	16	0	0	0	12	0	0	TCGA-EL-A3T9-01	49	0.2688962762028497	12	TCGA-EL-A3T9-01	11	8	4	0.03482875760432512	TCGA-EL-A3T9-01	3	2	2	7	PASS	10090	TCGA-EL-A3T9	THCA	69	FEMALE	WHITE	Stage IV	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2005	NA	-25484	Dead	WITH TUMOR	NA	174	NA	NA	NA	NA	NA	NA	NA	R1	1	174	1	174	NA	NA	1	174	
40	TCGA-EL-A3TA	0	0	0	0	0	0	0	0	0	4	0	0	0	2	0	0	TCGA-EL-A3TA-01	47	0.00017198926739794655	11	TCGA-EL-A3TA-01	0	0	19	0.00015574503641635026	TCGA-EL-A3TA-01	0	0	0	0	PASS	10091	TCGA-EL-A3TA	THCA	42	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2005	NA	-15366	Alive	TUMOR FREE	2035	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2035	0	2035	0	2035	0	2035	
50	TCGA-EL-A3TB	0	0	0	0	0	0	1	0	0	15	0	0	0	4	0	0	TCGA-EL-A3TB-01	57	1.5307075716831006e-05	16	TCGA-EL-A3TB-01	0	0	0	0.0	TCGA-EL-A3TB-01	0	0	0	0	PASS	10092	TCGA-EL-A3TB	THCA	47	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2005	NA	-17195	Alive	TUMOR FREE	2519	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2519	0	2519	0	2519	0	2519	
20	TCGA-EL-A3ZG	1	3	0	0	0	0	0	0	0	3	0	0	0	1	0	0	TCGA-EL-A3ZG-01	49	8.557720624312862e-05	14	TCGA-EL-A3ZG-01	0	0	8	0.0003183829971694703	TCGA-EL-A3ZG-01	0	0	0	0	PASS	10093	TCGA-EL-A3ZG	THCA	15	MALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2006	NA	-5612	Alive	TUMOR FREE	2724	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2724	0	2724	0	2724	0	2724	
40	TCGA-EL-A3ZH	0	0	0	0	0	0	0	0	0	7	1	0	0	2	1	0	TCGA-EL-A3ZH-01	47	0.027547432312977863	10	TCGA-EL-A3ZH-01	2	1	5	0.00018756128417833247	TCGA-EL-A3ZH-01	0	0	0	0	PASS	10094	TCGA-EL-A3ZH	THCA	42	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2006	NA	-15685	Alive	TUMOR FREE	2773	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2773	0	2773	0	2773	0	2773	
40	TCGA-EL-A3ZK	0	2	0	0	0	0	0	0	0	10	0	0	0	3	0	0	TCGA-EL-A3ZK-01	51	0.04832955223188138	11	TCGA-EL-A3ZK-01	0	0	6	0.0008649521106413702	TCGA-EL-A3ZK-01	0	0	0	0	PASS	10095	TCGA-EL-A3ZK	THCA	41	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-15121	Alive	TUMOR FREE	1575	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1575	0	1575	0	1575	0	1575	
30	TCGA-EL-A3ZL	0	0	0	2	0	0	0	0	0	8	1	0	0	6	0	0	TCGA-EL-A3ZL-01	51	0.01100560516539571	15	TCGA-EL-A3ZL-01	1	1	23	0.013862239110618159	TCGA-EL-A3ZL-01	0	0	0	0	PASS	10096	TCGA-EL-A3ZL	THCA	34	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-12649	Alive	TUMOR FREE	1895	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1895	0	1895	0	1895	0	1895	
60	TCGA-EL-A3ZM	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-EL-A3ZM-01	54	0.14364662627194347	14	TCGA-EL-A3ZM-01	6	3	11	0.0076591592625843315	TCGA-EL-A3ZM-01	1	0	1	2	PASS	10097	TCGA-EL-A3ZM	THCA	60	MALE	[Unknown]	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-21987	Alive	TUMOR FREE	1096	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	1096	0	1096	NA	NA	0	1096	
30	TCGA-EL-A3ZN	0	1	0	2	0	0	0	0	0	1	0	0	0	2	0	0	TCGA-EL-A3ZN-01	39	4.807338980603391e-05	7	TCGA-EL-A3ZN-01	0	0	9	0.0004420691086283878	TCGA-EL-A3ZN-01	0	0	0	0	PASS	10098	TCGA-EL-A3ZN	THCA	28	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-10266	Alive	TUMOR FREE	1614	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1614	0	1614	0	1614	0	1614	
80	TCGA-EL-A3ZO	1	11	2	2	0	1	0	0	5	57	7	0	0	30	1	0	TCGA-EL-A3ZO-01	47	0.0985934645246694	5	TCGA-EL-A3ZO-01	4	4	7	0.0503406725472036	TCGA-EL-A3ZO-01	2	1	0	3	PASS	10099	TCGA-EL-A3ZO	THCA	79	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-28924	Alive	TUMOR FREE	2211	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2211	0	2211	0	2211	0	2211	
20	TCGA-EL-A3ZP	1	0	0	0	0	0	0	0	0	3	0	0	0	3	0	0	TCGA-EL-A3ZP-01	41	8.518683034681233e-06	8	TCGA-EL-A3ZP-01	0	0	6	0.0002706027120767535	TCGA-EL-A3ZP-01	0	0	0	0	PASS	10100	TCGA-EL-A3ZP	THCA	19	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-7101	Alive	TUMOR FREE	1992	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1992	0	1992	0	1992	0	1992	
80	TCGA-EL-A3ZQ	1	1	0	0	0	1	0	0	0	8	0	0	0	1	1	0	TCGA-EL-A3ZQ-01	51	0.0001838927979353396	14	TCGA-EL-A3ZQ-01	0	0	16	0.0020591889974683037	TCGA-EL-A3ZQ-01	0	0	0	0	PASS	10101	TCGA-EL-A3ZQ	THCA	78	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-28783	Alive	TUMOR FREE	1862	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1862	0	1862	0	1862	0	1862	
50	TCGA-EL-A3ZR	0	1	1	2	0	0	0	0	0	9	1	0	0	7	0	0	TCGA-EL-A3ZR-01	48	0.14936784789350172	10	TCGA-EL-A3ZR-01	8	5	7	0.00046772859641172577	TCGA-EL-A3ZR-01	0	0	0	0	PASS	10102	TCGA-EL-A3ZR	THCA	46	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-16852	Alive	TUMOR FREE	1830	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1830	0	1830	0	1830	0	1830	
30	TCGA-EL-A3ZS	0	0	0	0	0	0	0	0	1	5	0	0	0	0	0	0	TCGA-EL-A3ZS-01	45	0.0064452654530176	12	TCGA-EL-A3ZS-01	0	0	8	0.006598983918735229	TCGA-EL-A3ZS-01	0	1	1	2	PASS	10103	TCGA-EL-A3ZS	THCA	22	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-8076	Alive	TUMOR FREE	215	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	215	0	215	0	215	0	215	
40	TCGA-EL-A3ZT	0	0	1	1	0	0	0	0	0	11	0	0	0	2	0	0	TCGA-EL-A3ZT-01	41	4.306071396605106e-05	10	TCGA-EL-A3ZT-01	0	0	10	0.001288087775187578	TCGA-EL-A3ZT-01	0	0	0	0	PASS	10104	TCGA-EL-A3ZT	THCA	35	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-13103	Alive	TUMOR FREE	1808	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1808	0	1808	0	1808	0	1808	
40	TCGA-EL-A4JV	0	1	0	0	0	0	0	0	1	9	0	0	0	1	0	0	TCGA-EL-A4JV-01	47	0.011053310859762742	9	TCGA-EL-A4JV-01	0	0	5	0.0002774462410689786	TCGA-EL-A4JV-01	0	0	0	0	PASS	10105	TCGA-EL-A4JV	THCA	41	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-15065	Alive	TUMOR FREE	1748	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1748	0	1748	0	1748	0	1748	
40	TCGA-EL-A4JW	0	0	1	0	1	0	0	0	0	7	0	0	0	2	0	0	TCGA-EL-A4JW-01	61	3.659169405581674e-05	18	TCGA-EL-A4JW-01	0	0	7	0.00036437973165457017	TCGA-EL-A4JW-01	0	0	0	0	PASS	10106	TCGA-EL-A4JW	THCA	38	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-13928	Alive	TUMOR FREE	1056	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1056	0	1056	0	1056	0	1056	
30	TCGA-EL-A4JX	0	0	1	0	0	0	0	0	0	7	0	0	0	3	1	0	TCGA-EL-A4JX-01	64	0.030722967409035382	22	TCGA-EL-A4JX-01	1	2	13	0.00040206540588705786	TCGA-EL-A4JX-01	0	1	0	1	PASS	10107	TCGA-EL-A4JX	THCA	31	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-11465	Alive	TUMOR FREE	1398	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1398	0	1398	0	1398	0	1398	
60	TCGA-EL-A4JZ	0	0	0	1	1	0	0	0	0	5	2	0	0	5	0	0	TCGA-EL-A4JZ-01	43	0.011085773079871812	10	TCGA-EL-A4JZ-01	1	1	12	0.013786337672875784	TCGA-EL-A4JZ-01	0	0	0	0	PASS	10108	TCGA-EL-A4JZ	THCA	55	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-20290	Alive	TUMOR FREE	1856	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1856	0	1856	0	1856	0	1856	
50	TCGA-EL-A4K0	0	0	0	0	0	0	0	0	1	10	1	0	0	1	0	0	TCGA-EL-A4K0-01	41	5.858130571497198e-06	6	TCGA-EL-A4K0-01	0	0	4	0.00019547140130218467	TCGA-EL-A4K0-01	0	0	0	0	PASS	10109	TCGA-EL-A4K0	THCA	54	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-20042	Alive	TUMOR FREE	944	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	944	0	944	NA	NA	0	944	
70	TCGA-EL-A4K1	0	1	1	3	0	0	0	0	0	6	0	0	0	2	1	0	TCGA-EL-A4K1-01	47	1.9527598812047407e-05	11	TCGA-EL-A4K1-01	0	0	6	0.002535065129318669	TCGA-EL-A4K1-01	0	0	0	0	PASS	10110	TCGA-EL-A4K1	THCA	68	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-24846	Alive	TUMOR FREE	1046	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1046	0	1046	0	1046	0	1046	
40	TCGA-EL-A4K2	0	1	0	0	1	0	0	0	1	8	0	0	1	2	0	0	TCGA-EL-A4K2-01	53	7.166854687480376e-05	17	TCGA-EL-A4K2-01	0	0	13	0.0014974612755314966	TCGA-EL-A4K2-01	0	0	0	0	PASS	10111	TCGA-EL-A4K2	THCA	43	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-15962	Alive	TUMOR FREE	928	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	928	0	928	0	928	0	928	
30	TCGA-EL-A4K4	0	0	0	0	0	0	0	0	1	9	0	0	0	1	0	0	TCGA-EL-A4K4-01	61	0.0001436239513563992	25	TCGA-EL-A4K4-01	0	0	11	0.0014302774988598974	TCGA-EL-A4K4-01	0	0	0	0	PASS	10112	TCGA-EL-A4K4	THCA	33	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-12368	Alive	WITH TUMOR	1623	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1623	0	1623	0	1623	0	1623	
80	TCGA-EL-A4K6	1	0	0	4	1	0	0	0	0	17	1	0	0	9	0	0	TCGA-EL-A4K6-01	39	0.13285098571481155	8	TCGA-EL-A4K6-01	5	3	14	0.11106949768728476	TCGA-EL-A4K6-01	0	0	0	0	PASS	10113	TCGA-EL-A4K6	THCA	75	MALE	WHITE	Stage IV	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-27416	Alive	WITH TUMOR	1343	NA	NA	Distant Metastasis	Lung	NA	874	NA	NA	R0	0	1343	0	1343	NA	NA	1	874	
70	TCGA-EL-A4K7	0	1	0	1	2	0	0	0	0	36	3	0	0	11	0	0	TCGA-EL-A4K7-01	44	6.307160917155058e-05	10	TCGA-EL-A4K7-01	0	0	7	0.00023032128654475303	TCGA-EL-A4K7-01	0	0	0	0	PASS	10114	TCGA-EL-A4K7	THCA	74	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-27306	Alive	TUMOR FREE	1251	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1251	0	1251	0	1251	0	1251	
70	TCGA-EL-A4K9	0	0	0	1	2	0	0	0	0	12	1	0	0	5	0	0	TCGA-EL-A4K9-01	34	0.0417133800057467	4	TCGA-EL-A4K9-01	2	2	10	0.012876667035497771	TCGA-EL-A4K9-01	1	1	0	2	PASS	10115	TCGA-EL-A4K9	THCA	68	MALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-24980	Alive	TUMOR FREE	1455	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1455	0	1455	0	1455	0	1455	
40	TCGA-EL-A4KD	0	0	0	1	0	0	0	0	0	10	1	0	0	8	1	0	TCGA-EL-A4KD-01	55	1.4678165432800809e-05	18	TCGA-EL-A4KD-01	0	0	5	0.00032807060382107915	TCGA-EL-A4KD-01	0	0	0	0	PASS	10116	TCGA-EL-A4KD	THCA	41	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-15291	Alive	TUMOR FREE	1326	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1326	0	1326	0	1326	0	1326	
40	TCGA-EL-A4KG	0	3	0	1	0	1	0	0	1	26	3	0	0	25	0	0	TCGA-EL-A4KG-01	71	0.00029164322984639464	30	TCGA-EL-A4KG-01	0	0	9	0.00048656050686782725	TCGA-EL-A4KG-01	0	0	0	0	PASS	10117	TCGA-EL-A4KG	THCA	35	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-12978	Alive	TUMOR FREE	739	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	739	0	739	0	739	0	739	
40	TCGA-EL-A4KH	0	0	0	0	0	0	0	0	0	4	0	0	0	1	0	0	TCGA-EL-A4KH-01	59	1.6832213782146514e-05	16	TCGA-EL-A4KH-01	0	0	6	0.0004589140098358919	TCGA-EL-A4KH-01	0	0	0	0	PASS	10118	TCGA-EL-A4KH	THCA	36	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-13275	Alive	TUMOR FREE	823	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	823	0	823	0	823	0	823	
60	TCGA-EL-A4KI	0	0	1	1	1	0	0	0	0	15	2	0	0	2	0	0	TCGA-EL-A4KI-01	67	0.371497725462529	21	TCGA-EL-A4KI-01	19	17	24	0.1117652015857837	TCGA-EL-A4KI-01	0	0	0	0	PASS	10119	TCGA-EL-A4KI	THCA	63	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-23182	Alive	WITH TUMOR	727	NA	NA	Distant Metastasis	Lung	NA	265	NA	NA	R0	0	727	0	727	1	265	1	265	
60	TCGA-EM-A1CS	0	4	0	0	0	0	0	0	3	7	2	0	4	0	0	0	TCGA-EM-A1CS-01	53	0.010997861427559078	12	TCGA-EM-A1CS-01	1	1	19	0.011597342734317673	TCGA-EM-A1CS-01	0	0	0	0	PASS	10120	TCGA-EM-A1CS	THCA	55	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-20284	Alive	TUMOR FREE	817	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	817	0	817	0	817	0	817	
80	TCGA-EM-A1CT	0	2	0	1	4	0	0	0	2	24	2	0	0	22	0	0	TCGA-EM-A1CT-01	53	1.7223893510581788e-05	14	TCGA-EM-A1CT-01	0	0	0	0.0	TCGA-EM-A1CT-01	0	0	0	0	PASS	10121	TCGA-EM-A1CT	THCA	76	MALE	NA	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-27944	Alive	TUMOR FREE	553	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	553	0	553	NA	NA	0	553	
30	TCGA-EM-A1CU	0	2	0	0	4	0	0	0	0	23	0	0	0	6	0	0	TCGA-EM-A1CU-01	65	0.0002092506782022168	24	TCGA-EM-A1CU-01	0	0	0	0.0	TCGA-EM-A1CU-01	0	0	0	0	PASS	10122	TCGA-EM-A1CU	THCA	31	MALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-11470	Alive	TUMOR FREE	636	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	636	0	636	NA	NA	0	636	
30	TCGA-EM-A1CV	0	4	0	1	0	0	0	0	0	10	0	0	0	8	4	0	TCGA-EM-A1CV-01	45	2.723502442645365e-05	11	TCGA-EM-A1CV-01	0	0	19	1.951910210115216e-05	TCGA-EM-A1CV-01	0	0	0	0	PASS	10123	TCGA-EM-A1CV	THCA	32	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-11932	Alive	TUMOR FREE	1475	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1475	0	1475	NA	NA	0	1475	
40	TCGA-EM-A1CW	0	1	0	0	2	2	0	0	0	12	0	0	0	0	2	0	TCGA-EM-A1CW-01	43	1.7343735737988552e-05	8	TCGA-EM-A1CW-01	0	0	0	0.0	TCGA-EM-A1CW-01	0	0	0	0	PASS	10124	TCGA-EM-A1CW	THCA	39	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-14263	Alive	TUMOR FREE	549	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	549	0	549	0	549	0	549	
70	TCGA-EM-A1YA	0	3	0	0	0	0	0	0	0	8	1	0	0	2	2	0	TCGA-EM-A1YA-01	45	8.876951656000034e-06	8	TCGA-EM-A1YA-01	0	0	0	0.0	TCGA-EM-A1YA-01	0	0	0	0	PASS	10125	TCGA-EM-A1YA	THCA	74	FEMALE	NA	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-27224	Alive	TUMOR FREE	602	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	602	0	602	0	602	0	602	
70	TCGA-EM-A1YB	0	5	0	12	1	0	0	0	2	26	2	0	1	14	3	0	TCGA-EM-A1YB-01	62	0.05763668784373896	16	TCGA-EM-A1YB-01	2	2	2	0.06084538192221984	TCGA-EM-A1YB-01	1	0	1	2	PASS	10126	TCGA-EM-A1YB	THCA	73	FEMALE	NA	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-26852	Alive	TUMOR FREE	592	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	592	0	592	0	592	0	592	
70	TCGA-EM-A1YC	0	1	0	2	0	0	0	0	0	10	0	0	0	7	0	0	TCGA-EM-A1YC-01	31	0.9477264942936344	4	TCGA-EM-A1YC	0	0	0	0	TCGA-EM-A1YC	0	0	0	0	PASS	10127	TCGA-EM-A1YC	THCA	71	FEMALE	NA	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2007	NA	-26143	Alive	TUMOR FREE	2391	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2391	0	2391	0	2391	0	2391	
50	TCGA-EM-A1YD	0	0	0	0	0	0	0	0	1	4	1	0	0	2	0	0	TCGA-EM-A1YD-01	69	0.9478338562736748	26	TCGA-EM-A1YD	0	0	0	0	TCGA-EM-A1YD	0	0	0	0	PASS	10128	TCGA-EM-A1YD	THCA	53	FEMALE	NA	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2007	NA	-19366	Alive	TUMOR FREE	1734	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1734	0	1734	0	1734	0	1734	
50	TCGA-EM-A1YE	0	0	0	1	0	1	0	0	1	7	1	0	0	4	0	0	TCGA-EM-A1YE-01	93	0.9144441594564366	46	TCGA-EM-A1YE-01	12	9	10	0.04937542965620839	TCGA-EM-A1YE-01	3	0	1	4	PASS	10129	TCGA-EM-A1YE	THCA	47	FEMALE	NA	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2007	NA	-17297	Alive	TUMOR FREE	1645	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1645	0	1645	0	1645	0	1645	
50	TCGA-EM-A22I	0	0	0	0	0	0	0	0	0	7	1	0	1	3	1	0	TCGA-EM-A22I-01	43	3.039164333041693e-05	7	TCGA-EM-A22I-01	0	0	0	0.0	TCGA-EM-A22I-01	0	0	0	0	PASS	10130	TCGA-EM-A22I	THCA	52	FEMALE	NA	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-19003	Alive	TUMOR FREE	448	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	448	0	448	NA	NA	0	448	
60	TCGA-EM-A22J	0	9	1	7	0	1	0	0	6	103	8	1	1	48	1	0	TCGA-EM-A22J-01	59	0.00013776841497501266	16	TCGA-EM-A22J-01	0	0	3	6.604727250246489e-05	TCGA-EM-A22J-01	0	0	0	0	PASS	10131	TCGA-EM-A22J	THCA	56	FEMALE	NA	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-20539	Alive	TUMOR FREE	441	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	441	0	441	NA	NA	0	441	
50	TCGA-EM-A22K	0	0	0	2	0	0	0	0	0	11	1	0	0	2	1	0	TCGA-EM-A22K-01	40	0.00981350503362061	8	TCGA-EM-A22K-01	1	1	19	0.00991146288463932	TCGA-EM-A22K-01	0	0	1	1	PASS	10132	TCGA-EM-A22K	THCA	46	FEMALE	NA	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-16890	Alive	TUMOR FREE	479	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	479	0	479	NA	NA	0	479	
30	TCGA-EM-A22L	0	2	0	1	0	0	0	0	1	21	1	0	0	6	0	0	TCGA-EM-A22L-01	35	0.01104889198699902	6	TCGA-EM-A22L-01	1	1	19	0.011597342734317673	TCGA-EM-A22L-01	0	0	0	0	PASS	10133	TCGA-EM-A22L	THCA	33	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-12092	Alive	TUMOR FREE	318	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	318	0	318	0	318	0	318	
50	TCGA-EM-A22M	0	5	0	4	1	0	0	0	2	63	12	0	0	28	3	0	TCGA-EM-A22M-01	37	0.0439046535717721	6	TCGA-EM-A22M-01	2	2	2	0.046322203827482096	TCGA-EM-A22M-01	0	0	0	0	PASS	10134	TCGA-EM-A22M	THCA	52	MALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-19059	Alive	TUMOR FREE	442	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	442	0	442	0	442	0	442	
70	TCGA-EM-A22N	0	0	0	0	0	0	0	0	0	8	0	0	2	4	0	0	TCGA-EM-A22N-01	39	0.5881681950642521	9	TCGA-EM-A22N-01	23	14	0	0.0	TCGA-EM-A22N-01	0	0	0	0	PASS	10135	TCGA-EM-A22N	THCA	68	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-25035	Alive	TUMOR FREE	324	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	324	0	324	NA	NA	0	324	
80	TCGA-EM-A22O	0	0	1	1	1	0	0	0	1	29	1	0	0	7	1	0	TCGA-EM-A22O-01	65	8.604583130669459e-05	25	TCGA-EM-A22O-01	0	0	3	4.129652650359384e-05	TCGA-EM-A22O-01	0	0	0	0	PASS	10136	TCGA-EM-A22O	THCA	75	MALE	ASIAN	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-27758	Alive	TUMOR FREE	1344	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	1344	0	1344	NA	NA	0	1344	
60	TCGA-EM-A22P	0	0	0	2	0	0	0	0	0	10	2	0	0	5	1	0	TCGA-EM-A22P-01	63	0.022428826818299854	19	TCGA-EM-A22P-01	2	2	4	0.023351031615282958	TCGA-EM-A22P-01	0	0	0	0	PASS	10137	TCGA-EM-A22P	THCA	64	MALE	NA	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-23723	Alive	TUMOR FREE	1256	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	1256	0	1256	NA	NA	0	1256	
40	TCGA-EM-A22Q	0	0	0	1	0	1	0	0	0	6	1	0	1	3	0	0	TCGA-EM-A22Q-01	79	0.033131052977266144	33	TCGA-EM-A22Q-01	1	1	4	0.03485216372378303	TCGA-EM-A22Q-01	0	0	0	0	PASS	10138	TCGA-EM-A22Q	THCA	36	MALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-13341	Alive	TUMOR FREE	433	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	433	0	433	0	433	0	433	
50	TCGA-EM-A2CJ	0	3	0	1	1	0	0	0	5	46	5	0	1	14	2	0	TCGA-EM-A2CJ-01	48	0.04556745196467159	12	TCGA-EM-A2CJ-01	1	2	2	0.024098795334334386	TCGA-EM-A2CJ-01	2	2	2	6	PASS	10139	TCGA-EM-A2CJ	THCA	49	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-18168	Alive	TUMOR FREE	1447	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1447	0	1447	0	1447	0	1447	
30	TCGA-EM-A2CK	0	1	0	2	0	0	0	0	0	16	3	0	0	2	0	0	TCGA-EM-A2CK-01	51	0.00011911213361743948	14	TCGA-EM-A2CK-01	0	0	0	0.0	TCGA-EM-A2CK-01	0	0	0	0	PASS	10140	TCGA-EM-A2CK	THCA	28	MALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-10485	Alive	TUMOR FREE	544	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	544	0	544	0	544	0	544	
30	TCGA-EM-A2CL	0	3	1	4	1	0	0	0	2	51	4	0	0	15	1	0	TCGA-EM-A2CL-01	53	2.5645271090599075e-05	15	TCGA-EM-A2CL-01	0	0	0	0.0	TCGA-EM-A2CL-01	0	0	0	0	PASS	10141	TCGA-EM-A2CL	THCA	31	MALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-11649	Alive	TUMOR FREE	401	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	401	0	401	0	401	0	401	
60	TCGA-EM-A2CM	0	2	1	1	0	1	0	0	1	22	1	0	0	10	0	0	TCGA-EM-A2CM	0	0	0	TCGA-EM-A2CM-01	1	1	19	0.011597586687935871	TCGA-EM-A2CM-01	0	0	0	0	PASS	10142	TCGA-EM-A2CM	THCA	62	FEMALE	NA	Stage III	NA	"Other, specify"	NA	2010	NA	-22726	Alive	WITH TUMOR	1253	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1253	0	1253	0	1253	0	1253	
60	TCGA-EM-A2CN	0	8	1	12	1	0	0	0	15	120	20	0	1	42	6	0	TCGA-EM-A2CN-01	43	1.4093359161111871e-05	11	TCGA-EM-A2CN-01	0	0	19	8.649580498998708e-06	TCGA-EM-A2CN-01	0	0	0	0	PASS	10143	TCGA-EM-A2CN	THCA	62	MALE	NA	Stage IVC	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-22817	Alive	WITH TUMOR	715	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	715	0	715	NA	NA	0	715	
80	TCGA-EM-A2CO	0	0	0	0	1	0	0	0	1	11	0	0	0	4	0	0	TCGA-EM-A2CO-01	37	0.5149424521671935	6	TCGA-EM-A2CO-01	6	3	19	0.0879502523634099	TCGA-EM-A2CO-01	0	1	0	1	PASS	10144	TCGA-EM-A2CO	THCA	77	FEMALE	NA	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-28424	Alive	TUMOR FREE	184	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	184	0	184	0	184	0	184	
30	TCGA-EM-A2CP	0	3	0	0	0	0	0	0	1	14	1	0	0	7	0	0	TCGA-EM-A2CP-01	53	0.00020414230958696217	16	TCGA-EM-A2CP-01	0	0	19	6.107409383275648e-05	TCGA-EM-A2CP-01	0	0	0	0	PASS	10145	TCGA-EM-A2CP	THCA	26	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-9759	Alive	TUMOR FREE	91	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	91	0	91	0	91	0	91	
40	TCGA-EM-A2CQ	0	1	0	0	0	0	0	0	1	5	1	0	0	2	0	0	TCGA-EM-A2CQ-01	81	6.876464604453023e-05	33	TCGA-EM-A2CQ-01	0	0	19	3.29455743070714e-06	TCGA-EM-A2CQ-01	0	0	0	0	PASS	10146	TCGA-EM-A2CQ	THCA	40	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-14776	Alive	TUMOR FREE	374	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	374	0	374	0	374	0	374	
50	TCGA-EM-A2CR	0	0	0	1	1	0	0	0	1	9	0	0	0	3	0	0	TCGA-EM-A2CR	0	0	0	TCGA-EM-A2CR	0	0	0	0	TCGA-EM-A2CR	0	0	0	0	PASS	10147	TCGA-EM-A2CR	THCA	46	FEMALE	NA	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-16807	Alive	TUMOR FREE	415	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	415	0	415	0	415	0	415	
50	TCGA-EM-A2CS	0	3	0	1	0	1	0	0	1	19	0	0	0	6	0	0	TCGA-EM-A2CS	0	0	0	TCGA-EM-A2CS	0	0	0	0	TCGA-EM-A2CS	0	0	0	0	mutation call filter	10148	TCGA-EM-A2CS	THCA	51	FEMALE	NA	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-18990	Alive	WITH TUMOR	841	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	841	0	841	NA	NA	0	841	
30	TCGA-EM-A2CT	0	6	0	0	0	0	0	0	1	18	1	0	0	9	1	0	TCGA-EM-A2CT-01	55	0.0008456560996080298	16	TCGA-EM-A2CT-01	0	0	19	2.4931799761984532e-05	TCGA-EM-A2CT-01	0	0	0	0	PASS	10149	TCGA-EM-A2CT	THCA	20	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-7558	Alive	TUMOR FREE	1474	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1474	0	1474	0	1474	0	1474	
50	TCGA-EM-A2CU	0	0	0	0	0	0	0	0	0	13	2	0	0	8	1	0	TCGA-EM-A2CU-01	45	8.515702720033909e-06	10	TCGA-EM-A2CU	0	0	0	0	TCGA-EM-A2CU	0	0	0	0	PASS	10150	TCGA-EM-A2CU	THCA	47	FEMALE	NA	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-17231	Alive	WITH TUMOR	400	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	400	0	400	0	400	0	400	
60	TCGA-EM-A2OV	0	0	0	0	0	1	0	0	1	14	0	0	1	1	0	0	TCGA-EM-A2OV-01	45	5.375109260045199e-05	9	TCGA-EM-A2OV-01	0	0	2	4.7618331778006405e-05	TCGA-EM-A2OV-01	0	0	0	0	PASS	10151	TCGA-EM-A2OV	THCA	64	FEMALE	ASIAN	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-23656	Alive	TUMOR FREE	674	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	674	0	674	0	674	0	674	
40	TCGA-EM-A2OW	0	2	0	0	0	1	0	0	0	10	0	0	0	6	1	0	TCGA-EM-A2OW-01	55	3.9403511120863145e-05	16	TCGA-EM-A2OW-01	0	0	19	2.8288614035851947e-05	TCGA-EM-A2OW-01	0	0	0	0	PASS	10152	TCGA-EM-A2OW	THCA	37	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-13761	Alive	TUMOR FREE	1227	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1227	0	1227	0	1227	0	1227	
50	TCGA-EM-A2OX	0	1	0	0	0	0	0	0	1	7	0	0	0	4	0	0	TCGA-EM-A2OX-01	57	0.02057227228146493	17	TCGA-EM-A2OX-01	0	1	3	0.021685951468424683	TCGA-EM-A2OX-01	0	1	1	2	PASS	10153	TCGA-EM-A2OX	THCA	46	MALE	NA	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-16911	Alive	TUMOR FREE	600	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	600	0	600	NA	NA	0	600	
50	TCGA-EM-A2OY	0	1	0	3	1	0	0	0	0	13	0	0	0	1	0	0	TCGA-EM-A2OY-01	43	0.4740041202454506	9	TCGA-EM-A2OY-01	21	20	2	0.028649645100117693	TCGA-EM-A2OY-01	0	0	0	0	PASS	10154	TCGA-EM-A2OY	THCA	46	FEMALE	NA	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-17075	Alive	TUMOR FREE	983	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	983	0	983	0	983	0	983	
70	TCGA-EM-A2OZ	0	3	0	4	0	0	1	0	3	27	3	0	0	24	1	0	TCGA-EM-A2OZ-01	39	2.8197736692278694e-05	4	TCGA-EM-A2OZ-01	0	0	19	2.7430705658726825e-05	TCGA-EM-A2OZ-01	0	0	0	0	PASS	10155	TCGA-EM-A2OZ	THCA	66	MALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-24195	Alive	TUMOR FREE	1033	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1033	0	1033	0	1033	0	1033	
30	TCGA-EM-A2P0	0	1	0	0	0	0	1	0	0	4	1	0	0	0	1	0	TCGA-EM-A2P0-01	49	8.806358037840492e-06	14	TCGA-EM-A2P0-01	0	0	0	0.0	TCGA-EM-A2P0-01	0	0	0	0	PASS	10156	TCGA-EM-A2P0	THCA	33	MALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-12127	Alive	TUMOR FREE	535	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	535	0	535	0	535	0	535	
30	TCGA-EM-A2P1	0	7	0	0	0	0	0	0	0	13	0	0	0	9	0	0	TCGA-EM-A2P1-01	51	5.235357314220025e-05	13	TCGA-EM-A2P1-06	0	0	19	3.462930005101544e-05	TCGA-EM-A2P1-06	0	0	0	0	mutation call filter	10157	TCGA-EM-A2P1	THCA	33	MALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-12320	Alive	WITH TUMOR	531	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	363	NA	NA	R0	0	531	0	531	1	363	1	363	
50	TCGA-EM-A2P2	0	0	0	1	1	0	0	0	1	16	0	0	0	3	0	0	TCGA-EM-A2P2-01	51	0.033398281320381466	8	TCGA-EM-A2P2-01	1	1	19	0.01565365418047139	TCGA-EM-A2P2-01	4	2	1	7	PASS	10158	TCGA-EM-A2P2	THCA	46	MALE	NA	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-16895	Alive	TUMOR FREE	526	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	526	0	526	0	526	0	526	
50	TCGA-EM-A2P3	0	0	0	0	1	0	1	0	1	8	0	0	0	4	0	0	TCGA-EM-A2P3-01	40	1.0527257422789464e-05	6	TCGA-EM-A2P3-01	0	0	19	5.8431959552045475e-06	TCGA-EM-A2P3-01	0	0	0	0	PASS	10159	TCGA-EM-A2P3	THCA	47	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-17495	Alive	TUMOR FREE	444	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	444	0	444	0	444	0	444	
70	TCGA-EM-A3AI	0	1	0	0	0	0	0	0	0	11	1	0	0	2	2	0	TCGA-EM-A3AI-01	47	0.947729633085554	10	TCGA-EM-A3AI-01	13	8	19	2.8180345136496244e-06	TCGA-EM-A3AI-01	0	0	0	0	PASS	10160	TCGA-EM-A3AI	THCA	67	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-24820	Alive	TUMOR FREE	685	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	685	0	685	0	685	0	685	
40	TCGA-EM-A3AJ	0	0	0	1	0	0	0	0	0	3	1	0	0	1	0	0	TCGA-EM-A3AJ-01	57	0.00037325191291441746	15	TCGA-EM-A3AJ-01	0	0	0	0.0	TCGA-EM-A3AJ-01	0	0	0	0	PASS	10161	TCGA-EM-A3AJ	THCA	39	MALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-14399	Alive	TUMOR FREE	941	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	941	0	941	NA	NA	0	941	
60	TCGA-EM-A3AK	0	0	0	1	0	0	0	0	0	8	0	0	0	4	1	0	TCGA-EM-A3AK-01	29	5.289083985700797e-06	2	TCGA-EM-A3AK-01	0	0	19	4.1297956821642025e-06	TCGA-EM-A3AK-01	0	0	0	0	PASS	10162	TCGA-EM-A3AK	THCA	62	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-22911	Alive	TUMOR FREE	477	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	477	0	477	0	477	0	477	
50	TCGA-EM-A3AL	0	0	0	0	0	0	0	0	0	10	0	0	0	8	0	0	TCGA-EM-A3AL-01	43	2.30874385742888e-05	8	TCGA-EM-A3AL-01	0	0	19	1.2374802490123139e-05	TCGA-EM-A3AL-01	0	0	0	0	PASS	10163	TCGA-EM-A3AL	THCA	45	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-16439	Alive	TUMOR FREE	430	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	430	0	430	0	430	0	430	
40	TCGA-EM-A3AN	0	0	0	1	0	1	0	0	1	7	0	0	0	0	0	0	TCGA-EM-A3AN-01	53	0.00134236021170585	12	TCGA-EM-A3AN-01	0	0	0	0.0	TCGA-EM-A3AN-01	0	0	0	0	PASS	10164	TCGA-EM-A3AN	THCA	36	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-13188	Alive	TUMOR FREE	1006	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	1006	0	1006	NA	NA	0	1006	
60	TCGA-EM-A3AO	0	0	0	0	0	0	0	0	2	5	1	0	0	2	1	0	TCGA-EM-A3AO-01	53	8.984012006186841e-05	19	TCGA-EM-A3AO-01	0	0	19	4.222097605725504e-05	TCGA-EM-A3AO-01	0	0	0	0	PASS	10165	TCGA-EM-A3AO	THCA	61	MALE	NA	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-22347	Alive	TUMOR FREE	1354	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1354	0	1354	NA	NA	0	1354	
30	TCGA-EM-A3AP	0	0	0	1	0	0	0	0	0	11	0	0	0	2	0	0	TCGA-EM-A3AP-01	63	0.011064803508421091	21	TCGA-EM-A3AP-01	1	1	4	0.011664530438653916	TCGA-EM-A3AP-01	0	0	0	0	PASS	10166	TCGA-EM-A3AP	THCA	31	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-11592	Alive	TUMOR FREE	254	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	254	0	254	0	254	0	254	
90	TCGA-EM-A3AQ	0	0	0	0	0	0	0	0	0	9	1	0	0	3	0	0	TCGA-EM-A3AQ-01	91	0.00013046041605677328	41	TCGA-EM-A3AQ	0	0	0	0	TCGA-EM-A3AQ	0	0	0	0	PASS	10167	TCGA-EM-A3AQ	THCA	85	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-31198	Alive	TUMOR FREE	904	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	904	0	904	0	904	0	904	
40	TCGA-EM-A3AR	0	0	0	0	0	0	1	0	0	4	0	0	0	2	0	0	TCGA-EM-A3AR-01	53	1.8846312428767724e-05	13	TCGA-EM-A3AR-01	0	0	0	0.0	TCGA-EM-A3AR-01	0	0	0	0	PASS	10168	TCGA-EM-A3AR	THCA	41	MALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-15313	Alive	TUMOR FREE	1133	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1133	0	1133	0	1133	0	1133	
30	TCGA-EM-A3FJ	0	1	0	1	1	0	0	0	0	1	0	0	0	1	0	0	TCGA-EM-A3FJ-01	41	2.232284630199503e-05	6	TCGA-EM-A3FJ-01	0	0	0	0.0	TCGA-EM-A3FJ-01	0	0	0	0	PASS	10169	TCGA-EM-A3FJ	THCA	24	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-9042	Alive	TUMOR FREE	850	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	850	0	850	0	850	0	850	
30	TCGA-EM-A3FK	0	1	0	1	0	0	0	0	0	8	0	0	0	4	0	0	TCGA-EM-A3FK-01	42	0.052261497882618115	14	TCGA-EM-A3FK-01	0	0	0	0.0	TCGA-EM-A3FK-01	0	0	0	0	PASS	10170	TCGA-EM-A3FK	THCA	30	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-10992	Alive	TUMOR FREE	723	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	723	0	723	0	723	0	723	
60	TCGA-EM-A3FL	0	1	0	0	0	0	0	0	0	7	0	0	0	5	0	0	TCGA-EM-A3FL-01	31	3.3139918330703112e-06	2	TCGA-EM-A3FL-01	0	0	0	0.0	TCGA-EM-A3FL-01	0	0	0	0	PASS	10171	TCGA-EM-A3FL	THCA	63	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-23183	Alive	TUMOR FREE	1441	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1441	0	1441	0	1441	0	1441	
60	TCGA-EM-A3FM	0	1	0	1	0	0	0	0	1	12	1	0	0	3	1	0	TCGA-EM-A3FM-01	61	3.819590816363963e-05	23	TCGA-EM-A3FM-01	0	0	0	0.0	TCGA-EM-A3FM-01	0	0	0	0	PASS	10172	TCGA-EM-A3FM	THCA	57	MALE	NA	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-20938	Alive	WITH TUMOR	639	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	514	NA	NA	R0	0	639	0	639	NA	NA	1	514	
40	TCGA-EM-A3FN	0	1	0	4	0	0	0	0	1	16	1	0	0	2	0	0	TCGA-EM-A3FN-01	155	0.000377316090456285	85	TCGA-EM-A3FN-01	0	0	8	0.004661436432227478	TCGA-EM-A3FN-01	0	0	0	0	PASS	10173	TCGA-EM-A3FN	THCA	42	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-15655	Alive	TUMOR FREE	367	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	367	0	367	0	367	0	367	
40	TCGA-EM-A3FO	0	1	0	0	0	0	0	0	0	5	1	0	0	1	0	0	TCGA-EM-A3FO-01	61	0.011034271139084655	18	TCGA-EM-A3FO-01	0	0	19	1.0536115430023818e-05	TCGA-EM-A3FO-01	0	0	0	0	PASS	10174	TCGA-EM-A3FO	THCA	40	MALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-14864	Alive	TUMOR FREE	532	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	532	0	532	0	532	0	532	
70	TCGA-EM-A3FP	0	0	0	1	0	0	0	0	0	11	1	0	0	2	0	0	TCGA-EM-A3FP-01	69	0.004674587184730746	25	TCGA-EM-A3FP-01	0	0	3	0.0046439842989303756	TCGA-EM-A3FP-01	1	1	0	2	PASS	10175	TCGA-EM-A3FP	THCA	71	FEMALE	NA	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-26158	Alive	TUMOR FREE	529	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	529	0	529	0	529	0	529	
20	TCGA-EM-A3FQ	1	0	0	0	0	0	0	0	1	12	0	0	0	3	2	0	TCGA-EM-A3FQ-01	43	0.00010016121908101497	7	TCGA-EM-A3FQ-06	0	0	19	1.7298455903104855e-05	TCGA-EM-A3FQ-06	0	0	0	0	mutation call filter	10176	TCGA-EM-A3FQ	THCA	19	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-7176	Alive	WITH TUMOR	492	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	492	0	492	0	492	0	492	
60	TCGA-EM-A3FR	0	0	0	2	1	0	0	0	0	14	1	0	0	1	0	0	TCGA-EM-A3FR-01	51	4.740016090303222e-05	12	TCGA-EM-A3FR-01	0	0	11	0.0009391697975564893	TCGA-EM-A3FR-01	0	0	0	0	PASS	10177	TCGA-EM-A3FR	THCA	55	FEMALE	NA	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-20349	Alive	TUMOR FREE	457	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	457	0	457	0	457	0	457	
80	TCGA-EM-A3O3	0	3	0	1	3	0	0	0	2	24	1	0	0	11	0	0	TCGA-EM-A3O3-01	83	0.11228368513344887	35	TCGA-EM-A3O3-01	4	5	7	0.06608147141495617	TCGA-EM-A3O3-01	2	1	1	4	PASS	10178	TCGA-EM-A3O3	THCA	83	FEMALE	[Unknown]	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-30500	Alive	TUMOR FREE	441	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	441	0	441	0	441	0	441	
50	TCGA-EM-A3O6	0	1	1	1	1	0	0	0	0	7	1	0	0	3	1	0	TCGA-EM-A3O6-01	41	0.00907774971118702	8	TCGA-EM-A3O6-01	0	0	19	0.009526147763211952	TCGA-EM-A3O6-01	0	2	1	3	PASS	10179	TCGA-EM-A3O6	THCA	54	FEMALE	[Unknown]	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-19856	Alive	TUMOR FREE	458	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	458	0	458	0	458	0	458	
50	TCGA-EM-A3O7	0	0	0	1	2	0	0	0	0	6	1	0	0	4	1	0	TCGA-EM-A3O7-01	81	2.57255772684871e-05	36	TCGA-EM-A3O7-01	0	0	0	0.0	TCGA-EM-A3O7-01	0	0	0	0	PASS	10180	TCGA-EM-A3O7	THCA	46	FEMALE	[Unknown]	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-16842	Alive	TUMOR FREE	223	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	223	0	223	0	223	0	223	
30	TCGA-EM-A3O8	0	2	1	1	0	0	0	0	1	3	1	0	0	2	1	0	TCGA-EM-A3O8-01	45	7.389676836468695e-05	11	TCGA-EM-A3O8-01	0	0	19	5.522957431147256e-05	TCGA-EM-A3O8-01	0	0	0	0	PASS	10181	TCGA-EM-A3O8	THCA	33	FEMALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-12405	Alive	TUMOR FREE	381	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	381	0	381	0	381	0	381	
40	TCGA-EM-A3O9	0	0	0	0	0	0	0	0	0	9	2	0	0	1	0	0	TCGA-EM-A3O9-01	47	0.4197084379169841	12	TCGA-EM-A3O9-01	20	26	19	1.6634409147315532e-05	TCGA-EM-A3O9-01	0	0	0	0	PASS	10182	TCGA-EM-A3O9	THCA	40	MALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-14783	Alive	TUMOR FREE	281	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	281	0	281	0	281	0	281	
60	TCGA-EM-A3OA	0	0	0	2	0	0	0	0	1	11	1	0	0	7	0	0	TCGA-EM-A3OA-01	41	2.252057677681347e-05	5	TCGA-EM-A3OA-01	0	0	0	0.0	TCGA-EM-A3OA-01	0	0	0	0	PASS	10183	TCGA-EM-A3OA	THCA	55	FEMALE	[Unknown]	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-20284	Alive	TUMOR FREE	822	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	822	0	822	0	822	0	822	
30	TCGA-EM-A3OB	0	0	0	1	0	0	0	0	0	6	0	0	0	3	0	0	TCGA-EM-A3OB-01	30	0.027540861991315575	1	TCGA-EM-A3OB-01	1	1	19	0.0031247568672434266	TCGA-EM-A3OB-01	1	0	0	1	PASS	10184	TCGA-EM-A3OB	THCA	33	FEMALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-12282	Alive	TUMOR FREE	1176	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1176	0	1176	0	1176	0	1176	
60	TCGA-EM-A3ST	0	2	0	0	0	0	1	0	0	14	3	0	1	4	1	0	TCGA-EM-A3ST-01	53	6.848729694962484e-05	12	TCGA-EM-A3ST-01	0	0	2	2.297598384164003e-05	TCGA-EM-A3ST-01	0	0	0	0	PASS	10185	TCGA-EM-A3ST	THCA	62	FEMALE	[Unknown]	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-22990	Alive	WITH TUMOR	1182	NA	NA	Biochemical evidence of disease	NA	NA	966	NA	NA	R0	0	1182	0	1182	1	966	1	966	
40	TCGA-EM-A3SU	0	0	0	1	0	1	0	0	0	18	0	0	0	3	1	0	TCGA-EM-A3SU-01	35	2.872059271885205e-06	3	TCGA-EM-A3SU-06	0	0	2	0.0005752371006897704	TCGA-EM-A3SU-06	0	0	0	0	mutation call filter	10186	TCGA-EM-A3SU	THCA	43	FEMALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-15768	Alive	TUMOR FREE	911	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	911	0	911	0	911	0	911	
30	TCGA-EM-A3SX	0	2	0	0	0	1	0	0	0	22	2	1	1	5	0	0	TCGA-EM-A3SX-01	47	0.011134695165283232	12	TCGA-EM-A3SX-01	1	1	12	0.013850061263308457	TCGA-EM-A3SX-01	0	0	0	0	PASS	10187	TCGA-EM-A3SX	THCA	28	FEMALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-10447	Alive	WITH TUMOR	908	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	908	0	908	NA	NA	0	908	
40	TCGA-EM-A3SY	0	0	0	0	1	0	2	0	1	10	0	0	1	1	0	0	TCGA-EM-A3SY-01	67	0.5556695847086033	26	TCGA-EM-A3SY-01	26	15	39	0.2188815702306385	TCGA-EM-A3SY-01	0	0	0	0	PASS	10188	TCGA-EM-A3SY	THCA	36	MALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-13461	Alive	TUMOR FREE	411	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	411	0	411	0	411	0	411	
40	TCGA-EM-A3SZ	0	1	0	0	1	1	0	0	0	18	0	0	0	2	1	0	TCGA-EM-A3SZ-01	47	0.01133220630429234	7	TCGA-EM-A3SZ-01	0	0	19	0.0002200527288517623	TCGA-EM-A3SZ-01	0	0	0	0	PASS	10189	TCGA-EM-A3SZ	THCA	42	FEMALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-15659	Alive	TUMOR FREE	389	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	389	0	389	0	389	0	389	
40	TCGA-EM-A4FF	0	0	1	2	1	0	0	0	1	7	0	0	0	0	1	0	TCGA-EM-A4FF-01	65	0.0002766103479605795	22	TCGA-EM-A4FF-01	0	0	6	0.0024031293183791554	TCGA-EM-A4FF-01	0	0	0	0	PASS	10190	TCGA-EM-A4FF	THCA	40	FEMALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2006	NA	-14796	Alive	TUMOR FREE	2573	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	1785	NA	NA	R1	0	2573	0	2573	NA	NA	1	1785	
70	TCGA-EM-A4FH	0	0	0	1	0	0	0	0	0	4	1	0	1	4	0	0	TCGA-EM-A4FH-01	37	5.037972104418472e-06	7	TCGA-EM-A4FH-01	0	0	8	0.0004164220352497108	TCGA-EM-A4FH-01	0	0	0	0	PASS	10191	TCGA-EM-A4FH	THCA	69	MALE	[Unknown]	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-25500	Alive	TUMOR FREE	892	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	892	0	892	0	892	0	892	
30	TCGA-EM-A4FK	0	0	1	0	0	0	0	0	0	6	0	0	0	4	0	0	TCGA-EM-A4FK-01	49	1.0244575829501886e-05	13	TCGA-EM-A4FK-01	0	0	5	0.0007794113174075492	TCGA-EM-A4FK-01	0	0	0	0	PASS	10192	TCGA-EM-A4FK	THCA	33	FEMALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-12383	Alive	TUMOR FREE	649	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	649	0	649	0	649	0	649	
60	TCGA-EM-A4FM	0	0	0	0	1	0	0	0	1	18	0	0	0	9	1	0	TCGA-EM-A4FM-01	37	4.952217231808025e-05	5	TCGA-EM-A4FM-01	0	0	11	0.0033176911035009467	TCGA-EM-A4FM-01	0	0	0	0	PASS	10193	TCGA-EM-A4FM	THCA	59	FEMALE	[Unknown]	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-21595	Alive	WITH TUMOR	162	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	162	0	162	NA	NA	0	162	
50	TCGA-EM-A4FN	0	0	0	0	0	0	0	0	1	11	0	0	0	4	0	0	TCGA-EM-A4FN-01	31	4.05276521469531e-05	0	TCGA-EM-A4FN-01	0	0	4	0.003943057640753324	TCGA-EM-A4FN-01	0	2	0	2	PASS	10194	TCGA-EM-A4FN	THCA	49	FEMALE	[Unknown]	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-18185	Alive	TUMOR FREE	802	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	802	0	802	NA	NA	0	802	
70	TCGA-EM-A4FO	0	0	0	0	0	0	0	0	0	13	1	0	2	3	0	0	TCGA-EM-A4FO-01	63	0.011175875556242687	24	TCGA-EM-A4FO-01	0	0	5	0.00024531228729448093	TCGA-EM-A4FO-01	0	0	0	0	PASS	10195	TCGA-EM-A4FO	THCA	72	MALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-26589	Alive	TUMOR FREE	802	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	802	0	802	0	802	0	802	
40	TCGA-EM-A4FQ	0	0	0	1	0	0	0	0	1	8	1	0	0	0	0	0	TCGA-EM-A4FQ-01	47	2.4506839714322102e-05	10	TCGA-EM-A4FQ-01	0	0	12	0.00038832927365967817	TCGA-EM-A4FQ-01	0	0	0	0	PASS	10196	TCGA-EM-A4FQ	THCA	42	FEMALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2012	NA	-15534	Alive	TUMOR FREE	683	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	683	0	683	0	683	0	683	
30	TCGA-EM-A4FR	0	0	0	0	0	0	0	0	1	5	0	0	0	0	0	0	TCGA-EM-A4FR-01	73	0.011365157827042362	33	TCGA-EM-A4FR-01	1	1	22	0.013041048015818738	TCGA-EM-A4FR-01	0	0	0	0	PASS	10197	TCGA-EM-A4FR	THCA	28	MALE	[Unknown]	Stage I	NA	"Other, specify"	NA	2012	NA	-10316	Alive	TUMOR FREE	655	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	655	0	655	0	655	0	655	
40	TCGA-EM-A4FU	0	0	0	1	0	0	0	0	0	4	1	0	0	2	0	0	TCGA-EM-A4FU-01	43	0.011023034792716704	8	TCGA-EM-A4FU-01	1	1	8	0.01299128978135866	TCGA-EM-A4FU-01	0	0	0	0	PASS	10198	TCGA-EM-A4FU	THCA	35	MALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2009	NA	-12912	Alive	TUMOR FREE	1840	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	781	NA	NA	R0	0	1840	0	1840	1	781	1	781	
60	TCGA-EM-A4FV	0	1	0	0	1	0	0	0	0	18	1	0	0	9	1	0	TCGA-EM-A4FV-01	45	0.00018449601205521146	12	TCGA-EM-A4FV-01	0	0	8	0.00025255560156087204	TCGA-EM-A4FV-01	0	0	0	0	PASS	10199	TCGA-EM-A4FV	THCA	64	FEMALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-23627	Alive	TUMOR FREE	744	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	744	0	744	0	744	0	744	
30	TCGA-EM-A4G1	0	2	0	0	0	0	0	0	0	2	0	0	0	1	0	0	TCGA-EM-A4G1-01	31	2.789029889480824e-06	2	TCGA-EM-A4G1-01	0	0	10	0.0004425955233490326	TCGA-EM-A4G1-01	0	0	0	0	PASS	10200	TCGA-EM-A4G1	THCA	26	FEMALE	[Unknown]	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2012	NA	-9844	Alive	TUMOR FREE	416	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	416	0	416	0	416	0	416	
60	TCGA-ET-A25G	0	4	0	1	0	0	0	0	1	11	0	0	1	2	1	0	TCGA-ET-A25G-01	53	1.991392778928084e-05	13	TCGA-ET-A25G-01	0	0	0	0.0	TCGA-ET-A25G-01	0	0	0	0	PASS	10201	TCGA-ET-A25G	THCA	56	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2008	NA	-20816	Alive	TUMOR FREE	2492	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2492	0	2492	0	2492	0	2492	
40	TCGA-ET-A25I	0	0	0	1	1	0	0	0	2	11	0	0	0	4	0	0	TCGA-ET-A25I-01	47	3.6569744667849216e-05	8	TCGA-ET-A25I-01	0	0	0	0.0	TCGA-ET-A25I-01	0	0	0	0	PASS	10202	TCGA-ET-A25I	THCA	37	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2008	NA	-13786	Alive	TUMOR FREE	2485	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2485	0	2485	0	2485	0	2485	
40	TCGA-ET-A25J	0	1	0	2	0	0	0	0	0	7	2	0	0	3	0	0	TCGA-ET-A25J-01	63	4.115327496856256e-05	20	TCGA-ET-A25J-01	0	0	0	0.0	TCGA-ET-A25J-01	0	0	0	0	PASS	10203	TCGA-ET-A25J	THCA	40	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-14843	Alive	TUMOR FREE	2359	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2359	0	2359	0	2359	0	2359	
40	TCGA-ET-A25K	0	1	0	2	0	0	0	0	0	11	3	0	0	6	0	1	TCGA-ET-A25K-01	35	7.468097328291023e-06	5	TCGA-ET-A25K-01	0	0	19	6.4589279219620525e-06	TCGA-ET-A25K-01	0	0	0	0	PASS	10204	TCGA-ET-A25K	THCA	36	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-13351	Alive	TUMOR FREE	2142	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2142	0	2142	0	2142	0	2142	
50	TCGA-ET-A25L	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-ET-A25L-01	73	0.011190323964187131	26	TCGA-ET-A25L-01	1	1	19	0.011597514915473029	TCGA-ET-A25L-01	0	0	0	0	PASS	10205	TCGA-ET-A25L	THCA	52	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2010	NA	-19159	Alive	TUMOR FREE	1721	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	1721	0	1721	NA	NA	0	1721	
30	TCGA-ET-A25M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-ET-A25M-01	29	1.6120342251344569e-06	1	TCGA-ET-A25M	0	0	0	0	TCGA-ET-A25M	0	0	0	0	PASS	10206	TCGA-ET-A25M	THCA	33	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-12085	Alive	TUMOR FREE	1831	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1831	0	1831	0	1831	0	1831	
30	TCGA-ET-A25N	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-ET-A25N-01	41	1.3368708355031925e-05	9	TCGA-ET-A25N	0	0	0	0	TCGA-ET-A25N	0	0	0	0	PASS	10207	TCGA-ET-A25N	THCA	28	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-10229	Alive	TUMOR FREE	1928	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1928	0	1928	0	1928	0	1928	
40	TCGA-ET-A25O	0	1	1	0	0	0	0	0	0	11	1	0	4	4	2	0	TCGA-ET-A25O-01	65	0.010998314778695915	22	TCGA-ET-A25O-01	1	1	2	0.011602746091565886	TCGA-ET-A25O-01	0	0	0	0	PASS	10208	TCGA-ET-A25O	THCA	35	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-12924	Alive	TUMOR FREE	1986	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1986	0	1986	0	1986	0	1986	
30	TCGA-ET-A25P	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-ET-A25P-01	43	0.027581120738143384	7	TCGA-ET-A25P-01	2	1	0	0.0	TCGA-ET-A25P-01	0	0	0	0	PASS	10209	TCGA-ET-A25P	THCA	24	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-8787	Alive	TUMOR FREE	559	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	559	0	559	0	559	0	559	
50	TCGA-ET-A25R	0	0	0	0	1	0	0	0	1	10	0	0	0	5	0	0	TCGA-ET-A25R-01	41	4.415910008179588e-06	10	TCGA-ET-A25R-01	0	0	0	0.0	TCGA-ET-A25R-01	0	0	0	0	PASS	10210	TCGA-ET-A25R	THCA	51	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2009	NA	-18863	Alive	TUMOR FREE	1930	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1930	0	1930	0	1930	0	1930	
30	TCGA-ET-A2MX	0	1	0	1	0	0	0	0	0	8	1	0	0	4	0	0	TCGA-ET-A2MX-01	55	0.00022101190464044425	14	TCGA-ET-A2MX-01	0	0	8	0.00034520286625729877	TCGA-ET-A2MX-01	0	0	0	0	PASS	10211	TCGA-ET-A2MX	THCA	27	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-10044	Alive	TUMOR FREE	2689	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2689	0	2689	0	2689	0	2689	
70	TCGA-ET-A2MY	0	3	0	2	0	0	0	0	1	48	3	0	0	14	0	0	TCGA-ET-A2MY-01	55	2.921496562121153e-05	20	TCGA-ET-A2MY-01	0	0	0	0.0	TCGA-ET-A2MY-01	0	0	0	0	PASS	10212	TCGA-ET-A2MY	THCA	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-26406	Alive	TUMOR FREE	1787	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1787	0	1787	0	1787	0	1787	
40	TCGA-ET-A2MZ	0	1	0	0	1	0	0	0	0	5	0	0	0	1	0	0	TCGA-ET-A2MZ-01	55	0.0849069867329848	20	TCGA-ET-A2MZ-01	0	23	0	0.0	TCGA-ET-A2MZ-01	0	0	0	0	PASS	10213	TCGA-ET-A2MZ	THCA	39	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-14408	Alive	TUMOR FREE	1133	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	1133	0	1133	NA	NA	0	1133	
50	TCGA-ET-A2N0	0	0	0	0	0	0	1	0	0	7	2	0	0	5	0	0	TCGA-ET-A2N0-01	55	3.1031102997040836e-05	14	TCGA-ET-A2N0-01	0	0	0	0.0	TCGA-ET-A2N0-01	0	0	0	0	PASS	10214	TCGA-ET-A2N0	THCA	51	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-18692	Alive	TUMOR FREE	1600	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1600	0	1600	0	1600	0	1600	
50	TCGA-ET-A2N1	0	0	0	0	0	0	0	0	0	14	1	0	0	5	0	0	TCGA-ET-A2N1-01	47	3.389564514938954e-05	12	TCGA-ET-A2N1-01	0	0	0	0.0	TCGA-ET-A2N1-01	0	0	0	0	PASS	10215	TCGA-ET-A2N1	THCA	47	FEMALE	ASIAN	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-17272	Alive	TUMOR FREE	1653	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1653	0	1653	0	1653	0	1653	
30	TCGA-ET-A2N3	0	0	0	1	0	2	0	0	0	4	0	0	0	3	2	0	TCGA-ET-A2N3-01	45	0.002236572468982379	9	TCGA-ET-A2N3-01	0	0	10	0.00042634365454462985	TCGA-ET-A2N3-01	0	0	0	0	PASS	10216	TCGA-ET-A2N3	THCA	34	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2008	NA	-12603	Alive	TUMOR FREE	2535	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	2535	0	2535	NA	NA	0	2535	
50	TCGA-ET-A2N4	0	1	0	0	0	0	0	0	0	15	0	0	0	6	0	0	TCGA-ET-A2N4-01	82	0.020767611078514773	36	TCGA-ET-A2N4-01	2	2	3	0.021628303982328127	TCGA-ET-A2N4-01	1	1	1	3	PASS	10217	TCGA-ET-A2N4	THCA	53	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2008	NA	-19671	Alive	TUMOR FREE	81	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	81	0	81	NA	NA	0	81	
50	TCGA-ET-A2N5	0	0	0	0	1	0	0	0	0	9	1	0	0	1	0	0	TCGA-ET-A2N5-01	43	6.3379711689962765e-06	4	TCGA-ET-A2N5-01	0	0	0	0.0	TCGA-ET-A2N5-01	0	0	0	0	PASS	10218	TCGA-ET-A2N5	THCA	46	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2008	NA	-17137	Alive	TUMOR FREE	2460	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	2460	0	2460	NA	NA	0	2460	
80	TCGA-ET-A39I	0	1	0	1	0	0	0	0	1	7	2	0	0	2	0	0	TCGA-ET-A39I-01	49	2.2983445573189405e-05	12	TCGA-ET-A39I-01	0	0	0	0.0	TCGA-ET-A39I-01	0	0	0	0	PASS	10219	TCGA-ET-A39I	THCA	83	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2007	NA	-30349	Dead	TUMOR FREE	NA	1011	NA	NA	NA	NA	NA	NA	NA	R0	1	1011	0	1011	0	1011	0	1011	
30	TCGA-ET-A39J	0	2	0	3	1	0	0	0	0	15	1	0	1	4	1	0	TCGA-ET-A39J-01	59	0.00011456543293295225	21	TCGA-ET-A39J-01	0	0	4	0.0035758212626826845	TCGA-ET-A39J-01	0	0	0	0	PASS	10220	TCGA-ET-A39J	THCA	23	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2006	NA	-8491	Alive	TUMOR FREE	3227	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	3227	0	3227	0	3227	0	3227	
50	TCGA-ET-A39K	0	0	0	2	0	0	0	0	0	5	1	0	0	2	0	0	TCGA-ET-A39K-01	43	2.477874636071076e-05	10	TCGA-ET-A39K-01	0	0	0	0.0	TCGA-ET-A39K-01	0	0	0	0	PASS	10221	TCGA-ET-A39K	THCA	48	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2006	NA	-17789	Alive	TUMOR FREE	3267	NA	NA	Locoregional Recurrence	NA	NA	711	NA	NA	R1	0	3267	0	3267	NA	NA	1	711	
30	TCGA-ET-A39L	0	0	0	0	0	0	0	0	0	1	0	0	1	2	0	0	TCGA-ET-A39L-01	59	1.2470138144911667e-05	19	TCGA-ET-A39L-01	0	0	0	0.0	TCGA-ET-A39L-01	0	0	0	0	PASS	10222	TCGA-ET-A39L	THCA	20	FEMALE	NA	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2006	NA	-7636	Alive	TUMOR FREE	3299	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	3299	0	3299	0	3299	0	3299	
30	TCGA-ET-A39M	0	1	0	1	0	0	0	0	0	8	1	0	0	4	0	0	TCGA-ET-A39M-01	47	0.010996480213814462	7	TCGA-ET-A39M-01	1	23	19	0.011597355557308358	TCGA-ET-A39M-01	0	0	0	0	PASS	10223	TCGA-ET-A39M	THCA	34	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2004	NA	-12441	Alive	TUMOR FREE	2582	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2582	0	2582	0	2582	0	2582	
40	TCGA-ET-A39N	0	0	0	2	0	0	0	0	1	8	2	0	0	1	0	0	TCGA-ET-A39N-01	45	0.9072937070873832	11	TCGA-ET-A39N-01	21	16	19	0.01159743065794414	TCGA-ET-A39N-01	1	2	0	3	PASS	10224	TCGA-ET-A39N	THCA	35	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2004	NA	-12904	Alive	TUMOR FREE	3751	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	3751	0	3751	0	3751	0	3751	
40	TCGA-ET-A39O	0	0	0	0	0	0	0	0	0	7	0	0	1	4	0	0	TCGA-ET-A39O-01	47	7.690281568423536e-06	8	TCGA-ET-A39O-01	0	0	0	0.0	TCGA-ET-A39O-01	0	0	0	0	PASS	10225	TCGA-ET-A39O	THCA	39	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2006	NA	-14295	Alive	TUMOR FREE	3059	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	3059	0	3059	0	3059	0	3059	
70	TCGA-ET-A39P	0	5	2	5	0	0	0	0	3	52	10	0	0	21	3	0	TCGA-ET-A39P-01	58	0.033869516377764766	18	TCGA-ET-A39P-01	1	1	0	0.0	TCGA-ET-A39P-01	1	1	0	2	PASS	10226	TCGA-ET-A39P	THCA	73	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-26817	Alive	TUMOR FREE	2900	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	2900	0	2900	NA	NA	0	2900	
30	TCGA-ET-A39R	0	16	2	5	0	0	0	0	18	224	24	0	1	89	11	0	TCGA-ET-A39R-01	35	2.908971257023081e-05	5	TCGA-ET-A39R-01	0	0	0	0.0	TCGA-ET-A39R-01	0	0	0	0	PASS	10227	TCGA-ET-A39R	THCA	24	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-8828	Alive	TUMOR FREE	2863	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2863	0	2863	0	2863	0	2863	
30	TCGA-ET-A39S	0	0	0	1	0	0	0	0	0	5	0	0	0	2	0	0	TCGA-ET-A39S-01	51	6.261912905483352e-05	13	TCGA-ET-A39S-01	0	0	2	3.927831005788498e-05	TCGA-ET-A39S-01	0	0	0	0	PASS	10228	TCGA-ET-A39S	THCA	27	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-10000	Alive	TUMOR FREE	1676	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1676	0	1676	0	1676	0	1676	
60	TCGA-ET-A39T	0	1	0	0	0	0	0	0	1	6	0	0	1	5	0	0	TCGA-ET-A39T-01	37	2.1597298715693072e-06	5	TCGA-ET-A39T-01	0	0	0	0.0	TCGA-ET-A39T-01	0	0	0	0	PASS	10229	TCGA-ET-A39T	THCA	55	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2006	NA	-20164	Alive	TUMOR FREE	2987	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2987	0	2987	0	2987	0	2987	
30	TCGA-ET-A3BN	0	1	0	0	0	0	0	1	1	7	0	0	0	3	0	0	TCGA-ET-A3BN-01	45	0.0001707337724395124	11	TCGA-ET-A3BN-01	0	0	0	0.0	TCGA-ET-A3BN-01	0	0	0	0	PASS	10230	TCGA-ET-A3BN	THCA	33	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-12122	Alive	TUMOR FREE	859	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	859	0	859	0	859	0	859	
40	TCGA-ET-A3BO	0	1	0	0	0	1	0	0	0	5	1	0	0	1	0	0	TCGA-ET-A3BO-01	61	1.4150546007618738e-05	18	TCGA-ET-A3BO-01	0	0	0	0.0	TCGA-ET-A3BO-01	0	0	0	0	PASS	10231	TCGA-ET-A3BO	THCA	44	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2010	NA	-16110	Alive	TUMOR FREE	1533	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	1533	0	1533	NA	NA	0	1533	
30	TCGA-ET-A3BP	0	0	0	0	0	0	0	0	0	5	0	0	0	2	0	0	TCGA-ET-A3BP-01	67	0.03748622061571481	22	TCGA-ET-A3BP-01	3	2	4	0.03962026587607178	TCGA-ET-A3BP-01	0	0	0	0	PASS	10232	TCGA-ET-A3BP	THCA	34	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-12594	Alive	TUMOR FREE	2406	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2406	0	2406	0	2406	0	2406	
30	TCGA-ET-A3BQ	0	0	0	0	1	0	0	0	0	13	1	0	0	4	0	0	TCGA-ET-A3BQ-01	37	1.0631628947451537e-05	5	TCGA-ET-A3BQ-01	0	0	0	0.0	TCGA-ET-A3BQ-01	0	0	0	0	PASS	10233	TCGA-ET-A3BQ	THCA	27	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-10034	Alive	TUMOR FREE	2331	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2331	0	2331	0	2331	0	2331	
40	TCGA-ET-A3BS	0	0	0	0	0	0	0	0	0	5	0	0	0	4	0	0	TCGA-ET-A3BS-01	67	3.61055571511877e-05	24	TCGA-ET-A3BS-01	0	0	0	0.0	TCGA-ET-A3BS-01	0	0	0	0	PASS	10234	TCGA-ET-A3BS	THCA	42	MALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-15421	Alive	TUMOR FREE	176	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	176	0	176	0	176	0	176	
60	TCGA-ET-A3BT	0	2	1	1	0	2	0	0	2	16	1	0	0	5	0	0	TCGA-ET-A3BT-01	38	0.002660973852103525	8	TCGA-ET-A3BT-01	0	0	0	0.0	TCGA-ET-A3BT-01	0	0	0	0	PASS	10235	TCGA-ET-A3BT	THCA	60	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2007	NA	-22108	Alive	TUMOR FREE	2665	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	267	NA	NA	R0	0	2665	0	2665	NA	NA	1	267	
30	TCGA-ET-A3BU	0	0	0	0	0	0	0	0	0	3	0	0	1	2	0	0	TCGA-ET-A3BU-01	57	4.6581769645359116e-05	16	TCGA-ET-A3BU-01	0	0	2	3.516579236421472e-05	TCGA-ET-A3BU-01	0	0	0	0	PASS	10236	TCGA-ET-A3BU	THCA	28	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-10510	Alive	TUMOR FREE	2367	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2367	0	2367	0	2367	0	2367	
50	TCGA-ET-A3BV	0	0	0	1	2	0	1	0	0	19	0	0	0	8	0	0	TCGA-ET-A3BV-01	35	0.10833509052547594	3	TCGA-ET-A3BV-01	0	0	0	0.0	TCGA-ET-A3BV-01	0	0	0	0	PASS	10237	TCGA-ET-A3BV	THCA	47	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-17441	Alive	TUMOR FREE	2294	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	1204	NA	NA	R0	0	2294	0	2294	1	1204	1	1204	
30	TCGA-ET-A3BW	0	0	0	0	1	0	0	0	5	5	0	0	0	3	0	0	TCGA-ET-A3BW-01	49	3.548378344508443e-05	11	TCGA-ET-A3BW-01	0	0	19	2.273304036395781e-05	TCGA-ET-A3BW-01	0	0	0	0	PASS	10238	TCGA-ET-A3BW	THCA	30	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-11032	Alive	TUMOR FREE	1419	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1419	0	1419	0	1419	0	1419	
30	TCGA-ET-A3BX	0	2	0	0	0	0	0	0	0	7	0	0	1	1	1	0	TCGA-ET-A3BX-01	35	3.2189127526377712e-06	6	TCGA-ET-A3BX-01	0	0	0	0.0	TCGA-ET-A3BX-01	0	0	0	0	PASS	10239	TCGA-ET-A3BX	THCA	24	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-8791	Alive	TUMOR FREE	1596	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1596	0	1596	0	1596	0	1596	
30	TCGA-ET-A3DO	0	0	0	1	0	0	0	0	0	12	2	0	0	2	0	0	TCGA-ET-A3DO-01	43	4.051370849147038e-05	9	TCGA-ET-A3DO-01	0	0	19	3.1748087502947205e-05	TCGA-ET-A3DO-01	0	0	0	0	PASS	10240	TCGA-ET-A3DO	THCA	33	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2005	NA	-12158	Alive	TUMOR FREE	3552	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	570	NA	NA	R0	0	3552	0	3552	1	570	1	570	
40	TCGA-ET-A3DP	0	0	0	1	0	0	0	0	0	12	3	0	0	7	0	0	TCGA-ET-A3DP-01	51	6.880986684336446e-05	15	TCGA-ET-A3DP-01	0	0	19	4.466301924819209e-05	TCGA-ET-A3DP-01	0	0	0	0	PASS	10241	TCGA-ET-A3DP	THCA	43	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-15876	Alive	TUMOR FREE	2877	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2877	0	2877	0	2877	0	2877	
40	TCGA-ET-A3DQ	0	0	0	0	0	0	0	0	0	3	0	0	0	3	0	0	TCGA-ET-A3DQ-01	47	0.01989330644507805	15	TCGA-ET-A3DQ-01	0	1	19	0.020965113857772496	TCGA-ET-A3DQ-01	0	1	1	2	PASS	10242	TCGA-ET-A3DQ	THCA	43	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2008	NA	-15871	Alive	TUMOR FREE	2581	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2581	0	2581	0	2581	0	2581	
40	TCGA-ET-A3DR	0	0	0	0	0	0	0	0	1	11	0	0	1	4	1	0	TCGA-ET-A3DR-01	59	3.582081828503281e-05	19	TCGA-ET-A3DR-01	0	0	19	1.4802464109662009e-05	TCGA-ET-A3DR-01	0	0	0	0	PASS	10243	TCGA-ET-A3DR	THCA	42	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-15404	Alive	TUMOR FREE	2451	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2451	0	2451	0	2451	0	2451	
30	TCGA-ET-A3DS	0	0	0	0	1	0	0	0	0	5	0	0	0	5	0	0	TCGA-ET-A3DS-01	67	0.09528371230374093	21	TCGA-ET-A3DS-01	5	5	5	0.041064390281644235	TCGA-ET-A3DS-01	4	3	4	11	PASS	10244	TCGA-ET-A3DS	THCA	33	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-12252	Alive	TUMOR FREE	2033	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2033	0	2033	0	2033	0	2033	
30	TCGA-ET-A3DT	0	0	0	0	0	0	0	0	0	3	0	0	0	2	0	0	TCGA-ET-A3DT-01	59	6.708106578507551e-05	22	TCGA-ET-A3DT-01	0	0	19	1.2520683167366753e-05	TCGA-ET-A3DT-01	0	0	0	0	PASS	10245	TCGA-ET-A3DT	THCA	23	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-8761	Alive	TUMOR FREE	1330	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1330	0	1330	0	1330	0	1330	
30	TCGA-ET-A3DU	0	0	0	2	0	0	0	0	0	11	2	0	0	5	0	0	TCGA-ET-A3DU-01	54	0.00010275100900451272	14	TCGA-ET-A3DU-01	0	0	2	7.934458556116008e-05	TCGA-ET-A3DU-01	0	0	0	0	PASS	10246	TCGA-ET-A3DU	THCA	21	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-7869	Alive	TUMOR FREE	1911	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	1911	0	1911	NA	NA	0	1911	
70	TCGA-ET-A3DV	0	0	0	1	1	0	0	0	0	7	1	0	0	1	0	0	TCGA-ET-A3DV-01	45	1.3126176984353982e-05	12	TCGA-ET-A3DV-01	0	0	0	0.0	TCGA-ET-A3DV-01	0	0	0	0	PASS	10247	TCGA-ET-A3DV	THCA	68	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2001	NA	-24905	Alive	TUMOR FREE	5068	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	5068	0	5068	0	5068	0	5068	
60	TCGA-ET-A3DW	0	0	1	2	0	1	0	0	1	15	0	0	0	4	0	0	TCGA-ET-A3DW-01	35	5.281936079626573e-05	2	TCGA-ET-A3DW-01	0	0	19	1.1810375236579202e-05	TCGA-ET-A3DW-01	0	0	0	0	PASS	10248	TCGA-ET-A3DW	THCA	64	MALE	ASIAN	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2003	NA	-23603	Alive	TUMOR FREE	752	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	752	0	752	0	752	0	752	
30	TCGA-ET-A40P	0	1	0	1	1	0	0	0	0	8	1	0	0	0	0	0	TCGA-ET-A40P-01	57	0.011037669662220329	12	TCGA-ET-A40P-01	1	1	16	0.015065144569116597	TCGA-ET-A40P-01	0	0	0	0	PASS	10249	TCGA-ET-A40P	THCA	32	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-11843	Alive	TUMOR FREE	1338	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1338	0	1338	0	1338	0	1338	
40	TCGA-ET-A40Q	0	3	0	0	0	0	0	0	0	10	0	0	0	2	1	0	TCGA-ET-A40Q-01	65	0.00017030733153097313	17	TCGA-ET-A40Q-01	0	0	8	0.0010969521484625845	TCGA-ET-A40Q-01	0	0	0	0	PASS	10250	TCGA-ET-A40Q	THCA	38	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2011	NA	-14136	Alive	TUMOR FREE	1407	NA	NA	Distant Metastasis	Lung	NA	218	NA	NA	R0	0	1407	0	1407	1	218	1	218	
30	TCGA-ET-A40R	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-ET-A40R-01	31	4.691450929555097e-07	3	TCGA-ET-A40R	0	0	0	0	TCGA-ET-A40R	0	0	0	0	PASS	10251	TCGA-ET-A40R	THCA	24	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-8963	Alive	TUMOR FREE	1350	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	1350	0	1350	NA	NA	0	1350	
60	TCGA-ET-A40S	0	1	0	0	3	1	0	0	1	8	0	0	1	3	1	0	TCGA-ET-A40S-01	60	0.049470709054119086	16	TCGA-ET-A40S-01	1	1	15	0.033225157476642904	TCGA-ET-A40S-01	1	1	1	3	PASS	10252	TCGA-ET-A40S	THCA	62	MALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-22733	Alive	TUMOR FREE	1223	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	1223	0	1223	NA	NA	0	1223	
30	TCGA-ET-A40T	2	0	0	4	0	0	0	0	0	8	0	0	2	7	0	0	TCGA-ET-A40T-01	35	0.011001545289923077	3	TCGA-ET-A40T-01	1	1	7	0.013420618738571552	TCGA-ET-A40T-01	0	0	0	0	PASS	10253	TCGA-ET-A40T	THCA	26	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-9531	Alive	TUMOR FREE	1140	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	1140	0	1140	NA	NA	0	1140	
50	TCGA-ET-A4KN	0	1	0	0	0	0	0	0	0	8	1	0	0	2	0	0	TCGA-ET-A4KN-01	49	0.00022619349433433857	10	TCGA-ET-A4KN-01	0	0	15	0.000794536120555239	TCGA-ET-A4KN-01	0	0	0	0	PASS	10254	TCGA-ET-A4KN	THCA	51	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2012	NA	-18889	Alive	TUMOR FREE	1009	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1009	0	1009	0	1009	0	1009	
50	TCGA-ET-A4KQ	0	0	0	1	0	0	0	0	0	9	0	0	0	1	0	0	TCGA-ET-A4KQ-01	37	6.674504078301798e-06	8	TCGA-ET-A4KQ-01	0	0	5	0.0008065207699802005	TCGA-ET-A4KQ-01	0	0	0	0	PASS	10255	TCGA-ET-A4KQ	THCA	45	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2012	NA	-16685	Alive	TUMOR FREE	955	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	955	0	955	0	955	0	955	
60	TCGA-FE-A22Z	0	2	1	1	0	0	0	0	2	14	2	0	1	5	0	0	TCGA-FE-A22Z-01	73	0.036903178679650345	27	TCGA-FE-A22Z-01	1	1	3	0.01922563877595993	TCGA-FE-A22Z-01	5	3	2	10	PASS	10256	TCGA-FE-A22Z	THCA	61	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2007	NA	-22286	Alive	WITH TUMOR	2243	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	1215	NA	NA	R0	0	2243	0	2243	NA	NA	1	1215	
30	TCGA-FE-A230	0	0	0	0	0	1	0	0	1	3	0	0	0	1	0	0	TCGA-FE-A230-01	53	2.956317398998988e-05	15	TCGA-FE-A230-01	0	0	0	0.0	TCGA-FE-A230-01	0	0	0	0	PASS	10257	TCGA-FE-A230	THCA	30	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2006	NA	-10999	Alive	TUMOR FREE	2173	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	526	NA	NA	R0	0	2173	0	2173	1	526	1	526	
70	TCGA-FE-A231	0	2	0	1	0	0	0	0	1	11	0	0	0	5	0	0	TCGA-FE-A231-01	60	0.05850032792390605	20	TCGA-FE-A231-01	2	2	3	0.02573885696505141	TCGA-FE-A231-01	2	1	1	4	PASS	10258	TCGA-FE-A231	THCA	70	MALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-25703	Alive	TUMOR FREE	961	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	961	0	961	NA	NA	0	961	
40	TCGA-FE-A232	0	0	0	0	0	0	0	0	1	14	0	0	0	1	0	0	TCGA-FE-A232-01	43	8.313774291765339e-06	9	TCGA-FE-A232-01	0	0	0	0.0	TCGA-FE-A232-01	0	0	0	0	PASS	10259	TCGA-FE-A232	THCA	44	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-16280	Alive	TUMOR FREE	2424	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2424	0	2424	0	2424	0	2424	
20	TCGA-FE-A233	0	1	0	0	0	0	0	0	1	9	0	0	0	3	1	0	TCGA-FE-A233-01	33	6.9552005481546765e-06	3	TCGA-FE-A233-01	0	0	0	0.0	TCGA-FE-A233-01	0	0	0	0	PASS	10260	TCGA-FE-A233	THCA	18	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-6770	Alive	TUMOR FREE	751	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	567	NA	NA	R0	0	751	0	751	1	567	1	567	
30	TCGA-FE-A234	0	1	0	0	0	0	0	0	1	6	0	0	1	3	0	0	TCGA-FE-A234-01	47	2.393529321705416e-05	13	TCGA-FE-A234-01	0	0	0	0.0	TCGA-FE-A234-01	0	0	0	0	PASS	10261	TCGA-FE-A234	THCA	26	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-9724	Alive	WITH TUMOR	2075	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	483	NA	NA	R0	0	2075	0	2075	1	483	1	483	
30	TCGA-FE-A235	0	0	0	0	2	0	0	0	0	9	1	0	0	1	0	0	TCGA-FE-A235-01	47	0.02305228998860067	6	TCGA-FE-A235-01	0	1	3	0.024189825861639445	TCGA-FE-A235-01	0	2	1	3	PASS	10262	TCGA-FE-A235	THCA	26	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2002	NA	-9859	Alive	TUMOR FREE	3571	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	3571	0	3571	0	3571	0	3571	
30	TCGA-FE-A236	0	3	1	0	0	0	1	0	0	8	0	0	0	2	0	0	TCGA-FE-A236-01	43	5.719661665792121e-06	12	TCGA-FE-A236-01	0	0	0	0.0	TCGA-FE-A236-01	0	0	0	0	PASS	10263	TCGA-FE-A236	THCA	33	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2004	NA	-12348	Alive	TUMOR FREE	2031	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2031	0	2031	0	2031	0	2031	
20	TCGA-FE-A237	1	1	1	3	0	0	0	0	0	13	3	0	0	10	0	0	TCGA-FE-A237-01	47	0.010997138024854063	11	TCGA-FE-A237-01	0	0	0	0.0	TCGA-FE-A237-01	0	0	0	0	PASS	10264	TCGA-FE-A237	THCA	19	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2005	NA	-7207	Alive	TUMOR FREE	3431	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	492	NA	NA	R0	0	3431	0	3431	1	492	1	492	
40	TCGA-FE-A238	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-FE-A238-01	50	0.027499767066577654	14	TCGA-FE-A238	0	0	0	0	TCGA-FE-A238	0	0	0	0	PASS	10265	TCGA-FE-A238	THCA	36	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2005	NA	-13159	Alive	WITH TUMOR	1215	NA	NA	Distant Metastasis	Lung	NA	431	NA	NA	R0	0	1215	0	1215	1	431	1	431	
80	TCGA-FE-A239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-FE-A239-01	63	0.2756291530357466	23	TCGA-FE-A239	0	0	0	0	TCGA-FE-A239	0	0	0	0	PASS	10266	TCGA-FE-A239	THCA	82	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2005	NA	-30259	Dead	WITH TUMOR	NA	1023	NA	Locoregional Recurrence	Lymph Node Only	NA	933	NA	NA	R0	1	1023	1	1023	1	933	1	933	
30	TCGA-FE-A23A	0	0	0	2	0	0	0	0	1	8	0	0	0	3	1	0	TCGA-FE-A23A-01	35	3.5489079295386866e-06	5	TCGA-FE-A23A-01	0	0	0	0.0	TCGA-FE-A23A-01	0	0	0	0	PASS	10267	TCGA-FE-A23A	THCA	27	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2006	NA	-10177	Alive	TUMOR FREE	2489	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2489	0	2489	0	2489	0	2489	
20	TCGA-FE-A3PA	0	0	0	0	0	0	0	0	0	3	0	0	0	1	0	0	TCGA-FE-A3PA-01	79	5.8156579334322326e-05	33	TCGA-FE-A3PA-01	0	0	0	0.0	TCGA-FE-A3PA-01	0	0	0	0	PASS	10268	TCGA-FE-A3PA	THCA	16	MALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2002	NA	-6068	Alive	TUMOR FREE	3235	NA	NA	NA	NA	NA	NA	NA	NA	R2	0	3235	0	3235	NA	NA	0	3235	
30	TCGA-FE-A3PB	0	1	0	0	0	0	0	0	0	3	0	0	0	0	0	0	TCGA-FE-A3PB-01	49	4.224971223334035e-05	10	TCGA-FE-A3PB-01	0	0	2	3.120210865103524e-05	TCGA-FE-A3PB-01	0	0	0	0	PASS	10269	TCGA-FE-A3PB	THCA	33	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2004	NA	-12136	Alive	TUMOR FREE	2590	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2590	0	2590	0	2590	0	2590	
40	TCGA-FE-A3PC	0	1	0	0	0	0	0	0	0	17	0	0	1	6	0	0	TCGA-FE-A3PC-01	59	2.361382147128257e-05	17	TCGA-FE-A3PC-01	0	0	19	1.4455502299523115e-05	TCGA-FE-A3PC-01	0	0	0	0	PASS	10270	TCGA-FE-A3PC	THCA	37	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2006	NA	-13817	Alive	TUMOR FREE	2606	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2606	0	2606	0	2606	0	2606	
20	TCGA-FE-A3PD	0	0	0	1	0	0	0	0	0	7	0	0	1	2	0	0	TCGA-FE-A3PD-01	51	7.10939308693118e-05	15	TCGA-FE-A3PD-01	0	0	3	6.282253770851239e-05	TCGA-FE-A3PD-01	0	0	0	0	PASS	10271	TCGA-FE-A3PD	THCA	17	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2006	NA	-6386	Alive	TUMOR FREE	2396	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2396	0	2396	0	2396	0	2396	
40	TCGA-FK-A3S3	0	1	0	0	1	0	0	0	1	5	0	0	0	4	0	0	TCGA-FK-A3S3-01	39	7.771102048955015e-05	6	TCGA-FK-A3S3-01	0	0	0	0.0	TCGA-FK-A3S3-01	0	0	0	0	PASS	10272	TCGA-FK-A3S3	THCA	43	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2008	NA	-15853	Alive	TUMOR FREE	2162	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2162	0	2162	0	2162	0	2162	
30	TCGA-FK-A3SB	0	0	0	0	0	0	0	0	0	5	0	0	0	2	0	0	TCGA-FK-A3SB-01	65	5.283931438344435e-05	24	TCGA-FK-A3SB-01	0	0	0	0.0	TCGA-FK-A3SB-01	0	0	0	0	PASS	10273	TCGA-FK-A3SB	THCA	28	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-10293	Alive	TUMOR FREE	125	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	125	0	125	0	125	0	125	
60	TCGA-FK-A3SD	0	0	0	1	0	0	0	0	1	14	2	0	1	4	0	0	TCGA-FK-A3SD-01	43	9.230427730653012e-05	8	TCGA-FK-A3SD-01	0	0	19	4.6708787682412704e-05	TCGA-FK-A3SD-01	0	0	0	0	PASS	10274	TCGA-FK-A3SD	THCA	61	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-22560	Alive	TUMOR FREE	32	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	32	0	32	0	32	0	32	
30	TCGA-FK-A3SE	0	0	0	0	0	0	0	0	1	2	0	0	0	4	0	0	TCGA-FK-A3SE-01	47	9.263500298897732e-05	14	TCGA-FK-A3SE-01	0	0	0	0.0	TCGA-FK-A3SE-01	0	0	0	0	PASS	10275	TCGA-FK-A3SE	THCA	31	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-11472	Alive	TUMOR FREE	670	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	670	0	670	0	670	0	670	
30	TCGA-FK-A3SG	0	1	0	1	0	0	0	0	0	6	1	0	0	3	0	0	TCGA-FK-A3SG-01	37	0.024353512553321487	6	TCGA-FK-A3SG-01	1	1	19	0.025708100298067367	TCGA-FK-A3SG-01	1	0	1	2	PASS	10276	TCGA-FK-A3SG	THCA	21	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-7710	Alive	TUMOR FREE	28	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	28	0	28	0	28	0	28	
50	TCGA-FK-A3SH	0	0	0	1	0	0	0	1	0	11	0	0	0	6	0	0	TCGA-FK-A3SH-01	59	2.4916130754823645e-05	21	TCGA-FK-A3SH-01	0	0	19	1.0664575810788634e-05	TCGA-FK-A3SH-01	0	0	0	0	PASS	10277	TCGA-FK-A3SH	THCA	50	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-18609	Alive	TUMOR FREE	1463	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1463	0	1463	0	1463	0	1463	
50	TCGA-FK-A4UB	0	0	0	0	1	0	0	0	0	3	0	0	1	2	0	0	TCGA-FK-A4UB-01	51	3.3618249148893515e-05	13	TCGA-FK-A4UB-01	0	0	10	0.00035823823797180213	TCGA-FK-A4UB-01	0	0	0	0	PASS	10278	TCGA-FK-A4UB	THCA	51	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2005	NA	-18792	Alive	TUMOR FREE	3531	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	3531	0	3531	NA	NA	0	3531	
60	TCGA-FY-A2QD	0	1	0	1	1	0	0	0	0	10	1	0	0	5	0	0	TCGA-FY-A2QD-01	35	0.0022112146519509017	6	TCGA-FY-A2QD-01	0	0	19	0.0023032514514599515	TCGA-FY-A2QD-01	0	0	0	0	PASS	10279	TCGA-FY-A2QD	THCA	61	FEMALE	BLACK OR AFRICAN AMERICAN	NA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-22491	Alive	TUMOR FREE	38	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	38	0	38	NA	NA	0	38	
30	TCGA-FY-A3BL	4	19	3	6	0	0	0	0	8	234	27	1	5	92	10	0	TCGA-FY-A3BL-01	55	6.170402161343492e-05	16	TCGA-FY-A3BL-01	0	0	0	0.0	TCGA-FY-A3BL-01	0	0	0	0	PASS	10280	TCGA-FY-A3BL	THCA	29	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-10667	Alive	TUMOR FREE	621	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	621	0	621	0	621	0	621	
30	TCGA-FY-A3I4	0	0	0	0	0	0	0	0	0	6	1	0	0	2	0	0	TCGA-FY-A3I4-01	51	0.00023762928683512466	11	TCGA-FY-A3I4-01	0	0	0	0.0	TCGA-FY-A3I4-01	0	0	0	0	PASS	10281	TCGA-FY-A3I4	THCA	34	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-12677	Alive	TUMOR FREE	542	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	542	0	542	0	542	0	542	
60	TCGA-FY-A3I5	0	2	0	1	1	0	0	0	0	9	2	0	0	3	0	0	TCGA-FY-A3I5-01	51	0.9367372507319296	15	TCGA-FY-A3I5-01	17	31	19	0.04899635039802756	TCGA-FY-A3I5-01	0	0	0	0	PASS	10282	TCGA-FY-A3I5	THCA	64	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-23654	Alive	TUMOR FREE	238	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	238	0	238	0	238	0	238	
50	TCGA-FY-A3NM	0	1	0	1	0	0	0	0	0	10	0	0	0	4	0	0	TCGA-FY-A3NM-01	69	0.9477285301462162	30	TCGA-FY-A3NM-01	13	7	19	8.43098505843918e-06	TCGA-FY-A3NM-01	0	0	0	0	PASS	10283	TCGA-FY-A3NM	THCA	48	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-17734	Alive	TUMOR FREE	885	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	885	0	885	0	885	0	885	
50	TCGA-FY-A3NN	0	1	0	0	0	0	0	0	0	8	0	0	1	4	0	0	TCGA-FY-A3NN-01	37	0.0001754134337907669	4	TCGA-FY-A3NN-01	0	0	19	0.00016762702202146728	TCGA-FY-A3NN-01	0	0	0	0	PASS	10284	TCGA-FY-A3NN	THCA	48	FEMALE	NA	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-17613	Alive	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	0	0	0	0	0	0	0	
70	TCGA-FY-A3NP	1	0	0	0	0	0	0	0	1	10	1	0	0	2	0	0	TCGA-FY-A3NP	0	0	0	TCGA-FY-A3NP	0	0	0	0	TCGA-FY-A3NP	0	0	0	0	PASS	10285	TCGA-FY-A3NP	THCA	69	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-25462	Alive	TUMOR FREE	491	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	491	0	491	0	491	0	491	
30	TCGA-FY-A3ON	0	0	0	0	1	0	0	0	0	4	1	0	0	0	0	0	TCGA-FY-A3ON-01	63	6.717700159072584e-05	16	TCGA-FY-A3ON-01	0	0	5	0.0005151185292981467	TCGA-FY-A3ON-01	0	0	0	0	PASS	10286	TCGA-FY-A3ON	THCA	20	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-7403	Alive	TUMOR FREE	595	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	595	0	595	0	595	0	595	
60	TCGA-FY-A3R6	0	0	0	0	1	0	0	0	0	7	0	0	0	4	0	0	TCGA-FY-A3R6-01	55	1.790439327219106e-05	19	TCGA-FY-A3R6-01	0	0	19	9.57383700788101e-06	TCGA-FY-A3R6-01	0	0	0	0	PASS	10287	TCGA-FY-A3R6	THCA	57	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-21009	Alive	TUMOR FREE	423	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	423	0	423	NA	NA	0	423	
50	TCGA-FY-A3R7	0	0	0	1	0	0	0	0	1	6	0	0	0	2	1	0	TCGA-FY-A3R7-01	43	0.011053025329432694	6	TCGA-FY-A3R7-01	1	1	3	0.011651905627810896	TCGA-FY-A3R7-01	0	0	0	0	PASS	10288	TCGA-FY-A3R7	THCA	50	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-18403	Alive	TUMOR FREE	495	NA	NA	NA	NA	NA	NA	NA	NA	[Unknown]	0	495	0	495	NA	NA	0	495	
60	TCGA-FY-A3R8	0	1	0	1	0	1	0	0	0	10	1	0	1	5	0	0	TCGA-FY-A3R8-01	35	0.0003849657735534916	4	TCGA-FY-A3R8-01	0	0	0	0.0	TCGA-FY-A3R8-01	0	0	0	0	PASS	10289	TCGA-FY-A3R8	THCA	62	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-22824	Alive	TUMOR FREE	477	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	477	0	477	0	477	0	477	
70	TCGA-FY-A3R9	0	3	1	1	1	0	0	0	2	13	1	0	1	5	0	0	TCGA-FY-A3R9-01	49	1.609313408638045e-05	15	TCGA-FY-A3R9-01	0	0	0	0.0	TCGA-FY-A3R9-01	0	0	0	0	PASS	10290	TCGA-FY-A3R9	THCA	66	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-24215	Alive	TUMOR FREE	504	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	504	0	504	0	504	0	504	
30	TCGA-FY-A3RA	0	0	0	0	0	0	0	0	1	4	1	0	0	0	0	0	TCGA-FY-A3RA-01	39	4.847833146910251e-05	3	TCGA-FY-A3RA-01	0	0	0	0.0	TCGA-FY-A3RA-01	0	0	0	0	PASS	10291	TCGA-FY-A3RA	THCA	21	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-7900	Alive	TUMOR FREE	550	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	550	0	550	0	550	0	550	
60	TCGA-FY-A3TY	0	3	0	0	0	0	0	0	0	9	2	0	0	2	0	0	TCGA-FY-A3TY-01	41	6.0809776065763986e-05	9	TCGA-FY-A3TY-01	0	0	9	0.00037264661954554033	TCGA-FY-A3TY-01	0	0	0	0	PASS	10292	TCGA-FY-A3TY	THCA	61	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-22556	Alive	TUMOR FREE	709	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	709	0	709	0	709	0	709	
70	TCGA-FY-A3W9	0	0	0	0	1	0	0	0	0	13	1	0	0	5	0	0	TCGA-FY-A3W9-01	71	0.0545856719345275	28	TCGA-FY-A3W9-01	2	3	8	0.05713882814757657	TCGA-FY-A3W9-01	2	2	3	7	PASS	10293	TCGA-FY-A3W9	THCA	66	FEMALE	WHITE	Stage II	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2012	NA	-24136	Alive	TUMOR FREE	658	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	658	0	658	NA	NA	0	658	
50	TCGA-FY-A3WA	0	0	0	2	0	0	0	0	0	5	0	0	0	2	0	0	TCGA-FY-A3WA-01	47	0.07524441836063722	10	TCGA-FY-A3WA-01	3	4	3	0.023590215354128617	TCGA-FY-A3WA-01	2	2	3	7	PASS	10294	TCGA-FY-A3WA	THCA	52	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2012	NA	-18993	Alive	TUMOR FREE	519	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	519	0	519	0	519	0	519	
60	TCGA-FY-A3YR	0	0	0	1	1	0	0	0	1	13	0	0	0	4	0	0	TCGA-FY-A3YR-01	37	3.7638376378171233e-06	5	TCGA-FY-A3YR-01	0	0	7	0.0015183015485013222	TCGA-FY-A3YR-01	0	0	0	0	PASS	10295	TCGA-FY-A3YR	THCA	64	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-23395	Alive	TUMOR FREE	528	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	528	0	528	0	528	0	528	
50	TCGA-FY-A40K	0	0	0	0	0	0	0	0	0	5	0	0	0	1	0	0	TCGA-FY-A40K-01	49	0.00013105844652036585	11	TCGA-FY-A40K-01	0	0	3	0.00022893774887086603	TCGA-FY-A40K-01	0	0	0	0	PASS	10296	TCGA-FY-A40K	THCA	46	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-17092	Alive	TUMOR FREE	461	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	461	0	461	0	461	0	461	
60	TCGA-FY-A40L	0	0	0	0	2	0	0	0	1	13	0	0	0	5	0	0	TCGA-FY-A40L-01	28	0.0438445918454843	0	TCGA-FY-A40L-01	1	1	8	0.0006928652786289657	TCGA-FY-A40L-01	1	1	0	2	PASS	10297	TCGA-FY-A40L	THCA	55	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-20243	Alive	TUMOR FREE	726	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	726	0	726	NA	NA	0	726	
50	TCGA-FY-A40M	0	1	0	1	0	0	0	0	0	9	0	0	0	6	0	0	TCGA-FY-A40M-01	41	0.048287420713189616	5	TCGA-FY-A40M-01	0	0	7	0.0003708742857685194	TCGA-FY-A40M-01	0	0	0	0	PASS	10298	TCGA-FY-A40M	THCA	51	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-18722	Alive	TUMOR FREE	684	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	684	0	684	0	684	0	684	
60	TCGA-FY-A40N	0	0	0	1	0	0	0	0	0	3	1	0	0	0	0	0	TCGA-FY-A40N-01	51	9.279452472057845e-05	17	TCGA-FY-A40N-01	0	0	7	0.00030326580283974183	TCGA-FY-A40N-01	0	0	0	0	PASS	10299	TCGA-FY-A40N	THCA	55	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2012	NA	-20320	Alive	TUMOR FREE	579	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	579	0	579	0	579	0	579	
80	TCGA-FY-A4B0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-FY-A4B0-01	65	0.195005090488363	23	TCGA-FY-A4B0-01	2	3	25	0.04020974880775744	TCGA-FY-A4B0-01	2	0	0	2	PASS	10300	TCGA-FY-A4B0	THCA	76	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-27946	Alive	TUMOR FREE	420	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	420	0	420	NA	NA	0	420	
50	TCGA-FY-A4B3	0	0	0	0	0	0	0	0	0	9	0	0	1	4	0	0	TCGA-FY-A4B3-01	39	4.551728876547786e-05	5	TCGA-FY-A4B3-01	0	0	5	0.0009883340608318198	TCGA-FY-A4B3-01	0	0	0	0	PASS	10301	TCGA-FY-A4B3	THCA	51	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-18969	Alive	WITH TUMOR	427	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	427	0	427	NA	NA	0	427	
60	TCGA-FY-A4B4	0	1	0	0	0	0	0	0	0	9	0	0	0	6	0	0	TCGA-FY-A4B4-01	37	0.00015261118067025966	6	TCGA-FY-A4B4-01	0	0	4	0.0010344155086549028	TCGA-FY-A4B4-01	0	0	0	0	PASS	10302	TCGA-FY-A4B4	THCA	62	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-22830	Alive	TUMOR FREE	657	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	657	0	657	NA	NA	0	657	
50	TCGA-FY-A76V	0	0	0	0	0	0	1	0	0	11	0	0	2	2	0	0	TCGA-FY-A76V-01	57	4.580321883759151e-05	19	TCGA-FY-A76V-01	0	0	8	0.00035260847772126936	TCGA-FY-A76V-01	0	0	0	0	PASS	10303	TCGA-FY-A76V	THCA	54	MALE	BLACK OR AFRICAN AMERICAN	Stage II	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2013	NA	-19872	Alive	TUMOR FREE	51	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	51	0	51	0	51	0	51	
30	TCGA-GE-A2C6	0	0	0	0	0	0	0	0	0	12	0	0	0	2	0	0	TCGA-GE-A2C6-01	41	0.011052884611511157	10	TCGA-GE-A2C6-01	1	1	2	0.011648912312780422	TCGA-GE-A2C6-01	0	0	0	0	PASS	10304	TCGA-GE-A2C6	THCA	33	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-12068	Alive	TUMOR FREE	381	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	381	0	381	NA	NA	0	381	
50	TCGA-H2-A26U	0	2	1	1	2	0	0	0	1	23	0	0	0	12	1	0	TCGA-H2-A26U-01	54	0.04404155665998577	21	TCGA-H2-A26U-01	1	1	2	0.00019281368487576896	TCGA-H2-A26U-01	1	0	0	1	PASS	10305	TCGA-H2-A26U	THCA	54	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-19927	Alive	TUMOR FREE	517	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	517	0	517	NA	NA	0	517	
30	TCGA-H2-A2K9	0	2	0	0	2	0	0	0	1	42	9	2	0	11	2	0	TCGA-H2-A2K9-01	63	3.404870949815938e-05	27	TCGA-H2-A2K9-01	0	0	2	1.8681299825214043e-05	TCGA-H2-A2K9-01	0	0	0	0	PASS	10306	TCGA-H2-A2K9	THCA	25	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-9221	Alive	TUMOR FREE	659	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	659	0	659	NA	NA	0	659	
40	TCGA-H2-A3RH	0	1	0	1	1	0	1	0	0	10	0	0	0	6	0	0	TCGA-H2-A3RH-01	43	1.8544822499620293e-05	9	TCGA-H2-A3RH-01	0	0	0	0.0	TCGA-H2-A3RH-01	0	0	0	0	PASS	10307	TCGA-H2-A3RH	THCA	41	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-15068	Alive	TUMOR FREE	379	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	379	0	379	NA	NA	0	379	
30	TCGA-H2-A3RI	0	0	0	0	0	0	0	0	0	8	2	0	0	2	0	0	TCGA-H2-A3RI-01	51	0.0005252181409825535	14	TCGA-H2-A3RI-01	0	0	0	0.0	TCGA-H2-A3RI-01	0	0	0	0	PASS	10308	TCGA-H2-A3RI	THCA	29	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-10956	Alive	[Discrepancy]	335	NA	NA	Locoregional Recurrence	Lymph Node Only	NA	279	NA	NA	NA	0	335	0	335	NA	NA	1	279	
30	TCGA-H2-A421	0	1	0	2	0	0	0	0	2	18	0	0	1	8	0	0	TCGA-H2-A421-01	49	4.4230951772765474e-05	15	TCGA-H2-A421-01	0	0	11	0.001300848708232318	TCGA-H2-A421-01	0	0	0	0	PASS	10309	TCGA-H2-A421	THCA	34	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-12657	Alive	TUMOR FREE	610	NA	NA	NA	NA	NA	NA	NA	NA	[Unknown]	0	610	0	610	NA	NA	0	610	
40	TCGA-H2-A422	0	2	0	0	1	0	0	0	1	9	1	0	0	3	0	0	TCGA-H2-A422-01	43	5.644746764432016e-05	5	TCGA-H2-A422-01	0	0	4	0.0009610083446466168	TCGA-H2-A422-01	0	0	0	0	PASS	10310	TCGA-H2-A422	THCA	40	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-14721	Alive	TUMOR FREE	566	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	566	0	566	NA	NA	0	566	
30	TCGA-IM-A3EB	0	0	0	0	0	0	0	0	0	7	0	0	0	1	0	0	TCGA-IM-A3EB-01	54	0.04623760696619556	16	TCGA-IM-A3EB-01	1	1	0	0.0	TCGA-IM-A3EB-01	1	0	0	1	PASS	10311	TCGA-IM-A3EB	THCA	32	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-11822	Alive	TUMOR FREE	1488	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1488	0	1488	0	1488	0	1488	
60	TCGA-IM-A3ED	0	0	0	0	0	0	0	0	0	4	0	0	0	6	1	0	TCGA-IM-A3ED-01	41	1.6540093194169613e-05	9	TCGA-IM-A3ED-01	0	0	19	8.672838491790412e-06	TCGA-IM-A3ED-01	0	0	0	0	PASS	10312	TCGA-IM-A3ED	THCA	58	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2008	NA	-21278	Alive	TUMOR FREE	1442	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1442	0	1442	0	1442	0	1442	
90	TCGA-IM-A3U2	2	3	0	2	2	1	0	0	0	30	1	0	0	8	1	1	TCGA-IM-A3U2-01	63	0.038609474764246615	21	TCGA-IM-A3U2-01	0	0	19	4.6294583987477795e-05	TCGA-IM-A3U2-01	0	0	0	0	PASS	10313	TCGA-IM-A3U2	THCA	89	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2012	NA	-32682	Alive	TUMOR FREE	563	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	563	0	563	NA	NA	0	563	
60	TCGA-IM-A3U3	0	0	0	0	1	0	1	0	0	20	0	0	0	2	1	0	TCGA-IM-A3U3-01	45	0.011007044116296388	11	TCGA-IM-A3U3-01	0	0	19	4.479839715180565e-06	TCGA-IM-A3U3-01	0	0	0	0	PASS	10314	TCGA-IM-A3U3	THCA	55	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2012	NA	-20117	Alive	TUMOR FREE	514	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	514	0	514	NA	NA	0	514	
40	TCGA-IM-A41Y	0	2	0	0	0	1	0	0	1	24	0	0	0	8	0	0	TCGA-IM-A41Y-01	55	0.00027323870022169365	10	TCGA-IM-A41Y-01	0	0	7	0.000159905003099049	TCGA-IM-A41Y-01	0	0	0	0	PASS	10315	TCGA-IM-A41Y	THCA	42	FEMALE	WHITE	Stage I	NA	"Other, specify"	NA	2012	NA	-15694	Alive	TUMOR FREE	664	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	664	0	664	0	664	0	664	
40	TCGA-IM-A41Z	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-IM-A41Z-01	39	0.01104376672054158	4	TCGA-IM-A41Z-01	0	0	9	0.0004244730600700373	TCGA-IM-A41Z-01	0	0	0	0	PASS	10316	TCGA-IM-A41Z	THCA	37	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2012	NA	-13704	Alive	TUMOR FREE	946	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	946	0	946	0	946	0	946	
40	TCGA-IM-A420	0	0	0	1	1	0	0	0	0	3	0	0	0	3	0	0	TCGA-IM-A420-01	47	5.36864119867968e-05	11	TCGA-IM-A420-01	0	0	6	0.00019124445114401123	TCGA-IM-A420-01	0	0	0	0	PASS	10317	TCGA-IM-A420	THCA	39	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-14332	Alive	TUMOR FREE	250	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	250	0	250	0	250	0	250	
40	TCGA-IM-A4EB	0	0	0	1	1	0	0	0	0	10	1	0	0	3	0	0	TCGA-IM-A4EB-01	67	3.340228869537666e-05	26	TCGA-IM-A4EB-01	0	0	9	0.0009699612379102543	TCGA-IM-A4EB-01	0	0	0	0	PASS	10318	TCGA-IM-A4EB	THCA	37	MALE	WHITE	Stage I	NA	"Other, specify"	NA	2012	NA	-13635	Alive	TUMOR FREE	780	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	780	0	780	0	780	0	780	
50	TCGA-J8-A3NZ	0	1	1	0	0	0	0	0	0	7	0	0	0	4	1	0	TCGA-J8-A3NZ-01	35	2.899277370839687e-06	5	TCGA-J8-A3NZ-01	0	0	0	0.0	TCGA-J8-A3NZ-01	0	0	0	0	PASS	10319	TCGA-J8-A3NZ	THCA	52	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-19058	Alive	TUMOR FREE	524	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	524	0	524	0	524	0	524	
40	TCGA-J8-A3O0	0	0	0	0	0	0	0	0	0	8	2	0	1	4	1	0	TCGA-J8-A3O0-01	72	0.01100909030322302	27	TCGA-J8-A3O0-01	1	1	19	0.011598404428107974	TCGA-J8-A3O0-01	0	0	0	0	PASS	10320	TCGA-J8-A3O0	THCA	38	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-14214	Alive	TUMOR FREE	1313	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1313	0	1313	0	1313	0	1313	
30	TCGA-J8-A3O1	0	3	0	1	0	0	0	0	1	17	0	0	1	3	0	0	TCGA-J8-A3O1-01	54	0.03447999642975603	10	TCGA-J8-A3O1-01	1	1	3	0.00028090665068811844	TCGA-J8-A3O1-01	1	0	0	1	PASS	10321	TCGA-J8-A3O1	THCA	33	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-12113	Alive	TUMOR FREE	827	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	827	0	827	0	827	0	827	
40	TCGA-J8-A3O2	0	1	0	1	0	0	0	0	2	16	4	0	0	7	0	0	TCGA-J8-A3O2-01	51	5.055686268236066e-05	12	TCGA-J8-A3O2-06	0	0	4	0.00012735298925388458	TCGA-J8-A3O2-06	0	0	0	0	mutation call filter	10322	TCGA-J8-A3O2	THCA	39	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-14339	Alive	TUMOR FREE	342	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	342	0	342	NA	NA	0	342	
50	TCGA-J8-A3YD	0	1	0	1	0	0	0	0	0	6	0	0	1	5	0	0	TCGA-J8-A3YD-01	37	0.011073580604841293	5	TCGA-J8-A3YD-01	1	1	12	0.012826733081976344	TCGA-J8-A3YD-01	0	0	0	0	PASS	10323	TCGA-J8-A3YD	THCA	47	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-17416	Alive	TUMOR FREE	968	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	968	0	968	0	968	0	968	
30	TCGA-J8-A3YE	0	0	0	0	1	0	0	0	0	7	0	0	0	1	0	0	TCGA-J8-A3YE-01	53	8.607550138526588e-05	11	TCGA-J8-A3YE-01	0	0	14	0.001812607941789152	TCGA-J8-A3YE-01	0	0	0	0	PASS	10324	TCGA-J8-A3YE	THCA	31	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-11446	Alive	TUMOR FREE	847	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	847	0	847	0	847	0	847	
80	TCGA-J8-A3YF	0	1	0	0	0	0	0	0	0	20	1	0	1	7	0	0	TCGA-J8-A3YF-01	57	9.469258700448062e-05	14	TCGA-J8-A3YF-01	0	0	9	0.0005057590524518051	TCGA-J8-A3YF-01	0	0	0	0	PASS	10325	TCGA-J8-A3YF	THCA	83	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2009	NA	-30661	Alive	TUMOR FREE	751	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	751	0	751	0	751	0	751	
50	TCGA-J8-A3YG	0	0	0	0	0	0	0	0	0	6	0	0	0	1	0	0	TCGA-J8-A3YG-01	43	1.580569273462306e-05	10	TCGA-J8-A3YG-01	0	0	10	0.0010847940877245234	TCGA-J8-A3YG-01	0	0	0	0	PASS	10326	TCGA-J8-A3YG	THCA	54	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-19785	Alive	TUMOR FREE	678	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	678	0	678	0	678	0	678	
40	TCGA-J8-A3YH	0	1	0	2	3	0	0	0	0	5	0	0	1	4	2	0	TCGA-J8-A3YH-01	45	0.01099858096328948	10	TCGA-J8-A3YH-06	0	0	19	1.461673480431105e-05	TCGA-J8-A3YH-06	0	0	0	0	mutation call filter	10327	TCGA-J8-A3YH	THCA	39	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-14470	Alive	TUMOR FREE	175	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	175	0	175	0	175	0	175	
50	TCGA-J8-A42S	0	0	0	0	0	0	0	0	0	11	1	0	0	2	0	0	TCGA-J8-A42S-01	31	1.4046388073471225e-05	3	TCGA-J8-A42S-01	0	0	7	0.009285382475854646	TCGA-J8-A42S-01	0	0	1	1	PASS	10328	TCGA-J8-A42S	THCA	45	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-16609	Alive	NA	75	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	75	0	75	0	75	0	75	
60	TCGA-J8-A4HW	0	1	0	2	1	0	0	0	0	15	0	0	0	6	0	0	TCGA-J8-A4HW-01	37	0.01120849414919836	5	TCGA-J8-A4HW-06	0	0	10	0.001261806134751432	TCGA-J8-A4HW-06	0	0	0	0	mutation call filter	10329	TCGA-J8-A4HW	THCA	59	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-21587	Alive	TUMOR FREE	79	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	79	0	79	0	79	0	79	
70	TCGA-J8-A4HY	0	2	2	4	0	0	1	0	0	28	4	0	2	6	0	0	TCGA-J8-A4HY-01	39	0.00039902648329345	9	TCGA-J8-A4HY-01	0	0	10	0.0008963247004181357	TCGA-J8-A4HY-01	0	0	0	0	PASS	10330	TCGA-J8-A4HY	THCA	68	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-25106	Alive	TUMOR FREE	6	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	6	0	6	NA	NA	0	6	
40	TCGA-KS-A41F	1	0	0	1	1	0	0	0	0	9	0	0	0	3	0	0	TCGA-KS-A41F-01	33	4.435523086679972e-06	3	TCGA-KS-A41F-01	0	0	2	5.433248384310213e-05	TCGA-KS-A41F-01	0	0	0	0	PASS	10331	TCGA-KS-A41F	THCA	37	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2002	NA	-13545	Alive	TUMOR FREE	4367	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	4367	0	4367	0	4367	0	4367	
50	TCGA-KS-A41I	0	0	0	0	1	0	0	0	0	9	0	0	0	2	0	0	TCGA-KS-A41I-01	37	0.011001169270762723	7	TCGA-KS-A41I-01	1	1	8	0.012958867316810741	TCGA-KS-A41I-01	0	0	0	0	PASS	10332	TCGA-KS-A41I	THCA	47	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2002	NA	-17196	Alive	TUMOR FREE	486	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	486	0	486	0	486	0	486	
30	TCGA-KS-A41J	0	2	0	0	0	0	0	0	0	8	0	0	0	3	0	0	TCGA-KS-A41J-01	37	0.00011839871682710532	5	TCGA-KS-A41J-01	0	0	8	0.000267711187050609	TCGA-KS-A41J-01	0	0	0	0	PASS	10333	TCGA-KS-A41J	THCA	28	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2000	NA	-10411	Alive	TUMOR FREE	477	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	477	0	477	0	477	0	477	
40	TCGA-KS-A41L	0	0	0	0	0	0	0	0	0	8	0	0	0	4	0	0	TCGA-KS-A41L-01	37	2.5155450418869702e-06	7	TCGA-KS-A41L-01	0	0	3	0.00014109247766280872	TCGA-KS-A41L-01	0	0	0	0	PASS	10334	TCGA-KS-A41L	THCA	39	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2004	NA	-14440	Alive	TUMOR FREE	3463	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	3463	0	3463	0	3463	0	3463	
40	TCGA-KS-A4I1	0	1	0	0	0	0	0	0	0	7	0	0	0	4	0	0	TCGA-KS-A4I1-01	61	0.0004396164438981668	20	TCGA-KS-A4I1-01	0	0	9	0.00036925965191199903	TCGA-KS-A4I1-01	0	0	0	0	PASS	10335	TCGA-KS-A4I1	THCA	37	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2012	NA	-13538	Alive	TUMOR FREE	812	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	812	0	812	NA	NA	0	812	
40	TCGA-KS-A4I3	0	1	0	0	0	0	0	0	0	8	0	0	1	3	0	0	TCGA-KS-A4I3-01	55	3.0987611480511435e-05	20	TCGA-KS-A4I3-01	0	0	5	0.00028504570177295647	TCGA-KS-A4I3-01	0	0	0	0	PASS	10336	TCGA-KS-A4I3	THCA	41	MALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-14992	Alive	TUMOR FREE	1329	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	1329	0	1329	NA	NA	0	1329	
50	TCGA-KS-A4I5	0	0	0	1	0	0	0	0	0	11	0	0	0	4	0	0	TCGA-KS-A4I5-01	57	0.00010075624779941354	17	TCGA-KS-A4I5-01	0	0	10	0.0004476813160041375	TCGA-KS-A4I5-01	0	0	0	0	PASS	10337	TCGA-KS-A4I5	THCA	49	FEMALE	WHITE	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-17963	Alive	TUMOR FREE	567	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	567	0	567	NA	NA	0	567	
60	TCGA-KS-A4I7	0	3	0	0	0	1	0	0	0	6	0	0	0	0	0	0	TCGA-KS-A4I7-01	41	0.010994767045174108	10	TCGA-KS-A4I7-01	1	1	10	0.014492138893187059	TCGA-KS-A4I7-01	0	0	0	0	PASS	10338	TCGA-KS-A4I7	THCA	61	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-22398	Alive	TUMOR FREE	987	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	987	0	987	0	987	0	987	
50	TCGA-KS-A4I9	0	1	0	0	0	0	0	0	0	8	0	0	0	1	1	0	TCGA-KS-A4I9-01	54	3.5548939080580705e-05	11	TCGA-KS-A4I9-01	0	0	5	0.00043269558291370887	TCGA-KS-A4I9-01	0	0	0	0	PASS	10339	TCGA-KS-A4I9	THCA	46	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-16961	Alive	TUMOR FREE	2658	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2658	0	2658	0	2658	0	2658	
40	TCGA-KS-A4IB	0	2	0	0	0	0	0	0	0	12	1	0	0	2	1	0	TCGA-KS-A4IB-01	56	0.04543553408725141	12	TCGA-KS-A4IB-01	2	2	6	0.014085211229211187	TCGA-KS-A4IB-01	1	0	0	1	PASS	10340	TCGA-KS-A4IB	THCA	41	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2007	NA	-15157	Alive	TUMOR FREE	2577	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	2577	0	2577	0	2577	0	2577	
50	TCGA-KS-A4IC	0	0	0	1	0	0	0	0	0	2	1	0	0	1	0	0	TCGA-KS-A4IC-01	27	2.782476340150382e-06	0	TCGA-KS-A4IC-01	0	0	2	4.3884199632752056e-05	TCGA-KS-A4IC-01	0	0	0	0	PASS	10341	TCGA-KS-A4IC	THCA	45	FEMALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-16671	Alive	TUMOR FREE	1073	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	1073	0	1073	NA	NA	0	1073	
60	TCGA-KS-A4ID	0	1	0	0	0	0	0	0	1	9	1	0	0	4	0	0	TCGA-KS-A4ID-01	62	0.003753339532357328	15	TCGA-KS-A4ID-01	0	0	5	0.0006563408754320947	TCGA-KS-A4ID-01	0	0	0	0	PASS	10342	TCGA-KS-A4ID	THCA	55	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2010	NA	-20413	Alive	TUMOR FREE	1011	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1011	0	1011	0	1011	0	1011	
40	TCGA-L6-A4EP	1	0	0	0	0	0	0	0	0	13	0	0	0	1	0	0	TCGA-L6-A4EP-01	49	0.05000688698296369	13	TCGA-L6-A4EP-01	0	0	7	0.0002531718976699665	TCGA-L6-A4EP-01	0	0	0	0	PASS	10343	TCGA-L6-A4EP	THCA	41	FEMALE	ASIAN	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-15292	Alive	TUMOR FREE	1016	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1016	0	1016	0	1016	0	1016	
50	TCGA-L6-A4EQ	0	1	0	1	0	0	0	0	0	14	0	0	0	4	0	0	TCGA-L6-A4EQ-01	53	1.5980032603427546e-05	21	TCGA-L6-A4EQ-01	0	0	6	0.0016230783934046936	TCGA-L6-A4EQ-01	0	0	0	0	PASS	10344	TCGA-L6-A4EQ	THCA	47	MALE	WHITE	Stage III	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2010	NA	-17351	Alive	TUMOR FREE	1228	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1228	0	1228	0	1228	0	1228	
50	TCGA-L6-A4ET	0	0	0	0	0	0	0	0	1	6	0	0	0	4	0	0	TCGA-L6-A4ET-01	59	0.0001506192292039873	22	TCGA-L6-A4ET-01	0	0	5	0.00034696227310297673	TCGA-L6-A4ET-01	0	0	0	0	PASS	10345	TCGA-L6-A4ET	THCA	49	FEMALE	WHITE	Stage IVC	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2011	NA	-17978	Alive	TUMOR FREE	664	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	664	0	664	NA	NA	0	664	
60	TCGA-L6-A4EU	0	9	1	8	2	1	1	0	3	34	2	1	1	18	2	0	TCGA-L6-A4EU-01	53	0.04445172708425681	16	TCGA-L6-A4EU-01	1	1	7	0.011378045305557069	TCGA-L6-A4EU-01	2	2	1	5	PASS	10346	TCGA-L6-A4EU	THCA	58	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	NA	2012	NA	-21192	Alive	TUMOR FREE	289	NA	NA	NA	NA	NA	NA	NA	NA	R1	0	289	0	289	NA	NA	0	289	
40	TCGA-MK-A4N6	0	1	0	0	1	0	0	0	0	7	1	0	0	5	0	0	TCGA-MK-A4N6-01	50	3.957538413944854e-05	14	TCGA-MK-A4N6-01	0	0	8	0.0011196582803030717	TCGA-MK-A4N6-01	0	0	0	0	PASS	10347	TCGA-MK-A4N6	THCA	35	MALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-12904	Alive	TUMOR FREE	1098	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	1098	0	1098	0	1098	0	1098	
30	TCGA-MK-A4N7	0	0	0	1	0	0	0	0	0	14	1	0	0	6	0	0	TCGA-MK-A4N7-01	51	8.44618907697155e-05	15	TCGA-MK-A4N7-01	0	0	11	0.0008302927075793517	TCGA-MK-A4N7-01	0	0	0	0	PASS	10348	TCGA-MK-A4N7	THCA	20	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-7570	Alive	TUMOR FREE	987	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	987	0	987	0	987	0	987	
40	TCGA-MK-A4N9	0	1	0	1	0	0	0	0	1	6	0	0	0	1	0	0	TCGA-MK-A4N9-01	49	6.425253024388337e-05	6	TCGA-MK-A4N9-01	0	0	6	0.0014375355706056825	TCGA-MK-A4N9-01	0	0	0	0	PASS	10349	TCGA-MK-A4N9	THCA	41	FEMALE	WHITE	Stage I	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2011	NA	-15255	Alive	TUMOR FREE	919	NA	NA	NA	NA	NA	NA	NA	NA	R0	0	919	0	919	0	919	0	919	
70	TCGA-MK-A84Z	0	0	0	1	2	0	0	0	0	15	0	0	0	4	0	0	TCGA-MK-A84Z-01	79	0.011050774412340746	35	TCGA-MK-A84Z-01	1	1	16	0.012741516508571991	TCGA-MK-A84Z-01	0	0	1	1	PASS	10350	TCGA-MK-A84Z	THCA	74	MALE	BLACK OR AFRICAN AMERICAN	Stage III	NA	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	NA	2013	NA	-27185	Alive	TUMOR FREE	728	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	728	0	728	NA	NA	0	728	
50	TCGA-QD-A8IV	0	0	0	0	0	0	0	0	0	5	2	0	0	5	0	0	TCGA-QD-A8IV-01	70	0.009834137814293492	31	TCGA-QD-A8IV-01	1	1	14	0.011024463501948715	TCGA-QD-A8IV-01	1	0	1	2	PASS	10351	TCGA-QD-A8IV	THCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVA	NA	Thyroid Papillary Carcinoma - Classical/usual	NA	2013	NA	-18288	Alive	TUMOR FREE	392	NA	NA	NA	NA	NA	NA	NA	NA	RX	0	392	0	392	NA	NA	0	392	
50	TCGA-3G-AB0O	0	3	0	0	1	0	0	0	2	9	0	0	0	3	0	0	TCGA-3G-AB0O-01	53	4.334341180238775e-05	12	TCGA-3G-AB0O-01	0	0	21	0.0010031947534485742	TCGA-3G-AB0O-01	0	0	0	0	PASS	10352	TCGA-3G-AB0O	THYM	47	MALE	WHITE	NA	I	Thymoma; Type B1	NA	2009	NA	-17528	Alive	TUMOR FREE	2086	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2086	0	2086	NA	NA	0	2086	
70	TCGA-3G-AB0Q	0	6	0	1	0	1	0	1	1	18	3	0	0	2	0	0	TCGA-3G-AB0Q-01	53	0.01978301283015177	13	TCGA-3G-AB0Q-01	0	0	21	0.02318604362676041	TCGA-3G-AB0Q-01	0	2	1	3	PASS	10353	TCGA-3G-AB0Q	THYM	66	MALE	WHITE	NA	IIa	Thymoma; Type A	NA	2009	NA	-24460	Alive	TUMOR FREE	1799	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1799	0	1799	NA	NA	0	1799	
50	TCGA-3G-AB0T	0	4	1	1	0	0	0	0	1	12	1	0	1	5	0	0	TCGA-3G-AB0T-01	59	0.05377934241480803	19	TCGA-3G-AB0T-01	1	1	11	0.009370861770534844	TCGA-3G-AB0T-01	2	1	1	4	PASS	10354	TCGA-3G-AB0T	THYM	45	MALE	WHITE	NA	IIb	Thymoma; Type B1	NA	2000	NA	-16728	Dead	WITH TUMOR	NA	2488	NA	Distant Metastasis	Pleura/Pleural effusion	NA	1786	NA	NA	NA	1	2488	1	2488	NA	NA	1	1786	
50	TCGA-3G-AB14	2	4	0	2	2	0	0	0	2	9	1	0	1	4	0	0	TCGA-3G-AB14-01	84	0.10273481470291047	33	TCGA-3G-AB14-01	3	2	45	0.10872403485433374	TCGA-3G-AB14-01	0	1	2	3	PASS	10355	TCGA-3G-AB14	THYM	51	MALE	WHITE	NA	III	Thymoma; Type B2	NA	2012	NA	-18733	Dead	TUMOR FREE	NA	775	NA	NA	NA	NA	NA	NA	NA	NA	1	775	0	775	NA	NA	0	775	
80	TCGA-3G-AB19	3	9	0	1	1	0	1	1	1	19	0	0	0	9	3	0	TCGA-3G-AB19-01	57	0.01102401292625228	25	TCGA-3G-AB19-01	1	1	9	0.01280105253797162	TCGA-3G-AB19-01	0	0	0	0	PASS	10356	TCGA-3G-AB19	THYM	76	FEMALE	WHITE	NA	IIb	Thymoma; Type A	NA	2006	NA	-27827	Dead	TUMOR FREE	NA	2910	NA	New Primary Tumor	Lung	NA	2420	NA	NA	NA	1	2910	0	2910	NA	NA	1	2420	
70	TCGA-3Q-A9WF	1	2	0	0	0	0	0	0	2	5	0	0	1	3	0	0	TCGA-3Q-A9WF-01	39	1.986548446394284e-05	5	TCGA-3Q-A9WF-01	0	0	9	0.0008645147832196952	TCGA-3Q-A9WF-01	0	0	0	0	PASS	10357	TCGA-3Q-A9WF	THYM	71	MALE	BLACK OR AFRICAN AMERICAN	NA	I	Thymoma; Type B2	NA	2013	NA	-26117	Alive	NA	467	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	467	0	467	NA	NA	0	467	
60	TCGA-3S-A8YW	1	10	1	0	1	0	0	0	3	27	0	1	1	15	1	0	TCGA-3S-A8YW-01	87	0.9466962623272334	32	TCGA-3S-A8YW-01	21	33	44	0.10871993512737647	TCGA-3S-A8YW-01	5	2	2	9	PASS	10358	TCGA-3S-A8YW	THYM	63	MALE	WHITE	NA	IIb	Thymoma; Type C	NA	2013	NA	-23053	Alive	TUMOR FREE	643	NA	NA	New Primary Tumor	"Other, specify"	Skin (cheek)	224	NA	NA	NA	0	643	0	643	NA	NA	1	224	
60	TCGA-3S-AAYX	0	7	0	0	2	0	0	0	0	11	4	0	0	0	0	0	TCGA-3S-AAYX-01	65	0.00012895863647911394	22	TCGA-3S-AAYX	0	0	0	0	TCGA-3S-AAYX	0	0	0	0	PASS	10359	TCGA-3S-AAYX	THYM	55	FEMALE	WHITE	NA	IIb	Thymoma; Type B1	NA	2013	NA	-20350	Alive	TUMOR FREE	571	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	571	0	571	NA	NA	0	571	
30	TCGA-3T-AA9L	1	2	0	0	1	0	0	0	1	5	0	0	0	0	0	0	TCGA-3T-AA9L-01	53	0.00015805009079372933	11	TCGA-3T-AA9L	0	0	0	0	TCGA-3T-AA9L	0	0	0	0	PASS	10360	TCGA-3T-AA9L	THYM	31	FEMALE	WHITE	NA	IIa	Thymoma; Type B1	NA	2011	NA	-11610	Alive	WITH TUMOR	1050	NA	NA	Distant Metastasis	"Other, specify"	Lung Pleura	702	NA	NA	NA	0	1050	0	1050	NA	NA	1	702	
70	TCGA-4V-A9QI	0	3	0	1	2	0	0	0	1	3	1	0	0	4	0	0	TCGA-4V-A9QI-01	45	3.404149385188531e-05	9	TCGA-4V-A9QI-01	0	0	16	0.0014022953616173856	TCGA-4V-A9QI-01	0	0	0	0	PASS	10361	TCGA-4V-A9QI	THYM	68	MALE	WHITE	NA	IIa	Thymoma; Type B2	NA	2007	NA	-25181	Alive	TUMOR FREE	2936	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2936	0	2936	NA	NA	0	2936	
60	TCGA-4V-A9QJ	2	7	0	3	0	0	1	0	0	21	1	0	0	7	2	0	TCGA-4V-A9QJ-01	71	0.07309751792398213	24	TCGA-4V-A9QJ-01	2	2	10	0.0004643079018650162	TCGA-4V-A9QJ-01	3	1	0	4	PASS	10362	TCGA-4V-A9QJ	THYM	64	MALE	WHITE	NA	III	Thymoma; Type B3	NA	2007	NA	-23510	Alive	TUMOR FREE	2849	NA	NA	Locoregional Recurrence	Pleura/Pleural effusion	NA	793	NA	NA	NA	0	2849	0	2849	NA	NA	1	793	
60	TCGA-4V-A9QL	0	8	1	1	0	0	0	0	0	11	1	0	0	6	0	0	TCGA-4V-A9QL-01	63	0.007020348039166683	18	TCGA-4V-A9QL-01	0	0	21	0.008922669155733538	TCGA-4V-A9QL-01	0	1	0	1	PASS	10363	TCGA-4V-A9QL	THYM	58	FEMALE	WHITE	NA	I	Thymoma; Type AB	NA	2009	NA	-21216	Alive	TUMOR FREE	1908	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1908	0	1908	NA	NA	0	1908	
40	TCGA-4V-A9QM	0	5	0	0	0	0	0	0	2	11	1	0	0	4	0	0	TCGA-4V-A9QM-01	55	0.00512435052828149	15	TCGA-4V-A9QM-01	0	0	14	0.006010449604019296	TCGA-4V-A9QM-01	0	1	0	1	PASS	10364	TCGA-4V-A9QM	THYM	39	MALE	WHITE	NA	I	Thymoma; Type AB	NA	2011	NA	-14576	Alive	TUMOR FREE	1253	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1253	0	1253	NA	NA	0	1253	
40	TCGA-4V-A9QN	0	2	0	2	0	0	1	0	4	7	0	0	1	4	2	0	TCGA-4V-A9QN-01	80	0.8667480584186557	31	TCGA-4V-A9QN-01	10	7	54	0.20768001126312954	TCGA-4V-A9QN-01	3	2	3	8	PASS	10365	TCGA-4V-A9QN	THYM	40	FEMALE	WHITE	NA	III	Thymoma; Type B3	NA	2012	NA	-14825	Alive	WITH TUMOR	970	NA	NA	Distant Metastasis	"Other, specify"	PLEURA	937	NA	NA	NA	0	970	0	970	NA	NA	1	937	
70	TCGA-4V-A9QQ	0	7	0	3	1	0	0	0	1	15	3	0	3	6	0	0	TCGA-4V-A9QQ-01	53	4.2587607986876736e-05	12	TCGA-4V-A9QQ	0	0	0	0	TCGA-4V-A9QQ	0	0	0	0	PASS	10366	TCGA-4V-A9QQ	THYM	65	FEMALE	WHITE	NA	IVa	Thymoma; Type B3	NA	2010	NA	-23894	Alive	WITH TUMOR	1572	NA	NA	Locoregional Recurrence	Pleura/Pleural effusion	NA	782	NA	NA	NA	0	1572	0	1572	NA	NA	1	782	
50	TCGA-4V-A9QR	0	5	0	3	1	0	0	0	1	28	0	0	0	6	0	1	TCGA-4V-A9QR-01	108	0.3662710274713604	57	TCGA-4V-A9QR-01	21	18	23	0.07597639879147852	TCGA-4V-A9QR-01	2	2	0	4	PASS	10367	TCGA-4V-A9QR	THYM	51	FEMALE	WHITE	NA	III	Thymoma; Type B3	NA	2012	NA	-18723	Alive	TUMOR FREE	780	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	780	0	780	NA	NA	0	780	
50	TCGA-4V-A9QS	0	4	0	2	0	0	0	0	0	9	0	0	0	4	1	0	TCGA-4V-A9QS-01	58	0.14675888103552898	16	TCGA-4V-A9QS-01	33	17	32	0.06224878048991396	TCGA-4V-A9QS-01	8	13	1	22	PASS	10368	TCGA-4V-A9QS	THYM	53	FEMALE	WHITE	NA	IVa	Thymoma; Type B2	NA	2012	NA	-19443	Alive	WITH TUMOR	774	NA	NA	Locoregional Recurrence	"Other, specify"	PLEURA	752	NA	NA	NA	0	774	0	774	NA	NA	1	752	
80	TCGA-4V-A9QT	0	1	0	1	0	0	0	0	0	6	0	0	1	2	0	0	TCGA-4V-A9QT-01	47	1.260847918578743e-05	10	TCGA-4V-A9QT-01	0	0	15	0.0014879137808289284	TCGA-4V-A9QT-01	0	0	0	0	PASS	10369	TCGA-4V-A9QT	THYM	79	FEMALE	WHITE	NA	IIa	Thymoma; Type B1	NA	2012	NA	-28951	Alive	TUMOR FREE	813	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	813	0	813	NA	NA	0	813	
80	TCGA-4V-A9QU	0	2	1	1	0	0	0	0	1	8	0	0	2	3	0	0	TCGA-4V-A9QU-01	29	3.861756492961608e-05	1	TCGA-4V-A9QU-01	0	0	11	0.002325055346055159	TCGA-4V-A9QU-01	0	0	0	0	PASS	10370	TCGA-4V-A9QU	THYM	76	FEMALE	WHITE	NA	IIa	Thymoma; Type AB	NA	2013	NA	-27896	Alive	TUMOR FREE	627	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	627	0	627	NA	NA	0	627	
60	TCGA-4V-A9QW	0	0	0	0	0	0	0	0	1	11	2	0	0	7	0	0	TCGA-4V-A9QW-01	87	0.002004810818580153	38	TCGA-4V-A9QW-01	0	0	13	0.0005880697385787793	TCGA-4V-A9QW-01	0	0	0	0	PASS	10371	TCGA-4V-A9QW	THYM	62	MALE	WHITE	NA	I	Thymoma; Type AB	NA	2013	NA	-22781	Alive	TUMOR FREE	630	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	630	0	630	NA	NA	0	630	
80	TCGA-4V-A9QX	0	6	1	0	0	0	0	0	2	11	2	0	0	14	0	0	TCGA-4V-A9QX-01	43	0.0406697783067614	6	TCGA-4V-A9QX-01	1	2	13	0.03219615186422777	TCGA-4V-A9QX-01	2	1	2	5	PASS	10372	TCGA-4V-A9QX	THYM	77	FEMALE	WHITE	NA	III	Thymoma; Type AB	NA	2013	NA	-28250	Alive	TUMOR FREE	434	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	434	0	434	NA	NA	0	434	
60	TCGA-4X-A9F9	0	0	0	0	0	0	0	0	0	11	1	0	0	5	0	0	TCGA-4X-A9F9-01	53	1.9605463675018292e-05	15	TCGA-4X-A9F9	0	0	0	0	TCGA-4X-A9F9	0	0	0	0	PASS	10373	TCGA-4X-A9F9	THYM	57	FEMALE	WHITE	NA	III	Thymoma; Type B1	NA	2013	NA	-21168	Alive	TUMOR FREE	669	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	669	0	669	NA	NA	0	669	
50	TCGA-4X-A9FA	0	2	0	0	0	0	0	0	1	14	0	0	0	3	0	0	TCGA-4X-A9FA-01	53	0.00022244452973394584	11	TCGA-4X-A9FA-01	0	0	5	0.00022249822592237432	TCGA-4X-A9FA-01	0	0	0	0	PASS	10374	TCGA-4X-A9FA	THYM	52	MALE	WHITE	NA	I	Thymoma; Type A	NA	2013	NA	-19032	Alive	TUMOR FREE	392	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	392	0	392	NA	NA	0	392	
40	TCGA-4X-A9FB	0	4	0	2	1	0	0	0	1	5	0	0	0	2	0	0	TCGA-4X-A9FB-01	55	4.067321985018387e-05	17	TCGA-4X-A9FB	0	0	0	0	TCGA-4X-A9FB	0	0	0	0	PASS	10375	TCGA-4X-A9FB	THYM	44	MALE	WHITE	NA	IIa	Thymoma; Type B2	NA	2012	NA	-16175	Alive	TUMOR FREE	717	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	717	0	717	NA	NA	0	717	
50	TCGA-4X-A9FC	0	5	0	0	1	0	0	0	3	11	0	0	1	4	0	0	TCGA-4X-A9FC-01	45	1.6645385646350622e-05	9	TCGA-4X-A9FC	0	0	0	0	TCGA-4X-A9FC	0	0	0	0	PASS	10376	TCGA-4X-A9FC	THYM	50	FEMALE	WHITE	NA	IIa	Thymoma; Type AB	NA	2009	NA	-18418	Alive	TUMOR FREE	2072	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2072	0	2072	NA	NA	0	2072	
40	TCGA-4X-A9FD	0	9	1	2	2	1	0	0	0	20	1	0	2	5	0	0	TCGA-4X-A9FD-01	67	0.5139404101841779	20	TCGA-4X-A9FD-01	22	32	9	0.028663443772262574	TCGA-4X-A9FD-01	2	2	1	5	PASS	10377	TCGA-4X-A9FD	THYM	43	FEMALE	WHITE	NA	IIa	Thymoma; Type B2	NA	2010	NA	-15968	Alive	TUMOR FREE	1503	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1503	0	1503	NA	NA	0	1503	
50	TCGA-5G-A9ZZ	1	3	0	2	0	0	0	0	3	9	0	0	1	5	0	0	TCGA-5G-A9ZZ-01	68	0.13561970016897532	24	TCGA-5G-A9ZZ-01	6	4	30	0.08500107421870501	TCGA-5G-A9ZZ-01	3	1	3	7	PASS	10378	TCGA-5G-A9ZZ	THYM	52	FEMALE	WHITE	NA	IIb	Thymoma; Type C	NA	2012	NA	-19117	Alive	TUMOR FREE	835	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	835	0	835	NA	NA	0	835	
50	TCGA-5K-AAAP	0	6	1	0	0	1	0	0	1	16	3	0	0	7	0	0	TCGA-5K-AAAP-01	79	0.012119008025741786	38	TCGA-5K-AAAP-01	0	0	34	0.015299811652813074	TCGA-5K-AAAP-01	2	2	0	4	PASS	10379	TCGA-5K-AAAP	THYM	54	MALE	WHITE	NA	III	Thymoma; Type A	NA	2010	NA	-19939	Alive	TUMOR FREE	1054	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1054	0	1054	NA	NA	0	1054	
70	TCGA-5U-AB0D	0	19	0	5	0	1	0	0	4	54	2	0	1	14	3	0	TCGA-5U-AB0D-01	172	0.9498600027725632	98	TCGA-5U-AB0D-01	22	18	48	0.09774717828106637	TCGA-5U-AB0D-01	13	4	5	22	PASS	10380	TCGA-5U-AB0D	THYM	71	FEMALE	WHITE	NA	IVb	Thymoma; Type C	NA	2013	NA	-26167	Alive	WITH TUMOR	714	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	714	0	714	NA	NA	0	714	
60	TCGA-5U-AB0E	0	9	0	1	4	0	0	0	0	16	0	0	0	3	2	0	TCGA-5U-AB0E-01	67	0.42853098147989777	20	TCGA-5U-AB0E-01	20	21	66	0.3355942852085857	TCGA-5U-AB0E-01	4	4	2	10	PASS	10381	TCGA-5U-AB0E	THYM	62	MALE	WHITE	NA	IIa	Thymoma; Type B3	NA	2013	NA	-22716	Alive	TUMOR FREE	687	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	687	0	687	NA	NA	0	687	
60	TCGA-5U-AB0F	0	3	0	2	2	1	0	0	1	12	0	0	0	9	0	0	TCGA-5U-AB0F-01	65	0.011157022419362138	20	TCGA-5U-AB0F-01	2	2	24	0.03129006624528926	TCGA-5U-AB0F-01	2	0	2	4	PASS	10382	TCGA-5U-AB0F	THYM	58	FEMALE	WHITE	NA	III	Thymoma; Type AB	NA	2013	NA	-21511	Alive	TUMOR FREE	459	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	459	0	459	NA	NA	0	459	
70	TCGA-5V-A9RR	1	5	0	1	1	0	0	0	0	9	1	0	0	8	0	0	TCGA-5V-A9RR-01	51	0.007499363611990039	13	TCGA-5V-A9RR-01	0	0	10	0.008097967243755945	TCGA-5V-A9RR-01	0	2	1	3	PASS	10383	TCGA-5V-A9RR	THYM	67	MALE	WHITE	NA	I	Thymoma; Type AB	NA	2012	NA	-24668	Alive	TUMOR FREE	827	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	827	0	827	NA	NA	0	827	
50	TCGA-X7-A8D6	2	3	0	0	0	0	0	0	2	21	0	0	0	3	0	0	TCGA-X7-A8D6-01	53	0.00018428079293856164	14	TCGA-X7-A8D6-01	0	0	13	0.0005709216295195022	TCGA-X7-A8D6-01	0	0	0	0	PASS	10384	TCGA-X7-A8D6	THYM	48	FEMALE	WHITE	NA	I	Thymoma; Type B2	NA	2002	NA	-17771	Alive	TUMOR FREE	4225	NA	NA	New Primary Tumor	"Other, specify"	breast	2928	NA	NA	NA	0	4225	0	4225	NA	NA	1	2928	
50	TCGA-X7-A8D7	0	7	0	2	0	0	0	0	1	5	0	0	0	2	0	0	TCGA-X7-A8D7-01	42	0.00011758933645050357	11	TCGA-X7-A8D7-01	0	0	24	0.000915920009885592	TCGA-X7-A8D7-01	0	0	0	0	PASS	10385	TCGA-X7-A8D7	THYM	46	FEMALE	BLACK OR AFRICAN AMERICAN	NA	IIa	Thymoma; Type B1	NA	2003	NA	-17161	Alive	TUMOR FREE	325	NA	NA	New Primary Tumor	Lung	NA	265	NA	NA	NA	0	325	0	325	NA	NA	1	265	
50	TCGA-X7-A8D8	2	9	0	3	0	0	0	0	2	30	2	0	0	12	0	0	TCGA-X7-A8D8-01	49	4.129808617620304e-05	12	TCGA-X7-A8D8-01	0	0	6	0.0003926343471846689	TCGA-X7-A8D8-01	0	0	0	0	PASS	10386	TCGA-X7-A8D8	THYM	53	MALE	WHITE	NA	IIa	Thymoma; Type AB	NA	2005	NA	-19441	Alive	TUMOR FREE	58	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	58	0	58	NA	NA	0	58	
NA	TCGA-X7-A8D9	0	6	0	1	0	0	0	0	0	14	1	0	0	7	0	0	TCGA-X7-A8D9-01	54	0.036786784956885095	12	TCGA-X7-A8D9-01	1	1	13	0.03461352520525513	TCGA-X7-A8D9-01	2	1	1	4	PASS	10387	TCGA-X7-A8D9	THYM	NA	FEMALE	WHITE	NA	I	Thymoma; Type AB	NA	2006	NA	NA	Alive	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
70	TCGA-X7-A8DB	0	2	0	0	3	0	0	0	0	3	0	0	0	1	0	0	TCGA-X7-A8DB-01	49	5.237792285597444e-06	11	TCGA-X7-A8DB-01	0	0	15	0.0018974018839999203	TCGA-X7-A8DB-01	0	0	0	0	PASS	10388	TCGA-X7-A8DB	THYM	71	FEMALE	WHITE	NA	I	Thymoma; Type B2	NA	2009	NA	-26035	Alive	TUMOR FREE	1992	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1992	0	1992	NA	NA	0	1992	
70	TCGA-X7-A8DC	0	5	2	0	0	0	0	0	0	10	0	0	1	7	1	0	TCGA-X7-A8DC-01	47	9.764978401907988e-06	16	TCGA-X7-A8DC-01	0	0	11	0.0002955147934958333	TCGA-X7-A8DC-01	0	0	0	0	PASS	10389	TCGA-X7-A8DC	THYM	68	MALE	WHITE	NA	I	Thymoma; Type AB	NA	2010	NA	-25066	Alive	TUMOR FREE	1798	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1798	0	1798	NA	NA	0	1798	
50	TCGA-X7-A8DD	0	2	1	1	1	0	0	0	0	9	1	0	0	4	2	0	TCGA-X7-A8DD-01	49	2.9653105665161153e-05	13	TCGA-X7-A8DD	0	0	0	0	TCGA-X7-A8DD	0	0	0	0	PASS	10390	TCGA-X7-A8DD	THYM	54	FEMALE	WHITE	NA	IIa	Thymoma; Type B1	NA	2011	NA	-19971	Alive	TUMOR FREE	1114	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1114	0	1114	NA	NA	0	1114	
40	TCGA-X7-A8DE	1	5	0	2	1	0	0	0	1	8	3	0	0	5	0	0	TCGA-X7-A8DE-01	47	1.0358765495183065e-05	9	TCGA-X7-A8DE	0	0	0	0	TCGA-X7-A8DE	0	0	0	0	PASS	10391	TCGA-X7-A8DE	THYM	35	FEMALE	WHITE	NA	I	Thymoma; Type B2	NA	2011	NA	-12957	Alive	TUMOR FREE	981	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	981	0	981	NA	NA	0	981	
40	TCGA-X7-A8DF	1	7	0	1	0	0	0	0	2	5	0	0	0	3	0	0	TCGA-X7-A8DF-01	61	0.01888138914962168	14	TCGA-X7-A8DF	0	0	0	0	TCGA-X7-A8DF	0	0	0	0	PASS	10392	TCGA-X7-A8DF	THYM	40	MALE	WHITE	NA	NA	Thymoma; Type AB	NA	2012	NA	-14804	Alive	TUMOR FREE	901	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	901	0	901	NA	NA	0	901	
50	TCGA-X7-A8DG	1	0	0	0	1	0	0	0	0	3	0	0	0	0	0	0	TCGA-X7-A8DG-01	45	7.799744758580047e-06	13	TCGA-X7-A8DG	0	0	0	0	TCGA-X7-A8DG	0	0	0	0	PASS	10393	TCGA-X7-A8DG	THYM	47	MALE	WHITE	NA	I	Thymoma; Type B2	NA	2012	NA	-17517	Alive	TUMOR FREE	695	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	695	0	695	NA	NA	0	695	
60	TCGA-X7-A8DI	0	5	0	0	0	0	0	0	0	8	2	0	1	3	0	0	TCGA-X7-A8DI-01	41	1.0084278065670418e-05	7	TCGA-X7-A8DI-01	0	0	11	0.002939912104108325	TCGA-X7-A8DI-01	0	0	0	0	PASS	10394	TCGA-X7-A8DI	THYM	57	FEMALE	WHITE	NA	I	Thymoma; Type AB	NA	2013	NA	-21086	Alive	TUMOR FREE	705	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	705	0	705	NA	NA	0	705	
70	TCGA-X7-A8DJ	0	2	0	0	0	0	0	0	1	12	0	1	0	2	0	0	TCGA-X7-A8DJ-01	63	0.0002814531056075584	18	TCGA-X7-A8DJ-01	0	0	20	0.012366057078991929	TCGA-X7-A8DJ-01	0	0	1	1	PASS	10395	TCGA-X7-A8DJ	THYM	68	MALE	[Unknown]	NA	I	Thymoma; Type AB	NA	2013	NA	-25042	Alive	TUMOR FREE	289	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	289	0	289	NA	NA	0	289	
60	TCGA-X7-A8M0	0	8	1	0	1	0	0	0	1	12	0	0	3	4	1	0	TCGA-X7-A8M0-01	53	0.08372114057431339	18	TCGA-X7-A8M0-01	2	3	44	0.08670615556183979	TCGA-X7-A8M0-01	3	1	3	7	PASS	10396	TCGA-X7-A8M0	THYM	61	FEMALE	WHITE	NA	IIa	Thymoma; Type B2|Thymoma; Type B3	NA	2007	NA	-22596	Alive	TUMOR FREE	441	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	441	0	441	NA	NA	0	441	
50	TCGA-X7-A8M1	0	4	0	1	1	0	0	0	1	13	2	0	0	7	0	0	TCGA-X7-A8M1-01	43	9.526600855241714e-06	10	TCGA-X7-A8M1-01	0	0	13	0.002055938115370834	TCGA-X7-A8M1-01	0	0	0	0	PASS	10397	TCGA-X7-A8M1	THYM	51	MALE	ASIAN	NA	NA	Thymoma; Type AB	NA	2009	NA	-18826	Alive	TUMOR FREE	1282	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1282	0	1282	NA	NA	0	1282	
60	TCGA-X7-A8M3	0	14	0	2	1	0	0	0	0	19	7	1	3	9	1	0	TCGA-X7-A8M3-01	91	1.0	39	TCGA-X7-A8M3-01	39	22	167	0.7708160496557331	TCGA-X7-A8M3-01	4	2	7	13	PASS	10398	TCGA-X7-A8M3	THYM	64	FEMALE	WHITE	NA	III	Thymoma; Type B3	NA	2001	NA	-23718	Alive	TUMOR FREE	50	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	50	0	50	NA	NA	0	50	
40	TCGA-X7-A8M4	0	5	0	0	0	0	0	0	0	8	0	0	0	2	1	0	TCGA-X7-A8M4-01	55	5.11305657228685e-05	16	TCGA-X7-A8M4	0	0	0	0	TCGA-X7-A8M4	0	0	0	0	PASS	10399	TCGA-X7-A8M4	THYM	41	MALE	WHITE	NA	IIa	Thymoma; Type B2	NA	2002	NA	-15070	Alive	TUMOR FREE	3808	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3808	0	3808	NA	NA	0	3808	
70	TCGA-X7-A8M5	0	8	0	0	0	0	1	0	3	23	0	0	0	13	1	0	TCGA-X7-A8M5-01	47	9.876581969237071e-05	12	TCGA-X7-A8M5-01	0	0	14	0.0015315107664445825	TCGA-X7-A8M5-01	0	0	0	0	PASS	10400	TCGA-X7-A8M5	THYM	65	FEMALE	WHITE	NA	IIa	Thymoma; Type B3	NA	2001	NA	-24036	Alive	TUMOR FREE	1645	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1645	0	1645	NA	NA	0	1645	
40	TCGA-X7-A8M6	0	3	0	1	2	0	0	0	0	9	0	0	0	1	0	0	TCGA-X7-A8M6-01	51	2.252922155514971e-05	12	TCGA-X7-A8M6-01	0	0	12	0.002107875660470173	TCGA-X7-A8M6-01	0	0	0	0	PASS	10401	TCGA-X7-A8M6	THYM	43	MALE	WHITE	NA	IIa	Thymoma; Type B2	NA	2002	NA	-15749	Alive	WITH TUMOR	4575	NA	NA	Locoregional Recurrence	"Other, specify"	mediastinum	1901	NA	NA	NA	0	4575	0	4575	NA	NA	1	1901	
30	TCGA-X7-A8M7	0	2	0	0	0	0	0	0	0	1	0	0	0	0	0	0	TCGA-X7-A8M7-01	68	8.137943334717595e-05	20	TCGA-X7-A8M7-01	0	0	18	0.0010134737715715167	TCGA-X7-A8M7-01	0	0	0	0	mutation call filter	10402	TCGA-X7-A8M7	THYM	26	MALE	WHITE	NA	I	Thymoma; Type B2	NA	2008	NA	-9815	Alive	TUMOR FREE	1972	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1972	0	1972	NA	NA	0	1972	
50	TCGA-X7-A8M8	0	1	0	0	1	0	0	0	1	4	0	0	0	2	0	0	TCGA-X7-A8M8-01	61	3.3079307249890345e-05	18	TCGA-X7-A8M8-01	0	0	9	0.0014785791676177056	TCGA-X7-A8M8-01	0	0	0	0	PASS	10403	TCGA-X7-A8M8	THYM	45	MALE	BLACK OR AFRICAN AMERICAN	NA	I	Thymoma; Type B2	NA	2007	NA	-16741	Alive	TUMOR FREE	2533	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2533	0	2533	NA	NA	0	2533	
70	TCGA-XH-A853	1	5	0	0	0	0	0	0	1	9	0	0	0	4	0	0	TCGA-XH-A853-01	57	2.4435394284379786e-05	19	TCGA-XH-A853	0	0	0	0	TCGA-XH-A853	0	0	0	0	PASS	10404	TCGA-XH-A853	THYM	67	MALE	BLACK OR AFRICAN AMERICAN	NA	I	Thymoma; Type AB	NA	2011	NA	-24556	Alive	TUMOR FREE	1220	NA	NA	New Primary Tumor	"Other, specify"	right axillary	196	NA	NA	NA	0	1220	0	1220	NA	NA	1	196	
70	TCGA-XM-A8R8	1	5	0	1	0	0	0	0	0	8	0	0	1	3	0	0	TCGA-XM-A8R8-01	63	3.0012282462957893e-05	20	TCGA-XM-A8R8-01	0	0	12	0.003041671860136516	TCGA-XM-A8R8-01	0	0	0	0	PASS	10405	TCGA-XM-A8R8	THYM	67	FEMALE	ASIAN	NA	I	Thymoma; Type C	NA	2010	NA	-24508	Alive	TUMOR FREE	1598	NA	NA	New Primary Tumor	"Other, specify"	Breast	244	NA	NA	NA	0	1598	0	1598	NA	NA	1	244	
70	TCGA-XM-A8R9	0	4	0	3	0	0	0	1	0	8	1	0	1	4	1	0	TCGA-XM-A8R9-01	63	2.514631803034144e-05	21	TCGA-XM-A8R9-01	0	0	12	0.0004572621830454462	TCGA-XM-A8R9-01	0	0	0	0	PASS	10406	TCGA-XM-A8R9	THYM	71	FEMALE	WHITE	NA	I	Thymoma; Type A	NA	2010	NA	-26176	Alive	TUMOR FREE	1488	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1488	0	1488	NA	NA	0	1488	
70	TCGA-XM-A8RB	0	4	0	0	0	0	0	0	1	4	0	0	2	3	0	0	TCGA-XM-A8RB-01	81	9.11533203919995e-05	33	TCGA-XM-A8RB-01	0	0	26	0.0008615456285850107	TCGA-XM-A8RB-01	0	0	0	0	PASS	10407	TCGA-XM-A8RB	THYM	68	FEMALE	BLACK OR AFRICAN AMERICAN	NA	I	Thymoma; Type B1	NA	2011	NA	-25080	Alive	TUMOR FREE	1144	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1144	0	1144	NA	NA	0	1144	
70	TCGA-XM-A8RC	0	4	0	2	2	0	0	0	0	21	0	0	0	11	1	0	TCGA-XM-A8RC-01	49	0.5329746658387251	8	TCGA-XM-A8RC-01	30	25	15	0.07035558641508415	TCGA-XM-A8RC-01	5	7	1	13	PASS	10408	TCGA-XM-A8RC	THYM	67	MALE	WHITE	NA	IIa	Thymoma; Type B2	NA	2006	NA	-24660	Alive	TUMOR FREE	2963	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2963	0	2963	NA	NA	0	2963	
70	TCGA-XM-A8RD	0	3	0	0	1	0	0	0	1	9	1	0	0	2	0	0	TCGA-XM-A8RD-01	51	0.14049172017790668	7	TCGA-XM-A8RD	0	0	0	0	TCGA-XM-A8RD	0	0	0	0	PASS	10409	TCGA-XM-A8RD	THYM	69	FEMALE	WHITE	NA	IIa	Thymoma; Type B2	NA	2010	NA	-25402	Alive	TUMOR FREE	1546	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1546	0	1546	NA	NA	0	1546	
50	TCGA-XM-A8RE	0	6	0	0	1	0	0	0	0	6	0	0	0	2	0	0	TCGA-XM-A8RE-01	63	7.816895916718264e-05	22	TCGA-XM-A8RE	0	0	0	0	TCGA-XM-A8RE	0	0	0	0	PASS	10410	TCGA-XM-A8RE	THYM	54	FEMALE	WHITE	NA	I	Thymoma; Type AB	NA	2013	NA	-19903	Alive	TUMOR FREE	422	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	422	0	422	NA	NA	0	422	
80	TCGA-XM-A8RF	0	11	0	1	0	1	0	0	3	26	2	0	1	6	3	0	TCGA-XM-A8RF-01	109	0.05020786788432733	63	TCGA-XM-A8RF-01	1	1	46	0.04496212864852546	TCGA-XM-A8RF-01	1	4	2	7	PASS	10411	TCGA-XM-A8RF	THYM	84	FEMALE	WHITE	NA	IIa	Thymoma; Type A	NA	2011	NA	-30893	Alive	TUMOR FREE	797	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	797	0	797	NA	NA	0	797	
70	TCGA-XM-A8RG	0	7	0	1	1	0	0	0	1	22	0	0	0	4	0	0	TCGA-XM-A8RG-01	48	0.0739949940019511	14	TCGA-XM-A8RG-01	4	2	22	0.05693833801611625	TCGA-XM-A8RG-01	1	0	1	2	PASS	10412	TCGA-XM-A8RG	THYM	67	MALE	WHITE	NA	I	Thymoma; Type A	NA	2013	NA	-24802	Alive	TUMOR FREE	386	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	386	0	386	NA	NA	0	386	
60	TCGA-XM-A8RH	0	4	0	0	0	0	0	0	0	6	0	0	0	2	0	0	TCGA-XM-A8RH-01	57	2.1219469425702443e-05	23	TCGA-XM-A8RH	0	0	0	0	TCGA-XM-A8RH	0	0	0	0	PASS	10413	TCGA-XM-A8RH	THYM	60	FEMALE	WHITE	NA	IIa	Thymoma; Type B1	NA	2013	NA	-21931	Alive	TUMOR FREE	363	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	363	0	363	NA	NA	0	363	
80	TCGA-XM-A8RI	0	5	0	0	0	0	0	0	2	12	2	0	1	11	0	0	TCGA-XM-A8RI-01	39	0.0001367876903881334	7	TCGA-XM-A8RI	0	0	0	0	TCGA-XM-A8RI	0	0	0	0	PASS	10414	TCGA-XM-A8RI	THYM	77	MALE	[Not Evaluated]	NA	IIa	Thymoma; Type B2	NA	2013	NA	-28246	Alive	TUMOR FREE	387	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	387	0	387	NA	NA	0	387	
40	TCGA-XM-A8RL	0	2	1	1	0	0	0	0	0	1	0	0	0	3	0	0	TCGA-XM-A8RL-01	49	1.548091919838991e-05	13	TCGA-XM-A8RL-01	0	0	12	0.0013322890022645802	TCGA-XM-A8RL-01	0	0	0	0	PASS	10415	TCGA-XM-A8RL	THYM	44	MALE	WHITE	NA	IIb	Thymoma; Type B1	NA	2007	NA	-16384	Alive	TUMOR FREE	2562	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2562	0	2562	NA	NA	0	2562	
40	TCGA-XM-AAZ1	0	3	0	0	0	0	0	0	1	13	0	0	2	2	0	0	TCGA-XM-AAZ1-01	72	0.045733664094808536	22	TCGA-XM-AAZ1-01	1	1	8	0.00035182060630393417	TCGA-XM-AAZ1-01	1	1	0	2	PASS	10416	TCGA-XM-AAZ1	THYM	42	MALE	WHITE	NA	IIb	Thymoma; Type B2|Thymoma; Type B3	NA	2013	NA	-15383	Alive	TUMOR FREE	397	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	397	0	397	NA	NA	0	397	
70	TCGA-XM-AAZ2	1	5	0	1	0	0	0	0	0	16	1	0	0	6	0	0	TCGA-XM-AAZ2-01	69	0.010052288480060005	22	TCGA-XM-AAZ2-01	0	0	9	0.011556795585596882	TCGA-XM-AAZ2-01	0	1	1	2	PASS	10417	TCGA-XM-AAZ2	THYM	73	MALE	BLACK OR AFRICAN AMERICAN	NA	I	Thymoma; Type A	NA	2012	NA	-26861	Alive	TUMOR FREE	981	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	981	0	981	NA	NA	0	981	
60	TCGA-XM-AAZ3	0	9	0	2	0	1	0	0	2	19	2	0	1	3	1	1	TCGA-XM-AAZ3-01	65	1.4629194113051633e-05	18	TCGA-XM-AAZ3-01	0	0	2	0.001683085504511731	TCGA-XM-AAZ3-01	0	0	0	0	PASS	10418	TCGA-XM-AAZ3	THYM	64	MALE	WHITE	NA	IIb	Thymoma; Type AB	NA	2011	NA	-23617	Alive	TUMOR FREE	1150	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1150	0	1150	NA	NA	0	1150	
60	TCGA-XU-A92O	0	6	1	0	1	0	0	0	1	22	2	0	0	11	0	0	TCGA-XU-A92O-01	41	1.2740688349444635e-05	8	TCGA-XU-A92O-01	0	0	6	0.000985327777713165	TCGA-XU-A92O-01	0	0	0	0	PASS	10419	TCGA-XU-A92O	THYM	63	MALE	ASIAN	NA	I	Thymoma; Type A	NA	2005	NA	-23186	Alive	TUMOR FREE	3410	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3410	0	3410	NA	NA	0	3410	
50	TCGA-XU-A92Q	2	4	0	0	1	0	0	0	1	21	0	0	1	2	0	0	TCGA-XU-A92Q-01	63	4.672717365347183e-05	24	TCGA-XU-A92Q-01	0	0	4	0.0002056929773955304	TCGA-XU-A92Q-01	0	0	0	0	PASS	10420	TCGA-XU-A92Q	THYM	50	MALE	ASIAN	NA	I	Thymoma; Type A	NA	2008	NA	-18281	Alive	TUMOR FREE	1092	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1092	0	1092	NA	NA	0	1092	
80	TCGA-XU-A92R	1	7	0	0	0	0	0	0	1	17	3	0	0	5	0	0	TCGA-XU-A92R-01	85	0.034562501790276534	38	TCGA-XU-A92R-01	1	1	20	0.007359143161285237	TCGA-XU-A92R-01	0	1	1	2	PASS	10421	TCGA-XU-A92R	THYM	76	FEMALE	ASIAN	NA	IVb	Thymoma; Type AB	NA	2007	NA	-27971	Alive	TUMOR FREE	2739	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2739	0	2739	NA	NA	0	2739	
80	TCGA-XU-A92T	1	8	1	2	1	0	0	0	0	24	3	0	1	6	1	0	TCGA-XU-A92T-01	43	1.0979885269733478e-05	7	TCGA-XU-A92T-01	0	0	5	0.0002442820196296282	TCGA-XU-A92T-01	0	0	0	0	PASS	10422	TCGA-XU-A92T	THYM	81	FEMALE	WHITE	NA	IIa	Thymoma; Type AB	NA	2010	NA	-29613	Alive	TUMOR FREE	1376	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1376	0	1376	NA	NA	0	1376	
70	TCGA-XU-A92U	1	9	0	0	2	0	0	0	1	13	0	0	2	5	0	0	TCGA-XU-A92U-01	43	2.413909610528241e-05	6	TCGA-XU-A92U-01	0	0	4	9.965352552029665e-05	TCGA-XU-A92U-01	0	0	0	0	PASS	10423	TCGA-XU-A92U	THYM	67	MALE	WHITE	NA	IIa	Thymoma; Type B2	NA	2002	NA	-24487	Alive	TUMOR FREE	4562	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4562	0	4562	NA	NA	0	4562	
70	TCGA-XU-A92V	0	10	0	1	0	0	0	0	0	35	2	0	1	4	0	0	TCGA-XU-A92V-01	75	0.007163338666133542	34	TCGA-XU-A92V-01	0	0	19	0.007812455432084187	TCGA-XU-A92V-01	2	0	0	2	PASS	10424	TCGA-XU-A92V	THYM	72	FEMALE	ASIAN	NA	IIa	Thymoma; Type AB	NA	2012	NA	-26646	Dead	TUMOR FREE	NA	124	NA	NA	NA	NA	NA	NA	NA	NA	1	124	0	124	NA	NA	0	124	
60	TCGA-XU-A92W	0	3	0	0	0	0	0	0	3	14	0	0	0	6	0	0	TCGA-XU-A92W-01	45	0.00018327809774890897	10	TCGA-XU-A92W-01	0	0	11	0.0011877809182532927	TCGA-XU-A92W-01	0	0	0	0	PASS	10425	TCGA-XU-A92W	THYM	61	MALE	WHITE	NA	IIa	Thymoma; Type AB	NA	2005	NA	-22554	Alive	TUMOR FREE	3279	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3279	0	3279	NA	NA	0	3279	
20	TCGA-XU-A92X	0	5	1	2	0	0	0	0	1	6	1	0	1	2	0	0	TCGA-XU-A92X-01	79	0.5300152260060101	33	TCGA-XU-A92X-01	23	18	62	0.3090483885538372	TCGA-XU-A92X-01	0	0	8	8	PASS	10426	TCGA-XU-A92X	THYM	17	MALE	ASIAN	NA	IIa	Thymoma; Type B2	NA	2008	NA	-6572	Alive	TUMOR FREE	2343	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2343	0	2343	NA	NA	0	2343	
70	TCGA-XU-A92Y	0	8	0	0	0	0	0	0	0	11	0	0	0	3	0	0	TCGA-XU-A92Y-01	109	0.17596871083920976	52	TCGA-XU-A92Y-01	6	5	19	0.055972342819008564	TCGA-XU-A92Y-01	2	1	1	4	PASS	10427	TCGA-XU-A92Y	THYM	71	FEMALE	WHITE	NA	IIb	Thymoma; Type B3	NA	2004	NA	-26021	Dead	WITH TUMOR	NA	3488	NA	Locoregional Recurrence	"Other, specify"	"posterior mediastinal tumour, adrenal/perinephric tumour involving left pleural space, diaphragm, chest wall, spine"	1224	NA	NA	NA	1	3488	1	3488	NA	NA	1	1224	
80	TCGA-XU-A92Z	0	11	0	1	1	0	0	0	2	21	2	0	5	4	0	0	TCGA-XU-A92Z-01	75	0.018413724315906828	26	TCGA-XU-A92Z-01	0	1	11	0.017776913056065255	TCGA-XU-A92Z-01	2	1	2	5	PASS	10428	TCGA-XU-A92Z	THYM	76	MALE	ASIAN	NA	III	Thymoma; Type C	NA	2004	NA	-28117	Alive	TUMOR FREE	3663	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3663	0	3663	NA	NA	0	3663	
40	TCGA-XU-A930	1	7	1	5	0	0	0	0	3	21	4	0	1	5	0	0	TCGA-XU-A930-01	88	0.6111120066531637	34	TCGA-XU-A930-01	24	52	13	0.012239387860548394	TCGA-XU-A930-01	3	5	0	8	PASS	10429	TCGA-XU-A930	THYM	43	MALE	WHITE	NA	III	Thymoma; Type B3	NA	2007	NA	-15777	Alive	TUMOR FREE	2514	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2514	0	2514	NA	NA	0	2514	
60	TCGA-XU-A931	0	6	0	2	0	0	0	0	2	11	0	0	2	5	0	0	TCGA-XU-A931-01	64	0.3850175555919788	23	TCGA-XU-A931-01	12	8	28	0.09061791982673496	TCGA-XU-A931-01	1	2	2	5	PASS	10430	TCGA-XU-A931	THYM	61	FEMALE	WHITE	NA	IIa	Thymoma; Type B3	NA	2007	NA	-22432	Dead	TUMOR FREE	NA	1609	NA	New Primary Tumor	Lung	NA	1377	NA	NA	NA	1	1609	0	1609	NA	NA	1	1377	
40	TCGA-XU-A932	0	2	0	0	3	0	0	0	0	8	0	0	1	8	0	0	TCGA-XU-A932-01	85	0.07829696993514294	39	TCGA-XU-A932-01	4	11	70	0.13439421558369558	TCGA-XU-A932-01	6	5	3	14	PASS	10431	TCGA-XU-A932	THYM	37	MALE	ASIAN	NA	IIa	Thymoma; Type B2	NA	2008	NA	-13618	Alive	TUMOR FREE	2149	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2149	0	2149	NA	NA	0	2149	
50	TCGA-XU-A933	1	9	1	3	4	1	0	0	4	28	3	0	1	10	0	0	TCGA-XU-A933-01	74	0.2158631982324279	26	TCGA-XU-A933-01	10	6	27	0.03041481282327974	TCGA-XU-A933-01	3	3	3	9	PASS	10432	TCGA-XU-A933	THYM	52	FEMALE	ASIAN	NA	IIb	Thymoma; Type C	NA	2009	NA	-19276	Alive	TUMOR FREE	1789	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1789	0	1789	NA	NA	0	1789	
70	TCGA-XU-A936	0	10	0	1	1	1	0	0	0	20	3	0	0	9	0	0	TCGA-XU-A936-01	56	0.4811856396964744	13	TCGA-XU-A936-01	21	23	30	0.09050241341253057	TCGA-XU-A936-01	3	3	2	8	PASS	10433	TCGA-XU-A936	THYM	65	FEMALE	WHITE	NA	IIa	Thymoma; Type C	NA	2012	NA	-23924	Alive	TUMOR FREE	643	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	643	0	643	NA	NA	0	643	
50	TCGA-XU-AAXV	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-XU-AAXV	0	0	0	TCGA-XU-AAXV	0	0	0	0	TCGA-XU-AAXV	0	0	0	0	PASS	10434	TCGA-XU-AAXV	THYM	45	FEMALE	WHITE	NA	IIa	Thymoma; Type B2	NA	2003	NA	-16582	Alive	TUMOR FREE	4070	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4070	0	4070	NA	NA	0	4070	
40	TCGA-XU-AAXW	0	1	0	1	0	0	0	0	0	5	0	0	0	4	1	0	TCGA-XU-AAXW-01	103	0.00010765805135311992	54	TCGA-XU-AAXW-01	0	0	20	0.0009477367852764408	TCGA-XU-AAXW-01	0	0	0	0	PASS	10435	TCGA-XU-AAXW	THYM	39	FEMALE	ASIAN	NA	IIa	Thymoma; Type B2	NA	2004	NA	-14408	Alive	TUMOR FREE	3762	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3762	0	3762	NA	NA	0	3762	
40	TCGA-XU-AAXX	0	2	0	2	0	0	0	0	1	7	2	0	1	4	1	0	TCGA-XU-AAXX-01	42	8.934677682269159e-05	9	TCGA-XU-AAXX-01	0	0	15	0.0006195050267774438	TCGA-XU-AAXX-01	0	2	0	2	PASS	10436	TCGA-XU-AAXX	THYM	44	FEMALE	WHITE	NA	IIa	Thymoma; Type B2	NA	2007	NA	-16265	Alive	TUMOR FREE	2721	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2721	0	2721	NA	NA	0	2721	
40	TCGA-XU-AAXY	2	2	0	0	0	0	0	0	0	3	0	0	1	2	0	0	TCGA-XU-AAXY-01	47	0.009218247766065285	9	TCGA-XU-AAXY-01	0	0	12	0.0004656554824128506	TCGA-XU-AAXY-01	0	0	0	0	PASS	10437	TCGA-XU-AAXY	THYM	43	MALE	WHITE	NA	IIb	Thymoma; Type B2	NA	2009	NA	-15756	Alive	TUMOR FREE	1891	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1891	0	1891	NA	NA	0	1891	
60	TCGA-XU-AAXZ	0	6	0	0	0	1	0	0	1	7	1	0	1	3	0	0	TCGA-XU-AAXZ-01	65	0.014239417460198715	22	TCGA-XU-AAXZ-01	0	0	3	5.3678465827645836e-05	TCGA-XU-AAXZ-01	0	0	0	0	PASS	10438	TCGA-XU-AAXZ	THYM	63	MALE	WHITE	NA	IIb	Thymoma; Type B3	NA	2010	NA	-23324	Alive	TUMOR FREE	1537	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1537	0	1537	NA	NA	0	1537	
60	TCGA-XU-AAY0	0	8	0	0	0	0	0	0	1	14	0	0	2	4	0	0	TCGA-XU-AAY0-01	67	7.955224199165913e-05	21	TCGA-XU-AAY0-01	0	0	20	0.008136037047607755	TCGA-XU-AAY0-01	0	0	0	0	PASS	10439	TCGA-XU-AAY0	THYM	62	FEMALE	ASIAN	NA	IIa	Thymoma; Type AB	NA	2010	NA	-22645	Alive	TUMOR FREE	1502	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1502	0	1502	NA	NA	0	1502	
50	TCGA-XU-AAY1	0	3	0	0	1	0	0	0	0	9	0	0	2	4	0	0	TCGA-XU-AAY1-01	53	9.85554800317338e-05	16	TCGA-XU-AAY1-01	0	0	11	0.0007212568753706128	TCGA-XU-AAY1-01	0	0	0	0	PASS	10440	TCGA-XU-AAY1	THYM	51	FEMALE	ASIAN	NA	IIa	Thymoma; Type AB	NA	2005	NA	-18777	Alive	TUMOR FREE	3268	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	3268	0	3268	NA	NA	0	3268	
50	TCGA-YT-A95D	0	5	0	2	1	2	0	0	2	18	0	0	0	3	0	0	TCGA-YT-A95D-01	51	0.03400306141348871	9	TCGA-YT-A95D-01	1	1	9	0.03659571759535449	TCGA-YT-A95D-01	0	0	0	0	PASS	10441	TCGA-YT-A95D	THYM	50	FEMALE	WHITE	NA	I	Thymoma; Type AB	NA	2012	NA	-18363	Alive	TUMOR FREE	750	NA	NA	New Primary Tumor	"Other, specify"	Thyroid papillary carcinoma	168	NA	NA	NA	0	750	0	750	NA	NA	1	168	
50	TCGA-YT-A95E	1	5	1	0	0	0	0	0	1	12	0	0	0	3	1	0	TCGA-YT-A95E-01	61	5.1258606427714336e-05	20	TCGA-YT-A95E-01	0	0	9	0.00025707720034315995	TCGA-YT-A95E-01	0	0	0	0	PASS	10442	TCGA-YT-A95E	THYM	52	MALE	WHITE	NA	I	Thymoma; Type B2	NA	2011	NA	-19172	Alive	TUMOR FREE	1070	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1070	0	1070	NA	NA	0	1070	
60	TCGA-YT-A95F	0	8	0	4	2	0	0	0	2	29	4	0	0	5	0	0	TCGA-YT-A95F-01	59	1.5816902914588842e-05	17	TCGA-YT-A95F	0	0	0	0	TCGA-YT-A95F-01	0	0	0	0	PASS	10443	TCGA-YT-A95F	THYM	55	FEMALE	WHITE	NA	I	Thymoma; Type AB	NA	2012	NA	-20363	Alive	TUMOR FREE	775	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	775	0	775	NA	NA	0	775	
60	TCGA-YT-A95G	0	1	1	1	0	0	0	0	0	12	1	0	1	4	2	0	TCGA-YT-A95G-01	63	0.05591547879787132	19	TCGA-YT-A95G-01	2	2	12	0.0016363836455944307	TCGA-YT-A95G-01	2	0	0	2	PASS	10444	TCGA-YT-A95G	THYM	61	FEMALE	WHITE	NA	I	Thymoma; Type B2	NA	2010	NA	-22541	Alive	TUMOR FREE	1514	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1514	0	1514	NA	NA	0	1514	
70	TCGA-YT-A95H	1	5	0	0	1	1	0	0	2	13	1	0	1	7	0	0	TCGA-YT-A95H-01	77	0.00017507948959084234	33	TCGA-YT-A95H-01	0	0	15	0.0013703028223917598	TCGA-YT-A95H-01	0	0	0	0	PASS	10445	TCGA-YT-A95H	THYM	69	MALE	WHITE	NA	I	Thymoma; Type AB	NA	2013	NA	-25376	Alive	TUMOR FREE	711	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	711	0	711	NA	NA	0	711	
70	TCGA-ZB-A961	0	4	1	1	0	0	0	0	0	26	3	0	2	10	0	0	TCGA-ZB-A961-01	98	0.14697522980882852	50	TCGA-ZB-A961-01	7	6	40	0.12028775749897185	TCGA-ZB-A961-01	2	2	3	7	PASS	10446	TCGA-ZB-A961	THYM	69	MALE	WHITE	NA	IIb	Thymoma; Type A	NA	2010	NA	-25419	Dead	TUMOR FREE	NA	180	NA	NA	NA	NA	NA	NA	NA	NA	1	180	0	180	NA	NA	0	180	
60	TCGA-ZB-A962	0	7	1	0	2	0	0	0	2	20	3	0	0	6	1	0	TCGA-ZB-A962-01	128	0.04309381908979613	73	TCGA-ZB-A962-01	2	1	49	0.034897870658280115	TCGA-ZB-A962-01	3	1	2	6	PASS	10447	TCGA-ZB-A962	THYM	64	MALE	WHITE	NA	IIb	Thymoma; Type A	NA	2010	NA	-23461	Alive	TUMOR FREE	1647	NA	NA	Distant Metastasis	Liver	NA	1091	NA	NA	NA	0	1647	0	1647	NA	NA	1	1091	
50	TCGA-ZB-A963	0	5	0	0	0	0	0	0	1	11	2	0	2	8	0	0	TCGA-ZB-A963-01	81	0.011012422042529885	40	TCGA-ZB-A963-01	0	0	20	0.01130827222223277	TCGA-ZB-A963-01	0	2	0	2	PASS	10448	TCGA-ZB-A963	THYM	46	MALE	WHITE	NA	IIa	Thymoma; Type AB	NA	2011	NA	-16990	Alive	TUMOR FREE	1482	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1482	0	1482	NA	NA	0	1482	
70	TCGA-ZB-A964	0	4	2	0	1	0	0	0	0	22	0	0	1	6	1	0	TCGA-ZB-A964-01	33	5.571530063227208e-06	4	TCGA-ZB-A964-01	0	0	3	0.000120253076222155	TCGA-ZB-A964-01	0	0	0	0	PASS	10449	TCGA-ZB-A964	THYM	70	MALE	WHITE	NA	IVb	Thymoma; Type A	NA	2011	NA	-25861	Alive	TUMOR FREE	1287	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1287	0	1287	NA	NA	0	1287	
80	TCGA-ZB-A965	2	9	0	2	1	0	1	0	2	26	2	0	3	9	0	0	TCGA-ZB-A965-01	41	2.8591920696170692e-05	6	TCGA-ZB-A965-01	0	0	7	0.0011083594664606188	TCGA-ZB-A965-01	0	0	0	0	PASS	10450	TCGA-ZB-A965	THYM	75	FEMALE	WHITE	NA	III	Thymoma; Type A|Thymoma; Type AB	NA	2012	NA	-27617	Alive	TUMOR FREE	816	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	816	0	816	NA	NA	0	816	
80	TCGA-ZB-A966	16	208	3	21	110	30	8	0	35	443	24	0	21	172	6	1	TCGA-ZB-A966-01	71	0.11573643284242495	25	TCGA-ZB-A966-01	4	3	16	0.04893026376104657	TCGA-ZB-A966-01	3	0	2	5	hypermutated sample	10451	TCGA-ZB-A966	THYM	78	FEMALE	WHITE	NA	IVb	Thymoma; Type C	NA	2012	NA	-28621	Dead	WITH TUMOR	NA	379	NA	Locoregional Recurrence	Lung	NA	296	NA	NA	NA	1	379	1	379	NA	NA	1	296	
70	TCGA-ZB-A969	0	7	0	2	1	1	0	0	1	26	2	0	0	12	0	0	TCGA-ZB-A969-01	156	0.09547818208863187	94	TCGA-ZB-A969-01	4	6	71	0.09385665635519176	TCGA-ZB-A969-01	6	6	6	18	PASS	10452	TCGA-ZB-A969	THYM	72	FEMALE	WHITE	NA	IVb	Thymoma; Type C	NA	2012	NA	-26458	Alive	TUMOR FREE	1046	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1046	0	1046	NA	NA	0	1046	
50	TCGA-ZB-A96A	1	3	0	1	3	0	0	0	6	17	0	0	1	7	0	0	TCGA-ZB-A96A-01	59	0.011000178279728387	18	TCGA-ZB-A96A-01	0	0	17	0.0033195773691213717	TCGA-ZB-A96A-01	0	0	0	0	PASS	10453	TCGA-ZB-A96A	THYM	53	MALE	WHITE	NA	I	Thymoma; Type B2|Thymoma; Type B3	NA	2008	NA	-19424	Alive	TUMOR FREE	2354	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2354	0	2354	NA	NA	0	2354	
50	TCGA-ZB-A96B	0	0	0	1	0	0	0	0	1	7	0	0	0	4	0	0	TCGA-ZB-A96B-01	49	0.000326425752755522	10	TCGA-ZB-A96B-01	0	0	17	0.0013870786280571114	TCGA-ZB-A96B-01	0	0	0	0	PASS	10454	TCGA-ZB-A96B	THYM	51	MALE	WHITE	NA	IIa	Thymoma; Type B1	NA	2009	NA	-18892	Alive	TUMOR FREE	2211	NA	NA	New Primary Tumor	"Other, specify"	bladder	91	NA	NA	NA	0	2211	0	2211	NA	NA	1	91	
80	TCGA-ZB-A96C	0	7	0	2	0	0	0	0	3	25	1	0	0	10	0	0	TCGA-ZB-A96C-01	47	0.006011641121071346	10	TCGA-ZB-A96C-01	0	0	8	0.007205570752843272	TCGA-ZB-A96C-01	0	1	1	2	PASS	10455	TCGA-ZB-A96C	THYM	77	FEMALE	WHITE	NA	I	Thymoma; Type AB	NA	2009	NA	-28222	Alive	TUMOR FREE	2163	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2163	0	2163	NA	NA	0	2163	
50	TCGA-ZB-A96D	0	2	1	0	0	0	0	0	0	19	2	0	0	3	0	0	TCGA-ZB-A96D-01	47	4.491023915789637e-05	12	TCGA-ZB-A96D-01	0	0	14	0.008887921434588658	TCGA-ZB-A96D-01	0	0	1	1	PASS	10456	TCGA-ZB-A96D	THYM	52	FEMALE	WHITE	NA	IIb	Thymoma; Type AB	NA	2009	NA	-19274	Alive	TUMOR FREE	1960	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1960	0	1960	NA	NA	0	1960	
60	TCGA-ZB-A96E	0	3	1	2	3	0	0	1	1	22	2	0	0	8	1	0	TCGA-ZB-A96E-01	47	2.361780052582659e-05	10	TCGA-ZB-A96E-01	0	0	2	0.0001330940822192838	TCGA-ZB-A96E-01	0	0	0	0	PASS	10457	TCGA-ZB-A96E	THYM	60	MALE	WHITE	NA	IIa	Thymoma; Type A|Thymoma; Type AB	NA	2010	NA	-22092	Alive	TUMOR FREE	1819	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1819	0	1819	NA	NA	0	1819	
40	TCGA-ZB-A96F	1	2	0	2	0	0	0	0	0	22	0	0	0	7	0	0	TCGA-ZB-A96F-01	83	0.4532983870376288	29	TCGA-ZB-A96F-01	16	22	196	0.7142235814621675	TCGA-ZB-A96F-01	3	4	6	13	PASS	10458	TCGA-ZB-A96F	THYM	39	MALE	WHITE	NA	I	Thymoma; Type AB	NA	2010	NA	-14344	Alive	TUMOR FREE	1761	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1761	0	1761	NA	NA	0	1761	
60	TCGA-ZB-A96G	0	1	0	2	0	0	0	0	0	10	1	0	0	0	0	1	TCGA-ZB-A96G-01	55	9.371598188480971e-05	17	TCGA-ZB-A96G-01	0	0	18	0.0011543978477880775	TCGA-ZB-A96G-01	0	0	0	0	PASS	10459	TCGA-ZB-A96G	THYM	59	MALE	WHITE	NA	IIa	Thymoma; Type AB	NA	2010	NA	-21598	Alive	TUMOR FREE	1606	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1606	0	1606	NA	NA	0	1606	
70	TCGA-ZB-A96H	0	6	0	1	2	0	0	0	1	21	0	0	1	2	0	0	TCGA-ZB-A96H-01	43	0.005905441737678059	11	TCGA-ZB-A96H-01	0	0	9	0.007331711867555607	TCGA-ZB-A96H-01	0	2	0	2	PASS	10460	TCGA-ZB-A96H	THYM	73	MALE	WHITE	NA	IIb	Thymoma; Type A	NA	2010	NA	-26683	Alive	TUMOR FREE	1504	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1504	0	1504	NA	NA	0	1504	
70	TCGA-ZB-A96I	2	4	0	3	2	0	0	0	0	26	4	0	1	7	1	0	TCGA-ZB-A96I-01	84	0.2651841440067381	37	TCGA-ZB-A96I-01	7	7	59	0.15155633081273992	TCGA-ZB-A96I-01	5	4	6	15	PASS	10461	TCGA-ZB-A96I	THYM	71	FEMALE	WHITE	NA	III	Thymoma; Type AB	NA	2010	NA	-26208	Alive	TUMOR FREE	1653	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1653	0	1653	NA	NA	0	1653	
70	TCGA-ZB-A96K	0	6	0	2	1	0	0	0	2	13	1	0	0	5	0	0	TCGA-ZB-A96K-01	59	0.02417205573931074	18	TCGA-ZB-A96K-01	0	0	13	0.025671263074310058	TCGA-ZB-A96K-01	0	2	1	3	PASS	10462	TCGA-ZB-A96K	THYM	69	MALE	WHITE	NA	I	Thymoma; Type AB	NA	2011	NA	-25498	Alive	TUMOR FREE	1388	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1388	0	1388	NA	NA	0	1388	
70	TCGA-ZB-A96L	0	14	0	0	2	0	0	0	5	27	0	0	0	5	0	0	TCGA-ZB-A96L-01	142	0.1205434144977069	75	TCGA-ZB-A96L-01	5	4	46	0.06272892465380363	TCGA-ZB-A96L-01	5	1	4	10	PASS	10463	TCGA-ZB-A96L	THYM	70	FEMALE	WHITE	NA	III	Thymoma; Type B3	NA	2011	NA	-25914	Alive	TUMOR FREE	1529	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1529	0	1529	NA	NA	0	1529	
60	TCGA-ZB-A96M	0	4	1	1	1	0	0	0	1	26	0	0	1	4	0	0	TCGA-ZB-A96M-01	47	4.332004117604897e-05	8	TCGA-ZB-A96M-01	0	0	7	0.00018812299804627232	TCGA-ZB-A96M-01	0	0	0	0	PASS	10464	TCGA-ZB-A96M	THYM	56	FEMALE	WHITE	NA	I	Thymoma; Type AB	NA	2011	NA	-20623	Alive	TUMOR FREE	14	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	14	0	14	NA	NA	0	14	
50	TCGA-ZB-A96O	0	3	0	2	2	0	0	0	2	5	0	0	0	0	0	0	TCGA-ZB-A96O-01	41	5.363175050636975e-06	4	TCGA-ZB-A96O-01	0	0	16	0.0017076005680654509	TCGA-ZB-A96O-01	0	0	0	0	PASS	10465	TCGA-ZB-A96O	THYM	54	FEMALE	WHITE	NA	III	Thymoma; Type B1	NA	2012	NA	-19782	Alive	TUMOR FREE	1050	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1050	0	1050	NA	NA	0	1050	
70	TCGA-ZB-A96P	0	4	1	0	0	0	0	0	1	8	0	0	0	3	0	0	TCGA-ZB-A96P-01	71	2.48547951893001e-05	23	TCGA-ZB-A96P-01	0	0	22	0.0016223080937679956	TCGA-ZB-A96P-01	0	0	0	0	PASS	10466	TCGA-ZB-A96P	THYM	73	MALE	WHITE	NA	I	Thymoma; Type B1	NA	2013	NA	-26870	Alive	TUMOR FREE	753	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	753	0	753	NA	NA	0	753	
50	TCGA-ZB-A96Q	0	4	0	0	0	1	0	0	0	20	2	0	0	6	0	0	TCGA-ZB-A96Q-01	41	7.057281299741135e-05	6	TCGA-ZB-A96Q-01	0	0	7	0.00023033829922229081	TCGA-ZB-A96Q-01	0	0	0	0	PASS	10467	TCGA-ZB-A96Q	THYM	49	MALE	WHITE	NA	IIa	Thymoma; Type AB	NA	2013	NA	-18249	Alive	TUMOR FREE	675	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	675	0	675	NA	NA	0	675	
40	TCGA-ZB-A96R	0	1	0	3	0	0	0	0	3	9	0	0	0	4	0	0	TCGA-ZB-A96R-01	49	0.0001266987592375286	15	TCGA-ZB-A96R-01	0	0	16	0.0017068202931096372	TCGA-ZB-A96R-01	0	0	0	0	PASS	10468	TCGA-ZB-A96R	THYM	38	MALE	WHITE	NA	IIa	Thymoma; Type B1|Thymoma; Type B2	NA	2010	NA	-13977	Alive	TUMOR FREE	1804	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1804	0	1804	NA	NA	0	1804	
40	TCGA-ZB-A96V	1	9	1	3	3	0	0	0	7	41	7	1	1	24	1	0	TCGA-ZB-A96V-01	67	0.12565281582262675	18	TCGA-ZB-A96V-01	4	4	19	0.03101703745369424	TCGA-ZB-A96V-01	4	3	2	9	PASS	10469	TCGA-ZB-A96V	THYM	44	MALE	WHITE	NA	IVb	Thymoma; Type C	NA	2012	NA	-16245	Alive	TUMOR FREE	932	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	932	0	932	NA	NA	0	932	
60	TCGA-ZC-AAA7	3	11	0	3	3	0	0	0	4	58	2	0	4	19	3	0	TCGA-ZC-AAA7-01	62	0.25996768447944113	15	TCGA-ZC-AAA7-01	11	12	39	0.11550737883544765	TCGA-ZC-AAA7-01	4	2	4	10	PASS	10470	TCGA-ZC-AAA7	THYM	63	MALE	WHITE	NA	IIa	Thymoma; Type C	NA	2008	NA	-23265	Dead	WITH TUMOR	NA	853	NA	NA	NA	NA	NA	NA	NA	NA	1	853	1	853	NA	NA	1	853	
40	TCGA-ZC-AAAA	0	3	0	1	0	0	0	0	1	13	2	0	1	4	1	0	TCGA-ZC-AAAA-01	51	2.674620850672939e-05	15	TCGA-ZC-AAAA-01	0	0	10	0.0006561981442530036	TCGA-ZC-AAAA-01	0	0	0	0	PASS	10471	TCGA-ZC-AAAA	THYM	39	MALE	WHITE	NA	IIb	Thymoma; Type B2	NA	2012	NA	-14429	Alive	TUMOR FREE	819	NA	NA	Locoregional Recurrence	"Other, specify"	Mediastinum	137	NA	NA	NA	0	819	0	819	NA	NA	1	137	
70	TCGA-ZC-AAAF	1	9	0	4	1	0	0	0	1	17	0	0	0	8	1	0	TCGA-ZC-AAAF-01	51	0.018830698400127386	12	TCGA-ZC-AAAF-01	0	2	36	0.0472882355010596	TCGA-ZC-AAAF-01	3	3	3	9	PASS	10472	TCGA-ZC-AAAF	THYM	74	FEMALE	WHITE	NA	IIb	Thymoma; Type AB	NA	2011	NA	-27099	Alive	TUMOR FREE	1165	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1165	0	1165	NA	NA	0	1165	
50	TCGA-ZC-AAAH	0	1	0	2	0	0	0	0	0	10	0	0	0	4	0	0	TCGA-ZC-AAAH-01	63	2.259736667059965e-05	21	TCGA-ZC-AAAH-01	0	0	12	0.0007663757497259084	TCGA-ZC-AAAH-01	0	0	0	0	PASS	10473	TCGA-ZC-AAAH	THYM	52	MALE	WHITE	NA	IIb	Thymoma; Type B2	NA	2013	NA	-19146	Alive	TUMOR FREE	497	NA	NA	Locoregional Recurrence	"Other, specify"	Mediastinum	166	NA	NA	NA	0	497	0	497	NA	NA	1	166	
60	TCGA-ZL-A9V6	1	5	0	2	1	0	0	0	1	19	4	0	1	7	0	0	TCGA-ZL-A9V6-01	55	1.835220538410421e-05	17	TCGA-ZL-A9V6-01	0	0	7	0.0012386075357659124	TCGA-ZL-A9V6-01	0	0	0	0	PASS	10474	TCGA-ZL-A9V6	THYM	61	MALE	WHITE	NA	I	Thymoma; Type AB	NA	2008	NA	-22447	Alive	TUMOR FREE	2096	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2096	0	2096	NA	NA	0	2096	
70	TCGA-ZT-A8OM	1	9	0	0	1	0	0	0	2	19	0	0	1	5	1	0	TCGA-ZT-A8OM-01	36	0.011005967648598392	9	TCGA-ZT-A8OM-01	0	0	12	0.001259545544254799	TCGA-ZT-A8OM-01	0	0	0	0	PASS	10475	TCGA-ZT-A8OM	THYM	73	FEMALE	WHITE	NA	IIb	Thymoma; Type A	NA	2011	NA	-26923	Alive	TUMOR FREE	1398	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1398	0	1398	NA	NA	0	1398	
60	TCGA-2E-A9G8	2	24	1	4	4	1	9	0	3	43	6	0	0	17	2	0	TCGA-2E-A9G8-01	407	0.8778857414744374	262	TCGA-2E-A9G8-01	9	12	175	0.2566527725228837	TCGA-2E-A9G8-01	15	11	14	40	PASS	10476	TCGA-2E-A9G8	UCEC	59	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage III	Endometrioid endometrial adenocarcinoma	G2	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	NA	Alive	TUMOR FREE	1249	NA	NA	Locoregional Recurrence	"Other, specify"	abdominal wall	335	Progressive Disease	NA	NA	0	1249	0	1249	NA	NA	1	335	
50	TCGA-4E-A92E	8	42	5	10	5	2	1	0	11	126	8	0	8	44	1	0	TCGA-4E-A92E-01	68	0.03414354591043468	29	TCGA-4E-A92E-01	1	1	5	0.00019834282206237643	TCGA-4E-A92E-01	1	0	0	1	PASS	10477	TCGA-4E-A92E	UCEC	54	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage I	Endometrioid endometrial adenocarcinoma	G1	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19818	Alive	TUMOR FREE	13	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	13	0	13	0	13	0	13	
70	TCGA-5B-A90C	0	16	0	1	3	0	1	0	2	39	2	0	0	15	2	0	TCGA-5B-A90C-01	540	0.7290030244030743	336	TCGA-5B-A90C-01	20	27	131	0.20069045500976085	TCGA-5B-A90C-01	16	13	13	42	PASS	10478	TCGA-5B-A90C	UCEC	69	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25518	Alive	TUMOR FREE	1202	NA	NA	Locoregional Recurrence	"Other, specify"	right pelvic mass	517	NA	NA	NA	0	1202	0	1202	NA	NA	1	517	
50	TCGA-5S-A9Q8	3	19	1	2	4	3	1	0	2	36	5	0	4	11	1	0	TCGA-5S-A9Q8-01	49	0.05806193238969583	11	TCGA-5S-A9Q8-01	1	2	9	0.02623230862692288	TCGA-5S-A9Q8-01	2	2	1	5	PASS	10479	TCGA-5S-A9Q8	UCEC	51	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2013	[Unknown]	-18785	Alive	NA	313	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	313	0	313	0	313	0	313	
70	TCGA-A5-A0G1	73	962	68	404	17	18	0	0	470	9576	798	3	240	3599	321	14	TCGA-A5-A0G1-01	39	7.156772339751e-05	4	TCGA-A5-A0G1	0	0	0	0	TCGA-A5-A0G1	0	0	0	0	hypermutated sample	10480	TCGA-A5-A0G1	UCEC	67	FEMALE	WHITE	NA	Stage IA	Serous endometrial adenocarcinoma	G3	1996	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24477	Dead	TUMOR FREE	NA	3251	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	3251	0	3251	0	3251	0	3251	
60	TCGA-A5-A0G2	181	2862	120	661	37	88	0	0	1242	22990	1804	5	412	9055	582	8	TCGA-A5-A0G2-01	113	0.43029177405292857	50	TCGA-A5-A0G2-01	12	8	19	0.2696832725975816	TCGA-A5-A0G2-01	5	2	4	11	mutation call filter	10481	TCGA-A5-A0G2	UCEC	57	FEMALE	ASIAN	NA	Stage IIIB	Serous endometrial adenocarcinoma	G3	1997	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20953	Alive	WITH TUMOR	4549	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4549	0	4549	0	4549	0	4549	
60	TCGA-A5-A0G3	1	5	0	1	0	0	2	0	1	31	3	0	2	12	0	0	TCGA-A5-A0G3	0	0	0	TCGA-A5-A0G3	0	0	0	0	TCGA-A5-A0G3	0	0	0	0	mutation call filter	10482	TCGA-A5-A0G3	UCEC	61	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22421	Alive	WITH TUMOR	1428	NA	NA	NA	NA	NA	795	Complete Remission/Response	NA	NA	0	1428	0	1428	1	795	1	795	
70	TCGA-A5-A0G5	0	14	1	2	1	2	0	0	8	107	10	0	8	32	4	0	TCGA-A5-A0G5-01	880	0.9695646171392964	596	TCGA-A5-A0G5-01	14	45	205	0.29118401168524244	TCGA-A5-A0G5-01	25	21	16	62	mutation call filter	10483	TCGA-A5-A0G5	UCEC	73	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26827	Alive	TUMOR FREE	1126	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1126	0	1126	0	1126	0	1126	
80	TCGA-A5-A0G9	1	34	0	11	48	9	4	1	17	343	16	3	4	106	12	0	TCGA-A5-A0G9-01	68	0.03410200797511667	29	TCGA-A5-A0G9-01	1	2	19	0.020247749412368628	TCGA-A5-A0G9-01	2	1	1	4	mutation call filter	10484	TCGA-A5-A0G9	UCEC	79	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29122	Alive	TUMOR FREE	2540	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2540	0	2540	0	2540	0	2540	
70	TCGA-A5-A0GA	3	39	2	6	39	10	7	0	21	222	13	0	4	92	4	0	TCGA-A5-A0GA-01	55	0.039133504477313986	16	TCGA-A5-A0GA-01	1	2	4	0.00942435884284895	TCGA-A5-A0GA-01	2	3	0	5	mutation call filter	10485	TCGA-A5-A0GA	UCEC	67	FEMALE	WHITE	NA	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24659	Dead	WITH TUMOR	NA	543	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	543	1	543	NA	NA	1	543	
70	TCGA-A5-A0GB	5	100	6	27	120	23	9	1	32	475	27	0	12	210	14	0	TCGA-A5-A0GB-01	63	0.03458525543830626	19	TCGA-A5-A0GB-01	1	1	19	0.002925200404760249	TCGA-A5-A0GB-01	2	1	0	3	mutation call filter	10486	TCGA-A5-A0GB	UCEC	65	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23883	Alive	TUMOR FREE	997	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	997	0	997	0	997	0	997	
80	TCGA-A5-A0GD	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A5-A0GD-01	1404	0.005285336982202844	1335	TCGA-A5-A0GD-01	0	0	54	0.0006009953121877648	TCGA-A5-A0GD-01	0	0	0	0	PASS	10487	TCGA-A5-A0GD	UCEC	75	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	1999	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27399	Dead	TUMOR FREE	NA	3423	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	3423	0	3423	0	3423	0	3423	
40	TCGA-A5-A0GE	0	0	1	0	3	1	1	0	0	26	1	1	0	7	0	0	TCGA-A5-A0GE-01	89	0.14207419157391032	30	TCGA-A5-A0GE-01	6	13	6	0.2041728910757512	TCGA-A5-A0GE-01	0	0	0	0	mutation call filter	10488	TCGA-A5-A0GE	UCEC	38	FEMALE	ASIAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2002	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14170	Alive	TUMOR FREE	3205	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3205	0	3205	0	3205	0	3205	
80	TCGA-A5-A0GG	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A5-A0GG-01	73	0.11080953606298782	26	TCGA-A5-A0GG-01	3	3	5	0.07518288982031363	TCGA-A5-A0GG-01	3	5	4	12	PASS	10489	TCGA-A5-A0GG	UCEC	76	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27809	Alive	TUMOR FREE	3762	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3762	0	3762	0	3762	0	3762	
60	TCGA-A5-A0GH	4	48	0	14	81	15	8	1	32	297	15	1	7	142	9	1	TCGA-A5-A0GH-01	121	0.003826606844687944	56	TCGA-A5-A0GH-01	0	0	19	0.003690399818352528	TCGA-A5-A0GH-01	0	2	0	2	mutation call filter	10490	TCGA-A5-A0GH	UCEC	57	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21090	Alive	TUMOR FREE	2254	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2254	0	2254	0	2254	0	2254	
60	TCGA-A5-A0GI	2	30	1	12	45	9	4	0	12	250	21	0	5	107	10	0	TCGA-A5-A0GI-01	64	0.043902594929453816	22	TCGA-A5-A0GI-01	1	3	19	0.0490010263908093	TCGA-A5-A0GI-01	1	0	0	1	mutation call filter	10491	TCGA-A5-A0GI	UCEC	63	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23195	Alive	TUMOR FREE	2682	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2682	0	2682	0	2682	0	2682	
40	TCGA-A5-A0GJ	1	3	0	2	1	1	0	0	1	54	3	0	3	20	2	0	TCGA-A5-A0GJ-01	466	0.8494873440298696	315	TCGA-A5-A0GJ-01	9	15	59	0.3017924520466857	TCGA-A5-A0GJ-01	20	17	17	54	mutation call filter	10492	TCGA-A5-A0GJ	UCEC	44	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16421	Alive	TUMOR FREE	2000	NA	NA	NA	NA	NA	12	Complete Remission/Response	NA	NA	0	2000	0	2000	1	12	1	12	
50	TCGA-A5-A0GM	0	4	0	1	2	2	0	0	1	34	3	0	1	7	1	0	TCGA-A5-A0GM-01	43	0.00017124070858827968	6	TCGA-A5-A0GM-01	0	0	0	0.0	TCGA-A5-A0GM-01	0	0	0	0	mutation call filter	10493	TCGA-A5-A0GM	UCEC	53	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19452	Alive	TUMOR FREE	1841	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1841	0	1841	0	1841	0	1841	
70	TCGA-A5-A0GN	0	3	0	2	0	2	1	0	3	51	1	0	2	13	1	0	TCGA-A5-A0GN-01	76	0.9471979584317616	30	TCGA-A5-A0GN-01	25	37	2	0.05292139481003219	TCGA-A5-A0GN-01	1	0	0	1	mutation call filter	10494	TCGA-A5-A0GN	UCEC	65	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24020	Alive	TUMOR FREE	1841	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1841	0	1841	0	1841	0	1841	
60	TCGA-A5-A0GP	12	213	10	43	0	7	0	0	66	1269	162	1	29	411	15	0	TCGA-A5-A0GP-01	73	0.00012351821315597042	30	TCGA-A5-A0GP-01	0	0	19	9.74867782230353e-05	TCGA-A5-A0GP-01	0	0	0	0	mutation call filter	10495	TCGA-A5-A0GP	UCEC	58	FEMALE	ASIAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21365	Alive	TUMOR FREE	1416	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1416	0	1416	0	1416	0	1416	
80	TCGA-A5-A0GQ	0	3	0	2	3	2	2	1	1	44	4	0	4	25	0	0	TCGA-A5-A0GQ-01	39	4.2619108999664685e-06	7	TCGA-A5-A0GQ-01	0	0	19	0.016003846006666038	TCGA-A5-A0GQ-01	1	1	1	3	PASS	10496	TCGA-A5-A0GQ	UCEC	76	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28078	Alive	TUMOR FREE	2247	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2247	0	2247	0	2247	0	2247	
70	TCGA-A5-A0GR	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A5-A0GR-01	383	0.4182073494102776	246	TCGA-A5-A0GR-01	8	12	33	0.2845413012426174	TCGA-A5-A0GR-01	11	13	12	36	PASS	10497	TCGA-A5-A0GR	UCEC	69	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25353	Alive	TUMOR FREE	1120	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1120	0	1120	0	1120	0	1120	
60	TCGA-A5-A0GU	1	8	0	0	2	2	0	0	2	34	2	0	2	10	2	0	TCGA-A5-A0GU-01	73	0.11245946962156762	22	TCGA-A5-A0GU-01	4	3	0	0.0	TCGA-A5-A0GU-01	2	0	0	2	mutation call filter	10498	TCGA-A5-A0GU	UCEC	58	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21192	Alive	TUMOR FREE	860	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	860	0	860	0	860	0	860	
70	TCGA-A5-A0GV	1	5	1	1	1	1	2	0	2	36	5	0	0	13	1	0	TCGA-A5-A0GV-01	74	0.895066398150287	28	TCGA-A5-A0GV-01	7	4	19	2.1732784455461148e-05	TCGA-A5-A0GV-01	1	0	0	1	mutation call filter	10499	TCGA-A5-A0GV	UCEC	67	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24540	Alive	TUMOR FREE	1643	NA	NA	NA	NA	NA	304	Complete Remission/Response	NA	NA	0	1643	0	1643	1	304	1	304	
50	TCGA-A5-A0GW	2	37	0	6	60	7	6	1	15	211	14	0	5	121	4	1	TCGA-A5-A0GW-01	89	0.0502151122187704	44	TCGA-A5-A0GW-01	2	1	7	0.0003697573265535162	TCGA-A5-A0GW-01	0	0	0	0	mutation call filter	10500	TCGA-A5-A0GW	UCEC	46	FEMALE	ASIAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17092	Alive	TUMOR FREE	706	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	706	0	706	0	706	0	706	
50	TCGA-A5-A0GX	0	2	1	0	0	0	1	0	0	28	3	0	2	10	0	0	TCGA-A5-A0GX-01	61	0.029858480733149832	22	TCGA-A5-A0GX-01	0	1	2	0.0007750125621628951	TCGA-A5-A0GX-01	2	1	0	3	mutation call filter	10501	TCGA-A5-A0GX	UCEC	53	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19625	Alive	TUMOR FREE	2088	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2088	0	2088	0	2088	0	2088	
60	TCGA-A5-A0R6	1	1	1	2	3	1	0	0	4	39	3	0	2	15	0	0	TCGA-A5-A0R6-01	293	0.8505981975066504	187	TCGA-A5-A0R6-01	17	15	24	0.09647042751321933	TCGA-A5-A0R6-01	9	6	5	20	PASS	10502	TCGA-A5-A0R6	UCEC	64	FEMALE	WHITE	NA	Stage IIIC1	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23449	Alive	TUMOR FREE	1153	NA	NA	New Primary Tumor	"Other, specify"	Rectum	961	Complete Remission/Response	NA	NA	0	1153	0	1153	0	1153	1	961	
60	TCGA-A5-A0R7	0	3	0	3	3	3	0	0	1	55	5	0	1	28	3	0	TCGA-A5-A0R7-01	107	0.5323921596575386	46	TCGA-A5-A0R7-01	10	9	13	0.2099487245662865	TCGA-A5-A0R7-01	3	1	1	5	PASS	10503	TCGA-A5-A0R7	UCEC	55	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20250	Alive	TUMOR FREE	535	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	535	0	535	0	535	0	535	
80	TCGA-A5-A0R8	0	1	0	2	6	2	2	0	3	59	5	0	0	18	3	0	TCGA-A5-A0R8-01	55	2.1323628125370512e-05	15	TCGA-A5-A0R8-01	0	0	0	0.0	TCGA-A5-A0R8-01	0	0	0	0	PASS	10504	TCGA-A5-A0R8	UCEC	81	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29777	Alive	TUMOR FREE	596	NA	NA	NA	NA	NA	42	Complete Remission/Response	NA	NA	0	596	0	596	1	42	1	42	
50	TCGA-A5-A0R9	0	4	0	2	3	1	1	0	2	37	1	0	1	10	1	0	TCGA-A5-A0R9-01	47	0.046539528584892915	10	TCGA-A5-A0R9-01	2	1	0	0.0	TCGA-A5-A0R9-01	0	0	0	0	PASS	10505	TCGA-A5-A0R9	UCEC	51	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18982	Alive	TUMOR FREE	749	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	749	0	749	0	749	0	749	
70	TCGA-A5-A0RA	0	5	1	1	4	3	2	1	0	63	2	0	0	15	1	0	TCGA-A5-A0RA-01	47	0.0017930660931660426	11	TCGA-A5-A0RA-01	0	0	0	0.0	TCGA-A5-A0RA-01	0	0	0	0	PASS	10506	TCGA-A5-A0RA	UCEC	68	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25060	Alive	TUMOR FREE	884	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	884	0	884	0	884	0	884	
60	TCGA-A5-A0VO	0	3	0	2	4	0	2	0	3	49	6	0	2	28	2	0	TCGA-A5-A0VO	0	0	0	TCGA-A5-A0VO	0	0	0	0	TCGA-A5-A0VO	0	0	0	0	PASS	10507	TCGA-A5-A0VO	UCEC	64	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23547	Dead	TUMOR FREE	NA	875	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	875	0	875	0	875	0	875	
70	TCGA-A5-A0VP	10	116	6	32	18	13	1	0	42	1307	85	1	16	596	30	2	TCGA-A5-A0VP-01	57	0.08125231757954303	13	TCGA-A5-A0VP-01	3	2	2	0.08566491553410753	TCGA-A5-A0VP-01	0	0	0	0	PASS	10508	TCGA-A5-A0VP	UCEC	74	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27335	Alive	TUMOR FREE	1288	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1288	0	1288	0	1288	0	1288	
60	TCGA-A5-A0VQ	4	39	2	15	58	16	3	1	16	262	16	0	5	109	11	0	TCGA-A5-A0VQ-01	47	7.095134344295075e-05	14	TCGA-A5-A0VQ-01	0	0	19	6.779775261203475e-05	TCGA-A5-A0VQ-01	0	0	0	0	PASS	10509	TCGA-A5-A0VQ	UCEC	62	FEMALE	NA	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22995	Alive	TUMOR FREE	485	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	485	0	485	0	485	0	485	
50	TCGA-A5-A1OF	238	2854	107	413	24	45	1	0	657	9427	632	6	345	3733	269	10	TCGA-A5-A1OF-01	69	0.0008541327317933832	23	TCGA-A5-A1OF-01	0	0	5	0.0006705043092668173	TCGA-A5-A1OF-01	0	0	0	0	hypermutated sample	10510	TCGA-A5-A1OF	UCEC	47	FEMALE	NA	NA	Stage IA	Mixed serous and endometrioid	High Grade	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17308	Alive	TUMOR FREE	973	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	973	0	973	0	973	0	973	
70	TCGA-A5-A1OG	0	2	0	1	0	0	0	0	2	34	2	0	0	6	0	0	TCGA-A5-A1OG-01	359	0.89301110875189	217	TCGA-A5-A1OG-01	18	30	50	0.18627815978937146	TCGA-A5-A1OG-01	18	13	12	43	PASS	10511	TCGA-A5-A1OG	UCEC	65	FEMALE	ASIAN	NA	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23956	Dead	WITH TUMOR	NA	973	NA	Metastatic	Lung	NA	337	Complete Remission/Response	NA	NA	1	973	1	973	1	337	1	337	
90	TCGA-A5-A1OH	6	31	1	4	2	1	1	0	10	98	6	0	3	42	4	0	TCGA-A5-A1OH-01	592	0.7637185196387761	393	TCGA-A5-A1OH	0	0	0	0	TCGA-A5-A1OH	0	0	0	0	PASS	10512	TCGA-A5-A1OH	UCEC	86	FEMALE	WHITE	NA	Stage IIIA	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31451	Alive	TUMOR FREE	1105	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1105	0	1105	0	1105	0	1105	
30	TCGA-A5-A1OJ	0	6	1	2	1	1	0	0	5	54	4	0	3	14	1	1	TCGA-A5-A1OJ-01	50	0.08100913556787921	10	TCGA-A5-A1OJ-01	3	2	0	0.0	TCGA-A5-A1OJ-01	1	0	0	1	PASS	10513	TCGA-A5-A1OJ	UCEC	31	FEMALE	ASIAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11635	Alive	TUMOR FREE	1006	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1006	0	1006	0	1006	0	1006	
60	TCGA-A5-A1OK	2	9	2	1	4	0	0	0	1	56	3	1	1	14	0	0	TCGA-A5-A1OK-01	48	0.034163847176239465	10	TCGA-A5-A1OK-01	2	8	2	0.03139863400089319	TCGA-A5-A1OK-01	1	0	0	1	PASS	10514	TCGA-A5-A1OK	UCEC	63	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23179	Alive	TUMOR FREE	917	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	917	0	917	0	917	0	917	
80	TCGA-A5-A2K2	2	34	3	8	3	0	0	1	5	104	10	0	0	30	4	0	TCGA-A5-A2K2-01	341	0.7310958668452141	222	TCGA-A5-A2K2-01	14	18	25	0.06589126652643558	TCGA-A5-A2K2-01	15	11	3	29	PASS	10515	TCGA-A5-A2K2	UCEC	77	FEMALE	WHITE	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28456	Alive	TUMOR FREE	3595	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3595	0	3595	0	3595	0	3595	
70	TCGA-A5-A2K3	20	294	15	47	36	9	1	1	62	1088	61	0	38	522	20	2	TCGA-A5-A2K3-01	64	0.3258095912964278	23	TCGA-A5-A2K3-01	18	17	3	0.04321647486928379	TCGA-A5-A2K3-01	4	0	1	5	PASS	10516	TCGA-A5-A2K3	UCEC	68	FEMALE	WHITE	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24907	Alive	TUMOR FREE	2012	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2012	0	2012	0	2012	0	2012	
70	TCGA-A5-A2K4	1	7	0	2	0	0	0	1	1	28	0	0	1	12	0	0	TCGA-A5-A2K4-01	334	0.7110045884475775	224	TCGA-A5-A2K4-01	30	16	54	0.10147161031421516	TCGA-A5-A2K4-01	7	5	3	15	PASS	10517	TCGA-A5-A2K4	UCEC	69	FEMALE	WHITE	NA	Stage IIIA	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25270	Dead	WITH TUMOR	NA	871	NA	Metastatic	"Other, specify"	Bowel	528	Complete Remission/Response	NA	NA	1	871	1	871	1	528	1	528	
80	TCGA-A5-A2K5	232	3168	76	314	4	21	0	0	566	7188	1086	10	350	2017	164	5	TCGA-A5-A2K5-01	37	6.119918142087963e-05	7	TCGA-A5-A2K5-01	0	0	19	5.7217465881620274e-05	TCGA-A5-A2K5-01	0	0	0	0	hypermutated sample	10518	TCGA-A5-A2K5	UCEC	76	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28057	Alive	TUMOR FREE	752	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	752	0	752	0	752	0	752	
40	TCGA-A5-A2K7	18	299	10	36	115	22	11	1	49	425	27	0	15	217	10	1	TCGA-A5-A2K7-01	99	0.00041610694681702416	48	TCGA-A5-A2K7-01	0	0	2	7.849143838415891e-05	TCGA-A5-A2K7-01	0	0	0	0	PASS	10519	TCGA-A5-A2K7	UCEC	41	FEMALE	NA	NA	Stage II	Endometrioid endometrial adenocarcinoma	G3	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14980	Alive	TUMOR FREE	1063	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1063	0	1063	0	1063	0	1063	
60	TCGA-A5-A3LO	0	6	1	6	1	2	0	0	0	25	1	0	0	9	1	0	TCGA-A5-A3LO-01	51	0.5140757321876867	14	TCGA-A5-A3LO-01	25	20	15	0.4383870300587141	TCGA-A5-A3LO-01	2	2	0	4	PASS	10520	TCGA-A5-A3LO	UCEC	64	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23401	Alive	TUMOR FREE	776	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	776	0	776	0	776	0	776	
70	TCGA-A5-A3LP	0	11	0	2	1	1	0	0	3	44	1	0	3	17	1	0	TCGA-A5-A3LP-01	364	0.6644756094362072	220	TCGA-A5-A3LP-01	16	26	38	0.15068359575469092	TCGA-A5-A3LP-01	16	14	6	36	PASS	10521	TCGA-A5-A3LP	UCEC	74	FEMALE	WHITE	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27131	Alive	TUMOR FREE	455	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	455	0	455	0	455	0	455	
60	TCGA-A5-A7WJ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-A5-A7WJ-01	74	0.034584577738031384	28	TCGA-A5-A7WJ	0	0	0	0	TCGA-A5-A7WJ	0	0	0	0	PASS	10522	TCGA-A5-A7WJ	UCEC	64	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23723	Alive	TUMOR FREE	341	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	341	0	341	0	341	0	341	
70	TCGA-A5-A7WK	0	27	1	9	2	0	0	1	7	57	1	0	2	19	3	0	TCGA-A5-A7WK-01	656	0.946592752847374	453	TCGA-A5-A7WK-01	5	9	187	0.1972654916295415	TCGA-A5-A7WK-01	11	7	11	29	PASS	10523	TCGA-A5-A7WK	UCEC	71	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Mixed serous and endometrioid	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26044	Alive	WITH TUMOR	560	NA	NA	Locoregional Recurrence	"Other, specify"	Paraaortic lymph node	350	Complete Remission/Response	NA	NA	0	560	0	560	1	350	1	350	
50	TCGA-A5-AB3J	0	7	0	1	1	1	1	0	0	35	3	0	3	13	2	0	TCGA-A5-AB3J-01	44	0.1191648903531482	6	TCGA-A5-AB3J-01	4	6	13	0.03141122733703498	TCGA-A5-AB3J-01	1	1	1	3	PASS	10524	TCGA-A5-AB3J	UCEC	52	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage II	Endometrioid endometrial adenocarcinoma	G2	2013	Peri (6-12 months since last menstrual period)	-19020	Alive	TUMOR FREE	512	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	512	0	512	0	512	0	512	
60	TCGA-AJ-A23M	0	6	1	3	3	1	0	1	5	88	9	0	2	40	3	0	TCGA-AJ-A23M-01	490	0.7294800742376333	309	TCGA-AJ-A23M-01	20	24	71	0.1808140699811068	TCGA-AJ-A23M-01	17	8	7	32	PASS	10525	TCGA-AJ-A23M	UCEC	61	FEMALE	WHITE	NA	Stage II	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22430	Dead	WITH TUMOR	NA	616	NA	Locoregional Recurrence	"Other, specify"	Abdominal Fluid	516	Stable Disease	NA	NA	1	616	1	616	NA	NA	1	516	
70	TCGA-AJ-A23N	3	7	1	1	2	0	1	0	3	41	1	0	1	9	0	0	TCGA-AJ-A23N-01	274	0.5938758763074027	162	TCGA-AJ-A23N-01	17	30	22	0.1130833489623478	TCGA-AJ-A23N-01	13	9	6	28	PASS	10526	TCGA-AJ-A23N	UCEC	70	FEMALE	WHITE	NA	Stage IIIA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25772	Dead	WITH TUMOR	NA	439	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	439	1	439	NA	NA	1	439	
70	TCGA-AJ-A23O	19	331	10	47	109	24	8	0	69	659	34	2	27	229	18	2	TCGA-AJ-A23O-01	54	0.1019184932826702	16	TCGA-AJ-A23O-01	3	6	3	0.09343165263266244	TCGA-AJ-A23O-01	3	3	2	8	PASS	10527	TCGA-AJ-A23O	UCEC	69	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25433	Dead	TUMOR FREE	NA	312	NA	NA	NA	NA	NA	NA	NA	NA	1	312	0	312	NA	NA	0	312	
70	TCGA-AJ-A2QK	1	15	1	4	0	0	1	0	0	60	7	0	5	24	2	0	TCGA-AJ-A2QK-01	120	0.5812007497104009	57	TCGA-AJ-A2QK-01	6	12	21	0.2694897809480973	TCGA-AJ-A2QK-01	12	8	9	29	PASS	10528	TCGA-AJ-A2QK	UCEC	65	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23945	Alive	WITH TUMOR	643	NA	NA	Distant Metastasis	Liver	NA	606	Complete Remission/Response	NA	NA	0	643	0	643	1	606	1	606	
60	TCGA-AJ-A2QL	1	17	0	0	4	2	0	0	5	64	10	0	4	24	2	0	TCGA-AJ-A2QL-01	33	0.01101546657489728	3	TCGA-AJ-A2QL-01	1	1	19	0.01159735923306897	TCGA-AJ-A2QL-01	0	0	0	0	PASS	10529	TCGA-AJ-A2QL	UCEC	60	FEMALE	WHITE	NA	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22057	Alive	TUMOR FREE	602	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	602	0	602	0	602	0	602	
70	TCGA-AJ-A2QM	1	44	5	8	2	1	1	0	8	159	13	1	4	56	1	0	TCGA-AJ-A2QM-01	312	0.9037576409241329	192	TCGA-AJ-A2QM-01	11	17	53	0.2098323386289836	TCGA-AJ-A2QM-01	16	9	6	31	PASS	10530	TCGA-AJ-A2QM	UCEC	67	FEMALE	WHITE	NA	Stage II	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24776	Alive	TUMOR FREE	894	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	894	0	894	0	894	0	894	
60	TCGA-AJ-A2QN	2	17	3	5	0	0	0	1	2	48	2	0	4	21	1	0	TCGA-AJ-A2QN-01	57	0.15580818865902354	16	TCGA-AJ-A2QN-01	6	4	5	0.0300850354975476	TCGA-AJ-A2QN-01	0	2	2	4	PASS	10531	TCGA-AJ-A2QN	UCEC	60	FEMALE	WHITE	NA	Stage II	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21915	Alive	TUMOR FREE	1069	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1069	0	1069	0	1069	0	1069	
90	TCGA-AJ-A2QO	33	464	17	70	252	59	13	1	100	738	40	0	46	333	20	0	TCGA-AJ-A2QO-01	43	1.1291652451117724e-05	9	TCGA-AJ-A2QO-01	0	0	19	5.110830329364752e-06	TCGA-AJ-A2QO-01	0	0	0	0	PASS	10532	TCGA-AJ-A2QO	UCEC	85	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31222	Dead	TUMOR FREE	NA	1045	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1045	0	1045	0	1045	0	1045	
60	TCGA-AJ-A3BD	0	16	0	5	0	3	2	1	4	65	2	1	0	20	2	0	TCGA-AJ-A3BD-01	316	0.7151677269617418	202	TCGA-AJ-A3BD-01	17	25	26	0.04791473020353732	TCGA-AJ-A3BD-01	17	10	1	28	PASS	10533	TCGA-AJ-A3BD	UCEC	57	FEMALE	WHITE	NA	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20998	Alive	TUMOR FREE	1039	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1039	0	1039	0	1039	0	1039	
70	TCGA-AJ-A3BF	0	12	0	2	3	0	2	0	1	18	2	0	2	10	1	0	TCGA-AJ-A3BF-01	416	0.6372993433326032	271	TCGA-AJ-A3BF-01	11	12	102	0.20835247225756634	TCGA-AJ-A3BF-01	9	8	7	24	PASS	10534	TCGA-AJ-A3BF	UCEC	65	FEMALE	WHITE	NA	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23906	Alive	TUMOR FREE	551	NA	NA	Locoregional Recurrence	"Other, specify"	Retroperitoneal LNs	384	Complete Remission/Response	NA	NA	0	551	0	551	1	384	1	384	
70	TCGA-AJ-A3BG	34	411	12	51	168	34	21	1	89	984	52	0	39	441	14	1	TCGA-AJ-A3BG-01	66	0.033908614499618614	19	TCGA-AJ-A3BG-01	1	1	3	0.011793209591323598	TCGA-AJ-A3BG-01	0	0	0	0	PASS	10535	TCGA-AJ-A3BG	UCEC	65	FEMALE	WHITE	NA	Stage IA	Mixed serous and endometrioid	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23861	Alive	WITH TUMOR	550	NA	NA	Locoregional Recurrence	"Other, specify"	Vagina	480	Complete Remission/Response	NA	NA	0	550	0	550	1	480	1	480	
NA	TCGA-AJ-A3BH	66	834	23	94	255	43	26	0	174	2192	109	0	101	918	41	2	TCGA-AJ-A3BH-01	53	0.1476230184032096	13	TCGA-AJ-A3BH-01	4	3	4	0.01415460049317335	TCGA-AJ-A3BH-01	2	2	2	6	hypermutated sample	10536	TCGA-AJ-A3BH	UCEC	NA	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	NA	Alive	TUMOR FREE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	0	NA	NA	NA	0	NA	
70	TCGA-AJ-A3BI	0	5	0	3	2	0	0	0	1	34	3	0	1	9	1	0	TCGA-AJ-A3BI-01	169	0.4838852148735263	82	TCGA-AJ-A3BI-01	19	20	35	0.2197124998540505	TCGA-AJ-A3BI-01	5	5	1	11	PASS	10537	TCGA-AJ-A3BI	UCEC	67	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24623	Alive	TUMOR FREE	575	NA	NA	Locoregional Recurrence	"Other, specify"	Anterior Abd. Mass	373	NA	NA	NA	0	575	0	575	NA	NA	1	373	
70	TCGA-AJ-A3BK	0	17	0	1	3	0	2	0	5	48	4	0	2	17	1	0	TCGA-AJ-A3BK-01	77	0.13334885641002545	24	TCGA-AJ-A3BK-01	4	2	19	2.5106365902258772e-05	TCGA-AJ-A3BK-01	0	0	0	0	PASS	10538	TCGA-AJ-A3BK	UCEC	68	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24943	Alive	TUMOR FREE	1031	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1031	0	1031	0	1031	0	1031	
70	TCGA-AJ-A3EJ	1	15	0	2	3	0	2	0	4	46	2	0	3	17	1	0	TCGA-AJ-A3EJ-01	304	0.6707197400055159	198	TCGA-AJ-A3EJ-01	18	23	61	0.2873995501988995	TCGA-AJ-A3EJ-01	15	9	6	30	PASS	10539	TCGA-AJ-A3EJ	UCEC	74	FEMALE	WHITE	NA	Stage IIIC2	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27317	Dead	WITH TUMOR	NA	50	NA	NA	NA	NA	NA	NA	NA	NA	1	50	1	50	NA	NA	1	50	
50	TCGA-AJ-A3EK	148	1893	76	214	60	74	1	0	416	5005	385	3	186	1885	155	5	TCGA-AJ-A3EK-01	55	0.00021387078843677223	17	TCGA-AJ-A3EK-01	0	0	19	1.6100734774892885e-05	TCGA-AJ-A3EK-01	0	0	0	0	hypermutated sample	10540	TCGA-AJ-A3EK	UCEC	53	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Peri (6-12 months since last menstrual period)	-19609	Alive	TUMOR FREE	446	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	446	0	446	0	446	0	446	
50	TCGA-AJ-A3EL	183	2510	80	293	3	40	0	0	515	6490	722	2	287	2165	99	3	TCGA-AJ-A3EL-01	111	0.0007862780961901236	48	TCGA-AJ-A3EL-01	0	0	5	0.00022772088007696732	TCGA-AJ-A3EL-01	0	0	0	0	hypermutated sample	10541	TCGA-AJ-A3EL	UCEC	47	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17442	Alive	TUMOR FREE	684	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	684	0	684	0	684	0	684	
70	TCGA-AJ-A3EM	4	13	0	5	0	2	0	0	4	41	4	0	2	11	4	0	TCGA-AJ-A3EM-01	671	0.6617254056887596	453	TCGA-AJ-A3EM-01	19	22	158	0.2825327216472762	TCGA-AJ-A3EM-01	10	16	8	34	PASS	10542	TCGA-AJ-A3EM	UCEC	69	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25557	Alive	TUMOR FREE	677	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	677	0	677	0	677	0	677	
50	TCGA-AJ-A3I9	0	11	1	2	1	0	1	0	2	23	1	0	0	9	1	0	TCGA-AJ-A3I9-01	211	0.4024191358414799	119	TCGA-AJ-A3I9-01	7	5	27	0.1603707047107905	TCGA-AJ-A3I9-01	4	4	3	11	PASS	10543	TCGA-AJ-A3I9	UCEC	52	FEMALE	WHITE	NA	Stage II	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19139	Dead	WITH TUMOR	NA	519	NA	Distant Metastasis	Bone	NA	370	Complete Remission/Response	NA	NA	1	519	1	519	1	370	1	370	
80	TCGA-AJ-A3IA	6	58	3	18	13	2	1	0	10	196	12	0	9	68	4	1	TCGA-AJ-A3IA-01	767	0.9588869332944052	579	TCGA-AJ-A3IA-01	18	43	218	0.3661343811802573	TCGA-AJ-A3IA-01	27	42	16	85	PASS	10544	TCGA-AJ-A3IA	UCEC	77	FEMALE	WHITE	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28470	Alive	TUMOR FREE	633	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	633	0	633	0	633	0	633	
60	TCGA-AJ-A3NC	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AJ-A3NC-01	103	0.08179602513766578	51	TCGA-AJ-A3NC-01	3	3	3	0.00024483437626837625	TCGA-AJ-A3NC-01	1	0	0	1	PASS	10545	TCGA-AJ-A3NC	UCEC	63	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23353	Alive	TUMOR FREE	1125	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1125	0	1125	0	1125	0	1125	
50	TCGA-AJ-A3NE	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AJ-A3NE-01	37	0.05598235025265412	6	TCGA-AJ-A3NE-01	0	0	2	0.006496911625071282	TCGA-AJ-A3NE-01	0	2	1	3	PASS	10546	TCGA-AJ-A3NE	UCEC	46	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16957	Alive	TUMOR FREE	628	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	628	0	628	0	628	0	628	
60	TCGA-AJ-A3NF	2	8	1	5	3	0	0	0	4	41	7	0	2	10	3	0	TCGA-AJ-A3NF-01	208	0.3359394719217443	110	TCGA-AJ-A3NF-01	12	16	15	0.10665827184958096	TCGA-AJ-A3NF-01	11	11	5	27	PASS	10547	TCGA-AJ-A3NF	UCEC	60	FEMALE	WHITE	NA	Stage IIIC	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22210	Alive	TUMOR FREE	645	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	645	0	645	0	645	0	645	
80	TCGA-AJ-A3NG	1	17	1	4	4	0	0	0	5	67	2	0	2	28	0	0	TCGA-AJ-A3NG-01	63	0.1453945279157048	14	TCGA-AJ-A3NG-01	4	4	4	0.030440721130678056	TCGA-AJ-A3NG-01	2	3	2	7	PASS	10548	TCGA-AJ-A3NG	UCEC	83	FEMALE	WHITE	NA	Stage II	Mixed serous and endometrioid	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30351	Alive	TUMOR FREE	475	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	475	0	475	0	475	0	475	
90	TCGA-AJ-A3NH	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AJ-A3NH-01	245	0.8612815171997977	142	TCGA-AJ-A3NH-01	27	17	83	0.4634587124005325	TCGA-AJ-A3NH-01	14	12	16	42	PASS	10549	TCGA-AJ-A3NH	UCEC	90	FEMALE	WHITE	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32871	Dead	TUMOR FREE	NA	310	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	310	0	310	0	310	0	310	
50	TCGA-AJ-A3OJ	28	379	9	39	181	33	22	1	63	601	39	0	24	300	12	2	TCGA-AJ-A3OJ-01	31	0.00031119920004121386	2	TCGA-AJ-A3OJ-01	0	0	19	0.0002309388535138141	TCGA-AJ-A3OJ-01	0	0	0	0	PASS	10550	TCGA-AJ-A3OJ	UCEC	54	FEMALE	WHITE	NA	Stage II	Endometrioid endometrial adenocarcinoma	G3	2011	Indeterminate (neither Pre or Postmenopausal)	-19826	Alive	TUMOR FREE	467	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	467	0	467	0	467	0	467	
70	TCGA-AJ-A3OK	14	116	7	17	10	2	0	0	28	591	45	0	27	289	4	0	TCGA-AJ-A3OK-01	39	3.675833344933194e-05	5	TCGA-AJ-A3OK-01	0	0	19	1.4387413883501391e-05	TCGA-AJ-A3OK-01	0	0	0	0	PASS	10551	TCGA-AJ-A3OK	UCEC	73	FEMALE	WHITE	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26851	Alive	TUMOR FREE	485	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	485	0	485	0	485	0	485	
60	TCGA-AJ-A3OL	13	110	3	11	66	18	4	1	25	197	6	0	10	88	3	0	TCGA-AJ-A3OL-01	76	0.08441212251192218	29	TCGA-AJ-A3OL-01	3	2	0	0.0	TCGA-AJ-A3OL-01	1	0	0	1	PASS	10552	TCGA-AJ-A3OL	UCEC	55	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20115	Dead	WITH TUMOR	NA	449	NA	Distant Metastasis	"Other, specify"	"Lung, Liver, and Brain"	424	Complete Remission/Response	NA	NA	1	449	1	449	1	424	1	424	
60	TCGA-AJ-A3QS	6	69	2	14	3	2	0	0	10	197	23	0	7	66	2	1	TCGA-AJ-A3QS-01	321	0.6565444071897671	185	TCGA-AJ-A3QS-01	16	30	22	0.13795343597529816	TCGA-AJ-A3QS-01	11	13	4	28	PASS	10553	TCGA-AJ-A3QS	UCEC	57	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21162	Alive	TUMOR FREE	513	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	513	0	513	0	513	0	513	
80	TCGA-AJ-A3TW	1	21	1	5	2	0	1	0	5	98	7	0	2	46	4	0	TCGA-AJ-A3TW-01	420	0.6918998479990608	261	TCGA-AJ-A3TW-01	12	34	91	0.2445023733161537	TCGA-AJ-A3TW-01	20	24	12	56	PASS	10554	TCGA-AJ-A3TW	UCEC	78	FEMALE	WHITE	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28559	Alive	TUMOR FREE	513	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	513	0	513	0	513	0	513	
50	TCGA-AJ-A4ZG	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AJ-A4ZG	0	0	0	TCGA-AJ-A4ZG	0	0	0	0	TCGA-AJ-A4ZG	0	0	0	0	PASS	10555	TCGA-AJ-A4ZG	UCEC	53	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IVB	Serous endometrial adenocarcinoma	G3	2012	[Unknown]	-19492	Alive	TUMOR FREE	498	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	498	0	498	NA	NA	0	498	Redacted
70	TCGA-AJ-A5DV	0	17	1	3	4	2	4	0	5	65	5	0	4	14	0	0	TCGA-AJ-A5DV-01	67	2.010853857200124e-05	25	TCGA-AJ-A5DV-01	0	0	5	7.453038145250377e-05	TCGA-AJ-A5DV-01	0	0	0	0	PASS	10556	TCGA-AJ-A5DV	UCEC	65	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23892	Alive	TUMOR FREE	679	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	679	0	679	0	679	0	679	
60	TCGA-AJ-A5DW	83	1176	44	123	2	12	1	1	198	2606	496	1	120	723	64	0	TCGA-AJ-A5DW-01	35	8.770551339244703e-05	2	TCGA-AJ-A5DW-01	0	0	5	0.0007921799859894125	TCGA-AJ-A5DW-01	0	0	0	0	hypermutated sample	10557	TCGA-AJ-A5DW	UCEC	56	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20711	Alive	TUMOR FREE	390	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	390	0	390	0	390	0	390	
60	TCGA-AJ-A6NU	0	9	0	4	2	0	0	0	0	37	3	0	2	16	0	0	TCGA-AJ-A6NU-01	250	0.20938279549371824	158	TCGA-AJ-A6NU-01	5	7	77	0.18271019154527304	TCGA-AJ-A6NU-01	9	6	8	23	PASS	10558	TCGA-AJ-A6NU	UCEC	64	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage II	Endometrioid endometrial adenocarcinoma	G1	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23498	Alive	TUMOR FREE	632	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	632	0	632	0	632	0	632	
60	TCGA-AJ-A8CT	13	137	5	21	53	14	6	0	37	503	44	0	13	216	9	0	TCGA-AJ-A8CT-01	61	0.000356967410325962	25	TCGA-AJ-A8CT-01	0	0	3	0.00018567497459963319	TCGA-AJ-A8CT-01	0	0	0	0	PASS	10559	TCGA-AJ-A8CT	UCEC	58	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21515	Alive	TUMOR FREE	82	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	82	0	82	0	82	0	82	
60	TCGA-AJ-A8CV	6	67	2	15	34	11	2	0	8	156	6	0	6	69	6	1	TCGA-AJ-A8CV-01	37	1.4271606380795944e-05	7	TCGA-AJ-A8CV-01	0	2	19	0.03270091002088013	TCGA-AJ-A8CV-01	1	0	1	2	PASS	10560	TCGA-AJ-A8CV	UCEC	58	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21336	Alive	TUMOR FREE	1068	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1068	0	1068	0	1068	0	1068	
60	TCGA-AJ-A8CW	17	240	10	32	118	25	8	0	55	458	34	0	12	192	14	1	TCGA-AJ-A8CW-01	68	0.5660016001378745	29	TCGA-AJ-A8CW-01	4	6	4	0.00011459289037420205	TCGA-AJ-A8CW-01	5	6	0	11	PASS	10561	TCGA-AJ-A8CW	UCEC	64	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23554	Alive	TUMOR FREE	4	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	4	0	4	NA	NA	0	4	
70	TCGA-AP-A051	66	841	44	201	230	65	5	1	362	7222	472	4	148	2653	226	5	TCGA-AP-A051-01	66	0.034090047729252775	28	TCGA-AP-A051-01	1	4	19	0.049524574821914066	TCGA-AP-A051-01	1	0	0	1	mutation call filter	10562	TCGA-AP-A051	UCEC	69	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25269	Alive	TUMOR FREE	3948	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3948	0	3948	0	3948	0	3948	
60	TCGA-AP-A052	0	0	1	1	0	0	0	0	0	36	4	0	2	10	2	0	TCGA-AP-A052-01	529	0.6588534346142357	342	TCGA-AP-A052-01	5	6	64	0.15993679939672445	TCGA-AP-A052-01	8	3	9	20	mutation call filter	10563	TCGA-AP-A052	UCEC	59	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IVB	Serous endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21721	Dead	WITH TUMOR	NA	669	NA	NA	NA	NA	394	Complete Remission/Response	NA	NA	1	669	1	669	NA	NA	1	394	
90	TCGA-AP-A053	0	2	0	0	1	0	0	0	1	40	3	0	1	10	1	0	TCGA-AP-A053	0	0	0	TCGA-AP-A053	0	0	0	0	TCGA-AP-A053-01	13	6	5	24	mutation call filter	10564	TCGA-AP-A053	UCEC	90	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32872	Dead	TUMOR FREE	NA	3365	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	3365	0	3365	0	3365	0	3365	
60	TCGA-AP-A054	13	189	5	31	101	40	6	1	65	849	25	2	22	337	41	3	TCGA-AP-A054-01	145	0.054539426177959024	87	TCGA-AP-A054-01	2	2	2	0.021374928202522552	TCGA-AP-A054-01	2	0	1	3	mutation call filter	10565	TCGA-AP-A054	UCEC	64	FEMALE	WHITE	NA	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23404	Dead	WITH TUMOR	NA	709	NA	NA	NA	NA	566	Complete Remission/Response	NA	NA	1	709	1	709	1	566	1	566	
60	TCGA-AP-A056	59	1120	35	236	15	34	1	1	452	7207	832	8	167	2269	94	1	TCGA-AP-A056-01	73	0.0011116844050857511	24	TCGA-AP-A056-01	0	0	6	0.0004989306805428384	TCGA-AP-A056-01	0	0	0	0	mutation call filter	10566	TCGA-AP-A056	UCEC	64	FEMALE	WHITE	NA	Stage II	Endometrioid endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23707	Alive	TUMOR FREE	2618	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2618	0	2618	0	2618	0	2618	
70	TCGA-AP-A059	60	961	53	309	35	24	1	0	486	9687	755	3	215	3579	323	6	TCGA-AP-A059-01	70	8.277055513732903e-05	29	TCGA-AP-A059-01	0	0	0	0.0	TCGA-AP-A059-01	0	0	0	0	hypermutated sample	10567	TCGA-AP-A059	UCEC	69	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25311	Alive	TUMOR FREE	1461	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1461	0	1461	0	1461	0	1461	
80	TCGA-AP-A05A	0	7	2	0	1	0	0	0	1	54	9	0	2	16	4	0	TCGA-AP-A05A-01	419	0.187506909185572	280	TCGA-AP-A05A-01	5	7	40	0.06866784411371595	TCGA-AP-A05A-01	10	1	3	14	mutation call filter	10568	TCGA-AP-A05A	UCEC	81	FEMALE	WHITE	NA	Stage II	Serous endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29914	Dead	TUMOR FREE	NA	1944	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1944	0	1944	0	1944	0	1944	
70	TCGA-AP-A05D	0	2	0	0	2	0	0	0	0	29	2	0	1	6	0	0	TCGA-AP-A05D-01	367	0.8246791903866126	224	TCGA-AP-A05D-01	11	13	66	0.17529769576048915	TCGA-AP-A05D-01	12	8	12	32	mutation call filter	10569	TCGA-AP-A05D	UCEC	67	FEMALE	WHITE	NA	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24597	Alive	TUMOR FREE	1758	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1758	0	1758	0	1758	0	1758	
80	TCGA-AP-A05H	1	6	0	0	1	1	0	0	5	59	3	0	1	10	0	0	TCGA-AP-A05H-01	558	0.9785766905037312	366	TCGA-AP-A05H-01	20	38	92	0.2350450726678617	TCGA-AP-A05H-01	20	10	10	40	mutation call filter	10570	TCGA-AP-A05H	UCEC	75	FEMALE	WHITE	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27744	Alive	TUMOR FREE	1385	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1385	0	1385	0	1385	0	1385	
70	TCGA-AP-A05J	0	3	0	1	1	0	0	0	2	41	1	1	0	11	0	0	TCGA-AP-A05J-01	337	0.2975445305246416	199	TCGA-AP-A05J-01	2	7	40	0.1284492067131733	TCGA-AP-A05J-01	12	8	9	29	mutation call filter	10571	TCGA-AP-A05J	UCEC	66	FEMALE	WHITE	NA	Stage II	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24119	Alive	TUMOR FREE	1122	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1122	0	1122	0	1122	0	1122	
60	TCGA-AP-A05N	1	24	1	5	46	18	1	0	9	164	18	0	11	76	10	0	TCGA-AP-A05N-01	55	0.0004219604964297128	17	TCGA-AP-A05N-01	0	0	2	0.0001829569278031816	TCGA-AP-A05N-01	0	0	0	0	mutation call filter	10572	TCGA-AP-A05N	UCEC	58	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-21254	Dead	TUMOR FREE	NA	726	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	726	0	726	0	726	0	726	
70	TCGA-AP-A05O	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AP-A05O-01	55	0.019662558591470924	15	TCGA-AP-A05O-01	0	1	0	0.0	TCGA-AP-A05O-01	0	1	0	1	PASS	10573	TCGA-AP-A05O	UCEC	68	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24978	Alive	TUMOR FREE	384	NA	NA	NA	NA	NA	340	Complete Remission/Response	NA	NA	0	384	0	384	1	340	1	340	
50	TCGA-AP-A05P	0	4	0	1	0	1	0	0	3	42	7	0	0	16	0	0	TCGA-AP-A05P-01	36	0.1688127722006024	6	TCGA-AP-A05P-01	5	4	19	5.029647161758537e-05	TCGA-AP-A05P-01	0	0	0	0	mutation call filter	10574	TCGA-AP-A05P	UCEC	54	FEMALE	ASIAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-20017	Alive	TUMOR FREE	636	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	636	0	636	0	636	0	636	
70	TCGA-AP-A0L8	0	5	0	3	1	0	1	0	3	51	4	0	1	17	2	0	TCGA-AP-A0L8-01	351	0.8344952907000264	220	TCGA-AP-A0L8-01	21	23	56	0.3220382025414541	TCGA-AP-A0L8-01	16	18	11	45	mutation call filter	10575	TCGA-AP-A0L8	UCEC	70	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2000	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25733	Dead	WITH TUMOR	NA	1484	NA	NA	NA	NA	1453	Complete Remission/Response	NA	NA	1	1484	1	1484	1	1453	1	1453	
70	TCGA-AP-A0L9	0	7	0	2	1	0	1	0	2	59	2	0	4	19	1	0	TCGA-AP-A0L9-01	465	0.7109751134310891	300	TCGA-AP-A0L9-01	14	49	111	0.3801020033609313	TCGA-AP-A0L9-01	22	21	12	55	mutation call filter	10576	TCGA-AP-A0L9	UCEC	71	FEMALE	WHITE	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2001	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26185	Alive	TUMOR FREE	3815	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3815	0	3815	0	3815	0	3815	
60	TCGA-AP-A0LD	6	87	2	6	70	6	2	0	20	338	21	2	9	151	5	1	TCGA-AP-A0LD-01	38	0.13001208439802098	4	TCGA-AP-A0LD-01	5	3	0	0.0	TCGA-AP-A0LD-01	1	1	0	2	mutation call filter	10577	TCGA-AP-A0LD	UCEC	63	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23216	Alive	TUMOR FREE	3589	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3589	0	3589	0	3589	0	3589	
60	TCGA-AP-A0LE	5	51	3	12	108	25	11	1	34	357	24	0	8	150	12	0	TCGA-AP-A0LE-01	40	0.034104820969796994	8	TCGA-AP-A0LE-01	1	1	19	0.014916089629569931	TCGA-AP-A0LE-01	2	1	1	4	PASS	10578	TCGA-AP-A0LE	UCEC	57	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20967	Alive	TUMOR FREE	3357	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3357	0	3357	0	3357	0	3357	
80	TCGA-AP-A0LF	1	17	2	9	1	0	3	0	9	214	12	0	1	56	7	0	TCGA-AP-A0LF-01	248	0.5927241461919023	149	TCGA-AP-A0LF-01	13	44	50	0.40920053520398303	TCGA-AP-A0LF-01	18	13	11	42	PASS	10579	TCGA-AP-A0LF	UCEC	82	FEMALE	WHITE	NA	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30027	Alive	WITH TUMOR	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2859	0	2859	NA	NA	0	2859	
50	TCGA-AP-A0LG	3	58	2	12	56	19	10	0	12	298	19	1	8	136	5	0	TCGA-AP-A0LG-01	53	2.6295792391620646e-05	17	TCGA-AP-A0LG-01	0	0	0	0.0	TCGA-AP-A0LG-01	0	0	0	0	mutation call filter	10580	TCGA-AP-A0LG	UCEC	54	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20047	Alive	TUMOR FREE	2015	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2015	0	2015	0	2015	0	2015	
60	TCGA-AP-A0LH	1	1	0	2	1	1	0	0	2	25	2	0	2	7	0	0	TCGA-AP-A0LH-01	275	0.11315887759745008	180	TCGA-AP-A0LH-01	5	4	15	0.049449484630384406	TCGA-AP-A0LH-01	4	0	2	6	mutation call filter	10581	TCGA-AP-A0LH	UCEC	60	FEMALE	WHITE	NA	Stage IA	Mixed serous and endometrioid	G3	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22169	Dead	WITH TUMOR	NA	1106	NA	NA	NA	NA	302	Complete Remission/Response	NA	NA	1	1106	1	1106	1	302	1	302	
70	TCGA-AP-A0LI	1	14	1	6	3	0	0	0	4	91	9	0	3	29	2	0	TCGA-AP-A0LI-01	410	0.7073264207163033	247	TCGA-AP-A0LI-01	20	22	65	0.2817702514101005	TCGA-AP-A0LI-01	22	10	11	43	mutation call filter	10582	TCGA-AP-A0LI	UCEC	67	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24573	Alive	TUMOR FREE	2972	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2972	0	2972	0	2972	0	2972	
40	TCGA-AP-A0LJ	0	4	0	1	2	1	0	0	1	31	2	0	1	12	1	0	TCGA-AP-A0LJ-01	81	0.04686207711915097	37	TCGA-AP-A0LJ-01	2	1	2	0.00014894509686578885	TCGA-AP-A0LJ-01	0	0	0	0	mutation call filter	10583	TCGA-AP-A0LJ	UCEC	42	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15577	Alive	TUMOR FREE	1421	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1421	0	1421	0	1421	0	1421	
60	TCGA-AP-A0LL	0	4	0	1	2	1	1	0	2	36	4	0	1	9	1	0	TCGA-AP-A0LL-01	74	0.034401082847680814	26	TCGA-AP-A0LL-01	1	4	2	0.03139834689371592	TCGA-AP-A0LL-01	1	0	0	1	PASS	10584	TCGA-AP-A0LL	UCEC	56	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20700	Alive	TUMOR FREE	2554	NA	NA	NA	NA	NA	790	Complete Remission/Response	NA	NA	0	2554	0	2554	1	790	1	790	
30	TCGA-AP-A0LM	76	1022	69	376	24	37	1	1	550	11810	1024	6	240	4628	193	5	TCGA-AP-A0LM-01	143	7.275403175104816e-05	74	TCGA-AP-A0LM-01	0	0	19	5.5139770051939906e-05	TCGA-AP-A0LM-01	0	0	0	0	hypermutated sample	10585	TCGA-AP-A0LM	UCEC	33	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G3	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12309	Alive	TUMOR FREE	825	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	825	0	825	0	825	0	825	
60	TCGA-AP-A0LN	0	7	0	1	5	0	2	0	1	49	3	0	2	12	1	0	TCGA-AP-A0LN-01	63	0.046479310914959736	20	TCGA-AP-A0LN-01	2	1	19	1.675907727072359e-05	TCGA-AP-A0LN-01	0	0	0	0	mutation call filter	10586	TCGA-AP-A0LN	UCEC	56	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20704	Alive	TUMOR FREE	2510	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2510	0	2510	0	2510	0	2510	
50	TCGA-AP-A0LO	0	3	1	1	1	0	1	0	0	26	0	0	0	8	0	0	TCGA-AP-A0LO-01	62	0.7380306084677832	18	TCGA-AP-A0LO-01	11	7	0	0.0	TCGA-AP-A0LO-01	1	0	0	1	mutation call filter	10587	TCGA-AP-A0LO	UCEC	45	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16493	Dead	WITH TUMOR	NA	1016	NA	NA	NA	NA	516	Complete Remission/Response	NA	NA	1	1016	1	1016	1	516	1	516	
80	TCGA-AP-A0LP	1	33	2	5	46	16	3	0	16	205	16	0	9	80	6	1	TCGA-AP-A0LP-01	69	2.588345498314905e-05	21	TCGA-AP-A0LP-01	0	0	0	0.0	TCGA-AP-A0LP-01	0	0	0	0	PASS	10588	TCGA-AP-A0LP	UCEC	76	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27898	Alive	TUMOR FREE	1875	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1875	0	1875	0	1875	0	1875	
60	TCGA-AP-A0LQ	0	8	0	2	1	1	2	0	1	41	5	0	1	15	2	0	TCGA-AP-A0LQ-01	47	0.04643899028015458	10	TCGA-AP-A0LQ-01	2	1	2	0.033687360787594635	TCGA-AP-A0LQ-01	2	2	2	6	PASS	10589	TCGA-AP-A0LQ	UCEC	59	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21629	Alive	TUMOR FREE	2457	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2457	0	2457	0	2457	0	2457	
60	TCGA-AP-A0LS	15	212	4	17	86	19	4	0	40	286	11	0	19	126	7	1	TCGA-AP-A0LS-01	63	0.00012892064468470902	20	TCGA-AP-A0LS-01	0	0	0	0.0	TCGA-AP-A0LS-01	0	0	0	0	PASS	10590	TCGA-AP-A0LS	UCEC	63	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23126	Alive	TUMOR FREE	2904	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2904	0	2904	0	2904	0	2904	
60	TCGA-AP-A0LT	2	96	4	19	132	18	8	0	45	425	31	0	13	198	10	3	TCGA-AP-A0LT-01	47	3.369498390576592e-06	13	TCGA-AP-A0LT-01	0	0	0	0.0	TCGA-AP-A0LT-01	0	0	0	0	mutation call filter	10591	TCGA-AP-A0LT	UCEC	57	FEMALE	WHITE	NA	Stage II	Endometrioid endometrial adenocarcinoma	G2	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21107	Alive	TUMOR FREE	1497	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1497	0	1497	0	1497	0	1497	
40	TCGA-AP-A0LV	0	0	0	0	2	1	0	0	2	16	1	0	1	10	0	0	TCGA-AP-A0LV-01	53	8.81134917839906e-05	15	TCGA-AP-A0LV-01	0	0	4	8.127982040465203e-05	TCGA-AP-A0LV-01	0	0	0	0	mutation call filter	10592	TCGA-AP-A0LV	UCEC	39	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14556	Alive	TUMOR FREE	763	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	763	0	763	0	763	0	763	
60	TCGA-AP-A1DH	18	186	9	38	143	16	7	1	23	369	28	0	20	208	8	0	TCGA-AP-A1DH-01	45	9.798416565618183e-06	12	TCGA-AP-A1DH-01	0	0	0	0.0	TCGA-AP-A1DH-01	0	0	0	0	PASS	10593	TCGA-AP-A1DH	UCEC	62	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22652	Alive	TUMOR FREE	2180	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2180	0	2180	0	2180	0	2180	
50	TCGA-AP-A1DK	204	2661	144	517	66	115	1	1	702	9034	558	17	326	4436	352	17	TCGA-AP-A1DK-01	43	0.00030931082905868	7	TCGA-AP-A1DK-01	0	0	19	0.00012492551579278046	TCGA-AP-A1DK-01	0	0	0	0	hypermutated sample	10594	TCGA-AP-A1DK	UCEC	53	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19509	Alive	TUMOR FREE	2767	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2767	0	2767	0	2767	0	2767	
60	TCGA-AP-A1DM	8	150	2	20	83	14	7	1	25	226	18	0	13	110	4	0	TCGA-AP-A1DM-01	47	0.0415248403532133	11	TCGA-AP-A1DM-01	1	2	0	0.0	TCGA-AP-A1DM-01	2	0	0	2	PASS	10595	TCGA-AP-A1DM	UCEC	60	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22239	Alive	TUMOR FREE	1700	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1700	0	1700	0	1700	0	1700	
60	TCGA-AP-A1DO	21	312	2	28	105	35	14	1	53	372	14	1	30	176	9	0	TCGA-AP-A1DO-01	72	0.8477371336560551	33	TCGA-AP-A1DO-01	9	10	3	0.12818903595027706	TCGA-AP-A1DO-01	2	1	1	4	PASS	10596	TCGA-AP-A1DO	UCEC	62	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22787	Alive	TUMOR FREE	952	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	952	0	952	0	952	0	952	
70	TCGA-AP-A1DP	19	221	4	25	76	24	8	0	35	311	18	1	20	147	5	1	TCGA-AP-A1DP-01	92	0.034148088981166995	35	TCGA-AP-A1DP-01	1	2	19	1.5039635766922961e-05	TCGA-AP-A1DP-01	1	0	0	1	PASS	10597	TCGA-AP-A1DP	UCEC	70	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25601	Dead	WITH TUMOR	NA	1081	NA	Metastatic	"Other, specify"	"Lung, liver, lymph nodes"	831	Complete Remission/Response	NA	NA	1	1081	1	1081	1	831	1	831	
80	TCGA-AP-A1DQ	0	2	1	0	1	0	0	0	1	26	2	0	2	8	0	0	TCGA-AP-A1DQ-01	280	0.5642775360649984	164	TCGA-AP-A1DQ-01	20	27	31	0.16870330713095613	TCGA-AP-A1DQ-01	13	10	7	30	PASS	10598	TCGA-AP-A1DQ	UCEC	76	FEMALE	WHITE	NA	Stage IIIC1	Serous endometrial adenocarcinoma	High Grade	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27815	Dead	WITH TUMOR	NA	1423	NA	Metastatic	"Other, specify"	"Lymph nodes, lung, bone"	905	Complete Remission/Response	NA	NA	1	1423	1	1423	1	905	1	905	
60	TCGA-AP-A1DR	42	431	9	43	164	41	8	0	59	472	28	0	30	213	18	2	TCGA-AP-A1DR-01	85	0.00024946298389815603	34	TCGA-AP-A1DR-01	0	0	0	0.0	TCGA-AP-A1DR-01	0	0	0	0	PASS	10599	TCGA-AP-A1DR	UCEC	59	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21904	Alive	TUMOR FREE	1495	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1495	0	1495	0	1495	0	1495	
60	TCGA-AP-A1DV	280	3559	150	452	5	15	2	0	727	10713	1023	5	452	3919	230	4	TCGA-AP-A1DV-01	56	0.01945821281984453	21	TCGA-AP-A1DV-01	0	1	2	0.0001077552591327172	TCGA-AP-A1DV-01	0	1	0	1	hypermutated sample	10600	TCGA-AP-A1DV	UCEC	59	FEMALE	WHITE	NA	Stage II	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21901	Alive	TUMOR FREE	204	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	204	0	204	0	204	0	204	
40	TCGA-AP-A1E0	109	1591	40	188	5	9	2	0	289	4147	584	3	182	1209	84	0	TCGA-AP-A1E0-01	109	0.00035023376598445716	59	TCGA-AP-A1E0-01	0	0	19	1.3378526227075835e-05	TCGA-AP-A1E0-01	0	0	0	0	hypermutated sample	10601	TCGA-AP-A1E0	UCEC	40	FEMALE	WHITE	NA	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G2	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14653	Alive	TUMOR FREE	1832	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1832	0	1832	0	1832	0	1832	
70	TCGA-AP-A1E1	13	180	8	24	94	27	5	0	35	390	23	0	22	160	11	0	TCGA-AP-A1E1-01	42	0.033758220052441036	9	TCGA-AP-A1E1-01	1	3	19	1.4113007491103173e-05	TCGA-AP-A1E1-01	1	1	0	2	PASS	10602	TCGA-AP-A1E1	UCEC	74	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27072	Alive	TUMOR FREE	1395	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1395	0	1395	0	1395	0	1395	
50	TCGA-AP-A1E3	0	9	0	1	2	0	0	0	2	34	1	0	2	13	3	0	TCGA-AP-A1E3-01	37	0.0465252137181098	7	TCGA-AP-A1E3-01	2	3	2	0.049020542303735926	TCGA-AP-A1E3-01	0	0	0	0	PASS	10603	TCGA-AP-A1E3	UCEC	45	FEMALE	WHITE	NA	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16544	Alive	WITH TUMOR	847	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	847	0	847	NA	NA	0	847	
50	TCGA-AP-A1E4	0	6	0	5	1	1	0	0	1	17	1	0	1	10	0	0	TCGA-AP-A1E4-01	62	0.12703189666921774	28	TCGA-AP-A1E4-01	5	4	0	0.0	TCGA-AP-A1E4-01	1	0	0	1	PASS	10604	TCGA-AP-A1E4	UCEC	54	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19814	Alive	WITH TUMOR	1555	NA	NA	Metastatic	"Other, specify"	"Bone, lymph nodes"	158	Progressive Disease	NA	NA	0	1555	0	1555	NA	NA	1	158	
60	TCGA-AP-A3K1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AP-A3K1-01	183	0.6112853107143893	100	TCGA-AP-A3K1-01	26	51	68	0.2708881901346238	TCGA-AP-A3K1-01	14	9	12	35	PASS	10605	TCGA-AP-A3K1	UCEC	56	FEMALE	WHITE	NA	Stage IVB	Serous endometrial adenocarcinoma	High Grade	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20594	Dead	WITH TUMOR	NA	666	NA	Locoregional Recurrence	"Other, specify"	Paracolic gutter	198	Progressive Disease	NA	NA	1	666	1	666	NA	NA	1	198	
70	TCGA-AP-A5FX	0	7	2	3	0	0	1	0	1	34	2	0	0	11	1	0	TCGA-AP-A5FX-01	474	0.7107540996102073	303	TCGA-AP-A5FX-01	16	22	136	0.1931498968194398	TCGA-AP-A5FX-01	12	9	11	32	PASS	10606	TCGA-AP-A5FX	UCEC	68	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC1	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25063	Dead	WITH TUMOR	NA	1099	NA	Locoregional Recurrence	"Other, specify"	Retroperitoneal LN; vulvar mass	407	Complete Remission/Response	NA	NA	1	1099	1	1099	1	407	1	407	
70	TCGA-AW-A1PO	0	18	2	4	3	0	4	0	4	54	3	0	3	21	1	0	TCGA-AW-A1PO-01	292	0.9486731919090956	172	TCGA-AW-A1PO-01	6	17	59	0.4442136591893711	TCGA-AW-A1PO-01	22	28	21	71	PASS	10607	TCGA-AW-A1PO	UCEC	66	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24225	Alive	TUMOR FREE	17	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	17	0	17	NA	NA	0	17	
80	TCGA-AX-A05S	5	71	1	17	75	15	12	0	35	362	21	2	12	149	4	0	TCGA-AX-A05S-01	82	0.09037635633661896	35	TCGA-AX-A05S-01	3	4	4	0.04907181332558196	TCGA-AX-A05S-01	1	0	0	1	mutation call filter	10608	TCGA-AX-A05S	UCEC	81	FEMALE	WHITE	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29928	Dead	WITH TUMOR	NA	413	NA	NA	NA	NA	338	Progressive Disease	NA	NA	1	413	1	413	NA	NA	1	338	
80	TCGA-AX-A05T	0	6	0	2	3	2	1	0	7	33	5	1	1	16	0	0	TCGA-AX-A05T-01	93	0.046434925422821134	48	TCGA-AX-A05T-01	2	3	3	0.0270814884724128	TCGA-AX-A05T-01	2	1	1	4	mutation call filter	10609	TCGA-AX-A05T	UCEC	82	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30137	Alive	TUMOR FREE	1010	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1010	0	1010	0	1010	0	1010	
60	TCGA-AX-A05U	0	0	0	0	2	0	1	0	2	19	3	1	0	10	1	0	TCGA-AX-A05U-01	137	0.05859365144164605	79	TCGA-AX-A05U-01	2	2	4	0.012482941521326249	TCGA-AX-A05U-01	0	0	1	1	mutation call filter	10610	TCGA-AX-A05U	UCEC	56	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20533	Alive	TUMOR FREE	903	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	903	0	903	0	903	0	903	
60	TCGA-AX-A05W	1	6	1	2	3	1	1	0	1	52	8	0	0	23	1	0	TCGA-AX-A05W-01	65	0.7077279596132231	22	TCGA-AX-A05W-01	6	4	19	4.7335069002935933e-05	TCGA-AX-A05W-01	0	1	0	1	mutation call filter	10611	TCGA-AX-A05W	UCEC	60	FEMALE	WHITE	NA	Stage IIB	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22200	Alive	TUMOR FREE	2450	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2450	0	2450	0	2450	0	2450	
60	TCGA-AX-A05Y	1	23	1	2	16	2	2	1	8	144	11	0	1	69	6	0	TCGA-AX-A05Y-01	74	0.04108300186991102	27	TCGA-AX-A05Y-01	1	1	2	0.007373800261608089	TCGA-AX-A05Y-01	2	1	1	4	mutation call filter	10612	TCGA-AX-A05Y	UCEC	57	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20904	Alive	TUMOR FREE	2684	NA	NA	NA	NA	NA	194	Complete Remission/Response	NA	NA	0	2684	0	2684	1	194	1	194	
40	TCGA-AX-A05Z	39	986	38	187	2	23	0	0	345	6049	1109	15	167	1586	119	7	TCGA-AX-A05Z-01	78	0.0189850516484708	30	TCGA-AX-A05Z-01	1	1	2	0.006447836356941386	TCGA-AX-A05Z-01	1	1	1	3	mutation call filter	10613	TCGA-AX-A05Z	UCEC	37	FEMALE	NA	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2006	Indeterminate (neither Pre or Postmenopausal)	-13529	Alive	TUMOR FREE	2175	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2175	0	2175	0	2175	0	2175	
80	TCGA-AX-A060	6	67	5	22	86	14	11	1	45	572	32	0	15	249	17	0	TCGA-AX-A060-01	102	0.041530709416061885	52	TCGA-AX-A060-01	1	2	3	0.009294614294513445	TCGA-AX-A060-01	2	1	1	4	mutation call filter	10614	TCGA-AX-A060	UCEC	77	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28472	Alive	TUMOR FREE	1075	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1075	0	1075	0	1075	0	1075	
50	TCGA-AX-A062	0	1	1	0	0	0	0	0	1	21	3	0	2	7	0	0	TCGA-AX-A062-01	65	6.135175102253725e-05	26	TCGA-AX-A062-01	0	0	19	0.0032708763678324987	TCGA-AX-A062-01	1	0	0	1	mutation call filter	10615	TCGA-AX-A062	UCEC	53	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2005	Indeterminate (neither Pre or Postmenopausal)	-19643	Alive	TUMOR FREE	1399	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1399	0	1399	0	1399	0	1399	
60	TCGA-AX-A063	6	114	3	17	105	17	10	0	51	806	27	3	21	300	24	0	TCGA-AX-A063-01	72	0.044021353141222234	30	TCGA-AX-A063-01	1	1	0	0.0	TCGA-AX-A063-01	1	0	0	1	mutation call filter	10616	TCGA-AX-A063	UCEC	63	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23045	Alive	TUMOR FREE	2417	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2417	0	2417	0	2417	0	2417	
80	TCGA-AX-A064	1	39	3	9	28	3	8	0	12	200	10	0	6	90	8	0	TCGA-AX-A064-01	76	0.03413438793946616	31	TCGA-AX-A064-01	1	2	19	9.59953015678676e-06	TCGA-AX-A064-01	1	0	0	1	mutation call filter	10617	TCGA-AX-A064	UCEC	81	FEMALE	WHITE	NA	Stage IIA	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29625	Alive	TUMOR FREE	1517	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1517	0	1517	0	1517	0	1517	
70	TCGA-AX-A06B	0	1	0	2	1	1	1	0	0	33	1	0	0	15	3	0	TCGA-AX-A06B-01	371	0.947155129359582	227	TCGA-AX-A06B-01	14	16	89	0.3760263172827377	TCGA-AX-A06B-01	10	9	15	34	mutation call filter	10618	TCGA-AX-A06B	UCEC	72	FEMALE	WHITE	NA	Stage IIA	Endometrioid endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26348	Alive	TUMOR FREE	2058	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2058	0	2058	0	2058	0	2058	
80	TCGA-AX-A06D	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AX-A06D	0	0	0	TCGA-AX-A06D	0	0	0	0	TCGA-AX-A06D-01	0	0	0	0	PASS	10619	TCGA-AX-A06D	UCEC	82	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30024	Dead	WITH TUMOR	NA	373	NA	NA	NA	NA	253	Progressive Disease	NA	NA	1	373	1	373	NA	NA	1	253	
60	TCGA-AX-A06F	56	877	49	188	10	13	1	0	386	6529	492	4	142	2339	166	6	TCGA-AX-A06F-01	116	0.00950053402020222	56	TCGA-AX-A06F-01	0	0	6	0.006121079175233709	TCGA-AX-A06F-01	1	1	1	3	mutation call filter	10620	TCGA-AX-A06F	UCEC	59	FEMALE	WHITE	NA	Stage IVA	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21624	Alive	TUMOR FREE	1748	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1748	0	1748	NA	NA	0	1748	
60	TCGA-AX-A06H	4	40	0	13	86	20	9	0	18	265	13	0	6	148	13	0	TCGA-AX-A06H-01	53	0.0004380159953596335	14	TCGA-AX-A06H-01	0	0	0	0.0	TCGA-AX-A06H-01	0	0	0	0	PASS	10621	TCGA-AX-A06H	UCEC	60	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22270	Alive	WITH TUMOR	833	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	833	0	833	0	833	0	833	
70	TCGA-AX-A06J	0	5	0	2	4	1	1	0	4	49	2	0	1	18	1	0	TCGA-AX-A06J-01	59	0.04644116101456845	22	TCGA-AX-A06J-01	2	5	6	0.10300483839729976	TCGA-AX-A06J-01	2	2	2	6	mutation call filter	10622	TCGA-AX-A06J	UCEC	71	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26000	Alive	TUMOR FREE	913	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	913	0	913	0	913	0	913	
60	TCGA-AX-A06L	0	3	0	1	1	3	0	0	4	31	1	0	2	10	3	1	TCGA-AX-A06L-01	39	0.0001886036015910258	4	TCGA-AX-A06L-01	0	0	19	0.00015338374616500057	TCGA-AX-A06L-01	0	0	0	0	PASS	10623	TCGA-AX-A06L	UCEC	63	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23294	Alive	TUMOR FREE	1845	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1845	0	1845	0	1845	0	1845	
50	TCGA-AX-A0IS	0	0	0	1	4	1	1	0	3	40	1	0	0	17	1	0	TCGA-AX-A0IS-01	48	0.10645000969764064	12	TCGA-AX-A0IS-01	3	5	3	0.06000740997704008	TCGA-AX-A0IS-01	1	2	1	4	PASS	10624	TCGA-AX-A0IS	UCEC	52	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19173	Dead	WITH TUMOR	NA	1858	NA	NA	NA	NA	448	Complete Remission/Response	NA	NA	1	1858	1	1858	1	448	1	448	
80	TCGA-AX-A0IU	0	4	0	1	3	1	0	0	7	44	2	0	1	19	2	1	TCGA-AX-A0IU-01	336	0.2225810089184312	207	TCGA-AX-A0IU-01	9	11	27	0.07052986138059689	TCGA-AX-A0IU-01	13	6	5	24	PASS	10625	TCGA-AX-A0IU	UCEC	79	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29063	Alive	TUMOR FREE	1087	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1087	0	1087	0	1087	0	1087	
70	TCGA-AX-A0IW	0	2	0	2	3	1	0	0	2	46	3	0	2	16	0	0	TCGA-AX-A0IW-01	402	0.9176000960217684	262	TCGA-AX-A0IW-01	17	36	102	0.262648988893231	TCGA-AX-A0IW-01	19	13	9	41	mutation call filter	10626	TCGA-AX-A0IW	UCEC	67	FEMALE	WHITE	NA	Stage IIIA	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24488	Alive	TUMOR FREE	1149	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1149	0	1149	0	1149	0	1149	
50	TCGA-AX-A0IZ	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-AX-A0IZ-01	51	0.00038054648255083685	12	TCGA-AX-A0IZ-01	0	0	3	0.00012110109476128987	TCGA-AX-A0IZ-01	0	0	0	0	PASS	10627	TCGA-AX-A0IZ	UCEC	53	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19364	Alive	TUMOR FREE	1333	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1333	0	1333	0	1333	0	1333	
50	TCGA-AX-A0J0	99	1935	70	525	7	78	0	0	767	12886	2111	24	294	3318	264	10	TCGA-AX-A0J0-01	69	0.0005943385191296372	22	TCGA-AX-A0J0-01	0	0	19	3.697764822785366e-05	TCGA-AX-A0J0-01	0	0	0	0	hypermutated sample	10628	TCGA-AX-A0J0	UCEC	47	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17466	Alive	TUMOR FREE	1220	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1220	0	1220	0	1220	0	1220	
80	TCGA-AX-A0J1	32	516	23	126	175	59	6	0	224	4480	273	1	96	1956	73	1	TCGA-AX-A0J1-01	56	0.03409374497952148	20	TCGA-AX-A0J1-01	1	4	2	0.03619288743191322	TCGA-AX-A0J1-01	1	0	1	2	mutation call filter	10629	TCGA-AX-A0J1	UCEC	80	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29501	Alive	TUMOR FREE	2354	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2354	0	2354	0	2354	0	2354	
50	TCGA-AX-A1C4	33	436	15	59	175	33	13	1	73	556	52	1	32	269	16	2	TCGA-AX-A1C4-01	123	0.08650843152843532	71	TCGA-AX-A1C4-01	5	3	2	0.01316940593645847	TCGA-AX-A1C4-01	1	1	1	3	PASS	10630	TCGA-AX-A1C4	UCEC	52	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Indeterminate (neither Pre or Postmenopausal)	-19209	Alive	TUMOR FREE	404	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	404	0	404	NA	NA	0	404	
50	TCGA-AX-A1C5	32	291	8	38	47	10	3	0	56	717	44	0	21	357	9	2	TCGA-AX-A1C5-01	95	0.00400686071256106	38	TCGA-AX-A1C5-01	0	0	2	0.00016712839910853114	TCGA-AX-A1C5-01	0	1	0	1	PASS	10631	TCGA-AX-A1C5	UCEC	47	FEMALE	WHITE	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2009	Indeterminate (neither Pre or Postmenopausal)	-17383	Alive	WITH TUMOR	1001	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1001	0	1001	0	1001	0	1001	
80	TCGA-AX-A1C7	0	2	0	2	0	1	0	0	5	37	2	0	0	11	2	0	TCGA-AX-A1C7-01	380	0.8374868513217926	252	TCGA-AX-A1C7-01	12	15	56	0.2480447935985803	TCGA-AX-A1C7-01	21	15	11	47	PASS	10632	TCGA-AX-A1C7	UCEC	77	FEMALE	WHITE	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28198	Alive	NA	1054	NA	NA	NA	NA	NA	390	NA	NA	NA	0	1054	0	1054	NA	NA	1	390	
80	TCGA-AX-A1C8	0	7	0	2	1	0	0	0	4	66	2	0	1	17	1	0	TCGA-AX-A1C8-01	303	0.28146920252987795	177	TCGA-AX-A1C8-01	3	9	37	0.1365864414487348	TCGA-AX-A1C8-01	11	16	9	36	PASS	10633	TCGA-AX-A1C8	UCEC	77	FEMALE	WHITE	NA	Stage IIIC	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28452	Alive	NA	776	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	776	0	776	NA	NA	0	776	
70	TCGA-AX-A1C9	22	227	6	22	15	10	1	0	46	871	47	0	33	386	17	0	TCGA-AX-A1C9-01	156	0.1302263608026316	86	TCGA-AX-A1C9-01	4	3	9	0.09572527734633243	TCGA-AX-A1C9-01	0	0	0	0	PASS	10634	TCGA-AX-A1C9	UCEC	73	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26903	Alive	TUMOR FREE	802	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	802	0	802	NA	NA	0	802	
70	TCGA-AX-A1CA	1	12	0	4	3	1	0	0	2	96	7	0	0	42	0	0	TCGA-AX-A1CA-01	223	0.6511537301818856	132	TCGA-AX-A1CA-01	22	26	49	0.2899076492908992	TCGA-AX-A1CA-01	15	9	10	34	PASS	10635	TCGA-AX-A1CA	UCEC	70	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2009	NA	-25817	Alive	TUMOR FREE	974	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	974	0	974	NA	NA	0	974	
70	TCGA-AX-A1CC	0	0	1	1	1	0	0	0	1	17	1	0	1	7	0	0	TCGA-AX-A1CC-01	103	0.21177893971055334	45	TCGA-AX-A1CC-01	7	8	19	0.15859381824537466	TCGA-AX-A1CC-01	2	4	4	10	PASS	10636	TCGA-AX-A1CC	UCEC	65	FEMALE	WHITE	NA	Stage IC	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23795	Alive	TUMOR FREE	788	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	788	0	788	NA	NA	0	788	
60	TCGA-AX-A1CE	292	3510	95	334	122	178	1	0	674	10160	707	4	365	3732	205	5	TCGA-AX-A1CE-01	68	0.0012873944000237698	18	TCGA-AX-A1CE-01	0	0	0	0.0	TCGA-AX-A1CE-01	0	0	0	0	hypermutated sample	10637	TCGA-AX-A1CE	UCEC	60	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21969	Alive	TUMOR FREE	1037	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1037	0	1037	NA	NA	0	1037	
70	TCGA-AX-A1CF	3	25	2	3	6	0	0	0	5	82	2	0	3	28	3	0	TCGA-AX-A1CF-01	315	0.8608364229345157	190	TCGA-AX-A1CF-01	5	15	78	0.4538045472254517	TCGA-AX-A1CF-01	26	33	22	81	PASS	10638	TCGA-AX-A1CF	UCEC	69	FEMALE	WHITE	NA	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2004	NA	-25300	Alive	WITH TUMOR	2337	NA	NA	NA	NA	NA	875	Progressive Disease	NA	NA	0	2337	0	2337	NA	NA	1	875	
60	TCGA-AX-A1CI	0	13	1	3	1	2	0	0	6	52	3	0	4	23	1	0	TCGA-AX-A1CI-01	69	0.09888751351555336	27	TCGA-AX-A1CI-01	2	4	2	0.04689037256970559	TCGA-AX-A1CI-01	2	1	1	4	PASS	10639	TCGA-AX-A1CI	UCEC	61	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22582	Alive	TUMOR FREE	2600	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2600	0	2600	NA	NA	0	2600	
60	TCGA-AX-A1CJ	2	11	0	1	4	1	0	1	3	43	1	0	1	24	0	0	TCGA-AX-A1CJ-01	114	0.08111581438973793	61	TCGA-AX-A1CJ-01	3	4	2	0.01172585457644155	TCGA-AX-A1CJ-01	1	0	0	1	PASS	10640	TCGA-AX-A1CJ	UCEC	59	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2006	Indeterminate (neither Pre or Postmenopausal)	-21655	Alive	TUMOR FREE	2233	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2233	0	2233	NA	NA	0	2233	
60	TCGA-AX-A1CK	1	16	0	0	5	1	1	0	0	47	4	0	1	14	1	0	TCGA-AX-A1CK-01	81	0.18332165170760828	34	TCGA-AX-A1CK-01	4	7	4	0.07328025884525399	TCGA-AX-A1CK-01	5	1	2	8	PASS	10641	TCGA-AX-A1CK	UCEC	58	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21200	Alive	WITH TUMOR	2441	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2441	0	2441	NA	NA	0	2441	
50	TCGA-AX-A1CN	0	6	0	1	1	0	0	0	0	28	2	0	0	11	2	1	TCGA-AX-A1CN-01	71	0.06900166912217763	25	TCGA-AX-A1CN-01	2	6	7	0.09868178988029554	TCGA-AX-A1CN-01	6	4	4	14	PASS	10642	TCGA-AX-A1CN	UCEC	54	FEMALE	WHITE	NA	Stage IIB	Endometrioid endometrial adenocarcinoma	G3	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19860	Alive	WITH TUMOR	1143	NA	NA	New Primary Tumor	Lung	NA	1105	NA	NA	NA	0	1143	0	1143	NA	NA	1	1105	
80	TCGA-AX-A1CP	0	0	0	1	0	0	0	0	3	24	1	0	1	9	0	0	TCGA-AX-A1CP	0	0	0	TCGA-AX-A1CP	0	0	0	0	TCGA-AX-A1CP-01	8	4	8	20	PASS	10643	TCGA-AX-A1CP	UCEC	84	FEMALE	WHITE	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30737	Alive	NA	1107	NA	NA	NA	NA	NA	722	NA	NA	NA	0	1107	0	1107	NA	NA	1	722	
70	TCGA-AX-A1CR	0	12	3	2	1	1	0	0	5	45	0	0	0	9	1	0	TCGA-AX-A1CR	0	0	0	TCGA-AX-A1CR	0	0	0	0	TCGA-AX-A1CR-01	8	8	12	28	mutation call filter	10644	TCGA-AX-A1CR	UCEC	70	FEMALE	WHITE	NA	Stage IIB	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25812	Alive	TUMOR FREE	701	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	701	0	701	NA	NA	0	701	
90	TCGA-AX-A2H2	3	47	2	17	2	1	1	0	8	152	20	0	3	60	7	1	TCGA-AX-A2H2-01	777	0.6929439423775237	509	TCGA-AX-A2H2-01	11	41	160	0.30196847408261723	TCGA-AX-A2H2-01	26	23	16	65	PASS	10645	TCGA-AX-A2H2	UCEC	86	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIA	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31524	Dead	TUMOR FREE	NA	145	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	145	0	145	0	145	0	145	
70	TCGA-AX-A2H4	4	37	4	9	3	1	0	0	13	148	11	0	4	60	0	0	TCGA-AX-A2H4-01	684	0.7384539578073726	445	TCGA-AX-A2H4-01	21	32	209	0.4843307232093387	TCGA-AX-A2H4-01	19	16	17	52	PASS	10646	TCGA-AX-A2H4	UCEC	66	FEMALE	WHITE	NA	Stage IIIA	Serous endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24234	Dead	WITH TUMOR	NA	916	NA	Locoregional Disease	"Other, specify"	"Vaginal cuff, iliac"	520	Complete Remission/Response	NA	NA	1	916	1	916	1	520	1	520	
70	TCGA-AX-A2H5	0	1	1	2	0	0	0	0	0	47	0	0	1	11	0	0	TCGA-AX-A2H5-01	512	0.3647934068417135	339	TCGA-AX-A2H5-01	9	8	92	0.2341716614343388	TCGA-AX-A2H5-01	19	11	7	37	PASS	10647	TCGA-AX-A2H5	UCEC	67	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous endometrial adenocarcinoma	G3	2005	NA	-24757	Alive	TUMOR FREE	2167	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2167	0	2167	0	2167	0	2167	
90	TCGA-AX-A2H7	2	41	1	10	9	2	0	0	8	141	12	0	5	54	2	0	TCGA-AX-A2H7-01	57	0.8988998108033902	19	TCGA-AX-A2H7-01	11	10	3	0.011969363970993652	TCGA-AX-A2H7-01	1	0	0	1	PASS	10648	TCGA-AX-A2H7	UCEC	87	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2008	NA	-32100	Dead	WITH TUMOR	NA	1241	NA	Metastatic	Lung	NA	684	Complete Remission/Response	NA	NA	1	1241	1	1241	1	684	1	684	
60	TCGA-AX-A2H8	0	12	0	6	1	2	0	0	0	44	1	0	2	11	0	0	TCGA-AX-A2H8	0	0	0	TCGA-AX-A2H8	0	0	0	0	TCGA-AX-A2H8-01	15	9	7	31	PASS	10649	TCGA-AX-A2H8	UCEC	64	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23448	Alive	TUMOR FREE	1861	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1861	0	1861	0	1861	0	1861	
40	TCGA-AX-A2HA	54	676	16	80	253	52	14	0	100	1100	55	0	41	497	24	1	TCGA-AX-A2HA-01	76	0.0934331936091806	30	TCGA-AX-A2HA-01	3	3	3	0.00017841484978111484	TCGA-AX-A2HA-01	0	0	0	0	hypermutated sample	10650	TCGA-AX-A2HA	UCEC	35	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2005	NA	-13142	Alive	TUMOR FREE	2475	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2475	0	2475	0	2475	0	2475	
50	TCGA-AX-A2HC	346	4322	159	588	63	52	1	0	893	11206	1282	8	448	3580	294	4	TCGA-AX-A2HC-01	139	0.0827750612663369	84	TCGA-AX-A2HC-01	4	2	19	6.292393226934288e-05	TCGA-AX-A2HC-01	0	0	0	0	hypermutated sample	10651	TCGA-AX-A2HC	UCEC	53	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2006	NA	-19485	Alive	WITH TUMOR	1044	NA	NA	Metastatic	"Other, specify"	Abdomen	756	Complete Remission/Response	NA	NA	0	1044	0	1044	1	756	1	756	
70	TCGA-AX-A2HD	206	2570	115	397	223	105	17	0	536	6862	423	1	283	3053	150	7	TCGA-AX-A2HD-01	99	0.02997219731065837	50	TCGA-AX-A2HD-01	0	1	4	0.019093617343643333	TCGA-AX-A2HD-01	2	3	2	7	hypermutated sample	10652	TCGA-AX-A2HD	UCEC	69	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2008	NA	-25499	Alive	WITH TUMOR	1414	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	1414	0	1414	NA	NA	0	1414	
70	TCGA-AX-A2HF	0	0	0	0	2	0	1	0	1	17	4	1	0	7	0	0	TCGA-AX-A2HF	0	0	0	TCGA-AX-A2HF	0	0	0	0	TCGA-AX-A2HF-01	10	9	11	30	PASS	10653	TCGA-AX-A2HF	UCEC	67	FEMALE	WHITE	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24689	Alive	WITH TUMOR	848	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	848	0	848	0	848	0	848	
60	TCGA-AX-A2HG	23	362	9	51	182	32	6	1	63	581	25	2	28	259	19	1	TCGA-AX-A2HG-01	47	0.000380725960149296	7	TCGA-AX-A2HG-01	0	0	19	0.00034464235882118667	TCGA-AX-A2HG-01	0	0	0	0	PASS	10654	TCGA-AX-A2HG	UCEC	56	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20771	Alive	TUMOR FREE	1163	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1163	0	1163	0	1163	0	1163	
60	TCGA-AX-A2HH	0	16	0	2	2	1	0	0	2	32	2	0	2	14	1	0	TCGA-AX-A2HH-01	86	0.9263391148317788	37	TCGA-AX-A2HH-01	7	7	5	0.0667617249379822	TCGA-AX-A2HH-01	5	1	1	7	PASS	10655	TCGA-AX-A2HH	UCEC	60	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	NA	-21924	Alive	WITH TUMOR	540	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	540	0	540	NA	NA	0	540	
40	TCGA-AX-A2HJ	59	670	22	91	237	49	13	0	107	1168	46	1	68	498	48	3	TCGA-AX-A2HJ-01	59	0.052404833800521834	17	TCGA-AX-A2HJ-01	2	1	6	0.03315250120911798	TCGA-AX-A2HJ-01	2	1	2	5	hypermutated sample	10656	TCGA-AX-A2HJ	UCEC	35	FEMALE	ASIAN	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2009	NA	-13112	Alive	TUMOR FREE	935	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	935	0	935	0	935	0	935	
80	TCGA-AX-A2HK	0	13	2	0	3	1	2	0	4	50	5	0	2	21	1	0	TCGA-AX-A2HK-01	353	0.6559695901003277	215	TCGA-AX-A2HK-01	19	67	37	0.2187900074735291	TCGA-AX-A2HK-01	22	12	7	41	PASS	10657	TCGA-AX-A2HK	UCEC	77	FEMALE	WHITE	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28316	Dead	WITH TUMOR	NA	90	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	90	1	90	NA	NA	1	90	
60	TCGA-AX-A2IN	15	209	1	30	80	26	6	0	34	364	23	1	20	180	12	1	TCGA-AX-A2IN-01	99	0.03406999975574747	43	TCGA-AX-A2IN-01	1	1	19	3.631910273635377e-05	TCGA-AX-A2IN-01	0	0	0	0	PASS	10658	TCGA-AX-A2IN	UCEC	63	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23275	Dead	WITH TUMOR	NA	947	NA	New Primary Tumor	"Other, specify"	Right Breast	257	NA	NA	NA	1	947	1	947	NA	NA	1	257	
80	TCGA-AX-A2IO	12	101	5	35	5	1	1	0	27	295	25	1	10	114	6	0	TCGA-AX-A2IO-01	328	0.32542872985251164	202	TCGA-AX-A2IO-01	7	12	71	0.2919478508451773	TCGA-AX-A2IO-01	13	6	7	26	PASS	10659	TCGA-AX-A2IO	UCEC	83	FEMALE	WHITE	NA	Stage IIA	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30539	Alive	TUMOR FREE	1975	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1975	0	1975	NA	NA	0	1975	
80	TCGA-AX-A3FS	41	371	11	54	189	20	12	1	64	484	29	0	20	242	13	1	TCGA-AX-A3FS-01	101	0.10233538460766214	47	TCGA-AX-A3FS-01	2	2	3	0.025902671494334555	TCGA-AX-A3FS-01	2	0	1	3	PASS	10660	TCGA-AX-A3FS	UCEC	82	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30102	Alive	NA	7	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	7	0	7	NA	NA	0	7	
60	TCGA-AX-A3FT	27	409	15	63	185	42	15	1	92	952	51	1	37	431	27	1	TCGA-AX-A3FT-01	73	0.04985750620401325	31	TCGA-AX-A3FT-01	2	1	19	1.9228426069876513e-05	TCGA-AX-A3FT-01	0	0	0	0	PASS	10661	TCGA-AX-A3FT	UCEC	64	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23543	Alive	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	6	0	6	NA	NA	0	6	
60	TCGA-AX-A3FV	2	26	2	7	2	0	0	0	4	71	3	1	2	29	4	0	TCGA-AX-A3FV-01	467	0.9461533244129549	285	TCGA-AX-A3FV-01	19	34	124	0.482026849614833	TCGA-AX-A3FV-01	27	18	13	58	PASS	10662	TCGA-AX-A3FV	UCEC	62	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2009	NA	-22752	Alive	NA	-6	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	
70	TCGA-AX-A3FW	0	12	0	6	1	0	1	0	2	38	2	0	1	16	0	0	TCGA-AX-A3FW-01	463	0.1919303505738061	287	TCGA-AX-A3FW-01	3	12	83	0.1946824656829101	TCGA-AX-A3FW-01	8	10	7	25	PASS	10663	TCGA-AX-A3FW	UCEC	66	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24419	Alive	NA	17	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	17	0	17	NA	NA	0	17	
70	TCGA-AX-A3FX	2	15	0	4	0	0	1	0	4	50	4	0	3	17	0	1	TCGA-AX-A3FX-01	486	0.3238777304358208	302	TCGA-AX-A3FX-01	5	5	75	0.1312820068522366	TCGA-AX-A3FX-01	10	4	2	16	PASS	10664	TCGA-AX-A3FX	UCEC	69	FEMALE	WHITE	NA	Stage IIB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25260	Dead	NA	NA	1333	NA	Locoregional Recurrence	"Other, specify"	Chest	938	NA	NA	NA	1	1333	NA	1333	NA	NA	1	938	
30	TCGA-AX-A3FZ	1	7	0	0	1	1	0	0	2	34	1	0	1	11	2	0	TCGA-AX-A3FZ-01	176	0.3532885912623281	107	TCGA-AX-A3FZ-01	16	23	19	0.20014224207796005	TCGA-AX-A3FZ-01	5	3	2	10	PASS	10665	TCGA-AX-A3FZ	UCEC	33	FEMALE	WHITE	NA	Stage IIIB	Endometrioid endometrial adenocarcinoma	G3	2010	NA	-12331	Alive	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	6	0	6	NA	NA	0	6	
80	TCGA-AX-A3G1	1	16	0	1	2	0	0	0	5	48	4	0	1	9	2	0	TCGA-AX-A3G1-01	284	0.6958175051034314	182	TCGA-AX-A3G1-01	12	14	62	0.3220632308237661	TCGA-AX-A3G1-01	10	9	8	27	PASS	10666	TCGA-AX-A3G1	UCEC	84	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31037	Dead	NA	NA	624	NA	NA	NA	NA	NA	NA	NA	NA	1	624	NA	624	NA	NA	0	624	
60	TCGA-AX-A3G3	7	43	4	3	3	0	2	0	6	121	7	0	5	39	3	0	TCGA-AX-A3G3	0	0	0	TCGA-AX-A3G3	0	0	0	0	TCGA-AX-A3G3-01	24	35	13	72	PASS	10667	TCGA-AX-A3G3	UCEC	58	FEMALE	WHITE	NA	Stage IIIA	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21308	Alive	NA	42	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	42	0	42	NA	NA	0	42	
60	TCGA-AX-A3G4	2	9	1	2	2	2	2	0	2	24	3	0	3	12	2	1	TCGA-AX-A3G4-01	512	0.8489405371512594	336	TCGA-AX-A3G4-01	13	17	138	0.30738951090471445	TCGA-AX-A3G4-01	19	15	17	51	PASS	10668	TCGA-AX-A3G4	UCEC	60	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NA	Stage IIIC	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22099	Alive	NA	9	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	9	0	9	NA	NA	0	9	
70	TCGA-AX-A3G6	1	11	0	1	4	1	0	0	1	45	4	0	1	13	1	0	TCGA-AX-A3G6-01	222	0.591972474034828	130	TCGA-AX-A3G6-01	21	61	30	0.1241044189141232	TCGA-AX-A3G6-01	8	10	1	19	PASS	10669	TCGA-AX-A3G6	UCEC	67	FEMALE	WHITE	NA	Stage IA	Serous endometrial adenocarcinoma	G2	2010	NA	-24681	Alive	NA	8	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	8	0	8	NA	NA	0	8	
70	TCGA-AX-A3G7	3	6	1	1	2	0	0	0	0	24	1	0	1	8	1	0	TCGA-AX-A3G7-01	306	0.2257810722870086	175	TCGA-AX-A3G7-01	4	7	71	0.12064271548789933	TCGA-AX-A3G7-01	9	8	7	24	PASS	10670	TCGA-AX-A3G7	UCEC	71	FEMALE	WHITE	NA	Stage IVB	Serous endometrial adenocarcinoma	G3	2010	NA	-26187	Alive	NA	9	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	9	0	9	NA	NA	0	9	
80	TCGA-AX-A3G8	31	303	13	44	155	36	18	1	60	526	40	0	22	235	11	0	TCGA-AX-A3G8-01	76	0.0345245018852281	34	TCGA-AX-A3G8-01	1	2	3	0.016978278341260974	TCGA-AX-A3G8-01	1	0	1	2	PASS	10671	TCGA-AX-A3G8	UCEC	76	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27899	Alive	NA	36	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	36	0	36	NA	NA	0	36	
60	TCGA-AX-A3G9	22	328	11	45	146	24	22	1	49	422	28	0	22	200	9	2	TCGA-AX-A3G9-01	63	5.2281902427849844e-05	24	TCGA-AX-A3G9-01	0	0	2	0.017598920281280638	TCGA-AX-A3G9-01	1	1	1	3	PASS	10672	TCGA-AX-A3G9	UCEC	63	FEMALE	WHITE	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2010	NA	-23361	Alive	NA	558	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	558	0	558	NA	NA	0	558	
70	TCGA-AX-A3GB	1	19	0	5	1	1	0	0	7	69	7	0	1	31	0	0	TCGA-AX-A3GB-01	62	0.03452869680282752	24	TCGA-AX-A3GB-01	1	2	19	0.005720583518937601	TCGA-AX-A3GB-01	2	1	1	4	PASS	10673	TCGA-AX-A3GB	UCEC	73	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26724	Alive	NA	440	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	440	0	440	NA	NA	0	440	
70	TCGA-AX-A3GI	2	16	0	4	1	0	1	0	3	37	1	0	2	10	0	0	TCGA-AX-A3GI-01	408	0.8177814987808414	253	TCGA-AX-A3GI-01	14	16	152	0.4310073759230133	TCGA-AX-A3GI-01	13	6	19	38	PASS	10674	TCGA-AX-A3GI	UCEC	66	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous endometrial adenocarcinoma	G3	2011	NA	-24388	Alive	NA	12	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	12	0	12	NA	NA	0	12	
80	TCGA-B5-A0JN	1	4	0	3	4	2	1	0	10	118	7	0	2	45	6	0	TCGA-B5-A0JN-01	578	0.7357506457787083	365	TCGA-B5-A0JN-01	10	32	80	0.2519367020786771	TCGA-B5-A0JN-01	25	22	11	58	PASS	10675	TCGA-B5-A0JN	UCEC	84	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IVB	Serous endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30933	Alive	TUMOR FREE	2445	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2445	0	2445	NA	NA	0	2445	
70	TCGA-B5-A0JR	8	100	1	19	65	28	3	1	41	425	27	0	20	196	17	0	TCGA-B5-A0JR-01	60	0.11870433512701585	16	TCGA-B5-A0JR-01	4	4	0	0.0	TCGA-B5-A0JR-01	1	0	0	1	mutation call filter	10676	TCGA-B5-A0JR	UCEC	73	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26814	Alive	TUMOR FREE	1731	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1731	0	1731	0	1731	0	1731	
50	TCGA-B5-A0JS	1	2	0	0	1	1	0	0	1	23	3	0	1	6	0	0	TCGA-B5-A0JS-01	88	0.01954105417455093	43	TCGA-B5-A0JS-01	1	1	0	0.0	TCGA-B5-A0JS-01	1	0	0	1	PASS	10677	TCGA-B5-A0JS	UCEC	54	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19995	Alive	TUMOR FREE	2627	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2627	0	2627	0	2627	0	2627	
60	TCGA-B5-A0JT	0	2	1	2	3	1	0	0	2	55	2	0	0	14	4	1	TCGA-B5-A0JT-01	46	0.9477292348717914	14	TCGA-B5-A0JT-01	13	7	19	2.124386760800333e-05	TCGA-B5-A0JT-01	1	0	0	1	PASS	10678	TCGA-B5-A0JT	UCEC	63	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23041	Alive	TUMOR FREE	1682	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1682	0	1682	0	1682	0	1682	
60	TCGA-B5-A0JU	27	218	8	33	93	16	7	1	39	268	13	2	14	163	3	0	TCGA-B5-A0JU-01	39	4.537069450430874e-05	9	TCGA-B5-A0JU-01	0	0	19	4.0886028571902034e-05	TCGA-B5-A0JU-01	0	0	0	0	PASS	10679	TCGA-B5-A0JU	UCEC	57	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21159	Alive	TUMOR FREE	1802	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1802	0	1802	NA	NA	0	1802	
60	TCGA-B5-A0JV	4	27	3	8	42	12	3	0	14	256	22	0	9	116	8	0	TCGA-B5-A0JV-01	172	0.035947174524645215	125	TCGA-B5-A0JV-01	1	1	4	0.0014036101154459673	TCGA-B5-A0JV-01	1	1	0	2	mutation call filter	10680	TCGA-B5-A0JV	UCEC	63	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23295	Alive	TUMOR FREE	2616	NA	NA	Locoregional Disease	"Other, specify"	vaginal wall	698	Complete Remission/Response	NA	NA	0	2616	0	2616	1	698	1	698	
60	TCGA-B5-A0JX	0	15	1	5	5	0	0	0	6	53	4	0	1	20	1	0	TCGA-B5-A0JX-01	49	0.12025825440995375	10	TCGA-B5-A0JX-01	1	7	8	0.07684736919898356	TCGA-B5-A0JX-01	9	10	3	22	PASS	10681	TCGA-B5-A0JX	UCEC	62	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22834	Alive	TUMOR FREE	1787	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1787	0	1787	0	1787	0	1787	
50	TCGA-B5-A0JY	67	1166	61	300	5	41	0	0	465	8143	1246	12	206	2406	181	8	TCGA-B5-A0JY-01	65	0.0003088314781709693	21	TCGA-B5-A0JY-01	0	0	0	0.0	TCGA-B5-A0JY-01	0	0	0	0	hypermutated sample	10682	TCGA-B5-A0JY	UCEC	50	FEMALE	WHITE	NA	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18475	Alive	TUMOR FREE	2107	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2107	0	2107	0	2107	0	2107	
60	TCGA-B5-A0JZ	6	63	5	12	106	16	12	0	28	324	25	1	11	141	10	0	TCGA-B5-A0JZ-01	49	9.899119123823289e-05	11	TCGA-B5-A0JZ-01	0	0	19	4.0731729309573054e-05	TCGA-B5-A0JZ-01	0	0	0	0	mutation call filter	10683	TCGA-B5-A0JZ	UCEC	60	FEMALE	WHITE	NA	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22106	Alive	TUMOR FREE	2173	NA	NA	Metastatic	"Other, specify"	inguinal lymph node	356	Progressive Disease	NA	NA	0	2173	0	2173	NA	NA	1	356	
50	TCGA-B5-A0K0	0	0	0	1	0	0	1	0	0	14	3	1	0	4	1	0	TCGA-B5-A0K0-01	58	0.08880744643679034	18	TCGA-B5-A0K0-01	3	2	19	1.6756217341116828e-05	TCGA-B5-A0K0-01	1	0	0	1	mutation call filter	10684	TCGA-B5-A0K0	UCEC	48	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2008	Indeterminate (neither Pre or Postmenopausal)	-17810	Alive	TUMOR FREE	1478	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1478	0	1478	0	1478	0	1478	
70	TCGA-B5-A0K1	0	10	0	1	3	1	0	0	2	32	4	0	0	17	2	0	TCGA-B5-A0K1-01	57	1.4688868395279096e-05	20	TCGA-B5-A0K1-01	0	0	0	0.0	TCGA-B5-A0K1-01	0	0	0	0	mutation call filter	10685	TCGA-B5-A0K1	UCEC	69	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25291	Alive	TUMOR FREE	1110	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1110	0	1110	0	1110	0	1110	
50	TCGA-B5-A0K2	5	24	2	13	41	13	3	2	18	223	11	0	5	90	3	0	TCGA-B5-A0K2-01	67	0.00041057591159475096	19	TCGA-B5-A0K2-01	0	0	2	0.00041727068564106234	TCGA-B5-A0K2-01	0	0	0	0	mutation call filter	10686	TCGA-B5-A0K2	UCEC	54	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2008	Indeterminate (neither Pre or Postmenopausal)	-20080	Alive	TUMOR FREE	2209	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2209	0	2209	0	2209	0	2209	
60	TCGA-B5-A0K3	1	4	0	1	1	1	0	0	2	41	9	0	0	17	2	0	TCGA-B5-A0K3-01	538	0.7280735934196927	379	TCGA-B5-A0K3-01	5	7	82	0.16694917496221404	TCGA-B5-A0K3-01	8	8	9	25	mutation call filter	10687	TCGA-B5-A0K3	UCEC	62	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22664	Dead	WITH TUMOR	NA	830	NA	Locoregional Disease	"Other, specify"	vaginal cuff	256	NA	NA	NA	1	830	1	830	NA	NA	1	256	
50	TCGA-B5-A0K4	0	3	0	0	2	1	0	0	2	39	7	0	1	9	1	0	TCGA-B5-A0K4-01	63	0.979816299111873	19	TCGA-B5-A0K4-01	10	6	0	0.0	TCGA-B5-A0K4-01	1	0	0	1	mutation call filter	10688	TCGA-B5-A0K4	UCEC	51	FEMALE	NA	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18631	Alive	TUMOR FREE	1757	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1757	0	1757	0	1757	0	1757	
60	TCGA-B5-A0K6	4	26	1	10	30	8	3	0	23	282	17	0	6	105	5	0	TCGA-B5-A0K6-01	49	0.04875206794325479	11	TCGA-B5-A0K6-01	2	2	19	0.01565675133566117	TCGA-B5-A0K6-01	2	1	1	4	mutation call filter	10689	TCGA-B5-A0K6	UCEC	58	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21515	Alive	TUMOR FREE	1953	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1953	0	1953	0	1953	0	1953	
60	TCGA-B5-A0K7	0	4	0	1	3	0	1	0	3	35	4	0	3	17	0	0	TCGA-B5-A0K7-01	56	0.11832021867426798	22	TCGA-B5-A0K7-01	3	3	0	0.0	TCGA-B5-A0K7-01	1	0	0	1	mutation call filter	10690	TCGA-B5-A0K7	UCEC	64	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23429	Alive	TUMOR FREE	1933	NA	NA	Metastatic	"Other, specify"	vagina	322	Complete Remission/Response	NA	NA	0	1933	0	1933	1	322	1	322	
70	TCGA-B5-A0K8	0	4	2	3	1	0	0	0	2	37	2	0	1	19	0	0	TCGA-B5-A0K8-01	226	0.7956034673563638	125	TCGA-B5-A0K8-01	10	12	43	0.2666505786297266	TCGA-B5-A0K8-01	11	5	14	30	PASS	10691	TCGA-B5-A0K8	UCEC	71	FEMALE	WHITE	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25992	Alive	TUMOR FREE	847	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	847	0	847	0	847	0	847	
90	TCGA-B5-A0K9	9	80	4	29	130	33	15	1	37	539	22	0	19	239	19	0	TCGA-B5-A0K9-01	40	0.11836249665068525	7	TCGA-B5-A0K9-01	3	3	0	0.0	TCGA-B5-A0K9-01	1	0	0	1	PASS	10692	TCGA-B5-A0K9	UCEC	88	FEMALE	WHITE	NA	Stage II	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32289	Dead	TUMOR FREE	NA	409	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	409	0	409	0	409	0	409	
60	TCGA-B5-A0KB	0	10	0	2	1	0	0	0	0	30	4	0	2	13	1	0	TCGA-B5-A0KB	0	0	0	TCGA-B5-A0KB	0	0	0	0	TCGA-B5-A0KB-01	13	11	14	38	PASS	10693	TCGA-B5-A0KB	UCEC	62	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22669	Alive	WITH TUMOR	824	NA	NA	Locoregional Disease	"Other, specify"	cul de sac mass	689	Complete Remission/Response	NA	NA	0	824	0	824	1	689	1	689	
50	TCGA-B5-A11E	45	774	51	230	14	27	2	0	416	8104	651	7	178	3070	166	5	TCGA-B5-A11E-01	76	0.10593845078256783	28	TCGA-B5-A11E-01	2	3	4	0.0060671133228611075	TCGA-B5-A11E-01	4	2	0	6	hypermutated sample	10694	TCGA-B5-A11E	UCEC	53	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Peri (6-12 months since last menstrual period)	-19458	Alive	TUMOR FREE	1820	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1820	0	1820	0	1820	0	1820	
60	TCGA-B5-A11F	0	6	0	0	2	0	0	0	1	32	3	1	1	13	1	0	TCGA-B5-A11F-01	77	0.06287509531520458	34	TCGA-B5-A11F-01	3	1	8	0.017302844163242584	TCGA-B5-A11F-01	0	2	1	3	PASS	10695	TCGA-B5-A11F	UCEC	55	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	1995	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20171	Alive	TUMOR FREE	5651	NA	NA	Metastatic	Bone	NA	1610	Complete Remission/Response	NA	NA	0	5651	0	5651	1	1610	1	1610	
70	TCGA-B5-A11G	7	68	2	24	26	94	2	2	45	383	15	1	11	173	18	0	TCGA-B5-A11G-01	264	0.04495186493882036	205	TCGA-B5-A11G-01	0	1	8	0.027394911748114804	TCGA-B5-A11G-01	1	2	2	5	PASS	10696	TCGA-B5-A11G	UCEC	71	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2001	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25995	Alive	TUMOR FREE	3448	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3448	0	3448	0	3448	0	3448	
70	TCGA-B5-A11H	8	122	8	49	221	40	29	0	55	665	37	0	20	293	18	4	TCGA-B5-A11H-01	101	0.06700800445215772	45	TCGA-B5-A11H-01	1	2	3	0.019604974349236682	TCGA-B5-A11H-01	2	3	1	6	PASS	10697	TCGA-B5-A11H	UCEC	67	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24556	Alive	TUMOR FREE	2687	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2687	0	2687	0	2687	0	2687	
70	TCGA-B5-A11I	1	3	0	3	0	1	0	0	3	42	3	0	2	13	3	0	TCGA-B5-A11I-01	264	0.7303000841587056	158	TCGA-B5-A11I-01	6	9	38	0.1992718418714334	TCGA-B5-A11I-01	10	13	12	35	PASS	10698	TCGA-B5-A11I	UCEC	65	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23857	Alive	TUMOR FREE	2303	NA	NA	Metastatic	Lung	NA	705	Complete Remission/Response	NA	NA	0	2303	0	2303	NA	NA	1	705	
60	TCGA-B5-A11J	1	52	2	20	68	16	9	1	27	299	28	0	8	135	10	1	TCGA-B5-A11J-01	55	4.160588790424338e-05	13	TCGA-B5-A11J-01	0	0	19	3.2565895177901977e-05	TCGA-B5-A11J-01	0	0	0	0	PASS	10699	TCGA-B5-A11J	UCEC	64	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23485	Alive	TUMOR FREE	1656	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1656	0	1656	0	1656	0	1656	
70	TCGA-B5-A11L	1	13	0	7	6	1	3	1	5	93	6	0	3	31	2	0	TCGA-B5-A11L-01	51	0.06783480459967113	10	TCGA-B5-A11L-01	4	4	3	0.03477215727065114	TCGA-B5-A11L-01	1	1	1	3	PASS	10700	TCGA-B5-A11L	UCEC	71	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26120	Dead	TUMOR FREE	NA	2240	NA	Locoregional Recurrence	"Other, specify"	Vaginal Apex	131	Complete Remission/Response	NA	NA	1	2240	0	2240	1	131	1	131	
40	TCGA-B5-A11M	0	1	0	0	1	0	1	0	1	28	3	0	1	7	0	0	TCGA-B5-A11M	0	0	0	TCGA-B5-A11M	0	0	0	0	TCGA-B5-A11M	0	0	0	0	PASS	10701	TCGA-B5-A11M	UCEC	43	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16063	Alive	TUMOR FREE	1362	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1362	0	1362	0	1362	0	1362	
70	TCGA-B5-A11N	10	181	10	58	1	6	2	1	89	1576	277	1	38	465	27	2	TCGA-B5-A11N-01	59	0.02792398594390133	21	TCGA-B5-A11N-01	2	1	3	0.029116459051699944	TCGA-B5-A11N-01	0	0	0	0	hypermutated sample	10702	TCGA-B5-A11N	UCEC	69	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25442	Alive	TUMOR FREE	1876	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1876	0	1876	0	1876	0	1876	
60	TCGA-B5-A11O	0	11	0	5	7	0	1	0	2	81	6	0	1	26	1	1	TCGA-B5-A11O-01	49	6.075379379136384e-05	10	TCGA-B5-A11O-01	0	0	0	0.0	TCGA-B5-A11O-01	0	0	0	0	PASS	10703	TCGA-B5-A11O	UCEC	62	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22720	Alive	TUMOR FREE	2609	NA	NA	New Primary Tumor	"Other, specify"	Right Breast	1924	Complete Remission/Response	NA	NA	0	2609	0	2609	0	2609	1	1924	
90	TCGA-B5-A11P	2	12	2	3	3	0	1	0	1	37	2	0	1	17	1	0	TCGA-B5-A11P-01	40	0.9471943686367612	7	TCGA-B5-A11P-01	20	35	2	0.07908018023928724	TCGA-B5-A11P-01	2	0	0	2	PASS	10704	TCGA-B5-A11P	UCEC	87	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32047	Alive	TUMOR FREE	1583	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1583	0	1583	NA	NA	0	1583	
60	TCGA-B5-A11Q	0	2	0	3	2	0	1	0	0	36	2	0	0	7	1	0	TCGA-B5-A11Q-01	79	0.11196269681509928	26	TCGA-B5-A11Q-01	4	5	9	0.04850339616175249	TCGA-B5-A11Q-01	4	1	2	7	PASS	10705	TCGA-B5-A11Q	UCEC	64	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23538	Alive	TUMOR FREE	976	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	976	0	976	0	976	0	976	
50	TCGA-B5-A11R	10	80	5	44	4	2	1	0	35	519	51	0	7	201	10	0	TCGA-B5-A11R-01	90	0.9471851803687216	43	TCGA-B5-A11R-01	11	7	0	0.0	TCGA-B5-A11R-01	1	0	0	1	PASS	10706	TCGA-B5-A11R	UCEC	51	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage II	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18878	Alive	TUMOR FREE	2349	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2349	0	2349	0	2349	0	2349	
60	TCGA-B5-A11S	0	2	1	1	1	2	0	0	0	46	1	0	1	11	1	0	TCGA-B5-A11S-01	41	0.15089459989495552	7	TCGA-B5-A11S-01	6	7	19	0.04376628513969897	TCGA-B5-A11S-01	2	1	1	4	PASS	10707	TCGA-B5-A11S	UCEC	63	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23085	Alive	TUMOR FREE	2229	NA	NA	New Primary Tumor	"Other, specify"	Breast	41	Complete Remission/Response	NA	NA	0	2229	0	2229	0	2229	1	41	
70	TCGA-B5-A11U	4	35	2	8	78	20	11	0	22	235	16	0	8	128	6	0	TCGA-B5-A11U-01	61	6.706828286344206e-05	22	TCGA-B5-A11U-01	0	0	2	0.007269889964028237	TCGA-B5-A11U-01	1	1	1	3	PASS	10708	TCGA-B5-A11U	UCEC	74	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27160	Alive	TUMOR FREE	509	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	509	0	509	NA	NA	0	509	
60	TCGA-B5-A11V	0	3	0	2	3	2	0	0	2	48	3	0	1	15	0	0	TCGA-B5-A11V-01	58	0.1219104446843494	11	TCGA-B5-A11V-01	6	4	0	0.0	TCGA-B5-A11V-01	2	1	0	3	PASS	10709	TCGA-B5-A11V	UCEC	64	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23630	Alive	TUMOR FREE	595	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	595	0	595	0	595	0	595	
60	TCGA-B5-A11W	0	3	0	0	0	2	0	0	4	62	6	0	0	16	2	0	TCGA-B5-A11W-01	63	0.0008985866911713373	21	TCGA-B5-A11W-01	0	0	5	0.02047150638966453	TCGA-B5-A11W-01	1	1	1	3	PASS	10710	TCGA-B5-A11W	UCEC	61	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22365	Alive	TUMOR FREE	593	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	593	0	593	0	593	0	593	
70	TCGA-B5-A11X	0	3	0	2	3	2	0	0	4	49	2	1	0	18	1	0	TCGA-B5-A11X	0	0	0	TCGA-B5-A11X	0	0	0	0	TCGA-B5-A11X	0	0	0	0	PASS	10711	TCGA-B5-A11X	UCEC	66	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24217	Alive	TUMOR FREE	596	NA	NA	Metastatic	"Other, specify"	lymph nodes	397	NA	NA	NA	0	596	0	596	NA	NA	1	397	
60	TCGA-B5-A11Y	7	70	8	30	14	0	5	0	23	860	44	1	22	412	9	1	TCGA-B5-A11Y-01	37	8.817706580343826e-06	1	TCGA-B5-A11Y-01	0	2	19	0.04899633134259285	TCGA-B5-A11Y-01	0	0	0	0	PASS	10712	TCGA-B5-A11Y	UCEC	59	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21860	Alive	TUMOR FREE	560	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	560	0	560	0	560	0	560	
60	TCGA-B5-A11Z	0	4	0	2	0	1	1	2	5	45	3	0	0	19	0	0	TCGA-B5-A11Z-01	48	0.034250891680496755	12	TCGA-B5-A11Z-01	1	2	2	0.01831013015400253	TCGA-B5-A11Z-01	2	1	1	4	PASS	10713	TCGA-B5-A11Z	UCEC	61	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22505	Alive	TUMOR FREE	528	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	528	0	528	0	528	0	528	
60	TCGA-B5-A121	1	5	0	0	3	1	0	0	0	23	2	0	1	9	2	0	TCGA-B5-A121-01	45	5.326831377475765e-05	9	TCGA-B5-A121-01	0	2	2	0.07561497539135073	TCGA-B5-A121-01	1	1	0	2	PASS	10714	TCGA-B5-A121	UCEC	57	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21018	Alive	TUMOR FREE	504	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	504	0	504	0	504	0	504	
70	TCGA-B5-A1MR	170	2371	59	197	3	13	0	0	400	6277	824	8	231	1605	143	9	TCGA-B5-A1MR-01	84	0.13477500077376064	36	TCGA-B5-A1MR-01	1	1	19	0.0008055662399320805	TCGA-B5-A1MR-01	4	0	0	4	hypermutated sample	10715	TCGA-B5-A1MR	UCEC	65	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	1995	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24017	Alive	TUMOR FREE	6859	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	6859	0	6859	0	6859	0	6859	
60	TCGA-B5-A1MS	0	10	1	1	3	0	0	0	3	39	3	0	0	11	0	0	TCGA-B5-A1MS-01	294	0.7651846517267815	173	TCGA-B5-A1MS-01	13	18	40	0.14206407638486468	TCGA-B5-A1MS-01	12	10	8	30	PASS	10716	TCGA-B5-A1MS	UCEC	60	FEMALE	WHITE	NA	Stage IC	Serous endometrial adenocarcinoma	G3	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22068	Dead	WITH TUMOR	NA	3112	NA	Locoregional Recurrence	"Other, specify"	Supraclavicular Fossa	2706	Partial Remission/Response	NA	NA	1	3112	1	3112	NA	NA	1	2706	
80	TCGA-B5-A1MU	0	1	0	3	0	0	0	0	0	30	2	0	1	6	1	0	TCGA-B5-A1MU-01	148	0.4391036915643855	84	TCGA-B5-A1MU-01	10	28	41	0.3305179795928252	TCGA-B5-A1MU-01	11	6	8	25	PASS	10717	TCGA-B5-A1MU	UCEC	79	FEMALE	WHITE	NA	Stage IVB	Serous endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29027	Dead	WITH TUMOR	NA	1548	NA	New Primary Tumor	"Other, specify"	Breast	1365	Complete Remission/Response	NA	NA	1	1548	1	1548	NA	NA	1	1365	
80	TCGA-B5-A1MV	2	15	0	4	2	1	1	0	1	49	5	0	2	22	3	0	TCGA-B5-A1MV-01	63	0.10075411724320717	27	TCGA-B5-A1MV-01	4	4	2	0.033329018222528754	TCGA-B5-A1MV-01	1	0	1	2	PASS	10718	TCGA-B5-A1MV	UCEC	84	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30926	Alive	TUMOR FREE	1565	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1565	0	1565	0	1565	0	1565	
60	TCGA-B5-A1MW	39	342	3	35	16	85	2	1	42	394	15	1	20	161	18	1	TCGA-B5-A1MW-01	105	0.049868499416377325	53	TCGA-B5-A1MW-01	2	2	0	0.0	TCGA-B5-A1MW-01	0	0	0	0	PASS	10719	TCGA-B5-A1MW	UCEC	55	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20183	Alive	TUMOR FREE	447	NA	NA	Locoregional Disease	"Other, specify"	vaginal cuff	311	Complete Remission/Response	NA	NA	0	447	0	447	1	311	1	311	
50	TCGA-B5-A1MX	120	1679	71	283	320	203	9	1	450	4480	354	6	178	2099	247	10	TCGA-B5-A1MX-01	65	0.0008148208865953727	29	TCGA-B5-A1MX-01	0	0	6	0.0007912886343998992	TCGA-B5-A1MX-01	0	0	0	0	hypermutated sample	10720	TCGA-B5-A1MX	UCEC	47	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17320	Alive	TUMOR FREE	1473	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1473	0	1473	0	1473	0	1473	
60	TCGA-B5-A1MY	0	3	0	0	1	0	2	0	0	41	3	1	1	13	1	0	TCGA-B5-A1MY-01	330	0.6328786358419008	197	TCGA-B5-A1MY-01	17	29	42	0.1833952959970304	TCGA-B5-A1MY-01	16	8	9	33	PASS	10721	TCGA-B5-A1MY	UCEC	62	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22805	Dead	WITH TUMOR	NA	361	NA	Locoregional Disease	"Other, specify"	peritoneum	333	NA	NA	NA	1	361	1	361	NA	NA	1	333	
50	TCGA-B5-A1MZ	2	13	1	0	2	1	1	0	1	42	1	0	1	14	3	1	TCGA-B5-A1MZ-01	66	0.03408716909341065	27	TCGA-B5-A1MZ-01	1	2	0	0.0	TCGA-B5-A1MZ-01	1	0	0	1	PASS	10722	TCGA-B5-A1MZ	UCEC	54	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Indeterminate (neither Pre or Postmenopausal)	-19955	Alive	TUMOR FREE	1598	NA	NA	Locoregional Recurrence	"Other, specify"	Vagina	613	Complete Remission/Response	NA	NA	0	1598	0	1598	1	613	1	613	
70	TCGA-B5-A1N2	2	14	1	6	4	0	0	0	5	126	9	0	4	33	2	0	TCGA-B5-A1N2-01	426	0.6979816747061611	275	TCGA-B5-A1N2-01	16	32	84	0.28849926769665313	TCGA-B5-A1N2-01	18	26	11	55	PASS	10723	TCGA-B5-A1N2	UCEC	70	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC1	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25612	Dead	WITH TUMOR	NA	954	NA	Distant Metastasis	Brain	NA	804	Complete Remission/Response	NA	NA	1	954	1	954	1	804	1	804	
60	TCGA-B5-A3F9	3	11	1	5	3	1	0	0	2	48	4	0	2	29	2	0	TCGA-B5-A3F9-01	123	0.2714436763305919	63	TCGA-B5-A3F9-01	15	28	10	0.06913781760347164	TCGA-B5-A3F9-01	3	1	0	4	PASS	10724	TCGA-B5-A3F9	UCEC	56	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20523	Alive	TUMOR FREE	4155	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4155	0	4155	NA	NA	0	4155	
70	TCGA-B5-A3FA	267	3367	102	329	51	112	1	0	685	8624	509	10	366	3426	232	6	TCGA-B5-A3FA-01	55	0.0003241292158703644	16	TCGA-B5-A3FA-01	0	0	5	0.000301950664103729	TCGA-B5-A3FA-01	0	0	0	0	hypermutated sample	10725	TCGA-B5-A3FA	UCEC	73	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26850	Alive	TUMOR FREE	2929	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2929	0	2929	NA	NA	0	2929	
70	TCGA-B5-A3FB	3	8	0	1	2	0	1	0	2	37	2	0	4	22	1	0	TCGA-B5-A3FB-01	243	0.011089247524516488	138	TCGA-B5-A3FB-01	0	0	6	0.0010014861734754094	TCGA-B5-A3FB-01	0	0	0	0	PASS	10726	TCGA-B5-A3FB	UCEC	73	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26779	Alive	TUMOR FREE	2844	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2844	0	2844	NA	NA	0	2844	
50	TCGA-B5-A3FC	306	3716	154	484	65	400	0	2	786	10746	666	3	391	5013	198	7	TCGA-B5-A3FC-01	137	0.004294104652106175	63	TCGA-B5-A3FC-01	0	0	4	0.0004126878839633983	TCGA-B5-A3FC-01	0	0	0	0	hypermutated sample	10727	TCGA-B5-A3FC	UCEC	53	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage II	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19422	Alive	TUMOR FREE	2185	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2185	0	2185	NA	NA	0	2185	
70	TCGA-B5-A3FD	1	12	1	0	2	2	0	0	4	34	1	0	1	20	1	0	TCGA-B5-A3FD-01	219	0.8945311519154909	127	TCGA-B5-A3FD-01	9	9	31	0.2380304497424155	TCGA-B5-A3FD-01	9	5	8	22	PASS	10728	TCGA-B5-A3FD	UCEC	70	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2009	Indeterminate (neither Pre or Postmenopausal)	-25813	Dead	TUMOR FREE	NA	1197	NA	Locoregional Recurrence	"Other, specify"	endometrium	562	NA	NA	NA	1	1197	0	1197	NA	NA	1	562	
70	TCGA-B5-A3FH	0	5	0	1	3	1	1	0	3	28	3	0	2	20	1	0	TCGA-B5-A3FH-01	140	0.04767108820717866	76	TCGA-B5-A3FH-01	1	2	10	0.006655011159098961	TCGA-B5-A3FH-01	3	0	0	3	PASS	10729	TCGA-B5-A3FH	UCEC	74	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27221	Alive	TUMOR FREE	841	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	841	0	841	0	841	0	841	
70	TCGA-B5-A3S1	3	21	2	2	1	0	1	0	5	75	9	0	4	29	0	0	TCGA-B5-A3S1-01	417	0.6571036394958083	275	TCGA-B5-A3S1-01	25	16	55	0.12774658888718746	TCGA-B5-A3S1-01	11	17	8	36	PASS	10730	TCGA-B5-A3S1	UCEC	71	FEMALE	WHITE	NA	Stage IIIC1	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26031	Alive	WITH TUMOR	902	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	902	0	902	0	902	0	902	
70	TCGA-B5-A5OC	38	424	11	55	151	34	7	0	62	713	33	0	28	334	27	2	TCGA-B5-A5OC-01	73	0.07956315850287901	36	TCGA-B5-A5OC-01	3	3	8	0.0007044334597078531	TCGA-B5-A5OC-01	1	0	0	1	PASS	10731	TCGA-B5-A5OC	UCEC	71	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIB	Endometrioid endometrial adenocarcinoma	G3	2011	NA	-26109	Alive	TUMOR FREE	1249	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1249	0	1249	NA	NA	0	1249	
70	TCGA-B5-A5OD	1	9	1	0	3	1	0	0	3	42	2	0	0	9	1	0	TCGA-B5-A5OD-01	458	0.6367827764956122	302	TCGA-B5-A5OD-01	16	31	112	0.13621280628220264	TCGA-B5-A5OD-01	17	18	7	42	PASS	10732	TCGA-B5-A5OD	UCEC	67	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous endometrial adenocarcinoma	G3	2011	NA	-24775	Alive	TUMOR FREE	1038	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1038	0	1038	NA	NA	0	1038	
70	TCGA-B5-A5OE	0	16	1	2	3	0	1	0	2	59	3	0	3	28	4	0	TCGA-B5-A5OE-01	411	0.917590147892937	264	TCGA-B5-A5OE-01	10	10	161	0.25175804691372616	TCGA-B5-A5OE-01	11	10	11	32	PASS	10733	TCGA-B5-A5OE	UCEC	68	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2011	NA	-24905	Alive	TUMOR FREE	1063	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1063	0	1063	NA	NA	0	1063	
50	TCGA-BG-A0LW	0	5	0	0	2	1	0	0	1	25	0	0	1	8	1	0	TCGA-BG-A0LW-01	63	5.0273912789460104e-05	18	TCGA-BG-A0LW-01	0	0	2	2.284769406870616e-05	TCGA-BG-A0LW-01	0	0	0	0	mutation call filter	10734	TCGA-BG-A0LW	UCEC	47	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	Indeterminate (neither Pre or Postmenopausal)	-17369	Alive	TUMOR FREE	566	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	566	0	566	0	566	0	566	
60	TCGA-BG-A0LX	4	59	1	17	88	12	5	0	21	313	18	0	3	171	12	0	TCGA-BG-A0LX-01	44	0.08114115863785619	10	TCGA-BG-A0LX-01	3	2	2	0.015691456865450596	TCGA-BG-A0LX-01	2	1	1	4	mutation call filter	10735	TCGA-BG-A0LX	UCEC	57	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20928	Alive	TUMOR FREE	614	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	614	0	614	0	614	0	614	
70	TCGA-BG-A0M0	1	18	2	3	22	3	1	0	6	101	8	0	5	41	3	0	TCGA-BG-A0M0-01	84	0.17323638561792828	30	TCGA-BG-A0M0-01	4	4	0	0.0	TCGA-BG-A0M0-01	2	0	0	2	mutation call filter	10736	TCGA-BG-A0M0	UCEC	66	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24427	Alive	TUMOR FREE	588	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	588	0	588	0	588	0	588	
60	TCGA-BG-A0M2	0	2	0	1	2	0	1	1	1	22	2	0	2	10	0	0	TCGA-BG-A0M2-01	88	0.9193151362079858	43	TCGA-BG-A0M2-01	10	14	8	0.20042284579826586	TCGA-BG-A0M2-01	4	5	4	13	mutation call filter	10737	TCGA-BG-A0M2	UCEC	62	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22822	Alive	TUMOR FREE	637	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	637	0	637	0	637	0	637	
70	TCGA-BG-A0M3	0	3	0	1	2	3	1	0	1	45	3	0	2	18	3	0	TCGA-BG-A0M3-01	63	0.16050292386167928	21	TCGA-BG-A0M3-01	6	4	0	0.0	TCGA-BG-A0M3-01	2	0	0	2	mutation call filter	10738	TCGA-BG-A0M3	UCEC	74	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27183	Alive	TUMOR FREE	1071	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1071	0	1071	0	1071	0	1071	
60	TCGA-BG-A0M4	6	54	6	22	78	9	6	0	24	448	22	1	13	174	13	1	TCGA-BG-A0M4-01	53	0.19392355457742505	18	TCGA-BG-A0M4-01	8	6	19	0.0341331408240375	TCGA-BG-A0M4-01	3	0	1	4	mutation call filter	10739	TCGA-BG-A0M4	UCEC	60	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22090	Alive	TUMOR FREE	2167	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2167	0	2167	0	2167	0	2167	
70	TCGA-BG-A0M6	0	0	0	2	1	1	0	1	0	39	1	0	0	12	0	0	TCGA-BG-A0M6-01	265	0.7062789069220454	167	TCGA-BG-A0M6-01	19	31	40	0.2791794544264521	TCGA-BG-A0M6-01	17	13	12	42	mutation call filter	10740	TCGA-BG-A0M6	UCEC	73	FEMALE	WHITE	NA	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26666	Dead	TUMOR FREE	NA	671	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	671	0	671	0	671	0	671	
60	TCGA-BG-A0M7	0	2	0	1	2	0	1	0	3	56	3	0	0	22	0	0	TCGA-BG-A0M7-01	73	5.946700887173678e-05	24	TCGA-BG-A0M7-01	0	2	4	0.04505642549406192	TCGA-BG-A0M7-01	1	1	1	3	mutation call filter	10741	TCGA-BG-A0M7	UCEC	60	FEMALE	WHITE	NA	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22096	Alive	TUMOR FREE	1937	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1937	0	1937	0	1937	0	1937	
50	TCGA-BG-A0M8	0	9	0	2	2	0	2	0	4	55	6	0	3	24	1	0	TCGA-BG-A0M8	0	0	0	TCGA-BG-A0M8	0	0	0	0	TCGA-BG-A0M8-01	20	23	5	48	PASS	10742	TCGA-BG-A0M8	UCEC	50	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2008	Indeterminate (neither Pre or Postmenopausal)	-18308	Alive	TUMOR FREE	2020	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2020	0	2020	0	2020	0	2020	
70	TCGA-BG-A0M9	0	10	1	1	2	2	1	0	2	43	9	0	0	11	1	0	TCGA-BG-A0M9-01	119	0.04982157707417094	69	TCGA-BG-A0M9	0	0	0	0	TCGA-BG-A0M9	0	0	0	0	mutation call filter	10743	TCGA-BG-A0M9	UCEC	73	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26708	Alive	TUMOR FREE	2270	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2270	0	2270	0	2270	0	2270	
60	TCGA-BG-A0MA	0	6	0	2	4	3	0	0	2	32	4	0	0	14	1	0	TCGA-BG-A0MA-01	93	0.04991180337681228	43	TCGA-BG-A0MA-01	2	1	19	1.5819013384848204e-05	TCGA-BG-A0MA-01	0	0	0	0	PASS	10744	TCGA-BG-A0MA	UCEC	60	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22036	Dead	WITH TUMOR	NA	326	NA	Metastatic	Bone	NA	70	Progressive Disease	NA	NA	1	326	1	326	NA	NA	1	70	
70	TCGA-BG-A0MC	1	1	1	2	3	0	1	0	2	45	1	0	3	15	1	0	TCGA-BG-A0MC-01	59	0.029636922333629807	16	TCGA-BG-A0MC-01	0	0	4	0.03524433568526435	TCGA-BG-A0MC-01	2	3	2	7	mutation call filter	10745	TCGA-BG-A0MC	UCEC	74	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27136	Alive	TUMOR FREE	1263	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1263	0	1263	0	1263	0	1263	
70	TCGA-BG-A0MG	1	7	0	7	6	3	2	0	5	77	10	1	5	39	0	0	TCGA-BG-A0MG-01	84	0.09379595660972284	33	TCGA-BG-A0MG-01	4	4	4	0.055322918248183035	TCGA-BG-A0MG-01	2	2	2	6	PASS	10746	TCGA-BG-A0MG	UCEC	73	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26957	Alive	TUMOR FREE	1477	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1477	0	1477	0	1477	0	1477	
60	TCGA-BG-A0MH	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BG-A0MH	0	0	0	TCGA-BG-A0MH	0	0	0	0	TCGA-BG-A0MH	0	0	0	0	PASS	10747	TCGA-BG-A0MH	UCEC	61	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22475	Alive	TUMOR FREE	1930	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1930	0	1930	0	1930	0	1930	
80	TCGA-BG-A0MI	0	1	0	3	1	0	1	0	1	47	2	0	2	19	1	0	TCGA-BG-A0MI-01	63	3.7937042438829136e-05	16	TCGA-BG-A0MI-01	0	0	2	0.02658807500397212	TCGA-BG-A0MI-01	2	2	2	6	mutation call filter	10748	TCGA-BG-A0MI	UCEC	83	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30334	Dead	TUMOR FREE	NA	714	NA	NA	NA	NA	NA	NA	NA	NA	1	714	0	714	NA	NA	0	714	
50	TCGA-BG-A0MK	1	23	0	8	3	2	0	0	3	68	5	0	3	32	2	1	TCGA-BG-A0MK-01	77	0.00017443798939173038	33	TCGA-BG-A0MK-01	0	0	19	7.115083176474036e-06	TCGA-BG-A0MK-01	0	0	0	0	PASS	10749	TCGA-BG-A0MK	UCEC	52	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIB	Endometrioid endometrial adenocarcinoma	G3	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19034	Dead	WITH TUMOR	NA	1317	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	1317	1	1317	NA	NA	1	1317	
60	TCGA-BG-A0MO	0	6	0	0	3	1	0	0	2	33	2	0	2	14	1	0	TCGA-BG-A0MO-01	41	0.043301803452524316	8	TCGA-BG-A0MO-01	2	7	2	0.058491240294116724	TCGA-BG-A0MO-01	2	0	2	4	mutation call filter	10750	TCGA-BG-A0MO	UCEC	63	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23287	Alive	TUMOR FREE	1309	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1309	0	1309	0	1309	0	1309	
70	TCGA-BG-A0MQ	2	58	2	24	128	23	8	0	42	408	17	1	7	192	14	0	TCGA-BG-A0MQ-01	69	0.04925243425476382	28	TCGA-BG-A0MQ-01	2	2	19	1.7583352743018115e-05	TCGA-BG-A0MQ-01	2	0	0	2	PASS	10751	TCGA-BG-A0MQ	UCEC	71	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26284	Alive	WITH TUMOR	1817	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1817	0	1817	NA	NA	0	1817	
50	TCGA-BG-A0MS	0	6	0	0	3	0	1	0	3	36	2	0	0	13	1	0	TCGA-BG-A0MS	0	0	0	TCGA-BG-A0MS	0	0	0	0	TCGA-BG-A0MS-01	2	0	0	2	mutation call filter	10752	TCGA-BG-A0MS	UCEC	53	FEMALE	WHITE	NA	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19547	Alive	TUMOR FREE	1882	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1882	0	1882	0	1882	0	1882	
60	TCGA-BG-A0MT	0	0	1	1	2	0	4	0	1	24	1	0	1	9	2	0	TCGA-BG-A0MT-01	139	0.1556295619580898	74	TCGA-BG-A0MT-01	4	7	14	0.045575559524952416	TCGA-BG-A0MT-01	7	6	3	16	mutation call filter	10753	TCGA-BG-A0MT	UCEC	64	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23574	Alive	TUMOR FREE	644	NA	NA	Locoregional Disease	"Other, specify"	locally in the endometrium	565	Partial Remission/Response	NA	NA	0	644	0	644	NA	NA	1	565	
80	TCGA-BG-A0MU	0	6	2	5	2	1	1	0	1	47	1	0	0	22	2	0	TCGA-BG-A0MU-01	89	0.049513386247512864	35	TCGA-BG-A0MU-01	2	2	2	0.025166973430809567	TCGA-BG-A0MU-01	3	1	2	6	PASS	10754	TCGA-BG-A0MU	UCEC	78	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28621	Alive	TUMOR FREE	617	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	617	0	617	0	617	0	617	
70	TCGA-BG-A0RY	1	6	0	1	1	2	0	0	2	39	3	0	2	16	1	0	TCGA-BG-A0RY-01	78	0.9471940500426532	32	TCGA-BG-A0RY-01	9	9	2	0.03015626640805709	TCGA-BG-A0RY-01	2	1	1	4	PASS	10755	TCGA-BG-A0RY	UCEC	68	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24952	Alive	TUMOR FREE	469	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	469	0	469	0	469	0	469	
60	TCGA-BG-A0VT	1	1	0	1	0	2	0	0	3	22	5	0	1	8	2	1	TCGA-BG-A0VT-01	39	0.16318755840140245	8	TCGA-BG-A0VT-01	2	4	2	0.04739782380397377	TCGA-BG-A0VT-01	2	0	1	3	mutation call filter	10756	TCGA-BG-A0VT	UCEC	56	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-20602	Alive	TUMOR FREE	1568	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1568	0	1568	0	1568	0	1568	
50	TCGA-BG-A0VV	0	8	0	1	0	0	1	0	2	33	7	0	1	10	1	0	TCGA-BG-A0VV-01	42	0.03418932909174008	6	TCGA-BG-A0VV-01	1	3	3	0.049567607743490436	TCGA-BG-A0VV-01	1	0	0	1	PASS	10757	TCGA-BG-A0VV	UCEC	53	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19581	Alive	TUMOR FREE	1553	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1553	0	1553	0	1553	0	1553	
80	TCGA-BG-A0VW	2	44	2	11	50	6	8	0	20	341	19	0	3	171	6	0	TCGA-BG-A0VW-01	63	0.011699434493189356	25	TCGA-BG-A0VW-01	0	1	4	0.04742732795707362	TCGA-BG-A0VW-01	1	2	2	5	PASS	10758	TCGA-BG-A0VW	UCEC	77	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28383	Alive	TUMOR FREE	1582	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1582	0	1582	0	1582	0	1582	
60	TCGA-BG-A0VX	4	19	0	6	2	3	1	0	7	157	9	0	3	68	3	0	TCGA-BG-A0VX-01	43	7.914498071834242e-06	7	TCGA-BG-A0VX-01	0	0	0	0.0	TCGA-BG-A0VX-01	0	0	0	0	PASS	10759	TCGA-BG-A0VX	UCEC	58	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21425	Alive	TUMOR FREE	1043	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1043	0	1043	0	1043	0	1043	
60	TCGA-BG-A0VZ	2	38	1	14	59	17	5	0	16	220	17	0	8	115	7	2	TCGA-BG-A0VZ-01	38	0.010996846055678609	10	TCGA-BG-A0VZ-01	0	0	2	0.023356666167717317	TCGA-BG-A0VZ-01	2	1	1	4	PASS	10760	TCGA-BG-A0VZ	UCEC	58	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21414	Alive	TUMOR FREE	1601	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1601	0	1601	0	1601	0	1601	
90	TCGA-BG-A0W1	0	2	1	2	8	2	4	0	2	43	5	0	1	21	3	0	TCGA-BG-A0W1-01	46	0.340233418354937	9	TCGA-BG-A0W1-01	7	7	19	0.04952744371302496	TCGA-BG-A0W1-01	1	0	0	1	PASS	10761	TCGA-BG-A0W1	UCEC	89	FEMALE	WHITE	NA	Stage II	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32750	Alive	TUMOR FREE	1607	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1607	0	1607	0	1607	0	1607	
60	TCGA-BG-A0W2	0	2	0	2	1	1	0	0	1	25	1	0	0	15	3	0	TCGA-BG-A0W2-01	51	0.04650416528392237	14	TCGA-BG-A0W2-01	2	1	19	2.9229887004932155e-05	TCGA-BG-A0W2-01	0	0	0	0	PASS	10762	TCGA-BG-A0W2	UCEC	57	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20998	Alive	TUMOR FREE	1721	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1721	0	1721	0	1721	0	1721	
40	TCGA-BG-A0YU	0	3	0	0	0	0	0	0	1	14	4	0	1	8	0	0	TCGA-BG-A0YU-01	47	0.049518913316274775	12	TCGA-BG-A0YU-01	0	1	2	0.00999644557422761	TCGA-BG-A0YU-01	2	2	1	5	PASS	10763	TCGA-BG-A0YU	UCEC	37	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13644	Alive	TUMOR FREE	451	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	451	0	451	0	451	0	451	
70	TCGA-BG-A0YV	1	2	1	2	3	1	0	0	7	62	4	0	3	18	1	1	TCGA-BG-A0YV-01	192	0.9679808456282096	110	TCGA-BG-A0YV-01	14	17	12	0.05726242531608072	TCGA-BG-A0YV-01	12	10	3	25	PASS	10764	TCGA-BG-A0YV	UCEC	67	FEMALE	WHITE	NA	Stage IIIA	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24567	Alive	TUMOR FREE	382	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	382	0	382	0	382	0	382	
60	TCGA-BG-A186	0	1	0	4	5	1	0	0	2	24	0	0	0	9	1	0	TCGA-BG-A186-01	69	0.049554181989963586	25	TCGA-BG-A186-01	2	2	2	0.01582613600059132	TCGA-BG-A186-01	2	0	1	3	PASS	10765	TCGA-BG-A186	UCEC	61	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2010	NA	-22370	Alive	TUMOR FREE	419	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	419	0	419	0	419	0	419	
70	TCGA-BG-A187	1	3	1	5	2	1	1	0	5	69	5	0	1	21	2	0	TCGA-BG-A187-01	75	0.04645268505423399	29	TCGA-BG-A187-01	2	1	19	5.877231491215426e-05	TCGA-BG-A187-01	0	0	0	0	PASS	10766	TCGA-BG-A187	UCEC	65	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	NA	-24099	Alive	TUMOR FREE	448	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	448	0	448	0	448	0	448	
70	TCGA-BG-A18A	1	3	0	4	4	2	0	0	1	43	4	0	1	24	0	0	TCGA-BG-A18A-01	49	0.046416655947856975	9	TCGA-BG-A18A-01	2	1	19	3.282607033464239e-05	TCGA-BG-A18A-01	0	0	0	0	PASS	10767	TCGA-BG-A18A	UCEC	74	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27086	Alive	TUMOR FREE	426	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	426	0	426	0	426	0	426	
50	TCGA-BG-A18B	1	49	2	14	73	27	0	0	18	241	21	0	6	93	8	0	TCGA-BG-A18B-01	55	0.0005067527103814852	17	TCGA-BG-A18B-01	0	0	19	0.014475446974761648	TCGA-BG-A18B-01	1	1	1	3	PASS	10768	TCGA-BG-A18B	UCEC	53	FEMALE	WHITE	NA	Stage I	Endometrioid endometrial adenocarcinoma	G2	2010	Peri (6-12 months since last menstrual period)	-19550	Alive	TUMOR FREE	470	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	470	0	470	0	470	0	470	
70	TCGA-BG-A18C	1	3	0	2	2	2	1	0	4	38	3	0	0	12	2	0	TCGA-BG-A18C-01	135	0.9018528879949274	64	TCGA-BG-A18C-01	16	14	37	0.4309144368089036	TCGA-BG-A18C-01	9	8	3	20	PASS	10769	TCGA-BG-A18C	UCEC	72	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	NA	-26602	Alive	TUMOR FREE	470	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	470	0	470	0	470	0	470	
70	TCGA-BG-A220	24	366	15	38	175	32	14	1	48	497	34	0	29	225	13	1	TCGA-BG-A220	0	0	0	TCGA-BG-A220	0	0	0	0	TCGA-BG-A220	0	0	0	0	PASS	10770	TCGA-BG-A220	UCEC	69	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	NA	-25346	Alive	TUMOR FREE	434	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	434	0	434	0	434	0	434	
80	TCGA-BG-A221	26	314	12	52	138	19	26	0	78	892	36	0	40	440	40	2	TCGA-BG-A221	0	0	0	TCGA-BG-A221	0	0	0	0	TCGA-BG-A221-01	2	0	1	3	PASS	10771	TCGA-BG-A221	UCEC	84	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30960	Alive	TUMOR FREE	55	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	55	0	55	0	55	0	55	
50	TCGA-BG-A222	102	1381	52	229	287	105	23	0	326	3556	123	6	129	1564	111	5	TCGA-BG-A222-01	64	0.044297831452278884	26	TCGA-BG-A222-01	1	1	2	0.03846102741266732	TCGA-BG-A222-01	1	1	1	3	hypermutated sample	10772	TCGA-BG-A222	UCEC	49	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	NA	-18220	Alive	TUMOR FREE	291	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	291	0	291	0	291	0	291	
60	TCGA-BG-A2AD	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-BG-A2AD-01	111	0.01259451456311424	56	TCGA-BG-A2AD	0	0	0	0	TCGA-BG-A2AD	0	0	0	0	PASS	10773	TCGA-BG-A2AD	UCEC	63	FEMALE	WHITE	NA	Stage IIIB	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23064	Alive	TUMOR FREE	609	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	609	0	609	0	609	0	609	
60	TCGA-BG-A2AE	0	10	0	5	2	2	3	0	8	89	8	0	2	40	4	0	TCGA-BG-A2AE-01	53	0.2454272456788883	14	TCGA-BG-A2AE-01	6	5	5	0.06242757882692725	TCGA-BG-A2AE-01	3	2	3	8	PASS	10774	TCGA-BG-A2AE	UCEC	57	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2011	Peri (6-12 months since last menstrual period)	-21069	Alive	TUMOR FREE	721	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	721	0	721	0	721	0	721	
70	TCGA-BG-A2L7	44	620	15	71	308	49	15	0	79	734	50	0	48	332	25	4	TCGA-BG-A2L7-01	43	0.0003511428555646554	5	TCGA-BG-A2L7-01	0	0	0	0.0	TCGA-BG-A2L7-01	0	0	0	0	PASS	10775	TCGA-BG-A2L7	UCEC	68	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	NA	-25091	Alive	TUMOR FREE	612	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	612	0	612	0	612	0	612	
60	TCGA-BG-A3EW	21	249	7	23	88	20	5	0	36	297	26	1	14	131	11	1	TCGA-BG-A3EW-01	78	0.03486336679448119	24	TCGA-BG-A3EW-01	1	2	19	3.769060090880487e-05	TCGA-BG-A3EW-01	1	0	0	1	PASS	10776	TCGA-BG-A3EW	UCEC	62	FEMALE	WHITE	NA	Stage III	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22705	Alive	TUMOR FREE	344	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	344	0	344	0	344	0	344	
80	TCGA-BG-A3PP	6	25	4	2	0	2	4	0	4	73	6	0	4	38	4	0	TCGA-BG-A3PP-01	357	0.6973029292727551	242	TCGA-BG-A3PP-01	18	25	44	0.20086940762655905	TCGA-BG-A3PP-01	13	8	12	33	PASS	10777	TCGA-BG-A3PP	UCEC	82	FEMALE	WHITE	NA	Stage II	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30227	Alive	WITH TUMOR	681	NA	NA	Locoregional Recurrence	"Other, specify"	Vagina apex	665	Progressive Disease	NA	NA	0	681	0	681	NA	NA	1	665	
60	TCGA-BK-A0C9	3	46	1	14	37	13	4	0	33	478	29	2	10	197	13	2	TCGA-BK-A0C9-01	86	0.9471975825454404	37	TCGA-BK-A0C9-01	12	8	2	0.010180288366869085	TCGA-BK-A0C9-01	2	1	1	4	mutation call filter	10778	TCGA-BK-A0C9	UCEC	57	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20876	Alive	TUMOR FREE	1092	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1092	0	1092	0	1092	0	1092	
60	TCGA-BK-A0CA	0	12	2	1	2	2	0	0	5	43	0	0	0	13	0	0	TCGA-BK-A0CA-01	63	0.0010671692917497335	19	TCGA-BK-A0CA-01	0	0	12	0.012619716680377549	TCGA-BK-A0CA-01	1	1	1	3	PASS	10779	TCGA-BK-A0CA	UCEC	61	FEMALE	WHITE	NA	Stage IIIC	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22378	Alive	TUMOR FREE	1064	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1064	0	1064	0	1064	0	1064	
60	TCGA-BK-A0CB	1	4	0	1	1	1	1	0	3	43	4	0	1	22	0	0	TCGA-BK-A0CB-01	53	0.04998414379564762	17	TCGA-BK-A0CB-01	0	0	2	9.991191915192303e-05	TCGA-BK-A0CB-01	0	0	0	0	PASS	10780	TCGA-BK-A0CB	UCEC	60	FEMALE	WHITE	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21930	Alive	TUMOR FREE	1092	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1092	0	1092	0	1092	0	1092	
70	TCGA-BK-A0CC	2	9	0	2	4	0	1	1	2	38	7	0	4	18	2	0	TCGA-BK-A0CC-01	234	0.6625954339996412	126	TCGA-BK-A0CC-01	16	52	126	0.2527379593299301	TCGA-BK-A0CC-01	28	28	12	68	PASS	10781	TCGA-BK-A0CC	UCEC	69	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25479	Alive	WITH TUMOR	1067	NA	NA	Locoregional Recurrence	"Other, specify"	Right Pelvic Mass	1010	Complete Remission/Response	NA	NA	0	1067	0	1067	1	1010	1	1010	
70	TCGA-BK-A139	1	68	3	30	0	0	2	0	17	238	10	2	18	83	5	0	TCGA-BK-A139-01	228	0.7303841801984525	122	TCGA-BK-A139-02	19	36	283	0.4107108297235014	TCGA-BK-A139-02	21	20	12	53	mutation call filter	10782	TCGA-BK-A139	UCEC	74	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27077	Dead	WITH TUMOR	NA	943	NA	Locoregional Recurrence	"Other, specify"	Paravaginal mass involving the bladder and rectal walls	684	[Discrepancy]	NA	NA	1	943	1	943	NA	NA	1	684	
60	TCGA-BK-A13B	25	284	4	32	96	37	11	1	46	444	29	0	25	173	18	0	TCGA-BK-A13B-01	76	0.034441683621787504	33	TCGA-BK-A13B-01	1	2	19	8.567407018512855e-06	TCGA-BK-A13B-01	1	0	0	1	PASS	10783	TCGA-BK-A13B	UCEC	58	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21493	Alive	WITH TUMOR	966	NA	NA	Locoregional Recurrence	"Other, specify"	Vaginal	760	Complete Remission/Response	NA	NA	0	966	0	966	1	760	1	760	
50	TCGA-BK-A13C	0	2	0	1	4	2	0	0	4	74	2	0	1	24	6	0	TCGA-BK-A13C-01	58	0.03428637231555199	18	TCGA-BK-A13C-01	1	2	19	0.018771672208927104	TCGA-BK-A13C-01	2	1	1	4	PASS	10784	TCGA-BK-A13C	UCEC	47	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Peri (6-12 months since last menstrual period)	-17317	Alive	TUMOR FREE	760	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	760	0	760	0	760	0	760	
70	TCGA-BK-A26L	3	13	2	4	2	1	0	0	8	65	2	0	2	21	4	0	TCGA-BK-A26L-01	162	0.7807843142924511	82	TCGA-BK-A26L-01	23	28	72	0.19961983499418048	TCGA-BK-A26L-01	14	10	7	31	PASS	10785	TCGA-BK-A26L	UCEC	71	FEMALE	WHITE	NA	Stage IIIC1	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26002	Alive	TUMOR FREE	734	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	734	0	734	0	734	0	734	
40	TCGA-BK-A4ZD	2	35	0	6	2	2	2	0	8	120	10	0	11	46	2	0	TCGA-BK-A4ZD-01	219	0.9649627089504209	124	TCGA-BK-A4ZD-01	27	62	73	0.1983043417644685	TCGA-BK-A4ZD-01	13	11	3	27	PASS	10786	TCGA-BK-A4ZD	UCEC	42	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15536	Alive	TUMOR FREE	506	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	506	0	506	0	506	0	506	
80	TCGA-BK-A56F	0	9	0	4	2	0	0	1	2	45	5	0	1	18	2	0	TCGA-BK-A56F-01	59	0.023692916458881687	20	TCGA-BK-A56F-01	0	0	7	0.003434965374646021	TCGA-BK-A56F-01	0	0	0	0	PASS	10787	TCGA-BK-A56F	UCEC	75	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27523	Alive	TUMOR FREE	401	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	401	0	401	0	401	0	401	
30	TCGA-BK-A6W3	118	1626	44	141	2	9	0	0	271	3273	563	5	144	946	72	4	TCGA-BK-A6W3-01	83	0.00030242125290723843	41	TCGA-BK-A6W3-01	0	0	6	7.742958257983032e-05	TCGA-BK-A6W3-01	0	0	0	0	hypermutated sample	10788	TCGA-BK-A6W3	UCEC	34	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage II	Endometrioid endometrial adenocarcinoma	G2	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12590	Alive	TUMOR FREE	305	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	305	0	305	0	305	0	305	
60	TCGA-BK-A6W4	0	9	0	0	1	1	0	0	2	18	4	0	1	6	0	0	TCGA-BK-A6W4-01	45	2.1732176995693748e-05	12	TCGA-BK-A6W4-01	0	0	2	1.0108019630237372e-05	TCGA-BK-A6W4-01	0	0	0	0	PASS	10789	TCGA-BK-A6W4	UCEC	62	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22766	Alive	TUMOR FREE	300	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	300	0	300	0	300	0	300	
40	TCGA-BS-A0T9	0	8	0	0	2	3	3	0	1	45	3	0	0	14	0	0	TCGA-BS-A0T9-01	51	0.09686555032103916	9	TCGA-BS-A0T9-01	4	2	2	0.00033956120892979154	TCGA-BS-A0T9-01	0	0	0	0	PASS	10790	TCGA-BS-A0T9	UCEC	39	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NA	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14253	Dead	WITH TUMOR	NA	1428	NA	NA	NA	NA	634	Complete Remission/Response	NA	NA	1	1428	1	1428	NA	NA	1	634	
60	TCGA-BS-A0TA	4	21	0	8	71	15	6	1	21	348	19	0	4	154	13	0	TCGA-BS-A0TA-01	59	0.00047263038473172947	17	TCGA-BS-A0TA-01	0	2	2	0.0525427963258394	TCGA-BS-A0TA-01	0	0	2	2	PASS	10791	TCGA-BS-A0TA	UCEC	58	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NA	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21505	Dead	WITH TUMOR	NA	740	NA	NA	NA	NA	394	Stable Disease	NA	NA	1	740	1	740	NA	NA	1	394	
70	TCGA-BS-A0TC	14	159	8	46	1	5	0	0	66	1060	214	0	39	256	22	4	TCGA-BS-A0TC-01	71	0.0005318728924354285	31	TCGA-BS-A0TC-01	0	0	2	0.016049503808515598	TCGA-BS-A0TC-01	1	1	1	3	PASS	10792	TCGA-BS-A0TC	UCEC	69	FEMALE	ASIAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25560	Alive	TUMOR FREE	2602	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2602	0	2602	0	2602	0	2602	
70	TCGA-BS-A0TD	0	5	0	2	3	1	2	0	3	25	2	0	0	10	2	0	TCGA-BS-A0TD-01	45	0.00012718378786973615	11	TCGA-BS-A0TD-01	0	0	19	1.248936888407912e-05	TCGA-BS-A0TD-01	0	0	0	0	PASS	10793	TCGA-BS-A0TD	UCEC	65	FEMALE	ASIAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23950	Alive	TUMOR FREE	2379	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2379	0	2379	0	2379	0	2379	
40	TCGA-BS-A0TE	0	26	3	16	31	9	4	0	16	230	18	0	4	110	5	0	TCGA-BS-A0TE-01	248	0.9479735155557928	163	TCGA-BS-A0TE-01	14	16	56	0.5819585639868439	TCGA-BS-A0TE-01	5	2	6	13	PASS	10794	TCGA-BS-A0TE	UCEC	35	FEMALE	ASIAN	NA	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12983	Dead	WITH TUMOR	NA	146	NA	NA	NA	NA	58	Progressive Disease	NA	NA	1	146	1	146	NA	NA	1	58	
60	TCGA-BS-A0TG	0	4	0	1	2	0	0	0	3	33	2	0	0	16	0	0	TCGA-BS-A0TG-01	29	0.04982806619491521	2	TCGA-BS-A0TG-01	2	1	19	0.012465241242614585	TCGA-BS-A0TG-01	1	1	1	3	PASS	10795	TCGA-BS-A0TG	UCEC	60	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22043	Alive	WITH TUMOR	2371	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2371	0	2371	0	2371	0	2371	
60	TCGA-BS-A0TI	1	6	0	1	3	0	1	0	2	75	4	1	4	18	0	0	TCGA-BS-A0TI-01	317	0.5101980846573503	209	TCGA-BS-A0TI-01	7	47	57	0.4398316747548363	TCGA-BS-A0TI-01	24	21	9	54	PASS	10796	TCGA-BS-A0TI	UCEC	64	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23705	Alive	TUMOR FREE	1882	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1882	0	1882	0	1882	0	1882	
60	TCGA-BS-A0TJ	8	83	5	26	135	21	5	2	41	485	33	0	10	212	11	0	TCGA-BS-A0TJ-01	105	0.00018461996307057163	52	TCGA-BS-A0TJ-01	0	0	2	0.00011286413931042316	TCGA-BS-A0TJ-01	0	0	0	0	PASS	10797	TCGA-BS-A0TJ	UCEC	59	FEMALE	ASIAN	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21663	Alive	TUMOR FREE	2068	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2068	0	2068	0	2068	0	2068	
80	TCGA-BS-A0U5	0	2	1	0	1	2	1	0	3	52	1	0	1	13	1	0	TCGA-BS-A0U5-01	71	9.43336867372412e-05	31	TCGA-BS-A0U5-01	0	2	3	0.01966479469551264	TCGA-BS-A0U5-01	1	1	1	3	PASS	10798	TCGA-BS-A0U5	UCEC	76	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27945	Alive	TUMOR FREE	2935	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2935	0	2935	0	2935	0	2935	
60	TCGA-BS-A0U7	2	19	1	7	11	8	2	0	13	141	15	0	3	73	5	0	TCGA-BS-A0U7-01	66	0.09079152697596976	20	TCGA-BS-A0U7-01	3	3	2	8.884357798257738e-05	TCGA-BS-A0U7-01	0	0	0	0	PASS	10799	TCGA-BS-A0U7	UCEC	63	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23166	Dead	TUMOR FREE	NA	935	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	935	0	935	0	935	0	935	
60	TCGA-BS-A0U8	5	50	3	15	85	11	15	0	28	286	16	0	6	142	8	1	TCGA-BS-A0U8-01	79	0.003428599615278594	32	TCGA-BS-A0U8-01	0	0	0	0.0	TCGA-BS-A0U8-01	0	0	0	0	PASS	10800	TCGA-BS-A0U8	UCEC	55	FEMALE	WHITE	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20402	Alive	TUMOR FREE	2963	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2963	0	2963	0	2963	0	2963	
60	TCGA-BS-A0U9	0	1	1	1	3	0	2	0	0	27	4	0	0	4	0	0	TCGA-BS-A0U9-01	344	0.9347493723973604	209	TCGA-BS-A0U9-01	18	17	39	0.2315548826869505	TCGA-BS-A0U9-01	9	3	5	17	PASS	10801	TCGA-BS-A0U9	UCEC	59	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NA	Stage IIA	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21580	Alive	TUMOR FREE	2825	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2825	0	2825	0	2825	0	2825	
70	TCGA-BS-A0UA	2	37	1	10	52	12	5	1	22	214	25	0	9	107	3	0	TCGA-BS-A0UA-01	71	1.4692371746940393e-05	26	TCGA-BS-A0UA-01	0	0	19	0.01993056708686448	TCGA-BS-A0UA-01	1	1	1	3	PASS	10802	TCGA-BS-A0UA	UCEC	68	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24872	Alive	TUMOR FREE	3495	NA	NA	Locoregional Disease	"Other, specify"	endometrium	520	Complete Remission/Response	NA	NA	0	3495	0	3495	1	520	1	520	
70	TCGA-BS-A0UF	51	850	50	261	36	15	3	0	363	7004	1151	8	152	1875	130	5	TCGA-BS-A0UF-01	43	0.0018056330345829702	6	TCGA-BS-A0UF-01	0	0	19	1.7854195863607246e-05	TCGA-BS-A0UF-01	0	0	0	0	hypermutated sample	10803	TCGA-BS-A0UF	UCEC	65	FEMALE	ASIAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23771	Alive	TUMOR FREE	2611	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2611	0	2611	0	2611	0	2611	
70	TCGA-BS-A0UJ	9	177	6	48	2	97	1	0	104	1319	69	4	17	542	57	3	TCGA-BS-A0UJ-01	111	0.00014660501411097932	64	TCGA-BS-A0UJ-01	0	0	19	0.00011491901312213047	TCGA-BS-A0UJ-01	0	0	0	0	PASS	10804	TCGA-BS-A0UJ	UCEC	68	FEMALE	ASIAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25149	Alive	TUMOR FREE	2506	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2506	0	2506	0	2506	0	2506	
50	TCGA-BS-A0UL	2	36	0	5	43	10	3	0	19	303	21	0	8	118	4	0	TCGA-BS-A0UL-01	61	7.498635558136442e-05	17	TCGA-BS-A0UL-01	0	0	2	0.00033526443245075917	TCGA-BS-A0UL-01	0	0	0	0	PASS	10805	TCGA-BS-A0UL	UCEC	54	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2004	Peri (6-12 months since last menstrual period)	-19982	Alive	TUMOR FREE	2481	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2481	0	2481	0	2481	0	2481	
60	TCGA-BS-A0UM	5	36	2	7	71	11	11	0	21	335	22	0	3	151	15	1	TCGA-BS-A0UM	0	0	0	TCGA-BS-A0UM	0	0	0	0	TCGA-BS-A0UM	0	0	0	0	mutation call filter	10806	TCGA-BS-A0UM	UCEC	64	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23400	Alive	WITH TUMOR	2644	NA	NA	Metastatic	Brain	NA	1454	Complete Remission/Response	NA	NA	0	2644	0	2644	1	1454	1	1454	
60	TCGA-BS-A0UT	0	2	0	0	1	0	2	0	1	28	4	0	0	8	2	0	TCGA-BS-A0UT-01	63	0.7857368776881731	23	TCGA-BS-A0UT-01	7	5	0	0.0	TCGA-BS-A0UT-01	1	0	0	1	PASS	10807	TCGA-BS-A0UT	UCEC	62	FEMALE	ASIAN	NA	Stage IIB	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22775	Alive	TUMOR FREE	2212	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2212	0	2212	0	2212	0	2212	
60	TCGA-BS-A0UV	63	986	31	290	6	27	0	0	452	7590	1146	3	201	2405	159	6	TCGA-BS-A0UV-01	142	0.12549843781504788	72	TCGA-BS-A0UV-01	4	2	3	0.000284237997521842	TCGA-BS-A0UV-01	1	1	0	2	hypermutated sample	10808	TCGA-BS-A0UV	UCEC	55	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20266	Alive	TUMOR FREE	2228	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2228	0	2228	0	2228	0	2228	
60	TCGA-BS-A0V4	13	144	5	20	70	22	6	0	26	201	17	0	10	98	4	1	TCGA-BS-A0V4-01	50	0.030695220012179083	10	TCGA-BS-A0V4-01	1	1	2	0.009856881478715874	TCGA-BS-A0V4-01	2	1	1	4	PASS	10809	TCGA-BS-A0V4	UCEC	56	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20777	Alive	TUMOR FREE	1810	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1810	0	1810	0	1810	0	1810	
60	TCGA-BS-A0V6	0	2	0	6	1	1	0	0	0	47	2	0	0	16	2	0	TCGA-BS-A0V6-01	69	0.00019490082371768715	26	TCGA-BS-A0V6-01	0	0	2	4.170027536165314e-05	TCGA-BS-A0V6-01	0	0	0	0	PASS	10810	TCGA-BS-A0V6	UCEC	55	FEMALE	ASIAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20369	Alive	TUMOR FREE	2725	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2725	0	2725	0	2725	0	2725	
50	TCGA-BS-A0V7	0	3	0	4	2	0	0	1	1	53	3	0	0	9	1	0	TCGA-BS-A0V7-01	67	0.15365443313584906	21	TCGA-BS-A0V7-01	5	3	2	1.741930614019957e-05	TCGA-BS-A0V7-01	1	1	0	2	PASS	10811	TCGA-BS-A0V7	UCEC	48	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17810	Alive	TUMOR FREE	1934	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1934	0	1934	0	1934	0	1934	
70	TCGA-BS-A0V8	0	8	0	1	7	0	0	0	2	61	5	0	3	25	3	0	TCGA-BS-A0V8-01	374	0.5749523701416404	257	TCGA-BS-A0V8-01	18	25	48	0.17610547556180445	TCGA-BS-A0V8-01	15	8	5	28	PASS	10812	TCGA-BS-A0V8	UCEC	68	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NA	Stage IIB	Endometrioid endometrial adenocarcinoma	G2	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24981	Alive	TUMOR FREE	2544	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2544	0	2544	0	2544	0	2544	
60	TCGA-BS-A0VI	11	128	3	22	41	18	6	0	27	217	14	0	11	86	7	0	TCGA-BS-A0VI-01	36	0.04399063272792418	4	TCGA-BS-A0VI-01	1	3	2	0.04901783098002771	TCGA-BS-A0VI-01	1	0	0	1	PASS	10813	TCGA-BS-A0VI	UCEC	58	FEMALE	WHITE	NA	Stage IIB	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21198	Alive	TUMOR FREE	2646	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2646	0	2646	0	2646	0	2646	
60	TCGA-BS-A0WQ	1	3	0	2	1	3	1	0	3	36	2	0	1	14	0	0	TCGA-BS-A0WQ-01	47	0.047054789763321885	16	TCGA-BS-A0WQ-01	2	1	0	0.0	TCGA-BS-A0WQ-01	0	0	0	0	PASS	10814	TCGA-BS-A0WQ	UCEC	55	FEMALE	ASIAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20131	Alive	TUMOR FREE	2022	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2022	0	2022	0	2022	0	2022	
60	TCGA-D1-A0ZN	0	2	2	0	2	2	1	0	1	32	2	0	0	18	1	0	TCGA-D1-A0ZN-01	41	0.07665965002236344	6	TCGA-D1-A0ZN-01	2	4	19	0.04899997025557752	TCGA-D1-A0ZN-01	1	0	0	1	PASS	10815	TCGA-D1-A0ZN	UCEC	60	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Peri (6-12 months since last menstrual period)	-22026	Alive	TUMOR FREE	512	NA	NA	New Primary Tumor	"Other, specify"	Breast left	448	Complete Remission/Response	NA	NA	0	512	0	512	0	512	1	448	
80	TCGA-D1-A0ZO	3	44	1	18	124	29	6	0	26	435	21	1	10	184	5	1	TCGA-D1-A0ZO-01	47	0.08343602001858243	9	TCGA-D1-A0ZO-01	2	1	2	0.0039268012356064785	TCGA-D1-A0ZO-01	1	1	0	2	PASS	10816	TCGA-D1-A0ZO	UCEC	75	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27482	Alive	TUMOR FREE	602	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	602	0	602	0	602	0	602	
60	TCGA-D1-A0ZP	0	1	0	2	0	0	1	1	2	29	1	0	1	10	0	0	TCGA-D1-A0ZP-01	236	0.23980056451318366	136	TCGA-D1-A0ZP-01	7	4	32	0.04803267314188237	TCGA-D1-A0ZP-01	6	3	4	13	PASS	10817	TCGA-D1-A0ZP	UCEC	59	FEMALE	WHITE	NA	Stage IVA	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21581	Alive	TUMOR FREE	911	NA	NA	Locoregional Disease	"Other, specify"	Recurrent endometrial carcinoma in retriponeal lymphnodes	629	Complete Remission/Response	NA	NA	0	911	0	911	NA	NA	1	629	
90	TCGA-D1-A0ZQ	0	5	0	3	4	0	4	0	8	60	6	0	3	23	1	0	TCGA-D1-A0ZQ-01	149	0.17719069329376402	70	TCGA-D1-A0ZQ-01	5	6	11	0.08882489171458621	TCGA-D1-A0ZQ-01	6	4	3	13	PASS	10818	TCGA-D1-A0ZQ	UCEC	90	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32873	Alive	TUMOR FREE	260	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	260	0	260	0	260	0	260	
60	TCGA-D1-A0ZR	0	6	0	1	2	2	1	0	2	38	4	0	1	15	3	1	TCGA-D1-A0ZR-01	52	0.034093743963664325	13	TCGA-D1-A0ZR-01	1	4	0	0.0	TCGA-D1-A0ZR-01	1	0	0	1	PASS	10819	TCGA-D1-A0ZR	UCEC	57	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Indeterminate (neither Pre or Postmenopausal)	-21157	Alive	TUMOR FREE	17	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	17	0	17	0	17	0	17	
50	TCGA-D1-A0ZS	0	50	0	15	65	20	7	1	26	273	19	0	13	124	5	0	TCGA-D1-A0ZS-01	53	2.729127319406915e-05	10	TCGA-D1-A0ZS-01	0	0	2	0.005037410343779046	TCGA-D1-A0ZS-01	1	1	0	2	PASS	10820	TCGA-D1-A0ZS	UCEC	54	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19821	Alive	TUMOR FREE	148	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	148	0	148	0	148	0	148	
30	TCGA-D1-A0ZU	0	1	0	1	2	1	1	0	0	21	6	0	0	13	1	0	TCGA-D1-A0ZU-01	51	0.09635380338724718	11	TCGA-D1-A0ZU	0	0	0	0	TCGA-D1-A0ZU	0	0	0	0	PASS	10821	TCGA-D1-A0ZU	UCEC	34	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12458	Alive	TUMOR FREE	872	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	872	0	872	0	872	0	872	
60	TCGA-D1-A0ZV	1	6	0	1	3	1	1	0	0	30	3	0	1	8	0	1	TCGA-D1-A0ZV-01	49	2.9178264912436047e-05	10	TCGA-D1-A0ZV-01	0	0	3	0.006786148127753926	TCGA-D1-A0ZV-01	1	1	1	3	PASS	10822	TCGA-D1-A0ZV	UCEC	58	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21374	Alive	TUMOR FREE	728	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	728	0	728	0	728	0	728	
80	TCGA-D1-A0ZZ	0	3	0	2	2	0	2	0	2	52	6	0	0	18	1	0	TCGA-D1-A0ZZ-01	315	0.9226904328382532	192	TCGA-D1-A0ZZ-01	18	23	79	0.3010369367657261	TCGA-D1-A0ZZ-01	17	13	13	43	PASS	10823	TCGA-D1-A0ZZ	UCEC	80	FEMALE	WHITE	NA	Stage IB	Mixed serous and endometrioid	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29420	Alive	TUMOR FREE	686	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	686	0	686	0	686	0	686	
60	TCGA-D1-A101	2	32	3	6	55	14	4	0	21	310	34	0	6	180	15	2	TCGA-D1-A101-01	41	0.00016431877506445136	6	TCGA-D1-A101-01	0	2	2	0.049147937926510434	TCGA-D1-A101-01	0	0	0	0	PASS	10824	TCGA-D1-A101	UCEC	60	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22078	Alive	TUMOR FREE	53	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	53	0	53	0	53	0	53	
50	TCGA-D1-A102	0	4	2	0	1	0	4	0	1	37	1	0	2	16	0	0	TCGA-D1-A102-01	51	0.21269765538657465	13	TCGA-D1-A102-01	8	8	4	0.06926371977836288	TCGA-D1-A102-01	4	1	1	6	PASS	10825	TCGA-D1-A102	UCEC	49	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Peri (6-12 months since last menstrual period)	-17991	Alive	TUMOR FREE	135	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	135	0	135	0	135	0	135	
90	TCGA-D1-A103	34	753	52	245	28	52	0	1	321	6016	504	5	132	2365	180	6	TCGA-D1-A103-01	49	0.0001468053710620111	13	TCGA-D1-A103-01	0	0	19	2.1711823982390554e-05	TCGA-D1-A103-01	0	0	0	0	hypermutated sample	10826	TCGA-D1-A103	UCEC	87	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31841	Alive	TUMOR FREE	669	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	669	0	669	0	669	0	669	
70	TCGA-D1-A15V	1	4	0	2	1	1	1	0	0	36	0	0	3	11	3	0	TCGA-D1-A15V-01	218	0.4541456597208188	134	TCGA-D1-A15V-01	16	20	29	0.1125501114029509	TCGA-D1-A15V-01	12	8	4	24	PASS	10827	TCGA-D1-A15V	UCEC	68	FEMALE	WHITE	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24886	Alive	TUMOR FREE	1201	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1201	0	1201	0	1201	0	1201	
60	TCGA-D1-A15W	1	2	0	1	2	0	4	0	4	59	3	0	1	19	0	0	TCGA-D1-A15W-01	69	0.002383216885828928	26	TCGA-D1-A15W-01	0	0	19	0.0021509559337871626	TCGA-D1-A15W-01	0	0	0	0	PASS	10828	TCGA-D1-A15W	UCEC	58	FEMALE	WHITE	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21545	Alive	TUMOR FREE	915	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	915	0	915	0	915	0	915	
50	TCGA-D1-A15X	12	146	10	46	17	7	2	0	88	1379	51	1	16	604	29	1	TCGA-D1-A15X-01	71	0.0005542282612374988	27	TCGA-D1-A15X-01	0	0	19	0.000157888406055011	TCGA-D1-A15X-01	0	0	0	0	PASS	10829	TCGA-D1-A15X	UCEC	45	FEMALE	WHITE	NA	Stage IA	Serous endometrial adenocarcinoma	High Grade	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16532	Alive	TUMOR FREE	909	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	909	0	909	0	909	0	909	
70	TCGA-D1-A15Z	1	8	0	1	5	2	1	1	4	52	5	0	0	20	1	0	TCGA-D1-A15Z-01	47	0.046468181395859565	12	TCGA-D1-A15Z-01	2	1	0	0.0	TCGA-D1-A15Z-01	0	0	0	0	PASS	10830	TCGA-D1-A15Z	UCEC	72	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26638	Dead	TUMOR FREE	NA	58	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	58	0	58	0	58	0	58	
70	TCGA-D1-A160	3	65	3	17	82	22	4	0	20	353	22	0	9	138	12	0	TCGA-D1-A160-01	44	0.034109447477427515	9	TCGA-D1-A160-01	1	2	0	0.0	TCGA-D1-A160-01	1	0	0	1	PASS	10831	TCGA-D1-A160	UCEC	70	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25673	Alive	TUMOR FREE	112	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	112	0	112	0	112	0	112	
80	TCGA-D1-A161	0	4	0	2	3	3	2	0	5	65	5	0	3	29	1	0	TCGA-D1-A161-01	62	0.04683151856409599	26	TCGA-D1-A161-01	2	1	5	0.00032607650359203663	TCGA-D1-A161-01	0	0	0	0	PASS	10832	TCGA-D1-A161	UCEC	78	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28695	Alive	TUMOR FREE	892	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	892	0	892	0	892	0	892	
70	TCGA-D1-A162	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-D1-A162	0	0	0	TCGA-D1-A162	0	0	0	0	TCGA-D1-A162	0	0	0	0	PASS	10833	TCGA-D1-A162	UCEC	69	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25543	Alive	TUMOR FREE	1145	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1145	0	1145	0	1145	0	1145	
50	TCGA-D1-A163	5	67	7	29	125	34	10	0	38	361	14	0	10	171	15	0	TCGA-D1-A163-01	49	0.00010994403778551784	8	TCGA-D1-A163-01	0	0	3	0.01407573155017484	TCGA-D1-A163-01	1	1	1	3	PASS	10834	TCGA-D1-A163	UCEC	50	FEMALE	WHITE	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G2	2008	Peri (6-12 months since last menstrual period)	-18604	Alive	TUMOR FREE	991	NA	NA	Metastatic	"Other, specify"	Paraaortic retroperitoneal lymphnode	223	Complete Remission/Response	NA	NA	0	991	0	991	1	223	1	223	
60	TCGA-D1-A165	0	4	0	0	2	1	2	0	1	50	6	0	1	24	1	0	TCGA-D1-A165-01	46	0.16455566960940454	7	TCGA-D1-A165-01	6	6	0	0.0	TCGA-D1-A165-01	1	0	0	1	PASS	10835	TCGA-D1-A165	UCEC	64	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23526	Alive	TUMOR FREE	20	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	20	0	20	0	20	0	20	
70	TCGA-D1-A167	10	116	5	43	54	14	4	0	69	1360	91	0	26	641	16	1	TCGA-D1-A167-01	127	5.293261278836279e-05	77	TCGA-D1-A167-01	0	2	3	0.0760621057463441	TCGA-D1-A167-01	1	2	2	5	PASS	10836	TCGA-D1-A167	UCEC	70	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25575	Alive	TUMOR FREE	478	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	478	0	478	0	478	0	478	
70	TCGA-D1-A168	1	2	0	2	3	1	1	0	3	40	4	0	0	13	1	1	TCGA-D1-A168-01	64	0.8761336549586408	21	TCGA-D1-A168-01	7	9	19	0.03491165036795312	TCGA-D1-A168-01	2	1	0	3	PASS	10837	TCGA-D1-A168	UCEC	67	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24586	Alive	TUMOR FREE	1098	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1098	0	1098	0	1098	0	1098	
60	TCGA-D1-A169	0	3	0	1	2	0	0	0	4	41	6	0	0	19	4	0	TCGA-D1-A169-01	101	0.4808163690484726	47	TCGA-D1-A169-01	7	5	11	0.12822444712203665	TCGA-D1-A169-01	2	2	2	6	PASS	10838	TCGA-D1-A169	UCEC	63	FEMALE	WHITE	NA	Stage IV	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23238	Alive	WITH TUMOR	1135	NA	NA	Metastatic	"Other, specify"	Bladder nodule	519	Complete Remission/Response	NA	NA	0	1135	0	1135	NA	NA	1	519	
60	TCGA-D1-A16B	0	3	0	1	3	1	0	0	2	37	4	0	1	11	3	0	TCGA-D1-A16B-01	53	0.00012371367492269132	12	TCGA-D1-A16B-01	0	0	0	0.0	TCGA-D1-A16B-01	0	0	0	0	PASS	10839	TCGA-D1-A16B	UCEC	64	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23450	Alive	TUMOR FREE	1106	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1106	0	1106	0	1106	0	1106	
50	TCGA-D1-A16D	0	2	0	1	2	1	0	0	2	31	3	0	1	7	3	1	TCGA-D1-A16D-01	45	0.00028746012290569296	6	TCGA-D1-A16D-01	0	2	2	0.04904900364829684	TCGA-D1-A16D-01	0	0	0	0	PASS	10840	TCGA-D1-A16D	UCEC	49	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2008	Peri (6-12 months since last menstrual period)	-17933	Alive	TUMOR FREE	1141	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1141	0	1141	0	1141	0	1141	
70	TCGA-D1-A16E	1	4	1	1	3	1	1	0	0	39	7	0	0	21	2	0	TCGA-D1-A16E-01	35	0.00013719259564454206	2	TCGA-D1-A16E-01	0	2	2	0.03247363144548372	TCGA-D1-A16E-01	1	1	1	3	PASS	10841	TCGA-D1-A16E	UCEC	73	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26859	Alive	TUMOR FREE	1119	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1119	0	1119	0	1119	0	1119	
60	TCGA-D1-A16F	5	48	4	10	86	18	8	0	23	345	23	0	14	161	7	2	TCGA-D1-A16F	0	0	0	TCGA-D1-A16F	0	0	0	0	TCGA-D1-A16F	0	0	0	0	PASS	10842	TCGA-D1-A16F	UCEC	60	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22242	Alive	TUMOR FREE	80	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	80	0	80	0	80	0	80	
70	TCGA-D1-A16G	0	3	0	0	2	0	1	0	4	32	3	0	0	12	0	0	TCGA-D1-A16G-01	205	0.14987212049901708	115	TCGA-D1-A16G-01	3	5	12	0.040774114782379495	TCGA-D1-A16G-01	10	5	4	19	PASS	10843	TCGA-D1-A16G	UCEC	74	FEMALE	WHITE	NA	Stage IV	Serous endometrial adenocarcinoma	High Grade	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27065	Dead	WITH TUMOR	NA	834	NA	Locoregional Disease	"Other, specify"	Lymph nodes	642	Complete Remission/Response	NA	NA	1	834	1	834	NA	NA	1	642	
60	TCGA-D1-A16I	1	2	0	1	3	0	1	0	0	28	2	0	2	15	3	0	TCGA-D1-A16I-01	541	0.5708637588131357	340	TCGA-D1-A16I-01	5	11	102	0.23736351150745802	TCGA-D1-A16I-01	18	16	16	50	PASS	10844	TCGA-D1-A16I	UCEC	62	FEMALE	WHITE	NA	Stage IC	Serous endometrial adenocarcinoma	High Grade	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22836	Dead	TUMOR FREE	NA	350	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	350	0	350	0	350	0	350	
60	TCGA-D1-A16J	3	19	1	4	4	0	1	0	8	195	16	0	1	75	4	0	TCGA-D1-A16J-01	98	0.10597703107662797	46	TCGA-D1-A16J-01	5	3	12	0.06100811652974247	TCGA-D1-A16J-01	3	4	5	12	PASS	10845	TCGA-D1-A16J	UCEC	61	FEMALE	WHITE	NA	Stage IIB	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22319	Alive	TUMOR FREE	910	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	910	0	910	0	910	0	910	
50	TCGA-D1-A16N	0	9	0	6	10	5	1	0	5	101	9	0	5	40	5	0	TCGA-D1-A16N-01	224	0.8552543118725489	138	TCGA-D1-A16N-01	15	12	37	0.3447973655697557	TCGA-D1-A16N-01	8	6	6	20	PASS	10846	TCGA-D1-A16N	UCEC	51	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2009	Peri (6-12 months since last menstrual period)	-18787	Alive	TUMOR FREE	945	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	945	0	945	0	945	0	945	
40	TCGA-D1-A16O	0	3	1	1	3	0	1	0	1	25	2	0	0	9	1	0	TCGA-D1-A16O-01	43	0.06354832832394419	7	TCGA-D1-A16O-01	0	1	19	0.0247481321160322	TCGA-D1-A16O-01	1	1	1	3	PASS	10847	TCGA-D1-A16O	UCEC	44	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16114	Alive	TUMOR FREE	1023	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1023	0	1023	0	1023	0	1023	
50	TCGA-D1-A16Q	1	1	0	4	0	1	1	0	1	23	4	0	1	5	1	0	TCGA-D1-A16Q-01	45	0.0060761616376802064	11	TCGA-D1-A16Q-01	0	0	2	0.006317034064161914	TCGA-D1-A16Q-01	0	1	1	2	PASS	10848	TCGA-D1-A16Q	UCEC	54	FEMALE	WHITE	NA	Stage II	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19873	Alive	TUMOR FREE	324	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	324	0	324	0	324	0	324	
40	TCGA-D1-A16R	0	3	0	2	1	0	0	0	1	38	3	0	1	10	2	0	TCGA-D1-A16R-01	1966	0.06664868307072104	1511	TCGA-D1-A16R-01	2	1	10	0.01336663390278935	TCGA-D1-A16R-01	1	1	1	3	PASS	10849	TCGA-D1-A16R	UCEC	39	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Indeterminate (neither Pre or Postmenopausal)	-14465	Alive	TUMOR FREE	21	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	21	0	21	0	21	0	21	
70	TCGA-D1-A16S	0	4	0	3	2	0	0	0	2	44	5	0	1	11	3	0	TCGA-D1-A16S-01	380	0.8274441147635364	252	TCGA-D1-A16S-01	19	22	67	0.25830819176059805	TCGA-D1-A16S-01	15	9	13	37	PASS	10850	TCGA-D1-A16S	UCEC	70	FEMALE	WHITE	NA	Stage IIIC	Serous endometrial adenocarcinoma	High Grade	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25690	Alive	TUMOR FREE	568	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	568	0	568	0	568	0	568	
80	TCGA-D1-A16V	0	4	0	2	2	0	1	1	3	30	4	0	3	8	2	0	TCGA-D1-A16V-01	113	0.909644331112792	49	TCGA-D1-A16V-01	6	12	25	0.24420208951139066	TCGA-D1-A16V-01	12	6	12	30	PASS	10851	TCGA-D1-A16V	UCEC	78	FEMALE	WHITE	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28635	Dead	TUMOR FREE	NA	120	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	120	0	120	0	120	0	120	
50	TCGA-D1-A16X	14	196	9	56	1	4	0	0	111	2271	389	2	49	702	41	0	TCGA-D1-A16X-01	45	5.580492935689063e-05	8	TCGA-D1-A16X-01	0	0	0	0.0	TCGA-D1-A16X-01	0	0	0	0	hypermutated sample	10852	TCGA-D1-A16X	UCEC	54	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19799	Alive	TUMOR FREE	111	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	111	0	111	0	111	0	111	
60	TCGA-D1-A16Y	8	107	6	25	0	1	0	0	44	927	119	1	27	271	15	0	TCGA-D1-A16Y-01	49	2.1481299369976766e-05	13	TCGA-D1-A16Y-01	0	0	0	0.0	TCGA-D1-A16Y-01	0	0	0	0	PASS	10853	TCGA-D1-A16Y	UCEC	56	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20455	Alive	TUMOR FREE	532	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	532	0	532	0	532	0	532	
50	TCGA-D1-A174	10	92	5	19	154	28	7	0	32	569	32	2	14	247	9	1	TCGA-D1-A174-01	53	0.0005856068173610932	11	TCGA-D1-A174-01	0	0	0	0.0	TCGA-D1-A174-01	0	0	0	0	PASS	10854	TCGA-D1-A174	UCEC	51	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Indeterminate (neither Pre or Postmenopausal)	-18702	Alive	TUMOR FREE	594	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	594	0	594	0	594	0	594	
50	TCGA-D1-A175	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-D1-A175-01	71	7.48869023588137e-05	25	TCGA-D1-A175-01	0	0	3	0.03299822617829791	TCGA-D1-A175-01	2	2	2	6	PASS	10855	TCGA-D1-A175	UCEC	48	FEMALE	WHITE	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2009	Indeterminate (neither Pre or Postmenopausal)	-17802	Alive	TUMOR FREE	202	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	202	0	202	0	202	0	202	
70	TCGA-D1-A176	1	39	2	19	63	19	5	0	14	304	25	0	5	137	17	0	TCGA-D1-A176-01	62	0.03916915645353045	15	TCGA-D1-A176-01	1	3	19	0.00817733237969201	TCGA-D1-A176-01	5	2	1	8	PASS	10856	TCGA-D1-A176	UCEC	67	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24521	Alive	TUMOR FREE	917	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	917	0	917	0	917	0	917	
70	TCGA-D1-A177	5	83	7	27	169	46	12	1	42	527	25	0	9	230	14	2	TCGA-D1-A177-01	93	0.034182309941604816	42	TCGA-D1-A177-01	1	1	2	3.921140249067341e-05	TCGA-D1-A177-01	1	0	0	1	PASS	10857	TCGA-D1-A177	UCEC	70	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25602	Alive	TUMOR FREE	548	NA	NA	Locoregional Disease	"Other, specify"	paraaortic lymph nodes	347	Complete Remission/Response	NA	NA	0	548	0	548	1	347	1	347	
80	TCGA-D1-A179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-D1-A179-01	391	0.9479868143772168	226	TCGA-D1-A179-01	10	13	136	0.4860483143167401	TCGA-D1-A179-01	13	5	4	22	PASS	10858	TCGA-D1-A179	UCEC	76	FEMALE	WHITE	NA	Stage IIIC	Serous endometrial adenocarcinoma	High Grade	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28037	Dead	WITH TUMOR	NA	448	NA	Metastatic	Lung	NA	427	Complete Remission/Response	NA	NA	1	448	1	448	1	427	1	427	
60	TCGA-D1-A17A	2	28	1	8	38	7	1	0	15	176	11	1	3	75	8	0	TCGA-D1-A17A-01	88	0.03499534069709009	38	TCGA-D1-A17A-01	1	2	3	0.00020892666234852416	TCGA-D1-A17A-01	1	0	0	1	PASS	10859	TCGA-D1-A17A	UCEC	59	FEMALE	WHITE	NA	Stage IIA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21560	Alive	TUMOR FREE	48	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	48	0	48	0	48	0	48	
70	TCGA-D1-A17B	1	26	2	15	32	5	14	0	9	212	15	0	0	82	5	0	TCGA-D1-A17B-01	50	0.034083240265633814	17	TCGA-D1-A17B-01	1	1	19	0.009703893213917706	TCGA-D1-A17B-01	2	1	1	4	PASS	10860	TCGA-D1-A17B	UCEC	69	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25504	Alive	TUMOR FREE	213	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	213	0	213	0	213	0	213	
80	TCGA-D1-A17C	0	2	0	1	4	0	3	0	2	39	4	0	0	19	0	0	TCGA-D1-A17C-01	55	0.0543775675421766	20	TCGA-D1-A17C-01	0	0	19	5.2052711408704904e-05	TCGA-D1-A17C-01	0	0	0	0	PASS	10861	TCGA-D1-A17C	UCEC	78	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28571	Alive	TUMOR FREE	30	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	30	0	30	0	30	0	30	
60	TCGA-D1-A17D	4	44	4	19	79	5	8	0	22	345	19	1	6	152	15	0	TCGA-D1-A17D-01	35	2.1093277703598072e-05	7	TCGA-D1-A17D-01	0	0	0	0.0	TCGA-D1-A17D-01	0	0	0	0	PASS	10862	TCGA-D1-A17D	UCEC	58	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21441	Alive	TUMOR FREE	926	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	926	0	926	0	926	0	926	
70	TCGA-D1-A17F	1	19	1	9	8	10	0	0	12	180	15	0	4	92	5	1	TCGA-D1-A17F-01	45	8.431339990756637e-06	16	TCGA-D1-A17F-01	2	1	2	0.09207610555932948	TCGA-D1-A17F-01	1	0	0	1	PASS	10863	TCGA-D1-A17F	UCEC	68	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25116	Alive	TUMOR FREE	39	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	39	0	39	0	39	0	39	
60	TCGA-D1-A17H	8	72	4	17	126	33	14	0	39	436	26	0	13	208	22	1	TCGA-D1-A17H-01	39	0.005183683429263675	8	TCGA-D1-A17H-01	0	0	19	0.005453393601917613	TCGA-D1-A17H-01	0	2	1	3	PASS	10864	TCGA-D1-A17H	UCEC	61	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22389	Alive	TUMOR FREE	852	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	852	0	852	0	852	0	852	
70	TCGA-D1-A17K	0	7	0	0	4	1	0	0	1	49	2	0	0	25	1	0	TCGA-D1-A17K-01	293	0.7878455436208754	185	TCGA-D1-A17K-01	5	12	69	0.2166434493575992	TCGA-D1-A17K-01	12	7	10	29	PASS	10865	TCGA-D1-A17K	UCEC	74	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27283	Alive	TUMOR FREE	854	NA	NA	Locoregional Disease	"Other, specify"	"Vagina, apex"	815	Complete Remission/Response	NA	NA	0	854	0	854	1	815	1	815	
80	TCGA-D1-A17L	0	4	0	2	0	1	0	1	0	57	3	0	0	17	1	1	TCGA-D1-A17L-01	62	0.03410301405929806	18	TCGA-D1-A17L-01	1	4	19	0.05002042388706867	TCGA-D1-A17L-01	1	1	1	3	PASS	10866	TCGA-D1-A17L	UCEC	81	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29899	Alive	TUMOR FREE	802	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	802	0	802	0	802	0	802	
60	TCGA-D1-A17M	2	41	2	9	71	13	3	0	14	318	20	0	9	132	6	0	TCGA-D1-A17M-01	43	0.04537104270621252	7	TCGA-D1-A17M-01	1	2	2	0.00854709231938098	TCGA-D1-A17M-01	2	1	1	4	PASS	10867	TCGA-D1-A17M	UCEC	56	FEMALE	WHITE	NA	Stage II	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20685	Alive	TUMOR FREE	311	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	311	0	311	0	311	0	311	
50	TCGA-D1-A17N	0	3	0	2	1	0	1	0	0	22	4	0	1	6	1	0	TCGA-D1-A17N-01	45	1.704318683677308e-05	11	TCGA-D1-A17N-01	0	0	0	0.0	TCGA-D1-A17N-01	0	0	0	0	PASS	10868	TCGA-D1-A17N	UCEC	46	FEMALE	NA	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Peri (6-12 months since last menstrual period)	-17045	Alive	TUMOR FREE	46	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	46	0	46	0	46	0	46	
50	TCGA-D1-A17Q	37	619	36	157	7	15	0	0	264	4996	761	3	107	1520	115	2	TCGA-D1-A17Q-01	37	1.815929314795556e-05	7	TCGA-D1-A17Q-01	0	0	0	0.0	TCGA-D1-A17Q-01	0	0	0	0	hypermutated sample	10869	TCGA-D1-A17Q	UCEC	54	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Peri (6-12 months since last menstrual period)	-20015	Alive	TUMOR FREE	54	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	54	0	54	0	54	0	54	
60	TCGA-D1-A17R	2	26	3	10	27	5	1	0	10	188	18	0	5	69	10	0	TCGA-D1-A17R-01	71	0.5817875365867062	30	TCGA-D1-A17R-01	8	5	3	0.01583676797952803	TCGA-D1-A17R-01	2	0	1	3	PASS	10870	TCGA-D1-A17R	UCEC	58	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-21382	Dead	TUMOR FREE	NA	339	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	339	0	339	0	339	0	339	
60	TCGA-D1-A17S	0	1	0	1	0	2	0	0	1	41	1	0	1	12	2	0	TCGA-D1-A17S-01	51	2.394944183545149e-05	13	TCGA-D1-A17S-01	0	0	19	0.006454869091013337	TCGA-D1-A17S-01	1	1	1	3	PASS	10871	TCGA-D1-A17S	UCEC	59	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21794	Alive	TUMOR FREE	739	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	739	0	739	0	739	0	739	
70	TCGA-D1-A17T	1	4	1	5	3	1	0	0	6	54	4	0	1	21	1	0	TCGA-D1-A17T-01	37	0.04644393005760759	6	TCGA-D1-A17T-01	2	1	0	0.0	TCGA-D1-A17T-01	0	0	0	0	PASS	10872	TCGA-D1-A17T	UCEC	67	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24652	Alive	TUMOR FREE	71	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	71	0	71	0	71	0	71	
50	TCGA-D1-A17U	2	32	0	17	86	13	7	0	15	274	25	1	10	126	13	0	TCGA-D1-A17U-01	41	0.0009427143895051988	5	TCGA-D1-A17U-01	0	0	4	0.0005161781116957643	TCGA-D1-A17U-01	0	0	0	0	PASS	10873	TCGA-D1-A17U	UCEC	53	FEMALE	WHITE	NA	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19544	Alive	TUMOR FREE	697	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	697	0	697	0	697	0	697	
50	TCGA-D1-A1NS	4	118	3	13	45	15	6	0	23	205	11	3	8	97	3	0	TCGA-D1-A1NS-01	35	0.00019763203167590668	2	TCGA-D1-A1NS-01	0	0	0	0.0	TCGA-D1-A1NS-01	0	0	0	0	PASS	10874	TCGA-D1-A1NS	UCEC	53	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19638	Alive	TUMOR FREE	43	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	43	0	43	0	43	0	43	
70	TCGA-D1-A1NU	0	6	0	2	2	0	0	0	4	69	5	0	1	22	2	0	TCGA-D1-A1NU-01	299	0.8695603050659118	186	TCGA-D1-A1NU-01	12	9	66	0.2773388299201967	TCGA-D1-A1NU-01	11	5	10	26	PASS	10875	TCGA-D1-A1NU	UCEC	74	FEMALE	WHITE	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27272	Alive	TUMOR FREE	402	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	402	0	402	0	402	0	402	
70	TCGA-D1-A1NW	1	1	0	2	1	0	1	0	0	47	3	0	0	16	2	0	TCGA-D1-A1NW-01	239	0.5430997915360551	131	TCGA-D1-A1NW-01	5	8	27	0.17074025683975474	TCGA-D1-A1NW-01	7	10	11	28	mutation call filter	10876	TCGA-D1-A1NW	UCEC	72	FEMALE	WHITE	NA	Stage IVB	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26556	Alive	TUMOR FREE	22	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	22	0	22	NA	NA	0	22	
70	TCGA-D1-A1NX	0	1	0	3	1	0	0	0	0	36	3	0	0	9	1	0	TCGA-D1-A1NX-01	316	0.18459974461493112	209	TCGA-D1-A1NX-01	4	8	38	0.10888475429845218	TCGA-D1-A1NX-01	9	6	6	21	PASS	10877	TCGA-D1-A1NX	UCEC	66	FEMALE	WHITE	NA	Stage IIIC	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24441	Alive	WITH TUMOR	555	NA	NA	Metastatic	"Other, specify"	Supraclavicular lymphnodes	476	Complete Remission/Response	NA	NA	0	555	0	555	1	476	1	476	
70	TCGA-D1-A1NY	19	242	6	23	119	30	11	0	46	370	27	0	19	172	12	0	TCGA-D1-A1NY-01	52	0.13420784168329988	9	TCGA-D1-A1NY-01	0	1	2	0.010249604680962842	TCGA-D1-A1NY-01	4	4	1	9	PASS	10878	TCGA-D1-A1NY	UCEC	67	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24683	Alive	TUMOR FREE	513	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	513	0	513	0	513	0	513	
60	TCGA-D1-A1NZ	19	295	10	46	120	30	8	0	55	518	33	0	24	246	9	0	TCGA-D1-A1NZ-01	36	0.03408632269860914	5	TCGA-D1-A1NZ-01	1	2	0	0.0	TCGA-D1-A1NZ-01	1	0	0	1	PASS	10879	TCGA-D1-A1NZ	UCEC	60	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22027	Alive	TUMOR FREE	548	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	548	0	548	0	548	0	548	
80	TCGA-D1-A1O0	1	17	2	2	3	0	0	0	6	42	3	0	2	18	1	0	TCGA-D1-A1O0-01	461	0.8188413977890194	297	TCGA-D1-A1O0-01	11	16	83	0.2271510624303151	TCGA-D1-A1O0-01	20	20	10	50	PASS	10880	TCGA-D1-A1O0	UCEC	77	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28162	Alive	TUMOR FREE	63	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	63	0	63	0	63	0	63	
60	TCGA-D1-A1O5	2	11	0	3	2	1	0	0	4	59	1	0	3	23	0	0	TCGA-D1-A1O5-01	37	0.0001690907285439475	4	TCGA-D1-A1O5-01	0	0	19	1.1799169105797396e-05	TCGA-D1-A1O5-01	0	0	0	0	PASS	10881	TCGA-D1-A1O5	UCEC	61	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22580	Alive	TUMOR FREE	458	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	458	0	458	0	458	0	458	
60	TCGA-D1-A1O7	9	101	4	11	38	13	3	0	21	251	15	0	14	145	3	0	TCGA-D1-A1O7-01	55	3.971600220092788e-05	16	TCGA-D1-A1O7-01	0	2	3	0.034747143706514334	TCGA-D1-A1O7-01	0	0	0	0	PASS	10882	TCGA-D1-A1O7	UCEC	60	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22037	Alive	TUMOR FREE	32	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	32	0	32	0	32	0	32	
70	TCGA-D1-A1O8	3	9	0	5	3	2	0	0	3	51	3	0	3	24	2	0	TCGA-D1-A1O8-01	63	2.4406021874316228e-05	23	TCGA-D1-A1O8-01	0	0	0	0.0	TCGA-D1-A1O8-01	0	0	0	0	PASS	10883	TCGA-D1-A1O8	UCEC	70	FEMALE	WHITE	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25789	Dead	TUMOR FREE	NA	120	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	120	0	120	0	120	0	120	
70	TCGA-D1-A2G0	32	318	16	63	173	34	18	0	63	538	31	1	24	267	14	0	TCGA-D1-A2G0-01	71	0.09162672374945073	26	TCGA-D1-A2G0-01	4	3	2	0.001387918013514308	TCGA-D1-A2G0-01	2	0	0	2	PASS	10884	TCGA-D1-A2G0	UCEC	70	FEMALE	WHITE	NA	Stage IB	Mixed serous and endometrioid	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25573	Alive	TUMOR FREE	1484	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1484	0	1484	NA	NA	0	1484	
50	TCGA-D1-A2G5	6	68	3	10	32	6	7	0	7	152	13	0	3	77	3	0	TCGA-D1-A2G5-01	54	0.9471947946846804	14	TCGA-D1-A2G5-01	15	12	19	0.011722621794895742	TCGA-D1-A2G5-01	1	0	0	1	PASS	10885	TCGA-D1-A2G5	UCEC	50	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18322	Alive	WITH TUMOR	1455	NA	NA	Distant Metastasis	"Other, specify"	omentum	1122	Complete Remission/Response	NA	NA	0	1455	0	1455	1	1122	1	1122	
50	TCGA-D1-A2G6	0	17	0	7	2	0	0	0	10	61	6	0	4	33	1	0	TCGA-D1-A2G6-01	60	0.7834269438378219	16	TCGA-D1-A2G6-01	9	6	0	0.0	TCGA-D1-A2G6-01	1	0	0	1	PASS	10886	TCGA-D1-A2G6	UCEC	53	FEMALE	WHITE	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19547	Dead	WITH TUMOR	NA	258	NA	NA	NA	NA	NA	NA	NA	NA	1	258	1	258	NA	NA	1	258	
70	TCGA-D1-A2G7	1	16	1	3	0	2	0	0	2	34	3	0	2	16	1	1	TCGA-D1-A2G7-01	259	0.2417882167470881	152	TCGA-D1-A2G7-01	6	9	41	0.16733949041653154	TCGA-D1-A2G7-01	9	8	8	25	PASS	10887	TCGA-D1-A2G7	UCEC	65	FEMALE	WHITE	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2007	Peri (6-12 months since last menstrual period)	-23913	Dead	TUMOR FREE	NA	1793	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	1793	0	1793	0	1793	0	1793	
80	TCGA-D1-A3DA	1	17	0	2	2	4	2	0	8	60	4	0	5	22	2	0	TCGA-D1-A3DA-01	84	0.03988890526496352	33	TCGA-D1-A3DA-01	1	2	19	0.006858287846543763	TCGA-D1-A3DA-01	2	1	1	4	PASS	10888	TCGA-D1-A3DA	UCEC	77	FEMALE	WHITE	NA	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28142	Alive	TUMOR FREE	483	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	483	0	483	0	483	0	483	
80	TCGA-D1-A3DG	2	36	1	6	5	1	0	0	7	84	3	0	10	28	3	1	TCGA-D1-A3DG-01	208	0.9477169330656371	125	TCGA-D1-A3DG-01	8	8	39	0.2782604264432105	TCGA-D1-A3DG-01	8	9	7	24	PASS	10889	TCGA-D1-A3DG	UCEC	81	FEMALE	WHITE	NA	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29771	Dead	TUMOR FREE	NA	130	NA	NA	NA	NA	NA	NA	NA	NA	1	130	0	130	NA	NA	0	130	
70	TCGA-D1-A3DH	2	30	3	8	2	1	1	0	5	78	6	1	1	21	1	0	TCGA-D1-A3DH-01	497	0.7159111086069936	324	TCGA-D1-A3DH-01	24	31	123	0.3557793662453385	TCGA-D1-A3DH-01	20	15	9	44	PASS	10890	TCGA-D1-A3DH	UCEC	71	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25935	Alive	TUMOR FREE	573	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	573	0	573	0	573	0	573	
60	TCGA-D1-A3JP	0	10	0	1	1	0	0	1	1	34	1	0	2	21	1	1	TCGA-D1-A3JP	0	0	0	TCGA-D1-A3JP	0	0	0	0	TCGA-D1-A3JP-01	12	11	15	38	PASS	10891	TCGA-D1-A3JP	UCEC	61	FEMALE	WHITE	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22538	Alive	TUMOR FREE	515	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	515	0	515	NA	NA	0	515	
60	TCGA-D1-A3JQ	0	8	1	1	0	0	0	0	2	25	4	0	1	12	0	0	TCGA-D1-A3JQ-01	181	0.7656643073722732	96	TCGA-D1-A3JQ-01	4	5	16	0.09350920211095896	TCGA-D1-A3JQ-01	5	5	5	15	PASS	10892	TCGA-D1-A3JQ	UCEC	61	FEMALE	WHITE	NA	Stage IIIC	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22297	Alive	TUMOR FREE	526	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	526	0	526	0	526	0	526	
NA	TCGA-DF-A2KN	103	1356	54	220	352	284	15	0	328	3209	221	2	132	1464	198	4	TCGA-DF-A2KN-01	72	0.0007545650054858392	25	TCGA-DF-A2KN-01	0	0	2	0.00016903465776898496	TCGA-DF-A2KN-01	0	0	0	0	hypermutated sample	10893	TCGA-DF-A2KN	UCEC	NA	FEMALE	[Not Evaluated]	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G3	NA	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	NA	Alive	TUMOR FREE	67	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	67	0	67	0	67	0	67	
80	TCGA-DF-A2KR	2	24	0	5	2	1	3	1	7	77	2	0	6	22	4	0	TCGA-DF-A2KR-01	290	0.7665860893123783	168	TCGA-DF-A2KR-01	9	36	61	0.3333698232388435	TCGA-DF-A2KR-01	27	35	11	73	PASS	10894	TCGA-DF-A2KR	UCEC	84	FEMALE	[Not Evaluated]	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	NA	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31007	Alive	TUMOR FREE	2178	NA	NA	New Primary Tumor	Lung	NA	2113	Complete Remission/Response	NA	NA	0	2178	0	2178	0	2178	1	2113	
70	TCGA-DF-A2KS	0	28	2	5	6	1	2	0	8	100	3	0	4	26	4	0	TCGA-DF-A2KS-01	228	0.7561295159877441	117	TCGA-DF-A2KS-01	15	31	60	0.3865758485729981	TCGA-DF-A2KS-01	27	29	12	68	PASS	10895	TCGA-DF-A2KS	UCEC	69	FEMALE	[Not Evaluated]	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	NA	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25313	Alive	TUMOR FREE	3318	NA	NA	New Primary Tumor	"Other, specify"	colorectal	2277	Complete Remission/Response	NA	NA	0	3318	0	3318	0	3318	1	2277	
NA	TCGA-DF-A2KU	210	2796	145	438	18	38	2	0	665	8973	732	3	324	3675	226	6	TCGA-DF-A2KU-01	77	0.004803932118763353	31	TCGA-DF-A2KU-01	0	2	4	0.014451340269905516	TCGA-DF-A2KU-01	2	0	0	2	hypermutated sample	10896	TCGA-DF-A2KU	UCEC	NA	FEMALE	[Not Evaluated]	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	NA	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	NA	Alive	TUMOR FREE	3067	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	3067	0	3067	0	3067	0	3067	
60	TCGA-DF-A2KV	35	504	9	56	1	2	0	0	100	1111	182	0	47	325	24	1	TCGA-DF-A2KV-01	55	0.00029769074730656204	18	TCGA-DF-A2KV-01	0	0	0	0.0	TCGA-DF-A2KV-01	0	0	0	0	PASS	10897	TCGA-DF-A2KV	UCEC	55	FEMALE	[Not Evaluated]	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	NA	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20160	Alive	TUMOR FREE	2717	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2717	0	2717	NA	NA	0	2717	
50	TCGA-DF-A2KY	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	TCGA-DF-A2KY-01	98	0.021551875351540142	47	TCGA-DF-A2KY-01	0	0	5	0.008578474985799011	TCGA-DF-A2KY-01	0	2	0	2	PASS	10898	TCGA-DF-A2KY	UCEC	49	FEMALE	[Not Evaluated]	NA	Stage IVA	Endometrioid endometrial adenocarcinoma	G3	NA	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18086	Alive	WITH TUMOR	332	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	332	0	332	NA	NA	0	332	
90	TCGA-DF-A2KZ	20	253	7	33	105	23	8	0	39	420	23	1	18	191	13	0	TCGA-DF-A2KZ-01	50	0.034099238781083466	15	TCGA-DF-A2KZ-01	1	3	2	0.04952316336603222	TCGA-DF-A2KZ-01	1	0	0	1	PASS	10899	TCGA-DF-A2KZ	UCEC	87	FEMALE	[Not Evaluated]	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	NA	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31973	Alive	TUMOR FREE	826	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	826	0	826	NA	NA	0	826	
60	TCGA-DF-A2L0	0	13	0	1	4	1	1	0	5	33	3	0	3	11	2	0	TCGA-DF-A2L0-01	109	0.7780512290551721	49	TCGA-DF-A2L0-01	18	27	28	0.3615519076170925	TCGA-DF-A2L0-01	11	10	5	26	PASS	10900	TCGA-DF-A2L0	UCEC	60	FEMALE	[Not Evaluated]	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	NA	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22200	Dead	WITH TUMOR	NA	788	NA	Distant Metastasis	"Other, specify"	lymph nodes and retroperitoneal tissue	523	Complete Remission/Response	NA	NA	1	788	1	788	1	523	1	523	
60	TCGA-DI-A0WH	3	41	5	19	90	15	11	0	32	422	21	0	18	226	16	1	TCGA-DI-A0WH-01	46	0.034555904988464725	14	TCGA-DI-A0WH-01	1	2	2	7.565348154600412e-05	TCGA-DI-A0WH-01	1	0	0	1	PASS	10901	TCGA-DI-A0WH	UCEC	64	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	NA	-23692	Alive	TUMOR FREE	496	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	496	0	496	0	496	0	496	
60	TCGA-DI-A1BU	194	2842	82	332	528	131	31	1	602	6424	141	16	249	2670	233	9	TCGA-DI-A1BU-01	46	0.00014486470698192618	9	TCGA-DI-A1BU-01	0	0	0	0.0	TCGA-DI-A1BU-01	0	0	0	0	hypermutated sample	10902	TCGA-DI-A1BU	UCEC	55	FEMALE	WHITE	NA	Stage IIB	Mixed serous and endometrioid	G3	2008	NA	-20114	Alive	TUMOR FREE	1195	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1195	0	1195	0	1195	0	1195	
60	TCGA-DI-A1BY	3	11	1	5	2	4	2	1	5	43	5	0	2	14	0	0	TCGA-DI-A1BY-01	55	0.00047947221063747366	17	TCGA-DI-A1BY-01	0	0	2	7.659025198724731e-05	TCGA-DI-A1BY-01	0	0	0	0	PASS	10903	TCGA-DI-A1BY	UCEC	63	FEMALE	WHITE	NA	Stage IIB	Endometrioid endometrial adenocarcinoma	G2	2008	NA	-23113	Alive	TUMOR FREE	1114	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1114	0	1114	0	1114	0	1114	
40	TCGA-DI-A1C3	0	3	0	1	3	0	0	0	2	36	2	0	1	12	0	0	TCGA-DI-A1C3-01	61	0.09541812268160006	18	TCGA-DI-A1C3-01	4	2	19	1.7435342862200858e-05	TCGA-DI-A1C3-01	0	0	0	0	PASS	10904	TCGA-DI-A1C3	UCEC	38	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2008	NA	-13885	Alive	TUMOR FREE	739	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	739	0	739	0	739	0	739	
60	TCGA-DI-A1NN	0	1	0	1	0	2	1	0	1	38	4	0	0	27	1	0	TCGA-DI-A1NN-01	242	0.7257571779479828	135	TCGA-DI-A1NN-01	19	21	31	0.10326890840693548	TCGA-DI-A1NN-01	15	11	7	33	PASS	10905	TCGA-DI-A1NN	UCEC	63	FEMALE	WHITE	NA	Stage IIIC	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23026	Alive	WITH TUMOR	1076	NA	NA	Metastatic	"Other, specify"	vagina	1023	Complete Remission/Response	NA	NA	0	1076	0	1076	1	1023	1	1023	
70	TCGA-DI-A1NO	3	51	4	15	13	2	2	0	20	191	11	1	9	61	7	1	TCGA-DI-A1NO-01	436	0.7994550003673341	287	TCGA-DI-A1NO-01	11	36	89	0.4432992018344449	TCGA-DI-A1NO-01	27	25	15	67	PASS	10906	TCGA-DI-A1NO	UCEC	68	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24996	Dead	WITH TUMOR	NA	285	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	285	1	285	NA	NA	1	285	
50	TCGA-DI-A2QT	0	9	2	1	0	1	0	0	0	20	1	0	0	4	0	0	TCGA-DI-A2QT-01	268	0.4254402382851969	163	TCGA-DI-A2QT-01	11	38	30	0.1321032758304754	TCGA-DI-A2QT-01	12	12	4	28	PASS	10907	TCGA-DI-A2QT	UCEC	51	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NA	Stage IIIC	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18835	Dead	WITH TUMOR	NA	377	NA	NA	NA	NA	NA	NA	NA	NA	1	377	1	377	NA	NA	1	377	
70	TCGA-DI-A2QU	2	16	1	2	7	1	1	0	2	50	2	0	1	17	2	0	TCGA-DI-A2QU-01	279	0.4355051838060973	174	TCGA-DI-A2QU-01	10	16	72	0.28940635665410225	TCGA-DI-A2QU-01	12	7	11	30	PASS	10908	TCGA-DI-A2QU	UCEC	67	FEMALE	WHITE	NA	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24488	Dead	WITH TUMOR	NA	946	NA	NA	NA	NA	NA	NA	NA	NA	1	946	1	946	NA	NA	1	946	
60	TCGA-DI-A2QY	1	17	0	4	1	0	4	0	7	99	5	0	2	21	0	0	TCGA-DI-A2QY-01	383	0.7048285280664324	230	TCGA-DI-A2QY-01	15	35	64	0.2105962398258117	TCGA-DI-A2QY-01	20	29	10	59	PASS	10909	TCGA-DI-A2QY	UCEC	64	FEMALE	WHITE	NA	Stage IIB	Serous endometrial adenocarcinoma	G3	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23398	Dead	TUMOR FREE	NA	3349	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	3349	0	3349	0	3349	0	3349	
40	TCGA-E6-A1LX	301	4081	126	444	30	36	0	0	776	10957	1332	17	415	3442	243	3	TCGA-E6-A1LX-01	67	0.011189632358995037	24	TCGA-E6-A1LX-01	1	1	2	0.011745045648615232	TCGA-E6-A1LX-01	0	0	0	0	hypermutated sample	10910	TCGA-E6-A1LX	UCEC	40	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14731	Alive	TUMOR FREE	711	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	711	0	711	0	711	0	711	
80	TCGA-E6-A1LZ	2	24	0	11	4	0	1	0	13	198	26	1	3	71	2	0	TCGA-E6-A1LZ-01	303	0.6354188576841748	186	TCGA-E6-A1LZ-01	18	35	46	0.25149412559262074	TCGA-E6-A1LZ-01	18	19	11	48	PASS	10911	TCGA-E6-A1LZ	UCEC	76	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28054	Alive	TUMOR FREE	2406	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2406	0	2406	0	2406	0	2406	
60	TCGA-E6-A1M0	86	1475	29	132	4	10	2	1	252	2889	468	6	130	755	60	2	TCGA-E6-A1M0-01	83	0.3953685805383549	33	TCGA-E6-A1M0-01	7	6	0	0.0	TCGA-E6-A1M0-01	0	0	0	0	hypermutated sample	10912	TCGA-E6-A1M0	UCEC	56	FEMALE	WHITE	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20629	Alive	TUMOR FREE	1793	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1793	0	1793	0	1793	0	1793	
50	TCGA-E6-A2P8	16	280	4	26	115	27	2	1	42	390	12	1	20	180	11	0	TCGA-E6-A2P8-01	73	0.00018271573941597763	31	TCGA-E6-A2P8-01	0	0	19	8.970433734585284e-05	TCGA-E6-A2P8-01	0	0	0	0	PASS	10913	TCGA-E6-A2P8	UCEC	53	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IV	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19448	Dead	WITH TUMOR	NA	72	NA	Metastatic	Lung	NA	60	Progressive Disease	NA	NA	1	72	1	72	NA	NA	1	60	
70	TCGA-E6-A2P9	43	420	14	56	153	43	7	0	61	609	36	0	31	299	17	0	TCGA-E6-A2P9-01	116	0.08571227390556739	66	TCGA-E6-A2P9-01	3	3	19	0.007915911604060999	TCGA-E6-A2P9-01	2	1	1	4	PASS	10914	TCGA-E6-A2P9	UCEC	65	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24088	Alive	TUMOR FREE	1386	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1386	0	1386	0	1386	0	1386	
60	TCGA-E6-A8L9	1	13	0	2	2	0	1	0	5	46	1	0	2	11	0	0	TCGA-E6-A8L9-01	735	0.7353472335588489	525	TCGA-E6-A8L9-01	26	20	228	0.3462013168724247	TCGA-E6-A8L9-01	19	9	12	40	PASS	10915	TCGA-E6-A8L9	UCEC	61	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22333	Alive	TUMOR FREE	1013	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1013	0	1013	0	1013	0	1013	
70	TCGA-EC-A1NJ	12	119	2	12	5	42	1	1	18	192	2	1	7	88	9	2	TCGA-EC-A1NJ-01	73	0.052985257767987966	24	TCGA-EC-A1NJ-01	2	1	19	0.020779881256038208	TCGA-EC-A1NJ-01	1	0	1	2	PASS	10916	TCGA-EC-A1NJ	UCEC	73	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27002	Alive	TUMOR FREE	488	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	488	0	488	0	488	0	488	
70	TCGA-EC-A1QX	20	221	7	35	95	16	8	0	52	483	27	0	14	228	11	1	TCGA-EC-A1QX-01	47	0.07960728331514931	9	TCGA-EC-A1QX-01	2	2	0	0.0	TCGA-EC-A1QX-01	1	0	0	1	PASS	10917	TCGA-EC-A1QX	UCEC	71	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26259	Alive	TUMOR FREE	224	NA	NA	NA	NA	NA	219	Progressive Disease	NA	NA	0	224	0	224	NA	NA	1	219	
60	TCGA-EC-A24G	27	283	10	49	27	7	0	0	77	895	60	4	24	422	20	0	TCGA-EC-A24G-01	43	0.0004568251732466292	8	TCGA-EC-A24G-01	0	0	2	0.0004026492167063393	TCGA-EC-A24G-01	0	0	0	0	PASS	10918	TCGA-EC-A24G	UCEC	57	FEMALE	WHITE	NA	Stage II	Endometrioid endometrial adenocarcinoma	G3	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-20857	Alive	TUMOR FREE	511	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	511	0	511	0	511	0	511	
60	TCGA-EO-A1Y5	0	5	0	2	2	0	0	0	7	58	9	0	0	27	1	0	TCGA-EO-A1Y5-01	421	0.7102773751516752	273	TCGA-EO-A1Y5-01	14	23	23	0.05988012516699132	TCGA-EO-A1Y5-01	14	13	4	31	PASS	10919	TCGA-EO-A1Y5	UCEC	63	FEMALE	NA	NA	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23251	Alive	TUMOR FREE	332	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	332	0	332	0	332	0	332	
70	TCGA-EO-A1Y7	2	16	1	0	0	1	1	0	0	32	6	0	0	20	1	0	TCGA-EO-A1Y7-01	449	0.4678066849216307	298	TCGA-EO-A1Y7-01	9	9	89	0.22417832997857312	TCGA-EO-A1Y7-01	7	5	4	16	PASS	10920	TCGA-EO-A1Y7	UCEC	65	FEMALE	NA	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24085	Alive	WITH TUMOR	1495	NA	NA	Distant Metastasis	Lung	NA	880	Progressive Disease	NA	NA	0	1495	0	1495	NA	NA	1	880	
90	TCGA-EO-A1Y8	1	3	0	4	1	0	1	0	3	45	1	0	0	17	1	0	TCGA-EO-A1Y8-01	358	0.37285054874627743	216	TCGA-EO-A1Y8-01	10	17	33	0.0950022911803176	TCGA-EO-A1Y8-01	14	9	3	26	PASS	10921	TCGA-EO-A1Y8	UCEC	87	FEMALE	NA	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31971	Alive	TUMOR FREE	1147	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1147	0	1147	0	1147	0	1147	
60	TCGA-EO-A22R	283	3799	160	582	27	53	0	0	830	11598	825	13	514	4117	203	9	TCGA-EO-A22R-01	85	0.00021859422043709042	39	TCGA-EO-A22R-01	0	0	2	0.00011855087124092883	TCGA-EO-A22R-01	0	0	0	0	hypermutated sample	10922	TCGA-EO-A22R	UCEC	56	FEMALE	NA	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20604	Alive	TUMOR FREE	1878	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1878	0	1878	0	1878	0	1878	
60	TCGA-EO-A22S	32	330	14	51	159	39	11	2	58	390	20	0	31	197	9	1	TCGA-EO-A22S-01	101	8.295500275949326e-05	50	TCGA-EO-A22S-01	0	0	19	2.984144024424207e-05	TCGA-EO-A22S-01	0	0	0	0	PASS	10923	TCGA-EO-A22S	UCEC	58	FEMALE	NA	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21328	Alive	TUMOR FREE	1872	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1872	0	1872	0	1872	0	1872	
60	TCGA-EO-A22T	29	337	10	44	157	35	9	0	63	716	37	2	32	352	18	0	TCGA-EO-A22T-01	85	0.049859201245663794	42	TCGA-EO-A22T-01	2	3	2	0.037829237742688614	TCGA-EO-A22T-01	0	0	1	1	PASS	10924	TCGA-EO-A22T	UCEC	56	FEMALE	ASIAN	NA	Stage II	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20608	Alive	TUMOR FREE	2035	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2035	0	2035	0	2035	0	2035	
80	TCGA-EO-A22U	308	4255	150	594	9	201	2	1	882	12144	1080	4	470	5383	283	10	TCGA-EO-A22U-01	77	0.0004030425213857608	30	TCGA-EO-A22U-01	0	0	3	6.938904645527216e-05	TCGA-EO-A22U-01	0	0	0	0	hypermutated sample	10925	TCGA-EO-A22U	UCEC	83	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30557	Alive	TUMOR FREE	1407	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1407	0	1407	0	1407	0	1407	
40	TCGA-EO-A22X	243	3397	103	366	4	26	0	1	665	8043	1182	12	387	2289	150	5	TCGA-EO-A22X-01	111	0.045843860810419385	47	TCGA-EO-A22X-01	1	1	11	0.016361668102876432	TCGA-EO-A22X-01	3	3	2	8	hypermutated sample	10926	TCGA-EO-A22X	UCEC	36	FEMALE	NA	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13245	Alive	TUMOR FREE	1752	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1752	0	1752	0	1752	0	1752	
70	TCGA-EO-A22Y	0	11	1	4	1	0	2	0	2	42	3	0	2	17	0	0	TCGA-EO-A22Y-01	46	0.9471936633414456	9	TCGA-EO-A22Y-01	25	30	4	0.16652735844609312	TCGA-EO-A22Y-01	1	0	0	1	PASS	10927	TCGA-EO-A22Y	UCEC	68	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25127	Alive	TUMOR FREE	1567	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1567	0	1567	0	1567	0	1567	
70	TCGA-EO-A2CG	1	3	1	0	2	0	0	0	0	31	1	0	1	14	1	0	TCGA-EO-A2CG-01	385	0.682188638199771	226	TCGA-EO-A2CG-01	24	28	51	0.10249528415235806	TCGA-EO-A2CG-01	16	10	8	34	PASS	10928	TCGA-EO-A2CG	UCEC	69	FEMALE	ASIAN	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25279	Alive	TUMOR FREE	1564	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1564	0	1564	0	1564	0	1564	
70	TCGA-EO-A2CH	0	10	1	0	2	0	0	0	0	38	1	0	1	15	0	0	TCGA-EO-A2CH-01	309	0.4757585105995297	186	TCGA-EO-A2CH-01	10	13	52	0.1614071699020705	TCGA-EO-A2CH-01	13	6	7	26	PASS	10929	TCGA-EO-A2CH	UCEC	73	FEMALE	NA	NA	Stage IVB	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26966	Dead	WITH TUMOR	NA	590	NA	Metastatic	Liver	NA	304	Progressive Disease	NA	NA	1	590	1	590	NA	NA	1	304	
90	TCGA-EO-A3AS	3	30	2	10	7	1	3	0	6	135	5	0	4	45	4	0	TCGA-EO-A3AS-01	428	0.5583426654142757	267	TCGA-EO-A3AS-01	5	15	82	0.34637267762630514	TCGA-EO-A3AS-01	23	26	19	68	PASS	10930	TCGA-EO-A3AS	UCEC	86	FEMALE	NA	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31450	Alive	TUMOR FREE	1046	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1046	0	1046	0	1046	0	1046	
70	TCGA-EO-A3AU	25	300	12	35	137	31	11	1	44	443	32	0	16	231	7	1	TCGA-EO-A3AU-01	57	3.33622469362189e-05	25	TCGA-EO-A3AU-01	0	0	19	3.695851289197129e-06	TCGA-EO-A3AU-01	0	0	0	0	PASS	10931	TCGA-EO-A3AU	UCEC	72	FEMALE	NA	NA	Stage II	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26406	Alive	TUMOR FREE	1543	NA	NA	New Primary Tumor	Lung	NA	1178	Complete Remission/Response	NA	NA	0	1543	0	1543	0	1543	1	1178	
50	TCGA-EO-A3AV	116	1560	46	135	3	6	0	0	258	3486	504	9	198	960	68	2	TCGA-EO-A3AV-01	58	0.06977346478395396	10	TCGA-EO-A3AV-01	4	2	0	0.0	TCGA-EO-A3AV-01	0	0	0	0	hypermutated sample	10932	TCGA-EO-A3AV	UCEC	51	FEMALE	NA	NA	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2010	Peri (6-12 months since last menstrual period)	-18713	Alive	TUMOR FREE	1069	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1069	0	1069	0	1069	0	1069	
60	TCGA-EO-A3AY	95	1557	42	143	1	7	0	1	266	2810	488	3	159	709	69	1	TCGA-EO-A3AY-01	93	0.00024827350453108274	44	TCGA-EO-A3AY-01	0	0	4	0.019794631974900282	TCGA-EO-A3AY-01	1	1	1	3	hypermutated sample	10933	TCGA-EO-A3AY	UCEC	58	FEMALE	NA	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21291	Alive	WITH TUMOR	1158	NA	NA	Locoregional Recurrence	"Other, specify"	Vaginal Vault	1163	Complete Remission/Response	NA	NA	0	1158	0	1158	1	1163	1	1163	
80	TCGA-EO-A3AZ	30	350	8	27	134	29	9	1	50	740	52	1	30	353	20	1	TCGA-EO-A3AZ-01	94	0.28451406302820936	41	TCGA-EO-A3AZ-01	18	13	14	0.4235611822910131	TCGA-EO-A3AZ-01	5	0	6	11	PASS	10934	TCGA-EO-A3AZ	UCEC	80	FEMALE	NA	NA	Stage IB	Mixed serous and endometrioid	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29234	Alive	TUMOR FREE	826	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	826	0	826	0	826	0	826	
40	TCGA-EO-A3B0	272	4045	125	476	6	34	3	0	725	9378	1265	10	443	2540	183	5	TCGA-EO-A3B0-01	87	0.050024565971544026	42	TCGA-EO-A3B0-01	2	1	3	7.557268090744347e-05	TCGA-EO-A3B0-01	0	0	0	0	hypermutated sample	10935	TCGA-EO-A3B0	UCEC	43	FEMALE	ASIAN	NA	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G3	2011	Indeterminate (neither Pre or Postmenopausal)	-15954	Alive	TUMOR FREE	1412	NA	NA	NA	NA	NA	NA	[Discrepancy]	NA	NA	0	1412	0	1412	NA	NA	0	1412	
60	TCGA-EO-A3B1	2	9	0	3	1	0	0	0	1	35	2	0	0	11	1	0	TCGA-EO-A3B1-01	338	0.7682007982564539	210	TCGA-EO-A3B1-01	20	27	62	0.2209946258736993	TCGA-EO-A3B1-01	21	18	11	50	PASS	10936	TCGA-EO-A3B1	UCEC	63	FEMALE	NA	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23162	Alive	TUMOR FREE	820	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	820	0	820	0	820	0	820	
70	TCGA-EO-A3KU	2	16	0	2	1	0	1	0	1	50	2	0	2	10	1	0	TCGA-EO-A3KU-01	337	0.7333453182185579	205	TCGA-EO-A3KU-01	14	30	17	0.056019323394953566	TCGA-EO-A3KU-01	20	11	3	34	PASS	10937	TCGA-EO-A3KU	UCEC	68	FEMALE	NA	NA	Stage II	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25116	Alive	TUMOR FREE	677	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	677	0	677	0	677	0	677	
70	TCGA-EO-A3KW	1	4	0	3	2	0	0	0	6	35	4	0	1	13	0	0	TCGA-EO-A3KW-01	438	0.6613274584215703	307	TCGA-EO-A3KW-01	16	19	53	0.12710599328413874	TCGA-EO-A3KW-01	16	12	9	37	PASS	10938	TCGA-EO-A3KW	UCEC	72	FEMALE	NA	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26492	Alive	TUMOR FREE	497	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	497	0	497	0	497	0	497	
80	TCGA-EO-A3KX	112	1278	39	182	372	222	16	1	264	2302	141	3	103	947	102	4	TCGA-EO-A3KX-01	93	0.00017890243822641405	42	TCGA-EO-A3KX-01	0	0	19	2.1428342872492827e-05	TCGA-EO-A3KX-01	0	0	0	0	hypermutated sample	10939	TCGA-EO-A3KX	UCEC	80	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29260	Alive	TUMOR FREE	1170	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1170	0	1170	0	1170	0	1170	
80	TCGA-EO-A3L0	4	19	0	3	6	5	0	0	6	55	4	1	2	26	1	0	TCGA-EO-A3L0-01	57	0.09630383600606483	15	TCGA-EO-A3L0-01	4	5	19	0.06174722529310254	TCGA-EO-A3L0-01	0	0	0	0	PASS	10940	TCGA-EO-A3L0	UCEC	76	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28003	Alive	TUMOR FREE	1554	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1554	0	1554	0	1554	0	1554	
90	TCGA-EY-A1G7	1	17	0	5	7	7	2	0	7	63	5	0	8	25	2	0	TCGA-EY-A1G7	0	0	0	TCGA-EY-A1G7	0	0	0	0	TCGA-EY-A1G7-01	2	2	1	5	PASS	10941	TCGA-EY-A1G7	UCEC	86	FEMALE	WHITE	NA	Stage II	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31603	Dead	WITH TUMOR	NA	189	NA	NA	NA	NA	95	Complete Remission/Response	NA	NA	1	189	1	189	1	95	1	95	
80	TCGA-EY-A1G8	68	945	19	97	6	9	0	0	160	2074	360	7	99	612	43	1	TCGA-EY-A1G8	0	0	0	TCGA-EY-A1G8	0	0	0	0	TCGA-EY-A1G8-01	1	0	0	1	hypermutated sample	10942	TCGA-EY-A1G8	UCEC	83	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30517	Dead	TUMOR FREE	NA	456	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	456	0	456	0	456	0	456	
60	TCGA-EY-A1GC	2	13	0	3	0	2	0	0	1	27	4	0	0	17	1	0	TCGA-EY-A1GC-01	302	0.6530685679050132	184	TCGA-EY-A1GC-01	18	23	66	0.2399810154925808	TCGA-EY-A1GC-01	22	19	8	49	PASS	10943	TCGA-EY-A1GC	UCEC	62	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22656	Alive	TUMOR FREE	1647	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1647	0	1647	0	1647	0	1647	
50	TCGA-EY-A1GD	29	372	16	39	0	6	0	0	77	928	123	0	43	264	12	2	TCGA-EY-A1GD-01	60	0.03469216666614563	18	TCGA-EY-A1GD-01	1	2	0	0.0	TCGA-EY-A1GD-01	0	0	0	0	PASS	10944	TCGA-EY-A1GD	UCEC	51	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18638	Alive	TUMOR FREE	1639	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1639	0	1639	0	1639	0	1639	
70	TCGA-EY-A1GE	1	6	0	2	2	3	0	0	1	31	3	0	0	13	2	0	TCGA-EY-A1GE-01	31	1.3974417573504469e-06	2	TCGA-EY-A1GE-01	0	0	0	0.0	TCGA-EY-A1GE-01	0	0	0	0	PASS	10945	TCGA-EY-A1GE	UCEC	67	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24667	Alive	TUMOR FREE	741	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	741	0	741	0	741	0	741	
80	TCGA-EY-A1GF	10	158	4	20	69	10	5	0	29	220	18	0	8	131	11	0	TCGA-EY-A1GF-01	56	0.04409682591235834	17	TCGA-EY-A1GF-01	1	2	4	0.050583689194936936	TCGA-EY-A1GF-01	2	1	2	5	PASS	10946	TCGA-EY-A1GF	UCEC	75	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27450	Alive	TUMOR FREE	826	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	826	0	826	0	826	0	826	
70	TCGA-EY-A1GH	3	15	4	2	4	1	2	1	3	40	6	1	1	17	0	0	TCGA-EY-A1GH-01	49	0.18414708554881068	12	TCGA-EY-A1GH-01	6	3	19	5.298490716411937e-05	TCGA-EY-A1GH-01	0	0	0	0	PASS	10947	TCGA-EY-A1GH	UCEC	70	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25802	Alive	TUMOR FREE	710	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	710	0	710	0	710	0	710	
50	TCGA-EY-A1GI	120	1620	52	173	5	15	1	0	277	3767	618	7	164	1032	60	3	TCGA-EY-A1GI-01	57	0.0004874727489522536	20	TCGA-EY-A1GI-01	0	0	19	7.169098529679229e-05	TCGA-EY-A1GI-01	0	0	0	0	hypermutated sample	10948	TCGA-EY-A1GI	UCEC	52	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19117	Alive	TUMOR FREE	710	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	710	0	710	0	710	0	710	
70	TCGA-EY-A1GJ	0	11	0	2	0	0	0	1	1	40	3	0	1	10	0	0	TCGA-EY-A1GJ-01	413	0.7091416235223014	261	TCGA-EY-A1GJ-01	5	11	66	0.1830843987654492	TCGA-EY-A1GJ-01	15	9	13	37	PASS	10949	TCGA-EY-A1GJ	UCEC	73	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26715	Alive	TUMOR FREE	727	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	727	0	727	0	727	0	727	
70	TCGA-EY-A1GK	17	348	11	49	190	48	9	0	54	544	26	1	32	276	19	1	TCGA-EY-A1GK-01	59	0.055034329016325344	19	TCGA-EY-A1GK-01	2	3	3	0.03424388791131413	TCGA-EY-A1GK-01	4	2	2	8	PASS	10950	TCGA-EY-A1GK	UCEC	74	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27127	Alive	TUMOR FREE	693	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	693	0	693	0	693	0	693	
50	TCGA-EY-A1GL	1	7	0	1	1	2	0	0	2	35	4	1	4	16	0	0	TCGA-EY-A1GL-01	67	0.06547806866223249	25	TCGA-EY-A1GL-01	3	2	3	0.043676556155295775	TCGA-EY-A1GL-01	2	1	1	4	PASS	10951	TCGA-EY-A1GL	UCEC	51	FEMALE	WHITE	NA	Stage II	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18761	Alive	TUMOR FREE	1014	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1014	0	1014	0	1014	0	1014	
60	TCGA-EY-A1GM	1	8	2	1	0	1	2	0	5	30	0	0	0	13	0	0	TCGA-EY-A1GM-01	334	0.3240439905870978	210	TCGA-EY-A1GM-01	11	12	51	0.1947118766257694	TCGA-EY-A1GM-01	9	5	11	25	PASS	10952	TCGA-EY-A1GM	UCEC	60	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIA	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22010	Dead	WITH TUMOR	NA	995	NA	Locoregional Recurrence	NA	NA	791	Complete Remission/Response	NA	NA	1	995	1	995	1	791	1	791	
70	TCGA-EY-A1GO	13	93	3	16	41	8	1	0	17	221	14	0	7	119	4	0	TCGA-EY-A1GO-01	97	0.7977692938116034	47	TCGA-EY-A1GO-01	22	18	5	0.1092424476905589	TCGA-EY-A1GO-01	4	2	2	8	PASS	10953	TCGA-EY-A1GO	UCEC	65	FEMALE	WHITE	NA	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23853	Alive	WITH TUMOR	586	NA	NA	Metastatic	Lung	NA	517	Complete Remission/Response	NA	NA	0	586	0	586	1	517	1	517	
50	TCGA-EY-A1GP	1	10	1	2	0	3	0	0	3	22	3	1	1	10	0	0	TCGA-EY-A1GP-01	144	0.9471828829926904	84	TCGA-EY-A1GP-01	16	13	26	0.4723625597296146	TCGA-EY-A1GP-01	4	1	2	7	PASS	10954	TCGA-EY-A1GP	UCEC	54	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20011	Alive	TUMOR FREE	573	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	573	0	573	0	573	0	573	
80	TCGA-EY-A1GQ	8	215	4	28	70	23	11	1	36	326	12	1	15	164	10	0	TCGA-EY-A1GQ-01	78	0.9448345751280092	28	TCGA-EY-A1GQ-01	9	6	0	0.0	TCGA-EY-A1GQ-01	1	0	0	1	PASS	10955	TCGA-EY-A1GQ	UCEC	76	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27905	Alive	WITH TUMOR	544	NA	NA	Metastatic	"Other, specify"	"R external iliac node, presacral peritoneal implant, ascitic fluid"	334	Complete Remission/Response	NA	NA	0	544	0	544	1	334	1	334	
70	TCGA-EY-A1GR	3	18	1	2	4	0	1	0	3	33	3	0	1	16	0	1	TCGA-EY-A1GR-01	395	0.8018626694923154	253	TCGA-EY-A1GR-01	24	23	77	0.3321803540649555	TCGA-EY-A1GR-01	17	13	12	42	PASS	10956	TCGA-EY-A1GR	UCEC	67	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24784	Alive	TUMOR FREE	536	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	536	0	536	0	536	0	536	
70	TCGA-EY-A1GS	4	22	0	11	3	0	4	1	18	303	34	1	6	95	6	0	TCGA-EY-A1GS-01	378	0.9889155513910812	250	TCGA-EY-A1GS-01	24	63	60	0.2998136487706187	TCGA-EY-A1GS-01	22	10	14	46	PASS	10957	TCGA-EY-A1GS	UCEC	71	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IVB	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26012	Dead	WITH TUMOR	NA	670	NA	NA	NA	NA	NA	Stable Disease	NA	NA	1	670	1	670	NA	NA	1	670	
70	TCGA-EY-A1GT	0	13	1	2	6	2	2	0	7	60	4	0	3	20	1	0	TCGA-EY-A1GT-01	42	0.08102864766585059	11	TCGA-EY-A1GT	0	0	0	0	TCGA-EY-A1GT	0	0	0	0	PASS	10958	TCGA-EY-A1GT	UCEC	68	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25151	Alive	TUMOR FREE	490	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	490	0	490	0	490	0	490	
70	TCGA-EY-A1GU	39	523	17	77	98	27	6	0	91	957	66	0	42	435	29	0	TCGA-EY-A1GU-01	60	0.03410153230856226	15	TCGA-EY-A1GU-01	1	2	0	0.0	TCGA-EY-A1GU-01	1	0	0	1	PASS	10959	TCGA-EY-A1GU	UCEC	66	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24304	Dead	TUMOR FREE	NA	997	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	997	0	997	0	997	0	997	
80	TCGA-EY-A1GV	2	4	2	0	0	1	1	0	0	31	1	0	2	9	0	1	TCGA-EY-A1GV-01	104	0.21576002369726666	47	TCGA-EY-A1GV-01	6	9	25	0.18361298635977427	TCGA-EY-A1GV-01	6	5	8	19	PASS	10960	TCGA-EY-A1GV	UCEC	75	FEMALE	WHITE	NA	Stage IIIC1	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27581	Alive	TUMOR FREE	481	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	481	0	481	0	481	0	481	
70	TCGA-EY-A1GW	1	12	0	2	4	2	0	0	4	44	2	0	1	8	1	1	TCGA-EY-A1GW-01	124	0.8575552056443047	59	TCGA-EY-A1GW-01	9	9	28	0.28163593454124114	TCGA-EY-A1GW-01	5	8	6	19	PASS	10961	TCGA-EY-A1GW	UCEC	73	FEMALE	WHITE	NA	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26979	Dead	WITH TUMOR	NA	337	NA	Metastatic	Liver	NA	190	Progressive Disease	NA	NA	1	337	1	337	NA	NA	1	190	
80	TCGA-EY-A1GX	2	15	2	6	3	2	1	0	6	63	3	0	4	25	1	0	TCGA-EY-A1GX-01	76	0.9361731316888616	26	TCGA-EY-A1GX-01	8	7	4	0.04912443663128396	TCGA-EY-A1GX-01	2	0	0	2	PASS	10962	TCGA-EY-A1GX	UCEC	76	FEMALE	WHITE	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27962	Dead	TUMOR FREE	NA	1127	NA	Locoregional Recurrence	"Other, specify"	pelvic mass	743	Complete Remission/Response	NA	NA	1	1127	0	1127	1	743	1	743	
60	TCGA-EY-A1H0	24	183	8	21	91	8	6	1	36	205	19	0	9	96	4	1	TCGA-EY-A1H0-01	81	0.1422871089443979	38	TCGA-EY-A1H0-01	6	3	2	0.014160078967129928	TCGA-EY-A1H0-01	1	1	1	3	PASS	10963	TCGA-EY-A1H0	UCEC	57	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20937	Alive	WITH TUMOR	588	NA	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	0	588	0	588	NA	NA	0	588	
80	TCGA-EY-A210	0	7	0	1	0	2	1	0	2	24	2	0	1	20	3	0	TCGA-EY-A210-01	190	0.33826287227513896	94	TCGA-EY-A210-01	5	9	24	0.14866752060205352	TCGA-EY-A210-01	7	8	9	24	PASS	10964	TCGA-EY-A210	UCEC	82	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC2	Mixed serous and endometrioid	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30095	Alive	TUMOR FREE	383	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	383	0	383	0	383	0	383	
80	TCGA-EY-A212	0	3	0	2	4	1	0	0	3	54	5	0	1	13	1	0	TCGA-EY-A212-01	762	0.6274033158649439	531	TCGA-EY-A212-01	5	11	123	0.2100398237179656	TCGA-EY-A212-01	13	14	15	42	PASS	10965	TCGA-EY-A212	UCEC	83	FEMALE	WHITE	NA	Stage IIIC1	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30680	Dead	WITH TUMOR	NA	310	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	310	1	310	NA	NA	1	310	
70	TCGA-EY-A214	1	10	1	5	0	0	1	0	5	42	6	0	3	15	2	0	TCGA-EY-A214-01	174	0.7974859382002898	95	TCGA-EY-A214-01	25	20	51	0.633355623187913	TCGA-EY-A214-01	12	8	13	33	PASS	10966	TCGA-EY-A214	UCEC	66	FEMALE	WHITE	NA	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24136	Alive	TUMOR FREE	438	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	438	0	438	0	438	0	438	
60	TCGA-EY-A215	95	1424	55	188	196	60	6	0	319	3957	260	2	144	1575	120	4	TCGA-EY-A215-01	61	0.0012925533873036578	15	TCGA-EY-A215-01	0	2	2	0.03651959788937442	TCGA-EY-A215-01	0	0	1	1	hypermutated sample	10967	TCGA-EY-A215	UCEC	60	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22076	Alive	TUMOR FREE	574	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	574	0	574	0	574	0	574	
60	TCGA-EY-A2OM	18	336	9	47	143	20	16	2	54	407	21	0	23	176	12	0	TCGA-EY-A2OM-01	61	0.05115167927539895	18	TCGA-EY-A2OM-01	2	1	4	0.00042109238514255985	TCGA-EY-A2OM-01	0	0	0	0	PASS	10968	TCGA-EY-A2OM	UCEC	55	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20398	Alive	TUMOR FREE	694	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	694	0	694	0	694	0	694	
60	TCGA-EY-A2ON	2	16	2	1	1	0	1	0	2	66	2	0	2	21	1	0	TCGA-EY-A2ON-01	290	0.5201830762284426	180	TCGA-EY-A2ON-01	19	29	15	0.030828638159406306	TCGA-EY-A2ON-01	15	11	1	27	PASS	10969	TCGA-EY-A2ON	UCEC	61	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IVB	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22624	Dead	WITH TUMOR	NA	610	NA	NA	NA	NA	226	Progressive Disease	NA	NA	1	610	1	610	NA	NA	1	226	
60	TCGA-EY-A2OO	1	7	0	2	3	1	3	0	5	49	9	0	3	12	0	0	TCGA-EY-A2OO-01	72	0.4278784551583657	29	TCGA-EY-A2OO-01	17	36	19	0.008635800920309425	TCGA-EY-A2OO-01	2	1	1	4	PASS	10970	TCGA-EY-A2OO	UCEC	56	FEMALE	WHITE	NA	Stage IB	Mixed serous and endometrioid	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20797	Alive	TUMOR FREE	1392	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1392	0	1392	0	1392	0	1392	
60	TCGA-EY-A2OP	5	206	10	24	86	22	8	0	45	314	19	0	13	140	7	0	TCGA-EY-A2OP-01	70	0.08033455258207782	27	TCGA-EY-A2OP-01	3	2	19	0.018101200729055425	TCGA-EY-A2OP-01	2	2	1	5	PASS	10971	TCGA-EY-A2OP	UCEC	63	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23090	Alive	TUMOR FREE	944	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	944	0	944	0	944	0	944	
60	TCGA-EY-A2OQ	1	9	0	1	1	0	1	0	1	40	3	0	1	16	0	0	TCGA-EY-A2OQ-01	393	0.8178927478148422	234	TCGA-EY-A2OQ-01	13	28	43	0.13788557450435682	TCGA-EY-A2OQ-01	17	23	5	45	PASS	10972	TCGA-EY-A2OQ	UCEC	61	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22309	Alive	TUMOR FREE	885	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	885	0	885	0	885	0	885	
80	TCGA-EY-A3L3	0	18	2	2	1	1	2	0	3	46	2	0	2	13	1	0	TCGA-EY-A3L3-01	483	0.5688586528235348	294	TCGA-EY-A3L3-01	15	29	62	0.2176099270958988	TCGA-EY-A3L3-01	20	6	12	38	PASS	10973	TCGA-EY-A3L3	UCEC	82	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30138	Alive	TUMOR FREE	832	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	832	0	832	0	832	0	832	
60	TCGA-EY-A3QX	1	13	0	3	1	0	0	0	1	41	6	0	2	18	1	0	TCGA-EY-A3QX-01	420	0.9621427615333524	254	TCGA-EY-A3QX-01	13	16	111	0.3916331620965491	TCGA-EY-A3QX-01	18	9	14	41	PASS	10974	TCGA-EY-A3QX	UCEC	64	FEMALE	WHITE	NA	Stage IVB	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23663	Dead	WITH TUMOR	NA	989	NA	Locoregional Recurrence	"Other, specify"	Peritoneum	896	Complete Remission/Response	NA	NA	1	989	1	989	NA	NA	1	896	
60	TCGA-EY-A4KR	1	29	1	5	3	0	2	0	2	63	3	0	5	30	1	0	TCGA-EY-A4KR-01	403	0.5385416119454537	241	TCGA-EY-A4KR-01	4	9	131	0.18557142021675094	TCGA-EY-A4KR-01	15	21	12	48	PASS	10975	TCGA-EY-A4KR	UCEC	56	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC1	Serous endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20669	Dead	WITH TUMOR	NA	346	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	346	1	346	NA	NA	1	346	
80	TCGA-EY-A547	6	65	2	12	19	4	2	0	13	113	4	0	2	61	3	0	TCGA-EY-A547-01	240	0.6660994076687161	140	TCGA-EY-A547-01	11	15	94	0.234501747086074	TCGA-EY-A547-01	9	7	10	26	PASS	10976	TCGA-EY-A547	UCEC	75	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27686	Alive	TUMOR FREE	545	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	545	0	545	0	545	0	545	
80	TCGA-EY-A548	19	227	9	29	129	23	11	1	47	394	24	0	20	165	9	0	TCGA-EY-A548-01	45	0.00013364800713711958	11	TCGA-EY-A548-01	0	0	8	0.0002764690897398731	TCGA-EY-A548-01	0	0	0	0	PASS	10977	TCGA-EY-A548	UCEC	83	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30544	Alive	TUMOR FREE	430	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	430	0	430	0	430	0	430	
80	TCGA-EY-A549	28	323	14	41	122	20	13	2	77	1092	57	0	26	490	9	0	TCGA-EY-A549-01	79	0.1592474610336642	29	TCGA-EY-A549-01	5	3	3	0.00010124419592655106	TCGA-EY-A549-01	1	0	0	1	PASS	10978	TCGA-EY-A549	UCEC	78	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28570	Alive	TUMOR FREE	605	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	605	0	605	0	605	0	605	
70	TCGA-EY-A54A	2	18	0	4	6	1	0	0	6	86	4	0	6	28	3	0	TCGA-EY-A54A-01	317	0.5847750167931888	188	TCGA-EY-A54A-01	5	7	114	0.1568534361085481	TCGA-EY-A54A-01	9	9	6	24	PASS	10979	TCGA-EY-A54A	UCEC	67	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24822	Alive	TUMOR FREE	447	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	447	0	447	0	447	0	447	
70	TCGA-EY-A5W2	23	310	16	44	165	33	14	1	55	512	34	2	18	231	13	1	TCGA-EY-A5W2-01	52	0.03409935574967796	12	TCGA-EY-A5W2-01	1	1	3	0.00010311055663795232	TCGA-EY-A5W2-01	1	0	0	1	PASS	10980	TCGA-EY-A5W2	UCEC	72	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26498	Alive	TUMOR FREE	516	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	516	0	516	0	516	0	516	
90	TCGA-EY-A72D	0	11	0	1	1	1	1	0	2	41	4	0	2	15	0	0	TCGA-EY-A72D-01	310	0.9999999220096522	182	TCGA-EY-A72D-01	23	35	200	0.4836502677342837	TCGA-EY-A72D-01	22	11	16	49	PASS	10981	TCGA-EY-A72D	UCEC	87	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage II	Endometrioid endometrial adenocarcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31818	Alive	TUMOR FREE	179	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	179	0	179	0	179	0	179	
80	TCGA-FI-A2CX	1	4	0	2	1	0	0	0	0	17	1	0	0	7	1	0	TCGA-FI-A2CX-01	90	0.07114758006441894	37	TCGA-FI-A2CX-01	0	0	0	0.0	TCGA-FI-A2CX-01	0	0	0	0	PASS	10982	TCGA-FI-A2CX	UCEC	82	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30224	Alive	TUMOR FREE	2031	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2031	0	2031	0	2031	0	2031	
60	TCGA-FI-A2CY	1	6	0	2	1	0	0	0	2	30	3	0	1	15	0	0	TCGA-FI-A2CY-01	334	0.3951747800151322	207	TCGA-FI-A2CY-01	6	8	48	0.16725946057229732	TCGA-FI-A2CY-01	14	7	6	27	PASS	10983	TCGA-FI-A2CY	UCEC	60	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Mixed serous and endometrioid	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22098	Alive	TUMOR FREE	2080	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2080	0	2080	0	2080	0	2080	
60	TCGA-FI-A2D0	146	1710	59	221	104	84	8	0	386	5757	330	2	194	2744	112	4	TCGA-FI-A2D0-01	51	1.3757037338339893e-05	16	TCGA-FI-A2D0-01	0	0	0	0.0	TCGA-FI-A2D0-01	0	0	0	0	hypermutated sample	10984	TCGA-FI-A2D0	UCEC	55	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2008	Peri (6-12 months since last menstrual period)	-20393	Alive	TUMOR FREE	1213	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1213	0	1213	0	1213	0	1213	
70	TCGA-FI-A2D2	0	1	0	0	2	1	1	0	0	33	1	0	2	12	1	0	TCGA-FI-A2D2-01	270	0.7522069974850427	153	TCGA-FI-A2D2-01	24	16	41	0.16640919189475464	TCGA-FI-A2D2-01	7	3	10	20	PASS	10985	TCGA-FI-A2D2	UCEC	66	FEMALE	WHITE	NA	Stage IB	Mixed serous and endometrioid	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24260	Dead	WITH TUMOR	NA	2352	NA	Locoregional Recurrence	Lung	Liver	1917	Complete Remission/Response	NA	NA	1	2352	1	2352	1	1917	1	1917	
40	TCGA-FI-A2D4	20	177	1	24	81	5	3	1	26	213	16	0	19	114	4	0	TCGA-FI-A2D4-01	71	0.8664598766779532	22	TCGA-FI-A2D4-01	6	4	4	0.015511938943613857	TCGA-FI-A2D4-01	1	1	1	3	PASS	10986	TCGA-FI-A2D4	UCEC	44	FEMALE	WHITE	NA	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16163	Dead	WITH TUMOR	NA	243	NA	NA	NA	NA	NA	Partial Remission/Response	NA	NA	1	243	1	243	NA	NA	1	243	
60	TCGA-FI-A2D5	283	3551	153	600	18	31	1	1	867	12765	731	7	482	4656	215	16	TCGA-FI-A2D5-01	115	0.0004862584713163715	52	TCGA-FI-A2D5-01	0	0	5	0.0001814727109240494	TCGA-FI-A2D5-01	0	0	0	0	hypermutated sample	10987	TCGA-FI-A2D5	UCEC	56	FEMALE	WHITE	NA	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20666	Dead	WITH TUMOR	NA	421	NA	Metastatic	"Other, specify"	vaginal cuff	280	Partial Remission/Response	NA	NA	1	421	1	421	NA	NA	1	280	
70	TCGA-FI-A2D6	27	274	5	37	138	45	8	1	44	404	20	0	22	209	12	0	TCGA-FI-A2D6-01	63	0.0455762834036294	16	TCGA-FI-A2D6-01	2	3	2	0.03821247344177663	TCGA-FI-A2D6-01	0	0	1	1	PASS	10988	TCGA-FI-A2D6	UCEC	74	FEMALE	WHITE	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27060	Dead	TUMOR FREE	NA	767	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	767	0	767	0	767	0	767	
70	TCGA-FI-A2EU	0	2	0	0	3	1	0	0	5	45	4	0	0	14	2	0	TCGA-FI-A2EU-01	268	0.7353199378779386	160	TCGA-FI-A2EU-01	10	11	57	0.2525263789361949	TCGA-FI-A2EU-01	10	6	8	24	PASS	10989	TCGA-FI-A2EU	UCEC	68	FEMALE	NA	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24837	Alive	TUMOR FREE	2941	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2941	0	2941	0	2941	0	2941	
70	TCGA-FI-A2EW	1	3	0	5	3	1	0	1	8	79	11	0	4	28	0	0	TCGA-FI-A2EW-01	372	0.7234620139915307	233	TCGA-FI-A2EW-01	18	26	39	0.12696144495243908	TCGA-FI-A2EW-01	11	8	3	22	PASS	10990	TCGA-FI-A2EW	UCEC	71	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIB	Serous endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26267	Alive	WITH TUMOR	1795	NA	NA	Metastatic	Liver	NA	1169	Complete Remission/Response	NA	NA	0	1795	0	1795	1	1169	1	1169	
60	TCGA-FI-A2EX	0	3	0	2	2	0	1	0	1	53	6	0	1	13	1	0	TCGA-FI-A2EX-01	344	0.6383166600485118	204	TCGA-FI-A2EX-01	15	29	51	0.14994814237559864	TCGA-FI-A2EX-01	16	17	9	42	PASS	10991	TCGA-FI-A2EX	UCEC	58	FEMALE	WHITE	NA	Stage IIIA	Serous endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21489	Alive	WITH TUMOR	284	NA	NA	Metastatic	NA	NA	213	Complete Remission/Response	NA	NA	0	284	0	284	1	213	1	213	
60	TCGA-FI-A2EY	5	16	1	7	3	0	4	0	9	83	5	0	3	20	1	0	TCGA-FI-A2EY-01	426	0.9234212536024792	263	TCGA-FI-A2EY-01	18	39	102	0.4131097583035748	TCGA-FI-A2EY-01	24	16	15	55	PASS	10992	TCGA-FI-A2EY	UCEC	63	FEMALE	WHITE	NA	Stage IIIA	Serous endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23042	Dead	TUMOR FREE	NA	880	NA	New Primary Tumor	Lung	NA	577	Complete Remission/Response	NA	NA	1	880	0	880	0	880	1	577	
60	TCGA-FI-A2F4	52	760	16	94	145	120	5	0	156	1440	66	3	65	594	98	4	TCGA-FI-A2F4-01	66	0.0343830598072911	22	TCGA-FI-A2F4-01	1	3	0	0.0	TCGA-FI-A2F4-01	1	0	0	1	hypermutated sample	10993	TCGA-FI-A2F4	UCEC	64	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23621	Alive	TUMOR FREE	2230	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2230	0	2230	0	2230	0	2230	
60	TCGA-FI-A2F8	0	6	1	2	0	0	0	0	4	62	3	0	1	32	0	0	TCGA-FI-A2F8-01	344	0.7488116985137772	201	TCGA-FI-A2F8-01	13	25	34	0.14162202763379475	TCGA-FI-A2F8-01	15	16	7	38	PASS	10994	TCGA-FI-A2F8	UCEC	64	FEMALE	WHITE	NA	Stage II	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23649	Alive	WITH TUMOR	933	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	933	0	933	0	933	0	933	
80	TCGA-FI-A2F9	1	8	0	0	4	0	2	1	4	35	2	0	1	11	0	0	TCGA-FI-A2F9-01	565	0.45998402658455295	364	TCGA-FI-A2F9-01	6	7	63	0.08824589347962287	TCGA-FI-A2F9-01	6	6	4	16	PASS	10995	TCGA-FI-A2F9	UCEC	79	FEMALE	WHITE	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28886	Alive	TUMOR FREE	1803	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1803	0	1803	0	1803	0	1803	
70	TCGA-FI-A3PV	2	14	4	4	1	0	0	0	3	53	3	1	5	14	3	0	TCGA-FI-A3PV-01	513	0.8942605640463108	340	TCGA-FI-A3PV-01	15	25	64	0.2468827435941049	TCGA-FI-A3PV-01	16	16	13	45	PASS	10996	TCGA-FI-A3PV	UCEC	68	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Serous endometrial adenocarcinoma	High Grade	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24898	Dead	WITH TUMOR	NA	1249	NA	NA	NA	NA	NA	NA	NA	NA	1	1249	1	1249	NA	NA	1	1249	
60	TCGA-FI-A3PX	1	13	0	6	2	0	2	0	0	72	4	0	4	26	5	0	TCGA-FI-A3PX-01	808	0.9391434190487477	565	TCGA-FI-A3PX-01	21	25	27	0.05132244582008067	TCGA-FI-A3PX-01	16	9	2	27	PASS	10997	TCGA-FI-A3PX	UCEC	57	FEMALE	WHITE	NA	Stage IIIC2	Serous endometrial adenocarcinoma	High Grade	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21063	Alive	TUMOR FREE	2384	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2384	0	2384	0	2384	0	2384	
70	TCGA-H5-A2HR	4	16	0	0	4	0	0	0	0	37	4	0	0	10	1	0	TCGA-H5-A2HR-01	576	0.3289053130395443	387	TCGA-H5-A2HR-01	5	9	104	0.17113506051944458	TCGA-H5-A2HR-01	16	13	8	37	PASS	10998	TCGA-H5-A2HR	UCEC	71	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25986	Alive	TUMOR FREE	53	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	53	0	53	NA	NA	0	53	
60	TCGA-JU-AAVI	2	10	1	1	1	2	0	1	5	39	6	0	0	16	0	0	TCGA-JU-AAVI-01	343	0.7229396018285883	212	TCGA-JU-AAVI-01	17	22	229	0.5273243015292197	TCGA-JU-AAVI-01	17	16	25	58	PASS	10999	TCGA-JU-AAVI	UCEC	61	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC1	Serous endometrial adenocarcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22289	Dead	WITH TUMOR	NA	540	NA	Distant Metastasis	"Other, specify"	Porta Hepatis	505	Complete Remission/Response	NA	NA	1	540	1	540	1	505	1	505	
60	TCGA-K6-A3WQ	0	6	0	2	1	0	0	0	1	32	1	0	2	10	0	0	TCGA-K6-A3WQ-01	390	0.817248141830394	241	TCGA-K6-A3WQ-01	18	24	49	0.2103894632833363	TCGA-K6-A3WQ-01	17	12	8	37	PASS	11000	TCGA-K6-A3WQ	UCEC	60	FEMALE	WHITE	NA	Stage IVB	Serous endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22092	Dead	WITH TUMOR	NA	427	NA	Locoregional Recurrence	"Other, specify"	uterine	351	NA	NA	NA	1	427	1	427	NA	NA	1	351	
60	TCGA-KJ-A3U4	0	8	1	3	1	1	0	0	1	41	2	0	3	13	2	0	TCGA-KJ-A3U4	0	0	0	TCGA-KJ-A3U4	0	0	0	0	TCGA-KJ-A3U4-01	10	4	7	21	PASS	11001	TCGA-KJ-A3U4	UCEC	55	FEMALE	WHITE	NA	Stage IA	Serous endometrial adenocarcinoma	G1	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20392	Alive	TUMOR FREE	1095	NA	NA	Locoregional Recurrence	"Other, specify"	abdominal	306	[Discrepancy]	NA	NA	0	1095	0	1095	NA	NA	1	306	
70	TCGA-KP-A3VZ	2	29	1	3	3	0	0	0	6	64	3	0	2	35	5	0	TCGA-KP-A3VZ-01	508	0.9133470946810276	340	TCGA-KP-A3VZ-01	18	31	119	0.3009156929616266	TCGA-KP-A3VZ-01	17	18	5	40	PASS	11002	TCGA-KP-A3VZ	UCEC	69	FEMALE	WHITE	NA	Stage IV	Serous endometrial adenocarcinoma	High Grade	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25366	Alive	WITH TUMOR	722	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	722	0	722	NA	NA	0	722	
70	TCGA-KP-A3W0	0	2	1	1	2	0	2	0	0	31	3	0	2	4	1	0	TCGA-KP-A3W0-01	197	0.4207246344831547	106	TCGA-KP-A3W0-01	9	10	41	0.2140191341986241	TCGA-KP-A3W0-01	12	4	4	20	PASS	11003	TCGA-KP-A3W0	UCEC	72	FEMALE	[Not Evaluated]	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26378	Alive	TUMOR FREE	404	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	404	0	404	0	404	0	404	
80	TCGA-KP-A3W1	1	14	0	1	1	1	1	0	3	36	1	0	2	13	2	0	TCGA-KP-A3W1-01	308	0.6419236912949042	182	TCGA-KP-A3W1-01	31	55	53	0.304289765398866	TCGA-KP-A3W1-01	17	8	8	33	PASS	11004	TCGA-KP-A3W1	UCEC	76	FEMALE	[Not Evaluated]	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27902	Alive	TUMOR FREE	288	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	288	0	288	0	288	0	288	
70	TCGA-KP-A3W3	2	10	0	1	1	0	0	0	2	29	1	0	3	15	1	0	TCGA-KP-A3W3-01	252	0.9292156087168764	151	TCGA-KP-A3W3-01	18	35	40	0.18440926250355288	TCGA-KP-A3W3-01	16	14	10	40	PASS	11005	TCGA-KP-A3W3	UCEC	72	FEMALE	WHITE	NA	Stage IB	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26310	Alive	WITH TUMOR	794	NA	NA	Distant Metastasis	Liver	NA	661	Complete Remission/Response	NA	NA	0	794	0	794	1	661	1	661	
60	TCGA-KP-A3W4	1	11	1	2	2	1	0	0	1	37	6	0	3	11	0	1	TCGA-KP-A3W4-01	276	0.233163237267561	172	TCGA-KP-A3W4-01	3	7	33	0.13308843176931426	TCGA-KP-A3W4-01	7	8	4	19	PASS	11006	TCGA-KP-A3W4	UCEC	63	FEMALE	WHITE	NA	Stage IIIA	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23200	Dead	WITH TUMOR	NA	554	NA	Distant Metastasis	Liver	NA	321	Partial Remission/Response	NA	NA	1	554	1	554	NA	NA	1	321	
70	TCGA-PG-A5BC	0	11	1	3	0	0	0	0	3	41	1	0	0	15	0	0	TCGA-PG-A5BC-01	303	1.0	188	TCGA-PG-A5BC-01	9	17	177	0.3966591262537909	TCGA-PG-A5BC-01	18	14	15	47	PASS	11007	TCGA-PG-A5BC	UCEC	72	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage II	Serous endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26436	Alive	TUMOR FREE	707	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	707	0	707	0	707	0	707	
70	TCGA-PG-A6IB	10	158	6	14	60	12	8	0	20	321	17	0	21	150	15	0	TCGA-PG-A6IB-01	63	0.0005692160420304624	20	TCGA-PG-A6IB-01	0	0	3	6.479054792523686e-05	TCGA-PG-A6IB-01	0	0	0	0	PASS	11008	TCGA-PG-A6IB	UCEC	68	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24969	Alive	TUMOR FREE	648	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	648	0	648	0	648	0	648	
60	TCGA-PG-A7D5	2	14	1	3	0	0	3	0	2	24	0	0	2	11	2	1	TCGA-PG-A7D5-01	397	0.7170989142263416	259	TCGA-PG-A7D5-01	5	8	150	0.23815121914679035	TCGA-PG-A7D5-01	15	9	10	34	PASS	11009	TCGA-PG-A7D5	UCEC	62	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23006	Alive	TUMOR FREE	1177	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	1177	0	1177	NA	NA	0	1177	
70	TCGA-PG-A914	2	42	0	12	3	1	0	0	3	116	13	0	4	31	3	1	TCGA-PG-A914-01	923	0.8971258696044341	614	TCGA-PG-A914-01	21	28	187	0.16301328357839598	TCGA-PG-A914-01	22	28	11	61	PASS	11010	TCGA-PG-A914	UCEC	73	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26992	Alive	TUMOR FREE	687	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	687	0	687	0	687	0	687	
60	TCGA-PG-A915	0	22	0	5	4	0	0	0	2	66	2	0	5	16	1	0	TCGA-PG-A915-01	382	0.8587538536203719	217	TCGA-PG-A915-01	19	25	41	0.0493014589866838	TCGA-PG-A915-01	12	12	3	27	PASS	11011	TCGA-PG-A915	UCEC	60	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Serous endometrial adenocarcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22119	Alive	TUMOR FREE	249	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	249	0	249	0	249	0	249	
70	TCGA-PG-A916	1	13	2	1	7	1	0	0	2	33	0	0	1	6	0	0	TCGA-PG-A916-01	61	2.063299601944868e-05	19	TCGA-PG-A916-01	0	0	18	0.040387604685138745	TCGA-PG-A916-01	1	1	1	3	PASS	11012	TCGA-PG-A916	UCEC	70	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage I	Endometrioid endometrial adenocarcinoma	G2	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25617	Alive	TUMOR FREE	522	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	522	0	522	0	522	0	522	
70	TCGA-PG-A917	22	277	11	37	115	23	19	0	53	500	38	1	28	226	20	3	TCGA-PG-A917-01	73	0.05161554745746883	25	TCGA-PG-A917-01	1	3	16	0.018844002631671287	TCGA-PG-A917-01	3	3	2	8	PASS	11013	TCGA-PG-A917	UCEC	74	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27104	Alive	TUMOR FREE	212	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	212	0	212	0	212	0	212	
60	TCGA-QF-A5YS	37	563	17	57	3	6	1	0	105	1283	241	0	78	396	21	0	TCGA-QF-A5YS-01	55	2.5989505226357266e-05	13	TCGA-QF-A5YS-01	0	0	3	9.775557809989622e-05	TCGA-QF-A5YS-01	0	0	0	0	hypermutated sample	11014	TCGA-QF-A5YS	UCEC	57	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage II	Mixed serous and endometrioid	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20841	Alive	TUMOR FREE	689	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	689	0	689	0	689	0	689	
60	TCGA-QF-A5YT	0	2	0	0	0	0	0	0	0	7	0	0	0	3	0	0	TCGA-QF-A5YT-01	133	0.0001565920696526773	74	TCGA-QF-A5YT-01	0	0	8	0.00045789140424172997	TCGA-QF-A5YT-01	0	0	0	0	PASS	11015	TCGA-QF-A5YT	UCEC	57	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage II	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20981	Alive	TUMOR FREE	1215	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1215	0	1215	0	1215	0	1215	
60	TCGA-QS-A5YQ	29	353	7	33	2	1	0	0	54	760	154	2	38	235	8	1	TCGA-QS-A5YQ-01	43	0.00032274755017641795	9	TCGA-QS-A5YQ-01	0	0	7	0.00033413350933297913	TCGA-QS-A5YQ-01	0	0	0	0	PASS	11016	TCGA-QS-A5YQ	UCEC	55	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20425	Alive	TUMOR FREE	759	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	759	0	759	0	759	0	759	
60	TCGA-QS-A5YR	5	87	3	5	49	12	3	0	18	166	12	0	9	84	2	0	TCGA-QS-A5YR-01	65	5.6863674082065835e-05	26	TCGA-QS-A5YR-01	0	0	13	0.0197088162925587	TCGA-QS-A5YR-01	1	1	1	3	PASS	11017	TCGA-QS-A5YR	UCEC	61	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIB	Endometrioid endometrial adenocarcinoma	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22372	Alive	WITH TUMOR	719	NA	NA	NA	NA	NA	NA	Stable Disease	NA	NA	0	719	0	719	NA	NA	0	719	
90	TCGA-QS-A744	1	14	1	4	1	0	3	1	7	49	4	0	2	19	1	0	TCGA-QS-A744-01	65	0.8594605894375958	20	TCGA-QS-A744-01	7	4	10	0.011026426414986204	TCGA-QS-A744-01	2	1	1	4	PASS	11018	TCGA-QS-A744	UCEC	86	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIB	Endometrioid endometrial adenocarcinoma	G2	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31520	Alive	TUMOR FREE	451	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	451	0	451	NA	NA	0	451	
90	TCGA-QS-A8F1	1	17	2	3	1	1	1	0	7	51	4	0	1	19	2	0	TCGA-QS-A8F1-01	364	0.6641347895400189	223	TCGA-QS-A8F1-01	19	25	137	0.2497851219625545	TCGA-QS-A8F1-01	13	12	12	37	PASS	11019	TCGA-QS-A8F1	UCEC	85	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIA	Serous endometrial adenocarcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31386	Dead	WITH TUMOR	NA	135	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	135	1	135	NA	NA	1	135	
60	TCGA-SJ-A6ZI	30	357	17	47	29	21	1	0	104	1152	71	1	39	569	23	1	TCGA-SJ-A6ZI-01	109	0.02746619183296989	57	TCGA-SJ-A6ZI-01	1	3	42	0.07547218477670514	TCGA-SJ-A6ZI-01	1	0	1	2	PASS	11020	TCGA-SJ-A6ZI	UCEC	64	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2013	[Unknown]	-23653	Alive	TUMOR FREE	631	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	631	0	631	0	631	0	631	
60	TCGA-SJ-A6ZJ	1	19	2	4	2	1	1	0	4	42	4	0	2	24	3	0	TCGA-SJ-A6ZJ-01	67	0.04662775870491637	22	TCGA-SJ-A6ZJ-01	2	1	13	0.0014690245240913662	TCGA-SJ-A6ZJ-01	0	0	0	0	PASS	11021	TCGA-SJ-A6ZJ	UCEC	61	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22597	Alive	TUMOR FREE	556	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	556	0	556	0	556	0	556	
70	TCGA-SL-A6J9	0	6	0	2	1	1	0	0	5	43	3	0	1	18	1	0	TCGA-SL-A6J9-01	262	0.6916078101902134	148	TCGA-SL-A6J9-01	19	26	52	0.08786510449753672	TCGA-SL-A6J9-01	15	12	5	32	PASS	11022	TCGA-SL-A6J9	UCEC	73	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26701	Alive	NA	2	NA	NA	NA	NA	NA	NA	[Unknown]	NA	NA	0	2	0	2	NA	NA	0	2	
80	TCGA-SL-A6JA	19	265	9	31	141	38	16	1	51	483	44	0	22	224	16	0	TCGA-SL-A6JA-01	45	0.04879863948700185	5	TCGA-SL-A6JA-01	2	2	10	0.020584600077809472	TCGA-SL-A6JA-01	3	1	1	5	PASS	11023	TCGA-SL-A6JA	UCEC	77	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28401	Alive	TUMOR FREE	7	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	7	0	7	0	7	0	7	
70	TCGA-N5-A4R8	0	5	2	1	1	1	1	0	2	42	4	0	0	7	2	0	TCGA-N5-A4R8	0	0	0	TCGA-N5-A4R8	0	0	0	0	TCGA-N5-A4R8	0	0	0	0	PASS	11024	TCGA-N5-A4R8	UCS	65	FEMALE	WHITE	NA	Stage IA	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24102	Dead	NA	NA	3115	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	3115	NA	3115	0	3115	0	3115	
60	TCGA-N5-A4RA	1	3	2	1	3	0	0	0	1	34	1	0	2	10	0	0	TCGA-N5-A4RA-01	506	0.7551557943686624	323	TCGA-N5-A4RA-01	20	28	173	0.3435903986316448	TCGA-N5-A4RA-01	11	5	8	24	PASS	11025	TCGA-N5-A4RA	UCS	63	FEMALE	WHITE	NA	Stage IIIC2	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23359	Dead	NA	NA	1591	NA	NA	NA	NA	NA	[Unknown]	NA	NA	1	1591	NA	1591	NA	NA	0	1591	
70	TCGA-N5-A4RD	0	4	0	2	1	2	0	1	2	47	4	0	1	10	0	0	TCGA-N5-A4RD-01	333	0.855310749419186	192	TCGA-N5-A4RD-01	5	6	114	0.1910114948023961	TCGA-N5-A4RD-01	7	14	8	29	PASS	11026	TCGA-N5-A4RD	UCS	69	FEMALE	WHITE	NA	Stage IVB	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25413	Dead	WITH TUMOR	NA	142	NA	Locoregional Recurrence	"Other, specify"	Vagina	75	Progressive Disease	NA	NA	1	142	1	142	NA	NA	1	75	
70	TCGA-N5-A4RF	1	7	0	3	2	2	1	0	3	57	5	0	2	15	1	0	TCGA-N5-A4RF-01	113	0.5624942772759319	47	TCGA-N5-A4RF-01	21	48	47	0.16868706640751305	TCGA-N5-A4RF-01	11	5	3	19	PASS	11027	TCGA-N5-A4RF	UCS	68	FEMALE	WHITE	NA	Stage IA	Uterine Carcinosarcoma/MMMT: Homologous Type	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25041	Alive	TUMOR FREE	1806	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1806	0	1806	0	1806	0	1806	
60	TCGA-N5-A4RJ	0	1	1	0	1	0	0	0	0	45	3	0	0	10	1	0	TCGA-N5-A4RJ-01	340	0.5160399432911941	201	TCGA-N5-A4RJ-01	19	27	113	0.18825456135737256	TCGA-N5-A4RJ-01	14	6	12	32	PASS	11028	TCGA-N5-A4RJ	UCS	61	FEMALE	WHITE	NA	Stage IVB	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22341	Dead	WITH TUMOR	NA	550	NA	Distant Metastasis	Lymph Node(s)	NA	287	Complete Remission/Response	NA	NA	1	550	1	550	NA	NA	1	287	
60	TCGA-N5-A4RM	2	5	0	2	3	0	1	0	3	31	2	0	3	11	0	1	TCGA-N5-A4RM-01	366	0.7084923830471869	219	TCGA-N5-A4RM-01	8	13	159	0.22158313991669187	TCGA-N5-A4RM-01	13	9	8	30	PASS	11029	TCGA-N5-A4RM	UCS	62	FEMALE	WHITE	NA	Stage IVB	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22886	Dead	WITH TUMOR	NA	148	NA	Locoregional Recurrence	Pelvis	NA	144	Progressive Disease	NA	NA	1	148	1	148	NA	NA	1	144	
70	TCGA-N5-A4RN	0	5	1	2	2	1	1	0	2	54	4	0	1	20	4	0	TCGA-N5-A4RN-01	252	0.5967777479233771	140	TCGA-N5-A4RN-01	17	29	86	0.18159538998576505	TCGA-N5-A4RN-01	14	20	11	45	PASS	11030	TCGA-N5-A4RN	UCS	71	FEMALE	WHITE	NA	Stage IVB	Uterine Carcinosarcoma/MMMT: Homologous Type	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26054	Alive	WITH TUMOR	1053	NA	NA	Locoregional Recurrence	Pelvis	NA	570	Complete Remission/Response	NA	NA	0	1053	0	1053	NA	NA	1	570	
70	TCGA-N5-A4RO	0	3	0	6	1	0	0	0	1	41	5	0	0	12	0	0	TCGA-N5-A4RO-01	481	0.9997030877158672	321	TCGA-N5-A4RO-01	15	34	183	0.24861861436064164	TCGA-N5-A4RO-01	10	7	6	23	PASS	11031	TCGA-N5-A4RO	UCS	67	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC2	Uterine Carcinosarcoma/MMMT: Homologous Type	NA	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24823	Dead	WITH TUMOR	NA	685	NA	Progression of Disease	Lymph Node(s)	NA	407	Progressive Disease	NA	NA	1	685	1	685	NA	NA	1	407	
70	TCGA-N5-A4RS	0	5	1	0	4	1	0	0	0	21	1	0	1	6	1	0	TCGA-N5-A4RS-01	260	0.2914781294554289	160	TCGA-N5-A4RS-01	8	36	276	0.7879877852019022	TCGA-N5-A4RS-01	13	23	41	77	PASS	11032	TCGA-N5-A4RS	UCS	65	FEMALE	WHITE	NA	Stage IB	Uterine Carcinosarcoma/MMMT: Homologous Type	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23893	Dead	WITH TUMOR	NA	911	NA	Distant Metastasis	Lung	NA	427	Complete Remission/Response	NA	NA	1	911	1	911	1	427	1	427	
70	TCGA-N5-A4RT	3	3	1	2	2	0	0	0	5	72	5	0	2	22	2	0	TCGA-N5-A4RT-01	410	0.7244609375651423	268	TCGA-N5-A4RT-01	20	32	145	0.3011787196955216	TCGA-N5-A4RT-01	20	18	7	45	PASS	11033	TCGA-N5-A4RT	UCS	69	FEMALE	WHITE	NA	Stage IIIC1	Uterine Carcinosarcoma/MMMT: Homologous Type	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25386	Alive	TUMOR FREE	2485	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2485	0	2485	0	2485	0	2485	
50	TCGA-N5-A4RU	1	6	0	3	1	1	0	0	2	55	0	0	1	12	2	0	TCGA-N5-A4RU-01	438	0.6638805921895699	276	TCGA-N5-A4RU-01	15	40	57	0.1205421613917836	TCGA-N5-A4RU-01	25	16	6	47	PASS	11034	TCGA-N5-A4RU	UCS	54	FEMALE	WHITE	NA	Stage IIIC2	Uterine Carcinosarcoma/MMMT: Homologous Type	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20025	Dead	WITH TUMOR	NA	1526	NA	Locoregional Recurrence	Pelvis	NA	253	Complete Remission/Response	NA	NA	1	1526	1	1526	1	253	1	253	
60	TCGA-N5-A4RV	0	0	0	2	3	0	0	0	1	40	3	0	0	18	1	0	TCGA-N5-A4RV-01	226	0.5832590720356713	139	TCGA-N5-A4RV-01	12	22	69	0.16329339101752074	TCGA-N5-A4RV-01	11	14	8	33	PASS	11035	TCGA-N5-A4RV	UCS	62	FEMALE	WHITE	NA	Stage IA	Uterine Carcinosarcoma/MMMT: Homologous Type	NA	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22978	Alive	TUMOR FREE	2042	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2042	0	2042	0	2042	0	2042	
60	TCGA-N5-A59E	0	2	1	2	5	1	2	0	1	43	2	0	0	19	0	0	TCGA-N5-A59E-01	420	0.8686421384036948	268	TCGA-N5-A59E-01	19	30	144	0.2889546826017702	TCGA-N5-A59E-01	23	25	21	69	PASS	11036	TCGA-N5-A59E	UCS	62	FEMALE	WHITE	NA	Stage IVB	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22650	Dead	WITH TUMOR	NA	447	NA	Locoregional Recurrence	Abdomen	NA	354	Complete Remission/Response	NA	NA	1	447	1	447	NA	NA	1	354	
70	TCGA-N5-A59F	1	3	1	1	0	0	0	0	1	44	1	0	0	9	2	0	TCGA-N5-A59F-01	328	0.8400360742541655	207	TCGA-N5-A59F-01	25	30	114	0.18706937600482493	TCGA-N5-A59F-01	15	13	10	38	PASS	11037	TCGA-N5-A59F	UCS	65	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Uterine Carcinosarcoma/MMMT: Homologous Type	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23826	Dead	WITH TUMOR	NA	361	NA	Locoregional Recurrence	Pelvis	NA	274	Complete Remission/Response	NA	NA	1	361	1	361	1	274	1	274	
60	TCGA-N6-A4V9	0	2	0	3	2	0	0	0	1	26	3	0	1	9	1	1	TCGA-N6-A4V9-01	185	0.8111255293583386	104	TCGA-N6-A4V9-01	14	11	101	0.2921446837355654	TCGA-N6-A4V9-01	9	6	8	23	PASS	11038	TCGA-N6-A4V9	UCS	59	FEMALE	WHITE	NA	Stage IA	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2011	[Unknown]	-21677	Alive	TUMOR FREE	979	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	979	0	979	0	979	0	979	
80	TCGA-N6-A4VC	1	1	0	1	1	0	0	0	1	33	5	0	1	13	0	0	TCGA-N6-A4VC-01	204	0.7950671273342067	106	TCGA-N6-A4VC-01	22	29	155	0.4090942235198649	TCGA-N6-A4VC-01	17	12	11	40	PASS	11039	TCGA-N6-A4VC	UCS	83	FEMALE	WHITE	NA	Stage III	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30643	Dead	WITH TUMOR	NA	597	NA	Distant Metastasis	Lung	NA	171	Progressive Disease	NA	NA	1	597	1	597	NA	NA	1	171	
80	TCGA-N6-A4VD	1	3	1	4	4	2	2	1	7	65	4	0	1	26	1	0	TCGA-N6-A4VD-01	97	0.04609708601303554	41	TCGA-N6-A4VD-01	0	1	34	0.07071409210701897	TCGA-N6-A4VD-01	6	6	4	16	PASS	11040	TCGA-N6-A4VD	UCS	81	FEMALE	WHITE	NA	Stage IIIA	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29658	Dead	WITH TUMOR	NA	112	NA	Distant Metastasis	Liver	NA	49	Progressive Disease	NA	NA	1	112	1	112	NA	NA	1	49	
80	TCGA-N6-A4VE	0	3	0	4	2	0	2	0	1	51	0	0	1	17	3	1	TCGA-N6-A4VE-01	364	0.8040895080255078	218	TCGA-N6-A4VE-01	17	20	105	0.15682655149563934	TCGA-N6-A4VE-01	16	19	11	46	PASS	11041	TCGA-N6-A4VE	UCS	84	FEMALE	WHITE	NA	Stage IIIC	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30794	Dead	WITH TUMOR	NA	291	NA	Distant Metastasis	Bone	NA	275	Progressive Disease	NA	NA	1	291	1	291	NA	NA	1	275	
50	TCGA-N6-A4VF	0	1	0	2	0	1	1	0	4	35	2	0	2	11	1	0	TCGA-N6-A4VF-01	52	0.5590530188192692	12	TCGA-N6-A4VF-01	10	8	36	0.2118837560756738	TCGA-N6-A4VF-01	3	3	5	11	PASS	11042	TCGA-N6-A4VF	UCS	51	FEMALE	WHITE	NA	Stage IB	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2009	Peri (6-12 months since last menstrual period)	-18806	Dead	TUMOR FREE	NA	522	NA	NA	NA	NA	NA	NA	NA	NA	1	522	0	522	NA	NA	0	522	
80	TCGA-N6-A4VG	0	1	0	1	1	0	0	0	0	36	0	0	0	17	3	0	TCGA-N6-A4VG-01	290	0.6915975228982111	171	TCGA-N6-A4VG-01	25	23	116	0.2781318599061108	TCGA-N6-A4VG-01	13	7	12	32	PASS	11043	TCGA-N6-A4VG	UCS	77	FEMALE	WHITE	NA	Stage IVB	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28428	Alive	WITH TUMOR	1574	NA	NA	Locoregional Recurrence	Lymph Node(s)	NA	493	Partial Remission/Response	NA	NA	0	1574	0	1574	NA	NA	1	493	
70	TCGA-N7-A4Y0	3	57	8	17	134	29	13	0	26	481	22	1	14	221	16	2	TCGA-N7-A4Y0-01	101	0.8957215888258397	51	TCGA-N7-A4Y0-01	8	6	9	0.0011161462903192068	TCGA-N7-A4Y0-01	2	0	0	2	hypermutated sample	11044	TCGA-N7-A4Y0	UCS	65	FEMALE	WHITE	NA	Stage IIIC	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23983	Dead	WITH TUMOR	NA	771	NA	Progression of Disease	"Other, specify"	retroperitoneum	281	[Unknown]	NA	NA	1	771	1	771	NA	NA	1	281	
90	TCGA-N7-A4Y5	1	4	0	0	1	1	0	0	2	41	1	0	1	22	3	1	TCGA-N7-A4Y5-01	260	0.9836735083108658	156	TCGA-N7-A4Y5-01	21	33	99	0.25448296720346625	TCGA-N7-A4Y5-01	18	9	11	38	PASS	11045	TCGA-N7-A4Y5	UCS	87	FEMALE	WHITE	NA	Stage IIB	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32058	Dead	WITH TUMOR	NA	8	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	8	1	8	NA	NA	1	8	
70	TCGA-N7-A4Y8	0	2	0	0	1	0	2	0	1	40	1	0	2	10	2	0	TCGA-N7-A4Y8-01	289	0.8920279975575068	170	TCGA-N7-A4Y8-01	26	27	73	0.11489703995078895	TCGA-N7-A4Y8-01	9	8	5	22	PASS	11046	TCGA-N7-A4Y8	UCS	72	FEMALE	WHITE	NA	Stage IVB	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26650	Dead	WITH TUMOR	NA	378	NA	Progression of Disease	"Other, specify"	Pleural effusion	187	Partial Remission/Response	NA	NA	1	378	1	378	NA	NA	1	187	
70	TCGA-N7-A59B	0	0	0	0	2	0	2	0	0	33	3	0	0	11	1	0	TCGA-N7-A59B-01	249	0.9829579466459348	137	TCGA-N7-A59B-01	21	16	49	0.1534953002537624	TCGA-N7-A59B-01	9	7	6	22	PASS	11047	TCGA-N7-A59B	UCS	69	FEMALE	WHITE	NA	Stage IA	Uterine Carcinosarcoma/MMMT: Homologous Type	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25360	Alive	TUMOR FREE	827	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	827	0	827	0	827	0	827	
70	TCGA-N8-A4PI	0	3	0	1	0	1	1	0	1	30	6	0	1	16	3	0	TCGA-N8-A4PI-01	148	0.44717593353324375	76	TCGA-N8-A4PI-01	11	13	16	0.033379986858882486	TCGA-N8-A4PI-01	6	1	2	9	PASS	11048	TCGA-N8-A4PI	UCS	71	FEMALE	WHITE	NA	Stage IA	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26270	Dead	WITH TUMOR	NA	810	NA	Locoregional Recurrence	"Other, specify"	Vagina	255	Partial Remission/Response	NA	NA	1	810	1	810	NA	NA	1	255	
80	TCGA-N8-A4PL	1	2	0	1	1	0	1	1	1	38	0	0	0	17	0	0	TCGA-N8-A4PL-01	162	0.6080347846309581	87	TCGA-N8-A4PL-01	22	21	61	0.2176761162741901	TCGA-N8-A4PL-01	8	7	8	23	PASS	11049	TCGA-N8-A4PL	UCS	82	FEMALE	WHITE	NA	Stage IA	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30069	Dead	WITH TUMOR	NA	418	NA	Locoregional Recurrence	Lymph Node(s)	NA	138	Progressive Disease	NA	NA	1	418	1	418	NA	NA	1	138	
70	TCGA-N8-A4PM	0	0	0	1	3	0	0	0	1	37	2	0	2	18	2	0	TCGA-N8-A4PM-01	393	0.719198608310986	258	TCGA-N8-A4PM-01	12	12	46	0.026886823553639503	TCGA-N8-A4PM-01	7	9	2	18	PASS	11050	TCGA-N8-A4PM	UCS	73	FEMALE	WHITE	NA	Stage IB	Uterine Carcinosarcoma/MMMT: Homologous Type	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26971	Alive	WITH TUMOR	829	NA	NA	Locoregional Recurrence	Lymph Node(s)	NA	524	Complete Remission/Response	NA	NA	0	829	0	829	1	524	1	524	
70	TCGA-N8-A4PN	0	3	0	0	0	1	0	1	1	41	4	0	0	9	0	0	TCGA-N8-A4PN-01	315	0.8030111108065244	190	TCGA-N8-A4PN-01	18	23	107	0.16519055028132631	TCGA-N8-A4PN-01	17	16	8	41	PASS	11051	TCGA-N8-A4PN	UCS	68	FEMALE	WHITE	NA	Stage IIIC1	Uterine Carcinosarcoma/MMMT: Homologous Type	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25064	Alive	TUMOR FREE	812	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	812	0	812	0	812	0	812	
70	TCGA-N8-A4PO	1	7	0	2	0	0	0	0	2	46	4	0	3	16	2	1	TCGA-N8-A4PO-01	334	0.950322663925858	200	TCGA-N8-A4PO-01	21	32	132	0.2836556268985975	TCGA-N8-A4PO-01	20	12	13	45	PASS	11052	TCGA-N8-A4PO	UCS	66	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage II	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24124	Alive	WITH TUMOR	781	NA	NA	Distant Metastasis	Bone	NA	158	Progressive Disease	NA	NA	0	781	0	781	NA	NA	1	158	
90	TCGA-N8-A4PP	0	3	0	1	2	0	1	0	3	78	6	0	0	35	1	0	TCGA-N8-A4PP-01	435	0.8185375915421967	267	TCGA-N8-A4PP-01	16	40	192	0.2775724656274462	TCGA-N8-A4PP-01	16	20	10	46	PASS	11053	TCGA-N8-A4PP	UCS	88	FEMALE	WHITE	NA	Stage IIIC1	Uterine Carcinosarcoma/MMMT: Homologous Type	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32415	Dead	WITH TUMOR	NA	611	NA	Locoregional Recurrence	"Other, specify"	Vagina	149	Partial Remission/Response	NA	NA	1	611	1	611	NA	NA	1	149	
80	TCGA-N8-A4PQ	0	2	0	0	0	1	0	0	0	44	3	0	0	22	1	0	TCGA-N8-A4PQ-01	327	0.7279365922922341	214	TCGA-N8-A4PQ-01	21	64	177	0.3713311583435565	TCGA-N8-A4PQ-01	21	16	10	47	PASS	11054	TCGA-N8-A4PQ	UCS	76	FEMALE	WHITE	NA	Stage IIIC2	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27772	Alive	TUMOR FREE	572	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	572	0	572	0	572	0	572	
80	TCGA-N8-A56S	0	0	0	3	3	0	1	0	4	35	2	0	5	13	0	0	TCGA-N8-A56S-01	495	0.6253243897062726	378	TCGA-N8-A56S-01	26	19	103	0.15998361886800624	TCGA-N8-A56S-01	13	6	6	25	PASS	11055	TCGA-N8-A56S	UCS	75	FEMALE	WHITE	NA	Stage IB	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27519	Dead	WITH TUMOR	NA	371	NA	Progression of Disease	Lung	NA	199	Stable Disease	NA	NA	1	371	1	371	NA	NA	1	199	
80	TCGA-N9-A4PZ	1	2	0	2	0	1	0	0	2	36	4	0	1	16	1	0	TCGA-N9-A4PZ-01	446	0.7616837391793622	281	TCGA-N9-A4PZ-01	20	37	70	0.13084526399021074	TCGA-N9-A4PZ-01	27	23	8	58	PASS	11056	TCGA-N9-A4PZ	UCS	77	FEMALE	WHITE	NA	Stage IIIC2	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28211	Dead	WITH TUMOR	NA	667	NA	Locoregional Recurrence	Pelvis	NA	487	Complete Remission/Response	NA	NA	1	667	1	667	1	487	1	487	
70	TCGA-N9-A4Q1	0	3	0	1	1	2	1	0	0	37	2	0	1	3	0	0	TCGA-N9-A4Q1-01	321	0.8367556392999147	194	TCGA-N9-A4Q1-01	21	31	168	0.3664579266124429	TCGA-N9-A4Q1-01	24	18	16	58	PASS	11057	TCGA-N9-A4Q1	UCS	70	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage II	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25791	Dead	WITH TUMOR	NA	2043	NA	Distant Metastasis	"Other, specify"	Pleural surface	1839	Complete Remission/Response	NA	NA	1	2043	1	2043	1	1839	1	1839	
70	TCGA-N9-A4Q3	0	0	0	2	0	2	1	0	2	32	2	0	2	7	1	0	TCGA-N9-A4Q3-01	367	0.6520190075600306	221	TCGA-N9-A4Q3-01	17	26	125	0.26621704806480384	TCGA-N9-A4Q3-01	18	12	10	40	PASS	11058	TCGA-N9-A4Q3	UCS	65	FEMALE	WHITE	NA	Stage IA	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24031	Alive	WITH TUMOR	1672	NA	NA	Distant Metastasis	Lung	NA	735	Complete Remission/Response	NA	NA	0	1672	0	1672	1	735	1	735	
60	TCGA-N9-A4Q4	0	2	0	2	2	1	2	0	1	24	2	0	2	18	0	0	TCGA-N9-A4Q4-01	332	0.7517025984141815	200	TCGA-N9-A4Q4-01	22	22	146	0.2838550725019188	TCGA-N9-A4Q4-01	16	7	13	36	PASS	11059	TCGA-N9-A4Q4	UCS	61	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22575	Alive	NA	1089	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	1089	0	1089	0	1089	0	1089	
70	TCGA-N9-A4Q7	0	18	0	5	2	0	0	0	9	219	17	0	1	63	3	0	TCGA-N9-A4Q7-01	85	0.6645048644588522	33	TCGA-N9-A4Q7-01	21	63	65	0.3690113270164056	TCGA-N9-A4Q7-01	13	11	12	36	PASS	11060	TCGA-N9-A4Q7	UCS	69	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IA	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25419	Alive	TUMOR FREE	604	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	604	0	604	0	604	0	604	
70	TCGA-N9-A4Q8	0	0	0	1	3	1	0	0	1	37	5	0	1	13	0	0	TCGA-N9-A4Q8-01	289	0.8432937176176031	185	TCGA-N9-A4Q8-01	18	30	110	0.2204189256908244	TCGA-N9-A4Q8-01	18	12	5	35	PASS	11061	TCGA-N9-A4Q8	UCS	68	FEMALE	WHITE	NA	Stage IA	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25185	Dead	WITH TUMOR	NA	481	NA	Locoregional Recurrence	"Other, specify"	Vagina	215	Complete Remission/Response	NA	NA	1	481	1	481	1	215	1	215	
70	TCGA-NA-A4QV	0	0	0	1	1	1	0	0	4	34	2	0	1	12	1	0	TCGA-NA-A4QV-01	586	0.6458721868853969	375	TCGA-NA-A4QV-01	18	30	163	0.23176660602232965	TCGA-NA-A4QV-01	18	14	11	43	PASS	11062	TCGA-NA-A4QV	UCS	72	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IB	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26379	Alive	TUMOR FREE	4269	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	4269	0	4269	0	4269	0	4269	
60	TCGA-NA-A4QW	0	1	0	0	3	0	1	0	1	45	0	0	0	16	1	0	TCGA-NA-A4QW-01	377	0.7755785136539859	225	TCGA-NA-A4QW-01	19	64	145	0.21873777477429804	TCGA-NA-A4QW-01	24	18	14	56	PASS	11063	TCGA-NA-A4QW	UCS	61	FEMALE	WHITE	NA	Stage IIA	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22588	Alive	TUMOR FREE	2457	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	2457	0	2457	0	2457	0	2457	
60	TCGA-NA-A4QX	0	2	0	1	1	0	2	0	0	21	2	0	1	12	0	0	TCGA-NA-A4QX-01	181	0.7566049312202833	99	TCGA-NA-A4QX-01	14	17	60	0.11467169330348427	TCGA-NA-A4QX-01	12	5	8	25	PASS	11064	TCGA-NA-A4QX	UCS	60	FEMALE	WHITE	NA	Stage IVB	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22264	Dead	WITH TUMOR	833	838	NA	Distant Metastasis	Pelvis	NA	566	NA	NA	NA	1	838	1	838	NA	NA	1	566	
60	TCGA-NA-A4QY	0	2	0	0	1	2	1	0	1	36	0	0	1	11	1	0	TCGA-NA-A4QY-01	278	0.6912934006787739	192	TCGA-NA-A4QY-01	27	24	66	0.09699172730910686	TCGA-NA-A4QY-01	13	2	5	20	PASS	11065	TCGA-NA-A4QY	UCS	62	FEMALE	WHITE	NA	Stage III	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22756	Dead	WITH TUMOR	NA	114	NA	NA	NA	NA	NA	NA	NA	NA	1	114	1	114	NA	NA	1	114	
80	TCGA-NA-A4R0	0	2	0	3	2	0	0	0	4	37	0	0	2	18	1	0	TCGA-NA-A4R0-01	269	0.5906447579921402	166	TCGA-NA-A4R0-01	22	21	99	0.23207130759358605	TCGA-NA-A4R0-01	18	14	11	43	PASS	11066	TCGA-NA-A4R0	UCS	80	FEMALE	WHITE	NA	Stage IVB	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29449	Dead	WITH TUMOR	NA	541	NA	NA	NA	NA	NA	NA	NA	NA	1	541	1	541	NA	NA	1	541	
80	TCGA-NA-A4R1	0	7	1	2	10	7	1	0	6	78	7	0	0	40	1	1	TCGA-NA-A4R1-01	572	0.9446304748405446	392	TCGA-NA-A4R1-01	16	15	215	0.313945269005509	TCGA-NA-A4R1-01	17	13	15	45	PASS	11067	TCGA-NA-A4R1	UCS	75	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC1	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27688	Dead	WITH TUMOR	NA	203	NA	NA	NA	NA	NA	NA	NA	NA	1	203	1	203	NA	NA	1	203	
80	TCGA-NA-A5I1	0	4	1	2	2	0	1	0	1	32	3	0	0	10	1	0	TCGA-NA-A5I1-01	274	0.616633554416339	189	TCGA-NA-A5I1-01	14	13	75	0.1416843271696591	TCGA-NA-A5I1-01	11	6	9	26	PASS	11068	TCGA-NA-A5I1	UCS	80	FEMALE	WHITE	NA	Stage IIIB	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2006	NA	-29329	Dead	WITH TUMOR	NA	2680	NA	Distant Metastasis	Pelvis	NA	2553	Complete Remission/Response	NA	NA	1	2680	1	2680	1	2553	1	2553	
70	TCGA-ND-A4W6	0	1	0	3	2	0	0	0	2	63	7	0	2	25	2	0	TCGA-ND-A4W6-01	216	0.4773951578178127	123	TCGA-ND-A4W6-01	21	62	59	0.12090699498601434	TCGA-ND-A4W6-01	22	20	4	46	PASS	11069	TCGA-ND-A4W6	UCS	67	FEMALE	BLACK OR AFRICAN AMERICAN	NA	Stage IIIC	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24835	Dead	WITH TUMOR	NA	317	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	317	1	317	NA	NA	1	317	
90	TCGA-ND-A4WA	1	2	0	4	3	0	0	0	3	39	4	0	0	9	2	0	TCGA-ND-A4WA-01	145	0.9974248554287896	70	TCGA-ND-A4WA-01	27	34	94	0.3033405946674393	TCGA-ND-A4WA-01	7	4	6	17	PASS	11070	TCGA-ND-A4WA	UCS	90	FEMALE	ASIAN	NA	Stage IC	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32872	Dead	TUMOR FREE	NA	714	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	1	714	0	714	0	714	0	714	
80	TCGA-ND-A4WC	20	313	18	88	1	13	0	0	136	3129	429	10	67	859	63	2	TCGA-ND-A4WC-01	107	0.003825711491969626	48	TCGA-ND-A4WC-01	0	0	31	0.01855873170782655	TCGA-ND-A4WC-01	2	1	1	4	hypermutated sample	11071	TCGA-ND-A4WC	UCS	83	FEMALE	ASIAN	NA	Stage IB	Uterine Carcinosarcoma/MMMT: Homologous Type	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30434	Alive	TUMOR FREE	766	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	766	0	766	0	766	0	766	
80	TCGA-ND-A4WF	0	4	1	2	0	0	0	0	2	56	3	0	0	16	0	0	TCGA-ND-A4WF-01	595	0.9300016037191974	377	TCGA-ND-A4WF-01	14	30	274	0.2649556015640974	TCGA-ND-A4WF-01	25	15	14	54	PASS	11072	TCGA-ND-A4WF	UCS	77	FEMALE	WHITE	NA	Stage IIIA	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28398	Dead	WITH TUMOR	NA	167	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	1	167	1	167	NA	NA	1	167	
60	TCGA-NF-A4WU	0	0	0	1	0	0	1	0	1	26	2	0	1	11	0	0	TCGA-NF-A4WU-01	138	0.6821503740030029	68	TCGA-NF-A4WU-01	20	18	40	0.18245673460444428	TCGA-NF-A4WU-01	10	5	7	22	PASS	11073	TCGA-NF-A4WU	UCS	59	FEMALE	WHITE	NA	Stage IA	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21901	Alive	TUMOR FREE	298	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	298	0	298	0	298	0	298	
60	TCGA-NF-A4WX	2	2	0	1	2	0	0	0	1	23	4	0	1	10	3	0	TCGA-NF-A4WX-01	328	0.7124863614810781	213	TCGA-NF-A4WX-01	27	44	93	0.1792683078923562	TCGA-NF-A4WX-01	18	11	8	37	PASS	11074	TCGA-NF-A4WX	UCS	61	FEMALE	[Unknown]	NA	Stage IV	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22407	Alive	TUMOR FREE	452	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	452	0	452	NA	NA	0	452	
60	TCGA-NF-A4X2	0	4	0	4	4	4	1	0	2	73	5	0	1	21	2	0	TCGA-NF-A4X2-01	121	0.8083729848021304	63	TCGA-NF-A4X2-01	11	35	101	0.30038301977553844	TCGA-NF-A4X2-01	18	31	7	56	PASS	11075	TCGA-NF-A4X2	UCS	59	FEMALE	WHITE	NA	Stage II	Uterine Carcinosarcoma/ MMMT: Heterologous Type	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21908	Alive	TUMOR FREE	81	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	81	0	81	0	81	0	81	
90	TCGA-NF-A5CP	0	1	0	4	3	1	0	0	1	50	2	0	1	20	0	0	TCGA-NF-A5CP-01	153	0.5176680077977893	79	TCGA-NF-A5CP-01	6	10	54	0.14396976688097265	TCGA-NF-A5CP-01	13	4	1	18	PASS	11076	TCGA-NF-A5CP	UCS	90	FEMALE	WHITE	NA	Stage IIIC2	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32871	Dead	WITH TUMOR	NA	167	NA	Progression of Disease	"Other, specify"	"systemic, lung"	106	Progressive Disease	NA	NA	1	167	1	167	NA	NA	1	106	
60	TCGA-NG-A4VU	0	3	0	0	0	0	0	0	0	28	2	0	1	11	2	0	TCGA-NG-A4VU-01	363	0.9454112327064336	226	TCGA-NG-A4VU-01	20	35	209	0.3885578833682417	TCGA-NG-A4VU-01	15	14	13	42	PASS	11077	TCGA-NG-A4VU	UCS	63	FEMALE	WHITE	NA	Stage IIIB	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23323	Dead	WITH TUMOR	NA	442	NA	Progression of Disease	Pelvis	NA	281	Progressive Disease	NA	NA	1	442	1	442	NA	NA	1	281	
70	TCGA-NG-A4VW	0	2	0	1	2	1	0	0	1	33	5	0	0	16	0	0	TCGA-NG-A4VW-01	55	0.3306936199689244	13	TCGA-NG-A4VW-01	9	7	7	0.007917572832211684	TCGA-NG-A4VW-01	1	2	1	4	PASS	11078	TCGA-NG-A4VW	UCS	74	FEMALE	WHITE	NA	Stage IC	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27326	Dead	WITH TUMOR	NA	949	NA	Distant Metastasis	Lung	NA	937	Complete Remission/Response	NA	NA	1	949	1	949	1	937	1	937	
70	TCGA-QM-A5NM	0	0	0	3	1	0	0	0	2	43	1	0	3	12	2	0	TCGA-QM-A5NM-01	221	0.8785459499461953	132	TCGA-QM-A5NM-01	21	22	42	0.12715941929689606	TCGA-QM-A5NM-01	5	2	6	13	PASS	11079	TCGA-QM-A5NM	UCS	67	FEMALE	WHITE	NA	Stage IA	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24781	Alive	WITH TUMOR	587	NA	NA	Locoregional Recurrence	"Other, specify"	Vagina	153	[Unknown]	NA	NA	0	587	0	587	NA	NA	1	153	
60	TCGA-QN-A5NN	0	2	0	1	0	0	5	0	0	51	2	1	1	19	1	0	TCGA-QN-A5NN-01	131	0.7752396548731093	68	TCGA-QN-A5NN-01	24	56	99	0.4293894935434569	TCGA-QN-A5NN-01	12	7	5	24	PASS	11080	TCGA-QN-A5NN	UCS	55	FEMALE	ASIAN	NA	Stage IB	Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS	NA	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20318	Alive	TUMOR FREE	0	NA	NA	NA	NA	NA	NA	Complete Remission/Response	NA	NA	0	0	0	0	0	0	0	0	
50	TCGA-RZ-AB0B	0	2	0	0	0	0	0	0	0	11	2	0	0	3	0	0	TCGA-RZ-AB0B-01	70	0.22295237022657802	28	TCGA-RZ-AB0B-01	5	7	22	0.12322635672569265	TCGA-RZ-AB0B-01	3	2	1	6	PASS	11081	TCGA-RZ-AB0B	UVM	47	FEMALE	WHITE	Stage IV	Stage IV	Epithelioid Cell	NA	2013	NA	-17514	Dead	TUMOR FREE	NA	149	Metastatic Uveal Melanoma	NA	NA	NA	NA	NA	NA	NA	1	149	1	149	NA	NA	0	149	
60	TCGA-V3-A9ZX	0	0	0	0	0	0	0	0	2	4	1	0	2	2	0	0	TCGA-V3-A9ZX-01	73	0.2034768477628071	34	TCGA-V3-A9ZX-01	7	6	35	0.14234158908060898	TCGA-V3-A9ZX-01	5	1	3	9	PASS	11082	TCGA-V3-A9ZX	UVM	56	MALE	WHITE	Stage IIB	Stage IIB	Epithelioid Cell|Spindle Cell	NA	2013	NA	-20539	Alive	TUMOR FREE	470	NA	NA	Distant Metastasis	Liver	NA	233	NA	NA	NA	0	470	0	470	NA	NA	1	233	
50	TCGA-V3-A9ZY	0	0	0	0	0	0	1	0	0	13	0	0	1	3	0	0	TCGA-V3-A9ZY-01	61	0.05854924605574492	20	TCGA-V3-A9ZY-01	2	1	2	0.0008984791447795899	TCGA-V3-A9ZY-01	0	0	0	0	PASS	11083	TCGA-V3-A9ZY	UVM	54	MALE	WHITE	Stage IIB	Stage IIB	Epithelioid Cell	NA	2013	NA	-19894	Alive	TUMOR FREE	459	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	459	0	459	NA	NA	0	459	
50	TCGA-V4-A9E5	0	0	0	1	1	0	0	0	0	10	1	0	0	4	0	0	TCGA-V4-A9E5-01	105	0.8193126476781586	56	TCGA-V4-A9E5-01	10	5	29	0.020257243309781042	TCGA-V4-A9E5-01	2	1	1	4	PASS	11084	TCGA-V4-A9E5	UVM	51	FEMALE	WHITE	Stage IIIB	Stage IIIB	Spindle Cell	NA	2008	NA	-18948	Alive	TUMOR FREE	2499	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	2499	0	2499	NA	NA	0	2499	
80	TCGA-V4-A9E7	0	1	0	1	2	0	0	0	0	14	0	0	0	3	0	0	TCGA-V4-A9E7-01	114	0.9472919448066948	63	TCGA-V4-A9E7-01	9	7	73	0.23587687550464945	TCGA-V4-A9E7-01	6	0	5	11	PASS	11085	TCGA-V4-A9E7	UVM	76	MALE	WHITE	Stage IIIA	Stage IIIA	Epithelioid Cell|Spindle Cell	NA	2011	NA	-28025	Dead	WITH TUMOR	NA	415	Metastatic Uveal Melanoma	Distant Metastasis	Liver	NA	35	NA	NA	NA	1	415	1	415	NA	NA	1	35	
50	TCGA-V4-A9E8	0	1	0	0	0	0	0	0	1	9	1	0	0	4	0	0	TCGA-V4-A9E8-01	106	0.5605700916779313	53	TCGA-V4-A9E8-01	14	11	32	0.1112548348243862	TCGA-V4-A9E8-01	3	0	1	4	PASS	11086	TCGA-V4-A9E8	UVM	49	MALE	WHITE	Stage IIIA	Stage IIIA	Epithelioid Cell|Spindle Cell	NA	2011	NA	-18073	Dead	WITH TUMOR	NA	808	Metastatic Uveal Melanoma	Distant Metastasis	Liver	NA	557	NA	NA	NA	1	808	1	808	NA	NA	1	557	
50	TCGA-V4-A9E9	0	1	0	1	1	0	0	0	0	10	0	0	0	2	0	0	TCGA-V4-A9E9-01	92	0.10484082204199052	38	TCGA-V4-A9E9-01	2	5	16	0.035667216731994036	TCGA-V4-A9E9-01	3	5	2	10	PASS	11087	TCGA-V4-A9E9	UVM	50	MALE	WHITE	Stage IIIA	Stage IIIA	Spindle Cell	NA	2012	NA	-18387	Alive	TUMOR FREE	1246	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1246	0	1246	NA	NA	0	1246	
70	TCGA-V4-A9EA	0	1	0	0	0	0	0	0	1	11	0	0	0	2	0	0	TCGA-V4-A9EA-01	60	0.0905584116387022	17	TCGA-V4-A9EA-01	2	3	17	0.03894865154977093	TCGA-V4-A9EA-01	6	6	2	14	PASS	11088	TCGA-V4-A9EA	UVM	66	MALE	WHITE	Stage IIIA	Stage IIIA	Spindle Cell	NA	2012	NA	-24234	Alive	TUMOR FREE	1348	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1348	0	1348	NA	NA	0	1348	
80	TCGA-V4-A9EC	0	1	0	0	2	1	0	0	0	16	0	0	0	4	0	0	TCGA-V4-A9EC-01	39	0.03076952584137588	5	TCGA-V4-A9EC-01	1	1	11	0.012573669976382115	TCGA-V4-A9EC-01	1	0	1	2	PASS	11089	TCGA-V4-A9EC	UVM	75	FEMALE	WHITE	Stage IIB	Stage IIB	Spindle Cell	NA	2012	NA	-27655	Alive	TUMOR FREE	743	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	743	0	743	NA	NA	0	743	
50	TCGA-V4-A9ED	0	2	0	1	0	0	0	0	2	5	1	0	0	3	0	0	TCGA-V4-A9ED-01	67	0.1097294842183238	27	TCGA-V4-A9ED-01	2	1	29	0.07179422023589438	TCGA-V4-A9ED-01	0	0	0	0	PASS	11090	TCGA-V4-A9ED	UVM	45	MALE	WHITE	Stage IIIA	Stage IIIA	Spindle Cell	NA	2012	NA	-16528	Alive	TUMOR FREE	1078	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1078	0	1078	NA	NA	0	1078	
90	TCGA-V4-A9EE	0	1	0	0	1	0	0	0	1	12	0	0	0	8	0	0	TCGA-V4-A9EE-01	70	0.25807454089092435	30	TCGA-V4-A9EE-01	5	6	38	0.12999407968380458	TCGA-V4-A9EE-01	3	0	2	5	PASS	11091	TCGA-V4-A9EE	UVM	86	MALE	WHITE	Stage IIB	Stage IIB	Epithelioid Cell	NA	2012	NA	-31421	Dead	WITH TUMOR	NA	398	Metastatic Uveal Melanoma	Distant Metastasis	Liver	NA	211	NA	NA	NA	1	398	1	398	NA	NA	1	211	
60	TCGA-V4-A9EF	0	0	0	0	1	0	0	0	0	6	1	0	0	1	0	0	TCGA-V4-A9EF-01	42	0.10115848866536148	11	TCGA-V4-A9EF-01	3	3	15	0.07290007976636785	TCGA-V4-A9EF-01	1	0	0	1	PASS	11092	TCGA-V4-A9EF	UVM	56	MALE	WHITE	Stage IIIB	Stage IIIB	Spindle Cell	NA	2012	NA	-20763	Alive	TUMOR FREE	1165	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1165	0	1165	NA	NA	0	1165	
50	TCGA-V4-A9EH	0	0	0	0	0	1	0	0	1	7	1	0	0	3	0	0	TCGA-V4-A9EH-01	85	0.02185470342539601	37	TCGA-V4-A9EH-01	2	4	6	0.0010400091021997287	TCGA-V4-A9EH-01	0	0	0	0	PASS	11093	TCGA-V4-A9EH	UVM	53	MALE	WHITE	Stage IIIB	Stage IIIB	Spindle Cell	NA	2012	NA	-19573	Alive	TUMOR FREE	670	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	670	0	670	NA	NA	0	670	
80	TCGA-V4-A9EI	0	0	0	1	1	0	0	0	1	19	0	0	0	5	0	0	TCGA-V4-A9EI-01	88	0.2867806965355869	47	TCGA-V4-A9EI-01	9	11	31	0.1477607531002437	TCGA-V4-A9EI-01	4	1	3	8	PASS	11094	TCGA-V4-A9EI	UVM	78	MALE	WHITE	Stage IIIB	Stage IIIB	Epithelioid Cell	NA	2012	NA	-28562	Dead	WITH TUMOR	NA	389	Metastatic Uveal Melanoma	Distant Metastasis	Liver	NA	203	NA	NA	NA	1	389	1	389	NA	NA	1	203	
40	TCGA-V4-A9EJ	0	3	0	0	0	0	0	0	1	20	0	0	0	4	1	0	TCGA-V4-A9EJ-01	71	0.058144330414815315	31	TCGA-V4-A9EJ-01	1	4	18	0.036833913146430336	TCGA-V4-A9EJ-01	3	3	1	7	PASS	11095	TCGA-V4-A9EJ	UVM	38	MALE	WHITE	Stage IIB	Stage IIB	Spindle Cell	NA	2012	NA	-13958	Alive	TUMOR FREE	746	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	746	0	746	NA	NA	0	746	
40	TCGA-V4-A9EK	0	0	0	0	1	0	0	0	3	12	1	0	0	2	0	0	TCGA-V4-A9EK-01	156	0.6462183911361532	88	TCGA-V4-A9EK-01	5	8	27	0.029229594890997482	TCGA-V4-A9EK-01	5	5	1	11	PASS	11096	TCGA-V4-A9EK	UVM	37	FEMALE	WHITE	Stage IIB	Stage IIB	Spindle Cell	NA	2012	NA	-13731	Alive	TUMOR FREE	1028	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1028	0	1028	NA	NA	0	1028	
60	TCGA-V4-A9EL	0	0	0	1	1	0	0	0	0	3	1	0	0	2	1	0	TCGA-V4-A9EL-01	72	0.16904790380360984	32	TCGA-V4-A9EL-01	6	6	37	0.1433048842894728	TCGA-V4-A9EL-01	3	2	3	8	PASS	11097	TCGA-V4-A9EL	UVM	60	MALE	WHITE	Stage IIIA	Stage IIIA	Epithelioid Cell	NA	2012	NA	-22150	Alive	WITH TUMOR	982	NA	NA	Distant Metastasis	Liver	NA	413	NA	NA	NA	0	982	0	982	NA	NA	1	413	
50	TCGA-V4-A9EM	0	0	0	1	1	0	1	0	0	15	1	0	0	3	0	0	TCGA-V4-A9EM-01	48	0.4308079493162308	11	TCGA-V4-A9EM-01	4	3	8	0.00022342640351357822	TCGA-V4-A9EM-01	1	1	0	2	PASS	11098	TCGA-V4-A9EM	UVM	53	MALE	WHITE	Stage IIIA	Stage IIIA	Epithelioid Cell	NA	2012	NA	-19413	Alive	TUMOR FREE	966	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	966	0	966	NA	NA	0	966	
70	TCGA-V4-A9EO	0	0	0	3	0	0	0	0	0	12	1	0	0	5	0	0	TCGA-V4-A9EO-01	67	0.9476552771650406	20	TCGA-V4-A9EO-01	23	13	16	0.07256589488603524	TCGA-V4-A9EO-01	2	1	0	3	PASS	11099	TCGA-V4-A9EO	UVM	74	MALE	WHITE	Stage IIIA	Stage IIIA	Epithelioid Cell|Spindle Cell	NA	2013	NA	-27190	Alive	TUMOR FREE	773	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	773	0	773	NA	NA	0	773	
60	TCGA-V4-A9EQ	0	0	0	0	0	0	0	0	0	9	0	0	0	4	0	0	TCGA-V4-A9EQ-01	93	0.1694143762118755	48	TCGA-V4-A9EQ-01	5	4	34	0.11547448609311065	TCGA-V4-A9EQ-01	2	0	1	3	PASS	11100	TCGA-V4-A9EQ	UVM	64	MALE	WHITE	Stage IIIA	Stage IIIA	Epithelioid Cell|Spindle Cell	NA	2010	NA	-23408	Dead	WITH TUMOR	NA	455	Metastatic Uveal Melanoma	Distant Metastasis	Liver	NA	252	NA	NA	NA	1	455	1	455	NA	NA	1	252	
50	TCGA-V4-A9ES	0	0	0	0	0	0	0	0	0	12	0	0	0	0	0	0	TCGA-V4-A9ES-01	98	0.9998789597370652	53	TCGA-V4-A9ES-01	6	5	56	0.1794079812243323	TCGA-V4-A9ES-01	1	2	2	5	PASS	11101	TCGA-V4-A9ES	UVM	54	FEMALE	WHITE	Stage IIIA	Stage IIIA	Epithelioid Cell|Spindle Cell	NA	2011	NA	-20054	Alive	WITH TUMOR	1511	NA	NA	Distant Metastasis	Liver	NA	1299	NA	NA	NA	0	1511	0	1511	NA	NA	1	1299	
60	TCGA-V4-A9ET	0	0	1	1	0	0	0	0	0	7	0	0	0	5	0	0	TCGA-V4-A9ET-01	100	0.12283159033276375	43	TCGA-V4-A9ET-01	3	6	19	0.04010522345231495	TCGA-V4-A9ET-01	5	3	1	9	PASS	11102	TCGA-V4-A9ET	UVM	57	MALE	WHITE	Stage IIIB	Stage IIIB	Spindle Cell|Epithelioid Cell	NA	2011	NA	-21113	Alive	TUMOR FREE	1362	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1362	0	1362	NA	NA	0	1362	
80	TCGA-V4-A9EU	0	0	0	0	0	0	0	0	1	8	1	0	0	2	0	0	TCGA-V4-A9EU-01	129	0.26198436115816753	77	TCGA-V4-A9EU-01	9	8	53	0.15535592747346713	TCGA-V4-A9EU-01	4	0	4	8	PASS	11103	TCGA-V4-A9EU	UVM	83	FEMALE	WHITE	Stage IIIC	Stage IIIC	Epithelioid Cell	NA	2011	NA	-30409	Alive	TUMOR FREE	709	NA	NA	New Primary Tumor	"Other, specify"	Biliary	86	NA	NA	NA	0	709	0	709	NA	NA	1	86	
60	TCGA-V4-A9EV	0	0	0	1	0	0	0	0	1	4	3	0	1	2	0	0	TCGA-V4-A9EV-01	52	0.10118976653174733	12	TCGA-V4-A9EV-01	3	4	20	0.08197369914325771	TCGA-V4-A9EV-01	2	1	1	4	PASS	11104	TCGA-V4-A9EV	UVM	59	FEMALE	WHITE	Stage IIIA	Stage IIIA	Spindle Cell|Epithelioid Cell	NA	2012	NA	-21855	Dead	WITH TUMOR	NA	1269	Metastatic Uveal Melanoma	NA	NA	NA	NA	NA	NA	NA	1	1269	1	1269	NA	NA	1	1269	
40	TCGA-V4-A9EW	0	1	0	0	0	0	1	0	0	7	0	0	0	4	1	0	TCGA-V4-A9EW-01	37	0.2993778920466525	3	TCGA-V4-A9EW-01	2	5	21	0.10455451516993568	TCGA-V4-A9EW-01	6	6	5	17	PASS	11105	TCGA-V4-A9EW	UVM	44	FEMALE	WHITE	Stage IIIA	Stage IIIA	Spindle Cell|Epithelioid Cell	NA	2012	NA	-16140	Alive	WITH TUMOR	1211	NA	NA	Distant Metastasis	Liver	NA	197	NA	NA	NA	0	1211	0	1211	NA	NA	1	197	
60	TCGA-V4-A9EX	0	1	0	0	0	1	0	0	0	5	1	0	1	7	0	0	TCGA-V4-A9EX-01	117	0.22860215294856534	61	TCGA-V4-A9EX-01	7	9	66	0.1879234486413356	TCGA-V4-A9EX-01	6	4	4	14	PASS	11106	TCGA-V4-A9EX	UVM	55	FEMALE	WHITE	Stage IIIA	Stage IIIA	Epithelioid Cell	NA	2012	NA	-20447	Dead	WITH TUMOR	NA	730	Metastatic Uveal Melanoma	Distant Metastasis	Liver	NA	381	NA	NA	NA	1	730	1	730	NA	NA	1	381	
70	TCGA-V4-A9EY	0	1	0	0	0	0	1	0	1	15	0	0	0	1	0	0	TCGA-V4-A9EY-01	59	0.009390164489831172	22	TCGA-V4-A9EY-01	0	0	15	0.0013573351730486606	TCGA-V4-A9EY-01	1	1	0	2	PASS	11107	TCGA-V4-A9EY	UVM	66	FEMALE	WHITE	Stage IIIA	Stage IIIA	Spindle Cell	NA	2012	NA	-24187	Alive	TUMOR FREE	837	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	837	0	837	NA	NA	0	837	
80	TCGA-V4-A9EZ	0	0	0	0	1	0	0	0	1	15	0	0	1	9	0	0	TCGA-V4-A9EZ-01	88	0.8747230257117238	39	TCGA-V4-A9EZ-01	6	5	58	0.16724493827632333	TCGA-V4-A9EZ-01	5	5	3	13	PASS	11108	TCGA-V4-A9EZ	UVM	78	FEMALE	WHITE	Stage IIB	Stage IIB	Spindle Cell|Epithelioid Cell	NA	2012	NA	-28619	Alive	TUMOR FREE	599	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	599	0	599	NA	NA	0	599	
60	TCGA-V4-A9F0	0	1	0	0	1	1	0	0	1	6	1	0	0	1	0	0	TCGA-V4-A9F0-01	87	0.22554327722287876	40	TCGA-V4-A9F0-01	5	3	44	0.11526045286197573	TCGA-V4-A9F0-01	1	0	1	2	PASS	11109	TCGA-V4-A9F0	UVM	59	MALE	WHITE	Stage IIIB	Stage IIIB	Epithelioid Cell|Spindle Cell	NA	2012	NA	-21675	Dead	WITH TUMOR	NA	945	Metastatic Uveal Melanoma	Distant Metastasis	Liver	NA	489	NA	NA	NA	1	945	1	945	NA	NA	1	489	
50	TCGA-V4-A9F1	0	0	0	0	0	1	0	0	0	6	1	0	0	3	0	0	TCGA-V4-A9F1-01	105	0.6213986969458273	55	TCGA-V4-A9F1-01	7	5	51	0.17149901311744453	TCGA-V4-A9F1-01	3	0	2	5	PASS	11110	TCGA-V4-A9F1	UVM	46	FEMALE	WHITE	Stage IIB	Stage IIB	Epithelioid Cell	NA	2012	NA	-16852	Alive	TUMOR FREE	938	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	938	0	938	NA	NA	0	938	
80	TCGA-V4-A9F2	0	1	1	0	0	0	0	0	0	5	0	0	0	2	0	0	TCGA-V4-A9F2-01	54	0.9471943572624041	14	TCGA-V4-A9F2-01	15	11	5	0.0013046776459279983	TCGA-V4-A9F2-01	1	1	0	2	PASS	11111	TCGA-V4-A9F2	UVM	78	FEMALE	WHITE	Stage IIIA	Stage IIIA	Spindle Cell	NA	2012	NA	-28832	Alive	TUMOR FREE	734	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	734	0	734	NA	NA	0	734	
50	TCGA-V4-A9F3	0	1	0	0	0	1	0	0	0	7	0	0	0	3	0	0	TCGA-V4-A9F3-01	49	0.2362280607176156	13	TCGA-V4-A9F3-01	6	4	22	0.12774122268217514	TCGA-V4-A9F3-01	4	1	2	7	PASS	11112	TCGA-V4-A9F3	UVM	49	FEMALE	WHITE	Stage IIIA	Stage IIIA	Epithelioid Cell	NA	2012	NA	-17997	Dead	WITH TUMOR	NA	873	NA	Distant Metastasis	Liver	NA	329	NA	NA	NA	1	873	1	873	NA	NA	1	329	
40	TCGA-V4-A9F4	0	1	0	0	0	0	0	0	0	18	0	0	0	3	0	0	TCGA-V4-A9F4-01	92	0.16419880614983584	46	TCGA-V4-A9F4-01	3	3	16	0.02835344924397096	TCGA-V4-A9F4-01	1	2	1	4	PASS	11113	TCGA-V4-A9F4	UVM	41	MALE	WHITE	Stage IIIA	Stage IIIA	Spindle Cell|Epithelioid Cell	NA	2013	NA	-15332	Alive	TUMOR FREE	634	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	634	0	634	NA	NA	0	634	
90	TCGA-V4-A9F5	0	1	0	0	0	0	0	0	0	6	1	0	0	3	0	0	TCGA-V4-A9F5-01	116	0.933060187795986	63	TCGA-V4-A9F5-01	7	6	55	0.17171552673168075	TCGA-V4-A9F5-01	4	0	3	7	PASS	11114	TCGA-V4-A9F5	UVM	85	FEMALE	WHITE	Stage IV	Stage IV	Epithelioid Cell|Spindle Cell	NA	2013	NA	-31314	Alive	WITH TUMOR	203	NA	NA	Distant Metastasis	Liver	NA	78	NA	NA	NA	0	203	0	203	NA	NA	1	78	
80	TCGA-V4-A9F7	0	2	0	0	0	0	0	0	0	11	2	0	0	3	0	0	TCGA-V4-A9F7-01	56	0.013805195785129887	15	TCGA-V4-A9F7-01	1	1	14	0.0051644892814656	TCGA-V4-A9F7-01	1	3	0	4	PASS	11115	TCGA-V4-A9F7	UVM	78	FEMALE	WHITE	Stage IIB	Stage IIB	Spindle Cell|Epithelioid Cell	NA	2011	NA	-28822	Alive	TUMOR FREE	1256	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1256	0	1256	NA	NA	0	1256	
70	TCGA-V4-A9F8	0	0	0	1	0	2	1	0	0	14	2	0	1	6	0	0	TCGA-V4-A9F8-01	71	0.2364616304778477	34	TCGA-V4-A9F8-01	8	6	43	0.1416311238764623	TCGA-V4-A9F8-01	1	4	3	8	PASS	11116	TCGA-V4-A9F8	UVM	68	MALE	WHITE	Stage IIIA	Stage IIIA	Epithelioid Cell|Spindle Cell	NA	2012	NA	-25168	Alive	TUMOR FREE	597	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	597	0	597	NA	NA	0	597	
40	TCGA-VD-A8K7	0	0	0	1	0	0	0	0	0	3	1	0	0	2	0	0	TCGA-VD-A8K7-01	44	0.027471815791770063	11	TCGA-VD-A8K7-01	1	2	4	0.0001500400175847512	TCGA-VD-A8K7-01	2	1	0	3	PASS	11117	TCGA-VD-A8K7	UVM	39	MALE	[Not Evaluated]	Stage IIIA	Stage IIIA	Spindle Cell	NA	2011	NA	-14294	Alive	TUMOR FREE	1459	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1459	0	1459	NA	NA	0	1459	
60	TCGA-VD-A8K8	0	0	0	0	1	0	0	0	0	11	1	0	0	2	0	0	TCGA-VD-A8K8-01	74	0.11572660867339502	32	TCGA-VD-A8K8-01	4	3	33	0.08906072245168123	TCGA-VD-A8K8-01	1	0	1	2	PASS	11118	TCGA-VD-A8K8	UVM	56	FEMALE	[Not Evaluated]	Stage IIB	Stage IIIA	Epithelioid Cell|Spindle Cell	NA	2011	NA	-20454	Dead	WITH TUMOR	NA	1377	Metastatic Uveal Melanoma	NA	NA	NA	NA	NA	NA	NA	1	1377	1	1377	NA	NA	1	1377	
70	TCGA-VD-A8K9	0	0	0	1	0	0	0	0	1	7	0	0	0	4	0	0	TCGA-VD-A8K9-01	87	0.11904741992028878	40	TCGA-VD-A8K9-01	2	7	13	0.0240663020651827	TCGA-VD-A8K9-01	5	5	2	12	PASS	11119	TCGA-VD-A8K9	UVM	71	FEMALE	[Not Evaluated]	Stage IIA	Stage IIB	Spindle Cell	NA	2011	NA	-26292	Alive	TUMOR FREE	1424	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1424	0	1424	NA	NA	0	1424	
30	TCGA-VD-A8KA	1	0	0	1	0	0	0	0	0	14	0	0	0	0	0	0	TCGA-VD-A8KA-01	74	0.17691887503471368	20	TCGA-VD-A8KA-01	3	4	22	0.04739702827637462	TCGA-VD-A8KA-01	4	2	1	7	PASS	11120	TCGA-VD-A8KA	UVM	22	MALE	[Not Evaluated]	Stage IIB	Stage IIB	Spindle Cell|Epithelioid Cell	NA	2011	NA	-8271	Alive	WITH TUMOR	1178	NA	NA	Distant Metastasis	Liver	NA	1008	NA	NA	NA	0	1178	0	1178	NA	NA	1	1008	
70	TCGA-VD-A8KB	0	2	0	0	0	0	0	0	0	14	1	0	0	6	0	0	TCGA-VD-A8KB-01	84	0.09437478109359418	39	TCGA-VD-A8KB-01	2	5	15	0.03647908766600793	TCGA-VD-A8KB-01	3	3	1	7	PASS	11121	TCGA-VD-A8KB	UVM	66	FEMALE	[Not Evaluated]	Stage IIB	Stage IIB	Epithelioid Cell|Spindle Cell	NA	2011	NA	-24393	Alive	TUMOR FREE	1354	NA	NA	Locoregional Recurrence	"Other, specify"	Choroid	1032	NA	NA	NA	0	1354	0	1354	NA	NA	1	1032	
70	TCGA-VD-A8KD	0	1	0	1	1	0	0	0	1	15	1	0	0	6	0	0	TCGA-VD-A8KD-01	66	0.12519908311921482	24	TCGA-VD-A8KD-01	4	2	22	0.08003122595852936	TCGA-VD-A8KD-01	0	2	1	3	PASS	11122	TCGA-VD-A8KD	UVM	72	MALE	[Not Evaluated]	Stage IV	Stage IV	Epithelioid Cell|Spindle Cell	NA	2012	NA	-26457	Dead	WITH TUMOR	NA	114	Metastatic Uveal Melanoma	Distant Metastasis	Liver	NA	-4	NA	NA	NA	1	114	1	114	NA	NA	1	NA	
70	TCGA-VD-A8KE	1	0	0	0	0	0	0	0	0	13	0	0	0	8	1	0	TCGA-VD-A8KE-01	62	0.11353203993311176	21	TCGA-VD-A8KE-01	4	2	7	0.0015042990269640644	TCGA-VD-A8KE-01	0	0	0	0	PASS	11123	TCGA-VD-A8KE	UVM	74	FEMALE	[Not Evaluated]	Stage IIA	Stage IIA	Epithelioid Cell|Spindle Cell	NA	2012	NA	-27290	Alive	TUMOR FREE	821	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	821	0	821	NA	NA	0	821	
70	TCGA-VD-A8KF	0	0	0	1	0	0	0	0	0	5	1	0	0	2	0	0	TCGA-VD-A8KF-01	90	0.17013608384637227	41	TCGA-VD-A8KF-01	6	3	39	0.08661163165310103	TCGA-VD-A8KF-01	1	0	3	4	PASS	11124	TCGA-VD-A8KF	UVM	68	MALE	[Not Evaluated]	Stage IIIB	Stage IIIB	Epithelioid Cell	NA	2013	NA	-25066	Dead	WITH TUMOR	NA	40	Metastatic Uveal Melanoma	NA	NA	NA	NA	NA	NA	NA	1	40	1	40	NA	NA	1	40	
50	TCGA-VD-A8KG	0	0	0	1	0	0	0	0	0	12	3	0	0	4	1	0	TCGA-VD-A8KG-01	141	0.145746611304643	83	TCGA-VD-A8KG-01	4	8	19	0.001889235937518409	TCGA-VD-A8KG-01	2	2	0	4	PASS	11125	TCGA-VD-A8KG	UVM	47	FEMALE	[Not Evaluated]	Stage IIA	Stage IIA	Spindle Cell	NA	2012	NA	-17417	Alive	TUMOR FREE	19	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	19	0	19	NA	NA	0	19	
70	TCGA-VD-A8KH	0	0	0	0	0	1	0	0	0	12	1	0	0	7	0	0	TCGA-VD-A8KH-01	203	0.6854126970716314	139	TCGA-VD-A8KH-01	3	5	94	0.12881562149609413	TCGA-VD-A8KH-01	2	4	4	10	PASS	11126	TCGA-VD-A8KH	UVM	69	MALE	[Not Evaluated]	Stage IIIB	Stage IIIB	Epithelioid Cell|Spindle Cell	NA	2012	NA	-25388	Alive	TUMOR FREE	1158	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1158	0	1158	NA	NA	0	1158	
70	TCGA-VD-A8KI	0	0	0	0	1	0	0	0	0	18	1	0	0	7	0	0	TCGA-VD-A8KI-01	88	0.2014461952367496	44	TCGA-VD-A8KI-01	7	5	48	0.12631370800937886	TCGA-VD-A8KI-01	3	0	2	5	PASS	11127	TCGA-VD-A8KI	UVM	68	MALE	[Not Evaluated]	Stage IIB	Stage IIB	Epithelioid Cell|Spindle Cell	NA	2012	NA	-24966	Dead	WITH TUMOR	NA	1113	Metastatic Uveal Melanoma	NA	NA	NA	NA	NA	NA	NA	1	1113	1	1113	NA	NA	1	1113	
50	TCGA-VD-A8KJ	0	0	0	0	0	0	0	0	0	10	1	0	1	1	0	0	TCGA-VD-A8KJ-01	1444	0.18735535009052312	1359	TCGA-VD-A8KJ-01	5	3	536	0.04122869901945973	TCGA-VD-A8KJ-01	4	2	1	7	PASS	11128	TCGA-VD-A8KJ	UVM	53	MALE	[Not Evaluated]	Stage IIB	Stage IIB	Spindle Cell|Epithelioid Cell	NA	2011	NA	-19562	Alive	TUMOR FREE	1150	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1150	0	1150	NA	NA	0	1150	
50	TCGA-VD-A8KK	0	0	0	0	1	0	0	0	0	11	1	0	0	3	1	0	TCGA-VD-A8KK-01	52	0.11651428150074306	18	TCGA-VD-A8KK-01	2	2	14	0.0715572166418589	TCGA-VD-A8KK-01	0	1	0	1	PASS	11129	TCGA-VD-A8KK	UVM	54	MALE	[Not Evaluated]	Stage IIIA	Stage IIIA	Spindle Cell	NA	2013	NA	-19958	Alive	TUMOR FREE	64	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	64	0	64	NA	NA	0	64	
80	TCGA-VD-A8KL	0	1	1	0	2	1	0	0	0	16	1	0	0	2	0	0	TCGA-VD-A8KL-01	64	0.6713935295223811	27	TCGA-VD-A8KL-01	20	18	26	0.0728661501619422	TCGA-VD-A8KL-01	1	0	2	3	PASS	11130	TCGA-VD-A8KL	UVM	77	FEMALE	[Not Evaluated]	Stage IIB	Stage IIB	Spindle Cell|Epithelioid Cell	NA	2013	NA	-28450	Alive	TUMOR FREE	638	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	638	0	638	NA	NA	0	638	
70	TCGA-VD-A8KM	0	0	0	0	0	0	0	0	2	9	0	0	1	6	1	0	TCGA-VD-A8KM-01	92	0.18908193528957346	36	TCGA-VD-A8KM-01	9	7	38	0.1061800820749646	TCGA-VD-A8KM-01	5	1	2	8	PASS	11131	TCGA-VD-A8KM	UVM	65	MALE	[Not Evaluated]	Stage IIB	Stage IIB	Epithelioid Cell	NA	2013	NA	-24047	Alive	TUMOR FREE	4	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	4	0	4	NA	NA	0	4	
60	TCGA-VD-A8KN	0	0	0	1	0	0	0	0	0	9	1	0	1	2	0	0	TCGA-VD-A8KN-01	76	0.12031536870694153	29	TCGA-VD-A8KN-01	3	3	19	0.07258296837456535	TCGA-VD-A8KN-01	1	0	0	1	PASS	11132	TCGA-VD-A8KN	UVM	60	FEMALE	[Not Evaluated]	Stage IIA	Stage IIB	Epithelioid Cell|Spindle Cell	NA	2013	NA	-21935	Alive	TUMOR FREE	68	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	68	0	68	NA	NA	0	68	
50	TCGA-VD-A8KO	0	1	0	0	2	0	1	0	0	5	0	0	1	3	0	0	TCGA-VD-A8KO-01	88	0.04634583382344283	40	TCGA-VD-A8KO-01	2	2	10	0.00834863356916264	TCGA-VD-A8KO-01	2	2	1	5	PASS	11133	TCGA-VD-A8KO	UVM	51	MALE	[Not Evaluated]	Stage IIA	Stage IIIA	Spindle Cell	NA	2012	NA	-18844	Alive	TUMOR FREE	795	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	795	0	795	NA	NA	0	795	
60	TCGA-VD-AA8M	0	1	0	0	0	0	0	0	0	21	0	0	1	3	0	0	TCGA-VD-AA8M-01	81	0.02051796379739173	32	TCGA-VD-AA8M-01	0	0	17	0.010089448206482223	TCGA-VD-AA8M-01	1	1	1	3	PASS	11134	TCGA-VD-AA8M	UVM	64	MALE	[Not Evaluated]	Stage IIA	Stage IIB	Spindle Cell|Epithelioid Cell	NA	2013	NA	-23507	Alive	TUMOR FREE	6	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	6	0	6	NA	NA	0	6	
90	TCGA-VD-AA8N	0	0	0	0	0	0	1	0	1	5	1	0	0	2	0	0	TCGA-VD-AA8N-01	64	0.23276705728169866	21	TCGA-VD-AA8N-01	6	7	40	0.1944529151371111	TCGA-VD-AA8N-01	1	1	3	5	PASS	11135	TCGA-VD-AA8N	UVM	86	MALE	[Not Evaluated]	Stage IIB	Stage IIIA	Epithelioid Cell|Spindle Cell	NA	2013	NA	-31475	Alive	TUMOR FREE	44	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	44	0	44	NA	NA	0	44	
80	TCGA-VD-AA8O	0	0	0	0	0	0	0	0	1	13	1	0	0	4	0	0	TCGA-VD-AA8O-01	94	0.9136265718147448	46	TCGA-VD-AA8O-01	24	20	77	0.2730119300919882	TCGA-VD-AA8O-01	0	1	1	2	PASS	11136	TCGA-VD-AA8O	UVM	77	MALE	[Not Evaluated]	Stage IIB	Stage IIB	Epithelioid Cell|Spindle Cell	NA	2013	NA	-28250	Dead	WITH TUMOR	NA	606	Metastatic Uveal Melanoma	NA	NA	NA	NA	NA	NA	NA	1	606	1	606	NA	NA	1	606	
60	TCGA-VD-AA8P	1	0	0	0	1	0	0	0	1	10	1	0	0	2	2	1	TCGA-VD-AA8P-01	78	0.4116183263235406	32	TCGA-VD-AA8P-01	8	6	43	0.16310103010482907	TCGA-VD-AA8P-01	5	1	2	8	PASS	11137	TCGA-VD-AA8P	UVM	64	FEMALE	[Not Evaluated]	Stage IIB	Stage IIB	Spindle Cell	NA	2013	NA	-23555	Alive	TUMOR FREE	86	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	86	0	86	NA	NA	0	86	
70	TCGA-VD-AA8Q	0	2	0	0	0	0	1	0	0	15	0	0	0	4	0	0	TCGA-VD-AA8Q-01	85	0.036781021063681474	33	TCGA-VD-AA8Q-01	3	2	16	0.017045235438397973	TCGA-VD-AA8Q-01	0	1	1	2	PASS	11138	TCGA-VD-AA8Q	UVM	71	MALE	[Not Evaluated]	Stage IIB	Stage IIB	Spindle Cell	NA	2013	NA	-26285	Dead	TUMOR FREE	NA	636	Metastatic Uveal Melanoma	NA	NA	NA	NA	NA	NA	NA	1	636	1	636	NA	NA	0	636	
80	TCGA-VD-AA8R	0	0	0	0	0	0	0	0	0	10	1	0	0	4	0	0	TCGA-VD-AA8R-01	43	0.0001578490863853835	7	TCGA-VD-AA8R-01	0	0	4	0.0002764444779932045	TCGA-VD-AA8R-01	0	0	0	0	PASS	11139	TCGA-VD-AA8R	UVM	78	FEMALE	[Not Evaluated]	Stage IIB	Stage IIB	Spindle Cell	NA	2013	NA	-28841	Alive	TUMOR FREE	6	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	6	0	6	NA	NA	0	6	
40	TCGA-VD-AA8S	0	0	0	0	1	0	0	0	1	6	1	0	0	0	0	0	TCGA-VD-AA8S-01	89	0.9475517018415056	45	TCGA-VD-AA8S-01	10	8	8	0.0004731810054776671	TCGA-VD-AA8S-01	2	0	0	2	PASS	11140	TCGA-VD-AA8S	UVM	40	MALE	[Not Evaluated]	Stage IIA	Stage IIB	Spindle Cell	NA	2013	NA	-14681	Alive	TUMOR FREE	427	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	427	0	427	NA	NA	0	427	
80	TCGA-VD-AA8T	0	2	0	0	1	0	1	0	2	6	1	0	0	6	0	0	TCGA-VD-AA8T-01	95	0.1767610531108467	53	TCGA-VD-AA8T-01	5	4	34	0.1134333333856444	TCGA-VD-AA8T-01	2	1	2	5	PASS	11141	TCGA-VD-AA8T	UVM	83	FEMALE	[Not Evaluated]	Stage IIA	Stage IIB	Spindle Cell	NA	2013	NA	-30475	Alive	TUMOR FREE	49	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	49	0	49	NA	NA	0	49	
60	TCGA-WC-A87T	0	0	0	0	0	0	0	0	0	9	1	0	0	1	1	1	TCGA-WC-A87T-01	53	0.02556490312581827	14	TCGA-WC-A87T-01	0	0	14	0.01794787790879767	TCGA-WC-A87T-01	2	2	1	5	PASS	11142	TCGA-WC-A87T	UVM	64	MALE	WHITE	Stage IIB	Stage IIB	Spindle Cell|Epithelioid Cell	NA	2007	NA	-23409	Alive	TUMOR FREE	2600	NA	NA	New Primary Tumor	Skin	NA	2020	NA	NA	NA	0	2600	0	2600	NA	NA	1	2020	
70	TCGA-WC-A87U	0	1	0	0	0	0	0	0	0	13	0	0	0	5	0	0	TCGA-WC-A87U-01	52	0.01940266009874831	17	TCGA-WC-A87U-01	1	1	4	9.121890091827437e-05	TCGA-WC-A87U-01	1	0	0	1	PASS	11143	TCGA-WC-A87U	UVM	73	MALE	WHITE	Stage IIIA	Stage IIB	Spindle Cell	NA	2007	NA	-26933	Dead	WITH TUMOR	NA	1581	"Other, specify"	NA	NA	NA	NA	NA	NA	NA	1	1581	0	1581	NA	NA	1	1581	
60	TCGA-WC-A87W	1	1	0	0	0	1	0	0	0	6	0	0	0	3	1	0	TCGA-WC-A87W-01	75	0.19031395123265624	33	TCGA-WC-A87W-01	3	3	26	0.0927217529045601	TCGA-WC-A87W-01	2	0	2	4	PASS	11144	TCGA-WC-A87W	UVM	57	FEMALE	WHITE	Stage IIA	Stage IIA	Spindle Cell	NA	2010	NA	-20872	Alive	TUMOR FREE	1703	NA	NA	New Primary Tumor	Skin	NA	606	NA	NA	NA	0	1703	0	1703	NA	NA	1	606	
60	TCGA-WC-A87Y	0	0	0	0	0	0	0	0	0	9	0	0	0	3	0	0	TCGA-WC-A87Y-01	52	0.11571522399579398	12	TCGA-WC-A87Y-01	3	3	23	0.07131946026149544	TCGA-WC-A87Y-01	2	0	0	2	PASS	11145	TCGA-WC-A87Y	UVM	59	MALE	WHITE	NA	Stage IIIA	Spindle Cell|Epithelioid Cell	NA	2011	NA	-21865	Dead	TUMOR FREE	NA	1314	Metastatic Uveal Melanoma	NA	NA	NA	NA	NA	NA	NA	1	1314	1	1314	NA	NA	0	1314	
60	TCGA-WC-A880	0	1	0	1	0	0	0	0	0	9	0	0	0	2	0	0	TCGA-WC-A880-01	54	0.020081058393539374	19	TCGA-WC-A880-01	1	1	15	0.00862565313396034	TCGA-WC-A880-01	1	2	1	4	PASS	11146	TCGA-WC-A880	UVM	63	MALE	WHITE	Stage IIIA	Stage IIB	Epithelioid Cell|Spindle Cell	NA	2011	NA	-23325	Alive	TUMOR FREE	1258	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1258	0	1258	NA	NA	0	1258	
80	TCGA-WC-A881	0	1	0	0	1	0	0	0	0	10	0	0	0	3	1	0	TCGA-WC-A881-01	82	0.13880215300599105	36	TCGA-WC-A881-01	3	5	22	0.08162682436880485	TCGA-WC-A881-01	6	5	3	14	PASS	11147	TCGA-WC-A881	UVM	75	MALE	WHITE	Stage IIB	Stage IIB	Spindle Cell	NA	2011	NA	-27443	Alive	TUMOR FREE	1065	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1065	0	1065	NA	NA	0	1065	
50	TCGA-WC-A882	0	0	0	0	0	0	1	0	2	9	1	0	0	3	0	0	TCGA-WC-A882-01	55	0.23611926453406856	10	TCGA-WC-A882-01	4	4	41	0.12923623764802927	TCGA-WC-A882-01	2	1	1	4	PASS	11148	TCGA-WC-A882	UVM	50	FEMALE	WHITE	Stage IIB	Stage IIB	Spindle Cell	NA	2012	NA	-18612	Alive	TUMOR FREE	1112	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1112	0	1112	NA	NA	0	1112	
80	TCGA-WC-A883	0	1	0	0	0	0	0	1	0	8	0	0	1	2	1	0	TCGA-WC-A883-01	61	0.2314018133360009	20	TCGA-WC-A883-01	8	9	37	0.1466349451951667	TCGA-WC-A883-01	5	1	3	9	PASS	11149	TCGA-WC-A883	UVM	76	FEMALE	WHITE	Stage IIIA	Stage IIIC	Spindle Cell|Epithelioid Cell	NA	2012	NA	-27953	Dead	WITH TUMOR	NA	241	[Unknown]	NA	NA	NA	NA	NA	NA	NA	1	241	1	241	NA	NA	1	241	
40	TCGA-WC-A884	0	0	0	2	0	0	0	0	0	9	0	0	0	2	0	0	TCGA-WC-A884-01	129	0.07186872708143424	74	TCGA-WC-A884-01	3	3	24	0.02317953615093108	TCGA-WC-A884-01	2	2	1	5	PASS	11150	TCGA-WC-A884	UVM	35	FEMALE	WHITE	Stage IIIB	Stage IIIB	Epithelioid Cell|Spindle Cell	NA	2013	NA	-12840	Alive	TUMOR FREE	12	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	12	0	12	NA	NA	0	12	
60	TCGA-WC-A885	0	0	0	0	1	0	0	0	0	13	2	0	0	8	0	0	TCGA-WC-A885-01	58	0.04615127591970161	18	TCGA-WC-A885-01	1	4	2	9.88206190253418e-05	TCGA-WC-A885-01	3	3	0	6	PASS	11151	TCGA-WC-A885	UVM	60	MALE	WHITE	Stage IIA	Stage IIB	Spindle Cell	NA	2013	NA	-21978	Alive	TUMOR FREE	686	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	686	0	686	NA	NA	0	686	
80	TCGA-WC-A888	0	1	0	0	1	0	1	0	0	11	0	0	0	3	0	0	TCGA-WC-A888-01	56	0.15553211529216113	18	TCGA-WC-A888-01	1	1	12	0.001225736538029559	TCGA-WC-A888-01	1	0	0	1	PASS	11152	TCGA-WC-A888	UVM	76	MALE	WHITE	Stage IIB	Stage IIB	Epithelioid Cell|Spindle Cell	NA	2013	NA	-28117	Dead	TUMOR FREE	NA	575	NA	NA	NA	NA	NA	NA	NA	NA	1	575	0	575	NA	NA	0	575	
80	TCGA-WC-A88A	0	0	0	0	0	0	0	0	0	14	1	0	0	2	0	0	TCGA-WC-A88A-01	82	0.2450732134976287	36	TCGA-WC-A88A-01	7	7	45	0.14654832155312594	TCGA-WC-A88A-01	6	3	3	12	PASS	11153	TCGA-WC-A88A	UVM	75	MALE	WHITE	Stage IV	Stage IV	Spindle Cell|Epithelioid Cell	NA	2013	NA	-27722	Dead	WITH TUMOR	NA	82	Metastatic Uveal Melanoma	NA	NA	NA	NA	NA	NA	NA	1	82	1	82	NA	NA	1	82	
70	TCGA-WC-AA9A	0	0	0	2	0	0	0	0	1	10	1	0	0	0	0	0	TCGA-WC-AA9A-01	79	0.8876137608611806	40	TCGA-WC-AA9A-01	6	4	36	0.1370931113075651	TCGA-WC-AA9A-01	1	0	2	3	PASS	11154	TCGA-WC-AA9A	UVM	70	FEMALE	WHITE	Stage IIA	Stage IIA	Spindle Cell	NA	2011	NA	-25641	Dead	WITH TUMOR	NA	453	Metastatic Uveal Melanoma	Distant Metastasis	Skin	NA	371	NA	NA	NA	1	453	1	453	NA	NA	1	371	
60	TCGA-WC-AA9E	0	1	0	0	1	0	0	0	1	13	0	0	1	6	1	0	TCGA-WC-AA9E-01	75	0.4176130418642272	23	TCGA-WC-AA9E-01	7	6	35	0.1537648724438544	TCGA-WC-AA9E-01	6	0	5	11	PASS	11155	TCGA-WC-AA9E	UVM	60	MALE	WHITE	Stage IIA	Stage IIIC	Spindle Cell	NA	2013	NA	-21976	Alive	WITH TUMOR	838	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	838	0	838	NA	NA	0	838	
80	TCGA-YZ-A980	0	1	0	0	1	2	0	0	0	5	0	0	0	6	0	0	TCGA-YZ-A980-01	52	0.11586312082657632	10	TCGA-YZ-A980-01	4	2	28	0.08723374094384341	TCGA-YZ-A980-01	1	0	1	2	PASS	11156	TCGA-YZ-A980	UVM	75	MALE	WHITE	Stage IIIA	Stage IIIA	Spindle Cell|Epithelioid Cell	NA	2010	NA	-27716	Alive	TUMOR FREE	1862	NA	NA	New Primary Tumor	"Other, specify"	Scalp	1556	NA	NA	NA	0	1862	0	1862	NA	NA	1	1556	
80	TCGA-YZ-A982	0	1	1	0	0	0	0	0	0	20	1	0	1	1	0	0	TCGA-YZ-A982-01	63	0.4340237049749889	19	TCGA-YZ-A982-01	18	18	6	0.0015112654711834225	TCGA-YZ-A982-01	3	1	0	4	PASS	11157	TCGA-YZ-A982	UVM	79	FEMALE	WHITE	Stage IIIB	Stage IIIB	Spindle Cell	NA	2013	NA	-28938	Alive	TUMOR FREE	495	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	495	0	495	NA	NA	0	495	
50	TCGA-YZ-A983	0	0	0	0	0	0	0	0	0	17	0	0	0	5	0	0	TCGA-YZ-A983-01	78	0.02512197781380781	32	TCGA-YZ-A983-01	1	1	5	0.00035802644032342714	TCGA-YZ-A983-01	1	0	0	1	PASS	11158	TCGA-YZ-A983	UVM	51	FEMALE	WHITE	Stage IIB	Stage IIB	Epithelioid Cell	NA	2013	NA	-18769	Alive	TUMOR FREE	798	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	798	0	798	NA	NA	0	798	
50	TCGA-YZ-A984	0	0	0	0	1	0	0	0	0	6	1	0	0	2	0	0	TCGA-YZ-A984-01	68	0.7093237322349891	26	TCGA-YZ-A984-01	19	14	29	0.1083500443173232	TCGA-YZ-A984-01	2	4	3	9	PASS	11159	TCGA-YZ-A984	UVM	50	FEMALE	WHITE	Stage IIB	Stage IIIA	Spindle Cell|Epithelioid Cell	NA	2011	NA	-18342	Dead	WITH TUMOR	NA	1396	Metastatic Uveal Melanoma	New Primary Tumor	"Other, specify"	Thyroid	154	NA	NA	NA	1	1396	1	1396	NA	NA	1	154	
40	TCGA-YZ-A985	0	10	2	5	1	0	0	0	8	361	23	0	7	176	3	0	TCGA-YZ-A985-01	47	0.06730362694369481	12	TCGA-YZ-A985-01	2	1	22	0.07122270594217953	TCGA-YZ-A985-01	0	0	0	0	PASS	11160	TCGA-YZ-A985	UVM	41	FEMALE	WHITE	Stage IIIA	Stage IIIA	Spindle Cell	NA	2012	NA	-15164	Alive	TUMOR FREE	1184	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	1184	0	1184	NA	NA	0	1184	
